FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Koh, YC
   Kuo, LH
   Tung, YC
   Weerawatanakorn, M
   Pan, MH
AF Koh, Yen-Chun
   Kuo, Lee-Han
   Tung, Yen-Chen
   Weerawatanakorn, Monthana
   Pan, Min-Hsiung
TI Identification of Indicative Gut Microbial Guilds in a Natural Aging
   Mouse Model
SO ACS OMEGA
LA English
DT Article
ID FATTY LIVER-DISEASE; BACTERIUM
AB Gut microbial dysbiosis during later life may contribute to health conditions, possibly due to an increase in intestinal permeability, immune changes, and systemic inflammation. Mouse models have been employed to determine the influence of gut microbes on aging; however, suitable gut microbial indicators are currently lacking. Therefore, this study aimed to determine the gut microbial indicators and their potential guilds in a natural aging mouse model. In agreement with previous studies, alpha diversity indices-including observed OTUs, ACE, Chao1, and Simpson-were significantly lower in aged mice than in younger mice. The results of beta diversity analysis revealed the compositional differences between young and aged mice, and the MRPP, ANOSIM, and Adonis tests indicated that the results were representative. By employing ANCOM and LEfSe analyses, Bacteroides thetaiotaomicron (Bacteroides) and Anaeroplasma were identified as the indicators of young and aged mice, respectively. Notably, these indicators were still present after 3 months. The result of network analysis confirmed the negative correlation of these genera in mice, and the potential guild members were identified based on the increased abundance of Anaeroplasma in aged mice. The gut microbes of aged mice tend to correspond to those involved in human diseases, selenocompound metabolism, and glycolysis/gluconeogenesis in functional predictions. In this study, the gut microbial indicators in aged mice have been identified, and it is envisaged that these findings could provide a new approach for future studies of antiaging.
C1 [Koh, Yen-Chun; Kuo, Lee-Han; Pan, Min-Hsiung] Natl Taiwan Univ, Inst Food Sci & Technol, Taipei 10617, Taiwan.
   [Tung, Yen-Chen] Natl Ilan Univ, Dept Food Sci, Yilan 26041, Taiwan.
   [Weerawatanakorn, Monthana] Naresuan Univ, Fac Agr Nat Resources & Environm, Dept Agroind, Phitsanulok 65000, Thailand.
   [Pan, Min-Hsiung] China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung 40402, Taiwan.
   [Pan, Min-Hsiung] Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung 41354, Taiwan.
C3 National Taiwan University; National Ilan University; Naresuan
   University; China Medical University Taiwan; China Medical University
   Hospital - Taiwan; Asia University Taiwan
RP Pan, MH (corresponding author), Natl Taiwan Univ, Inst Food Sci & Technol, Taipei 10617, Taiwan.; Weerawatanakorn, M (corresponding author), Naresuan Univ, Fac Agr Nat Resources & Environm, Dept Agroind, Phitsanulok 65000, Thailand.; Pan, MH (corresponding author), China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung 40402, Taiwan.; Pan, MH (corresponding author), Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung 41354, Taiwan.
EM mhpan@ntu.edu.tw; monthanac@nu.ac.th
RI Pan, Min-Hsiung/AAT-8865-2021
OI Pan, Min-Hsiung/0000-0002-5188-7030; KOH, YEN CHUN/0000-0001-7683-873X;
   Tung, Yen-Chen/0000-0001-9055-5509
FU Ministry of Science and Technology, Taiwan [108-2321-B-002-020];
   Reinventing University Program, The Ministry of Higher Education,
   Science, Research and Innovation (MHESI), Thailand
FX This work was supported by the Ministry of Science and Technology,
   Taiwan [108-2321-B-002-020], and was partially supported by the
   Reinventing University Program 2023, The Ministry of Higher Education,
   Science, Research and Innovation (MHESI), Thailand.
CR Amamoto R, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-91917-6
   Asshauer KP, 2015, BIOINFORMATICS, V31, P2882, DOI 10.1093/bioinformatics/btv287
   Bonomini F, 2015, AGING DIS, V6, P109, DOI 10.14336/AD.2014.0305
   Charlet R, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-68214-9
   Chen YF, 2020, AGING-US, V12, P4778, DOI 10.18632/aging.102872
   DeJong EN, 2020, CELL HOST MICROBE, V28, P180, DOI 10.1016/j.chom.2020.07.013
   Delday M, 2019, INFLAMM BOWEL DIS, V25, P85, DOI 10.1093/ibd/izy281
   Deng FL, 2019, AGING-US, V11, P289, DOI 10.18632/aging.101771
   Dingeo G, 2020, FOOD FUNCT, V11, P8444, DOI [10.1039/D0FO01483D, 10.1039/d0fo01483d]
   Durack J, 2019, J EXP MED, V216, P20, DOI 10.1084/jem.20180448
   Figliuolo VR, 2017, LIFE SCI, V189, P29, DOI 10.1016/j.lfs.2017.09.014
   Fransen F, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01385
   Ghosh TS, 2020, GUT, V69, P1218, DOI 10.1136/gutjnl-2019-319654
   Hong Y, 2021, GUT MICROBES, V13, P1, DOI 10.1080/19490976.2021.1930874
   Jandhyala SM, 2015, WORLD J GASTROENTERO, V21, P8787, DOI 10.3748/wjg.v21.i29.8787
   Ju TT, 2019, ISME J, V13, P1520, DOI 10.1038/s41396-019-0364-5
   Kang L, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-84031-0
   Ke SL, 2021, NUTRIENTS, V13, DOI 10.3390/nu13093290
   Kim S, 2018, GERONTOLOGY, V64, P513, DOI 10.1159/000490615
   Koh YC, 2023, MOL NUTR FOOD RES, V67, DOI 10.1002/mnfr.202200700
   Kong FL, 2019, GUT MICROBES, V10, P210, DOI 10.1080/19490976.2018.1494102
   Kong FL, 2016, CURR BIOL, V26, pR832, DOI 10.1016/j.cub.2016.08.015
   Langille MG, 2014, MICROBIOME, V2, DOI 10.1186/s40168-014-0050-9
   Le Roy T, 2013, GUT, V62, P1787, DOI 10.1136/gutjnl-2012-303816
   Lee J, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0686-7
   Leite G, 2021, CELL REP, V36, DOI 10.1016/j.celrep.2021.109765
   Li XA, 2021, PHARMACOL RES, V168, DOI 10.1016/j.phrs.2021.105587
   Liguori I, 2018, CLIN INTERV AGING, V13, P757, DOI 10.2147/CIA.S158513
   Maffei VJ, 2017, J GERONTOL A-BIOL, V72, P1474, DOI 10.1093/gerona/glx042
   Mimee M, 2015, CELL SYST, V1, P62, DOI 10.1016/j.cels.2015.06.001
   Mu QH, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00757
   Munderloh UG, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00086
   Murros KE, 2021, FRONT CELL INFECT MI, V11, DOI 10.3389/fcimb.2021.652617
   Nilsson AG, 2018, J INTERN MED, V284, P307, DOI 10.1111/joim.12805
   Odamaki T, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0708-5
   Parkhitko AA, 2020, ELIFE, V9, DOI 10.7554/eLife.58053
   Porter NT, 2018, TRENDS MICROBIOL, V26, P966, DOI 10.1016/j.tim.2018.08.005
   Ragonnaud E, 2021, IMMUN AGEING, V18, DOI 10.1186/s12979-020-00213-w
   Ren MH, 2021, MICROORGANISMS, V9, DOI 10.3390/microorganisms9122524
   Rinninella E, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7010014
   Rizzatti G, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/9351507
   Sorgdrager FJH, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02565
   Townsend GE, 2020, MBIO, V11, DOI 10.1128/mBio.03221-19
   Valdes AM, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k2179
   Wang W, 2021, J AGR FOOD CHEM, V69, P2745, DOI 10.1021/acs.jafc.0c06730
   Wen KC, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.535310
   Wrzosek L, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-61
   Wu GJ, 2021, GENOME MED, V13, DOI 10.1186/s13073-021-00840-y
   Xu CM, 2019, BMC MICROBIOL, V19, DOI 10.1186/s12866-019-1616-2
   Yin J, 2021, J AGR FOOD CHEM, V69, P4732, DOI 10.1021/acs.jafc.1c00706
   Yin Ran, 2019, Curr Pharmacol Rep, V5, P332, DOI 10.1007/s40495-019-00196-3
   Zhan GF, 2019, AGING-US, V11, P1778, DOI 10.18632/aging.101871
NR 52
TC 0
Z9 0
U1 1
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2470-1343
J9 ACS OMEGA
JI ACS Omega
PD SEP 21
PY 2023
VL 8
IS 39
BP 36569
EP 36580
DI 10.1021/acsomega.3c05949
PG 12
WC Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry
GA T9FZ1
UT WOS:001080981400001
PM 37810685
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Ramsey, JJ
   Harper, ME
   Humble, SJ
   Koomson, EK
   Ram, JJ
   Bevilacqua, L
   Hagopian, K
AF Ramsey, JJ
   Harper, ME
   Humble, SJ
   Koomson, EK
   Ram, JJ
   Bevilacqua, L
   Hagopian, K
TI Influence of mitochondrial membrane fatty acid composition on proton
   leak and H<sub>2</sub>O<sub>2</sub> production in liver
SO COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR
   BIOLOGY
LA English
DT Article
DE aging; calorie restriction; corn oil; fish oil; lipid peroxidation;
   metabolic control analysis; protein carbonyls; reactive oxygen species
ID RAT-LIVER; DIETARY-FAT; CALORIC RESTRICTION; PEROXIDE PRODUCTION; BRAIN
   MITOCHONDRIA; HYDROGEN-PEROXIDE; FOOD RESTRICTION; INNER-MEMBRANE; AGING
   RATS; LIFE-SPAN
AB Mitochondrial membrane fatty acid composition has been proposed to play a role in determining mitochondrial proton leak rate. The purpose of this study was to determine if feeding rats diets with different fatty acid sources produces changes in liver proton leak and H2O2 production. Six-month-old male FBNF1 rats were fed diets with a primary fat source of either corn or fish oil for a 6-month period. As expected, diet manipulations produced substantial differences in mitochondrial fatty acid composition. These changes were most striking for 20:4n6 and 22:6n3. However, proton leak and phosphorylation kinetics as well as lipid and protein oxidative damage were not different (P>0.10) between fish and corn oil groups. Metabolic control analysis, however, did show that control of both substrate oxidation and phosphorylation was shifted away from substrate oxidation reactions to increased control by phosphorylation reactions in fish versus corn oil groups. Increased mitochondrial H2O2 production was observed in corn versus fish oil-fed rats when mitochondria were respiring on succinate alone or on either succinate or pyruvate/malate in the presence of antimycin A. These results show that mitochondrial H2O2 production and the regulation of oxidative phosphorylation are altered in liver mitochondria from rats consuming diets with either fish or corn oil as the primary lipid source. (C) 2004 Elsevier Inc. All rights reserved.
C1 Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, Davis, CA 95616 USA.
   Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada.
C3 University of California System; University of California Davis;
   University of Ottawa
RP Ramsey, JJ (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, Davis, CA 95616 USA.
EM jjramsey@ucdavis.edu
RI Harper, Mary-Ellen/C-3103-2009
OI Harper, Mary-Ellen/0000-0003-3864-5886
FU NIA NIH HHS [R01 AG-17902] Funding Source: Medline; NIDDK NIH HHS
   [DK-35747-17/04] Funding Source: Medline
CR BARZANTI V, 1994, BRIT J NUTR, V71, P193, DOI 10.1079/BJN19940126
   BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707
   BRAND MD, 1994, COMP BIOCHEM PHYS B, V108, P181, DOI 10.1016/0305-0491(94)90064-7
   Brookes PS, 1998, COMP BIOCHEM PHYS B, V119, P325, DOI 10.1016/S0305-0491(97)00357-X
   Brookes PS, 1998, J NEUROCHEM, V70, P2195
   Buege J A, 1978, Methods Enzymol, V52, P302
   CLANDININ MT, 1985, CAN J PHYSIOL PHARM, V63, P546, DOI 10.1139/y85-094
   Fontaine EM, 1996, BBA-BIOENERGETICS, V1276, P181, DOI 10.1016/0005-2728(96)00075-8
   HAFNER RP, 1990, EUR J BIOCHEM, V188, P313, DOI 10.1111/j.1432-1033.1990.tb15405.x
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HARPER ME, 1995, P SOC EXP BIOL MED, V208, P228
   Herrero A, 2001, MECH AGEING DEV, V122, P427, DOI 10.1016/S0047-6374(01)00214-7
   Hoch FL, 1998, J BIOENERG BIOMEMBR, V30, P511, DOI 10.1023/A:1020576315771
   HUERTAS JR, 1991, FEBS LETT, V287, P89, DOI 10.1016/0014-5793(91)80022-U
   Hulbert AJ, 2003, J EXP BIOL, V206, P2303, DOI 10.1242/jeb.00399
   HYSLOP PA, 1984, ANAL BIOCHEM, V141, P280, DOI 10.1016/0003-2697(84)90457-3
   INNIS SM, 1981, BIOCHEM J, V193, P155, DOI 10.1042/bj1930155
   IVANOV AS, 1977, BIOFIZIKA+, V22, P621
   JONES PJH, 1995, J NUTR, V125, P1175
   LAGANIERE S, 1993, GERONTOLOGY, V39, P7, DOI 10.1159/000213509
   LAGANIERE S, 1989, MECH AGEING DEV, V48, P207, DOI 10.1016/0047-6374(89)90083-3
   Lal SB, 2001, J GERONTOL A-BIOL, V56, pB116, DOI 10.1093/gerona/56.3.B116
   LEVINE RL, 1990, METHOD ENZYMOL, V186, P464
   López-Torres M, 2002, FREE RADICAL BIO MED, V32, P882, DOI 10.1016/S0891-5849(02)00773-6
   Mataix J., 1997, MOL ASPECTS MED, V18, P129
   Nedergaard J, 2003, EXP PHYSIOL, V88, P65, DOI 10.1113/eph8802502
   Pamplona R, 2002, ANN NY ACAD SCI, V959, P475, DOI 10.1111/j.1749-6632.2002.tb02118.x
   PAN DA, 1993, J NUTR, V123, P512, DOI 10.1093/jn/123.3.512
   Pehowich DJ, 1999, BBA-BIOENERGETICS, V1411, P192, DOI 10.1016/S0005-2728(99)00041-9
   Porter Jr, 2001, POPTRONICS, V2, P3
   Porter RK, 1996, AM J PHYSIOL-REG I, V271, pR1550, DOI 10.1152/ajpregu.1996.271.6.R1550
   Ramsey JJ, 2004, AM J PHYSIOL-ENDOC M, V286, pE31, DOI 10.1152/ajpendo.00283.2003
   ROBBLEE NM, 1984, J NUTR, V114, P263, DOI 10.1093/jn/114.2.263
   Rolfe DFS, 1997, BIOSCIENCE REP, V17, P9, DOI 10.1023/A:1027327015957
   SPECTOR AA, 1985, J LIPID RES, V26, P1015
   Stuart JA, 2001, BBA-BIOENERGETICS, V1504, P144, DOI 10.1016/S0005-2728(00)00243-7
   SU WF, 1993, J NUTR, V123, P2109
   TAHIN QS, 1981, EUR J BIOCHEM, V121, P5, DOI 10.1111/j.1432-1033.1981.tb06421.x
   Watkins SM, 2001, LIPIDS, V36, P247, DOI 10.1007/s11745-001-0714-8
   YAMAOKA S, 1988, J NUTR, V118, P290, DOI 10.1093/jn/118.3.290
   Yu BP, 2002, J NUTR SCI VITAMINOL, V48, P257, DOI 10.3177/jnsv.48.257
NR 41
TC 35
Z9 39
U1 0
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1096-4959
J9 COMP BIOCHEM PHYS B
JI Comp. Biochem. Physiol. B-Biochem. Mol. Biol.
PD JAN
PY 2005
VL 140
IS 1
BP 99
EP 108
DI 10.1016/j.cbpc.2004.09.016
PG 10
WC Biochemistry & Molecular Biology; Zoology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Zoology
GA 889JU
UT WOS:000226440100011
PM 15621515
DA 2024-02-19
ER

PT J
AU Sawaya, BE
   Aunis, D
   Schaeffer, E
AF Sawaya, BE
   Aunis, D
   Schaeffer, E
TI Distinct positive and negative regulatory elements control neuronal and
   hepatic transcription of the human transferrin gene
SO JOURNAL OF NEUROSCIENCE RESEARCH
LA English
DT Article
DE transferrin; gene expression; transcription; neuronal cells
ID HORMONE RECEPTOR SUPERFAMILY; CENTRAL NERVOUS-SYSTEM; NUCLEAR FACTOR-I;
   TRANSGENIC MICE; RAT-BRAIN; EXPRESSION; ENHANCER; PROMOTER; LIVER;
   BINDING
AB Transferrin (Tf), the iron-transport protein, plays an essential role in the central nervous system development, plasticity, and aging. As a first step toward elucidating the role of each transcription factor involved in the regulation of Tf gene expression, we have recently shown that similar promoter elements direct cell-type specific transcription in oligodendrocytes, epithelial choroid plexus cells, and in the neuronal cell line B103. Here we have analyzed the regulatory elements that control the level of expression of the Tf gene in neuronal cells. Transient expression experiments in B103 cells revealed that the -164/+1 promoter region is stimulated by a position-dependent -1140/-1000 upstream region. DNase I footprinting, gel retardation assays, and antibody reactivity data allowed us to characterize the nuclear factors interacting with this region, The upstream region I-binding protein (URI-BP) belongs to the steroid/ retinoid receptor family, while URII-BP is a member of the nuclear factor I (NF-I) family. Interestingly, no enhancer nor silencer activity is detected in B103 cells. This contrasts with our findings in hepatoma cells, where the activity of the -125/+1 promoter can be repressed by a -1000/-819 upstream negative-acting region and stimulated by the -3600/-3300 enhancer. We demonstrate that the negative-acting region presents the characteristics of a silencer that interacts with a nuclear protein present in liver and absent in B103 cells, Similarly, B103 cells lack a nuclear protein able to bind to an essential site of the enhancer. This shows that in B103 cells, the inactivity of the silencer and the enhancer regions results from the absence of at least one essential nuclear protein. (C) 1996 Wiley-Liss, Inc.
C1 CTR NEUROCHIM,INSERM,U338,F-67084 STRASBOURG,FRANCE.
   INST PASTEUR,UNITE EXPRESS GENES EUCARYOTES,PARIS,FRANCE.
C3 Universites de Strasbourg Etablissements Associes; Universite de
   Strasbourg; Institut National de la Sante et de la Recherche Medicale
   (Inserm); Le Reseau International des Instituts Pasteur (RIIP);
   Universite Paris Cite; Institut Pasteur Paris
RI Dominique, Aunis/W-1419-2019
CR ADRIAN GS, 1990, J BIOL CHEM, V265, P13344
   ADRIAN GS, 1986, GENE, V49, P167, DOI 10.1016/0378-1119(86)90277-5
   ALDRED AR, 1987, J BIOL CHEM, V262, P5293
   AMEMIYA K, 1992, J BIOL CHEM, V267, P14204
   AUGEGOUILLOU C, 1993, FEBS LETT, V323, P4, DOI 10.1016/0014-5793(93)81436-4
   BLOCH B, 1985, P NATL ACAD SCI USA, V82, P6706, DOI 10.1073/pnas.82.19.6706
   BOISSIER F, 1991, J BIOL CHEM, V266, P9822
   BRUNEL F, 1988, J BIOL CHEM, V263, P10180
   CHU HM, 1991, NUCLEIC ACIDS RES, V19, P2721, DOI 10.1093/nar/19.10.2721
   CONNOR JR, 1987, J NEUROSCI RES, V17, P51, DOI 10.1002/jnr.490170108
   CONNOR JR, 1990, J NEUROSCI RES, V27, P595, DOI 10.1002/jnr.490270421
   DELOSMONTEROS AE, 1988, INT J DEV NEUROSCI, V6, P167, DOI 10.1016/0736-5748(88)90042-1
   DELOSMONTEROS AE, 1989, J NEUROSCI RES, V24, P125, DOI 10.1002/jnr.490240202
   DELOSMONTEROS AE, 1994, J BIOL CHEM, V269, P24504
   DELOSMONTEROS AE, 1993, J NEUROSCI RES, V25, P576
   DURAND B, 1992, CELL, V71, P73, DOI 10.1016/0092-8674(92)90267-G
   EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939
   GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3
   GUILLOU F, 1991, J BIOL CHEM, V266, P9876
   HOYLE GW, 1994, J NEUROSCI, V14, P2455
   IDZERDA RL, 1989, MOL CELL BIOL, V9, P5154, DOI 10.1128/MCB.9.11.5154
   INOUE T, 1990, J BIOL CHEM, V265, P19065
   LAI E, 1990, GENE DEV, V4, P1427, DOI 10.1101/gad.4.8.1427
   LEVIN MJ, 1984, BIOCHEM BIOPH RES CO, V122, P212, DOI 10.1016/0006-291X(84)90461-3
   MADER S, 1993, EMBO J, V12, P5029, DOI 10.1002/j.1460-2075.1993.tb06196.x
   MAUE RA, 1990, NEURON, V4, P223, DOI 10.1016/0896-6273(90)90097-Y
   NAKABAYASHI H, 1991, MOL CELL BIOL, V11, P5885, DOI 10.1128/MCB.11.12.5885
   OH TH, 1986, DEV BRAIN RES, V30, P207, DOI 10.1016/0165-3806(86)90111-2
   RUPP RAW, 1990, NUCLEIC ACIDS RES, V18, P2607, DOI 10.1093/nar/18.9.2607
   SAWAYA BE, 1995, NUCLEIC ACIDS RES, V23, P2206, DOI 10.1093/nar/23.12.2206
   SCHAEFFER E, 1993, J BIOL CHEM, V268, P23399
   SCHAEFFER E, 1989, J BIOL CHEM, V264, P7153
   SCHUBERT D, 1974, NATURE, V249, P224, DOI 10.1038/249224a0
   SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353
   THEISEN M, 1993, MOL CELL BIOL, V13, P7666, DOI 10.1128/MCB.13.12.7666
   TSUTSUMI M, 1989, J BIOL CHEM, V264, P9626
   WANG LH, 1989, NATURE, V340, P163, DOI 10.1038/340163a0
   WILSON TE, 1993, MOL CELL BIOL, V13, P861, DOI 10.1128/MCB.13.2.861
NR 38
TC 15
Z9 17
U1 0
U2 0
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0360-4012
J9 J NEUROSCI RES
JI J. Neurosci. Res.
PD FEB 1
PY 1996
VL 43
IS 3
BP 261
EP 272
DI 10.1002/(SICI)1097-4547(19960201)43:3<261::AID-JNR1>3.0.CO;2-H
PG 12
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA TT530
UT WOS:A1996TT53000001
PM 8714515
DA 2024-02-19
ER

PT J
AU Chen, NY
   Liu, CW
   Lin, W
   Ding, Y
   Bian, ZY
   Huang, L
   Huang, H
   Yu, KH
   Chen, SB
   Sun, Y
   Wei, L
   Peng, JH
   Pan, SL
AF Chen, Ning-Yuan
   Liu, Cheng-Wu
   Lin, Wei
   Ding, Yi
   Bian, Zhang-ya
   Huang, Ling
   Huang, Hao
   Yu, Kai-Hui
   Chen, Si-Bang
   Sun, Yu
   Wei, Lei
   Peng, Jun-Hua
   Pan, Shang-Ling
TI Extract of Fructus Cannabis Ameliorates Learning and Memory Impairment
   Induced by D-Galactose in an Aging Rats Model
SO EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE
LA English
DT Article
ID ALZHEIMERS-DISEASE; OXIDATIVE STRESS; COGNITIVE IMPAIRMENT; TAU; MICE;
   HEMPSEED; PROTEIN; DAMAGE; BRAIN; PHOSPHORYLATION
AB Hempseed (Cannabis sativa L.) has been used as a health food and folk medicine in China for centuries. In the present study, we sought to define the underlying mechanism by which the extract of Fructus Cannabis (EFC) protects against memory impairment induced by D-galactose in rats. To accelerate aging and induce memory impairment in rats, D-galactose (400mg/kg) was injected intraperitoneally once daily for 14 weeks. EFC (200 and 400mg/kg) was simultaneously administered intragastrically once daily in an attempt to slow the aging process. We found that EFC significantly increased the activity of superoxide dismutase, while lowering levels of malondialdehyde in the hippocampus. Moreover, EFC dramatically elevated the organ indices of some organs, including the heart, the liver, the thymus, and the spleen. In addition, EFC improved the behavioral performance of rats treated with D-galactose in the Morris water maze. Furthermore, EFC inhibited the activation of astrocytes and remarkably attenuated phosphorylated tau and suppressed the expression of presenilin 1 in the brain of D-galactose-treated rats. These findings suggested that EFC exhibits beneficial effects on the cognition of aging rats probably by enhancing antioxidant capacity and anti-neuroinflammation, improving immune function, and modulating tau phosphorylation and presenilin expression.
C1 [Chen, Ning-Yuan; Liu, Cheng-Wu; Ding, Yi; Bian, Zhang-ya; Huang, Ling; Huang, Hao; Yu, Kai-Hui; Peng, Jun-Hua; Pan, Shang-Ling] Guangxi Med Univ, Sch Preclin Med, Dept Pathophysiol, Nanning, Peoples R China.
   [Liu, Cheng-Wu; Peng, Jun-Hua; Pan, Shang-Ling] Guangxi Coll & Univ Key Lab Human Dev & Dis Res, 22 Shuangyong Rd, Nanning 530021, Guangxi, Peoples R China.
   [Lin, Wei] Guangxi Jiangbin Hosp, Dept Neurol Rehabil, Nanning 530021, Guangxi, Peoples R China.
   [Chen, Si-Bang; Sun, Yu; Wei, Lei] Guangxi Med Univ, Clin Med Sch 1, Nanning 530021, Guangxi, Peoples R China.
C3 Guangxi Medical University; Guangxi Medical University
RP Peng, JH; Pan, SL (corresponding author), Guangxi Med Univ, Sch Preclin Med, Dept Pathophysiol, Nanning, Peoples R China.; Peng, JH; Pan, SL (corresponding author), Guangxi Coll & Univ Key Lab Human Dev & Dis Res, 22 Shuangyong Rd, Nanning 530021, Guangxi, Peoples R China.
EM pengjh@gxmu.edu.cn; sl.pan.berkeley@gmail.com
RI Pan, Shang-Ling/G-9581-2016
FU National Science Foundation of China [30860126, 31160209]; Innovation
   Project of Guangxi Graduate Education [YCBZ2015032]
FX The authors thank Si-Bang Chen, Yu Sun, Rong-Bo Liao, Chun-Yu Chen,
   Sheng-Ying Gu, Hui Qin, Yan-Fen Zhong, Yi-Tong Zhang, Li-Ting Li, Lei
   Wei, Shao-Xin Huang, Ying Liang, and Wei Lin for their assistance in
   animal feeding and Morris water maze test. This work was supported by
   the National Science Foundation of China (Grants nos. 30860126 and
   31160209) and Innovation Project of Guangxi Graduate Education (Grant
   no. YCBZ2015032).
CR Ali T, 2015, J PINEAL RES, V58, P71, DOI 10.1111/jpi.12194
   Auffret A, 2010, J ALZHEIMERS DIS, V19, P1021, DOI 10.3233/JAD-2010-1302
   Avila J, 2004, PHYSIOL REV, V84, P361, DOI 10.1152/physrev.00024.2003
   Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194
   Callaway JC, 2004, EUPHYTICA, V140, P65, DOI 10.1007/s10681-004-4811-6
   Chen Tianpeng, 2010, Journal of Dietary Supplements, V7, P117, DOI 10.3109/19390211003781669
   Chun W, 2007, FRONT BIOSCI-LANDMRK, V12, P733, DOI 10.2741/2097
   Çoban J, 2015, METAB BRAIN DIS, V30, P793, DOI 10.1007/s11011-014-9643-z
   Cui X, 2006, J NEUROSCI RES, V84, P647, DOI 10.1002/jnr.20899
   Dulcy CP, 2012, J NEUROSCI RES, V90, P2053, DOI 10.1002/jnr.23080
   Feng RT, 2001, MECH AGEING DEV, V122, P547, DOI 10.1016/S0047-6374(01)00232-9
   Gao J, 2015, BEHAV BRAIN RES, V293, P27, DOI 10.1016/j.bbr.2015.06.045
   Girgih AT, 2014, NUTRIENTS, V6, P5652, DOI 10.3390/nu6125652
   Girgih AT, 2014, EUR J NUTR, V53, P1237, DOI 10.1007/s00394-013-0625-4
   GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084
   Harman D, 2009, BIOGERONTOLOGY, V10, P773, DOI 10.1007/s10522-009-9234-2
   Kanasi E, 2016, PERIODONTOL 2000, V72, P13, DOI 10.1111/prd.12126
   Kim DH, 2014, GENE, V545, P185, DOI 10.1016/j.gene.2014.05.031
   Kumar Anil, 2011, Int J Alzheimers Dis, V2011, P347569, DOI 10.4061/2011/347569
   Kumar H, 2012, INT J MOL SCI, V13, P10478, DOI 10.3390/ijms130810478
   Lee MJ, 2011, MOL CELLS, V31, P337, DOI 10.1007/s10059-011-0042-6
   Lei M, 2008, NEUROREPORT, V19, P1611, DOI 10.1097/WNR.0b013e3283136a1f
   Li JJ, 2015, BRAIN RES, V1595, P19, DOI 10.1016/j.brainres.2014.10.012
   [林珍梅 Lin Zhenmei], 2016, [中药药理与临床, Pharmacology and Clinics of Chinese Materia Medica], V32, P130
   Lu J, 2010, CEREB CORTEX, V20, P2540, DOI 10.1093/cercor/bhq002
   Lü JM, 2010, J CELL MOL MED, V14, P840, DOI 10.1111/j.1582-4934.2009.00897.x
   Luo J, 2003, ACTA PHARMACOL SIN, V24, P1137
   Luo J, 2003, PHARMACOL BIOCHEM BE, V75, P749, DOI 10.1016/S0091-3057(03)00148-5
   Maas T, 2000, J BIOL CHEM, V275, P15733, DOI 10.1074/jbc.M000389200
   Oliveira BF, 2010, THESCIENTIFICWORLDJO, V10, P1121, DOI 10.1100/tsw.2010.94
   Peng JH, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-016-0393-0
   Pigino G, 2001, J NEUROSCI, V21, P834, DOI 10.1523/JNEUROSCI.21-03-00834.2001
   Qu Z, 2016, NEUROCHEM RES, V41, P2199, DOI 10.1007/s11064-016-1934-9
   Richard MN, 2007, J THROMB HAEMOST, V5, P424, DOI 10.1111/j.1538-7836.2007.02327.x
   Rizvi SI, 2007, MOL BIOTECHNOL, V37, P58, DOI 10.1007/s12033-007-0048-7
   Ruan QW, 2014, GERONTOLOGY, V60, P424, DOI 10.1159/000358235
   Su HM, 2010, J NUTR BIOCHEM, V21, P364, DOI 10.1016/j.jnutbio.2009.11.003
   Sun XY, 2005, NEURODEGENER DIS, V2, P6, DOI 10.1159/000086426
   Takashima A, 1998, P NATL ACAD SCI USA, V95, P9637, DOI 10.1073/pnas.95.16.9637
   Tian Y, 2011, FOOD CHEM TOXICOL, V49, P1728, DOI 10.1016/j.fct.2011.04.018
   Minh Doan V, 2015, FOOD FUNCT, V6, P1712, DOI [10.1039/C5FO00238A, 10.1039/c5fo00238a]
   Wang R, 2004, NEUROSCIENCE, V126, P305, DOI 10.1016/j.neuroscience.2004.03.048
   Wei HF, 2005, BEHAV BRAIN RES, V157, P245, DOI 10.1016/j.bbr.2004.07.003
   Wolfe MS, 2016, CELL, V166, P13, DOI 10.1016/j.cell.2016.06.034
   Xekardaki A, 2015, ADV EXP MED BIOL, V821, P11, DOI 10.1007/978-3-319-08939-3_6
   Xian YF, 2014, NEUROCHEM INT, V76, P42, DOI 10.1016/j.neuint.2014.06.011
   Yoo DY, 2012, J PINEAL RES, V52, P21, DOI 10.1111/j.1600-079X.2011.00912.x
   Zhang C. E., 2012, CHINESE J GERONTOLOG, V32, P742
   Zhang Y, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0250-7
NR 49
TC 16
Z9 18
U1 1
U2 28
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1741-427X
EI 1741-4288
J9 EVID-BASED COMPL ALT
JI Evid.-based Complement Altern. Med.
PY 2017
VL 2017
AR 4757520
DI 10.1155/2017/4757520
PG 13
WC Integrative & Complementary Medicine
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Integrative & Complementary Medicine
GA FK2HS
UT WOS:000413303900001
PM 29234402
OA Green Submitted, Green Published, gold
DA 2024-02-19
ER

PT J
AU Hadzi-Petrushev, N
   Jankulovski, N
   Milev, M
   Filipovska, P
   Gagov, H
   Gjorgievska, E
   Mitrov, D
   Sopi, R
   Hristov, K
   Mladenov, M
AF Hadzi-Petrushev, Nikola
   Jankulovski, Nikola
   Milev, Mishko
   Filipovska, Pavlina
   Gagov, Hristo
   Gjorgievska, Elizabeta
   Mitrov, Dine
   Sopi, Ramadan
   Hristov, Kiril
   Mladenov, Mitko
TI L-2-oxothiazolidine-4-carboxylate influence on age- and heat
   exposure-dependent peroxidation in rat's liver and kidney
SO JOURNAL OF THERMAL BIOLOGY
LA English
DT Article
DE Antioxidant enzymes; Aging; Heat exposure; Wistar rats; Glutathione
ID GLUTATHIONE-REDUCTASE; ANTIOXIDANT ENZYMES; OXIDATIVE STRESS; VITAMIN-C;
   HSP70
AB To investigate the impact of acute heat exposure on maintenance of redox homeostasis and antioxidant balance related to aging, we have determined the GSH levels in the liver and kidney, and the activity of antioxidant enzymes in the same organs from Wistar rats at two different ages, 35 days and 18 months. The animals were housed individually in a special heated chamber maintaining a constant temperature of 40 +/- 0.5 degrees C. The results showed that the level of endogenous GSH was significantly lower in aged than in young animals. In general, the activity of antioxidant enzymes in investigated tissues displayed an age-dependent decline. Indeed, we found unchanged CAT activity and decreased GPx activity with age. On the other hand acute heat exposure led to disproportion between peroxide metabolizing enzymes (CAT, GPx) and GR, thus promoting H2O2 accumulation and prooxidative state in the liver of young animals. The results for the impact of L-2-oxothiazolidine-4-carboxylate in combined stress model suggested that in spite of restore levels of GSH, the restoration of oxido-reductive balance might have only been partial due to irreversible alterations in antioxidant enzymes set by acute heat exposure and aging. Interestingly, young animals appeared to be more sensitive to the supplementation of the L-2-oxothiazolidine-4-carboxylate, likely because of the more extensive increase of GSH observed in young L-2-oxothiazolidine-4-carboxylate treated animals. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Hadzi-Petrushev, Nikola; Milev, Mishko; Filipovska, Pavlina; Sopi, Ramadan; Mladenov, Mitko] Sts Cyril & Methodius Univ, Fac Nat Sci & Math, Inst Biol, POB 162, Skopje 1000, North Macedonia.
   [Jankulovski, Nikola] Sts Cyril & Methodius Univ, Fac Med, Skopje 1000, North Macedonia.
   [Gagov, Hristo; Hristov, Kiril; Mladenov, Mitko] Bulgarian Acad Sci, Inst Biophys, Dept Membrane Ion Channels, BU-1113 Sofia, Bulgaria.
   [Gjorgievska, Elizabeta] Sts Cyril & Methodius Univ, Fac Med Dent, Skopje 1000, North Macedonia.
   [Mitrov, Dine] Sts Cyril & Methodius Univ, Fac Vet Med, Skopje 1000, North Macedonia.
C3 Saints Cyril & Methodius University of Skopje; Saints Cyril & Methodius
   University of Skopje; Bulgarian Academy of Sciences; Saints Cyril &
   Methodius University of Skopje; Saints Cyril & Methodius University of
   Skopje
RP Mladenov, M (corresponding author), Sts Cyril & Methodius Univ, Fac Nat Sci & Math, Inst Biol, POB 162, Skopje 1000, North Macedonia.
EM mitkom@pmf.ukim.mk
RI Gjorgievska, Elizabeta/GZL-2414-2022; Gagov, Hristo S/W-7112-2018; Sopi,
   Ramadan/GYU-9796-2022; Gjorgievska, Elizabeta/AAB-3080-2021; Mladennov,
   Mitko/HDM-7959-2022
OI Mladennov, Mitko/0000-0003-3475-2131; Gagov, Hristo/0000-0002-2759-7981
FU Ministry of Education and Research of Macedonia; Biological Institute in
   the Faculty of Natural Sciences at the University "St Cyril and
   Methodius" in Skopje
FX The authors gratefully acknowledge the financial support from the
   Ministry of Education and Research of Macedonia. The Biological
   Institute in the Faculty of Natural Sciences at the University "St Cyril
   and Methodius" in Skopje also supported this research.
CR AW TY, 1984, J BIOL CHEM, V259, P9355
   CHAWLA RK, 1984, GASTROENTEROLOGY, V87, P770
   Davidson JF, 2001, MOL CELL BIOL, V21, P8483, DOI 10.1128/MCB.21.24.8483-8489.2001
   Djordjevic J, 2010, PHYSIOL RES, V59, P729, DOI 10.33549/physiolres.931862
   GHIBELLI L, 1995, BIOCHEM BIOPH RES CO, V216, P313, DOI 10.1006/bbrc.1995.2626
   GOAD MEP, 1987, TOXICOL APPL PHARM, V90, P10
   Gutierrez-Correa J, 1997, FREE RADICAL RES, V27, P543, DOI 10.3109/10715769709097858
   Hadzi-Petrushev N, 2011, J PHYSIOL SCI, V61, P437, DOI 10.1007/s12576-011-0165-8
   Hall DM, 2001, AM J PHYSIOL-HEART C, V280, pH509, DOI 10.1152/ajpheart.2001.280.2.H509
   Hall DM, 2000, J APPL PHYSIOL, V89, P749, DOI 10.1152/jappl.2000.89.2.749
   Jose HJ, 1997, LIFE SCI, V60, P2059, DOI 10.1016/S0024-3205(97)00193-8
   KEW M, 1971, T ROY SOC TROP MED H, V65, P325, DOI 10.1016/0035-9203(71)90007-1
   KREGEL KC, 1995, J APPL PHYSIOL, V79, P1673, DOI 10.1152/jappl.1995.79.5.1673
   LOOS H, 1976, BLOOD, V48, P53
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MEISTER A, 1983, SCIENCE, V220, P472, DOI 10.1126/science.6836290
   Michel V, 2007, BRAIN RES, V1164, P63, DOI 10.1016/j.brainres.2007.06.011
   Mladenov M, 2008, J THERM BIOL, V33, P431, DOI 10.1016/j.jtherbio.2008.07.001
   Mladenov M, 2006, J THERM BIOL, V31, P588, DOI 10.1016/j.jtherbio.2006.08.001
   Morrison JP, 2005, AM J PHYSIOL-REG I, V289, pR1035, DOI 10.1152/ajpregu.00254.2005
   REED DJ, 1990, ANNU REV PHARMACOL, V30, P603, DOI 10.1146/annurev.pa.30.040190.003131
   Vergauwen B, 2003, J BACTERIOL, V185, P5555, DOI 10.1128/JB.185.18.5555-5562.2003
   Williamson J.M., 1991, P NATL ACAD SCI USA, V78, P936
   YEN TC, 1994, FREE RADICAL BIO MED, V16, P207, DOI 10.1016/0891-5849(94)90145-7
   Zhang HJ, 2003, FASEB J, V17, P2293, DOI 10.1096/fj.03-0139fje
   Zuo L, 2000, AM J PHYSIOL-CELL PH, V279, pC1058, DOI 10.1152/ajpcell.2000.279.4.C1058
NR 26
TC 9
Z9 9
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0306-4565
J9 J THERM BIOL
JI J. Therm. Biol.
PD AUG
PY 2012
VL 37
IS 5
BP 361
EP 365
DI 10.1016/j.jtherbio.2011.12.013
PG 5
WC Biology; Zoology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics; Zoology
GA 941PS
UT WOS:000303975700001
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Al-Shahari, EA
   ElBealy, ER
   Alkhazendar, AA
   Alm-Eldeen, AA
AF Al-Shahari, Eman A.
   ElBealy, Eman R.
   Alkhazendar, Abdelhalim A.
   Alm-Eldeen, Abeer A.
TI Quercetin Improves Liver Function, Decreases the Expression of
   Pro-apoptotic Proteins p53 and Bax and Increases the Antioxidant Defense
   of Hepatocytes in Aged Male Rats
SO PAKISTAN JOURNAL OF ZOOLOGY
LA English
DT Article
DE Liver; Aging; Oxidative stress; Apoptosis; Quercetin
ID OXIDATIVE STRESS; IMPAIRMENT; FIBROSIS; MODEL
AB Aging is a natural biological process that leads to deterioration in the liver structures and functions due to oxidative stress and the reduction in the oxidative damage's tolerance. Quercetin, a flavonoid has the ability to face the oxidative injury through its antioxidant activity. Therefore, the present study was designed to investigate the possible role of quercetin in modulating liver's function and structure in aged male rats. Forty eight male albino rats (3 and 30 months old) were used. Half of the rats at each age received 200 mg quercetin/Kg every other day for 2 weeks. Thirty months old rats showed a decrease in the liver AST, albumin, SOD, CAT and GPx while showed an increase in the liver ALT, plasma cholesterol and MDA comparing with 3 months old rats. The percentages of p53 and bax positive areas/ field were 26.04% and 24.9%, respectively. After quercetin administration, 30 months old rats showed non-significant change in the previous biochemical parameters compared with 3 months old rats and the percentages of p53 and bax positive areas/ field were 0.6% and 0.9%, respectively. In conclusion, quercetin at a dose of 200 mg/kg every other day for 2 weeks could improve liver function, decrease the expression of pro-apoptotic proteins p53 and bax and increase the antioxidant defense of hepatocytes in aged male rats.
C1 [Al-Shahari, Eman A.] King Khaled Univ, Fac Sci & Arts, Dept Biol, Abha, Saudi Arabia.
   [Al-Shahari, Eman A.] Ibb Univ, Fac Sci, Dept Biol, Ibb, Yemen.
   [ElBealy, Eman R.] King Khaled Univ, Coll Sci Girls, Biol Dept, Abha, Saudi Arabia.
   [Alkhazendar, Abdelhalim A.; Alm-Eldeen, Abeer A.] Tanta Univ, Fac Sci, Dept Zool, Tanta, Egypt.
C3 King Khalid University; Imam Abdulrahman Bin Faisal University; King
   Khalid University; Egyptian Knowledge Bank (EKB); Tanta University
RP Alm-Eldeen, AA (corresponding author), Tanta Univ, Fac Sci, Dept Zool, Tanta, Egypt.
EM abeer.eldeen@science.tanta.edu.eg
RI Elbealy, Eman/HGA-3375-2022
FU Deanship of Scientific Research at King Khaled University [G.R.P.
   245/1440]
FX The authors extend their appreciation to the Deanship of Scientific
   Research at King Khaled University for funding this work through general
   project under grant number (G.R.P. 245/1440).
CR Abdelhalim MAK, 2018, INT J NANOMED, V13, P2821, DOI 10.2147/IJN.S160995
   AEBI H, 1984, METHOD ENZYMOL, V105, P121
   Afifi NA, 2018, CAN J PHYSIOL PHARM, V96, P624, DOI 10.1139/cjpp-2017-0651
   Ahmad R.A., 2019, BRAZ J PHARM SCI, DOI DOI 10.1590/S2175-979020200003180861
   Alm-Eldeen AA, 2017, BIOMED PHARMACOTHER, V87, P247, DOI 10.1016/j.biopha.2016.12.084
   Alm-Eldeen AA, 2015, TOXICOL IND HEALTH, V31, P1269, DOI 10.1177/0748233713491807
   Bancroft JD., 1994, MANUAL HISTOLOGICAL
   Bao DK, 2017, MOLECULES, V22, DOI 10.3390/molecules22071122
   Buege J A, 1978, Methods Enzymol, V52, P302
   Dong YS, 2014, INT J MED SCI, V11, P282, DOI 10.7150/ijms.7634
   Dudek H, 2001, Przegl Lek, V58, P504
   Gambino V, 2013, AGING CELL, V12, P435, DOI 10.1111/acel.12060
   Hagen TM, 2003, ANTIOXID REDOX SIGN, V5, P503, DOI 10.1089/152308603770310149
   He LW, 2016, PHARM BIOL, V54, P3237, DOI 10.1080/13880209.2016.1223143
   Höhn A, 2013, REDOX BIOL, V1, P140, DOI 10.1016/j.redox.2013.01.006
   ITZHAKI RF, 1964, ANAL BIOCHEM, V9, P401, DOI 10.1016/0003-2697(64)90200-3
   Iwaisako K, 2012, J GASTROEN HEPATOL, V27, P65, DOI 10.1111/j.1440-1746.2011.07002.x
   Le Couteur DG, 2010, J GERONTOL A-BIOL, V65, P712, DOI 10.1093/gerona/glq082
   Lien EJ, 1999, FREE RADICAL BIO MED, V26, P285, DOI 10.1016/S0891-5849(98)00190-7
   Liu H, 2012, MOLECULES, V17, P4281, DOI 10.3390/molecules17044281
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   MIYASHITA T, 1994, ONCOGENE, V9, P1799
   PAGLIA DE, 1967, J LAB CLIN MED, V70, P158
   PAOLETTI F, 1990, METHOD ENZYMOL, V186, P209
   Park JH, 2016, FEBS LETT, V590, P924, DOI 10.1002/1873-3468.12061
   Park JY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002346
   Polat C, 2006, PROSTAG LEUKOTR ESS, V74, P379, DOI 10.1016/j.plefa.2006.03.007
   Poynard T, 2001, J HEPATOL, V34, P730, DOI 10.1016/S0168-8278(00)00097-0
   REITMAN S, 1957, AM J CLIN PATHOL, V28, P56, DOI 10.1093/ajcp/28.1.56
   Roos WP, 2013, CANCER LETT, V332, P237, DOI 10.1016/j.canlet.2012.01.007
   Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Sharma DR, 2016, NEUROSCIENCE, V324, P163, DOI 10.1016/j.neuroscience.2016.02.055
   Stahl EC, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02795
   Taskan Mehmet Murat, 2020, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, V19, P436, DOI 10.2174/1871523019666200124114503
   Taslidere E, 2016, BIOTECH HISTOCHEM, V91, P116, DOI 10.3109/10520295.2015.1085093
   Tieppo J, 2007, FOOD CHEM TOXICOL, V45, P1140, DOI 10.1016/j.fct.2006.12.020
   TIETZ NW, 1992, CLIN CHEM, V38, P1167
   Tinay I, 2017, LUTS, V9, P117, DOI 10.1111/luts.12125
   Tousson E, 2011, TOXICOL IND HEALTH, V27, P711, DOI 10.1177/0748233710395350
   Wu LW, 2017, BIOMED PHARMACOTHER, V96, P1137, DOI 10.1016/j.biopha.2017.11.109
   Zhong SZ, 2009, J NEUROL SCI, V277, P58, DOI 10.1016/j.jns.2008.10.008
   Zhu Q, 2007, ONCOGENE, V26, P4199, DOI 10.1038/sj.onc.1210191
NR 43
TC 0
Z9 0
U1 0
U2 0
PU ZOOLOGICAL SOC PAKISTAN
PI LAHORE
PA UNIV PUNJAB, NEW CAMPUS, C/O DEPT ZOOLOGY, LAHORE, PAKISTAN
SN 0030-9923
J9 PAK J ZOOL
JI Pak. J. Zool.
PD DEC
PY 2022
VL 54
IS 6
BP 2691
EP 2698
DI 10.17582/journal.pjz/20191117091137
PG 8
WC Zoology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Zoology
GA 6U3JP
UT WOS:000894264500015
OA gold
DA 2024-02-19
ER

PT J
AU Naito, H
   Kamijima, M
   Yamanoshita, O
   Nakahara, A
   Katoh, T
   Tanaka, N
   Aoyama, T
   Gonzalez, FJ
   Nakajima, T
AF Naito, Hisao
   Kamijima, Michihiro
   Yamanoshita, Osamu
   Nakahara, Ai
   Katoh, Takahiko
   Tanaka, Naoki
   Aoyama, Toshifumi
   Gonzalez, Frank J.
   Nakajima, Tamie
TI Differential effects of aging, drinking and exercise on serum
   cholesterol levels dependent on the <i>PPARA-V227A</i> polymorphism
SO JOURNAL OF OCCUPATIONAL HEALTH
LA English
DT Article
DE peroxisome proliferator-activated receptor alpha; alcohol drinking;
   aging; exercise; polymorphism; molecular epidemiology; cholesterol; sex;
   Japanese
ID PROLIFERATOR-ACTIVATED RECEPTOR; CORONARY HEART-DISEASE; ALCOHOLIC
   LIVER-DISEASE; ESTER TRANSFER PROTEIN; ALPHA PPAR-ALPHA; JAPANESE
   POPULATION; LIPOPROTEIN CONCENTRATIONS; CARDIOVASCULAR-DISEASE; LIPID
   CONCENTRATIONS; RISK-FACTORS
AB Peroxisome proliferator-activated receptor alpha (PPAR alpha) plays a pivotal role in lipid metabolism. Our previous study reported that PPARA-V227A was a major polymorphism in Japanese, which was associated with markedly lower serum total cholesterol (TC) levels, which were significantly affected by alcohol drinking compared to subjects with the wild-type (PPARA-WT) allele. However, serum lipids are also associated with aging and exercise frequency. The objective of the present study was to evaluate the relationship between PPARA-V227A and these factors. Genetic analysis of the polymorphism was performed in 1058 Japanese men and 281 women, and the relationship with aging, drinking and exercise on serum lipids was analyzed in 989 men and 245 women after exclusion criteria had been applied. In men, drinking increased high-density lipoprotein cholesterol (HDL-C) levels in both PPARA-WT and A227 carriers, but to a significantly higher degree in the latter. In women, TC and low-density lipoprotein cholesterol (LDL-C) levels in the A227 carriers drinking at least once a week were significantly higher than in PPARA-WT carriers. TC and LDL-C levels in males with PPARA-WT increased with aging regardless of drinking habit, while LDL-C levels in the A227 drinking carriers were significantly lower in 45-yr-old or older subjects than in 35- to 45-yr-olds. In addition, no effect of exercising was observed in the A227 carriers, while increase in the HDL-C of the PPARA-WT carriers was exercise frequency dependent. These results suggest that the influence of drinking, aging or exercise on TC, LDL-C and HDL-C levels in the A227 carriers may be different from those in the PPARA-WT subjects.
C1 Nagoya Univ, Grad Sch Med, Dept Environm & Occupat Hlth, Showa Ku, Nagoya, Aichi 4668550, Japan.
   Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, Kasugai, Aichi 487, Japan.
   Miyazaki Univ, Miyazaki Med Coll, Dept Publ Hlth, Miyazaki, Japan.
   Shinshu Univ, Grad Sch Med, Inst Aging & Adaptat, Inst Metab Regulat, Nagano, Japan.
   Natl Canc Inst, Lab Metab, NIH, Bethesda, MD 20892 USA.
C3 Nagoya University; Chubu University; University of Miyazaki; Shinshu
   University; National Institutes of Health (NIH) - USA; NIH National
   Cancer Institute (NCI)
RP Nakajima, T (corresponding author), Nagoya Univ, Grad Sch Med, Dept Environm & Occupat Hlth, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.
EM tnasu23@med.nagoya-u.ac.jp
OI Naito, Hisao/0000-0003-4228-637X; Gonzalez, Frank/0000-0002-7990-2140;
   Tanaka, Naoki/0000-0002-3212-3836; Nakajima, Tamie/0000-0002-0474-7019;
   Kamijima, Michihiro/0000-0003-0670-8790
CR Agarwal DP, 2002, ALCOHOL ALCOHOLISM, V37, P409, DOI 10.1093/alcalc/37.5.409
   [Anonymous], 1994, CIRCULATION
   [Anonymous], J CARDIOPULM REHABIL, DOI DOI 10.1097/00008483-200605000-00002
   [Anonymous], J CARDIOPULM REHABIL
   [Anonymous], J ARTERIOSCLEROSIS T
   Aoyama T, 1998, J BIOL CHEM, V273, P5678, DOI 10.1074/jbc.273.10.5678
   Arai H, 2005, J ATHEROSCLER THROMB, V12, P98, DOI 10.5551/jat.12.98
   CASTELLI WP, 1986, JAMA-J AM MED ASSOC, V256, P2835, DOI 10.1001/jama.256.20.2835
   CASTELLI WP, 1977, LANCET, V2, P153
   Chan E, 2006, ATHEROSCLEROSIS, V187, P309, DOI 10.1016/j.atherosclerosis.2005.10.002
   CHOUDHURY SR, 1994, INT J EPIDEMIOL, V23, P940, DOI 10.1093/ije/23.5.940
   CRAIG WY, 1989, BMJ-BRIT MED J, V298, P784, DOI 10.1136/bmj.298.6676.784
   de Grooth GJ, 2002, CIRCULATION, V105, P2159, DOI 10.1161/01.CIR.0000015857.31889.7B
   Durstine J Larry, 2002, J Cardiopulm Rehabil, V22, P385, DOI 10.1097/00008483-200211000-00002
   Flavell DM, 2000, DIABETOLOGIA, V43, P673, DOI 10.1007/s001250051357
   Fruchart JC, 2002, CURR OPIN LIPIDOL, V13, P605, DOI 10.1097/00041433-200212000-00003
   Galli A, 2001, J BIOL CHEM, V276, P68, DOI 10.1074/jbc.M008791200
   Gaziano JM, 2000, J AM COLL CARDIOL, V35, P96, DOI 10.1016/S0735-1097(99)00531-8
   HANNUKSELA M, 1992, J LIPID RES, V33, P737
   HEISS G, 1980, CIRCULATION, V61, P302, DOI 10.1161/01.CIR.61.2.302
   Jee SH, 1999, JAMA-J AM MED ASSOC, V282, P2149, DOI 10.1001/jama.282.22.2149
   Kelley George A, 2006, J Cardiopulm Rehabil, V26, P131, DOI 10.1097/00008483-200605000-00002
   KEYS A, 1984, PREV MED, V13, P141, DOI 10.1016/0091-7435(84)90047-1
   KODAMA K, 1990, JPN CIRC J, V54, P414, DOI 10.1253/jcj.54.414
   KONISHI T, 1965, Jpn Circ J, V29, P505
   Lopez D, 2006, MOL CELL ENDOCRINOL, V247, P22, DOI 10.1016/j.mce.2005.10.005
   Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI [10.1007/s00018-003-3216-3, 10.1155/2010/612089]
   MARMOT MG, 1975, AM J EPIDEMIOL, V102, P514, DOI 10.1093/oxfordjournals.aje.a112189
   Naito H, 2006, PHARMACOGENET GENOM, V16, P569, DOI 10.1097/01.fpc.0000220565.90466.79
   Nakajima T, 2004, HEPATOLOGY, V40, P972, DOI 10.1002/hep.20399
   Nanji AA, 2002, ALCOHOL CLIN EXP RES, V26, P731, DOI 10.1111/j.1530-0277.2002.tb02598.x
   Ordovas JM, 2003, CURR OPIN LIPIDOL, V14, P47, DOI 10.1097/00041433-200302000-00009
   Peters JM, 1997, J BIOL CHEM, V272, P27307, DOI 10.1074/jbc.272.43.27307
   Poynter ME, 1998, J BIOL CHEM, V273, P32833, DOI 10.1074/jbc.273.49.32833
   Prescott E, 1998, BMJ-BRIT MED J, V316, P1043
   QUIG DW, 1990, ANNU REV NUTR, V10, P169, DOI 10.1146/annurev.nu.10.070190.001125
   Sapone A, 2000, PHARMACOGENETICS, V10, P321, DOI 10.1097/00008571-200006000-00006
   SEKIMOTO H, 1983, JPN CIRC J, V47, P1351, DOI 10.1253/jcj.47.1351
   Staels B, 1998, CIRCULATION, V98, P2088, DOI 10.1161/01.CIR.98.19.2088
   Tai ES, 2005, J NUTR, V135, P397, DOI 10.1093/jn/135.3.397
   Tai ES, 2002, ARTERIOSCL THROM VAS, V22, P805, DOI 10.1161/01.ATV.0000012302.11991.42
   WILLETT WC, 1987, NEW ENGL J MED, V317, P1303, DOI 10.1056/NEJM198711193172102
   Yamakawa-Kobayashi K, 2002, J MED GENET, V39, P189, DOI 10.1136/jmg.39.3.189
   Ye P, 2005, CHINESE MED J-PEKING, V118, P1093
   You M, 2004, AM J PHYSIOL-GASTR L, V287, pG1, DOI 10.1152/ajpgi.00056.2004
NR 45
TC 13
Z9 13
U1 0
U2 2
PU JAPAN SOC OCCUPATIONAL HEALTH
PI TOKYO
PA 1-29-8 SHINJUKU, SHINJUKU-KU, TOKYO, 160, JAPAN
SN 1341-9145
EI 1348-9585
J9 J OCCUP HEALTH
JI J. Occup. Health
PD SEP
PY 2007
VL 49
IS 5
BP 353
EP 362
DI 10.1539/joh.49.353
PG 10
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Public, Environmental & Occupational Health
GA 218KP
UT WOS:000250014700002
PM 17951966
OA Bronze
DA 2024-02-19
ER

PT J
AU Preuss, HG
   Kaats, GR
   Mrvichin, N
   Bagchi, D
   Preuss, JM
AF Preuss, Harry G.
   Kaats, Gilbert R.
   Mrvichin, Nate
   Bagchi, Debasis
   Preuss, Jeffrey M.
TI Circulating ALT Levels in Healthy Volunteers Over Life-Span: Assessing
   Aging Paradox and Nutritional Implications
SO JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION
LA English
DT Article; Early Access
DE NAFLD; insulin resistance; fatty liver; ALT; aging
ID FATTY LIVER-DISEASE; ALANINE AMINOTRANSFERASE; INSULIN-RESISTANCE;
   METABOLIC SYNDROME; DIABETES-MELLITUS; PREVALENCE; RISK; AGE;
   RESTRICTION
AB Background: Two facts are generally recognized: (1) development of nonalcoholic fatty liver disease (NAFLD) is consistently linked to insulin resistance which has dietary implications and (2) circulating alanine aminotransferase (ALT) levels are reasonable markers predicting NAFLD status. In a recent cross-sectional study employing nondiabetic subjects, ALT values rose steadily within a normal range early in the life cycle but begin decreasing steadily around age 65 years. Objectives: Because of important nutritional implications, the association between ALT levels and aging in a significantly larger population of healthy volunteers was examined for corroborative purposes. A secondary goal was to gain further knowledge concerning mechanisms behind any age-related decline in ALT activity. Methods: Baseline data from over 10,000 physician-approved, nondiabetic subjects (age 21-84 years) of both genders who had volunteered for previous clinical investigations were assessed. Results: In this cross-sectional examination, the line of best fit (weighted) for average yearly circulating ALT levels displayed an upward surge from ages 21 to 64 years with a discernible steady downward decline around 65 years-mimicking earlier results. Examining linear lines of correlation in the younger and older age groups, the following calculations were determined: a significant positive slope for 21 to 64 years, r = 0.42, n = 44, p < 0.005, and a trending negative slope for 65 and beyond, r = -0.43, n = 20, p < 0.057. Using this same datum base, the correlations between age and fasting blood glucose (FBG) mimicked the ALT results by once more showing a similar upward rise in the younger and a steady decline the older group of volunteers. Conclusions: A paradoxical downward age-related (>= 65 years) decline of circulating ALT coinciding with a comparable steady decrease in FBG levels was replicated in a larger population of volunteers. The close association of these two chemistries along with other findings suggest that altered glucose-insulin metabolism may participate via "survivor bias" in the ubiquitously found age-related decline of serum ALT-suggesting that nutritional measures could advance optimal health over the life-span.
C1 [Preuss, Harry G.] Georgetown Univ, Med Ctr, Dept Biochem, Washington, DC 20007 USA.
   [Kaats, Gilbert R.; Mrvichin, Nate] Integrat Hlth Technol, San Antonio, TX USA.
   [Bagchi, Debasis] Univ Houston, Dept Pharmacol & Pharmaceut Serv, Houston, TX USA.
   [Preuss, Jeffrey M.] Vet Adm Med Ctr, Emergency Dept, Salem, VA USA.
C3 Georgetown University; University of Houston System; University of
   Houston; US Department of Veterans Affairs; Veterans Health
   Administration (VHA); Salem Veterans Affairs Medical Center
RP Preuss, HG (corresponding author), 231B Basic Sci Bldg,3900 Reservoir RD,NW, Washington, DC 20057 USA.
EM preusshg@georgetown.edu
CR Adams LA, 2009, AM J GASTROENTEROL, V104, P861, DOI 10.1038/ajg.2009.67
   Appel Susan J, 2005, J Am Acad Nurse Pract, V17, P535, DOI 10.1111/j.1745-7599.2005.00083.x
   Bertolotti M, 2014, WORLD J GASTROENTERO, V20, P14185, DOI 10.3748/wjg.v20.i39.14185
   Carey E, NONALCOHOLIC FATTY L
   Chen ZW, 2008, J ZHEJIANG UNIV-SC B, V9, P616, DOI 10.1631/jzus.B0720016
   Clark JM, 2003, AM J GASTROENTEROL, V98, P960, DOI [10.1016/S0002-9270(03)00265-X, 10.1111/j.1572-0241.2003.07486.x]
   Dong MH, 2012, CLIN GASTROENTEROL H, V10, P285, DOI 10.1016/j.cgh.2011.10.014
   Franco OH, 2007, ARCH INTERN MED, V167, P1145, DOI 10.1001/archinte.167.11.1145
   Frith J, 2009, GERONTOLOGY, V55, P607, DOI 10.1159/000235677
   Gu K, 1998, DIABETES CARE, V21, P1138, DOI 10.2337/diacare.21.7.1138
   Hamaguchi M, 2012, WORLD J GASTROENTERO, V18, P1508, DOI 10.3748/wjg.v18.i13.1508
   Ioannou GN, 2006, AM J GASTROENTEROL, V101, P76, DOI 10.1111/j.1572-0241.2005.00341.x
   Ioannou GN, 2006, HEPATOLOGY, V43, P1145, DOI 10.1002/hep.21171
   Koehler EM, 2012, J HEPATOL, V57, P1305, DOI 10.1016/j.jhep.2012.07.028
   Kojima H, 2005, ALCOHOL CLIN EXP RES, V29, p259S, DOI 10.1097/01.alc.0000191776.37626.30
   Le Couteur DG, 2010, J GERONTOL A-BIOL, V65, P712, DOI 10.1093/gerona/glq082
   Lonardo A, 2015, DIGEST LIVER DIS, V47, P181, DOI 10.1016/j.dld.2014.09.020
   Loukine L, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-7
   MASORO EJ, 1992, J GERONTOL, V47, pB202, DOI 10.1093/geronj/47.6.B202
   Mofrad P, 2003, HEPATOLOGY, V37, P1286, DOI 10.1053/jhep.2003.50229
   Paolisso G, 2001, EXP GERONTOL, V37, P149, DOI 10.1016/S0531-5565(01)00148-6
   Petersen KF, 2006, P NATL ACAD SCI USA, V103, P18273, DOI 10.1073/pnas.0608537103
   Porter SA, 2013, ARTERIOSCL THROM VAS, V33, P139, DOI 10.1161/ATVBAHA.112.300075
   Preuss HG, 2018, J AM COLL NUTR, V37, P457, DOI 10.1080/07315724.2018.1443292
   Preuss HG, 2017, J AM COLL NUTR, V36, P556, DOI 10.1080/07315724.2017.1322545
   Preuss HG, 2011, J INORG BIOCHEM, V105, P1344, DOI 10.1016/j.jinorgbio.2011.01.005
   Preuss HG, 1997, J AM COLL NUTR, V16, P397, DOI 10.1080/07315724.1997.10718704
   Preuss HG, 2016, ORIG INTERN, V23, P78
   Preuss HG, 2016, ORIGINAL INTERNIST, V23, P13
   Preuss HG, 2001, ADV GUIDE LONGEVITY, P239
   REAVEN GM, 1981, METABOLISM, V30, P982, DOI 10.1016/0026-0495(81)90096-2
   Sanyal Debmalya, 2015, Indian J Endocrinol Metab, V19, P597, DOI 10.4103/2230-8210.163172
   Sattar N, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4596
   Schindhelm RK, 2006, DIABETES-METAB RES, V22, P437, DOI 10.1002/dmrr.666
   Shyangdan D, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15380
   Targher G, 2013, J CLIN ENDOCR METAB, V98, P483, DOI 10.1210/jc.2012-3093
   Thoma C, 2012, J HEPATOL, V56, P255, DOI 10.1016/j.jhep.2011.06.010
   Wainwright P, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030367
   Wang ZL, 2013, EXP GERONTOL, V48, P705, DOI 10.1016/j.exger.2013.05.059
   Weindruch R., 1988, RETARDATION AGING DI
   Xia MF, 2011, CLIN EXP PHARMACOL P, V38, P373, DOI 10.1111/j.1440-1681.2011.05519.x
NR 41
TC 15
Z9 15
U1 0
U2 1
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0731-5724
EI 1541-1087
J9 J AM COLL NUTR
JI J. Am. Coll. Nutr.
PD 2019 NOV 17
PY 2019
VL 38
IS 8
BP 661
EP 669
DI 10.1080/07315724.2019.1580169
EA APR 2019
PG 9
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA JJ6XR
UT WOS:000471403500001
PM 31075051
OA Bronze
DA 2024-02-19
ER

PT J
AU Lisanti, MP
   Martinez-Outschoorn, UE
   Lin, Z
   Pavlides, S
   Whitaker-Menezes, D
   Pestell, RG
   Howell, A
   Sotgia, F
AF Lisanti, Michael P.
   Martinez-Outschoorn, Ubaldo E.
   Lin, Zhao
   Pavlides, Stephanos
   Whitaker-Menezes, Diana
   Pestell, Richard G.
   Howell, Anthony
   Sotgia, Federica
TI Hydrogen peroxide fuels aging, inflammation, cancer metabolism and
   metastasis The seed and soil also needs "fertilizer"
SO CELL CYCLE
LA English
DT Article
DE hydrogen peroxide; tumor stroma; microenvironment; aging; DNA damage;
   inflammation; NF kappa B; cancer metabolism; HIF1; autophagy; hypoxia;
   oxidative stress; seed and soil hypothesis
ID IDIOPATHIC PULMONARY-FIBROSIS; EXHALED BREATH CONDENSATE; KAPPA-B
   ACTIVATION; TUMOR STROMA MODEL; OXIDATIVE STRESS; ENERGY-METABOLISM;
   ALLOGRAFT-REJECTION; HEPATIC METASTASIS; ACATALASEMIC MICE; TARGETED
   DELIVERY
AB In 1889, Dr. Stephen Paget proposed the "seed and soil" hypothesis, which states that cancer cells (the seeds) need the proper microenvironment (the soil) for them to grow, spread and metastasize systemically. In this hypothesis, Dr. Paget rightfully recognized that the tumor microenvironment has an important role to play in cancer progression and metastasis. In this regard, a series of recent studies have elegantly shown that the production of hydrogen peroxide, by both cancer cells and cancer-associated fibroblasts, may provide the necessary "fertilizer," by driving accelerated aging, DNA damage, inflammation and cancer metabolism, in the tumor microenvironment. By secreting hydrogen peroxide, cancer cells and fibroblasts are mimicking the behavior of immune cells (macrophages/neutrophils), driving local and systemic inflammation, via the innate immune response (NF kappa B). Thus, we should consider using various therapeutic strategies (such as catalase and/or other anti-oxidants) to neutralize the production of cancer-associated hydrogen peroxide, thereby preventing tumor-stroma co-evolution and metastasis. The implications of these findings for overcoming chemo-resistance in cancer cells are also discussed in the context of hydrogen peroxide production and cancer metabolism.
C1 [Lisanti, Michael P.; Martinez-Outschoorn, Ubaldo E.; Lin, Zhao; Pavlides, Stephanos; Whitaker-Menezes, Diana; Pestell, Richard G.; Sotgia, Federica] Thomas Jefferson Univ, Jefferson Stem Cell Biol & Regenerat Med Ctr, Philadelphia, PA 19107 USA.
   [Lisanti, Michael P.; Martinez-Outschoorn, Ubaldo E.; Lin, Zhao; Pavlides, Stephanos; Whitaker-Menezes, Diana; Pestell, Richard G.] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Stem Cell Biol & Regenerat Med, Philadelphia, PA 19107 USA.
   [Lisanti, Michael P.; Martinez-Outschoorn, Ubaldo E.; Lin, Zhao; Pavlides, Stephanos; Whitaker-Menezes, Diana; Pestell, Richard G.] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Canc Biol, Philadelphia, PA 19107 USA.
   [Lisanti, Michael P.; Martinez-Outschoorn, Ubaldo E.] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Med Oncol, Philadelphia, PA 19107 USA.
   [Lisanti, Michael P.; Howell, Anthony; Sotgia, Federica] Univ Manchester, Manchester Breast Ctr, Manchester M13 9PL, Lancs, England.
   [Lisanti, Michael P.; Howell, Anthony; Sotgia, Federica] Univ Manchester, Breakthrough Breast Canc Res Unit, Paterson Inst Canc Res, Sch Canc Enabling Sci & Technol,Manchester Acad H, Manchester M13 9PL, Lancs, England.
C3 Jefferson University; Jefferson University; Jefferson University;
   Jefferson University; University of Manchester; Paterson Institute for
   Cancer Research; University of Manchester
RP Lisanti, MP (corresponding author), Thomas Jefferson Univ, Jefferson Stem Cell Biol & Regenerat Med Ctr, Philadelphia, PA 19107 USA.
EM michael.lisanti@kimmelcancercenter.org; federica.sotgia@jefferson.edu
RI Lisanti, Michael/B-6131-2018; Pestell, Richard G/JQW-3484-2023;
   Pavlides, Stephanos/F-9673-2011; Lisanti, Michael P/C-6866-2013
OI Lisanti, Michael/0000-0003-2034-1382; Howell,
   Anthony/0000-0002-6233-719X; Sotgia, Federica/0000-0003-2826-4529;
   Martinez-Outschoorn, Ubaldo/0000-0003-1483-4551
FU W.W. Smith Charitable Trust; Breast Cancer Alliance (BCA); American
   Cancer Society (ACS); NIH/NCI [R01-CA-080250, R01-CA-098779,
   R01-CA-120876, R01-AR-055660, R01-CA-70896, R01-CA-75503, R01-CA-86072,
   R01-CA-107382]; Susan G. Komen Breast Cancer Foundation; Dr. Ralph and
   Marian C. Falk Medical Research Trust; NIH/NCI Cancer Center
   [P30-CA-56036]; Margaret Q. Landenberger Research Foundation;
   Pennsylvania Department of Health; Breakthrough Breast Cancer in the UK;
   European Research Council
FX F.S. and her laboratory were supported by grants from the W.W. Smith
   Charitable Trust, the Breast Cancer Alliance (BCA) and a Research
   Scholar Grant from the American Cancer Society (ACS). M. P. L. was
   supported by grants from the NIH/NCI (R01-CA-080250; R01-CA-098779;
   R01-CA-120876; R01-AR-055660), and the Susan G. Komen Breast Cancer
   Foundation. R. G. P. was supported by grants from the NIH/NCI
   (R01-CA-70896, R01-CA-75503, R01-CA-86072 and R01-CA-107382) and the Dr.
   Ralph and Marian C. Falk Medical Research Trust. The Kimmel Cancer
   Center was supported by the NIH/NCI Cancer Center Core grant
   P30-CA-56036 (to R. G. P.). Funds were also contributed by the Margaret
   Q. Landenberger Research Foundation (to M. P. L.). This project is
   funded, in part, under a grant with the Pennsylvania Department of
   Health (to M. P. L. and F. S.). The Department specifically disclaims
   responsibility for any analyses, interpretations or conclusions. This
   work was also supported, in part, by a Centre grant in Manchester from
   Breakthrough Breast Cancer in the UK (to A. H.) and an Advanced ERC
   Grant from the European Research Council.
CR Ahn J, 2005, AM J EPIDEMIOL, V162, P943, DOI 10.1093/aje/kwi306
   Alexandrova AY, 2006, EXP CELL RES, V312, P2066, DOI 10.1016/j.yexcr.2006.03.004
   Anderson EJ, 2006, AM J PHYSIOL-CELL PH, V290, pC844, DOI 10.1152/ajpcell.00402.2005
   BIGGERS JD, 1967, P NATL ACAD SCI USA, V58, P560, DOI 10.1073/pnas.58.2.560
   Bittar PG, 1996, J CEREBR BLOOD F MET, V16, P1079, DOI 10.1097/00004647-199611000-00001
   Blagosklonny MV, 2010, CELL CYCLE, V9, P4788, DOI 10.4161/cc.9.24.14360
   Blagosklonny MV, 2009, AGING-US, V1, P1
   Bonuccelli G, 2010, CELL CYCLE, V9, P3506, DOI 10.4161/cc.9.17.12731
   Bonuccelli G, 2010, CELL CYCLE, V9, P1960, DOI 10.4161/cc.9.10.11601
   Brigelius-Flohé R, 2009, BBA-GEN SUBJECTS, V1790, P1555, DOI 10.1016/j.bbagen.2009.03.006
   BRINSTER RL, 1971, J REPROD FERTIL, V24, P187
   BROOKS GA, 1986, MED SCI SPORT EXER, V18, P360, DOI 10.1249/00005768-198606000-00019
   BURDON RH, 1995, FREE RADICAL BIO MED, V18, P775, DOI 10.1016/0891-5849(94)00198-S
   CERUTTI PA, 1985, SCIENCE, V227, P375, DOI 10.1126/science.2981433
   Chan HP, 2009, J THORAC ONCOL, V4, P172, DOI 10.1097/JTO.0b013e3181949eb9
   Chan HP, 2009, LUNG CANCER, V63, P164, DOI 10.1016/j.lungcan.2008.05.020
   Chiavarina B, 2010, CELL CYCLE, V9, P3534, DOI 10.4161/cc.9.17.12908
   COLONNA R, 1983, CELL BIOL INT REP, V7, P1007, DOI 10.1016/0309-1651(83)90005-X
   COLONNA R, 1983, BIOL REPROD, V28, P797, DOI 10.1095/biolreprod28.4.797
   Dai DF, 2011, AUTOPHAGY, V7, P917, DOI 10.4161/auto.7.8.15813
   De Felice B, 2009, MOL CELL BIOCHEM, V327, P191, DOI 10.1007/s11010-009-0057-x
   DELVALLE LG, 2011, BIOMED PHAR IN PRESS
   Di Vizio D, 2009, CELL CYCLE, V8, P2420, DOI 10.4161/cc.8.15.9116
   DUC C, 2009, CANCER BIOL THER, V8, P1962, DOI DOI 10.4161/CBT.8.20.9648
   Feng Y, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000562
   Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098
   Fokas E, 2007, CANCER METAST REV, V26, P705, DOI 10.1007/s10555-007-9088-5
   Fukuoka N, 2008, AM J NEPHROL, V28, P661, DOI 10.1159/000121357
   Ghajar CM, 2009, AM J PATHOL, V174, P1996, DOI 10.2353/ajpath.2009.090363
   Glaudemans AWJM, 2010, EUR J NUCL MED MOL I, V37, P1986, DOI 10.1007/s00259-010-1587-x
   Goh J, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-191
   Graham KA, 2010, CANCER BIOL THER, V10, DOI 10.4161/cbt.10.3.12207
   Grek CL, 2011, PHARMACOL THERAPEUT, V129, P172, DOI 10.1016/j.pharmthera.2010.09.008
   Handa O, 2011, REDOX REP, V16, P1, DOI 10.1179/174329211X12968219310756
   Havre PA, 2002, CANCER RES, V62, P1443
   Hole PS, 2010, BLOOD, V115, P1238, DOI 10.1182/blood-2009-06-222869
   Hyoudou K, 2006, FREE RADICAL BIO MED, V41, P1449, DOI 10.1016/j.freeradbiomed.2006.08.004
   Hyoudou K, 2009, J CONTROL RELEASE, V137, P110, DOI 10.1016/j.jconrel.2009.04.005
   Ishii K, 1996, JPN J CANCER RES, V87, P680, DOI 10.1111/j.1349-7006.1996.tb00277.x
   Jasmin JF, 2006, CIRCULATION, V114, P912, DOI 10.1161/CIRCULATIONAHA.106.634709
   Jasmin JF, 2004, CARDIOVASC RES, V63, P747, DOI 10.1016/j.cardiores.2004.05.018
   JONES GM, 1985, BRIT J CANCER, V52, P583, DOI 10.1038/bjc.1985.230
   Kasapovic J, 2010, CLIN BIOCHEM, V43, P1287, DOI 10.1016/j.clinbiochem.2010.08.009
   KENSESE SM, 1989, TERATOGEN CARCIN MUT, V9, P211, DOI 10.1002/tcm.1770090404
   Khan N, 2008, ANTIOXID REDOX SIGN, V10, P475, DOI 10.1089/ars.2007.1740
   KIM JH, 2011, STEM CELLS IN PRESS
   Kobayashi M, 2005, KIDNEY INT, V68, P1018, DOI 10.1111/j.1523-1755.2005.00494.x
   Kobayashi Y, 2008, CANCER SCI, V99, P1546, DOI 10.1111/j.1349-7006.2008.00856.x
   Koo JS, 2011, TUMOR BIOL, V32, P787, DOI 10.1007/s13277-011-0181-6
   Kubota K, 2011, ANN NUCL MED, V25, P355, DOI 10.1007/s12149-011-0470-6
   Laughton JD, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-35
   Lisanti MP, 2011, CELL CYCLE, V10, P2059, DOI 10.4161/cc.10.13.16233
   Lisanti MP, 2010, CANCER BIOL THER, V10, P537, DOI 10.4161/cbt.10.6.13370
   Liu TY, 1996, MUTAT RES-GENET TOX, V367, P25, DOI 10.1016/S0165-1218(96)90018-X
   López-Lázaro M, 2007, CANCER LETT, V252, P1, DOI 10.1016/j.canlet.2006.10.029
   Magistretti PJ, 1996, ANN NY ACAD SCI, V777, P380, DOI 10.1111/j.1749-6632.1996.tb34449.x
   Martin KR, 2002, NUTR CANCER, V43, P59, DOI 10.1207/S15327914NC431_7
   Martinez-Outschoorn UE, 2011, CELL CYCLE, V10, P1784, DOI 10.4161/cc.10.11.15674
   Martinez-Outschoorn UE, 2011, CELL CYCLE, V10, P1271, DOI 10.4161/cc.10.8.15330
   Martinez-Outschoorn UE, 2010, CELL CYCLE, V9, P4297, DOI 10.4161/cc.9.21.13817
   Martinez-Outschoorn UE, 2010, CELL CYCLE, V9, P3515, DOI 10.4161/cc.9.17.12928
   Martinez-Outschoorn UE, 2010, CELL CYCLE, V9, P3256, DOI 10.4161/cc.9.16.12553
   Martinez-Outschoorn UE, 2010, CELL CYCLE, V9, P2423, DOI 10.4161/cc.9.12.12048
   MARTINEZOUTSCHO.UE, 2011, CELL CYCLE IN PRESS, V10
   MERLISS RR, 1971, SCIENCE, V173, P1141, DOI 10.1126/science.173.4002.1141
   Michielsen P, 2011, ACTA GASTRO-ENT BELG, V74, P4
   Migneco G, 2010, CELL CYCLE, V9, P2412, DOI 10.4161/cc.9.12.11989
   Naik E, 2011, J EXP MED, V208, P417, DOI 10.1084/jem.20110367
   Naik S, 2006, ORAL ONCOL, V42, P668, DOI 10.1016/j.oraloncology.2005.10.020
   NAIR UJ, 1992, ENVIRON HEALTH PERSP, V98, P203, DOI 10.2307/3431271
   Nechuta S, 2011, CANCER EPIDEM BIOMAR, V20, P262, DOI 10.1158/1055-9965.EPI-10-1072
   Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119
   Nishikawa M, 2004, CLIN EXP METASTAS, V21, P213, DOI 10.1023/B:CLIN.0000037706.13747.5e
   Nishikawa M, 2002, INT J CANCER, V99, P474, DOI 10.1002/ijc.10387
   Nishikawa M, 2008, CANCER LETT, V266, P53, DOI 10.1016/j.canlet.2008.02.031
   Nishikawa M, 2006, EXPERT OPIN DRUG DEL, V3, P355, DOI 10.1517/17425247.3.3.355
   Nishikawa M, 2009, ADV DRUG DELIVER REV, V61, P319, DOI 10.1016/j.addr.2009.01.001
   Nyaga SG, 2007, CELL CYCLE, V6, P1472
   Odajima N, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-183
   Ohshima H, 2003, ARCH BIOCHEM BIOPHYS, V417, P3, DOI 10.1016/S0003-9861(03)00283-2
   Pavlides S, 2010, CELL CYCLE, V9, P3485, DOI 10.4161/cc.9.17.12721
   Pavlides S, 2010, CELL CYCLE, V9, P2201, DOI 10.4161/cc.9.11.11848
   Pavlides S, 2010, AGING-US, V2, P185, DOI 10.18632/aging.100134
   Pavlides S, 2009, CELL CYCLE, V8, P3984, DOI 10.4161/cc.8.23.10238
   Pennisi E, 1997, SCIENCE, V275, P1567, DOI 10.1126/science.275.5306.1567
   Pervaiz S, 2007, INT J BIOCHEM CELL B, V39, P1297, DOI 10.1016/j.biocel.2007.04.007
   Psathakis K, 2006, EUR J CLIN INVEST, V36, P362, DOI 10.1111/j.1365-2362.2006.01636.x
   Qian N, 2011, CANCER SCI, V102, P1590, DOI 10.1111/j.1349-7006.2011.01985.x
   Qian NS, 2010, ARCH MED RES, V41, P297, DOI 10.1016/j.arcmed.2010.05.009
   Reuter S, 2010, J NUCL MED, V51, P1644, DOI 10.2967/jnumed.110.078550
   Reuter S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005296
   ROH M, 2011, J CELL PHYS IN PRESS
   Roszkowski K, 2011, MED SCI MONITOR, V17, pCR329, DOI 10.12659/MSM.881805
   Rui Q, 2010, ANAL CHIM ACTA, V670, P57, DOI 10.1016/j.aca.2010.04.065
   Schnöckel U, 2008, EUR J NUCL MED MOL I, V35, P2267, DOI 10.1007/s00259-008-0878-y
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   SIEWEKE MH, 1994, CRIT REV ONCOGENESIS, V5, P297, DOI 10.1615/CritRevOncog.v5.i2-3.90
   SINGHI AD, 2011, HEAD NECK IN PRESS
   Sloan EK, 2009, AM J PATHOL, V174, P2035, DOI 10.2353/ajpath.2009.080924
   Sotgia F, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-62
   Stanley M, 2010, GYNECOL ONCOL, V117, pS5, DOI [10.1016/j.ygyno.2010.01.024, 10.1016/j.ygyno.2010.04.002]
   Stolarek RA, 2010, J CANCER RES CLIN, V136, P923, DOI 10.1007/s00432-009-0734-x
   Su YQ, 2008, DEVELOPMENT, V135, P111, DOI 10.1242/dev.009068
   Su YQ, 2009, SEMIN REPROD MED, V27, P32, DOI 10.1055/s-0028-1108008
   Sugiura K, 2005, DEV BIOL, V279, P20, DOI 10.1016/j.ydbio.2004.11.027
   Sugiura K, 2007, DEVELOPMENT, V134, P2593, DOI 10.1242/dev.006882
   Sugiura K, 2009, BIOL REPROD, V81, P833, DOI 10.1095/biolreprod.109.078485
   Sunami R, 2004, AM J PHYSIOL-RENAL, V286, pF1030, DOI 10.1152/ajprenal.00266.2003
   SZATROWSKI TP, 1991, CANCER RES, V51, P794
   Talmadge JE, 2010, CANCER RES, V70, P5649, DOI 10.1158/0008-5472.CAN-10-1040
   Thorsteinsdottir S, 2011, NAT REV GASTRO HEPAT, V8, P395, DOI 10.1038/nrgastro.2011.96
   Toullec A, 2010, EMBO MOL MED, V2, P211, DOI 10.1002/emmm.201000073
   Treiber N, 2011, AGING CELL, V10, P239, DOI 10.1111/j.1474-9726.2010.00658.x
   Trimmer C, 2011, CANCER BIOL THER, V11, P383, DOI 10.4161/cbt.11.4.14101
   Tsacopoulos M, 1996, J NEUROSCI, V16, P877
   Tsuji AB, 2009, J NUCL MED, V50, P827, DOI 10.2967/jnumed.108.058925
   Ueda K, 2004, SCAND J PLAST RECONS, V38, P267, DOI 10.1080/02844310410029552
   Uziel O, 2008, BRIT J HAEMATOL, V142, P82, DOI 10.1111/j.1365-2141.2008.07137.x
   Van de Bittner GC, 2010, P NATL ACAD SCI USA, V107, P21316, DOI 10.1073/pnas.1012864107
   Vincent AS, 2008, J INVEST DERMATOL, V128, P702, DOI 10.1038/sj.jid.5701107
   Vos FJ, 2010, J NUCL MED, V51, P1234, DOI 10.2967/jnumed.109.072371
   Waghray M, 2005, FASEB J, V19, P854, DOI 10.1096/fj.04-2882fje
   Wang XM, 2006, J EXP MED, V203, P2895, DOI 10.1084/jem.20061536
   Wang XM, 2008, CANCER RES, V68, P9909, DOI 10.1158/0008-5472.CAN-08-1551
   WARBURG O, 1956, SCIENCE, V124, P269
   WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309
   Whitaker-Menezes D, 2011, CELL CYCLE, V10, P1772, DOI 10.4161/cc.10.11.15659
   Witkiewicz AK, 2011, CELL CYCLE, V10, P1794, DOI 10.4161/cc.10.11.15675
   Witkiewicz AK, 2010, CANCER BIOL THER, V10, P135, DOI 10.4161/cbt.10.2.11983
   Witkiewicz AK, 2009, CANCER BIOL THER, V8, P1071, DOI 10.4161/cbt.8.11.8874
   Witkiewicz AK, 2009, CELL CYCLE, V8, P1654, DOI 10.4161/cc.8.11.8544
   Witkiewicz AK, 2009, AM J PATHOL, V174, P2023, DOI 10.2353/ajpath.2009.080873
   Woo DK, 2011, CELL, V144, P11, DOI 10.1016/j.cell.2010.12.023
   Wu CY, 2011, CANCER-AM CANCER SOC, V117, P618, DOI 10.1002/cncr.25616
   Xie LF, 2009, BIOGERONTOLOGY, V10, P125, DOI 10.1007/s10522-008-9157-3
   Yu KJ, 2011, CLIN CANCER RES, V17, P1906, DOI 10.1158/1078-0432.CCR-10-1681
   Zhang GY, 2011, BRIT J DERMATOL, V164, P623, DOI 10.1111/j.1365-2133.2010.10111.x
NR 137
TC 176
Z9 198
U1 3
U2 47
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1538-4101
EI 1551-4005
J9 CELL CYCLE
JI Cell Cycle
PD AUG 1
PY 2011
VL 10
IS 15
BP 2440
EP 2449
DI 10.4161/cc.10.15.16870
PG 10
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA 800GD
UT WOS:000293346900018
PM 21734470
OA Green Published, Bronze
DA 2024-02-19
ER

PT J
AU D'Aquila, P
   Montesanto, A
   Mandalà, M
   Garasto, S
   Mari, V
   Corsonello, A
   Bellizzi, D
   Passarino, G
AF D'Aquila, Patrizia
   Montesanto, Alberto
   Mandala, Maurizio
   Garasto, Sabrina
   Mari, Vincenzo
   Corsonello, Andrea
   Bellizzi, Dina
   Passarino, Giuseppe
TI Methylation of the ribosomal RNA gene promoter is associated with aging
   and age-related decline
SO AGING CELL
LA English
DT Article
DE aging; biological age; chronological age; geriatric parameters;
   ribosomal DNA (rDNA) promoter; ribosomal RNA (rRNA) genes
ID POLYMERASE-I TRANSCRIPTION; MINI-MENTAL-STATE; PROTEIN-SYNTHESIS; DNA
   METHYLATION; RDNA TRANSCRIPTION; POPULATION; EXPRESSION; VALIDATION;
   CLUSTERS; SEQUENCE
AB The transcription of ribosomal RNA genes (rDNA) is subject to epigenetic regulation, as it is abrogated by the methylation of CpG dinucleotides within their promoter region. Here, we investigated, through Sequenom platform, the age-related methylation status of the CpG island falling into the rDNA promoter in 472 blood samples from 20- to 105-year-old humans and in different tissues (blood, heart, liver, kidney, and testis) of 15 rats 3-96 weeks old. In humans, we did not find a consistently significant correlation between CpG site methylation and chronological age. Furthermore, the methylation levels of one of the analyzed CpG sites were negatively associated with both cognitive performance and survival chance measured in a 9-year follow-up study. We consistently confirmed such result in a replication sample. In rats, the analysis of the homologous region in the tissues revealed the existence of increased methylation in old rats. rRNA expression data, in both humans and rats, were consistent with observed methylation patterns, with a lower expression of rRNA in highly methylated samples. As chronological and biological ages in rats of a given strain are likely to be much closer to each other than in humans, these results seem to provide the first evidence that epigenetic modifications of rDNA change over time according to the aging decline. Thus, the methylation profile of rDNA may represent a potential biomarker of aging.
C1 [D'Aquila, Patrizia; Montesanto, Alberto; Mandala, Maurizio; Bellizzi, Dina; Passarino, Giuseppe] Univ Calabria, Dept Biol Ecol & Earth Sci, I-87036 Arcavacata Di Rende, Italy.
   [Garasto, Sabrina; Mari, Vincenzo; Corsonello, Andrea] INRCA, I-87100 Cosenza, Italy.
C3 University of Calabria; IRCCS INRCA
RP Bellizzi, D; Passarino, G (corresponding author), Univ Calabria, Dept Biol Ecol & Earth Sci, I-87036 Arcavacata Di Rende, Italy.
EM dina.bellizzi@unical.it; giuseppe.passarino@unical.it
RI Passarino, Giuseppe/ISB-6758-2023; Andrea, Corsonello/AAC-1845-2022;
   Corsonello, Andrea/A-5637-2013; D'Aquila, Patrizia/AAC-3468-2022
OI Corsonello, Andrea/0000-0002-7276-3256; D'Aquila,
   Patrizia/0000-0001-5740-4733
FU European Union's Seventh Framework Programme (FP7, IDEAL Project)
   [259679]; Programma Operativo Nazionale-MIUR 'Modelli sperimentali
   biotecnologici integrati per lo sviluppo e la selezione di molecole di
   interesse per la salute dell'uomo' [01_00937]
FX This work was supported by the European Union's Seventh Framework
   Programme (FP7/2007-2011, IDEAL Project, grant number 259679) and by
   Programma Operativo Nazionale (01_00937)-MIUR 'Modelli sperimentali
   biotecnologici integrati per lo sviluppo e la selezione di molecole di
   interesse per la salute dell'uomo'.
CR Adalsteinsson BT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046705
   Bellizzi D, 2012, AGE, V34, P169, DOI 10.1007/s11357-011-9216-6
   Caburet S, 2005, GENOME RES, V15, P1079, DOI 10.1101/gr.3970105
   Charmpilas N, 2015, AGEING RES REV, V23, P75, DOI 10.1016/j.arr.2014.12.008
   FINANCSEK I, 1982, P NATL ACAD SCI-BIOL, V79, P3092, DOI 10.1073/pnas.79.10.3092
   FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6
   Fountoulakis KN, 1999, AGING CLIN EXP RES, V11, P367, DOI 10.1007/BF03339814
   Ghoshal K, 2004, J BIOL CHEM, V279, P6783, DOI 10.1074/jbc.M309393200
   GONZALEZ IL, 1995, GENOMICS, V27, P320, DOI 10.1006/geno.1995.1049
   Grigoletto F, 1999, NEUROLOGY, V53, P315, DOI 10.1212/WNL.53.2.315
   Grummt I, 2003, NAT REV MOL CELL BIO, V4, P641, DOI 10.1038/nrm1171
   Grummt I, 2007, HUM MOL GENET, V16, pR21, DOI 10.1093/hmg/ddm020
   Grummt I, 2010, CELL CYCLE, V9, P225, DOI 10.4161/cc.9.2.10614
   Hands SL, 2009, AGING-US, V1, P586, DOI 10.18632/aging.100070
   Joensuu EI, 2015, GENE CHROMOSOME CANC, V54, P776, DOI 10.1002/gcc.22289
   KATZ S, 1970, GERONTOLOGIST, V10, P20, DOI 10.1093/geront/10.1_Part_1.20
   Liu L, 2009, NEUROBIOL AGING, V30, P549, DOI 10.1016/j.neurobiolaging.2007.07.020
   Lopez M, 2005, ASSESSMENT, V12, P137, DOI 10.1177/1073191105275412
   Machwe A, 2000, FASEB J, V14, P1715, DOI 10.1096/fj.99-0926com
   Majumder S, 2006, J BIOL CHEM, V281, P22062, DOI 10.1074/jbc.M601155200
   Mayer C, 2006, ONCOGENE, V25, P6384, DOI 10.1038/sj.onc.1209883
   McGue M, 2001, PSYCHOL AGING, V16, P272, DOI 10.1037//0882-7974.16.2.272
   Montesanto A, 2010, AGE, V32, P385, DOI 10.1007/s11357-010-9136-x
   Nilsson LG, 2006, NEUROPSYCHOLOGY, V20, P645, DOI 10.1037/0894-4105.20.6.645
   Oakes CC, 2003, P NATL ACAD SCI USA, V100, P1775, DOI 10.1073/pnas.0437971100
   Passarino G, 2006, HUM HERED, V62, P213, DOI 10.1159/000097305
   Paule MR, 2000, NUCLEIC ACIDS RES, V28, P1283, DOI 10.1093/nar/28.6.1283
   Pietrzak M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022585
   Powell MA, 2002, CANCER-AM CANCER SOC, V94, P2941, DOI 10.1002/cncr.10559
   Russell J, 2005, TRENDS BIOCHEM SCI, V30, P87, DOI 10.1016/j.tibs.2004.12.008
   Song TJ, 2013, J BIOL CHEM, V288, P20908, DOI 10.1074/jbc.M113.470302
   Stults DM, 2008, GENOME RES, V18, P13, DOI 10.1101/gr.6858507
   Sun DQ, 2014, CELL STEM CELL, V14, P673, DOI 10.1016/j.stem.2014.03.002
   SWISSHELM K, 1990, MUTAT RES, V237, P131, DOI 10.1016/0921-8734(90)90019-N
   Syntichaki P, 2007, ANN NY ACAD SCI, V1119, P289, DOI 10.1196/annals.1404.001
   Tavernarakis N, 2008, TRENDS CELL BIOL, V18, P228, DOI 10.1016/j.tcb.2008.02.004
   Uemura M, 2012, ONCOGENE, V31, P1254, DOI 10.1038/onc.2011.319
   Yara S, 2015, EPIGENOMICS-UK, V7, P283, DOI [10.2217/EPI.14.84, 10.2217/epi.14.84]
   Yen PS, 2000, BRIT J CANCER, V82, P514, DOI 10.1054/bjoc.1999.0955
   Yuan T, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004996
   Zampieri M, 2010, MECH AGEING DEV, V131, P89, DOI 10.1016/j.mad.2009.12.005
   ZATSEPINA OV, 1993, CHROMOSOMA, V102, P599, DOI 10.1007/BF00352307
   Zhai WG, 2000, MOL CELL BIOL, V20, P5930, DOI 10.1128/MCB.20.16.5930-5938.2000
   Zhao M, 2015, INT J BIOCHEM CELL B, V67, P65, DOI 10.1016/j.biocel.2015.05.022
NR 44
TC 50
Z9 53
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9726
J9 AGING CELL
JI Aging Cell
PD OCT
PY 2017
VL 16
IS 5
BP 966
EP 975
DI 10.1111/acel.12603
PG 10
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA FP5GR
UT WOS:000417648500008
PM 28625020
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Zhuang, YL
   Ma, QY
   Guo, Y
   Sun, LP
AF Zhuang, Yongliang
   Ma, Qingyu
   Guo, Yan
   Sun, Liping
TI Protective effects of rambutan (<i>Nephelium lappaceum</i>) peel
   phenolics on H<sub>2</sub>O<sub>2</sub>-induced oxidative damages in
   HepG2 cells and D-galactose induced aging mice
SO FOOD AND CHEMICAL TOXICOLOGY
LA English
DT Article; Proceedings Paper
CT 2nd International Symposium on Phytochemicals in Medicine and Food
   (ISPMF)
CY APR 07-10, 2017
CL Fuzhou, PEOPLES R CHINA
SP Phytochem Soc Europe, Phytochem Soc Asia, Int Soc Chinese Med, Fujian Agr & Forestry Univ, Univ Macau, Univ Hong Kong, Kunming Univ Sci & Technol, Yancheng Inst Technol, Guiyang Med Univ, Nanchang Univ, Hebei Normal Univ Sci & Technol, Zhejiang Univ, Beijing Normal Univ, Jinan Univ
DE Rambutan peel phenolics; UPLC-MS/MS; Oxidative stress; HepG2 cells;
   D-galactose-induced aging mice; Histological analysis
ID ANTIOXIDANT ACTIVITIES; IN-VITRO; DIETARY POLYPHENOLS; STRESS;
   PURIFICATION; HYDROLYSATE; PERSIMMON; EXTRACTS; PLANTS; SEED
AB Rambutan peel phenolic (RPP) extracts were prepared via dynamic separation with macroporous resin. The total phenolic content and individual phenolics in RPP were determined. Results showed that the total phenolic content of RPP was 877.11 mg gallic acid equivalents (GAE)/g extract. The content of geranin (122.18 mg/g extract) was the highest among those of the 39 identified phenolic compounds. RPP protected against oxidative stress in H2O2-induced HepG2 cells in a dose-response manner. The inhibitory effects of RPP on cell apoptosis might be related to its inhibitory effects on the generation of intracellular reactive oxygen species and increased effects on superoxide dismutase activity. The in vivo anti-aging activity of RPP was evaluated using an aging mice model that was induced by D-galactose (D-gal). The results showed that RPP enhanced the antioxidative status of experimental mice. Moreover, histological analysis indicated that RPP effectively reduced D-gal-induced liver and kidney tissue damage in a dose-dependent manner. Therefore, RPP can be used as a natural antioxidant and anti-aging agent in the pharmaceutical and food industries. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Zhuang, Yongliang; Ma, Qingyu; Guo, Yan; Sun, Liping] Kunming Univ Sci & Technol, Yunnan Inst Food Safety, 727 South Jingming Rd, Kunming 650500, Yunnan, Peoples R China.
C3 Kunming University of Science & Technology
RP Sun, LP (corresponding author), Kunming Univ Sci & Technol, Yunnan Inst Food Safety, 727 South Jingming Rd, Kunming 650500, Yunnan, Peoples R China.
EM Ipsun@kmust.edu.cn
RI Qingyu, Ma/GYR-2651-2022
FU National Natural Science Foundation of China [31360381, 31301456]
FX We gratefully thank the National Natural Science Foundation of China
   (Grant No. 31360381, 31301456) for the financial support on this
   research.
CR Alkan D, 2016, FOOD HYDROCOLLOID, V55, P1, DOI 10.1016/j.foodhyd.2015.10.025
   Auten RL, 2009, PEDIATR RES, V66, P121, DOI 10.1203/PDR.0b013e3181a9eafb
   Boulekbache-Makhlouf L, 2013, PHYTOCHEM ANALYSIS, V24, P162, DOI 10.1002/pca.2396
   Chang L, 2014, J MED FOOD, V17, P357, DOI 10.1089/jmf.2013.2830
   Cho BO, 2015, FOOD SCI BIOTECHNOL, V24, P643, DOI 10.1007/s10068-015-0084-1
   de Camargo AC, 2014, J AGR FOOD CHEM, V62, P12159, DOI 10.1021/jf504185s
   Guéraud F, 2010, FREE RADICAL RES, V44, P1098, DOI 10.3109/10715762.2010.498477
   Isabelle M, 2010, FOOD CHEM, V120, P993, DOI 10.1016/j.foodchem.2009.11.038
   Jacobo-Velázquez DA, 2009, J FOOD SCI, V74, pR107, DOI 10.1111/j.1750-3841.2009.01352.x
   Jin HF, 2016, J NUTR BIOCHEM, V36, P81, DOI 10.1016/j.jnutbio.2016.07.006
   Katanic J, 2017, FOOD CHEM TOXICOL, V99, P86, DOI 10.1016/j.fct.2016.11.018
   Kawakami K, 1999, TOHOKU J EXP MED, V187, P157, DOI 10.1620/tjem.187.157
   Latté KP, 2004, J AGR FOOD CHEM, V52, P4899, DOI 10.1021/jf0495688
   Lee MS, 2014, FOOD SCI BIOTECHNOL, V23, P1247, DOI 10.1007/s10068-014-0171-8
   Lin SY, 2008, FOOD CHEM TOXICOL, V46, P2485, DOI 10.1016/j.fct.2008.04.007
   Lourith N, 2016, IND CROP PROD, V83, P149, DOI 10.1016/j.indcrop.2015.12.045
   Ma TT, 2015, J FUNCT FOODS, V18, P673, DOI 10.1016/j.jff.2015.09.001
   Priyadarsini KI, 2002, J AGR FOOD CHEM, V50, P2200, DOI 10.1021/jf011275g
   Rajendran P, 2014, CLIN CHIM ACTA, V436, P332, DOI 10.1016/j.cca.2014.06.004
   Rashidinejad A, 2016, J FOOD COMPOS ANAL, V48, P13, DOI 10.1016/j.jfca.2016.02.004
   Shen YB, 2016, FOOD CHEM, V194, P1003, DOI 10.1016/j.foodchem.2015.08.083
   Sun LP, 2013, J FUNCT FOODS, V5, P154, DOI 10.1016/j.jff.2012.09.006
   Sun LP, 2012, J FOOD SCI, V77, pC198, DOI 10.1111/j.1750-3841.2011.02548.x
   Thitilertdecha N, 2010, MOLECULES, V15, P1453, DOI 10.3390/molecules15031453
   Wong JY, 2014, INT J FOOD PROP, V17, P1763, DOI 10.1080/10942912.2012.724756
   Xiao JB, 2015, CURR MED CHEM, V22, P23
   Xiao JB, 2017, CRIT REV FOOD SCI, V57, P1874, DOI 10.1080/10408398.2015.1032400
   Xiao JB, 2016, CRIT REV FOOD SCI, V56, pS29, DOI 10.1080/10408398.2015.1067595
   Xiao JB, 2015, CRIT REV FOOD SCI, V55, P16, DOI 10.1080/10408398.2011.584252
   Yarnpakdee S, 2015, J FOOD SCI TECH MYS, V52, P6194, DOI 10.1007/s13197-014-1672-4
   Yu X., 2016, J DAIRY SCI, V99, P1
   Yuvakkumar R, 2015, SPECTROCHIM ACTA A, V137, P250, DOI 10.1016/j.saa.2014.08.022
   Zheng GM, 2009, FOOD CHEM, V116, P433, DOI 10.1016/j.foodchem.2009.02.059
   Zhou ZD, 2016, J ENVIRON RADIOACTIV, V162, P182, DOI 10.1016/j.jenvrad.2016.05.034
   Zhuang C, 2016, INT J BIOL MACROMOL, V87, P322, DOI 10.1016/j.ijbiomac.2016.02.031
   Zhuang YL, 2009, J FOOD SCI, V74, pH183, DOI 10.1111/j.1750-3841.2009.01236.x
   Zitka O, 2012, ONCOL LETT, V4, P1247, DOI 10.3892/ol.2012.931
NR 37
TC 107
Z9 113
U1 8
U2 101
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0278-6915
EI 1873-6351
J9 FOOD CHEM TOXICOL
JI Food Chem. Toxicol.
PD OCT
PY 2017
VL 108
SI SI
BP 554
EP 562
DI 10.1016/j.fct.2017.01.022
PN B
PG 9
WC Food Science & Technology; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Food Science & Technology; Toxicology
GA FJ9XP
UT WOS:000413135100021
PM 28137606
DA 2024-02-19
ER

PT J
AU Liu, MA
   Shahabi, S
   Jati, S
   Tang, K
   Gao, H
   Jin, ZM
   Miller, W
   Meunier, FA
   Ying, W
   van den Bogaart, G
   Ghosh, G
   Mahata, SK
AF Liu, Matthew A.
   Shahabi, Shandy
   Jati, Suborno
   Tang, Kechun
   Gao, Hong
   Jin, Zhongmou
   Miller, Wyatt
   Meunier, Frederic A.
   Ying, Wei
   van den Bogaart, Geert
   Ghosh, Gourisankar
   Mahata, Sushil K.
TI Gut microbial DNA and immune checkpoint gene Vsig4/CRIg are key
   antagonistic players in healthy aging and age-associated development of
   hypertension and diabetes
SO FRONTIERS IN ENDOCRINOLOGY
LA English
DT Article
DE Chromogranin A; catestatin; hypertension; pancreastatin; insulin
   resistance; diabetes; healthy aging
ID SKELETAL-MUSCLE MITOCHONDRIAL; CARDIAC SYMPATHETIC ACTIVITY;
   CHROMOGRANIN-A; INSULIN-RESISTANCE; NERVOUS-SYSTEM; CATECHOLAMINE
   RELEASE; COMPLEMENT RECEPTOR; PANCREASTATIN; INFLAMMATION; PEPTIDE
AB AimsAging is associated with the development of insulin resistance and hypertension which may stem from inflammation induced by accumulation of toxic bacterial DNA crossing the gut barrier. The aim of this study was to identify factors counter-regulating these processes. Taking advantage of the Chromogranin A (CgA) knockout (CgA-KO) mouse as a model for healthy aging, we have identified Vsig4 (V-set and immunoglobulin domain containing 4) as the critical checkpoint gene in offsetting age-associated hypertension and diabetes. Methods and ResultsThe CgA-KO mice display two opposite aging phenotypes: hypertension but heightened insulin sensitivity at young age, whereas the blood pressure normalizes at older age and insulin sensitivity further improves. In comparison, aging WT mice gradually lost glucose tolerance and insulin sensitivity and developed hypertension. The gut barrier, compromised in aging WT mice, was preserved in CgA KO mice leading to major 35-fold protection against bacterial DNA-induced inflammation. Similarly, RNA sequencing showed increased expression of the Vsig4 gene (which removes bacterial DNA) in the liver of 2-yr-old CgA-KO mice, which may account for the very low accumulation of microbial DNA in the heart. The reversal of hypertension in aging CgA-KO mice likely stems from (i) low accumulation of microbial DNA, (ii) decreased spillover of norepinephrine in the heart and kidneys, and (iii) reduced inflammation. ConclusionWe conclude that healthy aging relies on protection from bacterial DNA and the consequent low inflammation afforded by CgA-KO. Vsig4 also plays a crucial role in "healthy aging" by counteracting age-associated insulin resistance and hypertension.
C1 [Liu, Matthew A.; Gao, Hong; Jin, Zhongmou; Ying, Wei; Mahata, Sushil K.] Univ Calif La Jolla, Dept Med, La Jolla, CA 92093 USA.
   [Shahabi, Shandy; Jati, Suborno; Miller, Wyatt; Ghosh, Gourisankar] Univ Calif La Jolla, Dept Chem & Biochem, La Jolla, CA USA.
   [Tang, Kechun; Mahata, Sushil K.] Vet Affairs VA San Diego Healthcare Syst, San Diego, CA 92161 USA.
   [Meunier, Frederic A.] Univ Queensland, Queensland Brain Inst, Clem Jones Ctr Ageing Dementia Res, Brisbane, Qld, Australia.
   [van den Bogaart, Geert] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Mol Immunol & Microbiol, Groningen, Netherlands.
C3 University of California System; University of California San Diego;
   University of California System; University of California San Diego; US
   Department of Veterans Affairs; Veterans Health Administration (VHA); VA
   San Diego Healthcare System; University of Queensland; University of
   Groningen
RP Mahata, SK (corresponding author), Univ Calif La Jolla, Dept Med, La Jolla, CA 92093 USA.; Mahata, SK (corresponding author), Vet Affairs VA San Diego Healthcare Syst, San Diego, CA 92161 USA.
EM smahata@health.ucsd.edu
RI Gao, Hong/JCP-3260-2023; van den Bogaart, Geert/GLV-3283-2022; Meunier,
   Frederic A./C-8161-2009
OI Gao, Hong/0000-0003-1933-6826; van den Bogaart,
   Geert/0000-0003-2180-6735; Meunier, Frederic A./0000-0001-6400-1107;
   Jati, Suborno/0000-0003-1397-8318
FU Department of Veterans Affairs [I01 BX003934]; National Institutes of
   Health [R01 GM 085490, 1 R21 AG072487-01, 1 R01 AI163327-01A1,
   R00DK115998, R21HD107516, R01DK125560]; National Health and Medical
   Research Council [GNT1060075]
FX This research was supported by a grant from the Department of Veterans
   Affairs (I01 BX003934 to SM) and the National Institutes of Health (R01
   GM 085490 to GG; 1 R21 AG072487-01 and 1 R01 AI163327-01A1 to GG and SM;
   R00DK115998, R21HD107516, and R01DK125560 to WY). FM is a National
   Health and Medical Research Council Senior Research Fellow (GNT1060075).
CR Ahmadi S, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.132055
   Ahmadi S, 2020, J GERONTOL A-BIOL, V75, pE9, DOI 10.1093/gerona/glaa056
   Allu PKR, 2022, DIABETES, V71, P538, DOI 10.2337/db21-0289
   Angelone T, 2008, ENDOCRINOLOGY, V149, P4780, DOI 10.1210/en.2008-0318
   Anhê FF, 2020, NAT METAB, V2, P233, DOI 10.1038/s42255-020-0178-9
   Avolio E, 2014, NEUROSCIENCE, V270, P48, DOI 10.1016/j.neuroscience.2014.04.001
   Bandyopadhyay GK, 2015, DIABETES, V64, P104, DOI 10.2337/db13-1747
   Baumert M, 2011, AM J PHYSIOL-HEART C, V300, pH1412, DOI 10.1152/ajpheart.01184.2010
   Biswas N, 2012, HYPERTENSION, V60, P1552, DOI 10.1161/HYPERTENSIONAHA.112.202127
   Boucher J, 2014, P NATL ACAD SCI USA, V111, P14512, DOI 10.1073/pnas.1415475111
   Buford TW, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0296-0
   Buford TW, 2016, AGEING RES REV, V26, P96, DOI 10.1016/j.arr.2016.01.007
   Camilleri M, 2019, GUT, V68, P1516, DOI 10.1136/gutjnl-2019-318427
   Cevik M, 2020, MOL BIOL REP, V47, P9399, DOI 10.1007/s11033-020-05992-5
   Chambers ES, 2020, J ALLERGY CLIN IMMUN, V145, P1323, DOI 10.1016/j.jaci.2020.03.016
   Chen YQ, 2008, J AM COLL CARDIOL, V52, P1468, DOI 10.1016/j.jacc.2008.07.047
   Chung HY, 2019, AGING DIS, V10, P367, DOI 10.14336/AD.2018.0324
   Crane JD, 2010, J GERONTOL A-BIOL, V65, P119, DOI 10.1093/gerona/glp179
   De Miguel C, 2015, CURR HYPERTENS REP, V17, DOI 10.1007/s11906-014-0507-z
   DEFRONZO RA, 1979, DIABETES, V28, P1095, DOI 10.2337/diab.28.12.1095
   Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275
   DiBona GF, 2002, CURR OPIN NEPHROL HY, V11, P197, DOI 10.1097/00041552-200203000-00011
   ESLER M, 1989, AM J HYPERTENS, V2, pS140, DOI 10.1093/ajh/2.3.140S
   Esler M, 2000, AM J HYPERTENS, V13, p99S, DOI 10.1016/S0895-7061(00)00225-9
   Ferrucci L, 2018, NAT REV CARDIOL, V15, P505, DOI 10.1038/s41569-018-0064-2
   FINK RI, 1983, J CLIN INVEST, V71, P1523, DOI 10.1172/JCI110908
   Furman D, 2017, NAT MED, V23, P174, DOI 10.1038/nm.4267
   Gao H, 2022, J AM HEART ASSOC, V11, DOI 10.1161/JAHA.121.024561
   Gao H, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-28239-2
   Garcia S, 2018, AGING CELL, V17, DOI 10.1111/acel.12707
   Gayen JR, 2009, J BIOL CHEM, V284, P28498, DOI 10.1074/jbc.M109.020636
   Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220
   Gonzalez-Freire M, 2015, J GERONTOL A-BIOL, V70, P1334, DOI 10.1093/gerona/glv070
   Gorgani NN, 2011, AM J PATHOL, V179, P1310, DOI 10.1016/j.ajpath.2011.05.021
   Gorgani NN, 2008, J IMMUNOL, V181, P7902, DOI 10.4049/jimmunol.181.11.7902
   Grassi G, 2009, HYPERTENSION, V54, P690, DOI 10.1161/HYPERTENSIONAHA.108.119883
   Grisk O, 2004, CARDIOVASC RES, V61, P238, DOI 10.1016/j.cardiores.2003.11.024
   Haas RH, 2019, BIOLOGY-BASEL, V8, DOI 10.3390/biology8020048
   HASKING GJ, 1986, CIRCULATION, V73, P615, DOI 10.1161/01.CIR.73.4.615
   He JQ, 2013, J LEUKOCYTE BIOL, V93, P301, DOI 10.1189/jlb.0612311
   Helmy KY, 2006, CELL, V124, P915, DOI 10.1016/j.cell.2005.12.039
   Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048
   Huang XY, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau7426
   Jang JY, 2018, J CLIN INVEST, V128, P3662, DOI 10.1172/JCI120842
   Kavanagh K, 2019, GEROSCIENCE, V41, P923, DOI 10.1007/s11357-019-00112-z
   Ke SL, 2021, NUTRIENTS, V13, DOI 10.3390/nu13093290
   Kitajima S, 2004, DIABETOLOGIA, V47, P1202, DOI 10.1007/s00125-004-1429-0
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Laurent S, 2020, FRONT CARDIOVASC MED, V7, DOI 10.3389/fcvm.2020.544302
   Lenaz G, 1997, MOL CELL BIOCHEM, V174, P329, DOI 10.1023/A:1006854619336
   Li JL, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01327-4
   López-Otín C, 2016, CELL, V166, P802, DOI 10.1016/j.cell.2016.07.031
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Lu XY, 2020, NATURE, V588, P479, DOI 10.1038/s41586-020-2928-y
   Luo ZL, 2021, GASTROENTEROLOGY, V160, P863, DOI 10.1053/j.gastro.2020.10.042
   Mahapatra NR, 2005, J CLIN INVEST, V115, P1942, DOI 10.1172/JCI24354
   Mahata SK, 1997, J CLIN INVEST, V100, P1623, DOI 10.1172/JCI119686
   Mahata SK, 2018, CURR MED CHEM, V25, P1352, DOI 10.2174/0929867324666170425100416
   Mancia G, 2014, CIRC RES, V114, P1804, DOI 10.1161/CIRCRESAHA.114.302524
   Mateos-Cáceres PJ, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/150107
   MENEILLY GS, 1989, J CLIN ENDOCR METAB, V68, P566, DOI 10.1210/jcem-68-3-566
   Muntjewerff EM, 2021, ACTA PHYSIOL, V232, DOI 10.1111/apha.13655
   Nagpal Ravinder, 2018, Nutr Healthy Aging, V4, P267, DOI 10.3233/NHA-170030
   O'Connor DT, 2005, J CLIN ENDOCR METAB, V90, P5414, DOI 10.1210/jc.2005-0408
   Oeppen J, 2002, SCIENCE, V296, P1029, DOI 10.1126/science.1069675
   Oh TG, 2020, CELL METAB, V32, P878, DOI 10.1016/j.cmet.2020.06.005
   Oliveros E, 2020, CLIN CARDIOL, V43, P99, DOI 10.1002/clc.23303
   Pasqua T, 2016, CELL TISSUE RES, V363, P693, DOI 10.1007/s00441-015-2316-3
   Penna C, 2010, CELL MOL NEUROBIOL, V30, P1171, DOI 10.1007/s10571-010-9598-5
   POLLARE T, 1991, ARTERIOSCLER THROMB, V11, P1192, DOI 10.1161/01.ATV.11.5.1192
   Rodríguez-Mañas L, 2022, GEROSCIENCE, V44, P1095, DOI 10.1007/s11357-021-00384-4
   Roichman A, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23545-7
   Ropelle ER, 2013, DIABETES, V62, P466, DOI 10.2337/db12-0339
   ROWE JW, 1983, J CLIN INVEST, V71, P1581, DOI 10.1172/JCI110914
   Rundqvist B, 1997, CIRCULATION, V95, P169, DOI 10.1161/01.CIR.95.1.169
   Saltiel AR, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI142241
   Sánchez-Margalet V, 2010, REGUL PEPTIDES, V161, P8, DOI 10.1016/j.regpep.2010.02.005
   SANCHEZMARGALET V, 1992, HORM METAB RES, V24, P455, DOI 10.1055/s-2007-1003361
   Sata Y, 2020, HYPERTENSION, V76, P1470, DOI 10.1161/HYPERTENSIONAHA.120.15769
   Satoh A, 2013, CELL METAB, V18, P416, DOI 10.1016/j.cmet.2013.07.013
   Savoia C, 2006, CURR OPIN NEPHROL HY, V15, P152, DOI 10.1097/01.mnh.0000203189.57513.76
   Schlaich MP, 2003, CIRCULATION, V108, P560, DOI 10.1161/01.CIR.0000081775.72651.B6
   Scott AJ, 2021, NATURE AGING, V1, P616, DOI 10.1038/s43587-021-00080-0
   Sebastián D, 2017, TRENDS MOL MED, V23, P201, DOI 10.1016/j.molmed.2017.01.003
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Singh T, 2011, AGEING RES REV, V10, P319, DOI 10.1016/j.arr.2010.11.002
   STOCCO DM, 1978, J GERONTOL, V33, P802, DOI 10.1093/geronj/33.6.802
   Takei S, 2020, DIABETES, V69, P2352, DOI 10.2337/db19-0996
   TATEMOTO K, 1986, NATURE, V324, P476, DOI 10.1038/324476a0
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Wang C, 2020, J AM COLL CARDIOL, V75, P2921, DOI 10.1016/j.jacc.2020.04.038
   Wang HD, 2020, LANCET, V396, P1160, DOI 10.1016/S0140-6736(20)30977-6
   Ying W, 2021, HYPERTENSION, V77, P1670, DOI 10.1161/HYPERTENSIONAHA.120.16809
   Ying W, 2018, DIABETES, V67, P841, DOI 10.2337/db17-0788
   Zeng ZT, 2016, CELL HOST MICROBE, V20, P99, DOI 10.1016/j.chom.2016.06.002
   Zhang DZ, 2021, BRAIN RES BULL, V176, P67, DOI 10.1016/j.brainresbull.2021.08.008
NR 96
TC 1
Z9 1
U1 0
U2 4
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-2392
J9 FRONT ENDOCRINOL
JI Front. Endocrinol.
PD NOV 11
PY 2022
VL 13
AR 1037465
DI 10.3389/fendo.2022.1037465
PG 18
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 6O8UO
UT WOS:000890514300001
PM 36440192
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Sumida, Y
   Yonei, Y
   Tanaka, S
   Mori, K
   Kanemasa, K
   Imai, S
   Taketani, H
   Hara, T
   Seko, Y
   Ishiba, H
   Okajima, A
   Yamaguchi, K
   Moriguchi, M
   Mitsuyoshi, H
   Yasui, K
   Minami, M
   Itoh, Y
AF Sumida, Yoshio
   Yonei, Yoshikazu
   Tanaka, Saiyu
   Mori, Kojiroh
   Kanemasa, Kazuyuki
   Imai, Shunsuke
   Taketani, Hiroyoshi
   Hara, Tasuku
   Seko, Yuya
   Ishiba, Hiroshi
   Okajima, Akira
   Yamaguchi, Kanji
   Moriguchi, Michihisa
   Mitsuyoshi, Hironori
   Yasui, Kohichiroh
   Minami, Masahito
   Itoh, Yoshito
TI Lower levels of insulin-like growth factor-1 standard deviation score
   are associated with histological severity of non-alcoholic fatty liver
   disease
SO HEPATOLOGY RESEARCH
LA English
DT Article
DE fibrosis; insulin like growth factor-1; insulin resistance;
   non-alcoholic fatty liver disease; non-alcoholic steatohepatitis
ID NECROSIS-FACTOR-ALPHA; IGF-I; HEPATIC STEATOSIS; REDUCES FIBROGENESIS;
   AGING RATS; STEATOHEPATITIS; HORMONE; RESISTANCE; GH; POPULATION
AB AimGrowth hormone (GH) deficiency may be associated with histological progression of non-alcoholic fatty liver disease (NAFLD) which includes non-alcoholic fatty liver (NAFL) and non-alcoholic steatohepatitis (NASH). Insulin-like growth factor 1 (IGF-1) is mainly produced by hepatocytes and its secretion is stimulated by GH. Our aim was to determine whether more histologically advanced NAFLD is associated with low circulating levels of IGF-1 in Japanese patients.
   MethodsSerum samples were obtained in 199 Japanese patients with biopsy-proven NAFLD and in 2911 sex- and age-matched healthy people undergoing health checkups. The serum levels of IGF-1 were measured using a commercially available immunoradiometric assay. The standard deviation scores (SDS) of IGF-1 according to age and sex were also calculated in NAFLD patients.
   ResultsThe serum IGF-1 levels in NAFLD patients were significantly lower (median, 112ng/mL) compared with the control population (median, 121ng/mL, P<0.0001). IGF-1 SDS less than -2.0 SD from median were found in 11.6% of 199 patients. NASH patients exhibited significantly lower levels of IGF-1 SDS (n=130; median, -0.7) compared with NAFL patients (n=69; median, -0.3; P=0.026). The IGF-1 SDS values decreased significantly with increasing lobular inflammation (P<0.001) and fibrosis (P<0.001). In multiple regressions, the association between the IGF-1 SDS values and the severity of NAFLD persisted after adjusting for age, sex and insulin resistance.
   ConclusionLow levels of circulating IGF-1 may have a role in the development of advanced NAFLD, independent of insulin resistance. Supplementation with GH/IGF-1 may be a candidate for the treatment of NASH.
C1 [Sumida, Yoshio; Taketani, Hiroyoshi; Hara, Tasuku; Seko, Yuya; Ishiba, Hiroshi; Okajima, Akira; Yamaguchi, Kanji; Moriguchi, Michihisa; Mitsuyoshi, Hironori; Yasui, Kohichiroh; Minami, Masahito; Itoh, Yoshito] Kyoto Prefectural Univ Med, Dept Gastroenterol & Hepatol, Kyoto 6028566, Japan.
   [Yonei, Yoshikazu] Doshisha Univ, Fac Life & Med Sci, Antiaging Med Res Ctr, Kyotanabe, Japan.
   [Tanaka, Saiyu; Mori, Kojiroh; Kanemasa, Kazuyuki] Nara City Hosp, Ctr Digest & Liver Dis, Nara, Japan.
   [Imai, Shunsuke] Nara City Hosp, Dept Pathol, Nara, Japan.
C3 Kyoto Prefectural University of Medicine; Doshisha University
RP Sumida, Y (corresponding author), Kyoto Prefectural Univ Med, Dept Gastroenterol & Hepatol, Kamigyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan.
EM sumida@koto.kpu-m.ac.jp
RI Sumida, Yoshio/AAL-6723-2020
FU Chiyoda Mutual Life Foundation; Grants-in-Aid for Scientific Research
   [24590990] Funding Source: KAKEN
FX THIS STUDY WAS supported by a grant from the Chiyoda Mutual Life
   Foundation.
CR Anwar A, 2002, CIRCULATION, V105, P1220, DOI 10.1161/hc1002.105187
   Arturi F, 2011, J CLIN ENDOCR METAB, V96, pE1640, DOI 10.1210/jc.2011-1227
   Brown-Borg HM, 2002, EXP BIOL MED, V227, P94, DOI 10.1177/153537020222700203
   Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1016/S0002-9270(99)00433-5
   Cianfaranis S, 2014, J PEDIAT
   Colak Y, 2012, EUR J GASTROEN HEPAT, V24, P255, DOI 10.1097/MEG.0b013e32834e8041
   Dasarathy S, 2009, J HEPATOL, V51, P1061, DOI 10.1016/j.jhep.2009.09.001
   Dominici FP, 2005, GROWTH HORM IGF RES, V15, P324, DOI 10.1016/j.ghir.2005.07.001
   Eguchi Y, 2012, J GASTROENTEROL, V47, P586, DOI 10.1007/s00535-012-0533-z
   Friedrich N, 2012, DIABETES CARE, V35, P768, DOI 10.2337/dc11-1833
   Fusco A, 2012, CLIN ENDOCRINOL, V77, P531, DOI 10.1111/j.1365-2265.2011.04291.x
   García-Fernández M, 2008, ENDOCRINOLOGY, V149, P2433, DOI 10.1210/en.2007-1190
   García-Galiano D, 2007, OBES SURG, V17, P493, DOI 10.1007/s11695-007-9087-1
   Gavin JR, 1997, DIABETES CARE, V20, P1183
   Haos CN, 2011, APOPTOSIS, V16, P1118
   Hribal ML, 2013, J CLIN ENDOCR METAB, V98, pE304, DOI 10.1210/jc.2012-3290
   Ichikawa T, 2007, HEPATOL INT, V1, P287, DOI 10.1007/s12072-007-9007-4
   Isojima T, 2012, ENDOCR J, V59, P771, DOI 10.1507/endocrj.EJ12-0110
   Japan Society for the Study of Obesity, 2000, J JPN SOC STUD OBES, V6, P18
   JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3
   Khoshnood A, 2013, HEPAT MON, V13, DOI 10.5812/hepatmon.6181
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   Kokoszko A, 2008, EXP TOXICOL PATHOL, V60, P453, DOI 10.1016/j.etp.2008.04.012
   Lelbachs A, 2011, J HEPATOL, V35, P558
   Leung KC, 2000, J CLIN ENDOCR METAB, V85, P4712, DOI 10.1210/jc.85.12.4712
   LUDWIG J, 1980, MAYO CLIN PROC, V55, P434
   Mallea-Gil Maria Susana, 2012, Acta Gastroenterol Latinoam, V42, P20
   Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161
   Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   Neys DM, 1995, METABOLISM, V44, P152
   Nishizawa H, 2012, BIOCHEM BIOPH RES CO, V423, P295, DOI 10.1016/j.bbrc.2012.05.115
   Nishizawa H, 2012, EUR J ENDOCRINOL, V167, P67, DOI 10.1530/EJE-12-0252
   Nomoto K., 2011, ANTIAGING MED, V8, P69, DOI DOI 10.3793/JAAM.8.69
   Oliveira CPMS, 2002, J CELL MOL MED, V6, P399, DOI 10.1111/j.1582-4934.2002.tb00518.x
   Puche JE, 2008, ENDOCRINOLOGY, V149, P2620, DOI 10.1210/en.2007-1563
   Rafiq N, 2009, CLIN GASTROENTEROL H, V7, P234, DOI 10.1016/j.cgh.2008.11.005
   Saibara T, 2005, HEPATOL RES, V33, P64, DOI 10.1016/j.hepres.2005.09.005
   Sandhu MS, 2002, LANCET, V359, P1740, DOI 10.1016/S0140-6736(02)08655-5
   Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256
   Sanz S, 2005, GUT, V54, P134, DOI 10.1136/gut.2003.024505
   Savastano S, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-136
   Sesti G, 2005, DIABETES CARE, V28, P120, DOI 10.2337/diacare.28.1.120
   SHMUELI E, 1994, HEPATOLOGY, V19, P322
   Sirbu A, 2013, GROWTH HORM IGF RES, V23, P2, DOI 10.1016/j.ghir.2012.10.001
   Sobrevals L, 2010, HEPATOLOGY, V51, P912, DOI 10.1002/hep.23412
   Sumida Y, 2003, J HEPATOL, V38, P32, DOI 10.1016/S0168-8278(02)00331-8
   Tachibana K, 1999, HORUMON TO RINSHO, V47, P903
   Takada M, 1999, IGAKU TO YAKUGAKU, V41, P761
   Takahashi Y, 2007, GASTROENTEROLOGY, V132, P938, DOI 10.1053/j.gastro.2006.12.024
   Takahashi Y, 2012, ENDOCR J, V59, P955, DOI 10.1507/endocrj.EJ12-0322
   Takasu S, 1996, Horumon to Rinsho, V44, P383
   Thissen JP, 1997, ENDOCRINOLOGY, V138, P1078, DOI 10.1210/en.138.3.1078
   Völzke H, 2009, EUR J ENDOCRINOL, V161, P705, DOI 10.1530/EJE-09-0374
NR 54
TC 52
Z9 53
U1 0
U2 10
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1386-6346
EI 1872-034X
J9 HEPATOL RES
JI Hepatol. Res.
PD JUL
PY 2015
VL 45
IS 7
BP 771
EP 781
DI 10.1111/hepr.12408
PG 11
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA CM4WB
UT WOS:000357684900008
PM 25163357
DA 2024-02-19
ER

PT J
AU Griffin, CA
   Giacchetti, G
   Schambelan, M
   Sechi, LA
AF Griffin, CA
   Giacchetti, G
   Schambelan, M
   Sechi, LA
TI Ontogenic expression of renal and hepatic angiotensin II receptor genes
   in the rat
SO NEPHRON
LA English
DT Article
DE AT(1) mRNA; kidney; liver; losartan; PD-123177
ID SUBTYPE MESSENGER-RNAS; TYPE-1 RECEPTOR; DIFFERENTIAL EXPRESSION;
   SMOOTH-MUSCLE; KIDNEY; GROWTH; CLONING; FETUS; IDENTIFICATION; INDUCTION
AB In addition to its well-characterized renal hemodynamic effects, angiotensin II (Ang II) promotes growth of cultured glomerular and tubular cells, suggesting a possible role in renal development. To better define potential developmental effects of Ang II, we examined the expression of Ang II receptors in embryonic (E19) and postnatal(1, 2, 3, 10 days, 6 weeks, 3 and 9 months) rat kidneys, using in situ autoradiography and the nonpeptide antagonists losartan and PD-123177 to identify receptor subtypes. At E19, I-125-[Sar(1), Ile(8)]Ang II binding was equally reduced by losartan and PD-123177, indicating the presence of both AT(1) and AT(2) receptors. A progressive increase in Ang II receptor density occurred after birth, reaching a plateau at day 10. At that time, the AT(1) subtype predominated and was virtually the sole subtype present thereafter. Ang II receptor density and AT(1) mRNA levels decreased in aging rats. Total AT(1) receptor mRNA levels in both kidney and liver were determined by Northern hybridization analysis using a radiolabeled AT(1) anti-sense cRNA probe. In both tissues, ATI mRNA levels increased rapidly following birth, reached a maximum on day 10 and decreased thereafter. To further characterize the ontogenic effects on AT(1) gene expression, renal AT(1A) and AT(1B) receptor mRNA isoforms were determined by reverse transcription and the polymerase chain reaction. No significant differences were observed during maturation between the relative levels of AT(1A) and AT(1B) mRNAs, with the AT(1A) isoform accounting for approximately 78% at any time point. Thus, renal AT(1) receptor density increases rapidly after birth, in association with an increase in both AT(1A) and AT(1B) receptor gene expression. As the predominant receptor isoform in the adult kidney, the AT(1A) receptor may account for the majority of the effects of Ang II on glomerular and tubular function.
C1 UNIV UDINE,DEPT INTERNAL MED,HYPERTENS UNIT,I-33100 UDINE,ITALY.
C3 University of Udine
RP Griffin, CA (corresponding author), UNIV CALIF SAN FRANCISCO,SAN FRANCISCO GEN HOSP,DIV ENDOCRINOL,BLDG 100,ROOM 286,SAN FRANCISCO,CA 94110, USA.
RI Sechi, Leonardo Antonio/Y-3109-2018
OI Giacchetti, Gilberta/0000-0002-3942-1748
FU NHLBI NIH HHS [HL-11046] Funding Source: Medline
CR ABRAHAMSON DR, 1991, SEMIN NEPHROL, V11, P375
   AGUILERA G, 1994, KIDNEY INT, V46, P973, DOI 10.1038/ki.1994.356
   BROWN GP, 1980, ENDOCRINOLOGY, V106, P1923, DOI 10.1210/endo-106-6-1923
   BUMPUS FM, 1991, HYPERTENSION, V17, P720, DOI 10.1161/01.HYP.17.5.720
   BURSON JM, 1994, AM J PHYSIOL, V267, pE260, DOI 10.1152/ajpendo.1994.267.2.E260
   CHANG RSL, 1990, BIOCHEM BIOPH RES CO, V171, P813, DOI 10.1016/0006-291X(90)91218-H
   CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005
   CHIU AT, 1989, BIOCHEM BIOPH RES CO, V165, P196, DOI 10.1016/0006-291X(89)91054-1
   CHIU AT, 1989, EUR J PHARMACOL, V170, P117, DOI 10.1016/0014-2999(89)90145-3
   CIUFFO GM, 1993, AM J PHYSIOL, V265, pF264, DOI 10.1152/ajprenal.1993.265.2.F264
   DOUGLAS JG, 1990, KIDNEY INT, V38, pS43
   FOGO A, 1990, KIDNEY INT, V38, P1068, DOI 10.1038/ki.1990.314
   GOMEZ RA, 1988, ENDOCRINOLOGY, V123, P2298, DOI 10.1210/endo-123-5-2298
   GOMEZ RA, 1988, AM J PHYSIOL, V254, pF582, DOI 10.1152/ajprenal.1988.254.4.F582
   GRADY EF, 1991, J CLIN INVEST, V88, P921, DOI 10.1172/JCI115395
   ICHIKAWA I, 1991, KIDNEY INT, V40, P583, DOI 10.1038/ki.1991.249
   IWAI N, 1992, FEBS LETT, V298, P257, DOI 10.1016/0014-5793(92)80071-N
   IWAI N, 1992, BIOCHEM BIOPH RES CO, V188, P298, DOI 10.1016/0006-291X(92)92384-A
   KAKAR SS, 1992, BIOCHEM BIOPH RES CO, V185, P688, DOI 10.1016/0006-291X(92)91680-O
   KAKAR SS, 1992, BIOCHEM BIOPH RES CO, V183, P1090, DOI 10.1016/S0006-291X(05)80302-X
   KAKUCHI J, 1995, KIDNEY INT, V47, P140, DOI 10.1038/ki.1995.16
   KITAMI Y, 1992, BIOCHEM BIOPH RES CO, V188, P446, DOI 10.1016/0006-291X(92)92405-M
   LLORENSCORTES C, 1994, HYPERTENSION, V24, P538, DOI 10.1161/01.HYP.24.5.538
   MENDELSOHN FAO, 1987, KIDNEY INT, V31, pS40
   MILLAN MA, 1989, SCIENCE, V244, P1340, DOI 10.1126/science.2734613
   MUKOYAMA M, 1993, J BIOL CHEM, V268, P24539
   MURPHY TJ, 1991, NATURE, V351, P233, DOI 10.1038/351233a0
   NAFTILAN AJ, 1990, MOL CELL BIOL, V10, P5536, DOI 10.1128/MCB.10.10.5536
   NAFTILAN AJ, 1989, J CLIN INVEST, V83, P1419, DOI 10.1172/JCI114032
   NOMRAN J, 1987, AM J PHYSIOL, V253, pF299
   PUCELL AG, 1991, ENDOCRINOLOGY, V128, P1947, DOI 10.1210/endo-128-4-1947
   RAY PE, 1993, KIDNEY INT, V11, P34
   ROBILLARD JE, 1994, PEDIATR RES, V36, P755, DOI 10.1203/00006450-199412000-00013
   SANDBERG K, 1992, J BIOL CHEM, V267, P9455
   SASAKI K, 1991, NATURE, V351, P230, DOI 10.1038/351230a0
   SCHELLING P, 1991, J HYPERTENS, V9, P3
   SECHI LA, 1992, AM J PHYSIOL, V262, pF236, DOI 10.1152/ajprenal.1992.262.2.F236
   SECHI LA, 1992, CIRC RES, V71, P1482, DOI 10.1161/01.RES.71.6.1482
   SECHI LA, 1993, AM J PHYSIOL, V265, pG21, DOI 10.1152/ajpgi.1993.265.1.G21
   SECHI LA, 1994, AM J PHYSIOL, V266, pF31, DOI 10.1152/ajprenal.1994.266.1.F31
   SHANMUGAM S, 1995, AM J PHYSIOL-RENAL, V268, pF922, DOI 10.1152/ajprenal.1995.268.5.F922
   SHANMUGAM S, 1994, AM J PHYSIOL-ENDOC M, V267, pE828, DOI 10.1152/ajpendo.1994.267.6.E828
   SHANMUGAM S, 1994, HYPERTENSION, V23, P137, DOI 10.1161/01.HYP.23.1.137
   SPETH RC, 1990, BIOCHEM BIOPH RES CO, V169, P997, DOI 10.1016/0006-291X(90)91993-3
   TAUBMAN MB, 1989, J BIOL CHEM, V264, P526
   TUFROMCREDDIE A, 1993, J CLIN INVEST, V91, P530, DOI 10.1172/JCI116232
   TUFROMCREDDIE A, 1994, AM J PHYSIOL, V266, pF911, DOI 10.1152/ajprenal.1994.266.6.F911
   WALLACE KB, 1980, AM J PHYSIOL, V238, pR432, DOI 10.1152/ajpregu.1980.238.5.R432
   WALLACE KB, 1981, PEDIATR RES, V15, P1088, DOI 10.1203/00006450-198115080-00003
   WHITEBREAD S, 1989, BIOCHEM BIOPH RES CO, V163, P284, DOI 10.1016/0006-291X(89)92133-5
NR 50
TC 10
Z9 10
U1 0
U2 0
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0028-2766
J9 NEPHRON
JI Nephron
PD MAY
PY 1997
VL 76
IS 1
BP 103
EP 110
DI 10.1159/000190148
PG 8
WC Urology & Nephrology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Urology & Nephrology
GA WY142
UT WOS:A1997WY14200017
PM 9171308
DA 2024-02-19
ER

PT J
AU Stuart, GR
   Oda, Y
   de Boer, JG
   Glickman, BW
AF Stuart, GR
   Oda, Y
   de Boer, JG
   Glickman, BW
TI Mutation frequency and specificity with age in liver, bladder and brain
   of <i>lacI</i> transgenic mice
SO GENETICS
LA English
DT Article
ID SPONTANEOUS MUTANT FREQUENCY; MOUSE MUTAGENESIS ASSAY; SOMATIC MUTATION;
   DIETARY RESTRICTION; URINARY-BLADDER; BIG BLUE(R); NUCLEAR-DNA; IN-VIVO;
   GENE; SPECTRUM
AB Mutation frequency and specificity were determined as a function of age in nuclear DNA from liver, bladder, and brain of Big Blue lacI transgenic mice aged 1.5-25 months. Mutations accumulated with age ill liver and accumulated more rapidly in bladder. In the brain a small initial increase in mutation frequency was observed in young animals; however, no further increase was observed in adult mice. To investigate the origin of mutations, tie mutational spectra for each tissue and age were determined. DNA sequence analysis of mutant lad transgenes revealed no significant changes in mutational specificity in any tissue at any age. The spectra of mutations found in aging animals were identical to those in younger animals, suggesting that they originated from a common set of DNA lesions manifested during DNA replication. The data also indicated that there were no significant age-related mutational changes due to oxidative damage, or errors resulting from either changes ill the fidelity of DNA polymerase or the efficiency of DNA repair. Hence, no evidence was found to support hypotheses that predict that oxidative damage or accumulation of errors in nuclear DNA contributes significantly to the aging process, at least in these three somatic tissues.
C1 Univ Victoria, Ctr Environm Hlth, Victoria, BC V8W 3N5, Canada.
   Osaka Prefectural Inst Publ Hlth, Osaka 5370025, Japan.
C3 University of Victoria; Osaka Prefectural Institute of Public Health
RP Stuart, GR (corresponding author), Univ Victoria, Ctr Environm Hlth, POB 3020 STN CSC, Victoria, BC V8W 3N5, Canada.
EM gstuart@uvic.ca
OI Stuart, Victoria/0000-0002-2927-6719
CR ADAMS WT, 1987, J MOL BIOL, V194, P391, DOI 10.1016/0022-2836(87)90669-3
   ADELMAN R, 1988, P NATL ACAD SCI USA, V85, P2706, DOI 10.1073/pnas.85.8.2706
   Alexander P, 1967, Symp Soc Exp Biol, V21, P29
   AMES BN, 1993, ENVIRON HEALTH PERSP, V101, P35, DOI 10.2307/3431840
   AMES BN, 1992, ANN NY ACAD SCI, V663, P85, DOI 10.1111/j.1749-6632.1992.tb38652.x
   Andrew SE, 1997, ONCOGENE, V15, P123, DOI 10.1038/sj.onc.1201180
   Anson RM, 1999, FREE RADICAL BIO MED, V27, P456, DOI 10.1016/S0891-5849(99)00091-X
   Bernstein C., 1991, Aging, sex and DNA repair
   Brackley ME, 1999, MUTAT RES-FUND MOL M, V425, P55, DOI 10.1016/S0027-5107(98)00249-8
   Brodsky W Y, 1977, Int Rev Cytol, V50, P275
   Buettner VL, 1996, MUTAT RES-ENVIR MUTA, V361, P187, DOI 10.1016/S0165-1161(96)00032-5
   Buettner VL, 1999, ENVIRON MOL MUTAGEN, V33, P320, DOI 10.1002/(SICI)1098-2280(1999)33:4<320::AID-EM9>3.0.CO;2-S
   CAMERON I L, 1970, Texas Reports on Biology and Medicine, V28, P203
   CARIELLO NF, 1994, CARCINOGENESIS, V15, P2281, DOI 10.1093/carcin/15.10.2281
   CHENG KC, 1992, J BIOL CHEM, V267, P166
   Chung FL, 1999, MUTAT RES-FUND MOL M, V424, P71, DOI 10.1016/S0027-5107(99)00009-3
   CLAYSON DB, 1966, BRIT J CANCER, V20, P564, DOI 10.1038/bjc.1966.70
   COHEN SM, 1995, FOOD CHEM TOXICOL, V33, P715, DOI 10.1016/0278-6915(95)00040-9
   COHEN SM, 1991, PROG CLIN BIOL RES, V369, P347
   Curry J, 1999, GENETICS, V152, P1065
   CURTIS HJ, 1971, ADV GENET, V16, P305, DOI 10.1016/S0065-2660(08)60361-2
   de Boer JG, 1998, MUTAGENESIS, V13, P109
   de Boer JG, 1998, GENETICS, V148, P1441
   deBoer JG, 1996, MUTAT RES-FUND MOL M, V352, P73, DOI 10.1016/0027-5107(95)00254-5
   DEBOER JG, 1995, ENVIRON MOL MUTAGEN, V25, P256, DOI 10.1002/em.2850250312
   deBoer JG, 1996, ENVIRON MOL MUTAGEN, V28, P418
   deBoer JG, 1997, ENVIRON MOL MUTAGEN, V30, P273
   Dolle MET, 1997, NAT GENET, V17, P431, DOI 10.1038/ng1297-431
   DYCAICO MJ, 1994, MUTAT RES, V307, P461, DOI 10.1016/0027-5107(94)90257-7
   ENESCO HE, 1983, EXP GERONTOL, V18, P79, DOI 10.1016/0531-5565(83)90054-2
   Erfle HL, 1996, ENVIRON MOL MUTAGEN, V28, P393
   FARSUND T, 1975, VIRCHOWS ARCH B, V18, P35
   GENSLER HL, 1981, Q REV BIOL, V56, P279, DOI 10.1086/412317
   GLICKMAN BW, 1995, ENV MUTAGENESIS, P33
   GOSSEN JA, 1995, MUTAT RES-FUND MOL M, V331, P89, DOI 10.1016/0027-5107(95)00055-N
   HAMPSEY DM, 1988, J MOL BIOL, V201, P471, DOI 10.1016/0022-2836(88)90629-8
   Helbock HJ, 1998, P NATL ACAD SCI USA, V95, P288, DOI 10.1073/pnas.95.1.288
   HICKS RM, 1975, BIOL REV, V50, P215, DOI 10.1111/j.1469-185X.1975.tb01057.x
   Hirano T, 1996, J GERONTOL A-BIOL, V51, pB303, DOI 10.1093/gerona/51A.5.B303
   JOST SP, 1989, VIRCHOWS ARCH B, V57, P27, DOI 10.1007/BF02899062
   JOST SP, 1986, CELL TISSUE KINET, V19, P155, DOI 10.1111/j.1365-2184.1986.tb00725.x
   Kaneko T, 1997, FREE RADICAL BIO MED, V23, P76, DOI 10.1016/S0891-5849(96)00622-3
   Kawanishi M, 1998, CARCINOGENESIS, V19, P69, DOI 10.1093/carcin/19.1.69
   KAWANISHI M, 1999, MUTAT RES, V417, P65
   KETTERLING RP, 1994, AM J HUM GENET, V54, P201
   KOHLER SW, 1991, P NATL ACAD SCI USA, V88, P7958, DOI 10.1073/pnas.88.18.7958
   KOHLER SW, 1990, NUCLEIC ACIDS RES, V18, P3007, DOI 10.1093/nar/18.10.3007
   Korr H, 1980, Adv Anat Embryol Cell Biol, V61, P1
   KORR H, 1983, CELL TISSUE KINET, V16, P393
   Kowald A, 1996, MUTAT RES-DNAGING G, V316, P209, DOI 10.1016/S0921-8734(96)90005-3
   LEE AT, 1994, FASEB J, V8, P545, DOI 10.1096/fasebj.8.8.8181674
   Matsuda T, 1998, NUCLEIC ACIDS RES, V26, P1769, DOI 10.1093/nar/26.7.1769
   MEDVEDEV ZA, 1990, BIOL REV, V65, P375, DOI 10.1111/j.1469-185X.1990.tb01428.x
   Mirsalis JC, 1995, TOXICOL LETT, V82-3, P131, DOI 10.1016/0378-4274(95)03472-2
   MORLEY AA, 1995, MUTAT RES-DNAGING G, V338, P19, DOI 10.1016/0921-8734(95)00007-S
   Narayanan L, 1997, P NATL ACAD SCI USA, V94, P3122, DOI 10.1073/pnas.94.7.3122
   Nath RG, 1996, CANCER RES, V56, P452
   Okonogi H, 1997, MUTAT RES-GEN TOX EN, V395, P93, DOI 10.1016/S1383-5718(97)00146-0
   ONO T, 1995, MUTAT RES-DNAGING G, V338, P183, DOI 10.1016/0921-8734(95)00023-Y
   OSTROVSKY YM, 1986, ALCOHOL, V3, P239, DOI 10.1016/0741-8329(86)90032-7
   PIEGORSCH WW, 1994, GENETICS, V136, P403
   PROVOST GS, 1994, P NATL ACAD SCI USA, V91, P6564, DOI 10.1073/pnas.91.14.6564
   PROVOST GS, 1993, MUTAT RES, V288, P133
   ROGERS BJ, 1995, MUTAT RES-FUND MOL M, V327, P57, DOI 10.1016/0027-5107(94)00081-F
   Shane BS, 1999, CARCINOGENESIS, V20, P1315, DOI 10.1093/carcin/20.7.1315
   SHIGENAGA MK, 1993, BASIC LIFE SCI, V61, P419
   SKOPEK TR, 1995, ENVIRON MOL MUTAGEN, V26, P9, DOI 10.1002/em.2850260103
   STRATAGENE, 1997, BIG BLUE TRANSGENIC
   Stuart GR, 1996, ENVIRON MOL MUTAGEN, V28, P385, DOI 10.1002/(SICI)1098-2280(1996)28:4<385::AID-EM12>3.0.CO;2-B
   Suri A, 1996, MUTAT RES-FUND MOL M, V372, P23, DOI 10.1016/S0027-5107(96)00105-4
   SZILARD L, 1959, P NATL ACAD SCI USA, V45, P30, DOI 10.1073/pnas.45.1.30
   Taguchi T, 1997, MECH AGEING DEV, V99, P33, DOI 10.1016/S0047-6374(97)00092-4
   TAO KS, 1993, P NATL ACAD SCI USA, V90, P10681, DOI 10.1073/pnas.90.22.10681
   Vijg J, 1997, MECH AGEING DEV, V99, P257
   WALKER BE, 1958, CHROMOSOMA, V9, P105
   Walker VE, 1996, CANCER RES, V56, P4654
   WINEGAR RA, 1994, MUTAT RES, V307, P479, DOI 10.1016/0027-5107(94)90258-5
   Winick M, 1972, Curr Concepts Nutr, V1, P49
   You YH, 1998, MUTAT RES-GEN TOX EN, V420, P55, DOI 10.1016/S1383-5718(98)00147-8
   YOUNG RR, 1995, MUTAT RES-FUND MOL M, V327, P67, DOI 10.1016/0027-5107(94)00080-O
   ZHANG XB, 1995, MUTAT RES-DNAGING G, V338, P189, DOI 10.1016/0921-8734(95)00024-Z
NR 81
TC 90
Z9 95
U1 0
U2 4
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0016-6731
EI 1943-2631
J9 GENETICS
JI Genetics
PD MAR
PY 2000
VL 154
IS 3
BP 1291
EP 1300
PG 10
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 291EE
UT WOS:000085720500028
PM 10757770
DA 2024-02-19
ER

PT J
AU SOHAL, RS
   AGARWAL, S
   SOHAL, BH
AF SOHAL, RS
   AGARWAL, S
   SOHAL, BH
TI OXIDATIVE STRESS AND AGING IN THE MONGOLIAN GERBIL
   (MERIONES-UNGUICULATUS)
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE AGING; OXIDATIVE STRESS; OXYGEN FREE RADICALS; GERBIL; PROTEIN DAMAGE;
   DNA DAMAGE
ID HYDROGEN-PEROXIDE; GLUTATHIONE-REDUCTASE; SUPEROXIDE-DISMUTASE;
   INORGANIC PEROXIDES; DAMAGE; AGE; 8-HYDROXY-2'-DEOXYGUANOSINE;
   MITOCHONDRIA; LONGEVITY; PROTEINS
AB The objective of this study was to determine if aging in the gerbil, Meriones unguiculatus, is associated with elevation in the level of oxidative stress. Studies were conducted on the brain, heart, kidney, liver and testis of young (3-6 months), adult (15 months), and old (23-25 months) animals. Oxidative damage to proteins, measured as the concentration of protein carbonyls and loss of activity of glucose-6-phosphate dehydrogenase, and to DNA, measured as the concentration of 8-hydroxydeoxyguanosine, increased with age of the animals. There was no appreciable age-related change in the activity of alkaline proteases, which preferentially degrade oxidized protein. Rates of mitochondrial superoxide anion radical and hydrogen peroxide generation also increased with age, most notably in the heart. Antioxidative defenses, measured as activities of superoxide dismutase, catalase and glutathione peroxidase and concentration of glutathione, did not exhibit a uniform pattern of age-related changes. However, when the antioxidative potential of the tissue homogenates was measured as their susceptibility to undergo protein oxidation, in response to experimentally-induced oxidative stress, using X-irradiation, tissues of the old animals were significantly more vulnerable than those of the young animals. Results of this study are interpreted to indicate: (i) that the level of molecular oxidative damage to DNA and proteins increases with age, and (ii) that the increased oxidative damage is due to both an, elevation in the rates of oxidant generation and an increase in the susceptibility of tissues to oxidative damage.
RP SOHAL, RS (corresponding author), SO METHODIST UNIV, DEPT BIOL SCI, DALLAS, TX 75275 USA.
CR AGARWAL S, 1993, BIOCHEM BIOPH RES CO, V194, P1203, DOI 10.1006/bbrc.1993.1950
   AGARWAL S, 1994, MECH AGEING DEV, V75, P11, DOI 10.1016/0047-6374(94)90024-8
   AGARWAL S, 1994, P NATL ACAD SCI USA, V91, P12332, DOI 10.1073/pnas.91.25.12332
   AGARWAL S, 1994, ARCH BIOCHEM BIOPHYS, V309, P24, DOI 10.1006/abbi.1994.1078
   ALLEN RG, 1984, COMP BIOCHEM PHYS C, V78, P283, DOI 10.1016/0742-8413(84)90084-7
   AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   BARJA G, 1994, COMP BIOCHEM PHYS B, V108, P501, DOI 10.1016/0305-0491(94)90103-1
   Beutler E., 1971, Red Cell Metabolism
   BOVERIS A, 1984, METHOD ENZYMOL, V105, P429
   CARNEY JM, 1991, P NATL ACAD SCI USA, V88, P3633, DOI 10.1073/pnas.88.9.3633
   Cheal M L, 1987, Basic Life Sci, V42, P145
   DONATO H, 1979, EXP GERONTOL, V14, P133, DOI 10.1016/0531-5565(79)90028-7
   FRAGA CG, 1990, P NATL ACAD SCI USA, V87, P4533, DOI 10.1073/pnas.87.12.4533
   FUCCI L, 1983, P NATL ACAD SCI-BIOL, V80, P1521, DOI 10.1073/pnas.80.6.1521
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HYSLOP PA, 1984, ANAL BIOCHEM, V141, P280, DOI 10.1016/0003-2697(84)90457-3
   KU HH, 1993, FREE RADICAL BIO MED, V15, P621, DOI 10.1016/0891-5849(93)90165-Q
   LEVINE RL, 1990, METHOD ENZYMOL, V186, P464
   Luck H., 1971, Methods of enzyme analysis, P885, DOI DOI 10.1016/B978-0-12-395630-9.50158-4
   MATSUO M, 1994, FREE RADICALS AGING, P143
   MISRA HP, 1977, ANAL BIOCHEM, V79, P553, DOI 10.1016/0003-2697(77)90429-8
   OLIVER CN, 1987, J BIOL CHEM, V262, P5488
   ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730
   PAGLIA DE, 1967, J LAB CLIN MED, V70, P158
   RIVETT AJ, 1985, J BIOL CHEM, V260, P2600
   SHIGENAGA MK, 1990, METHOD ENZYMOL, V186, P521
   SOHAL RS, 1990, FREE RADICAL BIO MED, V9, P495, DOI 10.1016/0891-5849(90)90127-5
   SOHAL RS, 1990, MECH AGEING DEV, V56, P223, DOI 10.1016/0047-6374(90)90084-S
   SOHAL RS, 1991, MECH AGEING DEV, V57, P187, DOI 10.1016/0047-6374(91)90034-W
   SOHAL RS, 1994, MECH AGEING DEV, V74, P121, DOI 10.1016/0047-6374(94)90104-X
   SOHAL RS, 1993, P NATL ACAD SCI USA, V90, P7255, DOI 10.1073/pnas.90.15.7255
   SOHAL RS, 1994, FREE RADICAL BIO MED, V16, P621, DOI 10.1016/0891-5849(94)90062-0
   SOHAL RS, 1994, MECH AGEING DEV, V76, P215, DOI 10.1016/0047-6374(94)91595-4
   SOHAL RS, 1993, AGING-CLIN EXP RES, V5, P3, DOI 10.1007/BF03324120
   TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5
NR 35
TC 147
Z9 158
U1 0
U2 3
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
EI 1872-6216
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD JUN 30
PY 1995
VL 81
IS 1
BP 15
EP 25
DI 10.1016/0047-6374(94)01578-A
PG 11
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA RJ565
UT WOS:A1995RJ56500002
PM 7475349
DA 2024-02-19
ER

PT J
AU Mueller, KM
   Hartmann, K
   Kaltenecker, D
   Vettorazzi, S
   Bauer, M
   Mauser, L
   Amann, S
   Jall, S
   Fischer, K
   Esterbauer, H
   Müller, TD
   Tschöp, MH
   Magnes, C
   Haybaeck, J
   Scherer, T
   Bordag, N
   Tuckermann, JP
   Moriggl, R
AF Mueller, Kristina M.
   Hartmann, Kerstin
   Kaltenecker, Doris
   Vettorazzi, Sabine
   Bauer, Mandy
   Mauser, Lea
   Amann, Sabine
   Jall, Sigrid
   Fischer, Katrin
   Esterbauer, Harald
   Mueller, Timo D.
   Tschoep, Matthias H.
   Magnes, Christoph
   Haybaeck, Johannes
   Scherer, Thomas
   Bordag, Natalie
   Tuckermann, Jan P.
   Moriggl, Richard
TI Adipocyte Glucocorticoid Receptor Deficiency Attenuates Aging- and
   HFD-Induced Obesity and Impairs the Feeding-Fasting Transition
SO DIABETES
LA English
DT Article
ID SWITCH GENE 2; ADIPOSE-TISSUE; INSULIN-RESISTANCE; ENERGY-METABOLISM;
   VISCERAL OBESITY; LIPID-METABOLISM; CYCLE FUNCTION; FATTY-ACID;
   LIPOLYSIS; LIVER
AB Glucocorticoids (GCs) are important regulators of systemic energy metabolism, and aberrant GC action is linked to metabolic dysfunctions. Yet, the extent to which normal and pathophysiological energy metabolism depend on the GC receptor (GR) in adipocytes remains unclear. Here, we demonstrate that adipocyte GR deficiency in mice significantly impacts systemic metabolism in different energetic states. Plasma metabolomics and biochemical analyses revealed a marked global effect of GR deficiency on systemic metabolite abundance and, thus, substrate partitioning in fed and fasted states. This correlated with a decreased lipolytic capacity of GR-deficient adipocytes under postabsorptive and fasting conditions, resulting from impaired signal transduction from beta-adrenergic receptors to adenylate cyclase. Upon prolonged fasting, the impaired lipolytic response resulted in abnormal substrate utilization and lean mass wasting. Conversely, GR deficiency attenuated aging-/diet-associated obesity, adipocyte hypertrophy, and liver steatosis. Systemic glucose tolerance was improved in obese GR-deficient mice, which was associated with increased insulin signaling in muscle and adipose tissue. We conclude that the GR in adipocytes exerts central but diverging roles in the regulation of metabolic homeostasis depending on the energetic state. The adipocyte GR is indispensable for the feeding-fasting transition but also promotes adiposity and associated metabolic disorders in fat-fed and aged mice.
C1 [Mueller, Kristina M.; Moriggl, Richard] Univ Vet Med Vienna, Inst Anim Breeding & Genet, Vienna, Austria.
   [Mueller, Kristina M.; Kaltenecker, Doris; Moriggl, Richard] Ludwig Boltzmann Inst Canc Res, Vienna, Austria.
   [Hartmann, Kerstin; Vettorazzi, Sabine; Bauer, Mandy; Mauser, Lea; Tuckermann, Jan P.] Univ Ulm, Inst Comparat Mol Endocrinol, Ulm, Germany.
   [Amann, Sabine; Esterbauer, Harald] Med Univ Vienna, Dept Lab Med, Vienna, Austria.
   [Jall, Sigrid; Fischer, Katrin; Mueller, Timo D.; Tschoep, Matthias H.] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Diabet & Obes Helmholtz Diabet Ctr, Vienna, Austria.
   [Jall, Sigrid; Fischer, Katrin; Mueller, Timo D.; Tschoep, Matthias H.] German Ctr Diabet Res DZD, Neuherberg, Germany.
   [Jall, Sigrid; Fischer, Katrin; Mueller, Timo D.; Tschoep, Matthias H.] Tech Univ Munich, Div Metab Dis, Dept Med, Munich, Germany.
   [Magnes, Christoph] Forsch Gesell mbH, HLTH Inst Biomed & Hlth Sci, JOANNEUM RES, Graz, Austria.
   [Haybaeck, Johannes] Med Univ Graz, Inst Pathol, Graz, Austria.
   [Scherer, Thomas] Med Univ Vienna, Div Endocrinol & Metab, Dept Med 3, Vienna, Austria.
   [Bordag, Natalie] CBmed GmbH, Ctr Biomarker Res Med, Graz, Austria.
   [Moriggl, Richard] Med Univ Vienna, Vienna, Austria.
C3 University of Veterinary Medicine Vienna; Ludwig Boltzmann Institute;
   Ulm University; Medical University of Vienna; Technical University of
   Munich; Medical University of Graz; Medical University of Vienna;
   Medical University of Vienna
RP Moriggl, R (corresponding author), Univ Vet Med Vienna, Inst Anim Breeding & Genet, Vienna, Austria.; Moriggl, R (corresponding author), Ludwig Boltzmann Inst Canc Res, Vienna, Austria.; Tuckermann, JP (corresponding author), Univ Ulm, Inst Comparat Mol Endocrinol, Ulm, Germany.; Moriggl, R (corresponding author), Med Univ Vienna, Vienna, Austria.
EM jan.tuckermann@uni-ulm.de; richard.moriggl@lbicr.lbg.ac.at
RI Müller, Timo D./AAZ-4445-2020; Bordag, Natalie/M-7957-2013; Moriggl,
   Richard/H-8118-2019
OI Bordag, Natalie/0000-0002-9505-6271; Moriggl,
   Richard/0000-0003-0918-9463; Esterbauer, Harald/0000-0001-7343-7455;
   Scherer, Thomas/0000-0003-4980-706X; Fischer,
   Katrin/0000-0001-5278-3949; Jall, Sigrid/0000-0001-8716-4523;
   Vettorazzi, Dr. Sabine/0000-0001-8667-9488; Muller,
   Timo/0000-0002-0624-9339; Magnes, Christoph/0000-0002-5153-7444
FU Austrian Science Fund (FWF) [P26766, SFB F2807-620, SFB F4707-820];
   Deutsche Forschungsgemeinschaft (grants Priority Program Immunobone)
   [1468/Tu 220/6-1, 1468/Tu 220/6-2]; Collaborative Research Centre
   [1149/C02/INST 40/492-1, DFG-ANR/TU 220/13-1]; European Union Research
   and Innovation funding program (FP7 BRAINAGE); Osterreichische
   Forschungsforderungsgesellschaft (COMET Program/K1 COMET Competence
   Center CBmed, Land Steiermark and Land Wien); Austrian Science Fund
   (FWF) [P26766] Funding Source: Austrian Science Fund (FWF)
FX This work was supported by the Austrian Science Fund (FWF P26766 to T.S.
   and SFB F2807-620 and SFB F4707-820 to R.M.), the Deutsche
   Forschungsgemeinschaft (grants Priority Program Immunobone 1468/Tu
   220/6-1, 6-2, Collaborative Research Centre 1149/C02/INST 40/492-1, and
   DFG-ANR/TU 220/13-1), and the European Union Research and Innovation
   funding program (FP7 BRAINAGE) to J.P.T. Part of this work was funded by
   the Osterreichische Forschungsforderungsgesellschaft (COMET Program/K1
   COMET Competence Center CBmed, Land Steiermark and Land Wien).
CR Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002
   Bajad SU, 2006, J CHROMATOGR A, V1125, P76, DOI 10.1016/j.chroma.2006.05.019
   Bartness TJ, 2010, MOL CELL ENDOCRINOL, V318, P34, DOI 10.1016/j.mce.2009.08.031
   Bordag N, 2015, SCI REP-UK, V5, DOI 10.1038/srep15954
   Chimin P, 2014, ACTA PHYSIOL, V211, P409, DOI 10.1111/apha.12226
   Eguchi J, 2011, CELL METAB, V13, P249, DOI 10.1016/j.cmet.2011.02.005
   Engblom D, 2007, GENE DEV, V21, P1157, DOI 10.1101/gad.426007
   Engeli S, 2004, OBES RES, V12, P9, DOI 10.1038/oby.2004.3
   Fröhlich EE, 2016, BRAIN BEHAV IMMUN, V56, P140, DOI 10.1016/j.bbi.2016.02.020
   Gathercole LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026223
   Geer EB, 2014, ENDOCRIN METAB CLIN, V43, P75, DOI 10.1016/j.ecl.2013.10.005
   Goossens GH, 2008, PHYSIOL BEHAV, V94, P206, DOI 10.1016/j.physbeh.2007.10.010
   Gray NE, 2012, J BIOL CHEM, V287, P8444, DOI 10.1074/jbc.M111.294124
   Heckmann BL, 2014, J BIOL CHEM, V289, P1905, DOI 10.1074/jbc.M113.522011
   Jaeger D, 2015, J HEPATOL, V63, P437, DOI 10.1016/j.jhep.2015.02.035
   Kershaw EE, 2005, DIABETES, V54, P1023, DOI 10.2337/diabetes.54.4.1023
   Koonen DPY, 2007, DIABETES, V56, P2863, DOI 10.2337/db07-0907
   Kumashiro N, 2013, DIABETES, V62, P2183, DOI 10.2337/db12-1311
   LACASA D, 1988, BIOCHEM BIOPH RES CO, V153, P489, DOI 10.1016/S0006-291X(88)81121-5
   Lee MJ, 2008, OBESITY, V16, P1178, DOI 10.1038/oby.2008.207
   Li YQ, 2016, P NATL ACAD SCI USA, V113, P446, DOI 10.1073/pnas.1517142113
   Liang QN, 2014, DIABETES, V63, P4064, DOI 10.2337/db14-0541
   Lim HW, 2015, GENOME RES, V25, P836, DOI 10.1101/gr.188581.114
   Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285
   Morán-Salvador E, 2011, FASEB J, V25, P2538, DOI 10.1096/fj.10-173716
   Morgan SA, 2014, P NATL ACAD SCI USA, V111, pE2482, DOI 10.1073/pnas.1323681111
   Morton NM, 2004, DIABETES, V53, P931, DOI 10.2337/diabetes.53.4.931
   Mottillo EP, 2014, J LIPID RES, V55, P2276, DOI 10.1194/jlr.M050005
   Müller TD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2968
   Okun JG, 2015, MOL METAB, V4, P732, DOI 10.1016/j.molmet.2015.07.006
   Perry RJ, 2014, NAT MED, V20, P759, DOI 10.1038/nm.3579
   REBRIN K, 1995, DIABETES, V44, P1038, DOI 10.2337/diabetes.44.9.1038
   Rose AJ, 2013, MOL CELL ENDOCRINOL, V380, P65, DOI 10.1016/j.mce.2013.03.007
   Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012
   SAITO N, 1989, P NATL ACAD SCI USA, V86, P3906, DOI 10.1073/pnas.86.10.3906
   Samuel VT, 2016, J CLIN INVEST, V126, P12, DOI 10.1172/JCI77812
   Satapati S, 2012, J LIPID RES, V53, P1080, DOI 10.1194/jlr.M023382
   Scherer T, 2011, CELL METAB, V13, P183, DOI 10.1016/j.cmet.2011.01.008
   Schreiber R, 2015, P NATL ACAD SCI USA, V112, P13850, DOI 10.1073/pnas.1516004112
   Schweiger M, 2014, METHOD ENZYMOL, V538, P171, DOI 10.1016/B978-0-12-800280-3.00010-4
   Shimizu N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7693
   Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2
   Team RC, 2020, R: A Language and Environment for Statistical
   Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703
   Tschöp MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]
   Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307
   Wilson CG, 2016, ENDOCRINOLOGY, V157, P570, DOI 10.1210/en.2015-1866
   Wu JW, 2012, ENDOCRINOLOGY, V153, P2198, DOI 10.1210/en.2011-1518
   Wu QW, 2006, DIABETES, V55, P3229, DOI 10.2337/db06-0749
   Xu C, 2009, MOL ENDOCRINOL, V23, P1161, DOI 10.1210/me.2008-0464
   Yu CY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015188
   Yuan M, 2012, NAT PROTOC, V7, P872, DOI 10.1038/nprot.2012.024
   Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018
NR 53
TC 48
Z9 50
U1 0
U2 21
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0012-1797
EI 1939-327X
J9 DIABETES
JI Diabetes
PD FEB
PY 2017
VL 66
IS 2
BP 272
EP 286
DI 10.2337/db16-0381
PG 15
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA EI7PS
UT WOS:000392691000007
PM 27650854
OA Bronze
DA 2024-02-19
ER

PT J
AU Hsiao, HY
   Hsu, PJ
   Sampurna, BP
   Lin, YJ
   Lin, KH
   Zhao, YN
   Wang, HD
   Yuh, CH
AF Hsiao, He-Yun
   Hsu, Po-Jui
   Sampurna, Bonifasius Putera
   Lin, Yu-Ju
   Lin, Kuan-Hao
   Zhao, Yu-Ning
   Wang, Horng-Dar
   Yuh, Chiou-Hwa
TI The Comprehensive Effects of <i>Carassius auratus</i> Complex Formula
   against Lipid Accumulation, Hepatocarcinogenesis, and COVID-19
   Pathogenesis via Stabilized G-Quadruplex and Reduced Cell Senescence
SO ADVANCED BIOLOGY
LA English
DT Article; Early Access
DE Carassius auratus complex formula; coronavirus; hepatocarcinogenesis;
   microbial; steatosis
ID TELOMERASE REVERSE-TRANSCRIPTASE; TRADITIONAL CHINESE MEDICINE;
   ZEBRAFISH; LIVER; STEATOHEPATITIS; EXPRESSION; PROTEIN; GENE
AB Carassius auratus complex formula (CACF) is a traditional Chinese medicine known for its antidiabetic effects. Hepatocellular carcinoma (HCC) is a major cause of cancer-related deaths worldwide, and there are currently no effective therapies for advanced HCC. This study explores the comprehensive effects and possible mechanisms of CACF on HCC. The results show that CACF reduces the viability of hepatoma cells in vitro, while benefiting normal hepatocytes. In addition, CACF inhibits hepatoma cell growth in a zebrafish xenotransplantation model and decreases lipid accumulation, represses inflammation and cell proliferation markers in fatty acid translocase (CD36) transgenic zebrafish, and inhibits the expression of cell proliferation and beta-catenin downstream targets in telomerase (tert) transgenic zebrafish models. Ingenuity Pathway Analysis reveals that CACF exerts multiple functions, including reduction of inflammation and inhibition of lipid transporter and PPAR signaling pathway. Surprisingly, CACF also regulates the expression of genes and reduces coronavirus infection and pathogenesis in a zebrafish model. CACF treatment is validated to regulate the expression of genes for anti-coronavirus activity. Mechanistically, CACF stabilizes G-quadruplex and reduces cell senescence associated beta-galactosidase activity. In summary, CACF may be a promising therapeutic agent with multiple functions including anticancer, anti-inflammation, and anti-microorganisms in a zebrafish model.
C1 [Hsiao, He-Yun; Hsu, Po-Jui; Sampurna, Bonifasius Putera; Lin, Yu-Ju; Lin, Kuan-Hao; Zhao, Yu-Ning; Yuh, Chiou-Hwa] Natl Hlth Res Inst, Inst Mol & Genom Med, 35 Keyan Rd, Miaoli 35053, Taiwan.
   [Hsiao, He-Yun; Hsu, Po-Jui; Wang, Horng-Dar] Natl Tsing Hua Univ, Inst Biotechnol, 101,Sect 2, Kuang Fu Rd, Hsinchu 101, Taiwan.
   [Hsu, Po-Jui] Mackay Mem Hosp, Dept Lab Med, 92,Sec 2,Zhongshan N Rd, Taipei 10449, Taiwan.
   [Hsu, Po-Jui] Yuanpei Univ Med Technol, Dept Med Lab Sci & Biotechnol, 306 Yuanpei St, Hsinchu 30015, Taiwan.
   [Hsu, Po-Jui] MacKay Med Coll, Dept Nursing, 46,Sec 3,Zhongzheng Rd, New Taipei 252, Taiwan.
   [Yuh, Chiou-Hwa] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, 101,Sect 2,Kuang Fu Rd, Hsinchu 300044, Taiwan.
   [Yuh, Chiou-Hwa] Natl Yang Ming Chiao Tung Univ, Dept Biol Sci & Technol, 1001 Daxue Rd, Hsinchu 300093, Taiwan.
   [Yuh, Chiou-Hwa] Kaohsiung Med Univ, PhD Program Environm & Occupat Med, No 100, 100 Shih Chuan 1st Rd, Kaohsiung 80708, Taiwan.
C3 National Health Research Institutes - Taiwan; National Tsing Hua
   University; Mackay Memorial Hospital; Mackay Medical College; National
   Tsing Hua University; National Yang Ming Chiao Tung University;
   Kaohsiung Medical University
RP Yuh, CH (corresponding author), Natl Hlth Res Inst, Inst Mol & Genom Med, 35 Keyan Rd, Miaoli 35053, Taiwan.; Wang, HD (corresponding author), Natl Tsing Hua Univ, Inst Biotechnol, 101,Sect 2, Kuang Fu Rd, Hsinchu 101, Taiwan.; Yuh, CH (corresponding author), Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, 101,Sect 2,Kuang Fu Rd, Hsinchu 300044, Taiwan.; Yuh, CH (corresponding author), Natl Yang Ming Chiao Tung Univ, Dept Biol Sci & Technol, 1001 Daxue Rd, Hsinchu 300093, Taiwan.; Yuh, CH (corresponding author), Kaohsiung Med Univ, PhD Program Environm & Occupat Med, No 100, 100 Shih Chuan 1st Rd, Kaohsiung 80708, Taiwan.
EM hdwang@life.nthu.edu.tw; chyuh@nhri.edu.tw
RI Li, YiXue/JRW-6306-2023; qi, li/JFE-7167-2023; Liu, Jing/IQX-0664-2023
OI Hsu, Po-Jui/0000-0001-7153-1202; Yuh, Chiou-Hwa/0000-0002-2356-1551
FU NSTC [111-2320-B-400-018-MY3, 111-2320-B-007-006-MY3]; National Science
   and Technology Council; National Health Research Institutes
   [MG-109-PP-06]
FX The authors would like to thank Chia-Yueh Liao from the Everprofit Crop.
   for providing the material: Carassius Auratus complex formula (CACF) for
   this study. The authors also like to thank the Taiwan Zebrafish Core
   Facility at NTHU-NHRI for providing fish lines, resources, and technical
   support. Taiwan Zebrafish Core Facility at National Health Research
   Institutes was supported by a grant from NSTC (111-2740-B-400-001).
   Finally, the authors would like to thank Optical Biology Core at NHRI
   for technical support. This research was funded by National Science and
   Technology Council (Grant Nos. NSTC 111-2320-B-400-018-MY3 and
   111-2320-B-007-006-MY3), and National Health Research Institutes (Grant
   No. MG-109-PP-06).
CR Awadasseid A, 2021, BIOMED PHARMACOTHER, V139, DOI 10.1016/j.biopha.2021.111550
   Balasubramanian S, 2011, NAT REV DRUG DISCOV, V10, P261, DOI 10.1038/nrd3428
   Barker H, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240647
   Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349
   Buttmann M, 2007, J VASC RES, V44, P51, DOI 10.1159/000097977
   Cebrián R, 2021, J MED CHEM, DOI [10.1021/acs.jmedchem.1c01905, 10.1021/acs.jmedhcme.1c01905]
   Cheng CC, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10060898
   Chou YT, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2003714
   Christenson J. C., 2018, PRINCIPLES PRACTICE
   Combes T. W., 2021, IMMUNOTHERAPY ADV, V1, P003
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   de Oliveira S, 2019, J HEPATOL, V70, P710, DOI 10.1016/j.jhep.2018.11.034
   Enciu AM, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/7801202
   Ferber MJ, 2003, ONCOGENE, V22, P3813, DOI 10.1038/sj.onc.1206528
   Goessling W, 2015, GASTROENTEROLOGY, V149, P1361, DOI 10.1053/j.gastro.2015.08.034
   Goldsmith JR, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/817341
   Haraoka Y, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-29061-6
   Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111
   Hsu PJ, 2021, J BIOMED SCI, V28, DOI 10.1186/s12929-020-00707-1
   Hsu YL, 2008, J GASTROEN HEPATOL, V23, pE290, DOI 10.1111/j.1440-1746.2008.05390.x
   Hudzicki J., 2009, KIRBY BAUER DISK DIF
   Inoue M, 2005, BIOCHEM BIOPH RES CO, V336, P215, DOI 10.1016/j.bbrc.2005.08.070
   Ito M, 2007, HEPATOL RES, V37, P50, DOI 10.1111/j.1872-034X.2007.00008.x
   Jorgensen JH, 2009, CLIN INFECT DIS, V49, P1749, DOI 10.1086/647952
   KIM MJ, 2004, PLANTA MED, V4, P1489
   KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428
   Kincaid RP, 2018, P NATL ACAD SCI USA, V115, P8197, DOI 10.1073/pnas.1802326115
   Kirstein MM, 2020, INTERNIST, V61, P164, DOI 10.1007/s00108-019-00722-x
   Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343
   LEE J, 2022, ANN HUM GENET, V11, P2485
   Li L, 2017, NEOPLASMA, V64, P778, DOI 10.4149/neo_2017_517
   Li ZQ, 1998, WORLD J GASTROENTERO, V4, P360, DOI 10.3748/wjg.v4.i4.360
   Liao X, 2020, GENES DIS, V7, P370, DOI 10.1016/j.gendis.2019.10.016
   Liao YX, 2019, NUCLEIC ACIDS RES, V47, pW199, DOI 10.1093/nar/gkz401
   Llovet JM, 2016, NAT REV DIS PRIMERS, V2, DOI [10.1038/nrdp.2016.18, 10.1038/nrdp.2016.19]
   Lu JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085318
   Luo XQ, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-03596-w
   Mak Lung-Yi, 2018, Am Soc Clin Oncol Educ Book, V38, P262, DOI 10.1200/EDBK_200939
   Marques IJ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-128
   Memon RA, 1999, DIABETES, V48, P121, DOI 10.2337/diabetes.48.1.121
   Miglietta G, 2021, NUCLEIC ACIDS RES, V49, P6673, DOI 10.1093/nar/gkab500
   Mimeault M, 2013, DRUG DISCOV TODAY, V18, P128, DOI 10.1016/j.drudis.2012.08.002
   Nugent CI, 1998, GENE DEV, V12, P1073, DOI 10.1101/gad.12.8.1073
   OH MR, 2023, APPL PHYS LETT, DOI DOI 10.1007/S00394-022-03075-8
   Palermo E, 2021, BIOLOGY-BASEL, V10, DOI 10.3390/biology10090829
   Patton EE, 2021, NAT REV DRUG DISCOV, V20, P611, DOI 10.1038/s41573-021-00210-8
   Pfister D, 2021, NATURE, V592, P450, DOI 10.1038/s41586-021-03362-0
   Reeves HL, 2016, DIGEST DIS SCI, V61, P1234, DOI 10.1007/s10620-016-4085-6
   Rekha RD, 2008, TOXICOLOGY, V243, P11, DOI 10.1016/j.tox.2007.09.007
   Ryu MJ, 2020, MOLECULES, V25, DOI 10.3390/molecules25245835
   Sengupta A, 2019, MOLECULES, V24, DOI 10.3390/molecules24030582
   Shay JW, 2019, NAT REV GENET, V20, P299, DOI 10.1038/s41576-019-0099-1
   Spitsbergen Jan M., 2003, Toxicologic Pathology, V31, P62, DOI 10.1080/01926230390174959
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Thadathil N, 2022, AGING CELL, V21, DOI 10.1111/acel.13676
   Tsai KC, 2021, BIOMED PHARMACOTHER, V133, DOI 10.1016/j.biopha.2020.111037
   Tu HC, 2017, HEPATOL COMMUN, V1, P230, DOI 10.1002/hep4.1032
   Villanueva A, 2019, NEW ENGL J MED, V380, P1450, DOI 10.1056/NEJMra1713263
   Vogt Andreas, 2010, J Vis Exp, DOI 10.3791/1900
   Wang Z. H., 2014, J EVIDENCE BASED COM, V2014
   Worm N, 2020, NUTRIENTS, V12, DOI 10.3390/nu12051316
   Wu SY, 2020, CLIN TRANSL MED, V10, DOI 10.1002/ctm2.252
   Wu ZB, 2018, J APPL MICROBIOL, V124, P829, DOI 10.1111/jam.13674
   Yang M, 2017, BLOOD, V129, P2917, DOI 10.1182/blood-2016-11-750133
   ZHANG H, 2023, PHYS REV LETT, V303
   Zhang RJ, 2013, J AGR FOOD CHEM, V61, P7786, DOI 10.1021/jf4018492
   Zhang ZG, 2017, INT J MOL MED, V40, P1602, DOI 10.3892/ijmm.2017.3130
   Zhao CQ, 2021, ANGEW CHEM INT EDIT, V60, P432, DOI 10.1002/anie.202011419
   Zhao L, 2018, J HEPATOL, V69, P705, DOI 10.1016/j.jhep.2018.04.006
   Zhou Z, 2020, CELL HOST MICROBE, V27, P883, DOI 10.1016/j.chom.2020.04.017
NR 70
TC 0
Z9 0
U1 0
U2 5
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 2701-0198
J9 ADV BIOL-GER
JI Adv. Biol.
PD 2023 JUL
PY 2023
VL 7
IS 7
DI 10.1002/adbi.202200310
EA MAR 2023
PG 19
WC Materials Science, Biomaterials
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Materials Science
GA M1OM2
UT WOS:000955152100001
PM 36950773
OA hybrid
DA 2024-02-19
ER

PT J
AU Yao, JW
   Ma, YF
   Zhou, S
   Bao, TT
   Mi, YL
   Zeng, WD
   Li, J
   Zhang, CQ
AF Yao, Jinwei
   Ma, Yanfen
   Zhou, Shuo
   Bao, Tingting
   Mi, Yuling
   Zeng, Weidong
   Li, Jian
   Zhang, Caiqiao
TI Metformin Prevents Follicular Atresia in Aging Laying Chickens through
   Activation of PI3K/AKT and Calcium Signaling Pathways
SO OXIDATIVE MEDICINE AND CELLULAR LONGEVITY
LA English
DT Article
ID ENDOPLASMIC-RETICULUM; STIMULATING-HORMONE; OVARIAN-FOLLICLES;
   APOLIPOPROTEIN II; GROWTH; MICE; VITELLOGENIN; MITOCHONDRIA; EXPRESSION;
   RECEPTORS
AB Increased follicular atresia occurs with aging and results in reduced fecundity in laying chickens. Therefore, relieving follicular atresia of aging poultry is a crucial measure to maintain sustained high laying performance. As an antiaging agent, metformin was reported to play important roles in preventing aging in diverse animals. In this study, the physiological state of the prehierarchical follicles in the peak-laying hens (D280) and aged hens (D580) was compared, followed with exploration for the possible capacity of metformin in delaying atresia of the prehierarchical follicles in the aged D580 hens. Results showed that the capacity of yolk deposition within follicles declined with aging, and the point of endoplasmic reticulum- (ER-) mitochondrion contact decreased in the ultrastructure of the follicular cells. Meanwhile, the expression of apoptosis signaling genes was increased in the atretic small white follicles. Subsequently, the H2O2-induced follicular atresia model was established to evaluate the enhancing capacity of metformin on yolk deposition and inhibition of apoptosis in the atretic small white follicles. Metformin inhibited apoptosis through regulating cooperation of the mitochondrion-associated ER membranes and the insulin (PI3K/AKT) signaling pathway. Furthermore, metformin regulated calcium ion homeostasis to relieve ER-stress and inhibited release of mitochondrion apoptosis factors (BAD and caspase). Additionally, metformin activated PI3K/AKT that suppressed activation of BAD (downstream of the insulin signaling pathway) in the atretic follicles. Further, serum estrogen level and liver estrogen receptor-alpha expression were increased after dietary metformin supplementation in D580 hens. These results indicated that administration of dietary metformin activated the PI3K/AKT and calcium signaling pathway and enhanced yolk deposition to prevent chicken follicular atresia.
C1 [Yao, Jinwei; Ma, Yanfen; Zhou, Shuo; Bao, Tingting; Mi, Yuling; Zeng, Weidong; Li, Jian; Zhang, Caiqiao] Zhejiang Univ, Coll Anim Sci, Hangzhou 310058, Peoples R China.
C3 Zhejiang University
RP Li, J; Zhang, CQ (corresponding author), Zhejiang Univ, Coll Anim Sci, Hangzhou 310058, Peoples R China.
EM 21817035@zju.edu.cn; 11717040@zju.edu.cn; 21717037@zju.edu.cn;
   21917093@zju.edu.cn; yulingmi@zju.edu.cn; zengwd@zju.edu.cn;
   lijiannp@zju.edu.cn; cqzhang@zju.edu.cn
RI Yao, JW/HJA-7097-2022; zhou, shuo/IUM-4761-2023
OI BAO, TINGTING/0000-0002-4431-9406; Zhang, Caiqiao/0000-0002-3519-9457;
   Li, Jian/0000-0001-6691-2334; zhou, shuo/0000-0001-9405-6520
FU National Natural Science Foundation of China [31972635, 31772693,
   31472160]
FX We are grateful to Xin Lin, Xingting Liu, Keyang Jiang, Tongfa Qian,
   Lijuan Liu, Shuting Yang, Changquan Guo, Naiyao Ji, An Zhao, and Yi Hong
   (Zhejiang University) for help in the experiments. This study was
   supported by the National Natural Science Foundation of China (Nos.
   31972635, 31772693, and 31472160)
CR Aguirre SA, 2011, INSECT BIOCHEM MOLEC, V41, P832, DOI 10.1016/j.ibmb.2011.06.005
   Bailey CJ., 2004, Pract Diab Int, V21, P115, DOI [DOI 10.1002/PDI.606, 10.1002/pdi.606]
   Batandier C, 2006, J BIOENERG BIOMEMBR, V38, P33, DOI 10.1007/s10863-006-9003-8
   Bertero E, 2018, CIRC RES, V122, P1460, DOI 10.1161/CIRCRESAHA.118.310082
   Cai H, 2020, INT J MOL MED, V45, P715, DOI 10.3892/ijmm.2020.4453
   Chen Q, 2017, TRANSL RES, V190, P40, DOI 10.1016/j.trsl.2017.09.003
   Chen XB, 2017, REDOX BIOL, V12, P987, DOI 10.1016/j.redox.2017.04.031
   Fan HY, 2010, MOL ENDOCRINOL, V24, P286, DOI 10.1210/me.2009-0251
   Farr SA, 2014, FREE RADICAL BIO MED, V67, P387, DOI 10.1016/j.freeradbiomed.2013.11.014
   Fouqué A, 2016, CELL DEATH DIFFER, V23, P1702, DOI 10.1038/cdd.2016.61
   Glister C, 2001, BIOL REPROD, V65, P1020, DOI 10.1095/biolreprod65.4.1020
   Goetz JG, 2007, J CELL SCI, V120, P3553, DOI 10.1242/jcs.03486
   Kania E, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/352794
   Latruffe N, 1997, BIOCHIMIE, V79, P81, DOI 10.1016/S0300-9084(97)81496-4
   Leeb C, 2014, J BIOL CHEM, V289, P4161, DOI 10.1074/jbc.M113.529271
   Li J, 2014, THERIOGENOLOGY, V82, P517, DOI 10.1016/j.theriogenology.2014.05.003
   LILLPERS K, 1993, POULTRY SCI, V72, P2005, DOI 10.3382/ps.0722005
   Lin X, 2019, THERIOGENOLOGY, V139, P90, DOI 10.1016/j.theriogenology.2019.07.025
   Lin X, 2018, J CELL PHYSIOL, V233, P8984, DOI 10.1002/jcp.26844
   Lin X, 2018, AGING-US, V10, P819, DOI 10.18632/aging.101436
   Liu XH, 2016, ADV ELECTRON MATER, V2, DOI 10.1002/aelm.201500284
   Liu XT, 2018, J ZHEJIANG UNIV-SC B, V19, P390, DOI [10.1631/jzus.B1700054, 10.1631/jzus.b1700054]
   Liu YZ, 2020, BMC CARDIOVASC DISOR, V20, DOI 10.1186/s12872-020-01359-7
   Liu ZQ, 2015, REPROD SCI, V22, P696, DOI 10.1177/1933719114556483
   Ma YF, 2020, THERIOGENOLOGY, V157, P418, DOI 10.1016/j.theriogenology.2020.07.012
   Ma YF, 2020, POULTRY SCI, V99, P578, DOI 10.3382/ps/pez545
   Martin N, 2018, CELL CALCIUM, V70, P16, DOI 10.1016/j.ceca.2017.04.001
   Matsuda F, 2012, J REPROD DEVELOP, V58, P44, DOI 10.1262/jrd.2011-012
   Molnár A, 2016, BRIT POULTRY SCI, V57, P842, DOI 10.1080/00071668.2016.1209738
   Neuspiel M, 2005, J BIOL CHEM, V280, P25060, DOI 10.1074/jbc.M501599200
   Onagbesan OM, 2003, AM J PHYSIOL-ENDOC M, V285, pE973, DOI 10.1152/ajpendo.00104.2003
   Orrenius S, 2015, BIOCHEM BIOPH RES CO, V460, P72, DOI 10.1016/j.bbrc.2015.01.137
   Pertynska-Marczewska M, 2017, MENOPAUSE, V24, P345, DOI 10.1097/GME.0000000000000755
   Qi H, 2015, SCI REP-UK, V5, DOI 10.1038/srep07984
   Qin X, 2019, AGING-US, V11, P3785, DOI 10.18632/aging.102016
   Ratna WN, 2016, THERIOGENOLOGY, V85, P376, DOI 10.1016/j.theriogenology.2015.08.015
   Rencber SF, 2018, J OVARIAN RES, V11, DOI 10.1186/s13048-018-0427-7
   Restuccia DF, 2012, DIS MODEL MECH, V5, P403, DOI 10.1242/dmm.008136
   Salvetti NR, 2007, VET PATHOL, V44, P373, DOI 10.1354/vp.44-3-373
   Schuster MK, 2004, BIOL REPROD, V70, P1493, DOI 10.1095/biolreprod.103.024331
   Shen M, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.400
   Stephens CS, 2017, GEN COMP ENDOCR, V248, P106, DOI 10.1016/j.ygcen.2017.02.010
   Szabadkai G, 2006, J CELL BIOL, V175, P901, DOI 10.1083/jcb.200608073
   Tetsuka M, 2007, DOMEST ANIM ENDOCRIN, V33, P347, DOI 10.1016/j.domaniend.2006.08.001
   Wang HL, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/9741369
   Wu YY, 2018, EXP THER MED, V15, P2120, DOI 10.3892/etm.2017.5650
   Wu ZM, 2018, MOL MED REP, V18, P4163, DOI 10.3892/mmr.2018.9443
   Xue J, 2019, ENDOCR J, V66, P859, DOI 10.1507/endocrj.EJ18-0567
   Yao JW, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/4175613
   Yilmaz O, 2015, GEN COMP ENDOCR, V221, P16, DOI 10.1016/j.ygcen.2015.01.018
   Yuan SZ, 2016, CELL CYCLE, V15, P2895, DOI 10.1080/15384101.2016.1208873
   ZAKARIA AH, 1983, POULTRY SCI, V62, P670, DOI 10.3382/ps.0620670
   Zeleznik AJ, 2003, ENDOCRINOLOGY, V144, P3985, DOI 10.1210/en.2003-0293
   Zhang JB, 2019, REPROD BIOL ENDOCRIN, V17, DOI 10.1186/s12958-018-0450-y
   Zhao T, 2012, J BIOL CHEM, V287, P23615, DOI 10.1074/jbc.M112.379164
   Zheng WJ, 2012, MOL CELL ENDOCRINOL, V356, P24, DOI 10.1016/j.mce.2011.05.027
   Zhu XP, 2018, LIPIDS HEALTH DIS, V17, DOI 10.1186/s12944-018-0762-0
   Zumsteg ZS, 2016, CLIN CANCER RES, V22, P2009, DOI 10.1158/1078-0432.CCR-15-2245
NR 58
TC 16
Z9 20
U1 2
U2 29
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1942-0900
EI 1942-0994
J9 OXID MED CELL LONGEV
JI Oxidative Med. Cell. Longev.
PD NOV 27
PY 2020
VL 2020
AR 3648040
DI 10.1155/2020/3648040
PG 23
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA PE5IC
UT WOS:000598398300003
PM 33294120
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Aydin, AF
   Küçükgergin, C
   Özdemirler-Erata, G
   Koçak-Toker, N
   Uysal, M
AF Aydin, A. F.
   Kucukgergin, C.
   Ozdemirler-Erata, G.
   Kocak-Toker, N.
   Uysal, M.
TI The effect of carnosine treatment on prooxidant-antioxidant balance in
   liver, heart and brain tissues of male aged rats
SO BIOGERONTOLOGY
LA English
DT Article
DE Carnosine; Aging; Oxidative stress; Antioxidant system; Rat
ID OXIDATIVE DNA-DAMAGE; CU,ZN-SUPEROXIDE DISMUTASE; LIPID-PEROXIDATION;
   DIETARY CARNOSINE; VITAMIN-E; HISTIDINE; INJURY; GLYCATION; ORGANS
AB Carnosine (beta-alanyl-l-histidine) is a dipeptide with antioxidant properties. Oxidative damage by free radicals is one of the mechanisms underlying the aging process. This study was done to investigate the effects of carnosine treatment on lipid peroxidation and antioxidant status of liver, heart, brain in male young and aged rats. At the initiation of study, young and aged rats were 5 and 22 months old, respectively. Carnosine (250 mg/kg, daily, i.p.) was administered for 1 month to rats. At the end of this period, malondialdehyde (MDA) and diene conjugate (DC) and protein carbonyl (PC) levels, glutathione (GSH), vitamin E and vitamin C levels and Cu,Zn-superoxide dismutase (SOD), glutathione peroxidase (GSH-Px) and glutathione transferase (GST) activities were determined in tissues of carnosine-treated young and old rats. Liver and heart, but not brain MDA and DC levels increased significantly in aged rats as compared to young rats. Liver PC levels were also significantly elevated. Significant decreases in GSH and vitamin C levels and SOD activities were detected in liver of aged rats, but vitamin E levels and GSH-Px and GST activities remained unchanged. Non-enzymatic and enzymatic antioxidants did not change in heart and brain of aged rats. Carnosine treatment decreased high MDA, DC and PC levels and caused significant increases in vitamin E level and SOD activity in the liver of aged rats. There were no changes in non-enzymatic and enzymatic antioxidants in the heart and brain of carnosine-treated aged rats. In conclusion, carnosine treatment was found to be useful in the decrease of age-related oxidative stress in the liver.
C1 [Aydin, A. F.; Kucukgergin, C.; Ozdemirler-Erata, G.; Kocak-Toker, N.; Uysal, M.] Istanbul Univ, Istanbul Fac Med, Dept Biochem, TR-34093 Istanbul, Turkey.
C3 Istanbul University
RP Uysal, M (corresponding author), Istanbul Univ, Istanbul Fac Med, Dept Biochem, TR-34093 Istanbul, Turkey.
EM mujdatuysal@hotmail.com
RI Küçükgergin, Canan/AAD-9925-2020; Kocak-Toker, Necla/AAD-8944-2020;
   Aydın, Abdurrahman Fatih/AAD-9170-2020
FU University of Istanbul [BYP-969]
FX This work was supported by the Research Fund of University of Istanbul
   (Project No: BYP-969).
CR Aldini G, 2005, BIOFACTORS, V24, P77, DOI 10.1002/biof.5520240109
   BEUTLER E, 1979, LAB CLIN MED, V61, P882
   Boissonneault GA, 1998, NUTR RES, V18, P723, DOI 10.1016/S0271-5317(98)00058-X
   Boldyrev A.A., 2001, BIOKHIMIYA, V66, P1430
   Boldyrev AA, 1999, BIOSCIENCE REP, V19, P581, DOI 10.1023/A:1020271013277
   Boldyrev AA, 2005, ANN NY ACAD SCI, V1057, P1, DOI DOI 10.1196/ANNALS.1356.013
   Buege J A, 1978, Methods Enzymol, V52, P302
   DESAI ID, 1984, METHOD ENZYMOL, V105, P138, DOI 10.1016/S0076-6879(84)05019-9
   Dobrota D, 2005, NEUROCHEM RES, V30, P1283, DOI 10.1007/s11064-005-8799-7
   Fouad AA, 2007, EUR J PHARMACOL, V572, P61, DOI 10.1016/j.ejphar.2007.06.010
   Gallant S, 2000, BIOCHEMISTRY-MOSCOW+, V65, P866
   Habig W H, 1981, Methods Enzymol, V77, P398
   Harman D, 2001, ANN NY ACAD SCI, V928, P1, DOI 10.1111/j.1749-6632.2001.tb05631.x
   Hipkiss AR, 2006, ANN NY ACAD SCI, V1067, P369, DOI 10.1196/annals.1354.052
   Hipkiss AR, 2007, J ALZHEIMERS DIS, V11, P229
   Hipkiss AR, 2009, EXP GERONTOL, V44, P237, DOI 10.1016/j.exger.2008.11.001
   Hipkiss AR, 2005, MECH AGEING DEV, V126, P1034, DOI 10.1016/j.mad.2005.05.002
   Hipkiss AR, 2000, BIOGERONTOLOGY, V1, P217, DOI 10.1023/A:1010057412184
   Ibrahim W, 2008, INT J VITAM NUTR RES, V78, P230, DOI 10.1024/0300-9831.78.45.230
   Jayakumar T, 2007, EXP GERONTOL, V42, P183, DOI 10.1016/j.exger.2006.10.006
   Kang JH, 2002, BBA-GEN SUBJECTS, V1570, P89, DOI 10.1016/S0304-4165(02)00158-7
   LAWRENCE RA, 1976, BIOCHEM BIOPH RES CO, V71, P952, DOI 10.1016/0006-291X(76)90747-6
   Lee YT, 2005, EUR J PHARMACOL, V513, P145, DOI 10.1016/j.ejphar.2005.02.010
   Liu WH, 2008, FOOD CHEM TOXICOL, V46, P1503, DOI 10.1016/j.fct.2007.12.013
   Maynard LM, 2001, J NUTR, V131, P287, DOI 10.1093/jn/131.2.287
   Mehmetçik G, 2008, PEPTIDES, V29, P425, DOI 10.1016/j.peptides.2007.11.008
   MYLROIE AA, 1986, TOXICOL APPL PHARM, V82, P512, DOI 10.1016/0041-008X(86)90286-3
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   Omaye S. T., 1979, METHOD ENZYMOL, P3, DOI [DOI 10.1016/0076-6879(79)62181-X, 10.1016/0076-6879(79)62181-X, 10.1016/0076-6879(79)62181-x]
   Parildar H, 2008, J NUTR SCI VITAMINOL, V54, P61, DOI 10.3177/jnsv.54.61
   Parildar-Karpuzoglu H, 2008, PHARMACOL REP, V60, P673
   Rashid I, 2007, FEBS LETT, V581, P1067, DOI 10.1016/j.febslet.2007.01.082
   REZNICK AZ, 1994, METHOD ENZYMOL, V233, P357
   Siqueira IR, 2005, INT J DEV NEUROSCI, V23, P663, DOI 10.1016/j.ijdevneu.2005.03.001
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   Stuerenburg HJ, 1999, ARCH GERONTOL GERIAT, V29, P107, DOI 10.1016/S0167-4943(99)00020-5
   Stvolinskii SL, 2003, B EXP BIOL MED+, V135, P130, DOI 10.1023/A:1023855428130
   Stvolinsky SL, 2000, BIOCHEMISTRY-MOSCOW+, V65, P849
   Tian LQ, 1998, FREE RADICAL BIO MED, V24, P1477, DOI 10.1016/S0891-5849(98)00025-2
   Viña J, 2005, FEBS LETT, V579, P2541, DOI 10.1016/j.febslet.2005.03.090
   Wolf FI, 2005, EXP GERONTOL, V40, P181, DOI 10.1016/j.exger.2004.11.002
   Wong YT, 2006, FREE RADICAL RES, V40, P393, DOI 10.1080/10715760600556074
   Yuneva AO, 2002, B EXP BIOL MED+, V133, P559, DOI 10.1023/A:1020273506970
NR 43
TC 63
Z9 69
U1 3
U2 14
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1389-5729
EI 1573-6768
J9 BIOGERONTOLOGY
JI Biogerontology
PD FEB
PY 2010
VL 11
IS 1
BP 103
EP 109
DI 10.1007/s10522-009-9232-4
PG 7
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 536ZQ
UT WOS:000273082900009
PM 19430956
DA 2024-02-19
ER

PT S
AU Bushell, WC
AF Bushell, WC
BE Pierpaoli, W
TI From molecular biology to anti-aging cognitive-behavioral practices -
   The pioneering research of Walter Pierpaoli on the pineal and bone
   marrow foreshadows the contemporary revolution in stem cell and
   regenerative biology
SO REVERSAL OF AGING: RESETTING THE PINEAL CLOCK
SE Annals of the New York Academy of Sciences
LA English
DT Article; Proceedings Paper
CT 4th Stromboli Conference on Aging and Cancer
CY JUN 06-11, 2005
CL Sicily, ITALY
SP Walter Pierpaoli Fdn Life Sci
DE melatonin; pineal; bone marrow; regeneration; stem cells; aging
   reversal; longevity; transferrin; interleukin-10; negligible senescence;
   meditation; calorie restriction; exercise; yoga; cognitive-behavioral;
   anti-inflammatory; antioxidant; anti-stress; anticancer; peripheral
   nerve regeneration; Parkinson's disease
ID PROSTATE-CANCER OUTPATIENTS; PLASMA MELATONIN LEVELS; QUALITY-OF-LIFE;
   CALORIE RESTRICTION; DEHYDROEPIANDROSTERONE-SULFATE; RHESUS-MONKEYS;
   TRANSCENDENTAL-MEDITATION; TISSUE REGENERATION; OXIDATIVE STRESS;
   SKELETAL-MUSCLE
AB Evidence is accruing that a cognitive-behavioral regimen integrating cognitive techniques (meditation-based anti-stress, anti-inflammatory techniques, others), dietary modification ("dietary restriction" or modified dietary restriction), and certain forms of aerobic exercise, may prolong the healthy life span in humans. Recent research has identified some of the likely molecular mediators of these potentially broad-ranging, health-enhancing and anti-aging effects; these include DHEA, interleukins-10 and -4 (IL-10, IL-4), and especially melatonin. Relatedly, what some are calling a revolution in biology and medicine has been emerging from research on stem cells and regeneration processes more generally. Dogma regarding limitations on the regenerative capacities of adult vertebrates is being cautiously yet enthusiastically revised in the wake of rapidly accumulating discoveries of more types of adult stem cells in mammals, including humans. For example, a recent review by D. Krause of Yale concluded that "in the [adult] bone marrow, in addition to hematopoietic stem cells and supportive stromal cells, there are cells with the potential to differentiate into mature cells of the heart, liver, kidney, lungs, GI tract, skin, bone, muscle, cartilage, fat, endothelium and brain". In addition, very recent studies have shown that DHEA, ILs-10 and -4, and melatonin all possess potential regenerative, including stem cell-activating, properties. More than a quarter of a century ago, Walter Pierpaoli initiated a series of extraordinary studies that demonstrated in experimental animals the potential for dramatic regeneration associated with changes in the pineal gland and bone marrow. This appeared to be not only retardation of aging, but also its reversal. Furthermore, as Pierpaoli was attempting to understand both anti-aging regeneration and oncogenesis, he was focusing on both pro- and anti-mitotic mechanisms: recent research now suggests that there is a nonpathologic, "healthy" form of regeneration that is actually antagonistic to oncogenesis, and that melatonin may be important in this form of regeneration. This paper explores Pierpaoli's pioneering studies in light of recent developments in stem cell and regenerative biology, particularly as related to the regenerative potential associated with certain cognitive-behavioral practices, and includes evidence on this subject presented for the first time.
C1 MIT, Anthropol Program, Cambridge, MA 02139 USA.
C3 Massachusetts Institute of Technology (MIT)
RP Bushell, WC (corresponding author), MIT, Anthropol Program, 16-241,77 Massachusetts Ave, Cambridge, MA 02139 USA.
EM wcbphd@att.net
CR ABBASOGLU O, 1995, J HEPATOL, V23, P578, DOI 10.1016/0168-8278(95)80065-4
   Alpini D, 2004, ARCH GERONTOL GERIAT, P13
   AUSTAD SN, 1991, J GERONTOL, V46, pB47, DOI 10.1093/geronj/46.2.B47
   BEACH RL, 1983, FEBS LETT, V156, P151, DOI 10.1016/0014-5793(83)80267-1
   BENSON H, 1990, BEHAV MED, V16, P90, DOI 10.1080/08964289.1990.9934596
   Bhatt R, 2003, EPILEPSY RES, V54, P209, DOI 10.1016/S0920-1211(03)00081-0
   BLACK S, 1963, BMJ-BRIT MED J, P1649
   Blanc S, 2003, J CLIN ENDOCR METAB, V88, P16, DOI 10.1210/jc.2002-020405
   Bondy SC, 2004, ANN NY ACAD SCI, V1035, P197, DOI 10.1196/annals.1332.013
   Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616
   Bruinink A, 1996, INT J DEV NEUROSCI, V14, P785, DOI 10.1016/S0736-5748(96)00035-4
   Bubenik GA, 2002, DIGEST DIS SCI, V47, P2336, DOI 10.1023/A:1020107915919
   Bushell WC, 1995, ASCETICISM, P553
   BUSHELL WC, 2005, STEM CELL BIOL HUMAN
   BUSHELL WC, 2001, DEV BRAIN RES, V132, pA26
   Buxton OM, 1997, J BIOL RHYTHM, V12, P568, DOI 10.1177/074873049701200611
   Cadet P, 2003, INT J MOL MED, V12, P485
   Cardinali DP, 2003, J PINEAL RES, V34, P81, DOI 10.1034/j.1600-079X.2003.00028.x
   Carlson LE, 2003, PSYCHOSOM MED, V65, P571, DOI 10.1097/01.PSY.0000074003.35911.41
   Carlson LE, 2004, PSYCHONEUROENDOCRINO, V29, P448, DOI 10.1016/S0306-4530(03)00054-4
   Carrillo-Vico A, 2005, ENDOCRINE, V27, P189, DOI 10.1385/ENDO:27:2:189
   CHAPMAN LF, 1959, J PSYCHOSOM RES, P499
   Chung HY, 2002, MICROSC RES TECHNIQ, V59, P264, DOI 10.1002/jemt.10203
   Coker K H, 1999, Semin Urol Oncol, V17, P111
   Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260
   Conti A, 2000, J PINEAL RES, V28, P193, DOI 10.1034/j.1600-079X.2000.280401.x
   CSABA G, 1993, EXPERIENTIA, V49, P627, DOI 10.1007/BF01923943
   Danilova N, 2004, FASEB J, V18, P751, DOI 10.1096/fj.03-0544fje
   Davenport J., 1992, ANIMAL LIFE LOW TEMP
   DELRIOTSONIS K, 1992, INT J ONCOL, V1, P161
   EGUCHI G, 1973, J EMBRYOL EXP MORPH, V30, P63
   Elias AN, 2000, MED HYPOTHESES, V54, P660, DOI 10.1054/mehy.1999.0921
   Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101
   Esrefoglu M, 2005, J PINEAL RES, V39, P231, DOI 10.1111/j.1600-079X.2005.00235.x
   Fernández MA, 2004, J HEPATOL, V40, P132, DOI 10.1016/j.jhep.2003.09.024
   Fischer TW, 2004, BRIT J DERMATOL, V150, P341, DOI 10.1111/j.1365-2133.2004.05685.x
   Fontana L, 2004, P NATL ACAD SCI USA, V101, P6659, DOI 10.1073/pnas.0308291101
   Forbes SJ, 2002, CLIN SCI, V103, P355, DOI 10.1042/cs1030355
   Frangioni G, 2003, J EXP ZOOL PART A, V296A, P125, DOI 10.1002/jez.a.10261
   Frank LA, 2004, VET DERMATOL, V15, P278, DOI 10.1111/j.1365-3164.2004.00372.x
   FROLKIS VV, 1993, MECH AGEING DEV, V69, P93, DOI 10.1016/0047-6374(93)90074-2
   Ghosh AK, 2002, EXP BIOL MED, V227, P301, DOI 10.1177/153537020222700502
   GLASER JL, 1992, J BEHAV MED, V15, P327, DOI 10.1007/BF00844726
   Goolsby J, 2003, P NATL ACAD SCI USA, V100, P14926, DOI 10.1073/pnas.2434383100
   Goto S, 2004, ANN NY ACAD SCI, V1019, P471, DOI 10.1196/annals.1297.085
   Gredilla R, 2005, ENDOCRINOLOGY, V146, P3713, DOI 10.1210/en.2005-0378
   Green F, 2002, FEBS LETT, V518, P101, DOI 10.1016/S0014-5793(02)02655-8
   Hardeland R, 2005, ENDOCRINE, V27, P119, DOI 10.1385/ENDO:27:2:119
   Harinath K, 2004, J ALTERN COMPLEM MED, V10, P261, DOI 10.1089/107555304323062257
   Harty M, 2003, DEV DYNAM, V226, P268, DOI 10.1002/dvdy.10239
   Haus E, 1996, LIFE SCI, V58, pPL263, DOI 10.1016/0024-3205(96)00079-3
   HELLER HC, 1987, J THERM BIOL, V12, P171
   Helm HM, 2000, J GERONTOL A-BIOL, V55, pM400, DOI 10.1093/gerona/55.7.M400
   HOLLOSZY JO, 1991, J APPL PHYSIOL, V70, P1529, DOI 10.1152/jappl.1991.70.4.1529
   HOLLOSZY JO, 1993, J GERONTOL, V48, pB97, DOI 10.1093/geronj/48.3.B97
   Huang JS, 2002, FASEB J, V16, P1269, DOI 10.1096/fj.02-0103fje
   IERPAOLI W, 1988, BRIAN MIND B, V13, P1
   Ji LL, 2002, ANN NY ACAD SCI, V959, P82, DOI 10.1111/j.1749-6632.2002.tb02085.x
   JONES BM, 2001, ALTERN MED, V1, P8
   Kim DH, 2005, PROG NEURO-PSYCHOPH, V29, P327, DOI 10.1016/j.pnpbp.2004.11.019
   Kim HJ, 2002, MECH AGEING DEV, V123, P1589, DOI 10.1016/S0047-6374(02)00094-5
   Kobayashi H, 2005, FASEB J, V19, P1710, DOI 10.1096/fj.04-2293fje
   Komori M, 2005, WOUND REPAIR REGEN, V13, P109, DOI 10.1111/j.1067-1927.2005.130114.x
   Krause DS, 2002, GENE THER, V9, P754, DOI 10.1038/sj.gt.3301760
   Kucia M, 2004, BLOOD CELL MOL DIS, V32, P52, DOI 10.1016/j.bcmd.2003.09.025
   Kunz D, 2001, SLEEP, V24, P183
   Laidlaw TM, 1996, PSYCHOSOM MED, V58, P242, DOI 10.1097/00006842-199605000-00008
   Lane MA, 1997, J CLIN ENDOCR METAB, V82, P2093, DOI 10.1210/jc.82.7.2093
   LEE IM, 1995, JAMA-J AM MED ASSOC, V273, P1179, DOI 10.1001/jama.273.15.1179
   Lee J, 2000, J MOL NEUROSCI, V15, P99, DOI 10.1385/JMN:15:2:99
   Leferovich JM, 2001, P NATL ACAD SCI USA, V98, P9830, DOI 10.1073/pnas.181329398
   Leng S, 2002, J AM GERIATR SOC, V50, P1268, DOI 10.1046/j.1532-5415.2002.50315.x
   LESNIKOV VA, 1994, ANN NY ACAD SCI, V719, P456, DOI 10.1111/j.1749-6632.1994.tb56850.x
   LESNIKOVA M, J HEMATOTHER STEM CE, V9, P381
   Lio D, 2002, GENES IMMUN, V3, P20, DOI 10.1038/sj.gene.6363823
   Lio D, 2003, J MED GENET, V40, P296, DOI 10.1136/jmg.40.4.296
   Löwenheim H, 2003, DNA CELL BIOL, V22, P571, DOI 10.1089/104454903322405464
   Lutgendorf S, 2000, PSYCHOSOM MED, V62, P524, DOI 10.1097/00006842-200007000-00011
   LYMAN CP, 1981, SCIENCE, V212, P668, DOI 10.1126/science.7221552
   MAESTRONI GJM, 1988, ANN NY ACAD SCI, V521, P140, DOI 10.1111/j.1749-6632.1988.tb35272.x
   MAESTRONI GJM, 1988, IMMUNOLOGY, V63, P465
   MASSION AO, 1995, MED HYPOTHESES, V44, P39, DOI 10.1016/0306-9877(95)90299-6
   Mattison JA, 2003, EXP GERONTOL, V38, P35, DOI 10.1016/S0531-5565(02)00146-8
   Mattson MP, 2002, PHYSIOL REV, V82, P637, DOI 10.1152/physrev.00004.2002
   Mattson MP, 2005, ANNU REV NUTR, V25, P237, DOI 10.1146/annurev.nutr.25.050304.092526
   MCCALLON RL, 1996, MOL BIOL WOUND REPAI
   McEwen BS, 1999, FRONT NEUROENDOCRIN, V20, P49, DOI 10.1006/frne.1998.0173
   MCGAHAN MC, 1994, EXP EYE RES, V58, P509, DOI 10.1006/exer.1994.1044
   McGann CJ, 2001, P NATL ACAD SCI USA, V98, P13699, DOI 10.1073/pnas.221297398
   Mescher AL, 1997, DEV GROWTH DIFFER, V39, P677
   MOCCHEGIANI E, 1994, J NEUROIMMUNOL, V53, P189, DOI 10.1016/0165-5728(94)90029-9
   Morgan CA, 2004, ARCH GEN PSYCHIAT, V61, P819, DOI 10.1001/archpsyc.61.8.819
   Niles LP, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-41
   NIXON AJ, 1995, J EXP ZOOL, V272, P435, DOI 10.1002/jez.1402720605
   NIXON AJ, 1993, J EXP ZOOL, V267, P47, DOI 10.1002/jez.1402670108
   Öner J, 2003, ENDOCR RES, V29, P445, DOI 10.1081/ERC-120026950
   Palermo AT, 2005, DEV BIOL, V279, P336, DOI 10.1016/j.ydbio.2004.12.024
   Panjwani Usha, 1995, Indian Journal of Physiology and Pharmacology, V39, P111
   Paredes D, 1999, BRAIN RES, V850, P14, DOI 10.1016/S0006-8993(99)01992-7
   Pedersen BK, 2003, SCAND J MED SCI SPOR, V13, P56, DOI 10.1034/j.1600-0838.2003.20218.x
   Pierpaoli W, 1998, ANN NY ACAD SCI, V840, P491, DOI 10.1111/j.1749-6632.1998.tb09587.x
   PIERPAOLI W, 1987, IMMUNOL LETT, V16, P355, DOI 10.1016/0165-2478(87)90169-6
   PIERPAOLI W, 1988, ANN NY ACAD SCI, V521, P300, DOI 10.1111/j.1749-6632.1988.tb35287.x
   PIERPAOLI W, 1991, ANN NY ACAD SCI, V621, P291
   PIERPAOLI W, 1994, P NATL ACAD SCI USA, V91, P787, DOI 10.1073/pnas.91.2.787
   PIERPAOLI W, 1987, ANN NY ACAD SCI, V496, P27, DOI 10.1111/j.1749-6632.1987.tb35743.x
   Pierpaoli W, 2000, EXP GERONTOL, V35, P401, DOI 10.1016/S0531-5565(00)00089-9
   Pompeiano O, 2002, ARCH ITAL BIOL, V140, P129
   Prehn RT, 1997, CARCINOGENESIS, V18, P1439, DOI 10.1093/carcin/18.8.1439
   PREHN RT, 1971, PROG EXP TUMOR RES, V14, P1
   RAIVICH G, 1991, EUR J NEUROSCI, V3, P919, DOI 10.1111/j.1460-9568.1991.tb00027.x
   RAMACHANDRAN AV, 1989, J EXP BIOL, V143, P235
   ROSE J, 1987, GEN COMP ENDOCR, V65, P212, DOI 10.1016/0016-6480(87)90168-7
   Roth GS, 2004, SCIENCE, V305, P1423, DOI 10.1126/science.1102541
   Roth GS, 2001, J CLIN ENDOCR METAB, V86, P3292, DOI 10.1210/jc.86.7.3292
   Sainz RM, 2003, CELL MOL LIFE SCI, V60, P1407, DOI 10.1007/s00018-003-2319-1
   Salmon P, 2001, CLIN PSYCHOL REV, V21, P33, DOI 10.1016/S0272-7358(99)00032-X
   SANDYK R, 1990, INT J NEUROSCI, V52, P59, DOI 10.3109/00207459008994244
   Sandyk R, 1997, INT J NEUROSCI, V90, P145, DOI 10.3109/00207459709000634
   SAPOLSKY RM, 1986, ENDOCR REV, V7, P284, DOI 10.1210/edrv-7-3-284
   Schneider RH, 2005, AM J CARDIOL, V95, P1060, DOI 10.1016/j.amjcard.2004.12.058
   Schneider RH, 1998, PSYCHOSOM MED, V60, P38, DOI 10.1097/00006842-199801000-00008
   Schwartz AG, 2004, AGEING RES REV, V3, P171, DOI 10.1016/j.arr.2003.05.001
   Semenchenko GV, 2004, EXP GERONTOL, V39, P1499, DOI 10.1016/j.exger.2004.08.007
   Slominski A, 2005, FASEB J, V19, P176, DOI 10.1096/fj.04-2079rev
   SMITH GR, 1985, ARCH INTERN MED, V145, P2110, DOI 10.1001/archinte.145.11.2110
   Smith JK, 1999, JAMA-J AM MED ASSOC, V281, P1722, DOI 10.1001/jama.281.18.1722
   Stavisky RC, 2005, NEUROSCI LETT, V376, P98, DOI 10.1016/j.neulet.2004.11.033
   Steidl U, 2004, BLOOD, V104, P81, DOI 10.1182/blood-2004-01-0373
   Stocum DL, 2004, CURR TOP MICROBIOL, V280, P1
   Stocum DL, 1999, SEMIN CELL DEV BIOL, V10, P433, DOI 10.1006/scdb.1999.0330
   STOCUM DL, 2004, CELL SCI, V1, P1
   Tan DX, 1999, BBA-GEN SUBJECTS, V1472, P206, DOI 10.1016/S0304-4165(99)00125-7
   THURMAN RAF, 1995, ASCETICISM
   Tilden AR, 1997, J PINEAL RES, V23, P142, DOI 10.1111/j.1600-079X.1997.tb00347.x
   TIMIO M, 1988, HYPERTENSION, V12, P457, DOI 10.1161/01.HYP.12.4.457
   Tooley GA, 2000, BIOL PSYCHOL, V53, P69, DOI 10.1016/S0301-0511(00)00035-1
   Tremblay MS, 2004, J APPL PHYSIOL, V96, P531, DOI 10.1152/japplphysiol.00656.2003
   TSONIS PA, 1988, TUMOR BIOL, V9, P221, DOI 10.1159/000217565
   TSONIS PA, 1983, ANTICANCER RES, V3, P195
   Túnez I, 2005, PHARMACOLOGY, V74, P113, DOI 10.1159/000084169
   Turgut M, 2005, J PINEAL RES, V38, P284, DOI 10.1111/j.1600-079X.2004.00205.x
   VALCAVI R, 1993, CLIN ENDOCRINOL, V39, P193, DOI 10.1111/j.1365-2265.1993.tb01773.x
   Van Neste D, 2004, MICRON, V35, P193, DOI 10.1016/j.micron.2003.11.006
   Verrecchia F, 2002, J INVEST DERMATOL, V118, P211, DOI 10.1046/j.1523-1747.2002.01641.x
   Viola H, 2001, J NEUROSCI RES, V63, P196, DOI 10.1002/1097-4547(20010115)63:2<196::AID-JNR1011>3.0.CO;2-Y
   Waelde LC, 2004, J CLIN PSYCHOL, V60, P677, DOI 10.1002/jclp.10259
   Walford RL, 2002, J GERONTOL A-BIOL, V57, pB211, DOI 10.1093/gerona/57.6.B211
   WALLACE RK, 1982, INT J NEUROSCI, V16, P53, DOI 10.3109/00207458209147602
   Walton K G, 1995, J Altern Complement Med, V1, P263, DOI 10.1089/acm.1995.1.263
   Wang WZ, 2005, J PINEAL RES, V39, P57, DOI 10.1111/j.1600-079X.2005.00215.x
   WATANABE Y, BIOCH J, V267, P545
   Weber C, 2002, J PSYCHOSOM RES, V52, P29, DOI 10.1016/S0022-3999(01)00281-1
   Weindruch R., 1988, RETARDATION AGING DI
   Weyer C, 2000, AM J CLIN NUTR, V72, P946
   Willcox BJ, 2004, J GERONTOL A-BIOL, V59, P789
   Wölfler A, 2001, FEBS LETT, V502, P127, DOI 10.1016/S0014-5793(01)02680-1
   Wood GJ, 2003, AM J CLIN HYPN, V45, P179, DOI 10.1080/00029157.2003.10403525
   XIAO Y, 1995, J REPROD FERTIL, V105, P9, DOI 10.1530/jrf.0.1050009
   Young JDE, 1998, NEWS PHYSIOL SCI, V13, P149
   Yu QN, 2000, J PINEAL RES, V29, P86, DOI 10.1034/j.1600-079X.2000.290204.x
   ZACHARIAE R, 1989, ALLERGY, V44, P537, DOI 10.1111/j.1398-9995.1989.tb04198.x
   ZACHARIAE R, 1993, ALLERGY, V48, P6, DOI 10.1111/j.1398-9995.1993.tb02168.x
   ZACHARIAE R, 1994, PHOTODERMATOL PHOTO, V10, P154
   BREAKDOWN HUMAN ADAP
NR 165
TC 13
Z9 14
U1 0
U2 19
PU NEW YORK ACAD SCIENCES
PI NEW YORK
PA 2 EAST 63RD ST, NEW YORK, NY 10021 USA
SN 0077-8923
BN 1-57331-602-4
J9 ANN NY ACAD SCI
JI Ann.NY Acad.Sci.
PY 2005
VL 1057
BP 28
EP 49
DI 10.1196/annals.1322.002
PG 22
WC Geriatrics & Gerontology; Multidisciplinary Sciences
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology; Science & Technology - Other Topics
GA BDY45
UT WOS:000236116800003
PM 16399886
DA 2024-02-19
ER

PT J
AU Pawlowska-Góral, K
   Kusz, E
   Wardas, M
   Adamek, E
   Wardas, P
AF Pawlowska-Góral, K
   Kusz, E
   Wardas, M
   Adamek, E
   Wardas, P
TI The results of the interference of nitrates and vitamin E in the
   metabolism in the connective tissue of rat's liver
SO EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY
LA English
DT Article
DE nitrates; vitamin E; liver; glycosaminoglycans
ID LOW-DENSITY-LIPOPROTEIN; E SUPPLEMENTATION; GLYCOSAMINOGLYCANS;
   ORGANIZATION; OXIDATION; SULFATE; NITRITE; MATRIX
AB We examined 72 female Wistar rats which were divided into 6 groups. The animals were administered sodium nitrate (V), vitamin E or both compounds at the same time. In order to estimate the interference of nitrates in the presence of vitamin E with the metabolism of rat's liver, we determined the composition and the amount of glycosoaminoglycans (GAGs). It was stated that the total amount of GAGs increased in livers of all rats. Basing on all fractions of the examined GAGs it was determined that the most significant differences between individual groups appeared in the amount of heparane sulphate (HS). The results obtained confirmed the fact of the changes taking place in the picture of liver GAGs in the process of ageing of the examined animals. The results obtained, however, allowed to state the normalising influence of vitamin E on the quantitative composition of GAGs of rats which drank nitrates.
C1 L Warynski Silesian Med Acad, Fac Pharm, Dept Gen & Analyt Chem, PL-41200 Sosnowiec, Poland.
   L Warynski Silesian Med Acad, Inst & Paediat Clin, Katowice, Poland.
   L Warynski Silesian Med Acad, Fac Pharm, Dept Food & Nutr, PL-41200 Sosnowiec, Poland.
   L Warynski Silesian Med Acad, ENT Clin, Katowice, Poland.
C3 Medical University Silesia; Medical University Silesia; Medical
   University Silesia; Medical University Silesia
RP Pawlowska-Góral, K (corresponding author), L Warynski Silesian Med Acad, Fac Pharm, Dept Gen & Analyt Chem, Jagiellonska 4 St, PL-41200 Sosnowiec, Poland.
OI Pawlowska-Goral, Katarzyna/0000-0001-8652-8452; Adamek,
   Ewa/0000-0002-8996-8311
CR Aleksiewicz R, 2000, MED WETER, V56, P528
   BRUNINGFANN CS, 1993, VET HUM TOXICOL, V35, P521
   Cachia O, 1998, ATHEROSCLEROSIS, V138, P263, DOI 10.1016/S0021-9150(98)00028-8
   CASSENS RG, 1995, FOOD TECHNOL-CHICAGO, V49, P72
   DET NF, 1996, KIDNEY INT, V49, P1079
   ERNST S, 1995, CRIT REV BIOCHEM MOL, V30, P387, DOI 10.3109/10409239509083490
   Esko JD, 1996, CURR OPIN STRUC BIOL, V6, P663, DOI 10.1016/S0959-440X(96)80034-0
   FRANZEN A, 1984, BIOCHEM J, V224, P59, DOI 10.1042/bj2240059
   Gatellier P, 2000, J AGR FOOD CHEM, V48, P1427, DOI 10.1021/jf990943j
   Gronowska-Senger Anna, 1994, Polish Journal of Food and Nutrition Sciences, V3, P89
   HANSEN TM, 1980, ACTA PATH MICROBIO A, V80, P143
   Kusz Ewa, 2001, Polish Journal of Food and Nutrition Sciences, V10, P65
   SCOTT JE, 1992, FASEB J, V6, P2639, DOI 10.1096/fasebj.6.9.1612287
   Silbert JE, 1996, GLYCOCONJUGATE J, V13, P907, DOI 10.1007/BF01053185
   SLIM GC, 1994, CARBOHYD RES, V225, P285
   SVEJCAR J, 1967, ANAL BIOCHEM, V18, P333, DOI 10.1016/0003-2697(67)90017-6
   Wen Y, 1999, EUR J CLIN INVEST, V29, P1027, DOI 10.1046/j.1365-2362.1999.00579.x
   WOSICKI A, 1974, GINEKOL POL, V45, P137
   Ysart G, 1999, FOOD ADDIT CONTAM A, V16, P521, DOI 10.1080/026520399283669
NR 19
TC 2
Z9 2
U1 0
U2 6
PU URBAN & FISCHER VERLAG
PI JENA
PA BRANCH OFFICE JENA, P O BOX 100537, D-07705 JENA, GERMANY
SN 0940-2993
J9 EXP TOXICOL PATHOL
JI Exp. Toxicol. Pathol.
PD AUG
PY 2002
VL 54
IS 2
BP 147
EP 150
DI 10.1078/0940-2993-00243
PG 4
WC Pathology; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pathology; Toxicology
GA 587GJ
UT WOS:000177631900008
PM 12211635
DA 2024-02-19
ER

PT J
AU Taeb, M
   Mortazavi-Jahromi, S
   Jafarzadeh, A
   Mirzaei, MR
   Mirshafiey, A
AF Taeb, Mahsa
   Mortazavi-Jahromi, Shahabeddin
   Jafarzadeh, Abdollah
   Mirzaei, Mohammad Reza
   Mirshafiey, Abbas
TI An <i>in vitro</i> evaluation of anti-aging effect of guluronic acid
   (G2013) based on enzymatic oxidative stress gene expression using
   healthy individuals PBMCs
SO BIOMEDICINE & PHARMACOTHERAPY
LA English
DT Article
DE G2013 Guluronic acid; Anti-aging; Oxidative stress; NSAID; Aging
ID GLUTATHIONE-S-TRANSFERASE; NITRIC-OXIDE SYNTHASE; MANGANESE
   SUPEROXIDE-DISMUTASE; FREE-RADICALS; MYELOPEROXIDASE; DISEASE; AGE;
   DAMAGE; LIVER; ANTIOXIDANTS
AB Background: Aging is usually associated with increased levels of oxidants, and may result in damages caused by oxidative stress. There is a direct relationship between aging and increased incidence of inflammatory diseases. The present research intended to study the anti-aging and anti-inflammatory effects of the drug G2013 (guluronic acid) at low and high doses on the genes expression of a number of enzymes involved in oxidative stress (including SOD2, GPX1, CAT, GST, iNOS, and MPO) in peripheral blood mononuclear cells (PBMCs) of healthy individuals under in vitro conditions.
   Methods: Venous blood samples were taken from 20 healthy individuals, the PBMCs were isolated and their RNAs extracted and their cDNAs were synthesized, and the genes expression levels were measured using the qRT-PCR technique.
   Results: Our results indicated that this drug could, at both low and high doses, significantly reduce the expression of the genes for SOD2, GPX1, CAT, and GST compared to the LPS group (p < 0.0001). Moreover, it was noticed that the drug is able to significantly reduce gene expression levels at the high dose and at both doses (low and high), for iNOS and MPO compared to the LPS group (p < 0.0001), respectively.
   Conclusions: The present research showed that G2013, as a novel NSAID drug with immunomodulatory properties, could modulate the expression levels of the genes for SOD2, GPX1, CAT, GST, iNOS, and MPO, to the level of healthy gene expression, and possibly it might reduce the pathological process of aging and age-related inflammatory diseases. (C) 2017 Elsevier Masson SAS. All rights reserved.
C1 [Taeb, Mahsa; Jafarzadeh, Abdollah] Rafsanjan Univ Med Sci, Sch Med, Dept Immunol, Rafsanjan, Iran.
   [Mortazavi-Jahromi, Shahabeddin] Univ Tehran, Dept Cellular & Mol Biol, Kish Int Campus, Kish, Iran.
   [Mirzaei, Mohammad Reza] Rafsanjan Univ Med Sci, Mol Med Res Ctr, Box 771664-8798, Rafsanjan, Iran.
   [Mirshafiey, Abbas] Univ Tehran Med Sci, Sch Publ Hlth, Dept Immunol, Box 14155-6446, Tehran, Iran.
C3 Tehran University of Medical Sciences
RP Mirzaei, MR (corresponding author), Rafsanjan Univ Med Sci, Mol Med Res Ctr, Box 771664-8798, Rafsanjan, Iran.; Mirshafiey, A (corresponding author), Univ Tehran Med Sci, Sch Publ Hlth, Dept Immunol, Box 14155-6446, Tehran, Iran.
EM mirzaeemr@gmail.com; mirshafiey@tums.ac.ir
RI Jafarzadeh, Abdollah/AAX-2558-2020; Mirzaei, Mohammad Reza/O-1510-2017;
   Mirzaei, Mohammad Reza/S-3198-2017; Mortazavi-Jahromi, Seyed
   Shahabeddin/H-1916-2018
OI Jafarzadeh, Abdollah/0000-0002-8180-0602; Mirzaei, Mohammad
   Reza/0000-0002-6283-5332; Mortazavi-Jahromi, Seyed
   Shahabeddin/0000-0001-8786-4669; Mirzaei, Mohammad
   Reza/0000-0001-9799-7377; Mirshafiey, Abbas/0000-0003-1996-2747
FU Rafsanjan University of Medical Sciences [2021]
FX This project was supported by a grant from the Rafsanjan University of
   Medical Sciences (No. 2021)
CR Afraei S, 2015, ACTA NEUROL BELG, V115, P259, DOI 10.1007/s13760-014-0392-x
   Al-Gayyar MMH, 2007, J PHARM PHARMACOL, V59, P409, DOI 10.1211/jpp.59.3.0011
   [Anonymous], IMMUNOPHARMACOL IMMU
   Augustin W, 1997, MOL CELL BIOCHEM, V174, P199, DOI 10.1023/A:1006804423627
   Babich PS, 2013, CANCER BIOL THER, V14, P614, DOI 10.4161/cbt.24594
   Bala K, 2006, BIOGERONTOLOGY, V7, P81, DOI 10.1007/s10522-006-6495-x
   Basha PS, 2003, ECOTOX ENVIRON SAFE, V56, P218, DOI 10.1016/S0147-6513(03)00028-9
   Becuwe P, 2014, FREE RADICAL BIO MED, V77, P139, DOI 10.1016/j.freeradbiomed.2014.08.026
   Bekris LM, 2005, AUTOIMMUNITY, V38, P567, DOI 10.1080/08916930500407238
   Chelikani P, 2004, CELL MOL LIFE SCI, V61, P192, DOI 10.1007/s00018-003-3206-5
   Chhatbar M, 2009, CARBOHYD POLYM, V76, P650, DOI 10.1016/j.carbpol.2008.11.033
   Cho SG, 2001, J BIOL CHEM, V276, P12749, DOI 10.1074/jbc.M005561200
   Choi DK, 2005, J NEUROSCI, V25, P6594, DOI 10.1523/JNEUROSCI.0970-05.2005
   Clancy RM, 1998, ARTHRITIS RHEUM-US, V41, P1141, DOI 10.1002/1529-0131(199807)41:7<1141::AID-ART2>3.0.CO;2-S
   Eiserich JP, 2002, SCIENCE, V296, P2391, DOI 10.1126/science.1106830
   Fanò G, 2001, J MUSCLE RES CELL M, V22, P345, DOI 10.1023/A:1013122805060
   Fattahi MJ, 2015, IMMUNOPHARM IMMUNOT, V37, P535, DOI 10.3109/08923973.2015.1113296
   Ferrini M, 2001, NEUROENDOCRINOLOGY, V74, P1, DOI 10.1159/000054665
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   Fusco D, 2007, CLIN INTERV AGING, V2, P377
   Gavalas NG, 2006, BIOCHEM BIOPH RES CO, V345, P1586, DOI 10.1016/j.bbrc.2006.05.063
   Golden TR, 2002, AGING CELL, V1, P117, DOI 10.1046/j.1474-9728.2002.00015.x
   Green PS, 2004, J NEUROCHEM, V90, P724, DOI 10.1111/j.1471-4159.2004.02527.x
   Halliwell B, 2012, NUTR REV, V70, P257, DOI 10.1111/j.1753-4887.2012.00476.x
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   Jahromi SSM, 2016, EUR J INFLAMM, V14, P86, DOI 10.1177/1721727X16660093
   Jang YY, 2000, PHARMACOL RES, V42, P361, DOI 10.1006/phrs.2000.0705
   Karpuzoglu E, 2006, NITRIC OXIDE-BIOL CH, V15, P177, DOI 10.1016/j.niox.2006.03.009
   Keng T, 2000, MOL MED, V6, P779, DOI 10.1007/BF03402193
   Kolb H, 1998, IMMUNOL TODAY, V19, P556, DOI 10.1016/S0167-5699(98)01366-8
   Lau D, 2006, PHARMACOL THERAPEUT, V111, P16, DOI 10.1016/j.pharmthera.2005.06.023
   Lavrovsky Y, 2000, EXP GERONTOL, V35, P521, DOI 10.1016/S0531-5565(00)00118-2
   Liu RL, 2003, P NATL ACAD SCI USA, V100, P8526, DOI 10.1073/pnas.1332809100
   Lucena MI, 2008, HEPATOLOGY, V48, P588, DOI 10.1002/hep.22370
   MCCORD JM, 1985, NEW ENGL J MED, V312, P159
   Mikuls TR, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3190
   Mirshafiey Abbas, 2016, Curr Drug Discov Technol, V13, P25
   Palomero J, 2001, FREE RADICAL BIO MED, V30, P836, DOI 10.1016/S0891-5849(01)00471-3
   Pham-Huy Lien Ai, 2008, Int J Biomed Sci, V4, P89
   Polekhina G, 2001, BIOCHEMISTRY-US, V40, P1567, DOI 10.1021/bi002249z
   ROTRUCK JT, 1973, SCIENCE, V179, P588, DOI 10.1126/science.179.4073.588
   Sidiropoulos PI, 2008, RHEUMATOLOGY, V47, P355, DOI 10.1093/rheumatology/kem348
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   Son TG, 2005, FREE RADICAL RES, V39, P283, DOI 10.1080/10715760500053461
   StClair EW, 1996, J EXP MED, V184, P1173, DOI 10.1084/jem.184.3.1173
   Tanaka Y, 2002, P NATL ACAD SCI USA, V99, P12363, DOI 10.1073/pnas.192445199
   Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001
   Van Remmen H, 2003, PHYSIOL GENOMICS, V16, P29, DOI 10.1152/physiolgenomics.00122.2003
   van't Hof RJ, 2000, RHEUMATOLOGY, V39, P1004, DOI 10.1093/rheumatology/39.9.1004
   VANTUINEN P, 1987, ONCOGENE, V1, P319
   Wenzel P, 2008, CARDIOVASC RES, V80, P280, DOI 10.1093/cvr/cvn182
   WIJNEN LMM, 1978, CYTOGENET CELL GENET, V22, P232, DOI 10.1159/000130944
NR 52
TC 16
Z9 18
U1 2
U2 15
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI PARIS
PA 23 RUE LINOIS, 75724 PARIS, FRANCE
SN 0753-3322
EI 1950-6007
J9 BIOMED PHARMACOTHER
JI Biomed. Pharmacother.
PD JUN
PY 2017
VL 90
BP 262
EP 267
DI 10.1016/j.biopha.2017.03.066
PG 6
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA EW4KS
UT WOS:000402471000033
PM 28364598
DA 2024-02-19
ER

PT J
AU Haines, DC
   Chattopadhyay, S
   Ward, JM
AF Haines, DC
   Chattopadhyay, S
   Ward, JM
TI Pathology of aging B6;129 mice
SO TOXICOLOGIC PATHOLOGY
LA English
DT Article
DE lymphoma; genetically engineered mice; lung tumors; liver tumors;
   glomerulonephritis; otitis media; hyalinosis
ID WILD-TYPE MICE; OTITIS-MEDIA; P53-DEFICIENT MICE; B-CELL; LEUKEMIA;
   LACKING; WEIGHT
AB Fifty male and 49 female B6;129 mice (wild-type, +/+) were maintained until 2 years of age to study their age-related pathology. By 104-105 weeks, 14/50 (28%) of the males and 30/49 (61%) of the females were still alive. The most common contributing cause of morbidity or mortality was lymphoma. Lymphoma was observed in 21/50 (42%) of the males and 33/49 (67%) of the females with the most common sites being mesenteric lymph nodes, gut associated lymphoid tissue (Peyer's patches), and spleen. The lymphoma most often appeared to arise in the mesenteric node. Immunohistochemistry revealed CD45R expression as well as infiltration by many CD3+ cells. IgH gene rearrangements were found in typical mesenteric node lymphomas indicating B-cell origin. They bore similarities to the human T-cell rich, B-cell lymphomas. Other tumors included hepatocellular adenoma or carcinoma (male 12%, females 10%), lung alveolar Type II cell adenoma or carcinoma (male 32%, female 20%), thyroid follicular adenoma or carcinoma (male 2%, female 8%), ovarian tumors (17%), and endometrial tumors (6%). Nonneoplastic lesions included amyloid-like material in the nasal septum (male and female 100%), otitis media (male 84%, female 79%), epididymal epithelial karyomegaly (88%), melanosis (high incidences in various tissues including brain, parathyroid, and spleen), membranoproliferative glomerulonephritis (male 52%, female 71%), hyalinosis with extracellular crystals in several tissues (respiratory tract, gall bladder, stomach), islet cell hyperplasia (male 45%, female 29%) and esophageal dilation (male 10%, female 6%). The B6; 129 mouse is a mouse with aging lesions similar to those in other mouse strains but with a characteristic common lymphoma.
C1 NCI, Ctr Canc Res, Vet & Tumor Pathol Sect, Frederick, MD 21702 USA.
   SAIC Frederick, Pathol Histotechnol Lab, Vet Pathol Sect, Frederick, MD USA.
   NIAID, Immunopathol Lab, NIH, Bethesda, MD 20892 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Cancer Institute
   (NCI); Science Applications International Corporation (SAIC);
   SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National
   Institute of Allergy & Infectious Diseases (NIAID)
RP Ward, JM (corresponding author), NCI, Ctr Canc Res, Vet & Tumor Pathol Sect, Fairview 201,POB B, Frederick, MD 21702 USA.
FU NCI NIH HHS [N01-CO-56000] Funding Source: Medline
CR BLACKWELL BN, 1995, TOXICOL PATHOL, V23, P570, DOI 10.1177/019262339502300503
   Boorman GA, 2000, RADIAT RES, V153, P627, DOI 10.1667/0033-7587(2000)153[0627:LALIIR]2.0.CO;2
   DONEHOWER LA, 1995, MOL CARCINOGEN, V14, P16, DOI 10.1002/mc.2940140105
   Eckhaus MA, 2000, PATHOLOGY OF GENETICALLY ENGINEERED MICE, P347
   FRITH CH, 1996, PATHOBIOLOGY AGING M, P219
   GROSS-BELLARD MM, 1973, EUR J BIOCHEM, V36, P32, DOI 10.1111/j.1432-1033.1973.tb02881.x
   HARRIS NL, 1994, BLOOD, V84, P1361
   Hartley JW, 2000, LAB INVEST, V80, P159, DOI 10.1038/labinvest.3780020
   HENDRICK SM, 1985, P NATL ACAD SCI USA, V82, P531
   Herbert R.A., 1999, PATHOLOGY MOUSE REFE, P259
   Hursting SD, 1997, CANCER RES, V57, P2843
   *JACKS LAB, 2000, JAX B, V4
   Johnson M, 1997, LARYNGOSCOPE, V107, P1405, DOI 10.1097/00005537-199710000-00020
   KELEMEN G, 1978, PATHOLOGY LABORATORY, V1, P620
   KODELL RL, 1995, TOXICOL PATHOL, V23, P241, DOI 10.1177/019262339502300301
   LANG RB, 1982, NUCLEIC ACIDS RES, V10, P611, DOI 10.1093/nar/10.2.611
   Li SH, 2000, MOL CELL BIOL, V20, P697, DOI 10.1128/MCB.20.2.697-701.2000
   Losco PE, 1995, TOXICOL PATHOL, V23, P677, DOI 10.1177/019262339502300605
   Mähler M, 2000, PATHOLOGY OF GENETICALLY ENGINEERED MICE, P269
   Maronpot R., 1999, PATHOLOGY MOUSE REFE, P699
   McClatchey AI, 1998, GENE DEV, V12, P1121, DOI 10.1101/gad.12.8.1121
   MCGINN MD, 1992, HEARING RES, V59, P1, DOI 10.1016/0378-5955(92)90094-4
   Meek RB, 1999, ANN OTO RHINOL LARYN, V108, P31, DOI 10.1177/000348949910800105
   Mitchell CR, 1997, OTOLARYNG HEAD NECK, V117, P459, DOI 10.1016/S0194-5998(97)70014-7
   MOHR U, 1996, PATHOBIOLOGY AGING M, V1, P527
   Perkins SN, 1998, J INVEST DERMATOL, V111, P292, DOI 10.1046/j.1523-1747.1998.00270.x
   PINEAU T, 1995, P NATL ACAD SCI USA, V92, P5134, DOI 10.1073/pnas.92.11.5134
   PORTER DD, 1973, J IMMUNOL, V111, P1626
   SHELDON WG, 1996, PATHOBIOLOGY AGING M, V2, P21
   Sundberg JP, 2000, PATHOLOGY OF GENETICALLY ENGINEERED MICE, P183
   Taddesse-Heath L, 2000, PATHOLOGY OF GENETICALLY ENGINEERED MICE, P365
   TARONE RE, 1981, J NATL CANCER I, V66, P1175, DOI 10.1093/jnci/66.6.1175
   TURUSOV VS, 1994, IARC SCI PUBL, V111, P776
   Ward J.M., 1999, PATHOLOGY MOUSE, P333
   Ward JM, 1999, LAB INVEST, V79, P3
   Ward JM, 2000, PATHOLOGY OF GENETICALLY ENGINEERED MICE, P161
   Ward JM, 2001, AM J PATHOL, V158, P323, DOI 10.1016/S0002-9440(10)63972-7
   Ward JM, 2000, PATHOLOGY GENETICALL, P394
   WRIGHT JA, 1991, J COMP PATHOL, V104, P211, DOI 10.1016/S0021-9975(08)80104-1
NR 39
TC 106
Z9 109
U1 0
U2 1
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 0192-6233
J9 TOXICOL PATHOL
JI Toxicol. Pathol.
PD NOV 1
PY 2001
VL 29
IS 6
BP 653
EP 661
DI 10.1080/019262301753385988
PG 9
WC Pathology; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pathology; Toxicology
GA 558DW
UT WOS:000175951900008
PM 11794381
DA 2024-02-19
ER

PT J
AU KRAUPPGRASL, B
   HUBER, W
   TAPER, H
   SCHULTEHERMANN, R
AF KRAUPPGRASL, B
   HUBER, W
   TAPER, H
   SCHULTEHERMANN, R
TI INCREASED SUSCEPTIBILITY OF AGED RATS TO HEPATOCARCINOGENESIS BY THE
   PEROXISOME PROLIFERATOR NAFENOPIN AND THE POSSIBLE INVOLVEMENT OF
   ALTERED LIVER FOCI OCCURRING SPONTANEOUSLY
SO CANCER RESEARCH
LA English
DT Article
ID PROMOTING ACTIVITIES; HEPATIC FOCI; RISK; DIETHYLNITROSAMINE;
   CARCINOGENESIS; WY-14,643; NEOPLASMS; LESIONS; MICE
AB We investigated the mechanism of the hepatocarcinogenic action of nafenopin (NAF), a nongenotoxic peroxisome proliferator.  Groups of male rats aged 13 wk (designated "young") or 57 wk (designated "old") were fed NAF for 13 mo; additional groups received a basal diet or a phenobarbital (PB)-containing diet as positive control.
   The following results were obtained.  (a) NAF produced numerous hepatocellular adenomas and carcinomas in old animals but very few in young animals.  A similar result, although less pronounced, was seen with PB.  Adenomas of PB-treated groups mostly consisted of eosinophilic and glycogen-storing cells.  However, adenomas and carcinomas of NAF-treated livers were composed of weakly basophilic cells.  (b) Phenotypically altered foci, evaluated in hematoxylin:eosin-stained sections, appeared spontaneously in untreated livers.  The majority of these foci was either of the eosinophilic-clear cell or the tigroid cell type.  In addition, we identified foci which are characterized by weak, diffuse cytoplasmatic basophilia.  Their phenotype was similar to that of adenomas and carcinomas in NAF-treated rats.  The number and size of eosinophilic-clear cell and of tigroid cell foci increased considerably with the age of the animals.  At the end of the experiment, approximately 2.4% of liver tissue was occupied by focal cells.  NAF, but not PB, treatment led to a selective increase in number and size of weakly basophilic foci.  This subtype has previously been described as a likely precursor lesion for liver tumors induced by an aflatoxin B1-NAF initiation-promotion regimen (B.  Kraupp-Grasl et al., Cancer Res., 50:3701-3708, 1990).
   These findings suggest that the peroxisome proliferator NAF leads to tumor development in aging rat liver by promotion of spontaneously occurring preneoplastic lesions.  The type of lesion appears to be different from that promotable by PB.
C1 UNIV VIENNA,INST TUMORBIOL KREBSFORSCH,BORSCHKEGASSE 8A,A-1090 VIENNA,AUSTRIA.
   CATHOLIC UNIV LOUVAIN,UNITE BIOCHIM TOXICOL & CANCEROL,B-1200 BRUSSELS,BELGIUM.
C3 University of Vienna; Universite Catholique Louvain
CR [Anonymous], 1984, LANCET, V2, P600
   BANNASCH P, 1985, CARCINOGENESIS, V6, P1641, DOI 10.1093/carcin/6.11.1641
   CATTLEY RC, 1989, CANCER RES, V49, P3246
   CATTLEY RC, 1989, TOXICOLOGY, V56, P1, DOI 10.1016/0300-483X(89)90207-2
   CONWAY JG, 1989, DRUG METAB REV, V21, P65, DOI 10.3109/03602538909029956
   DELAIGLESIA FA, 1981, P S CHEM INDICES MEC, P175
   FAHIMI DH, 1982, ANN NY ACAD SCI, V383, P111
   FRICK MH, 1987, NEW ENGL J MED, V317, P1237, DOI 10.1056/NEJM198711123172001
   GERBRACHT U, 1990, CARCINOGENESIS, V11, P617, DOI 10.1093/carcin/11.4.617
   GLAUERT HP, 1986, CANCER RES, V46, P4601
   KRAUPPGRASL B, 1990, CANCER RES, V50, P3701
   MOCHIZUKI Y, 1982, CARCINOGENESIS, V3, P1027, DOI 10.1093/carcin/3.9.1027
   NUMOTO S, 1985, TOXICOL APPL PHARM, V77, P76, DOI 10.1016/0041-008X(85)90269-8
   PARZEFALL W, 1990, IN PRESS TOXICOL APP
   POPP JA, 1985, FUND APPL TOXICOL, V5, P314, DOI 10.1016/0272-0590(85)90079-X
   PREAT V, 1986, JPN J CANCER RES, V77, P629
   PREAT V, 1986, CARCINOGENESIS, V7, P1025, DOI 10.1093/carcin/7.6.1025
   REDDY JK, 1983, CRC CR REV TOXICOL, V12, P1, DOI 10.3109/10408448309029317
   REDDY JK, 1980, NATURE, V283, P397, DOI 10.1038/283397a0
   REDDY JK, 1977, J NATL CANCER I, V59, P1645, DOI 10.1093/jnci/59.6.1645
   Saltikov S. A., 1967, 2ND P INT C STER CHI, P163
   SCHULTEHERMANN R, 1983, CANCER RES, V43, P839
   SQUIRE RA, 1975, CANCER RES, V35, P3214
   Stewart HL, 1980, JNCI-J NATL CANCER I, V64, P178
   STOTT WT, 1988, REGUL TOXICOL PHARM, V8, P125, DOI 10.1016/0273-2300(88)90026-8
   WARD JM, 1988, CANCER LETT, V39, P9, DOI 10.1016/0304-3835(88)90035-3
   WARD JM, 1983, J NATL CANCER I, V71, P815
   WARD JM, 1986, ENVIRON HEALTH PERSP, V65, P279, DOI 10.2307/3430195
   WARD JM, 1979, J NATL CANCER I, V63, P849, DOI 10.1093/jnci/63.3.849
   WILLIAMS GM, 1987, CARCINOGENESIS, V8, P875, DOI 10.1093/carcin/8.7.875
   XU YH, 1990, CARCINOGENESIS, V11, P267, DOI 10.1093/carcin/11.2.267
NR 31
TC 94
Z9 94
U1 0
U2 0
PU AMER ASSOC CANCER RESEARCH
PI PHILADELPHIA
PA PUBLIC LEDGER BLDG, SUITE 816, 150 S. INDEPENDENCE MALL W.,
   PHILADELPHIA, PA 19106
SN 0008-5472
J9 CANCER RES
JI Cancer Res.
PD JAN 15
PY 1991
VL 51
IS 2
BP 666
EP 671
PG 6
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA ET789
UT WOS:A1991ET78900033
PM 1985784
DA 2024-02-19
ER

PT J
AU BENUCK, M
   BANAYSCHWARTZ, M
   DEGUZMAN, T
   LAJTHA, A
AF BENUCK, M
   BANAYSCHWARTZ, M
   DEGUZMAN, T
   LAJTHA, A
TI EFFECT OF FOOD-DEPRIVATION ON GLUTATHIONE AND AMINO-ACID LEVELS IN BRAIN
   AND LIVER OF YOUNG AND AGED RATS
SO BRAIN RESEARCH
LA English
DT Article
DE GLUTATHIONE; AMINO ACID; AGING; BRAIN AREA; LIVER; MALNUTRITION
ID CNS STRUCTURAL ELEMENTS; AGING MOUSE; ADULT-RATS; TAURINE; GLUTAMATE;
   REGIONS; HUMANS; SYSTEM; MONKEY; AREAS
AB The effect of short-term food deprivation on glutathione (GSH) and amino acid levels in brain regions of young and aged rats was compared with changes observed in liver. Animals aged 3 months and 24 months were deprived of food for 48 h. GSH and amino acid levels from cerebral cortex, cerebellum, pens medulla, and liver were assayed and compared with levels in animals of the same age fed normal diets. In liver in both young and old rats, GSH levels fell 30%, from 13 mu mol/g tissue to 8.7 mu mol/g tissue. Significant changes were observed in other amino acids, including an increase of 30-50% in methionine, glycine, and glutamine, and a decrease of 30-50% in alanine in liver of both young and aged rats, and a 4-fold increase in taurine in young. In brain, little change was observed upon food deprivation. No decrease was observed in GSH, and only small changes were observed in other amino acids. In the aged animal aspartate, glutamate, and alanine levels were slightly lower; tyrosine in cerebellum was reduced by 30%, and both glycine and tyrosine in the pens medulla were reduced by 20-30%. In the brain areas examined, levels of GSH ranged from 1-2 mu mol/g in young and 0.8-1.4 mu mol/g in old; with levels in pens medulla being lower than those in cerebral cortex. In brain, in contrast to liver, levels were scarcely affected by short-term food deprivation. The relative stability of amino acids paralleled that of brain proteins, which did not significantly decrease even under conditions in which protein content of most other tissues was greatly reduced, indicating specific control of cerebral protein metabolism in protection in malnutrition.
RP BENUCK, M (corresponding author), NATHAN S KLINE INST PSYCHIAT RES,CTR NEUROCHEM,140 OLD ORANGEBURG RD,ORANGEBURG,NY 10962, USA.
CR ADAMS JD, 1993, FREE RADICAL BIO MED, V15, P195, DOI 10.1016/0891-5849(93)90059-4
   BANAYSCHWARTZ M, 1990, J NEUROSCI RES, V26, P209, DOI 10.1002/jnr.490260210
   BANAYSCHWARTZ M, 1990, J NEUROSCI RES, V26, P217, DOI 10.1002/jnr.490260211
   BANAYSCHWARTZ M, 1989, NEUROCHEM RES, V14, P563, DOI 10.1007/BF00964919
   BANAYSCHWARTZ M, 1989, NEUROCHEM RES, V14, P555, DOI 10.1007/BF00964918
   BANAYSCHWARTZ M, 1992, BRAIN RES, V594, P343, DOI 10.1016/0006-8993(92)91149-9
   BANAYSCHWARTZ M, 1993, NEUROCHEM RES, V18, P417, DOI 10.1007/BF00967245
   BANAYSCHWARTZ M, 1993, AMINO ACIDS, V5, P273, DOI 10.1007/BF00805990
   BAYER SM, 1967, J NEUROCHEM, V14, P695, DOI 10.1111/j.1471-4159.1967.tb10303.x
   BENUCK M, 1992, BRAIN RES, V596, P296, DOI 10.1016/0006-8993(92)91560-2
   BENUCK M, 1993, LIFE SCI, V52, P877, DOI 10.1016/0024-3205(93)90517-7
   BENUCK M, IN PRESS J NEUROSCI
   BRAY TM, 1994, BIOCHEM PHARMACOL, V47, P2113, DOI 10.1016/0006-2952(94)90246-1
   CHEN TS, 1989, P SOC EXP BIOL MED, V190, P399
   CHEREL Y, 1991, NEUROCHEM RES, V16, P843, DOI 10.1007/BF00965531
   COOPER AJL, 1980, J NEUROCHEM, V35, P1242, DOI 10.1111/j.1471-4159.1980.tb07882.x
   DUNLOP DS, 1978, BIOCHEM J, V170, P637, DOI 10.1042/bj1700637
   DURING MJ, 1988, BRAIN RES, V452, P378, DOI 10.1016/0006-8993(88)90043-1
   HAZELTON GA, 1980, BIOCHEM J, V188, P25, DOI 10.1042/bj1880025
   HUM S, 1991, CAN J PHYSIOL PHARM, V69, P581, DOI 10.1139/y91-085
   HUTSON NJ, 1982, J BIOL CHEM, V257, P9548
   JAESCHKE H, 1985, BIOCHEM PHARMACOL, V34, P1029, DOI 10.1016/0006-2952(85)90606-9
   KAPLOWITZ N, 1985, ANNU REV PHARMACOL, V25, P715, DOI 10.1146/annurev.pharmtox.25.1.715
   KENESSEY A, 1991, NEUROCHEM RES, V16, P1001, DOI 10.1007/BF00965843
   KUDO H, 1990, BRAIN RES, V511, P326, DOI 10.1016/0006-8993(90)90178-E
   LANGLEY SC, 1992, BIOCHEM PHARMACOL, V44, P1489, DOI 10.1016/0006-2952(92)90462-R
   LEBEL CP, 1991, INT J DEV NEUROSCI, V9, P139, DOI 10.1016/0736-5748(91)90004-6
   MEISTER A, 1992, BIOCHEM PHARMACOL, V44, P1905, DOI 10.1016/0006-2952(92)90091-V
   MORTIMORE GE, 1988, J BIOL CHEM, V263, P19545
   NEIDLE A, 1989, ANAL BIOCHEM, V80, P291
   RAVINDRANATH V, 1989, NEUROSCI LETT, V101, P187, DOI 10.1016/0304-3940(89)90528-4
   SLIVKA A, 1987, NEUROSCI LETT, V74, P112, DOI 10.1016/0304-3940(87)90061-9
   STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616
   STURMAN JA, 1975, J NEUROCHEM, V25, P831, DOI 10.1111/j.1471-4159.1975.tb04414.x
   STURMAN JA, 1993, PHYSIOL REV, V73, P119, DOI 10.1152/physrev.1993.73.1.119
   VOGT BL, 1993, BIOCHEM PHARMACOL, V46, P257, DOI 10.1016/0006-2952(93)90412-P
NR 36
TC 26
Z9 28
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0006-8993
J9 BRAIN RES
JI Brain Res.
PD APR 24
PY 1995
VL 678
IS 1-2
BP 259
EP 264
DI 10.1016/0006-8993(95)00204-4
PG 6
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA QW662
UT WOS:A1995QW66200029
PM 7620894
DA 2024-02-19
ER

PT J
AU Matsuo, Y
   Imanishi, T
   Hayashi, Y
   Tomobuchi, Y
   Kubo, T
   Hano, T
   Akasaka, T
AF Matsuo, Yoshiki
   Imanishi, Toshio
   Hayashi, Yasushi
   Tomobuchi, Yoshiaki
   Kubo, Takashi
   Hano, Takuzo
   Akasaka, Takashi
TI The effect of senescence of endothelial progenitor cells on in-stent
   restenosis in patients undergoing coronary stenting
SO INTERNAL MEDICINE
LA English
DT Article
DE endothelial progenitor cell; in-stent restenosis; reendothelialization
AB Objective Restenosis after stent implantation is caused by endothelial cell damage and subsequent neointimal formation. The objective of this study is to elucidate the relevance of endothelial progenitor cells (EPCs) in the development of in-stent restenosis in patients undergoing stent implantation.
   Patients or Materials The subjects were 46 patients who underwent coronary stenting. Blood samples were collected at the time of follow-up coronary angiography after coronary stenting. EPCs were isolated from blood samples and cultured. Their phenotypes were confirmed by uptake of acetylated low-density lipoprotein and binding of fluorescein isothiocyanate-labeled Ulex europaeus agglutinin 1 lectin. The number of colony-forming units (CFUs) and the senescent cells, determined by acidic beta-galactosidase staining, was counted. Angiogenic growth factors secreted by EPCs, such as vascular endothelial growth factor (VEGF), basic fibroblast growth factor (b-FGF), hepatocyte growth factor (HGF), and macrophage chemoattractant protein (MCP-1) from the culture medium were also measured by enzyme-linked immunosorbent assay.
   Results Patients with in-stent restenosis (defined as > 40% stenosis, n=16) had a decreased number of CFUs (p < 0.05), and increased senescent cells (p < 0.05), compared to patients without restenosis (n = 30). There was no significant difference of angiogenic growth factors (VEGF, HGF, b-FGF, and MCP-1) secreted by EPCs between the two groups. On multivariate analysis, an increased number of senescent EPCs was the independent factor associated with in-stent restenosis (OR 1.10, 95% CI 1.01 to 1.20).
   Conclusion These data suggested that EPCs might be involved in the development of in-stent restenosis.
C1 [Matsuo, Yoshiki; Imanishi, Toshio; Kubo, Takashi; Hano, Takuzo; Akasaka, Takashi] Wakayama Med Univ, Dept Cardiovasc Med, Wakayama 6418509, Japan.
   [Hayashi, Yasushi; Tomobuchi, Yoshiaki] Wakayama Med Univ, Dept Crit Care Med, Wakayama 6418509, Japan.
C3 Wakayama Medical University; Wakayama Medical University
RP Imanishi, T (corresponding author), Wakayama Med Univ, Dept Cardiovasc Med, 811-1 Kimiidera, Wakayama 6418509, Japan.
CR Asahara T, 1996, CIRCULATION, V94, P3291, DOI 10.1161/01.CIR.94.12.3291
   Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Assmus B, 2003, CIRC RES, V92, P1049, DOI 10.1161/01.RES.0000070067.64040.7C
   Bauters C, 1997, PROG CARDIOVASC DIS, V40, P107, DOI 10.1016/S0033-0620(97)80003-5
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287
   Imanishi T, 2005, J HYPERTENS, V23, P97, DOI 10.1097/00004872-200501000-00018
   Imanishi T, 2004, CLIN EXP PHARMACOL P, V31, P407, DOI 10.1111/j.1440-1681.2004.04022.x
   Kipshidze N, 2004, J AM COLL CARDIOL, V44, P733, DOI 10.1016/j.jacc.2004.04.048
   Patti G, 2005, CIRCULATION, V111, P70, DOI 10.1161/01.CIR.0000151308.06673.D2
   Rafii S, 1995, ANN THORAC SURG, V60, P1627, DOI 10.1016/0003-4975(95)00807-1
   Shi Q, 1998, BLOOD, V92, P362, DOI 10.1182/blood.V92.2.362.414k38_362_367
   Shintani S, 2001, CIRCULATION, V103, P2776, DOI 10.1161/hc2301.092122
   Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953
   VITA JA, 1990, CIRCULATION, V81, P491, DOI 10.1161/01.CIR.81.2.491
   Walter DH, 2002, CIRCULATION, V105, P3017, DOI 10.1161/01.CIR.0000018166.84319.55
   Werner N, 2003, CIRC RES, V93, pE17, DOI 10.1161/01.RES.0000083812.30141.74
NR 17
TC 27
Z9 48
U1 0
U2 4
PU JAPAN SOC INTERNAL MEDICINE
PI TOKYO
PA 34-3 3-CHOME HONGO BUNKYO-KU, TOKYO, 113, JAPAN
SN 0918-2918
EI 1349-7235
J9 INTERNAL MED
JI Intern. Med.
PY 2006
VL 45
IS 9
BP 581
EP 587
DI 10.2169/internalmedicine.45.1663
PG 7
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA V50DI
UT WOS:000203388600004
PM 16755088
OA Bronze
DA 2024-02-19
ER

PT J
AU SIGAL, SH
   BRILL, S
   FIORINO, AS
   REID, LM
AF SIGAL, SH
   BRILL, S
   FIORINO, AS
   REID, LM
TI THE LIVER AS A STEM-CELL AND LINEAGE SYSTEM
SO AMERICAN JOURNAL OF PHYSIOLOGY
LA English
DT Article
DE OVAL CELLS; HEPATOCYTES; LIVER REGENERATION
ID HEPATITIS-B VIRUS; COMBINED HEPATOCELLULAR-CHOLANGIOCARCINOMA;
   MICROCARRIER-ATTACHED HEPATOCYTES; BILE-DUCT CELLS; ALPHA-FETOPROTEIN;
   RAT-LIVER; OVAL CELLS; GENE-EXPRESSION; SMALL-INTESTINE; GROWTH-FACTORS
AB We propose that liver is a stem cell and lineage system with many parallels to lineages in the bone marrow, gut, and epidermis, varying from them only in kinetics. All are organized with three compartments: a slow cycling stem cell compartment with cells expressing a fetal phenotype and responding slowly to injury; an amplification compartment with cells of intermediate phenotype rapidly proliferating in response to regenerative stimuli or acute injuries; and a terminal differentiation compartment in which cells increasingly differentiate and gradually lose their ability to divide. In all systems, both those with slow or rapid kinetics, the various compartments are positioned in a polarized organization, are associated with a gradient in the chemistry of the extracellular matrix, and show lineage-position-dependent growth responses, gene expression, pharmacological and toxicological responses, and reaction to viruses and radiation. In general, known oncogens selectively kill cells in the differentiation compartment inducing chronic regenerative responses of the cells in stem cell and/or amplification compartment. Tumors arise by subsequent transformation of the activated stem cells or early precursor cells. The evidence for a lineage model consists of the data implicating gradients in cell size, ploidy, growth potential, and antigenic and gene expression in the liver parenchyma along the sinusoidal plates. The traditional explanation for this heterogeneity is that it represents adaption of cells to a changing sinusoidal microenvironment dictated by the direction of blood flow. However, we review the extant data and suggest that it more readily supports a lineage model involving a maturation process beginning with stem cells and precursors in the periportal zone and ending with sensescing parenchyma near the central vein. Support for this theory is provided by the studies on phenotypic heterogeneity in liver, investigations into the embryology of the liver, and analyses of the responses of liver to chemical and viral oncogens that induce rapid proliferation of small cells with oval-shaped nuclei, "oval cells," now thought to be closely related to liver stem cells. The lineage model provides clarity and insights into many aspects of liver biology and disease including the limited proliferative ability of in vitro parenchymal cultures, liver regeneration, gene expression, viral infection, hepatocellular carcinogenesis, liver cell transplantation, and aging.
C1 YESHIVA UNIV ALBERT EINSTEIN COLL MED, DEPT MOLEC PHARMACOL, 1300 MORRIS PLC AVE, BRONX, NY 10461 USA.
   YESHIVA UNIV ALBERT EINSTEIN COLL MED, DEPT MICROBIOL & IMMUNOL, BRONX, NY 10461 USA.
   YESHIVA UNIV ALBERT EINSTEIN COLL MED, MARION BESSIN LIVER RES CTR, BRONX, NY 10461 USA.
C3 Yeshiva University; Albert Einstein College of Medicine; Yeshiva
   University; Albert Einstein College of Medicine; Yeshiva University;
   Albert Einstein College of Medicine
FU NCI NIH HHS [P30-CA-133330, CA-00783] Funding Source: Medline; NIADDK
   NIH HHS [AM-17702] Funding Source: Medline
CR ANDERSEN B, 1983, EUR J CELL BIOL, V30, P126
   ARBER N, 1988, LIVER, V8, P80
   BARBERIS A, 1990, GENE DEV, V4, P849, DOI 10.1101/gad.4.5.849
   BEASLEY RP, 1982, HEPATOLOGY, V2, pS21
   BENNETT AL, 1987, J CELL BIOL, V105, P1073, DOI 10.1083/jcb.105.3.1073
   BENVENISTY N, 1991, BIOL NEONATE, V59, P181
   BERRIDGE MJ, 1989, JAMA-J AM MED ASSOC, V262, P1834
   BISGAARD HC, 1991, J CELL PHYSIOL, V147, P333, DOI 10.1002/jcp.1041470220
   BLACKBURN MJ, 1977, BRIT J HAEMATOL, V37, P337, DOI 10.1111/j.1365-2141.1977.tb01004.x
   BUCHER NLR, 1990, SEMIN LIVER DIS, V10, P11, DOI 10.1055/s-2008-1040453
   CAMPER SA, 1989, PROG NUCLEIC ACID RE, V36, P131
   CAMPRA J, 1989, LIVER BIOL PATHOBIOL, P911
   CARON JM, 1990, MOL CELL BIOL, V10, P1239, DOI 10.1128/MCB.10.3.1239
   CASCIO S, 1991, DEVELOPMENT, V113, P217
   CASEY PJ, 1988, COLD SPRING HARB SYM, V53, P203, DOI 10.1101/SQB.1988.053.01.026
   CHANG HK, 1989, VIROLOGY, V170, P176, DOI 10.1016/0042-6822(89)90364-4
   CHAPMAN V, 1984, NATURE, V307, P284, DOI 10.1038/307284a0
   CHAUDHARY PM, 1991, CELL, V66, P85, DOI 10.1016/0092-8674(91)90141-K
   CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407
   CHIANALE J, 1986, HEPATOLOGY, V6, P945, DOI 10.1002/hep.1840060522
   CHOWDHURY JR, 1991, SCIENCE, V254, P1802, DOI 10.1126/science.1722351
   CLEARFIELD HR, 1985, GASTROENTEROLOGY, P2659
   COLIGE A, 1990, J CELL PHYSIOL, V145, P450, DOI 10.1002/jcp.1041450309
   COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C
   COTSARELIS G, 1989, CELL, V57, P201, DOI 10.1016/0092-8674(89)90958-6
   CROISILLE Y, 1965, ORGANOGENESIS, P421
   CUDKOWICZ G, 1964, ANN NY ACAD SCI, V114, P571
   Daniel C P, 1989, Haematol Blood Transfus, V32, P172
   DEMETRIOU AA, 1988, HEPATOLOGY, V8, P1006, DOI 10.1002/hep.1840080505
   DEMETRIOU AA, 1986, SCIENCE, V233, P1190, DOI 10.1126/science.2426782
   Dubois AM., 1963, The Liver, P1, DOI [10.1016/B978-1-4832-2824-2.50007-8, DOI 10.1016/B978-1-4832-2824-2.50007-8]
   DUNSFORD HA, 1989, CANCER RES, V49, P4887
   Elias H., 1969, MORPHOLOGY LIVER
   EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939
   EVARTS RP, 1989, CANCER RES, V49, P1541
   EVARTS RP, 1987, CARCINOGENESIS, V8, P1737, DOI 10.1093/carcin/8.11.1737
   EVARTS RP, 1987, CANCER RES, V47, P5469
   FARBER E, 1984, CANCER RES, V44, P5463
   FARIS RA, 1986, J CELL BIOL, V103, pA360
   Fausto N, 1990, CURR OPIN CELL BIOL, V2, P1036, DOI 10.1016/0955-0674(90)90153-6
   FAUSTO N, 1990, PROG CLIN BIOL RES, V331, P325
   FISCHER HP, 1988, VIRCHOWS ARCH B, V56, P71, DOI 10.1007/BF02890004
   FLANAGAN BF, 1990, IMMUNOGENETICS, V31, P13, DOI 10.1007/BF00702484
   FORD AM, 1988, EMBO J, V7, P2393, DOI 10.1002/j.1460-2075.1988.tb03084.x
   FREISSMUTH M, 1989, FASEB J, V3, P2125, DOI 10.1096/fasebj.3.10.2546847
   FRIEDMAN JM, 1984, J MOL BIOL, V179, P37, DOI 10.1016/0022-2836(84)90305-X
   FRIEDMAN JM, 1989, LIVER BIOL PATHOBIOL, P71
   FRIEDMAN SL, 1989, J BIOL CHEM, V264, P10756
   FURTH JJ, 1991, J GERONTOL, V46, pB122, DOI 10.1093/geronj/46.3.B122
   GEBHARDT R, 1988, SCAND J GASTROENTERO, V23, P8, DOI 10.3109/00365528809095909
   GERMAIN L, 1988, CANCER RES, V48, P368
   GERMAIN L, 1988, CANCER RES, V48, P4909
   GERMAIN L, 1985, CANCER RES, V45, P673
   GOLDSTEIN S, 1990, SCIENCE, V249, P1129, DOI 10.1126/science.2204114
   GOODMAN ZD, 1985, CANCER-AM CANCER SOC, V55, P124, DOI 10.1002/1097-0142(19850101)55:1<124::AID-CNCR2820550120>3.0.CO;2-Z
   GUPTA S, 1991, HEPATOLOGY, V14, P144, DOI 10.1002/hep.1840140124
   HAAS JE, 1989, CANCER-AM CANCER SOC, V64, P1082, DOI 10.1002/1097-0142(19890901)64:5<1082::AID-CNCR2820640520>3.0.CO;2-G
   HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0
   HAUSSINGER D, 1990, BIOCHEM J, V267, P281
   HAYNER NT, 1984, CANCER RES, V44, P332
   HEIMFELD S, 1991, CURR TOP DEV BIOL, V25, P155
   HELLMAN S, 1970, HEMOPOIETIC CELLULAR
   HIXSON DC, 1990, PATHOBIOLOGY, V58, P65, DOI 10.1159/000163565
   HOUSSAINT E, 1980, CELL DIFFER DEV, V9, P269, DOI 10.1016/0045-6039(80)90026-3
   Janzen JWG, 1987, J HISTOCHEM CYTOCHEM, V35, P49, DOI 10.1177/35.1.2878950
   JOHNSON A, 1986, BLOOD, V68, P1348
   JONES AL, 1983, HISTOLOGY CELL TISSU, P707
   JUNGERMANN K, 1986, ENZYME, V35, P161, DOI 10.1159/000469338
   KADISH JL, 1975, J IMMUNOL, V114, P452
   KANAMURA S, 1980, ANAT EMBRYOL, V158, P151, DOI 10.1007/BF00315902
   KELLY F, 1982, BIOCHIM BIOPHYS ACTA, V651, P105, DOI 10.1016/0304-419X(82)90009-9
   KINGSTON JE, 1983, ARCH DIS CHILD, V58, P959, DOI 10.1136/adc.58.12.959
   KRUSH AJ, 1988, AM J MED GENET, V29, P323, DOI 10.1002/ajmg.1320290211
   LAVKER RM, 1991, INVEST OPHTH VIS SCI, V32, P1864
   LEMIRE JM, 1991, CANCER RES, V51, P4656
   LITZ CE, 1990, CANCER RES, V50, P4984
   LIU JK, 1991, MOL CELL BIOL, V11, P773, DOI 10.1128/MCB.11.2.773
   LONDON WT, 1981, HUM PATHOL, V12, P1085, DOI 10.1016/S0046-8177(81)80329-2
   LOUD AV, 1968, J CELL BIOL, V37, P27, DOI 10.1083/jcb.37.1.27
   MAGANTO P, 1990, HEPATOLOGY, V11, P585, DOI 10.1002/hep.1840110410
   Marks P A, 1985, Prog Clin Biol Res, V191, P185
   MARTINEZHERNAND.A, IN PRESS EXTRACELLUL
   MECHAM RP, 1987, BIOL EXTRACELLULAR M
   MESSIER B, 1960, AM J ANAT, V106, P247, DOI 10.1002/aja.1001060305
   MOORE MAS, 1991, BLOOD, V78, P1
   MOORMAN AFM, 1990, HISTOCHEM J, V22, P653, DOI 10.1007/BF01047449
   MUTO M, 1978, LIVER ATLAS SCANNING
   NATHAN C, 1991, J CELL BIOL, V113, P981, DOI 10.1083/jcb.113.5.981
   PEACOCKE M, 1991, J CELL BIOCHEM, V45, P147, DOI 10.1002/jcb.240450205
   PETROPOULOS CJ, 1985, CANCER RES, V45, P5762
   PIERCE GB, 1974, AM J PATHOL, V77, P103
   POLIARD AM, 1986, J CELL BIOL, V103, P777, DOI 10.1083/jcb.103.3.777
   POTTEN CS, 1990, DEVELOPMENT, V110, P1001
   POTTEN CS, 1987, J THEOR BIOL, V127, P381, DOI 10.1016/S0022-5193(87)80136-4
   POTTEN CS, 1990, INT J RADIAT BIOL, V57, P185, DOI 10.1080/09553009014550431
   QUARONI A, 1978, P NATL ACAD SCI USA, V75, P5548, DOI 10.1073/pnas.75.11.5548
   RADAEVA SA, 1990, TSITOLOGIYA+, V32, P331
   RANEY AK, 1990, J VIROL, V64, P2360, DOI 10.1128/JVI.64.5.2360-2368.1990
   REDDY JK, 1984, J CELL BIOL, V98, P2082, DOI 10.1083/jcb.98.6.2082
   Reid LM, 1990, CURR OPIN CELL BIOL, V2, P121, DOI 10.1016/S0955-0674(05)80042-0
   ROBERTS R, 1988, NATURE, V332, P376, DOI 10.1038/332376a0
   SCHUETZ EG, 1990, J BIOL CHEM, V265, P1188
   SELL S, 1989, AM J PATHOL, V134, P1347
   SELL S, 1990, CANCER RES, V50, P3811
   SELL S, 1987, ADV CANCER RES, V48, P37, DOI 10.1016/S0065-230X(08)60690-9
   SELL S, 1983, CANCER RES, V43, P1761
   SELL S, 1980, ONCODEV BIOL MED, V1, P93
   SHIOJIRI N, 1981, J EMBRYOL EXP MORPH, V62, P139
   SHIOJIRI N, 1991, CANCER RES, V51, P2611
   SHIOJIRI N, 1984, J EMBRYOL EXP MORPH, V79, P25
   SIGAL S, IN PRESS EXTRACELLUL
   SIRICA AE, 1990, PATHOBIOLOGY, V58, P44, DOI 10.1159/000163564
   SPORN MB, 1988, NATURE, V332, P217, DOI 10.1038/332217a0
   SPRAY DC, 1987, J CELL BIOL, V105, P541, DOI 10.1083/jcb.105.1.541
   Sun T T, 1983, Curr Probl Dermatol, V11, P277
   TAKAHASHI T, 1990, BLOOD, V75, P603
   TAMIR M, 1989, INT J CELL CLONING, V7, P373, DOI 10.1002/stem.5530070605
   TATEMATSU M, 1985, LAB INVEST, V52, P354
   THOR G, 1987, EMBO J, V6, P2581, DOI 10.1002/j.1460-2075.1987.tb02548.x
   THURMAN RG, 1985, HEPATOLOGY, V5, P144, DOI 10.1002/hep.1840050128
   TILGHMAN SM, 1982, P NATL ACAD SCI-BIOL, V79, P5254, DOI 10.1073/pnas.79.17.5254
   TILL JE, 1961, RADIAT RES, V14, P213, DOI 10.2307/3570892
   TRABER PG, 1988, GASTROENTEROLOGY, V95, P1130, DOI 10.1016/0016-5085(88)90194-1
   UITTO J, 1989, J INVEST DERMATOL, V92, pS61, DOI 10.1111/1523-1747.ep13075039
   VLODAVSKY I, 1991, J CELL BIOCHEM, V45, P167, DOI 10.1002/jcb.240450208
   WILLIAMS N, 1978, BLOOD, V52, P163
   WILSON JW, 1963, ANN NY ACAD SCI, V111, P8, DOI 10.1111/j.1749-6632.1963.tb36945.x
   WILSON JW, 1948, AM J ANAT, V82, P353, DOI 10.1002/aja.1000820302
   WILSON JW, 1958, J PATHOL BACTERIOL, V76, P441, DOI 10.1002/path.1700760213
   WOJCIK E, 1988, J CLIN INVEST, V82, P658, DOI 10.1172/JCI113645
   WOTTON D, 1989, P NATL ACAD SCI USA, V86, P4195, DOI 10.1073/pnas.86.11.4195
   YASUMOTO M, 1991, BIOCHEM BIOPH RES CO, V174, P90
   YOSHIDA Y, 1978, CANCER RES, V38, P2753
   ZVIBEL I, 1991, MOL CELL BIOL, V11, P108, DOI 10.1128/MCB.11.1.108
   [No title captured]
NR 135
TC 202
Z9 216
U1 0
U2 3
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0002-9513
J9 AM J PHYSIOL
JI Am. J. Physiol.
PD AUG
PY 1992
VL 263
IS 2
BP G139
EP G148
DI 10.1152/ajpgi.1992.263.2.G139
PN 1
PG 10
WC Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology
GA JJ958
UT WOS:A1992JJ95800070
PM 1325126
DA 2024-02-19
ER

PT J
AU Phorl, S
   Memon, A
   Seo, Y
   Hoang, TO
   Tran, TN
   Nguyen, LMT
   Lee, CH
   Lee, WK
   Lee, JY
AF Phorl, Sophors
   Memon, Azra
   Seo, Yuri
   Hoang, Thi Oanh
   Tran, Trung Nghia
   Nguyen, Le Minh Tri
   Lee, Chang Hoon
   Lee, Woon Kyu
   Lee, Joo-Yong
TI Opposing roles of HDAC6 in liver regeneration and hepatocarcinogenesis
SO CANCER SCIENCE
LA English
DT Article; Early Access
DE acetylation; HDAC6; hepatocellular carcinogenesis; innate immunity; p53
ID HEPATOCELLULAR-CARCINOMA; TUMOR-SUPPRESSOR; P53; DEACETYLATION;
   ACETYLATION; PROGRESSION
AB Histone deacetylase 6 (HDAC6), a deacetylase of p53, has emerged as a privileged inhibitory target for cancer therapy because of its deacetylating activity for p53 at K120 and K373/382. However, intricate roles of HDAC6 in hepatocellular carcinogenesis have been suggested by recent evidence, namely that HDAC6 ablation suppresses innate immunity, which plays critical roles in tumor immunosurveillance and antitumor immune responses. Therefore, it is valuable to determine whether HDAC6 ablation inhibits hepatocellular carcinogenesis using in vivo animal models. Here, we firstly showed that HDAC6 ablation increased K320 acetylation of p53, known as pro-survival acetylation, in all tested animal models but did not always increase K120 and K373/382 acetylation of p53, known as pro-apoptotic acetylation. HDAC6 ablation induced cellular senescence in primary MEFs and inhibited cell proliferation in HepG2 cells and liver regeneration after two-thirds partial hepatectomy. However, the genetic ablation of HDAC6 did not inhibit hepatocarcinogenesis, but instead slightly enhanced it in two independent mouse models (DEN + HFD and DEN + TAA). Notably, HDAC6 ablation significantly promoted hepatocarcinogenesis in a multiple DEN treatment hepatocellular carcinoma (HCC) mouse model, mimicking chronic DNA damage in the liver, which correlated with hyperacetylation at K320 of p53 and a decrease in inflammatory cytokines and chemokines. Our data from three independent in vivo animal HCC models emphasize the importance of the complex roles of HDAC6 ablation in hepatocellular carcinogenesis, highlighting its immunosuppressive effects.
C1 [Phorl, Sophors; Seo, Yuri; Hoang, Thi Oanh; Tran, Trung Nghia; Nguyen, Le Minh Tri; Lee, Joo-Yong] Chungnam Natl Univ, Grad Sch Analyt Sci & Technol, 99 Daehak Ro St, Daejeon 305764, South Korea.
   [Memon, Azra; Lee, Woon Kyu] Inha Univ, Sch Med, Dept Biomed Sci, 100 inha ro, Incheon 22212, South Korea.
   [Lee, Chang Hoon] Korea Res Inst Chem Technol, Ctr Drug Platform Technol, Daejeon, South Korea.
C3 Chungnam National University; Inha University; Korea Research Institute
   of Chemical Technology (KRICT)
RP Lee, JY (corresponding author), Chungnam Natl Univ, Grad Sch Analyt Sci & Technol, 99 Daehak Ro St, Daejeon 305764, South Korea.; Lee, WK (corresponding author), Inha Univ, Sch Med, Dept Biomed Sci, 100 inha ro, Incheon 22212, South Korea.
EM wklee@inha.ac.kr; leejooyong@cnu.ac.kr
RI memon, azra/HGU-6410-2022
OI memon, azra/0000-0002-4971-6283; Lee, Joo-Yong/0000-0003-1049-6006
FU Ministry of Health & Welfare, Republic of Korea [HI21C1503]; Ministry of
   Science and ICT, South Korea [CNU(2021)--011]; National Research
   Foundation of Korea [2016M3A9E1918314, 2019R1A2C1005334]
FX the Ministry of Health & Welfare, Republic of Korea, Grant/Award Number:
   HI21C1503; Ministry of Science and ICT, South Korea, Grant/Award Number:
   CNU(2021)--011; National Research Foundation of Korea, Grant/Award
   Number: 2016M3A9E1918314 and 2019R1A2C1005334
CR Bae HJ, 2015, J HEPATOL, V63, P408, DOI 10.1016/j.jhep.2015.03.019
   Brown ZJ, 2018, NAT REV GASTRO HEPAT, V15, P536, DOI 10.1038/s41575-018-0033-6
   Charni M, 2017, CELL DEATH DIFFER, V24, P8, DOI 10.1038/cdd.2016.117
   Choi SJ, 2016, EMBO J, V35, P429, DOI 10.15252/embj.201592586
   Degasperi E, 2016, LANCET GASTROENTEROL, V1, P156, DOI 10.1016/S2468-1253(16)30018-8
   Demaria O, 2019, NATURE, V574, P45, DOI 10.1038/s41586-019-1593-5
   Ding G, 2013, FEBS LETT, V587, P880, DOI 10.1016/j.febslet.2013.02.001
   Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0
   Hafner A, 2019, NAT REV MOL CELL BIO, V20, P199, DOI 10.1038/s41580-019-0110-x
   Henderson JM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28486-8
   Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a
   Jung KH, 2012, HEPATOLOGY, V56, P644, DOI 10.1002/hep.25699
   Jung S, 2018, BIOCHEM BIOPH RES CO, V503, P285, DOI 10.1016/j.bbrc.2018.06.016
   Kaluza D, 2011, EMBO J, V30, P4142, DOI 10.1038/emboj.2011.298
   Kastenhuber ER, 2017, CELL, V170, P1062, DOI 10.1016/j.cell.2017.08.028
   Lee JY, 2010, EMBO J, V29, P969, DOI 10.1038/emboj.2009.405
   Lee YS, 2008, CANCER RES, V68, P7561, DOI 10.1158/0008-5472.CAN-08-0188
   Li Y, 2013, FEBS J, V280, P775, DOI 10.1111/febs.12079
   Liu HM, 2016, EBIOMEDICINE, V9, P195, DOI 10.1016/j.ebiom.2016.06.015
   Liu L, 2019, TOXICOL APPL PHARM, V370, P178, DOI 10.1016/j.taap.2019.03.017
   Magupalli VG, 2020, SCIENCE, V369, P1448, DOI 10.1126/science.aas8995
   Memon A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21155461
   Michalopoulos GK, 2010, AM J PATHOL, V176, P2, DOI 10.2353/ajpath.2010.090675
   Mu X, 2015, J CLIN INVEST, V125, P3891, DOI 10.1172/JCI77995
   Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052
   Park SY, 2017, BIOCHEM BIOPH RES CO, V494, P51, DOI 10.1016/j.bbrc.2017.10.087
   Pulya S, 2021, PHARMACOL RES, V163, DOI 10.1016/j.phrs.2020.105274
   Qian H, 2017, J CLIN INVEST, V127, P1353, DOI 10.1172/JCI85963
   Qiu WN, 2020, HEPATOLOGY, V71, P1967, DOI 10.1002/hep.30960
   Rui LY, 2014, COMPR PHYSIOL, V4, P177, DOI 10.1002/cphy.c130024
   Ryu HW, 2017, CANCER LETT, V391, P162, DOI 10.1016/j.canlet.2017.01.033
   Salomao M, 2012, HUM PATHOL, V43, P737, DOI 10.1016/j.humpath.2011.07.005
   Yang HD, 2019, HEPATOLOGY, V70, P1262, DOI 10.1002/hep.30657
   Zhang SY, 2019, CELL CYCLE, V18, P1302, DOI 10.1080/15384101.2019.1618123
   Zhang WB, 2018, BIOMED PHARMACOTHER, V97, P818, DOI 10.1016/j.biopha.2017.10.103
   Zhang Y, 2008, MOL CELL BIOL, V28, P1688, DOI 10.1128/MCB.01154-06
   Zhao Y, 2006, MOL CELL BIOL, V26, P2782, DOI 10.1128/MCB.26.7.2782-2790.2006
NR 37
TC 4
Z9 4
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1347-9032
EI 1349-7006
J9 CANCER SCI
JI Cancer Sci.
PD 2022 JUL
PY 2022
VL 113
IS 7
BP 2311
EP 2322
DI 10.1111/cas.15391
EA JUN 2022
PG 12
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA 2V1RV
UT WOS:000818573400001
PM 35534985
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Kiray, M
   Ergur, BU
   Bagriyanik, A
   Peketin, C
   Aksu, I
   Buldan, Z
AF Kiray, Muge
   Ergur, Bekir Ugur
   Bagriyanik, Alper
   Peketin, Cetin
   Aksu, Ilkay
   Buldan, Zisan
TI Suppression of apoptosis and oxidative stress by deprenyl and estradiol
   in aged rat liver
SO ACTA HISTOCHEMICA
LA English
DT Article
DE deprenyl; estradiol; aging; liver; apoptosis; oxidative stress
ID FREE-RADICAL THEORY; LIPID-PEROXIDATION; OXIDANT STRESS; DIETARY
   RESTRICTION; SPATIAL MEMORY; DNA-DAMAGE; F344 RATS; BRAIN; ANTIOXIDANT;
   SELEGILINE
AB Aging is accompanied by significant structural. and functional transformations of all organs and systems. Age-associated increase in apoptotic behavior may cause disease. Older cells are more susceptible to endogenous oxidative damage, and oxidative stress is a potent inducer of apoptosis. Deprenyl. is an irreversible monoamine-oxidase B inhibitor which has anti-oxidant, anti-apoptotic and neuroprotective effects. Estrogen is also a neuroprotective and anti-oxidant hormone. The objectives of this study were to determine whether the anti-oxidative effects of deprenyl. can suppress apoptotic activity, with or without estradiol, in aged female rat livers. In this study, ovariectomized female Wistar albino rats were divided into six groups as follows; young (3 months old) saline-treated control, aged (24 months old) saline-treated control., aged deprenyl. treated, aged estradiol. treated, aged deprenyl. plus estradiol. treated and aged sham controls. All rats except for the sham group were treated for 21 days. Determination of oxidative stress parameters was performed spectrophotometrically. To detect apoptotic cells, TUNEL staining was performed. The results were analyzed by one-way ANOVA post hoc Bonferroni test. Deprenyl. and estradiol. administration, alone or in combination, decreased significantly the levels of lipid peroxidation and increased superoxide dismutase activity in the liver relative to aged control, and sham rats (P < 0.05). The number of TUNEL positive cells decreased significantly in deprenyl. and estradiol-treated rats compared with aged control and sham rats. The results indicate that deprenyl, treatment alone, or in combination with estradiol, may modulate age-related apoptotic changes in rat liver by decreasing oxidative stress. (c) 2007 Elsevier GmbH. All rights reserved.
C1 Dokuz Eylul Univ, Sch Med, Dept Histol, TR-35340 Izmir, Turkey.
   Dokuz Eylul Univ, Sch Med, Dept Embryol, TR-35340 Izmir, Turkey.
   Dokuz Eylul Univ, Sch Med, Dept Physiol, TR-35340 Izmir, Turkey.
C3 Dokuz Eylul University; Dokuz Eylul University; Dokuz Eylul University
RP Kiray, M (corresponding author), Dokuz Eylul Univ, Sch Med, Dept Histol, TR-35340 Izmir, Turkey.
EM muge.kiray@deu.edu.tr
RI ergur, bekir/ABI-6751-2020; ERGÜR, BEKİR/P-7578-2019; Bagriyanik, Husnu
   Alper/H-7577-2013
OI ERGÜR, BEKİR/0000-0002-6448-2593; Bagriyanik, Husnu
   Alper/0000-0003-4064-7637; Kiray, Muge/0000-0001-5072-0100
CR Alper G, 2005, ENDOCR RES, V31, P199, DOI 10.1080/07435800500371805
   Alper G, 1999, EUR NEUROPSYCHOPHARM, V9, P247, DOI 10.1016/S0924-977X(98)00035-2
   Ashok BT, 1999, EXP GERONTOL, V34, P293, DOI 10.1016/S0531-5565(99)00005-4
   Barja G, 2004, TRENDS NEUROSCI, V27, P595, DOI 10.1016/j.tins.2004.07.005
   Bokov A, 2004, MECH AGEING DEV, V125, P811, DOI 10.1016/j.mad.2004.07.009
   CARRILLO MC, 1993, LIFE SCI, V52, P1925, DOI 10.1016/0024-3205(93)90633-E
   Davydov VV, 2004, EXP GERONTOL, V39, P11, DOI 10.1016/j.exger.2003.08.009
   de Lima MNM, 2005, EXP NEUROL, V196, P177, DOI 10.1016/j.expneurol.2005.07.017
   Garcia-Segura LM, 2001, PROG NEUROBIOL, V63, P29, DOI 10.1016/S0301-0082(00)00025-3
   Golden TR, 2002, AGING CELL, V1, P117, DOI 10.1046/j.1474-9728.2002.00015.x
   Gündüz F, 2004, PHYSIOL RES, V53, P171, DOI 10.33549/physiolres.930384
   HARMAN D, 1993, DRUG AGING, V3, P60, DOI 10.2165/00002512-199303010-00006
   Higami Y, 1997, CELL TISSUE RES, V288, P69, DOI 10.1007/s004410050793
   Kennedy MA, 2003, EXP GERONTOL, V38, P997, DOI 10.1016/S0531-5565(03)00164-5
   Kiray M, 2006, PHYSIOL RES, V55, P205, DOI 10.33549/physiolres.930742
   Kiray M, 2004, NEUROSCI LETT, V354, P225, DOI 10.1016/j.neulet.2003.10.019
   Kitani K, 2002, MECH AGEING DEV, V123, P1087, DOI 10.1016/S0047-6374(01)00392-X
   Lee JH, 2004, EXP GERONTOL, V39, P1361, DOI 10.1016/j.exger.2004.06.015
   Liu Y, 2002, WORLD J GASTROENTERO, V8, P363
   Liu ZP, 2001, J COMP NEUROL, V441, P1, DOI 10.1002/cne.1393
   Lu GM, 2004, LIFE SCI, V74, P897, DOI 10.1016/j.lfs.2003.08.004
   Miura T, 1996, STEROIDS, V61, P379, DOI 10.1016/0039-128X(96)00044-X
   Moorthy K, 2005, EXP GERONTOL, V40, P295, DOI 10.1016/j.exger.2005.01.004
   OZTEKIN E, 2006, CELL BIOCH FUNC 0807
   Palovaara S, 2002, EUR J CLIN PHARMACOL, V58, P259, DOI 10.1007/s00228-002-0469-y
   Poon R, 2005, TOXICOLOGY, V214, P99, DOI 10.1016/j.tox.2005.06.024
   REHNCRONA S, 1980, J NEUROCHEM, V34, P1630, DOI 10.1111/j.1471-4159.1980.tb11254.x
   Simon L, 2001, EUR J PHARMACOL, V430, P235, DOI 10.1016/S0014-2999(01)01375-9
   Spiteller G, 2001, EXP GERONTOL, V36, P1425, DOI 10.1016/S0531-5565(01)00131-0
   Tanaka K, 2004, EXP GERONTOL, V39, P195, DOI 10.1016/j.exger.2003.10.013
   TORONYI E, 2002, MED SCI MONITOR, V8, P65
   Unal I, 2001, BRAIN RES, V917, P174, DOI 10.1016/S0006-8993(01)02914-6
   Wickens AP, 2001, RESP PHYSIOL, V128, P379, DOI 10.1016/S0034-5687(01)00313-9
   Wong YT, 2006, FREE RADICAL RES, V40, P393, DOI 10.1080/10715760600556074
   Zhang YP, 2002, MECH AGEING DEV, V123, P245, DOI 10.1016/S0047-6374(01)00349-9
NR 35
TC 16
Z9 17
U1 0
U2 8
PU ELSEVIER GMBH, URBAN & FISCHER VERLAG
PI JENA
PA OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY
SN 0065-1281
J9 ACTA HISTOCHEM
JI Acta Histochem.
PY 2007
VL 109
IS 6
BP 480
EP 485
DI 10.1016/j.acthis.2007.04.008
PG 6
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA 229XB
UT WOS:000250838800008
PM 17698173
DA 2024-02-19
ER

PT J
AU Savastano, S
   Di Somma, C
   Pizza, G
   De Rosa, A
   Nedi, V
   Rossi, A
   Orio, F
   Lombardi, G
   Colao, A
   Tarantino, G
AF Savastano, Silvia
   Di Somma, Carolina
   Pizza, Genoveffa
   De Rosa, Annalba
   Nedi, Valeria
   Rossi, Annalisa
   Orio, Francesco
   Lombardi, Gaetano
   Colao, Annamaria
   Tarantino, Giovanni
TI Liver-spleen axis, insulin-like growth factor-(IGF)-I axis and fat mass
   in overweight/obese females
SO JOURNAL OF TRANSLATIONAL MEDICINE
LA English
DT Article
ID HEPATIC STEATOSIS; BINDING-PROTEINS; OBESE SUBJECTS; FACTOR-I;
   RESISTANCE; INFLAMMATION; GLUCOSE; HORMONE; INDEX; GH
AB Background: Fat mass (FM) in overweight/obese subjects has a primary role in determining low-grade chronic inflammation and, in turn, insulin resistance (IR) and ectopic lipid storage within the liver. Obesity, aging, and FM influence the growth hormone/insulin-like growth factor (IGF)-I axis, and chronic inflammation might reduce IGF-I signaling. Altered IGF-I axis is frequently observed in patients with Hepatic steatosis (HS). We tested the hypothesis that FM, or spleen volume and C-reactive protein (CRP)-all indexes of chronic inflammation-could affect the IGF-I axis status in overweight/obese, independently of HS.
   Methods: The study population included 48 overweight/obese women (age 41 +/- 13 years; BMI: 35.8 +/- 5.8 kg/m(2); range: 25.3-53.7), who underwent assessment of fasting plasma glucose and insulin, homeostasis model assessment of insulin resistance (HOMA), cholesterol and triglycerides, HDL-cholesterol, transaminases, high-sensitive CRP, uric acid, IGF-I, IGF binding protein (BP)-1, IGFBP-3, and IGF-I/IGFBP-3 ratio. Standard deviation score of IGF-I according to age (zSDS) were also calculated. FM was determined by bioelectrical impedance analysis. HS severity grading (score 0-4 according liver hyperechogenicity) and spleen longitudinal diameter (SLD) were evaluated by ultrasound.
   Results: Metabolic syndrome (MS) and HS were present in 33% and 85% of subjects, respectively. MS prevalence was 43% in subjects with increased SLD. IGF-I values, but not IGF-I zSDS, and IGF-I/IGFBP-3 ratio were significantly lower, while FM%, FPI, HOMA, ALT, CRP, were significantly higher in patients with severe HS than in those with mild HS. IGF-I zSDS (r = -0.42, r = -0.54, respectively; p < 0.05), and IGFBP-1 (r = -0.38, r = -0.42, respectively; p < 0.05) correlated negatively with HS severity and FM%. IGF-I/IGFBP-3 ratio correlated negatively with CRP, HS severity, and SLD (r = -0.30, r = -0.33, r = -0.43, respectively; p < 0.05). At multivariate analysis the best determinants of IGF-I were FM% (beta = -0.49; p = 0.001) and IGFBP-1 (beta = -0.32; p = 0.05), while SLD was in the IGF-I/IGFBP-3 ratio (beta = -0.43; p = 0.004).
   Conclusions: The present study suggests that lower IGF-I status in our study population is associated with higher FM, SLD, CRP and more severe HS.
C1 [Savastano, Silvia; Pizza, Genoveffa; De Rosa, Annalba; Nedi, Valeria; Rossi, Annalisa; Lombardi, Gaetano; Colao, Annamaria] Univ Naples Federico II, Dept Mol & Clin Endocrinol & Oncol, Div Endocrinol, Sch Med, I-80131 Naples, Italy.
   [Di Somma, Carolina] IRCCS SDN Fdn, I-80121 Naples, Italy.
   [Orio, Francesco] Parthenope Univ, I-80133 Naples, Italy.
   [Tarantino, Giovanni] Univ Naples Federico II, Dept Clin & Expt Med, Sch Med, I-80131 Naples, Italy.
C3 University of Naples Federico II; IRCCS Istituto di Ricerca Diagnostica
   e Nucleare (SDN); Parthenope University Naples; University of Naples
   Federico II
RP Savastano, S (corresponding author), Univ Naples Federico II, Dept Mol & Clin Endocrinol & Oncol, Div Endocrinol, Sch Med, Via S Pansini 5, I-80131 Naples, Italy.
EM sisavast@unina.it
RI Savastano, Silvia/K-6546-2016; Tarantino, Giovanni/AAW-2007-2021; Di
   Somma, Carolina/K-7772-2016
OI Savastano, Silvia/0000-0002-3211-4307; Di Somma,
   Carolina/0000-0002-5724-1951
FU Ministry of University Research of Italy [2007N4C5TY_005]; Ricerca
   finalizzata [229/99]
FX This study has been registered in the http://ClinicalTrials.gov Database
   with the number NCT00948402. It has been partially granted by the
   Ministry of University Research of Italy, PRIN, with the number
   2007N4C5TY_005 and by Ricerca finalizzata-art.12 bis Decreto Legislativo
   229/99.
CR Andreassen M, 2010, INFLAMM RES, V59, P503, DOI 10.1007/s00011-009-0154-z
   [Anonymous], 2002, Circulation
   Bohte AE, 2011, EUR RADIOL, V21, P87, DOI 10.1007/s00330-010-1905-5
   Dasarathy S, 2009, J HEPATOL, V51, P1061, DOI 10.1016/j.jhep.2009.09.001
   Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, 2003, DIABETES CARE S1, pS5
   Gustafson B, 2010, J ATHEROSCLER THROMB, V17, P332, DOI 10.5551/jat.3939
   Juul A, 2003, GROWTH HORM IGF RES, V13, P113, DOI 10.1016/S1096-6374(03)00038-8
   Lamberts SWJ, 1998, LANCET, V352, P127
   Loaeza-del-Castillo A, 2008, ANN HEPATOL, V7, P350, DOI 10.1016/S1665-2681(19)31836-8
   Maddux BA, 2006, DIABETES CARE, V29, P1535, DOI 10.2337/dc05-1367
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   O'Connor JC, 2008, CELL IMMUNOL, V252, P91, DOI 10.1016/j.cellimm.2007.09.010
   Oscarsson J, 1997, CLIN ENDOCRINOL, V46, P63, DOI 10.1046/j.1365-2265.1997.d01-1740.x
   Piccoli A, 1998, INT J OBESITY, V22, P97, DOI 10.1038/sj.ijo.0800551
   Rasmussen MH, 2010, MOL CELL ENDOCRINOL, V316, P147, DOI 10.1016/j.mce.2009.08.017
   Roubenoff R, 2003, CURR OPIN CLIN NUTR, V6, P295, DOI 10.1097/01.mco.0000068965.34812.62
   Savastano S, 2006, J ENDOCRINOL INVEST, V29, P536, DOI 10.1007/BF03344144
   Savastano S, 2010, OBES SURG, V20, P332, DOI 10.1007/s11695-009-0006-5
   Svensson J, 2003, J ENDOCRINOL INVEST, V26, P823, DOI 10.1007/BF03345231
   Tarantino G, 2007, J GASTROEN HEPATOL, V22, P293, DOI 10.1111/j.1440-1746.2007.04824.x
   Tarantino G, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-6
   Tarantino G, 2009, EUR J GASTROEN HEPAT, V21, P504, DOI 10.1097/MEG.0b013e3283229b40
   Tarantino G, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-72
   Tsushima Y., 2005, DIGEST DIS SCI, V4, P196
   Völzke H, 2009, EUR J ENDOCRINOL, V161, P705, DOI 10.1530/EJE-09-0374
   von Laue S, 2000, GROWTH HORM IGF RES, V10, P9, DOI 10.1016/S1096-6374(00)80003-9
   Wasada T, 2008, METABOLISM, V57, P980, DOI 10.1016/j.metabol.2008.02.015
   Webb M, 2009, AM J ROENTGENOL, V192, P909, DOI 10.2214/AJR.07.4016
   Yoshioka K, 2008, HEPATOL RES, V38, P1063, DOI 10.1111/j.1872-034X.2008.00386.x
NR 29
TC 49
Z9 49
U1 0
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1479-5876
J9 J TRANSL MED
JI J. Transl. Med.
PD AUG 16
PY 2011
VL 9
AR 136
DI 10.1186/1479-5876-9-136
PG 8
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA 843VW
UT WOS:000296704800001
PM 21846339
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Brazhnik, K
   Sun, S
   Alani, O
   Kinkhabwala, M
   Wolkoff, AW
   Maslov, AY
   Dong, X
   Vijg, J
AF Brazhnik, K.
   Sun, S.
   Alani, O.
   Kinkhabwala, M.
   Wolkoff, A. W.
   Maslov, A. Y.
   Dong, X.
   Vijg, J.
TI Single-cell analysis reveals different age-related somatic mutation
   profiles between stem and differentiated cells in human liver
SO SCIENCE ADVANCES
LA English
DT Article
ID DNA-DAMAGE; CANCER; EXPANSION; ACCUMULATION; REPAIR; GENES
AB Accumulating somatic mutations have been implicated in age-related cellular degeneration and death. Because of their random nature and low abundance, somatic mutations are difficult to detect except in single cells or clonal cell lineages. Here, we show that in single hepatocytes from human liver, an organ exposed to high levels of genotoxic stress, somatic mutation frequencies are high and increase substantially with age. Considerably lower mutation frequencies were observed in liver stem cells (LSCs) and organoids derived from them. Mutational spectra in hepatocytes showed signatures of oxidative stress that were different in old age and in LSCs. A considerable number of mutations were found in functional parts of the liver genome, suggesting that somatic mutagenesis could causally contribute to the age-related functional decline and increased incidence of disease of human liver. These results underscore the importance of stem cells in maintaining genome sequence integrity in aging somatic tissues.
C1 [Brazhnik, K.; Sun, S.; Maslov, A. Y.; Dong, X.; Vijg, J.] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA.
   [Alani, O.; Kinkhabwala, M.] Montefiore Med Ctr, Albert Einstein Coll Med, Div Transplant Surg, Bronx, NY 10467 USA.
   [Wolkoff, A. W.] Albert Einstein Coll Med, Div Hepatol, Marion Bessin Liver Res Ctr, Bronx, NY 10467 USA.
   [Wolkoff, A. W.] Montefiore Med Ctr, 111 E 210th St, Bronx, NY 10467 USA.
   [Wolkoff, A. W.] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10467 USA.
   [Vijg, J.] Shanghai Jiao Tong Univ, Ctr Single Cell Omics Aging & Dis, Sch Publ Hlth, Sch Med, Shanghai 200025, Peoples R China.
C3 Yeshiva University; Albert Einstein College of Medicine; Montefiore
   Medical Center; Yeshiva University; Albert Einstein College of Medicine;
   Yeshiva University; Albert Einstein College of Medicine; Montefiore
   Medical Center; Yeshiva University; Albert Einstein College of Medicine;
   Yeshiva University; Albert Einstein College of Medicine; Shanghai Jiao
   Tong University
RP Vijg, J (corresponding author), Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA.; Vijg, J (corresponding author), Shanghai Jiao Tong Univ, Ctr Single Cell Omics Aging & Dis, Sch Publ Hlth, Sch Med, Shanghai 200025, Peoples R China.
EM jan.vijg@einsteinmed.org
RI Sun, Shixiang/GQA-4872-2022
OI Sun, Shixiang/0000-0001-5499-2963; vijg, jan/0000-0002-8457-9595
FU NIH [P01 AG017242]; Liver Research Center NIH/NIDDK5 grant [P30
   DK041296]
FX This study was supported by NIH grant P01 AG017242 (J.V.) and Liver
   Research Center NIH/NIDDK5 grant P30 DK041296.
CR Alison Malcolm R, 2011, Hepatology, V53, P1393, DOI 10.1002/hep.24252
   Alt EU, 2012, STEM CELL RES, V8, P215, DOI 10.1016/j.scr.2011.11.002
   Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894
   Beerman I, 2017, SEMIN HEMATOL, V54, P12, DOI 10.1053/j.seminhematol.2016.11.001
   Blokzijl F, 2018, GENOME MED, V10, DOI 10.1186/s13073-018-0539-0
   Blokzijl F, 2016, NATURE, V538, P260, DOI 10.1038/nature19768
   Bohrson C. L., 2017, LINKED READ ANAL IDE, DOI 10.1101/211169
   Cervantes RB, 2002, P NATL ACAD SCI USA, V99, P3586, DOI 10.1073/pnas.062527199
   Choi Y, 2015, BIOINFORMATICS, V31, P2745, DOI 10.1093/bioinformatics/btv195
   Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514
   Cieslak KP, 2016, HPB, V18, P691, DOI 10.1016/j.hpb.2016.05.011
   De Bont R, 2004, MUTAGENESIS, V19, P169, DOI 10.1093/mutage/geh025
   Dollé MET, 2002, NUCLEIC ACIDS RES, V30, P545, DOI 10.1093/nar/30.2.545
   Dong X, 2017, NAT METHODS, V14, P491, DOI [10.1038/nmeth.4227, 10.1038/NMETH.4227]
   Duncan AW, 2009, GASTROENTEROLOGY, V137, P466, DOI 10.1053/j.gastro.2009.05.044
   Enge M, 2017, CELL, V171, P321, DOI 10.1016/j.cell.2017.09.004
   FAILLA G, 1958, ANN NY ACAD SCI, V71, P1124, DOI 10.1111/j.1749-6632.1958.tb46828.x
   Feng JX, 2012, NAT PROTOC, V7, P1728, DOI 10.1038/nprot.2012.101
   Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245
   Gundry M, 2012, NUCLEIC ACIDS RES, V40, P2032, DOI 10.1093/nar/gkr949
   Halpern KB, 2017, NATURE, V542, P352, DOI 10.1038/nature21065
   Herrera MB, 2006, STEM CELLS, V24, P2840, DOI 10.1634/stemcells.2006-0114
   Huch M, 2015, CELL, V160, P299, DOI 10.1016/j.cell.2014.11.050
   Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826
   Iourov IY, 2008, MOL CYTOGENET, V1, DOI 10.1186/1755-8166-1-26
   Jinks-Robertson S, 2014, ANNU REV GENET, V48, P341, DOI 10.1146/annurev-genet-120213-092015
   Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111
   Lebel M., 2011, CURR GERONTOL GERIAT, V2011, P1, DOI [DOI 10.1155/2011/859415, 10.1155/2011/859415]
   Lee HS, 2003, BIOTECHNOL BIOENG, V83, P760, DOI 10.1002/bit.10727
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0
   Lodato MA, 2018, SCIENCE, V359, P555, DOI 10.1126/science.aao4426
   Loeb KR, 2000, CARCINOGENESIS, V21, P379, DOI 10.1093/carcin/21.3.379
   Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653
   Martinez-Jimenez CP, 2017, SCIENCE, V355, P1433, DOI 10.1126/science.aah4115
   Maslov AY, 2009, BBA-GEN SUBJECTS, V1790, P963, DOI 10.1016/j.bbagen.2009.03.020
   McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110
   Milholland B, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15183
   Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007
   Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509
   Paré JF, 2006, CURR TOP DEV BIOL, V73, P141, DOI 10.1016/S0070-2153(05)73005-2
   Pauly GT, 2001, CHEM RES TOXICOL, V14, P894, DOI 10.1021/tx010032f
   Pomatto LCD, 2018, FREE RADICAL BIO MED, V124, P420, DOI 10.1016/j.freeradbiomed.2018.06.016
   Rouhani FJ, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005932
   Sanchez MBH, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0628-9
   Sanyal A. J., 2017, ZAKIM BOYERS HEPATHO
   Sherley JL, 2002, STEM CELLS, V20, P561, DOI 10.1634/stemcells.20-6-561
   SZILARD L, 1959, P NATL ACAD SCI USA, V45, P30, DOI 10.1073/pnas.45.1.30
   Vijg J, 2014, CURR OPIN GENET DEV, V26, P141, DOI 10.1016/j.gde.2014.04.002
   Wang D, 1998, MUTAT RES-FUND MOL M, V400, P99, DOI 10.1016/S0027-5107(98)00066-9
   Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603
   Wood RD, 2005, MUTAT RES-FUND MOL M, V577, P275, DOI 10.1016/j.mrfmmm.2005.03.007
   Wu Y., 2019, BIORXIV, DOI DOI 10.1101/322859
   Zhang L, 2019, P NATL ACAD SCI USA, V116, P9014, DOI 10.1073/pnas.1902510116
   Zhang L, 2018, ANNU REV GENET, V52, P397, DOI 10.1146/annurev-genet-120417-031501
NR 55
TC 60
Z9 63
U1 1
U2 15
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 2375-2548
J9 SCI ADV
JI Sci. Adv.
PD JAN
PY 2020
VL 6
IS 5
AR eaax2659
DI 10.1126/sciadv.aax2659
PG 10
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA KK7FS
UT WOS:000512904600009
PM 32064334
OA gold, Green Submitted, Green Published
DA 2024-02-19
ER

PT J
AU TIETZ, NW
   SHUEY, DF
   WEKSTEIN, DR
AF TIETZ, NW
   SHUEY, DF
   WEKSTEIN, DR
TI LABORATORY VALUES IN FIT AGING INDIVIDUALS - SEXAGENARIANS THROUGH
   CENTENARIANS
SO CLINICAL CHEMISTRY
LA English
DT Article
DE SEX-RELATED AND AGE-RELATED EFFECTS; REFERENCE VALUES; ELECTROLYTES;
   PROTEINS; ENZYME ACTIVITY; GLUCOSE; INSULIN; CARDIAC ISOENZYMES; STEROID
   HORMONES; RENAL FUNCTION; LIVER FUNCTION; IMMUNOGLOBULINS; CHOLESTEROL;
   LIPOPROTEINS; TRIGLYCERIDES; TRACE ELEMENTS; THYROID FUNCTION; BLOOD
   PRESSURE; HEMODYNAMIC VARIABLES; COMPLEMENT; VITAMINS
ID HEALTHY ELDERLY PEOPLE; IMMUNOREACTIVE PARATHYROID-HORMONE;
   AGE-RELATED-CHANGES; REFERENCE INTERVALS; CLINICAL-CHEMISTRY; DEPENDENT
   CHANGES; BLOOD COMPONENTS; SERUM-ALBUMIN; IRON STATUS; NORMAL MEN
AB We determined approximately 15 000 laboratory values in 236 individuals between the ages of 60 and 90 y, 22 individuals between 90 and 99 y, and 69 individuals greater-than-or-equal-to 100 y, and compared these with values in young adults. We tested 47 different analytes in the 60-90-y group and 93 analytes in the greater-than-or-equal-to 90-y group. Na, K, Cl, and CO2 values were either identical or showed minimal change with age; pH decreased slightly. Differences in Ca values were only minor, but ionized Ca increased slightly. Phosphate decreased in men, but changed only minimally in women; parathyroid hormone increased with age. Increases with age were also observed for glucose, insulin, and C-peptide. Among the enzymes, alkaline phosphatase increased in women, but in men only >90 y; gamma-glutamyltransferase increased in both sexes. Creatine kinase (CK) decreased slightly in individuals >70 y and markedly in those >90 y of age, whereas CK-MB decreased markedly >70 y, reaching the detection limit in individuals >90 y. Lactate dehydrogenase isoenzyme 5 decreased slightly with age. Urea nitrogen increased gradually with age, but creatinine increased only in individuals greater-than-or-equal-to 90 y. The increase in urea is not paralleled by a loss of protein in urine, suggesting that the possible cause of azotemia may not always be renal pathology. Urate increased in women but not in men. Liver function, as measured by total bilirubin and liver enzymes, was exceedingly well maintained. Concentrations of most proteins show little change, except for slight decreases in prealbumin, albumin, and transferrin, proteins used as an index of nutritional status. IgA values increased, IgG ranges were wider, IgM and IgD decreased, and the range for IgE was narrower than in young adults. Cholesterol, high-density lipoprotein cholesterol, and triglyceride values increased with age, but decreased in individuals greater-than-or-equal-to 90 y. Among the trace elements, magnesium changed little, zinc and lead decreased, and copper values increased with age. Total triiodothyronine and thyroxine decreased, with concomitant increases in thyroid-stimulating hormone. More individuals had increased microsomal antibodies and thyroglobulin titers in the aging population than in the young. In men, the free, percent free, bioactive, and total testosterone values decreased, but luteinizing hormone (LH) and follicle-stimulating hormone (FSH) values increased. In women, estrone and estradiol values decreased, with concomitant increases in LH and FSH. Androstenedione and progesterone decreased in both sexes. Gastrin values increased with age. Blood pressure in all aging individuals was either normal or well controlled with antihypertensive drugs. Hemoglobin, hematocrit, and erythrocyte, leukocyte, and platelet counts decreased with age, as did the total serum iron.
C1 UNIV KENTUCKY, SANDERS BROWN CTR AGING, LEXINGTON, KY 40536 USA.
C3 University of Kentucky
RP TIETZ, NW (corresponding author), UNIV KENTUCKY, MED CTR, DEPT PATHOL, LEXINGTON, KY 40536 USA.
CR ALVAREZ C, 1984, CLIN CHEM, V30, P404
   ASH KO, 1986, CLIN CHEM NEWS   NOV, P7
   Bakerman S., 1984, ABCS INTERPRETIVE LA
   BALDWIN JG, 1986, BLOOD S, V68, pA52
   BARZILAI N, 1989, AGE, V12, P13, DOI 10.1007/BF02432513
   Besa E C, 1988, Clin Geriatr Med, V4, P43
   BRUNELLE P, 1972, CLIN CHIM ACTA, V42, P201, DOI 10.1016/0009-8981(72)90397-X
   BUNKER VW, 1984, AM J CLIN NUTR, V40, P1096, DOI 10.1093/ajcn/40.5.1096
   CAMPION EW, 1988, J GERONTOL, V43, pM18, DOI 10.1093/geronj/43.1.M18
   CHATTORAJ SC, 1986, TXB CLIN CHEM
   CHEN FWK, 1972, MOD GERIATR      MAR, P92
   COHEN D, 1980, BRIT J PSYCHIAT, V136, P33, DOI 10.1192/bjp.136.1.33
   CORBERAND J, 1987, GERONTOLOGY, V33, P72, DOI 10.1159/000212856
   COSTONGS GMPJ, 1984, J CLIN CHEM CLIN BIO, V22, P613
   DATI F, 1984, RES CLIN LAB, V14, P399
   DAVIS PJ, 1979, CLIN ENDOCRINOL META, V8, P603, DOI 10.1016/S0300-595X(79)80033-X
   DEMERS LM, 1988, AACC ENDO, V6, P3
   DEMERS LM, 1988, LAB MANAGE, V26, P24
   DIETRICH T, 1983, CLIN CHEM NEWS   JUN, P19
   DILMAN VM, 1971, LANCET, V1, P1211
   DYBKAER R, 1981, ACTA MED SCAND, V209, P1
   Feit H, 1988, Clin Geriatr Med, V4, P151
   FELICETTA JV, 1988, AACC ENDO, V6, P7
   FORERO MS, 1987, J BONE MINER RES, V2, P363
   FULOP T, 1989, ARCH GERONTOL GERIAT, V8, P151, DOI 10.1016/0167-4943(89)90059-9
   GALLAGHER JC, 1980, J LAB CLIN MED, V95, P373
   GAMBINO R, 1990, LAB REP, V12, P65
   GARRY PJ, 1989, AM J CLIN NUTR, V50, P1219, DOI 10.1093/ajcn/50.5.1219
   GIBSON RS, 1985, J GERONTOL, V40, P296, DOI 10.1093/geronj/40.3.296
   GILLIBRAND D, 1980, AGING ITS CHEM
   GREENBLATT DJ, 1979, J AM GERIATR SOC, V27, P20, DOI 10.1111/j.1532-5415.1979.tb01715.x
   GULLO L, 1986, J AM GERIATR SOC, V34, P790, DOI 10.1111/j.1532-5415.1986.tb03983.x
   HAMMOND GL, 1977, CLIN ENDOCRINOL, V7, P129, DOI 10.1111/j.1365-2265.1977.tb01304.x
   Hays W. L., 1981, Statistics, V3rd ed.
   HESCH RD, 1976, CLIN CHIM ACTA, V70, P33, DOI 10.1016/0009-8981(76)90003-6
   HODKINSON HM, 1977, BIOCH DIAGNOSIS ELDE, P78
   HUMMER L, 1983, SCAND J CLIN LAB INV, V43, P301
   ISURUGI K, 1974, J CLIN ENDOCR METAB, V39, P955, DOI 10.1210/jcem-39-5-955
   JACOB RA, 1988, AM J CLIN NUTR, V48, P1436, DOI 10.1093/ajcn/48.6.1436
   JENSEN H K, 1971, Acta Endocrinologica, V66, P25
   JERNIGAN JA, 1980, J AM GERIATR SOC, V28, P308, DOI 10.1111/j.1532-5415.1980.tb00621.x
   KABADI UM, 1988, J AM GERIATR SOC, V36, P312, DOI 10.1111/j.1532-5415.1988.tb02357.x
   KELLY A, 1979, J GERONTOL, V34, P37, DOI 10.1093/geronj/34.1.37
   KRASINSKI SD, 1989, AM J CLIN NUTR, V49, P112, DOI 10.1093/ajcn/49.1.112
   LANDAHL S, 1981, CLIN CHIM ACTA, V112, P301, DOI 10.1016/0009-8981(81)90453-8
   LAZARUS JH, 1984, ACTA ENDOCRINOL-COP, V106, P199, DOI 10.1530/acta.0.1060199
   LEASK R G S, 1973, Age and Ageing, V2, P14, DOI 10.1093/ageing/2.1.14
   LIPSCHITZ DA, 1984, BLOOD, V63, P502
   LIPSON A, 1979, J NUCL MED, V20, P1124
   LYNGBYE J, 1971, CLIN CHEM, V17, P495
   MARCUS DL, 1987, J AM GERIATR SOC, V35, P635, DOI 10.1111/j.1532-5415.1987.tb04339.x
   MATTILA KS, 1986, SCAND J CLIN LAB INV, V46, P411, DOI 10.3109/00365518609083691
   MILMAN N, 1986, SCAND J CLIN LAB INV, V46, P19, DOI 10.3109/00365518609086476
   MOHIUDDIN J, 1984, ANN CLIN BIOCHEM, V21, P102, DOI 10.1177/000456328402100204
   MONTANINI V, 1988, HORM RES, V29, P1, DOI 10.1159/000180956
   MOORADIAN AD, 1988, DM-DIS MON, V34, P395
   NICHOLSON J, 1979, METABOLISM, V28, P51, DOI 10.1016/0026-0495(79)90167-7
   OLSEN T, 1978, J CLIN ENDOCR METAB, V47, P1111, DOI 10.1210/jcem-47-5-1111
   OSTERLIND PO, 1984, GERONTOLOGY, V30, P247, DOI 10.1159/000212639
   OSULLIVAN JB, 1974, DIABETES, V23, P713, DOI 10.2337/diab.23.8.713
   PURIFOY FE, 1980, HUM BIOL, V52, P181
   RADL J, 1982, PROTEIN ABNORMALITIE
   REIBNEGGER G, 1988, MECH AGEING DEV, V46, P67, DOI 10.1016/0047-6374(88)90115-7
   ROCK RC, 1985, GERIATRICS, V40, P61
   ROWE DJF, 1990, ANN CLIN BIOCHEM, V27, P297, DOI 10.1177/000456329002700404
   RUBENS R, 1974, J CLIN ENDOCR METAB, V39, P40, DOI 10.1210/jcem-39-1-40
   SCHRIER RW, 1982, CLIN INTERNAL MED AG
   SCHRIJVER J, 1985, INT J VITAM NUTR RES, V55, P337
   SEGAWA K, 1989, AM J GASTROENTEROL, V84, P514
   SHOCK N W, 1957, Geriatrics, V12, P40
   SIMONS RJ, 1989, AACC ENDO, V7, P5
   SOLBERG HE, 1986, TXB CLIN CHEM
   SOWERS JR, 1988, ENDOCRINOLOGY AGING
   STEINHAGENTHIESSEN E, 1976, MECH AGEING DEV, V5, P447, DOI 10.1016/0047-6374(76)90043-9
   SWANSON CA, 1988, AM J CLIN NUTR, V48, P343, DOI 10.1093/ajcn/48.2.343
   TENOVER JS, 1987, J CLIN ENDOCR METAB, V65, P1118, DOI 10.1210/jcem-65-6-1118
   TIETZ NW, 1984, J AM GERIATR SOC, V32, P563, DOI 10.1111/j.1532-5415.1984.tb06133.x
   TIETZ NW, 1990, CLIN GUIDE LABORATOR
   TIMIRAS ML, 1987, J AM GERIATR SOC, V35, P639, DOI 10.1111/j.1532-5415.1987.tb04340.x
   TRYDING N, 1986, DRUG INTERFERENCES D
   VELLAS B, 1988, INT J PANCREATOL, V3, P497
   VERMEULE.A, 1972, J CLIN ENDOCR METAB, V34, P730, DOI 10.1210/jcem-34-4-730
   WEST DW, 1984, AM J CLIN PATHOL, V81, P71, DOI 10.1093/ajcp/81.1.71
   WILSON JD, 1985, WILLIAMS TXB ENDOCRI, P707
   WISKE PS, 1979, NEW ENGL J MED, V300, P1419, DOI 10.1056/NEJM197906213002506
   YOUNG G, 1987, J BONE MINER RES, V2, P367
   ZAINO EC, 1981, NY STATE J MED   JUL, P1199
   ZAUBER NP, 1987, JAMA-J AM MED ASSOC, V257, P2181, DOI 10.1001/jama.257.16.2181
   1987, CURRENT POPULATION P, V23
NR 89
TC 193
Z9 204
U1 0
U2 8
PU AMER ASSOC CLINICAL CHEMISTRY
PI WASHINGTON
PA 2101 L STREET NW, SUITE 202, WASHINGTON, DC 20037-1526 USA
SN 0009-9147
EI 1530-8561
J9 CLIN CHEM
JI Clin. Chem.
PD JUN
PY 1992
VL 38
IS 6
BP 1167
EP 1185
PG 19
WC Medical Laboratory Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Medical Laboratory Technology
GA HY722
UT WOS:A1992HY72200022
PM 1596990
DA 2024-02-19
ER

PT J
AU Fujita, S
   Okamoto, R
   Taniguchi, M
   Ban-Tokuda, T
   Konishi, K
   Goto, I
   Yamamoto, Y
   Sugimoto, K
   Takamatsu, N
   Nakamura, M
   Shiraki, K
   Buechler, C
   Ito, M
AF Fujita, Satoshi
   Okamoto, Ryuji
   Taniguchi, Masaya
   Ban-Tokuda, Tomomi
   Konishi, Katsuhisa
   Goto, Itaru
   Yamamoto, Yasunari
   Sugimoto, Kazushi
   Takamatsu, Nobuhiko
   Nakamura, Mashio
   Shiraki, Katsuya
   Buechler, Christa
   Ito, Masaaki
TI Identification of bovine hibernation-specific protein complex and
   evidence of its regulation in fasting and aging
SO JOURNAL OF BIOCHEMISTRY
LA English
DT Article
DE adiponectin; bovine; C1q; hibernation; liver
ID BROWN ADIPOSE-TISSUE; MAMMALIAN HIBERNATION; ADIPONECTIN; KINASE; GENE;
   EXPRESSION; RECEPTORS
AB Hibernation-specific protein (HP) is a plasma protein that regulates hibernation in chipmunks. The HP complex (HP20c) consists of three homologous proteins, HP20, HP25 and HP27, all produced by liver and belonging to the C1q family. To date, HP20c has not been identified in any mammalian species except chipmunk and ground squirrel hibernators. Here, we report a bovine HP20 gene isolated from liver tissue and aortic endothelial cells. Total homology between bovine and chipmunk variants was 63% at the amino acid level. Gene expression was highest in the liver. Western blot revealed HP20 protein in foetal, newborn, calf and adult serum, with highest concentrations in the adult. Similar proteins were detected in sera of other ruminants but not in humans, bears, mice or rats. Bovine HP20 protein was found mainly in ovaries, stomach, heart, kidneys, lungs, testes and prostate, but not in the skeletal muscle. Native HP20 was purified from bovine adult serum as a complex containing 25 and 27 kDa proteins. Mass spectrometry revealed that these proteins are orthologues of chipmunk HP25 and HP27, respectively. Interestingly, bovine HP20 was highly expressed in cattle serum after fasting. Native bovine HP20c may be a useful tool for investigating HP function.
C1 [Fujita, Satoshi; Okamoto, Ryuji; Taniguchi, Masaya; Konishi, Katsuhisa; Goto, Itaru; Nakamura, Mashio; Ito, Masaaki] Mie Univ, Dept Cardiol & Nephrol, Grad Sch Med, Tsu, Mie 5148507, Japan.
   [Ban-Tokuda, Tomomi] Mie Univ, Grad Sch Bioresources, Tsu, Mie 5148507, Japan.
   [Yamamoto, Yasunari] Mie Prefecture Livestock Res Inst, Matsusaka, Mie 5152324, Japan.
   [Sugimoto, Kazushi; Shiraki, Katsuya] Mie Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, Tsu, Mie 5148507, Japan.
   [Takamatsu, Nobuhiko] Kitasato Univ, Sch Sci, Dept Biosci, Sagamihara, Kanagawa 2520373, Japan.
   [Buechler, Christa] Regensburg Univ Hosp, Dept Internal Med 1, D-93042 Regensburg, Germany.
C3 Mie University; Mie University; Mie University; Kitasato University;
   University of Regensburg
RP Okamoto, R (corresponding author), Mie Univ, Dept Cardiol & Nephrol, Grad Sch Med, 2-174 Edobashi, Tsu, Mie 5148507, Japan.
EM ryuji@clin.medic.mie-u.ac.jp
FU Ministry of Education, Science, Technology, Sports and Culture, Japan
   [24591113, 19390211]; Japan Vascular Disease Research Foundation; Mie
   Medical Foundation; Mie University Graduate School of Medicine;
   Grants-in-Aid for Scientific Research [24591113, 19390211, 22580107]
   Funding Source: KAKEN
FX This work was supported by Grants-in-Aid for Scientific Research from
   the Ministry of Education, Science, Technology, Sports and Culture,
   Japan (No. 24591113 and No. 19390211), the Japan Vascular Disease
   Research Foundation and the Mie Medical Foundation (to R.O. and M. I.).
   S. F. was supported by the new research fellowship from the Mie
   University Graduate School of Medicine. The funders had no role in study
   design, data collection and analysis, decision to publish or preparation
   of the manuscript.
CR Andrews MT, 2007, BIOESSAYS, V29, P431, DOI 10.1002/bies.20560
   Chen H, 2003, J BIOL CHEM, V278, P45021, DOI 10.1074/jbc.M307878200
   Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780
   Dausmann KH, 2004, NATURE, V429, P825, DOI 10.1038/429825a
   Drew KL, 2007, J NEUROCHEM, V102, P1713, DOI 10.1111/j.1471-4159.2007.04675.x
   Feng JH, 1999, J BIOL CHEM, V274, P3744, DOI 10.1074/jbc.274.6.3744
   Heller HC, 2004, ANNU REV PHYSIOL, V66, P275, DOI 10.1146/annurev.physiol.66.032102.115313
   Horton ND, 1998, COMP BIOCHEM PHYS B, V119, P787, DOI 10.1016/S0305-0491(98)00056-X
   Iwabu M, 2010, NATURE, V464, P1313, DOI 10.1038/nature08991
   Ju H, 2011, J CELL PHYSIOL, V226, P853, DOI 10.1002/jcp.22573
   Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126
   Kishore U, 2004, TRENDS IMMUNOL, V25, P551, DOI 10.1016/j.it.2004.08.006
   Kojima M, 2001, EUR J BIOCHEM, V268, P5997, DOI 10.1046/j.0014-2956.2001.02572.x
   KONDO N, 1992, J BIOL CHEM, V267, P473
   Kondo N, 2007, COLD SPRING HARB SYM, V72, P607, DOI 10.1101/sqb.2007.72.028
   Kondo N, 2006, CELL, V125, P161, DOI 10.1016/j.cell.2006.03.017
   Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718
   Lu JJ, 2007, J CHROMATOGR B, V857, P175, DOI 10.1016/j.jchromb.2007.06.038
   Morin P, 2009, INT J DEV BIOL, V53, P433, DOI 10.1387/ijdb.082643pm
   Nakakuki T, 2005, ARTERIOSCL THROM VAS, V25, P2088, DOI 10.1161/01.ATV.0000183607.50230.9f
   Nelson CJ, 2009, J PHYSIOL-LONDON, V587, P1863, DOI 10.1113/jphysiol.2008.167692
   Okamoto R, 2006, CELL SIGNAL, V18, P1408, DOI 10.1016/j.cellsig.2005.11.001
   Ono M, 2001, GENE, V277, P121, DOI 10.1016/S0378-1119(01)00699-0
   Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200
   Place NJ, 2000, J COMP PHYSIOL B, V170, P245, DOI 10.1007/s003600050282
   Revel FG, 2007, P NATL ACAD SCI USA, V104, P13816, DOI 10.1073/pnas.0704699104
   Storey KB, 2010, GERONTOLOGY, V56, P220, DOI 10.1159/000228829
   TAKAMATSU N, 1993, MOL CELL BIOL, V13, P1516, DOI 10.1128/MCB.13.3.1516
   Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949
   Zhang JF, 2006, NATURE, V439, P340, DOI 10.1038/nature04368
   Zhu WD, 2008, CLIN SCI, V114, P361, DOI 10.1042/CS20070347
   Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42
NR 32
TC 5
Z9 5
U1 1
U2 13
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0021-924X
EI 1756-2651
J9 J BIOCHEM
JI J. Biochem.
PD MAY
PY 2013
VL 153
IS 5
BP 453
EP 461
DI 10.1093/jb/mvt008
PG 9
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 139DN
UT WOS:000318561900007
PM 23389309
DA 2024-02-19
ER

PT J
AU Xiao, Y
   Duan, CS
   Gong, PS
   Zhao, Q
   Wang, XH
   Geng, F
   Zeng, J
   Luo, TF
   Xu, YS
   Zhao, JN
AF Xiao, Yu
   Duan, Changsong
   Gong, Pushuang
   Zhao, Qi
   Wang, Xin hui
   Geng, Fang
   Zeng, Jin
   Luo, Tianfeng
   Xu, Yisha
   Zhao, Junning
TI Kinsenoside from<i> Anoectochilus</i><i> roxburghii</i> (Wall.) Lindl.
   suppressed oxidative stress to attenuate aging-related learning and
   memory impairment via ERK/Nrf2 pathway
SO JOURNAL OF ETHNOPHARMACOLOGY
LA English
DT Article; Early Access
DE Kinsenoside; Anoectochilus roxburghii (Wall.) Lindl; Oxidative stress;
   Aging Learning and memory impairment; ERK/Nrf2 pathway
ID HEME OXYGENASE-1; D-GALACTOSE; GLUTATHIONE; ANTIOXIDANTS; ACTIVATION;
   EXPRESSION; FORMOSANUS; SUBUNIT; ALPHA; GENE
AB Ethnopharmacological relevance: Anoectochilus roxburghii (Wall.) Lindl. (AR), as an exceptionally valuable traditional Chinese medicine, has been widely used to treat hepatitis, cancer, diabetes, etc. But, the effects and the primary functioning element of AR on attenuating aging and aging-related learning and memory degradation has not yet been explored.Aim of the study: This study aimed at exploring the protective property of aqueous extract of AR (AEAR) on alleviation of aging and aging-related learning and memory impairment in vivo, and further investigating the main active ingredient and mechanism of AEAR. Materials and methods: D-galactose (D-gal) induced aging mice and HT22 cells exposed with L-Glutamic acid (Glu) were used as in vivo and in vitro model, separately. The effects of AEAR on aging and aging-related learning and memory degradation were explored by using morris water maze test, immunohistochemistry staining, biochemistry assay, etc. The effects and mechanism of AEAR and Kinsenoside (Kin) on antioxidation in vitro were investigated by cell viability assay, biochemistry assay, qRT-PCR, western blotting and molecular docking studies.Results: Treatment with AEAR (containing 69.52 +/- 0.85% Kin, i.g.) for 63 days, alleviated low growth rate, abnormal brain, liver and thymus index, and decline in learning and memory capability of aging mice. Meanwhile, AEAR inhibited the decreased activities of SOD and GSH-PX, the decline in the ratio of GSH to GSSG, and the increase of MDA in both serum and brain, and also promoted the Nrf2 nuclear translocation in brain of aging mice induced by D-gal. The effects of AEAR on alleviating abnormal physiological characteristics, attenuating learning and memory impairment, and inhibiting oxidative stress in aging mice was similar to or even better than that of Vc. In HT22 cells exposed with Glu, Kin increased the cell viability, up-regulated the activities of SOD and GSH-PX, enhanced the ratio of GSH to GSSG, and down-regulated MDA, which was superior to AEAR. Kin up regulated the ratio of p-ERK1/2 to ERK1/2, promoted the Nrf2 nuclear translocation and its downstream target genes, i.e. HO-1, NQO-1, GCLC and GCLM expression at the mRNA and protein levels, which were consistent with AEAR. Further, molecular docking results also confirmed that Kin had strong binding energy with ERK1 and ERK2.Conclusion: The present study indicated that Kin could alleviate the oxidative stress in aging mice via activating the ERK/Nrf2 signaling pathway, in order to attenuate aging and aging-related learning and memory impair-ment, as the main active ingredient of AR.
C1 [Xiao, Yu; Duan, Changsong; Gong, Pushuang; Zhao, Qi; Luo, Tianfeng] Chengdu Univ, Engn Res Ctr Sichuan Tibet Tradit Med Plant, Chengdu 610106, Peoples R China.
   [Xiao, Yu; Duan, Changsong; Gong, Pushuang; Wang, Xin hui; Geng, Fang; Luo, Tianfeng; Xu, Yisha] Chengdu Univ, Coll Food & Biol Engn, Chengdu 610106, Peoples R China.
   [Zhao, Junning] Natl Med Prod Adm China, Natl Inst Food & Drug Control, Natl Key Lab Drug Regulatory Sci, Beijing 100037, Peoples R China.
   [Zeng, Jin; Zhao, Junning] Sichuan Acad Chinese Med Sci, Sichuan Inst Translat Chinese Med, Key Lab Biol Evaluat Tradit Chinese Med Qual, Translat Chinese Med Key Lab Sichuan Prov,Natl Adm, Chengdu 610041, Peoples R China.
C3 Chengdu University; Chengdu University; National Institute of Food &
   Drug Control - China
RP Zhao, JN (corresponding author), Natl Med Prod Adm China, Natl Inst Food & Drug Control, Natl Key Lab Drug Regulatory Sci, Beijing 100037, Peoples R China.
EM 11593652@qq.com; 2447173690@qq.com; 1326259154@qq.com; 5385084@qq.com;
   wangxinhui19820319@163.com; gengfang@cdu.edu.cn; 466728392@qq.com;
   1780885217@qq.com; xuyisha0299@cdu.edu.com; junningzhaolab@163.com
OI zhao, jun ning/0009-0008-9190-1619
FU Key Laboratory of Coarse Cereal Processing, Ministry of Agriculture and
   Rural Affairs, Sichuan Province, China [2021HBZ002]; Sichuan Province,
   China
FX This work was supported by the Key Laboratory of Coarse Cereal
   Processing, Ministry of Agriculture and Rural Affairs (2021HBZ002) ,
   Sichuan Province, China.
CR Ali T, 2015, J PINEAL RES, V58, P71, DOI 10.1111/jpi.12194
   Argyropoulou A, 2013, NAT PROD REP, V30, P1412, DOI 10.1039/c3np70031c
   Baird L, 2020, MOL CELL BIOL, V40, DOI 10.1128/MCB.00099-20
   Banji OJF, 2014, FOOD CHEM TOXICOL, V74, P51, DOI 10.1016/j.fct.2014.08.020
   Bell WR, 2019, ALZHEIMERS DEMENT, V15, P8, DOI 10.1016/j.jalz.2018.07.215
   Beyer RE, 1996, P NATL ACAD SCI USA, V93, P2528, DOI 10.1073/pnas.93.6.2528
   Chen Y, 2005, J BIOL CHEM, V280, P33766, DOI 10.1074/jbc.M504604200
   Cheng KT, 2015, PHYTOMEDICINE, V22, P641, DOI 10.1016/j.phymed.2015.04.001
   Costa LG, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2986796
   Cuadrado A, 2019, NAT REV DRUG DISCOV, V18, P295, DOI 10.1038/s41573-018-0008-x
   Cui SC, 2013, EXP TOXICOL PATHOL, V65, P485, DOI 10.1016/j.etp.2012.02.003
   Cullinan SB, 2003, MOL CELL BIOL, V23, P7198, DOI 10.1128/MCB.23.20.7198-7209.2003
   Farooqui T, 2009, MECH AGEING DEV, V130, P203, DOI 10.1016/j.mad.2008.11.006
   Ha JS, 2006, NEUROSCI LETT, V393, P165, DOI 10.1016/j.neulet.2005.09.056
   Hsiao HB, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1054-8
   Hsieh WT, 2011, J ETHNOPHARMACOL, V135, P440, DOI 10.1016/j.jep.2011.03.040
   HUANG CS, 1993, J BIOL CHEM, V268, P19675
   Jiang T, 2020, TOXICOL IN VITRO, V62, DOI 10.1016/j.tiv.2019.104715
   Kansanen E, 2012, FREE RADICAL BIO MED, V52, P973, DOI 10.1016/j.freeradbiomed.2011.11.038
   Landi L, 1997, FREE RADICAL BIO MED, V22, P329, DOI 10.1016/S0891-5849(96)00294-8
   Lei LH, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1975-x
   Li D.M., 2023, J. Ethnopharmacol., V312
   Li QS, 2018, BRAIN RES BULL, V137, P311, DOI 10.1016/j.brainresbull.2018.01.007
   Liochev SI, 2013, FREE RADICAL BIO MED, V60, P1, DOI 10.1016/j.freeradbiomed.2013.02.011
   Liu XX, 2022, GENE, V822, DOI 10.1016/j.gene.2022.146348
   Liu ZL, 2013, FITOTERAPIA, V86, P163, DOI 10.1016/j.fitote.2013.03.006
   Loboda A, 2008, ANTIOXID REDOX SIGN, V10, P1767, DOI 10.1089/ars.2008.2043
   Lu QX, 2021, J ETHNOPHARMACOL, V266, DOI 10.1016/j.jep.2020.113454
   Lu SC, 2009, MOL ASPECTS MED, V30, P42, DOI 10.1016/j.mam.2008.05.005
   MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431
   Ming JX, 2021, PHARMACEUTICALS-BASE, V14, DOI 10.3390/ph14050452
   Nam SM, 2019, NUTRIENTS, V11, DOI 10.3390/nu11010176
   Nioi P, 2004, MUTAT RES-FUND MOL M, V555, P149, DOI 10.1016/j.mrfmmm.2004.05.023
   Padeiro M., 2023, Global Aging and Health Determinants in a Changing World, Aging, P3
   Pareek TK, 2011, SCI REP-UK, V1, DOI 10.1038/srep00201
   Prasad KN, 2017, MECH AGEING DEV, V164, P61, DOI 10.1016/j.mad.2017.04.004
   PRESTERA T, 1995, MOL MED, V1, P827, DOI 10.1007/BF03401897
   Rahman I, 2005, ANTIOXID REDOX SIGN, V7, P42, DOI 10.1089/ars.2005.7.42
   Shao QS, 2014, IND CROP PROD, V60, P104, DOI 10.1016/j.indcrop.2014.06.009
   Siegel D, 1997, MOL PHARMACOL, V52, P300, DOI 10.1124/mol.52.2.300
   Tang TT, 2018, INT J BIOL MACROMOL, V112, P882, DOI 10.1016/j.ijbiomac.2018.02.042
   Wu HQ, 2017, J MOL NEUROSCI, V61, P449, DOI 10.1007/s12031-017-0885-1
   Wu JB, 2007, PHYTOTHER RES, V21, P58, DOI 10.1002/ptr.2025
   Xu JG, 2014, FREE RADICAL BIO MED, V71, P186, DOI 10.1016/j.freeradbiomed.2014.03.009
   Ye SY, 2017, J ETHNOPHARMACOL, V209, P184, DOI 10.1016/j.jep.2017.07.032
   Yu R, 2000, J BIOL CHEM, V275, P39907, DOI 10.1074/jbc.M004037200
   Zhang L, 2019, ENVIRON TOXICOL PHAR, V72, DOI 10.1016/j.etap.2019.103236
   Zhou CH, 2014, J CARDIOVASC PHARM T, V19, P558, DOI 10.1177/1074248414524479
   Zhu K, 2019, FOOD SCI NUTR, V7, P4105, DOI 10.1002/fsn3.1278
NR 49
TC 0
Z9 0
U1 14
U2 14
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-8741
EI 1872-7573
J9 J ETHNOPHARMACOL
JI J. Ethnopharmacol.
PD 2024 JAN 30
PY 2024
VL 319
AR 117152
DI 10.1016/j.jep.2023.117152
EA SEP 2023
PN 1
PG 13
WC Plant Sciences; Chemistry, Medicinal; Integrative & Complementary
   Medicine; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary
   Medicine
GA T6AY0
UT WOS:001078806800001
PM 37689328
DA 2024-02-19
ER

PT J
AU Kilic, D
AF Kilic, D
TI The effects of ageing and sulfur dioxide inhalation exposure on
   visual-evoked potentials, antioxidant enzyme systems, and
   lipid-peroxidation levels of the brain and eye
SO NEUROTOXICOLOGY AND TERATOLOGY
LA English
DT Article
DE ageing; sulfur dioxide; lipid peroxidation; antioxidant enzyme systems;
   visual-evoked potentials (VEPs)
ID AGE-RELATED-CHANGES; SUPEROXIDE-DISMUTASE; GLUTATHIONE-PEROXIDASE;
   RAT-BRAIN; AIR-POLLUTION; VITAMIN-E; CATALASE; LIVER; MECHANISMS;
   RESPONSES
AB The effects of ageing and 10 ppm sulfur dioxide (SO2) inhalation exposure on visual-evoked potentials (VEPs), thiobarbituric acid reactive substances (TBARS), a product of lipid peroxidation, and the activities of Cu, Zn superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), and catalase (CAT) of brain and eye were investigated in young (3-month), adult (12-month), and mature (24-month) Swiss male albino rats. The experimental groups were placed in an exposure chamber containing a constant level of 10 ppm SO,, while control groups were placed in an exposure chamber, which was continually pumped with filtered air, for I h/day x 7 days/week for 6 weeks. SO2 inhalation exposure caused increased levels of brain, retina, and lens Cu, Zn SOD activity, and decreased levels of brain and lens GSH-Px activity in all experimental groups with respect to their corresponding control groups, whereas no change was observed in the level of retina GSH-Px activity. No alterations were observed in brain CAT activity. On the other hand, retina CAT activity was slightly decreased in SO2-exposed rats, but no change was observed in their lens CAT activity. The brain and lens TBARS levels of all SO2-exposed groups were significantly increased in comparison with their respective control groups. The amount of TBARS was only increased in the retina of the SO2-exposed 3-month group compared with its control. Of the SO-exposed rats, the mean latencies of the P-1, N-1, P-2, and P-3 components of the 3-month group, P-1, N-1, and N-2 components of the 12-month group, and only P3 of the 24-month group were significantly prolonged in comparison with those of their control groups. The amplitudes of N1P2 and P2N2 in the 12- and 24-month control groups were significantly decreased compared with those of the 3-month group. On the other hand, no differences were observed among those of SO2-exposed groups.
   These findings suggest that ageing and SO2 inhalation exposure have the potential to induce antioxidant enzymes in the brain and eye, and VEP alterations, which are the primary target for air pollutants. It could be concluded that lipid peroxidation could play a critical role in the mechanism responsible for VEP alterations with ageing. (C) 2003 Elsevier Inc. All rights reserved.
C1 Akdeniz Univ, Fac Arts & Sci, Dept Phys, TR-07058 Antalya, Turkey.
C3 Akdeniz University
RP Kilic, D (corresponding author), Akdeniz Univ, Fac Arts & Sci, Dept Phys, TR-07058 Antalya, Turkey.
RI Kilic, Dalokay/H-7700-2019
CR Aebi H.E., 1987, Methods Enzym. Anal., V3, P273
   ALARIE Y, 1972, ARCH ENVIRON HEALTH, V24, P115, DOI 10.1080/00039896.1972.10666060
   APAYDIN C, 1993, ACTA OPHTHALMOL, V71, P623
   BASKURT OK, 1990, ARCH ENVIRON HEALTH, V45, P224, DOI 10.1080/00039896.1990.9940806
   BAYNES JW, 1991, DIABETES, V40, P405, DOI 10.2337/diabetes.40.4.405
   BENZI G, 1989, EXP GERONTOL, V24, P137, DOI 10.1016/0531-5565(89)90024-7
   BODISWOLLNER I, 1986, EVOKED POTENTIAL, P15
   BOYES WK, 1991, VULNERABLE BRAIN MAL, V1
   CAND F, 1989, FREE RADICAL BIO MED, V7, P59, DOI 10.1016/0891-5849(89)90101-9
   CASTORINA C, 1992, NEUROCHEM RES, V17, P599, DOI 10.1007/BF00968789
   CEBALLOSPICOT I, 1992, MUTAT RES, V275, P281, DOI 10.1016/0921-8734(92)90032-K
   CELESIA GG, 1984, J CLIN NEUROPHYSIOL, V1, P55, DOI 10.1097/00004691-198401000-00003
   CELESIA GG, 1977, ARCH NEUROL-CHICAGO, V34, P403, DOI 10.1001/archneur.1977.00500190037005
   CELESIA GG, 1990, VISUAL EVOKED POTENT, P76
   CHIAPPA KH, 1983, EVOKED POTENTIALS CL
   CIRIOLO MR, 1991, MECH AGEING DEV, V61, P287, DOI 10.1016/0047-6374(91)90061-4
   CURTIS JF, 1988, CARCINOGENESIS, V9, P2015, DOI 10.1093/carcin/9.11.2015
   DALHAMN T, 1971, AM REV RESPIR DIS, V83, P566
   DEQUIROGA GB, 1990, BIOCHEM J, V272, P247
   Díaz F, 1998, NEUROPHYSIOL CLIN, V28, P399, DOI 10.1016/S0987-7053(99)80024-0
   DICE JF, 1993, PHYSIOL REV, V73, P149, DOI 10.1152/physrev.1993.73.1.149
   DYER RS, 1987, BRAIN RES BULL, V18, P227, DOI 10.1016/0361-9230(87)90194-8
   FERRIS BG, 1970, ARCH ENVIRON HEALTH, V21, P553, DOI 10.1080/00039896.1970.10667289
   FESTY B, 1991, Annales Pharmaceutiques Francaises, V49, P1
   GEREMIA E, 1990, NEUROCHEM RES, V15, P719, DOI 10.1007/BF00973653
   GILLES C, 1991, Neurophysiologie Clinique, V21, P425, DOI 10.1016/S0987-7053(05)80333-8
   GUNNISON AF, 1971, ARCH ENVIRON HEALTH, V22, P381, DOI 10.1080/00039896.1971.10665860
   GUPTA A, 1991, GERONTOLOGY, V37, P305, DOI 10.1159/000213277
   Hacioglu G, 2002, INT J NEUROSCI, V112, P1321, DOI 10.1080/00207450290158223
   HAIDER S S, 1984, Industrial Health, V22, P23
   HALLIDAY AM, 1976, T OPHTHAL SOC UK, V96, P372
   HETZLER BE, 1988, ELECTROEN CLIN NEURO, V70, P137, DOI 10.1016/0013-4694(88)90114-9
   HUDNELL HK, 1990, NEUROTOXICOL TERATOL, V12, P391, DOI 10.1016/0892-0362(90)90059-L
   KIYOSAWA I, 1994, EXP ANIM TOKYO, V43, P357, DOI 10.1538/expanim1978.43.3_357
   LAMARCHE JA, 1986, ELECTROEN CLIN NEURO, V65, P81, DOI 10.1016/0168-5597(86)90039-0
   LangleyEvans SC, 1996, COMP BIOCHEM PHYS C, V114, P89, DOI 10.1016/0742-8413(96)00012-6
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MATSUO M, 1992, MECH AGEING DEV, V64, P273, DOI 10.1016/0047-6374(92)90084-Q
   MIZUNO Y, 1986, J NEUROCHEM, V46, P1344, DOI 10.1111/j.1471-4159.1986.tb01745.x
   NOELL WK, 1980, VISION RES, V20, P1163, DOI 10.1016/0042-6989(80)90055-3
   OTTO D, 1988, TOXICOLOGY, V49, P205, DOI 10.1016/0300-483X(88)90001-7
   OTTO DA, 1993, ENVIRON RES, V62, P159, DOI 10.1006/enrs.1993.1100
   PAGLIA DE, 1967, J LAB CLIN MED, V70, P158
   PAL YB, 1994, PHYSIOL REV, V74, P139
   PEREZ R, 1991, FREE RADICAL BIO MED, V10, P35, DOI 10.1016/0891-5849(91)90019-Y
   RAO G, 1990, MECH AGEING DEV, V53, P49, DOI 10.1016/0047-6374(90)90033-C
   REBERT CS, 1983, NEUROBEH TOXICOL TER, V5, P659
   REEDSTARKE PE, 1989, ARCH BIOCHEM BIOPHYS, V275, P559
   REGAN D, 1989, HUMAN BRAIN ELECROPH
   ROSALIE KC, 1986, BIOL MED, V21, P647
   RUESSMANN K, 1991, INT J NEUROSCI, V56, P273, DOI 10.3109/00207459108985424
   SATO Y, 1979, BIOCHEM MED METAB B, V21, P104, DOI 10.1016/0006-2944(79)90061-9
   SAWADA M, 1987, MECH AGEING DEV, V41, P125, DOI 10.1016/0047-6374(87)90057-1
   SEMSEI I, 1990, MECH AGEING DEV, V52, P11
   Shearer D. E., 1980, American Journal of EEG Technology, V20, P185
   SINGH R, 1990, EPILEPSIA, V31, P15, DOI 10.1111/j.1528-1157.1990.tb05354.x
   SOHAL RS, 1993, BIOCHEM BIOPH RES CO, V196, P7, DOI 10.1006/bbrc.1993.2208
   STRATMANN U, 1991, ZBL HYG UMWELTMED, V192, P324
   SUN Y, 1989, CLIN CHEM, V35, P1265
   SUN Y, 1988, CLIN CHEM, V34, P397
   TAPPEL AL, 1981, FED PROC, V40, P174
   TEWARI A, 1991, Reviews on Environmental Health, V9, P39
   URBAN P, 1990, BRIT J IND MED, V47, P819
   VANELLA A, 1982, GERONTOLOGY, V28, P108, DOI 10.1159/000212519
   VANELLA A, 1989, J NEUROSCI RES, V22, P351, DOI 10.1002/jnr.490220316
   WASOWICZ W, 1993, CLIN CHEM, V39, P2522
   WHITE A, 1978, LIPID METABOLISM PRI, P38
   WRIGHT CE, 1985, DOC OPHTHALMOL, V59, P365, DOI 10.1007/BF00159171
   XINTARAS C, 1966, TOXICOL APPL PHARM, V8, P77, DOI 10.1016/0041-008X(66)90103-7
   ZHANG JR, 1993, J NEUROCHEM, V61, P1460
NR 70
TC 26
Z9 29
U1 0
U2 7
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0892-0362
J9 NEUROTOXICOL TERATOL
JI Neurotoxicol. Teratol.
PD SEP-OCT
PY 2003
VL 25
IS 5
BP 587
EP 598
DI 10.1016/S0892-0362(03)00090-4
PG 12
WC Neurosciences; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Toxicology
GA 725PX
UT WOS:000185552500009
PM 12972072
DA 2024-02-19
ER

PT J
AU Hong, SH
   Eun, JW
   Choi, SK
   Shen, Q
   Choi, WS
   Han, JW
   Nam, SW
   You, JS
AF Hong, Seong Hwi
   Eun, Jung Woo
   Choi, Sung Kyung
   Shen, Qingyu
   Choi, Wahn Soo
   Han, Jeung-Whan
   Nam, Suk Woo
   You, Jueng Soo
TI Epigenetic reader BRD4 inhibition as a therapeutic strategy to suppress
   E2F2-cell cycle regulation circuit in liver cancer
SO ONCOTARGET
LA English
DT Article
DE BET protein; epigenetic components; JQ1; hepatocellular carcinoma (HCC);
   E2F
ID HEPATOCELLULAR-CARCINOMA; SELECTIVE-INHIBITION; CELL-PROLIFERATION;
   TUMOR-SUPPRESSOR; MYC; GENES; E2F2; TARGET; INTERFERON; EXPRESSION
AB Deregulation of the epigenome component affects multiple pathways in the cancer phenotype since the epigenome acts at the pinnacle of the hierarchy of gene expression. Pioneering work over the past decades has highlighted that targeting enzymes or proteins involved in the epigenetic regulation is a valuable approach to cancer therapy. Very recent results demonstrated that inhibiting the epigenetic reader BRD4 has notable efficacy in diverse cancer types. We investigated the potential of BRD4 as a therapeutic target in liver malignancy. BRD4 was overexpressed in three different large cohort of hepatocellular carcinoma (HCC) patients as well as in liver cancer cell lines. BRD4 inhibition by JQ1 induced anti-tumorigenic effects including cell cycle arrest, cellular senescence, reduced wound healing capacity and soft agar colony formation in liver cancer cell lines. Notably, BRD4 inhibition caused MYC-independent large-scale gene expression changes in liver cancer cells. Serial gene expression analyses with SK-Hep1 liver cancer cells treated with JQ1 to delineate the key player of BRD4 inhibition identified E2F2 as the first line of downstream direct target of BRD4. Further experiments including chromatin immunoprecipitation (ChIP) assay and loss of function study confirmed E2F2 as key player of BRD4 inhibition. Overexpressed E2F2 is a crucial center of cell cycle regulation and high expression of E2F2 is significantly associated with poor prognosis of HCC patients. Our findings reveal BRD4-E2F2-cell cycle regulation as a novel molecular circuit in liver cancer and provide a therapeutic strategy and innovative insights for liver cancer therapies.
C1 [Hong, Seong Hwi; Choi, Sung Kyung; Choi, Wahn Soo; You, Jueng Soo] Konkuk Univ, Sch Med, Konkuk Univ Med Ctr, Seoul 143701, South Korea.
   [Eun, Jung Woo; Shen, Qingyu; Nam, Suk Woo] Catholic Univ, Coll Med, Funct RNom Res Ctr, Seoul 137701, South Korea.
   [Han, Jeung-Whan] Sungkyunkwan Univ, Sch Pharm, Res Ctr Epigenome Regulat, Suwon 440746, South Korea.
C3 Konkuk University; Konkuk University Medical Center; Catholic University
   of Korea; Sungkyunkwan University (SKKU)
RP You, JS (corresponding author), Konkuk Univ, Sch Med, Konkuk Univ Med Ctr, Seoul 143701, South Korea.; Nam, SW (corresponding author), Catholic Univ, Coll Med, Funct RNom Res Ctr, Seoul 137701, South Korea.
EM swnam@catholic.ac.kr; jsyou@kku.ac.kr
RI Eun, Jung Woo/ABB-5127-2020; SHEN, QINGYU/U-8848-2018
OI Eun, Jung Woo/0000-0002-2461-6702; 
FU Basic Science Research Program through the National Research Foundation
   of Korea (NRF) - Ministry of Science, ICT & Future Planning
   [2013R1A1A1057575]
FX This research was supported by the Basic Science Research Program
   through the National Research Foundation of Korea (NRF) funded by the
   Ministry of Science, ICT & Future Planning (2013R1A1A1057575).
CR Asangani IA, 2014, NATURE, V510, P278, DOI 10.1038/nature13229
   Bae HJ, 2014, ONCOGENE, V33, P2557, DOI 10.1038/onc.2013.216
   Belkina AC, 2012, NAT REV CANCER, V12, P465, DOI 10.1038/nrc3256
   Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553
   Bracken AP, 2004, TRENDS BIOCHEM SCI, V29, P409, DOI 10.1016/j.tibs.2004.06.006
   Chiappinelli KB, 2015, CELL, V162, P974, DOI 10.1016/j.cell.2015.07.011
   Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003
   Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013
   Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017
   Devaiah BN, 2012, P NATL ACAD SCI USA, V109, P6927, DOI 10.1073/pnas.1120422109
   Devaraj SGT, 2016, LEUKEMIA, V30, P504, DOI 10.1038/leu.2015.142
   Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934
   Filippakopoulos P, 2014, NAT REV DRUG DISCOV, V13, P339, DOI 10.1038/nrd4286
   Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504
   Fujiwara K, 2011, CANCER RES, V71, P1924, DOI 10.1158/0008-5472.CAN-10-2386
   Garraway LA, 2013, CELL, V153, P17, DOI 10.1016/j.cell.2013.03.002
   Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256
   Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053
   Infante A, 2008, CELL CYCLE, V7, P3915, DOI 10.4161/cc.7.24.7379
   Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027
   Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522
   Johnson DG, 2006, CURR MOL MED, V6, P731
   Kan ZY, 2013, GENOME RES, V23, P1422, DOI 10.1101/gr.154492.113
   Knoechel B, 2014, NAT GENET, V46, P364, DOI 10.1038/ng.2913
   Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020
   Li GQ, 2016, ONCOTARGET, V7, P2462, DOI 10.18632/oncotarget.6275
   Lockwood WW, 2012, P NATL ACAD SCI USA, V109, P19408, DOI 10.1073/pnas.1216363109
   Lovén J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036
   Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624
   Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589
   Opavsky R, 2007, P NATL ACAD SCI USA, V104, P15400, DOI 10.1073/pnas.0706307104
   Polager S, 2002, ONCOGENE, V21, P437, DOI 10.1038/sj.onc.1205102
   Roulois D, 2015, CELL, V162, P961, DOI 10.1016/j.cell.2015.07.056
   Sceusi EL, 2011, HPB, V13, P369, DOI 10.1111/j.1477-2574.2011.00303.x
   Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220
   Shi J, 2014, CANCER CELL, V25, P210, DOI 10.1016/j.ccr.2014.01.028
   Shi JW, 2014, MOL CELL, V54, P728, DOI 10.1016/j.molcel.2014.05.016
   Suzuki DE, 2014, STEM CELLS DEV, V23, P1266, DOI 10.1089/scd.2013.0592
   Nguyen-Vu T, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3443
   Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122
   Wu L, 2015, ONCOGENE, V34, P119, DOI 10.1038/onc.2013.511
   Wu N, 2012, FEBS LETT, V586, P3831, DOI 10.1016/j.febslet.2012.08.023
   Yang ZY, 2008, MOL CELL BIOL, V28, P967, DOI 10.1128/MCB.01020-07
   You JS, 2014, ARCH PHARM RES, V37, P1367, DOI 10.1007/s12272-014-0455-9
   You JS, 2012, CANCER CELL, V22, P9, DOI 10.1016/j.ccr.2012.06.008
   Yuwanita I, 2015, ONCOTARGET, V6, P38210, DOI 10.18632/oncotarget.5690
   Zhan L, 2014, CELL SIGNAL, V26, P1075, DOI 10.1016/j.cellsig.2014.01.008
   Zhang PF, 2015, INT J IMMUNOPATH PH, V28, P36, DOI 10.1177/0394632015572070
   Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033
   Zou Z, 2014, ONCOGENE, V33, P2395, DOI 10.1038/onc.2013.179
   Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334
NR 51
TC 42
Z9 48
U1 0
U2 11
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
EI 1949-2553
J9 ONCOTARGET
JI Oncotarget
PD MAY 31
PY 2016
VL 7
IS 22
BP 32628
EP 32640
DI 10.18632/oncotarget.8701
PG 13
WC Oncology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Cell Biology
GA DO4JP
UT WOS:000377748500077
PM 27081696
OA Green Published, gold, Green Submitted
DA 2024-02-19
ER

PT J
AU Wang, T
   Qu, GW
   Wang, C
   Cheng, YZ
   Shang, J
   Zheng, J
   Feng, ZQ
   Chen, Q
   He, NY
AF Wang, Ting
   Qu, Guanwen
   Wang, Chu
   Cheng, Yaozhong
   Shang, Jing
   Zheng, Jie
   Feng, Zhangqi
   Chen, Qiang
   He, Nongyue
TI Importance of Polyacrylamide Hydrogel Diverse Chains and Cross-Linking
   Density for Cell Proliferation, Aging, and Death
SO LANGMUIR
LA English
DT Article
ID ADHESION; SOFT
AB Diverse chains and cross-linking density of polymers are important for cell proliferation, aging, and death. In this study, by controlling the component ratio of N,N'-methylenebisacrylamide (Bis)/acrylamide (Acr), we prepared polyacrylamide (PAM) hydrogels with three different polymer structures using ultraviolet irradiation. Moreover, we quantified their Flory's cross-linking densities, gel concentrations, and mechanical properties and evaluated their influence to HL-7702 liver cell behavior and metabolism. Results showed that PAM hydrogel at a ratio of Bis/Acr = 1:50 (Acr-50) owned the highest cross-linking density (0.04), which provided abundant binding sites for cell adhesion and allowed for rapid cell proliferation. On the basis of the binding sites, cells had strong traction interaction from fibrillate adhesion with the polymers, allowed easy cell migration, and induced the living cell aggregations with a diameter of 800 mu m. Cells in aggregation exhibited healthy cell phenotypes and functions, and also the mitosis of the cells in aggregation is exactly the same with the cells in tissue. It is concluded that cell proliferation, aging, and death can be controlled by adjusting the cross-linking density and diverse chains of matrix hydrogels. This work will be helpful to design new functional soft biomaterials for tissue regeneration in the future.
C1 [Wang, Ting; Qu, Guanwen; Wang, Chu; Cheng, Yaozhong; Chen, Qiang; He, Nongyue] Southeast Univ, Natl Demonstrat Ctr Expt Biomed Engn Educ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing 210096, Jiangsu, Peoples R China.
   [Shang, Jing] China Pharmaceut Univ, Dept Pharmacol, Nanjing 210002, Jiangsu, Peoples R China.
   [Wang, Ting; Qu, Guanwen; Zheng, Jie] Univ Akron, Dept Chem & Biomol Engn, Akron, OH 44325 USA.
   [Feng, Zhangqi] Nanjing Daniel New Mstar Technol Ltd, Nanjing 211200, Jiangsu, Peoples R China.
   [Wang, Ting; Qu, Guanwen; Wang, Chu; Feng, Zhangqi; Chen, Qiang; He, Nongyue] Nanjing Univ Sci & Technol, Sch Chem Engn, 200 Xiao Ling Wei, Nanjing 210094, Jiangsu, Peoples R China.
C3 Southeast University - China; China Pharmaceutical University;
   University System of Ohio; University of Akron; Nanjing University of
   Science & Technology
RP Wang, T; Chen, Q (corresponding author), Southeast Univ, Natl Demonstrat Ctr Expt Biomed Engn Educ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing 210096, Jiangsu, Peoples R China.; Wang, T (corresponding author), Univ Akron, Dept Chem & Biomol Engn, Akron, OH 44325 USA.; Wang, T; Chen, Q (corresponding author), Nanjing Univ Sci & Technol, Sch Chem Engn, 200 Xiao Ling Wei, Nanjing 210094, Jiangsu, Peoples R China.
EM tingwang@seu.edu.cn; chenq999@gmail.com
RI Zheng, Jie/B-5057-2013; Feng, Zhang-Qi/C-4808-2013
FU National Natural Science Foundation of China [11204033, 51773093];
   Natural Science Foundation of Jiangsu Province [BK20141397]; Research
   Fund for the Doctoral Program of Higher Education of China
   [20120092120042]; CMA L'Oreal China Skin Grant 2015 [S2015121421]; Open
   Research Fund of State Key Laboratory of Natural Medicines, China
   Pharmaceutical University [SKLNMKF201803]; Southeast University
   [2242018K3DN14]; Nanjing Medical University Cooperation Project
   [2242018K3DN14]
FX This research is financially supported by the National Natural Science
   Foundation of China (11204033,51773093), the Natural Science Foundation
   of Jiangsu Province (BK20141397), the Research Fund for the Doctoral
   Program of Higher Education of China (20120092120042), the CMA L'Oreal
   China Skin Grant 2015 (S2015121421), the Open Research Fund of State Key
   Laboratory of Natural Medicines, China Pharmaceutical University
   (SKLNMKF201803), and the Southeast University and Nanjing Medical
   University Cooperation Project (2242018K3DN14).
CR Agnew DJG, 2014, J THEOR BIOL, V352, P16, DOI 10.1016/j.jtbi.2014.02.033
   Chung JY, 2005, J ADHESION, V81, P1119, DOI 10.1080/00218460500310887
   Delrio FW, 2005, NAT MATER, V4, P629, DOI 10.1038/nmat1431
   DERJAGUIN BV, 1975, J COLLOID INTERF SCI, V53, P314, DOI 10.1016/0021-9797(75)90018-1
   Dokukin ME, 2012, LANGMUIR, V28, P16060, DOI 10.1021/la302706b
   Du YN, 2006, BIOMATERIALS, V27, P5669, DOI 10.1016/j.biomaterials.2006.07.018
   Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5
   Feng ZQ, 2009, BIOMATERIALS, V30, P2753, DOI 10.1016/j.biomaterials.2009.01.053
   Flory P J., PRINCIPLES POLYM CHE
   Fu JP, 2010, NAT METHODS, V7, P733, DOI 10.1038/nmeth.1487
   Guo P, 2014, MAT SCI ENG C-MATER, V42, P622, DOI 10.1016/j.msec.2014.06.013
   He PS, 2014, STRUCTURE PROPERTIES
   Kam LC, 2013, ANNU REV BIOMED ENG, V15, P305, DOI 10.1146/annurev-bioeng-071811-150050
   Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004
   Khan SH, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4861856
   Khatiwala CB, 2006, AM J PHYSIOL-CELL PH, V290, pC1640, DOI 10.1152/ajpcell.00455.2005
   Kim S, 2003, BIOMACROMOLECULES, V4, P1214, DOI 10.1021/bm0340467
   Li GC, 2016, COLLOID SURFACE B, V143, P547, DOI 10.1016/j.colsurfb.2016.03.079
   Lin S, 2011, PHARM RES-DORDR, V28, P1422, DOI 10.1007/s11095-011-0378-9
   Lüthen F, 2005, BIOMATERIALS, V26, P2423, DOI 10.1016/j.biomaterials.2004.07.054
   MASON P, 1982, AUST J PHYS, V35, P737, DOI 10.1071/PH820737
   Nigmatullin R, 2014, SOFT MATTER, V10, P2035, DOI 10.1039/c3sm52887a
   Park CC, 2006, CANCER RES, V66, P1526, DOI 10.1158/0008-5472.CAN-05-3071
   Schweller RM, 2015, ACS BIOMATER SCI ENG, V1, P335, DOI 10.1021/acsbiomaterials.5b00064
   Slepicka P, 2015, BIOTECHNOL ADV, V33, P1120, DOI 10.1016/j.biotechadv.2015.01.001
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Tan LW, 2017, J BIOMED NANOTECHNOL, V13, P393, DOI 10.1166/jbn.2017.2356
   Tan LW, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/239838
   Wang J. K., 2013, BIOMEDICAL EXPT
   Wu DD, 2018, CHINESE CHEM LETT, V29, P1098, DOI 10.1016/j.cclet.2018.04.030
   Yuan NX, 2016, MAT SCI ENG C-MATER, V67, P221, DOI 10.1016/j.msec.2016.04.074
   Zhao AL, 2016, CELL CYCLE, V15, P644, DOI 10.1080/15384101.2016.1146838
NR 32
TC 7
Z9 7
U1 1
U2 37
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD OCT 29
PY 2019
VL 35
IS 43
BP 13999
EP 14006
DI 10.1021/acs.langmuir.9b02799
PG 8
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry; Materials Science
GA JI6OP
UT WOS:000493586900023
PM 31578065
DA 2024-02-19
ER

PT J
AU Gilglioni, EH
   Campos, LB
   Oliveira, MC
   Garcia, RF
   Ambiel, CR
   Buzzo, AJD
   Ishii-Iwamoto, EL
   Salgueiro-Pagadigorria, CL
AF Gilglioni, Eduardo Hideo
   Campos, Lilian Brites
   Oliveira, Monique Cristine
   Garcia, Rosangela Fernandes
   Ambiel, Celia Regina
   dos Reis Buzzo, Ana Julia
   Ishii-Iwamoto, Emy Luzia
   Salgueiro-Pagadigorria, Clairce Luzia
TI Beneficial Effects of Tibolone on Blood Pressure and Liver Redox Status
   in Ovariectomized Rats With Renovascular Hypertension
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
DE Hypertension; Liver lipid metabolism; Liver redox status; Estrogen
   deficiency; Tibolone
ID HORMONE REPLACEMENT THERAPY; OXIDATIVE STRESS; BODY-COMPOSITION;
   GLUCOSE-6-PHOSPHATE-DEHYDROGENASE; GLUTATHIONE; PURIFICATION;
   METABOLISM; OSTEOPENIA; PEROXIDES; STEATOSIS
AB Estrogen deficiency is associated with aging and increases the incidence of metabolic syndrome and hypertension. In this study, the effects of tibolone, a synthetic steroid, on the cardiovascular system, liver lipid metabolism, and redox status were evaluated, in ovariectomized (OVX) rats with renovascular hypertension (two-kidneys, one-clip, OVX + 2K1C). This study encompassed direct measurements of mean arterial pressure, plasma biochemical analysis, liver lipid contents, and assessments of the mitochondrial and peroxisomal beta-oxidation capacities. Additionally, the liver redox status was assayed. Tibolone significantly reduced the mean arterial pressure of OVX + 2K1C rats, albeit reducing total and high-density lipoprotein (HDL) cholesterol levels. In the liver, although exerting an undesirable inhibition of mitochondrial and peroxisomal beta-oxidation, tibolone reversed steatosis. Tibolone also improved the liver redox status: the reduced glutathione contents and the activity of glucose-6-phosphate dehydrogenase were restored by this compound, which also reduced the levels of thiobarbituric acid reactive substances and the generation of mitochondrial reactive oxygen species. So, tibolone reversed the main alterations caused by hypertension and estrogen deficiency.
C1 [Gilglioni, Eduardo Hideo; Campos, Lilian Brites; Garcia, Rosangela Fernandes; Ambiel, Celia Regina; dos Reis Buzzo, Ana Julia; Salgueiro-Pagadigorria, Clairce Luzia] Univ Maringa, Dept Physiol Sci, BR-87020900 Maringa, Parana, Brazil.
   [Oliveira, Monique Cristine; Ishii-Iwamoto, Emy Luzia; Salgueiro-Pagadigorria, Clairce Luzia] Univ Maringa, Dept Biochem, BR-87020900 Maringa, Parana, Brazil.
RP Salgueiro-Pagadigorria, CL (corresponding author), Univ Maringa, Dept Biochem, BR-87020900 Maringa, Parana, Brazil.
EM clspagadigorria@uem.br
RI Gilglioni, Eduardo H/H-2784-2012; Campos-Shimada, Lilian
   Brites/M-8719-2013; Oliveira, Monique/M-2241-2016
OI Gilglioni, Eduardo H/0000-0001-5137-4051; Campos-Shimada, Lilian
   Brites/0000-0002-5226-6519; Oliveira, Monique/0000-0002-9667-0724; Ishii
   Iwamoto, Emy Luiza/0000-0001-8708-3643
FU Conselho Nacional de Pesquisa Cientifica e Tecnologica [CNPq
   475704/2010]; Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior [CAPES 014/10]
FX Conselho Nacional de Pesquisa Cientifica e Tecnologica (CNPq
   475704/2010); Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES 014/10).
CR Adams LA, 2005, DIABETIC MED, V22, P1129, DOI 10.1111/j.1464-5491.2005.01748.x
   Aebi H., 1974, Methods of enzymatic analysis, P673, DOI [10.1016/B978-0-12-091302-2.50032-3, DOI 10.1016/B978-0-12-091302-2.50032-3]
   Albertazzi P, 1998, MATURITAS, V30, P295, DOI 10.1016/S0378-5122(98)00059-0
   [Anonymous], CITRIC ACID CYCLE CO
   Appt SE, 2008, MATURITAS, V60, P216, DOI 10.1016/j.maturitas.2008.06.003
   Behl C, 1997, MOL PHARMACOL, V51, P535, DOI 10.1124/mol.51.4.535
   Berson A, 1998, GASTROENTEROLOGY, V114, P764, DOI 10.1016/S0016-5085(98)70590-6
   Bianco V, 2006, Minerva Ginecol, V58, P335
   Borras C, 2007, FRONT BIOSCI, V12, P1008, DOI 10.2741/2120
   Bracht A., 2003, METODOS LAB BIOQUIMI, P77
   Coylewright M, 2008, HYPERTENSION, V51, P952, DOI 10.1161/HYPERTENSIONAHA.107.105742
   CRONA N, 1983, ACTA ENDOCRINOL-COP, V102, P451, DOI 10.1530/acta.0.1020451
   Czerny B, 2005, MENOPAUSE, V12, P609, DOI 10.1097/01.gme.0000178449.52248.39
   D'Eon TM, 2005, J BIOL CHEM, V280, P35983, DOI 10.1074/jbc.M507339200
   de Oliveira MC, 2011, EUR J PHARMACOL, V668, P248, DOI 10.1016/j.ejphar.2011.06.043
   Dedeoglu EN, 2009, FERTIL STERIL, V91, P425, DOI 10.1016/j.fertnstert.2007.11.061
   FARISH E, 1984, MATURITAS, V6, P297, DOI 10.1016/0378-5122(84)90046-X
   Fee JA, 1982, BIOL CLIN ASPECTS SU, P41
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Gol Mert, 2005, Archives of Gynecology and Obstetrics, V272, P127, DOI 10.1007/s00404-004-0686-y
   Goldblatt H, 1934, J EXP MED, V59, P347, DOI 10.1084/jem.59.3.347
   Haenggi W, 1999, GYNECOL ENDOCRINOL, V13, P202, DOI 10.3109/09513599909167556
   Hänggi W, 1998, CLIN ENDOCRINOL, V48, P691, DOI 10.1046/j.1365-2265.1998.00481.x
   Henriques HN, 2010, REV BRAS GINECOL OBS, V32, P88, DOI 10.1590/S0100-72032010000200007
   HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2
   IBIM SEM, 1989, LIFE SCI, V45, P1559, DOI 10.1016/0024-3205(89)90422-0
   Kankofer M, 2007, J VET MED A, V54, P225, DOI 10.1111/j.1439-0442.2007.00916.x
   Kumar S, 2010, BBA-GEN SUBJECTS, V1800, P1127, DOI 10.1016/j.bbagen.2010.04.011
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MARKLUND S, 1974, EUR J BIOCHEM, V47, P469
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   MIZE CE, 1962, J BIOL CHEM, V237, P1589
   Morley John E, 2003, J Gerontol A Biol Sci Med Sci, V58, pM409
   Natarajan SK, 2006, J GASTROEN HEPATOL, V21, P1240, DOI 10.1111/j.1440-1746.2006.04313.x
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   PAGLIA DE, 1967, J LAB CLIN MED, V70, P158
   Paquette A, 2007, MATURITAS, V58, P182, DOI 10.1016/j.maturitas.2007.08.002
   Park J, 2006, DIABETES, V55, P2939, DOI 10.2337/db05-1570
   Pytlik M, 2002, POL J PHARMACOL, V54, P35
   Rappelli A, 2002, J HYPERTENS, V20, pS26
   Reckelhoff JF, 2004, HYPERTENSION, V43, P918, DOI 10.1161/01.HYP.0000124670.03674.15
   REDDY JK, 1994, ANNU REV NUTR, V14, P343, DOI 10.1146/annurev.nu.14.070194.002015
   Rodrigo R, 2007, HYPERTENS RES, V30, P1159, DOI 10.1291/hypres.30.1159
   Seeger H, 2007, MATURITAS, V58, P42, DOI 10.1016/j.maturitas.2007.04.011
   Simoncini T, 2004, J CLIN ENDOCR METAB, V89, P4594, DOI 10.1210/jc.2003-032189
   SMALL GM, 1985, BIOCHEM J, V227, P205, DOI 10.1042/bj2270205
   Taguchi H, 1996, INVEST OPHTH VIS SCI, V37, P1444
   Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005
   TIAN WN, 1994, J BIOL CHEM, V269, P14798
   Uhler ML, 2000, MENOPAUSE, V7, P162, DOI 10.1097/00042192-200007030-00006
   Van Sinderen ML, 2009, MENOPAUSE, V16, P582, DOI 10.1097/gme.0b013e31818fb20b
   Vassalle C, 2011, GYNECOL ENDOCRINOL, V27, P163, DOI 10.3109/09513590.2010.488770
   Völzke H, 2007, GUT, V56, P594, DOI 10.1136/gut.2006.115345
   Yoshitake K, 1999, BONE, V25, P311, DOI 10.1016/S8756-3282(99)00172-6
NR 54
TC 8
Z9 8
U1 0
U2 39
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
EI 1758-535X
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD MAY
PY 2013
VL 68
IS 5
BP 510
EP 520
DI 10.1093/gerona/gls210
PG 11
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA 125KO
UT WOS:000317538900002
PM 23089337
OA Bronze
DA 2024-02-19
ER

PT J
AU Fu, ZD
   Csanaky, IL
   Klaassen, CD
AF Fu, Zidong Donna
   Csanaky, Ivan L.
   Klaassen, Curtis D.
TI Effects of Aging on mRNA Profiles for Drug-Metabolizing Enzymes and
   Transporters in Livers of Male and Female Mice
SO DRUG METABOLISM AND DISPOSITION
LA English
DT Article
ID GROWTH-HORMONE REGULATION; AGE-RELATED-CHANGES; TISSUE DISTRIBUTION;
   XENOBIOTIC TRANSPORTERS; GENE-EXPRESSION; WISTAR RATS; MOUSE-LIVER;
   SULFOTRANSFERASE; PROTEIN; SEX
AB Aging is a physiological process characterized by progressive functional decline in various organs over time. To reveal possible molecular mechanisms of altered xenobiotic disposition and toxicity in elderly individuals, age-dependent mRNA profiles for 101 xenobiotic-processing genes (XPGs), including seven uptake transporters, 41 phase I enzymes, 36 phase II enzymes, 10 efflux transporters, and seven transcription factors, were characterized in livers of male and female mice from 3 to 27 months of age. Gender differences across the lifespan (significant at five ages or more) were observed for 52 XPGs, including 15 male-predominant genes (e. g., Oatp1a1, Cyp3a11, Ugt1a6a, Comt, and Bcrp) and 37 female-predominant genes (e. g., Oatp1a4, Cyp2b10, Sult1a1, Ugt1a1, and Mrp3). During aging, the mRNA levels for 44% of the 101 XPGs changed in male mice and 63% changed in female mice. In male mice, mRNA levels for 40 XPGs (e. g., Oatp1a1, Ces2c, Gstm4, Gstp1, and Ces1e) were lower in aged mice (more than 21 months of age), whereas mRNA levels for four XPGs (e. g., Oat2 and Gstm2) were higher in aged mice. In female mice, mRNA levels for 43 XPGs (e. g., Oatp1a1, Cyp1a2, Ces1f, Sult3a1, Gstt2, Comt, Ent1, Fmo3, and Mrp6) were lower in aged mice, whereas mRNA levels for 21 XPGs (e. g., Oatp1a4, Nqo1, Adh7, Sult2a1/2, Gsta1, and Mrp4) were higher in aged mice. In conclusion, 51% of the 101 XPGs exhibited gender differences in liver mRNA levels across the lifespan of mice; the mRNA levels for 40% of the XPGs were lower in aged male mice and 43% were lower in aged female mice.
C1 [Fu, Zidong Donna; Csanaky, Ivan L.; Klaassen, Curtis D.] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA.
C3 University of Kansas; University of Kansas Medical Center
RP Klaassen, CD (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.
EM cklaasse@kumc.edu
RI Fu, Zidong/A-2703-2017
FU National Institutes of Health National Institute of Environmental
   Sciences [ES-009649]; National Institutes of Health National Institute
   of Diabetes and Digestive and Kidney Diseases [DK-081461]
FX This work was supported by the National Institutes of Health National
   Institute of Environmental Sciences [Grant ES-009649]; and the National
   Institutes of Health National Institute of Diabetes and Digestive and
   Kidney Diseases [Grant DK-081461].
CR Alnouti Y, 2006, TOXICOL SCI, V93, P242, DOI 10.1093/toxsci/kfl050
   BIRNBAUM LS, 1991, ANNU REV PHARMACOL, V31, P101
   Bjornerem Å, 2004, J CLIN ENDOCR METAB, V89, P6039, DOI 10.1210/jc.2004-0735
   Buckley DB, 2009, DRUG METAB DISPOS, V37, P834, DOI 10.1124/dmd.108.024224
   Cheng XG, 2005, DRUG METAB DISPOS, V33, P1062, DOI 10.1124/dmd.105.003640
   Cheng XG, 2006, MOL PHARMACOL, V70, P1291, DOI 10.1124/mol.106.025122
   CHHABRA RS, 1991, FOOD CHEM TOXICOL, V29, P119, DOI 10.1016/0278-6915(91)90166-5
   Cusack Barry J, 2004, Am J Geriatr Pharmacother, V2, P274, DOI 10.1016/j.amjopharm.2004.12.005
   Echchgadda I, 2004, MECH AGEING DEV, V125, P733, DOI 10.1016/j.mad.2004.08.008
   FALANY CN, 1995, J STEROID BIOCHEM, V52, P529, DOI 10.1016/0960-0760(95)00015-R
   Hagenbuch B, 2008, XENOBIOTICA, V38, P778, DOI [10.1080/00498250801986951, 10.1080/00498250801986951 ]
   Handler JA, 1997, BIOCHEM PHARMACOL, V54, P159, DOI 10.1016/S0006-2952(97)00159-7
   Holmes RS, 2010, MAMM GENOME, V21, P427, DOI 10.1007/s00335-010-9284-4
   Johansson AS, 2001, J BIOL CHEM, V276, P33061, DOI 10.1074/jbc.M104539200
   Klaassen CD, 2005, CURR DRUG METAB, V6, P309, DOI 10.2174/1389200054633826
   Klaassen CD, 2008, TOXICOL SCI, V101, P186, DOI 10.1093/toxsci/kfm214
   Klaassen CD, 2010, PHARMACOL REV, V62, P1, DOI 10.1124/pr.109.002014
   Knight TR, 2007, TOXICOL SCI, V100, P513, DOI 10.1093/toxsci/kfm233
   Lee JS, 2008, TOXICOL SCI, V106, P263, DOI 10.1093/toxsci/kfn144
   Liu L, 1996, J PHARMACOL EXP THER, V279, P386
   Maher JM, 2006, BIOCHEM PHARMACOL, V71, P1470, DOI 10.1016/j.bcp.2006.02.005
   Monostory K, 2011, CURR DRUG METAB, V12, P154, DOI 10.2174/138920011795016854
   Mori K, 2007, TOXICOL PATHOL, V35, P242, DOI 10.1080/01926230601156286
   Pampori NA, 1999, ENDOCRINOLOGY, V140, P1245, DOI 10.1210/en.140.3.1245
   Peng FC, 2005, J TOXICOL ENV HEAL A, V68, P1871, DOI 10.1080/15287390500226763
   Redinbo MR, 2005, DRUG DISCOV TODAY, V10, P313, DOI 10.1016/S1359-6446(05)03383-0
   RUDMAN D, 1990, NEW ENGL J MED, V323, P1, DOI 10.1056/NEJM199007053230101
   Sandhiya S, 2008, J Assoc Physicians India, V56, P525
   SRIVASTAVA PK, 1993, BIOCHEM J, V294, P159, DOI 10.1042/bj2940159
   Tanaka Y, 2005, BIOCHEM BIOPH RES CO, V326, P181, DOI 10.1016/j.bbrc.2004.11.012
   Townsend DM, 2009, BIOMED PHARMACOTHER, V63, P79, DOI 10.1016/j.biopha.2008.08.004
   Warrington JS, 2004, J PHARMACOL EXP THER, V309, P720, DOI 10.1124/jpet.103.061077
   Wauthier V, 2004, ARCH TOXICOL, V78, P131, DOI 10.1007/s00204-003-0526-z
   Waxman DJ, 2006, MOL ENDOCRINOL, V20, P2613, DOI 10.1210/me.2006-0007
   Weisz J, 1998, CARCINOGENESIS, V19, P1307, DOI 10.1093/carcin/19.7.1307
   Yoshinari K, 1998, J BIOCHEM-TOKYO, V123, P479
   Zhang YKJ, 2009, DRUG METAB DISPOS, V37, P106, DOI 10.1124/dmd.108.024174
NR 37
TC 53
Z9 59
U1 0
U2 12
PU AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA
SN 0090-9556
J9 DRUG METAB DISPOS
JI Drug Metab. Dispos.
PD JUN
PY 2012
VL 40
IS 6
BP 1216
EP 1225
DI 10.1124/dmd.111.044461
PG 10
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA 947IQ
UT WOS:000304424100020
PM 22446518
OA Green Published
DA 2024-02-19
ER

PT J
AU Muratore, KA
   Najt, CP
   Livezey, NM
   Marti, J
   Mashek, DG
   Arriaga, EA
AF Muratore, Katherine A.
   Najt, Charles P.
   Livezey, Nicholas M.
   Marti, James
   Mashek, Douglas G.
   Arriaga, Edgar A.
TI Sizing lipid droplets from adult and geriatric mouse liver tissue via
   nanoparticle tracking analysis
SO ANALYTICAL AND BIOANALYTICAL CHEMISTRY
LA English
DT Article
DE Lipid droplets; Nanoparticle tracking analysis; Aging; Liver; Organelles
ID STEROL CARRIER PROTEIN-2; INDIVIDUAL MITOCHONDRIA;
   CAENORHABDITIS-ELEGANS; REFRACTIVE-INDEX; RED O; SIZE; QUANTIFICATION;
   INFLAMMATION; MICROSCOPY; CELLS
AB The significance of lipid droplets in lipid metabolism, cell signaling, and regulating longevity is increasingly recognized, yet the lipid droplet's unique properties and architecture make it difficult to size and study using conventional methods. To begin to address this issue, we demonstrate the capabilities of nanoparticle tracking analysis (NTA) for sizing of lipid droplets. NTA was found to be adequate to assess lipid droplet stability over time, indicating that lipid droplet preparations are stable for up to 24 h. NTA had the ability to compare the size distributions of lipid droplets from adult and geriatric mouse liver tissue, suggesting an age-related decrease in lipid droplet size. This is the first report on the use of NTA to size intracellular organelles.
C1 [Muratore, Katherine A.; Najt, Charles P.; Mashek, Douglas G.; Arriaga, Edgar A.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, 321 Church St SE, Minneapolis, MN 55455 USA.
   [Livezey, Nicholas M.; Arriaga, Edgar A.] Univ Minnesota, Dept Chem, 207 Pleasant St SE, Minneapolis, MN 55455 USA.
   [Marti, James] Univ Minnesota, Minnesota Nano Ctr, 115 Union St SE, Minneapolis, MN 55455 USA.
C3 University of Minnesota System; University of Minnesota Twin Cities;
   University of Minnesota System; University of Minnesota Twin Cities;
   University of Minnesota System; University of Minnesota Twin Cities
RP Arriaga, EA (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, 321 Church St SE, Minneapolis, MN 55455 USA.; Arriaga, EA (corresponding author), Univ Minnesota, Dept Chem, 207 Pleasant St SE, Minneapolis, MN 55455 USA.
EM arriaga@umn.edu
RI Mashek, Douglas Gene/ABD-6844-2021
OI Mashek, Douglas Gene/0000-0001-7033-3386; Najt,
   Charles/0000-0001-6455-8810; Muratore, Katherine/0000-0001-5941-9859
FU NIH [AG020866, DK007203, GM008700, DK114401, AG055452]; University of
   Minnesota Doctoral Dissertation Fellowship; National Institutes of
   Health (NIH) [AG029796]; National Science Foundation (NSF) through the
   NNCI program; NSF through the MRSEC program
FX This work was supported by NIH AG020866. KAM acknowledges support
   through a University of Minnesota Doctoral Dissertation Fellowship and
   National Institutes of Health (NIH) AG029796. CPN acknowledges support
   from NIH DK007203. NML acknowledges support from NIH GM008700. DGM
   acknowledges support from NIH DK114401 and NIH AG055452. A portion of
   this work was carried out in the Minnesota Nano Center, which receives
   partial support from the National Science Foundation (NSF) through the
   NNCI program. A portion of this work was carried out in the
   Characterization Facility, University of Minnesota, which receives
   partial support from NSF through the MRSEC program.
CR Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41
   Atshaves BP, 2001, J BIOL CHEM, V276, P25324, DOI 10.1074/jbc.M100560200
   Bonda-Ostaszewska E, 2012, ACTA THERIOL, V57, P289, DOI 10.1007/s13364-012-0083-z
   Cao C, 2016, ANAL CHEM, V88, P4931, DOI 10.1021/acs.analchem.6b00862
   CHANDERBHAN R, 1982, J BIOL CHEM, V257, P8928
   CHANDRASEKHAR S, 1949, REV MOD PHYS, V21, P383, DOI 10.1103/RevModPhys.21.383
   Christwardana M, 2016, SCI REP-UK, V6, DOI 10.1038/srep30128
   Cohen BC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121645
   Daniele JR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05152-z
   Daniele JR, 2016, ANAL CHEM, V88, P6309, DOI 10.1021/acs.analchem.6b00542
   Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2
   Degtyarev M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087707
   Deutsch MJ, 2014, ANAL BIOCHEM, V445, P87, DOI 10.1016/j.ab.2013.10.001
   Ding YF, 2013, NAT PROTOC, V8, P43, DOI 10.1038/nprot.2012.142
   Einstein A, 1905, ANN PHYS-BERLIN, V17, P549, DOI 10.1002/andp.19053220806
   Gao M, 2017, CHEM COMMUN, V53, P921, DOI 10.1039/c6cc09471f
   Gardiner C, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.19671
   Goldberg AA, 2009, BIOCHEM SOC T, V37, P1050, DOI 10.1042/BST0371050
   Gouw TH, 1966, EUR J LIPID SCI TECH, V68, P544
   GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965
   Haseda K, 2015, BIOMED OPT EXPRESS, V6, P859, DOI 10.1364/BOE.6.000859
   James AE, 2013, ANALYST, V138, P1212, DOI 10.1039/c2an36467k
   Klapper M, 2011, J LIPID RES, V52, P1281, DOI 10.1194/jlr.D011940
   Krahmer N, 2013, EMBO MOL MED, V5, P973, DOI 10.1002/emmm.201100671
   Kramberger P, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-265
   Londos C, 1999, SEMIN CELL DEV BIOL, V10, P51, DOI 10.1006/scdb.1998.0275
   Malloy A, 2006, PART PART SYST CHAR, V23, P197, DOI 10.1002/ppsc.200601031
   MARX E, 1983, J RES NAT BUR STAND, V88, P321, DOI 10.6028/jres.088.016
   McIntosh AL, 2010, LIPIDS, V45, P465, DOI 10.1007/s11745-010-3424-1
   McManaman JL, 2013, J LIPID RES, V54, P1346, DOI 10.1194/jlr.M035063
   Mehlem A, 2013, NAT PROTOC, V8, P1149, DOI 10.1038/nprot.2013.055
   Murphy DJ, 2001, PROG LIPID RES, V40, P325, DOI 10.1016/S0163-7827(01)00013-3
   Najt CP, 2016, AM J PHYSIOL-GASTR L, V310, pG726, DOI 10.1152/ajpgi.00436.2015
   Nishimoto Y, 2017, J BIOL CHEM, V292, P10824, DOI 10.1074/jbc.M116.768820
   Oosthuyzen W, 2013, J PHYSIOL-LONDON, V591, P5833, DOI 10.1113/jphysiol.2013.264069
   Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889
   Shi X, 2013, J LIPID RES, V54, P2504, DOI 10.1194/jlr.M039669
   Slawik M, 2006, AGEING RES REV, V5, P144, DOI 10.1016/j.arr.2006.03.004
   Smus JP, 2015, CHEM SCI, V6, P7089, DOI 10.1039/c5sc02168e
   Soo CY, 2012, IMMUNOLOGY, V136, P192, DOI 10.1111/j.1365-2567.2012.03569.x
   Storey SM, 2011, AM J PHYSIOL-ENDOC M, V301, pE991, DOI 10.1152/ajpendo.00109.2011
   Suzuki M, 2011, J ELECTRON MICROSC, V60, pS101, DOI 10.1093/jmicro/dfr016
   Tatischeff I, 2012, J EXTRACELL VESICLES, V1, DOI 10.3402/jev.v1i0.19179
   Taylor TH, 2014, ANAL BIOANAL CHEM, V406, P1683, DOI 10.1007/s00216-013-7593-7
   Wu A, 2017, CHEM-ASIAN J, V12, P1704, DOI 10.1002/asia.201700423
   Yang H., 2012, EVID-BASED COMPL ALT, V2012, P10, DOI DOI 10.1200/JC0.2012.45.5758
   Zhang SY, 2016, SCI REP-UK, V6, DOI 10.1038/srep29539
NR 47
TC 3
Z9 3
U1 3
U2 36
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1618-2642
EI 1618-2650
J9 ANAL BIOANAL CHEM
JI Anal. Bioanal. Chem.
PD JUN
PY 2018
VL 410
IS 16
BP 3629
EP 3638
DI 10.1007/s00216-018-1016-8
PG 10
WC Biochemical Research Methods; Chemistry, Analytical
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA GG1AC
UT WOS:000432410700002
PM 29663061
OA Green Accepted
DA 2024-02-19
ER

PT J
AU DAS, SK
   CHAKRABARTI, P
   MUKHERJEE, S
AF DAS, SK
   CHAKRABARTI, P
   MUKHERJEE, S
TI EFFECTS OF AGING ON CHOLINEPHOSPHOTRANSFERASE ACTIVITY ON GUINEA-PIG
   LUNG MITOCHONDRIA AND MICROSOMES
SO MOLECULAR AND CELLULAR BIOCHEMISTRY
LA English
DT Article
DE AGING; CHOLINEPHOSPHOTRANSFERASE; MITOCHONDRIA; MICROSOMES; LUNG; GUINEA
   PIG
ID PHOSPHOLIPID-COMPOSITION; PULMONARY SURFACTANT; RAT-LIVER; AGE;
   PHOSPHATIDYLCHOLINE; METABOLISM; DISEASES; MEMBRANE; CORTISOL; LAVAGE
AB It is known that the composition of phospholipids in lung changes with age. The final step in the de novo synthesis of phosphatidylcholine, a major component of lung surfactant, by the CDP-choline pathway, requires the enzyme cholinephosphotransferase (CPT). Even though CPT has earlier been proposed to be located exclusively in the endoplasmic reticulum, we have recently demonstrated its presence also in the mitochondria. We have earlier reported a gestational variation of CPT activity in fetal mitochondria and microsomes. In the present study we examined the subcellular distribution of CPT activity in lung as a function of age. After birth, the microsomal CPT activity continued to increase until adulthood (24 wks of age), thereafter it gradually decreased. On the otherhand, the CPT activity of mitochondria continued to increase with the advancement of age and beyond 72 wks of age, it was approximately 2-fold higher than that of the microsomal fraction.
RP DAS, SK (corresponding author), MEHARRY MED COLL, DEPT BIOCHEM, NASHVILLE, TN 37208 USA.
FU NIGMS NIH HHS [GM-08198] Funding Source: Medline
CR Alder H.L., 1977, INTRO PROBABILITY ST
   [Anonymous], HDB BIOL AGING
   BEGIN R, 1975, J APPL PHYSIOL, V38, P199, DOI 10.1152/jappl.1975.38.2.199
   BROWN LAS, 1984, EXP LUNG RES, V6, P133, DOI 10.3109/01902148409087901
   CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527
   CHANG WC, 1979, J STEROID BIOCHEM, V11, P889
   CLERCX C, 1989, LUNG, V167, P351, DOI 10.1007/BF02714963
   COZZA EN, 1990, J STEROID BIOCHEM, V35, P511, DOI 10.1016/0022-4731(90)90261-P
   DAS SK, 1985, 13 P INT C BIOCH, P564
   GAIL DB, 1978, RESP PHYSIOL, V33, P289, DOI 10.1016/0034-5687(78)90057-9
   GHOSH S, 1991, MOL CELL BIOCHEM, V101, P157
   GHOSH S, 1990, LIPIDS, V25, P296, DOI 10.1007/BF02544391
   GRINNA LS, 1976, FED PROC, V35, P1425
   GRINNA LS, 1972, BIOCHIM BIOPHYS ACTA, V288, P347, DOI 10.1016/0005-2736(72)90255-6
   HERBENER GH, 1976, J GERONTOL, V31, P8, DOI 10.1093/geronj/31.1.8
   JELSEMA CL, 1978, J BIOL CHEM, V253, P7960
   KARMIN O, 1989, BIOCH CELL BIOL, V67, P680
   KARNOVSKY MJ, 1979, AM J PATHOL, V97, P212
   KHAN AQ, 1985, LIPIDS, V20, P7, DOI 10.1007/BF02534355
   KING RJ, 1982, J APPL PHYSIOL, V53, P1
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Mahler D A, 1986, Clin Geriatr Med, V2, P215
   MARX JL, 1987, SCIENCE, V235, P529, DOI 10.1126/science.3810154
   MAUDERLY JL, 1979, FED PROC, V38, P173
   MCMAHON KE, 1986, J NUTR, V116, P936, DOI 10.1093/jn/116.6.936
   PAVLOV EP, 1986, J CLIN ENDOCR METAB, V62, P767, DOI 10.1210/jcem-62-4-767
   PIERI C, 1975, EXP GERONTOL, V10, P291, DOI 10.1016/0531-5565(75)90006-6
   POSSMAYER F, 1977, CAN J BIOCHEM CELL B, V55, P609, DOI 10.1139/o77-088
   RATHA BK, 1977, BIOCHEM BIOPH RES CO, V76, P925, DOI 10.1016/0006-291X(77)91590-X
   ROS MH, 1954, J FRANKLIN I, V258, P63
   SCHLAME M, 1989, MOL CELL BIOCHEM, V85, P115, DOI 10.1007/BF00577107
   SHARMA R, 1988, PHYSL BASIS AGING GE, P75
   SIKPI MO, 1987, BIOCHIM BIOPHYS ACTA, V899, P35, DOI 10.1016/0005-2736(87)90236-7
   SIKPI MO, 1984, FED PROC, V43, pA165
   SOTTOCASA GL, 1967, J CELL BIOL, V32, P415, DOI 10.1083/jcb.32.2.415
   STITH IE, 1982, BIOCHIM BIOPHYS ACTA, V714, P250, DOI 10.1016/0304-4165(82)90331-2
   TIMIRAS PS, 1988, PHYSL BASIS GERIATRI, P303
   VANCE JE, 1988, J BIOL CHEM, V263, P5898
   VANGOLDE LMG, 1976, AM REV RESPIR DIS, V114, P977
   VANGOLDE LMG, 1988, PHYSIOL REV, V68, P374, DOI 10.1152/physrev.1988.68.2.374
   WHITBOURNE SK, 1985, AGING BODY PHYSL CHA, P49
   WIESSMAN KJ, 1987, Z GERONTOL, V20, P17
NR 42
TC 5
Z9 5
U1 0
U2 0
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0300-8177
EI 1573-4919
J9 MOL CELL BIOCHEM
JI Mol. Cell. Biochem.
PD APR 7
PY 1993
VL 121
IS 1
BP 31
EP 36
DI 10.1007/BF00928697
PG 6
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA KX990
UT WOS:A1993KX99000005
PM 8389981
DA 2024-02-19
ER

PT J
AU Masetti, M
   Bianchi, G
   Gianotti, G
   Giovagnoli, M
   Vizioli, L
   Zorzi, V
   Rossi, V
   Forti, P
   Zoli, M
AF Masetti, Marco
   Bianchi, Giampaolo
   Gianotti, Giordano
   Giovagnoli, Marco
   Vizioli, Luca
   Zorzi, Veronica
   Rossi, Valentina
   Forti, Paola
   Zoli, Marco
TI Adipocyte-fatty acid binding protein and non-alcoholic fatty liver
   disease in the elderly
SO AGING CLINICAL AND EXPERIMENTAL RESEARCH
LA English
DT Article
DE Metabolic syndrome; Metaflammation; Non-alcoholic fatty liver disease
ID CORONARY-ARTERY-DISEASE; METABOLIC SYNDROME; PHYSICAL-ACTIVITY; AP2;
   ASSOCIATION; EXPRESSION
AB Background Adipocyte-fatty acid binding protein (A-FABP) is an intracellular lipid transporter that mediates metabolically triggered inflammation, and it is associated with insulin resistance, atherogenic dyslipidemia, and cardiovascular risk.
   Aims The aim of this study was to evaluate A-FABP behavior in elderly people, and especially its association with liver steatosis at abdominal ultrasound.
   Method Cross-sectional study of two cohort of individuals with and without steatosis, with assessment of several clinical and laboratory variables. Prospective evaluation of liver steatosis remodeling after six years of follow-up. One hundred and fifty-six subjects aged over 65 years were enrolled.
   Results Serum A-FABP positively correlated with body fat percentage, total cholesterol, serum triglycerides and erythrocyte sedimentation rate. Unlike expected, high A-FABP levels were associated with absence of liver steatosis, while there was no evidence of association with steatosis grade changes after 6 years of follow-up.
   Conclusion Among individuals aging more than 65 years included in the study, A-FABP was inversely associated with liver steatosis. It can be argued, that still uncovered mechanisms modify A-FABP behavior in elderly people, especially its association with multifactorial diseases.
C1 [Masetti, Marco; Bianchi, Giampaolo; Gianotti, Giordano; Giovagnoli, Marco; Vizioli, Luca; Zorzi, Veronica; Rossi, Valentina; Forti, Paola; Zoli, Marco] Univ Bologna, Dept Med & Surg Sci, S Orsola Malpighi Hosp, I-40138 Bologna, Italy.
C3 IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of
   Bologna
RP Masetti, M (corresponding author), Univ Bologna, Dept Med & Surg Sci, S Orsola Malpighi Hosp, Via Albertoni 15, I-40138 Bologna, Italy.
EM marco.masetti3@studio.unibo.it; giampaolo.bianchi@unibo.it
RI bianchi, giampaolo/AAD-6147-2021; Vizioli, Luca/GMW-8549-2022
OI Vizioli, Luca/0000-0003-2278-2181; BIANCHI,
   GIAMPAOLO/0000-0002-7675-3426; FORTI, PAOLA/0000-0001-6452-8697
FU Fondazione Cassa di Risparmio di Bologna; Regione Emilia Romagna, Piani
   per la Salute
FX The authors would like to acknowledge the technical contributions of
   Raffaela Chianese and Franca Ferri. The study was supported by grants
   from Fondazione Cassa di Risparmio di Bologna and Regione Emilia
   Romagna, Piani per la Salute.
CR Amer Diabet Assoc, 2018, DIABETES CARE, V41, pS13, DOI [10.2337/dc11-S011, 10.2337/dc18-S002, 10.2337/dc09-S062, 10.2337/dc19-S002, 10.2337/dc12-S064]
   Baar RA, 2005, AM J PHYSIOL-ENDOC M, V288, pE187, DOI 10.1152/ajpendo.00256.2004
   Bianchi G, 2008, QJM-INT J MED, V101, P713, DOI 10.1093/qjmed/hcn084
   Byrne CD, 2009, CLIN SCI, V116, P539, DOI 10.1042/CS20080253
   Cabré A, 2008, J LIPID RES, V49, P1746, DOI 10.1194/jlr.M800102-JLR200
   Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486
   Doi M, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-44
   DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060
   Elmasri H, 2009, FASEB J, V23, P3865, DOI 10.1096/fj.09-134882
   Fu YC, 2002, ATHEROSCLEROSIS, V165, P259, DOI 10.1016/S0021-9150(02)00305-2
   Fu YC, 2000, J LIPID RES, V41, P2017
   Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844
   Furuhashi M, 2011, INT J INFLAMM, V2011, DOI 10.4061/2011/642612
   Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485
   Hsu BG, 2010, CIRC J, V74, P327, DOI 10.1253/circj.CJ-09-0568
   Hui XY, 2010, J BIOL CHEM, V285, P10273, DOI 10.1074/jbc.M109.097907
   Jin J, 2010, CLIN CHIM ACTA, V411, P1761, DOI 10.1016/j.cca.2010.07.031
   Kannel WB, 1997, AM HEART J, V134, P758, DOI 10.1016/S0002-8703(97)70061-9
   Kim YC, 2011, J NUTR BIOCHEM, V22, P289, DOI 10.1016/j.jnutbio.2010.02.007
   Leite NC, 2009, LIVER INT, V29, P113, DOI 10.1111/j.1478-3231.2008.01718.x
   Makowski L, 2005, J BIOL CHEM, V280, P12888, DOI 10.1074/jbc.M413788200
   Makowski L, 2004, J NUTR, V134, p2464S, DOI 10.1093/jn/134.9.2464S
   Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076
   Morley JE, 2012, FAM PRACT, V29, pi89, DOI 10.1093/fampra/cmr054
   Muscari A, 2010, INT J GERIATR PSYCH, V25, P1055, DOI 10.1002/gps.2462
   Rhee EJ, 2009, EUR J ENDOCRINOL, V160, P165, DOI 10.1530/EJE-08-0665
   Stejskal D, 2006, EUR J CLIN INVEST, V36, P621, DOI 10.1111/j.1365-2362.2006.01696.x
   Tuncman G, 2006, P NATL ACAD SCI USA, V103, P6970, DOI 10.1073/pnas.0602178103
   Wang XQ, 2011, LIPIDS, V46, P479, DOI 10.1007/s11745-011-3542-4
   WASHBURN RA, 1993, J CLIN EPIDEMIOL, V46, P153, DOI 10.1016/0895-4356(93)90053-4
NR 30
TC 9
Z9 9
U1 0
U2 4
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1594-0667
EI 1720-8319
J9 AGING CLIN EXP RES
JI Aging Clin. Exp. Res.
PD JUN
PY 2014
VL 26
IS 3
BP 241
EP 247
DI 10.1007/s40520-013-0156-0
PG 7
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA AX2WG
UT WOS:000346802400002
PM 24150574
DA 2024-02-19
ER

PT J
AU Pottecher, J
   Kindo, M
   Chamaraux-Tran, TN
   Charles, AL
   Lejay, A
   Kemmel, V
   Vogel, T
   Chakfe, N
   Zoll, J
   Diemunsch, P
   Geny, B
AF Pottecher, Julien
   Kindo, Michel
   Chamaraux-Tran, Thien-Nga
   Charles, Anne-Laure
   Lejay, Anne
   Kemmel, Veronique
   Vogel, Thomas
   Chakfe, Nabil
   Zoll, Joffrey
   Diemunsch, Pierre
   Geny, Bernard
TI Skeletal muscle ischemia-reperfusion injury and cyclosporine A in the
   aging rat
SO FUNDAMENTAL & CLINICAL PHARMACOLOGY
LA English
DT Article
DE aging; ischemia-reperfusion injury; skeletal muscle; cyclosporine;
   mitochondria; oxidative stress
ID CRITICAL LIMB ISCHEMIA; OXIDATIVE STRESS; ISCHEMIA/REPERFUSION INJURY;
   MITOCHONDRIAL DYSFUNCTION; INDUCED DAMAGE; CARDIOPROTECTION;
   PRETREATMENT; HEARTS; LIVER; REVASCULARIZATION
AB Old patients exhibit muscle impairments and increased perioperative risk during vascular surgery procedures. Although aging generally impairs protective mechanisms, data are lacking concerning skeletal muscle in elderly. We tested whether cyclosporine A (CsA), which protects skeletal muscle from ischemia-reperfusion (IR) in young rats, might reduce skeletal muscle mitochondrial dysfunction and oxidative stress in aging rats submitted to hindlimb IR. Wistar rats aged 71-73 weeks were randomized to IR (3 h unilateral tourniquet application and 2 h reperfusion) or IR + CsA (10 mg/kg cyclosporine IV before reperfusion). Maximal oxidative capacity (V-Max), acceptor control ratio (ACR), and relative contribution of the mitochondrial respiratory chain complexes II, III, IV (V-Succ), and IV (V-TMPD/Asc), together with calcium retention capacity (CRC) a marker of apoptosis, and tissue reactive oxygen species (ROS) production were determined in gastrocnemius muscles from both hindlimbs. Compared to the nonischemic hindlimb, IR significantly reduced mitochondrial coupling, V-Max (from 7.34 +/- 1.50 to 2.87 +/- 1.22 MO2/min/g; P < 0.05; -70%), and V-Succ (from 6.14 +/- 1.07 to 3.82 +/- 0.83 MO2/min/g; P < 0.05; -42%) but not V-TMPD/(Asc). IR also decreased the CRC from 15.58 +/- 3.85 to 6.19 +/- 0.86 MCa2+/min/g; P < 0.05; -42%). These alterations were not corrected by CsA (-77%, -49%, and -32% after IR for V-Max,V- V-Succ, and CRC, respectively). Further, CsA significantly increased ROS production in both hindlimbs (P < 0.05; +73%). In old rats, hindlimb IR impairs skeletal muscle mitochondrial function and increases oxidative stress. Cyclosporine A did not show protective effects.
C1 [Pottecher, Julien; Kindo, Michel; Chamaraux-Tran, Thien-Nga; Charles, Anne-Laure; Lejay, Anne; Vogel, Thomas; Chakfe, Nabil; Zoll, Joffrey; Diemunsch, Pierre; Geny, Bernard] Univ Strasbourg, Federat Med Translat FMTS, Fac Med, Inst Physiol,Equipe Accueil Mitochondrie Stress O, Strasbourg, France.
   [Pottecher, Julien; Chamaraux-Tran, Thien-Nga; Diemunsch, Pierre] Hop Univ Strasbourg, Hop Hautepierre, Serv Anesthesie Reanimat Chirurg, Pole Anesthesie Reanimat Chirurg SAMU, Strasbourg, France.
   [Kindo, Michel] Hop Univ Strasbourg, Serv Chirurg Cardiovasc, Strasbourg, France.
   [Charles, Anne-Laure; Zoll, Joffrey; Geny, Bernard] Hop Univ Strasbourg, Serv Physiol & Explorat Fonct, Strasbourg, France.
   [Lejay, Anne; Chakfe, Nabil] Hop Univ Strasbourg, Serv Chirurg Vasc & Transplantat Renale, Strasbourg, France.
   [Kemmel, Veronique] Hopitaux Univ Strasbourg, Hop Hautepierre, Lab Biochim & Biol Mole, Strasbourg, France.
   [Kemmel, Veronique] Univ Strasbourg, Fac Med, Unite Physiopathol & Med Translat, Equipe Accueil EA4438, Strasbourg, France.
   [Vogel, Thomas] Hop Univ Strasbourg, Pole Geriatrie, Strasbourg, France.
C3 Universites de Strasbourg Etablissements Associes; Universite de
   Strasbourg; CHU Strasbourg; Universites de Strasbourg Etablissements
   Associes; Universite de Strasbourg; CHU Strasbourg; Universites de
   Strasbourg Etablissements Associes; Universite de Strasbourg;
   Universites de Strasbourg Etablissements Associes; Universite de
   Strasbourg; CHU Strasbourg; Universites de Strasbourg Etablissements
   Associes; Universite de Strasbourg; CHU Strasbourg; Universites de
   Strasbourg Etablissements Associes; Universite de Strasbourg; CHU
   Strasbourg; Universites de Strasbourg Etablissements Associes;
   Universite de Strasbourg; CHU Strasbourg; Universites de Strasbourg
   Etablissements Associes; Universite de Strasbourg
RP Geny, B (corresponding author), Univ Strasbourg, Federat Med Translat FMTS, Fac Med, Inst Physiol,Equipe Accueil Mitochondrie Stress O, Strasbourg, France.; Geny, B (corresponding author), Hop Univ Strasbourg, Serv Physiol & Explorat Fonct, Strasbourg, France.
EM bernard.geny@chru-strasbourg.fr
RI Kemmel, Veronique/O-9018-2015; Pottecher, Julien/AAH-1572-2020; Kemmel,
   Véronique/V-2590-2019; Chamaraux-Tran, Thien-Nga/L-8258-2018
OI Kemmel, Veronique/0000-0003-4680-4293; Kemmel,
   Véronique/0000-0003-4680-4293; Pottecher, Julien/0000-0001-6073-4354;
   Chamaraux-Tran, Thien-Nga/0000-0001-9036-477X
CR Bailey CE, 2011, AGING-US, V3, P1003, DOI 10.18632/aging.100394
   Ballotta Enzo, 2007, Ann Vasc Surg, V21, P772, DOI 10.1016/j.avsg.2007.04.005
   Boengler K, 2009, CARDIOVASC RES, V83, P247, DOI 10.1093/cvr/cvp033
   Böning A, 2015, EXP GERONTOL, V67, P3, DOI 10.1016/j.exger.2015.04.012
   Bouitbir J, 2012, EUR HEART J, V33, P1397, DOI 10.1093/eurheartj/ehr224
   Chen Qun, 2012, J Aging Res, V2012, P753949, DOI 10.1155/2012/753949
   Collange O, 2011, ANESTH ANALG, V113, P1438, DOI 10.1213/ANE.0b013e3182367a10
   Cung TT, 2015, NEW ENGL J MED, V373, P1021, DOI 10.1056/NEJMoa1505489
   De Paulis D, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0379-4
   Ferdinandy P, 2014, PHARMACOL REV, V66, P1142, DOI 10.1124/pr.113.008300
   Garbaisz D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101067
   GRIFFITHS EJ, 1993, J MOL CELL CARDIOL, V25, P1461, DOI 10.1006/jmcc.1993.1162
   Guillot M, 2014, J VASC SURG, V60, P1043, DOI 10.1016/j.jvs.2013.07.100
   Hammers DW, 2008, J APPL PHYSIOL, V105, P1274, DOI 10.1152/japplphysiol.90418.2008
   Hiatt WR, 2015, CIRC RES, V116, P1527, DOI 10.1161/CIRCRESAHA.116.303566
   HOKANSON JF, 1995, AM J RESP CRIT CARE, V151, P1848, DOI 10.1164/ajrccm.151.6.7767529
   Huda R, 2004, CLIN SCI, V107, P497, DOI 10.1042/CS20040179
   Huhn R, 2008, BRIT J ANAESTH, V100, P465, DOI 10.1093/bja/aen022
   Huhn R, 2010, NUTR METAB CARDIOVAS, V20, P706, DOI 10.1016/j.numecd.2009.06.010
   Kato J, 2014, NEPHRON EXP NEPHROL, V126, P183, DOI 10.1159/000362555
   Koca K, 2011, J TRAUMA, V70, P717, DOI 10.1097/TA.0b013e3181f30fb0
   La Monaca E, 2012, CURR DRUG SAF, V7, P126, DOI 10.2174/157488612802715681
   Lejay A, 2012, EUR J VASC ENDOVASC, V44, P562, DOI 10.1016/j.ejvs.2012.09.007
   Lejay A, 2014, INT J BIOCHEM CELL B, V50, P101, DOI 10.1016/j.biocel.2014.02.013
   Mamou Z, 2015, FUND CLIN PHARMACOL, V29, P21, DOI 10.1111/fcp.12070
   Mansour Z, 2012, J VASC SURG, V55, P497, DOI 10.1016/j.jvs.2011.07.084
   Matsubara Y, 2015, J VASC SURG, V61, P945, DOI 10.1016/j.jvs.2014.10.094
   McAllister SE, 2008, AM J PHYSIOL-REG I, V295, pR681, DOI 10.1152/ajpregu.90303.2008
   Molpeceres J, 2000, INT J PHARMACEUT, V197, P129, DOI 10.1016/S0378-5173(99)00461-5
   N'Guessan BB, 2014, FUND CLIN PHARMACOL, V28, P151, DOI 10.1111/fcp.12002
   Paillard M, 2009, J MOL CELL CARDIOL, V46, P902, DOI 10.1016/j.yjmcc.2009.02.017
   Palomero J, 2001, FREE RADICAL BIO MED, V30, P836, DOI 10.1016/S0891-5849(01)00471-3
   Penna C, 2008, BASIC RES CARDIOL, V103, P368, DOI 10.1007/s00395-007-0695-7
   Piot C, 2008, NEW ENGL J MED, V359, P473, DOI 10.1056/NEJMoa071142
   Pottecher J, 2016, NEW ENGL J MED, V374, P88, DOI 10.1056/NEJMc1514192
   Pottecher J, 2013, J VASC SURG, V57, P1100, DOI 10.1016/j.jvs.2012.09.020
   Rezzani R, 2006, HISTOL HISTOPATHOL, V21, P301, DOI 10.14670/HH-21.301
   Saarinen E, 2015, EUR J VASC ENDOVASC, V49, P420, DOI 10.1016/j.ejvs.2014.12.027
   Sniecinski R, 2004, ANESTHESIOLOGY, V100, P589, DOI 10.1097/00000542-200403000-00019
   Talha S, 2013, J APPL PHYSIOL, V114, P172, DOI 10.1152/japplphysiol.00239.2012
   Thaveau F, 2007, J VASC SURG, V46, P541, DOI 10.1016/j.jvs.2007.04.075
   Thaveau F, 2010, FUND CLIN PHARMACOL, V24, P333, DOI 10.1111/j.1472-8206.2009.00763.x
   Thaveau F, 2009, J SURG RES, V155, P65, DOI 10.1016/j.jss.2008.08.001
   Thompson JR, 2015, ANN SURG, V261, P605, DOI 10.1097/SLA.0000000000000643
   Tran TP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043410
   Troitzsch D, 2013, SHOCK, V39, P220, DOI 10.1097/SHK.0b013e31828044f6
   Vessey DA, 2009, OXID MED CELL LONGEV, V2, P146, DOI 10.4161/oxim.2.3.8622
   Vogel TR, 2014, J VASC SURG, V59, P350, DOI 10.1016/j.jvs.2013.08.087
   Wojtovich AP, 2012, EXP GERONTOL, V47, P1, DOI 10.1016/j.exger.2011.11.001
NR 49
TC 15
Z9 15
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0767-3981
EI 1472-8206
J9 FUND CLIN PHARMACOL
JI Fundam. Clin. Pharmacol.
PD JUN
PY 2016
VL 30
IS 3
BP 216
EP 225
DI 10.1111/fcp.12180
PG 10
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA DM2BN
UT WOS:000376151100002
PM 26787364
DA 2024-02-19
ER

PT J
AU Chaurasia, P
   Mukherjee, S
   Thakur, MK
AF Chaurasia, P
   Mukherjee, S
   Thakur, MK
TI Age-related analysis of EcoRI generated satellite DNA-containing
   chromatin of rat liver
SO BIOCHEMISTRY AND MOLECULAR BIOLOGY INTERNATIONAL
LA English
DT Article
DE aging; satellite DNA; soluble chromatin; histone; rat liver
ID NUCLEOTIDE-SEQUENCE; SOLUBLE CHROMATIN; H-1; HISTONES; DOMAINS;
   HETEROCHROMATIN; ORGANIZATION; NUCLEOSOMES; REPRESSION; SITES
AB EcoRI digestion of nuclei and their subsequent lysis with EDTA solubilizes 45% and 36% of chromatin DNA from the liver of young (18+/-2 weeks) and old (100+/-5 weeks) rats, respectively. After hybridization with 185 bp rat satellite I DNA, these soluble fractions are found to be enriched in specific DNA sequences such as satellite DNA. Besides regular repeat pattern, a major portion of the satellite chromatin forms higher order organization. Digestion kinetics confirms condensation of satellite DNA-containing chromatin similar to that of bulk chromatin in old age. Furthermore, densitometric scanning of the slot-blot of soluble chromatin fractions reveals loss of satellite DNA in the old. However, an increase in the linker histone H1 and its subfraction H1(0) in the satellite DNA-enriched fraction of chromatin from old rats suggests greater compaction. These results provide the first evidence that the satellite DNA-containing chromatin differs in the liver of young and old rats.
C1 BANARAS HINDU UNIV,CTR ADV STUDY ZOOL,BIOCHEM & MOL BIOL LAB,VARANASI 221005,UTTAR PRADESH,INDIA.
C3 Banaras Hindu University (BHU)
CR ALLAN J, 1986, J MOL BIOL, V187, P591, DOI 10.1016/0022-2836(86)90337-2
   Ausubel FM, 1995, SHORT PROTOCOLS MOL
   BOCK H, 1984, J MOL BIOL, V176, P131, DOI 10.1016/0022-2836(84)90385-1
   BURGOYNE LA, 1978, CELL NUCLEUS, V4, P48
   COLE RD, 1987, INT J PEPT PROT RES, V30, P433
   ELGIN SCR, 1970, BIOCHEMISTRY-US, V9, P4440, DOI 10.1021/bi00824a027
   HARLEY CB, 1991, MUTAT RES, V256, P271, DOI 10.1016/0921-8734(91)90018-7
   HORZ W, 1976, NUCLEIC ACIDS RES, V3, P3213, DOI 10.1093/nar/3.11.3213
   IGOKEMENES T, 1977, NUCLEIC ACIDS RES, V4, P3387, DOI 10.1093/nar/4.10.3387
   IGOKEMENES T, 1982, ANNU REV BIOCHEM, V51, P89, DOI 10.1146/annurev.bi.51.070182.000513
   IGOKEMENES T, 1985, STRUCTURE FUNCTION G, P55
   LENNARD AC, 1985, EMBO J, V4, P3455, DOI 10.1002/j.1460-2075.1985.tb04104.x
   LEVYWILSON B, 1988, MOL CELL BIOL, V8, P71, DOI 10.1128/MCB.8.1.71
   MATHEW CGP, 1981, FEBS LETT, V125, P25, DOI 10.1016/0014-5793(81)80988-X
   MEDVEDEV ZA, 1978, GERONTOLOGY, V24, P286, DOI 10.1159/000212261
   MILLER JR, 1978, CELL, V13, P717
   MUSICH PR, 1977, P NATL ACAD SCI USA, V74, P3297, DOI 10.1073/pnas.74.8.3297
   OMORI A, 1980, NUCLEIC ACIDS RES, V8, P5363, DOI 10.1093/nar/8.22.5363
   PANYIM S, 1969, BIOCHEM BIOPH RES CO, V37, P1042, DOI 10.1016/0006-291X(69)90237-X
   PECH M, 1979, NUCLEIC ACIDS RES, V7, P417, DOI 10.1093/nar/7.2.417
   SANDALTZOPOULOS R, 1994, EMBO J, V13, P373, DOI 10.1002/j.1460-2075.1994.tb06271.x
   SEALY L, 1981, J MOL BIOL, V145, P291, DOI 10.1016/0022-2836(81)90207-2
   SOLLNERWEBB B, 1977, CELL, V10, P537, DOI 10.1016/0092-8674(77)90040-X
   SUGIMOTO K, 1994, J BIOL CHEM, V269, P24271
   THOMA F, 1983, J MOL BIOL, V167, P619, DOI 10.1016/S0022-2836(83)80102-8
   WOLFFE AP, 1989, EMBO J, V8, P527, DOI 10.1002/j.1460-2075.1989.tb03407.x
   YUNIS JJ, 1970, SCIENCE, V168, P263, DOI 10.1126/science.168.3928.263
   ZHANG XY, 1982, NUCLEIC ACIDS RES, V10, P1481, DOI 10.1093/nar/10.5.1481
   ZLATANOVA J, 1992, J CELL SCI, V103, P889
NR 29
TC 3
Z9 3
U1 0
U2 1
PU ACADEMIC PRESS AUST
PI MARRICKVILLE
PA LOCKED BAG 16, MARRICKVILLE NSW 2204, AUSTRALIA
SN 1039-9712
J9 BIOCHEM MOL BIOL INT
JI Biochem. Mol. Biol. Int.
PD DEC
PY 1996
VL 40
IS 6
BP 1261
EP 1270
PG 10
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA WA576
UT WOS:A1996WA57600021
PM 8988339
DA 2024-02-19
ER

PT J
AU Enderlin, V
   Alfos, S
   Pallet, V
   Garcin, H
   AzaisBraesco, V
   Jaffard, R
   Higueret, P
AF Enderlin, V
   Alfos, S
   Pallet, V
   Garcin, H
   AzaisBraesco, V
   Jaffard, R
   Higueret, P
TI Aging decreases the abundance of retinoic acid (RAR) and
   triiodothyronine (TR) nuclear receptor mRNA in rat brain: effect of the
   administration of retinoids
SO FEBS LETTERS
LA English
DT Article
DE aging; nuclear receptor; RAR; TR; mRNA; retinoid
ID THYROID-HORMONE RECEPTORS; CENTRAL-NERVOUS-SYSTEM; MESSENGER-RNA; TISSUE
   TRANSGLUTAMINASE; GENE-EXPRESSION; LIVER; ALPHA; DIFFERENTIATION;
   HIPPOCAMPUS; PROTEIN
AB Aging is accompanied by troubles resulting from changes in hormonal and nutritional status, Therefore, the abundance of mRNA coding for triiodothyronine (TR) and retinoic acid (EW) nuclear receptors was studied in the brain of young, adult and aged (2.5, 6 and 24 months, respectively) rats, In the brain of aged rats, there mas a lower abundance of TR and RAR mRNA and a loner activity of tissue transglutaminase (tTG), an enzyme the gene of which is a target for retinoids, Administration of RA in these rats restored TR and RAR mRNA and the activity of tTG in the brain, The importance of these observations to the function of the aged brain is discussed. (C) 1997 Federation of European Biochemical Societies.
C1 UNIV BORDEAUX 1, ISTAB, LAB NUTR, F-33405 TALENCE, FRANCE.
   INRA, CTR RECH NUTR HUMAINE, F-63009 CLERMONT FERRAND, FRANCE.
   UNIV BORDEAUX 1, LAB NEUROSCI COMPORTEMENTALES & COGNIT, F-33405 TALENCE, FRANCE.
C3 Universite de Bordeaux; INRAE; Universite de Bordeaux
OI ALFOS, Serge/0000-0001-7092-4370
CR Alfos S, 1996, NEUROSCI LETT, V206, P73, DOI 10.1016/S0304-3940(96)12455-1
   BERNAL J, 1995, EUR J ENDOCRINOL, V133, P390, DOI 10.1530/eje.0.1330390
   BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0
   BRENT G A, 1989, New Biologist, V1, P329
   CHELLY J, 1990, EUR J BIOCHEM, V187, P691, DOI 10.1111/j.1432-1033.1990.tb15355.x
   CHIOCCA EA, 1989, J CELL BIOCHEM, V39, P293, DOI 10.1002/jcb.240390309
   COOK CB, 1990, MOL CELL ENDOCRINOL, V70, P13, DOI 10.1016/0303-7207(90)90054-C
   Coustaut M, 1996, BRIT J NUTR, V76, P295, DOI 10.1079/BJN19960033
   DECOURCY GP, 1989, SCI ALIMENT, V9, P209
   DENAYER P, 1991, HORM METAB RES, V23, P12, DOI 10.1055/s-2007-1003600
   DEV S, 1993, BRAIN RES, V632, P325, DOI 10.1016/0006-8993(93)91170-W
   DICE JF, 1988, LIVER BIOL PATHOBIOL, P1245
   DONG JM, 1990, BIOCHEM BIOPH RES CO, V170, P147, DOI 10.1016/0006-291X(90)91252-N
   DURSTON AJ, 1989, NATURE, V340, P140, DOI 10.1038/340140a0
   EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939
   FROLKIS VV, 1978, GERONTOLOGY, V24, P81, DOI 10.1159/000212240
   Glass CK, 1996, J ENDOCRINOL, V150, P349, DOI 10.1677/joe.0.1500349
   INIGUEZ MA, 1993, ENDOCRINOLOGY, V133, P467, DOI 10.1210/en.133.2.467
   INIGUEZ MA, 1994, MOL BRAIN RES, V27, P205, DOI 10.1016/0169-328X(94)90002-7
   LEBEL JM, 1993, GLIA, V9, P105, DOI 10.1002/glia.440090203
   MURRAY MB, 1988, J BIOL CHEM, V263, P12770
   NUDEL U, 1983, NUCLEIC ACIDS RES, V11, P1759, DOI 10.1093/nar/11.6.1759
   OLSEN T, 1978, J CLIN ENDOCR METAB, V47, P1111, DOI 10.1210/jcem-47-5-1111
   PAILLERRODDE I, 1991, FEBS LETT, V289, P33, DOI 10.1016/0014-5793(91)80902-F
   PALLET V, 1994, EUR J ENDOCRINOL, V131, P377, DOI 10.1530/eje.0.1310377
   PETKOVICH M, 1987, NATURE, V330, P444, DOI 10.1038/330444a0
   PIACENTINI M, 1986, BIOCHEM J, V234, P435, DOI 10.1042/bj2340435
   ROGUE PJ, 1993, FEBS LETT, V334, P351, DOI 10.1016/0014-5793(93)80710-C
   SUTHERLAND MK, 1992, NEUROBIOL AGING, V13, P301, DOI 10.1016/0197-4580(92)90043-W
   VERMA AK, 1992, J NUTR, V122, P2144, DOI 10.1093/jn/122.11.2144
   YAGAMATA T, 1993, BIOMED RES, V14, P183
   ZELENT A, 1989, NATURE, V339, P714, DOI 10.1038/339714a0
   ZETTERSTROM RH, 1994, NEUROSCIENCE, V62, P899, DOI 10.1016/0306-4522(94)90482-0
   ZHANG XK, 1992, NATURE, V355, P441, DOI 10.1038/355441a0
NR 34
TC 31
Z9 34
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1873-3468
J9 FEBS LETT
JI FEBS Lett.
PD AUG 4
PY 1997
VL 412
IS 3
BP 629
EP 632
DI 10.1016/S0014-5793(97)00845-4
PG 4
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA XQ605
UT WOS:A1997XQ60500045
PM 9276480
OA Bronze
DA 2024-02-19
ER

PT J
AU Unal, D
   Aksak, S
   Halici, Z
   Sengul, O
   Polat, B
   Unal, B
   Halici, M
AF Unal, Deniz
   Aksak, Selina
   Halici, Zekai
   Sengul, Ozlem
   Polat, Beyzagul
   Unal, Bunyami
   Halici, Mesut
TI Effects of diabetes mellitus on the rat liver during the postmenopausal
   period
SO JOURNAL OF MOLECULAR HISTOLOGY
LA English
DT Article
DE Aging; Diabetes; Oxidative stress; Rat; Liver; Stereology
ID OXIDATIVE STRESS; LIPID-PEROXIDATION; INSULIN-RESISTANCE;
   PINEALECTOMIZED RATS; ESTROGEN; ESTRADIOL; ALPHA; ANTIOXIDANT;
   RALOXIFENE; TISSUE
AB The present study investigated whether diabetes worsened the onset of liver injury/damage during the ovariectomized (OVX)-induced postmenopausal period in rats. Diabetes results in severe complications in humans, such as liver failure. Estrogen and its derivatives are medically acceptable, powerful antioxidant agents that can enable liver and other important organs to defend themselves against oxidative related injury. Estrogen deficiency, which occurs in the postmenopausal period and in individuals with diabetes, may play a significant role in the progression of liver failure. In the present study, rats were divided into four groups: control (Group I), diabetic (Group II), ovariectomy (Group III) and ovariectomy plus diabetes (Group IV). After the experiments, quantitative histopathological and immunohistochemical changes in liver were detected using light microscopy and modern stereological systems. Histopathological examinations showed that there were many necrotic and apoptotic hepatocytes in the lobules of Group II. In addition, there were a larger number of necrotic cells in Group III than Group II. In contrast to Group II, there were also apoptotic cells in the portal areas in Group III. Moreover, evidence of liver injury was higher in the sections of Group IV compared with all other groups. In biochemical findings, there were statistically significant differences between all the groups (P < 0.001) for catalase (CAT), glutathione peroxidase (GSH) and myeloperoxidase (MPx) activity. In addition, the amount of lipid peroxidation (LPO) was significantly different between groups. In stereological results, there were significant differences between Groups I and II and Groups II and IV. The present study provided novel insight into the pernicious effects of ovariectomy on liver injury following the onset of diabetes. Indeed, the present study found that increases in liver oxidative activity in OVX rats following the onset of diabetes correlates with elevated MPx, LPO and histopathological changes in rat liver.
C1 [Halici, Zekai; Polat, Beyzagul] Ataturk Univ, Dept Pharmacol, Fac Med, TR-25240 Erzurum, Turkey.
   [Unal, Deniz; Aksak, Selina; Unal, Bunyami] Ataturk Univ, Dept Histol & Embryol, Fac Med, TR-25240 Erzurum, Turkey.
   [Sengul, Ozlem] Yenimahalle Govt Hosp, Dept Gynecol & Obstet, Ankara, Turkey.
   [Halici, Mesut] Ataturk Univ, Dept Biochem, Fac Vet, TR-25240 Erzurum, Turkey.
C3 Ataturk University; Ataturk University; Ankara Yenimahalle Training &
   Research Hospital; Ataturk University
RP Halici, Z (corresponding author), Ataturk Univ, Dept Pharmacol, Fac Med, TR-25240 Erzurum, Turkey.
EM hzekai@atauni.edu.tr
RI halici, zekai/HKN-9826-2023; HALICI, Mesut Bunyami/F-2886-2012; polat,
   beyzagul/G-6010-2012
OI HALICI, Mesut Bunyami/0000-0002-7473-2955; polat,
   beyzagul/0000-0003-2042-5949
CR AEBI H, 1984, METHOD ENZYMOL, V105, P121
   Albayrak A, 2011, J SURG RES, V169, P67, DOI 10.1016/j.jss.2009.09.055
   Altunkaynak ME, 2009, KAFKAS UNIV VET FAK, V15, P687
   Arteaga E, 2003, MENOPAUSE, V10, P142, DOI 10.1097/00042192-200310020-00005
   Bernardi F, 2003, ANN NY ACAD SCI, V997, P378, DOI 10.1196/annals.1290.041
   Borrás C, 2003, FREE RADICAL BIO MED, V34, P546, DOI 10.1016/S0891-5849(02)01356-4
   BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462
   Cadirci E, 2010, N-S ARCH PHARMACOL, V381, P455, DOI 10.1007/s00210-010-0504-y
   Cadirci E, 2010, SHOCK, V33, P479, DOI 10.1097/SHK.0b013e3181c3cf0e
   Cavadas LF, 2010, ACTA MEDICA PORT, V23, P227
   Chen JQ, 2005, BBA-MOL CELL RES, V1746, P1, DOI 10.1016/j.bbamcr.2005.08.001
   Forgiarini LA, 2009, J BRAS PNEUMOL, V35, P788, DOI 10.1590/S1806-37132009000800011
   Ginsberg HN, 2000, J CLIN INVEST, V106, P453, DOI 10.1172/JCI10762
   Gray Trevor, 1996, P641
   Halici Z, 2009, EUR J PHARMACOL, V614, P146, DOI 10.1016/j.ejphar.2009.04.042
   Hao LK, 2010, EUR J APPL PHYSIOL, V109, P879, DOI 10.1007/s00421-010-1426-6
   Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842
   Karakus B, 2009, PHYTOTHER RES, V23, P635, DOI 10.1002/ptr.2675
   Kharode Yogendra P., 2008, V455, P111, DOI 10.1007/978-1-59745-104-8_8
   Kireev RA, 2007, BIOGERONTOLOGY, V8, P469, DOI 10.1007/s10522-007-9089-3
   Kireev RA, 2010, BIOGERONTOLOGY, V11, P229, DOI 10.1007/s10522-009-9242-2
   Kulkarni RN, 2004, J CLIN INVEST, V114, P828, DOI 10.1172/JCI200421845
   Kumru S, 2005, GYNECOL OBSTET INVES, V59, P108, DOI 10.1159/000082647
   Maddux BA, 2001, DIABETES, V50, P404, DOI 10.2337/diabetes.50.2.404
   MAYES PA, 2003, HARPERS ILLUSTRATED, V26, P86
   Mendelsohn ME, 1999, NEW ENGL J MED, V340, P1801, DOI 10.1056/NEJM199906103402306
   Moreira PI, 2007, TOXICOL APPL PHARM, V221, P102, DOI 10.1016/j.taap.2007.02.006
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   Özgönül M, 2003, ENDOCR RES, V29, P183, DOI 10.1081/ERC-120022299
   Oztekin E, 2007, CELL BIOCHEM FUNCT, V25, P551, DOI 10.1002/cbf.1360
   Oztekin E, 2007, CELL BIOCHEM FUNCT, V25, P401, DOI 10.1002/cbf.1313
   Paquette A, 2007, MOL CELL BIOCHEM, V306, P179, DOI 10.1007/s11010-007-9568-5
   Riant E, 2009, ENDOCRINOLOGY, V150, P2109, DOI 10.1210/en.2008-0971
   Rogers NH, 2009, ENDOCRINOLOGY, V150, P2161, DOI 10.1210/en.2008-1405
   Saengsirisuwan V, 2009, METABOLISM, V58, P38, DOI 10.1016/j.metabol.2008.08.004
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4
   Shimizu I, 2003, LIVER INT, V23, P63, DOI 10.1034/j.1600-0676.2003.00811.x
   Simm P J, 2008, Pediatr Endocrinol Rev, V6, P32
   Solakidi S., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P240
   STERIO DC, 1984, J MICROSC-OXFORD, V134, P127, DOI 10.1111/j.1365-2818.1984.tb02501.x
   Stevenson M, 2005, HEALTH TECHNOL ASSES, V9, P1
   SUN Y, 1988, CLIN CHEM, V34, P497
   Uyanik A, 2010, RENAL FAILURE, V32, P592, DOI 10.3109/08860221003759478
   Uyanik A, 2009, RENAL FAILURE, V31, P573, DOI 10.1080/08860220903060776
   Vom Saal Frederick S., 1994, P1213
   West IC, 2000, DIABETIC MED, V17, P171, DOI 10.1046/j.1464-5491.2000.00259.x
NR 47
TC 14
Z9 14
U1 0
U2 12
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1567-2379
EI 1567-2387
J9 J MOL HISTOL
JI J. Mol. Histol.
PD JUN
PY 2011
VL 42
IS 3
BP 273
EP 287
DI 10.1007/s10735-011-9331-9
PG 15
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA 793QP
UT WOS:000292838500008
PM 21604006
DA 2024-02-19
ER

PT J
AU Stader, F
   Siccardi, M
   Battegay, M
   Kinvig, H
   Penny, MA
   Marzolini, C
AF Stader, Felix
   Siccardi, Marco
   Battegay, Manuel
   Kinvig, Hannah
   Penny, Melissa A.
   Marzolini, Catia
TI Repository Describing an Aging Population to Inform Physiologically
   Based Pharmacokinetic Models Considering Anatomical, Physiological, and
   Biological Age-Dependent Changes
SO CLINICAL PHARMACOKINETICS
LA English
DT Article
ID CEREBRAL-BLOOD-FLOW; NORMAL ORGAN WEIGHTS; TOTAL-BODY WATER;
   GLOMERULAR-FILTRATION-RATE; ALPHA-1 ACID GLYCOPROTEIN; METABOLIC-DRUG
   CLEARANCE; HUMAN MICROSOMAL PROTEIN; HUMAN LIVER-MICROSOMES;
   CROSS-SECTIONAL SURVEY; SKELETAL-MUSCLE MASS
AB BackgroundAging is characterized by anatomical, physiological, and biological changes that can impact drug kinetics. The elderly are often excluded from clinical trials and knowledge about drug kinetics and drug-drug interaction magnitudes is sparse. Physiologically based pharmacokinetic modeling can overcome this clinical limitation but detailed descriptions of the population characteristics are essential to adequately inform models.ObjectiveThe objective of this study was to develop and verify a population database for aging Caucasians considering anatomical, physiological, and biological system parameters required to inform a physiologically based pharmacokinetic model that included population variability.MethodsA structured literature search was performed to analyze age-dependent changes of system parameters. All collated data were carefully analyzed, and descriptive mathematical equations were derived.ResultsA total of 362 studies were found of which 318 studies were included in the analysis as they reported rich data for anthropometric parameters and specific organs (e.g., liver). Continuous functions could be derived for most system parameters describing a Caucasian population from 20 to 99years of age with variability. Areas with sparse data were identified such as tissue composition, but knowledge gaps were filled with plausible qualified assumptions. The developed population was implemented in Matlab((R)) and estimated system parameters from 1000 virtual individuals were in accordance with independent observed data showing the robustness of the developed population.ConclusionsThe developed repository for aging subjects provides a singular specific source for key system parameters needed for physiologically based pharmacokinetic modeling and can in turn be used to investigate drug kinetics and drug-drug interaction magnitudes in the elderly.
C1 [Stader, Felix; Battegay, Manuel; Marzolini, Catia] Univ Hosp Basel, Div Infect Dis & Hosp Epidemiol, Dept Med, Basel, Switzerland.
   [Stader, Felix; Battegay, Manuel; Marzolini, Catia] Univ Hosp Basel, Div Infect Dis & Hosp Epidemiol, Dept Clin Res, Basel, Switzerland.
   [Stader, Felix; Penny, Melissa A.] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Infect Dis Modelling Unit, Basel, Switzerland.
   [Stader, Felix; Battegay, Manuel; Penny, Melissa A.; Marzolini, Catia] Univ Basel, Basel, Switzerland.
   [Siccardi, Marco; Kinvig, Hannah] Univ Liverpool, Inst Translat Med, Dept Mol & Clin Pharmacol, Liverpool, Merseyside, England.
C3 University of Basel; University of Basel; University of Basel; Swiss
   Tropical & Public Health Institute; University of Basel; University of
   Liverpool
RP Stader, F (corresponding author), Univ Hosp Basel, Div Infect Dis & Hosp Epidemiol, Dept Med, Basel, Switzerland.; Stader, F (corresponding author), Univ Hosp Basel, Div Infect Dis & Hosp Epidemiol, Dept Clin Res, Basel, Switzerland.; Stader, F (corresponding author), Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Infect Dis Modelling Unit, Basel, Switzerland.; Stader, F (corresponding author), Univ Basel, Basel, Switzerland.
EM Felix.Stader@unibas.ch
RI Marzolini, Catia/C-8253-2019; Penny, Melissa A/N-6838-2015
OI Penny, Melissa A/0000-0002-4972-593X
FU Swiss National Foundation [166204]; OPO Foundation; Isaac Dreyfus
   Foundation
FX This study was supported by the Swiss National Foundation (Grant No.
   166204), the OPO Foundation, and the Isaac Dreyfus Foundation.
CR Abduljalil K, 2014, AAPS J, V16, P568, DOI 10.1208/s12248-014-9592-9
   Achour B, 2014, DRUG METAB DISPOS, V42, P1349, DOI 10.1124/dmd.114.058834
   Achour B, 2014, DRUG METAB DISPOS, V42, P500, DOI 10.1124/dmd.113.055632
   AMERY A, 1969, AM HEART J, V78, P211, DOI 10.1016/0002-8703(69)90010-6
   Andersson J, 2012, INT J OBESITY, V36, P783, DOI 10.1038/ijo.2011.152
   [Anonymous], EUR
   [Anonymous], HIV PEOPL AG 50
   [Anonymous], DTSCH Z GESAMTE GERI
   [Anonymous], PERM RES POP AG SEX
   [Anonymous], PHYSL REP
   [Anonymous], MIKR GES KORP BEV
   Baliga RR, 1998, CIRCULATION, V97, P1144, DOI 10.1161/01.CIR.97.12.1144
   Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2
   Bartali B, 2002, SOZ PRAVENTIV MED, V47, P336, DOI 10.1007/PL00012644
   Barter ZE, 2008, DRUG METAB DISPOS, V36, P2405, DOI 10.1124/dmd.108.021311
   Barter ZE, 2007, CURR DRUG METAB, V8, P33, DOI 10.2174/138920007779315053
   Barter ZE, 2013, CLIN PHARMACOKINET, V52, P1085, DOI 10.1007/s40262-013-0089-y
   BAUER JH, 1982, ARCH INTERN MED, V142, P1317, DOI 10.1001/archinte.142.7.1317
   Bedogni G, 2001, OBES RES, V9, P17, DOI 10.1038/oby.2001.3
   BENDER AD, 1968, J AM GERIATR SOC, V16, P1331, DOI 10.1111/j.1532-5415.1968.tb02776.x
   BERGMANN SR, 1989, J AM COLL CARDIOL, V14, P639, DOI 10.1016/0735-1097(89)90105-8
   Bertsch K, 2009, BRAIN RES, V1267, P77, DOI 10.1016/j.brainres.2009.02.053
   BLAIN PG, 1985, BRIT J CLIN PHARMACO, V20, P500, DOI 10.1111/j.1365-2125.1985.tb05107.x
   BODDY K, 1972, J CLIN PATHOL, V25, P512, DOI 10.1136/jcp.25.6.512
   Bosy-Westhal A, 2003, EUR J NUTR, V42, P207, DOI 10.1007/s00394-003-0416-4
   BRANDFONBRENER M, 1955, CIRCULATION, V12, P557, DOI 10.1161/01.CIR.12.4.557
   BROWN E, 1962, J CLIN INVEST, V41, P2182, DOI 10.1172/JCI104677
   BRUCE A, 1980, SCAND J CLIN LAB INV, V40, P461, DOI 10.3109/00365518009101869
   Burnham K.P., 2003, MODEL SELECTION MULT, DOI DOI 10.1007/B97636
   Burt HJ, 2016, DRUG METAB DISPOS, V44, P1550, DOI 10.1124/dmd.116.071183
   CALLOWAY NO, 1965, J AM GERIATR SOC, V13, P20, DOI 10.1111/j.1532-5415.1965.tb00569.x
   CAMPION EW, 1988, J GERONTOL, V43, pM18, DOI 10.1093/geronj/43.1.M18
   CARLISLE KM, 1992, GUT, V33, P92, DOI 10.1136/gut.33.1.92
   CASTLEDEN CM, 1979, BRIT J CLIN PHARMACO, V7, P49, DOI 10.1111/j.1365-2125.1979.tb00896.x
   CHAN SY, 1992, J AM COLL CARDIOL, V20, P979, DOI 10.1016/0735-1097(92)90201-W
   Chaw CS, 2001, INT J PHARMACEUT, V227, P167, DOI 10.1016/S0378-5173(01)00795-5
   Chen JJ, 2011, NEUROIMAGE, V55, P468, DOI 10.1016/j.neuroimage.2010.12.032
   CHIEN S, 1966, J APPL PHYSIOL, V21, P583, DOI 10.1152/jappl.1966.21.2.583
   Choukèr A, 2004, LIVER TRANSPLANT, V10, P678, DOI 10.1002/lt.20113
   Christensson A, 2011, NEPHRON CLIN PRACT, V117, pC40, DOI 10.1159/000319646
   Chumlea WC, 2001, KIDNEY INT, V59, P2250, DOI 10.1046/j.1523-1755.2001.00741.x
   CLARYS JP, 1984, HUM BIOL, V56, P459
   COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580
   COHN JE, 1949, AM J MED SCI, V217, P388, DOI 10.1097/00000441-194904000-00005
   Corish CA, 2003, BRIT J NUTR, V89, P137, DOI 10.1079/BJN2002748
   Cornish BH, 1996, EUR J CLIN NUTR, V50, P159
   COURNAND A, 1945, J CLIN INVEST, V24, P106, DOI 10.1172/JCI101570
   Court MH, 2010, DRUG METAB REV, V42, P209, DOI 10.3109/03602530903209288
   DAVIES DF, 1950, J CLIN INVEST, V29, P496, DOI 10.1172/JCI102286
   DAVIS SM, 1983, NEUROLOGY, V33, P391, DOI 10.1212/WNL.33.4.391
   DAVY KP, 1994, J APPL PHYSIOL, V76, P2059, DOI 10.1152/jappl.1994.76.5.2059
   de la Grandmaison GL, 2001, FORENSIC SCI INT, V119, P149, DOI 10.1016/S0379-0738(00)00401-1
   deGroot CPGM, 1996, EUR J CLIN NUTR, V50, pS9
   DELARUE J, 1994, BRIT J NUTR, V71, P295, DOI 10.1079/BJN19940135
   DENKO CW, 1981, ANN CLIN LAB SCI, V11, P63
   DESANTO NG, 1991, CHILD NEPHROL UROL, V11, P33
   DEVOUS MD, 1986, J CEREBR BLOOD F MET, V6, P95, DOI 10.1038/jcbfm.1986.12
   Dey DK, 2009, NUTRITION, V25, P613, DOI 10.1016/j.nut.2008.11.023
   Dey DK, 2003, EUR J CLIN NUTR, V57, P909, DOI 10.1038/sj.ejcn.1601625
   Dey DK, 1999, EUR J CLIN NUTR, V53, P905, DOI 10.1038/sj.ejcn.1600852
   DRESSMAN JB, 1990, PHARMACEUT RES, V7, P756, DOI 10.1023/A:1015827908309
   DuBois D, 1915, ARCH INTERN MED, V15, P868
   Dunbar SL, 2000, J APPL PHYSIOL, V89, P97, DOI 10.1152/jappl.2000.89.1.97
   DUNNILL M S, 1973, Journal of Pathology, V110, P113, DOI 10.1002/path.1711100202
   Duvernoy CS, 1999, J AM COLL CARDIOL, V33, P463, DOI 10.1016/S0735-1097(98)00575-0
   Eiben G, 2005, INT J OBESITY, V29, P810, DOI 10.1038/sj.ijo.0802940
   EVANS MA, 1981, J AM GERIATR SOC, V29, P201, DOI 10.1111/j.1532-5415.1981.tb01766.x
   FALLINGBORG J, 1989, ALIMENT PHARM THERAP, V3, P605
   Farinatti PTV, 2009, EUR J APPL PHYSIOL, V107, P625, DOI 10.1007/s00421-009-1162-y
   Fischer M, 2016, J PHARM SCI-US, V105, P682, DOI 10.1002/jps.24619
   FLISER D, 1993, J AM SOC NEPHROL, V3, P1371
   Fliser D, 1997, KIDNEY INT, V51, P1196, DOI 10.1038/ki.1997.163
   Fu AZ, 1998, AM J PHYSIOL-ENDOC M, V275, pE1023, DOI 10.1152/ajpendo.1998.275.6.E1023
   Fuiano G, 2001, KIDNEY INT, V59, P1052
   FULOP T, 1985, GERONTOLOGY, V31, P6
   GAINSBOROUGH N, 1993, AGE AGEING, V22, P37, DOI 10.1093/ageing/22.1.37
   Gallagher D, 1998, AM J PHYSIOL-ENDOC M, V275, pE249, DOI 10.1152/ajpendo.1998.275.2.E249
   Gallagher D, 2000, ANN NY ACAD SCI, V904, P449
   Gallagher D, 1997, J APPL PHYSIOL, V83, P229, DOI 10.1152/jappl.1997.83.1.229
   GARDNER MD, 1980, J CLIN PATHOL, V33, P380, DOI 10.1136/jcp.33.4.380
   GARRY PJ, 1989, AM J CLIN NUTR, V50, P1219, DOI 10.1093/ajcn/50.5.1219
   Gavriilidou NN, 2015, EUR J CLIN NUTR, V69, P1066, DOI 10.1038/ejcn.2015.73
   GERSOVITZ M, 1980, METABOLISM, V29, P1075, DOI 10.1016/0026-0495(80)90219-X
   GHOSE K, 1989, ARCH GERONTOL GERIAT, V9, P115, DOI 10.1016/0167-4943(89)90032-0
   Gibson JG, 1937, J CLIN INVEST, V16, P317, DOI 10.1172/JCI100860
   Gill KL, 2016, AAPS J, V18, P156, DOI 10.1208/s12248-015-9819-4
   Gillette-Goyonnet S, 2003, MECH AGEING DEV, V124, P311, DOI 10.1016/S0047-6374(02)00198-7
   Gillette-Guyonnet S, 2000, GERONTOLOGY, V46, P189, DOI 10.1159/000022158
   Gnudi S, 2007, J BONE MINER METAB, V25, P326, DOI 10.1007/s00774-007-0758-8
   Goldring W, 1940, J CLIN INVEST, V19, P739, DOI 10.1172/JCI101179
   GOO RH, 1987, GASTROENTEROLOGY, V93, P515, DOI 10.1016/0016-5085(87)90913-9
   Graff J, 2001, CLIN PHYSIOL, V21, P253, DOI 10.1046/j.1365-2281.2001.00308.x
   GREENBLATT DJ, 1991, NEW ENGL J MED, V324, P1691, DOI 10.1056/NEJM199106133242403
   Greene M, 2014, J AM GERIATR SOC, V62, P447, DOI 10.1111/jgs.12695
   HAGSTADIUS S, 1989, BRAIN COGNITION, V10, P28, DOI 10.1016/0278-2626(89)90073-0
   Henche SA, 2008, EUR J CLIN NUTR, V62, P1440, DOI 10.1038/sj.ejcn.1602883
   HENDERSON JM, 1981, RADIOLOGY, V141, P525, DOI 10.1148/radiology.141.2.6974875
   HERD B, 1991, BRIT J CLIN PHARMACO, V32, P768
   Heydari A, 2004, BRIT J CLIN PHARMACO, V57, P687
   Ho CW, 1997, J APPL PHYSIOL, V82, P1126, DOI 10.1152/jappl.1997.82.4.1126
   HOLLENBERG NK, 1974, CIRC RES, V34, P309, DOI 10.1161/01.RES.34.3.309
   Horber FF, 1997, NUTRITION, V13, P524, DOI 10.1016/S0899-9007(97)00031-2
   HOROWITZ M, 1984, CLIN SCI, V67, P213, DOI 10.1042/cs0670213
   Howgate EM, 2006, XENOBIOTICA, V36, P473, DOI 10.1080/00498250600683197
   Hozo Stela Pudar, 2005, BMC Med Res Methodol, V5, P13, DOI 10.1186/1471-2288-5-13
   HUME R, 1971, J CLIN PATHOL, V24, P234, DOI 10.1136/jcp.24.3.234
   HUNT CM, 1992, BIOCHEM PHARMACOL, V44, P275, DOI 10.1016/0006-2952(92)90010-G
   HUSEBYE E, 1992, SCAND J GASTROENTERO, V27, P397, DOI 10.3109/00365529209000095
   ISHII T, 1978, J AM GERIATR SOC, V26, P108, DOI 10.1111/j.1532-5415.1978.tb01219.x
   Jamei M, 2009, AAPS J, V11, P225, DOI 10.1208/s12248-009-9099-y
   Jamei M, 2009, DRUG METAB PHARMACOK, V24, P53, DOI 10.2133/dmpk.24.53
   Janssen I, 2000, J APPL PHYSIOL, V89, P81
   JERNIGAN JA, 1980, J AM GERIATR SOC, V28, P308, DOI 10.1111/j.1532-5415.1980.tb00621.x
   JOHNSON JM, 1976, J APPL PHYSIOL, V41, P826, DOI 10.1152/jappl.1976.41.6.826
   KASISKE BL, 1986, ARCH PATHOL LAB MED, V110, P55
   Kemmler W, 2015, CLIN INTERV AGING, V10, P1565, DOI 10.2147/CIA.S89585
   KOFF RS, 1973, GASTROENTEROLOGY, V65, P300
   Kumar NT, 2014, CARDIOVASC PATHOL, V23, P5, DOI 10.1016/j.carpath.2013.09.001
   KUPFER RM, 1985, J AM GERIATR SOC, V33, P340, DOI 10.1111/j.1532-5415.1985.tb07134.x
   Launer KJ, 1996, AGE AGEING, V25, P300, DOI 10.1093/ageing/25.4.300
   LEENDERS KL, 1990, BRAIN, V113, P27, DOI 10.1093/brain/113.1.27
   Legrand D, 2013, ARCH GERONTOL GERIAT, V57, P345, DOI 10.1016/j.archger.2013.06.003
   LEIGHT L, 1956, CIRCULATION, V14, P90, DOI 10.1161/01.CIR.14.1.90
   LESSER GT, 1967, J APPL PHYSIOL, V23, P621, DOI 10.1152/jappl.1967.23.5.621
   Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002
   Lewis WH, 1938, AM J PHYSIOL, V121, P517, DOI 10.1152/ajplegacy.1938.121.2.517
   Lu HZ, 2011, CEREB CORTEX, V21, P1426, DOI 10.1093/cercor/bhq224
   LUDIN H, 1967, ACTA RADIOL DIAGN, V6, P561, DOI 10.1177/028418516700600609
   MADSEN JL, 1992, DIGEST DIS SCI, V37, P1548, DOI 10.1007/BF01296501
   Maher RL, 2014, EXPERT OPIN DRUG SAF, V13, P57, DOI 10.1517/14740338.2013.827660
   MARCHESINI G, 1988, HEPATOLOGY, V8, P1079, DOI 10.1002/hep.1840080516
   MARTIN AJ, 1991, J CEREBR BLOOD F MET, V11, P684, DOI 10.1038/jcbfm.1991.121
   Masanes F, 2012, J NUTR HEALTH AGING, V16, P184, DOI 10.1007/s12603-011-0108-3
   MCDONALD RK, 1951, J CLIN INVEST, V30, P457, DOI 10.1172/JCI102462
   MCLACHLAN M, 1981, BRIT J RADIOL, V54, P488, DOI 10.1259/0007-1285-54-642-488
   MEYER WW, 1963, VIRCHOWS ARCH A, V337, P17, DOI 10.1007/BF00965815
   Mezzani A, 2010, AM J PHYSIOL-REG I, V299, pR968, DOI 10.1152/ajpregu.00739.2009
   MILLER J, 1951, J GERONTOL, V6, P213
   Minson CT, 1998, J APPL PHYSIOL, V84, P1323, DOI 10.1152/jappl.1998.84.4.1323
   Molina DK, 2015, AM J FOREN MED PATH, V36, P176, DOI 10.1097/PAF.0000000000000174
   Molina DK, 2015, AM J FOREN MED PATH, V36, P182, DOI 10.1097/PAF.0000000000000175
   Molina DK, 2012, AM J FOREN MED PATH, V33, P368, DOI 10.1097/PAF.0b013e31823d29ad
   Molina DK, 2012, AM J FOREN MED PATH, V33, P362, DOI 10.1097/PAF.0b013e31823d298b
   MOORE JG, 1983, DIGEST DIS SCI, V28, P340, DOI 10.1007/BF01324951
   Morgan ET, 2009, CLIN PHARMACOL THER, V85, P434, DOI 10.1038/clpt.2008.302
   Morihara M, 2001, BIOL PHARM BULL, V24, P313, DOI 10.1248/bpb.24.313
   Musso CG, 2011, NEPHRON PHYSIOL, V119, P1, DOI 10.1159/000328010
   NAKAMURA T, 1989, J CLIN ULTRASOUND, V17, P261, DOI 10.1002/jcu.1870170406
   NYENGAARD JR, 1992, ANAT REC, V232, P194, DOI 10.1002/ar.1092320205
   OCARROLL RE, 1991, LANCET, V337, P1250, DOI 10.1016/0140-6736(91)92920-W
   OLIVETTI G, 1995, J AM COLL CARDIOL, V26, P1068, DOI 10.1016/0735-1097(95)00282-8
   Parkes LM, 2004, MAGN RESON MED, V51, P736, DOI 10.1002/mrm.20023
   Parkinson A, 2004, TOXICOL APPL PHARM, V199, P193, DOI 10.1016/j.taap.2004.01.010
   PAXTON JW, 1984, BRIT J CLIN PHARMACO, V18, P806, DOI 10.1111/j.1365-2125.1984.tb02548.x
   Perissinotto E, 2002, BRIT J NUTR, V87, P177, DOI 10.1079/BJN2001487
   PICKART L, 1983, ATHEROSCLEROSIS, V46, P21, DOI 10.1016/0021-9150(83)90160-0
   Polasek TM, 2013, BRIT J CLIN PHARMACO, V75, P1019, DOI 10.1111/j.1365-2125.2012.04446.x
   Proctor DN, 2003, J APPL PHYSIOL, V95, P1963, DOI 10.1152/japplphysiol.00472.2003
   Proctor DN, 2003, J APPL PHYSIOL, V94, P1859, DOI 10.1152/japplphysiol.00898.2002
   Puggaard L, 2002, AM J HUM BIOL, V14, P486, DOI 10.1002/ajhb.10066
   Ravaglia G, 1997, BRIT J NUTR, V77, P9, DOI 10.1017/S0007114500002841
   Ravaglia G, 1999, J GERONTOL A-BIOL, V54, pM70, DOI 10.1093/gerona/54.2.M70
   Rea IM, 1997, EUR J CLIN NUTR, V51, P102, DOI 10.1038/sj.ejcn.1600370
   REED AH, 1972, CLIN CHEM, V18, P57
   ROBERTSON DRC, 1988, BRIT J CLIN PHARMACO, V25, P297, DOI 10.1111/j.1365-2125.1988.tb03307.x
   ROUTLEDGE PA, 1981, BRIT J CLIN PHARMACO, V11, P245, DOI 10.1111/j.1365-2125.1981.tb00528.x
   RUSSELL TL, 1993, PHARMACEUT RES, V10, P187, DOI 10.1023/A:1018970323716
   SAFAR M, 1990, DRUGS, V39, P1, DOI 10.2165/00003495-199000391-00003
   SALTZMAN JR, 1995, J AM GERIATR SOC, V43, P160, DOI 10.1111/j.1532-5415.1995.tb06382.x
   Santana H, 2001, AM J CLIN NUTR, V73, P827
   SCHEINBERG P, 1953, AMA ARCH NEUROL PSY, V70, P77, DOI 10.1001/archneurpsyc.1953.02320310083007
   Schlender JF, 2016, CLIN PHARMACOKINET, V55, P1573, DOI 10.1007/s40262-016-0422-3
   SCHMUCKER DL, 1990, CLIN PHARMACOL THER, V48, P365, DOI 10.1038/clpt.1990.164
   SCHOELLER DA, 1989, AM J CLIN NUTR, V50, P1176, DOI 10.1093/ajcn/50.5.1176
   Schutz Y, 2002, INT J OBESITY, V26, P953, DOI 10.1038/sj.ijo.0802037
   Schwartz JB, 2006, CLIN PHARMACOL THER, V79, P440, DOI 10.1016/j.clpt.2006.01.006
   SENNEFF MJ, 1991, J NUCL MED, V32, P2037
   SHAW TG, 1984, NEUROLOGY, V34, P855, DOI 10.1212/WNL.34.7.855
   SHIMADA T, 1994, J PHARMACOL EXP THER, V270, P414
   Shin WY, 2007, MAGN RESON MED, V58, P1232, DOI 10.1002/mrm.21420
   Simon T, 2001, BRIT J CLIN PHARMACO, V52, P601, DOI 10.1046/j.0306-5251.2001.01494.x
   Singh Shamsher, 2014, Pharmacy Pract (Granada), V12
   SKLAROFF DM, 1956, AMER J ROENTGENOL RA, V75, P1082
   Smith HL, 1928, AM HEART J, V4, P79, DOI 10.1016/S0002-8703(29)90099-5
   SMITH RH, 1958, ANESTHESIOLOGY, V19, P752, DOI 10.1097/00000542-195811000-00006
   SMITH WW, 1954, CIRCULATION, V9, P352, DOI 10.1161/01.CIR.9.3.352
   Snyder W.S., 1974, Report of the Task Group on Reference Man
   SprogoeJakobsen S, 1997, FORENSIC SCI INT, V88, P215, DOI 10.1016/S0379-0738(97)00103-5
   St-Onge MP, 2004, AM J PHYSIOL-ENDOC M, V287, pE842, DOI 10.1152/ajpendo.00361.2003
   Starr I, 1934, J CLIN INVEST, V13, P561, DOI 10.1172/JCI100606
   STEEN B, 1988, NUTR REV, V46, P45, DOI 10.1111/j.1753-4887.1988.tb05386.x
   Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415
   SVENDSEN OL, 1995, METABOLISM, V44, P369, DOI 10.1016/0026-0495(95)90168-X
   TANNER JM, 1949, J CLIN INVEST, V28, P567, DOI 10.1172/JCI102107
   Thompson CM, 2009, J TOXICOL ENV HEAL B, V12, P1, DOI 10.1080/10937400802545060
   THOMPSON EN, 1965, GUT, V6, P266, DOI 10.1136/gut.6.3.266
   Tichet J, 2008, J NUTR HEALTH AGING, V12, P202, DOI 10.1007/BF02982621
   TIETZ NW, 1992, CLIN CHEM, V38, P1167
   TIMIRAS ML, 1987, J AM GERIATR SOC, V35, P639, DOI 10.1111/j.1532-5415.1987.tb04340.x
   TYGSTRUP N, 1962, J CLIN INVEST, V41, P447, DOI 10.1172/JCI104497
   United Nations, 2017, WORLD POP AG
   Vaché C, 1998, INT J OBESITY, V22, P537, DOI 10.1038/sj.ijo.0800622
   Valentin J, 2002, ANN ICRP, V32, P1, DOI DOI 10.1016/S0146-6453(03)00002-2
   Van Den Noortgate NJ, 2002, J AM GERIATR SOC, V50, P1278, DOI 10.1046/j.1532-5415.2002.50317.x
   Vanis L, 2012, AM J PHYSIOL-REG I, V302, pR391, DOI 10.1152/ajpregu.00464.2011
   VEERING BT, 1990, BRIT J CLIN PHARMACO, V29, P201, DOI 10.1111/j.1365-2125.1990.tb03620.x
   Villesen Hanne H, 2007, Ther Clin Risk Manag, V3, P961
   WALLACE S, 1976, BRIT J CLIN PHARMACO, V3, P327, DOI 10.1111/j.1365-2125.1976.tb00611.x
   Wan X, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-135
   WARREN PM, 1978, LANCET, V2, P849
   Watts G, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3445
   WENNESLAND R, 1959, J CLIN INVEST, V38, P1065, DOI 10.1172/JCI103883
   WHIMSTER WF, 1974, AM REV RESPIR DIS, V110, P478
   WILLIAMS LR, 1989, CLIN PHYS PHYSIOL M, V10, P187, DOI 10.1088/0143-0815/10/3/001
   World Health Organization, 2010, DEF OLD ELD PERS
   WYNNE HA, 1989, HEPATOLOGY, V9, P297, DOI 10.1002/hep.1840090222
   Ylihärsilä H, 2008, AM J CLIN NUTR, V87, P1769, DOI 10.1093/ajcn/87.6.1769
   ZAUBER NP, 1987, JAMA-J AM MED ASSOC, V257, P2181, DOI 10.1001/jama.257.16.2181
   Zoico E, 2004, INT J OBESITY, V28, P234, DOI 10.1038/sj.ijo.0802552
   ZOLI M, 1989, GERONTOLOGY, V35, P61, DOI 10.1159/000213000
NR 220
TC 43
Z9 46
U1 1
U2 11
PU ADIS INT LTD
PI NORTHCOTE
PA 5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND
SN 0312-5963
EI 1179-1926
J9 CLIN PHARMACOKINET
JI Clin. Pharmacokinet.
PD APR
PY 2019
VL 58
IS 4
BP 483
EP 501
DI 10.1007/s40262-018-0709-7
PG 19
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Pharmacology & Pharmacy
GA HN3AE
UT WOS:000460055400006
PM 30128967
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Stroffolini, T
   Sagnelli, E
   Sagnelli, C
   Morisco, F
   Babudieri, S
   Furlan, C
   Pirisi, M
   Russello, M
   Smedile, A
   Pisaturo, M
   Almasio, PL
AF Stroffolini, Tommaso
   Sagnelli, Evangelista
   Sagnelli, Caterina
   Morisco, Filomena
   Babudieri, Sergio
   Furlan, Caterina
   Pirisi, Mario
   Russello, Maurizio
   Smedile, Antonina
   Pisaturo, Mariantonietta
   Almasio, Piero Luigi
TI Characteristics and Changes over Time of Alcohol-Related Chronic Liver
   Diseases in Italy
SO CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
LA English
DT Article
ID CHRONIC HEPATITIS; CIRRHOSIS; RISK; MANAGEMENT; BURDEN; CLASSIFICATION;
   INFECTION; DIAGNOSIS; GENDER; HCV
AB Introduction. To evaluate the characteristics of alcohol-related chronic liver disease (CLD) in Italy and their potential changes over time. Patients and Methods. Subjects with CLD were enrolled in two national surveys performed in 2001 and in 2014 in Italy. The two surveys prospectively recruited patients aged >= 18 years referring to more than 80 Italian liver units scattered all over the country using similar clinical approach, analytical methods, and threshold of risky alcohol intake definition (>= 3 units/day in men and >= 2 units/day in women). Results. Out of 12,256 enrolled subjects, 2,717 (22.2%) reported a risky alcohol intake. Of them, anti-HCV positive was observed in 48.3% of subjects. The overall sex ratio (M/F) was 3.1, decreasing from 3.8 in 2001 to 1.3 in 2014. Women were significantly older than men (58.9 versus 53.1 years; p < 0.01) and an increasing ageing over time was observed in both sexes. The proportion of subjects with liver cirrhosis increased over time in both sexes, and decompensated stage (Child B or C) was detected in 55.9% of cases in 2001 and 46.0% in 2014. Conclusions. Risky alcohol intake plays a role in more than one-fifth of CLD in Italy, with a shift over time towards an older age and a more severe liver disease stage. These data put alcohol back in the spotlight with an important role in CLD in the years to come in Italy.
C1 [Stroffolini, Tommaso; Furlan, Caterina] Policlin Umberto 1, Dept Trop & Infect Dis, Rome, Italy.
   [Sagnelli, Evangelista; Sagnelli, Caterina] Campania Univ Luigi Vanvitelli, Dept Mental Hlth & Publ Med, Naples, Italy.
   [Morisco, Filomena] Univ Naples Federico II, Dept Clin Med & Surg, Gastroenterol Unit, Naples, Italy.
   [Babudieri, Sergio] Univ Sassari, Clin Infect Dis, Sassari, Italy.
   [Pirisi, Mario] Univ Piemonte Orientale, Dept Translat Med, Novara, Italy.
   [Russello, Maurizio] Hosp G Garibaldi Catania, Liver Unit, Catania, Italy.
   [Smedile, Antonina] Univ Turin, Dept Med Sci, Turin, Italy.
   [Pisaturo, Mariantonietta] S Anna & S Sebastian Hosp, Unit Infect Dis, Caserta, Italy.
   [Almasio, Piero Luigi] Univ Palermo, Biomed Dept Internal Med & Special DiBiMIS, Palermo, Italy.
C3 Sapienza University Rome; University Hospital Sapienza Rome; Universita
   della Campania Vanvitelli; University of Naples Federico II; University
   of Sassari; University of Eastern Piedmont Amedeo Avogadro; University
   of Turin; University of Palermo
RP Almasio, PL (corresponding author), Univ Palermo, Biomed Dept Internal Med & Special DiBiMIS, Palermo, Italy.
EM piero.almasio@unipa.it
RI Pirisi, Mario/ABF-2102-2020; Sagnelli, caterina/K-9338-2016; Sagnelli,
   Caterina/AAD-4950-2022; Morisco, Filomena/AHI-0851-2022
OI Sagnelli, caterina/0000-0002-6413-7810; Morisco,
   Filomena/0009-0006-1537-5034; morisco, filomena/0000-0002-9059-8311
CR Adams PC, 1998, GASTROENTEROLOGY, V114, P319, DOI 10.1016/S0016-5085(98)70483-4
   Alvarez E, 1999, J HEPATOL, V31, P929, DOI 10.1016/S0168-8278(99)80297-9
   Angulo P, 2002, J GASTROEN HEPATOL, V17, pS186, DOI 10.1046/j.1440-1746.17.s1.10.x
   Askgaard G, 2015, J HEPATOL, V62, P1061, DOI 10.1016/j.jhep.2014.12.005
   Becker U, 1996, HEPATOLOGY, V23, P1025, DOI 10.1002/hep.510230513
   Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201
   Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1
   Corrao G, 1998, J HEPATOL, V28, P608, DOI 10.1016/S0168-8278(98)80284-5
   Dam MK, 2013, SCAND J GASTROENTERO, V48, P585, DOI 10.3109/00365521.2013.777469
   Eagon PK, 2010, WORLD J GASTROENTERO, V16, P1377, DOI 10.3748/wjg.v16.i11.1377
   Ferenci P, 2003, LIVER INT, V23, P139, DOI 10.1034/j.1600-0676.2003.00824.x
   Gaiani S, 1997, J HEPATOL, V27, P979, DOI 10.1016/S0168-8278(97)80140-7
   Gamal S, 2011, ISHAK VERSUS METAVIR
   ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6
   Kamper-Jorgensen M, 2004, J HEPATOL, V41, P25, DOI 10.1016/j.jhep.2004.03.002
   Leon DA, 2006, LANCET, V367, P52, DOI 10.1016/S0140-6736(06)67924-5
   Liangpunsakul S, 2016, GASTROENTEROLOGY, V150, P1786, DOI 10.1053/j.gastro.2016.02.043
   Mann RE, 2003, ALCOHOL RES HEALTH, V27, P209
   Mathurin P, 2015, J HEPATOL, V62, pS38, DOI 10.1016/j.jhep.2015.03.006
   Mathurin P, 2012, J HEPATOL, V57, P399, DOI 10.1016/j.jhep.2012.04.004
   McCullough A., AM J GASTROENTEROLOG, V93, P2022
   Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8
   Rehm J, 2013, J HEPATOL, V59, P160, DOI 10.1016/j.jhep.2013.03.007
   Rehm J, 2010, DRUG ALCOHOL REV, V29, P437, DOI 10.1111/j.1465-3362.2009.00153.x
   Sagnelli E, 2005, J MED VIROL, V75, P522, DOI 10.1002/jmv.20313
   Sagnelli E, 2018, INFECTION, V46, P93, DOI 10.1007/s15010-017-1101-5
   Sagnelli E, 2017, J MED VIROL, V89, P2138, DOI 10.1002/jmv.24873
   Sagnelli E, 2016, DIGEST LIVER DIS, V48, P1066, DOI 10.1016/j.dld.2016.05.014
   Scafato E., 2015, SISTEMA ITALIANO MON
   Stroffolini T, 1998, J HEPATOL, V28, P728, DOI 10.1016/S0168-8278(98)80300-0
   Stroffolini T, 2017, EUR J GASTROEN HEPAT, V29, P994, DOI 10.1097/MEG.0000000000000907
   TAAL BG, 1983, HEPATO-GASTROENTEROL, V30, P178
   Villa E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044624
   Zakhari S, 2007, HEPATOLOGY, V46, P2032, DOI 10.1002/hep.22010
NR 34
TC 2
Z9 2
U1 0
U2 0
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2291-2789
EI 2291-2797
J9 CAN J GASTROENTEROL
JI Can. J. Gastroenterol. Hepatol.
PY 2018
VL 2018
AR 9151820
DI 10.1155/2018/9151820
PG 7
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA GU4KA
UT WOS:000445251400001
PM 30345260
OA Green Published, gold, Green Submitted
DA 2024-02-19
ER

PT J
AU Mikami, K
   Endo, T
   Sawada, N
   Igarashi, G
   Kimura, M
   Hasegawa, T
   Iino, C
   Sawada, K
   Nakaji, S
   Ishibashi, Y
   Matsuzaka, M
   Fukuda, S
AF Mikami, Kenichiro
   Endo, Tetsu
   Sawada, Naoya
   Igarashi, Go
   Kimura, Masayo
   Hasegawa, Takuma
   Iino, Chikara
   Sawada, Kaori
   Nakaji, Shigeyuki
   Ishibashi, Yasuyuki
   Matsuzaka, Masashi
   Fukuda, Shinsaku
TI Association of Bone Metabolism with Fatty Liver Disease in the Elderly
   in Japan: A Community-based Study
SO INTERNAL MEDICINE
LA English
DT Article
DE bone mineral density; bone turnover markers; bone formation index; bone
   resorption index; fatty liver disease
ID ACID-PHOSPHATASE 5B; MINERAL DENSITY; HEPATIC OSTEODYSTROPHY; FRACTURE;
   RISK; OSTEOPOROSIS; OBESITY; CIRRHOSIS; POPULATION; PREVALENCE
AB Objective With the aging of society, both osteoporosis and fatty liver disease (FLD) are becoming important issues. However, the relationship between osteoporosis and FLD remains controversial. We investigated the association between bone metabolism and FLD in a Japanese community in a cross-sectional study.
   Methods A total of 1,020 participants were enrolled in a health survey. FLD was diagnosed by ultrasonography. Bone metabolism was evaluated based on bone mineral density (BMD), which was assessed using dual-energy X-ray absorptiometry. and with the bone formation index (total type I procollagen N-terminal propeptide/bone-alkaline phosphatase ratio; P1NP/BAP ratio) and the bone resorption index (crosslinked N-telopeptide of type I collagen/tartrate-resistant acid phosphatase-5b ratio; NTx/TRACP-5b ratio) calculated from serum bone turnover markers.
   Results The BMD (percentage of the young adult mean) was the same level in both male and female participants with and without FLD. Both men and women showed an age-dependent decrease in their bone formation index and bone resorption index values. Men of >= 70 years of age and women of 60-69 years of age with FLD had significantly lower bone formation index values and higher bone resorption index values. However, similar findings were not seen in women of >= 70 years of age.
   Conclusion Although the BMD levels were the same, regardless of the presence or absence of FLD, elderly participants with FLD showed decreased bone formation and increased bone resorption, with sex differences. Because our results suggest that FLD in elderly individuals is detrimental for bone metabolism, and that it leads to bone loss and osteoporosis, further studies using a cohort population are warranted.
C1 [Mikami, Kenichiro; Endo, Tetsu; Sawada, Naoya; Igarashi, Go; Kimura, Masayo; Hasegawa, Takuma; Iino, Chikara; Fukuda, Shinsaku] Hirosaki Univ, Dept Gastroenterol, Grad Sch Med, Hirosaki, Aomori, Japan.
   [Mikami, Kenichiro] Owani Hosp, Dept Internal Med, Owani, Japan.
   [Sawada, Kaori; Nakaji, Shigeyuki] Hirosaki Univ, Dept Social Med, Grad Sch Med, Hirosaki, Aomori, Japan.
   [Ishibashi, Yasuyuki] Hirosaki Univ, Dept Orthopaed Surg, Grad Sch Med, Hirosaki, Aomori, Japan.
   [Matsuzaka, Masashi] Hirosaki Univ Hosp, Clin Res Support Ctr, Hirosaki, Aomori, Japan.
C3 Hirosaki University; Hirosaki University; Hirosaki University; Hirosaki
   University; Hiroshima University
RP Mikami, K (corresponding author), Hirosaki Univ, Dept Gastroenterol, Grad Sch Med, Hirosaki, Aomori, Japan.; Mikami, K (corresponding author), Owani Hosp, Dept Internal Med, Owani, Japan.
EM kmikami@hirosaki-u.ac.jp
FU JST COI [JPMJCE 1302]
FX This work was supported by JST COI Grant Number JPMJCE 1302.
CR Abdelmalek MA, 2018, HARRISONS PRINCIPAL, P2401
   Alatalo SL, 2004, CLIN CHEM, V50, P883, DOI 10.1373/clinchem.2003.029355
   Bansal RK, 2016, UNITED EUR GASTROENT, V4, P77, DOI 10.1177/2050640615584535
   Bihari C, 2018, HEPATOL COMMUN, V2, P1095, DOI 10.1002/hep4.1234
   Chalasani N, 2012, GASTROENTEROLOGY, V142, P1592, DOI 10.1053/j.gastro.2012.04.001
   Chen HJ, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000012835
   Cheung Elaine Y N, 2016, Osteoporos Sarcopenia, V2, P118, DOI 10.1016/j.afos.2016.07.001
   CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202
   Rodríguez RD, 2014, NUTR HOSP, V30, P1256, DOI 10.3305/nh.2014.30.6.7948
   Dimitri P, 2012, BONE, V50, P457, DOI 10.1016/j.bone.2011.05.011
   Eckstein N, 2016, GERONTOLOGY, V62, P337, DOI 10.1159/000434678
   Ehnert S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20102555
   Elliot-Gibson V, 2004, OSTEOPOROSIS INT, V15, P767, DOI 10.1007/s00198-004-1675-5
   Fassio A, 2018, EAT WEIGHT DISORD-ST, V23, P293, DOI 10.1007/s40519-018-0505-2
   Faulkner KG, 1999, J CLIN DENSITOM, V2, P343, DOI 10.1385/JCD:2:3:343
   Giangregorio L, 2006, SEMIN ARTHRITIS RHEU, V35, P293, DOI 10.1016/j.semarthrit.2005.11.001
   Hernlund E, 2013, ARCH OSTEOPOROS, V8, DOI 10.1007/s11657-013-0136-1
   Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4
   Kanis JA, 2001, OSTEOPOROSIS INT, V12, P989, DOI 10.1007/s001980170006
   Karoli Y, 2016, J CLIN DIAGN RES, V10, pOC31, DOI 10.7860/JCDR/2016/21539.8367
   Kehlet SN, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194458
   Kim KM, 2018, J GERONTOL A-BIOL, V73, P1062, DOI 10.1093/gerona/glx188
   Kushner RF, 2018, HARRISONS PRINCIPAL, P2843
   Lindsay R., 2018, HARRISONS PRINCIPLES, V20, P2942
   Maagensen H, 2018, J CLIN ENDOCR METAB, V103, P2042, DOI 10.1210/jc.2018-00176
   Mantovani A, 2019, ALIMENT PHARM THER, V49, P375, DOI 10.1111/apt.15087
   Matsumoto T, 2019, BJU INT, V123, P877, DOI 10.1111/bju.14535
   Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8
   Mills Shane J, 2005, Curr Gastroenterol Rep, V7, P32, DOI 10.1007/s11894-005-0063-4
   Modig K, 2019, J BONE JOINT SURG AM, V101, P888, DOI 10.2106/JBJS.18.01249
   Muramatsu N, 2011, GERONTOLOGIST, V51, P425, DOI 10.1093/geront/gnr067
   Ninomiya T, 2018, J EPIDEMIOL, V28, P444, DOI [10.2188/jea.je20180150, 10.2188/jea.JE20180150]
   Odén A, 2015, OSTEOPOROSIS INT, V26, P2243, DOI 10.1007/s00198-015-3154-6
   Ota S, 2019, ARTHRITIS RES THER, V21, DOI 10.1186/s13075-019-1900-4
   Pouresmaeili F, 2018, THER CLIN RISK MANAG, V14, P2029, DOI 10.2147/TCRM.S138000
   Rissanen JP, 2008, CALCIFIED TISSUE INT, V82, P108, DOI 10.1007/s00223-007-9091-4
   Saadeh S, 2002, GASTROENTEROLOGY, V123, P745, DOI 10.1053/gast.2002.35354
   Sasaki E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192687
   Sasaki E, 2013, J ORTHOP SCI, V18, P121, DOI 10.1007/s00776-012-0329-2
   Satake R, 2015, INTERNAL MED, V54, P3105, DOI 10.2169/internalmedicine.54.5378
   Shapses SA, 2017, NUTR RES, V39, P1, DOI 10.1016/j.nutres.2016.12.010
   Solaymani-Dodaran M, 2006, GASTROENTEROLOGY, V131, P1752, DOI 10.1053/j.gastro.2006.09.012
   Tobari M, 2009, INTERNAL MED, V48, P739, DOI 10.2169/internalmedicine.48.1869
   Torgerson DJ, 1996, J BONE MINER RES, V11, P293
   Upala S, 2017, J BONE MINER METAB, V35, P685, DOI 10.1007/s00774-016-0807-2
   Viljakainen H, 2014, J CLIN ENDOCR METAB, V99, P2155, DOI 10.1210/jc.2013-3097
   Wani K, 2019, NUTRIENTS, V11, DOI 10.3390/nu11061405
   Wright NC, 2014, J BONE MINER RES, V29, P2520, DOI 10.1002/jbmr.2269
   Yang HJ, 2016, EUR J GASTROEN HEPAT, V28, P338, DOI 10.1097/MEG.0000000000000535
   Yoshimura N, 2009, J BONE MINER METAB, V27, P620, DOI 10.1007/s00774-009-0080-8
   Younossi Z, 2018, NAT REV GASTRO HEPAT, V15, P11, DOI 10.1038/nrgastro.2017.109
   Younossi Z, 2016, GASTROENTEROLOGY, V150, P1778, DOI 10.1053/j.gastro.2016.03.005
   Younossi ZM, 2019, J HEPATOL, V70, P531, DOI 10.1016/j.jhep.2018.10.033
NR 53
TC 7
Z9 7
U1 1
U2 5
PU JAPAN SOC INTERNAL MEDICINE
PI TOKYO
PA 34-3 3-CHOME HONGO BUNKYO-KU, TOKYO, 113, JAPAN
SN 0918-2918
EI 1349-7235
J9 INTERNAL MED
JI Intern. Med.
PY 2020
VL 59
IS 10
BP 1247
EP 1256
DI 10.2169/internalmedicine.3906-19
PG 10
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA LU0OU
UT WOS:000537464100002
PM 32101831
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Ishiko, T
   Inomata, Y
   Beppu, T
   Asonuma, K
   Okajima, H
   Takeitchi, T
   Baba, H
AF Ishiko, Takatoshi
   Inomata, Yukihiro
   Beppu, Toru
   Asonuma, Katuhiko
   Okajima, Hideaki
   Takeitchi, Takayuki
   Baba, Hideo
TI Age and Donor Safety in Living-Donor Liver Transplant in 110 Consecutive
   Cases at 1 Institute
SO EXPERIMENTAL AND CLINICAL TRANSPLANTATION
LA English
DT Article
DE Hepatectomy; Postoperative liver function; Serum albumin
ID SINGLE-CENTER; IMPACT; GRAFT; JAPAN
AB objectives: Since Japan began doing living-donor liver transplants, the demographics of living donors, including their age, have changed. We sought to assess the impact of aging on the feasibility and safety of doing a hepatectomy in living donors.
   Materials and Methods: We analyzed data from 110 consecutive liver donors who had undergone a hepatectomy at our institution. To extract the graft, 34 patients had a lateral segmentectomy, 38 had a left lobectomy, and 38 had a right lobectomy.
   Results: Mean intraoperative blood loss was significantly greater in older donors (age > 40 years) than it was in younger donors (age <= 40 years). In addition, the mean number of days required for the serum albumin level to return to normal after surgery was significantly longer in older donors (34.3 +/- 11.9 days vs 17.1 +/- 9.7 days). A multivariate analysis showed donor age to be a significant risk factor for prolonged serum albumin recovery.
   Conclusions: Donor age is a significant factor affecting postoperative liver functioning in the donor.
C1 [Ishiko, Takatoshi; Beppu, Toru; Baba, Hideo] Kumamoto Univ, Grad Sch Med, Dept Surg Gastroenterol, Kumamoto 8608556, Japan.
   [Inomata, Yukihiro; Asonuma, Katuhiko; Okajima, Hideaki; Takeitchi, Takayuki] Kumamoto Univ, Grad Sch Med, Dept Transplantat & Pediat Surg, Kumamoto 8608556, Japan.
C3 Kumamoto University; Kumamoto University
RP Ishiko, T (corresponding author), Kumamoto Univ, Grad Sch Med, Dept Surg Gastroenterol, 1-1-1 Honjyo, Kumamoto 6068556, Japan.
EM ishiko@krmc.or.jp
CR Aldrighetti L, 2004, AM SURGEON, V70, P453
   Egawa H, 1998, SURGERY, V124, P901, DOI 10.1016/S0039-6060(98)70015-7
   Fujita M, 2006, LIVER TRANSPLANT, V12, P768, DOI 10.1002/lt.20689
   Giovannini I, 2004, CLIN CHEM LAB MED, V42, P261, DOI 10.1515/CCLM.2004.048
   Inomata Y, 2000, TRANSPLANTATION, V69, P258, DOI 10.1097/00007890-200001270-00011
   Nagano Y, 2005, J AM COLL SURGEONS, V201, P511, DOI 10.1016/j.jamcollsurg.2005.05.010
   Pacheco-Moreira LF, 2006, PEDIATR TRANSPLANT, V10, P311, DOI 10.1111/j.1399-3046.2005.00465.x
   Papachristou C, 2004, TRANSPLANTATION, V78, P1506, DOI 10.1097/01.TP.0000142620.08431.26
   Schemmer P, 2005, TRANSPLANTATION, V80, pS138, DOI 10.1097/01.tp.0000187132.49178.ec
   Shimada M, 2005, J MED INVESTIG, V52, P22, DOI 10.2152/jmi.52.22
   SUGAWARA Y, 2006, BR MED B, V75, P15, DOI DOI 10.1093/BMB/LDH058
   TANAKA K, 1993, ANN SURG, V217, P82, DOI 10.1097/00000658-199301000-00014
   Tanaka K, 2004, YONSEI MED J, V45, P1089, DOI 10.3349/ymj.2004.45.6.1089
   Ueda M, 2006, LIVER TRANSPLANT, V12, P1326, DOI 10.1002/lt.20826
   Umeshita K, 2003, LANCET, V362, P687, DOI 10.1016/S0140-6736(03)14230-4
   URATA K, 1995, HEPATOLOGY, V21, P1317, DOI 10.1016/0270-9139(95)90053-5
NR 16
TC 8
Z9 8
U1 0
U2 2
PU BASKENT UNIV
PI ANKARA
PA TASKENT CADDESI NO 77, KAT 4, BAHCELIEVLER, ANKARA, 06490, TURKEY
SN 1304-0855
J9 EXP CLIN TRANSPLANT
JI Exp. Clin. Transplant.
PD SEP
PY 2008
VL 6
IS 3
BP 190
EP 193
PG 4
WC Transplantation
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Transplantation
GA 364XR
UT WOS:000260369500004
PM 18954295
DA 2024-02-19
ER

PT J
AU Han, B
   Lee, GB
   Yim, SY
   Cho, KH
   Shin, KE
   Kim, JH
   Park, YG
   Han, KD
   Kim, YH
AF Han, Byoungduck
   Lee, Gyu Bae
   Yim, Sun Young
   Cho, Kyung-Hwan
   Shin, Koh Eun
   Kim, Jung-Hwan
   Park, Yong-Gyu
   Han, Kyung-Do
   Kim, Yang-Hyun
TI Non-Alcoholic Fatty Liver Disease Defined by Fatty Liver Index and
   Incidence of Heart Failure in the Korean Population: A Nationwide Cohort
   Study
SO DIAGNOSTICS
LA English
DT Article
DE heart failure; non-alcoholic fatty liver disease; fatty liver index;
   waist circumference; obesity
ID CARDIOVASCULAR-DISEASE; RISK-FACTORS; FOLLOW-UP; EPIDEMIOLOGY;
   ASSOCIATION; MICROBIOME; PREVALENCE; STATEMENT; FIBROSIS; OBESITY
AB Fatty liver index (FLI) is a simple and useful index that evaluates non-alcoholic fatty liver disease (NAFLD), particularly in large epidemiologic studies. Heart failure (HF) is becoming a burden to public health as the global trend toward an aging society continues. Thus, we investigated the effect of FLI on the incidence of HF using large cohort data from the Korean National Health Insurance health database. Methods and Results: A total of 7,958,538 subjects aged over 19 years without baseline HF (men = 4,142,264 and women = 3,816,274) were included. Anthropometric and biochemical measurements were evaluated. FLI scores were calculated and FLI >= 60 was considered as having NAFLD. Hazard ratios (HRs) and 95% confidence intervals (CIs) for HF incidence were analysed using multivariable time-dependent Cox proportional hazard models. During a mean follow up of 8.26 years, 17,104 participants developed HF. The FLI components associated with the incidence of HF and FLI showed a causal relationship with HF; the FLI >= 60 group had a higher HR for HF (HR 1.493; 95% CIs 1.41-1.581) than the FLI < 30 group. Subgroup analysis showed that fatty liver (FLI >= 60) with age >= 65 years or women displayed higher HR for HF than fatty liver with age < 65 or men, respectively. An increase in FLI score significantly increased the HR for HF except for those with a FLI score change from <30 to 30-60. Conclusion: NAFLD defined by FLI and increase in FLI score were associated with the incidence of HF. Further detailed prospective studies are needed.
C1 [Han, Byoungduck; Lee, Gyu Bae; Cho, Kyung-Hwan; Kim, Yang-Hyun] Korea Univ, Coll Med, Dept Family Med, Seoul 02841, South Korea.
   [Yim, Sun Young] Korea Univ, Coll Med, Dept Internal Med, Seoul 02841, South Korea.
   [Shin, Koh Eun] Korea Univ, Anam Hosp, Int Healthcare Ctr, Seoul 02841, South Korea.
   [Kim, Jung-Hwan] Eulji Univ, Sch Med, Eulji Hosp Uijeongbu, Dept Family Med, Uijongbu 11749, South Korea.
   [Park, Yong-Gyu] Catholic Univ, Coll Med, Dept Med Stat, Seoul 06591, South Korea.
   [Han, Kyung-Do] Soongsil Univ, Dept Stat & Actuarial Sci, Seoul 06978, South Korea.
C3 Korea University; Korea University Medicine (KU Medicine); Korea
   University; Korea University Medicine (KU Medicine); Korea University;
   Korea University Medicine (KU Medicine); Eulji University; Catholic
   University of Korea; Soongsil University
RP Kim, YH (corresponding author), Korea Univ, Coll Med, Dept Family Med, Seoul 02841, South Korea.; Han, KD (corresponding author), Soongsil Univ, Dept Stat & Actuarial Sci, Seoul 06978, South Korea.
EM hbdfm@korea.ac.kr; glee@korea.ac.kr; eug203@korea.ac.kr;
   chokh@korea.ac.kr; kirry0806@gmail.com; 12thrib@hanmail.net;
   ygpark@catholic.ac.kr; hkd@ssu.ac.kr; mrchir00@gmail.com
RI Lee, Gyu Bae/GLN-2982-2022
OI Lee, Gyu Bae/0000-0002-1650-1278; Yim, Sun Young/0000-0001-7346-5974;
   han, byoungduck/0000-0003-2830-1174; Kim, Yang-Hyun/0000-0003-3548-8758
FU Alvogen Korea
FX This study was supported by Alvogen Korea.
CR Afolabi PR, 2018, J BREATH RES, V12, DOI 10.1088/1752-7163/aacf12
   [Anonymous], 2000, ASIA PACIFIC PERSPEC
   Anstee QM, 2018, NAT REV GASTRO HEPAT, V15, P425, DOI 10.1038/s41575-018-0010-0
   Aung LHH, 2021, MOL THER-NUCL ACIDS, V25, P416, DOI 10.1016/j.omtn.2021.06.006
   Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33
   Benjamin EJ, 2018, CIRCULATION, V137, pE67, DOI [10.1161/CIR.0000000000000530, 10.1161/CIR.0000000000000558, 10.1161/CIR.0000000000000485]
   Borges-Canha M, 2019, ENDOCRINE, V66, P467, DOI 10.1007/s12020-019-02070-0
   Byrne CD, 2022, DIABETES OBES METAB, V24, P28, DOI 10.1111/dom.14484
   Calori G, 2011, HEPATOLOGY, V54, P145, DOI 10.1002/hep.24356
   Carvalhana S, 2014, LIVER INT, V34, pE111, DOI 10.1111/liv.12305
   Chalasani N, 2018, HEPATOLOGY, V67, P328, DOI 10.1002/hep.29367
   Chang Y, 2013, AM J GASTROENTEROL, V108, P1861, DOI 10.1038/ajg.2013.349
   Cho EJ, 2021, DIAGNOSTICS, V11, DOI 10.3390/diagnostics11122233
   Chopyk DM, 2020, GASTROENTEROLOGY, V159, P849, DOI 10.1053/j.gastro.2020.04.077
   Climent M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21124370
   den Ruijter H, 2015, NETH HEART J, V23, P89, DOI 10.1007/s12471-014-0613-1
   Elagizi A, 2018, PROG CARDIOVASC DIS, V61, P142, DOI 10.1016/j.pcad.2018.07.003
   Fan JG, 2017, J HEPATOL, V67, P862, DOI 10.1016/j.jhep.2017.06.003
   Francque SM, 2016, J HEPATOL, V65, P425, DOI 10.1016/j.jhep.2016.04.005
   Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421
   He J, 2001, ARCH INTERN MED, V161, P996, DOI 10.1001/archinte.161.7.996
   Heidenreich PA, 2013, CIRC-HEART FAIL, V6, P606, DOI 10.1161/HHF.0b013e318291329a
   Houghton D, 2019, J HEPATOL, V70, P1203, DOI 10.1016/j.jhep.2019.01.035
   HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968
   Im HJ, 2021, CLIN RES HEPATOL GAS, V45, DOI 10.1016/j.clinre.2020.06.022
   Jacob JS, 2021, CURR OPIN INFECT DIS, V34, P477, DOI 10.1097/QCO.0000000000000759
   Jennison E, 2021, CLIN MOL HEPATOL, V27, P22
   Kasumov T, 2011, METABOLISM, V60, P776, DOI 10.1016/j.metabol.2010.07.027
   Lee JH, 2016, KOREAN CIRC J, V46, P658, DOI 10.4070/kcj.2016.46.5.658
   Lee YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107584
   Loomba R, 2017, CELL METAB, V25, P1054, DOI 10.1016/j.cmet.2017.04.001
   Mantovani A, 2022, J AM COLL CARDIOL, V79, P180, DOI 10.1016/j.jacc.2021.11.007
   Miller A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-69013-y
   Packer M, 2020, AM J MED, V133, P170, DOI 10.1016/j.amjmed.2019.09.002
   Park SH, 2006, J GASTROEN HEPATOL, V21, P138, DOI 10.1111/j.1440-1746.2005.04086.x
   Powell-Wiley TM, 2021, CIRCULATION, V143, pE984, DOI 10.1161/CIR.0000000000000973
   Ratziu V, 2019, CONTEMP CLIN TRIALS, V84, DOI 10.1016/j.cct.2019.06.017
   Roh JH, 2020, BMC CARDIOVASC DISOR, V20, DOI 10.1186/s12872-020-01444-x
   Seo SR, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17228451
   Seong SC, 2017, INT J EPIDEMIOL, V46, P799, DOI 10.1093/ije/dyw253
   Silva ACSE, 2017, WORLD J GASTROENTERO, V23, P3396, DOI 10.3748/wjg.v23.i19.3396
   Simon TG, 2021, GUT, V70, P1375, DOI 10.1136/gutjnl-2020-322786
   Simon TG, 2018, INT J CARDIOL, V259, P198, DOI 10.1016/j.ijcard.2018.01.046
   Sîrbu O, 2016, ANATOL J CARDIOL, V16, P534, DOI 10.14744/AnatolJCardiol.2016.7049
   Song SO, 2014, DIABETES METAB J, V38, P395
   Sotomi Y, 2021, J AM HEART ASSOC, V10, DOI 10.1161/JAHA.120.018574
   Stahl EP, 2019, J AM COLL CARDIOL, V73, P948, DOI 10.1016/j.jacc.2018.11.050
   Targher G, 2021, LANCET GASTROENTEROL, V6, pS78, DOI 10.1016/S2468-1253(21)00020-0
   VanWagner LB, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.119.014279
   Vita T, 2019, RADIOLOGY, V291, P329, DOI 10.1148/radiol.2019181793
   Wu N, 2013, INT J CARDIOL, V169, P62, DOI 10.1016/j.ijcard.2013.08.078
   Youn JC, 2017, KOREAN CIRC J, V47, P16, DOI 10.4070/kcj.2016.0429
   Younossi ZM, 2018, HEPATOLOGY, V68, P361, DOI 10.1002/hep.29724
   Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431
   Zhao Yongzhong, 2020, J Lab Precis Med, V5, DOI 10.21037/jlpm.2020.01.01
   Zhu LX, 2013, HEPATOLOGY, V57, P601, DOI 10.1002/hep.26093
NR 56
TC 5
Z9 5
U1 1
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2075-4418
J9 DIAGNOSTICS
JI Diagnostics
PD MAR
PY 2022
VL 12
IS 3
AR 663
DI 10.3390/diagnostics12030663
PG 12
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA 0C7CU
UT WOS:000775467800001
PM 35328216
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Hollingsworth, KG
   MacGowan, GA
   Morris, L
   Bates, MGD
   Taylor, R
   Jones, DEJ
   Newton, JL
   Blamire, AM
AF Hollingsworth, Kieren G.
   MacGowan, Guy A.
   Morris, Louise
   Bates, Matthew G. D.
   Taylor, Roy
   Jones, David E. J.
   Newton, Julia L.
   Blamire, Andrew M.
TI Cardiac torsion-strain relationships in fatigued primary biliary
   cirrhosis patients show accelerated aging: a pilot cross-sectional study
SO JOURNAL OF APPLIED PHYSIOLOGY
LA English
DT Article
DE torsion; strain; magnetic resonance imaging; liver disease; autoimmune
ID HEART-RATE-VARIABILITY; LEFT-VENTRICULAR TORSION; BAROREFLEX
   SENSITIVITY; PERIPHERAL NEUROPATHY; FRIEDREICH ATAXIA; MORTALITY; RISK;
   CARDIOMYOPATHY; DEFORMATION; HYPERTROPHY
AB Hollingsworth KG, MacGowan GA, Morris L, Bates MG, Taylor R, Jones DE, Newton JL, Blamire AM. Cardiac torsion-strain relationships in fatigued primary biliary cirrhosis patients show accelerated aging: a pilot cross-sectional study. J Appl Physiol 112: 2043-2048, 2012. First published March 29, 2012; doi:10.1152/japplphysiol.00195.2012.-The autoimmune liver disease primary biliary cirrhosis (PBC) is associated with life-altering fatigue in similar to 50% of patients. Previous work suggests that fatigued PBC subjects have evidence of autonomic dysfunction and may be at a higher risk of sudden cardiac death. The manifestation of this risk is not clear. This pilot study investigated whether alterations in cardiac torsion and strain could be detected in fatigued or nonfatigued early-stage PBC patients. We performed cardiac tissue tagging and anatomical cine-imaging in 13 early-stage PBC patients (including 7 with significant fatigue) and 10 control subjects to calculate cardiac torsion and strain throughout systole and diastole. From the cardiac tagging, we calculated the torsion-to-shortening ratio (TSR), a measure of subepicardial torsion exerting mechanical advantage over subendocardial shortening. Autonomic function testing was performed to evaluate baroreceptor effective index on standing. TSR was markedly increased in the fatigued PBC patients (0.70 +/- 0.13) compared with both controls (0.46 +/- 0.11, P = 0.002) and nonfatigued PBC patients (0.44 +/- 0.12, P = 0.003). Decreased baroreceptor effective index on standing strongly correlated with increased TSR within the whole PBC group (r = -0.71, P = 0.007). Fatigued PBC patients demonstrate a redistribution of myocardial strain characteristic of a reduced relative contribution to contraction from the subendocardium. This is analogous to the changes found in healthy aging for subjects similar to 16 yr older than the fatigued PBC patients. Hence the hearts of fatigued PBC patients may be subject to processes of accelerated aging.
C1 [Hollingsworth, Kieren G.; Morris, Louise; Taylor, Roy; Blamire, Andrew M.] Newcastle Univ, Newcastle Magnet Resonance Ctr, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England.
   [Hollingsworth, Kieren G.; Morris, Louise; Taylor, Roy; Jones, David E. J.; Blamire, Andrew M.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England.
   [MacGowan, Guy A.] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England.
   [MacGowan, Guy A.] Freeman Rd Hosp, Dept Cardiol, Newcastle Upon Tyne, Tyne & Wear, England.
   [Bates, Matthew G. D.] Newcastle Univ, Inst Ageing & Hlth, Mitochondrial Res Grp, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England.
C3 Newcastle University - UK; Newcastle University - UK; Newcastle
   University - UK; Newcastle Freeman Hospital; Newcastle University - UK;
   Newcastle University - UK
RP Hollingsworth, KG (corresponding author), Newcastle Univ, Newcastle Magnet Resonance Ctr, Campus Ageing & Vital, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England.
EM k.g.hollingsworth@ncl.ac.uk
RI Blamire, Andrew/AAU-6100-2021
OI Blamire, Andrew/0000-0002-8749-1257; Newton, Julia/0000-0002-1249-5253
FU Medical Research Council [G0500020]; Newcastle UK National Institutes of
   Health Research Biomedical Research Centre in Ageing and Age Related
   Diseases; MRC New Investigator Research Grant [G1100160]; Wellcome Trust
   Research Training Fellowship [BH092142]; MRC [G1100160, G0500020]
   Funding Source: UKRI; Medical Research Council [G0500020, G1100160]
   Funding Source: researchfish; National Institute for Health Research
   [IS-BRC-0211-10046] Funding Source: researchfish; NIHR Newcastle
   Biomedical Research Centre [BH121729] Funding Source: researchfish
FX The study was funded by Medical Research Council (MRC Grant G0500020)
   and the Newcastle UK National Institutes of Health Research Biomedical
   Research Centre in Ageing and Age Related Diseases. K. G. Hollingsworth
   is funded by an MRC New Investigator Research Grant (G1100160). M. G. D.
   Bates is funded by a Wellcome Trust Research Training Fellowship
   (BH092142).
CR BERTINIERI G, 1985, J HYPERTENS, V3, pS79
   BOLLI R, 1989, AM J PHYSIOL, V257, pH375, DOI 10.1152/ajpheart.1989.257.2.H375
   BUCHALTER MB, 1990, CIRCULATION, V81, P1236, DOI 10.1161/01.CIR.81.4.1236
   Camm AJ, 1996, EUR HEART J, V17, P354
   Cheng S, 2009, CIRC-CARDIOVASC IMAG, V2, P191, DOI 10.1161/CIRCIMAGING.108.819938
   Delhaas T, 2004, MAGNET RESON MED, V51, P135, DOI 10.1002/mrm.10679
   Di Rienzo M, 2001, AM J PHYSIOL-REG I, V280, pR744, DOI 10.1152/ajpregu.2001.280.3.R744
   FISCHER SE, 1993, MAGNET RESON MED, V30, P191, DOI 10.1002/mrm.1910300207
   Hart PE, 2005, ARCH NEUROL-CHICAGO, V62, P621, DOI 10.1001/archneur.62.4.621
   HENDRICKSE MT, 1993, J HEPATOL, V19, P401, DOI 10.1016/S0168-8278(05)80549-5
   Hollingsworth KG, 2012, AM J PHYSIOL-HEART C, V302, pH885, DOI 10.1152/ajpheart.00985.2011
   Hor KN, 2009, J AM COLL CARDIOL, V53, P1204, DOI 10.1016/j.jacc.2008.12.032
   ISHIJIMA M, 1990, JPN CIRC J, V54, P616, DOI 10.1253/jcj.54.616
   Jackson H, 2007, HEPATOLOGY, V46, P1131, DOI 10.1002/hep.21795
   Jones DE, 2010, J HEPATOL, V53, P911, DOI 10.1016/j.jhep.2010.05.026
   Jones DEJ, 2010, AM J PHYSIOL-GASTR L, V298, pG764, DOI 10.1152/ajpgi.00501.2009
   KEMPLER P, 1994, J HEPATOL, V21, P1150, DOI 10.1016/S0168-8278(05)80640-3
   Keresztes K, 2004, WORLD J GASTROENTERO, V10, P3039
   La Rovere MT, 2001, CIRCULATION, V103, P2072
   La Rovere MT, 1998, LANCET, V351, P478
   Lodi R, 2001, CARDIOVASC RES, V52, P111, DOI 10.1016/S0008-6363(01)00357-1
   Lumens J, 2006, AM J PHYSIOL-HEART C, V291, pH1573, DOI 10.1152/ajpheart.00074.2006
   Mazhari R, 2001, CIRCULATION, V104, P336, DOI 10.1161/01.CIR.104.3.336
   Metcalf JV, 1997, INT J EPIDEMIOL, V26, P830, DOI 10.1093/ije/26.4.830
   Newton JL, 2006, LIVER INT, V26, P197, DOI 10.1111/j.1478-3231.2005.01214.x
   Newton JL, 2007, EUR J GASTROEN HEPAT, V19, P125, DOI 10.1097/01.meg.0000252629.96043.67
   Oxenham HC, 2003, J CARDIOV MAGN RESON, V5, P421, DOI 10.1081/JCMR-120022258
   Parry SW, 2009, HEART, V95, P416, DOI 10.1136/hrt.2007.136457
   Prince M, 2002, GASTROENTEROLOGY, V123, P1044, DOI 10.1053/gast.2002.36027
   Prince MI, 2000, J HEPATOL, V32, P368, DOI 10.1016/S0168-8278(00)80385-2
   Rüssel IK, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-3
   Tsuji H, 1996, CIRCULATION, V94, P2850, DOI 10.1161/01.CIR.94.11.2850
   Van der Toorn A, 2002, AM J PHYSIOL-HEART C, V283, pH1609, DOI 10.1152/ajpheart.00239.2002
   YOUNG AA, 1994, CIRCULATION, V90, P854, DOI 10.1161/01.CIR.90.2.854
NR 34
TC 11
Z9 11
U1 0
U2 5
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 8750-7587
EI 1522-1601
J9 J APPL PHYSIOL
JI J. Appl. Physiol.
PD JUN
PY 2012
VL 112
IS 12
BP 2043
EP 2048
DI 10.1152/japplphysiol.00195.2012
PG 6
WC Physiology; Sport Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology; Sport Sciences
GA 960WB
UT WOS:000305422100012
PM 22461446
OA Green Published
DA 2024-02-19
ER

PT J
AU Wu, HK
   Liao, BL
   Li, XY
   Liu, HY
   Gong, MX
   Shi, HY
   Xie, S
   Guo, FX
   Chen, K
   Yan, R
   Zhao, H
   Li, LY
   Zheng, AN
   Liu, Y
   Wang, ZH
AF Wu, Hongkai
   Liao, Baolin
   Li, Xueying
   Liu, Huiyuan
   Gong, Mingxing
   Shi, Haiyan
   Xie, Shi
   Guo, Fengxia
   Chen, Keng
   Yan, Rong
   Zhao, Han
   Li, Liya
   Zheng, Anqi
   Liu, Yu
   Wang, Zhanhui
TI Increased hepatitis B virus quasispecies diversity is correlated with
   liver fibrosis progression
SO INFECTION GENETICS AND EVOLUTION
LA English
DT Article; Early Access
DE Hepatitis B virus; Quasispecies; Next-generation sequencing; Diversity;
   Fibrosis
ID E-ANTIGEN; HYPOTHESIS; RATES
AB Host immune response and viral factors are involved in disease progression in patients with chronic hepatitis B virus (HBV) infection. However, the relationship between HBV quasispecies and liver fibrosis progression remains unclear. In this study, 447 patients with chronic HBV infection, including 239 with chronic hepatitis B (CHB), 104 with liver cirrhosis (LC) and 104 with hepatocellular carcinoma (HCC) were enrolled. The 239 CHB patients were divided into groups F1, F2, and F3 according to liver fibrosis score. Four fragments of the HBV genome were determined and analyzed using next-generation sequencing. Specific mutations, such as A1762T, G1764A and G1896A, in the BCP/PC region were more common in patients with advanced liver disease and formed the majority of the viral quasispecies pool in patients with LC and HCC. The viral complexity and diversity increased as the fibrosis progressed, especially in patients with CHB who were comparable in age but at different stages of fibrosis. Patients with early-stage fibrosis experienced higher purifying selection pressure in the four sequenced regions, whereas different protein-coding region experienced different negative selection with disease progression. HBV quasispecies diversity may increase fibrosis progression in CHB patients with aging under immune selection.
C1 [Wu, Hongkai] Guangzhou Med Univ, Affiliated Hosp 1, Natl Clin Res Ctr Resp Dis, State Key Lab Resp Dis, Guangzhou, Peoples R China.
   [Liao, Baolin; Liu, Huiyuan; Shi, Haiyan; Guo, Fengxia; Chen, Keng; Zhao, Han; Li, Liya] Guangzhou Med Univ, Guangzhou Eighth Peoples Hosp, Dept Infect Dis, Guangzhou, Peoples R China.
   [Li, Xueying; Gong, Mingxing; Xie, Shi; Yan, Rong; Zheng, Anqi; Wang, Zhanhui] Southern Med Univ, Nanfang Hosp, State Key Lab Organ Failure Res, Guangdong Prov Key Lab Viral Hepatitis Res,Dept I, Guangzhou, Peoples R China.
   [Li, Xueying; Gong, Mingxing; Xie, Shi; Yan, Rong; Zheng, Anqi; Wang, Zhanhui] Southern Med Univ, Nanfang Hosp, Hepatol Unit, Guangzhou, Peoples R China.
   [Liu, Yu] Dalian Med Univ, Second Hosp, Dept Infect Dis, Dalian, Peoples R China.
C3 Guangzhou Medical University; State Key Laboratory of Respiratory
   Disease; Guangzhou Medical University; Southern Medical University -
   China; Southern Medical University - China; Dalian Medical University
RP Wang, ZH (corresponding author), Southern Med Univ, Nanfang Hosp, State Key Lab Organ Failure Res, Guangdong Prov Key Lab Viral Hepatitis Res,Dept I, Guangzhou, Peoples R China.; Wang, ZH (corresponding author), Southern Med Univ, Nanfang Hosp, Hepatol Unit, Guangzhou, Peoples R China.; Liu, Y (corresponding author), Dalian Med Univ, Second Hosp, Dept Infect Dis, Dalian, Peoples R China.
EM yuliu08@163.com; wangzhh@smu.edu.cn
RI Wang, Shan/JPX-1098-2023; zheng, Li/JVN-7465-2024; wang,
   wenxin/JOZ-3291-2023; Wang, Zhanhui/AAH-8601-2019
FU Science and Technology Program of Guangzhou [201803010041]; National
   Science and Technology Major Project [2018ZX10301-101,
   2017ZX10202101-003-001, 2018ZX10301-202]; National Natural Science
   Foundation of China [81772600]; Natural Science Foundation of Guangdong
   Province [2018A0303130345]
FX This work was supported by the Science and Technology Program of
   Guangzhou (201803010041) , the National Science and Technology Major
   Project (2018ZX10301-101, 2017ZX10202101-003-001, 2018ZX10301-202) , the
   National Natural Science Foundation of China (81772600) and the Natural
   Science Foundation of Guangdong Province (2018A0303130345) . The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Cheng Y, 2013, GUT, V62, P1347, DOI 10.1136/gutjnl-2012-302408
   Domingo E, 2006, CURR TOP MICROBIOL, V299, P51
   Frelin L, 2009, J VIROL, V83, P1379, DOI 10.1128/JVI.01902-08
   Hughes AL, 2005, VIRUS RES, V113, P81, DOI 10.1016/j.virusres.2005.03.030
   Jazayeri SM, 2010, J VIRAL HEPATITIS, V17, P229, DOI 10.1111/j.1365-2893.2009.01193.x
   Kennedy PTF, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9050096
   Kennedy PTF, 2012, GASTROENTEROLOGY, V143, P637, DOI 10.1053/j.gastro.2012.06.009
   Kim GA, 2018, GUT, V67, P945, DOI 10.1136/gutjnl-2017-314904
   KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581
   Kumar M, 2008, GASTROENTEROLOGY, V134, P1376, DOI 10.1053/j.gastro.2008.02.075
   Lesmana CRA, 2011, J DIGEST DIS, V12, P476, DOI 10.1111/j.1751-2980.2011.00540.x
   Liang YJ, 2018, MOL MED REP, V17, P5528, DOI 10.3892/mmr.2018.8551
   Liao BL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078672
   Mason WS, 2016, GASTROENTEROLOGY, V151, P986, DOI 10.1053/j.gastro.2016.07.012
   Milich D, 2003, HEPATOLOGY, V38, P1075, DOI 10.1053/jhep.2003.50453
   Paradis E, 2010, BIOINFORMATICS, V26, P419, DOI 10.1093/bioinformatics/btp696
   Park JJ, 2016, GASTROENTEROLOGY, V150, P684, DOI 10.1053/j.gastro.2015.11.050
   Pawlotsky JM, 2005, J CLIN VIROL, V34, pS125, DOI 10.1016/S1386-6532(05)80021-6
   Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079
   Sarin SK, 2016, HEPATOL INT, V10, P1, DOI 10.1007/s12072-015-9675-4
   Seto WK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032622
   TAJIMA F, 1989, GENETICS, V123, P585
   Tong SP, 2005, J CLIN VIROL, V34, pS134, DOI 10.1016/S1386-6532(05)80023-X
   Tseng TC, 2015, GUT, V64, P292, DOI 10.1136/gutjnl-2014-306977
   van de Klundert MAA, 2012, J VIRAL HEPATITIS, V19, pE34, DOI 10.1111/j.1365-2893.2011.01506.x
   Vanwolleghem T, 2015, HEPATOLOGY, V62, P87, DOI 10.1002/hep.27805
   Wang HY, 2010, J VIROL, V84, P3454, DOI 10.1128/JVI.02164-09
   Xiao L, 2011, J MED VIROL, V83, P1544, DOI 10.1002/jmv.22159
   Yang GF, 2017, J INFECTION, V75, P48, DOI 10.1016/j.jinf.2017.04.012
   Zhang DK, 2010, INFECT GENET EVOL, V10, P84, DOI 10.1016/j.meegid.2009.10.006
NR 30
TC 2
Z9 2
U1 1
U2 14
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1567-1348
EI 1567-7257
J9 INFECT GENET EVOL
JI Infect. Genet. Evol.
PD 2021 SEP
PY 2021
VL 93
AR 104938
DI 10.1016/j.meegid.2021.104938
EA MAY 2021
PG 8
WC Infectious Diseases
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Infectious Diseases
GA UF1FX
UT WOS:000688328300007
PM 34029727
DA 2024-02-19
ER

PT J
AU Krishna, TH
   Mahipal, S
   Sudhakar, A
   Sugimoto, H
   Kalluri, R
   Rao, KS
AF Krishna, TH
   Mahipal, S
   Sudhakar, A
   Sugimoto, H
   Kalluri, R
   Rao, KS
TI Reduced DNA gap repair in aging rat neuronal extracts and its
   restoration by DNA polymerase β and DNA-ligase
SO JOURNAL OF NEUROCHEMISTRY
LA English
DT Article
DE aging brain; DNA-gap repair; DNA-ligase; DNA-polymerase beta
ID BASE EXCISION-REPAIR; BRAIN; FRACTIONS; DELTA
AB Synthetic deoxy-oligo duplexes containing short gaps of 1 and 4 nucleotides were used as model substrates to assess the DNA gap repair ability of the neuronal extracts prepared from cerebral cortex of rats of different ages. Our results demonstrate that gap repair activity in neurons decreases markedly with age. The decreased activity could be restored by supplementing the neuronal extracts with pure recombinant rat liver DNA polymerase beta. High levels of DNA polymerase beta supplementation resulted in gap-filling activity that proceeded essentially through addition of nucleotides through a slow distributive strand displacement mode to achieve full template length (32-mer). However, at lower concentrations of DNA polymerase beta, the gap repair takes place quickly through gap filling followed by ligation to downstream primer, in an energy efficient manner. For this to happen, the conditions required are the presence of 5'-PO4 on the downstream primer and supplementation of aging neuronal extracts with DNA-ligase in addition to recombinant DNA polymerase beta. These results demonstrate that aging neurons are unable to affect base excision repair (BER) due to deficiency of DNA polymerase beta and DNA-ligase and fortifying aged neuronal extracts with these two factors can restore the lost BER activity.
C1 Univ Hyderabad, ICMR, Adv Ctr Res Aging & Brain, Dept Biochem, Hyderabad 500046, Andhra Pradesh, India.
   Beth Israel Deaconess Med Ctr, Ctr Matrix Biol, Dept Med, Boston, MA 02215 USA.
   Harvard Univ, Sch Med, Boston, MA 02215 USA.
C3 Indian Council of Medical Research (ICMR); University of Hyderabad;
   Harvard University; Beth Israel Deaconess Medical Center; Harvard
   University; Harvard Medical School
RP Rao, KS (corresponding author), Univ Hyderabad, ICMR, Adv Ctr Res Aging & Brain, Dept Biochem, Hyderabad 500046, Andhra Pradesh, India.
EM ksrsl@yahoo.com
RI Kalluri, Raghu/E-2677-2015
OI Kalluri, Raghu/0000-0002-2190-547X
FU NIDDK NIH HHS [DK 55001, DK 62987] Funding Source: Medline
CR Cabelof DC, 2002, MUTAT RES-FUND MOL M, V500, P135, DOI 10.1016/S0027-5107(02)00003-9
   Chagovetz AM, 1997, J BIOL CHEM, V272, P27501, DOI 10.1074/jbc.272.44.27501
   DIANOV G, 1992, MOL CELL BIOL, V12, P1605, DOI 10.1128/MCB.12.4.1605
   Dianov GL, 1999, J BIOL CHEM, V274, P13741, DOI 10.1074/jbc.274.20.13741
   Fortini P, 1998, BIOCHEMISTRY-US, V37, P3575, DOI 10.1021/bi972999h
   Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232
   Idriss HT, 2002, INT J BIOCHEM CELL B, V34, P321, DOI 10.1016/S1357-2725(01)00131-5
   Memisoglu A, 2000, MUTAT RES-FUND MOL M, V451, P39, DOI 10.1016/S0027-5107(00)00039-7
   Podlutsky AJ, 2001, EMBO J, V20, P1477, DOI 10.1093/emboj/20.6.1477
   Prapurna DR, 1997, INT J DEV NEUROSCI, V15, P67, DOI 10.1016/S0736-5748(96)00047-0
   PRASAD R, 1994, J BIOL CHEM, V269, P18096
   Raji NS, 2002, INT J DEV NEUROSCI, V20, P491, DOI 10.1016/S0736-5748(02)00079-5
   RANI BU, 1983, J NEUROSCI RES, V10, P101, DOI 10.1002/jnr.490100112
   Rao Kalluri Subba, 2003, Proceedings of the Indian National Science Academy Part B Biological Sciences, V69, P141
   Rao KS, 2000, MOL BRAIN RES, V85, P251, DOI 10.1016/S0169-328X(00)00266-7
   SINGHAL RK, 1993, J BIOL CHEM, V268, P15906
   Tomkinson AE, 1998, MUTAT RES-DNA REPAIR, V407, P1, DOI 10.1016/S0921-8777(97)00050-5
   WASER J, 1979, EUR J BIOCHEM, V97, P361, DOI 10.1111/j.1432-1033.1979.tb13122.x
   Wilson DM, 1997, P NATL ACAD SCI USA, V94, P12754, DOI 10.1073/pnas.94.24.12754
   Wilson SH, 1998, MUTAT RES-DNA REPAIR, V407, P203, DOI 10.1016/S0921-8777(98)00002-0
   Wood RD, 1997, CARCINOGENESIS, V18, P605, DOI 10.1093/carcin/18.4.605
NR 21
TC 49
Z9 49
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3042
EI 1471-4159
J9 J NEUROCHEM
JI J. Neurochem.
PD FEB
PY 2005
VL 92
IS 4
BP 818
EP 823
DI 10.1111/j.1471-4159.2004.02923.x
PG 6
WC Biochemistry & Molecular Biology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA 893GF
UT WOS:000226706600012
PM 15686483
DA 2024-02-19
ER

PT J
AU Chang, JS
   Van Remmen, H
   Cornell, J
   Richardson, A
   Ward, WF
AF Chang, JS
   Van Remmen, H
   Cornell, J
   Richardson, A
   Ward, WF
TI Comparative proteomics: characterization of a two-dimensional gel
   electrophoresis system to study the effect of aging on mitochondrial
   proteins
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article; Proceedings Paper
CT International Conference on Functional Genomics of Ageing
CY APR 24-27, 2002
CL SEVILLE, SPAIN
DE 2-D PAGE; mitochondria proteins; aging; skeletal muscle
ID IMMOBILIZED PH GRADIENTS; 2-DIMENSIONAL ELECTROPHORESIS; OXIDATIVE
   STRESS; IDENTIFICATION; COMPLEX; LIVER
AB To study the effect of aging and anti-aging strategies on mitochondria, we have characterized a two-dimensional polyacrylamide gel electrophoresis (2-D PAGE) system to analyze the profile of mitochondrial proteins. We have optimized the separation of proteins by 2-D PAGE and established the linearity and reproducibility of the system with mitochondria isolated from skeletal muscle of mice. Using total mitochondria protein ranging from 10 to 200 mug, we found that 74% of the proteins resolved by 2-D PAGE had coefficient of determination (R-2) values greater than 0.8, showing a linear increase in fluorescence with increasing protein concentration. The coefficient of variation (CV) was less than 50% for at least 93% of the 424 spots analyzed for both gel-to-gel variance and animal-to-animal variance. Using mitochondrial protein fractions prepared from skeletal muscle of 18-month-old mice, we show that 10 animals will be sufficient to detect a 100% difference in the 97% (i.e. 505) of the proteins resolved by 2-D PAGE. Thus, 2-D PAGE provides a sensitive and reliable technique for analysis of protein expression in mitochondria. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
C1 Univ Texas, Hlth Sci Ctr, Dept Physiol, San Antonio, TX 78229 USA.
   S Texas Vet Hlth Care Syst, GRECC, San Antonio, TX 78229 USA.
   S Texas Vet Hlth Care Syst, Audie L Murphy Div, Vet Evidence Based Res Disseminat & Implementat C, San Antonio, TX 78229 USA.
   Univ Texas, Hlth Sci Ctr, Div Geriatr & Gerontol, San Antonio, TX 78229 USA.
C3 University of Texas System; University of Texas Health Science Center at
   San Antonio; Geriatric Research Education & Clinical Center; US
   Department of Veterans Affairs; Veterans Health Administration (VHA);
   Audie L. Murphy Memorial Veterans Hospital; US Department of Veterans
   Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial
   Veterans Hospital; University of Texas System; University of Texas
   Health Science Center at San Antonio
RP Ward, WF (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Physiol, 7703 Floyd Curl Dr,MSC 7756, San Antonio, TX 78229 USA.
EM wardw@uthscsa.edu
FU NIA NIH HHS [P01 AG19316, P01 AG20591, P01AG14674, P01 AG13319] Funding
   Source: Medline
CR AMILS R, 1977, BIOCHEM J, V164, P363, DOI 10.1042/bj1640363
   Berggren K, 2000, ELECTROPHORESIS, V21, P2509, DOI 10.1002/1522-2683(20000701)21:12<2509::AID-ELPS2509>3.0.CO;2-9
   BJELLQVIST B, 1982, J BIOCHEM BIOPH METH, V6, P317, DOI 10.1016/0165-022X(82)90013-6
   BOVERIS A, 1976, BIOCHEM J, V156, P435, DOI 10.1042/bj1560435
   Ernster L., 1967, METHOD ENZYMOL, V10, P86
   Fountoulakis M, 2002, ELECTROPHORESIS, V23, P311, DOI 10.1002/1522-2683(200202)23:2<311::AID-ELPS311>3.0.CO;2-0
   GORG A, 1988, ELECTROPHORESIS, V9, P57, DOI 10.1002/elps.1150090111
   Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Jung E, 2000, ELECTROPHORESIS, V21, P3369, DOI 10.1002/1522-2683(20001001)21:16<3369::AID-ELPS3369>3.0.CO;2-7
   Kenrick K G, 1970, Anal Biochem, V33, P204, DOI 10.1016/0003-2697(70)90454-9
   Kernec F, 2001, PHYSIOL GENOMICS, V6, P117, DOI 10.1152/physiolgenomics.2001.6.2.117
   KLOSE J, 1975, HUMANGENETIK, V26, P231
   KLOSE J, 1995, ELECTROPHORESIS, V16, P1034, DOI 10.1002/elps.11501601175
   LEE CP, 1979, MUSCLE NERVE, V2, P340, DOI 10.1002/mus.880020504
   Lenaz G, 1998, BBA-BIOENERGETICS, V1366, P53, DOI 10.1016/S0005-2728(98)00120-0
   LEVINE RL, 1996, PROTEIN MODIFICATION, P184
   Lopez MF, 2000, ELECTROPHORESIS, V21, P3427, DOI 10.1002/1522-2683(20001001)21:16<3427::AID-ELPS3427>3.0.CO;2-L
   Lopez MF, 2000, ELECTROPHORESIS, V21, P3673, DOI 10.1002/1522-2683(200011)21:17<3673::AID-ELPS3673>3.3.CO;2-D
   MARKINEN MW, 1968, ARCH BIOCHEM BIOPHYS, V126, P75
   Mitsumoto A, 2002, FREE RADICAL BIO MED, V32, P22, DOI 10.1016/S0891-5849(01)00755-9
   OFARRELL PH, 1975, J BIOL CHEM, V250, P4007
   Rabilloud T, 2001, PROTEOMICS, V1, P1105, DOI 10.1002/1615-9861(200109)1:9<1105::AID-PROT1105>3.0.CO;2-M
   Rabilloud T, 1998, ELECTROPHORESIS, V19, P1006, DOI 10.1002/elps.1150190616
   Raha S, 2000, FREE RADICAL BIO MED, V29, P170, DOI 10.1016/S0891-5849(00)00338-5
   RIGHETTI PG, 1990, J CHROMATOGR, V516, P3, DOI 10.1016/S0021-9673(01)90200-6
   Ross HM, 1996, P ROY SOC B-BIOL SCI, V263, P283, DOI 10.1098/rspb.1996.0043
   SCHATZ G, 1995, BBA-MOL BASIS DIS, V1271, P123, DOI 10.1016/0925-4439(95)00018-Y
   Scheffler NK, 2001, MITOCHONDRION, V1, P161, DOI 10.1016/S1567-7249(01)00007-1
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   Yan JX, 2000, ELECTROPHORESIS, V21, P3657, DOI 10.1002/1522-2683(200011)21:17<3657::AID-ELPS3657>3.0.CO;2-2
NR 32
TC 35
Z9 43
U1 0
U2 2
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD JAN
PY 2003
VL 124
IS 1
BP 33
EP 41
AR PII S0047-6374(02)00167-7
DI 10.1016/S0047-6374(02)00167-7
PG 9
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Cell Biology; Geriatrics & Gerontology
GA 665BJ
UT WOS:000182099500006
PM 12618004
DA 2024-02-19
ER

PT J
AU Sundaresan, NR
   Bindu, S
   Pillai, VB
   Samant, S
   Pan, Y
   Huang, JY
   Gupta, M
   Nagalingam, RS
   Wolfgeher, D
   Verdin, E
   Gupta, MP
AF Sundaresan, Nagalingam R.
   Bindu, Samik
   Pillai, Vinodkumar B.
   Samant, Sadhana
   Pan, Yong
   Huang, Jing-Yi
   Gupta, Madhu
   Nagalingam, Raghu S.
   Wolfgeher, Donald
   Verdin, Eric
   Gupta, Mahesh P.
TI SIRT3 Blocks Aging-Associated Tissue Fibrosis in Mice by Deacetylating
   and Activating Glycogen Synthase Kinase 3β
SO MOLECULAR AND CELLULAR BIOLOGY
LA English
DT Article
ID LIFE-SPAN; MESENCHYMAL TRANSITION; MOLECULAR-MECHANISMS;
   SUPEROXIDE-DISMUTASE; PROTEIN STABILITY; OXIDATIVE DAMAGE; CELL-DEATH;
   MITOCHONDRIAL; STRESS; KINASE-3-BETA
AB Tissue fibrosis is a major cause of organ dysfunction during chronic diseases and aging. A critical step in this process is transforming growth factor beta 1 (TGF-beta 1)-mediated transformation of fibroblasts into myofibroblasts, cells capable of synthesizing extracellular matrix. Here, we show that SIRT3 controls transformation of fibroblasts into myofibroblasts via suppressing the profibrotic TGF-beta 1 signaling. We found that Sirt3 knockout (KO) mice with age develop tissue fibrosis of multiple organs, including heart, liver, kidney, and lungs but not whole-body SIRT3-overexpressing mice. SIRT3 deficiency caused induction of TGF-beta 1 expression and hyperacetylation of glycogen synthase kinase 3 beta(GSK3 beta) at residue K15, which negatively regulated GSK3 beta activity to phosphorylate the substrates Smad3 and beta-catenin. Reduced phosphorylation led to stabilization and activation of these transcription factors regulating expression of the profibrotic genes. SIRT3 deacetylated and activated GSK3 beta and thereby blocked TGF-beta 1 signaling and tissue fibrosis. These data reveal a new role of SIRT3 to negatively regulate aging-associated tissue fibrosis and discloses a novel phosphorylation-independent mechanism controlling the catalytic activity of GSK3 beta.
C1 [Sundaresan, Nagalingam R.; Bindu, Samik; Pillai, Vinodkumar B.; Samant, Sadhana; Gupta, Mahesh P.] Univ Chicago, Dept Surg, Div Biol Sci, 5841 S Maryland Ave, Chicago, IL 60637 USA.
   [Gupta, Mahesh P.] Univ Chicago, Comm Mol Pathol & Mol Med, Chicago, IL 60637 USA.
   [Pan, Yong; Huang, Jing-Yi; Verdin, Eric] Univ Calif San Francisco, Gladstone Inst, San Francisco, CA 94143 USA.
   [Gupta, Madhu; Nagalingam, Raghu S.] Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60680 USA.
   [Wolfgeher, Donald] Univ Chicago, Dept Mol Genet & Cell Biol, 920 E 58Th St, Chicago, IL 60637 USA.
C3 University of Chicago; University of Chicago; University of California
   System; University of California San Francisco; The J David Gladstone
   Institutes; University of Illinois System; University of Illinois
   Chicago; University of Illinois Chicago Hospital; University of Chicago
RP Gupta, MP (corresponding author), Univ Chicago, Dept Surg, Div Biol Sci, 5841 S Maryland Ave, Chicago, IL 60637 USA.; Gupta, MP (corresponding author), Univ Chicago, Comm Mol Pathol & Mol Med, Chicago, IL 60637 USA.; Verdin, E (corresponding author), Univ Calif San Francisco, Gladstone Inst, San Francisco, CA 94143 USA.
EM everdin@gladstone.ucsf.edu; mgupta@surgery.bsd.uchicago.edu
RI Verdin, Eric/AAB-7999-2019
OI Bindu, Samik/0000-0003-1416-2003
FU HHS\ NIH \ National Heart, Lung, and Blood Institute (NHLBI) [RO1
   HL117041, RO1 HL111455]
FX HHS vertical bar NIH vertical bar National Heart, Lung, and Blood
   Institute (NHLBI) provided funding to Mahesh P. Gupta under grant number
   RO1 HL117041. HHS vertical bar NIH vertical bar National Heart, Lung,
   and Blood Institute (NHLBI) provided funding to Mahesh P. Gupta under
   grant number RO1 HL111455.
CR Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105
   [Anonymous], 2004, MOL PHARM
   Bellizzi D, 2005, GENOMICS, V85, P258, DOI 10.1016/j.ygeno.2004.11.003
   Bjelakovic G, 2007, JAMA-J AM MED ASSOC, V297, P842, DOI 10.1001/jama.297.8.842
   Brown K, 2013, CELL REP, V3, P319, DOI 10.1016/j.celrep.2013.01.005
   Brown KD, 2014, CELL METAB, V20, P1059, DOI 10.1016/j.cmet.2014.11.003
   Cabreiro F, 2011, FREE RADICAL BIO MED, V51, P1575, DOI 10.1016/j.freeradbiomed.2011.07.020
   Chen J, 2013, HEPATOLOGY, V57, P2287, DOI 10.1002/hep.26278
   Chiara F, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00016
   Cobbs SL, 2007, BIOCHEM BIOPH RES CO, V362, P288, DOI 10.1016/j.bbrc.2007.07.186
   D'Souza KM, 2011, J BIOL CHEM, V286, P15507, DOI 10.1074/jbc.M111.218263
   Doonan R, 2008, GENE DEV, V22, P3236, DOI 10.1101/gad.504808
   Doyle KP, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-62
   Finley LWS, 2011, CANCER CELL, V19, P416, DOI 10.1016/j.ccr.2011.02.014
   Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001
   Griese M, 2013, AM J RESP CRIT CARE, V188, P83, DOI 10.1164/rccm.201303-0427OC
   Guarente L, 2011, NEW ENGL J MED, V364, P2235, DOI 10.1056/NEJMra1100831
   Guo X, 2008, GENE DEV, V22, P106, DOI 10.1101/gad.1590908
   He WC, 2009, J AM SOC NEPHROL, V20, P765, DOI 10.1681/ASN.2008060566
   Hebert AS, 2013, MOL CELL, V49, P186, DOI 10.1016/j.molcel.2012.10.024
   Hirschey MD, 2011, MOL CELL, V44, P177, DOI 10.1016/j.molcel.2011.07.019
   HOSHI M, 1995, J BIOCHEM-TOKYO, V118, P683, DOI 10.1093/oxfordjournals.jbchem.a124965
   Huang XZ, 2014, J CELL BIOCHEM, V115, P996, DOI 10.1002/jcb.24748
   Ichikawa T, 2013, EXP CELL RES, V319, P1176, DOI 10.1016/j.yexcr.2013.02.014
   Inoue Y, 2007, ONCOGENE, V26, P500, DOI 10.1038/sj.onc.1209826
   Inuzuka H, 2012, CELL, V150, P179, DOI 10.1016/j.cell.2012.05.038
   Iwahara T, 2012, MOL CELL BIOL, V32, P5022, DOI 10.1128/MCB.00822-12
   Jin JL, 2009, AGING-US, V1, P582, DOI 10.18632/aging.100060
   Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530
   Kanfi Y, 2012, NATURE, V483, P218, DOI 10.1038/nature10815
   Krenning G, 2010, J CELL PHYSIOL, V225, P631, DOI 10.1002/jcp.22322
   Lanza IR, 2008, DIABETES, V57, P2933, DOI 10.2337/db08-0349
   Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev
   Massagué J, 2000, GENE DEV, V14, P627
   Matsuda T, 2008, P NATL ACAD SCI USA, V105, P20900, DOI 10.1073/pnas.0808315106
   Mehal WZ, 2011, NAT MED, V17, P552, DOI 10.1038/nm0511-552
   Meyer TE, 2006, J AM COLL CARDIOL, V47, P398, DOI 10.1016/j.jacc.2005.08.069
   Minagawa S, 2011, AM J PHYSIOL-LUNG C, V300, pL391, DOI 10.1152/ajplung.00097.2010
   Mora-Santos M, 2011, J BIOL CHEM, V286, P30047, DOI 10.1074/jbc.M111.232330
   Oka S, 2012, CELL CYCLE, V11, P856, DOI 10.4161/cc.11.5.19210
   Petit-Paitel A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005491
   Raghu G, 2012, NEW ENGL J MED, V366, P1968, DOI 10.1056/NEJMoa1113354
   Ristow M, 2009, P NATL ACAD SCI USA, V106, P8665, DOI 10.1073/pnas.0903485106
   Rong YQ, 1999, P NATL ACAD SCI USA, V96, P9897, DOI 10.1073/pnas.96.17.9897
   Rose G, 2003, EXP GERONTOL, V38, P1065, DOI 10.1016/S0531-5565(03)00209-2
   Sack MN, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013102
   Samant SA, 2014, MOL CELL BIOL, V34, P807, DOI 10.1128/MCB.01483-13
   Samarakoon R, 2013, CELL SIGNAL, V25, P264, DOI 10.1016/j.cellsig.2012.10.003
   Satoh A, 2013, CELL METAB, V18, P416, DOI 10.1016/j.cmet.2013.07.013
   Schwer B, 2002, J CELL BIOL, V158, P647, DOI 10.1083/jcb.200205057
   Shi T, 2005, J BIOL CHEM, V280, P13560, DOI 10.1074/jbc.M414670200
   Simic P, 2013, CELL REP, V3, P1175, DOI 10.1016/j.celrep.2013.03.019
   Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002
   Sundaresan NR, 2008, MOL CELL BIOL, V28, P6384, DOI 10.1128/MCB.00426-08
   Sundaresan NR, 2012, NAT MED, V18, P1643, DOI 10.1038/nm.2961
   Sundaresan NR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001465
   Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162
   Tanno M, 2014, J BIOL CHEM, V289, P29285, DOI 10.1074/jbc.M114.563924
   Tao RD, 2014, ANTIOXID REDOX SIGN, V20, P1646, DOI 10.1089/ars.2013.5482
   Tipton DA, 2004, J PERIODONTOL, V75, P360, DOI 10.1902/jop.2004.75.3.360
   Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277
   Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807
   Yu W, 2012, J BIOL CHEM, V287, P14078, DOI 10.1074/jbc.M112.355206
   Zafarullah M, 2003, CELL MOL LIFE SCI, V60, P6, DOI 10.1007/s000180300001
NR 64
TC 144
Z9 158
U1 1
U2 16
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0270-7306
EI 1098-5549
J9 MOL CELL BIOL
JI Mol. Cell. Biol.
PD MAR
PY 2016
VL 36
IS 5
BP 678
EP 692
DI 10.1128/MCB.00586-15
PG 15
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA DG8IY
UT WOS:000372328600003
PM 26667039
OA Green Published, Bronze
DA 2024-02-19
ER

PT J
AU Hsieh, HM
   Wu, WM
   Hu, ML
AF Hsieh, Huei-Min
   Wu, Wen-Mein
   Hu, Miao-Lin
TI Soy isoflavones attenuate oxidative stress and improve parameters
   related to aging and Alzheimer's disease in C57BL/6J mice treated with
   D-galactose
SO FOOD AND CHEMICAL TOXICOLOGY
LA English
DT Article
DE Soy isoflavones; D-galactose; Anti-aging; Alzheimer's disease; Melatonin
ID GLYCATION END-PRODUCTS; SERUM-LEVELS; SOLUBLE FORM; DNA-DAMAGE;
   MELATONIN; ASSOCIATION; RECEPTOR; SUPPLEMENTATION; MECHANISMS; CELLS
AB D-galactose (DG)-induced aging in C57BL/6J (B6) mice (3-4 mo) was used to examine the effects of soy isoflavones (SIF). Mice were divided into six groups: corn oil control, DG treatment, DG + melatonin (1 mg/kg BW), and DG + low (0.1 mg/kg), median (0.5 mg/kg) or high (2.5 mg/kg) SIF DG was administered (s.c., 0.3 mL of 1% solution/mouse) daily for 50 days, during which melatonin and SIF were given (p.o.) 5 d/wk. A 7th group of 136 mice (11 mo) served as natural aging (NA) control, which received neither DG nor other treatments. DG significantly increased: (1) thiobarbituric acid-reactive substances in serum and brain; (2) protein carbonyls in liver, kidney and brain: (3) soluble extracellular receptors for advanced glycation end products in serum: (4) expression of Bax and caspase-3 proteins in splenocytes: (5) protein expression of AD, presenilin-1 and p-site amyloid precursor protein cleaving enzyme-1 in brain. SIF significantly attenuated DG-induced changes, with high SIF completely reversing most of these changes. The DG treatment group and the NA group had similar changes in most of the parameters measured. Overall, this DG-mimetic aging study shows that SIF effectively attenuate oxidative damage and improve parameters related to aging and Alzheimer's disease. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Hu, Miao-Lin] Natl Chung Hsing Univ, Dept Food Sci & Biotechnol, Taichung 402, Taiwan.
   [Hsieh, Huei-Min; Wu, Wen-Mein] Fu Jen Catholic Univ, Dept Nutr Sci, Taipei, Taiwan.
C3 National Chung Hsing University; Fu Jen Catholic University
RP Hu, ML (corresponding author), Natl Chung Hsing Univ, Dept Food Sci & Biotechnol, 250 Kuo Kuang Rd, Taichung 402, Taiwan.
EM mlhuhu@nchu.edu.tw
FU National Science Council, Republic of China [NSC-94-WFD0-2001-74]
FX Supported by grants from the National Science Council, Republic of China
   (NSC-94-WFD0-2001-74).
CR ARENDASH GW, 2006, NEUROSCIENCE, V11, P1
   ARIA Y, 2000, J NUTR, V130, P2243
   BOWLING AC, 1995, LIFE SCI, V56, P1151, DOI 10.1016/0024-3205(95)00055-B
   Butterfield DA, 2007, FREE RADICAL BIO MED, V43, P658, DOI 10.1016/j.freeradbiomed.2007.05.037
   Butterfield DA, 2004, BRAIN PATHOL, V14, P426
   Chang HC, 2000, J NUTR, V130, P1963, DOI 10.1093/jn/130.8.1963
   Chavarro JE, 2008, HUM REPROD, V23, P2584, DOI 10.1093/humrep/den243
   Dewji NN, 2005, CELL MOL LIFE SCI, V62, P1109, DOI 10.1007/s00018-005-4566-9
   Djuric Z, 2001, CANCER LETT, V172, P1, DOI 10.1016/S0304-3835(01)00627-9
   Feng Z, 2004, FREE RADICAL BIO MED, V37, P1790, DOI 10.1016/j.freeradbiomed.2004.08.023
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   Fukumoto H, 2004, AM J PATHOL, V164, P719, DOI 10.1016/S0002-9440(10)63159-8
   GERALD R, 2008, FOOD CHEM TOXICOL, V46, P1308
   Ghosh S, 2008, NEUROCHEM RES, V33, P365, DOI 10.1007/s11064-007-9424-8
   Gong G.Q., 1991, J CHINA PHARM U, V22, P101
   Guo Jianli, 1999, Acta Nutrimenta Sinica, V21, P149
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Ho SC, 2003, BIOGERONTOLOGY, V4, P15, DOI 10.1023/A:1022417102206
   Ho SC, 2000, J NUTR, V130, P2590, DOI 10.1093/jn/130.10.2590
   HOWANITZ PJ, 1983, CLIN CHEM, V29, P396
   Izumi T, 2000, J NUTR, V130, P1695, DOI 10.1093/jn/130.7.1695
   Kapasi A A, 1999, Mol Cell Biol Res Commun, V1, P78, DOI 10.1006/mcbr.1999.0106
   Kaplan L. A., 1996, CLIN CHEM, P954
   Karasek M, 2004, EXP GERONTOL, V39, P1723, DOI 10.1016/j.exger.2004.04.012
   Kawakami Y, 2004, J AGR FOOD CHEM, V52, P1764, DOI 10.1021/jf0345898
   KUDOU S, 1991, AGR BIOL CHEM TOKYO, V55, P2227, DOI 10.1080/00021369.1991.10870966
   Lei M, 2008, BIOCHEM BIOPH RES CO, V369, P1082, DOI 10.1016/j.bbrc.2008.02.151
   León J, 2005, J PINEAL RES, V38, P1, DOI 10.1111/j.1600-079X.2004.00181.x
   Li W.B., 1995, CHIN J PHARM TOXICOL, V9, P93
   Liu JenFang, 2002, Nutritional Sciences Journal, V27, P221
   MAHN K, 2005, FASEB J, V17, P1
   Markesbery WR, 1997, FREE RADICAL BIO MED, V23, P134, DOI 10.1016/S0891-5849(96)00629-6
   Maskarinec G, 1998, CANCER EPIDEM BIOMAR, V7, P613
   MENG QH, 1999, BIOCHIM BIOPHYS ACTA, V1438, P69
   Messina MJ, 2001, J NUTR, V131, p3095S, DOI 10.1093/jn/131.11.3095S
   Mizutani K, 2000, J HYPERTENS, V18, P1833, DOI 10.1097/00004872-200018120-00018
   Nakamura K, 2007, CLIN EXP MED, V7, P188, DOI 10.1007/s10238-007-0146-7
   Omoni AO, 2005, NUTR REV, V63, P272, DOI 10.1111/j.1753-4887.2005.tb00141.x
   Pastorino L, 2006, EUR J PHARMACOL, V545, P29, DOI 10.1016/j.ejphar.2006.06.078
   Perry G, 2000, INT J DEV NEUROSCI, V18, P417, DOI 10.1016/S0736-5748(00)00006-X
   POEGGELER B, 1993, J PINEAL RES, V14, P151, DOI 10.1111/j.1600-079X.1993.tb00498.x
   Reiter RJ, 1998, NUTRITION, V14, P691, DOI 10.1016/S0899-9007(98)00064-1
   REZNICK AZ, 1994, METHOD ENZYMOL, V233, P357
   Sepehr E, 2007, MOL NUTR FOOD RES, V51, P799, DOI 10.1002/mnfr.200700083
   Shen YX, 2002, J PINEAL RES, V32, P173, DOI 10.1034/j.1600-079x.2002.1o850.x
   Sho H, 2001, ASIA PAC J CLIN NUTR, V10, P159, DOI 10.1046/j.1440-6047.2001.00235.x
   Sierens J, 2001, MUTAT RES-DNA REPAIR, V485, P169, DOI 10.1016/S0921-8777(00)00069-0
   Song X, 1999, MECH AGEING DEV, V108, P239, DOI 10.1016/S0047-6374(99)00022-6
   Tan KCB, 2006, DIABETOLOGIA, V49, P2756, DOI 10.1007/s00125-006-0394-1
   Wang Shufen, 1999, Journal of China Medical University, V28, P164
   WANG Z, 1999, LAB ANIM SCI ADM, V16, P23
   WASOWICZ W, 1993, CLIN CHEM, V39, P2522
   Wei HF, 2005, BEHAV BRAIN RES, V157, P245, DOI 10.1016/j.bbr.2004.07.003
   Wiseman H, 2000, AM J CLIN NUTR, V72, P395
   Xu XH, 2002, ACTA PHARMACOL SIN, V23, P587
   Yamagishi S, 2006, METABOLISM, V55, P1227, DOI 10.1016/j.metabol.2006.05.007
   ZUO S, 1998, CHIN J BIOCH PHARM, V19, P15
NR 57
TC 169
Z9 179
U1 0
U2 52
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0278-6915
EI 1873-6351
J9 FOOD CHEM TOXICOL
JI Food Chem. Toxicol.
PD MAR
PY 2009
VL 47
IS 3
BP 625
EP 632
DI 10.1016/j.fct.2008.12.026
PG 8
WC Food Science & Technology; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Toxicology
GA 417BQ
UT WOS:000264050000015
PM 19146912
DA 2024-02-19
ER

PT J
AU Jia, W
   Rajani, C
   Kaddurah-Daouk, R
   Li, HK
AF Jia, Wei
   Rajani, Cynthia
   Kaddurah-Daouk, Rima
   Li, Houkai
TI Expert insights: The potential role of the gut microbiome-bile
   acid-brain axis in the development and progression of Alzheimer's
   disease and hepatic encephalopathy
SO MEDICINAL RESEARCH REVIEWS
LA English
DT Article; Early Access
DE Alzheimer's disease; bile acid; farnesoid X receptor; gut microbiome;
   hepatic encephalopathy
ID CHOLESTEROL-METABOLISM; MECHANISMS; COGNITION; MOUSE
AB Recent epidemiological and molecular studies have linked the disruption of cholesterol homeostasis to increased risk for developing Alzheimer's disease (AD). Emerging evidence also suggests that brain cholesterol accumulation contributes to the progression of hepatic encephalopathy (HE) via bile acid (BA)-mediated effects on the farnesoid X receptor. In this perspective paper, we reviewed several recently published studies that suggested a role for the gut microbiota transformation of BAs as a factor in AD and HE development/progression. We hypothesize that in addition to cholesterol elimination pathways, alteration of the gut microbiota and subsequent changes in both the serum and brain BA profiles are mechanistically involved in the development of both AD and HE, and thus, are a potential target for the prevention and treatment of the two diseases. Our understanding of the microbiome-BAs-brain axis in central nervous system disease is still evolving, and critical questions regarding the emerging links among central, peripheral, and intestinal metabolic failures contributing to brain health and disease during aging have yet to be addressed.
C1 [Jia, Wei; Li, Houkai] Shanghai Univ Tradit Chinese Med, Inst Interdisciplinary Integrat Med Res, Funct Metabol & Gut Microbiome Lab, Shanghai 201203, Peoples R China.
   [Jia, Wei; Rajani, Cynthia] Univ Hawaii Manoa, Univ Hawaii, Ctr Canc, Honolulu, HI 96822 USA.
   [Kaddurah-Daouk, Rima] Duke Univ, Dept Med, Duke Inst Brain Sci, Dept Psychiat & Behav Sci, Durham, NC USA.
C3 Shanghai University of Traditional Chinese Medicine; University of
   Hawaii System; University of Hawaii Manoa; Cancer Research Center of
   Hawaii; Duke University
RP Li, HK (corresponding author), Shanghai Univ Tradit Chinese Med, Inst Interdisciplinary Integrat Med Res, Funct Metabol & Gut Microbiome Lab, Shanghai 201203, Peoples R China.; Jia, W (corresponding author), Univ Hawaii, Ctr Canc, Honolulu, HI 96813 USA.
EM wjia@cc.hawaii.edu; houkai1976@126.com
RI li, houkai/S-6785-2019; Jia, Wei/AAN-5102-2020
OI li, houkai/0000-0003-2846-7895; Jia, Wei/0000-0002-3739-8994
FU National Key Research and Development Program of China [2017YFC1700200];
   National Natural Science Foundation of China [81673662, 81873059];
   Program for Professor of Special Appointment (Eastern Scholar); 
   [16SG36]
FX National Key Research and Development Program of China, Grant/Award
   Number: 2017YFC1700200; Shuguang Scholar, Grant/Award Number: 16SG36;
   National Natural Science Foundation of China, Grant/Award Numbers:
   81673662, 81873059; Program for Professor of Special Appointment
   (Eastern Scholar)
CR Adlimoghaddam A, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00057
   Akbari E, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00256
   Bajaj JS, 2012, AM J PHYSIOL-GASTR L, V303, pG675, DOI 10.1152/ajpgi.00152.2012
   Campion D, 2019, WORLD J HEPATOL, V11, P489, DOI 10.4254/wjh.v11.i6.489
   Cash WJ, 2010, QJM-INT J MED, V103, P9, DOI 10.1093/qjmed/hcp152
   Castillo X, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00728
   Cattaneo A, 2017, NEUROBIOL AGING, V49, P60, DOI 10.1016/j.neurobiolaging.2016.08.019
   Chan RB, 2012, J BIOL CHEM, V287, P2678, DOI 10.1074/jbc.M111.274142
   D'Argenio V, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20194704
   DeMorrow S, 2019, J CLIN EXP HEPATOL, V9, P117, DOI 10.1016/j.jceh.2018.04.011
   Fol R, 2016, ACTA NEUROPATHOL, V131, P247, DOI 10.1007/s00401-015-1498-9
   Gamba P, 2012, ANN NY ACAD SCI, V1259, P54, DOI 10.1111/j.1749-6632.2012.06513.x
   Garrett WS, 2015, SCIENCE, V348, P80, DOI 10.1126/science.aaa4972
   Griffin WST, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-5
   Hufeldt MR, 2010, COMPARATIVE MED, V60, P336
   Kiriyama Y, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9060232
   Kobayashi Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13368-2
   Kosari S, 2012, BEHAV BRAIN RES, V235, P98, DOI 10.1016/j.bbr.2012.07.017
   La Rosa F, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091267
   La Rosa F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16754-y
   Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007
   Li TG, 2015, CURR OPIN GASTROEN, V31, P159, DOI 10.1097/MOG.0000000000000156
   Li TG, 2014, PHARMACOL REV, V66, P948, DOI 10.1124/pr.113.008201
   Liu S, 2019, ALZH DEMENT-DADM, V11, P85, DOI 10.1016/j.dadm.2018.11.003
   Lue LF, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080838
   MahmoudianDehkordi S, 2019, ALZHEIMERS DEMENT, V15, P76, DOI 10.1016/j.jalz.2018.07.217
   Mano N, 2004, J LIPID RES, V45, P1741, DOI 10.1194/jlr.M400157-JLR200
   McMillin M, 2018, CELL MOL GASTROENTER, V6, P47, DOI 10.1016/j.jcmgh.2018.02.008
   Murray CA, 1998, J NEUROSCI, V18, P2974
   Nho K, 2019, ALZHEIMERS DEMENT, V15, P232, DOI 10.1016/j.jalz.2018.08.012
   Ni J, 2013, BIOCHEM BIOPH RES CO, V434, P363, DOI 10.1016/j.bbrc.2013.03.079
   Pan XB, 2017, METABOLITES, V7, DOI 10.3390/metabo7020028
   Pickering M, 2007, PROG BRAIN RES, V163, P339, DOI 10.1016/S0079-6123(07)63020-9
   Prasanthi JRP, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-1
   Pu S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01612
   Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142
   Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200
   Saresella M, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0088-1
   Saresella M, 2014, J ALZHEIMERS DIS, V38, P403, DOI 10.3233/JAD-131160
   Schwartz M, 2017, SCIENCE, V357, P254, DOI 10.1126/science.aai8231
   Solomon A, 2007, NEUROLOGY, V68, P751, DOI 10.1212/01.wnl.0000256368.57375.b7
   Song ZW, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0628-3
   Staley C, 2017, APPL MICROBIOL BIOT, V101, P47, DOI 10.1007/s00253-016-8006-6
   Sung CM, 2019, CELL MOL GASTROENTER, V8, P301, DOI 10.1016/j.jcmgh.2019.04.008
   Sutinen EM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-199
   Syeda T, 2018, J ALZHEIMERS DIS, V66, P1657, DOI 10.3233/JAD-180556
   Town T, 2008, NAT MED, V14, P681, DOI 10.1038/nm1781
   Vogt NM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13601-y
   Wang DJ, 2015, MOL NUTR FOOD RES, V59, P1025, DOI 10.1002/mnfr.201400544
   Wu X, 2018, BRAIN BEHAV IMMUN, V73, P533, DOI 10.1016/j.bbi.2018.06.018
   Xie GX, 2018, EBIOMEDICINE, V37, P294, DOI 10.1016/j.ebiom.2018.10.030
   Xie GX, 2013, FASEB J, V27, P3583, DOI 10.1096/fj.13-231860
   Zhang ZG, 2013, AM J GASTROENTEROL, V108, P1601, DOI 10.1038/ajg.2013.221
   Zhao XS, 2016, CLIN CHIM ACTA, V456, P107, DOI 10.1016/j.cca.2016.02.024
   Zheng XJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep24125
   Zhuang ZQ, 2018, J ALZHEIMERS DIS, V63, P1337, DOI 10.3233/JAD-180176
NR 56
TC 42
Z9 49
U1 10
U2 72
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0198-6325
EI 1098-1128
J9 MED RES REV
JI Med. Res. Rev.
PD 2020 JUL
PY 2020
VL 40
IS 4
BP 1496
EP 1507
DI 10.1002/med.21653
EA DEC 2019
PG 12
WC Chemistry, Medicinal; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA LY6IX
UT WOS:000500717100001
PM 31808182
DA 2024-02-19
ER

PT J
AU Mandal, P
   Azad, GK
   Tomar, RS
AF Mandal, Papita
   Azad, Gajendra K.
   Tomar, Raghuvir S.
TI Identification of a novel histone H3 specific protease activity in
   nuclei of chicken liver
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE H3 protease; Chicken; Liver nucleus; Epigenetics
ID REGULATED EVENT; CHROMATIN; TRANSCRIPTION; CLEAVAGE; H-3
AB Evolutionary conserved histone proteins play a very important role in the regulation of eukaryotic gene expression by undergoing post translational modifications within the tail regions. However, their role in tissue-specific gene expression and development remains unclear. In this study, we provide evidence for in vivo tissue-specific proteolytic cleavage of histone H3 in the liver of adult white Leghorn chickens, which we believe to be regulated by tissue-specific protease activity and epigenetic markers. The cleavage of histone H3 in the liver of adult chickens is very unique, and can serve as a model for studying tissue-specific changes in chromatin organization and gene expression. For the first time, we have identified and partially purified histone H3-specific protease activity that is distinct from histone H3 protease activities recently reported. Together, our data provide evidence of proteolytic processing and identification of protease activity that is specific to histone H3 in the liver of adult chickens, which may be involved in the regulation of gene expression during development, aging, and age-associated diseases. (C) 2012 Elsevier Inc. All rights reserved.
C1 [Mandal, Papita; Azad, Gajendra K.; Tomar, Raghuvir S.] Indian Inst Sci Educ & Res, Dept Biol Sci, Lab Chromatin Biol, Bhopal 462023, India.
C3 Indian Institute of Science Education & Research (IISER) - Bhopal
RP Tomar, RS (corresponding author), Indian Inst Sci Educ & Res, Dept Biol Sci, Lab Chromatin Biol, Bhopal 462023, India.
EM rst@iiserb.ac.in
RI Azad, Gajendra Kumar/AAC-7014-2019; Azad, Gajendra/K-3381-2014; Azad,
   Gajendra Kumar/HJH-8895-2023
OI Azad, Gajendra/0000-0003-0338-3265; Azad, Gajendra
   Kumar/0000-0001-5478-526X
FU Department of Biotechnology; Indian Institute of Science Education and
   Research (IISER) Bhopal; CSIR
FX We thank all the members of the lab for their valuable comments. Joseph
   Reese and Narayanan Sathish are acknowledged for critical reading of
   this manuscript. This research work was supported by the funds from the
   Department of Biotechnology to R.S.T, Government of India, and Director
   of the Indian Institute of Science Education and Research (IISER)
   Bhopal. CSIR is acknowledged for providing fellowship support to P.M.
CR ALLIS CD, 1984, J CELL BIOL, V99, P1669, DOI 10.1083/jcb.99.5.1669
   ALLIS CD, 1984, EXP CELL RES, V153, P287, DOI 10.1016/0014-4827(84)90601-3
   ALLIS CD, 1980, CELL, V20, P55
   BARTLEY J, 1970, J BIOL CHEM, V245, P4286
   Bertin A, 2007, BIOPHYS J, V92, P2633, DOI 10.1529/biophysj.106.093815
   Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5
   Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223
   DAVIE JR, 1986, J BIOL CHEM, V261, P410
   Duncan EM, 2008, CELL, V135, P284, DOI 10.1016/j.cell.2008.09.055
   EICKBUSH TH, 1976, CELL, V9, P785, DOI 10.1016/0092-8674(76)90141-0
   ELIA MC, 1988, J BIOL CHEM, V263, P9958
   Elsaesser SJ, 2010, CURR OPIN GENET DEV, V20, P110, DOI 10.1016/j.gde.2010.01.003
   FALK MM, 1990, J VIROL, V64, P748, DOI 10.1128/JVI.64.2.748-756.1990
   Garcia BA, 2005, BIOCHEMISTRY-US, V44, P13202, DOI 10.1021/bi050906n
   Gonzalo S, 2010, J APPL PHYSIOL, V109, P586, DOI 10.1152/japplphysiol.00238.2010
   GORSKI K, 1986, CELL, V47, P767, DOI 10.1016/0092-8674(86)90519-2
   GRIGERA PR, 1984, VIROLOGY, V136, P10, DOI 10.1016/0042-6822(84)90243-5
   HEWISH DR, 1973, BIOCHEM BIOPH RES CO, V52, P504, DOI 10.1016/0006-291X(73)90740-7
   Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444
   MISHRA RN, 1994, MOL BIOL REP, V20, P15, DOI 10.1007/BF00999850
   Santos-Rosa H, 2009, NAT STRUCT MOL BIOL, V16, P17, DOI 10.1038/nsmb.1534
   Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114
   Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202
   Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422
   Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412
   Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338
   TESAR M, 1990, VIROLOGY, V174, P364, DOI 10.1016/0042-6822(90)90090-E
   Wang GG, 2007, TRENDS MOL MED, V13, P363, DOI 10.1016/j.molmed.2007.07.003
   Wang Y, 2004, COLD SPRING HARB SYM, V69, P161, DOI 10.1101/sqb.2004.69.161
NR 29
TC 27
Z9 29
U1 0
U2 3
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD MAY 4
PY 2012
VL 421
IS 2
BP 261
EP 267
DI 10.1016/j.bbrc.2012.03.149
PG 7
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA 944QZ
UT WOS:000304220200018
PM 22503985
DA 2024-02-19
ER

PT J
AU Taguchi, T
   Ohashi, M
AF Taguchi, T
   Ohashi, M
TI Age-associated changes in the template-reading fidelity of DNA
   polymerase alpha from regenerating rat liver
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE rat; regenerating liver; DNA polymerases; synthetic template-primer;
   fidelity; aging
ID AGING HUMAN FIBROBLASTS; I KLENOW FRAGMENT; DIETARY RESTRICTION; REDUCED
   FIDELITY; REPLICATION; MICE; FREQUENCY; DELTA; EXPRESSION; INHIBITION
AB DNA polymerases (deoxynucleosidetriphosphate : DNA deoxynucleotidyltransferase EC 2.7.7.7.) were extracted from regenerating livers from young and aged rats. DNA polymerase a was separated and partially purified by DEAE-cellulose column chromatography, polyethyleneglycol precipitation, and phosphocellulose column chromatography, and fidelity levels were then monitored with the synthetic template-primer poly (dG-dC). The fidelity level of the DNA polymerase from regenerating liver of a 4-month-old rat was very high, while that of the DNA polymerase from a 24-month-old rat was significantly decreased. To confirm this result, DNA was synthesized on poly (dG-dC) in a reaction mixture containing [P-32]dTTP, and the synthetic polynucleotide was purified and digested with HhaI restriction endonuclease. After hydrolysis, the oligonucleotides were developed by two dimensional thin layer chromatography on PEI cellulose plates. Spots containing [P-32]dTMP were observed when DNA polymerase from a 24 month-old rat was used, but none was found in polynucleotides synthesized using DNA polymerase from a 4 month-old rat. Nearest neighbor analysis suggested that dG-dT and dC-dT pairs were constructed by mis-incorporation due to DNA polymerase alpha. (C) 1996 Elsevier Science Ireland Ltd.
RP Taguchi, T (corresponding author), TOKYO METROPOLITAN INST GERONTOL,DEPT MOL BIOL,ITABASHI KU,35-2 SAKAE CHO,TOKYO 173,JAPAN.
CR AGARWAL SS, 1978, J CELL PHYSIOL, V96, P235, DOI 10.1002/jcp.1040960212
   BYRNES JJ, 1976, BIOCHEMISTRY-US, V15, P2817, DOI 10.1021/bi00658a018
   CARROLL SS, 1991, BIOCHEMISTRY-US, V30, P804, DOI 10.1021/bi00217a034
   CLAVERYS JP, 1986, MICROBIOL REV, V50, P133, DOI 10.1128/MMBR.50.2.133-165.1986
   DEVRIES FAJ, 1971, MUTAT RES, V11, P438
   DEVRIES FAJ, 1971, J MOL BIOL, V11, P438
   DRAKE JW, 1969, NATURE, V221, P1132, DOI 10.1038/2211132a0
   ECHOLS H, 1991, ANNU REV BIOCHEM, V60, P477, DOI 10.1146/annurev.biochem.60.1.477
   EGER BT, 1991, BIOCHEMISTRY-US, V30, P1441, DOI 10.1021/bi00219a039
   FRAGA CG, 1990, P NATL ACAD SCI USA, V87, P4533, DOI 10.1073/pnas.87.12.4533
   FRY M, 1981, J CELL PHYSIOL, V106, P435, DOI 10.1002/jcp.1041060313
   FRY M, 1976, BIOCHEMISTRY-US, V15, P4319, DOI 10.1021/bi00664a028
   GERSHON H, 1973, P NATL ACAD SCI USA, V70, P909, DOI 10.1073/pnas.70.3.909
   GOSCIN LP, 1982, BIOCHEMISTRY-US, V21, P2513, DOI 10.1021/bi00539a034
   HALL ZW, 1968, J MOL BIOL, V36, P321, DOI 10.1016/0022-2836(68)90158-7
   HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0
   HELFMAN PM, 1974, EXP GERONTOL, V9, P209, DOI 10.1016/0531-5565(74)90014-X
   Higgins GM, 1931, ARCH PATHOL, V12, P186
   HOLLAND JJ, 1973, NATURE, V245, P316, DOI 10.1038/245316a0
   HOLLIDAY R, 1972, NATURE, V238, P26, DOI 10.1038/238026a0
   INAMIZU T, 1986, P NATL ACAD SCI USA, V83, P2488, DOI 10.1073/pnas.83.8.2488
   Jinno S, 1995, MECH AGEING DEV, V85, P95, DOI 10.1016/0047-6374(95)01659-7
   JOYCE CM, 1992, J BIOL CHEM, V267, P24485
   KIRKWOOD TBL, 1989, MUTAT RES, V219, P1, DOI 10.1016/0921-8734(89)90035-0
   KRAUSS SW, 1982, BIOCHEMISTRY-US, V21, P1002, DOI 10.1021/bi00534a027
   KRAUSS SW, 1982, J BIOL CHEM, V262, P3432
   KUCHINO Y, 1987, NATURE, V327, P77, DOI 10.1038/327077a0
   LINN S, 1976, P NATL ACAD SCI USA, V73, P2818, DOI 10.1073/pnas.73.8.2818
   LOEB LA, 1982, ANNU REV BIOCHEM, V52, P429
   MIRZABEKOV AD, 1972, J MOL BIOL, V72, P633, DOI 10.1016/0022-2836(72)90181-7
   MORLEY AA, 1982, MECH AGEING DEV, V19, P21, DOI 10.1016/0047-6374(82)90046-X
   MURRAY V, 1981, J MOL BIOL, V146, P55, DOI 10.1016/0022-2836(81)90366-1
   OHASHI M, 1978, BIOCHEM BIOPH RES CO, V82, P1084, DOI 10.1016/0006-291X(78)90298-X
   ONO T, 1995, MUTAT RES-DNAGING G, V338, P183, DOI 10.1016/0921-8734(95)00023-Y
   PENDERGRASS WR, 1975, J CELL PHYSL, V87, P3
   QUE BG, 1979, BIOCHEMISTRY-US, V18, P2064, DOI 10.1021/bi00577a034
   RAO KS, 1985, J NEUROCHEM, V45, P1273, DOI 10.1111/j.1471-4159.1985.tb05553.x
   REHAKRANTZ LJ, 1977, J MOL BIOL, V116, P99, DOI 10.1016/0022-2836(77)90121-8
   ROBERTS RJ, 1976, J MOL BIOL, V10, P199
   ROTHSTEIN M, 1975, MECH AGEING DEV, V4, P325, DOI 10.1016/0047-6374(75)90033-0
   SAFFHILL R, 1974, BIOCHIM BIOPHYS ACTA, V349, P23, DOI 10.1016/0005-2787(74)90004-5
   SHAKESPEARE V, 1978, J CELL PHYSIOL, V94, P105, DOI 10.1002/jcp.1040940114
   SILBER JR, 1985, J BIOL CHEM, V260, P1304
   SRIVASTAVA V, 1992, EXP GERONTOL, V27, P593, DOI 10.1016/0531-5565(92)90014-Q
   SRIVASTAVA VK, 1993, MUTAT RES, V295, P265, DOI 10.1016/0921-8734(93)90025-X
   SRIVASTAVA VK, 1991, EXP GERONTOL, V26, P453, DOI 10.1016/0531-5565(91)90034-J
   SRIVASTAVA VK, 1992, BIOCHEM BIOPH RES CO, V182, P717
   SZILARD L, 1959, P NATL ACAD SCI USA, V45, P30, DOI 10.1073/pnas.45.1.30
   TADDIE JA, 1991, J VIROL, V65, P869, DOI 10.1128/JVI.65.2.869-879.1991
   TAGUCHI T, 1992, BIOCHEM BIOPH RES CO, V185, P1133, DOI 10.1016/0006-291X(92)91744-B
   TRAUTNER TA, 1962, P NATL ACAD SCI USA, V48, P449, DOI 10.1073/pnas.48.3.449
   WAHL AF, 1986, BIOCHEMISTRY-US, V25, P7821, DOI 10.1021/bi00372a006
   WALLACE DC, 1995, BBA-MOL BASIS DIS, V1271, P141, DOI 10.1016/0925-4439(95)00021-U
   YAGIL G, 1976, EXP GERONTOL, V11, P73, DOI 10.1016/0531-5565(76)90016-4
NR 54
TC 9
Z9 10
U1 0
U2 1
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD DEC 20
PY 1996
VL 92
IS 2-3
BP 143
EP 157
DI 10.1016/S0047-6374(96)01816-7
PG 15
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA WN476
UT WOS:A1996WN47600006
PM 9080395
DA 2024-02-19
ER

PT J
AU HORBACH, GJMJ
   VANASTEN, JG
   RIETJENS, IMCM
   KREMERS, P
   VANBEZOOIJEN, CFA
AF HORBACH, GJMJ
   VANASTEN, JG
   RIETJENS, IMCM
   KREMERS, P
   VANBEZOOIJEN, CFA
TI THE EFFECT OF AGE ON INDUCIBILITY OF VARIOUS TYPES OF RAT-LIVER
   CYTOCHROME-P-450
SO XENOBIOTICA
LA English
DT Article
ID MESSENGER-RNAS; INDUCTION; METABOLISM
AB 1. The content and specific activities of inducible cytochrome P-450 enzymes were determined in liver microscomes of rats of various ages after maximal induction with phenobarbital, isosafrole of 3-methylcholanthrene, and in untreated animals.
   2. With age an increase in liver weight was observed both in untreated rats and in maximally induced ones; the microsomal protein content/g of liver decreased with age in untreated animals but not in induced ones. Total cytochrome P-450 content/mg microsomal protein remained unchanged with age in all experimental groups.
   3. Immunologically detectable levels of cytochrome P4501A1/1A2 and 2B1/2B2 remain unchanged with age both in untreated animals and in maximally induced ones.
   4. Several cytochrome P-450 activities showed an age-related decrease in untreated animals, but no change with age was observed in the activities of cytochrome P4501A1, 2A2 and 2B1/2B2 in rat liver microsomes. This indicates that ageing affects only the activity of some constitutive forms of cytochrome P-450 in male rats, but not the activity of inducible types of P-450.
   5. Although previous results indicated decreased inducibility of the cytochrome P-450 mRNA levels with age, the present study clearly demonstrates that this is not reflected in decreased enzyme levels or activities after maximal induction. From this it is concluded that the decreased mRNA levels might rather be reflected in a decreased rate at which maximal induction can be achieved.
C1 AGR UNIV WAGENINGEN,6700 HB WAGENINGEN,NETHERLANDS.
   STATE UNIV LIEGE,B-4000 LIEGE,BELGIUM.
   TNO,INST AGEING & VASC RES,2300 AK LEIDEN,NETHERLANDS.
C3 Wageningen University & Research; University of Liege; Netherlands
   Organization Applied Science Research
RP HORBACH, GJMJ (corresponding author), RES INST TOXICOL,POB 80176,3508 TD UTRECHT,NETHERLANDS.
OI Rietjens, Ivonne/0000-0003-1894-3544
CR BAIRD MB, 1975, EXP GERONTOL, V10, P89, DOI 10.1016/0531-5565(75)90039-X
   BIRNBAUM LS, 1978, EXP GERONTOL, V13, P299, DOI 10.1016/0531-5565(78)90038-4
   BRODIE BB, 1948, J PHARMACOL EXP THER, V94, P22
   BURKE MD, 1985, BIOCHEM PHARMACOL, V34, P3337, DOI 10.1016/0006-2952(85)90355-7
   CONNEY AH, 1986, LIFE SCI, V39, P2493, DOI 10.1016/0024-3205(86)90103-7
   FUJITA S, 1982, LIVER AGING 1982, P55
   GUENGERICH FP, 1990, CRIT REV BIOCHEM MOL, V25, P97
   HOLLANDER CF, 1976, LAB ANIM SCI, V26, P320
   HORBACH GJMJ, 1990, MUTAT RES, V237, P117, DOI 10.1016/0921-8734(90)90017-L
   HORBACH GJMJ, 1990, BIOCHEM PHARMACOL, V40, P529, DOI 10.1016/0006-2952(90)90552-V
   KAO J, 1982, BIOCHEM PHARMACOL, V29, P1191
   KITAHARA A, 1982, LIVER AGING 1982, P135
   KREMERS P, 1981, EUR J BIOCHEM, V118, P599, DOI 10.1111/j.1432-1033.1981.tb05561.x
   LETAWEGOUJON F, 1984, BIOCHEM BIOPH RES CO, V119, P744, DOI 10.1016/S0006-291X(84)80313-7
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   LU AYH, 1980, PHARMACOL REV, V31, P277
   MEIHUIZEN SP, 1980, MECH AGEING DEV, V13, P111, DOI 10.1016/0047-6374(80)90054-8
   NEBERT DW, 1991, DNA CELL BIOL, V10, P1, DOI 10.1089/dna.1991.10.1
   OMURA T, 1964, J BIOL CHEM, V239, P2370
   PAYE M, 1984, BIOCHEM BIOPH RES CO, V122, P137, DOI 10.1016/0006-291X(84)90450-9
   PIERI C, 1975, EXP GERONTOL, V10, P291, DOI 10.1016/0531-5565(75)90006-6
   RIETJENS IMCM, 1989, XENOBIOTICA, V19, P1297, DOI 10.3109/00498258909043181
   RIKANS LE, 1982, EXPT GERONTOLOGY, V16, P253
   SCHMUCKER DL, 1977, SCIENCE, V197, P1005, DOI 10.1126/science.887935
   UCHIDA K, 1982, LIVER AGING 1982, P195
   Van Bezooijen C. F. A., 1986, DRUGS AGING, P45
   VANBEZOOIJEN CFA, 1984, MECH AGEING DEV, V25, P1, DOI 10.1016/0047-6374(84)90126-X
   VANCANTFORT J, 1978, BIOCH BIOPHYSICAL RE, V79, P505
   WOLFF T, 1979, DRUG METAB DISPOS, V7, P301
NR 29
TC 23
Z9 23
U1 0
U2 1
PU TAYLOR & FRANCIS LTD
PI LONDON
PA ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE
SN 0049-8254
J9 XENOBIOTICA
JI Xenobiotica
PD MAY
PY 1992
VL 22
IS 5
BP 515
EP 522
DI 10.3109/00498259209053114
PG 8
WC Pharmacology & Pharmacy; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy; Toxicology
GA HY710
UT WOS:A1992HY71000004
PM 1413866
DA 2024-02-19
ER

PT J
AU Lee, EY
   Yoo, JA
   Lim, SM
   Cho, KH
AF Lee, Eun-Young
   Yoo, Jeong-Ah
   Lim, So-Mang
   Cho, Kyung-Hyun
TI Anti-Aging and Tissue Regeneration Ability of Policosanol Along with
   Lipid-Lowering Effect in Hyperlipidemic Zebrafish via Enhancement of
   High-Density Lipoprotein Functionality
SO REJUVENATION RESEARCH
LA English
DT Article
ID ESTER TRANSFER PROTEIN; CHOLESTERYL-ESTER; HDL; CETP;
   HYPERCHOLESTEROLEMIA; ATHEROSCLEROSIS; SIMULATION; BINDING; MUTANT
AB We investigated the tissue regeneration and lipid-lowering effects of policosanol (PCO) by employing a hyperlipidemic zebrafish model. A reconstituted high-density lipoprotein containing policosanol (PCO-rHDL) facilitated greater cell growth and replication with less apoptosis and reactive oxygen species (ROS) production in BV-2 microglial cell lines. From in vivo study, injection of rHDL containing apolipoprotein A-I (ApoA-I) caused 76 +/- 4% (p=0.01) greater tissue regeneration activity than the phosphate-buffered saline (PBS) control, whereas PCO-rHDL caused 94 +/- 7% (p=0.002) increased regeneration. PCO in ethanol (EtOH) showed lower cholesteryl ester transfer protein (CETP) inhibitory ability than did anacetrapib, whereas PCO-rHDL showed higher inhibitory ability than anacetrapib, suggesting a synergistic effect between PCO and rHDL. Following 9 weeks of PCO consumption, the PCO group (0.003% PCO in Tetrabit) showed the highest survivability (80%), whereas normal diet (ND) and high-cholesterol diet (HCD) control groups showed 67% and 70% survival rates, respectively. Supplementation with a HCD resulted in two-fold elevation of CETP activity along with 3- and 2.5-fold increases in serum total cholesterol (TC) and triglycerides (TGs) levels, respectively. Consumption of PCO for 9 weeks resulted in 40 +/- 5% (p=0.01 vs. HCD) and 33 +/- 4% (p=0.02 vs. HCD) reduction of TC and TGs levels, respectively. Serum high-density lipoprotein cholesterol (HDL-C) level increased up to 37 +/- 2mg/dL (p=0.004), whereas the percentage of HDL-C/TC increased up to 20 +/- 2% from 5 +/- 1% compared to the HCD control. The serum glucose level was reduced to 47 +/- 2% (p=0.002) compared to the HCD control. Fatty liver change and hepatic inflammation levels were remarkably increased upon HCD consumption and were two-fold higher than that under ND. However, the PCO group showed 58 +/- 5% (p=0.001) and 50 +/- 3% (p=0.006) reduction of inflammation enzyme levels and lipid content in hepatic tissue under HCD. In conclusion, PCO supplementation showed lipid-lowering and HDL-C-elevating effects with ameliorating fatty liver change. These in vivo anti-atherosclerotic and anti-diabetic effects of PCO are well associated with in vitro anti-apoptotic activities.
C1 [Lee, Eun-Young; Yoo, Jeong-Ah; Lim, So-Mang; Cho, Kyung-Hyun] Yeungnam Univ, Sch Biotechnol, Kyongsan 712749, South Korea.
   [Lee, Eun-Young; Yoo, Jeong-Ah; Lim, So-Mang; Cho, Kyung-Hyun] Yeungnam Univ, Res Inst Prot Sensor, Kyongsan 712749, South Korea.
   [Lee, Eun-Young; Yoo, Jeong-Ah; Lim, So-Mang; Cho, Kyung-Hyun] Yeungnam Univ, Program Serum Biomed Res & Educ Team BK21plus, Kyongsan 712749, South Korea.
C3 Yeungnam University; Yeungnam University; Yeungnam University
RP Cho, KH (corresponding author), Yeungnam Univ, Sch Biotechnol, Kyongsan 712749, South Korea.
EM chok@yu.ac.kr
FU National Research Foundation (NRF) - Ministry of Science, ICT and Future
   Planning of Korea [2014-11049455, 2015R1A5A2009124]
FX This work was supported by a grant from the Mid-carrier Researcher
   Program (grant no 2014-11049455) and Medical Research Center Program
   (grant no. 2015R1A5A2009124) through the National Research Foundation
   (NRF), funded by the Ministry of Science, ICT and Future Planning of
   Korea.
CR Arruzazabala M L, 1994, Biol Res, V27, P205
   Barzilai N, 2003, JAMA-J AM MED ASSOC, V290, P2030, DOI 10.1001/jama.290.15.2030
   Blois MS., 1199, NATURE, V958, P181
   Cho KH, 2009, BMB REP, V42, P393, DOI 10.5483/BMBRep.2009.42.7.393
   Cho KH, 2009, MOL CELLS, V27, P291, DOI 10.1007/s10059-009-0037-8
   Cilpa-Karhu G, 2015, J LIPID RES, V56, P98, DOI 10.1194/jlr.M054288
   Eghdamian B, 1998, DRUGS TODAY, V34, P943, DOI 10.1358/dot.1998.34.11.487479
   García-González V, 2013, BIOCHEM BIOPH RES CO, V434, P54, DOI 10.1016/j.bbrc.2013.03.067
   Gouni-Berthold I, 2002, AM HEART J, V143, P356, DOI 10.1067/mhj.2002.119997
   GRIFFIN A, 1994, ANN NY ACAD SCI, V736, P205, DOI 10.1111/j.1749-6632.1994.tb12833.x
   HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182
   IHM J, 1982, J LIPID RES, V23, P1328
   IhM S, 2015, REJUVENATIO IN PRESS
   INAZU A, 1990, NEW ENGL J MED, V323, P1234, DOI 10.1056/NEJM199011013231803
   Karadag AS, 2011, ACTA DERM-VENEREOL, V91, P541, DOI 10.2340/00015555-1141
   Kim JY, 2011, FOOD CHEM TOXICOL, V49, P2899, DOI 10.1016/j.fct.2011.08.001
   Kim SM, 2014, CLIN BIOCHEM, V47, P869, DOI 10.1016/j.clinbiochem.2013.10.026
   Kim SH, 2015, REJUV RES, V18, P20, DOI 10.1089/rej.2014.1594
   McMahon M, 2006, ARTHRITIS RHEUM, V54, P2541, DOI 10.1002/art.21976
   Menendez R, 1997, BRIT J NUTR, V77, P923, DOI 10.1079/BJN19970090
   Menéndez R, 2001, ARCH MED RES, V32, P8, DOI 10.1016/S0188-4409(00)00265-4
   Mineo C, 2006, CIRC RES, V98, P1352, DOI 10.1161/01.RES.0000225982.01988.93
   Noa M, 1996, J PHARM PHARMACOL, V48, P306, DOI 10.1111/j.2042-7158.1996.tb05922.x
   Owusu-Ansah E, 2008, NAT GENET, V40, P356, DOI 10.1038/ng.2007.50
   Park KH, 2014, MOL NUTR FOOD RES, V58, P1537, DOI 10.1002/mnfr.201300955
   Park KH, 2011, FISH SHELLFISH IMMUN, V31, P904, DOI 10.1016/j.fsi.2011.08.006
   Park KH, 2011, J GERONTOL A-BIOL, V66, P511, DOI 10.1093/gerona/glr016
   Park KH, 2010, BIOCHEM BIOPH RES CO, V392, P295, DOI 10.1016/j.bbrc.2009.12.179
   PONGOR S, 1984, P NATL ACAD SCI-BIOL, V81, P2684, DOI 10.1073/pnas.81.9.2684
   Potter LK, 2009, J LIPID RES, V50, P2222, DOI 10.1194/jlr.M900015-JLR200
   Ranalletta M, 2010, J LIPID RES, V51, P2739, DOI 10.1194/jlr.M007468
   Reitz C, 2010, ARCH NEUROL-CHICAGO, V67, P1491, DOI 10.1001/archneurol.2010.297
   RODRIGUEZECHENIQUE C, 1994, FOOD CHEM TOXICOL, V32, P565, DOI 10.1016/0278-6915(94)90115-5
   Singh DK, 2006, J PHARMACOL EXP THER, V318, P1020, DOI 10.1124/jpet.106.107144
   Stoletov K, 2009, CIRC RES, V104, P952, DOI 10.1161/CIRCRESAHA.108.189803
   Tsutsumi K, 2001, BIOL PHARM BULL, V24, P579, DOI 10.1248/bpb.24.579
   Vitali C, 2014, CARDIOVASC RES, V103, P405, DOI 10.1093/cvr/cvu148
   WANG SK, 1995, J BIOL CHEM, V270, P612, DOI 10.1074/jbc.270.2.612
   Wang YW, 2003, LIPIDS, V38, P165, DOI 10.1007/s11745-003-1047-3
   Yoon JH, 2012, REJUV RES, V15, P313, DOI 10.1089/rej.2011.1246
   Zhang M, 2015, SCI REP-UK, V5, DOI 10.1038/srep08741
NR 41
TC 30
Z9 32
U1 1
U2 17
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1549-1684
EI 1557-8577
J9 REJUV RES
JI Rejuv. Res.
PD APR
PY 2016
VL 19
IS 2
BP 149
EP 158
DI 10.1089/rej.2015.1745
PG 10
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA DK1CJ
UT WOS:000374649800007
PM 26413884
OA Green Published, Green Submitted, hybrid
DA 2024-02-19
ER

PT J
AU Yang, F
   Huang, XF
   Yi, TS
   Yen, Y
   Moore, DD
   Huang, WD
AF Yang, Fan
   Huang, Xiongfei
   Yi, Tangsheng
   Yen, Yun
   Moore, David D.
   Huang, Wendong
TI Spontaneous development of liver tumors in the absence of the bile acid
   receptor farnesoid X receptor
SO CANCER RESEARCH
LA English
DT Article
ID NUCLEAR RECEPTOR; CANCER; MICE; FXR; HOMEOSTASIS; INFLAMMATION;
   CHOLESTEROL; DISRUPTION; LIGANDS; MODEL
AB Farnesoid X receptor (FXR, NR1H4) is a member of the nuclear hormone receptor superfamily, which plays an essential role in regulating bile acid, lipid, and glucose homeostasis. Both male and female FXR-/- mice spontaneously developed liver tumors; however, no other tumors were developed after 15 months of age. In contrast, no liver tumors were observed in wild-type mice of the same age. Histologic analyses confirm that tumors were hepatocellular adenoma and carcinoma. Although there was no obvious tumor at ages 9 to 12 months, FXR-/- livers displayed prominent liver injury and inflammation. Strong labeling of apoptotic hepatocytes and liver damage-induced compensatory regeneration were observed. Deregulation of genes involved in bile acid homeostasis in FXR-/- mice was consistent with abnormal levels of bile acids presented in serum and liver. Genes involved in inflammation and cell cycle were up-regulated in aging FXR-/- mice but not in wild-type controls. Increasing the bile acid levels by feeding mice with a 0.2% cholic acid diet strongly promoted N-nitrosodiethylamine-initiated liver tumorigenesis, whereas lowering bile acid pool in FXR-/- mice by a 2% cholestyramine feeding significantly reduced the malignant lesions. Our results suggest an intriguing link between metabolic regulation and hepatocarcinogenesis.
C1 City Hope Natl Med Ctr, Beckman Res Inst, Dept Gene Regulat & Drug Discovery, Duarte, CA 91010 USA.
   City Hope Natl Med Ctr, Beckman Res Inst, Dept Clin & Mol Pharmacol, Duarte, CA 91010 USA.
   Fujian Med Univ, Fujian, Peoples R China.
   Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.
C3 City of Hope; Beckman Research Institute of City of Hope; City of Hope;
   Beckman Research Institute of City of Hope; Fujian Medical University;
   Baylor College of Medicine
RP Huang, WD (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Gene Regulat & Drug Discovery, 1500 E Duarte Rd, Duarte, CA 91010 USA.
EM whuang@coh.org
RI Moore, David Dudley/JQI-9927-2023; Yen, Yun/H-9591-2016; yi,
   tangsheng/E-5014-2011
FU NIDDK NIH HHS [R01 DK 053366] Funding Source: Medline
CR Balkwill F, 2004, NATURE, V431, P405, DOI 10.1038/431405a
   Barone M, 2003, HEPATOLOGY, V37, P880, DOI 10.1053/jhep.2003.50175
   Cariou B, 2006, J BIOL CHEM, V281, P11039, DOI 10.1074/jbc.M510258200
   Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4
   Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013
   Huang WD, 2006, SCIENCE, V312, P233, DOI 10.1126/science.1121435
   Inagaki T, 2006, P NATL ACAD SCI USA, V103, P3920, DOI 10.1073/pnas.0509592103
   Kalaany NY, 2006, ANNU REV PHYSIOL, V68, P159, DOI 10.1146/annurev.physiol.68.033104.152158
   Lambert G, 2003, J BIOL CHEM, V278, P2563, DOI 10.1074/jbc.M209525200
   Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2
   Ma K, 2006, J CLIN INVEST, V116, P1102, DOI 10.1172/JCI25604
   Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362
   MAUAD TH, 1994, AM J PATHOL, V145, P1237
   McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4
   Parkin DM, 2001, LANCET ONCOL, V2, P533, DOI 10.1016/S1470-2045(01)00486-7
   Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365
   Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924
   Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3
   Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2
   Zhang YQ, 2006, P NATL ACAD SCI USA, V103, P1006, DOI 10.1073/pnas.0506982103
NR 20
TC 368
Z9 415
U1 2
U2 39
PU AMER ASSOC CANCER RESEARCH
PI PHILADELPHIA
PA 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA
SN 0008-5472
J9 CANCER RES
JI Cancer Res.
PD FEB 1
PY 2007
VL 67
IS 3
BP 863
EP 867
DI 10.1158/0008-5472.CAN-06-1078
PG 5
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA 135EQ
UT WOS:000244137300005
PM 17283114
OA Bronze
DA 2024-02-19
ER

PT J
AU Yin, L
   Ghebranious, N
   Chakraborty, S
   Sheehan, CE
   Ilic, Z
   Sell, S
AF Yin, L
   Ghebranious, N
   Chakraborty, S
   Sheehan, CE
   Ilic, Z
   Sell, S
TI Control of mouse hepatocyte proliferation and ploidy by p53 and
   p53ser246 mutation <i>in vivo</i>
SO HEPATOLOGY
LA English
DT Article
ID TUMOR-SUPPRESSOR GENE; DNA POLYMERASE-DELTA; CYCLIN-DEPENDENT KINASES;
   CELL NUCLEAR ANTIGEN; HEPATOCELLULAR-CARCINOMA; P53-DEFICIENT MICE;
   IN-VITRO; AFLATOXIN EXPOSURE; AUXILIARY PROTEIN; APOPTOSIS
AB The effect of expression of the p53 gene, in the presence or absence of the p53ser246 mutation (p53*), on ploidization (image cytometry), proliferation (expression of proliferating cell nuclear antigen and radioactive thymidine histoautoradiography), and apoptosis (in situ detection of DNA fragments) is determined in hepatocytes of p53-null and p53*-transgenic mice. The mouse p53ser246 mutation is equivalent to the pS3ser249 mutation found in human hepatomas associated with hepatitis B virus infection and aflatoxin exposure, The hepatocytes of heterozygous or homozygous p53-knockout mice (p53+/-; p53-/-), as well as knockout mice expressing one allele of p53ser246 (p53+/-, p53*; p53-/-, p53*), do not undergo normal polyploidization with aging and show an increase in the number of cycling (G(1)-, S-, and M-phase) cells. In addition, p53ser246-transgenic mice (pS3+/+, p53*; p53+/-, p53*; and p53-/-, p53*) have a greatly increased number of hepatocytes in the G(1) phase. No differences in rates of apoptotic hepatocytes are found among any of the mouse groups studied, so the increased proliferation results in a hyperplasia manifested by a increased number of small periportal cells, We conclude that loss of p53 removes blocks in the cell cycle, leading to increased proliferation, whereas expression of the p53ser246 mutation stimulates G(0) to G(1) and/or M to G(1) transition of hepatocytes. Increased proliferation of hepatocytes, combined with no concomitant increase in apoptosis, may in part explain the enhanced development of hepatocellular carcinomas in p53-knockout and p53*-transgenic mice exposed to aflatoxin.
C1 Albany Med Coll, Dept Lab Med & Pathol, Div Expt Pathol, Albany, NY 12208 USA.
   Methodist Hosp, Dept Lab Med & Pathol, Houston, TX 77030 USA.
C3 Albany Medical College; The Methodist Hospital System; The Methodist
   Hospital - Houston
RP Sell, S (corresponding author), Albany Med Coll, Dept Lab Med & Pathol, Div Expt Pathol, A-81,47 New Scotland Ave, Albany, NY 12208 USA.
RI Sheehan, Christine E/AAW-1429-2021
FU NCI NIH HHS [CA-09598, CA-54526] Funding Source: Medline
CR AGUILAR F, 1994, SCIENCE, V264, P1317, DOI 10.1126/science.8191284
   ALMENDRAL JM, 1987, P NATL ACAD SCI USA, V84, P1575, DOI 10.1073/pnas.84.6.1575
   BACUS JW, 1987, APPL OPTICS, V26, P3280, DOI 10.1364/AO.26.003280
   Bellamy COC, 1997, FASEB J, V11, P591, DOI 10.1096/fasebj.11.7.9212083
   BRAVO R, 1987, NATURE, V326, P515, DOI 10.1038/326515a0
   BRESSAC B, 1991, NATURE, V350, P429, DOI 10.1038/350429a0
   Bucher N.L.R., 1971, Regeneration of Liver and Kidney
   CLARKE AR, 1993, NATURE, V362, P849, DOI 10.1038/362849a0
   CROSS SM, 1995, SCIENCE, V267, P1353, DOI 10.1126/science.7871434
   DEFROMENTEL CC, 1992, GENE CHROMOSOME CANC, V4, P1
   Di Leonardo A, 1997, CANCER RES, V57, P1013
   DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0
   DUNENIO L, 1995, HEPATOLOGY, V22, P1279
   DUTTA A, 1993, NATURE, V365, P79, DOI 10.1038/365079a0
   ELDEIRY WS, 1994, CANCER RES, V54, P1169
   FAIRMAN MP, 1990, J CELL SCI, V95, P1
   Geyp M, 1996, CANCER GENET CYTOGEN, V87, P117, DOI 10.1016/0165-4608(95)00235-9
   GHEBRANIOUS N, 1995, MOL CARCINOGEN, V13, P104, DOI 10.1002/mc.2940130207
   HARTWELL L, 1992, CELL, V71, P543, DOI 10.1016/0092-8674(92)90586-2
   HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877
   HARVEY M, 1993, ONCOGENE, V8, P2457
   HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840
   KASTAN MB, 1991, CANCER RES, V51, P6304
   KHAONSTOV VL, 1995, LAB INVEST, V72, P118
   KUDRYAVTSEV BN, 1993, VIRCHOWS ARCH B, V64, P387, DOI 10.1007/BF02915139
   KUKI P, 1986, EXP CELL RES, V166, P209
   LEE JM, 1995, CANCER METAST REV, V14, P149, DOI 10.1007/BF00665797
   LEONARD CJ, 1995, IMPORTANT ADV ONCOLO, V3, P33
   LEVINE AJ, 1991, NATURE, V351, P453, DOI 10.1038/351453a0
   Linke SP, 1996, GENE DEV, V10, P934, DOI 10.1101/gad.10.8.934
   LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0
   LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7
   NAKANISHI M, 1995, P NATL ACAD SCI USA, V92, P4352, DOI 10.1073/pnas.92.10.4352
   NELSON WG, 1994, MOL CELL BIOL, V14, P1815, DOI 10.1128/MCB.14.3.1815
   OHTSUBO K, 1986, MECH AGEING DEV, V36, P125, DOI 10.1016/0047-6374(86)90013-8
   OZTURK M, 1991, LANCET, V338, P1356, DOI 10.1016/0140-6736(91)92236-U
   PRELICH G, 1987, NATURE, V326, P517, DOI 10.1038/326517a0
   Rao PS, 1996, TOXICOL APPL PHARM, V140, P235, DOI 10.1006/taap.1996.0218
   RYAN JJ, 1993, MOL CELL BIOL, V13, P711, DOI 10.1128/MCB.13.1.711
   SEGLEN PO, 1973, EXP CELL RES, V82, P391, DOI 10.1016/0014-4827(73)90357-1
   SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149
   SHIMA A, 1976, EXP GERONTOL, V11, P193, DOI 10.1016/0531-5565(76)90033-4
   SMITH ML, 1994, SCIENCE, V266, P1376, DOI 10.1126/science.7973727
   TSUKADA T, 1993, ONCOGENE, V8, P3313
   WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0
   WAGA S, 1994, NATURE, V369, P207, DOI 10.1038/369207a0
   Winey M, 1996, CURR BIOL, V6, P962, DOI 10.1016/S0960-9822(02)00639-5
   Wu H, 1996, GENE DEV, V10, P245, DOI 10.1101/gad.10.3.245
   YAHANDA AM, 1995, MOL CELL BIOL, V15, P4249
   YAVORKOVSKY L, 1995, HEPATOLOGY, V21, P1702, DOI 10.1016/0270-9139(95)90478-6
   ZAJICEK G, 1989, LIVER, V9, P164
   ZHAN QM, 1994, CANCER RES, V54, P2755
NR 52
TC 29
Z9 29
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD JAN
PY 1998
VL 27
IS 1
BP 73
EP 80
DI 10.1002/hep.510270113
PG 8
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA YP091
UT WOS:000071240300013
PM 9425920
DA 2024-02-19
ER

PT J
AU Ming, Z
   Legare, DJ
   Lautt, WW
AF Ming, Zhi
   Legare, Dallas J.
   Lautt, W. Wayne
TI Absence of meal-induced insulin sensitization (AMIS) in aging rats is
   associated with cardiac dysfunction that is protected by antioxidants
SO JOURNAL OF APPLIED PHYSIOLOGY
LA English
DT Article
DE age; HISS-dependent insulin sensitivity; cardiac dysfunction; metabolic
   syndrome
ID PRESSURE-VOLUME RELATIONSHIPS; HIGH-FRUCTOSE DIET; METABOLIC SYNDROME;
   SYNDROME-X; VASCULAR DYSFUNCTION; HISS HYPOTHESIS; RISK-FACTORS;
   RESISTANCE; AGE; SUCROSE
AB Ming Z, Legare DJ, Lautt WW. Absence of meal-induced insulin sensitization (AMIS) in aging rats is associated with cardiac dysfunction that is protected by antioxidants. J Appl Physiol 111: 704-714, 2011. First published May 26, 2011; doi: 10.1152/japplphysiol.00057.2011.-We have previously demonstrated that progressive development of absence of meal-induced insulin sensitization (AMIS) leads to postprandial hyperglycemia, compensatory hyperinsulinemia, resultant hyperlipidemia, increased oxidative stress, and obesity, progressing to syndrome X in aging rats. The present study tested the hypothesis that progressive development of AMIS in aging rats further resulted in deterioration in cardiac performance. Anesthetized male Sprague-Dawley rats were tested at 9, 26, and 52 wk to determine their dynamic response to insulin and cardiac function. Dynamic insulin sensitivity was determined before and after atropine to quantitate hepatic insulin sensitizing substance (HISS)-dependent and -independent insulin action. Cardiac performance was evaluated using a Millar pressure-volume conductance catheter system. AMIS developed with age, as demonstrated by significant decrease in HISS-dependent insulin action, and this syndrome was increased by sucrose supplementation and inhibited by the antioxidant treatment. Associated with progressive development of AMIS, aging rats showed impaired cardiac performance, including the reduction in cardiac index, heart rate, dP/dt(max), dP/dt(min), ejection fraction and decreased slope of left ventricular end-systolic pressure-volume relationship, and increased relaxation time constant of left ventricular pressure as well as increased left ventricular end-diastolic pressure. Total peripheral vascular resistance also increased with age. Sucrose supplementation and antioxidant treatment, respectively, potentiated and attenuated cardiac dysfunction associated with age. In addition, poor cardiac performance correlated closely with the development of AMIS. These results indicate that AMIS is the first metabolic defect that leads to homeostatic disturbances and dysfunctions, including cardiovascular diseases.
C1 [Ming, Zhi; Legare, Dallas J.; Lautt, W. Wayne] Univ Manitoba, Fac Med, Dept Pharmacol & Therapeut, Winnipeg, MB R3E 0T6, Canada.
   [Lautt, W. Wayne] Univ Manitoba, Fac Med, Ctr Aging, Winnipeg, MB R3E 0T6, Canada.
C3 University of Manitoba; University of Manitoba
RP Lautt, WW (corresponding author), Univ Manitoba, Fac Med, Dept Pharmacol & Therapeut, A210-753 McDermot Ave, Winnipeg, MB R3E 0T6, Canada.
EM wlautt@cc.umanitoba.ca
RI Lautt, W. Wayne/AAC-6106-2021; Legare, Dallas/AAC-3234-2021
OI Lautt, W. Wayne/0000-0002-7239-1798
FU Canadian Institutes of Health Research [FRN-82037, FRN-84533]; Manitoba
   Health Research Council; Canadian Liver Foundation; Canadian Diabetes
   Association
FX This study was funded by operating grants from the Canadian Institutes
   of Health Research (FRN-82037 and FRN-84533) and the Manitoba Health
   Research Council Regional Partnership Program, the Canadian Liver
   Foundation, and the Canadian Diabetes Association.
CR Bal MP, 2008, J APPL PHYSIOL, V104, P446, DOI 10.1152/japplphysiol.00951.2007
   Bal MP, 2005, ACTA PHYSIOL SCAND, V185, P181, DOI 10.1111/j.1365-201X.2005.01484.x
   Belke DD, 2002, J CLIN INVEST, V109, P629, DOI 10.1172/JCI200213946
   Chess DJ, 2008, AM J PHYSIOL-HEART C, V295, pH2223, DOI 10.1152/ajpheart.00563.2008
   Choi SY, 2009, J KOREAN MED SCI, V24, P32, DOI 10.3346/jkms.2009.24.1.32
   Cruzen C, 2009, CLIN GERIATR MED, V25, P733, DOI 10.1016/j.cger.2009.07.001
   Dai DF, 2009, TRENDS CARDIOVAS MED, V19, P213, DOI 10.1016/j.tcm.2009.12.004
   Deng JY, 2007, AM J PHYSIOL-HEART C, V293, pH978, DOI 10.1152/ajpheart.01002.2006
   Dhingra R, 2007, CIRCULATION, V116, P480, DOI 10.1161/CIRCULATIONAHA.107.689935
   Fried SK, 2003, AM J CLIN NUTR, V78, p873S, DOI 10.1093/ajcn/78.4.873S
   Griel AE, 2006, ARTERIOSCL THROM VAS, V26, P1958, DOI 10.1161/01.ATV.0000233384.97125.bd
   Hildrum B, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-220
   HWANG IS, 1987, HYPERTENSION, V10, P512, DOI 10.1161/01.HYP.10.5.512
   Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683
   Johnson RJ, 2007, AM J CLIN NUTR, V86, P899
   KASS DA, 1989, CIRCULATION, V79, P167, DOI 10.1161/01.CIR.79.1.167
   Kraja AT, 2006, NUTR METAB, V3, DOI 10.1186/1743-7075-3-41
   Lautt WW, 2008, EXP GERONTOL, V43, P790, DOI 10.1016/j.exger.2008.04.013
   Lautt WW, 2010, CAN J PHYSIOL PHARM, V88, P313, DOI 10.1139/Y09-130
   Lautt W Wayne, 2007, Ther Clin Risk Manag, V3, P761
   Lautt WW, 1999, CAN J PHYSIOL PHARM, V77, P553, DOI 10.1139/cjpp-77-8-553
   Lautt WW, 2004, J PHARMACOL SCI, V95, P9, DOI 10.1254/jphs.95.9
   Lautt WW, 2003, MED RES REV, V23, P1, DOI 10.1002/med.10022
   Lautt WW, 2001, AM J PHYSIOL-GASTR L, V281, pG29, DOI 10.1152/ajpgi.2001.281.1.G29
   LAUTT WW, 1998, FALK S, V103, P1
   Ming Z, 2006, FREE RADICAL BIO MED, V40, P617, DOI 10.1016/j.freeradbiomed.2005.09.034
   Ming Z, 2011, J APPL PHYSIOL, V110, P60, DOI 10.1152/japplphysiol.00714.2010
   Ming Z, 2009, CAN J PHYSIOL PHARM, V87, P873, DOI 10.1139/Y09-079
   Moore MC, 2002, AM J PHYSIOL-ENDOC M, V282, pE286, DOI 10.1152/ajpendo.00201.2001
   Pacher P, 2004, J PHARMACOL EXP THER, V311, P485, DOI 10.1124/jpet.104.069658
   Pacher P, 2004, AM J PHYSIOL-HEART C, V287, pH2132, DOI 10.1152/ajpheart.00405.2004
   Pacher P, 2008, NAT PROTOC, V3, P1422, DOI 10.1038/nprot.2008.138
   Park SY, 2006, LIFE SCI, V79, P2228, DOI 10.1016/j.lfs.2006.07.014
   Patarrao Rita S, 2007, Proc West Pharmacol Soc, V50, P105
   Patarrao RS, 2008, CAN J PHYSIOL PHARM, V86, P880, DOI 10.1139/Y08-080
   Radovits T, 2007, EXP GERONTOL, V42, P676, DOI 10.1016/j.exger.2007.01.013
   Ribeiro R, 2005, DIABETOLOGIA, V48, P976, DOI 10.1007/s00125-005-1714-6
   Ribeiro RT, 2008, J GERONTOL A-BIOL, V63, P560, DOI 10.1093/gerona/63.6.560
   Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998
   Sadri P, 1999, AM J PHYSIOL-GASTR L, V277, pG101, DOI 10.1152/ajpgi.1999.277.1.G101
   Sadri P, 2006, BRIT J NUTR, V95, P288, DOI 10.1079/BJN20051644
   Sharma N, 2008, J HYPERTENS, V26, P1402, DOI 10.1097/HJH.0b013e3283007dda
   Sharma N, 2007, AM J HYPERTENS, V20, P403, DOI 10.1016/j.amjhyper.2006.09.022
   Shi JQ, 2001, ALCOHOL, V24, P197, DOI 10.1016/S0741-8329(01)00154-9
   Xie H, 1996, AM J PHYSIOL-ENDOC M, V271, pE587, DOI 10.1152/ajpendo.1996.271.3.E587
   Xie HS, 1996, AM J PHYSIOL-ENDOC M, V270, pE858, DOI 10.1152/ajpendo.1996.270.5.E858
   Yang B, 1999, AM J PHYSIOL-HEART C, V277, pH1906, DOI 10.1152/ajpheart.1999.277.5.H1906
NR 47
TC 10
Z9 11
U1 0
U2 6
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 8750-7587
J9 J APPL PHYSIOL
JI J. Appl. Physiol.
PD SEP
PY 2011
VL 111
IS 3
BP 704
EP 714
DI 10.1152/japplphysiol.00057.2011
PG 11
WC Physiology; Sport Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology; Sport Sciences
GA 817QM
UT WOS:000294688900010
PM 21617079
DA 2024-02-19
ER

PT J
AU Ishinaga, M
AF Ishinaga, M
TI Effects of aging and diet on the accumulation of dolichol in rat tissues
SO BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE
LA English
DT Article
DE dolichol; cholesterol; dietary protein; aging; rat
ID SOY PROTEIN; CHOLESTEROL; LIVER; AGE; FAT; METABOLISM; EXCRETION;
   PHOSPHATE; ORGANS; CASEIN
AB A diet containing 15% (w/w) fat and 20% (w/w) of either casein or soy protein was fed to rats between 1 and 18 months of age. The effects of these dietary proteins on the accumulation of cholesterol and dolichols in kidney, spleen, brain, and heart were studied. The amount of cholesterol in these tissues was not influenced by the diet. In kidney and spleen, the amount of dolichols in rats fed the experimental diets was 50-70% higher than those in rats fed the lab chow diet. The contents of spleen dolichols in rats fed the soy protein diet tended to be higher than those in rats fed the casein diet. The amount of dolichols in heart and brain was not influenced by the diet. The proportion of spleen dolichyl fatty eater in rats fed the experimental diets was higher than that in rats fed the lab chow. The distribution of the dolichol isoprenologues was not influenced by the diet. There was a shift in the dolichol isoprenologues in kidney and spleen toward ones of lower chain length until 2 months of age, and after that there was no change. However, in heart and brain they shifted toward ones of lower chain length with aging. Our results suggested that dolichol metabolism may be influenced by fat content in the diets and differed among rat tissues.
RP Ishinaga, M (corresponding author), HIROSHIMA WOMENS UNIV,DEPT HLTH SCI,MINAMI KU,1-1-71 UJINA HIGASHI,HIROSHIMA 734,JAPAN.
CR CHOI YS, 1989, LIPIDS, V24, P506, DOI 10.1007/BF02535130
   CHOJNACKI T, 1988, BIOCHEM J, V251, P1
   Christie W., 1989, GAS CHROMATOGRAPHY L
   CRICK DC, 1987, BIOCHEM CELL BIOL, V65, P317, DOI 10.1139/o87-041
   DANIELS I, 1990, LIPIDS, V25, P586, DOI 10.1007/BF02536006
   DESCHRIJVER R, 1992, J NUTR, V122, P1979, DOI 10.1093/jn/122.10.1979
   DUNCAN DB, 1955, BIOMETRICS, V11, P1, DOI 10.2307/3001478
   ELMBERGER PG, 1987, EUR J BIOCHEM, V168, P1, DOI 10.1111/j.1432-1033.1987.tb13379.x
   HUSSEIN M M, 1989, Egyptian Journal of Food Science, V17, P15
   ISHINAGA M, 1992, BIOCHEM CELL BIOL, V70, P466, DOI 10.1139/o92-071
   ISHINAGA M, 1993, P SOC EXP BIOL MED, V203, P74, DOI 10.3181/00379727-203-43575
   JAKOBSSON A, 1989, FEBS LETT, V255, P32, DOI 10.1016/0014-5793(89)81055-5
   JAKOBSSONBORIN A, 1991, LIPIDS, V26, P915, DOI 10.1007/BF02535977
   KALEN A, 1989, LIPIDS, V24, P579, DOI 10.1007/BF02535072
   KELLER RK, 1986, LIPIDS, V21, P353, DOI 10.1007/BF02535700
   KELLER RK, 1982, J BIOL CHEM, V257, P8985
   LOW P, 1992, BIOCHIM BIOPHYS ACTA, V1165, P102, DOI 10.1016/0005-2760(92)90081-6
   MINDHAM MA, 1990, BIOCHEM J, V268, P499, DOI 10.1042/bj2680499
   NAGATA Y, 1982, J NUTR, V112, P1614, DOI 10.1093/jn/112.8.1614
   NG YKN, 1983, J NEUROCHEM, V40, P1465
   RIP JW, 1985, BIOCHEM J, V227, P705, DOI 10.1042/bj2270705
   RIP JW, 1994, BIOCHEM J, V296, P321
   SAGAMI H, 1989, BIOCHIM BIOPHYS ACTA, V1002, P218, DOI 10.1016/0005-2760(89)90290-7
   SAKAKIHARA Y, 1984, DEV BRAIN RES, V14, P255, DOI 10.1016/0165-3806(84)90310-9
   SUGANO M, 1988, J NUTR, V118, P548, DOI 10.1093/jn/118.5.548
   TAVARES IA, 1981, ARCH BIOCHEM BIOPHYS, V207, P427, DOI 10.1016/0003-9861(81)90050-3
   THATCHER CD, 1984, NUTR RES, V4, P1013, DOI 10.1016/S0271-5317(84)80082-2
   TOLLBOM O, 1988, J BIOL CHEM, V263, P1347
   VANDESSEL G, 1990, SUBCELLULAR BIOCH, P227
   WOLFE LS, 1982, LANCET, V2, P99
NR 30
TC 2
Z9 2
U1 0
U2 0
PU NATL RESEARCH COUNCIL CANADA
PI OTTAWA
PA RESEARCH JOURNALS, MONTREAL RD, OTTAWA ON K1A 0R6, CANADA
SN 0829-8211
J9 BIOCHEM CELL BIOL
JI Biochem. Cell Biol.
PY 1996
VL 74
IS 2
BP 265
EP 270
DI 10.1139/o96-028
PG 6
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA UK248
UT WOS:A1996UK24800014
PM 9213436
DA 2024-02-19
ER

PT J
AU RicardBlum, S
   BressonHadni, S
   Guerret, S
   Grenard, P
   Volle, PJ
   Risteli, L
   Grimaud, JA
   Vuitton, DA
AF RicardBlum, S
   BressonHadni, S
   Guerret, S
   Grenard, P
   Volle, PJ
   Risteli, L
   Grimaud, JA
   Vuitton, DA
TI Mechanism of collagen network stabilization in human irreversible
   granulomatous liver fibrosis
SO GASTROENTEROLOGY
LA English
DT Article
ID ECHINOCOCCUS-MULTILOCULARIS INFECTION; PRIMARY BILIARY-CIRRHOSIS;
   PYRIDINIUM CROSS-LINKS; ALVEOLAR ECHINOCOCCOSIS; BONE-RESORPTION;
   MAILLARD REACTION; AGING PROCESS; PYRIDINOLINE; MARKERS; DISEASE
AB Background & Aims: Cross-linking participates in the increased stability of collagen towards proteolytic degradation. Liver collagen cross-linking by pyridinoline, from the lysyl oxidase pathway, and by pentosidine, issued from glycation, was investigated to determine their respective contribution to collagen stabilization in patients with an irreversible liver fibrosis caused by the parasitic granulomatous disease alveolar echinococcosis. Method: Liver pyridinoline and pentosidine were analyzed by high-performance liquid chromatography, and urinary pyridinoline was analyzed by immunoassay. Cross-linked type 1 collagen was localized by immunohistochemistry with an antibody against. the C-terminal part of the molecule, involved in pyridinoline formation, that was measured in serum by radioimmunoassay. Results: In contrast to pyridinoline, pentosidine decreased in fibrotic lesions. Cross-linked type I collagen was located predominantly in collagen bundles in the periparasitic granuloma. Serum pentosidine and urinary pyridinoline levels did not differ significantly from controls, but the serum concentration of the C-terminal telopeptide of type I collagen increased significantly. Conclusions: Lysyl oxidase-mediated cross-linking is the major process contributing to the stabilization of collagen in granulomatous fibrosis, and glycation is not significantly involved in it. The changes induced by alveolar echinococcosis in liver collagen metabolism are associated with an increase in serum C-telopeptide of type 1 collagen.
C1 UNIV FRANCHE COMTE,UNIV FRANCHE COMTE UNIT,ASSOC RECH ECHINOCOCCOCE ALVEOLAIRE,BESANCON,FRANCE.
   HOECHST BEHRING,RUEIL MALMAISON,FRANCE.
   UNIV OULU,DEPT MED BIOCHEM,OULU,FINLAND.
C3 Universite de Franche-Comte; University of Oulu
RP RicardBlum, S (corresponding author), INST PASTEUR,CNRS URA 1459,AVE TONY GARNIER,F-69365 LYON 07,FRANCE.
RI YAMAMOTO, MASAHIRO/F-9094-2011
OI YAMAMOTO, MASAHIRO/0000-0003-3859-0125; Risteli,
   Leila/0000-0002-5532-5895; RICARD-BLUM, Sylvie/0000-0001-9263-1851
CR AESCHLIMANN D, 1994, THROMB HAEMOSTASIS, V71, P402
   ALVAREZ L, 1995, J BONE MINER RES, V10, P458
   BABBS C, 1988, LANCET, V1, P1021
   BLACK D, 1988, ANAL BIOCHEM, V169, P197, DOI 10.1016/0003-2697(88)90274-6
   BRESSONHADNI S, 1994, EUR CYTOKINE NETW, V5, P461
   BRESSONHADNI S, 1990, CLIN EXP IMMUNOL, V82, P378, DOI 10.1111/j.1365-2249.1990.tb05457.x
   BROWNLEE M, 1994, DIABETES, V43, P836, DOI 10.2337/diab.43.6.836
   COLWELL A, 1993, EUR J CLIN INVEST, V23, P341, DOI 10.1111/j.1365-2362.1993.tb02034.x
   FREVERT EU, 1994, EUR J ENDOCRINOL, V131, P145, DOI 10.1530/eje.0.1310145
   GARNERO P, 1994, J CLIN ENDOCR METAB, V79, P1693, DOI 10.1210/jc.79.6.1693
   HANSON DA, 1992, J BONE MINER RES, V7, P1251
   HASSAGER C, 1994, CALCIFIED TISSUE INT, V54, P30, DOI 10.1007/BF00316286
   Miguet J., 1991, OXFORD TXB CLIN HEPA, P721
   MONNIER VM, 1992, ACTA DIABETOL, V29, P130, DOI 10.1007/BF00573477
   MONNIER VM, 1990, J GERONTOL, V45, pB105, DOI 10.1093/geronj/45.4.B105
   Murphy Gillian, 1993, P287
   NIEMELA O, 1988, J HEPATOL, V6, P307, DOI 10.1016/S0168-8278(88)80047-3
   REISER K, 1992, FASEB J, V6, P2439, DOI 10.1096/fasebj.6.7.1348714
   RICARDBLUM S, 1993, CELL MOL BIOL, V39, P723
   RICARDBLUM S, 1995, PARASITE, V2, P113, DOI 10.1051/parasite/1995022113
   RICARDBLUM S, 1992, AM J TROP MED HYG, V47, P816, DOI 10.4269/ajtmh.1992.47.816
   RICARDBLUM S, 1992, HEPATOLOGY, V15, P599, DOI 10.1002/hep.1840150408
   RICARDBLUM S, IN PRESS CLIN CHIM A
   RISTELI J, 1995, J HEPATOL, V22, P77
   RISTELI J, 1993, CLIN CHEM, V394, P636
   SAIRANEN S, 1994, CALCIFIED TISSUE INT, V55, P349, DOI 10.1007/BF00299313
   Schantz P. M., 1995, P233
   SEIBEL MJ, 1992, TRENDS ENDOCRIN MET, V3, P263, DOI 10.1016/1043-2760(92)90129-O
   SELL DR, 1989, J BIOL CHEM, V264, P21597
   TAKAHASHI M, 1993, J LIQ CHROMATOGR, V16, P1355, DOI 10.1080/10826079308020958
   TALONPOIKA JT, 1994, J CLIN PERIODONTOL, V21, P320, DOI 10.1111/j.1600-051X.1994.tb00720.x
   VALIMAKI MJ, 1994, EUR J ENDOCRINOL, V131, P258, DOI 10.1530/eje.0.1310258
   VATER CA, 1979, BIOCHEM J, V181, P639, DOI 10.1042/bj1810639
   VONDERMARK K, 1982, COLLAGEN REL RES, V2, P541
   VUITTON DA, 1986, Z PARASITENKD, V72, P97, DOI 10.1007/BF00927740
   VUITTON DA, 1989, CLIN EXP IMMUNOL, V78, P67
   WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0
   YAMAMOTO H, 1992, RES COMMUN CHEM PATH, V76, P95
   ZHU GG, 1995, CANCER, V75, P1010, DOI 10.1002/1097-0142(19950215)75:4<1010::AID-CNCR2820750417>3.0.CO;2-O
NR 39
TC 56
Z9 60
U1 0
U2 3
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399
SN 0016-5085
J9 GASTROENTEROLOGY
JI Gastroenterology
PD JUL
PY 1996
VL 111
IS 1
BP 172
EP 182
DI 10.1053/gast.1996.v111.pm8698196
PG 11
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA UV622
UT WOS:A1996UV62200029
PM 8698196
DA 2024-02-19
ER

PT J
AU Huang, CY
   Cheng, YM
   Li, W
   Huang, YC
   Luo, H
   Zhong, C
   Liu, FB
AF Huang, Chao-yuan
   Cheng, Yi-min
   Li, Wei
   Huang, Yuan-cheng
   Luo, Hu
   Zhong, Chong
   Liu, Feng-bin
TI Examining the Mechanisms of Huachansu Injection on Liver Cancer through
   Integrated Bioinformatics Analysis
SO RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY
LA English
DT Article
DE Huachansu injection; hepatocellular carcinoma; effector mechanism;
   network pharmacology; weighted gene coexpression network analysis;
   molecular docking
ID HORMONE-BINDING GLOBULIN; HEPATOCELLULAR-CARCINOMA; CYTOTOXIC
   CONSTITUENTS; GASTRIC-CANCER; TOAD VENOM; SRD5A2; RISK; BUFADIENOLIDES;
   POLYMORPHISMS; EXPRESSION
AB Objective The objective of this study is to explore the potential anti-liver cancer mechanism of Huachansu injection through integrated bioinformatics analysis. Methods Active ingredients of Huachansu injection (extraction of toad skin) were obtained, and their potential drug targets were predicted via SwissTargetPrediction database. Liver cancer disease targets were identified from the GEO (Gene Expression Omnibus) dataset and four public databases. Then Protein-Protein Interaction (PPI) network of toad skin was constructed. GO (Gene Ontology) enrichment analysis and KEGG (Kyoto Encyclopedia of Genes and Genomes) enrichment analysis were performed subsequently. Finally, molecular docking was performed using Auto Dock Vina. Results In the search for therapeutic targets, twenty active components of toad skin were screened for further study, five hundred and sixty-eight targets of components were identified. In the search for disease targets, three thousand two hundred and twenty-seven genes were identified after removal of duplicated genes, one hundred and fifty-nine genes were up-regulated in liver cancer samples while two hundred and seventy-eight were down-regulated in liver cancer patients. After predicting the therapeutic targets of the components, the results were cross-checked with the disease targets, thirteen up-regulated targets and ten down-regulated targets were obtained. Finally, in the results of molecular docking, seven targets (CDK1, AKR1B1, MMP12, AURKB, CHEK1, AURKA, TTK) were potential up-regulated targets, three targets (SHBG, SRD5A2, NR1I2) were potential down-regulated targets, all of which have the best binding energy and molecular interactions. Conclusion CDK1, AKR1B1, MMP12, AURKB, CHEK1, AURKA, and TTK could be potential up-regulated target proteins of Huachansu injection for treating liver cancer. The mechanism of Huachansu injection in the treatment of liver cancer through these up-regulated targets is related to cell cycle, cellular senescence, viral carcinogenesis, p53 signaling pathway. SHBG, SRD5A2, and NR1I2 could be potential down-regulated target proteins of Huachansu injection in treating liver cancer.
C1 [Huang, Chao-yuan; Cheng, Yi-min; Li, Wei; Huang, Yuan-cheng; Luo, Hu] Guangzhou Univ Chinese Med, Clin Med Sch 1, Guangzhou, Peoples R China.
   [Huang, Chao-yuan] Guangzhou Univ Chinese Med, Lingnan Med Res Ctr, Guangzhou, Peoples R China.
   [Zhong, Chong] Guangzhou Univ Chinese Med, Affiliated Hosp 1, Dept Hepatobiliary Surg, Guangzhou, Peoples R China.
   [Liu, Feng-bin] Guangzhou Univ Chinese Med, Affiliated Hosp 1, Dept Gastroenterol, Guangzhou, Peoples R China.
   [Liu, Feng-bin] Guangzhou Univ Chinese Med, Baiyun Hosp, Affiliated Hosp 1, Guangzhou, Peoples R China.
C3 Guangzhou University of Chinese Medicine; Guangzhou University of
   Chinese Medicine; Guangzhou University of Chinese Medicine; Guangzhou
   University of Chinese Medicine; Guangzhou University of Chinese Medicine
RP Zhong, C (corresponding author), Guangzhou Univ Chinese Med, Affiliated Hosp 1, Dept Hepatobiliary Surg, Guangzhou, Peoples R China.; Liu, FB (corresponding author), Guangzhou Univ Chinese Med, Affiliated Hosp 1, Dept Gastroenterol, Guangzhou, Peoples R China.
EM liufb163@vip.163.com; zhongchong1732@gzucm.edu.cn
RI Huang, Chaoyuan/GRS-4965-2022
OI Huang, Chaoyuan/0000-0002-2227-7276
CR Amberger JS, 2015, NUCLEIC ACIDS RES, V43, pD789, DOI 10.1093/nar/gku1205
   Chelluboina B, 2018, MOL NEUROBIOL, V55, P1405, DOI 10.1007/s12035-017-0418-5
   Chen Y, 2014, CANCERS, V6, P2155, DOI 10.3390/cancers6042155
   Cheng CS, 2019, CANCER CELL INT, V19, DOI 10.1186/s12935-019-0806-1
   Deswal R, 2018, SYST BIOL REPROD MED, V64, P12, DOI 10.1080/19396368.2017.1410591
   Enserink JM, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-11
   Fang C, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006791
   Ferreira LG, 2015, MOLECULES, V20, P13384, DOI 10.3390/molecules200713384
   Gong D, 2020, MOL THER-NUCL ACIDS, V19, P482, DOI 10.1016/j.omtn.2019.10.007
   Hamosh A, 2021, AM J MED GENET A, V185, P3259, DOI 10.1002/ajmg.a.62407
   He MK, 2018, ONCOL LETT, V16, P475, DOI 10.3892/ol.2018.8642
   Hernandez-Segura A, 2018, TRENDS CELL BIOL, V28, P436, DOI 10.1016/j.tcb.2018.02.001
   Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118
   Jez JM, 1997, BIOCHEM PHARMACOL, V54, P639, DOI 10.1016/S0006-2952(97)84253-0
   Ji J, 2020, MOL BIOL REP, V47, P6091, DOI 10.1007/s11033-020-05685-z
   Khayami R, 2020, J CELL MOL MED, V24, P8890, DOI 10.1111/jcmm.15581
   Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559
   Lefrançois-Martinez AM, 2004, J CLIN ENDOCR METAB, V89, P3010, DOI 10.1210/jc.2003-031830
   Li J, 2010, AM J EPIDEMIOL, V171, P1, DOI 10.1093/aje/kwp318
   Li Q, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000021539
   Lin ZZ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-461
   Losic B, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14050-z
   Lv FZ, 2015, INT J IMMUNOPATH PH, V28, P77, DOI 10.1177/0394632015572557
   McNeely S, 2014, PHARMACOL THERAPEUT, V142, P1, DOI 10.1016/j.pharmthera.2013.10.005
   Meng Q, 2016, J ETHNOPHARMACOL, V187, P74, DOI 10.1016/j.jep.2016.03.062
   Moribe T, 2008, INT J ONCOL, V33, P949, DOI 10.3892/ijo_00000082
   Nagtegaal ID, 2020, HISTOPATHOLOGY, V76, P182, DOI 10.1111/his.13975
   Nie M, 2020, AGING-US, V12, P1304, DOI 10.18632/aging.102684
   Odle RI, 2021, TRENDS CELL BIOL, V31, P95, DOI 10.1016/j.tcb.2020.11.001
   Okeigwe I, 2014, CURR OPIN ENDOCRINOL, V21, P483, DOI 10.1097/MED.0000000000000116
   Pal PB, 2019, J MOL ENDOCRINOL, V63, P11, DOI 10.1530/JME-19-0080
   Piñero J, 2017, NUCLEIC ACIDS RES, V45, pD833, DOI 10.1093/nar/gkw943
   Prevo R, 2018, CELL CYCLE, V17, P1513, DOI 10.1080/15384101.2018.1491236
   Qi FH, 2015, BIOSCI TRENDS, V9, P16, DOI 10.5582/bst.2015.01019
   Qi FH, 2012, FOOD CHEM TOXICOL, V50, P295, DOI 10.1016/j.fct.2011.10.040
   Qi FH, 2011, CANCER SCI, V102, P951, DOI 10.1111/j.1349-7006.2011.01900.x
   Qi FH, 2011, INT IMMUNOPHARMACOL, V11, P342, DOI 10.1016/j.intimp.2010.12.007
   Rahman N, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms222111315
   Ramos L, 2020, J STEROID BIOCHEM, V200, DOI 10.1016/j.jsbmb.2020.105691
   Ren W, 2018, ANAL BIOANAL CHEM, V410, P4419, DOI 10.1007/s00216-018-1097-4
   Rodriguez C, 2017, J ETHNOPHARMACOL, V198, P235, DOI 10.1016/j.jep.2016.12.021
   Safran M, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq020
   Shen EH, 2022, BIOENGINEERED, V13, P1103, DOI 10.1080/21655979.2021.2017629
   Shin AS, 2005, BREAST CANCER RES, V7, pR506, DOI 10.1186/bcr1033
   Sia D, 2017, GASTROENTEROLOGY, V152, P745, DOI 10.1053/j.gastro.2016.11.048
   Simó R, 2015, TRENDS ENDOCRIN MET, V26, P376, DOI 10.1016/j.tem.2015.05.001
   Sung H, 2021, CA-CANCER J CLIN, V71, P209, DOI 10.3322/caac.21660
   Thaler MA, 2015, BEST PRACT RES CL EN, V29, P749, DOI 10.1016/j.beem.2015.06.005
   Tsunedomi R, 2010, INT J ONCOL, V36, P205, DOI 10.3892/ijo_00000491
   Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103
   Wan BB, 2019, PEERJ, V7, DOI 10.7717/peerj.7718
   Wang XD, 2007, CURR DRUG METAB, V8, P778, DOI 10.2174/138920007782798199
   Wang YM, 2015, J ASIAN NAT PROD RES, V17, P364, DOI 10.1080/10286020.2014.995174
   Wang-Bishop L, 2019, GASTROENTEROLOGY, V156, P662, DOI 10.1053/j.gastro.2018.10.030
   Weber S, 2015, J BIOL CHEM, V290, P6531, DOI 10.1074/jbc.M114.610121
   Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD1074, DOI 10.1093/nar/gkx1037
   Wu CX, 2018, THERANOSTICS, V8, P3737, DOI 10.7150/thno.25487
   Wu FK, 2011, J ASIAN NAT PROD RES, V13, P111, DOI 10.1080/10286020.2010.545350
   Wu JR, 2020, J TRADIT CHIN MED, V40, P749, DOI 10.19852/j.cnki.jtcm.2020.05.004
   Yang L H, 1992, Yao Xue Xue Bao, V27, P679
   Zhao HY, 2010, J ASIAN NAT PROD RES, V12, P793, DOI 10.1080/10286020.2010.505187
   Zhou BD, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/408145
   Zhou J, 2015, J PHARMACEUT BIOMED, V114, P482, DOI 10.1016/j.jpba.2015.05.032
   Zou YP, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.925289
NR 64
TC 2
Z9 2
U1 3
U2 12
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1574-8928
EI 2212-3970
J9 RECENT PAT ANTI-CANC
JI Recent Patents Anti-Canc. Drug Discov.
PY 2023
VL 18
IS 3
BP 408
EP 425
DI 10.2174/1574892817666220511162046
PG 18
WC Oncology; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Pharmacology & Pharmacy
GA J8MN0
UT WOS:001012110900011
PM 35546757
DA 2024-02-19
ER

PT J
AU Qannan, A
   Bejaoui, Y
   Izadi, M
   Yousri, NA
   Razzaq, A
   Christiansen, C
   Martin, GM
   Bell, JT
   Horvath, S
   Oshima, J
   Megarbane, A
   Ericsson, J
   Pourkarimi, E
   Hajj, NE
AF Qannan, Abeer
   Bejaoui, Yosra
   Izadi, Mahmoud
   Yousri, Noha A.
   Razzaq, Aleem
   Christiansen, Colette
   Martin, George M.
   Bell, Jordana T.
   Horvath, Steve
   Oshima, Junko
   Megarbane, Andre
   Ericsson, Johan
   Pourkarimi, Ehsan
   Hajj, Nady El
TI Accelerated epigenetic aging and DNA methylation alterations in
   Berardinelli-Seip congenital lipodystrophy
SO HUMAN MOLECULAR GENETICS
LA English
DT Article; Early Access
ID GENERALIZED LIPODYSTROPHY; LIPID DROPLETS; CELLS; DIFFERENTIATION;
   MUTATION; DISEASES
AB Berardinelli-Seip congenital lipodystrophy type 2 (CGL2) is a very rare human genetic disorder with potential significance to the understanding of the pathobiology of aging. CGL2 patients display characteristic progeroid features and suffer from type 2 diabetes, insulin resistance and fatty liver. In this study, we profiled genome-wide DNA methylation levels in CGL2 patients with BSCL2 mutations to study epigenetic age acceleration and DNA methylation alterations. This analysis revealed significant age acceleration in blood DNA of CGL2 patients using both first- and second-generation epigenetic clocks. We also observed a shortened lifespan of Caenorhabditis elegans following knockdown of the BSCL2 homolog seip-1 on a daf-16/forkhead box, class O mutant background. DNA methylation analysis revealed significant differentially methylated sites enriched for lyase activity, kinase regulator activity, protein kinase regulator activity and kinase activator activity. We could also observe significant hypomethylation in the promoter of the dual specificity phosphatase 22 gene when comparing CGL2 patients versus controls. We conclude that in line with the observed progeroid features, CGL2 patients exhibit significant epigenetic age acceleration and DNA methylation alterations that might affect pathways/genes of potential relevance to the disease.
C1 [Qannan, Abeer; Bejaoui, Yosra; Izadi, Mahmoud; Razzaq, Aleem; Ericsson, Johan; Pourkarimi, Ehsan; Hajj, Nady El] Hamad Bin Khalifa Univ, Qatar Fdn, Coll Hlth & Life Sci, Doha, Qatar.
   [Yousri, Noha A.] Weill Cornell Med Qatar, Genet Med, Doha, Qatar.
   [Yousri, Noha A.] Alexandria Univ, Comp & Syst Engn, Alexandria, Egypt.
   [Christiansen, Colette; Bell, Jordana T.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London, England.
   [Martin, George M.; Oshima, Junko] Univ Washington, Dept Lab Med & Pathol, Seattle, WA 98105 USA.
   [Horvath, Steve] Altos Labs, San Diego, CA USA.
   [Horvath, Steve] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA.
   [Oshima, Junko] Chiba Univ, Grad Sch Med, Dept Clin Cell Biol & Med, Chiba, Japan.
   [Megarbane, Andre] Lebanese Amer Univ, Gilbert & Rose Marie Chagoury Sch Med, Dept Human Genet, Byblos, Lebanon.
   [Megarbane, Andre] Inst Jerome Lejeune, Qatar Fdn, Coll Sci & Engn, Paris, France.
   [Pourkarimi, Ehsan; Hajj, Nady El] Hamad Bin Khalifa Univ, Qatar Fdn, Coll Hlth & Life Sci, 34110, Doha, Qatar.
C3 Qatar Foundation (QF); Hamad Bin Khalifa University-Qatar; Qatar
   Foundation (QF); Weill Cornell Medical College Qatar; Egyptian Knowledge
   Bank (EKB); Alexandria University; University of London; King's College
   London; University of Washington; University of Washington Seattle;
   University of California System; University of California Los Angeles;
   University of California Los Angeles Medical Center; David Geffen School
   of Medicine at UCLA; Chiba University; Lebanese American University;
   Qatar Foundation (QF); Hamad Bin Khalifa University-Qatar
RP Pourkarimi, E; Hajj, NE (corresponding author), Hamad Bin Khalifa Univ, Qatar Fdn, Coll Hlth & Life Sci, 34110, Doha, Qatar.
EM abma22342@hbku.edu.qa; YBejaoui@hbku.edu.qa; maiz30979@hbku.edu.qa;
   AlRazzaq@hbku.edu.qa; colette.christiansen@kcl.ac.uk; gmmartin@uw.edu;
   Jordana.bell@kcl.ac.uk; SHorvath@mednet.ucla.edu; picard@uw.edu;
   andre.megarbane@lau.edu.lb; pericsson@hbku.edu.qa;
   EDaryakenari@hbku.edu.qa; nelhajj@hbku.edu.qa
RI Megarbane, Andre/ABD-5574-2021; Bell, Jordana/AAH-7312-2019
OI Megarbane, Andre/0000-0003-0714-2469; Yousri, Noha/0000-0003-1918-0331;
   Horvath, Steve/0000-0002-4110-3589; Razzaq, Dr.
   Aleem/0000-0002-9920-1392; El Hajj, Nady/0000-0003-3420-8531;
   Pourkarimi, Ehsan/0000-0001-9598-3465; Christiansen,
   Colette/0000-0001-6034-5746
FU NIH Office of Research Infrastructure Programs [P40 OD010440]; Qatar
   National Library
FX The authors would like to acknowledge the Qatar BioBank, the Qatar
   Genome Project and the Genomics Core at Weill Cornell Medicine-Qatar. We
   would like to thank the Caenorhabditis Genetics Center (CGC), funded by
   the NIH Office of Research Infrastructure Programs (P40 OD010440), for
   providing the worm strains. The authors would like to also acknowledge
   Arwa Aldaalis. Open Access funding provided by the Qatar National
   Library. Conflict of Interest statement. S.H. is the founder of the
   non-profit Epigenetic Clock Development Foundation, which plans to
   license several patents from his employer UC Regents. The other authors
   declare no conflicts of interest.
CR Agarwal AK, 2003, J CLIN ENDOCR METAB, V88, P4840, DOI 10.1210/jc.2003-030855
   Agarwal AK, 2002, NAT GENET, V31, P21, DOI 10.1038/ng880
   Agarwal AK, 2006, ANNU REV GENOM HUM G, V7, P175, DOI 10.1146/annurev.genom.7.080505.115715
   Akinci G, 2021, PRESSE MED, V50, DOI 10.1016/j.lpm.2021.104085
   Aldaalis A, 2022, FRONT ONCOL, V12, DOI 10.3389/fonc.2022.942386
   [Anonymous], BMC GENOMICS, V14
   Beas AO, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16358-7
   Bejaoui Y, 2022, AGING CELL, V21, DOI 10.1111/acel.13555
   Bizzari S, 2021, GENES-BASEL, V12, DOI 10.3390/genes12101518
   Boutet E, 2009, BIOCHIMIE, V91, P796, DOI 10.1016/j.biochi.2009.01.011
   Breeze CE, 2016, CELL REP, V17, P2137, DOI 10.1016/j.celrep.2016.10.059
   BRENNER S, 1974, GENETICS, V77, P71
   Cai YQ, 2015, PLANT CELL, V27, P2616, DOI 10.1105/tpc.15.00588
   Cao Z, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10835-4
   Christiansen C, 2022, GENOME MED, V14, DOI 10.1186/s13073-022-01077-z
   Fei WH, 2008, J CELL BIOL, V180, P473, DOI 10.1083/jcb.200711136
   Fei WH, 2011, TRENDS ENDOCRIN MET, V22, P204, DOI 10.1016/j.tem.2011.02.004
   Felder T, 2021, AGING-US, V13, P7709, DOI 10.18632/aging.202883
   Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517
   Garg A, 2004, NEW ENGL J MED, V350, P1220, DOI 10.1056/NEJMra025261
   Garg A, 2011, J CLIN ENDOCR METAB, V96, P3313, DOI 10.1210/jc.2011-1159
   Geltinger F, 2020, MOLECULES, V25, DOI 10.3390/molecules25215053
   Gensous N, 2017, BIOGERONTOLOGY, V18, P549, DOI 10.1007/s10522-017-9695-7
   Haertle L, 2019, CLIN EPIGENETICS, V11, DOI 10.1186/s13148-019-0787-x
   Hazra A, 2017, INDIAN J DERMATOL, V62, P251, DOI 10.4103/ijd.IJD_201_17
   Hennekam RCM, 2020, EUR J MED GENET, V63, DOI 10.1016/j.ejmg.2020.104028
   Heyn H, 2012, P NATL ACAD SCI USA, V109, P10522, DOI 10.1073/pnas.1120658109
   Hisama FM, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a025882
   Horvath S, 2018, AGING-US, V10, P1758, DOI 10.18632/aging.101508
   Horvath S, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1030-0
   Horvath S, 2015, AGING CELL, V14, P491, DOI 10.1111/acel.12325
   Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115
   Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86
   Huang YH, 2021, SCI DATA, V8, DOI 10.1038/s41597-021-01040-4
   Hussain I, 2016, ENDOCRIN METAB CLIN, V45, P783, DOI 10.1016/j.ecl.2016.06.012
   Jarc E, 2019, YALE J BIOL MED, V92, P435
   Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278
   Keller M, 2017, MOL METAB, V6, P86, DOI 10.1016/j.molmet.2016.11.003
   Kim CA, 2008, J CLIN ENDOCR METAB, V93, P1129, DOI 10.1210/jc.2007-1328
   Kornke JM, 2017, BIOL OPEN, V6, P1294, DOI 10.1242/bio.025478
   Levine ME, 2018, AGING-US, V10, P573, DOI 10.18632/aging.101414
   Li Y, 2022, BIOMOLECULES, V12, P840
   Lima JG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199052
   Lu AT, 2019, AGING-US, V11, P303, DOI 10.18632/aging.101684
   Magré J, 2001, NAT GENET, V28, P365, DOI 10.1038/ng585
   Maierhofer A, 2019, AGING CELL, V18, DOI 10.1111/acel.12995
   Maierhofer A, 2017, AGING-US, V9, P1143, DOI 10.18632/aging.101217
   Martin G M, 1978, Birth Defects Orig Artic Ser, V14, P5
   Misra A, 2003, MEDICINE, V82, P129, DOI 10.1097/00005792-200303000-00007
   Moleres A, 2013, FASEB J, V27, P2504, DOI 10.1096/fj.12-215566
   Müller F, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1664-9
   Papsdorf K., 2021, RES SQUARE, DOI [10.21203/rs.3.rs-740521/v1, DOI 10.21203/RS.3.RS-740521/V1]
   Patni N, 2015, NAT REV ENDOCRINOL, V11, P522, DOI 10.1038/nrendo.2015.123
   Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234
   Purizaca-Rosillo N, 2017, AM J MED GENET A, V173, P471, DOI 10.1002/ajmg.a.38053
   Rajab A, 2005, COMMUNITY GENET, V8, P27, DOI 10.1159/000083334
   Rizzo HE, 2020, CLIN EPIGENETICS, V12, DOI 10.1186/s13148-020-0824-9
   Saez I, 2014, CURR GENOMICS, V15, P38, DOI 10.2174/138920291501140306113344
   Salameh Y, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00171
   Salo VT, 2016, EMBO J, V35, P2699, DOI 10.15252/embj.201695170
   Sanchez-Mut JV, 2018, NAT MED, V24, P598, DOI 10.1038/s41591-018-0013-y
   Schneiter R, 2022, CURR OPIN CELL BIOL, V75, DOI 10.1016/j.ceb.2022.02.004
   Shastry S, 2010, AM J MED GENET A, V152A, P2245, DOI 10.1002/ajmg.a.33578
   Sierra MI, 2015, CURR GENOMICS, V16, P435, DOI 10.2174/1389202916666150817203459
   Solinas G, 2017, MOL METAB, V6, DOI 10.1016/j.molmet.2016.12.001
   Sutphin George L, 2009, J Vis Exp, DOI 10.3791/1152
   Szymanski KM, 2007, P NATL ACAD SCI USA, V104, P20890, DOI 10.1073/pnas.0704154104
   Van Maldergem L, 2002, J MED GENET, V39, P722, DOI 10.1136/jmg.39.10.722
   Vevea JD, 2015, DEV CELL, V35, P584, DOI 10.1016/j.devcel.2015.11.010
   Vilchez D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6659
   Walther TC, 2012, ANNU REV BIOCHEM, V81, P687, DOI 10.1146/annurev-biochem-061009-102430
   Wang Huajin, 2016, Elife, V5, DOI 10.7554/eLife.16582
   Wang Q, 2020, CLIN EPIGENETICS, V12, DOI 10.1186/s13148-020-00984-5
   Welte MA, 2017, BBA-MOL CELL BIOL L, V1862, P1260, DOI 10.1016/j.bbalip.2017.07.006
   Welte MA, 2015, CURR BIOL, V25, pR470, DOI 10.1016/j.cub.2015.04.004
   Yung JHM, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9030706
   Zebisch K, 2012, ANAL BIOCHEM, V425, P88, DOI 10.1016/j.ab.2012.03.005
   Zhou HY, 2020, MOL METAB, V36, DOI 10.1016/j.molmet.2020.02.014
   Zhou WD, 2018, NAT GENET, V50, P591, DOI 10.1038/s41588-018-0073-4
NR 79
TC 2
Z9 2
U1 1
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD 2023 MAY 18
PY 2023
VL 32
IS 11
BP 1826
EP 1835
DI 10.1093/hmg/ddad016
EA JAN 2023
PG 10
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA G3ZI6
UT WOS:000946703400001
PM 36715159
OA Green Accepted, hybrid, Green Published
DA 2024-02-19
ER

PT J
AU Chinnappan, SM
   George, A
   Pandey, P
   Nark, G
   Choudhary, YK
AF Chinnappan, Sasikala M.
   George, Annie
   Pandey, Pragya
   Nark, Govinda
   Choudhary, Yogendra Kumar
TI Effect of <i>Eurycoma longifolia</i> standardised aqueous root
   extract-Physta® on testosterone levels and quality of life in ageing
   male subjects: a randomised, double-blind, placebo-controlled
   multicentre study
SO FOOD & NUTRITION RESEARCH
LA English
DT Article
DE Eurycoma longifolia; testosterone; quality of life; ageing; Physta (R)
ID TONGKAT ALI; REPLACEMENT THERAPY; THYROID-HORMONES; GLYCEMIC CONTROL;
   HYPOGONADAL MEN; MALE RATS; FATIGUE; EXTRACT; SPERMATOGENESIS;
   QUASSINOIDS
AB Background: Low testosterone levels cause physiological changes that compromise the quality of life in ageing men. A standardised water extract from the root of Eurycoma longifolia (EL), known as Physta (R), is known to increase testosterone levels.
   Objective: To evaluate the safety and efficacy of Physta (R) in improving the testosterone levels and quality of life in ageing male subjects.
   Design: This randomised, double-blind, placebo-controlled study enrolled 105 male subjects aged 50-70 years with a testosterone level <300 ng/dL, BMI >= 18 and <= 30.0 kg/m(2). The subjects were given either Physta (R) 100 mg, 200 mg or placebo daily for 12 weeks. The primary endpoints were changes in serum total and free testosterone levels. The secondary endpoints included changes in the level of sex hormone-binding globulin (SIIBG), dihydroepiandrosterone (DIIEA), glycated haemoglobin (IIbAlc), insulin-like growth factor-1 (IGF-1), thyroid function tests (T3, T4, TSH and Free T3) and cortisol. Changes in Ageing Male Symptoms (AMS) score, Fatigue Severity Scale (FSS) score and muscle strength are other secondary endpoints. The safety of the intervention products was measured by complete blood count, lipid profile, liver and renal function tests.
   Results: There was a significant increase in the total testosterone levels at week 12 (P < 0.05) in the Pliysta (R) 100 mg group and at weeks 4 (P < 0.05), 8 (P < 0.01) and 12 (P < 0.001) in the Physta (R) 200 mg group compared to placebo. No significant between-group differences in free testosterone levels were observed but a significant within-group increase occurred at weeks 4 (P < 0.01), 8 (P < 0.001) and 12 (P < 0.001) in the Physta (R) 100 mg group and at weeks 2 (P < 0.01), 4 (P < 0.01), 8 (P < 0.001) and 12 (P < 0.001) in the Physta (R) 200 mg group. The AMS and FSS showed significant reduction (P < 0.001) in total scores at all time-points within- and between-group in both Physta (R) groups. DIIEA levels significantly increased (P < 0.05) within-group in both Physta (R) groups from week 2 onwards. Cortisol levels significantly (P < 0.01) decreased in the Physta (R) 200 mg group, while muscle strength significantly (P < 0.001) increased in both Physta (R) groups at week 12 in the within-group comparison. There were no significant changes in SI IBG. No safety related clinically relevant changes were observed.
   Conclusion: Supplementation of Physta (R) at 200 mg was able to increase the serum total testosterone, reduce fatigue and improve the quality of life in ageing men within 2 weeks' time.
C1 [Chinnappan, Sasikala M.; George, Annie] Biotrop Malaysia Berhad, Lot 21 Jalan U1-19,Sect U1,Hicom Glenmarie Ind Pk, Shah Alam 40150, Selangor, Malaysia.
   [Pandey, Pragya] Oriana Hosp, Varanasi, Uttar Pradesh, India.
   [Nark, Govinda] Lokmanya Multispecialty Hosp, Pune, Maharashtra, India.
   [Choudhary, Yogendra Kumar] Ethix Pharma, Raipur, Chhattisgarh, India.
RP Chinnappan, SM (corresponding author), Biotrop Malaysia Berhad, Lot 21 Jalan U1-19,Sect U1,Hicom Glenmarie Ind Pk, Shah Alam 40150, Selangor, Malaysia.
FU Biotropics Malaysia Berhad, Shah Alam, Selangor, Malaysia
FX SMC and AG are employees of the Biotropics Malaysia Berhad. The authors
   declare that there is no conflict of interests. Biotropics Malaysia
   Berhad, Shah Alam, Selangor, Malaysia, funded the study.
CR Ang HH, 2002, FUND CLIN PHARMACOL, V16, P479, DOI 10.1046/j.1472-8206.2002.00106.x
   Ang HH, 2002, PHYTOCHEMISTRY, V59, P833, DOI 10.1016/S0031-9422(01)00480-0
   Ang HH, 2001, FUNDAM CLIN PHARM, V15, P265, DOI 10.1046/j.1472-8206.2001.00038.x
   Ang Hooi Hoon, 2003, Journal of Basic and Clinical Physiology and Pharmacology, V14, P301
   Batrinos ML, 2012, HORM-INT J ENDOCRINO, V11, P241, DOI 10.14310/horm.2002.1354
   Bedir E, 2003, CHEM PHARM BULL, V51, P1301, DOI 10.1248/cpb.51.1301
   Bhat R, 2010, FITOTERAPIA, V10, P1
   Bloise FF, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00560
   Boyanov M A, 2003, Aging Male, V6, P1
   Ceponis J, 2017, CONT ENDOCRINOLOGY, P367
   Chahal HS, 2007, J PATHOL, V211, P173, DOI 10.1002/path.2110
   Choudhary YK, 2012, Int JPharm Pharm Sci, V4, P232
   Chueh KS, 2012, J ANDROL, V33, P817, DOI 10.2164/jandrol.111.015628
   Collomp K, 2016, PHYSIOL BEHAV, V164, P68, DOI 10.1016/j.physbeh.2016.05.039
   Dandona Paresh, 2008, Curr Mol Med, V8, P816, DOI 10.2174/156652408786733658
   de Ronde W, 2005, J CLIN ENDOCR METAB, V90, P157, DOI 10.1210/jc.2004-0422
   De Ronde W, 2006, CLIN CHEM, V52, P1777, DOI 10.1373/clinchem.2005.063354
   Feldman HA, 2002, J CLIN ENDOCR METAB, V87, P589, DOI 10.1210/jc.87.2.589
   George A, 2014, ANDROLOGIA, V46, P708, DOI 10.1111/and.12214
   Girish S, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0942-y
   Goglia F, 1999, FEBS LETT, V452, P115, DOI 10.1016/S0014-5793(99)00642-0
   Grossmann M, 2011, J CLIN ENDOCR METAB, V96, P2341, DOI 10.1210/jc.2011-0118
   Groti K, 2018, AGING MALE, V21, P158, DOI 10.1080/13685538.2018.1468429
   Gunnels TA, 2014, J Plant Biochem Physiol, V2, P1, DOI [10.4172/2329-9029.1000130, DOI 10.4172/2329-9029.1000130]
   Hackney AC, 2003, EUR J APPL PHYSIOL, V89, P198, DOI 10.1007/s00421-003-0794-6
   Hajimonfarednejad M, 2019, CLIN NUTR, V38, P594, DOI 10.1016/j.clnu.2018.03.013
   Harman SM, 2001, J CLIN ENDOCR METAB, V86, P724, DOI 10.1210/jc.86.2.724
   Heinemann LA, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-23
   Henkel RR, 2014, PHYTOTHER RES, V28, P544, DOI 10.1002/ptr.5017
   Heufelder AE, 2009, J ANDROL, V30, P726, DOI 10.2164/jandrol.108.007005
   Ismail SB, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/429268
   Jiwajinda S, 2001, PHYTOCHEMISTRY, V58, P959, DOI 10.1016/S0031-9422(01)00333-8
   Jones H, 2010, END ABSTR, V21
   Kapoor D, 2006, EUR J ENDOCRINOL, V154, P899, DOI 10.1530/eje.1.02166
   Kaufman JM, 2005, ENDOCR REV, V26, P833, DOI 10.1210/er.2004-0013
   Khera M, 2016, CURR OPIN UROL, V26, P152, DOI 10.1097/MOU.0000000000000256
   Kong SH, 2020, OSTEOPOROSIS INT, V31, P525, DOI 10.1007/s00198-019-05137-w
   Lanfranco F, 2003, J ENDOCRINOL INVEST, V26, P861, DOI 10.1007/BF03345237
   Lippi G, 2010, BLOOD TRANSFUS-ITALY, V8, P94, DOI 10.2450/2009.0142-09
   Louwerens M, 2012, EUR J ENDOCRINOL, V167, P809, DOI 10.1530/EJE-12-0501
   Low BS, 2013, J ETHNOPHARMACOL, V149, P201, DOI 10.1016/j.jep.2013.06.023
   Low BS, 2013, J ETHNOPHARMACOL, V145, P706, DOI 10.1016/j.jep.2012.11.013
   Matsumoto AM, 2002, J GERONTOL A-BIOL, V57, pM76, DOI 10.1093/gerona/57.2.M76
   Meikle AW, 2004, THYROID, V14, pS17
   Mohr BA, 2005, CLIN ENDOCRINOL, V62, P64, DOI 10.1111/j.1365-2265.2004.02174.x
   Myon E., 2003, LIFE OUTCOMES, V1, P1, DOI 10.1186/1477- 7525-1-15
   Olarinoye J K, 2006, West Afr J Med, V25, P84
   Pexman-Fieth C, 2014, AGING MALE, V17, P1, DOI 10.3109/13685538.2013.858113
   Rehman SU, 2016, MOLECULES, V21, DOI 10.3390/molecules21030331
   Roy TA, 2002, AM J PHYSIOL-ENDOC M, V283, pE284, DOI 10.1152/ajpendo.00334.2001
   Sambandan TG, 2006, United States Patent, Patent No. [7132117 B2, 7132117]
   Schwid SR, 2002, J REHABIL RES DEV, V39, P211
   Sellami M, 2018, J INT SOC SPORT NUTR, V15, DOI 10.1186/s12970-018-0218-y
   Skrzypczak MA, 2002, VAR EVOL, V10, P39
   Sternbach H, 1998, AM J PSYCHIAT, V155, P1310, DOI 10.1176/ajp.155.10.1310
   Talbott S, 2006, J INT SOC SPORT NUTR, V3, P1
   Talbott SM, 2013, J INT SOC SPORT NUTR, V10, DOI 10.1186/1550-2783-10-28
   Tambi MIBM, 2012, ANDROLOGIA, V44, P226, DOI 10.1111/j.1439-0272.2011.01168.x
   Tambi MI, 2006, ASIAN J ANDROL S1, V8, P49
   Tan R S, 2003, Aging Male, V6, P13, DOI 10.1080/713604736
   Udani JK, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/179529
   Umpierre D, 2011, JAMA-J AM MED ASSOC, V305, P1790, DOI 10.1001/jama.2011.576
   Valko PO, 2008, SLEEP, V31, P1601, DOI 10.1093/sleep/31.11.1601
   van den Beld AW, 2005, J CLIN ENDOCR METAB, V90, P6403, DOI 10.1210/jc.2005-0872
   Wekking EM, 2005, EUR J ENDOCRINOL, V153, P747, DOI 10.1530/eje.1.02025
NR 65
TC 2
Z9 2
U1 0
U2 7
PU SWEDISH NUTRITION FOUNDATION-SNF
PI LUND
PA IDEON SCIENCE PARK, BESOK SCHEELEV 17 BETA 5, 3V, LUND, 223 70, SWEDEN
SN 1654-6628
EI 1654-661X
J9 FOOD NUTR RES
JI Food Nutr. Res.
PD MAY 19
PY 2021
VL 65
AR 5647
DI 10.29219/fnr.v65.5647
PG 15
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA SJ3WW
UT WOS:000655464100001
PM 34262417
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Calderon-Cortés, E
   Clemente-Guerrero, M
   Sierra-Campos, E
   Cortés-Rojo, C
   Gaona-Zamudio, FJ
   Villalobos-Molina, R
   Saavedra-Molina, A
AF Calderon-Cortés, E
   Clemente-Guerrero, M
   Sierra-Campos, E
   Cortés-Rojo, C
   Gaona-Zamudio, FJ
   Villalobos-Molina, R
   Saavedra-Molina, A
TI Functional characterization of brain mitochondrial nitric oxide synthase
   during hypertension and aging
SO AMINO ACIDS
LA English
DT Article
DE mitochondrial L-citrulline; rat brain; spontaneously hypertensive rats;
   aging; L-arginine; nitric oxide synthase
ID RAT-HEART; ENDOTHELIAL DYSFUNCTION; INHIBITION; RESPIRATION; MODULATION;
   HYPOXIA; RELEASE; OXYGEN; CELLS; LIVER
AB Nitric oxide (NOcenter dot) plays an important role in various physiological processes. The aim of the present study was to investigate if brain mitochondrial nitric oxide synthase (mtNOS) is active and functional during hypertension. L-citrulline production, an indicator of nitric oxide synthesis, was concentration-dependent on L-arginine in all strains and all ages tested, and was inhibited by 7-Nitroindazole (7-NI). Brain mitochondria of 1 month-old (prehypertensive) spontaneously hypertensive rats (SHR) exhibited a significantly (p < 0.05) low basal L-citrulline content as compared to age-matched Wistar (W) and Wistar-Kyoto (WKY) rats. L-citrulline synthesis in SHR rats showed a significant (p < 0.01) low response to L-arginine in 3 and 7 months-old rats. Respiratory rates in states 3 and 4 increased with low L-arginine concentration in all strains and all ages. The results suggest that in rat brain mitochondria, L-citrulline synthesis is constant once age-related hypertension is installed and NOcenter dot does not regulate oxidative phosphorylation.
C1 Univ Michoacana, Inst Invest Quim Biol, Morelia 58030, Michoacan, Mexico.
   Univ Nacl Autonoma Mexico, Unidad Biomed, Fac Estudios Super Iztacala, Mexico City 04510, DF, Mexico.
   Ctr Invest & Estudios Avanzados, Dept Farmacobiol, Mexico City, DF, Mexico.
C3 Universidad Michoacana de San Nicolas de Hidalgo; Universidad Nacional
   Autonoma de Mexico; CINVESTAV - Centro de Investigacion y de Estudios
   Avanzados del Instituto Politecnico Nacional
RP Calderon-Cortés, E (corresponding author), Univ Michoacana, Inst Invest Quim Biol, Edificio B-3 CU Morelia, Morelia 58030, Michoacan, Mexico.
RI Sierra-Campos, Erick/AAQ-2993-2021; Saavedra-Molina,
   Alfredo/AAH-5607-2020; Cortes, Christian./ABF-4312-2021; SIERRA-CAMPOS,
   ERICK/T-9331-2019
OI SIERRA-CAMPOS, ERICK/0000-0001-8622-4045; Cortes-Rojo,
   Christian/0000-0002-4850-772X
CR Aguilera-Aguirre L, 2002, MITOCHONDRION, V1, P413, DOI 10.1016/S1567-7249(02)00002-8
   Bordet R, 2000, FUND CLIN PHARMACOL, V14, P177, DOI 10.1111/j.1472-8206.2000.tb00014.x
   Brown GC, 2002, FREE RADICAL BIO MED, V33, P1440, DOI 10.1016/S0891-5849(02)01112-7
   Chou TC, 1998, HYPERTENSION, V31, P643, DOI 10.1161/01.HYP.31.2.643
   Elfering SL, 2002, J BIOL CHEM, V277, P38079, DOI 10.1074/jbc.M205256200
   FRNECH S, 2001, AM J PUBLIC PHYSL, V280, pH2863
   Ghafourifar P, 1999, BIOL CHEM, V380, P1025, DOI 10.1515/BC.1999.127
   Ghafourifar P, 1999, J BIOL CHEM, V274, P31185, DOI 10.1074/jbc.274.44.31185
   Ghafourifar P, 1997, FEBS LETT, V418, P291, DOI 10.1016/S0014-5793(97)01397-5
   Ghafourifar P, 2001, BIOL SIGNAL RECEPT, V10, P57
   Giulivi C, 2003, FREE RADICAL BIO MED, V34, P397, DOI 10.1016/S0891-5849(02)01298-4
   Giulivi C, 1998, J BIOL CHEM, V273, P11038, DOI 10.1074/jbc.273.18.11038
   GORNALL AG, 1949, J BIOL CHEM, V177, P751
   Kanai AJ, 2001, P NATL ACAD SCI USA, V98, P14126, DOI 10.1073/pnas.241380298
   Knipp M, 2000, ANAL BIOCHEM, V286, P257, DOI 10.1006/abio.2000.4805
   Lacza Z, 2001, FREE RADICAL BIO MED, V31, P1609, DOI 10.1016/S0891-5849(01)00754-7
   López-Figueroa MO, 2000, BIOCHEM BIOPH RES CO, V272, P129, DOI 10.1006/bbrc.2000.2748
   Manzo-Avalos S, 2002, AMINO ACIDS, V22, P381, DOI 10.1007/s007260200022
   Marín J, 2000, CLIN SCI, V99, P277, DOI 10.1042/CS20000009
   Mayer B, 1997, TRENDS BIOCHEM SCI, V22, P477, DOI 10.1016/S0968-0004(97)01147-X
   Nakahara H, 1998, FREE RADICAL BIO MED, V24, P85, DOI 10.1016/S0891-5849(97)00164-0
   Orsi A, 2000, BIOCHEM J, V346, P407, DOI 10.1042/0264-6021:3460407
   Radi R, 2002, FREE RADICAL BIO MED, V33, P1451, DOI 10.1016/S0891-5849(02)01111-5
   Riobó NA, 2002, J BIOL CHEM, V277, P42447, DOI 10.1074/jbc.M204580200
   Saavedra-Molina A, 2003, AMINO ACIDS, V24, P95, DOI 10.1007/s00726-002-0331-7
   Sarkela TM, 2001, J BIOL CHEM, V276, P6945, DOI 10.1074/jbc.M007625200
   Shiva S, 2001, P NATL ACAD SCI USA, V98, P7212, DOI 10.1073/pnas.131128898
   SIMS NR, 1990, J NEUROCHEM, V55, P698, DOI 10.1111/j.1471-4159.1990.tb04189.x
   Taddei S, 1998, J CARDIOVASC PHARM, V32, pS41
   Tatoyan A, 1998, J BIOL CHEM, V273, P11044, DOI 10.1074/jbc.273.18.11044
   THAKAR JH, 1988, LIFE SCI, V43, P143, DOI 10.1016/0024-3205(88)90291-3
   WOLFF DJ, 1994, ARCH BIOCHEM BIOPHYS, V314, P360, DOI 10.1006/abbi.1994.1454
NR 32
TC 4
Z9 5
U1 0
U2 5
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0939-4451
J9 AMINO ACIDS
JI Amino Acids
PD FEB
PY 2006
VL 30
IS 1
BP 73
EP 80
DI 10.1007/s00726-005-0213-x
PG 8
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 013YD
UT WOS:000235445000009
PM 15990946
DA 2024-02-19
ER

PT J
AU Babenko, NA
   Shakhova, EG
AF Babenko, NA
   Shakhova, EG
TI Effects of Chamomilla recutita flavonoids on age-related liver
   sphingolipid turnover in rats
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE ceramide; sphingomyelin; sphingomyelinase; liver; hepatocytes;
   flavonoids; aging
ID OXIDATIVE STRESS; CYTOKINE PRODUCTION; ENZYME-ACTIVITIES;
   PHOSPHOLIPASE-D; IN-VITRO; CERAMIDE; SPHINGOMYELIN; GLUTATHIONE;
   EXPRESSION; APOPTOSIS
AB The increased sphingolipid turnover in the liver is associated with elevation of free radical production and state of chronic inflammation at old age. Plant polyphenols are reported to exhibit antioxidant and anti-inflammatory effects. In the present paper, the lipids contents and ceramide production in the liver and hepatocytes as well as the correction of sphingolipid metabolism at old age using the mixture of Chamomilla recutita flavonoids (chamiloflan) or apigenin-7-glucoside or luteolin-7-glucoside alone have been investigated. To study the sphingolipids turnover, the [14C]serine-pre-labeled hepatocytes and [14C-methyl]- or [14C]palmitate-pre-labeled sphingomyelin (SM) and ceramide were used. The ceramide content was higher in the liver and hepatocytes of 24- and 27-28-month-old animals as compared to adult 3-month-old Wistar rats. An addition of flavonoids to the culture medium did not influence significantly on the lipids contents and metabolism in the isolated hepatocytes. The administration of flavonoids to old rats decreased the elevated neutral and acid SMases activities and ceramide mass and did not affect both the lipid content in the liver of adult animals and ceramide conversion to the sphingosine or SM. These results suggest that the SMases play a key role in the flavonoid-induced decrease of ceramide levels in the liver of old rats.
C1 Kharkov Karazin Natl Univ, Inst Biol, UA-61077 Kharkov, Ukraine.
C3 Ministry of Education & Science of Ukraine; VN Karazin Kharkiv National
   University
RP Babenko, NA (corresponding author), Kharkov Karazin Natl Univ, Inst Biol, 4 Svobody pl, UA-61077 Kharkov, Ukraine.
EM babenko@univer.kharkov.ua
OI Shakhova, Olena/0000-0002-7860-6972
CR Babenko N., 2004, Annales Universitatis Mariae Curie-Sklodowska. Sectio DDD, Pharmacia, V17, P173
   BABENKO N, 2005, UKRAINIAN BIOCHEM J, V77, P94
   BABENKO NA, 2005, MED SCI MONIT
   Ballou SP, 1996, AGE AGEING, V25, P224, DOI 10.1093/ageing/25.3.224
   Bastianetto S, 2002, NEUROBIOL AGING, V23, P891, DOI 10.1016/S0197-4580(02)00024-6
   Bladergroen BA, 1999, EUR J BIOCHEM, V264, P152, DOI 10.1046/j.1432-1327.1999.00589.x
   BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
   Chen CY, 2005, J NUTR, V135, P1366, DOI 10.1093/jn/135.6.1366
   CHEN JQ, 1995, J BIOL CHEM, V270, P25233, DOI 10.1074/jbc.270.42.25233
   Cutler RG, 2004, P NATL ACAD SCI USA, V101, P2070, DOI 10.1073/pnas.0305799101
   Cutler RG, 2001, MECH AGEING DEV, V122, P895, DOI 10.1016/S0047-6374(01)00246-9
   Denis U, 2002, FREE RADICAL BIO MED, V33, P236, DOI 10.1016/S0891-5849(02)00879-1
   Farrell AM, 1998, J LIPID RES, V39, P2031
   FERRANDIZ ML, 1994, LIFE SCI, V55, pPL145, DOI 10.1016/0024-3205(94)00490-0
   García-Ruiz C, 2000, HEPATOLOGY, V32, P56, DOI 10.1053/jhep.2000.8267
   GIUSTO NM, 1992, LIPIDS, V27, P835, DOI 10.1007/BF02535859
   GUSTAVSSON L, 1994, J BIOL CHEM, V269, P849
   Horváthová K, 2003, NEOPLASMA, V50, P291
   Hougee S, 2005, BIOCHEM PHARMACOL, V69, P241, DOI 10.1016/j.bcp.2004.10.002
   IGARASHI K, 1995, BIOSCI BIOTECH BIOCH, V59, P595, DOI 10.1271/bbb.59.595
   Jansen PLM, 2002, BEST PRACT RES CL GA, V16, P149, DOI 10.1053/bega.2002.0271
   Karakashian AA, 2004, FASEB J, V18, P968, DOI 10.1096/fj.03-0875fje
   Kavok NS, 2003, EXP GERONTOL, V38, P441, DOI 10.1016/S0531-5565(02)00246-2
   Lightle SA, 2000, MECH AGEING DEV, V120, P111, DOI 10.1016/S0047-6374(00)00191-3
   Liu B, 1997, J BIOL CHEM, V272, P16281, DOI 10.1074/jbc.272.26.16281
   Liu B, 1998, J BIOL CHEM, V273, P11313, DOI 10.1074/jbc.273.18.11313
   Lozanski G, 1997, BIOCHEM J, V328, P271, DOI 10.1042/bj3280271
   MARSH JB, 1966, J LIPID RES, V7, P574
   Memon RA, 1999, J BIOL CHEM, V274, P19707, DOI 10.1074/jbc.274.28.19707
   MICHALOPOULOS G, 1975, EXP CELL RES, V33, P545
   Mouton RE, 2000, MECH AGEING DEV, V113, P169, DOI 10.1016/S0047-6374(99)00105-0
   Nakata K, 1996, MECH AGEING DEV, V90, P195, DOI 10.1016/0047-6374(96)01771-X
   Nijveldt RJ, 2001, AM J CLIN NUTR, V74, P418
   Pena LA, 1997, BIOCHEM PHARMACOL, V53, P615, DOI 10.1016/S0006-2952(96)00834-9
   Peres W, 2000, J HEPATOL, V33, P742, DOI 10.1016/S0168-8278(00)80305-0
   Perry DK, 1998, BBA-MOL CELL BIOL L, V1436, P233, DOI 10.1016/S0005-2760(98)00145-3
   Pettus BJ, 2002, BBA-MOL CELL BIOL L, V1585, P114, DOI 10.1016/S1388-1981(02)00331-1
   Rikans LE, 1999, MECH AGEING DEV, V108, P173, DOI 10.1016/S0047-6374(99)00012-3
   Safari MR, 2003, PROSTAG LEUKOTR ESS, V69, P73, DOI 10.1016/S0952-3278(03)00085-1
   Scheel-Toellner D, 2004, BLOOD, V104, P2557, DOI 10.1182/blood-2004-01-0191
   Sietsma H, 2000, CLIN CANCER RES, V6, P942
   Smolinski AT, 2003, FOOD CHEM TOXICOL, V41, P1381, DOI 10.1016/S0278-6915(03)00146-7
   Su JF, 2003, BIOMED ENVIRON SCI, V16, P1
   Tsyupko AN, 2001, BIOCHEMISTRY-MOSCOW+, V66, P1028, DOI 10.1023/A:1012381928535
   Venable ME, 1995, J BIOL CHEM, V270, P30701, DOI 10.1074/jbc.270.51.30701
   Venable ME, 1999, BBA-MOL CELL BIOL L, V1439, P291, DOI 10.1016/S1388-1981(99)00101-8
   VRANCKX R, 1995, AM J PHYSIOL-REG I, V268, pR536, DOI 10.1152/ajpregu.1995.268.2.R536
   Wätjen W, 2005, J NUTR, V135, P525, DOI 10.1093/jn/135.3.525
   Wu DY, 2003, J BIOL CHEM, V278, P10983, DOI 10.1074/jbc.M207470200
   Yamano T, 2000, TOXICOL APPL PHARM, V162, P68, DOI 10.1006/taap.1999.8833
   Zheng QS, 2005, BIOMED ENVIRON SCI, V18, P65
   Zheng QS, 2004, PHARMAZIE, V59, P286
NR 52
TC 33
Z9 37
U1 0
U2 7
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD JAN
PY 2006
VL 41
IS 1
BP 32
EP 39
DI 10.1016/j.exger.2005.08.008
PG 8
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 004YN
UT WOS:000234788700004
PM 16183236
DA 2024-02-19
ER

PT J
AU Mallis, RJ
   Hamann, MJ
   Zhao, W
   Zhang, TQ
   Hendrich, S
   Thornas, JA
AF Mallis, RJ
   Hamann, MJ
   Zhao, W
   Zhang, TQ
   Hendrich, S
   Thornas, JA
TI Irreversible thiol oxidation in carbonic anhydrase III: Protection by
   S-glutathiolation and detection in aging rats
SO BIOLOGICAL CHEMISTRY
LA English
DT Article
DE aging; antioxidant; oxidation; reactive oxygen species; S-thiolation
ID REACTIVE PROTEIN SULFHYDRYLS; CYSTEINE-SULFENIC ACID; IN-VIVO; REDUCED
   GLUTATHIONE; RESPIRATORY BURST; HYDROGEN-PEROXIDE; HYPOCHLOROUS ACID;
   ENDOTHELIAL-CELLS; REDOX REGULATION; CIGARETTE-SMOKE
AB Proteins with reactive sulfhydryls are central to many important metabolic reactions and also contribute to a variety of signal transduction systems. In this report, we examine the mechanisms of oxidative damage to the two reactive sulfhydryls of carbonic anhydrase III. Hydrogen peroxide (H2O2), peroxy radicals, or hypochlorous acid (HOCl) produced irreversibly oxidized forms, primarily cysteine sulfinic acid or cysteic acid, of carbonic anhydrase III if glutathione (GSH) was not present. When GSH was approximately equimolar to protein thiols, irreversible oxidation was prevented. H2O2 and peroxyl radicals both generated S-glutathiolated carbonic anhydrase III via partially oxidized protein sulfhydryl intermediates, while HOCl did not cause S-glutathiolation. Thus, oxidative damage from H2O2 or AAPH was prevented by protein S-glutathiolation, while a direct reaction between GSH and oxidant likely prevents HOCl-mediated protein damage. In cultured rat hepatocytes, carbonic anhydrase III was rapidly S-glutathiolated by menadione. When hepatocyte glutathione was depleted, menadione instead caused irreversible oxidation. We hypothesized that normal depletion of glutathione in aged animals might also lead to an increase in irreversible oxidation. Indeed, both total protein extracts and carbonic anhydrase III contained significantly more cysteine sulfinic acid in older rats compared to young animals. These experiments show that, in the absence of sufficient GSH, oxidation reactions lead to irreversible protein sulfhydryl damage in purified proteins, cellular systems, and whole animals.
C1 Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50014 USA.
   Iowa State Univ, Dept Food Sci & Human Nutr, Ames, IA 50014 USA.
C3 Iowa State University; Iowa State University
RP Thornas, JA (corresponding author), Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50014 USA.
RI Mallis, Robert J/A-2270-2015
OI Hendrich, Suzanne/0000-0001-8700-4765
CR Barrett WC, 1999, J BIOL CHEM, V274, P34543, DOI 10.1074/jbc.274.49.34543
   Barrett WC, 1999, BIOCHEMISTRY-US, V38, P6699, DOI 10.1021/bi990240v
   Becker K, 1998, NAT STRUCT BIOL, V5, P267, DOI 10.1038/nsb0498-267
   Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313
   CABISCOL E, 1995, J BIOL CHEM, V270, P14742, DOI 10.1074/jbc.270.24.14742
   CHAI YC, 1991, ARCH BIOCHEM BIOPHYS, V284, P270, DOI 10.1016/0003-9861(91)90295-T
   CHAI YC, 1994, ARCH BIOCHEM BIOPHYS, V310, P273, DOI 10.1006/abbi.1994.1167
   Cotgreave IA, 1998, BIOCHEM BIOPH RES CO, V242, P1, DOI 10.1006/bbrc.1997.7812
   Dafré AL, 1998, ARCH BIOCHEM BIOPHYS, V358, P291
   Denu JM, 1998, BIOCHEMISTRY-US, V37, P5633, DOI 10.1021/bi973035t
   DROGE W, 1994, FASEB J, V8, P1131
   ENGBERG P, 1985, ARCH BIOCHEM BIOPHYS, V241, P628, DOI 10.1016/0003-9861(85)90589-2
   Gesquière L, 1999, FREE RADICAL BIO MED, V27, P134, DOI 10.1016/S0891-5849(99)00055-6
   Hagen TM, 1999, FASEB J, V13, P411, DOI 10.1096/fasebj.13.2.411
   HAMANN M, 2001, IN PRESS METHODS ENZ
   Herzenberg LA, 1997, P NATL ACAD SCI USA, V94, P1967, DOI 10.1073/pnas.94.5.1967
   Jung CH, 1996, ARCH BIOCHEM BIOPHYS, V335, P61, DOI 10.1006/abbi.1996.0482
   LII CK, 1994, ARCH BIOCHEM BIOPHYS, V308, P231, DOI 10.1006/abbi.1994.1033
   Liu YS, 1996, J BIOL CHEM, V271, P3604
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Mallis RJ, 2000, FEBS LETT, V482, P237, DOI 10.1016/S0014-5793(00)02022-6
   Mallis RJ, 2001, BIOCHEM J, V355, P145, DOI 10.1042/bj3550145
   Mallis RJ, 2000, ARCH BIOCHEM BIOPHYS, V383, P60, DOI 10.1006/abbi.2000.2048
   Marangon K, 1999, FREE RADICAL BIO MED, V27, P1114, DOI 10.1016/S0891-5849(99)00155-0
   MILLER H, 1991, J BIOL CHEM, V266, P19342
   Müller T, 1998, CARCINOGENESIS, V19, P797, DOI 10.1093/carcin/19.5.797
   Navarro J, 1999, FREE RADICAL BIO MED, V26, P410, DOI 10.1016/S0891-5849(98)00213-5
   NIKI E, 1990, METHOD ENZYMOL, V186, P100
   PARK EM, 1988, BIOCHIM BIOPHYS ACTA, V964, P151, DOI 10.1016/0304-4165(88)90161-4
   Park EM, 1998, FREE RADICAL BIO MED, V25, P79, DOI 10.1016/S0891-5849(98)00041-0
   PICHORNER H, 1995, ARCH BIOCHEM BIOPHYS, V323, P429, DOI 10.1006/abbi.1995.0064
   Pullar JM, 2001, J BIOL CHEM, V276, P22120, DOI 10.1074/jbc.M102088200
   Raftery MJ, 2001, J BIOL CHEM, V276, P33393, DOI 10.1074/jbc.M101566200
   Rattan SIS, 1996, BIOCHEM SOC T, V24, P1043, DOI 10.1042/bst0241043
   RAVICHANDRAN V, 1994, J BIOL CHEM, V269, P25010
   SCHUPPEKOISTINEN I, 1994, ARCH BIOCHEM BIOPHYS, V315, P226, DOI 10.1006/abbi.1994.1494
   Sen CK, 1996, FASEB J, V10, P709, DOI 10.1096/fasebj.10.7.8635688
   STORZ G, 1990, SCIENCE, V248, P189, DOI 10.1126/science.2183352
   TERRADEZ P, 1993, BIOCHEM J, V292, P477, DOI 10.1042/bj2920477
   THOMAS JA, 1995, METHOD ENZYMOL, V251, P423, DOI 10.1016/0076-6879(95)51145-8
   THOMAS JA, 1995, ARCH BIOCHEM BIOPHYS, V319, P1, DOI 10.1006/abbi.1995.1261
   Thomas JA, 2001, EXP GERONTOL, V36, P1519, DOI 10.1016/S0531-5565(01)00137-1
   TIETZE KF, 1969, ANAL BIOCHEM, V7, P502
   Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0
   WEFERS H, 1983, EUR J BIOCHEM, V137, P29, DOI 10.1111/j.1432-1033.1983.tb07791.x
   WINTERBOURN CC, 1994, ARCH BIOCHEM BIOPHYS, V314, P284, DOI 10.1006/abbi.1994.1444
   Winterbourn CC, 1999, FREE RADICAL BIO MED, V27, P322, DOI 10.1016/S0891-5849(99)00051-9
   WINTERBOURN CC, 1993, FREE RADICAL BIO MED, V14, P85, DOI 10.1016/0891-5849(93)90512-S
   Winterbourn CC, 1997, BIOCHEM J, V326, P87, DOI 10.1042/bj3260087
   Wu HH, 2000, BIOCHEM J, V351, P87, DOI 10.1042/0264-6021:3510087
   Yeh JI, 1996, BIOCHEMISTRY-US, V35, P9951, DOI 10.1021/bi961037s
NR 51
TC 84
Z9 99
U1 0
U2 5
PU WALTER DE GRUYTER & CO
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 1431-6730
J9 BIOL CHEM
JI Biol. Chem.
PD MAR-APR
PY 2002
VL 383
IS 3-4
BP 649
EP 662
DI 10.1515/BC.2002.067
PG 14
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 551PV
UT WOS:000175570800030
PM 12033454
OA Green Submitted
DA 2024-02-19
ER

PT J
AU Ayala, V
   Naudi, A
   Sanz, A
   Caro, P
   Portero-Otin, M
   Barja, G
   Pamplona, R
AF Ayala, Victoria
   Naudi, Alba
   Sanz, Alberto
   Caro, Pilar
   Portero-Otin, Manuel
   Barja, Gustavo
   Pamplona, Reinald
TI Dietary protein restriction decreases oxidative protein damage,
   peroxidizability index, and mitochondrial complex I content in rat liver
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
ID OXYGEN RADICAL GENERATION; TERM CALORIC RESTRICTION; FATTY-ACID
   UNSATURATION; MAXIMUM LIFE-SPAN; DNA-DAMAGE; BODY-WEIGHT; NUTRITIONAL
   INFLUENCES; FISCHER-344 RATS; FOOD RESTRICTION; H2O2 PRODUCTION
AB Caloric restriction (CR) decreases oxidative damage, which contributes to the slowing of aging rate. It is not known if such decreases are due to calories themselves or specific dietary components. In this work, the ingestion of proteins of Wistar rats was decreased by 40% below that of controls. After 7 weeks, the liver of the protein-restricted (PR) animals showed decreases in oxidative protein damage, degree of membrane unsaturation, and mitochondrial complex I content. The results and previous information suggest that the decrease in the rate of aging induced by PR can be due in part to decreases in mitochondrial reactive oxygen species production and DNA and protein oxidative modification, increases in fatty acid components more resistant to oxidative damage, and decreased expression of complex I, analogously to what occurs during CR. Recent studies suggest that those benefits of PR could be caused, in turn, by the lowered methionine intake of that dietary manipulation.
C1 Univ Lleida, Fac Med, Dept Basic Med Sci, Lleida 25008, Spain.
   Univ Complutense, Fac Biol Sci, Dept Anim Physiol 2, E-28040 Madrid, Spain.
C3 Universitat de Lleida; Complutense University of Madrid
RP Ayala, V (corresponding author), Univ Lleida, Fac Med, Dept Basic Med Sci, C Montserrat Roig 2, Lleida 25008, Spain.
RI Ayala, Maria Victoria/A-7391-2010; Naudí, Alba/B-5594-2009; Sanz,
   Alberto/O-2329-2015; Pamplona, Reinald/A-7359-2010; Barja,
   Gustavo/AAA-5903-2019; SANZ, ALBERTO/F-8432-2011; Portero-Otin,
   Manuel/B-7122-2009; Gustavo, Barja/B-5591-2012
OI Ayala, Maria Victoria/0000-0002-1496-966X; Naudí,
   Alba/0000-0003-0699-1004; Sanz, Alberto/0000-0003-2149-1753; Pamplona,
   Reinald/0000-0003-4337-6107; Barja, Gustavo/0000-0001-5736-4735;
   Portero-Otin, Manuel/0000-0002-1823-0299; Caro,
   Pilar/0000-0002-7531-3234
CR Barger JL, 2003, EXP GERONTOL, V38, P1343, DOI 10.1016/j.exger.2003.10.017
   Barja G, 2004, BIOL REV, V79, P235, DOI 10.1017/S1464793103006213
   BARROWS CH, 1975, GROWTH, V39, P525
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   BRENDEL V, 1992, P NATL ACAD SCI USA, V89, P2002, DOI 10.1073/pnas.89.6.2002
   DAVIS TA, 1983, EXP GERONTOL, V18, P427, DOI 10.1016/0531-5565(83)90021-9
   DIBAK O, 1984, PHYSIOL BOHEMOSLOV, V33, P320
   Dirks AJ, 2006, MECH AGEING DEV, V127, P1, DOI 10.1016/j.mad.2005.09.001
   Djuric Z, 2002, TOXICOL SCI, V66, P125, DOI 10.1093/toxsci/66.1.125
   Doi SQ, 2001, AM J NEPHROL, V21, P331, DOI 10.1159/000046270
   Dröge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001
   FERNANDES G, 1976, P NATL ACAD SCI USA, V73, P1279, DOI 10.1073/pnas.73.4.1279
   GOODRICK CL, 1978, J GERONTOL, V33, P184, DOI 10.1093/geronj/33.2.184
   Gredilla R, 2003, ADV CELL AGING GERON, V14, P105
   Gredilla R, 2002, MICROSC RES TECHNIQ, V59, P273, DOI 10.1002/jemt.10204
   Gredilla R, 2001, FASEB J, V15, P1589, DOI 10.1096/fj.00-0764fje
   Gredilla R, 2001, J BIOENERG BIOMEMBR, V33, P279, DOI 10.1023/A:1010603206190
   HORAKOVA M, 1988, MECH AGEING DEV, V45, P1, DOI 10.1016/0047-6374(88)90014-0
   Hubert MF, 2000, TOXICOL SCI, V58, P195, DOI 10.1093/toxsci/58.1.195
   Hulbert AJ, 2005, J THEOR BIOL, V234, P277, DOI 10.1016/j.jtbi.2004.11.024
   Keenan KP, 1997, J NUTR, V127, pS851, DOI 10.1093/jn/127.5.851S
   Lambert AJ, 2004, MECH AGEING DEV, V125, P529, DOI 10.1016/j.mad.2004.06.002
   LETO S, 1976, J GERONTOL, V31, P144, DOI 10.1093/geronj/31.2.144
   López-Torres M, 2002, FREE RADICAL BIO MED, V32, P882, DOI 10.1016/S0891-5849(02)00773-6
   MAEDA H, 1985, J GERONTOL, V40, P671, DOI 10.1093/geronj/40.6.671
   Mair W, 2005, PLOS BIOL, V3, P1305, DOI 10.1371/journal.pbio.0030223
   Masoro EJ, 2005, MECH AGEING DEV, V126, P913, DOI 10.1016/j.mad.2005.03.012
   MASORO EJ, 1991, ANN NY ACAD SCI, V621, P337
   Mattison JA, 2003, EXP GERONTOL, V38, P35, DOI 10.1016/S0531-5565(02)00146-8
   MILLER DS, 1968, EXP GERONTOL, V3, P231, DOI 10.1016/0531-5565(68)90006-5
   OOKA H, 1988, MECH AGEING DEV, V43, P79, DOI 10.1016/0047-6374(88)90099-1
   Pamplona R, 2005, J BIOL CHEM, V280, P21522, DOI 10.1074/jbc.M502255200
   Pamplona R, 2004, EXP GERONTOL, V39, P725, DOI 10.1016/j.exger.2004.01.006
   Pamplona R, 2002, ANN NY ACAD SCI, V959, P475, DOI 10.1111/j.1749-6632.2002.tb02118.x
   Pamplona R, 2002, MECH AGEING DEV, V123, P1437, DOI 10.1016/S0047-6374(02)00076-3
   Pamplona R, 2006, BBA-BIOENERGETICS, V1757, P496, DOI 10.1016/j.bbabio.2006.01.009
   Piper MDW, 2005, J GERONTOL A-BIOL, V60, P549, DOI 10.1093/gerona/60.5.549
   Pugh TD, 1999, NEUROBIOL AGING, V20, P157, DOI 10.1016/S0197-4580(99)00043-3
   RAMANADHAM M, 1979, NUTR METAB, V23, P235
   Ramsey JJ, 2004, AM J PHYSIOL-ENDOC M, V286, pE31, DOI 10.1152/ajpendo.00283.2003
   RICHIE JP, 1994, FASEB J, V8, P1302, DOI 10.1096/fasebj.8.15.8001743
   RODRIGUES MAM, 1991, FOOD CHEM TOXICOL, V29, P757, DOI 10.1016/0278-6915(91)90184-9
   ROSS MH, 1961, J NUTR, V75, P197, DOI 10.1093/jn/75.2.197
   Ruiz MC, 2005, MECH AGEING DEV, V126, P1106, DOI 10.1016/j.mad.2005.04.005
   Sanz A, 2006, J BIOENERG BIOMEMBR, V38, P327, DOI 10.1007/s10863-006-9051-0
   Sanz A, 2005, BIOGERONTOLOGY, V6, P15, DOI 10.1007/s10522-004-7380-0
   Sanz A, 2004, J BIOENERG BIOMEMBR, V36, P545, DOI 10.1007/s10863-004-9001-7
   Sanz A, 2006, ANN NY ACAD SCI, V1067, P200, DOI 10.1196/annals.1354.024
   Sanz A, 2006, FASEB J, V20, P1064, DOI 10.1096/fj.05-5568com
   Sanz A, 2006, ANTIOXID REDOX SIGN, V8, P582, DOI 10.1089/ars.2006.8.582
   STOLTZNER G, 1977, GROWTH, V41, P337
   Tamburini I, 2004, AGING CLIN EXP RES, V16, P425, DOI 10.1007/BF03327396
   Wang C, 2004, INT J OBESITY, V28, P357, DOI 10.1038/sj.ijo.0802518
   YOUNGMAN LD, 1992, P NATL ACAD SCI USA, V89, P9112, DOI 10.1073/pnas.89.19.9112
   YOUNGMAN LD, 1993, MUTAT RES, V295, P165, DOI 10.1016/0921-8734(93)90018-X
   Yu BP, 2005, MECH AGEING DEV, V126, P1003, DOI 10.1016/j.mad.2005.03.020
   YU BP, 1985, J GERONTOL, V40, P657, DOI 10.1093/geronj/40.6.657
NR 57
TC 78
Z9 87
U1 0
U2 25
PU GERONTOLOGICAL SOC AMER
PI WASHINGTON
PA 1030 15TH ST NW, STE 250, WASHINGTON, DC 20005202-842 USA
SN 1079-5006
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD APR
PY 2007
VL 62
IS 4
BP 352
EP 360
DI 10.1093/gerona/62.4.352
PG 9
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA 228WN
UT WOS:000250763400003
PM 17452727
OA Bronze, Green Submitted
DA 2024-02-19
ER

PT J
AU Dickerson, RN
   Maish, GO
   Croce, MA
   Minard, G
   Brown, RO
AF Dickerson, Roland N.
   Maish, George O., III
   Croce, Martin A.
   Minard, Gayle
   Brown, Rex O.
TI Influence of Aging on Nitrogen Accretion During Critical Illness
SO JOURNAL OF PARENTERAL AND ENTERAL NUTRITION
LA English
DT Article
DE geriatrics; life cycle; trauma; research and diseases; parenteral
   nutrition; nutrition; enteral nutrition; critical care; amino acids
ID MUSCLE PROTEIN ANABOLISM; CREATININE CLEARANCE; TRAUMA PATIENTS; ENTERAL
   NUTRITION; ILL PATIENTS; EXCRETION; THERAPY; METABOLISM; HEALTHY;
   INSULIN
AB Background: Aging adversely affects nitrogen accretion during health, but its effect during critical illness is unknown. Nitrogen balance (NB) response to varying protein intakes was compared between critically ill, older and younger patients. Methods: Adult patients admitted to the trauma intensive care unit, given enteral or parenteral nutrition, and who had a NB determination within 5-14 days after injury were evaluated. Patients with renal or hepatic disease were excluded. Patients were categorized as older (60 years) or younger (18-59 years of age). Data are given as mean +/- SD or median [interquartile range]. Results: Fifty-four older (69 [65, 77] years) and 195 younger (35 [27, 47] years) patients were evaluated. NB was blunted for the older patients with an observed trending improvement in NB from -13.5 +/- 5.5 to -5.6 +/- 8.8 g/d (P = NS) noted at 1.5-1.99 g/kg/d. NB improved from -22.2 +/- 8.2 to -11.8 +/- 9.9 g/d (P = .05) at 1-1.49 g/kg/d and modestly thereafter for each 0.5-g/kg/d increase in protein intake for the younger patients. Serum urea nitrogen concentration during the NB was highly variable but overall greater for the older patients (20 [14, 33] vs 15 [10, 20] mg/dL, P = .001). Conclusions: Improvement in nitrogen accretion was blunted at lower protein intakes in critically ill, older patients compared with younger patients. Individualization of protein intake is warranted.
C1 [Dickerson, Roland N.; Brown, Rex O.] Univ Tennessee Hlth Sci Ctr, Dept Clin Pharm, Memphis, TN 38163 USA.
   [Maish, George O., III; Croce, Martin A.; Minard, Gayle] Univ Tennessee Hlth Sci Ctr, Dept Surg, Memphis, TN 38163 USA.
C3 University of Tennessee System; University of Tennessee Health Science
   Center; University of Tennessee System; University of Tennessee Health
   Science Center
RP Dickerson, RN (corresponding author), Univ Tennessee Hlth Sci Ctr, Dept Clin Pharm, 881 Madison Ave,Suite 345, Memphis, TN 38163 USA.
EM rdickerson@uthsc.edu
RI Dickerson, Roland N/C-5185-2008
OI Dickerson, Roland/0000-0002-2086-6317
CR Abraham E, 2000, CRIT CARE MED, V28, P232, DOI 10.1097/00003246-200001000-00039
   [Anonymous], 1985, WHO TECH REP SER, P1
   BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001
   BIRKHAHN RH, 1981, AM J PHYSIOL, V241, pE64, DOI 10.1152/ajpendo.1981.241.1.E64
   BLUMENKRANTZ MJ, 1980, AM J CLIN NUTR, V33, P1567, DOI 10.1093/ajcn/33.7.1567
   Bos C, 2000, AM J CLIN NUTR, V71, P1129
   BOYCE EG, 1989, CLIN PHARMACY, V8, P721
   CAMPBELL WW, 1994, AM J CLIN NUTR, V60, P501, DOI 10.1093/ajcn/60.4.501
   Carlotti APCP, 2008, QJM-INT J MED, V101, P197, DOI 10.1093/qjmed/hcm127
   COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580
   Dickerson RN, 2005, NUTRITION, V21, P332, DOI 10.1016/j.nut.2004.07.005
   Dickerson RN, 2002, NUTRITION, V18, P241, DOI 10.1016/S0899-9007(01)00793-6
   Dickerson RN, 2008, NUTRITION, V24, P536, DOI 10.1016/j.nut.2008.02.008
   Dickerson RN, 2005, JPEN-PARENTER ENTER, V29, P429, DOI 10.1177/0148607105029006429
   Dickerson RN, 2013, JPEN-PARENTER ENTER, V37, P506, DOI 10.1177/0148607112458526
   Dickerson RN, 2013, JPEN-PARENTER ENTER, V37, P342, DOI 10.1177/0148607112466894
   Dickerson RN, 2012, J TRAUMA ACUTE CARE, V73, P549, DOI 10.1097/TA.0b013e318256de1b
   Dickerson RN, 2009, JPEN-PARENTER ENTER, V33, P646, DOI 10.1177/0148607109335307
   Doig GS, 2011, INJURY, V42, P50, DOI 10.1016/j.injury.2010.06.008
   FLISER D, 1993, J AM SOC NEPHROL, V3, P1371
   FORD EG, 1987, J TRAUMA, V27, P1074, DOI 10.1097/00005373-198709000-00020
   FRIED RC, 1989, J TRAUMA, V29, P1558, DOI 10.1097/00005373-198911000-00017
   Guillet C, 2004, FASEB J, V18, P1586, DOI 10.1096/fj.03-1341fje
   Harris J, 1919, 279 CARN I WASH
   Iannuzzi-Sucich M, 2002, J GERONTOL A-BIOL, V57, pM772, DOI 10.1093/gerona/57.12.M772
   Katsanos CS, 2005, AM J CLIN NUTR, V82, P1065, DOI 10.1093/ajcn/82.5.1065
   Koopman R, 2009, J NUTR, V139, P1707, DOI 10.3945/jn.109.109173
   MACKENZIE TA, 1985, J AM COLL NUTR, V4, P575
   Manatt M. W., 1992, Modern methods in protein nutrition and metabolism., P9
   Melzer K, 2007, CLIN NUTR, V26, P498, DOI 10.1016/j.clnu.2007.05.002
   Minville V, 2011, CRIT CARE, V15, DOI 10.1186/cc10013
   Morgan Laurie M, 2004, Nutr Clin Pract, V19, P511, DOI 10.1177/0115426504019005511
   Neelemaat F, 2012, CLIN NUTR, V31, P958, DOI 10.1016/j.clnu.2012.04.010
   Ostermann M, 2007, CRIT CARE MED, V35, P2669, DOI 10.1097/01.CCM.0000288115.09689.3C
   RAPP RP, 1983, J NEUROSURG, V58, P906, DOI 10.3171/jns.1983.58.6.0906
   Rasmussen BB, 2006, FASEB J, V20, P768, DOI 10.1096/fj.05-4607fje
   SACKS GS, 1995, JPEN-PARENTER ENTER, V19, P387, DOI 10.1177/0148607195019005387
   SCHILLER WR, 1979, SURG GYNECOL OBSTET, V149, P561
   SHAW JHF, 1989, ANN SURG, V209, P63, DOI 10.1097/00000658-198901000-00010
   Udy A, 2010, ANESTH ANALG, V111, P1505, DOI 10.1213/ANE.0b013e3181f7107d
   Volpi E, 1998, J CLIN INVEST, V101, P2000, DOI 10.1172/JCI939
   Volpi E, 2000, J CLIN ENDOCR METAB, V85, P4481, DOI 10.1210/jc.85.12.4481
   Volpi E, 1999, AM J PHYSIOL-ENDOC M, V277, pE513, DOI 10.1152/ajpendo.1999.277.3.E513
   Walrand S, 2005, CURR OPIN CLIN NUTR, V8, P89, DOI 10.1097/00075197-200501000-00014
   Wolfe RR, 2008, CLIN NUTR, V27, P675, DOI 10.1016/j.clnu.2008.06.008
NR 45
TC 30
Z9 33
U1 0
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0148-6071
EI 1941-2444
J9 JPEN-PARENTER ENTER
JI J. Parenter. Enter. Nutr.
PD MAR
PY 2015
VL 39
IS 3
BP 282
EP 290
DI 10.1177/0148607113506939
PG 9
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA CC4PM
UT WOS:000350335300005
PM 24121182
DA 2024-02-19
ER

PT J
AU Zheng, HC
   Zhou, J
   Chen, YC
   Yu, Y
   Dai, W
   Han, Y
   Li, XP
   Jiang, SF
AF Zheng, Hui-Chao
   Zhou, Jing
   Chen, Yi-Chen
   Yu, Ying
   Dai, Wei
   Han, Yan
   Li, Xiao-Pan
   Jiang, Sun-Fang
TI The burden and trend of liver metastases in Shanghai, China: a
   population-based study
SO EUROPEAN JOURNAL OF CANCER PREVENTION
LA English
DT Article
DE burden; cancer; liver metastases; retrospective study; trend
ID COST-EFFECTIVENESS; CANCER STATISTICS; EPIDEMIOLOGY; RESECTION; SURVIVAL
AB Background: Studies on the epidemiology of liver metastases (LM)-related mortality are rare. we aimed to describe the burden and trend of liver metastases in Pudong of Shanghai, which could be beneficial to cancer prevention.Methods We performed a retrospective population-based analysis of cancer mortality data with liver metastases in Shanghai Pudong from 2005 to 2021. Long-term trends in crude mortality rates (CMRs), age-standardized mortality rates worldwide, and rate of years of life lost (YLL) were analyzed by the Join-point regression model. In addition, we evaluate the impact of the demographic and nondemographic factors on the mortality of disease by the decomposition method.Results Cancer with liver metastases accounted for 26.68% of all metastases. The CMR and age-standardized mortality rates by Segi's world population (ASMRW) of cancer with liver metastases were 15.12/105 person-years and 6.33/105 person-years, respectively. The YLL from cancer with liver metastases was 84 959.87 years, with the age group of 60-69 years having the highest YLL of 26 956.40 years. The top three cancer types in liver metastases are colorectal, gastric, and pancreatic cancer. The long-term trend of ASMRW significantly decreased by 2.31% per year (P<0.05). The ASMRW and YLL rates of those over 45 decreased year by year. Particularly striking was the 70-79 age group. Although the overall mortality of cancer with liver metastases decreased, there was still a significant upward trend toward an increased mortality rate caused by cancer with liver metastases in aging patients.Conclusion Liver metastases were a common site of metastases in patients with cancers originating from the digestive system. The disease burden caused by cancer with liver metastases provides valuable evidence for cancer management.
C1 [Zheng, Hui-Chao; Zhou, Jing; Dai, Wei; Han, Yan; Li, Xiao-Pan; Jiang, Sun-Fang] Fudan Univ, Zhongshan Hosp, Dept Hlth Management Ctr, Shanghai, Peoples R China.
   [Zheng, Hui-Chao; Yu, Ying; Jiang, Sun-Fang] Fudan Univ, Zhongshan Hosp, Dept Gen Practice, Shanghai, Peoples R China.
   [Chen, Yi-Chen] Fudan Univ, Sch Publ Hlth, Dept Epidemiol, Shanghai, Peoples R China.
   [Chen, Yi-Chen; Li, Xiao-Pan] Pudong Inst Prevent Med, Dept Sci Res & Informat Management, Shanghai, Peoples R China.
   [Chen, Yi-Chen] CDCP, Dept Sci Res & Informat Management, Pudong New Area, Shanghai, Peoples R China.
C3 Fudan University; Fudan University; Fudan University
RP Li, XP (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Hlth Management Ctr, Shanghai, Peoples R China.; Li, XP (corresponding author), Pudong Inst Prevent Med, Dept Sci Res & Informat Management, Shanghai, Peoples R China.
EM xiaopanli0224@126.com
OI Li, Xiaopan/0000-0002-9625-478X
FU Shanghai Municipal Program for Medical Leading Talents [2019LJ15];
   Shanghai Public Health System Construction Three-year Action Plan
   Outstanding Youth Talent Training Program [GWV-10.2-YQ43]; National Key
   Research and Development Program [2022YFC3600901]
FX We thank all the staff in Vital Statistics of Pudong New Area from 2005
   to 2021, for their great work in data collection and assuring data of
   high quality. This study was funded by a grant from Shanghai Municipal
   Program for Medical Leading Talents (2019LJ15 to SJ), Shanghai Public
   Health System Construction Three-year Action Plan Outstanding Youth
   Talent Training Program (GWV-10.2-YQ43 to Y.C.) and the National Key
   Research and Development Program (2022YFC3600901). H.-C.Z., J.Z., and
   Y.-C.C. contributed to the conception of the research ideas, study
   design, interpretation of the findings, writing of the first draft of
   the manuscript, and provided intellectual input regarding the
   translational aspects of the study. Y.Y., W.D., Y.H., X.-P.L., and
   S.-F.J. were involved in retrieving information from relevant databases
   and performing statistical analysis. X.-P.L. and S.-F.J. made critical
   revisions to the manuscripts and provided expert opinions on the
   implications of the study findings. S.-F.J. provided the research
   funding support. Research Ethics Committee of School of Public Health,
   Fudan University (Approval #: IRB#2016-04-0586).
CR Abbott DE, 2014, J SURG ONCOL, V109, P516, DOI 10.1002/jso.23539
   Alzubi MA, 2019, CLIN EXP METASTAS, V36, P257, DOI 10.1007/s10585-019-09968-z
   Brawley OW, 2021, JNCI-J NATL CANCER I, V113, P1272, DOI 10.1093/jnci/djab073
   Budh DP., 2022, StatPearls
   Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543
   Clark AM, 2021, SEMIN CANCER BIOL, V71, P157, DOI 10.1016/j.semcancer.2020.06.010
   Clark AM, 2016, EXP BIOL MED, V241, P1639, DOI 10.1177/1535370216658144
   Gesthalter Yaron B, 2021, Am J Respir Crit Care Med, V204, pP19, DOI 10.1164/rccm.20411P19
   Horn SR, 2020, CANCER EPIDEMIOL, V67, DOI 10.1016/j.canep.2020.101760
   Hu JX, 2021, WORLD J GASTROENTERO, V27, P4298, DOI 10.3748/wjg.v27.i27.4298
   Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.21492, 10.3322/caac.20107]
   Kocarnik JM, 2022, JAMA ONCOL, V8, P420, DOI 10.1001/jamaoncol.2021.6987
   Li XP, 2019, PREV MED, V118, P243, DOI 10.1016/j.ypmed.2018.11.002
   Li YQ, 2020, J CANCER, V11, P6213, DOI 10.7150/jca.46155
   Litwic A, 2013, BRIT MED BULL, V105, P185, DOI 10.1093/bmb/lds038
   Luo Z, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01353
   Luo Z, 2021, FRONT NEUROL, V12, DOI 10.3389/fneur.2021.625042
   Ma GF, 2022, FRONT ONCOL, V12, DOI 10.3389/fonc.2022.873918
   Markar SR, 2016, ANN SURG, V263, P1092, DOI 10.1097/SLA.0000000000001542
   Mise Y, 2016, ANN SURG, V263, P146, DOI 10.1097/SLA.0000000000001194
   Moleyar-Narayana P., 2022, StatPearls
   Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622
   Odd D, 2022, BMJ OPEN, V12, DOI 10.1136/bmjopen-2022-066214
   Ransome Y, 2020, AM J EPIDEMIOL, V189, P755, DOI 10.1093/aje/kwaa022
   Rawla P, 2019, GASTROENTEROL REV, V14, P26, DOI 10.5114/pg.2018.80001
   Schnitzer ML, 2023, EUR J RADIOL, V163, DOI 10.1016/j.ejrad.2023.110803
   Sharma KP, 2021, AM J PREV MED, V61, P402, DOI 10.1016/j.amepre.2021.03.002
   Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI 10.3322/caac.21708
   Taylor PN, 2018, NAT REV ENDOCRINOL, V14, P301, DOI 10.1038/nrendo.2018.18
   Wang CF, 2020, DIS MARKERS, V2020, DOI 10.1155/2020/8850873
   Wang HD, 2020, LANCET, V396, P1160, DOI 10.1016/S0140-6736(20)30977-6
   Wang SC, 2020, AM J CANCER RES, V10, P1477
   Wu Y, 2022, MEDICINE, V101, DOI 10.1097/MD.0000000000028492
   Xia CF, 2022, CHINESE MED J-PEKING, V135, P584, DOI 10.1097/CM9.0000000000002108
   Zheng WB, 2021, ONCOTARGETS THER, V14, P3013, DOI 10.2147/OTT.S301371
   Zhou WT, 2020, CANCER CONTROL, V27, DOI 10.1177/1073274820976593
NR 36
TC 0
Z9 0
U1 5
U2 14
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0959-8278
EI 1473-5709
J9 EUR J CANCER PREV
JI Eur. J. Cancer Prev.
PD NOV
PY 2023
VL 32
IS 6
BP 517
EP 524
DI 10.1097/CEJ.0000000000000823
PG 8
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA U2CI7
UT WOS:001082932600001
PM 37401477
DA 2024-02-19
ER

PT J
AU Baird, A
   Gomes, M
   Souza, CA
   Magner, K
   Alvarez, G
AF Baird, Andrew
   Gomes, Marcio
   Souza, Carolina A. A.
   Magner, Kate
   Alvarez, Gonzalo
TI Short Telomere Syndrome presenting with pulmonary fibrosis, liver
   cirrhosis and hepatopulmonary syndrome: a case report
SO BMC PULMONARY MEDICINE
LA English
DT Article
DE Case report; Short teleomere syndrome; Pulmonary fibrosis
ID LENGTH
AB BackgroundIdiopathic pulmonary fibrosis is thought to result from aberrant post-injury activation of epithelial cells leading to fibroblast proliferation and activation. A number of genetic aetiologies have been implicated in this disease process, including, among others, the short telomere syndromes. Short telomere syndromes follow an autosomal dominant pattern of inheritance resulting in shortened telomere length, which consequently leads to accelerated cell death. Organs with rapid cell turnover are most affected.Case presentationWe describe a case of a 53-year-old man with a chief complaint of cough and dyspnea on exertion. His presentation was otherwise significant for features of accelerated aging, including a history of osteoporosis and early greying, and a family history of pulmonary fibrosis in his father. Pulmonary function testing revealed a restrictive pattern with severely reduced diffusion capacity and high resolution CT of the chest showed diffuse lung disease with mild fibrosis, in pattern suggesting an alternative diagnosis to IPF. Biopsy of the lung was in keeping with chronic fibrosing interstitial pneumonia. Imaging of the abdomen showed splenomegaly, hepatic cirrhosis and portal hypertension. Transthoracic contrast echocardiogram showed intrapulmonary shunting consistent with hepatopulmonary syndrome. Given the constellation of early aging, idiopathic pulmonary fibrosis, cryptogenic cirrhosis and a family history of pulmonary fibrosis in this patient, the Short Telomere Syndrome was suspected. Peripheral blood was sent for Flow-cytometry FISH, which demonstrated granulocyte telomere length below the 10(th) percentile for the patient's age, consistent with a diagnosis of Short Telomere Syndrome in this clinical context. Targeted genetic testing of mutations known to be associated with short telomere was negative though it was acknowledged that the full spectrum of disease-causing mutations remains unknown. Given the extensive fibrosis on biopsy and his progressive hypoxemia he was treated with mycophenolate and prednisone. Ultimately, he developed progressive respiratory failure and underwent double lung and concurrent liver transplant 18 months after the initial diagnosis was made.ConclusionsShort Telomere Syndrome is a rare cause of end stage organ disease and testing lacks sensitivity making diagnosis challenging. Organ transplant is still the mainstay of treatment. Nevertheless, disease identification is important because of implications for family member screening and the possibility of future treatment options.
C1 [Baird, Andrew; Magner, Kate; Alvarez, Gonzalo] Univ Ottawa, Ottawa Hosp, Dept Med, Div Respirol, Gen Campus,501 Smyth Rd, Ottawa, ON K1H 8L6, Canada.
   [Baird, Andrew; Gomes, Marcio; Souza, Carolina A. A.; Magner, Kate; Alvarez, Gonzalo] Ottawa Hosp Res Inst, Ottawa, ON, Canada.
   [Gomes, Marcio] Univ Ottawa, Ottawa Hosp, Dept Pathol, Ottawa, ON, Canada.
   [Souza, Carolina A. A.] Univ Ottawa, Ottawa Hosp, Dept Med Imaging & Internal Med, Div Respirol, Ottawa, ON, Canada.
C3 University of Ottawa; Ottawa Hospital Research Institute; University of
   Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa
   Hospital Research Institute; University of Ottawa; Ottawa Hospital
   Research Institute
RP Magner, K (corresponding author), Univ Ottawa, Ottawa Hosp, Dept Med, Div Respirol, Gen Campus,501 Smyth Rd, Ottawa, ON K1H 8L6, Canada.; Magner, K (corresponding author), Ottawa Hosp Res Inst, Ottawa, ON, Canada.
EM kmagner@toh.ca
CR Alder JK, 2018, P NATL ACAD SCI USA, V115, pE2358, DOI 10.1073/pnas.1720427115
   Baerlocher GM, 2006, NAT PROTOC, V1, P2365, DOI 10.1038/nprot.2006.263
   Calado RT, 2009, NEW ENGL J MED, V361, P2353, DOI 10.1056/NEJMra0903373
   Flaherty KR, 2019, NEW ENGL J MED, V381, P1718, DOI 10.1056/NEJMoa1908681
   Kropski JA, 2017, AM J RESP CRIT CARE, V195, P1423, DOI 10.1164/rccm.201609-1820PP
   Raghu G, 2018, AM J RESP CRIT CARE, V198, pE44, DOI 10.1164/rccm.201807-1255ST
   Silhan LL, 2014, EUR RESPIR J, V44, P178, DOI 10.1183/09031936.00060014
   Townsley DM, 2016, NEW ENGL J MED, V374, P1922, DOI 10.1056/NEJMoa1515319
NR 8
TC 0
Z9 0
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2466
J9 BMC PULM MED
JI BMC Pulm. Med.
PD APR 11
PY 2023
VL 23
IS 1
AR 114
DI 10.1186/s12890-023-02378-8
PG 5
WC Respiratory System
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Respiratory System
GA D3CG6
UT WOS:000967531000002
PM 37041499
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Anisimov, VN
   Labunets, IF
   Popovich, IG
   Tyndyk, ML
   Yurova, MN
   Golubev, AG
AF Anisimov, Vladimir N.
   Labunets, Irina F.
   Popovich, Irina G.
   Tyndyk, Margarita L.
   Yurova, Maria N.
   Golubev, Alexey G.
TI In mice transgenic for IGF1 under keratin-14 promoter, lifespan is
   decreased and the rates of aging and thymus involution are accelerated
SO AGING-US
LA English
DT Article
DE aging; IGF1; thymus; thymulin; papilloma; cancer; survival pattern;
   parametric analysis; Gompertz model; Strehler-Mildvan correlation;
   age-related-diseases
ID GROWTH-FACTOR-I; OXIDATIVE STRESS; EPITHELIAL-CELL; EXPRESSION;
   LONGEVITY; OVEREXPRESSION; RECEPTOR; HORMONE; APOPTOSIS; AXIS
AB IGF1 signaling is supposedly a key lifespan determinant in metazoans. However, controversial lifespan data were obtained with different means used to modify IGF1 or its receptor (IGF1R) expression in mice. The emerging puzzle lacks pieces of evidence needed to construct a coherent picture. We add to the available evidence by using the Gompertz model (GM), with account for the artifactual component of the Strehler-Mildvan correlation between its parameters, to compare the survival patterns of female FVB/N and FVB/Nderived K14/mIGF1 mice. In K14/mIGF1 vs. FVB/N mice, the rate of aging (gamma) is markedly increased without concomitant changes in the initial mortality (mu(0)). In published cases where IGF1 signaling was altered by modifying liver or muscle IGF1 or whole body IGF1R expression, lifespan changes are attributable to mu(0). The accelerated aging and associated tumor yield in K14/mIGF1 mice are consistent with the finding that the age-associated decreases in thymus weight and serum thymulin are accelerated in K14/mIGF1 mice. Our results underscore the importance of accounting for the mathematical artifacts of data fitting to GM in attempts to resolve discrepancies in survival data and to differentiate the contributions of the initial mortality and the rate of aging to changes in lifespan.
C1 [Anisimov, Vladimir N.; Popovich, Irina G.; Tyndyk, Margarita L.; Yurova, Maria N.; Golubev, Alexey G.] NN Petrov Natl Med Res Ctr Oncol, Dept Carcinogenesis & Oncogerontol, St Petersburg 197758, Russia.
   [Labunets, Irina F.] Natl Acad Med Sci Ukraine, State Inst Genet & Regenerat Med, Lab Expt Models, UA-04114 Kiev, Ukraine.
C3 National Academy of Medical Sciences of Ukraine; Institute of Genetic &
   Regenerative Medicine NAMS Ukraine
RP Anisimov, VN (corresponding author), NN Petrov Natl Med Res Ctr Oncol, Dept Carcinogenesis & Oncogerontol, St Petersburg 197758, Russia.
EM aging@mail.ru
RI Labunets, Irina/JUF-8383-2023; Yurova, Maria N/E-3913-2017; Margarita,
   Tyndyk/AAA-8919-2020
OI Labunets, Irina/0009-0000-3854-0959; Yurova, Maria
   N/0000-0003-3589-5871; Margarita, Tyndyk/0000-0002-4755-9317
FU Ministry of Health of the Russian Federation
FX The study was partly supported by the Ministry of Health of the Russian
   Federation.
CR Anisimov VN, 2013, CRIT REV ONCOL HEMAT, V87, P201, DOI 10.1016/j.critrevonc.2013.01.005
   Anisimov VN, 2013, METHODS MOL BIOL, V1048, P145, DOI 10.1007/978-1-62703-556-9_12
   Anversa P, 2005, CIRC RES, V97, P411, DOI 10.1161/01.RES.0000182212.09147.56
   Ashpole NM, 2017, GEROSCIENCE, V39, P129, DOI 10.1007/s11357-017-9971-0
   BACH JF, 1978, B I PASTEUR, V76, P325
   Bokov AF, 2017, IEEE SYMP COMP COMMU, P290, DOI 10.1109/ISCC.2017.8024544
   Bokov AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026891
   Bol DK, 1997, ONCOGENE, V14, P1725, DOI 10.1038/sj.onc.1201011
   Brayton CF, 2012, VET PATHOL, V49, P85, DOI 10.1177/0300985811430696
   Brown-Borg HM, 2015, AM J PHYSIOL-ENDOC M, V309, pE503, DOI 10.1152/ajpendo.00262.2015
   Burger O, 2016, J THEOR BIOL, V408, P34, DOI 10.1016/j.jtbi.2016.08.002
   Chu YW, 2008, BLOOD, V112, P2836, DOI 10.1182/blood-2008-04-149435
   Csaba G, 2016, ACTA MICROBIOL IMM H, V63, P139, DOI 10.1556/030.63.2016.2.1
   de Magalhaes JP, 2005, GENETICS, V169, P265, DOI 10.1534/genetics.104.032292
   DiGiovanni J, 2000, CANCER RES, V60, P1561
   George AJT, 1996, IMMUNOL TODAY, V17, P267, DOI 10.1016/0167-5699(96)80543-3
   Golubev A, 2018, BIOGERONTOLOGY, V19, P341, DOI 10.1007/s10522-018-9759-3
   Gong ZW, 2014, AGING CELL, V13, P408, DOI 10.1111/acel.12188
   Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298
   Kelley KW, 1998, ANN NY ACAD SCI, V840, P518, DOI 10.1111/j.1749-6632.1998.tb09590.x
   Kermani H, 2012, NEUROIMMUNOMODULAT, V19, P137, DOI 10.1159/000328844
   KOOIJMAN R, 1995, J ENDOCRINOL, V147, P203, DOI 10.1677/joe.0.1470203
   Lee EN, 2011, ANAT CELL BIOL, V44, P14, DOI 10.5115/acb.2011.44.1.14
   Li Q, 2007, AM J PHYSIOL-HEART C, V292, pH1398, DOI 10.1152/ajpheart.01036.2006
   Lunin SM, 2017, INT J IMMUNOPATH PH, V30, P58, DOI 10.1177/0394632017694625
   Nabarra B, 2001, DEV COMP IMMUNOL, V25, P231, DOI 10.1016/S0145-305X(00)00054-9
   Palmer S, 2018, P NATL ACAD SCI USA, V115, P1883, DOI 10.1073/pnas.1714478115
   Petrascheck Michael, 2017, Front Genet, V8, P92, DOI 10.3389/fgene.2017.00092
   Pletcher SD, 2000, J GERONTOL A-BIOL, V55, pB381, DOI 10.1093/gerona/55.8.B381
   Semenova E, 2008, AM J PATHOL, V173, P1295, DOI 10.2353/ajpath.2008.071177
   Shanley DP, 2009, TRENDS IMMUNOL, V30, P374, DOI 10.1016/j.it.2009.05.001
   Sharples AP, 2015, AGING CELL, V14, P511, DOI 10.1111/acel.12342
   Sonntag WE, 2012, J GERONTOL A-BIOL, V67, P587, DOI 10.1093/gerona/gls115
   Sun LY, 2017, ELIFE, V6, DOI 10.7554/eLife.24059
   Tarkhov AE, 2017, J THEOR BIOL, V416, P180, DOI 10.1016/j.jtbi.2017.01.017
   Tasaki M, 2016, AM J TRANSPLANT, V16, P2877, DOI 10.1111/ajt.13855
   TIMSIT J, 1992, J CLIN ENDOCR METAB, V75, P183, DOI 10.1210/jc.75.1.183
   Wrigley S, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00014
   Xu J, 2014, AGING CELL, V13, P19, DOI 10.1111/acel.12145
   Yen K, 2008, EXP GERONTOL, V43, P1044, DOI 10.1016/j.exger.2008.09.006
   2002, NEUROENDOCRINOLOGY, V75, P139, DOI DOI 10.1159/000048230
NR 41
TC 0
Z9 0
U1 0
U2 4
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1945-4589
J9 AGING-US
JI Aging-US
PD APR 15
PY 2019
VL 11
IS 7
BP 2098
EP 2110
DI 10.18632/aging.101903
PG 13
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA HV4MF
UT WOS:000465959700016
PM 30981207
OA Green Published, Green Submitted, gold
DA 2024-02-19
ER

PT J
AU Varela-Lopez, A
   Pérez-López, MP
   Ramirez-Tortosa, CL
   Battino, M
   Granados-Principal, S
   Ramirez-Tortosa, MD
   Ochoa, JJ
   Vera-Ramirez, L
   Giampieri, F
   Quiles, JL
AF Varela-Lopez, Alfonso
   Patricia Perez-Lopez, Maria
   Luis Ramirez-Tortosa, Cesar
   Battino, Maurizio
   Granados-Principal, Sergio
   del Carmen Ramirez-Tortosa, Maria
   Jose Ochoa, Julio
   Vera-Ramirez, Laura
   Giampieri, Francesca
   Luis Quiles, Jose
TI Gene pathways associated with mitochondrial function, oxidative stress
   and telomere length are differentially expressed in the liver of rats
   fed lifelong on virgin olive, sunflower or fish oils
SO JOURNAL OF NUTRITIONAL BIOCHEMISTRY
LA English
DT Article
DE Gene expression; Mitochondria; MUFA; Oxidative stress; PUFA; Telomere
ID AGE-RELATED-CHANGES; QUANTITATIVE PCR; SKELETAL-MUSCLE; DNA DELETION;
   DISEASE; ACID; DIET; STEATOHEPATITIS; PROTEINS; SUPPLEMENTATION
AB This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated (virgin olive oil), n6 polyunsaturated (sunflower oil) or n3 polyunsaturated (fish oil) fatty acids in the aged liver. Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age. Liver histopathology, mitochondrial ultrastructure, biogenesis, oxidative stress, mitochondrial electron transport chain, relative telomere length and gene expression profiles were studied. Aging led to lipid accumulation in the liver. Virgin olive oil led to the lowest oxidation and ultrastructural alterations. Sunflower oil induced fibrosis, ultrastructural alterations and high oxidation. Fish oil intensified oxidation associated with age, lowered electron transport chain activity and enhanced the relative telomere length. Gene expression changes associated with age in animals fed virgin olive oil and fish oil were related mostly to mitochondria] function and oxidative stress pathways, followed by cell cycle and telomere length control. Sunflower oil avoided gene expression changes related to age. According to the results, virgin olive oil might be considered the dietary fat source that best preserves the liver during the aging process. (C) 2017 Published by Elsevier Inc.
C1 [Varela-Lopez, Alfonso; Patricia Perez-Lopez, Maria; Jose Ochoa, Julio; Luis Quiles, Jose] Univ Granada, Inst Nutr & Food Technol Jose Mataix Verdu, Dept Physiol, Biomed Res Ctr, Av Conocimiento S-N, Armilla 18100, Granada, Spain.
   [Luis Ramirez-Tortosa, Cesar] Complejo Hosp Jaen, Dept Pathol, Av Ejercito Espanol 10, Jaen 23007, Spain.
   [Battino, Maurizio; Giampieri, Francesca] Univ Politecn Marche, Dip Sci Clin Specialist & Odontostomatol, Via Ranieri 65, I-60131 Ancona, Italy.
   [Granados-Principal, Sergio] Hosp Complex Jaen, Dept Oncol, Av Ilustrac 114, Granada 18007, Spain.
   [Granados-Principal, Sergio] Univ Granada Junta Andalucia Genom & Invest Oncol, Ctr Pfizer, Av Ilustrac 114, Granada 18007, Spain.
   [del Carmen Ramirez-Tortosa, Maria] Univ Granada, Inst Nutr & Food Technol Jose Mataix Verdu, Dept Biochem & Mol Biol 2, Biomed Res Ctr, Av Conocimiento S-N, Armilla 18100, Granada, Spain.
   [Vera-Ramirez, Laura] NCI, Lab Canc Biol & Genet, NIH, Bethesda, MD 20892 USA.
C3 University of Granada; Complejo Hospitalario de Jaen; Marche Polytechnic
   University; Pfizer; University of Granada; National Institutes of Health
   (NIH) - USA; NIH National Cancer Institute (NCI)
RP Quiles, JL (corresponding author), Inst Nutr & Tecnol Alimentos Jose Mataix Verdu, Dept Fisiol, Lab 250,Parque Tecnol Ciencias Salud, Armilla 18100, Granada, Spain.
EM alvarela@ugr.es; patriciapl@ugr.es;
   cesarl.ramirez.sspa@juntadeandalucia.es; m.a.battino@univpm.it;
   sgranados@fibao.es; mramirez@ugr.es; jjoh@ugr.es;
   laura.veraramirez@nih.gov; f.giampieri@univpm.it; jlquiles@ugr.es
RI Ochoa, Julio/L-8733-2014; Varela-López, Alfonso/F-8055-2016; Giampieri,
   Francesca/I-1911-2015; Granados-Principal, Sergio/B-4987-2014; Battino,
   Maurizio/E-6103-2012; Ramirez, Laura Vera/S-3375-2018; Ramírez-Tortosa,
   César/F-2055-2016; Quiles, José L./C-6911-2013
OI Ochoa, Julio/0000-0001-8976-6296; Varela-López,
   Alfonso/0000-0002-0504-5086; Giampieri, Francesca/0000-0002-8151-9132;
   Granados-Principal, Sergio/0000-0001-8773-9489; Battino,
   Maurizio/0000-0002-7250-1782; Ramirez, Laura Vera/0000-0001-9184-9875;
   Ramírez-Tortosa, César/0000-0002-3302-707X; Quiles, José
   L./0000-0002-9048-9086
FU Spanish Ministry of Education and Science [AGL2008-01057]; Government of
   Andalusia [AGR832]; CEI BioTic Granada [CEI2013-P-20]; FPU program from
   the Spanish Ministry of Education; FPI program from the Spanish Ministry
   of Education
FX This work was supported by I+D grants from the Spanish Ministry of
   Education and Science (AGL2008-01057), the Government of Andalusia
   (AGR832) and CEI BioTic Granada (CEI2013-P-20). A. Varela-Lopez and P.
   Perez-Lopez were recipients, respectively, of a fellowship of FPU and
   FPI programs from the Spanish Ministry of Education.
CR AI-Dwairi A, 2012, PLOS ONE, V7
   Amano A, 2013, J NUTR SCI VITAMINOL, V59, P489, DOI 10.3177/jnsv.59.489
   Anantharaju A, 2002, GERONTOLOGY, V48, P343, DOI 10.1159/000065506
   Aoun M, 2012, BRIT J NUTR, V107, P647, DOI 10.1017/S000711451100331X
   Bakala H, 2013, BBA-MOL BASIS DIS, V1832, P2057, DOI 10.1016/j.bbadis.2013.07.015
   Barden A, 2016, NUTRIENTS, V8, DOI 10.3390/nu8030175
   Bardia A, 2012, INFLAMM RES, V61, P359, DOI 10.1007/s00011-011-0418-2
   Barja G, 2013, ANTIOXID REDOX SIGN, V19, P1420, DOI 10.1089/ars.2012.5148
   Bose C, 2005, MECH AGEING DEV, V126, P740, DOI 10.1016/j.mad.2005.02.003
   Cakatay Ufuk, 2013, Curr Aging Sci, V6, P135
   Ramirez-Tortosa MC, 2009, FREE RADICAL BIO MED, V47, P924, DOI 10.1016/j.freeradbiomed.2009.06.015
   Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47
   Chou HC, 2007, CANCER LETT, V253, P138, DOI 10.1016/j.canlet.2007.01.016
   Clichici S, 2011, ACTA PHYSIOL HUNG, V98, P195, DOI 10.1556/APhysiol.98.2011.2.11
   Cogger VC, 2014, J GERONTOL A-BIOL, V69, P1076, DOI 10.1093/gerona/glt169
   Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265
   Diamanti J, 2014, J AGR FOOD CHEM
   Espinosa-Diez C, 2015, REDOX BIOL, V6, P183, DOI 10.1016/j.redox.2015.07.008
   Fiamoncini J, 2013, OBESITY, V21, P1200, DOI 10.1002/oby.20132
   Fleischer S, 1979, Methods Enzymol, V55, P32
   Fontana L, 2013, HEPATOLOGY, V57, P995, DOI 10.1002/hep.26099
   Frith J, 2009, AGE AGEING, V38, P11, DOI 10.1093/ageing/afn242
   Gan L, 2011, CURR GERONTOL GERIAT, V31536
   Hock MB, 2009, ANNU REV PHYSIOL, V71, P177, DOI 10.1146/annurev.physiol.010908.163119
   Hsieh CC, 2003, MECH AGEING DEV, V124, P733, DOI 10.1016/S0047-6374(03)00083-6
   Jiang WQ, 2012, CANCER RES, V72, P3795, DOI 10.1158/0008-5472.CAN-12-1047
   Jousse C, 2007, J BIOL CHEM, V282, P15851, DOI 10.1074/jbc.M611723200
   LEPAGE G, 1986, J LIPID RES, V27, P114
   Li SP, 2016, J NUTR BIOCHEM, V27, P96, DOI 10.1016/j.jnutbio.2015.08.021
   Lin CF, 2007, J CELL SCI, V120, P2935, DOI 10.1242/jcs.03473
   Liu J, 2012, CURR MOL MED, V12, P982, DOI 10.2174/156652412802480916
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lopez-Cruzan M, 2013, BIOGERONTOLOGY, V14, P121, DOI 10.1007/s10522-013-9415-x
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   LUDWIG J, 1980, MAYO CLIN PROC, V55, P434
   Meng QY, 2007, MECH AGEING DEV, V128, P286, DOI 10.1016/j.mad.2006.12.008
   O'Leary MF, 2013, AM J PHYSIOL-CELL PH, V304, pC422, DOI 10.1152/ajpcell.00240.2012
   Ochoa JJ, 2003, J BIOENERG BIOMEMBR, V35, P267, DOI 10.1023/A:1024615816839
   Ochoa JJ, 2007, J GERONTOL A-BIOL, V62, P1211, DOI 10.1093/gerona/62.11.1211
   Ochoa JJ, 2011, FREE RADICAL BIO MED, V50, P1053, DOI 10.1016/j.freeradbiomed.2011.02.004
   Ochoa-Herrera JJ, 2001, J NUTR BIOCHEM, V12, P357, DOI 10.1016/S0955-2863(01)00150-4
   Penumathsa SV, 2006, TOXICOL MECH METHOD, V16, P267, DOI 10.1080/15376520500194734
   Pereira AF, 2012, J BIOENERG BIOMEMBR, V44, P587, DOI 10.1007/s10863-012-9463-y
   Picca A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074644
   Pierce AA, 2016, J NUTR BIOCHEM, V29, P12, DOI 10.1016/j.jnutbio.2015.10.020
   Port M, 2012, HEALTH PHYS, V103, P159, DOI 10.1097/HP.0b013e31824ac318
   Quiles JL, 2006, J GERONTOL A-BIOL, V61, P107, DOI 10.1093/gerona/61.2.107
   Quiles JL, 2004, EXP GERONTOL, V39, P1189, DOI 10.1016/j.exger.2004.05.002
   Quiles JL, 2002, BRIT J NUTR, V88, P57, DOI [10.1079/BJN2002588, 10.1079/BJNBJN2002588]
   Quiles JL, 2004, ENDOCRINOL NUTR, V51, P107
   Quiles JL, 2010, MECH AGEING DEV, V131, P38, DOI 10.1016/j.mad.2009.11.004
   Rasband WS, IMAGEJ SOFTWARE, P1997
   Reeves PG, 1997, J NUTR, V127, pS838
   Rolo AP, 2012, FREE RADICAL BIO MED, V52, P59, DOI 10.1016/j.freeradbiomed.2011.10.003
   Sastre J, 2003, FREE RADICAL BIO MED, V35, P1, DOI 10.1016/S0891-5849(03)00184-9
   Slawik M, 2006, AGEING RES REV, V5, P144, DOI 10.1016/j.arr.2006.03.004
   Sohal RS, 2012, FREE RADICAL BIO MED, V52, P539, DOI 10.1016/j.freeradbiomed.2011.10.445
   Solanas M, 2010, CARCINOGENESIS, V31, P871, DOI 10.1093/carcin/bgp243
   Sunny NE, 2017, TRENDS ENDOCRIN MET, V28, P250, DOI 10.1016/j.tem.2016.11.006
   Tao LL, 2012, CHIN J INTEGR MED, V18, P582, DOI 10.1007/s11655-012-1180-1
   Yeh MM, 2007, AM J CLIN PATHOL, V128, P837, DOI 10.1309/RTPM1PY6YGBL2G2R
NR 61
TC 31
Z9 31
U1 0
U2 23
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0955-2863
EI 1873-4847
J9 J NUTR BIOCHEM
JI J. Nutr. Biochem.
PD FEB
PY 2018
VL 52
BP 36
EP 44
DI 10.1016/j.jnutbio.2017.09.007
PG 9
WC Biochemistry & Molecular Biology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Nutrition & Dietetics
GA FX1VQ
UT WOS:000425840400005
PM 29144994
DA 2024-02-19
ER

PT J
AU Li, Q
   Wu, FJ
   Wen, M
   Yanagita, T
   Xue, CH
   Zhang, TT
   Wang, YM
AF Li, Qian
   Wu, Fengjuan
   Wen, Min
   Yanagita, Teruyoshi
   Xue, Changhu
   Zhang, Tiantian
   Wang, Yuming
TI The Protective Effect of Antarctic Krill Oil on Cognitive Function by
   Inhibiting Oxidative Stress in the Brain of Senescence-Accelerated Prone
   Mouse Strain 8 (SAMP8) Mice
SO JOURNAL OF FOOD SCIENCE
LA English
DT Article
DE Alzheimer's disease; Antarctic krill oil; oxidative stress;
   neuroprotection; SAMP8
ID DIETARY DOCOSAHEXAENOIC ACID; ALZHEIMERS-DISEASE; EICOSAPENTAENOIC ACID;
   AMYLOID-BETA; ENRICHED PHOSPHOLIPIDS; WATER-MAZE; CELLS; RATS;
   ANTIOXIDANT; DEFICIENCY
AB Alzheimer's disease (AD) is a common neurodegenerative disorder, and oxidative stress plays a vital role in its progression. Antarctic krill oil (AKO) is rich in polyunsaturated fatty acids, which has various biological activities, such as improving insulin sensitivity, alleviating inflammation and ameliorating oxidative stress. In this study, the protective effect of AKO against AD were investigated in senescence-accelerated prone mouse strain 8 (SAMP8) mice. Results showed that treatment with AKO could effectively ameliorate learning and memory deficits and ease the anxiety in SAMP8 mice by Morris water maze, Barnes maze test and open-field test. Further analysis indicated that AKO might reduce -amyloid (A) accumulation in hippocampus through decreasing the contents of malondialdehyde (MDA) and 7,8-dihydro-8-oxoguanine (8-oxo-G), increasing the superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) activities in the brain of SAMP8 mice.
   Practical ApplicationThe results of Morris water maze, Barnes maze test and open-field test indicated that Antarctic krill oil (AKO) improved the cognitive function and anxiety of SAMP8 mice. AKO reduced the A(42) level in hippocampus of SAMP8 mice. AKO ameliorated oxidative stress in brain rather than in serum and liver of SAMP8 mice.
C1 [Li, Qian; Wu, Fengjuan; Wen, Min; Xue, Changhu; Zhang, Tiantian; Wang, Yuming] Ocean Univ China, Coll Food Sci & Engn, 5 Yushan Rd, Qingdao 266003, Peoples R China.
   [Xue, Changhu; Wang, Yuming] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Drugs & Biol Prod, Qingdao 266237, Shandong, Peoples R China.
   [Wen, Min] Liaocheng Univ, BioPharmaceut Res, Liaocheng 252059, Peoples R China.
   [Yanagita, Teruyoshi] Nishikyushu Univ, Dept Hlth & Nutr Sci, Kanzaki, Japan.
C3 Ocean University of China; Laoshan Laboratory; Liaocheng University
RP Zhang, TT; Wang, YM (corresponding author), Ocean Univ China, Coll Food Sci & Engn, 5 Yushan Rd, Qingdao 266003, Peoples R China.
EM zhangtiantian@ouc.edu.cn; wangyuming@ouc.edu.cn
RI zhang, tian/GZK-6001-2022; yuming, wang/K-8179-2012
FU National Natural Science Foundation of China [31371757]; State Key
   Program of National Natural Science of China [31330060]; National
   Natural Science Foundation of China-Shandong Joint Fund for Marine
   Science Research Centers [U1606403]; Fundamental Research Funds for the
   Central Universities [201762028]; Grants-in-Aid for Scientific Research
   [16K00890] Funding Source: KAKEN
FX This work was funded by the National Natural Science Foundation of China
   (No. 31371757), State Key Program of National Natural Science of China
   (No. 31330060), National Natural Science Foundation of China-Shandong
   Joint Fund for Marine Science Research Centers (U1606403) and
   Fundamental Research Funds for the Central Universities (No. 201762028).
CR Autry AE, 2012, PHARMACOL REV, V64, P238, DOI 10.1124/pr.111.005108
   Bazan NG, 2005, BRAIN PATHOL, V15, P159
   Castro-Gómez MP, 2015, FOOD ANAL METHOD, V8, P2568, DOI 10.1007/s12161-015-0150-6
   Craft S, 2009, ARCH NEUROL-CHICAGO, V66, P300, DOI 10.1001/archneurol.2009.27
   del Valle J, 2010, J ALZHEIMERS DIS, V19, P1303, DOI 10.3233/JAD-2010-1321
   Gallagher M, 2015, BEHAV NEUROSCI, V129, P540, DOI 10.1037/bne0000080
   Gamoh S., 2011, Journal of Agricultural Science (Toronto), V3, P3, DOI 10.5539/jas.v3n4p3
   Gaugler J., 2016, ALZHEIMERS DEMENT, V12, P459, DOI 10.1016/j.jalz.2016.03.001
   Green KN, 2007, J NEUROSCI, V27, P4385, DOI 10.1523/JNEUROSCI.0055-07.2007
   Grimm MOW, 2016, BIOCHEM CELL BIOL, V94, P534, DOI 10.1139/bcb-2015-0149
   Hiratsuka S, 2009, J NUTR SCI VITAMINOL, V55, P374, DOI 10.3177/jnsv.55.374
   Huang Y, 2016, INT J ONCOL, V49, P153, DOI 10.3892/ijo.2016.3525
   Ivanova Z, 2015, EUR J NUTR, V54, P1055, DOI 10.1007/s00394-014-0782-0
   LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168
   Levant B, 2008, PSYCHONEUROENDOCRINO, V33, P1279, DOI 10.1016/j.psyneuen.2008.06.012
   Liao WZ, 2016, J AGR FOOD CHEM, V64, P1509, DOI 10.1021/acs.jafc.5b04924
   Liao WZ, 2014, J AGR FOOD CHEM, V62, P8648, DOI 10.1021/jf502359x
   Locklear MN, 2014, HORM BEHAV, V66, P298, DOI 10.1016/j.yhbeh.2014.06.006
   MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4
   Niedernhofer LJ, 2003, J BIOL CHEM, V278, P31426, DOI 10.1074/jbc.M212549200
   Oboh G, 2017, J FOOD BIOCHEM, V41, DOI 10.1111/jfbc.12358
   Ong YS, 2017, CURR TOP MED CHEM, V17, P2302, DOI 10.2174/1568026617666170224121658
   Özbek H, 2017, REC NAT PROD, V11, P485, DOI 10.25135/rnp.62.16.05.040
   Pallas M, 2008, J ALZHEIMERS DIS, V15, P615
   Pifferi F, 2015, J LIPID RES, V56, P1511, DOI 10.1194/jlr.M058933
   Takagane K, 2015, BIOSCI BIOTECH BIOCH, V79, P912, DOI 10.1080/09168451.2014.1002449
   Tatem KS, 2014, JOVE-J VIS EXP, DOI 10.3791/51785
   Tou JC, 2007, NUTR REV, V65, P63, DOI 10.1301/nr.2007.feb.63-77
   Vigerust NF, 2013, EUR J NUTR, V52, P1315, DOI 10.1007/s00394-012-0441-2
   Wang XL, 2014, BBA-MOL BASIS DIS, V1842, P1240, DOI 10.1016/j.bbadis.2013.10.015
   Wen M, 2016, J FUNCT FOODS, V24, P537, DOI 10.1016/j.jff.2016.04.034
   Wen M, 2016, J FUNCT FOODS, V22, P417, DOI 10.1016/j.jff.2016.02.004
   Wu FJ, 2014, NEUROCHEM INT, V64, P9, DOI 10.1016/j.neuint.2013.10.015
   Xiao Q., 2017, CURRENT MED CHEM
   Xie D, 2017, FOOD CHEM, V233, P434, DOI 10.1016/j.foodchem.2017.04.138
   Yu ZQ, 2016, CURR CANCER DRUG TAR, V16, P509, DOI 10.2174/1568009616666151130213910
   Zhang TT, 2015, J FUNCT FOODS, V18, P423, DOI 10.1016/j.jff.2015.08.005
   Zheng JF, 2009, J PROTEOME RES, V8, P4479, DOI 10.1021/pr9002596
NR 38
TC 29
Z9 31
U1 3
U2 71
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-1147
EI 1750-3841
J9 J FOOD SCI
JI J. Food Sci.
PD FEB
PY 2018
VL 83
IS 2
BP 543
EP 551
DI 10.1111/1750-3841.14044
PG 9
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA FV5UN
UT WOS:000424648000036
PM 29350764
DA 2024-02-19
ER

PT J
AU Carregal-Romero, S
   Plaza-García, S
   Piñol, R
   Murillo, JL
   Ruiz-Cabello, J
   Padro, D
   Millán, A
   Ramos-Cabrer, P
AF Carregal-Romero, Susana
   Plaza-Garcia, Sandra
   Pinol, Rafael
   Murillo, Jose L.
   Ruiz-Cabello, Jesus
   Padro, Daniel
   Millan, Angel
   Ramos-Cabrer, Pedro
TI MRI Study of the Influence of Surface Coating Aging on the In Vivo
   Biodistribution of Iron Oxide Nanoparticles
SO BIOSENSORS-BASEL
LA English
DT Article
DE iron oxide nanoparticles; multimodal nanoparticles; biodistribution;
   magnetic resonance imaging; aging; coating degradation
ID GOLD NANOPARTICLES; CONTRAST AGENTS; PARTICLES; STABILITY; SIZE
AB Medical imaging is an active field of research that fosters the necessity for novel multimodal imaging probes. In this line, nanoparticle-based contrast agents are of special interest, since those can host functional entities either within their interior, reducing potential toxic effects of the imaging tracers, or on their surface, providing high payloads of probes, due to their large surface-to-volume ratio. The long-term stability of the particles in solution is an aspect usually under-tackled during probe design in research laboratories, since their performance is generally tested briefly after synthesis. This may jeopardize a later translation into practical medical devices, due to stability reasons. To dig into the effects of nanoparticle aging in solution, with respect to their behavior in vivo, iron oxide stealth nanoparticles were used at two stages (3 weeks vs. 9 months in solution), analyzing their biodistribution in mice. Both sets of nanoprobes showed similar sizes, zeta potentials, and morphology, as observed by dynamic light scattering (DLS) and transmission electronic microscopy (TEM), but fresh nanoparticles accumulated in the kidneys after systemic administration, while aged ones accumulated in liver and spleen, confirming an enormous effect of particle aging on their in vivo behavior, despite barely noticeable changes perceived on a simple inspection of their structural integrity.
C1 [Carregal-Romero, Susana; Ruiz-Cabello, Jesus] CIC biomaGUNE, Mol & Funct Biomarkers Grp, Donostia San Sebastian 20014, Spain.
   [Carregal-Romero, Susana; Ruiz-Cabello, Jesus] CIBER Enfermedades Resp CIBERES, Madrid, Spain.
   [Plaza-Garcia, Sandra; Padro, Daniel; Ramos-Cabrer, Pedro] CIC BiomaGUNE, Magnet Resonance Imaging Lab, Donostia San Sebastian 20014, Spain.
   [Pinol, Rafael; Murillo, Jose L.; Millan, Angel] Univ Zaragoza, CSIC, ICMA, E-50009 Zaragoza, Spain.
   [Ruiz-Cabello, Jesus; Ramos-Cabrer, Pedro] Basque Fdn Sci, Ikerbasque, Bilbao 48013, Spain.
   [Ruiz-Cabello, Jesus] Univ Complutense Madrid, Dept Quim Ciencias Farmaceut, E-28040 Madrid, Spain.
C3 CIC biomaGUNE; CIBER - Centro de Investigacion Biomedica en Red;
   CIBERES; CIC biomaGUNE; Consejo Superior de Investigaciones Cientificas
   (CSIC); CSIC - Centro de Quimica y Materiales de Aragon (CEQMA); CSIC -
   Instituto de Ciencia de Materiales de Aragon (ICMA); University of
   Zaragoza; Basque Foundation for Science; Complutense University of
   Madrid
RP Carregal-Romero, S (corresponding author), CIC biomaGUNE, Mol & Funct Biomarkers Grp, Donostia San Sebastian 20014, Spain.; Carregal-Romero, S (corresponding author), CIBER Enfermedades Resp CIBERES, Madrid, Spain.; Ramos-Cabrer, P (corresponding author), CIC BiomaGUNE, Magnet Resonance Imaging Lab, Donostia San Sebastian 20014, Spain.; Ramos-Cabrer, P (corresponding author), Basque Fdn Sci, Ikerbasque, Bilbao 48013, Spain.
EM scarregal.ciberes@cicbiomagune.es; splaza@cicbiomagune.es;
   pinol@unizar.es; jlmpola@unizar.es; jruizcabello@cicbiomagune.es;
   dpadro@cicbiomagune.es; amillan@unizar.es; pramos@cicbiomagune.es
RI Padro, Daniel/L-4091-2015; Ramos-Cabrer, Pedro/AAF-1467-2020; Pinol,
   Rafael/K-4643-2013; Carregal-Romero, Susana/K-6493-2019; Millan,
   Angel/N-6157-2016; Carregal-Romero, Susana/I-7946-2014; Ruiz-Cabello,
   Jesus/A-9570-2012; Padro, Daniel/AAG-3529-2021
OI Padro, Daniel/0000-0002-3932-9351; Ramos-Cabrer,
   Pedro/0000-0003-0368-7031; Carregal-Romero, Susana/0000-0003-1444-6268;
   Ruiz-Cabello, Jesus/0000-0001-8681-5056; Padro,
   Daniel/0000-0002-3932-9351; Millan Escolano, Angel/0000-0003-0828-3212
FU Ministerio de Ciencia, Innovacion y Universidades (MEIC)
   [SAF2017-87670-R, SAF2017-84494-C2-R]; Programa Red Guipuzcoana de
   Ciencia, Tecnologia e Informacion [2018-CIEN-000058-01]; EU (FET-OPEN
   NanoTBTech) [801305]; Ikerbasque, The Basque foundation for science
FX This research was funded by Ministerio de Ciencia, Innovacion y
   Universidades (MEIC) (grant number SAF2017-87670-R and
   SAF2017-84494-C2-R), Programa Red Guipuzcoana de Ciencia, Tecnologia e
   Informacion (Grant number 2018-CIEN-000058-01), and The EU (FET-OPEN
   NanoTBTech grant Number 801305). J.R.-C. and P.R.-C. are funded by
   Ikerbasque, The Basque foundation for science.
CR Ai FR, 2016, WIRES NANOMED NANOBI, V8, P619, DOI 10.1002/wnan.1386
   Alexis F, 2008, MOL PHARMACEUT, V5, P505, DOI 10.1021/mp800051m
   Bhatnagar P, 2014, SCI REP-UK, V4, DOI 10.1038/srep04502
   Briley-Saebo KC, 2011, J AM COLL CARDIOL, V57, P337, DOI 10.1016/j.jacc.2010.09.023
   Caravan P, 1999, CHEM REV, V99, P2293, DOI 10.1021/cr980440x
   Cole AJ, 2011, BIOMATERIALS, V32, P2183, DOI 10.1016/j.biomaterials.2010.11.040
   Colombo M, 2012, CHEM SOC REV, V41, P4306, DOI 10.1039/c2cs15337h
   Di Marco M, 2007, INT J NANOMED, V2, P609
   Dutz S, 2017, NANOMATERIALS-BASEL, V7, DOI 10.3390/nano7120453
   Fang C, 2009, SMALL, V5, P1637, DOI 10.1002/smll.200801647
   Gómez-Vallejo V, 2018, NANOSCALE, V10, P14153, DOI 10.1039/c8nr03084g
   Jennings LE, 2009, CHEM COMMUN, P3511, DOI 10.1039/b821903f
   Jokerst JV, 2011, NANOMEDICINE-UK, V6, P715, DOI [10.2217/NNM.11.19, 10.2217/nnm.11.19]
   Karakoti AS, 2011, ANGEW CHEM INT EDIT, V50, P1980, DOI 10.1002/anie.201002969
   Kim J, 2009, CHEM SOC REV, V38, P372, DOI 10.1039/b709883a
   Kreyling WG, 2015, NAT NANOTECHNOL, V10, P619, DOI [10.1038/nnano.2015.111, 10.1038/NNANO.2015.111]
   Larson TA, 2012, ACS NANO, V6, P9182, DOI 10.1021/nn3035155
   Lartigue L, 2013, ACS NANO, V7, P3939, DOI 10.1021/nn305719y
   Levy M, 2011, BIOMATERIALS, V32, P3988, DOI 10.1016/j.biomaterials.2011.02.031
   Na HB, 2009, ADV MATER, V21, P2133, DOI 10.1002/adma.200802366
   Pelaz B, 2015, ACS NANO, V9, P6996, DOI 10.1021/acsnano.5b01326
   Pellico J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12829-y
   Pellico J, 2016, CONTRAST MEDIA MOL I, V11, P203, DOI 10.1002/cmmi.1681
   Leal MP, 2015, NANOSCALE, V7, P2050, DOI 10.1039/c4nr05781c
   Reguera J, 2017, NANOSCALE, V9, P9467, DOI 10.1039/c7nr01406f
   Sánchez A, 2018, ACS APPL MATER INTER, V10, P31032, DOI 10.1021/acsami.8b10452
   Tong S, 2010, NANO LETT, V10, P4607, DOI 10.1021/nl102623x
   Veiseh O, 2009, CANCER RES, V69, P6200, DOI 10.1158/0008-5472.CAN-09-1157
   Wang B, 2013, ACCOUNTS CHEM RES, V46, P761, DOI 10.1021/ar2003336
   Wong RM, 2012, ACS NANO, V6, P3461, DOI 10.1021/nn300494k
   Wu W, 2016, NANOSCALE, V8, P19421, DOI 10.1039/c6nr07542h
   Yoo JW, 2010, CURR PHARM DESIGN, V16, P2298, DOI 10.2174/138161210791920496
   Zhang GD, 2009, BIOMATERIALS, V30, P1928, DOI 10.1016/j.biomaterials.2008.12.038
NR 33
TC 8
Z9 8
U1 0
U2 10
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2079-6374
J9 BIOSENSORS-BASEL
JI Biosensors-Basel
PD DEC
PY 2018
VL 8
IS 4
AR 127
DI 10.3390/bios8040127
PG 12
WC Chemistry, Analytical; Nanoscience & Nanotechnology; Instruments &
   Instrumentation
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry; Science & Technology - Other Topics; Instruments &
   Instrumentation
GA HG2UU
UT WOS:000454821900041
PM 30545065
OA Green Submitted, gold, Green Published
DA 2024-02-19
ER

PT J
AU Xu, LQ
   Xie, YL
   Gui, SH
   Zhang, X
   Mo, ZZ
   Sun, CY
   Li, CL
   Luo, DD
   Zhang, ZB
   Su, ZR
   Xie, JH
AF Xu, Lie-Qiang
   Xie, You-Liang
   Gui, Shu-Hua
   Zhang, Xie
   Mo, Zhi-Zhun
   Sun, Chao-Yue
   Li, Cai-Lan
   Luo, Dan-Dan
   Zhang, Zhen-Biao
   Su, Zi-Ren
   Xie, Jian-Hui
TI Polydatin attenuates D-galactose-induced liver and brain damage through
   its anti-oxidative, anti-inflammatory and anti-apoptotic effects in mice
SO FOOD & FUNCTION
LA English
DT Article
ID OXIDATIVE STRESS; LUNG INJURY; IN-VITRO; RESVERATROL; MECHANISM;
   PHARMACOLOGY; DEFICITS; PATHWAY; DISEASE; MODEL
AB Accumulating evidence has shown that chronic injection of D-galactose (D-gal) can mimic natural aging, with accompanying liver and brain injury. Oxidative stress and apoptosis play a vital role in the aging process. In this study, the antioxidant ability of polydatin (PD) was investigated using four established in vitro systems. An in vivo study was also conducted to investigate the possible protective effect of PD on D-gal-induced liver and brain damage. The results showed that PD had remarkable in vitro free radical scavenging activity on 2,2-diphenyl-1-picryl-hydrazyl (DPPH center dot), 2,2'-azino-bis(3-ethylbenzo-thiazoline-6-sulfonic acid) (ABTS(+center dot)) radical ions, and hydroxyl and superoxide anions. Results in vivo indicated that, in a group treated with D-gal plus PD, PD remarkably decreased the depression of body weight and organ indexes, reduced the levels of the serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST), and alleviated alterations in liver and brain histopathology. PD also significantly decreased the level of MDA and elevated SOD, GSH-Px, CAT activity and T-AOC levels in the liver and brain. In addition, the levels of inflammatory mediators, such as TNF-alpha, IL-1 beta and IL-6 in serum were markedly reduced after PD treatment. Western blotting results revealed that PD treatment noticeably attenuated the D-gal-induced elevation of Bcl-2/Bax ratio and caspase-3 protein expression in liver and brain. Overall, our findings indicate that PD treatment could effectively attenuate D-gal-induced liver and brain damage, and the mechanism might be associated with decreasing the oxidative stress, inflammation and apoptosis caused by D-gal. PD holds good potential for further development into a promising pharmaceutical candidate for the treatment of age-associated diseases.
C1 [Xu, Lie-Qiang; Xie, You-Liang; Gui, Shu-Hua; Zhang, Xie; Mo, Zhi-Zhun; Li, Cai-Lan; Luo, Dan-Dan; Zhang, Zhen-Biao; Su, Zi-Ren] Guangzhou Univ Chinese Med, Sch Chinese Mat Med, Guangzhou 510006, Guangdong, Peoples R China.
   [Sun, Chao-Yue; Xie, Jian-Hui] Guangzhou Univ Chinese Med, Affiliated Hosp 2, Guangdong Prov Key Lab Clin Res Tradit Chinese Me, Guangzhou 510120, Guangdong, Peoples R China.
   [Xu, Lie-Qiang; Xie, You-Liang; Gui, Shu-Hua; Zhang, Xie; Mo, Zhi-Zhun; Li, Cai-Lan; Luo, Dan-Dan; Zhang, Zhen-Biao; Su, Zi-Ren] Guangzhou Univ Chinese Med, Guangdong Prov Key Lab New Chinese Med Dev & Res, Guangzhou 510006, Guangdong, Peoples R China.
C3 Guangzhou University of Chinese Medicine; Guangzhou University of
   Chinese Medicine; Guangzhou University of Chinese Medicine
RP Su, ZR (corresponding author), Guangzhou Univ Chinese Med, Sch Chinese Mat Med, Guangzhou 510006, Guangdong, Peoples R China.; Xie, JH (corresponding author), Guangzhou Univ Chinese Med, Affiliated Hosp 2, Guangdong Prov Key Lab Clin Res Tradit Chinese Me, Guangzhou 510120, Guangdong, Peoples R China.; Su, ZR (corresponding author), Guangzhou Univ Chinese Med, Guangdong Prov Key Lab New Chinese Med Dev & Res, Guangzhou 510006, Guangdong, Peoples R China.
EM suziren@126.com; xiejianhui888@hotmail.com
RI Luo, Dan/HZM-2412-2023; Su, Zi-Ren/O-5014-2019; Zhang,
   Zhenbiao/JES-5169-2023
FU National Science Foundation of China [81503202]; Guangdong Natural
   Science Foundation [2015 A030310217]; Science and Technology Planning
   Project of Guangdong Province [2014A020221042]; Hong Kong, Macao and
   Taiwan Science & Technology Cooperation Program of China [2014DFH30010];
   Science and Technology Planning Project of Guangdong Province, China
   [2013B090600007]; Guangdong International Cooperation Project
   [2013508102016]
FX This work was supported by National Science Foundation of China (No.
   81503202), Guangdong Natural Science Foundation (No. 2015 A030310217),
   Science and Technology Planning Project of Guangdong Province (No.
   2014A020221042), Hong Kong, Macao and Taiwan Science & Technology
   Cooperation Program of China (No. 2014DFH30010), Science and Technology
   Planning Project of Guangdong Province, China (No. 2013B090600007),
   Guangdong International Cooperation Project (No. 2013508102016).
CR Ames B. B. N., 2010, P NATL ACAD SCI USA, V90, P7915
   Anand KV, 2012, GERIATR GERONTOL INT, V12, P741, DOI 10.1111/j.1447-0594.2012.00843.x
   Bellaver B, 2016, BBA-MOL BASIS DIS, V1862, P1827, DOI 10.1016/j.bbadis.2016.06.018
   Bhullar KS, 2015, BBA-MOL BASIS DIS, V1852, P1209, DOI 10.1016/j.bbadis.2015.01.012
   Castillo C, 2005, BIOGERONTOLOGY, V6, P313, DOI 10.1007/s10522-005-4806-2
   Ceriello A, 2004, ARTERIOSCL THROM VAS, V24, P816, DOI 10.1161/01.ATV.0000122852.22604.78
   Chen MH, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/9394150
   Çoban J, 2014, GERIATR GERONTOL INT, V14, P490, DOI 10.1111/ggi.12096
   Dkhar P, 2010, INT J DEV NEUROSCI, V28, P351, DOI 10.1016/j.ijdevneu.2010.04.005
   Du QH, 2013, PHARM BIOL, V51, P1347, DOI 10.3109/13880209.2013.792849
   Floyd RA, 2002, NEUROBIOL AGING, V23, P795, DOI 10.1016/S0197-4580(02)00019-2
   He D, 2016, INT IMMUNOPHARMACOL, V35, P201, DOI 10.1016/j.intimp.2016.03.032
   Ho SC, 2003, BIOGERONTOLOGY, V4, P15, DOI 10.1023/A:1022417102206
   Holden HM, 2003, J BIOL CHEM, V278, P43885, DOI 10.1074/jbc.R300025200
   Hsieh HM, 2009, FOOD CHEM TOXICOL, V47, P625, DOI 10.1016/j.fct.2008.12.026
   Huang B., 2005, CHIN J CLIN REHABIL, V9, P178
   Huang ZS, 1999, WORLD J GASTROENTERO, V5, P41
   Li RP, 2012, PHYTOMEDICINE, V19, P677, DOI 10.1016/j.phymed.2012.03.002
   Li SY, 2012, FOOD CHEM, V135, P1914, DOI 10.1016/j.foodchem.2012.06.048
   Li T, 2014, INT J CLIN EXP PATHO, V7, P8401
   Li T, 2014, RESP CARE, V59, P1412, DOI 10.4187/respcare.02831
   Li XC, 2012, CHEM CENT J, V6, DOI 10.1186/1752-153X-6-140
   Liu LT, 2012, CHIN J INTEGR MED, V18, P714, DOI 10.1007/s11655-012-1060-8
   Lu J, 2007, BIOCHEM PHARMACOL, V74, P1078, DOI 10.1016/j.bcp.2007.07.007
   Lu Y, 2016, INT IMMUNOPHARMACOL, V34, P44, DOI 10.1016/j.intimp.2016.02.003
   Lü JM, 2010, J CELL MOL MED, V14, P840, DOI 10.1111/j.1582-4934.2009.00897.x
   Mäkynen K, 2013, FOOD CHEM, V139, P735, DOI 10.1016/j.foodchem.2013.02.017
   Peng W, 2013, J ETHNOPHARMACOL, V148, P729, DOI 10.1016/j.jep.2013.05.007
   Peng XY, 2014, INT DAIRY J, V34, P80, DOI 10.1016/j.idairyj.2013.08.004
   Qiao HL, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/5139458
   Sastre J, 2000, IUBMB LIFE, V49, P427
   Ullah F, 2015, NEUROCHEM INT, V90, P114, DOI 10.1016/j.neuint.2015.07.001
   Minh Doan V, 2015, FOOD FUNCT, V6, P1712, DOI [10.1039/C5FO00238A, 10.1039/c5fo00238a]
   Wang DL, 2012, BIOL PHARM BULL, V35, P2128, DOI 10.1248/bpb.b12-00238
   Wang HL, 2015, PHYTOMEDICINE, V22, P553, DOI 10.1016/j.phymed.2015.03.014
   Xie JH, 2010, FOOD CHEM, V119, P1626, DOI 10.1016/j.foodchem.2009.09.055
   Xu G, 2016, AM J TRANSL RES, V8, P922
   Xu RH, 2011, ANAEROBE, V17, P226, DOI 10.1016/j.anaerobe.2011.07.010
   Yu YH, 2015, PHARMACOL BIOCHEM BE, V133, P122, DOI 10.1016/j.pbb.2015.03.020
   Zhang C.-H. Y. Hong, 2012, PLOS ONE, V7, P1602
   Zhang ZF, 2009, FOOD CHEM TOXICOL, V47, P496, DOI 10.1016/j.fct.2008.12.005
   Zhao HF, 2012, BRAIN RES, V1467, P67, DOI 10.1016/j.brainres.2012.05.040
   Zhong WQ, 2013, INT J BIOL MACROMOL, V60, P355, DOI 10.1016/j.ijbiomac.2013.06.018
   Zhou YY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132088
   Zhu JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101291
NR 45
TC 109
Z9 118
U1 3
U2 93
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2042-6496
EI 2042-650X
J9 FOOD FUNCT
JI Food Funct.
PY 2016
VL 7
IS 11
BP 4545
EP 4555
DI 10.1039/c6fo01057a
PG 11
WC Biochemistry & Molecular Biology; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Food Science & Technology
GA EC8AT
UT WOS:000388363000007
PM 27714005
DA 2024-02-19
ER

PT J
AU Liu, JF
   Meng, J
   Du, JH
   Liu, XF
   Pu, QS
   Di, DL
   Chen, C
AF Liu, Jianfei
   Meng, Jiao
   Du, Jinhao
   Liu, Xiaofeng
   Pu, Qiaosheng
   Di, Duolong
   Chen, Chang
TI Preparative Separation of Flavonoids from Goji Berries by Mixed-Mode
   Macroporous Adsorption Resins and Effect on Aβ-Expressing and Anti-Aging
   Genes
SO MOLECULES
LA English
DT Article
DE flavonoids; mixed-mode macroporous adsorption; resins; Goji berries; A
   beta-expressing; anti-aging genes
ID LYCIUM-BARBARUM POLYSACCHARIDES; (-)-EPIGALLOCATECHIN GALLATE;
   PURIFICATION; AMINO; CHLOROMETHYL; WOLFBERRY; EXTRACTS; CAFFEINE;
   BEHAVIOR; LIVER
AB Flavonoids are the main constituents of Goji berries and have good biological and pharmacological activities. The mixed-mode macroporous adsorption resins (MARs) for purification of flavonoids from Goji berries through computer-assisted calculation of the molecular size of flavonoids and the precise matching of MAR physical and chemical properties was firstly developed in the present study. Ten varieties of MARs with suitable molecular dimensions and polarities were used for investigating the adsorption/desorption behaviors of the flavonoids. Both AUKJ-1 and BWKX-1 showed higher separation efficiency than other MARs and then were mixed in different ratios to constitute a mixed-mode macroporous adsorption resin to obtain the optimal adsorption phase. Under optimal conditions, total flavonoid content of purified flavonoid (p-FLA) extract increased from 0.97% to 36.88% after one purification. The p-FLA extract from Goji berries significantly improved the expression of six genes with anti-aging effects and played an important role in aging-related Alzheimer's disease by down-regulating A beta expression.
C1 [Liu, Jianfei; Di, Duolong] Chinese Acad Sci, Lanzhou Inst Chem Phys, CAS Key Lab Chem Northwestern Plant Resources, Lanzhou 730000, Peoples R China.
   [Liu, Jianfei; Di, Duolong] Chinese Acad Sci, Lanzhou Inst Chem Phys, Key Lab Nat Med Gansu Prov, Lanzhou 730000, Peoples R China.
   [Liu, Jianfei; Di, Duolong; Chen, Chang] Univ Chinese Acad Sci, Beijing 100049, Peoples R China.
   [Meng, Jiao; Chen, Chang] Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Natl Lab Biomacromol, Beijing 100101, Peoples R China.
   [Du, Jinhao; Liu, Xiaofeng] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China.
   [Pu, Qiaosheng] Lanzhou Univ, Dept Chem, Key Lab Nonferrous Met Chem & Resources Utilizat, State Key Lab Appl Organ Chem, Lanzhou 730000, Peoples R China.
C3 Chinese Academy of Sciences; Lanzhou Institute of Chemical Physics, CAS;
   Chinese Academy of Sciences; Lanzhou Institute of Chemical Physics, CAS;
   Chinese Academy of Sciences; University of Chinese Academy of Sciences,
   CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese
   Academy of Sciences; Institute of Biophysics, CAS; Lanzhou University
RP Di, DL (corresponding author), Chinese Acad Sci, Lanzhou Inst Chem Phys, CAS Key Lab Chem Northwestern Plant Resources, Lanzhou 730000, Peoples R China.; Di, DL (corresponding author), Chinese Acad Sci, Lanzhou Inst Chem Phys, Key Lab Nat Med Gansu Prov, Lanzhou 730000, Peoples R China.; Di, DL; Chen, C (corresponding author), Univ Chinese Acad Sci, Beijing 100049, Peoples R China.; Chen, C (corresponding author), Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Natl Lab Biomacromol, Beijing 100101, Peoples R China.
EM jfliu@licp.cas.cn; mengjiao@ibp.ac.cn; djh_8122069@163.com;
   18009400938@163.com; puqs@lzu.edu.cn; didl@licp.cas.cn;
   changchen@moon.ibp.ac.cn
RI Chen, Chang/ITD-0049-2023
OI Meng, Jiao/0000-0001-9645-758X
FU Key Research and Development Program of Ningxia Hui Autonomous Region;
   Key Research and Development Program of Gansu Province [18YF1FA126]
FX The authors gratefully acknowledge the financial support provided by the
   Key Research and Development Program of Ningxia Hui Autonomous Region
   and the Key Research and Development Program of Gansu Province: grant
   number 18YF1FA126.
CR Amagase H, 2011, FOOD RES INT, V44, P1702, DOI 10.1016/j.foodres.2011.03.027
   Chang XL, 2012, J AGR FOOD CHEM, V60, P2368, DOI 10.1021/jf205311v
   Chen ZB, 2010, J PHYS CHEM B, V114, P4841, DOI 10.1021/jp910115q
   Dong J. Z., 2012, Journal of Medicinal Plants Research, V6, P2276
   Gao K, 2015, J AGR FOOD CHEM, V63, P1067, DOI 10.1021/jf5049222
   Huang JH, 2009, J COLLOID INTERF SCI, V332, P60, DOI 10.1016/j.jcis.2008.12.039
   Inbaraj BS, 2010, J PHARMACEUT BIOMED, V51, P549, DOI 10.1016/j.jpba.2009.09.006
   Jin ML, 2013, INT J BIOL MACROMOL, V54, P16, DOI 10.1016/j.ijbiomac.2012.11.023
   Kammerer DR, 2010, J AGR FOOD CHEM, V58, P6787, DOI 10.1021/jf1000869
   Li J, 2012, FOOD CHEM, V132, P268, DOI 10.1016/j.foodchem.2011.10.077
   Li XL, 2007, CARBOHYD POLYM, V69, P172, DOI 10.1016/j.carbpol.2006.09.021
   Li XT, 2016, COLLOID SURFACE A, V500, P1, DOI 10.1016/j.colsurfa.2016.03.061
   Lin LZ, 2012, FOOD CHEM, V130, P417, DOI 10.1016/j.foodchem.2011.07.069
   Liu Y, 2017, COLLOID SURFACE A, V520, P166, DOI 10.1016/j.colsurfa.2017.01.037
   Liu YF, 2012, J AGR FOOD CHEM, V60, P1555, DOI 10.1021/jf204710h
   Liu YF, 2010, FOOD CHEM, V123, P1027, DOI 10.1016/j.foodchem.2010.05.055
   Lou S, 2015, CHEMPHYSCHEM, V16, P1329, DOI 10.1002/cphc.201402614
   Lou S, 2012, IND ENG CHEM RES, V51, P2682, DOI 10.1021/ie201494k
   Lou S, 2011, LANGMUIR, V27, P9314, DOI 10.1021/la200858c
   Lu WY, 2014, J AGR FOOD CHEM, V62, P9073, DOI 10.1021/jf502156n
   Lui YF, 2011, J AGR FOOD CHEM, V59, P9629, DOI 10.1021/jf2020232
   Scordino M, 2004, J AGR FOOD CHEM, V52, P1965, DOI 10.1021/jf035220l
   Tian XJ, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9090389
   Wang H, 2019, LANGMUIR, V35, P4471, DOI 10.1021/acs.langmuir.8b03997
   Wu SH, 2015, FOOD BIOPROD PROCESS, V93, P148, DOI 10.1016/j.fbp.2013.12.006
   Xiao GQ, 2014, J HAZARD MATER, V280, P97, DOI 10.1016/j.jhazmat.2014.07.057
   Xiao J, 2012, J ETHNOPHARMACOL, V139, P462, DOI 10.1016/j.jep.2011.11.033
   Xiao J, 2019, MOLECULES, V24, DOI 10.3390/molecules24030388
   Yao X, 2011, CHEM BIODIVERS, V8, P976, DOI 10.1002/cbdv.201000018
   Zain MSC, 2020, MOLECULES, V25, DOI 10.3390/molecules25040778
   Zheng J, 2011, FOOD CHEM, V126, P859, DOI 10.1016/j.foodchem.2010.11.052
   Zhou ZQ, 2017, FOOD CHEM, V214, P644, DOI 10.1016/j.foodchem.2016.07.105
   Zhou ZQ, 2016, J AGR FOOD CHEM, V64, P2223, DOI 10.1021/acs.jafc.5b05274
NR 33
TC 14
Z9 15
U1 11
U2 70
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1420-3049
J9 MOLECULES
JI Molecules
PD AUG
PY 2020
VL 25
IS 15
AR 3511
DI 10.3390/molecules25153511
PG 14
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA MZ3FH
UT WOS:000559007600001
PM 32752084
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU van de Putte, DEF
   Fischer, K
   Roosendaal, G
   Hoepelman, AIM
   Mauser-Bunschoten, EP
AF van de Putte, D. E. Fransen
   Fischer, K.
   Roosendaal, G.
   Hoepelman, A. I. M.
   Mauser-Bunschoten, E. P.
TI Morbidity and mortality in ageing HIV-infected haemophilia patients
SO HAEMOPHILIA
LA English
DT Article
DE AIDS; haemophilia; highly active antiretroviral therapy; HIV;
   intracranial bleeding
ID ACTIVE ANTIRETROVIRAL THERAPY; PROTEASE INHIBITOR THERAPY; HEPATITIS-C
   VIRUS; RISK-FACTORS; MYOCARDIAL-INFARCTION; CARDIOVASCULAR-DISEASE;
   POSITIVE HEMOPHILIACS; CLINICAL FACTORS; LIVER-DISEASE; FOLLOW-UP
AB Over 25 years of follow-up is now available for HIV-infected haemophilia patients. The aim of this study was to retrospectively asses the morbidity and mortality of HIV infection and the effects of HAART in these patients. Data on HIV infection, its treatment and all types of comorbidity were collected from medical records of all 60 HIV-positive haemophilia patients who were treated at the Van Creveldkliniek since 1980 and compared with data from 152 HIV-negative patients with severe haemophilia and the general age-matched male population. AIDS developed in 27 patients (45%), while 31 patients died (52%). Death was solely or partially AIDS-related in 71%. Development of AIDS and AIDS-related deaths declined strongly after the introduction of HAART. Only one major ischaemic cardiovascular event occurred in our study population. Of the 27 patients who were still treated at our clinic in 2010, 25 (93%) were on HAART. They had more often hypertension and diabetes, but less often overweight and obesity and lower cholesterol levels than the general population. The occurrence of spontaneous intracranial bleeding was higher in HIV-positive haemophilia patients on HAART than in HIV-negative patients with severe haemophilia (16.6 vs. 1.2 per 1000 patient years). Since the introduction of HAART, the impact of HIV infection on morbidity and survival has decreased. The increased prevalences of hypertension and diabetes, however, warrant regular screening. HIV-positive haemophilia patients on HAART appear to have an increased risk of spontaneous intracranial bleeding.
C1 [van de Putte, D. E. Fransen; Fischer, K.; Roosendaal, G.; Mauser-Bunschoten, E. P.] Univ Med Ctr Utrecht, Dept Haematol, Van Creveldklin, NL-3508 GA Utrecht, Netherlands.
   [Fischer, K.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands.
   [Hoepelman, A. I. M.] Univ Med Ctr Utrecht, Dept Internal Med & Infect Dis, NL-3508 GA Utrecht, Netherlands.
C3 Utrecht University; Utrecht University Medical Center; Utrecht
   University; Utrecht University Medical Center; Utrecht University;
   Utrecht University Medical Center
RP van de Putte, DEF (corresponding author), Univ Med Ctr Utrecht, Dept Haematol, Van Creveldklin, Internal Post C01-425,POB 85500, NL-3508 GA Utrecht, Netherlands.
EM d.e.fransenvandeputte@umcutrecht.nl
RI Fischer, Kathelijn/M-2395-2017
OI Fischer, Kathelijn/0000-0001-7126-6613
FU CSL Behring
FX The authors would like to thank Astrid Pulles, Wiebe Verra and Mirthe de
   Boer for their help with data collection. This study was supported by an
   unrestricted grant from CSL Behring to DEFvdP.
CR ANCELLEPARK R, 1993, LANCET, V341, P441, DOI 10.1016/0140-6736(93)93040-8
   Arnold DM, 2006, BLOOD, V108, P460, DOI 10.1182/blood-2005-11-4407
   Bergersen BM, 2006, DRUGS, V66, P1971, DOI 10.2165/00003495-200666150-00006
   Besson C, 2001, BLOOD, V98, P2339, DOI 10.1182/blood.V98.8.2339
   Bohlius J, 2009, ANTIVIR THER, V14, P1065, DOI 10.3851/IMP1462
   Carr A, 2003, JAIDS-J ACQ IMM DEF, V34, pS73, DOI 10.1097/00126334-200309011-00011
   Currier Judith S, 2008, Circulation, V118, pe29, DOI 10.1161/CIRCULATIONAHA.107.189624
   Daar ES, 2001, J INFECT DIS, V183, P589, DOI 10.1086/318539
   Darby SC, 2007, BLOOD, V110, P815, DOI 10.1182/blood-2006-10-050435
   del Amo J, 2006, JAIDS-J ACQ IMM DEF, V41, P624, DOI 10.1097/01.qai.0000194232.85336.dc
   Friis-Moller N, 2007, NEW ENGL J MED, V356, P1723, DOI 10.1056/NEJMoa062744
   Graff J, 2008, J ANTIMICROB CHEMOTH, V61, P394, DOI 10.1093/jac/dkm486
   Hollmig KA, 2001, EUR J MED RES, V6, P112
   Katsarou O, 2005, HAEMOPHILIA, V11, P360, DOI 10.1111/j.1365-2516.2005.01109.x
   Kodoth S, 2001, AIDS PATIENT CARE ST, V15, P347, DOI 10.1089/108729101750301898
   KOUMBARELIS E, 1994, THROMB HAEMOSTASIS, V72, P808
   Lang S, 2010, ARCH INTERN MED, V170, P1228, DOI 10.1001/archinternmed.2010.197
   Lim MY, 2011, BLOOD COAGUL FIBRIN, V22, P402, DOI 10.1097/MBC.0b013e328345f582
   Lorenzo JI, 2001, HAEMATOLOGICA, V86, P291
   Mary-Krause M, 2003, AIDS, V17, P2479, DOI 10.1097/00002030-200311210-00010
   Mauser-Bunschoten EP, 1995, THESIS UTRECHT, P53
   Mesri EA, 2010, NAT REV CANCER, V10, P707, DOI 10.1038/nrc2888
   Miller MF, 2005, CLIN INFECT DIS, V41, P713, DOI 10.1086/432618
   Nuss R, 2001, AM J HEMATOL, V68, P37, DOI 10.1002/ajh.1146
   Plug I, 2006, J THROMB HAEMOST, V4, P510, DOI 10.1111/j.1538-7836.2006.01808.x
   Porter K, 2003, LANCET, V362, P1267, DOI 10.1016/S0140-6736(03)14570-9
   Quintana M, 2003, HAEMOPHILIA, V9, P605, DOI 10.1046/j.1365-2516.2003.00804.x
   RABKIN CS, 1992, JAMA-J AM MED ASSOC, V267, P1090, DOI 10.1001/jama.267.8.1090
   Racoosin JA, 1999, HAEMOPHILIA, V5, P266
   RAGNI MV, 1993, BLOOD, V81, P1889
   Roosendaal G, 1998, VOX SANG, V75, P261, DOI 10.1159/000031001
   ROSENBERG PS, 1994, AIDS, V8, P803, DOI 10.1097/00002030-199406000-00013
   ROSENDAAL FR, 1990, BRIT J HAEMATOL, V75, P525, DOI 10.1111/j.1365-2141.1990.tb07793.x
   Sabin CA, 2005, BRIT MED J, V331, P997, DOI 10.1136/bmj.38604.468785.DE
   Sabin CA, 2000, AIDS, V14, P1001, DOI 10.1097/00002030-200005260-00012
   SCHINAIA N, 1994, THROMB HAEMOSTASIS, V72, P33
   Sharathkumar AA, 2011, HAEMOPHILIA, V17, P597, DOI 10.1111/j.1365-2516.2010.02463.x
   Stanworth SJ, 1998, HAEMOPHILIA, V4, P109
   Tagliaferri A, 2010, HAEMOPHILIA, V16, P437, DOI 10.1111/j.1365-2516.2009.02188.x
   Tatsunami S, 2004, ACTA HAEMATOL-BASEL, V111, P181, DOI 10.1159/000077549
   van de Putte DEF, 2012, THROMB RES, V130, P157, DOI 10.1016/j.thromres.2011.12.012
   van Leth F, 2004, LANCET, V363, P1253, DOI 10.1016/S0140-6736(04)15997-7
   VICARIOT M, 1993, REV FR TRANSFUS HEM, V36, P417, DOI 10.1016/S1140-4639(05)80154-6
   Wilde JT, 1999, BRIT J HAEMATOL, V107, P556, DOI 10.1046/j.1365-2141.1999.01748.x
   Worm SW, 2010, J INFECT DIS, V201, P318, DOI 10.1086/649897
   Yazdanpanah Y, 2003, AIDS, V17, P2397, DOI 10.1097/00002030-200311070-00017
   Yee TT, 1997, HAEMOPHILIA, V3, P220, DOI 10.1046/j.1365-2516.1997.t01-1-00098.x
   Zanon E, 2012, HAEMOPHILIA, V18, P39, DOI 10.1111/j.1365-2516.2011.02611.x
NR 48
TC 12
Z9 12
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1351-8216
EI 1365-2516
J9 HAEMOPHILIA
JI Haemophilia
PD JAN
PY 2013
VL 19
IS 1
BP 141
EP 149
DI 10.1111/j.1365-2516.2012.02912.x
PG 9
WC Hematology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Hematology
GA 088IJ
UT WOS:000314827200029
PM 22830609
OA Bronze
DA 2024-02-19
ER

PT J
AU Qu, XQ
   Seale, JP
   Donnelly, R
AF Qu, XQ
   Seale, JP
   Donnelly, R
TI Tissue- and isoform-specific effects of aging in rats on protein kinase
   C in insulin-sensitive tissues
SO CLINICAL SCIENCE
LA English
DT Article
DE aging; insulin resistance; protein kinase C
ID SKELETAL-MUSCLE; NPKC-THETA; TNF-ALPHA; RESISTANCE; RECEPTOR;
   DIACYLGLYCEROL; PHOSPHORYLATION; STIMULATION; ADIPOCYTES; ISOENZYMES
AB The mechanisms responsible for the age-related decline in insulin sensitivity have not been clearly identified, but activation of the diacylglycerol/protein kinase C (PKC) signalling pathway (often confined to individual isoforms of PKC) has recently been implicated in the pathogenesis of other insulin-resistant states in both humans and animal models. Fasting serum glucose, insulin and triacylglycerol (triglyceride) concentrations, and results of oral glucose tolerance tests, were compared in groups of 6-week-old (n = 8) and 6-month-old (n = 8) Sprague-Dawley rats. Insulin-responsive tissues (liver, soleus muscle and epididymal fat pad) were collected to com pare levels of diacylglycerol, PKC enzyme activity and protei n expression of individual PKC isoforms in cytosol and membrane fractions. The older group were heavier (556 +/- 14 g, compared with 188 +/- 7 g) and relatively insulin-resistant and hyperinsulinaemic (477 +/- 73 pM compared with 293 +/- 51 pM; P < 0.05) compared with young rats; they also had greater areas under the serum glucose (old, 20.3 +/- 1.1; young, 17.3 +/- 0.7 mmol.h(-1).l(-1)) and insulin (old, 1254 +/- 76; young, 721 +/- 113 mmol.h(-1).l(-1)) profiles following an oral glucose tolerance test, and significantly higher fasting triacylglycerol levels (old, 1.24 +/- 0.06 mM; young, 0.92 +/- 0.07 mM; P < 0.01). There were no age-related differences in diacylglycerol levels or PKC activity in muscle and liver, but membrane-associated PKC activity was 2.5-fold higher in the adipose tissue of older rats (101 +/- 19 compared with 40 +/- 5 pmol.min(-1).mg(-1) protein; P < 0.05) due to increased translocation of PKC-beta(I), -beta(II) and -epsilon. Thus insulin resistance due to normal aging is associated with tissue- and isoform-specific changes in diacylglycerol/PKC signalling. In contrast with diabetes and dietary-induced insulin resistance, there were no changes in diacylglycerol/PKC signalling in skeletal muscle and liver, but isoform-specific translocation and higher PKC activity in adipose tissue may blunt the insulin-mediated inhibition of lipolysis and contribute to the increased triacylglycerol levels observed in older animals.
C1 Univ Nottingham, Derbyshire Royal Infirm, Sch Med & Surg Sci, Div Vasc Med, Derby DE1 2QY, England.
   Univ Sydney, Dept Pharmacol, Sydney, NSW 2006, Australia.
C3 University of Nottingham; University of Sydney
RP Donnelly, R (corresponding author), Univ Nottingham, Derbyshire Royal Infirm, Sch Med & Surg Sci, Div Vasc Med, Derby DE1 2QY, England.
CR AZHAR S, 1991, J NUTR BIOCHEM, V2, P165, DOI 10.1016/0955-2863(91)90011-S
   BARNARD RJ, 1992, AM J PHYSIOL, V262, pE1
   Barthel A, 1998, BIOCHEM BIOPH RES CO, V243, P509, DOI 10.1006/bbrc.1998.8134
   BASSENMAIER B, 1997, DIABETOLOGIA, V40, P863
   BLACKMORE PF, 1986, BIOCHEM J, V237, P235, DOI 10.1042/bj2370235
   BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
   CHIN JE, 1993, J BIOL CHEM, V268, P6338
   CONSIDINE RV, 1993, J CELL BIOCHEM, V52, P8, DOI 10.1002/jcb.240520103
   CONSIDINE RV, 1995, J CLIN INVEST, V95, P2938, DOI 10.1172/JCI118001
   DeFea K, 1997, BIOCHEMISTRY-US, V36, P12939, DOI 10.1021/bi971157f
   DONNELLY R, 1994, ENDOCRINOLOGY, V135, P2369, DOI 10.1210/en.135.6.2369
   Ferrannini E, 1996, DIABETES, V45, P947, DOI 10.2337/diabetes.45.7.947
   HEYDRICK SJ, 1991, DIABETES, V40, P1707, DOI 10.2337/diabetes.40.12.1707
   HILGENBERG L, 1995, J CELL SCI, V108, P51
   Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665
   HUG H, 1993, BIOCHEM J, V291, P329, DOI 10.1042/bj2910329
   ISHIZUKA T, 1993, METABOLISM, V42, P420, DOI 10.1016/0026-0495(93)90097-8
   KATADA T, 1985, EUR J BIOCHEM, V151, P431, DOI 10.1111/j.1432-1033.1985.tb09120.x
   Kellerer M, 1997, FEBS LETT, V418, P119, DOI 10.1016/S0014-5793(97)01357-4
   KONO S, 1990, AM J PHYSIOL, V259, pE27, DOI 10.1152/ajpendo.1990.259.1.E27
   Mosthaf L, 1998, DIABETOLOGIA, V41, pA10
   NISHIMURA H, 1988, AM J PHYSIOL, V254, pE92, DOI 10.1152/ajpendo.1988.254.1.E92
   OSADA S, 1992, MOL CELL BIOL, V12, P3930, DOI 10.1128/MCB.12.9.3930
   PAOLISSO G, 1995, HORM RES, V43, P52, DOI 10.1159/000184237
   Paolisso G, 1998, AM J PHYSIOL-ENDOC M, V275, pE294, DOI 10.1152/ajpendo.1998.275.2.E294
   PREISS JE, 1987, METHOD ENZYMOL, V141, P294
   QU X, 1999, IN PRESS J ENDOCRINO
   REED MJ, 1993, J GERONTOL, V48, pB139, DOI 10.1093/geronj/48.4.B139
   SALTIS J, 1991, J BIOL CHEM, V266, P261
   SchmitzPeiffer C, 1997, DIABETES, V46, P169, DOI 10.2337/diabetes.46.2.169
   SCHUTZE S, 1990, J IMMUNOL, V144, P2604
   SHMUELI E, 1993, J INTERN MED, V234, P397, DOI 10.1111/j.1365-2796.1993.tb00761.x
   VIKMAN HL, 1993, CLIN SCI, V85, P265, DOI 10.1042/cs0850265
   YOSHIDA K, 1992, P NATL ACAD SCI USA, V89, P6443, DOI 10.1073/pnas.89.14.6443
NR 34
TC 16
Z9 18
U1 0
U2 0
PU PORTLAND PRESS
PI LONDON
PA 59 PORTLAND PLACE, LONDON W1N 3AJ, ENGLAND
SN 0143-5221
J9 CLIN SCI
JI Clin. Sci.
PD SEP
PY 1999
VL 97
IS 3
BP 355
EP 361
DI 10.1042/CS19990054
PG 7
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA 236CX
UT WOS:000082581600018
PM 10464061
DA 2024-02-19
ER

PT J
AU Samarghandian, S
   Azimi-Nezhad, M
   Afshari, R
   Farkhondeh, T
   Karimnezhad, F
AF Samarghandian, Saeed
   Azimi-Nezhad, Mohsen
   Afshari, Reza
   Farkhondeh, Tahereh
   Karimnezhad, Fatemeh
TI Effects of Buprenorphine on Balance of Oxidant/Antioxidant System in the
   Different Ages of Male Rat Liver
SO JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
LA English
DT Article
DE Buprenorphine; Oxidative Damage; Liver; Age; Rat
ID INJECTION-DRUG USERS; C VIRUS-INFECTION; LIPID-PEROXIDATION;
   HEPATITIS-C; ANTIOXIDANT ENZYMES; OXIDATIVE STRESS; TRIGONELLA;
   MECHANISMS; MORPHINE; HIV
AB Our knowledge about a link between buprenorphine and hepatotoxicity is controversial. This study evaluated the effects of buprenorphine on the liver of young, adult, and aged rats. For this reason, young, adult, and aged rats received intraperitoneally 0.25, 0.5, and 1 mg/kg buprenorphine for 30 days. The present results revealed that the normal aging was associated with a significant decrease in the activities of antioxidant enzymes, and an increase in the liver lipid peroxidation, serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), and lactate dehydrogenase (LDH) activities in the aged rats. This study also demonstrated that buprenorphine led to a significant increase in the serum activities of ALT, AST, and LDH as well as liver lipid peroxidation content with a decrease in the antioxidant enzymes in the liver of buprenorphine-treated aged rat versus the aged matched control animals. In conclusion, the present results demonstrate that buprenorphine deteriorated oxidative damage in the aged livers. (C) 2015 Wiley Periodicals, Inc.
C1 [Samarghandian, Saeed] Neyshabur Univ Med Sci, Dept Basic Med Sci, Neyshabur, Iran.
   [Azimi-Nezhad, Mohsen] Mashhad Univ Med Sci, Dept Genet, Fac Med, Mashhad, Iran.
   [Afshari, Reza; Farkhondeh, Tahereh] Mashhad Univ Med Sci, Addict Res Ctr, Mashhad, Iran.
   [Karimnezhad, Fatemeh] Islamic Azad Univ, Sci & Res Branch, Dept Food Hyg, Tehran, Iran.
C3 Mashhad University Medical Science; Mashhad University Medical Science;
   Islamic Azad University
RP Samarghandian, S (corresponding author), Neyshabur Univ Med Sci, Dept Basic Med Sci, Neyshabur, Iran.
EM samarghandians@mums.ac.ir
RI Farkhondeh, Tahereh/Y-2083-2018
OI farkhondeh, tahereh/0000-0002-9579-8339
FU Research Affairs of Neyshabur Faculty of Medical Sciences
FX Contract Grant Sponsor: Research Affairs of Neyshabur Faculty of Medical
   Sciences.
CR AEBI H, 1984, METHOD ENZYMOL, V105, P121
   Alto WA, 2011, AM J OBSTET GYNECOL, V205, P302, DOI 10.1016/j.ajog.2011.04.001
   Berson A, 2001, J HEPATOL, V34, P261, DOI 10.1016/S0168-8278(00)00050-7
   Bogenschutz MP, 2010, J ADDICT MED, V4, P211, DOI 10.1097/ADM.0b013e3181c4e27e
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Diaz T, 2001, AM J PUBLIC HEALTH, V91, P23, DOI 10.2105/AJPH.91.1.23
   Farahmand SK, 2013, BIOGERONTOLOGY, V14, P63, DOI 10.1007/s10522-012-9409-0
   Gagliano N, 2007, DIGEST DIS, V25, P118, DOI 10.1159/000099475
   Genet S, 2002, MOL CELL BIOCHEM, V236, P7, DOI 10.1023/A:1016103131408
   Han Y., 2002, Drug and Alcohol Dependence, V66, pS74
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   HARMAN D, 1992, MUTAT RES, V275, P257, DOI 10.1016/0921-8734(92)90030-S
   Hayase T, 2000, LIFE SCI, V67, P45, DOI 10.1016/S0024-3205(00)00599-3
   Hervé S, 2004, EUR J GASTROEN HEPAT, V16, P1033, DOI 10.1097/00042737-200410000-00013
   Houdret N, 1999, ACTA CLIN BELG, P29
   Johnson RE, 2005, J PAIN SYMPTOM MANAG, V29, P297, DOI 10.1016/j.jpainsymman.2004.07.005
   Law FD, 2003, LANCET, V361, P634, DOI 10.1016/S0140-6736(03)12612-8
   Lund IO, 2013, SUBST ABUS-RES TREAT, V7, P61, DOI 10.4137/SART.S10955
   LURIE E, 1995, BIOCHEM MOL BIOL INT, V36, P13
   Mantha AK, 2006, BIOGERONTOLOGY, V7, P19, DOI 10.1007/s10522-005-6044-z
   MARKLUND S, 1974, EUR J BIOCHEM, V47, P469
   Murrill CS, 2002, AM J PUBLIC HEALTH, V92, P385, DOI 10.2105/AJPH.92.3.385
   Patrick DM, 2001, CAN MED ASSOC J, V165, P889
   Petry NM, 2000, AM J ADDICTION, V9, P265
   PIEPER GM, 1995, DIABETES, V44, P884, DOI 10.2337/diabetes.44.8.884
   PONTANI RB, 1985, XENOBIOTICA, V15, P287, DOI 10.3109/00498258509045363
   Samarghandian S, 2014, INT J CLIN EXP MED, V7, P1449
   Samarghandian S, 2013, J PHARM PHARM SCI, V16, P352, DOI 10.18433/J3ZS3Q
   Siddiqui MR, 2005, J BIOSCIENCES, V30, P483, DOI 10.1007/BF02703722
   Singh SP, 2002, J BIOL CHEM, V277, P4232, DOI 10.1074/jbc.M109678200
   SINGHAL PC, 1994, INFLAMMATION, V18, P293, DOI 10.1007/BF01534270
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   Tew KD, 1999, DRUG RESIST UPDATE, V2, P143, DOI 10.1054/drup.1999.0086
   Tolman Keith G., 1998, American Journal of Medicine, V105, p13S, DOI 10.1016/S0002-9343(98)00070-9
   Upadhyay A, 2010, J CHILD ADOL PSYCHOP, V20, P545, DOI 10.1089/cap.2009.0093
   Zuin M, 2009, DIGEST LIVER DIS, V41, pE8, DOI 10.1016/j.dld.2007.12.014
NR 37
TC 22
Z9 25
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1095-6670
EI 1099-0461
J9 J BIOCHEM MOL TOXIC
JI J. Biochem. Mol. Toxicol.
PD JUN
PY 2015
VL 29
IS 6
BP 249
EP 253
DI 10.1002/jbt.21691
PG 5
WC Biochemistry & Molecular Biology; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Toxicology
GA CK1ED
UT WOS:000355948000001
PM 25683329
DA 2024-02-19
ER

PT J
AU Mukherjee, S
   Sainis, KB
   Deobagkar, D
AF Mukherjee, Sanjay
   Sainis, Krishna B.
   Deobagkar, Deepti
TI Identification of methylated genes in BALB/c mice liver using monoclonal
   antibody combined with the high-throughput cDNA microarray approach
SO CURRENT SCIENCE
LA English
DT Article
DE DNA methylation; epigenetics; imprinting; microarray
ID DNA METHYLATION; EPIGENETIC REGULATION; GENOME; WIDE; EXPRESSION;
   ISLANDS; PATTERNS; SITES
AB We have employed a microarray-based genome-wide methylation detection method to analyse methylation in internal coding regions of genes in a sequence-independent manner in liver tissue of BALB/c mouse. Using mouse 7.4k cDNA microarray, methylation status of genes spotted on the array was analysed. We detected methylation in coding and its proximal regions of 1415 genes, 70% of which contained CpG islands. Gene ontology analyses of these 1415 genes revealed that they were mainly involved in nucleic acid metabolism and signal transduction processes. Molecular function analysis revealed that these genes were mainly transcription factors, DNA repair proteins, chromatin remodelling enzymes and receptor molecules. The set of methylated genes also contained 11 imprinted genes and 9 genes known to be hyper-methylated in liver cancers. Our analysis has led to the identification of methylation in many new regions. The analysis thus provides a methylation landscape in normal mouse liver. The platform can be used to analyse epigenetic alterations during oncogenesis, ageing, in response to environmental stimuli, etc.
C1 [Mukherjee, Sanjay; Deobagkar, Deepti] Univ Pune, Dept Zool, Ctr Adv Studies, Mol Biol Res Lab, Pune 411007, Maharashtra, India.
   [Sainis, Krishna B.] Bhabha Atom Res Ctr, Biomed Grp, Bombay 400085, Maharashtra, India.
C3 Savitribai Phule Pune University; Bhabha Atomic Research Center (BARC)
RP Deobagkar, D (corresponding author), Univ Pune, Dept Zool, Ctr Adv Studies, Mol Biol Res Lab, Pune 411007, Maharashtra, India.
EM dddeo@unipune.ernet.in
RI Mukherjee, Sanjay/R-9913-2019
OI Mukherjee, Sanjay/0000-0003-4853-2332
CR Baylin SB, 2001, HUM MOL GENET, V10, P687, DOI 10.1093/hmg/10.7.687
   Baylin Stephen B, 2005, Nat Clin Pract Oncol, V2 Suppl 1, pS4, DOI 10.1038/ncponc0354
   BIRD A, 1985, CELL, V40, P91, DOI 10.1016/0092-8674(85)90312-5
   BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0
   BLIN N, 1976, NUCLEIC ACIDS RES, V3, P2303, DOI 10.1093/nar/3.9.2303
   Bock C, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn122
   BRENNA RM, 2007, HUM MOL GENET REV IS, V16, P96
   Chen TP, 2002, J BIOL CHEM, V277, P38746, DOI 10.1074/jbc.M205312200
   Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909
   Estécio MRH, 2009, GENOME MED, V1, DOI 10.1186/gm106
   Feil R, 2009, INT J DEV BIOL, V53, P191, DOI 10.1387/ijdb.082654rf
   Hoque MO, 2008, CANCER RES, V68, P2661, DOI 10.1158/0008-5472.CAN-07-5913
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Illingworth R, 2008, PLOS BIOL, V6, P37, DOI 10.1371/journal.pbio.0060022
   Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089
   Kaminsky ZA, 2009, NAT GENET, V41, P240, DOI 10.1038/ng.286
   KELKAR A, 2009, EPIGENETICS, V6, P1
   Lee YJ, 2000, FEBS LETT, V472, P230, DOI 10.1016/S0014-5793(00)01461-7
   Lorincz MC, 2004, NAT STRUCT MOL BIOL, V11, P1068, DOI 10.1038/nsmb840
   Maegawa S, 2010, GENOME RES, V20, P332, DOI 10.1101/gr.096826.109
   Malumbres M, 1999, ONCOGENE, V18, P385, DOI 10.1038/sj.onc.1202299
   Mi HY, 2007, NUCLEIC ACIDS RES, V35, pD247, DOI 10.1093/nar/gkl869
   Mizuno Y, 2002, BIOCHEM BIOPH RES CO, V290, P1499, DOI 10.1006/bbrc.2002.6370
   Morison IM, 2001, NUCLEIC ACIDS RES, V29, P275, DOI 10.1093/nar/29.1.275
   ONGENAERT M, 2007, NUCLEIC ACIDS RES, V1093, P1
   Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0
   Schilling E, 2007, GENOMICS, V90, P314, DOI 10.1016/j.ygeno.2007.04.011
   Shen L, 2007, PLOS GENET, V3, P2023, DOI 10.1371/journal.pgen.0030181
   Shiota K, 2002, GENES CELLS, V7, P961, DOI 10.1046/j.1365-2443.2002.00574.x
   Suzuki M, 2007, GENES CELLS, V12, P1305, DOI 10.1111/j.1365-2443.2007.01136.x
   Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341
   Verona RI, 2003, ANNU REV CELL DEV BI, V19, P237, DOI 10.1146/annurev.cellbio.19.111401.092717
   Wakaguri H, 2008, NUCLEIC ACIDS RES, V36, pD97, DOI 10.1093/nar/gkm901
   Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598
   Weber M, 2007, CURR OPIN CELL BIOL, V19, P273, DOI 10.1016/j.ceb.2007.04.011
   Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990
   Zilberman D, 2007, DEVELOPMENT, V134, P3959, DOI 10.1242/dev.001131
   Zilberman D, 2007, NAT GENET, V39, P442, DOI 10.1038/ng0407-442
NR 38
TC 3
Z9 3
U1 0
U2 3
PU INDIAN ACAD SCIENCES
PI BANGALORE
PA C V RAMAN AVENUE, SADASHIVANAGAR, P B #8005, BANGALORE 560 080, INDIA
SN 0011-3891
J9 CURR SCI INDIA
JI Curr. Sci.
PD JUL 10
PY 2011
VL 101
IS 1
BP 66
EP 72
PG 7
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 795BY
UT WOS:000292947700019
DA 2024-02-19
ER

PT J
AU Wang, LH
   Zhang, X
   Lü, Y
   Tian, MY
   Li, Y
AF Wang, Linhui
   Zhang, Xiong
   Lu, Yang
   Tian, Mingyuan
   Li, Yu
TI Dynamic changes of Apo A1 mediated by LXR/RXR/ABCA1 pathway in brains of
   the aging rats with cerebral hypoperfusion
SO BRAIN RESEARCH BULLETIN
LA English
DT Article
DE Vascular dementia; Liver X receptor-beta; Retinoic X receptor-alpha;
   ABCA1; Apolipoprotein A1
ID ALZHEIMERS-DISEASE; VASCULAR DEMENTIA; CHOLESTEROL; ABCA1; RECEPTORS;
   RISK; LXR; METABOLISM; ACTIVATION; MECHANISMS
AB Cerebral hypoperfusion or aging often results into the disturbances of cholesterol and lipoprotein, which have been tightly associated with numerous neurological and psychiatric diseases, such as vascular dementia. The pathway of liver X receptor-beta (LXR-beta)/retinoic X receptor-at (RXR-alpha)/ABCA1 plays a vital role in lipoprotein metabolism. However, there were no reports about the relationship between the signal molecules of the pathway and lipoprotein homeostasis in cerebral hypoperfusion models. Therefore, we aimed to detect the expression of the pathway molecules in the aging rat models of chronic cerebral hypoperfusion and to explore its underlying mechanism. The model with cerebral hypoperfusion was established by ligating of the bilateral common carotid arteries (2VO). The temporal blood flow in the model rats was significantly decreased 14 d, 21 d and 28 d after 2VO compared with the control. The serum levels of high-density lipoprotein (HDL) and total cholesterol (TC) were reached a peak at 14 d, then, they were gradually decreased. The changes of LXR-beta, RXR-alpha, ABCA1 and apolipoprotein A1 (apo A1) of the pathway were consistent with the changes of HDL and TC. We conclude that LXR-beta/RXR-alpha/ABCA1 and downstream genes apo A1 undergo dynamic changes during the process of cerebral hypoperfusion. The LR-beta/RXR-alpha/ABCA1 mediated apo A1 cholesterol may play a protective effect, and the effect only exists in a certain period of time. Crown Copyright (C) 2013 Published by Elsevier Inc. All rights reserved.
C1 [Wang, Linhui; Tian, Mingyuan; Li, Yu] Chongqing Med Univ, Dept Pathol, Chongqing Key Lab Neurobiol, Inst Neurosci, Chongqing 400016, Peoples R China.
   [Wang, Linhui; Zhang, Xiong; Tian, Mingyuan; Li, Yu] Chongqing Med Univ, Inst Neurosci, Chongqing 400016, Peoples R China.
   [Wang, Linhui; Zhang, Xiong; Tian, Mingyuan; Li, Yu] Chongqing Med Univ, Chongqing Key Lab Neurobiol, Chongqing 400016, Peoples R China.
   [Lu, Yang] Chongqing Med Univ, Affiliated Hosp 1, Dept Geriatr, Chongqing 400016, Peoples R China.
C3 Chongqing Medical University; Chongqing Medical University; Chongqing
   Medical University; Chongqing Medical University
RP Li, Y (corresponding author), Chongqing Med Univ, Dept Pathol, Chongqing Key Lab Neurobiol, Inst Neurosci, Chongqing 400016, Peoples R China.
EM liyu100@163.com
RI liu, qi/IQR-4870-2023; Lü, Yang/ADW-2164-2022; wang, lin/GSE-3040-2022;
   zhou, wei/JQJ-0490-2023; liu, lingling/IUQ-7478-2023
OI Lü, Yang/0000-0002-9425-2967; 
FU National Science Foundation of China (NSFC) [81100948, 81271426];
   Science Foundation of Chongqing(CSTC) [2009BB5270]
FX This work was supported by the National Science Foundation of China
   (NSFC: 81100948, 81271426), and the Science Foundation of
   Chongqing(CSTC, 2009BB5270).
CR Björkhem I, 2004, ARTERIOSCL THROM VAS, V24, P806, DOI 10.1161/01.ATV.0000120374.59826.1b
   Buono C, 2007, J LIPID RES, V48, P2411, DOI 10.1194/jlr.M700170-JLR200
   Cheng O, 2010, NEUROSCIENCE, V166, P1101, DOI 10.1016/j.neuroscience.2010.01.024
   Crisafulli C, 2010, J LEUKOCYTE BIOL, V87, P309, DOI 10.1189/jlb.0609438
   ElAli A, 2012, BRAIN PATHOL, V22, P175, DOI 10.1111/j.1750-3639.2011.00517.x
   Fan JJ, 2009, BIOFACTORS, V35, P239, DOI 10.1002/biof.37
   Farkas E, 2007, BRAIN RES REV, V54, P162, DOI 10.1016/j.brainresrev.2007.01.003
   Feingold KR, 2011, DERM-ENDOCRINOL, V3, P113, DOI 10.4161/derm.3.2.14996
   Francis GA, 2003, ANNU REV PHYSIOL, V65, P261, DOI 10.1146/annurev.physiol.65.092101.142528
   Hartmann T, 2007, J NEUROCHEM, V103, P159, DOI 10.1111/j.1471-4159.2007.04715.x
   Hozoji-Inada M, 2011, J BIOL CHEM, V286, P20117, DOI 10.1074/jbc.M111.235846
   Jiang XC, 2011, ADV EXP MED BIOL, V721, P19, DOI 10.1007/978-1-4614-0650-1_2
   Joyce C, 2003, ARTERIOSCL THROM VAS, V23, P965, DOI 10.1161/01.ATV.0000055194.85073.FF
   Kalaria RN, 2008, LANCET NEUROL, V7, P812, DOI 10.1016/S1474-4422(08)70169-8
   Karasinska JM, 2009, J NEUROSCI, V29, P3579, DOI 10.1523/JNEUROSCI.4741-08.2009
   Kivipelto M, 2005, ARCH NEUROL-CHICAGO, V62, P1556, DOI 10.1001/archneur.62.10.1556
   Koldamova R, 2007, CURR ALZHEIMER RES, V4, P171, DOI 10.2174/156720507780362227
   Michel V, 2007, BIOL CELL, V99, P129, DOI 10.1042/BC20060051
   Morales JR, 2008, CIRCULATION, V118, P1450, DOI 10.1161/CIRCULATIONAHA.108.782300
   Puca AA, 2008, INT J BIOCHEM CELL B, V40, P324, DOI 10.1016/j.biocel.2007.04.003
   Raffaitin C, 2009, DIABETES CARE, V32, P169, DOI 10.2337/dc08-0272
   Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712
   Sironi L, 2008, FEBS LETT, V582, P3396, DOI 10.1016/j.febslet.2008.08.035
   Tontonoz P, 2003, MOL ENDOCRINOL, V17, P985, DOI 10.1210/me.2003-0061
   Yokoyama S, 2006, ARTERIOSCL THROM VAS, V26, P20, DOI 10.1161/01.ATV.0000195789.39418.e8
   Yoshikawa T, 2003, J NEUROL, V250, P194, DOI 10.1007/s00415-003-0972-9
   Zelcer N, 2007, P NATL ACAD SCI USA, V104, P10601, DOI 10.1073/pnas.0701096104
NR 27
TC 9
Z9 11
U1 0
U2 7
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0361-9230
EI 1873-2747
J9 BRAIN RES BULL
JI Brain Res. Bull.
PD JAN
PY 2014
VL 100
BP 84
EP 92
DI 10.1016/j.brainresbull.2013.11.004
PG 9
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA AB0KG
UT WOS:000331480000012
PM 24291698
DA 2024-02-19
ER

PT J
AU Dlugos, CA
AF Dlugos, Cynthia A.
TI Ethanol-related increases in degenerating bodies in the Purkinje neuron
   dendrites of aging rats
SO BRAIN RESEARCH
LA English
DT Article
DE alcohol; dendrites; aging; mitochondria; myelin figures; degeneration
ID SMOOTH ENDOPLASMIC-RETICULUM; TERM ALCOHOL-CONSUMPTION; CEREBELLAR
   PURKINJE; ULTRASTRUCTURAL EVIDENCE; LIVER-MITOCHONDRIA; MYELIN FIGURES;
   SYNAPSE LOSS; BRAIN; EXPOSURE; STRESS
AB Chronic ethanol consumption in aging rats results in regression of Purkinje neuron (PN) dendritic arbors ([Pentney, 1995 Measurements of dendritic pathlengths provide evidence that ethanol-induced lengthening of terminal dendritic segments may result from dendritic regression. Alcohol Alcohol. 30, 87-96]), loss of synapses (Dlugos and Pentney, 1997), dilation of the smooth endoplasmic reticulum (SER), and the formation of degenerating bodies within PN dendrites ([Dlugos, C.A., 2006a. Ethanol-Related Smooth Endoplasmic Reticulum Dilation in Purkinje Dendrites of Aging Rats. Alcohol., Clin. Exp. Res. 30, 883-891,Dlugos, C.A., 2006b. Smooth endoplasmic reticulum dilation and degeneration in Purkinje neuron dendrites of aging ethanol-fed female rats. Cerebellum. 5,155-162]). Dilation of the SER and the formation of degenerating bodies maybe a predictor of dendritic regression. Ethanol-induced effects on mitochondria may be involved as mitochondria cooperate with the SER to maintain calcium homeostasis. The purpose of this study was to determine whether degenerating body number and mitochondrial density and structure are altered by chronic ethanol treatment in PN dendrites. Male, Fischer 344 rats, 12 months of age, were fed an ethanol or pair-fed liquid diet, or rat chow for a period of 10, 20, or 40 weeks (15 rats/treatment; 4S rats/treatment duration). Ethanol-fed rats received 35% of their calories as ethanol. At the end of treatment, all animals were euthanized, perfused, and tissue prepared for electron microscopy. The densities of degenerating bodies and mitochondria, mitochondrial areas, and the distance between the SER and the mitochondria were measured. Results showed that there was an ethanol-related increase in degenerating bodies compared to controls at 40 weeks. Ethanol-induced alterations to mitochondria were absent, Correlation of the present results with those of previous studies suggest that degenerating bodies may be formed from membrane reabsorption during dendritic regression or from degenerating SER whose function has been compromised by dilation. (C) Elsevier B.V. All rights reserved.
C1 SUNY Buffalo, Sch Med & Biomed Sci, Dept Pathol & Anat Sci, Buffalo, NY 14214 USA.
C3 State University of New York (SUNY) System; State University of New York
   (SUNY) Buffalo
RP Dlugos, CA (corresponding author), SUNY Buffalo, Sch Med & Biomed Sci, Dept Pathol & Anat Sci, 206 Farber Hall, Buffalo, NY 14214 USA.
EM cadlugos@buffalo.edu
FU NIAAA NIH HHS [AA143104, R03 AA013104, R03 AA013104-02] Funding Source:
   Medline
CR Ahluwala B, 2000, ALCOHOL ALCOHOLISM, V35, P452, DOI 10.1093/alcalc/35.5.452
   Anken R, 2004, ADV SPACE RES, V33, P1411, DOI 10.1016/j.asr.2003.09.046
   BABEL J, 1970, ATLAS NORMAL PATHOLO
   BOGOLEPOV N N, 1981, Arkhiv Anatomii Gistologii i Embriologii, V81, P5
   Breslow RA, 2003, J STUD ALCOHOL, V64, P884, DOI 10.15288/jsa.2003.64.884
   Cahill A, 2005, AM J PHYSIOL-GASTR L, V289, pG1115, DOI 10.1152/ajpgi.00193.2005
   CARBONELL LM, 1962, J BACTERIOL, V83, P1356, DOI 10.1128/JB.83.6.1356-1357.1962
   CASEY MA, 1985, J COMP NEUROL, V232, P401, DOI 10.1002/cne.902320311
   Cassarino DS, 1999, BRAIN RES REV, V29, P1, DOI 10.1016/S0165-0173(98)00046-0
   Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638
   CHEDOTAL A, 1993, DEV BRAIN RES, V76, P207, DOI 10.1016/0165-3806(93)90209-S
   Chen S, 1999, J NEUROCYTOL, V28, P187, DOI 10.1023/A:1007015721754
   COLE GT, 1971, J CELL BIOL, V51, P873, DOI 10.1083/jcb.51.3.873
   CURGY JJ, 1968, J MICROSC-PARIS, V7, P63
   Darios F, 2005, J NEUROSCI, V25, P4159, DOI 10.1523/JNEUROSCI.0060-05.2005
   Davila MD, 1994, NEUROPSYCHOLOGY, V8, P433, DOI [10.1037/0894-4105.8.3.433, DOI 10.1037/0894-4105.8.3.433]
   Deshmukh A, 2002, SCHIZOPHR RES, V57, P281, DOI 10.1016/S0920-9964(01)00300-0
   Dlugos CA, 2006, ALCOHOL CLIN EXP RES, V30, P883, DOI 10.1111/j.1530-0277.2006.00103.x
   Dlugos CA, 1997, ALCOHOL ALCOHOLISM, V32, P161
   Dlugos CA, 2000, ALCOHOL, V20, P125, DOI 10.1016/S0741-8329(99)00064-6
   DLUGOS CA, 2005, ALCOHOL CLIN EXP R S, V29, pA122
   Dlugos CA, 2006, CEREBELLUM, V5, P155, DOI 10.1080/14734220600697187
   FELDMAN ML, 1976, AGING NEUROBIOLOGY A, V3, P214
   FLAKS B, 1968, J CELL BIOL, V36, P410, DOI 10.1083/jcb.36.2.410
   GARTHWAITE G, 1992, NEUROSCIENCE, V48, P681, DOI 10.1016/0306-4522(92)90411-T
   GUNDERSEN HJG, 1977, J MICROSC-OXFORD, V111, P219, DOI 10.1111/j.1365-2818.1977.tb00062.x
   HAGLID KG, 1981, NEUROTOXICOLOGY, V2, P659
   Hall GF, 2000, J CELL SCI, V113, P1373
   HAMRE KM, 1993, ALCOHOL CLIN EXP RES, V17, P610, DOI 10.1111/j.1530-0277.1993.tb00808.x
   HENKART M, 1975, BIOPHYS J, V15, pA267
   HIGASHI Y, 1995, ACTA NEUROPATHOL, V90, P158
   HILDEBRAND C, 1994, PROG NEUROBIOL, V43, P85, DOI 10.1016/0301-0082(94)90010-8
   HOHL HR, 1965, J BACTERIOL, V90, P755, DOI 10.1128/JB.90.3.755-765.1965
   IONTOV A S, 1981, Arkhiv Anatomii Gistologii i Embriologii, V81, P11
   KOCH OR, 1978, AM J PATHOL, V90, P325
   Koch Osvaldo R., 2004, Molecular Aspects of Medicine, V25, P191, DOI 10.1016/j.mam.2004.02.019
   KRIEBEL RM, 1993, EXP NEUROL, V119, P89, DOI 10.1006/exnr.1993.1009
   LARSELL O, 1952, J COMP NEUROL, V97, P281, DOI 10.1002/cne.900970204
   Lewandowska E, 1994, Folia Neuropathol, V32, P61
   MALUNOVA L B, 1984, Arkhiv Anatomii Gistologii i Embriologii, V86, P46
   Mannella CA, 1998, BIOFACTORS, V8, P225, DOI 10.1002/biof.5520080309
   MARTONE ME, 1993, J NEUROSCI, V13, P4636
   MCMULLEN PA, 1981, J COMP NERUOL, V225, P111
   Michaud J, 2001, J NEUROPATH EXP NEUR, V60, P574, DOI 10.1093/jnen/60.6.574
   Morara S, 2001, NEUROSCIENCE, V108, P655, DOI 10.1016/S0306-4522(01)00433-X
   Mukamal KJ, 2001, STROKE, V32, P1939, DOI 10.1161/hs0901.095723
   *NAT I ALC AB ALC, 1998, ALC AL 40
   Oscar-Berman M, 2003, ALCOHOL RES HEALTH, V27, P125
   OUDEA MC, 1973, DIGEST DIS SCI, V18, P1573
   Palay S. L., 1974, Cerebellar Cortex
   Park SH, 1999, ULTRASTRUCT PATHOL, V23, P311
   PAULABARBOSA MM, 1985, BRAIN RES, V339, P195, DOI 10.1016/0006-8993(85)90645-6
   PAVELKA M, 2005, FUNCTIONAL ULTRASTRU, P295
   PENTNEY RJ, 1991, ALCOHOL CLIN EXP RES, V15, P1024, DOI 10.1111/j.1530-0277.1991.tb05205.x
   PENTNEY RJ, 1990, ALCOHOL CLIN EXP RES, V14, P878, DOI 10.1111/j.1530-0277.1990.tb01831.x
   PENTNEY RJ, 1995, ALCOHOL ALCOHOLISM, V30, P87
   Pentney RJ, 2000, ALCOHOL ALCOHOLISM, V35, P35, DOI 10.1093/alcalc/35.1.35
   PETERS A, 1994, CEREB CORTEX, V4, P621, DOI 10.1093/cercor/4.6.621
   Reiter-Funk CK, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-16
   Rolls MM, 2002, MOL BIOL CELL, V13, P1778, DOI 10.1091/mbc.01-10-0514
   Simpson PB, 1998, BRAIN RES REV, V26, P72, DOI 10.1016/S0165-0173(97)00056-8
   SMALL JV, 1968, 4TH P EUR C EL MICR, V1, P609
   Spencer RL, 1997, NEUROENDOCRINOLOGY, V65, P353, DOI 10.1159/000127195
   Spencer RL, 1999, ALCOHOL RES HEALTH, V23, P272
   Sullivan EV, 2000, ALCOHOL CLIN EXP RES, V24, P611, DOI 10.1111/j.1530-0277.2000.tb02032.x
   Sullivan EV, 2002, ALCOHOL CLIN EXP RES, V26, P705, DOI 10.1097/00000374-200205000-00017
   Szczesna-Skorupa E, 2004, J BIOL CHEM, V279, P13953, DOI 10.1074/jbc.M312170200
   Tabouy L, 1998, LIFE SCI, V63, P2259, DOI 10.1016/S0024-3205(98)00511-6
   TANAKA J, 1988, J NEUROPATH EXP NEUR, V47, P291, DOI 10.1097/00005072-198805000-00008
   TANI E, 1971, CANCER RES, V31, P2120
   TAVARES MA, 1983, J NEUROCYTOL, V12, P939, DOI 10.1007/BF01153343
   TAVARES MA, 1983, J SUBMICR CYTOL PATH, V15, P713
   THAYER WS, 1992, ALCOHOL CLIN EXP RES, V16, P1, DOI 10.1111/j.1530-0277.1992.tb00625.x
   Thomas JD, 1998, DEV BRAIN RES, V105, P159, DOI 10.1016/S0165-3806(97)00164-8
   VESTAL RE, 1977, CLIN PHARMACOL THER, V21, P343
   VICTOR M, 1959, ARCH NEUROL-CHICAGO, V1, P579, DOI 10.1001/archneur.1959.03840060001001
   VOLK B, 1984, ACTA NEUROPATHOL, V63, P57, DOI 10.1007/BF00688471
   WAKAYAMA I, 1993, ACTA NEUROPATHOL, V85, P122
   WALKER DE, 1980, PSYCHOPHARMACOLOGY E
   Wang HJ, 2000, J CELL BIOL, V150, P1489, DOI 10.1083/jcb.150.6.1489
   WoodruffPak DS, 1996, NEUROPSYCHOLOGY, V10, P443
   YORK JL, 1991, ALCOHOL CLIN EXP RES, V15, P982, DOI 10.1111/j.1530-0277.1991.tb05199.x
   Yu BP, 1996, FREE RADICAL BIO MED, V21, P651, DOI 10.1016/0891-5849(96)00162-1
NR 83
TC 23
Z9 25
U1 0
U2 2
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0006-8993
EI 1872-6240
J9 BRAIN RES
JI Brain Res.
PD JUL 24
PY 2008
VL 1221
BP 98
EP 107
DI 10.1016/j.brainres.2008.05.015
PG 10
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 334XF
UT WOS:000258254300012
PM 18559274
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Jugé, L
   Foley, P
   Hatt, A
   Yeung, J
   Bilston, LE
AF Juge, Lauriane
   Foley, Patrick
   Hatt, Alice
   Yeung, Jade
   Bilston, Lynne E.
TI Ex vivo bovine liver nonlinear viscoelastic properties: MR elastography
   and rheological measurements
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
DE Magnetic resonance elastography; Rheometry; Nonlinear viscoelastic
   mechanical properties; Static preloads; Liver
ID MAGNETIC-RESONANCE ELASTOGRAPHY; MUSCLE-STIFFNESS; BREAST-LESIONS;
   SOFT-TISSUE; SHEAR; MULTIFREQUENCY; STRAIN; COMPRESSION; RHEOMETRY; TIME
AB Introduction: Knowledge of the nonlinear viscoelastic properties of the liver is important, but the complex tissue behavior outside the linear viscoelastic regime has impeded their characterization, particularly in vivo. Combining static compression with magnetic resonance (MR) elastography has the potential to be a useful im-aging method for assessing large deformation mechanical properties of soft tissues in vivo. However, this remains to be verified. Therefore this study aims first to determine whether MR elastography can measure the nonlinear mechanical properties of ex vivo bovine liver tissue under varying levels of uniform and focal preloads (up to 30%), and second to compare MR elastography-derived complex shear modulus with standard rheological measurements.
   Method: Nine fresh bovine livers were collected from a local abattoir, and experiments were conducted within 12hr of death. Two cubic samples (similar to 10 x 10 x 10 cm(3)) were dissected from each liver and imaged using MR elastography (60 Hz) under 4 levels of uniform and focal preload (1, 10, 20, and 30% of sample width) to investigate the relationship between MR elastography-derived complex shear modulus (G*) and the maximum principal Right Cauchy Green Strain (C11). Three tissue samples from each of the same 9 livers underwent oscillatory rheometry under the same 4 preloads (1, 10, 20, and 30% strain). MR elastography-derived complex shear modulus (G*) from the uniform preload was validated against rheometry by fitting the frequency dependence of G* with a power-law and extrapolating rheometry-derived G* to 60 Hz.
   Results: MR elastography-derived G* increased with increasing compressive large deformation strain, and fol-lowed a power-law curve (G* = 1.73 x C-11(-0.38), R-2 = 0.96). Similarly, rheometry-derived G* at 1 Hz, increasing from 0.66 +/- 1.03 kPa (1% strain) to 1.84 +/- 1.65 kPa (30% strain, RM one-way ANOVA, P < 0.001), and the frequency dependence of G* followed a power-law with the exponent decreasing from 0.13 to 0.06 with increasing preload. MR elastography-derived G* was 1.4-3.1 times higher than the extrapolated rheometry-derived G* at 60 Hz, but the strain dependence was consistent between rheometry and MR elastography measurements.
   Conclusions: This study demonstrates that MR elastography can detect changes in ex vivo bovine liver complex shear modulus due to either uniform or focal preload and therefore can be a useful technique to characterize nonlinear viscoelastic properties of soft tissue, provided that strains applied to the tissue can be quantified. Although MR elastography could reliably characterize the strain dependence of the ex vivo bovine liver, MR elastography overestimated the complex shear modulus of the tissue compared to rheological measurements, particularly at lower preload (<10%). That is likely to be important in clinical hepatic MR elastography diagnosis studies if preload is not carefully considered. A limitation is the absence of overlapping frequency between rheometry and MR elastography for formal validation.
C1 [Juge, Lauriane; Foley, Patrick; Hatt, Alice; Yeung, Jade; Bilston, Lynne E.] Neurosci Res Australia, POB 1165, Randwick, NSW 2031, Australia.
   [Juge, Lauriane; Bilston, Lynne E.] Univ New South Wales, Fac Med & Hlth, UNSW Sydney, 18 High St, Kensington, NSW 2052, Australia.
C3 Neuroscience Research Australia; University of New South Wales Sydney
RP Bilston, LE (corresponding author), Neurosci Res Australia, POB 1165, Randwick, NSW 2031, Australia.
EM l.bilston@neura.edu.au
RI Jugé, Lauriane/F-7085-2014; Bilston, Lynne/C-9665-2011
OI Jugé, Lauriane/0000-0002-4136-8069; Bilston, Lynne/0000-0001-8250-9019
FU National Health & Medical Research Council (NHMRC) of Australia
   Fellowship [APP1172988]; Australian Research Council [DP160100061]
FX L. Bilston is supported by a National Health & Medical Research Council
   (NHMRC) of Australia Fellowship (#APP1172988) . The study was supported
   by an Australian Research Council Discovery grant (DP160100061) .
CR Arbogast KB, 2007, J TRAUMA, V62, P1473, DOI 10.1097/01.ta.0000231965.20704.16
   Ayyildiz M, 2015, J MECH BEHAV BIOMED, V49, P235, DOI 10.1016/j.jmbbm.2015.05.011
   Ayyildiz M, 2014, BIORHEOLOGY, V51, P47, DOI 10.3233/BIR-14007
   Babaei B, 2021, MED IMAGE ANAL, V74, DOI 10.1016/j.media.2021.102212
   Barnhill E, 2013, PHYSIOL MEAS, V34, P1675, DOI 10.1088/0967-3334/34/12/1675
   Bilston LE, 2018, NMR BIOMED, V31, DOI 10.1002/nbm.3832
   Bilston Lynne E, 2002, Comput Methods Biomech Biomed Engin, V5, P283, DOI 10.1080/10255840290032658
   Braun J, 2018, MAGN RESON MED, V79, P470, DOI 10.1002/mrm.26659
   Capilnasiu A, 2020, BIOMECH MODEL MECHAN, V19, P1641, DOI 10.1007/s10237-020-01297-5
   Capilnasiu A, 2019, BIOMECH MODEL MECHAN, V18, P111, DOI 10.1007/s10237-018-1072-1
   Cheng SK, 2009, J BIOMECH, V42, P1360, DOI 10.1016/j.jbiomech.2009.03.023
   Chouhan MD, 2021, ABDOM RADIOL, V46, P4660, DOI 10.1007/s00261-021-03168-8
   Chung SH, 2011, MAGN RESON MED, V65, P949, DOI 10.1002/mrm.22785
   Clarke EC, 2011, J BIOMECH, V44, P2461, DOI 10.1016/j.jbiomech.2011.06.023
   Debernard L, 2011, CLIN BIOMECH, V26, P836, DOI 10.1016/j.clinbiomech.2011.04.004
   DeWall RJ, 2012, PHYS MED BIOL, V57, P2273, DOI 10.1088/0031-9155/57/8/2273
   Dittmann F, 2017, MAGN RESON MED, V78, P976, DOI 10.1002/mrm.26484
   Dresner MA, 2001, J MAGN RESON IMAGING, V13, P269, DOI 10.1002/1522-2586(200102)13:2<269::AID-JMRI1039>3.3.CO;2-T
   Etchell E., 2016, MR ELASTOGRAPHY STUD
   Frulio N, 2013, Diagn Interv Imaging, V94, P515, DOI 10.1016/j.diii.2013.02.005
   Fung YC., 1993, Biomechanics: Mechanical Properties of Living Tissues, V2nd edn
   Gandhi D, 2020, NMR BIOMED, V33, DOI 10.1002/nbm.4237
   Garteiser P, 2013, NMR BIOMED, V26, P1326, DOI 10.1002/nbm.2958
   Green MA, 2013, NMR BIOMED, V26, P1387, DOI 10.1002/nbm.2964
   Green MA, 2008, NMR BIOMED, V21, P755, DOI 10.1002/nbm.1254
   Hansen LK, 2006, CURR TOP DEV BIOL, V72, P205, DOI 10.1016/S0070-2153(05)72004-4
   Harouni AA, 2015, MAGN RESON MED, V74, P106, DOI 10.1002/mrm.25379
   Hoodeshenas Safa, 2018, Top Magn Reson Imaging, V27, P319, DOI 10.1097/RMR.0000000000000177
   Huwart L, 2006, NMR BIOMED, V19, P173, DOI 10.1002/nbm.1030
   Huwart L, 2008, GASTROENTEROLOGY, V135, P32, DOI 10.1053/j.gastro.2008.03.076
   Idilman IS, 2020, ABDOM RADIOL, V45, P3444, DOI 10.1007/s00261-020-02656-7
   Ipek-Ugay S, 2017, J ULTRAS MED, V36, P1305, DOI 10.7863/ultra.16.07046
   Jajamovich GH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097355
   Jugé L, 2015, NMR BIOMED, V28, P1763, DOI 10.1002/nbm.3438
   Kanamoto M, 2009, J HEPATO-BILIARY-PAN, V16, P463, DOI 10.1007/s00534-009-0075-9
   Kang N, 2012, IEEE COMPUT GRAPH, V32, P29, DOI 10.1109/MCG.2012.65
   Klatt D, 2010, BIORHEOLOGY, V47, P133, DOI 10.3233/BIR-2010-0565
   Lambert SA, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.094301
   Lefebvre T, 2020, J MAGN RESON IMAGING, V51, P1570, DOI 10.1002/jmri.26935
   Liu Z, 2000, BIORHEOLOGY, V37, P191
   Macosko CW., 1996, Rheology: Principles, Measurements, and Applications, DOI DOI 10.1016/S0032-5910(96)90008-X
   Marchesseau S, 2017, ACAD PR SER BIOM ENG, P243, DOI 10.1016/B978-0-12-804009-6.00011-0
   MUTHUPILLAI R, 1995, SCIENCE, V269, P1854, DOI 10.1126/science.7569924
   Nelissen JL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169864
   Ocal S, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4002489
   Parker KJ, 2019, PHYS MED BIOL, V64, DOI 10.1088/1361-6560/ab453d
   Perepelyuk M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146588
   Schrank F, 2020, MAGN RESON MED, V84, P103, DOI 10.1002/mrm.28095
   Sinkus R, 2000, PHYS MED BIOL, V45, P1649, DOI 10.1088/0031-9155/45/6/317
   Sinkus R, 2005, MAGN RESON IMAGING, V23, P159, DOI 10.1016/j.mri.2004.11.060
   Sinkus R, 2007, MAGN RESON MED, V58, P1135, DOI 10.1002/mrm.21404
   Sinkus R, 2018, NMR BIOMED, V31, DOI 10.1002/nbm.3956
   Tan K, 2018, NMR BIOMED, V31, DOI 10.1002/nbm.3925
   Tan K, 2013, J BIOMECH, V46, P1060, DOI 10.1016/j.jbiomech.2013.01.028
   Thirion J P, 1998, Med Image Anal, V2, P243, DOI 10.1016/S1361-8415(98)80022-4
   Valtorta D, 2005, MED IMAGE ANAL, V9, P481, DOI 10.1016/j.media.2005.05.002
   Vappou J, 2007, MAGN RESON MATER PHY, V20, P273, DOI 10.1007/s10334-007-0098-7
   Venkatesh SK, 2013, J MAGN RESON IMAGING, V37, P544, DOI 10.1002/jmri.23731
   Vercauteren T, 2009, NEUROIMAGE, V45, pS61, DOI 10.1016/j.neuroimage.2008.10.040
   Watanabe H, 2010, EUR RADIOL, V20, P2381, DOI 10.1007/s00330-010-1800-0
   Wex C, 2013, BIORHEOLOGY, V50, P115, DOI 10.3233/BIR-130632
NR 61
TC 2
Z9 2
U1 1
U2 3
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1751-6161
EI 1878-0180
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD FEB
PY 2023
VL 138
AR 105638
DI 10.1016/j.jmbbm.2022.105638
EA JAN 2023
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Engineering; Materials Science
GA 8H9VJ
UT WOS:000921376600001
PM 36623403
DA 2024-02-19
ER

PT J
AU VANERMEN, A
   VANDEVELDE, E
   VANSCHEEUWIJCK, P
   FRAEYMAN, N
AF VANERMEN, A
   VANDEVELDE, E
   VANSCHEEUWIJCK, P
   FRAEYMAN, N
TI INFLUENCE OF AGE ON THE BETA-1-ADRENERGIC AND BETA-2-ADRENERGIC
   RECEPTORS IN RAT-LIVER
SO MOLECULAR PHARMACOLOGY
LA English
DT Article
ID BETA-2 ADRENERGIC-RECEPTORS; HEPATIC GLYCOGENOLYSIS; GLUCOSE OUTPUT;
   BINDING; PHOSPHORYLASE; ADRENOCEPTORS; ACTIVATION; INACTIVATION;
   HEPATOCYTES; KINETICS
AB The influence of maturation and aging on beta receptors in rat liver was studied. Competition binding experiments with the nonselective beta-antagonist propranolol and the subtype selective antagonists ICI 118,551 (beta2), ICI 89,406 (beta1), and CGP 20,712A (beta1) revealed the presence of a mixed beta1 and beta2 receptor population in crude plasma membrane preparations from livers of newborn, mature, and senescent rats. The percentage of beta1 receptors was lowest in livers from newborn rats and was increased in livers from mature and senescent rats. This increase is caused by a decrease in beta2 receptor density on maturation, although the beta1 receptor density is nearly constant throughout the life span of the rat. Isoproterenol-stimulated adenylate cyclase activity was inhibited in livers from senescent rats by propranolol and ICI 11 8,551 and to a lesser extent by ICI 89,406 and CGP 20,712A. The isoproterenol-stimulated glucose output in hepatocytes from senescent rats was inhibited concentration dependently by propranolol, ICI 118,551, ICi 89,406, and CGP 20,712A. From these results we conclude that beta1 and beta2 receptors are present in livers from rats of the three age groups and that the beta1 to beta2 receptor ratio is increased in livers from mature and senescent rats compared with newborn rats. Both beta receptor subtypes are linked to the cAMP second messenger system in newborn and senescent rats; beta1 and beta2 receptors are equally involved in the regulation of glycogenolysis in hepatocytes from senescent rats.
C1 HEYMANS INST PHARMACOL,DE PINTELAAN 185,B-9000 GENT,BELGIUM.
C3 Ghent University
CR AGERBECK M, 1980, BIOCHEM PHARMACOL, V29, P643
   BENDECK JL, 1985, PEDIATR RES, V19, P862, DOI 10.1203/00006450-198508000-00018
   Bergmeyer H. U., 1974, METHOD ENZYMAT AN, P1205
   BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506
   BILSKI AJ, 1983, J CARDIOVASC PHARM, V5, P430, DOI 10.1097/00005344-198305000-00013
   BLAIR JB, 1979, J BIOL CHEM, V254, P7579
   CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
   DAX EM, 1982, MOL PHARMACOL, V22, P5
   DAX EM, 1986, J RECEPTOR RES, V6, P165, DOI 10.3109/10799898609073931
   DAX EM, 1989, ENDOCRINOLOGY, V44, pB72
   DOOLEY DJ, 1986, EUR J PHARMACOL, V130, P137, DOI 10.1016/0014-2999(86)90193-7
   FRAEYMAN N, 1991, J RECEPTOR RES, V11, P985, DOI 10.3109/10799899109064692
   GRAHAM SM, 1987, AM J PHYSIOL, V253, pE277, DOI 10.1152/ajpendo.1987.253.3.E277
   HEDBERG A, 1985, J PHARMACOL EXP THER, V234, P561
   HUTSON NJ, 1976, J BIOL CHEM, V251, P5200
   IWAMOTO K, 1986, BIOCHEM PHARMACOL, V35, P2677
   KATZ MS, 1987, BIOCHEM BIOPH RES CO, V147, P724, DOI 10.1016/0006-291X(87)90990-9
   KATZ MS, 1988, AM J PHYSIOL, V254, pE54, DOI 10.1152/ajpendo.1988.254.1.E54
   KIM YS, 1991, BIOCHEM PHARMACOL, V42, P1783, DOI 10.1016/0006-2952(91)90516-8
   MACART M, 1982, CLIN CHIM ACTA, V122, P93, DOI 10.1016/0009-8981(82)90100-0
   MCMILLIAN MK, 1983, J PHARMACOL EXP THER, V227, P181
   MINNEMAN KP, 1979, J PHARMACOL EXP THER, V211, P502
   MOLENAAR P, 1987, J PHARMACOL EXP THER, V241, P1041
   MOTOULSKY HJ, 1987, PLOT ANAL DATA DIGIT
   MUNNICH A, 1981, HORM METAB RES, V13, P18, DOI 10.1055/s-2007-1019157
   NEVE KA, 1985, J PHARMACOL EXP THER, V235, P657
   SAWADA MU, 1992, J CELL BIOL, V8, P296
   SCARPACE P J, 1991, Drugs and Aging, V1, P116
   SEGLEN PO, 1972, EXP CELL RES, V74, P450, DOI 10.1016/0014-4827(72)90400-4
   SNEDECOR GW, 1973, STATISTICAL METHODS, P447
   SNELL K, 1988, BRIT J PHARMACOL, V93, P817, DOI 10.1111/j.1476-5381.1988.tb11467.x
   STALMANS W, 1974, EUR J BIOCHEM, V41, P127, DOI 10.1111/j.1432-1033.1974.tb03252.x
   STUDER RK, 1982, J BIOL CHEM, V257, P7987
   TOVEY KC, 1974, CLIN CHIM ACTA, V56, P221, DOI 10.1016/0009-8981(74)90133-8
   VANSCHEEUWIJCK P, 1990, EUR J PHARM-MOLEC PH, V188, P129, DOI 10.1016/0922-4106(90)90048-3
   WALLENSTEIN S, 1980, CIRC RES, V47, P1, DOI 10.1161/01.RES.47.1.1
NR 36
TC 21
Z9 21
U1 0
U2 0
PU WILLIAMS & WILKINS
PI BALTIMORE
PA 351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436
SN 0026-895X
J9 MOL PHARMACOL
JI Mol. Pharmacol.
PD OCT
PY 1992
VL 42
IS 4
BP 649
EP 655
PG 7
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA JU460
UT WOS:A1992JU46000016
PM 1331756
DA 2024-02-19
ER

PT J
AU Ferreira, FM
   Moreno, AJ
   Seiça, R
   Santos, MS
   Palmeira, CM
AF Ferreira, Fernanda M.
   Moreno, Antonio J.
   Seiça, Raquel
   Santos, Maria S.
   Palmeira, Carlos M.
TI Mitochondrial bioenergetics, diabetes, and aging:: Top-down analysis
   using the diabetic Goto-Kakizaki (GK) rat as a model
SO TOXICOLOGY MECHANISMS AND METHODS
LA English
DT Article
DE Goto-Kakizaki (GK) rats; type 2 diabetes mellitus; liver mitochondria;
   redox chain; phosphorylative system; metabolic control analysis;
   top-down analysis
ID LIVER-MITOCHONDRIA; PROTONMOTIVE FORCE; RESPIRATION RATE; LEAK;
   PHOSPHORYLATION
AB In the present study we investigated the changes in the oxidative phosphorylation system of liver mitochondria, isolated from diabetic Goto-Kakizaki (GK) and Wistar (control) rats with different ages (6, 12, 26, and 52 weeks). We used a kinetic approach known as "top-down" analysis, which conceptually divides the oxidative phosphorylation system into two subsystems: one producing the protonmotive force (Delta p) and another that consumes Delta p. The overall response of the Delta p generators to Delta p was obtained from an uncoupler titration of respiration rate versus Delta p, while the overall response of Delta p consumers to Delta p was obtained from an inhibitor titration of respiration rate versus Delta p.
   Our results showed that GK liver mitochondrial preparations presented an increase in Delta p production and phosphorylative subsystems (using succinate as respiratory substrate). The alterations observed may suggest the existence of biochemical compensatory mechanisms to type 2 diabetes mellitus in GK rats during their first year of life, in order to reduce the injury associated with the disease. Furthermore, we observed that liver metabolic efficiency of mitochondrial respiration declined with age, this decrease in respiratory activity being visible both in control and diabetic rats.
C1 Univ Coimbra, Dept Zool, Ctr Neurosci & Cell Biol Coimbra, P-3004517 Coimbra, Portugal.
   Univ Coimbra, Fac Med, P-3004517 Coimbra, Portugal.
C3 Universidade de Coimbra; Universidade de Coimbra
RP Palmeira, CM (corresponding author), Univ Coimbra, Dept Zool, Ctr Neurosci & Cell Biol Coimbra, P-3004517 Coimbra, Portugal.
EM palmeira@ci.uc.pt
RI Ferreira, Fernanda M. L./K-1984-2013; Ferreira, Fernanda
   Maria/AAD-6450-2020; Palmeira, Carlos M/L-3390-2014
OI Ferreira, Fernanda M. L./0000-0003-3326-1250; Ferreira, Fernanda
   Maria/0000-0003-3326-1250; Palmeira, Carlos M/0000-0002-2639-7697;
   Seica, Raquel/0000-0002-8378-0895; Moreno, Antonio/0000-0003-3575-7604;
   santos, maria sancha/0000-0002-6881-9392
CR BRAND MD, 1994, BBA-BIOENERGETICS, V1187, P132, DOI 10.1016/0005-2728(94)90099-X
   BRAND MD, 1990, BIOCHIM BIOPHYS ACTA, V1018, P128, DOI 10.1016/0005-2728(90)90232-S
   BROWN GC, 1990, EUR J BIOCHEM, V188, P321, DOI 10.1111/j.1432-1033.1990.tb15406.x
   ENGELGAU MM, 2000, CLIN G MED MANAG, P1
   Estabrook R.W., 1967, METHOD ENZYMOL, V10, P41, DOI DOI 10.1016/0076-6879(67)10010-4
   Ferreira FML, 1997, BIOCHEM PHARMACOL, V53, P299, DOI 10.1016/S0006-2952(96)00689-2
   Ferreira FML, 1999, ACTA DIABETOL, V36, P173, DOI 10.1007/s005920050163
   Fosslien E, 2001, ANN CLIN LAB SCI, V31, P25
   FUSI F, 1992, BIOCHEM PHARMACOL, V43, P1203, DOI 10.1016/0006-2952(92)90493-3
   Gazotti P., 1979, MEMBRANE BIOCH LAB M, P62
   Gerbitz KD, 1996, DIABETES, V45, P113, DOI 10.2337/diabetes.45.2.113
   GOTO Y, 1975, P JPN ACAD, V51, P80, DOI 10.2183/pjab1945.51.80
   HAFNER RP, 1988, EUR J BIOCHEM, V178, P511, DOI 10.1111/j.1432-1033.1988.tb14477.x
   HAFNER RP, 1990, EUR J BIOCHEM, V188, P313, DOI 10.1111/j.1432-1033.1990.tb15405.x
   HAFNER RP, 1990, BIOCHEM J, V265, P731, DOI 10.1042/bj2650731
   Knight JA, 2001, ADV CLIN CHEM, V35, P1, DOI 10.1016/S0065-2423(01)35014-X
   Lionetti L, 1998, ARCH BIOCHEM BIOPHYS, V352, P240, DOI 10.1006/abbi.1998.0579
   Marcinkeviciute  A, 2000, BIOCHEM J, V349, P519, DOI 10.1042/0264-6021:3490519
   McIntosh CHS, 1999, EXPERIMENTAL MODELS OF DIABETES, P337
   MURPHY MP, 1987, BIOCHEM J, V243, P499, DOI 10.1042/bj2430499
   MURPHY MP, 1989, BIOCHIM BIOPHYS ACTA, V977, P123, DOI 10.1016/S0005-2728(89)80063-5
   OSTENSON CG, 1993, DIABETOLOGIA, V36, P3, DOI 10.1007/BF00399086
   PACKER L, 1998, OXIDATIVE STRESS ANT, P1
   SEDMAK JJ, 1977, ANAL BIOCHEM, V79, P544, DOI 10.1016/0003-2697(77)90428-6
   TRISCHLER HJ, 1998, EXPT DIABETIC NEUROP, P121
NR 25
TC 3
Z9 4
U1 0
U2 5
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1537-6516
EI 1537-6524
J9 TOXICOL MECH METHOD
JI Toxicol. Mech. Methods
PD AUG
PY 2006
VL 16
IS 6
BP 323
EP 330
DI 10.1080/15376520600616925
PG 8
WC Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Toxicology
GA 051XD
UT WOS:000238194100004
PM 20021031
OA Green Submitted
DA 2024-02-19
ER

PT J
AU Bloomer, SA
   Brown, KE
   Kregel, KC
AF Bloomer, Steven A.
   Brown, Kyle E.
   Kregel, Kevin C.
TI Renal Iron Accumulation and Oxidative Injury With Aging: Effects of
   Treatment With an Iron Chelator
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
DE Deferoxamine; Inflammation; Autophagy; Oxidative stress
ID LIPID-PEROXIDATION; HEPATIC IRON; RAT; DEFEROXAMINE; RESTRICTION; STRESS
AB Dysregulation of iron metabolism in the kidney may contribute to age-related increases in renal oxidative stress and dysfunction. This study assessed the effects of short-term iron chelation on markers of iron status, oxidative stress, inflammation, and autophagy in the kidneys of old rats. Old Fischer 344 rats (24 months) were treated with deferoxamine (DFO; 200 mg/kg, twice daily for 4.5 days); saline-treated young (6 months) and old rats served as controls. Renal nonheme iron was significantly higher in the old rats, with iron localized in the renal cortex. Ferritin levels were elevated in the kidneys of old rats, while expression of several antioxidant enzymes and mitochondrial proteins were reduced and protein carbonyls increased compared to young rats. DFO treatment significantly reduced ferritin levels, and increased transferrin receptor-1 protein, but did not affect nonheme iron content or protein carbonyls, nor did it reverse age-related changes in antioxidant enzymes and mitochondrial proteins. Although short-term DFO treatment did not mitigate the age-related increase in iron content and oxidative damage, this work demonstrates that old rats respond appropriately to DFO, suggesting that optimization of iron chelation regimens could be useful in improving renal homeostasis with aging.
C1 [Bloomer, Steven A.] Penn State Univ, Abington Coll, Div Sci & Engn, 1600 Woodland Rd, Abington, PA 19001 USA.
   [Brown, Kyle E.] Iowa City Vet Adm Med Ctr, Iowa City, IA USA.
   [Brown, Kyle E.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Div Gastroenterol Hepatol, Iowa City, IA USA.
   [Brown, Kyle E.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Program Free Rad & Radiat Biol, Iowa City, IA USA.
   [Kregel, Kevin C.] Univ Iowa, Dept Hlth & Human Physiol, Iowa City, IA USA.
C3 Pennsylvania Commonwealth System of Higher Education (PCSHE);
   Pennsylvania State University; University of Iowa; University of Iowa;
   University of Iowa
RP Bloomer, SA (corresponding author), Penn State Univ, Abington Coll, Div Sci & Engn, 1600 Woodland Rd, Abington, PA 19001 USA.
EM sab320@psu.edu
OI Brown, Kyle/0000-0002-8206-036X
FU Penn State University, Abington College; National Institutes of Health
   [AG-12350]
FX This work was supported by a Faculty Development Grant from Penn State
   University, Abington College (S.A.B.), and National Institutes of Health
   grant AG-12350 (K.C.K.).
CR Bloomer SA, 2008, AM J PHYSIOL-REG I, V294, pR1165, DOI 10.1152/ajpregu.00719.2007
   Bloomer SA, 2014, BLOOD CELL MOL DIS, V52, P19, DOI 10.1016/j.bcmd.2013.07.002
   Cermanova J, 2014, SHOCK, V42, P372, DOI 10.1097/SHK.0000000000000210
   Chen LG, 2001, EXP NEPHROL, V9, P198
   Cook CI, 1998, MECH AGEING DEV, V102, P1, DOI 10.1016/S0047-6374(98)00005-0
   Coombes JD, 2005, KIDNEY INT, V68, P2599, DOI 10.1111/j.1523-1755.2005.00732.x
   Huang Q, 2018, J GERONTOL A-BIOL, V73, P421, DOI 10.1093/gerona/glx183
   Jassal S V, 1998, Geriatr Nephrol Urol, V8, P141, DOI 10.1023/A:1008316016640
   Jung KJ, 2009, INFLAMM RES, V58, P143, DOI 10.1007/s00011-008-7227-2
   KIM BK, 1985, J LAB CLIN MED, V105, P440
   MASSIE HR, 1983, EXP GERONTOL, V18, P277, DOI 10.1016/0531-5565(83)90038-4
   Moreno-Ulloa A, 2015, J GERONTOL A-BIOL, V70, P1370, DOI 10.1093/gerona/glu131
   OCONNELL MJ, 1989, BIOCHEM J, V260, P903, DOI 10.1042/bj2600903
   PALLER MS, 1988, KIDNEY INT, V34, P474, DOI 10.1038/ki.1988.205
   PIPPARD MJ, 1982, BRIT J HAEMATOL, V52, P211, DOI 10.1111/j.1365-2141.1982.tb03883.x
   Qian SY, 1999, FREE RADICAL BIO MED, V26, P1447, DOI 10.1016/S0891-5849(99)00002-7
   Rajapurkar MM, 2013, TOXICOL MECH METHOD, V23, P5, DOI 10.3109/15376516.2012.730558
   Reckelhoff JF, 1998, AM J PHYSIOL-REG I, V274, pR767, DOI 10.1152/ajpregu.1998.274.3.R767
   REICHEL W, 1968, J GERONTOL, V23, P145, DOI 10.1093/geronj/23.2.145
   Saad SY, 2001, PHARMACOL RES, V43, P211, DOI 10.1006/phrs.2000.0769
   Smith CP, 2009, BBA-GEN SUBJECTS, V1790, P724, DOI 10.1016/j.bbagen.2008.10.010
   SOHAL RS, 1994, MECH AGEING DEV, V74, P121, DOI 10.1016/0047-6374(94)90104-X
   Wang X, 2017, CELL PHYSIOL BIOCHEM, V43, P2535, DOI 10.1159/000484506
   Ward WF, 2005, J GERONTOL A-BIOL, V60, P847, DOI 10.1093/gerona/60.7.847
   Zanninelli G, 1997, MOL PHARMACOL, V51, P842, DOI 10.1124/mol.51.5.842
NR 25
TC 9
Z9 9
U1 1
U2 5
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
EI 1758-535X
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD APR
PY 2020
VL 75
IS 4
BP 680
EP 684
DI 10.1093/gerona/glz055
PG 5
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA LS6KI
UT WOS:000536490100009
PM 30794723
DA 2024-02-19
ER

PT J
AU Atayik, MC
   Çakatay, U
AF Atayik, Mehmet Can
   Cakatay, Ufuk
TI Melatonin-related signaling pathways and their regulatory effects in
   aging organisms
SO BIOGERONTOLOGY
LA English
DT Article; Early Access
DE Aging; Melatonin; Evolution; Adaptive redox response; Mitochondria;
   Redox signaling
ID ANTIOXIDANT; PROOXIDANT; MITOCHONDRIA; POLYPHENOLS; GLUTATHIONE; LIVER
AB Melatonin is a tryptophan-derived ancestral molecule evolved in bacteria. According to the endosymbiotic theory, eukaryotic cells received mitochondria, plastids, and other organelles from bacteria by internalization. After the endosymbiosis, bacteria evolved into organelles and retained their ability of producing melatonin. Melatonin is a small, evolutionarily conserved indole with multiple receptor-mediated, receptor-dependent, and independent actions. Melatonin's initial function was likely a radical scavenger in bacteria that's why there was high intensity of free radicals on primitive atmosphere in the ancient times, and hormetic functions of melatonin, which are effecting through the level of gene expression via prooxidant and antioxidant redox pathways, are developed in throughout the eukaryotic evolution. In the earlier stages of life, endosymbiotic events between mitochondria and other downstream organelles continue with mutual benefits. However, this interaction gradually deteriorates as a result of the imperfection of both mitochondrial and extramitochondrial endosymbiotic crosstalk with the advancing age of eukaryotic organisms. Throughout the aging process melatonin levels tend to reduce and as a manifestation of this, many symptoms in organisms' homeostasis, such as deterioration in adjustment of cellular clocks, are commonly seen. In addition, due to deterioration in mitochondrial integrity and functions, immunity decreases, and lower levels of melatonin renders older individuals to be more susceptible to impaired redox modulation and age-related diseases. Our aim in this paper is to focus on the several redox modulation mechanisms in which melatonin signaling has a central role, to discuss melatonin's gerontological aspects and to provide new research ideas with researchers.
C1 [Atayik, Mehmet Can] Istanbul Univ Cerrahpasa, Cerrahpasa Fac Med, Med Program, Istanbul, Turkey.
   [Cakatay, Ufuk] Istanbul Univ Cerrahpasa, Cerrahpasa Fac Med, Dept Med Biochem, Istanbul, Turkey.
C3 Istanbul University - Cerrahpasa; Istanbul University - Cerrahpasa
RP Çakatay, U (corresponding author), Istanbul Univ Cerrahpasa, Cerrahpasa Fac Med, Dept Med Biochem, Istanbul, Turkey.
RI Atayik, Mehmet Can/GQI-2860-2022; Cakatay, Ufuk/D-2752-2015
OI Atayik, Mehmet Can/0000-0002-9869-0518; Cakatay,
   Ufuk/0000-0001-9861-7380
CR Agathokleous E, 2019, CHEM-BIOL INTERACT, V299, P163, DOI 10.1016/j.cbi.2018.12.008
   Araujo JA, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00119
   Arnao MB, 2018, MOLECULES, V23, DOI 10.3390/molecules23010238
   Atayik M. C., 2022, Redox signaling and biomarkers in ageing, healthy ageing and longevity, P209, DOI [10.1007/978-3-030-84965-8_10, DOI 10.1007/978-3-030-84965-8_10]
   Atayik MC, 2022, BIOGERONTOLOGY, V23, P401, DOI 10.1007/s10522-022-09973-y
   Atukeren P, 2010, OXID MED CELL LONGEV, V3, P206, DOI 10.4161/oxim.3.3.11786
   Bakula D, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00239
   Bona Silvia, 2022, World J Gastrointest Pharmacol Ther, V13, P11, DOI 10.4292/wjgpt.v13.i2.11
   Calabrese EJ, 2021, PHARMACOL RES, V167, DOI 10.1016/j.phrs.2021.105526
   Cardoso S, 2022, REDOX SIGNALING BIOM, P147
   Chen G, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00200
   Cheng CF, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113447
   Díaz-Casado ME, 2016, J PINEAL RES, V61, P96, DOI 10.1111/jpi.12332
   Dikmenoglu N, 2008, CLIN HEMORHEOL MICRO, V40, P235, DOI 10.3233/CH-2008-1132
   Ding J, 2012, EXP GERONTOL, V47, P483, DOI 10.1016/j.exger.2012.03.020
   Favero G, 2017, AGEING RES REV, V35, P336, DOI 10.1016/j.arr.2016.11.007
   Favero G, 2015, AGE, V37, DOI 10.1007/s11357-015-9824-7
   Ganie SA, 2016, REJUV RES, V19, P21, DOI 10.1089/rej.2015.1704
   Grzesik M, 2019, FOOD CHEM, V278, P692, DOI 10.1016/j.foodchem.2018.11.109
   Guo P, 2014, TOXICOL SCI, V142, P182, DOI 10.1093/toxsci/kfu164
   Gupta A, 2021, MOL BIOL REP, V48, P2761, DOI 10.1007/s11033-021-06257-5
   Gurer-Orhan H, 2015, CURR MED CHEM, V22, P490
   Hardeland Rudiger, 2005, Nutr Metab (Lond), V2, P22, DOI 10.1186/1743-7075-2-22
   Hardeland R, 2017, HEALTHY AGEING LONG, V6, P209, DOI 10.1007/978-3-319-63001-4_10
   Hussain F., 2022, REDOX SIGNALING BIOM, P117, DOI [10.1007/978-3-030-84965-8_7, DOI 10.1007/978-3-030-84965-8_7]
   Karasek M, 2004, EXP GERONTOL, V39, P1723, DOI 10.1016/j.exger.2004.04.012
   Kilic U, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-7
   Kouda K, 2010, J PHYSIOL ANTHROPOL, V29, P127, DOI 10.2114/jpa2.29.127
   Kuciel-Lewandowska J, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/8423105
   Lecour S, 2011, MINI-REV MED CHEM, V11, P1191
   Lee JH, 2020, AGING CELL, V19, DOI 10.1111/acel.13111
   León-González AJ, 2015, BIOCHEM PHARMACOL, V98, P371, DOI 10.1016/j.bcp.2015.07.017
   Li YM, 2020, BIOMED PHARMACOTHER, V132, DOI 10.1016/j.biopha.2020.110887
   Lin QY, 2021, STEM CELL RES THER, V12, DOI 10.1186/s13287-021-02520-5
   Luo F, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21197174
   Lyons TW, 2014, NATURE, V506, P307, DOI 10.1038/nature13068
   Mannino G, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22189996
   Mattam U, 2014, BIOGERONTOLOGY, V15, P257, DOI 10.1007/s10522-014-9495-2
   McCord JM, 2000, AM J MED, V108, P652, DOI 10.1016/S0002-9343(00)00412-5
   Okeke ES, 2022, MICROBES INFECT, V24, DOI 10.1016/j.micinf.2021.104886
   Onphachanh X, 2017, J PINEAL RES, V63, DOI 10.1111/jpi.12427
   Osseni RA, 2000, LIFE SCI, V68, P387, DOI 10.1016/S0024-3205(00)00955-3
   Rattan SIS, 2001, CRIT REV TOXICOL, V31, P663, DOI 10.1080/20014091111929
   Rattan SIS, 2008, HUM EXP TOXICOL, V27, P151, DOI 10.1177/0960327107083409
   Rattan SIS, 2022, CURR OPIN TOXICOL, V29, P19, DOI 10.1016/j.cotox.2022.01.001
   Reiter RJ, 2020, PHYSIOLOGY, V35, P86, DOI 10.1152/physiol.00034.2019
   Reiter RJ, 2016, J PINEAL RES, V61, P253, DOI 10.1111/jpi.12360
   Rius-Pérez S, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/1452696
   Roy J, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22136841
   Salehi B, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8070681
   Sedlak TW, 2009, P NATL ACAD SCI USA, V106, P5171, DOI 10.1073/pnas.0813132106
   Simsek B, 2021, CLIN NUTR ESPEN, V42, P1, DOI 10.1016/j.clnesp.2021.02.014
   Suofu Y, 2017, P NATL ACAD SCI USA, V114, pE7997, DOI 10.1073/pnas.1705768114
   Swiderska-Kolacz G, 2006, NEUROENDOCRINOL LETT, V27, P365
   Tan DX, 2000, BIOL SIGNAL RECEPT, V9, P137
   Teodoro BG, 2014, J PINEAL RES, V57, P155, DOI 10.1111/jpi.12157
   Terán R, 2012, INVEST CLIN, V53, P250
   Tkachev VO, 2011, BIOCHEMISTRY-MOSCOW+, V76, P407, DOI 10.1134/S0006297911040031
   Venegas C, 2012, J PINEAL RES, V52, P217, DOI 10.1111/j.1600-079X.2011.00931.x
   Vriend J, 2015, MOL CELL ENDOCRINOL, V401, P213, DOI 10.1016/j.mce.2014.12.013
   Wang JJ, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080903
   Wang SJ, 2018, J CELL MOL MED, V22, P5132, DOI 10.1111/jcmm.13802
   Watabe Naoki, 2007, J Oleo Sci, V56, P73
   Wu CC, 2012, J PINEAL RES, V52, P460, DOI 10.1111/j.1600-079X.2011.00960.x
   Ximenes VF, 2009, BBA-GEN SUBJECTS, V1790, P787, DOI 10.1016/j.bbagen.2009.03.021
   Xu J, 2022, CURR EYE RES, V47, P688, DOI 10.1080/02713683.2021.2022163
   Yanar K, 2019, REJUV RES, V22, P409, DOI 10.1089/rej.2018.2159
   Yang AJT, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22094628
   Yoon YM, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20184545
   Zhang HM, 2014, J PINEAL RES, V57, P131, DOI 10.1111/jpi.12162
   Zhao D, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00249
   Zimorski V, 2014, CURR OPIN MICROBIOL, V22, P38, DOI 10.1016/j.mib.2014.09.008
NR 72
TC 12
Z9 12
U1 1
U2 4
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1389-5729
EI 1573-6768
J9 BIOGERONTOLOGY
JI Biogerontology
PD 2022 OCT
PY 2022
VL 23
IS 5
BP 529
EP 539
DI 10.1007/s10522-022-09981-y
EA JUL 2022
PG 11
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 4M7IG
UT WOS:000830962400001
PM 35895186
DA 2024-02-19
ER

PT J
AU Borchert, D
   Glanemann, M
   Mogl, M
   Langrehr, JM
   Neuhaus, P
AF Borchert, D
   Glanemann, M
   Mogl, M
   Langrehr, JM
   Neuhaus, P
TI Older liver graft transplantation, cholestasis and synthetic graft
   function
SO TRANSPLANT INTERNATIONAL
LA English
DT Article
DE cadaveric donors; donation; expanded donor pool; outcome; selection
   criteria
ID DONOR AGE; PRESERVATION INJURY; PARTIAL-HEPATECTOMY; MARGINAL DONORS;
   AGING LIVER; RECIPIENT; VARIABLES; SURVIVAL
AB Older liver grafts are often discarded because of conservative selection criteria. We report on our clinical experience with graft-age related outcome. Patients transplanted with livers older than 70 years (70.2-80.2 years, n = 38) were compared with controls transplanted with livers younger than 70 years. Pairs were matched for age, gender, indication and cold ischemic time. Mean donor age was 73.4 +/- 2 vs. 39 +/- 16 years. Patient and graft survival did not differ between both groups after I-year follow-up (P = 0.19 and P = 0.24 respectively). Retransplantation rate was 10.5 % vs. 5.3 % (P = 0.40). Initial poor function occurred in two patients in the study group versus four patients in the control group (P = 0.69). The incidence of rejection episodes was comparable. Parameters of cholestasis and protein synthesis showed no difference I-year post-transplant. Mean age of donor organs in matched pairs group B was near by half of that in the older donor group A (39.0 vs. 73.4 years). Post-transplant outcome as indicated by patient and graft survival was comparable between both groups. Donor organ age had no impact on postoperative organ function. We recommend to accept liver grafts from organ donors older than 70 years to expand the donor pool.
C1 Univ Med Berlin, Charite, Dept Gen Visceral & Transplant Surg, Berlin, Germany.
C3 Free University of Berlin; Humboldt University of Berlin; Charite
   Universitatsmedizin Berlin
RP Borchert, D (corresponding author), Addenbrookes Hosp, Dept Surg, Hills Rd, Cambridge CB2 2QQ, England.
EM dietmar.borchert@doctors.org.uk
OI Mogl, Martina/0000-0002-3676-047X; Borchert, Dietmar/0000-0002-6050-6324
CR ABRAHAM SC, 1995, TRANSPLANTATION, V59, P740, DOI 10.1097/00007890-199503150-00018
   Adam P, 2003, LIVER TRANSPLANT, V9, P1231, DOI 10.1016/j.lts.2003.09.018
   Alexander JW, 1996, CLIN TRANSPLANT, V10, P1
   Anantharaju A, 2002, GERONTOLOGY, V48, P343, DOI 10.1159/000065506
   BELTEMPO P, 2004, INT C TRANSPL SOC VI
   Briceño J, 2002, TRANSPLANTATION, V74, P522, DOI 10.1097/01.TP.0000026307.14572.8D
   Cescon M, 2003, LIVER TRANSPLANT, V9, P1174, DOI 10.1053/jlts.2003.50234
   Emre S, 1996, TRANSPLANTATION, V62, P62, DOI 10.1097/00007890-199607150-00013
   Glanemann M, 2003, AM J TRANSPLANT, V3, P1003, DOI 10.1034/j.1600-6143.2003.00167.x
   Glanemann M, 2001, ACTA ANAESTH SCAND, V45, P333, DOI 10.1034/j.1399-6576.2001.045003333.x
   Hoofnagle JH, 1996, HEPATOLOGY, V24, P89, DOI 10.1053/jhep.1996.v24.pm0008707288
   Ikegami T, 2000, TRANSPLANTATION, V70, P1703, DOI 10.1097/00007890-200012270-00007
   Keswani RN, 2004, LIVER TRANSPLANT, V10, P957, DOI 10.1002/lt.20155
   Kimura F, 1996, RES EXP MED, V196, P281, DOI 10.1007/s004330050037
   Levy MF, 2001, ANN SURG, V233, P107, DOI 10.1097/00000658-200101000-00016
   MAKOWKA L, 1987, TRANSPLANT P, V19, P2378
   MIMEAULT R, 1989, TRANSPLANT P, V21, P3355
   NEUHAUS P, 1994, ANN SURG, V219, P426, DOI 10.1097/00000658-199404000-00014
   NEUHAUS P, 1989, LANCET, V2, P924
   PLOEG RJ, 1993, TRANSPLANTATION, V55, P807, DOI 10.1097/00007890-199304000-00024
   Romero CJ, 1999, TRANSPLANTATION, V68, P572, DOI 10.1097/00007890-199908270-00021
   Rull R, 2003, LIVER TRANSPLANT, V9, P389, DOI 10.1053/jlts.2003.50050
   Salizzoni M, 2003, TRANSPLANT INT, V16, P486, DOI 10.1007/s00147-003-0572-8
   Sapey T, 2000, J CLIN GASTROENTEROL, V30, P259, DOI 10.1097/00004836-200004000-00011
   TSUKAMOTO I, 1993, BIOCHEM MOL BIOL INT, V30, P773
   Verran D, 2003, LIVER TRANSPLANT, V9, P500, DOI 10.1053/jlts.2003.50099
   Verran DJ, 2001, CLIN TRANSPLANT, V15, P106, DOI 10.1034/j.1399-0012.2001.150205.x
   Washburn WK, 1996, TRANSPLANTATION, V61, P1062, DOI 10.1097/00007890-199604150-00013
   YERSIZ H, 1995, TRANSPLANTATION, V60, P790, DOI 10.1097/00007890-199510270-00005
   Zeeh J, 2002, GERONTOLOGY, V48, P121, DOI 10.1159/000052829
NR 30
TC 22
Z9 27
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0934-0874
EI 1432-2277
J9 TRANSPL INT
JI Transpl. Int.
PD JUN
PY 2005
VL 18
IS 6
BP 709
EP 715
DI 10.1111/j.1432-2277.2005.00128.x
PG 7
WC Surgery; Transplantation
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Surgery; Transplantation
GA 932JX
UT WOS:000229551100013
PM 15910298
DA 2024-02-19
ER

PT J
AU Api, M
   Biondi, P
   Olivotto, I
   Terzibasi, E
   Cellerino, A
   Carnevali, O
AF Api, Martina
   Biondi, Piera
   Olivotto, Ike
   Terzibasi, Eva
   Cellerino, Alessandro
   Carnevali, Oliana
TI Effects of Parental Aging During Embryo Development and Adult Life: The
   Case of <i>Nothobranchius furzeri</i>
SO ZEBRAFISH
LA English
DT Article; Early Access
DE IGF system; transgenerational effects; killifish; embryo development
   plasticity; diapause
ID NEW-MODEL SYSTEM; ANNUAL FISHES; GROWTH; AGE; TEMPERATURE; LONGEVITY;
   EVOLUTION; DIAPAUSE; BINDING; LIVER
AB Studies on parental aging are a very attractive field, although it is poorly understood how parental age affects embryonic development and adult traits of the offspring. In this study, we used the turquoise killifish Nothobranchius furzeri, as is the vertebrate with shortest captive lifespan and an interesting model. The embryos of N. furzeri can follow two distinct developmental pathways either entering diapause or proceeding through direct development. Thus, this embryonic plasticity allows this model to be used to study different factors that could affect their embryonic development, including parental age. The first goal of the present study was to investigate whether parental aging could affect the embryo development. To do this, we collected F1 embryos from two breeder groups (old parents and young parents). We monitored the duration of embryonic development and analyzed genes involved in dorsalization process. The second goal was to investigate if embryonic developmental plasticity could be modulated by an epigenetic process. To this end, the expression of DNMTs genes was examined. Our data support the hypothesis that diapause, occurring more frequently in embryos from old parents, is associated with increased expression of DNMT3A and DNMT3B suggesting an epigenetic control. Finally, we analyzed whether parental age could affect metabolism and growth during adult life. Morphometric results and qPCR analysis of genes from IGF system showed a slower growth in adults from old breeders. Moreover, a gender-specificity effect on growth emerged. In conclusion, these results may contribute to the better understanding of the complex mechanism of aging.
C1 [Api, Martina; Biondi, Piera; Olivotto, Ike; Carnevali, Oliana] Univ Politecn Marche, Dept Life & Environm Sci, Via Brecce Bianche, I-60131 Ancona, Italy.
   [Terzibasi, Eva; Cellerino, Alessandro] Scuola Normale Super Pisa, Pisa, Italy.
C3 Marche Polytechnic University; Scuola Normale Superiore di Pisa
RP Carnevali, O (corresponding author), Univ Politecn Marche, Dept Life & Environm Sci, Via Brecce Bianche, I-60131 Ancona, Italy.
EM o.carnevali@univpm.it
RI Cellerino, Alessandro/AAJ-7453-2020; Tozzini, Eva/JQI-3406-2023;
   Cellerino, Alessandro/AAB-4398-2020; Terzibasi Tozzini, Eva/J-9466-2016;
   Olivotto, Ike/K-9397-2014
OI Cellerino, Alessandro/0000-0003-3834-0097; Cellerino,
   Alessandro/0000-0003-3834-0097; Terzibasi Tozzini,
   Eva/0000-0003-3317-1538; Api, Martina/0000-0003-2636-2969; Olivotto,
   Ike/0000-0002-0906-4225
FU Fondo di Ateneo
FX The authors wish to thank Dr. Chiara Carla Piccinetti for the technical
   support at the fish facilities. The study was supported by Fondo di
   Ateneo 2016 to OC.
CR Annunziata M, 2011, ACTA DIABETOL, V48, P1, DOI 10.1007/s00592-010-0227-z
   [Anonymous], P ROYAL SOC LONDON B
   Beckman BR, 2011, GEN COMP ENDOCR, V170, P233, DOI 10.1016/j.ygcen.2010.08.009
   Blazek R, 2017, EVOLUTION, V71, P386, DOI 10.1111/evo.13127
   Blazek R, 2013, EVODEVO, V4, DOI 10.1186/2041-9139-4-24
   Branam AM, 2010, DEV BIOL, V341, P444, DOI 10.1016/j.ydbio.2010.03.001
   CARO JF, 1988, J CLIN INVEST, V81, P976, DOI 10.1172/JCI113451
   Cellerino A, 2016, BIOL REV, V91, P511, DOI 10.1111/brv.12183
   CLAIRMONT KB, 1989, J BIOL CHEM, V264, P16390
   Clemmons David R., 1997, Cytokine and Growth Factor Reviews, V8, P45, DOI 10.1016/S1359-6101(96)00053-6
   de Magalhaes JP, 2012, FASEB J, V26, P4821, DOI 10.1096/fj.12-210872
   Di Cicco E, 2011, EXP GERONTOL, V46, P249, DOI 10.1016/j.exger.2010.10.011
   Ekamper P, 2015, AM J EPIDEMIOL, V181, P271, DOI 10.1093/aje/kwu288
   Furness AI, 2016, BIOL REV, V91, P796, DOI 10.1111/brv.12194
   Furness AI, 2015, EVOLUTION, V69, P1461, DOI 10.1111/evo.12669
   Gabillard JC, 2005, CYBIUM, V29, P107
   Genade T, 2005, AGING CELL, V4, P223, DOI 10.1111/j.1474-9726.2005.00165.x
   Genade T., LAB MANUAL CULTURING
   Greer EL, 2011, NATURE, V479, P365, DOI 10.1038/nature10572
   Hartmann N, 2012, DEV DYNAM, V241, P1133, DOI 10.1002/dvdy.23789
   Hercus MJ, 2000, P ROY SOC LOND B BIO, P267
   KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302
   Li JY, 2007, MOL CELL BIOL, V27, P8748, DOI 10.1128/MCB.01380-07
   Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850
   LINTS FA, 1977, EVOLUTION, V31, P387, DOI 10.1111/j.1558-5646.1977.tb01020.x
   LINTS FA, 1974, EXP GERONTOL, V9, P51, DOI 10.1016/0531-5565(74)90008-4
   Liu YS, 2011, AGEING RES REV, V10, P115, DOI 10.1016/j.arr.2010.09.004
   Mhanni AA, 2004, DEV GENES EVOL, V214, P412, DOI 10.1007/s00427-004-0418-0
   Miccoli A, 2017, GEN COMP ENDOCR, V245, P55, DOI 10.1016/j.ygcen.2016.03.028
   Mishra N, 2016, IMP J INTERDISCIP RE, V2, P2454
   Mitteldorf J, 2014, AM NAT, V184, P289, DOI 10.1086/677387
   Nelson SN, 2010, GEN COMP ENDOCR, V168, P111, DOI 10.1016/j.ygcen.2010.04.020
   Papadakis IE, 2013, AQUACULTURE, V388, P76, DOI 10.1016/j.aquaculture.2013.01.012
   Picha ME, 2008, N AM J AQUACULT, V70, P196, DOI 10.1577/A07-038.1
   Podrabsky JE, 2010, J EXP BIOL, V213, P3280, DOI 10.1242/jeb.045906
   Polacik M, 2017, J EVOLUTION BIOL, V30, P738, DOI 10.1111/jeb.13038
   Polacik M, 2014, J EVOLUTION BIOL, V27, P854, DOI 10.1111/jeb.12359
   Priest NK, 2002, EVOLUTION, V56, P927, DOI 10.1111/j.0014-3820.2002.tb01405.x
   Spencer CC, 2005, J HERED, V96, P513, DOI 10.1093/jhered/esi071
   Terzibasi E, 2007, EXP GERONTOL, V42, P81, DOI 10.1016/j.exger.2006.06.039
   Tobi EW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8740
   Torres R, 2011, PLOS ONE, V6, P1
   Tozzini ET, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-77
   Valenzano DR, 2006, AGING CELL, V5, P275, DOI 10.1111/j.1474-9726.2006.00212.x
   Werner H, 1996, ADV CANCER RES, V68, P183, DOI 10.1016/S0065-230X(08)60354-1
NR 45
TC 6
Z9 6
U1 0
U2 9
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1545-8547
EI 1557-8542
J9 ZEBRAFISH
JI Zebrafish
PD 2018 APR
PY 2018
VL 15
IS 2
BP 112
EP 123
DI 10.1089/zeb.2017.1494
EA JAN 2018
PG 12
WC Developmental Biology; Zoology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Developmental Biology; Zoology
GA GA9NO
UT WOS:000419441100001
PM 29304310
DA 2024-02-19
ER

PT J
AU Guo, W
   Pirtskhalava, T
   Tchkonia, T
   Xie, WS
   Thomou, T
   Han, JR
   Wang, T
   Wong, S
   Cartwright, A
   Hegardt, FG
   Corkey, BE
   Kirkland, JL
AF Guo, Wen
   Pirtskhalava, Tamar
   Tchkonia, Tamara
   Xie, Weisheng
   Thomou, Thomas
   Han, Jianrong
   Wang, Tong
   Wong, Siu
   Cartwright, Andrew
   Hegardt, Fausto G.
   Corkey, Barbara E.
   Kirkland, James L.
TI Aging results in paradoxical susceptibility of fat cell progenitors to
   lipotoxicity
SO AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
LA English
DT Article
DE fatty acid metabolism; oleic acid; peroxisome proliferator-activated
   receptor-gamma; CCAAT/enhancer-binding protein-alpha; beta-oxidation
ID ADIPOCYTE PRECURSOR CLONES; RAT ADIPOSE-TISSUE; GENE-EXPRESSION;
   ANATOMIC SITE; ANTIMICROBIAL ACTIVITY; LIVER-MITOCHONDRIA; METABOLIC
   SYNDROME; INDUCED APOPTOSIS; ACID-COMPOSITION; PRIMARY CULTURE
AB Aging results in paradoxical susceptibility of fat cell progenitors to lipotoxicity. Am J Physiol Endocrinol Metab 292: E1041-E1051, 2007. First published December 5, 2006; doi:10.1152/ajpendo.00557.2006. - Aging is associated with metabolic syndrome, tissue damage by cytotoxic lipids, and altered fatty acid handling. Fat tissue dysfunction may contribute to these processes. This could result, in part, from age-related changes in preadipocytes, since they give rise to new fat cells throughout life. To test this hypothesis, preadipocytes cultured from rats of different ages were exposed to oleic acid, the most abundant fatty acyl moiety in fat tissue and the diet. At fatty acid concentrations at which preadipocytes from young animals remained viable, cells from old animals accumulated lipid in multiple small lipid droplets and died, with increased apoptotic index, caspase activity, BAX, and p53. Rather than inducing apoptosis, oleic acid promoted adipogenesis in preadipocytes from young animals, with appearance of large lipid droplets. CCAAT/enhancer-binding protein-alpha (C/EBP alpha) and peroxisome proliferator-activated receptor-gamma (PPAR gamma) increased to a greater extent in cells from young than old animals after oleate exposure. Oleic acid, but not glucose, oxidation was impaired in preadipocytes and fat cells from old animals. Expression of carnitine palmitoyltransferase (CPT)-1, which catalyzes the rate-limiting step in fatty acid beta-oxidation, was not reduced in preadipocytes from old animals. At lower fatty acid levels, constitutively active CPT I expression enhanced beta-oxidation. At higher levels, CPT I was not as effective in enhancing beta-oxidation in preadipocytes from old as young animals, suggesting that mitochondrial dysfunction may contribute. Consistent with this, medium-chain acyl-CoA dehydrogenase expression was reduced in preadipocytes from old animals. Thus preadipocyte fatty acid handling changes with aging, with increased susceptibly to lipotoxicity and impaired fatty acid-induced adipogenesis and beta-oxidation.
C1 Boston Univ, Med Ctr, Obes Res Ctr, Evans Dept Med, Boston, MA 02118 USA.
   Boston Univ, Med Ctr, Obes Res Ctr, Dept Biochem, Boston, MA 02118 USA.
   Univ Barcelona, Sch Pharm, Dept Biochem & Mol Biol, E-08007 Barcelona, Spain.
C3 Boston University; Boston University; University of Barcelona
RP Kirkland, JL (corresponding author), Boston Univ, Med Ctr, Obes Res Ctr, Evans Dept Med, Rm F435,88 E Newton St, Boston, MA 02118 USA.
RI Kirkland, James/F-9159-2016; Han, Jian/ABZ-1060-2022; Corkey,
   Barbara/E-7712-2015
OI Guo, Wen/0000-0002-4474-2837; Tchkonia, Tamar/0000-0003-4623-7145;
   Corkey, Barbara/0000-0002-5467-1630
FU NIA NIH HHS [AG/DK-13925] Funding Source: Medline; NIDDK NIH HHS
   [DK-59261, DK-46200] Funding Source: Medline
CR Akaki T, 1997, J LEUKOCYTE BIOL, V62, P795, DOI 10.1002/jlb.62.6.795
   Akaki T, 2000, CLIN EXP IMMUNOL, V121, P302, DOI 10.1046/j.1365-2249.2000.01298.x
   AMRI EZ, 1994, J LIPID RES, V35, P930
   AMRI EZ, 1991, J LIPID RES, V32, P1449
   [Anonymous], 1986, STAT ANAL
   Aronis A, 2005, FREE RADICAL BIO MED, V38, P1221, DOI 10.1016/j.freeradbiomed.2005.01.015
   BERTRAND HA, 1978, SCIENCE, V201, P1234, DOI 10.1126/science.151328
   BJORNTORP P, 1980, J LIPID RES, V21, P714
   BJORNTORP P, 1968, J BIOL CHEM, V243, P2130
   BRAND MD, 1991, BIOCHEM J, V275, P81, DOI 10.1042/bj2750081
   Brenner B, 1997, J BIOL CHEM, V272, P22173, DOI 10.1074/jbc.272.35.22173
   Caserta F, 2001, AM J PHYSIOL-ENDOC M, V280, pE238, DOI 10.1152/ajpendo.2001.280.2.E238
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   Civelek VN, 1996, P NATL ACAD SCI USA, V93, P10139, DOI 10.1073/pnas.93.19.10139
   COONROD J D, 1987, European Journal of Respiratory Diseases Supplement, V71, P209
   DAX EM, 1981, J LIPID RES, V22, P934
   DECKWERTH TL, 1993, J CELL BIOL, V123, P1207, DOI 10.1083/jcb.123.5.1207
   DECLERCQ PE, 1987, J BIOL CHEM, V262, P9812
   DeFronzo RA, 2004, INT J CLIN PRACT, V58, P9, DOI 10.1111/j.1368-504X.2004.00389.x
   DISTEL RJ, 1992, J BIOL CHEM, V267, P5937
   DJIAN P, 1983, J CLIN INVEST, V72, P1200, DOI 10.1172/JCI111075
   DJIAN P, 1985, METABOLISM, V34, P880, DOI 10.1016/0026-0495(85)90114-3
   Flegal KM, 1998, INT J OBESITY, V22, P39, DOI 10.1038/sj.ijo.0800541
   Gormsen LC, 2006, EUR J ENDOCRINOL, V154, P667, DOI 10.1530/eje.1.02146
   GREGERMAN RI, 1994, J GERONTOL, V49, pB135, DOI 10.1093/geronj/49.4.B135
   Guo W, 1998, LIPIDS, V33, P449, DOI 10.1007/s11745-998-0227-5
   Guo W, 1999, LIPIDS, V34, P825, DOI 10.1007/s11745-999-0429-x
   Guo W, 2000, BIOCHEM J, V349, P463, DOI 10.1042/0264-6021:3490463
   HAUNER H, 1991, INT J OBESITY, V15, P121
   Hicks GE, 2005, J GERONTOL A-BIOL, V60, P882, DOI 10.1093/gerona/60.7.882
   HOLLENBERG CH, 1968, J CLIN INVEST, V47, P2485, DOI 10.1172/JCI105930
   Ido Y, 2002, DIABETES, V51, P159, DOI 10.2337/diabetes.51.1.159
   Karagiannides I, 2001, AM J PHYSIOL-REG I, V280, pR1772, DOI 10.1152/ajpregu.2001.280.6.R1772
   Karagiannides I, 2006, J BIOL CHEM, V281, P23025, DOI 10.1074/jbc.M513187200
   Kehayias JJ, 1997, AM J CLIN NUTR, V66, P904, DOI 10.1093/ajcn/66.4.904
   Kelley DE, 1999, AM J PHYSIOL-ENDOC M, V277, pE1130
   Kelley DE, 2001, DIABETES CARE, V24, P933, DOI 10.2337/diacare.24.5.933
   KELLY DP, 1987, P NATL ACAD SCI USA, V84, P4068, DOI 10.1073/pnas.84.12.4068
   Keppel G, 1973, Design and Analysis: A Researcher's Handbook
   KIRKLAND JL, 1990, AM J PHYSIOL, V258, pC206, DOI 10.1152/ajpcell.1990.258.2.C206
   Kirkland JL, 2002, EXP GERONTOL, V37, P757, DOI 10.1016/S0531-5565(02)00014-1
   KIRKLAND JL, 1984, J AM GERIATR SOC, V32, P219, DOI 10.1111/j.1532-5415.1984.tb02006.x
   Kirkland JL, 1997, J AM GERIATR SOC, V45, P959, DOI 10.1111/j.1532-5415.1997.tb02967.x
   KIRKLAND JL, 1993, BIOCHEM CELL BIOL, V71, P556, DOI 10.1139/o93-079
   Kirkland JL, 1996, INT J OBESITY, V20, pS102
   KIRKLAND JL, 1994, J GERONTOL, V49, pB31, DOI 10.1093/geronj/49.1.B31
   KLYDE BJ, 1979, J LIPID RES, V20, P691
   KOKATNUR MG, 1979, AM J CLIN NUTR, V32, P2198, DOI 10.1093/ajcn/32.11.2198
   Lelliott C, 2004, INT J OBESITY, V28, pS22, DOI 10.1038/sj.ijo.0802854
   LEYTON J, 1987, BRIT J NUTR, V57, P383, DOI 10.1079/BJN19870046
   Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100
   Llado I, 1996, BIOCHEM MOL BIOL INT, V40, P295
   Lundgren M, 2004, HORM METAB RES, V36, P203
   Magun R, 1998, DIABETES, V47, P1948, DOI 10.2337/diabetes.47.12.1948
   MARAGOUDAKIS ME, 1975, P SOC EXP BIOL MED, V148, P606, DOI 10.3181/00379727-148-38593
   MILLER WH, 1984, J LIPID RES, V25, P336
   Morillas M, 2003, J BIOL CHEM, V278, P9058, DOI 10.1074/jbc.M209999200
   Morin CL, 1997, J GERONTOL A-BIOL, V52, pB190, DOI 10.1093/gerona/52A.4.B190
   Petschow BW, 1996, ANTIMICROB AGENTS CH, V40, P302, DOI 10.1128/AAC.40.2.302
   Ravaglia G, 1999, J GERONTOL A-BIOL, V54, pM70, DOI 10.1093/gerona/54.2.M70
   RIAL E, 1983, EUR J BIOCHEM, V137, P197, DOI 10.1111/j.1432-1033.1983.tb07815.x
   Rodriguez A, 2005, METABOLISM, V54, P542, DOI 10.1016/j.metabol.2004.11.010
   SPECTOR AA, 1969, J LIPID RES, V10, P56
   Strawford A, 2004, AM J PHYSIOL-ENDOC M, V286, pE577, DOI 10.1152/ajpendo.00093.2003
   Tchkonia T, 2006, ENDOCR UPDAT, V26, P105
   Thiberge S, 2004, P NATL ACAD SCI USA, V101, P3346, DOI 10.1073/pnas.0400088101
   Unger RH, 2003, TRENDS ENDOCRIN MET, V14, P398, DOI 10.1016/j.tem.2003.09.008
   Unger RH, 2002, ANNU REV MED, V53, P319, DOI 10.1146/annurev.med.53.082901.104057
   WAHLE KWJ, 1991, EUR J CLIN NUTR, V45, P195
   WANG H, 1989, J CLIN INVEST, V83, P1741, DOI 10.1172/JCI114075
   Wang MY, 2005, AM J PHYSIOL-ENDOC M, V288, pE216, DOI 10.1152/ajpendo.00004.2004
   Wang T, 2003, OBES RES, V11, P880, DOI 10.1038/oby.2003.121
   WIEDERER O, 1987, J LIPID RES, V28, P649
   Zang Y, 2005, OBES RES, V13, P1530, DOI 10.1038/oby.2005.188
NR 74
TC 59
Z9 67
U1 0
U2 6
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0193-1849
EI 1522-1555
J9 AM J PHYSIOL-ENDOC M
JI Am. J. Physiol.-Endocrinol. Metab.
PD APR
PY 2007
VL 292
IS 4
BP E1041
EP E1051
DI 10.1152/ajpendo.00557.2006
PG 11
WC Endocrinology & Metabolism; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Physiology
GA 152KV
UT WOS:000245361800008
PM 17148751
DA 2024-02-19
ER

PT J
AU Kapsa, RMI
   Quigley, AF
   Han, TF
   Jean-Francois, MJB
   Vaughan, P
   Byrne, E
AF Kapsa, RMI
   Quigley, AF
   Han, TF
   Jean-Francois, MJB
   Vaughan, P
   Byrne, E
TI MtDNA replicative potential remains constant during ageing:: polymerase
   γ activity does not correlate with age related cytochrome oxidase
   activity decline in platelets
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID MITOCHONDRIAL-DNA POLYMERASE; RESPIRATORY-CHAIN FUNCTION; RAT-LIVER
   MITOCHONDRIA; OXIDATIVE DAMAGE; SKELETAL-MUSCLE; 55-KDA ENDONUCLEASE;
   COPY NUMBER; C-OXIDASE; CELLS; ZIDOVUDINE
AB Progressive age-related oxidative phosphorylation (OxPhos) decline is well known in human tissues. Depletion of mitochondrial DNA (mtDNA) causes OxPhos defects in patients with myopathic syndromes and deficient mtDNA replication has been observed in cells cultured from patients with mitochondrial disease. Patients undergoing treatment for AIDS develop OxPhos defects via mtDNA depletion resulting from inhibition of mtDNA polymerase gamma (Pol gamma) by 2'-deoxy 3'-azido thymidine. These findings by others give rise to a possible link between mtDNA replication and bioenergetic decline in disease and during ageing, We have designed an in vitro assay for Poly function in small tissue samples to explore this possible link. Platelet homogenate Pol gamma showed an activity with a K-m of 150 mu M (dTTP), a V-max of 11.0 pmol/min/mg, inhibited (41% inhibition; 50 mu M) by ethidium bromide. Determination of several storage characteristics showed that platelets were a convenient source of Poly for assay. Poly activity in 45 subjects did not coincide with significant age-related decline (P < 0.002; P) observed in cytochrome oxidase (CytOx) activity or with citrate synthase activity. Of the activities studied, the only significant age-wise variation was a 24% CytOx deficiency in elderly (>50; n = 19) compared to young (<51; n = 24) individuals (P < 0.01; t). These results suggest a maintenance of total cellular mtDNA Poly processive levels during ageing, largely independent of total cellular bioenergetic status or mitochondrial number/density. The processive component of Poly is therefore unlikely to make a major contribution to age-related bioenergetic activity decline. This does not, however, preclude the possibility that transient periods of inhibition at crucial points of the cell cycle or development may augment existing intracellular deficiencies. The assay described here greatly facilitates study of Pol gamma activity in patients with conditions involving mtDNA depletion or rearrangement.
C1 St Vincents Hosp, Melbourne Neuromuscular Res Ctr, Fitzroy, Vic 3065, Australia.
   St Vincents Hosp, Dept Clin Neurosci, Fitzroy, Vic 3065, Australia.
   CSIRO, Div Mol Sci, Parkville Lab, Parkville, Vic 3052, Australia.
C3 St Vincent's Hospital Melbourne; St Vincents Hospital Sydney; St
   Vincents Hospital Sydney; St Vincent's Hospital Melbourne; Commonwealth
   Scientific & Industrial Research Organisation (CSIRO)
RP Kapsa, RMI (corresponding author), St Vincents Hosp, Melbourne Neuromuscular Res Ctr, 41 Victoria Parade, Melbourne, Vic 3065, Australia.
EM rkapsa@ariel.ucs.unimelb.edu.au
RI Kapsa, Robert MI/H-8916-2013
OI Kapsa, Robert Michail Ivan/0000-0002-6113-5174; Quigley,
   Anita/0000-0002-4060-2079
CR ANTONETTI DA, 1995, J CLIN INVEST, V95, P1383, DOI 10.1172/JCI117790
   BANDY B, 1990, FREE RADICAL BIO MED, V8, P523, DOI 10.1016/0891-5849(90)90152-9
   Barrientos A, 1997, MOL BRAIN RES, V52, P284, DOI 10.1016/S0169-328X(97)00278-7
   BODNAR AG, 1995, BIOCHEM J, V305, P817, DOI 10.1042/bj3050817
   BOLDEN A, 1977, J BIOL CHEM, V252, P3351
   BRUN GM, 1978, DNA SYNTHESIS PRESEN, P597
   CHEN CH, 1989, J BIOL CHEM, V264, P11934
   COOPER JM, 1992, J NEUROL SCI, V113, P91, DOI 10.1016/0022-510X(92)90270-U
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Croteau DL, 1997, J BIOL CHEM, V272, P27338, DOI 10.1074/jbc.272.43.27338
   DALAKAS MC, 1990, NEW ENGL J MED, V322, P1098, DOI 10.1056/NEJM199004193221602
   Davis AF, 1996, J CELL BIOL, V135, P883, DOI 10.1083/jcb.135.4.883
   Davis AF, 1996, NUCLEIC ACIDS RES, V24, P2753, DOI 10.1093/nar/24.14.2753
   FOX JEB, 1992, METHOD ENZYMOL, V215, P42
   GERSCHENSON M, 1994, J MOL CELL CARDIOL, V26, P31, DOI 10.1006/jmcc.1994.1005
   GIULIVI C, 1995, ARCH BIOCHEM BIOPHYS, V316, P909, DOI 10.1006/abbi.1995.1122
   Graves SW, 1998, BIOCHEMISTRY-US, V37, P6050, DOI 10.1021/bi972685u
   HARDT N, 1980, EXP CELL RES, V127, P269, DOI 10.1016/0014-4827(80)90432-2
   HAROSH I, 1992, EUR J BIOCHEM, V210, P455, DOI 10.1111/j.1432-1033.1992.tb17442.x
   HAYAKAWA M, 1991, BIOCHEM BIOPH RES CO, V179, P1023, DOI 10.1016/0006-291X(91)91921-X
   HAYAKAWA M, 1993, MOL CELL BIOCHEM, V119, P95, DOI 10.1007/BF00926859
   HAYAKAWA M, 1992, INT J IMMUNOTHER, V8, P171
   HOLT IJ, 1988, HUM GENET, V79, P53, DOI 10.1007/BF00291710
   Ikeda S, 1996, BIOCHEM MOL BIOL INT, V38, P1049
   Ikeda S, 1997, ACTA MED OKAYAMA, V51, P55
   Ikeda S, 1996, BIOCHEM MOL BIOL INT, V40, P1017
   JOHNSON JBJ, 1987, MITOCHONDRIA PRACTIC, V1, P153
   King M P, 1996, Methods Enzymol, V264, P339, DOI 10.1016/S0076-6879(96)64032-4
   KNOPF KW, 1976, BIOCHEMISTRY-US, V15, P4540, DOI 10.1021/bi00665a032
   LERTRIT P, 1994, HUM MOL GENET, V3, P1973, DOI 10.1093/hmg/3.11.1973
   LEWIS W, 1994, CIRC RES, V74, P344, DOI 10.1161/01.RES.74.2.344
   Marzuki S, 1997, J NEUROL SCI, V145, P155, DOI 10.1016/S0022-510X(96)00241-9
   MCDONALD MR, 1955, METHOD ENZYMOL, V2, P427, DOI 10.1016/S0076-6879(55)02226-X
   MECOCCI P, 1993, ANN NEUROL, V34, P609, DOI 10.1002/ana.410340416
   MEYER RR, 1968, P NATL ACAD SCI USA, V61, P130, DOI 10.1073/pnas.61.1.130
   Morten KJ, 1996, J INHERIT METAB DIS, V19, P123, DOI 10.1007/BF01799409
   PICCOLO G, 1991, J NEUROL SCI, V105, P57, DOI 10.1016/0022-510X(91)90118-Q
   Pinz KG, 1998, MOL CELL BIOL, V18, P1257, DOI 10.1128/MCB.18.3.1257
   PINZ KG, 1995, J BIOL CHEM, V270, P9202, DOI 10.1074/jbc.270.16.9202
   ROBIN ED, 1988, J CELL PHYSIOL, V136, P507, DOI 10.1002/jcp.1041360316
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   Schultz RA, 1998, J BIOL CHEM, V273, P3447, DOI 10.1074/jbc.273.6.3447
   Tanaka M, 1996, ANN NY ACAD SCI, V786, P102, DOI 10.1111/j.1749-6632.1996.tb39055.x
   TARRAGOLITVAK L, 1978, NUCLEIC ACIDS RES, V5, P2197, DOI 10.1093/nar/5.6.2197
   TARRAGOLITVAK L, 1979, EUR J BIOCHEM, V93, P271, DOI 10.1111/j.1432-1033.1979.tb12820.x
   TASHIRO F, 1978, J BIOCHEM-TOKYO, V84, P385, DOI 10.1093/oxfordjournals.jbchem.a132139
   TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0
   VANDENBOGERT C, 1993, BIOCHIM BIOPHYS ACTA, V1144, P177, DOI 10.1016/0005-2728(93)90170-K
   VELTRI KL, 1990, J CELL PHYSIOL, V143, P160, DOI 10.1002/jcp.1041430122
   Wang HY, 1996, BBA-MOL BASIS DIS, V1316, P51, DOI 10.1016/0925-4439(96)00015-4
   WIESNER RJ, 1994, AM J PHYSIOL, V267, pC229, DOI 10.1152/ajpcell.1994.267.1.C229
   Ye F, 1996, NUCLEIC ACIDS RES, V24, P1481, DOI 10.1093/nar/24.8.1481
NR 52
TC 6
Z9 7
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD OCT 1
PY 1998
VL 26
IS 19
BP 4365
EP 4373
DI 10.1093/nar/26.19.4365
PG 9
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 126JF
UT WOS:000076289600008
PM 9742236
OA Green Published
DA 2024-02-19
ER

PT J
AU Swierczynski, J
   Slominska, E
   Smolenski, RT
   Mayer, D
AF Swierczynski, J
   Slominska, E
   Smolenski, RT
   Mayer, D
TI Increase in NAD but not ATP and GTP concentrations in rat liver by
   dehydroepiandrosterone feeding
SO POLISH JOURNAL OF PHARMACOLOGY
LA English
DT Article
DE dehydroepiandrosterone (DHEA); NAD; NADP; ATP; GTT; adenine nucleotide;
   liver (rat)
ID PERFORMANCE LIQUID-CHROMATOGRAPHY; CARCINOGENESIS; BIOSYNTHESIS;
   HEPATOCYTES; MODULATION; METABOLISM; TRYPTOPHAN; FOCI; DHEA
AB Dehydroepiandrosterone (5-androsten-3 beta -ol-17-one; DHEA), the main circulating steroid in humans, has been described to exert varied beneficial effects including antiobesity, anti-aging and anticancer action when used at pharmacological doses in experimental animals. To elucidate the mechanism of the pleiotropic effects of DHEA, we studied the effect of this steroid on concentrations of NAD and adenine and guanine nucleotides in rat liver. Administration of DHEA at 0.3% in the diet for 7 consecutive days caused an increase in liver NAD and NADP, but was without effect on NADH concentrations. This indicates a shift of the redox couple (NAD/NADH) towards oxidation in the DHEA-treated rats. Moreover, there was no change in adenine and guanine nucleotide concentrations, which disproves the hypothesis that the DHEA anticancer actions are due to a decrease in the availability of nucleosides for DNA synthesis. The findings indicate that an increase in liver NAD pool and/or altered redox status, but no changes in adenine or guanine nucleotide content, may be involved in the pleiotropic effects of DHEA.
C1 Med Univ Gdansk, Dept Biochem, PL-80211 Gdansk, Poland.
   Med Acad Gdansk, Dept Biochem, PL-80211 Gdansk, Poland.
   Deutsch Krebsforschungszentrum, D-69120 Heidelberg, Germany.
C3 Fahrenheit Universities; Medical University Gdansk; Fahrenheit
   Universities; Medical University Gdansk; Helmholtz Association; German
   Cancer Research Center (DKFZ)
RI Smolenski, Ryszard/AEV-2370-2022; Smolenski, Ryszard T/B-9713-2013
OI Smolenski, Ryszard/0000-0002-0190-9414; Slominska,
   Ewa/0000-0002-3037-1844
CR BERDANIER CD, 1993, FASEB J, V7, P414, DOI 10.1096/fasebj.7.5.8462783
   BOONE CW, 1990, CANCER RES, V9, P931
   CASAZZA JP, 1986, J NUTR, V116, P304, DOI 10.1093/jn/116.2.304
   CLEARY MP, 1985, NUTR RES, V5, P1247, DOI 10.1016/S0271-5317(85)80068-3
   CLEARY MP, 1986, INT J OBESITY, V10, P193
   D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249
   GARCEA R, 1988, CARCINOGENESIS, V9, P931, DOI 10.1093/carcin/9.6.931
   GORDON GB, 1987, ADV ENZYME REGUL, V26, P355, DOI 10.1016/0065-2571(87)90023-9
   HULLRYDE EA, 1986, J CHROMATOGR, V377, P165, DOI 10.1016/S0378-4347(00)80771-9
   JACOBSON MK, 1999, TRENDS BIOL SCI, V24, P425
   KALIMI M, 1990, BIOL ROLE DEHYDROEPI
   Kroboth PD, 1999, J CLIN PHARMACOL, V39, P327, DOI 10.1177/00912709922007903
   LOCK EA, 1989, ANNU REV PHARMACOL, V29, P145
   MARKS PA, 1960, P NATL ACAD SCI USA, V46, P447, DOI 10.1073/pnas.46.4.447
   METZGER C, 1995, TOXICOL PATHOL, V23, P591, DOI 10.1177/019262339502300505
   MOHAN PF, 1988, AM J PHYSIOL, V255, pE1, DOI 10.1152/ajpendo.1988.255.1.E1
   RAINERI R, 1970, BIOCHEMISTRY-US, V9, P2233, DOI 10.1021/bi00813a003
   SCHWARTZ AG, 1988, ADV CANCER RES, V51, P391, DOI 10.1016/S0065-230X(08)60227-4
   Shin M, 1998, INT J VITAM NUTR RES, V68, P104
   Shin M, 1998, BIOCHEM PHARMACOL, V55, P367, DOI 10.1016/S0006-2952(97)00507-8
   Shin M, 1996, BIOCHEM PHARMACOL, V52, P247, DOI 10.1016/0006-2952(96)00201-8
   SMOLENSKI RT, 1990, J CHROMATOGR-BIOMED, V527, P414, DOI 10.1016/S0378-4347(00)82125-8
   Spencer NFL, 1995, ANN NY ACAD SCI, V774, P200
   TAGLIAFERRO AR, 1995, AM J PHYSIOL-REG I, V268, pR1374, DOI 10.1152/ajpregu.1995.268.6.R1374
   VANDEWIELE RL, 1963, RECENT PROG HORM RES, V19, P275
   WEBER E, 1988, CARCINOGENESIS, V9, P1191, DOI 10.1093/carcin/9.7.1191
   WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514
NR 27
TC 10
Z9 11
U1 0
U2 1
PU POLISH ACAD SCIENCES INST PHARMACOLOGY
PI KRAKOW
PA SMETNA 12, 31-343 KRAKOW, POLAND
SN 1230-6002
J9 POL J PHARMACOL
JI Pol. J. Pharmacol.
PD MAR-APR
PY 2001
VL 53
IS 2
BP 125
EP 130
PG 6
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA 436EE
UT WOS:000168922900004
PM 11787951
DA 2024-02-19
ER

PT J
AU Donato, AJ
   Henson, GD
   Hart, CR
   Layec, G
   Trinity, JD
   Bramwell, RC
   Enz, RA
   Morgan, RG
   Reihl, KD
   Hazra, S
   Walker, AE
   Richardson, RS
   Lesniewski, LA
AF Donato, Anthony J.
   Henson, Grant D.
   Hart, Corey R.
   Layec, Gwenael
   Trinity, Joel D.
   Bramwell, R. Colton
   Enz, Ryley A.
   Morgan, R. Garrett
   Reihl, Kelly D.
   Hazra, Sugata
   Walker, Ashley E.
   Richardson, Russell S.
   Lesniewski, Lisa A.
TI The impact of ageing on adipose structure, function and vasculature in
   the B6D2F1 mouse: evidence of significant multisystem dysfunction
SO JOURNAL OF PHYSIOLOGY-LONDON
LA English
DT Article
ID SKELETAL-MUSCLE; WEIGHT CHANGE; MITOCHONDRIAL RESPIRATION;
   INSULIN-RESISTANCE; OXIDATIVE STRESS; BODY-COMPOSITION; ELDERLY-MEN; FAT
   MASS; TISSUE; AGE
AB Key points Dysfunction in the adipose tissue, characterized by reduced adipocyte size, tissue fibrosis and ectopic lipid accumulation, has been implicated in age-associated metabolic dysfunction, but it is not known how ageing affects the function of the arteries and mitochondria within the adipose tissue. Mitochondrial lipid utilization is impaired in adipose tissue of old mice, evidenced by reduced substrate control ratios in the presence of lipid substrates and is concomitant with increased oxidative stress. Ageing leads to endothelial dysfunction, evidenced by reduced endothelium-dependent dilation in resistance arteries, reduced angiogenic capacity and reduced vascularity of the adipose tissue. These results indicate that arterial and mitochondrial dysfunction accompany age-associated adipose tissue and systemic metabolic dysfunction and suggest that targeting arterial or mitochondrial function to improve adipose tissue function may have important application in the treatment of age-associated metabolic dysfunction.
   Abstract The critical influence of the white adipose tissue (WAT) on metabolism is well-appreciated in obesity, but adipose tissue dysfunction as a mechanism underlying age-associated metabolic dysfunction requires elucidation. To explore this possibility, we assessed metabolism and measures of epididymal (e)WAT mitochondria and artery function in young (6.1 +/- 0.4months) and old (29.6 +/- 0.2months) B6D2F1 mice. There were no group differences in average daily oxygen consumption, fasted blood glucose or plasma free fatty acids, but fasted plasma insulin and the homeostatic model assessment of insulin resistance (HOMA-IR%) were higher in the old (approximate to 50-85%, P<0.05). Tissue mass (P<0.05) and adipocyte area were lower (approximate to 60%) (P<0.01) and fibrosis was greater (sevenfold, P<0.01) in eWAT with older age. The old also exhibited greater liver triglycerides (approximate to 60%, P<0.05). The mitochondrial respiratory oxygen flux after the addition of glutamate and malate (GM), adenosine diphosphate (d), succinate (S) and octanoyl carnitine (O) were one- to twofold higher in eWAT of old mice (P<0.05). Despite no change in the respiratory control ratio, substrate control ratios of GMO(d)/GM(d) and GMOS(d)/GM(d) were approximate to 30-40% lower in old mice (P<0.05) and were concomitant with increased nitrotyrosine (P<0.05) and reduced expression of brown adipose markers (P<0.05). Ageing reduced vascularity (approximate to 50%, P<0.01), angiogenic capacity (twofold, P<0.05) and expression of vascular endothelial growth factor (approximate to 50%, P<0.05) in eWAT. Finally, endothelium-dependent dilation was lower (P<0.01) in isolated arteries from eWAT arteries of the old mice. Thus, metabolic dysfunction with advancing age occurs in concert with dysfunction in the adipose tissue characterized by both mitochondrial and arterial dysfunction.
C1 [Donato, Anthony J.; Layec, Gwenael; Trinity, Joel D.; Bramwell, R. Colton; Enz, Ryley A.; Morgan, R. Garrett; Reihl, Kelly D.; Hazra, Sugata; Walker, Ashley E.; Richardson, Russell S.; Lesniewski, Lisa A.] Univ Utah, Sch Med, Dept Internal Med, Div Geriatr, Salt Lake City, UT 84148 USA.
   [Donato, Anthony J.; Richardson, Russell S.; Lesniewski, Lisa A.] Vet Affairs Med Ctr, Geriatr Res Educ & Clin Ctr, Salt Lake City, UT 84148 USA.
   [Donato, Anthony J.; Henson, Grant D.; Hart, Corey R.; Richardson, Russell S.; Lesniewski, Lisa A.] Univ Utah, Dept Exercise & Sports Sci, Salt Lake City, UT 84148 USA.
C3 Utah System of Higher Education; University of Utah; US Department of
   Veterans Affairs; Veterans Health Administration (VHA); Geriatric
   Research Education & Clinical Center; Utah System of Higher Education;
   University of Utah
RP Lesniewski, LA (corresponding author), Univ Utah, Dept Internal Med, Div Geriatr, GRECC Bldg 2,Rm 1C06,500 Foothill Dr, Salt Lake City, UT 84148 USA.
EM lisa.lesniewski@utah.edu
RI LESNIEWSKI, LISA/ISV-5811-2023; Lesniewski, Lisa A/B-2443-2012; Walker,
   Ashley E/AGV-9029-2022; Layec, Gwenael/H-9141-2013
OI LESNIEWSKI, LISA/0000-0002-2138-1450; Walker, Ashley
   E/0000-0003-1612-4545; Reihl, Kelly/0000-0001-8980-8062
FU National Institute on Aging [K01 AG033196, R21 AG033755, T35HL007744,
   R01 AG040297, P01 HL091830, T32 HL007576, R21 AG043952, VA Merit
   E6910R]; National Heart Lung and Blood Institute [K01 AG033196, R21
   AG033755, T35HL007744, R01 AG040297, P01 HL091830, T32 HL007576, R21
   AG043952, VA Merit E6910R]
FX This work was supported by awards from the National Institute on Aging
   and the National Heart Lung and Blood Institute; K01 AG033196, R21
   AG033755, T35HL007744, R01 AG040297, P01 HL091830 and T32 HL007576, R21
   AG043952 and VA Merit E6910R.
CR BAUMGARTNER RN, 1995, J GERONTOL A-BIOL, V50, pM307, DOI 10.1093/gerona/50A.6.M307
   CHUMLEA W C, 1989, American Journal of Human Biology, V1, P457, DOI 10.1002/ajhb.1310010408
   Cooke JP, 2002, CIRCULATION, V105, P2133, DOI 10.1161/01.CIR.0000014928.45119.73
   Cree MG, 2004, J CLIN ENDOCR METAB, V89, P3864, DOI 10.1210/jc.2003-031986
   Davis RT, 2013, J APPL PHYSIOL, V114, P808, DOI 10.1152/japplphysiol.01358.2012
   Divoux A, 2010, DIABETES, V59, P2817, DOI 10.2337/db10-0585
   Donato AJ, 2012, AM J PHYSIOL-HEART C, V303, pH672, DOI 10.1152/ajpheart.00271.2012
   Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7
   Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014
   Festuccia William T, 2011, Front Endocrinol (Lausanne), V2, P84, DOI 10.3389/fendo.2011.00084
   Frayn KN, 2002, DIABETOLOGIA, V45, P1201, DOI 10.1007/s00125-002-0873-y
   Garg Abhimanyu, 2006, Clin Cornerstone, V8 Suppl 4, pS7, DOI 10.1016/S1098-3597(06)80039-6
   Gealekman O, 2011, CIRCULATION, V123, P186, DOI 10.1161/CIRCULATIONAHA.110.970145
   Goodpaster BH, 2001, J APPL PHYSIOL, V90, P2157, DOI 10.1152/jappl.2001.90.6.2157
   Goossens GH, 2008, PHYSIOL BEHAV, V94, P206, DOI 10.1016/j.physbeh.2007.10.010
   Gregor MF, 2007, J LIPID RES, V48, P1905, DOI 10.1194/jlr.R700007-JLR200
   Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361
   IGNARRO LJ, 1987, P NATL ACAD SCI USA, V84, P9265, DOI 10.1073/pnas.84.24.9265
   JACKSON RA, 1988, DIABETES, V37, P119, DOI 10.2337/diabetes.37.1.119
   Karakelides H, 2010, DIABETES, V59, P89, DOI 10.2337/db09-0591
   Kelley DE, 1999, AM J PHYSIOL-ENDOC M, V277, pE1130
   Khan T, 2009, MOL CELL BIOL, V29, P1575, DOI 10.1128/MCB.01300-08
   Kirkland JL, 2002, EXP GERONTOL, V37, P757, DOI 10.1016/S0531-5565(02)00014-1
   Kirkland JL, 1997, J AM GERIATR SOC, V45, P959, DOI 10.1111/j.1532-5415.1997.tb02967.x
   KIRKLAND JL, 1994, J GERONTOL, V49, pB31, DOI 10.1093/geronj/49.1.B31
   Koonen DPY, 2010, DIABETES, V59, P1366, DOI 10.2337/db09-1142
   Kraunsoe R, 2010, J PHYSIOL-LONDON, V588, P2023, DOI 10.1113/jphysiol.2009.184754
   Kyle UG, 2001, EUR J CLIN NUTR, V55, P663, DOI 10.1038/sj.ejcn.1601198
   Larsen S, 2012, ACTA PHYSIOL, V205, P423, DOI 10.1111/j.1748-1716.2012.02408.x
   LAUNER LJ, 1994, JAMA-J AM MED ASSOC, V271, P1093, DOI 10.1001/jama.271.14.1093
   Lesniewski LA, 2007, NAT MED, V13, P455, DOI 10.1038/nm1550
   Lesniewski LA, 2009, J GERONTOL A-BIOL, V64, P9, DOI 10.1093/gerona/gln049
   Levy JC, 1998, DIABETES CARE, V21, P2191, DOI 10.2337/diacare.21.12.2191
   Lindström J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725
   Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872
   Mansouri A, 2006, MECH AGEING DEV, V127, P298, DOI 10.1016/j.mad.2005.11.004
   Meijer RI, 2013, DIABETES, V62, P590, DOI 10.2337/db11-1603
   National Research Council, 2011, GUIDE CARE USE LAB A, DOI DOI 10.17226/12910
   Newman AB, 2005, AM J CLIN NUTR, V82, P872, DOI 10.1093/ajcn/82.4.872
   Ravaglia G, 1999, J GERONTOL A-BIOL, V54, pM70, DOI 10.1093/gerona/54.2.M70
   Reddy AK, 2003, AM J PHYSIOL-HEART C, V285, pH1464, DOI 10.1152/ajpheart.00004.2003
   Rodríguez-Sureda V, 2005, ANAL BIOCHEM, V343, P277, DOI 10.1016/j.ab.2005.05.009
   Rogers NH, 2012, AGING CELL, V11, P1074, DOI 10.1111/acel.12010
   Rossi AP, 2011, J GERONTOL A-BIOL, V66, P801, DOI [10.1093/gerona/glr058, 10.1093/gerona/glr059]
   Rupnick MA, 2002, P NATL ACAD SCI USA, V99, P10730, DOI 10.1073/pnas.162349799
   SHIMOKATA H, 1989, J GERONTOL, V44, pM66, DOI 10.1093/geronj/44.2.M66
   Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887
   Timmons JA, 2009, NEW ENGL J MED, V361, P415, DOI 10.1056/NEJMc091009
   Trayhurn P, 2004, BRIT J NUTR, V92, P347, DOI 10.1079/BJN20041213
   TURNER RC, 1979, METABOLISM, V28, P1086, DOI 10.1016/0026-0495(79)90146-X
   Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478
   Vanltallie TB, 2003, METABOLISM, V52, P22, DOI 10.1053/S0026-0495(03)00297-X
   WALLACE JI, 1995, J AM GERIATR SOC, V43, P329, DOI 10.1111/j.1532-5415.1995.tb05803.x
   WILLIAMSON DF, 1993, ANN INTERN MED, V119, P646, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00004
   Wu DY, 2007, J IMMUNOL, V179, P4829, DOI 10.4049/jimmunol.179.7.4829
   YAMATE J, 1990, LAB ANIM, V24, P332, DOI 10.1258/002367790780865976
   Yilmaz M, 2013, CELL METAB, V17, P7, DOI 10.1016/j.cmet.2012.12.014
   YU BP, 1982, J GERONTOL, V37, P130, DOI 10.1093/geronj/37.2.130
   Zhang L, 2011, AM J PHYSIOL-ENDOC M, V301, pE599, DOI 10.1152/ajpendo.00059.2011
NR 59
TC 45
Z9 46
U1 0
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3751
EI 1469-7793
J9 J PHYSIOL-LONDON
JI J. Physiol.-London
PD SEP 15
PY 2014
VL 592
IS 18
BP 4083
EP 4096
DI 10.1113/jphysiol.2014.274175
PG 14
WC Neurosciences; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Physiology
GA AP6VO
UT WOS:000342216400018
PM 25038241
OA Green Published, Bronze
DA 2024-02-19
ER

PT J
AU Li, ZC
   Chen, YL
   Ren, W
   Hu, SF
   Tan, ZL
   Wang, Y
   Chen, YW
   Zhang, J
   Wu, JQ
   Li, TT
   Xu, JM
   Ying, XM
AF Li, Zongcheng
   Chen, Yuling
   Ren, Wu
   Hu, Shuofeng
   Tan, Zhaoli
   Wang, Yan
   Chen, Yaowen
   Zhang, Jian
   Wu, Jiaqi
   Li, Tingting
   Xu, Jianming
   Ying, Xiaomin
TI Transcriptome Alterations in Liver Metastases of Colorectal Cancer After
   Acquired Resistance to Cetuximab
SO CANCER GENOMICS & PROTEOMICS
LA English
DT Article
DE Acquired resistance; cetuximab; colorectal cancer; transcriptome
   alteration; regulatory networks
ID LONG NONCODING RNA; CELLULAR SENESCENCE; DRIVES RESISTANCE; PLUS
   IRINOTECAN; EGFR; PANITUMUMAB; THERAPY; GROWTH; KRAS; IDENTIFICATION
AB Background/Aim: Cetuximab in combination with chemotherapy is recommended as first-line therapy for metastatic colorectal cancer (mCRC) with wild-type RAS. However, drug resistance to cetuximab exists widely in mCRC and reduces the prognosis of patients. Although some genomic alterations have been demonstrated to drive acquired resistance to cetuximab, the overall compendium of inherent molecular mechanisms is still incomplete. Materials and Methods: Four liver metastasis biopsies were collected from two mCRC patients who were treated with cetuximab in combination with 5-fluororacil plus leucovorin and oxaliplatin (FOLFOX) regimen. Results: Transcriptomic analysis revealed global gene expression alterations between paired samples prior to treatment and after acquired resistance. Further bioinformatics analysis discovered differentially expressed protein-coding genes/lncRNAs/miRNAs, potential miRNA-mRNA regulatory networks and lncRNA-mRNA competing endogenous RNA network, which may be potential biomarkers or play roles during the process of acquired resistance to cetuximab. Conclusion: Our study contributes to deciphering the molecular mechanisms of acquired resistance to cetuximab.
C1 [Li, Zongcheng; Ren, Wu; Hu, Shuofeng; Chen, Yaowen; Zhang, Jian; Wu, Jiaqi; Ying, Xiaomin] Beijing Inst Basic Med Sci, Ctr Computat Biol, Beijing 100850, Peoples R China.
   [Li, Zongcheng] Acad Mil Med Sci, Affiliated Hosp, Lab Oncol,State Key Lab Prote, 307 Ivy Translat Med Ctr,Translat Med Ctr Stem Ce, Beijing, Peoples R China.
   [Chen, Yuling; Tan, Zhaoli; Wang, Yan; Xu, Jianming] Acad Mil Med Sci, Hosp PLA 307, Dept GI Oncol, Beijing 100071, Peoples R China.
   [Ren, Wu] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Obstet & Gynecol, Wuhan, Hubei, Peoples R China.
   [Chen, Yaowen] Nanjing Mil Command, Fuzhou Gen Hosp, Dept Obstet & Gynecol, Fuzhou, Fujian, Peoples R China.
   [Li, Tingting] Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Gastroenterol, Beijing, Peoples R China.
   [Li, Tingting] Chinese Peoples Liberat Army Gen Hosp, State Key Lab Kidney Dis, Beijing, Peoples R China.
C3 Academy of Military Medical Sciences - China; Academy of Military
   Medical Sciences - China; Academy of Military Medical Sciences - China;
   Huazhong University of Science & Technology; Chinese People's Liberation
   Army General Hospital; Chinese People's Liberation Army General Hospital
RP Ying, XM (corresponding author), Beijing Inst Basic Med Sci, Ctr Computat Biol, Beijing 100850, Peoples R China.; Xu, JM (corresponding author), Acad Mil Med Sci, Hosp PLA 307, Dept GI Oncol, Beijing 100071, Peoples R China.
EM jmxu2003@yahoo.com; yingxmbio@foxmail.com
RI Lu, Jia/JVO-6891-2024; Li, Tingting/HKE-0812-2023; Li,
   Zongcheng/AFP-2645-2022; zhang, ting/IYT-0642-2023; zhou,
   wei/JQJ-0490-2023; L, J/JEF-9564-2023; Li, Zc/AAN-1952-2021; chen,
   yuling/JMQ-4121-2023; lei, lei/JSL-3106-2023
OI Li, Zongcheng/0000-0002-5189-5268; chen, yaowen/0000-0002-7936-3861;
   Ying, Xiaomin/0000-0001-6126-7372; ZHANG, JIAN/0000-0002-4966-2086
FU National Key R&D Program of China [2017YFC0908300]; China National High
   Technology Research and Development Program [2014AA020604]; National
   Natural Science Foundation of China Project [81573458]; National Natural
   Science Foundation of China [81703006]
FX This work was supported by National Key R&D Program of China (Grant No.
   2017YFC0908300 to X. Ying), the China National High Technology Research
   and Development Program (No. 2014AA020604 to X. Ying), the National
   Natural Science Foundation of China Project (No. 81573458 to J. Xu), and
   the National Natural Science Foundation of China (Grant No. 81703006 to
   T. Li).
CR Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116
   Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638
   Bardelli A, 2013, CANCER DISCOV, V3, P658, DOI 10.1158/2159-8290.CD-12-0558
   Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989
   Bertotti A, 2011, CANCER DISCOV, V1, P508, DOI 10.1158/2159-8290.CD-11-0109
   Bokemeyer C, 2009, J CLIN ONCOL, V27, P663, DOI 10.1200/JCO.2008.20.8397
   Brenner H, 2014, LANCET, V383, P1490, DOI 10.1016/S0140-6736(13)61649-9
   Cheng HY, 2015, CANCER RES, V75, P2737, DOI 10.1158/0008-5472.CAN-15-0370
   Cheung KJ, 2013, CELL, V155, P1639, DOI 10.1016/j.cell.2013.11.029
   Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704
   Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003
   Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100
   Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025
   De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3
   Della Corte CM, 2015, CLIN CANCER RES, V21, P4686, DOI 10.1158/1078-0432.CCR-14-3319
   Di Nicolantonio F, 2008, J CLIN ONCOL, V26, P5705, DOI 10.1200/JCO.2008.18.0786
   Dong SY, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-015-0140-6
   Dweep H, 2014, METHODS MOL BIOL, V1182, P289, DOI 10.1007/978-1-4939-1062-5_25
   Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745
   Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026
   Giampieri R, 2013, CRIT REV ONCOL HEMAT, V88, P272, DOI 10.1016/j.critrevonc.2013.05.008
   Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013
   Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111
   Hsieh JC, 1999, NATURE, V398, P431, DOI 10.1038/18899
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923
   Hur K, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju492
   Jonker DJ, 2007, NEW ENGL J MED, V357, P2040, DOI 10.1056/NEJMoa071834
   Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385
   Keniry A, 2012, NAT CELL BIOL, V14, P659, DOI 10.1038/ncb2521
   Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36
   Ko YB, 2014, CELL SIGNAL, V26, P2562, DOI 10.1016/j.cellsig.2014.07.026
   Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027
   Li SB, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00047
   Li WT, 2016, ONCOTARGET, V7, P27778, DOI 10.18632/oncotarget.8413
   Liang WC, 2015, ONCOTARGET, V6, P22513, DOI 10.18632/oncotarget.4154
   Lièvre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191
   Loupakis F, 2009, BRIT J CANCER, V101, P715, DOI 10.1038/sj.bjc.6605177
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Malinauskas T, 2011, NAT STRUCT MOL BIOL, V18, P886, DOI 10.1038/nsmb.2081
   Misale S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007947
   Mitsuhashi K, 2015, ONCOTARGET, V6, P22114, DOI 10.18632/oncotarget.4294
   Montagut C, 2012, NAT MED, V18, P221, DOI 10.1038/nm.2609
   Moqadam FA, 2013, LEUKEMIA RES, V37, P1315, DOI 10.1016/j.leukres.2013.06.027
   Morandi A, 2013, CANCER RES, V73, P3783, DOI 10.1158/0008-5472.CAN-12-4265
   Overall CM, 2002, NAT REV CANCER, V2, P657, DOI 10.1038/nrc884
   Plaza-Menacho I, 2010, ONCOGENE, V29, P4648, DOI 10.1038/onc.2010.209
   Poliseno L, 2015, METHODS, V77-78, P41, DOI 10.1016/j.ymeth.2015.01.013
   Rahman M, 2015, METABOLITES, V5, P571, DOI 10.3390/metabo5040571
   Rayess H, 2012, INT J CANCER, V130, P1715, DOI 10.1002/ijc.27316
   Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014
   Sartore-Bianchi A, 2009, CANCER RES, V69, P1851, DOI 10.1158/0008-5472.CAN-08-2466
   Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011
   Toivola DM, 2015, CURR OPIN CELL BIOL, V32, P73, DOI 10.1016/j.ceb.2014.12.008
   Tsang WP, 2007, ONCOGENE, V26, P4877, DOI 10.1038/sj.onc.1210266
   Valentin MD, 2012, BREAST CANCER RES TR, V134, P21, DOI 10.1007/s10549-011-1934-z
   Van Cutsem E, 2014, ANN ONCOL, V25, P1, DOI 10.1093/annonc/mdu260
   Van Cutsem E, 2007, J CLIN ONCOL, V25, P1658, DOI 10.1200/JCO.2006.08.1620
   Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019
   Vychytilova-Faltejskova P, 2016, CANCER GENOM PROTEOM, V13, P311
   Xing X, 2013, BRIT J CANCER, V108, P2542, DOI 10.1038/bjc.2013.251
   Yang XJ, 2016, GENE, V592, P172, DOI 10.1016/j.gene.2016.08.002
   Yin DD, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0253-8
   Yonesaka K, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002442
   Yoshihara K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3612
   Zhang HH, 2013, INT J CLIN EXP PATHO, V6, P1734
   2012, NATURE, V486, P532, DOI DOI 10.1038/NATURE11156
   2007, CANCER RES, V67, P2643, DOI DOI 10.1158/0008-5472.CAN-06-4158
   2006, CANCER RES, V66, P5330, DOI DOI 10.1158/0008-5472.CAN-06-0037
   2016, EUR REV MED PHARM SC, V20, P2271
   2015, NAT REV CLIN ONCOL, V12, P573, DOI DOI 10.1038/NRCLINONC.2015.117
   2011, BREAST CANC RES TREA, V127, P345, DOI DOI 10.1007/S10549-010-0984-Y
NR 72
TC 9
Z9 9
U1 1
U2 7
PU INT INST ANTICANCER RESEARCH
PI ATHENS
PA EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22,
   ATHENS 19014, GREECE
SN 1109-6535
EI 1790-6245
J9 CANCER GENOM PROTEOM
JI Cancer Genomics Proteomics
PD MAY-JUN
PY 2019
VL 16
IS 3
BP 207
EP 219
DI 10.21873/cgp.20126
PG 13
WC Oncology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Genetics & Heredity
GA HU8BD
UT WOS:000465506400007
PM 31018951
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Barlagiannis, D
   Dietrich, EM
   Papaliagkas, V
   Makri, S
   Toskas, A
   Papamitsou, T
AF Barlagiannis, D.
   Dietrich, E. M.
   Papaliagkas, V
   Makri, S.
   Toskas, A.
   Papamitsou, T.
TI Ultrastructural aspects of the effects of L-carnitine administration on
   epithelial cells in the aging rat tongue
SO HIPPOKRATIA
LA English
DT Article
DE Carnitine; tongue; microscopy; electron
ID SKELETAL-MUSCLE; SUPPLEMENTATION; TRANSPORT; DEFICIENCY; METABOLISM;
   PROTECTION; ENZYMES; ESTERS; DAMAGE; LIVER
AB Background: The investigators hypothesized that degenerative changes accumulate in epithelial cells in the aging rat tongue and that carnitine administration is effective at reversing these alterations.
   Material and Methods: To gain insights into the effects of carnitine on epithelial cells of the tongue, the investigators used 15 Wistar rats [3 experimental groups: 5-(A), 12-(B) and 18-(C) month old rats] with 4 rats per group and 1 control group with 1 rat per age group). L-carnitine was administered intraperitoneally to animals of the experimental group for 35 days. Samples of the tongue were processed for electron microscopy.
   Results: Degeneration of epithelial cells of the rat tongue was shown to begin early in life (5 months) and alterations were shown to accumulate while aging. L-carnitine administration eliminated degenerative changes when administered in the first age group A, while in the older rats the regeneration was only partial for the epithelium (groups B and C).
   Conclusions: The results of this study suggest that profound ultrastructural alterations commence in the degenerating rat tongue and that L-carnitine administration results into partial regeneration of epithelial cells.
C1 [Barlagiannis, D.] Lukas Hosp, Med Clin 1, Catheterizat Lab, Neuss, Germany.
   [Dietrich, E. M.; Toskas, A.; Papamitsou, T.] Aristotle Univ Thessaloniki, Sch Med, Dept Histol & Embryol, GR-54006 Thessaloniki, Greece.
   [Papaliagkas, V] Gen Hosp Georgios Papanikolaou, Dept Neurol, Thessaloniki, Greece.
   [Makri, S.] Inst Educ Technol, Fac Hlth Sci & Caring Profess, Dept Biomed Sci, Thessaloniki, Greece.
C3 Aristotle University of Thessaloniki
RP Dietrich, EM (corresponding author), PB 1033, Thessaloniki 57006, Greece.
EM aeffchen.dietrich@gmail.com
RI Papamitsou, Theodora/ABA-9855-2020
OI TOSKAS, ALEXANDROS/0000-0003-2642-1367; Papamitsou,
   Theodora/0000-0002-0709-5407
CR Bernard A, 2008, J GERONTOL A-BIOL, V63, P1027, DOI 10.1093/gerona/63.10.1027
   BERTELLI A, 1999, DRUGS EXP CLIN RES, V19, P75
   BRASS EP, 1995, CLIN THER, V17, P176, DOI 10.1016/0149-2918(95)80017-4
   Calò LA, 2006, INT J CARDIOL, V107, P54, DOI 10.1016/j.ijcard.2005.02.053
   Cameron NE, 1997, EUR J PHARMACOL, V319, P239, DOI 10.1016/S0014-2999(96)00844-8
   CAPALDO B, 1991, DIABETES RES CLIN PR, V14, P191, DOI 10.1016/0168-8227(91)90020-E
   CHRISTOPHERSEN BO, 1981, FEBS LETT, V133, P201, DOI 10.1016/0014-5793(81)80505-4
   ENGEL AG, 1984, J INHERIT METAB DIS, V7, P38, DOI 10.1007/BF03047372
   Ferrari R, 2004, ANN NY ACAD SCI, V1033, P79, DOI 10.1196/annals.1320.007
   FRITZ IB, 1965, P NATL ACAD SCI USA, V54, P1226, DOI 10.1073/pnas.54.4.1226
   Karanth J, 2010, INDIAN J EXP BIOL, V48, P503
   MARTINUZZI A, 1991, BIOCHIM BIOPHYS ACTA, V1095, P217, DOI 10.1016/0167-4889(91)90102-4
   Moustafa AM, 2011, J MOL HISTOL, V42, P217, DOI 10.1007/s10735-011-9326-6
   Okada FK, 2009, CELL TISSUE RES, V337, P269, DOI 10.1007/s00441-009-0801-2
   Ozsoy SY, 2011, BIOTECH HISTOCHEM, V86, P436, DOI 10.3109/10520295.2010.529825
   PAPAMITSOU T, 2011, BASIC CLIN PHARMA S1, V109, P105
   PAULSON DJ, 1986, CARDIOVASC RES, V20, P536, DOI 10.1093/cvr/20.7.536
   REBOUCHE CJ, 1984, J CLIN INVEST, V73, P857, DOI 10.1172/JCI111281
   REBOUCHE CJ, 1992, FASEB J, V6, P3379, DOI 10.1096/fasebj.6.15.1464372
   REBOUCHE CJ, 1980, BIOCHIM BIOPHYS ACTA, V630, P22, DOI 10.1016/0304-4165(80)90133-6
   REDDY TS, 1983, ARCH BIOCHEM BIOPHYS, V226, P125, DOI 10.1016/0003-9861(83)90277-1
   Ringseis R, 2012, EUR J NUTR, V51, P1, DOI 10.1007/s00394-011-0284-2
   Shaankar SS, 2004, ANN NY ACAD SCI, V1033, P189, DOI 10.1196/annals.1320.018
   Vaz FM, 2002, BIOCHEM J, V361, P417, DOI 10.1042/0264-6021:3610417
   Vescovo G, 2002, AM J PHYSIOL-CELL PH, V283, pC802, DOI 10.1152/ajpcell.00046.2002
NR 25
TC 3
Z9 4
U1 0
U2 3
PU LITHOGRAPHIA
PI THESSALONIKI
PA ANTONIADIS I-PSARRAS TH G P, NEA REDESTOS, THESSALONIKI, 00000, GREECE
SN 1108-4189
J9 HIPPOKRATIA
JI Hippokratia
PY 2014
VL 18
IS 1
BP 32
EP 36
PG 5
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA AG5EP
UT WOS:000335442400007
PM 25125949
DA 2024-02-19
ER

PT J
AU Arce, A
   Aicher, L
   Wahl, D
   Anderson, NL
   Meheus, L
   Raymackers, J
   Cordier, A
   Steiner, S
AF Arce, A
   Aicher, L
   Wahl, D
   Anderson, NL
   Meheus, L
   Raymackers, J
   Cordier, A
   Steiner, S
TI Changes in the liver protein pattern of female Wistar rats treated with
   the hypoglycemic agent SDZ PGU 693
SO LIFE SCIENCES
LA English
DT Article
DE SDZ PGU 693; hypoglycemic agent; liver; toxicity; 2D-electrophoresis;
   proteome pattern
ID CELL
AB SDZ PGU 693 acts as a hypoglycemic agent by stimulating glucose utilisation in insulin-sensitive peripheral tissues, such as skeletal muscle and fat. In a 28 day toxicity study the compound was found to induce hepatocellular hypertrophy in Wistar rats treated with 300 mg/kg/day. To gain insights into the pathomechanism of these alterations, aliquots of liver samples from control and treated female Wistar rats were separated by two-dimensional protein gel electrophoresis and the digitized images of the protein patterns were searched for protein abundance changes. Significant treatment-related quantitative changes (P < 0.001) were found in 29 liver proteins. Major increases were observed in several microsomal proteins, including NADPH cytochrome P-450 reductase, cytochrome b5 and serine protease inhibitor. The changes in the cytochrome related enzymes, both known co-factors of the P-450 enzyme system, strongly suggest that SDZ PGU 693 induces microsomal proliferation and induction of the P-450 enzyme system. Decreases were observed in a series of mitochondrial proteins, such as F(1)ATPase-delta subunit and ornithine aminotransferase precursor as well as in several cytosolic proteins such as the liver fatty acid binding protein, arylsulfotransferase and the senescence marker protein-30. The changes in F(1)ATPase-delta subunit and liver fatty acid binding protein together suggest a down-regulation of the mitochondrial liver fatty acid metabolism, likely reflecting the pharmacological action of the compound. These results show that SDZ PGU 693 produces a complex pattern of gene expression changes which give insights into the molecular mechanisms of both its pharmacological action and a toxic response.
C1 Novartis Pharma AG, Preclin Safety, CH-4002 Basel, Switzerland.
   Large Scale Biol Corp, Rockville, MD USA.
   Innogenet Ltd, Ghent, Belgium.
C3 Novartis; Innogenetics NV
RP Steiner, S (corresponding author), Novartis Pharma AG, Preclin Safety, Toxicol WS-2881 3 08, CH-4002 Basel, Switzerland.
EM sandra.steiner@pharma.novartis.com
CR ANDERSON L, 1995, J CELL BIOCHEM, P108
   ANDERSON NG, 1978, ANAL BIOCHEM, V85, P331, DOI 10.1016/0003-2697(78)90229-4
   ANDERSON NL, 1991, ELECTROPHORESIS, V12, P907, DOI 10.1002/elps.1150121110
   DEFRONZO RA, 1988, DIABETES, V37, P667, DOI 10.2337/diab.37.6.667
   HILL RE, 1987, NATURE, V326, P96, DOI 10.1038/326096a0
   KHAN SH, 1994, P NATL ACAD SCI USA, V91, P848, DOI 10.1073/pnas.91.3.848
   MATSUZAWA T, 1994, J BIOCHEM-TOKYO, V116, P721, DOI 10.1093/oxfordjournals.jbchem.a124587
   OZAWA S, 1995, JPN J CANCER RES, V86, P264, DOI 10.1111/j.1349-7006.1995.tb03049.x
   PORTER TD, 1990, BIOCHEMISTRY-US, V29, P9814, DOI 10.1021/bi00494a009
   ROSENFELD J, 1992, ANAL BIOCHEM, V203, P173, DOI 10.1016/0003-2697(92)90061-B
   STEINER S, 1995, ELECTROPHORESIS, V16, P1969, DOI 10.1002/elps.11501601323
NR 11
TC 22
Z9 23
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0024-3205
EI 1879-0631
J9 LIFE SCI
JI Life Sci.
PD NOV 13
PY 1998
VL 63
IS 25
BP 2243
EP 2250
DI 10.1016/S0024-3205(98)00509-8
PG 8
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA 139HX
UT WOS:000077023400005
PM 9870710
DA 2024-02-19
ER

PT J
AU Patrono, D
   Rigo, F
   Bormida, S
   Berchialla, P
   Giordanengo, L
   Skurzak, S
   Balagna, R
   Romagnoli, R
AF Patrono, D.
   Rigo, F.
   Bormida, S.
   Berchialla, P.
   Giordanengo, L.
   Skurzak, S.
   Balagna, R.
   Romagnoli, R.
TI Graft factors as determinants of postoperative delirium after liver
   transplantation
SO UPDATES IN SURGERY
LA English
DT Article; Early Access
DE Cognitive impairment; Postoperative delirium; Surgical quality; Ageing;
   Outcomes; Liver transplantation
ID INTENSIVE-CARE-UNIT; CONFUSION ASSESSMENT METHOD; RISK-FACTORS;
   POSTREPERFUSION SYNDROME; COMPLICATIONS; POPULATION; DEFINITION;
   OUTCOMES; SURGERY; LENGTH
AB Post-operative delirium (POD) is a frequent complication after surgery, occurring in 15-20% of patients. POD is associated with a higher complications rate and mortality. Literature on POD after liver transplantation (LT) is limited, with the few available studies reporting an incidence of 10-47%. The aim of this study was analyzing pattern, risk factors and clinical impact of POD after LT. Data on donor and recipient characteristics, postoperative course and POD of consecutive adult LT recipients from March 2016 to May 2018 were prospectively collected and retrospectively analyzed. Risk factors for POD were analyzed using univariable logistic regression and Lasso regression. Kaplan-Meier method was used for survival analysis. 309 patients underwent LT during study period; 3 were excluded due to perioperative death. Incidence of POD was 13.4% (n = 41). The median day of onset was 5th (IQR [4-7]) with a median duration of 4 days (IQR [3-7]). Several risk factors, related to the severity of liver disease and graft characteristics, were identified. Graft macrovesicular steatosis was the only factor independently associated with POD at multivariable analysis (OR 1.27, CI 1.09-1.51,p = 0.003). POD was associated with a higher rate of severe postoperative complications and longer intensive care unit and hospital stay, but did not significantly impact on patient and graft survival. Incidence of POD after LT is comparable to that observed after general surgery and graft factors are strongly associated with its onset. These results help identifying a subset of patients to be considered for preventive interventions.
C1 [Patrono, D.; Rigo, F.; Bormida, S.; Romagnoli, R.] Univ Turin, Gen Surg Liver Transplant Unit 2U, AOU Citta Salute & Sci Torino, Corso Bramante 88-90, I-10126 Turin, Italy.
   [Berchialla, P.] Univ Turin, Dept Clin & Biol Sci, Turin, Italy.
   [Giordanengo, L.] AOU Citta Salute & Sci Torino, Unit Med Psychol Transplantat, Reg Transplant Ctr, Turin, Italy.
   [Skurzak, S.; Balagna, R.] AOU Citta Salute & Sci Torino, Anesthesia & Intens Care Serv 2, Turin, Italy.
C3 University of Turin; A.O.U. Citta della Salute e della Scienza di
   Torino; University of Turin; A.O.U. Citta della Salute e della Scienza
   di Torino; A.O.U. Citta della Salute e della Scienza di Torino
RP Romagnoli, R (corresponding author), Univ Turin, Gen Surg Liver Transplant Unit 2U, AOU Citta Salute & Sci Torino, Corso Bramante 88-90, I-10126 Turin, Italy.
EM renato.romagnoli@unito.it
RI Patrono, Damiano/AAP-7491-2021; Patrono, Damiano/JMC-7416-2023;
   Romagnoli, Renato/AAB-9311-2019; Rigo, Federica/JVE-2198-2024;
   Berchialla, Paola/A-3208-2009
OI Patrono, Damiano/0000-0002-4096-4504; Romagnoli,
   Renato/0000-0001-8340-8885; Rigo, Federica/0000-0001-6575-1305;
   Berchialla, Paola/0000-0001-5835-5638
FU Universita degli Studi di Torino within the CRUI-CARE Agreement
FX Open access funding provided by Universita degli Studi di Torino within
   the CRUI-CARE Agreement.
CR AGGARWAL S, 1987, TRANSPLANT P, V19, P54
   Ansaloni L, 2010, BRIT J SURG, V97, P273, DOI 10.1002/bjs.6843
   Avolio AW, 2011, AM J TRANSPLANT, V11, P2724, DOI 10.1111/j.1600-6143.2011.03732.x
   Berian JR, 2018, ANN SURG, V268, P93, DOI 10.1097/SLA.0000000000002436
   Bhattacharya B, 2017, J SURG RES, V207, P223, DOI 10.1016/j.jss.2016.08.084
   Buis CI, 2002, NEUROLOGY, V59, P601, DOI 10.1212/WNL.59.4.601
   Chiu NM, 2009, PSYCHIAT CLIN NEUROS, V63, P471, DOI 10.1111/j.1440-1819.2009.01987.x
   Croome KP, 2019, LIVER TRANSPLANT, V25, P488, DOI 10.1002/lt.25408
   de Castro SMM, 2014, AM J SURG, V208, P26, DOI 10.1016/j.amjsurg.2013.12.029
   Dhar R, 2008, NEUROCRIT CARE, V8, P253, DOI 10.1007/s12028-007-9020-4
   Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae
   Ely EW, 2001, JAMA-J AM MED ASSOC, V286, P2703, DOI 10.1001/jama.286.21.2703
   Etzioni DA, 2003, ANN SURG, V238, P170, DOI 10.1097/01.SLA.0000081085.98792.3d
   Feng S, 2006, AM J TRANSPLANT, V6, P783, DOI 10.1111/j.1600-6143.2006.01242.x
   Gleason LJ, 2015, JAMA SURG, V150, P1134, DOI 10.1001/jamasurg.2015.2606
   Golse N, 2019, ANN SURG, V270, P131, DOI 10.1097/SLA.0000000000002726
   Hilmi I, 2008, LIVER TRANSPLANT, V14, P504, DOI 10.1002/lt.21381
   Hubbard RE, 2004, AGE AGEING, V33, P479, DOI 10.1093/ageing/afh164
   INOUYE SK, 1990, ANN INTERN MED, V113, P941, DOI 10.7326/0003-4819-113-12-941
   Khwaja A, 2012, NEPHRON CLIN PRACT, V120, pC179, DOI 10.1159/000339789
   Lescot T, 2013, CAN J GASTROENTEROL, V27, P207, DOI 10.1155/2013/289185
   McNeish DM, 2015, MULTIVAR BEHAV RES, V50, DOI 10.1080/00273171.2015.1036965
   Mo Y, 2013, ANN PHARMACOTHER, V47, P869, DOI 10.1345/aph.1AR708
   Neufeld KJ, 2013, J CLIN NEUROPHYSIOL, V30, P438, DOI 10.1097/WNP.0b013e3182a73e31
   Oliver N, 2017, OCHSNER J, V17, P25
   Olthoff KM, 2010, LIVER TRANSPLANT, V16, P943, DOI 10.1002/lt.22091
   Patrono D, 2019, TRANSL GASTROENT HEP, V4, DOI 10.21037/tgh.2019.08.12
   Patrono D, 2016, DIGEST LIVER DIS, V48, P414, DOI 10.1016/j.dld.2015.11.018
   Roberts Brigit, 2005, Aust Crit Care, V18, P8, DOI 10.1016/S1036-7314(05)80019-0
   Roberts H, 2005, AUST CRIT CARE, V18, P173
   Robinson TN, 2009, ANN SURG, V249, P173, DOI 10.1097/SLA.0b013e31818e4776
   Saczynski JS, 2012, NEW ENGL J MED, V367, P30, DOI 10.1056/NEJMoa1112923
   Shi QY, 2013, NEUROPSYCH DIS TREAT, V9, P1359, DOI 10.2147/NDT.S49520
   Wang SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096676
   Weerink MAS, 2017, CLIN PHARMACOKINET, V56, P893, DOI 10.1007/s40262-017-0507-7
NR 35
TC 5
Z9 6
U1 0
U2 4
PU SPRINGER-VERLAG ITALIA SRL
PI MILAN
PA VIA DECEMBRIO, 28, MILAN, 20137, ITALY
SN 2038-131X
EI 2038-3312
J9 UPDATES SURG
JI Updates Surg.
PD 2020 DEC
PY 2020
VL 72
IS 4
BP 1053
EP 1063
DI 10.1007/s13304-020-00887-3
EA SEP 2020
PG 11
WC Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Surgery
GA OU9GL
UT WOS:000572621700002
PM 32974861
OA Green Published, hybrid
DA 2024-02-19
ER

PT J
AU Thomas, RP
   Slogoff, M
   Smith, FW
   Evers, BA
AF Thomas, RP
   Slogoff, M
   Smith, FW
   Evers, BA
TI Effect of aging on the adaptive and proliferative capacity of the small
   bowel
SO JOURNAL OF GASTROINTESTINAL SURGERY
LA English
DT Article; Proceedings Paper
CT 43rd Annual Meeting of the Society-for-Surgery-of-the-Alimentary-Tract
CY MAY 19-22, 2002
CL SAN FRANCISCO, CA
SP Soc Surg Alimentary Tract
DE aging; neurotensin; small bowel resection; intestinal proliferation
ID EPITHELIAL-CELL PROLIFERATION; EPIDERMAL GROWTH-FACTOR; ELEMENTAL DIET;
   NEUROTENSIN; RATS; RESECTION; AGE; ADAPTATION; CANCER; LIVER
AB Our society is aging at a rapid rate; the effects of aging on physiologic functions (e.g., small bowel adaptation) are poorly understood. The purpose of this study was to determine the ability of the aged small bowel mucosa to adapt after resection. Young (2-month-old) and aged (24-month-old) F344 rats underwent massive (70%) proximal small bowel resection (SBR) or sham operation; rats were killed at 9 or 16 days after surgery. The remnant small bowel and corresponding sham segments were harvested, weighed, and analyzed for DNA content and villus height. To determine whether the adaptive response after SBR could be enhanced, aged rats underwent SBR or sham operation and were treated with either neurotensin or saline solution (control). SBR resulted in adaptive hyperplasia in the remaining small bowel remnant in both young and aged rats at 9 and 16 days compared with sham animals. At 9 days, significant increases were noted in weights villus height, and DNA content of the distal remnant in young and aged rats after SBR; the increases were similar in both young and aged rats. At 16 days, both young and aged rats displayed significant increases in remnant weight after SBR. Administration of neurotensin increased the weight of the remnant intestine in aged rats after SBR compared with saline treatment. Our findings demonstrate that aged small bowel mucosa exhibits a proliferative and adaptive capacity in response to SBR that was similar to that of the young animals. In addition, neurotensin administration enhanced the normal adaptive response of the small bowel in aged rats, providing further evidence that neurotensin may be therapeutically useful to augment mucosal regeneration in the early periods after massive SBR.
C1 Univ Texas, Med Branch, Dept Surg, Galveston, TX 77555 USA.
C3 University of Texas System; University of Texas Medical Branch Galveston
RP Evers, BA (corresponding author), Univ Texas, Med Branch, Dept Surg, 301 Univ Blvd, Galveston, TX 77555 USA.
EM mevers@utmb.edu
FU NIA NIH HHS [R37 AG10885] Funding Source: Medline; NIDDK NIH HHS [P01
   DK35608, T32 DK07639] Funding Source: Medline
CR ANDERSSON S, 1977, ACTA PHYSIOL SCAND, V100, P231, DOI 10.1111/j.1748-1716.1977.tb05941.x
   BACA I, 1982, DIGESTION, V23, P174, DOI 10.1159/000198725
   BOOTH CC, 1959, BRIT J SURG, V46, P403, DOI 10.1002/bjs.18004619821
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   BUCHER NLR, 1964, CANCER RES, V24, P509
   BUCHER NLR, 1950, CANCER RES, V10, P324
   BURTON K, 1956, BIOCHEM J, V62, P315, DOI 10.1042/bj0620315
   CHESKY J A, 1976, Experimental Aging Research, V2, P399, DOI 10.1080/03610737608257998
   CHUNG DH, 1992, GASTROENTEROLOGY, V103, P1254, DOI 10.1016/0016-5085(92)91512-3
   Day J.C., 1993, CURRENT POPULATION R, P25
   DEMIGUEL E, 1994, DIGEST DIS SCI, V39, P59, DOI 10.1007/BF02090061
   DESCHNER EE, 1988, CANCER, V61, P2286, DOI 10.1002/1097-0142(19880601)61:11<2286::AID-CNCR2820611124>3.0.CO;2-K
   DOWLING RH, 1967, CLIN SCI, V32, P139
   EVERS BM, 1990, ANN SURG, V211, P630
   EVERS BM, 1994, AM J PHYSIOL, V267, pG180, DOI 10.1152/ajpgi.1994.267.2.G180
   EVERS BM, 1992, DIGEST DIS SCI, V37, P426, DOI 10.1007/BF01307738
   EVERS BM, 2001, SABISTON TXB SURG BI, P873
   Fadrique B, 2001, EXP GERONTOL, V36, P1727, DOI 10.1016/S0531-5565(01)00119-X
   HANSON WR, 1982, SCAND J GASTROENTERO, V17, P11
   HANSON WR, 1977, CELL TISSUE KINET, V10, P543, DOI 10.1111/j.1365-2184.1977.tb00311.x
   HOLT PR, 1989, J GERONTOL, V44, pB9, DOI 10.1093/geronj/44.1.B9
   HOLT PR, 1988, GASTROENTEROLOGY, V95, P1556, DOI 10.1016/S0016-5085(88)80077-5
   IZUKURA M, 1990, Gastroenterology, V98, pA416
   IZUKURA M, 1992, ANN SURG, V215, P520, DOI 10.1097/00000658-199205000-00015
   KHALIL T, 1987, GASTROINTEST ENDOSC, P147
   KROPACOVA K, 1992, PHYSIOL RES, V41, P135
   LIPKIN M, 1974, CANCER, V34, P878, DOI 10.1002/1097-0142(197409)34:3+<878::AID-CNCR2820340715>3.0.CO;2-R
   OLOUGHLIN E, 1994, GASTROENTEROLOGY, V107, P87, DOI 10.1016/0016-5085(94)90064-7
   RONCUCCI L, 1988, CANCER, V62, P2373, DOI 10.1002/1097-0142(19881201)62:11<2373::AID-CNCR2820621120>3.0.CO;2-Y
   ROSENTHAL RA, 2001, SABISTON TXB SURG, P226
   Ryan C K, 1997, J Gastrointest Surg, V1, P467, DOI 10.1016/S1091-255X(97)80135-7
   Scolapio JS, 1998, GASTROENTEROL CLIN N, V27, P467, DOI 10.1016/S0889-8553(05)70014-5
   Sim FJ, 2002, J NEUROSCI, V22, P2451, DOI 10.1523/JNEUROSCI.22-07-02451.2002
   STADLER J, 1988, GUT, V29, P1326, DOI 10.1136/gut.29.10.1326
   Stern LE, 2000, MICROSC RES TECHNIQ, V51, P138, DOI 10.1002/1097-0029(20001015)51:2<138::AID-JEMT5>3.3.CO;2-K
   Tanigawa K, 1997, PANCREAS, V15, P53, DOI 10.1097/00006676-199707000-00008
   Timchenko NA, 1998, NUCLEIC ACIDS RES, V26, P3293, DOI 10.1093/nar/26.13.3293
   Wang XH, 2001, P NATL ACAD SCI USA, V98, P11468, DOI 10.1073/pnas.201360898
   Wilmore DW, 2000, WORLD J SURG, V24, P1486, DOI 10.1007/s002680010266
   WOOD JG, 1988, AM J PHYSIOL, V255, pG813, DOI 10.1152/ajpgi.1988.255.6.G813
NR 40
TC 6
Z9 7
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1091-255X
EI 1873-4626
J9 J GASTROINTEST SURG
JI J. Gastrointest. Surg.
PD JAN
PY 2003
VL 7
IS 1
BP 88
EP 95
AR PII S1091-255X(02)00128-2
DI 10.1016/S1091-255X(02)00128-2
PG 8
WC Gastroenterology & Hepatology; Surgery
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Gastroenterology & Hepatology; Surgery
GA 636WP
UT WOS:000180480500024
PM 12559189
DA 2024-02-19
ER

PT J
AU Chowdhury, KK
   Legare, DJ
   Lautt, WW
AF Chowdhury, Kawshik K.
   Legare, Dallas J.
   Lautt, W. Wayne
TI Exercise enhancement of hepatic insulin-sensitising substance-mediated
   glucose uptake in diet-induced prediabetic rats
SO BRITISH JOURNAL OF NUTRITION
LA English
DT Article
DE Insulin resistance; Exercise; Diets; Hepatic insulin-sensitising
   substance
ID SYNDROME-X; ANTIOXIDANT COCKTAIL; AGING RATS; HISS; SENSITIVITY;
   RESISTANCE; SUCROSE; MEAL; OBESITY; AMIS
AB The sensitisation of insulin action in response to a meal (i.e. meal-induced insulin sensitisation, MIS) represents one of the major means of increased glucose disposal in peripheral tissues during the postprandial state. MIS occurs when the release of hepatic insulin-sensitising substance (HISS) stimulates skeletal muscle glucose uptake. Our previous study had demonstrated that the HISS pathway is impaired in age-associated insulin resistance, and in the rats which were part of that study, voluntary exercise improved the response to insulin by restoring HISS action. The present study tests the hypothesis that voluntary exercise would reverse insulin resistance in diet-induced models of insulin resistance, and that the benefits are attributed through the improvement in HISS action. In this study, two experimental diets, a high-fat diet (for 4 weeks) and 35% sucrose solution (for 9 and 16 weeks), were used to induce insulin resistance in rats. These rats were assigned to the exercise/no-exercise intervention. The effect of 7 d voluntary running-wheel exercise was determined by measuring insulin- and HISS action in the exercised rats and comparing them with the non-exercised controls. Voluntary exercise reversed insulin resistance, caused by dietary manipulation, through restoration of the HISS action. The direct insulin action was not changed by either diet or exercise. The metabolic improvements and reduced adiposity correlated with the extent of reversal of HISS action induced by exercise. Exercise improves insulin sensitivity in diet-induced insulin resistance primarily by restoration of HISS-mediated glucose uptake.
C1 [Chowdhury, Kawshik K.; Legare, Dallas J.; Lautt, W. Wayne] Univ Manitoba, Fac Med, Dept Pharmacol & Therapeut, Winnipeg, MB R3E 0T6, Canada.
C3 University of Manitoba
RP Lautt, WW (corresponding author), Univ Manitoba, Fac Med, Dept Pharmacol & Therapeut, A210-753 McDermot Ave, Winnipeg, MB R3E 0T6, Canada.
EM wlautt@cc.umanitoba.ca
RI Lautt, W. Wayne/AAC-6106-2021; Legare, Dallas/AAC-3234-2021
OI Lautt, W. Wayne/0000-0002-7239-1798
FU Canadian Institutes of Health Research [CIHR ROP-96705]; SciMar Limited;
   CIHR Doctoral Fellowship
FX The present study was funded by operating grants from the Canadian
   Institutes of Health Research (CIHR ROP-96705) and SciMar Limited to W.
   W. L. K. K. C. was supported by a CIHR Doctoral Fellowship (2009-12).
   Manuscript preparation was assisted by Karen Sanders. We acknowledge the
   excellent daily and long-term care and monitoring of the animals
   provided by Gerry Nolette and the staff of the Central Animal Care
   Services at the University of Manitoba. The authors' contributions to
   this study were as follows: K. K. C. contributed to the design and
   conducted the study, performed data collection and analysis, data
   interpretation, and manuscript writing and review. D. J. L. and W. W. L.
   contributed to the design of the study, and manuscript writing and
   review. The authors declare that there are no conflicts of interest
   related to this study.
CR Afonso RA, 2010, BRIT J NUTR, V104, P1450, DOI 10.1017/S0007114510002400
   Boulé NG, 2001, JAMA-J AM MED ASSOC, V286, P1218, DOI 10.1001/jama.286.10.1218
   Chowdhury KK, 2011, EXP GERONTOL, V46, P73, DOI 10.1016/j.exger.2010.10.006
   Colberg SR, 2009, CURR SPORT MED REP, V8, P169, DOI 10.1249/JSR.0b013e3181ae0654
   DEFRONZO RA, 1985, J CLIN INVEST, V76, P149, DOI 10.1172/JCI111938
   Guarino MP, 2003, AM J PHYSIOL-GASTR L, V284, pG588, DOI 10.1152/ajpgi.00423.2002
   HALL CB, 1989, NUTR REP INT, V39, P627
   Kuk JL, 2008, APPL PHYSIOL NUTR ME, V33, P769, DOI 10.1139/H08-060
   LaMonte MJ, 2005, J APPL PHYSIOL, V99, P1205, DOI 10.1152/japplphysiol.00193.2005
   Latour MG, 2002, CAN J PHYSIOL PHARM, V80, P8, DOI 10.1139/Y01-094
   Lautt WW, 2008, EXP GERONTOL, V43, P790, DOI 10.1016/j.exger.2008.04.013
   Lautt WW, 2010, CAN J PHYSIOL PHARM, V88, P313, DOI 10.1139/Y09-130
   Lautt WW, 1999, CAN J PHYSIOL PHARM, V77, P553, DOI 10.1139/cjpp-77-8-553
   Lautt WW, 1998, CAN J PHYSIOL PHARM, V76, P1080, DOI 10.1139/cjpp-76-12-1080
   Lautt WW, 2004, J PHARMACOL SCI, V95, P9, DOI 10.1254/jphs.95.9
   Lautt WW, 2001, AM J PHYSIOL-GASTR L, V281, pG29, DOI 10.1152/ajpgi.2001.281.1.G29
   Ming Z, 2011, J APPL PHYSIOL, V111, P704, DOI 10.1152/japplphysiol.00057.2011
   Ming Z, 2011, J APPL PHYSIOL, V110, P60, DOI 10.1152/japplphysiol.00714.2010
   Ming Z, 2009, CAN J PHYSIOL PHARM, V87, P873, DOI 10.1139/Y09-079
   Patarrao RS, 2008, CAN J PHYSIOL PHARM, V86, P880, DOI 10.1139/Y08-080
   Ribeiro R, 2005, DIABETOLOGIA, V48, P976, DOI 10.1007/s00125-005-1714-6
   Ribeiro RT, 2008, J GERONTOL A-BIOL, V63, P560, DOI 10.1093/gerona/63.6.560
   Sadri P, 2006, BRIT J NUTR, V95, P288, DOI 10.1079/BJN20051644
   Schafer J, 2010, J PHARMACOL EXP THER, V333, P621, DOI 10.1124/jpet.109.164509
   Sigal RJ, 2006, DIABETES CARE, V29, P1433, DOI 10.2337/dc06-9910
NR 25
TC 12
Z9 15
U1 1
U2 9
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 0007-1145
EI 1475-2662
J9 BRIT J NUTR
JI Br. J. Nutr.
PD MAR 14
PY 2013
VL 109
IS 5
BP 844
EP 852
DI 10.1017/S0007114512002267
PG 9
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 097EL
UT WOS:000315456700009
PM 23021417
OA Bronze
DA 2024-02-19
ER

PT J
AU Cavallini, G
   Donati, A
   Taddei, M
   Bergamini, E
AF Cavallini, Gabriella
   Donati, Alessio
   Taddei, Michele
   Bergamini, Ettore
TI Peroxisomes proliferation and pharmacological stimulation of autophagy
   in rat liver: evidence to support that autophagy may remove the "older"
   peroxisomes
SO MOLECULAR AND CELLULAR BIOCHEMISTRY
LA English
DT Article
DE Peroxisomes; Autophagy; Perfluorooctanoic acid; Antilipolytic drugs;
   Aging; Rat liver
ID PERFLUOROOCTANOIC ACID; OXIDATIVE STRESS; SELECTIVE DEGRADATION; EXCESS
   PEROXISOMES; MAMMALIAN-CELLS; GENE-EXPRESSION; MITOCHONDRIA;
   MAINTENANCE; MITOPHAGY; PEXOPHAGY
AB Like mitochondria, peroxisomes produce reactive oxygen species (ROS), compounds which have been implicated to play an important role in many degenerative diseases and aging itself, and an exaggerated ROS production might occur in altered or older organelles. Growing evidence shows that autophagy, a required function in cell housekeeping during fasting, can remove damaged macromolecules, organelles, and membranes selectively. Proliferation of peroxisomes can be enhanced in liver cells by perfluorooctanoic acid (PFOA), which causes a marked increase of the Acyl-CoA oxidase (ACOX) activity and no significant change in urate oxidase (UOX) activity. The administration of antilipolytic drugs to fasted animals was shown to intensify autophagy. Here we tested the hypothesis that autophagy may distinguish and remove older from younger peroxisomes in rat liver. Male Sprague-Dawley rats were given PFOA (150 mg/kg body weight) or vehicle. Animals were sacrificed at different times following PFOA administration, and 3 h after the induction of autophagy with the antilipolytic agent 3,5-dimethyl pyrazole (DMP, 12 mg/kg body weight). The levels of ACOX and UOX activity were measured in the liver tissue. Results showed that autophagy caused a parallel, significant decrease in both enzymes activity in control rats, and that in PFOA-treated rats the effects were different and changed with PFOA time administration. Changes are compatible with the hypothesis that newly formed ACOX-rich peroxisomes are resistant to pexophagy and that sensitivity to pexophagy increases with increasing peroxisomal "age." In conclusion, there is indirect evidence supporting the hypothesis that autophagy may recognize and degrade older peroxisomes.
C1 [Cavallini, Gabriella; Donati, Alessio; Taddei, Michele; Bergamini, Ettore] Univ Pisa, Interdept Res Ctr Biol & Pathol Aging, Via Roma 55, I-56126 Pisa, Italy.
C3 University of Pisa
RP Cavallini, G (corresponding author), Univ Pisa, Interdept Res Ctr Biol & Pathol Aging, Via Roma 55, I-56126 Pisa, Italy.
EM gabriella.cavallini@med.unipi.it
CR ABDELLATIF AG, 1990, CARCINOGENESIS, V11, P1899, DOI 10.1093/carcin/11.11.1899
   Badr MZ, 2004, MECH AGEING DEV, V125, P69, DOI 10.1016/j.mad.2003.10.006
   Cavallini G, 2007, AUTOPHAGY, V3, P26, DOI 10.4161/auto.3268
   Cavallini G, 2014, AGING CLIN EXP RES, V26, P13, DOI 10.1007/s40520-013-0116-8
   CRANE DI, 1990, MOL CELL BIOCHEM, V96, P153, DOI 10.1007/BF00420907
   CUBEDDU TL, 1985, BIOCHIM BIOPHYS ACTA, V839, P96, DOI 10.1016/0304-4165(85)90186-2
   Cuervo AM, 2004, MOL CELL BIOCHEM, V263, P55, DOI 10.1023/B:MCBI.0000041848.57020.57
   Donati A, 2004, EXP GERONTOL, V39, P1061, DOI 10.1016/j.exger.2004.03.025
   Donati A, 2008, BIOCHEM BIOPH RES CO, V366, P786, DOI 10.1016/j.bbrc.2007.12.023
   Donati A, 2009, METHOD ENZYMOL, V452, P441, DOI 10.1016/S0076-6879(08)03626-4
   Erdmann R, 2016, BBA-MOL CELL RES, V1863, P787, DOI 10.1016/j.bbamcr.2016.01.020
   FLATMARK T, 1981, EUR J CELL BIOL, V24, P62
   Fransen Marc, 2013, Subcell Biochem, V69, P45, DOI 10.1007/978-94-007-6889-5_3
   HAYASHI H, 1971, BIOCHIM BIOPHYS ACTA, V252, P58, DOI 10.1016/0304-4165(71)90092-4
   Honsho M, 2016, BBA-MOL CELL RES, V1863, P984, DOI 10.1016/j.bbamcr.2015.09.032
   Hubbard VM, 2012, BIOGERONTOLOGY, V13, P21, DOI 10.1007/s10522-011-9331-x
   Huybrechts SJ, 2009, TRAFFIC, V10, P1722, DOI 10.1111/j.1600-0854.2009.00970.x
   INESTROSA NC, 1979, BIOCHEM J, V182, P779, DOI 10.1042/bj1820779
   Islinger M, 2012, HISTOCHEM CELL BIOL, V137, P547, DOI 10.1007/s00418-012-0941-4
   Iwata J, 2006, J BIOL CHEM, V281, P4035, DOI 10.1074/jbc.M512283200
   Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034
   Kim J, 2000, ANNU REV BIOCHEM, V69, P303, DOI 10.1146/annurev.biochem.69.1.303
   Kim PK, 2006, J CELL BIOL, V173, P521, DOI 10.1083/jcb.200601036
   Knuppertz L, 2016, MECH AGEING DEV, V153, P30, DOI 10.1016/j.mad.2016.01.003
   Kudo N, 2006, BIOL PHARM BULL, V29, P1952, DOI 10.1248/bpb.29.1952
   LAZAROW PB, 1976, P NATL ACAD SCI USA, V73, P2043, DOI 10.1073/pnas.73.6.2043
   López-Erauskin J, 2013, HUM MOL GENET, V22, P3296, DOI 10.1093/hmg/ddt186
   Lopez-Huertas E, 2000, EMBO J, V19, P6770, DOI 10.1093/emboj/19.24.6770
   Montecucco F, 2011, AM J PHYSIOL-ENDOC M, V300, pE681, DOI 10.1152/ajpendo.00527.2010
   Oku M, 2016, BBA-MOL CELL RES, V1863, P992, DOI 10.1016/j.bbamcr.2015.09.023
   Pan J, 2005, J ELECTRON MICROSC, V54, P385, DOI 10.1093/jmicro/dfi048
   PFEIFER U, 1978, J CELL BIOL, V78, P152, DOI 10.1083/jcb.78.1.152
   Pomatto LCD, 2017, BIOL REV, V92, P739, DOI 10.1111/brv.12253
   Santos RX, 2014, MOL CELL BIOCHEM, V394, P13, DOI 10.1007/s11010-014-2076-5
   Schönenberger MJ, 2015, AUTOPHAGY, V11, P967, DOI 10.1080/15548627.2015.1045180
   Schrader M, 2006, BBA-MOL CELL RES, V1763, P1755, DOI 10.1016/j.bbamcr.2006.09.006
   Schrader M, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00056
   Sentelle RD, 2012, NAT CHEM BIOL, V8, P1008, DOI 10.1038/nchembio1212-1008c
   Sentelle RD, 2012, NAT CHEM BIOL, V8, P831, DOI 10.1038/NCHEMBIO.1059
   Till Andreas, 2012, Int J Cell Biol, V2012, P512721, DOI 10.1155/2012/512721
   Titorenko VI, 2011, TRAFFIC, V12, P252, DOI 10.1111/j.1600-0854.2010.01144.x
   van Zutphen T, 2011, AUTOPHAGY, V7, P863, DOI 10.4161/auto.7.8.15697
   Wanders RJA, 2014, BIOCHIMIE, V98, P36, DOI 10.1016/j.biochi.2013.08.022
   Wang B, 2013, FREE RADICAL BIO MED, V65, P882, DOI 10.1016/j.freeradbiomed.2013.08.173
   Waterham HR, 2016, BBA-MOL CELL RES, V1863, P922, DOI 10.1016/j.bbamcr.2015.11.015
   Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814
   Yokota S, 2009, HISTOCHEM CELL BIOL, V131, P455, DOI 10.1007/s00418-009-0564-6
   Youssef J, 1997, MOL CELL BIOCHEM, V169, P143, DOI 10.1023/A:1006806820951
NR 48
TC 5
Z9 6
U1 0
U2 10
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0300-8177
EI 1573-4919
J9 MOL CELL BIOCHEM
JI Mol. Cell. Biochem.
PD JUL
PY 2017
VL 431
IS 1-2
BP 97
EP 102
DI 10.1007/s11010-017-2979-z
PG 6
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA EX7GJ
UT WOS:000403416000011
PM 28255846
OA Green Submitted
DA 2024-02-19
ER

PT J
AU CHATTERJEE, B
   SONG, CS
   KIM, JM
   ROY, AK
AF CHATTERJEE, B
   SONG, CS
   KIM, JM
   ROY, AK
TI ANDROGEN AND ESTROGEN SULFOTRANSFERASES OF THE RAT-LIVER -
   PHYSIOLOGICAL-FUNCTION, MOLECULAR-CLONING, AND IN-VITRO EXPRESSION
SO CHEMICO-BIOLOGICAL INTERACTIONS
LA English
DT Article; Proceedings Paper
CT 2nd International Workshop on Sulfation of Xenobiotics and Endogenous
   Compounds
CY JUN 03-06, 1993
CL SAMUEL ROBERTS NOBLE FDN, ARDMORE, OK
SP SAMUEL ROBERTS NOBLE FDN
HO SAMUEL ROBERTS NOBLE FDN
DE STEROID SULFOTRANSFERASE; RECOMBINANT SULFOTRANSFERASE; LIVER; SEX
   HORMONE ACTION; BACULOVIRAL EXPRESSION; AGING
ID MESSENGER-RNA; STEROID SULFOTRANSFERASES; GENE; ALPHA-2U-GLOBULIN;
   HORMONE; SMP-2; CDNA
AB Cloning of the androgen and estrogen sulfotransferases has allowed studies on their spatiotemporal regulation and physiological function. These two enzymes appear to be involved in regulating target cell sensitivity for the androgenic and estrogenic steroids. Recombinant androgen sulfotransferase produced in insect Sf9 cells through a baculoviral expression vector is capable of transferring the sulfate from PAPS (phosphoadenosine phosphosulfate) to 3 alpha, 3 beta, 17 alpha, and 17 beta hydroxyl groups of a number of steroid substrates indicating a broad range of substrate specificity.
C1 UNIV TEXAS,HLTH SCI CTR,DEPT CELLULAR & STRUCT BIOL,SAN ANTONIO,TX 78284.
C3 University of Texas System; University of Texas Health Science Center at
   San Antonio
FU NIA NIH HHS [P01 AG06872, R01 AG 03527] Funding Source: Medline; NIDDK
   NIH HHS [R-37 DK 14744] Funding Source: Medline
CR ANDERSON KM, 1968, NATURE, V219, P277, DOI 10.1038/219277a0
   BROOKS SC, 1987, J STEROID BIOCHEM, V26, P285, DOI 10.1016/0022-4731(87)90084-7
   BRUCHOVSKY N, 1968, J BIOL CHEM, V243, P2012
   BUIRCHELL BJ, 1975, J STEROID BIOCHEM, V6, P1489, DOI 10.1016/0022-4731(75)90202-2
   CHATTERJEE B, 1987, J BIOL CHEM, V262, P822
   CHATTERJEE B, 1940, BIOCHIM BIOPHYS ACTA, V1034, P162
   DEMYAN WF, 1992, MOL ENDOCRINOL, V6, P589, DOI 10.1210/me.6.4.589
   GURPIDE E, 1978, J TOXICOL ENV HEALTH, V4, P249, DOI 10.1080/15287397809529660
   HOBKIRK R, 1985, CAN J BIOCHEM CELL B, V63, P1127, DOI 10.1139/o85-141
   HOMMA H, 1992, BIOCHEM BIOPH RES CO, V183, P872, DOI 10.1016/0006-291X(92)90564-2
   LUCKOW VA, 1988, BIO-TECHNOL, V6, P47, DOI 10.1038/nbt0188-47
   MANCINI MA, 1992, ENDOCRINOLOGY, V131, P1541, DOI 10.1210/en.131.3.1541
   MANCINI MA, 1991, J HISTOCHEM CYTOCHEM, V39, P401, DOI 10.1177/39.4.1706374
   MONDER C, 1991, FASEB J, V5, P3047, DOI 10.1096/fasebj.5.15.1743437
   NASH AR, 1988, AUST J BIOL SCI, V41, P507
   OEDA T, 1992, MOL ENDOCRINOL, V6, P1216, DOI 10.1210/me.6.8.1216
   OGURA J, 1990, BIOCHEM BIOPH RES CO, V165, P168
   PACK BA, 1979, J CLIN ENDOCR METAB, V48, P420, DOI 10.1210/jcem-48-3-420
   ROY AK, 1983, RECENT PROG HORM RES, V39, P425
   ROY AK, 1992, P SOC EXP BIOL MED, V199, P265
   ROY AK, 1983, ANNU REV PHYSIOL, V45, P37, DOI 10.1146/annurev.ph.45.030183.000345
   SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7
   SONG CS, 1990, BIOCHEMISTRY-US, V29, P542, DOI 10.1021/bi00454a031
   SONG CS, 1991, ENDOCRINOLOGY, V128, P349, DOI 10.1210/endo-128-1-349
   SUPAKAR PC, 1993, J BIOL CHEM, V268, P26400
   TSENG L, 1980, 8TH P BROOK LODG C P
NR 26
TC 24
Z9 26
U1 2
U2 3
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0009-2797
J9 CHEM-BIOL INTERACT
JI Chem.-Biol. Interact.
PD JUN
PY 1994
VL 92
IS 1-3
BP 273
EP 279
DI 10.1016/0009-2797(94)90069-8
PG 7
WC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Toxicology
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Toxicology
GA PD138
UT WOS:A1994PD13800023
PM 8033260
DA 2024-02-19
ER

PT J
AU Zillich, L
   Wagner, J
   McMahan, RH
   Park, LM
   Hodgkinson, C
   Kovacs, EJ
   Lohoff, FW
AF Zillich, Lea
   Wagner, Josephin
   McMahan, Rachel H.
   Park, Lauren M.
   Hodgkinson, Colin
   Kovacs, Elizabeth J.
   Lohoff, Falk W.
TI Multi-omics analysis of alcohol effects on the liver in young and aged
   mice
SO ADDICTION BIOLOGY
LA English
DT Article
DE ageing; binge drinking; DNA methylation; gene expression
ID ETHANOL EXPOSURE; USE DISORDER; METABOLISM; PACKAGE; PATHOPHYSIOLOGY;
   BIOCONDUCTOR; EPIGENETICS; TOXICITY; SEX
AB Excessive alcohol consumption has detrimental effects on the entire organism, especially on the liver. The toxicity is partly dependent on age, as older individuals metabolize alcohol more slowly leading to increased cellular injury. This study aimed to investigate the effects of moderate binge drinking on the liver of young and aged mice in a genome-wide multi-omics approach. We determined DNA methylation (DNAm) using the Illumina MouseMethylation array and gene expression by RNA sequencing in 18 female Balb/c mice in a 2 x 2 design. The animals underwent three moderate binge drinking cycles (ethanol vs. vehicle) and liver tissue was harvested at 4 or 19 months of age. We tested differential gene expression (DE) and DNAm associated with ethanol intake in linear models separately in young and aged mice, performed enrichment analyses for pathways and GWAS signatures of problematic alcohol use, and analysed the overlap of DNAm and gene expression. We observed DE in young and aged animals and substantial overlap in genes such as Bhlhe40, Klf10, and Frmd8. DE genes in aged animals were enriched for biological processes related to alcohol metabolism, inflammation, liver fibrosis, and GWAS signatures of problematic alcohol use. We identified overlapping signatures from DNAm and gene expression, for example, Frmd8 in aged and St6galnac4 in young mice. This study offers converging evidence of novel age-related targets in a moderate alcohol consumption model highlighting dysregulations in genes related to alcohol metabolism, inflammation, and liver fibrosis. Future studies are needed to confirm these results and elucidate the underlying mechanisms.
   Young and aged female mice were treated with ethanol in a moderate binge drinking paradigm. Liver tissue was harvested and DNA methylation and gene expression levels were determined.image
C1 [Zillich, Lea; Wagner, Josephin; Park, Lauren M.; Lohoff, Falk W.] Natl Inst Alcohol Abuse & Alcoholism, NIH, Sect Clin Genom & Expt Therapeut, 10 Ctr Dr,10CRC-2-2352, Bethesda, MD 20892 USA.
   [Zillich, Lea] Cent Inst Mental Hlth, Dept Genet Epidemiol Psychiat, Mannheim, Germany.
   [McMahan, Rachel H.; Kovacs, Elizabeth J.] Univ Colorado Denver, Dept Surg, Alcohol Res Program, Burn Res Program,Div GI Trauma & Endocrine Surg, Aurora, CO USA.
   [McMahan, Rachel H.; Kovacs, Elizabeth J.] Univ Colorado Denver, GI & Liver Innate Immune Program, Anschutz Med Campus, Aurora, CO 80045 USA.
   [Hodgkinson, Colin] Natl Inst Alcohol Abuse & Alcoholism, Natl Inst Mental Hlth, Lab Neurogenet, Bethesda, MD USA.
   [Kovacs, Elizabeth J.] Rocky Mt Reg Vet Affairs Med Ctr RMRVAMC, Eastern Colorado Hlth Care Syst, Vet Hlth Adm, Aurora, CO 80045 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute on
   Alcohol Abuse & Alcoholism (NIAAA); Central Institute of Mental Health;
   University of Colorado System; University of Colorado Anschutz Medical
   Campus; Children's Hospital Colorado; Children's Hospital Colorado;
   University of Colorado System; University of Colorado Anschutz Medical
   Campus; National Institutes of Health (NIH) - USA; NIH National
   Institute of Mental Health (NIMH); NIH National Institute on Alcohol
   Abuse & Alcoholism (NIAAA); US Department of Veterans Affairs; Veterans
   Health Administration (VHA)
RP Lohoff, FW (corresponding author), Natl Inst Alcohol Abuse & Alcoholism, NIH, Sect Clin Genom & Expt Therapeut, 10 Ctr Dr,10CRC-2-2352, Bethesda, MD 20892 USA.
EM falk.lohoff@nih.gov
OI Wagner, Josephin/0000-0002-8880-5721; Zillich, Lea/0000-0001-7457-374X
FU This work was supported by the National Institutes of Health (NIH)
   intramural funding [ZIA-AA000242 to F.W.L]; Division of Intramural
   Clinical and Biological Research of the National Institute on Alcohol
   Abuse and Alcoholism (NIAAA). Additional support was [ZIA-AA000242];
   National Institutes of Health (NIH); Division of Intramural Clinical and
   Biological Research of the National Institute on Alcohol Abuse and
   Alcoholism (NIAAA) [R01 AG018859, R35 GM131831, R21 AA026295, 1 I01
   BX004335]; NIH
FX This work was supported by the National Institutes of Health (NIH)
   intramural funding [ZIA-AA000242 to F.W.L]; Division of Intramural
   Clinical and Biological Research of the National Institute on Alcohol
   Abuse and Alcoholism (NIAAA). Additional support was provided by NIH R01
   AG018859 to E.J.K, R35 GM131831 to E.J.K.; R21 AA026295 to E.J.K and VA
   Merit Award Application 1 I01 BX004335 to E.J.K. This work utilized the
   computational resources of the NIH HPC Biowulf cluster (). We thank
   Chiara Herzog for the helpful discussions about the Illumina mouse
   methylation array and for developing the
   IlluminaMouseMethylationmanifest.
CR Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049
   Bell AS., 2022, Cholesterol, P747, DOI [10.1016/B978-0-323-85857-1.00036-5, DOI 10.1016/B978, DOI 10.1016/B978-0-323-85857-1.00036-5]
   Carlson M.., 2019, ORG HS EG DB GENOME
   Cederbaum AI, 2012, CLIN LIVER DIS, V16, P667, DOI 10.1016/j.cld.2012.08.002
   Chen MM, 2014, EXP GERONTOL, V54, P42, DOI 10.1016/j.exger.2013.12.010
   Curtis BJ, 2014, ALCOHOL CLIN EXP RES, V38, P1347, DOI 10.1111/acer.12369
   de Leeuw CA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004219
   Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525
   Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97
   Erol A, 2015, DRUG ALCOHOL DEPEN, V156, P1, DOI 10.1016/j.drugalcdep.2015.08.023
   Flurkey K., 2007, Mouse Models in Aging Research, V2nd, DOI [10.1016/B978-012369454-6/50074-1, DOI 10.1016/B978]
   Friso S, 2017, MOL ASPECTS MED, V54, P28, DOI 10.1016/j.mam.2016.11.007
   Gartner U, 1996, Z GASTROENTEROL, V34, P675
   Gibney ER, 2010, HEREDITY, V105, P4, DOI 10.1038/hdy.2010.54
   Gomez KU, 2023, BMC PSYCHIATRY, V23, DOI 10.1186/s12888-023-04577-3
   Guerrero L, 2022, METABOLITES, V12, DOI 10.3390/metabo12090779
   Heo MJ, 2019, GUT, V68, P708, DOI 10.1136/gutjnl-2017-315123
   Karim S, 2012, WORLD J GASTROENTERO, V18, P6771, DOI 10.3748/wjg.v18.i46.6771
   Kasahara Y, 2023, J ENDOCRINOL, V257, DOI 10.1530/JOE-22-0254
   Keyes KM, 2022, ALCOHOL RES-CURR REV, V42, DOI 10.35946/arcr.v42.1.02
   Künzel U, 2018, ELIFE, V7, DOI 10.7554/eLife.35012
   Lee J, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22010331
   Liu C, 2018, MOL PSYCHIATR, V23, P422, DOI 10.1038/mp.2016.192
   Lohoff FW, 2022, MOL PSYCHIATR, V27, P1754, DOI 10.1038/s41380-021-01378-6
   Lohoff FW, 2020, PHARMACOGENOMICS, V21, P1117, DOI 10.2217/pgs-2020-0079
   Lohoff FW, 2021, MOL PSYCHIATR, V26, P2224, DOI 10.1038/s41380-020-0734-4
   Longley MJ, 2021, ADDICT BIOL, V26, DOI 10.1111/adb.13006
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Luo A, 2020, NEUROPSYCHOPHARMACOL, V45, P327, DOI 10.1038/s41386-019-0500-y
   Maeda K, 2022, AM J DRUG ALCOHOL AB, V48, P302, DOI 10.1080/00952990.2022.2037137
   McCaul ME, 2019, ALCOHOL CLIN EXP RES, V43, P774, DOI 10.1111/acer.13985
   McMahan RH, 2023, ALCOHOL, V107, P136, DOI 10.1016/j.alcohol.2022.08.011
   McMahan RH, 2021, IMMUN AGEING, V18, DOI 10.1186/s12979-021-00247-8
   Meier P, 2008, CURR OPIN CLIN NUTR, V11, P21, DOI 10.1097/MCO.0b013e3282f30564
   MENDENHALL CL, 1993, ALCOHOL ALCOHOLISM, V28, P675
   O'Farrell M, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-19459-z
   Rachdaoui N, 2017, ALCOHOL RES-CURR REV, V38, P255
   Rosoff DB, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.5844
   Schmidt-Arras D, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8101226
   Seitz HK, 2007, CLIN GERIATR MED, V23, P905, DOI 10.1016/j.cger.2007.06.010
   SEITZ HK, 1993, GUT, V34, P1433, DOI 10.1136/gut.34.10.1433
   SEITZ HK, 1989, GASTROENTEROLOGY, V97, P446, DOI 10.1016/0016-5085(89)90082-6
   Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110
   Tice AL, 2023, J BIOL RHYTHM, V38, P159, DOI 10.1177/07487304221141464
   Towers EB, 2023, PHARMACOL REV, V75, P217, DOI 10.1124/pharmrev.121.000361
   Wagner JR, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r37
   Wang QY, 2019, NAT METAB, V1, P251, DOI 10.1038/s42255-018-0020-9
   Wedemeyer F, 2020, CURR ADDICT REP, V7, P446, DOI 10.1007/s40429-020-00331-x
   Xu YK, 2022, J ONCOL, V2022, DOI 10.1155/2022/7204415
   Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118
   Zhang N, 2023, FRONT IMMUNOL, V14, DOI 10.3389/fimmu.2023.1148722
   Zhang Y, 2020, LIFE SCI, V263, DOI 10.1016/j.lfs.2020.118670
   Zhou H, 2020, NAT NEUROSCI, V23, P809, DOI 10.1038/s41593-020-0643-5
   Zillich L, 2022, NEUROPSYCHOPHARMACOL, V47, P832, DOI 10.1038/s41386-021-01228-7
NR 54
TC 1
Z9 1
U1 1
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1355-6215
EI 1369-1600
J9 ADDICT BIOL
JI Addict. Biol.
PD DEC
PY 2023
VL 28
IS 12
AR e13342
DI 10.1111/adb.13342
PG 10
WC Biochemistry & Molecular Biology; Substance Abuse
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Substance Abuse
GA X8IF0
UT WOS:001100812200001
PM 38017640
OA hybrid
DA 2024-02-19
ER

PT J
AU Cogger, VC
   McNerney, GP
   Nyunt, T
   DeLeve, LD
   McCourt, P
   Smedsrod, B
   Le Couteur, DG
   Huser, TR
AF Cogger, Victoria C.
   McNerney, Gregory P.
   Nyunt, Tun
   DeLeve, Laurie D.
   McCourt, Peter
   Smedsrod, Bard
   Le Couteur, David G.
   Huser, Thomas R.
TI Three-dimensional structured illumination microscopy of liver sinusoidal
   endothelial cell fenestrations
SO JOURNAL OF STRUCTURAL BIOLOGY
LA English
DT Article
DE Structured illumination microscopy; Liver sinusoidal endothelial cell;
   Fenestrations; Nitric oxide synthase; Actin
ID GROWTH-FACTOR; RAT; SIEVE; CAVEOLIN-1; CIRRHOSIS; ACTIN; AGE
AB Fenestrations are pores in liver sinusoidal endothelial cells that filter substrates and debris between the blood and hepatocytes. Fenestrations have significant roles in aging and the regulation of lipoproteins. However their small size (<200 nm) has prohibited any functional analysis by light microscopy. We employed structured illumination light microscopy to observe fenestrations in isolated rat liver sinusoidal endothelial cells with great clarity and spatial resolution. With this method, the three-dimensional structure of fenestrations (diameter 123 +/- 24 nm) and sieve plates was elucidated and it was shown that fenestrations occur in areas of abrupt cytoplasmic thinning (165 +/- 54 nm vs. 292 +/- 103 nm in non-fenestrated regions, P < 0.0001). Sieve plates were not preferentially co-localized with fluorescently labeled F-actin stress fibers and endothelial nitric oxide synthase but appeared to occur in primarily attenuated non-raft regions of the cell membrane. Labyrinthine structures were not seen and all fenestrations were short cylindrical pores. In conclusion, three-dimensional structured illumination microscopy has enabled the unlimited power of fluorescent immunostaining and co-localization to reveal new structural and functional information about fenestrations and sieve plates. (C) 2010 Elsevier Inc. All rights reserved.
C1 [Cogger, Victoria C.; Le Couteur, David G.] Univ Sydney, Sydney Med Sch, Ctr Educ & Res Ageing, Sydney, NSW 2139, Australia.
   [Cogger, Victoria C.; Le Couteur, David G.] Univ Sydney, Sydney Med Sch, ANZAC Res Inst, Sydney, NSW 2139, Australia.
   [Cogger, Victoria C.; Le Couteur, David G.] Concord RG Hosp, Sydney, NSW 2139, Australia.
   [McNerney, Gregory P.; Nyunt, Tun; Huser, Thomas R.] Univ Calif Davis, NSF Ctr Biophoton Sci & Technol, Sacramento, CA 95817 USA.
   [DeLeve, Laurie D.] Univ So Calif, Keck Sch Med, Div Gastrointestinal & Liver Dis, Los Angeles, CA 90033 USA.
   [DeLeve, Laurie D.] Univ So Calif, Keck Sch Med, USC Res Ctr Liver Dis, Los Angeles, CA 90033 USA.
   [McCourt, Peter; Smedsrod, Bard] Univ Tromso, Inst Med Biol, Vasc Biol Res Grp, N-9001 Tromso, Norway.
   [Huser, Thomas R.] Univ Calif Davis, Med Ctr, Dept Internal Med, Sacramento, CA 95817 USA.
C3 University of Sydney; University of Sydney; ANZAC Research Institute;
   Concord Repatriation General Hospital; National Science Foundation
   (NSF); University of California System; University of California Davis;
   University of Southern California; University of Southern California;
   UiT The Arctic University of Tromso; University of California System;
   University of California Davis
RP Le Couteur, DG (corresponding author), Univ Sydney, Sydney Med Sch, Ctr Educ & Res Ageing, Sydney, NSW 2139, Australia.
EM victoria.cogger@sydney.edu.au; greg.mcnerney@cbst.ucdavis.edu;
   mtnyunt@ucdavis.edu; deleve@usc.edu; peter.mccourt@uit.no;
   bard.smedsrod@uit.no; david.lecouteur@sydney.edu.au; trhuser@ucdavis.edu
RI DeLeve, Laurie D/F-3549-2012; Research Institute, ANZAC/CAE-9030-2022;
   Huser, Thomas/K-7291-2019; McCourt, Peter/B-3043-2009
OI Huser, Thomas/0000-0003-2348-7416; McCourt, Peter/0000-0001-5072-4590;
   Smedsrod, Bard/0000-0002-3308-8948; Le Couteur,
   David/0000-0002-4227-5817
FU American Heart Association; National Science Foundation; National Center
   for Research Resources (NCRR) [UL1 RR024146]; National Institutes of
   Health [DK66423]; National Institutes of Health and National Institute
   of Aging [AG026582]; Australian National Health and Medical Research
   Council; Ageing and Alzheimers Research Foundation
FX This work was supported in part by the American Heart Association
   through the Grant-in-Aid program, and in part by funding from the
   National Science Foundation. The Center for Biophotonics, an NSF Science
   and Technology Center, is managed by the University of California,
   Davis, under Cooperative Agreement No. PHY 0120999. Support is also
   acknowledged from: the UCD Clinical Translational Science Center under
   Grant Number UL1 RR024146 from the National Center for Research
   Resources (NCRR); National Institutes of Health Grant DK66423; National
   Institutes of Health and National Institute of Aging Grant AG026582; the
   Australian National Health and Medical Research Council and; the Ageing
   and Alzheimers Research Foundation (a division of the Medical Foundation
   of the University of Sydney).
CR Baker R.W., 2004, Membrane Technology and Applications, P15, DOI [DOI 10.1002/0470020393.CH2, 10.1002/0470020393.ch2]
   Braet F, 2003, HEPATOLOGY, V38, P394, DOI 10.1053/jhep.2003.50347
   Braet F, 1996, HEPATOLOGY, V24, P627
   Braet F, 2007, MICROSC RES TECHNIQ, V70, P230, DOI 10.1002/jemt.20408
   Carlton PM, 2008, CHROMOSOME RES, V16, P351, DOI 10.1007/s10577-008-1231-9
   Cogger VC, 2009, LIVER BIOL PATHOBIOL, P387
   Cogger VC, 2008, AM J PHYSIOL-GASTR L, V295, pG137, DOI 10.1152/ajpgi.00069.2008
   DeLeve LD, 2006, AM J PHYSIOL-GASTR L, V291, pG1187, DOI 10.1152/ajpgi.00229.2006
   FRASER R, 1995, HEPATOLOGY, V21, P863, DOI 10.1016/0270-9139(95)90542-1
   Hilmer SN, 2005, HEPATOLOGY, V42, P1349, DOI 10.1002/hep.20937
   Huser T, 2008, CURR OPIN CHEM BIOL, V12, P497, DOI 10.1016/j.cbpa.2008.08.012
   KWOK W, 2009, AM J PHYSL GASTROINT
   Le Couteur DG, 2008, ANAT REC, V291, P672, DOI 10.1002/ar.20661
   Le Couteur DG, 2005, CLIN PHARMACOKINET, V44, P187, DOI 10.2165/00003088-200544020-00004
   Lippincott-Schwartz J, 2009, NAT METHODS, V6, P21, DOI [10.1038/NMETH.F.233, 10.1038/nmeth.f.233]
   Merkel SM, 2005, MICROCIRCULATION, V12, P433, DOI 10.1080/10739680590960377
   Nagai Toshihiro, 2004, Medical Electron Microscopy, V37, P252, DOI 10.1007/s00795-004-0262-3
   Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947
   Warren A, 2006, HEPATOLOGY, V44, P1182, DOI 10.1002/hep.21378
   Warren A, 2010, MICROCIRCULATION, V17, P32, DOI 10.1111/j.1549-8719.2009.00004.x
   WISSE E, 1985, HEPATOLOGY, V5, P683, DOI 10.1002/hep.1840050427
   Yokomori H, 2004, LAB INVEST, V84, P857, DOI 10.1038/labinvest.3700114
   Yokomori H, 2003, LIVER INT, V23, P467, DOI 10.1111/j.1478-3231.2003.00880.x
   Yokomori H, 2001, LIVER, V21, P198, DOI 10.1034/j.1600-0676.2001.021003198.x
NR 24
TC 71
Z9 80
U1 0
U2 20
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1047-8477
EI 1095-8657
J9 J STRUCT BIOL
JI J. Struct. Biol.
PD SEP
PY 2010
VL 171
IS 3
BP 382
EP 388
DI 10.1016/j.jsb.2010.06.001
PG 7
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 635TS
UT WOS:000280680100015
PM 20570732
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Koh, M
   Okamoto, E
   Yamanaka, J
   Fujimoto, J
AF Koh, M
   Okamoto, E
   Yamanaka, J
   Fujimoto, J
TI Impact of donor age on the growth of young recipient rats after liver
   transplantation
SO SURGERY TODAY
LA English
DT Article
DE aging; rat; orthotopic liver transplantation; donor age; developmental
   growth
ID PROTEIN-SYNTHESIS; HEPATOCYTES; PATIENT
AB Purpose: We studied the age-related changes in graft livers, and their impact on post-transplantation liver function and the growth of young recipient rats.
   Results: Rats aged 11-68 weeks old were studied as controls to assess liver histology, liver function, and body weight. We performed orthotopic liver transplantation using Kamada's cuff technique without arterial reconstruction. Young rats aged 11 weeks were randomized to receive livers from either 11-week-old donors (YD group) or 52-week-old donors (OD group). Recipient rats were killed 0, 8, or 16 weeks after surgery and we assessed the same variables as in the controls.
   Methods: We confirmed an age-related increase in the average size of hepatocytes and their nuclei. These age-related changes persisted and progressed in the graft liver after transplantation. There were no significant differences in the levels of serum transaminases or total bilirubin between the YD and OD groups, but the serum albumin level was significantly lower in the OD group. The YD group grew normally, whereas the OD group recipients lagged significantly in gaining body weight.
   Conclusions: We found that 52-week-old grafts transplanted into 11-week-old recipients resulted in deficient growth and a decline in serum albumin, suggesting that grafted old livers fail to produce enough protein to meet the demands of growth adequately.
C1 Hyogo Med Univ, Dept Surg 1, Nishinomiya, Hyogo 6638501, Japan.
   Kyoritsu Hosp, Dept Surg, Kawanishi, Japan.
   Amagasaki Cent Hosp, Dept Surg, Amagasaki, Hyogo, Japan.
C3 Hyogo College of Medicine; University of Hyogo
RP Fujimoto, J (corresponding author), Hyogo Med Univ, Dept Surg 1, Nishinomiya, Hyogo 6638501, Japan.
CR Busquets J, 2001, TRANSPLANTATION, V71, P1765, DOI 10.1097/00007890-200106270-00011
   Detre K M, 1995, Liver Transpl Surg, V1, P311, DOI 10.1002/lt.500010507
   Fernández-Merino FJ, 2003, TRANSPLANT P, V35, P1795, DOI 10.1016/S0041-1345(03)00594-3
   GREENBLATT DJ, 1979, J AM GERIATR SOC, V27, P20, DOI 10.1111/j.1532-5415.1979.tb01715.x
   Ikegami T, 2000, TRANSPLANTATION, V70, P1703, DOI 10.1097/00007890-200012270-00007
   ISHIKAWA M, 1994, SURG TODAY, V24, P403, DOI 10.1007/BF01427032
   KAMADA N, 1979, TRANSPLANTATION, V28, P47, DOI 10.1097/00007890-197907000-00011
   KELLY DA, 1997, LIVER TRANSPLANT, V3, P32
   MAKUUCHI M, 1992, SURG TODAY, V22, P297, DOI 10.1007/BF00308735
   McDiarmid SV, 1999, TRANSPLANTATION, V67, P404, DOI 10.1097/00007890-199902150-00011
   Oh CK, 2000, CLIN TRANSPLANT, V14, P386, DOI 10.1034/j.1399-0012.2000.14040502.x
   Ohhama Y, 1998, SURG TODAY, V28, P173, DOI 10.1007/s005950050101
   Sakai Y, 1997, HEPATOLOGY, V25, P421
   SARNA S, 1995, PEDIATR RES, V38, P366, DOI 10.1203/00006450-199509000-00016
   Schmucker DL, 1998, J GERONTOL A-BIOL, V53, pB315, DOI 10.1093/gerona/53A.5.B315
   STUPINA AS, 1988, B EXP BIOL MED+, V105, P451, DOI 10.1007/BF00835777
   TIETZ NW, 1992, CLIN CHEM, V38, P1167
   VISKUP RW, 1979, EXP AGING RES, V5, P487, DOI 10.1080/03610737908257223
   WARD W, 1991, HEPATOLOGY, V14, P935, DOI 10.1002/hep.1840140529
   WARD WF, 1988, J GERONTOL, V43, pB50, DOI 10.1093/geronj/43.2.B50
   WATANABE T, 1978, VIRCHOWS ARCH B, V27, P307
NR 21
TC 4
Z9 5
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0941-1291
EI 1436-2813
J9 SURG TODAY
JI Surg. Today
PD MAY
PY 2006
VL 36
IS 5
BP 457
EP 464
DI 10.1007/s00595-005-3183-4
PG 8
WC Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Surgery
GA 035EP
UT WOS:000236983500011
PM 16633753
DA 2024-02-19
ER

PT J
AU Kim, KC
   Jang, H
   Sauer, J
   Zimmerly, EM
   Liu, ZH
   Chanson, A
   Smith, DE
   Friso, S
   Choi, SW
AF Kim, Kyong-Chol
   Jang, Hyeran
   Sauer, Julia
   Zimmerly, Ella M.
   Liu, Zhenhua
   Chanson, Aurelie
   Smith, Donald E.
   Friso, Simonetta
   Choi, Sang-Woon
TI Folate supplementation differently affects uracil content in DNA in the
   mouse colon and liver
SO BRITISH JOURNAL OF NUTRITION
LA English
DT Article
DE Folate; Uracil; Thymidine; Colon; Liver; Mice
ID FED METHYL-DEFICIENT; ACID-DEFINED DIETS; HEPATOCELLULAR-CARCINOMA;
   FOLIC-ACID; COLORECTAL ADENOMAS; EXCISION-REPAIR; AMINO-ACIDS; CANCER;
   DAMAGE; RATS
AB High folate intake may increase the risk of cancer, especially in the elderly. The present study examined the effects of ageing and dietary folate on uracil misincorporation into DNA, which has a mutagenic effect, in the mouse colon and liver. Old (18 months; n 42) and young (4 months; n 42) male C57BL/6 mice were pair-fed with four different amino acid-defined diets for 20 weeks: folate deplete (0 mg/kg diet); folate replete (2 mg/kg diet); folate supplemented (8 mg/kg diet); folate deplete (0 mg/kg diet) with thymidine supplementation (1.8 g/kg diet). Thymidylate synthesis from uracil requires folate, but synthesis from thymidine is folate independent. Liver folate concentrations were determined by the Lactobacillus casei assay. Uracil misincorporation into DNA was measured by a GC/MS method. Liver folate concentrations demonstrated a stepwise increase across the spectrum of dietary folate levels in both old (P=0.003) and young (P<0.001) mice. Uracil content in colonic DNA was paradoxically increased in parallel with increasing dietary folate among the young mice (P trend=0.033), but differences were not observed in the old mice. The mean values of uracil in liver DNA, in contrast, decreased with increasing dietary folate among the old mice, but it did not reach a statistically significant level (P<0.1). Compared with the folate-deplete group, thymidine supplementation reduced uracil misincorporation into the liver DNA of aged mice (P=0.026). The present study suggests that the effects of folate and thymidine supplementation on uracil misincorporation into DNA differ depending on age and tissue. Further studies are needed to clarify the significance of increased uracil misincorporation into colonic DNA of folate-supplemented young mice.
C1 [Jang, Hyeran; Sauer, Julia; Zimmerly, Ella M.; Liu, Zhenhua; Chanson, Aurelie; Choi, Sang-Woon] Tufts Univ, Vitamins & Carcinogenesis Lab, Jean Mayer USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA.
   [Kim, Kyong-Chol] Mizmedi Hosp, Dept Family Med, Seoul, South Korea.
   [Smith, Donald E.] Tufts Univ, Comparat Biol Unit, Jean Mayer USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA.
   [Friso, Simonetta] Univ Verona, Sch Med, I-37100 Verona, Italy.
C3 Tufts University; United States Department of Agriculture (USDA); Tufts
   University; United States Department of Agriculture (USDA); University
   of Verona
RP Choi, SW (corresponding author), Tufts Univ, Vitamins & Carcinogenesis Lab, Jean Mayer USDA Human Nutr Res Ctr Aging, 711 Washington St, Boston, MA 02111 USA.
EM sang.choi@tufts.edu
RI Friso, Simonetta/K-4715-2016; Kim, Kyong-Chol/JWP-8847-2024
FU US Department of Agriculture [581950-9-001]; National Institute of
   Health [R21 AA016681, R01 AG025834]
FX The present study was supported by the US Department of Agriculture,
   under agreement no. 581950-9-001. Any opinions, findings, conclusion or
   recommendations expressed in this publication are those of the author(s)
   and do not necessarily reflect the view of the US Department of
   Agriculture. The authors have no conflicts of interest. This project has
   been supported in part by the National Institute of Health Grants R21
   AA016681 and R01 AG025834 (S.-W. C.). All authors participated in the
   conception, design and conduction of the study as well as in the
   interpretation of the data and drafting the manuscript. K.-C. K., H. J.
   and S.-W. C. also performed the generation, collection and analysis of
   the data.
CR Adjei AA, 1996, GUT, V38, P531, DOI 10.1136/gut.38.4.531
   Basten GP, 2006, BRIT J CANCER, V94, P1942, DOI 10.1038/sj.bjc.6603197
   Bauchart-Thevret C, 2009, NUTR RES REV, V22, P175, DOI 10.1017/S0954422409990138
   BLOUNT BC, 1995, BAILLIERE CLIN HAEM, V8, P461, DOI 10.1016/S0950-3536(05)80216-1
   Blount BC, 1997, P NATL ACAD SCI USA, V94, P3290, DOI 10.1073/pnas.94.7.3290
   Chen H, 2007, GASTROENTEROLOGY, V133, P207, DOI 10.1053/j.gastro.2007.03.114
   Choi SW, 2003, J NUTR, V133, P1206, DOI 10.1093/jn/133.4.1206
   Choi SW, 2000, J NUTR, V130, P129, DOI 10.1093/jn/130.2.129
   Choi SW, 1998, GUT, V43, P93, DOI 10.1136/gut.43.1.93
   CHOI SW, 1996, J NUTR BIOCH, V7, P35
   Cole BF, 2007, JAMA-J AM MED ASSOC, V297, P2351, DOI 10.1001/jama.297.21.2351
   Duthie SJ, 2010, CANCER PREV RES, V3, P92, DOI 10.1158/1940-6207.CAPR-09-0231
   Fenech M, 1998, CARCINOGENESIS, V19, P1163, DOI 10.1093/carcin/19.7.1163
   Hazra A, 2010, AM J CLIN NUTR, V91, P160, DOI 10.3945/ajcn.2009.28527
   Hirsch S, 2009, EUR J GASTROEN HEPAT, V21, P346, DOI 10.1097/MEG.0b013e328306ccdb
   Jang HR, 2005, J NUTR, V135, p2967S, DOI 10.1093/jn/135.12.2967S
   Kapiszewska M, 2005, J NUTR BIOCHEM, V16, P467, DOI 10.1016/j.jnutbio.2005.01.018
   KISLIUK RL, 2006, ENCY LIFE SCI
   Kuo CS, 2008, BRIT J NUTR, V100, P596, DOI 10.1017/S0007114508911557
   Linhart HG, 2009, GASTROENTEROLOGY, V136, P227, DOI 10.1053/j.gastro.2008.10.016
   Mason JB, 2007, CANCER EPIDEM BIOMAR, V16, P1325, DOI 10.1158/1055-9965.EPI-07-0329
   MIKOL YB, 1983, CARCINOGENESIS, V4, P1619, DOI 10.1093/carcin/4.12.1619
   Sauer J, 2009, CURR OPIN CLIN NUTR, V12, P30, DOI 10.1097/MCO.0b013e32831cec62
   Tamura T, 1990, FOLIC ACID METABOLIS, P121
   van den Donk M, 2007, J NUTR, V137, P2114, DOI 10.1093/jn/137.9.2114
   WALZEM RL, 1988, J NUTR, V118, P1089, DOI 10.1093/jn/118.9.1089
   Welzel TM, 2007, CANCER EPIDEM BIOMAR, V16, P1279, DOI 10.1158/1055-9965.EPI-06-0853
   Xu G, 2008, MECH AGEING DEV, V129, P366, DOI 10.1016/j.mad.2008.03.001
   Yu MC, 2008, J GASTROEN HEPATOL, V23, pS92, DOI 10.1111/j.1440-1746.2007.05293.x
   ZAPISEK WF, 1992, CARCINOGENESIS, V13, P1869, DOI 10.1093/carcin/13.10.1869
NR 30
TC 5
Z9 8
U1 0
U2 6
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 0007-1145
EI 1475-2662
J9 BRIT J NUTR
JI Br. J. Nutr.
PD MAR
PY 2011
VL 105
IS 5
BP 688
EP 693
DI 10.1017/S0007114510004332
PG 6
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 724WC
UT WOS:000287606000005
PM 21251336
OA Green Accepted, Bronze
DA 2024-02-19
ER

PT J
AU Solomon, IH
   De Girolami, U
   Chettimada, S
   Misra, V
   Singer, EJ
   Gabuzda, D
AF Solomon, Isaac H.
   De Girolami, Umberto
   Chettimada, Sukrutha
   Misra, Vikas
   Singer, Elyse J.
   Gabuzda, Dana
TI Brain and liver pathology, amyloid deposition, and interferon responses
   among older HIV-positive patients in the late HAART era
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE HIV; HIV-associated neurocognitive disorders; Alzheimer's disease;
   Amyloid; Neuropathology; Liver; White matter; Inflammation; Interferon
   response
ID HUMAN-IMMUNODEFICIENCY-VIRUS; NEUROCOGNITIVE DISORDERS; ANTIRETROVIRAL
   THERAPY; INFECTED PATIENTS; RISK-FACTORS; COGNITIVE PERFORMANCE;
   HEPATITIS-C; ENCEPHALITIS; NEUROPATHOGENESIS; IMPAIRMENT
AB Background: HIV+ patients on highly active antiretroviral therapy (HAART) with suppressed viral loads have a low incidence of HIV-associated dementia, but increased prevalence of milder forms of HIV-associated neurocognitive disorders (HAND). These milder forms of HAND are often associated with minimal histological abnormalities, and their pathophysiology is unclear. Comorbidities, altered amyloid metabolism, accelerated brain aging, and activated interferon responses are suspected to play a role in HAND pathogenesis in HAART-treated persons.
   Methods: To investigate associations between liver disease, accelerated brain aging, and HAND in HIV+ patients in the late HAART era (2002-2015), we studied liver and brain autopsy tissues from 53 older subjects evaluated at UCLA and BWH using histopathological stains, a sensitive fluorescent amyloid stain (AmyloGlo), and targeted gene expression profiling (NanoString).
   Results: The majority of HIV+ subjects (median age 56) were on HAART (89.3%) with last pre-mortem plasma viral load < 400 copies/mL (81.5%); 50% had CD4+ counts < 200 cells/mu L. Compared to HIV- controls (median age 65), HIV+ subjects had more cancer (p = 0.04), illicit drug use (p <0.00001), and HCV co-infection (p = 0.002), less cardiovascular disease (p = 0.03), and similar prevalence of cerebrovascular disease (similar to 40%), hypertension, hyperlipidemia, and diabetes. Deep frontal white matter showed increased gliosis in HIV+ subjects vs. HIV- controls (p = 0.09), but no significant differences in myelin loss, blood vessel thickening, or inflammation. Liver showed more severe fibrosis/cirrhosis (p = 0.02) and less steatosis (p = 0.03) in HIV+ subjects, but no significant differences in inflammation, blood vessel thickness, or pigment deposition. There were no significant associations between liver and brain pathologies. AmyloGlo staining detected large amyloid deposits in only one HIV+ case (age 69 with Alzheimer's disease pathology) and two HIV- controls (ages 66 and 74). White matter from HIV+ cases vs. HIV- seronegative controls showed a trend (p = 0.06) towards increased interferon response gene expression (ISG15, MX1, IFIT1, IFIT2, and IFITM1).
   Conclusions: Gliosis and cerebrovascular disease, but not accelerated amyloid deposition, are common brain pathologies among older HIV+ patients in the late HAART era. Although HIV+ subjects had more cirrhosis, liver pathology was not associated with any consistent pattern of brain pathology. Cerebrovascular disease, interferon responses, and neuroinflammation are likely factors contributing to brain aging and HAND in older HIV+ patients on current HAART regimens.
C1 [Solomon, Isaac H.; Chettimada, Sukrutha; Gabuzda, Dana] Dana Farber Canc Inst, Dept Canc Immunol & Virol, Boston, MA 02215 USA.
   [Gabuzda, Dana] Harvard Med Sch, Dept Neurol, Boston, MA 02115 USA.
   [Gabuzda, Dana] CLS 1010,450 Brookline Ave, Boston, MA 02215 USA.
   [Solomon, Isaac H.; De Girolami, Umberto] Brigham & Womens Hosp, Dept Pathol, Boston, MA USA.
   [Singer, Elyse J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA USA.
   [Singer, Elyse J.] Univ Calif Los Angeles, David Geffen Sch Med, UCLA Natl Neurol AIDS Bank NNAB, Los Angeles, CA USA.
C3 Harvard University; Dana-Farber Cancer Institute; Harvard University;
   Harvard Medical School; Harvard University; Brigham & Women's Hospital;
   University of California System; University of California Los Angeles;
   University of California Los Angeles Medical Center; David Geffen School
   of Medicine at UCLA; University of California System; University of
   California Los Angeles; University of California Los Angeles Medical
   Center; David Geffen School of Medicine at UCLA
RP Gabuzda, D (corresponding author), Dana Farber Canc Inst, Dept Canc Immunol & Virol, Boston, MA 02215 USA.; Gabuzda, D (corresponding author), Harvard Med Sch, Dept Neurol, Boston, MA 02115 USA.; Gabuzda, D (corresponding author), CLS 1010,450 Brookline Ave, Boston, MA 02215 USA.
EM dana_gabuzda@dfci.harvard.edu
RI Gabuzda, Dana/HJI-8303-2023
OI Gabuzda, Dana/0000-0002-4964-5083; Singer, Elyse/0000-0001-9166-6534;
   Chettimada, Sukrutha/0000-0002-2224-9988
FU NNTC Data Coordinating Center [R01 MH97659, DP1 DA28994, U24 MH100929,
   U24MH100925]; Research Pathology and Molecular Biology Cores of the Dana
   Farber/Harvard Cancer Center [P30 CA06516]; Harvard Center for AIDS
   Research (CFAR) [P30 AI060354]; Harvard NeuroDiscovery Center Enhanced
   Neuroimaging Core
FX This research was supported by R01 MH97659 and DP1 DA28994 (to D.G.),
   U24 MH100929 (to E.J.S.), U24MH100925 (NNTC Data Coordinating Center),
   Research Pathology and Molecular Biology Cores of the Dana
   Farber/Harvard Cancer Center (P30 CA06516) and Harvard Center for AIDS
   Research (CFAR) (P30 AI060354), and Harvard NeuroDiscovery Center
   Enhanced Neuroimaging Core.
CR Amitrano L, 2002, SEMIN LIVER DIS, V22, P83, DOI 10.1055/s-2002-23205
   Ances BM, 2012, ARCH NEUROL-CHICAGO, V69, P72, DOI 10.1001/archneurol.2011.761
   Becker JT, 2015, J NEUROVIROL, V21, P24, DOI 10.1007/s13365-014-0290-2
   Benjamin LA, 2012, LANCET NEUROL, V11, P878, DOI 10.1016/S1474-4422(12)70205-3
   Borjabad A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002213
   Breton G, 2003, AM J MED, V114, P769, DOI 10.1016/S0002-9343(03)00157-8
   Brousseau KM, 2009, AIDS, V23, P1029, DOI 10.1097/QAD.0b013e32832ac380
   Brown LAM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095500
   Chen MF, 2014, CURR OPIN HIV AIDS, V9, P559, DOI 10.1097/COH.0000000000000105
   Chow FC, 2012, JAIDS-J ACQ IMM DEF, V60, P351, DOI 10.1097/QAI.0b013e31825c7f24
   Esiri MM, 1998, J NEUROL NEUROSUR PS, V65, P29, DOI 10.1136/jnnp.65.1.29
   Everall I, 2005, J NEUROIMMUNOL, V170, P158, DOI 10.1016/j.jneuroim.2005.09.009
   Everall I, 2009, J NEUROVIROL, V15, P360, DOI 10.3109/13550280903131915
   Foley J, 2010, CLIN NEUROPSYCHOL, V24, P265, DOI 10.1080/13854040903482830
   Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385
   Gelman BB, 2015, CURR HIV-AIDS REP, V12, P272, DOI 10.1007/s11904-015-0266-8
   Gelman BB, 2013, JAIDS-J ACQ IMM DEF, V62, P487, DOI 10.1097/QAI.0b013e31827f1bdb
   Gelman BB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046178
   González-Scarano F, 2005, NAT REV IMMUNOL, V5, P69, DOI 10.1038/nri1527
   Green DA, 2005, AIDS, V19, P407, DOI 10.1097/01.aids.0000161770.06158.5c
   Gutierrez J, 2016, AIDS, V30, P415, DOI 10.1097/QAD.0000000000000927
   Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727
   Heaton RK, 2011, J NEUROVIROL, V17, P3, DOI 10.1007/s13365-010-0006-1
   Jayakumar AR, 2015, J CLIN EXP HEPATOL, V5, pS21, DOI 10.1016/j.jceh.2014.07.006
   Lamers SL, 2016, J VIROL, V90, P8968, DOI 10.1128/JVI.00674-16
   Levine AJ, 2016, J NEUROVIROL, V22, P431, DOI 10.1007/s13365-015-0410-7
   Levine AJ, 2016, J NEUROVIROL, V22, P366, DOI 10.1007/s13365-015-0406-3
   Lovelace MD, 2017, NEUROPHARMACOLOGY, V112, P373, DOI 10.1016/j.neuropharm.2016.03.024
   Masliah E, 2004, J NEUROIMMUNOL, V157, P163, DOI 10.1016/j.jneuroim.2004.08.026
   Morgan EE, 2013, J NEUROVIROL, V19, P150, DOI 10.1007/s13365-013-0152-3
   Morgello S, 2002, ARCH PATHOL LAB MED, V126, P182
   Morgello S, 2001, NEUROPATH APPL NEURO, V27, P326, DOI 10.1046/j.0305-1846.2001.00334.x
   Mukerji SS, 2016, CLIN INFECT DIS, V63, P1130, DOI 10.1093/cid/ciw495
   Nakamoto BK, 2011, JAIDS-J ACQ IMM DEF, V57, pE66, DOI 10.1097/QAI.0b013e31821ff8bd
   Pfefferbaum A, 2014, NEUROBIOL AGING, V35, P1755, DOI 10.1016/j.neurobiolaging.2014.01.008
   Puri P, 2016, INDIAN J GASTROENTER, V35, P260, DOI 10.1007/s12664-016-0666-8
   Saylor D, 2016, NAT REV NEUROL, V12, P234, DOI [10.1038/nrneurol.2016.27, 10.1038/nrneurol.2016.53]
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]
   Schmued L, 2012, J NEUROSCI METH, V209, P120, DOI 10.1016/j.jneumeth.2012.05.019
   Shah A, 2016, NEUROTOX RES, V30, P677, DOI 10.1007/s12640-016-9646-0
   Shityakov S, 2015, HIV AIDS-RES PALLIAT, V7, P265, DOI 10.2147/HIV.S88438
   Soontornniyomkij V, 2012, AIDS, V26, P2327, DOI 10.1097/QAD.0b013e32835a117c
   Steinbrink F, 2013, EUR J NEUROL, V20, P420, DOI 10.1111/ene.12006
   Tavazzi E, 2014, CURR HIV RES, V12, P97, DOI 10.2174/1570162X12666140526114956
   Turner Raymond Scott, 2016, Alzheimers Dement (Amst), V4, P1, DOI 10.1016/j.dadm.2016.03.009
   Tyor WR, 1999, J LEUKOCYTE BIOL, V65, P475, DOI 10.1002/jlb.65.4.475
   Valcour VG, 2016, JAIDS-J ACQ IMM DEF, V72, P266, DOI 10.1097/QAI.0000000000000957
   Vivithanaporn P, 2012, J NEUROL SCI, V312, P45, DOI 10.1016/j.jns.2011.08.025
   Whiteside Y Omar, 2015, Open AIDS J, V9, P14, DOI 10.2174/1874613601509010014
   WILEY CA, 1994, ANN NEUROL, V36, P673, DOI 10.1002/ana.410360422
   Wright EJ, 2010, NEUROLOGY, V75, P864, DOI 10.1212/WNL.0b013e3181f11bd8
NR 51
TC 28
Z9 31
U1 0
U2 2
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD FEB 17
PY 2017
VL 17
AR 151
DI 10.1186/s12879-017-2246-7
PG 13
WC Infectious Diseases
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Infectious Diseases
GA EP4XX
UT WOS:000397384300001
PM 28212619
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Wang, L
   Derous, D
   Huang, XH
   Mitchell, SE
   Douglas, A
   Lusseau, D
   Wang, YC
   Speakman, JR
AF Wang, Lu
   Derous, Davina
   Huang, Xiahe
   Mitchell, Sharon E.
   Douglas, Alex
   Lusseau, David
   Wang, Yingchun
   Speakman, John R.
TI The Effects of Graded Levels of Calorie Restriction: XIX. Impact of
   Graded Calorie Restriction on Protein Expression in the Liver
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article; Early Access
DE Carnitine; "Clean cupboard hypothesis"; Hepatic proteome; Major urinary
   proteins; Metabolic pathways
ID SHORT-TERM CALORIE; LIFE-SPAN; DIETARY RESTRICTION; GENE-EXPRESSION;
   METABOLISM; LONG; GLUCOSE; HOMEOSTASIS; EXTENSION; EXOSOMES
AB Calorie restriction (CR) extends life span by modulating the mechanisms involved in aging. We quantified the hepatic proteome of male C57BL/6 mice exposed to graded levels of CR (0%-40% CR) for 3 months, and evaluated which signaling pathways were most affected. The metabolic pathways most significantly stimulated by the increase in CR, included the glycolysis/gluconeogenesis pathway, the pentose phosphate pathway, the fatty acid degradation pathway, the valine, leucine, and isoleucine degradation pathway, and the lysine degradation pathway. The metabolism of xenobiotics by cytochrome P450 pathway was activated and feminized by increased CR, while production in major urinary proteins (Mups) was strongly reduced, consistent with a reduced investment in reproduction as predicted by the disposable soma hypothesis. However, we found no evidence of increased somatic protection, and none of the 4 main pathways implied to be linked to the impact of CR on life span (insulin/insulin-like growth factor [IGF-1], nuclear factor-kappa B [NF-kappa B], mammalian Target of Rapamycin [mTOR], and sirtuins) as well as pathways in cancer, were significantly changed at the protein level in relation to the increase in CR level. This was despite previous work at the transcriptome level in the same individuals indicating such changes. On the other hand, we found Aldh2, Aldh3a2, and Aldh9a1 in carnitine biosynthesis and Acsl5 in carnitine shuttle system were up-regulated by increased CR, which are consistent with our previous work on metabolome of the same individuals. Overall, the patterns of protein expression were more consistent with a "clean cupboards" than a "disposable soma" interpretation.
C1 [Wang, Lu] Yantai Univ, Collaborat Innovat Ctr Adv Drug Delivery Syst & Bi, Sch Pharm, Key Lab Mol Pharmacol & Drug Evaluat,Minist Educ, Yantai, Peoples R China.
   [Derous, Davina; Mitchell, Sharon E.; Douglas, Alex; Lusseau, David; Wang, Yingchun; Speakman, John R.] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland.
   [Huang, Xiahe; Wang, Yingchun; Speakman, John R.] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing, Peoples R China.
   [Speakman, John R.] CAS Ctr Excellence Anim Evolut & Genet CCEAEG, Kunming, Peoples R China.
   [Speakman, John R.] Chinese Acad Sci, Shenzhen Inst Adv technol, Ctr Energy Metab & Reprod, Shenzhen Key Lab Metab Hlth, Shenzhen, Peoples R China.
C3 Yantai University; University of Aberdeen; Chinese Academy of Sciences;
   Institute of Genetics & Developmental Biology, CAS; Chinese Academy of
   Sciences; Shenzhen Institute of Advanced Technology, CAS
RP Wang, YC; Speakman, JR (corresponding author), Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland.; Wang, YC; Speakman, JR (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing, Peoples R China.
EM ycwang@genetics.ac.cn; j.speakman@abdn.ac.uk
RI Lusseau, David/AAV-9295-2021; John, Speakman R/A-9494-2008; Mitchell,
   Sharon/GYD-4854-2022
OI Lusseau, David/0000-0003-1245-3747; Mitchell,
   Sharon/0000-0003-3941-0309; Derous, Davina/0000-0002-9041-4607; Douglas,
   Alex/0000-0001-6606-1058
CR Achouri Y, 2005, BIOCHIMIE, V87, P1149, DOI 10.1016/j.biochi.2005.04.015
   Allaman I, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00023
   Argentino DP, 2005, J GERONTOL A-BIOL, V60, P28, DOI 10.1093/gerona/60.1.28
   Barzilai N, 2012, DIABETES, V61, P1315, DOI 10.2337/db11-1300
   Bruss MD, 2010, AM J PHYSIOL-ENDOC M, V298, pE108, DOI 10.1152/ajpendo.00524.2009
   Buckley DB, 2009, DRUG METAB DISPOS, V37, P834, DOI 10.1124/dmd.108.024224
   Derous D, 2017, AGING-US, V9, P1770, DOI 10.18632/aging.101269
   Duffy PH, 2004, AGING CLIN EXP RES, V16, P448, DOI 10.1007/BF03327400
   Fu ZD, 2014, TOXICOL APPL PHARM, V274, P137, DOI 10.1016/j.taap.2013.11.003
   García-Flores LA, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2101977118
   Giannakou ME, 2004, SCIENCE, V305, P361, DOI 10.1126/science.1098219
   Green CL, 2017, AGING CELL, V16, P529, DOI 10.1111/acel.12570
   Hipkiss AR, 2007, BIOGERONTOLOGY, V8, P221, DOI 10.1007/s10522-006-9034-x
   Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923
   Ji YD, 2021, NAT METAB, V3, P1163, DOI 10.1038/s42255-021-00444-1
   Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861
   Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570
   Kalluri R, 2020, SCIENCE, V367, P640, DOI 10.1126/science.aau6977
   Kanehisa M, 2021, NUCLEIC ACIDS RES, V49, pD545, DOI 10.1093/nar/gkaa970
   Kanfi Y, 2012, NATURE, V483, P218, DOI 10.1038/nature10815
   Katsyuba E, 2018, NATURE, V563, P354, DOI 10.1038/s41586-018-0645-6
   KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0
   Kim SS, 2016, MOL GENET GENOMICS, V291, P831, DOI 10.1007/s00438-015-1150-3
   KIRKWOOD TBL, 1979, PROC R SOC SER B-BIO, V205, P531, DOI 10.1098/rspb.1979.0083
   Kuhla A, 2014, J GERONTOL A-BIOL, V69, P915, DOI 10.1093/gerona/glt160
   Longo VD, 2010, TRENDS PHARMACOL SCI, V31, P89, DOI 10.1016/j.tips.2009.11.004
   Merry BJ, 2002, INT J BIOCHEM CELL B, V34, P1340, DOI 10.1016/S1357-2725(02)00038-9
   Mitchell SE, 2015, ONCOTARGET, V6, P23213, DOI 10.18632/oncotarget.4003
   Mitchell SE, 2015, ONCOTARGET, V6, P15902, DOI 10.18632/oncotarget.4142
   Osborne TB, 1917, SCIENCE, V45, P294, DOI 10.1126/science.45.1160.294
   Schwanhäusser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098
   Selman C, 2008, FASEB J, V22, P807, DOI 10.1096/fj.07-9261com
   Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221
   Sohal RS, 2014, FREE RADICAL BIO MED, V73, P366, DOI 10.1016/j.freeradbiomed.2014.05.015
   Speakman JR, 2016, EXP GERONTOL, V86, P28, DOI 10.1016/j.exger.2016.03.011
   Speakman JR, 2020, NATL SCI REV, V7, P1153, DOI 10.1093/nsr/nwaa078
   Speakman JR, 2011, MOL ASPECTS MED, V32, P159, DOI 10.1016/j.mam.2011.07.001
   Steinbaugh MJ, 2012, AM J PHYSIOL-ENDOC M, V303, pE488, DOI 10.1152/ajpendo.00110.2012
   Takahashi A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15287
   Takemon Y, 2021, ELIFE, V10, DOI 10.7554/eLife.62585
   Takemori K, 2011, LIFE SCI, V88, P1088, DOI 10.1016/j.lfs.2011.04.002
   Théry C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855
   Tian Q, 2004, MOL CELL PROTEOMICS, V3, P960, DOI 10.1074/mcp.M400055-MCP200
   Tilstra JS, 2011, AGING DIS, V2, P449
   Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638
   Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185
   Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147
   Yaku K, 2018, AGEING RES REV, V47, P1, DOI 10.1016/j.arr.2018.05.006
   Zhang XY, 2017, P NATL ACAD SCI USA, V114, P3181, DOI 10.1073/pnas.1700172114
NR 51
TC 2
Z9 2
U1 13
U2 18
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
EI 1758-535X
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD 2023 JUL 8
PY 2023
VL 78
IS 7
BP 1125
EP 1134
DI 10.1093/gerona/glad017
EA FEB 2023
PG 10
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA L6FL8
UT WOS:000951999400001
PM 36757838
OA Green Published, hybrid
DA 2024-02-19
ER

PT J
AU KOTZE, HF
   VANWYK, V
   BADENHORST, PN
   HEYNS, AD
   ROODT, JP
   LOTTER, MG
AF KOTZE, HF
   VANWYK, V
   BADENHORST, PN
   HEYNS, AD
   ROODT, JP
   LOTTER, MG
TI INFLUENCE OF PLATELET MEMBRANE SIALIC-ACID AND PLATELET-ASSOCIATED IGG
   ON AGING AND SEQUESTRATION OF BLOOD-PLATELETS IN BABOONS
SO THROMBOSIS AND HAEMOSTASIS
LA English
DT Article
ID KINETICS; INVIVO; IN-111-PLATELETS; CELLS; SITES
AB Platelets were isolated from blood of baboons and treated with neuraminidase to remove platelet membrane sialic acid, a process which artificially ages the platelets. The platelets were then labelled with In-111 and their mean life span, in vivo distribution and sites of sequestration were measured. The effect of removal of sialic acid on the attachment of immunoglobulin to platelets were investigated and related to the sequestration of the platelets by the spleen, liver, and bone marrow. Removal of sialic acid by neuraminidase did not affect the aggregation of platelets by agonists in vitro, nor their sites of sequestration. The removal of 0.51 (median, range 0.01 to 2.10) nmol sialic acid/10(8) platelets shortened their life span by 75 h (median, range 0 to 132) h (n = 19, p <0.001), and there was an exponential correlation between the shortening of the mean platelet life span and the amount of sialic acid removed. The increase in platelet-associated IgG was 0.112 (median, range 0.007 to 0.309) fg/platelet (n = 25, p <0.001) after 0.79 (median, range 0.00 to 6.70) nmol sialic acid/10(8) platelets was removed (p <0.001). There was an exponential correlation between the shortening of mean platelet life span after the removal of sialic acid and the increase in platelet-associated IgG. The results suggest that platelet membrane sialic acid influences ageing of circulating platelets, and that the loss of sialic acid may have exposed a senescent cell antigen that binds IgG on the platelet membrane. The antibody-antigen complex may then provide a signal to the macrophages that the platelet is old, and can be phagocytosed and destroyed.
RP KOTZE, HF (corresponding author), UNIV ORANGE FREE STATE,FAC MED,DEPT HAEMATOL,POB 339 G2,BLOEMFONTEIN 9300,SOUTH AFRICA.
RI Kotze, Harry F/B-2734-2008
CR AMINOFF D, 1988, BLOOD CELLS, V14, P229
   BADENHORST PN, 1985, PLATELET KINETICS IM, V1, P159
   GALILI U, 1987, P NATL ACAD SCI USA, V84, P1369, DOI 10.1073/pnas.84.5.1369
   GALILI U, 1988, BLOOD CELLS, V14, P205
   GREENBERG J, 1975, LAB INVEST, V32, P476
   GREENBERG JP, 1979, BLOOD, V53, P916
   HANSON SR, 1985, ARTERIOSCLEROSIS, V5, P595, DOI 10.1161/01.ATV.5.6.595
   Harker L A, 1978, Prog Hemost Thromb, V4, P321
   HEYNS AD, 1985, BRIT J HAEMATOL, V60, P323, DOI 10.1111/j.1365-2141.1985.tb07418.x
   KAY MMB, 1981, NATURE, V289, P491, DOI 10.1038/289491a0
   KOTZE HF, 1985, THROMB HAEMOSTASIS, V53, P408
   KOTZE HF, 1985, THROMB HAEMOSTASIS, V53, P404
   KOTZE HF, 1991, J NUCL MED, V32, P62
   LOTTER MG, 1986, J NUCL MED, V27, P1192
   NEL JD, 1980, BRIT J HAEMATOL, V44, P281, DOI 10.1111/j.1365-2141.1980.tb01210.x
   NORDT FJ, 1981, BLUT, V42, P95, DOI 10.1007/BF01030031
   NURDEN AT, 1986, BIOCH PLATELETS, P160
   PACKHAM MA, 1980, BLOOD, V56, P876
   RAND ML, 1981, BLOOD, V57, P741
   Reimers H J, 1977, Adv Exp Med Biol, V82, P231
   SCHELEPPERSCHAF.J, 1988, BLOOD CELLS, V14, P259
   SCOTT S, 1978, BLOOD, V52, P47
   SMEDSROD B, 1983, AM J HEMATOL, V15, P123, DOI 10.1002/ajh.2830150204
   STEINER M, 1985, THROMB RES, V40, P465, DOI 10.1016/0049-3848(85)90283-X
   WARREN L, 1963, METHOD ENZYMOL, V6, P463, DOI 10.1016/0076-6879(63)06207-8
NR 25
TC 35
Z9 36
U1 0
U2 1
PU F K SCHATTAUER VERLAG GMBH
PI STUTTGART
PA P O BOX 10 45 45, LENZHALDE 3, D-70040 STUTTGART, GERMANY
SN 0340-6245
J9 THROMB HAEMOSTASIS
JI Thromb. Haemost.
PD OCT 18
PY 1993
VL 70
IS 4
BP 676
EP 680
PG 5
WC Hematology; Peripheral Vascular Disease
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Hematology; Cardiovascular System & Cardiology
GA MD218
UT WOS:A1993MD21800025
PM 8115995
DA 2024-02-19
ER

PT J
AU Papaconstantinou, J
   DeFord, JH
   Gerstner, A
   Hsieh, CC
   Boylston, WH
   Guigneaux, MA
   Flurkey, K
   Harrison, DE
AF Papaconstantinou, J
   DeFord, JH
   Gerstner, A
   Hsieh, CC
   Boylston, WH
   Guigneaux, MA
   Flurkey, K
   Harrison, DE
TI Hepatic gene and protein expression of primary components of the IGF-I
   axis in long lived Snell dwarf mice
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE IGF-I axis; mRNA levels; protein levels; longevity; Snell dwarf; liver
ID ACID-LABILE SUBUNIT; GROWTH-FACTOR-I; INSULIN SIGNALING PATHWAY; FACTOR
   BINDING PROTEIN-1; CAENORHABDITIS-ELEGANS; LIFE-SPAN; NUTRITIONAL
   REGULATION; REGULATES LONGEVITY; RAT HEPATOCYTES; KUPFFER CELLS
AB Recent evidence indicates that the GH/IGF-I axis plays a key role in the control of aging and longevity. To better understand this biological relationship we examined the mRNA and corresponding protein levels of primary IGF-I axis genes in the livers of young and aged long-lived Snell dwarf mice relative to their age-matched controls. We demonstrated that the level of IGF-I and ALS mRNAs is dramatically decreased in both young and aged dwarf livers, transcripts encoding IGF-IR and IGFBP-I are elevated in young dwarfs, but normalize to control levels in aged dwarf livers while transcripts encoding IGFBP-3 are elevated only in aged controls. Interestingly, regulation at the protein level of several IGF-I axis components in the Snell dwarf appears to involve both altered gene expression and post-translational regulation. In this study, we reveal both concordant and discordant relationships between mRNA and protein levels for particular components of the IGF-I axis, illustrating that some of these gene products are not solely regulated by transcriptional mechanisms. These results are consistent with a delay in the molecular maturation of the IGF-I axis in dwarf livers, suggesting the preservation of some neonatal characteristics in young adult and aged dwarf livers. Our studies provide gene expression and protein abundance profiles for components of IGF-I axis that are distinguishing characteristics of both young and aged dwarf mice, and suggest that delayed development of the IGF-I axis in the young adult Pit1(dw/dwJ) dwarf liver may play an important role in the endocrine regulation of mammalian longevity. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
C1 Univ Texas, Med Branch, Dept Human Biol Chem & Genet, Galveston, TX 77555 USA.
   Univ Texas, Med Branch, Sealy Ctr Mol Sci, Galveston, TX 77555 USA.
   Jackson Lab, Bar Harbor, ME 04609 USA.
C3 University of Texas System; University of Texas Medical Branch
   Galveston; University of Texas System; University of Texas Medical
   Branch Galveston; Jackson Laboratory
RP Papaconstantinou, J (corresponding author), Univ Texas, Med Branch, Dept Human Biol Chem & Genet, 301 Univ Blvd,Route 0643, Galveston, TX 77555 USA.
EM jpapacon@utmb.edu
RI Papaconstantinou, John/E-3312-2010
FU NIA NIH HHS [P30 AG024832, P02 AG16622, AG17231] Funding Source: Medline
CR *AFF, 2002, GEN EXPR AN DAT AN F
   *AFF, 2002, AFF MICR SUIT US GUI
   Bartke A, 2003, BIOGERONTOLOGY, V4, P1, DOI 10.1023/A:1022448532248
   Bartke A, 1998, EXP GERONTOL, V33, P675, DOI 10.1016/S0531-5565(98)00032-1
   Boylston WH, 2004, AGING CELL, V3, P283, DOI 10.1111/j.1474-9728.2004.00115.x
   BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0
   CHIN E, 1994, ENDOCRINOLOGY, V134, P2498, DOI 10.1210/en.134.6.2498
   Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991
   Coschigano KT, 2003, ENDOCRINOLOGY, V144, P3799, DOI 10.1210/en.2003-0374
   DAI J, 1994, ENDOCRINOLOGY, V135, P2335, DOI 10.1210/en.135.6.2335
   DORMAN JB, 1995, GENETICS, V141, P1399
   Dozmorov I, 2002, J GERONTOL A-BIOL, V57, pB99, DOI 10.1093/gerona/57.3.B99
   Flurkey K, 2001, P NATL ACAD SCI USA, V98, P6736, DOI 10.1073/pnas.111158898
   Flurkey K, 2002, MECH AGEING DEV, V123, P121, DOI 10.1016/S0047-6374(01)00339-6
   FROST RA, 1991, J BIOL CHEM, V266, P18082
   Fung YWW, 1996, J MOL CELL CARDIOL, V28, P1203, DOI 10.1006/jmcc.1996.0111
   Gems D, 2002, AGING CELL, V1, P1, DOI 10.1046/j.1474-9728.2002.00003.x
   Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700
   Han VKM, 1996, HORM RES, V45, P160, DOI 10.1159/000184780
   Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298
   Hsieh CC, 2002, MECH AGEING DEV, V123, P1229, DOI 10.1016/S0047-6374(02)00036-2
   Hsieh CC, 2002, MECH AGEING DEV, V123, P1245, DOI 10.1016/S0047-6374(02)00037-4
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   JONES JI, 1993, P NATL ACAD SCI USA, V90, P10553, DOI 10.1073/pnas.90.22.10553
   JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3
   JYUNG RW, 1994, SURGERY, V115, P233
   KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0
   Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942
   Kinney BA, 2001, HORM BEHAV, V39, P277, DOI 10.1006/hbeh.2001.1654
   Kinney-Forshee BA, 2004, PHYSIOL BEHAV, V80, P589, DOI 10.1016/j.physbeh.2003.10.018
   Kong SE, 2002, ENDOCRINOLOGY, V143, P4505, DOI 10.1210/en.2002-220527
   LARSEN PL, 1995, GENETICS, V139, P1567
   Lee WH, 1997, ENDOCR J, V44, P163, DOI 10.1507/endocrj.44.163
   Liang HY, 2003, EXP GERONTOL, V38, P1353, DOI 10.1016/j.exger.2003.10.019
   Liu GY, 2003, NUCLEIC ACIDS RES, V31, P82, DOI 10.1093/nar/gkg121
   McCarty MF, 1997, MED HYPOTHESES, V48, P297, DOI 10.1016/S0306-9877(97)90098-0
   Mihaylova VT, 1999, P NATL ACAD SCI USA, V96, P7427, DOI 10.1073/pnas.96.13.7427
   Miller RA, 2002, MOL ENDOCRINOL, V16, P2657, DOI 10.1210/me.2002-0142
   Minabe-Saegusa C, 1998, DEV GROWTH DIFFER, V40, P343
   Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0
   Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194
   OKAJIMA T, 1993, J ENDOCRINOL, V136, P457, DOI 10.1677/joe.0.1360457
   Parks JS, 1999, J CLIN ENDOCR METAB, V84, P4362, DOI 10.1210/jc.84.12.4362
   Partridge L, 2002, CURR BIOL, V12, pR544, DOI 10.1016/S0960-9822(02)01048-5
   Pearce JJH, 1999, DEV BIOL, V209, P98, DOI 10.1006/dbio.1999.9240
   Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36
   POIRIER F, 1991, DEVELOPMENT, V113, P1105
   Rhoads RP, 2000, J ANIM SCI, V78, P2681
   Richardson A, 2004, BEST PRACT RES CL EN, V18, P393, DOI 10.1016/j.beem.2004.02.002
   Scharf JG, 1996, HEPATOLOGY, V23, P818, DOI 10.1002/hep.510230424
   Scharf JG, 2001, J CLIN PATHOL-MOL PA, V54, P138, DOI 10.1136/mp.54.3.138
   Scharf JG, 2001, J CELL PHYSIOL, V186, P425, DOI 10.1002/1097-4652(2000)9999:999<000::AID-JCP1036>3.3.CO;2-P
   Silha JV, 2002, ENDOCRINOLOGY, V143, P3711, DOI 10.1210/en.2002-220116
   Sudo S, 2004, J BIOL CHEM, V279, P23134, DOI 10.1074/jbc.M402376200
   Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987
   Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447
   Tissenbaum HA, 1998, GENETICS, V148, P703
   Tusher VG, 2001, P NATL ACAD SCI USA, V98, P10515
   ULLRICH A, 1986, EMBO J, V5, P2503, DOI 10.1002/j.1460-2075.1986.tb04528.x
   Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034
NR 60
TC 11
Z9 12
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD JUN-JUL
PY 2005
VL 126
IS 6-7
BP 692
EP 704
DI 10.1016/j.mad.2005.01.002
PG 13
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 932EC
UT WOS:000229536000011
PM 15888324
DA 2024-02-19
ER

PT J
AU Jiang, F
   Zhu, TM
   Yang, CF
   Chen, Y
   Fu, ZD
   Jiang, LH
   Liu, YZ
AF Jiang, Feng
   Zhu, Tieming
   Yang, Chunfeng
   Chen, Yang
   Fu, Zhidong
   Jiang, Lihui
   Liu, Yongzhi
TI Pachymic Acid Inhibits Growth and Metastatic Potential in Liver Cancer
   HepG2 and Huh7 Cells
SO BIOLOGICAL & PHARMACEUTICAL BULLETIN
LA English
DT Article
DE pachymic acid; liver cancer; apoptosis; epithelial-to-mesenchymal
   transition (EMT)
ID APOPTOSIS; PATHWAYS
AB Pachymic acid (PA), exacted from Polyporaceae, has been known for its biological activities including diuretic, dormitive, anti-oxidant, anti-aging, anti-inflammatory and anticancer properties in several types of diseases. Recently, studies have demonstrated that PA could suppress cell growth and induce cell apoptosis in different kinds of cancer cells. But the underlying mechanisms remain poorly elucidated. In the current study, we investigated the effect of pachymic acid on liver cancer cells and its underlying mechanisms. Our results evidenced that pachymic acid effectively inhibited the cell growth and metastatic potential in HepG2 and Huh7 cells. Mechanistically, we revealed that pachymic acid triggered cell apoptosis by increasing caspase 3 and caspase 9 cleavage, upregulating Bax and cytochrome c expression, while reducing the expression of Bcl2. Besides, pachymic acid could markedly inhibit the cell invasion and migration and cell metastatic potential by mediating epithelial-to-mesenchymal transition (EMT) markers and metastasis-associated genes in HepG2 and Huh7 cells. In addition, we demonstrated that FAK-Src-Jun N-terminal kinase (JNK)-matrix metalloproteinase 2 (MMP2) axis was involved in PA-inhibited liver cell EMT. Together, these results contribute to our deeper understanding of the anti-cancer effects of pachymic acid on liver cancer cells. This study also provided compelling evidence that PA might be a potential therapeutic agent for liver cancer treatment.
C1 [Jiang, Feng; Zhu, Tieming; Yang, Chunfeng; Chen, Yang; Fu, Zhidong; Jiang, Lihui; Liu, Yongzhi] Hangzhou Normal Univ, Affiliated Xiaoshan Hosp, Dept Gen Surg, Hangzhou 311202, Zhejiang, Peoples R China.
C3 Hangzhou Normal University
RP Liu, YZ (corresponding author), Hangzhou Normal Univ, Affiliated Xiaoshan Hosp, Dept Gen Surg, Hangzhou 311202, Zhejiang, Peoples R China.
EM yongzhiliu2020@126.com
CR Cheng SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122270
   Cheng SJ, 2013, INT J ONCOL, V42, P1869, DOI 10.3892/ijo.2013.1902
   Forner A, 2018, LANCET, V391, P1301, DOI 10.1016/S0140-6736(18)30010-2
   Gapter L, 2005, BIOCHEM BIOPH RES CO, V332, P1153, DOI 10.1016/j.bbrc.2005.05.044
   Gu Y, 2021, MOL CANCER, V20, DOI 10.1186/s12943-021-01435-2
   Gui YJ, 2021, ALLERGOL IMMUNOPATH, V49, P87, DOI 10.15586/aei.v49i5.468
   Hartke J, 2017, SEMIN DIAGN PATHOL, V34, P153, DOI 10.1053/j.semdp.2016.12.011
   Jeong JW, 2015, PHYTOTHER RES, V29, P1516, DOI 10.1002/ptr.5402
   Jiang Y, 2020, J ETHNOPHARMACOL, V257, DOI 10.1016/j.jep.2020.112851
   Kim E, 2020, EXP MOL MED, V52, P1898, DOI 10.1038/s12276-020-00527-1
   Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018
   Li WT, 2015, ONCOL REP, V34, P1345, DOI 10.3892/or.2015.4103
   Li YN, 2020, NANOMED-NANOTECHNOL, V23, DOI 10.1016/j.nano.2019.102095
   Ling H, 2010, MOL CARCINOGEN, V49, P271, DOI 10.1002/mc.20597
   Liu J, 2016, BIOORG MED CHEM LETT, V26, P4970, DOI 10.1016/j.bmcl.2016.09.005
   Liu YC, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9061331
   Ma J, 2015, CANCER CELL INT, V15, DOI 10.1186/s12935-015-0230-0
   Miao GP, 2019, BIOL PHARM BULL, V42, P123, DOI 10.1248/bpb.b18-00730
   Musso O, 1997, J HEPATOL, V26, P593, DOI 10.1016/S0168-8278(97)80425-4
   Popescu NC, 2014, MOL DIAGN THER, V18, P293, DOI 10.1007/s40291-014-0086-3
   Rogers C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14128
   Roomi MW, 2009, ONCOL REP, V21, P1323, DOI 10.3892/or_00000358
   Steeg PS, 2016, NAT REV CANCER, V16, P201, DOI 10.1038/nrc.2016.25
   Sun KX, 2018, ONCOL LETT, V16, P2517, DOI 10.3892/ol.2018.8899
   Trimmer C, 2010, CANCER RES, V70, P7489, DOI 10.1158/0008-5472.CAN-10-0900
   Wang C, 2021, NAT REV GASTRO HEPAT, V18, P690, DOI 10.1038/s41575-021-00465-x
   Wei DM, 2018, J CANCER, V9, P1568, DOI 10.7150/jca.24525
   Wen HL, 2018, J NAT MED-TOKYO, V72, P57, DOI 10.1007/s11418-017-1117-2
   Wu L, 2008, ONCOGENE, V27, P1439, DOI 10.1038/sj.onc.1210770
   Yang T, 2022, ENVIRON TOXICOL, V37, P2121, DOI 10.1002/tox.23555
   Yingling JM, 2004, NAT REV DRUG DISCOV, V3, P1011, DOI 10.1038/nrd1580
   Zhang J, 2021, PHARM BIOL, V59, P1256, DOI 10.1080/13880209.2021.1942924
   Zhang Yu, 2020, Zhongguo Zhong Yao Za Zhi, V45, P3395, DOI 10.19540/j.cnki.cjcmm.20200429.601
   Zhao X, 2011, ADV DRUG DELIVER REV, V63, P610, DOI 10.1016/j.addr.2010.11.001
NR 34
TC 0
Z9 0
U1 2
U2 2
PU PHARMACEUTICAL SOC JAPAN
PI TOKYO
PA 2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN
SN 0918-6158
EI 1347-5215
J9 BIOL PHARM BULL
JI Biol. Pharm. Bull.
PD JAN
PY 2023
VL 46
IS 1
BP 35
EP 41
PG 7
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA O1UQ4
UT WOS:001041744300005
PM 36273899
OA gold
DA 2024-02-19
ER

PT J
AU Yang, WJ
   Xie, Y
   Song, B
   Xia, CC
   Tang, CW
   Li, J
AF Yang, Wenjuan
   Xie, Yi
   Song, Bin
   Xia, Chunchao
   Tang, Chengwei
   Li, Jing
TI Effects of aging and menopause on pancreatic fat fraction in healthy
   women population A strobe-compliant article
SO MEDICINE
LA English
DT Article
DE aging; fat; women; menopause; pancreas
ID HEPATIC STEATOSIS; BODY-FAT; REPLACEMENT; AGE; QUANTIFICATION;
   ACCUMULATION; INFILTRATION; LIPOMATOSIS; FIBROSIS; TISSUE
AB Pancreatic fat fraction has been shown to increase in many pathological situations. However, pancreatic fat fraction and its physiological changes in healthy women are still unclear. The aim of this study is to investigate the effect of aging and menopause on pancreatic fat fraction in healthy female population. This was a cross-sectional study. A phantom of fat-water mixtures was established. One hundred sixty-seven healthy women (20-70 years) were recruited. Fat fraction was quantified with double-echo chemical shift magnetic resonance imaging with T1 and T2* correction. The association between measured and actual fat fractions was determined with Pearson correlation. Linear regression analysis was used to establish the calibration curve. Fat fractions were analyzed via analysis of variance. A significant positive linear correlation was revealed between the measured and actual fat fractions on the phantom (r(2) = 0.991, P < .001). There was no significant difference in fat fractions among caput, corpus, and cauda of the pancreas. Pancreatic fat fraction remained constant during the age of 20 to 40 years (4.41 +/- 0.79%) but significantly increased during the ages of 41 to 50 and 51 to 70 years (7.49 +/- 1.10% and 9.43 +/- 1.51%, respectively, P < .001). Moreover, pancreatic fat fractions of the healthy women aged 41 to 70 years were still significantly higher than these in the groups aged 20 to 40 years when postmenopausal healthy women were removed (P < .001). For volunteers aged 46 to 49 years, pancreatic fat fraction of the postmenopausal women was significantly increased compared with that of their premenopausal counterparts (P < .001). We found that an even distribution of pancreatic fat in healthy women, aging and menopause as 2 independent risk factors for pancreatic steatosis, a fatty infiltration in the pancreas beginning in the fifth decade in women.
C1 [Yang, Wenjuan; Xie, Yi; Tang, Chengwei; Li, Jing] Sichuan Univ, West China Hosp, Dept Gastroenterol, Guoxue Lane 37, Chengdu 610041, Sichuan, Peoples R China.
   [Song, Bin; Xia, Chunchao] Sichuan Univ, West China Hosp, Dept Radiol, Chengdu, Sichuan, Peoples R China.
C3 Sichuan University; Sichuan University
RP Li, J (corresponding author), Sichuan Univ, West China Hosp, Dept Gastroenterol, Guoxue Lane 37, Chengdu 610041, Sichuan, Peoples R China.
EM melody224@163.com
RI Wang, Peiyun/JVE-1196-2024; cheng, shu/IZE-4788-2023; Song,
   Bin/AAD-3670-2020; zhang, yue/JAC-3705-2023
OI Song, Bin/0000-0002-7269-2101
FU Natural Science Fund of China [81170384]
FX This study is supported by Grant #81170384 of Natural Science Fund of
   China.
CR Ahangarpour A, 2014, IRAN J PHARM RES, V13, P937
   Aronow WS, 2004, REV ENDOCR METAB DIS, V5, P359, DOI 10.1023/B:REMD.0000045108.30411.2b
   Aubert A, 2007, GASTROEN CLIN BIOL, V31, P303, DOI 10.1016/S0399-8320(07)89379-1
   Baum T, 2015, J MAGN RESON IMAGING, V42, P1018, DOI 10.1002/jmri.24854
   Cassidy FH, 2009, RADIOGRAPHICS, V29, P231, DOI 10.1148/rg.291075123
   Chen Z, 2002, CANCER-AM CANCER SOC, V95, P2136, DOI 10.1002/cncr.10967
   Duan JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059636
   Fernando SM, 2010, ENDOCRINOLOGY, V151, P3125, DOI 10.1210/en.2010-0018
   Gokalp G, 2011, SKELETAL RADIOL, V40, P577, DOI 10.1007/s00256-010-1048-4
   Gokalp G, 2010, SKELETAL RADIOL, V39, P1211, DOI 10.1007/s00256-010-0927-z
   Hellara Olfa, 2013, Tunis Med, V91, P359
   Heni M, 2010, DIABETES-METAB RES, V26, P200, DOI 10.1002/dmrr.1073
   Henninger B, 2015, EUR RADIOL, V25, P1356, DOI 10.1007/s00330-014-3528-8
   Herrmann J, 2013, J MAGN RESON IMAGING, V37, P886, DOI 10.1002/jmri.23871
   Isserow JA, 1999, AM J ROENTGENOL, V173, P1263, DOI 10.2214/ajr.173.5.10541101
   Junqueira Virginia B. C., 2004, Molecular Aspects of Medicine, V25, P5, DOI 10.1016/j.mam.2004.02.003
   Kühn JP, 2015, RADIOLOGY, V276, P129, DOI 10.1148/radiol.15140446
   Lee J, 2015, BIOCHEM BIOPH RES CO, V464, P229, DOI 10.1016/j.bbrc.2015.06.121
   Lee JS, 2009, WORLD J GASTROENTERO, V15, P1869, DOI 10.3748/wjg.15.1869
   LEY CJ, 1992, AM J CLIN NUTR, V55, P950, DOI 10.1093/ajcn/55.5.950
   Li J, 2011, PANCREAS, V40, P295, DOI 10.1097/MPA.0b013e318201669f
   LOZANO M, 1988, PANCREAS, V3, P580, DOI 10.1097/00006676-198810000-00012
   Mathur Abhishek, 2007, HPB (Oxford), V9, P312, DOI 10.1080/13651820701504157
   MATSUMOTO S, 1995, RADIOLOGY, V194, P453, DOI 10.1148/radiology.194.2.7824726
   Morimoto S, 2010, J STEROID BIOCHEM, V122, P107, DOI 10.1016/j.jsbmb.2010.05.003
   Nakamura Soichi, 2003, Pancreas, V26, pe59, DOI 10.1097/00006676-200304000-00024
   Namimoto T, 2001, RADIOLOGY, V218, P642, DOI 10.1148/radiology.218.3.r01mr15642
   OLSEN TS, 1978, ACTA PATH MICRO IM A, V86, P367
   Ou HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062561
   Ozbulbul NI, 2010, EURASIAN J MED, V42, P24, DOI 10.5152/eajm.2010.08
   Patel NS, 2013, ALIMENT PHARM THER, V37, P630, DOI 10.1111/apt.12237
   PATEL S, 1980, AM J ROENTGENOL, V135, P843, DOI 10.2214/ajr.135.4.843
   Pelosi E, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.127381
   Saisho Y, 2007, CLIN ANAT, V20, P933, DOI 10.1002/ca.20543
   Sato T, 2012, EUR J RADIOL, V81, P2093, DOI 10.1016/j.ejrad.2011.07.014
   Sodhi KS, 2010, INDIAN J GASTROENTER, V29, P65, DOI 10.1007/s12664-010-0023-2
   Soyer P, 1999, RADIOLOGY, V210, P611, DOI 10.1148/radiology.210.3.r99mr08611
   Stolk L, 2012, NAT GENET, V44, P260, DOI 10.1038/ng.1051
   Szczepaniak LS, 2005, AM J PHYSIOL-ENDOC M, V288, pE462, DOI 10.1152/ajpendo.00064.2004
   Takeshita N, 2010, INT SURG, V95, P261
   Tsushima Y, 1998, PANCREAS, V17, P148, DOI 10.1097/00006676-199808000-00006
   Uygun A, 2015, EUR J INTERN MED, V26, P37, DOI 10.1016/j.ejim.2014.11.007
   van Herpen NA, 2008, PHYSIOL BEHAV, V94, P231, DOI 10.1016/j.physbeh.2007.11.049
   Wang CY, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000297
   Wong VWS, 2014, AM J GASTROENTEROL, V109, P589, DOI 10.1038/ajg.2014.1
   Yang DM, 2010, J CLIN ULTRASOUND, V38, P45, DOI 10.1002/jcu.20632
   Yang WJ, 2016, PANCREAS, V45, P836, DOI 10.1097/MPA.0000000000000557
   Yuan F, 2018, ACTA RADIOL, V59, P1021, DOI 10.1177/0284185117745908
NR 48
TC 10
Z9 10
U1 3
U2 9
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0025-7974
EI 1536-5964
J9 MEDICINE
JI Medicine (Baltimore)
PD FEB
PY 2019
VL 98
IS 7
AR e14451
DI 10.1097/MD.0000000000014451
PG 8
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA HQ4NV
UT WOS:000462389000035
PM 30762758
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Sharma, M
   Ahmed, A
   Wong, RJ
AF Sharma, Mokshya
   Ahmed, Aijaz
   Wong, Robert J.
TI Significantly Higher Mortality Following Liver Transplantation Among
   Patients Aged 70 Years and Older
SO PROGRESS IN TRANSPLANTATION
LA English
DT Article
DE septuagenarians; posttransplant survival; chronic hepatitis C virus;
   hepatocellular carcinoma; UNOS/OPTN
ID RECIPIENTS OLDER; DISEASE; SURVIVAL; OUTCOMES; MODEL
AB Introduction: The age of liver transplantation recipients in the United States is steadily increasing. However, the impact of age on liver transplant outcomes has demonstrated contradictory results. Research Questions: We aim to evaluate the impact of age on survival following liver transplantation among US adults. Design: Using data from the United Network for Organ Sharing registry, we retrospectively evaluated all adults undergoing liver transplantation from 2002 to 2012 stratified by age (aged 70 years and older vs aged < 70 years), presence of hepatocellular carcinoma, and hepatitis C virus status. Overall survival was evaluated with Kaplan-Meier methods and multivariate Cox proportional hazards models. Results: Compared to patients aged < 70 years, those aged 70 years and older had significantly lower 5-year survival following transplantation among all groups analyzed (hepatocellular carcinoma: 59.9% vs 68.6%, P <.01; nonhepatocellular carcinoma: 61.2% vs 74.2%, P <.001; hepatitis C: 60.7% vs 69.0%, P <.01; nonhepatitis C: 62.6% vs 78.5%, P <.001). On multivariate regression, patients aged 70 years and older at time of transplantation was associated with significantly higher mortality compared to those aged < 70 years (hazards ratio: 1.67; 95% confidence interval: 1.48-1.87; P <.001). Conclusion: The age at the time of liver transplantation has continued to increase in the United States. However, patients aged 70 years and older had significantly higher mortality following liver transplantation. These observations are especially important given the aging cohort of patients with chronic liver disease in the United States.
C1 [Sharma, Mokshya; Wong, Robert J.] Highland Hosp, Div Gastroenterol & Hepatol, Alameda Hlth Syst, Oakland, CA 94602 USA.
   [Ahmed, Aijaz] Stanford Univ, Div Gastroenterol & Hepatol, Sch Med, Stanford, CA 94305 USA.
C3 Stanford University
RP Wong, RJ (corresponding author), Highland Hosp, Div Gastroenterol & Hepatol, Alameda Hlth Syst, Endoscopy Unit, 1411 East 31st St, Oakland, CA 94602 USA.
EM rowong@alamedahealthsystem.org
OI Wong, Robert/0000-0002-8923-2806
CR Aduen JF, 2009, MAYO CLIN PROC, V84, P973, DOI 10.1016/S0025-6196(11)60667-8
   Colby SL, 2014, Projections of the Size and Composition of the US Population: 2014 to 2060
   Frith J, 2009, AGE AGEING, V38, P11, DOI 10.1093/ageing/afn242
   Fussner LA, 2015, LIVER TRANSPLANT, V21, P889, DOI 10.1002/lt.24137
   Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80
   Herrero JI, 2003, AM J TRANSPLANT, V3, P1407, DOI 10.1046/j.1600-6143.2003.00227.x
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   Lai JC, 2016, HEPATOLOGY, V63, P574, DOI 10.1002/hep.28316
   Leithead JA, 2015, GUT, V64, P1111, DOI 10.1136/gutjnl-2013-306502
   Prince MJ, 2015, LANCET, V385, P549, DOI 10.1016/S0140-6736(14)61347-7
   Schwartz JJ, 2012, LIVER TRANSPLANT, V18, P423, DOI 10.1002/lt.23385
   Su F, 2016, GASTROENTEROLOGY, V150, P441, DOI 10.1053/j.gastro.2015.10.043
   Taner CB, 2012, HEPATOL INT, V6, P403, DOI 10.1007/s12072-011-9286-7
   Vrsalovic M, 2017, CLIN CARDIOL, V40, P287, DOI 10.1002/clc.22657
   Wiesner R, 2003, GASTROENTEROLOGY, V124, P91, DOI 10.1053/gast.2003.50016
   Wong RJ, 2015, GASTROENTEROLOGY, V148, P547, DOI 10.1053/j.gastro.2014.11.039
   Wong RJ, 2014, LIVER TRANSPLANT, V20, P1454, DOI 10.1002/lt.23981
NR 17
TC 16
Z9 17
U1 0
U2 2
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1526-9248
EI 2164-6708
J9 PROG TRANSPLANT
JI Prog. Transplant.
PD SEP
PY 2017
VL 27
IS 3
BP 225
EP 231
DI 10.1177/1526924817715468
PG 7
WC Surgery; Transplantation
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Surgery; Transplantation
GA FC8UW
UT WOS:000407117900002
PM 29187098
DA 2024-02-19
ER

PT J
AU Shchepinov, MS
   Pestov, NB
AF Shchepinov, M. S.
   Pestov, N. B.
TI Isotope Effect, Essential Diet Components, and Prospects of Aging
   Retardation
SO RUSSIAN JOURNAL OF GENERAL CHEMISTRY
LA English
DT Article
ID OXIDATIVE DAMAGE; STABLE-ISOTOPES; FATTY-ACIDS; DNA-DAMAGE; REACTIVITY;
   DEUTERIUM; LIVER
AB A method is proposed that has the potential to increase the stability of lipids, proteins, nucleic acids and other cellular components towards the detrimental damages caused by reactive oxygen species (ROS). The rate-limiting step of most ROS-driven oxidation reactions is hydrogen abstraction. The oxidation-susceptible sites within these (bio) molecules can thus be made less vulnerable to ROS-driven oxidation by incorporating heavy stable isotopes, such as deuterium or/and carbon-13. Ingestion of isotopically reinforced building blocks, such as amino acids, lipids, and components of nucleic acids and their subsequent incorporation into macromolecules would make the latter more stable to ROS courtesy of the isotope effect. The suggested approach may lead to enhanced resistance toward oxidative stress and, hence, to enhanced longevity.
C1 [Shchepinov, M. S.] Retrotope, Oxford OX3 0PN, England.
   [Pestov, N. B.] Russian Acad Sci, Shemyakin & Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia.
C3 Russian Academy of Sciences; Pushchino Scientific Center for Biological
   Research (PSCBI) of the Russian Academy of Sciences; Institute of
   Bioorganic Chemistry of the Russian Academy of Sciences
RP Shchepinov, MS (corresponding author), Retrotope, 8 Barns Hay, Oxford OX3 0PN, England.
EM misha@retrotope.com; korn@mail.ibch.ru
RI Pestov, Nikolay/M-9495-2013
OI Pestov, Nikolay/0000-0002-9973-0120
CR BADA JL, 1989, GEOCHIM COSMOCHIM AC, V53, P3337, DOI 10.1016/0016-7037(89)90114-2
   Balasubramanian B, 1998, P NATL ACAD SCI USA, V95, P9738, DOI 10.1073/pnas.95.17.9738
   Beckman KB, 1999, MUTAT RES-FUND MOL M, V424, P51, DOI 10.1016/S0027-5107(99)00007-X
   BIELSKI BHJ, 1983, J BIOL CHEM, V258, P4759
   BIGELEISEN J, 1949, SCIENCE, V110, P14, DOI 10.1126/science.110.2844.14
   Brocklehurst B, 1997, INT J RADIAT BIOL, V72, P587, DOI 10.1080/095530097143086
   BUCHACHENKO AL, 1995, CHEM REV, V95, P2507, DOI 10.1021/cr00039a009
   Carver JD, 1999, ACTA PAEDIATR, V88, P83, DOI 10.1080/080352599750029790
   CLELAND WW, 1987, BIOORG CHEM, V15, P283, DOI 10.1016/0045-2068(87)90026-5
   Cloos PAC, 2003, CALCIFIED TISSUE INT, V72, P8, DOI 10.1007/s00223-002-2034-1
   DAMGAARD SE, 1981, BIOCHEMISTRY-US, V20, P5662, DOI 10.1021/bi00523a004
   De Grey ADNJ, 2002, DNA CELL BIOL, V21, P251, DOI 10.1089/104454902753759672
   Garber K, 2007, SCIENCE, V317, P190, DOI 10.1126/science.317.5835.190
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Hekimi S, 2006, NAT GENET, V38, P985, DOI 10.1038/ng1881
   Jackson AL, 2001, MUTAT RES-FUND MOL M, V477, P7, DOI 10.1016/S0027-5107(01)00091-4
   Jacquot C, 2008, BIOORG MED CHEM LETT, V18, P5959, DOI 10.1016/j.bmcl.2008.08.108
   Kitaguchi H, 2006, CHEM COMMUN, P979, DOI 10.1039/b515004c
   Kushner DJ, 1999, CAN J PHYSIOL PHARM, V77, P79, DOI 10.1139/cjpp-77-2-79
   LIBBY WF, 1964, SCIENCE, V146, P1171
   Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661
   LUNDQUIST F, 1989, PHARMACOL TOXICOL, V65, P55, DOI 10.1111/j.1600-0773.1989.tb01126.x
   Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200
   Nair KS, 2005, AM J CLIN NUTR, V81, P953
   Negre-Salvayre A, 2008, BRIT J PHARMACOL, V153, P6, DOI 10.1038/sj.bjp.0707395
   Nyström T, 2005, EMBO J, V24, P1311, DOI 10.1038/sj.emboj.7600599
   PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453
   Poli G, 2008, MED RES REV, V28, P569, DOI 10.1002/med.20117
   REQUENA JR, 2001, P NATL ACAD SCI US, V98
   Ros E, 2003, AM J CLIN NUTR, V78, p617S, DOI 10.1093/ajcn/78.3.617S
   Sanz A, 2006, ANTIOXID REDOX SIGN, V8, P582, DOI 10.1089/ars.2006.8.582
   Shchepinov MS, 2007, BIOESSAYS, V29, P1247, DOI 10.1002/bies.20681
   Shchepinov MS, 2007, REJUV RES, V10, P47, DOI 10.1089/rej.2006.0506
   Spalding KL, 2005, CELL, V122, P133, DOI 10.1016/j.cell.2005.04.028
   SPIELMANN H, 1976, LIFE SCI, V19, P633, DOI 10.1016/0024-3205(76)90159-4
   SPIELMANN H, 1986, J CLIN PHARMACOL, V26, P474, DOI 10.1002/j.1552-4604.1986.tb03561.x
   STORZ P, 2006, SCI STKE, P1
   Vijg J, 2007, AGING GENOME
NR 38
TC 3
Z9 13
U1 0
U2 8
PU MAIK NAUKA/INTERPERIODICA/SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013-1578 USA
SN 1070-3632
EI 1608-3350
J9 RUSS J GEN CHEM+
JI Russ. J. Gen. Chem.
PD JUL
PY 2010
VL 80
IS 7
BP 1514
EP 1522
DI 10.1134/S1070363210070480
PG 9
WC Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry
GA 655GA
UT WOS:000282235200048
DA 2024-02-19
ER

PT J
AU Jia, L
   Wang, T
   Sun, YY
   Zhang, MR
   Tian, JY
   Chen, H
   Shen, ZG
   Abro, HK
   Su, NN
   Cui, J
AF Jia, Li
   Wang, Tao
   Sun, Yuanyuan
   Zhang, Miaoran
   Tian, Jiyuan
   Chen, Hui
   Shen, Zhenguo
   Abro, Hashmat Khan
   Su, Nana
   Cui, Jin
TI Protective Effect of Selenium-Enriched Red Radish Sprouts on Carbon
   Tetrachloride-Induced Liver Injury in Mice
SO JOURNAL OF FOOD SCIENCE
LA English
DT Article; Early Access
DE anthocyanins; flavonoids compounds; liver injury; phenolics compounds;
   radish sprouts; selenium
ID ANTIOXIDANT; DAMAGE; RATS; SE; FERTILIZATION; ANTHOCYANINS; SUPPLEMENTS;
   QUALITY; YIELD
AB This study aimed to investigate the effect of Se (Selenium) treatment on nutritional quality in radish sprouts. The results showed that 15 mu M sodium selenite significantly increased phenolics compounds, flavonoids compounds, anthocyanins, and some essential amino acid content, while improving the total antioxidant capacity of radish sprouts. Besides, the Se-enriched radish sprouts significantly alleviated the liver damage caused by carbon tetrachloride (CCl4) in mice and improved the antioxidant capacity of the liver in mice, whereas the Se-enriched radish sprouts alleviated the inflammatory reaction and apoptosis caused by CCl4. These results imply that Se-enriched radish sprouts have a positive impact on mice with CCl4-induced liver injury, and that in future Se-enriched radish sprouts could be developed into an effective food and health care product for the liver injury prevention. Practical Application Because selenium is an essential trace element in the human body, selenium-enriched sprouts can help eliminate free radicals in the body, relieve aging, and selenium-deficient diseases. They are easy to grow and have low costs. Hence, selenium-enriched sprouts have a great potential of being widely consumed.
C1 [Jia, Li; Wang, Tao; Sun, Yuanyuan; Zhang, Miaoran; Tian, Jiyuan; Chen, Hui; Shen, Zhenguo; Su, Nana; Cui, Jin] Nanjing Agr Univ, Coll Life Sci, Nanjing 210095, Jiangsu, Peoples R China.
   [Abro, Hashmat Khan] Guangxi Univ, Coll Agr, Nanning 530004, Guangxi, Peoples R China.
C3 Nanjing Agricultural University; Guangxi University
RP Su, NN; Cui, J (corresponding author), Nanjing Agr Univ, Coll Life Sci, Nanjing 210095, Jiangsu, Peoples R China.
EM sunana@njau.edu.cn; cuijin@njau.edu.cn
RI Cui, Jin/I-4496-2016
FU National Natural Science Foundation of China [31801849]; Jiangsu
   Provincial Natural Science Foundation of China [BK20180522]
FX This work was supported by National Natural Science Foundation of China
   (31801849) and Jiangsu Provincial Natural Science Foundation of China
   (BK20180522).
CR Baskaran Y, 2010, TOXICOLOGY, V268, P204, DOI 10.1016/j.tox.2009.12.018
   Chacko BK, 2011, HEPATOLOGY, V54, P153, DOI 10.1002/hep.24377
   Chen L, 2005, WORLD J GASTROENTERO, V11, P5795, DOI 10.3748/wjg.v11.i37.5795
   Chen Z, 2013, FOOD CHEM, V138, P414, DOI 10.1016/j.foodchem.2012.11.001
   Dai N, 2014, J MED FOOD, V17, P663, DOI 10.1089/jmf.2013.2834
   Domitrovic R, 2013, FOOD CHEM TOXICOL, V51, P370, DOI 10.1016/j.fct.2012.10.021
   Dumont E, 2005, J CHROMATOGR A, V1071, P191, DOI 10.1016/j.chroma.2004.11.046
   Ebaid H, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-20
   Ebert AW, 2017, FOOD CHEM, V237, P15, DOI 10.1016/j.foodchem.2017.05.073
   Frias J, 2010, J AGR FOOD CHEM, V58, P2331, DOI 10.1021/jf903458u
   Hartikainen H, 2005, J TRACE ELEM MED BIO, V18, P309, DOI 10.1016/j.jtemb.2005.02.009
   Kandimalla R, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00205
   Karakus E, 2011, J HAZARD MATER, V195, P208, DOI 10.1016/j.jhazmat.2011.08.027
   Karakus SC, 2011, EUR J PEDIATR SURG, V21, P356, DOI 10.1055/s-0031-1286340
   Li HF, 2008, NEW PHYTOL, V178, P92, DOI 10.1111/j.1469-8137.2007.02343.x
   Li X, 2016, BIOL TRACE ELEM RES, V173, P433, DOI 10.1007/s12011-016-0681-8
   LIU Yahui, 2014, J SHANGHAI U ENG SCI, V01, P63
   Long ZD, 2018, J TRACE ELEM MED BIO, V50, P111, DOI 10.1016/j.jtemb.2018.06.019
   Lu Y, 2016, INT IMMUNOPHARMACOL, V34, P44, DOI 10.1016/j.intimp.2016.02.003
   Mirwais Ghani, 2016, Plant Breeding and Biotechnology, V4, P398
   Müller AS, 2002, J ANIM PHYSIOL AN N, V86, P273, DOI 10.1046/j.1439-0396.2002.00373.x
   Nováková L, 2010, TALANTA, V82, P1271, DOI 10.1016/j.talanta.2010.06.057
   Ohyama T, 2012, BRIT J PHARMACOL, V165, P1173, DOI 10.1111/j.1476-5381.2011.01599.x
   Oumi N., 2012, INT J HEPATOLOGY, V2012, P1
   Pedrero Z, 2006, J AGR FOOD CHEM, V54, P2412, DOI 10.1021/jf052500n
   Peng W, 2009, BIOMED PHARMACOTHER, V63, P592, DOI 10.1016/j.biopha.2008.08.023
   Pezzarossa B, 2014, SCI HORTIC-AMSTERDAM, V165, P106, DOI 10.1016/j.scienta.2013.10.029
   Piekarska A, 2014, INT J FOOD SCI NUTR, V65, P692, DOI 10.3109/09637486.2014.917148
   Rayman MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045269
   Ríos JJ, 2008, SCI HORTIC-AMSTERDAM, V116, P248, DOI 10.1016/j.scienta.2008.01.008
   Rossé T, 1998, NATURE, V391, P496, DOI 10.1038/35160
   Schiavon M, 2013, J AGR FOOD CHEM, V61, P10542, DOI 10.1021/jf4031822
   Sefi M, 2012, TOXICOL IND HEALTH, V30, P653
   Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663
   Shi L, 2014, J FUNCT FOODS, V11, P71, DOI 10.1016/j.jff.2014.07.008
   Su NN, 2016, J SCI FOOD AGR, V96, P886, DOI 10.1002/jsfa.7161
   Su NN, 2014, J AGR FOOD CHEM, V62, P6454, DOI 10.1021/jf5019593
   Tian M, 2016, FOOD CHEM, V190, P374, DOI 10.1016/j.foodchem.2015.05.098
   Wang YD, 2013, FOOD CHEM, V141, P2385, DOI 10.1016/j.foodchem.2013.05.095
   Whanger PD, 2004, BRIT J NUTR, V91, P11, DOI 10.1079/BJN20031015
   Xia YM, 2005, AM J CLIN NUTR, V81, P829, DOI 10.1093/ajcn/81.4.829
   Zamara E, 2007, J HEPATOL, V46, P230, DOI 10.1016/j.jhep.2006.09.007
   Zhou CG, 2013, J AGR FOOD CHEM, V61, P7552, DOI 10.1021/jf402174f
   Zhu Z, 2018, FOOD CHEM, V252, P9, DOI 10.1016/j.foodchem.2018.01.064
   Zhu Z, 2017, FOOD CHEM, V219, P179, DOI 10.1016/j.foodchem.2016.09.138
NR 45
TC 15
Z9 15
U1 1
U2 33
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-1147
EI 1750-3841
J9 J FOOD SCI
JI J. Food Sci.
PD 2019 OCT
PY 2019
VL 84
IS 10
BP 3027
EP 3036
DI 10.1111/1750-3841.14727
EA SEP 2019
PG 10
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA JD2QF
UT WOS:000486780900001
PM 31529805
DA 2024-02-19
ER

PT J
AU Stadler, K
   Jenei, V
   von Bölcsházy, G
   Somogyi, A
   Jakus, J
AF Stadler, K
   Jenei, V
   von Bölcsházy, G
   Somogyi, A
   Jakus, J
TI Increased nitric oxide levels as an early sign of premature aging in
   diabetes
SO FREE RADICAL BIOLOGY AND MEDICINE
LA English
DT Article
DE diabetes mellitus; late complications; EPR spectroscopy; spin trapping;
   nitric oxide; peroxynitrite; reactive oxygen species; free radicals
ID OXIDATIVE STRESS; FREE-RADICALS; ENDOTHELIAL DYSFUNCTION; POSTISCHEMIC
   HEART; L-ARGININE; IN-VIVO; MELLITUS; RAT; STREPTOZOTOCIN; SUPEROXIDE
AB The levels of different reactive species, especially those of nitric oxide and peroxynitrite, were determined in streptozotocin-induced diabetic rat tissues, before the development of histopathological damages. Significantly higher steady state free radical concentrations were found in the liver 3 weeks after the onset of diabetes compared to age-matched control groups. Increased nitric oxide levels in diabetic vasculature and kidney decreased the production of detectable reactive oxygen species. High peroxynitrite generation suggested the onset of processes characteristic to premature aging of the endothelium. According to the histopathological results, there were no signs of late complications in the tissues up to 7 weeks after induction of diabetes. These results support the idea that oxidative stress is increased at a very early stage of diabetes and, in particular, that high levels of nitric oxide and peroxynitrite could play a decisive role in the development of late complications in the diabetic vasculature and kidney. (C) 2003 Elsevier Inc.
C1 Hungarian Acad Sci, Chem Res Ctr, Inst Chem, H-1525 Budapest, Hungary.
   Univ Vet Med Budapest, Budapest, Hungary.
   Semmelweis Univ, Dept Internal Med 2, Budapest, Hungary.
C3 Hungarian Research Network; HUN-REN Research Centre for Natural
   Sciences; Hungarian Academy of Sciences; University of Veterinary
   Medicine Budapest; Semmelweis University
RP Stadler, K (corresponding author), Hungarian Acad Sci, Chem Res Ctr, Inst Chem, POB 17, H-1525 Budapest, Hungary.
EM krisz@chemres.hu
RI Stadler, Krisztian/N-1992-2017
CR BAYNES JW, 1991, DIABETES, V40, P405, DOI 10.2337/diabetes.40.4.405
   Bielschowsky M, 1904, J PSYCHOL NEUROL, V3, P169
   BLOUGH NV, 1985, INORG CHEM, V24, P3502, DOI 10.1021/ic00216a003
   BRAVENBOER B, 1992, DIABETOLOGIA, V35, P813, DOI 10.1007/BF00399926
   Brovkovych V, 1997, J PHYSIOL PHARMACOL, V48, P633
   Cernadas MR, 1998, CIRC RES, V83, P279, DOI 10.1161/01.RES.83.3.279
   Dandona P, 1996, LANCET, V347, P444, DOI 10.1016/S0140-6736(96)90013-6
   De Vriese AS, 2001, KIDNEY INT, V60, P202, DOI 10.1046/j.1523-1755.2001.00787.x
   FEHER J, 1992, ACTA PHYSIOL HUNG, V80, P351
   Ferrini M, 2001, BIOL REPROD, V64, P974, DOI 10.1095/biolreprod64.3.974
   FINKELSTEIN E, 1984, BIOCHIM BIOPHYS ACTA, V802, P90, DOI 10.1016/0304-4165(84)90038-2
   Fischer B., 1902, CBL ALLG PAT, V13, P943
   GILLERY P, 1989, MED HYPOTHESES, V29, P47, DOI 10.1016/0306-9877(89)90167-9
   Goettsch W, 2001, BIOCHEM BIOPH RES CO, V280, P908, DOI 10.1006/bbrc.2000.4180
   Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341
   Hink U, 2001, CIRC RES, V88, pE14
   Jakus J, 2002, BRIT J NUTR, V87, P501, DOI 10.1079/BJN2002559
   JIANG ZY, 1990, FEBS LETT, V268, P69, DOI 10.1016/0014-5793(90)80974-N
   Kakkar R, 1997, LIFE SCI, V60, P667, DOI 10.1016/S0024-3205(96)00702-3
   Kakkar R, 1998, CLIN SCI, V94, P623, DOI 10.1042/cs0940623
   Komarov AM, 1997, MOL CELL BIOCHEM, V175, P91, DOI 10.1023/A:1006897530800
   KRUTSAY M, 1999, PATOLOGIAI TECHNIKA, P148
   KRUTSAY M, 1991, LAB DIAGN, V18, P58
   KUBRINA LN, 1993, BIOCHIM BIOPHYS ACTA, V1176, P240, DOI 10.1016/0167-4889(93)90050-Y
   Leinonen J, 1997, FEBS LETT, V417, P150, DOI 10.1016/S0014-5793(97)01273-8
   LEVINE RL, 1994, METHOD ENZYMOL, V233, P346
   Matz RL, 2000, PHYSIOL RES, V49, P11
   MCMANUS JFA, 1948, STAIN TECHNOL, V23, P99, DOI 10.3109/10520294809106232
   Mohamed AK, 1999, BIOFACTORS, V10, P157, DOI 10.1002/biof.5520100211
   Mohan IK, 1998, FREE RADICAL BIO MED, V25, P757, DOI 10.1016/S0891-5849(98)00129-4
   OBERLEY LW, 1988, FREE RADICAL BIO MED, V5, P113, DOI 10.1016/0891-5849(88)90036-6
   Pieper GM, 1999, DIABETOLOGIA, V42, P204, DOI 10.1007/s001250051140
   PORTHA B, 1989, DIABETES METAB, V15, P61
   QU HB, 1991, MED HYPOTHESES, V34, P60, DOI 10.1016/0306-9877(91)90066-8
   Rockenbauer A, 1996, APPL MAGN RESON, V10, P29, DOI 10.1007/BF03163097
   SAKURAI T, 1988, FEBS LETT, V236, P406, DOI 10.1016/0014-5793(88)80066-8
   SAMUNI A, 1989, FREE RADICAL BIO MED, V6, P141, DOI 10.1016/0891-5849(89)90111-1
   Sano T, 1998, DIABETOLOGIA, V41, P1355, DOI 10.1007/s001250051076
   SPICER SS, 1965, J HISTOCHEM CYTOCHEM, V13, P211, DOI 10.1177/13.3.211
   Suzuki Y, 1997, BBA-GEN SUBJECTS, V1335, P242, DOI 10.1016/S0304-4165(97)00027-5
   Szabo ME, 1997, CLIN NEUROSCI, V4, P240
   Takeda N, 2001, DIABETOLOGIA, V44, P1043, DOI 10.1007/s001250100588
   Tannous M, 1999, DIABETOLOGIA, V42, P539, DOI 10.1007/s001250051192
   UTSUMI H, 1990, BIOCHEM BIOPH RES CO, V172, P1342, DOI 10.1016/0006-291X(90)91597-L
   Wang PH, 1996, J BIOL CHEM, V271, P29223, DOI 10.1074/jbc.271.46.29223
   WOHAIEB SA, 1987, DIABETES, V36, P1014, DOI 10.2337/diabetes.36.9.1014
   WOLFF SP, 1993, BRIT MED BULL, V49, P642, DOI 10.1093/oxfordjournals.bmb.a072637
   Zieman SJ, 2001, CIRC RES, V88, P97, DOI 10.1161/01.RES.88.1.97
   [No title captured]
NR 49
TC 89
Z9 95
U1 0
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0891-5849
EI 1873-4596
J9 FREE RADICAL BIO MED
JI Free Radic. Biol. Med.
PD NOV 15
PY 2003
VL 35
IS 10
BP 1240
EP 1251
DI 10.1016/S0891-5849(03)00499-4
PG 12
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA 743UQ
UT WOS:000186592300008
PM 14607523
DA 2024-02-19
ER

PT J
AU Kwon, S
   Seok, S
   Yau, P
   Li, XL
   Kemper, B
   Kemper, JK
AF Kwon, Sanghoon
   Seok, Sunmi
   Yau, Peter
   Li, Xiaoling
   Kemper, Byron
   Kemper, Jongsook Kim
TI Obesity and aging diminish sirtuin 1(SIRT1)-mediated deacetylation of
   SIRT3, leading to hyperacetylation and decreased activity and stability
   of SIRT3
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID FATTY-ACID OXIDATION; MITOCHONDRIAL PROTEIN HYPERACETYLATION; SMALL
   HETERODIMER PARTNER; DIET-INDUCED OBESITY; CALORIE RESTRICTION; LYSINE
   ACETYLATION; INSULIN-RESISTANCE; METABOLIC DISEASE; COA; PGC-1-ALPHA
AB Sirtuin 3 (SIRT3) deacetylates and regulates many mitochondrial proteins to maintain health, but its functions are depressed in aging and obesity. The best-studied sirtuin, SIRT1, counteracts aging-and obesity-related diseases by deacetylating many proteins, but whether SIRT1 has a role in deacetylating and altering the function of SIRT3 is unknown. Here we show that SIRT3 is reversibly acetylated in the mitochondria and unexpectedly is a target of SIRT1 deacetylation. SIRT3 is hyperacety-lated in aged and obese mice, in which SIRT1 activity is low, and SIRT3 acetylation at Lys(57) inhibits its deacetylase activity and promotes protein degradation. Adenovirus-mediated expression of SIRT3 or an acetylation-defective SIRT3-K57R mutant in diet-induced obese mice decreased acetylation of mitochondrial long-chain acyl-CoA dehydrogenase, a known SIRT3 deacetylation target; improved fatty acid beta-oxidation; and ameliorated liver steatosis and glucose intolerance. These SIRT3-mediated beneficial effects were not observed with an acetylation-mimic SIRT3-K57Q mutant. Our findings reveal an unexpected mechanism for SIRT3 regulation via SIRT1-mediated deacetylation. Improving mitochondrial SIRT3 functions by inhibiting SIRT3 acetylation may offer a new therapeutic approach for obesity-and aging-related diseases associated with mitochondrial dysfunction.
C1 [Kwon, Sanghoon; Seok, Sunmi; Kemper, Byron; Kemper, Jongsook Kim] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA.
   [Yau, Peter] Univ Illinois, Prote Ctr, Urbana, IL 61801 USA.
   [Li, Xiaoling] NIEHS, Lab Signal Transduct, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.
C3 University of Illinois System; University of Illinois Urbana-Champaign;
   University of Illinois System; University of Illinois Urbana-Champaign;
   National Institutes of Health (NIH) - USA; NIH National Institute of
   Environmental Health Sciences (NIEHS)
RP Kemper, JK (corresponding author), Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA.
EM jongsook@illinois.edu
RI ; Li, Xiaoling/A-2994-2015
OI Kemper, Jongsook/0000-0002-5534-0286; Li, Xiaoling/0000-0001-5920-7784
FU National Institutes of Health [DK062777, DK095842]; American Diabetes
   Association [1-16-IBS-156]
FX This work was supported by National Institutes of Health Grants DK062777
   and DK095842 and a Basic Science Award 1-16-IBS-156 from the American
   Diabetes Association (to J.K.K.). The authors declare that they have no
   conflicts of interest with the contents of this article. The content is
   solely the responsibility of the authors and does not necessarily
   represent the official views of the National Institutes of Health.
CR Albani D, 2014, AGE, V36, P469, DOI 10.1007/s11357-013-9559-2
   Aquilano K, 2013, CURR MOL MED, V13, P140, DOI 10.2174/156652413804486241
   Aquilano K, 2010, J BIOL CHEM, V285, P21590, DOI 10.1074/jbc.M109.070169
   Bharathi SS, 2013, J BIOL CHEM, V288, P33837, DOI 10.1074/jbc.M113.510354
   Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637
   Cantó C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022
   Choi SE, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00006-17
   Choi SE, 2013, AGING CELL, V12, P1062, DOI 10.1111/acel.12135
   Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371
   Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197
   Flick F, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00029
   Ghisays F, 2015, CELL REP, V10, P1665, DOI 10.1016/j.celrep.2015.02.036
   Nguyen GTT, 2013, CHEM BIOL, V20, P1375, DOI 10.1016/j.chembiol.2013.09.019
   Giblin W, 2014, TRENDS GENET, V30, P271, DOI 10.1016/j.tig.2014.04.007
   Giralt A, 2011, J BIOL CHEM, V286, P16958, DOI 10.1074/jbc.M110.202390
   Guarente L, 2011, COLD SH Q B, V76, P81, DOI 10.1101/sqb.2011.76.010629
   Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250
   Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103
   Hallows WC, 2011, MOL CELL, V41, P139, DOI 10.1016/j.molcel.2011.01.002
   He WJ, 2012, TRENDS ENDOCRIN MET, V23, P467, DOI 10.1016/j.tem.2012.07.004
   Hebert AS, 2013, MOL CELL, V49, P186, DOI 10.1016/j.molcel.2012.10.024
   Hirschey MD, 2011, MOL CELL, V44, P177, DOI 10.1016/j.molcel.2011.07.019
   Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778
   Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293
   Hubbard BP, 2013, SCIENCE, V339, P1216, DOI 10.1126/science.1231097
   Imai S, 2009, FRONT BIOSCI-LANDMRK, V14, P2983, DOI 10.2741/3428
   Ji H, 2008, INT J OBESITY, V32, P1331, DOI 10.1038/ijo.2008.71
   Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482
   Kemper JK, 2009, CELL METAB, V10, P392, DOI 10.1016/j.cmet.2009.09.009
   Kendrick AA, 2011, BIOCHEM J, V433, P505, DOI 10.1042/BJ20100791
   Kim DH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12179
   Kim DH, 2015, EMBO J, V34, P184, DOI 10.15252/embj.201489527
   Kong XX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011707
   Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013
   Lee J, 2010, AGING-US, V2, P527, DOI 10.18632/aging.100184
   Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07
   Miao J, 2009, GENE DEV, V23, P986, DOI 10.1101/gad.1773909
   PAIK WK, 1970, BIOCHIM BIOPHYS ACTA, V213, P513, DOI 10.1016/0005-2787(70)90058-4
   Ponugoti B, 2010, J BIOL CHEM, V285, P33959, DOI 10.1074/jbc.M110.122978
   Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015
   Revollo JR, 2013, TRENDS BIOCHEM SCI, V38, P160, DOI 10.1016/j.tibs.2012.12.004
   Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354
   Scott I, 2012, BIOCHEM J, V443, P655, DOI 10.1042/BJ20120118
   Shi T, 2005, J BIOL CHEM, V280, P13560, DOI 10.1074/jbc.M414670200
   Shimazu T, 2010, CELL METAB, V12, P654, DOI 10.1016/j.cmet.2010.11.003
   Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200
   Taylor EB, 2011, BIOCHEM SOC T, V39, P1509, DOI 10.1042/BST0391509
   Tian Y, 2016, CELL, V165, P1197, DOI 10.1016/j.cell.2016.04.011
   Yamamoto H, 2007, MOL ENDOCRINOL, V21, P1745, DOI 10.1210/me.2007-0079
   Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014
NR 50
TC 72
Z9 78
U1 1
U2 19
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD OCT 20
PY 2017
VL 292
IS 42
BP 17312
EP 17323
DI 10.1074/jbc.M117.778720
PG 12
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA FL1YC
UT WOS:000414009300014
PM 28808064
OA hybrid, Green Published
DA 2024-02-19
ER

PT S
AU Liu, HL
   Wang, H
   Shenvi, S
   Hagen, TM
   Liu, RM
AF Liu, HL
   Wang, H
   Shenvi, S
   Hagen, TM
   Liu, RM
BE DeGrey, ADN
TI Glutathione metabolism during aging and in Alzheimer disease
SO STRATEGIES FOR ENGINEERED NEGLIGIBLE SENESCENCE: WHY GENUINE CONTROL OF
   AGING MAY BE FORESEEABLE
SE Annals of the New York Academy of Sciences
LA English
DT Article; Proceedings Paper
CT 10th Congress of the International-Association-of-Biomedical-Gerontology
CY SEP 19-23, 2003
CL Cambridge, ENGLAND
SP Int Assoc Biomed Gerontol
DE glutathione; aging; gender; glutamate cysteine ligase;
   gamma-glutamylcysteine synthetase; Alzheimer disease; estrogen
ID AGE-ASSOCIATED DECLINE; OXIDATIVE DAMAGE; BODY-COMPOSITION;
   GENE-EXPRESSION; ELDERLY-MEN; RATS; TESTOSTERONE; ESTRADIOL
AB The concentration of glutathione (GSH), the most abundant intracellular nonprotein thiol and important antioxidant, declines with age and in some age-related diseases. The underlying mechanism, however, is not clear. The previous studies from our laboratory showed that the age-dependent decline in GSH content in Fisher 344 rats was associated with a downregulation of glutamate cysteine ligase (GCL), the rate-limiting enzyme in de novo GSH synthesis. Our recent studies further indicated that the activity and mRNA content of glutathione synthase (GS), which catalyzes the second reaction in de novo GSH synthesis, were also decreased with age in some tissues. No age-associated change was observed in glutathione reductase or gamma-glutamyl transpeptidase activities. Also, although GSH content declined with age in both male and female mice, male mice experienced more dramatic age-associated decline in many tissues/organs than female mice. Furthermore, we found that GSH content was significantly decreased in the red blood cells from male Alzheimer disease patients, which was associated with decreases in GCL and GS activities. Finally, we showed that estrogen increased GSH content, GS and GR activities, and GCL gene expression in the liver of both male and female mice. Taken together, our results suggest that (1) GCL plays a critical role in maintaining GSH homeostasis under both physiological and pathological conditions; (2) decreased GSH content may be involved in AD pathology in humans; and (3) estrogen increases GSH content in mice by multiple mechanisms.
C1 Univ Alabama Birmingham, Sch Publ Hlth, Dept Environm Hlth Sci, Birmingham, AL 35294 USA.
   Univ Alabama Birmingham, Sch Med, Dept Immunol, Birmingham, AL 35294 USA.
   Oregon State Univ, Linus Pauling Inst Sci & Med, Corvallis, OR 97331 USA.
C3 University of Alabama System; University of Alabama Birmingham;
   University of Alabama System; University of Alabama Birmingham; Oregon
   State University
RP Liu, RM (corresponding author), Univ Alabama Birmingham, Sch Publ Hlth, Dept Environm Hlth Sci, 1665 Univ Blvd, Birmingham, AL 35294 USA.
EM rliu@uab.edu
CR Carlson LE, 2000, MENOPAUSE, V7, P168, DOI 10.1097/00042192-200007030-00007
   Denti L, 2000, J AM GERIATR SOC, V48, P51, DOI 10.1111/j.1532-5415.2000.tb03028.x
   Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698
   Liu RM, 2000, FREE RADICAL BIO MED, V28, P566, DOI 10.1016/S0891-5849(99)00269-5
   Liu RM, 2003, ANTIOXID REDOX SIGN, V5, P529, DOI 10.1089/152308603770310176
   Liu RM, 2002, J NEUROSCI RES, V68, P344, DOI 10.1002/jnr.10217
   Miró O, 2000, CARDIOVASC RES, V47, P624, DOI 10.1016/S0008-6363(00)00122-X
   Perry G, 2002, FREE RADICAL BIO MED, V33, P1475, DOI 10.1016/S0891-5849(02)01113-9
   Tian LQ, 1998, FREE RADICAL BIO MED, V24, P1477, DOI 10.1016/S0891-5849(98)00025-2
   van den Beld AW, 2000, J CLIN ENDOCR METAB, V85, P3276, DOI 10.1210/jc.85.9.3276
   Wang H, 2003, EXP GERONTOL, V38, P507, DOI 10.1016/S0531-5565(03)00036-6
   Zeevalk GD, 1998, J NEUROCHEM, V70, P1421
NR 12
TC 200
Z9 224
U1 3
U2 21
PU NEW YORK ACAD SCIENCES
PI NEW YORK
PA 2 EAST 63RD ST, NEW YORK, NY 10021 USA
SN 0077-8923
BN 1-57331-497-8; 1-57331-496-X
J9 ANN NY ACAD SCI
JI Ann.NY Acad.Sci.
PY 2004
VL 1019
BP 346
EP 349
DI 10.1196/annals.1297.059
PG 4
WC Biochemistry & Molecular Biology; Cell Biology; Geriatrics &
   Gerontology; Multidisciplinary Sciences
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology; Geriatrics &
   Gerontology; Science & Technology - Other Topics
GA BAN77
UT WOS:000223002700059
PM 15247041
DA 2024-02-19
ER

PT J
AU Endlicher, R
   Drahota, Z
   Kucera, O
   Cervinkova, Z
AF Endlicher, Rene
   Drahota, Zdenek
   Kucera, Otto
   Cervinkova, Zuzana
TI Age-Dependent Changes in the Function of Mitochondrial Membrane
   Permeability Transition Pore in Rat Liver Mitochondria
SO PHYSIOLOGICAL RESEARCH
LA English
DT Article
DE Rat liver mitochondria; Mitochondrial permeability transition pore;
   Calcium retention capacity; Calcium-induced swelling
ID F0F1 ATP SYNTHASE; FREE-RADICALS
AB Mitochondria play an important role in the cell aging process. Changes in calcium homeostasis and/or increased reactive oxygen species (ROS) production lead to the opening of mitochondrial permeability transition pore (MPTP), depolarization of the inner mitochondrial membrane, and decrease of ATP production. Our work aimed to monitor age-related changes in the Ca2+ ion effect on MPTP and the ability of isolated rat liver mitochondria to accumulate calcium. The mitochondrial calcium retention capacity (CRC) was found to be significantly affected by the age of rats. Measurement of CRC values of the rat liver mitochondria showed two periods when 3 to 17-week old rats were tested. 3-week and 17-week old rats showed lower CRC values than 7-week old animals. Similar changes were observed while testing calcium-induced swelling of rat liver mitochondria. These findings indicate that the mitochondrial energy production system is more resistant to calcium-induced MPTP opening accompanied by the damaging effect of ROS in adult rats than in young and aged animals.
C1 [Endlicher, Rene; Drahota, Zdenek; Kucera, Otto; Cervinkova, Zuzana] Charles Univ Prague, Fac Med Hradec Kralove, Dept Physiol, Simkova 870, Hradec Kralove 50003, Czech Republic.
   [Endlicher, Rene] Charles Univ Prague, Fac Med Hradec Kralove, Dept Anat, Hradec Kralove, Czech Republic.
   [Drahota, Zdenek] Czech Acad Sci, Inst Physiol, Prague, Czech Republic.
C3 University Hospital Hradec Kralove; Charles University Prague; Charles
   University Prague; University Hospital Hradec Kralove; Czech Academy of
   Sciences; Institute of Physiology of the Czech Academy of Sciences
RP Cervinkova, Z (corresponding author), Charles Univ Prague, Fac Med Hradec Kralove, Dept Physiol, Simkova 870, Hradec Kralove 50003, Czech Republic.
EM wolff@lfhk.cuni.cz
RI Endlicher, René/B-7696-2017; Kučera, Otto/S-3734-2016
OI Endlicher, René/0000-0002-5781-4115; Kučera, Otto/0000-0002-5251-5343
FU Charles University Program PROGRES [Q40/02]
FX This work was supported by the Charles University Program PROGRES
   Q40/02.
CR BARJA G, 1994, COMP BIOCHEM PHYS B, V108, P501, DOI 10.1016/0305-0491(94)90103-1
   Barja G, 2004, TRENDS NEUROSCI, V27, P595, DOI 10.1016/j.tins.2004.07.005
   Barja G, 2014, PROG MOL BIOL TRANSL, V127, P1, DOI 10.1016/B978-0-12-394625-6.00001-5
   Barja G, 2010, AGING ISS HEALTH FIN, P1
   BENZI G, 1992, NEUROBIOL AGING, V13, P361, DOI 10.1016/0197-4580(92)90109-B
   Bonora M, 2015, ONCOGENE, V34, P1608, DOI [10.1038/onc.2014.462, 10.1038/onc.2014.96]
   Bonora M, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00302
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Brand MD, 2000, EXP GERONTOL, V35, P811, DOI 10.1016/S0531-5565(00)00135-2
   BUSTAMANTE E, 1977, ANAL BIOCHEM, V80, P401, DOI 10.1016/0003-2697(77)90661-3
   Cedikova M, 2016, PHYSIOL RES, V65, pS519, DOI 10.33549/physiolres.933538
   Ciccarone F, 2018, MECH AGEING DEV, V174, P3, DOI 10.1016/j.mad.2017.12.002
   Davies SMK, 2001, FREE RADICAL BIO MED, V31, P181, DOI 10.1016/S0891-5849(01)00576-7
   Di Lisa F, 2005, CARDIOVASC RES, V66, P222, DOI 10.1016/j.cardiores.2005.02.009
   Drahota Z, 2012, PHYSIOL RES, V61, pS165, DOI 10.33549/physiolres.932377
   Drahota Z, 2012, J BIOENERG BIOMEMBR, V44, P309, DOI 10.1007/s10863-012-9443-2
   Endlicher R, 2019, PHYSIOL RES, V68, P59, DOI 10.33549/physiolres.933912
   Fontaine E, 1998, J BIOL CHEM, V273, P12662, DOI 10.1074/jbc.273.20.12662
   Guerrieri F, 1996, ANN NY ACAD SCI, V786, P62, DOI 10.1111/j.1749-6632.1996.tb39052.x
   GUERRIERI F, 1994, BIOCHEM MOL BIOL INT, V33, P117
   Ichas F, 1997, CELL, V89, P1145, DOI 10.1016/S0092-8674(00)80301-3
   Kalous M, 1996, PHYSIOL RES, V45, P351
   Lenaz G, 1997, MOL CELL BIOCHEM, V174, P329, DOI 10.1023/A:1006854619336
   Mather M, 2000, BIOCHEM BIOPH RES CO, V273, P603, DOI 10.1006/bbrc.2000.2994
   Ostádalová I, 2012, PHYSIOL RES, V61, pS1, DOI 10.33549/physiolres.932385
   Pamplona R, 1996, MECH AGEING DEV, V86, P53, DOI 10.1016/0047-6374(95)01673-2
   Papa S, 1997, MOL CELL BIOCHEM, V174, P305, DOI 10.1023/A:1006873518427
   Son JM, 2019, BMB REP, V52, P13, DOI 10.5483/BMBRep.2019.52.1.300
   Yen K, 2009, MECH AGEING DEV, V130, P173, DOI 10.1016/j.mad.2008.11.003
NR 29
TC 1
Z9 1
U1 0
U2 14
PU ACAD SCIENCES CZECH REPUBLIC, INST PHYSIOLOGY
PI PRAGUE 4
PA VIDENSKA 1083, PRAGUE 4 142 20, CZECH REPUBLIC
SN 0862-8408
EI 1802-9973
J9 PHYSIOL RES
JI Physiol. Res.
PD DEC
PY 2021
VL 70
IS 6
BP 905
EP 911
DI 10.33549/physiolres.934734
PG 7
WC Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology
GA XW1NT
UT WOS:000735395600009
PM 34717067
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Chen, YX
   Le, PTN
   Tzeng, TT
   Tran, TH
   Nguyen, AT
   Cheng, IHJ
   Huang, CYF
   Shiao, YJ
   Ching, TT
AF Chen, Yan-Xi
   Le, Phuong Thu Nguyen
   Tzeng, Tsai-Teng
   Tran, Thu-Ha
   Nguyen, Anh Thuc
   Cheng, Irene Han-Juo
   Huang, Chi-Ying F.
   Shiao, Young-Ji
   Ching, Tsui-Ting
TI Graptopetalum paraguayenseExtract Ameliorates Proteotoxicity in Aging
   and Age-Related Diseases in Model Systems
SO NUTRIENTS
LA English
DT Article
DE GP extract; neurodegenerative disease; Alzheimer's disease;
   amyloid-beta; autophagy; longevity
ID LIFE-SPAN; MAMMALIAN TARGET; AUTOPHAGY; CLEARANCE; CELLS; BETA;
   DEFICITS; NEURONS
AB Declines in physiological functions are the predominant risk factors for age-related diseases, such as cancers and neurodegenerative diseases. Therefore, delaying the aging process is believed to be beneficial in preventing the onset of age-related diseases. Previous studies have demonstrated that Graptopetalum paraguayense (GP) extract inhibits liver cancer cell growth and reduces the pathological phenotypes of Alzheimer's disease (AD) in patient IPS-derived neurons. Here, we show that GP extract suppresses beta-amyloid pathology in SH-SYS5Y-APP(695) cells and APP/PS1 mice. Moreover, AMP-activated protein kinase (AMPK) activity is enhanced by GP extract in U87 cells and APP/PS1 mice. Intriguingly, GP extract enhances autophagy in SH-SYS5Y-APP(695) cells, U87 cells, and the nematode Caenorhabditis elegans, suggesting a conserved molecular mechanism by which GP extract might regulate autophagy. In agreement with its role as an autophagy activator, GP extract markedly diminishes mobility decline in polyglutamine Q35 mutants and aged wild-type N2 animals in C. elegans. Furthermore, GP extract significantly extends lifespan in C. elegans.
C1 [Chen, Yan-Xi; Tzeng, Tsai-Teng; Nguyen, Anh Thuc; Huang, Chi-Ying F.; Shiao, Young-Ji; Ching, Tsui-Ting] Natl Yang Ming Chiao Tung Univ, Inst Biopharmaceut Sci, Taipei 112, Taiwan.
   [Le, Phuong Thu Nguyen; Tran, Thu-Ha; Huang, Chi-Ying F.; Ching, Tsui-Ting] Natl Yang Ming Chiao Tung Univ, Taiwan Int Grad Program Mol Med, Taipei 115, Taiwan.
   [Le, Phuong Thu Nguyen; Tran, Thu-Ha; Huang, Chi-Ying F.; Ching, Tsui-Ting] Acad Sinica, Taipei 115, Taiwan.
   [Cheng, Irene Han-Juo] Natl Yang Ming Chiao Tung Univ, Inst Brain Sci, Taipei 112, Taiwan.
   [Shiao, Young-Ji] Minist Hlth & Welf, Natl Res Inst Chinese Med, Taipei 112, Taiwan.
C3 National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung
   University; Academia Sinica - Taiwan; National Yang Ming Chiao Tung
   University; National Research Institute of Chinese Medicine
RP Huang, CYF; Shiao, YJ; Ching, TT (corresponding author), Natl Yang Ming Chiao Tung Univ, Inst Biopharmaceut Sci, Taipei 112, Taiwan.; Huang, CYF; Ching, TT (corresponding author), Natl Yang Ming Chiao Tung Univ, Taiwan Int Grad Program Mol Med, Taipei 115, Taiwan.; Huang, CYF; Ching, TT (corresponding author), Acad Sinica, Taipei 115, Taiwan.; Shiao, YJ (corresponding author), Minist Hlth & Welf, Natl Res Inst Chinese Med, Taipei 112, Taiwan.
EM sunkist210@hotmail.com; thuphuonglenguyen96@gmail.com;
   fly23242530@hotmail.com; tranthuha164@gmail.com;
   anhthucnguyen1004@gmail.com; ihjcheng@gmail.com; cyhuang5@nycu.edu.tw;
   yshiao@nricm.edu.tw; ttching@nycu.edu.tw
RI Huang, Chi-Ying/AFL-7729-2022; Shiao, Young-Ji/AAA-9647-2022; Nguyen,
   Anh/GQQ-3393-2022; Huang, Chi-Ying/AAG-7672-2022; Nguyen,
   Anh/HTO-8740-2023
OI Huang, Chi-Ying/0000-0003-4898-4937; Huang,
   Chi-Ying/0000-0003-4898-4937; Shiao, Young-Ji/0000-0002-2699-116X;
   Ching, Tsui-Ting/0000-0001-7650-1766; Cheng, Irene
   Han-Jou/0000-0002-3737-3877; Tran, Thu-Ha/0000-0002-2273-2793
FU Minister of Science and Technology, Taiwan [MOST 106-2311-B-010-005,
   MOST 106-2320-B-077-001, MOST 110-2320-B-A49A-541]; NIH Office of
   Research Infrastructure Programs [P40 OD010440]
FX This work was supported by grants from the Minister of Science and
   Technology, Taiwan to T.-T.C. (MOST 106-2311-B-010-005), to Y.-J.S.
   (MOST 106-2320-B-077-001), and to C.-Y.F.H. (MOST 110-2320-B-A49A-541).
   Some worm strains were provided by the CGC, which is funded by NIH
   Office of Research Infrastructure Programs (P40 OD010440).
CR Apfeld J, 2004, GENE DEV, V18, P3004, DOI 10.1101/gad.1255404
   Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544
   Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008
   Caballero B, 2018, AGING CELL, V17, DOI 10.1111/acel.12692
   Caccamo A, 2014, J NEUROSCI, V34, P7988, DOI 10.1523/JNEUROSCI.0777-14.2014
   Caccamo A, 2010, J BIOL CHEM, V285, P13107, DOI 10.1074/jbc.M110.100420
   Congdon EE, 2012, AUTOPHAGY, V8, P609, DOI 10.4161/auto.19048
   Deng ZQ, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0232-6
   Dikic I, 2017, ANNU REV BIOCHEM, V86, P193, DOI 10.1146/annurev-biochem-061516-044908
   Duh PD, 2011, J ETHNOPHARMACOL, V134, P379, DOI 10.1016/j.jep.2010.12.029
   Dzamba D, 2016, CURR ALZHEIMER RES, V13, P894, DOI 10.2174/1567205013666160129095924
   Fernandez Alvaro F, 2018, Nature, V558, P136, DOI 10.1038/s41586-018-0162-7
   Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697
   Halama A, 2018, CANCER LETT, V430, P133, DOI 10.1016/j.canlet.2018.05.017
   Hipp MS, 2019, NAT REV MOL CELL BIO, V20, P421, DOI 10.1038/s41580-019-0101-y
   Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701
   Hsu WH, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20102592
   Hsu WH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121298
   Kaushik S, 2015, NAT MED, V21, P1406, DOI 10.1038/nm.4001
   Khan SS, 2017, AGING CELL, V16, P624, DOI 10.1111/acel.12601
   Kuo CT, 2020, AGING CELL, V19, DOI 10.1111/acel.13157
   Lapierre LR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3267
   Lee S, 2011, AUTOPHAGY, V7, P1562, DOI 10.4161/auto.7.12.17956
   Lin AL, 2017, J CEREBR BLOOD F MET, V37, P217, DOI 10.1177/0271678X15621575
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Ma JF, 2010, NEUROPATH APPL NEURO, V36, P312, DOI 10.1111/j.1365-2990.2010.01067.x
   Ma T, 2014, J NEUROSCI, V34, P12230, DOI 10.1523/JNEUROSCI.1694-14.2014
   Majumder S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025416
   Martin DDO, 2015, TRENDS NEUROSCI, V38, P26, DOI 10.1016/j.tins.2014.09.003
   Menzies FM, 2015, NAT REV NEUROSCI, V16, P345, DOI 10.1038/nrn3961
   Nakamura S, 2018, MOL CELLS, V41, P65, DOI 10.14348/molcells.2018.2333
   Nixon RA, 2011, NEUROBIOL DIS, V43, P38, DOI 10.1016/j.nbd.2011.01.021
   Pyo JO, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3300
   Rocchi A, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006962
   Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030
   Sanchez MIGL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10233-0
   Schaeffer V, 2012, BRAIN, V135, P2169, DOI 10.1093/brain/aws143
   Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189
   Shin JY, 2014, AUTOPHAGY, V10, P32, DOI 10.4161/auto.26508
   Simonovitch S, 2016, J ALZHEIMERS DIS, V51, P915, DOI 10.3233/JAD-151101
   Simonsen A, 2008, AUTOPHAGY, V4, P176, DOI 10.4161/auto.5269
   Su LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053988
   Subramanian A, 2017, CELL, V171, P1437, DOI 10.1016/j.cell.2017.10.049
   Weir HJ, 2017, CELL METAB, V26, P884, DOI 10.1016/j.cmet.2017.09.024
   Wu PC, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55614-9
   Xiao QL, 2014, J NEUROSCI, V34, P9607, DOI 10.1523/JNEUROSCI.3788-13.2014
NR 46
TC 3
Z9 3
U1 1
U2 9
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD DEC
PY 2021
VL 13
IS 12
AR 4317
DI 10.3390/nu13124317
PG 14
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA YI6IM
UT WOS:000743950100001
PM 34959868
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Sack, I
   Beierbach, B
   Wuerfel, J
   Klatt, D
   Hamhaber, U
   Papazoglou, S
   Martus, P
   Braun, J
AF Sack, Ingolf
   Beierbach, Bernd
   Wuerfel, Jens
   Klatt, Dieter
   Hamhaber, Uwe
   Papazoglou, Sebastian
   Martus, Peter
   Braun, Juergen
TI The impact of aging and gender on brain viscoelasticity
SO NEUROIMAGE
LA English
DT Article
DE Brain viscoelasticity; Stiffness; Age; Sex; Rheology; Springpot
ID MAGNETIC-RESONANCE ELASTOGRAPHY; MR ELASTOGRAPHY; NEURONS; CELLS; LIFE
AB Viscoelasticity is a sensitive measure of the microstructural constitution of soft biological tissue and is increasingly used as a diagnostic marker, e.g. in staging liver fibrosis or characterizing breast tumors. In this study, multifrequency magnetic resonance elastography was used to investigate the in vivo viscoelasticity of healthy human brain in 55 volunteers (23 females) ranging in age from 18 to 88 years. The application of four vibration frequencies in an acoustic range from 25 to 62.5 Hz revealed for the first time how physiological aging changes the global viscosity and elasticity of the brain. Using the theological springpot model, viscosity and elasticity are combined in a parameter mu that describes the solid-fluid behavior of the tissue and a parameter a related to the tissue's microstructure. It is shown that the healthy adult brain undergoes steady parenchymal 'liquefaction' characterized by a continuous decline in mu of 0.8% per year (P<0.001), whereas alpha remains unchanged. Furthermore, significant sex differences were found with female brains being on average 9% more solid-like than their male counterparts rendering women more than a decade 'younger' than men with respect to brain mechanics (P = 0.016). These results set the background for using cerebral multifrequency elastography in diagnosing subtle neurodegenerative processes not detectable by other diagnostic methods. (C) 2009 Elsevier Inc. All rights reserved.
C1 [Sack, Ingolf; Beierbach, Bernd; Klatt, Dieter; Papazoglou, Sebastian] Charite, Dept Radiol, D-10117 Berlin, Germany.
   [Wuerfel, Jens] Univ Schleswig Holstein, Inst Neuroradiol, Lubeck, Germany.
   [Hamhaber, Uwe; Braun, Juergen] Charite, Inst Med Informat, D-10117 Berlin, Germany.
   [Martus, Peter] Charite, Inst Biometry & Clin Epidemiol, D-10117 Berlin, Germany.
C3 Free University of Berlin; Humboldt University of Berlin; Charite
   Universitatsmedizin Berlin; University of Kiel; Schleswig Holstein
   University Hospital; Free University of Berlin; Humboldt University of
   Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin;
   Humboldt University of Berlin; Charite Universitatsmedizin Berlin
RP Sack, I (corresponding author), Charite, Dept Radiol, Charitepl 1,Campus Charite Mitte, D-10117 Berlin, Germany.
EM ingolf.sack@charite.de
RI Braun, Jochen/F-1370-2013
OI Braun, Jochen/0000-0002-8886-078X; Braun, Jurgen/0000-0001-5183-7546;
   Wuerfel, Jens/0000-0002-0034-8053
CR Asbach P, 2008, MAGN RESON MED, V60, P373, DOI 10.1002/mrm.21636
   DEKABAN AS, 1978, ANN NEUROL, V4, P345, DOI 10.1002/ana.410040410
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Fung YC., 1993, Biomechanics: Mechanical Properties of Living Tissues, V2nd edn
   Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786
   Green MA, 2008, NMR BIOMED, V21, P755, DOI 10.1002/nbm.1254
   Hamhaber U, 2007, ACTA BIOMATER, V3, P127, DOI 10.1016/j.actbio.2006.08.007
   Hrapko M, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2907746
   Hsu JL, 2008, NEUROIMAGE, V39, P566, DOI 10.1016/j.neuroimage.2007.09.017
   KLATT D, 2008, ROFO FORTSCHR RONTG, V180, P1106
   Klatt D, 2007, PHYS MED BIOL, V52, P7281, DOI 10.1088/0031-9155/52/24/006
   KOELLER RC, 1984, J APPL MECH-T ASME, V51, P299, DOI 10.1115/1.3167616
   Kruse SA, 2008, NEUROIMAGE, V39, P231, DOI 10.1016/j.neuroimage.2007.08.030
   Lu YB, 2006, P NATL ACAD SCI USA, V103, P17759, DOI 10.1073/pnas.0606150103
   McCracken PJ, 2005, MAGN RESON MED, V53, P628, DOI 10.1002/mrm.20388
   Morrison JH, 1997, SCIENCE, V278, P412, DOI 10.1126/science.278.5337.412
   Mueller SG, 2006, NMR BIOMED, V19, P655, DOI 10.1002/nbm.1062
   Pakkenberg B, 2003, EXP GERONTOL, V38, P95, DOI 10.1016/S0531-5565(02)00151-1
   Papazoglou S, 2008, PHYS MED BIOL, V53, P3147, DOI 10.1088/0031-9155/53/12/005
   Papazoglou S, 2007, PHYS MED BIOL, V52, P675, DOI 10.1088/0031-9155/52/3/010
   PELVIG DP, 2007, NEUROBIOL AGING
   Sack I, 2008, NMR BIOMED, V21, P265, DOI 10.1002/nbm.1189
   Sinkus R, 2007, MAGN RESON MED, V58, P1135, DOI 10.1002/mrm.21404
   TERRY RD, 1987, ANN NEUROL, V21, P530, DOI 10.1002/ana.410210603
   Thibault KL, 1998, J BIOMECH, V31, P1119, DOI 10.1016/S0021-9290(98)00122-5
   Tschoegl N. W., 1989, PHENOMENOLOGICAL THE
   VanEssen DC, 1997, NATURE, V385, P313, DOI 10.1038/385313a0
   Vappou J, 2007, MAGN RESON MATER PHY, V20, P273, DOI 10.1007/s10334-007-0098-7
   WUERFEL J, 2008, P 16 SCI M INT SOC M, P1547
   Xu L, 2007, ACTA RADIOL, V48, P327, DOI 10.1080/02841850701199967
NR 30
TC 292
Z9 326
U1 0
U2 52
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1053-8119
EI 1095-9572
J9 NEUROIMAGE
JI Neuroimage
PD JUL 1
PY 2009
VL 46
IS 3
BP 652
EP 657
DI 10.1016/j.neuroimage.2009.02.040
PG 6
WC Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical
   Imaging
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging
GA 443VK
UT WOS:000265938700012
PM 19281851
DA 2024-02-19
ER

PT J
AU Van Remmen, H
   Ikeno, Y
   Hamilton, M
   Pahlavani, M
   Wolf, N
   Thorpe, SR
   Alderson, NL
   Baynes, JW
   Epstein, CJ
   Huang, TT
   Nelson, J
   Strong, R
   Richardson, A
AF Van Remmen, H
   Ikeno, Y
   Hamilton, M
   Pahlavani, M
   Wolf, N
   Thorpe, SR
   Alderson, NL
   Baynes, JW
   Epstein, CJ
   Huang, TT
   Nelson, J
   Strong, R
   Richardson, A
TI Life-long reduction in MnSOD activity results in increased DNA damage
   and higher incidence of cancer but does not accelerate aging
SO PHYSIOLOGICAL GENOMICS
LA English
DT Article
DE oxidative damage; mitochondria
ID MITOCHONDRIAL TARGETING SEQUENCE; CUZN SUPEROXIDE-DISMUTASE; AGE-RELATED
   CATARACT; OXIDATIVE DAMAGE; CALORIC RESTRICTION; DIETARY RESTRICTION;
   TRANSGENIC MICE; SPAN; OVEREXPRESSION; POLYMORPHISM
AB Mice heterozygous for the Sod2 gene (Sod2(+/)- mice) have been used to study the phenotype of life- long reduced Mn- superoxide dismutase ( MnSOD) activity. The Sod2(+/-) mice have reduced MnSOD activity ( similar to 50%) in all tissues throughout life. The Sod2(+/-) mice have increased oxidative damage as demonstrated by significantly elevated levels of 8- oxo- 2- deoxyguanosine ( 8oxodG) in nuclear DNA in all tissues of Sod2(+/-) mice studied. The levels of 8oxodG in nuclear DNA increased with age in all tissues of Sod2(+/-) and wild- type ( WT) mice, and at 26 mo of age, the levels of 8oxodG in nuclear DNA were significantly higher ( from 15% in heart to over 60% in liver) in the Sod2(+/-) mice compared with WT mice. The level of 8oxodG was also higher in mitochondrial DNA isolated from liver and brain in Sod2(+/-) mice compared with WT mice. The increased oxidative damage to DNA in the Sod2(+/-) mice is associated with a 100% increase in tumor incidence ( the number of mice with tumors) in old Sod2(+/-) mice compared with the old WT mice. However, the life spans ( mean and maximum survival) of the Sod2(+/-) and WT mice were identical. In addition, biomarkers of aging, such as cataract formation, immune response, and formation of glycoxidation products carboxymethyl lysine and pentosidine in skin collagen changed with age to the same extent in both WT and Sod2(+/-) mice. Thus life- long reduction of MnSOD activity leads to increased levels of oxidative damage to DNA and increased cancer incidence but does not appear to affect aging.
C1 Univ Texas, Hlth Sci Ctr, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA.
   Univ Texas, Hlth Sci Ctr, Dept Physiol, San Antonio, TX 78229 USA.
   Univ Texas, Hlth Sci Ctr, Dept Pharmacol, San Antonio, TX 78229 USA.
   Univ Texas, Hlth Sci Ctr, Barshop Ctr Longev Studies, San Antonio, TX 78229 USA.
   S Texas Vet Hlth Care Syst, Ctr Geriatr Res Educ & Clin, San Antonio, TX 78284 USA.
   S Texas Vet Hlth Care Syst, Res Serv, San Antonio, TX 78284 USA.
   Univ Washington, Dept Pathol, Seattle, WA 98195 USA.
   Univ S Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA.
   Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA.
   Stanford Univ, Palo Alto, CA 94304 USA.
C3 University of Texas System; University of Texas Health Science Center at
   San Antonio; University of Texas System; University of Texas Health
   Science Center at San Antonio; University of Texas System; University of
   Texas Health Science Center at San Antonio; University of Texas System;
   University of Texas Health Science Center at San Antonio; Geriatric
   Research Education & Clinical Center; US Department of Veterans Affairs;
   Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans
   Hospital; US Department of Veterans Affairs; Veterans Health
   Administration (VHA); Audie L. Murphy Memorial Veterans Hospital;
   University of Washington; University of Washington Seattle; University
   of South Carolina System; University of South Carolina Columbia;
   University of California System; University of California San Francisco;
   Stanford University
RP Richardson, A (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Cellular & Struct Biol, 7703 Floyd Curl Dr,MSC 7762, San Antonio, TX 78229 USA.
EM richardsona@uthscsa.edu
RI YAMAMOTO, MASAHIRO/F-9094-2011
OI YAMAMOTO, MASAHIRO/0000-0003-3859-0125
FU NEI NIH HHS [R01-EY-11733] Funding Source: Medline; NIA NIH HHS
   [1P30-AG-13319, R01-AG-16998, R01-AG-015908, P01-AG-19316,
   P01-AG-020591] Funding Source: Medline; NIDDK NIH HHS [R01-DK-19971]
   Funding Source: Medline
CR AUTOR AP, 1974, LIFE SCI, V14, P1309, DOI 10.1016/0024-3205(74)90439-1
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   BLACKWELL BN, 1995, TOXICOL PATHOL, V23, P570, DOI 10.1177/019262339502300503
   BORGSTAHL GEO, 1992, CELL, V71, P107, DOI 10.1016/0092-8674(92)90270-M
   BUS JS, 1974, BIOCHEM BIOPH RES CO, V58, P749, DOI 10.1016/S0006-291X(74)80481-X
   CADET JL, 1994, BRAIN RES, V655, P259, DOI 10.1016/0006-8993(94)91624-1
   García-Cao I, 2002, EMBO J, V21, P6225, DOI 10.1093/emboj/cdf595
   Goto S, 2001, ANN NY ACAD SCI, V928, P54
   Hamilton ML, 2001, NUCLEIC ACIDS RES, V29, P2117, DOI 10.1093/nar/29.10.2117
   Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698
   HO YS, 1988, FEBS LETT, V229, P256, DOI 10.1016/0014-5793(88)81136-0
   Horie Y, 1998, CIRC RES, V83, P691, DOI 10.1161/01.RES.83.7.691
   HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661
   Huang TT, 2000, J GERONTOL A-BIOL, V55, pB5
   KASAI H, 1986, CARCINOGENESIS, V7, P1849, DOI 10.1093/carcin/7.11.1849
   Kasprzak KS, 2002, FREE RADICAL BIO MED, V32, P958, DOI 10.1016/S0891-5849(02)00809-2
   Lebovitz RM, 1996, P NATL ACAD SCI USA, V93, P9782, DOI 10.1073/pnas.93.18.9782
   LEPAGE F, 1995, CARCINOGENESIS, V16, P2779
   LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376
   MAEDA H, 1985, J GERONTOL, V40, P671, DOI 10.1093/geronj/40.6.671
   Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311
   Mitrunen K, 2001, CARCINOGENESIS, V22, P827, DOI 10.1093/carcin/22.5.827
   Moskovitz J, 2001, P NATL ACAD SCI USA, V98, P12920, DOI 10.1073/pnas.231472998
   PAHLAVANI MA, 1988, J APPL PHYSIOL, V64, P1997, DOI 10.1152/jappl.1988.64.5.1997
   Pamplona R, 2002, FREE RADICAL RES, V36, P47, DOI 10.1080/10715760210165
   Parkes TL, 1998, NAT GENET, V19, P171, DOI 10.1038/534
   REQUENA JR, 1999, METHODS MOL MED AGIN, V38, P209
   ROWLATT C, 1976, Laboratory Animals (London), V10, P419, DOI 10.1258/002367776780956917
   Samper E, 2003, AGING CELL, V2, P277, DOI 10.1046/j.1474-9728.2003.00062.x
   Sell DR, 1997, J GERONTOL A-BIOL, V52, pB277, DOI 10.1093/gerona/52A.5.B277
   Sell DR, 2001, J GERONTOL A-BIOL, V56, pB405, DOI 10.1093/gerona/56.9.B405
   Sharp ZD, 2003, CARCINOGENESIS, V24, P179, DOI 10.1093/carcin/24.2.179
   Shaw J Nikki, 2002, Methods Mol Biol, V186, P129
   ShimodaMatsubayashi S, 1996, BIOCHEM BIOPH RES CO, V226, P561, DOI 10.1006/bbrc.1996.1394
   SHIMOKAWA I, 1991, J GERONTOL, V46, pB228, DOI 10.1093/geronj/46.6.B228
   SHIMOKAWA I, 1993, J GERONTOL, V48, pB68, DOI 10.1093/geronj/48.2.B68
   SIEGEL S, 1956, NONPARAMETRIC STAT B
   Stoehlmacher J, 2002, ONCOL REP, V9, P235
   Sun JT, 1999, MOL CELL BIOL, V19, P216
   SUN Y, 1988, FREE RADICAL RES COM, V5, P67, DOI 10.3109/10715768809066913
   Van Remmen H, 2001, AM J PHYSIOL-HEART C, V281, pH1422, DOI 10.1152/ajpheart.2001.281.3.H1422
   Van Remmen H, 2001, EXP GERONTOL, V36, P957
   Van Remmen H, 1999, ARCH BIOCHEM BIOPHYS, V363, P91, DOI 10.1006/abbi.1998.1060
   VOLK MJ, 1994, CANCER RES, V54, P3054
   Wang LI, 2001, J NATL CANCER I, V93, P1818, DOI 10.1093/jnci/93.23.1818
   Williams MD, 1998, J BIOL CHEM, V273, P28510, DOI 10.1074/jbc.273.43.28510
   Wolf NS, 2000, EXP EYE RES, V70, P683, DOI 10.1006/exer.2000.0835
   Wolf NS, 2001, EXP EYE RES, V73, P37, DOI 10.1006/exer.2001.1010
   Ying WH, 2000, J CEREBR BLOOD F MET, V20, P359, DOI 10.1097/00004647-200002000-00018
   YU BP, 1996, FREE RADIC BIOL MED, V21
NR 50
TC 561
Z9 653
U1 2
U2 23
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 1094-8341
EI 1531-2267
J9 PHYSIOL GENOMICS
JI Physiol. Genomics
PD DEC 16
PY 2003
VL 16
IS 1
BP 29
EP 37
DI 10.1152/physiolgenomics.00122.2003
PG 9
WC Cell Biology; Genetics & Heredity; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity; Physiology
GA 754PW
UT WOS:000187327300005
PM 14679299
DA 2024-02-19
ER

PT J
AU Shi, L
AF Shi, Lin
TI Association of energy-adjusted dietary inflammatory index and frailty in
   older adults with nonalcoholic fatty liver disease
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE Energy-adjusted dietary inflammatory index; NHANES; Frailty;
   Nonalcoholic fatty liver disease; Aging
ID HEALTH
AB Background: Energy-adjusted dietary inflammatory index (E-DII) can represent daily inflammatory dietary components and chronic inflammatory response is an important pathogenesis of aging, nonalcoholic fatty liver disease (NAFLD) and frailty. Therefore, the purpose of this study is to explore the association of E-DII and frailty in older adults with NAFLD. Methods: This cross-sectional study utilized data from the National Health and Nutrition Examination Survey (2005-2016) to investigate the association between E-DII and frailty. The NAFLD status was determined using the US Fatty Liver Index (FLI) value >= 30. The relationship between E-DII and frailty was examined through multivariate weighted logistic regression analysis and smooth curve fitting. Subgroup analyses were conducted, considering various demographic and clinical variables. Results: Our final analysis included 1586 individuals, with an average age of 69.42 years, and 53.15 % of them were males. The overall prevalence of frailty in the study population was 39.42 %. Smooth curve fitting analysis demonstrated a nearly linear relationship between E-DII and H. pylori. Utilizing multivariate weighted logistic regression analysis, we found that the odds ratio (OR) of E-DII for frailty was 1.08 (95%CI, 1.03-1.15). Subgroup analysis further confirmed that E-DII independently increased the risk of frailty. Conclusion: Higher E-DII levels were found to be associated with an increased risk of frailty in older adults with NAFLD. However, further studies are required to fully elucidate the precise mechanisms underlying the relationship between E-DII and frailty.
C1 [Shi, Lin] Xuzhou Med Univ, Xuzhou Cent Hosp, Xuzhou Clin Sch, Dept Gastroenterol, Xuzhou, Jiangsu, Peoples R China.
   [Shi, Lin] Xuzhou Cent Hosp, Dept Gastroenterol, Xuzhou, Jiangsu, Peoples R China.
C3 Xuzhou Medical University
RP Shi, L (corresponding author), Xuzhou Cent Hosp, Dept Gastroenterol, Xuzhou, Jiangsu, Peoples R China.
EM linshi_xuzhou@outlook.com
CR Alqahtani SA, 2021, CLIN INTERV AGING, V16, P1633, DOI 10.2147/CIA.S295524
   Baechle JJ, 2023, MOL METAB, V74, DOI 10.1016/j.molmet.2023.101755
   Belizário JE, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2197-2
   Bhanji RA, 2019, LIVER TRANSPLANT, V25, P14, DOI 10.1002/lt.25346
   Bo YC, 2022, NUTRIENTS, V14, DOI 10.3390/nu14112253
   Bradley N., 2023, Ann. Vasc. Surg.
   Cai SF, 2021, ECOTOX ENVIRON SAFE, V224, DOI 10.1016/j.ecoenv.2021.112665
   Chen C, 2021, ECOTOX ENVIRON SAFE, V218, DOI 10.1016/j.ecoenv.2021.112295
   Jimenez-Gutierrez GE, 2022, CELLS-BASEL, V11, DOI 10.3390/cells11152359
   Gainfort A., 2023, AJOG Global Reports, V3
   Geladari E, 2023, ANN GASTROENTEROL, V36, P392, DOI 10.20524/aog.2023.0804
   Hakeem FF, 2021, J AM MED DIR ASSOC, V22, P559, DOI 10.1016/j.jamda.2020.07.023
   Hammerich L, 2023, NAT REV GASTRO HEPAT, V20, P633, DOI 10.1038/s41575-023-00807-x
   Huang Y, 2022, FRONT NUTR, V9, DOI 10.3389/fnut.2022.899004
   Jurado-Fasoli L, 2020, NUTRIENTS, V12, DOI 10.3390/nu12020281
   Karakousis ND, 2022, ANN GASTROENTEROL, V35, P234, DOI 10.20524/aog.2022.0705
   Lai JC, 2020, J HEPATOL, V73, P575, DOI 10.1016/j.jhep.2020.03.029
   Londhe P, 2015, BONE, V80, P131, DOI 10.1016/j.bone.2015.03.015
   Mazidi M, 2018, ATHEROSCLEROSIS, V276, P23, DOI 10.1016/j.atherosclerosis.2018.02.020
   Naimimohasses S, 2022, BMJ OPEN GASTROENTER, V9, DOI 10.1136/bmjgast-2021-000861
   Niranjan S, 2023, FRONT ENDOCRINOL, V14, DOI 10.3389/fendo.2023.1193373
   Novi S, 2023, NUTRIENTS, V15, DOI 10.3390/nu15122748
   Ruhl CE, 2015, ALIMENT PHARM THER, V41, P65, DOI 10.1111/apt.13012
   Searle Samuel D, 2008, BMC Geriatr, V8, P24, DOI 10.1186/1471-2318-8-24
   Shi L., 2023, Mediators Inflamm, V2023, P1
   Shi L, 2023, BMC PUBLIC HEALTH, V23, DOI 10.1186/s12889-023-16338-8
   Shi L, 2023, DIABETOL METAB SYNDR, V15, DOI 10.1186/s13098-023-01016-x
   Shivappa N, 2014, PUBLIC HEALTH NUTR, V17, P1689, DOI 10.1017/S1368980013002115
   Tuttle CSL, 2020, AGEING RES REV, V64, DOI 10.1016/j.arr.2020.101185
   Vilar-Gomez E, 2023, CLIN GASTROENTEROL H, V21, P115, DOI 10.1016/j.cgh.2021.12.029
   Wang J, 2021, CLIN INTERV AGING, V16, P97, DOI 10.2147/CIA.S285000
   Wang X., 2023, BMJ Open Respir. Res., V10
   Xiang ST, 2022, CLIN RHEUMATOL, V41, P2647, DOI 10.1007/s10067-022-06217-9
   Xu B, 2023, ENVIRON SCI POLLUT R, V30, P98261, DOI 10.1007/s11356-023-29290-2
   Younossi ZM, 2022, LIVER INT, V42, P2646, DOI 10.1111/liv.15437
   Zhao LY, 2023, J AFFECT DISORDERS, V323, P257, DOI 10.1016/j.jad.2022.11.052
NR 36
TC 0
Z9 0
U1 2
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD OCT 15
PY 2023
VL 182
AR 112296
DI 10.1016/j.exger.2023.112296
EA OCT 2023
PG 8
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA X4PU8
UT WOS:001098295800001
PM 37734669
OA hybrid
DA 2024-02-19
ER

PT J
AU Hunt, CM
   Yuen, NA
   Stirnadel-Farrant, HA
   Suzuki, A
AF Hunt, Christine M.
   Yuen, Nancy A.
   Stirnadel-Farrant, Heide A.
   Suzuki, Ayako
TI Age-related differences in reporting of drug-associated liver injury:
   Data-mining of WHO Safety Report Database
SO REGULATORY TOXICOLOGY AND PHARMACOLOGY
LA English
DT Article
DE Hepatotoxicity; Drug-induced liver injury; Aging; Pediatric;
   Data-mining; Mitochondrial dysfunction; Cholestatic injury;
   Lipophilicity; Acute liver failure
ID DELAYED-TYPE HYPERSENSITIVITY; INDUCED HEPATOTOXICITY; ORAL MEDICATIONS;
   BILIARY-EXCRETION; ADVERSE-REACTIONS; TRANSPORTERS; MECHANISMS; FAILURE;
   RISK; PHARMACOKINETICS
AB Background/aims: Age-differences in the frequency and manifestations of drug-induced liver injury are not fully characterized. Data-mining analyses were performed to assess the impact of age on liver event reporting frequency with different phenotypes and agents.
   Methods: 236 drugs associated with hepatotoxicity were evaluated using the Empirical Bayes Geometric Mean (EBGM) of the relative reporting ratio with 90% confidence interval (EB05 and EB95) calculated for the age groups: 0-17, 18-64, and >= 65 years (or elderly), for overall, serious (acute liver failure), hepatocellular, and cholestatic liver injury, using the WHO Safety Report Database.
   Results: Overall, cases of age 0-17, 18-64, and 65 years or older comprised 6%, 62%, and 32% of liver event reports. Acute liver failure and hepatocellular injury were more frequently reported among children compared to adults and the elderly while reports with cholestatic injury were more frequent among the elderly (p < 0.00001). A potential to cause mitochondrial dysfunction was more prevalent among the drugs with increased pediatric reporting frequency while high lipophilicity and biliary excretion were more common among the drugs associated with higher reporting frequency in the elderly.
   Conclusion: Age-specific phenotypes and potential drug properties associated with age-specific hepatotoxicity were identified in reported liver events; further analyses are warranted. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Hunt, Christine M.] Duke Univ, Med Ctr, Div Gastroenterol, Durham, NC 27710 USA.
   [Hunt, Christine M.] Durham Vet Adm Med Ctr, Durham, NC USA.
   [Yuen, Nancy A.] GlaxoSmithKline, Global Clin Safety & Pharmacovigilance, Res Triangle Pk, NC USA.
   [Stirnadel-Farrant, Heide A.] GlaxoSmithICline, Worldwide Epidemiol, Brentford, England.
   [Suzuki, Ayako] Univ Arkansas Med Sci, Div Gastroenterol, Little Rock, AR 72205 USA.
   [Suzuki, Ayako] Cent Arkansas Vet Healthcare Syst, Div Gastroenterol, Little Rock, AR USA.
C3 Duke University; GlaxoSmithKline; University of Arkansas System;
   University of Arkansas Medical Sciences; US Department of Veterans
   Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans
   Healthcare System
RP Hunt, CM (corresponding author), Box 3913 DUMC, Durham, NC 27710 USA.
EM Christine.M.Hunt@earthlink.net
OI Suzuki, Ayako/0000-0003-1824-1067
CR Alfirevic A, 2011, PHARMACEUTICALS, V4, P69, DOI 10.3390/ph4010069
   Almenoff J, 2005, DRUG SAFETY, V28, P981, DOI 10.2165/00002018-200528110-00002
   Almenoff JS, 2006, DRUG SAFETY, V29, P875, DOI 10.2165/00002018-200629100-00005
   [Anonymous], 2013, ARR ROX
   Apostolova N, 2011, TRENDS PHARMACOL SCI, V32, P715, DOI 10.1016/j.tips.2011.07.007
   Bernareggi A, 1998, CLIN PHARMACOKINET, V35, P247, DOI 10.2165/00003088-199835040-00001
   Bode KA, 2002, BIOCHEM PHARMACOL, V64, P151, DOI 10.1016/S0006-2952(02)01015-8
   Boelsterli UA, 2002, DRUG SAFETY, V25, P633, DOI 10.2165/00002018-200225090-00003
   Bucuvalas John, 2006, Clin Liver Dis, V10, P149, DOI 10.1016/j.cld.2005.10.006
   Caster O, 2014, EUR J CLIN PHARMACOL, V70, P501, DOI 10.1007/s00228-013-1632-3
   Chen LH, 2010, AGEING RES REV, V9, pS59, DOI 10.1016/j.arr.2010.08.002
   Chen MJ, 2013, HEPATOLOGY, V58, P388, DOI 10.1002/hep.26208
   Cheung CK, 2007, J ALTERN COMPLEM MED, V13, P997, DOI 10.1089/acm.2007.0527
   Chew GYJ, 2006, PATHOLOGY, V38, P475, DOI 10.1080/00313020600922348
   Chowdhury A, 2006, J HEPATOL, V45, P117, DOI 10.1016/j.jhep.2006.01.027
   Daly AK, 2012, DRUG METAB REV, V44, P116, DOI 10.3109/03602532.2011.605790
   Dawson S, 2012, DRUG METAB DISPOS, V40, P130, DOI 10.1124/dmd.111.040758
   de Abajo FJ, 2004, BRIT J CLIN PHARMACO, V58, P71, DOI 10.1111/j.1365-2125.2004.02133.x
   Dykens JA, 2007, EXPERT REV MOL DIAGN, V7, P161, DOI 10.1586/14737159.7.2.161
   EVERED DC, 1976, BRIT MED J, V1, P264, DOI 10.1136/bmj.1.6004.264
   Ferrajolo C, 2010, BRIT J CLIN PHARMACO, V70, P721, DOI 10.1111/j.1365-2125.2010.03754.x
   Forget EJ, 2006, EXPERT OPIN DRUG SAF, V5, P231, DOI 10.1517/14740338.5.2.231
   Freymond N, 2003, ALLERGY, V58, P1319, DOI 10.1046/j.1398-9995.2003.00288.x
   Grolleau-Julius A, 2010, CLIN REV ALLERG IMMU, V39, P42, DOI 10.1007/s12016-009-8169-3
   Gurwitz JH, 2003, JAMA-J AM MED ASSOC, V289, P1107, DOI 10.1001/jama.289.9.1107
   Hohensinner PJ, 2011, AGING DIS, V2, P524
   HORIO T, 1975, ARCH DERMATOL, V111, P1469, DOI 10.1001/archderm.111.11.1469
   Huang YS, 2012, J FORMOS MED ASSOC, V111, P237, DOI 10.1016/j.jfma.2011.11.034
   HUNT CM, 1992, MECH AGEING DEV, V64, P189, DOI 10.1016/0047-6374(92)90106-N
   HUNT CM, 1990, BIOCHEM PHARMACOL, V40, P1666, DOI 10.1016/0006-2952(90)90470-6
   HUNT CM, 1992, BIOCHEM PHARMACOL, V44, P275, DOI 10.1016/0006-2952(92)90010-G
   Lucena MI, 2009, HEPATOLOGY, V49, P2001, DOI 10.1002/hep.22895
   Jemnitz K, 2010, TOXICOL IN VITRO, V24, P605, DOI 10.1016/j.tiv.2009.10.009
   Kalliokoski A, 2009, BRIT J PHARMACOL, V158, P693, DOI 10.1111/j.1476-5381.2009.00430.x
   Karras S, 2012, J PEDIATR ENDOCR MET, V25, P623, DOI 10.1515/jpem-2012-0059
   Kearns GL, 2003, NEW ENGL J MED, V349, P1157, DOI 10.1056/NEJMra035092
   Klotz U, 2009, DRUG METAB REV, V41, P67, DOI 10.1080/03602530902722679
   Kuhnz W, 1997, EUR J CLIN PHARMACOL, V53, P75, DOI 10.1007/s002280050340
   Lammert C, 2008, HEPATOLOGY, V47, P2003, DOI 10.1002/hep.22272
   Lammert C, 2010, HEPATOLOGY, V51, P615, DOI 10.1002/hep.23317
   Lindquist M, 2008, DRUG INF J, V42, P409, DOI 10.1177/009286150804200501
   López-Lluch G, 2008, EXP GERONTOL, V43, P813, DOI 10.1016/j.exger.2008.06.014
   Marotta PJ, 1998, J PEDIATR-US, V132, P894, DOI 10.1016/S0022-3476(98)70329-4
   McFarland R, 2008, ARCH DIS CHILD, V93, P151, DOI 10.1136/adc.2007.122911
   Mindikoglu AL, 2009, LIVER TRANSPLANT, V15, P719, DOI 10.1002/lt.21692
   Minuesa G, 2011, PHARMACOL THERAPEUT, V132, P268, DOI 10.1016/j.pharmthera.2011.06.007
   Molleston JP, 2011, J PEDIATR GASTR NUTR, V53, P182, DOI 10.1097/MPG.0b013e31821d6cfd
   Moore TJ, 2007, ARCH INTERN MED, V167, P1752, DOI 10.1001/archinte.167.16.1752
   Morgan RE, 2013, TOXICOL SCI, V136, P216, DOI 10.1093/toxsci/kft176
   Murray KF, 2008, J PEDIATR GASTR NUTR, V47, P395, DOI 10.1097/MPG.0b013e3181709464
   Nadanaciva S, 2010, J BIOMOL SCREEN, V15, P937, DOI 10.1177/1087057110373547
   NORRBY SR, 1987, B NEW YORK ACAD MED, V63, P519
   Ostapowicz G, 2002, ANN INTERN MED, V137, P947, DOI 10.7326/0003-4819-137-12-200212170-00007
   OUSLANDER JG, 1981, ANN INTERN MED, V95, P711, DOI 10.7326/0003-4819-95-6-711
   PAPAPETROU PD, 1972, BIOCHEM PHARMACOL, V21, P363, DOI 10.1016/0006-2952(72)90348-6
   Pauli-Magnus C, 2006, HEPATOLOGY, V44, P778, DOI 10.1002/hep.21359
   Pessayre D, 2012, DRUG METAB REV, V44, P34, DOI 10.3109/03602532.2011.604086
   Petronijevic M, 2013, J CLIN PHARMACOL, V53, P435, DOI 10.1002/jcph.3
   PURI SK, 1987, J ANTIMICROB CHEMOTH, V20, P89, DOI 10.1093/jac/20.suppl_B.89
   Ramappa V, 2013, J CLIN EXP HEPATOL, V3, P37, DOI 10.1016/j.jceh.2012.12.001
   RIESS CE, 1990, LANCET, V335, P1525, DOI 10.1016/0140-6736(90)93062-T
   Rivkees SA, 2010, J CLIN ENDOCR METAB, V95, P3260, DOI 10.1210/jc.2009-2546
   Rosh JR, 1998, PEDIATRICS, V101, P921, DOI 10.1542/peds.101.5.921
   Russmann S, 2010, HEPATOLOGY, V52, P748, DOI 10.1002/hep.23720
   Saab L, 2013, CYTOM PART A, V83A, P403, DOI 10.1002/cyto.a.22263
   Sakatis MZ, 2012, CHEM RES TOXICOL, V25, P2067, DOI [10.1021/tx300075J, 10.1021/tx300075j]
   Schiodt FV, 2009, LIVER TRANSPLANT, V15, P1481, DOI 10.1002/lt.21865
   SchmUcker DL, 2011, CURRENT GERONTOLOGY
   Schwartz JB, 2006, CLIN PHARMACOL THER, V79, P440, DOI 10.1016/j.clpt.2006.01.006
   Sgro C, 2002, HEPATOLOGY, V36, P451, DOI 10.1053/jhep.2002.34857
   Suzuki A, 2010, DRUG SAFETY, V33, P503, DOI 10.2165/11535340-000000000-00000
   Tachibana A, 1975, Jpn J Antibiot, V28, P558
   Tapner MJ, 2004, J HEPATOL, V40, P454, DOI 10.1016/j.jhep.2003.11.024
   Thompson RA, 2012, CHEM RES TOXICOL, V25, P1616, DOI 10.1021/tx300091x
   Turnheim Klaus, 2005, Expert Opin Drug Metab Toxicol, V1, P33, DOI 10.1517/17425255.1.1.33
   Van Steenbergen W, 1998, J HEPATOL, V29, P135, DOI 10.1016/S0168-8278(98)80188-8
   Wolf KK, 2010, TOXICOL IN VITRO, V24, P297, DOI 10.1016/j.tiv.2009.08.009
   Yang K, 2013, J PHARM SCI-US, V102, P3037, DOI 10.1002/jps.23584
   Zamek-Gliszczynski MJ, 2005, DRUG METAB DISPOS, V33, P1158, DOI 10.1124/dmd.104.002188
NR 79
TC 34
Z9 42
U1 0
U2 15
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0273-2300
EI 1096-0295
J9 REGUL TOXICOL PHARM
JI Regul. Toxicol. Pharmacol.
PD NOV
PY 2014
VL 70
IS 2
BP 519
EP 526
DI 10.1016/j.yrtph.2014.09.007
PG 8
WC Medicine, Legal; Pharmacology & Pharmacy; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Legal Medicine; Pharmacology & Pharmacy; Toxicology
GA AS0FN
UT WOS:000343953700011
PM 25236535
OA Green Submitted
DA 2024-02-19
ER

PT J
AU Paradies, G
   Petrosillo, G
   Gadaleta, MN
   Ruggiero, FM
AF Paradies, G
   Petrosillo, G
   Gadaleta, MN
   Ruggiero, FM
TI The effect of aging and acetyl-L-carnitine on the pyruvate transport and
   oxidation in rat heart mitochondria
SO FEBS LETTERS
LA English
DT Article
DE aging; pyruvate metabolism; acetyl-L-carnitine; cardiolipin; rat heart
   mitochondrion
ID AGE-RELATED-CHANGES; LIVER-MITOCHONDRIA; LIPID-COMPOSITION; CARDIAC
   MITOCHONDRIA; PHOSPHATE CARRIER; TRANSLOCATOR; SPECIFICITY; KINETICS
AB The effect of aging and acute treatment with acetyl-L-carnitine on the pyruvate transport and oxidation in rat heart mitochondria was studied. The activity of the pyruvate carrier as well as the rates of pyruvate-supported respiration mere both depressed (around 40%) in heart mitochondria from aged rats, the major decrease occurring during the second year of life, Administration of acetyl-L-carnitine to aged rats almost completely restored the rates of these metabolic functions to the level of young control rats, This effect of acetyl-L-carnitine was not due to changes in the content of pyruvate carrier molecules. The heart mitochondrial content of cardiolipin, a key phospholipid necessary for mitochondrial substrate transport, was markedly reduced (approximately 40%) in aged rats. Treatment of aged rats with acetyl-L-carnitine reversed the age-associated decline in cardiolipin content, As the changes in cardiolipin content mere correlated with changes in rates of pyruvate transport and oxidation, it is suggested that acetyl-L-carnitine reverses the age-related decrement in the mitochondrial pyruvate metabolism by restoring the normal cardiolipin content. (C) 1999 Federation of European Biochemical Societies.
C1 Univ Bari, Dept Biochem & Mol Biol, Bari, Italy.
   Univ Bari, CNR, Unit Study Mitochondria & Bioenerget, Bari, Italy.
C3 Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari
   Aldo Moro; Consiglio Nazionale delle Ricerche (CNR)
RP Paradies, G (corresponding author), Univ Bari, Dept Biochem & Mol Biol, Bari, Italy.
CR GADALETA MN, 1990, EUR J BIOCHEM, V187, P501, DOI 10.1111/j.1432-1033.1990.tb15331.x
   GOORMAGHTIGH E, 1980, BIOCHIM BIOPHYS ACTA, V597, P1, DOI 10.1016/0005-2736(80)90145-5
   Hagen TM, 1998, P NATL ACAD SCI USA, V95, P9562, DOI 10.1073/pnas.95.16.9562
   HALESTRAP AP, 1975, BIOCHEM J, V148, P85, DOI 10.1042/bj1480085
   HANSFORD RG, 1983, BIOCHIM BIOPHYS ACTA, V726, P41, DOI 10.1016/0304-4173(83)90010-1
   HOSTETLER KY, 1991, BIOCHIM BIOPHYS ACTA, V1086, P139, DOI 10.1016/0005-2760(91)90165-E
   HOVIUS R, 1990, BIOCHIM BIOPHYS ACTA, V1021, P217, DOI 10.1016/0005-2736(90)90036-N
   KIM JH, 1988, MECH AGEING DEV, V46, P279, DOI 10.1016/0047-6374(88)90130-3
   NALECZ KA, 1986, BIOCHIM BIOPHYS ACTA, V851, P29
   PARADIES G, 1990, BIOCHIM BIOPHYS ACTA, V1016, P207, DOI 10.1016/0005-2728(90)90060-H
   PARADIES G, 1991, ARCH BIOCHEM BIOPHYS, V284, P332, DOI 10.1016/0003-9861(91)90304-2
   PARADIES G, 1984, BIOCHIM BIOPHYS ACTA, V766, P446, DOI 10.1016/0005-2728(84)90260-3
   PARADIES G, 1988, BIOCHEM BIOPH RES CO, V156, P1302, DOI 10.1016/S0006-291X(88)80774-5
   PARADIES G, 1992, BIOCHIM BIOPHYS ACTA, V1103, P324, DOI 10.1016/0005-2736(92)90103-S
   PARADIES G, 1994, FEBS LETT, V350, P213, DOI 10.1016/0014-5793(94)00763-2
   PARADIES G, 1977, BIOCHIM BIOPHYS ACTA, V462, P333, DOI 10.1016/0005-2728(77)90132-3
   Paradies G, 1995, MECH AGEING DEV, V84, P103, DOI 10.1016/0047-6374(95)01636-8
   RUGGIERO FM, 1984, LIPIDS, V19, P171, DOI 10.1007/BF02534794
   SHEARMAN MS, 1984, BIOCHEM J, V223, P673, DOI 10.1042/bj2230673
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   VILLA RF, 1998, NEUROCHEM RES, V10, P909
NR 21
TC 67
Z9 70
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0014-5793
J9 FEBS LETT
JI FEBS Lett.
PD JUL 9
PY 1999
VL 454
IS 3
BP 207
EP 209
DI 10.1016/S0014-5793(99)00809-1
PG 3
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 217AV
UT WOS:000081477900008
PM 10431808
OA Bronze
DA 2024-02-19
ER

PT J
AU Taura, N
   Yatsuhashi, H
   Hamasaki, K
   Nakao, K
   Daikoku, M
   Ueki, T
   Yano, K
   Matsumoto, T
   Ishibashi, H
   Eguchi, K
AF Taura, N
   Yatsuhashi, H
   Hamasaki, K
   Nakao, K
   Daikoku, M
   Ueki, T
   Yano, K
   Matsumoto, T
   Ishibashi, H
   Eguchi, K
TI Increasing hepatitis C virus-associated hepatocellular carcinoma
   mortality and aging: Long term trends in Japan
SO HEPATOLOGY RESEARCH
LA English
DT Article
DE hepatitis C virus; hepatocellular carcinoma; epidemiological
ID UNITED-STATES; VARICEAL HEMORRHAGE; INFECTION; PREVALENCE; CANCER; RISK;
   CIRRHOSIS; SURVIVAL; VETERANS; FUTURE
AB Background: The incidence of hepatocellular carcinoma (HCC) in Japan has been increasing. The aim of the study was to determine the epidemiological trends in HCC mortality in Japan.
   Methods: We reviewed the medical records of all patients whose death was caused by liver disease between 1981 and 2000 at two hospitals. The courses of death were separated based on presence or absence of HCC when death ensued. Additionally, cohorts of patients with HCC were analyzed in 5-year time periods.
   Results: The number of deaths from hepatitis C virus (HCV)-associated HCC steadily increased 2.6 times from 49 to 128 during observation period. The mean age at death from HCV-associated HCC from 1996 to 2000 was significantly higher than that in the period from 1981 to 1985 (p < 0.0001).
   Interpretation: Deaths from HCV-associated HCC increased from 1981 to 2000, consistent with the aging of the population in Japan. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
C1 Natl Nagasaki Med Ctr, Clin Res Ctr, Nagasaki 8568562, Japan.
   Nagasaki Univ, Sch Med, Dept Internal Med 1, Nagasaki 8528501, Japan.
   Nagasaki Univ, Hlth Res Ctr, Nagasaki 8528501, Japan.
C3 Nagasaki University; Nagasaki University
RP Yatsuhashi, H (corresponding author), Natl Nagasaki Med Ctr, Clin Res Ctr, Kubara 2-1001-1, Nagasaki 8568562, Japan.
EM yatsubashi@nmc.hosp.go.jp
CR Ajiki W, 2004, JPN J CLIN ONCOL, V34, P352, DOI 10.1093/jjco/hyh056
   Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802
   Armstrong GL, 2000, HEPATOLOGY, V31, P777, DOI 10.1002/hep.510310332
   El-Serag HB, 2000, ARCH INTERN MED, V160, P3227, DOI 10.1001/archinte.160.21.3227
   El-Serag HB, 2002, HEPATOLOGY, V36, pS74, DOI 10.1053/jhep.2002.36807
   El-Serag HB, 2002, GASTROENTEROLOGY, V122, P1822, DOI 10.1053/gast.2002.33650
   El-Serag HB, 2003, AM J GASTROENTEROL, V98, P167, DOI 10.1111/j.1572-0241.2003.07176.x
   El-Serag HB, 2002, J CLIN GASTROENTEROL, V35, pS72, DOI 10.1097/00004836-200211002-00002
   El-Serag HB, 2002, HEPATOLOGY, V36, P1439, DOI 10.1053/jhep.2002.37191
   El-Serag HB, 2004, GASTROENTEROLOGY, V127, pS27, DOI 10.1053/j.gastro.2004.09.013
   El-Serag HB, 2000, AM J GASTROENTEROL, V95, P3566
   Hamada H, 2002, CANCER, V95, P331, DOI 10.1002/cncr.10662
   HAMASAKI K, 1993, J MED VIROL, V40, P146, DOI 10.1002/jmv.1890400212
   Hassan MM, 2002, J CLIN GASTROENTEROL, V35, P266, DOI 10.1097/00004836-200209000-00013
   KATO Y, 1994, CANCER, V74, P2234, DOI 10.1002/1097-0142(19941015)74:8<2234::AID-CNCR2820740805>3.0.CO;2-6
   Kiyosawa K, 2004, GASTROENTEROLOGY, V127, pS17, DOI 10.1053/j.gastro.2004.09.012
   Kiyosawa K, 2002, ONCOLOGY-BASEL, V62, P5, DOI 10.1159/000048269
   Marchesini G, 2003, GASTROENTEROLOGY, V124, P1792, DOI 10.1016/S0016-5085(03)00323-8
   Marchesini Giulio, 2000, Journal of Gastroenterology, V35, P7
   McCormick PA, 2001, GUT, V49, P682, DOI 10.1136/gut.49.5.682
   McGlynn KA, 2001, INT J CANCER, V94, P290, DOI 10.1002/ijc.1456
   Nair S, 2002, AM J GASTROENTEROL, V97, P167, DOI 10.1111/j.1572-0241.2002.05432.x
   Rabeneck L, 2003, AM J GASTROENTEROL, V98, P471, DOI 10.1016/S0002-9270(02)05928-2
   SHIRATORI Y, 1995, HEPATOLOGY, V22, P1027, DOI 10.1002/hep.1840220403
   Shiratori Y, 1997, CANCER, V80, P2060, DOI 10.1002/(SICI)1097-0142(19971201)80:11<2060::AID-CNCR4>3.3.CO;2-0
   Tanaka Y, 2002, P NATL ACAD SCI USA, V99, P15584, DOI 10.1073/pnas.242608099
   Wada I, 2002, HEPATOL RES, V23, P18, DOI 10.1016/S1386-6346(01)00161-9
   Yoshizawa H, 2002, ONCOLOGY-BASEL, V62, P8, DOI 10.1159/000048270
NR 28
TC 14
Z9 14
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1386-6346
EI 1872-034X
J9 HEPATOL RES
JI Hepatol. Res.
PD FEB
PY 2006
VL 34
IS 2
BP 130
EP 134
DI 10.1016/j.hepres.2005.11.007
PG 5
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 014TK
UT WOS:000235502800011
PM 16426888
DA 2024-02-19
ER

PT J
AU Namieno, T
   Sato, N
   Uchino, J
   Hosokawa, M
AF Namieno, T
   Sato, N
   Uchino, J
   Hosokawa, M
TI Postoperative immunocompetence and immunosuppressive effect of rat liver
   tumors
SO INTERNATIONAL JOURNAL OF ONCOLOGY
LA English
DT Article
DE surgical stress; postoperative immunocompetence; postoperative
   immunosuppression; natural killer cell; lymphatic blastogenesis
ID GROWTH-FACTOR-BETA; KILLER CELL-ACTIVITY; MEDIATED CYTO-TOXICITY;
   SURGICAL STRESS; CANCER-PATIENTS; PHYTOHEMAGGLUTININ RESPONSIVENESS;
   PROGRESSIVE INCREASE; SUPPRESSOR CELLS; IMMUNE-RESPONSE; AGING HUMANS
AB To investigate the kinetics of postoperative immunocompetence and immunosuppressive effects of rat liver tumors, we examined natural killer cell cytotoxicity and blastogeneses to phytohemagllutinin-P, concanavalin A, and lipopolysaccharide on 1-, 2-, 3-, 5-, 7-, 9- and 14- postoperative days (-POD) after partial hepatectomy in tumor-bearing or healthy rats. The immunosuppressive effects of the tumor were observed on all the parameters examined, particularly from 1- to 3-POD and on 14-POD. Surgical stress induced immunosuppression in the early postoperative stage which lasted over 1 week, and the immunosuppression was seriously affected by the presence of the tumor. The present study suggests that surgery without curability is closely related to enhancement of the growth of the remaining or occult cancer, leading to worse survival.
C1 HOKKAIDO UNIV,SCH MED,PATHOL LAB,INST CANC,SAPPORO,HOKKAIDO 060,JAPAN.
C3 Hokkaido University
RP Namieno, T (corresponding author), HOKKAIDO UNIV,SCH MED,DEPT SURG 1,SAPPORO,HOKKAIDO 060,JAPAN.
CR BARNARD JA, 1990, BIOCHIM BIOPHYS ACTA, V1032, P79, DOI 10.1016/0304-419X(90)90013-Q
   BRAUN DP, 1981, J NATL CANCER I, V67, P809
   BUCHER NLR, 1963, INT REV CYTOL, V15, P245, DOI 10.1016/S0074-7696(08)61119-5
   BUINAUSKAS P, 1958, ANN SURG, V148, P642, DOI 10.1097/00000658-195810000-00011
   COFFEY RJ, 1986, CANCER RES, V46, P1164
   COLE WH, 1985, ANN SURG, V202, P9, DOI 10.1097/00000658-198507000-00002
   CONSTANTIAN MB, 1977, ANN SURG, V185, P73, DOI 10.1097/00000658-197701000-00012
   CRADDOCK CG, 1964, J EXP MED, V120, P389, DOI 10.1084/jem.120.3.389
   CURRIE GA, 1972, BRIT J CANCER, V26, P427, DOI 10.1038/bjc.1972.59
   EGGERMONT AMM, 1987, SURGERY, V102, P71
   GOTTFRIED B, 1961, ANN SURG, V153, P138, DOI 10.1097/00000658-196115310-00016
   HALLGREN HM, 1973, J IMMUNOL, V111, P1101
   HALLGREN HM, 1978, CLIN IMMUNOL IMMUNOP, V10, P65, DOI 10.1016/0090-1229(78)90010-7
   Higgins GM, 1931, ARCH PATHOL, V12, P186
   HOLCH MW, 1989, 2 VIENN SHOCK FORUM, P491
   JENSEN LS, 1992, BRIT J SURG, V79, P513, DOI 10.1002/bjs.1800790613
   KEHRL JH, 1991, INT J CELL CLONING, V9, P438, DOI 10.1002/stem.1991.5530090502
   LENNARD TWJ, 1985, BRIT J SURG, V72, P771, DOI 10.1002/bjs.1800721002
   LEWIS MR, 1958, ARCH SURG-CHICAGO, V77, P621
   LI XF, 1993, JPN J CANCER RES, V84, P315, DOI 10.1111/j.1349-7006.1993.tb02873.x
   LINN BS, 1983, ARCH SURG-CHICAGO, V118, P405
   LUKOMSKA B, 1983, CANCER-AM CANCER SOC, V51, P465, DOI 10.1002/1097-0142(19830201)51:3<465::AID-CNCR2820510318>3.0.CO;2-9
   LUNDY J, 1978, CANCER, V41, P827, DOI 10.1002/1097-0142(197803)41:3<827::AID-CNCR2820410307>3.0.CO;2-#
   LUNDY J, 1983, ANN SURG, V197, P434, DOI 10.1097/00000658-198304000-00010
   MAETA M, 1994, J SURG ONCOL, V55, P149, DOI 10.1002/jso.2930550304
   MIYAZAKI S, 1983, CLIN EXP IMMUNOL, V54, P573
   MIYAZAKI S, 1983, JPN J SURG, V13, P191, DOI 10.1007/BF02469475
   NAMIENO T, 1991, Gastroenterologia Japonica, V26, P29
   NOHR CW, 1984, ANN SURG, V200, P373, DOI 10.1097/00000658-198409000-00015
   ORITA K, 1976, CANCER, V38, P2343, DOI 10.1002/1097-0142(197612)38:6<2343::AID-CNCR2820380621>3.0.CO;2-T
   POLLOCK RE, 1984, CANCER RES, V44, P3888
   POLLOCK RE, 1991, ARCH SURG-CHICAGO, V126, P338
   RYHANEN P, 1984, ACTA ANAESTH SCAND, V28, P490, DOI 10.1111/j.1399-6576.1984.tb02104.x
   SAKAI A, 1970, ACTA PATHOLOG MICROB, V78, P652
   SALOMON DS, 1984, CANCER RES, V44, P4069
   SLADE MS, 1975, SURGERY, V78, P363
   TANEMURA H, 1982, J SURG ONCOL, V21, P189, DOI 10.1002/jso.2930210312
   TONNESEN E, 1983, ACTA ANAESTH SCAND, V27, P238, DOI 10.1111/j.1399-6576.1983.tb01943.x
   TRINCHIERI G, 1984, LAB INVEST, V50, P489
   UCHIDA A, 1982, JNCI-J NATL CANCER I, V68, P735
   UNGER SW, 1983, CANCER, V51, P669, DOI 10.1002/1097-0142(19830215)51:4<669::AID-CNCR2820510420>3.0.CO;2-1
   WAHL SM, 1991, IMMUNOL RES, V10, P249, DOI 10.1007/BF02919701
   WEESE JL, 1986, SURGERY, V100, P273
   WOOD GW, 1979, J NATL CANCER I, V63, P587, DOI 10.1093/jnci/63.3.587
   YOSHIHARA H, 1986, ACTA MED OKAYAMA, V40, P113
   ZOU JP, 1992, J IMMUNOL, V148, P648
NR 46
TC 2
Z9 2
U1 0
U2 0
PU PROFESSOR D A SPANDIDOS
PI ATHENS
PA 1, S MERKOURI ST, EDITORIAL OFFICE,, ATHENS 116 35, GREECE
SN 1019-6439
J9 INT J ONCOL
JI Int. J. Oncol.
PD APR
PY 1996
VL 8
IS 4
BP 785
EP 790
PG 6
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA UB251
UT WOS:A1996UB25100020
PM 21544427
DA 2024-02-19
ER

PT J
AU Nomi, T
   Hirokawa, F
   Kaibori, M
   Ueno, M
   Tanaka, S
   Hokuto, D
   Noda, T
   Nakai, T
   Ikoma, H
   Iida, H
   Komeda, K
   Ishizaki, M
   Hayami, S
   Eguchi, H
   Matsumoto, M
   Morimura, R
   Maehira, H
   Sho, M
   Kubo, S
AF Nomi, Takeo
   Hirokawa, Fumitoshi
   Kaibori, Masaki
   Ueno, Masaki
   Tanaka, Shogo
   Hokuto, Daisuke
   Noda, Takehiro
   Nakai, Takuya
   Ikoma, Hisashi
   Iida, Hiroya
   Komeda, Koji
   Ishizaki, Morihiko
   Hayami, Shinya
   Eguchi, Hidetoshi
   Matsumoto, Masataka
   Morimura, Ryo
   Maehira, Hiromitsu
   Sho, Masayuki
   Kubo, Shoji
TI Laparoscopic versus open liver resection for hepatocellular carcinoma in
   elderly patients: a multi-centre propensity score-based analysis
SO SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
LA English
DT Article
DE Laparoscopic liver resection; Elderly; Hepatocellular carcinoma;
   Propensity score matching; Ageing
ID QUALITY-OF-LIFE; POSTOPERATIVE COMPLICATIONS; SINGLE-CENTER;
   RISK-FACTORS; METASTASES; TUMORS
AB Background The frequency of liver resection in elderly patients has been increasing. However, data are limited regarding the safety of laparoscopic liver resection (LLR) compared with that of open liver resection (OLR) for hepatocellular carcinoma (HCC) in elderly patients. The present study aimed to compare short-term outcomes between LLR and OLR in elderly patients with HCC using propensity score matching. Methods The study included 630 patients (age, >= 75 years) who underwent liver resection for HCC at nine liver centres between April 2010 and December 2017. Patients were divided into LLR and OLR groups, and perioperative outcomes were compared between the groups. In addition, subgroup analysis was performed according to age (75-79 and >= 80 years). Results Of the 630 patients, 221 and 409 were included in the LLR and OLR groups, respectively. After propensity score matching, 155 patients were included in each group. Intraoperative blood loss and the transfusion, post-operative overall complication and major complication rates were lower in the matched LLR than the matched OLR group (P < 0.001, P = 0.004, P < 0.001 and P < 0.001, respectively). Moreover, post-operative pulmonary and cardiovascular complications were less frequent in the matched LLR group (P = 0.008 and P = 0.014, respectively). In subgroup analysis, among octogenarians, the post-operative major complication rate was lower and hospital stay was shorter in the matched LLR than the matched OLR group (P < 0.001 and P < 0.001, respectively). Conclusion LLR for HCC is associated with good short-term outcomes in patients aged >= 75 years compared with OLR. LLR is safe and feasible in selected octogenarians with HCC.
C1 [Nomi, Takeo; Hokuto, Daisuke; Sho, Masayuki] Nara Med Univ, Dept Surg, 840 Shijocho, Kashihara, Nara 6348522, Japan.
   [Hirokawa, Fumitoshi; Komeda, Koji] Osaka Med Coll, Dept Gen & Gastroenterol Surg, Takatsuki, Osaka, Japan.
   [Kaibori, Masaki; Ishizaki, Morihiko] Kansai Med Univ, Hirakata Hosp, Dept Surg, Hirakata, Osaka, Japan.
   [Ueno, Masaki; Hayami, Shinya] Wakayama Med Univ, Dept Surg 2, Wakayama, Japan.
   [Tanaka, Shogo; Kubo, Shoji] Osaka City Univ, Dept Hepatobiliary Pancreat Surg, Grad Sch Med, Osaka, Japan.
   [Noda, Takehiro; Eguchi, Hidetoshi] Osaka Univ, Grad Sch Med, Dept Gastroenterol Surg, Suita, Osaka, Japan.
   [Nakai, Takuya; Matsumoto, Masataka] Kindai Univ, Fac Med, Dept Surg, Osakasayama, Osaka, Japan.
   [Ikoma, Hisashi; Morimura, Ryo] Kyoto Prefectural Univ Med, Dept Surg, Div Digest Surg, Kyoto, Japan.
   [Iida, Hiroya; Maehira, Hiromitsu] Shiga Univ Med Sci, Dept Surg, Div Gastrointestinal Breast & Gen Surg, Otsu, Shiga, Japan.
C3 Nara Medical University; Osaka Medical College; Osaka Medical &
   Pharmaceutical University; Kansai Medical University; Wakayama Medical
   University; Osaka Metropolitan University; Osaka University; Kyoto
   Prefectural University of Medicine; Shiga University of Medical Science
RP Nomi, T (corresponding author), Nara Med Univ, Dept Surg, 840 Shijocho, Kashihara, Nara 6348522, Japan.
EM nomi@naramed-u.ac.jp
OI Noda, Takehiro/0000-0002-6768-5783
CR Amemiya T, 2007, ANN SURG, V246, P222, DOI 10.1097/SLA.0b013e3180caa3fb
   Badawy A, 2019, J INVEST SURG, V32, P75, DOI 10.1080/08941939.2017.1373170
   Cauchy F, 2016, J AM COLL SURGEONS, V222, P174, DOI 10.1016/j.jamcollsurg.2015.11.006
   Chan ACY, 2014, J GASTROEN HEPATOL, V29, P1279, DOI 10.1111/jgh.12539
   Cho SW, 2011, ANN SURG ONCOL, V18, P1088, DOI 10.1245/s10434-010-1404-6
   Chok KS, 2009, BRIT J SURG, V96, P81, DOI 10.1002/bjs.6358
   Devereaux PJ, 2015, NEW ENGL J MED, V373, P2258, DOI 10.1056/NEJMra1502824
   Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae
   FORD GT, 1993, CLIN CHEST MED, V14, P237
   Fretland ÅA, 2018, ANN SURG, V267, P199, DOI 10.1097/SLA.0000000000002353
   Fuks D, 2016, ANN SURG, V263, P353, DOI 10.1097/SLA.0000000000001140
   Goh BKP, 2019, WORLD J SURG, V43, P878, DOI 10.1007/s00268-018-4828-y
   Goh BKP, 2018, WORLD J SURG, V42, P4063, DOI 10.1007/s00268-018-4741-4
   Goldman L, 1987, J Cardiothorac Anesth, V1, P237, DOI 10.1016/S0888-6296(87)80011-X
   Ide T, 2013, J SURG RES, V185, P614, DOI 10.1016/j.jss.2013.07.016
   Inoue Y, 2017, J GASTROINTEST SURG, V21, P2135, DOI 10.1007/s11605-017-3516-9
   Kaibori M, 2017, ANN SURG, V264, P692
   Koch M, 2011, SURGERY, V149, P680, DOI 10.1016/j.surg.2010.12.002
   Lentschener C, 2002, EUR J ANAESTH, V19, P780, DOI 10.1017/S0265021502001266
   Mangano DT, 1995, NEW ENGL J MED, V333, P1750, DOI 10.1056/NEJM199512283332607
   Nomi T, 2018, ANN SURG ONCOL, V25, P3982, DOI 10.1245/s10434-018-6768-z
   Nomi T, 2015, SURG ENDOSC, V29, P1368, DOI 10.1007/s00464-014-3806-1
   Nozawa A, 2015, SURG TODAY, V45, P851, DOI 10.1007/s00595-014-0994-1
   Pirat A, 2004, TRANSPL P, V36, P218, DOI 10.1016/j.transproceed.2003.11.026
   Rahbari NN, 2011, SURGERY, V149, P713, DOI 10.1016/j.surg.2010.10.001
   REICH H, 1991, OBSTET GYNECOL, V78, P956
   Schiergens TS, 2014, J GASTROINTEST SURG, V18, P1161, DOI 10.1007/s11605-014-2516-2
   Tanaka S, 2018, J HEPATO-BIL-PAN SCI, V25, P377, DOI 10.1002/jhbp.568
   Treska V, 2017, ANTICANCER RES, V37, P1529, DOI 10.21873/anticanres.11481
   Ulander K, 1997, SUPPORT CARE CANCER, V5, P402, DOI 10.1007/s005200050099
   Wakabayashi G, 2015, ANN SURG, V261, P619, DOI 10.1097/SLA.0000000000001184
   Wang XT, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001854
   Williamson WK, 2001, J VASC SURG, V33, P913, DOI 10.1067/mva.2001.115164
   Yazici P, 2017, SURG ENDOSC, V31, P1269, DOI 10.1007/s00464-016-5105-5
   Yoshikawa T, 2017, WORLD J SURG, V41, P2095, DOI 10.1007/s00268-017-4003-x
   Zolfaghari PS, 2011, CRIT CARE, V15, DOI 10.1186/cc10352
NR 36
TC 34
Z9 35
U1 0
U2 7
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0930-2794
EI 1432-2218
J9 SURG ENDOSC
JI Surg. Endosc.
PD FEB
PY 2020
VL 34
IS 2
BP 658
EP 666
DI 10.1007/s00464-019-06812-z
PG 9
WC Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Surgery
GA KK6BM
UT WOS:000512824800018
PM 31093748
DA 2024-02-19
ER

PT J
AU Zhao, D
   Qian, LP
   Zhuang, DM
   Wang, L
   Cao, Y
   Zhou, F
   Zhang, S
   Liu, Y
   Liang, Y
   Zhang, WJ
   Kang, W
   Zhang, M
   Wang, Y
   Zhang, F
   Zhang, W
   Xiao, JQ
   Xu, GF
   Lv, Y
   Zou, XP
   Zhuge, YZ
   Zhang, B
AF Zhao, Dian
   Qian, Liping
   Zhuang, Duanming
   Wang, Lei
   Cao, Yu
   Zhou, Fan
   Zhang, Shu
   Liu, Ying
   Liang, Ying
   Zhang, Wenjie
   Kang, Wei
   Zhang, Ming
   Wang, Yi
   Zhang, Feng
   Zhang, Wei
   Xiao, Jiangqiang
   Xu, Guifang
   Lv, Ying
   Zou, Xiaoping
   Zhuge, Yuzheng
   Zhang, Bin
TI Inhibition of ribosomal RNA processing 15 Homolog (RRP15), which is
   overexpressed in hepatocellular carcinoma, suppresses tumour growth via
   induction of senescence and apoptosis
SO CANCER LETTERS
LA English
DT Article; Early Access
DE Liver cancer; Ribosomal RNA Processing 15 Homolog gene; Growth
   inhibition; Ribosomal stress; Glucose metabolism remodelling
ID PENTOSE-PHOSPHATE PATHWAY; C-MYC; UP-REGULATION; BIOGENESIS;
   PROLIFERATION; EXPRESSION; PROTEIN; CANCER; PHOSPHORYLATION; P53
AB Recent studies suggest that RRP15 (Ribosomal RNA Processing 15 Homolog) might be a potential target for cancer therapy. However, the role of RRP15 in hepatocarcinogenesis remains poorly delineated. In this study, we aimed to evaluate the expression and biological function of RRP15 in human hepatocellular carcinoma (HCC). We show that RRP15 was up regulated in HCC cell lines and tumours. Up-regulation of RRP15 in HCC tumours was also correlated with unfavorable prognosis. We further show that the frequent up-regulation of RRP15 in HCCs is at least partly driven by recurrent gene copy gain at chromosome 1q41. Functional studies indicated that RRP15 knockdown suppresses HCC proliferation and growth both in vitro and in vivo. Mechanistically, RRP15 depletion in p53-wild-type HepG2 cells induced senescence via activation of the p53-p21 signalling pathway through enhanced interaction of RPL11 with MDM2, as well as inhibition of SIRT1-mediated p53 deacetylation. Moreover, RRP15 depletion in p53-mutant PLC5 and p53-deleted Hep3B cells induced metabolic shift from the glycolytic pentose-phosphate to mitochondrial oxidative phosphorylation via regulating a series of key genes such as HK2 and TIGAR, and thus, promoted the generation of ROS and apoptosis. Taken together, our findings provide evidence for an important role of the RRP15 gene in hepatocarcinogenesis through regulation of HCC proliferation and growth, raising the possibility that targeting RRP15 may represent a potential therapeutic strategy for HCC treatment.
C1 [Zhao, Dian; Wang, Lei; Zhou, Fan; Zhang, Shu; Zhang, Ming; Wang, Yi; Zhang, Feng; Zhang, Wei; Xiao, Jiangqiang; Xu, Guifang; Lv, Ying; Zou, Xiaoping; Zhuge, Yuzheng; Zhang, Bin] Nanjing Univ, Sch Med, Affiliated Hosp, Dept Gastroenterol,Nanjing Drum Tower Hosp, 321 Zhongshan Rd, Nanjing, Jiangsu, Peoples R China.
   [Qian, Liping] Nanjing Univ, Sch Med, Affiliated Hosp, Ctr Expt Anim,Nanjing Drum Tower Hosp, Nanjing, Jiangsu, Peoples R China.
   [Zhuang, Duanming; Zhang, Bin] Gaochun Peoples Hosp, Dept Gastroenterol, Nanjing, Jiangsu, Peoples R China.
   [Cao, Yu] Naval Med Univ, Mil Med Univ 2, Changhai Hosp, Dept Gastroenterol, Shanghai, Peoples R China.
   [Liu, Ying] Nanjing Univ, Sch Med, Affiliated Hosp, Dept Ultrasound Diagnost,Nanjing Drum Tower Hosp, Nanjing, Jiangsu, Peoples R China.
   [Liang, Ying] Nanjing Univ, Sch Med, Affiliated Hosp, Dept Anesthesiol,Nanjing Drum Tower Hosp, Nanjing, Jiangsu, Peoples R China.
   [Zhang, Wenjie] Nanjing Univ, Sch Med, Affiliated Hosp, Dept Hepatobiliary Surg,Nanjing Drum Tower Hosp, Nanjing, Jiangsu, Peoples R China.
   [Kang, Wei] Chinese Univ Hong Kong, Prince Wales Hosp, State Key Lab Translat Oncol, Dept Anat & Cellular Pathol, Hong Kong, Peoples R China.
   [Zhang, Bin] Yining Peoples Hosp, Dept Gastroenterol, Yining, Peoples R China.
C3 Nanjing University; Nanjing University; Naval Medical University;
   Nanjing University; Nanjing University; Nanjing University; Chinese
   University of Hong Kong; Prince of Wales Hospital
RP Zou, XP; Zhuge, YZ; Zhang, B (corresponding author), Nanjing Univ, Sch Med, Affiliated Hosp, Dept Gastroenterol,Nanjing Drum Tower Hosp, 321 Zhongshan Rd, Nanjing, Jiangsu, Peoples R China.
EM zouxiaoping795@hotmail.com; yuzheng9111963@aliyun.com;
   billzhangnju@foxmail.com
RI KANG, Wei/C-5451-2016; Xia, Xianfeng/F-9169-2011; zhang,
   yue/JAC-3705-2023
OI KANG, Wei/0000-0002-4651-677X; Zhang, Ming/0009-0009-7742-3128
FU Natural Science Foundation of Jiangsu Province, China [BK20191119];
   Jiangsu Provincial Medical Youth Talent [QNRC2016031]; National Natural
   Science Foundation of China [81701102]
FX We are grateful to Dr. Shouyu Wang, Dr. Runqiu Jiang and Dr. Ping Zhan
   for their helpful suggestions in conducting this project and critical
   review of the manuscript. We would also like to thank Prof. Honlgi Yan
   for his expert assistance. We thank LetPub (www.letpub.com) for its
   linguistic assistance during the preparation of this manuscript. This
   study was supported by the Natural Science Foundation of Jiangsu
   Province, China (BK20191119), Jiangsu Provincial Medical Youth Talent
   (QNRC2016031), as well as the National Natural Science Foundation of
   China (81701102).
CR Beltran C, 2020, METABOLITES, V10, DOI 10.3390/metabo10040132
   Bursac S, 2021, TRENDS CANCER, V7, P57, DOI 10.1016/j.trecan.2020.08.003
   Calvisi DF, 2011, GASTROENTEROLOGY, V140, P1071, DOI 10.1053/j.gastro.2010.12.006
   Cao H, 2020, CELL DEATH DISCOV, V6, DOI 10.1038/s41420-020-0287-y
   Chen J, 2011, CANCER RES, V71, P4138, DOI 10.1158/0008-5472.CAN-10-4274
   Chen Z, 2007, J BIOENERG BIOMEMBR, V39, P267, DOI 10.1007/s10863-007-9086-x
   Cheung EC, 2016, GENE DEV, V30, P52, DOI 10.1101/gad.271130.115
   De Marchis ML, 2005, RNA, V11, P495, DOI 10.1261/rna.7200205
   Dong Y, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00235-2
   Dong ZX, 2017, ONCOTARGET, V8, P13240, DOI 10.18632/oncotarget.14658
   Ferguson B, 2019, ELIFE, V8, DOI 10.7554/eLife.42424
   Gao Q, 2019, CELL, V179, P561, DOI 10.1016/j.cell.2019.08.052
   Ge TX, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00365
   Guo PY, 2018, ONCOGENE, V37, P1220, DOI 10.1038/s41388-017-0017-y
   Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.21492, 10.3322/caac.20107]
   Kim K, 2012, ONCOGENE, V31, P4290, DOI 10.1038/onc.2011.605
   Klinge S, 2019, NAT REV MOL CELL BIO, V20, P116, DOI 10.1038/s41580-018-0078-y
   Kulik L, 2019, GASTROENTEROLOGY, V156, P477, DOI 10.1053/j.gastro.2018.08.065
   Macias E, 2010, CANCER CELL, V18, P231, DOI 10.1016/j.ccr.2010.08.007
   Martinez-Outschoorn UE, 2017, NAT REV CLIN ONCOL, V14, P11, DOI 10.1038/nrclinonc.2016.60
   Patra KC, 2014, TRENDS BIOCHEM SCI, V39, P347, DOI 10.1016/j.tibs.2014.06.005
   Pelletier J, 2018, NAT REV CANCER, V18, P51, DOI 10.1038/nrc.2017.104
   Raychaudhuri S, 2009, CANCER RES, V69, P2057, DOI 10.1158/0008-5472.CAN-08-3468
   Rodic S., 2017, INT J CANCER
   Rodríguez-Enríquez S, 2011, CURR MED CHEM, V18, P3156, DOI 10.2174/092986711796391561
   Ruan YY, 2012, J CLIN INVEST, V122, P2554, DOI 10.1172/JCI58488
   Shah ZH, 2012, MOL CELL BIOL, V32, P704, DOI 10.1128/MCB.06448-11
   Shukla SK, 2012, FEBS J, V279, P3859, DOI 10.1111/j.1742-4658.2012.08745.x
   Skawran B, 2008, MODERN PATHOL, V21, P505, DOI 10.1038/modpathol.3800998
   Tafforeau L, 2013, MOL CELL, V51, P539, DOI 10.1016/j.molcel.2013.08.011
   Villanueva A, 2019, NEW ENGL J MED, V380, P1450, DOI 10.1056/NEJMra1713263
   Wu T, 2016, FEBS OPEN BIO, V6, P1085, DOI 10.1002/2211-5463.12128
   Xu L, 2019, CANCER MED-US, V8, P2380, DOI 10.1002/cam4.2089
   Yang XC, 2018, BIOCHEM BIOPH RES CO, V498, P207, DOI 10.1016/j.bbrc.2018.02.211
   Zhan P, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0682-z
   Zhang B, 2019, CANCER LETT, V452, P23, DOI 10.1016/j.canlet.2019.03.029
   Zhang B, 2018, MOL CARCINOGEN, V57, P201, DOI 10.1002/mc.22747
   Zhang B, 2017, J PATHOL, V243, P418, DOI 10.1002/path.4976
   Zhang B, 2017, J CELL MOL MED, V21, P1329, DOI 10.1111/jcmm.13063
   Zhang B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084931
   Zhang Q, 2020, ONCOGENE, V39, P1484, DOI 10.1038/s41388-019-1071-4
   Zhao LJ, 2019, NUCLEIC ACIDS RES, V47, P2011, DOI 10.1093/nar/gky1209
NR 42
TC 8
Z9 8
U1 5
U2 19
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0304-3835
EI 1872-7980
J9 CANCER LETT
JI Cancer Lett.
PD 2021 OCT 28
PY 2021
VL 519
BP 315
EP 327
DI 10.1016/j.canlet.2021.07.046
EA AUG 2021
PG 13
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA UI3EJ
UT WOS:000690494700003
PM 34343634
DA 2024-02-19
ER

PT J
AU Yoshida, K
   Nakashima, E
   Kubo, Y
   Yamaoka, M
   Kajimura, J
   Kyoizumi, S
   Hayashi, T
   Ohishi, W
   Kusunoki, Y
AF Yoshida, Kengo
   Nakashima, Eiji
   Kubo, Yoshiko
   Yamaoka, Mika
   Kajimura, Junko
   Kyoizumi, Seishi
   Hayashi, Tomonori
   Ohishi, Waka
   Kusunoki, Yoichiro
TI Inverse Associations between Obesity Indicators and Thymic T-Cell
   Production Levels in Aging Atomic-Bomb Survivors
SO PLOS ONE
LA English
DT Article
ID AGE-RELATED-CHANGES; CALORIC RESTRICTION; LYMPHOCYTE POPULATIONS;
   GROWTH-HORMONE; HOMEOSTASIS; LEPTIN; DEFICIENCY; INCREASES; IMMUNITY;
   SUBSETS
AB Reduction of the naive T-cell population represents a deteriorating state in the immune system that occurs with advancing age. In animal model studies, obesity compromises the T-cell immune system as a result of enhanced adipogenesis in primary lymphoid organs and systemic inflammation. In this study, to test the hypothesis that obesity may contribute to the aging of human T-cell immunity, a thousand atomic-bomb survivors were examined for obesity status and ability to produce naive T cells, i.e., T-cell receptor excision circle (TREC) numbers in CD4 and CD8 T cells. The number of TRECs showed a strong positive correlation with naive T cell numbers, and lower TREC numbers were associated with higher age. We found that the TREC number was inversely associated with levels of obesity indicators (BMI, hemoglobin A1c) and serum CRP levels. Development of type-2 diabetes and fatty liver was also associated with lower TREC numbers. This population study suggests that obesity with enhanced inflammation is involved in aging of the human T-cell immune system. Given the fact that obesity increases the risk of numerous age-related diseases, attenuated immune competence is a possible mechanistic link between obesity and disease development among the elderly.
C1 [Yoshida, Kengo; Kubo, Yoshiko; Yamaoka, Mika; Kajimura, Junko; Kyoizumi, Seishi; Hayashi, Tomonori; Kusunoki, Yoichiro] Radiat Effects Res Fdn, Dept Radiobiol Mol Epidemiol, Hiroshima, Japan.
   [Nakashima, Eiji] Radiat Effects Res Fdn, Dept Stat, Hiroshima, Japan.
   [Ohishi, Waka] Radiat Effects Res Fdn, Dept Clin Studies, Hiroshima, Japan.
C3 Radiation Effects Research Foundation - Japan; Radiation Effects
   Research Foundation - Japan; Radiation Effects Research Foundation -
   Japan
RP Yoshida, K (corresponding author), Radiat Effects Res Fdn, Dept Radiobiol Mol Epidemiol, Hiroshima, Japan.
EM kyoshi@rerf.or.jp
FU Japanese Ministry of Health, Labour and Welfare (MHLW); U.S. Department
   of Energy (DOE) [DE-HS0000031]; MHLW; U.S. National Institute of Allergy
   and Infectious Diseases (NIAID) [HHSN272200900059C]; Grants-in-Aid for
   Scientific Research [24390162, 23590840] Funding Source: KAKEN
FX The Radiation Effects Research Foundation (RERF, http://www.rerf.or.jp),
   Hiroshima and Nagasaki, Japan is a private, non-profit foundation funded
   by the Japanese Ministry of Health, Labour and Welfare (MHLW) and the
   U.S. Department of Energy (DOE), the latter in part through DOE Award
   DE-HS0000031 to the National Academy of Sciences. This study is based on
   RERF Research Protocols #4-02 and 3-09, and is supported by the MHLW
   (http://www.mhlw.go.jp) Grant-in-Aid and the U.S. National Institute of
   Allergy and Infectious Diseases (NIAID Contract HHSN272200900059C,
   http://www.niaid.nih.gov). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript. The views of the authors do not necessarily reflect those of
   the two governments.
CR Beebe GW, 1960, 1060 AT BOMB CAS COM
   Chen C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000559
   Chen J, 2010, MECH AGEING DEV, V131, P29, DOI 10.1016/j.mad.2009.11.003
   Chinn IK, 2012, SEMIN IMMUNOL, V24, P309, DOI 10.1016/j.smim.2012.04.005
   Cullings HM, 2006, RADIAT RES, V166, P219, DOI 10.1667/RR3546.1
   Dixit VD, 2008, J LEUKOCYTE BIOL, V84, P882, DOI 10.1189/jlb.0108028
   Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925
   Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374
   Falagas ME, 2006, LANCET INFECT DIS, V6, P438, DOI 10.1016/S1473-3099(06)70523-0
   Ferrando-Martínez S, 2013, AGE, V35, P251, DOI 10.1007/s11357-011-9341-2
   Flegal KM, 2007, JAMA-J AM MED ASSOC, V298, P2028, DOI 10.1001/jama.298.17.2028
   Haynes L, 2012, SEMIN IMMUNOL, V24, P350, DOI 10.1016/j.smim.2012.04.001
   Herasimtschuk AA, 2013, CLIN EXP IMMUNOL, V173, P444, DOI 10.1111/cei.12141
   Howard JK, 1999, J CLIN INVEST, V104, P1051, DOI 10.1172/JCI6762
   Hsu HC, 2010, CURR OPIN IMMUNOL, V22, P541, DOI 10.1016/j.coi.2010.05.002
   Karlsson EA, 2010, EXP BIOL MED, V235, P1412, DOI 10.1258/ebm.2010.010227
   Koetz K, 2000, P NATL ACAD SCI USA, V97, P9203, DOI 10.1073/pnas.97.16.9203
   Kusunoki Y, 2008, INT J RADIAT BIOL, V84, P1, DOI 10.1080/09553000701616106
   Kyoizumi S, 2010, INT J RADIAT BIOL, V86, P56, DOI 10.3109/09553000903272641
   Linton PJ, 2004, NAT IMMUNOL, V5, P133, DOI 10.1038/ni1033
   Messaoudi I, 2006, P NATL ACAD SCI USA, V103, P19448, DOI 10.1073/pnas.0606661103
   Morrhaye G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005668
   Naveiras O, 2009, NATURE, V460, P259, DOI 10.1038/nature08099
   Naylor K, 2005, J IMMUNOL, V174, P7446, DOI 10.4049/jimmunol.174.11.7446
   Nikolich-Zugich J, 2012, SEMIN IMMUNOL, V24, P356, DOI 10.1016/j.smim.2012.04.009
   Oysyannikova IG, 2014, VACCINE, V32, P881, DOI 10.1016/j.vaccine.2013.12.009
   Palmer G, 2006, J IMMUNOL, V177, P2899, DOI 10.4049/jimmunol.177.5.2899
   Prasad S, 2012, PREV MED, V54, pS29, DOI 10.1016/j.ypmed.2011.11.011
   Priceman SJ, 2013, P NATL ACAD SCI USA, V110, P13079, DOI 10.1073/pnas.1311557110
   Qiu Q, 2010, J IMMUNOL, V184, P1681, DOI 10.4049/jimmunol.0900062
   Semposski GD, 2002, MOL IMMUNOL, V38, P841, DOI 10.1016/S0161-5890(01)00122-5
   Serana F, 2011, J CLIN IMMUNOL, V31, P540, DOI 10.1007/s10875-011-9526-6
   Thewissen M, 2007, CLIN IMMUNOL, V123, P209, DOI 10.1016/j.clim.2007.01.005
   Verschuren MCM, 1997, J IMMUNOL, V158, P1208
   Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001
   Yamaoka M, 2004, RADIAT RES, V161, P290, DOI 10.1667/RR3143
   Yang H, 2009, BLOOD, V114, P3803, DOI 10.1182/blood-2009-03-213595
   Yang HW, 2009, J IMMUNOL, V183, P3040, DOI 10.4049/jimmunol.0900562
   Yasunaga J, 2001, BLOOD, V97, P3177, DOI 10.1182/blood.V97.10.3177
   Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025
NR 40
TC 17
Z9 17
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 20
PY 2014
VL 9
IS 3
AR e91985
DI 10.1371/journal.pone.0091985
PG 8
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA AD6FV
UT WOS:000333352800062
PM 24651652
OA Green Published, gold, Green Submitted
DA 2024-02-19
ER

PT J
AU POWERS, SK
   LAWLER, J
   CRISWELL, D
   LIEU, FK
   MARTIN, D
AF POWERS, SK
   LAWLER, J
   CRISWELL, D
   LIEU, FK
   MARTIN, D
TI AGING AND RESPIRATORY MUSCLE METABOLIC PLASTICITY - EFFECTS OF ENDURANCE
   TRAINING
SO JOURNAL OF APPLIED PHYSIOLOGY
LA English
DT Article
DE DIAPHRAGM; EXPIRATORY MUSCLES; INSPIRATORY MUSCLES; MUSCLE PLASTICITY;
   SKELETAL MUSCLE; EXERCISE
ID SKELETAL-MUSCLE; CELLULAR ADAPTATIONS; VENTILATORY MUSCLES; RIB CAGE;
   DIAPHRAGM; RAT; EXERCISE; COSTAL; LIVER
AB We examined the oxidative and antioxidant enzyme activities in respiratory and locomotor muscles in response to endurance training in young and aging rats.  Young adult (4-mo-old) and old (24-mo-old) female Fischer 344 rats were divided into four groups:  1) young trained (n = 12), 2) young untrained (n = 12), 3) old trained (n = 10), and 4) old untrained (n = 6).  Both young and old endurance-trained animals performed the same training protocol during 10 wk of continuous treadmill exercise (60 min/day, 5 days/wk).  Compared with young untrained animals, the young trained group had significantly elevated (P < 0.05) activities of 3-hydroxyacyl-CoA dehydrogenase (HADH), glutathione peroxidase (GPX), and citrate synthase (CS) in both the costal diaphragm and the plantaris muscle.  In contrast, training had no influence (P > 0.05) on the activity of lactate dehydrogenase within the costal diaphragm in young animals.  In the aging animals, training did not alter (P > 0.05) activities of CS, HADH, GPX, or lactate dehydrogenase in the costal diaphragm but significantly (P < 0.05) increased CS, HADH, and GPX activities in the plantaris muscle.  Furthermore, training resulted in higher activities of CS and HADH in the intercostal muscles in the old trained than in the old untrained animals.  Finally, activities of CS, HADH, and GPX were significantly (P < 0.05) lower in the plantaris in the old untrained than in the young untrained animals; however, CS, HADH, and GPX activities were greater (P < 0.05) in the costal diaphragm in the old sedentary than in the young untrained animals.  We speculate that the lack of training-induced metabolic adaptation in the costal diaphragm in old animals is due to the elevated basal level of oxidative enzymes in this group.
C1 UNIV FLORIDA,CTR EXERCISE SCI,DEPT EXERCISE & SPORT SCI,GAINESVILLE,FL 32611.
   UNIV FLORIDA,CTR EXERCISE SCI,DEPT PHYS THERAPY,GAINESVILLE,FL 32611.
C3 State University System of Florida; University of Florida; State
   University System of Florida; University of Florida
RP POWERS, SK (corresponding author), UNIV FLORIDA,CTR EXERCISE SCI,DEPT PHYSIOL,RM 33 FLG,GAINESVILLE,FL 32611, USA.
CR AKABAS SR, 1989, J APPL PHYSIOL, V66, P529, DOI 10.1152/jappl.1989.66.2.529
   BASS A, 1969, EUR J BIOCHEM, V10, P198, DOI 10.1111/j.1432-1033.1969.tb00674.x
   Bergmeyer H.-U., 1965, Methods of Enzymatic Analysis, P736
   COHN JE, 1963, J CLIN INVEST, V42, P1406, DOI 10.1172/JCI104825
   DARIAN GB, 1989, J APPL PHYSIOL, V66, P2579, DOI 10.1152/jappl.1989.66.6.2579
   DAVIDSON JT, 1966, J APPL PHYSIOL, V21, P837, DOI 10.1152/jappl.1966.21.3.837
   DETROYER A, 1981, SCIENCE, V213, P237, DOI 10.1126/science.7244632
   DETROYER A, 1982, J APPL PHYSIOL, V53, P30, DOI 10.1152/jappl.1982.53.1.30
   ESTENNE M, 1985, J APPL PHYSIOL, V59, P1842, DOI 10.1152/jappl.1985.59.6.1842
   GOLLNICK PD, 1985, J EXP BIOL, V115, P191
   HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831
   IANUZZO CD, 1982, J APPL PHYSIOL, V52, P1471, DOI 10.1152/jappl.1982.52.6.1471
   JI LL, 1990, AM J PHYSIOL, V258, pR918, DOI 10.1152/ajpregu.1990.258.4.R918
   KEENS TG, 1978, J APPL PHYSIOL, V44, P905, DOI 10.1152/jappl.1978.44.6.905
   LAWLER J, 1989, Medicine and Science in Sports and Exercise, V21, pS70
   LAWLER J M, 1991, Medicine and Science in Sports and Exercise, V23, pS99
   METZGER JM, 1986, J APPL PHYSIOL, V60, P1752, DOI 10.1152/jappl.1986.60.5.1752
   MOORE RL, 1982, PFLUG ARCH EUR J PHY, V392, P268, DOI 10.1007/BF00584308
   NAKAMURA W, 1974, BIOCHIM BIOPHYS ACTA, V358, P251, DOI 10.1016/0005-2744(74)90455-0
   POWERS SK, 1990, J APPL PHYSIOL, V69, P648, DOI 10.1152/jappl.1990.69.2.648
   POWERS SK, 1990, J APPL PHYSIOL, V68, P2114, DOI 10.1152/jappl.1990.68.5.2114
   RIZZATO G, 1970, J APPL PHYSIOL, V28, P457, DOI 10.1152/jappl.1970.28.4.457
   SIMONEAU J, 1988, BIOCH EXERCISE, V7, P95
   SJODIN B, 1990, SPORTS MED, V10, P236
   Srere P.A., 1969, METHOD ENZYMOL, V13, P3, DOI DOI 10.1016/0076-6879(69)13005-0
   ZADAI C, 1985, TOP GERIATR REHABIL, V1, P49
NR 26
TC 46
Z9 49
U1 0
U2 5
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814
SN 8750-7587
J9 J APPL PHYSIOL
JI J. Appl. Physiol.
PD MAR
PY 1992
VL 72
IS 3
BP 1068
EP 1073
DI 10.1152/jappl.1992.72.3.1068
PG 6
WC Physiology; Sport Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology; Sport Sciences
GA HK063
UT WOS:A1992HK06300037
PM 1568962
DA 2024-02-19
ER

PT J
AU SZWEDA, LI
AF SZWEDA, LI
TI AGE-RELATED INCREASE IN LIVER RETINYL PALMITATE - RELATIONSHIP TO
   LIPOFUSCIN
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID VITAMIN-A; LIPID-PEROXIDATION; AGING RATS; FLUORESCENT; PRODUCTS;
   TISSUES; INVOLVEMENT; SUBSTANCES; STORAGE
AB Lipofuscin is a general term assigned to fluorescent material that accumulates in cells as they age. It is apparent from this study that the fluorescent intensity of detergent-solubilized liver from Fisher-344 rats increased as a function of age. The fluorophore responsible for this increase was extracted with methanol and could be resolved from other cellular components when the methanol extracts were chromatographed over a re verse phase column. This compound was identified as retinyl palmitate and was found to increase throughout the entire life of the Fisher-344 rat (2-24 months), from a value of 0.26-1.77 mg/g of liver. In addition, the results presented here demonstrate that concentration, time between extraction and analysis, exposure to light, and degree of purity affect the observed fluorescent properties of retinyl palmitate. These factors affect many fluorophores and are likely to be, at least in part, responsible for the multiplicity of reported properties of lipofuscin. As has been reported for lipofuscin, retinyl palmitate accumulates in intracellular granules and exhibits fluorescence between 450 and 600 nm. Due to these similarities, the relationship between retinyl palmitate and lipofuscin warrants further investigation.
RP SZWEDA, LI (corresponding author), NHLBI,BIOCHEM LAB,BLDG 3,RM 221,BETHESDA,MD 20892, USA.
CR BANKSON DD, 1989, EXP GERONTOL, V24, P127, DOI 10.1016/0531-5565(89)90023-5
   BHAT PV, 1983, J CHROMATOGR, V272, P269, DOI 10.1016/S0378-4347(00)86129-0
   CHIO KS, 1969, SCIENCE, V166, P1535, DOI 10.1126/science.166.3912.1535
   CHIO KS, 1969, BIOCHEMISTRY-US, V8, P2821, DOI 10.1021/bi00835a019
   CSALLANY AS, 1976, LIPIDS, V11, P412, DOI 10.1007/BF02532849
   ELDRED GE, 1989, FREE RADICAL BIO MED, V7, P157, DOI 10.1016/0891-5849(89)90007-5
   ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6
   FERLAND G, 1992, J GERONTOL, V47, pB3, DOI 10.1093/geronj/47.1.B3
   FLETCHER BL, 1973, ANAL BIOCHEM, V52, P1, DOI 10.1016/0003-2697(73)90327-8
   GANGULY J, 1989, BIOCH VITAMIN A
   GUERRANT N. B., 1949, JOUR NUTRITION, V37, P37
   HARMAN D, 1990, LIPOFUSCIN CEROID PI, P3
   IVY GO, 1991, MECH AGEING DEV, V57, P213, DOI 10.1016/0047-6374(91)90048-5
   KAHAN J, 1967, ACTA CHEM SCAND, V21, P2515, DOI 10.3891/acta.chem.scand.21-2515
   KATZ ML, 1987, MECH AGEING DEV, V39, P81, DOI 10.1016/0047-6374(87)90088-1
   KIKUGAWA K, 1987, CHEM PHYS LIPIDS, V44, P277, DOI 10.1016/0009-3084(87)90054-5
   KIRK JE, 1962, VITAM HORM, V20, P67, DOI 10.1016/S0083-6729(08)60716-5
   MOBARHAN S, 1991, J NUTR, V121, P510, DOI 10.1093/jn/121.4.510
   Olson J.A., 1991, HDB VITAMINS 2 REVIS, Vsecond, P1
   PLANTA CV, 1962, HELV CHIM ACTA, V45, P548, DOI 10.1002/hlca.19620450218
   PORTA EA, 1991, ARCH GERONTOL GERIAT, V12, P303, DOI 10.1016/0167-4943(91)90036-P
   Sobotka H, 1943, J AM CHEM SOC, V65, P1959, DOI 10.1021/ja01250a042
   SUNDBOOM J, 1984, EXP GERONTOL, V19, P257, DOI 10.1016/0531-5565(84)90021-4
   TOTARO EA, 1985, ADV AGE PIGMENTS RES, V64
   TSUCHIDA M, 1987, CHEM PHYS LIPIDS, V44, P297, DOI 10.1016/0009-3084(87)90055-7
   WOLFE LS, 1977, SCIENCE, V195, P1360, DOI 10.1126/science.841336
   ZSNAGY I, 1988, INT C SERIES, V782
NR 27
TC 16
Z9 17
U1 0
U2 1
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PD MAR 25
PY 1994
VL 269
IS 12
BP 8712
EP 8715
PG 4
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA NB411
UT WOS:A1994NB41100017
PM 8132600
DA 2024-02-19
ER

PT J
AU LEMESHKO, VV
   SHEKH, VE
AF LEMESHKO, VV
   SHEKH, VE
TI HYPOTONIC FRAGILITY OF OUTER-MEMBRANE AND ACTIVATION OF EXTERNAL PATHWAY
   OF NADH OXIDATION IN RAT-LIVER MITOCHONDRIA ARE INCREASED WITH AGE
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE AGING; MITOCHONDRIA; OUTER MEMBRANE HYPOTONIC FRAGILITY;
   ROTENONE-INSENSITIVE NADH OXIDATION; MG(2+) IONS; CYTOCHROME-C-MEMBRANE
   INTERACTION
ID HEART-MITOCHONDRIA; RESPIRATION; PHOSPHORYLATION; RELEASE; INJURY;
   VOLUME; CA-2+
AB Great importance is attached to structural and functional deterioration of mitochondria as a reason for ageing of an organism; the attention of many scientists has been concentrated on such questions as age changes in the system of oxidative phosphorylation, damage of mitochondrial DNA by free radicals generated in the respiratory chain and inclusion of some fragments of mitochondrial DNA into the nuclear genome. Mitochondrial high amplitude swelling in a cell under some extreme conditions can possibly play a very important role in mechanisms of deterioration of energy transformation function, in activation of lipid peroxidation and mitochondrial DNA damage as a result of outer membrane disruption and release of enzymes from the intermembrane space (e.g. superoxide dismutase and adenylate kinase). In this work the age changes of the hypotonic fragility of the outer membrane of rat liver mitochondria and the activation of the external, rotenone-insensitive pathway of NADH oxidation have been examined. It is shown that the obligatory condition for activation of rotenone-insensitive NADH oxidation is a break in the outer membrane and that the rate of NADH oxidation substantially increases in the presence of physiological concentrations of Mg2+ which cause a multiple increase in the affinity of the inner membrane to cytochrome c. Research on the rate of rotenone-insensitive NADH oxidation with respect to the osmotic pressure, the ionic strength of the medium, the presence of Mg2+ ions and cytochrome c in the medium has demonstrated a considerable increase in the hypotonic fragility of the outer membrane of liver mitochondria with age in male rats. In female rats the age changes were insignificant. It is supposed that the damage to the outer membrane of mitochondria in cells can serve as one of the possible explanations of both decrease in the reliability of an aged organism under extreme conditions and sex differences of life-span.
RP LEMESHKO, VV (corresponding author), KHARKOV AM GORKII STATE UNIV,BIOL RES INST,SVOBODI SQ 4,KHARKOV 310077,UKRAINE.
OI Shekh, Vera/0000-0001-7184-3898
CR ABUERREISH GM, 1978, MECH AGEING DEV, V7, P425, DOI 10.1016/0047-6374(78)90083-0
   ASHRAF M, 1978, J MOL CELL CARDIOL, V10, P535, DOI 10.1016/0022-2828(78)90012-3
   BAKEEVA LE, 1972, BIOCHIM BIOPHYS ACTA, V275, P319, DOI 10.1016/0005-2728(72)90213-7
   BAKER KP, 1990, NATURE, V348, P605, DOI 10.1038/348605a0
   BARRETT MC, 1976, BIOCHEM SOC T, V4, P64, DOI 10.1042/bst0040064
   BAUM H, 1984, MEMBRANE PROCESSES M, P167
   BERDANIER CD, 1980, EXP GERONTOL, V15, P519, DOI 10.1016/0531-5565(80)90004-2
   Beregi E, 1983, Aktuelle Gerontol, V13, P226
   CHIU YJD, 1980, EXP GERONTOL, V15, P511, DOI 10.1016/0531-5565(80)90003-0
   CORBISIER P, 1990, EUR J CELL BIOL, V51, P173
   DARNOLD JR, 1990, MECH AGEING DEV, V53, P157, DOI 10.1016/0047-6374(90)90067-P
   DAVIDSON AM, 1987, BIOCHEM J, V246, P715, DOI 10.1042/bj2460715
   FLEMING JE, 1982, GERONTOLOGY, V28, P44, DOI 10.1159/000212510
   GORNALL AG, 1949, J BIOL CHEM, V177, P751
   HANSFORD RG, 1978, BIOCHEM J, V170, P285, DOI 10.1042/bj1700285
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   JANCSIK V, 1988, ARCH BIOCHEM BIOPHYS, V264, P295, DOI 10.1016/0003-9861(88)90597-8
   JENNINGS RB, 1985, CIRC RES, V56, P262, DOI 10.1161/01.RES.56.2.262
   KIM JH, 1988, MECH AGEING DEV, V46, P263
   KIM JH, 1988, MECH AGEING DEV, V46, P279, DOI 10.1016/0047-6374(88)90130-3
   KUCK U, 1985, CURR GENET, V9, P373, DOI 10.1007/BF00421608
   LEMESHKO V V, 1982, Biokhimiya, V47, P752
   LEMESHKO V V, 1981, Biokhimiya, V46, P1807
   LEMESHKO VV, 1982, BIOCHEMISTRY-MOSCOW+, V47, P465
   LEMESHKO VV, 1982, BIOFIZIKA+, V27, P837
   LEMESHKO VV, 1978, DOKL AKAD NAUK SSSR+, V243, P1579
   MANZELMANN MS, 1987, MECH AGEING DEV, V39, P281, DOI 10.1016/0047-6374(87)90067-4
   MATLIB MA, 1976, ARCH BIOCHEM BIOPHYS, V173, P27, DOI 10.1016/0003-9861(76)90230-7
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   NOHL H, 1978, EUR J BIOCHEM, V90, P385, DOI 10.1111/j.1432-1033.1978.tb12615.x
   OOKA H, 1983, MECH AGEING DEV, V22, P113, DOI 10.1016/0047-6374(83)90104-5
   PACKER L, 1985, MEMBRANES MUSCLE, V20, P135
   RICHTER C, 1988, FREE RADICAL BIO MED, V4, P365, DOI 10.1016/0891-5849(88)90088-3
   RICHTER C, 1988, FEBS LETT, V241, P1, DOI 10.1016/0014-5793(88)81018-4
   SOHAL RS, 1991, MECH AGEING DEV, V57, P187, DOI 10.1016/0047-6374(91)90034-W
   Spencer JA, 1979, BIOCHEM SOC T, V7, P1260, DOI 10.1042/bst0071260
   TAPLEY DF, 1967, NEW ENGL J MED, V276, P1182, DOI 10.1056/NEJM196705252762106
NR 37
TC 11
Z9 11
U1 0
U2 0
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD MAY
PY 1993
VL 68
IS 1-3
BP 221
EP 233
DI 10.1016/0047-6374(93)90153-I
PG 13
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA LG147
UT WOS:A1993LG14700019
PM 8350660
DA 2024-02-19
ER

PT J
AU Belinskaya, T
   Pattabiraman, N
   DiTargiani, R
   Choi, M
   Saxena, A
AF Belinskaya, Tatyana
   Pattabiraman, Nagarajan
   diTargiani, Robert
   Choi, Moonsuk
   Saxena, Ashima
TI Differences in amino acid residues in the binding pockets dictate
   substrate specificities of mouse senescence marker protein-30, human
   paraoxonase1, and squid diisopropylfluorophosphatase
SO BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
LA English
DT Article
DE Mouse SMP-30; Squid DFPase; Human PON1; DFP; Catalytic bioscavenger;
   Molecular docking
ID DIISOPROPYL FLUOROPHOSPHATASE; CRYSTAL-STRUCTURE; LOLIGO-VULGARIS;
   ENZYME; PROPHYLAXIS; LACTONASE; MICE; PHOSPHOROFLUORIDATE;
   PHOSPHOTRIESTERASE; GLUCONOLACTONASE
AB Senescence marker protein-30 (SMP-30) is a candidate enzyme that can function as a catalytic bioscavenger of organophosphorus (OP) nerve agents. We purified SMP-30 from mouse (Mo) liver and compared its hydrolytic activity towards various esters, lactones, and G-type nerve agents with that of human paraoxonase1 (Hu PON1) and squid diisopropylfluorophosphatase (DFPase). All three enzymes contain one or two metal ions in their active sites and fold into six-bladed beta-propeller structures. While Hu PON1 hydrolyzed a variety of lactones, the only lactone that was a substrate for Mo SMP-30 was D-(+)-gluconic acid delta-lactone. Squid DFPase was much more efficient at hydrolyzing DFP and G-type nerve agents as compared to Mo SMP-30 or Hu PON1. The K-m values for DFP were in the following order: Mo SMP-30 > Hu PON1 > squid DFPase, suggesting that the efficiency of DFP hydrolysis may be related to its binding in the active sites of these enzymes. Thus, homology modeling and docking were used to simulate the binding of DFP and selected delta-lactones in the active sites of Hu SMP-30, Hu PON1, and squid DFPase. Results from molecular modeling studies suggest that differences in metal-ligand coordinations, the hydrophobicity of the binding pockets, and limited space in the binding pocket due to the presence of a loop, are responsible for substrate specificities of these enzymes. Published by Elsevier B.V.
C1 [Belinskaya, Tatyana; Pattabiraman, Nagarajan; diTargiani, Robert; Choi, Moonsuk; Saxena, Ashima] Walter Reed Army Inst Res, Div Bacterial & Rickettsial Dis, Silver Spring, MD 20910 USA.
C3 Walter Reed Army Institute of Research (WRAIR); United States Department
   of Defense; United States Army
RP Saxena, A (corresponding author), Walter Reed Army Inst Res, Div Bacterial & Rickettsial Dis, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.
EM Ashima.saxena@us.army.mil
RI Pattabiraman, Nagarjan/A-9347-2011
FU Defense Threat Reduction Agency
FX The authors wish to thank Ms. Amy Michels for her assistance in
   preparation of the manuscript. This research was supported by funding
   from the Defense Threat Reduction Agency.
CR ASHANI Y, 1991, LIFE SCI, V49, P367, DOI 10.1016/0024-3205(91)90444-G
   Billecke SS, 1999, CHEM-BIOL INTERACT, V119, P251, DOI 10.1016/S0009-2797(99)00034-4
   Billeclke S, 2000, DRUG METAB DISPOS, V28, P1335
   Blum MM, 2006, J AM CHEM SOC, V128, P12750, DOI 10.1021/ja061887n
   Blum MM, 2009, P NATL ACAD SCI USA, V106, P713, DOI 10.1073/pnas.0807842106
   Briggs GE, 1925, BIOCHEM J, V19, P338, DOI 10.1042/bj0190338
   Broomfield C.A., 2000, KINETICS NERVE AGENT
   BROOMFIELD CA, 1993, CHEM-BIOL INTERACT, V87, P279, DOI 10.1016/0009-2797(93)90055-4
   Chakraborti S, 2010, BIOCHEMISTRY-US, V49, P3436, DOI 10.1021/bi9022297
   Chen CN, 2008, J MOL BIOL, V384, P604, DOI 10.1016/j.jmb.2008.09.055
   DECANDOLE CA, 1953, BRIT J PHARM CHEMOTH, V8, P466
   DEFRANK JJ, 1993, CHEM-BIOL INTERACT, V87, P141, DOI 10.1016/0009-2797(93)90035-W
   Ditargiani RC, 2010, CHEM-BIOL INTERACT, V187, P349, DOI 10.1016/j.cbi.2010.02.021
   Draganov DI, 2000, J BIOL CHEM, V275, P33435, DOI 10.1074/jbc.M004543200
   DUMAS DP, 1990, ARCH BIOCHEM BIOPHYS, V277, P155, DOI 10.1016/0003-9861(90)90564-F
   ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2
   Fujita T, 1999, BIOCHEM BIOPH RES CO, V254, P1, DOI 10.1006/bbrc.1998.9841
   Fujita T, 1996, BBA-GENE STRUCT EXPR, V1308, P49, DOI 10.1016/0167-4781(96)00064-4
   Gäb J, 2009, ANAL BIOCHEM, V385, P187, DOI 10.1016/j.ab.2008.11.012
   GAN KN, 1991, DRUG METAB DISPOS, V19, P100
   Harel M, 2004, NAT STRUCT MOL BIOL, V11, P412, DOI 10.1038/nsmb767
   Hartleib J, 2001, PROTEIN EXPRES PURIF, V21, P210, DOI 10.1006/prep.2000.1360
   HEFFRON PF, 1979, BRIT J PHARMACOL, V66, P323, DOI 10.1111/j.1476-5381.1979.tb13683.x
   Katsemi V, 2005, BIOCHEMISTRY-US, V44, P9022, DOI 10.1021/bi0500675
   Khersonsky O, 2006, J BIOL CHEM, V281, P7649, DOI 10.1074/jbc.M512594200
   Kondo Y, 2006, P NATL ACAD SCI USA, V103, P5723, DOI 10.1073/pnas.0511225103
   Kondo Y, 2004, FEBS LETT, V570, P57, DOI 10.1016/j.febslet.2004.06.028
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LITTLE JS, 1989, BIOCHEM PHARMACOL, V38, P23, DOI 10.1016/0006-2952(89)90144-5
   Melzer M, 2009, J AM CHEM SOC, V131, P17226, DOI 10.1021/ja905444g
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   RAVEH L, 1992, BIOCHEM PHARMACOL, V44, P397, DOI 10.1016/0006-2952(92)90028-H
   Rochu D, 2007, TOXICOLOGY, V233, P47, DOI 10.1016/j.tox.2006.08.037
   SAXENA A, 2007, CHEM WARFARE AGENTS, P145
   Scharff EI, 2001, STRUCTURE, V9, P493, DOI 10.1016/S0969-2126(01)00610-4
   Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h
   STEWART WC, 1968, J PHARMACOL EXP THER, V162, P309
   Tavori H, 2008, BIOORGAN MED CHEM, V16, P7504, DOI 10.1016/j.bmc.2008.06.008
   Taylor P., 1985, PHARMACOL BASIS THER, P10
NR 39
TC 15
Z9 18
U1 0
U2 15
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1570-9639
EI 1878-1454
J9 BBA-PROTEINS PROTEOM
JI BBA-Proteins Proteomics
PD MAY
PY 2012
VL 1824
IS 5
BP 701
EP 710
DI 10.1016/j.bbapap.2012.02.007
PG 10
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA 942VD
UT WOS:000304077200001
PM 22401958
DA 2024-02-19
ER

PT J
AU Shimamura, T
   Iijima, S
   Hirayama, M
   Iwashita, M
   Akiyama, S
   Takaku, Y
   Yumoto, S
AF Shimamura, Tadashi
   Iijima, Satoe
   Hirayama, Mitsuhiro
   Iwashita, Masato
   Akiyama, Shigeru
   Takaku, Yuichi
   Yumoto, Sakae
TI The concentrations of major and trace elements in rat kidney: Aging
   effects and mutual relationships
SO JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY
LA English
DT Article
DE Rat kidney; Elemental concentrations; Aging effects; Elemental
   correlations; Cluster analysis
ID CADMIUM TOXICITY; ACCUMULATION; LIVER; TISSUES; METALLOTHIONEIN; COPPER;
   AGE; ZINC; MANGANESE; EXPOSURE
AB The concentrations of 26 major to trace elements in rat kidneys aging from 5 to 113 weeks old were determined. The rats investigated were the same rats used previously reported to have 29 elements in bones (femurs). The samples were decomposed by high purity nitric acid and hydrogen peroxide. Eight elements (Na, Mg, Si, P. K, Ca, Fe and Zn) were determined using inductively coupled plasma atomic emission spectrometry (ICP-AES) and 18 elements (Mn, Co, Ni, Cu, As, Se, Rb, Sr, Mo, Cd, Sn, Sb, Cs, Ba, Tl, Pb, Bi and U) were determined using inductively coupled plasma mass spectrometry (ICP-MS). The aging effects on the concentrations of these elements and mutual elemental relationships were investigated. Analysis of variance (ANOVA) for age variations indicated that the concentrations of P, K, Mn and Mo were almost constant across the age of rats (p > 0.3). The concentration of many elements such as Na, Mg, Ca, Fe, Co, Cu, Zn, As, Se, Cd, Sn, Sb, Tl, Pb and Bi, showed significant increasing trends (p < 0.01) with different patterns. Rubidium, Cs, Pb and Bi showed significant age variations but not monotonic trends. Silicon, Ni, Sr, Ba and U showed large concentration scatterings without any significant trends (p > 0.01). The metabolism of these elements may not be well established in the kidney. Many toxic elements such as As, Cd, Sn, Pb and Bi showed a narrow concentration range among age-matched rats. The kidney may have established metabolic mechanisms to confine or accumulate these toxic elements even though their concentrations are very low (e.g., 10 ng g(-1) of Cd). These elements also closely coupled with Fe. A cluster analysis was performed using an elemental correlation matrix and indicated that these elements, including Fe, formed a cluster. However, another cluster analysis using "an aging effect eliminated" elemental correlation showed different clustering in which the Fe, Cd cluster disappeared. (C) 2012 Elsevier GmbH. All rights reserved.
C1 [Shimamura, Tadashi; Iwashita, Masato; Akiyama, Shigeru] Kitasato Univ, Sch Allied Hlth Sci, Minami Ku, Sagamihara, Kanagawa 2520373, Japan.
   [Iijima, Satoe] JASCO Corp, LC & SFC Applicat Lab, Hachioji, Tokyo 1928537, Japan.
   [Hirayama, Mitsuhiro] Entex Inc, Kashiwa, Chiba 2770852, Japan.
   [Takaku, Yuichi] Inst Environm Sci, Aomori 0393212, Japan.
   [Yumoto, Sakae] Yumoto Inst Neurol, Shinjuku Ku, Tokyo 1620054, Japan.
C3 Kitasato University
RP Shimamura, T (corresponding author), Kitasato Univ, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520373, Japan.
EM sima2758@kitasato-u.ac.jp
CR Ademuyiwa O, 2000, BIOL TRACE ELEM RES, V74, P81, DOI 10.1385/BTER:74:1:81
   Agusa T, 2005, ENVIRON TOXICOL CHEM, V24, P2107, DOI 10.1897/04-617R.1
   Andreani G, 2010, BIOL TRACE ELEM RES, V137, P177, DOI 10.1007/s12011-009-8569-5
   BELIVEAU R, 1990, BIOCHEM CELL BIOL, V68, P1272, DOI 10.1139/o90-189
   Cinier CD, 1998, B ENVIRON CONTAM TOX, V61, P793, DOI 10.1007/s001289900830
   Cui X, 2008, FOOD CHEM TOXICOL, V46, P3646, DOI 10.1016/j.fct.2008.09.040
   Daggett DA, 1998, TOXICOLOGY, V128, P191, DOI 10.1016/S0300-483X(98)00080-8
   Danielsson R, 2009, ENVIRON MONIT ASSESS, V157, P73, DOI 10.1007/s10661-008-0516-y
   Dehn LA, 2005, CAN J ZOOL, V83, P726, DOI 10.1139/Z05-053
   Galazyn-Sidorczuk M, 2009, CHEM-BIOL INTERACT, V180, P31, DOI 10.1016/j.cbi.2009.01.014
   GELINAS Y, 1992, ANAL CHIM ACTA, V269, P115, DOI 10.1016/0003-2670(92)85140-2
   Goering PL, 1999, TOXICOL SCI, V49, P5, DOI 10.1093/toxsci/49.1.5
   Grawe KP, 1997, SCI TOTAL ENVIRON, V208, P111, DOI 10.1016/S0048-9697(97)00280-5
   Han SG, 1999, ENVIRON HEALTH PERSP, V107, P657, DOI 10.2307/3434458
   Hirayama M, 2011, J TRACE ELEM MED BIO, V25, P73, DOI 10.1016/j.jtemb.2011.02.002
   Hook JB, 1986, CASARETT DOULLS TOXI, P310
   Inaba T, 2005, TOXICOL LETT, V159, P192, DOI 10.1016/j.toxlet.2005.05.011
   Katoh Y, 2003, KEITAI KINOU, V1, P13
   Klaassen CD, 1999, ANNU REV PHARMACOL, V39, P267, DOI 10.1146/annurev.pharmtox.39.1.267
   KUNIFUJI Y, 1987, BIOL TRACE ELEM RES, V14, P237, DOI 10.1007/BF02795690
   Kuriwaki J, 2005, TOXICOL LETT, V156, P369, DOI 10.1016/j.toxlet.2004.12.009
   LEBER AP, 1976, TOXICOL APPL PHARM, V37, P403, DOI 10.1016/0041-008X(76)90202-7
   Milicevic DR, 2009, INT J ENV RES PUB HE, V6, P3127, DOI 10.3390/ijerph6123127
   Morita A, 2001, BIOL TRACE ELEM RES, V80, P53, DOI 10.1385/BTER:80:1:53
   Nam DH, 2005, ENVIRON POLLUT, V134, P503, DOI 10.1016/j.envpol.2004.09.003
   NIELSEN FH, 1991, FASEB J, V5, P2661, DOI 10.1096/fasebj.5.12.1916090
   Nriagu J, 2009, ECOTOX ENVIRON SAFE, V72, P564, DOI 10.1016/j.ecoenv.2008.05.001
   OHTA H, 1991, TOXICOL APPL PHARM, V107, P63, DOI 10.1016/0041-008X(91)90331-8
   SCHROEDER HA, 1974, J NUTR, V104, P167, DOI 10.1093/jn/104.2.167
   Seixas TG, 2007, SCI TOTAL ENVIRON, V385, P208, DOI 10.1016/j.scitotenv.2007.06.045
   Shen SG, 2005, ENVIRON TOXICOL PHAR, V19, P379, DOI 10.1016/j.etap.2004.09.008
   SPIERENBURG TJ, 1989, ENVIRON MONIT ASSESS, V11, P107, DOI 10.1007/BF00401723
   Suzuki Y, 2006, CHEMOSPHERE, V64, P1296, DOI 10.1016/j.chemosphere.2005.12.068
   UCHINO E, 1990, LAB ANIM, V24, P253, DOI 10.1258/002367790780866182
   VUORI E, 1979, SCAND J WORK ENV HEA, V5, P16, DOI 10.5271/sjweh.2670
   Waegeneers N, 2009, FOOD ADDIT CONTAM A, V26, P326, DOI 10.1080/02652030802429096
   WEBB M, 1972, BIOCHEM PHARMACOL, V21, P2751, DOI 10.1016/0006-2952(72)90023-8
   Webb M., 1979, CHEM BIOCH BIOL CADM
   Wilkinson JM, 2001, ANIM SCI, V72, P179, DOI 10.1017/S1357729800055673
   Yasutake A, 2004, J HEALTH SCI, V50, P372, DOI 10.1248/jhs.50.372
NR 40
TC 17
Z9 18
U1 0
U2 32
PU ELSEVIER GMBH, URBAN & FISCHER VERLAG
PI JENA
PA OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY
SN 0946-672X
J9 J TRACE ELEM MED BIO
JI J. Trace Elem. Med. Biol.
PY 2013
VL 27
IS 1
BP 12
EP 20
DI 10.1016/j.jtemb.2012.05.005
PG 9
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA 097MH
UT WOS:000315477700003
PM 22748942
DA 2024-02-19
ER

PT J
AU Vyskocilová, E
   Szotáková, B
   Skálová, L
   Bártíková, H
   Hlavácová, J
   Bousová, I
AF Vyskocilova, Erika
   Szotakova, Barbora
   Skalova, Lenka
   Bartikova, Hana
   Hlavacova, Jitka
   Bousova, Iva
TI Age-Related Changes in Hepatic Activity and Expression of Detoxification
   Enzymes in Male Rats
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID GLUTATHIONE S-TRANSFERASES; FLAVIN-CONTAINING MONOOXYGENASES;
   ALKOXYRESORUFIN O-DEALKYLATION; ZINC-SUPEROXIDE-DISMUTASE; MESSENGER-RNA
   LEVELS; SEX-RELATED CHANGES; OXIDATIVE STRESS; ANTIOXIDANT ENZYMES;
   DRUG-METABOLISM; LIPID-PEROXIDATION
AB Process of aging is accompanied by changes in the biotransformation of xenobiotics and impairment of normal cellular functions by free radicals. Therefore, this study was designed to determine age-related differences in the activities and/or expressions of selected drug-metabolizing and antioxidant enzymes in young and old rats. Specific activities of 8 drug-metabolizing enzymes and 4 antioxidant enzymes were assessed in hepatic subcellular fractions of 6-week-old and 21-month-old male Wistar rats. Protein expressions of carbonyl reductase 1 (CBR1) and glutathione S-transferase (GST) were determined using immunoblotting. Remarkable age-related decrease in specific activities of CYP2B, CYP3A, and UDP-glucuronosyl transferase was observed, whereas no changes in activities of CYP1A2, flavine monooxygenase, aldo-keto reductase 1C, and antioxidant enzymes with advancing age were found. On the other hand, specific activity of CBR1 and GST was 2.4 folds and 5.6 folds higher in the senescent rats compared with the young ones, respectively. Interindividual variability in CBR1 activity increased significantly with rising age. We suppose that elevated activities of GST and CBR1 may protect senescent rats against xenobiotic as well as eobiotic electrophiles and reactive carbonyls, but they may alter metabolism of drugs, which are CBR1 and especially GSTs substrates.
C1 [Vyskocilova, Erika; Szotakova, Barbora; Skalova, Lenka; Bartikova, Hana; Hlavacova, Jitka; Bousova, Iva] Charles Univ Prague, Dept Biochem Sci, Fac Pharm Hradec Kralove, CZ-50005 Hradec Kralove, Czech Republic.
C3 Charles University Prague
RP Bousová, I (corresponding author), Charles Univ Prague, Dept Biochem Sci, Fac Pharm Hradec Kralove, Heyrovskeho 1203, CZ-50005 Hradec Kralove, Czech Republic.
EM iva.bousova@faf.cuni.cz
RI Hrudikova, Erika/GQO-7468-2022; Bousova, Iva/S-5572-2017; Szotakova,
   Barbora/S-8742-2017; Skálová, Lenka/S-9187-2017
OI Bousova, Iva/0000-0003-2863-717X; Szotakova,
   Barbora/0000-0002-0377-0743; Skálová, Lenka/0000-0003-0741-3871
FU Czech Science Foundation [P303/12/G163]; Charles University in Prague
   [SVV 267 004, UNCE 204026/2012]
FX This work was made possible due to the financial support of the Czech
   Science Foundation (Grant no. P303/12/G163) and the Charles University
   in Prague (Projects nos. SVV 267 004 and UNCE 204026/2012).
CR Aydin AF, 2010, BIOGERONTOLOGY, V11, P103, DOI 10.1007/s10522-009-9232-4
   Barja G, 2002, FREE RADICAL BIO MED, V33, P1167, DOI 10.1016/S0891-5849(02)00910-3
   Behne D, 2001, ANNU REV NUTR, V21, P453, DOI 10.1146/annurev.nutr.21.1.453
   Benedetti MS, 2007, DRUG DISCOV TODAY, V12, P599, DOI 10.1016/j.drudis.2007.06.011
   Bousová I, 2012, DRUG METAB REV, V44, P267, DOI 10.3109/03602532.2012.713969
   BURKE MD, 1994, BIOCHEM PHARMACOL, V48, P923, DOI 10.1016/0006-2952(94)90363-8
   CARRILLO MC, 1991, BIOCHIM BIOPHYS ACTA, V1077, P325, DOI 10.1016/0167-4838(91)90547-D
   CASHMAN JR, 1981, BIOCHEM BIOPH RES CO, V98, P147, DOI 10.1016/0006-291X(81)91881-7
   CEBALLOSPICOT I, 1992, CLIN CHEM, V38, P66
   CHENGELIS CP, 1988, XENOBIOTICA, V18, P1225, DOI 10.3109/00498258809042246
   CHENGELIS CP, 1988, XENOBIOTICA, V18, P1211, DOI 10.3109/00498258809042245
   Dröge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001
   Farahmand SK, 2013, BIOGERONTOLOGY, V14, P63, DOI 10.1007/s10522-012-9409-0
   FLOHE L, 1984, METHOD ENZYMOL, V105, P114
   Gil L, 2006, FREE RADICAL RES, V40, P495, DOI 10.1080/10715760600592962
   Gillette J. R., 1971, FUNDAMENTALS DRUG ME, P400
   GOTH L, 1991, CLIN CHIM ACTA, V196, P143, DOI 10.1016/0009-8981(91)90067-M
   HABIG WH, 1974, J BIOL CHEM, V249, P7130
   Handler JA, 1997, BIOCHEM PHARMACOL, V54, P159, DOI 10.1016/S0006-2952(97)00159-7
   Handy DE, 2009, J BIOL CHEM, V284, P11913, DOI 10.1074/jbc.M900392200
   Helmy MM, 2012, PHARMACOL REP, V64, P698, DOI 10.1016/S1734-1140(12)70864-2
   HINES RN, 1994, TOXICOL APPL PHARM, V125, P1, DOI 10.1006/taap.1994.1042
   Inal ME, 2001, CLIN CHIM ACTA, V305, P75, DOI 10.1016/S0009-8981(00)00422-8
   INAZU N, 1993, JPN J PHARMACOL, V63, P65, DOI 10.1254/jjp.63.65
   Janmohamed A, 2004, BIOCHEM PHARMACOL, V68, P73, DOI 10.1016/j.bcp.2004.02.036
   JI LL, 1990, AM J PHYSIOL, V258, pR918, DOI 10.1152/ajpregu.1990.258.4.R918
   Kassner N, 2008, DRUG METAB DISPOS, V36, P2113, DOI 10.1124/dmd.108.022251
   Kim HG, 2003, MOL CELLS, V16, P278
   Klaassen CD., 2001, CASARETT DOULLS TOXI, P133, DOI DOI 10.1036/0071470514
   Klaunig JE, 2010, TOXICOL PATHOL, V38, P96, DOI 10.1177/0192623309356453
   Klinger W, 2005, EUR J DRUG METAB PH, V30, P3, DOI 10.1007/BF03226403
   Klotz U, 2009, DRUG METAB REV, V41, P67, DOI 10.1080/03602530902722679
   Kobayashi K, 2002, BIOCHEM PHARMACOL, V63, P889, DOI 10.1016/S0006-2952(01)00843-7
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Mármol F, 2010, PHYSIOL RES, V59, P553, DOI 10.33549/physiolres.931768
   Maté L, 2008, BIOCHEM PHARMACOL, V76, P773, DOI 10.1016/j.bcp.2008.07.002
   Maurya PK, 2010, INDIAN J CLIN BIOCHE, V25, P398, DOI 10.1007/s12291-010-0047-5
   MIZUMA T, 1982, J PHARMACOBIO-DYNAM, V5, P811
   OKAMOTO M, 1994, PHARMACOL TOXICOL, V75, P1, DOI 10.1111/j.1600-0773.1994.tb00316.x
   OMURA T, 1964, J BIOL CHEM, V239, P2370
   Öztürk O, 2004, EXP GERONTOL, V39, P211, DOI 10.1016/j.exger.2003.10.015
   Palackal NT, 2002, J BIOL CHEM, V277, P24799, DOI 10.1074/jbc.M112424200
   Pérez FJ, 2002, PHYTOCHEMISTRY, V60, P573, DOI 10.1016/S0031-9422(02)00146-2
   Rizvi SI, 2007, MOL BIOTECHNOL, V37, P58, DOI 10.1007/s12033-007-0048-7
   Schmucker DL, 2001, DRUG AGING, V18, P837, DOI 10.2165/00002512-200118110-00005
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   SOUTHORN PA, 1988, MAYO CLIN PROC, V63, P381, DOI 10.1016/S0025-6196(12)64861-7
   TARLOFF JB, 1991, P SOC EXP BIOL MED, V197, P297
   Testa B., 2010, BIOCH DRUG METABOLIS
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   Warrington JS, 2004, J PHARMACOL EXP THER, V309, P720, DOI 10.1124/jpet.103.061077
   Wauthier V, 2007, CURR MED CHEM, V14, P745, DOI 10.2174/092986707780090981
   Wauthier V, 2004, ARCH TOXICOL, V78, P131, DOI 10.1007/s00204-003-0526-z
   WEAVER RJ, 1994, BIOCHEM PHARMACOL, V47, P763, DOI 10.1016/0006-2952(94)90475-8
   Yun KU, 2010, ARCH TOXICOL, V84, P939, DOI 10.1007/s00204-010-0520-1
   Zhang J, 2006, DRUG METAB DISPOS, V34, P19, DOI 10.1124/dmd.105.006171
NR 56
TC 28
Z9 32
U1 0
U2 11
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2013
VL 2013
AR 408573
DI 10.1155/2013/408573
PG 10
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA 194TU
UT WOS:000322656400001
PM 23971034
OA Green Published, Green Submitted, gold
DA 2024-02-19
ER

PT J
AU Parikh, ND
   Hutton, D
   Marrero, W
   Sanghani, K
   Xu, YC
   Lavieri, M
AF Parikh, Neehar D.
   Hutton, David
   Marrero, Wesley
   Sanghani, Kunal
   Xu, Yongcai
   Lavieri, Mariel
TI Projections in donor organs available for liver transplantation in the
   United States: 2014-2025
SO LIVER TRANSPLANTATION
LA English
DT Article
ID BODY-MASS INDEX; NONALCOHOLIC STEATOHEPATITIS; HEPATOCELLULAR-CARCINOMA;
   HEPATITIS-C; DONATION; PERFORMANCE; PREVALENCE; TRENDS; PAY;
   COMPLICATIONS
AB With the aging US population, demographic shifts, and obesity epidemic, there is potential for further exacerbation of the current liver donor shortage. We aimed to project the availability of liver grafts in the United States. We performed a secondary analysis of the Organ Procurement and Transplantation Network database of all adult donors from 2000 to 2012 and calculated the total number of donors available and transplanted donor livers stratified by age, race, and body mass index (BMI) group per year. We used National Health and Nutrition Examination Survey and Centers for Disease Control and Prevention historical data to stratify the general population by age, sex, race, and BMI. We then used US population age and race projections provided by the US Census Bureau and the Weldon Cooper Center for Public Service and made national and regional projections of available donors and donor liver utilization from 2014 to 2025. We performed sensitivity analyses and varied the rate of the rise in obesity, proportion of Hispanics, population growth, liver utilization rate, and donation after cardiac death (DCD) utilization. The projected adult population growth in the United States from 2014 to 2025 will be 7.1%. However, we project that there will be a 6.1% increase in the number of used liver grafts. There is marked regional heterogeneity in liver donor growth. Projections were significantly affected by changes in BMI, DCD utilization, and liver utilization rates but not by changes in the Hispanic proportion of the US population or changes in the overall population growth. Overall population growth will outpace the growth of available donor organs and thus potentially exacerbate the existing liver graft shortage. The projected growth in organs is highly heterogeneous across different United Network for Organ Sharing regions. Focused strategies to increase the liver donor pool are warranted. Liver Transpl 21:855-863, 2015. (c) 2015 AASLD.
C1 [Parikh, Neehar D.] Univ Michigan, Div Gastroenterol, Ann Arbor, MI 48109 USA.
   [Hutton, David] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA.
   [Marrero, Wesley; Sanghani, Kunal; Xu, Yongcai; Lavieri, Mariel] Univ Michigan, Ind & Operat Engn, Ann Arbor, MI 48109 USA.
C3 University of Michigan System; University of Michigan; University of
   Michigan System; University of Michigan; University of Michigan System;
   University of Michigan
RP Parikh, ND (corresponding author), Univ Michigan Hlth Syst, Div Gastroenterol, Taubman Ctr Suite 3920,1500 East Med Ctr Dr, Ann Arbor, MI 48104 USA.
EM ndparikh@med.umich.edu
OI Parikh, Neehar/0000-0002-5874-9933; Marrero, Wesley
   J./0000-0002-7092-2292
CR Abecassis MM, 2012, AM J TRANSPLANT, V12, P1208, DOI 10.1111/j.1600-6143.2011.03972.x
   Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454
   Agopian VG, 2012, ANN SURG, V256, P624, DOI 10.1097/SLA.0b013e31826b4b7e
   [Anonymous], 2012, 2012 NAT POP PROJ SU
   [Anonymous], POP EST
   Axelrod DA, 2013, AM J TRANSPLANT, V13, P7, DOI 10.1111/j.1600-6143.2012.04346.x
   Bardach NS, 2013, JAMA-J AM MED ASSOC, V310, P1051, DOI 10.1001/jama.2013.277353
   Brennan T, 2014, JAMA-J AM MED ASSOC, V312, P593, DOI 10.1001/jama.2014.8897
   Broomhead RH, 2012, LIVER TRANSPLANT, V18, P771, DOI 10.1002/lt.23406
   Calikoglu S, 2012, HEALTH AFFAIR, V31, P2649, DOI 10.1377/hlthaff.2012.0357
   Dienstag JL, 2012, NEW ENGL J MED, V367, P1483, DOI 10.1056/NEJMp1210159
   Doyle MBM, 2014, AM J TRANSPLANT, V14, P615, DOI 10.1111/ajt.12607
   Eurostat Statistics Explained, POP STRUCT AG 2012
   Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39
   Geiss LS, 2014, JAMA-J AM MED ASSOC, V312, P1218, DOI 10.1001/jama.2014.11494
   Graham JA, 2014, J HEPATOL, V61, P418, DOI 10.1016/j.jhep.2014.04.019
   Hall EC, 2014, JAMA SURG, V149, P288, DOI 10.1001/jamasurg.2013.3835
   Janssen I, 2005, J AM GERIATR SOC, V53, P2112, DOI 10.1111/j.1532-5415.2005.00505.x
   Jha AK, 2013, JAMA-J AM MED ASSOC, V309, P347, DOI 10.1001/jama.2012.196646
   Kadry Z, 2012, J HEPATOL, V56, P618, DOI 10.1016/j.jhep.2011.08.019
   Li DY, 2013, J HEALTH ECON, V32, P1117, DOI 10.1016/j.jhealeco.2013.09.007
   Northup PG, 2015, HEPATOLOGY, V61, P285, DOI 10.1002/hep.27283
   Orman ES, 2013, LIVER TRANSPLANT, V19, P59, DOI 10.1002/lt.23547
   Rayhill SC, 2007, TRANSPLANTATION, V84, P331, DOI 10.1097/01.tp.0000270313.31328.63
   Salim A, 2014, JAMA SURG, V149, P71, DOI 10.1001/jamasurg.2013.3967
   Schneider ALC, 2014, OBESITY, V22, P292, DOI 10.1002/oby.20426
   Skinner AC, 2014, JAMA PEDIATR, V168, P561, DOI 10.1001/jamapediatrics.2014.21
   STARZL TE, 1984, JAMA-J AM MED ASSOC, V251, P1592
   United Nations, 2009, WORLD POP AG 2009
   Weldon Cooper Center for Public Service. University of Virginia, NAT POP PROJ
   Werner CA, 2011, The older population: 2010
   Wertheim JA, 2011, AM J TRANSPLANT, V11, P1773, DOI 10.1111/j.1600-6143.2011.03587.x
   Wong RJ, 2014, HEPATOLOGY, V59, P2188, DOI 10.1002/hep.26986
   Wong RJ, 2014, LIVER TRANSPLANT, V20, P528, DOI 10.1002/lt.23820
   Yersiz H, 2013, LIVER TRANSPLANT, V19, P437, DOI 10.1002/lt.23615
NR 35
TC 27
Z9 29
U1 0
U2 5
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1527-6465
EI 1527-6473
J9 LIVER TRANSPLANT
JI Liver Transplant.
PD JUN
PY 2015
VL 21
IS 6
BP 855
EP 863
DI 10.1002/lt.24136
PG 9
WC Gastroenterology & Hepatology; Surgery; Transplantation
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology; Surgery; Transplantation
GA CJ1GJ
UT WOS:000355231400017
PM 25845830
OA Green Submitted
DA 2024-02-19
ER

PT J
AU Swegert, CV
   Dave, KR
   Katyare, SS
AF Swegert, CV
   Dave, KR
   Katyare, SS
TI Effect of aluminium-induced Alzheimer like condition on oxidative energy
   metabolism in rat liver, brain and heart mitochondria
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE aluminium; Alzheimer's disease; ATPase; membrane fluidity; mitochondria;
   oxidative phosphorylation
ID PARKINSONS-DISEASE; DEFICIENCY; PHOSPHORYLATION; FRAGMENTS; MEMBRANE;
   FLUIDITY; PROTEIN; KIDNEY
AB Prolonged exposure of rats to aluminium (Al) can result in an Alzheimer-like condition. To get better insights into the biochemical defects underlying AD, senility and ageing we exposed rats for long durations (90-100 days) to soluble salt of aluminium (AlCl3) and checked its influence on mitochondrial respiratory activity in the liver, brain and heart. In the liver and brain mitochondria the ADP/O ratio was impaired with NAD(+) linked substrates. State three respiration decreased with glutamate in the liver. For succinate, the ADP/O ratio decreased in the liver mitochondria while stare three and four respiration decreased in the brain mitochondria. In both the tissues respiration rates decreased with ascorbate + TMPD as the substrate. In the heart mitochondria ADP/O ratios with NAD+ linked substrates decreased, while respiration rates increased with all the substrates except for ascorbate + TMPD. Temperature kinetics data showed different effects on ATPase in the mitochondria from the three tissues. Data on lipid/phospholipid profiles suggested that the observed changes in energy metabolism were not mediated via lipid changes. Long-term exposure to Al resulted in approximate to 100% increase in Al content of liver and brain mitochondria but in the heart there was phenomenal 11-fold increase, indicating thereby that the effects of Al exposure were indirect rather than direct due to Al accumulation. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
C1 Maharaja Sayajirao Univ Baroda, Fac Sci, Dept Biochem, Baroda 390002, Gujarat, India.
C3 Maharaja Sayajirao University Baroda
RP Katyare, SS (corresponding author), Maharaja Sayajirao Univ Baroda, Fac Sci, Dept Biochem, Baroda 390002, Gujarat, India.
CR ASHALL F, 1994, TRENDS BIOCHEM SCI, V19, P42, DOI 10.1016/0968-0004(94)90173-2
   BANGUR CS, 1995, BIOCHEM J, V305, P29, DOI 10.1042/bj3050029
   BARTLETT GR, 1959, J BIOL CHEM, V234, P466
   BASSETT J, 1978, VOGELS TXB QUANTITAT, P729
   BERLYNE GM, 1972, LANCET, V1, P564
   BILKEIGORZO A, 1993, FOOD CHEM TOXICOL, V31, P357, DOI 10.1016/0278-6915(93)90191-Z
   BINDOFF LA, 1991, J NEUROL SCI, V104, P203, DOI 10.1016/0022-510X(91)90311-T
   CRAPPER DR, 1976, BRAIN, V99, P67, DOI 10.1093/brain/99.1.67
   CROWTHER RA, 1995, BIOESSAYS, V17, P593, DOI 10.1002/bies.950170705
   DAVIS WM, 1993, MED HYPOTHESES, V41, P341, DOI 10.1016/0306-9877(93)90079-6
   DELONCLE R, 1990, NEUROCHEM RES, V15, P1239, DOI 10.1007/BF01208586
   FERREIRA J, 1984, BIOCHEM J, V218, P61, DOI 10.1042/bj2180061
   Fiske CH, 1925, J BIOL CHEM, V66, P375
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   HALVERSON K, 1990, BIOCHEMISTRY-US, V29, P2639, DOI 10.1021/bi00463a003
   HUTCHIN T, 1995, P NATL ACAD SCI USA, V92, P6892, DOI 10.1073/pnas.92.15.6892
   JANI MS, 1991, J STEROID BIOCHEM, V38, P587, DOI 10.1016/0960-0760(91)90317-X
   KATYARE SS, 1977, ARCH BIOCHEM BIOPHYS, V182, P155, DOI 10.1016/0003-9861(77)90294-6
   KATYARE SS, 1994, BIOCHEM J, V302, P857, DOI 10.1042/bj3020857
   KISH SJ, 1992, J NEUROCHEM, V59, P776, DOI 10.1111/j.1471-4159.1992.tb09439.x
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MACKLER B, 1973, ARCH BIOCHEM BIOPHYS, V159, P885, DOI 10.1016/0003-9861(73)90531-6
   MCDERMOTT JR, 1979, NEUROLOGY, V29, P809, DOI 10.1212/WNL.29.6.809
   MEHTA JR, 1991, NEUROCHEM RES, V16, P129, DOI 10.1007/BF00965700
   NAKAGAWAHATTORI Y, 1992, J NEUROL SCI, V107, P29, DOI 10.1016/0022-510X(92)90205-Y
   PANDYA JD, 1997, THESIS MS U BARODA I
   PARMAR DV, 1995, EUR J PHARM-ENVIRON, V293, P225, DOI 10.1016/0926-6917(95)00021-6
   POTTER VR, 1972, MANOMETRIC BIOCH TEC, P177
   RICHTER C, 1988, FEBS LETT, V241, P1, DOI 10.1016/0014-5793(88)81018-4
   SATAV JG, 1982, MOL CELL ENDOCRINOL, V28, P173, DOI 10.1016/0303-7207(82)90030-2
   SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x
   SCHNABEL J, 1993, NEW SCI, V138, P22
   SKIPSKI VP, 1967, BIOCHEM J, V104, P340, DOI 10.1042/bj1040340
   SMITH MA, 1995, TRENDS NEUROSCI, V18, P172, DOI 10.1016/0166-2236(95)93897-7
   SWEGERT CV, 1996, THESIS MS U BARODA I
   SYAL A, 1996, THESIS MS U BARODA I
   TANAKA M, 1986, BIOCHEM BIOPH RES CO, V137, P911, DOI 10.1016/0006-291X(86)91166-6
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   WURTMAN RJ, 1985, SCI AM, V252, P48
   ZHONG X, 1990, BIOCHIM BIOPHYS ACTA, V1019, P1
   ZLATKIS A, 1953, J LAB CLIN MED, V41, P486
NR 41
TC 70
Z9 81
U1 0
U2 6
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD DEC 7
PY 1999
VL 112
IS 1
BP 27
EP 42
DI 10.1016/S0047-6374(99)00051-2
PG 16
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 269ZX
UT WOS:000084511700003
PM 10656181
DA 2024-02-19
ER

PT J
AU Waits, SA
   Kim, EK
   Terjimanian, MN
   Tishberg, LM
   Harbaugh, CM
   Sheetz, KH
   Sonnenday, CJ
   Sullivan, J
   Wang, SC
   Englesbe, MJ
AF Waits, Seth A.
   Kim, Edward K.
   Terjimanian, Michael N.
   Tishberg, Lindsay M.
   Harbaugh, Calista M.
   Sheetz, Kyle H.
   Sonnenday, Christopher J.
   Sullivan, June
   Wang, Stewart C.
   Englesbe, Michael J.
TI Morphometric Age and Mortality After Liver Transplant
SO JAMA SURGERY
LA English
DT Article
ID CORE MUSCLE SIZE; SARCOPENIA; RESECTION; OUTCOMES
AB IMPORTANCE Morphometric assessment has emerged as a strong predictor of postoperative morbidity and mortality. However, a gap exists in translating this knowledge to bedside decision making. We introduced a novel measure of patient-centered surgical risk assessment: morphometric age.
   OBJECTIVE To investigate the relationship between morphometric age and posttransplant survival.
   DATA SOURCES Medical records of recipients of deceased-donor liver transplants (study population) and kidney donors/trauma patients (morphometric age control population).
   STUDY SELECTION A retrospective cohort study of 348 liver transplant patients and 3313 control patients. We assessed medical records for validated morphometric characteristics of aging (psoas area, psoas density, and abdominal aortic calcification). We created a model (stratified by sex) for a morphometric age equation, which we then calculated for the control population using multivariate linear regression modeling (covariates). These models were then applied to the study population to determine each patient's morphometric age.
   DATA EXTRACTION AND SYNTHESIS All analytic steps related to measuring morphometric characteristics were obtained via custom algorithms programmed into commercially available software. An independent observer confirmed all algorithm outputs. Trained assistants performed medical record review to obtain patient characteristics.
   RESULTS Cox proportional hazards regression model showed that morphometric age was a significant independent predictor of overall mortality (hazard ratio, 1.03 per morphometric year [95% CI, 1.02-1.04; P < .001]) after liver transplant. Chronologic age was not a significant covariate for survival (hazard ratio, 1.02 per year [95% CI, 0.99-1.04; P = .21]). Morphometric age stratified patients at high and low risk for mortality. For example, patients in the middle chronologic age tertile who jumped to the oldest morphometric tertile have worse outcomes than those who jumped to the youngest morphometric tertile (74.4% vs 93.2% survival at 1 year [P = .03]; 45.2% vs 75.0% at 5 years [P = .03]).
   CONCLUSIONS AND RELEVANCE Morphometric age correlated with mortality after liver transplant with better discrimination than chronologic age. Assigning a morphometric age to potential liver transplant recipients could improve prediction of postoperative mortality risk.
C1 [Waits, Seth A.; Kim, Edward K.; Terjimanian, Michael N.; Harbaugh, Calista M.; Sheetz, Kyle H.; Sonnenday, Christopher J.; Sullivan, June; Wang, Stewart C.; Englesbe, Michael J.] Univ Michigan, Sch Med, Dept Surg, Morph Anal Grp, Ann Arbor, MI 48109 USA.
C3 University of Michigan System; University of Michigan
RP Englesbe, MJ (corresponding author), Univ Michigan, Sch Med, Dept Surg, Morph Anal Grp, 2926A Taubman Ctr,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.
EM englesbe@med.umich.edu
RI Harbaugh, Calista/M-5747-2019
OI Englesbe, Michael/0000-0001-8691-9111; Sullivan,
   June/0000-0003-3051-9834; Kim, Edward/0000-0001-5719-334X
FU National Institute of Diabetes and Digestive and Kidney Diseases,
   National Institutes of Health [K08 DK0827508]; Blue Cross/Blue Shield of
   Michigan Foundation
FX This study was supported by grant K08 DK0827508 from the National
   Institute of Diabetes and Digestive and Kidney Diseases, National
   Institutes of Health, and by Blue Cross/Blue Shield of Michigan
   Foundation (Dr Englesbe).
CR Chretien KC, 2011, JAMA-J AM MED ASSOC, V305, P566, DOI 10.1001/jama.2011.68
   COX DR, 1972, J R STAT SOC B, V34, P187
   Englesbe MJ, 2012, ANN SURG, V256, P255, DOI 10.1097/SLA.0b013e31826028b1
   Englesbe MJ, 2010, J AM COLL SURGEONS, V211, P271, DOI 10.1016/j.jamcollsurg.2010.03.039
   Harbaugh CM, 2013, ANN SURG, V257, P774, DOI 10.1097/SLA.0b013e31826ddd5f
   Lee JSJ, 2011, J VASC SURG, V53, P912, DOI 10.1016/j.jvs.2010.10.111
   Lieffers JR, 2012, BRIT J CANCER, V107, P931, DOI 10.1038/bjc.2012.350
   LINN BS, 1988, ANN SURG, V207, P267, DOI 10.1097/00000658-198803000-00008
   Merion RM, 2011, TRANSPL INT, V24, P965, DOI 10.1111/j.1432-2277.2011.01274.x
   Peng P, 2012, J GASTROINTEST SURG, V16, P1478, DOI 10.1007/s11605-012-1923-5
   Peng PD, 2011, HPB, V13, P439, DOI 10.1111/j.1477-2574.2011.00301.x
   Schaubel DE, 2009, AM J TRANSPLANT, V9, P970, DOI 10.1111/j.1600-6143.2009.02571.x
   Sheetz KH, 2013, DIS ESOPHAGUS, V26, P716, DOI 10.1111/dote.12020
NR 13
TC 50
Z9 50
U1 0
U2 1
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6254
EI 2168-6262
J9 JAMA SURG
JI JAMA Surg.
PD APR
PY 2014
VL 149
IS 4
BP 335
EP 340
DI 10.1001/jamasurg.2013.4823
PG 6
WC Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Surgery
GA AF3KC
UT WOS:000334609900005
PM 24500820
DA 2024-02-19
ER

PT J
AU Kerner, J
   Turkaly, PJ
   Minkler, PE
   Hoppel, CL
AF Kerner, J
   Turkaly, PJ
   Minkler, PE
   Hoppel, CL
TI Aging skeletal muscle mitochondria in the rat: decreased uncoupling
   protein-3 content
SO AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
LA English
DT Article; Proceedings Paper
CT Experimental Biology 2000 Meeting
CY APR 14-19, 2000
CL SAN DIEGO, CA
DE aging; fuel utilization; carnitine palmitoyltransferase; carnitine
ID CARNITINE PALMITOYLTRANSFERASE; ELECTRON-TRANSPORT; FISCHER-344 RATS;
   MALONYL-COA; OLD RATS; LIVER MITOCHONDRIA; EXERCISE; AGE; HEART; MICE
AB The goal of the present study was to discern the cellular mechanism(s) that contributes to the age-associated decrease in skeletal muscle aerobic capacity. Skeletal muscle mitochondrial content, a parameter of oxidative capacity, was significantly lower (25 and 20% calculated on the basis of citrate synthase and succinate dehydrogenase activities, respectively) in 24-mo-old Fischer 344 rats compared with 6-mo-old adult rats. Mitochondria isolated from skeletal muscle of both age groups had identical state 3 (ADP-stimulated) and ADP-stimulated maximal respiratory rates and phosphorylation potential (ADP-to-O ratios) with both nonlipid and lipid substrates. In contrast, mitochondria from 24-mo-old rats displayed significantly lower state 4 (ADP-limited) respiratory rates and, consequently, higher respiratory control ratios. Consistent with the tighter coupling, there was a 68% reduction in uncoupling protein-3 (UCP-3) abundance in mitochondria from elderly compared with adult rats. Congruent with the respiratory studies, there was no age-associated decrease in carnitine palmitoyltransferase I and carnitine palmitoyltransferase II activities in isolated skeletal muscle mitochondria. However, there was a small, significant decrease in tissue total carnitine content. It is concluded that the in vivo observed decrease in skeletal muscle aerobic capacity with advanced age is a consequence of the decreased mitochondrial density. On the basis of the dramatic reduction of UCP-3 content associated with decreased state 4 respiration of skeletal muscle mitochondria from elderly rats, we propose that an increased free radical production might contribute to the metabolic compromise in aging.
C1 Case Western Reserve Univ, Dept Nutr, Cleveland, OH 44106 USA.
   Case Western Reserve Univ, Dept Med & Pharmacol, Cleveland, OH 44106 USA.
   Vet Affairs Med Res Ctr, Ctr Geriatr Res Educ & Clin, Cleveland, OH 44106 USA.
C3 University System of Ohio; Case Western Reserve University; University
   System of Ohio; Case Western Reserve University; Geriatric Research
   Education & Clinical Center
RP Kerner, J (corresponding author), Louis Stokes Cleveland VA Med Ctr, Med Res Ctr 151W, 10701 East Blvd, Cleveland, OH 44106 USA.
EM jxk81@po.cwru.edu
FU NIA NIH HHS [1-R01 AG-12447, P0I AG-15885, P60 AG-10418] Funding Source:
   Medline
CR Barazzoni R, 2001, AM J PHYSIOL-ENDOC M, V280, pE413, DOI 10.1152/ajpendo.2001.280.3.E413
   Bejma J, 1999, J APPL PHYSIOL, V87, P465, DOI 10.1152/jappl.1999.87.1.465
   BERGMEYER H.U., 1974, METHODS ENZYMATIC AN, P574, DOI DOI 10.1016/B978-0-12-091302-2.50010-4
   BEYER RE, 1984, MECH AGEING DEV, V24, P309, DOI 10.1016/0047-6374(84)90116-7
   Brooks GA, 1997, AM J PHYSIOL-ENDOC M, V273, pE655, DOI 10.1152/ajpendo.1997.273.3.E655
   CARMELI E, 1994, P SOC EXP BIOL MED, V206, P103
   CARTEE GD, 1987, J APPL PHYSIOL, V63, P257, DOI 10.1152/jappl.1987.63.1.257
   CHANCE B, 1963, ADV ENZYMOLOGY, V17, P65
   CHEN JC, 1972, J CELL PHYSIOL, V80, P141, DOI 10.1002/jcp.1040800115
   Clapham JC, 2000, NATURE, V406, P415, DOI 10.1038/35019082
   COSTELL M, 1989, BIOCHEM BIOPH RES CO, V161, P1135, DOI 10.1016/0006-291X(89)91360-0
   Denjean F, 1999, BIOCHEM BIOPH RES CO, V266, P518, DOI 10.1006/bbrc.1999.1847
   Desai VG, 1996, ARCH BIOCHEM BIOPHYS, V333, P145, DOI 10.1006/abbi.1996.0375
   Dulloo AG, 2000, NEWS PHYSIOL SCI, V15, P313
   Fannin SW, 1999, ARCH BIOCHEM BIOPHYS, V372, P399, DOI 10.1006/abbi.1999.1508
   FARRAR RP, 1981, J GERONTOL, V36, P642, DOI 10.1093/geronj/36.6.642
   Fuentes JM, 2000, ANAL BIOCHEM, V285, P276, DOI 10.1006/abio.2000.4784
   Gong DW, 2000, J BIOL CHEM, V275, P16251, DOI 10.1074/jbc.M910177199
   HANSFORD RG, 1983, BIOCHIM BIOPHYS ACTA, V726, P41, DOI 10.1016/0304-4173(83)90010-1
   HANSFORD RG, 1982, MECH AGEING DEV, V19, P191, DOI 10.1016/0047-6374(82)90010-0
   HOLLOSZY JO, 1991, MECH AGEING DEV, V60, P199, DOI 10.1016/0047-6374(91)90131-I
   HOLLOSZY JO, 1985, J APPL PHYSIOL, V59, P826, DOI 10.1152/jappl.1985.59.3.826
   HOPPEL C, 1968, BIOCHEM J, V107, P367, DOI 10.1042/bj1070367
   Hoppel CL, 1998, J BIOL CHEM, V273, P23495, DOI 10.1074/jbc.273.36.23495
   HOPPEL CL, 1987, J CLIN INVEST, V80, P71, DOI 10.1172/JCI113066
   IDELLWENGER JA, 1978, J BIOL CHEM, V253, P4310
   KERNER J, 1983, COMP BIOCHEM PHYS B, V75, P311, DOI 10.1016/0305-0491(83)90331-0
   KRIEGER DA, 1980, J APPL PHYSIOL, V48, P23, DOI 10.1152/jappl.1980.48.1.23
   Larkin L, 1997, J APPL PHYSIOL, V83, P1623, DOI 10.1152/jappl.1997.83.5.1623
   LARSSON L, 1979, J APPL PHYSIOL, V46, P451, DOI 10.1152/jappl.1979.46.3.451
   Li B, 2000, NAT MED, V6, P1115, DOI 10.1038/80450
   LILIENTHAL JL, 1950, J BIOL CHEM, V182, P501
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Mahler D A, 1986, Clin Geriatr Med, V2, P433
   MCBRIDE TA, 1995, MECH AGEING DEV, V83, P185, DOI 10.1016/0047-6374(95)01629-E
   MCGARRY JD, 1983, BIOCHEM J, V214, P21, DOI 10.1042/bj2140021
   MCMILLIN JB, 1993, CARDIOVASC RES, V27, P2222, DOI 10.1093/cvr/27.12.2222
   MINKLER PE, 1995, ANAL BIOCHEM, V231, P315, DOI 10.1006/abio.1995.0057
   MURTHY MSR, 1987, P NATL ACAD SCI USA, V84, P378, DOI 10.1073/pnas.84.2.378
   ODIET JA, 1995, MECH AGEING DEV, V79, P127, DOI 10.1016/0047-6374(94)01552-W
   PALMER JW, 1977, J BIOL CHEM, V252, P8731
   RODGERS MA, 1993, EXERCISE SPORT SCI R, V21, P65
   RUMSEY WL, 1987, EXP GERONTOL, V22, P271, DOI 10.1016/0531-5565(87)90006-4
   Sial S, 1996, AM J PHYSIOL-ENDOC M, V271, pE983, DOI 10.1152/ajpendo.1996.271.6.E983
   Skorjanc D, 1998, J APPL PHYSIOL, V85, P437, DOI 10.1152/jappl.1998.85.2.437
   SPRIET LL, 1992, AM J PHYSIOL, V263, pC653, DOI 10.1152/ajpcell.1992.263.3.C653
   STARNES JW, 1989, J APPL PHYSIOL, V67, P69, DOI 10.1152/jappl.1989.67.1.69
   Stump CS, 1997, J APPL PHYSIOL, V82, P1875, DOI 10.1152/jappl.1997.82.6.1875
   SUGIYAMA S, 1993, BIOCHEM MOL BIOL INT, V30, P937
   SYROVY I, 1970, EXP GERONTOL, V5, P31, DOI 10.1016/0531-5565(70)90026-4
   TOMEC RJ, 1975, ARCH BIOCHEM BIOPHYS, V170, P716, DOI 10.1016/0003-9861(75)90169-1
   TORII K, 1992, AM J RESP CELL MOL, V6, P88, DOI 10.1165/ajrcmb/6.1.88
   van Loon LJC, 2000, FASEB J, V14, pA429
   VANEKEREN GJ, 1992, INT J EXP PATHOL, V73, P51
   Vidal-Puig AJ, 2000, J BIOL CHEM, V275, P16258, DOI 10.1074/jbc.M910179199
   WALTERS TJ, 1991, J APPL PHYSIOL, V71, P1921, DOI 10.1152/jappl.1991.71.5.1921
   YOUNG JC, 1983, MED SCI SPORT EXER, V15, P243
   YU BP, 1985, J GERONTOL, V40, P657, DOI 10.1093/geronj/40.6.657
NR 58
TC 88
Z9 98
U1 0
U2 5
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0193-1849
EI 1522-1555
J9 AM J PHYSIOL-ENDOC M
JI Am. J. Physiol.-Endocrinol. Metab.
PD NOV
PY 2001
VL 281
IS 5
BP E1054
EP E1062
PG 9
WC Endocrinology & Metabolism; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Endocrinology & Metabolism; Physiology
GA 484MM
UT WOS:000171694200022
PM 11595663
DA 2024-02-19
ER

PT J
AU Gong, X
   Shang, F
   Obin, M
   Palmer, H
   Scrofano, MM
   Jahngen-Hodge, J
   Smith, DE
   Taylor, A
AF Gong, X
   Shang, F
   Obin, M
   Palmer, H
   Scrofano, MM
   Jahngen-Hodge, J
   Smith, DE
   Taylor, A
TI Antioxidant enzyme activities in lens, liver and kidney of calorie
   restricted Emory mice
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE calorie restriction; aging; antioxidant enzymes; lens; liver; kidney;
   sex-linked
ID DIETARY RESTRICTION; GLUTATHIONE-PEROXIDASE; SUPEROXIDE-DISMUTASE;
   LIPID-PEROXIDATION; CATARACT FORMATION; FOOD RESTRICTION; DELAYS
   CATARACT; RAT-LIVER; MOUSE; AGE
AB Dietary calorie restriction extends both mean and maximum life span and retards age-related diseases, including eye lens cataract in Emery mice. The beneficial effects of calorie restriction have been hypothesized to reflect enhanced tissue antioxidant capacity. As a test of this hypothesis, we reared male and female Emery mice on control (C) or 40% calorie-restricted (R) diets. We then determined activities of total superoxide dismutase (T-SOD), Cu/Zn-SOD, Mn-SOD, glutathione peroxidase (GPx), glutathione reductase (GR) and catalase (CAT) in eye lens, liver and kidney of young (4.5 or 6 months), mature (11 or 12 months) and old (22 months) animals. Effects of diet, age and sex were evaluated by multi-factor ANOVA. Only kidney GR activities (mean +/- S.E.M.) were significantly enhanced with the R diet (R, 61 +/ 2 vs. C, 54 +/- 3 U/mg protein; P = 0.03). More frequently, we noted reduced antioxidant enzyme activity in R as compared with C animals, including reduced activities of T-SOD in lens, liver and kidney, Cu/Zn-SOD, in liver and kidney, liver Mn-SOD and liver CAT (P < 0.05). Effects of age on antioxidant enzyme activity in C mice included age-dependent decreases in lens and kidney CAT and in liver Mn-SOD. There was also an age-dependent increases in liver and kidney Cu/Zn-SOD and liver GR. None of these age-dependent alterations in antioxidant enzyme function were attenuated in tissues of mice fed the R diet. Values for liver CAT were significantly lower in females than in males (P = 0.05). These results indicate that antioxidant enzyme activities in Emery mouse tissues are influenced by diet, age and sex. However, it is unlikely that increased lifespan and attenuation of cataract (and perhaps other age-dependent debilities), which are associated with the R diet in the Emery mouse, are due to enhanced antioxidant enzyme capabilities. (C) 1997 Elsevier Science Ireland Ltd.
C1 Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr, Lab Nutr & Vis Res, Boston, MA 02111 USA.
C3 United States Department of Agriculture (USDA); Tufts University
RP Taylor, A (corresponding author), Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr, Lab Nutr & Vis Res, 711 Washington St, Boston, MA 02111 USA.
CR AEBI H, 1984, METHOD ENZYMOL, V105, P121
   AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   BHUYAN KC, 1983, CURR EYE RES, V2, P597
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   CAND F, 1989, FREE RADICAL BIO MED, V7, P59, DOI 10.1016/0891-5849(89)90101-9
   CARRILLO MC, 1992, MECH AGEING DEV, V65, P187, DOI 10.1016/0047-6374(92)90035-C
   CHIPALKATTI S, 1983, J NUTR, V113, P944, DOI 10.1093/jn/113.5.944
   ELSTNER EF, 1976, ANAL BIOCHEM, V70, P616, DOI 10.1016/0003-2697(76)90488-7
   FERNANDES G, 1978, P NATL ACAD SCI USA, V75, P1500, DOI 10.1073/pnas.75.3.1500
   FEUERS RJ, 1993, MUTAT RES, V295, P191, DOI 10.1016/0921-8734(93)90020-4
   FLOHE L, 1984, METHOD ENZYMOL, V105, P114
   FRIEND PS, 1978, LAB INVEST, V38, P629
   GANTHER HE, 1976, TRACE ELEMENTS HUMAN, V2, P165
   GOLDSTEI.DB, 1968, ANAL BIOCHEM, V24, P431, DOI 10.1016/0003-2697(68)90148-6
   HALLIWELL B, 1994, NUTR REV, V52, P253
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HAZELTON GA, 1985, MECH AGEING DEV, V29, P71, DOI 10.1016/0047-6374(85)90048-X
   JOCELYN PC, 1972, BIOCH SH GROUP, P180
   Kehrer J P, 1994, NATURAL ANTIOXXIDANT, P25
   KOIZUMI A, 1987, J NUTR, V117, P361, DOI 10.1093/jn/117.2.361
   KUCK JFR, 1983, EXP EYE RES, V36, P351, DOI 10.1016/0014-4835(83)90117-3
   LUHTALA TA, 1994, J GERONTOL, V49, pB231, DOI 10.1093/geronj/49.5.B231
   MASORO EJ, 1984, J AM GERIATR SOC, V32, P296, DOI 10.1111/j.1532-5415.1984.tb02025.x
   MASSEY V, 1965, J BIOL CHEM, V240, P4470
   MOTE PL, 1991, J GERONTOL, V46, pB95, DOI 10.1093/geronj/46.3.B95
   Mune M, 1995, AGE, V18, P43, DOI 10.1007/BF02432518
   MURA CV, 1993, CURR EYE RES, V12, P1081, DOI 10.3109/02713689309033506
   Mura CV, 1996, MECH AGEING DEV, V91, P115, DOI 10.1016/0047-6374(96)01780-0
   OHRLOFF C, 1984, CURR EYE RES, V3, P109, DOI 10.3109/02713688408997191
   RAO G, 1990, J NUTR, V120, P602, DOI 10.1093/jn/120.6.602
   RATHBUN WB, 1986, CURR EYE RES, V5, P189, DOI 10.3109/02713688609020042
   RIKANS LE, 1991, BIOCHIM BIOPHYS ACTA, V1074, P195, DOI 10.1016/0304-4165(91)90061-K
   ROJAS C, 1993, ARCH BIOCHEM BIOPHYS, V306, P59, DOI 10.1006/abbi.1993.1480
   ROSS MH, 1961, J NUTR, V75, P197, DOI 10.1093/jn/75.2.197
   SEMSEI I, 1989, BIOCHEM BIOPH RES CO, V164, P620, DOI 10.1016/0006-291X(89)91505-2
   SOHAL RS, 1994, MECH AGEING DEV, V74, P121, DOI 10.1016/0047-6374(94)90104-X
   SPECTOR A, 1995, FASEB J, V9, P1173, DOI 10.1096/fasebj.9.12.7672510
   TANNENBAUM ALBERT, 1942, CANCER RES, V2, P460
   TAYLOR A, 1995, MECH AGEING DEV, V79, P33, DOI 10.1016/0047-6374(94)01541-S
   TAYLOR A, 1995, EXP EYE RES, V61, P55, DOI 10.1016/S0014-4835(95)80058-1
   Taylor A, 1997, Adv Pharmacol, V38, P515
   TAYLOR A, 1987, FREE RADICAL BIO MED, V3, P371, DOI 10.1016/0891-5849(87)90015-3
   TAYLOR A, 1989, FASEB J, V3, P1741, DOI 10.1096/fasebj.3.6.2703107
   TENOVUO J, 1986, BIOCHIM BIOPHYS ACTA, V870, P377, DOI 10.1016/0167-4838(86)90244-X
   Weindruch R., 1988, RETARDATION AGING DI
   Weindruch R., 1993, FREE RADICALS AGING, P269
   XIA EN, 1995, J NUTR, V125, P195
   YU BP, 1989, OXYGEN RADICALS BIOL, P1067
NR 48
TC 37
Z9 38
U1 0
U2 3
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
EI 1872-6216
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD DEC 30
PY 1997
VL 99
IS 3
BP 181
EP 192
DI 10.1016/S0047-6374(97)00102-4
PG 12
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA YU212
UT WOS:000071693500002
PM 9483491
DA 2024-02-19
ER

PT J
AU Chimienti, G
   Picca, A
   Fracasso, F
   Marzetti, E
   Calvani, R
   Leeuwenburgh, C
   Russo, F
   Lezza, AMS
   Pesce, V
AF Chimienti, Guglielmina
   Picca, Anna
   Fracasso, Flavio
   Marzetti, Emanuele
   Calvani, Riccardo
   Leeuwenburgh, Christiaan
   Russo, Francesco
   Lezza, Angela Maria Serena
   Pesce, Vito
TI Differences in Liver TFAM Binding to mtDNA and mtDNA Damage between Aged
   and Extremely Aged Rats
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE rat liver; longevity; mtDNA content; mtDNA common deletion; TFAM
   binding; 8-oxodG incidence
ID MITOCHONDRIAL TRANSCRIPTION INITIATION; HEAVY-STRAND PROMOTER; DNA COPY
   NUMBER; SKELETAL-MUSCLE; F344BNF1-HYBRID RATS; CALORIE RESTRICTION;
   BIOGENESIS; QUANTITATION; EXPRESSION; LONGEVITY
AB While mitochondrial dysfunction is acknowledged as a major feature of aging, much less is known about the role of mitochondria in extended longevity. Livers from aged (28-month-old) and extremely aged (32-month-old) rats were analyzed for citrate synthase activity, mitochondrial transcription factor A (TFAM) amount, mitochondrial DNA (mtDNA), and 4.8 Kb common deletion contents. None of the assayed parameters differed significantly between age groups. TFAM-binding to mtDNA and the incidence of 8-oxo-deoxyguanosine in specific mtDNA regions, encompassing the origins of mtDNA replication (D-loop and Ori-L) and the 16-bp long direct repeat 1 (DR1) of the 4.8 Kb deletion, were determined. A decrease in TFAM binding was unveiled at all regions in extremely aged in comparison with aged rats. Reduced incidence of oxidized purines at all assayed regions was detected in 32-month-old rats compared with the 28-month-old group. A significant positive correlation between the incidence of 8-oxo-deoxoguanosine and TFAM-bound mtDNA was found at D-Loop and Ori-L regions only in 28-month-old rats. The absence of such correlation in 32-month-old rats indicates a different, fine-tuned regulation of TFAM binding in the two age groups and supports the existence of two different paces in aging and extended aging.
C1 [Chimienti, Guglielmina; Fracasso, Flavio; Lezza, Angela Maria Serena; Pesce, Vito] Univ Bari Aldo Moro, Dept Biosci Biotechnol & Biopharmaceut, I-70125 Bari, Italy.
   [Picca, Anna; Calvani, Riccardo] Univ Cattolica Sacro Cuore, Lgo A Gemelli 1, I-00168 Rome, Italy.
   [Picca, Anna; Marzetti, Emanuele; Calvani, Riccardo] Fdn Policlin Univ Agostino Gemelli IRCCS, Lgo F Vito 8, I-00168 Rome, Italy.
   [Leeuwenburgh, Christiaan] Univ Florida, Div Biol Aging, Inst Aging, Dept Aging & Geriatr Res, Gainesville, FL 32611 USA.
   [Russo, Francesco] Natl Inst Gastroenterol S de Bellis, Lab Nutr Pathophysiol, I-70013 Castellana Grotte, Italy.
C3 Universita degli Studi di Bari Aldo Moro; Catholic University of the
   Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the
   Sacred Heart; IRCCS Policlinico Gemelli; State University System of
   Florida; University of Florida
RP Pesce, V (corresponding author), Univ Bari Aldo Moro, Dept Biosci Biotechnol & Biopharmaceut, I-70125 Bari, Italy.
EM guglielminaalessandra.chimienti@uniba.it; anna.picca1@gmail.com;
   flavio.fracasso@uniba.it; emanuele.marzetti@policlinicogemelli.it;
   riccardo.calvani@gmail.com; cleeuwen@ufl.edu;
   francesco.russo@irccsdebellis.it; angelamariaserena.lezza@uniba.it;
   vito.pesce@uniba.it
RI Picca, Anna/K-2305-2018; Marzetti, Emanuele/A-9430-2010; Calvani,
   Riccardo/K-2011-2018; Chimienti, Guglielmina/H-3122-2016
OI Picca, Anna/0000-0001-7032-3487; Marzetti, Emanuele/0000-0001-9567-6983;
   Calvani, Riccardo/0000-0001-5472-2365; Leeuwenburgh,
   Christiaan/0000-0003-0826-4257; PESCE, VITO/0000-0002-9148-3129;
   Chimienti, Guglielmina/0000-0002-4403-2317
FU MIUR-FFABR; Istituto Banco di Napoli-Fondazione; Innovative Medicine
   Initiative-Joint Undertaking (IMI-JU) [115621]; nonprofit research
   foundation "Centro Studi Achille e Linda Lorenzon"
FX This work was partly supported by MIUR-FFABR 2018 to V.P., MIUR-FFABR
   2018 to A.M.S.L., Istituto Banco di Napoli-Fondazione 2015 to A.M.S.L.,
   and Innovative Medicine Initiative-Joint Undertaking (IMI-JU #115621) to
   A.P., E.M., and R.C. The work was also partly supported by the nonprofit
   research foundation "Centro Studi Achille e Linda Lorenzon".
CR Baker DJ, 2006, EXP GERONTOL, V41, P1149, DOI 10.1016/j.exger.2006.08.007
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Campbell CT, 2012, BBA-GENE REGUL MECH, V1819, P921, DOI 10.1016/j.bbagrm.2012.03.002
   Caston RA, 2017, FREE RADICAL BIO MED, V107, P146, DOI 10.1016/j.freeradbiomed.2016.11.025
   Chimienti G, 2018, FREE RADICAL BIO MED, V124, P447, DOI 10.1016/j.freeradbiomed.2018.06.041
   De Benedictis G, 1999, FASEB J, V13, P1532, DOI 10.1096/fasebj.13.12.1532
   EDRIS W, 1994, MUTAT RES-DNAGING G, V316, P69, DOI 10.1016/0921-8734(94)90009-4
   GADALETA MN, 1992, MUTAT RES, V275, P181, DOI 10.1016/0921-8734(92)90022-H
   Gondo Y., 2016, ENCY GEROPSYCHOLOGY, P1, DOI [10.1007/978-981-287-080-3_182-1, DOI 10.1007/978-981-287-080-3_182-1]
   Hagen JL, 2004, J GERONTOL A-BIOL, V59, P1099, DOI 10.1093/gerona/59.11.1099
   Hebert SL, 2015, J GERONTOL A-BIOL, V70, P1409, DOI 10.1093/gerona/glv086
   Held NM, 2015, BIOESSAYS, V37, P867, DOI 10.1002/bies.201500013
   Hepple RT, 2004, J GERONTOL A-BIOL, V59, P1111, DOI 10.1093/gerona/59.11.1111
   Hudson EK, 1998, FREE RADICAL RES, V29, P573, DOI 10.1080/10715769800300611
   Khan SS, 2017, AGING CELL, V16, P624, DOI 10.1111/acel.12601
   Kolovou GD, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/808307
   Li CC, 2018, EXP GERONTOL, V102, P19, DOI 10.1016/j.exger.2017.11.022
   Lodeiro MF, 2012, P NATL ACAD SCI USA, V109, P6513, DOI 10.1073/pnas.1118710109
   López-Lluch G, 2015, BIOGERONTOLOGY, V16, P599, DOI 10.1007/s10522-015-9585-9
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   López-Torres M, 2002, FREE RADICAL BIO MED, V32, P882, DOI 10.1016/S0891-5849(02)00773-6
   Marzetti E, 2008, MECH AGEING DEV, V129, P542, DOI 10.1016/j.mad.2008.05.005
   Mengel-From J, 2014, HUM GENET, V133, P1149, DOI 10.1007/s00439-014-1458-9
   Montier LLC, 2009, J GENET GENOMICS, V36, P125, DOI 10.1016/S1673-8527(08)60099-5
   Nakamoto H, 2007, EXP GERONTOL, V42, P287, DOI 10.1016/j.exger.2006.11.006
   Navarro A, 2007, AM J PHYSIOL-CELL PH, V292, pC670, DOI 10.1152/ajpcell.00213.2006
   Nicassio L, 2017, EXP GERONTOL, V98, P99, DOI 10.1016/j.exger.2017.08.017
   Pastukh VM, 2016, FREE RADICAL BIO MED, V96, P78, DOI 10.1016/j.freeradbiomed.2016.04.011
   Pesce V, 2012, REJUV RES, V15, P136, DOI 10.1089/rej.2011.1255
   Picca A, 2018, BIOMOLECULES, V8, DOI 10.3390/biom8040177
   Picca A, 2016, EXP GERONTOL, V85, P33, DOI 10.1016/j.exger.2016.09.010
   Picca A, 2015, MITOCHONDRION, V25, P67, DOI 10.1016/j.mito.2015.10.001
   Picca A, 2014, BBA-GEN SUBJECTS, V1840, P2184, DOI 10.1016/j.bbagen.2014.03.004
   Picca A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074644
   Picca A, 2013, AGE, V35, P1607, DOI 10.1007/s11357-012-9465-z
   Puca AA, 2018, MECH AGEING DEV, V174, P95, DOI 10.1016/j.mad.2017.10.004
   Shadyab AH, 2015, AGEING RES REV, V19, P1, DOI 10.1016/j.arr.2014.10.005
   Shutt TE, 2011, TRANSCR-AUSTIN, V2, P55, DOI 10.4161/trns.2.2.14296
   Souza-Pinto NC, 1999, NUCLEIC ACIDS RES, V27, P1935, DOI 10.1093/nar/27.8.1935
   Srere P.A., 1969, METHOD ENZYMOL, V13, P3, DOI DOI 10.1016/0076-6879(69)13005-0
   Turturro A, 1999, J GERONTOL A-BIOL, V54, pB492, DOI 10.1093/gerona/54.11.B492
   Vercauteren K, 2006, MOL CELL BIOL, V26, P7409, DOI 10.1128/MCB.00585-06
   Yowe DL, 1998, GENE, V209, P23, DOI 10.1016/S0378-1119(97)00628-8
   Zollo O, 2012, P NATL ACAD SCI USA, V109, P6508, DOI 10.1073/pnas.1118594109
NR 44
TC 15
Z9 15
U1 0
U2 5
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD MAY 2
PY 2019
VL 20
IS 10
AR 2601
DI 10.3390/ijms20102601
PG 13
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA IC5IP
UT WOS:000471001400232
PM 31137890
OA gold, Green Published, Green Submitted
DA 2024-02-19
ER

PT J
AU Anson, RM
   Sentürker, S
   Dizdaroglu, M
   Bohr, VA
AF Anson, RM
   Sentürker, S
   Dizdaroglu, M
   Bohr, VA
TI Measurement of oxidatively induced base lesions in liver from Wistar
   rats of different ages
SO FREE RADICAL BIOLOGY AND MEDICINE
LA English
DT Article
DE oxidative DNA damage; GC/MS; mitochondrial DNA; aging; free radicals
ID CHROMATOGRAPHY MASS-SPECTROMETRY; FORMAMIDOPYRIMIDINE DNA GLYCOSYLASE;
   HUMAN MITOCHONDRIAL-DNA; MAMMALIAN CHROMATIN; IONIZING-RADIATION;
   HYDROGEN-PEROXIDE; NUCLEAR-DNA; DAMAGE; REPAIR; OXYGEN
AB Mitochondrial and nuclear DNA were isolated from the livers of young (6-7 month) and old (23-24 month) Wistar rats and the levels of 10 different oxidatively induced lesions were analyzed by gas chromatography/mass spectrometry. This is the first study to measure several different oxidatively induced base lesions in both mitochondrial and nuclear DNA as a function of age. No significant age effects were observed for any lesion. Furthermore, contrary to expectations, we did not observe elevated levels of oxidatively induced base lesions in mitochondrial DNA. This contrasts with 50-fold differences reported for several lesions between mitochondrial and nuclear DNA from porcine liver (Zastawny et al., Free Radic. Biol. Med. 24:722-725, 1998). The fact that different lesion levels are observed even when similar techniques are employed emphasizes that the role of oxidative mitochondrial DNA damage and its repair in aging must continue to be the subject of intense investigation. Questions concerning endogenous levels of damage should be revisited as existing methods are improved and new methods become available. (C) 1999 Elsevier Science Inc.
C1 NIA, Gerontol Res Ctr, Mol Genet Lab, NIH, Baltimore, MD 21224 USA.
   Natl Inst Stand & Technol, Chem Sci & Technol Lab, Gaithersburg, MD 20899 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute on
   Aging (NIA); National Institute of Standards & Technology (NIST) - USA
RP Bohr, VA (corresponding author), NIA, Gerontol Res Ctr, Mol Genet Lab, NIH, 5600 Nathan Shock Dr,Box 01, Baltimore, MD 21224 USA.
RI Bohr, Vilhelm/AAP-5931-2020
OI Anson, Robert/0000-0002-7913-3644
CR Anson RM, 1998, NUCLEIC ACIDS RES, V26, P662, DOI 10.1093/nar/26.2.662
   Beckman K B, 1996, Methods Enzymol, V264, P442, DOI 10.1016/S0076-6879(96)64040-3
   Beckman KB, 1997, J BIOL CHEM, V272, P19633, DOI 10.1074/jbc.272.32.19633
   BLAKELY WF, 1990, RADIAT RES, V121, P338, DOI 10.2307/3577785
   BOITEUX S, 1992, BIOCHEMISTRY-US, V31, P106, DOI 10.1021/bi00116a016
   Collins A, 1997, CARCINOGENESIS, V18, P1833, DOI 10.1093/carcin/18.9.1833
   Croteau DL, 1997, J BIOL CHEM, V272, P27338, DOI 10.1074/jbc.272.43.27338
   DIZDAROGLU M, 1991, ARCH BIOCHEM BIOPHYS, V285, P317, DOI 10.1016/0003-9861(91)90366-Q
   DIZDAROGLU M, 1994, METHOD ENZYMOL, V234, P3
   DIZDAROGLU M, 1992, MUTAT RES, V275, P331, DOI 10.1016/0921-8734(92)90036-O
   DRIGGERS WJ, 1993, J BIOL CHEM, V268, P22042
   FUCIARELLI AF, 1989, RADIAT RES, V119, P219, DOI 10.2307/3577615
   GAJEWSKI E, 1990, BIOCHEMISTRY-US, V29, P7876, DOI 10.1021/bi00486a014
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   Helbock HJ, 1998, P NATL ACAD SCI USA, V95, P288, DOI 10.1073/pnas.95.1.288
   HILLERED L, 1983, J CEREBR BLOOD F MET, V3, P207, DOI 10.1038/jcbfm.1983.28
   HORAI S, 1990, AM J HUM GENET, V46, P828
   Jenner A, 1998, BIOCHEM J, V331, P365, DOI 10.1042/bj3310365
   KOUCHAKDJIAN M, 1991, BIOCHEMISTRY-US, V30, P1403, DOI 10.1021/bi00219a034
   MIQUEL J, 1992, MUTAT RES, V275, P209, DOI 10.1016/0921-8734(92)90024-J
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   NACKERDIEN Z, 1992, FREE RADICAL RES COM, V16, P259, DOI 10.3109/10715769209049179
   RICHTER C, 1992, MUTAT RES, V275, P249, DOI 10.1016/0921-8734(92)90029-O
   RICHTER C, 1995, INT J BIOCHEM CELL B, V27, P647, DOI 10.1016/1357-2725(95)00025-K
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   Taffe BG, 1996, MUTAT RES-DNA REPAIR, V364, P183, DOI 10.1016/S0921-8777(96)00031-6
   WHIPPS DE, 1984, BIOCHEM J, V221, P147, DOI 10.1042/bj2210147
   Zastawny TH, 1998, FREE RADICAL BIO MED, V24, P722, DOI 10.1016/S0891-5849(97)00331-6
NR 30
TC 49
Z9 55
U1 0
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0891-5849
J9 FREE RADICAL BIO MED
JI Free Radic. Biol. Med.
PD AUG
PY 1999
VL 27
IS 3-4
BP 456
EP 462
DI 10.1016/S0891-5849(99)00091-X
PG 7
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA 227YL
UT WOS:000082107500028
PM 10468222
DA 2024-02-19
ER

PT J
AU MEDRANO, EE
   YANG, F
   BOISSY, R
   FAROOQUI, J
   SHAH, V
   MATSUMOTO, K
   NORDLUND, JJ
   PARK, HY
AF MEDRANO, EE
   YANG, F
   BOISSY, R
   FAROOQUI, J
   SHAH, V
   MATSUMOTO, K
   NORDLUND, JJ
   PARK, HY
TI TERMINAL DIFFERENTIATION AND SENESCENCE IN THE HUMAN MELANOCYTE -
   REPRESSION OF TYROSINE-PHOSPHORYLATION OF THE EXTRACELLULAR
   SIGNAL-REGULATED KINASE-2 SELECTIVELY DEFINES THE 2 PHENOTYPES
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Article
ID ACTIVATED PROTEIN-KINASE; HEPATOCYTE GROWTH-FACTOR; MAP KINASE; C-FOS;
   HUMAN-FIBROBLASTS; PHORBOL ESTER; NUCLEAR-LOCALIZATION; HUMAN
   MELANOGENESIS; HUMAN KERATINOCYTES; PIGMENT-CELLS
AB Melanocytes are pigmented cells distributed in humans in several organs like the epidermis, the leptomeninges, the eye, and the inner ear. Epidermal melanocytes, whether derived from adult or neonatal skin, proliferate well in a medium supplemented with phorbol esters and other mitogens before they undergo senescence. Potent cAMP inducers like cholera toxin are also growth promoters for neonatal melanocytes but only transient growth stimulators for cells derived from adults. We used this cellular system to delineate biochemical pathways involved in proliferation and in terminal differentiation. Here we show that after a period of 4-8 wk of sustained proliferation in the presence of cholera toxin, the adult melanocytes became round, flat, and enlarged. These changes were associated with terminal growth and preceded by a five- to sixfold increase in cAMP levels and an 8- to 10-fold increase in melanin content. The simultaneous addition of phorbol esters and cholera toxin did not prevent cells from reaching terminal differentiation. Identified targets for phorbol esters are protein kinase C (PKC) and the mitogen-activated kinases (MAPKs), also called extracellular signal-regulated kinases (ERKs). PKC was found to be similarly regulated in proliferating and in terminally differentiated melanocytes. Proliferating melanocytes in early or late passage showed identical activation of the kinase ERK2. This kinase was rapidly phosphorylated upon phorbol 12-myristate 13-acetate (PMA) addition and specifically accumulated in the nucleus of the cells, whereas in unstimulated cells it had a perinuclear distribution. In contrast, senescent and terminally differentiated cells were unable to phosphorylate tyrosine residues of the ERK2 gene product in spite of presenting normal amounts of ERK2 protein. In addition, ERK2 did not show the nuclear accumulation observed in proliferating melanocytes after PMA activation and remained localized in the perinuclear area. These results demonstrate that senescent and terminally differentiated melanocytes share a common block in a critical pathway thought to integrate multiple intracellular signals transmitted by various second messengers and specifically prevent the continuation of the signal transduction cascade initiated by PMA activation of PKC.
C1 BOSTON UNIV,SCH MED,DEPT DERMATOL,BOSTON,MA 02118.
C3 Boston University
RP MEDRANO, EE (corresponding author), UNIV CINCINNATI,COLL MED,DEPT DERMATOL,CINCINNATI,OH 45267, USA.
FU NIA NIH HHS [1K04 AGOO594-01] Funding Source: Medline
CR ABDELMALEK Z, 1992, J CELL PHYSIOL, V150, P416, DOI 10.1002/jcp.1041500226
   ABDELMALEK ZA, 1988, J CELL PHYSIOL, V136, P247, DOI 10.1002/jcp.1041360206
   ARITA Y, 1992, CANCER RES, V52, P4514
   BASERGA R, 1985, BIOL CELL REPRODUCTI
   BENNETT DC, 1989, ENVIRON HEALTH PERSP, V80, P49, DOI 10.2307/3430731
   BOISSY RE, 1991, J INVEST DERMATOL, V97, P395, DOI 10.1111/1523-1747.ep12480976
   BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J
   BREATHNACH AS, 1991, PIGM CELL RES, V4, P71, DOI 10.1111/j.1600-0749.1991.tb00318.x
   BROOKS G, 1991, CANCER RES, V51, P3281
   BURCHILL SA, 1990, J INVEST DERMATOL, V95, P558, DOI 10.1111/1523-1747.ep12504908
   CAMPISI J, 1991, PERSPECTIVES CELLUL, P153
   CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G
   CHAOHSING KAO, 1991, ARCH DERMATOL RES, V283, P119, DOI 10.1007/BF00371620
   CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915
   COBB MH, 1991, CELL REGUL, V2, P965, DOI 10.1091/mbc.2.12.965
   EISINGER M, 1982, P NATL ACAD SCI-BIOL, V79, P2018, DOI 10.1073/pnas.79.6.2018
   ERICKSON CA, 1993, PIGM CELL RES, V6, P336, DOI 10.1111/j.1600-0749.1993.tb00611.x
   FUNASAKA Y, 1992, MOL BIOL CELL, V3, P197, DOI 10.1091/mbc.3.2.197
   GILCHREST BA, 1984, J INVEST DERMATOL, V83, P370, DOI 10.1111/1523-1747.ep12264638
   GILLE H, 1992, NATURE, V358, P414, DOI 10.1038/358414a0
   GORDON PR, 1989, J INVEST DERMATOL, V93, P700, DOI 10.1111/1523-1747.ep12319900
   GOTOH Y, 1991, NATURE, V349, P251, DOI 10.1038/349251a0
   HALABAN R, 1988, J CELL BIOL, V107, P1611, DOI 10.1083/jcb.107.4.1611
   HALABAN R, 1992, ONCOGENE, V7, P2195
   Harlow E., 1988, Antibodies : a laboratorv manual
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   HEARING VJ, 1993, AM J HUM GENET, V52, P1
   HERLYN M, 1988, EXP CELL RES, V179, P322, DOI 10.1016/0014-4827(88)90271-6
   Holbrook KA, 1988, PIGMENT CELL RES, V1, P6, DOI DOI 10.1111/J.1600-0749.1988.TB00789.X
   HOWE LR, 1992, CELL, V71, P335, DOI 10.1016/0092-8674(92)90361-F
   IMOKAWA G, 1992, J BIOL CHEM, V267, P24675
   KAMESHITA I, 1989, ANAL BIOCHEM, V183, P139, DOI 10.1016/0003-2697(89)90181-4
   LANGECARTER CA, 1993, SCIENCE, V260, P315, DOI 10.1126/science.8385802
   LIN BTY, 1992, CIBA F SYMP, V170, P227
   LORTON CA, 1991, CLIN DERMATOL, V2, P1
   MATSUMOTO K, 1991, BIOCHEM BIOPH RES CO, V176, P45, DOI 10.1016/0006-291X(91)90887-D
   MEDRANO EE, 1993, P NATL ACAD SCI USA, V90, P1790, DOI 10.1073/pnas.90.5.1790
   MEDRANO EE, 1990, J INVEST DERMATOL, V95, P441
   MOODIE SA, 1993, SCIENCE, V260, P1658, DOI 10.1126/science.8503013
   MORELLI JG, 1992, J INVEST DERMATOL, V98, P55, DOI 10.1111/1523-1747.ep12494602
   MULLER R, 1984, NATURE, V312, P716, DOI 10.1038/312716a0
   NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571
   NORDLUND JJ, 1986, DERMATOL CLIN, V4, P407, DOI 10.1016/S0733-8635(18)30803-9
   PAGES G, 1993, P NATL ACAD SCI USA, V90, P8319, DOI 10.1073/pnas.90.18.8319
   PARK HY, 1990, CANCER RES, V50, P7145
   PARK HY, 1993, J BIOL CHEM, V268, P11742
   PITTELKOW MR, 1989, J CELL PHYSIOL, V140, P565, DOI 10.1002/jcp.1041400323
   QUEVEDO WC, 1986, DERMATOLOGY GENERAL, P224
   ROSE DW, 1992, J CELL BIOL, V119, P1405, DOI 10.1083/jcb.119.6.1405
   ROZENGURT E, 1988, COLD SPRING HARB SYM, V53, P945, DOI 10.1101/SQB.1988.053.01.109
   SANGHERA JS, 1992, MOL BIOL CELL, V3, P775, DOI 10.1091/mbc.3.7.775
   SESHADRI T, 1990, SCIENCE, V247, P205, DOI 10.1126/science.2104680
   SETH A, 1992, J BIOL CHEM, V267, P24796
   STEIN GH, 1990, SCIENCE, V249, P666, DOI 10.1126/science.2166342
   STEIN GH, 1991, P NATL ACAD SCI USA, V88, P11012, DOI 10.1073/pnas.88.24.11012
   SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2
   TASSABEHJI M, 1992, NATURE, V355, P635, DOI 10.1038/355635a0
   THOMAS SM, 1992, CELL, V68, P1031, DOI 10.1016/0092-8674(92)90075-N
   URABE K, 1993, PIGM CELL RES, V6, P186, DOI 10.1111/j.1600-0749.1993.tb00601.x
   YAAR M, 1991, J INVEST DERMATOL, V97, P611, DOI 10.1111/1523-1747.ep12482985
NR 60
TC 69
Z9 75
U1 0
U2 2
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA PUBL OFFICE, 9650 ROCKVILLE PIKE, BETHESDA, MD 20814
SN 1059-1524
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD APR
PY 1994
VL 5
IS 4
BP 497
EP 509
DI 10.1091/mbc.5.4.497
PG 13
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA NL247
UT WOS:A1994NL24700010
PM 8054689
OA Green Published
DA 2024-02-19
ER

PT J
AU Liu, J
   Wang, C
   Wang, YT
   Liu, JX
   Zhou, TH
   Yao, SK
   Chen, G
AF Liu, Jing
   Wang, Che
   Wang, Yu-Tong
   Liu, Ji-Xiang
   Zhou, Tian-Hui
   Yao, Shu-Kun
   Chen, Gang
TI Hyperuricemia as an independent risk factor for metabolic
   dysfunction-associated fatty liver disease in nonobese patients without
   type 2 diabetes mellitus
SO AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
LA English
DT Article
DE chronic liver disease; hyperuricemia; metabolic dysfunction-associated
   fatty liver disease; nonobese; uric acid
ID SERUM URIC-ACID; MANAGEMENT; DIAGNOSIS
AB According to the latest consensus statement, fatty liver complicated by specific metabolic abnormalities can be diagnosed as metabolic dysfunction-associated fatty liver disease (MAFLD) in nonobese patients without type 2 diabetes mellitus (T2DM). However, hyperuricemia (HUA), a manifestation of metabolic disorders, is excluded from diagnostic criteria. This study explored the association between HUA and MAFLD in nonobese patients without T2DM. A total of 28,187 participants were recruited from the Examination Center of the China-Japan Friendship Hospital from 2018 to 2022 and divided into four subgroups: nonobese patients without T2DM, obese patients without T2DM, nonobese patients with T2DM, and obese patients with T2DM. MAFLD was diagnosed by ultrasound combined with laboratory examinations. The association of HUA with MAFLD subgroups was performed by logistical regression analysis. The predictive ability of UA for MAFLD subgroups was assessed by receiver operating characteristics (ROC). HUA was positively associated with MAFLD in nonobese patients without T2DM in both males and females, even after adjusting for sex, BMI, dyslipidemia, and abnormal liver function. The association increased gradually with aging, especially in those over 40 yr old. HUA was an independent risk factor for MAFLD in nonobese patients without T2DM. We suggest that UA abnormalities might be considered in the diagnosis of MAFLD in nonobese patients without T2DM.NEW & NOTEWORTHY HUA is an independent risk factor for MAFLD in nonobese patients without T2DM. The association of HUA with MAFLD in nonobese patients without T2DM increased gradually with aging, especially in those over 40 yr old. In non obese patients without T2DM, univariate analysis showed that females with HUA had a higher risk of MAFLD than males. However, the difference was narrowed after adjustment for confounders.
C1 [Liu, Jing] Chinese Acad Med Sci & Peking Union Med Coll, China Japan Friendship Hosp, Beijing, Peoples R China.
   [Wang, Che; Wang, Yu-Tong] Beijing Univ Chinese Med, Sch Qi Huang, Beijing, Peoples R China.
   [Liu, Ji-Xiang; Zhou, Tian-Hui] Beijing Univ Chinese Med, Beijing, Peoples R China.
   [Yao, Shu-Kun] China Japan Friendship Hosp, Dept Gastroenterol, Beijing, Peoples R China.
   [Chen, Gang] China Japan Friendship Hosp, Examinat Ctr, Beijing, Peoples R China.
C3 Chinese Academy of Medical Sciences - Peking Union Medical College;
   Peking Union Medical College; China-Japan Friendship Hospital; Beijing
   University of Chinese Medicine; Beijing University of Chinese Medicine;
   China-Japan Friendship Hospital; China-Japan Friendship Hospital
RP Yao, SK (corresponding author), China Japan Friendship Hosp, Dept Gastroenterol, Beijing, Peoples R China.; Chen, G (corresponding author), China Japan Friendship Hosp, Examinat Ctr, Beijing, Peoples R China.
EM shukunyao@126.com; thirteeneast@163.com
RI Liu, JiXiang/HSB-9462-2023
CR Carobene A, 2013, CLIN CHEM LAB MED, V51, P1997, DOI 10.1515/cclm-2013-0096
   Chalasani N, 2018, HEPATOLOGY, V67, P328, DOI 10.1002/hep.29367
   Chan KE, 2022, J CLIN ENDOCR METAB, V107, P2691, DOI 10.1210/clinem/dgac321
   Chang CC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22997-0
   Chen F, 2020, HEPATOLOGY, V71, P1213, DOI 10.1002/hep.30908
   Choi YJ, 2014, LAB INVEST, V94, P1114, DOI 10.1038/labinvest.2014.98
   Cruz A.C.D., 2014, Gastroenterology, V146, pS, DOI [10.1016/S0016-5085(14)63307-2, DOI 10.1016/S0016-5085(14)63307-2]
   Das K, 2013, HEPATOL INT, V7, pS806, DOI 10.1007/s12072-013-9477-5
   Ding C, 2016, CURR OPIN CLIN NUTR, V19, P408, DOI 10.1097/MCO.0000000000000317
   Elizalde-Barrera CI, 2017, THER ADV ENDOCRINOL, V8, P141, DOI 10.1177/2042018817732731
   Eslam M, 2020, J HEPATOL, V73, P202, DOI 10.1016/j.jhep.2020.03.039
   Eslam M, 2020, GASTROENTEROLOGY, V158, P1999, DOI 10.1053/j.gastro.2019.11.312
   Fracanzani AL, 2017, CLIN GASTROENTEROL H, V15, P1604, DOI 10.1016/j.cgh.2017.04.045
   Gao X, 2013, J DIABETES, V5, P406, DOI 10.1111/1753-0407.12056
   Hagström H, 2018, HEPATOL COMMUN, V2, P48, DOI 10.1002/hep4.1124
   Kurt Z, 2018, BIOL SEX DIFFER, V9, DOI 10.1186/s13293-018-0205-7
   Li CG, 2013, CURR OPIN RHEUMATOL, V25, P210, DOI 10.1097/BOR.0b013e32835d951e
   Lim JS, 2010, NAT REV GASTRO HEPAT, V7, P251, DOI 10.1038/nrgastro.2010.41
   Liu SYW, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-83782-0
   RADER DJ, 1994, ANN INTERN MED, V120, P1012, DOI 10.7326/0003-4819-120-12-199406150-00008
   Society CD., 2014, CHIN J ENDOCRINOL ME, V30, P26
   Tocchi A, 2015, BBA-BIOENERGETICS, V1847, P1424, DOI 10.1016/j.bbabio.2015.07.009
   Tomas TC, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00360
   Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279
   Wijarnpreecha K, 2017, LIVER INT, V37, P906, DOI 10.1111/liv.13329
   Yang C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177249
   Yu XL, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000008164
   Zheng XY, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0531-5
   Zhou YJ, 2016, CLIN BIOCHEM, V49, P636, DOI 10.1016/j.clinbiochem.2015.12.010
   Zhu XY., 2018, CLIN RES PRACT, V3, P6, DOI [10.19347/j.cnki.2096-1413.201823003, DOI 10.19347/J.CNKI.2096-1413.201823003]
   Zhu YZ, 2014, BIOCHEM BIOPH RES CO, V447, P707, DOI 10.1016/j.bbrc.2014.04.080
   Zou HJ, 2017, CHINESE MED J-PEKING, V130, P2473, DOI 10.4103/0366-6999.216416
NR 32
TC 0
Z9 0
U1 2
U2 3
PU AMER PHYSIOLOGICAL SOC
PI Rockville
PA 6120 Executive Blvd, Suite 600, Rockville, MD, UNITED STATES
SN 0193-1849
EI 1522-1555
J9 AM J PHYSIOL-ENDOC M
JI Am. J. Physiol.-Endocrinol. Metab.
PD JUL 1
PY 2023
VL 325
IS 1
BP E62
EP E71
DI 10.1152/ajpendo.00001.2023
PG 10
WC Endocrinology & Metabolism; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Physiology
GA L2EB7
UT WOS:001021428800002
PM 37285598
DA 2024-02-19
ER

PT J
AU Swanlund, JM
   Kregel, KC
   Oberley, TD
AF Swanlund, Jamie M.
   Kregel, Kevin C.
   Oberley, Terry D.
TI Autophagy following heat stress - The role of aging and protein
   nitration
SO AUTOPHAGY
LA English
DT Article
DE mitochondria; 3-nitrotyrosine; autophagy; heat stress; oxidative stress;
   nitric oxide
ID OXIDATIVE STRESS; RAT HEPATOCYTES; CELLS; PEROXYNITRITE; SECTIONS
AB Stress can originate from a variety of sources (e.g., physical, chemical, etc.,) and cause protein denaturation, DNA damage and possibly death. In an effort to prevent such deleterious consequences, most organisms possess one or more ways to counteract or even prevent the harmful effect(s) from a given stressor. Such compensation by an organism is known as a stress response; this involves inhibition of housekeeping genes and subsequent activation of genes associated with the stress response.(1) One of the most widely studied groups of stress response genes Is a family of molecular chaperones known as heat shock proteins (HSPs). Work from our laboratory agrees with many other studies showing an age-related decline in stress-induced synthesis of HSPs.(2) A decline in the availability and/or function of HSPs with age can lead to accumulation of damaged proteins, which in turn damages cells. Recently, our laboratory found a significant increase in mitochondrial damage as well as evidence of increased autophagy in rat hepatocytes following heat stress.(3) These results, along with findings of increased protein nitration with age, suggest a major role for reactive nitrogen species (RNS) in both the decline in HSP induction and increased hepatocyte pathology observed in old rats following heat stress.
C1 [Swanlund, Jamie M.; Oberley, Terry D.] William S Middleton Mem Vet Adm Med Ctr, Dept Pathol & Lab Med, Madison, WI 53705 USA.
   [Oberley, Terry D.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pathol & Lab Med, Madison, WI USA.
   [Kregel, Kevin C.] Univ Iowa, Dept Radiat Oncol, Dept Integrat Physiol, Iowa City, IA USA.
   [Kregel, Kevin C.] Univ Iowa, Dept Radiat Oncol, Free Radical & Radiat Biol Program, Iowa City, IA USA.
C3 US Department of Veterans Affairs; Veterans Health Administration (VHA);
   William S Middleton Memorial Veterans Hospital; University of Wisconsin
   System; University of Wisconsin Madison; University of Iowa; University
   of Iowa
RP Oberley, TD (corresponding author), William S Middleton Mem Vet Adm Med Ctr, Dept Pathol & Lab Med, Room A-35,2500 Overlook Terrace, Madison, WI 53705 USA.
EM toberley@wisc.edu
FU NIA NIH HHS [R01 AG012350-09A1] Funding Source: Medline
CR ARNES BN, 1993, P NATL ACAD SCI USA, V90, P7915
   Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424
   BECKMAN JS, 1994, METHOD ENZYMOL, V233, P229
   Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313
   Brunk UT, 1997, FREE RADICAL BIO MED, V23, P616, DOI 10.1016/S0891-5849(97)00007-5
   Cuervo AM, 2000, J BIOL CHEM, V275, P31505, DOI 10.1074/jbc.M002102200
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   Garigan D, 2002, GENETICS, V161, P1101
   GHADIALLY F, 1997, ULTRASTRUCT PATHOL, V2, P195
   GORDON PB, 1987, BIOCHIM BIOPHYS ACTA, V929, P128, DOI 10.1016/0167-4889(87)90167-4
   HADDAD IY, 1994, J CLIN INVEST, V94, P2407, DOI 10.1172/JCI117607
   Hall DM, 2000, J APPL PHYSIOL, V89, P749, DOI 10.1152/jappl.2000.89.2.749
   Heydari AR, 2000, EXP CELL RES, V256, P83, DOI 10.1006/excr.2000.4808
   Lucocq JM, 2004, J HISTOCHEM CYTOCHEM, V52, P991, DOI 10.1369/jhc.3a6178.2004
   Mayhew TM, 2004, HISTOCHEM CELL BIOL, V122, P171, DOI 10.1007/s00418-004-0685-x
   Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421
   Moore MN, 2008, AUTOPHAGY, V4, P254, DOI 10.4161/auto.5528
   Nithipongvanitch R, 2007, J HISTOCHEM CYTOCHEM, V55, P629, DOI 10.1369/jhc.6A7146.2007
   Oberley TD, 2008, J HISTOCHEM CYTOCHEM, V56, P615, DOI 10.1369/jhc.2008.950873
   Riezman H, 2004, CELL CYCLE, V3, P61
   RUBBO H, 1994, J BIOL CHEM, V269, P26066
   Stadtman ER, 2001, ANN NY ACAD SCI, V928, P22
   Terman A, 2004, INT J BIOCHEM CELL B, V36, P1400, DOI 10.1016/j.biocel.2003.08.009
   TOYOKUNI S, 1995, FEBS LETT, V359, P189, DOI 10.1016/0014-5793(95)00033-6
   Verbeke P, 2001, CELL BIOL INT, V25, P845, DOI 10.1006/cbir.2001.0789
NR 25
TC 32
Z9 38
U1 0
U2 7
PU LANDES BIOSCIENCE
PI AUSTIN
PA 1002 WEST AVENUE, 2ND FLOOR, AUSTIN, TX 78701 USA
SN 1554-8627
J9 AUTOPHAGY
JI Autophagy
PD OCT 1
PY 2008
VL 4
IS 7
BP 936
EP 939
DI 10.4161/auto.6768
PG 4
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA 357ES
UT WOS:000259829700016
PM 18758235
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Du, ZD
   He, L
   Tu, CM
   Guo, XA
   Yu, SK
   Liu, K
   Gong, SS
AF Du, Zheng-De
   He, Lu
   Tu, Chunmei
   Guo, Xiao-An
   Yu, Shukui
   Liu, Ke
   Gong, Shusheng
TI Mitochondrial DNA 3,860-bp Deletion Increases with Aging in the Auditory
   Nervous System of C57BL/6J Mice
SO ORL-JOURNAL FOR OTO-RHINO-LARYNGOLOGY HEAD AND NECK SURGERY
LA English
DT Article
DE Age-related hearing loss; mtDNA 3; 860-bp deletion; mtDNA oxidative
   damage; Auditory nervous system; C57BL; 6J mice
ID 4977 BP DELETION; COMMON DELETION; HEARING-LOSS; DAMAGE; MUTATIONS;
   BIOMARKER; 8-OHDG
AB Background/Aims: Mitochondrial DNA (mtDNA) is sensitive to oxidative damage during aging, which can result in mtDNA mutations. A previous study reported that a 3,860-bp mtDNA deletion, similar to a 4,977-bp mtDNA deletion in humans, is also common occurrence in murine tissues, and increases in the brain and liver with aging. However, no previous study evaluated both topics in the murine auditory nervous system. Methods: We compared mtDNA oxidative damage, mitochondrial ultrastructural changes, and the frequency of the 3,860-bp deletion in the peripheral (spiral ganglion, SG) and central (auditory cortex, AC) auditory nervous system of C57BL/6J mice aged 2, 12, and 18 months. Results: We found that the threshold of auditory brainstem response increased with age along with the signal of 8-hydroxy-2 '-deoxyguanosine - a marker of DNA oxidative damage - in the mitochondria of SG and AC neurons. The mitochondrial ultrastructural damage also increased with aging in the SG and AC neurons. Moreover, the relative amount of mtDNA 3,860-bp deletion in 12- and 18-month-old mice was significantly higher in the SG and AC as compared to 2-month-old mice. Conclusion: These results suggest that the mtDNA 3,860-bp deletion is common in the auditory nervous system of mice and increases with age and may contribute to age-related hearing loss.
C1 [Du, Zheng-De; He, Lu; Yu, Shukui; Liu, Ke; Gong, Shusheng] Capital Med Univ, Bejing Friendship Hosp, Dept Otorhinolaryngol, Beijing, Peoples R China.
   [Tu, Chunmei] First Peoples Hosp Jinan, Dept Otorhinolaryngol, Jinan, Shandong, Peoples R China.
   [Guo, Xiao-An] China Med Univ, Affiliated Hosp 1, Dept Otorhinolaryngol, Shenyang, Liaoning, Peoples R China.
C3 Capital Medical University; China Medical University
RP Gong, SS (corresponding author), Capital Med Univ, Beijing Friendship Hosp, Beijing 100050, Peoples R China.
EM gongss1962@163.com
OI liu, ke/0000-0002-0505-920X
FU National Natural Science Foundation of China [81700917, 81830030]; China
   Postdoctoral Science Foundation [2018M630180]; Shenzhen Knowledge
   Innovation Program of China [JCYJ20160429181957912]; Shenzhen Nanshan
   District Science and Technology Key Program of China [2016004]
FX This work was supported by grants from the National Natural Science
   Foundation of China (No. 81700917 and 81830030), the China Postdoctoral
   Science Foundation (No. 2018M630180), the Shenzhen Knowledge Innovation
   Program of China (No. JCYJ20160429181957912), and the Shenzhen Nanshan
   District Science and Technology Key Program of China (No. 2016004).
CR Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   BYRNE E, 1991, AUST NZ J MED, V21, P837, DOI 10.1111/j.1445-5994.1991.tb01404.x
   Chen B, 2010, BRAIN RES, V1344, P43, DOI 10.1016/j.brainres.2010.04.082
   Du ZD, 2012, HEARING RES, V287, P15, DOI 10.1016/j.heares.2012.04.012
   Eshaghian A, 2006, J INVEST DERMATOL, V126, P336, DOI 10.1038/sj.jid.5700088
   Fujimoto C, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/582849
   Gates GA, 2005, LANCET, V366, P1111, DOI 10.1016/S0140-6736(05)67423-5
   Gendron SP, 2012, MECH AGEING DEV, V133, P68, DOI 10.1016/j.mad.2012.01.002
   Han C, 2013, MOL CELL NEUROSCI, V55, P95, DOI 10.1016/j.mcn.2012.07.004
   Hiona A, 2008, EXP GERONTOL, V43, P24, DOI 10.1016/j.exger.2007.10.001
   Honda M, 2000, LEUKEMIA RES, V24, P461, DOI 10.1016/S0145-2126(00)00006-0
   Kamogashira T, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/617207
   Kim MA, 2016, ANTIOXID REDOX SIGN, V24, P590, DOI 10.1089/ars.2015.6442
   Lai LP, 2003, CHEST, V123, P539, DOI 10.1378/chest.123.2.539
   Lenaz G, 2001, IUBMB LIFE, V52, P159, DOI 10.1080/15216540152845957
   Markaryan A, 2009, LARYNGOSCOPE, V119, P1184, DOI 10.1002/lary.20218
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   Quan CJ, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0167-6
   Rubel EW, 2002, ANNU REV NEUROSCI, V25, P51, DOI 10.1146/annurev.neuro.25.112701.142849
   Soong N W, 1996, Methods Enzymol, V264, P421, DOI 10.1016/S0076-6879(96)64038-5
   Tavanai E, 2017, EUR ARCH OTO-RHINO-L, V274, P1821, DOI 10.1007/s00405-016-4378-6
   Ueda N, 1998, LARYNGOSCOPE, V108, P580, DOI 10.1097/00005537-199804000-00022
   Vendelbo MH, 2011, BBA-MOL CELL RES, V1813, P634, DOI 10.1016/j.bbamcr.2011.01.029
   Wu DN, 2017, J CHROMATOGR B, V1064, P1, DOI 10.1016/j.jchromb.2017.08.033
   Yamasoba T, 2007, HEARING RES, V226, P185, DOI 10.1016/j.heares.2006.06.004
   Yamasoba T, 2013, HEARING RES, V303, P30, DOI 10.1016/j.heares.2013.01.021
   Zhang HS, 2009, ADV EXP MED BIOL, V645, P43, DOI 10.1007/978-0-387-85998-9_7
   Zhang SB, 2013, RADIAT RES, V180, P407, DOI 10.1667/RR3373.1
   Zhang Y, 2017, ORL J OTO-RHINO-LARY, V79, P153, DOI 10.1159/000468944
   Zheng YJ, 2012, BOSNIAN J BASIC MED, V12, P187, DOI 10.17305/bjbms.2012.2480
NR 30
TC 10
Z9 13
U1 1
U2 4
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0301-1569
EI 1423-0275
J9 ORL J OTO-RHINO-LARY
JI ORL-J. Oto-Rhino-Laryngol. Head Neck Surg.
PY 2019
VL 81
IS 2-3
BP 92
EP 100
DI 10.1159/000499475
PG 9
WC Otorhinolaryngology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Otorhinolaryngology
GA IL9FJ
UT WOS:000477590300004
PM 31129670
DA 2024-02-19
ER

PT J
AU Chen, CY
AF Chen, Chunye
TI Sinapic Acid and Its Derivatives as Medicine in Oxidative Stress-Induced
   Diseases and Aging
SO OXIDATIVE MEDICINE AND CELLULAR LONGEVITY
LA English
DT Article
ID ANTIOXIDANT ACTIVITY; PHENOLIC-ACIDS; 4-VINYL-2,6-DIMETHOXYPHENOL
   CANOLOL; HELICOBACTER-PYLORI; SCAVENGING ACTIVITY; CAFFEIC ACID;
   IN-VITRO; CARBON-TETRACHLORIDE; LIVER-DAMAGE; FERULIC ACID
AB Sinapic acid (3,5-dimethoxy-4-hydroxycinnamic acid) is an orally bioavailable phytochemical, extensively found in spices, citrus and berry fruits, vegetables, cereals, and oilseed crops and is known to exhibit antioxidant, anti-inflammatory, anticancer, antimutagenic, antiglycemic, neuroprotective, and antibacterial activities. The literature reveals that sinapic acid is a bioactive phenolic acid and has the potential to attenuate various chemically induced toxicities. This minireview is an effort to summarize the available literature about pharmacokinetic, therapeutic, and protective potential of this versatile molecule in health related areas.
C1 [Chen, Chunye] Chongqing Univ, Bioengn Coll, Key Lab Biorheol Sci & Technol, Minist Educ, Chongqing 400030, Peoples R China.
C3 Chongqing University
RP Chen, CY (corresponding author), Chongqing Univ, Bioengn Coll, Key Lab Biorheol Sci & Technol, Minist Educ, Chongqing 400030, Peoples R China.
EM chunyech@gmail.com
FU Key Laboratory of Biorheological Science and Technology (Chongqing
   University); General Program of National Natural Science Foundation of
   China [81202202]
FX This work was supported by the Key Laboratory of Biorheological Science
   and Technology (Chongqing University) and the General Program of
   National Natural Science Foundation of China [Grant no. 81202202].
CR Ader P, 1996, EXP PHYSIOL, V81, P943, DOI 10.1113/expphysiol.1996.sp003995
   Akhter S, 2003, NITRIC OXIDE-BIOL CH, V8, P214, DOI 10.1016/S1089-8603(03)00031-4
   Andreasen MF, 2001, J AGR FOOD CHEM, V49, P4090, DOI 10.1021/jf0101758
   [Anonymous], 2011, INT J PHARM PHARM SC
   Anson NM, 2011, J NUTR, V141, P137, DOI 10.3945/jn.110.127720
   Ao CW, 2008, FOOD CONTROL, V19, P940, DOI 10.1016/j.foodcont.2007.09.007
   Bakalbassis EG, 2001, LIPIDS, V36, P181, DOI 10.1007/s11745-001-0705-9
   Barber MS, 2000, PHYTOCHEMISTRY, V54, P53, DOI 10.1016/S0031-9422(00)00038-8
   Bortolomeazzi R, 2007, FOOD CHEM, V100, P1481, DOI 10.1016/j.foodchem.2005.11.039
   Bountagladou OG, 2010, FOOD RES INT, V43, P2014, DOI 10.1016/j.foodres.2010.05.021
   Brinkel J, 2009, INT J ENV RES PUB HE, V6, P1609, DOI 10.3390/ijerph6051609
   Bunzel M, 2003, J AGR FOOD CHEM, V51, P1427, DOI 10.1021/jf020910v
   Cao X, 2008, INT J CANCER, V122, P1445, DOI 10.1002/ijc.23245
   Cavin JF, 1997, FEMS MICROBIOL LETT, V147, P291, DOI 10.1016/S0378-1097(97)00004-9
   Chalas J, 2001, BIOMED PHARMACOTHER, V55, P54, DOI 10.1016/S0753-3322(00)00011-1
   Chawla A. S., 1993, Indian Journal of Pharmaceutical Sciences, V55, P184
   Cherng YG, 2013, J AGR FOOD CHEM, V61, P12053, DOI 10.1021/jf403092b
   Chung SY, 2003, J PINEAL RES, V34, P95, DOI 10.1034/j.1600-079X.2003.00010.x
   Connelly L, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2935
   Cowan MM, 1999, CLIN MICROBIOL REV, V12, P564, DOI 10.1128/CMR.12.4.564
   Craft S, 2009, ARCH NEUROL-CHICAGO, V66, P300, DOI 10.1001/archneurol.2009.27
   Dong X, 2011, MOL VIS, V17, P2040
   Eid Y. Z., 2010, Egyptian Poultry Science Journal, V30, P917
   Engels C, 2012, EUR FOOD RES TECHNOL, V234, P535, DOI 10.1007/s00217-012-1669-z
   ESTERBAUER H, 1993, AM J CLIN NUTR, V57, P779, DOI 10.1093/ajcn/57.5.779S
   Fabre N, 2000, FITOTERAPIA, V71, P425, DOI 10.1016/S0367-326X(00)00127-1
   Fang J, 2013, CARCINOGENESIS, V34, P2833, DOI 10.1093/carcin/bgt309
   Ferreres F, 2009, J AGR FOOD CHEM, V57, P8884, DOI 10.1021/jf902661g
   Galano A, 2011, J PHYS CHEM B, V115, P8590, DOI 10.1021/jp2022105
   Galano A, 2011, PHYS CHEM CHEM PHYS, V13, P11199, DOI 10.1039/c1cp20722a
   Gaspar A, 2010, J AGR FOOD CHEM, V58, P11273, DOI 10.1021/jf103075r
   George J, 2001, TOXICOLOGY, V156, P129, DOI 10.1016/S0300-483X(00)00352-8
   Gibbons Simon, 2005, Phytochemistry Reviews, V4, P63, DOI 10.1007/s11101-005-2494-9
   GRIFFITHS LA, 1969, BIOCHEM J, V113, P603, DOI 10.1042/bj1130603
   Gutteridge J. M. C., 1989, FREE RADICALS BIOL M
   GUTTERIDGE JMC, 1988, BIOCHEM J, V253, P932, DOI 10.1042/bj2530932
   Harbaum-Piayda B, 2010, FOOD CHEM, V123, P607, DOI 10.1016/j.foodchem.2010.04.078
   He Ling, 2008, Zhongguo Zhong Yao Za Zhi, V33, P813
   Hotta H, 2002, BBA-GEN SUBJECTS, V1572, P123, DOI 10.1016/S0304-4165(02)00285-4
   Hudson EA, 2000, CANCER EPIDEM BIOMAR, V9, P1163
   Hynes MJ, 2002, J INORG BIOCHEM, V90, P18, DOI 10.1016/S0162-0134(02)00383-5
   Izquierdo LA, 2000, BEHAV BRAIN RES, V111, P93, DOI 10.1016/S0166-4328(00)00137-6
   Jalaludeen AM., 2011, J PHARM SCI RES, V3, P1447
   Janbaz KH, 2004, PHYTOMEDICINE, V11, P424, DOI 10.1016/j.phymed.2003.05.002
   Johnson ML, 2008, POULTRY SCI, V87, P958, DOI 10.3382/ps.2007-00349
   Jung JW, 2006, J ETHNOPHARMACOL, V108, P193, DOI 10.1016/j.jep.2006.05.019
   Kampa M, 2004, BREAST CANCER RES, V6, pR63, DOI 10.1186/bcr752
   Kanchana G., 2011, Glob. J. Pharmacol, V5, P33
   Kannan MM, 2011, EUR J PHARMACOL, V659, P45, DOI 10.1016/j.ejphar.2011.02.037
   Karakida F, 2007, BIOL PHARM BULL, V30, P514, DOI 10.1248/bpb.30.514
   Kelly C., 2008, BIOTECHNOLOGY FUELS, P615, DOI 10.1007/978- 1-60327- 526-2_57.
   Kern SM, 2003, J AGR FOOD CHEM, V51, P6050, DOI 10.1021/jf0302299
   Kikuzaki H, 2002, J AGR FOOD CHEM, V50, P2161, DOI 10.1021/jf011348w
   Kim DH, 2010, NEUROPHARMACOLOGY, V59, P20, DOI 10.1016/j.neuropharm.2010.03.012
   KLIGMAN LH, 1986, PHOTODERMATOLOGY, V3, P215
   Koski A, 2003, EUR FOOD RES TECHNOL, V217, P110, DOI 10.1007/s00217-003-0721-4
   Kuwahara H, 2004, J AGR FOOD CHEM, V52, P4380, DOI 10.1021/jf040045+
   Kuwahara H, 2009, MICROBIOL IMMUNOL, V53, P1, DOI 10.1111/j.1348-0421.2008.00089.x
   Kylli P, 2008, J AGR FOOD CHEM, V56, P4797, DOI 10.1021/jf800317v
   LADER M, 1991, BRIT J ADDICT, V86, P823
   Lee HE, 2012, PHARMACOL BIOCHEM BE, V103, P260, DOI 10.1016/j.pbb.2012.08.015
   Lee JJ, 2003, NEUROPHARMACOLOGY, V44, P573, DOI 10.1016/S0028-3908(03)00039-X
   Lehtimäki KA, 2003, MOL BRAIN RES, V110, P253, DOI 10.1016/S0169-328X(02)00654-X
   Lin LZ, 2010, J AGR FOOD CHEM, V58, P6850, DOI 10.1021/jf1004786
   Maddox CE, 2010, CURR MICROBIOL, V60, P53, DOI 10.1007/s00284-009-9501-0
   MAEDA H, 1992, JPN J CANCER RES, V83, P923, DOI 10.1111/j.1349-7006.1992.tb02001.x
   Martin KR, 2010, NUTR DIET SUPPL, V2, P1
   Moreno DA, 2010, FOOD CHEM, V123, P358, DOI 10.1016/j.foodchem.2010.04.044
   Mukherjee PK, 2011, PHYTOMEDICINE, V19, P64, DOI 10.1016/j.phymed.2011.10.003
   Murtaza G, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/145342
   NARDINI M, 1995, FREE RADICAL BIO MED, V19, P541, DOI 10.1016/0891-5849(95)00052-Y
   Natella F, 1999, J AGR FOOD CHEM, V47, P1453, DOI 10.1021/jf980737w
   Nenadis N, 2002, J AM OIL CHEM SOC, V79, P1191, DOI 10.1007/s11746-002-0626-z
   Niciforovic N, 2014, COMPR REV FOOD SCI F, V13, P34, DOI 10.1111/1541-4337.12041
   Niwa T, 1999, FEBS LETT, V459, P43, DOI 10.1016/S0014-5793(99)01216-8
   Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9
   NOWAK H, 1992, FETT WISS TECHNOL, V94, P149, DOI 10.1002/lipi.19920940406
   Pandey KB, 2009, OXID MED CELL LONGEV, V2, P270, DOI 10.4161/oxim.2.5.9498
   Pari L, 2011, CHEM-BIOL INTERACT, V194, P40, DOI 10.1016/j.cbi.2011.08.004
   Pekkarinen SS, 1999, J AGR FOOD CHEM, V47, P3036, DOI 10.1021/jf9813236
   POLI G, 1993, BRIT MED BULL, V49, P604, DOI 10.1093/oxfordjournals.bmb.a072634
   Prince PSM, 2011, EUR J PHARMACOL, V671, P95, DOI 10.1016/j.ejphar.2011.09.036
   Prince PSM, 2009, EUR J PHARMACOL, V615, P139, DOI 10.1016/j.ejphar.2009.05.003
   Qiao HY, 2008, POULTRY SCI, V87, P719, DOI 10.3382/ps.2007-00357
   Rechner AR, 2002, FREE RADICAL RES, V36, P1229, DOI 10.1080/246-1071576021000016472
   Reyes-Gordillo K, 2007, BBA-GEN SUBJECTS, V1770, P989, DOI 10.1016/j.bbagen.2007.02.004
   RiceEvans CA, 1996, FREE RADICAL BIO MED, V20, P933, DOI 10.1016/0891-5849(95)02227-9
   Roy SJ, 2013, EUR J PHARMACOL, V699, P213, DOI 10.1016/j.ejphar.2012.11.012
   Roy SJ, 2012, FOOD CHEM TOXICOL, V50, P3984, DOI 10.1016/j.fct.2012.08.017
   Saleem M, 2010, NAT PROD REP, V27, P238, DOI 10.1039/b916096e
   Sarsour EH, 2009, ANTIOXID REDOX SIGN, V11, P2985, DOI [10.1089/ars.2009.2513, 10.1089/ARS.2009.2513]
   Sawa T, 1999, J AGR FOOD CHEM, V47, P397, DOI 10.1021/jf980765e
   Sawa T, 1998, CANCER EPIDEM BIOMAR, V7, P1007
   Shahidi F., 2004, PHENOLICS FOOD NUTRA
   Shi HL, 2004, MOL CELL BIOCHEM, V255, P67, DOI 10.1023/B:MCBI.0000007262.26044.e8
   Shin DS, 2013, ARCH PHARM RES, V36, P608, DOI 10.1007/s12272-013-0033-6
   Shin DS, 2013, ARCH PHARM RES, V36, P626, DOI 10.1007/s12272-013-0050-5
   Shukla Y, 2011, ANN NY ACAD SCI, V1215, P1, DOI 10.1111/j.1749-6632.2010.05870.x
   Stocker R, 2004, PHYSIOL REV, V84, P1381, DOI 10.1152/physrev.00047.2003
   Sun XL, 2007, BIOL PHARM BULL, V30, P1727, DOI 10.1248/bpb.30.1727
   Sun YQ, 2005, HELICOBACTER, V10, P33, DOI 10.1111/j.1523-5378.2005.00289.x
   Takaya Y, 2003, J AGR FOOD CHEM, V51, P8061, DOI 10.1021/jf0346206
   Terpinc P, 2011, FOOD CHEM, V128, P62, DOI 10.1016/j.foodchem.2011.02.077
   Tesaki S, 1998, BIOSCI BIOTECH BIOCH, V62, P998, DOI 10.1271/bbb.62.998
   Thiyam U, 2006, J AM OIL CHEM SOC, V83, P523, DOI 10.1007/s11746-006-1235-6
   Thiyam U, 2006, EUR J LIPID SCI TECH, V108, P239, DOI 10.1002/ejlt.200500292
   Thiyam U, 2004, CR CHIM, V7, P611, DOI 10.1016/j.crci.2004.02.011
   Trnkova L., 2010, NAT SCI, V2, P563, DOI [10.4236/ns.2010.26071, DOI 10.4236/NS.2010.26071, DOI 10.4236/ns.2010.26071]
   Trnková L, 2009, PROCEEDINGS ECOPOLE, V3, P27
   Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823
   Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001
   Vuorela S, 2005, J AGR FOOD CHEM, V53, P5922, DOI 10.1021/jf050554r
   Wakamatsu D, 2005, BIOSCI BIOTECH BIOCH, V69, P1568, DOI 10.1271/bbb.69.1568
   Wang F, 2012, LWT-FOOD SCI TECHNOL, V46, P239, DOI 10.1016/j.lwt.2011.09.025
   Wang JF, 2006, TEX HEART I J, V33, P290
   Weber LWD, 2003, CRIT REV TOXICOL, V33, P105, DOI 10.1080/713611034
   Yoon BH, 2007, LIFE SCI, V81, P234, DOI 10.1016/j.lfs.2007.05.007
   Yun KJ, 2008, J AGR FOOD CHEM, V56, P10265, DOI 10.1021/jf802095g
   Zagulska-Szymczak S, 2001, NEUROCHEM INT, V38, P485, DOI 10.1016/S0197-0186(00)00101-7
   Zeng XY, 2013, MOL PHARMACOL, V83, P1099, DOI 10.1124/mol.112.084368
   Zhang JL, 2006, MOL NUTR FOOD RES, V50, P714, DOI 10.1002/mnfr.200600018
   Zhang K, 2004, J AGR FOOD CHEM, V52, P222, DOI 10.1021/jf035073r
   Zou YN, 2002, J AGR FOOD CHEM, V50, P5884, DOI 10.1021/jf020496z
NR 123
TC 199
Z9 202
U1 2
U2 41
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1942-0900
EI 1942-0994
J9 OXID MED CELL LONGEV
JI Oxidative Med. Cell. Longev.
PY 2016
VL 2016
AR 3571614
DI 10.1155/2016/3571614
PG 11
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA DG5LL
UT WOS:000372119600001
PM 27069529
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Zhang, X
   Qiu, K
   Wang, LQ
   Xu, DD
   Yin, JD
AF Zhang, Xin
   Qiu, Kai
   Wang, Liqi
   Xu, Doudou
   Yin, Jingdong
TI Integrated Remodeling of Gut-Liver Metabolism Induced by Moderate
   Protein Restriction Contributes to Improvement of Insulin Sensitivity
SO MOLECULAR NUTRITION & FOOD RESEARCH
LA English
DT Article
DE gut-liver metabolism; insulin sensitivity; moderate protein restriction
ID CHAIN AMINO-ACIDS; DIETARY-PROTEIN; DECREASED CONSUMPTION; LIFE-SPAN;
   IN-VIVO; RESISTANCE; MICE; GLUCOSE; OBESITY; HEALTH
AB ScopeProtein restriction (PR) is beneficial for relieving metabolic disorders and aging-related diseases. However, extreme PR could result in malnutrition due to severe deficiency of essential amino acids. Therefore, the effect of moderate PR on insulin sensitivity is investigated.
   Methods and resultsThe growing and adult pigs are subjected to moderate PR by 15-30%. Plasma insulin concentration and insulin resistance index HOMA-IR are significantly decreased upon moderate PR. Furthermore, IRS1/PI3K/AKT pathway in the basal state is enhanced in both liver and skeletal muscle. The adapted metabolism in the liver upon moderate PR is in support of improving insulin sensitivity. The liver shares a coordinated metabolic adaption in terms of energy metabolism and amino acid metabolism with the small intestine. Particularly, alteration of the metabolic footprint appeared in the portal venous blood, representing metabolites to be absorbed into liver after intestinal metabolism, is also in favor of improvement of insulin sensitivity.
   ConclusionIn summary, the study proves that moderate PR could improve insulin sensitivity from childhood to adulthood in a pig model, and sheds a new light on the role of integrated remodeling of gut and liver metabolism in the improved insulin sensitivity induced by moderate PR.
C1 [Zhang, Xin; Qiu, Kai; Wang, Liqi; Xu, Doudou; Yin, Jingdong] China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, Beijing 100193, Peoples R China.
C3 China Agricultural University
RP Yin, JD (corresponding author), China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, Beijing 100193, Peoples R China.
EM yinjd@cau.edu.cn
RI Qiu, Kai/ACR-6488-2022
OI Qiu, Kai/0000-0002-6575-5346; Yin, Jingdong/0000-0003-4623-0568; Zhang,
   Xin/0000-0003-2632-4567
FU National Key Research and Development Program of China [2018YFD0500402,
   2016YFD0700201]
FX This study was financially supported by National Key Research and
   Development Program of China (2018YFD0500402, 2016YFD0700201).
CR Adam TC, 2010, J CLIN ENDOCR METAB, V95, P4729, DOI 10.1210/jc.2010-0322
   [Anonymous], 2012, NUTR REQ SWIN, V11th
   Cai CB, 2017, ONCOTARGET, V8, P34911, DOI 10.18632/oncotarget.16822
   Cao H, 2007, J AGR FOOD CHEM, V55, P6372, DOI 10.1021/jf070695o
   CHEATHAM B, 1995, ENDOCR REV, V16, P117, DOI 10.1210/er.16.2.117
   Copps KD, 2010, CELL METAB, V11, P84, DOI 10.1016/j.cmet.2009.11.003
   Cummings N. E., 2017, J PHYSL, V10, P1113
   Cummings NE, 2018, J PHYSIOL-LONDON, V596, P623, DOI 10.1113/JP275075
   Daly K, 2013, AM J PHYSIOL-GASTR L, V304, pG271, DOI 10.1152/ajpgi.00074.2012
   Ding L, 2017, J ENDOCRINOL, V232, P59, DOI 10.1530/JOE-16-0276
   Duca FA, 2015, CELL METAB, V22, P367, DOI 10.1016/j.cmet.2015.07.003
   Everard A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6648
   Fisher E, 2009, MOL GENET METAB, V98, P400, DOI 10.1016/j.ymgme.2009.08.001
   Flint A, 2011, DIABETES CARE, V34, pS177, DOI 10.2337/dc11-s215
   Fontana L, 2016, CELL REP, V16, P520, DOI 10.1016/j.celrep.2016.05.092
   Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539
   Furuhashi M, 2008, J CLIN INVEST, V118, P2640, DOI 10.1172/JCI34750
   Gómez-Valadés AG, 2008, DIABETES, V57, P2199, DOI 10.2337/db07-1087
   Goto S, 2010, NEUROSCIENCE, V166, P333, DOI 10.1016/j.neuroscience.2009.12.013
   Gupta A, 2012, BBA-MOL BASIS DIS, V1822, P1030, DOI 10.1016/j.bbadis.2012.02.011
   Harputlugil E, 2014, CELL REP, V8, P1160, DOI 10.1016/j.celrep.2014.07.018
   Herzig S, 2003, NATURE, V426, P190, DOI 10.1038/nature02110
   Hoenig MR, 2010, ATHEROSCLEROSIS, V211, P260, DOI 10.1016/j.atherosclerosis.2010.02.029
   Japtok L, 2015, FASEB J, V29, P3357, DOI 10.1096/fj.14-263194
   Jhala US, 2003, GENE DEV, V17, P1575, DOI 10.1101/gad.1097103
   Kovacic S, 2003, J BIOL CHEM, V278, P39422, DOI 10.1074/jbc.M305371200
   Kowalski GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072449
   Labonte CC, 2015, CLIN NUTR, V34, P1115, DOI 10.1016/j.clnu.2014.12.022
   Le Couteur DG, 2016, CELL MOL LIFE SCI, V73, P1237, DOI 10.1007/s00018-015-2120-y
   Levine ME, 2014, CELL METAB, V19, P407, DOI 10.1016/j.cmet.2014.02.006
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   McCurdy CE, 2012, DIABETES, V61, P2495, DOI 10.2337/db11-1433
   Métayer-Coustard S, 2010, J NUTR, V140, P1539, DOI 10.3945/jn.110.122663
   Mullur R, 2014, PHYSIOL REV, V94, P355, DOI 10.1152/physrev.00030.2013
   Naruta E, 2001, EXP TOXICOL PATHOL, V53, P393, DOI 10.1078/0940-2993-00205
   Ostler JE, 2014, AM J PHYSIOL-ENDOC M, V306, pE592, DOI 10.1152/ajpendo.00277.2013
   Ozaki K, 2016, AM J PHYSIOL-ENDOC M, V310, pE643, DOI 10.1152/ajpendo.00445.2015
   Qin CF, 2016, SCI REP-UK, V6, DOI 10.1038/srep36888
   Qin CF, 2015, J ANIM SCI BIOTECHNO, V6, DOI 10.1186/s40104-015-0052-x
   Qiu K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162475
   QUON MJ, 1994, J BIOL CHEM, V269, P27920
   Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017
   Shi SQ, 2013, CURR BIOL, V23, P372, DOI 10.1016/j.cub.2013.01.048
   Simpson SJ, 2017, AGEING RES REV, V39, P78, DOI 10.1016/j.arr.2017.03.001
   Snel M, 2010, EUR J CLIN NUTR, V64, P419, DOI 10.1038/ejcn.2009.154
   Soultoukis GA, 2016, ANNU REV BIOCHEM, V85, P5, DOI 10.1146/annurev-biochem-060815-014422
   Stone KP, 2014, DIABETES, V63, P3721, DOI 10.2337/db14-0464
   Tan E, 2014, CURR OPIN CLIN NUTR, V17, P343, DOI 10.1097/MCO.0000000000000061
   Vergès B, 2015, DIABETOLOGIA, V58, P886, DOI 10.1007/s00125-015-3525-8
   Wan X., 2017, PLOS ONE, V12
   Wang P, 2012, DIABETES, V61, P1051, DOI 10.2337/db11-1180
   Wang X, 2015, ELECTROPHORESIS, V36, P2250, DOI 10.1002/elps.201500007
   Wu GY, 2016, FOOD FUNCT, V7, P1251, DOI 10.1039/c5fo01530h
   Xiao F, 2011, DIABETES, V60, P746, DOI 10.2337/db10-1246
   Xiao N, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00043
   Zhang JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083509
NR 56
TC 6
Z9 7
U1 0
U2 23
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1613-4125
EI 1613-4133
J9 MOL NUTR FOOD RES
JI Mol. Nutr. Food Res.
PD OCT
PY 2018
VL 62
IS 19
AR 1800637
DI 10.1002/mnfr.201800637
PG 10
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA GV6YP
UT WOS:000446267300008
PM 30030886
OA Green Published, hybrid
DA 2024-02-19
ER

PT J
AU DCOSTA, AP
   LENHAM, JE
   INGRAM, RL
   SONNTAG, WE
AF DCOSTA, AP
   LENHAM, JE
   INGRAM, RL
   SONNTAG, WE
TI MODERATE CALORIC RESTRICTION INCREASES TYPE-1 IGF RECEPTORS AND
   PROTEIN-SYNTHESIS IN AGING RATS
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE AGING; MODERATE CALORIC RESTRICTION; PROTEIN SYNTHESIS; PLASMA IGF-1;
   TYPE-1 IGF RECEPTORS
ID GROWTH FACTOR-I; MESSENGER RIBONUCLEIC-ACID; DIETARY RESTRICTION;
   AMINO-ACIDS; HORMONE; AGE; LONGEVITY; DERIVATIZATION; BINDING; LESIONS
AB Insulin-like growth factor-1 (IGF-1) is an anabolic hormone that mediates the actions of growth hormone (GH) and is found at lower concentrations in aged animals. These decreases in GH and IGF-1 appear to have important physiological consequences for aging, since protein synthesis decreases with age, and administration of GH and/or IGF-1 has been shown to increase protein synthesis. The present study was designed to determine (a) the relationship between the age-related changes in rates of tissue protein synthesis and plasma IGF-1 concentrations, (b) type 1 IGF receptor density in tissues and (c) whether long-term moderate caloric restriction, which is known to increase life-span, affects these relationships. Male Brown Norway rats were fed ad libitum or caloric-restricted (60% ad libitum) from 14 weeks of age and sacrificed at different ages. In ad libitum fed animals there were age-related decreases in plasma IGF-1 concentrations (14%) and in the rates of protein synthesis of the heart (36%) and liver (38%). Type 1 IGF receptor density remained constant in all tissues with age. The caloric-restricted animals exhibited plasma IGF-1 concentrations 33 to 42% lower than the ad libitum fed animals. However, rates of protein synthesis increased by 70 and 30% in heart and diaphragm, and this increase was associated with 60 to 100% increases in type 1 IGF receptor densities when compared with ad libitum fed animals. These data suggest that alterations in tissue type 1 IGF receptors as well as availability of IGF-1 may be important factors in understanding the regulation of protein synthesis by IGF-1 during aging or under conditions of long-term caloric restriction.
RP DCOSTA, AP (corresponding author), WAKE FOREST UNIV,BOWMAN GRAY SCH MED,DEPT PHYSIOL & PHARMACOL,MED CTR BLVD,WINSTON SALEM,NC 27157, USA.
OI sonntag, William/0000-0003-1850-2407
FU NIA NIH HHS [AG 07752] Funding Source: Medline
CR BIDLINGMEYER BA, 1984, J CHROMATOGR, V336, P93, DOI 10.1016/S0378-4347(00)85133-6
   BIRCHENALLSPARKS MC, 1985, J NUTR, V115, P944, DOI 10.1093/jn/115.7.944
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   BREESE CR, 1991, J GERONTOL, V46, pB180, DOI 10.1093/geronj/46.5.B180
   BRONSON RT, 1991, GROWTH DEVELOP AGING, V55, P169
   BURTON K, 1956, BIOCHEM J, V62, P315, DOI 10.1042/bj0620315
   CARLSON HE, 1972, J CLIN ENDOCR METAB, V34, P1102, DOI 10.1210/jcem-34-6-1102
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   DAERCOLE AJ, 1984, P NATL ACAD SCI USA, V81, P935
   DAUGHADAY WH, 1989, ENDOCR REV, V10, P68, DOI 10.1210/edrv-10-1-68
   DCOSTA A, 1991, BRAIN RES, V567, P204, DOI 10.1016/0006-8993(91)90797-Y
   FLORINI JR, 1979, MECH AGEING DEV, V35, pB23
   FOSTER JA, 1990, J GERONTOL BIOL SCI, V45, P113
   IWASAKI K, 1988, J GERONTOL, V43, pB13, DOI 10.1093/geronj/43.1.B13
   JOHANSON AJ, 1981, JOHNS HOPKINS MED J, V149, P115
   McCAY C. M., 1943, Arch. Biochem., V2, P469
   MORGAN JI, 1989, TRENDS NEUROSCI, V12, P459, DOI 10.1016/0166-2236(89)90096-9
   MURPHY LJ, 1987, ENDOCRINOLOGY, V120, P1279, DOI 10.1210/endo-120-4-1279
   NAKAGAWA I, 1974, J NUTR, V104, P1576, DOI 10.1093/jn/104.12.1576
   NOGUCHI T, 1987, NEUROENDOCRINOLOGY, V46, P277, DOI 10.1159/000124833
   PRINZ PN, 1983, J GERONTOL, pB519
   RECHLER MM, 1985, ANNU REV PHYSIOL, V47, P425
   RICHARDSON A, 1981, HDB BIOCH AGING, P70
   RICKETTS WG, 1985, J CELL PHYSIOL, V125, P492, DOI 10.1002/jcp.1041250319
   RUDMAN D, 1990, NEW ENGL J MED, V323, P1, DOI 10.1056/NEJM199007053230101
   SALMON WD, 1957, J LAB CLIN MED, V49, P825
   SHESHADRI T, 1990, SCIENCE, V247, P205
   SONNTAG WE, 1980, ENDOCRINOLOGY, V107, P1875, DOI 10.1210/endo-107-6-1875
   SONNTAG WE, 1992, J GERONTOL, V47, pB159, DOI 10.1093/geronj/47.5.B159
   SONNTAG WE, 1988, LIFE SCI, V43, P1325, DOI 10.1016/0024-3205(88)90588-7
   TURNELL DC, 1982, CLIN CHEM, V28, P527
   ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K
   VANWYK JJ, 1974, RECENT PROG HORM RES, V259, P318
   WARD WF, 1988, J GERONTOL, V43, pB50, DOI 10.1093/geronj/43.2.B50
   WITT WM, 1989, LAB ANIM, V18, P37
   YU BP, 1982, J GERONTOL, V37, P130, DOI 10.1093/geronj/37.2.130
NR 36
TC 49
Z9 55
U1 0
U2 1
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD OCT 1
PY 1993
VL 71
IS 1-2
BP 59
EP 71
DI 10.1016/0047-6374(93)90035-P
PG 13
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Cell Biology; Geriatrics & Gerontology
GA MD032
UT WOS:A1993MD03200006
PM 7508538
DA 2024-02-19
ER

PT J
AU Dhar, D
   Antonucci, L
   Nakagawa, H
   Kim, JY
   Glitzner, E
   Caruso, S
   Shalapour, S
   Yang, L
   Valasek, MA
   Lee, S
   Minnich, K
   Seki, E
   Tuckermann, J
   Sibilia, M
   Zucman-Rossi, J
   Karin, M
AF Dhar, Debanjan
   Antonucci, Laura
   Nakagawa, Hayato
   Kim, Ju Youn
   Glitzner, Elisabeth
   Caruso, Stefano
   Shalapour, Shabnam
   Yang, Ling
   Valasek, Mark A.
   Lee, Sooyeon
   Minnich, Kerstin
   Seki, Ekihiro
   Tuckermann, Jan
   Sibilia, Maria
   Zucman-Rossi, Jessica
   Karin, Michael
TI Liver Cancer Initiation Requires p53 Inhibition by CD44-Enhanced Growth
   Factor Signaling
SO CANCER CELL
LA English
DT Article
ID NF-KAPPA-B; HEPATOCELLULAR-CARCINOMA; IN-VIVO; OXIDATIVE STRESS;
   STEM-CELLS; CD44; EXPRESSION; ACTIVATION; PATHWAY; PROGRESSION
AB How fully differentiated cells that experience carcinogenic insults become proliferative cancer progenitors that acquire multiple initiating mutations is not clear. This question is of particular relevance to hepatocellular carcinoma (HCC), which arises from differentiated hepatocytes. Here we show that one solution to this problem is provided by CD44, a hyaluronic acid receptor whose expression is rapidly induced in carcinogen-exposed hepatocytes in a STAT3-dependent manner. Once expressed, CD44 potentiates AKT activation to induce the phosphorylation and nuclear translocation of Mdm2, which terminates the p53 genomic surveillance response. This allows DNA-damaged hepatocytes to escape p53-induced death and senescence and respond to proliferative signals that promote fixation of mutations and their transmission to daughter cells that go on to become HCC progenitors.
C1 [Dhar, Debanjan; Antonucci, Laura; Nakagawa, Hayato; Kim, Ju Youn; Shalapour, Shabnam; Karin, Michael] Univ Calif San Diego, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, Sch Med, 9500 Gilman Dr, San Diego, CA 92093 USA.
   [Valasek, Mark A.; Karin, Michael] Univ Calif San Diego, Sch Med, Dept Pathol, 9500 Gilman Dr, San Diego, CA 92093 USA.
   [Yang, Ling; Seki, Ekihiro] Univ Calif San Diego, Sch Med, Dept Med, 9500 Gilman Dr, San Diego, CA 92093 USA.
   [Karin, Michael] Univ Calif San Diego, Sch Med, Moores Canc Ctr, 9500 Gilman Dr, La Jolla, CA 92093 USA.
   [Nakagawa, Hayato] Univ Tokyo, Dept Gastroenterol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.
   [Glitzner, Elisabeth; Sibilia, Maria] Med Univ Vienna, Ctr Comprehens Canc, Dept Med 1, Inst Canc Res, Borschkegasse 8a, A-1090 Vienna, Austria.
   [Caruso, Stefano; Zucman-Rossi, Jessica] Univ Paris 13, Univ Paris Diderot, Genom Fonct Tumeurs Solides,Labex Immunooncol, Inserm,UMR 1162,Univ Paris Descartes,, F-75010 Paris, France.
   [Yang, Ling] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Div Gastroenterol, Wuhan 430022, Hubei, Peoples R China.
   [Seki, Ekihiro] Cedars Sinai, Dept Med, 8700 Beverly Blvd,Davis Bldg, Los Angeles, CA 90048 USA.
   [Lee, Sooyeon; Tuckermann, Jan] Univ Ulm, Inst Comparat Mol Endocrinol CME, Helmholtzstr 8-1, D-89081 Ulm, Germany.
   [Minnich, Kerstin; Tuckermann, Jan] Fritz Lipmann Inst, Leibniz Inst Age Res, Beutenbergstr 11, D-07745 Jena, Germany.
C3 University of California System; University of California San Diego;
   University of California System; University of California San Diego;
   University of California System; University of California San Diego;
   University of California System; University of California San Diego;
   University of Tokyo; Medical University of Vienna; Institut National de
   la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite;
   Universite Paris 13; Huazhong University of Science & Technology; Cedars
   Sinai Medical Center; Ulm University; Leibniz Institut fur
   Alternsforschung - Fritz-Lipmann-Institut (FLI)
RP Karin, M (corresponding author), Univ Calif San Diego, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, Sch Med, 9500 Gilman Dr, San Diego, CA 92093 USA.; Karin, M (corresponding author), Univ Calif San Diego, Sch Med, Dept Pathol, 9500 Gilman Dr, San Diego, CA 92093 USA.; Karin, M (corresponding author), Univ Calif San Diego, Sch Med, Moores Canc Ctr, 9500 Gilman Dr, La Jolla, CA 92093 USA.
EM karinoffice@ucsd.edu
RI Nakagawa, Hayato/I-2837-2012; Yang, Ling/AAC-6469-2022; zucman-rossi,
   Jessica/B-5098-2009; Seki, Ekihiro/K-2481-2016; j,
   zucman-rossi/AAV-3594-2021; Kim, Ju Youn/GNW-6324-2022; Caruso,
   Stefano/AAA-9564-2020; LEE, SOOYEON/KAM-6204-2024
OI Nakagawa, Hayato/0000-0002-6973-5094; Yang, Ling/0000-0002-0751-5600;
   zucman-rossi, Jessica/0000-0002-5687-0334; Seki,
   Ekihiro/0000-0002-9472-6085; j, zucman-rossi/0000-0002-5687-0334;
   Caruso, Stefano/0000-0002-6319-3642; Lee, Sooyeon/0000-0001-6244-4975;
   Glitzner, Elisabeth/0000-0002-1541-4076; Sibilia,
   Maria/0000-0001-6129-5613
FU Superfund Basic Research Program [P42ES010337]; NIH [R01-CA118165]; ALF
   Liver scholar award; Young Investigator Award from CureSearch
   Foundation; CRI-Irvington; PCF Young Investigator Award; iCARE
   Fellowship; AIRC (Associazione Italiana per la ricerca sul cancro) -
   European Union; AACR-Bayer HCC post-doctoral fellowship; JSPS KAKENHI
   Grant [15K19313]; Japanese Society of Gastroenterology; Astelas
   Foundation for Research on Metabolic Disorders; National Natural Science
   Foundation of China [30500658, 81370550, 81570530]; FLI; Boehringer
   Ingelheim Stiftung; DFG [He-551]; European Research Council (ERC)
   [694883]; Austrian Science Fund special research program [SFB
   F3518-B20]; Ligue Nationale contre le Cancer (Equipe Labellisee); Labex
   OncoImmunology (investissement d'avenir); Coup d'Elan de la Fondation
   Bettencourt-Shueller; SIRIC CARPEM; Fondation Merieux; European Research
   Council (ERC) [694883] Funding Source: European Research Council (ERC);
   Grants-in-Aid for Scientific Research [15K19313] Funding Source: KAKEN
FX Research was supported by the Superfund Basic Research Program
   (P42ES010337) to M.K. and E.S., NIH (R01-CA118165) grant to M.K. D.D was
   supported by the ALF Liver scholar award and a Young Investigator Award
   from the CureSearch Foundation; S.S. by the fellowship from
   CRI-Irvington and PCF Young Investigator Award; L.A. by the iCARE
   Fellowship, AIRC (Associazione Italiana per la ricerca sul cancro)
   co-founded by the European Union; J.Y.K. by the AACR-Bayer HCC
   post-doctoral fellowship; H.N. by the JSPS KAKENHI Grant Number
   15K19313, Japanese Society of Gastroenterology, and Astelas Foundation
   for Research on Metabolic Disorders; and L.Y. by the National Natural
   Science Foundation of China (30500658, 81370550 and 81570530). S.L. and
   K.M. were supported by intramural grants from the FLI. J.T. was
   supported by the Boehringer Ingelheim Stiftung. Generation of
   Cd44-Floxed mice was supported by DFG grant He-551 to Peter Herrlich. We
   are grateful to Dr. Zhao-Qi Wang for advice in ES cell targeting and Dr.
   Milen Kirilov for providing targeting vectors and advice in the
   targeting strategy. M.S. was supported by the European Research Council
   (ERC) Advanced Grant 694883 and Austrian Science Fund special research
   program SFB F3518-B20. J.Z.R. was supported by the Ligue Nationale
   contre le Cancer (Equipe Labellisee), Labex OncoImmunology
   (investissement d'avenir), Coup d'Elan de la Fondation
   Bettencourt-Shueller, the SIRIC CARPEM, and Fondation Merieux. We thank
   Souradipta Ganguly for help with experiments.
CR Aubrey BJ, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026062
   Bergmann J, 2017, HEPATOLOGY, V65, P89, DOI 10.1002/hep.28874
   Bettermann K, 2010, CANCER CELL, V17, P481, DOI 10.1016/j.ccr.2010.03.021
   Bourguignon LYW, 2008, SEMIN CANCER BIOL, V18, P251, DOI 10.1016/j.semcancer.2008.03.007
   Brown RL, 2011, J CLIN INVEST, V121, P1064, DOI 10.1172/JCI44540
   Buckley AF, 2008, AM J CLIN PATHOL, V129, P245, DOI 10.1309/WF10QAAED3PP93BH
   Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028
   Canettieri G, 2010, NAT CELL BIOL, V12, P132, DOI 10.1038/ncb2013
   Cederbaum AI, 2012, CLIN LIVER DIS, V16, P667, DOI 10.1016/j.cld.2012.08.002
   Chakrabarti SK, 2002, J BIOL CHEM, V277, P13286, DOI 10.1074/jbc.M111857200
   Dahl JA, 2007, STEM CELLS, V25, P1037, DOI 10.1634/stemcells.2006-0430
   El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061
   Endo K, 2000, J HEPATOL, V32, P78, DOI 10.1016/S0168-8278(00)80192-0
   Fitzgerald KA, 2000, J IMMUNOL, V164, P2053, DOI 10.4049/jimmunol.164.4.2053
   FLANAGAN BF, 1989, IMMUNOLOGY, V67, P167
   Font-Burgada J, 2015, CELL, V162, P766, DOI 10.1016/j.cell.2015.07.026
   Fridman JS, 2003, ONCOGENE, V22, P9030, DOI 10.1038/sj.onc.1207116
   Fuchs BC, 2014, HEPATOLOGY, V59, P1577, DOI 10.1002/hep.26898
   Gartel AL, 2002, MOL CANCER THER, V1, P639
   Godar S, 2008, CELL, V134, P62, DOI 10.1016/j.cell.2008.06.006
   Gregorieff A, 2005, GASTROENTEROLOGY, V129, P626, DOI 10.1053/j.gastro.2005.06.007
   Halpern KB, 2017, NATURE, V542, P352, DOI 10.1038/nature21065
   He GB, 2013, CELL, V155, P384, DOI 10.1016/j.cell.2013.09.031
   He GB, 2010, CANCER CELL, V17, P286, DOI 10.1016/j.ccr.2009.12.048
   Hedvat M, 2009, CANCER CELL, V16, P487, DOI 10.1016/j.ccr.2009.10.015
   Hijmans BS, 2014, BIOCHIMIE, V96, P121, DOI 10.1016/j.biochi.2013.06.007
   Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615
   Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235
   Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101
   Inokuchi S, 2010, P NATL ACAD SCI USA, V107, P844, DOI 10.1073/pnas.0909781107
   Inokuchi-Shimizu S, 2014, J CLIN INVEST, V124, P3566, DOI 10.1172/JCI74068
   Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747
   Kang JS, 2007, CANCER RES, V67, P11141, DOI 10.1158/0008-5472.CAN-07-1369
   Kinjyo I, 2006, J EXP MED, V203, P1021, DOI 10.1084/jem.20052333
   Kopp JL, 2012, CANCER CELL, V22, P737, DOI 10.1016/j.ccr.2012.10.025
   Lanaya H, 2014, NAT CELL BIOL, V16, P972, DOI 10.1038/ncb3031
   Lane D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000893
   Lee JL, 2009, J CELL BIOL, V185, P949, DOI 10.1083/jcb.200812060
   Mas VR, 2009, MOL MED, V15, P85, DOI 10.2119/molmed.2008.00110
   Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198
   Michael D, 2002, CURR OPIN GENET DEV, V12, P53, DOI 10.1016/S0959-437X(01)00264-7
   Natarajan A, 2007, P NATL ACAD SCI USA, V104, P17081, DOI 10.1073/pnas.0704126104
   Nault JC, 2013, GASTROENTEROLOGY, V145, P176, DOI 10.1053/j.gastro.2013.03.051
   Orian-Rousseau V, 2002, GENE DEV, V16, P3074, DOI 10.1101/gad.242602
   Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052
   Pilati C, 2014, CANCER CELL, V25, P428, DOI 10.1016/j.ccr.2014.03.005
   Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004
   Protin U, 1999, J IMMUNOL, V163, P4917
   Sakurai T, 2008, CANCER CELL, V14, P156, DOI 10.1016/j.ccr.2008.06.016
   Shalapour S, 2017, NATURE, V551, P340, DOI 10.1038/nature24302
   Shi Dingding, 2012, Genes Cancer, V3, P240, DOI 10.1177/1947601912455199
   SOLTOFF SP, 1994, MOL CELL BIOL, V14, P3550, DOI 10.1128/MCB.14.6.3550
   Spencer SL, 2013, CELL, V155, P369, DOI 10.1016/j.cell.2013.08.062
   Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472
   Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864
   Vries RGJ, 2010, MOL ONCOL, V4, P373, DOI 10.1016/j.molonc.2010.05.001
   Weglarz TC, 2000, AM J PATHOL, V157, P1963, DOI 10.1016/S0002-9440(10)64835-3
   Weinberg R., 2013, The Biology of Cancer
   Wielenga VJM, 1999, AM J PATHOL, V154, P515, DOI 10.1016/S0002-9440(10)65297-2
   Wu H, 1996, GENE DEV, V10, P245, DOI 10.1101/gad.10.3.245
   Yamashita T, 2013, J CLIN INVEST, V123, P1911, DOI 10.1172/JCI66024
   Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973
   Zöller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023
NR 63
TC 131
Z9 145
U1 0
U2 29
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1535-6108
EI 1878-3686
J9 CANCER CELL
JI Cancer Cell
PD JUN 11
PY 2018
VL 33
IS 6
BP 1061
EP +
DI 10.1016/j.ccell.2018.05.003
PG 23
WC Oncology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Cell Biology
GA GJ2CB
UT WOS:000435074300010
PM 29894692
OA hybrid, Green Accepted, Green Published
DA 2024-02-19
ER

PT J
AU Podolin, DA
   Wills, BK
   Wood, IO
   Lopez, M
   Mazzeo, RS
   Roth, DA
AF Podolin, DA
   Wills, BK
   Wood, IO
   Lopez, M
   Mazzeo, RS
   Roth, DA
TI Attenuation of age-related declines in glucagon-mediated signal
   transduction in rat liver by exercise training
SO AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
LA English
DT Article
DE adenylyl cyclase; hepatic membranes; GTP-binding proteins;
   gluconeogenesis; aging; glucose homeostasis
ID BETA-ADRENERGIC RECEPTORS; ADENYLATE-CYCLASE; DOWN-REGULATION;
   LEFT-VENTRICLE; GLUCONEOGENESIS; HEPATOCYTES; MUSCLE; PROTEINS; HEART
AB This study investigated alterations in glucagon receptor-mediated signal transduction in rat livers from 7- to 25-mo-old animals and examined the effects of exercise training on ameliorating these changes. Sixty-six young (4 mo), middle-aged (12 mo), and old (22 mo) male Fischer 344 rats were divided into sedentary and trained (treadmill running) groups. Isolated hepatic membranes were combined with [I-125-Tyr(10)]monoiodoglucagon and nine concentrations of glucagon to determine maximal binding capacity (B-max) and dissociation constant (K-d). No alterations were found in B-max among groups; however, middle-aged trained animals had significantly higher glucagon affinity (lower K-d; 21.1 +/- 1.8 nM) than did their untrained counterparts (50.2 +/- 7.1 nM). Second messenger studies were performed by measuring adenylyl cyclase (AC) specific activity under basal conditions and with four pharmacological stimulations to assess changes in receptor-dependent, G protein-dependent, and AC catalyst-dependent cAMP production. Age-related declines were observed in the old animals under all five conditions. Training resulted in increased cAMP production in the old animals when AC was directly stimulated by forskolin. Stimulatory G protein (G(s)) content was reduced with age in the sedentary group; however training offset this decline. We conclude that age-related declines in glucagon signaling capacity and responsiveness may be attributed, in part, to declines in intrinsic AC activity and changes in G protein [inhibitory G protein (G(i))/G(s)] ratios. These age-related changes occur in the absence of alterations in glucagon receptor content and appear to involve both G protein- and AC-related changes. Endurance training was able to Significantly offset these declines through restoration of the G(i)/G(s) ratio and AC activity.
C1 Univ New England, Dept Physiol & Pharmacol, Biddeford, ME 04005 USA.
   Univ Colorado, Boulder, CO 80303 USA.
   Collateral Therapeut, San Diego, CA 92121 USA.
C3 University of New England - Maine; University of Colorado System;
   University of Colorado Boulder
RP Podolin, DA (corresponding author), Univ New England, Dept Physiol & Pharmacol, 11 Hills Beach Rd, Biddeford, ME 04005 USA.
CR AIZAWA T, 1994, PANCREAS, V9, P454, DOI 10.1097/00006676-199407000-00007
   BARON J, 1969, MOL PHARMACOL, V5, P10
   Bergman BC, 2000, AM J PHYSIOL-ENDOC M, V278, pE244, DOI 10.1152/ajpendo.2000.278.2.E244
   BESSEY OA, 1946, J BIOL CHEM, V164, P321
   BITENSKY MW, 1970, ENDOCRINOLOGY, V86, P154, DOI 10.1210/endo-86-1-154
   BROOKS GA, 1983, AM J PHYSIOL, V244, pE505, DOI 10.1152/ajpendo.1983.244.5.E505
   COTROZZI G, 1991, ARCH GERONTOL GERI S, V2, P203
   DAVIDSON MB, 1978, METABOLISM, V27, P1994, DOI 10.1016/S0026-0495(78)80015-8
   DAX EM, 1987, ENDOCRINOLOGY, V120, P1534, DOI 10.1210/endo-120-4-1534
   DIXON BS, 1993, AM J PHYSIOL, V265, pG686, DOI 10.1152/ajpgi.1993.265.4.G686
   DOHM GL, 1976, BIOCHEM MED METAB B, V16, P138, DOI 10.1016/0006-2944(76)90016-8
   DONOVAN CM, 1990, AM J PHYSIOL, V258, pR770, DOI 10.1152/ajpregu.1990.258.3.R770
   Drouin R, 1998, AM J PHYSIOL-ENDOC M, V274, pE23, DOI 10.1152/ajpendo.1998.274.1.E23
   DROUIN R, 2000, MED SCI SPORTS EXERC, V3, pS224
   FINK RI, 1983, J CLIN INVEST, V71, P1523, DOI 10.1172/JCI110908
   FRAEYMAN N, 1993, MECH AGEING DEV, V70, P115, DOI 10.1016/0047-6374(93)90063-W
   GALBO H, 1977, J APPL PHYSIOL, V43, P953, DOI 10.1152/jappl.1977.43.6.953
   GOLDBARG JA, 1958, CANCER, V11, P283, DOI 10.1002/1097-0142(195803/04)11:2<283::AID-CNCR2820110209>3.0.CO;2-8
   GOODMAN MN, 1983, AM J PHYSIOL, V244, pE93, DOI 10.1152/ajpendo.1983.244.1.E93
   Hall K M, 1994, NeuroRehabilitation, V4, P76, DOI 10.3233/NRE-1994-4204
   HAMMOND HK, 1993, J CLIN INVEST, V92, P2644, DOI 10.1172/JCI116880
   HORN DB, 1997, METABOLISM, V46, P1
   KERN M, 1992, AM J PHYSIOL, V263, pE362, DOI 10.1152/ajpendo.1992.263.2.E362
   KMIEC Z, 1983, EXP GERONTOL, V18, P173, DOI 10.1016/0531-5565(83)90030-X
   Lavoie C., 2000, Medicine and Science in Sports and Exercise, V32, pS224
   LIMBIRD LE, 1986, CELL SURFACE RECEPTO, P63
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MEIER SL, 1987, J CELL BIOL, V98, P39
   NEVILLE DM, 1968, BIOCHIM BIOPHYS ACTA, V154, P540, DOI 10.1016/0005-2795(68)90014-7
   ORTIZALONSO FJ, 1994, AM J PHYSIOL-ENDOC M, V267, pE497, DOI 10.1152/ajpendo.1994.267.4.E497
   Podolin DA, 1996, AM J PHYSIOL-REG I, V270, pR365, DOI 10.1152/ajpregu.1996.270.2.R365
   PODOLIN DA, 1994, AM J PHYSIOL-ENDOC M, V267, pE680, DOI 10.1152/ajpendo.1994.267.5.E680
   ROTH DA, 1995, J MOL CELL CARDIOL, V27, P2315, DOI 10.1016/S0022-2828(95)91875-2
   ROTH DA, 1993, J CLIN INVEST, V91, P939, DOI 10.1172/JCI116315
   ROTH DA, 1992, FEBS LETT, V296, P46, DOI 10.1016/0014-5793(92)80400-B
   Roth DA, 1998, J APPL PHYSIOL, V84, P177, DOI 10.1152/jappl.1998.84.1.177
   SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X
   Sastre J, 1996, HEPATOLOGY, V24, P1199, DOI 10.1002/hep.510240536
   SCHONER W, 1967, EUR J BIOCHEM, V1, P334, DOI 10.1111/j.1432-1033.1967.tb00078.x
   Srere P.A., 1969, METHOD ENZYMOL, V13, P3, DOI DOI 10.1016/0076-6879(69)13005-0
   SUMIDA KD, 1993, J APPL PHYSIOL, V74, P782, DOI 10.1152/jappl.1993.74.2.782
   TSUJIMOTO A, 1986, MECH AGEING DEV, V33, P167, DOI 10.1016/0047-6374(86)90025-4
   WINDER WW, 1981, AM J PHYSIOL, V240, pR330, DOI 10.1152/ajpregu.1981.240.5.R330
NR 43
TC 20
Z9 20
U1 0
U2 0
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0193-1849
J9 AM J PHYSIOL-ENDOC M
JI Am. J. Physiol.-Endocrinol. Metab.
PD SEP
PY 2001
VL 281
IS 3
BP E516
EP E523
DI 10.1152/ajpendo.2001.281.3.E516
PG 8
WC Endocrinology & Metabolism; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Physiology
GA 465BZ
UT WOS:000170569900013
PM 11500307
DA 2024-02-19
ER

PT J
AU Yu, YH
   Bai, FL
   Wang, WF
   Liu, YN
   Yuan, QY
   Qu, SS
   Zhang, T
   Tian, GY
   Li, SM
   Li, DS
   Ren, GP
AF Yu, Yinhang
   Bai, Fuliang
   Wang, Wenfei
   Liu, Yaonan
   Yuan, Qingyan
   Qu, Susu
   Zhang, Tong
   Tian, Guiyou
   Li, Siming
   Li, Deshan
   Ren, Guiping
TI Fibroblast growth factor 21 protects mouse brain against D-galactose
   induced aging via suppression of oxidative stress response and advanced
   glycation end products formation
SO PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
LA English
DT Article
DE FGF21; D-galactose; Aging; Oxidative stress; AGEs; Inflammation
ID RECEPTOR; MEMORY; EXPRESSION; FGF21; MICE; ACETYLCHOLINESTERASE;
   HIPPOCAMPUS; MONKEYS; MARKERS; DAMAGE
AB Fibroblast growth factor 21 (FGF21) is a hormone secreted predominantly in the liver, pancreas and adipose tissue. Recently, it has been reported that FGF21-Transgenic mice can extend their lifespan compared with wild type counterparts. Thus, we hypothesize that FGF21 may play some roles in aging of organisms. In this study h-galactose (D-gal)-induced aging mice were used to study the mechanism that FGF21 protects mice from aging. The three-month-old Kunming mice were subcutaneously injected with D-gal (180 mg.kg(-1).d(-1)) for 8 weeks and administered simultaneously with FGF21 (1, 2 or 5 mg.kg(-1).d(-1)). Our results showed that administration of FGF21 significantly improved behavioral performance of D-gal-treated mice in water maze task and step-down test, reduced brain cell damage in the hippocampus, and attenuated the D-gal-induced production of MDA, ROS and advanced glycation end products (AGEs). At the same time, FGF21 also markedly renewed the activities of superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx) and total anti-oxidation capability (T-AOC), and decreased the enhanced total cholinesterase (TChE) activity in the brain of D-gal-treated mice. The expression of aldose reductase (AR), sorbitol dehydrogenase (SDH) and member-anchored receptor for AGEs (RAGE) declined significantly after FGF21 treatment. Furthermore, FGF21 suppressed inflamm-aging by inhibiting I kappa B alpha degradation and NF-kappa B p65 nuclear translocation. The expression levels of pro-inflammatory cytokines, such as TNF-alpha and IL-6, decreased significantly. In conclusion, these results suggest that FGF21 protects the aging mice brain from D-gal-induced injury by attenuating oxidative stress damage and decreasing AGE formation. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Yu, Yinhang; Bai, Fuliang; Wang, Wenfei; Liu, Yaonan; Yuan, Qingyan; Zhang, Tong; Tian, Guiyou; Li, Siming; Li, Deshan; Ren, Guiping] Northeast Agr Univ, Life Sci Coll, Biopharmaceut Lab, Harbin 150030, Peoples R China.
   [Wang, Wenfei; Li, Deshan; Ren, Guiping] Key Lab Agr Biol Funct Gene, Harbin 150030, Peoples R China.
   [Li, Siming] Harbin Univ Commerce, Harbin 150028, Peoples R China.
   [Qu, Susu] Chinese Acad Sci, Inst Psychol, Beijing 100101, Peoples R China.
C3 Northeast Agricultural University - China; Harbin University of
   Commerce; Chinese Academy of Sciences; Institute of Psychology, CAS
RP Li, DS (corresponding author), Northeast Agr Univ, Coll Life Sci, Biopharmaceut Teaching & Res Sect, 59 Mucai St,Box 180, Harbin 150030, Peoples R China.
EM deshanli@163.com; renguiping@126.com
RI Wang, Wenfei/N-5594-2019
OI Wang, Wenfei/0000-0003-3360-8082; Bai, Fuliang/0000-0002-8773-6779;
   Tian, Guiyou/0000-0003-4478-4399
FU Development and Reform Commission of Heilongjiang Province [[2011]1570];
   Department of Education Science and Technology Research Projects of
   Heilongjiang Province [12521Z004]; Department of Education,
   Pre-University Technology Industrialization Projects Fostering
   Development of Heilongjiang Province [1252CGZH29]; Municipal Science and
   Technology Bureau of Technological Innovation Research Special Funds of
   Harbin [2012RFXXS034]
FX This work was supported by a major pre-project of the Development and
   Reform Commission of Heilongjiang Province (No. [2011]1570), Department
   of Education Science and Technology Research Projects of Heilongjiang
   Province (No. 12521Z004), Department of Education, Pre-University
   Technology Industrialization Projects Fostering Development of
   Heilongjiang Province (No. 1252CGZH29) and Municipal Science and
   Technology Bureau of Technological Innovation Research Special Funds of
   Harbin (No. 2012RFXXS034).
CR Assady M, 2011, IRAN J PARASITOL, V6, P17
   Bierhaus A, 2005, J MOL MED, V83, P876, DOI 10.1007/s00109-005-0688-7
   Bookout AL, 2013, NAT MED, V19, P1147, DOI 10.1038/nm.3249
   Candela P, 2010, J ALZHEIMERS DIS, V22, P849, DOI 10.3233/JAD-2010-100462
   Cong WT, 2013, CAN J PHYSIOL PHARM, V91, P973, DOI 10.1139/cjpp-2012-0441
   Cui X, 2006, J NEUROSCI RES, V83, P1584, DOI 10.1002/jnr.20845
   Dammann P, 2012, J GERONTOL A-BIOL, V67, P573, DOI 10.1093/gerona/glr208
   De la Fuente M, 2009, CURR PHARM DESIGN, V15, P3003, DOI 10.2174/138161209789058110
   Feingold KR, 2012, ENDOCRINOLOGY, V153, P2689, DOI 10.1210/en.2011-1496
   GEINISMAN Y, 1995, PROG NEUROBIOL, V45, P223, DOI 10.1016/0301-0082(94)00047-L
   Glynn D, 2003, HUM MOL GENET, V12, P2431, DOI 10.1093/hmg/ddg249
   Halliwell B, 2007, BIOCHEM SOC T, V35, P1147, DOI 10.1042/BST0351147
   Helenius M, 1996, BIOCHEM J, V318, P603, DOI 10.1042/bj3180603
   Ho SC, 2003, BIOGERONTOLOGY, V4, P15, DOI 10.1023/A:1022417102206
   Hsuchou H, 2007, PEPTIDES, V28, P2382, DOI 10.1016/j.peptides.2007.10.007
   Kawakami K, 1999, TOHOKU J EXP MED, V187, P157, DOI 10.1620/tjem.187.157
   Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606
   Kharitonenkov A, 2007, ENDOCRINOLOGY, V148, P774, DOI 10.1210/en.2006-1168
   Lee A T, 1989, Prog Clin Biol Res, V304, P291
   Lee MS, 2012, METABOLISM, V61, P1142, DOI 10.1016/j.metabol.2012.01.012
   Li K, 2009, EUR J ENDOCRINOL, V161, P391, DOI 10.1530/EJE-09-0335
   Liu YY, 2013, NEUROCHEM INT, V62, P603, DOI 10.1016/j.neuint.2012.12.010
   Liu YL, 2012, TOXICOL APPL PHARM, V264, P212, DOI 10.1016/j.taap.2012.08.003
   Lu J, 2006, BEHAV BRAIN RES, V171, P251, DOI 10.1016/j.bbr.2006.03.043
   Lu J, 2007, BIOCHEM PHARMACOL, V74, P1078, DOI 10.1016/j.bcp.2007.07.007
   Lu J, 2010, NEUROBIOL LEARN MEM, V93, P157, DOI 10.1016/j.nlm.2009.09.006
   Mallidis C, 2007, HUM REPROD, V22, P2169, DOI 10.1093/humrep/dem156
   Mao Z, 2007, MOLECULES, V12, P1455, DOI 10.3390/12071455
   Masoro EJ, 2005, MECH AGEING DEV, V126, P913, DOI 10.1016/j.mad.2005.03.012
   Moser PC, 2002, J PHARMACOL EXP THER, V302, P731, DOI 10.1124/jpet.102.034249
   Mukherjee TK, 2005, BBA-MOL CELL RES, V1744, P213, DOI 10.1016/j.bbamcr.2005.03.007
   PAGLIA DE, 1967, J LAB CLIN MED, V70, P158
   Pazdro R, 2012, EXP DIABETES RES, DOI 10.1155/2012/137607
   Prickaerts J, 2005, PSYCHOPHARMACOLOGY, V177, P381, DOI 10.1007/s00213-004-1967-7
   Rolewska P, 2013, EXP GERONTOL, V48, P29, DOI 10.1016/j.exger.2012.04.012
   Ruan QW, 2013, MECH AGEING DEV, V134, P89, DOI 10.1016/j.mad.2012.12.005
   Rydén M, 2009, CELL MOL LIFE SCI, V66, P2067, DOI 10.1007/s00018-009-0003-9
   Shan Q, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/564737
   SILMAN I, 1987, EUR J BIOCHEM, V170, P11, DOI 10.1111/j.1432-1033.1987.tb13662.x
   Song X, 1999, MECH AGEING DEV, V108, P239, DOI 10.1016/S0047-6374(99)00022-6
   SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195
   Srikanth V, 2011, NEUROBIOL AGING, V32, P763, DOI 10.1016/j.neurobiolaging.2009.04.016
   Tan BK, 2011, DIABETES, V60, P2758, DOI 10.2337/db11-0672
   Tian Y, 2011, FOOD CHEM TOXICOL, V49, P1728, DOI 10.1016/j.fct.2011.04.018
   Tsai SJ, 2012, FOOD CHEM TOXICOL, V50, P3198, DOI 10.1016/j.fct.2012.05.056
   Vander Jagt David L., 2008, Drug Metabolism and Drug Interactions, V23, P93
   Wang QO, 2011, PHARMACOL BIOCHEM BE, V98, P140, DOI 10.1016/j.pbb.2010.12.006
   Wente W, 2006, DIABETES, V55, P2470, DOI 10.2337/db05-1435
   Wu CH, 2009, MOL NUTR FOOD RES, V53, P984, DOI 10.1002/mnfr.200800495
   Wu DM, 2008, NEUROBIOL LEARN MEM, V90, P19, DOI 10.1016/j.nlm.2008.01.010
   Zhang Chun, 2004, Chinese Medical Sciences Journal, V19, P180
   Zhang Q, 2005, NEUROL RES, V27, P552, DOI 10.1179/016164105X25126
   Zhang QB, 2003, PHARMACOL RES, V48, P151, DOI 10.1016/S1043-6618(03)00103-8
   Zhang Y, 2012, ELIFE, V1, DOI 10.7554/eLife.00065
NR 54
TC 85
Z9 95
U1 0
U2 54
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0091-3057
EI 1873-5177
J9 PHARMACOL BIOCHEM BE
JI Pharmacol. Biochem. Behav.
PD JUN
PY 2015
VL 133
BP 122
EP 131
DI 10.1016/j.pbb.2015.03.020
PG 10
WC Behavioral Sciences; Neurosciences; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Behavioral Sciences; Neurosciences & Neurology; Pharmacology & Pharmacy
GA CK0GF
UT WOS:000355883000015
PM 25871519
DA 2024-02-19
ER

PT J
AU Bingül, I
   Yilmaz, Z
   Aydin, AF
   Çoban, J
   Dogru-Abbasoglu, S
   Uysal, M
AF Binguel, Ilknur
   Yilmaz, Zulbiye
   Aydin, A. Fatih
   Coban, Jale
   Dogru-Abbasoglu, Semra
   Uysal, Mujdat
TI Antiglycation and anti-oxidant efficiency of carnosine in the plasma and
   liver of aged rats
SO GERIATRICS & GERONTOLOGY INTERNATIONAL
LA English
DT Article
DE advanced glycation end-products; aged rats; carnosine; liver; oxidative
   stress
ID GLYCATION END-PRODUCTS; OXIDATIVE STRESS; PROTEINS; TISSUES; DAMAGE;
   ACCUMULATION; BRAIN; HEART; ASSAY; SERUM
AB AimIncreases in oxidative stress and advanced glycation end-products (AGE) formation play an important role in the pathogenesis of aging. Carnosine (CAR; -alanyl-L-histidine) has anti-oxidant and antiglycating properties. We investigated the effect of CAR supplementation on AGE levels, and protein and lipid oxidation products in the serum and liver tissue in aged rats.
   MethodsYoung (3months-of-age) and aged (20months-of-age) rats were injected with CAR (250mg/kg/daily; i.p.; 5days per week) for 2months. At the end of this period, AGE, protein carbonyl, advanced oxidized protein products, and malondialdehyde levels were determined in the serum and liver tissue. Furthermore, reactive oxygen species formation and ferric reducing anti-oxidant power values were measured.
   ResultsAGE, malondialdehyde, protein carbonyl and advanced oxidized protein products levels, and reactive oxygen species formation were higher in the serum and liver tissue of aged rats compared with young rats. CAR treatment was observed to significantly decrease AGE, malondialdehyde, protein carbonyl and advanced oxidized protein products levels, and reactive oxygen species formation in the serum and liver of aged rats.
   ConclusionsThese results clearly show that CAR might be useful for decreasing glycoxidant stress in aged rats. Geriatr Gerontol Int 2017; 17: 2610-2614.
C1 [Binguel, Ilknur; Yilmaz, Zulbiye; Aydin, A. Fatih; Dogru-Abbasoglu, Semra; Uysal, Mujdat] Istanbul Univ, Istanbul Fac Med, Dept Biochem, TR-34093 Istanbul, Turkey.
   [Coban, Jale] Yeditepe Univ, Dept Biochem, Fac Med, Istanbul, Turkey.
C3 Istanbul University; Yeditepe University
RP Dogru-Abbasoglu, S (corresponding author), Istanbul Univ, Istanbul Fac Med, Dept Biochem, TR-34093 Istanbul, Turkey.
EM sdabbasoglu@yahoo.com
RI Aydın, Abdurrahman Fatih/AAD-9170-2020; Abbasoglu, Semra/AAD-9014-2020;
   Bingul, Ilknur/AAD-9926-2020
OI Abbasoglu, Semra/0000-0003-3467-9763; Demirturk,
   Zulbiye/0000-0002-3107-4278
FU Istanbul University [48787]
FX This study was supported by the Istanbul University Scientific Research
   Projects (project no: 48787).
CR Aydin AF, 2010, BIOGERONTOLOGY, V11, P103, DOI 10.1007/s10522-009-9232-4
   Aydin AF, 2010, PHARMACOL REP, V62, P733
   Baye E, 2016, AMINO ACIDS, V48, P1131, DOI 10.1007/s00726-016-2208-1
   Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292
   Boldyrev AA, 2013, PHYSIOL REV, V93, P1803, DOI 10.1152/physrev.00039.2012
   Buege J A, 1978, Methods Enzymol, V52, P302
   Capeillère-Blandin C, 2004, BBA-MOL BASIS DIS, V1689, P91, DOI 10.1016/j.bbadis.2004.02.008
   Çoban J, 2014, GERIATR GERONTOL INT, V14, P996, DOI 10.1111/ggi.12192
   Colzani M, 2015, FOOD NUTR COMPON FOC, V8, P139
   De la Maza MP, 2012, J DIABETES MELLITUS, V2, P19357
   Garg G, 2017, REJUV RES, V20, P16, DOI 10.1089/rej.2016.1826
   Gu Q, 2014, EUR J PHARMACOL, V741, P186, DOI 10.1016/j.ejphar.2014.08.017
   Guo Y, 2009, J GERONTOL A-BIOL, V64, P629, DOI 10.1093/gerona/glp023
   Hamelin M, 2003, ARCH BIOCHEM BIOPHYS, V411, P215, DOI 10.1016/S0003-9861(02)00735-X
   Hanasand M, 2012, CLIN CHIM ACTA, V413, P901, DOI 10.1016/j.cca.2012.01.038
   Harman D, 2001, ANN NY ACAD SCI, V928, P1, DOI 10.1111/j.1749-6632.2001.tb05631.x
   Hipkiss AR, 2009, ADV FOOD NUTR RES, V57, P87, DOI 10.1016/S1043-4526(09)57003-9
   Hsieh HM, 2009, FOOD CHEM TOXICOL, V47, P625, DOI 10.1016/j.fct.2008.12.026
   Munch G, 1997, EUR J CLIN CHEM CLIN, V35, P669
   Mutlu-Türkoglu Ü, 2003, CLIN BIOCHEM, V36, P397, DOI 10.1016/S0009-9120(03)00035-3
   Nowotny K, 2014, EXP GERONTOL, V59, P3, DOI 10.1016/j.exger.2014.10.001
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   REZNICK AZ, 1994, METHOD ENZYMOL, V233, P357
   Sakul A, 2013, EXP GERONTOL, V48, P476, DOI 10.1016/j.exger.2013.02.028
   Simm A, 2015, EXP GERONTOL, V68, P71, DOI 10.1016/j.exger.2014.12.013
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   Uribarri J, 2007, J GERONTOL A-BIOL, V62, P427, DOI 10.1093/gerona/62.4.427
   Uysal M, 2015, FOOD NUTR COMPON FOC, V8, P510
   Vlassara H, 2009, J CLIN ENDOCR METAB, V94, P4483, DOI 10.1210/jc.2009-0089
   Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0
NR 30
TC 13
Z9 13
U1 3
U2 16
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1444-1586
EI 1447-0594
J9 GERIATR GERONTOL INT
JI Geriatr. Gerontol. Int.
PD DEC
PY 2017
VL 17
IS 12
BP 2610
EP 2614
DI 10.1111/ggi.13126
PG 5
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA FQ4SF
UT WOS:000418347300045
PM 28776910
DA 2024-02-19
ER

PT J
AU Tillou, X
   Chiche, L
   Guleryuz, K
   Hervé, S
   Bensadoun, H
   Doerfler, A
AF Tillou, Xavier
   Chiche, Laurence
   Guleryuz, Kerem
   Herve, Sophie
   Bensadoun, Henri
   Doerfler, Arnaud
TI Prostate carcinoma in liver transplant recipients: Think about it!
SO UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
LA English
DT Article
DE Prostate; Cancer; Liver transplantation; Cancer screening
AB Objectives: To analyze retrospectively our series of prostate cancer (PC) in liver transplant recipients (LTRs) given an increase in frequency in an aging recipient population when no studies were reported in literature.
   Methods: We conducted a retrospective analysis of LTRs in a single institution. After liver transplantation, all patients were followed up in our institution with an annual digital rectal examination by a urologist and prostate-specific antigen measurement after the age of 50 years.
   Results: Between 1995 and 2013, among 361 male LTRs, 12 (3.3%) had PC. The mean age at diagnosis was 62.8 years, and the time lapse between liver transplantation and diagnosis was 55.7 months. The median initial prostate-specific antigen level was 7.4 ng/ml. In total, 9 patients underwent radical prostatectomy. Histological findings showed 5 pT2 and 4 pT3 cancers. A patient showed invasion in the lymph nodes and was treated with hormonotherapy. Another patient had a biochemical recurrence at 10 months and underwent salvage radiotherapy. After 32.9 months of follow-up, no other patients showed any recurrence. Moreover, 1 patient was treated by radiohormonotherapy for high-risk PC with no recurrence at 65 months, and 1 patient was treated with high-intensity focal ultrasound. There was 1 patient with metastatic disease who received hormonotherapy and died 5 months after diagnosis.
   Conclusion: Our incidence of intermediate-and high-risk PCs in LTRs was slightly higher than in the general population. In the absence of any recommendations, individual screening should be proposed to LTRs. The treatment of choice remains surgery or radiotherapy to ensure a good carcinologic control. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Tillou, Xavier; Guleryuz, Kerem; Doerfler, Arnaud] CHU Caen, Urol & Transplantat Dept, Caen, France.
   [Chiche, Laurence] CHU Bordeaux, Surg & Liver Transplantat Dept, Bordeaux, France.
   [Herve, Sophie] CHU Caen, Gastroenterol & Liver Dis Dept, Caen, France.
   [Bensadoun, Henri] CHU Bordeaux, Urol Dept, Bordeaux, France.
C3 CHU de Caen NORMANDIE; Universite de Caen Normandie; Universite de
   Bordeaux; CHU Bordeaux; Universite de Caen Normandie; CHU de Caen
   NORMANDIE; CHU Bordeaux; Universite de Bordeaux
RP Tillou, X (corresponding author), CHU Caen, Urol & Transplantat Dept, Caen, France.
EM xavtillou@hotmail.com
RI Tillou, Xavier/V-1999-2019; Doerfler, Arnaud/AAD-4240-2019
OI Tillou, Xavier/0000-0002-8575-4156; CHICHE, LAURENCE/0000-0001-9081-4750
CR Agha AH, 1996, J UROLOGY, V155, P1332, DOI 10.1016/S0022-5347(01)66259-1
   [Anonymous], J UROL
   Bayne Aaron, 2005, Urology, V65, P175, DOI 10.1016/j.urology.2004.08.008
   Branco F, 2011, TRANSPL P, V43, P137, DOI 10.1016/j.transproceed.2010.12.039
   Breyer BN, 2009, J UROLOGY, V181, P2018, DOI 10.1016/j.juro.2009.01.021
   Chak E, 2010, LIVER INT, V30, P1247, DOI 10.1111/j.1478-3231.2010.02303.x
   Chandok N, 2012, LIVER TRANSPLANT, V18, P1277, DOI 10.1002/lt.23531
   Engels EA, 2011, JAMA-J AM MED ASSOC, V306, P1891, DOI 10.1001/jama.2011.1592
   Finkenstedt A, 2009, AM J TRANSPLANT, V9, P2355, DOI 10.1111/j.1600-6143.2009.02766.x
   Hall EC, 2013, CANCER-AM CANCER SOC, V119, P2300, DOI 10.1002/cncr.28043
   Herrero JI, 2005, LIVER TRANSPLANT, V11, P89, DOI 10.1002/lt.20319
   Herrero JI, 2009, LIVER TRANSPLANT, V15, pS90, DOI 10.1002/lt.21898
   Jain A, 2009, TRANSPLANTATION, V88, P706, DOI 10.1097/TP.0b013e3181b3918e
   Kleinclauss F, 2008, NEPHROL DIAL TRANSPL, V23, P2374, DOI 10.1093/ndt/gfn008
   Medina EM, 2009, TRANSPL P, V41, P2447, DOI 10.1016/j.transproceed.2009.06.153
   Mottet N, 2011, EUR UROL, V59, P572, DOI 10.1016/j.eururo.2011.01.025
   Palmerola R, 2012, CAN J UROL, V19, P6542
   Reiter WJ, 2005, UROL INT, V74, P95, DOI 10.1159/000082718
   Sampaio MS, 2012, TRANSPLANTATION, V94, P990, DOI 10.1097/TP.0b013e318270bc7b
   Vallin M, 2011, CLIN TRANSPLANT, V25, P660, DOI 10.1111/j.1399-0012.2010.01370.x
   Vicentini FC, 2009, UROLOGY, V73, P1032, DOI 10.1016/j.urology.2009.01.015
   Yao FY, 2006, CLIN TRANSPLANT, V20, P617, DOI 10.1111/j.1399-0012.2006.00527.x
NR 22
TC 6
Z9 6
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1078-1439
EI 1873-2496
J9 UROL ONCOL-SEMIN ORI
JI Urol. Oncol.-Semin. Orig. Investig.
PD JUN
PY 2015
VL 33
IS 6
AR 265.e9
DI 10.1016/j.urolonc.2015.02.014
PG 5
WC Oncology; Urology & Nephrology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Urology & Nephrology
GA V59BW
UT WOS:000210739500002
PM 25817389
DA 2024-02-19
ER

PT J
AU Kim, JH
   Han, JW
   Choi, YJ
   Rha, MS
   Koh, JY
   Kim, KH
   Kim, CG
   Lee, YJ
   Kim, AR
   Park, J
   Kim, HK
   Min, BS
   Il Seo, S
   Kang, M
   Park, HJ
   Han, DH
   Kim, SI
   Kim, MS
   Lee, JG
   Lee, DH
   Kim, W
   Park, JY
   Park, SH
   Joo, DJ
   Shin, EC
AF Kim, Jong Hoon
   Han, Ji Won
   Choi, Young Joon
   Rha, Min-Seok
   Koh, June Young
   Kim, Kyung Hwan
   Kim, Chang Gon
   Lee, Yong Joon
   Kim, A. Reum
   Park, Junsik
   Kim, Hong Kwan
   Min, Byung Soh
   Il Seo, Seong
   Kang, Minyong
   Park, Hye Jung
   Han, Dai Hoon
   Kim, Soon Il
   Kim, Myoung Soo
   Lee, Jae Geun
   Lee, Dong Hyeon
   Kim, Won
   Park, Jun Yong
   Park, Su-Hyung
   Joo, Dong Jin
   Shin, Eui-Cheol
TI Functions of human liver
   CD69<SUP>+</SUP>CD103<SUP>-</SUP>CD8<SUP>+</SUP> T cells depend on
   HIF-2α activity in healthy and pathologic livers
SO JOURNAL OF HEPATOLOGY
LA English
DT Article
DE Human liver; CD69(+)CD103(-)CD8(+) T cells; Terminal differentiation;
   Tissue residency; HIF-2 alpha
ID METABOLISM; SENESCENCE; EPITHELIUM; RESPONSES; PATHWAY; TRIGGER; INNATE
AB Background & Aims: Human liver CD69(+)CD8(+) T cells are similar to 95% CD103(-) and similar to 5% CD103(+). Although CD69(+)CD103(+)CD8(+) T cells show tissue residency and robustly respond to antigens, CD69(+)CD103(-)CD8(+) T cells are not yet well understood.
   Methods: Liver perfusate and paired peripheral blood were collected from healthy living donors and recipients with cirrhosis during liver transplantation. Liver tissues were obtained from patients with acute hepatitis A. Phenotypic and functional analyses were performed by flow cytometry. Gene expression profiles were determined by microarray and quantitative reverse transcription PCR. PT-2385 was used to inhibit hypoxia-inducible factor (HIF)-2 alpha.
   Results: Human liver CD69(+)CD103(-)CD8(+) T cells exhibited HIF-2 alpha upregulation with a phenotype of tissue residency and terminal differentiation. CD103(-) cells comprised non-hepatotropic virus-specific T cells as well as hepatotropic virus-specific T cells, but CD103(+) cells exhibited only hepatotropic virus specificity. Although CD103(-) cells were weaker effectors on a per cell basis than CD103(+) cells, following T cell receptor or interleukin-15 stimulation, they remained the major CD69(+)CD8(+) effector population in the liver, surviving with less cell death. An HIF-2 alpha inhibitor suppressed the effector functions and survival of CD69(+)CD103(-)CD8(+) T cells. In addition, HIF-2a alpha expression in liver CD69(+)CD103(-)CD8(+) T cells was significantly increased in patients with acute hepatitis A or cirrhosis.
   Conclusions: Liver CD69(+)CD103(-)CD8(+) T cells are tissue resident and terminally differentiated, and their effector functions depend on HIF-2 alpha. Furthermore, activation of liver CD69(+)CD103(-)CD8(+) T cells with HIF-2 alpha upregulation is observed during liver pathology.
   Lay summary: The immunologic characteristics and the role of CD69(+)CD103(-)CD8(+) T cells, which are a major population of human liver CD8(+) T cells, remain unknown. Our study shows that these T cells have a terminally differentiated tissue-resident phenotype, and their effector functions depend on a transcription factor, HIF-2 alpha. Furthermore, these T cells were activated and expressed higher levels of HIF-2 alpha in liver pathologies, suggesting that they play an important role in immune responses in liver tissues and the pathogenesis of human liver disease. (C) 2020 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
C1 [Kim, Jong Hoon; Han, Ji Won; Choi, Young Joon; Rha, Min-Seok; Koh, June Young; Kim, Kyung Hwan; Kim, Chang Gon; Lee, Yong Joon; Kim, A. Reum; Park, Junsik; Park, Su-Hyung; Shin, Eui-Cheol] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Daejeon 34141, South Korea.
   [Kim, Jong Hoon] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Dermatol,Cutaneous Biol Res Inst, Seoul 06273, South Korea.
   [Kim, Hong Kwan] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Thorac & Cardiovasc Surg, Seoul 06351, South Korea.
   [Min, Byung Soh; Han, Dai Hoon; Kim, Soon Il; Kim, Myoung Soo; Lee, Jae Geun; Joo, Dong Jin] Yonsei Univ, Coll Med, Dept Surg, 50-1 Yonsei Ro, Seoul 03722, South Korea.
   [Il Seo, Seong; Kang, Minyong] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Urol, Seoul 06351, South Korea.
   [Kang, Minyong] Sungkyunkwan Univ, SAIHST, Dept Hlth Sci & Technol, Seoul 06351, South Korea.
   [Park, Hye Jung; Park, Jun Yong] Yonsei Univ, Coll Med, Dept Internal Med, Seoul 03722, South Korea.
   [Lee, Dong Hyeon; Kim, Won] Seoul Natl Univ, Boramae Med Ctr, Seoul Metropolitan Govt, Dept Internal Med, Seoul 07061, South Korea.
C3 Korea Advanced Institute of Science & Technology (KAIST); Yonsei
   University; Yonsei University Health System; Sungkyunkwan University
   (SKKU); Samsung Medical Center; Yonsei University; Yonsei University
   Health System; Sungkyunkwan University (SKKU); Samsung Medical Center;
   Sungkyunkwan University (SKKU); Yonsei University; Yonsei University
   Health System; Seoul National University (SNU); Seoul National
   University Hospital
RP Joo, DJ (corresponding author), Yonsei Univ, Coll Med, Dept Surg, 50-1 Yonsei Ro, Seoul 03722, South Korea.; Shin, EC (corresponding author), Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Lab Immunol & Infect Dis, 291 Daehak Ro, Daejeon 34141, South Korea.; Park, SH (corresponding author), Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Lab Translat Immunol & Vaccinol, 291 Daehak Ro, Daejeon 34141, South Korea.
EM park3@kaist.ac.kr; djjoo@yuhs.ac; ecshin@kaist.ac.kr
RI 서, 성일/HPD-3967-2023; Kim, Sun/GSN-4867-2022; Kim, Won/H-6940-2019; Kim,
   Hong Kwan/AAR-4892-2020; Park, Su-Hyung/N-3514-2014; Kim, Chang
   Gon/IAP-6721-2023; Park, Jun/HPH-3570-2023; Han, Dai Hoon/AAS-3726-2021;
   Lee, Jaewon/IQR-8432-2023
OI Kim, Won/0000-0002-2926-1007; Kim, Hong Kwan/0000-0002-7815-3336; Park,
   Su-Hyung/0000-0001-6363-7736; Kim, Jong Hoon/0000-0002-3385-8180; Joo,
   Dong Jin/0000-0001-8405-1531; Kim, Myoung Soo/0000-0002-8975-8381; Han,
   Dai Hoon/0000-0003-2787-7876; Park, Hye Jung/0000-0002-1862-1003; Rha,
   Min-Seok/0000-0003-1426-7534; Park, Jun Yong/0000-0001-6324-2224; Lee,
   Jae Geun/0000-0002-6722-0257; Kim, Soon/0000-0002-0783-7538
FU Samsung Science and Technology Foundation [SSTF-BA1402-51]
FX This work was supported by Samsung Science and Technology Foundation
   under Project Number SSTF-BA1402-51.
CR Akbar AN, 2016, TRENDS IMMUNOL, V37, P866, DOI 10.1016/j.it.2016.09.002
   Akbar AN, 2011, NAT REV IMMUNOL, V11, P289, DOI 10.1038/nri2959
   Ariotti S, 2014, SCIENCE, V346, P101, DOI 10.1126/science.1254803
   Casey KA, 2012, J IMMUNOL, V188, P4866, DOI 10.4049/jimmunol.1200402
   CERFBENSUSSAN N, 1987, EUR J IMMUNOL, V17, P1279, DOI 10.1002/eji.1830170910
   Chen WF, 2016, NATURE, V539, P112, DOI 10.1038/nature19796
   Courtney KD, 2018, J CLIN ONCOL, V36, P867, DOI 10.1200/JCO.2017.74.2627
   Crispe IN, 2014, HEPATOLOGY, V60, P2109, DOI 10.1002/hep.27254
   Doedens AL, 2013, NAT IMMUNOL, V14, P1173, DOI 10.1038/ni.2714
   El-Asady R, 2005, J EXP MED, V201, P1647, DOI 10.1084/jem.20041044
   Fernandez-Ruiz D, 2016, IMMUNITY, V45, P889, DOI 10.1016/j.immuni.2016.08.011
   Finlay DK, 2012, J EXP MED, V209, P2441, DOI 10.1084/jem.20112607
   Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010
   Guidotti LG, 2015, CELL, V161, P486, DOI 10.1016/j.cell.2015.03.005
   Hardenberg JHB, 2018, J INVEST DERMATOL, V138, P23, DOI 10.1016/j.jid.2017.05.026
   Hombrink P, 2016, NAT IMMUNOL, V17, P1467, DOI 10.1038/ni.3589
   Jaensson E, 2008, J EXP MED, V205, P2139, DOI 10.1084/jem.20080414
   Jenne CN, 2013, NAT IMMUNOL, V14, P996, DOI 10.1038/ni.2691
   Jung MK, 2017, IMMUNE NETW, V17, P276, DOI 10.4110/in.2017.17.5.276
   Kim J, 2018, IMMUNITY, V48, P161, DOI 10.1016/j.immuni.2017.11.025
   Kumar BV, 2017, CELL REP, V20, P2921, DOI 10.1016/j.celrep.2017.08.078
   Mackay LK, 2017, TRENDS IMMUNOL, V38, P94, DOI 10.1016/j.it.2016.11.004
   Mackay LK, 2016, SCIENCE, V352, P459, DOI 10.1126/science.aad2035
   Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744
   Man K, 2015, NAT REV IMMUNOL, V15, P574, DOI 10.1038/nri3874
   Mueller SN, 2016, NAT REV IMMUNOL, V16, P79, DOI 10.1038/nri.2015.3
   Nakagawa H, 2014, P NATL ACAD SCI USA, V111, P1090, DOI 10.1073/pnas.1322731111
   Nakamura H, 2005, J IMMUNOL, V174, P7592, DOI 10.4049/jimmunol.174.12.7592
   Palazon A, 2014, IMMUNITY, V41, P518, DOI 10.1016/j.immuni.2014.09.008
   Pallett LJ, 2017, J EXP MED, V214, P1567, DOI 10.1084/jem.20162115
   Racanelli V, 2006, HEPATOLOGY, V43, pS54, DOI 10.1002/hep.21060
   Rouault-Pierre K, 2013, CELL STEM CELL, V13, P549, DOI 10.1016/j.stem.2013.08.011
   Sanmugalingam D, 2000, J LEUKOCYTE BIOL, V68, P38
   Schenkel JM, 2014, IMMUNITY, V41, P886, DOI 10.1016/j.immuni.2014.12.007
   Schenkel JM, 2014, SCIENCE, V346, P98, DOI 10.1126/science.1254536
   Shin EC, 2016, NAT REV IMMUNOL, V16, P509, DOI 10.1038/nri.2016.69
   Skon CN, 2013, NAT IMMUNOL, V14, P1285, DOI 10.1038/ni.2745
   Stelma F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06352-3
   Tang XZ, 2013, J IMMUNOL, V190, P3142, DOI 10.4049/jimmunol.1203218
   Wakim LM, 2010, P NATL ACAD SCI USA, V107, P17872, DOI 10.1073/pnas.1010201107
NR 40
TC 37
Z9 38
U1 1
U2 8
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0168-8278
EI 1600-0641
J9 J HEPATOL
JI J. Hepatol.
PD JUN
PY 2020
VL 72
IS 6
BP 1170
EP 1181
DI 10.1016/j.jhep.2020.01.010
PG 12
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA LT9FZ
UT WOS:000537372900020
PM 31987989
DA 2024-02-19
ER

PT J
AU Ishchenko, A
   Sinitsyna, O
   Krysanova, Z
   Vasyunina, E
   Saparbaev, M
   Sidorkina, O
   Nevinsky, G
AF Ishchenko, Alexander
   Sinitsyna, Olga
   Krysanova, Zhanna
   Vasyunina, Elena
   Saparbaev, Murat
   Sidorkina, Olga
   Nevinsky, Georgy
TI Age-dependent increase of 8-oxoguanine-, hypoxanthine-, and uracil- DNA
   glycosylase activities in liver extracts from OXYS rats with inherited
   overgeneration of free radicals and Wistar rats
SO MEDICAL SCIENCE MONITOR
LA English
DT Article
DE 8-oxoguanine; nuclear and mitochondrial extracts;
   8-oxoguanine-DNA-glycosylase; substrate specificity; aging in rat
AB Background: Oxygen free radicals have been hypothesized to play an important role in the process of aging.
   Material/Methods: To investigate the correlation between oxidative stress and accumulation of DNA damage we determined age-dependent levels of activities eliminating 8-oxoguanine, hypoxanthine and uracil from DNA in liver cells from OXYS rats, which are characterized by inherited overgeneration of free radicals, in comparison with those of control Wistar rats.
   Results: A pronounced difference in the specificity of mitochondrial and nuclear 8-oxoguanine DNA glycosylase/AP lyase activities were revealed in both cases. Our results suggest the induction of an 8-oxoG-, uracil- and hypoxanthine-specific repair pathway with age in both types of rats. The levels of 8-oxoguanine DNA glycosylase/AP lyase activities in nuclear extracts from both strains of rats are comparable and approximately tenfold higher than in mitochondrial extracts. On the contrary, 8-oxoguanine DNA glycosylase/AP lyase activity in OXYS mitochondrial extracts was remarkably higher than that from old Wistar rats, and a significant increase of this activity occurs earlier in OXYS than in Wistar rats.
   Conclusion: Our results are consistent with the shorter life-span of OXYS rats, and with the mitochondrial theory of aging, which postulates that the accumulation of DNA damage in mitochondrial genomes leads to mitochondrial dysfunction and accelerates the process of aging.
C1 [Nevinsky, Georgy] Novosibirsk Bioorgan Chem Inst, Lab Repair Enzymes, Novosibirsk 630090, Russia.
   [Sinitsyna, Olga; Krysanova, Zhanna; Vasyunina, Elena] Russian Acad Sci, Inst Cytol & Genet, Novosibirsk 630090, Russia.
   [Saparbaev, Murat; Sidorkina, Olga] Grp Reparat Les Radio & Chimioinduites, Paris, France.
C3 Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of
   the RAS; Russian Academy of Sciences; Institute of Cytology & Genetics
   ICG SB RAS
RP Nevinsky, G (corresponding author), Novosibirsk Bioorgan Chem Inst, Lab Repair Enzymes, 8 Lavrentieva Ave, Novosibirsk 630090, Russia.
EM nevinsky@niboch.nsc.ru
RI Saparbaev, Murat/AAC-5478-2020; Ishchenko, Alexander/D-4133-2013;
   Sinitsyna, Olga/U-3682-2019; Nevinsky, Georgy/E-6053-2012; Saparbaev,
   Murat K/N-3225-2015
OI Saparbaev, Murat/0000-0002-4630-1074; Ishchenko,
   Alexander/0000-0002-0488-8858; Saparbaev, Murat K/0000-0002-4630-1074
FU INTAS [97-1645]; Wellcome Trust (U. K.); Russian Fund of Fundamental
   Investigations [01-04-48892, 02-04-49889]; Siberian Division of the
   Russian Academy of Sciences
FX The research was made possible in part by grants from INTAS (97-1645),
   the Wellcome Trust (U. K.), the Russian Fund of Fundamental
   Investigations (01-04-48892; 02-04-49889), and the Siberian Division of
   the Russian Academy of Sciences.
CR ADELMAN R, 1988, P NATL ACAD SCI USA, V85, P2706, DOI 10.1073/pnas.85.8.2706
   Alamo MJP, 1998, NUCLEIC ACIDS RES, V26, P5199, DOI 10.1093/nar/26.22.5199
   AMES BN, 1983, SCIENCE, V221, P1256, DOI 10.1126/science.6351251
   BAILLY V, 1987, BIOCHEM J, V242, P565, DOI 10.1042/bj2420565
   BAILLY V, 1989, BIOCHEM J, V262, P581, DOI 10.1042/bj2620581
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   BHUYAN KC, 1986, LIFE SCI, V38, P1463, DOI 10.1016/0024-3205(86)90559-X
   Bjoras M, 1997, EMBO J, V16, P6314, DOI 10.1093/emboj/16.20.6314
   BODEPUDI V, 1992, CHEM RES TOXICOL, V5, P608, DOI 10.1021/tx00029a004
   BOITEUX S, 1992, BIOCHEMISTRY-US, V31, P106, DOI 10.1021/bi00116a016
   BOITEUX S, 1983, BIOCHEM BIOPH RES CO, V110, P552, DOI 10.1016/0006-291X(83)91185-3
   CATHCART R, 1984, P NATL ACAD SCI-BIOL, V81, P5633, DOI 10.1073/pnas.81.18.5633
   CHENG KC, 1992, J BIOL CHEM, V267, P166
   Croteau DL, 1997, J BIOL CHEM, V272, P27338, DOI 10.1074/jbc.272.43.27338
   CUTLER RG, 1991, AM J CLIN NUTR, V53, pS373, DOI 10.1093/ajcn/53.1.373S
   DOMENA JD, 1985, BIOCHEMISTRY-US, V24, P7320, DOI 10.1021/bi00346a045
   Fasman GD., 1975, HDB BIOCH MOL BIOL N, V1, P589
   FLOYD RA, 1986, BIOCHEM BIOPH RES CO, V137, P841, DOI 10.1016/0006-291X(86)91156-3
   FRAGA CG, 1990, P NATL ACAD SCI USA, V87, P4533, DOI 10.1073/pnas.87.12.4533
   Friedberg E.F., 1985, DNA Repair
   GRAVES RJ, 1992, J BIOL CHEM, V267, P14429
   HALLIWELL B, 1994, LANCET, V344, P721, DOI 10.1016/S0140-6736(94)92211-X
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HAYAKAWA M, 1991, BIOCHEM BIOPH RES CO, V179, P1023, DOI 10.1016/0006-291X(91)91921-X
   Hudson EK, 1998, MECH AGEING DEV, V103, P179, DOI 10.1016/S0047-6374(98)00043-8
   Ishchenko AA, 1999, J BIOMOL STRUCT DYN, V17, P301, DOI 10.1080/07391102.1999.10508363
   Ishchenko AA, 1998, MOL BIOL+, V32, P454
   Ishchenko AA, 1997, MOL BIOL+, V31, P278
   KASAI H, 1989, CANCER RES, V49, P2603
   Kim HS, 1996, MUTAT RES-DNA REPAIR, V363, P115, DOI 10.1016/0921-8777(96)00006-7
   Lee YS, 1996, MUTAT RES-DNA REPAIR, V364, P227, DOI 10.1016/S0921-8777(96)00038-9
   Lenaz G, 1998, BIOCHIM BIOPHYS ACTA, V1366, P57
   MALINS DC, 1991, CANCER RES, V51, P5430
   Maxam A M, 1980, Methods Enzymol, V65, P499
   MAZUMDER A, 1991, BIOCHEMISTRY-US, V30, P1119, DOI 10.1021/bi00218a033
   MORIYA M, 1991, MUTAT RES, V254, P281, DOI 10.1016/0921-8777(91)90067-Y
   Nakahara H, 1998, FREE RADICAL BIO MED, V24, P85, DOI 10.1016/S0891-5849(97)00164-0
   PRYOR WA, 1988, FREE RADICAL BIO MED, V4, P219, DOI 10.1016/0891-5849(88)90043-3
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465
   Rosenquist TA, 1997, P NATL ACAD SCI USA, V94, P7429, DOI 10.1073/pnas.94.14.7429
   ROY D, 1991, CANCER RES, V51, P3882
   SALGANIK RI, 1994, BIOCHEM BIOPH RES CO, V199, P726, DOI 10.1006/bbrc.1994.1289
   Saparbaev M, 2000, NUCLEIC ACIDS RES, V28, P1332, DOI 10.1093/nar/28.6.1332
   SCHARF J, 1986, OPHTHALMIC RES, V18, P332, DOI 10.1159/000265459
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   Souza-Pinto NC, 1999, NUCLEIC ACIDS RES, V27, P1935, DOI 10.1093/nar/27.8.1935
   TCHOU J, 1991, P NATL ACAD SCI USA, V88, P4690, DOI 10.1073/pnas.88.11.4690
   vanderKemp PA, 1996, P NATL ACAD SCI USA, V93, P5197, DOI 10.1073/pnas.93.11.5197
   WEITZMAN SA, 1994, P NATL ACAD SCI USA, V91, P1261, DOI 10.1073/pnas.91.4.1261
NR 49
TC 15
Z9 17
U1 0
U2 2
PU INT SCIENTIFIC INFORMATION, INC
PI MELVILLE
PA 150 BROADHOLLOW RD, STE 114, MELVILLE, NY 11747 USA
SN 1643-3750
J9 MED SCI MONITOR
JI Med. Sci. Monitor
PD JAN
PY 2003
VL 9
IS 1
BP BR16
EP BR24
PG 9
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA V24YP
UT WOS:000208446000003
PM 12552232
DA 2024-02-19
ER

PT J
AU Petursson, F
   Husa, M
   June, R
   Lotz, M
   Terkeltaub, R
   Liu-Bryan, R
AF Petursson, Freyr
   Husa, Matt
   June, Ron
   Lotz, Martin
   Terkeltaub, Robert
   Liu-Bryan, Ru
TI Linked decreases in liver kinase B1 and AMP-activated protein kinase
   activity modulate matrix catabolic responses to biomechanical injury in
   chondrocytes
SO ARTHRITIS RESEARCH & THERAPY
LA English
DT Article
DE osteoarthritis; cartilage; aging; MMP-3; nitric oxide
ID SKELETAL-MUSCLE; OSTEOARTHRITIS; CARTILAGE; AUTOPHAGY
AB Introduction: AMP-activated protein kinase (AMPK) maintains cultured chondrocyte matrix homeostasis in response to inflammatory cytokines. AMPK activity is decreased in human knee osteoarthritis (OA) chondrocytes. Liver kinase B1 (LKB1) is one of the upstream activators of AMPK. Hence, we examined the relationship between LKB1 and AMPK activity in OA and aging cartilages, and in chondrocytes subjected to inflammatory cytokine treatment and biomechanical compression injury, and performed translational studies of AMPK pharmacologic activation.
   Methods: We assessed activity (phosphorylation) of LKB1 and AMPK alpha in mouse knee OA cartilage, in aging mouse cartilage (6 to 24 months), and in chondrocytes after mechanical injury by dynamic compression, via immunohistochemistry or western blot. We knocked down LKB1 by siRNA transfection. Nitric oxide, matrix metalloproteinase (MMP)-3, and MMP-13 release were measured by Griess reaction and ELISA, respectively.
   Results: Knockdown of LKB1 attenuated chondrocyte AMPK activity, and increased nitric oxide, MMP-3 and MMP-13 release (P <0.05) in response to IL-1 beta and TNF alpha. Both LKB1 and AMPK activity were decreased in mouse knee OA and aged knee cartilage, and in bovine chondrocytes after biomechanical injury. Pretreatment of bovine chondrocytes with AMPK activators AICAR and A-769662 inhibited both AMPK alpha dephosphorylation and catabolic responses after biomechanical injury.
   Conclusion: LKB1 is required for chondrocyte AMPK activity, thereby inhibiting matrix catabolic responses to inflammatory cytokines. Concurrent loss of LKB1 and AMPK activity in articular chondrocytes is associated with OA, aging and biomechanical injury. Conversely, pharmacologic AMPK activation attenuates catabolic responses to biomechanical injury, suggesting a potentially novel approach to inhibit OA development and progression.
C1 [Petursson, Freyr; Terkeltaub, Robert; Liu-Bryan, Ru] Univ Calif San Diego, Dept Med, VA San Diego Healthcare Syst, San Diego, CA 92161 USA.
   [Husa, Matt] Ohio State Univ, Dept Med, Columbus, OH 43210 USA.
   [June, Ron] Montana State Univ, Dept Mech & Ind Engn, Bozeman, MT 59717 USA.
   [Lotz, Martin] Scripps Res Inst, La Jolla, CA 92037 USA.
C3 US Department of Veterans Affairs; Veterans Health Administration (VHA);
   VA San Diego Healthcare System; University of California System;
   University of California San Diego; University System of Ohio; Ohio
   State University; Montana State University System; Montana State
   University Bozeman; Scripps Research Institute
RP Terkeltaub, R (corresponding author), Univ Calif San Diego, Dept Med, VA San Diego Healthcare Syst, 111K,3350 La Jolla Village Dr, San Diego, CA 92161 USA.
EM rterkeltaub@ucsd.edu; ruliu@ucsd.edu
FU Research Service of the Department of Veterans Affairs, National
   Institutes of Health [PO1 AG007996, AR54135, HL077360, AR1067966]
FX Studies were supported by the Research Service of the Department of
   Veterans Affairs, National Institutes of Health grants PO1 AG007996 (to
   ML and RT), AR54135 (to RT), HL077360 (to RT) and AR1067966 (to R-LB).
CR Anderson DD, 2011, J ORTHOP RES, V29, P802, DOI 10.1002/jor.21359
   Bohensky J, 2010, PEDIATR NEPHROL, V25, P633, DOI 10.1007/s00467-009-1310-y
   Buckwalter JA, 2006, BIORHEOLOGY, V43, P603
   Buckwalter JA, 2006, ADV DRUG DELIVER REV, V58, P150, DOI 10.1016/j.addr.2006.01.006
   Caramés B, 2012, ARTHRITIS RHEUM-US, V64, P1182, DOI 10.1002/art.33444
   Caramés B, 2010, ARTHRITIS RHEUM-US, V62, P791, DOI 10.1002/art.27305
   De Ceuninck F, 2004, METH MOLEC MED, V100, P15
   Goldring MB, 2007, J CELL PHYSIOL, V213, P626, DOI 10.1002/jcp.21258
   Griffin TM, 2005, EXERC SPORT SCI REV, V33, P195, DOI 10.1097/00003677-200510000-00008
   Grogan SP, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2719
   Leong DJ, 2011, ANN NY ACAD SCI, V1240, P32, DOI 10.1111/j.1749-6632.2011.06301.x
   Leong Daniel J, 2011, Curr Osteoporos Rep, V9, P196, DOI 10.1007/s11914-011-0070-3
   Liu R, 2004, ARTHRITIS RHEUM, V50, P247, DOI 10.1002/art.11486
   Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P1697, DOI 10.1002/art.34453
   Loeser RF, 2011, CURR OPIN RHEUMATOL, V23, P492, DOI 10.1097/BOR.0b013e3283494005
   Lotz M, 2012, BONE, V51, P241, DOI 10.1016/j.bone.2012.03.023
   Qiang W, 2007, EXP MOL MED, V39, P535, DOI 10.1038/emm.2007.59
   Salminen A, 2012, AGEING RES REV, V11, P230, DOI 10.1016/j.arr.2011.12.005
   Salminen A, 2011, J MOL MED, V89, P667, DOI 10.1007/s00109-011-0748-0
   Srinivas V, 2009, CELLS TISSUES ORGANS, V189, P88, DOI 10.1159/000151428
   Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008
   Terkeltaub R, 2011, ARTHRITIS RHEUM-US, V63, P1928, DOI 10.1002/art.30333
   Turdi S, 2010, AGING CELL, V9, P592, DOI 10.1111/j.1474-9726.2010.00586.x
   Uhl M, 1998, SKELETAL RADIOL, V27, P677, DOI 10.1007/s002560050458
   Witczak CA, 2008, CELL MOL LIFE SCI, V65, P3737, DOI 10.1007/s00018-008-8244-6
NR 25
TC 64
Z9 78
U1 0
U2 14
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1478-6354
EI 1478-6362
J9 ARTHRITIS RES THER
JI Arthritis Res. Ther.
PY 2013
VL 15
IS 4
AR R77
DI 10.1186/ar4254
PG 11
WC Rheumatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Rheumatology
GA 302TR
UT WOS:000330628300007
PM 23883619
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Tsai, S
   Sitzmann, JM
   Dastidar, SG
   Rodriguez, AA
   Vu, SL
   McDonald, CE
   Academia, EC
   O'Leary, MN
   Ashe, TD
   La Spada, AR
   Kennedy, BK
AF Tsai, Shihyin
   Sitzmann, Joanna M.
   Dastidar, Somasish G.
   Rodriguez, Ariana A.
   Vu, Stephanie L.
   McDonald, Circe E.
   Academia, Emmeline C.
   O'Leary, Monique N.
   Ashe, Travis D.
   La Spada, Albert R.
   Kennedy, Brian K.
TI Muscle-specific 4E-BP1 signaling activation improves metabolic
   parameters during aging and obesity
SO JOURNAL OF CLINICAL INVESTIGATION
LA English
DT Article
ID EXTENDS LIFE-SPAN; SKELETAL-MUSCLE; INSULIN-RESISTANCE; S6 KINASE;
   MITOCHONDRIAL ACTIVITY; MOLECULAR-MECHANISMS; DIETARY RESTRICTION;
   ADIPOSE-TISSUE; FIBER GROWTH; MTOR
AB Eukaryotic translation initiation factor 4E-binding protein 1 (4E-BP1) is a key downstream effector of mTOR complex 1 (mTORC1) that represses cap-dependent mRNA translation initiation by sequestering the translation initiation factor eIF4E. Reduced mTORC1 signaling is associated with life span extension and improved metabolic homeostasis, yet the downstream targets that mediate these benefits are unclear. Here, we demonstrated that enhanced 4E-BP1 activity in mouse skeletal muscle protects against age- and diet-induced insulin resistance and metabolic rate decline. Transgenic animals displayed increased energy expenditure; altered adipose tissue distribution, including reduced white adipose accumulation and preserved brown adipose mass; and were protected from hepatic steatosis. Skeletal muscle-specific 4E-BP1 mediated metabolic protection directly through increased translation of peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1 alpha) and enhanced respiratory function. Non-cell autonomous protection was through preservation of brown adipose tissue metabolism, which was increased in 4E-BP1 transgenic animals during normal aging and in a response to diet-induced type 2 diabetes. Adipose phenotypes may derive from enhanced skeletal muscle expression and secretion of the known myokine FGF21. Unlike skeletal muscle, enhanced adipose-specific 4E-BP1 activity was not protective but instead was deleterious in response to the same challenges. These findings indicate that regulation of 4E-BP1 in skeletal muscle may serve as an important conduit through which mTORC1 controls metabolism.
C1 [Tsai, Shihyin; Sitzmann, Joanna M.; Rodriguez, Ariana A.; Vu, Stephanie L.; McDonald, Circe E.; Academia, Emmeline C.; O'Leary, Monique N.; Kennedy, Brian K.] Buck Inst Res Aging, Novato, CA USA.
   [Dastidar, Somasish G.; Ashe, Travis D.; La Spada, Albert R.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA.
   [Dastidar, Somasish G.; Ashe, Travis D.; La Spada, Albert R.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.
   [Dastidar, Somasish G.; Ashe, Travis D.; La Spada, Albert R.] Univ Calif San Diego, Dept Neurosci, Div Biol Sci, Inst Genom Med, La Jolla, CA 92093 USA.
   [Dastidar, Somasish G.; Ashe, Travis D.; La Spada, Albert R.] Univ Calif San Diego, Sanford Consortium Regenerat Med, La Jolla, CA 92093 USA.
   [La Spada, Albert R.] Rady Childrens Hosp, San Diego, CA USA.
C3 Buck Institute for Research on Aging; University of California System;
   University of California San Diego; University of California System;
   University of California San Diego; University of California System;
   University of California San Diego; University of California System;
   University of California San Diego; Rady Childrens Hospital San Diego
RP La Spada, AR (corresponding author), 2800 Torrey Pines Scen Dr, La Jolla, CA 92037 USA.
EM alaspada@ucsd.edu; bkennedy@buckinstitute.org
RI Rodriguez, Ariana/JDM-5284-2023; La Spada, Albert/AAG-8809-2020
OI Tsai, Shih-Yin/0000-0002-2834-6383; Kennedy, Brian/0000-0002-5754-1874;
   Academia, Emmeline/0000-0001-7514-1754; Ghosh Dastidar,
   Somasish/0000-0003-4123-1801
FU NIH [R01AG033373, R01AG035336, R01 AG033082]
FX This study was supported by NIH grants R01AG033373 and R01AG035336 to
   B.K. Kennedy and R01 AG033082 to A.R. La Spada. B.K. Kennedy is also an
   Ellison Medical Foundation Senior Scholar in Aging. We thank Gary Scott,
   Pankaj Kapahi (Buck Institute for Research on Aging), and Matt
   Kaeberlein (University of Washington) for critical discussion, technical
   expertise, and reading of the manuscript. We also thank Philippe Pierre
   (INSERM, Marseille, France) for providing us with the anti-puromycin
   antibody and Pierre Chanbon (IGBMC, Illkirch, France) for providing us
   with HSA-Cre-ER<SUP>T2</SUP> transgenic mice.
CR Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575
   Affourtit C, 2012, METHODS MOL BIOL, V810, P165, DOI 10.1007/978-1-61779-382-0_11
   Aguilar V, 2007, CELL METAB, V5, P476, DOI 10.1016/j.cmet.2007.05.006
   Amati F, 2011, DIABETES, V60, P2588, DOI 10.2337/db10-1221
   Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002
   Bentzinger CF, 2013, SKELET MUSCLE, V3, DOI 10.1186/2044-5040-3-6
   Blackshear PJ, 1997, J BIOL CHEM, V272, P31510, DOI 10.1074/jbc.272.50.31510
   Bloemberg D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035273
   Boström P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777
   Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0
   Camporez JPG, 2013, ENDOCRINOLOGY, V154, P3099, DOI 10.1210/en.2013-1191
   Castets P, 2013, CELL METAB, V17, P731, DOI 10.1016/j.cmet.2013.03.015
   Choo AY, 2010, MOL CELL, V38, P487, DOI 10.1016/j.molcel.2010.05.007
   Chuang SY, 2014, NUTR METAB CARDIOVAS, V24, P784, DOI 10.1016/j.numecd.2013.11.010
   Cornu M, 2013, CURR OPIN GENET DEV, V23, P53, DOI 10.1016/j.gde.2012.12.005
   Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816
   Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198
   Csibi A, 2013, CELL, V153, P840, DOI 10.1016/j.cell.2013.04.023
   Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780
   Demontis F, 2010, CELL, V143, P813, DOI 10.1016/j.cell.2010.10.007
   Dutchak PA, 2012, CELL, V148, P556, DOI 10.1016/j.cell.2011.11.062
   Emanuelli B, 2014, J CLIN INVEST, V124, P515, DOI 10.1172/JCI67353
   Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539
   Gan ZJ, 2013, J CLIN INVEST, V123, P2564, DOI 10.1172/JCI67652
   Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422
   Goodman CA, 2011, CELL SIGNAL, V23, P1896, DOI 10.1016/j.cellsig.2011.07.013
   Goodman CA, 2011, FASEB J, V25, P1028, DOI 10.1096/fj.10-168799
   Goodman CA, 2010, MOL BIOL CELL, V21, P3258, DOI 10.1091/mbc.E10-05-0454
   Goodpaster BH, 2001, J CLIN ENDOCR METAB, V86, P5755, DOI 10.1210/jc.86.12.5755
   Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221
   Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704
   He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100
   Hensley CT, 2013, J CLIN INVEST, V123, P3678, DOI 10.1172/JCI69600
   Houtkooper RH, 2011, SCI REP-UK, V1, DOI 10.1038/srep00134
   Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912
   Hsieh AC, 2010, CANCER CELL, V17, P249, DOI 10.1016/j.ccr.2010.01.021
   Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003
   Janssen I, 2005, J NUTR HEALTH AGING, V9, P408
   Johnson SC, 2013, SCIENCE, V342, P1524, DOI 10.1126/science.1244360
   Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861
   Kaeberlein M, 2007, CURR GENOMICS, V8, P73, DOI 10.2174/138920207780368196
   Kamei Y, 2004, J BIOL CHEM, V279, P41114, DOI 10.1074/jbc.M400674200
   Karakelides H, 2005, CURR TOP DEV BIOL, V68, P123, DOI 10.1016/S0070-2153(05)68005-2
   Katewa SD, 2012, CELL METAB, V16, P97, DOI 10.1016/j.cmet.2012.06.005
   Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135
   Le Bacquer O, 2007, J CLIN INVEST, V117, P387, DOI 10.1172/JCI29528
   LEITER EH, 1988, FASEB J, V2, P2807, DOI 10.1096/fasebj.2.12.3044905
   Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904
   Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004
   Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672
   Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008
   Mehlem A, 2013, NAT PROTOC, V8, P1149, DOI 10.1038/nprot.2013.055
   Morita M, 2013, CELL METAB, V18, P698, DOI 10.1016/j.cmet.2013.10.001
   Nadeau KJ, 2006, AM J PHYSIOL-ENDOC M, V291, pE90, DOI 10.1152/ajpendo.00543.2005
   Nader GA, 2001, J APPL PHYSIOL, V90, P1936, DOI 10.1152/jappl.2001.90.5.1936
   Ohanna M, 2005, NAT CELL BIOL, V7, P286, DOI 10.1038/ncb1231
   Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004
   Picard M, 2012, AM J PHYSIOL-CELL PH, V302, pC629, DOI 10.1152/ajpcell.00368.2011
   Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003
   Polak P, 2009, CURR OPIN CELL BIOL, V21, P209, DOI 10.1016/j.ceb.2009.01.024
   Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703
   Pyo JO, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3300
   Risson V, 2009, J CELL BIOL, V187, P859, DOI 10.1083/jcb.200903131
   Rogers GW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021746
   Rogers NH, 2012, AGING CELL, V11, P1074, DOI 10.1111/acel.12010
   Sandri M, 2013, BIOGERONTOLOGY, V14, P303, DOI 10.1007/s10522-013-9432-9
   Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3
   Scarpulla RC, 2012, TRENDS ENDOCRIN MET, V23, P459, DOI 10.1016/j.tem.2012.06.006
   Schenk S, 2007, J CLIN INVEST, V117, P1690, DOI 10.1172/JCI30566
   Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]
   Schuler M, 2005, GENESIS, V41, P165, DOI 10.1002/gene.20107
   Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221
   Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040
   Srikanthan P, 2014, AM J MED, V127, P547, DOI 10.1016/j.amjmed.2014.02.007
   Stanfel MN, 2009, BBA-GEN SUBJECTS, V1790, P1067, DOI 10.1016/j.bbagen.2009.06.007
   Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083
   Tseng YH, 2010, NAT REV DRUG DISCOV, V9, P465, DOI 10.1038/nrd3138
   Tsukiyama-Kohara K, 2001, NAT MED, V7, P1128, DOI 10.1038/nm1001-1128
   Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866
   Um SH, 2006, CELL METAB, V3, P393, DOI 10.1016/j.cmet.2006.05.003
   van Wessel T, 2010, EUR J APPL PHYSIOL, V110, P665, DOI 10.1007/s00421-010-1545-0
   Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294
   Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1
   White RB, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-21
   Wu J, 2013, GENE DEV, V27, P234, DOI 10.1101/gad.211649.112
   Zhang JF, 2013, SCI REP-UK, V3, DOI 10.1038/srep01476
   Zid BM, 2009, CELL, V139, P149, DOI 10.1016/j.cell.2009.07.034
NR 87
TC 86
Z9 98
U1 0
U2 24
PU AMER SOC CLINICAL INVESTIGATION INC
PI ANN ARBOR
PA 2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA
SN 0021-9738
EI 1558-8238
J9 J CLIN INVEST
JI J. Clin. Invest.
PD AUG
PY 2015
VL 125
IS 8
BP 2952
EP 2964
DI 10.1172/JCI77361
PG 13
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA CO3CS
UT WOS:000359034800010
PM 26121750
OA Bronze, Green Published
DA 2024-02-19
ER

PT J
AU Sakano, Y
   Noda, T
   Kobayashi, S
   Akasaka, H
   Kato, K
   Sasaki, K
   Iwagami, Y
   Yamada, D
   Tomimaru, Y
   Takahashi, H
   Asaoka, T
   Shimizu, J
   Rakugi, H
   Doki, Y
   Eguchi, H
AF Sakano, Yoshihiro
   Noda, Takehiro
   Kobayashi, Shogo
   Akasaka, Hiroshi
   Kato, Kazuya
   Sasaki, Kazuki
   Iwagami, Yoshifumi
   Yamada, Daisaku
   Tomimaru, Yoshito
   Takahashi, Hidenori
   Asaoka, Tadafumi
   Shimizu, Junzo
   Rakugi, Hiromi
   Doki, Yuichiro
   Eguchi, Hidetoshi
TI Geriatric prognostic scoring system predicts survival after hepatectomy
   for elderly patients with liver cancer
SO ANNALS OF GASTROENTEROLOGICAL SURGERY
LA English
DT Article; Early Access
DE elderly patients; hepatectomy; liver cancer; prognosis; score
ID POSTOPERATIVE COMPLICATIONS; SARCOPENIA; RESECTION; FRAILTY; CIRRHOSIS;
   DELIRIUM; SURGERY
AB Aim: The number of elderly patients with liver cancer is increasing with the aging society. The Geriatric Prognostic Scoring System is useful in predicting the postoperative prognosis for elderly patients with gastrointestinal cancer. The aim of the present study was to assess the predictive ability of the geriatric prognostic scoring system for postoperative survival in elderly patients with liver cancer.Methods: Eighty-eight patients aged >= 75 years who were treated for primary liver cancer and metastatic liver tumor were retrospectively analyzed. The Geriatric Prognostic Score (GPS) was created by several clinical parameters such as age, sex, type of cancer, stage, performance status, body mass index, and comprehensive geriatric assessment. Each patient was divided into two groups of high-risk to low-risk according to their GPS: >= 30 high-risk group and <30 low-risk. The predictive ability of geriatric prognostic scoring system for postoperative survival was assessed in univariate and multivariate analyses.Results: Of the 88 patients, 75 were diagnosed as hepatocellular carcinoma and 13 as colorectal liver metastasis. After geriatric prognostic scoring system assessments, 26 patients were diagnosed as high-risk and the remaining 62 as low-risk. The 3-year overall survival rates were 78.5% in the low-risk group and 35.1% in the high-risk group (p < 0.001). The univariate and multivariate analyses of overall survival identified high GPS as an independent significant factor (p < 0.001).Conclusions: We could conclude that the geriatric prognostic scoring system is useful in predicting patients' prognosis after hepatectomy and it can provide helpful information to surgeons for determining treatment strategies for elderly patients with liver cancer.
C1 [Sakano, Yoshihiro; Noda, Takehiro; Kobayashi, Shogo; Kato, Kazuya; Sasaki, Kazuki; Iwagami, Yoshifumi; Yamada, Daisaku; Tomimaru, Yoshito; Takahashi, Hidenori; Asaoka, Tadafumi; Shimizu, Junzo; Doki, Yuichiro; Eguchi, Hidetoshi] Osaka Univ, Grad Sch Med, Dept Gastroenterol Surg, Osaka, Japan.
   [Akasaka, Hiroshi; Rakugi, Hiromi] Osaka Univ, Grad Sch Med, Dept Geriatr & Gen Med, Osaka, Japan.
   [Asaoka, Tadafumi] Osaka Police Hosp, Dept Surg, Osaka, Japan.
   [Shimizu, Junzo] Toyonaka City Hosp, Dept Surg, Osaka, Japan.
   [Kobayashi, Shogo] Osaka Univ, Grad Sch Med, Dept Gastroenterol Surg, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.
C3 Osaka University; Osaka University; Osaka Police Hospital; Osaka
   University
RP Kobayashi, S (corresponding author), Osaka Univ, Grad Sch Med, Dept Gastroenterol Surg, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.
EM s-kobayashi@umin.ac.jp
RI Takahashi, Hidenori/I-1231-2019
OI Takahashi, Hidenori/0000-0003-4801-3540; Yamada,
   Daisaku/0000-0002-6702-3800; Noda, Takehiro/0000-0002-6768-5783
CR Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025
   Dedinská I, 2017, ANN HEPATOL, V16, P149, DOI 10.5604/16652681.1226934
   Garrard JW, 2020, AGING CLIN EXP RES, V32, P197, DOI 10.1007/s40520-019-01183-w
   Gassmann P, 2010, WORLD J SURG, V34, P2442, DOI 10.1007/s00268-010-0655-5
   Guan TW, 2023, AGE AGEING, V52, DOI 10.1093/ageing/afad068
   Hashimoto T, 2019, WORLD J SURG, V43, P2885, DOI 10.1007/s00268-019-05109-5
   Hirahara N, 2021, SURG ENDOSC, V35, P1202, DOI 10.1007/s00464-020-07487-7
   Hisaka T, 2019, ANTICANCER RES, V39, P4549, DOI 10.21873/anticanres.13632
   Ida M, 2020, GERIATR GERONTOL INT, V20, P1208, DOI 10.1111/ggi.14066
   Kaibori M, 2019, ANN SURG, V270, P121, DOI 10.1097/SLA.0000000000002751
   Kaibori M, 2016, LANGENBECK ARCH SURG, V401, P205, DOI 10.1007/s00423-016-1388-1
   Kamiya A, 2022, BMC SURG, V22, DOI 10.1186/s12893-022-01670-4
   Lai JC, 2021, HEPATOLOGY, V74, P1611, DOI 10.1002/hep.32049
   Levolger S, 2015, J SURG ONCOL, V112, P208, DOI 10.1002/jso.23976
   Li L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30906-8
   Lin HS, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0329-8
   Madrigal J, 2022, J AM MED DIR ASSOC, V23, P684, DOI 10.1016/j.jamda.2022.02.004
   Michalik C, 2020, ADV CLIN EXP MED, V29, P399, DOI 10.17219/acem/115085
   Nishizawa Y, 2018, SURG ENDOSC, V32, P1434, DOI 10.1007/s00464-017-5827-z
   Noda T, 2023, ANN GASTROENT SURG, V7, P479, DOI 10.1002/ags3.12631
   Noda T, 2018, SURG ENDOSC, V32, P46, DOI 10.1007/s00464-017-5632-8
   Samuelsson KS, 2019, J GERIATR ONCOL, V10, P709, DOI 10.1016/j.jgo.2019.01.020
   Siegel RL, 2020, CA-CANCER J CLIN, V70, P7, DOI 10.3322/caac.21590
   Tanaka S, 2018, J HEPATO-BIL-PAN SCI, V25, P377, DOI 10.1002/jhbp.568
   Tandon P, 2009, LIVER INT, V29, P502, DOI 10.1111/j.1478-3231.2008.01957.x
   Tran HPT, 2017, PRIMARY CARE, V44, P399, DOI 10.1016/j.pop.2017.05.001
   Ukawa S, 2017, J EPIDEMIOL, V27, pS43, DOI 10.1016/j.je.2016.12.007
   van Tuil T, 2019, DIGEST SURG, V36, P111, DOI 10.1159/000487274
   Velanovich V, 2013, J SURG RES, V183, P104, DOI 10.1016/j.jss.2013.01.021
   Wang YY, 2016, BRIT J SURG, V103, P725, DOI 10.1002/bjs.10095
   Woo J, 2015, J AM MED DIR ASSOC, V16, P412, DOI 10.1016/j.jamda.2015.01.087
   Yamada S, 2021, ANN SURG ONCOL, V28, P439, DOI 10.1245/s10434-020-08742-w
   Yamamoto M, 2016, WORLD J SURG, V40, P2705, DOI 10.1007/s00268-016-3602-2
   Yamasaki M, 2019, ANN SURG ONCOL, V26, P3644, DOI 10.1245/s10434-019-07687-z
   Zhao WC, 2012, WORLD J GASTROENTERO, V18, P3272, DOI 10.3748/wjg.v18.i25.3272
NR 35
TC 0
Z9 0
U1 0
U2 0
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 2475-0328
J9 ANN GASTROENT SURG
JI Ann. Gastroent. Surg.
PD 2023 DEC 19
PY 2023
DI 10.1002/ags3.12762
EA DEC 2023
PG 9
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA CY3S6
UT WOS:001128759700001
DA 2024-02-19
ER

PT J
AU Jakhmola-Mani, R
   Islam, A
   Katare, DP
AF Jakhmola-Mani, Ruchi
   Islam, Anam
   Katare, Deepshikha Pande
TI Liver-Brain Axis in Sporadic Alzheimer's Disease: Role of Ten Signature
   Genes in a Mouse Model
SO CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS
LA English
DT Article
DE Liver-brain axis; NAFLD; Alzheimer's disease; DEGs; gene interaction
   networks; TUBB5
ID APOLIPOPROTEIN-E; AMINO-ACID; TCA CYCLE; A-BETA; CHOLESTEROL;
   DYSREGULATION; HYPOXIA; FAT; GLUTATHIONE; METABOLISM
AB : Aim: Poor nutritional effect of junk food induces injuries to the liver and the brain but still most of the developing nations survive on these diets to compensate for the fast-paced lifestyle. The aim of the study is to infer the protein-connections behind the liver-brain axis and identify the role of these proteins in causing neurodegenerative disorders. Background: Chronic consumption of fructose and fat-rich food works as a toxin in the body and has the ability to cause a negative metabolic shift. Recently a study was published in Annals of Internal Medicine (2019) citing the loss of vision and hearing in a 14-year-old boy whose diet was strictly restricted to fries and junk-food for almost a decade. This puts the entire body on insulin resistance and related co-morbidities and causes simultaneous damaging effects on the liver as well as the brain. This work provides insights into the liver-brain axis and explains how the liver is involved in brain related disorders. Objective: In this study, transcriptomic data related to chronic eating of junk-food was analyzed and simultaneous damage that happens in the liver and the brain was assessed at the molecular level. Methods: Transcriptomic study was taken from the GEO database and analysed to find out the genes dysregulated in both the liver and the brain during this metabolic stress. Cytoscapev3.7 was used to decipher the signalling between the liver and the brain. This connection between both is called as the liver-brain axis. Result: The results obtained from our study indicate the role of TUBB5-HYOU1-SDF2L1-DECR1-CDH1-EGFR-SKP2-SOD1-IRAK1-FOXO1 gene signature in the decline of concurrent liver and brain health. Dysregulated levels of these genes are linked to molecular processes like cellular senescence, hypoxia, glutathione synthesis, amino acid modification, increased nitrogen content, synthesis of BCAAs, cholesterol biosynthesis, steroid hormone signalling and VEGF pathway. Conclusion: We strongly advocate that prolonged consumption of junk food is a major culprit in brain related disorders like Alzheimer's disease and propose that receptors for brain diseases lie outside the brain and aiming them for drug discovery and design may be beneficial in future clinical studies. This study also discusses the connection between NAFLD (non-alcoholic fatty liver disease) and sAD (sporadic Alzheimer's disease) owing to liver-brain axis.
C1 [Jakhmola-Mani, Ruchi; Islam, Anam; Katare, Deepshikha Pande] Amity Univ, Ctr Med Biotechnol, Amity Inst Biotechnol, Prote & Translat Res Lab, Noida 201313, India.
C3 Amity University Noida
RP Katare, DP (corresponding author), Amity Univ, Ctr Med Biotechnol, Amity Inst Biotechnol, Prote & Translat Res Lab, Noida 201313, India.
EM dpkatare@amity.edu
RI Jakhmola-Mani, Ruchi/AAG-5958-2020; Jakhmola, Ruchi/ABD-7835-2021;
   Jakhmola-Mani, Dr Ruchi/HPG-2832-2023
OI Jakhmola-Mani, Ruchi/0000-0002-8404-9375; Jakhmola,
   Ruchi/0000-0001-9264-867X; Jakhmola-Mani, Dr Ruchi/0000-0001-9264-867X;
   Katare, Dr. Deepshikha Pande/0000-0002-1881-3566; Islam,
   Anam/0000-0002-2815-2458
CR Ahmad SS, 2019, CNS NEUROL DISORD-DR, V18, P657, DOI 10.2174/1871527318666191011145941
   Ali F, 2019, CNS NEUROL DISORD-DR, V18, P352, DOI 10.2174/1871527318666190319141835
   Alzheimer's Assoc, 2018, ALZHEIMERS DEMENT, V14, P367, DOI 10.1016/j.jalz.2018.02.001
   Banks WA, 2006, PHYSIOL BEHAV, V88, P244, DOI 10.1016/j.physbeh.2006.05.037
   Barrett T, 2005, NUCLEIC ACIDS RES, V33, pD562
   Becskei C, 2010, AM J PHYSIOL-REG I, V299, pR632, DOI 10.1152/ajpregu.00674.2009
   Beilharz JE, 2014, BRAIN BEHAV IMMUN, V37, P134, DOI 10.1016/j.bbi.2013.11.016
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Bopp AF, 2019, AM CHEM SOC, DOI [10.1021/bk-2019-1314, DOI 10.1021/BK-2019-1314]
   Burns MP, 2003, MOL BRAIN RES, V110, P119, DOI 10.1016/S0169-328X(02)00647-2
   Canevari L, 2007, NEUROCHEM RES, V32, P739, DOI 10.1007/s11064-006-9200-1
   Chen SY, 2019, NEUROPHARMACOLOGY, V157, DOI 10.1016/j.neuropharm.2019.107668
   Chen Xuesong, 2014, J Parkinsons Dis Alzheimers Dis, V1
   Chen Z, 2017, J NEUROENDOCRINOL, V29, DOI 10.1111/jne.12462
   Cheng KC, 2019, ALZHEIMERS DEMENT, V15, P1004, DOI DOI 10.1016/J.JALZ.2019.06.3223
   Clough E, 2016, METHODS MOL BIOL, V1418, P93, DOI 10.1007/978-1-4939-3578-9_5
   Cunnane S, 2011, NUTRITION, V27, P3, DOI 10.1016/j.nut.2010.07.021
   Domínguez-Pérez M, 2019, J CELL PHYSIOL, V234, P7213, DOI 10.1002/jcp.27474
   Estrada LD, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00174
   Fernstrom JD, 2005, J NUTR, V135, p1539S, DOI 10.1093/jn/135.6.1539S
   Fonteh AN, 2007, AMINO ACIDS, V32, P213, DOI 10.1007/s00726-006-0409-8
   Gaggini M, 2018, HEPATOLOGY, V67, P145, DOI 10.1002/hep.29465
   Gupta S, 2019, CNS NEUROL DISORD-DR, V18, P172, DOI 10.2174/1871527317666181114163515
   Habchi J, 2018, NAT CHEM, V10, P673, DOI 10.1038/s41557-018-0031-x
   Hamlin AN, 2018, J BIOL CHEM, V293, P9674, DOI 10.1074/jbc.RA118.001952
   Harrison R, 2019, ANN INTERN MED, V171, P859, DOI 10.7326/L19-0361
   Iizuka K, 2008, ENDOCR J, V55, P617, DOI 10.1507/endocrj.K07E-110
   Ishimoto T, 2013, HEPATOLOGY, V58, P1632, DOI 10.1002/hep.26594
   Jiang XW, 2018, CNS NEUROL DISORD-DR, V17, P608, DOI 10.2174/1871527317666180724150839
   Kanekiyo T, 2014, NEURON, V81, P740, DOI 10.1016/j.neuron.2014.01.045
   Kanekiyo T, 2012, J NEUROSCI, V32, P16458, DOI 10.1523/JNEUROSCI.3987-12.2012
   Kim DG, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-015-0467-5
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   Kolosova NG., 2016, J GENET APPL RES, V6, P437, DOI [10.1134/S2079059716040195, DOI 10.1134/S2079059716040195]
   Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377
   Landel V, 2016, J ALZHEIMERS DIS, V53, P419, DOI 10.3233/JAD-150943
   Li L, 2016, FREE RADICAL BIO MED, V96, P13, DOI 10.1016/j.freeradbiomed.2016.03.032
   Lieberman HB, 2017, RADIAT RES, V187, P424, DOI 10.1667/RR003CC.1
   Maarouf CL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203659
   Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551
   Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507
   Mardinoglu A, 2017, MOL SYST BIOL, V13, DOI 10.15252/msb.20167422
   McLean FH, 2019, NUTR METAB, V16, DOI 10.1186/s12986-019-0352-9
   McMillin M, 2016, FASEB J, V30, P3658, DOI 10.1096/fj.201600275R
   Min HK, 2012, CELL METAB, V15, P665, DOI 10.1016/j.cmet.2012.04.004
   Mittal K, 2016, SCI REP-UK, V6, DOI 10.1038/srep25589
   Moreira PI, 2010, BBA-MOL BASIS DIS, V1802, P2, DOI 10.1016/j.bbadis.2009.10.006
   Nath B, 2012, HEPATOLOGY, V55, P622, DOI 10.1002/hep.25497
   Navarro A, 2004, AM J PHYSIOL-REG I, V287, pR1244, DOI 10.1152/ajpregu.00226.2004
   Neelakandan AR, 2018, CNS NEUROL DISORD-DR, V17, P6, DOI 10.2174/1871527317666180213143832
   Noureddin M, 2020, HEPATOLOGY, V71, P1940, DOI 10.1002/hep.30967
   Pinçon A, 2019, METABOLITES, V9, DOI 10.3390/metabo9050104
   Puglielli L, 2003, NAT NEUROSCI, V6, P345, DOI 10.1038/nn0403-345
   Reeta, 2019, CNS NEUROL DISORD-DR, V18, P643, DOI 10.2174/1871527318666190906101326
   REISS U, 1976, BIOCHEM BIOPH RES CO, V73, P255, DOI 10.1016/0006-291X(76)90701-4
   Rivera-Andrade A, 2019, NUTR METAB CARDIOVAS, V29, P191, DOI 10.1016/j.numecd.2018.10.008
   Ross AP, 2012, PHYSIOL BEHAV, V106, P133, DOI 10.1016/j.physbeh.2012.01.008
   Ruiz HH, 2016, ALZHEIMERS DEMENT, V12, P851, DOI 10.1016/j.jalz.2016.01.008
   Saharan S, 2014, J ALZHEIMERS DIS, V40, P519, DOI 10.3233/JAD-132483
   Satapati S, 2012, J LIPID RES, V53, P1080, DOI 10.1194/jlr.M023382
   Seo SW, 2016, NEUROLOGY, V86, P1136, DOI 10.1212/WNL.0000000000002498
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   Shirakawa J, 2011, DIABETES, V60, P1246, DOI 10.2337/db10-1338
   Simonen P, 2011, J HEPATOL, V54, P153, DOI 10.1016/j.jhep.2010.05.037
   Singh A, 2018, CNS NEUROL DISORD-DR, V17, P571, DOI 10.2174/1871527317666180627122448
   Somel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001504
   Sunny NE, 2011, CELL METAB, V14, P804, DOI 10.1016/j.cmet.2011.11.004
   Sutcliffe JG, 2011, J NEUROSCI RES, V89, P808, DOI 10.1002/jnr.22603
   Suzuki T, 2014, WORLD J GASTROENTERO, V20, P15087, DOI 10.3748/wjg.v20.i41.15087
   Tappy L, 2012, CLIN RES HEPATOL GAS, V36, P554, DOI 10.1016/j.clinre.2012.06.005
   Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403
   Vance JE, 2012, DIS MODEL MECH, V5, P746, DOI 10.1242/dmm.010124
   WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510
   WURTMAN RJ, 1986, APPETITE, V7, P99, DOI 10.1016/S0195-6663(86)80055-1
   Zhang X, 2010, EXP NEUROL, V223, P299, DOI 10.1016/j.expneurol.2009.07.033
NR 76
TC 4
Z9 5
U1 2
U2 5
PU BENTHAM SCIENCE PUBL
PI BUSUM
PA PO BOX 294, BUSUM, 1400 AG, NETHERLANDS
SN 1871-5273
EI 1996-3181
J9 CNS NEUROL DISORD-DR
JI CNS Neurol. Disord.-Drug Targets
PD NOV
PY 2021
VL 20
IS 9
BP 871
EP 885
DI 10.2174/1871527319666201209111006
PG 15
WC Neurosciences; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pharmacology & Pharmacy
GA XO2RQ
UT WOS:000730038400007
PM 33297922
DA 2024-02-19
ER

PT J
AU Bulvik, BE
   Berenshtein, E
   Konijn, AM
   Grinberg, L
   Vinokur, V
   Eliashar, R
   Chevion, M
AF Bulvik, Baruch E.
   Berenshtein, Eduard
   Konijn, Abraham Marim
   Grinberg, Leonid
   Vinokur, Vladimir
   Eliashar, Ron
   Chevion, Mordechai (Mottie)
TI Aging is an organ-specific process: changes in homeostasis of iron and
   redox proteins in the rat
SO AGE
LA English
DT Article
DE Aging; Organ specific; Iron; Redox state; Ferritin; Methionine-centered
   redox cycle
ID OXIDATIVE STRESS; ANTIOXIDANT DEFENSE; FERRITIN SYNTHESIS; HUMAN
   THIOREDOXIN; AGE; EXPRESSION; REDUCTASE; RNA; RESIDUES; MUSCLE
AB Organ-specific changes of iron- and redox-related proteins occur with age in the rat. Ferritin, the major iron storage and detoxifying protein, as well as the proteins of the methionine-centered redox cycle (MCRC) were examined in old and young animals, and showed organ-dependent changes. In spleens and livers of aged rats, ferritin (protein) levels were greater than in young ones, and their iron saturation increased, rendering higher ferritin-bound iron (FtBI). Iron saturation of the ferritin molecule in the tongues and sternohyoids of old rats was lower but ferritin level was higher than in young rats, resulting in increased FtBI with age. Ferritin level in the esophagus of older rats was lower than in young rats but its molecular iron content higher thus the total FtBI remained the same. In the larynx, both ferritin and its iron content were the same in young and old animals. MCRC proteins were measured in livers and spleens only. With aging, methionine sulfoxide reductase A and B (MsrA and MsrB) levels in livers and spleens decreased. Thioredoxin1 (Trx) and Trx-reductase1 were elevated in old spleens, but reduced in livers. Aged spleens showed reduced Msr isozyme activity; but in the liver, its activity increased. mRNA changes with age were monitored and found to be organ specific. These organ-specific changes could reflect the different challenges and the selective pathways of each organ and its resultant capacity to cope with aging.
C1 [Chevion, Mordechai (Mottie)] Hebrew Univ Jerusalem Hadassah Hosp & Med Sch, Hebrew Univ Jerusalem, Sch Dent, IL-91120 Jerusalem, Israel.
   [Chevion, Mordechai (Mottie)] Hebrew Univ Jerusalem Hadassah Hosp & Med Sch, Hebrew Univ Jerusalem, Sch Med, IL-91120 Jerusalem, Israel.
   [Vinokur, Vladimir; Eliashar, Ron] Hadassah Hebrew Univ Hosp, Dept Otolaryngol Head & Neck Surg, Jerusalem, Israel.
   [Konijn, Abraham Marim] Hebrew Univ Jerusalem, Fac Med, Dept Human Nutr & Metab, IL-91120 Jerusalem, Israel.
   [Bulvik, Baruch E.; Berenshtein, Eduard; Grinberg, Leonid; Chevion, Mordechai (Mottie)] Hebrew Univ Jerusalem, Fac Med & Dent Med, Dept Cellular Biochem & Human Genet, IL-91120 Jerusalem, Israel.
C3 Hebrew University of Jerusalem; Hadassah University Medical Center;
   Hebrew University of Jerusalem; Hadassah University Medical Center;
   Hebrew University of Jerusalem; Hadassah University Medical Center;
   Hebrew University of Jerusalem; Hebrew University of Jerusalem
RP Chevion, M (corresponding author), Hebrew Univ Jerusalem Hadassah Hosp & Med Sch, Hebrew Univ Jerusalem, Sch Dent, POB 12272, IL-91120 Jerusalem, Israel.
EM mottiec@ekmd.huji.ac.il
RI Vinokur, Valerii M/J-7299-2013; Eliashar, Ron/GZH-0089-2022
OI Eliashar, Ron/0000-0003-0740-4975
CR Altun M, 2007, MUSCLE NERVE, V36, P223, DOI 10.1002/mus.20808
   Bandyopadhyay U, 1999, CURR SCI INDIA, V77, P658
   Berenshtein E, 2002, MOL CELL BIOCHEM, V234, P283, DOI 10.1023/A:1015923202082
   BROT N, 1991, BIOFACTORS, V3, P91
   Bulvik B, 2009, MECH AGEING DEV, V130, P139, DOI 10.1016/j.mad.2008.10.002
   CAIRO G, 1995, J BIOL CHEM, V270, P700, DOI 10.1074/jbc.270.2.700
   Chen Y, 2002, J BIOL CHEM, V277, P33242, DOI 10.1074/jbc.M202026200
   CHEUNG HT, 1983, MECH AGEING DEV, V22, P23
   Ercal Nuran, 2001, Current Topics in Medicinal Chemistry, V1, P529, DOI 10.2174/1568026013394831
   Frasca D, 2005, J IMMUNOL, V175, P6633, DOI 10.4049/jimmunol.175.10.6633
   Friguet B, 2006, FEBS LETT, V580, P2910, DOI 10.1016/j.febslet.2006.03.028
   Gallegos A, 1996, CANCER RES, V56, P5765
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9
   Hintze KJ, 2006, CELL MOL LIFE SCI, V63, P591, DOI 10.1007/s00018-005-5285-y
   HOY TG, 1981, BRIT J HAEMATOL, V49, P593, DOI 10.1111/j.1365-2141.1981.tb07269.x
   KONIJN AM, 1982, J IMMUNOL METHODS, V54, P297, DOI 10.1016/0022-1759(82)90314-3
   Konijn AM, 1999, BLOOD, V94, P2128, DOI 10.1182/blood.V94.6.2128.418k20_2128_2134
   KONIJN AM, 1985, ANAL BIOCHEM, V144, P423, DOI 10.1016/0003-2697(85)90135-6
   KONIJN AM, 1977, BRIT J HAEMATOL, V37, P7, DOI 10.1111/j.1365-2141.1977.tb08758.x
   Koolhaas J.M., 2010, UFAW HDB CARE MANAGE, V8th
   Kregel KC, 2007, AM J PHYSIOL-REG I, V292, pR18, DOI 10.1152/ajpregu.00327.2006
   LEIBOVITZ BE, 1980, J GERONTOL, V35, P45, DOI 10.1093/geronj/35.1.45
   Levenson CW, 2004, AGEING RES REV, V3, P251, DOI 10.1016/j.arr.2004.03.001
   Liu XF, 2005, ANN NY ACAD SCI, V1054, P136, DOI 10.1196/annals.1345.016
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   MASUDA T, 1993, TOHOKU J EXP MED, V170, P169, DOI 10.1620/tjem.170.169
   Mitsui A, 2002, ANTIOXID REDOX SIGN, V4, P693, DOI 10.1089/15230860260220201
   Moskovitz J, 2005, BBA-PROTEINS PROTEOM, V1703, P213, DOI 10.1016/j.bbapap.2004.09.003
   Moskovitz J, 1997, P NATL ACAD SCI USA, V94, P9585, DOI 10.1073/pnas.94.18.9585
   Moskovitz J, 2001, P NATL ACAD SCI USA, V98, P12920, DOI 10.1073/pnas.231472998
   Nilsson UA, 2002, FREE RADICAL RES, V36, P677, DOI 10.1080/10715760290029128
   Petropoulos I, 2006, FREE RADICAL RES, V40, P1269, DOI 10.1080/10715760600917144
   Ponka P, 1998, SEMIN HEMATOL, V35, P35
   Reno C, 1997, BIOTECHNIQUES, V22, P1082, DOI 10.2144/97226bm16
   Rikans LE, 1997, ARCH BIOCHEM BIOPHYS, V344, P85, DOI 10.1006/abbi.1997.0172
   Rohrbach S, 2006, AM J PHYSIOL-REG I, V291, pR927, DOI 10.1152/ajpregu.00890.2005
   Sen CK, 1996, FASEB J, V10, P709, DOI 10.1096/fasebj.10.7.8635688
   Sen CK, 2000, AM J CLIN NUTR, V72, p653S, DOI 10.1093/ajcn/72.2.653S
   Shioji K, 2000, FEBS LETT, V472, P109, DOI 10.1016/S0014-5793(00)01446-0
   Squier TC, 2001, EXP GERONTOL, V36, P1539, DOI 10.1016/S0531-5565(01)00139-5
   Stadtman ER, 2003, ANTIOXID REDOX SIGN, V5, P577, DOI 10.1089/152308603770310239
   Takeda T, 1996, BIOL TRACE ELEM RES, V54, P55, DOI 10.1007/BF02785320
   Tappia PS, 2006, FREE RADICAL BIO MED, V41, P349, DOI 10.1016/j.freeradbiomed.2006.03.025
   Thomson AM, 1999, INT J BIOCHEM CELL B, V31, P1139, DOI 10.1016/S1357-2725(99)00080-1
   Vaisman B, 1999, CLIN CHEM LAB MED, V37, P121, DOI 10.1515/CCLM.1999.022
   Vaisman B, 2000, BRIT J HAEMATOL, V110, P394, DOI 10.1046/j.1365-2141.2000.02167.x
   Vinokur V, 2009, BIOGERONTOLOGY, V10, P43, DOI 10.1007/s10522-008-9152-8
   Yoshida T, 2003, ANTIOXID REDOX SIGN, V5, P563, DOI 10.1089/152308603770310211
NR 50
TC 16
Z9 18
U1 0
U2 4
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0161-9152
EI 1574-4647
J9 AGE
JI Age
PD JUN
PY 2012
VL 34
IS 3
BP 693
EP 704
DI 10.1007/s11357-011-9268-7
PG 12
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 935GP
UT WOS:000303507400015
PM 21643761
OA Green Published
DA 2024-02-19
ER

PT J
AU KREGEL, KC
AF KREGEL, KC
TI INFLUENCE OF AGING ON TISSUE-SPECIFIC NORADRENERGIC ACTIVITY AT REST AND
   DURING NONEXERTIONAL HEATING IN RATS
SO JOURNAL OF APPLIED PHYSIOLOGY
LA English
DT Article
DE HYPERTHERMIA; THERMOREGULATION; SYMPATHETIC NERVOUS SYSTEM
ID AGE-RELATED-CHANGES; SYMPATHETIC ACTIVITY; NOREPINEPHRINE TURNOVER;
   FISCHER-344 RATS; BLOOD-PRESSURE; STRESS; ADJUSTMENTS; IMPAIRMENT;
   RESPONSES; INCREASES
AB The purpose of this study was to test the hypothesis that sympathetic nervous system (SNS) activity to internal organs during nonexertional heat stress is exaggerated with advancing age. Norepinephrine (NE) synthesis was blocked with alpha-methyl-DL-p-tyrosine, and NE turnover rates were determined in the left ventricle, renal cortex, liver, and adrenal gland in groups of conscious unrestrained mature (12-mo-old) and senescent (24-mo-old) Fischer 344 rats before and after whole body heating. Animals were maintained in thermoneutral control conditions (n = 10 per group) or exposed to an ambient temperature of 42 degrees C until colonic temperature (T-co) reached a designated level (39.5 or 41.0 degrees C; n = 10 per group at both temperature levels). NE turnover rates were similar in all four tissues sampled for both mature and senescent rats in the resting condition. Over the course of the heating period, progressive increases in arterial blood pressure and heart rate were observed, with the magnitudes of the presser and tachycardic responses similar between age groups. At T-co of 39.5 degrees C, calculated NE turnover rates were unchanged from control levels for the senescent and mature animals, whereas animals heated to 41.0 degrees C demonstrated marked elevations in NE turnover in all four tissues for both age groups. In addition, the increase in NE turnover rate at this T-co was significantly higher for senescent rats compared with their younger counterparts in the renal cortex (410 vs. 278%) and liver (557 vs. 170%). These results indicate that nonexertional heating and the concomitant rise in Tco are potent stimuli for increasing sympathetic neural outflow to internal organs such as the heart, kidney, liver, and adrenal gland in mature and senescent Fischer 344 rats. This increase in SNS activity, estimated from NE turnover rates, is tissue specific and dependent on the level of hyperthermia attained in both age groups. Finally, the elevated NE turnover rates in the kidney and liver of older animals suggest that aging is associated with increased efferent SNS activation in response to acute heat stress.
C1 UNIV ARIZONA,DEPT EXERCISE & SPORT SCI,TUCSON,AZ 85721.
   UNIV ARIZONA,DEPT PHYSIOL,TUCSON,AZ 85721.
C3 University of Arizona; University of Arizona
FU NHLBI NIH HHS [HL-07249] Funding Source: Medline; NIA NIH HHS [AG-12350]
   Funding Source: Medline; NIGMS NIH HHS [GM-08400] Funding Source:
   Medline
CR [Anonymous], 1983, HDB PHYSL CARDIOVA 2
   BHAGAT B, 1967, J PHARMACOL EXP THER, V157, P74
   BRODIE BB, 1966, J PHARMACOL EXP THER, V154, P493
   CARTEE GD, 1987, J APPL PHYSIOL, V63, P257, DOI 10.1152/jappl.1987.63.1.257
   CHIUEH CC, 1980, NEUROBIOL AGING, V1, P157, DOI 10.1016/0197-4580(80)90010-X
   COLEMAN GL, 1977, J GERONTOL, V32, P258, DOI 10.1093/geronj/32.3.258
   ESLER M, 1988, HYPERTENSION, V11, P3, DOI 10.1161/01.HYP.11.1.3
   ESLER M, 1989, HDB HYPERTENSION HYP, V12, P85
   FOLKOW B, 1982, PHYSIOL REV, V62, P347, DOI 10.1152/physrev.1982.62.2.347
   GOLDBERG PB, 1986, FASEB J, V45, P45
   HAJDUCZOK G, 1991, AM J PHYSIOL, V260, pH1113, DOI 10.1152/ajpheart.1991.260.4.H1113
   HANDA RK, 1987, AM J PHYSIOL, V253, pH1566, DOI 10.1152/ajpheart.1987.253.6.H1566
   HENRY DP, 1986, LIFE SCI, V38, P1473, DOI 10.1016/0024-3205(86)90560-6
   KREGEL KC, 1990, J APPL PHYSIOL, V69, P2043, DOI 10.1152/jappl.1990.69.6.2043
   KREGEL KC, 1993, J APPL PHYSIOL, V74, P1988, DOI 10.1152/jappl.1993.74.4.1988
   KREGEL KC, 1990, HYPERTENSION, V15, P497, DOI 10.1161/01.HYP.15.5.497
   KREGEL KC, 1992, PHYSIOLOGIST, V35, P236
   LAKATTA EG, 1975, CIRC RES, V36, P262, DOI 10.1161/01.RES.36.2.262
   MAZZEO RS, 1987, AM J PHYSIOL, V252, pE762, DOI 10.1152/ajpendo.1987.252.6.E762
   MAZZEO RS, 1989, J APPL PHYSIOL, V66, P1506, DOI 10.1152/jappl.1989.66.3.1506
   MCCARTY R, 1986, GERONTOLOGY, V32, P172, DOI 10.1159/000212785
   NG AV, 1993, HYPERTENSION, V21, P498, DOI 10.1161/01.HYP.21.4.498
   PALMER GJ, 1978, J GERONTOL, V33, P482, DOI 10.1093/geronj/33.4.482
   Rowe J W, 1980, Endocr Rev, V1, P167
   SIMON E, 1975, BRAIN RES, V87, P323, DOI 10.1016/0006-8993(75)90429-1
   SUNDLOF G, 1978, J PHYSIOL-LONDON, V274, P621, DOI 10.1113/jphysiol.1978.sp012170
   TANABE S, 1989, AM J PHYSIOL, V256, pH1399, DOI 10.1152/ajpheart.1989.256.5.H1399
   TUMA RF, 1985, AM J PHYSIOL, V249, pH485, DOI 10.1152/ajpheart.1985.249.3.H485
   WALTHER OE, 1970, PFLUG ARCH EUR J PHY, V319, P162, DOI 10.1007/BF00592494
   WEI JY, 1986, AM J PHYSIOL, V250, P1047
   YU BP, 1982, J GERONTOL, V37, P130, DOI 10.1093/geronj/37.2.130
   ZIEGLER MG, 1976, NATURE, V261, P333, DOI 10.1038/261333a0
NR 32
TC 6
Z9 6
U1 0
U2 0
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814
SN 8750-7587
J9 J APPL PHYSIOL
JI J. Appl. Physiol.
PD MAR
PY 1994
VL 76
IS 3
BP 1226
EP 1231
DI 10.1152/jappl.1994.76.3.1226
PG 6
WC Physiology; Sport Sciences
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Physiology; Sport Sciences
GA NB204
UT WOS:A1994NB20400036
PM 7911798
DA 2024-02-19
ER

PT J
AU Nosrati, Z
   Khanchi, AR
   Sheybani, S
AF Nosrati, Zeynab
   Khanchi, Ali Reza
   Sheybani, Shahab
TI Preparation of low-density <SUP>90</SUP>Y microspheres consisting of
   mesoporous silica core/yttria shell: a potential therapeutic agent for
   hepatic tumors
SO JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY
LA English
DT Article
DE Core/Shell microspheres; Cancer treatment; Radiotherapy; Mesoporous
   silica beads; Chemical durability
ID INTERNAL RADIATION-THERAPY; IN-SITU RADIOTHERAPY; DEEP-SEATED CANCER;
   CERAMIC MICROSPHERES; GLASS MICROSPHERES; LIVER-TUMORS; FABRICATION;
   MALIGNANCY; POWDERS
AB A new low-density silica core/yttria shell microspheres was developed for medical purposes. For preparing the core of this material, sol-emulsion-gel method was used. It was then calcined at 1,000 degrees C to increase the strength of the mesoporous beads. After cooling, it was added into a solution containing the mixture of yttrium chloride and urea. Under these circumstances, yttrium chloride can decompose to yttrium basic carbonate particles by the gradual hydrolysis of urea. These particles are able to deposit on the surface of mesoporous silica beads. Different coated samples were prepared under various pH, temperature and stirring conditions. Samples were heated to convert yttrium basic carbonate to yttria. The resulting silica core/yttria shell microspheres was characterized by laser diffractometer, scanning electron and optical microscopy techniques. It was found the pH of silica sols, aging time and Span-80 play important role in the stage of mesoporous bead preparation. Furthermore, the findings showed the heating of core/shell microspheres was essential for the ultimate strength of the shell. The in vitro chemical durability tests showed the release of yttrium ion in two simulated body fluids at pH 6 and 7 was negligible after 4 weeks.
C1 [Nosrati, Zeynab] Islamic Azad Univ, Fac Engn, Sci & Res Branch, Tehran, Iran.
   [Khanchi, Ali Reza; Sheybani, Shahab] Nucl Sci & Technol Res Inst, Tehran, Iran.
C3 Islamic Azad University
RP Khanchi, AR (corresponding author), Nucl Sci & Technol Res Inst, Karghar Ave, Tehran, Iran.
EM khanchi@gmail.com
FU nuclear science and technology research institute
FX The authors would like to acknowledge the nuclear science and technology
   research institute for financial and technical supports.
CR [Anonymous], J RADIOTHERAPY
   Bortot MB, 2012, PROC MAT SCI, V1, P351, DOI 10.1016/j.mspro.2012.06.047
   Burness LT, 2009, MATER SCI TECHNOL, P1
   Cao SS, 2009, AUST J CHEM, V62, P1561, DOI 10.1071/CH08420
   Chakravarty R, 2008, NUCL MED BIOL, V35, P245, DOI 10.1016/j.nucmedbio.2007.10.009
   EHRHARDT GJ, 1987, NUCL MED BIOL, V14, P233
   Ehrhardt GJ, 1989, European Patent, Patent No. 0201601
   ERBE EM, 1993, J BIOMED MATER RES, V27, P1301, DOI 10.1002/jbm.820271010
   Garrean S, 2005, SURG ONCOL, V14, P179, DOI 10.1016/j.suronc.2006.01.003
   GIESCHE H, 1994, J MATER RES, V9, P436, DOI 10.1557/JMR.1994.0436
   Giesche H, 1998, J DISPER SCI TECHNOL, V19, P249, DOI 10.1080/01932699808913174
   HAFELI UO, 1994, J BIOMED MATER RES, V28, P901
   Hoffmann F, 2006, ANGEW CHEM INT EDIT, V45, P3216, DOI 10.1002/anie.200503075
   Kawashita M, 2006, J AM CERAM SOC, V89, P1347, DOI 10.1111/j.1551-2916.2005.00867.x
   Kawashita M, 2005, INT J APPL CERAM TEC, V2, P173, DOI 10.1111/j.1744-7402.2005.02023.x
   Kawashita M, 2003, BIOMATERIALS, V24, P2955, DOI 10.1016/S0142-9612(03)00094-2
   Kokubo T, 2004, European patent, Patent No. 1162626
   Lau WY, 1998, INT J RADIAT ONCOL, V40, P583, DOI 10.1016/S0360-3016(97)00818-3
   Montaña RL, 2012, CURR RADIOPHARM, V5, P253, DOI 10.2174/1874471011205030253
   Murthy R, 2005, RADIOGRAPHICS, V25, pS41, DOI 10.1148/rg.25si055515
   Nijsen JFW, 2002, CURR MED CHEM, V9, P73, DOI 10.2174/0929867023371454
   Osso JA, 2009, THERAPEUTIC RADIONUC, P45
   Pal R, 2009, J NON-CRYST SOLIDS, V355, P76, DOI 10.1016/j.jnoncrysol.2008.03.052
   Poorbaygi H, 2011, APPL RADIAT ISOTOPES, V69, P1407, DOI 10.1016/j.apradiso.2011.05.026
   Rahaman M.N., 2003, CERAMIC PROCESSING S, P95
   Ruys, 2002, US Patent, Patent No. 0197207
   Salem R, 2006, INT J RADIAT ONCOL, V66, pS83, DOI 10.1016/j.ijrobp.2006.02.061
   SCHUBIGER PA, 1991, NUCL MED BIOL, V18, P305
   Smitha S, 2008, J SOL-GEL SCI TECHN, V48, P356, DOI 10.1007/s10971-008-1803-3
   Stubbs R S, 2004, HPB (Oxford), V6, P133, DOI 10.1080/13651820410025084
   Uthappa MC, 2011, INDIAN J CANCER, V48, P18, DOI 10.4103/0019-509X.76625
   Vallet-Regi Maria, 2008, Open Biomed Eng J, V2, P1, DOI 10.2174/1874120700802010001
   Van de Wiele C, 2009, Q J NUCL MED MOL IM, V53, P317
   Vente MAD, 2009, EUR RADIOL, V19, P951, DOI 10.1007/s00330-008-1211-7
   Verin V, 1996, J AM COLL CARDIOL  S, V27, P321
   WALKER LA, 1964, ACTA RADIOL THER PHY, V2, P302
   Wang WC, 2011, J COLLOID INTERF SCI, V358, P567, DOI 10.1016/j.jcis.2011.03.023
   Watanabe N, 1999, NUCL MED BIOL, V26, P847, DOI 10.1016/S0969-8051(99)00064-5
   Yoo HS, 2010, J LUMIN, V130, P153, DOI 10.1016/j.jlumin.2009.08.005
NR 39
TC 4
Z9 4
U1 4
U2 20
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0236-5731
EI 1588-2780
J9 J RADIOANAL NUCL CH
JI J. Radioanal. Nucl. Chem.
PD AUG
PY 2014
VL 301
IS 2
BP 373
EP 382
DI 10.1007/s10967-014-3168-0
PG 10
WC Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry; Nuclear Science & Technology
GA AN3LW
UT WOS:000340490600009
DA 2024-02-19
ER

PT J
AU Dowgray, N
   Pinchbeck, G
   Eyre, K
   Biourge, V
   Comerford, E
   German, AJ
AF Dowgray, Nathalie
   Pinchbeck, Gina
   Eyre, Kelly
   Biourge, Vincent
   Comerford, Eithne
   German, Alexander J.
TI Aging in Cats: Owner Observations and Clinical Finding in 206 Mature
   Cats at Enrolment to the Cat Prospective Aging and Welfare Study
SO FRONTIERS IN VETERINARY SCIENCE
LA English
DT Article
DE cat; feline; mature; middle-aged; survey; dental; welfare
ID DEGENERATIVE JOINT DISEASE; ISFM CONSENSUS GUIDELINES;
   CHRONIC-RENAL-FAILURE; RISK-FACTORS; BLOOD-PRESSURE; FELINE OBESITY;
   HEALTHY CATS; VETERINARY PRACTICES; PREVALENCE; MANAGEMENT
AB Two hundred and six cats, aged between 7 and 10 years, from the North-west of the UK, were enrolled in a cat aging and welfare study to determine the frequency of age-related conditions and associations with husbandry, owner observations of physical appearance, activity and behavior. This is the largest study to date of mature cats that includes data from an owner questionnaire and clinical examinations. At enrolment, owners frequently reported physical changes (53%), behavioral changes (47%), changes to eating patterns (41%), and activity changes (40%) in their mature cats. On physical examination, 45% cats were in overweight condition and 12% were obese. A heart murmur was detected in 29% cats, whilst indirect systolic blood pressure (SBP) was >160 mmHg in 5% cats. Dental disease was present in 54% cats and was associated with a matted hair coat (P = 0.01), increased sleeping (P = 0.02), absence of gray hairs (P = 0.03), and increased irritability to other pets (P = 0.04). Abnormalities were evident in 58% of cats that allowed an orthopedic examination (OE) to be performed. These cats were older than cats with a normal OE (P = 0.01), and abnormal OE findings were associated with a matted coat (P = 0.03) and increased grooming (P = 0.04). Aazotaemia was present in 10% cats, and this was associated with cats being observed to "sniff their food and then walk away" (P = 0.04). Hyperthyroidism was diagnosed in 3% cats, who were older (P = 0.02), had a leaner BCS (P = 0.02) and lesser blood creatinine concentrations (P = 0.01). Hyperthyroid cats were also more likely to have increased liver enzyme activity and increased SBP (P = <0.001) compared with non-hyperthyroid cats. Of the 176 cats where all clinical assessments were conducted, only 12% had no evidence of any disease. Clinical abnormalities are commonly identified when thorough, clinical assessments are performed in mature pet cats visiting primary care practice.
C1 [Dowgray, Nathalie; Eyre, Kelly; Comerford, Eithne; German, Alexander J.] Univ Liverpool, Inst Life Course & Med Sci, Liverpool, England.
   [Dowgray, Nathalie] Int Cat Care, Tisbury, England.
   [Pinchbeck, Gina] Univ Liverpool, Inst Infect Vet & Ecol Sci, Liverpool, England.
   [Biourge, Vincent] Royal Canin Res Ctr, Aimargues, France.
   [Comerford, Eithne; German, Alexander J.] Univ Liverpool, Sch Vet Sci, Liverpool, England.
C3 University of Liverpool; University of Liverpool; University of
   Liverpool
RP Dowgray, N (corresponding author), Univ Liverpool, Inst Life Course & Med Sci, Liverpool, England.; Dowgray, N (corresponding author), Int Cat Care, Tisbury, England.
EM ndowgray@liverpool.ac.uk
OI Comerford, Eithne/0000-0002-5244-6042
CR [Anonymous], 2020, J FELINE MED SURG, V22, P813, DOI 10.1177/1098612X20941784
   Bellows J, 2016, J FELINE MED SURG, V18, P551, DOI 10.1177/1098612X16649525
   Bellows J, 2016, J FELINE MED SURG, V18, P533, DOI 10.1177/1098612X16649523
   Bennett D., 2015, OSTEOARTHRITIS AGING, V7, P957, DOI [10.1016/B978-0-323-22652-3.00096-7, DOI 10.1016/B978-0-323-22652-3.00096-7]
   Bennett D, 2009, J FELINE MED SURG, V11, P997, DOI 10.1016/j.jfms.2009.09.016
   Bijsmans ES, 2015, J VET INTERN MED, V29, P855, DOI 10.1111/jvim.12600
   Bodey AR, 1998, J SMALL ANIM PRACT, V39, P567, DOI 10.1111/j.1748-5827.1998.tb03710.x
   Cannon M, 2013, J FELINE MED SURG, V15, P21, DOI 10.1177/1098612X12470342
   Carney HC, 2016, J FELINE MED SURG, V18, P400, DOI 10.1177/1098612X16643252
   Cats Protection, 2021, CATS THEIR STATS REP
   Cave NJ, 2012, VET QUART, V32, P131, DOI 10.1080/01652176.2012.745957
   Cave NJ, 2012, PREV VET MED, V107, P121, DOI 10.1016/j.prevetmed.2012.05.006
   Clarke SP, 2005, VET REC, V157, P793, DOI 10.1136/vr.157.25.793
   Conroy M, 2019, VET REC, V184, DOI 10.1136/vr.105100
   Courcier EA, 2012, VET REC, V171, P560, DOI 10.1136/vr.100953
   D White J, 2006, AUST VET J, V84, P188, DOI 10.1111/j.1751-0813.2006.tb12796.x
   Day M J, 2016, J Small Anim Pract, V57, P4, DOI 10.1111/jsap.12431
   Dell'Osa D, 2016, AUST VET J, V94, P317, DOI 10.1111/avj.12481
   Dowgray N., 2020, THESIS U LIVERPOOL U, P66
   Eddelbuettel D, 2011, J STAT SOFTW, V40, P1
   Finch NC, 2016, J VET INTERN MED, V30, P602, DOI 10.1111/jvim.13917
   Freeman LM, 2016, J VET INTERN MED, V30, P1661, DOI 10.1111/jvim.14561
   Freeman L, 2011, J FELINE MED SURG, V13, P516, DOI 10.1016/j.jfms.2011.05.009
   German AJ, 2008, VET REC, V163, P503, DOI 10.1136/vr.163.17.503
   Girard N, 2009, J VET DENT, V26, P147, DOI 10.1177/089875640902600301
   Godfrey DR, 2005, J SMALL ANIM PRACT, V46, P425, DOI 10.1111/j.1748-5827.2005.tb00340.x
   Hardie EM, 2002, J AM VET MED ASSOC, V220, P628, DOI 10.2460/javma.2002.220.628
   Her Majesty's Government UK, 2018, DATA PROTECTION ACT
   Jepson RE, 2009, J VET INTERN MED, V23, P806, DOI 10.1111/j.1939-1676.2009.0339.x
   Jin K, 2016, PATHOBIOL AGING AGE, V6, DOI 10.3402/pba.v6.33276
   KOBAYASHI DL, 1990, J VET INTERN MED, V4, P58, DOI 10.1111/j.1939-1676.1990.tb00877.x
   Lascelles BDX, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-10
   Lascelles BDX, 2010, VET SURG, V39, P535, DOI 10.1111/j.1532-950X.2010.00708.x
   Little SE., 2012, MANAGING SENIOR CAT, P1166, DOI [10.1016/B978-1-4377-0660-4.00037-5, DOI 10.1016/B978-1-4377-0660-4.00037-5]
   Marino CL, 2014, J FELINE MED SURG, V16, P465, DOI 10.1177/1098612X13511446
   Merola I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150040
   Morrow LD., 2009, J VET INTERN MED, V23, P673, DOI [10.1111/j.1939-1676.2009.0316.x, DOI 10.1111/J.1939-1676.2009.0316.X]
   Murray JK, 2010, VET REC, V166, P163, DOI 10.1136/vr.b4712
   Murray JK, 2009, VET REC, V164, P137, DOI 10.1136/vr.164.5.137
   Murray JK, 2012, VET J, V192, P461, DOI 10.1016/j.tvjl.2011.08.035
   O'Neill DG, 2014, VET J, V202, P286, DOI 10.1016/j.tvjl.2014.08.004
   Paepe D, 2013, J FELINE MED SURG, V15, P8, DOI 10.1177/1098612X12464628
   Payne JR, 2017, J VET INTERN MED, V31, P15, DOI 10.1111/jvim.14625
   Payne JR, 2015, J VET CARDIOL, V17, pS244, DOI 10.1016/j.jvc.2015.03.008
   PDSA, 2019, PAW REP PDSA AN WELL
   PDSA, 2020, PDSA AN WELLB PAW RE, P60
   Pebesma E. J., 2005, R News, V5, P9
   Perez-Camargo G., 2010, FOC GER 2010 PUR COM, P6
   Peron L, 2016, TOP COMPANION ANIM M, V31, P122, DOI 10.1053/j.tcam.2016.08.008
   Pittari J, 2009, J FELINE MED SURG, V11, P763, DOI 10.1016/j.jfms.2009.07.011
   Quimby J, 2021, J FELINE MED SURG, V23, P211, DOI 10.1177/1098612X21993657
   Quimby JM, 2011, J FELINE MED SURG, V13, P733, DOI 10.1016/j.jfms.2011.07.003
   R Foundation for Statistical Computing, 2017, R LANG ENV STAT COMP
   Ray M, 2021, J FELINE MED SURG, V23, P613, DOI 10.1177/1098612X211021538
   Reppas G, 2016, J FELINE MED SURG, V18, P190, DOI 10.1177/1098612X16631228
   Robertson ID, 1999, PREV VET MED, V40, P75, DOI 10.1016/S0167-5877(99)00024-0
   Rolph NC, 2014, J NUTR SCI, V3, DOI 10.1017/jns.2014.42
   Rowe E, 2015, PREV VET MED, V121, P273, DOI 10.1016/j.prevetmed.2015.07.011
   Sánchez-Vizcaíno F, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-1138-9
   Sansom J, 2004, AM J VET RES, V65, P245, DOI 10.2460/ajvr.2004.65.245
   Slingerland LI, 2011, VET J, V187, P304, DOI 10.1016/j.tvjl.2009.12.014
   Sordo L, 2020, VET SCI, V7, DOI 10.3390/vetsci7030085
   Sparkes AH, 2016, J FELINE MED SURG, V18, P219, DOI 10.1177/1098612X16631234
   Sparkes AH, 2015, J FELINE MED SURG, V17, P235, DOI 10.1177/1098612X15571880
   Stephens MJ, 2014, VET REC, V175, DOI 10.1136/vr.102431
   Syme HM, 2002, J AM VET MED ASSOC, V220, P1799, DOI 10.2460/javma.2002.220.1799
   Taylor SS, 2017, J FELINE MED SURG, V19, P288, DOI 10.1177/1098612X17693500
   Teng KT, 2017, PREV VET MED, V144, P102, DOI 10.1016/j.prevetmed.2017.05.021
   Tyler S, 2019, J FELINE MED SURG, V21, P282, DOI 10.1177/1098612X18773911
   Volk JO, 2014, JAVMA-J AM VET MED A, V244, P799, DOI 10.2460/javma.244.7.799
   Wakeling J, 2009, J SMALL ANIM PRACT, V50, P406, DOI 10.1111/j.1748-5827.2009.00756.x
   Wakeling J, 2011, J VET INTERN MED, V25, P1057, DOI 10.1111/j.1939-1676.2011.00790.x
   Welsh CP, 2013, VET REC, V172, P578, DOI 10.1136/vr.101362
   Westgarth C, 2010, VET REC, V166, P354, DOI 10.1136/vr.c1606
   Wilson J., 2016, SOC VET EP PREV MED
NR 75
TC 7
Z9 7
U1 2
U2 21
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 2297-1769
J9 FRONT VET SCI
JI Front. Vet. Sci.
PD APR 4
PY 2022
VL 9
AR 859041
DI 10.3389/fvets.2022.859041
PG 13
WC Veterinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Veterinary Sciences
GA 0V9RX
UT WOS:000788677800001
PM 35445099
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Baran, M
   Cakir, M
   Unal, F
   Tumgor, G
   Yuksekkaya, HA
   Arikan, C
   Kilic, M
   Aydogdu, S
AF Baran, Masallah
   Cakir, Murat
   Unal, Fatih
   Tumgor, Gokhan
   Yuksekkaya, Hasan Ali
   Arikan, Cigdem
   Kilic, Murat
   Aydogdu, Sema
TI Evaluation of Growth After Liver Transplantation in Turkish Children
SO DIGESTIVE DISEASES AND SCIENCES
LA English
DT Article
DE Liver transplantation; Children; Growth
ID CATCH-UP GROWTH; POSTTRANSPLANTATION GROWTH; NUTRITIONAL ASPECTS;
   PEDIATRIC-PATIENTS; PLATE SENESCENCE; BILIARY ATRESIA; RECIPIENTS;
   DISEASE; HEIGHT
AB Aims Currently, the main interest in childhood liver transplantation (LT) is to prevent long-term complications and optimize growth. The aim of this study is to analyze (1) nutritional status in the pretransplantation period, and (2) posttransplantation growth and associated factors in children.
   Patients and Methods Eighty children were included in the study. Height (Z (H)) and weight (Z (W)) Z scores were calculated before transplantation and postoperatively at the 6th month and 1st, 2nd, 3rd, 4th, and 5th year.
   Results Patients' Z (H) and Z (W) scores at LT were -1.6 +/- A 1.3 and -1.5 +/- A 1.4, respectively. Both Z (H) and Z (W) scores increased after LT, especially in the first 6 months, and then continued to rise gradually. Both reached beyond -1 Z score at 2nd year and -0.5 at 4th year. Age, primary diagnosis, total steroid dose (< 1,000 mg), and absence of rejection episodes had positive impact on posttransplantation growth, whereas gender, immunosuppression type, surgical complications, and presence of tumor had no impact on posttransplantation growth. Age at time of LT was negatively correlated with Z (W) score at 5th year (P = 0.02, r = -0.43). Both Z (W) and Z (H) scores at time of LT were positively correlated with Z (W) and Z (H) scores and negatively correlated with a dagger Z (W) and a dagger Z (H) scores at 5th year.
   Conclusions LT is not only a modern, life-saving treatment technique but also an efficient method of facilitating growth, an indispensable component of childhood and the best indicator of health.
C1 [Baran, Masallah; Cakir, Murat; Unal, Fatih; Tumgor, Gokhan; Yuksekkaya, Hasan Ali; Arikan, Cigdem; Aydogdu, Sema] Ege Univ, Dept Pediat Gastroenterol Hepatol & Nutr, Izmir, Turkey.
   [Kilic, Murat] Kent Hosp, Organ Transplantat Ctr, Izmir, Turkey.
C3 Ege University; Kent Hospital
RP Cakir, M (corresponding author), Ege Univ, Dept Pediat Gastroenterol Hepatol & Nutr, Izmir, Turkey.
EM muratcak@hotmail.com
RI arikan, cigdem/ABF-2764-2020; Tumgor, Gokhan/K-3055-2018; Çakır,
   Murat/AAW-4255-2020; Baran, Masallah/ACJ-1208-2022
OI Çakır, Murat/0000-0003-4071-6129; Baran, Masallah/0000-0003-3827-2039;
   ARIKAN, Cigdem/0000-0002-0794-2741; kilic, murat/0000-0002-2887-1487
CR Alonso G, 2004, PEDIATR TRANSPLANT, V8, P255, DOI 10.1111/j.1399-3046.2004.00160.x
   Bartosh SM, 1999, J PEDIATR-US, V135, P624, DOI 10.1016/S0022-3476(99)70062-4
   Baruch Y, 2000, J HEPATOL, V32, P505, DOI 10.1016/S0168-8278(00)80403-1
   Bassanello M, 2004, LIVER TRANSPLANT, V10, P692, DOI 10.1002/lt.20111
   Cabré E, 2001, CURR OPIN CLIN NUTR, V4, P581, DOI 10.1097/00075197-200111000-00020
   CODONERFRANCH P, 1994, J PEDIATR-US, V124, P368, DOI 10.1016/S0022-3476(94)70357-4
   De Palo EF, 2001, CLIN CHIM ACTA, V310, P31, DOI 10.1016/S0009-8981(01)00511-3
   El Moghazy WM, 2010, LIVER TRANSPLANT, V16, P453, DOI 10.1002/lt.22010
   Emons JAM, 2005, J PEDIATR-US, V147, P843, DOI 10.1016/j.jpeds.2005.07.033
   Evans IVR, 2005, PEDIATR TRANSPLANT, V9, P480, DOI 10.1111/j.1399-3046.2005.00326.x
   McDiarmid SV, 1999, TRANSPLANTATION, V67, P404, DOI 10.1097/00007890-199902150-00011
   McDiarmid SV, 1995, TRANSPLANTATION, V60, P1443, DOI 10.1097/00007890-199560120-00013
   Nilsson O, 2005, PEDIATR NEPHROL, V20, P319, DOI 10.1007/s00467-004-1689-4
   Park SJ, 2005, J KOREAN MED SCI, V20, P835, DOI 10.3346/jkms.2005.20.5.835
   Pawlowska J, 2010, ANN TRANSPL, V15, P72
   Ramaccioni V, 2000, J PEDIATR GASTR NUTR, V30, P361, DOI 10.1097/00005176-200004000-00003
   Reding R, 2003, LANCET, V362, P2068, DOI 10.1016/S0140-6736(03)15104-5
   Renz JF, 2001, LIVER TRANSPLANT, V7, P1040, DOI 10.1053/jlts.2001.29413
   Saito T, 2007, PEDIATR TRANSPLANT, V11, P764, DOI 10.1111/j.1399-3046.2007.00744.x
   Scheenstra R, 2008, J PEDIATR GASTR NUTR, V47, P165, DOI 10.1097/MPG.0b013e3181623279
   Viner RM, 1999, ARCH DIS CHILD, V80, P235, DOI 10.1136/adc.80.3.235
   Yuksekkaya HA, 2008, DIGEST DIS SCI, V53, P803, DOI 10.1007/s10620-007-9917-y
NR 22
TC 3
Z9 5
U1 0
U2 3
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0163-2116
J9 DIGEST DIS SCI
JI Dig. Dis. Sci.
PD NOV
PY 2011
VL 56
IS 11
BP 3343
EP 3349
DI 10.1007/s10620-011-1727-6
PG 7
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 843AE
UT WOS:000296643400033
PM 21562786
DA 2024-02-19
ER

PT J
AU Mahler, JF
   Stokes, W
   Mann, PC
   Takaoka, M
   Maronpot, RR
AF Mahler, JF
   Stokes, W
   Mann, PC
   Takaoka, M
   Maronpot, RR
TI Spontaneous lesions in aging FVB/N mice
SO TOXICOLOGIC PATHOLOGY
LA English
DT Article
DE tumors; mouse; spontaneous; transgenic
ID TRANSGENIC MICE; HA-RAS; MOUSE; NEOPLASMS; INDUCTION; GENES; SKIN; STEP
AB The FVB/N mouse strain was created in the early 1970s and has since been used extensively in transgenic research because of its well-defined inbred background, superior reproductive performance, and prominent pronuclei of fertilized zygotes, which facilitate microinjection of DNA. Little is known, however, about the survivability and spontaneous disease of nontransgenic FVB/N mice. Therefore, the purpose of this study was to determine survival to 24 mo of age and the incidence of neoplastic and nonneoplastic disease at 14 and 24 mo of age. At 14 mo of age, the incidence of tumor-bearing mice was 13% in males (n = 45) and 26% in females (n = 98). All tumors in males and most in females at this time were alveolar-bronchiolar (AB) neoplasms of the lung. Survival to 24 mo of age was approximately 60% in both sexes (29/50 males, 71/116 females), and the incidence of mice with tumors at this time was 55% in males and 66% in females. In decreasing order of frequency, the following neoplasms were observed in >5% of subjects: in males, lung AB tumors, liver hepatocellular tumors, subcutis neural crest tumors, and Harderian gland adenomas; in females, lung AB tumors, pituitary gland adenomas, ovarian tumors (combined types), lymphomas, histiocytic sarcomas, Harderian gland adenomas, and pheochromocytomas. Compared with other mouse strains, the observed incidences of tumors in FVB/N mice suggest a higher than usual rate of lung tumors and a lower than usual incidence of liver tumors and lymphomas. This tumor profile should be considered in the interpretation of neoplastic phenotypes in FVB/N-derived transgenic lines.
RP Mahler, JF (corresponding author), NIEHS,ENVIRONM TOXICOL PROGRAM,LAB EXPT PATHOL,MD B3-06,POB 12233,RES TRIANGLE PK,NC 27709, USA.
CR [Anonymous], 1990, PATHOLOGY FISCHER RA
   BRINSTER RL, 1985, P NATL ACAD SCI USA, V82, P4438, DOI 10.1073/pnas.82.13.4438
   CUTHBERTSON RA, 1988, LAB INVEST, V58, P484
   DRINKWATER NR, 1986, CARCINOGENESIS, V7, P1701, DOI 10.1093/carcin/7.10.1701
   FRITH CH, 1993, TOXICOL PATHOL, V21, P206, DOI 10.1177/019262339302100213
   FRITH CH, 1996, MONOGRAPHS PATHOLOGY, P386
   Haseman JK, 1996, MUTAT RES-FUND MOL M, V350, P131, DOI 10.1016/0027-5107(95)00098-4
   HENNINGS H, 1993, CARCINOGENESIS, V14, P2353, DOI 10.1093/carcin/14.11.2353
   LEDER A, 1990, P NATL ACAD SCI USA, V87, P9178, DOI 10.1073/pnas.87.23.9178
   MAHLER JF, 1995, TOXICOL PATHOL, V23, P744
   MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5
   Overbeek Paul A., 1994, P69
   Polites H. Greg, 1994, P15
   RITTINGHAUSEN S, 1996, MONOGRAPHS PATHOLOGY, P183
   SCHULZ N, 1992, CANCER RES, V52, P450
   SINN E, 1987, CELL, V49, P465, DOI 10.1016/0092-8674(87)90449-1
   STEWART TA, 1984, CELL, V38, P627, DOI 10.1016/0092-8674(84)90257-5
   SZTEIN JM, 1994, LAB ANIMAL, V23, P19
   TAKETO M, 1991, P NATL ACAD SCI USA, V88, P2065, DOI 10.1073/pnas.88.6.2065
   TURUSOV VS, 1994, PATHOLOGY TUMORS LAB, V2, P671
NR 20
TC 161
Z9 171
U1 0
U2 3
PU SOC TOXICOLOGIC PATHOLOGISTS
PI LAWRENCE
PA 1041 NEW HAMPSHIRE ST PO BOX 368, LAWRENCE, KS 66044
SN 0192-6233
J9 TOXICOL PATHOL
JI Toxicol. Pathol.
PD NOV-DEC
PY 1996
VL 24
IS 6
BP 710
EP 716
DI 10.1177/019262339602400606
PG 7
WC Pathology; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pathology; Toxicology
GA WB824
UT WOS:A1996WB82400006
PM 8994298
DA 2024-02-19
ER

PT J
AU Koch, OR
   Fusco, S
   Ranieri, SC
   Maulucci, G
   Palozza, P
   Larocca, LM
   Cravero, AAM
   Farre, SM
   De Spirito, M
   Galeotti, T
   Pani, G
AF Koch, Osvaldo R.
   Fusco, Salvatore
   Ranieri, Sofia Chiatamone
   Maulucci, Giuseppe
   Palozza, Paola
   Larocca, Luigi Maria
   Cravero, Amerys A. M.
   Farre, Stella M.
   De Spirito, Marco
   Galeotti, Tommaso
   Pani, Giovambattista
TI Role of the life span determinant P66<SUP>shcA</SUP> in ethanol-induced
   liver damage
SO LABORATORY INVESTIGATION
LA English
DT Article
DE alcohol-related liver damage; reactive oxygen species (ROS); p66shcA;
   manganese superoxide dismutase; mitochondria; p66 KO mice
ID MANGANESE SUPEROXIDE-DISMUTASE; ALCOHOLIC FATTY LIVER; OXIDATIVE STRESS;
   MOLECULAR-MECHANISMS; CYTOCHROME-P450 2E1; SIGNALING PATHWAY; RAT-LIVER;
   APOPTOSIS; MICE; MITOCHONDRIA
AB Mice lacking the 66 kDa isoform of the adapter molecule shcA (p66(shcA)) display increased resistance to oxidative stress and delayed aging. In cultured cell lines, p66 promotes formation of Reactive Oxygen Species (ROS) in mitochondria, and apoptotic cell death in response to a variety of pro-oxidant noxious stimuli. As mitochondrial ROS and oxidative cell damage are clearly involved in alcohol-induced pathology, we hypothesized that p66 may also have a role in ethanol. In vivo, changes observed in p66+/+ mice after 6-week exposure to ethanol in the drinking water, including elevated serum alanine aminotransferase (ALT), liver swelling and evident liver steatosis, were significantly attenuated in p66-/- mutant mice. Biochemical analysis of liver tissues revealed induction of the p66 protein by ethanol, whereas p66-deficient livers responded to alcohol with a significant upregulation of the mitochondrial antioxidant enzyme MnSOD, nearly absent in control mice. Evidence of an inverse correlation between expression level of p66 and protection from alcohol-induced oxidative stress was also confirmed in vitro in primary hepatocytes and in HepG2-E47 cells, an ethanol-responsive hepatoma cell line. In fact, MnSOD upregulation by exposure to ethanol in vitro was much more pronounced in p66KO versus wild-type isolated liver cells, and blunted in HepG2 cells overexpressing p66shc. p66 overexpression also prevented the activation of a luciferase reporter gene controlled by the SOD2 promoter, indicating that p66 repression of MnSOD operates at a transcriptional level. Finally, p66 generated ROS in HepG2 cells and potentiated oxidative stress and mitochondrial depolarization by ethanol. Taken together, the above observations clearly indicate a role for p66 in alcohol-induced cell damage, likely via a cell-autonomous mechanism involving reduced expression of antioxidant defenses and mitochondrial dysfunction.
C1 [Fusco, Salvatore; Ranieri, Sofia Chiatamone; Palozza, Paola; Galeotti, Tommaso; Pani, Giovambattista] Univ Cattolica Sacro Cuore, Sch Med, Inst Gen Pathol, I-00168 Rome, Italy.
   [Koch, Osvaldo R.; Cravero, Amerys A. M.; Farre, Stella M.] Univ Buenos Aires, Fac Med, Dept Pathol, Buenos Aires, DF, Argentina.
   [Maulucci, Giuseppe; De Spirito, Marco] Univ Cattolica Sacro Cuore, Sch Med, Inst Phys, Rome, Italy.
   [Larocca, Luigi Maria] Univ Cattolica Sacro Cuore, Sch Med, Dept Pathol, Rome, Italy.
C3 Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli;
   University of Buenos Aires; Catholic University of the Sacred Heart;
   IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart;
   IRCCS Policlinico Gemelli
RP Pani, G (corresponding author), Univ Cattolica Sacro Cuore, Sch Med, Inst Gen Pathol, Largo F Vito 1, I-00168 Rome, Italy.
EM gpani@rm.unicatt.it
RI Larocca, Luigi M/A-1577-2008; Fusco, Salvatore/K-7867-2018; Fusco,
   Salvatore/AAA-6651-2021; De Spirito, Marco/U-3817-2019; Maulucci,
   Giuseppe/C-7400-2009; Pani, Giovambattista/AAB-1446-2019; De Spirito,
   Marco/C-5386-2008; Larocca, Luigi Maria/M-9590-2019
OI Larocca, Luigi M/0000-0003-1739-4758; Fusco,
   Salvatore/0000-0003-3294-0016; Fusco, Salvatore/0000-0003-3294-0016; De
   Spirito, Marco/0000-0003-4260-5107; Maulucci,
   Giuseppe/0000-0002-2154-319X; De Spirito, Marco/0000-0003-4260-5107;
   Larocca, Luigi Maria/0000-0003-1739-4758; Chiatamone Ranieri,
   Sofia/0000-0003-3151-5894; Pani, Giovambattista/0000-0001-7133-8728
CR Adachi M, 2002, FREE RADICAL BIO MED, V32, P487, DOI 10.1016/S0891-5849(02)00740-2
   Bai JX, 2001, J BIOL CHEM, V276, P4315, DOI 10.1074/jbc.M008895200
   Bailey SM, 2002, FREE RADICAL BIO MED, V32, P11, DOI 10.1016/S0891-5849(01)00769-9
   Bradford BU, 2005, HEPATOLOGY, V41, P336, DOI 10.1002/hep.20532
   Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637
   Caro AA, 2004, ANNU REV PHARMACOL, V44, P27, DOI 10.1146/annurev.pharmtox.44.101802.121704
   Chen Q, 1998, MOL PHARMACOL, V53, P638, DOI 10.1124/mol.53.4.638
   Crabb DW, 2004, ALCOHOL, V34, P35, DOI 10.1016/j.alcohol.2004.07.005
   Francia P, 2004, CIRCULATION, V110, P2889, DOI 10.1161/01.CIR.0000147731.24444.4D
   Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011
   Herzig S, 2003, NATURE, V426, P190, DOI 10.1038/nature02110
   Hoek JB, 2002, GASTROENTEROLOGY, V122, P2049, DOI 10.1053/gast.2002.33613
   Kessova IG, 2003, HEPATOLOGY, V38, P1136, DOI 10.1053/jhep.2003.50450
   Kim HP, 1999, J BIOL CHEM, V274, P37455, DOI 10.1074/jbc.274.52.37455
   Koch O, 2000, ALCOHOL ALCOHOLISM, V35, P159, DOI 10.1093/alcalc/35.2.159
   KOCH OR, 1991, XENOBIOTICA, V21, P1077, DOI 10.3109/00498259109039547
   KOCH OR, 1994, BIOCHEM BIOPH RES CO, V201, P1356, DOI 10.1006/bbrc.1994.1853
   Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036
   Lieber CS, 2004, ALCOHOL, V34, P9, DOI 10.1016/j.alcohol.2004.07.008
   LIEBER CS, 1989, HEPATOLOGY, V10, P501, DOI 10.1002/hep.1840100417
   McKim SE, 2003, GASTROENTEROLOGY, V125, P1834, DOI 10.1053/j.gastro.2003.08.030
   Mendez-Sanchez Nahum, 2005, Ann Hepatol, V4, P32
   Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311
   Morgan K, 2002, HEPATOLOGY, V36, P122, DOI 10.1053/jhep.2002.33720
   MUFTI SI, 1992, CANCER DETECT PREV, V16, P157
   NANJI AA, 1989, ALCOHOL CLIN EXP RES, V13, P15, DOI 10.1111/j.1530-0277.1989.tb00276.x
   Napoli C, 2003, P NATL ACAD SCI USA, V100, P2112, DOI 10.1073/pnas.0336359100
   Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004
   Orsini F, 2004, J BIOL CHEM, V279, P25689, DOI 10.1074/jbc.M401844200
   Ostergaard H, 2001, EMBO J, V20, P5853, DOI 10.1093/emboj/20.21.5853
   Palozza P, 1998, J NUTR, V128, P1989, DOI 10.1093/jn/128.11.1989
   Pani G, 2004, BIOCHEM BIOPH RES CO, V325, P97, DOI 10.1016/j.bbrc.2004.09.213
   Pérez MJ, 2003, HEPATOLOGY, V38, P1146, DOI 10.1053/jhep.2003.50479
   Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525
   Trinei M, 2002, ONCOGENE, V21, P3872, DOI 10.1038/sj.onc.1205513
   Wheeler MD, 2001, J BIOL CHEM, V276, P36664, DOI 10.1074/jbc.M105352200
   Wu DF, 1996, J BIOL CHEM, V271, P23914, DOI 10.1074/jbc.271.39.23914
   You M, 2004, ALCOHOL, V34, P39, DOI 10.1016/j.alcohol.2004.07.004
   You M, 2004, GASTROENTEROLOGY, V127, P1798, DOI 10.1053/j.gastro.2004.09.049
   You M, 2002, J BIOL CHEM, V277, P29342, DOI 10.1074/jbc.M202411200
   Zaccagnini G, 2004, CIRCULATION, V109, P2917, DOI 10.1161/01.CIR.0000129309.58874.0F
NR 41
TC 62
Z9 75
U1 0
U2 8
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA
SN 0023-6837
J9 LAB INVEST
JI Lab. Invest.
PD JUL
PY 2008
VL 88
IS 7
BP 750
EP 760
DI 10.1038/labinvest.2008.44
PG 11
WC Medicine, Research & Experimental; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pathology
GA 318DY
UT WOS:000257073000006
PM 18490896
OA hybrid
DA 2024-02-19
ER

PT J
AU MO, JQ
   HOM, DG
   ANDERSON, JK
AF MO, JQ
   HOM, DG
   ANDERSON, JK
TI DECREASES IN PROTECTIVE ENZYMES CORRELATES WITH INCREASED OXIDATIVE
   DAMAGE IN THE AGING MOUSE-BRAIN
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE FREE-RADICAL DAMAGE; OXIDATIVE STRESS; AGING MOUSE BRAIN; FREE-RADICAL
   SCAVENGING ENZYMES; LIPID PEROXIDATION; PROTEIN OXIDATION
ID SUPEROXIDE-DISMUTASE; PARKINSONS-DISEASE; LIPID-PEROXIDATION;
   GLUTATHIONE-PEROXIDASE; SUBSTANTIA NIGRA; RAT-LIVER; CATALASE;
   HYPOTHESIS; RADICALS; STRESS
AB We used several biochemical assays to evaluate age-related changes in antioxidant enzyme levels vs. free-radical damage in the murine brain. We found levels of several free-radical scavenging enzymes in the brains of 24-month-old C57Bl male mice vs. 12-month-old animals were decreased, including superoxide dismutase (SOD), catalase, and glutathione reductase (GSSG-Rd). In addition, we found concomitant increases in the levels of several forms of free-radical damage including sensitivity to lipid peroxidation as measured by the thiobarbituric acid test, protein oxidation as measured by glutamine synthetase (Gln Syn) activity, as well as increases in oxidized glutathione (GSSG) levels, a measure of oxidative stress. These data suggest that decreases in levels of enzymes which ordinarily protect neuronal cells against oxidative stress with age may be responsible for increased levels of free-radical damage in the murine brain, or that these enzymes themselves are susceptible to inactivation by free radical molecules which increase with age in the brain.
C1 UNIV SO CALIF, ETHEL PERCY ANDRUS GERONTOL CTR, DIV NEUROGERONTOL, LOS ANGELES, CA 90089 USA.
C3 University of Southern California
OI Andersen, Julie/0000-0003-1324-4875
CR AMBANI LM, 1975, ARCH NEUROL-CHICAGO, V32, P114, DOI 10.1001/archneur.1975.00490440064010
   ANDERSEN JK, 1994, NEURODEGENERATION, V3, P97
   Artur Y, 1992, EXS, V62, P359
   CARLBERG I, 1975, J BIOL CHEM, V250, P5475
   CHEN TS, 1989, P SOC EXP BIOL MED, V190, P399
   COHEN G, 1970, ANAL BIOCHEM, V34, P30, DOI 10.1016/0003-2697(70)90083-7
   COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908
   DEHAAN JB, 1992, MOL BRAIN RES, V13, P179, DOI 10.1016/0169-328X(92)90025-7
   DEXTER DT, 1989, J NEUROCHEM, V52, P381, DOI 10.1111/j.1471-4159.1989.tb09133.x
   DEXTERDT, 1989, LANCET, V11, P639
   Evans P H, 1992, EXS, V62, P178
   FAHN S, 1992, ANN NEUROL, V32, P804, DOI 10.1002/ana.410320616
   HAJIMOHAMMADREZA I, 1990, NEUROSCI LETT, V112, P333, DOI 10.1016/0304-3940(90)90226-Y
   HALLIWELL B, 1985, TRENDS NEUROSCI, V8, P22, DOI 10.1016/0166-2236(85)90010-4
   KELLOGG EW, 1976, J GERONTOL, V31, P405, DOI 10.1093/geronj/31.4.405
   KOSTYUK VA, 1989, BIOCHEM INT, V19, P1117
   KOVACHICH GB, 1980, J NEUROCHEM, V35, P1449, DOI 10.1111/j.1471-4159.1980.tb09022.x
   LAWRENCE RA, 1976, BIOCHEM BIOPH RES CO, V71, P952, DOI 10.1016/0006-291X(76)90747-6
   MEISTER A, 1985, METHOD ENZYMOL, V113, P185
   MICHIELS C, 1988, EXP CELL RES, V179, P581, DOI 10.1016/0014-4827(88)90296-0
   MICHIELS C, 1990, J CELL PHYSIOL, V144, P295, DOI 10.1002/jcp.1041440216
   NAKASHIMA K, 1993, JPN J CLIN MED, V51, P1017
   OLANOW CW, 1992, ANN NEUROL, V32, pS2, DOI 10.1002/ana.410320703
   PERRY TL, 1986, NEUROSCI LETT, V67, P269, DOI 10.1016/0304-3940(86)90320-4
   PIGEOLET E, 1990, MECH AGEING DEV, V51, P283, DOI 10.1016/0047-6374(90)90078-T
   SLIVKA A, 1987, NEUROSCI LETT, V74, P112, DOI 10.1016/0304-3940(87)90061-9
   SMITH CD, 1991, P NATL ACAD SCI USA, V88, P10540, DOI 10.1073/pnas.88.23.10540
   WESTLUND KN, 1985, SCIENCE, V230, P181, DOI 10.1126/science.3875898
   WILBUR KM, 1949, ARCH BIOCHEM, V24, P305
NR 29
TC 91
Z9 98
U1 0
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD JUL 14
PY 1995
VL 81
IS 2-3
BP 73
EP 82
DI 10.1016/0047-6374(95)01586-O
PG 10
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA RL162
UT WOS:A1995RL16200002
PM 8569282
DA 2024-02-19
ER

PT J
AU Hong, HT
   Hsu, TH
   Hung, SW
   Chiu, CC
   Wu, CY
   Chen, CC
   Lee, GC
   Lin, JS
   Wu, CP
AF Hong, Hsin-Tai
   Hsu, Tsung-Hsien
   Hung, Shao-Wen
   Chiu, Chien-Chao
   Wu, Chun-Yun
   Chen, Chia-Chi
   Lee, Guo-Chi
   Lin, Jyh-Shiun
   Wu, Chean-Ping
TI Different Parts of the Chicken Embryo Egg Improve D-Galactose-Induced
   Aging in a Mice Model
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID EXERCISE PERFORMANCE; OXIDATIVE STRESS; MOUSE MODELS; MUSCLE
AB Chick (CE) or duck embryo eggs are known for nutritional supplement foods in traditional East countries for physical fitness enhancement and postpartum conditioning for many years. In this study, we evaluated the effects of different parts of the 10-day CE (embryo: CEr, yolk: CEw, and chorioallantoic membrane: CEp) on the antifatigue and antiaging activities in a D-galactose- (D-gal) induced aging mice model. The results showed CEp obviously increased the muscle weight and the liver and muscle glycogen content and enhanced exercise performance. In the antiaging assay, CEp significantly increased the activity of superoxide dismutase (SOD) and Glutathione Peroxidase (GPx). Moreover, the immunohistochemistry results of NRF-2 and HO-1 were also detected in the livers of mice in the D-gal/CEp group. The only partially potential such as CEr might improve OFT function with TG level, and CEw had strange grip strength. Therefore, we suggest that CEp has a potent antifatigue ability and could minimize the occurrence of age-associated disorders, more than other parts of the 10 days chicken embryo egg.
C1 [Hong, Hsin-Tai; Hsu, Tsung-Hsien; Wu, Chean-Ping] Natl Chiayi Univ, Dept Anim Sci, Chiayi 600, Taiwan.
   [Hsu, Tsung-Hsien; Hung, Shao-Wen; Chiu, Chien-Chao; Wu, Chun-Yun; Chen, Chia-Chi; Lin, Jyh-Shiun] Agr Technol Res Inst, Anim Technol Res Ctr, Div Anim Ind, Miaoli 350, Taiwan.
   [Lee, Guo-Chi] Council Agr Execut Yuan, Dept Sci & Technol, Taipei 100, Taiwan.
C3 National Chiayi University; Agricultural Technology Research Institute
RP Wu, CP (corresponding author), Natl Chiayi Univ, Dept Anim Sci, Chiayi 600, Taiwan.
EM s1030006@mail.ncyu.edu.tw; tzong@mail.atri.org.tw;
   1032169@mail.atri.org.tw; chiu2295@yahoo.com.tw;
   1072097@mail.atri.org.tw; 102234@mail.atri.org.tw;
   coachlee@mail.coa.gov.tw; jsl@mail.atri.org.tw; wcp20200409@gmail.com
RI Chia-Chi, Chen/HPE-6882-2023; Wang, Han/JJF-2614-2023; wang,
   KiKi/JFZ-3334-2023
CR Aartsma-Rus A, 2014, JOVE-J VIS EXP, DOI 10.3791/51303
   Barreto G, 2010, J NEUROSURG ANESTH, V22, P214, DOI 10.1097/ANA.0b013e3181d56c98
   Chehelcheraghi F, 2015, IRAN J BASIC MED SCI, V18, P764
   Dillin A, 2014, CURR OPIN CELL BIOL, V26, P107, DOI 10.1016/j.ceb.2013.12.003
   Farjah GH, 2015, IRAN J VET RES, V16, P167
   Fujita S, 2006, J NUTR, V136, p277S, DOI 10.1093/jn/136.1.277S
   Harkema L, 2016, VET PATHOL, V53, P366, DOI 10.1177/0300985815625169
   Ho SC, 2003, BIOGERONTOLOGY, V4, P15, DOI 10.1023/A:1022417102206
   Hsu TH, 2020, J FUNCT FOODS, V75, DOI 10.1016/j.jff.2020.104232
   Hsu TH, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111740
   Huang WC, 2014, NUTRIENTS, V6, P2681, DOI 10.3390/nu6072681
   Kim EN, 2018, AGING-US, V10, P83, DOI 10.18632/aging.101361
   Kitaoka Y, 2019, PHYSIOL REP, V7, DOI 10.14814/phy2.13998
   Kou XJ, 2017, BIOMED PHARMACOTHER, V90, P311, DOI 10.1016/j.biopha.2017.03.070
   Lees H, 2016, MATURITAS, V93, P18, DOI 10.1016/j.maturitas.2016.06.008
   Liao CY, 2014, CURR TOP DEV BIOL, V109, P249, DOI 10.1016/B978-0-12-397920-9.00003-2
   Lin CI, 2015, METABOLISM, V64, P1146, DOI 10.1016/j.metabol.2015.05.007
   Liu C, 2017, CLIN INTERV AGING, V12, P593, DOI 10.2147/CIA.S132277
   Loboda A, 2016, CELL MOL LIFE SCI, V73, P3221, DOI 10.1007/s00018-016-2223-0
   Magat M, 2002, WESTERN FOLKLORE, V61, P63, DOI 10.2307/1500289
   Mitchell SJ, 2015, ANNU REV ANIM BIOSCI, V3, P283, DOI 10.1146/annurev-animal-022114-110829
   Osama A, 2020, AGEING RES REV, V64, DOI 10.1016/j.arr.2020.101206
   Parameshwaran K, 2010, REJUV RES, V13, P729, DOI 10.1089/rej.2010.1020
   Shahroudi MJ, 2017, J PHARMACOPUNCT, V20, P29, DOI 10.3831/KPI.2017.20.006
   Shinmura K, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/528935
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   Sun KY, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/7108604
   Wei HF, 2005, BEHAV BRAIN RES, V157, P245, DOI 10.1016/j.bbr.2004.07.003
NR 28
TC 1
Z9 1
U1 1
U2 7
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PD APR 28
PY 2021
VL 2021
AR 6654683
DI 10.1155/2021/6654683
PG 11
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA SX0TX
UT WOS:000664926600005
PM 33997037
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Pillai, AA
AF Pillai, Anjana A.
TI Management of <i>de novo</i> malignancies after liver transplantation
SO TRANSPLANTATION REVIEWS
LA English
DT Article
ID POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDERS; PAPILLOMA-VIRUS INFECTION;
   RISK-FACTORS; LONG-TERM; ORGAN-TRANSPLANTATION; INITIAL THERAPY;
   CANCER-RISK; RECIPIENTS; IMMUNOSUPPRESSION; NEOPLASIA
AB Due to advances in medical and surgical expertise leading to significant improvements in graft and patient survival, there is an increased recognition of long term complications in survivors such as de novo malignancies, cardiovascular events and infections.
   Data show solid organ transplant recipients have 2-3 times the increased risk of developing a de novo malignancy compared to an age-matched and sex-matched general population and malignancy is expected to be the number one cause of mortality in long term transplant recipients in the next two decades. Risk factors include an aging transplant population, oncogenic viruses and the long term effects of immunosuppression in the development of carcinogenesis.
   This review summarizes common de novo malignancies occurring in the post liver transplant population and current strategies for their prevention and management. Unfortunately, due to limited evidence based data, robust screening guidelines for post transplant cancer prevention have yet to be implemented in this population. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Pillai, Anjana A.] Emory Univ Hosp, Emory Transplant Ctr, Dept Med, Div Digest Dis,Emory Clin, Atlanta, GA 30322 USA.
C3 Emory University
RP Pillai, AA (corresponding author), Emory Univ Hosp, 1365 Clifton Rd NE,Ste B1600, Atlanta, GA 30322 USA.
EM anjana.a.pillai@emory.edu
CR ABEL EA, 1989, J AM ACAD DERMATOL, V21, P167, DOI 10.1016/S0190-9622(89)70157-2
   Åberg F, 2008, LIVER TRANSPLANT, V14, P1428, DOI 10.1002/lt.21475
   Adami J, 2003, BRIT J CANCER, V89, P1221, DOI 10.1038/sj.bjc.6601219
   Alberu J, 2011, TRANSPLANTATION, V92, P303, DOI 10.1097/TP.0b013e3182247ae2
   Albright JB, 2010, COLORECTAL DIS, V12, P657, DOI 10.1111/j.1463-1318.2009.01840.x
   Atassi T, 2003, J CLIN GASTROENTEROL, V37, P72, DOI 10.1097/00004836-200307000-00018
   Benlloch S, 2004, AM J TRANSPLANT, V4, P596, DOI 10.1111/j.1600-6143.2004.00380.x
   BLEDAY R, 1993, DIS COLON RECTUM, V36, P908, DOI 10.1007/BF02050624
   Buell JF, 2005, TRANSPLANTATION, V80, pS254, DOI 10.1097/01.tp.0000186382.81130.ba
   Butel JS, 2000, CARCINOGENESIS, V21, P405, DOI 10.1093/carcin/21.3.405
   Campistol JM, 2012, TRANSPLANT REV-ORLAN, V26, P261, DOI 10.1016/j.trre.2012.07.001
   Campistol JM, 2006, J AM SOC NEPHROL, V17, P581, DOI 10.1681/ASN.2005090993
   Collett D, 2010, AM J TRANSPLANT, V10, P1889, DOI 10.1111/j.1600-6143.2010.03181.x
   Dantal J, 1998, LANCET, V351, P623, DOI 10.1016/S0140-6736(97)08496-1
   Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017
   Engels EA, 2011, JAMA-J AM MED ASSOC, V306, P1891, DOI 10.1001/jama.2011.1592
   Euvrard S, 2006, J HEPATOL, V44, P27, DOI 10.1016/j.jhep.2005.10.010
   Finkenstedt A, 2009, AM J TRANSPLANT, V9, P2355, DOI 10.1111/j.1600-6143.2009.02766.x
   Flechner SM, 2011, AM J TRANSPLANT, V11, P1633, DOI 10.1111/j.1600-6143.2011.03573.x
   Frezza EE, 1997, HEPATO-GASTROENTEROL, V44, P1172
   Fung JJ, 2001, LIVER TRANSPLANT, V7, pS109, DOI 10.1053/jlts.2001.28645
   Grulich AE, 2007, LANCET, V370, P59, DOI 10.1016/S0140-6736(07)61050-2
   Haagsma EB, 2001, J HEPATOL, V34, P84, DOI 10.1016/S0168-8278(00)00077-5
   Hanouneh IA, 2012, INFLAMM BOWEL DIS, V18, P269, DOI 10.1002/ibd.21692
   Herrero JI, 2005, LIVER TRANSPLANT, V11, P89, DOI 10.1002/lt.20319
   Hinten F, 2012, CRIT REV ONCOL HEMAT, V84, P161, DOI 10.1016/j.critrevonc.2012.02.008
   Jain A, 2002, ANN SURG, V236, P429, DOI 10.1097/00000658-200210000-00005
   Jain AB, 1998, TRANSPLANTATION, V66, P1193, DOI 10.1097/00007890-199811150-00014
   Jonas S, 1997, CANCER, V80, P1141, DOI 10.1002/(SICI)1097-0142(19970915)80:6<1141::AID-CNCR18>3.0.CO;2-8
   Knight JS, 2009, J CLIN ONCOL, V27, P3354, DOI 10.1200/JCO.2008.20.0857
   Kremers WK, 2006, AM J TRANSPLANT, V6, P1017, DOI 10.1111/j.1600-6143.2006.01294.x
   Lodhi SA, 2011, AM J TRANSPLANT, V11, P1226, DOI 10.1111/j.1600-6143.2011.03539.x
   Lucey MR, 2013, LIVER TRANSPLANT, V19, P3, DOI 10.1002/lt.23566
   Mathew T, 2004, CLIN TRANSPLANT, V18, P446, DOI 10.1111/j.1399-0012.2004.00188.x
   Mithoefer AB, 2002, LIVER TRANSPLANT, V8, P939, DOI 10.1053/jlts.2002.35551
   Nicolaas JS, 2010, AM J TRANSPLANT, V10, P868, DOI 10.1111/j.1600-6143.2010.03049.x
   Paternoster DM, 2008, TRANSPL P, V40, P1877, DOI 10.1016/j.transproceed.2008.05.074
   PENN I, 1991, TRANSPLANT P, V23, P1101
   Penn I., 2008, CLIN TRANSPL, V14, P1428
   Presser SJ, 2007, LIVER TRANSPLANT, V13, P443, DOI 10.1002/lt.21058
   Pruthi J, 2001, LIVER TRANSPLANT, V7, P811, DOI 10.1053/jlts.2001.27084
   Reshef R, 2011, AM J TRANSPLANT, V11, P336, DOI 10.1111/j.1600-6143.2010.03387.x
   Saigal S, 2002, LIVER TRANSPLANT, V8, P842
   Schena FP, 2009, TRANSPLANTATION, V87, P233, DOI 10.1097/TP.0b013e3181927a41
   Shroff R, 2004, PEDIATR NEPHROL, V19, P369, DOI 10.1007/s00467-003-1392-x
   Silva MA, 2005, CRIT REV ONCOL HEMAT, V56, P147, DOI 10.1016/j.critrevonc.2004.12.013
   Smets F, 2002, PEDIATR TRANSPLANT, V6, P280, DOI 10.1034/j.1399-3046.2002.02029.x
   Tsai DE, 2001, TRANSPLANTATION, V71, P1076, DOI 10.1097/00007890-200104270-00012
   Veroux M, 2009, TRANSPL P, V41, P1191, DOI 10.1016/j.transproceed.2009.03.015
   Wagner HJ, 2004, BLOOD, V103, P3979, DOI 10.1182/blood-2003-12-4287
   Watt KDS, 2010, AM J TRANSPLANT, V10, P1420, DOI 10.1111/j.1600-6143.2010.03126.x
   Watt KDS, 2009, GASTROENTEROLOGY, V137, P2010, DOI 10.1053/j.gastro.2009.08.070
   Xiol X, 2001, LIVER TRANSPLANT, V7, P971, DOI 10.1053/jlts.2001.28744
   Yang J, 2000, BLOOD, V96, P4055
NR 54
TC 8
Z9 10
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0955-470X
J9 TRANSPLANT REV-ORLAN
JI Transplant. Rev.
PD JAN
PY 2015
VL 29
IS 1
BP 38
EP 41
DI 10.1016/j.trre.2014.11.002
PG 4
WC Immunology; Transplantation
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology; Transplantation
GA AY0GM
UT WOS:000347275500006
PM 25510578
DA 2024-02-19
ER

PT J
AU Kleno, TG
   Leonardsen, LR
   Kjeldal, HO
   Laursen, SM
   Jensen, ON
   Baunsgaard, D
AF Kleno, TG
   Leonardsen, LR
   Kjeldal, HO
   Laursen, SM
   Jensen, ON
   Baunsgaard, D
TI Mechanisms of hydrazine toxicity in rat liver investigated by Proteomics
   and multivariate data analysis
SO PROTEOMICS
LA English
DT Article
DE biomarkers; chemometrics; differential gel electrophoresis; hydrazine
   toxicity; mass spectrometry
ID APOLIPOPROTEIN-A-IV; LEAST-SQUARES REGRESSION; DIFFERENCE
   GEL-ELECTROPHORESIS; SENESCENCE MARKER PROTEIN-30; HEAT-SHOCK PROTEINS;
   BINDING PROTEIN; THYROID-HORMONE; MESSENGER-RNA; ALPHA-2U-GLOBULIN;
   EXPRESSION
AB A proteomics approach combined with multivariate data analysis was used to examine the hepatotoxic effect of hydrazine in 30 male Sprague Dawley rats, assigned to four treatment groups and two control groups. Liver samples from the individual animals were resolved by two-dimensional differential gel electrophoresis (2-D DIGE) and protein patterns from the 2-D gels were analyzed by principal component analysis (PCA) and partial least squares regression (PLSR). The PCA plot was able to describe the variation in the protein expression related to dose and time, by separation or clustering of different animal groups. PLSR followed by variable selection (Jack-knifing) was used to select proteins that varied significantly in relation to the dose related response of the hydrazine treatment. The 10 up-regulated and 10 down-regulated proteins with highest rank in the PLSR model were identified by mass spectrometry. Hydrazine treatment induced altered expression of proteins related to lipid metabolism, Call homeostasis, thyroid hormone pathways and stress response. Several of the identified proteins have not previously been implicated in hydrazine toxicity and may thus be regarded as new potential biomarkers of induced liver toxicity.
C1 Novo Nordisk AS, Appl Trinom, Malov, Denmark.
   Novo Nordisk AS, Toxicol, Malov, Denmark.
   Univ So Denmark, Dept Biochem & Mol Biol, Odense, Denmark.
C3 Novo Nordisk; Novo Nordisk; University of Southern Denmark
RP Kleno, TG (corresponding author), Novo Nordisk Pk,F9-1-20, DK-2760 Malov, Denmark.
EM tgkl@novonordisk.com
RI Jensen, Ole N./J-1763-2012
OI Jensen, Ole N./0000-0003-1862-8528
CR Alaiya AA, 2000, INT J CANCER, V86, P731, DOI 10.1002/(SICI)1097-0215(20000601)86:5<731::AID-IJC20>3.0.CO;2-A
   AMENTA JS, 1962, LAB INVEST, V11, P956
   AOKI Y, 1990, TOXICOL APPL PHARM, V106, P462, DOI 10.1016/0041-008X(90)90341-Q
   Arce A, 1998, LIFE SCI, V63, P2243, DOI 10.1016/S0024-3205(98)00509-8
   BARLOW PB, 1974, AM REV RESPIR DIS, V110, P371
   BLAIR IA, 1985, HUM TOXICOL, V4, P195, DOI 10.1177/096032718500400210
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   CHAN KM, 1978, BIOCHEMISTRY-US, V17, P3092, DOI 10.1021/bi00608a023
   CLARK DA, 1970, BIOCHEM PHARMACOL, V19, P1743, DOI 10.1016/0006-2952(70)90166-8
   COCHRANE BJ, 1991, COMP BIOCHEM PHYS C, V98, P385, DOI 10.1016/0742-8413(91)90221-E
   Cuervo AM, 1998, J MOL MED-JMM, V76, P6, DOI 10.1007/s109-1998-8099-y
   Cuervo AM, 1999, KIDNEY INT, V55, P529, DOI 10.1046/j.1523-1755.1999.00268.x
   DEATON MA, 1990, FUND APPL TOXICOL, V14, P471, DOI 10.1016/0272-0590(90)90251-E
   Dilworth C, 1998, BIOMARKERS, V3, P177, DOI 10.1080/135475098231200
   Feigelson P, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P275
   Fujita T, 1999, BIOCHEM BIOPH RES CO, V254, P1, DOI 10.1006/bbrc.1998.9841
   GENT WL, 1992, EUR J CLIN PHARMACOL, V43, P131, DOI 10.1007/BF01740658
   GOLD J, 1987, Nutrition and Cancer, V9, P59
   HINCH S G, 1987, Coenoses, V2, P19
   Hoskuldsson A., 1988, J CHEMOMETR, V2, P211, DOI [10.1002/CEM.1180020306, DOI 10.1002/CEM.1180020306]
   Ishigami T, 2001, PATHOL INT, V51, P491, DOI 10.1046/j.1440-1827.2001.01238.x
   JENNER AM, 1994, ARCH TOXICOL, V68, P240, DOI 10.1007/s002040050063
   Jessen F, 2002, PROTEOMICS, V2, P32, DOI 10.1002/1615-9861(200201)2:1<32::AID-PROT32>3.3.CO;2-A
   KIMURA H, 1989, FEBS LETT, V246, P101, DOI 10.1016/0014-5793(89)80261-3
   KLENO TG, 2002, 50 ASMS C MASS SPECT
   LAGROST L, 1989, J LIPID RES, V30, P1525
   LEHMANMCKEEMAN LD, 1992, TOXICOL APPL PHARM, V116, P170, DOI 10.1016/0041-008X(92)90296-5
   LEHMANMCKEEMAN LD, 1992, TOXICOL APPL PHARM, V112, P214, DOI 10.1016/0041-008X(92)90190-4
   LINLEE YC, 1993, J LIPID RES, V34, P249
   LOWFRIEDRICH I, 1991, J PHARMACOL METHOD, V25, P133, DOI 10.1016/0160-5402(91)90004-O
   LYNCH KR, 1982, CELL, V28, P185, DOI 10.1016/0092-8674(82)90388-9
   Martens H, 2000, FOOD QUAL PREFER, V11, P5, DOI 10.1016/S0950-3293(99)00039-7
   Martens H., 1989, MULTIVARIATE CALIBRA
   MOLENEY SJ, 2003, REV BIOCHEM TOXICOL, V5, P313
   Nguyen DV, 2002, BIOINFORMATICS, V18, P39, DOI 10.1093/bioinformatics/18.1.39
   NODA A, 1983, Journal of UOEH, V5, P183
   PERVAIZ S, 1987, FASEB J, V1, P209, DOI 10.1096/fasebj.1.3.3622999
   Power DM, 2000, GEN COMP ENDOCR, V119, P241, DOI 10.1006/gcen.2000.7520
   ROY AK, 1980, J BIOL CHEM, V255, P1614
   Sakai N, 1997, J BIOL CHEM, V272, P7506, DOI 10.1074/jbc.272.11.7506
   Sarich TC, 1998, PHARMACOL RES, V38, P199, DOI 10.1006/phrs.1998.0347
   Snoeckx LHEH, 2001, PHYSIOL REV, V81, P1461, DOI 10.1152/physrev.2001.81.4.1461
   STEINMETZ A, 1985, J BIOL CHEM, V260, P2258
   Stensballe A, 2001, PROTEOMICS, V1, P955, DOI 10.1002/1615-9861(200108)1:8<955::AID-PROT955>3.0.CO;2-P
   TIMBRELL JA, 1982, J TOXICOL ENV HEALTH, V10, P955, DOI 10.1080/15287398209530309
   Tso P, 2001, ANNU REV NUTR, V21, P231, DOI 10.1146/annurev.nutr.21.1.231
   Unlu M, 1997, ELECTROPHORESIS, V18, P2071, DOI 10.1002/elps.1150181133
   Ünlü M, 1999, BIOCHEM SOC T, V27, P547, DOI 10.1042/bst0270547
   Waterfield CJ, 1997, CHEM-BIOL INTERACT, V107, P157, DOI 10.1016/S0009-2797(97)00090-2
   Westad F, 2000, J NEAR INFRARED SPEC, V8, P117, DOI 10.1255/jnirs.271
   WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9
   WOO J, 1992, J MED, V23, P51
   Yamaguchi M, 2002, MOL CELL BIOCHEM, V241, P61, DOI 10.1023/A:1020822610085
NR 53
TC 63
Z9 70
U1 0
U2 13
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1615-9853
EI 1615-9861
J9 PROTEOMICS
JI Proteomics
PD MAR
PY 2004
VL 4
IS 3
BP 868
EP 880
DI 10.1002/pmic.200300663
PG 13
WC Biochemical Research Methods; Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 802QX
UT WOS:000220179100029
PM 14997507
DA 2024-02-19
ER

PT J
AU Zubrzycki, A
   Wronska, A
   Kotulak-Chrzaszcz, A
   Wierzbicki, PM
   Kmiec, Z
AF Zubrzycki, Adrian
   Wronska, Agata
   Kotulak-Chrzaszcz, Anna
   Wierzbicki, Piotr Mieczyslaw
   Kmiec, Zbigniew
TI Fenofibrate impairs liver function and structure more pronounced in old
   than young rats
SO ARCHIVES OF GERONTOLOGY AND GERIATRICS
LA English
DT Article
DE Aging; Fenofibrate; Rat; serum; Lipids; Liver function and morphology
ID ACTIVATED-RECEPTOR-ALPHA; PPAR-ALPHA; NONALCOHOLIC STEATOHEPATITIS;
   MIXED DYSLIPIDEMIA; BETA-OXIDATION; LIPID THERAPY; DOUBLE-BLIND;
   MODULATION; MODEL; EXPRESSION
AB Introduction: Since old animals are known to accumulate lipids in some organs, we compared effects of fenofibrate (FN) on systemic lipid metabolism, activity of liver marker enzymes and structure in young and old rats.
   Material and methods: Young and old rats were fed chow supplemented with 0.1 % or 0.5 % FN. After 30 days, intraperitoneal glucose tolerance test (IPGTT) was performed, and blood and liver samples were collected.
   Results: In young rats, 0.1 % FN, but not 0.5 FN, decreased serum Chol by 74 %, and did not affect TG levels at either doses. In old rats, 0.5 % FN, but not 0.1 % FN, decreased Chol and TG level by 56 % and 49 %, respectively. In young rats, 0.1 % and 0.5 % FN increased serum activity of ALP by 227 % and 260 %, respectively, and did not affect AST and ALT activities. In old rats, only 0.5 % FN increased serum ALP activity by 150 %, respectively. In old rats, neither dose of FN affected serum AST activity, and only 0.5 FN increased serum ALT activity by 200 %. The histological examination of liver structure revealed that both doses of FN impaired lobular architecture, expansion of bile canaliculi, and degeneration of parenchymal cells with the presence of cells containing fat droplets; administration of FN increased area occupied by collagen fibers.
   Conclusions: Although 0.5 % FN decreased serum Chol concentration, it increased serum ALP activity and impaired liver structure in both in both age groups of rats. Thus, FN treatment should be under the control of liver function, especially in older patients.
C1 [Zubrzycki, Adrian; Wronska, Agata; Kotulak-Chrzaszcz, Anna; Wierzbicki, Piotr Mieczyslaw; Kmiec, Zbigniew] Med Univ Gdansk, Dept Histol, 1 Debinki Str, PL-80211 Gdansk, Poland.
C3 Fahrenheit Universities; Medical University Gdansk
RP Zubrzycki, A (corresponding author), Med Univ Gdansk, Dept Histol, 1 Debinki Str, PL-80211 Gdansk, Poland.
EM adrian.zubrzycki@gumed.edu.pl
RI Zubrzycki, Adrian/N-5937-2018; Wronska, Agata/GMW-4913-2022
OI Zubrzycki, Adrian/0000-0002-4303-5620; Kotulak-Chrzaszcz,
   Anna/0000-0002-2942-6270
FU Medical University of Gdansk, Gdansk, Poland [ST-12]
FX The research was financed by the statutory grant (ST-12) of the Medical
   University of Gdansk, Gdansk, Poland.
CR Abd El-Haleim EA, 2016, WORLD J GASTROENTERO, V22, P2931, DOI 10.3748/wjg.v22.i10.2931
   Ahmad J, 2017, DIGEST DIS SCI, V62, P3596, DOI 10.1007/s10620-017-4812-7
   Al-Rasheed NM, 2015, PHARMACOLOGY, V95, P229, DOI 10.1159/000381190
   Bragt MCE, 2012, NUTR METAB CARDIOVAS, V22, P966, DOI 10.1016/j.numecd.2010.12.010
   Cheng SL, 2018, INT J MOL MED, V41, P1089, DOI 10.3892/ijmm.2017.3291
   Cindoruk M, 2007, BMC GASTROENTEROL, V7, DOI 10.1186/1471-230X-7-44
   Colton HM, 2004, TOXICOL SCI, V80, P183, DOI 10.1093/toxsci/kfh144
   Cong WN, 2008, LIFE SCI, V82, P983, DOI 10.1016/j.lfs.2008.01.022
   Davidson MH, 2009, CLIN THER, V31, P2824, DOI 10.1016/j.clinthera.2009.12.007
   Dohmen Kazufumi, 2013, Fukuoka Acta Medica, V104, P350
   El-Sisi A, 2013, PPAR RES, V2013, DOI 10.1155/2013/781348
   Fernandez NJ, 2007, VET CLIN PATH, V36, P223, DOI 10.1111/j.1939-165X.2007.tb00216.x
   Ferreira ES, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-11
   Fruchart JC, 2001, PHARMACOL RES, V44, P345, DOI 10.1006/phrs.2001.0871
   Fruchart Jean-Charles, 1999, Journal de la Societe de Biologie, V193, P67
   Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282
   Gonzalez FJ, 2002, MOL CELL ENDOCRINOL, V193, P71, DOI 10.1016/S0303-7207(02)00098-9
   Goto T, 2017, J BIOL CHEM, V292, P9175, DOI 10.1074/jbc.M116.767590
   Gross B, 2017, NAT REV ENDOCRINOL, V13, P36, DOI 10.1038/nrendo.2016.135
   Gu JY, 2017, ARCH GERONTOL GERIAT, V68, P62, DOI 10.1016/j.archger.2016.09.001
   Hamed AM, 2017, BIOMED PHARMACOTHER, V85, P68, DOI 10.1016/j.biopha.2016.11.114
   Hoare M, 2010, J HEPATOL, V53, P950, DOI 10.1016/j.jhep.2010.06.009
   Jameson J. L., 2018, HARRISONS PRINCIPLES, V20th, P2338
   Johnson AA, 2019, AGING CELL, V18, DOI 10.1111/acel.13048
   Kersten S, 2017, BIOCHIMIE, V136, P75, DOI 10.1016/j.biochi.2016.12.019
   Krempf M, 2000, DIABETES METAB, V26, P184
   Krysiak R, 2010, PHARMACOL REP, V62, P120, DOI 10.1016/S1734-1140(10)70249-8
   Li WH, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-131
   Liu ZT, 2014, INT J MED SCI, V11, P925, DOI 10.7150/ijms.8951
   Mancini FP, 2001, FEBS LETT, V491, P154, DOI 10.1016/S0014-5793(01)02146-9
   May HT, 2008, AM J CARDIOL, V101, P486, DOI 10.1016/j.amjcard.2007.09.095
   Melenovsky Vojtech, 2002, Am Heart J, V144, pE6, DOI 10.1016/S0002-8703(02)00142-4
   Mitchell SJ, 2010, THER ADV DRUG SAF, V1, P65, DOI 10.1177/2042098610386281
   Miyata A, 1997, CLIN EXP PHARMACOL P, V24, P714, DOI 10.1111/j.1440-1681.1997.tb02118.x
   Mohamed DI, 2013, EUR J PHARMACOL, V721, P35, DOI 10.1016/j.ejphar.2013.09.058
   Niesor EJ, 2013, LIPIDS, V48, P1185, DOI 10.1007/s11745-013-3841-z
   Oh TJ, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.58
   Oosterveer MH, 2009, J BIOL CHEM, V284, P34036, DOI 10.1074/jbc.M109.051052
   Ouwens MJNM, 2015, CURR MED RES OPIN, V31, P2273, DOI 10.1185/03007995.2015.1098597
   Papadakis MA, 2017, CURRENT MED DIAGNOSI
   Park MK, 2007, J KOREAN MED SCI, V22, P235, DOI 10.3346/jkms.2007.22.2.235
   Pettersen JC, 2012, TOXICOL PATHOL, V40, P435, DOI 10.1177/0192623311431945
   Ramakrishnan SK, 2016, J BIOL CHEM, V291, P23915, DOI 10.1074/jbc.M116.745778
   Rodriguez MA, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4834-3
   Rosenson RS, 2014, J CLIN LIPIDOL, V8, pS58, DOI 10.1016/j.jacl.2014.03.004
   Sahebkar A, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0787-7
   Sairyo M, 2018, J ATHEROSCLER THROMB, V25, P142, DOI 10.5551/jat.39693
   Skop V, 2016, PHYSIOL RES, V65, P891, DOI 10.33549/physiolres.933304
   STEINBERG P, 1988, EUR J BIOCHEM, V176, P39, DOI 10.1111/j.1432-1033.1988.tb14248.x
   Tawfeeq MM, 2011, ARCH TOXICOL, V85, P1003, DOI 10.1007/s00204-010-0628-3
   Toutouzas K, 2010, EXPERT OPIN PHARMACO, V11, P1659, DOI 10.1517/14656561003774080
   Valasek MA, 2007, J LIPID RES, V48, P2725, DOI 10.1194/jlr.M700345-JLR200
   Wiggins BS, 2016, CURR ATHEROSCLER REP, V18, DOI 10.1007/s11883-016-0571-8
   Xi Y, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9020352
   Yang Q, 2008, TOXICOL SCI, V101, P132, DOI 10.1093/toxsci/kfm206
   Ye P, 2005, CHINESE MED J-PEKING, V118, P1093
   Zeeh J, 2001, ARCH GERONTOL GERIAT, V32, P255, DOI 10.1016/S0167-4943(01)00090-5
   Zhao ZS, 2009, LIFE SCI, V84, P688, DOI 10.1016/j.lfs.2009.02.021
NR 58
TC 6
Z9 6
U1 0
U2 3
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0167-4943
EI 1872-6976
J9 ARCH GERONTOL GERIAT
JI Arch. Gerontol. Geriatr.
PD NOV-DEC
PY 2020
VL 91
AR 104244
DI 10.1016/j.archger.2020.104244
PG 12
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA OC9DZ
UT WOS:000579456600052
PM 32927318
DA 2024-02-19
ER

PT J
AU Tulsian, R
   Velingkaar, N
   Kondratov, R
AF Tulsian, Richa
   Velingkaar, Nikkhil
   Kondratov, Roman
TI Caloric restriction effects on liver mTOR signaling are time-of-day
   dependent
SO AGING-US
LA English
DT Article
DE metabolism; mTOR signaling pathway; aging; glucose; biological clocks;
   circadian clocks; insulin sensitivity; protein translation
ID PERIPHERAL CIRCADIAN CLOCKS; LIFE-SPAN; DIETARY RESTRICTION; MECHANISTIC
   TARGET; BMAL1; METABOLISM; RAPAMYCIN; PATHWAYS; MICE; DEFICIENT
AB The regulation of mechanistic target of rapamycin (mTOR) signaling contributes to the metabolic effects of a calorie restriction (CR) diet. We assayed the effect of CR on the activity of mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2) in the liver of mice at six different times across the day. CR effects on mTORC1 and mTORC2 activities were time-of-day dependent. CR induced mTORC1 activity at one time, reduced at two times and has no effect during other times. CR induced mTORC2 activity at one time of the day and has no effects at other times. Circadian clocks are implemented in the regulation of mTOR signaling in mammals and mechanisms of CR. We assayed the effect of CR on mTOR signaling in the liver of mice deficient for circadian transcriptional regulators BMAL1 and CRYs. The CR induced suppression of mTORC1 activity was observed in both clock mutants, while up regulation of mTORC2 was observed in the liver of CRY deficient but not in the liver of BMAL1 deficient mice. Our finding revealed that CR has different time dependent effect on the activity of mTOR complexes 1 and 2 and suggest that circadian clock protein BMAL1 is involved in the up regulation of mTORC2 upon CR in mammals.
C1 [Tulsian, Richa; Velingkaar, Nikkhil; Kondratov, Roman] Cleveland State Univ, Dept Biol Geol & Environm Sci, Cleveland, OH 44115 USA.
   [Tulsian, Richa; Velingkaar, Nikkhil; Kondratov, Roman] Cleveland State Univ, Ctr Gene Regulat Hlth & Dis, Cleveland, OH 44115 USA.
C3 University System of Ohio; Cleveland State University; University System
   of Ohio; Cleveland State University
RP Kondratov, R (corresponding author), Cleveland State Univ, Dept Biol Geol & Environm Sci, Cleveland, OH 44115 USA.; Kondratov, R (corresponding author), Cleveland State Univ, Ctr Gene Regulat Hlth & Dis, Cleveland, OH 44115 USA.
EM r.kondratov@csuohio.edu
RI Tulsian, Richa/L-5266-2019; Velingkaar, Nikkhil/ABC-8132-2020
OI Velingkaar, Nikkhil/0000-0003-1571-0833; Kondratov,
   Roman/0000-0003-3449-745X
FU NIH [1R01AG039547]; GRHD CSU
FX This work was supported by NIH grants 1R01AG039547 and funds from GRHD
   CSU.
CR Acosta-Rodriguez VA, 2017, CELL METAB, V26, P267, DOI 10.1016/j.cmet.2017.06.007
   Anton S, 2013, EXP GERONTOL, V48, P1003, DOI 10.1016/j.exger.2013.04.011
   Bracho-Valdés I, 2011, IUBMB LIFE, V63, P896, DOI 10.1002/iub.558
   Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1
   Chaudhari A, 2017, MOL BIOL CELL, V28, P834, DOI 10.1091/mbc.E16-08-0624
   Cornu M, 2014, P NATL ACAD SCI USA, V111, P11592, DOI 10.1073/pnas.1412047111
   Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500
   Dennis MD, 2013, J BIOL CHEM, V288, P10, DOI 10.1074/jbc.M112.402461
   González A, 2017, EMBO J, V36, P397, DOI 10.15252/embj.201696010
   Huang JX, 2009, BIOCHEM SOC T, V37, P217, DOI 10.1042/BST0370217
   Jouffe C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001455
   Kapahi P, 2017, AGEING RES REV, V39, P3, DOI 10.1016/j.arr.2016.12.005
   Katewa SD, 2016, CELL METAB, V23, P143, DOI 10.1016/j.cmet.2015.10.014
   Kennedy BK, 2016, CELL METAB, V23, P990, DOI 10.1016/j.cmet.2016.05.009
   Khapre RV, 2014, AGING-US, V6, P675, DOI 10.18632/aging.100686
   Khapre RV, 2014, AGING-US, V6, P48, DOI 10.18632/aging.100633
   Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206
   Lamming DW, 2011, CELL METAB, V13, P617, DOI 10.1016/j.cmet.2011.05.006
   Lipton JO, 2017, CELL REP, V20, P868, DOI 10.1016/j.celrep.2017.07.008
   Lipton JO, 2015, CELL, V161, P1138, DOI 10.1016/j.cell.2015.04.002
   Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001
   McGinnis GR, 2017, J MOL CELL CARDIOL, V110, P80, DOI 10.1016/j.yjmcc.2017.07.005
   Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128
   Moore T, 2008, CANCER PREV RES, V1, P65, DOI 10.1158/1940-6207.CAPR-08-0022
   Okamura H, 1999, SCIENCE, V286, P2531, DOI 10.1126/science.286.5449.2531
   Pan H, 2017, J BIOL CHEM, V292, P6452, DOI 10.1074/jbc.R116.771915
   Patel SA, 2016, SCI REP-UK, V6, DOI 10.1038/srep25970
   Patel SA, 2016, FASEB J, V30, P1634, DOI 10.1096/fj.15-282475
   Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003
   Saraswat K, 2017, EXPERT OPIN DRUG DIS, V12, P955, DOI 10.1080/17460441.2017.1349750
   Sato S, 2017, CELL, V170, P664, DOI 10.1016/j.cell.2017.07.042
   Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]
   Sharma N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038835
   Solanas G, 2017, CELL, V170, P678, DOI 10.1016/j.cell.2017.07.035
   Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114
   Zhang DQ, 2014, J BIOL CHEM, V289, P25925, DOI 10.1074/jbc.M114.567628
NR 36
TC 19
Z9 20
U1 0
U2 4
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1945-4589
J9 AGING-US
JI Aging-US
PD JUL
PY 2018
VL 10
IS 7
BP 1640
EP 1648
DI 10.18632/aging.101498
PG 9
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA GO8VH
UT WOS:000440376500012
PM 30018180
OA Green Published, Green Submitted, gold
DA 2024-02-19
ER

PT J
AU Gibier, JB
   Bouchindhomme, B
   Dubois, R
   Hivert, B
   Grardel, N
   Copin, MC
AF Gibier, Jean-Baptiste
   Bouchindhomme, Brigitte
   Dubois, Romain
   Hivert, Benedicte
   Grardel, Nathalie
   Copin, Marie-Christine
TI Coexistence of age-related EBV-associated follicular hyperplasia and
   large B-cell EBV plus lymphoma of the elderly. Two distinct features of
   the same T-cell dysfunction related to senescence?
SO PATHOLOGY RESEARCH AND PRACTICE
LA English
DT Article
DE Diffuse large B-cell lymphoma; Epstein Barr virus; Reactive hyperplasia;
   Elderly
ID LYMPHOPROLIFERATIVE DISORDERS
AB Age-related EBV-associated lymphoproliferative disorders form a new clinicopathological group. Until recently, this group was associated with diffuse large B-cell lymphoma (DLBCL), characterised by an aggressive clinical presentation and a poor prognosis. Recent findings in Western Caucasian patients, however, suggest that this entity covers a wide spectrum of diseases, ranging from reactive follicular hyperplasia (HR) to DLBCL. We report the case of an 85-year-old Caucasian man showing lymphadenopathy and numerous hypodense lesions of the liver. Examination of a lymph node revealed follicular hyperplasia with EBV expression confined to germinal centres. The patient was treated with Rituximab and subsequently, the lesions of the liver were explored. They showed extensive necrosis and a polymorphic large B-cell population with strong EBV expression. This is the first report to describe age-related EBV-associated follicular hyperplasia at one site coexisting with DLBCL at another. This case warrants undertaking further investigations each time a diagnosis of age-related EBV-HR is associated with extranodal lesions. (C) 2016 Elsevier GmbH. All rights reserved.
C1 [Gibier, Jean-Baptiste; Bouchindhomme, Brigitte; Dubois, Romain; Copin, Marie-Christine] Univ Lille, Inst Pathol, Ctr Biol Pathol, CHU Lille, F-59000 Lille, France.
   [Hivert, Benedicte] Univ Lille, Dept Hematol Oncol & Blood Disorders, Hop Claude Huriez, CHU Lille, F-59000 Lille, France.
   [Grardel, Nathalie] Univ Lille, Inst Hematol, Ctr Biol Pathol, CHU Lille, F-59000 Lille, France.
C3 Universite de Lille; CHU Lille; Universite de Lille; CHU Lille;
   Universite de Lille; CHU Lille
RP Gibier, JB (corresponding author), CHU Lille, Ctr Biol Pathol, Inst Pathol, CS 70001, F-59037 Lille, France.
EM jeanbaptiste.gibier@chru-lille.fr
RI Grardel, Nathalie/U-9067-2018
OI Grardel, Nathalie/0000-0001-6573-1312; Gibier,
   Jean-Baptiste/0000-0002-1194-5590
CR Ambrosio MR, 2015, AM J CLIN PATHOL, V144, P817, DOI 10.1309/AJCP2G0VKTKPNPRR
   Asano N, 2009, BLOOD, V113, P2629, DOI 10.1182/blood-2008-06-164806
   de la Hera Magallanes A., 2011, HISTOPATHOLOGY, V59, P571
   Dojcinov SD, 2011, BLOOD, V117, P4726, DOI 10.1182/blood-2010-12-323238
   Kojima M, 2006, PATHOL RES PRACT, V202, P609, DOI 10.1016/j.prp.2006.04.006
   Montes-Moreno S, 2012, MODERN PATHOL, V25, P968, DOI 10.1038/modpathol.2012.52
   Ok CY, 2013, BLOOD, V122, P328, DOI 10.1182/blood-2013-03-489708
   Oyama T, 2003, AM J SURG PATHOL, V27, P16, DOI 10.1097/00000478-200301000-00003
   Oyama T, 2007, CLIN CANCER RES, V13, P5124, DOI 10.1158/1078-0432.CCR-06-2823
   Pawelec G., 2007, EXP GERONTOL
   Sansoni P, 2008, EXP GERONTOL, V43, P61, DOI 10.1016/j.exger.2007.06.008
   Shimoyama Y, 2009, PATHOL INT, V59, P835, DOI 10.1111/j.1440-1827.2009.02466.x
   Vardiman JW., 2008, WHO CLASSIFICATION T
NR 13
TC 2
Z9 2
U1 0
U2 4
PU ELSEVIER GMBH, URBAN & FISCHER VERLAG
PI JENA
PA OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY
SN 0344-0338
J9 PATHOL RES PRACT
JI Pathol. Res. Pract.
PY 2017
VL 213
IS 3
BP 277
EP 280
DI 10.1016/j.prp.2016.12.012
PG 4
WC Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pathology
GA EP4TB
UT WOS:000397371700018
PM 28215641
DA 2024-02-19
ER

PT J
AU Graja, A
   Garcia-Carrizo, F
   Jank, AM
   Gohlke, S
   Ambrosi, TH
   Jonas, W
   Ussar, S
   Kern, M
   Schürmann, A
   Aleksandrova, K
   Blüher, M
   Schulz, TJ
AF Graja, Antonia
   Garcia-Carrizo, Francisco
   Jank, Anne-Marie
   Gohlke, Sabrina
   Ambrosi, Thomas H.
   Jonas, Wenke
   Ussar, Siegfried
   Kern, Matthias
   Schurmann, Annette
   Aleksandrova, Krasimira
   Bluher, Matthias
   Schulz, Tim J.
TI Loss of periostin occurs in aging adipose tissue of mice and its genetic
   ablation impairs adipose tissue lipid metabolism
SO AGING CELL
LA English
DT Article
DE adipogenic progenitor cells; adipose tissue; aging; extracellular
   matrix; fatty acid metabolism; periostin
ID EXTRACELLULAR-MATRIX; FAT; DIFFERENTIATION; ADIPOCYTES; FIBRILLOGENESIS;
   PROLIFERATION; ACCUMULATION; EXPRESSION; OSTEOBLAST; FIBROSIS
AB Remodeling of the extracellular matrix is a key component of the metabolic adaptations of adipose tissue in response to dietary and physiological challenges. Disruption of its integrity is a well-known aspect of adipose tissue dysfunction, for instance, during aging and obesity. Adipocyte regeneration from a tissue-resident pool of mesenchymal stem cells is part of normal tissue homeostasis. Among the pathophysiological consequences of adipogenic stem cell aging, characteristic changes in the secretory phenotype, which includes matrix-modifying proteins, have been described. Here, we show that the expression of the matricellular protein periostin, a component of the extracellular matrix produced and secreted by adipose tissue-resident interstitial cells, is markedly decreased in aged brown and white adipose tissue depots. Using a mouse model, we demonstrate that the adaptation of adipose tissue to adrenergic stimulation and high-fat diet feeding is impaired in animals with systemic ablation of the gene encoding for periostin. Our data suggest that loss of periostin attenuates lipid metabolism in adipose tissue, thus recapitulating one aspect of age-related metabolic dysfunction. In human white adipose tissue, periostin expression showed an unexpected positive correlation with age of study participants. This correlation, however, was no longer evident after adjusting for BMI or plasma lipid and liver function biomarkers. These findings taken together suggest that age-related alterations of the adipose tissue extracellular matrix may contribute to the development of metabolic disease by negatively affecting nutrient homeostasis.
C1 [Graja, Antonia; Garcia-Carrizo, Francisco; Jank, Anne-Marie; Gohlke, Sabrina; Ambrosi, Thomas H.; Schulz, Tim J.] German Inst Human Nutr, Dept Adipocyte Dev & Nutr, 114-116 Arthur Scheunert Allee, D-14558 Potsdam, Germany.
   [Graja, Antonia; Schurmann, Annette; Schulz, Tim J.] Univ Potsdam, Inst Nutr Sci, Potsdam, Germany.
   [Jonas, Wenke; Schurmann, Annette] German Inst Human Nutr, Dept Expt Diabetol, Potsdam, Germany.
   [Jonas, Wenke; Ussar, Siegfried; Schurmann, Annette; Schulz, Tim J.] German Ctr Diabet Res DZD, Munich, Germany.
   [Ussar, Siegfried] Helmholtz Ctr Munich, Inst Diabet & Obes, JRG Adipocytes & Metab, Garching, Germany.
   [Kern, Matthias; Bluher, Matthias] Univ Leipzig, Dept Med, Leipzig, Germany.
   [Aleksandrova, Krasimira] German Inst Human Nutr, Nutr Immun & Metab Senior Scientist Grp, Potsdam, Germany.
C3 Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE);
   University of Potsdam; Deutsches Institut fur Ernahrungsforschung
   Potsdam-Rehbrucke (DIfE); Helmholtz Association; Helmholtz-Center Munich
   - German Research Center for Environmental Health; Leipzig University;
   Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE)
RP Schulz, TJ (corresponding author), German Inst Human Nutr, Dept Adipocyte Dev & Nutr, 114-116 Arthur Scheunert Allee, D-14558 Potsdam, Germany.
EM Tim.Schulz@dife.de
RI Ussar, Siegfried/AAL-4331-2021; Schulz, Tim J/F-4842-2013; Ambrosi,
   Thomas/HNI-0862-2023
OI Ussar, Siegfried/0000-0001-7575-0920; Schulz, Tim J/0000-0002-8413-3972;
   Schurmann, Annette/0000-0002-4113-4377; Garcia-Carrizo,
   Francisco/0000-0002-2484-4000; Jank, Anne-Marie/0009-0002-3770-2156;
   Ambrosi, Thomas/0000-0002-7149-041X
FU Bundesministerium fur Bildung und Forschung (BMBF); Bundesland
   Brandenburg [82DZD00302]; Deutsche Forschungsgemeinschaft [SCHU
   2445/2-1]; European Research Council [ERC-StG 311082]; Helmholtz
   Association
FX Bundesministerium fur Bildung und Forschung (BMBF) and Bundesland
   Brandenburg, Grant/Award Number: 82DZD00302; Deutsche
   Forschungsgemeinschaft, Grant/Award Number: SCHU 2445/2-1; European
   Research Council, Grant/Award Number: ERC-StG 311082; Helmholtz
   Association
CR Aukkarasongsup P, 2013, BIOCHEM BIOPH RES CO, V441, P126, DOI 10.1016/j.bbrc.2013.10.027
   BENJAMIN W, 1961, AM J PHYSIOL, V201, P540, DOI 10.1152/ajplegacy.1961.201.3.540
   Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989
   Chumlea WC, 2002, INT J OBESITY, V26, P1596, DOI 10.1038/sj.ijo.0802167
   Farnier C, 2003, INT J OBESITY, V27, P1178, DOI 10.1038/sj.ijo.0802399
   Florez-Duquet M, 1998, AM J PHYSIOL-REG I, V274, pR196, DOI 10.1152/ajpregu.1998.274.1.R196
   GELLHORN A, 1965, ANN NY ACAD SCI, V131, P344, DOI 10.1111/j.1749-6632.1965.tb34802.x
   Gillan L, 2002, CANCER RES, V62, P5358
   Guiu-Jurado E, 2016, OBESITY, V24, P2092, DOI 10.1002/oby.21571
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923
   Idolazzi L, 2017, EUR J INTERN MED, V38, P12, DOI 10.1016/j.ejim.2016.11.015
   Ji XH, 2000, J BONE MINER METAB, V18, P132, DOI 10.1007/s007740050103
   Khan T, 2009, MOL CELL BIOL, V29, P1575, DOI 10.1128/MCB.01300-08
   Kubo Y, 2000, IN VITRO CELL DEV-AN, V36, P38
   Kudo A, 2011, CELL MOL LIFE SCI, V68, P3201, DOI 10.1007/s00018-011-0784-5
   Kühn B, 2007, NAT MED, V13, P962, DOI 10.1038/nm1619
   Lemoine AY, 2012, J CLIN ENDOCR METAB, V97, pE775, DOI 10.1210/jc.2011-2649
   Lin D, 2016, BIOCHEM PHARMACOL, V119, P8, DOI 10.1016/j.bcp.2016.05.005
   Lu PF, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005058
   Lu Y, 2014, J CLIN INVEST, V124, P3501, DOI 10.1172/JCI74438
   Mariman ECM, 2010, CELL MOL LIFE SCI, V67, P1277, DOI 10.1007/s00018-010-0263-4
   Morita S, 2016, SCI REP-UK, V6, DOI 10.1038/srep21693
   Morra L, 2011, VIRCHOWS ARCH, V459, P465, DOI 10.1007/s00428-011-1151-5
   Murota H, 2017, CELL MOL LIFE SCI, V74, P4321, DOI 10.1007/s00018-017-2647-1
   Nakajima I, 1998, DIFFERENTIATION, V63, P193, DOI 10.1111/j.1432-0436.1998.00193.x
   Norris RA, 2007, J CELL BIOCHEM, V101, P695, DOI 10.1002/jcb.21224
   Oshima A, 2002, J CELL BIOCHEM, V86, P792, DOI 10.1002/jcb.10272
   Parlee SD, 2014, METHOD ENZYMOL, V537, P93, DOI 10.1016/B978-0-12-411619-1.00006-9
   Pfannenberg C, 2010, DIABETES, V59, P1789, DOI 10.2337/db10-0004
   Reilly SM, 2017, NAT REV ENDOCRINOL, V13, P633, DOI 10.1038/nrendo.2017.90
   Rios H, 2005, MOL CELL BIOL, V25, P11131, DOI 10.1128/MCB.25.24.11131-11144.2005
   Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Schulz TJ, 2011, P NATL ACAD SCI USA, V108, P143, DOI 10.1073/pnas.1010929108
   Steinbring J, 2017, METHODS MOL BIOL, V1566, P25, DOI 10.1007/978-1-4939-6820-6_4
   Sun K, 2013, CELL METAB, V18, P470, DOI 10.1016/j.cmet.2013.06.016
   Tchkonia T, 2010, AGING CELL, V9, P667, DOI 10.1111/j.1474-9726.2010.00608.x
   Vaicik MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109854
   Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487
   Yang Z, 2016, SCI REP-UK, V6, DOI 10.1038/srep37886
   Yoneshiro T, 2011, OBESITY, V19, P1755, DOI 10.1038/oby.2011.125
NR 42
TC 22
Z9 23
U1 1
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
EI 1474-9726
J9 AGING CELL
JI Aging Cell
PD OCT
PY 2018
VL 17
IS 5
AR e12810
DI 10.1111/acel.12810
PG 13
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA GU8OD
UT WOS:000445599100006
PM 30088333
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Battaglia, RA
   Kabiraj, P
   Willcockson, HH
   Lian, M
   Snider, NT
AF Battaglia, Rachel A.
   Kabiraj, Parijat
   Willcockson, Helen H.
   Lian, Melinda
   Snider, Natasha T.
TI Isolation of Intermediate Filament Proteins from Multiple Mouse Tissues
   to Study Aging-associated Post-translational Modifications
SO JOVE-JOURNAL OF VISUALIZED EXPERIMENTS
LA English
DT Article
DE Biochemistry; Issue 123; intermediate filaments; post-translational
   modification; mass spectrometry; immunoprecipitation; aging; stress;
   animal models; tissue fractionation
ID SIMPLE EPITHELIAL KERATINS; PHOSPHORYLATION SITES; SMOOTH-MUSCLE;
   IN-VITRO; LYSINE ACETYLATION; CELLS; STRESS; PURIFICATION; SOLUBILITY;
   DISEASE
AB Intermediate filaments (IFs), together with actin filaments and microtubules, form the cytoskeleton - a critical structural element of every cell. Normal functioning IFs provide cells with mechanical and stress resilience, while a dysfunctional IF cytoskeleton compromises cellular health and has been associated with many human diseases. Post-translational modifications (PTMs) critically regulate IF dynamics in response to physiological changes and under stress conditions. Therefore, the ability to monitor changes in the PTM signature of IFs can contribute to a better functional understanding, and ultimately conditioning, of the IF system as a stress responder during cellular injury. However, the large number of IF proteins, which are encoded by over 70 individual genes and expressed in a tissue-dependent manner, is a major challenge in sorting out the relative importance of different PTMs. To that end, methods that enable monitoring of PTMs on IF proteins on an organism-wide level, rather than for isolated members of the family, can accelerate research progress in this area. Here, we present biochemical methods for the isolation of the total, detergent-soluble, and detergent-resistant fraction of IF proteins from 9 different mouse tissues (brain, heart, lung, liver, small intestine, large intestine, pancreas, kidney, and spleen). We further demonstrate an optimized protocol for rapid isolation of IF proteins by using lysing matrix and automated homogenization of different mouse tissues. The automated protocol is useful for profiling IFs in experiments with high sample volume (such as in disease models involving multiple animals and experimental groups). The resulting samples can be utilized for various downstream analyses, including mass spectrometry-based PTM profiling. Utilizing these methods, we provide new data to show that IF proteins in different mouse tissues (brain and liver) undergo parallel changes with respect to their expression levels and PTMs during aging.
C1 [Battaglia, Rachel A.; Kabiraj, Parijat; Willcockson, Helen H.; Lian, Melinda; Snider, Natasha T.] Univ North Carolina Chapel Hill, Sch Med, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA.
C3 University of North Carolina; University of North Carolina Chapel Hill;
   University of North Carolina School of Medicine
RP Snider, NT (corresponding author), Univ North Carolina Chapel Hill, Sch Med, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA.
EM natasha_snider@med.unc.edu
RI Kabiraj, Parijat/AAE-9797-2020
OI Battaglia, Rachel/0000-0003-3187-6964; , Parijat/0000-0003-3936-3143
FU NIH [NIH R01 DK110355, DK093776, DK102450, P30 DK034987]
FX This work was supported by the NIH grants NIH R01 DK110355, DK093776
   [N.T.S.], DK102450 [N.T.S.], and P30 DK034987 [to UNC-Chapel Hill]. The
   authors thank Deekshita Ramanarayanan for assistance with qPCR and
   western blot experiments.
CR ACHTSTAETTER T, 1986, METHOD ENZYMOL, V134, P355
   AYNARDI MW, 1984, J CELL BIOL, V98, P1407, DOI 10.1083/jcb.98.4.1407
   CHOU CF, 1993, J CELL SCI, V105, P433
   Choudhary C, 2014, NAT REV MOL CELL BIO, V15, P536, DOI 10.1038/nrm3841
   Choudhary C, 2010, NAT REV MOL CELL BIO, V11, P427, DOI 10.1038/nrm2900
   Chung BM, 2013, CURR OPIN CELL BIOL, V25, P600, DOI 10.1016/j.ceb.2013.06.008
   Creixell P, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.33
   DAHL D, 1973, BRAIN RES, V57, P343, DOI 10.1016/0006-8993(73)90141-8
   DANNEMAN P, 2013, LAB MOUSE
   David DC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000450
   Dephoure N, 2013, MOL BIOL CELL, V24, P535, DOI 10.1091/mbc.E12-09-0677
   Dialynas G, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005231
   Eriksson JE, 2004, J CELL SCI, V117, P919, DOI 10.1242/jcs.00906
   Eriksson JE, 2009, J CLIN INVEST, V119, P1763, DOI 10.1172/JCI38339
   FRANKE WW, 1978, CYTOBIOLOGIE, V17, P392
   Goldman RD, 2012, J STRUCT BIOL, V177, P14, DOI 10.1016/j.jsb.2011.11.017
   Gorospe JR, 2002, NEUROLOGY, V58, P1494, DOI 10.1212/WNL.58.10.1494
   Gruenbaum Yosef, 2014, F1000Prime Rep, V6, P54, DOI 10.12703/P6-54
   Hendriks IA, 2016, NAT REV MOL CELL BIO, V17, P581, DOI 10.1038/nrm.2016.81
   Herhaus L, 2015, EMBO REP, V16, P1071, DOI 10.15252/embr.201540891
   Hobbs R. P, 2015, NAT GENET
   HUBBARD BD, 1979, J CELL BIOL, V80, P166, DOI 10.1083/jcb.80.1.166
   HUIATT TW, 1980, J BIOL CHEM, V255, P6981
   JULIEN JP, 1982, J BIOL CHEM, V257, P467
   Kammers K., 2016, MANUAL CARDIOVASCULA
   Ku NO, 2016, HEPATOLOGY, V64, P966, DOI 10.1002/hep.28493
   Ku NO, 2004, METHOD CELL BIOL, V78, P489
   Ku NO, 2004, J CELL BIOL, V166, P479, DOI 10.1083/jcb.200402051
   Lemieux GA, 2015, CELL, V160, P119, DOI 10.1016/j.cell.2014.12.028
   LIAO J, 1995, J BIOL CHEM, V270, P915, DOI 10.1074/jbc.270.2.915
   Liao J, 1996, J CELL BIOL, V133, P345, DOI 10.1083/jcb.133.2.345
   Lowery J, 2015, J BIOL CHEM, V290, P17145, DOI 10.1074/jbc.R115.640359
   LOWTHERT LA, 1995, BIOCHEM BIOPH RES CO, V206, P370, DOI 10.1006/bbrc.1995.1051
   Mashukova A, 2016, METHOD ENZYMOL, V569, P139, DOI 10.1016/bs.mie.2015.08.019
   Minguez P, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.31
   Omary M B, 1998, Subcell Biochem, V31, P105
   Omary MB, 2009, J CLIN INVEST, V119, P1794, DOI 10.1172/JCI37762
   Omary MB, 2009, J CLIN INVEST, V119, P1756, DOI 10.1172/JCI39894
   OSHEA JM, 1981, BIOCHEM J, V195, P345, DOI 10.1042/bj1950345
   Oshima RG, 2007, EXP CELL RES, V313, P1981, DOI 10.1016/j.yexcr.2007.04.007
   Pérez-Sala D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8287
   Sahlgren CM, 2001, J BIOL CHEM, V276, P16456, DOI 10.1074/jbc.M009669200
   Schinzel R, 2015, CURR OPIN CELL BIOL, V33, P102, DOI 10.1016/j.ceb.2015.01.006
   SMALL JV, 1977, J CELL SCI, V23, P243
   Snider NT, 2016, METHOD ENZYMOL, V568, P113, DOI 10.1016/bs.mie.2015.09.005
   Snider NT, 2014, NAT REV MOL CELL BIO, V15, P163, DOI 10.1038/nrm3753
   Snider NT, 2013, J BIOL CHEM, V288, P31329, DOI 10.1074/jbc.M113.502724
   Snider NT, 2013, J CELL BIOL, V200, P241, DOI 10.1083/jcb.201209028
   Snider NT, 2011, J BIOL CHEM, V286, P2273, DOI 10.1074/jbc.M110.171314
   STEINERT PM, 1976, J MOL BIOL, V108, P547, DOI 10.1016/S0022-2836(76)80136-2
   Taylor RC, 2014, NAT REV MOL CELL BIO, V15, P211, DOI 10.1038/nrm3752
   Toivola DM, 2010, TRENDS CELL BIOL, V20, P79, DOI 10.1016/j.tcb.2009.11.004
   Ulgherait M, 2014, CELL REP, V8, P1767, DOI 10.1016/j.celrep.2014.08.006
   van Oosten-Hawle P, 2013, CELL, V153, P1366, DOI 10.1016/j.cell.2013.05.015
   Walther DM, 2015, CELL, V161, P919, DOI 10.1016/j.cell.2015.03.032
   Weiss Walter, 2009, Methods Mol Biol, V564, P59, DOI 10.1007/978-1-60761-157-8_4
   Windoffer R, 2011, J CELL BIOL, V194, P669, DOI 10.1083/jcb.201008095
   ZACKROFF RV, 1979, P NATL ACAD SCI USA, V76, P6226, DOI 10.1073/pnas.76.12.6226
NR 58
TC 3
Z9 4
U1 0
U2 12
PU JOURNAL OF VISUALIZED EXPERIMENTS
PI CAMBRIDGE
PA 1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA
SN 1940-087X
J9 JOVE-J VIS EXP
JI J. Vis. Exp.
PD MAY
PY 2017
IS 123
AR e55655
DI 10.3791/55655
PG 8
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA FN1LI
UT WOS:000415749600011
PM 28570536
OA Green Published, Green Accepted
DA 2024-02-19
ER

PT J
AU Mönkemöller, V
   Schüttpelz, M
   McCourt, P
   Sorensen, K
   Smedsrod, B
   Huser, T
AF Moenkemoeller, Viola
   Schuettpelz, Mark
   McCourt, Peter
   Sorensen, Karen
   Smedsrod, Bard
   Huser, Thomas
TI Imaging fenestrations in liver sinusoidal endothelial cells by optical
   localization microscopy
SO PHYSICAL CHEMISTRY CHEMICAL PHYSICS
LA English
DT Article
ID RECONSTRUCTION MICROSCOPY; RESOLUTION; LIMIT
AB Liver sinusoidal endothelial cells (LSEC) are an important class of endothelial cells facilitating the translocation of lipoproteins and small molecules between the liver and blood. A number of clinical conditions, especially metabolic and aging-related disorders, are implicated by improper function of LSECs. Despite their importance, research into these cells is limited because the primary ultrastructures involved in their function are transcellular pores, called fenestrations, with diameters in a size range between 50-200 nm, i.e. well below the optical diffraction limit. Here, we show that we are able to resolve fenestrations with a spatial resolution of similar to 20 nm by direct stochastic optical reconstruction microscopy (dSTORM). The cellular plasma membrane was labeled at high fluorophore density with CellMask Deep Red and imaged using a reducing buffer system. We compare the higher degree of structural detail that dSTORM provides to results obtained by 3D structured illumination microscopy (3D-SIM). Our results open up a path to image these physiologically important cells in vitro using highly resolving localization microscopy techniques that could be implemented on non-specialized fluorescence microscopes, enabling their investigation in most biomedical laboratories without the need for electron microscopy.
C1 [Moenkemoeller, Viola; Schuettpelz, Mark; Huser, Thomas] Univ Bielefeld, Dept Phys, D-33615 Bielefeld, Germany.
   [McCourt, Peter; Sorensen, Karen; Smedsrod, Bard] Univ Tromso, Tromso, Norway.
   [Huser, Thomas] Univ Calif Davis, Dept Internal Med, Sacramento, CA 95817 USA.
C3 University of Bielefeld; UiT The Arctic University of Tromso; University
   of California System; University of California Davis
RP Huser, T (corresponding author), Univ Bielefeld, Dept Phys, D-33615 Bielefeld, Germany.
EM thomas.huser@physik.uni-bielefeld.de
RI Schüttpelz, Mark/B-2295-2008; Huser, Thomas/K-7291-2019; McCourt,
   Peter/B-3043-2009
OI Schüttpelz, Mark/0000-0001-5338-1706; Huser, Thomas/0000-0003-2348-7416;
   McCourt, Peter/0000-0001-5072-4590; Smedsrod, Bard/0000-0002-3308-8948;
   Monkemoller, Viola/0000-0002-0931-3877
FU Ministry of Innovation, Science, Research and Technology of the State of
   North Rhine-Westphalia (MIWFT) [321 - 8.03.04.03 - 2012/02]; Tromso
   Research Foundation
FX This work was supported in parts by the Ministry of Innovation, Science,
   Research and Technology of the State of North Rhine-Westphalia (MIWFT)
   as part of the research cooperation "MoRitS - Model-based Realization of
   intelligent Systems in Nano- and Biotechnologies" (grant no. 321 -
   8.03.04.03 - 2012/02), and the Tromso Research Foundation (supported by
   Trond Mohn).
CR BETZIG E, 1995, OPT LETT, V20, P237, DOI 10.1364/OL.20.000237
   Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344
   Braet Filip, 2002, Comp Hepatol, V1, P1, DOI 10.1186/1476-5926-1-1
   Cogger VC, 2010, J STRUCT BIOL, V171, P382, DOI 10.1016/j.jsb.2010.06.001
   Dertinger T, 2009, P NATL ACAD SCI USA, V106, P22287, DOI 10.1073/pnas.0907866106
   Fiolka R, 2012, P NATL ACAD SCI USA, V109, P5311, DOI 10.1073/pnas.1119262109
   Ganesan LP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002281
   Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345
   Gustafsson MGL, 2000, PROC SPIE, V3919, P141, DOI 10.1117/12.384189
   Heilemann M, 2008, ANGEW CHEM INT EDIT, V47, P6172, DOI 10.1002/anie.200802376
   Heilemann M, 2009, ANGEW CHEM INT EDIT, V48, P6903, DOI 10.1002/anie.200902073
   Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395
   HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780
   Holm T, 2014, CHEMPHYSCHEM, V15, P651, DOI 10.1002/cphc.201300739
   Huser T, 2008, CURR OPIN CHEM BIOL, V12, P497, DOI 10.1016/j.cbpa.2008.08.012
   Ito Y, 2003, MICROCIRCULATION, V10, P391, DOI 10.1038/sj.mn.7800204
   Kner P, 2009, NAT METHODS, V6, P339, DOI [10.1038/NMETH.1324, 10.1038/nmeth.1324]
   Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929
   Shao L, 2011, NAT METHODS, V8, P1044, DOI [10.1038/nmeth.1734, 10.1038/NMETH.1734]
   SMEDSROD B, 1985, CELL TISSUE RES, V241, P639
   Sorensen KK, 2012, AM J PHYSIOL-REG I, V303, pR1217, DOI 10.1152/ajpregu.00686.2011
   Svistounov D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046134
   van de Linde S, 2009, PHOTOCH PHOTOBIO SCI, V8, P465, DOI 10.1039/b822533h
   van de Linde S, 2011, NAT PROTOC, V6, P991, DOI 10.1038/nprot.2011.336
   van de Linde S, 2008, J STRUCT BIOL, V164, P250, DOI 10.1016/j.jsb.2008.08.002
   Wolter S, 2010, J MICROSC-OXFORD, V237, P12, DOI 10.1111/j.1365-2818.2009.03287.x
   Wolter S, 2012, NAT METHODS, V9, P1040, DOI 10.1038/nmeth.2224
   Wombacher R, 2010, NAT METHODS, V7, P717, DOI [10.1038/NMETH.1489, 10.1038/nmeth.1489]
   Yahiatène I, 2013, CHEM PHYS LETT, V587, P1, DOI 10.1016/j.cplett.2013.08.102
NR 29
TC 28
Z9 29
U1 0
U2 29
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1463-9076
EI 1463-9084
J9 PHYS CHEM CHEM PHYS
JI Phys. Chem. Chem. Phys.
PY 2014
VL 16
IS 24
BP 12576
EP 12581
DI 10.1039/c4cp01574f
PG 6
WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry; Physics
GA AI7ZR
UT WOS:000337122000081
PM 24830784
DA 2024-02-19
ER

PT J
AU Henwood, A
AF Henwood, A
TI Current applications of orcein in histochemistry. A brief review with
   some new observations concerning influence of dye batch variation and
   aging of dye solutions on staining
SO BIOTECHNIC & HISTOCHEMISTRY
LA English
DT Article
DE batch variation; copper associated proteins; dyestuff chemistry; elastic
   tissue; hepatitis B surface antigen; orcein; stain aging; sulfated
   mucins
ID B SURFACE-ANTIGEN; HEPATOCELLULAR-CARCINOMA; ELASTIC FIBERS; LIVER;
   COPPER; LOCALIZATION; SECTIONS; FIBROSIS; DISEASE
AB Current uses of orcein to demonstrate elastic fibers and, following permanganate oxidation (Shikata's modification), hepatitis B surface antigen, copper associated protein, and sulfated mucins, are reviewed. Variations in staining performance with batch of dye and age of dye solution is also discussed. Additional experimental findings support the view that the orcein stain for elastic tissue and Shikata's modification produces consistent, high quality results as long as appropriate controls and suitable dye batches, e.g., Biological Stain Commission certified dyes, are used.
C1 Childrens Hosp, Dept Histopathol, Westmead, NSW 2145, Australia.
C3 University of Sydney; NSW Health; Sydney Childrens Hospitals Network
RP Henwood, A (corresponding author), Childrens Hosp, Dept Histopathol, Locked Bag 4001, Westmead, NSW 2145, Australia.
RI Henwood, Anthony/JSK-2853-2023
OI Henwood, Anthony/0000-0001-5499-060X
CR Akinyinka OO, 2001, ANN TROP PAEDIATR, V21, P165, DOI 10.1080/02724930120058250
   ALONSOMARTI C, 1990, HISTOPATHOLOGY, V16, P304, DOI 10.1111/j.1365-2559.1990.tb01122.x
   BAKER A, 1995, J HEPATOL, V23, P538, DOI 10.1016/0168-8278(95)80059-X
   BEECKEN H, 1961, ANGEW CHEM INT EDIT, V73, P665, DOI 10.1002/ange.19610732002
   CROWDER CH, 1993, HISTOLOGIC, V23, P9
   Derancourt C, 2000, ANN DERMATOL VENER, V127, P723
   Fujita S, 2001, J ORAL REHABIL, V28, P962, DOI 10.1046/j.1365-2842.2001.00747.x
   Gupta S C, 1997, Indian J Pathol Microbiol, V40, P327
   Gupta S C, 2000, Indian J Pathol Microbiol, V43, P147
   Henwood A, 2002, J HISTOTECHNOL, V25, P29
   Henwood A. F., 1983, AUST J MED LAB SC, V4, P76
   HENWOOD AF, 1981, AUST J MED LAB SCI, V2, P55
   HOROBIN RW, 2002, CONNS BIOL STAINS HD, P288
   Ito I, 2001, LARYNGOSCOPE, V111, P881, DOI 10.1097/00005537-200105000-00023
   KERR R, 1986, STAIN TECHNOL, V61, P243, DOI 10.3109/10520298609109945
   KIRKPATRICK P, 1982, J CLIN PATHOL, V35, P430, DOI 10.1136/jcp.35.4.430
   Koukoulis GK, 2001, HUM PATHOL, V32, P1356, DOI 10.1053/hupa.2001.29675
   Metaxa-Mariatou V, 2002, MOL HUM REPROD, V8, P559, DOI 10.1093/molehr/8.6.559
   NAKAMURA H, 1977, J HISTOCHEM CYTOCHEM, V25, P306, DOI 10.1177/25.4.858912
   Panicker JN, 1996, INDIAN J MED RES, V104, P374
   Pilloni L, 1998, HISTOPATHOLOGY, V33, P28, DOI 10.1046/j.1365-2559.1998.00455.x
   Salvato G, 2001, THORAX, V56, P902, DOI 10.1136/thorax.56.12.902
   SCHEUER PJ, 1980, HISTOPATHOLOGY, V4, P487, DOI 10.1111/j.1365-2559.1980.tb02943.x
   Sethi S, 2000, J Indian Med Assoc, V98, P434
   SHOUSHA S, 1981, J CLIN PATHOL, V34, P1063, DOI 10.1136/jcp.34.9.1063
   Sims FH, 2001, CORONARY ARTERY DIS, V12, P21
   SINGH R, 1989, J CLIN PATHOL, V42, P881, DOI 10.1136/jcp.42.8.881
   Steven P, 2000, ARCH HISTOL CYTOL, V63, P397, DOI 10.1679/aohc.63.397
   Tsuji N, 2001, PHOTOCHEM PHOTOBIOL, V74, P283, DOI 10.1562/0031-8655(2001)074<0283:TROESB>2.0.CO;2
   UNNA PG, 1890, MH PRAKT DERM, V11, P366
NR 30
TC 20
Z9 22
U1 0
U2 7
PU B I O S SCIENTIFIC PUBLISHERS LTD
PI OXFORD
PA 9 NEWTEC PLACE, MAGDALEN RD, OXFORD OX4 1RE, ENGLAND
SN 1052-0295
J9 BIOTECH HISTOCHEM
JI Biotech. Histochem.
PD DEC
PY 2003
VL 78
IS 6
BP 303
EP 308
DI 10.1080/10520290410001671335
PG 6
WC Biotechnology & Applied Microbiology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Cell Biology
GA 830JI
UT WOS:000222117800004
PM 15473577
DA 2024-02-19
ER

PT J
AU Walrand, S
   Chambon-Savanovitch, C
   Felgines, C
   Chassagne, J
   Raul, F
   Normand, B
   Farges, MC
   Beaufrère, B
   Vasson, MP
   Cynober, L
AF Walrand, S
   Chambon-Savanovitch, C
   Felgines, C
   Chassagne, J
   Raul, F
   Normand, B
   Farges, MC
   Beaufrère, B
   Vasson, MP
   Cynober, L
TI Aging:: a barrier to renutrition?: Nutritional and immunologic evidence
   in rats
SO AMERICAN JOURNAL OF CLINICAL NUTRITION
LA English
DT Article
DE aging; dietary restriction; acute renutrition; protein supplementation;
   protein metabolism; intestinal morphometry; nonspecific immune response;
   elderly; aged; old; rats
ID CYCLIC ENTERAL NUTRITION; DIETARY WHEY PROTEINS; TUMOR-NECROSIS-FACTOR;
   STARVED RATS; AMINO-ACIDS; GLUTAMINE CONCENTRATION; NITROGEN-RETENTION;
   YOUNGER PATIENTS; AGED RATS; METABOLISM
AB Background: Previous reports suggest that correcting the malnourished state is more difficult in elderly people than in younger ones and that protein requirements may be higher in elderly than in younger adults.
   Objective: The aim of this study was to establish whether malnourished old rats respond to protein-supplemented nutritional repletion as do young adult rats.
   Design: Adult (3 mo old) and old (22 mo old) rats were submitted to dietary restriction programs that induced similar metabolic and nutritional alterations. Malnourished adult and old rats were then killed (R groups) or refed for 1 wk with a high-protein diet (HPD; 23% protein) or a very-high-protein diet (VHPD; 27% protein). Control groups at both ages were fed ad libitum throughout the experiment. Effects of food repletion were evaluated in terms of protein metabolism intestinal histomorphometry, and nonspecific immune status.
   Results: In adult rats, HPD sufficed to increase body weight and restore basal values of liver weight and protein content (P < 0.01 compared with the R adult group), nitrogen balance (P < 0.01 compared with the R adult group), and hydrogen peroxide production by polymorphonuclear neutrophils and monocytes (P < 0.01 compared with the R group); VHPD had no supplementary effect except on nitrogen balance. In old rats, HPD was less effective and greater benefit was observed with VHPD in terms of body weight gain (10%; P < 0.01 compared with the old group fed HPD), albuminemia, muscle weight and protein content, plasma arginine concentration, and hydrogen peroxide production by stimulated polymorphonuclear neutrophils and monocytes compared with the old R group (P < 0.01).
   Conclusion: Aging is a significant variable affecting the response to nutritional support.
C1 Fac Pharm Clermont Ferrand, Lab Biochim Biol Mol & Nutr, Equipe Acceuil 2416, Ctr Rech Nutr Humaine, F-63001 Clermont Ferrand 1, France.
   Ctr Anticanc Jean Perrin, Immunol Lab, Clermont Ferrand, France.
   Inst Rech Canc Appareil Digestif, Strasbourg, France.
   Fac Med, Lab Biostat, Equipe Acceuil 2416, Clermont Ferrand, France.
   Ctr Rech Nutr Humaine, Lab Nutr Humaine, Clermont Ferrand, France.
C3 CHU Clermont Ferrand; UNICANCER; Centre Jean Perrin
RP Walrand, S (corresponding author), Fac Pharm Clermont Ferrand, Lab Biochim Biol Mol & Nutr, Equipe Acceuil 2416, Ctr Rech Nutr Humaine, 28 Pl Henri Dunant,BP 38, F-63001 Clermont Ferrand 1, France.
RI Cynober, Luc/ABB-2368-2020; FELGINES, Catherine/D-5501-2015; vasson,
   marie-paule/ABA-2486-2021
CR BALDWIN JK, 1985, EXP GERONTOL, V20, P29, DOI 10.1016/0531-5565(85)90006-3
   BARBUL A, 1990, NUTRITION, V6, P53
   BEAUMONT D, 1989, AGE AGEING, V18, P235, DOI 10.1093/ageing/18.4.235
   Boirie Y, 1997, AM J CLIN NUTR, V65, P489
   BOZA J, 1995, JPEN-PARENTER ENTER, V19, P216, DOI 10.1177/0148607195019003216
   Boza J, 1996, J PEDIATR GASTR NUTR, V22, P186, DOI 10.1097/00005176-199602000-00010
   CALDER PC, 1994, CLIN NUTR, V13, P2, DOI 10.1016/0261-5614(94)90003-5
   CAMPBELL WW, 1994, AM J CLIN NUTR, V60, P501, DOI 10.1093/ajcn/60.4.501
   CASIMIR CM, 1998, IMMUNOPHARMACOLOGY N, P27
   Chambon-Savanovitch C, 1999, EUR J CLIN INVEST, V29, P504, DOI 10.1046/j.1365-2362.1999.00469.x
   Chandra Ranjit Kumar, 1997, American Journal of Clinical Nutrition, V66, p460S
   CHYUN JH, 1984, NUTR RES, V4, P123, DOI 10.1016/S0271-5317(84)80141-4
   CHYUN JH, 1984, J NUTR, V114, P1697, DOI 10.1093/jn/114.9.1697
   Cynober L, 1997, NUTRITION, V13, P688, DOI 10.1016/S0899-9007(97)83013-4
   CYNOBER L, 1995, J NUTR BIOCHEM, V6, P402, DOI 10.1016/0955-2863(95)00066-9
   Farges MC, 1996, NUTRITION, V12, P189, DOI 10.1016/S0899-9007(96)91124-7
   Felgines C, 1999, JPEN-PARENTER ENTER, V23, P32, DOI 10.1177/014860719902300132
   GORNALL AG, 1949, J BIOL CHEM, V177, P751
   HEBUTERNE X, 1995, JAMA-J AM MED ASSOC, V273, P638, DOI 10.1001/jama.273.8.638
   Hébuterne X, 1997, CLIN NUTR, V16, P283, DOI 10.1016/S0261-5614(97)80013-1
   HOLT PR, 1988, P NATL ACAD SCI USA, V85, P2771, DOI 10.1073/pnas.85.8.2771
   KAMINSKI MV, 1982, J AM COLL NUTR, V1, P35
   Lesourd BM, 1997, AM J CLIN NUTR, V66, P478, DOI 10.1093/ajcn/66.2.478S
   MICHEL JP, 1997, J NUTR HLTH AGING, V1, P13
   MILLWARD DJ, 1989, METABOLISM, V38, P6, DOI 10.1016/0026-0495(89)90132-7
   MOSONI L, 1993, AM J PHYSIOL, V264, pE614, DOI 10.1152/ajpendo.1993.264.4.E614
   MUNOZ C, 1994, NUTR RES, V14, P347, DOI 10.1016/S0271-5317(05)80173-3
   Munro H N, 1982, Clin Nutr, V1, P95, DOI 10.1016/0261-5614(82)90031-0
   National Research Council, 1985, NIH PUBL
   POULLAIN MG, 1991, CLIN NUTR, V10, P49, DOI 10.1016/0261-5614(91)90081-M
   POULLAIN MG, 1989, JPEN-PARENTER ENTER, V13, P382, DOI 10.1177/0148607189013004382
   POULLAIN MG, 1989, AM J CLIN NUTR, V49, P71, DOI 10.1093/ajcn/49.1.71
   RENNIE MJ, 1989, METABOLISM, V38, P47, DOI 10.1016/0026-0495(89)90140-6
   REVILLE M, 1991, J NUTR, V121, P498, DOI 10.1093/jn/121.4.498
   SHIZGAL HM, 1992, AM J CLIN NUTR, V55, P783, DOI 10.1093/ajcn/55.4.783
   SULLIVAN DH, 1995, J AM GERIATR SOC, V43, P507, DOI 10.1111/j.1532-5415.1995.tb06097.x
   VILCEK J, 1991, J BIOL CHEM, V266, P7313
   YOSHINAGA K, 1993, EXP GERONTOL, V28, P565, DOI 10.1016/0531-5565(93)90045-F
NR 38
TC 48
Z9 50
U1 0
U2 1
PU AMER SOC CLINICAL NUTRITION
PI BETHESDA
PA 9650 ROCKVILLE PIKE, SUBSCRIPTIONS, RM L-3300, BETHESDA, MD 20814-3998
   USA
SN 0002-9165
J9 AM J CLIN NUTR
JI Am. J. Clin. Nutr.
PD SEP
PY 2000
VL 72
IS 3
BP 816
EP 824
PG 9
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 349AH
UT WOS:000089021300025
PM 10966905
DA 2024-02-19
ER

PT J
AU SNOECK, E
   VANPEER, A
   SACK, M
   HORTON, M
   MANNENS, G
   WOESTENBORGHS, R
   MEIBACH, R
   HEYKANTS, J
AF SNOECK, E
   VANPEER, A
   SACK, M
   HORTON, M
   MANNENS, G
   WOESTENBORGHS, R
   MEIBACH, R
   HEYKANTS, J
TI INFLUENCE OF AGE, RENAL AND LIVER IMPAIRMENT ON THE PHARMACOKINETICS OF
   RISPERIDONE IN MAN
SO PSYCHOPHARMACOLOGY
LA English
DT Article
DE RISPERIDONE; PHARMACOKINETICS; ELDERLY; RENAL DISEASE; LIVER DISEASE
ID PLASMA-PROTEIN BINDING; ALPHA-1-ACID GLYCOPROTEIN; PSYCHOTIC-PATIENTS;
   DRUG-THERAPY; DISEASE; DIPHENYLHYDANTOIN; POLYMORPHISM; METABOLISM;
   CLEARANCE; SEX
AB The pharmacokinetics of the antipsychotic agent risperidone were investigated in healthy young and elderly subjects, cirrhotic patients and patients with moderate and severe renal insufficiency. In a comparative trial, a single oral 1-mg dose was administered to fasting subjects. Plasma and urine concentrations of the parent compound risperidone and the active moiety (i.e. risperidone plus 9-hydroxy-risperidone) were measured by radioimmunoassays. No or only small changes in plasma protein binding were observed in hepatic and renal disease, whereas the protein binding was not influenced by aging. The inter-individual variability in plasma concentrations of the active moiety was much less than the variability in plasma concentrations of risperidone. Three out of six subjects, behaving like poor metabolizers, were on medication (thiethylperazine, amitriptyline, metoprolol) that may inhibit risperidone metabolism by CYP2D6 (debrisoquine 4-hydroxylase). The pharmacokinetics of risperidone in elderly and cirrhotic patients were comparable to those in young subjects, whereas total oral clearance was reduced in renal disease patients. The elimination rate and clearance of 9-hydroxy-risperidone was reduced in elderly and renal disease patients because of a diminished creatinine clearance. The CL(oral) of the active moiety, which is primarily 9-hydroxy-risperidone, was reduced by about 30% in the elderly and by about 50% in renal disease patients. In addition, the t(1/2) of the active moiety was prolonged (19 h in young subjects versus about 25 h in elderly and renal disease patients). Based upon the pharmacokinetics of the active moiety, a dose reduction and a cautious dose titration is advised in the elderly and in patients with renal disease. In cirrhotic patients, the single-dose pharmacokinetics were comparable to those in healthy young subjects.
C1 CLIN RES CTR,AUSTIN,TX.
   JANSSEN RES FDN,DEPT CLIN RES,TITUSVILLE,NJ.
C3 Johnson & Johnson; Johnson & Johnson USA
RP SNOECK, E (corresponding author), JANSSEN RES FDN,DEPT DRUG METAB & PHARMACOKINET,TURNHOUTSEWEG 30,B-2340 BEERSE,BELGIUM.
CR AFFRIME M, 1975, EUR J CLIN PHARMACOL, V8, P267, DOI 10.1007/BF00567126
   ANDREASEN F, 1973, ACTA PHARMACOL TOX, V32, P417
   BARRE J, 1984, BRIT J CLIN PHARMACO, V18, P652, DOI 10.1111/j.1365-2125.1984.tb02525.x
   BROSEN K, 1989, EUR J CLIN PHARMACOL, V36, P537, DOI 10.1007/BF00637732
   CLAUS A, 1992, ACTA PSYCHIAT SCAND, V85, P295, DOI 10.1111/j.1600-0447.1992.tb01473.x
   DOCCI D, 1985, NEPHRON, V39, P160, DOI 10.1159/000183364
   DYKBAR R, 1981, ACTA MED SCAND, V209, P1
   EICHELBAUM M, 1990, PHARMACOL THERAPEUT, V46, P377, DOI 10.1016/0163-7258(90)90025-W
   GELDERS YG, 1990, PHARMACOPSYCHIATRY, V23, P206, DOI 10.1055/s-2007-1014509
   GILES HG, 1982, CLIN PHARMACOL THER, V31, P77, DOI 10.1038/clpt.1982.12
   GREENBLATT DJ, 1982, NEW ENGL J MED, V306, P1081
   GREENBLATT DJ, 1986, THER DRUG MONIT, V8, P249, DOI 10.1097/00007691-198609000-00001
   GROSSMAN SH, 1982, CLIN PHARMACOL THER, V31, P350, DOI 10.1038/clpt.1982.45
   HOOPER WD, 1974, CLIN PHARMACOL THER, V15, P276
   HUANG ML, 1993, CLIN PHARMACOL THER, V54, P257, DOI 10.1038/clpt.1993.146
   JANSSEN PAJ, 1988, J PHARMACOL EXP THER, V244, P685
   KREMER JMH, 1988, PHARMACOL REV, V40, P1
   LARSSON M, 1986, SCAND J CLIN LAB INV, V46, P593, DOI 10.3109/00365518609083718
   LEYSEN JE, 1988, J PHARMACOL EXP THER, V247, P661
   MANNENS G, 1993, DRUG METAB DISPOS, V21, P1134
   MANNENS G, 1994, PSYCHOPHARMACOLOGY, V114, P566, DOI 10.1007/BF02244986
   MCLENNAN WJ, 1977, GERONTOLOGY, V23, P360
   MESOTTEN F, 1989, PSYCHOPHARMACOLOGY, V99, P445, DOI 10.1007/BF00589890
   MEULDERMANS W, 1993, DRUG METAB DISPOS, V22, P129
   PACIFICI GM, 1986, THER DRUG MONIT, V8, P259, DOI 10.1097/00007691-198609000-00003
   PIAFSKY KM, 1978, NEW ENGL J MED, V299, P1435, DOI 10.1056/NEJM197812282992604
   REIDENBERG MM, 1971, NEW ENGL J MED, V285, P264, DOI 10.1056/NEJM197107292850506
   REIDENBERG MM, 1984, CLIN PHARMACOKINET, V9, P18, DOI 10.2165/00003088-198400091-00003
   RITCHELL WA, 1988, GERONTOKINETICS
   RITCHELL WA, 1992, METHOD FIND EXP CLIN, V14, P555
   SERBOURCEGOGUEL SN, 1986, J HEPATOL, V2, P245
   SPINA E, 1991, EUR J CLIN PHARMACOL, V41, P467, DOI 10.1007/BF00626371
   STEINER E, 1985, CLIN PHARMACOL THER, V38, P394, DOI 10.1038/clpt.1985.193
   URIEN S, 1981, INT J CLIN PHARM TH, V19, P319
   VANBEIJSTERVELD.L, 1993, PSYCHOPHARMACOLOGY, V114, P53
   VERBEECK RK, 1984, EUR J CLIN PHARMACOL, V27, P91, DOI 10.1007/BF00553161
   VESTAL RE, 1989, HEPATOLOGY, V9, P331, DOI 10.1002/hep.1840090228
NR 37
TC 95
Z9 97
U1 0
U2 6
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010
SN 0033-3158
J9 PSYCHOPHARMACOLOGY
JI Psychopharmacology
PD DEC
PY 1995
VL 122
IS 3
BP 223
EP 229
DI 10.1007/BF02246543
PG 7
WC Neurosciences; Pharmacology & Pharmacy; Psychiatry
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry
GA TJ462
UT WOS:A1995TJ46200003
PM 8748391
DA 2024-02-19
ER

PT J
AU Maeda, T
   Miki, S
   Morihara, N
   Kagawa, Y
AF Maeda, Toshio
   Miki, Satomi
   Morihara, Naoaki
   Kagawa, Yoshiyuki
TI Aged garlic extract ameliorates fatty liver and insulin resistance and
   improves the gut microbiota profile in a mouse model of insulin
   resistance
SO EXPERIMENTAL AND THERAPEUTIC MEDICINE
LA English
DT Article
DE aged garlic extract; fatty liver; intestinal fat absorption; insulin
   resistance; gut microbiota
ID HEPATIC STEATOSIS; ADIPOSE-TISSUE; IMMUNE-SYSTEM; EXPRESSION; OBESITY;
   DISEASE; TARGET; INJURY; INFLAMMATION; MACROPHAGES
AB Aged garlic extract (AGE) produced by the aging process has various beneficial pharmacological effects. In this study, the effects of AGE on fatty liver, insulin resistance and intestinal microbiota were compared between ddY-H mice, an insulin resistance mouse, and ddY-L mice, normal mice. Mice were fed an AGE-supplemented diet (4% w/w) for 7 weeks. The administration of AGE had no effect on the body weight and dietary intake of both types of mice. In the ddY-H mice, the serum levels of glucose and insulin were increased and glucose tolerance was impaired; however, the administration of AGE ameliorated these abnormal conditions. AGE did not have these effects in ddY-L mice. Triglyceride (TG) accumulation in the liver and fat absorption from the digestive tract were increased in the ddY-H mice; however, the administration of AGE reduced this increase. On the other hand, AGE exerted no such effects in the ddY-L mice. In addition, the gut microbiota has been shown to be closely associated with obesity, diabetes, dyslipidemia and non-alcoholic fatty liver disease in human and animal models. The bacterial composition of the gut microbiota in the feces of the ddY-H mice did not differ from that of the ddY-L mice at 5 weeks of age; however, it was altered in the mice at 9 and 12 weeks of age even when the mice were fed a standard diet. In the ddY-H mice, the relative presence of Lactobacillales was increased, while that of Bifidobacterium, Clostridium cluster XVIII and Prevotella was decreased. The alteration of the bacterial composition in the ddY-H mice was reversed by the administration of AGE; however, this effect of AGE was not observed in the ddY-L mice. On the whole, the findings of this study indicate that AGE improves abnormal fat accumulation and insulin resistance, and also alters the intestinal flora in ddY-H mice, suggesting the possibility that these effects of AGE may be related.
C1 [Maeda, Toshio; Kagawa, Yoshiyuki] Univ Shizuoka, Grad Sch Pharmaceut Sci, Dept Clin Pharmaceut & Pharm Practice, Shizuoka 4228526, Japan.
   [Miki, Satomi; Morihara, Naoaki] Wakunaga Pharmaceut Co Ltd, Cent Res Inst, Akitakata, Hiroshima 7391195, Japan.
C3 University of Shizuoka; Wakunaga Pharmaceutical Co., Ltd.
RP Maeda, T (corresponding author), Univ Shizuoka, Grad Sch Pharmaceut Sci, Dept Clin Pharmaceut & Pharm Practice, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan.
EM maeda@u-shizuoka-ken.ac.jp
CR Alpers DH, 2009, CURR OPIN GASTROEN, V25, P116, DOI 10.1097/MOG.0b013e32831ef221
   Amagase H, 2001, J NUTR, V131, p955S, DOI 10.1093/jn/131.3.955S
   Angulo P, 2007, ALIMENT PHARM THER, V25, P883, DOI 10.1111/j.1365-2036.2007.03246.x
   Bagarolli RA, 2017, J NUTR BIOCHEM, V50, P16, DOI 10.1016/j.jnutbio.2017.08.006
   Bordia T, 1996, PROSTAG LEUKOTR ESS, V54, P183, DOI 10.1016/S0952-3278(96)90014-9
   Brix AE, 2002, MOL GENET METAB, V75, P219, DOI 10.1006/mgme.2002.3298
   Brunt EM, 2010, WORLD J GASTROENTERO, V16, P5286, DOI 10.3748/wjg.v16.i42.5286
   Burcelin Remy, 2017, Biologie Aujourd hui, V211, P1, DOI 10.1051/jbio/2017008
   Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403
   Chen SX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079730
   Chi YL, 2019, SCI TOTAL ENVIRON, V653, P274, DOI 10.1016/j.scitotenv.2018.10.387
   Cho MS, 2018, J MICROBIOL, V56, P855
   Compare D, 2012, NUTR METAB CARDIOVAS, V22, P471, DOI 10.1016/j.numecd.2012.02.007
   Ferramosca A, 2014, WORLD J GASTROENTERO, V20, P1746, DOI 10.3748/wjg.v20.i7.1746
   Gérard P, 2016, CELL MOL LIFE SCI, V73, P147, DOI 10.1007/s00018-015-2061-5
   Honda K, 2016, NATURE, V535, P75, DOI 10.1038/nature18848
   Ide N, 2015, BIOL PHARM BULL, V38, P1925, DOI 10.1248/bpb.b15-00602
   Jang HJ, 2018, FOOD SCI BIOTECHNOL, V27, P219, DOI 10.1007/s10068-017-0246-4
   Khan RS, 2019, HEPATOLOGY, V70, P711, DOI 10.1002/hep.30429
   Kim JY, 2017, J HEPATOL, V67, P349, DOI 10.1016/j.jhep.2017.03.023
   Kim MJ, 2014, J MED FOOD, V17, P1057, DOI 10.1089/jmf.2013.3043
   Kodai S, 2007, FREE RADICAL RES, V41, P489, DOI 10.1080/10715760601118361
   Law K, 2010, CLIN LIVER DIS, V14, P591, DOI 10.1016/j.cld.2010.07.006
   Lieber CS, 2004, AM J CLIN NUTR, V79, P502
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Logan AC, 2016, CURR ALLERGY ASTHM R, V16, DOI 10.1007/s11882-015-0590-5
   Lonardo A, 2019, ACTA DIABETOL, V56, P385, DOI 10.1007/s00592-018-1266-0
   Ma JL, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101124
   Maeda T, 2013, BIOL PHARM BULL, V36, P825, DOI 10.1248/bpb.b12-01014
   Memon RA, 2000, ENDOCRINOLOGY, V141, P4021, DOI 10.1210/en.141.11.4021
   Miki S, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600797
   Nagashima K., 2006, Bioscience and Microflora, V25, P99
   Nagashima K, 2003, APPL ENVIRON MICROB, V69, P1251, DOI 10.1128/AEM.69.2.1251-1262.2003
   Nagata Kiyoshi, 2007, Journal of Toxicological Sciences, V32, P453, DOI 10.2131/jts.32.453
   Noge I, 2010, BIOL PHARM BULL, V33, P988, DOI 10.1248/bpb.33.988
   O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731
   Okumura K, 2006, HEPATOL RES, V36, P217, DOI 10.1016/j.hepres.2006.07.009
   Perumpail BJ, 2019, DISEASES-BASEL, V7, DOI 10.3390/diseases7010027
   Pollak M, 2017, DIABETOLOGIA, V60, P1662, DOI 10.1007/s00125-017-4352-x
   RABHI N, 2014, J DIABETES RES, V2014, DOI DOI 10.1155/2014/795171
   Rahimian R, 2001, MOL CELL BIOCHEM, V224, P29, DOI 10.1023/A:1011927113563
   Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002
   Rana SV, 2011, NUTR RES REV, V24, P60, DOI 10.1017/S0954422410000338
   Riad K, 2018, FRONT NUTR, V5, DOI 10.3389/fnut.2018.00122
   Ried K, 2016, INTEGR BLOOD PRESS C, V9, P9, DOI 10.2147/IBPC.S93335
   Saad MJA, 2016, PHYSIOLOGY, V31, P283, DOI 10.1152/physiol.00041.2015
   Safari Z, 2019, CELL MOL LIFE SCI, V76, P1541, DOI 10.1007/s00018-019-03011-w
   Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017
   Satoh H, 2013, BIOL PHARM BULL, V36, P616
   Sedighi M, 2017, MICROB PATHOGENESIS, V111, P362, DOI 10.1016/j.micpath.2017.08.038
   Suk KT, 2019, EXPERT REV GASTROENT, V13, P193, DOI 10.1080/17474124.2019.1569513
   Sumioka I, 2001, EUR J PHARMACOL, V433, P177, DOI 10.1016/S0014-2999(01)01503-5
   Takemura S, 2013, J CLIN BIOCHEM NUTR, V53, P94, DOI 10.3164/jcbn.13-1
   Wang BH, 1999, TOXICOLOGY, V132, P215, DOI 10.1016/S0300-483X(99)00004-9
   Winer DA, 2016, CELL METAB, V23, P413, DOI 10.1016/j.cmet.2016.01.003
   Wortham M, 2008, DIGEST DIS SCI, V53, P2761, DOI 10.1007/s10620-007-0193-7
   Yeh YY, 2001, J NUTR, V131, p989S, DOI 10.1093/jn/131.3.989S
   Yilmaz Y, 2012, ALIMENT PHARM THER, V36, P815, DOI 10.1111/apt.12046
   Zhou WB, 2019, FOOD FUNCT, V10, P1073, DOI [10.1039/c8fo02192a, 10.1039/C8FO02192A]
   Zhou YL, 2018, CELL PHYSIOL BIOCHEM, V51, P2123, DOI 10.1159/000495830
NR 60
TC 19
Z9 19
U1 1
U2 10
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1792-0981
EI 1792-1015
J9 EXP THER MED
JI Exp. Ther. Med.
PD JUL
PY 2019
VL 18
IS 1
BP 857
EP 866
DI 10.3892/etm.2019.7636
PG 10
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA IK5DN
UT WOS:000476606000110
PM 31281460
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU André, A
   Juanéda, P
   Sébédio, JL
   Chardigny, JM
AF André, A
   Juanéda, P
   Sébédio, JL
   Chardigny, JM
TI Plasmalogen metabolism-related enzymes in rat brain during aging::
   influence of n-3 fatty acid intake
SO BIOCHIMIE
LA English
DT Article
DE plasmalogen; dihydroxyacetone phosphate acyltransferase; phospholipase
   A(2); aging; brain
ID PHOSPHOLIPASE A(2); SIGNAL-TRANSDUCTION; LIVER; LIPIDS; ACYL;
   PLASMENYLETHANOLAMINE; LOCALIZATION; PURIFICATION; PEROXISOMES;
   DEFICIENCY
AB Plasmalogens (Pls) are phospholipids containing a vinyl-ether bond at the sn-1 position of the glycerol backbone. They represent between 1/2 and 2/3 of the ethanolamine phospholipids in the brain. During aging, the Pis content in human brain falls down. However, the role of Pis metabolism-related enzymes in the regulation of Pis levels remains to be determined. Dihydroxyacetone phosphate acyltransferase (DHAPAT) is the enzyme involved in the first step of Pls biosynthesis. In the brain, a phospholipase A(2), which selectively acts on Pis, has been isolated (Pls-PLA(2)s). In this work, we aimed to evaluate the impact of DHAP-AT (a key enzyme of Pis biosynthesis) and Pls-PLA(2) (a specific Pis degradation enzyme) on the evolution of Pis content in the rat brain during aging. The influence of n-3 fatty acid intake was also evaluated. Littermates from two generations of n-3 deficient rats were fed an equilibrated diet containing either alpha-LNA alone or with two doses of DHA. After weaning, 3.9 or 21 months of diet, rats were sacrificed. Enzymatic assays were performed, Pis levels were assessed and the sn-2 position of ethanolamine Pis was analyzed. DHAP-AT activity significantly increased between weaning and 3 months with a concomitant increase of brain Pis, which reached maximal levels after 9 months. Then, Pis levels and DHAP-AT activity significantly decreased while Pls-PLA(2)s activity significantly increased. Dietary n-3 fatty acids had no effect on DHAP-AT activity and on Pis levels. In conclusion, the increase of brain Pis content in the first part of the life may be related to the high increase of DHAP-AT activity, probably stimulated by DHA. In aged animals, the decrease of Pis levels may mainly be caused to an increase of their degradation by Pls-PLA2. Dietary DHA may not oppose the physiologic aging (C) 2005 Elsevier SAS. All rights reserved.
C1 ENESAD, INRA, UMR Flaveur Vis & Comportement Consommateur, F-21065 Dijon, France.
C3 INRAE
RP Chardigny, JM (corresponding author), ENESAD, INRA, UMR Flaveur Vis & Comportement Consommateur, 17 Rue Sully,BP 86510, F-21065 Dijon, France.
EM chardign@dijon.inra.fr
OI Chardigny, Jean-Michel/0000-0001-5446-6517
CR BARTLETT GR, 1959, J BIOL CHEM, V234, P466
   CAUSERET C, 1993, CELL MOL BIOL, V39, P65
   Engelmann B, 2004, BIOCHEM SOC T, V32, P147, DOI 10.1042/BST0320147
   Farooqui AA, 2000, J MOL NEUROSCI, V14, P123, DOI 10.1385/JMN:14:3:123
   Farooqui AA, 1995, BRAIN RES REV, V21, P152, DOI 10.1016/0165-0173(95)00008-9
   Farooqui AA, 2001, J MOL NEUROSCI, V16, P263, DOI 10.1385/JMN:16:2-3:263
   Farooqui AA, 1997, J NEUROCHEM, V69, P889
   Favrelière S, 1998, LIPIDS, V33, P401, DOI 10.1007/s11745-998-0221-y
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Guttmann CRG, 1998, NEUROLOGY, V50, P972, DOI 10.1212/WNL.50.4.972
   HIRASHIMA Y, 1990, BIOCHIM BIOPHYS ACTA, V1047, P35, DOI 10.1016/0005-2760(90)90257-X
   Horrocks LA., 1972, ETHER LIPIDS CHEM BI, P177, DOI DOI 10.1016/B978-0-12-654150-2.50016-6
   JUANEDA P, 1985, LIPIDS, V20, P40, DOI 10.1007/BF02534360
   Kovacs WJ, 2001, EUR J BIOCHEM, V268, P4850, DOI 10.1046/j.0014-2956.2001.02409.x
   Martinez M, 2001, J MOL NEUROSCI, V16, P309, DOI 10.1385/JMN:16:2-3:309
   Martínez M, 2000, AM J CLIN NUTR, V71, p376S, DOI 10.1093/ajcn/71.1.376s
   Moriguchi T, 2004, J LIPID RES, V45, P1437, DOI 10.1194/jlr.M400087-JLR200
   Moriguchi T, 2001, J LIPID RES, V42, P419
   MORRISON WR, 1964, J LIPID RES, V5, P600
   Muzzio IA, 2001, J NEUROPHYSIOL, V85, P1639, DOI 10.1152/jn.2001.85.4.1639
   Nagan N, 2001, PROG LIPID RES, V40, P199, DOI 10.1016/S0163-7827(01)00003-0
   SINGH H, 1993, J LIPID RES, V34, P467
   Sovik O, 1998, J INHERIT METAB DIS, V21, P662, DOI 10.1023/A:1005484617709
   SUN GY, 1970, LIPIDS, V5, P1006, DOI 10.1007/BF02533205
   Weisser M, 1997, CHEM PHYS LIPIDS, V90, P135, DOI 10.1016/S0009-3084(97)00089-3
   Yang HC, 1996, J LIPID MEDIAT CELL, V14, P9, DOI 10.1016/0929-7855(96)01502-7
NR 26
TC 37
Z9 44
U1 0
U2 4
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI ISSY-LES-MOULINEAUX
PA 65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE
SN 0300-9084
EI 1638-6183
J9 BIOCHIMIE
JI Biochimie
PD JAN
PY 2006
VL 88
IS 1
BP 103
EP 111
DI 10.1016/j.biochi.2005.06.010
PG 9
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 002WW
UT WOS:000234643800013
PM 16046045
DA 2024-02-19
ER

PT J
AU Rikans, LE
   DeCicco, LA
   Hornbrook, KR
   Yamano, T
AF Rikans, LE
   DeCicco, LA
   Hornbrook, KR
   Yamano, T
TI Effect of age and carbon tetrachloride on cytokine concentrations in rat
   liver
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE interleukin-1 beta; interleukin-6; tumor necrosis factor-alpha; carbon
   tetrachloride hepatotoxicity; rat liver
ID NECROSIS-FACTOR-ALPHA; MICROSOMAL DRUG-METABOLISM; INDUCED
   HEPATOTOXICITY; DEFENSE-MECHANISMS; FACTOR RECEPTOR; ENDOTOXIN; INJURY;
   RESTRICTION; CELLS; IL-6
AB Interleukin-1 beta (IL-1 beta), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-alpha) concentrations were measured in livers of young-adult and old rats administered carbon tetrachloride or vehicle. IL-1 beta levels were higher and IL-6 levels were lower in old rats than in young-adult rats. Carbon tetrachloride treatment increased IL-1 beta and decreased TNF-alpha and IL-6. The elevation in IL-1 beta was diminished by aging. These results indicate that the increase in carbon tetrachloride hepatotoxicity that occurs in old age could be related to a dysregulation of inflammatory cytokines. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
C1 Univ Oklahoma, Hlth Sci Ctr, Coll Pharm, Oklahoma City, OK 73190 USA.
   Osaka City Inst Publ Hlth & Environm Sci, Osaka 543, Japan.
C3 University of Oklahoma System; University of Oklahoma Health Sciences
   Center
RP Rikans, LE (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Coll Pharm, POB 26901, Oklahoma City, OK 73190 USA.
FU NIA NIH HHS [AG04984] Funding Source: Medline
CR BELMIN J, 1995, AM J PHYSIOL-HEART C, V268, pH2288, DOI 10.1152/ajpheart.1995.268.6.H2288
   BLAZKA ME, 1995, TOXICOL APPL PHARM, V133, P43, DOI 10.1006/taap.1995.1125
   Blazka ME, 1996, J INFLAMM, V47, P138
   BOERMEESTER MA, 1995, HEPATOLOGY, V22, P1499, DOI 10.1002/hep.1840220525
   BRADLEY SF, 1989, J LEUKOCYTE BIOL, V45, P510, DOI 10.1002/jlb.45.6.510
   BROUWER A, 1995, CLIN SCI, V88, P211, DOI 10.1042/cs0880211
   Bruccoleri A, 1997, HEPATOLOGY, V25, P133, DOI 10.1053/jhep.1997.v25.pm0008985279
   Caruso C, 1996, IMMUNOL RES, V15, P84, DOI 10.1007/BF02918286
   CZAJA MJ, 1995, GASTROENTEROLOGY, V108, P1849, DOI 10.1016/0016-5085(95)90149-3
   DeCicco LA, 1998, TOXICOL LETT, V98, P115, DOI 10.1016/S0378-4274(98)00110-6
   DIRENZO AB, 1985, DRUG CHEM TOXICOL, V8, P207, DOI 10.3109/01480548509038646
   DURHAM SK, 1990, J PATHOL, V162, P341, DOI 10.1002/path.1711620412
   EFFROS RB, 1991, LYMPHOKINE CYTOK RES, V10, P347
   HORAN MA, 1991, MECH AGEING DEV, V57, P145, DOI 10.1016/0047-6374(91)90031-T
   Horan MA, 1997, AGE AGEING, V26, P15, DOI 10.1093/ageing/26.suppl_4.15
   James K, 1997, MECH AGEING DEV, V93, P15, DOI 10.1016/S0047-6374(96)01807-6
   KAYAMA F, 1995, TOXICOL APPL PHARM, V131, P224, DOI 10.1006/taap.1995.1065
   Kim MJ, 1997, J NUTR, V127, P2293, DOI 10.1093/jn/127.12.2293
   Koj A, 1996, BBA-MOL BASIS DIS, V1317, P84, DOI 10.1016/S0925-4439(96)00048-8
   Laskin DL, 1996, TOXICOL PATHOL, V24, P112, DOI 10.1177/019262339602400115
   LIAO ZH, 1993, GERONTOLOGY, V39, P19
   Meydani SN, 1998, Z ERNAHRUNGSWISS, V37, P35
   Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60
   NAGAKI M, 1991, GASTROENTEROL JPN, V26, P448
   Ohira H, 1996, J HEPATOL, V25, P941, DOI 10.1016/S0168-8278(96)80300-X
   PELTEKIAN KM, 1997, ACUTE LIVER FAILURE, P67
   RIANCHO JA, 1994, GERONTOLOGY, V40, P8
   RIKANS LE, 1986, IRCS MED SCI-BIOCHEM, V14, P467
   RIKANS LE, 1988, BIOCHIM BIOPHYS ACTA, V966, P269, DOI 10.1016/0304-4165(88)90076-1
   RIKANS LE, 1989, DRUG METAB REV, V20, P87, DOI 10.3109/03602538908994145
   RIKANS LE, 1992, GERONTOLOGY, V38, P133
   RIKANS LE, 1990, MECH AGEING DEV, V51, P139, DOI 10.1016/0047-6374(90)90096-X
   RIKANS LE, 1991, BIOCHIM BIOPHYS ACTA, V1074, P195, DOI 10.1016/0304-4165(91)90061-K
   Rikans LE, 1998, GERONTOLOGY, V44, P72, DOI 10.1159/000021987
   RIKANS LE, 1984, DRUG CHEM TOXICOL, V7, P595, DOI 10.3109/01480548409042822
   RIKANS LE, 1982, J PHARMACOL EXP THER, V220, P574
   Rikans LE, 1996, MECH AGEING DEV, V91, P165, DOI 10.1016/S0047-6374(96)01784-8
   Rikans LE, 1997, ENVIRON TOXICOL PHAR, V4, P339, DOI 10.1016/S1382-6689(97)10032-1
   Roubenoff R, 1998, J GERONTOL A-BIOL, V53, pM20, DOI 10.1093/gerona/53A.1.M20
   SCHOEFFNER DJ, 1998, TOXICOLOGIST, V42, P130
   SCHOEFFNER DJ, 1996, TOXICOLOGIST, V30, P289
   Scotte M, 1996, CYTOKINE, V8, P115, DOI 10.1006/cyto.1996.0016
   Simpson KJ, 1997, J HEPATOL, V27, P1120, DOI 10.1016/S0168-8278(97)80160-2
   Spaulding CC, 1997, MECH AGEING DEV, V93, P87, DOI 10.1016/S0047-6374(96)01824-6
   Takiguchi H, 1997, MECH AGEING DEV, V98, P75, DOI 10.1016/S0047-6374(97)00068-7
   Tateda K, 1996, INFECT IMMUN, V64, P769, DOI 10.1128/IAI.64.3.769-774.1996
   Yamada Y, 1998, AM J PATHOL, V152, P1577
NR 47
TC 21
Z9 24
U1 0
U2 3
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
EI 1872-6216
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD MAY 3
PY 1999
VL 108
IS 2
BP 173
EP 182
DI 10.1016/S0047-6374(99)00012-3
PG 10
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 202RL
UT WOS:000080665900007
PM 10400310
DA 2024-02-19
ER

PT J
AU Boveris, A
   D'Amico, G
   Lores-Arnaiz, S
   Costa, LE
AF Boveris, A
   D'Amico, G
   Lores-Arnaiz, S
   Costa, LE
TI Enalapril increases mitochondrial nitric oxide synthase activity in
   heart and liver
SO ANTIOXIDANTS & REDOX SIGNALING
LA English
DT Article
ID RENIN-ANGIOTENSIN SYSTEM; SUPEROXIDE-DISMUTASE; DEPENDENT REGULATION;
   RESPIRATORY-CHAIN; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; OXYGEN;
   MODULATION; APOPTOSIS; INHIBITION
AB Heart and liver mitochondria isolated from rats treated with enalapril, 3-30 mg/kg/day in the drinking water for 7-120 days, showed a time- and dose-dependent increased nitric oxide (NO) production in the range of 14-250%. Heart and liver mitochondria from control rats produced 0.69 and 0.50 nmol of NO/min/mg of protein, respectively, as determined by dual wavelength spectrophotometry (577-591 nm) following hemoglobin oxidation to methemoglobin. The response to enalapril treatment, attributed to a gene-mediated up-regulation of mitochondrial nitric oxide synthase (mtNOS) activity, was half-maximal at 5-6 days and was maintained up to 120 days. Enalapril-treated animals showed an increased mtNOS functional activity in heart mitochondria that inhibited state 3 O-2 uptake (from 22% in control rats to 43%) and increased state 4 hydrogen peroxide (H2O2) production (from 30% in control rats to 52%). Calculated heart intramitochondrial NO and H2O2 steady-state concentrations were increased 66% and 20%, respectively, by enalapril treatment. Signaling path-ways dependent on mitochondrial NO and H2O2 may account for the beneficial effects of enalapril in aging mammals.
C1 Univ Buenos Aires, Sch Pharm & Biochem, Lab Free Rad Biol, RA-1113 Buenos Aires, DF, Argentina.
C3 University of Buenos Aires
RP Boveris, A (corresponding author), Univ Buenos Aires, Sch Pharm & Biochem, Lab Free Rad Biol, Junin 956, RA-1113 Buenos Aires, DF, Argentina.
EM aboveris@ffyb.uba.ar
RI D'Amico, Gabriela/H-6310-2011; D'Amico, Gabriela/AAD-1182-2020
OI D'Amico, Gabriela/0000-0002-5619-6749
CR Antunes F, 2001, FREE RADICAL BIO MED, V30, P1008, DOI 10.1016/S0891-5849(01)00493-2
   Arnaiz SL, 1999, NITRIC OXIDE-BIOL CH, V3, P235, DOI 10.1006/niox.1999.0229
   Aviv A, 2002, J HYPERTENS, V20, P2357, DOI 10.1097/00004872-200212000-00012
   Bosc LVG, 2001, J HYPERTENS, V19, P1403, DOI 10.1097/00004872-200108000-00008
   BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707
   Boveris A, 2003, ANTIOXID REDOX SIGN, V5, P265, DOI 10.1089/152308603322110841
   Boveris A, 2002, METHOD ENZYMOL, V359, P328
   Boveris A, 2002, FREE RADICAL BIO MED, V33, P1186, DOI 10.1016/S0891-5849(02)01009-2
   BOVERIS A, 1984, METHOD ENZYMOL, V105, P429
   Boveris A, 2000, ANN NY ACAD SCI, V899, P121
   Boyd CS, 2002, BIOL CHEM, V383, P411, DOI 10.1515/BC.2002.045
   Brookes PS, 1999, FEBS LETT, V446, P261, DOI 10.1016/S0014-5793(99)00217-3
   BROWN GC, 1994, FEBS LETT, V356, P295, DOI 10.1016/0014-5793(94)01290-3
   Bustamante J, 2002, NITRIC OXIDE-BIOL CH, V6, P333, DOI 10.1006/niox.2001.0420
   Bustamante J, 2000, ARCH BIOCHEM BIOPHYS, V376, P239, DOI 10.1006/abbi.2000.1716
   Carreras MC, 2001, AM J PHYSIOL-HEART C, V281, pH2282, DOI 10.1152/ajpheart.2001.281.6.H2282
   CHANCE B, 1956, ADV ENZYMOL REL S BI, V17, P65
   CLEETER MWJ, 1994, FEBS LETT, V345, P50, DOI 10.1016/0014-5793(94)00424-2
   Costa LE, 2002, J HYPERTENS, V20, P2487, DOI 10.1097/00004872-200212000-00029
   De Cavanagh EMV, 2000, AM J PHYSIOL-REG I, V278, pR572, DOI 10.1152/ajpregu.2000.278.3.R572
   de Cavanagh EMV, 2001, HYPERTENSION, V38, P1130, DOI 10.1161/hy1101.092845
   deCavanagh EMV, 1997, AM J PHYSIOL-REG I, V272, pR514, DOI 10.1152/ajpregu.1997.272.2.R514
   DECAVANAGH EMV, 1995, FEBS LETT, V361, P22, DOI 10.1016/0014-5793(95)00137-X
   Dobashi K, 1997, J NEUROCHEM, V68, P1896
   Elfering SL, 2002, J BIOL CHEM, V277, P38079, DOI 10.1074/jbc.M205256200
   FERDER L, 1993, AM J PHYSIOL, V265, pC15, DOI 10.1152/ajpcell.1993.265.1.C15
   Ferder LF, 2002, CURR OPIN PHARMACOL, V2, P189, DOI 10.1016/S1471-4892(02)00139-X
   Fernández-Alfonso MS, 1999, J HYPERTENS, V17, P1355, DOI 10.1097/00004872-199917100-00001
   French S, 2001, AM J PHYSIOL-HEART C, V280, pH2863, DOI 10.1152/ajpheart.2001.280.6.H2863
   Ghafourifar P, 1997, FEBS LETT, V418, P291, DOI 10.1016/S0014-5793(97)01397-5
   Giulivi C, 1998, BIOCHEM J, V332, P673, DOI 10.1042/bj3320673
   Giulivi C, 1998, J BIOL CHEM, V273, P11038, DOI 10.1074/jbc.273.18.11038
   Kanai AJ, 2001, P NATL ACAD SCI USA, V98, P14126, DOI 10.1073/pnas.241380298
   Melov S, 2000, SCIENCE, V289, P1567, DOI 10.1126/science.289.5484.1567
   MISRA HP, 1972, J BIOL CHEM, V247, P3170
   Poderoso JJ, 1999, J BIOL CHEM, V274, P37709, DOI 10.1074/jbc.274.53.37709
   Riobó NA, 2002, J BIOL CHEM, V277, P42447, DOI 10.1074/jbc.M204580200
   Rubbo H, 2000, J BIOL CHEM, V275, P10812, DOI 10.1074/jbc.275.15.10812
   Sarkela TM, 2001, J BIOL CHEM, V276, P6945, DOI 10.1074/jbc.M007625200
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   TAKEHARA Y, 1995, ARCH BIOCHEM BIOPHYS, V323, P27, DOI 10.1006/abbi.1995.0005
   TROTSCHANSKY A, 2001, ARCH BIOCHEM BIOPHYS, V395, P225
NR 42
TC 39
Z9 42
U1 0
U2 1
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1523-0864
EI 1557-7716
J9 ANTIOXID REDOX SIGN
JI Antioxid. Redox Signal.
PD DEC
PY 2003
VL 5
IS 6
BP 691
EP 697
DI 10.1089/152308603770379982
PG 7
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA 740BK
UT WOS:000186380800002
PM 14588141
DA 2024-02-19
ER

PT J
AU Dass, SB
   Ali, SF
   Heflich, RH
   Casciano, DA
AF Dass, SB
   Ali, SF
   Heflich, RH
   Casciano, DA
TI Frequency of spontaneous and induced micronuclei in the peripheral blood
   of aging mice
SO MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
LA English
DT Article
DE aging mouse; mutation; micronucleus; mitomycin C; micronucleated
   reticulocyte
ID AGE-DEPENDENT ALTERATIONS; CLOFIBRATE-TREATED MICE; RAT-LIVER
   MICROSOMES; MITOMYCIN-C; SOMATIC MUTATION; MUTANT FREQUENCY;
   ACRIDINE-ORANGE; IN-VIVO; ACTIVATION; RETICULOCYTES
AB The mouse peripheral blood micronucleus assay, a measure of DNA damage in erythroblastic cells, was used to determine: (I) the incidence of spontaneously occurring micronucleated reticulocytes (MNRETs) as a function of age, and (2) the induction of micronuclei following treatment of young and old animals with mitomycin C. Male C57BL/6 mice, 92 weeks of age, exhibited a significantly higher frequency of spontaneously occurring peripheral blood MNRETs than mice that were 6 or 10 weeks of age, Mice that were 5-6 weeks or 91-92 weeks old were treated with one dose, or two consecutive doses of mitomycin C; this resulted in dose-related increases in the frequency of MNRETs. Mitomycin C, at a single dose of I or 2 mg/kg, induced one-third as many MNRETs in the older animals as compared to the younger animals. When treated with a split dose of mitomycin C (total dose 0.5 to 2 mg/kg), older animals displayed on average two-thirds the mutagenic response of the younger animals. However, analysis of variance performed on these data indicated that the age of the animals did not have a significant effect on their mutagenic response to mitomycin C at any dose level. It appears that aging mice may not be more sensitive to the mutagenic effects of chemically-induced DNA damage than younger mice, suggesting that the higher spontaneous mutation frequency in older mice could be the result of an increased load of accumulated DNA damage. (C) 1997 Elsevier Science B.V.
C1 NATL CTR TOXICOL RES,DIV NEUROTOXICOL,JEFFERSON,AR 72079.
C3 US Food & Drug Administration (FDA)
RP Dass, SB (corresponding author), NATL CTR TOXICOL RES,DIV GENET TOXICOL,JEFFERSON,AR 72079, USA.
CR AKIYAMA M, 1990, PROG CLIN BIOL RES, V340, P69
   BASU AK, 1993, BIOCHEMISTRY-US, V32, P4708, DOI 10.1021/bi00069a004
   BEGLEITER A, 1993, MOL PHARMACOL, V44, P210
   COLE J, 1994, MUTAT RES, V304, P33, DOI 10.1016/0027-5107(94)90320-4
   *CSGMT, 1992, MUTAT RES, V278, P83
   DEMPSEY JL, 1993, MUTAT RES, V291, P141, DOI 10.1016/0165-1161(93)90153-Q
   DICE JF, 1993, PHYSIOL REV, V73, P149, DOI 10.1152/physrev.1993.73.1.149
   FENECH M, 1985, MUTAT RES, V148, P99, DOI 10.1016/0027-5107(85)90212-X
   FINETTE BA, 1994, MUTAT RES, V308, P223, DOI 10.1016/0027-5107(94)90157-0
   GAZIEV AI, 1995, MUTAT RES-DNAGING G, V338, P77, DOI 10.1016/0921-8734(95)00013-V
   GRIST SA, 1992, MUTAT RES, V266, P189, DOI 10.1016/0027-5107(92)90186-6
   HARA M, 1992, MUTAT RES, V278, P175
   HAYASHI M, 1990, MUTAT RES, V245, P245, DOI 10.1016/0165-7992(90)90153-B
   HEDDLE JA, 1981, ENVIRON HEALTH PERSP, V39, P23, DOI 10.2307/3429275
   HEDDLE JA, 1990, PROG CLIN BIOL RES, V340, P185
   HODNICK WF, 1993, CANCER RES, V53, P4907
   Joseph P, 1996, INT J CANCER, V65, P263
   KAMATAKI T, 1985, J PHARMACOL EXP THER, V233, P222
   KRAM D, 1978, EXP CELL RES, V114, P471, DOI 10.1016/0014-4827(78)90512-8
   KUSHIRO J, 1992, MUTAT RES, V272, P17, DOI 10.1016/0165-1161(92)90005-7
   LILP IG, 1982, GENETIKA+, V18, P1976
   Martin GM, 1996, NAT GENET, V13, P25, DOI 10.1038/ng0596-25
   MARTUS HJ, 1995, MUTAT RES-DNAGING G, V338, P203, DOI 10.1016/0921-8734(95)00025-2
   MASSIE HR, 1979, MECH AGEING DEV, V10, P93, DOI 10.1016/0047-6374(79)90073-3
   MIYA T, 1992, JPN J CANCER RES, V83, P1382, DOI 10.1111/j.1349-7006.1992.tb02773.x
   MORLEY AA, 1995, MUTAT RES-DNAGING G, V338, P19, DOI 10.1016/0921-8734(95)00007-S
   NISITANI S, 1990, MUTAT RES, V273, P221
   ONO T, 1995, MUTAT RES-DNAGING G, V338, P183, DOI 10.1016/0921-8734(95)00023-Y
   Perichon R, 1996, MECH AGEING DEV, V87, P115, DOI 10.1016/0047-6374(96)01705-8
   Perichon R, 1995, BIOCHEM MOL BIOL INT, V37, P475
   ROMAGNA F, 1992, MUTAT RES, V278, P197, DOI 10.1016/0165-1218(92)90234-Q
   SATO S, 1995, MUTAT RES-DNAGING G, V338, P51, DOI 10.1016/0921-8734(95)00011-T
   SAURA J, 1994, NEUROBIOL AGING, V15, P399, DOI 10.1016/0197-4580(94)90071-X
   SCHISLER NJ, 1985, BIOCHEM GENET, V23, P291, DOI 10.1007/BF00504326
   SCHMUCKER DL, 1983, MECH AGEING DEV, V21, P137, DOI 10.1016/0047-6374(83)90070-2
   SCHMUCKER DL, 1984, MECH AGEING DEV, V27, P207, DOI 10.1016/0047-6374(84)90046-0
   WYNNE H, 1987, AGE AGEING, V16, P153, DOI 10.1093/ageing/16.3.153
   ZHANG XB, 1995, MUTAT RES-DNAGING G, V338, P189, DOI 10.1016/0921-8734(95)00024-Z
NR 38
TC 17
Z9 17
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0027-5107
J9 MUTAT RES-FUND MOL M
JI Mutat. Res.-Fundam. Mol. Mech. Mutagen.
PD NOV 19
PY 1997
VL 381
IS 1
BP 105
EP 110
DI 10.1016/S0027-5107(97)00156-5
PG 6
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology
GA YH086
UT WOS:A1997YH08600012
PM 9403036
DA 2024-02-19
ER

PT J
AU Staudt, A
   Stock, K
   Gande, N
   Bernar, B
   Hochmayr, C
   Pechlaner, R
   Kiechl, SJ
   Geiger, R
   Griesmacher, A
   Anliker, M
   Kiechl, S
   Kiechl-Kohlendorfer, U
   Knoflach, M
   Winder, B
   Reiter, C
   Burger, C
   Klingenschmid, J
   Marxer, J
   Asare, M
   Bock-Bartl, M
   Kothmayer, M
   Bohl, M
   Pircher, M
AF Staudt, Anna
   Stock, Katharina
   Gande, Nina
   Bernar, Benoit
   Hochmayr, Christoph
   Pechlaner, Raimund
   Kiechl, Sophia J.
   Geiger, Ralf
   Griesmacher, Andrea
   Anliker, Markus
   Kiechl, Stefan
   Kiechl-Kohlendorfer, Ursula
   Knoflach, Michael
   Winder, Bernhard
   Reiter, Carmen
   Burger, Christina
   Klingenschmid, Julia
   Marxer, Julia
   Asare, Mandy
   Bock-Bartl, Manuela
   Kothmayer, Martina
   Bohl, Maximilian
   Pircher, Maximilian
CA Early Vasc Ageing EVA Study Grp
TI Impact of lifestyle and cardiovascular risk factors on early
   atherosclerosis in a large cohort of healthy adolescents: The Early
   Vascular Ageing (EVA)-Tyrol Study
SO ATHEROSCLEROSIS
LA English
DT Article
DE Atherosclerosis; Cardiovascular disease; Young; Lifestyle; IMT
ID INTIMA-MEDIA THICKNESS; PHYSICAL-ACTIVITY; ARTERY INTIMA; PRECLINICAL
   ATHEROSCLEROSIS; SUBCLINICAL ATHEROSCLEROSIS; CHILDHOOD OBESITY;
   SEX-DIFFERENCES; CHILDREN; ADULTHOOD; DISEASE
AB Background and aims: Atherosclerosis starts early in life. We aimed to assess the dimension and progression of the intima-media thickness, a surrogate marker for early vascular aging, and its association with a broad palette of cardiovascular risk and lifestyle factors in a large cohort of healthy adolescents.
   Methods: The EVA-Tyrol cohort study enrolled 1573 adolescents with a mean age of 16.0 years (SD 0.9). 1000 participants had a prospective follow-up after 22.1 months on average (SD 3.4). Cardiovascular risk and lifestyle factors were evaluated by standardized interviews, physical examination, and fasting blood analyses. Carotid intima-media thickness (cIMT) was measured at baseline and follow-up by high-resolution ultrasound. Aortic intima-media thickness (aIMT) was assessed during follow-up only.
   Results: Several vascular risk factors like elevated blood pressure (4.7% > 95th percentile), overweight (9.2% > 95th percentile) and smoking (29.7%) were already prevalent at this age. Maximum cIMT progressed by 2.78 mu m (95% CI, 0.39-5.17) per year. In multivariable linear regression analysis, sex, body weight, systolic blood pressure, LDL-cholesterol and physical activity were independent predictors of cIMT both at baseline and follow-up. In addition, alanine-aminotransferase, a laboratory surrogate of non-alcoholic fatty liver disease, was independently associated with cIMT at follow-up and pack-years of smoking with aIMT.
   Conclusions: Unfavourable lifestyle and vascular risk factors were prevalent in adolescents and several of them were associated with vessel wall thickness, even though effect sizes were modest and cIMT variability was limited. These data suggest adolescence as a prime age range for early vascular prevention.
C1 [Staudt, Anna; Stock, Katharina; Gande, Nina; Hochmayr, Christoph; Kiechl-Kohlendorfer, Ursula; Winder, Bernhard; Reiter, Carmen; Burger, Christina; Klingenschmid, Julia; Marxer, Julia; Kothmayer, Martina; Pircher, Maximilian] Med Univ Innsbruck, Dept Paediat 2, Innsbruck, Austria.
   [Stock, Katharina; Geiger, Ralf] Med Univ Innsbruck, Dept Paediat 3, Innsbruck, Austria.
   [Bernar, Benoit] Med Univ Innsbruck, Dept Paediat 1, Innsbruck, Austria.
   [Bernar, Benoit; Pechlaner, Raimund; Kiechl, Sophia J.; Kiechl, Stefan; Knoflach, Michael; Asare, Mandy; Bock-Bartl, Manuela; Bohl, Maximilian] Med Univ Innsbruck, Dept Neurol, Anichstr 35, A-6020 Innsbruck, Austria.
   [Kiechl, Sophia J.; Kiechl, Stefan] VASCage, Res Ctr Vasc Ageing & Stroke, Innsbruck, Austria.
   [Griesmacher, Andrea; Anliker, Markus] Med Univ Innsbruck, Cent Inst Clin Chem & Lab Med ZIMCL, Innsbruck, Austria.
C3 Medical University of Innsbruck; Medical University of Innsbruck;
   Medical University of Innsbruck; Medical University of Innsbruck;
   Medical University of Innsbruck
RP Knoflach, M (corresponding author), Med Univ Innsbruck, Dept Neurol, Anichstr 35, A-6020 Innsbruck, Austria.; Kiechl-Kohlendorfer, U (corresponding author), Med Univ Innsbruck, Dept Paediat Neonatol 2, Anichstr 35, A-6020 Innsbruck, Austria.
EM Ursula.Kohlendorfer@i-med.ac.at; Michael.Knoflach@i-med.ac.at
RI Bernar, Benoit/KAM-4191-2024
OI Pechlaner, Raimund/0000-0001-9006-5606; Kiechl,
   Sophia/0000-0001-8856-5986; Stock, Anna Katharina/0000-0001-9300-7882
FU excellence initiative (Competence Centers for Excellent
   Technologies-COMET) of the Austrian Research Promotion Agency FFG:
   "Research Center of Excellence in Vascular Ageing-Tyrol, VASCage" -
   Austrian Ministry for Transport, Innovation and Technology [843536];
   excellence initiative VASCage (Centre for Promoting Vascular Health in
   the Ageing Community) of the Austrian Research Promotion Agency FFG
   (COMET program) - Austrian Ministry for Transport, Innovation and
   Technology [868624]; Austrian Ministry for Digital and Economic Affairs;
   federal state Tyrol (Standortagentur); federal state Salzburg; federal
   state Vienna (Vienna Business Agency)
FX The EVA-Tyrol study is financially supported by the excellence
   initiative (Competence Centers for Excellent Technologies-COMET) of the
   Austrian Research Promotion Agency FFG: "Research Center of Excellence
   in Vascular Ageing-Tyrol, VASCage" (K project number 843536) and by the
   excellence initiative VASCage (Centre for Promoting Vascular Health in
   the Ageing Community, project number 868624) of the Austrian Research
   Promotion Agency FFG (COMET program), both funded by the Austrian
   Ministry for Transport, Innovation and Technology, the Austrian Ministry
   for Digital and Economic Affairs and the federal states Tyrol (via
   Standortagentur), Salzburg and Vienna (via Vienna Business Agency).
CR Afifi A., 2020, VARIABLE SELECTION R, P145
   [Anonymous], 1993, Arterioscler Thromb, V13, P1291
   Ascenso A, 2016, EUR J PEDIATR, V175, P391, DOI 10.1007/s00431-015-2654-x
   Ayer J, 2015, EUR HEART J, V36, P1371, DOI 10.1093/eurheartj/ehv089
   Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515
   Bernar B, 2020, BMC CARDIOVASC DISOR, V20, DOI 10.1186/s12872-020-01357-9
   Böhma B, 2009, ATHEROSCLEROSIS, V206, P458, DOI 10.1016/j.atherosclerosis.2009.03.016
   Brix N, 2019, PAEDIATR PERINAT EP, V33, P70, DOI 10.1111/ppe.12507
   Chiesa ST, 2021, JACC-CARDIOVASC IMAG, V14, P468, DOI 10.1016/j.jcmg.2019.08.026
   Dawson JD, 2009, J AM COLL CARDIOL, V53, P2273, DOI 10.1016/j.jacc.2009.03.026
   de Groot E, 2004, CIRCULATION, V109, P33, DOI 10.1161/01.CIR.0000131516.65699.ba
   Doyon A, 2013, HYPERTENSION, V62, P550, DOI 10.1161/HYPERTENSIONAHA.113.01297
   Eikendal ALM, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002941
   Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3
   Franks PW, 2010, NEW ENGL J MED, V362, P485, DOI 10.1056/NEJMoa0904130
   HOLMAN RL, 1958, AM J PATHOL, V34, P209
   Inchley J., 2016, GROWING UNEQUAL GEND, P135
   Järvisalo MJ, 2001, CIRCULATION, V104, P2943, DOI 10.1161/hc4901.100522
   Kaikkonen JE, 2013, ANN MED, V45, P120, DOI 10.3109/07853890.2012.671537
   Kiechl S, 1999, ARTERIOSCL THROM VAS, V19, P1484, DOI 10.1161/01.ATV.19.6.1484
   Knoflach M, 2003, CIRCULATION, V108, P1064, DOI 10.1161/01.CIR.0000085996.95532.FF
   Knoflach M, 2009, STROKE, V40, P1063, DOI 10.1161/STROKEAHA.108.525675
   Koskinen J, 2018, CIRCULATION, V137, P1246, DOI 10.1161/CIRCULATIONAHA.117.029726
   Li SX, 2003, JAMA-J AM MED ASSOC, V290, P2271, DOI 10.1001/jama.290.17.2271
   Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146
   Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703
   Lorenz MW, 2012, LANCET, V379, P2053, DOI 10.1016/S0140-6736(12)60441-3
   Mendelsohn ME, 1999, NEW ENGL J MED, V340, P1801, DOI 10.1056/NEJM199906103402306
   Neuhauser HK, 2011, PEDIATRICS, V127, pE978, DOI 10.1542/peds.2010-1290
   O'Leary DH, 2010, EUR HEART J, V31, P1682, DOI 10.1093/eurheartj/ehq185
   Osika W, 2009, ATHEROSCLEROSIS, V203, P172, DOI 10.1016/j.atherosclerosis.2008.05.054
   Pahkala K, 2013, CIRCULATION, V127, P2088, DOI 10.1161/CIRCULATIONAHA.112.000761
   Pahkala K, 2011, CIRCULATION, V124, P1956, DOI 10.1161/CIRCULATIONAHA.111.043851
   Park MH, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0478-5
   Peña AS, 2016, PEDIATR DIABETES, V17, P199, DOI 10.1111/pedi.12265
   Piercy KL, 2018, JAMA-J AM MED ASSOC, V320, P2020, DOI 10.1001/jama.2018.14854
   Raitakari OT, 2003, JAMA-J AM MED ASSOC, V290, P2277, DOI 10.1001/jama.290.17.2277
   Ried-Larsen M, 2015, BRIT J SPORT MED, V49, P107, DOI 10.1136/bjsports-2013-092409
   Rinella ME, 2015, JAMA-J AM MED ASSOC, V313, P2263, DOI 10.1001/jama.2015.5370
   Sabatine MS, 2015, NEW ENGL J MED, V372, P1500, DOI 10.1056/NEJMoa1500858
   Stelcar A, 2017, KLIN PADIATR, V229, P286, DOI 10.1055/s-0043-104220
   Toth PP, 2008, INT J CLIN PRACT, V62, P1246, DOI 10.1111/j.1742-1241.2008.01804.x
   Urbina EM, 2011, J CLIN HYPERTENS, V13, P332, DOI 10.1111/j.1751-7176.2011.00471.x
   Volanen I, 2006, ARTERIOSCL THROM VAS, V26, P649, DOI 10.1161/01.ATV.0000202664.76816.bb
   Volanen I, 2008, PEDIATRICS, V122, pE675, DOI 10.1542/peds.2008-0220
   West S., 1995, STRUCTURAL EQUATION, P56, DOI DOI 10.1037/0008-400X.26.2.210
   WHO, 2011, WORLD REPORT ON DISABILITY, P1
   Willeit J, 2000, ARTERIOSCL THROM VAS, V20, P529, DOI 10.1161/01.ATV.20.2.529
NR 48
TC 10
Z9 13
U1 0
U2 4
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD JUL
PY 2020
VL 305
BP 26
EP 33
DI 10.1016/j.atherosclerosis.2020.05.011
PG 8
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology
GA MO5JA
UT WOS:000551560900004
PM 32603950
DA 2024-02-19
ER

PT J
AU Calhoon, EA
   Ro, J
   Williams, JB
AF Calhoon, Elisabeth A.
   Ro, Jennifer
   Williams, Joseph B.
TI Perspectives on the membrane fatty acid unsaturation/pacemaker
   hypotheses of metabolism and aging
SO CHEMISTRY AND PHYSICS OF LIPIDS
LA English
DT Article
DE Membrane pacemaker; Acyl composition; Metabolic rate; Peroxidation;
   Longevity; Phospholipids
ID MAXIMUM LIFE-SPAN; PUMP MOLECULAR ACTIVITY; NA+-K+-ATPASE; MITOCHONDRIAL
   PHOSPHOLIPID CLASSES; LIVER-MITOCHONDRIA; LIPID-PEROXIDATION; OXIDATIVE
   STRESS; SODIUM-PUMP; DOCOSAHEXAENOIC ACID; PROTON PERMEABILITY
AB The membrane pacemaker hypotheses of metabolism and aging are distinct, but interrelated hypotheses positing that increases in unsaturation of lipids within membranes are correlated with increasing basal metabolic rate and decreasing longevity, respectively. The two hypotheses each have evidence that either supports or contradicts them, but consensus has failed to emerge. In this review, we identify sources of weakness of previous studies supporting and contradicting these hypotheses and suggest different methods and lines of inquiry. The link between fatty acyl composition of membranes and membrane-bound protein activity is a central tenet of the membrane pacemaker hypothesis of metabolism, but the mechanism by which unsaturation would change protein activity is not well defined and, whereas fatty acid desaturases have been put forward by some as the mechanism behind evolutionary differences in fatty acyl composition of phospholipids among organisms, there have been no studies to differentiate whether desaturases have been more affected by natural selection on aging and metabolic rate than have elongases or acyltransferases. Past analyses have been hampered by potentially incorrect estimates of the peroxidizability of lipids and longevity of study animals, and by the confounding effect of phylogeny. According to some authors, body mass may also be a confounding effect that should be taken into account, though this is not universally accepted. Further research on this subject should focus more on mechanisms and take weaknesses of past studies into account. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
C1 [Calhoon, Elisabeth A.; Williams, Joseph B.] Ohio State Univ, Dept Evolut Ecol & Organismal Biol, Columbus, OH 43210 USA.
   [Ro, Jennifer] Univ Michigan, Cellular & Mol Biol Program, Ann Arbor, MI 48109 USA.
C3 University System of Ohio; Ohio State University; University of Michigan
   System; University of Michigan
RP Calhoon, EA (corresponding author), Ohio State Univ, Dept Evolut Ecol & Organismal Biol, 416 Aronoff Lab 318W,12th Ave, Columbus, OH 43210 USA.
EM calhoon.18@osu.edu
OI Ro, Jennifer/0000-0002-6351-2498
FU NSF [IOS-1036914]; Direct For Biological Sciences; Division Of
   Integrative Organismal Systems [1036914] Funding Source: National
   Science Foundation
FX We acknowledge all members of the Williams lab, past and present, who
   have contributed to the research discussed in this review. Work in the
   Williams lab is supported by a grant to J.W. from NSF (IOS-1036914).
CR Aguilar-Toral R, 2014, J BIOENERG BIOMEMBR, V46, P205, DOI 10.1007/s10863-014-9550-3
   Almaida-Pagán PF, 2014, BBA-MOL CELL BIOL L, V1841, P1003, DOI 10.1016/j.bbalip.2014.04.004
   [Anonymous], AM J PHYSL
   Aoun M, 2012, J BIOENERG BIOMEMBR, V44, P439, DOI 10.1007/s10863-012-9448-x
   Barja G, 2014, J GERONTOL A-BIOL, V69, P1096, DOI 10.1093/gerona/glu020
   Baylis SM, 2014, ECOGRAPHY, V37, P770, DOI 10.1111/ecog.00507
   Bielski B., 1983, J BIOL CHEM, V258, P25
   BLANK ML, 1984, J CHROMATOGR, V298, P473, DOI 10.1016/S0021-9673(01)92744-X
   Böttinger L, 2012, J MOL BIOL, V423, P677, DOI 10.1016/j.jmb.2012.09.001
   BRAND MD, 1991, BIOCHEM J, V275, P81, DOI 10.1042/bj2750081
   Brand MD, 2003, BIOCHEM J, V376, P741, DOI 10.1042/BJ20030984
   Brand MD, 2000, EXP GERONTOL, V35, P811, DOI 10.1016/S0531-5565(00)00135-2
   BRENNER RR, 1984, PROG LIPID RES, V23, P69, DOI 10.1016/0163-7827(84)90008-0
   Brookes PS, 1998, COMP BIOCHEM PHYS B, V119, P325, DOI 10.1016/S0305-0491(97)00357-X
   Brookes PS, 1997, BBA-BIOMEMBRANES, V1330, P157, DOI 10.1016/S0005-2736(97)00160-0
   Brzek P, 2007, PHYSIOL BIOCHEM ZOOL, V80, P491, DOI 10.1086/520617
   Buttemer WA, 2008, BIOL LETTERS, V4, P351, DOI 10.1098/rsbl.2008.0145
   Buttemer WA, 2010, FUNCT ECOL, V24, P971, DOI 10.1111/j.1365-2435.2010.01740.x
   Calhoon EA, 2013, CAN J ZOOL, V91, P653, DOI 10.1139/cjz-2013-0128
   Calhoon EA, 2014, PHYSIOL BIOCHEM ZOOL, V87, P265, DOI 10.1086/674696
   Carey J.R., 2003, Longevity: The biology and demography of life span
   Chicco AJ, 2007, AM J PHYSIOL-CELL PH, V292, pC33, DOI 10.1152/ajpcell.00243.2006
   COSGROVE JP, 1987, LIPIDS, V22, P299, DOI 10.1007/BF02533996
   COUTURE P, 1995, J MEMBRANE BIOL, V148, P27
   Else PL, 2003, CLIN EXP PHARMACOL P, V30, P559, DOI 10.1046/j.1440-1681.2003.03883.x
   Else PL, 2003, ANN NY ACAD SCI, V986, P525, DOI 10.1111/j.1749-6632.2003.tb07240.x
   Else PL, 1999, J COMP PHYSIOL B, V169, P296, DOI 10.1007/s003600050224
   EPAND RM, 1991, CHEM PHYS LIPIDS, V57, P75, DOI 10.1016/0009-3084(91)90051-C
   ESCRIBA PV, 1995, P NATL ACAD SCI USA, V92, P7595, DOI 10.1073/pnas.92.16.7595
   Fujii T, 2008, J BIOL CHEM, V283, P6869, DOI 10.1074/jbc.M708429200
   Furse S, 2015, ORG BIOMOL CHEM, V13, P2001, DOI 10.1039/c4ob02258k
   Gamliel A, 2008, FREE RADICAL BIO MED, V44, P1394, DOI 10.1016/j.freeradbiomed.2007.12.028
   GARLAND T, 1994, PHYSIOL ZOOL, V67, P797, DOI 10.1086/physzool.67.4.30163866
   Gómez A, 2014, AGING CELL, V13, P551, DOI 10.1111/acel.12205
   Gregory MK, 2013, J NUTR, V143, P12, DOI 10.3945/jn.112.170290
   Gregory MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029662
   Grim JM, 2010, J EXP BIOL, V213, P445, DOI 10.1242/jeb.036939
   Gruber J, 2008, FRONT BIOSCI-LANDMRK, V13, P6554, DOI 10.2741/3174
   GUDBJARNASON S, 1989, J INTERN MED, V225, P117, DOI 10.1111/j.1365-2796.1989.tb01445.x
   Guderley H, 2008, J COMP PHYSIOL B, V178, P385, DOI 10.1007/s00360-007-0231-y
   Guderley H, 2005, COMP BIOCHEM PHYS B, V142, P172, DOI 10.1016/j.cbpc.2005.07.006
   Guillou H, 2010, PROG LIPID RES, V49, P186, DOI 10.1016/j.plipres.2009.12.002
   Haddad LS, 2007, EXP GERONTOL, V42, P601, DOI 10.1016/j.exger.2007.02.008
   Haggerty C, 2008, MECH AGEING DEV, V129, P129, DOI 10.1016/j.mad.2007.11.001
   Hagopian K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012696
   Halliwell B, 2004, BRIT J PHARMACOL, V142, P231, DOI 10.1038/sj.bjp.0705776
   Harper JM, 2007, AGING CELL, V6, P1, DOI 10.1111/j.1474-9726.2006.00255.x
   Hickey AJR, 2012, AGEING RES REV, V11, P242, DOI 10.1016/j.arr.2011.12.002
   HOCH FL, 1992, BIOCHIM BIOPHYS ACTA, V1113, P71, DOI 10.1016/0304-4157(92)90035-9
   Hodson L, 2002, CLIN CHIM ACTA, V321, P63, DOI 10.1016/S0009-8981(02)00100-6
   HOLLIDAY MA, 1967, PEDIATR RES, V1, P185, DOI 10.1203/00006450-196705000-00005
   Holman R.T., 1954, Prog. Chem. Fats Other Lipids, V2, P51, DOI [10.1016/0079-6832(54)90004-X, DOI 10.1016/0079-6832(54)90004-X]
   Houjou T, 2005, RAPID COMMUN MASS SP, V19, P654, DOI 10.1002/rcm.1836
   Hulbert AJ, 2008, EXP GERONTOL, V43, P729, DOI 10.1016/j.exger.2008.05.015
   Hulbert AJ, 2008, AGE, V30, P89, DOI 10.1007/s11357-008-9055-2
   Hulbert AJ, 2008, COMP BIOCHEM PHYS A, V150, P196, DOI 10.1016/j.cbpa.2006.05.014
   Hulbert AJ, 2007, LIPIDS, V42, P811, DOI 10.1007/s11745-007-3058-0
   Hulbert AJ, 2007, PHYSIOL REV, V87, P1175, DOI 10.1152/physrev.00047.2006
   Hulbert AJ, 2006, J GERONTOL A-BIOL, V61, P1009, DOI 10.1093/gerona/61.10.1009
   Hulbert AJ, 2006, MECH AGEING DEV, V127, P653, DOI 10.1016/j.mad.2006.03.002
   Hulbert AJ, 2014, J COMP PHYSIOL B, V184, P149, DOI 10.1007/s00360-013-0786-8
   Hulbert AJ, 2011, AGING-US, V3, P81, DOI 10.18632/aging.100288
   Hulbert AJ, 2010, INTEGR COMP BIOL, V50, P808, DOI 10.1093/icb/icq007
   Hulbert AJ, 1999, J THEOR BIOL, V199, P257, DOI 10.1006/jtbi.1999.0955
   Hulbert AJ, 2005, J THEOR BIOL, V234, P277, DOI 10.1016/j.jtbi.2004.11.024
   Hulbert AJ, 2000, ANNU REV PHYSIOL, V62, P207, DOI 10.1146/annurev.physiol.62.1.207
   Hulbert AJ, 2006, J COMP PHYSIOL B, V176, P93, DOI 10.1007/s00360-005-0025-z
   Hulbert AJ, 2003, J EXP BIOL, V206, P2303, DOI 10.1242/jeb.00399
   Hulbert AJ, 2002, J COMP PHYSIOL B, V172, P387, DOI 10.1007/s00360-002-0264-1
   Hulbert AJ, 2002, J EXP BIOL, V205, P3561
   Hulbert AJ, 2002, COMP BIOCHEM PHYS B, V132, P515, DOI 10.1016/S1096-4959(02)00066-0
   Jaureguiberry MS, 2014, ACTA BIOCH BIOPH SIN, V46, P273, DOI 10.1093/abbs/gmt155
   Jeon TI, 2001, LIPIDS, V36, P589, DOI 10.1007/s11745-001-0761-1
   Jimenez AG, 2014, J COMP PHYSIOL B, V184, P545, DOI 10.1007/s00360-014-0825-0
   Jimenez AG, 2014, COMP BIOCHEM PHYS A, V171, P23, DOI 10.1016/j.cbpa.2014.02.006
   Jimenez AG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087349
   Jobson RW, 2010, MOL BIOL EVOL, V27, P840, DOI 10.1093/molbev/msp293
   Jové M, 2013, SCI REP-UK, V3, DOI 10.1038/srep03346
   KAWAKATSU M, 1984, AGR BIOL CHEM TOKYO, V48, P1275, DOI 10.1080/00021369.1984.10866305
   Kelly MA, 2014, MECH AGEING DEV, V138, P15, DOI 10.1016/j.mad.2014.02.001
   Konarzewski M, 2013, J COMP PHYSIOL B, V183, P27, DOI 10.1007/s00360-012-0698-z
   KREBS HA, 1950, BIOCHIM BIOPHYS ACTA, V4, P249, DOI 10.1016/0006-3002(50)90032-1
   Krivoi I. I., 2014, Biophysics, V59, P708, DOI 10.1134/S000635091405011X
   Kubo K, 2005, J AGR FOOD CHEM, V53, P750, DOI 10.1021/jf048867u
   Li YY, 2010, P NATL ACAD SCI USA, V107, P16840, DOI 10.1073/pnas.1008429107
   Lingwood D, 2005, J BIOL CHEM, V280, P36545, DOI 10.1074/jbc.M506670200
   Lucero HA, 2004, ARCH BIOCHEM BIOPHYS, V426, P208, DOI 10.1016/j.abb.2004.03.020
   Martin N, 2015, J EXP ZOOL PART A, V323, P60, DOI 10.1002/jez.1896
   Martínez J, 2005, MOL PHARMACOL, V67, P531, DOI 10.1124/mol.104.000778
   Mckechnie AE, 2010, CURR ZOOL, V56, P741, DOI 10.1093/czoolo/56.6.741
   Merry BJ, 2000, ANN NY ACAD SCI, V908, P180
   Mitchell TW, 2007, EXP GERONTOL, V42, P1053, DOI 10.1016/j.exger.2007.09.004
   Mitchell TW, 2004, J APPL PHYSIOL, V97, P1823, DOI 10.1152/japplphysiol.00344.2004
   Miyazaki M, 2008, N COMP BIOC, P191, DOI 10.1016/B978-044453219-0.50009-X
   Moghadam NN, 2013, EXP GERONTOL, V48, P1362, DOI 10.1016/j.exger.2013.08.018
   Möller M, 2005, J BIOL CHEM, V280, P8850, DOI 10.1074/jbc.M413699200
   Montgomery MK, 2012, J COMP PHYSIOL B, V182, P127, DOI 10.1007/s00360-011-0603-1
   Montgomery MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024138
   Munro D, 2012, AGING CELL, V11, P845, DOI 10.1111/j.1474-9726.2012.00847.x
   Naudí A, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00372
   Nicolson GL, 2014, BBA-BIOMEMBRANES, V1838, P1657, DOI 10.1016/j.bbamem.2013.11.010
   Norris SE, 2012, LIPIDS, V47, P451, DOI 10.1007/s11745-012-3654-5
   Pamplona R, 2000, J GERONTOL A-BIOL, V55, pB286, DOI 10.1093/gerona/55.6.B286
   Pamplona R, 2004, EXP GERONTOL, V39, P725, DOI 10.1016/j.exger.2004.01.006
   Pamplona R, 2002, ANN NY ACAD SCI, V959, P475, DOI 10.1111/j.1749-6632.2002.tb02118.x
   Pamplona R, 1999, AGING CLIN EXP RES, V11, P44, DOI 10.1007/BF03399636
   Pamplona R, 2000, MECH AGEING DEV, V112, P169, DOI 10.1016/S0047-6374(99)00045-7
   Pamplona R, 2002, MECH AGEING DEV, V123, P1437, DOI 10.1016/S0047-6374(02)00076-3
   Pamplona R, 1996, MECH AGEING DEV, V86, P53, DOI 10.1016/0047-6374(95)01673-2
   Pamplona R, 1999, MECH AGEING DEV, V106, P283, DOI 10.1016/S0047-6374(98)00121-3
   Pamplona R, 1998, J LIPID RES, V39, P1989
   Pamplona R, 2008, BBA-BIOENERGETICS, V1777, P1249, DOI 10.1016/j.bbabio.2008.07.003
   Pamplona R, 2005, AGE, V27, P267, DOI 10.1007/s11357-005-4562-x
   Pamplona R, 2011, AM J PHYSIOL-REG I, V301, pR843, DOI 10.1152/ajpregu.00034.2011
   Pannorfi R, 2012, PHYSIOL BIOCHEM ZOOL, V85, P405, DOI 10.1086/666473
   Paradies G, 2010, FREE RADICAL BIO MED, V48, P1286, DOI 10.1016/j.freeradbiomed.2010.02.020
   Paradies G, 2010, J PINEAL RES, V48, P297, DOI 10.1111/j.1600-079X.2010.00759.x
   PATTON GM, 1982, J LIPID RES, V23, P190
   Paula S, 1996, BIOPHYS J, V70, P339, DOI 10.1016/S0006-3495(96)79575-9
   Perry CGR, 2013, DIABETES, V62, P1041, DOI 10.2337/db12-1219
   Porter RK, 1996, AM J PHYSIOL-REG I, V271, pR1550, DOI 10.1152/ajpregu.1996.271.6.R1550
   Portero-Otín M, 2001, LIPIDS, V36, P491, DOI 10.1007/s11745-001-0748-y
   Price ER, 2009, AM J PHYSIOL-REG I, V297, pR775, DOI 10.1152/ajpregu.00150.2009
   Quinn PJ, 2010, PROG LIPID RES, V49, P390, DOI 10.1016/j.plipres.2010.05.002
   Reis RJS, 2011, AGING-US, V3, P125, DOI 10.18632/aging.100275
   Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731
   Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842
   Schenkel LC, 2014, INT J CELL BIOL, V2014, P1
   SEDDON JM, 1990, BIOCHIM BIOPHYS ACTA, V1031, P1, DOI 10.1016/0304-4157(90)90002-T
   Shaikh SR, 2015, BBA-BIOMEMBRANES, V1848, P211, DOI 10.1016/j.bbamem.2014.04.020
   Speakman JR, 2005, AGING CELL, V4, P167, DOI 10.1111/j.1474-9726.2005.00162.x
   Spindler SR, 2013, AGE, V35, P2099, DOI 10.1007/s11357-012-9498-3
   Sprecher H, 2000, BBA-MOL CELL BIOL L, V1486, P219, DOI 10.1016/S1388-1981(00)00077-9
   Stroud CK, 2009, J LIPID RES, V50, P1870, DOI 10.1194/jlr.M900039-JLR200
   Tacutu R, 2013, NUCLEIC ACIDS RES, V41, pD1027, DOI 10.1093/nar/gks1155
   Tosato M, 2007, CLIN INTERV AGING, V2, P401
   Turner N, 2005, J COMP PHYSIOL B, V175, P77, DOI 10.1007/s00360-004-0464-y
   Turner N, 2005, J EXP BIOL, V208, P371, DOI 10.1242/jeb.01377
   Turner N, 2005, AM J PHYSIOL-REG I, V288, pR301, DOI 10.1152/ajpregu.00297.2004
   Turner N, 2004, J APPL PHYSIOL, V96, P974, DOI 10.1152/japplphysiol.01003.2003
   Turner N, 2003, NATURWISSENSCHAFTEN, V90, P521, DOI 10.1007/s00114-003-0470-z
   Turner N, 2006, CURR OPIN CLIN NUTR, V9, P691, DOI 10.1097/01.mco.0000247474.56908.79
   Turner N, 2006, PHYSIOL BIOCHEM ZOOL, V79, P522, DOI 10.1086/502815
   Valencak TG, 2007, AGING CELL, V6, P15, DOI 10.1111/j.1474-9726.2006.00257.x
   Valencak TG, 2013, AGE, V35, P2303, DOI 10.1007/s11357-013-9533-z
   Valencak TG, 2011, J COMP PHYSIOL B, V181, P289, DOI 10.1007/s00360-010-0520-8
   Vögler O, 2004, J BIOL CHEM, V279, P36540, DOI 10.1074/jbc.M402061200
   WANG JY, 1995, J NUTR SCI VITAMINOL, V41, P273
   WANG JY, 1994, CHEM PHYS LIPIDS, V71, P197, DOI 10.1016/0009-3084(94)90071-X
   Wassall SR, 2004, CHEM PHYS LIPIDS, V132, P79, DOI 10.1016/j.chemphyslip.2004.09.007
   Wassall SR, 2009, BBA-BIOMEMBRANES, V1788, P24, DOI 10.1016/j.bbamem.2008.10.011
   Watkins SM, 1998, J LIPID RES, V39, P1583
   Welker P, 2007, AM J PHYSIOL-REG I, V292, pR1328, DOI 10.1152/ajpregu.00166.2006
   Wiersma P, 2007, P NATL ACAD SCI USA, V104, P9340, DOI 10.1073/pnas.0702212104
   Wiersma P, 2012, J EXP BIOL, V215, P1662, DOI 10.1242/jeb.065144
   Wijesundera C, 2008, J AM OIL CHEM SOC, V85, P543, DOI 10.1007/s11746-008-1224-z
   WITTING LA, 1964, J NUTR, V82, P19, DOI 10.1093/jn/82.1.19
   Wone BWM, 2013, COMP BIOCHEM PHYS A, V165, P70, DOI 10.1016/j.cbpa.2013.02.010
   Wu BJ, 2004, AM J PHYSIOL-REG I, V287, pR633, DOI 10.1152/ajpregu.00549.2003
   Wu BJ, 2001, J EXP BIOL, V204, P4271
   Xu LB, 2009, J AM CHEM SOC, V131, P13037, DOI 10.1021/ja9029076
   Yamashita A, 2014, PROG LIPID RES, V53, P18, DOI 10.1016/j.plipres.2013.10.001
   Yang Q, 2005, MOL PHARMACOL, V68, P210, DOI 10.1124/mol.105.011692
   ZEROUGA M, 1995, BBA-BIOMEMBRANES, V1236, P266, DOI 10.1016/0005-2736(95)00058-B
   Zhang J, 2012, NAT PROTOC, V7, P1068, DOI 10.1038/nprot.2012.048
NR 165
TC 14
Z9 15
U1 0
U2 29
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0009-3084
EI 1873-2941
J9 CHEM PHYS LIPIDS
JI Chem. Phys. Lipids
PD OCT
PY 2015
VL 191
BP 48
EP 60
DI 10.1016/j.chemphyslip.2015.08.008
PG 13
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA CZ2SH
UT WOS:000366954400006
PM 26291495
DA 2024-02-19
ER

PT J
AU Gredilla, R
   Barja, G
   López-Torres, M
AF Gredilla, R
   Barja, G
   López-Torres, M
TI Effect of short-term caloric restriction on H<sub>2</sub>O<sub>2</sub>
   production and oxidative DNA damage in rat liver mitochondria and
   location of the free radical source
SO JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
LA English
DT Article
DE oxidative stress; oxygen radicals; free radical production
ID HYDROGEN-PEROXIDE PRODUCTION; BOVINE HEART-MITOCHONDRIA; DIETARY
   RESTRICTION; METABOLIC-RATE; FISCHER-344 RATS; FOOD RESTRICTION;
   SUPEROXIDE ANION; COMPLEX-I; GENERATION; MECHANISMS
AB oxygen free radicals (ROS) of mitochondrial origin seem to be involved in aging. Whereas in other tissues complexes I or III of the respiratory chain contain the ROS generators, in this study we find that rat liver mitochondria generate oxygen radicals at complexes 1, II, and III. Short-term (6 weeks) caloric restriction significantly decreased H2O2 production in rat liver mitochondria. This decrease in ROS production was located at complex I because it occurred with complex I-linked substrates (pyruvate/malate), but did not reach statistical significance with the complex II-linked substrate succinate, The mechanism responsible for the lowered ROS production was not a decrease in oxygen consumption, Instead, the mitochondria of caloric-restricted animals released less ROS per unit electron flow. This was due to a decrease in the degree of reduction of the complex I generator. Furthermore, oxidative damage to mitochondrial and nuclear DNA was also decreased in the liver by short-term caloric restriction. The results agree with the idea that caloric restriction delays aging, at least in part, by decreasing the rate of mitochondrial ROS generation and thus the rate of attack to molecules, like DNA, highly relevant for the accumulation of age-dependent changes.
C1 Univ Complutense Madrid, Fac Biol, Dept Anim Biol Anim Physiol 2, E-28040 Madrid, Spain.
C3 Complutense University of Madrid
EM mltorres@bio.ucm.es
RI Gustavo, Barja/B-5591-2012; Barja, Gustavo/AAA-5903-2019
OI Barja, Gustavo/0000-0001-5736-4735; GREDILLA,
   RICARDO/0000-0003-4501-1355
CR Barja G, 1998, J BIOENERG BIOMEMBR, V30, P235, DOI 10.1023/A:1020592719405
   Barja G, 2000, FASEB J, V14, P312, DOI 10.1096/fasebj.14.2.312
   Barja G, 1998, ANN NY ACAD SCI, V854, P224, DOI 10.1111/j.1749-6632.1998.tb09905.x
   Barja G, 1999, J BIOENERG BIOMEMBR, V31, P347, DOI 10.1023/A:1005427919188
   BARJA G, 1994, FREE RADICAL RES, V21, P317, DOI 10.3109/10715769409056584
   Barja G, 1999, METHODS AGING RES, P533
   Beckman K B, 1996, Methods Enzymol, V264, P442, DOI 10.1016/S0076-6879(96)64040-3
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707
   BOVERIS A, 1976, BIOCHEM J, V156, P435, DOI 10.1042/bj1560435
   CHUNG MH, 1992, FREE RADICAL BIO MED, V12, P523, DOI 10.1016/0891-5849(92)90105-P
   DeLaAsuncion JG, 1996, FASEB J, V10, P333, DOI 10.1096/fasebj.10.2.8641567
   DJURIC Z, 1992, TOXICOL APPL PHARM, V115, P156, DOI 10.1016/0041-008X(92)90318-M
   Greenberg JA, 2000, MECH AGEING DEV, V113, P37, DOI 10.1016/S0047-6374(99)00094-9
   Hansford RG, 1997, J BIOENERG BIOMEMBR, V29, P89, DOI 10.1023/A:1022420007908
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Herrero A, 1997, J BIOENERG BIOMEMBR, V29, P241, DOI 10.1023/A:1022458010266
   Herrero A, 1998, MECH AGEING DEV, V103, P133, DOI 10.1016/S0047-6374(98)00035-9
   Herrero A, 1997, MECH AGEING DEV, V98, P95, DOI 10.1016/S0047-6374(97)00076-6
   Kaneko T, 1997, FREE RADICAL BIO MED, V23, P76, DOI 10.1016/S0891-5849(96)00622-3
   Kang CM, 1998, FREE RADICAL BIO MED, V24, P148, DOI 10.1016/S0891-5849(97)00204-9
   KU HH, 1993, FREE RADICAL BIO MED, V15, P621, DOI 10.1016/0891-5849(93)90165-Q
   LATORRE A, 1986, P NATL ACAD SCI USA, V83, P8649, DOI 10.1073/pnas.83.22.8649
   Loft S, 1999, METHOD ENZYMOL, V300, P166
   MCCARTER R, 1985, AM J PHYSIOL, V248, pE488
   Nohl H, 1996, FREE RADICAL BIO MED, V20, P207, DOI 10.1016/0891-5849(95)02038-1
   Orr W. C., 2000, ANTIOXIDANTS REDOX R, P517
   RUCH W, 1983, J IMMUNOL METHODS, V63, P347, DOI 10.1016/S0022-1759(83)80008-8
   SOHAL RS, 1990, MECH AGEING DEV, V53, P209, DOI 10.1016/0047-6374(90)90039-I
   SOHAL RS, 1994, MECH AGEING DEV, V74, P121, DOI 10.1016/0047-6374(94)90104-X
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   SOHAL RS, 1994, MECH AGEING DEV, V76, P215, DOI 10.1016/0047-6374(94)91595-4
   TAKESHIGE K, 1979, BIOCHEM J, V180, P129, DOI 10.1042/bj1800129
   TURRENS JF, 1980, BIOCHEM J, V191, P421, DOI 10.1042/bj1910421
   TURRENS JF, 1985, ARCH BIOCHEM BIOPHYS, V237, P408, DOI 10.1016/0003-9861(85)90293-0
   Wanagat J, 1999, TOXICOL SCI, V52, P35
   Zhang L, 1998, J BIOL CHEM, V273, P33972, DOI 10.1074/jbc.273.51.33972
NR 37
TC 123
Z9 134
U1 0
U2 8
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0145-479X
EI 1573-6881
J9 J BIOENERG BIOMEMBR
JI J. Bioenerg. Biomembr.
PD AUG
PY 2001
VL 33
IS 4
BP 279
EP 287
DI 10.1023/A:1010603206190
PG 9
WC Biophysics; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biophysics; Cell Biology
GA 487XQ
UT WOS:000171904900002
PM 11710804
DA 2024-02-19
ER

PT J
AU Lyu, H
   Zhang, H
   Dong, JR
   Shen, BX
   Cheng, Z
   Yu, JH
   Li, RY
   Shao, NN
   Tang, JC
AF Lyu, Honghong
   Zhang, Hui
   Dong, Jinrui
   Shen, Boxiong
   Cheng, Zi
   Yu, Junhui
   Li, Ruiyan
   Shao, Ningning
   Tang, Jingchun
TI Pyrolysis temperature matters: Biochar-derived dissolved organic matter
   modulates aging behavior and biotoxicity of microplastics
SO WATER RESEARCH
LA English
DT Article
DE Microplastics; Biochar dissolved organic matter; Pyrolysis temperature;
   Photo-aging; Biotoxicity
ID OXIDATIVE STRESS; FRESH-WATER; MICRO
AB Microplastics (MPs) have emerged as a novel and highly concerning contaminant that is ubiquitous in the aqueous environment. However, the aging of MPs induced by dissolved organic matter (DOM), especially biochar-derived dissolved organic matter (BDOM), and the biological toxicity after aging are not fully understood. In this study, the effects of biochar-derived BDOMs on the photoaging and biotoxicity of MPs were investigated at different pyrolysis temperatures using micro-scale polyethylene (PE) as an example. The results showed that the amount of center dot OH generated by the BDOM/PE systems was related to the molecular composition and structure of BDOMs. High temperature BDOM7/9 with less lignin-like (34.33 % / 41.80 %) and more lipid (24.58 % / 19.88 %) content could produce more center dot OH by itself, and its binding ability with PE was weaker due to its less hydrophobic components (SUVA260 = 0.10 / 0.11), which resulted in a weaker shading effect and less inhibition of the system, thus resulting in more center dot OH production in the high temperature BDOM7/9/PE system. However, the involvement of BDOM, although favoring the long-term stable center dot OH production of the system, did not significantly promote the photoaging of MPs. Furthermore, combined in vivo and in vitro biotoxicity studies of MPs showed that photoaging PE with the involvement of BDOM greatly improved systemic inflammation and tissue damage, as well as reactive oxygen species (ROS, such as center dot OH and -OH)-induced cell death. For example, the addition of BDOM5/PE-light reduced the cell death of human lung, liver, and kidney cells from 54.70 %, 69.39 %, and 48.35 % to 22.78 %, 33.13 %, and 25.83 %, respectively, compared to the PE-light group. The results of this study contribute to an in-depth understanding of the environmental behavior of BDOM and MPs systems.
C1 [Lyu, Honghong; Zhang, Hui; Shen, Boxiong; Cheng, Zi] Hebei Univ Technol, Sch Energy & Environm Engn, Tianjin Key Lab Clean Energy & Pollut Control, Tianjin 300401, Peoples R China.
   [Dong, Jinrui; Yu, Junhui; Li, Ruiyan] Tianjin Univ, Acad Med Engn & Translat Med, Med Coll, Tianjin 300072, Peoples R China.
   [Shao, Ningning] Tianjin Univ, Haihe Hosp, Dept Basic Med, Tianjin 300350, Peoples R China.
   [Tang, Jingchun] Nankai Univ, Coll Environm Sci & Engn,Minist Educ, Tianjin Engn Ctr Environm Diag & Contaminat Remedi, Key Lab Pollut Proc & Environm Criteria, Tianjin 300350, Peoples R China.
C3 Hebei University of Technology; Tianjin University; Tianjin University;
   Nankai University
RP Lyu, H (corresponding author), Hebei Univ Technol, Sch Energy & Environm Engn, Tianjin Key Lab Clean Energy & Pollut Control, Tianjin 300401, Peoples R China.; Dong, JR (corresponding author), Tianjin Univ, Acad Med Engn & Translat Med, Med Coll, Tianjin 300072, Peoples R China.; Tang, JC (corresponding author), Nankai Univ, Coll Environm Sci & Engn,Minist Educ, Tianjin Engn Ctr Environm Diag & Contaminat Remedi, Key Lab Pollut Proc & Environm Criteria, Tianjin 300350, Peoples R China.
EM honghonglyu@hebut.edu.cn; jinrui_dong@tju.edu.cn; tangjch@nankai.edu.cn
OI Tang, Jingchun/0000-0001-7633-1701
FU Science Fund for Distinguished Young Scholars of Hebei Province
   [D2023202007]; National Natural Science Foundation of China [42177218,
   U20A20302]; Inno-vative Group Projects in Hebei Province [E2021202006]
FX This work was supported by the (1) Science Fund for Distinguished Young
   Scholars of Hebei Province [D2023202007] ; (2) National Natural Science
   Foundation of China [42177218, U20A20302] ; and (3) Inno-vative Group
   Projects in Hebei Province [E2021202006] .
CR Abdurahman A, 2020, ECOTOX ENVIRON SAFE, V198, DOI 10.1016/j.ecoenv.2020.110658
   Bhagat J, 2021, J HAZARD MATER, V405, DOI 10.1016/j.jhazmat.2020.123913
   Brown DM, 2001, TOXICOL APPL PHARM, V175, P191, DOI 10.1006/taap.2001.9240
   Cai L, 2019, ACS OMEGA, V4, P12036, DOI 10.1021/acsomega.9b01142
   Cao RZ, 2022, ENVIRON POLLUT, V315, DOI 10.1016/j.envpol.2022.120304
   Chen MX, 2022, J HAZARD MATER, V440, DOI 10.1016/j.jhazmat.2022.129784
   Duan JJ, 2022, WATER RES, V216, DOI 10.1016/j.watres.2022.118320
   Fan XL, 2021, J HAZARD MATER, V401, DOI [10.1016/j.jhazmat.2020.123363, 10.1016/j.jhazmal.2020.123363]
   Forte M, 2016, TOXICOL IN VITRO, V31, P126, DOI 10.1016/j.tiv.2015.11.006
   Gewert B, 2015, ENVIRON SCI-PROC IMP, V17, P1513, DOI 10.1039/c5em00207a
   Han L, 2021, SCI TOTAL ENVIRON, V751, DOI 10.1016/j.scitotenv.2020.141491
   Hao SL, 2018, ENVIRON SCI TECHNOL, V52, P7486, DOI 10.1021/acs.est.7b04983
   He CJ, 2021, J ENVIRON CHEM ENG, V9, DOI 10.1016/j.jece.2021.106075
   Horton AA, 2017, SCI TOTAL ENVIRON, V586, P127, DOI 10.1016/j.scitotenv.2017.01.190
   Hu KS, 2021, WATER RES, V198, DOI 10.1016/j.watres.2021.117144
   Huang M, 2021, J HAZARD MATER, V410, DOI 10.1016/j.jhazmat.2020.124537
   Huang M, 2019, SCI TOTAL ENVIRON, V646, P220, DOI 10.1016/j.scitotenv.2018.07.282
   Hüffer T, 2018, ENVIRON POLLUT, V236, P218, DOI 10.1016/j.envpol.2018.01.022
   Jia JL, 2020, CHEM ENG J, V400, DOI 10.1016/j.cej.2020.125853
   Kaja Simon, 2017, Curr Protoc Toxicol, V72, DOI 10.1002/cptx.21
   Kany S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20236008
   Koelmans AA, 2019, WATER RES, V155, P410, DOI 10.1016/j.watres.2019.02.054
   Li XR, 2022, ECOTOX ENVIRON SAFE, V232, DOI 10.1016/j.ecoenv.2022.113238
   Liu GZ, 2019, ENVIRON POLLUT, V246, P26, DOI 10.1016/j.envpol.2018.11.100
   Liu Y, 2021, SCI TOTAL ENVIRON, V779, DOI 10.1016/j.scitotenv.2021.146589
   Liu Y, 2020, ENVIRON POLLUT, V262, DOI 10.1016/j.envpol.2020.114261
   Lyu HH, 2018, ENVIRON POLLUT, V233, P54, DOI 10.1016/j.envpol.2017.10.037
   Lyu HH, 2017, CHEM ENG J, V322, P516, DOI 10.1016/j.cej.2017.04.058
   Maizel AC, 2017, WATER RES, V122, P42, DOI 10.1016/j.watres.2017.05.055
   Mao RF, 2020, J HAZARD MATER, V393, DOI 10.1016/j.jhazmat.2020.122515
   Mignone RA, 2012, PHOTOCHEM PHOTOBIOL, V88, P792, DOI 10.1111/j.1751-1097.2012.01135.x
   Oliveira M, 2019, TRAC-TREND ANAL CHEM, V112, P196, DOI 10.1016/j.trac.2019.01.005
   Peng N, 2020, RSC ADV, V10, P31502, DOI 10.1039/d0ra02706e
   Prietl B, 2014, CELL BIOL TOXICOL, V30, P1, DOI 10.1007/s10565-013-9265-y
   Qiao RX, 2019, SCI TOTAL ENVIRON, V662, P246, DOI 10.1016/j.scitotenv.2019.01.245
   Rachman CM, 2018, SCIENCE, V360, P28, DOI 10.1126/science.aar7734
   Rajapaksha AU, 2019, J ENVIRON MANAGE, V233, P393, DOI 10.1016/j.jenvman.2018.12.069
   Shan EC, 2022, SCI TOTAL ENVIRON, V831, DOI 10.1016/j.scitotenv.2022.154769
   Sharma VK, 2021, CHEMOSPHERE, V271, DOI 10.1016/j.chemosphere.2021.129597
   Song FH, 2019, ENVIRON SCI TECHNOL, V53, P13495, DOI 10.1021/acs.est.9b04595
   Song FH, 2019, J CLEAN PROD, V237, DOI 10.1016/j.jclepro.2019.117855
   Stock V, 2019, ARCH TOXICOL, V93, P1817, DOI 10.1007/s00204-019-02478-7
   Strungaru SA, 2019, TRAC-TREND ANAL CHEM, V110, P116, DOI 10.1016/j.trac.2018.10.025
   Tang JC, 2021, J HAZARD MATER, V413, DOI 10.1016/j.jhazmat.2021.125415
   Tiago GAO, 2023, SCI TOTAL ENVIRON, V892, DOI 10.1016/j.scitotenv.2023.164629
   Valavanidis A, 2008, J HAZARD MATER, V156, P277, DOI 10.1016/j.jhazmat.2007.12.019
   Wan D, 2020, WATER RES, V185, DOI 10.1016/j.watres.2020.116301
   Wang F, 2018, WATER RES, V139, P208, DOI 10.1016/j.watres.2018.04.003
   Wang XQ, 2021, CHEM ENG J, V408, DOI 10.1016/j.cej.2020.127322
   Wright SL, 2017, ENVIRON SCI TECHNOL, V51, P6634, DOI 10.1021/acs.est.7b00423
   Wu YF, 2018, J THORAC DIS, V10, DOI 10.21037/jtd.2018.07.74
   Xia XH, 2009, ENVIRON POLLUT, V157, P1352, DOI 10.1016/j.envpol.2008.11.039
   Xiang YJ, 2022, J HAZARD MATER, V422, DOI 10.1016/j.jhazmat.2021.126843
   Xu FC, 2017, ENVIRON SCI TECHNOL, V51, P13723, DOI 10.1021/acs.est.7b04232
   Yang LL, 2017, ENVIRON SCI TECHNOL, V51, P4999, DOI 10.1021/acs.est.7b00828
   Zhang HF, 2022, J WATER PROCESS ENG, V46, DOI 10.1016/j.jwpe.2021.102544
   Zhang M, 2022, CRIT REV ENV SCI TEC, V52, P810, DOI 10.1080/10643389.2020.1845531
   Zhang P, 2020, SCI TOTAL ENVIRON, V708, DOI 10.1016/j.scitotenv.2019.134619
   Zhang XX, 2020, SEP PURIF TECHNOL, V253, DOI 10.1016/j.seppur.2020.117390
   Zhong YH, 2023, ENVIRON POLLUT, V316, DOI 10.1016/j.envpol.2022.120617
   Zhu KC, 2019, ENVIRON SCI TECHNOL, V53, P8177, DOI 10.1021/acs.est.9b01474
NR 61
TC 0
Z9 0
U1 22
U2 22
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0043-1354
EI 1879-2448
J9 WATER RES
JI Water Res.
PD FEB 15
PY 2024
VL 250
AR 121064
DI 10.1016/j.watres.2023.121064
EA DEC 2023
PG 13
WC Engineering, Environmental; Environmental Sciences; Water Resources
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Engineering; Environmental Sciences & Ecology; Water Resources
GA GX5K0
UT WOS:001155982900001
PM 38154336
DA 2024-02-19
ER

PT J
AU Jing, L
   Jiang, JR
   Liu, DM
   Sheng, JW
   Zhang, WF
   Li, ZJ
   Wei, LY
AF Jing, Liang
   Jiang, Jing-Ru
   Liu, Dong-Mei
   Sheng, Ji-Wen
   Zhang, Wei-Fen
   Li, Zhi-Jian
   Wei, Liu-Ya
TI Structural Characterization and Antioxidant Activity of Polysaccharides
   from <i>Athyrium multidentatum</i> (Doll.) Ching in d-Galactose-Induced
   Aging Mice via PI3K/AKT Pathway
SO MOLECULES
LA English
DT Article
DE aging; Athyrium multidentatum (Doll; ) Ching; d-galactose;
   polysaccharides; PI3K; Akt pathway
ID GANODERMA-LUCIDUM; EXPRESSION; ELUCIDATION; ACTIVATION; GENES
AB The purpose of this study was to characterize the polysaccharides from Athyrium multidentatum (Doll.) Ching (AMC) rhizome and explore the protective mechanism against d-galactose-induced oxidative stress in aging mice. Methods: A series of experiments, including molecular weight, monosaccharide composition, Fourier transform infrared (FT-IR) spectroscopy, and H-1 nuclear magnetic resonance (H-1 NMR) spectroscopy were carried out to characterize AMC polysaccharides. The mechanism was investigated exploring d-galactose-induced aging mouse model. Quantitative real-time reverse transcription polymerase chain reaction (RT-qPCR) and western blotting assays were performed to assess the gene and protein expression in liver. Key findings: Our results showed that AMC polysaccharides were mainly composed of mannose (Man), rhamnose (Rha), glucuronic acid (Glc A), glucose (Glc), galactose (Gal), arabinose (Ara), and fucose (Fuc) in a molar ratio of 0.077:0.088:0.09:1:0.375:0.354:0.04 with a molecular weight of 33203 Da (Mw). AMC polysaccharides strikingly reversed d-galactose-induced changes in mice, including upregulated phosphatidylinositol 3-kinase (PI3K), Akt, nuclear factor-erythroid 2-related factor 2 (Nrf2), forkhead box O3a (FOXO3a), and hemeoxygenase-1 (HO-1) mRNA expression, raised Bcl-2/Bax ratio, downregulated caspase-3 mRNA expression, enhanced Akt, phosphorylation of Akt (p-Akt), Nrf2 and HO-1 protein expression, decreased caspase-3, and Bax protein expression. Conclusion: AMC polysaccharides attenuated d-galactose-induced oxidative stress and cell apoptosis by activating the PI3K/AKT pathway, which might in part contributed to their anti-aging activity.
C1 [Jing, Liang; Jiang, Jing-Ru; Liu, Dong-Mei; Sheng, Ji-Wen; Zhang, Wei-Fen; Li, Zhi-Jian; Wei, Liu-Ya] Weifang Med Univ, Dept Pharm, Weifang 261053, Peoples R China.
C3 Shandong Second Medical University
RP Liu, DM; Li, ZJ (corresponding author), Weifang Med Univ, Dept Pharm, Weifang 261053, Peoples R China.
EM 18369607956@163.com; jjr17865639968@163.com; ldmwfmc@163.com;
   sjwchy@wfmc.edu.cn; zwf2024@126.com; zhijian_l@163.com;
   xiaoyawfmc@163.com
RI zhang, weifen/AAM-7180-2020; Liu, DY/JPL-4171-2023
FU National Natural Science Foundation of China [81774125, 81573717];
   Shandong Provincial Natural Science Foundation [ZR2018LH017,
   ZR2016HM47]; Project of Shandong Province Higher Educational Science and
   Technology Program [J16LM04, J17KB097]; Traditional Chinese Medicine
   Science and Technology Development Project of Shandong Province
   [2017-205]
FX This research was supported by National Natural Science Foundation of
   China (No. 81774125 and 81573717), Shandong Provincial Natural Science
   Foundation (No. ZR2018LH017 and ZR2016HM47), Project of Shandong
   Province Higher Educational Science and Technology Program (No. J16LM04
   and J17KB097) and Traditional Chinese Medicine Science and Technology
   Development Project of Shandong Province (No. 2017-205).
CR BARKER SA, 1954, J CHEM SOC, P171, DOI 10.1039/jr9540000171
   Bo-Htay C, 2018, J CELL MOL MED, V22, P1392, DOI 10.1111/jcmm.13472
   Chen CF, 2006, PSYCHONEUROENDOCRINO, V31, P805, DOI 10.1016/j.psyneuen.2006.03.004
   Cozzolino R, 2006, CARBOHYD POLYM, V65, P263, DOI 10.1016/j.carbpol.2006.01.012
   Devi Kangabam Sanjana Priyadarshini, 2016, Recent Pat Biotechnol, V10, P72
   Harman D, 2009, BIOGERONTOLOGY, V10, P783, DOI 10.1007/s10522-009-9253-z
   Hsu MJ, 2002, J LEUKOCYTE BIOL, V72, P207
   Kansanen E, 2012, FREE RADICAL BIO MED, V52, P973, DOI 10.1016/j.freeradbiomed.2011.11.038
   Li MJ, 2015, FUNGAL GENET BIOL, V82, P251, DOI 10.1016/j.fgb.2015.07.012
   Li ZM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163536
   Liu DM, 2013, INT J BIOL MACROMOL, V56, P1, DOI 10.1016/j.ijbiomac.2013.01.023
   MATHLOUTHI M, 1986, ADV CARBOHYD CHEM BI, V44, P7
   Melo MRS, 2002, CARBOHYD POLYM, V49, P491, DOI 10.1016/S0144-8617(02)00006-1
   Mooney SM, 2000, DEV BRAIN RES, V123, P103, DOI 10.1016/S0165-3806(00)00081-X
   Mu J., 2018, J CHEM PHARM RES, V10, P40
   Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789
   Nakao T, 2008, CELL CYCLE, V7, P257, DOI 10.4161/cc.7.2.5148
   Nakaso K, 2003, FEBS LETT, V546, P181, DOI 10.1016/S0014-5793(03)00517-9
   Schavolt KL, 2007, ONCOGENE, V26, P6125, DOI 10.1038/sj.onc.1210441
   Shen S, 2018, INT J BIOL MACROMOL, V107, P1613, DOI 10.1016/j.ijbiomac.2017.10.026
   Sheng JW, 2014, CARBOHYD POLYM, V108, P41, DOI 10.1016/j.carbpol.2014.03.011
   Wang Q, 2017, MOLECULES, V22, DOI 10.3390/molecules22060955
   Wang S, 2018, FISH PHYSIOL BIOCHEM, V9, P1, DOI DOI 10.3389/fgene.2018.00247
   Wang XQ, 2019, CARBOHYD POLYM, V203, P292, DOI 10.1016/j.carbpol.2018.09.059
   Wu W, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/5707830
   Xiao JH, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/273435
   Xu L, 2016, INT J HYPERTHER, V32, P465, DOI 10.3109/02656736.2016.1155762
   Xu X, 2015, MEDIAT INFLAMM, V2015, DOI [10.1155/2015/810798, 10.1155/2015/380218]
NR 28
TC 20
Z9 23
U1 7
U2 32
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1420-3049
J9 MOLECULES
JI Molecules
PD SEP
PY 2019
VL 24
IS 18
AR 3364
DI 10.3390/molecules24183364
PG 12
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA JB8ON
UT WOS:000488830500156
PM 31527444
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU BENOIT, E
   CRESTEIL, T
   RIVIERE, JL
   DELATOUR, P
AF BENOIT, E
   CRESTEIL, T
   RIVIERE, JL
   DELATOUR, P
TI SPECIFIC AND ENANTIOSELECTIVE SULFOXIDATION OF AN ARYL-TRIFLUOROMETHYL
   SULFIDE BY RAT-LIVER CYTOCHROMES-P-450
SO DRUG METABOLISM AND DISPOSITION
LA English
DT Article
ID MONO-OXYGENASE; CYTOCHROME-P-450; BIOTRANSFORMATION; MONOOXYGENASES;
   ISOENZYMES; OXIDATION
AB Evidence based on thermal stability and enzyme inhibition data suggests that the sulfoxidation of the drug toltrazuril by rat liver microsomes is catalyzed by different cytochromes P-450. Pretreatment of rats by different inducers-phenobarbital, 3-methylcholanthrene, dexamethasone, and triacetyloleandomycin-results in a 2.1-, 2.6-, 2.9-, and 1.8-fold increase, respectively, in the rate of sulfoxidation. The highest increase (8.4-fold) was observed after treatment of microsomes from triacetyloleandomycin-treated animals by potassium ferricyanide. Castration and aging also modify the sulfoxidase activity. The relative rate of formation of the two toltrazuril enantiomers [(A)- and (B)-sulfoxides] depends on the source of the microsomes, suggesting that different cytochromes P-450 have different stereoselectivities.
RP BENOIT, E (corresponding author), INRA,ECOLE NATL VET LYON,UNITE TOXICOL METAB & ECOTOXICOL,BP83,F-69280 MARCY LETOILE,FRANCE.
RI Cresteil, Thierry/L-3641-2019
CR [Anonymous], METABOLIC BASIS DETO
   BOYD DR, 1989, SULPHUR CONTAINING D, V2, P66
   BURKE MD, 1985, BIOCHEM PHARMACOL, V34, P3337, DOI 10.1016/0006-2952(85)90355-7
   CASHMAN JR, 1990, CHEM RES TOXICOL, V3, P344, DOI 10.1021/tx00016a012
   CASHMAN JR, 1988, DRUG METAB DISPOS, V16, P607
   DIXIT A, 1984, ARCH BIOCHEM BIOPHYS, V233, P50, DOI 10.1016/0003-9861(84)90600-3
   GONZALEZ FJ, 1989, PHARMACOL REV, V40, P244
   GUENGERICH FP, 1987, MAMMALIAN CYTOCHROME, P1
   HARTREE EF, 1972, ANAL BIOCHEM, V48, P422, DOI 10.1016/0003-2697(72)90094-2
   HOLLAND HL, 1988, CHEM REV, V88, P473, DOI 10.1021/cr00085a002
   JEFCOATE CR, 1969, BIOCHEMISTRY-US, V8, P3455, DOI 10.1021/bi00836a049
   KAHL R, 1980, DRUG METAB DISPOS, V8, P191
   LEVI PE, 1988, XENOBIOTICA, V18, P29, DOI 10.3109/00498258809055134
   LIGHT DR, 1982, BIOCHEMISTRY-US, V21, P2490, DOI 10.1021/bi00539a031
   MURRAY M, 1990, PHARMACOL REV, V42, P85
   NASH T, 1953, BIOCHEM J, V55, P416, DOI 10.1042/bj0550416
   REINERINK EJM, 1991, J CHROMATOGR, V553, P233, DOI 10.1016/S0021-9673(01)88493-4
   RIVIERE JL, 1985, COMP BIOCHEM PHYS C, V82, P439, DOI 10.1016/0742-8413(85)90189-6
   UEHLEKE H, 1973, DRUG METAB DISPOS, V1, P299
   WAXMAN DJ, 1982, BIOCHEMISTRY-US, V21, P2499, DOI 10.1021/bi00539a032
   WAXMAN DJ, 1985, BIOCHEMISTRY-US, V24, P4409, DOI 10.1021/bi00337a023
   WRIGHTON SA, 1985, BIOCHEMISTRY-US, V24, P2171, DOI 10.1021/bi00330a010
   ZIEGLER DM, 1988, DRUG METAB REV, V19, P1, DOI 10.3109/03602538809049617
NR 23
TC 21
Z9 21
U1 0
U2 0
PU WILLIAMS & WILKINS
PI BALTIMORE
PA 351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436
SN 0090-9556
J9 DRUG METAB DISPOS
JI Drug Metab. Dispos.
PD NOV-DEC
PY 1992
VL 20
IS 6
BP 877
EP 881
PG 5
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA KA065
UT WOS:A1992KA06500015
PM 1362940
DA 2024-02-19
ER

PT J
AU Ohkoshi-Yamada, M
   Kamimura, K
   Kimura, A
   Tanaka, Y
   Nagayama, I
   Yakubo, S
   Abe, H
   Yokoo, T
   Sakamaki, A
   Kamimura, H
   Terai, S
AF Ohkoshi-Yamada, Marina
   Kamimura, Kenya
   Kimura, Atsushi
   Tanaka, Yuto
   Nagayama, Itsuo
   Yakubo, Shunta
   Abe, Hiroyuki
   Yokoo, Takeshi
   Sakamaki, Akira
   Kamimura, Hiroteru
   Terai, Shuji
TI Effects of a selective PPARa modulator, sodium-glucose cotransporter 2
   inhibitor, and statin on the myocardial morphology of medaka
   nonalcoholic fatty liver disease model
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article; Early Access
DE Nonalcoholic fatty liver disease; Heart disease; Medaka; Selective
   peroxisome proliferator-activated; receptor alpha; Sodium-glucose
   cotransporter 2 inhibitor; Statin
ID STEATOHEPATITIS; FIBROSIS
AB Objective: Nonalcoholic fatty liver disease (NAFLD) is associated with metabolic dysregulation and is linked with various cardiovascular complications, which often lead to poor prognostic outcomes. To develop a standard therapy for NAFLD and to urgently address its complications, the current study aimed to investigate the mechanisms of NAFLD-related heart disease and the therapeutic effects of drugs targeting various metabolic pathways. Methods: To explore the mechanism of NAFLD-related heart disease, a medaka model of high-fat diet -induced NAFLD was utilized. The gross structural, histological, and inflammatory changes in the myocardium were evaluated in a time-dependent manner. In addition, the therapeutic effects of medicines used for NAFLD treatment including, selective peroxisome proliferator-activated receptor alpha modulator (SPPARM alpha, pemafibrate), sodium-glucose cotransporter 2 (SGLT2) inhibitor (tofogliflozin), and statin (pitavastatin), and their combinations on heart pathology were evaluated. To determine the mechanisms underlying the therapeutic effects, the expression of genes related to liver inflammation was assessed via whole transcriptome sequencing analysis. Results: The fish with NAFLD-related heart injury presented with cardiomyocyte hypertrophy, which led to cardiac hypertrophy. This morphological change was caused by the infiltration of inflammatory cells, including macrophages and CD4- and CD8-positive lymphocytes, in the cardiac wall and the expression of transforming growth factor beta 1 in the cardiomyocytes. Further, the livers of the fish had upregulated expressions of senescence-associated secretory phenotype -related genes. Treatment with pemafibrate, tofogliflozin, and pitavastatin reduced these changes and, consequently, cardiomyopathy. Conclusion: Our results demonstrated that NAFLD-related heart disease was attributed to the senescence-associated secretory phenotype-induced inflammatory activity in the cardiac wall, which resulted in myocardial hypertrophy. Moreover, the effects of SPPARM alpha, SGLT2 inhibitor, and statin on NAFLD-related heart disease were evident in the medaka NAFLD model. (c) 2022 Elsevier Inc. All rights reserved.
C1 [Ohkoshi-Yamada, Marina; Kamimura, Kenya; Kimura, Atsushi; Tanaka, Yuto; Nagayama, Itsuo; Yakubo, Shunta; Abe, Hiroyuki; Yokoo, Takeshi; Sakamaki, Akira; Kamimura, Hiroteru; Terai, Shuji] Niigata Univ, Grad Sch Med & Dent Sci, Div Gastroenterol & Hepatol, 1-757 Asahimachi Dori,Chuo Ku, Niigata, Japan.
   [Kamimura, Kenya] Niigata Univ, Dept Gen Med, Sch Med, 1-757 Asahimachi Dori,Chuo Ku, Niigata, Japan.
   [Kamimura, Kenya] Niigata Univ, Grad Sch Med & Dent Sci, Div Gastroenterol & Hepatol, Niigata, Japan.
C3 Niigata University; Niigata University; Niigata University
RP Kamimura, K (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Div Gastroenterol & Hepatol, Niigata, Japan.
EM kenya-k@med.niigata-u.ac.jp
RI Kamimura, Kenya/U-6797-2019
OI Kamimura, Kenya/0000-0001-7182-4400; Yokoo, Takeshi/0000-0001-7138-1785;
   Terai, Shuji/0000-0002-5439-635X
FU Japanese Society for the Promotion of Sciences [25670370, 16K15424,
   21K19478]; Kowa Co., Ltd.
FX Funding The research was supported in part by Grant-in-Aid for
   Scientific Research from the Japanese Society for the Promotion of
   Sciences 25670370, 16K15424, and 21K19478 to Terai S and Kamimura K.
   This work was partly supported by Kowa Co., Ltd. The funders had no role
   in the study design, data collection and analysis, and manuscript
   preparation and publication.
CR Anstee QM, 2018, NAT REV GASTRO HEPAT, V15, P425, DOI 10.1038/s41575-018-0010-0
   Armstrong MJ, 2014, HEPATOLOGY, V59, P1174, DOI 10.1002/hep.26717
   Baudouy D, 2017, JOVE-J VIS EXP, DOI 10.3791/55843
   Byrne CD, 2020, J HEPATOL, V72, P785, DOI 10.1016/j.jhep.2020.01.013
   El-Kassas M, 2022, SEMIN LIVER DIS, V42, P401, DOI 10.1055/a-1862-9088
   Goto R, 2019, FEBS OPEN BIO, V9, P643, DOI 10.1002/2211-5463.12598
   Guixé-Muntet S, 2022, ALIMENT PHARM THER, V56, P209, DOI 10.1111/apt.17046
   Honda Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep42477
   Hyogo H, 2011, HEPATOL RES, V41, P1057, DOI 10.1111/j.1872-034X.2011.00849.x
   Kawanishi H, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235362
   Kimura A, 2022, BIOCHEM BIOPH RES CO, V596, P76, DOI 10.1016/j.bbrc.2022.01.086
   Kondo H, 2018, CIRC-ARRHYTHMIA ELEC, V11, DOI 10.1161/CIRCEP.117.006040
   Li Q, 2014, BIOCHEM BIOPH RES CO, V452, P497, DOI 10.1016/j.bbrc.2014.08.109
   Loomba R, 2021, CELL, V184, P2537, DOI 10.1016/j.cell.2021.04.015
   Mantovani A, 2020, METABOLISM, V111, DOI 10.1016/j.metabol.2020.154170
   Mantovani A, 2016, DIGEST DIS SCI, V61, P1246, DOI 10.1007/s10620-016-4040-6
   Nagoya T, 2019, FEBS OPEN BIO, V9, P2016, DOI 10.1002/2211-5463.12734
   Nakajima A, 2021, ALIMENT PHARM THER, V54, P1263, DOI 10.1111/apt.16596
   Neal B, 2017, NEW ENGL J MED, V377, P644, DOI 10.1056/NEJMoa1611925
   Omori S, 2020, CELL METAB, V32, P814, DOI 10.1016/j.cmet.2020.09.006
   Rai V, 2017, MOL CELL BIOCHEM, V424, P123, DOI 10.1007/s11010-016-2849-0
   Shinagawa-Kobayashi Y, 2018, BIOCHEM BIOPH RES CO, V496, P556, DOI 10.1016/j.bbrc.2018.01.057
   Simon TG, 2017, OBESITY, V25, P1313, DOI 10.1002/oby.21879
   Targher G, 2005, DIABETES, V54, P3541, DOI 10.2337/diabetes.54.12.3541
   Thomson MJ, 2022, CLIN GASTROENTEROL H, V20, P458, DOI 10.1016/j.cgh.2021.03.031
   Vrekoussis T, 2009, ANTICANCER RES, V29, P4995
   Wang JH, 2016, LAB INVEST, V96, P839, DOI 10.1038/labinvest.2016.65
   Wanner C, 2018, DIABETOLOGIA, V61, P2134, DOI 10.1007/s00125-018-4678-z
   Yoneda M, 2021, BMJ OPEN DIAB RES CA, V9, DOI 10.1136/bmjdrc-2020-001990
   Zhang QQ, 2020, THER ADV CHRONIC DIS, V11, DOI 10.1177/2040622320974833
NR 30
TC 1
Z9 1
U1 1
U2 4
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD 2022 OCT 15
PY 2022
VL 625
BP 116
EP 121
DI 10.1016/j.bbrc.2022.07.117
EA AUG 2022
PG 6
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA 4X2RG
UT WOS:000860694300008
PM 35952608
OA hybrid
DA 2024-02-19
ER

PT J
AU Girerd, N
   Levy, D
   Duarte, K
   Ferreira, JP
   Ballantyne, C
   Collier, T
   Pizard, A
   Bjoerkman, J
   Butler, J
   Clark, A
   Cleland, JG
   Delles, C
   Diez, J
   Gonzalez, A
   Hazebroek, M
   Ho, JNF
   Huby, AC
   Hwang, SJ
   Latini, R
   Mariottoni, B
   Mebazaa, A
   Pellicori, P
   Sattar, N
   Sever, P
   Staessen, JA
   Verdonschot, J
   Heymans, S
   Rossignol, P
   Zannad, F
AF Girerd, Nicolas
   Levy, Daniel
   Duarte, Kevin
   Ferreira, Joao Pedro
   Ballantyne, Christie
   Collier, Timothy
   Pizard, Anne
   Bjoerkman, Jens
   Butler, Javed
   Clark, Andrew
   Cleland, John G.
   Delles, Christian
   Diez, Javier
   Gonzalez, Arantxa
   Hazebroek, Mark
   Ho, Jennifer
   Huby, Anne-Cecile
   Hwang, Shih-Jen
   Latini, Roberto
   Mariottoni, Beatrice
   Mebazaa, Alexandre
   Pellicori, Pierpaolo
   Sattar, Naveed
   Sever, Peter
   Staessen, Jan A.
   Verdonschot, Job
   Heymans, Stephane
   Rossignol, Patrick
   Zannad, Faiez
TI Protein Biomarkers of New-Onset Heart Failure: Insights From the Heart
   Omics and Ageing Cohort, the Atherosclerosis Risk in Communities Study,
   and the Framingham Heart Study
SO CIRCULATION-HEART FAILURE
LA English
DT Article
DE biomarkers; cardiovascular diseases; heart failure; protein interaction
   maps; proteomics
ID PREDICTORS; DESIGN; MODELS
AB Background:We sought to identify protein biomarkers of new-onset heart failure (HF) in 3 independent cohorts (HOMAGE cohort [Heart Omics and Ageing], ARIC study [Atherosclerosis Risk in Communities], and FHS [Framingham Heart Study]) and assess if and to what extent they improve HF risk prediction compared to clinical risk factors alone. Methods:A nested case-control design was used with cases (incident HF) and controls (without HF) matched on age and sex within each cohort. Plasma concentrations of 276 proteins were measured at baseline in ARIC (250 cases/250 controls), FHS (191/191), and HOMAGE cohort (562/871). Results:In single protein analysis, after adjusting for matching variables and clinical risk factors (and correcting for multiple testing), 62 proteins were associated with incident HF in ARIC, 16 in FHS, and 116 in HOMAGE cohort. Proteins associated with incident HF in all cohorts were BNP (brain natriuretic peptide), NT-proBNP (N-terminal pro-B-type natriuretic peptide), eukaryotic translation initiation factor 4E-BP1 (4E-binding protein 1), hepatocyte growth factor (HGF), Gal-9 (galectin-9), TGF-alpha (transforming growth factor alpha), THBS2 (thrombospondin-2), and U-PAR (urokinase plasminogen activator surface receptor). The increment in C-index for incident HF based on a multiprotein biomarker approach, in addition to clinical risk factors and NT-proBNP, was 11.1% (7.5%-14.7%) in ARIC, 5.9% (2.6%-9.2%) in FHS, and 7.5% (5.4%-9.5%) in HOMAGE cohort, all P<0.001), each of which was a larger increase than that for NT-proBNP on top of clinical risk factors. Complex network analysis revealed a number of overrepresented pathways related to inflammation (eg, tumor necrosis factor and interleukin) and remodeling (eg, extracellular matrix and apoptosis). Conclusions:A multiprotein biomarker approach improves prediction of incident HF when added to natriuretic peptides and clinical risk factors.
EM levyd@nhlbi.nih.gov; k.duarte@chru-nancy.fr; jp7ferreira@hotmail.com;
   cmb@bcm.edu; Timothy.Collier@lshtm.ac.uk; anne.pizard@inserm.fr;
   Jens.bjorkman@tataa.com; javed.butler@bswhealth.org;
   a.l.clark@hull.ac.uk; j.cleland@imperial.ac.uk;
   Christian.Delles@glasgow.ac.uk; jadimar@unav.es; amiqueo@unav.es;
   mark.hazebroek@mumc.nl; jho@bidmc.harvard.edu; annececilehuby@yahoo.fr;
   Hwangs2@nhlbi.nih.gov; roberto.latini@marionegri.it;
   beatrice.m91@virgilio.it; alexandre.mebazaa@aphp.fr;
   pierpaolo.pellicori@glasgow.ac.uk; naveed.sattar@glasgow.ac.uk;
   p.sever@imperial.ac.uk; jan.staessen@appremed.org;
   job.verdonschot@mumc.nl; s.heymans@maastrichtuniversity.nl;
   p.rossignol@chu-nancy.fr; f.zannad@chru-nancy.fr
RI Ferreira, João Pedro/AAB-2489-2022; Cleland, John G./AAZ-4185-2020;
   Díez, Javier/D-7014-2017; González, Arantxa/D-6860-2017; Levy,
   Daniel/ABF-6873-2021; Ballantyne, Christie/A-6599-2008; ferreira,
   joao/JJE-8433-2023; Pizard, Anne/P-4754-2016
OI Ferreira, João Pedro/0000-0002-2304-6138; Cleland, John
   G./0000-0002-1471-7016; Díez, Javier/0000-0002-3414-6919; Levy,
   Daniel/0000-0003-1843-8724; Ballantyne, Christie/0000-0002-6432-1730;
   Pizard, Anne/0000-0003-2705-6365; Girerd, Nicolas/0000-0002-3278-2057;
   Clark, Andrew/0000-0001-8362-668X; Collier, Timothy/0000-0002-3095-277X
FU European Union Commission [305507]; Netherlands Cardiovascular Research
   Initiative; Dutch Heart Foundation
FX The research leading to these results has received funding from the
   European Union Commission's Seventh Framework Programme under grant
   agreement 305507 (HOMAGE [Heart Omics in Ageing consortium]). The
   authors acknowl-edge the support from the Netherlands Cardiovascular
   Research Initiative, an ini-tiative with the support of the Dutch Heart
   Foundation CVON2016-Early HFPEF, and CVON 2017, ShePREDICTS.
CR Beavers KM, 2013, J GERONTOL A-BIOL, V68, P617, DOI 10.1093/gerona/gls213
   Borné Y, 2014, EUR J HEART FAIL, V16, P377, DOI 10.1002/ejhf.49
   Conrad N, 2018, LANCET, V391, P572, DOI 10.1016/S0140-6736(17)32520-5
   Driscoll A, 2017, INT J CARDIOL, V248, P361, DOI 10.1016/j.ijcard.2017.06.098
   Echouffo-Tcheugui JB, 2015, CIRC-HEART FAIL, V8, P438, DOI 10.1161/CIRCHEARTFAILURE.114.001896
   Essebag V, 2003, AM HEART J, V146, P581, DOI 10.1016/S0002-8703(03)00512-X
   Ferreira JP, 2019, CIRC-HEART FAIL, V12, DOI 10.1161/CIRCHEARTFAILURE.118.005897
   Girerd N, 2020, INT J CARDIOL, V300, P252, DOI 10.1016/j.ijcard.2019.11.100
   Green GH, 2007, STAT APPL GENET MOL, V6, DOI 10.2202/1544-6115.1302
   Ho JE, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.008108
   Jacobs L, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.005231
   Jacobs L, 2014, J BIOMED RES, V28, P349, DOI 10.7555/JBR.28.20140045
   Lundberg M, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr424
   Manzano L, 2011, EUR J HEART FAIL, V13, P528, DOI 10.1093/eurjhf/hfr030
   McMurray JJ, 2000, HEART, V83, P596, DOI 10.1136/heart.83.5.596
   Morris JH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-436
   Mureddu GF, 2012, EUR J HEART FAIL, V14, P718, DOI 10.1093/eurjhf/hfs052
   Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.026113
   Paulus WJ, 2013, J AM COLL CARDIOL, V62, P263, DOI 10.1016/j.jacc.2013.02.092
   Pearce N, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i969
   Petrie M, 2001, LANCET, V358, P432, DOI 10.1016/S0140-6736(01)05664-1
   Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Shepherd J, 1999, AM J CARDIOL, V84, P1192, DOI 10.1016/S0002-9149(99)00533-0
   Smith JG, 2017, CIRCULATION, V135, P1651, DOI 10.1161/CIRCULATIONAHA.116.025446
   Stenemo M, 2018, EUR J HEART FAIL, V20, P55, DOI 10.1002/ejhf.980
   Su G, 2010, BIOINFORMATICS, V26, P3135, DOI 10.1093/bioinformatics/btq596
   Wang TJ, 2012, CIRCULATION, V126, P1596, DOI 10.1161/CIRCULATIONAHA.112.129437
   WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184
   Wiviott SD, 2019, NEW ENGL J MED, V380, P347, DOI [10.1056/NEJMoa1812389, 10.1056/NEJMc1902837]
   Yancy CW, 2017, CIRCULATION, V136, pE137, DOI [10.1161/CIR.0000000000000509, 10.1016/j.cardfail.2017.04.014]
NR 31
TC 4
Z9 5
U1 5
U2 5
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1941-3289
EI 1941-3297
J9 CIRC-HEART FAIL
JI Circ.-Heart Fail.
PD MAY
PY 2023
VL 16
IS 5
BP 426
EP 441
AR e009694
DI 10.1161/CIRCHEARTFAILURE.122.009694
PG 16
WC Cardiac & Cardiovascular Systems
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology
GA G9SE7
UT WOS:000992460200008
PM 37192292
OA Green Accepted, Green Published, hybrid
DA 2024-02-19
ER

PT J
AU Malagon, SGG
   Melidoni, AN
   Hernandez, D
   Omar, BA
   Houseman, L
   Veeravalli, S
   Scott, F
   Varshavi, D
   Everett, J
   Tsuchiya, Y
   Timms, JF
   Phillips, IR
   Shephard, EA
AF Malagon, Sandra G. Gonzalez
   Melidoni, Anna N.
   Hernandez, Diana
   Omar, Bilal A.
   Houseman, Lyndsey
   Veeravalli, Sunil
   Scott, Flora
   Varshavi, Dorsa
   Everett, Jeremy
   Tsuchiya, Yugo
   Timms, John F.
   Phillips, Ian R.
   Shephard, Elizabeth A.
TI The phenotype of a knockout mouse identifies flavin-containing
   monooxygenase 5 (FMO5) as a regulator of metabolic ageing
SO BIOCHEMICAL PHARMACOLOGY
LA English
DT Article
DE Body weight; Cholesterol; Glucose; Malic enzyme 1; White adipose tissue
ID MESSENGER-RNA LEVELS; FUNCTIONAL-ACTIVITY; EXPRESSION; GENES; SYNTHASE;
   ENZYMES; OXIDATION; ISOFORM; COA
AB We report the production and metabolic phenotype of a mouse line in which the Fmo5 gene is disrupted. In comparison with wild-type (WT) mice, Fmo5(-/-) mice exhibit a lean phenotype, which is age-related, becoming apparent after 20 weeks of age. Despite greater food intake, Fmo5(-/-) mice weigh less, store less fat in white adipose tissue (WAT), have lower plasma glucose and cholesterol concentrations and enhanced whole-body energy expenditure, due mostly to increased resting energy expenditure, with no increase in physical activity. An increase in respiratory exchange ratio during the dark phase, the period in which the mice are active, indicates a switch from fat to carbohydrate oxidation. In comparison with WT mice, the rate of fatty acid oxidation in Fmo5(-/-) mice is higher in WAT, which would contribute to depletion of lipid stores in this tissue, and lower in skeletal muscle. Five proteins were down regulated in the liver of Fmo5(-/-) mice: aldolase B, ketohexokinase and cytosolic glycerol 3-phosphate dehydrogenase (GPD1) are involved in glucose or fructose metabolism and GPD1 also in production of glycerol 3-phosphate, a precursor of triglyceride biosynthesis; HMG-CoA synthase 1 is involved in cholesterol biosynthesis; and malic enzyme 1 catalyzes the oxidative decarboxylation of malate to pyruvate, in the process producing NADPH for use in lipid and cholesterol biosynthesis. Down regulation of these proteins provides a potential explanation for the reduced fat deposits and lower plasma cholesterol characteristic of Fmo5(-/-) mice. Our results indicate that disruption of the Fmo5 gene slows metabolic ageing via pleiotropic effects. (C) 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
C1 [Malagon, Sandra G. Gonzalez; Hernandez, Diana; Houseman, Lyndsey; Veeravalli, Sunil; Scott, Flora; Tsuchiya, Yugo; Phillips, Ian R.; Shephard, Elizabeth A.] UCL, Inst Struct & Mol Biol, London WC1E 6BT, England.
   [Melidoni, Anna N.; Omar, Bilal A.; Phillips, Ian R.] Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England.
   [Varshavi, Dorsa; Everett, Jeremy] Univ Greenwich, Medway Metabon Res Grp, Chatham ME4 4TB, Kent, England.
   [Timms, John F.] UCL, Inst Womens Hlth, Womens Canc, London WC1E 6BT, England.
C3 University of London; University College London; Birkbeck University
   London; University of London; Queen Mary University London; University
   of Greenwich; University of London; University College London
RP Shephard, EA (corresponding author), UCL, Inst Struct & Mol Biol, Mortimer St, London WC1E 6BT, England.
EM e.shephard@ucl.ac.uk
RI Hernandez, Diana/AAE-4613-2021; Everett, Jeremy R/B-5613-2012; Timms,
   John F/A-1556-2010
OI Everett, Jeremy R/0000-0003-1550-4482; Timms, John
   F/0000-0002-4507-835X; Gonzalez Malagon, Sandra/0000-0003-4479-4001;
   Veeravalli, Sunil Kumar/0000-0002-9652-8461; Hernandez,
   Diana/0000-0002-1353-2175; Melidoni, Anna/0000-0002-2535-883X; Houseman,
   Lyndsey/0000-0002-2503-3293
FU CONACYT, Mexico; Barts and the Royal London School of Medicine and
   Dentistry; Drummond Trust; Wellcome Trust [053590]; ORS and UCL graduate
   School; Primer Design; National Institute for Health Research (NIHR),
   University College London Hospitals (UCLH) Biomedical Research Centre
FX We thank V.L.J. Tybulewicz for pPNT. Work was supported by scholarships
   or studentships from: CONACYT, Mexico (SGGM), Barts and the Royal London
   School of Medicine and Dentistry (ANM), the Drummond Trust (LH), the
   Wellcome Trust (FS), ORS and UCL graduate School (SV) and Primer Design
   (SGGM and FS). Work was funded in part by a grant from the Wellcome
   Trust (053590) to EAS and IRP. The proteomics work was supported by the
   National Institute for Health Research (NIHR), University College London
   Hospitals (UCLH) Biomedical Research Centre.
CR Alam N, 1998, BIOCHEM J, V334, P233, DOI 10.1042/bj3340233
   Cashman JR, 2006, ANNU REV PHARMACOL, V46, P65, DOI 10.1146/annurev.pharmtox.46.120604.141043
   Dolphin CT, 1998, J BIOL CHEM, V273, P30599, DOI 10.1074/jbc.273.46.30599
   Dolphin CT, 1997, NAT GENET, V17, P491, DOI 10.1038/ng1297-491
   DOZIN B, 1986, P NATL ACAD SCI USA, V83, P4705, DOI 10.1073/pnas.83.13.4705
   Furnes B, 2003, DRUG METAB DISPOS, V31, P187, DOI 10.1124/dmd.31.2.187
   Furnes B, 2004, TOXICOL SCI, V78, P196, DOI 10.1093/toxsci/kfh079
   Gharbi S, 2002, MOL CELL PROTEOMICS, V1, P91, DOI 10.1074/mcp.T100007-MCP200
   GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0
   GREENSPAN MD, 1987, P NATL ACAD SCI USA, V84, P7488, DOI 10.1073/pnas.84.21.7488
   Haan C, 2007, J IMMUNOL METHODS, V318, P11, DOI 10.1016/j.jim.2006.07.027
   Hernandez D, 2004, PHARMACOGENETICS, V14, P117, DOI 10.1097/00008571-200402000-00006
   HERNANDEZ D, 2006, METHOD MOL BIOL, V320, P329
   Hernandez D, 2009, PHARMACOGENET GENOM, V19, P289, DOI 10.1097/FPC.0b013e328328d507
   Hough TA, 2002, MAMM GENOME, V13, P595, DOI 10.1007/s00335-002-2188-1
   HUIJING F, 1970, CLIN CHIM ACTA, V30, P567, DOI 10.1016/0009-8981(70)90246-9
   Janmohamed A, 2004, BIOCHEM PHARMACOL, V68, P73, DOI 10.1016/j.bcp.2004.02.036
   Jiang P, 2013, NATURE, V493, P689, DOI 10.1038/nature11776
   Krueger SK, 2005, PHARMACOL THERAPEUT, V106, P357, DOI 10.1016/j.pharmthera.2005.01.001
   Krusekopf S, 2005, PHARMACOGENET GENOM, V15, P817, DOI 10.1097/01.fpc.0000175597.60066.3d
   Lai WG, 2011, DRUG METAB DISPOS, V39, P61, DOI 10.1124/dmd.110.035360
   Lang DH, 2000, BRIT J CLIN PHARMACO, V50, P311, DOI 10.1046/j.1365-2125.2000.00265.x
   Lang DH, 1998, BIOCHEM PHARMACOL, V56, P1005, DOI 10.1016/S0006-2952(98)00218-4
   Liu WH, 2002, ANAL BIOCHEM, V302, P52, DOI 10.1006/abio.2001.5530
   MEHRABIAN M, 1986, J BIOL CHEM, V261, P6249
   Memon RA, 1997, J LIPID RES, V38, P1620
   Miller MM, 1997, J CLIN ENDOCR METAB, V82, P2956, DOI 10.1210/jc.82.9.2956
   Motika MS, 2012, BIOCHEM PHARMACOL, V83, P962, DOI 10.1016/j.bcp.2012.01.006
   Ness GC, 2000, P SOC EXP BIOL MED, V224, P8, DOI 10.1046/j.1525-1373.2000.22359.x
   Ohmi N, 2003, XENOBIOTICA, V33, P1221, DOI 10.1080/00498250310001624627
   OVERBY LH, 1995, ARCH BIOCHEM BIOPHYS, V317, P275, DOI 10.1006/abbi.1995.1163
   Overby LH, 1997, CHEM-BIOL INTERACT, V106, P29, DOI 10.1016/S0009-2797(97)00055-0
   Philips IR., 2007, CURR PHARMACOGENOMIC, V5, P292, DOI 10.2174/157016007782793683
   Phillips IR, 2008, TRENDS PHARMACOL SCI, V29, P294, DOI 10.1016/j.tips.2008.03.004
   Rae JM, 2001, J PHARMACOL EXP THER, V299, P849
   Roslund MU, 2008, CARBOHYD RES, V343, P101, DOI 10.1016/j.carres.2007.10.008
   Shephard EA, 2010, EXPERT OPIN DRUG MET, V6, P1083, DOI 10.1517/17425255.2010.503705
   Sinclair J, 2011, J PROTEOMICS, V74, P451, DOI 10.1016/j.jprot.2010.12.009
   SUGIYAMA T, 1972, BIOCHEM BIOPH RES CO, V48, P255, DOI 10.1016/S0006-291X(72)80043-3
   Takamura T, 2004, DIABETOLOGIA, V47, P638, DOI 10.1007/s00125-004-1366-y
   Tsuchiya Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097693
   Veeramah KR, 2008, PHARMACOGENET GENOM, V18, P877, DOI 10.1097/FPC.0b013e3283097311
   Veeravalli S, 2014, BIOCHEM PHARMACOL, V90, P88, DOI 10.1016/j.bcp.2014.04.007
   Zhang J, 2007, J BIOCHEM MOL TOXIC, V21, P206, DOI 10.1002/jbt.20176
   Zheng FJ, 2012, CHIN J CANCER, V31, P519, DOI 10.5732/cjc.012.10088
NR 45
TC 34
Z9 38
U1 3
U2 26
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0006-2952
EI 1873-2968
J9 BIOCHEM PHARMACOL
JI Biochem. Pharmacol.
PD AUG 1
PY 2015
VL 96
IS 3
BP 267
EP 277
DI 10.1016/j.bcp.2015.05.013
PG 11
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA CN5JJ
UT WOS:000358465300012
PM 26049045
OA Green Published, hybrid
DA 2024-02-19
ER

PT J
AU Nasiri, L
   Vaez-Mahdavi, MR
   Hassanpour, H
   Askari, N
   Ardestani, SK
   Ghazanfari, T
AF Nasiri, Leila
   Vaez-Mahdavi, Mohammad-Reza
   Hassanpour, Hossein
   Askari, Nayere
   Ardestani, Sussan Kaboudanian
   Ghazanfari, Tooba
TI Concomitant use of relative telomere length, biological health score and
   physical/social statuses in the biological aging evaluation of
   mustard-chemical veterans
SO INTERNATIONAL IMMUNOPHARMACOLOGY
LA English
DT Article; Early Access
DE Biological aging; Biological health score; Relative telomere length;
   Socioeconomic position
ID SULFUR MUSTARD; ALLOSTATIC LOAD; CARDIOVASCULAR-DISEASE; ASSOCIATION;
   EXPOSURE; VICTIMS; STRESS; BLOOD; COMPLICATIONS; METAANALYSIS
AB Sulfur mustard (SM) is a toxic gas that has been used as a chemical weapon in wars. After many years, SM-exposed people are still suffering from its side effects such as biological and premature aging. This study was aimed to evaluate biological aging rate via involving biological health scoring (BHS), relative telomere length (TL) and different physical/social variables i.e. marital and smoking statuses, body mass index, salary and educational levels. BHS was calculated according to measurement of 18 biomarkers related to function of four physiological systems (endocrine, inflammatory, cardiovascular and metabolic systems) and two organs (liver and kidney). The volunteers were 442 individuals exposed to SM gas in 1987 and 119 healthy individuals as non-exposed group. Each group was divided based on leukocyte relative TL (short, intermediate and long). Our data showed an inverse correlation between BHS and relative TL in two groups. The BHS was significantly higher in SM-exposed group than non-exposed group, especially in the participants with short and intermediate TL. The BHS had also a positive correlation with smoking and BMI parameters, and a negative correlation with salary and educational levels in the participants with shorter telomeres; and SM strengthened these correlations in the shorter telomeres. It is concluded that the higher BHS along with shorter relative TL that are indices for lower health quality and biological aging, could be used in the health evaluation of non- and SM-exposed people; and involving of BHS, TL and physical/social covariates could be useful to make this evaluation more accurate.
C1 [Nasiri, Leila] Shahed Univ, Fac Basic Sci, Dept Biol, Tehran, Iran.
   [Vaez-Mahdavi, Mohammad-Reza] Shahed Univ, Med Fac, Dept Physiol, Tehran, Iran.
   [Vaez-Mahdavi, Mohammad-Reza; Askari, Nayere; Ardestani, Sussan Kaboudanian; Ghazanfari, Tooba] Shahed Univ, Immunoregulat Res Ctr, Tehran, Iran.
   [Hassanpour, Hossein] Shahrekord Univ, Res Inst Anim Embryo Technol, Dept Gametes & Cloning, Shahrekord, Iran.
   [Ardestani, Sussan Kaboudanian] Univ Tehran, Inst Biochem & Biophys, Dept Biochem, Tehran, Iran.
   [Askari, Nayere] Shahid Bahonar Univ Kerman, Fac Basic Sci, Dept Biol, Kerman, Iran.
C3 Shahed University; Shahed University; Shahed University; Shahrekord
   University; University of Tehran; Shahid Bahonar University of Kerman
   (SBUK)
RP Vaez-Mahdavi, MR (corresponding author), Shahed Univ, Med Fac, Dept Physiol, Tehran, Iran.
EM vaezmahdavi@shahed.ac.ir
RI Ghazanfari, Tooba/C-7258-2008
OI Ghazanfari, Tooba/0000-0002-1049-7095
FU Shahed University; Janbazan Medical and Engineering Research Center
   (JMERC); Iranian Foundation of Martyr and Veterans Affairs; Ministry of
   Health and Medical Education, Tehran, Iran; Shahed University
   [IR.SHAHED.REC.1399. 151]
FX Immunoregulation Research Center of Shahed University has carried out
   this study and acknowledged the spiritual and financial supports of
   Shahed University and Janbazan Medical and Engineering Research Center
   (JMERC) , Iranian Foundation of Martyr and Veterans Affairs and the
   Ministry of Health and Medical Education, Tehran, Iran. We would like to
   kindly thank all the participants who took part in this study. This
   research had been supported by the funds granted for Sardasht Iran
   Cohort study (code no.: IR.SHAHED.REC.1399. 151) via Vice Chancellor for
   Research of Shahed University.
CR Abbasi M., 2012, QOM U MED SCI J, V5, P34
   Ahrens KA, 2016, PAEDIATR PERINAT EP, V30, P325, DOI 10.1111/ppe.12277
   [Anonymous], 2014, J BIOREPOSITORY SCI, DOI DOI 10.2147/BSAM.S46573
   Astuti Y, 2017, ENVIRON RES, V158, P480, DOI 10.1016/j.envres.2017.06.038
   Ataran D., 2006, IRAN J OTORHINOLARYN, V18, P21
   Aubert G, 2008, PHYSIOL REV, V88, P557, DOI 10.1152/physrev.00026.2007
   Azizi F, 2003, ANN MILITARY HLTH SC, P147
   Balali-Mood M., 2005, ARCH IRAN MED, V8, P162
   Behboudi H, 2018, INT IMMUNOPHARMACOL, V61, P37, DOI 10.1016/j.intimp.2018.05.008
   Behravan E, 2018, MUTAT RES-GEN TOX EN, V834, P1, DOI 10.1016/j.mrgentox.2018.06.017
   Bischoff C, 2006, EPIDEMIOLOGY, V17, P190, DOI 10.1097/01.ede.0000199436.55248.10
   Castagne R., 2016, SCI REP-UK, V6
   Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027
   Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7
   Chen RQ, 2020, HEART, V106, P267, DOI 10.1136/heartjnl-2019-315629
   Darrow SM, 2016, PSYCHOSOM MED, V78, P776, DOI 10.1097/PSY.0000000000000356
   Desai N, 2010, UROLOGY, V75, P14, DOI 10.1016/j.urology.2009.05.025
   Dong K, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm.2020.03.10
   Edes AN, 2018, J ZOO WILDLIFE MED, V49, P272, DOI 10.1638/2016-0070.1
   Ellehoj H, 2016, CARDIOLOGY, V133, P173, DOI 10.1159/000441819
   Emad A, 2007, TOXICOLOGY, V240, P60, DOI 10.1016/j.tox.2007.07.014
   Fang CL, 2020, RESPIROLOGY, V25, P1265, DOI 10.1111/resp.13871
   Fitzpatrick AL, 2007, AM J EPIDEMIOL, V165, P14, DOI [10.1093/aje/kwj346, 10.1093/aje/kw346]
   Fujishiro K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204704
   Gao X, 2021, J CLIN ENDOCR METAB, V106, pE4634, DOI 10.1210/clinem/dgab455
   Ghanei M, 2004, EUR J RADIOL, V52, P164, DOI 10.1016/j.ejrad.2004.03.018
   Ghasemi H, 2008, CUTAN OCUL TOXICOL, V27, P317, DOI 10.1080/15569520802404382
   Ghazanfari T, 2020, INT IMMUNOPHARMACOL, V80, DOI 10.1016/j.intimp.2019.105895
   Ghazanfari T, 2009, TOXIN REV, V28, P1, DOI 10.1080/15569540802689022
   Gholamrezanezhad A, 2007, INT J CARDIOVAS IMAG, V23, P197, DOI 10.1007/s10554-006-9122-7
   Gielen M, 2018, AM J CLIN NUTR, V108, P453, DOI 10.1093/ajcn/nqy107
   Gruenewald TL, 2012, SOC SCI MED, V74, P75, DOI 10.1016/j.socscimed.2011.09.037
   Hang D, 2018, EUR J EPIDEMIOL, V33, P485, DOI 10.1007/s10654-018-0382-z
   Haycock PC, 2017, JAMA ONCOL, V3, P636, DOI 10.1001/jamaoncol.2016.5945
   Houin PR, 2015, PEDIATR PULM, V50, P118, DOI 10.1002/ppul.23043
   Jafari F., 2012, J WAR PUBLIC HLTH, V4, P46
   Juster RP, 2010, NEUROSCI BIOBEHAV R, V35, P2, DOI 10.1016/j.neubiorev.2009.10.002
   Karimi M, 2019, J EPIDEMIOL COMMUN H, V73, P693, DOI 10.1136/jech-2018-212010
   Khan F, 2017, ARCH TOXICOL, V91, P1143, DOI 10.1007/s00204-016-1911-8
   Khazdair MR, 2015, INHAL TOXICOL, V27, P731, DOI 10.3109/08958378.2015.1114056
   Kozlitina J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051046
   Logan JG, 2008, J CLIN NURS, V17, P201, DOI 10.1111/j.1365-2702.2008.02347.x
   Lung FW, 2008, J HUM HYPERTENS, V22, P230, DOI 10.1038/sj.jhh.1002314
   Martin-Ruiz CM, 2005, AGING CELL, V4, P287, DOI 10.1111/j.1474-9726.2005.00171.x
   McEwen BS, 2003, HORM BEHAV, V43, P2, DOI 10.1016/S0018-506X(02)00024-7
   Moin A, 2009, TOXIN REV, V28, P24, DOI 10.1080/15569540802689311
   Mosayebzadeh M, 2016, IRAN J ALLERGY ASTHM, V15, P283
   Mousavi B, 2011, J MED CBR DEF, V8
   Müezzinler A, 2013, AGEING RES REV, V12, P509, DOI 10.1016/j.arr.2013.01.003
   Nasiri L, 2021, INT IMMUNOPHARMACOL, V101, DOI 10.1016/j.intimp.2021.108375
   Needham BL, 2019, PSYCHONEUROENDOCRINO, V102, P182, DOI 10.1016/j.psyneuen.2018.12.007
   Petrovic D, 2016, PSYCHONEUROENDOCRINO, V67, P76, DOI 10.1016/j.psyneuen.2016.02.003
   Pohanka M, 2012, MINI-REV MED CHEM, V12, P742, DOI 10.2174/138955712801264783
   Purnawati S., ACTA MED PHILIP, V55
   Razavi SM, 2014, IRAN J PSYCHIATR BEH, V8, P11
   Razgonova MP, 2020, MOL MED REP, V22, P1679, DOI 10.3892/mmr.2020.11274
   Reichert S, 2017, BIOL LETTERS, V13, DOI 10.1098/rsbl.2017.0463
   Rejaei M, 2010, INT J OCCUP ENV MED, V1, P95
   Robertson T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-184
   Rodriquez EJ, 2018, PREV MED, V110, P9, DOI 10.1016/j.ypmed.2018.02.002
   Rohani A, 2010, INDIAN J CRIT CARE M, V14, P109, DOI 10.4103/0972-5229.74168
   Schetz M, 2019, INTENS CARE MED, V45, P757, DOI 10.1007/s00134-019-05594-1
   Sezigen S, 2020, TOXICOL LETT, V318, P92, DOI 10.1016/j.toxlet.2019.10.017
   Shay JW, 2018, CURR OPIN CELL BIOL, V52, P1, DOI 10.1016/j.ceb.2017.12.001
   Shayan H. Ranjebar, 2008, J MILIT MED, V10, P99
   Shoeb M, 2021, PHARMACOL THERAPEUT, V220, DOI 10.1016/j.pharmthera.2020.107742
   Sprott RL, 2010, EXP GERONTOL, V45, P2, DOI 10.1016/j.exger.2009.07.008
   Tang FR, 2012, CRIT REV TOXICOL, V42, P688, DOI 10.3109/10408444.2012.698405
   Tavalie S., 2008, J BEHAV SCI, V1, P19
   Tavallaii S., 2005, RAZI J MED SCI, V12, P29
   Wallace M, 2020, AIDS BEHAV, V24, P1653, DOI 10.1007/s10461-019-02684-5
   Wang FF, 2012, ASIAN J ANDROL, V14, P643, DOI 10.1038/aja.2011.183
   Yaraee R, 2009, INT IMMUNOPHARMACOL, V9, P1466, DOI 10.1016/j.intimp.2009.09.001
NR 73
TC 2
Z9 2
U1 0
U2 4
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1567-5769
EI 1878-1705
J9 INT IMMUNOPHARMACOL
JI Int. Immunopharmacol.
PD 2022 AUG
PY 2022
VL 109
AR 108785
DI 10.1016/j.intimp.2022.108785
EA MAY 2022
PG 10
WC Immunology; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology; Pharmacology & Pharmacy
GA 3F6TE
UT WOS:000830798400007
PM 35533552
DA 2024-02-19
ER

PT J
AU Tarry-Adkins, JL
   Aiken, CE
   Dearden, L
   Fernandez-Twinn, DS
   Ozanne, S
AF Tarry-Adkins, Jane L.
   Aiken, Catherine E.
   Dearden, Laura
   Fernandez-Twinn, Denise S.
   Ozanne, Susan
TI Exploring Telomere Dynamics in Aging Male Rat Tissues: Can
   Tissue-Specific Differences Contribute to Age-Associated Pathologies?
SO GERONTOLOGY
LA English
DT Article; Early Access
DE Aging; Telomeres; Noncommunicable disease; Analysis
ID OXIDATIVE STRESS; LENGTH; MITOCHONDRIA; DISEASE; CELL; CAPACITY;
   SKELETAL; MUSCLE; BLOOD; DIET
AB Introduction: Due to increasing lifespan, global aging rates are rising rapidly and age-associated diseases are increasing. To ensure that health span is concomitant with life span, a greater understanding of cellular mechanisms of aging is important. Methods: Telomere length analysis from a wide range of tissues from weaning, young adult, and middle-aged (3, 12 and 52 week) male Wistar rats were conducted using Southern blotting. Telomere lengths were compared between tissues and ages using regression models based on the ratios of longest-to-shortest telomere fragments. Results: Robust linear age-dependent telomere attrition was observed in the liver; 3 versus 12 weeks, 3 versus 52 weeks (p < 0.01), 12 versus 52 weeks (p < 0.05) and the heart; 3 versus 12 weeks (p < 0.05) and 3 versus 52 weeks (p < 0.001). More subtle shortening was observed in aorta and epididymal fat; 3 and 12 versus 52 weeks (p < 0.001) and in skeletal muscle; 3 versus 52 weeks (p < 0.05), 12 versus 52 weeks (p < 0.01). Young thymus telomeres increased in length (3 vs. 12 weeks) and then shortened between 12 and 52 weeks (p < 0.001). We also reported disparity in telomere shortening within tissues: telomeres in aging brain cortex significantly shortened; 3 versus 52 weeks (p < 0.05), 12 versus 52 weeks (p < 0.01). This was not seen in the hypothalamic region. A robust stepwise shortening was observed in the renal cortex; 3 versus 12 weeks, 12 versus 52 weeks (p < 0.05), and 3 versus 52 weeks (p < 0.001), which was not as apparent in the renal medulla; 3 versus 12 weeks (p < 0.01) and 3 versus 52 weeks (p < 0.01). The vastus lateralis skeletal muscle demonstrated the shortest telomere length at weaning and underwent robust age-associated attrition; 3 versus 52 weeks (p < 0.05), 12 versus 52 weeks (p < 0.01). We demonstrated that specific tissues exhibit unique telomere attrition profiles which may partially explain why certain diseases are more prevalent in aged individuals. Discussion/Conclusion: We show wide variations between tissues in vulnerability to the aging process. In the future, this may help target potential interventions to improve health span.
C1 [Tarry-Adkins, Jane L.; Aiken, Catherine E.; Dearden, Laura; Fernandez-Twinn, Denise S.; Ozanne, Susan] Univ Cambridge, Addenbrookes Hosp, Wellcome Trust MRC Inst Metab Sci, Metab Res Labs, Cambridge, England.
   [Tarry-Adkins, Jane L.; Aiken, Catherine E.; Dearden, Laura; Fernandez-Twinn, Denise S.; Ozanne, Susan] Univ Cambridge, Addenbrookes Hosp, Wellcome Trust MRC Inst Metab Sci, MRC Metab Dis Unit, Cambridge, England.
   [Tarry-Adkins, Jane L.; Aiken, Catherine E.] Univ Cambridge, Rosie Hosp, Dept Obstet & Gynaecol, Cambridge, England.
   [Tarry-Adkins, Jane L.; Aiken, Catherine E.] Univ Cambridge, NIHR Cambridge Comprehens Biomed Res Ctr, Cambridge, England.
C3 University of Cambridge; Cambridge University Hospitals NHS Foundation
   Trust; Addenbrooke's Hospital; Cambridge University Hospitals NHS
   Foundation Trust; Addenbrooke's Hospital; University of Cambridge;
   University of Cambridge; University of Cambridge
RP Tarry-Adkins, JL (corresponding author), Univ Cambridge, Rosie Hosp, Dept Obstet & Gynaecol, Cambridge, England.; Tarry-Adkins, JL (corresponding author), Univ Cambridge, NIHR Cambridge Comprehens Biomed Res Ctr, Cambridge, England.
EM jlt28@cam.ac.uk
RI Fernandez-Twinn, Denise/B-3881-2011; Aiken, Catherine/JQI-3228-2023
OI Fernandez-Twinn, Denise/0000-0003-2610-277X; Aiken,
   Catherine/0000-0002-6510-5626; Dearden, Laura/0000-0002-0804-074X
FU British Heart Foundation [RG/17/12/33167]; Medical Research Council
   [MC_UU_00014/4, MC_UU_12012/4]; Action Medical Research grant [GN2788]
FX J.L.A., S.E.O., and D.S.F.T. are funded by the British Heart Foundation
   (RG/17/12/33167). J.L.A., S.E.O. (MC_UU_00014/4), and D.S.F.T.
   (MC_UU_12012/4) are also funded by the Medical Research Council. C.E.A.
   is supported by an Action Medical Research grant (GN2788). L.D. is a Sir
   Henry Wellcome Post-Doctoral Fellow (106026/Z/14/Z).
CR Adaikalakoteswari A, 2005, DIABETIC MED, V22, P1151, DOI 10.1111/j.1464-5491.2005.01574.x
   Ahmad S, 2012, DIABETIC MED, V29, pe377, DOI 10.1111/j.1464-5491.2012.03737.x
   ALLSOPP RC, 1995, EXP CELL RES, V220, P194, DOI 10.1006/excr.1995.1306
   BLACKBURN EH, 1984, ANNU REV BIOCHEM, V53, P163, DOI 10.1146/annurev.bi.53.070184.001115
   Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656
   Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7
   Cherif H, 2003, NUCLEIC ACIDS RES, V31, P1576, DOI 10.1093/nar/gkg208
   Donati B, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030383
   FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491
   Gardner JP, 2005, CIRCULATION, V111, P2171, DOI 10.1161/01.CIR.0000163550.70487.0B
   Golubovskaya VM, 1997, ONCOGENE, V15, P1233, DOI 10.1038/sj.onc.1201278
   Haycock PC, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4227
   He SH, 2017, CELL, V169, P1000, DOI 10.1016/j.cell.2017.05.015
   Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9
   IWASAKI K, 1988, J GERONTOL, V43, pB5, DOI 10.1093/geronj/43.1.B5
   Kimura M, 2010, NAT PROTOC, V5, P1596, DOI 10.1038/nprot.2010.124
   KITADA T, 1995, BIOCHEM BIOPH RES CO, V211, P33, DOI 10.1006/bbrc.1995.1774
   Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561
   Lopez AD, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0200-8
   Maunsbach AB, 1992, HDB PHYSL SECTION 8, V1, P41
   Melk A, 2000, J AM SOC NEPHROL, V11, P444, DOI 10.1681/ASN.V113444
   Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386
   Oeseburg H, 2010, PFLUG ARCH EUR J PHY, V459, P259, DOI 10.1007/s00424-009-0728-1
   Park SY, 2014, AM J PHYSIOL-HEART C, V307, pH346, DOI 10.1152/ajpheart.00227.2014
   PROWSE KR, 1995, P NATL ACAD SCI USA, V92, P4818, DOI 10.1073/pnas.92.11.4818
   ROBIN ED, 1988, J CELL PHYSIOL, V136, P507, DOI 10.1002/jcp.1041360316
   Rufer N, 1999, J EXP MED, V190, P157, DOI 10.1084/jem.190.2.157
   SNOECK A, 1990, BIOL NEONATE, V57, P107, DOI 10.1159/000243170
   Tarry-Adkins JL, 2008, FASEB J, V22, P2037, DOI 10.1096/fj.07-099523
   Tarry-Adkins JL, 2019, FASEB J, V33, P239, DOI 10.1096/fj.201701350RR
   Tarry-Adkins JL, 2017, AGEING RES REV, V39, P96, DOI 10.1016/j.arr.2016.08.003
   Tarry-Adkins JL, 2006, AM J PHYSIOL-RENAL, V290, pF509, DOI 10.1152/ajprenal.00215.2005
   Tarry-Adkins JL, 2018, METHODS MOL BIOL, V1735
   von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2
   Wang XK, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00012
   Wege Henning, 2007, Curr Stem Cell Res Ther, V2, P31, DOI 10.2174/157488807779317062
   Weng NP, 1998, IMMUNITY, V9, P151, DOI 10.1016/S1074-7613(00)80597-X
   Whittemore K, 2019, P NATL ACAD SCI USA, V116, P15122, DOI 10.1073/pnas.1902452116
   Yamaguchi Y, 1998, EXP CELL RES, V242, P120, DOI 10.1006/excr.1998.4102
   Zhao JZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079993
NR 40
TC 3
Z9 5
U1 0
U2 5
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0304-324X
EI 1423-0003
J9 GERONTOLOGY
JI Gerontology
PD 2021 APR
PY 2021
VL 67
IS 2
BP 233
EP 242
DI 10.1159/000511608
EA MAR 2021
PG 10
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA RN4LL
UT WOS:000627439500001
PM 33677456
OA hybrid, Green Submitted
DA 2024-02-19
ER

PT J
AU Danielsson, R
   Frank, A
AF Danielsson, Rolf
   Frank, Adrian
TI Cadmium in moose kidney and liver - age and gender dependency, and
   standardisation for environmental monitoring
SO ENVIRONMENTAL MONITORING AND ASSESSMENT
LA English
DT Article
DE Cadmium; Moose; Monitoring; Age dependency; Cd accumulation
ID ALCES-ALCES; HEAVY-METALS; SWEDISH ENVIRONMENT; MOLYBDENOSIS; ELEMENTS;
   TISSUES; DISEASE; ALASKA; DEER
AB In the northern hemisphere moose has been found to be suitable as a monitoring animal for the presence of cadmium in the environment. The metal accumulates mainly in the kidney and the liver, with the rate of accumulation dependent on age and possibly also on gender. Collection of tissue material often results in sample selections with disparate age and gender composition, which makes comparison between different regions and different studies difficult. A previous large scale investigation of metals in kidney and liver from moose in Sweden provided Cd data (n = 3,817 and 3,802, respectively) to further explore the relation between Cd accumulation and age/gender. Based on local averages, the individual deviations were analysed with respect to the factors age and gender resulting in an 'ageing function' for each gender and organ. In addition, estimates of the pure individual variations were obtained; the standard deviations correspond to a factor 1.7-1.9 for the Cd concentration, which indicates that 25-30 samples are needed to give a representative mean value (with RSD a parts per thousand 10%). In order to be able to compare results from different studies, all individual results can be transformed to represent a 'standard moose' with respect to age and gender. A comparison along these lines was undertaken between Cd levels in Alaska and Sweden. Finally, a relationship between the Cd levels in kidney and liver was derived, providing at least rough estimates for kidney from liver values (or vice versa).
C1 [Danielsson, Rolf] Uppsala Univ, Dept Phys & Analyt Chem, S-75124 Uppsala, Sweden.
   [Frank, Adrian] Swedish Univ Agr Sci, Fac Vet Med & Anim Sci, Dept Clin Sci, S-75007 Uppsala, Sweden.
C3 Uppsala University; Swedish University of Agricultural Sciences
RP Danielsson, R (corresponding author), Uppsala Univ, Dept Phys & Analyt Chem, POB 599, S-75124 Uppsala, Sweden.
EM rolf.danielsson@kemi.uu.se; dr.a.frank@rocketmail.com
CR Arnold SM, 2006, SCI TOTAL ENVIRON, V357, P103, DOI 10.1016/j.scitotenv.2005.02.040
   BRAZIL J, 1989, ALCES-N AM MOOSE CON, V25, P52
   CRETE M, 1987, SCI TOTAL ENVIRON, V66, P45, DOI [10.1016/0048-9697(87)90076-3, 10.1016/0048-9697(95)04505-U]
   Crichton Vince, 2000, Alces, V36, P205
   Custer TW, 2004, SCI TOTAL ENVIRON, V330, P81, DOI 10.1016/j.scitotenv.2004.03.019
   Eilers PHC, 1996, STAT SCI, V11, P89, DOI 10.1214/ss/1038425655
   Frank A, 2004, BIOL TRACE ELEM RES, V102, P143, DOI 10.1385/BTER:102:1-3:143
   FRANK A, 1983, SPECTROCHIM ACTA B, V38, P207, DOI 10.1016/0584-8547(83)80118-9
   Frank A, 1997, ACS SYM SER, V654, P57
   Frank A, 1998, SCI TOTAL ENVIRON, V209, P17, DOI 10.1016/S0048-9697(97)00303-3
   Frank A, 2004, SCI TOTAL ENVIRON, V330, P131, DOI 10.1016/j.scitotenv.2004.04.001
   FRANK A, 1986, SCI TOTAL ENVIRON, V57, P57, DOI 10.1016/0048-9697(86)90009-4
   FRANK A, 1984, FRESEN Z ANAL CHEM, V317, P652, DOI 10.1007/BF00593816
   Frank A, 1988, TRACE ELEMENT ANAL C, V5, P78
   FROESLIE A, 1984, ACTA VET SCAND, V25, P333
   FROESLIE A, 1986, B ENV CONTAMINATION, V37, P453, DOI DOI 10.1007/BF01607788
   Gamberg M, 2005, SCI TOTAL ENVIRON, V351, P530, DOI 10.1016/j.scitotenv.2004.05.033
   GLOOSCHENKO V, 1988, SCI TOTAL ENVIRON, V71, P173, DOI 10.1016/0048-9697(88)90165-9
   Gustafson Kent A., 2000, Alces, V36, P35
   Iyengar G V, 1998, ELEMENT ANAL BIOL SA
   IYENGAR GV, 1982, ANAL CHEM, V54, pA558
   Medvedev N, 1999, ENVIRON MONIT ASSESS, V56, P177, DOI 10.1023/A:1005988511058
   NIEMI A, 1993, B ENVIRON CONTAM TOX, V50, P834
   O'Hara TM, 2001, J WILDLIFE DIS, V37, P509, DOI 10.7589/0090-3558-37.3.509
   ODSJO T, 2006, TIME TRENDS METALS L
   Paré M, 1999, ALCES-N AM MOOSE CON, V35, P177
   SCANLON PF, 1986, ALCESTIS, V22, P303
   SERGEANT DAVID E., 1959, JOUR WILDLIFE MANAGEMENT, V23, P315, DOI 10.2307/3796891
   SIVERTSEN T, 1995, ENVIRON POLLUT, V90, P75, DOI 10.1016/0269-7491(94)00091-Q
   Venäläinen ER, 2005, B ENVIRON CONTAM TOX, V74, P526, DOI [10.1007/s00128-05-0616-0, 10.1007/s00128-005-0616-0]
NR 30
TC 13
Z9 13
U1 0
U2 10
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0167-6369
J9 ENVIRON MONIT ASSESS
JI Environ. Monit. Assess.
PD OCT
PY 2009
VL 157
IS 1-4
BP 73
EP 88
DI 10.1007/s10661-008-0516-y
PG 16
WC Environmental Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Environmental Sciences & Ecology
GA 495IH
UT WOS:000269883900008
PM 18758976
DA 2024-02-19
ER

PT J
AU Daniel, ZC
   Akyol, A
   McMullen, S
   Langley-Evans, SC
AF Daniel, Zoe C.
   Akyol, Asli
   McMullen, Sarah
   Langley-Evans, Simon C.
TI Exposure of neonatal rats to maternal cafeteria feeding during suckling
   alters hepatic gene expression and DNA methylation in the insulin
   signalling pathway
SO GENES AND NUTRITION
LA English
DT Article
DE Programming; Epigenetics; Insulin signalling; Cafeteria diet
ID JUNK FOOD DIET; BLOOD-PRESSURE; EPIGENETIC REGULATION; SEX-DIFFERENCES;
   FETAL EXPOSURE; OBESITY; RECEPTOR; PREGNANCY; BEHAVIOR; GLUCOSE
AB Nutrition in early life is a determinant of lifelong physiological and metabolic function. Diseases that are associated with ageing may, therefore, have their antecedents in maternal nutrition during pregnancy and lactation. Rat mothers were fed either a standard laboratory chow diet (C) or a cafeteria diet (O) based upon a varied panel of highly palatable human foods, during lactation. Their offspring were then weaned onto chow or cafeteria diet giving four groups of animals (CC, CO, OC, OO n = 9-10). Livers were harvested 10 weeks post-weaning for assessment of gene and protein expression, and DNA methylation. Cafeteria feeding post-weaning impaired glucose tolerance and was associated with sex-specific altered mRNA expression of peroxisome proliferator activated receptor gamma and components of the insulin signalling pathway (Irs2, Akt1 and IrB). Exposure to the cafeteria diet during the suckling period modified the later response to the dietary challenge. Post-weaning cafeteria feeding only down-regulated IrB when associated with cafeteria feeding during suckling (group OO, interaction of diet in weaning and lactation P = 0.041). Responses to cafeteria diet during both phases of the experiment varied between males and females. Global DNA methylation was altered in the liver following cafeteria feeding in the post-weaning period, in males but not females. Methylation of the IrB promoter was increased in group OC, but not OO P = 0.036). The findings of this study add to a growing evidence base that suggests tissue function across the lifespan a product of cumulative modifications to the epigenome and transcriptome, which may be both tissue and sex-specific.
C1 [Daniel, Zoe C.; McMullen, Sarah; Langley-Evans, Simon C.] Univ Nottingham, Sch Biosci, Loughborough LE12 5RD, Leics, England.
C3 University of Nottingham
RP Langley-Evans, SC (corresponding author), Univ Nottingham, Sch Biosci, Sutton Bonington Campus, Loughborough LE12 5RD, Leics, England.
EM Simon.Langley-Evans@Nottingham.ac.uk
RI Langley-Evans, Simon C/F-3564-2012; Langley-Evans, Simon/AAR-4181-2020;
   Akyol, Aslı/I-9987-2013
OI Langley-Evans, Simon C/0000-0002-1969-8416; Akyol,
   Aslı/0000-0001-6301-6358
FU Diabetes UK
FX This work was funded by a small project grant from Diabetes UK.
CR Aagaard-Tillery KM, 2008, J MOL ENDOCRINOL, V41, P91, DOI 10.1677/JME-08-0025
   Akyol A, 2012, BRIT J NUTR, V107, P964, DOI 10.1017/S0007114511003916
   Akyol A, 2009, BRIT J NUTR, V102, P1601, DOI 10.1017/S0007114509990961
   Altobelli G, 2013, PLOS ONE IN PRESS
   Austin RM, 2011, J DEV ORIG HLTH DIS, V2, P190, DOI 10.1017/S2040174411000183
   Bayol SA, 2008, J PHYSIOL-LONDON, V586, P3219, DOI 10.1113/jphysiol.2008.153817
   Bayol SA, 2010, ENDOCRINOLOGY, V151, P1451, DOI 10.1210/en.2009-1192
   Bogdarina I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009237
   Buettner R, 2007, OBESITY, V15, P798, DOI 10.1038/oby.2007.608
   Burdge GC, 2009, J NUTR, V139, P1054, DOI 10.3945/jn.109.104653
   Carlin J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063549
   Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008
   Chen YW, 2013, SCHIZOPHR B IN PRESS
   Crozier SR, 2006, EUR J CLIN NUTR, V60, P1391, DOI 10.1038/sj.ejcn.1602469
   Duan SZ, 2010, DIABETOLOGIA, V53, P1493, DOI 10.1007/s00125-010-1748-2
   Fernandez-Twinn DS, 2005, AM J PHYSIOL-REG I, V288, pR368, DOI 10.1152/ajpregu.00206.2004
   Floyd ZE, 2012, BBA-MOL BASIS DIS, V1822, P1090, DOI 10.1016/j.bbadis.2012.03.014
   Foryst-Ludwig A, 2011, AM J PHYSIOL-HEART C, V301, pH115, DOI 10.1152/ajpheart.01222.2010
   Gambling L, 2003, J PHYSIOL-LONDON, V552, P603, DOI 10.1113/jphysiol.2003.051383
   Jacobsen SC, 2012, DIABETOLOGIA, V55, P3341, DOI 10.1007/s00125-012-2717-8
   Kadowaki K, 2007, BIOL PHARM BULL, V30, P818, DOI 10.1248/bpb.30.818
   Kahn A, 1997, BIOCHIMIE, V79, P113, DOI 10.1016/S0300-9084(97)81501-5
   Kant AK, 2004, J AM DIET ASSOC, V104, P615, DOI 10.1016/j.jada.2004.01.010
   Langie SAS, 2013, FASEB J, V27, P3323, DOI [10.1096/fj.12-224121, 10.1096]
   LANGLEY SC, 1994, CLIN SCI, V86, P217, DOI 10.1042/cs0860217
   Langley-Evans SC, 1999, LIFE SCI, V64, P965, DOI 10.1016/S0024-3205(99)00022-3
   Langley-Evans SC, 2010, MED PRIN PRACT, V19, P87, DOI 10.1159/000273066
   Lillycrop KA, 2011, INT J OBESITY, V35, P72, DOI 10.1038/ijo.2010.122
   Lillycrop KA, 2007, BRIT J NUTR, V97, P1064, DOI 10.1017/S000711450769196X
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Masaki T, 2004, OBES RES, V12, P878, DOI 10.1038/oby.2004.106
   Menéndez-Gutiérrez MP, 2012, CURR TOP MED CHEM, V12, P548
   ROTHWELL NJ, 1979, J COMP PHYSIOL PSYCH, V93, P1024, DOI 10.1037/h0077631
   Ryan KJP, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/397389
   Sampey BP, 2011, OBESITY, V19, P1109, DOI 10.1038/oby.2011.18
   Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477
   Schwanhäusser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098
   Seki Y, 2012, ENDOCRINOLOGY, V153, P1031, DOI 10.1210/en.2011-1805
   Shankar K, 2008, AM J PHYSIOL-REG I, V294, pR528, DOI 10.1152/ajpregu.00316.2007
   Sinclair KD, 2007, P NATL ACAD SCI USA, V104, P19351, DOI 10.1073/pnas.0707258104
   Swali A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048133
   Swali A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023189
   Szyf M, 2009, BBA-GEN SUBJECTS, V1790, P878, DOI 10.1016/j.bbagen.2009.01.009
   Torrens C, 2009, BRIT J NUTR, V101, P27, DOI 10.1017/S0007114508988760
   Abranches MV, 2011, NUTR HOSP, V26, P271, DOI [10.3305/nh.2011.26.2.4875, 10.1590/S0212-16112011000200005]
   Vickers MH, 2003, AM J PHYSIOL-REG I, V285, pR271, DOI 10.1152/ajpregu.00051.2003
   Vogel C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.59
   Vucetic Z, 2011, NEUROPSYCHOPHARMACOL, V36, P1199, DOI 10.1038/npp.2011.4
   Vucetic Z, 2010, ENDOCRINOLOGY, V151, P4756, DOI 10.1210/en.2010-0505
   Wright T, 2011, PHYSIOL BEHAV, V103, P164, DOI 10.1016/j.physbeh.2011.01.008
   Wright TM, 2011, INT J DEV NEUROSCI, V29, P785, DOI 10.1016/j.ijdevneu.2011.09.007
   Yates Z, 2009, BRIT J NUTR, V101, P1185, DOI 10.1017/S0007114508066786
   Zhou ZF, 2011, P NATL ACAD SCI USA, V108, P6626, DOI 10.1073/pnas.1018514108
NR 53
TC 10
Z9 10
U1 0
U2 27
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1555-8932
EI 1865-3499
J9 GENES NUTR
JI Genes Nutr.
PD JAN
PY 2014
VL 9
IS 1
DI 10.1007/s12263-013-0365-3
PG 10
WC Genetics & Heredity; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity; Nutrition & Dietetics
GA AA2PJ
UT WOS:000330936200007
PM 24357221
OA Green Accepted, Bronze, Green Published
DA 2024-02-19
ER

PT J
AU THELIN, A
   RUNQUIST, M
   ERICSSON, J
   SWIEZEWSKA, E
   DALLNER, G
AF THELIN, A
   RUNQUIST, M
   ERICSSON, J
   SWIEZEWSKA, E
   DALLNER, G
TI AGE-DEPENDENT CHANGES IN RAT-LIVER PRENYLTRANSFERASES
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE AGING; DOLICHOL; FARNESYL PYROPHOSPHATE SYNTHASE; SQUALENE;
   CIS-PRENYLTRANSFERASE
ID FARNESYL PYROPHOSPHATE SYNTHETASE; DEHYDRODOLICHYL DIPHOSPHATE SYNTHASE;
   CIS-PRENYLTRANSFERASE; DOLICHYL PHOSPHATE; MICROSOMES; PEROXISOMES;
   MEMBRANES
AB Mevalonate pathway lipids including cholesterol, ubiquinone and dolichol, are of great importance for cellular function. Many of the enzymes of this pathway are thus strictly regulated. During development of the rat, the cellular levels of certain of these lipids vary. Prenyltransferases have been investigated and it is reported here that farnesyl pyrophosphate synthase activity in rat liver cytosol decreases after birth to a lower, steady level. This decrease is not paralleled by the level of synthase protein, which shows two maxima, one immediately after birth and the other 30 days later. cis-Prenyltransferase activity is low after birth, increases continuously up to day-54 and then decreases to a low level which was maintained throughout the remainder of the study (365 days). Squalene synthase exhibits high activity after birth, but decreases during the first 100 days thereafter, and subsequently remains at the low level thus reached. In contrast to these changes in the activities of the prenyltransferases, the level of cholesterol is constant and the dolichol concentration increases continuously throughout the entire period studied.
C1 POLISH ACAD SCI, INST BIOCHEM & BIOPHYS, PL-02532 WARSAW, POLAND.
   KAROLINSKA INST, NOVUM, CLIN RES CTR, S-14186 HUDDINGE, SWEDEN.
C3 Polish Academy of Sciences; Institute of Biochemistry & Biophysics -
   Polish Academy of Sciences; Karolinska Institutet
RP THELIN, A (corresponding author), UNIV STOCKHOLM, ARRHENIUS LABS NAT SCI, DEPT BIOCHEM, S-10691 STOCKHOLM, SWEDEN.
RI Swiezewska, Ewa/B-8362-2009; Runquist, Marten/AAF-7613-2019; Ericsson,
   Johan/AAA-6664-2020
OI Swiezewska, Ewa/0000-0002-3439-8948; Ericsson, Johan/0000-0003-1186-6574
CR ASHBY MN, 1989, J BIOL CHEM, V264, P635
   BLOCH K, 1985, BIOCH LIPIDS MEMBRAN, P1
   CARSON DD, 1981, J BIOL CHEM, V256, P4679
   CHEN Z, 1988, ARCH BIOCHEM BIOPHYS, V266, P98, DOI 10.1016/0003-9861(88)90240-8
   CHEN Z, 1989, J BIOL CHEM, V264, P3849
   CHOJNACKI T, 1984, ACTA BIOCHIM POL, V31, P115
   DALLNER G, 1966, J CELL BIOL, V30, P97, DOI 10.1083/jcb.30.1.97
   DALLNER G, 1966, J CELL BIOL, V30, P73, DOI 10.1083/jcb.30.1.73
   DEROPP JS, 1985, J BIOL CHEM, V260, P5669
   EDLUND C, 1987, CHEM-BIOL INTERACT, V62, P191, DOI 10.1016/0009-2797(87)90090-1
   ERICSSON J, 1992, J BIOL CHEM, V267, P18708
   ERICSSON J, 1992, J BIOL CHEM, V267, P19730
   Ericsson Johan, 1993, V21, P229
   ERNSTER L, 1993, ACTIVE OXYGENS, LIPID PEROXIDES, AND ANTIOXIDANTS, P1
   ISHII K, 1983, J BIOCHEM-TOKYO, V93, P1635, DOI 10.1093/oxfordjournals.jbchem.a134302
   KALEN A, 1989, LIPIDS, V24, P579, DOI 10.1007/BF02535072
   KEENAN RW, 1976, BIOCHEMISTRY-US, V15, P1586, DOI 10.1021/bi00652a032
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LAI CS, 1984, FEBS LETT, V169, P279, DOI 10.1016/0014-5793(84)80333-6
   LOW P, 1992, LIPIDS, V27, P1, DOI 10.1007/BF02537050
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   NAZIAN SJ, 1991, J ANDROL, V12, P264
   POPJAK G, 1962, J BIOL CHEM, V237, P56
   Poulter C.D., 1981, BIOSYNTHESIS ISOPREN, P161
   RILLING HC, 1986, BIOCHIM BIOPHYS ACTA, V876, P500
   STRUCK DK, 1980, BIOCH GLYCOPROTEINS, P35
   VALTERSSON C, 1985, J BIOL CHEM, V260, P2742
   VANDUIJN G, 1986, BIOCHIM BIOPHYS ACTA, V861, P211
NR 28
TC 19
Z9 19
U1 1
U2 2
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD OCT 20
PY 1994
VL 76
IS 2-3
BP 165
EP 176
DI 10.1016/0047-6374(94)91591-1
PG 12
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA PQ152
UT WOS:A1994PQ15200010
PM 7885063
DA 2024-02-19
ER

PT J
AU Zhai, MM
   Liu, ZD
   Long, JH
   Zhou, QX
   Yang, LP
   Zhou, Q
   Liu, SS
   Dai, Y
AF Zhai, Mimi
   Liu, Zhide
   Long, Jianhai
   Zhou, Qingxiang
   Yang, Leping
   Zhou, Qin
   Liu, Sushun
   Dai, Yu
TI The incidence trends of liver cirrhosis caused by nonalcoholic
   steatohepatitis via the GBD study 2017
SO SCIENTIFIC REPORTS
LA English
DT Article
ID FATTY LIVER; HEPATOCELLULAR-CARCINOMA; NATURAL-HISTORY; RISK-FACTORS;
   DISEASE; PREVALENCE; EPIDEMIOLOGY; OVERWEIGHT; FIBROSIS; OBESITY
AB Nonalcoholic steatohepatitis (NASH) has rapidly become the most common cause of chronic liver diseases. We aimed to explore the incidence and distribution characteristics of NASH by sex, region and sociodemographic index (SDI). We collected data, including sex and region, on NASH-related liver cirrhosis from the 2017 GBD study. The age-standardized incidence rates (ASRs) and estimated annual percentage changes (EAPCs) were used to estimate the incidence trend and distribution characteristics. Globally, the incidence of liver cirrhosis caused by NASH increased from 178,430 cases in 1990 to 367,780 cases in 2017, an increase of approximately 105.56%. The ASR of NASH increased by an average of 1.35% per year (95% CI 1.28-1.42). Meanwhile, large differences in the ASR and the EAPC were observed across regions. The middle-high SDI region had the highest increase among all five SDI regions, followed by middle SDI region. In addition, Eastern Europe, Andean Latin America and Central Asia showed a more significant growth trend of ASR. In contrast, the high SDI region demonstrated the slowest increasing trend of ASR, and the high-income Asia Pacific demonstrated a decreasing trend among the 21 regions. Liver cirrhosis has caused a huge and rising health burden in many countries and regions. In addition, with the growth of obesity, population and aging, NASH might replace viral hepatitis as the most important cause of liver cirrhosis in the near future. Therefore, appropriate interventions are needed in coming decades to realize early diagnosis and prevention of NASH-related liver cirrhosis.
C1 [Zhai, Mimi] Cent South Univ, Xiangya Nursing Sch, Changsha 410013, Hunan, Peoples R China.
   [Liu, Zhide; Zhou, Qingxiang; Yang, Leping; Zhou, Qin; Liu, Sushun] Cent South Univ, Xiangya Hosp 2, Dept Gen Surg, Changsha 410011, Hunan, Peoples R China.
   [Liu, Zhide] Cent Hosp Shaoyang, Dept Gen Surg, Shaoyang 42200, Hunan, Peoples R China.
   [Long, Jianhai] Capital Med Univ, Beijing Tiantan Hosp, Dept Resp, Beijing 100050, Peoples R China.
   [Dai, Yu] Cent South Univ, Xiangya Hosp 2, Dept Orthoped, Clin Nursing Teaching & Res Sect, Changsha 410011, Hunan, Peoples R China.
C3 Central South University; Central South University; Capital Medical
   University; Central South University
RP Liu, SS (corresponding author), Cent South Univ, Xiangya Hosp 2, Dept Gen Surg, Changsha 410011, Hunan, Peoples R China.; Dai, Y (corresponding author), Cent South Univ, Xiangya Hosp 2, Dept Orthoped, Clin Nursing Teaching & Res Sect, Changsha 410011, Hunan, Peoples R China.
EM surun9566@csu.edu.cn; csdaiyu@csu.edu.cn
FU Chen Xiaoping Science and Technology Development Foundation
   [CXPJJH11900001-2019334]; Hunan Provincial Natural Science Foundation of
   China [2018JJ3715, 2018JJ3732]
FX This study was supported by Chen Xiaoping Science and Technology
   Development Foundation (CXPJJH11900001-2019334), and Hunan Provincial
   Natural Science Foundation of China (No. 2018JJ3715 and No. 2018JJ3732).
CR Aburizaiza O.S., 2015, REV ENVIRON HEALTH, P191
   Afshin A, 2017, NEW ENGL J MED, V377, P1496, DOI 10.1056/NEJMc1710026
   Al-Muhaimeed AA, 2015, ANN SAUDI MED, V35, P275, DOI 10.5144/0256-4947.2015.275
   Alswat K, 2018, SAUDI J GASTROENTERO, V24, P211, DOI [10.4103/sjg.sjg_122_18, 10.4103/sjg.SJG_122_18]
   Angulo P, 2015, GASTROENTEROLOGY, V149, P389, DOI 10.1053/j.gastro.2015.04.043
   Alvarez MA, 2011, J CLIN GASTROENTEROL, V45, P906, DOI 10.1097/MCG.0b013e3182284e13
   Ascha MS, 2010, HEPATOLOGY, V51, P1972, DOI 10.1002/hep.23527
   Bosetti C, 2007, J HEPATOL, V46, P827, DOI 10.1016/j.jhep.2007.01.025
   Chalasani N, 2018, HEPATOLOGY, V67, P328, DOI 10.1002/hep.29367
   Cholankeril George, 2016, Hepatology, V64, P954, DOI 10.1002/hep.28719
   Clark JM, 2003, JAMA-J AM MED ASSOC, V289, P3000, DOI 10.1001/jama.289.22.3000
   Colquhoun H., 2018, LANCET, V392, P1116
   Coppell KJ, 2015, OBES SCI PRACT, V1, P67, DOI 10.1002/osp4.13
   D'Amico G, 2006, J HEPATOL, V44, P217, DOI 10.1016/j.jhep.2005.10.013
   Das K, 2010, HEPATOLOGY, V51, P1593, DOI 10.1002/hep.23567
   de Carvalho JR, 2017, ANN HEPATOL, V16, P893, DOI 10.5604/01.3001.0010.5280
   Della Corte C, 2017, NUTRITION, V39-40, P8, DOI 10.1016/j.nut.2017.02.008
   Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3
   Fan JG, 2017, J HEPATOL, V67, P862, DOI 10.1016/j.jhep.2017.06.003
   Farrell GC, 2013, NAT REV GASTRO HEPAT, V10, P307, DOI 10.1038/nrgastro.2013.34
   Fazel Y, 2016, METABOLISM, V65, P1017, DOI 10.1016/j.metabol.2016.01.012
   Fitzmaurice C, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.15_suppl.1568
   GBD 2017 Gastrooesophageal, 2020, LANCET GASTROENTEROL, V5, P561, DOI 10.1016/S2468-1253(19)30408-X
   Hankey BF, 2000, CANCER CAUSE CONTROL, V11, P31, DOI 10.1023/A:1008953201688
   Hu XN, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-123
   Hung GY, 2015, J HEPATOL, V63, P1390, DOI 10.1016/j.jhep.2015.07.032
   James SL, 2018, LANCET, V392, P1789, DOI [10.1016/S0140-6736(18)32335-3, 10.1016/s0140-6736(18)32279-7]
   Kalia HS, 2016, CLIN LIVER DIS, V20, P215, DOI 10.1016/j.cld.2015.10.005
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   Kotronen A, 2007, J CLIN ENDOCR METAB, V92, P3490, DOI 10.1210/jc.2007-0482
   LeCroy MN, 2017, NUTR REV, V75, P391, DOI 10.1093/nutrit/nux023
   Liu ZQ, 2019, J HEPATOL, V70, P674, DOI 10.1016/j.jhep.2018.12.001
   Loomba R, 2019, HEPATOLOGY, V70, P1885, DOI 10.1002/hep.30946
   McGlynn KA, 2015, CLIN LIVER DIS, V19, P223, DOI 10.1016/j.cld.2015.01.001
   Modin L, 2019, J HEPATOL, V70, P371, DOI 10.1016/j.jhep.2018.11.013
   Mokdad AA, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0145-y
   Mongraw-Chaffin M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139559
   Musaiger AO, 2016, NUTR HOSP, V33, P1062
   Pinidiyapathirage M Janani, 2011, BMC Res Notes, V4, P513, DOI 10.1186/1756-0500-4-513
   Poynard T, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-40
   Rinella M, 2016, HEPATOLOGY, V64, P19, DOI 10.1002/hep.28524
   Rinella ME, 2015, JAMA-J AM MED ASSOC, V313, P2263, DOI 10.1001/jama.2015.5370
   Sayiner M, 2016, CLIN LIVER DIS, V20, P205, DOI 10.1016/j.cld.2015.10.001
   Shaikh MA, 2016, INT J HEALTH SCI-IJH, V10, P381
   Tada T, 2018, J GASTROENTEROL, V53, P1196, DOI 10.1007/s00535-018-1467-x
   Tuangratananon T, 2019, B WORLD HEALTH ORGAN, V97, P129, DOI 10.2471/BLT.18.220483
   Yang JD, 2014, HEPATOLOGY, V59, P1406, DOI 10.1002/hep.26761
   Yki-Järvinen H, 2014, LANCET DIABETES ENDO, V2, P901, DOI 10.1016/S2213-8587(14)70032-4
   Younossi Z, 2018, NAT REV GASTRO HEPAT, V15, P11, DOI 10.1038/nrgastro.2017.109
   Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431
   Zhou F, 2019, HEPATOLOGY, V70, P1119, DOI 10.1002/hep.30702
NR 51
TC 20
Z9 21
U1 2
U2 6
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAR 4
PY 2021
VL 11
IS 1
AR 5195
DI 10.1038/s41598-021-84577-z
PG 9
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA QS8JO
UT WOS:000626140000023
PM 33664363
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Greco, M
   Villani, G
   Mazzucchelli, F
   Bresolin, N
   Papa, S
   Attardi, G
AF Greco, M
   Villani, G
   Mazzucchelli, F
   Bresolin, N
   Papa, S
   Attardi, G
TI Marked aging-related decline in efficiency of oxidative phosphorylation
   in human skin fibroblasts
SO FASEB JOURNAL
LA English
DT Article
DE fetal fibroblasts; mitochondrial respiration; cytochrome c oxidase
ID CYTOCHROME-C-OXIDASE; MITOCHONDRIAL-DNA; RESPIRATORY-CHAIN;
   SKELETAL-MUSCLE; HUMAN-CELLS; IN-VIVO; WILD-TYPE; AGE; MUTATION; LIVER
AB An extensive analysis has been carried out of mitochondrial biochemical and bioenergetic properties of fibroblasts, mostly skin-derived, from a large group of subjects ranging in age between 20 wk fetal and 103 yr. A striking age-related change observed in a fundamental process underlying mitochondrial biogenesis and function was the very significant decrease in rate of mitochondrial protein synthesis in individuals above 40 yr. The analysis of endogenous respiration rate revealed a significant decrease in the age range from 40 to 90 yr and a tendency to uncoupling in the samples from subjects above 60 year. A surprising finding was the occurrence of a subgroup of individuals greater than or equal to90 yr old whose skin fibroblasts exhibited an exceptionally high respiration rate. This high rate was not due to respiration uncoupling, rather pointing to a compensatory phenomenon, not involving an increase in mtDNA content, in the corresponding skin fibroblast populations, or, possibly, to a selection of a different cell type secondary to more extensive dermal atrophy. The most important aging-related phenotypic effects observed were those that affected the cell oxidative phosphorylation (OX-PHOS) capacity. These were, in particular, the very significant reduction in the ratio of uncoupled to oligomycin-inhibited endogenous respiration observed in intact fibroblasts, which pointed to a decrease with donor's age in the control of respiration by the mitochondrial membrane potential, the very significant decrease in efficiency of OX-PHOS, as determined by novel in situ measurements of P:O ratios, and, consistent with these results, the very significant reduction in the respiratory control ratios. These findings clearly pointed to a dramatic mitochondrial dysfunction, which would lead to a decrease in ATP synthesis rate, with the observed decline in mitochondrial protein synthesis rate being a likely contributing factor. These observations have important implications for understanding the biology of aging, as well as the pathogenesis of aging-related degenerative diseases.
C1 CALTECH, Div Biol, Pasadena, CA 91125 USA.
   Univ Milan, Inst Clin Neurol, Osped Maggiore Policlin, I-20122 Milan, Italy.
   Univ Bari, Dept Med Biochem & Biol, I-70124 Bari, Italy.
C3 California Institute of Technology; University of Milan; IRCCS Ca Granda
   Ospedale Maggiore Policlinico; Universita degli Studi di Bari Aldo Moro
RP Attardi, G (corresponding author), CALTECH, Div Biol, 156-29, Pasadena, CA 91125 USA.
EM attardi@caltech.edu
OI GRECO, MARILENA/0000-0002-6829-897X; Papa, Sergio/0000-0002-4417-1763;
   Bresolin, Nereo/0000-0001-6694-3595
CR Allen RG, 1997, J BIOL CHEM, V272, P24805, DOI 10.1074/jbc.272.40.24805
   Attardi G, 2002, MITOCHONDRION, V2, P27, DOI 10.1016/S1567-7249(02)00032-6
   Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343
   BOFFOLI D, 1994, BBA-MOL BASIS DIS, V1226, P73, DOI 10.1016/0925-4439(94)90061-2
   Boffoli D, 1996, BBA-MOL BASIS DIS, V1315, P66, DOI 10.1016/0925-4439(95)00107-7
   BOWLING AC, 1993, J NEUROCHEM, V60, P1964, DOI 10.1111/j.1471-4159.1993.tb13430.x
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   CHOMYN A, 1994, AM J HUM GENET, V54, P966
   Chomyn A, 1996, Methods Enzymol, V264, P197, DOI 10.1016/S0076-6879(96)64020-8
   Cuezva JM, 1997, J BIOENERG BIOMEMBR, V29, P365, DOI 10.1023/A:1022450831360
   FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9
   GONZALEZ IL, 1985, P NATL ACAD SCI USA, V82, P7666, DOI 10.1073/pnas.82.22.7666
   Hagen TM, 1997, P NATL ACAD SCI USA, V94, P3064, DOI 10.1073/pnas.94.7.3064
   HAYASHI JI, 1994, J BIOL CHEM, V269, P6878
   Isobe K, 1998, J BIOL CHEM, V273, P4601, DOI 10.1074/jbc.273.8.4601
   KING MP, 1988, CELL, V52, P811, DOI 10.1016/0092-8674(88)90423-0
   KUNTZ WS, 2000, J BIOL CHEM, V275, P27741
   KUNZ D, 1995, BIOCHEM MOL MED, V54, P105, DOI 10.1006/bmme.1995.1015
   Laderman KA, 1996, J BIOL CHEM, V271, P15891, DOI 10.1074/jbc.271.27.15891
   Lenaz G, 2000, BBA-BIOENERGETICS, V1459, P397, DOI 10.1016/S0005-2728(00)00177-8
   Michikawa Y, 1999, Somat Cell Mol Genet, V25, P333, DOI 10.1023/A:1019972500785
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   MULLERHOCKER J, 1990, J NEUROL SCI, V100, P14, DOI 10.1016/0022-510X(90)90006-9
   MULLERHOCKER J, 1989, AM J PATHOL, V134, P1167
   MULLERHOCKER J, 1993, VIRCHOWS ARCH A, V422, P7, DOI 10.1007/BF01605127
   Papa S, 1996, BBA-BIOENERGETICS, V1276, P87, DOI 10.1016/0005-2728(96)00077-1
   REIS RJS, 1983, J BIOL CHEM, V258, P9078
   TORII K, 1992, AM J RESP CELL MOL, V6, P88, DOI 10.1165/ajrcmb/6.1.88
   TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0
   Ventura B, 2002, BBA-BIOENERGETICS, V1553, P249, DOI 10.1016/S0005-2728(01)00246-8
   Villani G, 1998, J BIOL CHEM, V273, P31829, DOI 10.1074/jbc.273.48.31829
   Villani G, 1997, P NATL ACAD SCI USA, V94, P1166, DOI 10.1073/pnas.94.4.1166
   Villani G, 2001, METHOD CELL BIOL, V65, P119, DOI 10.1016/S0091-679X(01)65007-6
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
   Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499
   YEN TC, 1989, BIOCHEM BIOPH RES CO, V165, P994, DOI 10.1016/0006-291X(89)92701-0
   YONEDA M, 1992, P NATL ACAD SCI USA, V89, P11164, DOI 10.1073/pnas.89.23.11164
   YONEDA M, 1994, MOL CELL BIOL, V14, P2699, DOI 10.1128/MCB.14.4.2699
NR 38
TC 84
Z9 90
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD JUL
PY 2003
VL 17
IS 10
BP 1706
EP +
DI 10.1096/fj.02-1009fje
PG 26
WC Biochemistry & Molecular Biology; Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 706TR
UT WOS:000184471600007
PM 12958183
DA 2024-02-19
ER

PT J
AU Ryu, KY
   Maehr, R
   Gilchrist, CA
   Long, MA
   Bouley, DM
   Mueller, B
   Ploegh, HL
   Kopito, RR
AF Ryu, Kwon-Yul
   Maehr, Rene
   Gilchrist, Catherine A.
   Long, Michael A.
   Bouley, Donna M.
   Mueller, Britta
   Ploegh, Hidde L.
   Kopito, Ron R.
TI The mouse polyubiquitin gene UbC is essential for fetal liver
   development, cell-cycle progression and stress tolerance
SO EMBO JOURNAL
LA English
DT Article
DE cellular stress; gene expression; liver development; polyubiquitin;
   ubiquitin
ID MULTI-UBIQUITIN CHAINS; PROTEIN-DEGRADATION; DEUBIQUITINATING ENZYMES;
   MESSENGER-RNA; EXPRESSION; MONOUBIQUITIN; DISRUPTION; APOPTOSIS;
   PROMOTER; REVEALS
AB UbC is one of two stress- inducible polyubiquitin genes in mammals and is thought to supplement the constitutive UbA genes in maintaining cellular ubiquitin ( Ub) levels during episodes of cellular stress. We have generated mice harboring a targeted disruption of the UbC gene. UbC (-/-) embryos die between embryonic days 12.5 and 14.5 in utero, most likely owing to a severe defect in liver cell proliferation. Mouse embryonic fibroblasts from UbC(-/-) embryos exhibit reduced growth rates, premature senescence, increased apoptosis and delayed cell-cycle progression, with slightly, but significantly, decreased steady-state Ub levels. UbC(-/-) fibroblasts are hypersensitive to proteasome inhibitors and heat shock, and unable to adequately increase Ub levels in response to these cellular stresses. Most, but not all of the UbC(-/-) phenotypes can be rescued by providing additional Ub from a poly hemagglutinin-tagged Ub minigene expressed from the Hprt locus. We propose that UbC is regulated by a process that senses Ub pool dynamics. These data establish that UbC constitutes an essential source of Ub during cell proliferation and stress that cannot be compensated by other Ub genes.
C1 Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.
   Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.
   Univ Auckland, Fac Med & Hlth Sci, Auckland Canc Soc Res Ctr, Auckland 1, New Zealand.
   Univ British Columbia, Vancouver, BC V5Z 1M9, Canada.
   Stanford Univ, Dept Comparat Med, Stanford, CA 94305 USA.
   Whitehead Inst, Cambridge Ctr 9, Cambridge, MA 02142 USA.
C3 Stanford University; Harvard University; University of Auckland;
   University of British Columbia; Stanford University; Massachusetts
   Institute of Technology (MIT); Whitehead Institute
RP Kopito, RR (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.
EM kopito@stanford.edu
RI Gilchrist, Catherine/GPW-8606-2022
OI Ryu, Kwon-Yul/0000-0001-6104-8575; Kopito, Ron/0000-0001-5027-6935;
   Gilchrist, Catherine/0000-0002-7467-7933
CR BAKER RT, 1991, NUCLEIC ACIDS RES, V19, P1035, DOI 10.1093/nar/19.5.1035
   BAKER RT, 1987, NUCLEIC ACIDS RES, V15, P443, DOI 10.1093/nar/15.2.443
   BOND U, 1986, MOL CELL BIOL, V6, P4602, DOI 10.1128/MCB.6.12.4602
   Bronson SK, 1996, P NATL ACAD SCI USA, V93, P9067, DOI 10.1073/pnas.93.17.9067
   D'Andrea A, 1998, CRIT REV BIOCHEM MOL, V33, P337, DOI 10.1080/10409239891204251
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   DZIERZAK E, 1995, TRENDS GENET, V11, P359, DOI 10.1016/S0168-9525(00)89107-6
   ELLISON MJ, 1991, J BIOL CHEM, V266, P21150
   FINCH JS, 1992, CELL GROWTH DIFFER, V3, P269
   FINLEY D, 1987, CELL, V48, P1035, DOI 10.1016/0092-8674(87)90711-2
   FINLEY D, 1989, NATURE, V338, P394, DOI 10.1038/338394a0
   FORNACE AJ, 1989, NUCLEIC ACIDS RES, V17, P1215, DOI 10.1093/nar/17.3.1215
   GOLDSTEIN S, 1990, SCIENCE, V249, P1129, DOI 10.1126/science.2204114
   HAAS AL, 1987, J BIOL CHEM, V262, P345
   Hanna J, 2003, MOL CELL BIOL, V23, P9251, DOI 10.1128/MCB.23.24.9251-9261.2003
   Hershko A, 2005, CELL DEATH DIFFER, V12, P1191, DOI 10.1038/sj.cdd.4401702
   Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425
   Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405
   Kugawa F, 2004, DNA SEQUENCE, V15, P237, DOI 10.1080/10425170400006372
   LUND PK, 1985, J BIOL CHEM, V260, P7609
   Mathew A, 1998, MOL CELL BIOL, V18, P5091, DOI 10.1128/MCB.18.9.5091
   McMillan DR, 1998, J BIOL CHEM, V273, P7523, DOI 10.1074/jbc.273.13.7523
   Murray JI, 2004, MOL BIOL CELL, V15, P2361, DOI 10.1091/mbc.E03-11-0799
   OhtaniKaneko R, 1996, NEUROSCI RES, V26, P349, DOI 10.1016/S0168-0102(96)01117-0
   Osaka H, 2003, HUM MOL GENET, V12, P1945, DOI 10.1093/hmg/ddg211
   Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9
   Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009
   Pirkkala L, 2000, MOL CELL BIOL, V20, P2670, DOI 10.1128/MCB.20.8.2670-2675.2000
   REDMAN KL, 1989, NATURE, V338, P438, DOI 10.1038/338438a0
   Roccaro AM, 2006, CURR PHARM BIOTECHNO, V7, P441, DOI 10.2174/138920106779116865
   Ryu KY, 2006, ANAL BIOCHEM, V353, P153, DOI 10.1016/j.ab.2006.03.038
   Schorpp M, 1996, NUCLEIC ACIDS RES, V24, P1787, DOI 10.1093/nar/24.9.1787
   Sherlock G, 2001, NUCLEIC ACIDS RES, V29, P152, DOI 10.1093/nar/29.1.152
   Takada K, 1996, BBA-GEN SUBJECTS, V1290, P282, DOI 10.1016/0304-4165(96)00032-3
   Teicher BA, 1999, CLIN CANCER RES, V5, P2638
   WIBORG O, 1985, EMBO J, V4, P755, DOI 10.1002/j.1460-2075.1985.tb03693.x
   Wilkinson KD, 1997, FASEB J, V11, P1245, DOI 10.1096/fasebj.11.14.9409543
   Zaret K, 1998, CURR OPIN GENET DEV, V8, P526, DOI 10.1016/S0959-437X(98)80006-3
NR 38
TC 124
Z9 145
U1 0
U2 8
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA
SN 0261-4189
J9 EMBO J
JI Embo J.
PD JUN 6
PY 2007
VL 26
IS 11
BP 2693
EP 2706
DI 10.1038/sj.emboj.7601722
PG 14
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA 176KO
UT WOS:000247084100008
PM 17491588
OA Green Published
DA 2024-02-19
ER

PT J
AU Bourre, JM
   Piciotti, M
AF Bourre, JM
   Piciotti, M
TI Alterations in eighteen-carbon saturated, monounsaturated and
   polyunsaturated fatty acid peroxisomal oxidation in mouse brain during
   development and aging.
SO BIOCHEMISTRY AND MOLECULAR BIOLOGY INTERNATIONAL
LA English
DT Article
ID RAT-LIVER PEROXISOMES; BETA-OXIDATION; LIGNOCERIC ACID; MITOCHONDRIAL;
   INHIBITION; DIETS
AB Peroxisomal oxidation was measured in mouse brain homogenate by adding cyanide to the test tube (which inhibits mitochondrial oxidation). Eighteen-carbon fatty acids (saturated, monounsaturated and polyunsaturated) were oxidized by brain peroxisomes. At nearly all ages, oxidation of oleic acid was higher (about 2 fold) than oxidation of other eighteen-carbon fatty acids. In contrast to other fatty acids, stearic acid oxidation decreased regularly up to weaning (6 fold) and was stable thereafter. Oleic acid oxidation increased up to weaning, decreased during development up to day 70 and remained subsequently nearly stable. Linoleic acid and alpha-linolenic acid oxidation increased up to weaning, decreased up to day 105 and was nearly stable thereafter. Alpha-linolenic acid oxidation about was two fold lower than linoleic acid oxidation. Interestingly, peroxisomal oxidation for all fatty acids examined declined during aging, between day 365 and day 450.
RP Bourre, JM (corresponding author), HOP FERNAND WIDAL,INSERM,U26,200 RUE FAUBOURG ST DENIS,F-75475 PARIS 10,FRANCE.
CR ALEXSON SEH, 1984, BIOCHIM BIOPHYS ACTA, V796, P1, DOI 10.1016/0005-2760(84)90231-5
   BUARD A, 1992, NEUROSCI LETT, V141, P72, DOI 10.1016/0304-3940(92)90337-7
   CIMINI AM, 1993, NEUROCHEM INT, V23, P249, DOI 10.1016/0197-0186(93)90116-M
   CLOUET P, 1989, BIOCHEM J, V263, P867, DOI 10.1042/bj2630867
   GRONN M, 1991, BIOCHIM BIOPHYS ACTA, V1081, P85, DOI 10.1016/0005-2760(91)90254-F
   HILTUNEN JK, 1986, J BIOL CHEM, V261, P6484
   KAINU T, 1994, NEUROREPORT, V5, P2481, DOI 10.1097/00001756-199412000-00019
   LAZAROW PB, 1987, J INHERIT METAB DIS, V1, P11
   LAZO O, 1991, J NEUROCHEM, V56, P1343, DOI 10.1111/j.1471-4159.1991.tb11431.x
   MARTINEZ M, 1994, LIPIDS, V29, P273, DOI 10.1007/BF02536332
   Molzer Brunhilde, 1993, Paediatrie und Paedologie, V28, P43
   NEAT CE, 1980, BIOCHEM J, V186, P369, DOI 10.1042/bj1860369
   NEAT CE, 1981, BIOCHEM J, V196, P149, DOI 10.1042/bj1960149
   OSMUNDSEN H, 1991, BIOCHIM BIOPHYS ACTA, V1085, P141, DOI 10.1016/0005-2760(91)90089-Z
   PERICHON R, 1995, BIOCHIMIE, V77, P288, DOI 10.1016/0300-9084(96)88138-7
   Perichon R, 1995, BIOCHEM MOL BIOL INT, V37, P475
   REUBSAET FAG, 1989, LIPIDS, V24, P945, DOI 10.1007/BF02544539
   SINGH H, 1989, J NEUROCHEM, V53, P1711, DOI 10.1111/j.1471-4159.1989.tb09235.x
   SINGH I, 1983, J LIPID RES, V24, P662
   SINGH RP, 1986, NEUROCHEM RES, V11, P281, DOI 10.1007/BF00967975
   TAYARANI I, 1989, J NEUROCHEM, V53, P817, DOI 10.1111/j.1471-4159.1989.tb11778.x
   VANDENBRANDEN C, 1990, GLIA, V3, P458, DOI 10.1002/glia.440030604
   VANDENBRANDEN C, 1989, GLIA, V2, P260, DOI 10.1002/glia.440020407
   WANDERS RJ, 1993, PEROXISOMES BIOL IMP
   WANDERS RJA, 1986, CLIN CHIM ACTA, V159, P1, DOI 10.1016/0009-8981(86)90160-9
   WANDERS RJA, 1987, BIOCHIM BIOPHYS ACTA, V919, P21, DOI 10.1016/0005-2760(87)90213-X
NR 26
TC 6
Z9 6
U1 0
U2 1
PU ACADEMIC PRESS AUST
PI MARRICKVILLE
PA LOCKED BAG 16, MARRICKVILLE NSW 2204, AUSTRALIA
SN 1039-9712
J9 BIOCHEM MOL BIOL INT
JI Biochem. Mol. Biol. Int.
PD MAR
PY 1997
VL 41
IS 3
BP 461
EP 468
PG 8
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA WQ348
UT WOS:A1997WQ34800004
PM 9090453
DA 2024-02-19
ER

PT J
AU Mosca, N
   Khoubai, FZ
   Fedou, S
   Carrillo-Reixach, J
   Caruso, S
   Del Rio-Alvarez, A
   Dubois, E
   Avignon, C
   Dugot-Senant, N
   Guettier, C
   Mussini, C
   Zucman-Rossi, J
   Armengol, C
   Thiébaud, P
   Veschambre, P
   Grosset, CF
AF Mosca, Nicola
   Khoubai, Fatma Zohra
   Fedou, Sandrine
   Carrillo-Reixach, Juan
   Caruso, Stefano
   Del Rio-Alvarez, Alvaro
   Dubois, Emeric
   Avignon, Christophe
   Dugot-Senant, Nathalie
   Guettier, Catherine
   Mussini, Charlotte
   Zucman-Rossi, Jessica
   Armengol, Carolina
   Thiebaud, Pierre
   Veschambre, Philippe
   Grosset, Christophe Francois
TI LIM Homeobox-2 Suppresses Hallmarks of Adult and Pediatric Liver Cancers
   by Inactivating MAPK/ERK and Wnt/Beta-Catenin Pathways
SO LIVER CANCER
LA English
DT Article
DE Hepatocellular carcinoma; Hepatoblastoma; LHX2; Wnt pathway; MAPK; ERK
   pathway
ID HEPATOCELLULAR-CARCINOMA; BETA-CATENIN; TRANSCRIPTION FACTORS;
   CELL-PROLIFERATION; TUMOR-GROWTH; HEPATOBLASTOMA; LHX2; GENE;
   ACTIVATION; MUTATIONS
AB Introduction: Hepatocellular carcinoma and hepatoblastoma are two liver cancers characterized by gene deregulations, chromosomal rearrangements, and mutations in Wnt/beta-catenin (Wnt) pathway-related genes. LHX2, a transcriptional factor member of the LIM homeobox gene family, has important functions in embryogenesis and liver development. LHX2 is oncogenic in many solid tumors and leukemia, but its role in liver cancer is unknown. Methods: We analyzed the expression of LHX2 in hepatocellular carcinoma and hepatoblastoma samples using various transcriptomic datasets and biological samples. The role of LHX2 was studied using lentiviral transduction, in vitro cell-based assays (growth, migration, senescence, and apoptosis), molecular approaches (phosphokinase arrays and RNA-seq), bioinformatics, and two in vivo models in chicken and Xenopus embryos. Results: We found a strong connection between LHX2 downregulation and Wnt activation in these two liver cancers. In hepatoblastoma, LHX2 downregulation correlated with multiple poor outcome parameters including higher patient age, intermediate- and high-risk tumors, and low patient survival. Forced expression of LHX2 reduced the proliferation, migration, and survival of liver cancer cells in vitro through the inactivation of MAPK/ERK and Wnt signals. In vivo, LHX2 impeded the development of tumors in chick embryos and repressed the Wnt pathway in Xenopus embryos. RNA-sequencing data and bioinformatic analyses confirmed the deregulation of many biological functions and molecular processes associated with cell migration, cell survival, and liver carcinogenesis in LHX2-expressing hepatoma cells. At a mechanistic level, LHX2 mediated the disassembling of beta-catenin/T-cell factor 4 complex and induced expression of multiple inhibitors of Wnt (e.g., TLE/Groucho) and MAPK/ERK (e.g., DUSPs) pathways. Conclusion: Collectively, our findings demonstrate a tumor suppressive function of LHX2 in adult and pediatric liver cancers.
C1 [Mosca, Nicola; Khoubai, Fatma Zohra; Fedou, Sandrine; Thiebaud, Pierre; Veschambre, Philippe; Grosset, Christophe Francois] Univ Bordeaux, MIRCADE Team, Inserm,U1035, BMGIC,Biotherapy Genet Dis Inflammatory Disorders, Bordeaux, France.
   [Fedou, Sandrine; Thiebaud, Pierre] Univ Bordeaux, XenoFish, Inserm,Bmgic,U1035, Biotherapy Genet Dis Inflammatory Disorders & Can, Bordeaux, France.
   [Carrillo-Reixach, Juan; Del Rio-Alvarez, Alvaro; Armengol, Carolina] Germans Trias & Pujol Res Inst IGTP, Childhood Liver Oncol Grp, Program Predict & Personalized Med Canc PMPPC, Badalona, Spain.
   [Carrillo-Reixach, Juan; Armengol, Carolina] CIBER, Hepat & Digest Dis, Barcelona, Spain.
   [Caruso, Stefano; Zucman-Rossi, Jessica] Univ Paris, Sorbonne Univ, Ctr Rech Cordeliers, INSERM,Funct Genom Solid Tumors Lab, Paris, France.
   [Dubois, Emeric] Univ Montpellier, INSERM, CNRS, Montpellier GenomiX, Montpellier, France.
   [Avignon, Christophe; Guettier, Catherine; Mussini, Charlotte] Univ Paris Saclay, Bicetre Univ Hosp, AP HP, Dept Pathol, Le Kremlin Bicetre, France.
   [Dugot-Senant, Nathalie] Plateforme Histopathol Inserm, US UMS3427 TBMCore 005, Bordeaux, France.
   [Zucman-Rossi, Jessica] Hop Europesen Georges Pompidou, AP HP, Paris, France.
C3 Institut National de la Sante et de la Recherche Medicale (Inserm);
   Universite de Bordeaux; Universite de Bordeaux; Institut National de la
   Sante et de la Recherche Medicale (Inserm); Fundacio Institut
   d'Investigacio en Ciencies de la Salut Germans Trias i Pujol (IGTP);
   CIBER - Centro de Investigacion Biomedica en Red; Sorbonne Universite;
   Institut National de la Sante et de la Recherche Medicale (Inserm);
   Universite Paris Cite; Universite de Montpellier; Centre National de la
   Recherche Scientifique (CNRS); Institut National de la Sante et de la
   Recherche Medicale (Inserm); Universite Paris Saclay; Assistance
   Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital
   Universitaire Hotel-Dieu - APHP; Hopital Universitaire Bicetre - APHP;
   Hopital Universitaire Paul-Brousse - APHP; Assistance Publique Hopitaux
   Paris (APHP); Universite Paris Cite; Hopital Universitaire Hotel-Dieu -
   APHP; Hopital Universitaire Paul-Brousse - APHP
RP Grosset, CF (corresponding author), Univ Bordeaux, MIRCADE Team, Inserm,U1035, BMGIC,Biotherapy Genet Dis Inflammatory Disorders, Bordeaux, France.
EM christophe.grosset@inserm.fr
RI zucman-rossi, Jessica/B-5098-2009; Grosset, Christophe/I-5059-2016;
   Caruso, Stefano/AAA-9564-2020
OI zucman-rossi, Jessica/0000-0002-5687-0334; Grosset,
   Christophe/0000-0002-0479-6291; Caruso, Stefano/0000-0002-6319-3642;
   Dubois, Emeric/0000-0002-6052-4178; MOSCA, Nicola/0000-0003-0405-3807;
   KHOUBAI, Fatma Zohra/0000-0001-9988-2856; del Rio Alvarez,
   Alvaro/0000-0003-2338-0782; Carrillo Reixach, Juan/0000-0002-8538-8264
FU "Investments for the future" Programme IdEx Bordeaux
   [ANR-10-IDEX-03-02]; Fondation Groupama pour la Sante; Groupama
   Centre-Atlantique; la Ligue Nationale contre le Cancer; Region
   Nouvelle-Aquitaine [2018-1R30114]; France Genomique National program as
   part of the "Investissement d'Avenir" program [ANR-10-INBS-09]; National
   du Cancer (INCa) [2020-012]; SFCE; Etoile de Martin; FES; Hubert;
   INSERM; HTE (Cancer plan); Ligue Nationale contre le Cancer (Equipe
   Labellisee); Labex OncoImmunology (investissement d'avenir); IREB grant;
   Coup d'Elan de la Fondation Bettencourt-Schueller; SIRIC CARPEM; FRM
   Rosen award; Ligue Contre le Cancer Comite de Paris (Rene et Andre
   Duquesne award); Fondation Merieux; Labex OncoImunology; CARPEM; Catalan
   Agency for the Management of University and Research Grants (AGAUR)
   [2019 FI_ B01024]; Instituto de Salud Carlos III [PI10/02082,
   PI13/02340]; European Union [668596]; CIBERehd [CB06/04/0033]; AGAUR
   [2017SGR-490]; Spanish Ministry of Science and Innovation
   [RYC-2010-07249]; H2020 Societal Challenges Programme [668596] Funding
   Source: H2020 Societal Challenges Programme
FX This study was supported by grants to N.M., F.Z.K., and C.F.G. from the
   French State in the framework of the "Investments for the future"
   Programme IdEx Bordeaux (Grant ANR-10-IDEX-03-02), the Fondation
   Groupama pour la Sante, Groupama Centre-Atlantique, la Ligue Nationale
   contre le Cancer, and the Region Nouvelle-Aquitaine (No. 2018-1R30114).
   N.M., C.F.G., and MIRCADE team also received donations from the
   following charities: Aidons Marina, E.S.CA.P.E., Eva pour la Vie, Les
   Recoltes de l'Espoir, and Spheres. Montpellier GenomiX acknowledges
   financial support from the France Genomique National program, funded as
   part of the "Investissement d'Avenir" program managed by the Agence
   Nationale pour la Recherche (contract ANR-10-INBS-09). The teams of
   J.Z.-R. and C.F.G. were funded by the National du Cancer (INCa) in the
   framework of the PELICAN.resist projects (N degrees 2020-012). The team
   of J.Z.-R. was also funded by SFCE, Etoile de Martin, FES, Hubert,
   INSERM with the HTE (Cancer plan), Ligue Nationale contre le Cancer
   (Equipe Labellisee), Labex OncoImmunology (investissement d'avenir), the
   IREB grant, Coup d'Elan de la Fondation Bettencourt-Schueller, the SIRIC
   CARPEM, FRM Rosen award, Ligue Contre le Cancer Comite de Paris (Rene et
   Andre Duquesne award), and Fondation Merieux. S.C. received funding from
   Labex OncoImunology and CARPEM. J.C.-R. was funded by the Catalan Agency
   for the Man-agement of University and Research Grants (AGAUR, 2019 FI_
   B01024). C.A. received funding from Instituto de Salud Carlos III
   (PI10/02082, PI13/02340), the European Union's Horizon 2020 research and
   innovation program under grant agreement No. 668596 (ChiLTERN), CIBERehd
   (CB06/04/0033), AGAUR (2017SGR-490), and the Ramon y Cajal
   (RYC-2010-07249) program of the Spanish Ministry of Science and
   Innovation.
CR Bayard Q, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07552-9
   Boyault S, 2007, HEPATOLOGY, V45, P42, DOI 10.1002/hep.21467
   Buendia MA, 2014, J HEPATOL, V61, P1202, DOI 10.1016/j.jhep.2014.09.016
   Cairo S, 2008, CANCER CELL, V14, P471, DOI 10.1016/j.ccr.2008.11.002
   Carrillo-Reixach J, 2020, J HEPATOL, V73, P328, DOI 10.1016/j.jhep.2020.03.025
   Coker EA, 2019, NUCLEIC ACIDS RES, V47, pD917, DOI 10.1093/nar/gky1129
   Cusimano A, 2007, CANCER BIOL THER, V6, P1461
   de La Coste A, 1998, P NATL ACAD SCI USA, V95, P8847
   Doucet-Beaupré H, 2015, FEBS LETT, V589, P3727, DOI 10.1016/j.febslet.2015.10.020
   Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207
   Eichenmüller M, 2014, J HEPATOL, V61, P1312, DOI [10.1016/j.jhep.2014.08.009, 10.1016/j.jhep.2014.09.016]
   Eicher C, 2013, BRIT J CANCER, V108, P334, DOI 10.1038/bjc.2012.539
   Genz B, 2014, EXP CELL RES, V328, P429, DOI 10.1016/j.yexcr.2014.06.019
   Ghousein A, 2020, LIVER INT, V40, P240, DOI 10.1111/liv.14276
   Hirsch TZ, 2020, J HEPATOL, V72, P924, DOI 10.1016/j.jhep.2019.12.006
   Hiyama E., 2019, GENE EXPRESSION PROF
   Hooks KB, 2018, HEPATOLOGY, V68, P89, DOI 10.1002/hep.29672
   Hsu LCL, 2015, P NATL ACAD SCI USA, V112, P12199, DOI 10.1073/pnas.1507145112
   Huang CY, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-24
   Indersie Emilie, 2018, Oncotarget, V9, P16149, DOI 10.18632/oncotarget.24598
   Indersie E, 2017, HEPATOL COMMUN, V1, P168, DOI 10.1002/hep4.1029
   Kolterud Å, 2004, GENE EXPR PATTERNS, V4, P521, DOI 10.1016/j.modgep.2004.03.001
   Kuzmanov A, 2014, MOL ONCOL, V8, P401, DOI 10.1016/j.molonc.2013.12.009
   Liang TS, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1023-4
   Llovet JM, 2016, NAT REV DIS PRIMERS, V2, DOI [10.1038/nrdp.2016.18, 10.1038/nrdp.2016.19]
   Llovet JM, 2015, NAT REV CLIN ONCOL, V12, P408, DOI [10.1038/nrclinonc.2015.103, 10.1038/nrclinonc.2015.121]
   Malarkey DE, 2013, HASCHEK AND ROUSSEAUX'S HANDBOOK OF TOXICOLOGIC PATHOLOGY, VOL 1-3, 3RD EDITION, P107, DOI 10.1016/B978-0-12-415759-0.00005-4
   Meyers RL, 2017, LANCET ONCOL, V18, P122, DOI 10.1016/S1470-2045(16)30598-8
   Miyashita K, 2018, BIOCHEM BIOPH RES CO, V495, P2310, DOI 10.1016/j.bbrc.2017.12.135
   Nathalia E, 2018, ROM J INTERN MED, V56, P135, DOI 10.2478/rjim-2018-0008
   Pez F, 2013, J HEPATOL, V59, P1107, DOI 10.1016/j.jhep.2013.07.001
   Porter FD, 1997, DEVELOPMENT, V124, P2935
   Ramakrishnan AB, 2018, BIOESSAYS, V40, DOI 10.1002/bies.201700162
   Rauscher GH, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1777-9
   Rebouissou S, 2016, HEPATOLOGY, V64, P2047, DOI 10.1002/hep.28638
   Shi XG, 2015, ONCOTARGET, V6, P19043, DOI 10.18632/oncotarget.4232
   Sumazin P, 2017, HEPATOLOGY, V65, P104, DOI 10.1002/hep.28888
   Valanejad L, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0077-8
   von Schweinitz D, 2012, SEMIN PEDIATR SURG, V21, P21, DOI 10.1053/j.sempedsurg.2011.10.011
   Wandzioch E, 2004, P NATL ACAD SCI USA, V101, P16549, DOI 10.1073/pnas.0404678101
   Wang HW, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-736
   Wang X, 2014, ONCOL REP, V31, P1975, DOI 10.3892/or.2014.3112
   Wu HK, 1997, BIOCHEM BIOPH RES CO, V234, P742, DOI 10.1006/bbrc.1997.6592
   Zhang KL, 2015, CANCER LETT, V357, P404, DOI 10.1016/j.canlet.2014.11.047
   Zhang SW, 2014, DEVELOPMENT, V141, P4794, DOI 10.1242/dev.115691
   Zhou F, 2014, MOL BIOL REP, V41, P8163, DOI 10.1007/s11033-014-3716-2
NR 46
TC 3
Z9 3
U1 1
U2 11
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 2235-1795
EI 1664-5553
J9 LIVER CANCER
JI Liver Cancer
PD APR
PY 2022
VL 11
IS 2
BP 126
EP 140
DI 10.1159/000521595
PG 15
WC Oncology; Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Gastroenterology & Hepatology
GA 0Z0RZ
UT WOS:000790789600004
PM 35634422
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Lai, HC
   Chien, WC
   Chung, CH
   Lee, WL
   Wu, TJ
   Wang, KY
   Liu, CN
   Liu, TJ
AF Lai, Hui-Chin
   Chien, Wu-Chien
   Chung, Chi-Hsiang
   Lee, Wen-Lieng
   Wu, Tsu-Juey
   Wang, Kuo-Yang
   Liu, Chia-Ning
   Liu, Tsun-Jui
TI Atrial fibrillation, liver disease, antithrombotics and risk of
   cerebrovascular events: A population-based cohort study
SO INTERNATIONAL JOURNAL OF CARDIOLOGY
LA English
DT Article
DE Atrial fibrillation; Liver; Cerebrovascular; Stroke; Antithrombotic;
   CHA2DS2-VASc
ID CHA2DS2-VASC SCORE; STROKE; HYPERCOAGULATION; THROMBOPHILIA;
   THROMBOEMBOLISM; COAGULOPATHY; VALIDATION; MECHANISMS; PREVENTION;
   MANAGEMENT
AB Background: Whether patients with atrial fibrillation (AF) and liver disease are also prone to cerebrovascular events and respond similarly favorably to antithrombotic therapy remains under-investigated.
   Methods: Patients >= 18 years with newly-diagnosed AF in the period 2005 to 2009 were scrutinized from the "Longitudinal Health Insurance Database 2005" (1 million beneficiaries) of Taiwan's National Health Insurance Institute. Patients were categorized into the Liver (N = 433) or the Non-liver (N = 3490) cohort according to whether they had a diagnosis of advanced liver disease. Patientswere then followed to determine cumulative incidence of hospitalization-requiring cerebrovascular events, preventive effects of antithrombotics, and predictors of cerebrovascular events by Cox regression analysis.
   Results: Within amean follow-up of 3.3 +/- 1.4 years, ischemic stroke (89.2 vs. 50.3 per 1000 person-years, adjusted HR 1.502, 95% CI 1.207-1.868, p < 0.001) and overall cerebrovascular events (102.3 vs. 56.4 per 1000 person years, adjusted HR 1.535, 95% CI 1.251-1.883, p < 0.001) occurred significantly more often in the Liver than in the Non-liver cohort. Coxmodels identified aging (>= 65 years), DM, and CHA2DS-VASc score >= 2 points as risk factors for overall cerebrovascular events in the Liver cohort, whereas antiplatelet agents (HR 0.932, 95% CI 0.128-6.803, p = NS) and vit-K antagonistic anticoagulants (HR 1.087, 95% CI 0.150-7.862, p = NS) showed no correlation.
   Conclusion: AF patients comorbidwith advanced liver disease aremore vulnerable to ischemic and therein overall cerebrovascular events, especially in those with old age, DM, or high CHA2DS-VASc scores. This propensity to cerebrovascular events, however, can't be altered by antithrombotic therapy. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
C1 [Lai, Hui-Chin; Lee, Wen-Lieng; Wu, Tsu-Juey; Wang, Kuo-Yang; Liu, Tsun-Jui] Taichung Vet Gen Hosp, Cardiovasc Ctr, 1650,Sec 4,Taiwan Blvd, Taichung 40705, Taiwan.
   [Lai, Hui-Chin; Lee, Wen-Lieng; Wu, Tsu-Juey; Wang, Kuo-Yang; Liu, Tsun-Jui] Taichung Vet Gen Hosp, Dept Anesthesiol, Taichung, Taiwan.
   [Lai, Hui-Chin; Lee, Wen-Lieng; Wu, Tsu-Juey; Liu, Chia-Ning; Liu, Tsun-Jui] Natl Yang Ming Univ, Sch Med, Dept Med, Taipei, Taiwan.
   [Lai, Hui-Chin; Lee, Wen-Lieng; Wu, Tsu-Juey; Liu, Chia-Ning; Liu, Tsun-Jui] Natl Yang Ming Univ, Sch Med, Dept Surg, Taipei, Taiwan.
   [Chien, Wu-Chien] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan.
   [Chien, Wu-Chien] Natl Def Med Ctr, Dept Med Res, Triserv Gen Hosp, Taipei, Taiwan.
   [Chung, Chi-Hsiang] Taiwanese Injury Prevent & Safety Promot Assoc, Taipei, Taiwan.
   [Wang, Kuo-Yang] Chung Shan Med Univ, Dept Med, Sch Med, Taichung, Taiwan.
   [Liu, Tsun-Jui] China Med Univ, Taichung, Taiwan.
C3 Taichung Veterans General Hospital; Taichung Veterans General Hospital;
   National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung
   University; National Defense Medical Center; National Defense Medical
   Center; Tri-Service General Hospital; Chung Shan Medical University;
   China Medical University Taiwan
RP Liu, TJ (corresponding author), Taichung Vet Gen Hosp, Cardiovasc Ctr, 1650,Sec 4,Taiwan Blvd, Taichung 40705, Taiwan.
EM trliu@vghtc.gov.tw
RI Chung, Chi-Hsiang/AAY-3386-2021
OI Lai, Hui-Chin/0000-0002-0077-9881
CR Alonso A, 2014, HEART, V100, P1511, DOI 10.1136/heartjnl-2014-305756
   Basili S, 2010, EUR J INTERN MED, V21, P62, DOI 10.1016/j.ejim.2010.01.005
   BICK RL, 1992, SEMIN THROMB HEMOST, V18, P353, DOI 10.1055/s-2007-1002575
   CAIRNS JA, 1991, CIRCULATION, V84, P469, DOI 10.1161/01.CIR.84.2.469
   Chen CY, 2012, PHARMACOEPIDEM DR S, V21, P1334, DOI 10.1002/pds.3359
   Chen D S, 1995, Princess Takamatsu Symp, V25, P27
   CHEN DS, 1978, ACTA HEPATO-GASTRO, V25, P423
   Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087
   Dabbagh O, 2010, CHEST, V137, P1145, DOI 10.1378/chest.09-2177
   Dammacco F, 2013, CLIN EXP MED, V13, P85, DOI 10.1007/s10238-013-0230-0
   Davenport A, 2001, CARDIOLOGY, V96, P190, DOI 10.1159/000047403
   De Feo P, 2002, CURR OPIN CLIN NUTR, V5, P47, DOI 10.1097/00075197-200201000-00009
   Hoteit MA, 2008, WORLD J GASTROENTERO, V14, P1774, DOI 10.3748/wjg.14.1774
   Hsu CS, 2012, J FORMOS MED ASSOC, V111, P527, DOI 10.1016/j.jfma.2012.07.002
   Ichida F, 1977, Nihon Rinsho, V35 Suppl 1, P906
   January CT, 2014, CIRCULATION, V130, pE270, DOI [10.1161/CIR.0000000000000142, 10.1161/CIR.0000000000000041, 10.1016/j.jacc.2014.03.022]
   Lai HC, 2015, EUR J INTERN MED, V26, P798, DOI 10.1016/j.ejim.2015.10.002
   Lai HC, 2015, INT J CARDIOL, V197, P133, DOI 10.1016/j.ijcard.2015.06.056
   Lai HC, 2014, INT J CARDIOL, V177, P964, DOI 10.1016/j.ijcard.2014.09.190
   Lee SJ, 2015, INT J CARDIOL, V180, P185, DOI 10.1016/j.ijcard.2014.11.183
   Lip GYH, 2011, J AM COLL CARDIOL, V57, P173, DOI 10.1016/j.jacc.2010.09.024
   Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584
   Macle L, 2015, CAN J CARDIOL, V31, P1207, DOI 10.1016/j.cjca.2015.06.005
   Muszkat M, 2007, CLIN THER, V29, P427, DOI 10.1016/S0149-2918(07)80081-6
   Northup PG, 2008, J THROMB HAEMOST, V6, P2
   Northup PG, 2012, SEMIN LIVER DIS, V32, P39, DOI 10.1055/s-0032-1306425
   Northup PG, 2009, CLIN LIVER DIS, V13, P109, DOI 10.1016/j.cld.2008.09.003
   Papatheodoridis GV, 2003, GUT, V52, P404, DOI 10.1136/gut.52.3.404
   Patel NJ, 2014, CIRCULATION, V129, P2371, DOI 10.1161/CIRCULATIONAHA.114.008201
   Plompen EPC, 2013, HEPATOL INT, V7, P369, DOI 10.1007/s12072-013-9427-2
   RITLAND S, 1973, SCAND J GASTROENTERO, V8, P113
   Targher G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057183
   Targher G, 2013, SEMIN THROMB HEMOST, V39, P214, DOI 10.1055/s-0033-1334866
   Targher G, 2009, SEMIN THROMB HEMOST, V35, P277, DOI 10.1055/s-0029-1222606
   Tripodi A, 2011, NEW ENGL J MED, V365, P147, DOI 10.1056/NEJMra1011170
   WalshMcMonagle D, 1997, CANCER-AM CANCER SOC, V80, P649, DOI 10.1002/(SICI)1097-0142(19970815)80:4<649::AID-CNCR1>3.0.CO;2-I
   Wang YS, 2014, THER ADV DRUG SAF, V5, P21, DOI 10.1177/2042098613506592
   Yuri T, 2014, CASE REP ONCOL, V7, P376, DOI 10.1159/000363689
   Zocco MA, 2009, J HEPATOL, V51, P682, DOI 10.1016/j.jhep.2009.03.013
NR 39
TC 14
Z9 15
U1 0
U2 2
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0167-5273
EI 1874-1754
J9 INT J CARDIOL
JI Int. J. Cardiol.
PD NOV 15
PY 2016
VL 223
BP 829
EP 837
DI 10.1016/j.ijcard.2016.08.297
PG 9
WC Cardiac & Cardiovascular Systems
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology
GA EB0LV
UT WOS:000387036200220
PM 27580216
DA 2024-02-19
ER

PT J
AU Rao, ZJ
   Landry, T
   Li, PX
   Bunner, W
   Laing, BT
   Yuan, Y
   Huang, H
AF Rao, Zhijian
   Landry, Taylor
   Li, Peixin
   Bunner, Wyatt
   Laing, Brenton Thomas
   Yuan, Yuan
   Huang, Hu
TI Administration of alpha klotho reduces liver and adipose lipid
   accumulation in obese mice
SO HELIYON
LA English
DT Article
DE Molecular biology; Physiology
AB alpha-Klotho, a known anti-aging protein, exerts diverse physiological effects including: maintenance of phosphate and calcium homeostasis, modulation of cell proliferation, and enhanced buffering of reactive oxygen species. However, the role of alpha-Klotho in the regulation of energy metabolism is complex and poorly understood. Here we investigated the effects of 5 weeks peripheral administration of alpha-Klotho in high fat diet induced obese mice. Food intake, blood glucose, and body weight were measured daily. Energy expenditure was determined with indirect calorimetry and body composition with magnetic resonance imaging. Liver and adipose tissue were collected for lipid content measurements and gene expression analysis. alpha-Klotho-treated mice experienced reduced adiposity, increased lean mass, and elevated energy expenditure, despite no changes in food intake, body weight, or fed blood glucose levels. Lipid accumulation in liver and adipose tissue was also reduced compared to controls. Furthermore, Real-time quantitative PCR showed reduced expression of key lipogenic genes in alpha-Klotho treated mice in these organs. Taken together, these data suggest encouraging therapeutic potential of alpha-Klotho and highlight a need for further research into the specific mechanisms explaining improved body composition, elevated energy expenditure, and reduced lipid content in both liver and adipose tissue in alpha-Klotho-treated mice.
C1 [Rao, Zhijian; Landry, Taylor; Li, Peixin; Bunner, Wyatt; Laing, Brenton Thomas; Yuan, Yuan; Huang, Hu] East Carolina Univ, East Carolina Diabet & Obes Inst, Greenville, NC 27858 USA.
   [Rao, Zhijian; Landry, Taylor; Li, Peixin; Bunner, Wyatt; Laing, Brenton Thomas; Yuan, Yuan; Huang, Hu] East Carolina Univ, Coll Hlth & Human Performance, Human Performance Lab, Greenville, NC 27858 USA.
   [Rao, Zhijian; Landry, Taylor; Li, Peixin; Bunner, Wyatt; Laing, Brenton Thomas; Yuan, Yuan; Huang, Hu] East Carolina Univ, Dept Kinesiol, Greenville, NC 27858 USA.
   [Huang, Hu] East Carolina Univ, Dept Physiol, Greenville, NC 27858 USA.
   [Rao, Zhijian] China Inst Sport Sci, Sport Hlth & Rehabil Ctr, Beijing, Peoples R China.
C3 University of North Carolina; East Carolina University; University of
   North Carolina; East Carolina University; University of North Carolina;
   East Carolina University; University of North Carolina; East Carolina
   University
RP Huang, H (corresponding author), East Carolina Univ, East Carolina Diabet & Obes Inst, Greenville, NC 27858 USA.; Huang, H (corresponding author), East Carolina Univ, Coll Hlth & Human Performance, Human Performance Lab, Greenville, NC 27858 USA.; Huang, H (corresponding author), East Carolina Univ, Dept Kinesiol, Greenville, NC 27858 USA.; Huang, H (corresponding author), East Carolina Univ, Dept Physiol, Greenville, NC 27858 USA.
EM huangh@ecu.edu
OI Li, Peixin/0000-0002-3353-6448; Bunner, Wyatt/0000-0001-7590-5312;
   Landry, Taylor/0000-0002-5267-6585
FU East Carolina University
FX This work was supported by start-up funds from East Carolina University
   to H. Huang.
CR Chen CD, 2007, P NATL ACAD SCI USA, V104, P19796, DOI 10.1073/pnas.0709805104
   Do K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190205
   Foltz IN, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004690
   Pardridge William M, 2005, NeuroRx, V2, P3
   Smith GR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011092
   2005, SCIENCE, V309, P1829, DOI DOI 10.1126/SCIENCE.1112766
   2005, J BIOL CHEM, V280, P3802, DOI DOI 10.1074/JBC.M509039200
   2016, DEVELOPMENT, V143, P3050, DOI DOI 10.1242/DEV.137075
   2018, NATURE, V553, P461, DOI DOI 10.1038/NATURE25451
   2014, ANAL BIOCHEM, V445, P87, DOI DOI 10.1016/J.AB.2013.10.001
   2006, EUR J CELL BIOL, V85, P367, DOI DOI 10.1016/J.EJCB.2005.11.005
   2003, SCIENCE, V299, P572
   2010, KIDNEY INT, V77, P855, DOI DOI 10.1038/KI.2010.73
   2015, DIABETES, V64, P4298, DOI DOI 10.2337/DB15-0066
   2006, J BIOL CHEM, V281, P6120, DOI DOI 10.1074/JBC.C500457200
   2010, AGING DIS, V1, P147
   2006, ENDOCRINOLOGY, V147, P3835, DOI DOI 10.1210/EN.2005-1529
   BIOCH BIOPHYS RES CO, V278, P665
   2008, ONCOGENE, V27, P7094, DOI DOI 10.1038/ONC.2008.292
   2007, J CELL BIOCHEM, V101, P1492, DOI DOI 10.1002/JCB.21265
   2014, J BIOL CHEM, V289, P2470, DOI DOI 10.1074/JBC.M114.567321
   2003, MOL ENDOCRINOL, V17, P2393, DOI DOI 10.1210/ME.2003-0048
   2003, ONCOGENE, V22, P4380, DOI DOI 10.1038/SJ.ONC.1206499
   2017, INT J CLIN EXP MED, V10, P4342
   1997, NATURE, V390, P45, DOI 10.1038/36285
   2013, NUTRITION, V29, P1106, DOI DOI 10.1016/J.NUT.2013.02.005
   2015, DIABETES, V64, P1444, DOI DOI 10.2337/DB14-0632
   2010, CANCER RES, V70, P4151, DOI DOI 10.1158/0008-5472.CAN-09-4479
   2007, SCIENCE, V317, P803, DOI DOI 10.1126/SCIENCE.1143578
   2012, ENDOCRINOLOGY, V153, P3029, DOI DOI 10.1210/EN.2012-1091
   NATURE, V404, P635
   2017, CELL REP, V20, P1360, DOI DOI 10.1016/J.CELREP.2017.07.024
   2009, DIABETES, V58, P250, DOI DOI 10.2337/DB08-0392
   2011, PFLUG ARCH EUR J PHY, V462, P185, DOI DOI 10.1007/S00424-011-0950-5
   2009, J BIOL CHEM, V284, P1218, DOI DOI 10.1074/JBC.M808915200
NR 35
TC 31
Z9 32
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
EI 2405-8440
J9 HELIYON
JI Heliyon
PD APR
PY 2019
VL 5
IS 4
AR e01494
DI 10.1016/j.heliyon.2019.e01494
PG 16
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA HW8VZ
UT WOS:000466970300034
PM 31049427
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Kook, SH
   Cheon, SR
   Kim, JH
   Choi, KC
   Kim, MK
   Lee, JC
AF Kook, Sung-Ho
   Cheon, Sa-Ra
   Kim, Jae-Hwan
   Choi, Ki-Choon
   Kim, Min-Kook
   Lee, Jeong-Chae
TI Dietary hydroxycinnamates prevent oxidative damages to liver, spleen,
   and bone marrow cells in irradiation-exposed mice
SO FOOD SCIENCE AND BIOTECHNOLOGY
LA English
DT Article
DE total body irradiation; reactive oxygen species; bone marrow;
   radioprotection; phenolic compounds
ID FERULIC ACID; PHENOLIC-ACID; DNA-DAMAGE; RADIATION; PROTECTS; GAMMA;
   RADIOPROTECTION; LYMPHOCYTES; MODEL
AB Dietary hydroxycinnamates are considered as attractive materials for radioprotection. This study explores whether hydroxycinnamates protect against gamma-radiation-induced cellular damages and hematopoietic stem cell senescence. C57BL/6 mice were orally administered with each of caffeic acid, p-coumaric acid, and ferulic acid (20mg/kg body weight) once per three days for five times before exposure to total body radiation (5 Gy). Irradiation increased the activities of alanine amino transaminase and aspartate aminotransferase in blood serum but decreased the anti-oxidant defense enzyme activities in the liver and spleen tissues. Oral administration of the compounds almost completely prevented irradiation-mediated changes in these enzyme activities. The hydroxycinnamates also inhibited the irradiation-mediated increases in the mitochondrial superoxide anions of Lin(-)Sca-1(+)c-Kit(+) (LSK) cells and CD150(+)CD48(-) LSK cells in the bone marrow. These results suggest that dietary hydroxycinnamates protect against irradiation-mediated oxidative damages of tissues and bone marrow progenitor cells.
C1 [Kook, Sung-Ho; Kim, Min-Kook; Lee, Jeong-Chae] Chonbuk Natl Univ, Inst Oral Biosci, Cluster Craniofacial Dev & Regenerat Res, Jeonju 54896, Jeonbuk, South Korea.
   [Kook, Sung-Ho; Kim, Min-Kook; Lee, Jeong-Chae] Chonbuk Natl Univ, Sch Dent, Jeonju 54896, Jeonbuk, South Korea.
   [Kook, Sung-Ho; Cheon, Sa-Ra; Lee, Jeong-Chae] Chonbuk Natl Univ, Dept Bioact Mat Sci, Jeonju 54896, Jeonbuk, South Korea.
   [Kook, Sung-Ho; Cheon, Sa-Ra; Lee, Jeong-Chae] Chonbuk Natl Univ, Res Ctr Bioact Mat, Jeonju 54896, Jeonbuk, South Korea.
   [Kim, Jae-Hwan] Chonnam Natl Univ, Dent Hosp, Kwangju 61186, South Korea.
   [Choi, Ki-Choon] Natl Inst Anim Sci, Grassland & Forages Res Ctr, Cheonan 31002, Chungnam, South Korea.
C3 Jeonbuk National University; Jeonbuk National University; Jeonbuk
   National University; Jeonbuk National University; Chonnam National
   University; National Institute of Animal Science, Republic of Korea
RP Lee, JC (corresponding author), Chonbuk Natl Univ, Inst Oral Biosci, Cluster Craniofacial Dev & Regenerat Res, Jeonju 54896, Jeonbuk, South Korea.; Lee, JC (corresponding author), Chonbuk Natl Univ, Sch Dent, Jeonju 54896, Jeonbuk, South Korea.; Lee, JC (corresponding author), Chonbuk Natl Univ, Dept Bioact Mat Sci, Jeonju 54896, Jeonbuk, South Korea.; Lee, JC (corresponding author), Chonbuk Natl Univ, Res Ctr Bioact Mat, Jeonju 54896, Jeonbuk, South Korea.
EM leejc88@jbnu.ac.kr
RI Soundharrajan, Ilavenil/ABD-6774-2021
OI Soundharrajan, Ilavenil/0000-0002-7854-5954; KIM, MIN
   GUK/0000-0002-1611-290X
FU RDA, Ministry of Agriculture and Forestry, Republic of Korea
   [PJ010903032015]; research funds for newly appointed professors at
   Chonbuk National University
FX This paper was supported by the research funds for newly appointed
   professors at Chonbuk National University in 2015. This work was also
   supported by a grant from the RDA, Ministry of Agriculture and Forestry,
   Republic of Korea (Grant No. PJ010903032015).
CR Arora R, 2005, PHYTOTHER RES, V19, P1, DOI 10.1002/ptr.1605
   Baliga MS, 2012, FOOD FUNCT, V3, P714, DOI 10.1039/c2fo10225k
   Chang JH, 2015, RADIAT RES, V183, P240, DOI 10.1667/RR13887.1
   Chua HL, 2012, HEALTH PHYS, V103, P356, DOI 10.1097/HP.0b013e3182666d6f
   Cinkilic N, 2013, FOOD CHEM TOXICOL, V53, P359, DOI 10.1016/j.fct.2012.12.008
   Das U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097599
   Hosseinimehr SJ, 2007, J RADIAT RES, V48, P63, DOI 10.1269/jrr.06032
   Hudson EA, 2000, CANCER EPIDEM BIOMAR, V9, P1163
   Islam MS, 2011, CURR TOP MED CHEM, V11, P1847
   Kang KA, 2006, J RADIAT RES, V47, P61, DOI 10.1269/jrr.47.61
   Kim KA, 2014, J CELL BIOCHEM, V115, P1877, DOI 10.1002/jcb.24857
   Kim SB, 2012, P NATL ACAD SCI USA, V109, pE2949, DOI 10.1073/pnas.1207718109
   Kim SS, 2005, REDOX REP, V10, P311, DOI 10.1179/135100005X83734
   King AD, 2010, EUR J RADIOL, V73, P629, DOI 10.1016/j.ejrad.2008.12.016
   Kovács E, 2002, MICRON, V33, P199, DOI 10.1016/S0968-4328(01)00012-9
   Ma ZC, 2011, INT J RADIAT BIOL, V87, P130, DOI 10.3109/09553002.2011.523510
   Masuda T, 2008, J PERS SOC PSYCHOL, V94, P365, DOI 10.1037/0022-3514.94.3.365
   Mathew S, 2006, CRIT REV MICROBIOL, V32, P115, DOI 10.1080/10408410600709628
   Nagiev E. R., 1994, Radiatsionnaya Biologiya Radioekologiya, V34, P639
   Piazzon A, 2012, J AGR FOOD CHEM, V60, P12312, DOI 10.1021/jf304076z
   Rana T, 2012, FREE RADICAL BIO MED, V53, P2298, DOI 10.1016/j.freeradbiomed.2012.10.536
   Scalbert A, 2000, J NUTR, V130, p2073S, DOI 10.1093/jn/130.8.2073S
   Schultze-Mosgau S, 2005, INT J RADIAT ONCOL, V61, P1189, DOI 10.1016/j.ijrobp.2004.12.008
   Shanthakumar J, 2012, EUR J PHARMACOL, V691, P268, DOI 10.1016/j.ejphar.2012.06.027
   Shao LJ, 2014, BLOOD, V123, P3105, DOI 10.1182/blood-2013-07-515619
   Shimoi K, 1996, MUTAT RES-FUND MOL M, V350, P153, DOI 10.1016/0027-5107(95)00116-6
   Singh PK, 2012, RADIAT RES, V177, P133, DOI 10.1667/RR2627.1
   Song IH, 2008, ARTHRITIS RHEUM-US, V58, P929, DOI 10.1002/art.23275
   Wang Y, 2006, BLOOD, V107, P358, DOI 10.1182/blood-2005-04-1418
   Weiss JF, 1997, ENVIRON HEALTH PERSP, V105, P1473, DOI 10.2307/3433654
   Zhang R, 2011, BASIC CLIN PHARMACOL, V108, P63, DOI 10.1111/j.1742-7843.2010.00629.x
NR 31
TC 4
Z9 4
U1 0
U2 7
PU KOREAN SOCIETY FOOD SCIENCE & TECHNOLOGY-KOSFOST
PI SEOUL
PA #605, KOREA SCI TECHNOL CENT, 635-4 YEOKSAM-DONG, KANGNAM-GU, SEOUL,
   135-703, SOUTH KOREA
SN 1226-7708
EI 2092-6456
J9 FOOD SCI BIOTECHNOL
JI Food Sci. Biotechnol.
PD FEB
PY 2017
VL 26
IS 1
BP 279
EP 285
DI 10.1007/s10068-017-0037-y
PG 7
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA EN8RT
UT WOS:000396268200037
PM 30263539
OA Green Published
DA 2024-02-19
ER

PT J
AU Wang, YQ
   Zhang, LY
   Han, F
   Li, RH
   Cheng, YR
   Jiang, XY
   Wang, LY
   Chen, JF
   Ji, JG
   Zhang, YH
   Chen, TH
AF Wang, Youqing
   Zhang, Luyao
   Han, Fang
   Li, Runhua
   Cheng, Yongran
   Jiang, Xiyi
   Wang, Liangyou
   Chen, Jinfei
   Ji, Jianguang
   Zhang, Yuhua
   Chen, Tianhui
TI Using Period Analysis to Timely Assess and Predict 5-Year Relative
   Survival for Liver Cancer Patients From Taizhou, Eastern China
SO FRONTIERS IN ONCOLOGY
LA English
DT Article
DE 5-year relative survival; liver cancer; period analysis; cancer
   registry; eastern China
ID HEPATOCELLULAR-CARCINOMA; SURVEILLANCE; TRENDS; END; RESECTION; IMPACT
AB IntroductionWhile timely assessment of long-term survival for patients with liver cancer is essential for the evaluation of early detection and screening programs of liver cancer, those data are extremely scarce in China. We aimed to timely and accurately assess long-term survival for liver cancer patients in eastern China. MethodsPatients diagnosed with liver cancer during 2004-2018 from four cancer registries with high-quality data from Taizhou, eastern China, were included. The period analysis was used to calculate the 5-year relative survival (RS) for overall and the stratification by sex, age at diagnosis, and region. The projected 5-year RS of liver cancer patients during 2019-2023 was also assessed using a model-based period analysis. ResultsThe overall 5-year RS for patients with liver cancer during 2014-2018 reached 32.4%, being 29.3% for men and 36.1% for women. The 5-year RS declined along with aging, decreasing from 38.2% for age 74 years, while the 5-year RS for urban area was higher compared to rural area (36.8% vs. 29.3%). The projected overall 5-year RS of liver cancer patients could reach 41.4% during the upcoming period 2019-2023. ConclusionsWe provided, for first time in China using the period analysis, the most up-to-date 5-year RS for patients with liver cancer from Taizhou, eastern China, and also found that the 5-year RS for liver cancer patients have improved greatly during 2004-2018, which has important implications for the timely evaluation of early detection and screening programs for patients with liver cancer in eastern China.
C1 [Wang, Youqing; Li, Runhua; Chen, Tianhui] Univ Chinese Acad Sci, Zhejiang Canc Hosp, Zhejiang Canc Inst, Dept Canc Prevent,Canc Hosp, Hangzhou, Peoples R China.
   [Wang, Youqing; Li, Runhua; Zhang, Yuhua; Chen, Tianhui] Chinese Acad Sci, Inst Basic Med & Canc IBMC, Hangzhou, Peoples R China.
   [Zhang, Luyao] Zhengzhou Univ, Henan Canc Hosp, Henan Engn Res Ctr Canc Prevent & Control, Dept Canc Epidemiol & Prevent,Affiliated Canc Hosp, Zhengzhou, Peoples R China.
   [Han, Fang; Zhang, Yuhua] Univ Chinese Acad Sci, Zhejiang Canc Hosp, Canc Hosp, Dept Hepatobiliary & Pancreat Surg, Hangzhou, Peoples R China.
   [Cheng, Yongran; Jiang, Xiyi] Hangzhou Med Coll, Sch Publ Hlth, Hangzhou, Peoples R China.
   [Wang, Liangyou] Taizhou Ctr Dis Control & Prevent, Dept Noncommunicable Chron Dis Control & Prevent, Taizhou, Peoples R China.
   [Chen, Jinfei] Wenzhou Med Univ, Affiliated Hosp 1, Dept Oncol, Wenzhou, Peoples R China.
   [Ji, Jianguang] Lund Univ, Ctr Primary Hlth Care Res, Dept Clin Sci, Malmo, Sweden.
C3 Zhejiang Cancer Hospital; Chinese Academy of Sciences; University of
   Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Zhengzhou
   University; Chinese Academy of Sciences; University of Chinese Academy
   of Sciences, CAS; Zhejiang Cancer Hospital; Hangzhou Medical College;
   Wenzhou Medical University; Lund University
RP Chen, TH (corresponding author), Univ Chinese Acad Sci, Zhejiang Canc Hosp, Zhejiang Canc Inst, Dept Canc Prevent,Canc Hosp, Hangzhou, Peoples R China.; Zhang, YH; Chen, TH (corresponding author), Chinese Acad Sci, Inst Basic Med & Canc IBMC, Hangzhou, Peoples R China.; Zhang, YH (corresponding author), Univ Chinese Acad Sci, Zhejiang Canc Hosp, Canc Hosp, Dept Hepatobiliary & Pancreat Surg, Hangzhou, Peoples R China.; Ji, JG (corresponding author), Lund Univ, Ctr Primary Hlth Care Res, Dept Clin Sci, Malmo, Sweden.
EM jianguang.ji@med.lu.se; zhangyh@zjcc.org.cn; chenth@zjcc.org.cn
RI Chen, Tianhui/Y-3500-2018; Ji, Jianguang/E-9579-2011
OI Chen, Tianhui/0000-0003-4677-0361; Ji, Jianguang/0000-0003-0324-9496;
   Li, Runhua/0000-0003-1971-0726
FU National Key Research-Development Program of China [2021YFC2500400,
   2021YFC2500401]; Zhejiang Provincial Ten-Thousand Talents Plan
   [2021R52020]; Joint Key Program of Zhejiang Province-Ministry of Health
   [WKJ-ZJ-1714]
FX This work was supported by grants from the National Key
   Research-Development Program of China (2021YFC2500400 and
   2021YFC2500401), Zhejiang Provincial Ten-Thousand Talents Plan
   (2021R52020), and Joint Key Program of Zhejiang Province-Ministry of
   Health (WKJ-ZJ-1714). The funding agencies had no role in the design and
   conduct of the study; collection, management, analysis, and
   interpretation of the data; preparation, review, or approval of the
   article; and decision to submit the article for publication.
CR Brenner H, 2002, LANCET, V360, P1131, DOI 10.1016/S0140-6736(02)11199-8
   Brenner H, 1996, CANCER-AM CANCER SOC, V78, P2004, DOI 10.1002/(SICI)1097-0142(19961101)78:9<2004::AID-CNCR23>3.3.CO;2-6
   Brenner H, 2006, AM J EPIDEMIOL, V164, P689, DOI 10.1093/aje/kwj243
   Chai W., 2019, PREV MDE, V31, P31, DOI [10.19485/j.cnki.issn2096-5087.2019.09.019, DOI 10.19485/J.CNKI.ISSN2096-5087.2019.09.019]
   Chen J G, 2017, Zhonghua Zhong Liu Za Zhi, V39, P946, DOI 10.3760/cma.j.issn.0253-3766.2017.12.013
   Chen JG, 2021, J HEPATOCELL CARCINO, V8, P1023, DOI 10.2147/JHC.S321346
   Chen WQ, 2019, LANCET GLOB HEALTH, V7, pE257, DOI 10.1016/S2214-109X(18)30488-1
   Ding C, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-025613
   Dong W, 2014, WORLD J GASTROENTERO, V20, P10174, DOI 10.3748/wjg.v20.i29.10174
   Fei FR, 2019, CAN J GASTROENTEROL, V2019, DOI 10.1155/2019/1074286
   Fodor M, 2022, TRANSPLANTATION, V106, P938, DOI 10.1097/TP.0000000000003973
   Hong TP, 2018, MED J AUSTRALIA, V209, P348, DOI 10.5694/mja18.00373
   Hsiao CY, 2020, AM J SURG, V220, P958, DOI 10.1016/j.amjsurg.2020.03.017
   Islami F, 2017, CA-CANCER J CLIN, V67, P273, DOI 10.3322/caac.21402
   Jiang JJ, 2021, J VIRAL HEPATITIS, V28, P934, DOI 10.1111/jvh.13498
   Jiang XY, 2020, INT J CANCER, V147, P996, DOI 10.1002/ijc.32866
   Kim H, 2017, BRIT J SURG, V104, P1045, DOI 10.1002/bjs.10541
   Lee S, 2018, J HEPATOL, V69, P70, DOI 10.1016/j.jhep.2018.02.026
   National Health Commission of China, 2021, 2021 NFL rule book, P1
   Singh GK, 2017, J ENVIRON PUBLIC HEA, V2017, P1, DOI 10.1155/2017/2819372
   Sirri E, 2016, PANCREAS, V45, P908, DOI 10.1097/MPA.0000000000000588
   Sung H, 2021, CA-CANCER J CLIN, V71, P209, DOI 10.3322/caac.21660
   Tanaka H, 2006, LIVER INT, V26, P543, DOI 10.1111/j.1478-3231.2006.01270.x
   Wang L., 2021, J PREV MED, V33, P757, DOI 10.19485/j.cnki.issn2096-5087.2021.08.001
   Woods LM, 2007, BRIT J CANCER, V96, P1135, DOI 10.1038/sj.bjc.6603668
   YAMANAKA N, 1994, ANN SURG, V219, P342, DOI 10.1097/00000658-199404000-00003
   Yang DY, 2014, CANCER-AM CANCER SOC, V120, P3707, DOI 10.1002/cncr.28912
   Zeng HM, 2018, LANCET GLOB HEALTH, V6, pE555, DOI 10.1016/S2214-109X(18)30127-X
   Zeng HM, 2015, INT J CANCER, V136, P1921, DOI 10.1002/ijc.29227
   Zhang WJ, 2015, ONCOTARGET, V6, P633, DOI 10.18632/oncotarget.2719
   Zheng RS, 2018, CHINESE J CANCER RES, V30, P571, DOI 10.21147/j.issn.1000-9604.2018.06.01
   Zhou ZW., 2021, CHIN J ONCOL PREV TR, V13, P14, DOI [10.3969/j.issn.1674-5671.2021.01.03, DOI 10.3969/J.ISSN.1674-5671.2021.01.03]
NR 32
TC 2
Z9 2
U1 3
U2 11
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2234-943X
J9 FRONT ONCOL
JI Front. Oncol.
PD JUL 4
PY 2022
VL 12
AR 920094
DI 10.3389/fonc.2022.920094
PG 8
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA 3C2DO
UT WOS:000828439500001
PM 35860562
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Kokkonen, GC
   Kitano, S
   Mock, YD
   Ishigami, A
   Reed, TD
   Chrest, FJ
   Roth, GS
AF Kokkonen, GC
   Kitano, S
   Mock, YD
   Ishigami, A
   Reed, TD
   Chrest, FJ
   Roth, GS
TI Aging reduces the numbers of hepatocytes synthesizing DNA in response to
   EGF and epinephrine
SO EXPERIMENTAL CELL RESEARCH
LA English
DT Article
ID CULTURED RAT HEPATOCYTES; AGE
AB Primary cultures of hepatocytes were prepared from young (6 month) and old (24 month) Wistar rats and exposed to epinephrine or epidermal growth factor. Incorporation of [H-3]thymidine into DNA was determined both radiochemically and autoradiographically, The numbers of responding cells and degree of response per cell were determined and the results confirmed by FACScan analysis. Such analyses clearly demonstrate a reduced number of hepatocytes capable of responding to the above stimuli in cultures obtained from old rats, Thus, changes in numbers of responding cells may be an important mechanism involved in reduced responsiveness of the aged liver to agents which stimulate DNA synthesis and cell division. (C) 1997 Academic Press.
C1 NIA, Gerontol Res Ctr, Mol Physiol & Genet Sect, Lab Cellular & Mol Physiol,NIH, Baltimore, MD 21224 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute on
   Aging (NIA)
RP Roth, GS (corresponding author), NIA, Gerontol Res Ctr, Mol Physiol & Genet Sect, Lab Cellular & Mol Physiol,NIH, Baltimore, MD 21224 USA.
CR Adelman RC, 1972, MECH AGEING DEV, V1, P49, DOI 10.1016/0047-6374(72)90052-8
   BRUCE SA, 1991, EXP GERONTOL, V26, P17, DOI 10.1016/0531-5565(91)90058-T
   BUCHER NLR, 1964, CANCER RES, V24, P509
   CRISTOFALO VJ, 1985, CRC HDB CELL BIOL AG
   DUTARTRE P, 1991, MECH AGEING DEV, V59, P275, DOI 10.1016/0047-6374(91)90138-P
   Hagen TM, 1997, P NATL ACAD SCI USA, V94, P3064, DOI 10.1073/pnas.94.7.3064
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   ISHIGAMI A, 1993, BIOCHEM BIOPH RES CO, V196, P181, DOI 10.1006/bbrc.1993.2232
   ISHIGAMI A, 1994, J CELL PHYSIOL, V158, P231, DOI 10.1002/jcp.1041580204
   Kitano S, 1996, BIOCHEM BIOPH RES CO, V225, P122, DOI 10.1006/bbrc.1996.1140
   KITANO S, 1997, UNPUB
   KITANO S, UNPUB
   KOLLER MM, 1992, ARCH ORAL BIOL, V37, P219, DOI 10.1016/0003-9969(92)90092-M
   LIU Y, 1996, J BIOL CHEM, V271, P1
   Ohashi M, 1980, EXP GERONTOL, V15, P539
   ROTH GS, 1994, AGING-CLIN EXP RES, V6, P139, DOI 10.1007/BF03324227
   SAWADA N, 1988, CANCER RES, V48, P1618
   SAWADA N, 1989, EXP CELL RES, V181, P584, DOI 10.1016/0014-4827(89)90115-8
   Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5
   TAKAI S, 1988, J BIOCHEM-TOKYO, V103, P848, DOI 10.1093/oxfordjournals.jbchem.a122359
NR 20
TC 1
Z9 1
U1 0
U2 4
PU ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0014-4827
J9 EXP CELL RES
JI Exp. Cell Res.
PD NOV 25
PY 1997
VL 237
IS 1
BP 77
EP 82
DI 10.1006/excr.1997.3763
PG 6
WC Oncology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Cell Biology
GA YN237
UT WOS:000071146800011
PM 9417869
DA 2024-02-19
ER

PT J
AU Nishikawa, H
   Shiraki, M
   Hiramatsu, A
   Moriya, K
   Hino, K
   Nishiguchi, S
AF Nishikawa, Hiroki
   Shiraki, Makoto
   Hiramatsu, Akira
   Moriya, Kyoji
   Hino, Keisuke
   Nishiguchi, Shuhei
TI Japan Society of Hepatology guidelines for sarcopenia in liver disease
   (1st edition): Recommendation from the working group for creation of
   sarcopenia assessment criteria
SO HEPATOLOGY RESEARCH
LA English
DT Article
DE assessment criteria; liver disease; mechanism; prognosis; sarcopenia
ID SKELETAL-MUSCLE MASS; AMINO-ACID GRANULES; HEPATOCELLULAR-CARCINOMA;
   NUTRITIONAL-STATUS; PERFORMANCE STATUS; PROGNOSTIC-FACTOR;
   GENE-EXPRESSION; RISK-FACTOR; STEM-CELLS; CIRRHOSIS
AB Sarcopenia is defined by muscle loss and muscle dysfunction. Sarcopenia is classified into primary and secondary types, based on the cause. Primary sarcopenia is mainly aging-related sarcopenia, whereas secondary sarcopenia is the reduced muscle mass and strength that accompanies an underlying disease. Given the essential role of the liver in metabolism, secondary sarcopenia due to nutritional disorders or other factors can frequently occur in liver disease. In 2015, the Japan Society of Hepatology (JSH) decided to establish its own assessment criteria for sarcopenia in liver disease because the number of liver disease patients with sarcopenia is expected to increase and there is cumulative evidence to indicate sarcopenic patients have poor clinical outcomes. A working group to create assessment criteria for sarcopenia has thus been established by the JSH. In this article, we summarize the current knowledge with regard to sarcopenia and present the assessment criteria for sarcopenia in liver disease proposed by the JSH (1st edition). To the best of our knowledge, this is globally the first proposed assessment criteria for sarcopenia specializing in liver disease.
C1 [Nishikawa, Hiroki; Nishiguchi, Shuhei] Hyogo Coll Med, Dept Internal Med, Div Hepatobiliary & Pancreat Dis, 1-1 Mukogawacho, Nishinomiya, Hyogo 6638501, Japan.
   [Shiraki, Makoto] Gifu Univ, Dept Gastroenterol & Internal Med, Grad Sch Med, Gifu, Japan.
   [Hiramatsu, Akira] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Gastroenterol & Metab, Appl Life Sci, Hiroshima, Japan.
   [Moriya, Kyoji] Univ Tokyo, Grad Sch Med, Dept Infect Control & Prevent, Tokyo, Japan.
   [Hino, Keisuke] Kawasaki Med Sch, Dept Hepatol & Pancreatol, Okayama, Japan.
C3 Hyogo College of Medicine; Gifu University; Hiroshima University;
   University of Tokyo; Kawasaki Medical School
RP Nishiguchi, S (corresponding author), Hyogo Coll Med, Dept Internal Med, Div Hepatobiliary & Pancreat Dis, 1-1 Mukogawacho, Nishinomiya, Hyogo 6638501, Japan.
EM nishiguc@hyo-med.ac.jp
RI Hiramatsu, Akira/G-9594-2019
FU EA Pharma Co.; Otsuka Pharmaceutical Co.; Terumo Corp; Bristol-Myers Co
FX Shuhei Nishiguchi: EA Pharma Co., Otsuka Pharmaceutical Co., Terumo
   Corp, Research Grants. Keisuke Hino: EA Pharma Co., Bristol-Myers Co,
   Lecture Fee. None of the other authors have any conflict of interest.
CR Blau HM, 2015, NAT MED, V21, P854, DOI 10.1038/nm.3918
   Borsheim E, 2008, CLIN NUTR, V27, P189, DOI 10.1016/j.clnu.2008.01.001
   Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1
   Bryant RV, 2015, ALIMENT PHARM THER, V41, P895, DOI 10.1111/apt.13156
   Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025
   Cruz-Jentoft AJ, 2014, AGE AGEING, V43, P748, DOI 10.1093/ageing/afu115
   Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034
   Dasarathy S, 2016, CURR OPIN GASTROEN, V32, P159, DOI 10.1097/MOG.0000000000000261
   Dasarathy S, 2012, J CACHEXIA SARCOPENI, V3, P225, DOI 10.1007/s13539-012-0069-3
   DiMartini A, 2013, LIVER TRANSPLANT, V19, P1172, DOI 10.1002/lt.23724
   Dodds RM, 2015, J CLIN DENSITOM, V18, P461, DOI 10.1016/j.jocd.2015.04.012
   Duan YH, 2016, AMINO ACIDS, V48, P41, DOI 10.1007/s00726-015-2067-1
   Durand F, 2014, J HEPATOL, V60, P1151, DOI 10.1016/j.jhep.2014.02.026
   Fielding RA, 2011, J AM MED DIR ASSOC, V12, P249, DOI 10.1016/j.jamda.2011.01.003
   Fujiwara N, 2015, J HEPATOL, V63, P131, DOI 10.1016/j.jhep.2015.02.031
   García PS, 2010, ANESTH ANALG, V111, P707, DOI 10.1213/ANE.0b013e3181eac1c9
   Goldspink G, 2002, CLIN ORTHOP RELAT R, pS146, DOI 10.1097/01.blo.0000031972.69509.68
   Grossmann M, 2012, CLIN ENDOCRINOL, V77, P323, DOI 10.1111/j.1365-2265.2012.04347.x
   Hamaguchi Y, 2016, NUTRITION IN PRESS, DOI [10.1016/j.nut.2016.04.003, DOI 10.1016/J.NUT.2016.04.003]
   Hamaguchi Y, 2014, LIVER TRANSPLANT, V20, P1413, DOI 10.1002/lt.23970
   Hanai T, 2016, HEPATOL RES, V46, P743, DOI 10.1111/hepr.12616
   Hanai T, 2015, NUTRITION, V31, P193, DOI 10.1016/j.nut.2014.07.005
   Harimoto N, 2013, BRIT J SURG, V100, P1523, DOI 10.1002/bjs.9258
   Harimoto N, 2016, HEPATOL RES, V46, P1247, DOI 10.1111/hepr.12674
   Hayashi F, 2013, HEPATOL RES, V43, P1264, DOI 10.1111/hepr.12085
   Higashi T, 2016, INT J CLIN ONCOL, V21, P310, DOI 10.1007/s10147-015-0898-0
   Hiraoka A, 2015, J GASTROENTEROL, V50, P1206, DOI 10.1007/s00535-015-1068-x
   Hsu CY, 2013, HEPATOLOGY, V57, P112, DOI 10.1002/hep.25950
   Iritani S, 2015, J GASTROENTEROL, V50, P323, DOI 10.1007/s00535-014-0964-9
   Itoh S, 2014, ANN SURG ONCOL, V21, P3063, DOI 10.1245/s10434-014-3686-6
   Iwasa M, 2014, HEPATOL RES, V44, pE316, DOI 10.1111/hepr.12217
   Iwasa M, 2014, ANN HEPATOL, V13, P407, DOI 10.1016/S1665-2681(19)30874-9
   Janssen I, 2000, J APPL PHYSIOL, V89, P81
   Kaibori M, 2013, AM J SURG, V206, P202, DOI 10.1016/j.amjsurg.2012.07.035
   Kaido T, 2013, AM J TRANSPLANT, V13, P1549, DOI 10.1111/ajt.12221
   Kamachi S, 2016, HEPATOL RES, V46, P201, DOI 10.1111/hepr.12562
   Katsanos CS, 2006, AM J PHYSIOL-ENDOC M, V291, pE381, DOI 10.1152/ajpendo.00488.2005
   Kawaguchi T, 2014, CLIN GASTROENTEROL H, V12, P1012, DOI 10.1016/j.cgh.2013.08.050
   Lin SY, 2005, AM J PHYSIOL-ENDOC M, V288, pE493, DOI 10.1152/ajpendo.00186.2004
   Masuda T, 2014, LIVER TRANSPLANT, V20, P401, DOI 10.1002/lt.23811
   McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0
   Miljkovic N, 2015, ANN REHABIL MED-ARM, V39, P155, DOI 10.5535/arm.2015.39.2.155
   Mitch W E, 2000, Trans Am Clin Climatol Assoc, V111, P258
   Montano-Loza A J, 2013, Minerva Gastroenterol Dietol, V59, P173
   Montano-Loza AJ, 2015, CLIN TRANSL GASTROEN, V6, DOI 10.1038/ctg.2015.31
   Montano-Loza AJ, 2012, CLIN GASTROENTEROL H, V10, P166, DOI 10.1016/j.cgh.2011.08.028
   Moriwaki H, 2004, BIOCHEM BIOPH RES CO, V313, P405, DOI 10.1016/j.bbrc.2003.07.016
   Muto Y, 2005, CLIN GASTROENTEROL H, V3, P705, DOI 10.1016/S1542-3565(05)00017-0
   Nishikawa H, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002442
   Nishikawa H, 2015, J CANCER, V6, P394, DOI 10.7150/jca.11212
   Nishikawa H, 2014, HEPATOL RES, V44, P149, DOI 10.1111/hepr.12194
   Qiu J, 2013, P NATL ACAD SCI USA, V110, P18162, DOI 10.1073/pnas.1317049110
   ROSENBERG IH, 1989, AM J CLIN NUTR, V50, P1231, DOI 10.1093/ajcn/50.5.1231
   Sadowski CL, 2001, ENDOCRINOLOGY, V142, P3890, DOI 10.1210/en.142.9.3890
   Santilli V, 2014, CLIN CASES MINER BON, V11, P177, DOI 10.11138/ccmbm/2014.11.3.177
   Scaglione S, 2015, J CLIN GASTROENTEROL, V49, P690, DOI 10.1097/MCG.0000000000000208
   Shiraki M, 2013, HEPATOL RES, V43, P106, DOI 10.1111/hepr.12004
   Sinclair M, 2016, ALIMENT PHARM THER, V43, P765, DOI 10.1111/apt.13549
   Sousa-Victor P, 2016, MOL ASPECTS MED, V50, P109, DOI 10.1016/j.mam.2016.02.002
   Tandon P, 2012, LIVER TRANSPLANT, V18, P1209, DOI 10.1002/lt.23495
   Thompson D. D., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P344
   TILG H, 1992, GASTROENTEROLOGY, V103, P264, DOI 10.1016/0016-5085(92)91122-K
   Toshikuni N, 2014, WORLD J GASTROENTERO, V20, P7286, DOI 10.3748/wjg.v20.i23.7286
   Yoshida D, 2014, GERIATR GERONTOL INT, V14, P46, DOI 10.1111/ggi.12210
NR 64
TC 407
Z9 413
U1 0
U2 25
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1386-6346
EI 1872-034X
J9 HEPATOL RES
JI Hepatol. Res.
PD SEP
PY 2016
VL 46
IS 10
BP 951
EP 963
DI 10.1111/hepr.12774
PG 13
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA DW5WY
UT WOS:000383719600001
PM 27481650
HC Y
HP N
DA 2024-02-19
ER

PT J
AU Esrefoglu, M
   Iraz, M
   Ates, B
   Gül, M
AF Esrefoglu, Mukaddes
   Iraz, Mustafa
   Ates, Burhan
   Gul, Mehmet
TI Not Only Melatonin but also Caffeic Acid Phenethyl Ester Protects
   Kidneys against Aging-related Oxidative Damage in Sprague Dawley Rats
SO ULTRASTRUCTURAL PATHOLOGY
LA English
DT Article
DE Aging; caffeic acid phenethyl ester; kidney; melatonin; oxidative stress
ID GLUTATHIONE PEROXIDASE; LIPID-PEROXIDATION; DIFFERENT AGES; STRESS;
   CELLS; TOXICITY; SELENIUM; INJURY; CORTEX; LIVER
AB Microscopic features and antioxidant status of kidneys of young, old, and caffeic acid phenethyl ester (CAPE) and melatonin administered old Sprague Dawley rats were evaluated. Aging-related tubular and glomerular changes were evident. The most prominent tubular alterations were massive vacuole formation, mitochondrial degeneration, and lysosome accumulation. Mean tissue malondialdehyde (MDA) level was increased, mean tissue superoxide dismutase (SOD), catalase (CAT) (p<.001), and glutathione peroxidase (GPx) activities (p<.05), and total glutathione (GSH) level were decreased in old animals. Melatonin significantly reduced tissue MDA levels (p<.005), but increased tissue SOD (p<.001), CAT, and GPx activities (p<.05), and GSH levels (p<.005) in old animals. CAPE also significantly reduced tissue MDA levels (p<.005), but increased tissue SOD (p<.05), CAT (p<.005), GPx activities, and GSH levels (p<.001) in old rats. Mean tissue MDA levels of melatonin and CAPE-administered rats were even lower than those of young rats (p<.05). In conclusion, tubular and glomerular structures and tissue antioxidant enzyme activities were very well preserved in CAPE and melatonin-administered rats.
C1 [Esrefoglu, Mukaddes] Bezmialem Vakif Univ, Tip Fak, Histoloji & Embriyoloji AbD, TR-34093 Istanbul, Turkey.
   [Iraz, Mustafa] Bezmialem Vakif Univ, Dept Pharmacol, Fac Med, TR-34093 Istanbul, Turkey.
   [Ates, Burhan] Inonu Univ, Fac Sci & Art, Dept Chem, Malatya, Turkey.
   [Gul, Mehmet] Inonu Univ, Dept Histol & Embryol, Fac Med, Malatya, Turkey.
C3 Bezmialem Vakif University; Bezmialem Vakif University; Inonu
   University; Inonu University
RP Esrefoglu, M (corresponding author), Bezmialem Vakif Univ, Tip Fak, Histoloji & Embriyoloji AbD, Adnan Menderes Bulvari,Vatan Cad, TR-34093 Istanbul, Turkey.
EM drmukaddes@hotmail.com
RI Eşrefoğlu, Mukaddes/JWA-4590-2024; Gül, Mehmet/ABI-6336-2020; Ateş,
   Burhan/AAA-3730-2021
OI Eşrefoğlu, Mukaddes/0000-0003-3380-1480; Gül,
   Mehmet/0000-0002-1374-0783; Ateş, Burhan/0000-0001-6080-229X
CR ANDERSON S, 1986, AM J MED, V80, P435, DOI 10.1016/0002-9343(86)90718-7
   BOVERIS A, 1999, OXIDAT STRESS DIS, V2, P1
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   BRENNER BM, 1983, KIDNEY INT, V23, P647, DOI 10.1038/ki.1983.72
   BUEGE AJ, 1978, METHOD ENZYMOL, V52, P302
   Çakatay U, 2010, AGING MALE, V13, P51, DOI 10.3109/13685530903236470
   COMPORTI M, 1987, CHEM PHYS LIPIDS, V45, P143, DOI 10.1016/0009-3084(87)90064-8
   Cui X, 2006, J NEUROSCI RES, V84, P647, DOI 10.1002/jnr.20899
   de Cavanagh EMV, 2003, FASEB J, V17, P1096, DOI 10.1096/fj.02-0063fje
   DONTAS AS, 1972, POSTGRAD MED J, V48, P295, DOI 10.1136/pgmj.48.559.295
   Esrefoglu M, ULTRASTRUCT IN PRESS
   Esrefoglu M, 2006, FUND CLIN PHARMACOL, V20, P605, DOI 10.1111/j.1472-8206.2006.00439.x
   Esrefoglu M, 2011, FUND CLIN PHARMACOL, V25, P580, DOI 10.1111/j.1472-8206.2010.00876.x
   Esrefoglu M, 2010, FUND CLIN PHARMACOL, V24, P305, DOI 10.1111/j.1472-8206.2009.00782.x
   GRUNBERGER D, 1988, EXPERIENTIA, V44, P230, DOI 10.1007/BF01941717
   Gurel A, 2004, CLIN CHIM ACTA, V339, P33, DOI 10.1016/j.cccn.2003.09.013
   Herbert BS, 1999, P NATL ACAD SCI USA, V96, P14276, DOI 10.1073/pnas.96.25.14276
   IKEDA H, 1985, MECH AGEING DEV, V33, P77, DOI 10.1016/0047-6374(85)90110-1
   Inserra Felipe, 2009, Ther Adv Cardiovasc Dis, V3, P341, DOI 10.1177/1753944709339195
   KAPLAN C, 1975, AM J PATHOL, V80, P227
   KARTTUNEN T, 1986, KIDNEY INT, V30, P586, DOI 10.1038/ki.1986.225
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   LANGEVELD JPM, 1981, KIDNEY INT, V20, P104, DOI 10.1038/ki.1981.111
   LAWRENCE RA, 1976, BIOCHEM BIOPH RES CO, V71, P952, DOI 10.1016/0006-291X(76)90747-6
   Leyko W, 1986, INT J RADIAT BIOL, V49, P734
   LINDEMAN RD, 1986, EXP GERONTOL, V21, P379, DOI 10.1016/0531-5565(86)90044-6
   Liu AJ, 2009, BIOSCI BIOTECH BIOCH, V73, P1461, DOI 10.1271/bbb.80558
   Luck H, 1963, Methods in Enzymatic Analysis
   MCCORD JM, 1969, J BIOL CHEM, V244, P6049
   Melk A, 2000, J AM SOC NEPHROL, V11, P444, DOI 10.1681/ASN.V113444
   Mühlberg W, 1999, GERONTOLOGY, V45, P243, DOI 10.1159/000022097
   NAKANO M, 1985, MECH AGEING DEV, V33, P95, DOI 10.1016/0047-6374(85)90111-3
   Neugarten J, 1999, AM J KIDNEY DIS, V34, P884, DOI 10.1016/S0272-6386(99)70046-6
   Ocak S, 2007, BASIC CLIN PHARMACOL, V100, P328, DOI 10.1111/j.1742-7843.2007.00051.x
   Ogeturk M, 2005, J ETHNOPHARMACOL, V97, P273, DOI 10.1016/j.jep.2004.11.019
   Ozguner F, 2005, UROL RES, V33, P239, DOI 10.1007/s00240-005-0470-x
   Percy C, 2005, ADV CHRONIC KIDNEY D, V12, P78, DOI 10.1053/j.ackd.2004.10.006
   Pérez VI, 2009, BBA-GEN SUBJECTS, V1790, P1005, DOI 10.1016/j.bbagen.2009.06.003
   Radke J, 1994, ANNA J, V21, P191
   Radke J, 1994, ANNA J, V21, P181
   REITER RJ, 1995, AGING-CLIN EXP RES, V7, P340, DOI 10.1007/BF03324344
   REITER RJ, 1995, FRONT NEUROENDOCRIN, V16, P383, DOI 10.1006/frne.1995.1014
   Reiter RJ, 1994, ACTA NEUROBIOL EXP W, V54, P13
   ROTRUCK JT, 1973, SCIENCE, V179, P588, DOI 10.1126/science.179.4073.588
   SATO T, 1982, MECH AGEING DEV, V20, P111, DOI 10.1016/0047-6374(82)90063-X
   Singh NP, 2001, BIOGERONTOLOGY, V2, P261, DOI 10.1023/A:1013262327193
   Tan DX, 2000, BIOL SIGNAL RECEPT, V9, P137
   THEODORUS P, 1981, METHOD ENZYMOL, V77, P373
   Yilmaz HR, 2004, J BIOCHEM MOL TOXIC, V18, P234, DOI 10.1002/jbt.20028
NR 49
TC 16
Z9 17
U1 0
U2 13
PU INFORMA HEALTHCARE
PI NEW YORK
PA 52 VANDERBILT AVE, NEW YORK, NY 10017 USA
SN 0191-3123
J9 ULTRASTRUCT PATHOL
JI Ultrastruct. Pathol.
PD AUG
PY 2012
VL 36
IS 4
BP 244
EP 251
DI 10.3109/01913123.2012.679351
PG 8
WC Microscopy; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microscopy; Pathology
GA 981LA
UT WOS:000306968500007
PM 22849526
DA 2024-02-19
ER

PT J
AU Ohmura, N
   Fukuo, Y
   Akimoto, T
   Watanabe, H
   Abo, T
AF Ohmura, N
   Fukuo, Y
   Akimoto, T
   Watanabe, H
   Abo, T
TI Accelerated expansion of extrathymic T cells in the liver and other
   atherosclerotic lesions in mice fed with atherogenic diets
SO BIOMEDICAL RESEARCH-TOKYO
LA English
DT Article
ID INTERMEDIATE TCR CELLS; HUMAN AORTIC INTIMA; ADHESION MOLECULES; IMMUNE
   ORGANS; MOUSE-LIVER; RECEPTOR; LYMPHOCYTES; POPULATION; APPEARANCE;
   EXPRESSION
AB Immunoparameters in mice fed with atherogenic diets for 4 months were examined. In parallel with accelerated thymic involution, a prominent increase in the proportion of IL-2R beta(+) intermediate TCR cells (i.e., extrathymic T cells) was seen in the liver and other immune organs of mice with atherosclerosis. In contrast, NK cells and high TCR cells (i.e., conventional T cells of thymic origin) decreased. The majority of mononuclear cells isolated from the aorta and kidneys in these mice were also found to be intermediate TCR cells. The present results suggest that mice with atherosclerosis have an accelerated pattern of aging of the immune system and that extrathymic T cells may be responsible for the formation of atheroscherotic lesions.
C1 NIPPON MED COLL,DIV LAB ANIM SCI,TOKYO 102,JAPAN.
   NIIGATA UNIV,DEPT IMMUNOL,SCH MED,NIIGATA 951,JAPAN.
C3 Nippon Medical School; Niigata University
RP Ohmura, N (corresponding author), NIPPON MED COLL,DEPT INTERNAL MED 2,TOKYO 102,JAPAN.
CR ABO T, 1993, MICROBIOL IMMUNOL, V37, P247, DOI 10.1111/j.1348-0421.1993.tb03207.x
   ABO T, 1991, J EXP MED, V174, P417, DOI 10.1084/jem.174.2.417
   ARAI K, 1995, IMMUNOLOGY, V84, P64
   FINKEL TH, 1989, CELL, V58, P1047, DOI 10.1016/0092-8674(89)90503-5
   HANSSON GK, 1989, ARTERIOSCLEROSIS, V9, P567, DOI 10.1161/01.ATV.9.5.567
   IIAI T, 1992, IMMUNOLOGY, V77, P556
   KAWACHI Y, 1995, EUR J IMMUNOL, V25, P2272, DOI 10.1002/eji.1830250824
   KISHIKAWA H, 1993, VIRCHOWS ARCH A, V423, P433, DOI 10.1007/BF01606532
   KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0
   OHTEKI T, 1992, J IMMUNOL, V149, P1562
   OHTSUKA K, 1994, CELL IMMUNOL, V153, P52, DOI 10.1006/cimm.1994.1005
   OHTSUKA K, 1994, MICROBIOL IMMUNOL, V38, P677, DOI 10.1111/j.1348-0421.1994.tb01840.x
   SATO K, 1995, J EXP MED, V182, P759, DOI 10.1084/jem.182.3.759
   SHIMOKAMA T, 1991, MODERN PATHOL, V4, P101
   WATANABE H, 1992, J IMMUNOL METHODS, V146, P145, DOI 10.1016/0022-1759(92)90223-G
   WATANABE H, 1995, J IMMUNOL, V155, P2972
NR 16
TC 0
Z9 0
U1 0
U2 0
PU BIOMED RES FOUND
PI TOKYO
PA KANDA PO BOX 182 CHIYODAKU, TOKYO 101-91, JAPAN
SN 0388-6107
J9 BIOMED RES-TOKYO
JI Biomed. Res.
PD JUN
PY 1996
VL 17
IS 3
BP 265
EP 270
DI 10.2220/biomedres.17.265
PG 6
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA VA406
UT WOS:A1996VA40600012
OA Bronze
DA 2024-02-19
ER

PT J
AU Sun, CC
   Yin, ZP
   Chen, JG
   Wang, WJ
   Zheng, GD
   Li, JE
   Chen, LL
   Zhang, QF
AF Sun, Cui-Cui
   Yin, Zhong-Ping
   Chen, Ji-Guang
   Wang, Wen-Jun
   Zheng, Guo-Dong
   Li, Jing-En
   Chen, Ling-Li
   Zhang, Qing-Feng
TI Dihydromyricetin Improves Cognitive Impairments in d-Galactose-Induced
   Aging Mice through Regulating Oxidative Stress and Inhibition of
   Acetylcholinesterase
SO MOLECULAR NUTRITION & FOOD RESEARCH
LA English
DT Article; Early Access
DE acetylcholinesterase; Alzheimer's disease; behavior tests;
   dihydromyricetin; oxidative stress
ID TEA AMPELOPSIS-GROSSEDENTATA; INDUCED MEMORY IMPAIRMENT; DEFICITS;
   MODEL; BIOAVAILABILITY; PEROXIDATION; FLAVONOIDS; PATHOLOGY; EXTRACT
AB Scope Alzheimer's disease (AD) is a neurodegenerative disease with phenomena of cognitive impairments. Oxidative stress and cholinergic system dysfunction are two widely studied pathogenesis of AD. Dihydromyricetin (DMY) is a natural dihydroflavonol with many bioactivities. In this study, it is aimed to investigate the effects of DMY on cognitive impairment in d-galactose (d-gal) induced aging mice. Methods and Results Mice are intraperitoneally injected with d-gal for 16 weeks, and DMY is supplemented in drinking water. The results show that DMY significantly improves d-gal-induced cognitive impairments in novel object recognition and Y-maze studies. H&E and TUNEL staining show that DMY could improve histopathological changes and cell apoptosis in mice brain. DMY effectively induces the activities of catalase, superoxide dismutase and glutathione peroxidase, and reduces malondialdehyde level in mice brain and liver. Furthermore, DMY reduces cholinergic injury by inhibiting the activity of Acetylcholinesterase (AChE) in mice brain. In vitro studies show that DMY is a non-competitive inhibitor of AChE with IC50 value of 161.2 mu g mL(-1). Conclusion DMY alleviates the cognitive impairments in d-gal-induced aging mice partly through regulating oxidative stress and inhibition of acetylcholinesterase.
C1 [Sun, Cui-Cui; Yin, Zhong-Ping; Chen, Ji-Guang; Wang, Wen-Jun; Zheng, Guo-Dong; Li, Jing-En; Chen, Ling-Li; Zhang, Qing-Feng] Jiangxi Agr Univ, Coll Food Sci & Engn, Jiangxi Key Lab Nat Prod & Funct Food, Nanchang 330045, Jiangxi, Peoples R China.
C3 Jiangxi Agricultural University
RP Zhang, QF (corresponding author), Jiangxi Agr Univ, Coll Food Sci & Engn, Jiangxi Key Lab Nat Prod & Funct Food, Nanchang 330045, Jiangxi, Peoples R China.
EM zhqf619@jxau.edu.cn
RI Yin, Zhongping/GSJ-1685-2022; Wang, Wen-Jun/ACT-5615-2022; Zhang,
   Qing-Feng/F-6875-2015
OI Zhang, Qing-Feng/0000-0002-1277-042X; Zheng, Guodong/0000-0002-9601-0056
FU National Natural Science Foundation of China [31760461]
FX This work was supported by the National Natural Science Foundation of
   China (Grant Number 31760461).
CR Ali T, 2015, J PINEAL RES, V58, P71, DOI 10.1111/jpi.12194
   Anilakumar KR, 2009, FOOD CHEM TOXICOL, V47, P279, DOI 10.1016/j.fct.2008.09.061
   Annunziato L, 2003, TOXICOL LETT, V139, P125, DOI 10.1016/S0378-4274(02)00427-7
   Ano Y, 2019, J AGR FOOD CHEM, V67, P8160, DOI 10.1021/acs.jafc.9b02495
   Azman KF, 2019, BIOGERONTOLOGY, V20, P763, DOI 10.1007/s10522-019-09837-y
   BALAZS L, 1994, NEUROCHEM RES, V19, P1131, DOI 10.1007/BF00965146
   Banji OJF, 2014, FOOD CHEM TOXICOL, V74, P51, DOI 10.1016/j.fct.2014.08.020
   Birla H, 2020, CURR NEUROPHARMACOL, V18, P552, DOI 10.2174/1570159X18666200122122512
   EFTINK MR, 1981, ANAL BIOCHEM, V114, P199, DOI 10.1016/0003-2697(81)90474-7
   ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9
   Fan L, 2017, J AGR FOOD CHEM, V65, P4597, DOI 10.1021/acs.jafc.7b01155
   Fan Y, 2005, NEUROSCI LETT, V374, P222, DOI 10.1016/j.neulet.2004.10.063
   Fatemi I, 2018, FUND CLIN PHARMACOL, V32, P392, DOI 10.1111/fcp.12364
   Fatemi I, 2018, IRAN J BASIC MED SCI, V21, P19, DOI 10.22038/IJBMS.2017.24331.6071
   Feng J, 2018, CNS NEUROSCI THER, V24, P1207, DOI 10.1111/cns.12983
   Figueira I, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11512-6
   Furcila D, 2019, FRONT NEUROANAT, V13, DOI 10.3389/fnana.2019.00099
   Gao JH, 2009, J FOOD BIOCHEM, V33, P808, DOI 10.1111/j.1745-4514.2009.00253.x
   Gefen T, 2021, CEREB CORTEX, V31, P3177, DOI 10.1093/cercor/bhaa409
   Gefen T, 2012, BRAIN, V135, P1554, DOI 10.1093/brain/aws076
   Gold Carl A, 2008, Expert Rev Neurother, V8, P1879, DOI 10.1586/14737175.8.12.1879
   Hasselmo ME, 2006, CURR OPIN NEUROBIOL, V16, P710, DOI 10.1016/j.conb.2006.09.002
   He XQ, 2020, J FUNCT FOODS, V73, DOI 10.1016/j.jff.2020.104089
   Hua F, 2018, FOOD FUNCT, V9, P4173, DOI 10.1039/c8fo00562a
   Hua YY, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21186699
   Inoue T, 2019, P NATL ACAD SCI USA, V116, P10031, DOI 10.1073/pnas.1901659116
   IZQUIERDO I, 1995, NEUROBIOL LEARN MEM, V63, P19, DOI 10.1006/nlme.1995.1002
   Liang J, 2014, NEUROCHEM RES, V39, P1171, DOI 10.1007/s11064-014-1304-4
   Liao WZ, 2014, REJUV RES, V17, P422, DOI 10.1089/rej.2014.1555
   Ling HY, 2018, ACTA BIOCH BIOPH SIN, V50, P298, DOI 10.1093/abbs/gmy003
   Liu CM, 2018, J AGR FOOD CHEM, V66, P7975, DOI 10.1021/acs.jafc.8b02433
   Liu D, 2019, TRENDS FOOD SCI TECH, V91, P586, DOI 10.1016/j.tifs.2019.07.038
   Liu JH, 2020, J AGR FOOD CHEM, V68, P33, DOI 10.1021/acs.jafc.9b06817
   Lu J, 2010, NEUROBIOL LEARN MEM, V93, P157, DOI 10.1016/j.nlm.2009.09.006
   Marcus DL, 1998, EXP NEUROL, V150, P40, DOI 10.1006/exnr.1997.6750
   Mattson MP, 1998, INT J DEV NEUROSCI, V16, P737, DOI 10.1016/S0736-5748(98)00082-3
   Melone M, 2018, J CELL PHYSL
   Mufson Elliott J, 2008, Expert Rev Neurother, V8, P1703, DOI 10.1586/14737175.8.11.1703
   Procházková D, 2011, FITOTERAPIA, V82, P513, DOI 10.1016/j.fitote.2011.01.018
   Qu Z, 2017, J AGR FOOD CHEM, V65, P291, DOI 10.1021/acs.jafc.6b04597
   Ren ZX, 2016, ACTA PHARMACOL SIN, V37, P1315, DOI 10.1038/aps.2016.42
   Rui X, 2017, FOOD FUNCT, V8, P1323, DOI [10.1039/c6fo01656a, 10.1039/C6FO01656A]
   Sato M, 2013, J BIOL CHEM, V288, P23212, DOI 10.1074/jbc.M113.464222
   Sha JY, 2019, J AGR FOOD CHEM, V67, P10342, DOI 10.1021/acs.jafc.9b04614
   Shen Y, 2012, J NEUROSCI, V32, P390, DOI 10.1523/JNEUROSCI.4639-11.2012
   Sun CC, 2021, J SCI FOOD AGR, V101, P3862, DOI 10.1002/jsfa.11022
   Sun CC, 2020, FOOD CHEM, V330, DOI 10.1016/j.foodchem.2020.127245
   Suryanarayanan A., 2014, Encycl. Toxicol, P49, DOI [10.1016/B978-0-12-386454-3.00218-9, DOI 10.1016/B978-0-12-386454-3.00218-9]
   Thilakarathna SH, 2013, NUTRIENTS, V5, P3367, DOI 10.3390/nu5093367
   Ullah F, 2015, NEUROCHEM INT, V90, P114, DOI 10.1016/j.neuint.2015.07.001
   Wang XY, 2019, CELL RES, V29, P787, DOI 10.1038/s41422-019-0216-x
   Williamson G, 2018, COMPR REV FOOD SCI F, V17, P1054, DOI 10.1111/1541-4337.12351
   Ye LY, 2015, FOOD CHEM, V172, P416, DOI 10.1016/j.foodchem.2014.09.090
   Zhao BT, 2018, J AGR FOOD CHEM, V66, P3127, DOI 10.1021/acs.jafc.7b05770
NR 54
TC 7
Z9 8
U1 4
U2 30
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1613-4125
EI 1613-4133
J9 MOL NUTR FOOD RES
JI Mol. Nutr. Food Res.
PD 2022 FEB
PY 2022
VL 66
IS 4
AR 2101002
DI 10.1002/mnfr.202101002
EA DEC 2021
PG 9
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA ZD2UV
UT WOS:000736111000001
PM 34932880
DA 2024-02-19
ER

PT J
AU SAWADA, M
   SESTER, U
   CARLSON, JC
AF SAWADA, M
   SESTER, U
   CARLSON, JC
TI SUPEROXIDE RADICAL FORMATION AND ASSOCIATED BIOCHEMICAL-ALTERATIONS IN
   THE PLASMA-MEMBRANE OF BRAIN, HEART, AND LIVER DURING THE LIFETIME OF
   THE RAT
SO JOURNAL OF CELLULAR BIOCHEMISTRY
LA English
DT Article
DE SUPEROXIDE RADICAL; LIPID PEROXIDATION; MEMBRANE FLUIDITY; PROTEIN
   SYNTHESIS; CALCIUM; AGING
ID OXYGEN RADICALS; LIPID-PEROXIDATION; SYSTEM; MECHANISM; INVITRO;
   BIOLOGY; ACID
AB Plasma membrane samples from rat brain, heart, and liver were examined for biochemical changes with age. A rise in superoxide radical (SOR) levels was followed by increases in thiobarbituric acid reactive substances and decreases in membrane fluidity with age. The earliest rise in SOR formation appeared in the plasma membrane from the brain. With age, protein synthesis also decreased significantly in tissue homogenates from brain and heart but was unchanged in the liver. Exposure of plasma membrane samples to in vitro-elevated SOR levels stimulated formation of lipid peroxides, as indicated by the thiobarbituric acid test, and resulted in a decrease in membrane fluidity in each tissue and in a decline in protein synthesis in brain and heart. Changes in brain lipid peroxidation and in membrane fluidity in brain and heart as a result of SOR supplementation were further enhanced due to age. In addition, the mechanism of SOR formation was examined in plasma membrane samples from the brain. SOR generation was Ca2+-sensitive, blocked by superoxide dismutase or vitamin E and inhibited by both indomethacin, a cyclooxygenase inhibitor, and bromophenacyl bromide, a phospholipase A2 inhibitor. These results show significant increases in SOR formation and biochemical alterations in plasma membranes from brain, heart, and liver in aging rats. SOR formation appears to be enzyme-mediated and elevated levels of this oxygen radical could be involved in membrane breakdown in older rats.
C1 UNIV WATERLOO,DEPT BIOL,WATERLOO N2L 3G1,ONTARIO,CANADA.
C3 University of Waterloo
CR [Anonymous], 1982, FREE RADIC LIPID PER
   BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8
   BRUNETTE DM, 1971, J MEMBRANE BIOL, V5, P215, DOI 10.1007/BF01870550
   BURTON GW, 1981, J AM CHEM SOC, V103, P6472, DOI 10.1021/ja00411a035
   CARNEY JM, 1991, P NATL ACAD SCI USA, V88, P3633, DOI 10.1073/pnas.88.9.3633
   CLARK RA, 1987, J BIOL CHEM, V262, P4065
   COLE CH, 1976, J CLIN ENDOCR METAB, V42, P1056, DOI 10.1210/jcem-42-6-1056
   CRAWFORD CG, 1979, LIPIDS, V14, P757, DOI 10.1007/BF02533512
   CRECHET JB, 1986, EUR J BIOCHEM, V161, P635, DOI 10.1111/j.1432-1033.1986.tb10488.x
   DELEO JA, 1986, NEUROSCI LETT, V67, P63, DOI 10.1016/0304-3940(86)90209-0
   Dittmur JC, 1969, METHOD ENZYMOL, V14, P482, DOI DOI 10.1016/S0076-6879(69)14055-0
   FLOYD RA, 1984, FREE RADICALS MOL BI, P143
   FLOYD RA, 1980, FREE RADICALS BIOL, V4, P187
   FRIDOVICH I, 1978, SCIENCE, V201, P875, DOI 10.1126/science.210504
   FRIDOVICH I, 1986, ARCH BIOCHEM BIOPHYS, V247, P1, DOI 10.1016/0003-9861(86)90526-6
   GUTTERIDGE JMC, 1990, TRENDS BIOCHEM SCI, V15, P129, DOI 10.1016/0968-0004(90)90206-Q
   HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001
   HALLIWELL B, 1985, TRENDS NEUROSCI, V8, P22, DOI 10.1016/0166-2236(85)90010-4
   HALLIWELL B, 1986, ARCH BIOCHEM BIOPHYS, V246, P501, DOI 10.1016/0003-9861(86)90305-X
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   LABEUR M, 1991, NEUROSCI LETT, V125, P129, DOI 10.1016/0304-3940(91)90008-H
   LEIBOVITZ BE, 1980, J GERONTOL, V35, P45, DOI 10.1093/geronj/35.1.45
   LESHEM YY, 1984, PLANT PHYSIOL, V75, P329, DOI 10.1104/pp.75.2.329
   MCCORD JM, 1985, NEW ENGL J MED, V312, P159
   MEITES J, 1987, EXP GERONTOL, V22, P1, DOI 10.1016/0531-5565(87)90010-6
   NAGY IZ, 1978, J THEOR BIOL, V75, P189
   NAUSEEF WM, 1991, J BIOL CHEM, V266, P5911
   PACKER L, 1967, ADV GERONTOLOGICAL R, P77
   PENNINGTON R, 1961, BIOCHEM J, V80, P649, DOI 10.1042/bj0800649
   Pryor W.A., 1984, FREE RADICALS MOL BI, P13
   REFF ME, 1985, HDB BIOL AGING, P225
   ROBERTS MF, 1977, J BIOL CHEM, V252, P2405
   SAWADA M, 1989, CAN J PHYSIOL PHARM, V67, P465, DOI 10.1139/y89-074
   SAWADA M, 1987, MECH AGEING DEV, V41, P125, DOI 10.1016/0047-6374(87)90057-1
   SAWADA M, 1991, ENDOCRINOLOGY, V128, P2992, DOI 10.1210/endo-128-6-2992
   SAWADA M, 1990, J CELL BIOCHEM, V44, P153, DOI 10.1002/jcb.240440304
   SEMSEI I, 1991, MECH AGEING DEV, V58, P13, DOI 10.1016/0047-6374(91)90116-H
   Shock N. W., 1977, Handbook of the biology of aging, P639
   SLATER TF, 1984, METHOD ENZYMOL, V105, P283
   SLATER TF, 1972, FREE RADICAL MECHANI, P21
   SORENSEN K, 1986, EXPERIENTIA, V42, P161, DOI 10.1007/BF01952446
   SOTTOCASA GL, 1967, J CELL BIOL, V32, P415, DOI 10.1083/jcb.32.2.415
   UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1
   VANE JR, 1971, NATURE-NEW BIOL, V231, P232, DOI 10.1038/newbio231232a0
NR 44
TC 59
Z9 60
U1 0
U2 6
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0730-2312
J9 J CELL BIOCHEM
JI J. Cell. Biochem.
PD MAR
PY 1992
VL 48
IS 3
BP 296
EP 304
DI 10.1002/jcb.240480310
PG 9
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA HH508
UT WOS:A1992HH50800009
PM 1328256
DA 2024-02-19
ER

PT J
AU Lonnrot, K
   MetsaKetela, T
   Alho, H
AF Lonnrot, K
   MetsaKetela, T
   Alho, H
TI The role of coenzyme Q-10 in aging: A follow-up study on lifelong oral
   supplementation Q-10 in rats
SO GERONTOLOGY
LA English
DT Article; Proceedings Paper
CT 5th International Symposium on Lipofuscin and Ceroid Pigments, at the
   International Gerontology Week
CY 1995
CL TOKYO, JAPAN
DE ubiquinone; coenzyme Q-10; supplementation; life-span; aging
ID SPAN
AB The essential role of coenzyme Q - ubiquinone - in biological energy transduction is well established. Reduced Q - ubiquinol- has also been shown to act as an antioxidant and to decrease the action of free radicals, which in turn could cause damage to structural lipids or proteins. The accumulation of lipopigments during aging in several peripheral organs and in the nervous system is considered to be related to the peroxidation of unsaturated fatty acids. An age-related decline of Q-10 has been suggested to occur in man and rats. In this study we followed the effects of life-long oral supplementation of coenzyme Q-10 on the development and life-span and pigment accumulation in peripheral tissues and the nervous system of laboratory rats. The Q-10 supplemented group showed a significant increase in Q-10 in plasma and liver, while it was unchanged in other tissues. There was no significant difference between the two groups in the development and mortality of the animals. No differences were observed in lipopigment accumulation. Our results indicate that in rats, life-long supplementation of Q-10 has no beneficial effects on life-span or pigment accumulation.
C1 TAMPERE UNIV,SCH MED,NEUROBIOL LAB,SF-33101 TAMPERE,FINLAND.
   TAMPERE UNIV,SCH MED,DEPT PHARMACOL,SF-33101 TAMPERE,FINLAND.
C3 Tampere University; Tampere University
OI Lonnrot, Kimmo/0000-0003-4361-1007
CR ALHO H, 1990, ADV EXP MED BIOL, V266, P143
   APPELKVIST EL, 1991, BIOMED CLIN, V6, P141
   ARKIN R, 1991, BIOL AGING OBSERVATI, P255
   Armstrong D., 1984, FREE RADICALS MOL BI, P129
   BEYER RE, 1985, MECH AGEING DEV, V32, P267, DOI 10.1016/0047-6374(85)90085-5
   BEYER RE, 1987, CHEM SCRIPTA, V27, P145
   BLIZNAKOV EG, 1981, BIOMEDICAL CLIN ASPE, V3, P311
   Einarson L., 1960, Biologiske Skrifter, V11, P1
   Ernster L., 1993, CLIN INVESTIGATOR, V71, P60
   FOLKERS K, 1992, MED CHEM RES, V2, P48
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   HERVONEN A, 1986, NEUROHISTOCHEM, P569
   IVY G, 1984, SCIENCE, V23, P985
   KITANI K, 1992, LIFE SCI, V52, P281
   KNOLL J, 1988, MECH AGEING DEV, V46, P237, DOI 10.1016/0047-6374(88)90128-5
   KOISTINAHO J, 1986, MECH AGEING DEV, V37, P79, DOI 10.1016/0047-6374(86)90120-X
   LAGSJOEN P, 1990, AM J CARDIOL, V65, P521
   LANG JK, 1986, ANAL BIOCHEM, V157, P106, DOI 10.1016/0003-2697(86)90203-4
   LONNROT K, 1995, IN PRESS FREE RAD BI
   MASORO EJ, 1988, J GERONTOL, V43, P59
   SAWADA M, 1984, EXP GERONTOL, V19, P179, DOI 10.1016/0531-5565(84)90036-6
   Sohal R. S., 1981, AGE PIGMENTS
   SOHAL RS, 1990, ADV EXP MED BIOL, V266, P17
   UOTILA JT, 1994, FREE RADICAL BIO MED, V16, P581, DOI 10.1016/0891-5849(94)90058-2
NR 25
TC 12
Z9 12
U1 0
U2 0
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0304-324X
J9 GERONTOLOGY
JI Gerontology
PY 1995
VL 41
SU 2
BP 109
EP 118
PG 10
WC Geriatrics & Gerontology
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA TT821
UT WOS:A1995TT82100017
PM 8821325
DA 2024-02-19
ER

PT J
AU Smith, EJ
   Shay, KP
   Thomas, NO
   Butler, JA
   Finlay, LF
   Hagen, TM
AF Smith, Eric J.
   Shay, Kate P.
   Thomas, Nicholas O.
   Butler, Judy A.
   Finlay, Liam F.
   Hagen, Tory M.
TI Age-related loss of hepatic Nrf2 protein homeostasis: Potential role for
   heightened expression of miR-146a
SO FREE RADICAL BIOLOGY AND MEDICINE
LA English
DT Article
DE Nrf2; Translation; MicroRNA; Aging; Antioxidant response element
ID ANTIOXIDANT RESPONSE; LIPOIC ACID; CANCER CHEMOPREVENTION; RAT-LIVER;
   IN-VITRO; GLUTATHIONE; MICRORNA; REDOX; TRANSLATION; METABOLISM
AB Nrf2 regulates the expression of numerous anti-oxidant, anti-inflammatory, and metabolic genes. We observed that, paradoxically, Nrf2 protein levels decline in the livers of aged rats despite the inflammatory environment evident in that organ. To examine the cause(s) of this loss, we investigated the age-related changes in Nrf2 protein homeostasis and activation in cultured hepatocytes from young (4-6 months) and old (24-28 months) Fischer 344 rats. While no age-dependent change in Nrf2 mRNA levels was observed (p > 0.05), Nrf2 protein content, and the basal and anetholetrithione (A3T)-induced expression of Nrf2-dependent genes were attenuated with age. Conversely, overexpression of Nrf2 in cells from old animals reinstated gene induction. Treatment with A3T, along with bortezomib to inhibit degradation of existing protein, caused Nrf2 to accumulate significantly in cells from young animals (p < 0.05), but not old, indicating a lack of new Nrf2 synthesis. We hypothesized that the loss of Nrf2 protein synthesis with age may partly stem from an age-related increase in microRNA inhibition of Nrf2 translation. Microarray analysis revealed that six microRNAs significantly increase > 2-fold with age (p < 0.05). One of these, miRNA-146a, is predicted to bind Nri2 mRNA. Transfection of hepatocytes from young rats with a miRNA-146a mimic caused a 55% attenuation of Nrf2 translation that paralleled the age-related loss of Nrf2. Overall, these results provide novel insights for the age-related decline in Nrf2 and identify new targets to maintain Nrf2-dependent detoxification with age. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Smith, Eric J.; Shay, Kate P.; Thomas, Nicholas O.; Butler, Judy A.; Finlay, Liam F.; Hagen, Tory M.] Oregon State Univ, Linus Pauling Inst, Corvallis, OR 97331 USA.
   [Smith, Eric J.; Thomas, Nicholas O.; Hagen, Tory M.] Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA.
C3 Oregon State University; Oregon State University
RP Hagen, TM (corresponding author), Oregon State Univ, Linus Pauling Sci Ctr, Corvallis, OR 97331 USA.
EM tory.hagen@oregonstate.edu
OI , Tushar/0000-0002-8527-8719
FU NIH Grant [P01AT002034, R01 2AG17141]; Medical Research Foundation of
   Oregon [2014-14-1837]
FX This work was supported by NIH Grant P01AT002034 and NIH R01 2AG17141
   and a grant from the Medical Research Foundation of Oregon (Grant number
   2014-14-1837).
CR Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90
   Butler JM, 2008, CLIN PHARMACOKINET, V47, P297, DOI 10.2165/00003088-200847050-00002
   Cheng XH, 2013, FREE RADICAL BIO MED, V64, P4, DOI 10.1016/j.freeradbiomed.2013.07.025
   Dai DF, 2014, AGING CELL, V13, P529, DOI 10.1111/acel.12203
   Dalal Sushila R, 2010, Gastroenterol Hepatol (N Y), V6, P714
   Finlay LA, 2012, AM J PHYSIOL-REG I, V302, pR587, DOI 10.1152/ajpregu.00393.2011
   Geismann C, 2014, ONCOTARGETS THER, V7, P1497, DOI 10.2147/OTT.S36624
   Hagen TM, 2000, ANTIOXID REDOX SIGN, V2, P473, DOI 10.1089/15230860050192251
   Hayes JD, 2001, CANCER LETT, V174, P103, DOI 10.1016/S0304-3835(01)00695-4
   Hayes JD, 2014, TRENDS BIOCHEM SCI, V39, P199, DOI 10.1016/j.tibs.2014.02.002
   Hine CM, 2012, J CLIN EXPT PATHOL, VS4, P1
   Hur W, 2011, CURR OPIN CHEM BIOL, V15, P162, DOI 10.1016/j.cbpa.2010.12.009
   Jiang P, 2012, EXP CELL RES, V318, P1175, DOI 10.1016/j.yexcr.2012.03.018
   Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035
   Kwak MK, 2002, MOL CELL BIOL, V22, P2883, DOI 10.1128/MCB.22.9.2883-2892.2002
   Li N, 2006, ANTIOXID REDOX SIGN, V8, P88, DOI 10.1089/ars.2006.8.88
   Li N, 2011, MECH AGEING DEV, V132, P75, DOI 10.1016/j.mad.2010.12.004
   Li WG, 2010, NUCLEIC ACIDS RES, V38, P778, DOI 10.1093/nar/gkp1048
   McLachlan AJ, 2011, BRIT J CLIN PHARMACO, V71, P351, DOI 10.1111/j.1365-2125.2010.03847.x
   Moon EJ, 2015, FREE RADICAL BIO MED, V79, P292, DOI 10.1016/j.freeradbiomed.2014.11.009
   Mori MA, 2012, CELL METAB, V16, P336, DOI 10.1016/j.cmet.2012.07.017
   NOHL H, 1993, BRIT MED BULL, V49, P653, DOI 10.1093/oxfordjournals.bmb.a072638
   O'Connell RM, 2012, ANNU REV IMMUNOL, V30, P295, DOI 10.1146/annurev-immunol-020711-075013
   Paraskevi A, 2012, J CROHNS COLITIS, V6, P900, DOI 10.1016/j.crohns.2012.02.006
   Purdom-Dickinson SE, 2007, MOL PHARMACOL, V72, P1074, DOI 10.1124/mol.107.035360
   RICHIE JP, 1992, BIOCHEM PHARMACOL, V44, P129, DOI 10.1016/0006-2952(92)90046-L
   Salminen A, 2012, AGING-US, V4, P166, DOI 10.18632/aging.100444
   Schöneich C, 1999, EXP GERONTOL, V34, P19, DOI 10.1016/S0531-5565(98)00066-7
   Shay KP, 2012, BBA-MOL CELL RES, V1823, P1102, DOI 10.1016/j.bbamcr.2012.04.002
   Shenvi S.V., 2008, CURR PROTOC TOXICOL, V37
   Shenvi SV, 2012, AGING CELL, V11, P297, DOI 10.1111/j.1474-9726.2011.00788.x
   Sohal RS, 2012, FREE RADICAL BIO MED, V52, P539, DOI 10.1016/j.freeradbiomed.2011.10.445
   Suh JH, 2004, P NATL ACAD SCI USA, V101, P3381, DOI 10.1073/pnas.0400282101
   Testa R, 1998, FUNDAM CLIN PHARM, V12, P220, DOI 10.1111/j.1472-8206.1998.tb00945.x
   Vadhana MSD, 2013, CHEMOSPHERE, V93, P1029, DOI 10.1016/j.chemosphere.2013.05.073
   Vasilaki A, 2006, AGING CELL, V5, P109, DOI 10.1111/j.1474-9726.2006.00198.x
   Walker JR, 2004, GENOME RES, V14, P742, DOI 10.1101/gr.2161804
   WIBERG GS, 1970, TOXICOL APPL PHARM, V16, P718, DOI 10.1016/0041-008X(70)90077-3
   Xu BB, 2014, BBA-MOL BASIS DIS, V1842, P1638, DOI 10.1016/j.bbadis.2014.06.002
   Yang MH, 2011, BREAST CANCER RES TR, V129, P983, DOI 10.1007/s10549-011-1604-1
   Zhang YS, 2008, MOL CANCER THER, V7, P3470, DOI 10.1158/1535-7163.MCT-08-0625
NR 41
TC 36
Z9 41
U1 1
U2 29
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0891-5849
EI 1873-4596
J9 FREE RADICAL BIO MED
JI Free Radic. Biol. Med.
PD DEC
PY 2015
VL 89
BP 1184
EP 1191
DI 10.1016/j.freeradbiomed.2015.11.003
PG 8
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA CY4CI
UT WOS:000366355800110
PM 26549877
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Chandra, PK
   Cikic, S
   Rutkai, I
   Guidry, JJ
   Katakam, PVG
   Mostany, R
   Busija, DW
AF Chandra, Partha K.
   Cikic, Sinisa
   Rutkai, Ibolya
   Guidry, Jessie J.
   Katakam, Prasad V. G.
   Mostany, Ricardo
   Busija, David W.
TI Effects of aging on protein expression in mice brain microvessels: ROS
   scavengers, mRNA/protein stability, glycolytic enzymes, mitochondrial
   complexes, and basement membrane components
SO GEROSCIENCE
LA English
DT Article; Early Access
DE Cortical microvessels; Proteomics; Brain aging; ROS scavengers; mRNA;
   protein stability; Glycolytic; mitochondrial proteins
ID AGE-RELATED-CHANGES; FRONTOTEMPORAL LOBAR DEGENERATION;
   GLUTATHIONE-PEROXIDASE DEFICIENCY; MESSENGER-RNA TURNOVER; CEREBRAL
   BLOOD-FLOW; OXIDATIVE STRESS; AEROBIC GLYCOLYSIS; ENDOTHELIAL
   DYSFUNCTION; LIVER-MITOCHONDRIA; NAD(P)H OXIDASE
AB Differentially expressed (DE) proteins in the cortical microvessels (MVs) of young, middle-aged, and old male and female mice were evaluated using discovery-based proteomics analysis (> 4,200 quantified proteins/group). Most DE proteins (> 90%) showed no significant differences between the sexes; however, some significant DE proteins showing sexual differences in MVs decreased from young (8.3%), to middle-aged (3.7%), to old (0.5%) mice. Therefore, we combined male and female data for age-dependent comparisons but noted sex differences for examination. Key proteins involved in the oxidative stress response, mRNA or protein stability, basement membrane (BM) composition, aerobic glycolysis, and mitochondrial function were significantly altered with aging. Relative abundance of superoxide dismutase-1/-2, catalase and thioredoxin were reduced with aging. Proteins participating in either mRNA degradation or pre-mRNA splicing were significantly increased in old mice MVs, whereas protein stabilizing proteins decreased. Glycolytic proteins were not affected in middle age, but the relative abundance of these proteins decreased in MVs of old mice. Although most of the 41 examined proteins composing mitochondrial complexes I-V were reduced in old mice, six of these proteins showed a significant reduction in middle-aged mice, but the relative abundance increased in fourteen proteins. Nidogen, collagen, and laminin family members as well as perlecan showed differing patterns during aging, indicating BM reorganization starting in middle age. We suggest that increased oxidative stress during aging leads to adverse protein profile changes of brain cortical MVs that affect mRNA/protein stability, BM integrity, and ATP synthesis capacity.
C1 [Chandra, Partha K.; Cikic, Sinisa; Rutkai, Ibolya; Katakam, Prasad V. G.; Mostany, Ricardo; Busija, David W.] Tulane Univ, Dept Pharmacol, Sch Med, 1430 Tulane Ave 8683, New Orleans, LA 70112 USA.
   [Rutkai, Ibolya; Katakam, Prasad V. G.; Mostany, Ricardo; Busija, David W.] Tulane Univ, Tulane Brain Inst, 200 Flower Hall, New Orleans, LA 70118 USA.
   [Guidry, Jessie J.] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA.
   [Guidry, Jessie J.] Louisiana State Univ, Prote Core Facil, Hlth Sci Ctr, New Orleans, LA 70112 USA.
C3 Tulane University; Tulane University; Louisiana State University System;
   Louisiana State University Health Sciences Center New Orleans; Louisiana
   State University System; Louisiana State University Health Sciences
   Center New Orleans
RP Chandra, PK (corresponding author), Tulane Univ, Dept Pharmacol, Sch Med, 1430 Tulane Ave 8683, New Orleans, LA 70112 USA.
EM pchandr1@tulane.edu
RI Mostany, Ricardo/B-3624-2008
OI Mostany, Ricardo/0000-0002-5379-0080; Katakam,
   Prasad/0000-0002-4708-9140; Guidry, Jessie/0000-0002-5601-0430
FU NIH [HL-148836, AG-063345]; Louisiana Board of Regents Endowed Chairs
   for Eminent Scholars program [NS094834, AG074489, NS114286, AG047296]
FX This research was supported in whole or in part by the grants NIH
   HL-148836 (DWB), NIH AG-063345 (DWB), the Louisiana Board of Regents
   Endowed Chairs for Eminent Scholars program (DWB), NS094834 (PVKG),
   AG074489 (PVKG and RM), NS114286 (PVKG and RM), and AG047296 (RM).
CR ABERNETHY WB, 1993, EXP NEUROL, V121, P270, DOI 10.1006/exnr.1993.1095
   Aldana BI, 2019, J MOL BIOL, V431, P1830, DOI 10.1016/j.jmb.2019.03.006
   Alluri H, 2014, MICROCIRCULATION, V21, P187, DOI 10.1111/micc.12110
   Anisimova AS, 2018, AGING-US, V10, P4269, DOI 10.18632/aging.101721
   Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093
   Araki Y, 2001, EMBO J, V20, P4684, DOI 10.1093/emboj/20.17.4684
   Barros LF, 2018, GLIA, V66, P1134, DOI 10.1002/glia.23316
   Bauernfeind AL, 2014, J HUM EVOL, V77, P132, DOI 10.1016/j.jhevol.2014.05.016
   Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005
   BELL MA, 1986, CAN J NEUROL SCI, V13, P456
   BELL MA, 1990, NEUROBIOL AGING, V11, P359, DOI 10.1016/0197-4580(90)90001-G
   BELL MA, 1981, ACTA NEUROPATHOL, V53, P299, DOI 10.1007/BF00690372
   BLACK JE, 1989, NEUROBIOL AGING, V10, P353, DOI 10.1016/0197-4580(89)90048-1
   Borbolis F, 2015, MECH AGEING DEV, V152, P32, DOI 10.1016/j.mad.2015.09.006
   Brewer G, 2002, AGEING RES REV, V1, P607, DOI 10.1016/S1568-1637(02)00023-5
   Brown WR, 2011, NEUROPATH APPL NEURO, V37, P56, DOI 10.1111/j.1365-2990.2010.01139.x
   Brown WR, 2007, J NEUROL SCI, V257, P62, DOI 10.1016/j.jns.2007.01.015
   BUCHWEITZMILTON E, 1987, NEUROBIOL AGING, V8, P271, DOI 10.1016/0197-4580(87)90012-1
   Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840
   Cai W, 2017, AGEING RES REV, V34, P77, DOI 10.1016/j.arr.2016.09.006
   Calderwood SK, 2009, GERONTOLOGY, V55, P550, DOI 10.1159/000225957
   Candiello J, 2010, MATRIX BIOL, V29, P402, DOI 10.1016/j.matbio.2010.03.004
   CASEY MA, 1985, NEUROBIOL AGING, V6, P39, DOI 10.1016/0197-4580(85)90070-3
   Ceafalan LC, 2019, J CELL MOL MED, V23, P819, DOI 10.1111/jcmm.13980
   Cerella C, 2014, BIOCHEM PHARMACOL, V92, P22, DOI 10.1016/j.bcp.2014.07.005
   CERVOSNAVARRO J, 1987, MECH AGEING DEV, V39, P223, DOI 10.1016/0047-6374(87)90062-5
   Chandra PK, 2021, J CEREBR BLOOD F MET, V41, P2311, DOI 10.1177/0271678X21999553
   Chiarugi A, 2012, NAT REV CANCER, V12, P741, DOI 10.1038/nrc3340
   Chrissobolis S, 2008, HYPERTENSION, V51, P872, DOI 10.1161/HYPERTENSIONAHA.107.103572
   Chung HY, 2009, AGEING RES REV, V8, P18, DOI 10.1016/j.arr.2008.07.002
   Cikic S, 2021, J CEREBR BLOOD F MET, V41, P397, DOI 10.1177/0271678X20915127
   Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635
   Cunnane SC, 2020, NAT REV DRUG DISCOV, V19, P609, DOI 10.1038/s41573-020-0072-x
   DASTUR DK, 1985, J CEREBR BLOOD F MET, V5, P1, DOI 10.1038/jcbfm.1985.1
   De Bock K, 2013, CELL, V154, P651, DOI 10.1016/j.cell.2013.06.037
   de la Torre JC, 2017, J ALZHEIMERS DIS, V57, P353, DOI 10.3233/JAD-161266
   Eelen G, 2013, TRENDS ENDOCRIN MET, V24, P589, DOI 10.1016/j.tem.2013.08.006
   Eichmann A, 2013, EMBO MOL MED, V5, P1459, DOI 10.1002/emmm.201303174
   Elahy M, 2015, IMMUN AGEING, V12, DOI 10.1186/s12979-015-0029-9
   Epstein T, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-7
   Fang EF, 2016, NAT REV MOL CELL BIO, V17, P308, DOI 10.1038/nrm.2016.14
   Feher J, 2006, NEUROBIOL AGING, V27, P983, DOI 10.1016/j.neurobiolaging.2005.05.012
   Ferszt R, 1983, Brain aging: neuropathology and neuropharmacology, P133
   Forgione MA, 2002, CIRCULATION, V106, P1154, DOI 10.1161/01.CIR.0000026820.87824.6A
   Forgione MA, 2002, AM J PHYSIOL-HEART C, V282, pH1255, DOI 10.1152/ajpheart.00598.2001
   Fu XD, 2014, NAT REV GENET, V15, P689, DOI 10.1038/nrg3778
   Giresi PG, 2005, PHYSIOL GENOMICS, V21, P253, DOI 10.1152/physiolgenomics.00249.2004
   Goveia J, 2014, EMBO MOL MED, V6, P1105, DOI 10.15252/emmm.201404156
   Goyal MS, 2017, CELL METAB, V26, P353, DOI 10.1016/j.cmet.2017.07.010
   Goyal MS, 2014, CELL METAB, V19, P49, DOI 10.1016/j.cmet.2013.11.020
   Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494
   Grimm A, 2017, J NEUROCHEM, V143, P418, DOI 10.1111/jnc.14037
   Grosset C, 2000, CELL, V103, P29, DOI 10.1016/S0092-8674(00)00102-1
   Guzik TJ, 2000, CIRC RES, V86, pE85, DOI 10.1161/01.RES.86.9.e85
   Hagen TM, 2003, ANTIOXID REDOX SIGN, V5, P503, DOI 10.1089/152308603770310149
   Halfter W, 2015, FEBS J, V282, P4466, DOI 10.1111/febs.13495
   Han BH, 2015, P NATL ACAD SCI USA, V112, pE881, DOI 10.1073/pnas.1414930112
   Harries LW, 2011, AGING CELL, V10, P868, DOI 10.1111/j.1474-9726.2011.00726.x
   Heintz C, 2017, NATURE, V541, P102, DOI 10.1038/nature20789
   HINDS JW, 1982, NEUROBIOL AGING, V3, P197, DOI 10.1016/0197-4580(82)90040-9
   Holly AC, 2013, MECH AGEING DEV, V134, P356, DOI 10.1016/j.mad.2013.05.006
   Hurst RD, 2001, BRAIN RES, V894, P181, DOI 10.1016/S0006-8993(01)01992-8
   Hussain B, 2021, FRONT NEUROSCI-SWITZ, V15, DOI 10.3389/fnins.2021.688090
   Inukai S, 2013, J MOL BIOL, V425, P3601, DOI 10.1016/j.jmb.2013.01.023
   Jain S, 2013, ADV EXP MED BIOL, V768, P23, DOI 10.1007/978-1-4614-5107-5_3
   Jessen SB, 2017, CEREB CORTEX, V27, P646, DOI 10.1093/cercor/bhv261
   JUCKER M, 1990, NEUROBIOL AGING, V11, P39, DOI 10.1016/0197-4580(90)90060-D
   Kalaria RN, 1996, PHARMACOL THERAPEUT, V72, P193, DOI 10.1016/S0163-7258(96)00116-7
   KLEIN AW, 1977, MECH AGEING DEV, V6, P441, DOI 10.1016/0047-6374(77)90045-8
   Klosinski LP, 2015, EBIOMEDICINE, V2, P1888, DOI 10.1016/j.ebiom.2015.11.002
   Kour S, 2016, AGEING RES REV, V26, P1, DOI 10.1016/j.arr.2015.12.001
   Krause KH, 2007, EXP GERONTOL, V42, P256, DOI 10.1016/j.exger.2006.10.011
   Kregel KC, 2007, AM J PHYSIOL-REG I, V292, pR18, DOI 10.1152/ajpregu.00327.2006
   Lassègue B, 2012, CIRC RES, V110, P1364, DOI 10.1161/CIRCRESAHA.111.243972
   LeBleu VS, 2007, EXP BIOL MED, V232, P1121, DOI 10.3181/0703-MR-72
   Lee KH, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21197152
   Lee P, 2012, EXP NEUROL, V234, P50, DOI 10.1016/j.expneurol.2011.12.016
   Lennicke C, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0118-6
   Leuner K, 2007, ANTIOXID REDOX SIGN, V9, P1659, DOI 10.1089/ars.2007.1763
   Lim J, 2014, CELL, V159, P1365, DOI 10.1016/j.cell.2014.10.055
   Loll-Krippleber R, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00632-2
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Magistretti PJ, 2016, P NATL ACAD SCI USA, V113, P7015, DOI 10.1073/pnas.1607423113
   Mandal PK, 2012, BIOCHEM BIOPH RES CO, V417, P43, DOI 10.1016/j.bbrc.2011.11.047
   Mengel-From J, 2014, HUM GENET, V133, P1149, DOI 10.1007/s00439-014-1458-9
   Merdzo I, 2017, J VASC RES, V54, P1, DOI 10.1159/000454812
   Moeini M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26543-w
   MOODY DM, 1991, CLIN NEUR, V37, P372
   Moody DM, 1997, ANN NY ACAD SCI, V826, P103, DOI 10.1111/j.1749-6632.1997.tb48464.x
   Navarro A, 2004, AM J PHYSIOL-REG I, V287, pR1244, DOI 10.1152/ajpregu.00226.2004
   Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108
   Noda A, 2002, BRAIN RES, V936, P76, DOI 10.1016/S0006-8993(02)02558-1
   Pandya JD, 2015, NEUROBIOL AGING, V36, P1903, DOI 10.1016/j.neurobiolaging.2015.01.018
   Patel GP, 2006, FEBS J, V273, P5678, DOI 10.1111/j.1742-4658.2006.05556.x
   Bordone MP, 2019, J NEUROCHEM, V151, P139, DOI 10.1111/jnc.14829
   Petrosillo G, 2009, FREE RADICAL BIO MED, V46, P88, DOI 10.1016/j.freeradbiomed.2008.09.031
   Pollard AK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157405
   Pyle A, 2016, NEUROBIOL AGING, V38, DOI 10.1016/j.neurobiolaging.2015.10.033
   Ravens J R, 1978, Adv Neurol, V20, P487
   Rivard A, 1999, CIRCULATION, V99, P111, DOI 10.1161/01.CIR.99.1.111
   Rosenberg GA, 2012, J CEREBR BLOOD F MET, V32, P1139, DOI 10.1038/jcbfm.2011.197
   Rygiel KA, 2014, NEUROBIOL AGING, V35, P2230, DOI 10.1016/j.neurobiolaging.2014.02.027
   Salmina AB, 2015, INT J BIOCHEM CELL B, V64, P174, DOI 10.1016/j.biocel.2015.04.005
   Sandhu SK, 2003, BIOGERONTOLOGY, V4, P19, DOI 10.1023/A:1022473219044
   Schoors S, 2014, CELL CYCLE, V13, P16, DOI 10.4161/cc.27519
   Seo M, 2016, CELL CYCLE, V15, P1821, DOI 10.1080/15384101.2016.1183845
   Shannon BJ, 2016, P NATL ACAD SCI USA, V113, pE3782, DOI 10.1073/pnas.1604977113
   Shao WH, 2010, ANAT REC, V293, P1400, DOI 10.1002/ar.21184
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Skourti-Stathaki K, 2011, MOL CELL, V42, P794, DOI 10.1016/j.molcel.2011.04.026
   Sokolov SS, 2020, BIOCHEMISTRY-MOSCOW+, V85, P651, DOI 10.1134/S0006297920060024
   Sonntag WE, 1997, ENDOCRINOLOGY, V138, P3515, DOI 10.1210/en.138.8.3515
   Soti C, 2003, EXP GERONTOL, V38, P1037, DOI 10.1016/S0531-5565(03)00185-2
   Southworth LK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000776
   Sure VN, 2018, GEROSCIENCE, V40, P365, DOI 10.1007/s11357-018-0037-8
   Sweeney MD, 2019, ALZHEIMERS DEMENT, V15, P158, DOI 10.1016/j.jalz.2018.07.222
   Taylor JM, 2005, J NEUROCHEM, V92, P283, DOI 10.1111/j.1471-4159.2004.02863.x
   Tollervey JR, 2011, GENOME RES, V21, P1572, DOI 10.1101/gr.122226.111
   Touyz RM, 2004, HYPERTENSION, V44, P248, DOI 10.1161/01.HYP.0000138070.47616.9d
   Tucsek Z, 2014, J GERONTOL A-BIOL, V69, P1212, DOI 10.1093/gerona/glt177
   Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478
   Ubaida-Mohien C, 2019, ELIFE, V8, DOI 10.7554/eLife.49874
   van Hoof A, 2000, MOL CELL BIOL, V20, P8230, DOI 10.1128/MCB.20.21.8230-8243.2000
   Venkateshappa C, 2012, NEUROCHEM RES, V37, P1601, DOI 10.1007/s11064-012-0755-8
   Ventura B, 2002, BBA-BIOENERGETICS, V1553, P249, DOI 10.1016/S0005-2728(01)00246-8
   Verheggen ICM, 2020, GEROSCIENCE, V42, P1183, DOI 10.1007/s11357-020-00211-2
   Wang J, 2015, NEUROL SCI, V36, P743, DOI 10.1007/s10072-014-2029-5
   Welle S, 2003, PHYSIOL GENOMICS, V14, P149, DOI 10.1152/physiolgenomics.00049.2003
   WILKINSON JH, 1981, NEUROPATH APPL NEURO, V7, P451, DOI 10.1111/j.1365-2990.1981.tb00245.x
   Willcox JK, 2004, CRIT REV FOOD SCI, V44, P275, DOI 10.1080/10408690490468489
   Winklhofer KF, 2008, EMBO J, V27, P336, DOI 10.1038/sj.emboj.7601930
   Xu J, 2007, J BIOENERG BIOMEMBR, V39, P195, DOI 10.1007/s10863-007-9077-y
   Yue XP, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20143401
NR 134
TC 10
Z9 10
U1 0
U2 6
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 2509-2715
EI 2509-2723
J9 GEROSCIENCE
JI GeroScience
PD 2022 FEB
PY 2022
VL 44
IS 1
SI SI
BP 371
EP 388
DI 10.1007/s11357-021-00468-1
EA OCT 2021
PG 18
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA YR7XN
UT WOS:000712490700001
PM 34708300
OA hybrid, Green Published
DA 2024-02-19
ER

PT J
AU PROUDLER, AJ
   FELTON, CV
   STEVENSON, JC
AF PROUDLER, AJ
   FELTON, CV
   STEVENSON, JC
TI AGING AND THE RESPONSE OF PLASMA-INSULIN, GLUCOSE AND C-PEPTIDE
   CONCENTRATIONS TO INTRAVENOUS GLUCOSE IN POSTMENOPAUSAL WOMEN
SO CLINICAL SCIENCE
LA English
DT Article
DE AGING; C-PEPTIDE; GLUCOSE; INSULIN; MENOPAUSE
ID CORONARY HEART-DISEASE; RISK-FACTORS; CARBOHYDRATE-METABOLISM;
   CARDIOVASCULAR-DISEASE; HEPATIC EXTRACTION; DIABETES-MELLITUS; HUMAN
   PROINSULIN; MENOPAUSE; SECRETION; FRAMINGHAM
AB 1. Eighty-six apparently healthy postmenopausal women not receiving hormone replacement therapy were given an intravenous glucose tolerance test. Plasma glucose, insulin and C-peptide concentrations were determined in fasting and post-glucose challenge samples.
   2. Using a multivariate regression model, with predictor variables of chronological age, menopausal age and body mass index, neither chronological age nor menopausal age correlated with fasting or post-challenge plasma glucose or C-peptide concentrations. In contrast, menopausal age was positively associated with fasting plasma insulin concentration (P=0.038, model r2=0.107), insulin area (P=0.01, model r2=0.236) and incremental insulin area (P=0.024, model r2=0.243). This relationship could not be explained by differences in lifestyle variables of alcohol consumption, physical activity, previous duration of oral contraceptive usage, history of cigarette smoking or body mass index.
   3. Our findings suggest that loss of ovarian function is associated with hyperinsulinaemia, possibly via alterations in the clearance of circulating insulin from the plasma. The hyperinsulinaemia observed may contribute to the increased risk of cardiovascular disease seen in postmenopausal women.
C1 WYNN INST METABOL RES, 21 WELLINGTON RD, ST JOHNS WOOD, LONDON NW8 9SQ, ENGLAND.
C3 Imperial College London
CR ANDRES R, 1907, HDB BIOL AGING, P357
   BAILEY CJ, 1980, DIABETOLOGIA, V19, P475, DOI 10.1007/BF00281829
   BALLEISEN L, 1985, THROMB HAEMOSTASIS, V54, P475
   BJORNTORP P, 1990, ARTERIOSCLEROSIS, V10, P493, DOI 10.1161/01.ATV.10.4.493
   BONITHONKOPP C, 1990, INT J EPIDEMIOL, V19, P42, DOI 10.1093/ije/19.1.42
   COLDITZ GA, 1987, NEW ENGL J MED, V316, P1105, DOI 10.1056/NEJM198704303161801
   DAVIDSON MB, 1979, METABOLISM, V28, P688, DOI 10.1016/0026-0495(79)90024-6
   DEFRONZO RA, 1979, DIABETES, V28, P1095, DOI 10.2337/diab.28.12.1095
   DEHAEN C, 1978, J CLIN INVEST, V62, P727, DOI 10.1172/JCI109183
   DUCKWORTH WC, 1976, J LAB CLIN MED, V88, P359
   DUCKWORTH WC, 1988, ENDOCR REV, V9, P319, DOI 10.1210/edrv-9-3-319
   ELSEIFI S, 1981, J ENDOCRINOL, V90, P59, DOI 10.1677/joe.0.0900059
   FINK RI, 1985, DIABETES, V34, P275, DOI 10.2337/diabetes.34.3.275
   GORDON T, 1978, ANN INTERN MED, V89, P157, DOI 10.7326/0003-4819-89-2-157
   GUMBINER B, 1989, DIABETES, V38, P1549, DOI 10.2337/diabetes.38.12.1549
   HJORTLAND MC, 1976, AM J EPIDEMIOL, V103, P304, DOI 10.1093/oxfordjournals.aje.a112228
   HLAD CJ, 1959, J CLIN ENDOCR METAB, V19, P1258, DOI 10.1210/jcem-19-10-1258
   HOLLENBECK C, 1987, J CLIN ENDOCR METAB, V64, P1169, DOI 10.1210/jcem-64-6-1169
   KANNEL WB, 1976, ANN INTERN MED, V85, P447, DOI 10.7326/0003-4819-85-4-447
   LEY CJ, 1992, AM J CLIN NUTR, V55, P950, DOI 10.1093/ajcn/55.5.950
   MATTHEWS KA, 1989, NEW ENGL J MED, V321, P641, DOI 10.1056/NEJM198909073211004
   MEADE TW, 1983, LANCET, V1, P22
   MINAKER KL, 1982, DIABETES, V31, P851, DOI 10.2337/diabetes.31.10.851
   NOTELOVITZ M, 1981, AM J OBSTET GYNECOL, V141, P149, DOI 10.1016/S0002-9378(16)32582-0
   OLIVER MF, 1959, LANCET, V2, P690
   PACINI G, 1990, J AM GERIATR SOC, V38, P1283, DOI 10.1111/j.1532-5415.1990.tb03449.x
   Peiris A N, 1988, Acta Med Scand Suppl, V723, P179
   PEIRIS AN, 1987, J CLIN ENDOCR METAB, V64, P162, DOI 10.1210/jcem-64-1-162
   POLONSKY KS, 1984, DIABETES, V33, P486, DOI 10.2337/diabetes.33.5.486
   REAVEN GM, 1980, MOL CELL BIOCHEM, V31, P37, DOI 10.1007/BF00817889
   RENAULD A, 1987, ACTA PHYSIOL PHARM L, V37, P289
   REVERS RR, 1984, DIABETES, V33, P762, DOI 10.2337/diabetes.33.8.762
   SALLIS JF, 1985, AM J EPIDEMIOL, V121, P91, DOI 10.1093/oxfordjournals.aje.a113987
   STEVENSON JC, 1990, LANCET, V336, P265, DOI 10.1016/0140-6736(90)91801-G
   TILLIL H, 1990, ENDOCRINOLOGY, V127, P2418, DOI 10.1210/endo-127-5-2418
   VAGUE J, 1969, PHYSIOPATHOLOGY ADIP, P360
   WARD WK, 1987, DIABETOLOGIA, V30, P698, DOI 10.1007/BF00296991
   WEISS NS, 1972, AM J EPIDEMIOL, V96, P237, DOI 10.1093/oxfordjournals.aje.a121454
NR 38
TC 59
Z9 67
U1 0
U2 2
PU PORTLAND PRESS LTD
PI LONDON
PA 1ST FLR, 10 QUEEN STREET PLACE, LONDON, ENGLAND
SN 0143-5221
EI 1470-8736
J9 CLIN SCI
JI Clin. Sci.
PD OCT
PY 1992
VL 83
IS 4
BP 489
EP 494
DI 10.1042/cs0830489
PG 6
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA JR654
UT WOS:A1992JR65400015
PM 1330412
DA 2024-02-19
ER

PT J
AU Whitfield, M
   Ouvrier, A
   Cadet, R
   Damon-Soubeyrand, C
   Guiton, R
   Janny, L
   Kocer, A
   Marceau, G
   Pons-Rejraji, H
   Trousson, A
   Drevet, JR
   Saez, F
AF Whitfield, Marjorie
   Ouvrier, Aurelia
   Cadet, Remi
   Damon-Soubeyrand, Christelle
   Guiton, Rachel
   Janny, Laurent
   Kocer, Ayhan
   Marceau, Geoffroy
   Pons-Rejraji, Hanae
   Trousson, Amalia
   Drevet, Joel R.
   Saez, Fabrice
TI Liver X Receptors (LXRs) Alpha and Beta Play Distinct Roles in the Mouse
   Epididymis
SO BIOLOGY OF REPRODUCTION
LA English
DT Article
DE cholesterol homeostasis; epididymis; inflammation; lipids; LXR;
   spermatozoa
ID CHOLESTEROL HOMEOSTASIS; OXYSTEROL RECEPTORS; TNF-ALPHA; EXPRESSION;
   INFLAMMATION; METABOLISM; MATURATION; MICE
AB After its production in the testis, a spermatozoon has to undergo posttesticular maturation steps to become fully motile and fertile. The first step is epididymal maturation, during which immature spermatozoa are transformed into biochemically mature cells ready to proceed to the next step, capacitation, a physiological process occurring in the female genital tract. The biochemical transformations include modification of sperm lipid composition during epididymal transit, with significant changes in fatty acids, phospholipids, and sterols between the caput and the cauda epididymal spermatozoa. Although quantitative aspects of these changes are well documented for several mammalian species, molecular mechanisms governing these steps are poorly understood. Transgenic male mice invalidated for the two liver X receptors (LXRalpha and LXRbeta, nuclear oxysterol receptors regulating cholesterol and lipid metabolism) become sterile when aging, showing an epididymal phenotype. We used single-knockout-model mice to characterize the role of each LXR isoform during sperm maturation in the epididymis. We show here that although a certain redundancy exists in the functions of the two LXR isoforms, some physiological processes are more under the influence of only one of them. In both cases, aging males showed slight subfertility, associated with dyslipidemia, emphasizing the importance of lipid metabolism in relation with male fertility.
C1 [Whitfield, Marjorie; Ouvrier, Aurelia; Cadet, Remi; Damon-Soubeyrand, Christelle; Guiton, Rachel; Janny, Laurent; Kocer, Ayhan; Pons-Rejraji, Hanae; Drevet, Joel R.; Saez, Fabrice] Univ Blaise Pascal, Equipe Mecanismes Posttesticulaires Infertilite, Clermont Univ, UMR GReD Genet Reprod & Dev CNRS 6293,INSERM,U110, Aubiere, France.
   [Marceau, Geoffroy] Univ Auvergne, Retinoids Reprod Dev Dis, Sch Med, Clermont Univ, Clermont Ferrand, France.
   [Marceau, Geoffroy] CHU Clermont Ferrand, Biochem & Mol Biol Dept, Clermont Ferrand, France.
   [Trousson, Amalia] Univ Blaise Pascal, Equipe Lipides Recepteurs Nucl & Troubles Chez Ho, Clermont Univ, UMR GReD Genet Reprod & Dev CNRS 6293,INSERM,U110, Aubiere, France.
   [Trousson, Amalia] Univ Blaise Pascal, Ctr Rech Nutr Humaine Auvergne CRNH, Clermont Univ, UMR GReD Genet Reprod & Dev CNRS 6293,INSERM,U110, Aubiere, France.
C3 Centre National de la Recherche Scientifique (CNRS); CNRS - National
   Institute for Biology (INSB); Institut National de la Sante et de la
   Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA);
   Universite Clermont Auvergne (UCA); CHU Clermont Ferrand; Centre
   National de la Recherche Scientifique (CNRS); CNRS - National Institute
   for Biology (INSB); Universite Clermont Auvergne (UCA); Institut
   National de la Sante et de la Recherche Medicale (Inserm); Centre
   National de la Recherche Scientifique (CNRS); CNRS - National Institute
   for Biology (INSB); Universite Clermont Auvergne (UCA); Institut
   National de la Sante et de la Recherche Medicale (Inserm)
RP Drevet, JR (corresponding author), GReD Campus Univ Cezeaux, CNRS, UMR 6293, INSERM,U1103, 10 Ave Blaise Pascal,TSA 60026,CS 60026, F-63178 Aubiere, France.
EM joel.drevet@univ-bpclermont.fr
RI PONS, HANAE/X-8673-2019; Drevet, Joël/W-2692-2019; WHITFIELD,
   Marjorie/ABH-3433-2021
OI PONS, HANAE/0000-0002-9779-9693; Drevet, Joël/0000-0003-3077-6558;
   WHITFIELD, Marjorie/0000-0001-7956-3436; Trousson,
   Amalia/0000-0001-6587-9501; MARCEAU, GEOFFROY/0000-0003-4713-7162;
   Guiton, Rachel/0000-0002-7155-8736
FU French Ministry of Higher Education and Research (MESR); INSERM; CNRS;
   MESR
FX M.W. and A.O. were supported by the French Ministry of Higher Education
   and Research (MESR). R.C., C.D.-S., R.G., L.J., A.K., H.P.R, A.T.,
   J.R.D., and F.S. received funds from INSERM, CNRS, and MESR.
CR ABE K, 1983, ARCH HISTOL JAPON, V46, P51, DOI 10.1679/aohc.46.51
   Bialas M, 2009, AM J REPROD IMMUNOL, V62, P51, DOI 10.1111/j.1600-0897.2009.00711.x
   Björkgren I, 2015, FASEB J, V29, P433, DOI 10.1096/fj.14-259382
   Castrillo A, 2003, J BIOL CHEM, V278, P10443, DOI 10.1074/jbc.M213071200
   Cooper TG, 2007, ASIAN J ANDROL, V9, P533, DOI 10.1111/j.1745-7262.2007.00285.x
   Cornwall GA, 2001, BIOL REPROD, V64, P1600, DOI 10.1095/biolreprod64.6.1600
   Cornwall GA, 2009, HUM REPROD UPDATE, V15, P213, DOI 10.1093/humupd/dmn055
   Dacheux JL, 2014, REPRODUCTION, V147, pR27, DOI 10.1530/REP-13-0420
   Dohle GR, 2005, EUR UROL, V48, P703, DOI 10.1016/j.eururo.2005.06.002
   El-Hajjaji FZ, 2011, BBA-MOL BASIS DIS, V1812, P974, DOI 10.1016/j.bbadis.2011.02.004
   Fouad TM, 2014, ADV EXP MED BIOL, V816, P53, DOI 10.1007/978-3-0348-0837-8_3
   Frenoux JM, 2004, J MOL ENDOCRINOL, V33, P361, DOI 10.1677/jme.1.01515
   García RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053192
   Hong C, 2011, J LIPID RES, V52, P531, DOI 10.1194/jlr.M010686
   Hong C, 2008, CURR OPIN GENET DEV, V18, P461, DOI 10.1016/j.gde.2008.07.016
   Jamroz-Wisniewska Anna, 2007, Postepy Hig Med Dosw (Online), V61, P760
   Jones R, 2004, BIOL REPROD, V71, P1405, DOI 10.1095/biolreprod.104.031252
   Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820
   Jrad-Lamine A, 2011, J BIOL CHEM, V286, P8030, DOI 10.1074/jbc.M110.172114
   Kalaany NY, 2005, CELL METAB, V1, P231, DOI 10.1016/j.cmet.2005.03.001
   Keber R, 2013, J LIPID RES, V54, P20, DOI 10.1194/jlr.R032326
   Mouzat K, 2007, J BIOL CHEM, V282, P4693, DOI 10.1074/jbc.M606718200
   Ouvrier A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026966
   Ouvrier A, 2009, J LIPID RES, V50, P1766, DOI 10.1194/jlr.M800657-JLR200
   Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4
   Pyttel S, 2014, THERIOGENOLOGY, V82, P396, DOI 10.1016/j.theriogenology.2014.04.017
   Quinet EM, 2006, MOL PHARMACOL, V70, P1340, DOI 10.1124/mol.106.022608
   Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900
   Robertson KM, 2005, ENDOCRINOLOGY, V146, P2519, DOI 10.1210/en.2004-1413
   Rodríguez-Berriguete G, 2013, CYTOKINE, V64, P555, DOI 10.1016/j.cyto.2013.09.003
   Saez F, 2007, ASIAN J ANDROL, V9, P574, DOI 10.1111/j.1745-7262.2007.00301.x
   Saez F, 2011, ASIAN J ANDROL, V13, P11, DOI 10.1038/aja.2010.64
   Shimomura I, 1997, P NATL ACAD SCI USA, V94, P12354, DOI 10.1073/pnas.94.23.12354
   SHORR EPHRAIM, 1941, SCIENCE, V94, P545, DOI 10.1126/science.94.2449.545-a
   Sullivan R, 2013, REPRODUCTION, V146, pR21, DOI 10.1530/REP-13-0058
   Sutovsky P, 2001, J CELL SCI, V114, P1665
   TOWERS B, 1953, J PHYSIOL-LONDON, V119, pP23
   Volle DH, 2007, MOL ENDOCRINOL, V21, P1014, DOI 10.1210/me.2006-0277
   Xu BF, 2014, P NATL ACAD SCI USA, V111, P18643, DOI 10.1073/pnas.1413186112
   Zhang Y, 2012, J CLIN INVEST, V122, P1688, DOI 10.1172/JCI59817
NR 40
TC 6
Z9 6
U1 0
U2 4
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0006-3363
EI 1529-7268
J9 BIOL REPROD
JI Biol. Reprod.
PD MAR 1
PY 2016
VL 94
IS 3
AR 55
DI 10.1095/biolreprod.115.133538
PG 11
WC Reproductive Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Reproductive Biology
GA DG1IK
UT WOS:000371819800007
PM 26792941
OA hybrid
DA 2024-02-19
ER

PT J
AU Mousa, OY
   Nguyen, JH
   Ma, YH
   Rawal, B
   Musto, KR
   Dougherty, MK
   Shalev, JA
   Harnois, DM
AF Mousa, Omar Y.
   Nguyen, Justin H.
   Ma, Yaohua
   Rawal, Bhupendra
   Musto, Kaitlyn R.
   Dougherty, Marjorie K.
   Shalev, Jefree A.
   Harnois, Denise M.
TI Evolving Role of Liver Transplantation in Elderly Recipients
SO LIVER TRANSPLANTATION
LA English
DT Article; Early Access
ID SEPTUAGENARIANS RECEIVING MODEL; DISEASE EXCEPTION POINTS;
   HEPATOCELLULAR-CARCINOMA; OLDER; SURVIVAL; OUTCOMES; IMPACT
AB The need for liver transplantation (LT) among older patients is increasing, but the role of LT in the elderly (>= 70 years) is not well defined. We retrospectively reviewed all primary LTs from 1998 through 2016 at our center. Survival and associated risk factors were analyzed with Cox regression and Kaplan-Meier methods for LT recipients in 3 age groups: <60, 60-69, and >= 70 years. Among 2281 LT recipients, the median age was 56 years (range, 15-80 years), and 162 were aged >= 70 years. The estimated 5- and 10-year patient survival probabilities for elderly LT recipients were lower (70.8% and 43.6%) than for recipients aged 60-69 years (77.2% and 64.6%) and <60 years (80.7% and 67.6%). Patient and graft survival rates associated with LT improved over time from the pre-Model for End-Stage Liver Disease era to Share 15, pre-Share 35, and Share 35 for the cohort overall (P < 0.001), but rates remained relatively stable in septuagenarians throughout the study periods (all P > 0.45). There was no incremental negative effect of age at LT among elderly patients aged 70-75 years (log-rank P = 0.32). Among elderly LT recipients, greater requirement for packed red blood cells and longer warm ischemia times were significantly associated with decreased survival (P < 0.05). Survival of LT recipients, regardless of age, markedly surpassed that of patients who were denied LT, but it was persistently 20%-30% lower than the expected survival of the general US population (P < 0.001). With the aging of the population, select older patients with end-stage liver diseases can benefit from LT, which largely restores their expected life spans.
C1 [Mousa, Omar Y.; Harnois, Denise M.] Mayo Clin, Div Gastroenterol & Hepatol, Jacksonville, FL 32224 USA.
   [Ma, Yaohua; Rawal, Bhupendra] Mayo Clin, Div Biomed Stat & Informat, Jacksonville, FL 32224 USA.
   [Nguyen, Justin H.; Musto, Kaitlyn R.; Dougherty, Marjorie K.; Harnois, Denise M.] Mayo Clin, Dept Transplantat, 4500 San Pablo Rd, Jacksonville, FL 32224 USA.
   [Shalev, Jefree A.] Mayo Clin, Dept Informat Technol, Jacksonville, FL 32224 USA.
C3 Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic
RP Nguyen, JH (corresponding author), Mayo Clin, Dept Transplantat, 4500 San Pablo Rd, Jacksonville, FL 32224 USA.
EM nguyen.justin@mayo.edu
RI Mousa, Omar Y/AAE-6113-2020
OI Mousa, Omar Y/0000-0002-8411-3859
FU National Institutes of Health [R21 AG052822-01A1]
FX This study was partially supported by the National Institutes of Health
   grant R21 AG052822-01A1 to Justin H. Nguyen.
CR Åberg F, 2015, HEPATOLOGY, V61, P668, DOI 10.1002/hep.27538
   Aduen JF, 2009, MAYO CLIN PROC, V84, P973, DOI 10.1016/S0025-6196(11)60667-8
   Agopian VG, 2013, ANN SURG, V258, P409, DOI 10.1097/SLA.0b013e3182a15db4
   Aloia TA, 2010, LIVER TRANSPLANT, V16, P950, DOI 10.1002/lt.22098
   Aranda-Michel J, 2008, MAYO CLIN PROC, V83, P165, DOI 10.4065/83.2.165
   Arias E., 2017, National Vital Statistics Report
   Barber K, 2007, GUT, V56, P279, DOI 10.1136/gut.2006.093195
   Chen HP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152324
   Goldberg DS, 2016, GASTROENTEROLOGY, V150, P306, DOI 10.1053/j.gastro.2015.12.020
   Gavara CG, 2019, HPB, V21, P14, DOI 10.1016/j.hpb.2018.07.025
   He W, 2016, AGING WORLD 2015, DOI DOI 10.13140/RG.2.1.1088.9362
   Herrero JI, 2003, AM J TRANSPLANT, V3, P1407, DOI 10.1046/j.1600-6143.2003.00227.x
   Jain A, 2000, ANN SURG, V232, P490, DOI 10.1097/00000658-200010000-00004
   Jain A, 2011, TRANSPLANTATION, V91, P1025, DOI 10.1097/TP.0b013e3182129215
   Keswani RN, 2004, LIVER TRANSPLANT, V10, P957, DOI 10.1002/lt.20155
   Levy MF, 2001, ANN SURG, V233, P107, DOI 10.1097/00000658-200101000-00016
   Lipshutz GS, 2007, ARCH SURG-CHICAGO, V142, P775, DOI 10.1001/archsurg.142.8.775
   Lunsford KE, 2016, J AM COLL SURGEONS, V223, pE51, DOI 10.1016/j.jamcollsurg.2016.08.149
   Martin P, 2014, HEPATOLOGY, V59, P1144, DOI 10.1002/hep.26972
   Nguyen Justin H, 2008, Clin Transpl, P127
   Park H, 2014, VOLATILE CAPITAL FLOWS IN KOREA: CURRENT POLICIES AND FUTURE RESPONSES, P83
   Randall HB, 2003, ARCH SURG-CHICAGO, V138, P1089, DOI 10.1001/archsurg.138.10.1089
   Schnitzler MA, 2005, AM J TRANSPLANT, V5, P2289, DOI 10.1111/j.1600-6143.2005.01021.x
   Schwartz J, 2012, LIVER TRANSPLANT, V18, P1395, DOI 10.1002/lt.23513
   Schwartz JJ, 2012, LIVER TRANSPLANT, V18, P423, DOI 10.1002/lt.23385
   Su F, 2016, GASTROENTEROLOGY, V150, P441, DOI 10.1053/j.gastro.2015.10.043
   Wilson GC, 2014, HPB, V16, P1088, DOI 10.1111/hpb.12312
NR 27
TC 13
Z9 14
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1527-6465
EI 1527-6473
J9 LIVER TRANSPLANT
JI Liver Transplant.
PD 2019 SEP
PY 2019
VL 25
IS 9
BP 1363
EP 1374
DI 10.1002/lt.25589
EA JUL 2019
PG 12
WC Gastroenterology & Hepatology; Surgery; Transplantation
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology; Surgery; Transplantation
GA IS0YK
UT WOS:000477287700001
PM 31233673
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Seo, YK
   Chung, YT
   Kim, S
   Echchgadda, I
   Song, CS
   Chatterjee, B
AF Seo, Young-Kyo
   Chung, Yoon-Tae
   Kim, Soyoung
   Echchgadda, Ibtissam
   Song, Chung S.
   Chatterjee, Bandana
TI Xenobiotic- and vitamin D-responsive induction of the steroid/bile
   acid-sulfotransferase Sult2A1 in young and old mice: The role of a gene
   enhancer in the liver chromatin
SO GENE
LA English
DT Article
DE aging; sulfotransferase; gene enhancer; nuclear receptor; tissue ChIP
ID DEHYDROEPIANDROSTERONE SULFOTRANSFERASE; EXPRESSION PROFILE; D-RECEPTOR;
   METABOLISM; TRANSCRIPTION; IMMUNOPRECIPITATION; SYSTEM; ALPHA; CAR
AB The xenobiotic-activated nuclear receptors PXR (pregnane X receptor) and CAR (constitutive androstane receptor) and the vitamin D-3-activated nuclear receptor VDR regulate steroid and xenobiotic metabolism by inducing the phase I cytochrome P450 monooxygenases, phase II conjugating transferases, and the phase III transporters, which mediate the efflux of water-soluble lipid metabolites from cells. Metabolic stress due to the deviant expression of steroid- and xenobiotic-metabolizing enzymes is known to have severe health consequences including accelerated aging, and increased expression of these enzymes is associated with extended longevity [Gachon, F, Olela, FF, Schaad, O, Descombes, P and Schibler, U, 2006. The circadian PAR-domain basic leucine zipper transcription factors DBP, TEE, and HLF modulate basal and inducible xenobiotic detoxification. 4, 25-36.; McElwee, JJ, Schuster, E, Blanc, E, Thomas, JH and Gems, D, 2004. Shared Transcriptional Signature in Caenorhabditis elegans Dauer Larvae and Long-lived daf-2 Mutants Implicates Detoxification System in Longevity Assurance. J. Biol. Chem., 279, 44533-43.]. Information on the similarities and dissimilarities in drug metabolism between the young and old, as may be uncovered by studying aging regulation of the genes relevant to steroid and xenobiotic metabolism, is likely to have clinical significance. In this report, we examined the VDR- and PXR-mediated gene induction of the phase II sulfotransferase Sult2Al in the livers of 4-month- and 20-month-old mice. Sult2Al converts bile acids, steroids and a number of drugs to the corresponding sulfated metabolites, which are readily eliminated from the body due to increased water solubility. In RT-PCR assay, aging did not change the induction of Sult2Al mRNAs by the hormonally active vitamin D-3 and the catatoxic synthetic steroid PCN (pregnenolone-16 alpha-carbonitrile). Chromatin immunoprecipitation (ChlP) from liver nuclei showed that aging had no effect on the activity of an IR0 enhancer in the Sult2Al chromatin to recruit VDR, RXR-alpha (retinoid X receptor) and PXR in mice injected with D-3 or PCN. Thus, mice in late life are as competent as those in early life in responding to the hormonal and xenobiotic signaling for Sult2Al induction. This is the first report describing the role of aging in the functional response of an enhancer in the liver chromatin to the nuclear receptor-dependent signaling. (c) 2006 Elsevier B.V. All rights reserved.
C1 S Texas Vet Hlth Care Syst, Inst Biotechnol, Dept Mol Med, San Antonio, TX 78245 USA.
   S Texas Vet Hlth Care Syst, San Antonio, TX 78245 USA.
C3 US Department of Veterans Affairs; Veterans Health Administration (VHA);
   Audie L. Murphy Memorial Veterans Hospital; US Department of Veterans
   Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial
   Veterans Hospital
RP Chatterjee, B (corresponding author), S Texas Vet Hlth Care Syst, Inst Biotechnol, Dept Mol Med, 15355 Lambda Dr, San Antonio, TX 78245 USA.
EM Chatterjee@uthscsa.edu
FU NIA NIH HHS [R37 AG010486, AG 10486, AG-19660, R01 AG010486, R01
   AG019660] Funding Source: Medline
CR Amador-Noguez D, 2004, AGING CELL, V3, P423, DOI 10.1111/j.1474-9728.2004.00125.x
   Assem M, 2004, J BIOL CHEM, V279, P22250, DOI 10.1074/jbc.M314111200
   Blanchard RL, 2004, PHARMACOGENETICS, V14, P199, DOI 10.1097/00008571-200403000-00009
   Chatterjee B, 2005, METHOD ENZYMOL, V400, P165, DOI 10.1016/S0076-6879(05)00010-8
   Chaya D, 2004, METHOD ENZYMOL, V376, P361
   Echchgadda I, 2004, MECH AGEING DEV, V125, P733, DOI 10.1016/j.mad.2004.08.008
   Echchgadda I, 2004, MOL PHARMACOL, V65, P720, DOI 10.1124/mol.65.3.720
   Fang HL, 2005, MOL PHARMACOL, V67, P1257, DOI 10.1124/mol.104.005389
   Gachon F, 2006, CELL METAB, V4, P25, DOI 10.1016/j.cmet.2006.04.015
   Green CB, 2006, CELL METAB, V4, P3, DOI 10.1016/j.cmet.2006.06.002
   Handschin C, 2003, PHARMACOL REV, V55, P649, DOI 10.1124/pr.55.4.2
   Havis E, 2006, BIOTECHNIQUES, V40, P34, DOI 10.2144/000112098
   Havis E, 2003, EMBO REP, V4, P883, DOI 10.1038/sj.embor.embor908
   Ledda-Columbano GM, 2004, HEPATOLOGY, V40, P981, DOI 10.1002/hep.20403
   Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661
   Maglich JM, 2004, J BIOL CHEM, V279, P19832, DOI 10.1074/jbc.M313601200
   Makishima M, 2002, SCIENCE, V296, P1313, DOI 10.1126/science.1070477
   McElwee JJ, 2004, J BIOL CHEM, V279, P44533, DOI 10.1074/jbc.M406207200
   PALMER RH, 1971, J LIPID RES, V12, P680
   Park SK, 2005, AGEING RES REV, V4, P55, DOI 10.1016/j.arr.2004.09.003
   Reschly EJ, 2006, CURR DRUG METAB, V7, P349, DOI 10.2174/138920006776873526
   Sandoval J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh091
   Seely J, 2005, ENDOCRINOLOGY, V146, P3605, DOI 10.1210/en.2004-1619
   SELYE H, 1971, J PHARM SCI, V60, P1, DOI 10.1002/jps.2600600102
   Song CS, 2006, MOL ENDOCRINOL, V20, P795, DOI 10.1210/me.2005-0428
   Song CS, 2001, J BIOL CHEM, V276, P42549, DOI 10.1074/jbc.M107557200
   Sonoda J, 2002, P NATL ACAD SCI USA, V99, P13801, DOI 10.1073/pnas.212494599
   Xu CJ, 2005, ARCH PHARM RES, V28, P249, DOI 10.1007/BF02977789
NR 28
TC 19
Z9 24
U1 0
U2 11
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0378-1119
EI 1879-0038
J9 GENE
JI Gene
PD JAN 15
PY 2007
VL 386
IS 1-2
BP 218
EP 223
DI 10.1016/j.gene.2006.10.006
PG 6
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 129NU
UT WOS:000243737000025
PM 17123747
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Liu, CC
   Hung, CL
   Shih, SC
   Ko, HJ
   Lu, YT
   Wu, YJ
   Cheng, HY
   Hu, KC
   Yeh, HI
   Chang, RE
AF Liu, Chuan-Chuan
   Hung, Chung-Lieh
   Shih, Shou-Chuan
   Ko, Hung-Ju
   Lu, Yi-Ting
   Wu, Yih-Jer
   Cheng, Hui-Yun
   Hu, Kuang-Chun
   Yeh, Hung-I
   Chang, Ray-E
TI Age-related Differences in the Clinical Presentation, Associated
   Metabolic Abnormality, and Estimated Cardiovascular Risks from
   Nonalcoholic Fatty Liver Disease: A Cross-sectional Study from Health
   Evaluation Center in Taiwan
SO INTERNATIONAL JOURNAL OF GERONTOLOGY
LA English
DT Article
DE nonalcoholic fatty liver disease; (NAFLD); biochemical markers;
   metabolic abnormality; cardiovascular risk scores
ID ALANINE AMINOTRANSFERASE; HEPATOCELLULAR-CARCINOMA; GLUCOSE-METABOLISM;
   INSULIN-RESISTANCE; PREVALENCE; HEPATITIS; OBESITY; PREDICTORS;
   DIAGNOSIS; FIBROSIS
AB Background: Nonalcoholic fatty liver disease (NAFLD), which represents metabolic abnormality and reflects extra visceral fat deposition, has been shown to be a threat to public health and associated with cardiovascular risks. However, data regarding the differences in clinical presentation and related metabolic abnormalities in the aging group population remained scarce in the Taiwanese population.
   Methods: We subsequently examined 8,658 subjects participating general health evaluation in Mackay Memorial hospital from 2003 to 2007. Baseline characteristics, anthropometrics, medical history, and biochemical markers were all collected. Abdominal ultrasonography was performed in all subjects. Two estimated cardiovascular risk scores were calculated according to criteria of the U.S. National Cholesterol Education Program Adult Treatment Panel Ill as metabolic score and Framingham risk score. Univariate logistic regression model was used to examine whether the baseline characteristics, anthropometrics, histories, and biochemical markers were independently associated with NAFLD from various age groups (young vs. aging groups) classified by 60 years of age. Respective receiver operating characteristic curves (ROC) with area under the curve were generated to test the capability of both cardiovascular risk scores in NAFLD discrimination from different age groups.
   Results: Totally 7,204 subjects (mean age: 44.5 +/- 11 years, 36% female) were finally enrolled in our study. Subjects with NAFLD were observed to have high body weight, body mass index, and circumferential waist and significantly abnormal biochemical markers accompanying worsening lipid profiles when compared with those without NAFLD in both the young and aging group populations (all p < 0.001) although alkaline phosphatase, total cholesterol, and low-density lipoprotein did not show significant differences with and without NAFLD in the aging group population. Diabetes history remained a strong independent predictor of NAFLD in both young and aging groups (odds ratio: 3.3, p < 0.001 vs. 2.51, p = 0.014). The prediction model by using different cardiovascular risk scores yielded a meaningful ROC value of 0.82 (young group) and 0.71 (aging group) (both p < 0.001) for metabolic score with ROC value of 0.67 (young group) and 0.52 (aging group) for Framingham risk score (p < 0.001 vs. 0.408, respectively).
   Conclusion: The prevalence of NAFLD demonstrated a bimodal distribution with age in different genders. Although baseline characters and biochemical markers were demonstrated to be potential screening tools in detecting such clinical abnormality, they actually exerted diverse capabilities in the prediction of NAFLD in the different age groups. Traditional cardiovascular risk scores were less effective in predicting NAFLD in the aging group population. Copyright (C) 2010, Taiwan Society of Geriatric Emergency & Critical Care Medicine. Published by Elsevier Taiwan LLC. All rights reserved.
C1 [Liu, Chuan-Chuan; Shih, Shou-Chuan; Ko, Hung-Ju; Lu, Yi-Ting; Cheng, Hui-Yun; Hu, Kuang-Chun] Mackay Mem Hosp, Hlth Evaluat Ctr, Taipei, Taiwan.
   [Liu, Chuan-Chuan; Ko, Hung-Ju] Yuanpei Univ, Dept Med Lab Sci & Biotechnol, Hsinchu, Taiwan.
   [Liu, Chuan-Chuan; Hung, Chung-Lieh; Chang, Ray-E] Natl Taiwan Univ, Inst Hlth Policy & Management, Taipei 10764, Taiwan.
   [Shih, Shou-Chuan; Cheng, Hui-Yun; Hu, Kuang-Chun] Mackay Mem Hosp, Dept Internal Med, Div Gastroenterol, Taipei, Taiwan.
   [Hung, Chung-Lieh; Wu, Yih-Jer; Yeh, Hung-I] Mackay Mem Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan.
   [Hung, Chung-Lieh; Wu, Yih-Jer; Yeh, Hung-I] Mackay Med Coll, Dept Med, Taipei, Taiwan.
   [Hung, Chung-Lieh; Wu, Yih-Jer; Yeh, Hung-I] Mackay Med Nursing & Management Coll, Taipei, Taiwan.
   [Wu, Yih-Jer] Natl Yang Ming Univ, Inst Tradit Med, Taipei 112, Taiwan.
C3 Mackay Memorial Hospital; National Taiwan University; Mackay Memorial
   Hospital; Mackay Memorial Hospital; Mackay Medical College; Mackay
   Junior College of Medicine, Nursing & Management; National Yang Ming
   Chiao Tung University
RP Chang, RE (corresponding author), Natl Taiwan Univ, Grad Inst Hlth Care Org Adm, Coll Publ Hlth, 17 Shu Chow Rd,Room 639, Taipei 10764, Taiwan.
EM rchang@ntu.edu.tw
RI Hu, Kuang-Chun/L-9095-2019
OI CHANG, RAY-E/0000-0003-3891-5313
FU Mackay Memorial Hospital, Taipei, Taiwan
FX This work was supported by research grants from the Mackay Memorial
   Hospital, Taipei, Taiwan. All contributing authors claim no conflict of
   interest with regard to the publication of these results.
CR Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014
   Adams LA, 2005, CAN MED ASSOC J, V172, P899, DOI 10.1503/cmaj.045232
   ANDERSON KM, 1991, CIRCULATION, V83, P356, DOI 10.1161/01.CIR.83.1.356
   Angelico F, 2003, J GASTROEN HEPATOL, V18, P588, DOI 10.1046/j.1440-1746.2003.02958.x
   Angulo P, 1999, HEPATOLOGY, V30, p406A
   Anuurad E, 2003, J OCCUP HEALTH, V45, P335, DOI 10.1539/joh.45.335
   Chang Y, 2007, CLIN CHEM, V53, P686, DOI 10.1373/clinchem.2006.081257
   Chen CH, 2006, J CLIN GASTROENTEROL, V40, P745, DOI 10.1097/00004836-200609000-00016
   Clark JM, 2006, J CLIN GASTROENTEROL, V40, pS5
   Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486
   de Ledinghen V, 2006, J HEPATOL, V45, P592, DOI 10.1016/j.jhep.2006.05.008
   Dufour DR, 2000, CLIN CHEM, V46, P2027
   Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280
   Fan JG, 2007, J GASTROEN HEPATOL, V22, P794, DOI 10.1111/j.1440-1746.2007.04952.x
   Ferrara A, 1997, CIRCULATION, V96, P37
   Guzman G, 2008, ARCH PATHOL LAB MED, V132, P1761, DOI 10.1043/1543-2165-132.11.1761
   Kagansky N, 2004, LIVER INT, V24, P588, DOI 10.1111/j.1478-3231.2004.0969.x
   Kang HL, 2006, AM J GASTROENTEROL, V101, P2247, DOI 10.1111/j.1572-0241.2006.00719.x
   Kunde SS, 2005, HEPATOLOGY, V42, P650, DOI 10.1002/hep.20818
   Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002
   Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   Méndez-Sánchez N, 2006, DIGEST DIS SCI, V51, P1716, DOI 10.1007/s10620-006-9093-5
   Oh SY, 2006, METABOLISM, V55, P1604, DOI 10.1016/j.metabol.2006.07.021
   Osawa H, 1996, J CLIN ULTRASOUND, V24, P25, DOI 10.1002/(SICI)1097-0096(199601)24:1<25::AID-JCU4>3.0.CO;2-N
   Parekh S, 2007, GASTROENTEROLOGY, V132, P2191, DOI 10.1053/j.gastro.2007.03.055
   Park HS, 2005, AM J CLIN NUTR, V82, P1046, DOI 10.1093/ajcn/82.5.1046
   Poynard T, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-34
   Raszeja-Wyszomirska Joanna, 2008, Pol Merkur Lekarski, V24, P568
   Riley TR, 2006, DIGEST DIS SCI, V51, P41, DOI 10.1007/s10620-006-3082-6
   Rocha R, 2005, J HUM NUTR DIET, V18, P365, DOI 10.1111/j.1365-277X.2005.00634.x
   Ryysy L, 2000, DIABETES, V49, P749, DOI 10.2337/diabetes.49.5.749
   Sattar N, 2004, DIABETES, V53, P2855, DOI 10.2337/diabetes.53.11.2855
   Schindhelm RK, 2006, DIABETES-METAB RES, V22, P437, DOI 10.1002/dmrr.666
   Shen L, 2003, WORLD J GASTROENTERO, V9, P1106
   Siegel AB, 2009, CANCER-AM CANCER SOC, V115, P5651, DOI 10.1002/cncr.24687
   Sorbi D, 1999, AM J GASTROENTEROL, V94, P1018
   Su CC, 2006, J CLIN GASTROENTEROL, V40, P551, DOI 10.1097/00004836-200607000-00015
   Suzuki A, 2005, J HEPATOL, V43, P1060, DOI 10.1016/j.jhep.2005.06.008
   Targher G, 2006, CLIN ENDOCRINOL, V64, P679, DOI 10.1111/j.1365-2265.2006.02527.x
   Thomopoulos KC, 2006, EUR J GASTROEN HEPAT, V18, P233, DOI 10.1097/00042737-200603000-00002
   Tiikkainen M, 2003, DIABETES, V52, P701, DOI 10.2337/diabetes.52.3.701
   Wannamethee SG, 2005, DIABETES CARE, V28, P2913, DOI 10.2337/diacare.28.12.2913
   Wong VWS, 2004, ALIMENT PHARM THER, V20, P45, DOI 10.1111/j.1365-2036.2004.02012.x
NR 44
TC 6
Z9 6
U1 1
U2 4
PU TAIWAN SOC GERIATRIC EMERGENCY & CRITICAL CARE MEDICINE-TSGECM
PI TAIPEI
PA 12F-14, NO 42, SEC 1, MINSHENG E RD, ZHONGSHAN DIST, TAIPEI, 104, TAIWAN
SN 1873-9598
EI 1873-958X
J9 INT J GERONTOL
JI Int. J. Gerontol.
PD DEC
PY 2010
VL 4
IS 4
BP 184
EP 191
DI 10.1016/j.ijge.2010.11.005
PG 8
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 709OV
UT WOS:000286450900005
OA hybrid
DA 2024-02-19
ER

PT J
AU Pereira, MBC
   Traverse, MCF
   Barros, DA
   Bianchini, A
   Martínez, PE
AF Pereira, MBC
   Traverse, MCF
   Barros, DA
   Bianchini, A
   Martínez, PE
TI The effects of aging on leukocyte glucocorticoid receptor concentration
   and response to dexamethasone in dogs
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE aging; dexamethasone; dog; glucocorticoid receptors; leukocytes;
   mononuclear cells; polymorphonuclear cells
ID IMMUNE-SYSTEM; STRESS; AGE; MECHANISMS; LYMPHOCYTE; APOPTOSIS; DISEASE;
   HEALTH; GENDER; LIVER
AB Glucocorticoid receptor concentration (GR) was determined in mononuclear (MNS) and polymorphonuclear (PMNS) cells isolated from 8 aged and 9 young male dogs. In addition, leukocyte responses to dexamethasone (0.1 mg kg(-1) iv) and plasma glucose concentration were also measured. The GR in MNS and PMNS was higher (p < 0.05) in young dogs (6.64 +/- 0.57 and 7.04 +/- 0.29 fmoles x 10(6) cells, respectively, versus 4.40 +/- 0.24 and 5.06 +/- 0.33 fmoles x 10(6) cells, respectively, in aged dogs). The maximum increase in neutrophils (Delta NEU) was lower (p < 0.05) in aged dogs 6003.38 +/- 1398.5 x 10(6) versus 11168.67 +/- 1863.16 x 10(6) cells l(-1) in young dogs. The maximum decrease in lymphocytes (Delta LYM) was lower (p < 0.05) in aged dogs 550 +/- 56.75 x 10(6) cells l(-1) versus 1825.89 +/- 313.1 x 10(6) cells l(-1) in young dogs. In young dogs, significant (p < 0.05) correlations between GR in PMNS and Delta NEU (r = 0.80) and between GR in MNS and Delta LYM (r = 0.76) were observed. In aged dogs, these correlations were not significant. The lower GR value and the lack of correlation between this parameter and its respective Delta in aged dogs suggest that changes in leukocytes responsiveness to glucocorticoids is occurring during the aging process. (C) 2003 Elsevier Inc. All rights reserved.
C1 Fundacao Univ Fed Rio Grande, Dept Ciencias Fisiol, Lab Zoofisiol, BR-96201900 Rio Grande, RS, Brazil.
C3 Universidade Federal do Rio Grande
RP Martínez, PE (corresponding author), Fundacao Univ Fed Rio Grande, Dept Ciencias Fisiol, Lab Zoofisiol, Rua Eng Alfredo Huch 475, BR-96201900 Rio Grande, RS, Brazil.
RI Martínez, Pablo Elías/D-4556-2016; Martinez, Pablo/M-4092-2019;
   Bianchini, Adalto/C-5384-2013
OI Martinez, Pablo/0000-0003-1585-6162; Bianchini,
   Adalto/0000-0002-7627-7650
CR ARMANINI D, 1992, AM J PHYSIOL, V262, pE464, DOI 10.1152/ajpendo.1992.262.4.E464
   BREAZILE JE, 1988, VET CLIN N AM-FOOD A, V4, P441, DOI 10.1016/S0749-0720(15)31025-2
   Buttgereit F, 1999, BIOCHEM PHARMACOL, V58, P363, DOI 10.1016/S0006-2952(99)00090-8
   Chappey O, 1997, EUR J CLIN INVEST, V27, P97, DOI 10.1046/j.1365-2362.1997.710624.x
   COX G, 1995, J IMMUNOL, V154, P4719
   DALE DC, 1975, J CLIN INVEST, V56, P808, DOI 10.1172/JCI108159
   De Kloet ER, 1998, ENDOCR REV, V19, P269, DOI 10.1210/er.19.3.269
   DHABHAR FS, 1994, BRAIN BEHAV IMMUN, V8, P66, DOI 10.1006/brbi.1994.1006
   Djordjevic-Markovic R, 1999, EXP GERONTOL, V34, P971, DOI 10.1016/S0531-5565(99)00067-4
   Falkenstein E, 2000, PHARMACOL REV, V52, P513
   FAUCI AS, 1976, ANN INTERN MED, V84, P304, DOI 10.7326/0003-4819-84-3-304
   Feldman EC, 1996, J AM VET MED ASSOC, V209, P772
   Ginaldi L, 1999, IMMUNOL RES, V20, P109, DOI 10.1007/BF02786467
   Grasso G, 1997, LIFE SCI, V61, P301, DOI 10.1016/S0024-3205(97)00386-X
   Greeley EH, 2001, VET IMMUNOL IMMUNOP, V82, P57, DOI 10.1016/S0165-2427(01)00336-1
   Greeley EH, 1996, VET IMMUNOL IMMUNOP, V55, P1, DOI 10.1016/S0165-2427(96)05563-8
   KALIMI M, 1983, ENDOCRINOLOGY, V112, P341, DOI 10.1210/endo-112-1-341
   MAKINODAN T, 1984, GERONTOLOGY, V30, P279, DOI 10.1159/000212647
   MARGARINOS AM, 2001, BRAIN RES, V902, P282
   Martinez PE, 1998, REPROD DOMEST ANIM, V33, P61, DOI 10.1111/j.1439-0531.1998.tb01316.x
   McEwen BS, 1999, FRONT NEUROENDOCRIN, V20, P49, DOI 10.1006/frne.1998.0173
   MIGLIORATI G, 1994, IMMUNOLOGY, V81, P21
   MILLER AH, 1994, ENDOCRINOLOGY, V135, P1934, DOI 10.1210/en.135.5.1934
   Nakagawa M, 1998, CIRCULATION, V98, P2307, DOI 10.1161/01.CIR.98.21.2307
   PARRILLO JE, 1979, ANNU REV PHARMACOL, V19, P179, DOI 10.1146/annurev.pa.19.040179.001143
   ROTHUIZEN J, 1993, ENDOCRINOLOGY, V132, P161, DOI 10.1210/en.132.1.161
   SAPOLSKY R, 1987, ENDOCRIN METAB CLIN, V16, P965, DOI 10.1016/S0889-8529(18)30453-5
   SAPOLSKY RM, 1986, ENDOCR REV, V7, P284, DOI 10.1210/edrv-7-3-284
   SAPOLSKY RM, 1984, P NATL ACAD SCI-BIOL, V81, P6174, DOI 10.1073/pnas.81.19.6174
   Seeman TE, 1997, ARCH INTERN MED, V157, P2259
   SHARMA R, 1987, BIOCHIM BIOPHYS ACTA, V930, P237, DOI 10.1016/0167-4889(87)90036-X
   STRASSER A, 1993, J VET MED A, V40, P720, DOI 10.1111/j.1439-0442.1993.tb00689.x
   Strasser A, 2000, J VET MED A, V47, P181, DOI 10.1046/j.1439-0442.2000.00278.x
   Straub RH, 2001, MECH AGEING DEV, V122, P1591, DOI 10.1016/S0047-6374(01)00289-5
   TANAKA H, 1991, CLIN CHEM, V37, P1715
   TANAKA H, 1989, ACTA ENDOCRINOL-COP, V121, P470, DOI 10.1530/acta.0.1210470
   Wang PS, 1997, J FORMOS MED ASSOC, V96, P792
   Yen SSC, 1998, EXP GERONTOL, V33, P897, DOI 10.1016/S0531-5565(98)00046-1
NR 38
TC 6
Z9 8
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
J9 EXP GERONTOL
JI Exp. Gerontol.
PD SEP
PY 2003
VL 38
IS 9
BP 989
EP 995
DI 10.1016/S0531-5565(03)00163-3
PG 7
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 726VW
UT WOS:000185622700009
PM 12954486
DA 2024-02-19
ER

PT J
AU Shimamura, T
   Iijima, S
   Hirayama, M
   Iwashita, M
   Akiyama, S
   Takaku, Y
   Yumoto, S
AF Shimamura, Tadashi
   Iijima, Satoe
   Hirayama, Mitsuhiro
   Iwashita, Masato
   Akiyama, Shigeru
   Takaku, Yuichi
   Yumoto, Sakae
TI Age-related effects of major and trace element concentrations in rat
   liver and their mutual relationships
SO JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY
LA English
DT Article
DE Rat liver; Element concentrations; Aging effects; Elemental correlations
ID ATOMIC-EMISSION-SPECTROMETRY; POTENTIALLY TOXIC ELEMENTS; TRANSFERRIN
   RECEPTOR 2; MULTIELEMENT ANALYSIS; MASS-SPECTROMETRY; AUTOPSY TISSUES;
   ICP-AES; ACCUMULATION; KIDNEY; COPPER
AB The concentrations of 22 major and trace elements in livers from rats aging from 5 to 113 weeks old were determined. The rats investigated were the same rats previously reported with respect to 29 elements-in bones (femur) and 26 elements in kidneys. The samples were decomposed with high-purity nitric acid and hydrogen peroxide. Seven elements (Na, Mg, P, K, Ca, Fe and Zn) were determined by inductively coupled plasma atomic emission spectrometry (ICP-AES), and 15 elements (Mn, Co, Cu, As, Se, Rb, Sr, Mo, Cd, Sn, Sb, Cs, Ba, Pb and Bi) were determined by inductively coupled plasma mass spectrometry (ICP-MS). Analysis of variance (ANOVA) for age variations indicated that the concentrations of many elements, such as Mg, P, K, Mn, Fe, Cu, Zn, Sr, Mo and Cd, were almost constant across the ages of the rats with the exception of 5 weeks old (p>0.05). Arsenic, Pb and Bi showed significant increasing trends, while Na and Co showed decreasing trends (p<0.01). Selenium showed a decreasing trend except at the initial stage of 5-9 weeks old. Calcium, Rb, Sn, Sb, Cs and Ba showed significant age-related variations, but their patterns were not monotonic. The liver clearly contrasts with the kidneys, in which many elements showed significant age-related variations with increasing trends. The concentration ranges of Mg, P, K, Mn, Cu, Zn, and Mo were controlled within 15% across all ages of rats. The homeostasis of the aforementioned elements may be well established in the liver. The toxic elements, such as Cd, Pb and Bi, showed a narrow concentration range among age-matched rats. (C) 2013 Elsevier GmbH. All rights reserved.
C1 [Shimamura, Tadashi; Iwashita, Masato; Akiyama, Shigeru] Kitasato Univ, Sch Allied Hlth Sci, Minami Ku, Sagamihara, Kanagawa 2520373, Japan.
   [Iijima, Satoe] JASCO Corp, LC & SFC Applicat Lab, Hachioji, Tokyo 1928537, Japan.
   [Hirayama, Mitsuhiro] Entex Inc, Kashiwa, Chiba 2770852, Japan.
   [Takaku, Yuichi] Inst Environm Sci, Aomori 0393212, Japan.
   [Yumoto, Sakae] Yumoto Inst Neurol, Shinjuku Ku, Tokyo 1620054, Japan.
C3 Kitasato University
RP Shimamura, T (corresponding author), Kitasato Univ, Sch Allied Hlth Sci, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520373, Japan.
EM tksima@tbc.t-com.ne.jp
CR Agusa T, 2005, ENVIRON TOXICOL CHEM, V24, P2107, DOI 10.1897/04-617R.1
   Agusa T, 2008, MAR POLLUT BULL, V57, P807, DOI 10.1016/j.marpolbul.2008.01.039
   Alonso ML, 2004, BIOMETALS, V17, P389, DOI 10.1023/B:BIOM.0000029434.89679.a2
   Brown KE, 2011, TXB HEPATOLOGY, P221
   Cui X, 2008, FOOD CHEM TOXICOL, V46, P3646, DOI 10.1016/j.fct.2008.09.040
   Dehn LA, 2005, CAN J ZOOL, V83, P726, DOI 10.1139/Z05-053
   Drobyshev AI, 2011, J ANAL CHEM+, V66, P777, DOI 10.1134/S1061934811080107
   Fleming RE, 2000, P NATL ACAD SCI USA, V97, P2214, DOI 10.1073/pnas.040548097
   GELINAS Y, 1992, ANAL CHIM ACTA, V269, P115, DOI 10.1016/0003-2670(92)85140-2
   Han SG, 1999, ENVIRON HEALTH PERSP, V107, P657, DOI 10.2307/3434458
   Hirayama M, 2011, J TRACE ELEM MED BIO, V25, P73, DOI 10.1016/j.jtemb.2011.02.002
   Katoh Y, 2003, KEITAI KINOU, V1, P13
   Kawabata H, 1999, J BIOL CHEM, V274, P20826, DOI 10.1074/jbc.274.30.20826
   KUNIFUJI Y, 1987, BIOL TRACE ELEM RES, V14, P237, DOI 10.1007/BF02795690
   Kuriwaki J, 2005, TOXICOL LETT, V156, P369, DOI 10.1016/j.toxlet.2004.12.009
   Lyon TDB, 2002, J ENVIRON MONITOR, V4, P1034, DOI 10.1039/b205972j
   Matsumoto K, 2009, MOLECULES, V14, P4440, DOI 10.3390/molecules14114440
   Nam DH, 2005, ENVIRON POLLUT, V134, P503, DOI 10.1016/j.envpol.2004.09.003
   Neuschwander-Tetri BA, 2011, TXB HEPATOLOGY, P233
   Nriagu J, 2009, ECOTOX ENVIRON SAFE, V72, P564, DOI 10.1016/j.ecoenv.2008.05.001
   Rahil-Khazen R, 2002, J TRACE ELEM MED BIO, V16, P15, DOI 10.1016/S0946-672X(02)80004-9
   Rahil-Khazen R, 2002, BIOMETALS, V15, P87, DOI 10.1023/A:1013197120350
   Roy P, 2002, CURR SCI INDIA, V82, P38
   Sakai T, 2004, BIOL TRACE ELEM RES, V97, P163, DOI 10.1385/BTER:97:2:163
   Seixas TG, 2007, SCI TOTAL ENVIRON, V385, P208, DOI 10.1016/j.scitotenv.2007.06.045
   Shen SG, 2005, ENVIRON TOXICOL PHAR, V19, P379, DOI 10.1016/j.etap.2004.09.008
   Shimamura T, 2013, J TRACE ELEM MED BIO, V27, P12, DOI 10.1016/j.jtemb.2012.05.005
   Suzuki Y, 2006, CHEMOSPHERE, V64, P1296, DOI 10.1016/j.chemosphere.2005.12.068
   Takahashi S, 2000, LAB ANIM, V34, P97, DOI 10.1258/002367700780577966
   UCHINO E, 1990, LAB ANIM, V24, P253, DOI 10.1258/002367790780866182
   Varga I, 2005, ANAL BIOANAL CHEM, V383, P476, DOI 10.1007/s00216-005-0010-0
   VUORI E, 1979, SCAND J WORK ENV HEA, V5, P16, DOI 10.5271/sjweh.2670
   Wilkinson JM, 2001, ANIM SCI, V72, P179, DOI 10.1017/S1357729800055673
NR 33
TC 12
Z9 12
U1 0
U2 10
PU ELSEVIER GMBH, URBAN & FISCHER VERLAG
PI JENA
PA OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY
SN 0946-672X
J9 J TRACE ELEM MED BIO
JI J. Trace Elem. Med. Biol.
PY 2013
VL 27
IS 4
BP 286
EP 294
DI 10.1016/j.jtemb.2013.04.006
PG 9
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA 252IR
UT WOS:000326998900004
PM 23701987
DA 2024-02-19
ER

PT J
AU Maida, A
   Zota, A
   Sjoberg, KA
   Schumacher, J
   Sijmonsma, TP
   Pfenninger, A
   Christensen, MM
   Gantert, T
   Fuhrmeister, J
   Rothermel, U
   Schmoll, D
   Heikenwäder, M
   Iovanna, JL
   Stemmer, K
   Kiens, B
   Herzig, S
   Rose, AJ
AF Maida, Adriano
   Zota, Annika
   Sjoberg, Kim A.
   Schumacher, Jonas
   Sijmonsma, Tjeerd P.
   Pfenninger, Anja
   Christensen, Marie M.
   Gantert, Thomas
   Fuhrmeister, Jessica
   Rothermel, Ulrike
   Schmoll, Dieter
   Heikenwaeder, Mathias
   Iovanna, Juan L.
   Stemmer, Kerstin
   Kiens, Bente
   Herzig, Stephan
   Rose, Adam J.
TI A liver stress-endocrine nexus promotes metabolic integrity during
   dietary protein dilution
SO JOURNAL OF CLINICAL INVESTIGATION
LA English
DT Article
ID AMINO-ACID DEPRIVATION; BROWN ADIPOSE-TISSUE; GROWTH-FACTOR 21;
   ENERGY-BALANCE; METHIONINE RESTRICTION; MICE LACKING; NONSHIVERING
   THERMOGENESIS; TRANSCRIPTIONAL ACTIVATION; INSULIN-RESISTANCE;
   LIPID-METABOLISM
AB Dietary protein intake is linked to an increased incidence of type 2 diabetes (T2D). Although dietary protein dilution (DPD) can slow the progression of some aging-related disorders, whether this strategy affects the development and risk for obesity associated metabolic disease such as T2D is unclear. Here, we determined that DPD in mice and humans increases serum markers of metabolic health. In lean mice, DPD promoted metabolic inefficiency by increasing carbohydrate and fat oxidation. In nutritional and polygenic murine models of obesity, DPD prevented and curtailed the development of impaired glucose homeostasis independently of obesity and food intake. DPD-mediated metabolic inefficiency and improvement of glucose homeostasis were independent of uncoupling protein 1 (UCP1), but required expression of liver-derived fibroblast growth factor 21 (FGF21) in both lean and obese mice. FGF21 expression and secretion as well as the associated metabolic remodeling induced by DPD also required induction of liver-integrated stress response-driven nuclear protein 1 (NUPR1). Insufficiency of select nonessential amino acids (NEAAs) was necessary and adequate for NUPR1 and subsequent FGF21 induction and secretion in hepatocytes in vitro and in vivo. Taken together, these data indicate that DPD promotes improved glucose homeostasis through an NEAA insufficiency-induced liver NUPR1/FGF21 axis.
C1 [Maida, Adriano; Zota, Annika; Herzig, Stephan] Helmholtz Ctr Munich, IDC, Munich, Germany.
   [Maida, Adriano; Zota, Annika; Herzig, Stephan] Joint Heidelberg IDC Translat Diabet Program, Munich, Germany.
   [Sjoberg, Kim A.; Christensen, Marie M.; Kiens, Bente] Univ Copenhagen, Fac Sci, Sect Mol Physiol, August Krogh Ctr,Dept Nutr Exercise & Sports, Copenhagen, Denmark.
   [Schumacher, Jonas; Sijmonsma, Tjeerd P.; Gantert, Thomas; Fuhrmeister, Jessica; Rose, Adam J.] Heidelberg Univ, Joint Res Div Mol Metab Control, German Canc Res Ctr, Ctr Mol Biol, Heidelberg, Germany.
   [Schumacher, Jonas; Sijmonsma, Tjeerd P.; Gantert, Thomas; Fuhrmeister, Jessica; Rose, Adam J.] Univ Heidelberg Hosp, Heidelberg, Germany.
   [Sijmonsma, Tjeerd P.; Heikenwaeder, Mathias] German Canc Res Ctr, Div Chron Inflammat & Canc, Heidelberg, Germany.
   [Pfenninger, Anja; Schmoll, Dieter] Sanofi Aventis Deutschland GmbH, Ind Pk Hoechst, Frankfurt, Germany.
   [Rothermel, Ulrike] German Canc Res Ctr, Div Cellular & Mol Pathol, Heidelberg, Germany.
   [Iovanna, Juan L.] Aix Marseille Univ, Ctr Rech Cancerol Marseille, CNRS, INSERM,U1068,UMR 7258, Marseille, France.
   [Iovanna, Juan L.] Inst Paoli Calmettes, Parc Sci & Technol Luminy, Marseille, France.
   [Stemmer, Kerstin] Helmholtz Ctr Munich, Inst Diabet & Obes, Div Metab & Canc, Munich, Germany.
C3 Helmholtz Association; Helmholtz-Center Munich - German Research Center
   for Environmental Health; University of Copenhagen; Helmholtz
   Association; German Cancer Research Center (DKFZ); Ruprecht Karls
   University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz
   Association; German Cancer Research Center (DKFZ); Sanofi-Aventis;
   Helmholtz Association; German Cancer Research Center (DKFZ); Centre
   National de la Recherche Scientifique (CNRS); CNRS - National Institute
   for Biology (INSB); Aix-Marseille Universite; Institut National de la
   Sante et de la Recherche Medicale (Inserm); Aix-Marseille Universite;
   UNICANCER; Institut Paoli-Calmette (IPC); Helmholtz Association;
   Helmholtz-Center Munich - German Research Center for Environmental
   Health
RP Rose, AJ (corresponding author), DKFZ A170,Neuenheimer Feld 280, Heidelberg, Germany.
EM a.rose@dkfz.de
RI Rose, Adam John/AAC-6274-2019; Iovanna, Juan/M-9805-2017; Kiens,
   Bente/B-1375-2015; Sjoberg, Kim/D-7612-2015
OI Rose, Adam John/0000-0001-9132-8244; Iovanna, Juan/0000-0003-1822-2237;
   Schmoll, Dieter/0000-0003-2578-3366; Kiens, Bente/0000-0001-5705-5625;
   Sjoberg, Kim/0000-0001-6880-4804; Schumacher, Jonas/0000-0002-5671-3160;
   Stemmer, Kerstin/0000-0002-7526-2326; Gantert,
   Thomas/0000-0002-0945-3167; Moller Jensen, Marie/0000-0003-2660-3240
FU CIHR fellowship; University of Copenhagen Excellence Program for
   Interdisciplinary Research; Helmholtz Program "ICEMED"; Helmholtz
   Program "Metabolic Dysfunction"; Deutsche Forschungsgemeinschaft
   [He3260/8-1]; EFSD/Lilly European Diabetes Research Programme
FX The authors acknowledge the experimental support from Oksana Seibert,
   Yvonne Feuchter, Jessica Chan, Joshua Mouatt, Anja Reimann, Maximilian
   Schuster, and Hermann-Josef Grone (DKFZ). We thank Martin Klingenspor
   (TUM, Germany) for the provision of the UCP1 knockout mice breeding
   pairs and Emerald Perlas (EMBL) for experimental support for ISH assays.
   AM was supported by a CIHR fellowship. The human diet study was
   supported by the grant "Physical Activity and Nutrition for Improvement
   of Health" from the University of Copenhagen Excellence Program for
   Interdisciplinary Research (2016) to BK. These studies were supported by
   the Helmholtz Programs "ICEMED" and "Metabolic Dysfunction" as well as
   the Deutsche Forschungsgemeinschaft (He3260/8-1) to SH and by a project
   grant from the EFSD/Lilly European Diabetes Research Programme to AJR.
CR Averous J, 2011, BIOCHEM BIOPH RES CO, V413, P24, DOI 10.1016/j.bbrc.2011.08.028
   Ayala JE, 2010, DIS MODEL MECH, V3, P525, DOI 10.1242/dmm.006239
   Baird TD, 2012, ADV NUTR, V3, P307, DOI 10.3945/an.112.002113
   Barbosa-Sampaio HC, 2013, DIABETOLOGIA, V56, P2477, DOI 10.1007/s00125-013-3006-x
   Bielohuby M, 2013, AM J PHYSIOL-ENDOC M, V305, pE1059, DOI 10.1152/ajpendo.00208.2013
   Blüher M, 2010, CURR OPIN LIPIDOL, V21, P38, DOI 10.1097/MOL.0b013e3283346ccc
   Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989
   Cano CE, 2011, J CELL PHYSIOL, V226, P1439, DOI 10.1002/jcp.22324
   COONEY GJ, 1987, DIABETES, V36, P152, DOI 10.2337/diabetes.36.2.152
   Cornu M, 2014, P NATL ACAD SCI USA, V111, P11592, DOI 10.1073/pnas.1412047111
   De Sousa-Coelho AL, 2013, J LIPID RES, V54, P1786, DOI 10.1194/jlr.M033415
   DESCHATRETTE J, 1974, BIOCHIMIE, V56, P1603
   Du FY, 2000, J NUTR, V130, P514, DOI 10.1093/jn/130.3.514
   Dushay JR, 2015, MOL METAB, V4, P51, DOI 10.1016/j.molmet.2014.09.008
   Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0
   Fisher FM, 2014, GASTROENTEROLOGY, V147, P1073, DOI 10.1053/j.gastro.2014.07.044
   Franz Marion J, 2002, Curr Diab Rep, V2, P457, DOI 10.1007/s11892-002-0111-5
   FRAYN KN, 1983, J APPL PHYSIOL, V55, P628, DOI 10.1152/jappl.1983.55.2.628
   Gerich JE, 2000, DIABETES OBES METAB, V2, P345, DOI 10.1046/j.1463-1326.2000.00085.x
   Gimeno RE, 2014, TRENDS ENDOCRIN MET, V25, P303, DOI 10.1016/j.tem.2014.03.001
   Goruppi S, 2010, J BIOL CHEM, V285, P1577, DOI 10.1074/jbc.R109.080887
   Gosby AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025929
   Harputlugil E, 2014, CELL REP, V8, P1160, DOI 10.1016/j.celrep.2014.07.018
   Hotta Y, 2009, ENDOCRINOLOGY, V150, P4625, DOI 10.1210/en.2009-0119
   Jiang Y, 2015, MOL METAB, V4, P406, DOI 10.1016/j.molmet.2015.02.003
   Jin HO, 2009, IUBMB LIFE, V61, P1153, DOI 10.1002/iub.271
   Jousse C, 2007, J BIOL CHEM, V282, P15851, DOI 10.1074/jbc.M611723200
   JUNGAS RL, 1992, PHYSIOL REV, V72, P419, DOI 10.1152/physrev.1992.72.2.419
   Keller U, 2011, INT J VITAM NUTR RES, V81, P125, DOI 10.1024/0300-9831/a000059
   Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021
   Klingmüller U, 2006, IEE P SYST BIOL, V153, P433, DOI 10.1049/ip-syb:20050067
   Kong DK, 2010, MOL BIOL CELL, V21, P1335, DOI 10.1091/mbc.E09-09-0818
   Krebs M, 2002, DIABETES, V51, P599, DOI 10.2337/diabetes.51.3.599
   Laeger T, J CLIN INVEST
   Lees EK, 2014, AGING CELL, V13, P817, DOI 10.1111/acel.12238
   Levine ME, 2014, CELL METAB, V19, P407, DOI 10.1016/j.cmet.2014.02.006
   Maarbjerg SJ, AM J PHYSL ENDOCRINO
   MILLER DS, 1968, EXP GERONTOL, V3, P231, DOI 10.1016/0531-5565(68)90006-5
   Mittelman SD, 1997, J CLIN INVEST, V100, P3121, DOI 10.1172/JCI119867
   Morrison CD, 2012, AM J PHYSIOL-REG I, V302, pR917, DOI 10.1152/ajpregu.00609.2011
   Nässl AM, 2011, AM J PHYSIOL-GASTR L, V301, pG128, DOI 10.1152/ajpgi.00017.2011
   Nedergaard J, 2001, BBA-BIOENERGETICS, V1504, P82, DOI 10.1016/S0005-2728(00)00247-4
   Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002
   Owen BM, 2015, TRENDS ENDOCRIN MET, V26, P22, DOI 10.1016/j.tem.2014.10.002
   Parrella E, 2013, AGING CELL, V12, P257, DOI 10.1111/acel.12049
   Perry RJ, 2015, CELL, V160, P745, DOI 10.1016/j.cell.2015.01.012
   Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x
   Ravussin E, 2000, BRIT J NUTR, V83, pS17
   Renne U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079788
   ROSSETTI L, 1989, AM J PHYSIOL, V257, pE212, DOI 10.1152/ajpendo.1989.257.2.E212
   ROTHWELL NJ, 1982, J NUTR, V112, P1663, DOI 10.1093/jn/112.9.1663
   ROTHWELL NJ, 1979, NATURE, V281, P31, DOI 10.1038/281031a0
   Sadagurski M, 2013, ENDOCRIN METAB CLIN, V42, P127, DOI 10.1016/j.ecl.2012.11.008
   SCHUTZ Y, 1995, METABOLISM, V44, P7, DOI 10.1016/0026-0495(95)90311-9
   Shan JX, 2010, PHYSIOL GENOMICS, V41, P315, DOI 10.1152/physiolgenomics.00217.2009
   Shimizu N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7693
   Sidrauski C, 2015, ELIFE, V4, DOI 10.7554/eLife.05033
   Sidrauski C, 2013, ELIFE, V2, DOI 10.7554/eLife.00498
   Simpson SJ, 2005, OBES REV, V6, P133, DOI 10.1111/j.1467-789X.2005.00178.x
   Solon-Biet SM, 2014, CELL METAB, V19, P418, DOI 10.1016/j.cmet.2014.02.009
   Sorensen A, 2008, OBESITY, V16, P566, DOI 10.1038/oby.2007.58
   Speakman JR, 2005, J EXP BIOL, V208, P1717, DOI 10.1242/jeb.01556
   SPECTER SE, 1995, J NUTR, V125, P2183, DOI 10.1093/jn/125.8.2183
   Stettner P, 2013, P NATL ACAD SCI USA, V110, P9998, DOI 10.1073/pnas.1217775110
   Stock MJ, 1999, INT J OBESITY, V23, P1105, DOI 10.1038/sj.ijo.0801108
   STOCK MJ, 1986, INT J VITAM NUTR RES, V56, P205
   Stone KP, 2014, DIABETES, V63, P3721, DOI 10.2337/db14-0464
   Sun K, 2013, CELL METAB, V18, P470, DOI 10.1016/j.cmet.2013.06.016
   Tseng YH, 2010, NAT REV DRUG DISCOV, V9, P465, DOI 10.1038/nrd3138
   van Nielen M, 2014, DIABETES CARE, V37, P1854, DOI [10.2337/dc13-2627, 10.2337/dc15-er10b]
   Vasseur S, 2002, ONCOGENE, V21, P1685, DOI 10.1038/sj.onc.1205222
   Wanders D, 2016, DIABETES, V65, P1499, DOI 10.2337/db15-1324
   Wanders D, 2015, FASEB J, V29, P2603, DOI 10.1096/fj.14-270348
   Wilson GJ, 2015, AM J PHYSIOL-ENDOC M, V308, pE283, DOI 10.1152/ajpendo.00361.2014
   Ye JB, 2015, GENE DEV, V29, P2331, DOI 10.1101/gad.269324.115
   Zhang YMD, 2012, EURASIP J ADV SIG PR, DOI 10.1186/1687-6180-2012-102
NR 76
TC 119
Z9 130
U1 2
U2 18
PU AMER SOC CLINICAL INVESTIGATION INC
PI ANN ARBOR
PA 2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA
SN 0021-9738
EI 1558-8238
J9 J CLIN INVEST
JI J. Clin. Invest.
PD SEP
PY 2016
VL 126
IS 9
BP 3263
EP 3278
DI 10.1172/JCI85946
PG 16
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA DU9CI
UT WOS:000382513400012
PM 27548521
OA Green Published, Bronze, Green Submitted
DA 2024-02-19
ER

PT J
AU Long, JG
   Wang, XM
   Gao, HX
   Liu, Z
   Liu, CS
   Miao, MY
   Liu, JK
AF Long, Jiangang
   Wang, Xuemin
   Gao, Hongxiang
   Liu, Zhi
   Liu, Changsheng
   Miao, Mingyong
   Liu, Jiankang
TI Malonaldehyde acts as a mitochondrial toxin: Inhibitory effects on
   respiratory function and enzyme activities in isolated rat liver
   mitochondria
SO LIFE SCIENCES
LA English
DT Article
DE mitochondrial respiration; mitochondrial complex; alpha-ketoglutaric
   dehydrogenase (KGDH); pyruvate dehydrogenase (PDH); malate dehydrogenase
   (MDH)
ID LIPID-PEROXIDATION; PYRUVATE-DEHYDROGENASE; PARKINSONS-DISEASE; BRAIN
   MITOCHONDRIA; BINDING-AFFINITY; OXIDATIVE STRESS; AMINO-ACIDS; LIPOIC
   ACID; MALONDIALDEHYDE; ACROLEIN
AB Malonaldehyde (MDA) is a product of oxidative damage to lipids, amino acids and DNA, and accumulates with aging and diseases. MDA can possibly react with amines to modify proteins to inactivity enzymes and also modify nucleosides to cause mutagenicity. Mitochondrial dysfunction is a major contributor to aging and age-associated diseases. We hypothesize that accumulated MDA due to mitochondrial dysfunction during aging targets mitochondrial enzymes to cause further mitochondrial dysfunction and contribute to aging and age-associated diseases. We investigated the effects of MDA on mitochondrial respiration and enzymes (membrane complexes I, II, III and IV, and dehydrogenases, including alpha-ketoglutaric dehydrogenase (KGDH), pyruvate dehydrogenase (PDH), malate dehydrogenase (MDH)) in isolated rat liver mitochondria. MDA showed a dose-dependent inhibition on mitochondrial NADH-linked respiratory control ratio (RCR) and ADP/O ratio declined from the concentrations of 0.2 and 0.8 mu mol/mg protein, respectively, and succinate-linked mitochondrial RCR and ADP/O ratio declined from 1.6 and 0.8 mu mol/mg protein. MDA also showed dose-dependent inhibition on the activity of PDH, KGDH and MDH significantly from 0.1, 0.2 and 2 mu mol/mg protein, respectively. Activity of the complexes I and II was depressed by MDA at 0.8 and 1.6 mu mol/mg protein. However, MDA did not affect activity of complexes III and IV in the concentration range studied (0-6.4 mu mol/mg protein). These results suggest that MDA can cause mitochondrial dysfunction by inhibiting mitochondrial respiration and enzyme activity, and the sensitivity of the enzymes examined to MDA is in the order of PDH > KGDH > complexes I and II > MDH > complexes III and IV. (c) 2006 Published by Elsevier Inc.
C1 Univ Calif Irvine, Inst Brain Aging & Dementia, Gillespie Neurosci Res Facil 1261, Irvine, CA 92697 USA.
   Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutrit Sci, Shanghai 200031, Peoples R China.
   Second Mil Med Univ, Coll Basic Med Sci, Dept Biochem & Mol Biol, Shanghai 200433, Peoples R China.
   Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA.
C3 University of California System; University of California Irvine;
   Chinese Academy of Sciences; Naval Medical University; Children's
   Hospital Oakland Research Institute; Children's Hospital Los Angeles
RP Liu, JK (corresponding author), Univ Calif Irvine, Inst Brain Aging & Dementia, Gillespie Neurosci Res Facil 1261, Irvine, CA 92697 USA.
EM jkliu@sibs.ac.en
RI Liu, Chang/ISV-3950-2023; gao, hongxiang/HGU-2554-2022; Long,
   Jiangang/A-7835-2015; liu, yang/HQY-7531-2023; Liu, Jiankang/A-1610-2011
OI Long, Jiangang/0000-0002-6584-3880; Jiangang, Long/0000-0001-8074-957X
CR Ames BN, 2003, CLIN NEUROSCI RES, V2, P331, DOI 10.1016/S1566-2772(03)00010-0
   Ames BN, 2002, AM J CLIN NUTR, V75, P616, DOI 10.1093/ajcn/75.4.616
   BEPPU M, 1988, CHEM PHARM BULL, V36, P4519
   BIAGINI RE, 1990, TOXICOLOGY, V62, P95, DOI 10.1016/0300-483X(90)90034-E
   BURGER RM, 1980, J BIOL CHEM, V255, P1832
   BUTTKUS H, 1967, J FOOD SCI, V32, P432, DOI 10.1111/j.1365-2621.1967.tb09703.x
   CHEESEMAN KH, 1988, BIOCHEM J, V250, P247, DOI 10.1042/bj2500247
   ECKL PM, 1993, MUTAT RES, V290, P183, DOI 10.1016/0027-5107(93)90158-C
   ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6
   Floyd RA, 2001, EXP GERONTOL, V36, P619, DOI 10.1016/S0531-5565(00)00231-X
   GUTTERIDGE JMC, 1981, FEBS LETT, V128, P343, DOI 10.1016/0014-5793(81)80113-5
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   HARMAN D, 2002, INCREASING HLTH LIFE
   HINMAN LM, 1981, J BIOL CHEM, V256, P6583
   HIROSE S, 1973, BIOCHIM BIOPHYS ACTA, V305, P52, DOI 10.1016/0005-2728(73)90230-2
   Humphries KM, 1998, BIOCHEMISTRY-US, V37, P15835, DOI 10.1021/bi981512h
   Humphries KM, 1998, BIOCHEMISTRY-US, V37, P552, DOI 10.1021/bi971958i
   Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483
   Keller JN, 1997, NEUROSCIENCE, V80, P685, DOI 10.1016/S0306-4522(97)00065-1
   KIKUGAWA K, 1985, CHEM PHARM BULL, V33, P5437
   Liu JK, 2005, NUTR NEUROSCI, V8, P67, DOI 10.1080/10284150500047161
   Liu JK, 2002, ANN NY ACAD SCI, V959, P133, DOI 10.1111/j.1749-6632.2002.tb02090.x
   Liu JK, 2002, P NATL ACAD SCI USA, V99, P1876, DOI 10.1073/pnas.261709098
   Liu LX, 1999, ANN ACAD SCI FENN-M, V24, P11
   Luo J, 2005, NEUROCHEM INT, V46, P243, DOI 10.1016/j.neuint.2004.09.001
   MARNETT LJ, 1980, CANCER RES, V40, P276
   NAIR V, 1981, J AM CHEM SOC, V103, P3030, DOI 10.1021/ja00401a020
   Neely MD, 2000, FREE RADICAL BIO MED, V29, P1028, DOI 10.1016/S0891-5849(00)00411-1
   Picklo MJ, 2001, BBA-MOL BASIS DIS, V1535, P145, DOI 10.1016/S0925-4439(00)00093-4
   Picklo MJ, 1999, J NEUROCHEM, V72, P1617, DOI 10.1046/j.1471-4159.1999.721617.x
   STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616
   STEPHAN K, 1991, J BIOL CHEM, V266, P20998
   SUN LJ, IN PRESS MITOCHONDRI
   Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0
   Ullrich O, 1996, FREE RADICAL RES, V24, P421, DOI 10.3109/10715769609088041
   Yang S, 2004, CELL MOL LIFE SCI, V61, P220, DOI 10.1007/s00018-003-3357-4
   Yeo HC, 1999, METHOD ENZYMOL, V300, P70
   Zhu Xiongwei, 2004, Am J Alzheimers Dis Other Demen, V19, P345, DOI 10.1177/153331750401900611
   ZOLLNER H, 1973, BIOCHEM PHARMACOL, V22, P1171, DOI 10.1016/0006-2952(73)90234-7
NR 39
TC 74
Z9 91
U1 4
U2 16
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0024-3205
EI 1879-0631
J9 LIFE SCI
JI Life Sci.
PD SEP 5
PY 2006
VL 79
IS 15
BP 1466
EP 1472
DI 10.1016/j.lfs.2006.04.024
PG 7
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA 080LN
UT WOS:000240249400009
PM 16737718
DA 2024-02-19
ER

PT J
AU Elias, AE
   Kun, B
   Sabula, IMC
   Golomb-Mello, G
   Zablah, AC
   Kreiling, JA
AF Elias, Amy E.
   Kun, Bianca
   Sabula, Ian M. C.
   Golomb-Mello, Gail
   Zablah, Andrea Cespedes
   Kreiling, Jill A.
TI The mir-465 family is upregulated with age and attenuates growth hormone
   signaling in mouse liver
SO AGING CELL
LA English
DT Article
DE aging; growth hormone receptor; growth hormone signaling; liver; miRNAs;
   mouse
ID PROTEIN PHOSPHATASE 2A; ACID-LABILE SUBUNIT; FACTOR-I; SOMATOTROPIC
   AXIS; IGF-I; EXPRESSION; COMPLEX; GENOME; MICRORNAS; LONGEVITY
AB We analyzed the small RNA transcriptome from 5-month-old, 24-month-old, and 36-month-old mouse liver and found 56 miRNAs that changed their expression profile with age. Among these is a cluster of 18 miRNAs that are upregulated between 50- and 1,000-fold at 24 and 36 months of age. This cluster is located in a 60-kb region of the X-chromosome that is devoid of other coding sequences and is part of a lamin-associated domain. Potential targets of the miRNAs in the cluster suggest they may regulate several pathways altered in aging, including the PI3K-Akt pathway. Total transcriptome analyses indicate that expression of several potential genes in the PI3K-Akt pathway that may be targeted by the mir-465 family (mmu-mir-465a, mmu-mir-465b, and mmu-mir-465c) is downregulated with age. Transfection of the liver cell line AML12 with mir-465 family members leads to a reduction of three of these potential targets at the mRNA level: a 40% reduction of the growth hormone receptor (GHR), and a 25% reduction in Kitl and PPP2R3C. Further investigation of the GHR 3 ' UTR revealed that the mir-465 family directly targets the GHR mRNA. Cells transfected with mir-465 showed a reduction of JAK2 and STAT5 phosphorylation upon growth hormone (GH) stimulation, resulting in a reduction in insulin-like growth factor 1 (IGF-1) and IGF-1-binding protein 3 expression. With age, GH signaling falls and there is a reduction in circulating IGF-1. Our data suggest that an increase in expression of the mir-465 family with age may contribute to the reduction in the GH signaling.
C1 [Elias, Amy E.; Kun, Bianca; Sabula, Ian M. C.; Golomb-Mello, Gail; Zablah, Andrea Cespedes; Kreiling, Jill A.] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Brown Ctr Biol Aging, Providence, RI 02912 USA.
C3 Brown University
RP Kreiling, JA (corresponding author), Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA.
EM jill_kreiling@brown.edu
OI Kreiling, Jill/0000-0003-4440-2039; Elias, Amy/0000-0001-9013-6240
FU National Institutes of Health [5P30 4G038072, K01 AG039410, P01
   AG051449, P20 GM119943, P30 GM103410, T32 AG041688]
FX National Institutes of Health, Grant/Award Number: 5P30 4G038072, K01
   AG039410, P01 AG051449, P20 GM119943, P30 GM103410, T32 AG041688
CR Alvarez-Nava F, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18101624
   Balcells I, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-70
   Bartke A, 2016, GROWTH HORM IGF RES, V27, P41, DOI 10.1016/j.ghir.2016.02.002
   Bartke A, 2008, CLIN INTERV AGING, V3, P659, DOI 10.2147/CIA.S3697
   Barzilai N, 2012, DIABETES, V61, P1315, DOI 10.2337/db11-1300
   Brautigan DL, 2013, FEBS J, V280, P324, DOI 10.1111/j.1742-4658.2012.08609.x
   Brown-Borg HM, 2015, AM J PHYSIOL-ENDOC M, V309, pE503, DOI 10.1152/ajpendo.00262.2015
   Cecco M, 2013, AGING CELL, V12, P247, DOI 10.1111/acel.12047
   Criscione SW, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1500882
   Criscione SW, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-583
   DAI J, 1994, ENDOCRINOLOGY, V135, P1066, DOI 10.1210/en.135.3.1066
   De Cecco M, 2013, AGING-US, V5, P867, DOI 10.18632/aging.100621
   Gong ZW, 2014, AGING CELL, V13, P408, DOI 10.1111/acel.12188
   Guevara-Aguirre J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001845
   Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417
   Kaltenecker D, 2019, CYTOKINE, V124, DOI 10.1016/j.cyto.2018.10.010
   Katayama K, 2014, CANCER LETT, V345, P124, DOI 10.1016/j.canlet.2013.12.007
   Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102
   Kono Y, 2002, GENES CELLS, V7, P821, DOI 10.1046/j.1365-2443.2002.00562.x
   Kreiling JA, 2011, AGING CELL, V10, P292, DOI 10.1111/j.1474-9726.2010.00666.x
   Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040
   Laughlin GA, 2004, J CLIN ENDOCR METAB, V89, P114, DOI 10.1210/jc.2003-030967
   Lennartsson J, 2012, PHYSIOL REV, V92, P1619, DOI 10.1152/physrev.00046.2011
   Liang RQ, 2011, AGING CELL, V10, P1080, DOI 10.1111/j.1474-9726.2011.00751.x
   List EO, 2014, ENDOCRINOLOGY, V155, P1793, DOI 10.1210/en.2013-2086
   Lombardi G, 2005, J Endocrinol Invest, V28, P36
   Ooi GT, 1997, MOL ENDOCRINOL, V11, P997, DOI 10.1210/me.11.7.997
   Panici JA, 2010, FASEB J, V24, P5073, DOI 10.1096/fj.10-163253
   Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016
   Perrotti D, 2013, LANCET ONCOL, V14, pE229, DOI 10.1016/S1470-2045(12)70558-2
   Ro S, 2007, NUCLEIC ACIDS RES, V35, P5944, DOI 10.1093/nar/gkm641
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Schoeftner S, 2009, P NATL ACAD SCI USA, V106, P19387, DOI 10.1073/pnas.0909265106
   Suh Y, 2008, P NATL ACAD SCI USA, V105, P3438, DOI 10.1073/pnas.0705467105
   Sun LY, 2017, ELIFE, V6, DOI 10.7554/eLife.24059
   Swanson EC, 2013, J CELL BIOL, V203, P929, DOI 10.1083/jcb.201306073
   Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299
   Toth P, 2015, AGING CELL, V14, P1034, DOI 10.1111/acel.12372
   van Spronsen M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074907
   Westwood AJ, 2014, NEUROLOGY, V82, P1613, DOI 10.1212/WNL.0000000000000382
   Wood JG, 2010, AGING CELL, V9, P971, DOI 10.1111/j.1474-9726.2010.00624.x
   WU JC, 1994, P NATL ACAD SCI USA, V91, P674, DOI 10.1073/pnas.91.2.674
NR 42
TC 9
Z9 9
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
EI 1474-9726
J9 AGING CELL
JI Aging Cell
PD APR
PY 2019
VL 18
IS 2
AR e12892
DI 10.1111/acel.12892
PG 11
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA HO5JY
UT WOS:000460963500002
PM 30637918
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Araki, S
   Okazaki, M
   Goto, S
AF Araki, S
   Okazaki, M
   Goto, S
TI Impaired lipid metabolism in aged mice as revealed by fasting-induced
   expression of apolipoprotein mRNAs in the liver and changes in serum
   lipids
SO GERONTOLOGY
LA English
DT Article
DE lipid metabolism; apolipoproteins; triglyceride; cholesterol; fasting;
   gene expression; aging
ID TRIGLYCERIDE-RICH LIPOPROTEINS; LECITHIN-CHOLESTEROL ACYLTRANSFERASE;
   HIGH-DENSITY-LIPOPROTEINS; A-IV; SCAVENGER RECEPTOR; C-III; LIPASE
   ACTIVITY; RAT-LIVER; WILD-TYPE; BINDING
AB Background: Changes in apolipoprotein (Apo) metabolism can cause an increased incidence of diseases such as cardiovascular disorders and diabetes with advancing age. Limited reports are available on this topic, however. Objective: To investigate age-related changes in mobilization of stored lipid, we studied the effects of fasting on the gene expression of Apos in the liver as well as serum triglyceride (TG) and cholesterol levels in the serum. Methods: Using young (6- to 8-month-old) and old (24- to 28-month-old) fasted and re-fed mice, Northern blots of hepatic mRNAs for Apos A-I, A-IV, C-II, C-III, and liver-type fatty acid-binding protein and HPLC analyses of serum lipids were conducted. Results: Fasting induced 4- and 20-fold increases in the mRNA of Apo C-II and A-IV, respectively, in young mice while only 1.1- and 7-fold increases, respectively, were detected in old mice. In contrast, the Apo C-III gene expression was significantly reduced by fasting in the young mice but the reduction was small in the old. In view of the stimulating effect of Apo C-II and A-IV and the inhibiting effect of C-III on lipoprotein lipase (LPL), these findings suggest that the fasting-induced activation of LPL may be considerably decreased in old mice. The amount of TG in very low-density lipoprotein ( VLDL), a major form of the transport of TG to peripheral tissues, was significantly greater in the young than in the old mice. Despite possible activation of LPL by fasting, the amount of TG in VLDL, a major form of the transport of TG to peripheral tissues, was significantly greater in the young mice than in the old. It is indicated that the synthesis of VLDL in the liver is high in the young but low in the old mice, which also may be true for the rate of transport of TG. Conclusion: The present findings suggest that mobilization of lipids is impaired in old animals due to decreased gene expression of Apos, possibly leading in the long run to excessive lipid accumulation in tissues such as the liver, adipose tissues and blood vessels even in normal feeding, and resulting in an increased incidence of age-related diseases. Copyright (C) 2004 S. Karger AG, Basel.
C1 Toho Univ, Fac Pharmaceut Sci, Dept Biochem, Chiba 2748510, Japan.
   Tokyo Med & Dent Univ, Coll Liberal Arts & Sci, Chem Lab, Ichikawa, Chiba, Japan.
C3 Toho University; Tokyo Medical & Dental University (TMDU)
RP Goto, S (corresponding author), Toho Univ, Fac Pharmaceut Sci, Dept Biochem, Miyama 2-2-1, Chiba 2748510, Japan.
EM goto@phar.toho-u.ac.jp
CR Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518
   Araki S, 2003, EXP GERONTOL, V38, P499, DOI 10.1016/S0531-5565(03)00038-X
   BISGAIER CL, 1987, J LIPID RES, V28, P693
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   DUCHATEAU P, 1993, BIOCHIM BIOPHYS ACTA, V1182, P30, DOI 10.1016/0925-4439(93)90149-U
   DVORIN E, 1986, J BIOL CHEM, V261, P5714
   EMMANUEL F, 1994, J BIOL CHEM, V269, P29883
   Frank PG, 2000, J LIPID RES, V41, P853
   GINSBERG HN, 1986, J CLIN INVEST, V78, P1287, DOI 10.1172/JCI112713
   GOLDBERG IJ, 1990, J BIOL CHEM, V265, P4266
   Goldberg IJ, 1996, J LIPID RES, V37, P693
   ISHIGAMI A, 1988, MECH AGEING DEV, V46, P125, DOI 10.1016/0047-6374(88)90120-0
   Jong MC, 2001, J LIPID RES, V42, P1578
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Liu HQ, 2000, BIOCHEMISTRY-US, V39, P9201, DOI 10.1021/bi0009441
   MacPhee CE, 2000, BIOCHEMISTRY-US, V39, P3433, DOI 10.1021/bi992523t
   Mori N, 1982, Arch Gerontol Geriatr, V1, P143, DOI 10.1016/0167-4943(82)90014-0
   MOTOJIMA K, 1992, FEBS LETT, V308, P207, DOI 10.1016/0014-5793(92)81275-Q
   Nakamura A, 1996, J BIOCHEM, V119, P768
   Olivecrona G, 1997, ARTERIOSCL THROM VAS, V17, P1545, DOI 10.1161/01.ATV.17.8.1545
   Pennacchio LA, 2001, SCIENCE, V294, P169, DOI 10.1126/science.1064852
   Qin XF, 1998, AM J PHYSIOL-HEART C, V274, pH1836, DOI 10.1152/ajpheart.1998.274.5.H1836
   REICHL D, 1989, ARTERIOSCLEROSIS, V9, P785, DOI 10.1161/01.ATV.9.6.785
   Reynisdottir S, 1997, ARTERIOSCL THROM VAS, V17, P2287, DOI 10.1161/01.ATV.17.10.2287
   Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610
   Scarpace PJ, 2000, J GERONTOL A-BIOL, V55, pB588, DOI 10.1093/gerona/55.12.B588
   SHELBURNE F, 1980, J CLIN INVEST, V65, P652, DOI 10.1172/JCI109710
   SHIMIZU S, 1979, BIOCHEM BIOPH RES CO, V91, P108, DOI 10.1016/0006-291X(79)90589-8
   Silver DL, 2001, J BIOL CHEM, V276, P25287, DOI 10.1074/jbc.M101726200
   Sokal R.R, 1981, BIOMETRY
   STEIN O, 1986, BIOCHIM BIOPHYS ACTA, V878, P7, DOI 10.1016/0005-2760(86)90337-1
   Tso P, 1999, J NUTR, V129, P1503, DOI 10.1093/jn/129.8.1503
   USUI S, 1992, J LIPID RES, V43, P805
   Van Lenten BJ, 2001, TRENDS CARDIOVAS MED, V11, P155, DOI 10.1016/S1050-1738(01)00095-0
   WANG CS, 1985, J CLIN INVEST, V75, P384, DOI 10.1172/JCI111711
   WINDLER E, 1985, J LIPID RES, V26, P556
   Xiang SQ, 1999, J LIPID RES, V40, P1655
NR 37
TC 18
Z9 21
U1 0
U2 6
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0304-324X
EI 1423-0003
J9 GERONTOLOGY
JI Gerontology
PY 2004
VL 50
IS 4
BP 206
EP 215
DI 10.1159/000078349
PG 10
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 835IQ
UT WOS:000222476600003
PM 15258425
DA 2024-02-19
ER

PT J
AU HUBATSCH, I
   MAURER, P
   ENGEL, D
   ADOLPH, HW
AF HUBATSCH, I
   MAURER, P
   ENGEL, D
   ADOLPH, HW
TI PREPARATION AND CHARACTERIZATION OF ISOZYMES AND ISOFORMS OF HORSE LIVER
   ALCOHOL-DEHYDROGENASE
SO JOURNAL OF CHROMATOGRAPHY A
LA English
DT Article; Proceedings Paper
CT 14th International Symposium on the Separation and Analysis of Proteins,
   Peptides and Polynucleotides (ISPPP 94)
CY NOV 02-04, 1994
CL HEIDELBERG, GERMANY
SP Pharm Biotech, E Merck, TosoHaas, PerSeptive Biosyst, Bischoff Chromatog, Eka Nobel, Firma Dr Ing H Knauer Gmbh, Rockland Technol, Shandon HPLC Div, Supelco
ID AFFINITY CHROMATOGRAPHY; ISOENZYMES; GLYCATION; GLYCOSYLATION;
   SPECIFICITY; ENZYME; INVIVO; SITES
AB The procedure described allows the simultaneous large-scale preparation of the three main isozymes (EE, ES, SS) of alcohol dehydrogenase from horse liver (HLADH) and their subfractions using heat denaturation, ammonium sulfate precipitation, DEAF and CM ion-exchange chromatography as well as AMP-Sepharose affinity chromatography. Typical yields that can be obtained within three weeks are 1.5-2.5 g of EE-HLADH, 300-800 mg of ES-HLADH, 20-400 mg of SS-HLADH and 50-100 mg of EE-HLADH isoforms from 5 kg of horse liver. The EE-HLADH isoform prepared has a pi of 7.8, which is 0.3 pH units lower as compared to the main fraction; the zinc content and number of free sulfhydryl groups are unchanged but matrix-assisted laser desorption ionization mass spectrometry resulted in a molecular mass difference of + 130 to 165 relative molecular mass. From a sugar determination and comparison of its pi with an artificial glycosylation product of the EE-HLADH isozyme we concluded that the isoforms of HLADH are non-enzymatic glycosylation products which have been described to occur during protein aging.
C1 UNIV SAARLAND,DEPT BIOCHEM,D-66041 SAARBRUCKEN,GERMANY.
C3 Saarland University
RI Adolph, Hans W/A-2104-2008
CR ADOLPH HW, 1991, EUR J BIOCHEM, V201, P615, DOI 10.1111/j.1432-1033.1991.tb16322.x
   ANDERSSON L, 1974, BIOCHIM BIOPHYS ACTA, V364, P1, DOI 10.1016/0005-2744(74)90126-0
   [Anonymous], PYRIDINE NUCLEOTIDE
   BONNICHSEN RK, 1948, ARCH BIOCHEM, V18, P361
   BONNICHSEN RK, 1950, ACTA CHEM SCAND, V4, P715, DOI 10.3891/acta.chem.scand.04-0715
   BROWNLEE M, 1984, ANN INTERN MED, V101, P527, DOI 10.7326/0003-4819-101-4-527
   DWORSCHACK RT, 1977, BIOCHEMISTRY-US, V16, P111, DOI 10.1021/bi00620a018
   ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6
   GALLOP PM, 1981, ANAL BIOCHEM, V117, P427, DOI 10.1016/0003-2697(81)90802-2
   HUBATSCH I, 1993, ENZYMOLOGY MOL BIOL, V4, P451
   JONES JB, 1976, TECH CHEM NY, V10, P107
   JORNVALL H, 1970, EUR J BIOCHEM, V16, P41, DOI 10.1111/j.1432-1033.1970.tb01050.x
   JORNVALL H, 1987, EUR J BIOCHEM, V167, P195, DOI 10.1111/j.1432-1033.1987.tb13323.x
   JORNVALL H, 1973, BIOCHEM BIOPH RES CO, V53, P1096, DOI 10.1016/0006-291X(73)90577-9
   JORNVALL H, 1993, ENZYMOLOGY MOL BIOL, V4, P533
   LANGE LG, 1976, BIOCHEMISTRY-US, V15, P4681, DOI 10.1021/bi00666a022
   LUTSTORF U M, 1970, European Journal of Biochemistry, V17, P497, DOI 10.1111/j.1432-1033.1970.tb01192.x
   LUTSTORF UM, 1969, FEBS LETT, V5, P202, DOI 10.1016/0014-5793(69)80332-7
   MCKINLEY.JS, 1965, BIOCHEM J, V96, P583, DOI 10.1042/bj0960583
   MCPHERSON JD, 1988, BIOCHEM BIOPH RES CO, V152, P711, DOI 10.1016/S0006-291X(88)80096-2
   PARK DH, 1991, J BIOL CHEM, V266, P13296
   PIETRUSZKO R, 1969, ARCH BIOCHEM BIOPHYS, V131, P288, DOI 10.1016/0003-9861(69)90133-7
   PIETRUSZKO R, 1982, METHOD ENZYMOL, V89, P428
   PIETRUSZKO REGINA, 1966, BIOCHEM BIOPHYS RES COMMUN, V23, P526, DOI 10.1016/0006-291X(66)90761-3
   SAMAMA JP, 1981, EUR J BIOCHEM, V118, P479, DOI 10.1111/j.1432-1033.1981.tb05544.x
   SHILTON BH, 1991, J BIOL CHEM, V266, P5587
   SHILTON BH, 1993, EUR J BIOCHEM, V215, P567, DOI 10.1111/j.1432-1033.1993.tb18067.x
   THEORELL H, 1966, BIOCHEM BIOPH RES CO, V24, P603, DOI 10.1016/0006-291X(66)90365-2
NR 28
TC 6
Z9 6
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0021-9673
J9 J CHROMATOGR A
JI J. Chromatogr. A
PD SEP 8
PY 1995
VL 711
IS 1
BP 105
EP 112
DI 10.1016/0021-9673(95)00227-E
PG 8
WC Biochemical Research Methods; Chemistry, Analytical
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA RW015
UT WOS:A1995RW01500011
PM 7496481
DA 2024-02-19
ER

PT J
AU Mahendra, G
   Kanungo, MS
AF Mahendra, G
   Kanungo, MS
TI Age-related and steroid induced changes in the histones of the quail
   liver
SO ARCHIVES OF GERONTOLOGY AND GERIATRICS
LA English
DT Article
DE Japanese quail; 17 beta estradiol; progesterone; histones; aging
ID JAPANESE-QUAIL; CHROMATIN; ACETYLATION; ESTRADIOL; BRAIN; RATS;
   TRANSCRIPTION; CONFORMATION; PROGESTERONE; MODULATION
AB Histones were extracted from the liver of young, adult and old Japanese quails. Both linker and core histones were found to vary with age. An extra band, H3X, was found between H2A and H4. Its level is higher in young and old birds in comparison to that of the adult. H3X shows interesting changes under steroid induction. Its level is higher in progesterone administered young birds. In adult and old birds, it is higher in progesterone treated (P) and progesterone primed estradiol administered (P + E) birds, and lower in all estradiol (E) and estradiol primed progesterone administered (E + P) birds. The relative levels of H3X in the steroid administered birds also vary with age. Such changes may influence chromatin conformation and gene expression. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
C1 Banaras Hindu Univ, Dept Zool, Mol Biol Lab, Varanasi 221005, Uttar Pradesh, India.
C3 Banaras Hindu University (BHU)
RP Kanungo, MS (corresponding author), Banaras Hindu Univ, Dept Zool, Mol Biol Lab, Varanasi 221005, Uttar Pradesh, India.
CR BLOBEL G, 1966, SCIENCE, V154, P1662, DOI 10.1126/science.154.3757.1662
   CHATURVEDI MM, 1985, MOL BIOL REP, V10, P215
   ELGIN SCR, 1970, BIOCHEMISTRY-US, V7, P4440
   Gupta S, 1996, BIOCHEM BIOPH RES CO, V222, P181, DOI 10.1006/bbrc.1996.0718
   HEWISH DR, 1973, BIOCHEM BIOPH RES CO, V52, P504, DOI 10.1016/0006-291X(73)90740-7
   Hoffmann P, 1978, Methods Cell Biol, V17, P1, DOI 10.1016/S0091-679X(08)61130-9
   KANUNGO MS, 1979, J STEROID BIOCHEM, V11, P879, DOI 10.1016/0022-4731(79)90024-4
   KANUNGO MS, 1979, BIOCHEM BIOPH RES CO, V87, P266, DOI 10.1016/0006-291X(79)91675-9
   KANUNGO MS, 1975, J THEOR BIOL, V53, P253, DOI 10.1016/S0022-5193(75)80002-6
   KANUNGO MS, 1994, GENES AGING, P274
   KANUNGO MS, 1980, BIOCH AGEING, P281
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LI W, 1993, BIOCHEM J, V296, P737, DOI 10.1042/bj2960737
   Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444
   Mahendra G, 1999, ARCH GERONTOL GERIAT, V28, P149, DOI 10.1016/S0167-4943(99)00002-3
   MISHRA RN, 1994, MOL BIOL REP, V20, P15, DOI 10.1007/BF00999850
   NOLL M, 1975, SCIENCE, V187, P1203, DOI 10.1126/science.187.4182.1203
   SMITH DL, 1973, NATURE, V246, P103, DOI 10.1038/246103a0
   SOLLNERWEBB B, 1975, BIOCHEMISTRY-US, V14, P2915, DOI 10.1021/bi00684a019
   SOLLNERWEBB B, 1976, CELL, V9, P179, DOI 10.1016/0092-8674(76)90063-5
   Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599
   Thomas J O, 1978, Methods Cell Biol, V18, P429
   TORDERA V, 1993, EXPERIENTIA, V49, P780, DOI 10.1007/BF01923548
   UPADHYAY R, 1996, THESIS BANARAS HINDU
   Walia H, 1998, J BIOL CHEM, V273, P14516, DOI 10.1074/jbc.273.23.14516
NR 25
TC 11
Z9 11
U1 0
U2 4
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0167-4943
J9 ARCH GERONTOL GERIAT
JI Arch. Gerontol. Geriatr.
PD MAR-APR
PY 2000
VL 30
IS 2
BP 109
EP 114
DI 10.1016/S0167-4943(00)00042-X
PG 6
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 312LX
UT WOS:000086945700003
PM 15374037
DA 2024-02-19
ER

PT J
AU Trocha, M
   Merwid-Lad, A
   Chlebda-Sieragowska, E
   Szuba, A
   Piesniewska, M
   Fereniec-Golebiewska, L
   Kwiatkowska, J
   Szelag, A
   Sozanski, T
AF Trocha, Malgorzata
   Merwid-Lad, Anna
   Chlebda-Sieragowska, Ewa
   Szuba, Andrzej
   Piesniewska, Malgorzata
   Fereniec-Golebiewska, Lidia
   Kwiatkowska, Joanna
   Szelag, Adam
   Sozanski, Tomasz
TI Age-related changes in ADMA-DDAH-NO pathway in rat liver subjected to
   partial ischemia followed by global reperfusion
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE Age; Liver; Ischemia/reperfusion; iNOS; ADMA; Rat
ID NITRIC-OXIDE SYNTHASE; ASYMMETRIC DIMETHYLARGININE ADMA;
   ISCHEMIA/REPERFUSION INJURY; ENDOTHELIAL DYSFUNCTION; HEPATIC ISCHEMIA;
   INHIBITORS; ARGININE; INOS; DIMETHYLAMINOHYDROLASE; TRANSPLANTATION
AB Background: Liver function is affected during ischemia/reperfusion (IR). Weevaluated the effect of the aging process on selected parameters determining the NO level in rat liver subjected to IR.
   Methods: The animals were divided into the C-2 and the IR-2 group of young rats (2-4 months old) and the C-12 and the IR-12 group of older rats (12-14 months old). Livers belonging to the IR-2 and the IR-12 group were subjected to partial ischemia (60 min) and reperfusion (4 h). Blood samples were obtained after surgeries to estimate the activity of aminotransferases, as well as just before ischemia and during reperfusion (15, 120, and 240 min) to estimate concentration of arginine (Arg) and its derivatives: asymmetric and symmetric dimethylarginine (ADMA, SDMA). After IR, dimethylarginine dimethylaminohydrolase (DDAH) activity and protein concentration of inducible nitric oxide synthase (iNOS) were measured in liver homogenates.
   Results: In the IR-2 group ADMA level increased the most between 15 and 120 min of reperfusion and was the highest of all the groups (0.72 +/- 0.2 mu mol/l). In the IR-12 group ADMA level decreased significantly and was lower compared to all the other groups at 15 min (0.42 +/- 0.2 mu mol/l) and to IR-2 at 120 (0.52 +/- 0.1 mu mol/l) and 240 min (0.38 +/- 0.1 mu mol/l) of reperfusion. Only the IR-2 group SDMAlevel increased significantly between 15 (0.75 +/- 0.9 mu mol/l) and 240 min (1.0 +/- 1.2 mu mol/l) of reperfusion. At the beginning of the surgery the Arg level was significantly higher in young rats (C-2: 102.1 +/- 35.7 mu mol/l; IR-2: 114.63 +/- 28.9 mu mol/l) than in older ones (C-12: 41.88 +/- 44.7 mu mol/l; IR-12: 28.64 +/- 30.6 mu mol/l). In the C-2 group the Arg level (77.41 +/- 37.5 mu mol/l) and Arg/ADMA (A/A) ratio (138.03 +/- 62.8 mu mol/l) were significantly higher compared to the ischemic groups at 15 min and to all the other groups at 120 (Arg: 47.17 +/- 31.7 mu mol/l; A/A: 88.28 +/- 66.2 mu mol/l) and 240 min (Arg: 43.87 +/- 21.9 mu mol/l; A/A: 118.02 +/- 106.3 mu mol/l). In the IR-2 group Arg level (11.4 +/- 12.0 mu mol/l) and A/A ratio (16.11 +/- 16.2 mu mol/l) decreased significantly at 15 min and during the next phase of reperfusion the levels of those parameters were low, comparably to those in IR-12. As a result of IR, a decrease in DDAH activity and an increase in iNOS protein concentration were observed only in the young rats.
   Conclusions: Wefound that in the non-ischemic groups the Arg levelmay be affected by the aging process. Under IR conditions, important changes in DDAH-ADMA-NO pathway were observed only in young livers. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Trocha, Malgorzata; Merwid-Lad, Anna; Chlebda-Sieragowska, Ewa; Piesniewska, Malgorzata; Fereniec-Golebiewska, Lidia; Kwiatkowska, Joanna; Szelag, Adam; Sozanski, Tomasz] Wroclaw Med Univ, Dept Pharmacol, PL-50345 Wroclaw, Poland.
   [Szuba, Andrzej] 4th Mil Hosp Policlin Wroclaw, Dept Internal Med, PL-50981 Wroclaw, Poland.
   [Szuba, Andrzej] Wroclaw Med Univ, Fac Hlth Sci, PL-50996 Wroclaw, Poland.
C3 Wroclaw Medical University; Wroclaw Medical University
RP Sozanski, T (corresponding author), Wroclaw Med Univ, Dept Pharmacol, Mikulicza Radeckiego 2, PL-50345 Wroclaw, Poland.
EM tsoz@wp.pl
RI Szuba, Andrzej/AAY-1162-2020; Merwid-Ląd, Anna/ABD-2151-2021; Szelag,
   Adam/AAS-8198-2021
OI Merwid-Ląd, Anna/0000-0002-4597-0241; Sozanski,
   Tomasz/0000-0003-1722-3190; Piesniewska, Malgorzata/0000-0003-3368-3496;
   Trocha, Malgorzata/0000-0002-3951-205X; Szuba,
   Andrzej/0000-0002-7555-6201; Kwiatkowska, Joanna/0000-0002-2871-3366;
   Szelag, Adam/0000-0001-8104-5267
FU Wroclaw Medical University [ST-555]
FX The study was financially supported by the statutory means of Wroclaw
   Medical University (ST-555).
CR Abe Y, 2009, FREE RADICAL BIO MED, V46, P1, DOI 10.1016/j.freeradbiomed.2008.09.029
   Alkofer B, 2006, SEMIN LIVER DIS, V26, P221, DOI 10.1055/s-2006-947292
   Anantharaju A, 2002, GERONTOLOGY, V48, P343, DOI 10.1159/000065506
   Böger RH, 1998, CIRCULATION, V98, P1842, DOI 10.1161/01.CIR.98.18.1842
   Buttery LDK, 1996, LAB INVEST, V75, P77
   Chobanyan K, 2007, J CHROMATOGR B, V858, P32, DOI 10.1016/j.jchromb.2007.08.002
   Clavien PA, 2003, ANN SURG, V238, P843, DOI 10.1097/01.sla.0000098620.27623.7d
   Collins BH, 2000, TRANSPLANTATION, V70, P780, DOI 10.1097/00007890-200009150-00012
   Dimitrow PR, 2007, PHARMACOL REP, V59, P715
   Fan CG, 1999, J MOL MED, V77, P577, DOI 10.1007/s001099900029
   Feng S, 2006, AM J TRANSPLANT, V6, P783, DOI 10.1111/j.1600-6143.2006.01242.x
   Foster Richard, 2007, Clin Liver Dis, V11, P417, DOI 10.1016/j.cld.2007.04.004
   Fu AZ, 1998, AM J PHYSIOL-ENDOC M, V275, pE1023, DOI 10.1152/ajpendo.1998.275.6.E1023
   Furchgott RF, 1996, JAMA-J AM MED ASSOC, V276, P1186, DOI 10.1001/jama.276.14.1186
   Gasbarrini A, 1998, FREE RADICAL BIO MED, V24, P211, DOI 10.1016/S0891-5849(97)00056-7
   Habior A., 2002, MED SCI REV HEPATOLO, V2, P85
   Hierholzer C, 1998, J EXP MED, V187, P917, DOI 10.1084/jem.187.6.917
   Hines IN, 2005, BIOMED PHARMACOTHER, V59, P183, DOI 10.1016/j.biopha.2005.03.011
   Hornig B, 1998, CIRCULATION, V98, P318
   IGNARRO LJ, 1989, FASEB J, V3, P31, DOI 10.1096/fasebj.3.1.2642868
   Kang ES, 1999, AM J MED SCI, V317, P9, DOI 10.1097/00000441-199901000-00003
   Kelly DM, 2011, LIVER TRANSPLANT, V17, P1448, DOI 10.1002/lt.22424
   Kireev RA, 2012, J SURG RES, V178, P922, DOI 10.1016/j.jss.2012.04.060
   Kobayashi H, 1995, J SURG RES, V59, P772, DOI 10.1006/jsre.1995.1238
   Laleman W, 2005, HEPATOLOGY, V42, P1382, DOI 10.1002/hep.20968
   LECOUTEUR DG, 1994, TRANSPLANTATION, V58, P531, DOI 10.1097/00007890-199409150-00001
   Leiper J, 2002, P NATL ACAD SCI USA, V99, P13527, DOI 10.1073/pnas.212269799
   Leiper J, 1999, CARDIOVASC RES, V43, P542, DOI 10.1016/S0008-6363(99)00162-5
   Lhuillier F, 2003, ANESTHESIOLOGY, V98, P373, DOI 10.1097/00000542-200302000-00017
   Lin KY, 2002, CIRCULATION, V106, P987, DOI 10.1161/01.CIR.0000027109.14149.67
   Martín-Sanz P, 2003, LIVER TRANSPLANT, V9, P40, DOI 10.1053/jlts.2003.50008
   Massip-Salcedo M, 2007, LIVER INT, V27, P6, DOI 10.1111/j.1478-3231.2006.01390.x
   Mishima T, 2004, DEV BRAIN RES, V148, P223, DOI 10.1016/j.devbrainres.2003.09.021
   Mookerjee RP, 2007, LIVER TRANSPLANT, V13, P400, DOI 10.1002/lt.21053
   Nijveldt RJ, 2003, CLIN NUTR, V22, P17, DOI 10.1054/clnu.2002.0612
   Okaya T, 2005, SHOCK, V24, P421, DOI 10.1097/01.shk.0000181282.14050.11
   Parker RA, 2003, ATHEROSCLEROSIS, V169, P19, DOI 10.1016/S0021-9150(03)00100-X
   Peralta C, 2001, TRANSPLANTATION, V71, P529, DOI 10.1097/00007890-200102270-00008
   Rivera-Chavez FA, 2001, J INVEST SURG, V14, P267, DOI 10.1080/089419301753170048
   Scalera F, 2004, ARTERIOSCL THROM VAS, V24, P1816, DOI 10.1161/01.ATV.0000141843.77133.fc
   Schemmer P, 1999, J PHARMACOL EXP THER, V290, P235
   Schmucker DL, 1998, J GERONTOL A-BIOL, V53, pB315, DOI 10.1093/gerona/53A.5.B315
   Shah V, 1997, J CLIN INVEST, V100, P2923, DOI 10.1172/JCI119842
   Sohal RS, 2002, FREE RADICAL BIO MED, V33, P575, DOI 10.1016/S0891-5849(02)00886-9
   Tran CTL, 2003, ATHEROSCLEROSIS SUPP, V4, P33, DOI 10.1016/S1567-5688(03)00032-1
   Trocha M, 2007, HEPATO-GASTROENTEROL, V54, P1207
   Trocha M, 2013, PHARMACOL REP, V65, P122, DOI 10.1016/S1734-1140(13)70970-8
   Trocha M, 2010, PHARMACOL REP, V62, P343, DOI 10.1016/S1734-1140(10)70274-7
   Trocha M, 2010, ADV CLIN EXP MED, V19, P233
   Ueda S, 2003, CIRC RES, V92, P226, DOI 10.1161/01.RES.0000052990.68216.EF
   Vallance P, 2004, ARTERIOSCL THROM VAS, V24, P1023, DOI 10.1161/01.ATV.0000128897.54893.26
   Wnuk Z, 2012, POL ARCH MED WEWN, V122, P367, DOI 10.20452/pamw.1355
   Xiong Y, 2003, J CARDIOVASC PHARM, V42, P191, DOI 10.1097/00005344-200308000-00006
NR 53
TC 11
Z9 12
U1 0
U2 12
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD FEB
PY 2014
VL 50
BP 45
EP 51
DI 10.1016/j.exger.2013.11.004
PG 7
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 288JS
UT WOS:000329608500007
PM 24269305
DA 2024-02-19
ER

PT J
AU Ii, K
   Towatari, T
   Ito, M
   Ohama, E
   Hirano, A
AF Ii, K
   Towatari, T
   Ito, M
   Ohama, E
   Hirano, A
TI Impairment of cathepsin B immunoreactivity in the hippocampal nerve
   cells with aging in the elderly: Possible evidence for dysfunction of
   lysosomal proteolysis in relation to the pathogenesis of Alzheimer's
   disease
SO NEUROPATHOLOGY
LA English
DT Article
DE aging; Alzheimer's disease; brain; cathepsin B; immunohistochemistry;
   lysosome; protease
ID AMYLOID PRECURSOR PROTEIN; HEREDITARY CEREBRAL-HEMORRHAGE;
   APOLIPOPROTEIN-E; BETA-PROTEIN; RAT-LIVER; BRAIN; IDENTIFICATION;
   NEURONS; GENE; ALPHA-1-ANTICHYMOTRYPSIN
AB Immunohistochemical localization of cathepsin B (CB) in the hippocampal nerve cells was examined in patients ranging from age 18 days to 82 years to examine the change of proteolytic activity of nerve cells with aging through the CB immunoreactivity. Although it varied from case to case, region to region, and to some degree cell to cell, generally, CB immunoreactivity in the nerve cells was weak in the newborn, strong from age 7 to about 60, and decreased in most nerve cells, or the number of nerve cells with impaired CB immunoreactivity increased, after about 60 years of age, This suggests impairment of protein metabolism and/or dysfunction of lysosomal proteolysis in the nerve cells with aging, The last finding may be important as a background or preceding phenomenon that may cause abnormal protein metabolism relating to the formation of neurofibrillary tangles and/or senile plaques with aging and in Alzheimer's disease (AD), The involvement of CB in the metabolism of A beta-amyloid protein precursors (APP) and the possible close relation of presenilins to APP should also be considered.
C1 UNIV TOKUSHIMA, SCH MED, DEPT PATHOL 1, TOKUSHIMA 770, JAPAN.
   UNIV TOKUSHIMA, INST ENZYME RES, DIV ENZYME CHEM, TOKOROZAWA, SAITAMA, JAPAN.
   TOTTORI UNIV, FAC MED, INST NEUROL SCI, DIV NEUROPATHOL, TOTTORI 680, JAPAN.
   MONTEFIORE MED CTR, ALBERT EINSTEIN COLL MED, DIV NEUROPATHOL, BRONX, NY 10467 USA.
   MONTEFIORE MED CTR, ALBERT EINSTEIN COLL MED, DEPT MED, BRONX, NY 10467 USA.
C3 Tokushima University; Tokushima University; Tottori University; Yeshiva
   University; Albert Einstein College of Medicine; Montefiore Medical
   Center; Montefiore Medical Center; Yeshiva University; Albert Einstein
   College of Medicine
CR ABRAHAM CR, 1992, ANN NY ACAD SCI, V674, P174, DOI 10.1111/j.1749-6632.1992.tb27486.x
   ABRAHAM CR, 1990, NEUROBIOL AGING, V11, P123, DOI 10.1016/0197-4580(90)90045-2
   ABRAHAM CR, 1988, CELL, V52, P487, DOI 10.1016/0092-8674(88)90462-X
   ASHALL F, 1994, TRENDS BIOCHEM SCI, V19, P42, DOI 10.1016/0968-0004(94)90173-2
   CATALDO AM, 1994, BRAIN RES, V640, P68, DOI 10.1016/0006-8993(94)91858-9
   CATALDO AM, 1991, P NATL ACAD SCI USA, V88, P10998, DOI 10.1073/pnas.88.24.10998
   CATALDO AM, 1990, P NATL ACAD SCI USA, V87, P3861, DOI 10.1073/pnas.87.10.3861
   COLE GM, 1992, ANN NY ACAD SCI, V674, P103
   Dewji NN, 1996, SCIENCE, V271, P159, DOI 10.1126/science.271.5246.159
   ESTUS S, 1992, ANN NY ACAD SCI, V674, P138, DOI 10.1111/j.1749-6632.1992.tb27483.x
   GHISO J, 1986, P NATL ACAD SCI USA, V83, P2974, DOI 10.1073/pnas.83.9.2974
   HAASS C, 1992, NATURE, V357, P500, DOI 10.1038/357500a0
   HIRANO A, 1988, COLOR ATLAS PATHOLOG, P225
   II K, 1985, J HISTOCHEM CYTOCHEM, V33, P1173, DOI 10.1177/33.11.4056381
   II K, 1986, AM J PATHOL, V122, P193
   II K, 1993, VIRCHOWS ARCH A, V423, P185, DOI 10.1007/BF01614769
   II K, 1995, DRUG AGING, V7, P97, DOI 10.2165/00002512-199507020-00004
   ISHIURA S, 1990, FEBS LETT, V260, P131, DOI 10.1016/0014-5793(90)80084-V
   ISHIURA S, 1989, FEBS LETT, V257, P388, DOI 10.1016/0014-5793(89)81579-0
   IVY GO, 1992, ANN NY ACAD SCI, V674, P89, DOI 10.1111/j.1749-6632.1992.tb27479.x
   Kamino K, 1996, NEUROSCI LETT, V208, P195, DOI 10.1016/0304-3940(96)12587-8
   KENESSEY A, 1990, NEUROCHEM RES, V15, P243, DOI 10.1007/BF00968667
   KIRSCHKE H, 1987, LYSOSOMES THEIR ROLE, P193
   KITAGUCHI N, 1988, NATURE, V331, P530, DOI 10.1038/331530a0
   KOMINAMI E, 1982, J BIOCHEM-TOKYO, V91, P67, DOI 10.1093/oxfordjournals.jbchem.a133709
   LAJTHA A, 1992, ANN NY ACAD SCI, V674, P16, DOI 10.1111/j.1749-6632.1992.tb27473.x
   LEVY E, 1989, J EXP MED, V169, P1771, DOI 10.1084/jem.169.5.1771
   LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584
   LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622
   MCDERMOTT JR, 1991, BIOCHEM BIOPH RES CO, V179, P1148, DOI 10.1016/0006-291X(91)91691-5
   Metzger RE, 1996, J NEUROPATH EXP NEUR, V55, P372, DOI 10.1097/00005072-199603000-00013
   NELSON RB, 1990, J BIOL CHEM, V265, P3836
   NIXON RA, 1992, ANN NY ACAD SCI, V674, P65
   PONTE P, 1988, NATURE, V331, P525, DOI 10.1038/331525a0
   ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0
   SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467
   SCHELLENBERG GD, 1992, SCIENCE, V258, P668, DOI 10.1126/science.1411576
   SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0
   SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760
   STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977
   TAGAWA K, 1991, BIOCHEM BIOPH RES CO, V177, P377, DOI 10.1016/0006-291X(91)91994-N
   TAGAWA K, 1992, ANN NY ACAD SCI, V674, P129, DOI 10.1111/j.1749-6632.1992.tb27482.x
   TANZI RE, 1988, NATURE, V331, P528, DOI 10.1038/331528a0
   TOWATARI T, 1979, EUR J BIOCHEM, V102, P279, DOI 10.1111/j.1432-1033.1979.tb06290.x
   TROJANOWSKI JQ, 1994, ANN NY ACAD SCI, V747, P92
   Uchihara T, 1996, ACTA NEUROPATHOL, V92, P325, DOI 10.1007/s004010050526
   Van Broeckhoven C, 1995, NAT GENET, V11, P230
NR 47
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0919-6544
EI 1440-1789
J9 NEUROPATHOLOGY
JI Neuropathology
PD SEP
PY 1997
VL 17
IS 3
BP 189
EP 195
DI 10.1111/j.1440-1789.1997.tb00037.x
PG 7
WC Clinical Neurology; Neurosciences; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pathology
GA YC433
UT WOS:A1997YC43300008
DA 2024-02-19
ER

PT J
AU Tang, QZ
   Leung, J
   Peng, YN
   Sanchez-Fueyo, A
   Lozano, JJ
   Lam, A
   Lee, K
   Greenland, JR
   Hellerstein, M
   Fitch, M
   Li, KW
   Esensten, JH
   Putnam, AL
   Lares, A
   Nguyen, V
   Liu, WH
   Bridges, ND
   Odim, J
   Demetris, AJ
   Levitsky, J
   Taner, T
   Feng, S
AF Tang, Qizhi
   Leung, Joey
   Peng, Yani
   Sanchez-Fueyo, Alberto
   Lozano, Juan-Jose
   Lam, Alice
   Lee, Karim
   Greenland, John R.
   Hellerstein, Marc
   Fitch, Mark
   Li, Kelvin W.
   Esensten, Jonathan H.
   Putnam, Amy L.
   Lares, Angela
   Nguyen, Vinh
   Liu, Weihong
   Bridges, Nancy D.
   Odim, Jonah
   Demetris, Anthony J.
   Levitsky, Josh
   Taner, Timucin
   Feng, Sandy
TI Selective decrease of donor-reactive T<sub>regs</sub> after liver
   transplantation limits T<sub>reg</sub> therapy for promoting allograft
   tolerance in humans
SO SCIENCE TRANSLATIONAL MEDICINE
LA English
DT Article
ID CELL-FUNCTION; R PACKAGE; EXPANSION; IMMUNOSUPPRESSION; EXPRESSION;
   AUTOIMMUNE; WITHDRAWAL; RECIPIENTS; TREGS
AB Promoting immune tolerance to transplanted organs can minimize the amount of immunosuppressive drugs that patients need to take, reducing lifetime risks of mortality and morbidity. Regulatory T cells (T-regs) are essential for immune tolerance, and preclinical studies have shown their therapeutic efficacy in inducing transplantation tolerance. Here, we report the results of a phase 1/2 trial (ARTEMIS, NCT02474199) of autologous donor alloantigen-reactive T-reg (darT(reg)) therapy in individuals 2 to 6 years after receiving a living donor liver transplant. The primary efficacy endpoint was calcineurin inhibitor dose reduction by 75% with stable liver function tests for at least 12 weeks. Among 10 individuals who initiated immunosuppression withdrawal, 1 experienced rejection before planned darTreg infusion, 5 received darT(regs), and 4 were not infused because of failure to manufacture the minimal infusible dose of 100 x 10(6) cells. darT(reg) infusion was not associated with adverse events. Two darT(reg)-infused participants reached the primary endpoint, but an insufficient number of recipients were treated for assessing the efficacy of darT(regs). Mechanistic studies revealed generalized T-reg activation, senescence, and selective reduction of donor reactivity after liver transplantation. Overall, the ARTEMIS trial features a design concept for evaluating the efficacy of T-reg therapy in transplantation. The mechanistic insight gained from the study may help guide the design of future trials.
C1 [Tang, Qizhi; Leung, Joey; Peng, Yani; Lam, Alice; Lee, Karim; Nguyen, Vinh; Feng, Sandy] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA.
   [Tang, Qizhi; Putnam, Amy L.; Lares, Angela; Liu, Weihong] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA.
   [Tang, Qizhi; Esensten, Jonathan H.] Gladstone UCSF, Inst Genom Immunol, San Francisco, CA 94158 USA.
   [Sanchez-Fueyo, Alberto] Univ London, Kings Coll, Inst Liver Studies, Sch Immunol & Microbial Sci, London WC2R 2LS, England.
   [Lozano, Juan-Jose] Inst Salud Carlos III, Biomed Res Ctr Hepat & Digest Dis, Bioinformat Platform, Madrid 28029, Spain.
   [Greenland, John R.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.
   [Greenland, John R.] San Francisco VA Hlth Care Syst, Med Serv, San Francisco, CA 94121 USA.
   [Hellerstein, Marc; Fitch, Mark; Li, Kelvin W.] Univ Calif Berkeley, Nutr Sci & Toxicol, Berkeley, CA 94720 USA.
   [Esensten, Jonathan H.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.
   [Bridges, Nancy D.; Odim, Jonah] Natl Inst Allergy & Infect Dis, NIH, Bethesda, MD 20852 USA.
   [Demetris, Anthony J.] Univ Pittsburgh, Thomas E Starzl Transplantat Inst, Pittsburgh, PA 15213 USA.
   [Demetris, Anthony J.] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15213 USA.
   [Levitsky, Josh] Northwestern Univ, Dept Med, Chicago, IL 60611 USA.
   [Taner, Timucin] Mayo Clin, Dept Surg, Rochester, MN 55905 USA.
   [Taner, Timucin] Mayo Clin, Dept Immunol, Rochester, MN 55905 USA.
C3 University of California System; University of California San Francisco;
   University of California System; University of California San Francisco;
   University of California System; University of California San Francisco;
   The J David Gladstone Institutes; University of London; King's College
   London; Instituto de Salud Carlos III; University of California System;
   University of California San Francisco; University of California System;
   University of California Berkeley; University of California System;
   University of California San Francisco; National Institutes of Health
   (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases
   (NIAID); Pennsylvania Commonwealth System of Higher Education (PCSHE);
   University of Pittsburgh; Pennsylvania Commonwealth System of Higher
   Education (PCSHE); University of Pittsburgh; Northwestern University;
   Mayo Clinic; Mayo Clinic
RP Tang, QZ; Feng, S (corresponding author), Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA.; Tang, QZ (corresponding author), Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA.; Tang, QZ (corresponding author), Gladstone UCSF, Inst Genom Immunol, San Francisco, CA 94158 USA.
EM qizhi.tang@ucsf.e-du; sandy.feng@ucsf.edu
RI Taner, Timucin/J-8588-2019
OI Taner, Timucin/0000-0003-0641-2930; Greenland, John/0000-0003-1422-8367;
   Fitch, Mark/0000-0001-9058-4529; Tang, Qizhi/0000-0001-7313-3574; Leung,
   Joey Chung Yee/0000-0002-2528-9555; Peng, Yani/0000-0002-3711-7160
FU NIAID [1U01AI104347]
FX The study is funded by a grant from NIAID 1U01AI104347 (to S.F. and
   Q.T.).
CR Abbas AK, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat1482
   Abrol N, 2019, WORLD J GASTROENTERO, V25, P3123, DOI 10.3748/wjg.v25.i25.3123
   [Anonymous], 2016, SCI REP, V6, P11
   Azzi JR, 2013, J IMMUNOL, V191, P5785, DOI 10.4049/jimmunol.1390055
   Balcerek J, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.744763
   Bénéchet AP, 2019, NATURE, V574, P200, DOI 10.1038/s41586-019-1620-6
   Benítez C, 2013, HEPATOLOGY, V58, P1824, DOI 10.1002/hep.26426
   Bluestone JA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad4134
   Carambia A, 2014, J HEPATOL, V61, P594, DOI 10.1016/j.jhep.2014.04.027
   Chandran S, 2017, AM J TRANSPLANT, V17, P2945, DOI 10.1111/ajt.14415
   Clark RA, 2007, BLOOD, V109, P194, DOI 10.1182/blood-2006-02-002873
   Colf LA, 2007, CELL, V129, P135, DOI 10.1016/j.cell.2007.01.048
   Dangi A, 2012, J IMMUNOL, V188, P3667, DOI 10.4049/jimmunol.1102460
   Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60
   Dobin Alexander, 2015, Curr Protoc Bioinformatics, V51, DOI 10.1002/0471250953.bi1114s51
   Dong S, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.147474
   Feng S., 2019, PEDIAT HEPATOLOGY LI, P625
   Feng S, 2012, JAMA-J AM MED ASSOC, V307, P283, DOI 10.1001/jama.2011.2014
   Ferreira LMR, 2019, NAT REV DRUG DISCOV, V18, P749, DOI 10.1038/s41573-019-0041-4
   Greenland JR, 2016, TRANSPLANTATION, V100, P2090, DOI 10.1097/TP.0000000000001191
   He XH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156311
   Higdon LE, 2016, TRANSPLANT DIRECT, V2, DOI 10.1097/TXD.0000000000000613
   Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476
   Kang HG, 2007, AM J TRANSPLANT, V7, P1907, DOI 10.1111/j.1600-6143.2007.01881.x
   Kendal AR, 2011, J EXP MED, V208, P2043, DOI 10.1084/jem.20110767
   Klatzmann D, 2015, NAT REV IMMUNOL, V15, P283, DOI 10.1038/nri3823
   Kubes P, 2018, ANNU REV IMMUNOL, V36, P247, DOI 10.1146/annurev-immunol-051116-052415
   Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29
   Lessard F, 2018, NAT CELL BIOL, V20, P789, DOI 10.1038/s41556-018-0127-y
   Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323
   Lim T. Y., 2022, J HEPATOL
   Lüth S, 2008, J CLIN INVEST, V118, P3403, DOI 10.1172/JCI32132
   Luttropp K, 2016, TRANSPLANT DIRECT, V2, DOI 10.1097/TXD.0000000000000629
   Mehal WZ, 2001, J IMMUNOL, V167, P667, DOI 10.4049/jimmunol.167.2.667
   Morris H, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010760
   Putnam AL, 2013, AM J TRANSPLANT, V13, P3010, DOI 10.1111/ajt.12433
   Rodríguez-Perálvarez M, 2014, CURR OPIN ORGAN TRAN, V19, P253, DOI 10.1097/MOT.0000000000000069
   Romano M, 2017, TRANSPL INT, V30, P745, DOI 10.1111/tri.12909
   Sagoo P, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002076
   Sakaguchi S, 2020, ANNU REV IMMUNOL, V38, P541, DOI 10.1146/annurev-immunol-042718-041717
   Sánchez-Fueyo A, 2006, J IMMUNOL, V176, P329, DOI 10.4049/jimmunol.176.1.329
   Savage TM, 2020, AM J TRANSPLANT, V20, P538, DOI 10.1111/ajt.15592
   Sawitzki B, 2020, LANCET, V395, P1627, DOI 10.1016/S0140-6736(20)30167-7
   Shaked A, 2019, AM J TRANSPLANT, V19, P1397, DOI 10.1111/ajt.15205
   Silva SL, 2016, ONCOTARGET, V7, P12163, DOI 10.18632/oncotarget.7512
   Skartsis N, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.783282
   Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23
   Taner T, 2018, KIDNEY INT, V93, P1465, DOI 10.1016/j.kint.2018.01.022
   Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572
   Tang QZ, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a015552
   Tang QZ, 2012, CURR OPIN ORGAN TRAN, V17, P349, DOI 10.1097/MOT.0b013e328355a992
   Thomson AW, 2020, NAT REV GASTRO HEPAT, V17, P719, DOI 10.1038/s41575-020-0334-4
   Thomson AW, 2010, NAT REV IMMUNOL, V10, P753, DOI 10.1038/nri2858
   Todo S, 2016, HEPATOLOGY, V64, P632, DOI 10.1002/hep.28459
   Veerapathran A, 2011, BLOOD, V118, P5671, DOI 10.1182/blood-2011-02-337097
   Vignali D, 2016, TRANSPLANTATION, V100, P1853, DOI 10.1097/TP.0000000000001276
   Walter W, 2015, BIOINFORMATICS, V31, P2912, DOI 10.1093/bioinformatics/btv300
   Wang P, 2022, J HEART LUNG TRANSPL, V41, P641, DOI 10.1016/j.healun.2021.11.012
   Watt KDS, 2010, AM J TRANSPLANT, V10, P1420, DOI 10.1111/j.1600-6143.2010.03126.x
   Welzl K, 2014, GERONTOLOGY, V60, P229, DOI 10.1159/000356020
   Whitehouse G, 2017, P NATL ACAD SCI USA, V114, P7083, DOI 10.1073/pnas.1620835114
   Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118
   Zhang YP, 2009, CANCER CELL, V16, P369, DOI 10.1016/j.ccr.2009.09.024
   Zuber J, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aah3732
NR 64
TC 16
Z9 16
U1 0
U2 4
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 1946-6234
EI 1946-6242
J9 SCI TRANSL MED
JI Sci. Transl. Med.
PD NOV 2
PY 2022
VL 14
IS 669
AR eabo2628
DI 10.1126/scitranslmed.abo2628
PG 12
WC Cell Biology; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Research & Experimental Medicine
GA 7Q1SJ
UT WOS:000909177500004
PM 36322627
DA 2024-02-19
ER

PT J
AU Roncalés, M
   Achón, M
   Manzarbeitia, F
   de las Casas, MC
   Ramírez, C
   Varela-Moreiras, G
   Pérez-Miguelsanz, J
AF Roncalés, M
   Achón, M
   Manzarbeitia, F
   de las Casas, MC
   Ramírez, C
   Varela-Moreiras, G
   Pérez-Miguelsanz, J
TI Folic acid supplementation for 4 weeks affects liver morphology in aged
   rats
SO JOURNAL OF NUTRITION
LA English
DT Article; Proceedings Paper
CT 4th Congress of the Spanish-Society-of-Community-Nutrition (SENC)/3rd
   International Workshop of Community Nutrition
CY OCT 04-08, 2000
CL BILBAO, SPAIN
SP Spanish Soc Community Nutrit, World Hlth Org, Nutrit Soc, Municipal Bilbao, Dept Public Hlth
DE folic acid supplementation; liver morphology; aging; rats
ID NEURAL-TUBE DEFECTS; FOLATE-DEFICIENCY; VASCULAR-DISEASE; DNA
   METHYLATION; COLON-CANCER; REGENERATION; METHOTREXATE; PROLIFERATION;
   FORTIFICATION; HOMOCYSTEINE
AB Several countries have approved universal folic acid (FA) fortification to prevent neural tube defects and/or high homocysteine levels; this has led to a chronic intake of FA. Traditionally, the vitamin is considered to be safe and nontoxic, except for the potential masking of vitamin B-12 deficiency. Recent reports from our laboratories showed several effects of high-dose folate supplementation in rats. In this work, we compared the effect of FA on the liver of weanling (3 wk) and aged (18 mo) male rats fed either a diet supplemented with 40 mg FA/kg diet or a control diet (1 mg FA/kg diet) for 4 wk. FA supplementation did not alter serum aspartate aminotransferase, alanine aminotransferase, urea, glucose oxidase, total bilirubin, or uric acid. Routine histological staining as well as immunohistochemistry with proliferating cell nuclear antibody for dividing cells, and cytokeratin-8 against bile ductal cells, showed that aged, supplemented rats had the same number of hepatocytes as both control and supplemented weanling rats, and tended to have more (17%, P = 0.07) hepatocytes than aged, control rats. Moreover, the bile duct cells of aged, control rats proliferated and transformed into cholestatic rosettes at a higher frequency than in aged, supplemented rats. The morphology of the liver in weanling rats was similar in both diet groups, and comparable to the supplemented, aged rats, thus indicating that a high intake of FA improves normal liver morphology in livers of aged rats.
C1 Univ Complutense Madrid, Fac Med, Dept Anat & Embriol Humana 1, E-28040 Madrid, Spain.
   Univ San Pablo, Fac Ciencias Expt & Salud, Secc Nutr Bromatol & Dietet, Boadilla Del Monte 28668, Spain.
   Fdn Jimenez Diaz, Dept Anat Patol, E-28040 Madrid, Spain.
C3 Complutense University of Madrid; San Pablo CEU University
EM jperezm@med.ucm.es
RI TUÑON, MARIA ACHON Y/G-5426-2017; Varela, Maria/H-2648-2012;
   Pérez-Miguelsanz, María Juliana/H-1038-2017
OI TUÑON, MARIA ACHON Y/0000-0003-3692-6377; VARELA-MOREIRAS,
   GREGORIO/0000-0001-5158-4999; Perez-Miguelsanz,
   Juliana/0000-0001-8926-5248
CR Achón M, 2000, BRIT J NUTR, V83, P177, DOI 10.1017/S0007114500000222
   Achón M, 1999, J NUTR, V129, P1204, DOI 10.1093/jn/129.6.1204
   ACHON M, 2001, NUTRITION, V17, P1018
   Akoglu B, 2001, NUTRITION, V17, P652, DOI 10.1016/S0899-9007(01)00594-9
   AlonsoAperte E, 1996, INT J VITAM NUTR RES, V66, P232
   Bailey LB, 2003, J NUTR, V133, p1961S, DOI 10.1093/jn/133.6.1961S
   BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049
   Branda RF, 2002, J LAB CLIN MED, V140, P358, DOI 10.1067/mlc.2002.128648
   Choi SW, 2002, J NUTR, V132, p2413S, DOI 10.1093/jn/132.8.2413S
   Choumenkovitch SF, 2002, J NUTR, V132, P2792, DOI 10.1093/jn/132.9.2792
   CZEIZEL AE, 1992, NEW ENGL J MED, V341, P1485
   Deulofeu R, 2000, CLIN SCI, V99, P315, DOI 10.1042/CS20000127
   Giovannucci E, 1998, ANN INTERN MED, V129, P517, DOI 10.7326/0003-4819-129-7-199810010-00002
   Halsted CH, 2002, ALCOHOL, V27, P169, DOI 10.1016/S0741-8329(02)00225-2
   Iqbal MP, 2001, BIOPHARM DRUG DISPOS, V22, P169
   James SJ, 1997, CARCINOGENESIS, V18, P287, DOI 10.1093/carcin/18.2.287
   Mori H, 1999, MUTAT RES-FUND MOL M, V428, P291, DOI 10.1016/S1383-5742(99)00055-1
   *NAT RES COUNC, 1995, NUTR REQ LAB AN, P11
   NENSEY YM, 1995, DIGEST DIS SCI, V40, P396, DOI 10.1007/BF02065427
   PERENTES E, 1994, EXP TOXICOL PATHOL, V46, P104
   PEREZMIGUELSANZ J, 2001, NUTRITION, V17, P1019
   POPPER H, 1985, HEPATOLOGY, V5, P1224, DOI 10.1002/hep.1840050627
   PORTUGAL V, 1993, REV ESP ENFERM DIG, V83, P434
   Portugal V, 1996, J SURG RES, V61, P527, DOI 10.1006/jsre.1996.0158
   SCHAPIRO H, 1982, EXPERIENTIA, V38, P1075, DOI 10.1007/BF01955375
   SCHMUCKER DL, 1990, EXP GERONTOL, V25, P403, DOI 10.1016/0531-5565(90)90029-2
   SCHON M, 2002, J NUTR HLTH AGING, V6, P51
   Selzner M, 2000, HEPATOLOGY, V31, P35, DOI 10.1002/hep.510310108
   Tanno M, 1996, MECH AGEING DEV, V92, P53, DOI 10.1016/S0047-6374(96)01802-7
   U.S. Food and Drug Administration, 1996, Fed. Reg., V61, P8781
   VARELAMOREIRAS G, 1995, J AM COLL NUTR, V14, P480
   VARELAMOREIRAS G, 1992, J NUTR, V122, P986, DOI 10.1093/jn/122.4.986
   VIEJO F, 2001, EUR J ANAT S1, V5, P44
   WALD N, 1991, LANCET, V338, P131
   WALZEM RL, 1988, J NUTR, V118, P1089, DOI 10.1093/jn/118.9.1089
   WOLF HK, 1992, HEPATOLOGY, V15, P707, DOI 10.1002/hep.1840150426
   WUINLIVAN EP, 2003, AM J CLIN NUTR, V77, P221
NR 37
TC 19
Z9 20
U1 0
U2 5
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0022-3166
EI 1541-6100
J9 J NUTR
JI J. Nutr.
PD MAY
PY 2004
VL 134
IS 5
BP 1130
EP 1133
DI 10.1093/jn/134.5.1130
PG 4
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Nutrition & Dietetics
GA 820XK
UT WOS:000221423000024
PM 15113958
OA hybrid
DA 2024-02-19
ER

PT J
AU Chen, TP
   Lai, MH
   Lin, WY
   Huang, KC
   Yang, KC
AF Chen, Tsung-Po
   Lai, Michelle
   Lin, Wen-Yuan
   Huang, Kuo-Chin
   Yang, Kuen-Cheh
TI Metabolic profiles and fibrosis of non-alcoholic fatty liver disease in
   the elderly: A community-based study
SO JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
LA English
DT Article; Early Access
DE advanced fibrosis; elderly; metabolic syndrome; non-alcoholic fatty
   liver disease
ID VISCERAL FAT; POPULATION; PREVALENCE; NAFLD; RISK; AGE; PARAMETERS;
   ULTRASOUND; STEATOSIS; INDICATOR
AB Background and Aims There are sparse data on the epidemiology of fatty liver in the elderly Asian population. We evaluated for predictors of fatty liver and high risk of advanced fibrosis in a community-based elderly population.
   Methods A total of 1091 participants (mean age was 74.6 +/- 6.3 years) were enrolled from 2017 to 2018. Subjects with age younger than 65 years, alcoholism, and history of hepatitis B and hepatitis C were excluded. Fatty liver was diagnosed with abdominal ultrasound by using ultrasonographic fatty liver indicator, a semi-quantitative measurement grading the severity (normal, mild, and moderate-to-severe). Fibrosis-4 score was used for the prediction of the high risk of advanced fibrosis. Using a multivariable logistic regression model, we identified predictors of fatty liver and high risk of advanced fibrosis.
   Results In this ambulatory elderly Asian population, the prevalence of fatty liver is 41.9% and of high risk of advanced fibrosis is 12.3%. The prevalence of fatty liver decreases (44.5% to 31.8%), and the high risk of advanced fibrosis increases (3.9% to 27.0%) with aging significantly (both P < 0.05). Metabolic syndrome is a risk factor for fatty liver (odds ratio [OR], 3.19; 95% CI, 2.41-4.22) but not for high risk of advanced fibrosis (OR, 0.67; 95% CI, 0.41-1.08). Hypertriglyceridemia decreases the risk for high risk of advanced fibrosis (OR, 0.53; 95% CI, 0.33-0.87).
   Conclusion Fatty liver is prevalent in the ambulatory elderly Asian population, affecting over 40% of this population. Age is a risk factor for high risk of advanced fibrosis, with the disease likely progressing from a steatotic to a fibrotic picture with age.
C1 [Chen, Tsung-Po; Lin, Wen-Yuan] China Med Univ Hosp, Dept Community & Family Med, Taichung, Taiwan.
   [Lin, Wen-Yuan] China Med Univ, Coll Med, Dept Social Med & Family Med, Taichung, Taiwan.
   [Huang, Kuo-Chin] Natl Taiwan Univ Hosp, Dept Family Med, Taipei, Taiwan.
   [Huang, Kuo-Chin; Yang, Kuen-Cheh] Natl Taiwan Univ Hosp, Dept Family Med, Bei Hu Branch, 87 Neijiang St, Taipei 108, Taiwan.
   [Yang, Kuen-Cheh] Natl Taiwan Univ Hosp, Community & Geriatr Med Res Ctr, Bei Hu Branch, Taipei, Taiwan.
   [Lai, Michelle] Beth Israel Deaconess Med Ctr, Div Gastroenterol & Hepatol, Boston, MA 02215 USA.
C3 China Medical University Taiwan; China Medical University Hospital -
   Taiwan; China Medical University Taiwan; National Taiwan University;
   National Taiwan University Hospital; National Taiwan University;
   National Taiwan University Hospital; National Taiwan University;
   National Taiwan University Hospital; Harvard University; Beth Israel
   Deaconess Medical Center
RP Yang, KC (corresponding author), Natl Taiwan Univ Hosp, Dept Family Med, Bei Hu Branch, 87 Neijiang St, Taipei 108, Taiwan.
EM quintino.yang@gmail.com
OI YANG, KUEN-CHEH/0000-0003-0047-2238
CR Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644
   Angulo P, 2007, HEPATOLOGY, V45, P846, DOI 10.1002/hep.21496
   Ballestri S, 2017, METABOLISM, V72, P57, DOI 10.1016/j.metabol.2017.04.003
   Ballestri S, 2015, EXPERT REV GASTROENT, V9, P603, DOI 10.1586/17474124.2015.1007955
   Ballestri S, 2012, LIVER INT, V32, P1242, DOI 10.1111/j.1478-3231.2012.02804.x
   Bertolotti M, 2014, WORLD J GASTROENTERO, V20, P14185, DOI 10.3748/wjg.v20.i39.14185
   Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9
   Doehner W, 2012, INT J CARDIOL, V162, P20, DOI 10.1016/j.ijcard.2011.09.039
   Dulai PS, 2017, HEPATOLOGY, V65, P1557, DOI 10.1002/hep.29085
   Fan JG, 2005, J GASTROEN HEPATOL, V20, P1825, DOI 10.1111/j.1440-1746.2005.04058.x
   Frith J, 2009, GERONTOLOGY, V55, P607, DOI 10.1159/000235677
   GARFEIN AJ, 1995, J GERONTOL B-PSYCHOL, V50, pS77, DOI 10.1093/geronb/50B.2.S77
   Hamaguchi M, 2007, AM J GASTROENTEROL, V102, P2708, DOI 10.1111/j.1572-0241.2007.01526.x
   Hartleb M, 2017, LIVER INT, V37, P1706, DOI 10.1111/liv.13471
   Hossain N, 2009, CLIN GASTROENTEROL H, V7, P1224, DOI 10.1016/j.cgh.2009.06.007
   Kagansky N, 2004, LIVER INT, V24, P588, DOI 10.1111/j.1478-3231.2004.0969.x
   Kaswala DH, 2016, DIGEST DIS SCI, V61, P1356, DOI 10.1007/s10620-016-4079-4
   Kawano Y, 2013, J GASTROENTEROL, V48, P434, DOI 10.1007/s00535-013-0758-5
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   Koehler EM, 2016, HEPATOLOGY, V63, P138, DOI 10.1002/hep.27981
   Koehler EM, 2012, J HEPATOL, V57, P1305, DOI 10.1016/j.jhep.2012.07.028
   Lonardo A, 2015, DIGEST LIVER DIS, V47, P181, DOI 10.1016/j.dld.2014.09.020
   McPherson S, 2017, AM J GASTROENTEROL, V112, P740, DOI 10.1038/ajg.2016.453
   Nagai M, 2010, DIABETES CARE, V33, P1077, DOI 10.2337/dc09-1099
   Nguyen P, 2008, J ANIM PHYSIOL AN N, V92, P272, DOI 10.1111/j.1439-0396.2007.00752.x
   Noureddin M, 2013, HEPATOLOGY, V58, P1644, DOI 10.1002/hep.26465
   Oreopoulos A, 2009, CLIN GERIATR MED, V25, P643, DOI 10.1016/j.cger.2009.07.005
   Petta S, 2017, LIVER INT, V37, P1389, DOI 10.1111/liv.13397
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Shah AG, 2009, CLIN GASTROENTEROL H, V7, P1104, DOI 10.1016/j.cgh.2009.05.033
   Shen HC, 2014, CLIN INTERV AGING, V9, P501, DOI 10.2147/CIA.S59538
   Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178
   van der Poorten D, 2008, HEPATOLOGY, V48, P449, DOI 10.1002/hep.22350
   Wang ZL, 2013, EXP GERONTOL, V48, P705, DOI 10.1016/j.exger.2013.05.059
   Wong RJ, 2017, ALIMENT PHARM THER, V46, P974, DOI 10.1111/apt.14327
   Wong VWS, 2012, GUT, V61, P409, DOI 10.1136/gutjnl-2011-300342
   Xiao GQ, 2017, HEPATOLOGY, V66, P1486, DOI 10.1002/hep.29302
   Yang KC, 2016, SCI REP-UK, V6, DOI 10.1038/srep27034
NR 38
TC 11
Z9 13
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0815-9319
EI 1440-1746
J9 J GASTROEN HEPATOL
JI J. Gastroenterol. Hepatol.
PD 2020 SEP
PY 2020
VL 35
IS 9
BP 1636
EP 1643
DI 10.1111/jgh.15073
EA MAY 2020
PG 8
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA NP3GB
UT WOS:000530412600001
PM 32333452
DA 2024-02-19
ER

PT J
AU Ke, YB
   Karki, P
   Kim, J
   Son, S
   Berdyshev, E
   Bochkov, VN
   Birukova, AA
   Birukov, KG
AF Ke, Yunbo
   Karki, Pratap
   Kim, Junghyun
   Son, Sophia
   Berdyshev, Evgeny
   Bochkov, Valery N.
   Birukova, Anna A.
   Birukov, Konstantin G.
TI Elevated truncated oxidized phospholipids as a factor exacerbating ALI
   in the aging lungs
SO FASEB JOURNAL
LA English
DT Article
DE lung injury; vascular permeability; inflammation
ID OXIDATIVE STRESS; PERMEABILITY; PATHWAY; ACETYLHYDROLASE; INHIBITION;
   INJURY
AB As mechanisms controlling redox homeostasis become impaired with aging, exaggerated oxidant stress may cause disproportional oxidation of cell membranes and circulating phospholipids (PLs), leading to the formation of truncated oxidized PL products (Tr-OxPLs), which exhibit deleterious effects. This study investigated the role of elevated Tr-OxPLs as a factor exacerbating inflammation and lung barrier dysfunction in an animal model of aging. Mass spectrometry analysis of Tr-OxPL species in young (2-4 mo) and aging (18-24 mo) mice revealed elevated basal levels of several products [1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-phosphocholine (POVPC), 1-palmitoyl-2-glutaroyl-sn-glycero-phosphocholine, lysophosphocholine, 1-palmitoyl-2-(9-oxo-nonanoyl)-sn-glycero-3-phosphocholine, 1-palmitoyl-2-azelaoyl-sn-glycero-3-phosphocholine, O-1-O-palmitoyl-2-O-(5,8-dioxo-8-hydroxy-6-octenoyl)-l-glycero-3-phosphocholine, and others] in the aged lungs. An intratracheal (i.t.) injection of bacterial LPS caused increased generation of Tr-OxPLs in the lungs but not in the liver, with higher levels detected in the aged group. In addition, OxPLs clearance from the lung tissue after LPS challenge was delayed in the aged group. The impact of Tr-OxPLs on endothelial cell (EC) barrier compromise under inflammatory conditions was further evaluated in the 2-hit cell culture model of acute lung injury (ALI). EC barrier dysfunction caused by cell treatment with a cytokine mixture (CM) was augmented by cotreatment with low-dose Tr-OxPLs, which did not significantly affect endothelial function when added alone. Deleterious effects of Tr-OxPLs on inflamed ECs stimulated with CM were associated with further weakening of cell junctions and more robust EC hyperpermeability. Aged mice injected intratracheally with TNF- exhibited a more pronounced elevation of cell counts and protein content in bronchoalveolar lavage (BAL) samples. Interestingly, intravenous administration of low POVPC doseswhich did not affect BAL parameters alone in young mice exposed to i.t. TNF- challengeaugmented lung injury to the levels observed in aged mice stimulated with TNF- alone. Inhibition of Tr-OxPL generation by ectopic expression of PL-specific platelet-activating factor acetylhydrolase 2 (PAFAH2) markedly reduced EC dysfunction induced by CM, whereas PAFAH2 pharmacologic inhibition augmented deleterious effects of cytokines on EC barrier function. Moreover, exacerbating effects of PAFAH2 inhibition on TNF--induced lung injury were observed in vivo. These results demonstrate an age-dependent increase in Tr-OxPL production under basal conditions and augmented Tr-OxPL generation upon inflammatory stimulation, suggesting a major role for elevated Tr-OxPLs in more severe ALI and delayed resolution in aging lungs.Ke, Y., Karki, P., Kim, J., Son, S., Berdyshev, E., Bochkov, V. N., Birukova, A. A., Birukov, K. G. Elevated truncated oxidized phospholipids as a factor exacerbating ALI in the aging lungs.
C1 [Ke, Yunbo; Kim, Junghyun; Birukov, Konstantin G.] Univ Maryland, Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA.
   [Karki, Pratap; Birukova, Anna A.] Univ Maryland, Sch Med, Dept Med, Div Pulm & Crit Care Med, Baltimore, MD 21201 USA.
   [Son, Sophia] Univ Chicago, Dept Med, Sect Pulm & Crit Care Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.
   [Berdyshev, Evgeny] Natl Jewish Hlth, Denver, CO USA.
   [Bochkov, Valery N.] Karl Franzens Univ Graz, Dept Pharmaceut Chem, Graz, Austria.
C3 University System of Maryland; University of Maryland Baltimore;
   University System of Maryland; University of Maryland Baltimore;
   University of Chicago; National Jewish Health; University of Graz
RP Birukov, KG (corresponding author), Univ Maryland, Sch Med, UMSOM Lung Biol Program, Dept Anesthesiol, 20 Penn St,HSF 2,Room S145, Baltimore, MD 21201 USA.
EM kbirukov@som.umaryland.edu
RI Birukov, Konstantin/FJB-5755-2022; Bochkov, Valery/HNR-8336-2023
FU U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood
   Institute [HL076259, HL087823, HL107920, HL130431]; NIH National
   Institute on Aging Grant [AG048231]; NIH National Institute of General
   Medical Sciences [GM122940, GM114171]
FX This work was supported by U.S. National Institutes of Health (NIH)
   National Heart, Lung, and Blood Institute Grants HL076259 (to K.G.B.),
   HL087823, HL107920, and HL130431; NIH National Institute on Aging Grant
   AG048231 (to K.G.B.); and NIH National Institute of General Medical
   Sciences Grants GM122940 (to K.G.B.) and GM114171 (to A.A.B.). The
   authors declare no conflicts of interest.
CR Akbaraly TN, 2009, BRIT J NUTR, V101, P86, DOI 10.1017/S0007114508998445
   Bhatia M, 2004, J PATHOL, V202, P145, DOI 10.1002/path.1491
   Birukov KG, 2004, CIRC RES, V95, P892, DOI 10.1161/01.RES.0000147310.18962.06
   Birukova AA, 2004, FASEB J, V18, P1879, DOI 10.1096/fj.04-2328com
   Birukova AA, 2015, BBA-MOL BASIS DIS, V1852, P778, DOI 10.1016/j.bbadis.2014.12.016
   Birukova AA, 2013, TRANSL RES, V161, P495, DOI 10.1016/j.trsl.2012.12.008
   Birukova AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030957
   Bochkov VN, 2006, CURR RESPIR MED REV, V2, P27, DOI 10.2174/157339806775486182
   Cao LC, 2004, J STEROID BIOCHEM, V88, P61, DOI 10.1016/j.jsbmb.2003.10.007
   Chabot F, 1998, EUR RESPIR J, V11, P745
   Dröge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001
   Dubrovskyi O, 2013, LAB INVEST, V93, P254, DOI 10.1038/labinvest.2012.159
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   Foulks JM, 2008, FREE RADICAL BIO MED, V45, P434, DOI 10.1016/j.freeradbiomed.2008.04.034
   Fu P, 2009, EUR RESPIR J, V33, P612, DOI 10.1183/09031936.00014808
   Gruber F, 2012, J LIPID RES, V53, P1232, DOI 10.1194/jlr.D025270
   Guo F, 2012, MOL IMMUNOL, V50, P98, DOI 10.1016/j.molimm.2011.12.009
   Hecker L, 2018, AM J PHYSIOL-LUNG C, V314, P1642, DOI 10.1152/ajplung.00275.2017
   Heffern CTR, 2013, CHEM PHYS LIPIDS, V175, P9, DOI 10.1016/j.chemphyslip.2013.07.003
   Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043
   József L, 2006, J IMMUNOL, V176, P1195, DOI 10.4049/jimmunol.176.2.1195
   Kalyanaraman B, 2004, P NATL ACAD SCI USA, V101, P11527, DOI 10.1073/pnas.0404309101
   Ma Z, 2004, AM J PHYSIOL-LUNG C, V286, pL808, DOI 10.1152/ajplung.00220.2003
   McIntyre TM, 2012, BBA-BIOMEMBRANES, V1818, P2456, DOI 10.1016/j.bbamem.2012.03.004
   Meliton AY, 2015, AM J PHYSIOL-LUNG C, V308, pL550, DOI 10.1152/ajplung.00248.2014
   Morrow JD, 2002, AM J RESP CRIT CARE, V166, pS25, DOI 10.1164/rccm.2206011
   Munoz Nilda M, 2012, Pulm Circ, V2, P182, DOI 10.4103/2045-8932.97604
   Nonas S, 2008, CRIT CARE, V12, DOI 10.1186/cc6805
   Oskolkova OV, 2010, J IMMUNOL, V185, P7706, DOI 10.4049/jimmunol.0903594
   Pennathur S, 2004, J BIOL CHEM, V279, P42977, DOI 10.1074/jbc.M406762200
   Prauchner CA, 2017, BURNS, V43, P471, DOI 10.1016/j.burns.2016.09.023
   Sprong RC, 1998, AM J RESP CRIT CARE, V157, P1283
   Starosta V, 2012, AM J RESP CELL MOL, V46, P331, DOI 10.1165/rcmb.2011-0153OC
   Starr ME, 2011, FREE RADICAL BIO MED, V50, P371, DOI 10.1016/j.freeradbiomed.2010.11.013
   Stengle J, 1994, Crit Care Nurs Clin North Am, V6, P421
   STREMLER KE, 1991, J BIOL CHEM, V266, P11095
   Tanaka K, 2017, AM J RESP CELL MOL, V56, P179, DOI 10.1165/rcmb.2016-0158OC
   Thannickal VJ, 2015, AM J RESP CRIT CARE, V191, P261, DOI 10.1164/rccm.201410-1876PP
   von Schlieffen E, 2009, ARTERIOSCL THROM VAS, V29, P356, DOI 10.1161/ATVBAHA.108.173799
   Webster RG, 2000, VACCINE, V18, P1686, DOI 10.1016/S0264-410X(99)00507-1
   Wu JZ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/615312
NR 41
TC 22
Z9 22
U1 1
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD MAR
PY 2019
VL 33
IS 3
BP 3887
EP 3900
DI 10.1096/fj.201800981R
PG 14
WC Biochemistry & Molecular Biology; Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA HM9HS
UT WOS:000459794800063
PM 30521374
OA Green Published, Bronze
DA 2024-02-19
ER

PT J
AU Rao, KS
   Annapurna, VV
   Raji, NS
   Harikrishna, T
AF Rao, KS
   Annapurna, VV
   Raji, NS
   Harikrishna, T
TI Loss of base excision repair in aging rat neurons and its restoration by
   DNA polymerase β
SO MOLECULAR BRAIN RESEARCH
LA English
DT Article
DE neuron; aging; DNA polymerase-beta; primer extension; mismatch base
   excision
ID BRAIN; EXONUCLEASE; ALPHA; DELTA; FRACTIONS; EXTENSION; FIDELITY;
   MISPAIRS; EPSILON; DAMAGE
AB Synthetic staggered oligodeoxynucleotide duplexes are formed by annealing a 5'-P-32-labeled 14-mer with four different 21-mers. These duplexes have either a correct or mismatched base pair at 3'-end of the primer. With these model template primers the ability of neuronal extracts, obtained from rats of different ages, to extend the primer to the predicted length was tested. While the neuronal extracts of all ages were able to degrade the 14-mer to shorter lengths, extension of the primers in general and in particular, the mismatched, is achieved only feebly by the young and adult neuronal extracts and undetectable with old neuronal extracts. The possibility of restoring the lost activity by supplementing the neuronal extracts with pure DNA polymerases was examined. Of the three polymerases tested (calf thymus alpha polymerase, E. coli DNA polymerase I and rat liver DNA polymerase beta) only polymerase beta gave consistent and encouraging results although the extension was slow and distributive in nature and mismatched primers were extended much less efficiently than the correctly paired primer. However, significantly improved extension, including those of mismatched primers, was achieved by prior removal of mismatched bases in a preincubation with just the neuronal extracts (3'-5'exonuclease activity) followed by extension by the added polymerase beta and dNTPs in the presence of Mn2+ instead of the usual Mg2+. These results are taken to indicate that the activity of polymerase beta in brain cells is compromised with age and that this deficit can be corrected in vitro by the addition of pure recombinant rat liver polymerase beta under appropriate conditions. (C) 2000 Elsevier Science B.V. All rights reserved.
C1 Univ Hyderabad, Sch Life Sci, Dept Biochem, Hyderabad 500046, Andhra Pradesh, India.
C3 University of Hyderabad
RP Rao, KS (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Biochem, Hyderabad 500046, Andhra Pradesh, India.
EM ksrsl@uohyd.ernet.in
CR BIALEK G, 1993, J BIOL CHEM, V268, P6024
   Brooks PJ, 1996, J NEUROSCI, V16, P939
   Budd ME, 1997, MUTAT RES-DNA REPAIR, V384, P157, DOI 10.1016/S0921-8777(97)00024-4
   DONIGER J, 1976, J BIOL CHEM, V251, P4579
   IVANOV VA, 1983, EUR J BIOCHEM, V137, P517, DOI 10.1111/j.1432-1033.1983.tb07856.x
   LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0
   LINDAHL T, 1973, BIOCHEMISTRY-US, V12, P5151, DOI 10.1021/bi00749a020
   MATSUMOTO Y, 1995, SCIENCE, V269, P699, DOI 10.1126/science.7624801
   MOSBAUGH DW, 1980, J BIOL CHEM, V255, P239
   PERRINO FW, 1990, BIOCHEMISTRY-US, V29, P5226, DOI 10.1021/bi00474a002
   PERRINO FW, 1989, J BIOL CHEM, V264, P2898
   Prapurna DR, 1997, INT J DEV NEUROSCI, V15, P67, DOI 10.1016/S0736-5748(96)00047-0
   Raji NS, 1998, MECH AGEING DEV, V104, P133, DOI 10.1016/S0047-6374(98)00062-1
   RANI BU, 1983, J NEUROSCI RES, V10, P101, DOI 10.1002/jnr.490100112
   RAO KS, 1992, MUTAT RES, V275, P317
   RAO KS, 1993, MOL NEUROBIOL, V7, P23
   RAO KS, 1994, BIOCHEM MOL BIOL INT, V34, P287
   Saul R.L., 1987, MODERN BIOL THEORIES, P113
   SHEN JC, 1994, NUCLEIC ACIDS RES, V22, P972, DOI 10.1093/nar/22.6.972
   Shevelev IV, 1996, MUTAT RES-FUND MOL M, V352, P51, DOI 10.1016/0027-5107(95)00230-8
   SPADARI S, 1988, In Vivo (Attiki), V2, P317
   SUBRAHMANYAM K, 1991, MECH AGEING DEV, V57, P283, DOI 10.1016/0047-6374(91)90053-3
   SUBRAHMANYAM K, 1988, BIOCHEM INT, V16, P1111
   Taguchi T, 1998, MECH AGEING DEV, V100, P1, DOI 10.1016/S0047-6374(97)00114-0
   VENUGOPAL J, 1993, BIOCHEM ARCH, V9, P341
   WANG TSF, 1991, ANNU REV BIOCHEM, V60, P513, DOI 10.1146/annurev.biochem.60.1.513
   WANG TSF, 1982, BIOCHEMISTRY-US, V21, P1597, DOI 10.1021/bi00536a021
   WASER J, 1979, EUR J BIOCHEM, V97, P361, DOI 10.1111/j.1432-1033.1979.tb13122.x
   Wilson DM, 1997, P NATL ACAD SCI USA, V94, P12754, DOI 10.1073/pnas.94.24.12754
   WILSON SH, 1998, MUTAT RES, V407, P205
   Wood RD, 1997, CARCINOGENESIS, V18, P605, DOI 10.1093/carcin/18.4.605
   Wood RD, 1996, ANNU REV BIOCHEM, V65, P135, DOI 10.1146/annurev.bi.65.070196.001031
   YANG RW, 1995, SCI CHINA SER B, V38, P1237
NR 33
TC 29
Z9 29
U1 0
U2 0
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0169-328X
J9 MOL BRAIN RES
JI Mol. Brain Res.
PD DEC 28
PY 2000
VL 85
IS 1-2
BP 251
EP 259
DI 10.1016/S0169-328X(00)00266-7
PG 9
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 392VE
UT WOS:000166432600028
PM 11146128
DA 2024-02-19
ER

PT J
AU Donati, A
   Ventruti, A
   Cavallini, G
   Masini, M
   Vittorini, S
   Chantret, I
   Codogno, P
   Bergamini, E
AF Donati, Alessio
   Ventruti, Annamaria
   Cavallini, Gabriella
   Masini, Matilde
   Vittorini, Simona
   Chantret, Isabelle
   Codogno, Patrice
   Bergamini, Ettore
TI <i>In vivo</i> effect of an antilipolytic drug (3,5′-dimethylpyrazole)
   on autophagic proteolysis and autophagy-related gene expression in rat
   liver
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE 3.5'-dimethylpyrazole; antilipolytic drugs; LC3 gene expression;
   autophagy; autophagic proteolysis; amino acid; insulin; glucose
ID PROTEIN-DEGRADATION; MECHANISM; MACROAUTOPHAGY; INHIBITION; ENDOCRINE;
   INSULIN; KINASE
AB Autophagy is an intracellular pathway induced by starvation, inhibited by nutrients, that is responsible for degradation of long-lived proteins and altered cell organelles. This process is involved in cell maintenance could be induced by antilipolytic drugs and may have anti-aging effects (A. Donati, The involvement of macroautophagy in aging and anti-aging interventions, Mol. Aspects Med. 27 (2006) 455-470]. We analyzed the effect of an intraperitoneal injection of an antilipolytic agent (3,5'-dimethylpyrazole, DMP, 12 mg/kg b.w.), that mimics nutrient shortage on autophagy and expression of autophagic genes in the liver of male 3-month-old Sprague-Dawley albino rats. Autophagy was evaluated by observing electron micrographs of the liver autophagosomal compartment and by monitoring protein degradation assessed by the release of valine into the bloodstream. LC3 gene expression, whose product is one of the best known markers of autophagy, was also monitored. As expected, DMP decreased the plasma levels of free fatty acids, glucose, and insulin and increased autophagic vacuoles and proteolysis. DMP treatment caused an increase in the expression of the LC3 gene although this occurred later than the induction of authophagic proteolysis caused by DMP. Glucose treatment rescued the effects caused by DMP on glucose and insulin plasma levels and negatively affected the rate of autophagic proteolysis, but did not suppress the positive regulatory effect on LC3 mRNA levels. In conclusion, antilipolytic drugs may induce both autophagic proteolysis and higher expression of an autophagy-related gene and the effect on autophagy gene expression might not be secondary to the stimulation of autophagic proteolysis. (c) 2007 Elsevier Inc. All rights reserved.
C1 [Donati, Alessio; Ventruti, Annamaria; Cavallini, Gabriella; Masini, Matilde; Vittorini, Simona; Bergamini, Ettore] Univ Pisa, Ctr Ric Biol & Patol Invecchiamento, I-56126 Pisa, Italy.
   [Ventruti, Annamaria; Chantret, Isabelle; Codogno, Patrice] Inst Andre Lwoff, INSERM, U504, F-94807 Villejuif, France.
C3 University of Pisa; Institut National de la Sante et de la Recherche
   Medicale (Inserm)
RP Bergamini, E (corresponding author), Univ Pisa, Ctr Ric Biol & Patol Invecchiamento, Via Roma 55, I-56126 Pisa, Italy.
EM ebergami@med.unipi.it
RI CHANTRET, Isabelle/AAF-7134-2021; Codogno, Patrice/G-1384-2013
OI CHANTRET, Isabelle/0000-0002-0896-1274; Codogno,
   Patrice/0000-0002-5492-3180
CR Abeliovich H, 2000, J CELL BIOL, V151, P1025, DOI 10.1083/jcb.151.5.1025
   Bergamini E, 1995, AGING-CLIN EXP RES, V7, P473, DOI 10.1007/BF03324374
   BERGAMINI E, 1993, EXP MOL PATHOL, V59, P13, DOI 10.1006/exmp.1993.1023
   BERGAMINI E, 1994, AM J PHYSIOL, V266, pG118, DOI 10.1152/ajpgi.1994.266.1.G118
   Donati A, 2004, EXP GERONTOL, V39, P1061, DOI 10.1016/j.exger.2004.03.025
   Donati A, 2006, REJUV RES, V9, P408, DOI 10.1089/rej.2006.9.408
   Dubbelhuis PF, 2002, FEBS LETT, V521, P39, DOI 10.1016/S0014-5793(02)02815-6
   HERBERT V, 1965, J CLIN ENDOCR METAB, V25, P1375, DOI 10.1210/jcem-25-10-1375
   Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720
   Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061
   Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257
   Majno G., 1996, CELLS TISSUES DIS
   MANIATIS T, 2008, MOL CLONING LAB MAN
   Martinet W, 2006, J HISTOCHEM CYTOCHEM, V54, P85, DOI 10.1369/jhc.5A6743.2005
   Meley D, 2006, J BIOL CHEM, V281, P34870, DOI 10.1074/jbc.M605488200
   Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005
   MORTIMORE GE, 1987, ANNU REV NUTR, V7, P539, DOI 10.1146/annurev.nu.07.070187.002543
   MORTIMORE GE, 1989, DIABETES METAB REV, V5, P49, DOI 10.1002/dmr.5610050105
   PFEIFER U, 1978, J CELL BIOL, V78, P152, DOI 10.1083/jcb.78.1.152
   Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993
   TAPHUI Y, 1981, ANAL BIOCHEM, V115, P123
   Wang CW, 2003, MOL MED, V9, P65, DOI 10.1007/BF03402040
NR 22
TC 17
Z9 21
U1 0
U2 3
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD FEB 15
PY 2008
VL 366
IS 3
BP 786
EP 792
DI 10.1016/j.bbrc.2007.12.023
PG 7
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA 253KZ
UT WOS:000252518400030
PM 18082617
DA 2024-02-19
ER

PT J
AU Guest, I
   Ilic, Z
   Scrable, H
   Sell, S
AF Guest, Ian
   Ilic, Zoran
   Scrable, Heidi
   Sell, Stewart
TI Survival of irradiated recipient mice after transplantation of bone
   marrow from young, old and "early aging" mice
SO AGING-US
LA English
DT Article
DE p53; p44; bone marrow transplantation; aging
ID HEMATOPOIETIC STEM-CELLS; NICOTINAMIDE NUCLEOTIDE TRANSHYDROGENASE;
   WILD-TYPE P53; PROGENITOR CELLS; TUMOR-SUPPRESSOR; SELF-RENEWAL;
   MECHANISM; DOSAGE; HEPATOCYTES; ENGRAFTMENT
AB Bone marrow transplantation is used to examine survival, hematopoietic stem cell function and pathology in recipients of young and old wild type bone marrow derived stem cells (BMDSCs) as well as cells from p53-based models of premature aging. There is no difference in the long term survival of recipients of 8 week-old p53+/m donor cells compared to recipients of 8 week-old wild-type (WT) donor cells (70 weeks) or of recipients of 16-18 weeks-old donor cells from either p53+/m or WT mice. There is shorter survival in recipients of older versus younger WT donor bone marrow, but the difference is only significant when comparing 8 and 18 week-old donors. In the p44-based model, short term survival/engraftment is significantly reduced in recipients of 11 month-old p44 donor cells compared to 4 week-old p44 or wild type donor cells of either age; mid-life survival at 40 weeks is also significantly less in recipients of p44 cells. BMDSCs are readily detectable within recipient bone marrow, lymph node, intestinal villi and liver sinusoids, but not in epithelial derived cells. These results indicate that recipients of young BMDSCs may survive longer than recipients of old bone marrow, but the difference is marginal at best.
C1 [Guest, Ian; Ilic, Zoran; Sell, Stewart] New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12201 USA.
   [Scrable, Heidi] Mayo Clin, Lab Med & Pathol, Rochester, MN 55905 USA.
C3 State University of New York (SUNY) System; Wadsworth Center; Mayo
   Clinic
RP Sell, S (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12201 USA.
EM stewart.sell@health.ny.gov
FU NIH/NIA [R01 AAG 023410]
FX This work was supported by R01 AAG 023410 grant from NIH/NIA.
CR Beckman KB, 1998, ANN NY ACAD SCI, V854, P118, DOI 10.1111/j.1749-6632.1998.tb09897.x
   BHATIA SK, 1995, J EXP MED, V181, P1399, DOI 10.1084/jem.181.4.1399
   Brayton CF, 2012, VET PATHOL, V49, P85, DOI 10.1177/0300985811430696
   Chambers Stuart M, 2007, Cell Stem Cell, V1, P578, DOI 10.1016/j.stem.2007.10.003
   Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201
   COLE LJ, 1953, P NATL ACAD SCI USA, V39, P759, DOI 10.1073/pnas.39.8.759
   Courtois S, 2002, ONCOGENE, V21, P6722, DOI 10.1038/sj.onc.1205874
   Dumble M, 2007, BLOOD, V109, P1736, DOI 10.1182/blood-2006-03-010413
   Dykstra B, 2008, CELL TISSUE RES, V331, P91, DOI 10.1007/s00441-007-0529-9
   Feng ZH, 2007, P NATL ACAD SCI USA, V104, P16633, DOI 10.1073/pnas.0708043104
   Frazier KS, 2012, TOXICOL PATHOL, V40, P14, DOI 10.1177/0192623312438736
   Freeman H, 2006, BIOCHEM SOC T, V34, P806, DOI 10.1042/BST0340806
   Freeman HC, 2006, DIABETES, V55, P2153, DOI 10.2337/db06-0358
   García-Cao I, 2002, EMBO J, V21, P6225, DOI 10.1093/emboj/cdf595
   Gatza C, 2007, CELL CYCLE, V6, P52, DOI 10.4161/cc.6.1.3667
   Grove JE, 2004, STEM CELLS, V22, P487, DOI 10.1634/stemcells.22-4-487
   HARRISON DE, 1979, MECH AGEING DEV, V9, P427, DOI 10.1016/0047-6374(79)90083-6
   HARRISON DE, 1978, J EXP MED, V147, P1526, DOI 10.1084/jem.147.5.1526
   Hinkal G, 2007, P NATL ACAD SCI USA, V104, P18347, DOI 10.1073/pnas.0709330104
   Huang TT, 2006, HUM MOL GENET, V15, P1187, DOI 10.1093/hmg/ddl034
   JACOBSON LO, 1950, J LAB CLIN MED, V35, P746
   Ju ZY, 2008, BIOCHIMIE, V90, P24, DOI 10.1016/j.biochi.2007.09.006
   Kim M, 2003, ANN NY ACAD SCI, V996, P195, DOI 10.1111/j.1749-6632.2003.tb03247.x
   Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2
   Kurien BT, 2005, BMJ-BRIT MED J, V331, P1503, DOI 10.1136/bmj.331.7531.1503
   LI CL, 1995, BLOOD, V85, P1472, DOI 10.1182/blood.V85.6.1472.bloodjournal8561472
   Li F, 2001, EUR J IMMUNOL, V31, P500, DOI 10.1002/1521-4141(200102)31:2<500::AID-IMMU500>3.0.CO;2-C
   Liang Y, 2005, BLOOD, V106, P1479, DOI 10.1182/blood-2004-11-4282
   LORENZ E, 1951, J NATL CANCER I, V12, P197
   Maier B, 2004, GENE DEV, V18, P306, DOI 10.1101/gad.1162404
   Meek DW, 2015, BIOCHEM J, V469, P325, DOI 10.1042/BJ20150517
   Mendrysa SM, 2006, GENE DEV, V20, P16, DOI 10.1101/gad.1378506
   Muller-Sieburg CE, 2004, BLOOD, V103, P4111, DOI 10.1182/blood-2003-10-3448
   Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875
   O'Neill M, 2003, MECH AGEING DEV, V124, P599, DOI 10.1016/S0047-6374(03)00007-1
   Pettan-Brewer C, 2011, PATHOBIOL AGING AGE, V1, DOI 10.3402/pba.v1i0.7202
   Richardson B, 2003, AGEING RES REV, V2, P245, DOI 10.1016/S1568-1637(03)00010-2
   Rossi DJ, 2007, EXP GERONTOL, V42, P385, DOI 10.1016/j.exger.2006.11.019
   ROVINSKI B, 1987, MOL CELL BIOL, V7, P847, DOI 10.1128/MCB.7.2.847
   Sell S, 2005, STEM CELL REV, V1, P1, DOI 10.1385/SCR:1:1:001
   SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810
   Sudo K, 2000, J EXP MED, V192, P1273, DOI 10.1084/jem.192.9.1273
   Swenson ES, 2008, STEM CELLS, V26, P1768, DOI 10.1634/stemcells.2008-0148
   Theise ND, 2000, HEPATOLOGY, V31, P235, DOI 10.1002/hep.510310135
   Tominaga K, 2015, PATHOBIOL AGING AGE, V5, DOI 10.3402/pba.v5.27743
   Troen BR, 2003, MT SINAI J MED, V70, P3
   Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a
   Tyner SD, 1999, MOL CARCINOGEN, V24, P197, DOI 10.1002/(SICI)1098-2744(199903)24:3<197::AID-MC6>3.0.CO;2-V
   Van Zant G, 2003, EXP HEMATOL, V31, P659, DOI 10.1016/S0301-472X(03)00088-2
   Warner HR, 2003, MECH AGEING DEV, V124, P581, DOI 10.1016/S0047-6374(03)00008-3
   Weissman IL, 2001, ANNU REV CELL DEV BI, V17, P387, DOI 10.1146/annurev.cellbio.17.1.387
   Xing ZL, 2006, BLOOD, V108, P2190, DOI 10.1182/blood-2005-12-010272
   Yin YL, 2002, NAT CELL BIOL, V4, P462, DOI 10.1038/ncb801
NR 53
TC 4
Z9 7
U1 0
U2 2
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1945-4589
J9 AGING-US
JI Aging-US
PD DEC
PY 2015
VL 7
IS 12
BP 1212
EP 1223
DI 10.18632/aging.100867
PG 12
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA DB5BU
UT WOS:000368528900018
PM 26796640
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Lechel, A
   Holstege, H
   Begus, Y
   Schienke, A
   Kamino, K
   Lehmann, U
   Kubicka, S
   Schirmacher, P
   Jonkers, J
   Rudolph, KL
AF Lechel, Andre
   Holstege, Henne
   Begus, Yvonne
   Schienke, Andrea
   Kamino, Kenji
   Lehmann, Ulrich
   Kubicka, Stefan
   Schirmacher, Peter
   Jonkers, Jos
   Rudolph, K. Lenhard
TI Telomerase deletion limits progression of p53-mutant hepatocellular
   carcinoma with short telomeres in chronic liver disease
SO GASTROENTEROLOGY
LA English
DT Article
ID CHROMOSOMAL INSTABILITY; MOLECULAR PATHOGENESIS; DEFICIENT MICE;
   DYSFUNCTION; P53; SENESCENCE; MOUSE; CANCER; DAMAGE; CELLS
AB Background & Aims: During early stages of carcinogenesis most human epithelial cancers including hepatocellular carcinoma (HCC) have been observed to transit through a "crisis" stage characterized by telomere shortening, loss of p53 checkpoint function, and a sharp increase in aneuploidy. The function of telomerase during in vivo hepatocarcinogenesis has not been studied in this genetic context. Methods: Here we generated a mouse model in which HCC was induced by chronic organ damage (HBs-AG transgene) in the presence of telomere shortening and p53 deletion. Tumor development was analyzed in late-generation telomerase knockout mice (mTERC(-/-)) and littermates, genetically rescued for telomerase gene expression (mTERC(+/-)). Results: The formation of HCCs was strongly suppressed in mTERC(-/-) mice compared to mTERC(+/-) siblings correlating with reduced rates of tumor cell proliferation and elevated rates of tumor cell apoptosis. Although the prevalence of short telomeres was similar in chronically damaged liver of both cohorts, mTERC(-/-) HCC developed increased levels of DNA damage and aneuploidy compared to mTERC(+/-) HCC. Conclusions: This study provides direct evidence that telomerase is a critical component for in vivo progression of p53 mutant HCC with short telomeres in the chronically damaged liver. In this molecular context, telomerase limits the accumulation of telomere dysfunction, the evolution of excessive aneuploidy, and the activation of p53-independent checkpoints suppressing hepatocarcinogenesis.
C1 Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-30625 Hannover, Germany.
   Netherlands Canc Inst, Div Mol Biol, NL-1066 CX Amsterdam, Netherlands.
   Hannover Med Sch, Dept Mol Pathol, D-30625 Hannover, Germany.
   Hannover Med Sch, Dept Pathol, D-30625 Hannover, Germany.
   Univ Heidelberg, Inst Pathol, D-6900 Heidelberg, Germany.
C3 Hannover Medical School; Netherlands Cancer Institute; Hannover Medical
   School; Hannover Medical School; Ruprecht Karls University Heidelberg
RP Rudolph, KL (corresponding author), Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Carl Neuberg Str 1, D-30625 Hannover, Germany.
EM Rudolph.Lenhard@MH-Hannover.de
RI Holstege, Henne/ISB-2240-2023; Lechel, André/AAQ-2041-2021; Jonkers,
   Jos/AAG-3246-2019
OI Lechel, André/0000-0003-0221-6959; Jonkers, Jos/0000-0002-9264-9792;
   Rudolph, Karl Lenhard/0000-0002-4839-2862; Holstege,
   Henne/0000-0002-7688-3087
CR Akagi K, 1997, NUCLEIC ACIDS RES, V25, P1766, DOI 10.1093/nar/25.9.1766
   Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592
   Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4
   BOND JA, 1994, ONCOGENE, V9, P1885
   Chang S, 2003, GENE DEV, V17, P88, DOI 10.1101/gad.1029903
   Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X
   CHISARI FV, 1989, CELL, V59, P1145, DOI 10.1016/0092-8674(89)90770-8
   Chung YJ, 2004, GENOME RES, V14, P188, DOI 10.1101/gr.1878804
   COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x
   di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118
   Farazi PA, 2003, CANCER RES, V63, P5021
   Farazi PA, 2006, CANCER RES, V66, P4766, DOI 10.1158/0008-5472.CAN-05-4608
   FRITH CH, 1994, PATHOLOGY TUMORS LAB, V2, P223
   González-Suárez E, 2000, NAT GENET, V26, P114, DOI 10.1038/79089
   Greenberg RA, 1999, CELL, V97, P515, DOI 10.1016/S0092-8674(00)80761-8
   Hashimoto K, 2004, MODERN PATHOL, V17, P617, DOI 10.1038/modpathol.3800107
   Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9
   Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5
   Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747
   Kim NW, 1997, NUCLEIC ACIDS RES, V25, P2595, DOI 10.1093/nar/25.13.2595
   Lechel A, 2005, EMBO REP, V6, P275, DOI 10.1038/sj.embor.7400352
   Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1
   LOTZE MT, 1993, CANCER PRINCIPLES PR, P883
   Miura N, 1997, CANCER GENET CYTOGEN, V93, P56, DOI 10.1016/S0165-4608(96)00329-9
   Moinzadeh P, 2005, BRIT J CANCER, V92, P935, DOI 10.1038/sj.bjc.6602448
   Nishida N, 2003, HISTOL HISTOPATHOL, V18, P897, DOI 10.14670/HH-18.897
   Ohashi K, 1996, CANCER, V77, P1747, DOI 10.1002/(SICI)1097-0142(19960415)77:8+<1747::AID-CNCR26>3.0.CO;2-X
   Plentz RR, 2005, HEPATOLOGY, V42, P522, DOI 10.1002/hep.20847
   Plentz RR, 2004, HEPATOLOGY, V40, P80, DOI 10.1002/hep.20271
   Poon SSS, 1999, CYTOMETRY, V36, P267, DOI 10.1002/(SICI)1097-0320(19990801)36:4<267::AID-CYTO1>3.0.CO;2-O
   Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2
   Rudolph KL, 2001, NAT GENET, V28, P155, DOI 10.1038/88871
   Takahashi S, 2000, EUR J CANCER, V36, P496, DOI 10.1016/S0959-8049(99)00284-1
   Tannapfel A, 2001, ONCOGENE, V20, P7104, DOI 10.1038/sj.onc.1204902
   Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339
   Wiemann SU, 2005, ONCOGENE, V24, P1501, DOI 10.1038/sj.onc.1208308
   Wilkens L, 2004, P NATL ACAD SCI USA, V101, P1309, DOI 10.1073/pnas.0305817101
   WRIGHT WE, 1992, EXP GERONTOL, V27, P383, DOI 10.1016/0531-5565(92)90069-C
   Zhu JY, 1999, P NATL ACAD SCI USA, V96, P3723, DOI 10.1073/pnas.96.7.3723
NR 39
TC 50
Z9 60
U1 1
U2 3
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0016-5085
J9 GASTROENTEROLOGY
JI Gastroenterology
PD APR
PY 2007
VL 132
IS 4
BP 1465
EP 1475
DI 10.1053/j.gastro.2007.01.045
PG 11
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 161MZ
UT WOS:000246020900033
PM 17433324
OA Bronze
DA 2024-02-19
ER

PT J
AU Su, CC
   Chen, BS
   Chen, HH
   Sung, WW
   Wang, CC
   Tsai, MC
AF Su, Chang-Cheng
   Chen, Brian-Shiian
   Chen, Hsin-Hung
   Sung, Wen-Wei
   Wang, Chi-Chih
   Tsai, Ming-Chang
TI Improved Trends in the Mortality-to-Incidence Ratios for Liver Cancer in
   Countries with High Development Index and Health Expenditures
SO HEALTHCARE
LA English
DT Article
DE liver cancer; mortality; incidence; mortality-to-incidence ratio;
   expenditure
ID INTRAHEPATIC CHOLANGIOCARCINOMA; HEPATOCELLULAR-CARCINOMA; RISK-FACTORS;
   DIAGNOSIS; IMPACT
AB Primary liver cancer is one of the leading causes of death globally. Liver cancer has a unique geographical distribution, as its etiologies include chronic viral infections and aging. We hypothesize that the human development index (HDI), current health expenditure (CHE) per capita, and CHE-to-gross domestic product ratio (CHE/GDP) influence the incidence, mortality, and mortality-to-incidence ratios (MIRs) of liver cancer worldwide. Data were obtained from the Global Cancer Observatory (GLOBOCAN) database and the World Health Organization. MIRs and the changes in MIR over time (delta MIR) were used to evaluate the correlation of expenditures on healthcare and the HDI disparities via Spearman's rank correlation coefficient. The crude incidence and mortality were significantly associated with HDI, CHE per capita, and CHE/GDP. Specifically, there were significant associations between delta MIR and HDI, as well as between delta MIR and CHE per capita. However, there were no significant associations between delta MIR and CHE/GDP. Evidently, a favorable liver cancer delta MIR was not associated with CHE/GDP, although it had a significant association with HDI and CHE per capita. These results are worthy of the attention of public health systems in correlation to improved outcomes in liver cancer.
C1 [Su, Chang-Cheng; Wang, Chi-Chih; Tsai, Ming-Chang] Chung Shan Med Univ Hosp, Dept Internal Med, Div Gastroenterol & Hepatol, Taichung 40201, Taiwan.
   [Su, Chang-Cheng; Chen, Brian-Shiian; Chen, Hsin-Hung; Sung, Wen-Wei; Wang, Chi-Chih; Tsai, Ming-Chang] Chung Shan Med Univ, Sch Med, Taichung 40201, Taiwan.
   [Su, Chang-Cheng; Sung, Wen-Wei; Wang, Chi-Chih; Tsai, Ming-Chang] Chung Shan Med Univ, Inst Med, Taichung 40201, Taiwan.
   [Sung, Wen-Wei] Chung Shan Med Univ Hosp, Dept Urol, Taichung 40201, Taiwan.
C3 Chung Shan Medical University; Chung Shan Medical University Hospital;
   Chung Shan Medical University; Chung Shan Medical University; Chung Shan
   Medical University; Chung Shan Medical University Hospital
RP Wang, CC; Tsai, MC (corresponding author), Chung Shan Med Univ Hosp, Dept Internal Med, Div Gastroenterol & Hepatol, Taichung 40201, Taiwan.; Wang, CC; Tsai, MC (corresponding author), Chung Shan Med Univ, Sch Med, Taichung 40201, Taiwan.; Wang, CC; Tsai, MC (corresponding author), Chung Shan Med Univ, Inst Med, Taichung 40201, Taiwan.
EM bananaudwang@gmail.com; tmc1110@yahoo.com.tw
RI Sung, Wen-Wei/P-5053-2019
OI Sung, Wen-Wei/0000-0002-2375-0029; Wang, Chi- Chih/0000-0002-8222-0503
FU Chung Shan Medical University Hospital research program [CSH-2021-A-001]
FX This work was supported by the grants from Chung Shan Medical University
   Hospital research program (CSH-2021-A-001) of Taiwan.
CR Akinyemiju T, 2017, JAMA ONCOL, V3, P1683, DOI 10.1001/jamaoncol.2017.3055
   [Anonymous], UN DEV PROGRAMME HUM
   Baecker A, 2018, EUR J CANCER PREV, V27, P205, DOI [10.1097/cej.0000000000000428, 10.1097/CEJ.0000000000000428]
   Bertuccio P, 2013, ANN ONCOL, V24, P1667, DOI 10.1093/annonc/mds652
   Chen SL, 2017, SCI REP-UK, V7, DOI [10.1038/srep40003, 10.1038/s41598-017-12388-2]
   Cho EJ, 2017, CLIN MOL HEPATOL, V23, P205, DOI 10.3350/cmh.2017.0104
   Choi E, 2017, EPIDEMIOL HEALTH, V39, DOI 10.4178/epih.e2017006
   Clements O, 2020, J HEPATOL, V72, P95, DOI 10.1016/j.jhep.2019.09.007
   De Villa V, 2007, ONCOLOGIST, V12, P1321, DOI 10.1634/theoncologist.12-11-1321
   Ferlay J., Global Cancer Observatory: Cancer Today
   Fuchs VR, 2013, NEW ENGL J MED, V369, P107, DOI 10.1056/NEJMp1305298
   Ghamari SH, 2022, HEPATOL COMMUN, V6, P1764, DOI 10.1002/hep4.1910
   Ghislandi S, 2019, POPUL DEV REV, V45, P219, DOI 10.1111/padr.12205
   Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.21492, 10.3322/caac.20107]
   Kennedy K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204031
   Khetsuriani N, 2021, VACCINE, V39, P1485, DOI 10.1016/j.vaccine.2021.02.004
   Kim E, 2020, EXP MOL MED, V52, P1898, DOI 10.1038/s12276-020-00527-1
   Klushkina VV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157161
   Larroca SGT, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1515-1
   Lee YCA, 2009, INT J EPIDEMIOL, V38, P1497, DOI 10.1093/ije/dyp280
   Marrero JA, 2018, HEPATOLOGY, V68, P723, DOI 10.1002/hep.29913
   Nagtegaal ID, 2020, HISTOPATHOLOGY, V76, P182, DOI 10.1111/his.13975
   Papanicolas I, 2018, JAMA-J AM MED ASSOC, V319, P1024, DOI 10.1001/jama.2018.1150
   Petrick JL, 2020, INT J CANCER, V147, P317, DOI 10.1002/ijc.32723
   Plummer M, 2016, LANCET GLOB HEALTH, V4, pE609, DOI 10.1016/S2214-109X(16)30143-7
   Prueksapanich P, 2018, GUT LIVER, V12, P236, DOI 10.5009/gnl17102
   Shao SY, 2019, WORLD J GASTROENTERO, V25, P4749, DOI 10.3748/wjg.v25.i32.4749
   Sung WW, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4698-6
   Sunkara V, 2016, CANCER-AM CANCER SOC, V122, P487, DOI 10.1002/cncr.29746
   Sunkara V, 2015, CANCER-AM CANCER SOC, V121, P1563, DOI 10.1002/cncr.29228
   Tu Hong Anh T, 2012, Value Health Reg Issues, V1, P7, DOI 10.1016/j.vhri.2012.03.007
   Tyson GL, 2011, HEPATOLOGY, V54, P173, DOI 10.1002/hep.24351
   Wang SC, 2020, AGING-US, V12, P21308, DOI 10.18632/aging.103865
   Wang SC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04083-z
   Watanapa P, 2002, BRIT J SURG, V89, P962, DOI 10.1046/j.1365-2168.2002.02143.x
   World Health Organization, Current health expenditure (CHE) per capita in US$: Data by country
   World Health Organization, Immunization coverage
   Yang JD, 2019, NAT REV GASTRO HEPAT, V16, P589, DOI 10.1038/s41575-019-0186-y
   Yang JD, 2017, CANCER-AM CANCER SOC, V123, P81, DOI 10.1002/cncr.30246
   Zhang H, 2016, CANCER LETT, V379, P198, DOI 10.1016/j.canlet.2015.09.008
NR 40
TC 2
Z9 2
U1 1
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2227-9032
J9 HEALTHCARE-BASEL
JI Healthcare
PD JAN
PY 2023
VL 11
IS 2
AR 159
DI 10.3390/healthcare11020159
PG 11
WC Health Care Sciences & Services; Health Policy & Services
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA 7Z3JR
UT WOS:000915459800001
PM 36673528
OA Green Submitted, gold, Green Published
DA 2024-02-19
ER

PT J
AU Amirbeigiarab, S
   Kiani, P
   Sanchez, AV
   Krisp, C
   Kazantsev, A
   Fester, L
   Schlüter, H
   Ignatova, Z
AF Amirbeigiarab, Susan
   Kiani, Parnian
   Sanchez, Ana Velazquez
   Krisp, Christoph
   Kazantsev, Andriy
   Fester, Lars
   Schlueter, Hartmut
   Ignatova, Zoya
TI Invariable stoichiometry of ribosomal proteins in mouse brain tissues
   with aging
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE ribosome; translation; mass spectrometry; neuronal tissues; aging
ID MESSENGER-RNA TRANSLATION; GENE-EXPRESSION; DYNAMICS; SPECIFICITY;
   EVOLUTION; TURNOVER; MUSCLE
AB Across phyla, the ribosomes-the central molecular machines for translation of genetic information-exhibit an overall preserved architecture and a conserved functional core. The natural heterogeneity of the ribosome periodically phases a debate on their functional specialization and the tissue-specific variations of the ribosomal protein (RP) pool. Using sensitive differential proteomics, we performed a thorough quantitative inventory of the protein composition of ribosomes from 3 different mouse brain tissues, i.e., hippocampus, cortex, and cerebellum, across various ages, i.e., juvenile, adult, and middle-aged mouse groups. In all 3 brain tissues, in both monosomal and polysomal ribosome fractions, we detected an invariant set of 72 of 79 core RPs, RACK1 and 2 of the 8 RP paralogs, the stoichiometry of which remained constant across different ages. The amount of a few RPs punctually varied in either one tissue or one age group, but these fluctuations were within the tight bounds of the measurement noise. Further comparison with the ribosomes from a high-metabolic-rate organ, e.g., the liver, revealed protein composition identical to that of the ribosomes from the 3 brain tissues. Together, our data show an invariant protein composition of ribosomes from 4 tissues across different ages of mice and support the idea that functional heterogeneity may arise from factors other than simply ribosomal protein stoichiometry.
C1 [Amirbeigiarab, Susan; Sanchez, Ana Velazquez; Kazantsev, Andriy; Ignatova, Zoya] Univ Hamburg, Dept Chem, Biochem & Mol Biol, D-20146 Hamburg, Germany.
   [Kiani, Parnian; Krisp, Christoph; Schlueter, Hartmut] Univ Med Ctr Hamburg Eppendorf, Ctr Diagnost Clin Chem & Lab Med, D-20251 Hamburg, Germany.
   [Fester, Lars] Univ Med Ctr Hamburg Eppendorf, Ctr Expt Med, Inst Neuroanat, D-20251 Hamburg, Germany.
C3 University of Hamburg; University of Hamburg; University Medical Center
   Hamburg-Eppendorf; University of Hamburg; University Medical Center
   Hamburg-Eppendorf
RP Ignatova, Z (corresponding author), Univ Hamburg, Dept Chem, Biochem & Mol Biol, D-20146 Hamburg, Germany.
EM zoya.ignatova@uni-hamburg.de
OI Ignatova, Zoya/0000-0002-9478-8825; Velazquez Sanchez, Ana
   Karen/0000-0001-9374-4006; Kiani, Parnian/0000-0002-8838-6221
FU Deutsche Forschungsgemeinschaft [FOR1805]
FX We thank Paul Saffert for the initial protocol for dissection and
   isolation of tissues and polysomes from brain tissues, Andreas Czech for
   his help with organizing the mice experiments, and Chrsitian Lohr and
   his coworkers for helping with maintanance of the mouse colony. This
   work was supported by Deutsche Forschungsgemeinschaft Grant FOR1805 (to
   Z.I.).
CR Adamla F, 2015, SCI REP-UK, V5, DOI 10.1038/srep10692
   Baumgart M, 2014, AGING CELL, V13, P965, DOI 10.1111/acel.12257
   Bhavsar Rital B., 2010, Human Genomics, V4, P327
   Brekke TD, 2018, G3-GENES GENOM GENET, V8, P679, DOI 10.1534/g3.117.300495
   Candès EJ, 2011, J ACM, V58, DOI 10.1145/1970392.1970395
   Cenik ES, 2019, DEV CELL, V48, P811, DOI 10.1016/j.devcel.2019.01.019
   Chaillou T, 2016, J CELL PHYSIOL, V231, P1894, DOI 10.1002/jcp.25294
   DICE JF, 1972, J BIOL CHEM, V247, P98
   Dörrbaum AR, 2018, ELIFE, V7, DOI 10.7554/eLife.34202
   Emmott E, 2019, TRENDS BIOCHEM SCI, V44, P95, DOI 10.1016/j.tibs.2018.10.009
   FINLAY BL, 1995, SCIENCE, V268, P1578, DOI 10.1126/science.7777856
   Flurkey K., 2007, MOUSE BIOMEDICAL RES, P637, DOI DOI 10.1016/B978-012369454-6/50074-1
   Franks A, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005535
   Gonskikh Y, 2017, MECH AGEING DEV, V168, P30, DOI 10.1016/j.mad.2017.04.003
   Guimaraes JC, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1104-z
   Gupta V, 2014, RNA, V20, P1004, DOI 10.1261/rna.043653.113
   Imami K, 2018, MOL CELL, V72, P84, DOI 10.1016/j.molcel.2018.08.019
   Khajuria RK, 2018, CELL, V173, P90, DOI 10.1016/j.cell.2018.02.036
   Komili S, 2007, CELL, V131, P557, DOI 10.1016/j.cell.2007.08.037
   Kondrashov N, 2011, CELL, V145, P383, DOI 10.1016/j.cell.2011.03.028
   Kurylo CM, 2018, CELL REP, V25, P236, DOI 10.1016/j.celrep.2018.08.093
   Lee CH, 2018, DEV CELL, V46, P807, DOI 10.1016/j.devcel.2018.09.009
   LODISH HF, 1974, NATURE, V251, P385, DOI 10.1038/251385a0
   Malinovskaya EM, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00306
   Mazumder B, 2003, CELL, V115, P187, DOI 10.1016/S0092-8674(03)00773-6
   Mills EW, 2017, SCIENCE, V358, DOI 10.1126/science.aan2755
   MORI N, 1979, MECH AGEING DEV, V10, P379, DOI 10.1016/0047-6374(79)90020-4
   NAKANO K, 1978, J NUTR, V108, P399, DOI 10.1093/jn/108.3.399
   O'Leary MN, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003708
   Parks MM, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aao0665
   Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106
   Petrov AS, 2014, P NATL ACAD SCI USA, V111, P10251, DOI 10.1073/pnas.1407205111
   Price JC, 2010, P NATL ACAD SCI USA, V107, P14508, DOI 10.1073/pnas.1006551107
   Pulk A, 2010, MOL MICROBIOL, V75, P801, DOI 10.1111/j.1365-2958.2009.07002.x
   Rattan SIS, 1996, EXP GERONTOL, V31, P33, DOI 10.1016/0531-5565(95)02022-5
   Reschke M, 2013, CELL REP, V4, P1276, DOI 10.1016/j.celrep.2013.08.014
   Roberts E, 2008, P NATL ACAD SCI USA, V105, P13953, DOI 10.1073/pnas.0804861105
   Sinturel F, 2017, CELL, V169, P651, DOI 10.1016/j.cell.2017.04.015
   Slavov N, 2015, CELL REP, V13, P865, DOI 10.1016/j.celrep.2015.09.056
   Song W, 2019, NAT MICROBIOL, V4, P515, DOI 10.1038/s41564-018-0341-1
   STEELE RE, 1984, DEV BIOL, V102, P409, DOI 10.1016/0012-1606(84)90205-7
   Sugihara Y, 2010, J PROTEOME RES, V9, P1351, DOI 10.1021/pr9008964
   Thompson A, 2016, GENETICS, V202, P765, DOI 10.1534/genetics.115.178137
   Tuttle AH, 2018, NAT METHODS, V15, P994, DOI 10.1038/s41592-018-0224-7
   Werner A, 2015, NATURE, V525, P523, DOI 10.1038/nature14978
   Wohlbach DJ, 2009, CURR OPIN GENET DEV, V19, P571, DOI 10.1016/j.gde.2009.09.007
   Wong QWL, 2014, RNA BIOL, V11, P33, DOI 10.4161/rna.27427
   Xue SF, 2015, NATURE, V517, P33, DOI 10.1038/nature14010
   Xue SF, 2012, NAT REV MOL CELL BIO, V13, P355, DOI 10.1038/nrm3359
   Yang HW, 2019, J GERONTOL A-BIOL, V74, P1015, DOI 10.1093/gerona/gly228
   Zahn JM, 2007, PLOS GENET, V3, P2326, DOI 10.1371/journal.pgen.0030201
   Zeidan Q, 2010, MOL BIOL CELL, V21, P1922, DOI 10.1091/mbc.E09-11-0941
   Zhao LQ, 2016, NEUROBIOL AGING, V42, P69, DOI 10.1016/j.neurobiolaging.2016.02.011
   Zong WH, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2004506
NR 54
TC 18
Z9 19
U1 1
U2 10
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD NOV 5
PY 2019
VL 116
IS 45
BP 22567
EP 22572
DI 10.1073/pnas.1912060116
PG 6
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA JJ9FM
UT WOS:000494457400031
PM 31636180
OA Bronze, Green Published
DA 2024-02-19
ER

PT J
AU Adil, MD
   Kaiser, P
   Satti, NK
   Zargar, AM
   Vishwakarma, RA
   Tasduq, SA
AF Adil, Mushtaq D.
   Kaiser, Peerzada
   Satti, Naresh K.
   Zargar, Afzal M.
   Vishwakarma, Ram A.
   Tasduq, Sheikh A.
TI Effect of <i>Emblica officinalis</i> (fruit) against UVB-induced
   photo-aging in human skin fibroblasts
SO JOURNAL OF ETHNOPHARMACOLOGY
LA English
DT Article
DE Skin fibroblast; UVB; Photo-aging; Emblica officinalis
ID HUMAN DERMAL FIBROBLASTS; ACTIVATED PROTEIN-KINASE; INDUCED OXIDATIVE
   STRESS; DNA-DAMAGE; IN-VITRO; ACID; GAERTN.; CELLS; ANTIOXIDANT; EXTRACT
AB Ethnopharmacological relevance: Emblica officinalis fruit (EO), commonly known as Amla is a reputed traditional medicine and functional food used in Indian subcontinent. It has long been used in Indian folk medicine to treat liver diseases, stomach ulcers, inflammatory diseases, metabolic disorders, geriatric complaints, skin disorders and beauty care.
   Aim of the study: Recently, it has been shown to promote pro-collagen content and inhibit matrix metalloproteinase levels in skin fibroblast. The aim of the present study was to investigate the efficacy of EO to inhibit UVB-induced photo-aging in human skin fibroblasts.
   Materials and methods: Mitochondrial activity of human skin fibroblasts was measured by MTT-assay. Quantifications of pro-collagen 1 and matrix metalloproteinase 1 (MMP-1) release were performed by immunoassay techniques. Hyaluronidase inhibition assay was studied in vitro using bovine testicular hyaluronidase and human umbilical cord hyaluronic acid. Cell cycle analysis was performed by flowcytometry using propidium iodide.
   Results: EO stimulated, the otherwise UVB inhibited cellular proliferation and protected pro-collagen 1 against UVB-induced depletion via inhibition of UVB-induced MMP-1 in skin fibroblasts (10-40 mu g/mL, p > 0.001). EO exhibited inhibitory activity of hyaluronidase (10-40 mu g/mL, p > 0.001). Treatment with EO also prevented UVB disturbed cell cycle to normal phase.
   Conclusion: The results of the present study suggests that EO effectively inhibits UVB-induced photoaging in human skin fibroblast via its strong ROS scavenging ability and its therapeutic and cosmetic applications remain to be explored. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
C1 [Adil, Mushtaq D.; Kaiser, Peerzada; Satti, Naresh K.; Vishwakarma, Ram A.; Tasduq, Sheikh A.] Indian Inst Integrat Med, Council Sci & Ind Res, Jammu 180001, Jammu & Kashmir, India.
   [Zargar, Afzal M.] Univ Kashmir, Dept Biochem, Srinagar 190006, Jammu & Kashmir, India.
C3 Council of Scientific & Industrial Research (CSIR) - India; CSIR -
   Indian Institute of Integrative Medicine (IIIM); University of Kashmir
RP Tasduq, SA (corresponding author), Indian Inst Integrat Med, Council Sci & Ind Res, Canal Rd, Jammu 180001, Jammu & Kashmir, India.
EM stabdullah@iiim.ac.in
RI Zargar, Mohammad Afzal/G-7393-2018
OI Zargar, Mohammad Afzal/0000-0002-2844-7141; Abdullah,
   Tasduq/0000-0001-6474-1009
CR Bae JY, 2008, FOOD CHEM TOXICOL, V46, P1298, DOI 10.1016/j.fct.2007.09.112
   Bae JY, 2009, MOL NUTR FOOD RES, V53, P726, DOI 10.1002/mnfr.200800245
   Booij-James IS, 2000, PLANT PHYSIOL, V124, P1275, DOI 10.1104/pp.124.3.1275
   Chanvorachote P, 2009, J COSMET SCI, V60, P395
   Chaudhuri RK, 2002, SKIN PHARMACOL APPL, V15, P374, DOI 10.1159/000064544
   Chin YW, 2006, AAPS J, V8, pE239, DOI 10.1007/BF02854894
   Di Girolamo N, 2003, INVEST OPHTH VIS SCI, V44, pU315
   Ding BX, 2003, ACTA PHARMACOL SIN, V24, P1006
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   Fisher GJ, 1998, J CLIN INVEST, V101, P1432, DOI 10.1172/JCI2153
   Fisher GJ, 2002, ARCH DERMATOL, V138, P1462, DOI 10.1001/archderm.138.11.1462
   Fujii T, 2008, J ETHNOPHARMACOL, V119, P53, DOI 10.1016/j.jep.2008.05.039
   Ho JN, 2005, BIOL PHARM BULL, V28, P1244, DOI 10.1248/bpb.28.1244
   Hsu MF, 2009, J ETHNOPHARMACOL, V125, P474, DOI 10.1016/j.jep.2009.07.011
   Jones SA, 1999, REDOX REP, V4, P291, DOI 10.1179/135100099101535133
   Katiyar SK, 2001, J PHOTOCH PHOTOBIO B, V65, P109, DOI 10.1016/S1011-1344(01)00248-2
   Kim EM, 2008, CELL SIGNAL, V20, P916, DOI 10.1016/j.cellsig.2008.01.002
   Kim HJ, 2005, J NUTR SCI VITAMINOL, V51, P413, DOI 10.3177/jnsv.51.413
   Majeed M, 2009, J AGR FOOD CHEM, V57, P220, DOI 10.1021/jf802900b
   Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119
   Moon HJ, 2008, BIOL PHARM BULL, V31, P284, DOI 10.1248/bpb.31.284
   Offord EA, 2002, FREE RADICAL BIO MED, V32, P1293, DOI 10.1016/S0891-5849(02)00831-6
   Oh JH, 2004, ARCH BIOCHEM BIOPHYS, V423, P218, DOI 10.1016/j.abb.2003.12.026
   Poltanov EA, 2009, PHYTOTHER RES, V23, P1309, DOI 10.1002/ptr.2775
   Rittié L, 2002, AGEING RES REV, V1, P705, DOI 10.1016/S1568-1637(02)00024-7
   Skandrani I, 2009, TOXICOL IN VITRO, V23, P166, DOI 10.1016/j.tiv.2008.10.010
   Sudheer AR, 2007, TOXICOLOGY, V230, P11, DOI 10.1016/j.tox.2006.10.010
   Sumantran VN, 2007, J BIOSCIENCES, V32, P755, DOI 10.1007/s12038-007-0075-3
   Tasduq SA, 2005, PHYTOTHER RES, V19, P193, DOI 10.1002/ptr.1631
   Trautinger F, 2001, CLIN EXP DERMATOL, V26, P573, DOI 10.1046/j.1365-2230.2001.00893.x
   Wang KH, 2006, J ETHNOPHARMACOL, V106, P353, DOI 10.1016/j.jep.2006.01.010
   Yang DQ, 2007, BIOCHEM PHARMACOL, V73, P1665, DOI 10.1016/j.bcp.2007.01.020
NR 32
TC 71
Z9 75
U1 0
U2 32
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-8741
J9 J ETHNOPHARMACOL
JI J. Ethnopharmacol.
PD OCT 28
PY 2010
VL 132
IS 1
BP 109
EP 114
DI 10.1016/j.jep.2010.07.047
PG 6
WC Plant Sciences; Chemistry, Medicinal; Integrative & Complementary
   Medicine; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary
   Medicine
GA 682ZS
UT WOS:000284442100011
PM 20688142
DA 2024-02-19
ER

PT J
AU Rutkute, K
   Nikolova-Karakashian, MN
AF Rutkute, Kristina
   Nikolova-Karakashian, Mariana N.
TI Regulation of insulin-like growth factor binding protein-1 expression
   during aging
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE IGFBP-1; inflammation; glutathione; JNK; liver; oxidative stress
ID FACTOR-I; IGF-I; HEPATOCYTES; ACTIVATION; LONGEVITY; JNK
AB Insulin-like growth factor (IGF) binding protein-1 (IGFBP-1) is primarily produced in the liver during inflammation and regulates biological activities of IGF-I. Here we demonstrate that interleukin-1 beta (IL-1 beta) stimulates IGFBP-1 mRNA production in a dose-dependent manner in hepatocytes from Fisher 344 rats. Employment of c-Jun N-terminal kinase (JNK) inhibitor SP600125 resulted in 3-fold reduction of IGFBP-1 mRNA and protein levels, indicating that IL-1 beta-induced IGFBP-1 production is mediated through JNK activation. We further show that hepatocytes from aged rats (20-22 mo), as compared to young (3-4 mo), exhibit up to 2-fold higher levels of IGFBP-1 in response to IL-1 beta. IL-1 beta-induced phosphorylation of JNK was also significantly higher in aged hepatocytes, and SP600125 treatment eliminated age-related differences in IGFBP-1 mRNA production. Moreover, glutathione depletion in hepatocytes from young rats potently activated JNK, as well as increased IL-1 beta-induced IGFBP-1 mRNA levels, suggesting that age-related oxidative stress underlies the upregulated JNK activation and IGFBP-1 expression. (c) 2007 Elsevier Inc. All rights reserved.
C1 Univ Kentucky, Albert B Chandler Med Ctr, Coll Med, Dept Physiol, Lexington, KY 40536 USA.
C3 University of Kentucky
RP Nikolova-Karakashian, MN (corresponding author), Univ Kentucky, Albert B Chandler Med Ctr, Coll Med, Dept Physiol, 800 Rose St, Lexington, KY 40536 USA.
EM mnikolo@uky.edu
FU NIA NIH HHS [R01 AG026711-01A2, R01 AG019233, R01 AG019223-01A2, R01
   AG026711, R01 AG019223] Funding Source: Medline
CR Arvat E, 2000, DRUG AGING, V16, P29, DOI 10.2165/00002512-200016010-00003
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   Duan CM, 2005, GEN COMP ENDOCR, V142, P44, DOI 10.1016/j.ygcen.2004.12.022
   Fan J, 1996, AM J PHYSIOL-REG I, V270, pR621, DOI 10.1152/ajpregu.1996.270.3.R621
   FAN J, 1994, ENDOCRINOLOGY, V134, P1685, DOI 10.1210/en.134.4.1685
   Frost RA, 2000, ENDOCRINOLOGY, V141, P3156, DOI 10.1210/en.141.9.3156
   Hagen TM, 1997, P NATL ACAD SCI USA, V94, P3064, DOI 10.1073/pnas.94.7.3064
   Hagen TM, 2000, ANTIOXID REDOX SIGN, V2, P473, DOI 10.1089/15230860050192251
   Heemskerk VH, 1999, CYTOKINE GROWTH F R, V10, P5, DOI 10.1016/S1359-6101(98)00022-7
   Janssen JAMJL, 1998, ARTERIOSCL THROM VAS, V18, P277, DOI 10.1161/01.ATV.18.2.277
   Janssen JAMJL, 1998, GERONTOLOGY, V44, P277, DOI 10.1159/000022026
   Karakashian AA, 2004, FASEB J, V18, P968, DOI 10.1096/fj.03-0875fje
   Lang CH, 1997, AM J PHYSIOL-REG I, V273, pR371, DOI 10.1152/ajpregu.1997.273.1.R371
   Lang CH, 1996, AM J PHYSIOL-ENDOC M, V270, pE430, DOI 10.1152/ajpendo.1996.270.3.E430
   Lang CH, 1999, AM J PHYSIOL-GASTR L, V276, pG719, DOI 10.1152/ajpgi.1999.276.3.G719
   LEE A, 1993, J LEUKOCYTE BIOL, V54, P283, DOI 10.1002/jlb.54.4.283
   Lee PDK, 1997, P SOC EXP BIOL MED, V216, P319
   LIDDLE C, 1992, ARCH BIOCHEM BIOPHYS, V298, P159, DOI 10.1016/0003-9861(92)90107-8
   Lightle SA, 2000, MECH AGEING DEV, V120, P111, DOI 10.1016/S0047-6374(00)00191-3
   Lo YYC, 1996, J BIOL CHEM, V271, P15703, DOI 10.1074/jbc.271.26.15703
   Maggio M, 2005, J ENDOCRINOL INVEST, V28, P711, DOI 10.1007/BF03347554
   Rutkute K, 2007, HEPATOLOGY, V46, P1166, DOI 10.1002/HEP.21777
   Silha JV, 2002, ENDOCRINOLOGY, V143, P3711, DOI 10.1210/en.2002-220116
   VERICEL E, 1994, MOL CELL BIOCHEM, V132, P25, DOI 10.1007/BF00925671
   Walston J, 1999, MED CLIN N AM, V83, P1173, DOI 10.1016/S0025-7125(05)70157-7
   Whitmarsh AJ, 2001, METHOD ENZYMOL, V332, P319
   Yang J, 2005, EXP GERONTOL, V40, P867, DOI 10.1016/j.exger.2005.08.001
NR 27
TC 16
Z9 18
U1 1
U2 3
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD SEP 21
PY 2007
VL 361
IS 2
BP 263
EP 269
DI 10.1016/j.bbrc.2007.06.079
PG 7
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA 200BH
UT WOS:000248738400001
PM 17645865
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Sun, YY
   Wang, YH
   Li, MM
   Cheng, KL
   Zhao, XY
   Zheng, Y
   Liu, Y
   Lei, SY
   Wang, L
AF Sun, Yuanyuan
   Wang, Yanhong
   Li, Mengmeng
   Cheng, Kailiang
   Zhao, Xinyu
   Zheng, Yuan
   Liu, Yan
   Lei, Shaoyuan
   Wang, Li
TI Long-term trends of liver cancer mortality by gender in urban and rural
   areas in China: an age-period-cohort analysis
SO BMJ OPEN
LA English
DT Article
AB Objectives To provide an up-to-date overview of long-term trends of liver cancer mortality and evaluate the effects attributable to age, period and cohort in Chinese population stratified by gender and urban/rural areas.
   Methods Population and liver cancer mortality data were obtained based on the Disease Surveillance Points in China from 1991 to 2014. To examine the time trends of liver cancer mortality by gender in urban and rural areas in China, Joinpoint analysis was used to estimate the annual per cent change. The intrinsic estimator, a method of age-period-cohort analysis to estimate age, period and cohort effects simultaneously, was used to analyse the underlying mechanisms for liver cancer mortality trends in the aforementioned four groups.
   Results We observed a significant decline in liver cancer mortality for urban men (average annual per cent change (AAPC)=-1.1%, P<0.05) and urban women (AAPC=-1.4%, P<0.05), while the liver cancer mortality remained stable for rural men (AAPC=-0.1%, P>0.05) and rural women (AAPC=-0.9%, P>0.05). Compared with the 15-19 age group, the liver cancer mortality risk of the 85 and above age group increased 65 and 42 times for urban and rural men, and 102 and 70 times for urban and rural women. From the 1990-1994 period to the 2005-2009 period, the risk increased 56% and 92% for urban and rural men, and 30% and 74% for urban and rural women. Compared with period and cohort effects, age effects were the most influential factor in liver cancer mortality.
   Conclusions As the status of ageing population in China gets worse, the burden caused by liver cancer mortality could still be a great challenge for China in the future. The disparity of liver cancer mortality trends between urban and rural residents can be attributed to period effects, referring to the unequal medical levels and resources between urban and rural areas.
C1 [Sun, Yuanyuan; Wang, Yanhong; Li, Mengmeng; Cheng, Kailiang; Zhao, Xinyu; Zheng, Yuan; Liu, Yan; Lei, Shaoyuan; Wang, Li] Chinese Acad Med Sci, Peking Union Med Coll, Sch Basic Med, Dept Epidemiol & Biostat,Inst Basic Med Sci, Beijing, Peoples R China.
C3 Chinese Academy of Medical Sciences - Peking Union Medical College;
   Peking Union Medical College; Institute of Basic Medical Sciences - CAMS
RP Wang, L (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Sch Basic Med, Dept Epidemiol & Biostat,Inst Basic Med Sci, Beijing, Peoples R China.
EM liwang@ibms.pumc.edu.cn
RI wang, yan/GSE-6489-2022; wangwangwang, yuanyaunyuan/HHN-6432-2022; Wang,
   Yuan/HHC-1520-2022; wang, yi/GVT-8516-2022; Wang, Yin/HCI-9352-2022;
   Wang, Yanbo/HFZ-8018-2022; zhang, yan/JGL-8022-2023; wang,
   yiran/IAP-0414-2023
OI Sun, Yuanyuan/0000-0001-5142-3626; Li, Mengmeng/0000-0001-6630-7468
FU CAMS Innovation Fund for Medical Sciences (CIFMS) [2016-I2M-3-001];
   Special Fund for Health-Scientific Research in the Public Interest
   [201502005]; National Infectious Disease Major Projects in China
   [2017ZX10105005-004-003]
FX This work was supported by CAMS Innovation Fund for Medical Sciences
   (CIFMS) (2016-I2M-3-001), Special Fund for Health-Scientific Research in
   the Public Interest (201502005) and the National Infectious Disease
   Major Projects in China (2017ZX10105005-004-003).
CR Akita T, 2014, HEPATOL RES, V44, P713, DOI 10.1111/hepr.12177
   [Anonymous], 2012, GLOBOCAN 2012 V1 0 C
   Beal EW, 2017, J GASTROINTEST SURG, V21, P2033, DOI 10.1007/s11605-017-3526-7
   CDC TNCfCaNDCaPC, 2010, MON DAT NAT DIS SURV
   Chen JG, 2013, CANCER PREV RES, V6, P1038, DOI 10.1158/1940-6207.CAPR-13-0168
   Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338
   Guo K, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0051-3
   Jia S, 2014, CHINA CANC, V23, P999
   Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.3.CO;2-Q
   Land KennethC, 2013, AGE PERIOD COHORT AN, DOI DOI 10.1201/B13902
   Lee LT, 2009, ANN EPIDEMIOL, V19, P323, DOI 10.1016/j.annepidem.2008.12.013
   Liang XF, 2013, VACCINE, V31, pJ21, DOI 10.1016/j.vaccine.2013.08.012
   Liu SW, 2016, B WORLD HEALTH ORGAN, V94, P46, DOI 10.2471/BLT.15.153148
   Lu FM, 2009, CHINESE MED J-PEKING, V122, P3, DOI 10.3760/cma.j.issn.0366-6999.2009.01.001
   MASON KO, 1973, AM SOCIOL REV, V38, P242, DOI 10.2307/2094398
   Ministry of Health of the People's Republic of China, 2011, CHIN CLIN ONCOL, V16, P929
   National Cancer Institute, STAT RES APPL BRANCH
   Nguyen VTT, 2009, J VIRAL HEPATITIS, V16, P453, DOI 10.1111/j.1365-2893.2009.01117.x
   Park Jihwan, 2015, Asian Pac J Cancer Prev, V16, P8589
   Ren L, 2008, DIS SURVEILLANCE, V23, P1
   Vlachogiannakos J, 2013, WORLD J GASTROENTERO, V19, P8822, DOI 10.3748/wjg.v19.i47.8822
   Wang Lin, 2011, Zhonghua Yu Fang Yi Xue Za Zhi, V45, P1061
   Xiang YB, 2001, B CHINESE CANC, V05, P9
   Yang Gonghuan, 2005, Popul Health Metr, V3, P3, DOI 10.1186/1478-7954-3-3
   Yang Y, 2004, SOCIOL METHODOL, V34, P75, DOI 10.1111/j.0081-1750.2004.00148.x
   Zhang BH, 1999, J MED SCREEN, V6, P108, DOI 10.1136/jms.6.2.108
   Zhao P, 2010, JPN J CLIN ONCOL, V40, P281, DOI 10.1093/jjco/hyp187
   Zheng Rongshou, 2015, Zhonghua Zhong Liu Za Zhi, V37, P697
   Zhou MG, 2016, LANCET, V387, P251, DOI 10.1016/S0140-6736(15)00551-6
   Zhou MaiGeng, 2010, Disease Surveillance, V25, P239
NR 30
TC 32
Z9 36
U1 1
U2 12
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 2044-6055
J9 BMJ OPEN
JI BMJ Open
PD MAY
PY 2018
VL 8
IS 2
AR e020490
DI 10.1136/bmjopen-2017-020490
PG 8
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA VJ4CU
UT WOS:000591687400001
PM 29439081
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Guedj, A
   Geiger-Maor, A
   Galun, E
   Amsalem, H
   Rachmilewitz, J
AF Guedj, Avital
   Geiger-Maor, Anat
   Galun, Eithan
   Amsalem, Hagai
   Rachmilewitz, Jacob
TI Early age decline in DNA repair capacity in the liver: in depth profile
   of differential gene expression
SO AGING-US
LA English
DT Article
DE DNA repair; aging; gamma H2AX; KAP-1; p53; RNAseq
ID DOUBLE-STRAND BREAKS; DAMAGE; P53; STRESS; CANCER; CELLS; ATM;
   INSTABILITY; FREQUENCY; SUBSTRATE
AB Aging is associated with progressive decline in cell function and with increased damage to macromolecular components. DNA damage, in the form of double-strand breaks (DSBs), increases with age and in turn, contributes to the aging process and age-related diseases. DNA strand breaks triggers a set of highly orchestrated signaling events known as the DNA damage response (DDR), which coordinates DNA repair. However, whether the accumulation of DNA damage with age is a result of decreased repair capacity, remains to be determined. In our study we showed that with age there is a decline in the resolution of foci containing gamma H2AX and pKAP-1 in diethylnitrosamine (DEN)-treated mouse livers, already evident at a remarkably early age of 6-months. Considerable age-dependent differences in global gene expression profiles in mice livers after exposure to DEN, further affirmed these age related differences in the response to DNA damage. Functional analysis identified p53 as the most overrepresented pathway that is specifically enhanced and prolonged in 6 month-old mice. Collectively, our results demonstrated an early decline in DNA damage repair that precedes 'old age', suggesting this may be a driving force contributing to the aging process rather than a phenotypic consequence of old age.
C1 [Guedj, Avital; Geiger-Maor, Anat; Galun, Eithan; Rachmilewitz, Jacob] Hadassah Hebrew Univ, Med Ctr, Goldyne Savad Inst Gene Therapy, Jerusalem, Israel.
   [Amsalem, Hagai] Hadassah Univ Hosp Mt Scopus, Dept Obstet & Gynecol, Jerusalem, Israel.
C3 Hebrew University of Jerusalem; Hadassah University Medical Center;
   Hebrew University of Jerusalem
RP Rachmilewitz, J (corresponding author), Hadassah Hebrew Univ, Med Ctr, Goldyne Savad Inst Gene Therapy, Jerusalem, Israel.
EM rjacob444@gmail.com
RI Galun, Eithan/AAD-9117-2022
OI Galun, Eithan/0000-0002-6243-6702
FU I-CORE Program of the Planning and Budgeting Committee; Israel Science
   Foundation
FX This study was supported in part by the I-CORE Program of the Planning
   and Budgeting Committee and the Israel Science Foundation.
CR Atamna H, 2000, P NATL ACAD SCI USA, V97, P686, DOI 10.1073/pnas.97.2.686
   Burgess RC, 2012, CURR OPIN CELL BIOL, V24, P724, DOI 10.1016/j.ceb.2012.07.005
   Cabelof DC, 2006, J GERONTOL A-BIOL, V61, P427, DOI 10.1093/gerona/61.5.427
   Dollé MET, 2011, PATHOBIOL AGING AGE, V1, DOI 10.3402/pba.v1i0.7219
   Finkel T, 2007, NATURE, V448, P767, DOI 10.1038/nature05985
   Freitas AA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-27
   Garm C, 2013, AGING CELL, V12, P58, DOI 10.1111/acel.12019
   Geiger-Maor A, 2015, CANCER RES, V75, P2663, DOI 10.1158/0008-5472.CAN-14-3635
   Geiger-Maor A, 2012, J IMMUNOL, V188, P1234, DOI 10.4049/jimmunol.1101740
   Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017
   Goukassian D, 2000, FASEB J, V14, P1325, DOI 10.1096/fj.14.10.1325
   Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698
   Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615
   Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615
   Horn HF, 2007, ONCOGENE, V26, P1306, DOI 10.1038/sj.onc.1210263
   KING CM, 1994, MUTAT RES-DNAGING G, V316, P79, DOI 10.1016/0921-8734(94)90010-8
   Li H, 2008, MECH AGEING DEV, V129, P416, DOI 10.1016/j.mad.2008.02.002
   Li WG, 2012, GERONTOLOGY, V58, P129, DOI 10.1159/000334368
   Li Z, 2016, CELL DEATH DIFFER, V23, P1765, DOI 10.1038/cdd.2016.65
   Lobrich M, 1995, P NATL ACAD SCI USA, V92, P12050, DOI 10.1073/pnas.92.26.12050
   Loewer A, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-114
   Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028
   Martínez P, 2009, GENE DEV, V23, P2060, DOI 10.1101/gad.543509
   ONO T, 1995, MUTAT RES-DNAGING G, V338, P183, DOI 10.1016/0921-8734(95)00023-Y
   Purvis JE, 2012, SCIENCE, V336, P1440, DOI 10.1126/science.1218351
   Ren KQ, 2002, J NEUROCHEM, V80, P949, DOI 10.1046/j.0022-3042.2002.00776.x
   Schaefer MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031826
   Schumacher B, 2008, TRENDS GENET, V24, P77, DOI 10.1016/j.tig.2007.11.004
   Sedelnikova OA, 2008, AGING CELL, V7, P89, DOI 10.1111/j.1474-9726.2007.00354.x
   Stuart GR, 2000, GENETICS, V154, P1291
   Vermeij WP, 2016, NATURE, V537, P427, DOI 10.1038/nature19329
   Verna L, 1996, PHARMACOL THERAPEUT, V71, P57, DOI 10.1016/0163-7258(96)00062-9
   Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675
   Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147
   Vyjayanti VN, 2006, NEUROSCI LETT, V393, P18, DOI 10.1016/j.neulet.2005.09.053
   White D, 2012, MOL CANCER RES, V10, P401, DOI 10.1158/1541-7786.MCR-11-0134
   White DE, 2006, CANCER RES, V66, P11594, DOI 10.1158/0008-5472.CAN-06-4138
   White RR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7790
   Zhang XP, 2009, P NATL ACAD SCI USA, V106, P12245, DOI 10.1073/pnas.0813088106
   Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446
NR 40
TC 16
Z9 17
U1 0
U2 3
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1945-4589
J9 AGING-US
JI Aging-US
PD NOV
PY 2016
VL 8
IS 11
BP 3131
EP 3146
DI 10.18632/aging.101120
PG 16
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA EF4PA
UT WOS:000390311900037
PM 27922819
OA gold, Green Published, Green Submitted
DA 2024-02-19
ER

PT J
AU Shi, LH
   Ko, S
   Kim, S
   Echchgadda, I
   Oh, TS
   Song, CS
   Chatterjee, B
AF Shi, Liheng
   Ko, Soyoung
   Kim, Soyoung
   Echchgadda, Ibtissam
   Oh, Tae-Sung
   Song, Chung S.
   Chatterjee, Bandana
TI Loss of Androgen Receptor in Aging and Oxidative Stress through Myb
   Protooncoprotein-regulated Reciprocal Chromatin Dynamics of p53 and
   Poly(ADP-ribose) Polymerase PARP-1
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID FACTOR-KAPPA-B; HEPATOCELLULAR-CARCINOMA; TRANSCRIPTION; GENE;
   EXPRESSION; COREPRESSOR; PROTEIN; FAMILY; LIVER; SPECIFICITY
AB Poly(ADP-ribosyl)ation of transcription factors and coregulators, mediated by the poly(ADP-ribose) polymerase PARP-1, has been emerging as an important epigenetic mechanism that controls transcriptional dynamics in response to diverse intra- and extracellular signals. PARP-1 activity is also implicated in the regulation of mammalian lifespan. Herein we show that transcriptional down-regulation of androgen receptor (AR) in the aging rat liver and in oxidatively stressed hepatoma cells involves exchange of a PARP-1-associated, p/CAF-containing coactivator assembly for a p53-interacting, Groucho/TLE1-, and mSin3A-induded corepressor complex at an age- and oxidant-responsive DNA element (age- dependent factor (ADF) element) in the AR promoter. The coregulator switch is mediated by B-Myb and c-Myb, which bind to the ADF element and physically associate with PARP-1 and the tumor suppressor p53. Heterogeneous nuclear ribonucleoprotein K, residing at the ADF element in association with PARP-1, may serve a platform role in stabilizing the activating complex. PARP-1 coactivated B-Myb- and c-Myb-mediated transactivation of the AR promoter, and p53 antagonized the B-Myb/c-Myb-induced AR promoter activation. PARP-1, heterogeneous nuclear ribonucleoprotein K, B-Myb, and c-Myb each serves as a positive regulator of cellular AR content, whereas p53 negatively regulates AR expression. Our results identify a shared, PARP-1-regulated sensing mechanism that coordinates transcriptional repression of AR during aging and in response to oxidative stress. This study may provide insights as to how advancing age and intracellular redox balance might influence androgen-regulated physiology.
C1 [Shi, Liheng; Ko, Soyoung; Kim, Soyoung; Echchgadda, Ibtissam; Oh, Tae-Sung; Song, Chung S.; Chatterjee, Bandana] Univ Texas Hlth Sci Ctr San Antonio, Inst Biotechnol, Dept Mol Med, San Antonio, TX 78245 USA.
   [Chatterjee, Bandana] S Texas Vet Hlth Care Syst, San Antonio, TX 78229 USA.
C3 University of Texas System; University of Texas Health Science Center at
   San Antonio; US Department of Veterans Affairs; Veterans Health
   Administration (VHA); Audie L. Murphy Memorial Veterans Hospital
RP Chatterjee, B (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Inst Biotechnol, Dept Mol Med, 15355 Lambda Dr, San Antonio, TX 78245 USA.
EM chatterjee@uthscsa.edu
RI Shi, Liheng/T-3250-2017
OI Shi, Liheng/0000-0002-0813-3962
FU National Institutes of Health [AG-10486, AG-19660]
FX This work was supported, in whole or in part, by National Institutes of
   Health Grants AG-10486 and AG-19660. This work was also supported by a
   merit review grant from Veterans Affairs. The costs of publication of
   this article were defrayed in part by the payment of page charges. This
   article must therefore be hereby marked "advertisement" in accordance
   with 18 U. S. C. Section 1734 solely to indicate this fact.
CR Alimirah F, 2007, NEOPLASIA, V9, P1152, DOI 10.1593/neo.07769
   BOIX L, 1995, J HEPATOL, V22, P616, DOI 10.1016/0168-8278(95)80217-7
   Bomsztyk K, 2004, BIOESSAYS, V26, P629, DOI 10.1002/bies.20048
   Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616
   Bowerman B, 2005, SCIENCE, V308, P1119, DOI 10.1126/science.1113356
   Cai Y, 2003, ENDOCRINOLOGY, V144, P2311, DOI 10.1210/en.2002-0129
   Cervellera MN, 2000, J BIOL CHEM, V275, P10692, DOI 10.1074/jbc.275.14.10692
   Chen GQ, 2000, GENE, V249, P1, DOI 10.1016/S0378-1119(00)00161-X
   D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249
   DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475
   El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   Gagné JP, 2003, BIOCHEM J, V371, P331, DOI 10.1042/BJ20021675
   Germain M, 1999, J BIOL CHEM, V274, P28379, DOI 10.1074/jbc.274.40.28379
   GRUBE K, 1992, P NATL ACAD SCI USA, V89, P11759, DOI 10.1073/pnas.89.24.11759
   Helenius M, 1996, BIOCHEM J, V318, P603, DOI 10.1042/bj3180603
   Jennings BH, 2006, MOL CELL, V22, P645, DOI 10.1016/j.molcel.2006.04.024
   Ju BG, 2004, CELL, V119, P815, DOI 10.1016/j.cell.2004.11.017
   Kanai M, 2007, NAT CELL BIOL, V9, P1175, DOI 10.1038/ncb1638
   KEMP CJ, 1989, P NATL ACAD SCI USA, V86, P7505, DOI 10.1073/pnas.86.19.7505
   Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002
   Ko S, 2008, MOL ENDOCRINOL, V22, P273, DOI 10.1210/me.2007-0332
   Kraus WL, 2003, CELL, V113, P677, DOI 10.1016/S0092-8674(03)00433-1
   Li XL, 2002, MOL CELL BIOL, V22, P3663, DOI 10.1128/MCB.22.11.3663-3673.2002
   Lin HY, 2008, HEPATOLOGY, V47, P1924, DOI 10.1002/hep.22252
   Lonard DM, 2007, MOL CELL, V27, P691, DOI 10.1016/j.molcel.2007.08.012
   Mendoza-Alvarez H, 2001, J BIOL CHEM, V276, P36425, DOI 10.1074/jbc.M105215200
   Métivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6
   Miglarese MR, 1996, J BIOL CHEM, V271, P22697, DOI 10.1074/jbc.271.37.22697
   MOTICELLI S, 2001, MOL IMMUNOL, V38, P1129
   Muiras ML, 1998, J MOL MED-JMM, V76, P346, DOI 10.1007/s001090050226
   Murphy M, 1999, GENE DEV, V13, P2490, DOI 10.1101/gad.13.19.2490
   Nantermet P, 2008, ENDOCRINOLOGY, V149, P1551, DOI 10.1210/en.2007-1151
   Ness SA, 2003, BLOOD CELL MOL DIS, V31, P192, DOI 10.1016/S1079-9796(03)00151-7
   OCHI T, 1989, TOXICOLOGY, V55, P69, DOI 10.1016/0300-483X(89)90175-3
   Pavri R, 2005, MOL CELL, V18, P83, DOI 10.1016/j.molcel.2005.02.034
   Pienta KJ, 2006, CLIN CANCER RES, V12, P1665, DOI 10.1158/1078-0432.CCR-06-0067
   Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806
   Roy AK, 2002, AGEING RES REV, V1, P367, DOI 10.1016/S1568-1637(02)00006-5
   Roy AK, 1996, EXP GERONTOL, V31, P83, DOI 10.1016/0531-5565(95)00020-8
   Sala A, 2005, EUR J CANCER, V41, P2479, DOI 10.1016/j.ejca.2005.08.004
   Seo YK, 2007, GENE, V386, P218, DOI 10.1016/j.gene.2006.10.006
   Song CS, 1998, J BIOL CHEM, V273, P21856, DOI 10.1074/jbc.273.34.21856
   SONG CS, 1991, ENDOCRINOLOGY, V128, P349, DOI 10.1210/endo-128-1-349
   Stains JP, 2005, BIOCHEM J, V385, P613, DOI 10.1042/BJ20040680
   SUPAKAR PC, 1995, J BIOL CHEM, V270, P837, DOI 10.1074/jbc.270.2.837
   SUPAKAR PC, 1993, J BIOL CHEM, V268, P26400
   Supakar PC, 1996, BIOL SIGNAL, V5, P170
   Tanikawa J, 2004, J BIOL CHEM, V279, P55393, DOI 10.1074/jbc.M411658200
   Wang LG, 1999, BIOCHEM BIOPH RES CO, V259, P21, DOI 10.1006/bbrc.1999.0655
   Wang LG, 2008, CANCER RES, V68, P2678, DOI 10.1158/0008-5472.CAN-07-6017
   Yaklichkin S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-201
   Yochum GS, 2001, MOL CELL BIOL, V21, P4110, DOI 10.1128/MCB.21.13.4110-4118.2001
NR 53
TC 26
Z9 30
U1 0
U2 5
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI ROCKVILLE
PA 11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD DEC 26
PY 2008
VL 283
IS 52
BP 36474
EP 36485
DI 10.1074/jbc.M805980200
PG 12
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 385VA
UT WOS:000261840500045
PM 18945670
OA hybrid, Green Published
DA 2024-02-19
ER

PT J
AU Galván, I
   Erritzoe, J
   Karadas, F
   Moller, AP
AF Galvan, Ismael
   Erritzoe, Johannes
   Karadas, Filiz
   Moller, Anders P.
TI High levels of liver antioxidants are associated with life-history
   strategies characteristic of slow growth and high survival rates in
   birds
SO JOURNAL OF COMPARATIVE PHYSIOLOGY B-BIOCHEMICAL SYSTEMS AND
   ENVIRONMENTAL PHYSIOLOGY
LA English
DT Article
DE Carotenoids; Life-history evolution; Oxidative damage; Senescence;
   Vitamin E
ID OXIDATIVE STRESS; ENERGY-EXPENDITURE; METABOLIC-RATE; CAROTENOIDS;
   EVOLUTION; PLASMA; COST; SIZE; RED; MANIPULATION
AB Antioxidants have a large potential to coevolve with life-histories because of their capacity to counteract the negative effects of free radicals on fitness. However, only a few studies have explored the association between antioxidant levels and life-history strategies comparing a large number of species. Here we used an extensive dataset of 125 species of birds to investigate the association between concentrations of antioxidants (carotenoids and vitamin E) in the liver, which is the main storage organ for fat-soluble antioxidants, and life-history and morphology. We found that high liver antioxidant concentrations were associated with life-history strategies characterized by "live slow, die old", in clear contrast to previous studies reporting a relationship between high plasma antioxidants and life-histories characterized by "live fast, die young". Thus, high carotenoid concentrations were present in species with large body, brain and egg sizes, high absolute metabolic rate and a resident lifestyle, while high vitamin E concentrations were present in species with large brain size and long life span and incubation period. Our results indicate that antioxidants and life-histories coevolve, and that this may be mediated by positive fitness consequences of the accumulation of liver antioxidants, as species with higher antioxidant levels live longer.
C1 [Galvan, Ismael; Moller, Anders P.] Univ Paris 11, Lab Ecol Systemat & Evolut, CNRS, UMR 8079, F-91405 Orsay, France.
   [Erritzoe, Johannes] Taps Old Rectory, DK-6040 Christiansfeld, Denmark.
   [Karadas, Filiz] Yuzuncu Yil Univ, Dept Anim Sci, TR-65080 Van, Turkey.
C3 AgroParisTech; Universite Paris Saclay; Centre National de la Recherche
   Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE);
   Yuzuncu Yil University
RP Galván, I (corresponding author), Univ Paris 11, Lab Ecol Systemat & Evolut, CNRS, UMR 8079, F-91405 Orsay, France.
EM ismael.galvan@u-psud.fr
RI Karadas, Filiz/K-2750-2016; Moller, Anders/O-6665-2016; Galvan,
   Ismael/H-8602-2015
OI Moller, Anders/0000-0003-3739-4675; Galvan, Ismael/0000-0002-6523-8592
FU European Community [PIEF-GA-2009-252145]
FX This manuscript was improved by comments from two anonymous reviewers.
   IG was supported by a Marie Curie Intra-European Fellowship
   (PIEF-GA-2009-252145) within the 7th European Community Framework
   Programme.
CR Alonso-Alvarez C, 2004, ECOL LETT, V7, P363, DOI 10.1111/j.1461-0248.2004.00594.x
   Alström P, 2008, MOL PHYLOGENET EVOL, V47, P960, DOI 10.1016/j.ympev.2007.12.007
   Antoniazza S, 2010, EVOLUTION, V64, P1944, DOI 10.1111/j.1558-5646.2010.00969.x
   Barja G, 2004, BIOL REV, V79, P235, DOI 10.1017/S1464793103006213
   Barón V, 1999, BBA-GEN SUBJECTS, V1472, P173, DOI 10.1016/S0304-4165(99)00118-X
   Biard C, 2009, AM NAT, V174, P696, DOI 10.1086/606021
   Carrascal LM, 2009, OIKOS, V118, P681, DOI 10.1111/j.1600-0706.2008.16881.x
   Castenmiller JJM, 1998, ANNU REV NUTR, V18, P19, DOI 10.1146/annurev.nutr.18.1.19
   Cohen AA, 2008, AM NAT, V172, P178, DOI 10.1086/589456
   Cohen AA, 2009, OIKOS, V118, P1854, DOI 10.1111/j.1600-0706.2009.17785.x
   Cohen AA, 2009, OECOLOGIA, V161, P673, DOI 10.1007/s00442-009-1423-9
   Costantini D, 2008, FUNCT ECOL, V22, P367, DOI 10.1111/j.1365-2435.2007.01366.x
   Costantini D, 2008, J EXP BIOL, V211, P377, DOI 10.1242/jeb.012856
   Costantini D, 2009, COMP BIOCHEM PHYS A, V153, P339, DOI 10.1016/j.cbpa.2009.03.010
   Cramp S., 1993, BIRDS W PALEARCTIC, V7
   Cramp S., 1977, BIRDS W PALEARCTIC, V1
   CUTLER RG, 1991, AM J CLIN NUTR, V53, pS373, DOI 10.1093/ajcn/53.1.373S
   Davis KE., 2008, THESIS U GLASGOW GLA
   del Val Esther, 2009, Revista Catalana d'Ornitologia, V25, P19
   del Val E, 2009, NATURWISSENSCHAFTEN, V96, P797, DOI 10.1007/s00114-009-0534-9
   DiazUriarte R, 1996, SYST BIOL, V45, P27, DOI 10.2307/2413510
   Diniz JAF, 1998, EVOLUTION, V52, P1247, DOI 10.1111/j.1558-5646.1998.tb02006.x
   Dowling DK, 2009, P ROY SOC B-BIOL SCI, V276, P1737, DOI 10.1098/rspb.2008.1791
   Dunning J.B., 1993, Handbook of Avian Body Masses
   Dvorska JE, 2007, COMP BIOCHEM PHYS C, V145, P582, DOI 10.1016/j.cbpc.2007.02.005
   FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231
   Galván I, 2011, OECOLOGIA, V165, P827, DOI 10.1007/s00442-010-1860-5
   Galván I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013369
   Galván I, 2009, P ROY SOC B-BIOL SCI, V276, P3089, DOI 10.1098/rspb.2009.0774
   Garamszegi LZ, 2005, P ROY SOC B-BIOL SCI, V272, P159, DOI 10.1098/rspb.2004.2940
   Garratt M, 2011, P ROY SOC B-BIOL SCI, V278, P1098, DOI 10.1098/rspb.2010.1818
   Ghalambor CK, 2002, BEHAV ECOL, V13, P101, DOI 10.1093/beheco/13.1.101
   GOODWIN TW, 1950, BIOL REV, V25, P391, DOI 10.1111/j.1469-185X.1950.tb00765.x
   Grosso AR, 2006, FOLIA ZOOL, V55, P131
   Hill GE, 1996, ETHOL ECOL EVOL, V8, P157, DOI 10.1080/08927014.1996.9522926
   Hoffman DJ, 1998, ENVIRON TOXICOL CHEM, V17, P161, DOI 10.1002/etc.5620170204
   Hood G. M, 2010, POPTOOLS VERSION 3 2
   Horak P, 2010, FUNCT ECOL, V24, P960, DOI 10.1111/j.1365-2435.2010.01755.x
   Horak Peeter, 2002, Avian Science, V2, P123
   Hoyo J.d., 1992, Handbook of the birds of the world
   Isaksson Caroline, 2005, EcoHealth, V2, P138, DOI 10.1007/s10393-005-3869-5
   Iwaniuk AN, 2003, CAN J ZOOL, V81, P1913, DOI 10.1139/Z03-190
   Jensen C, 1998, TRENDS FOOD SCI TECH, V9, P62, DOI 10.1016/S0924-2244(98)00004-1
   Julliard R, 2006, ECOL LETT, V9, P1237, DOI 10.1111/j.1461-0248.2006.00977.x
   KODRICBROWN A, 1978, ECOLOGY, V59, P285, DOI 10.2307/1936374
   Koutsos EA, 2003, COMP BIOCHEM PHYS A, V135, P635, DOI 10.1016/S1095-6433(03)00158-2
   Kurien BT, 2008, AUTOIMMUN REV, V7, P567, DOI 10.1016/j.autrev.2008.04.019
   LASIEWSKI RC, 1967, CONDOR, V69, P13, DOI 10.2307/1366368
   Latscha T, 1990, CAROTENOIDS THEIR NA
   MARTIN TE, 1995, ECOL MONOGR, V65, P101, DOI 10.2307/2937160
   Martin TE, 2000, SCIENCE, V287, P1482, DOI 10.1126/science.287.5457.1482
   Martínez A, 2008, J PHYS CHEM A, V112, P9037, DOI 10.1021/jp803218e
   McCord JM, 2000, AM J MED, V108, P652, DOI 10.1016/S0002-9343(00)00412-5
   McGraw KJ, 2006, FUNCT ECOL, V20, P678, DOI 10.1111/j.1365-2435.2006.01121.x
   Mcgraw KJ, 2004, CONDOR, V106, P686, DOI 10.1650/7418.1
   McKechnie AE, 2006, P ROY SOC B-BIOL SCI, V273, P931, DOI 10.1098/rspb.2005.3415
   Mcnab BK, 2009, COMP BIOCHEM PHYS A, V152, P22, DOI 10.1016/j.cbpa.2008.08.021
   Mecocci P, 2000, FREE RADICAL BIO MED, V28, P1243, DOI 10.1016/S0891-5849(00)00246-X
   Metcalfe NB, 2010, FUNCT ECOL, V24, P984, DOI 10.1111/j.1365-2435.2010.01750.x
   Meyskens FL, 1999, CLIN CANCER RES, V5, P1197
   Mlikovsky J., 1989, Vestnik Ceskoslovenske Spolecnosti Zoologicke, V53, P200
   Moller AP, 2008, J EVOLUTION BIOL, V21, P1379, DOI 10.1111/j.1420-9101.2008.01556.x
   Moller AP, 2007, J EVOLUTION BIOL, V20, P750, DOI 10.1111/j.1420-9101.2006.01236.x
   Moller AP, 2010, OECOLOGIA, V163, P35, DOI 10.1007/s00442-009-1525-4
   Moller AP, 2000, AVIAN POULT BIOL REV, V11, P137
   Morales AE, 2004, COMP BIOCHEM PHYS C, V139, P153, DOI 10.1016/j.cca.2004.10.008
   MORENO J, 1994, J AVIAN BIOL, V25, P125, DOI 10.2307/3677030
   Nguembock B, 2009, MOL PHYLOGENET EVOL, V51, P169, DOI 10.1016/j.ympev.2008.10.022
   Ozeki H, 1997, BBA-GEN SUBJECTS, V1336, P539, DOI 10.1016/S0304-4165(97)00068-8
   PAGEL MD, 1988, EVOLUTION, V42, P948, DOI 10.1111/j.1558-5646.1988.tb02513.x
   Ricklefs RE, 1996, AM NAT, V147, P1047, DOI 10.1086/285892
   Ricklefs RE, 2002, TRENDS ECOL EVOL, V17, P462, DOI 10.1016/S0169-5347(02)02578-8
   Saino N, 2003, P ROY SOC B-BIOL SCI, V270, P2485, DOI 10.1098/rspb.2003.2534
   Seddon N, 2010, AUK, V127, P283, DOI 10.1525/auk.2009.09070
   Sewalk CJ, 2000, J TOXICOL ENV HEAL A, V62, P33, DOI 10.1080/00984100050201659
   STRADI R, 1995, COLORE VOLO
   Surai P. F., 2002, NATURAL ANTIOXIDANTS
   Surai PF, 2000, EUR J CLIN NUTR, V54, P298, DOI 10.1038/sj.ejcn.1600939
   Tella JL, 2004, J EVOLUTION BIOL, V17, P156, DOI 10.1046/j.1420-9101.2003.00634.x
   Thomson DL, 1998, BIOL REV, V73, P293, DOI 10.1017/S0006323198005180
   Toral GM, 2008, COMP BIOCHEM PHYS B, V150, P147, DOI 10.1016/j.cbpb.2008.02.006
   Vinuela J, 1997, J ANIM ECOL, V66, P781, DOI 10.2307/5995
   VLECK CM, 1980, AM ZOOL, V20, P405
   Voelker G, 2007, MOL PHYLOGENET EVOL, V42, P422, DOI 10.1016/j.ympev.2006.07.016
   Weathers Wesley W., 1996, P461
   WIERSMA P, 1994, CONDOR, V96, P257, DOI 10.2307/1369313
   Wikelski M, 2003, NATURE, V423, P704, DOI 10.1038/423704a
   Wikelski Martin, 2001, Trends in Ecology and Evolution, V16, P479, DOI 10.1016/S0169-5347(01)02279-0
NR 90
TC 13
Z9 16
U1 0
U2 65
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0174-1578
EI 1432-136X
J9 J COMP PHYSIOL B
JI J. Comp. Physiol. B-Biochem. Syst. Environ. Physiol.
PD OCT
PY 2012
VL 182
IS 7
BP 947
EP 959
DI 10.1007/s00360-012-0671-x
PG 13
WC Physiology; Zoology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology; Zoology
GA 010NY
UT WOS:000309102400007
PM 22573032
DA 2024-02-19
ER

PT J
AU Zois, CE
   Hendriks, AM
   Haider, S
   Pires, E
   Bridges, E
   Kalamida, D
   Voukantsis, D
   Lagerholm, BC
   Fehrmann, RSN
   den Dunnen, WFA
   Tarasov, AI
   Baba, O
   Morris, J
   Buffa, FM
   McCullagh, JSO
   Jalving, M
   Harris, AL
AF Zois, Christos E.
   Hendriks, Anne M.
   Haider, Syed
   Pires, Elisabete
   Bridges, Esther
   Kalamida, Dimitra
   Voukantsis, Dimitrios
   Lagerholm, B. Christoffer
   Fehrmann, Rudolf S. N.
   den Dunnen, Wilfred F. A.
   Tarasov, Andrei I.
   Baba, Otto
   Morris, John
   Buffa, Francesca M.
   McCullagh, James S. O.
   Jalving, Mathilde
   Harris, Adrian L.
TI Liver glycogen phosphorylase is upregulated in glioblastoma and provides
   a metabolic vulnerability to high dose radiation
SO CELL DEATH & DISEASE
LA English
DT Article
ID PENTOSE-PHOSPHATE PATHWAY; MITOCHONDRIAL DYSFUNCTION; CANCER; BRAIN;
   SENESCENCE; IRRADIATION; HALLMARKS; AUTOPHAGY; SURVIVAL; MUSCLE
AB Channelling of glucose via glycogen, known as the glycogen shunt, may play an important role in the metabolism of brain tumours, especially in hypoxic conditions. We aimed to dissect the role of glycogen degradation in glioblastoma (GBM) response to ionising radiation (IR). Knockdown of the glycogen phosphorylase liver isoform (PYGL), but not the brain isoform (PYGB), decreased clonogenic growth and survival of GBM cell lines and sensitised them to IR doses of 10-12 Gy. Two to five days after IR exposure of PYGL knockdown GBM cells, mitotic catastrophy and a giant multinucleated cell morphology with senescence-like phenotype developed. The basal levels of the lysosomal enzyme alpha-acid glucosidase (GAA), essential for autolysosomal glycogen degradation, and the lipidated forms of gamma-aminobutyric acid receptor-associated protein-like (GABARAPL1 and GABARAPL2) increased in shPYGL U87MG cells, suggesting a compensatory mechanism of glycogen degradation. In response to IR, dysregulation of autophagy was shown by accumulation of the p62 and the lipidated form of GABARAPL1 and GABARAPL2 in shPYGL U87MG cells. IR increased the mitochondrial mass and the colocalisation of mitochondria with lysosomes in shPYGL cells, thereby indicating reduced mitophagy. These changes coincided with increased phosphorylation of AMP-activated protein kinase and acetyl-CoA carboxylase 2, slower ATP generation in response to glucose loading and progressive loss of oxidative phosphorylation. The resulting metabolic deficiencies affected the availability of ATP required for mitosis, resulting in the mitotic catastrophy observed in shPYGL cells following IR. PYGL mRNA and protein levels were higher in human GBM than in normal human brain tissues and high PYGL mRNA expression in GBM correlated with poor patient survival. In conclusion, we show a major new role for glycogen metabolism in GBM cancer. Inhibition of glycogen degradation sensitises GBM cells to high-dose IR indicating that PYGL is a potential novel target for the treatment of GBMs.
C1 [Zois, Christos E.; Hendriks, Anne M.; Bridges, Esther; Harris, Adrian L.] Univ Oxford, MRC Weatherall Inst Mol Med, John Radcliffe Hosp, Dept Oncol,Mol Oncol Labs, Oxford, England.
   [Hendriks, Anne M.; Fehrmann, Rudolf S. N.; Jalving, Mathilde] Univ Med Ctr Groningen, Univ Groningen, Dept Med Oncol, Groningen, Netherlands.
   [Haider, Syed] Breast Canc Now Toby Robins Res Ctr, Inst Canc Res, London, England.
   [Pires, Elisabete; McCullagh, James S. O.] Univ Oxford, Dept Chem, Oxford, England.
   [Kalamida, Dimitra] Democritus Univ Thrace, Dept Oncol, Alexandroupolis, Greece.
   [Voukantsis, Dimitrios] Univ Oxford, Dept Oncol, Bioinformat Hub, Oxford, England.
   [Lagerholm, B. Christoffer] Wolfson Imaging Ctr Oxford, MRC Weatherall Inst Mol Med, Oxford, England.
   [den Dunnen, Wilfred F. A.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol, Groningen, Netherlands.
   [Tarasov, Andrei I.] Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England.
   [Tarasov, Andrei I.] Univ Ulster, Sch Biomed Sci, Coleraine, Londonderry, North Ireland.
   [Baba, Otto] Tokushima Univ, Grad Sch, Tokushima, Japan.
   [Morris, John] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England.
   [Buffa, Francesca M.] Univ Oxford, Churchill Hosp, Dept Oncol, Oxford, England.
C3 University of Oxford; University of Groningen; University of London;
   Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust;
   University of Oxford; Democritus University of Thrace; University of
   Oxford; University of Groningen; University of Oxford; Ulster
   University; Tokushima University; University of Oxford; University of
   Oxford
RP Zois, CE; Harris, AL (corresponding author), Univ Oxford, MRC Weatherall Inst Mol Med, John Radcliffe Hosp, Dept Oncol,Mol Oncol Labs, Oxford, England.
EM christos.zois@oncology.ox.ac.uk; adrian.harris@oncology.ox.ac.uk
RI Dunnen, Wilfred FA den/A-4034-2009; Zois, Christos/HKM-9869-2023;
   Harris, Adrian L/ABA-3343-2020; Tarasov, Andrei I/I-6210-2012; Fehrmann,
   Rudolf/E-2551-2011
OI Zois, Christos/0000-0001-5850-5907; Harris, Adrian
   L/0000-0003-1376-8409; Tarasov, Andrei I/0000-0002-8883-176X; Fehrmann,
   Rudolf/0000-0002-7516-315X; den Dunnen, Wilfred/0000-0002-4168-1207;
   Pires, Elisabete/0000-0001-8646-062X
FU Cancer Research UK [C19591/A19076]; Oxford NIHR Biomedical Research
   Centre, Breast Cancer Research Foundation; Kennington Cancer Fund;
   Stichting De Drie Lichten; Willem Meindert de Hoop Stichting; MRC
   [MC_UU_12009, MC_UU_12010]; Wolfson Foundation [18272]; Wellcome Trust
   [Micron 107457/Z/15Z]
FX We thank Professor Wojciech Niedzwiedz for the discussions and technical
   help. We thank Coby Meijer en Natalia Penaranda Fajardo for their
   assistance with conducting and analysing the immunohistochemical stains.
   This research was supported by funding from Cancer Research UK
   (C19591/A19076; D.C.I.G.), Oxford NIHR Biomedical Research Centre,
   Breast Cancer Research Foundation (C.E.Z, A.L.H.), Kennington Cancer
   Fund (A.L.H.), Stichting De Drie Lichten (AMH), Willem Meindert de Hoop
   Stichting (AMH). Spinning disc confocal imaging was carried out in the
   Wolfson Imaging Centre Oxford which was supported by the MRC
   (MC_UU_12009; MC_UU_12010), the Wolfson Foundation (18272), and the
   Wellcome Trust (Micron 107457/Z/15Z).
CR Adeva-Andany MM, 2016, BBA CLIN, V5, P85, DOI 10.1016/j.bbacli.2016.02.001
   Agius L, 2015, MOL ASPECTS MED, V46, P34, DOI 10.1016/j.mam.2015.09.002
   Altemus MA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220973
   Baba O, 1993, Kokubyo Gakkai Zasshi, V60, P264
   Barot S, 2019, EXP CELL RES, V381, P288, DOI 10.1016/j.yexcr.2019.05.017
   Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193
   Berg J, 2009, NAT METHODS, V6, P161, DOI [10.1038/NMETH.1288, 10.1038/nmeth.1288]
   Chen WJ, 2014, JOVE-J VIS EXP, DOI 10.3791/51639
   Correia-Melo C, 2015, BBA-BIOENERGETICS, V1847, P1373, DOI 10.1016/j.bbabio.2015.05.017
   CRERAR MM, 1995, J BIOL CHEM, V270, P13748, DOI 10.1074/jbc.270.23.13748
   Crijns APG, 2009, PLOS MED, V6, P181, DOI 10.1371/journal.pmed.1000024
   Dirkse A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09853-z
   Donnier-Maréchal M, 2016, EXPERT OPIN THER PAT, V26, P199, DOI 10.1517/13543776.2016.1131268
   Favaro E, 2012, CELL METAB, V16, P751, DOI 10.1016/j.cmet.2012.10.017
   Fehrmann RSN, 2015, NAT GENET, V47, P115, DOI 10.1038/ng.3173
   Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013
   Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311
   Heijink DM, 2011, ONCOGENE, V30, P2026, DOI 10.1038/onc.2010.578
   Henke BR, 2006, MINI-REV MED CHEM, V6, P845, DOI 10.2174/138955706777934991
   Henke BR, 2013, RSC DRUG DISCOV, V27, P324, DOI 10.1039/9781849735322-00324
   Jiang SX, 2011, BIOCHEM BIOPH RES CO, V413, P420, DOI 10.1016/j.bbrc.2011.08.106
   Johansen T, 2017, METHOD ENZYMOL, V587, P143, DOI 10.1016/bs.mie.2016.10.023
   Kathagen-Buhmann A, 2016, NEURO-ONCOLOGY, V18, P1219, DOI 10.1093/neuonc/now024
   Kaur E, 2019, CELL ONCOL, V42, P107, DOI 10.1007/s13402-018-0411-7
   Kaur E, 2015, CARCINOGENESIS, V36, P685, DOI 10.1093/carcin/bgv050
   Khan T, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.592455
   Kobak D, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13056-x
   Kotoulas OB, 2004, MICROSC RES TECHNIQ, V64, P10, DOI 10.1002/jemt.20046
   Koukourakis MI, 2018, ANTICANCER RES, V38, P227, DOI 10.21873/anticanres.12212
   Lamark T, 2017, ESSAYS BIOCHEM, V61, P609, DOI 10.1042/EBC20170035
   LOWRY OH, 1967, J BIOL CHEM, V242, P271
   Lukinavicius G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9497
   Maier P, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010102
   Mathieu C, 2017, FEBS J, V284, P546, DOI 10.1111/febs.13937
   Mathieu C, 2016, J BIOL CHEM, V291, P23842, DOI 10.1074/jbc.M116.757062
   Meijer TWH, 2012, CLIN CANCER RES, V18, P5585, DOI 10.1158/1078-0432.CCR-12-0858
   Mirzayans R, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020360
   Moreno-Blas D, 2019, AGING-US, V11, P6175, DOI 10.18632/aging.102181
   Müller MS, 2015, GLIA, V63, P154, DOI 10.1002/glia.22741
   Nadeau OW, 2018, J BIOL CHEM, V293, P7099, DOI 10.1074/jbc.R117.803023
   Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257
   Patra KC, 2014, TRENDS BIOCHEM SCI, V39, P347, DOI 10.1016/j.tibs.2014.06.005
   Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006
   Philips KB, 2014, CANCER CHEMOTH PHARM, V73, P349, DOI 10.1007/s00280-013-2358-8
   Prats C, 2018, J BIOL CHEM, V293, P7089, DOI 10.1074/jbc.R117.802843
   Roach PJ, 2012, BIOCHEM J, V441, P763, DOI 10.1042/BJ20111416
   Shen H, 2015, MOL CANCER THER, V14, P1794, DOI 10.1158/1535-7163.MCT-15-0247
   Shulman RG, 2001, P NATL ACAD SCI USA, V98, P457, DOI 10.1073/pnas.98.2.457
   Shulman RG, 2017, TRENDS CANCER, V3, P761, DOI 10.1016/j.trecan.2017.09.007
   Strickland M, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00043
   Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031
   Tang ZF, 2017, NUCLEIC ACIDS RES, V45, pW98, DOI 10.1093/nar/gkx247
   Tarasov AI, 2018, LAB CHIP, V18, P2838, DOI 10.1039/c8lc00417j
   Tarasov AI, 2014, METHOD ENZYMOL, V542, P289, DOI 10.1016/B978-0-12-416618-9.00015-7
   Team RC, 2020, R: A Language and Environment for Statistical
   Thakkar JP, 2014, CANCER EPIDEM BIOMAR, V23, P1985, DOI 10.1158/1055-9965.EPI-14-0275
   Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848
   Wang Z, 2018, MOL MED REP, V18, P3800, DOI 10.3892/mmr.2018.9388
   Wiley CD, 2016, CELL METAB, V23, P303, DOI 10.1016/j.cmet.2015.11.011
   Xia BN, 2020, TECHNOL CANCER RES T, V19, DOI 10.1177/1533033820926592
   Zannella VE, 2011, RADIOTHER ONCOL, V99, P293, DOI 10.1016/j.radonc.2011.05.049
   Zhang B, 2013, CANCER RES, V73, P6700, DOI 10.1158/0008-5472.CAN-13-1411
   Zhao CY, 2021, FRONT NEUROL, V12, DOI 10.3389/fneur.2021.652931
   Zhao H, 2018, CLIN CHIM ACTA, V484, P298, DOI 10.1016/j.cca.2018.06.014
   Zhou Y, 2019, BIOMED PHARMACOTHER, V120, DOI 10.1016/j.biopha.2019.109449
   Zois CE, 2011, BIOCHEM BIOPH RES CO, V404, P552, DOI 10.1016/j.bbrc.2010.12.024
NR 66
TC 6
Z9 7
U1 1
U2 8
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 2041-4889
J9 CELL DEATH DIS
JI Cell Death Dis.
PD JUN 28
PY 2022
VL 13
IS 6
AR 573
DI 10.1038/s41419-022-05005-2
PG 15
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA 2O4HL
UT WOS:000819021200001
PM 35764612
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Chen, JC
   Astle, CM
   Harrison, DE
AF Chen, JC
   Astle, CM
   Harrison, DE
TI Development and aging of primitive hematopoietic stem cells in BALB cBy
   mice
SO EXPERIMENTAL HEMATOLOGY
LA English
DT Article
DE hematopoietic stem cell; development; aging; BALB mice; competitive
   dilution
ID MURINE BONE-MARROW; DAY-12 CFU-S; LONG-TERM; IN-VIVO; COMPETITIVE
   REPOPULATION; RADIOPROTECTIVE ABILITY; GENETIC-CONTROL; GENOTYPE;
   NUMBERS; TRANSPLANTATION
AB Evaluating the function of an individual hematopoietic stem cell (HSC) is a difficult and important problem, The functional ability per FISC, as well as the HSC concentration, was measured with minimal disruption to the cells in vivo using the new competitive dilution assay. Distribution of HSC into recipients was modeled based on Poisson probabilities. Predictions of donor contributions front models assuming different levels of donor HSC functional ability and concentration were compared to actual observations. The model with the least difference between predictions and observations was accepted. In BALB/cBy (BALB) mice, models assuming equal functional ability of HSC from the same donor fit extremely well with actual observations, suggesting that all HSC are functionally homogeneous at any particular time point during development or aging. Relative HSC functional ability per cell declined during development, so that a fetal HSC had 1.6 to 3.0 times the functional ability of a young adult HSC. The decline continued with age, so that a young adult HSC had 1.6 to 2.0 times the functional ability of an old HSC, Concentrations of HSC that engrafted and functioned were similar among 16-day fetal liver cells and bone marrow cells (BMC) from 3-month and 25 to 28-month-old adult mice. They were either 10 or 4 HSC per million cells when tested in BALE or CByD6F1 recipients, respectively, All HSC were pluripotent and produced lymphoid and myeloid descendants proportionally (r = 0.80 to 0.98, p < 0.01), Fetal and young HSC in both types of recipients maintained clonal stability long term so that percentages of donor cells at 6 and 9 months were strongly correlated (r = 0.72 to 0.93, p < 0.01), Although HSC from aged donors in BALE recipients maintained clonal stability, HSC from the same aged donors failed to show clonal stability in CByB6F1 recipients, perhaps due to the less suitable host environment, All HSC from BALE mice seemed to have equal functional levels at a given stage of life and were gradually exhausted simultaneously through development and aging. (C) 1999 International Society for Experimental Hematology. Published by Elsevier Science Inc.
C1 Jackson Lab, Bar Harbor, ME 04609 USA.
C3 Jackson Laboratory
RP Harrison, DE (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.
FU NHLBI NIH HHS [HL 58820, HL 55281] Funding Source: Medline; NIA NIH HHS
   [AG 05754] Funding Source: Medline
CR deHaan G, 1997, BLOOD, V89, P1543, DOI 10.1182/blood.V89.5.1543.1543_1543_1550
   HARRISON DE, 1993, EXP HEMATOL, V21, P206
   HARRISON DE, 1983, J IMMUNOL, V130, P484
   HARRISON DE, 1983, J EXP MED, V157, P1496, DOI 10.1084/jem.157.5.1496
   HARRISON DE, 1979, MECH AGEING DEV, V9, P427, DOI 10.1016/0047-6374(79)90083-6
   HARRISON DE, 1990, J EXP MED, V172, P431, DOI 10.1084/jem.172.2.431
   Harrison DE, 1997, EXP HEMATOL, V25, P293
   HARRISON DE, 1989, J IMMUNOL, V142, P3833
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   JORDAN CT, 1995, EXP HEMATOL, V23, P1011
   LANSDORP PM, 1993, J EXP MED, V178, P787, DOI 10.1084/jem.178.3.787
   LANSDORP PM, 1995, J CELL SCI, V108, P1
   LANSDORP PM, 1994, BLOOD CELLS, V20, P376
   MICKLEM HS, 1987, EXP HEMATOL, V15, P251
   MICKLEM HS, 1972, J CELL PHYSIOL, V79, P293, DOI 10.1002/jcp.1040790214
   MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X
   Morrison SJ, 1996, IMMUNITY, V5, P207, DOI 10.1016/S1074-7613(00)80316-7
   MORRISON SJ, 1995, P NATL ACAD SCI USA, V92, P10302, DOI 10.1073/pnas.92.22.10302
   Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011
   MullerSieburg CE, 1996, J EXP MED, V183, P1141, DOI 10.1084/jem.183.3.1141
   Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242
   PHILLIPS RL, 1992, P NATL ACAD SCI USA, V89, P11607, DOI 10.1073/pnas.89.23.11607
   PLOEMACHER RE, 1988, EXP HEMATOL, V16, P21
   PLOEMACHER RE, 1988, EXP HEMATOL, V16, P27
   Rebel VI, 1996, BLOOD, V87, P3500, DOI 10.1182/blood.V87.8.3500.bloodjournal8783500
   *SAS I INC, 1998, JMP STAT GRAPH GUID
   SPANGRUDE GJ, 1995, BLOOD, V85, P1006, DOI 10.1182/blood.V85.4.1006.bloodjournal8541006
   SPANGRUDE GJ, 1989, SCIENCE, V244, P1030
   SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810
   *STAFF JACKS LAB, 1997, HDB GEN STAND JAX MI
   VANZANT G, 1991, EXP HEMATOL, V19, P941
   VANZANT G, 1992, EXP HEMATOL, V20, P470
   VANZANT G, 1990, J EXP MED, V171, P1547, DOI 10.1084/jem.171.5.1547
   VanZant G, 1997, EXP HEMATOL, V25, P187
   VISSER JWM, 1984, J EXP MED, V159, P1576, DOI 10.1084/jem.159.6.1576
   Yoder MC, 1997, P NATL ACAD SCI USA, V94, P6776, DOI 10.1073/pnas.94.13.6776
   Zhong RK, 1996, J IMMUNOL, V157, P138
NR 37
TC 80
Z9 82
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA
SN 0301-472X
J9 EXP HEMATOL
JI Exp. Hematol.
PD MAY
PY 1999
VL 27
IS 5
BP 928
EP 935
DI 10.1016/S0301-472X(99)00018-1
PG 8
WC Hematology; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Hematology; Research & Experimental Medicine
GA 196LZ
UT WOS:000080311000018
PM 10340409
OA hybrid
DA 2024-02-19
ER

PT J
AU Sun, S
   Xu, MZ
   Poon, RT
   Day, PJ
   Luk, JM
AF Sun, Stella
   Xu, Michelle Z.
   Poon, Ronnie T.
   Day, Philip J.
   Luk, John M.
TI Circulating Lamin B1 (LMNB1) Biomarker Detects Early Stages of Liver
   Cancer in Patients
SO JOURNAL OF PROTEOME RESEARCH
LA English
DT Article
DE circulating mRNA; early HCC; proteomic profiling; tumor marker
ID HEPATOCELLULAR-CARCINOMA; MESSENGER-RNA; INTESTINE-CADHERIN; PLASMA;
   SERUM; MARKER; CELLS; EXPRESSION; PROTEINS; ASSAY
AB Hepatocellular carcinoma (HCC) is a major liver malignancy possessing a high mortality rate and is particularly prevalent in China and Asia. While surgery is the most effective treatment for liver tumor, about 80% of HCC patients are inoperable at presentation and die early due to late diagnosis. For early cancer detection, we employed a proteomic expression profiling approach to identify biomarkers for early stages of HCC and subsequently assessed the clinical feasibility of a novel marker in plasma. Frozen liver tissues from a retrospective cohort of 75 liver patients (39 HCCs, 20 cirrhosis, and 16 nondiseased subjects) were subjected to proteome-wide expression profiling by 2-DE. MALDI-TOF/TOF was used to identify differentially expressed proteins, which were further confirmed by immunoblotting, qPCR, and immunohistochemistry. Conventional RT-PCR was employed to further analyze the abundance of selected biomarker at mRNA level in a separate cohort of 63 plasma samples (35 HCCs, 16 liver cirrhosis, 12 healthy individuals). We successfully identified lamin B1 (LMNB1) that was significantly upregulated in HCC tumors and present in patients' plasma. LMNB1 functions in nuclear envelope lamina and possesses a transcriptional coregulatory activity having an important role in DNA replication, cellular aging, and stress responses. Clinically, the expression level of lamin B1 correlated positively with tumor stages, tumor sizes, and number of nodules. Our findings further showed elevation of circulating LMNB1 marker in plasma could detect early stages of HCC patients, with 76% sensitivity and 82% specificity. In conclusion, lamin Ell is a clinically useful biomarker for early stages of HCC in tumor tissues and plasma, and warrants further clinical investigation.
C1 [Sun, Stella; Xu, Michelle Z.; Poon, Ronnie T.; Luk, John M.] Univ Hong Kong, LKS Fac Med, Dept Surg, Pokfulam, Hong Kong, Peoples R China.
   [Sun, Stella; Xu, Michelle Z.; Poon, Ronnie T.; Luk, John M.] Univ Hong Kong, LKS Fac Med, Ctr Canc Res, Pokfulam, Hong Kong, Peoples R China.
   [Day, Philip J.] Univ Manchester, Manchester Interdisciplinary Bioctr, Manchester, Lancs, England.
C3 University of Hong Kong; University of Hong Kong; University of
   Manchester
RP Luk, JM (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Clin Res Ctr, Dept Pharmacol, MD11,10 Med Dr, Singapore 117597, Singapore.
EM lukjohn@yahoo.com
RI Luk, John/A-4085-2008
OI Luk, John/0000-0002-6323-7940
FU Research Grants Council of Hong Kong [N_HKU718/03]; Sun C.Y. Research
   Foundation for Hepatobiliary and Pancreatic Surgery
FX we thank the technical Support from the Surgical Tissue Bank staff
   (Jasmine Yu, S. Y. Yik, Noel Kwong) and insightful advice and comments
   by Professor S. T. Fan (Queen Mary Hospital, HK). The work was supported
   by the Research Grants Council of Hong Kong (N_HKU718/03) and Sun C.Y.
   Research Foundation for Hepatobiliary and Pancreatic Surgery.
CR Aravalli RN, 2008, HEPATOLOGY, V48, P2047, DOI 10.1002/hep.22580
   Chan ACY, 2008, ANN SURG, V247, P666, DOI 10.1097/SLA.0b013e31816a747a
   Chen XQ, 2000, CLIN CANCER RES, V6, P3823
   Cheung ST, 2008, TRANSPLANTATION, V85, P81, DOI 10.1097/01.tp.0000298003.88530.11
   Chiarini A, 2008, BBA-MOL CELL RES, V1783, P1642, DOI 10.1016/j.bbamcr.2008.03.014
   Collier J, 1998, HEPATOLOGY, V27, P273, DOI 10.1002/hep.510270140
   Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708
   Dynlacht JR, 2000, RADIAT RES, V154, P515, DOI 10.1667/0033-7587(2000)154[0515:DPODFA]2.0.CO;2
   Fan AC, 2009, NAT MED, V15, P566, DOI 10.1038/nm.1903
   Fiume R, 2009, FASEB J, V23, P957, DOI 10.1096/fj.08-121244
   Goldberg MW, 2008, BIOCHEM SOC T, V36, P1339, DOI 10.1042/BST0361339
   Greene FL., 2002, Liver, VSixth Edition, P131
   Henry L, 2009, GUT, V58, P833, DOI 10.1136/gut.2008.157016
   Ikoma J, 2002, HEPATO-GASTROENTEROL, V49, P235
   Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43
   Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308
   Kopreski MS, 1999, CLIN CANCER RES, V5, P1961
   Lai ECH, 2005, SURG-J R COLL SURG E, V3, P210, DOI 10.1016/S1479-666X(05)80043-5
   Lau WY, 2008, HEPATOB PANCREAT DIS, V7, P237
   Lee NP, 2009, J PROTEOME RES, V8, P1293, DOI 10.1021/pr800637z
   Lee NPY, 2008, PROTEOMICS, V8, P2136, DOI 10.1002/pmic.200700590
   Lim SO, 2002, BIOCHEM BIOPH RES CO, V291, P1031, DOI 10.1006/bbrc.2002.6547
   Luk JM, 2006, PROTEOMICS, V6, P1049, DOI 10.1002/pmic.200500306
   Malhas AN, 2009, J CELL BIOL, V184, P45, DOI 10.1083/jcb.200804155
   Miura N, 2007, ONCOLOGY-BASEL, V72, P45, DOI 10.1159/000111706
   Moisan E, 2006, J LEUKOCYTE BIOL, V79, P489, DOI 10.1189/jlb.0405190
   Mok BW, 1999, FEBS LETT, V453, P243, DOI 10.1016/S0014-5793(99)00714-0
   OKUDA K, 1985, CANCER, V56, P918, DOI 10.1002/1097-0142(19850815)56:4<918::AID-CNCR2820560437>3.0.CO;2-E
   Pang RWC, 2008, ANN SURG ONCOL, V15, P962, DOI 10.1245/s10434-007-9730-z
   Poon Ronnie Tung-Ping, 2004, Liver Transpl, V10, pS39, DOI 10.1002/lt.20040
   Salway F, 2008, INT J EPIDEMIOL, V37, P11, DOI 10.1093/ije/dym279
   Silva JM, 2002, GUT, V50, P530, DOI 10.1136/gut.50.4.530
   Sun S, 2007, LIVER INT, V27, P1021, DOI 10.1111/j.1478-3231.2007.01533.x
   Tang CW, 2008, J CELL SCI, V121, P1014, DOI 10.1242/jcs.020982
   Wang XQ, 2005, CLIN CANCER RES, V11, P483
   Wang YQ, 2004, BIOCHEM BIOPH RES CO, V317, P358, DOI 10.1016/j.bbrc.2004.03.050
   Wong BW, 2003, BIOCHEM BIOPH RES CO, V311, P618, DOI 10.1016/j.bbrc.2003.10.032
   Wong SCC, 2004, CLIN CANCER RES, V10, P1613, DOI 10.1158/1078-0432.CCR-1168-3
   Yi X, 2008, MOL CELL PROTEOMICS, V7, P315, DOI 10.1074/mcp.M700116-MCP200
   Yung TKF, 2009, CLIN CANCER RES, V15, P2076, DOI 10.1158/1078-0432.CCR-08-2622
   Zinkin NT, 2008, CLIN CANCER RES, V14, P470, DOI 10.1158/1078-0432.CCR-07-0586
NR 41
TC 98
Z9 120
U1 0
U2 25
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1535-3893
J9 J PROTEOME RES
JI J. Proteome Res.
PD JAN
PY 2010
VL 9
IS 1
BP 70
EP 78
DI 10.1021/pr9002118
PG 9
WC Biochemical Research Methods
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 539PI
UT WOS:000273267900008
PM 19522540
DA 2024-02-19
ER

PT J
AU Jung, KY
   Dean, D
   Jiang, J
   Gaylor, S
   Griffith, WH
   Burghardt, RC
   Parrish, AR
AF Jung, KY
   Dean, D
   Jiang, J
   Gaylor, S
   Griffith, WH
   Burghardt, RC
   Parrish, AR
TI Loss of N-cadherin and α-catenin in the proximal tubules of aging male
   Fischer 344 rats
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE aging; cadherin; catenins; kidney; rat
ID CELL-ADHESION MOLECULE; DIFFERENTIAL EXPRESSION; EPITHELIAL POLARITY;
   MESSENGER-RNA; MEMBRANE-CYTOSKELETON; KIDNEY NEPHRON; RENAL-FUNCTION;
   KSP-CADHERIN; K+-ATPASE; OLD RATS
AB Aging is associated with a loss of renal reserve, and increased sensitivity to either xenobiotic or physiologic insult. Given the critical role of the cadherin/catenin complex in establishing and maintaining the integrity and polarity of tubular epithelial cells, it was hypothesized that aging was associated with alterations in renal cadherin/catenin complexes. Histological assessment of aged (24 months) kidneys harvested from male Fischer 344 rats demonstrates mild degeneration of proximal tubules, multifocal chronic lymphocytic infiltration, moderate development of protein casts inside tubules, and tubular dilatation or degeneration. Western blot analysis revealed that N-cadherin protein expression is not constant over 24 months. N-cadherin expression increased from 4 to 9 months, with peak levels at 9 and 13 months. A decrease in expression was seen at 19 months and an almost complete loss of expression was seen at 24 months. In contrast, the expression of E- and Ksp-cadherin was constant over 24 months. A loss of alpha-catenin at was seen at 19 and 24 months in the absence of changes in beta-, gamma-, and p120-catenin. This pattern of N-cadherin expression (increase followed by decrease) was confirmed by real-time PCR analysis, which demonstrated a similar pattern as the Western blot, suggesting that the loss of N-cadherin protein was due to decreased gene expression. The loss of N-cadherin was specific for the kidney, as no changes in N-cadherin expression in the liver, brain, or testes were seen during aging. The conclusion that loss of N-cadherin expression is a critical component of the renal dysfunction associated with aging is supported by the finding that caloric restriction attenuates the loss of N-cadherin, as well as the finding that a significant loss of N-cadherin is seen in the kidneys of ZDF x SHHF rats. a genetic model of end-stage renal disease. Cadherin and catenin expression was further analyzed by immunofluorescence. A significant loss of staining of both N-cadherin and alpha-catenin was seen in the proximal tubules of rats at 24 months. Interestingly, this corresponded with delocalization of the alpha-1 subunit of the Na+K+-ATPase, i.e. aberrant staining on cell-cell borders and some indication of apical staining in proximal tubules. Taken together, these data suggest that aging is associated with decreased expression of N-cadherin and alpha-catenin and is associated with a loss of cell polarity. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
C1 Texas A&M Univ, Hlth Sci Ctr, Coll Med, Dept Med Pharmacol & Toxicol, College Stn, TX 77843 USA.
   Texas A&M Univ, Coll Vet Med, Dept Vet Anat & Publ Hlth, College Stn, TX 77843 USA.
C3 Texas A&M University System; Texas A&M University College Station; Texas
   A&M Health Science Center; Texas A&M University System; Texas A&M
   University College Station
RP Parrish, AR (corresponding author), Texas A&M Univ, Hlth Sci Ctr, Coll Med, Dept Med Pharmacol & Toxicol, College Stn, TX 77843 USA.
EM parrish@medicine.tamu.edu
RI Burghardt, Robert Casey/AAF-4847-2021
OI Burghardt, Robert Casey/0000-0003-1021-8444; Parrish,
   Alan/0000-0002-5215-4496
FU NIA NIH HHS [AG21230] Funding Source: Medline; NIEHS NIH HHS [ES09106]
   Funding Source: Medline
CR ABRASS CK, 1995, AM J PATHOL, V146, P742
   Abrass CK, 2000, ADV RENAL REPLACE TH, V7, P4, DOI 10.1016/S1073-4449(00)70001-X
   ANDERSSON AM, 1993, BIOCHEM J, V290, P641, DOI 10.1042/bj2900641
   Ashcroft GS, 1998, LAB INVEST, V78, P47
   BAYLIS C, 1994, J CLIN INVEST, V94, P1823, DOI 10.1172/JCI117531
   Baylis C, 1998, J AM SOC NEPHROL, V9, P699
   BEIERSCHMITT WP, 1986, LIFE SCI, V39, P2335, DOI 10.1016/0024-3205(86)90664-8
   BENGELE HH, 1983, KIDNEY INT, V23, P684, DOI 10.1038/ki.1983.79
   BREZIS M, 1989, NEW ENGL J MED, V320, P179, DOI 10.1056/NEJM198901193200309
   BYERS SW, 1994, ENDOCRINOLOGY, V134, P630, DOI 10.1210/en.134.2.630
   Cho EA, 1998, DEVELOPMENT, V125, P803
   Corman B., 1992, PATHOBIOLOGY AGING R, P195
   Dahl U, 2002, MOL CELL BIOL, V22, P1474, DOI 10.1128/MCB.22.5.1474-1487.2002
   DALSEG AM, 1990, FEBS LETT, V262, P234, DOI 10.1016/0014-5793(90)80198-R
   Epstein M, 1996, J AM SOC NEPHROL, V7, P1106
   FILLIT H, 1992, TXB GERIATRICS GERON, P612
   GAMBERT SR, 1981, ENDOCRINOLOGY, V108, P27, DOI 10.1210/endo-108-1-27
   Goto S, 1998, J AM SOC NEPHROL, V9, P1234
   GOYAL VK, 1982, EXP GERONTOL, V17, P321, DOI 10.1016/0531-5565(82)90032-8
   Johnson KJ, 2002, BIOL REPROD, V66, P992, DOI 10.1095/biolreprod66.4.992
   KINNE RKH, 1988, PEDIATR NEPHROL, V2, P477, DOI 10.1007/BF00853444
   KOBAYASHI H, 1992, NEUROSCIENCE, V48, P237, DOI 10.1016/0306-4522(92)90352-3
   Leussink BT, 2001, TOXICOL APPL PHARM, V175, P54, DOI 10.1006/taap.2001.9228
   Li B, 1997, GENE, V191, P7, DOI 10.1016/S0378-1119(97)00006-1
   LINASK KK, 1992, DEV BIOL, V151, P213, DOI 10.1016/0012-1606(92)90228-9
   LINDEMAN RD, 1985, J AM GERIATR SOC, V33, P278, DOI 10.1111/j.1532-5415.1985.tb07117.x
   LINNEMANN D, 1994, INT J DEV NEUROSCI, V12, P441, DOI 10.1016/0736-5748(94)90028-0
   MARIN R, 1985, BIOCHEM PHARMACOL, V34, P2275, DOI 10.1016/0006-2952(85)90781-6
   MARRS JA, 1993, J CELL BIOL, V123, P149, DOI 10.1083/jcb.123.1.149
   Mays RW, 1995, COLD SPRING HARB SYM, V60, P763, DOI 10.1101/SQB.1995.060.01.082
   Merat S, 2000, J GERONTOL A-BIOL, V55, pB85
   MOLITORIS BA, 1989, J MEMBRANE BIOL, V107, P119, DOI 10.1007/BF01871717
   NATHKE IS, 1993, J CELL SCI, P139
   NOUWEN EJ, 1993, KIDNEY INT, V44, P147, DOI 10.1038/ki.1993.225
   Orme IM, 1998, MECH AGEING DEV, V105, P19, DOI 10.1016/S0047-6374(98)00079-7
   Piepenhagen PA, 1995, AM J PHYSIOL-CELL PH, V269, pC1417, DOI 10.1152/ajpcell.1995.269.6.C1417
   Piepenhagen PA, 1995, AM J PHYSIOL-CELL PH, V269, pC1433, DOI 10.1152/ajpcell.1995.269.6.C1433
   Prozialeck WC, 2003, TOXICOL APPL PHARM, V189, P180, DOI 10.1016/S0041-008X(03)00130-3
   Richardson B, 2003, AGEING RES REV, V2, P245, DOI 10.1016/S1568-1637(03)00010-2
   Shimazui T, 2000, EUR UROL, V38, P331, DOI 10.1159/000020302
   SIMONNEAU L, 1995, CELL ADHES COMMUN, V3, P115, DOI 10.3109/15419069509081281
   SPIEGEL DM, 1989, AM J PHYSIOL, V256, pF430, DOI 10.1152/ajprenal.1989.256.3.F430
   Stern JS, 2001, J NUTR, V131, p913S, DOI 10.1093/jn/131.3.913S
   Thomson RB, 1999, AM J PHYSIOL-RENAL, V277, pF146, DOI 10.1152/ajprenal.1999.277.1.F146
   THOMSON RB, 1995, J BIOL CHEM, V270, P17594, DOI 10.1074/jbc.270.29.17594
   Tofovic SP, 2000, RENAL FAILURE, V22, P387, DOI 10.1081/JDI-100100882
   WAGNER AP, 1992, MECH AGEING DEV, V62, P201, DOI 10.1016/0047-6374(92)90056-J
   Wagner MC, 1999, PEDIATR NEPHROL, V13, P163, DOI 10.1007/s004670050586
   Wertz K, 1999, MECH DEVELOP, V84, P185, DOI 10.1016/S0925-4773(99)00074-X
   YOSHIURA K, 1995, P NATL ACAD SCI USA, V92, P7416, DOI 10.1073/pnas.92.16.7416
   ZAWADA ET, 1997, CURR NEPHRO, V20, P1
NR 51
TC 29
Z9 30
U1 0
U2 5
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD JUN
PY 2004
VL 125
IS 6
BP 445
EP 453
DI 10.1016/j.mad.2004.04.001
PG 9
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 831ND
UT WOS:000222200200006
PM 15178134
DA 2024-02-19
ER

PT J
AU Luo, HM
   Sawashita, J
   Tian, G
   Liu, YY
   Li, L
   Ding, X
   Xu, Z
   Yang, M
   Miyahara, H
   Mori, M
   Qian, JZ
   Wang, YY
   Higuchi, K
AF Luo, Hongmin
   Sawashita, Jinko
   Tian, Geng
   Liu, Yingye
   Li, Lin
   Ding, Xin
   Xu, Zhe
   Yang, Mu
   Miyahara, Hiroki
   Mori, Masayuki
   Qian, Jinze
   Wang, Yaoyong
   Higuchi, Keiichi
TI Extracellular deposition of mouse senile AApoAII amyloid fibrils induced
   different unfolded protein responses in the liver, kidney, and heart
SO LABORATORY INVESTIGATION
LA English
DT Article
ID ENDOPLASMIC-RETICULUM STRESS; APOLIPOPROTEIN-A-II; APOA-II; INBRED
   STRAINS; BETA PEPTIDES; MICE; SENESCENCE; APOPTOSIS; AUTOPHAGY; GENE
AB Mouse senile amyloidosis is a disorder in which apolipoprotein A-II deposits extracellularly in many organs as amyloid fibrils (AApoAII). In this study, we intravenously injected 1 mu g of isolated AApoAII fibrils into R1.P1-Apoa2(c) mice, to induce AApoAII amyloidosis. We observed that the unfolded protein response was induced by deposition of AApoAII amyloid. We found that the mRNA and the protein expression levels of heat shock protein A5 (HSPA5; also known as glucose-regulated protein 78) were increased in the liver with AApoAII amyloid deposits. Immunohistochemistry showed that HSPA5 was only detected in hepatocytes close to AApoAII amyloid deposits. Furthermore, gene transcription of several endoplasmic reticulum (ER) stress-related proteins increased, including eukaryotic translation initiation factor 2 alpha kinase 3 (Eif2ak3), activating transcription factor 6 (Atf6), activating transcription factor 4 (Atf4), X-box-binding protein 1 splicing (Xbp1s), DNA-damage inducible transcript 3 (Ddit3), and autophagy protein 5 (Atg5). Moreover, apoptosis-positive cells were increased in the liver. Similar results were seen in the kidney but not in the heart. Our study indicates that ER stress responses differed among tissues with extracellular AApoAII amyloid fibril deposition. Although upregulated HSPA5 and the activated unfolded protein response might have roles in protecting tissues against aggregated extracellular AApoAII amyloid deposition, prolonged ER stress induced apoptosis in the liver and the kidney.
C1 [Luo, Hongmin; Sawashita, Jinko; Tian, Geng; Liu, Yingye; Li, Lin; Ding, Xin; Xu, Zhe; Yang, Mu; Miyahara, Hiroki; Mori, Masayuki; Qian, Jinze; Wang, Yaoyong; Higuchi, Keiichi] Shinshu Univ, Grad Sch Med, Inst Pathogenesis & Dis Prevent, Dept Aging Biol, Matsumoto, Nagano 3908621, Japan.
   [Luo, Hongmin] Hebei Med Univ, Hosp 3, Shijiazhuang, Peoples R China.
   [Sawashita, Jinko; Higuchi, Keiichi] Shinshu Univ, Interdisciplinary Cluster Cutting Edge Res, Inst Biomed Sci, Dept Biol Sci Intractable Neurol Dis, Matsumoto, Nagano 3908621, Japan.
   [Tian, Geng] Shijiazhuang Obstet & Gynecol Hosp, Shijiazhuang, Peoples R China.
   [Mori, Masayuki] Shinshu Univ, Interdisciplinary Cluster Cutting Edge Res, Inst Biomed Sci, Dept Adv Med Hlth Promot, Matsumoto, Nagano 3908621, Japan.
   [Qian, Jinze] Hebei Med Univ, Dept Pathol, Shijiazhuang, Peoples R China.
C3 Shinshu University; Hebei Medical University; Shinshu University;
   Shinshu University; Hebei Medical University
RP Higuchi, K (corresponding author), Shinshu Univ, Grad Sch Med, Inst Pathogenesis & Dis Prevent, Dept Aging Biol, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.
EM keiichih@shinshu-u.ac.jp
OI Sawashita, Jinko/0000-0001-8016-6649
FU Grants-in-Aid for Scientific Research [25293094, 26670152] Funding
   Source: KAKEN
CR Back SH, 2012, ANNU REV BIOCHEM, V81, P767, DOI 10.1146/annurev-biochem-072909-095555
   Benson MD, 2008, KIDNEY INT, V74, P218, DOI 10.1038/ki.2008.152
   Casas S, 2007, DIABETES, V56, P2284, DOI 10.2337/db07-0178
   Delpino A, 2002, BIOSCIENCE REP, V22, P407, DOI 10.1023/A:1020966008615
   Distelhorst CW, 1996, CELL CALCIUM, V19, P473, DOI 10.1016/S0143-4160(96)90056-1
   Doyle KM, 2011, J CELL MOL MED, V15, P2025, DOI 10.1111/j.1582-4934.2011.01374.x
   Ferreira N, 2012, PLOS ONE, V7, P232, DOI 10.1371/journal.pone.0029933
   Ferreiro E, 2006, NEUROBIOL DIS, V23, P669, DOI 10.1016/j.nbd.2006.05.011
   Flamment M, 2013, M S-MED SCI, V29, P756, DOI 10.1051/medsci/2013298015
   Gavilán MP, 2006, NEUROBIOL AGING, V27, P973, DOI 10.1016/j.neurobiolaging.2005.05.010
   Gorbatyuk MS, 2013, J GENET SYNDR GENE T, V4, P128, DOI [DOI 10.4172/2157-7412.1000128, 10.4172/2157-7412.1000128]
   Groenendyk J, 2010, CIRC RES, V107, P1185, DOI 10.1161/CIRCRESAHA.110.227033
   Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787
   He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910
   Hendershot L, 1996, P NATL ACAD SCI USA, V93, P5269, DOI 10.1073/pnas.93.11.5269
   Higuchi K, 1996, J GERONTOL A-BIOL, V51, pB295, DOI 10.1093/gerona/51A.4.B295
   HIGUCHI K, 1983, LAB INVEST, V48, P231
   HIGUCHI K, 1993, FEBS LETT, V317, P207, DOI 10.1016/0014-5793(93)81277-7
   HIGUCHI K, 1991, BIOCHEM J, V279, P427, DOI 10.1042/bj2790427
   HIGUCHI K, 1995, LAB INVEST, V72, P75
   Higuchi K, 1998, LAB INVEST, V78, P1535
   HIGUCHI K, 1986, J BIOL CHEM, V261, P2834
   Hoozemans JJM, 2005, ACTA NEUROPATHOL, V110, P165, DOI 10.1007/s00401-005-1038-0
   Hoyer-Hansen M, 2007, CELL DEATH DIFFER, V14, P1576, DOI 10.1038/sj.cdd.4402200
   Imaizumi K, 2001, BBA-MOL BASIS DIS, V1536, P85, DOI 10.1016/S0925-4439(01)00049-7
   Inagi R, 2014, NAT REV NEPHROL, V10, P369, DOI 10.1038/nrneph.2014.67
   Inoue K, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-48
   Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7
   Kitagawa K, 2003, AMYLOID, V10, P207, DOI 10.3109/13506120309041737
   KITAGAWA K, 1994, LAB INVEST, V70, P565
   Korenaga T, 2006, AM J PATHOL, V168, P898, DOI 10.2353/ajpath.2006.050350
   Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023
   Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003
   Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010
   Lee do Y, 2010, PLOS ONE, V5
   Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704
   McClellan AJ, 2005, NAT CELL BIOL, V7, P736, DOI 10.1038/ncb0805-736
   Mishra S, 2013, AM J PHYSIOL-HEART C, V305, pH95, DOI 10.1152/ajpheart.00186.2013
   Naidoo N, 2008, J NEUROSCI, V28, P6539, DOI 10.1523/JNEUROSCI.5685-07.2008
   NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8
   Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513
   Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045
   Nijholt DAT, 2011, CELL DEATH DIFFER, V18, P1071, DOI 10.1038/cdd.2010.176
   Nilsson P, 2013, CELL REP, V5, P61, DOI 10.1016/j.celrep.2013.08.042
   Novoa I, 2003, EMBO J, V22, P1180, DOI 10.1093/emboj/cdg112
   Ozcan L, 2012, ANNU REV MED, V63, P317, DOI 10.1146/annurev-med-043010-144749
   Pereira C, 2004, J MOL NEUROSCI, V23, P97, DOI 10.1385/JMN:23:1-2:097
   PRAS M, 1968, J CLIN INVEST, V47, P924
   PRAS M, 1969, J EXP MED, V130, P777, DOI 10.1084/jem.130.4.777
   Rao RV, 2004, CELL DEATH DIFFER, V11, P372, DOI 10.1038/sj.cdd.4401378
   Sipe JD, 2000, J STRUCT BIOL, V130, P88, DOI 10.1006/jsbi.2000.4221
   Sipe JD, 2012, AMYLOID, V19, P167, DOI 10.3109/13506129.2012.734345
   Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779
   Takeda T, 1997, EXP GERONTOL, V32, P117, DOI 10.1016/S0531-5565(96)00068-X
   Teixeira PF, 2006, J BIOL CHEM, V281, P21998, DOI 10.1074/jbc.M602302200
   Viana RJS, 2012, MOL NEUROBIOL, V46, P522, DOI 10.1007/s12035-012-8301-x
   Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108
   Xing YM, 2002, J BIOL CHEM, V277, P33164, DOI 10.1074/jbc.M111570200
   Xing YM, 2001, LAB INVEST, V81, P493, DOI 10.1038/labinvest.3780257
   YONEZU T, 1986, FEBS LETT, V203, P149, DOI 10.1016/0014-5793(86)80732-3
   Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0
   Yu ZF, 1999, EXP NEUROL, V155, P302, DOI 10.1006/exnr.1998.7002
NR 62
TC 9
Z9 10
U1 0
U2 13
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0023-6837
EI 1530-0307
J9 LAB INVEST
JI Lab. Invest.
PD MAR
PY 2015
VL 95
IS 3
BP 320
EP 333
DI 10.1038/labinvest.2014.158
PG 14
WC Medicine, Research & Experimental; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pathology
GA CC4EL
UT WOS:000350303500007
PM 25545477
OA Bronze
DA 2024-02-19
ER

PT J
AU Vanli, G
   Sempoux, C
   Widmann, C
AF Vanli, Guliz
   Sempoux, Christine
   Widmann, Christian
TI The caspase-3/p120 RasGAP stress-sensing module reduces liver cancer
   incidence but does not affect overall survival in gamma-irradiated and
   carcinogen-treated mice
SO MOLECULAR CARCINOGENESIS
LA English
DT Article
DE caspase-3; p120 RasGAP; stress-sensor module; tumorigenesis
ID ONCOGENE-INDUCED SENESCENCE; DNA-REPLICATION STRESS; C-MYC; APOPTOSIS;
   CELLS; CLEAVAGE; SUPPRESSION; METABOLISM; ACTIVATION; CASPASES
AB Activation of oncogenes is the initial step in cellular transformation. Oncogenes favor aberrant proliferation, which, at least initially, induces cellular stress. This oncogenic stress can act as a safeguard mechanism against further transformation by inducing senescence or apoptosis. Yet, the few premalignant cells that tolerate and escape these senescent or apoptotic responses are those that will ultimately generate tumors. The caspase-3/p120 RasGAP module is a stress-sensing device that promotes survival under mild stress conditions. A point mutation in RasGAP that prevents its cleavage by caspase-3 inactivates the pro-survival capacity of the device. When the mice homozygous for this mutation (D455A knock-in mice) are patho-physiologically challenged, they experience much stronger cellular damage than their wild-type counterparts and the affected organs rapidly lose their functionality. We reasoned that the caspase-3/p120 RasGAP module could help premalignant cells to cope with oncogenic stress and hence favor the development of tumors. Using gamma-irradiation and N-ethyl-N-nitrosourea (ENU) as tumor initiators, we assessed the survival advantage that the caspase-3/p120 RasGAP module could provide to premalignant cells. No difference in overall mortality between wild-type and D455A knock-in mice were observed. However, the number of ENU-induced liver tumors in the knock-in mice was higher than in control mice. These results indicate that the caspase-3/p120 RasGAP stress-sensing module impacts on carcinogen-induced liver cancer incidence but not sufficiently so as to affect overall survival. Hence, gamma irradiation and ENU-induced tumorigenesis processes do not critically rely on a survival mechanism that contributes to the maintenance of organ homeostasis in stressed healthy tissues.
C1 [Vanli, Guliz; Widmann, Christian] Univ Lausanne, Dept Physiol, Lausanne, Switzerland.
   [Sempoux, Christine] Univ Lausanne, Inst Pathol, Lausanne, Switzerland.
C3 University of Lausanne; University of Lausanne
RP Widmann, C (corresponding author), Quartier UNIL CHUV, Dept Physiol, Rue Bugnon 7, CH-1005 Lausanne, Switzerland.
EM christian.widmannn@unil.ch
RI Widmann, Christian/N-9851-2013
OI Widmann, Christian/0000-0002-6881-0363; Sempoux,
   Christine/0000-0003-1375-3979
FU Swiss National Science Foundation [31003A_160181/1, 31003A_141242/1];
   Swiss National Science Foundation (SNF) [31003A_160181, 31003A_141242]
   Funding Source: Swiss National Science Foundation (SNF)
FX Swiss National Science Foundation, Grant numbers: 31003A_160181/1,
   31003A_141242/1
CR Annibaldi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029024
   Bai L, 2005, AM J PATHOL, V166, P1523, DOI 10.1016/S0002-9440(10)62368-1
   Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268
   Cheng ZX, 2013, CLIN CANCER RES, V19, P1748, DOI 10.1158/1078-0432.CCR-12-3066
   Cheon DJ, 2011, ANNU REV PATHOL-MECH, V6, P95, DOI 10.1146/annurev.pathol.3.121806.154244
   Dang CV, 1999, MOL CELL BIOL, V19, P1
   Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327
   Eil R, 2016, NATURE, V537, P539, DOI 10.1038/nature19364
   Ferenc B, 2009, IN VIVO, V23, P591
   Fero ML, 1998, NATURE, V396, P177, DOI 10.1038/24179
   Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485
   Guicciardi ME, 2013, COMPR PHYSIOL, V3, P977, DOI 10.1002/cphy.c120020
   Gurley KE, 2015, COLD SPRING HARB PRO, V2015
   Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735
   Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9
   Hoffman B, 2008, ONCOGENE, V27, P6462, DOI 10.1038/onc.2008.312
   Hotti A, 2000, ONCOGENE, V19, P2354, DOI 10.1038/sj.onc.1203567
   Ichim G, 2016, NAT REV CANCER, V16, P539, DOI 10.1038/nrc.2016.58
   Jones RM, 2013, ONCOGENE, V32, P3744, DOI 10.1038/onc.2012.387
   Khalil H, 2014, TRENDS CELL BIOL, V24, P83, DOI 10.1016/j.tcb.2013.08.002
   Khalil H, 2012, MOL CELL BIOL, V32, P4523, DOI 10.1128/MCB.00774-12
   Labi V, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.20
   Li B, 2013, CLIN CANCER RES, V19, P5835, DOI 10.1158/1078-0432.CCR-12-3629
   LOQUET C, 1982, CARCINOGENESIS, V3, P1213, DOI 10.1093/carcin/3.10.1213
   Luo J, 2009, CELL, V138, P807, DOI 10.1016/j.cell.2009.08.006
   Maya-Mendoza A, 2015, MOL ONCOL, V9, P601, DOI 10.1016/j.molonc.2014.11.001
   Pierce RH, 2002, AM J PATHOL, V160, P1555, DOI 10.1016/S0002-9440(10)61101-7
   Prendergast GC, 1999, ONCOGENE, V18, P2967, DOI 10.1038/sj.onc.1202727
   Qiu W, 2011, HEPATOLOGY, V54, P1249, DOI 10.1002/hep.24516
   Sasaki YF, 1997, MUTAT RES-GEN TOX EN, V388, P33, DOI 10.1016/S1383-5718(96)00133-7
   Scaiewicz V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081065
   Srinivasan SV, 2013, CELL REP, V3, P1629, DOI 10.1016/j.celrep.2013.04.002
   TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234
   Tsujiguchi T, 2016, J RADIAT RES, V57, P35, DOI 10.1093/jrr/rrv071
   Wade MA, 2015, ONCOGENE, V34, P4985, DOI 10.1038/onc.2014.427
   Yang JY, 2004, MOL CELL BIOL, V24, P10425, DOI 10.1128/MCB.24.23.10425-10436.2004
   Yang JY, 2002, J BIOL CHEM, V277, P14641, DOI 10.1074/jbc.M111540200
   Yang JY, 2001, MOL CELL BIOL, V21, P5346, DOI 10.1128/MCB.21.16.5346-5358.2001
   Yu CS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155211
NR 39
TC 3
Z9 3
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0899-1987
EI 1098-2744
J9 MOL CARCINOGEN
JI Mol. Carcinog.
PD JUN
PY 2017
VL 56
IS 6
BP 1680
EP 1684
DI 10.1002/mc.22624
PG 5
WC Biochemistry & Molecular Biology; Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Oncology
GA EY1BW
UT WOS:000403698200014
PM 28150874
DA 2024-02-19
ER

PT J
AU Tang, YT
   Xiong, K
   Shen, M
   Mu, YL
   Li, K
   Liu, HL
AF Tang, Yiting
   Xiong, Kai
   Shen, Ming
   Mu, Yulian
   Li, Kui
   Liu, Honglin
TI CCAAT-enhancer binding protein (C/EBP) β regulates insulin-like growth
   factor (IGF) 1 expression in porcine liver during prenatal and postnatal
   development
SO MOLECULAR AND CELLULAR BIOCHEMISTRY
LA English
DT Article
DE C/EBP beta; IGF1; Liver; Transcription factor; Porcine
ID FACTOR-I IGF-1; GENE-EXPRESSION; GRANULOSA-CELLS; HUMAN LONGEVITY;
   MESSENGER-RNA; PHOSPHORYLATION; MUTATIONS; HORMONES; ALPHA; MICE
AB IGF1 expression regulation attracts numerous interests because of its important role during mammalian growth and development. Domestic pig can be used as a valuable animal model to investigate human development since they share the high similarity in general physiology and metabolism. In this study, we examined the expression pattern of IGF1 and found it associated with liver C/EBP beta expression pattern in porcine liver during embryonic and postnatal development. Both IGF1 and C/EBP beta expression in liver maintained at low levels before birth and increased after birth. Correspondingly, C/EBP beta demonstrated high binding activity to two sites at IGF1 promoter region in liver after birth. Additionally, IGF1 expression can be activated by C/EBP beta overexpression in porcine primary hepatocytes. These results indicated that C/EBP beta can activate IGF1 expression after birth by binding to IGF1 promoter. Our study may contribute to a better understanding of mammalian development and bring a novel anti-aging pathway in human.
C1 [Tang, Yiting; Xiong, Kai; Shen, Ming; Liu, Honglin] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing 210095, Jiangsu, Peoples R China.
   [Tang, Yiting; Mu, Yulian; Li, Kui] Chinese Acad Agr Sci, Inst Anim Sci, Dept Gene & Cell Engn, Beijing 100094, Peoples R China.
   [Xiong, Kai] Univ Copenhagen, Dept Vet Clin & Anim Sci, DK-1870 Frederiksberg C, Denmark.
C3 Nanjing Agricultural University; Chinese Academy of Agricultural
   Sciences; Institute of Animal Science, CAAS; University of Copenhagen
RP Liu, HL (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing 210095, Jiangsu, Peoples R China.
EM yaobo12@sina.com; kai.xiong@sund.ku.dk; sm870221@qq.com;
   muyulian76@iascaas.net.cn; likui@caas.cn; liuhonglinnjau@163.com
RI liu, honglin/HDN-0409-2022
OI liu, honglin/0000-0002-1254-3163; Xiong, Kai/0000-0001-8045-0252
FU National Natural Science Foundation of China [31472073]; Cultivating New
   Varieties by Transgenic Technology [2012ZX08006-003]; China Scholarship
   Council
FX This study was supported by Grants from the following Projects: Study on
   the regulation of IGF1 gene in pig liver (National Natural Science
   Foundation of China 31472073 2015-2019); Cultivating New Varieties by
   Transgenic Technology (#2012ZX08006-003); and China Scholarship Council.
CR Annunziata M, 2011, ACTA DIABETOL, V48, P1, DOI 10.1007/s00592-010-0227-z
   ARGENTE J, 1993, J CLIN ENDOCR METAB, V77, P1522, DOI 10.1210/jc.77.6.1522
   BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O
   Bartke A, 2011, PHILOS T R SOC B, V366, P28, DOI 10.1098/rstb.2010.0281
   Barzilai N, 2009, J GERONTOL A-BIOL, V64, P187, DOI 10.1093/gerona/gln061
   Cesi V, 2005, EXP CELL RES, V305, P179, DOI 10.1016/j.yexcr.2004.12.015
   Christoforidis Athanasios, 2005, Pediatr Endocrinol Rev, V3, P5
   Clemmons David R., 1997, Cytokine and Growth Factor Reviews, V8, P45, DOI 10.1016/S1359-6101(96)00053-6
   Guevara-Aguirre J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001845
   Harries LW, 2012, AGING CELL, V11, P262, DOI 10.1111/j.1474-9726.2011.00782.x
   Hemati N, 1997, J BIOL CHEM, V272, P25913, DOI 10.1074/jbc.272.41.25913
   HINEY JK, 1991, NEUROENDOCRINOLOGY, V54, P420, DOI 10.1159/000125924
   JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3
   Joung YH, 2007, BIOCHEM BIOPH RES CO, V358, P733, DOI 10.1016/j.bbrc.2007.04.201
   Kitanaka Sachiko, 2008, Expert Rev Endocrinol Metab, V3, P441, DOI 10.1586/17446651.3.4.441
   Kovács KA, 2003, J BIOL CHEM, V278, P36959, DOI 10.1074/jbc.M303147200
   Laron Z, 1998, EUR J ENDOCRINOL, V138, P176, DOI 10.1530/eje.0.1380176
   LaVoie HA, 2010, BIOL REPROD, P185
   LaVoie HA, 2010, BIOL REPROD, V83, P1015, DOI 10.1095/biolreprod.110.085969
   [李发弟 Li Fadi], 2003, [南京农业大学学报, Journal of Nanjing Agricultural University], V26, P117
   Li S, 2011, CANCER METAST BIOL T, V16, P233, DOI 10.1007/978-94-007-0292-9_9
   LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4
   Loughna PT, 1992, S SOC EXPT BIOL, P319
   MIURA Y, 1992, BRIT J NUTR, V67, P257, DOI 10.1079/BJN19920029
   Ohlsson C, 2009, ENDOCR REV, V30, P494, DOI 10.1210/er.2009-0010
   Pan ZX, 2012, ASIAN AUSTRAL J ANIM, V25, P903, DOI 10.5713/ajas.2011.11385
   Pawlikowska L, 2009, AGING CELL, V8, P460, DOI 10.1111/j.1474-9726.2009.00493.x
   Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/bj20020508
   Rosenbloom AL, 2007, CURR OPIN PEDIATR, V19, P458, DOI 10.1097/MOP.0b013e3282094126
   Ruffell D, 2009, P NATL ACAD SCI USA, V106, P17475, DOI 10.1073/pnas.0908641106
   Sjögren K, 1999, P NATL ACAD SCI USA, V96, P7088, DOI 10.1073/pnas.96.12.7088
   Staiger J, 2009, CARCINOGENESIS, V30, P832, DOI 10.1093/carcin/bgn273
   Suh Y, 2008, P NATL ACAD SCI USA, V105, P3438, DOI 10.1073/pnas.0705467105
   TANNENBAUM GS, 1983, SCIENCE, V220, P77, DOI 10.1126/science.6338593
   Umayahara Y, 2002, J BIOL CHEM, V277, P15261, DOI 10.1074/jbc.M110827200
   van Heemst D, 2005, AGING CELL, V4, P79, DOI 10.1111/j.1474-9728.2005.00148.x
   Vaught J, 2008, GROWTH FACTORS DRUGS, V777, P18
   Wessells J, 2004, MOL CELL BIOL, V24, P3238, DOI 10.1128/MCB.24.8.3238-3250.2004
   Wolfrum C, 2003, P NATL ACAD SCI USA, V100, P11624, DOI 10.1073/pnas.1931483100
NR 39
TC 13
Z9 14
U1 0
U2 10
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0300-8177
EI 1573-4919
J9 MOL CELL BIOCHEM
JI Mol. Cell. Biochem.
PD MAR
PY 2015
VL 401
IS 1-2
BP 209
EP 218
DI 10.1007/s11010-014-2308-8
PG 10
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA CF8YU
UT WOS:000352848900021
PM 25543525
DA 2024-02-19
ER

PT J
AU Yang, ZJ
   Zhang, L
   Ma, AH
   Liu, LL
   Li, JJ
   Gu, JR
   Liu, YZ
AF Yang, Zhaojuan
   Zhang, Li
   Ma, Aihui
   Liu, Lanlan
   Li, Jinjun
   Gu, Jianren
   Liu, Yongzhong
TI Transient mTOR Inhibition Facilitates Continuous Growth of Liver Tumors
   by Modulating the Maintenance of CD133+Cell Populations
SO PLOS ONE
LA English
DT Article
ID CANCER STEM-CELLS; MAMMALIAN TARGET; HEPATOCELLULAR-CARCINOMA;
   EPIGENETIC REGULATION; CELLULAR SENESCENCE; HUMAN GLIOBLASTOMA;
   COLORECTAL-CANCER; PANCREATIC-CANCER; 1A-DEFICIENT MICE; INITIATING
   CELLS
AB The mammalian target of the rapamycin (mTOR) pathway, which drives cell proliferation, is frequently hyperactivated in a variety of malignancies. Therefore, the inhibition of the mTOR pathway has been considered as an appropriate approach for cancer therapy. In this study, we examined the roles of mTOR in the maintenance and differentiation of cancer stem-like cells (CSCs), the conversion of conventional cancer cells to CSCs and continuous tumor growth in vivo. In H-Ras-transformed mouse liver tumor cells, we found that pharmacological inhibition of mTOR with rapamycin greatly increased not only the CD133+ populations both in vitro and in vivo but also the expression of stem cell-like genes. Enhancing mTOR activity by over-expressing Rheb significantly decreased CD133 expression, whereas knockdown of the mTOR yielded an opposite effect. In addition, mTOR inhibition severely blocked the differentiation of CD133+ to CD133-liver tumor cells. Strikingly, single-cell culture experiments revealed that CD133- liver tumor cells were capable of converting to CD133+ cells and the inhibition of mTOR signaling substantially promoted this conversion. In serial implantation of tumor xenografts in nude BALB/c mice, the residual tumor cells that were exposed to rapamycin in vivo displayed higher CD133 expression and had increased secondary tumorigenicity compared with the control group. Moreover, rapamycin treatment also enhanced the level of stem cell-associated genes and CD133 expression in certain human liver tumor cell lines, such as Huh7, PLC/PRC/7 and Hep3B. The mTOR pathway is significantly involved in the generation and the differentiation of tumorigenic liver CSCs. These results may be valuable for the design of more rational strategies to control clinical malignant HCC using mTOR inhibitors.
C1 [Yang, Zhaojuan; Zhang, Li; Ma, Aihui; Liu, Lanlan; Li, Jinjun; Gu, Jianren; Liu, Yongzhong] Shanghai Jiao Tong Univ, State Key Lab Oncogenes & Related Genes, Sch Med, Renji Hosp,Shanghai Canc Inst, Shanghai 200030, Peoples R China.
   [Liu, Lanlan] Jinan Univ, Inst Reprod Immunol, Guangzhou, Guangdong, Peoples R China.
C3 Shanghai Jiao Tong University; Jinan University
RP Yang, ZJ (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Oncogenes & Related Genes, Sch Med, Renji Hosp,Shanghai Canc Inst, Shanghai 200030, Peoples R China.
EM liuyzg@yahoo.com
FU Ministry of Health of China [2008ZX10002-022]
FX This work was supported by grants from the Ministry of Health of China
   (2008ZX10002-022). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Anido J, 2010, CANCER CELL, V18, P655, DOI 10.1016/j.ccr.2010.10.023
   Baba T, 2009, ONCOGENE, V28, P209, DOI 10.1038/onc.2008.374
   Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236
   Campbell TB, 2009, BLOOD, V114, P3392, DOI 10.1182/blood-2008-12-195214
   Castilho RM, 2009, CELL STEM CELL, V5, P279, DOI 10.1016/j.stem.2009.06.017
   Chang CJ, 2011, CANCER CELL, V19, P86, DOI 10.1016/j.ccr.2010.10.035
   Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297
   Curtin JC, 2010, ONCOTARGET, V1, P563, DOI 10.18632/oncotarget.191
   Demidenko ZN, 2009, CELL CYCLE, V8, P1896, DOI 10.4161/cc.8.12.8809
   Demidenko ZN, 2009, CELL CYCLE, V8, P1888, DOI 10.4161/cc.8.12.8606
   Ding W, 2009, HEPATOLOGY, V49, P1277, DOI 10.1002/hep.22743
   Dubrovska A, 2009, P NATL ACAD SCI USA, V106, P268, DOI 10.1073/pnas.0810956106
   Dudkin L, 2001, CLIN CANCER RES, V7, P1758
   Easley CA, 2010, CELL REPROGRAM, V12, P263, DOI 10.1089/cell.2010.0011
   Easton JB, 2006, ONCOGENE, V25, P6436, DOI 10.1038/sj.onc.1209886
   Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X
   Horst D, 2008, BRIT J CANCER, V99, P1285, DOI 10.1038/sj.bjc.6604664
   Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002
   Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494
   Javle MM, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-368
   Kemper K, 2010, ONCOTARGET, V1, P387, DOI 10.18632/oncotarget.173
   Kenerson HL, 2002, CANCER RES, V62, P5645
   Korkaya H, 2008, ONCOGENE, V27, P6120, DOI 10.1038/onc.2008.207
   Korotchkina LG, 2010, AGING-US, V2, P344, DOI 10.18632/aging.100160
   Lee TKW, 2011, CELL STEM CELL, V9, P50, DOI 10.1016/j.stem.2011.06.005
   Liu L, 2006, ONCOGENE, V25, P7029, DOI 10.1038/sj.onc.1209691
   Liu SL, 2010, J CLIN ONCOL, V28, P4006, DOI 10.1200/JCO.2009.27.5388
   Lu ZH, 2010, CANCER RES, V70, P3287, DOI 10.1158/0008-5472.CAN-09-3467
   Ma S, 2008, ONCOGENE, V27, P1749, DOI 10.1038/sj.onc.1210811
   Ma S, 2007, GASTROENTEROLOGY, V132, P2542, DOI 10.1053/j.gastro.2007.04.025
   Ma S, 2010, CELL STEM CELL, V7, P694, DOI 10.1016/j.stem.2010.11.010
   Majumder PK, 2004, NAT MED, V10, P594, DOI 10.1038/nm1052
   Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027
   Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009
   Matsumoto K, 2009, CANCER RES, V69, P7160, DOI 10.1158/0008-5472.CAN-09-1289
   McCord AM, 2009, MOL CANCER RES, V7, P489, DOI 10.1158/1541-7786.MCR-08-0360
   Miki J, 2007, CANCER RES, V67, P3153, DOI 10.1158/0008-5472.CAN-06-4429
   Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888
   Naka K, 2010, NATURE, V463, P676, DOI 10.1038/nature08734
   Nardella C, 2008, GENE DEV, V22, P2172, DOI 10.1101/gad.1699608
   Platet N, 2007, CANCER LETT, V258, P286, DOI 10.1016/j.canlet.2007.09.012
   Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384
   Rountree CB, 2008, HEPATOLOGY, V47, P1288, DOI 10.1002/hep.22141
   Rountree CB, 2007, STEM CELLS, V25, P2419, DOI 10.1634/stemcells.2007-0176
   Rountree CB, 2009, STEM CELLS, V27, P290, DOI 10.1634/stemcells.2008-0332
   Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974
   Sansal I, 2004, J CLIN ONCOL, V22, P2954, DOI 10.1200/jco.2004.02.141
   Schewe DM, 2008, P NATL ACAD SCI USA, V105, P10519, DOI 10.1073/pnas.0800939105
   Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869
   Soeda A, 2009, ONCOGENE, V28, P3949, DOI 10.1038/onc.2009.252
   Song W, 2008, INT J CLIN PRACT, V62, P1212, DOI 10.1111/j.1742-1241.2008.01777.x
   Sunayama J, 2010, STEM CELLS, V28, P1930, DOI 10.1002/stem.521
   Tee AR, 2005, FEBS LETT, V579, P4763, DOI 10.1016/j.febslet.2005.07.054
   Vignot S, 2005, ANN ONCOL, V16, P525, DOI 10.1093/annonc/mdi113
   Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839
   Wolpin BM, 2009, J CLIN ONCOL, V27, P193, DOI 10.1200/JCO.2008.18.9514
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
   Yin SY, 2007, INT J CANCER, V120, P1444, DOI 10.1002/ijc.22476
   You HN, 2010, HEPATOLOGY, V51, P1635, DOI 10.1002/hep.23544
   Zender L, 2005, COLD SH Q B, V70, P251, DOI 10.1101/sqb.2005.70.059
   Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030
   Zhou JB, 2007, P NATL ACAD SCI USA, V104, P16158, DOI 10.1073/pnas.0702596104
NR 62
TC 35
Z9 40
U1 0
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 1
PY 2011
VL 6
IS 12
AR e28405
DI 10.1371/journal.pone.0028405
PG 13
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 863MQ
UT WOS:000298168900025
PM 22145042
OA gold, Green Published, Green Submitted
DA 2024-02-19
ER

PT J
AU Lopez-Lopez, V
   Martínez-Caceres, C
   Ferreras, D
   De La Peña-Moral, J
   De La Cruz, J
   Royo-Villanova, M
   Rodríguez, JM
   Fernández-Hernández, JA
   Zambudio, AR
   Pons, JA
   Martínez-Barba, E
   Sánchez-Bueno, F
   Campos, RR
   Ramírez, P
AF Lopez-Lopez, Victor
   Martinez-Caceres, Carlos
   Ferreras, David
   De La Pena-Moral, Jesus
   De La Cruz, Juan
   Royo-Villanova, Mario
   Manuel Rodriguez, Jose
   Angel Fernandez-Hernandez, Juan
   Rios Zambudio, Antonio
   Antonio Pons, Jose
   Martinez-Barba, Enrique
   Sanchez-Bueno, Francisco
   Campos, Ricardo Robles
   Ramirez, Pablo
TI Biomarkers of Early Liver Graft Damage in Circulatory Death and Brain
   Death Donors: A Propensity Score Matching Analysis
SO TRANSPLANTATION PROCEEDINGS
LA English
DT Article; Early Access
ID DONATION; OUTCOMES; METAANALYSIS
AB Background. Donation after circulatory death (DCD) is related to a warm ischemia time and more complications compared with traditional donors (donation after brain death [DBD]).
   Methods. This study included biopsy samples retrospectively collected from November 2014 to December 2018 to compare histologic and biological markers of DCD and DBD liver grafts. The analysis includes marker of early apoptosis (p21), senescence (telomerase reverse transcriptase [TERT]), cell damage (caspase-3 active), endothelial damage (vascular endothelial growth factor), stem cell (CD90), hypoxia (HIF1A), inflammatory activation (COX-2), and cross-organ allograft rejection (CD44). A propensity score matching (PSM) was used to match patients receiving DCD livers to those receiving DBD livers. We analyzed the immunohistochemical initial liver damage-related warm ischemia time.
   Results. Positive staining expression of liver damage biomarkers (COX-2, CD44, TERT, HIF1A, and CD90) was found, but no significant differences were found between DCD and DBD and with ischemic cholangiopathy. After PSM, there was a significant relationship between CD90 and male donors (odds ratio [OR], 0.26; 95% confidence interval [CI], 0.07-0.91), TERT with donor sodium (OR, 1.11; 95% CI, 1.02-1.2), HIF1A with steatosis (OR, 0.33; 95% CI, 0.13-0.83), and CD44 with donor vasoactive drugs (OR, 0.36; 95% CI, 0.13-1) and glutamic oxaloacetic transaminase 1 week increase (OR, 1.01; 95% CI, 1-1.03).
   Conclusions. DCD immunohistochemical initial liver damage was found to behave similarly to DBD. The increase in complications and cholangiopathy associated with warm ischemia could be related to a different later phenomenon.
C1 [Lopez-Lopez, Victor; Ferreras, David; Manuel Rodriguez, Jose; Angel Fernandez-Hernandez, Juan; Rios Zambudio, Antonio; Sanchez-Bueno, Francisco; Campos, Ricardo Robles; Ramirez, Pablo] Virgen de la Arrixaca Univ Hosp, Dept Surg, Biomed Res Inst Murcia Virgen da La Arrixaca IMIB, Ctra Madrid Cartagena, Murcia 30120, Spain.
   [Martinez-Caceres, Carlos] IMIB Arrixaca, Invest Support Platforms, Murcia, Spain.
   [De La Pena-Moral, Jesus; Martinez-Barba, Enrique] IMIB, Dept Pathol, Virgen de la Arrixaca Univ Hosp, Murcia, Spain.
   [De La Cruz, Juan] Univ Murcia, Fac Comp Sci, Grp Appl Math Sci & Engn, Murcia, Spain.
   [Royo-Villanova, Mario] Hosp Clin Univ Virgen de la Arrixaca, Intens Care Unit, Murcia, Spain.
   [Antonio Pons, Jose] Hosp Clin Univ Virgen de la Arrixaca, Dept Hepatol, Murcia, Spain.
C3 Hospital Clinico Universitario Virgen de la Arrixaca; Hospital Clinico
   Universitario Virgen de la Arrixaca; Hospital Clinico Universitario
   Virgen de la Arrixaca; University of Murcia; Hospital Clinico
   Universitario Virgen de la Arrixaca; Hospital Clinico Universitario
   Virgen de la Arrixaca
RP Lopez-Lopez, V (corresponding author), Virgen de la Arrixaca Univ Hosp, Dept Surg, Biomed Res Inst Murcia Virgen da La Arrixaca IMIB, Ctra Madrid Cartagena, Murcia 30120, Spain.
EM victorrelopez@gmail.com
RI Miñano, Jose Antonio Pons/S-4644-2019; Rios, Antonio/L-3870-2017
OI Miñano, Jose Antonio Pons/0000-0001-5017-7240; Rios,
   Antonio/0000-0001-5512-9010; Royo-Villanova Reparaz,
   Mario/0000-0002-2898-2312
CR Cascales-Campos PA, 2020, AM J TRANSPLANT, V20, P204, DOI 10.1111/ajt.15537
   Coffey JC., 2017, CLIN TRANSPLANT, P31
   Doyle MBM, 2015, J AM COLL SURGEONS, V221, P142, DOI 10.1016/j.jamcollsurg.2015.03.053
   Dubbeld J, 2010, BRIT J SURG, V97, P744, DOI 10.1002/bjs.7043
   Guo YJ, 2015, TRANSPLANT REV-ORLAN, V29, P127, DOI 10.1016/j.trre.2015.05.001
   Han J, 2019, J CELL BIOCHEM, V120, P14735, DOI 10.1002/jcb.28734
   Hirota Kiichi, 2015, Cardiovascular & Hematological Disorders - Drug Targets, V15, P29
   Jassem W, 2003, TRANSPLANTATION, V75, P1386, DOI 10.1097/01.TP.0000062863.06782.89
   Kalisvaart M, 2017, ANN SURG, V266, P772, DOI 10.1097/SLA.0000000000002419
   Maeno H, 2005, LIVER INT, V25, P1002, DOI 10.1111/j.1478-3231.2005.01144.x
   Monbaliu D, 2008, LIVER TRANSPLANT, V14, P1256, DOI 10.1002/lt.21513
   O'Neill S, 2014, TRANSPL INT, V27, P1159, DOI 10.1111/tri.12403
   Reich DJ, 2009, AM J TRANSPLANT, V9, P2004, DOI 10.1111/j.1600-6143.2009.02739.x
   Rhee JY, 2011, AM J TRANSPLANT, V11, P1169, DOI 10.1111/j.1600-6143.2011.03567.x
   Schön MR, 1998, TRANSPLANT P, V30, P2318, DOI 10.1016/S0041-1345(98)00638-1
NR 15
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0041-1345
EI 1873-2623
J9 TRANSPL P
JI Transplant. Proc.
PD 2021 NOV
PY 2021
VL 53
IS 9
BP 2659
EP 2662
DI 10.1016/j.transproceed.2021.07.055
EA NOV 2021
PG 4
WC Immunology; Surgery; Transplantation
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology; Surgery; Transplantation
GA YZ3PH
UT WOS:000755390700004
PM 34602295
DA 2024-02-19
ER

PT J
AU Bello, RI
   Gómez-Díaz, C
   Burón, MI
   Alcaín, FJ
   Navas, P
   Villalba, JM
AF Bello, RI
   Gómez-Díaz, C
   Burón, MI
   Alcaín, FJ
   Navas, P
   Villalba, JM
TI Enhanced anti-oxidant protection of liver membranes in long-lived rats
   fed on a coenzyme Q<sub>10</sub>-suplemented diet
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE aging; cellular membranes; glutathione-S-transferase; NQO1;
   oxidative-stress; PUFA; ubiquinone
ID MICROSOMAL GLUTATHIONE TRANSFERASE; OXIDATIVE STRESS HYPOTHESIS;
   DOUBLE-STRAND-BREAKS; AGE-RELATED-CHANGES; PLASMA-MEMBRANE; LIFE-SPAN;
   LIPID-PEROXIDATION; FATTY-ACIDS; TISSUE CONCENTRATIONS; DEPENDENT
   PROTECTION
AB Coenzyme Q(10) supplementation increases life-span of rats fed on a diet enriched with polyunsaturated fatty acids (Quiles, J.L., Ochoa, J.J., Huertas, J.R., Mataix, J., 2004b. Coenzyme Q supplementation protects from age-related DNA double-strand breaks and increased lifespan in rats fed on a PUFA-rich diet. Exp. Gerontol. 39, 189-194). Our study was set as a first attempt to establish a mechanistic link between life span extension and CoQ(10) supplementation. When rats were fed on a PUFAn - 6 plus CoQ(10) diet, levels of CoQjo were increased in plasma membrane at every time point compared to control rats fed on a PUFAn-6-alone diet. Ratios of CoQ(9) to CoQ(10) were significantly lower at every time point in both liver plasma membranes and homogenates of CoQ(10)-supplemented animals. CoQjo supplementation did not affect cytosolic NAD(P)H:quinone oxidoreductase 1 (NQO1), which increased significantly with aging, but plasma membrane-bound NQO1 decreased significantly in the CoQ(10)-supplemented group at 12 months, when maximal incorporation of exogenous CoQ(10) was observed. Neither aging nor the diet affected NADH-cytochrome b(5) reductase levels. Glutathione-dependent anti-oxidant activities such as cytosolic glutathione-S-transferase (GST) and microsomal Se-independent glutathione peroxidase decreased with aging and supplementation with CoQ(10) attenuated this decay. 2,2' Azobis amidinopropane (AAPH)-induced oxidation of membranes was significantly higher in aged rats, and supplementation with CoQ(10) also inhibited this increase. Consistent with higher CoQ(10) levels and enhanced anti-oxidant protection, plasma membrane Mg2+ -dependent neutral sphingomyelinase was inhibited by dietary CoQ(10)n aged rats. Our results support the involvement of thiol-dependent mechanisms in the potentiation of the anti-oxidant capacity of membranes in CoQ(10)- supplemented rats, further supporting the potentially beneficial anti-oxidative role of dietary CoQjo during aging. The possibility that a decreased CoQ(9)/CoQ(10) ratio in animals fed on the PUFAn-6-rich plus CoQ(10) diet could also influence longevity is also discussed. (c) 2005 Elsevier Inc. All rights reserved.
C1 Univ Cordoba, Fac Ciencias, Dept Biol Celular Fision & Inmunol, Cordoba 14014, Spain.
   Univ Pablo de Olavide, CSIC, CABD, Seville, Spain.
C3 Universidad de Cordoba; Consejo Superior de Investigaciones Cientificas
   (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for
   Developmental Biology (CABD)
RP Villalba, JM (corresponding author), Univ Cordoba, Fac Ciencias, Dept Biol Celular Fision & Inmunol, Campus Rabanales,Edif Severo Ochoa,3a Planta, Cordoba 14014, Spain.
EM bc1vimoj@uco.es
RI Alcain, Francisco J./N-7503-2016; NAVAS, PLACIDO/R-5943-2019
OI Alcain, Francisco J./0000-0002-6833-7940; NAVAS,
   PLACIDO/0000-0002-4115-7966; Villalba Montoro, Jose
   Manuel/0000-0001-8554-3802
CR Anisimov VN, 2001, EXP GERONTOL, V36, P1101, DOI 10.1016/S0531-5565(01)00114-0
   Arroyo A, 1998, PROTOPLASMA, V205, P107, DOI 10.1007/BF01279300
   Barja G, 2000, FASEB J, V14, P312, DOI 10.1096/fasebj.14.2.312
   Barja G, 2004, TRENDS NEUROSCI, V27, P595, DOI 10.1016/j.tins.2004.07.005
   BARJA G, 2002, FREE RADIC BIOL MED, V33, P575
   Bello RI, 2003, J BIOENERG BIOMEMBR, V35, P169, DOI 10.1023/A:1023702321148
   Beyer RE, 1996, P NATL ACAD SCI USA, V93, P2528, DOI 10.1073/pnas.93.6.2528
   BURON MI, 1987, EPITHELIA, V1, P295
   Collin P, 2001, BONE, V28, P9, DOI 10.1016/S8756-3282(00)00435-X
   Dallner G, 2000, FREE RADICAL BIO MED, V29, P285, DOI 10.1016/S0891-5849(00)00307-5
   De Cabo R, 2004, EXP GERONTOL, V39, P297, DOI 10.1016/j.exger.2003.12.003
   Diniz YS, 2004, NUTRITION, V20, P230, DOI 10.1016/j.nut.2003.10.012
   ERNSTER L, 1995, BBA-MOL BASIS DIS, V1271, P195, DOI 10.1016/0925-4439(95)00028-3
   ERNSTER L, 1984, BIOMEDICAL CLIN ASPE, V4, P3
   Finkel T, 2003, NATURE, V425, P132, DOI 10.1038/425132a
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   Gómez-Díaz C, 2003, PROTOPLASMA, V221, P11, DOI 10.1007/s00709-002-0067-y
   GUO ZY, 1993, GROWTH DEVELOP AGING, V57, P85
   HABIG WH, 1974, J BIOL CHEM, V249, P7130
   Harman D, 2003, ANTIOXID REDOX SIGN, V5, P557, DOI 10.1089/152308603770310202
   Hayashi T, 1998, MECH AGEING DEV, V100, P231, DOI 10.1016/S0047-6374(97)00149-8
   Horvath TL, 2003, ENDOCRINOLOGY, V144, P2757, DOI 10.1210/en.2003-0163
   Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960
   JIANG ZY, 1991, LIPIDS, V26, P853, DOI 10.1007/BF02536169
   Kamzalov S, 2004, EXP GERONTOL, V39, P1199, DOI 10.1016/j.exger.2004.04.007
   Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682
   Kwong LK, 2002, FREE RADICAL BIO MED, V33, P627, DOI 10.1016/S0891-5849(02)00916-4
   Lass A, 1999, FREE RADICAL BIO MED, V27, P220, DOI 10.1016/S0891-5849(99)00085-4
   Lass A, 1999, FREE RADICAL BIO MED, V26, P1375, DOI 10.1016/S0891-5849(98)00330-X
   Lass A, 1997, J BIOL CHEM, V272, P19199, DOI 10.1074/jbc.272.31.19199
   Li DY, 2004, BIOCHEM BIOPH RES CO, V318, P253, DOI 10.1016/j.bbrc.2004.04.022
   Lightle SA, 2000, MECH AGEING DEV, V120, P111, DOI 10.1016/S0047-6374(00)00191-3
   LIND C, 1990, METHOD ENZYMOL, V186, P287
   Liu B, 1997, SEMIN CELL DEV BIOL, V8, P311, DOI 10.1006/scdb.1997.0153
   Lönnrot K, 1998, BIOCHEM MOL BIOL INT, V44, P727
   Martín SF, 2002, BIOCHEM BIOPH RES CO, V297, P581, DOI 10.1016/S0006-291X(02)02222-2
   Martín SF, 2001, J BIOENERG BIOMEMBR, V33, P143, DOI 10.1023/A:1010704715979
   Mataix J, 1998, FREE RADICAL BIO MED, V24, P511, DOI 10.1016/S0891-5849(97)00288-8
   MOSIALOU E, 1989, ARCH BIOCHEM BIOPHYS, V275, P289, DOI 10.1016/0003-9861(89)90375-5
   MOSIALOU E, 1993, BIOCHEM PHARMACOL, V45, P1645, DOI 10.1016/0006-2952(93)90305-G
   Navarro F, 1998, FASEB J, V12, P1665, DOI 10.1096/fasebj.12.15.1665
   NAVARRO F, 1995, BIOCHEM BIOPH RES CO, V212, P138, DOI 10.1006/bbrc.1995.1947
   Navas P, 2004, METHOD ENZYMOL, V378, P200
   Ochoa JJ, 2003, J BIOENERG BIOMEMBR, V35, P267, DOI 10.1023/A:1024615816839
   PETKOVA DH, 1988, EXP GERONTOL, V23, P19, DOI 10.1016/0531-5565(88)90016-2
   Plewka A, 1998, MECH AGEING DEV, V105, P197, DOI 10.1016/S0047-6374(98)00086-4
   Quiles JL, 2004, EXP GERONTOL, V39, P1189, DOI 10.1016/j.exger.2004.05.002
   Quiles JL, 2004, EXP GERONTOL, V39, P189, DOI 10.1016/j.exger.2003.10.002
   Quiles JL, 2001, J BIOENERG BIOMEMBR, V33, P127, DOI 10.1023/A:1010700515071
   Ramsey JJ, 2005, COMP BIOCHEM PHYS B, V140, P99, DOI 10.1016/j.cbpc.2004.09.016
   REDDY CC, 1981, BIOCHEM BIOPH RES CO, V101, P970
   SCHLAGER JJ, 1993, CANCER RES, V53, P1338
   SCHRINER SE, 2005, SCIENCE
   Sies H., 1994, NATURAL ANTIOXIDANTS, P107
   Sohal RS, 2002, FREE RADICAL BIO MED, V33, P573, DOI 10.1016/S0891-5849(02)00885-7
   Sohal RS, 2002, FREE RADICAL BIO MED, V33, P575, DOI 10.1016/S0891-5849(02)00886-9
   SPEARMAN ME, 1984, BIOCHEM PHARMACOL, V33, P1309, DOI 10.1016/0006-2952(84)90185-0
   STOSCHECK CM, 1990, METHOD ENZYMOL, V182, P50
   Thomas RP, 2002, J GASTROINTEST SURG, V6, P445, DOI 10.1016/S1091-255X(01)00010-5
   Troen BR, 2003, MT SINAI J MED, V70, P3
   Turunen M, 2004, BBA-BIOMEMBRANES, V1660, P171, DOI 10.1016/j.bbamem.2003.11.012
   VILLALBA JM, 1993, J BIOENERG BIOMEMBR, V25, P411, DOI 10.1007/BF00762467
   Villalba JM, 2000, ANTIOXID REDOX SIGN, V2, P213, DOI 10.1089/ars.2000.2.2-213
   WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
   Yang YS, 2002, TOXICOL APPL PHARM, V182, P105, DOI 10.1006/taap.2002.9450
NR 66
TC 42
Z9 43
U1 1
U2 4
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD AUG-SEP
PY 2005
VL 40
IS 8-9
BP 694
EP 706
DI 10.1016/j.exger.2005.07.003
PG 13
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 970SO
UT WOS:000232330100009
PM 16125350
DA 2024-02-19
ER

PT J
AU Danielsson, J
   Kangastupa, P
   Laatikainen, T
   Aalto, M
   Niemelä, O
AF Danielsson, Joanna
   Kangastupa, Paivikki
   Laatikainen, Tiina
   Aalto, Mauri
   Niemela, Onni
TI Impacts of common factors of life style on serum liver enzymes
SO WORLD JOURNAL OF GASTROENTEROLOGY
LA English
DT Article
DE Alcohol; Obesity; Aging; Smoking; Liver enzymes; Oxidative stress
ID GAMMA-GLUTAMYL-TRANSFERASE; UNITED-STATES POPULATION; ALANINE
   AMINOTRANSFERASE; REFERENCE INTERVALS; BODY-WEIGHT;
   CARDIOVASCULAR-DISEASE; ALCOHOL-CONSUMPTION; OXIDATIVE STRESS; COFFEE
   CONSUMPTION; GGT ACTIVITY
AB AIM: To investigate the impacts of gender, age and factors of life style (alcohol, overweight, coffee and smoking) on serum liver enzymes.
   METHODS: Serum alanine aminotransferase (ALT) and gamma-glutamyltransferase (GGT) were measured from 6269 apparently healthy individuals (2851 men, 3418 women, mean age 45 +/- 12 years, range 25-74 years) in a national cross-sectional health survey. All subjects underwent detailed clinical examinations and interviews including the amount and pattern of alcohol use, coffee consumption and smoking habits.
   RESULTS: In this population with a mean +/- SD alcohol consumption of 65 +/- 105 g/wk and body mass index (BMI) of 26.1 +/- 4.3 kg/m(2), both ALT and GGT were significantly influenced by alcohol use (P < 0.001) and BMI (P < 0.001), whereas smoking increased only GGT (P < 0.001). A significant effect of age on ALT was seen in men (P < 0.001) whereas not in women. Significant two-factor interactions of alcohol use in men were observed with age (ALT: P < 0.01; GGT: P < 0.001) and BMI (GGT: P < 0.05). For ALT, a significant interaction also occurred between BMI and age (P < 0.005). In contrast, women showed significant interactions of alcohol use with BMI (GGT: P < 0.05), smoking (GGT: P < 0.001), and coffee consumption (GGT: P < 0.001).
   CONCLUSION: Life-style associated changes in liver enzymes may reflect health risks, which should be considered in the definition of normal limits for liver enzymes. (C) 2014 Baishideng Publishing Group Inc. All rights reserved.
C1 [Danielsson, Joanna; Kangastupa, Paivikki; Niemela, Onni] Seinajoki Cent Hosp, Dept Lab Med, Seinajoki 60220, Finland.
   [Danielsson, Joanna; Kangastupa, Paivikki; Niemela, Onni] Univ Tampere, Seinajoki 60220, Finland.
   [Danielsson, Joanna; Kangastupa, Paivikki; Niemela, Onni] Seinajoki Cent Hosp, Med Res Unit, Seinajoki 60220, Finland.
   [Laatikainen, Tiina; Aalto, Mauri] Natl Inst Hlth & Welf THL, Helsinki 00271, Finland.
   [Laatikainen, Tiina] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio 70211, Finland.
   [Laatikainen, Tiina] Hosp Dist North Karelia, Joensuu 80210, Finland.
C3 Seinajoki Central Hospital; Seinajoki Central Hospital; Finland National
   Institute for Health & Welfare; University of Eastern Finland
RP Niemelä, O (corresponding author), Seinajoki Cent Hosp, Dept Lab Med, Hanneksenrinne 7, Seinajoki 60220, Finland.
EM onni.niemela@epshp.fi
RI Laatikainen, Tiina/ABD-6622-2021; Kangastupa, Päivikki/JZZ-0468-2024
OI Laatikainen, Tiina/0000-0002-6614-4782; Kangastupa,
   Päivikki/0000-0003-0695-6073; Aalto, Mauri/0000-0003-3424-3767
FU Competitive State Research Financing of the Expert Responsibility area
   of Seinajoki Central Hospital and University of Tampere [VTR110]
FX Supported by Competitive State Research Financing of the Expert
   Responsibility area of Seinajoki Central Hospital and University of
   Tampere, VTR110
CR Alatalo PI, 2008, AM J CLIN NUTR, V88, P1097, DOI 10.1093/ajcn/88.4.1097
   Alatalo P, 2010, SCAND J CLIN LAB INV, V70, P104, DOI 10.3109/00365510903548818
   Blachier M, 2013, J HEPATOL, V58, P593, DOI 10.1016/j.jhep.2012.12.005
   Breitling LP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027951
   Breitling LP, 2009, HEPATOLOGY, V49, P802, DOI 10.1002/hep.22727
   Carmiel-Haggai M, 2003, GASTROENTEROLOGY, V125, P1818, DOI 10.1053/j.gastro.2003.09.019
   Conway B, 2004, Obes Rev, V5, P145, DOI 10.1111/j.1467-789X.2004.00144.x
   Danielsson J, 2013, INT J MOL SCI, V14, P11929, DOI 10.3390/ijms140611929
   Danielsson J, 2013, ALCOHOL ALCOHOLISM, V48, P303, DOI 10.1093/alcalc/agt017
   Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2
   Dufi'y J.C., 1992, J OFF STAT, V8, P327
   Emdin M, 2005, CIRCULATION, V112, P2078, DOI 10.1161/CIRCULATIONAHA.105.571919
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   Floegel A, 2012, AM J CLIN NUTR, V95, P901, DOI 10.3945/ajcn.111.023648
   Fontana L, 2013, HEPATOLOGY, V57, P995, DOI 10.1002/hep.26099
   Fraser A, 2009, DIABETES CARE, V32, P741, DOI 10.2337/dc08-1870
   Freedman ND, 2012, NEW ENGL J MED, V366, P1891, DOI 10.1056/NEJMoa1112010
   Ghouri N, 2010, HEPATOLOGY, V52, P1156, DOI 10.1002/hep.23789
   Halsted C H, 1999, Curr Opin Clin Nutr Metab Care, V2, P425, DOI 10.1097/00075197-199909000-00012
   Kazemi-Shirazi L, 2007, CLIN CHEM, V53, P940, DOI 10.1373/clinchem.2006.081620
   Kim HC, 2004, BMJ-BRIT MED J, V328, P983, DOI 10.1136/bmj.38050.593634.63
   Kim WR, 2008, HEPATOLOGY, V47, P1363, DOI 10.1002/hep.22109
   Korner J, 2003, J CLIN INVEST, V111, P565, DOI [10.1172/JCI200317953, 10.1172/JCI17953]
   Kozakova M, 2012, HEPATOLOGY, V55, P1406, DOI 10.1002/hep.25555
   LANCA AJ, 1991, HEPATOLOGY, V14, P857, DOI 10.1002/hep.1840140518
   Lawlor DA, 2005, AM J EPIDEMIOL, V161, P1081, DOI 10.1093/aje/kwi125
   Lee DH, 2006, AM J EPIDEMIOL, V163, P57, DOI 10.1093/aje/kwj006
   Lee DH, 2003, CLIN CHEM, V49, P1358, DOI 10.1373/49.8.1358
   Lee DH, 2006, EUR HEART J, V27, P2170, DOI 10.1093/eurheartj/ehl086
   Lee DH, 2009, EUR J CARDIOV PREV R, V16, P16, DOI 10.1097/HJR.0b013e32830aba5c
   Lee TH, 2008, HEPATOLOGY, V47, P880, DOI 10.1002/hep.22090
   LEINO A, 1995, SCAND J CLIN LAB INV, V55, P243, DOI 10.3109/00365519509089619
   Leon DA, 2006, LANCET, V367, P52, DOI 10.1016/S0140-6736(06)67924-5
   Loomba R, 2009, ALIMENT PHARM THER, V30, P1137, DOI 10.1111/j.1365-2036.2009.04141.x
   Montonen J, 2011, DIABETOLOGIA, V54, P1676, DOI 10.1007/s00125-011-2124-6
   Moore AA, 2006, J AM GERIATR SOC, V54, P757, DOI 10.1111/j.1532-5415.2006.00728.x
   Puukka K, 2006, ALCOHOL ALCOHOLISM, V41, P522, DOI 10.1093/alcalc/agl052
   Room R, 2005, LANCET, V365, P519, DOI 10.1016/S0140-6736(05)70276-2
   Ruhl CE, 2005, CLIN GASTROENTEROL H, V3, P1260, DOI 10.1016/S1542-3565(05)00743-3
   Ruhl CE, 2012, HEPATOLOGY, V55, P447, DOI 10.1002/hep.24725
   Rustad P, 2004, SCAND J CLIN LAB INV, V64, P271, DOI 10.1080/00365510410006324
   Ruttmann E, 2005, CIRCULATION, V112, P2130, DOI 10.1161/CIRCULATIONAHA.105.552547
   Söderberg C, 2010, HEPATOLOGY, V51, P595, DOI 10.1002/hep.23314
   SPEISKY H, 1990, HEPATOLOGY, V11, P843, DOI 10.1002/hep.1840110520
   Stromme JH, 2004, SCAND J CLIN LAB INV, V64, P371, DOI 10.1080/00365510410002742
   Sturgill MG, 1997, CLIN CHEM, V43, P1512
   Targher G, 2007, DIABETES CARE, V30, P2119, DOI 10.2337/dc07-0349
   Tsai J, 2012, J BEHAV MED, V35, P200, DOI 10.1007/s10865-011-9353-5
   TSUKAMOTO H, 1995, J CLIN INVEST, V96, P620, DOI 10.1172/JCI118077
   Vartiainen E, 2010, INT J EPIDEMIOL, V39, P504, DOI 10.1093/ije/dyp330
   Yokoyama A, 2013, ALCOHOL CLIN EXP RES, V37, P1123, DOI 10.1111/acer.12069
   Yu ZB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051949
   Zhang HQ, 2009, AM J RESP CELL MOL, V41, P509, DOI 10.1165/rcmb.2009-0169TR
   1988, J CLIN EPIDEMIOL, V41, P105
NR 54
TC 28
Z9 29
U1 0
U2 5
PU BAISHIDENG PUBLISHING GROUP INC
PI PLEASANTON
PA 8226 REGENCY DR, PLEASANTON, CA 94588 USA
SN 1007-9327
EI 2219-2840
J9 WORLD J GASTROENTERO
JI World J. Gastroenterol.
PD SEP 7
PY 2014
VL 20
IS 33
BP 11743
EP 11752
DI 10.3748/wjg.v20.i33.11743
PG 10
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA AO9ZA
UT WOS:000341718600024
PM 25206278
OA hybrid, Green Published
DA 2024-02-19
ER

PT J
AU Coricovac, D
   Soica, C
   Muntean, D
   Popovici, RA
   Dehelean, CA
   Hogea, E
AF Coricovac, Dorina
   Soica, Codruta
   Muntean, Danina
   Popovici, Ramona Amina
   Dehelean, Cristina A.
   Hogea, Elena
TI Assessment of the Effects Induced by Two Triterpenoids on Liver
   Mitochondria Respiratory Function Isolated from Aged Rats
SO REVISTA DE CHIMIE
LA English
DT Article
DE betulin; betulinic acid; GCDG; mitochondria; aging
ID BETULINIC ACID; CHORIOALLANTOIC MEMBRANE; NATURAL-PRODUCT; COMPLEX;
   PROLIFERATION; NANOEMULSION; FORMULATION; APOPTOSIS; BCL-2
AB Betulin and betulinic acid are natural compounds widely distributed in the plant kingdom, known to exhibit multiple biological activities, including: antitumoral, anti-inflammatory, antiangiogenic, anti-HIV, immunomodulatory and hepatoprotective. The aim of this study was to evaluate the effects of betulin and betulinic acid formulated as complexes with cyclodextrins on mitochondrial respiration using mitochondria isolated from the liver of aged rats. The mitochondria were isolated by the differential centrifugation technique and the oxygen consumption studies were measured using a Clark-type electrode. The respiratory parameters evaluated were basal respiration (State 2), active respiration (State 3) and the respiration control ratio (RCR).
C1 [Coricovac, Dorina; Dehelean, Cristina A.] Victor Babes Univ Med & Pharm Timisoara, Dept Toxicol, Fac Pharm, Timisoara 300041, Romania.
   [Soica, Codruta] Victor Babes Univ Med & Pharm Timisoara, Dept Pharmaceut Chem, Fac Pharm, Timisoara 300041, Romania.
   [Muntean, Danina] Victor Babes Univ Med & Pharm Timisoara, Dept Pathophysiol, Timisoara 300041, Romania.
   [Popovici, Ramona Amina] Victor Babes Univ Med & Pharm Timisoara, Fac Med Dent, Timisoara 300041, Romania.
   [Hogea, Elena] Victor Babes Univ Med & Pharm Timisoara, Fac Med, Timisoara 300041, Romania.
C3 Victor Babes University of Medicine & Pharmacy, Timisoara; Victor Babes
   University of Medicine & Pharmacy, Timisoara; Victor Babes University of
   Medicine & Pharmacy, Timisoara; Victor Babes University of Medicine &
   Pharmacy, Timisoara; Victor Babes University of Medicine & Pharmacy,
   Timisoara
RP Popovici, RA (corresponding author), Victor Babes Univ Med & Pharm Timisoara, Fac Med Dent, 2 Eftimie Murgu Sq, Timisoara 300041, Romania.
EM ramona.popovici@umft.ro
RI MUNTEAN, Danina M./G-3138-2016; Soica, Codruta/C-2585-2011
OI MUNTEAN, Danina M./0000-0001-6186-5321; 
FU postdoctoral fellowship POSDRU [159/1.5/S/136893 - DocMed.Net_2.0]
FX Research supported by the postdoctoral fellowship POSDRU no.
   159/1.5/S/136893 - DocMed.Net_2.0.
CR Alakurtti S, 2006, EUR J PHARM SCI, V29, P1, DOI 10.1016/j.ejps.2006.04.006
   Bonomini F, 2015, AGING DIS, V6, P109, DOI 10.14336/AD.2014.0305
   Citu IM, 2015, FARMACIA, V63, P99
   Dehelean CA, 2013, J BIOMED NANOTECHNOL, V9, P577, DOI 10.1166/jbn.2013.1563
   Dehelean CA, 2011, J BIOMED NANOTECHNOL, V7, P317, DOI 10.1166/jbn.2011.1297
   Duicu O, 2014, REV CHIM-BUCHAREST, V65, P956
   Fulda S, 2009, MOL NUTR FOOD RES, V53, P140, DOI 10.1002/mnfr.200700491
   Gheorgheosu D, 2014, ANTI-CANCER AGENT ME, V14, P936, DOI 10.2174/1871520614666140223192148
   KERTI V, 2012, B UASMV VET MED, V69, P101
   Krol SK, 2015, BIOMED RES INT-UK, V2015, DOI 10.1155/2015/584189
   Oh SH, 2006, TOXICOLOGY, V220, P1, DOI 10.1016/j.tox.2005.08.025
   Poulose N, 2014, AGING DIS, V5, P101, DOI 10.14336/AD.2014.0500101
   Rzeski W, 2006, N-S ARCH PHARMACOL, V374, P11, DOI 10.1007/s00210-006-0090-1
   Sersté T, 2006, ACTA GASTRO-ENT BELG, V69, P296
   Serviddio G, 2007, REDOX REP, V12, P91, DOI 10.1179/135100007X162112
   Shikov AN, 2011, PHYTOMEDICINE, V18, P807, DOI 10.1016/j.phymed.2011.01.021
   Soica C, 2014, INT J MOL SCI, V15, P8235, DOI 10.3390/ijms15058235
   Soica C, 2012, INT J MOL SCI, V13, P14992, DOI 10.3390/ijms131114992
   Szuster-Ciesielska A., 2010, JPCCR, V4, P96
   Trumbeckaite S, 2009, PHARMACOL REP, V61, P859, DOI 10.1016/S1734-1140(09)70142-2
   Ventura B, 2002, BBA-BIOENERGETICS, V1553, P249, DOI 10.1016/S0005-2728(01)00246-8
   Wang HM, 2012, NAT PROD COMMUN, V7, P289
   Zheng ZW, 2011, J PHARM PHARMACOL, V63, P572, DOI 10.1111/j.2042-7158.2010.01239.x
   Zuco V, 2002, CANCER LETT, V175, P17, DOI 10.1016/S0304-3835(01)00718-2
NR 24
TC 10
Z9 10
U1 1
U2 6
PU CHIMINFORM DATA S A
PI BUCHAREST
PA CALEA PLEVNEI NR 139, SECTOR 6, BUCHAREST R-77131, ROMANIA
SN 0034-7752
J9 REV CHIM-BUCHAREST
JI Rev. Chim.
PD OCT
PY 2015
VL 66
IS 10
BP 1707
EP 1710
PG 4
WC Chemistry, Multidisciplinary; Engineering, Chemical
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry; Engineering
GA DB3UB
UT WOS:000368436300034
DA 2024-02-19
ER

PT J
AU Maalouf, NM
   Zhang, S
   Drechsler, H
   Brown, GR
   Tebas, P
   Bedimo, R
AF Maalouf, Naim M.
   Zhang, Song
   Drechsler, Henning
   Brown, Geri R.
   Tebas, Pablo
   Bedimo, Roger
TI Hepatitis C Co-infection and Severity of Liver Disease as Risk Factors
   for Osteoporotic Fractures Among HIV-Infected Patients
SO JOURNAL OF BONE AND MINERAL RESEARCH
LA English
DT Article
DE CIRRHOSIS; FRACTURE; HIV; HEPATITIS C; OSTEOPOROSIS
ID BONE-MINERAL DENSITY; ENDOTHELIAL DYSFUNCTION; VIRUS-INFECTION;
   FIBROSIS; CIRRHOSIS; COHORT; INDEX; POPULATION; PREVALENCE; VALIDATION
AB Osteoporosis is increasingly reported in the aging HIV-positive population, and co-infection with hepatitis C virus (HCV) may further increase the risk of osteoporosis. However, it remains unclear whether HCV-related increased fracture risk is a function of the severity of liver disease. We calculated the time-updated alanine aminotransferase to platelet ratio index (APRI) score (an indirect marker of hepatic fibrosis) in all HIV-infected patients enrolled in the Veterans Affairs' Clinical Case Registry between 1984 and 2009. The association between HCV co-infection and incident osteoporotic fracture (defined as closed wrist, vertebral, or hip fracture) was assessed in univariate and multivariate Cox survival models adjusting for traditional risk factors for osteoporosis and APRI score or the presence of cirrhosis. A total of 772 osteoporotic fractures were identified among 56,660 HIV-infected patients (98.1% male; 31.3% HCV co-infected; median age 44.0 years) contributing 305,237 patient-years of follow-up. Fracture rates were significantly higher among HIV/HCV patients than HIV-only patients (2.57 versus 2.07/1000 patient-years, relative risk=1.24, p<0.0001). In a Cox multivariable model including age, race, smoking, drug use, body mass index, and antiretroviral therapy, HCV co-infection remained an independent predictor of osteoporotic fractures after controlling for presence of cirrhosis (hazard ratio [HR]=1.32; p<0.001) or APRI score (HR=1.30; p=0.003). Among HIV/HCV co-infected patients, cirrhosis strongly predicted osteoporotic fractures (HR=1.65; 95% confidence interval [CI] 1.11-2.44; p=0.012), but APRI score was a weaker predictor (HR=1.008; 95% CI 1.002-1.014; p=0.015). In conclusion, among HIV-infected patients, severity of liver disease partly explains the HCV-associated increased risk of osteoporotic fractures. Other determinants of this increased risk remain to be defined. (c) 2013 American Society for Bone and Mineral Research.
C1 [Maalouf, Naim M.; Zhang, Song; Drechsler, Henning; Brown, Geri R.; Bedimo, Roger] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA.
   [Drechsler, Henning; Brown, Geri R.; Bedimo, Roger] VA North Texas Hlth Care Syst, Dallas, TX USA.
   [Tebas, Pablo] Univ Penn, Philadelphia, PA 19104 USA.
C3 University of Texas System; University of Texas Southwestern Medical
   Center Dallas; US Department of Veterans Affairs; Veterans Health
   Administration (VHA); VA North Texas Health Care System; University of
   Pennsylvania
RP Maalouf, NM (corresponding author), 5323 Harry Hines Blvd, Dallas, TX 75390 USA.
EM Naim.Maalouf@UTSouthwestern.edu
RI Zhang, Song/IXD-2243-2023; Tebas, Pablo/A-7061-2008
OI Zhang, Song/0000-0002-3855-2113; Tebas, Pablo/0000-0001-5345-7942
FU Veterans Administration [I01 CX000418-01A1]
FX The study was funded by Veterans Administration Merit Grant I01
   CX000418-01A1.
CR Al-Mohri H, 2005, HIV MED, V6, P375, DOI 10.1111/j.1468-1293.2005.00330.x
   Amiel C, 2004, J BONE MINER RES, V19, P402, DOI 10.1359/JBMR.0301246
   Arase Y, 2010, J MED VIROL, V82, P390, DOI 10.1002/jmv.21691
   Bambha K, 2012, AIDS, V26, P599, DOI 10.1097/QAD.0b013e32834fa121
   Bedimo R, 2012, AIDS, V26, P825, DOI 10.1097/QAD.0b013e32835192ae
   Brown TT, 2006, AIDS, V20, P2165, DOI 10.1097/QAD.0b013e32801022eb
   Campillo B, 2006, GASTROEN CLIN BIOL, V30, P1137, DOI 10.1016/S0399-8320(06)73491-1
   Collin F, 2009, AIDS, V23, P1021, DOI 10.1097/QAD.0b013e3283292195
   de Larrañaga GF, 2006, EUR J CLIN MICROBIOL, V25, P98, DOI 10.1007/s10096-006-0090-6
   Di Martino V, 2001, HEPATOLOGY, V34, P1193, DOI 10.1053/jhep.2001.29201
   El-Maouche D, 2011, J HEPATOL, V55, P770, DOI 10.1016/j.jhep.2011.01.035
   de Castro IF, 2010, AIDS, V24, P2059, DOI 10.1097/QAD.0b013e32833ce54d
   Giordano TP, 2004, ARCH INTERN MED, V164, P2349, DOI 10.1001/archinte.164.21.2349
   Hansen ABE, 2012, AIDS, V26, P285, DOI 10.1097/QAD.0b013e32834ed8a7
   Hofmann WP, 2008, J VIRAL HEPATITIS, V15, P790, DOI 10.1111/j.1365-2893.2008.01038.x
   Izzo I., 2011, OPEN INFECT DIS J, V5, P1, DOI [10.2174/1874279301105010001, DOI 10.2174/1874279301105010001]
   Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912
   Kühne CA, 2001, J BONE MINER RES, V16, P2, DOI 10.1359/jbmr.2001.16.1.2
   Leslie WD, 2003, GASTROENTEROLOGY, V125, P941, DOI 10.1016/S0016-5085(03)01062-X
   Lo Re V, 2012, HEPATOLOGY, V56, P1688, DOI 10.1002/hep.25866
   Martinez-Sierra C, 2003, CLIN INFECT DIS, V36, P491, DOI 10.1086/367643
   McComsey GA, 2010, CLIN INFECT DIS, V51, P937, DOI 10.1086/656412
   Mendeni M, 2011, CLIN INFECT DIS, V52, P1164, DOI 10.1093/cid/cir071
   Merriman Raphael B, 2006, Curr HIV/AIDS Rep, V3, P113, DOI 10.1007/BF02696654
   Pawlak K, 2010, THROMB RES, V126, P393, DOI 10.1016/j.thromres.2010.07.023
   Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494
   Price JC, 2012, J INFECT DIS, V205, P1005, DOI 10.1093/infdis/jir885
   Romas E, 2006, RHEUM DIS CLIN N AM, V32, P759, DOI 10.1016/j.rdc.2006.07.004
   Schiefke I, 2005, WORLD J GASTROENTERO, V11, P1843, DOI 10.3748/wjg.v11.i12.1843
   Sterling RK, 2013, J CLIN GASTROENTEROL, V47, P182, DOI 10.1097/MCG.0b013e318264181d
   Takahashi N, 2011, FRONT BIOSCI-LANDMRK, V16, P21, DOI 10.2741/3673
   Tebas P, 2000, AIDS, V14, pF63, DOI 10.1097/00002030-200003100-00005
   Triant VA, 2008, J CLIN ENDOCR METAB, V93, P3499, DOI 10.1210/jc.2008-0828
   van der Pas VR, 2011, CLIN INFECT DIS, V53, P613, DOI 10.1093/cid/cir479
   van der Pas VR, 2011, CLIN INFECT DIS, V53, P614
   Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346
   Womack JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017217
   Young B, 2011, CLIN INFECT DIS, V52, P1061, DOI 10.1093/cid/ciq242
NR 38
TC 34
Z9 36
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0884-0431
EI 1523-4681
J9 J BONE MINER RES
JI J. Bone Miner. Res.
PD DEC
PY 2013
VL 28
IS 12
BP 2577
EP 2583
DI 10.1002/jbmr.1988
PG 7
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 295FQ
UT WOS:000330102400016
PM 23677838
OA Bronze
DA 2024-02-19
ER

PT J
AU Navarro, A
   Gomez, C
   López-Cepero, JM
   Boveris, A
AF Navarro, A
   Gomez, C
   López-Cepero, JM
   Boveris, A
TI Beneficial effects of moderate exercise on mice aging:: survival,
   behavior, oxidative stress, and mitochondrial electron transfer
SO AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE
   PHYSIOLOGY
LA English
DT Article
DE cytochrome oxidase
ID AGE-RELATED-CHANGES; LIFELONG VOLUNTARY EXERCISE; FREE-RADICALS;
   LIPID-PEROXIDATION; GENE-EXPRESSION; DAMAGE; METABOLISM; MECHANISM;
   NOVELTY
AB Moderate exercise in a treadmill (10, 15, and 20 cm/s, for 5 min each, weekly) from 28 to 78 wk of age extended male and female mice life span by 19 and 9% accompanied by 36 and 13% and 13 and 9% increased performance in behavioral assays (tightrope and T-maze tests) at 52 wk of age. Moderate exercise significantly decreased the aging-associated development of oxidative stress by preventing 1) the increase in protein carbonyls and thiobarbituric acid-reactive substances contents of submitochondrial membranes; 2) the decrease in antioxidant enzyme activities (Mn- and Cu,Zn-superoxide dismutase and catalase); and 3) the decrease in mitochondrial NADH-cytochrome-c reductase and cytochrome oxidase activities observed at 52 wk of mice age in brain, heart, liver, and kidney. These effects were no longer significant at 78 wk of age in mice. Moderate exercise, started at young age in mice, increased life span, decreased oxidative stress, and prevented the decline of cytochrome oxidase activity and behavioral performance at middle age but not at old age.
C1 Univ Cadiz, Fac Med, Dept Bioquim & Biol Mol, Cadiz 11003, Spain.
   Univ Cadiz, Fac Med, Dept Histol, Cadiz 11003, Spain.
   Univ Buenos Aires, Sch Pharm & Biochem, Lab Free Rad Biol, RA-1113 Buenos Aires, DF, Argentina.
C3 Universidad de Cadiz; Universidad de Cadiz; University of Buenos Aires
RP Navarro, A (corresponding author), Univ Cadiz, Fac Med, Dept Bioquim & Biol Mol, Plaza Fragela 9, Cadiz 11003, Spain.
EM ana.navarro@uca.es
RI Gómez-Gómez, Carmen/AAN-2273-2020
OI Gomez Gomez, Carmen/0000-0002-9619-5927
CR BADANO BN, 1973, MOL CELL BIOCHEM, V2, P157, DOI 10.1007/BF01795470
   Bailey DM, 2003, J APPL PHYSIOL, V94, P1714, DOI 10.1152/japplphysiol.01024.2002
   BENZI G, 1992, NEUROBIOL AGING, V13, P361, DOI 10.1016/0197-4580(92)90109-B
   BOVERIS A, 1972, BIOCHEM J, V128, P617, DOI 10.1042/bj1280617
   Brechue WF, 1996, CLIN GERIATR MED, V12, P207, DOI 10.1016/S0749-0690(18)30254-4
   Bronikowski AM, 2003, PHYSIOL GENOMICS, V12, P129, DOI 10.1152/physiolgenomics.00082.2002
   Carmeli E, 2002, EXP GERONTOL, V37, P477, DOI 10.1016/S0531-5565(01)00220-0
   CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527
   Churchill JD, 2002, NEUROBIOL AGING, V23, P941, DOI 10.1016/S0197-4580(02)00028-3
   Colcombe SJ, 2003, J GERONTOL A-BIOL, V58, P176
   Cooper CE, 2002, BIOCHEM SOC T, V30, P280, DOI 10.1042/bst0300280
   Davison GW, 2002, FREE RADICAL BIO MED, V33, P1543, DOI 10.1016/S0891-5849(02)01090-0
   De la Fuente M, 1998, MECH AGEING DEV, V102, P263, DOI 10.1016/S0047-6374(98)00015-3
   DELLU F, 1994, BRAIN RES, V653, P51, DOI 10.1016/0006-8993(94)90371-9
   Dellu F, 2000, NEUROBIOL LEARN MEM, V73, P31, DOI 10.1006/nlme.1999.3919
   Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780
   Forster MJ, 1996, P NATL ACAD SCI USA, V93, P4765, DOI 10.1073/pnas.93.10.4765
   FRAGA CG, 1988, FREE RADICAL BIO MED, V4, P155, DOI 10.1016/0891-5849(88)90023-8
   GILAD GM, 1995, MECH AGEING DEV, V78, P75, DOI 10.1016/0047-6374(94)01529-U
   GONZALEZFLECHA B, 1993, J CLIN INVEST, V91, P456, DOI 10.1172/JCI116223
   Hagen TM, 1998, P NATL ACAD SCI USA, V95, P9562, DOI 10.1073/pnas.95.16.9562
   Ji LL, 2001, ANN NY ACAD SCI, V928, P236
   Kirkwood TBL, 2002, J INHERIT METAB DIS, V25, P189, DOI 10.1023/A:1015625811569
   Kwong LK, 2000, ARCH BIOCHEM BIOPHYS, V373, P16, DOI 10.1006/abbi.1999.1495
   Lenaz G, 2002, ANN NY ACAD SCI, V959, P199, DOI 10.1111/j.1749-6632.2002.tb02094.x
   MARTINEZ M, 1994, NEUROSCI LETT, V170, P121, DOI 10.1016/0304-3940(94)90254-2
   McArdle A, 2002, AGEING RES REV, V1, P79, DOI 10.1016/S0047-6374(01)00368-2
   MIQUEL J, 1978, EXP GERONTOL, V13, P389, DOI 10.1016/0531-5565(78)90049-9
   Navarro A, 2002, AM J PHYSIOL-REG I, V282, pR985, DOI 10.1152/ajpregu.00537.2001
   OLIVER CN, 1987, J BIOL CHEM, V262, P5488
   Radák Z, 2002, PFLUG ARCH EUR J PHY, V445, P273, DOI 10.1007/s00424-002-0918-6
   Radzewitz A, 2002, EUR J HEART FAIL, V4, P627, DOI 10.1016/S1388-9842(02)00090-9
   Sohal RS, 2002, FREE RADICAL BIO MED, V33, P37, DOI 10.1016/S0891-5849(02)00856-0
   Tipton KD, 2001, CAN J APPL PHYSIOL, V26, P588, DOI 10.1139/h01-033
   TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0
   Viña J, 2000, IUBMB LIFE, V50, P271, DOI 10.1080/15216540051080994
   Welle S, 2003, PHYSIOL GENOMICS, V12, P71, DOI 10.1152/physiolgenomics.00177.2002
   Westerterp KR, 2001, J GERONTOL A-BIOL, V56, P7, DOI 10.1093/gerona/56.suppl_2.7
   WILHELM D, 1993, COMP BIOCHEM PHYS C, V106, P415
NR 39
TC 339
Z9 383
U1 0
U2 30
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0363-6119
EI 1522-1490
J9 AM J PHYSIOL-REG I
JI Am. J. Physiol.-Regul. Integr. Comp. Physiol.
PD MAR 1
PY 2004
VL 286
IS 3
BP R505
EP R511
DI 10.1152/ajpregu.00208.2003
PG 7
WC Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology
GA 770TQ
UT WOS:000188747300012
PM 14615275
OA Green Published, Green Submitted
DA 2024-02-19
ER

PT J
AU Zhou, YZ
   Zhao, FF
   Gao, L
   Du, GH
   Zhang, X
   Qin, XM
AF Zhou, Yu-Zhi
   Zhao, Fan-Fan
   Gao, Li
   Du, Guan-Hua
   Zhang, Xiang
   Qin, Xue-Mei
TI Licorice extract attenuates brain aging of D-galactose induced rats
   through inhibition of oxidative stress and attenuation of neuronal
   apoptosis
SO RSC ADVANCES
LA English
DT Article
ID INDUCED COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; MEMORY DEFICITS;
   MODEL; ACID; MICE; LIVER; ISOLIQUIRITIGENIN; NEUROINFLAMMATION;
   GLYCYRRHIZIN
AB Licorice, an edible and officinal plant, has attracted considerable attention for its wide range of pharmacological activities. The present study focused on the protective effect of licorice on aging rats and on exploring its potential mechanisms. Aging in rats was induced by D-gal (300 mg kg(-1)) for 5 weeks continuously with intraperitoneal injection, while control rats received physiological saline, and other groups received different concentrations of licorice extract (1, 5 and 10 g of herb per kg) by oral gavage after being D-gal induced. Their spatial and learning memory abilities were evaluated by the Morris water maze test and an object-place recognition test. Some related biochemical indices were also determined by assay kits. Neuronal cell injury in the hippocampal region was observed by hematoxylin and eosin (HE) staining. The expression levels of Bax, Bcl-2, caspase-3 and Cyt-C in the hippocampus were detected by western blot. The results showed that licorice extract could significantly ameliorate the learning and memory abilities impaired by D-gal. The licorice extract significantly increased the SOD, GSH-Px and CAT activity and synchronously decreased the content of MDA in the hippocampus. It also ameliorated the dysfunction of the cholinergic system induced by D-gal. Furthermore, the licorice extract also protected the hippocampal neurons against damage and could significantly reduce the expression of the Bax/Bcl-2 protein ratio, caspase-3 and Cyt-C protein in the hippocampus. These findings indicate that the licorice extract effectively attenuated cognitive damage, improved oxidative stress and apoptosis in aging rats induced by D-gal, and played a significant role in antioxidation and anti-neuronal apoptosis.
C1 [Zhou, Yu-Zhi; Zhao, Fan-Fan; Gao, Li; Du, Guan-Hua; Zhang, Xiang; Qin, Xue-Mei] Shanxi Univ, Modern Res Ctr Tradit Chinese Med, 92 Wu Cheng Rd, Taiyuan 030006, Shanxi, Peoples R China.
   [Zhao, Fan-Fan] Shanxi Univ, Coll Chem & Chem Engn, Taiyuan 030006, Peoples R China.
   [Du, Guan-Hua] Chinese Acad Med Sci, Peking Union Med Coll, Inst Mat Med, Beijing 100050, Peoples R China.
   [Zhang, Xiang] Univ Louisville, Dept Chem, Louisville, KY 40229 USA.
C3 Shanxi University; Shanxi University; Chinese Academy of Medical
   Sciences - Peking Union Medical College; Institute of Materia Medica -
   CAMS; Peking Union Medical College; University of Louisville
RP Zhou, YZ; Qin, XM (corresponding author), Shanxi Univ, Modern Res Ctr Tradit Chinese Med, 92 Wu Cheng Rd, Taiyuan 030006, Shanxi, Peoples R China.
EM zhouyuzhi@sxu.edu.cn; qinxm@sxu.edu.cn
FU Applied Basic Research Project of Shanxi Province [201601D021164];
   Innovation Project of Higher Education Institutions in Shanxi Province
   [2016120]; Construction of the Science and Technology Basic Condition
   Platform of Shanxi Province [2014091022]; Program of Science and
   Technology of Shanxi Province [20140313008-14]
FX We acknowledge financial support from the Applied Basic Research Project
   of Shanxi Province (No. 201601D021164), the Innovation Project of Higher
   Education Institutions in Shanxi Province (No. 2016120), the
   Construction of the Science and Technology Basic Condition Platform of
   Shanxi Province (No. 2014091022), and the Program of Science and
   Technology of Shanxi Province (No. 20140313008-14).
CR Ali T, 2015, J PINEAL RES, V58, P71, DOI 10.1111/jpi.12194
   Aydin AF, 2016, METAB BRAIN DIS, V31, P337, DOI 10.1007/s11011-015-9755-0
   Budni J, 2016, BEHAV BRAIN RES, V302, P35, DOI 10.1016/j.bbr.2015.12.041
   Chen HJ, 2014, J AGR FOOD CHEM, V62, P618, DOI 10.1021/jf405352g
   Chen ZA, 2009, CYTOTECHNOLOGY, V60, P125, DOI 10.1007/s10616-009-9226-8
   Cunningham GM, 2015, ARCH BIOCHEM BIOPHYS, V576, P32, DOI 10.1016/j.abb.2015.02.025
   Du ZD, 2015, MOL MED REP, V12, P7883, DOI 10.3892/mmr.2015.4430
   Fujii S, 2016, J AGR FOOD CHEM, V64, P1087, DOI 10.1021/acs.jafc.5b04732
   Fukami H, 2010, J AGR FOOD CHEM, V58, P4084, DOI 10.1021/jf9045842
   Gao J, 2016, METAB BRAIN DIS, V31, P771, DOI 10.1007/s11011-016-9813-2
   Gao J, 2015, BEHAV BRAIN RES, V293, P27, DOI 10.1016/j.bbr.2015.06.045
   García-Mesa Y, 2016, J GERONTOL A-BIOL, V71, P40, DOI 10.1093/gerona/glv005
   Haider S, 2015, LIFE SCI, V124, P110, DOI 10.1016/j.lfs.2015.01.016
   Hasanein P, 2011, ACTA PHYSIOL HUNG, V98, P221, DOI 10.1556/APhysiol.98.2011.2.14
   Huo HZ, 2011, INT J MOL SCI, V12, P6529, DOI 10.3390/ijms12106529
   Iriondo-DeHond A, 2016, MOLECULES, V21, DOI 10.3390/molecules21060721
   Jamwal S, 2016, PHYSIOL BEHAV, V155, P180, DOI 10.1016/j.physbeh.2015.12.015
   Ji S, 2016, J NAT PROD, V79, P281, DOI 10.1021/acs.jnatprod.5b00877
   Kao TC, 2014, J AGR FOOD CHEM, V62, P542, DOI 10.1021/jf404939f
   Kim M, 2014, INT J MOL MED, V33, P870, DOI 10.3892/ijmm.2014.1656
   Kim YM, 2010, FREE RADICAL BIO MED, V49, P1722, DOI 10.1016/j.freeradbiomed.2010.09.001
   Leger M, 2013, NAT PROTOC, V8, P2531, DOI 10.1038/nprot.2013.155
   Lei YF, 2012, FOOD CHEM, V135, P2702, DOI 10.1016/j.foodchem.2012.07.043
   Li WJ, 2012, J AGR FOOD CHEM, V60, P1413, DOI 10.1021/jf204748a
   Li X, 2016, EXP GERONTOL, V83, P89, DOI 10.1016/j.exger.2016.07.012
   Liang SH, 2016, CHEM-BIOL INTERACT, V258, P40, DOI 10.1016/j.cbi.2016.08.013
   Liu RT, 2010, BEHAV BRAIN RES, V210, P24, DOI 10.1016/j.bbr.2010.01.041
   Ntsapi C, 2016, EXP GERONTOL, V83, P97, DOI 10.1016/j.exger.2016.07.014
   Park SM, 2016, EUR J NUTR, V55, P2431, DOI 10.1007/s00394-015-1051-6
   Rofiee MS, 2015, J ETHNOPHARMACOL, V166, P109, DOI 10.1016/j.jep.2015.03.016
   Ruan QW, 2013, MECH AGEING DEV, V134, P89, DOI 10.1016/j.mad.2012.12.005
   Silva MAD, 2013, P NATL ACAD SCI USA, V110, P15097, DOI 10.1073/pnas.1306884110
   Song X, 1999, MECH AGEING DEV, V108, P239, DOI 10.1016/S0047-6374(99)00022-6
   Sun SL, 2014, MOL BIOL REP, V41, P6117, DOI 10.1007/s11033-014-3490-1
   Tabuchi M, 2012, CELL MOL NEUROBIOL, V32, P1139, DOI 10.1007/s10571-012-9839-x
   Ullah F, 2015, NEUROCHEM INT, V90, P114, DOI 10.1016/j.neuint.2015.07.001
   Wang PP, 2016, PHYTOMEDICINE, V23, P460, DOI 10.1016/j.phymed.2016.02.014
   Wang T, 2015, J PHARM PHARMACOL, V67, P1284, DOI 10.1111/jphp.12413
   Wang Y, 2016, J AGR FOOD CHEM, V64, P161, DOI 10.1021/acs.jafc.5b04874
   Wei HY, 2017, MAR DRUGS, V15, DOI 10.3390/md15030077
   Xiang Z, 2015, MOL BIOSYST, V11, P1067, DOI 10.1039/c4mb00573b
   Zhang ZF, 2009, J AGR FOOD CHEM, V57, P7731, DOI 10.1021/jf9012357
   Zhao HY, 2016, EUR J PHARMACOL, V781, P92, DOI 10.1016/j.ejphar.2016.04.006
NR 43
TC 9
Z9 9
U1 0
U2 16
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2017
VL 7
IS 75
BP 47758
EP 47766
DI 10.1039/c7ra07110h
PG 9
WC Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry
GA FJ7YQ
UT WOS:000412977000063
OA gold
DA 2024-02-19
ER

PT J
AU Ma, XK
   Guo, DD
   Peterson, EC
   Dun, Y
   Li, DY
AF Ma, Xiao-kui
   Guo, Dan Dan
   Charles Peterson, Eric
   Dun, Ying
   Li, Dan Yang
TI Structural characterization and anti-aging activity of a novel
   extracellular polysaccharide from fungus <i>Phellinus</i> sp in a
   mammalian system
SO FOOD & FUNCTION
LA English
DT Article
ID ANTIOXIDANT ACTIVITY; STRUCTURE ELUCIDATION; ANTITUMOR-ACTIVITY; LINTEUS
   EXTRACT; PURIFICATION; CAPACITY; MYCELIA; STRESS; CELLS; MICE
AB Little is known about the chemical structure of purified extracellular polysaccharides from Phellinus sp., a fungal species with known medicinal properties. A combination of IR spectroscopy, methylation analysis and NMR were performed for the structural analysis of a purified extracellular polysaccharide derived from Phellinus sp. culture, denoted as SHP-1, along with an evaluation of the anti-aging effect in vivo of the polysaccharide supplementation. The structure of SHP-1 was established, with a backbone composed of -> 2,4)-alpha-D-glucopyranose-(1 -> and -> 2)-beta-D-mannopyranose-(1 -> and two terminal glucopyranose branches. Biochemical analysis from mammalian animal experiments demonstrated that SHP-1 possesses the ability to enhance antioxidant enzyme activities, such as catalase (CAT) and superoxide dismutase (SOD) activities, Trolox equivalent antioxidant capacity (TEAC) in serum of D-galactose-aged mice, while reducing lipofuscin levels, another indicator of cell aging, indicating a potential association with antiaging activities in a dose dependent manner. This compound had a favourable influence on immune organ indices, and a marked amelioration ability of histopathological hepatic lesions such as necrosis, karyolysis and reduced inflammation and apoptosis in mouse hepatocytes. These results suggest that SHP-1 has strong antioxidant activities and a significant protective effect against oxidative stress or hepatotoxicity induced by D-galactose in mice and it could be developed as a food ingredient or a pharmaceutical to prevent many age-associated diseases such as major depressive disorder and hepatotoxicity. To our knowledge, this is the first report on the antioxidant effects of a novel purified exopolysaccharide derived from Phellinus sp.
C1 [Ma, Xiao-kui; Guo, Dan Dan; Dun, Ying; Li, Dan Yang] Shaanxi Normal Univ, Coll Life Sci, Natl Engn Lab Resource Developing Endangered Chin, Minist Educ,Key Lab Med Resources & Nat Pharmaceu, Xian 710055, Shaanxi, Peoples R China.
   [Charles Peterson, Eric] Univ Icesi, Dept Biochem Engn, Cali, Colombia.
C3 Shaanxi Normal University; Universidad ICESI
RP Ma, XK (corresponding author), Shaanxi Normal Univ, Coll Life Sci, Natl Engn Lab Resource Developing Endangered Chin, Minist Educ,Key Lab Med Resources & Nat Pharmaceu, Xian 710055, Shaanxi, Peoples R China.
EM biomarkuis@gmail.com
RI Peterson, Eric Charles/E-7696-2016
OI Peterson, Eric Charles/0000-0003-1513-6106
FU Key Projects in the National "948" Program during the Twelfth Five-year
   Plan Period of China [2011-G30]; Science and Technology Major Projects
   of Shandong Province [2014ZZCX07301]; Projects of Science and Technology
   in Shaanxi Province [2015JM3101]; Fundamental Research Funds for the
   Central Universities of China [GK201402022]
FX The authors are grateful for the financial support from the Key Projects
   in the National "948" Program during the Twelfth Five-year Plan Period
   of China (grant No. 2011-G30), the Science and Technology Major Projects
   of Shandong Province (grant no. 2014ZZCX07301), Projects of Science and
   Technology in Shaanxi Province (grant no. 2015JM3101) and Fundamental
   Research Funds for the Central Universities of China (grant no.
   GK201402022).
CR BEATTY CH, 1982, AGE, V5, P1, DOI 10.1007/BF02431717
   Bezza FA, 2016, CHEMOSPHERE, V144, P635, DOI 10.1016/j.chemosphere.2015.08.027
   Carbonero ER, 2008, FOOD CHEM, V111, P531, DOI 10.1016/j.foodchem.2008.04.015
   Chen H, 2011, J IND MICROBIOL BIOT, V38, P291, DOI 10.1007/s10295-010-0772-z
   Chen YL, 2015, MAR BIOTECHNOL, V17, P219, DOI 10.1007/s10126-015-9611-6
   Colantoni A, 2001, J AM AGING ASSOC, V24, P51, DOI 10.1007/s11357-001-0007-3
   Cotoras M, 2014, MOLECULES, V19, P21154, DOI 10.3390/molecules191221154
   Demkowicz-Dobrzanski K, 1992, Postepy Biochem, V38, P37
   Ding X, 2012, INT J BIOL MACROMOL, V50, P613, DOI 10.1016/j.ijbiomac.2012.01.021
   Dröge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001
   Fu LH, 2013, FOOD FUNCT, V4, P871, DOI 10.1039/c3fo60033e
   Giavasis I, 2014, CURR OPIN BIOTECH, V26, P162, DOI 10.1016/j.copbio.2014.01.010
   Guennel P, 2015, J NEUROCHEM, V134, P198
   Hirose M, 1998, EUR J CANCER PREV, V7, P233, DOI 10.1097/00008469-199806000-00008
   Hu WL, 2013, BIOTECHNOL LETT, V35, P1309, DOI 10.1007/s10529-013-1206-6
   Hu XQ, 2011, J AGR FOOD CHEM, V59, P11548, DOI 10.1021/jf203179y
   Jing YS, 2015, J AGR FOOD CHEM, V63, P3464, DOI 10.1021/jf505915t
   Kang J, 2011, FOOD HYDROCOLLOID, V25, P1999, DOI 10.1016/j.foodhyd.2010.11.020
   KRAUS GA, 1986, SYNTHETIC COMMUN, V16, P1037, DOI 10.1080/00397918608056345
   Kumar A, 2010, FOOD CHEM TOXICOL, V48, P626, DOI 10.1016/j.fct.2009.11.043
   Li B, 2013, CARBOHYD POLYM, V92, P1991, DOI 10.1016/j.carbpol.2012.11.088
   Li L, 2014, FOOD FUNCT, V5, P3261, DOI [10.1039/C4FO00565A, 10.1039/c4fo00565a]
   Li SC, 2015, CARBOHYD POLYM, V133, P24, DOI 10.1016/j.carbpol.2015.07.013
   Luca M, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/230797
   Ma XK, 2014, CARBOHYD POLYM, V107, P214, DOI 10.1016/j.carbpol.2014.02.077
   Maurya PK, 2016, PROG NEURO-PSYCHOPH, V65, DOI 10.1016/j.pnpbp.2015.08.016
   Mei YX, 2015, CARBOHYD POLYM, V124, P90, DOI 10.1016/j.carbpol.2015.02.009
   Park IH, 2004, ARCH PHARM RES, V27, P615, DOI 10.1007/BF02980159
   Patra P, 2012, CARBOHYD POLYM, V87, P2169, DOI 10.1016/j.carbpol.2011.10.042
   Posadas SJ, 2009, EXP GERONTOL, V44, P383, DOI 10.1016/j.exger.2009.02.015
   Smith H, 2015, FOOD CHEM, V185, P389, DOI 10.1016/j.foodchem.2015.03.134
   SOHAL RS, 1986, PROG BRAIN RES, V70, P171
   Sun YX, 2009, BIORESOURCE TECHNOL, V100, P1860, DOI 10.1016/j.biortech.2008.09.036
   Tian Y, 2011, FOOD CHEM TOXICOL, V49, P1728, DOI 10.1016/j.fct.2011.04.018
   Tsai MC, 2007, FOOD CHEM, V104, P1115, DOI 10.1016/j.foodchem.2007.01.018
   Tsuji T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009885
   Wang LQ, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0630-7
   WEISIGER RA, 1973, J BIOL CHEM, V248, P3582
   Wu XJ, 2008, J FOOD SCI, V73, pM1, DOI 10.1111/j.1750-3841.2007.00595.x
   Yang LQ, 2009, CARBOHYD POLYM, V76, P349, DOI 10.1016/j.carbpol.2008.12.015
   Yang Y, 2007, CARBOHYD RES, V342, P1063, DOI 10.1016/j.carres.2007.02.019
   Yang Y, 2009, BIOSCI BIOTECH BIOCH, V73, P134, DOI 10.1271/bbb.80546
   Ye M, 2012, FOOD CHEM, V132, P338, DOI 10.1016/j.foodchem.2011.10.087
   Ye SF, 2007, PHYTOTHER RES, V21, P948, DOI 10.1002/ptr.2182
   Zhao C, 2014, J FOOD SCI, V79, pH1002, DOI 10.1111/1750-3841.12464
   Zhong WQ, 2013, INT J BIOL MACROMOL, V60, P355, DOI 10.1016/j.ijbiomac.2013.06.018
NR 46
TC 23
Z9 24
U1 2
U2 88
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2042-6496
EI 2042-650X
J9 FOOD FUNCT
JI Food Funct.
PD AUG 1
PY 2016
VL 7
IS 8
BP 3468
EP 3479
DI 10.1039/c6fo00422a
PG 12
WC Biochemistry & Molecular Biology; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Food Science & Technology
GA DT3XP
UT WOS:000381414800014
PM 27405813
DA 2024-02-19
ER

PT J
AU Denniss, SG
   Levy, AS
   Rush, JWE
AF Denniss, Steven G.
   Levy, Andrew S.
   Rush, James W. E.
TI Effects of Glutathione-depleting Drug Buthionine Sulfoximine and Aging
   on Activity of Endothelium-derived Relaxing and Contracting Factors in
   Carotid Artery of Sprague-Dawley Rats
SO JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
LA English
DT Article
DE buthionine sulfoximine; GSH; aging; vasomotor dysfunction; EDCF; EDRF
ID SPONTANEOUSLY HYPERTENSIVE-RATS; NITRIC-OXIDE BIOAVAILABILITY;
   STRESS-INDUCED HYPERTENSION; OXIDATIVE STRESS; DEPENDENT CONTRACTIONS;
   HYDROGEN-PEROXIDE; FEMORAL ARTERIES; VASCULAR DYSFUNCTION;
   BLOOD-PRESSURE; RELAXATION
AB The role of the antioxidant glutathione (GSH) in mediating endothelial (dys) function, and how that role may depend on age, is unclear. The main purpose of the current study was to investigate the effect of 10-day treatment with the GSH-depleting drug L-bu thionine sulfoximine (BSO) on endothelium-derived relaxing factor and endothelium-derived contracting factor activities in the isolated common carotid artery (CCA) of Adult and Aging animals. CCA blood pressure and flow were unaffected by age or BSO. Endothelium-derived relaxing factor activity, examined in precontracted CCA as relaxation to cumulative acetylcholine (ACh), was largely nitric oxide synthase (NOS) mediated and was not different between Adult and Aging animals at lower ACh; however, at higher ACh, relaxation was blunted in Aging CCA, an effect abolished by cyclooxygenase (COX) inhibition but not by NOS inhibition nor by the reactive oxygen species (ROS) inhibitors 4-hydroxy-TEMPO or Mn(III)tetrakis(1-methyl- 4-pyridyl) porphyrin, tetratosylate, hydroxide. Specific examination of endothelium-derived contracting factor activity in quiescent NOS-inhibited CCA established that higher ACh elicited a contractile response, similar to 3.5-fold greater in Aging versus Adult CCA, which was abolished by COX-1-specific inhibition but unaffected by ROS inhibitors. Aging was unrelated to changes in liver or vascular tissue GSH or ROS content. BSO was effective in significantly decreasing GSH and increasing ROS content in both animal cohorts. However, NOS-mediated endothelium-derived relaxing factor activity was well preserved and age-related COX-mediated endothelium-derived contracting factor activity was unaffected in response to these BSO-induced perturbations, as were exogenous H2O2-stimulated NOS/non-NOS-mediated relaxation and COX-mediated contractile activities. These data suggest that, regardless of age, chronic partial depletion of GSH in vivo does not necessarily cause endothelium-dependent vasomotor dysfunction.
C1 [Denniss, Steven G.; Levy, Andrew S.; Rush, James W. E.] Univ Waterloo, Integrat Vasc Biol Lab, Dept Kinesiol, Fac Appl Hlth Sci, Waterloo, ON N2L 3G1, Canada.
C3 University of Waterloo
RP Rush, JWE (corresponding author), Univ Waterloo, Integrat Vasc Biol Lab, Dept Kinesiol, Fac Appl Hlth Sci, Waterloo, ON N2L 3G1, Canada.
EM jwerush@uwaterloo.ca
FU Natural Sciences and Engineering Research Council of Canada
   [RGPIN238342]; University of Waterloo; Canadian Institutes of Health
   Research
FX Supported by a grant from the Natural Sciences and Engineering Research
   Council of Canada (RGPIN238342). S. G. Denniss and A. S. Levy were
   supported by Natural Sciences and Engineering Research Council of Canada
   Post-Graduate Fellowships and University of Waterloo President's
   Graduate Scholarships. J. W. E. Rush holds the Canada Research Chair in
   Integrative Vascular Biology sponsored by the Canadian Institutes of
   Health Research.
CR Adachi T, 2000, BRIT J PHARMACOL, V129, P1014, DOI 10.1038/sj.bjp.0703127
   Banday AA, 2007, HYPERTENSION, V49, P664, DOI 10.1161/01.HYP.0000255233.56410.20
   Banday AA, 2009, AM J PHYSIOL-RENAL, V297, pF397, DOI 10.1152/ajprenal.90729.2008
   Bayorh MA, 2003, AM J HYPERTENS, V16, P387, DOI 10.1016/S0895-7061(03)00054-2
   BUCKLEY BJ, 1991, J BIOL CHEM, V266, P16659
   Chrissobolis S, 2008, HYPERTENSION, V51, P872, DOI 10.1161/HYPERTENSIONAHA.107.103572
   Day BJ, 1997, ARCH BIOCHEM BIOPHYS, V347, P256, DOI 10.1006/abbi.1997.0341
   Denniss SG, 2010, AM J PHYSIOL-HEART C, V298, pH1391, DOI 10.1152/ajpheart.01233.2009
   Denniss SG, 2009, AM J PHYSIOL-HEART C, V296, pH1038, DOI 10.1152/ajpheart.00933.2008
   Dikalov S, 2007, HYPERTENSION, V49, P717, DOI 10.1161/01.HYP.0000258594.87211.6b
   Edwards G, 2010, PFLUG ARCH EUR J PHY, V459, P863, DOI 10.1007/s00424-010-0817-1
   Félétou M, 2006, AM J PHYSIOL-HEART C, V291, pH985, DOI 10.1152/ajpheart.00292.2006
   Félétou M, 2010, PFLUG ARCH EUR J PHY, V459, P941, DOI 10.1007/s00424-010-0812-6
   Ford RJ, 2006, FREE RADICAL BIO MED, V40, P670, DOI 10.1016/j.freeradbiomed.2005.09.020
   Ganafa AA, 2002, EUR J PHARMACOL, V454, P217, DOI 10.1016/S0014-2999(02)02500-1
   Ganafa AA, 2002, AM J HYPERTENS, V15, P725, DOI 10.1016/S0895-7061(02)02963-1
   Gao YJ, 2004, BRIT J PHARMACOL, V142, P143, DOI 10.1038/sj.bjp.0705727
   Graham DA, 2004, J APPL PHYSIOL, V96, P2088, DOI 10.1152/japplphysiol.01252.2003
   Hayes JD, 1999, FREE RADICAL RES, V31, P273, DOI 10.1080/10715769900300851
   Iwata C, 2007, LIFE SCI, V80, P873, DOI 10.1016/j.lfs.2006.11.012
   Kugiyama K, 1998, CIRCULATION, V97, P2299, DOI 10.1161/01.CIR.97.23.2299
   Laursen JB, 2001, FREE RADICAL RES, V35, P387, DOI 10.1080/10715760100300901
   MATSUO M, 1993, FREE RADICAL AGING
   MEISTER A, 1983, SCIENCE, V220, P472, DOI 10.1126/science.6836290
   MUGGE A, 1991, CIRC RES, V69, P1293, DOI 10.1161/01.RES.69.5.1293
   Prasad A, 1999, J AM COLL CARDIOL, V34, P507, DOI 10.1016/S0735-1097(99)00216-8
   Rajagopalan S, 1996, J CLIN INVEST, V97, P1916, DOI 10.1172/JCI118623
   Rush JWE, 2007, EXP BIOL MED, V232, P814
   Rush JWE, 2005, CAN J APPL PHYSIOL, V30, P442, DOI 10.1139/h05-133
   Shi Y, 2008, BRIT J PHARMACOL, V154, P639, DOI 10.1038/bjp.2008.110
   Shi Y, 2007, BRIT J PHARMACOL, V152, P1033, DOI 10.1038/sj.bjp.0707439
   Shi Y, 2007, BRIT J PHARMACOL, V150, P624, DOI 10.1038/sj.bjp.0706999
   Shi Y, 2008, ACTA PHARMACOL SIN, V29, P185, DOI 10.1111/j.1745-7254.2008.00749.x
   Tang EHC, 2009, PHARMACOL THERAPEUT, V122, P140, DOI 10.1016/j.pharmthera.2009.02.006
   Thakali K, 2006, HYPERTENSION, V47, P482, DOI 10.1161/01.HYP.0000201540.91234.8f
   Vaziri ND, 2000, HYPERTENSION, V36, P142, DOI 10.1161/01.HYP.36.1.142
   Vita JA, 1998, J CLIN INVEST, V101, P1408, DOI 10.1172/JCI1155
   Wilcox CS, 2008, PHARMACOL REV, V60, P418, DOI 10.1124/pr.108.000240
   Yang D, 2002, BRIT J PHARMACOL, V136, P104, DOI 10.1038/sj.bjp.0704669
   Zhou XJ, 2002, J PHARMACOL EXP THER, V300, P762, DOI 10.1124/jpet.300.3.762
NR 40
TC 8
Z9 8
U1 0
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0160-2446
EI 1533-4023
J9 J CARDIOVASC PHARM
JI J. Cardiovasc. Pharmacol.
PD SEP
PY 2011
VL 58
IS 3
BP 272
EP 283
DI 10.1097/FJC.0b013e3182239f36
PG 12
WC Cardiac & Cardiovascular Systems; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology; Pharmacology & Pharmacy
GA 816KW
UT WOS:000294599400007
PM 21654325
DA 2024-02-19
ER

PT J
AU Wu, CK
   Hsu, CN
   Cho, WR
   Yang, SC
   Liu, AC
   Tai, WC
   Lee, CH
   Yang, YH
   Chuah, SK
   Liang, CM
AF Wu, Cheng-Kun
   Hsu, Chien-Ning
   Cho, Wei-Ru
   Yang, Shih-Cheng
   Liu, An-Che
   Tai, Wei-Chen
   Lee, Chen-Hsiang
   Yang, Yao-Hsu
   Chuah, Seng-Kee
   Liang, Chih-Ming
TI Increased Risk of Pyogenic Liver Abscess after Endoscopic Sphincterotomy
   for Treatment of Choledocholithiasis
SO INFECTION AND DRUG RESISTANCE
LA English
DT Article
DE pyogenic liver abscess; endoscopic sphincterotomy; choledocholithiasis;
   endoscopic retrograde cholangiopancreatography
ID BILE-DUCT STONES; LARGE BALLOON DILATION; LATE COMPLICATIONS; LONG-TERM;
   FOLLOW-UP; RETRIEVAL
AB Background and Aim: Endoscopic sphincterotomy (ES) abolished the barrier between the hepatobiliary system and duodenum and might be at risk of pyogenic liver abscess (PLA). We aimed to identify the association factors of PLA in patients who underwent endoscopic retrograde cholangiopancreatography (ERCP) procedures for treatment of choledocholithiasis.
   Methods: This study was based on the Chung Gung Research Database (CGRD) between January 1, 2001 and December 31, 2018. Those who had an International Classification of Diseases, Ninth and Tenth Revision (ICD9 and ICD10) codes of choledocholithiasis and received ERCP were enrolled. After strict exclusions, 11,697 patients were further divided into the endoscopic sphincterotomy (ES) group (n=7,111) and other ERCP group (n=4,586) for analysis.
   Results: Patients receiving ES had significantly higher rates of PLA than those of the other ERCP group (5-year cumulative incidence 2.4% versus 1.7%; 10-year cumulative incidence 3.9% versus 3.2%, log-rank p=0.0177). Aging, male gender, surgery for hepato-pancreato-biliary system and hepatobiliary malignancy were significant association factors of PLA. On multivariate analysis, the ES increased the risk of PLA (adjusted hazard ratio [aHR]=1.49; 95% CI=1.12-1.98; p=0.0058) but decreased the risks for acute pancreatitis (aHR=0.72; 95% CI=0.60-0.85; p=0.0002) and cholangitis (aHR=0.91; 95% CI=0.84-0.99; p=0.0259). There was no significant difference about recurrent choledocholithiasis between groups.
   Conclusion: This study demonstrated a significant risk of PLA after patients receiving ES compared with the other ERCP group. We should also carefully monitor the association factors of PLA after ERCP treatment of choledocholithiasis including aging, male gender, surgery for the hepato-pancreato-biliary system and hepatobiliary malignancy.
C1 [Wu, Cheng-Kun; Cho, Wei-Ru; Yang, Shih-Cheng; Tai, Wei-Chen; Chuah, Seng-Kee; Liang, Chih-Ming] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Hepatogastroenterol, 123 Dabi Rd, Kaohsiung 833, Taiwan.
   [Wu, Cheng-Kun; Cho, Wei-Ru; Yang, Shih-Cheng; Liu, An-Che; Tai, Wei-Chen; Lee, Chen-Hsiang; Chuah, Seng-Kee; Liang, Chih-Ming] Chang Gung Univ, Coll Med, 123 Dabi Rd, Kaohsiung 833, Taiwan.
   [Hsu, Chien-Ning] Kaohsiung Chang Gung Mem Hosp, Dept Pharm, Kaohsiung, Taiwan.
   [Hsu, Chien-Ning] Kaohsiung Med Univ, Sch Pharm, Kaohsiung, Taiwan.
   [Liu, An-Che] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Kaohsiung, Taiwan.
   [Lee, Chen-Hsiang] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Infect Dis, Kaohsiung, Taiwan.
   [Yang, Yao-Hsu] Chiayi Chang Gung Mem Hosp, Dept Tradit Chinese Med, Chiayi, Taiwan.
   [Yang, Yao-Hsu] Chang Gung Mem Hosp, Hlth Informat & Epidemiol Lab, Chiayi, Taiwan.
   [Yang, Yao-Hsu] Chang Gung Univ, Coll Med, Sch Tradit Chinese Med, Taoyuan, Taiwan.
C3 Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial
   Hospital; Kaohsiung Medical University; Chang Gung Memorial Hospital;
   Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung
   Memorial Hospital; Chang Gung University
RP Liang, CM (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Hepatogastroenterol, 123 Dabi Rd, Kaohsiung 833, Taiwan.; Liang, CM (corresponding author), Chang Gung Univ, Coll Med, 123 Dabi Rd, Kaohsiung 833, Taiwan.
EM gimy54861439@gmail.com
RI Hsu, Chien-Ning/GLS-4014-2022; Yang, Yao-Hsu/A-3450-2019
OI Hsu, Chien-Ning/0000-0001-7470-528X; Wu, Cheng-Kun/0000-0003-4105-4913;
   Yang, Yao-Hsu/0000-0002-8080-0504; Chuah, Seng-Kee/0000-0002-8934-3223
FU Kaohsiung Chang Gung Memorial Hospital [CFRPG8J0081]
FX This work was funded by the Kaohsiung Chang Gung Memorial Hospital
   (CFRPG8J0081) in Taiwan.
CR ESCOURROU J, 1984, GUT, V25, P598, DOI 10.1136/gut.25.6.598
   Feng YD, 2012, J GASTROENTEROL, V47, P655, DOI 10.1007/s00535-012-0528-9
   Heneghan Helen M, 2011, BMC Res Notes, V4, P80, DOI 10.1186/1756-0500-4-80
   Itokawa F, 2015, J GASTROEN HEPATOL, V30, P223, DOI 10.1111/jgh.12675
   Jin PP, 2014, WORLD J GASTROENTERO, V20, P5548, DOI 10.3748/wjg.v20.i18.5548
   Kim KY, 2013, CLIN ENDOSC, V46, P637, DOI 10.5946/ce.2013.46.6.637
   Köksal AS, 2018, WORLD J CLIN CASES, V6, P1073, DOI 10.12998/wjcc.v6.i16.1073
   Liao WC, 2020, J FORMOS MED ASSOC, V119, P1343, DOI 10.1016/j.jfma.2019.07.019
   Manes G, 2019, ENDOSCOPY, V51, P472, DOI 10.1055/a-0862-0346
   Oliveira-Cunha M, 2016, SURG LAPARO ENDO PER, V26, P1, DOI 10.1097/SLE.0000000000000226
   Peng YC, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-018818
   Lima JCP, 2020, DIGEST DIS, V38, P534, DOI 10.1159/000507321
   Prat F, 1996, GASTROENTEROLOGY, V110, P894, DOI 10.1053/gast.1996.v110.pm8608900
   Rahimian J, 2004, CLIN INFECT DIS, V39, P1654, DOI 10.1086/425616
   Ryozawa S, 2018, DIGEST ENDOSC, V30, P149, DOI 10.1111/den.13001
   Sugiyama M, 2002, AM J GASTROENTEROL, V97, P2763, DOI 10.1111/j.1572-0241.2002.07019.x
   Sugiyama M, 1998, BRIT J SURG, V85, P917
   Tanaka M, 1998, GASTROINTEST ENDOSC, V48, P465, DOI 10.1016/S0016-5107(98)70086-0
   Thomsen RW, 2007, CLIN INFECT DIS, V44, P1194, DOI 10.1086/513201
   Tsai FC, 2008, EMERG INFECT DIS, V14, P1592, DOI 10.3201/eid1410.071254
   Tsai MS, 2017, BIOMED J, V40, P263, DOI 10.1016/j.bj.2017.08.002
   Tsai TJ, 2015, J CHIN MED ASSOC, V78, P56, DOI 10.1016/j.jcma.2014.08.004
   Williams E, 2017, GUT, V66, P765, DOI 10.1136/gutjnl-2016-312317
   Yasuda I, 2010, GASTROINTEST ENDOSC, V72, P1185, DOI 10.1016/j.gie.2010.07.006
NR 24
TC 3
Z9 4
U1 0
U2 1
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-6973
J9 INFECT DRUG RESIST
JI Infect. Drug Resistance
PY 2021
VL 14
BP 2121
EP 2131
DI 10.2147/IDR.S312545
PG 11
WC Infectious Diseases; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Infectious Diseases; Pharmacology & Pharmacy
GA SX2ZV
UT WOS:000665079700001
PM 34135602
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Leithead, JA
   Ferguson, JW
   Hayes, PC
AF Leithead, Joanna A.
   Ferguson, James W.
   Hayes, Peter C.
TI Modifiable patient factors are associated with the late decline in renal
   function following liver transplantation
SO CLINICAL TRANSPLANTATION
LA English
DT Article
DE chronic kidney disease; decline; glomerular filtration rate; liver
   transplantation; progression
ID STANDARD-DOSE TACROLIMUS; MYCOPHENOLATE-MOFETIL; CALCINEURIN INHIBITORS;
   ALLOGRAFT FUNCTION; RISK-FACTORS; CLINICAL-TRIAL; DYSFUNCTION;
   RECIPIENTS; KIDNEY; DISEASE
AB Strategies to delay or avoid the long-term decline in renal function and progression to chronic kidney disease (CKD) in liver transplant recipients remain unclear. Our aim was to examine the change in estimated GFR (eGFR) from six months after liver transplantation, and to identify modifiable factors associated with a faster rate of decline. This was a single-center retrospective study of 97 patients who underwent elective liver transplantation and survived =5 yr. eGFR was estimated using the MDRD6-variable equation, and the annualized change in eGFR was determined using simple linear regression. The baseline eGFR was 75 mL/min/1.73 m2. Thereafter, eGFR declined at a mean rate of 1.08 mL/min/1.73 m2 per year. 49% had a decline in renal function greater than the rate expected with aging. Decline in eGFR was an independent predictor of CKD by five yr post-transplant (p = 0.001). Multivariate modeling found a higher baseline eGFR (p < 0.001), female gender (p = 0.006), hypertension (p = 0.019), and dyslipidemia (p = 0.034) to be associated with a faster rate of decline in renal function. In conclusion, liver transplant recipients have a clinically relevant decline in eGFR from six months post-transplant. Prospective studies are required to examine the effects of aggressive blood pressure and lipid control on the development of CKD in this setting.
C1 [Leithead, Joanna A.; Hayes, Peter C.] Royal Infirm Edinburgh NHS Trust, Scottish Liver Transplant Unit, Edinburgh EH16 4SA, Midlothian, Scotland.
   [Ferguson, James W.] Queen Elizabeth Hosp, Liver Unit, Birmingham B15 2TH, W Midlands, England.
C3 Royal Infirmary of Edinburgh; University of Edinburgh; University of
   Birmingham
RP Leithead, JA (corresponding author), Royal Infirm Edinburgh NHS Trust, Scottish Liver Transplant Unit, 51 Little France Crescent, Edinburgh EH16 4SA, Midlothian, Scotland.
EM jleithea@staffmail.ed.ac.uk
CR Agarwal R, 2007, MAYO CLIN PROC, V82, P1381, DOI 10.4065/82.11.1381
   Barnett AG, 2005, INT J EPIDEMIOL, V34, P215, DOI 10.1093/ije/dyh299
   Boudjema K, 2011, AM J TRANSPLANT, V11, P965, DOI 10.1111/j.1600-6143.2011.03486.x
   Calmus Y, 2010, TRANSPLANTATION, V89, P1504, DOI 10.1097/TP.0b013e3181db8cf0
   Cicinnati VR, 2007, ALIMENT PHARM THER, V26, P1195, DOI 10.1111/j.1365-2036.2007.03466.x
   Cohen AJ, 2002, LIVER TRANSPLANT, V8, P916, DOI 10.1053/jlts.2002.35668
   DISTANT DA, 1993, J AM SOC NEPHROL, V4, P129
   Fisher NC, 1998, TRANSPLANTATION, V66, P59, DOI 10.1097/00007890-199807150-00010
   Fried LF, 2005, J AM SOC NEPHROL, V16, P3728, DOI 10.1681/ASN.2005040384
   Gill JS, 2004, KIDNEY INT, V65, P692, DOI 10.1111/j.1523-1755.2004.00431.x
   Gill JS, 2003, J AM SOC NEPHROL, V14, P1636, DOI 10.1097/01.ASN.0000070621.06264.86
   Gonwa T, 2004, LIVER TRANSPLANT, V10, P301, DOI 10.1002/lt.20017
   Gonwa TA, 2001, TRANSPLANTATION, V72, P1934, DOI 10.1097/00007890-200112270-00012
   Halbesma N, 2008, KIDNEY INT, V74, P505, DOI 10.1038/ki.2008.200
   Kronborg J, 2008, NEPHROL DIAL TRANSPL, V23, P2818, DOI 10.1093/ndt/gfn148
   LEVEY AS, 1991, J AM SOC NEPHROL, V1, P1087
   Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002
   Moreno JM, 2003, TRANSPLANT P, V35, P1907, DOI 10.1016/S0041-1345(03)00642-0
   Neal DAJ, 2001, TRANSPLANTATION, V72, P1689, DOI 10.1097/00007890-200111270-00021
   Neuberger JM, 2009, AM J TRANSPLANT, V9, P327, DOI 10.1111/j.1600-6143.2008.02493.x
   O'Riordan A, 2006, NEPHROL DIAL TRANSPL, V21, P2630, DOI 10.1093/ndt/gfl247
   Ojo AO, 2007, SEMIN NEPHROL, V27, P498, DOI 10.1016/j.semnephrol.2007.03.010
   Ojo AO, 2003, NEW ENGL J MED, V349, P931, DOI 10.1056/NEJMoa021744
   Olyaei A J, 2001, Curr Opin Crit Care, V7, P384, DOI 10.1097/00075198-200112000-00003
   Pageaux GP, 2007, HEPATOLOGY, V46, p233A
   Pageaux GP, 2006, LIVER TRANSPLANT, V12, P1755, DOI 10.1002/lt.20903
   Pawarode A, 2003, LIVER TRANSPLANT, V9, P741, DOI 10.1053/jlts.2003.50113
   Pillebout E, 2005, AM J TRANSPLANT, V5, P1120, DOI 10.1111/j.1600-6143.2005.00852.x
   Reich DJ, 2005, TRANSPLANTATION, V80, P18, DOI 10.1097/01.TP.0000165118.00988.D7
   Schlitt HJ, 2001, LANCET, V357, P587, DOI 10.1016/S0140-6736(00)04055-1
   Wilkinson AH, 1999, J AM SOC NEPHROL, V10, P1136
   Yoshida EM, 2005, LIVER TRANSPLANT, V11, P1064, DOI 10.1002/lt.20490
NR 32
TC 13
Z9 14
U1 0
U2 1
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0902-0063
J9 CLIN TRANSPLANT
JI Clin. Transplant.
PD MAY-JUN
PY 2012
VL 26
IS 3
BP E316
EP E323
DI 10.1111/j.1399-0012.2012.01650.x
PG 8
WC Surgery; Transplantation
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Surgery; Transplantation
GA 957DB
UT WOS:000305137800018
PM 22686956
DA 2024-02-19
ER

PT J
AU Hallberg, LM
   Ikeno, Y
   Englander, E
   Greeley, GH
AF Hallberg, LM
   Ikeno, Y
   Englander, E
   Greeley, GH
TI Effects of aging and caloric restriction on IGF-I, IGF-I receptor,
   IGFBP-3 and IGFBP-4 gene expression in the rat stomach and colon
SO REGULATORY PEPTIDES
LA English
DT Article
DE gastrointestinal; insulin-like growth factor; insulin-like growth factor
   binding proteins
ID GROWTH-FACTOR-I; MESSENGER RIBONUCLEIC-ACIDS; FACTOR BINDING-PROTEINS;
   SMALL-BOWEL RESECTION; DIETARY RESTRICTION; INHIBITS APOPTOSIS; LIVER;
   SERUM; AGE; PEPTIDES
AB The purpose of this study was to determine the effects of aging and caloric restriction (CR) on insulin-like growth factor-I (IGF-I), IGF-I receptor (IGF-IR), IGF-binding protein-3 (IGFBP-3) and IGFBP-4 expression in the stomach and colon of male Fischer 344 rats. Stomach and colonic RNA were prepared from ad libitum (AL) fed or long-term CR rats. Stomach IGF-I, IGFBP-3 and IGFBP-4 mRNA levels increased significantly (P less than or equal to 0.05), while colonic IGF-I mRNA levels were unchanged in aged AL rats. In aged CR rats, stomach IGFBP-3 mRNA levels decreased. Stomach and colonic IGF-IR mRNA levels declined with aging in AL and CR rats (P less than or equal to 0.05). Colonic IGFBP-3 mRNA levels decreased significantly with aging in AL rats. There were no changes in colonic IGFBP-4 mRNA levels in aged AL or CR rats. Increased expression of stomach IGF-I, IGFBP-3 and IGFBP-4 in aged AL rats suggests that the stomach attempts to preserve IGF activity by increasing local expression of IGF-I and IGFBPs. Because the aging colon has a propensity to develop cancer, it may adapt to increased colonic IGF-I expression by reducing IGF-IR and IGFBP-3 expression. Additionally, CR lowers colonic IGF-I expression in aged rats (24 months) which may also be a protective adaptive mechanism. (C) 2000 Elsevier Science BN. All rights reserved.
C1 Univ Texas, Med Branch, Dept Surg, Galveston, TX 77555 USA.
   Univ Texas, Hlth Sci Ctr, Dept Physiol, San Antonio, TX 78284 USA.
   Shriners Hosp Children, Galveston, TX USA.
C3 University of Texas System; University of Texas Medical Branch
   Galveston; University of Texas System; University of Texas Health
   Science Center at San Antonio
RP Greeley, GH (corresponding author), Univ Texas, Med Branch, Dept Surg, 301 Univ Blvd, Galveston, TX 77555 USA.
FU NIA NIH HHS [AG01188] Funding Source: Medline; NIDDK NIH HHS
   [R01DK15241, P01DK35608] Funding Source: Medline
CR ALBISTON AL, 1992, MOL CELL ENDOCRINOL, V83, pR17, DOI 10.1016/0303-7207(92)90166-4
   Benson D, 1996, MUTAT RES-FUND MOL M, V356, P209, DOI 10.1016/0027-5107(96)00057-7
   BREESE CR, 1991, J GERONTOL, V46, pB180, DOI 10.1093/geronj/46.5.B180
   Chan K, 1997, ENDOCRINE, V7, P95, DOI 10.1007/BF02778072
   CLEMMONS DR, 1991, ANNU REV NUTR, V11, P393, DOI 10.1146/annurev.nu.11.070191.002141
   CollettSolberg PF, 1996, ENDOCRIN METAB CLIN, V25, P591, DOI 10.1016/S0889-8529(05)70342-X
   Conover CA, 1997, ENDOCRINE, V7, P93, DOI 10.1007/BF02778071
   CONOVER CA, 1994, CURRENT DIRECTIONS I, P255
   DAUGHADAY WH, 1989, ENDOCR REV, V10, P68, DOI 10.1210/edrv-10-1-68
   DESCHNER EE, 1988, SCAND J GASTROENTERO, V23, P94, DOI 10.3109/00365528809095919
   Estivariz CF, 1997, ENDOCRINE, V7, P65, DOI 10.1007/BF02778066
   Fante R, 1997, AM J GASTROENTEROL, V92, P1505
   FROESCH ER, 1985, ANNU REV PHYSIOL, V47, P443
   GOMEZ G, 1995, AM J PHYSIOL-GASTR L, V268, pG71, DOI 10.1152/ajpgi.1995.268.1.G71
   IWASAKI K, 1988, J GERONTOL, V43, P5
   Kelley KW, 1998, ANN NY ACAD SCI, V840, P518, DOI 10.1111/j.1749-6632.1998.tb09590.x
   LABURTHE M, 1988, AM J PHYSIOL, V254, P457
   LEMMEY AB, 1994, GROWTH FACTORS, V10, P243, DOI 10.3109/08977199409010990
   LEMOZY S, 1994, ENDOCRINOLOGY, V135, P617, DOI 10.1210/en.135.2.617
   LOWE WL, 1987, P NATL ACAD SCI USA, V84, P8946, DOI 10.1073/pnas.84.24.8946
   MacDonald RS, 1999, HORM METAB RES, V31, P103, DOI 10.1055/s-2007-978706
   Majumdar APN, 1997, P SOC EXP BIOL MED, V215, P134, DOI 10.3181/00379727-215-44120
   Mantell MP, 1995, AM J PHYSIOL-GASTR L, V269, pG974, DOI 10.1152/ajpgi.1995.269.6.G974
   MASORO EJ, 1991, ANN NY ACAD SCI, V621, P337
   Masoro EJ, 1996, TOXICOL PATHOL, V24, P738, DOI 10.1177/019262339602400617
   MASORO EJ, 1993, J AM GERIATR SOC, V41, P994, DOI 10.1111/j.1532-5415.1993.tb06767.x
   Mohan S., 1995, Progress in Growth Factor Research, V6, P465, DOI 10.1016/0955-2235(95)00027-5
   Neuberg M, 1997, ENDOCRINE, V7, P107, DOI 10.1007/BF02778075
   NICOLAS V, 1994, J CLIN ENDOCR METAB, V78, P1011, DOI 10.1210/jc.78.5.1011
   OLANREWAJU H, 1992, AM J PHYSIOL, V263, pE282, DOI 10.1152/ajpendo.1992.263.2.E282
   Parrizas M, 1997, J BIOL CHEM, V272, P154
   READ LC, 1991, MODERN CONCEPTS INSU, P225
   SCHLENKER ED, 1999, NUTR AGING, P77
   SHIMASAKI S, 1989, BIOCHEM BIOPH RES CO, V165, P907, DOI 10.1016/S0006-291X(89)80052-X
   SHIMASAKI S, 1990, MOL ENDOCRINOL, V4, P1451, DOI 10.1210/mend-4-10-1451
   Sjögren K, 1999, P NATL ACAD SCI USA, V96, P7088, DOI 10.1073/pnas.96.12.7088
   Stewart CEH, 1996, PHYSIOL REV, V76, P1005, DOI 10.1152/physrev.1996.76.4.1005
   TOMAS FM, 1993, J ENDOCRINOL, V137, P413, DOI 10.1677/joe.0.1370413
   VANDEHAAR MJ, 1991, J ENDOCRINOL, V130, P305, DOI 10.1677/joe.0.1300305
   WERNER H, 1989, P NATL ACAD SCI USA, V86, P7451, DOI 10.1073/pnas.86.19.7451
   WINESETT DE, 1995, AM J PHYSIOL-GASTR L, V268, pG631, DOI 10.1152/ajpgi.1995.268.4.G631
   Yakar S, 1999, P NATL ACAD SCI USA, V96, P7324, DOI 10.1073/pnas.96.13.7324
   YU BP, 1985, J GERONTOL, V40, P657, DOI 10.1093/geronj/40.6.657
   Zhang JH, 1997, ENDOCRINOLOGY, V138, P3112, DOI 10.1210/en.138.8.3112
   ZHANG W, 1995, TRANSPLANTATION, V59, P755, DOI 10.1097/00007890-199503150-00020
   Ziegler TR, 1996, AM J PHYSIOL-GASTR L, V271, pG866, DOI 10.1152/ajpgi.1996.271.5.G866
NR 46
TC 13
Z9 17
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-0115
J9 REGUL PEPTIDES
JI Regul. Pept.
PD MAY 10
PY 2000
VL 89
IS 1-3
BP 37
EP 44
DI 10.1016/S0167-0115(00)00095-1
PG 8
WC Endocrinology & Metabolism; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Physiology
GA 312GX
UT WOS:000086935900006
PM 10771311
DA 2024-02-19
ER

PT J
AU Chick, CN
   Sasaki, Y
   Kawaguchi, M
   Tanaka, E
   Niikura, T
   Usuki, T
AF Chick, Christian Nanga
   Sasaki, Yusuke
   Kawaguchi, Mari
   Tanaka, Eri
   Niikura, Takako
   Usuki, Toyonobu
TI LC-MS/MS quantitation of elastin crosslinker desmosines and histological
   analysis of skin aging characteristics in mice
SO BIOORGANIC & MEDICINAL CHEMISTRY
LA English
DT Article
DE Elastin; Desmosines; LC-MS; MS; Senescent Accelerated Mouse Prone
   (SAMP); Resistant (SAMR)
ID ACCELERATED MOUSE SAM; MODEL; ISODESMOSINE
AB Elastic fibers consist of an insoluble inner core of elastin, which confers elasticity and resilience to vertebral organs and tissues. Desmosine (DES) and isodesmosine (IDES) are potential biomarkers of pathologies that lead to decreased elastin turnover. Mice are commonly used in research to mimic humans because of their similar genetics, physiology, and organ systems. The present study thus used senescent accelerated prone (SAMP10) and senescent accelerated resistant (SAMR1) mice to examine the connection between aging and histological or biomolecular changes. Mice were divided into three groups: SAMP10 fed a control diet (CD), SAMP10 fed a highfat diet (HFD), and SAMR1 fed a CD. The percent liver to total body weight ratio (%LW/BW), desmosines (DESs or DES/IDES) content, and histological alterations in skin samples were evaluated. DESs were quantified using an isotope-dilution liquid chromatography-tandem mass spectrometry method with isodesmosine-13C3,15N1 as the internal standard (ISTD). The assays were repeatable, reproducible, and accurate, with %CV values & LE; (1.90, 1.77, and 3.03), ISTD area %RSD of (1.54, 0.92, and 1.13), and %AC of (99.02 & PLUSMN; 1.86, 101.00 & PLUSMN; 2.30, and 101.30 & PLUSMN; 2.90) for the calibrations (equimolar DES/IDES, DES, and IDES, respectively). The average DESs content per dry-weight abdominal skin and %LW/BW were similar between the three groups. Histological analyses revealed elastin fibers in five randomly selected samples. The epidermis and dermal white adipose tissue layers were thicker in SAMP10 mice than SAMR1 mice. Thus, characteristic signs of aging in SAMP10 and SAMR1 mice could not be differentiated based on measurement of DESs content of the skin or %LW/BW, but aging could be differentiated based on microscopic analysis of histological changes in the skin components of SAMP10 and SAMR1 mice.
C1 [Chick, Christian Nanga; Kawaguchi, Mari; Tanaka, Eri; Usuki, Toyonobu] Sophia Univ, Fac Sci & Technol, Dept Mat & Life Sci, 7-1 Kioicho,Chiyoda Ku, Tokyo 1028554, Japan.
   [Sasaki, Yusuke; Niikura, Takako] Sophia Univ, Fac Sci & Technol, Dept Informat & Commun Sci, 7-1 Kioicho,Chiyoda Ku, Tokyo 1028554, Japan.
C3 Sophia University; Sophia University
RP Kawaguchi, M; Usuki, T (corresponding author), Sophia Univ, Fac Sci & Technol, Dept Mat & Life Sci, 7-1 Kioicho,Chiyoda Ku, Tokyo 1028554, Japan.; Niikura, T (corresponding author), Sophia Univ, Fac Sci & Technol, Dept Informat & Commun Sci, 7-1 Kioicho,Chiyoda Ku, Tokyo 1028554, Japan.
EM k-mari@sophia.ac.jp; niikura@sophia.ac.jp; t-usuki@sophia.ac.jp
RI Usuki, Toyonobu/AAZ-4774-2021
OI Usuki, Toyonobu/0000-0002-0212-5371; Niikura, Takako/0000-0003-2672-1335
FU JSPS KAKENHI [19KK0420, 20K05734]
FX This work was supported in part by the JSPS KAKENHI (grant nos. 19KK0420
   and 20K05734) .
CR Alexander CM, 2015, J LIPID RES, V56, P2061, DOI 10.1194/jlr.R062893
   Ali SM, 2021, PHOTODERMATOL PHOTO, V37, P140, DOI 10.1111/phpp.12623
   Anzawa R, 2023, EUR FOOD RES TECHNOL, V249, P829, DOI 10.1007/s00217-022-04180-y
   Bahri OA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52071-2
   Bartstra JW, 2020, J CLIN MED, V9, DOI 10.3390/jcm9092771
   Boisvert FM, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011429
   Brazelton TR, 2003, DEV BIOL, V262, P64, DOI 10.1016/S0012-1606(03)00357-9
   Burger O, 2012, P NATL ACAD SCI USA, V109, P18210, DOI 10.1073/pnas.1215627109
   Chick CN, 2023, BIOORGAN MED CHEM, V82, DOI 10.1016/j.bmc.2023.117216
   de Brouwer B, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0747-6
   Driskell RR, 2014, EXP DERMATOL, V23, P629, DOI 10.1111/exd.12450
   Emes RD, 2003, HUM MOL GENET, V12, P701, DOI 10.1093/hmg/ddg078
   Fessel G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110948
   Franco Oscar H, 2007, BMC Geriatr, V7, P10, DOI 10.1186/1471-2318-7-10
   Fulop T, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01508
   Heinz A, 2021, AGEING RES REV, V66, DOI 10.1016/j.arr.2021.101255
   Hirose M, 2021, BIOORGAN MED CHEM, V52, DOI 10.1016/j.bmc.2021.116519
   Huang JTJ, 2016, EUR RESPIR J, V48, P1215, DOI 10.1183/13993003.01125-2016
   Huertas ACM, 2016, BIOCHIMIE, V128, P163, DOI 10.1016/j.biochi.2016.08.010
   Katayama M, 1990, Nihon Ronen Igakkai Zasshi, V27, P584
   Kim MS, 2022, COSMETICS-BASEL, V9, DOI 10.3390/cosmetics9030051
   Kumagai N, 2007, BRAIN RES, V1185, P75, DOI 10.1016/j.brainres.2007.09.021
   Lee YI, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22083849
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Luo Yu, 2002, Medical Electron Microscopy, V35, P31, DOI 10.1007/s007950200004
   Naldaiz-Gastesi N, 2018, J ANAT, V233, P275, DOI 10.1111/joa.12840
   Oikarinen A, 2014, INT J COSMETIC SCI, V26, P107, DOI DOI 10.1111/J.1467-2494.2004.213_6.X
   Okuma Y, 1998, JPN J PHARMACOL, V78, P399, DOI 10.1254/jjp.78.399
   Pierre A, 2019, AM J PHYSIOL-LUNG C, V316, pL608, DOI 10.1152/ajplung.00402.2018
   Reilly DM, 2021, Plast Aesthet Res, V8, DOI [10.20517/2347-9264.2020.153, DOI 10.20517/2347-9264.2020.153]
   Rogers A.B., 2018, Comparative anatomy and histology, V13, P229, DOI 10.1016/B978-0-12-802900-8.00013-0
   Schmelzer CEH, 2022, FEBS J, V289, P3704, DOI 10.1111/febs.15899
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Sgarbieri Valdemiro Carlos, 2017, Braz. J. Food Technol., V20, pe2016194, DOI 10.1590/1981-6723.19416
   SHAPIRO SD, 1991, J CLIN INVEST, V87, P1828, DOI 10.1172/JCI115204
   Shimada A, 2011, AGING DIS, V2, P414
   Takeda T, 1997, EXP GERONTOL, V32, P105, DOI 10.1016/S0531-5565(96)00036-8
   Takeda T, 2009, NEUROCHEM RES, V34, P639, DOI 10.1007/s11064-009-9922-y
   Tanigawa T, 2015, BIOORG MED CHEM LETT, V25, P2046, DOI 10.1016/j.bmcl.2015.03.084
   Turino GM, 2011, AM J RESP CRIT CARE, V184, P637, DOI 10.1164/rccm.201103-0450PP
   Usuki T, 2014, ORG LETT, V16, P1672, DOI 10.1021/ol500333t
   Viglio S, 2017, AMINO ACID NEW INSIG, DOI [10.5772/intechopen.68570, DOI 10.5772/INTECHOPEN.68570]
   Viglio S, 2007, J SEP SCI, V30, P202, DOI 10.1002/jssc.200600260
NR 43
TC 1
Z9 1
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0968-0896
EI 1464-3391
J9 BIOORGAN MED CHEM
JI Bioorg. Med. Chem.
PD JUL 15
PY 2023
VL 90
AR 117351
DI 10.1016/j.bmc.2023.117351
EA MAY 2023
PG 7
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry,
   Organic
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry
GA J8AH2
UT WOS:001011789800001
PM 37247585
DA 2024-02-19
ER

PT J
AU Huang, H
   Zheng, CJ
   Wang, LF
   Che-Nordin, N
   Wáng, YXJ
AF Huang, Hua
   Zheng, Cun-Jing
   Wang, Li-Fei
   Che-Nordin, Nazmi
   Wang, Yi Xiang J.
TI Age and gender dependence of liver diffusion parameters and the
   possibility that intravoxel incoherent motion modeling of the perfusion
   component is constrained by the diffusion component
SO NMR IN BIOMEDICINE
LA English
DT Article; Early Access
DE aging; biophysical mechanisms of MR diffusion liver; diffusion&#8208;
   weighted imaging; hepatobiliary; intravoxel incoherent motion
ID BLOOD-FLOW; IRON OVERLOAD; WEIGHTED MRI; AGING LIVER; FIBROSIS; TISSUE;
   IMAGE
AB The aim of this study was to establish reference values for middle-aged subjects and to investigate the age and gender dependence of liver diffusion MRI parameters. The IVIM type of liver diffusion scan was based on a single-shot spin-echo-type echo-planar sequence using a 1.5 T magnet with 16 b-values. Diffusion-derived vessel density (DDVD)(b0b2) or DDVD(b0b10) was the signal difference between b = 0 and b = 2 (or b = 10) s/mm(2) images after removing visible vessels. IVIM analysis was performed with full fitting and segmented fitting, and with a threshold b-value of 60 or 200 s/mm(2), and fitting started from b = 2 s/mm(2). Thirty-one men (age range: 25-71 years) and 26 men (age: 22-69 years) had DDVD and IVIM analysis, respectively, while 37 women (age: 20-71 years) and 36 women (age: 20-71 years) had DDVD and IVIM analysis, respectively. DDVD results showed a significant age-related reduction for women. IVIM results for full fitting showed excellent agreement with those for segmented fitting using a threshold b of 60 s/mm(2), but this was less good for results with a threshold b of 200 s/mm(2). As age increased, female subjects' D-slow measure showed a significant reduction, while their PF and D-fast measures showed a significant increase. For the age group of 40-55 years, DDVD(b0b2), DDVD(b0b10), D-slow, PF and D-fast were 12.26 +/- 3.90 au/pixel, 16.95 +/- 5.45 au/pixel, 1.072 +/- 0.067 (10(-3) mm(2)/s), 0.141 +/- 0.025 and 61.0 +/- 14.0 (10(-3) mm(2)/s) for men, and 13.35 +/- 3.6 au/pixel, 17.20 +/- 3.62 au/pixel, 1.069 +/- 0.074 (10(-3) mm(2)/s), 0.119 +/- 0.014 and 57.1 +/- 13.2 (10(-3) mm(2)/s) for women, respectively. DDVD measure of this study suggest that aging is associated with a reduction in liver perfusion. There is a possibility that a lower D-slow measure is associated with artificially higher PF and D-fast measures, and that IVIM modeling of the perfusion component is constrained by the diffusion component.
C1 [Huang, Hua; Wang, Li-Fei] Southern Univ Sci & Technol, Natl Clin Res Ctr Infect Dis, Affiliated Hosp 2, Peoples Hosp Shenzhen 3,Dept Radiol, Shenzhen, Guangdong, Peoples R China.
   [Zheng, Cun-Jing; Che-Nordin, Nazmi; Wang, Yi Xiang J.] Chinese Univ Hong Kong, Fac Med, Dept Imaging & Intervent Radiol, Shatin, Hong Kong, Peoples R China.
C3 Southern University of Science & Technology; Chinese University of Hong
   Kong
RP Wáng, YXJ (corresponding author), Chinese Univ Hong Kong, Fac Med, Dept Imaging & Intervent Radiol, Shatin, Hong Kong, Peoples R China.
EM yixiang_wang@cuhk.edu.hk
OI Zheng, Cunjing/0000-0002-0836-6598
FU Hong Kong GRF [14109218]; Sanming Project of Medicine in Shenzhen
   [SZSM201612053]
FX Hong Kong GRF, Grant/Award Number: Project No. 14109218; Sanming Project
   of Medicine in Shenzhen, Grant/Award Number: SZSM201612053
CR Bülow R, 2013, EUR RADIOL, V23, P1281, DOI 10.1007/s00330-012-2700-2
   Cercueil JP, 2015, EUR RADIOL, V25, P1541, DOI 10.1007/s00330-014-3554-6
   Chen LS, 2014, EUR RADIOL, V24, P1715, DOI 10.1007/s00330-014-3178-x
   Chevallier O, 2019, NMR BIOMED, V32, DOI 10.1002/nbm.4155
   Chevallier O, 2018, ACTA RADIOL, V59, P1157, DOI 10.1177/0284185118756949
   Cook CI, 1998, MECH AGEING DEV, V102, P1, DOI 10.1016/S0047-6374(98)00005-0
   Fiel MI, 2011, J HEPATOL, V55, P582, DOI 10.1016/j.jhep.2010.12.018
   Gambarota G, 2017, MAGN RESON MED, V77, P310, DOI 10.1002/mrm.26085
   Gan Lay, 2011, Curr Gerontol Geriatr Res, V2011, P831536, DOI 10.1155/2011/831536
   Gurney-Champion OJ, 2016, INVEST RADIOL, V51, P211, DOI 10.1097/RLI.0000000000000225
   Huang H, 2019, ANN TRANSL MED, V7, DOI 10.21037/atm.2018.12.33
   Le Couteur DG, 1998, CLIN PHARMACOKINET, V34, P359, DOI 10.2165/00003088-199834050-00003
   LEBIHAN D, 1986, RADIOLOGY, V161, P401, DOI 10.1148/radiology.161.2.3763909
   LEBIHAN D, 1991, JMRI-J MAGN RESON IM, V1, P7, DOI 10.1002/jmri.1880010103
   Li T, 2019, QUANT IMAG MED SURG, V9, P371, DOI 10.21037/qims.2019.02.11
   Li YT, 2017, QUANT IMAGING MED SU, V7, P59, DOI 10.21037/qims.2017.02.03
   Lu PX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113846
   Ludwig J, 1997, GASTROENTEROLOGY, V112, P882, DOI 10.1053/gast.1997.v112.pm9041250
   Maeso-Díaz R, 2018, AGING CELL, V17, DOI 10.1111/acel.12829
   Murphy P, 2015, J MAGN RESON IMAGING, V41, P1629, DOI 10.1002/jmri.24755
   Park HJ, 2017, J MAGN RESON IMAGING, V45, P1637, DOI 10.1002/jmri.25535
   Regini F, 2015, J COMPUT ASSIST TOMO, V39, P365, DOI 10.1097/RCT.0000000000000220
   Riexinger AJ, 2019, J MAGN RESON IMAGING, V50, P1883, DOI 10.1002/jmri.26730
   Schwenzer NF, 2008, INVEST RADIOL, V43, P854, DOI 10.1097/RLI.0b013e3181862413
   ter Voert EEGW, 2016, INVEST RADIOL, V51, P90, DOI 10.1097/RLI.0000000000000207
   Ulbrich EJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141691
   Wang YXJ, 2019, QUANT IMAG MED SURG, V9, P1840, DOI 10.21037/qims.2019.09.18
   Wáng YXJ, 2019, QUANT IMAG MED SURG, V9, P127, DOI 10.21037/qims.2019.01.07
   Wáng YXJ, 2019, ACTA RADIOL, V60, P3, DOI 10.1177/0284185118774913
   Wáng YXJ, 2018, SLAS TECHNOL, V23, P179, DOI 10.1177/2472630317747198
   Wang YXJ, 2018, SLAS TECHNOL, V23, P259, DOI 10.1177/2472630317717049
   Wáng YXJ, 2018, ACTA RADIOL, V59, P257, DOI 10.1177/0284185117717764
   WEINFELD A, 1968, J CLIN PATHOL, V21, P35, DOI 10.1136/jcp.21.1.35
   Wurnig MC, 2018, NMR BIOMED, V31, DOI 10.1002/nbm.3852
   Wurnig MC, 2015, MAGN RESON MED, V74, P1414, DOI 10.1002/mrm.25506
   WYNNE HA, 1989, HEPATOLOGY, V9, P297, DOI 10.1002/hep.1840090222
   Xiao BH, 2020, SLAS TECHNOL, V25, P474, DOI 10.1177/2472630320915838
   Yuan J, 2016, QUANT IMAG MED SURG, V6, P418, DOI 10.21037/qims.2016.08.05
   Zeeh J, 2002, GERONTOLOGY, V48, P121, DOI 10.1159/000052829
   Zoli M, 1999, AGE AGEING, V28, P29, DOI 10.1093/ageing/28.1.29
NR 40
TC 18
Z9 19
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0952-3480
EI 1099-1492
J9 NMR BIOMED
JI NMR Biomed.
PD 2021 MAR
PY 2021
VL 34
IS 3
AR e4449
DI 10.1002/nbm.4449
EA DEC 2020
PG 12
WC Biophysics; Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biophysics; Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy
GA QF4IA
UT WOS:000600886400001
PM 33354829
OA Green Submitted
DA 2024-02-19
ER

PT J
AU Akashi, K
   Ebata, T
   Mizuno, T
   Yokoyama, Y
   Igami, T
   Yamaguchi, J
   Onoe, S
   Nagino, M
AF Akashi, Kumiko
   Ebata, Tomoki
   Mizuno, Takashi
   Yokoyama, Yukihiro
   Igami, Tsuyoshi
   Yamaguchi, Junpei
   Onoe, Shunsuke
   Nagino, Masato
TI Surgery for perihilar cholangiocarcinoma from a viewpoint of age: Is it
   beneficial to octogenarians in an aging society?
SO SURGERY
LA English
DT Article
ID CONSECUTIVE HEPATOBILIARY RESECTIONS; ELDERLY-PATIENTS;
   SURGICAL-TREATMENT; HILAR CHOLANGIOCARCINOMA; HEPATOCELLULAR-CARCINOMA;
   HEPATIC RESECTION; BILIARY DRAINAGE; LIVER RESECTION; CANCER-SURGERY;
   PORTAL-VEIN
AB Background: Whether operative treatment provides benefits for elderly patients with perihilar cholan-giocarcinoma is unknown. The aim of this study was to review resection of perihilar cholangiocarcinoma according to age and to clarify its value for octogenarians.
   Methods: Between April 1977 and December 2015, we reviewed consecutive patients who underwent resection for perihilar cholangiocarcinoma with a special focus on patient age.
   Results: During the study interval, 831 patients underwent resection for perihilar cholangiocarcinoma. The median age of the resected patients increased by 11 years over approximately 40 years. Before 2001, no octogenarians underwent operative intervention; however, the proportion of operations for octogenarians increased to 9% after 2010. Further analyses were performed on 643 resected patients between 2001 and 2015. The resectability rate was not different between the octogenarians and the other age groups (71% vs 72.4%). The Charlson Comorbidity Index and preoperative laboratory data were similar between the 2 groups. A less advanced tumor was a predominant feature in the octogenarians compared to the other age groups. Consequently, the procedure used in the octogenarians were less extensive, but the proportion of R-0 resection was greater in the octogenarians than in the other age groups (95.% vs 78.3%, P=.008). The ratio of patients who died of other diseases was also greater among octogenarians (29% vs 6.0%, P < .001). Overall survival was similar between the 2 groups (41% vs 38.9% at 5 years).
   Conclusion: Resection of perihilar cholangiocarcinoma can be performed with low mortality irrespective of age with careful patient selection and offers long-term survival even in octogenarians. (C) 2018 Elsevier Inc. All rights reserved.
C1 [Akashi, Kumiko; Ebata, Tomoki; Mizuno, Takashi; Yokoyama, Yukihiro; Igami, Tsuyoshi; Yamaguchi, Junpei; Onoe, Shunsuke; Nagino, Masato] Nagoya Univ, Grad Sch Med, Dept Surg, Div Surg Oncol, Nagoya, Aichi, Japan.
C3 Nagoya University
RP Nagino, M (corresponding author), Nagoya Univ, Grad Sch Med, Dept Surg, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.
EM nagino@med.nagoya-u.ac.jp
RI Mizuno, Takashi/JVZ-2749-2024; MIZUNO, Takashi/I-7471-2014; Nagino,
   Masato/I-7342-2014
OI MIZUNO, Takashi/0000-0001-8802-1188; Maeda, Takashi/0000-0003-2238-0633
CR Adam R, 2010, BRIT J SURG, V97, P366, DOI 10.1002/bjs.6889
   DeOliveira ML, 2007, ANN SURG, V245, P755, DOI 10.1097/01.sla.0000251366.62632.d3
   Ebata T, 2003, ANN SURG, V238, P720, DOI 10.1097/01.sla.0000094437.68038.a3
   Ebata T, 2012, ANN SURG, V256, P297, DOI 10.1097/SLA.0b013e31826029ca
   Hellmann S, 2010, HEPATO-GASTROENTEROL, V57, P403
   Kamiya S, 2004, ANN SURG, V239, P510, DOI 10.1097/01.sla.0000118594.23874.89
   Kawashima H, 2013, ANN SURG, V257, P121, DOI 10.1097/SLA.0b013e318262b2e9
   Koerkamp BG, 2015, J AM COLL SURGEONS, V221, P1041, DOI 10.1016/j.jamcollsurg.2015.09.005
   Kondo K, 2008, WORLD J SURG, V32, P2223, DOI 10.1007/s00268-008-9688-4
   Lee SG, 2010, J HEPATO-BIL-PAN SCI, V17, P476, DOI 10.1007/s00534-009-0204-5
   Matsuoka H, 2018, ASIAN J SURG, V41, P192, DOI 10.1016/j.asjsur.2016.10.001
   Matsuoka K, 2018, WORLD J SURG, V42, P153, DOI 10.1007/s00268-017-4142-0
   Mazzoni G, 2007, INT J COLORECTAL DIS, V22, P77, DOI 10.1007/s00384-006-0096-7
   NAGINO M, 1992, HEPATO-GASTROENTEROL, V39, P296
   Nagino M, 2005, SURGERY, V137, P148, DOI 10.1016/j.surg.2004.06.006
   Nagino M, 2006, ANN SURG, V244, P524
   Nagino M, 2013, ANN SURG, V258, P129, DOI 10.1097/SLA.0b013e3182708b57
   Nagino M, 2010, ANN SURG, V252, P115, DOI 10.1097/SLA.0b013e3181e463a7
   Nanashima A, 2011, J SURG ONCOL, V104, P284, DOI 10.1002/jso.21932
   Nuzzo G, 2012, ARCH SURG-CHICAGO, V147, P26, DOI 10.1001/archsurg.2011.771
   Oishi K, 2009, J GASTROINTEST SURG, V13, P695, DOI 10.1007/s11605-008-0758-6
   Pope D, 2006, SURG ONCOL, V15, P189, DOI 10.1016/j.suronc.2007.04.009
   Reddy SK, 2011, J AM COLL SURGEONS, V212, P787, DOI 10.1016/j.jamcollsurg.2010.12.048
   Sano T, 2006, ANN SURG, V244, P240, DOI 10.1097/01.sla.0000217605.66519.38
   Sawada T, 2008, HEPATO-GASTROENTEROL, V55, P1971
   Shirabe K, 2009, WORLD J SURG, V33, P1927, DOI 10.1007/s00268-009-0122-3
   Sugawara G, 2006, ANN SURG, V244, P706, DOI 10.1097/01.sla.0000219039.20924.88
   Takahashi Y, 2013, J HEPATO-BIL-PAN SCI, V20, P324, DOI 10.1007/s00534-012-0529-3
   Yeh CN, 2006, ANN SURG ONCOL, V13, P1553, DOI 10.1245/s10434-006-9085-x
   Yokoyama Y, 2010, BRIT J SURG, V97, P1260, DOI 10.1002/bjs.7084
NR 30
TC 29
Z9 29
U1 0
U2 1
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0039-6060
J9 SURGERY
JI Surgery
PD NOV
PY 2018
VL 164
IS 5
BP 1023
EP 1029
DI 10.1016/j.surg.2018.05.051
PG 7
WC Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Surgery
GA GY7CJ
UT WOS:000448761400019
PM 30082134
DA 2024-02-19
ER

PT J
AU Loguercio, C
   Taranto, D
   Vitale, LM
   Beneduce, F
   Blanco, CD
AF Loguercio, C
   Taranto, D
   Vitale, LM
   Beneduce, F
   Blanco, CD
TI Effect of liver cirrhosis and age on the glutathione concentration in
   the plasma, erythrocytes, and gastric mucosa of man
SO FREE RADICAL BIOLOGY AND MEDICINE
LA English
DT Article
DE age; cirrhosis; glutathione; free radicals
ID NONALCOHOLIC CIRRHOSIS; DISEASE; RAT; GASTROPATHY; CYSTEINE; INJURY
AB GSH and its related enzymes are one of the protective mechanisms vs. the oxidative damage, both in the circulation and in various tissues, including gastric mucose. Patients with liver cirrhosis frequently suffer from a gastropathy caused by portal hypertension and they present low circulating levels of GSH. Aging processes cause an increase of gastric damage, of lipoperoxidative phenomenons, and a decrease of GSH in animals. The aim of this study was the evaluation, in humans, of the effect of both these factors, age and liver cirrhosis, on the global pool of GSH and on the antioxidant capability of the cells of gastric mucosa. Therefore, we evaluated the effect of liver cirrhosis and age on the circulating levels of GSH, both in the plasma and in the erythrocytes, and the GSH concentration and the activity of the total GSH-transferase (GSH-T) in gastric mucosa of healthy subjects and in patients affected by liver cirrhosis. Age, but not liver cirrhosis, induced a significant decrease of GSH and GSH-T activity in gastric mucosa; on the contrary, the plasma levels of GSH decreased in cirrhotics but not in elderly healthy subjects. In the erythrocytes, GSH was affected by both these factors (age and liver cirrhosis). These findings indicate that both in patients with liver disease and in elderly healthy subjects the GSH-related cellular defensive mechanisms are depressed and therefore susceptibility to oxidative damage may increase.
C1 UNIV NAPLES 2, DEPT INTERNAL MED, GASTROENTEROL UNIT, NAPLES, ITALY.
C3 Universita della Campania Vanvitelli
OI LOGUERCIO, Carmelina/0000-0002-6863-6510
CR ALTOMARE E, 1988, LIFE SCI, V43, P991, DOI 10.1016/0024-3205(88)90544-9
   AMES BN, 1988, IARC SCI PUBL, V89, P407
   BECKETT GJ, 1987, J CLIN BIOCHEM NUTR, V2, P1
   BEUTLER E, 1989, ANNU REV NUTR, V9, P287, DOI 10.1146/annurev.nu.09.070189.001443
   BLANCO CD, 1983, PANMINERVA MED, V25, P225
   CAPORASO N, 1987, ANN ITAL MED INTERN, V3, P189
   CHASSEAUD LF, 1988, GLUTATHIONE CONJUGAT, P391
   DASS PD, 1992, BIOCHIM BIOPHYS ACTA, V1156, P99, DOI 10.1016/0304-4165(92)90102-Z
   Emerit I., 1992, FREE RADICALS AGING
   HANSEN RM, 1980, AM J GASTROENTEROL, V74, P497
   Hietanen E, 1992, Eur J Cancer Prev, V1 Suppl 3, P51, DOI 10.1097/00008469-199210003-00008
   HIROTA M, 1989, GASTROENTEROLOGY, V97, P853, DOI 10.1016/0016-5085(89)91488-1
   HOPPENKAMPS R, 1984, KLIN WOCHENSCHR, V62, P183, DOI 10.1007/BF01731642
   INONE M, 1986, NEFROTOXICITY ANTIBI, P51
   JENKINSON SG, 1991, AM J MED SCI, V302, P347, DOI 10.1097/00000441-199112000-00004
   KIKKAWA S, 1992, RES COMMUN CHEM PATH, V78, P289
   KURATA JH, 1989, GASTROENTEROLOGY, V96, P569, DOI 10.1016/S0016-5085(89)80052-6
   LAUTERBURG BH, 1984, HEPATOLOGY, V4, P586, DOI 10.1002/hep.1840040402
   LOGUERCIO C, 1992, SCAND J CLIN LAB INV, V52, P207, DOI 10.3109/00365519209088787
   LOGUERCIO C, 1990, ITAL J GASTROENTEROL, V22, P13
   LOGUERCIO C, IN PRESS OXIDATIVE M
   LOGUERCIO C, 1993, SCAND J GASTROENTERO, V26, P161
   LOGUERCIO C, 1988, VARIAZIONI RADICALI, P483
   MAJUMDAR APN, 1989, BIOCHIM BIOPHYS ACTA, V992, P35, DOI 10.1016/0304-4165(89)90047-0
   MAJUMDAR APN, 1990, DIGEST DIS SCI, V35, P1364, DOI 10.1007/BF01536742
   MAKARENKO EV, 1989, TERAPEVT ARKH, V61, P115
   MCCORMACK TT, 1985, GUT, V26, P1226, DOI 10.1136/gut.26.11.1226
   NEWTON GL, 1981, ANAL BIOCHEM, V114, P383, DOI 10.1016/0003-2697(81)90498-X
   OWEN JS, 1982, J LIPID RES, V23, P124
   PAPAZIAN A, 1986, GUT, V27, P1199, DOI 10.1136/gut.27.10.1199
   PEREZAYUSO RM, 1991, LANCET, V337, P1431, DOI 10.1016/0140-6736(91)93125-S
   PETERS WHM, 1992, FUNCTIONS GLUTATHION, P23
   PIHAN G, 1987, DIGEST DIS SCI, V32, P1395, DOI 10.1007/BF01296666
   PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817
   SHIGESAWA T, 1992, J GASTROEN HEPATOL, V7, P7, DOI 10.1111/j.1440-1746.1992.tb00926.x
   SZABO S, 1981, SCIENCE, V214, P200, DOI 10.1126/science.7280691
   SZABO S, 1989, J CLIN GASTROENTEROL, V9, P8
   TABAQCHALI S, 1974, GUT, V20, P417
   Taniguchi N, 1989, GLUTATHIONE CENTENNI
   VONRITTER C, 1988, DIGEST DIS SCI, V33, P857, DOI 10.1007/BF01550976
NR 40
TC 57
Z9 61
U1 2
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0891-5849
EI 1873-4596
J9 FREE RADICAL BIO MED
JI Free Radic. Biol. Med.
PY 1996
VL 20
IS 3
BP 483
EP 488
DI 10.1016/0891-5849(96)02057-6
PG 6
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA TY878
UT WOS:A1996TY87800028
PM 8720922
DA 2024-02-19
ER

PT J
AU Correa-Burrows, P
   Burrows, R
   Albala, C
   Court, FA
   Salech, F
   Sanhueza, G
   Gonzalez-Billault, C
AF Correa-Burrows, P.
   Burrows, R.
   Albala, C.
   Court, F. A.
   Salech, F.
   Sanhueza, G.
   Gonzalez-Billault, C.
TI Multiple events case-control study in a prospective cohort to identify
   systemic, cellular, and molecular biomarkers of obesity-induced
   accelerated aging in 30-years-olds: the ObAGE study protocol
SO BMC GERIATRICS
LA English
DT Article
DE Obesity; Aging; Epigentic age; Resilience; Early-onset cardiometabolic
   risk; Sarcopenia; Dysbiosis
ID KOREA NATIONAL-HEALTH; LOW MUSCLE MASS; METABOLIC SYNDROME;
   CARDIOMETABOLIC OUTCOMES; CHILDHOOD ADVERSITY; SENSITIVE PERIODS;
   YOUNG-ADULTS; LIFE-SPAN; STRESS; CHALLENGES
AB Background Aging is characterized by a progressive loss of capacities linked to fundamental alterations/damage in multiple cellular and molecular pathways. It is the most significant risk factor for all non-communicable diseases (NCDs). Another contributing factor to the rise in NCDs is obesity. It has been suggested that obesity not only accelerates the onset of metabolic imbalances but also decreases lifespan and impacts cellular and molecular processes in a manner similar to aging. Obesity might accelerate the pace of aging. Guided by a lifecourse approach, we will explore how exposure to obesity in critical developmental stages disrupt homeostatic resilience mechanisms that preserve physiological integrity, inducing an early expression of aging phenotypes. Also, we will determine whether exposure to early psychosocial adversity influences vulnerability to obesity as a risk factor for accelerated aging. Methods Multiple events case-control study embedded in a prospective cohort of Chileans at 30-31y, 50% females, of low- to-middle socioeconomic status, who participated in nutrition research since birth. At 23y, 25% had obesity and cardiometabolic risk was high. We will use a multi-layer approach including: anthropometric assessment; DXA scan for body composition; abdominal ultrasound of the liver; stool samples collection and sequencing of the ribosomal RNA 16S gene to characterize the gut microbiome; determination of age-related pro-inflammatory cytokynes and anti-inflammatory miokynes. For the first time in Chile, we will address age-related epigenetic changes using the Horvath ' s epigenetic clock. In a subset we will conduct a controlled physical challenge to characterize physical resilience (autophagy). Discussion ObAGE is in an excellent position to: approach aging as a process whose expression involves multiple factors from the early stages of a person's life; understand how longitudinal changes in health trajectories impact the biological mechanisms of aging; identify potential resilience mechanisms that help prevent unhealthy aging. Because SLS participants are still young, our research setting combined with advanced scientific techniques may identify individuals or groups at risk of early onset health issues. Results from ObAGE may pave the way to address the contribution of obesity to aging through lifespan from cells to systems and might be instrumental to developing interventions to improve health span in the Chilean population.
C1 [Correa-Burrows, P.; Burrows, R.; Albala, C.; Gonzalez-Billault, C.] Univ Chile, Inst Nutr & Food Technol, Santiago, Chile.
   [Court, F. A.] Univ Mayor, Ctr Integrat Biol, Santiago, Chile.
   [Court, F. A.; Salech, F.; Gonzalez-Billault, C.] Gerosci Ctr Brain Hlth & Metab GERO, Santiago, Chile.
   [Court, F. A.; Gonzalez-Billault, C.] Buck Inst Aging Res, Novato, CA USA.
   [Salech, F.; Gonzalez-Billault, C.] Univ Chile, Fac Med, Santiago, Chile.
   [Sanhueza, G.] Univ Chile, Fac Social Sci, Santiago, Chile.
   [Gonzalez-Billault, C.] Univ Chile, Fac Sci, Santiago, Chile.
C3 Universidad de Chile; Universidad Mayor; Buck Institute for Research on
   Aging; Universidad de Chile; Universidad de Chile; Universidad de Chile
RP Correa-Burrows, P (corresponding author), Univ Chile, Inst Nutr & Food Technol, Santiago, Chile.
EM paulina.correa@inta.uchile.cl
RI Correa-Burrows, Paulina/O-7436-2014; Court, Felipe A/C-5911-2015;
   Gonzalez-Billault, Christian/K-9622-2013
OI Correa-Burrows, Paulina/0000-0002-6177-1162; Sanhueza,
   Guillermo/0000-0003-1971-7362; Gonzalez-Billault,
   Christian/0000-0003-0335-1482; Salech, Felipe/0000-0003-1575-7658
FU Agencia Nacional de Investigacion y Desarrollo (ANID) (Chile) through:
   Anillos de Investigacion en Ciencia y Tecnologia [ACT210006]; Fondo
   Nacional de Investigaciones Cientificas y Tecnologicas (FONDECYT)
   [1210283]; Centro de Gerociencia, Salud Mental y Metabolismo (GERO)
   (FONDAP) [15150012]; Fundacion MAPFRE (Spain) [MAPFRE-2101]
FX This research will be supported by grants from Agencia Nacional de
   Investigacion y Desarrollo (ANID) (Chile) through: Anillos de
   Investigacion en Ciencia y Tecnologia (ACT210006 to PC, CA, RB, FS, GS,
   CGB); Fondo Nacional de Investigaciones Cientificas y Tecnologicas
   (FONDECYT #1210283 to RB, PC, GS); Centro de Gerociencia, Salud Mental y
   Metabolismo (GERO) (FONDAP #15150012 to CGB, FC, FS). Fundacion MAPFRE
   (Spain) Will also provide support through Ayudas a la Investigacion
   Ignacio H. de Larramendi (MAPFRE-2101 to PC, CA, RB, FS, GS, CGB). The
   funders do not have and will not have any no role in study design, data
   collection and analysis, data interpretation, decision to publish or
   preparation of manuscripts from the ObAGE Study.
CR Abbasi A, 2017, J ENDOCR SOC, V1, P524, DOI 10.1210/js.2017-00044
   Aguilera G, 2011, EXP GERONTOL, V46, P90, DOI 10.1016/j.exger.2010.08.023
   Ahima RS, 2009, NAT MED, V15, P996, DOI 10.1038/nm0909-996
   Albala C, 2001, NUTR REV, V59, P170, DOI 10.1111/j.1753-4887.2001.tb07008.x
   Andersen SL, 2008, TRENDS NEUROSCI, V31, P183, DOI 10.1016/j.tins.2008.01.004
   [Anonymous], 2018, EST PROYECC POBL CHI
   Arpino B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195320
   Ashwell M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103483
   Ben-Shlomo Y, 2002, INT J EPIDEMIOL, V31, P285, DOI 10.1093/ije/31.2.285
   Brown WM, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2014-094073
   Bunea IM, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/s41398-017-0032-3
   Burrows R, 2017, PEDIATR DIABETES, V18, P895, DOI 10.1111/pedi.12505
   Burrows R, 2021, DIABETES-METAB RES, V37, DOI 10.1002/dmrr.3371
   Cizza G, 2012, J ENDOCRINOL INVEST, V35, P541, DOI 10.3275/8411
   Correa-Burrows P, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-97683-9
   Crimmins EM, 2020, AGEING RES REV, V63, DOI 10.1016/j.arr.2020.101136
   de Toro-Martín J, 2019, CLIN EPIGENETICS, V11, DOI 10.1186/s13148-019-0754-6
   Di Ciaula A, 2020, MECH AGEING DEV, V188, DOI 10.1016/j.mad.2020.111244
   Doom JR, 2020, DEV PSYCHOPATHOL, V32, P1864, DOI 10.1017/S0954579420001248
   Escobar KA, 2021, HUM NUTR METAB, V23, DOI 10.1016/j.hnm.2020.200118
   Ferrucci L, 2020, AGING CELL, V19, DOI 10.1111/acel.13080
   Franceschi C, 2018, NAT REV ENDOCRINOL, V14, P576, DOI 10.1038/s41574-018-0059-4
   Fülöp T, 2019, GERONTOLOGY, V65, P495, DOI 10.1159/000497375
   Hamaguchi M, 2007, AM J GASTROENTEROL, V102, P2708, DOI 10.1111/j.1572-0241.2007.01526.x
   Head T, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00216
   Horvath S, 2018, NAT REV GENET, V19, P371, DOI 10.1038/s41576-018-0004-3
   Horvath S, 2014, P NATL ACAD SCI USA, V111, P15538, DOI 10.1073/pnas.1412759111
   Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115
   Hughes K, 2017, LANCET PUBLIC HEALTH, V2, pE356, DOI 10.1016/S2468-2667(17)30118-4
   Ibacahe C, 2020, DIAGNOSTICS, V10, DOI 10.3390/diagnostics10060431
   Informe de Desarrollo Social 2020, 2020, SUBS EV SOC
   Jakubowski KP, 2018, HEALTH PSYCHOL, V37, P701, DOI 10.1037/hea0000637
   Khoury JE, 2019, PSYCHONEUROENDOCRINO, V103, P104, DOI 10.1016/j.psyneuen.2019.01.009
   Kim BC, 2015, NUTR RES, V35, P1070, DOI 10.1016/j.nutres.2015.09.020
   Kim JH, 2016, NUTR RES, V36, P1423, DOI 10.1016/j.nutres.2016.09.013
   Kuh D, 2003, J EPIDEMIOL COMMUN H, V57, P778, DOI 10.1136/jech.57.10.778
   Levine ME, 2018, AGING-US, V10, P573, DOI 10.18632/aging.101414
   Lozoff B, 2003, PEDIATRICS, V112, P846
   Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639
   Mamoshina P, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-35704-w
   McEniry M, 2013, J DEV ORIG HLTH DIS, V4, P10, DOI 10.1017/S2040174412000499
   McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006
   McLaughlin KA, 2010, PSYCHOL MED, V40, P1647, DOI 10.1017/S0033291709992121
   Melzer D, 2020, NAT REV GENET, V21, P88, DOI 10.1038/s41576-019-0183-6
   Nadeau KJ, 2016, DIABETES CARE, V39, P1635, DOI 10.2337/dc16-1066
   Newsholme P, 2014, CURR OPIN CLIN NUTR, V17, P295, DOI 10.1097/MCO.0000000000000077
   Pakpahan E, 2017, ADV LIFE COURSE RES, V31, P1, DOI 10.1016/j.alcr.2016.10.003
   Power C, 2012, BRIT J PSYCHIAT, V201, P199, DOI 10.1192/bjp.bp.111.096032
   Quach A, 2017, AGING-US, V9, P419, DOI 10.18632/aging.101168
   Reid BM, 2020, BRAIN BEHAV IMMUN, V86, P4, DOI 10.1016/j.bbi.2019.06.003
   Salvestrini V, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00266
   Srikanthan P, 2014, AM J MED, V127, P547, DOI 10.1016/j.amjmed.2014.02.007
   Suglia SF, 2018, CIRCULATION, V137, pE15, DOI 10.1161/CIR.0000000000000536
   Sun WG, 2010, BIOMETRICS, V66, P1220, DOI 10.1111/j.1541-0420.2009.01369.x
   Tam BT, 2020, OBES REV, V21, DOI 10.1111/obr.12991
   Wagner KH, 2016, NUTRIENTS, V8, DOI 10.3390/nu8060338
   Wahl HW, 2012, GERONTOLOGIST, V52, P306, DOI 10.1093/geront/gnr154
   Wang JC, 2012, CIRC RES, V111, P245, DOI 10.1161/CIRCRESAHA.111.261388
   Zhang YM, 2018, NAT REV ENDOCRINOL, V14, P356, DOI 10.1038/s41574-018-0009-1
   Zierer J, 2015, AGING CELL, V14, P933, DOI 10.1111/acel.12386
NR 60
TC 3
Z9 3
U1 1
U2 12
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2318
J9 BMC GERIATR
JI BMC Geriatr.
PD MAY 2
PY 2022
VL 22
IS 1
AR 387
DI 10.1186/s12877-022-03032-4
PG 11
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA 0X6IY
UT WOS:000789808800005
PM 35501766
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Mosoni, L
   Malmezat, T
   Valluy, MC
   Houlier, ML
   Mirand, PP
AF Mosoni, L
   Malmezat, T
   Valluy, MC
   Houlier, ML
   Mirand, PP
TI Muscle and liver protein synthesis adapt efficiently to food deprivation
   and refeeding in 12-month-old rats
SO JOURNAL OF NUTRITION
LA English
DT Article
DE rats; starvation; recovery; aging; protein
ID SKELETAL-MUSCLE; POSTABSORPTIVE RATS; AMINO-ACIDS; WHOLE-BODY;
   STARVATION; INSULIN; TURNOVER; MYOFIBRILLAR; INITIATION; RESPONSES
AB Our aim was to analyze mechanisms involved in the adaptation of protein metabolism to food deprivation and refeeding in adult rats. Twelve-month-old rats, which had been food-deprived for 113 h and refed for 6 h, were injected subcutaneously with a flooding dose of valine (with 50% [1(13)C]-L-valine) to measure in vivo protein synthesis in tibialis anterior, soleus and liver. Protein and RNA contents were also measured. In both muscles, protein mass was maintained during food deprivation. Due to a drop in protein synthetic capacity (Cs), total and myofibrillar protein synthesis rates were reduced in food-deprived rats and were not stimulated by a 6-h refeeding. In contrast, protein levels were maintained lower than RNA levels in liver during food deprivation, and Cs was higher than in fed rats. Protein synthesis rates and ribosomal efficiency were reduced in food-deprived rats. Due to maintenance of protein synthetic capacity, there was a rapid stimulation of liver protein synthesis with refeeding, which induced a significant rise in protein mass (also related to an inhibition of protein degradation). In conclusion, coordinated responses of liver and muscles allowed a sparing of muscle proteins during food deprivation and a rapid recovery of liver proteins during refeeding. Control of ribosome quantity could play a critical role in these adaptations in tissue protein synthesis in adult rats.
RP Mosoni, L (corresponding author), INRA CLERMONT FERRAND THEIX,LAB ETUD METAB AZOTE,F-63122 ST GENES CHAMPANE,FRANCE.
OI Mosoni, Laurent/0000-0002-5409-6760
CR ADEOLA O, 1992, J NUTR, V122, P488, DOI 10.1093/jn/122.3.488
   BAILLIE AGS, 1991, AM J PHYSIOL, V260, pE891, DOI 10.1152/ajpendo.1991.260.6.E891
   BAILLIE AGS, 1992, AM J PHYSIOL, V262, pE1, DOI 10.1152/ajpendo.1992.262.1.E1
   BATES PC, 1983, BIOCHEM J, V214, P587, DOI 10.1042/bj2140587
   BLOMQVIST BI, 1991, J CLIN BIOCHEM NUTR, V11, P223
   BURRIN DG, 1992, PEDIATR RES, V31, P247, DOI 10.1203/00006450-199203000-00010
   CHEREL Y, 1991, CLIN SCI, V81, P611, DOI 10.1042/cs0810611
   CHIKU K, 1993, J NUTR, V123, P1771, DOI 10.1093/jn/123.11.1771
   DARDEVET D, 1994, ENDOCRINOLOGY, V134, P1475, DOI 10.1210/en.134.3.1475
   DAVIS TA, 1993, AM J PHYSIOL, V265, pR334, DOI 10.1152/ajpregu.1993.265.2.R334
   DAVIS TA, 1991, AM J PHYSIOL, V261, pR1373, DOI 10.1152/ajpregu.1991.261.6.R1373
   DEJONG FA, 1988, BRIT J NUTR, V59, P81, DOI 10.1079/BJN19880012
   DUNCAN DB, 1975, BIOMETRICS, V31, P339, DOI 10.2307/2529425
   EVERSON WV, 1989, AM J PHYSIOL, V256, pC18, DOI 10.1152/ajpcell.1989.256.1.C18
   GARLICK PJ, 1989, CLIN SCI, V77, P329, DOI 10.1042/cs0770329
   GARLICK PJ, 1983, BIOCHEM J, V210, P669, DOI 10.1042/bj2100669
   GOODMAN MN, 1981, AM J PHYSIOL, V241, pE321, DOI 10.1152/ajpendo.1981.241.4.E321
   HOFFER LJ, 1990, AM J PHYSIOL, V258, pE832, DOI 10.1152/ajpendo.1990.258.5.E832
   JEFFREY IW, 1990, BIOCHIMIE, V72, P751, DOI 10.1016/0300-9084(90)90160-I
   KITA K, 1993, COMP BIOCHEM PHYS A, V104, P589, DOI 10.1016/0300-9629(93)90469-K
   MANCHESTER KL, 1968, BIOCHEM J, V108, P177, DOI 10.1042/bj1080177
   MCNURLAN MA, 1979, BIOCHEM J, V178, P373, DOI 10.1042/bj1780373
   MOSONI L, 1995, AM J PHYSIOL-ENDOC M, V268, pE328, DOI 10.1152/ajpendo.1995.268.2.E328
   NISHIZAWA N, 1978, AGR BIOL CHEM TOKYO, V42, P2083, DOI 10.1080/00021369.1978.10863311
   OBLED C, 1991, J NUTR, V121, P1990, DOI 10.1093/jn/121.12.1990
   PREEDY VR, 1989, BIOCHEM J, V257, P519, DOI 10.1042/bj2570519
   PREEDY VR, 1986, BIOSCIENCE REP, V6, P177, DOI 10.1007/BF01115004
   REEDS PJ, 1993, P NUTR SOC, V52, P57, DOI 10.1079/PNS19930037
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   SUGDEN PH, 1991, BIOCHEM J, V273, P21, DOI 10.1042/bj2730021
   TAUVERON I, 1994, AM J PHYSIOL-ENDOC M, V267, pE877, DOI 10.1152/ajpendo.1994.267.6.E877
   Waterlow J.C., 1978, PROTEIN TURNOVER MAM
   WERNERMAN J, 1986, METABOLISM, V35, P447, DOI 10.1016/0026-0495(86)90136-8
NR 33
TC 31
Z9 31
U1 0
U2 3
PU AMER INST NUTRITION
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814
SN 0022-3166
J9 J NUTR
JI J. Nutr.
PD FEB
PY 1996
VL 126
IS 2
BP 516
EP 522
DI 10.1093/jn/126.2.516
PG 7
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA TU525
UT WOS:A1996TU52500019
PM 8632226
OA hybrid
DA 2024-02-19
ER

PT J
AU To, K
   Yamaza, H
   Komatsu, T
   Hayashida, T
   Hayashi, H
   Toyama, H
   Chiba, T
   Higami, Y
   Shimokawa, I
AF To, Kazuo
   Yamaza, Haruyoshi
   Komatsu, Toshimitsu
   Hayashida, Takahiro
   Hayashi, Hiroko
   Toyama, Hiroaki
   Chiba, Takuya
   Higami, Yoshikazu
   Shimokawa, Isao
TI Down-regulation of AMP-activated protein kinase by calorie restriction
   in rat liver
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE AMP-activated protein kinase; acetyl-CoA carboxylase; calorie
   restriction; aging; growth hormone; IGF-1; metabolic adaptation
ID ACETYL-COA CARBOXYLASE; LIFE-SPAN EXTENSION; FACTOR-I AXIS;
   ENERGY-METABOLISM; HEART; REDUCTION; MUSCLE; MODEL
AB AMP-activated protein kinase (AMPK) may act as a key enzyme for metabolic adaptation to calorie restriction (CR) or reduced growth hormone (GH)-insulin-like growth factor (IGF)-1 signaling, an experimental intervention for lifespan extension in animals. We investigated the protein levels of AMPK alpha and a downstream enzyme, acetyl-CoA carboxylase (ACC), by immunoblotting of liver and quadriceps femoris muscle (QFM) extracts from 6-month-old wild-type (W) and GH-suppressed transgenic (Tg) Wistar rats fed ad libitum (AL) or 30% CR diets from 6 weeks of age. A modified alternate-day feeding regimen for CR yielded a fed-fasted cycle in CR rats, and therefore the effects of overnight fasting in W-AL rats were also evaluated. CR decreased threonine-172-phosphorylated AMPK alpha (p-AMPK alpha; an activated form) levels in the liver, whereas the CR-fed-fasted cycle or overnight fasting did not significantly affect the p-AMPK alpha level. In the QFM, the p-AMPK alpha level was slightly elevated in the CR-fasted phase, but greatly increased in the AL-fasted phase. Suppression of GH did not affect the p-AMPK alpha level. The phosphorylated-ACC levels did not alter in parallel with the p-AMPK alpha level, particularly in the liver. The present results suggest that CR down-regulates the AMPK activity in the liver on a long-term basis. (C) 2007 Published by Elsevier Inc.
C1 Nagasaki Univ, Grad Sch Biomed Sci, Dept Investigat Pathol, Unit Basic Med Sci, Nagasaki 8528523, Japan.
C3 Nagasaki University
RP Shimokawa, I (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Investigat Pathol, Unit Basic Med Sci, 12-4 Sakamoto I-chome, Nagasaki 8528523, Japan.
EM shimo@nagasaki-u.ac.jp
RI Yamaza, Haruyoshi/AAD-4011-2019
OI Yamaza, Haruyoshi/0000-0003-1138-3943; Higami,
   Yoshikazu/0000-0003-1381-0777; Shimokawa, Isao/0000-0001-8901-1029
CR Al-Regaiey KA, 2005, ENDOCRINOLOGY, V146, P851, DOI 10.1210/en.2004-1120
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Brownsey RW, 2006, BIOCHEM SOC T, V34, P223, DOI 10.1042/BST0340223
   Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005
   Clark H, 2004, EUR J BIOCHEM, V271, P2215, DOI 10.1111/j.1432-1033.2004.04151.x
   DUFFY PH, 1989, MECH AGEING DEV, V48, P117, DOI 10.1016/0047-6374(89)90044-4
   Fediuc S, 2006, J LIPID RES, V47, P412, DOI 10.1194/jlr.M500438-JLR200
   Foretz M, 2005, DIABETES, V54, P1331, DOI 10.2337/diabetes.54.5.1331
   Gonzalez AA, 2004, AM J PHYSIOL-ENDOC M, V287, pE1032, DOI 10.1152/ajpendo.00172.2004
   HOLLIDAY R, 1989, BIOESSAYS, V10, P125, DOI 10.1002/bies.950100408
   Hong YH, 2003, J BIOL CHEM, V278, P27495, DOI 10.1074/jbc.M304112200
   Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003
   Kudo N, 1996, BBA-LIPID LIPID MET, V1301, P67, DOI 10.1016/0005-2760(96)00013-6
   Longo VD, 2003, SCIENCE, V299, P1342, DOI 10.1126/science.1077991
   MASOOD S, 1996, ASCP THEOR & PRACT, V5, P1
   MASORO EJ, 2003, SCI AGING KNOWLEDGE, pRE2
   MATSUMOTO K, 1993, MOL REPROD DEV, V36, P53, DOI 10.1002/mrd.1080360109
   MCCARTER RJ, 1992, AM J PHYSIOL, V263, pE448, DOI 10.1152/ajpendo.1992.263.3.E448
   Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781
   Shimokawa I, 2003, FASEB J, V17, P1108, DOI 10.1096/fj.02-0819fje
   Shimokawa I, 2002, AM J PATHOL, V160, P2259, DOI 10.1016/S0002-9440(10)61173-X
   SHIMOKAWA I, 2006, HDB MODELS HUMAN AGI, P367
   SHIMOKAWA I, 2006, SOMATOTROPHIC AXIS B, P173
   Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a
   WEINDRUCH R, 1988, RETARDATION AGING DI
   Yamada Y, 2001, NEUROSCI RES, V39, P269, DOI 10.1016/S0168-0102(00)00221-2
NR 26
TC 34
Z9 38
U1 0
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
J9 EXP GERONTOL
JI Exp. Gerontol.
PD NOV
PY 2007
VL 42
IS 11
BP 1063
EP 1071
DI 10.1016/j.exger.2007.07.003
PG 9
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 237YI
UT WOS:000251411900004
PM 17709221
DA 2024-02-19
ER

PT J
AU So-Armah, KA
   Lim, JK
   Lo Re, V
   Tate, JP
   Chang, CCH
   Butt, AA
   Gibert, CL
   Rimland, D
   Marconi, VC
   Goetz, MB
   Rodriguez-Barradas, MC
   Budoff, MJ
   Tindle, HA
   Samet, JH
   Justice, AC
   Freiberg, MS
AF So-Armah, Kaku A.
   Lim, Joseph K.
   Lo Re, Vincent
   Tate, Janet P.
   Chang, Chung-Chou H.
   Butt, Adeel A.
   Gibert, Cynthia L.
   Rimland, David
   Marconi, Vincent C.
   Goetz, Matthew B.
   Rodriguez-Barradas, Maria C.
   Budoff, Matthew J.
   Tindle, Hilary A.
   Samet, Jeffrey H.
   Justice, Amy C.
   Freiberg, Matthew S.
CA Vet Aging Cohort Study Project Tea
TI FIB-4 Stage of Liver Fibrosis Predicts Incident Heart Failure Among
   HIV-Infected and Uninfected Patients
SO HEPATOLOGY
LA English
DT Article
ID HEPATITIS-C VIRUS; GAMMA-GLUTAMYL-TRANSFERASE; CARDIOVASCULAR-DISEASE;
   FOLLOW-UP; RISK; MORTALITY; VETERANS; EVENTS; ADULTS; ABNORMALITIES
AB Liver fibrosis is common, particularly in individuals who are infected with human immunodeficiency virus (HIV). HIV-infected individuals have excess congestive heart failure (CHF) risk compared with uninfected people. It remains unknown whether liver fibrosis stage influences the CHF risk or if HIV or hepatitis C virus (HCV) infection modifies this association. Our objectives were to assess whether 1) stage of liver fibrosis is independently associated with incident CHF and 2) the association between stage of liver fibrosis and incident CHF is modified by HIV/HCV status. Participants alive on or after April 1, 2003, in the Veterans Aging Cohort Study were included. Those without prevalent cardiovascular disease were followed until their first CHF event, death, last follow-up date, or December 31, 2011. Liver fibrosis was measured using the fibrosis 4 index (FIB-4), which is calculated using age, aminotransferases, and platelets. Cox proportional hazards regression models were adjusted for cardiovascular disease risk factors. Among 96,373 participants over 6.9 years, 3844 incident CHF events occurred. FIB-4 between 1.45 and 3.25 (moderate fibrosis) and FIB-4 > 3.25 (advanced fibrosis/cirrhosis) were associated with CHF (hazard ratio [95% confidence interval], 1.17 [1.07-1.27] and 1.65 [1.43-1.92], respectively). The association of advanced fibrosis/cirrhosis and incident CHF persisted regardless of HIV/HCV status. Conclusion: Moderate and advanced liver fibrosis/cirrhosis are associated with an increased risk of CHF. The association for advanced fibrosis/cirrhosis persists even among participants without hepatitis C and/or HIV infection. Assessing liver health may be important for reducing the risk of future CHF events, particularly among HIV and hepatitis C infected people among whom cardiovascular disease risk is elevated and liver disease is common.
C1 [So-Armah, Kaku A.; Samet, Jeffrey H.] Boston Univ, Sch Med, CARE Unit, Crosstown Bldg,2nd Floor,801 Massachusetts Ave, Boston, MA 02118 USA.
   [Lim, Joseph K.; Tate, Janet P.; Justice, Amy C.] Yale Univ, Sch Med, New Haven, CT USA.
   [Lo Re, Vincent] Univ Penn, Sch Med, Philadelphia VA Med Ctr, Philadelphia, PA 19104 USA.
   [Tate, Janet P.] VA Connecticut Healthcare Syst, West Haven, CT USA.
   [Chang, Chung-Chou H.] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA.
   [Chang, Chung-Chou H.] Univ Pittsburgh, Sch Publ Hlth, Pittsburgh, PA 15260 USA.
   [Butt, Adeel A.] Weill Cornell Med Coll, New York, NY USA.
   [Butt, Adeel A.] VA Pittsburgh Healthcare Syst, Pittsburgh, PA USA.
   [Butt, Adeel A.] Hamad Healthcare Qual Inst, Hamad Med Corp, Doha, Qatar.
   [Gibert, Cynthia L.] VA Med Ctr, Washington, DC USA.
   [Gibert, Cynthia L.] George Washington Univ, Sch Med & Publ Hlth, Washington, DC USA.
   [Rimland, David; Marconi, Vincent C.] Atlanta VA Med Ctr, Atlanta, GA USA.
   [Rimland, David; Marconi, Vincent C.] Emory Univ, Sch Med, Atlanta, GA USA.
   [Marconi, Vincent C.] Rollins Sch Publ Hlth, Atlanta, GA USA.
   [Goetz, Matthew B.] VA Greater Los Angeles Healthcare Syst, Los Angeles, CA USA.
   [Goetz, Matthew B.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.
   [Rodriguez-Barradas, Maria C.] Michael E DeBakey VA Med Ctr, Houston, TX USA.
   [Rodriguez-Barradas, Maria C.] Baylor Coll Med, Houston, TX 77030 USA.
   [Budoff, Matthew J.] Harbor UCLA Med Ctr, Los Angeles, CA USA.
   [Budoff, Matthew J.] Los Angeles Biomed Res Inst, Los Angeles, CA USA.
   [Tindle, Hilary A.] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA.
   [Samet, Jeffrey H.] Boston Univ, Sch Publ Hlth, Boston, MA USA.
   [Samet, Jeffrey H.] Boston Med Ctr, Boston, MA USA.
   [Justice, Amy C.] Yale Univ, Sch Publ Hlth, New Haven, CT USA.
   [Freiberg, Matthew S.] Vet Affairs Med Ctr, Nashville, TN 37212 USA.
   [Freiberg, Matthew S.] Tennessee Valley Healthcare Syst, Nashville, TN USA.
C3 Boston University; Yale University; University of Pennsylvania;
   Pennsylvania Medicine; US Department of Veterans Affairs; Veterans
   Health Administration (VHA); Philadelphia Veterans Affairs Medical
   Center; US Department of Veterans Affairs; Veterans Health
   Administration (VHA); VA Connecticut Healthcare System; Pennsylvania
   Commonwealth System of Higher Education (PCSHE); University of
   Pittsburgh; Pennsylvania Commonwealth System of Higher Education
   (PCSHE); University of Pittsburgh; Cornell University; Weill Cornell
   Medicine; US Department of Veterans Affairs; Veterans Health
   Administration (VHA); VA Pittsburgh Healthcare System; Hamad Medical
   Corporation; Hamad General Hospital; George Washington University; US
   Department of Veterans Affairs; Veterans Health Administration (VHA);
   Atlanta VA Medical Center; Atlanta VA Health Care System; Emory
   University; Emory University; Rollins School Public Health; US
   Department of Veterans Affairs; Veterans Health Administration (VHA); VA
   Greater Los Angeles Healthcare System; University of California System;
   University of California Los Angeles; University of California Los
   Angeles Medical Center; David Geffen School of Medicine at UCLA; Baylor
   College of Medicine; Baylor College of Medicine; University of
   California System; University of California Los Angeles; University of
   California Los Angeles Medical Center; Vanderbilt University; Boston
   University; Boston Medical Center; Yale University; US Department of
   Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee
   Valley Healthcare System; US Department of Veterans Affairs; Veterans
   Health Administration (VHA); VA Tennessee Valley Healthcare System
RP So-Armah, KA (corresponding author), Boston Univ, Sch Med, CARE Unit, Crosstown Bldg,2nd Floor,801 Massachusetts Ave, Boston, MA 02118 USA.
EM kaku@bu.edu
RI Freiberg, Matthew/IYJ-5456-2023; Budoff, Matthew/ABD-5175-2021; Marconi,
   Vincent/GRJ-4553-2022; Marconi, Vincent/N-3210-2014; Goetz, Matthew
   Bidwell/GPX-4090-2022; Marconi, Vincent/AFK-5812-2022
OI Budoff, Matthew/0000-0002-9616-1946; Marconi,
   Vincent/0000-0001-8409-4689; Marconi, Vincent/0000-0001-8409-4689;
   Goetz, Matthew/0000-0003-4542-992X; So-Armah, Kaku/0000-0003-1505-6384;
   Samet, Jeffrey/0000-0002-0897-3400
FU National Heart, Lung, and Blood Institute at the National Institutes of
   Health [K01 HL1314701, HL095136]; National Institute on Alcohol Abuse
   and Alcoholism at the National Institutes of Health [AA013566-10,
   AA020790, AA020794]
FX This work was supported by grants K01 HL1314701 and HL095136 from the
   National Heart, Lung, and Blood Institute and grants AA013566-10,
   AA020790, and AA020794 from the National Institute on Alcohol Abuse and
   Alcoholism at the National Institutes of Health.
CR Alvarez AM, 2011, INT J ANGIOL, V20, P135, DOI 10.1055/s-0031-1284434
   Bedimo R, 2010, HIV MED, V11, P462, DOI 10.1111/j.1468-1293.2009.00815.x
   Berenguer J, 2017, HEPATOLOGY, V66, P344, DOI 10.1002/hep.29071
   Butt AA, 2009, AIDS, V23, P1227, DOI 10.1097/QAD.0b013e32832bd7af
   Caldwell SH, 2006, HEPATOLOGY, V44, P1039, DOI 10.1002/hep.21303
   Chen YH, 2011, LIVER INT, V31, P354, DOI 10.1111/j.1478-3231.2010.02350.x
   Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2
   Chrysohoou C, 2009, HEART VESSELS, V24, P22, DOI 10.1007/s00380-008-1080-7
   Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486
   Colloredo G, 2003, J HEPATOL, V39, P239, DOI 10.1016/S0168-8278(03)00191-0
   Ding DP, 2015, INT J CLIN EXP MED, V8, P20876
   Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327
   Feinstein MJ, 2016, AM J CARDIOL, V117, P214, DOI 10.1016/j.amjcard.2015.10.030
   Freiberg MS, 2013, JAMA INTERN MED, V173, P614, DOI 10.1001/jamainternmed.2013.3728
   Fultz SL, 2006, MED CARE, V44, pS25, DOI 10.1097/01.mlr.0000223670.00890.74
   Gill J, 2010, CLIN INFECT DIS, V50, P1387, DOI 10.1086/652283
   Gillis J, 2014, ANTIVIR THER, V19, P309, DOI 10.3851/IMP2724
   Goulet JL, 2005, AIDS, V19, pS99, DOI 10.1097/01.aids.0000192077.11067.e5
   Gronbæk H, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-16
   Ives Diane G., 1995, Annals of Epidemiology, V5, P278, DOI 10.1016/1047-2797(94)00093-9
   Kim D, 2013, HEPATOLOGY, V57, P1357, DOI 10.1002/hep.26156
   Kraemer KL, 2006, MED CARE, V44, pS44, DOI 10.1097/01.mlr.0000223703.91275.78
   Lau GT, 2002, AM J CARDIOL, V90, P1405, DOI 10.1016/S0002-9149(02)02886-2
   Lee DS, 2007, ARTERIOSCL THROM VAS, V27, P127, DOI 10.1161/01.ATV.0000251993.20372.40
   Lee MH, 2012, J INFECT DIS, V206, P469, DOI 10.1093/infdis/jis385
   Liu Xiao, 2013, Curr Pathobiol Rep, V1, P209
   Lo Re V, 2011, PHARMACOEPIDEM DR S, V20, P689, DOI 10.1002/pds.2148
   Loko MA, 2008, AM J GASTROENTEROL, V103, P1973, DOI 10.1111/j.1572-0241.2008.01954.x
   LUNA A, 1968, AM J CLIN PATHOL, V49, P710
   McGinnis KA, 2011, NICOTINE TOB RES, V13, P1233, DOI 10.1093/ntr/ntr206
   Moller S, 2013, EUR HEART J, V34, P2804, DOI 10.1093/eurheartj/eht246
   Montes-De-Oca M, 2011, LIVER INT, V31, P852, DOI 10.1111/j.1478-3231.2011.02505.x
   Morling JR, 2015, DIABETOLOGIA, V58, P1484, DOI 10.1007/s00125-015-3575-y
   Myers RP, 2003, HEPATOLOGY, V37, P393, DOI 10.1053/jhep.2003.50062
   Petersen LA, 1999, J GEN INTERN MED, V14, P555, DOI 10.1046/j.1525-1497.1999.10198.x
   Rentsch C, 2016, AIDS BEHAV, V20, P555, DOI 10.1007/s10461-015-1025-y
   Sabin CA, 2013, JAIDS-J ACQ IMM DEF, V63, P456, DOI 10.1097/QAI.0b013e318291cd29
   Sagir A, 2015, INFECT DIS THER, V4, P355, DOI 10.1007/s40121-015-0073-y
   Schindhelm RK, 2007, ATHEROSCLEROSIS, V191, P391, DOI 10.1016/j.atherosclerosis.2006.04.006
   Sico JJ, 2015, NEUROLOGY, V84, P1933, DOI 10.1212/WNL.0000000000001560
   Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178
   Sumida Y, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-2
   Unalp-Arida A, 2017, HEPATOLOGY, V66, P84, DOI 10.1002/hep.29113
   WANLESS IR, 1995, HEPATOLOGY, V21, P1232, DOI 10.1016/0270-9139(95)90042-X
   White IR, 2009, STAT MED, V28, P1982, DOI 10.1002/sim.3618
   Wiest R, 2005, HEPATOLOGY, V41, P422, DOI 10.1002/hep.20632
   Womack JA, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001035
   Zheng YX, 2016, HEPAT MON, V16, DOI 10.5812/hepatmon.31983
NR 48
TC 23
Z9 25
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD OCT
PY 2017
VL 66
IS 4
BP 1286
EP 1295
DI 10.1002/hep.29285
PG 10
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA FI1ZM
UT WOS:000411735900026
PM 28543215
OA Bronze, Green Accepted, Green Submitted
DA 2024-02-19
ER

PT J
AU Inceer, M
   Brouillette, MJ
   Fellows, LK
   Morais, JA
   Harris, M
   Smaill, F
   Smith, G
   Thomas, R
   Mayo, NE
AF Inceer, Mehmet
   Brouillette, Marie-J
   Fellows, Lesley K.
   Morais, Jose A.
   Harris, Marianne
   Smaill, Fiona
   Smith, Graham
   Thomas, Rejean
   Mayo, Nancy E.
TI Factors partitioning physical frailty in people aging with HIV: A
   classification and regression tree approach
SO HIV MEDICINE
LA English
DT Article; Early Access
DE ageing; cannabis; cognitive; comorbidity; emotional; frailty; HIV;
   tobacco
ID OLDER-ADULTS; HEALTH; PHENOTYPE; INDEX; INTERVENTIONS; DEFINITION;
   PREVALENCE; DEPRESSION; MORTALITY; EXERCISE
AB Objective To estimate the extent to which comorbidity and lifestyle factors were associated with physical frailty in middle-aged and older Canadians living with HIV. Design Cross-sectional analysis of 856 participants from the Canadian Positive Brain Health Now cohort. Methods The frailty indicator phenotype was adapted from Fried's criteria using self-report items. Univariate logistic regression and classification and regression tree (CaRT) models were used to identify the most relevant independent contributors to frailty. Results In all, 100 men (14.0%) and 26 women (19.7%) were identified as frail (>= 3/5 criteria) for an overall prevalence of 15.2%. Nine comorbidities showed an influential association with frailty. The most influential comorbidities were hypothyroidism [odds ratio (OR) = 2.55, 95% confidence interval (CI): 1.29-50.3] and arthritis (OR = 2.54, 95% CI: 1.58-4.09). Additionally, tobacco (OR = 1.79, 95% CI: 1.05-3.04) showed an association. Any level of alcohol consumption showed a protective effect for frailty. The CaRT model showed nine pathways that led to frailty. Arthritis was the most discriminatory variable followed by alcohol, hypothyroidism, tobacco, cancer, cannabis, liver disease, kidney disease, osteoporosis, lung disease and peripheral vascular disease. The prevalence of physical frailty for people with arthritis was 27.4%; with additional cancer or tobacco and alcohol the prevalence rates were 47.1% and 46.1%, respectively. The protective effect of alcohol consumption evident in the univariate model appeared again in the CaRT model, but this effect varied. Cognitive frailty (19.5% overall) and emotional frailty (37.9% overall) were higher than the prevalence of physical frailty. Conclusions Specific comorbidities and tobacco use were implicated in frailty, suggesting that it is comorbidities causing frailty. However, some frailty still appears to be HIV-related. The higher prevalence of cognitive and emotional frailty highlights the fact that physical frailty should not be the only focus in HIV.
C1 [Inceer, Mehmet; Brouillette, Marie-J; Smaill, Fiona] McGill Univ, Fac Med & Hlth Sci, Sch Phys & Occupat Therapy, Montreal, PQ, Canada.
   McGill Univ, Hlth Ctr, Res Inst, Ctr Outcomes Res & Evaluat CORE, Montreal, PQ, Canada.
   [Brouillette, Marie-J] McGill Univ, Fac Med, Dept Psychiat, Montreal, PQ, Canada.
   [Brouillette, Marie-J] McGill Univ, Hlth Ctr, Montreal, PQ, Canada.
   McGill Univ, lIealth Ctr, Tesearch Inst, Montreal, PQ, Canada.
   [Fellows, Lesley K.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ, Canada.
   [Inceer, Mehmet; Brouillette, Marie-J; Smaill, Fiona] McGill Univ, Fac Med, Div Geriatr Med, Montreal, PQ, Canada.
   Univ British Columbia, Fac Med, Dept Family Practice, Vancouver, BC, Canada.
   British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada.
   McMaster Univ, Fac Hlth Sci, Dept Pathol & Mol Med, Hamilton, ON, Canada.
   [Harris, Marianne; Smaill, Fiona] Hamilton Hlth Sci, Hamilton, ON, Canada.
   [Smith, Graham] Maple Leaf Med Clin, Toronto, ON, Canada.
   [Thomas, Rejean] Clin Wdicale Actuel, Montreal, PQ, Canada.
C3 McGill University; McGill University; McGill University; McGill
   University; McGill University; McGill University; McGill University;
   University of British Columbia; B.C. Centre for Excellence in HIV/AIDS;
   McMaster University; McMaster University
RP Inceer, M (corresponding author), McGill Univ, Sch Phys & Occupat Therapy, 5252 Maisonneuve,2B 24, Montreal, PQ II4A 3S5, Canada.; Inceer, M (corresponding author), Res Inst McGill Univ Hlth Ctr RI MUHC, 5252 Maisonneuve,2B 24, Montreal, PQ II4A 3S5, Canada.
EM mehmet.inceer@mail.mcgill.ca
RI Brouillette, Marie-Josee/AGX-7314-2022
OI Inceer, Mehmet/0000-0002-2594-9760
FU Canadian Institutes of Health Research [TCO-125272]; CIHR Canadian HIV
   Trial Network [CTN 273]; Turkish Ministry of Education; BHN
FX This project was supported by Grants from the Canadian Institutes of
   Health Research (LKF, MJB, NM, TCO-125272) and the CIHR Canadian HIV
   Trial Network (CTN 273). None of the funding agencies play any role in
   the data collection, design, analysis, and interpretation in this study.
   The authors would like to thank all the BHN participants and Susan Scott
   and Lyne Nadeau for their assistance with database development &
   management and statistical programming. Mehmet Inceer would like to
   express special thanks to the Turkish Ministry of Education for
   financial support for the earlier stages of his doctoral studies
   (2016-2018) and to the BHN grant for financial support for his doctoral
   studies from 2018 onwards. Mehmet Inceer would also like to extend very
   special thanks and to Anne DeChavigny for the language editing of this
   manuscript.
CR Akgün KM, 2014, JAIDS-J ACQ IMM DEF, V67, P397, DOI 10.1097/QAI.0000000000000341
   Allen KB, 2014, J THORAC CARDIOV SUR, V148, P3117, DOI 10.1016/j.jtcvs.2014.10.013
   Azzopardi RV, 2016, J AM MED DIR ASSOC, V17, DOI 10.1016/j.jamda.2016.07.023
   Bauman A, 2016, GERONTOLOGIST, V56, pS268, DOI 10.1093/geront/gnw031
   Blanco JR, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215764
   Blewitt ME, 2008, NAT GENET, V40, P663, DOI 10.1038/ng.142
   Braithwaite RS, 2005, AM J MED, V118, P890, DOI 10.1016/j.amjmed.2004.12.034
   Brothers TD, 2014, CURR OPIN HIV AIDS, V9, P412, DOI 10.1097/COH.0000000000000070
   Buta BJ, 2016, AGEING RES REV, V26, P53, DOI 10.1016/j.arr.2015.12.003
   Canadian Centre on Substance and Addiction, ALC 2019
   CATIE, EP HIV CAN
   CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8
   Clayton JA, 2016, JAMA-J AM MED ASSOC, V316, P1863, DOI 10.1001/jama.2016.16405
   Cooper V, 2017, HEALTH QUAL LIFE OUT, V15, DOI 10.1186/s12955-017-0778-6
   Desquilbet L, 2007, J GERONTOL A-BIOL, V62, P1279, DOI 10.1093/gerona/62.11.1279
   Drewes Jochen, 2013, J Int Assoc Provid AIDS Care, V12, P18, DOI 10.1177/1545109712456429
   Escota GV, 2015, AIDS RES HUM RETROV, V31, P313, DOI [10.1089/aid.2014.0225, 10.1089/AID.2014.0225]
   Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146
   Fried LP, 2004, J GERONTOL A-BIOL, V59, P255
   Friedman B, 2005, J AM GERIATR SOC, V53, P1978, DOI 10.1111/j.1532-5415.2005.00469.x
   Fukui SM, 2018, CURR HIV-AIDS REP, V15, P20, DOI 10.1007/s11904-018-0372-5
   Government of Canada, CAN CANN SURV 2017 S
   Guaraldi G, 2014, CURR OPIN HIV AIDS, V9, P386, DOI 10.1097/COH.0000000000000079
   Guaraldi G, 2011, CLIN INFECT DIS, V53, P1120, DOI 10.1093/cid/cir627
   Hays RD, 2001, ANN MED, V33, P350, DOI 10.3109/07853890109002089
   Hopman WM, 2000, CAN MED ASSOC J, V163, P265
   Hubbard RE, 2014, ANAESTHESIA, V69, P26, DOI 10.1111/anae.12490
   Justice AC, 2010, HIV MED, V11, P143, DOI 10.1111/j.1468-1293.2009.00757.x
   Kehler DS, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0423-6
   Kojima G, 2018, AGE AGEING, V47, P26, DOI 10.1093/ageing/afx086
   Kojima G, 2017, BIOSCI TRENDS, V11, P600, DOI 10.5582/bst.2017.01237
   Kojima G, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0134-9
   Lam RW, 2018, NEUROPSYCH DIS TREAT, V14, P2861, DOI 10.2147/NDT.S175188
   Lang PO, 2009, GERONTOLOGY, V55, P539, DOI 10.1159/000211949
   Lau B, 2006, ARCH INTERN MED, V166, P64, DOI 10.1001/archinte.166.1.64
   Levasseur M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1824-0
   Lewden C, 2007, JAIDS-J ACQ IMM DEF, V46, P72
   Maffei VJ, 2020, AIDS, V34, P245, DOI 10.1097/QAD.0000000000002426
   Margolick JB, 2017, JAIDS-J ACQ IMM DEF, V74, P407, DOI [10.1097/QAI.0000000000001261, 10.1097/qai.0000000000001261]
   Marzetti E, 2017, AGING CLIN EXP RES, V29, P35, DOI 10.1007/s40520-016-0705-4
   Mayo NE, 2018, JAIDS-J ACQ IMM DEF, V78, pE7, DOI 10.1097/QAI.0000000000001668
   Mayo NE, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0527-1
   Mitnitski A B, 2001, ScientificWorldJournal, V1, P323
   Nakagawa F, 2012, AIDS, V26, P335, DOI 10.1097/QAD.0b013e32834dcec9
   Onen Nur F, 2011, Curr Aging Sci, V4, P33
   Pathai S, 2014, J GERONTOL A-BIOL, V69, P833, DOI 10.1093/gerona/glt168
   Piggott DA, 2016, CURR HIV-AIDS REP, V13, P340, DOI 10.1007/s11904-016-0334-8
   Rodríguez-Mañas L, 2013, J GERONTOL A-BIOL, V68, P62, DOI 10.1093/gerona/gls119
   Saloner R, 2019, J INT NEUROPSYCH SOC, V25, P507, DOI 10.1017/S1355617719000018
   Scully EP, 2018, CURR HIV-AIDS REP, V15, P136, DOI 10.1007/s11904-018-0383-2
   Sirola J, 2011, J NUTR HEALTH AGING, V15, P783, DOI 10.1007/s12603-011-0131-4
   Speir A, 2015, J THORAC CARDIOV SUR, V149, P875, DOI 10.1016/j.jtcvs.2014.11.008
   Statistics Canada, 2018, SMOK HLTH FACT SHEET
   Sullivan M. J., 1990, CANADIAN J REHABILIT, V4, P99
   Theou O, 2015, AGEING RES REV, V21, P78, DOI 10.1016/j.arr.2015.04.001
   Viña J, 2016, FREE RADICAL BIO MED, V98, P159, DOI 10.1016/j.freeradbiomed.2016.03.024
   Walston J, 2006, J AM GERIATR SOC, V54, P991, DOI 10.1111/j.1532-5415.2006.00745.x
   Womack JA, 2013, CLIN INFECT DIS, V56, P1498, DOI 10.1093/cid/cit056
NR 58
TC 5
Z9 7
U1 2
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1464-2662
EI 1468-1293
J9 HIV MED
JI HIV Med.
PD 2022 AUG
PY 2022
VL 23
IS 7
BP 738
EP 749
DI 10.1111/hiv.13236
EA FEB 2022
PG 12
WC Infectious Diseases
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Infectious Diseases
GA 2T8RL
UT WOS:000749264000001
PM 35106895
OA Bronze
DA 2024-02-19
ER

PT J
AU Babenko, NA
   Hassouneh, LKM
   Kharchenko, VS
   Garkavenko, VV
AF Babenko, Nataliya A.
   Hassouneh, Loay Kh. M.
   Kharchenko, Vitalina S.
   Garkavenko, Vladimir V.
TI Vitamin E prevents the age-dependent and palmitate-induced disturbances
   of sphingolipid turnover in liver cells
SO AGE
LA English
DT Article
DE Old age; Liver cells; Vitamin E; alpha-Tocopherol; Palmitic acid;
   Ceramide; Sphingomyelinases
ID INDUCED INSULIN-RESISTANCE; OXIDATIVE STRESS; DE-NOVO; ACID
   SPHINGOMYELINASE; CERAMIDE GENERATION; INDUCED APOPTOSIS; RAT
   HEPATOCYTES; UVA RADIATION; LIFE-SPAN; GLUTATHIONE
AB Sphingolipid turnover has been shown to be activated at old age and in response to various stress stimuli including oxidative stress. Reduction of vitamin E content in the liver under the pro-oxidant action is associated with enhanced sphingolipid turnover and ceramide accumulation in hepatocytes. In the present paper, the correction of sphingolipid metabolism in the liver cells of old rats and in the palmitate-treated young hepatocytes using alpha-tocopherol has been investigated. 3- and 24-month-old rats, [(14) C]palmitic acid, [methyl-(14) C-choline]sphingomyelin (SM), and [(14) C]serine were used. alpha-Tocopherol administration to old rats or addition to the culture medium of old liver slices or hepatocytes prevented age-dependent increase of ceramide synthesis and lipid accumulation, and increased SM content in liver tissue and cells. alpha-Tocopherol treatment of old cells decreased the neutral and acid sphingomyelinase (SMase) activities in hepatocytes and serine palmitoyl transferase activity in the liver cell microsomes. Effect of alpha- or gamma-tocopherol, but not of delta-tocopherol, on the newly synthesized ceramide content in old cells was correlated with the action of inhibitor of serine palmitoyl transferase (SPT) activity (myriocin) and SMase inhibitors (glutathione, imipramine). Addition of alpha-tocopherol as well as myriocin to the culture medium of young hepatocytes, treated by palmitate, abolished ceramide accumulation and synthesis. The data obtained demonstrate that alpha-tocopherol normalized elevated ceramide content in the old liver cells via inhibition of acid and neutral SMase activities and lipid synthesis de novo. alpha-Tocopherol, reducing ceramide synthesis, prevented palmitate-induced aging-like ceramide accumulation in young liver cells.
C1 [Babenko, Nataliya A.; Kharchenko, Vitalina S.; Garkavenko, Vladimir V.] Kharkov Karazin Natl Univ, Inst Biol, Dept Physiol Ontogenesis, UA-61077 Kharkov, Ukraine.
   [Hassouneh, Loay Kh. M.] Hail Univ, Fac Sci, Dept Biol, Hail, Saudi Arabia.
C3 Ministry of Education & Science of Ukraine; VN Karazin Kharkiv National
   University; University Ha'il
RP Babenko, NA (corresponding author), Kharkov Karazin Natl Univ, Inst Biol, Dept Physiol Ontogenesis, 4 Svobody Pl, UA-61077 Kharkov, Ukraine.
EM babenko@univer.kharkov.ua
RI HASSOUNEH, LOAY KHALED/K-2709-2019
OI HASSOUNEH, LOAY KHALED/0000-0002-8278-7278
CR Ayasolla K, 2004, FREE RADICAL BIO MED, V37, P325, DOI 10.1016/j.freeradbiomed.2004.04.007
   Babenko NA, 2006, EXP GERONTOL, V41, P32, DOI 10.1016/j.exger.2005.08.008
   Babenko NA, 2010, EXP GERONTOL, V45, P375, DOI 10.1016/j.exger.2010.02.010
   Babenko NA, 2008, LIPIDS HEALTH DIS, V7, DOI 10.1186/1476-511X-7-1
   Bai YL, 2007, CELL PHYSIOL BIOCHEM, V20, P429, DOI 10.1159/000107527
   Bansal AK, 2005, CHEM-BIOL INTERACT, V156, P101, DOI 10.1016/j.cbi.2005.08.001
   BARTLETT GR, 1959, J BIOL CHEM, V234, P466
   BEUTLER E, 1963, J LAB CLIN MED, V61, P882
   Blázquez C, 2000, FASEB J, V14, P2315, DOI 10.1096/fj.00-0122com
   BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
   Charruyer A, 2005, J BIOL CHEM, V280, P19196, DOI 10.1074/jbc.M412867200
   Crivello NA, 2005, NEUROCHEM INT, V47, P573, DOI 10.1016/j.neuint.2005.06.011
   Cutler RG, 2001, MECH AGEING DEV, V122, P895, DOI 10.1016/S0047-6374(01)00246-9
   Denis U, 2002, FREE RADICAL BIO MED, V33, P236, DOI 10.1016/S0891-5849(02)00879-1
   Dumitru CA, 2006, ONCOGENE, V25, P5612, DOI 10.1038/sj.onc.1209568
   Freisleben H-Y, 1992, VITAMIN E HLTH DIS, P193
   García-Ruiz C, 2000, HEPATOLOGY, V32, P56, DOI 10.1053/jhep.2000.8267
   Grether-Beck S, 2005, J INVEST DERMATOL, V125, P545, DOI 10.1111/j.0022-202X.2005.23782.x
   Grether-Beck S, 2000, EMBO J, V19, P5793, DOI 10.1093/emboj/19.21.5793
   Hatanaka Y, 1998, BBA-LIPID LIPID MET, V1393, P203, DOI 10.1016/S0005-2760(98)00066-6
   Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002
   Ichi I, 2009, TOXICOLOGY, V261, P33, DOI 10.1016/j.tox.2009.04.040
   Kavok NS, 2003, EXP GERONTOL, V38, P441, DOI 10.1016/S0531-5565(02)00246-2
   Lauter CJ, 1962, J LIPID RES, V3, P135
   Lightle SA, 2000, MECH AGEING DEV, V120, P111, DOI 10.1016/S0047-6374(00)00191-3
   Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100
   Liu B, 1997, J BIOL CHEM, V272, P16281, DOI 10.1074/jbc.272.26.16281
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Martín SF, 2001, J BIOENERG BIOMEMBR, V33, P143, DOI 10.1023/A:1010704715979
   Massip L, 2010, FASEB J, V24, P158, DOI 10.1096/fj.09-137133
   Mazière C, 2001, BIOCHEM BIOPH RES CO, V281, P289, DOI 10.1006/bbrc.2001.4348
   MERRILL AH, 1995, J BIOL CHEM, V270, P13834, DOI 10.1074/jbc.270.23.13834
   MERRILL AH, 1985, J LIPID RES, V26, P617
   Nagle CA, 2009, J LIPID RES, V50, pS74, DOI 10.1194/jlr.R800053-JLR200
   Nakamura S, 2009, J BIOL CHEM, V284, P14809, DOI 10.1074/jbc.M901488200
   Nakata K, 1996, MECH AGEING DEV, V90, P195, DOI 10.1016/0047-6374(96)01771-X
   Perry DK, 2000, J BIOL CHEM, V275, P9078, DOI 10.1074/jbc.275.12.9078
   Post A, 1998, J NEUROSCI, V18, P8236
   Rutkute K, 2007, J LIPID RES, V48, P2443, DOI 10.1194/jlr.M700227-JLR200
   Sanvicens N, 2006, J NEUROCHEM, V98, P1432, DOI 10.1111/j.1471-4159.2006.03977.x
   Sathishkumar S, 2005, CANCER BIOL THER, V4, P979, DOI 10.4161/cbt.4.9.1915
   Scheel-Toellner D, 2004, BLOOD, V104, P2557, DOI 10.1182/blood-2004-01-0191
   Strivastava S, 2007, FREE RADICAL RES, V41, P38, DOI [10.1080/10715760600943900, DOI 10.1080/10715760600943900]
   Su JF, 2003, BIOMED ENVIRON SCI, V16, P1
   Watson ML, 2009, BIOCHEM J, V417, P791, DOI 10.1042/BJ20081149
   Wei YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE275, DOI 10.1152/ajpendo.00644.2005
   Yamagata K, 2009, J EXP STROKE TRANSL, V2, P2, DOI [10.1016/j.neuroscience.2010.07.013, DOI 10.1016/J.NEUROSCIENCE.2010.07.013]
   Zeidan YH, 2007, J BIOL CHEM, V282, P11549, DOI 10.1074/jbc.M609424200
NR 48
TC 13
Z9 16
U1 0
U2 6
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0161-9152
J9 AGE
JI Age
PD AUG
PY 2012
VL 34
IS 4
BP 905
EP 915
DI 10.1007/s11357-011-9288-3
PG 11
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 979PP
UT WOS:000306832500010
PM 21796379
OA Green Published
DA 2024-02-19
ER

PT J
AU González-Navarro, H
   Vinué, A
   Sanz, MJ
   Delgado, M
   Pozo, MA
   Serrano, M
   Burks, DJ
   Andres, V
AF Gonzalez-Navarro, Herminia
   Vinue, Angela
   Jesus Sanz, Maria
   Delgado, Mercedes
   Angel Pozo, Miguel
   Serrano, Manuel
   Burks, Deborah J.
   Andres, Vicente
TI Increased dosage of Ink4/Arf protects against glucose intolerance and
   insulin resistance associated with aging
SO AGING CELL
LA English
DT Article
DE 18F-fluorodeoxyglucose-PET; ARF; CDKN2A; CDKN2B; diabetes; insulin
   resistance; insulin signaling; p15ink4b; p16ink4a; pancreatic islet
ID GENOME-WIDE ASSOCIATION; HEMATOPOIETIC STEM-CELLS;
   CORONARY-ARTERY-DISEASE; SUSCEPTIBILITY LOCI; METABOLIC SYNDROME;
   TUMOR-SUPPRESSOR; 9P21 LOCUS; ATHEROSCLEROSIS; P16(INK4A); EXPRESSION
AB Recent genome-wide association studies have linked type-2 diabetes mellitus to a genomic region in chromosome 9p21 near the Ink4/Arf locus, which encodes tumor suppressors that are up-regulated in a variety of mammalian organs during aging. However, it is unclear whether the susceptibility to type-2 diabetes is associated with altered expression of the Ink4/Arf locus. In the present study, we investigated the role of Ink4/Arf in age-dependent alterations of insulin and glucose homeostasis using Super-Ink4/Arf mice which bear an extra copy of the entire Ink4/Arf locus. We find that, in contrast to age-matched wild-type controls, Super-Ink4/Arf mice do not develop glucose intolerance with aging. Insulin tolerance tests demonstrated increased insulin sensitivity in Super-Ink4/Arf compared with wild-type mice, which was accompanied by higher activation of the insulin receptor substrate (IRS)-PI3K-AKT pathway in liver, skeletal muscle and heart. Glucose uptake studies in Super-Ink4/Arf mice showed a tendency toward increased 18F-fluorodeoxyglucose uptake in skeletal muscle compared with wild-type mice (P = 0.079). Furthermore, a positive correlation between glucose uptake and baseline glucose levels was observed in Super-Ink4/Arf mice (P < 0.008) but not in wild-type mice. Our studies reveal a protective role of the Ink4/Arf locus against the development of age-dependent insulin resistance and glucose intolerance.
C1 [Gonzalez-Navarro, Herminia; Jesus Sanz, Maria] Inst Hlth Res INCLIVA, Valencia 46010, Spain.
   [Vinue, Angela] Spanish Council Sci Res CSIC, IBV, Dept Mol & Cellular Pathol & Therapy, Vasc Biol Unit, Valencia 46010, Spain.
   [Jesus Sanz, Maria] Univ Valencia INCLIVA, Dept Farmacol, Valencia 46010, Spain.
   [Delgado, Mercedes; Angel Pozo, Miguel] Univ Complutense Madrid, Inst Pluridisciplinar, CAI Cartog Cerebral, E-28040 Madrid, Spain.
   [Serrano, Manuel] Spanish Natl Canc Res Ctr CNIO, Madrid 28029, Spain.
   [Burks, Deborah J.] CIPF, CIBER Diabet Enfermedades Metab CIBERDEM, Valencia 46012, Spain.
   [Andres, Vicente] CNIC, Dept Epidemiol Atherothrombosis & Imaging, Lab Mol & Genet Cardiovasc Pathophysiol, Madrid 28029, Spain.
C3 Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto
   de Biomedicina de Valencia (IBV); Complutense University of Madrid;
   Centro Nacional de Investigaciones Oncologicas (CNIO); Prince Felipe
   Research Center; CIBER - Centro de Investigacion Biomedica en Red;
   CIBERDEM; Centro Nacional de Investigaciones Cardiovasculares (CNIC)
RP Andres, V (corresponding author), CNIC, Dept Epidemiol Atherothrombosis & Imaging, Lab Mol & Genet Cardiovasc Pathophysiol, Melchor Fernandez Almagro 3, Madrid 28029, Spain.
EM gonzaleh@uv.es; vandres@cnic.es
RI Delgado, Mercedes/L-1830-2014; Pozo, Miguel A/AAO-3977-2021; Andres,
   Vicente/I-6440-2014; Pozo, Miguel/L-1021-2014; Serrano,
   Manuel/H-2634-2015
OI Delgado, Mercedes/0000-0001-5595-4897; Pozo, Miguel
   A/0000-0001-9303-0513; Andres, Vicente/0000-0002-0125-7209; Pozo,
   Miguel/0000-0001-5934-1510; Sanz, Maria Jesus/0000-0002-8885-294X;
   Serrano, Manuel/0000-0001-7177-9312; Gonzalez-Navarro,
   Herminia/0000-0001-6883-3808
FU Spanish Ministry of Economy and Competiveness (MINECO); European
   Regional Development Fund [SAF2007-62110, SAF2010-16044, SAF2008-0011,
   SAF2011-23777]; Instituto de Salud Carlos III [FIS: PI-CP10/00555,
   RECAVA: RD06/0014/0021, EMER07-12]; MINECO; Pro-CNIC Foundation
FX We thank M. J. Andres-Manzano for help with figure preparation and L.
   Nunez for excellent technical assistance. Work supported by grants from
   the Spanish Ministry of Economy and Competiveness (MINECO) and European
   Regional Development Fund (SAF2007-62110, SAF2010-16044, SAF2008-0011,
   SAF2011-23777), and from the Instituto de Salud Carlos III (FIS:
   PI-CP10/00555, RECAVA: RD06/0014/0021, and EMER07-12). H.G.-N. is an
   investigator from 'Miguel Servet' programme (CP10/00555) and A. V. from
   MINECO. The Centro Nacional de Investigaciones Cardiovasculares (CNIC)
   is supported by the MINECO and the Pro-CNIC Foundation.
CR Annicotte JS, 2009, NAT CELL BIOL, V11, P1017, DOI 10.1038/ncb1915
   Baker DJ, 2008, NAT CELL BIOL, V10, P825, DOI 10.1038/ncb1744
   Beckman JA, 2002, JAMA-J AM MED ASSOC, V287, P2570, DOI 10.1001/jama.287.19.2570
   Benetos A, 2008, AM J CARDIOL, V102, P188, DOI 10.1016/j.amjcard.2008.03.037
   Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911
   Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728
   Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003
   Cunnington MS, 2011, CURR ATHEROSCLER REP, V13, P193, DOI 10.1007/s11883-011-0178-z
   Doria A, 2008, JAMA-J AM MED ASSOC, V300, P2389, DOI 10.1001/jama.2008.649
   Gan BY, 2010, NATURE, V468, P701, DOI 10.1038/nature09595
   Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987
   Gonzalez S, 2006, CELL CYCLE, V5, P1382, DOI 10.4161/cc.5.13.2901
   González-Navarro H, 2008, ARTERIOSCL THROM VAS, V28, P2187, DOI 10.1161/ATVBAHA.108.175299
   Gonzalez-Navarro H, 2007, FRONT BIOSCI, V12, P2291, DOI 10.2741/2231
   González-Navarro H, 2010, J AM COLL CARDIOL, V55, P2258, DOI 10.1016/j.jacc.2010.01.026
   Gurumurthy S, 2010, NATURE, V468, P659, DOI 10.1038/nature09572
   Hamsten A, 2008, J INTERN MED, V263, P538, DOI 10.1111/j.1365-2796.2008.01958.x
   Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137
   Hotta K, 2012, J HUM GENET, V57, P305, DOI 10.1038/jhg.2012.21
   Hribal ML, 2011, DIABETOLOGIA, V54, P795, DOI 10.1007/s00125-010-2038-8
   Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159
   Kippin TE, 2005, GENE DEV, V19, P756, DOI 10.1101/gad.1272305
   Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475
   Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092
   Kuo CL, 2011, ARTERIOSCL THROM VAS, V31, P2483, DOI 10.1161/ATVBAHA.111.234492
   Liu Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005027
   Matheu A, 2004, GENE DEV, V18, P2736, DOI 10.1101/gad.310304
   Matheu A, 2007, NATURE, V448, P375, DOI 10.1038/nature05949
   Matheu A, 2009, AGING CELL, V8, P152, DOI 10.1111/j.1474-9726.2009.00458.x
   Melzer D, 2007, MECH AGEING DEV, V128, P370, DOI 10.1016/j.mad.2007.03.005
   Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091
   Nunn AVW, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-16
   Qian ZJ, 2008, J EXP MED, V205, P2163, DOI 10.1084/jem.20080578
   Ressler S, 2006, AGING CELL, V5, P379, DOI 10.1111/j.1474-9726.2006.00231.x
   Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345
   Ruchat SM, 2009, ACTA DIABETOL, V46, P217, DOI 10.1007/s00592-008-0080-5
   Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358
   Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382
   Sharpless NE, 2007, NAT REV MOL CELL BIO, V8, P703, DOI 10.1038/nrm2241
   Stancáková A, 2009, DIABETES, V58, P2129, DOI 10.2337/db09-0117
   Vidal A, 2000, GENE, V247, P1, DOI 10.1016/S0378-1119(00)00092-5
   Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116
   Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364
   Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747
   Zindy F, 1997, ONCOGENE, V15, P203, DOI 10.1038/sj.onc.1201178
NR 45
TC 30
Z9 29
U1 2
U2 18
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
J9 AGING CELL
JI Aging Cell
PD FEB
PY 2013
VL 12
IS 1
BP 102
EP 111
DI 10.1111/acel.12023
PG 10
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 073LS
UT WOS:000313745100013
PM 23107464
OA hybrid, Green Submitted
DA 2024-02-19
ER

PT J
AU Aydin, AF
   Coban, J
   Dogan-Ekici, I
   Betül-Kalaz, E
   Dogru-Abbasoglu, S
   Uysal, M
AF Aydin, A. Fatih
   Coban, Jale
   Dogan-Ekici, Isin
   Betul-Kalaz, Esra
   Dogru-Abbasoglu, Semra
   Uysal, Mujdat
TI Carnosine and taurine treatments diminished brain oxidative stress and
   apoptosis in D-galactose aging model
SO METABOLIC BRAIN DISEASE
LA English
DT Article
DE D-Galactose; Carnosine; Taurine; Oxidative stress; Brain
ID ANTIOXIDANT BALANCE; DAMAGE; LIVER; RATS; PATHOPHYSIOLOGY; TISSUES;
   YOUNG; ACID
AB D-galactose (GAL) has been used as an animal model for brain aging and antiaging studies. GAL stimulates oxidative stress in several tissues including brain. Carnosine (CAR; beta-alanil-L-histidine) and taurine (TAU; 2-aminoethanesulfonic acid) exhibit antioxidant properties. CAR and TAU have anti-aging and neuroprotective effects. We investigated the effect of CAR and TAU supplementations on oxidative stress and brain damage in GAL-treated rats. Rats received GAL (300 mg/kg; s.c.; 5 days per week) alone or together with CAR (250 mg/kg/daily; i.p.; 5 days per week) or TAU (2.5 % w/w; in rat chow) for 2 months. Brain malondialdehyde (MDA), protein carbonyl (PC) and glutathione (GSH) levels and superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), glutathione transferase (GST) and acetylcholinesterase (AChE) activities were determined. Expressions of B cell lymphoma-2 (Bcl-2), Bax and caspase-3 were also evaluated in the brains by immunohistochemistry. GAL treatment increased brain MDA and PC levels and AChE activities. It decreased significantly brain GSH levels, SOD and GSH-Px but not GST activities. GAL treatment caused histopathological changes and increased apoptosis. CAR and TAU significantly reduced brain AChE activities, MDA and PC levels and elevated GSH levels in GAL-treated rats. CAR, but not TAU, significantly increased low activities of SOD and GSH-Px. Both CAR and TAU diminished apoptosis and ameliorated histopathological findings in the brain of GAL-treated rats. Our results indicate that CAR and TAU may be effective to prevent the development of oxidative stress, apoptosis and histopathological deterioration in the brain of GAL-treated rats.
C1 [Aydin, A. Fatih; Betul-Kalaz, Esra; Dogru-Abbasoglu, Semra; Uysal, Mujdat] Istanbul Univ, Dept Biochem, Istanbul Fac Med, Istanbul, Turkey.
   [Coban, Jale] Yeditepe Univ, Fac Med, Dept Biochem, Istanbul, Turkey.
   [Dogan-Ekici, Isin] Yeditepe Univ, Fac Med, Dept Pathol, Istanbul, Turkey.
C3 Istanbul University; Yeditepe University; Yeditepe University
RP Uysal, M (corresponding author), Istanbul Univ, Dept Biochem, Istanbul Fac Med, Istanbul, Turkey.
EM m.mujdatuysal@hotmail.com
RI Aydın, Abdurrahman Fatih/AAD-9170-2020; Abbasoglu, Semra/AAD-9014-2020
OI Abbasoglu, Semra/0000-0003-3467-9763
FU Istanbul University [5786]
FX The present work was supported by Research Fund of Istanbul University
   (Project No: 5786).
CR Anand KV, 2012, GERIATR GERONTOL INT, V12, P741, DOI 10.1111/j.1447-0594.2012.00843.x
   Aydin AF, 2010, BIOGERONTOLOGY, V11, P103, DOI 10.1007/s10522-009-9232-4
   BEUTLER E, 1963, J LAB CLIN MED, V61, P882
   Boldyrev AA, 2013, PHYSIOL REV, V93, P1803, DOI 10.1152/physrev.00039.2012
   Çoban J, 2015, METAB BRAIN DIS, V30, P793, DOI 10.1007/s11011-014-9643-z
   Das J, 2012, FOOD FUNCT, V3, P1251, DOI 10.1039/c2fo30117b
   Idrissi A, 2013, AMINO ACIDS, V45, P735, DOI 10.1007/s00726-013-1544-7
   ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9
   Fayaz SM, 2015, FOOD NUTR COMPON FOC, V8, P412
   Habig W H, 1981, Methods Enzymol, V77, P398
   Haider S, 2015, LIFE SCI, V124, P110, DOI 10.1016/j.lfs.2015.01.016
   Han CH, 2014, FOOD FUNCT, V5, P2228, DOI 10.1039/c4fo00205a
   Harman D, 2001, ANN NY ACAD SCI, V928, P1, DOI 10.1111/j.1749-6632.2001.tb05631.x
   Hipkiss AR, 2009, ADV FOOD NUTR RES, V57, P87, DOI 10.1016/S1043-4526(09)57003-9
   Hsia CH, 2012, BRIT J NUTR, V107, P1787, DOI 10.1017/S0007114511005150
   Jin CL, 2005, NEUROSCIENCE, V135, P939, DOI 10.1016/j.neuroscience.2005.06.066
   Kalaz EB, 2014, J PHYSIOL BIOCHEM, V70, P15, DOI 10.1007/s13105-013-0275-2
   Lan Z, 2012, J ETHNOPHARMACOL, V141, P386, DOI 10.1016/j.jep.2012.02.050
   LAWRENCE RA, 1976, BIOCHEM BIOPH RES CO, V71, P952, DOI 10.1016/0006-291X(76)90747-6
   Menzie J, 2013, BRAIN SCI, V3, P877, DOI 10.3390/brainsci3020877
   Miyazaki T, 2014, AMINO ACIDS, V46, P101, DOI 10.1007/s00726-012-1381-0
   MYLROIE AA, 1986, TOXICOL APPL PHARM, V82, P512, DOI 10.1016/0041-008X(86)90286-3
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   Parildar-Karpuzoglu H, 2008, PHARMACOL REP, V60, P673
   Prakash A, 2013, CLIN EXP PHARMACOL P, V40, P644, DOI 10.1111/1440-1681.12144
   Rosemberg DB, 2010, NEUROSCIENCE, V171, P683, DOI 10.1016/j.neuroscience.2010.09.030
   Ruan QW, 2014, GERONTOLOGY, V60, P424, DOI 10.1159/000358235
   Schaffer S, 2003, ADV EXP MED BIOL, V526, P307
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   Stvolinskii SL, 2003, B EXP BIOL MED+, V135, P130, DOI 10.1023/A:1023855428130
   Tsai SJ, 2012, EUR J PHARMACOL, V689, P81, DOI 10.1016/j.ejphar.2012.05.018
   Uysal M, 2015, FOOD NUTR COMPON FOC, V8, P510
   Wu WQ, 2014, FOOD FUNCT, V5, P158, DOI 10.1039/c3fo60400d
   Xian YF, 2014, NEUROCHEM INT, V76, P42, DOI 10.1016/j.neuint.2014.06.011
   Yildirim ZL, 2007, ANN NY ACAD SCI, V1100, P553, DOI 10.1196/annals.1395.061
   Zhang Wei-Wei, 2011, Sheng Li Xue Bao, V63, P245
NR 36
TC 62
Z9 66
U1 1
U2 31
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0885-7490
EI 1573-7365
J9 METAB BRAIN DIS
JI Metab. Brain Dis.
PD APR
PY 2016
VL 31
IS 2
BP 337
EP 345
DI 10.1007/s11011-015-9755-0
PG 9
WC Endocrinology & Metabolism; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Neurosciences & Neurology
GA DG8GI
UT WOS:000372320600013
PM 26518192
DA 2024-02-19
ER

PT J
AU DARDEVET, D
   SORNET, C
   TAILLANDIER, D
   SAVARY, I
   ATTAIX, D
   GRIZARD, J
AF DARDEVET, D
   SORNET, C
   TAILLANDIER, D
   SAVARY, I
   ATTAIX, D
   GRIZARD, J
TI SENSITIVITY AND PROTEIN-TURNOVER RESPONSE TO GLUCOCORTICOIDS ARE
   DIFFERENT IN SKELETAL-MUSCLE FROM ADULT AND OLD RATS - LACK OF
   REGULATION OF THE UBIQUITIN-PROTEASOME PROTEOLYTIC PATHWAY IN AGING
SO JOURNAL OF CLINICAL INVESTIGATION
LA English
DT Article
DE AGING; MUSCLE; GLUCOCORTICOIDS; PROTEIN TURNOVER; UBIQUITIN; PROTEASOME
ID MESSENGER-RNA; MYOFIBRILLAR PROTEINS; MOLECULAR-CLONING; DEGRADATION;
   LIVER; INSULIN; CDNA; RESTRICTION; SYSTEM; BREAKDOWN
AB We studied glucocorticoid-induced muscle wasting and subsequent recovery in adult (7-mo-old) and old (22-mo-old) rats, since the increased incidence of various disease states may result in glucocorticoids hypersecretion in aging, Adult and old rats received dexamethasone in their drinking water and were then allowed to recover, Muscle wasting occurred more rapidly in old rats and the recovery of muscle mass was impaired, suggesting that glucocorticoids may be involved in the emergence of muscle atrophy with advancing age. According to measurements in incubated epitrochlearis muscles, dexamethasone-induced muscle wasting mainly resulted from increased protein breakdown in the adult, but from depressed protein synthesis in the aged animal, Increased expression of cathepsin D, m-calpain, and ubiquitin was observed in the muscles from both dexamethasone-treated adult and old rats, By contrast, the disappearance of the stimulatory effect of glucocorticoids on protein breakdown in aging occurred along with a loss of ability of steroids to enhance the expression of the 14-kD ubiquitin carrier protein E2, which is involved in protein substrates ubiquitinylation, and of subunits of the 20 S proteasome (the proteolytic core of the 26 S proteasome that degrades ubiquitin conjugates). Thus, if glucocorticoids play any role in the progressive muscle atrophy seen in aging, this is unlikely to result from an activation of the ubiquitin-proteasome proteolytic pathway.
C1 CTR RECH NUTR HUMAINE, F-63122 CEYRAT, FRANCE.
RP DARDEVET, D (corresponding author), INRA, UNITE ETUD METAB AZOTE, F-63122 CEYRAT, FRANCE.
RI Attaix, Didier/H-5247-2011; Dardevet, Dominique/IAM-3666-2023
OI Taillandier, Daniel/0000-0003-4520-0551; Savary-Auzeloux,
   Isabelle/0000-0002-3298-9787; Dardevet, Dominique/0000-0001-7320-9970;
   Attaix, Didier/0000-0002-0429-9957
CR AGELL N, 1988, P NATL ACAD SCI USA, V85, P3693, DOI 10.1073/pnas.85.11.3693
   ATTAIX D, 1994, REPROD NUTR DEV, V34, P583, DOI 10.1051/rnd:19940605
   BONDY P K, 1985, P816
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   CIECHANOVER A, 1994, CELL, V79, P13, DOI 10.1016/0092-8674(94)90396-4
   CLARK AS, 1984, J CLIN INVEST, V74, P888, DOI 10.1172/JCI111506
   DARDEVET D, 1994, ENDOCRINOLOGY, V134, P1475, DOI 10.1210/en.134.3.1475
   DARDEVET D, 1991, AM J PHYSIOL, V261, pE562, DOI 10.1152/ajpendo.1991.261.5.E562
   DICE FJ, 1990, WORLD REV NUTR DIET, V63, P175
   DUJOVNE CA, 1975, STEROID THERAPY, P27
   ELHAJ AJ, 1986, COMP BIOCHEM PHYS A, V85, P281, DOI 10.1016/0300-9629(86)90251-3
   FAGAN JM, 1987, BIOCHEM J, V243, P335, DOI 10.1042/bj2430335
   FAUST PL, 1985, P NATL ACAD SCI USA, V82, P4910, DOI 10.1073/pnas.82.15.4910
   FORBES GB, 1976, HUM BIOL, V48, P161
   FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431
   FUJIWARA T, 1989, BIOCHEMISTRY-US, V28, P7332, DOI 10.1021/bi00444a028
   FURUNO K, 1990, J BIOL CHEM, V265, P8550
   GOLDBERG AL, 1992, NATURE, V357, P375, DOI 10.1038/357375a0
   GOLDSPINK DF, 1987, EXP GERONTOL, V22, P67, DOI 10.1016/0531-5565(87)90016-7
   HOLLOSZY JO, 1991, MECH AGEING DEV, V60, P199, DOI 10.1016/0047-6374(91)90131-I
   ILIAN MA, 1992, BIOCHEM J, V287, P163, DOI 10.1042/bj2870163
   IMAJOH S, 1988, BIOCHEMISTRY-US, V27, P8122, DOI 10.1021/bi00421a022
   JOHNSON P, 1990, INT J BIOCHEM, V22, P811, DOI 10.1016/0020-711X(90)90284-A
   KAYALI AG, 1987, AM J PHYSIOL, V252, pE621, DOI 10.1152/ajpendo.1987.252.5.E621
   KELLY FJ, 1982, BIOCHEM J, V208, P147, DOI 10.1042/bj2080147
   KETTELHUT IC, 1988, DIABETES METAB REV, V4, P751, DOI 10.1002/dmr.5610040805
   KLITGAARD H, 1989, J APPL PHYSIOL, V67, P1409, DOI 10.1152/jappl.1989.67.4.1409
   KUMATORI A, 1990, FEBS LETT, V264, P279, DOI 10.1016/0014-5793(90)80267-M
   LEGASPI A, 1985, SURG FORUM, V36, P16
   LOUARD RJ, 1994, J CLIN ENDOCR METAB, V79, P278, DOI 10.1210/jc.79.1.278
   LOWELL BB, 1986, BIOCHEM J, V234, P237, DOI 10.1042/bj2340237
   MAKRIDES SC, 1983, BIOL REV, V58, P343, DOI 10.1111/j.1469-185X.1983.tb00394.x
   MAY RC, 1986, J CLIN INVEST, V77, P614, DOI 10.1172/JCI112344
   MCGRATH JA, 1982, BIOCHEM J, V206, P641, DOI 10.1042/bj2060641
   MEDINA R, 1995, BIOCHEM J, V307, P631, DOI 10.1042/bj3070631
   MEZQUITA J, 1993, FEBS LETT, V319, P244, DOI 10.1016/0014-5793(93)80555-9
   MITCH WE, 1994, J CLIN INVEST, V93, P2127, DOI 10.1172/JCI117208
   MOSONI L, 1995, AM J PHYSIOL-ENDOC M, V268, pE328, DOI 10.1152/ajpendo.1995.268.2.E328
   MOSONI L, 1993, AM J PHYSIOL, V264, pE614, DOI 10.1152/ajpendo.1993.264.4.E614
   NISHIMURA H, 1988, AM J PHYSIOL, V254, pE92, DOI 10.1152/ajpendo.1988.254.1.E92
   ODEDRA BR, 1983, BIOCHEM J, V214, P617, DOI 10.1042/bj2140617
   PAN JX, 1993, EXP GERONTOL, V28, P39, DOI 10.1016/0531-5565(93)90018-9
   PRICE SR, 1994, AM J PHYSIOL-CELL PH, V267, pC955, DOI 10.1152/ajpcell.1994.267.4.C955
   RANNELS SR, 1980, AM J PHYSIOL, V238, pE564, DOI 10.1152/ajpendo.1980.238.6.E564
   RECHSTEINER M, 1991, CELL, V66, P615, DOI 10.1016/0092-8674(91)90104-7
   SABATINO F, 1991, J GERONTOL, V46, pB171, DOI 10.1093/geronj/46.5.B171
   SAPOLSKY R, 1987, ENDOCRIN METAB CLIN, V16, P965, DOI 10.1016/S0889-8529(18)30453-5
   SEGUNDO BS, 1985, P NATL ACAD SCI USA, V82, P2320, DOI 10.1073/pnas.82.8.2320
   SPINDLER SR, 1991, J GERONTOL, V46, pB233, DOI 10.1093/geronj/46.6.B233
   TEMPARIS S, 1994, CANCER RES, V54, P5568
   TESSITORE L, 1993, BRIT J CANCER, V67, P15, DOI 10.1038/bjc.1993.4
   TIAO G, 1994, J CLIN INVEST, V94, P2255, DOI 10.1172/JCI117588
   TISCHLER ME, 1982, J BIOL CHEM, V257, P1613
   TOMAS FM, 1979, BIOCHEM J, V178, P139, DOI 10.1042/bj1780139
   VAUGHAN GM, 1982, J TRAUMA, V22, P263, DOI 10.1097/00005373-198204000-00001
   VELLAS BJ, 1992, AM J CLIN NUTR, V55, P1225
   VINCENTMANSOOR O, 1994, 10TH P INT C INTR PR
   VOISIN L, 1994, CLIN NUTR, V13, P34
   WAALKES TP, 1957, J LAB CLIN MED, V50, P733
   WING SS, 1994, AM J PHYSIOL, V267, pE39, DOI 10.1152/ajpendo.1994.267.1.E39
   WING SS, 1993, AM J PHYSIOL, V264, pE668, DOI 10.1152/ajpendo.1993.264.4.E668
NR 61
TC 148
Z9 156
U1 0
U2 3
PU AMER SOC CLINICAL INVESTIGATION INC
PI ANN ARBOR
PA 2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA
SN 0021-9738
EI 1558-8238
J9 J CLIN INVEST
JI J. Clin. Invest.
PD NOV
PY 1995
VL 96
IS 5
BP 2113
EP 2119
DI 10.1172/JCI118264
PG 7
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA TC979
UT WOS:A1995TC97900006
PM 7593595
OA Bronze, Green Published
DA 2024-02-19
ER

PT J
AU Luo, A
   Jung, J
   Longley, M
   Rosoff, DB
   Charlet, K
   Muench, C
   Lee, J
   Hodgkinson, CA
   Goldman, D
   Horvath, S
   Kaminsky, ZA
   Lohoff, FW
AF Luo, Audrey
   Jung, Jeesun
   Longley, Martha
   Rosoff, Daniel B.
   Charlet, Katrin
   Muench, Christine
   Lee, Jisoo
   Hodgkinson, Colin A.
   Goldman, David
   Horvath, Steve
   Kaminsky, Zachary A.
   Lohoff, Falk W.
TI Epigenetic aging is accelerated in alcohol use disorder and regulated by
   genetic variation in <i>APOL2</i>
SO NEUROPSYCHOPHARMACOLOGY
LA English
DT Article
ID LONG-TERM DEPRESSION; BONE-MINERAL DENSITY; DNA METHYLATION AGE;
   ALL-CAUSE MORTALITY; RECEPTOR GENE; ASSOCIATION; DOPAMINE; BLOOD;
   POLYMORPHISMS; CANCER
AB To investigate the potential role of alcohol use disorder (AUD) in aging processes, we employed Levine's epigenetic clock (DNAm PhenoAge) to estimate DNA methylation age in 331 individuals with AUD and 201 healthy controls (HC). We evaluated the effects of heavy, chronic alcohol consumption on epigenetic age acceleration (EAA) using clinical biomarkers, including liver function test enzymes (LFTs) and clinical measures. To characterize potential underlying genetic variation contributing to EAA in AUD, we performed genome-wide association studies (GWAS) on EAA, including pathway analyses. We followed up on relevant top findings with in silico expression quantitative trait loci (eQTL) analyses for biological function using the BRAINEAC database. There was a 2.22-year age acceleration in AUD compared to controls after adjusting for gender and blood cell composition (p = 1.85 x 10(-5)). This association remained significant after adjusting for race, body mass index, and smoking status (1.38 years, p = 0.02). Secondary analyses showed more pronounced EAA in individuals with more severe AUD-associated phenotypes, including elevated gammaglutamyl transferase (GGT) and alanine aminotransferase (ALT), and higher number of heavy drinking days (all ps < 0.05). The genome-wide meta-analysis of EAA in AUD revealed a significant single nucleotide polymorphism (SNP), rs916264 (p = 5.43 x 10(-8)), in apolipoprotein L2 (APOL2) at the genome-wide level. The minor allele A of rs916264 was associated with EAA and with increased mRNA expression in hippocampus (p = 0.0015). Our data demonstrate EAA in AUD and suggest that disease severity further accelerates epigenetic aging. EAA was associated with genetic variation in APOL2, suggesting potential novel biological mechanisms for age acceleration in AUD.
C1 [Luo, Audrey; Jung, Jeesun; Longley, Martha; Rosoff, Daniel B.; Charlet, Katrin; Muench, Christine; Lee, Jisoo; Lohoff, Falk W.] NIAAA, Sect Clin Genom & Expt Therapeut, NIH, Bethesda, MD 20892 USA.
   [Charlet, Katrin] Charite Univ Med Berlin, Dept Psychiat & Psychotherapy, Berlin, Germany.
   [Hodgkinson, Colin A.; Goldman, David] NIAAA, Lab Neurogenet, NIH, Bethesda, MD USA.
   [Horvath, Steve] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA.
   [Horvath, Steve] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Biostat, Los Angeles, CA USA.
   [Kaminsky, Zachary A.] Univ Ottawa, Royals Inst Mental Hlth Res, Ottawa, ON, Canada.
C3 National Institutes of Health (NIH) - USA; NIH National Institute on
   Alcohol Abuse & Alcoholism (NIAAA); Free University of Berlin; Humboldt
   University of Berlin; Charite Universitatsmedizin Berlin; National
   Institutes of Health (NIH) - USA; NIH National Institute on Alcohol
   Abuse & Alcoholism (NIAAA); University of California System; University
   of California Los Angeles; University of California Los Angeles Medical
   Center; David Geffen School of Medicine at UCLA; University of
   California System; University of California Los Angeles; University of
   Ottawa
RP Lohoff, FW (corresponding author), NIAAA, Sect Clin Genom & Expt Therapeut, NIH, Bethesda, MD 20892 USA.
EM falk.lohoff@nih.gov
RI Hodgkinson, Colin A/F-9899-2010; Goldman, David/F-9772-2010; Lohoff,
   Falk W/M-7951-2016
OI Goldman, David/0000-0002-1724-5405; Luo, Audrey/0000-0001-6798-1876;
   Hodgkinson, Colin/0000-0002-5365-8119; Longley,
   Martha/0000-0002-7120-3484
FU National Institutes of Health (NIH) [ZIA-AA000242]; Division of
   Intramural Clinical and Biological Research of the National Institute on
   Alcohol Abuse and Alcoholism (NIAAA); NATIONAL INSTITUTE ON ALCOHOL
   ABUSE AND ALCOHOLISM [ZIAAA000301, ZIAAA000242] Funding Source: NIH
   RePORTER
FX This work was supported by the National Institutes of Health (NIH)
   intramural funding [ZIA-AA000242 to F.W.L]; Division of Intramural
   Clinical and Biological Research of the National Institute on Alcohol
   Abuse and Alcoholism (NIAAA). The authors declare no competing
   interests.
CR Ballard HS, 1997, ALCOHOL HEALTH RES W, V21, P42
   Beach SRH, 2015, J AM GERIATR SOC, V63, P2519, DOI 10.1111/jgs.13830
   Belmeguenai A, 2008, J NEUROPHYSIOL, V100, P3167, DOI 10.1152/jn.90384.2008
   Boks MP, 2015, PSYCHONEUROENDOCRINO, V51, P506, DOI 10.1016/j.psyneuen.2014.07.011
   Cacabelos R, 2011, CNS NEUROSCI THER, V17, P541, DOI 10.1111/j.1755-5949.2010.00187.x
   Cho Y, 2018, ARCH OSTEOPOROS, V13, DOI 10.1007/s11657-018-0462-4
   Dhingra R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0207834
   Di Chiara G, 2004, NEUROPHARMACOLOGY, V47, P227, DOI 10.1016/j.neuropharm.2004.06.032
   DIFRANZA JR, 1990, J STUD ALCOHOL, V51, P130, DOI 10.15288/jsa.1990.51.130
   Elliott DA, 2010, CLIN LIPIDOL, V5, P555, DOI 10.2217/CLP.10.37
   Fiorito G, 2019, AGING-US, V11, P2045, DOI 10.18632/aging.101900
   Gaddini GW, 2016, ALCOHOL CLIN EXP RES, V40, P657, DOI 10.1111/acer.13000
   Galindo-Moreno J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.237
   Goldstein RB, 2015, J STUD ALCOHOL DRUGS, V76, P378, DOI 10.15288/jsad.2015.76.378
   Griswold MG, 2018, LANCET, V392, P1015, DOI 10.1016/S0140-6736(18)31310-2
   Han LKM, 2018, AM J PSYCHIAT, V175, P774, DOI 10.1176/appi.ajp.2018.17060595
   Hannum G, 2013, MOL CELL, V49, P359, DOI 10.1016/j.molcel.2012.10.016
   Hattab MW, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1148-8
   HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119
   Hirano T, 2013, P JPN ACAD B-PHYS, V89, P183, DOI 10.2183/pjab.89.183
   Horvath S, 2018, AGING-US, V10, P1758, DOI 10.18632/aging.101508
   Horvath S, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1030-0
   Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115
   Houseman EA, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1140-4
   Jaffe AE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r31
   Kanehisa M, 2019, NUCLEIC ACIDS RES, V47, pD590, DOI 10.1093/nar/gky962
   Kuan PF, 2010, BIOINFORMATICS, V26, P2849, DOI 10.1093/bioinformatics/btq553
   Kustanovich V, 2004, MOL PSYCHIATR, V9, P711, DOI 10.1038/sj.mp.4001466
   Laramée P, 2015, EBIOMEDICINE, V2, P1394, DOI 10.1016/j.ebiom.2015.08.040
   Lehrmann E, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000114
   Levine ME, 2018, AGING-US, V10, P573, DOI 10.18632/aging.101414
   Levine ME, 2015, AGING-US, V7, P690, DOI 10.18632/aging.100809
   Li DY, 2019, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00521
   Lohoff FW, 2018, MOL PSYCHIATR, V23, DOI 10.1038/mp.2017.168
   Lu AT, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02697-5
   Lu AT, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15353
   Ma DX, 2017, AM J MED GENET A, V173, P2605, DOI 10.1002/ajmg.a.38350
   Marioni RE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0584-6
   Masi L, 1998, BIOCHEM BIOPH RES CO, V248, P190, DOI 10.1006/bbrc.1998.8880
   McEwen LM, 2018, CLIN EPIGENETICS, V10, DOI 10.1186/s13148-018-0556-2
   McKinney BC, 2018, SCHIZOPHR RES, V196, P39, DOI 10.1016/j.schres.2017.09.025
   Millet B, 2003, AM J MED GENET B, V116B, P55, DOI 10.1002/ajmg.b.10034
   Noble EP, 2000, EUR PSYCHIAT, V15, P79, DOI 10.1016/S0924-9338(00)00208-X
   Okazaki S, 2019, NPJ SCHIZOPHR, V5, DOI 10.1038/s41537-019-0072-1
   Peterson K, 2004, ALCOHOL RES HEALTH, V28, P30
   Quach A, 2017, AGING-US, V9, P419, DOI 10.18632/aging.101168
   Ramasamy A, 2014, NAT NEUROSCI, V17, P1418, DOI 10.1038/nn.3801
   RICO H, 1990, ALCOHOL ALCOHOLISM, V25, P345
   Rosen AD, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-018-0233-4
   Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311
   Ruby Christina L, 2010, Curr Drug Abuse Rev, V3, P163
   Saieva C, 2012, ALCOHOL CLIN EXP RES, V36, P342, DOI 10.1111/j.1530-0277.2011.01626.x
   Segrè AV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001058
   SOBELL LC, 1992, MEASURING ALCOHOL CONSUMPTION, P41, DOI 10.1007/978-1-4612-0357-5_3
   Su LD, 2010, ALCOHOL CLIN EXP RES, V34, P1140, DOI 10.1111/j.1530-0277.2010.01190.x
   Takahashi S, 2008, SCHIZOPHR RES, V104, P153, DOI 10.1016/j.schres.2008.05.028
   Turner RT, 2000, ALCOHOL CLIN EXP RES, V24, P1693, DOI 10.1111/j.1530-0277.2000.tb01971.x
   Tylee DS, 2013, AM J MED GENET B, V162, P595, DOI 10.1002/ajmg.b.32150
   Udo T, 2015, DRUG ALCOHOL DEPEN, V157, P68, DOI 10.1016/j.drugalcdep.2015.10.008
   Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419
   Walters RK, 2018, NAT NEUROSCI, V21, P1656, DOI 10.1038/s41593-018-0275-1
   Wand G, 2001, J NEUROSCI, V21, P5297, DOI 10.1523/JNEUROSCI.21-14-05297.2001
   Wang ML, 2016, CANCER RES, V76, P3277, DOI 10.1158/0008-5472.CAN-15-2564
   Ward-Caviness CK, 2016, ONCOTARGET, V7, P74510, DOI 10.18632/oncotarget.12903
   Westman J, 2015, ACTA PSYCHIAT SCAND, V131, P297, DOI 10.1111/acps.12330
   Wiers CE, 2018, MOL PSYCHIATR, V23, P1711, DOI 10.1038/mp.2017.208
   Xu MC, 2017, AM J HUM GENET, V100, P592, DOI 10.1016/j.ajhg.2017.02.008
   Zhang HP, 2017, AM J ADDICTION, V26, P502, DOI 10.1111/ajad.12465
   Zhang HP, 2013, ALCOHOL CLIN EXP RES, V37, pE108, DOI 10.1111/j.1530-0277.2012.01928.x
NR 69
TC 50
Z9 51
U1 2
U2 22
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 0893-133X
EI 1740-634X
J9 NEUROPSYCHOPHARMACOL
JI Neuropsychopharmacology
PD FEB
PY 2020
VL 45
IS 2
BP 327
EP 336
DI 10.1038/s41386-019-0500-y
PG 10
WC Neurosciences; Pharmacology & Pharmacy; Psychiatry
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry
GA JV0GG
UT WOS:000502044600012
PM 31466081
OA Green Published, hybrid
DA 2024-02-19
ER

PT J
AU Wang, CM
   Cigliano, A
   Delogu, S
   Armbruster, J
   Dombrowski, F
   Evert, M
   Chen, X
   Calvisi, DF
AF Wang, Chunmei
   Cigliano, Antonio
   Delogu, Salvatore
   Armbruster, Julia
   Dombrowski, Frank
   Evert, Matthias
   Chen, Xin
   Calvisi, Diego F.
TI Functional crosstalk between AKT/mTOR and Ras/MAPK pathways in
   hepatocarcinogenesis Implications for the treatment of human liver
   cancer
SO CELL CYCLE
LA English
DT Article
DE liver cancer; Ras; AKT; mTOR; Rapamycin; mouse models
ID MTOR INHIBITORS; MAMMALIAN TARGET; TUMOR-SUPPRESSOR; DRUG-RESISTANCE;
   RAPAMYCIN; MOUSE; ACTIVATION; RAS; AKT; SENESCENCE
AB Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related death worldwide, with limited treatment options. AKT/mTOR and Ras/MAPK pathways are frequently deregulated in human hepatocarcinogenesis. Recently, we generated an animal model characterized by the co-expression of activated forms of AKT and Ras in the mouse liver. We found that concomitant activation of AKT/mTOR and Ras/MAPK cascades leads to rapid liver tumor development in AKT/Ras mice, mainly through mTORC1 induction. To further define the role of mTORC1 cascade in AKT/Ras induced HCC development, the mTORC1 inhibitor Rapamycin was administered to AKT/Ras mice at the time when small tumors started to emerge in the liver. Of note, Rapamycin treatment significantly delayed hepatocarcinogenesis in AKT/Ras mice. However, some microscopic lesions persisted in the livers of AKT/Ras mice despite the treatment and rapidly gave rise to HCC following Rapamycin withdrawal. Mechanistically, Rapamycin inhibited mTORC1 and mTORC2 pathways, lipogenesis and glycolysis, resulting in inhibition of proliferation in the treated livers. However, activated ERK and its downstream effectors, Mnk1 and eIF4E, were strongly upregulated in the residual lesions. Concomitant suppression of AKT/mTOR and Ras/MAPK pathways was highly detrimental for the growth of AKT/Ras cells in vitro. The study indicates the existence of a complex interplay between AKT/mTOR and Ras/MAPK pathways during hepatocarcinogenesis, with important implications for the understanding of HCC pathogenesis as well as for its prevention and treatment.
C1 [Wang, Chunmei; Chen, Xin] Univ Calif San Francisco, Dept Bioengn, San Francisco, CA 94143 USA.
   [Wang, Chunmei; Chen, Xin] Univ Calif San Francisco, Therapeut Sci & Liver Ctr, San Francisco, CA 94143 USA.
   [Cigliano, Antonio; Delogu, Salvatore; Armbruster, Julia; Dombrowski, Frank; Evert, Matthias; Calvisi, Diego F.] Univ Med Greifswald, Inst Pathol, Greifswald, Germany.
C3 University of California System; University of California San Francisco;
   University of California System; University of California San Francisco;
   Greifswald Medical School
RP Chen, X (corresponding author), Univ Calif San Francisco, Dept Bioengn, San Francisco, CA 94143 USA.
EM xin.chen@ucsf.edu; diego.calvisi@uni-greifswald.de
RI Cigliano, Antonio/J-4660-2017; cigliano, antonio/J-1836-2015; Wang,
   Chunmei/J-2423-2013
OI Cigliano, Antonio/0000-0002-6408-3613; Wang, Chunmei/0000-0003-4615-0517
FU Deutsche Forschungsgemeinschaft DFG [Do622/2-1, Ev168/2-1]; NIH
   [R01CA136606]
FX This study was supported by grants from the Deutsche
   Forschungsgemeinschaft DFG (grant number Do622/2-1) to F.D. and (grant
   number Ev168/2-1) to M.E. and NIH R01CA136606 to X.C. We would like to
   thank UCSF Liver Center (P30DK026743) for the histology support.
CR Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199
   Calvisi DF, 2006, GASTROENTEROLOGY, V130, P1117, DOI 10.1053/j.gastro.2006.01.006
   Calvisi DF, 2011, GASTROENTEROLOGY, V140, P1071, DOI 10.1053/j.gastro.2010.12.006
   Calvisi DF, 2011, J HEPATOL, V54, P311, DOI 10.1016/j.jhep.2010.06.036
   Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]
   Carracedo A, 2008, CELL CYCLE, V7, P3805, DOI 10.4161/cc.7.24.7244
   Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105
   Choo AY, 2009, CELL CYCLE, V8, P567, DOI 10.4161/cc.8.4.7659
   El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683
   Guertin DA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe24
   Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069
   Hay N, 2005, CANCER CELL, V8, P179, DOI 10.1016/j.ccr.2005.08.008
   Ho C, 2012, HEPATOLOGY, V55, P833, DOI 10.1002/hep.24736
   Hollander MC, 2011, NAT REV CANCER, V11, P289, DOI 10.1038/nrc3037
   Hsieh AC, 2010, CANCER CELL, V17, P249, DOI 10.1016/j.ccr.2010.01.021
   Huynh H, 2010, CANCER-AM CANCER SOC, V116, P1315, DOI 10.1002/cncr.24863
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Kennedy AL, 2011, MOL CELL, V42, P36, DOI 10.1016/j.molcel.2011.02.020
   Kinkade CW, 2008, J CLIN INVEST, V118, P3051, DOI 10.1172/JCI34764
   Kudo M, 2011, DIGEST DIS, V29, P273, DOI 10.1159/000327558
   Ladu S, 2008, GASTROENTEROLOGY, V135, P1322, DOI 10.1053/j.gastro.2008.07.012
   Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017
   Lee SA, 2008, HEPATOLOGY, V47, P1200, DOI 10.1002/hep.22169
   Lee SA, 2010, HEPATOLOGY, V52, P506, DOI 10.1002/hep.23681
   Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926
   Newell P, 2009, J HEPATOL, V51, P725, DOI 10.1016/j.jhep.2009.03.028
   Posch C, 2013, P NATL ACAD SCI USA, V110, P4015, DOI 10.1073/pnas.1216013110
   Sahin F, 2004, CLIN CANCER RES, V10, P8421, DOI 10.1158/1078-0432.CCR-04-0941
   Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109
   Steelman LS, 2008, ONCOGENE, V27, P4086, DOI 10.1038/onc.2008.49
   Steelman LS, 2011, CELL CYCLE, V10, P3003, DOI 10.4161/cc.10.17.17119
   Stiles B, 2004, P NATL ACAD SCI USA, V101, P2082, DOI 10.1073/pnas.0308617100
   Tamburini J, 2008, BLOOD, V111, P379, DOI 10.1182/blood-2007-03-080796
   Taylor JR, 2011, ONCOTARGET, V2, P610
   Treiber G, 2009, EXPERT REV ANTICANC, V9, P247, DOI 10.1586/14737140.9.2.247
   Villanueva A, 2008, GASTROENTEROLOGY, V135, P1972, DOI 10.1053/j.gastro.2008.08.008
   Wan X, 2007, ONCOGENE, V26, P1932, DOI 10.1038/sj.onc.1209990
   Wander SA, 2011, J CLIN INVEST, V121, P1231, DOI 10.1172/JCI44145
   Zaytseva YY, 2012, CANCER LETT, V319, P1, DOI 10.1016/j.canlet.2012.01.005
NR 39
TC 72
Z9 80
U1 1
U2 18
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1538-4101
EI 1551-4005
J9 CELL CYCLE
JI Cell Cycle
PD JUL 1
PY 2013
VL 12
IS 13
BP 1999
EP 2010
DI 10.4161/cc.25099
PG 12
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA 201VI
UT WOS:000323170700013
PM 23759595
OA Bronze, Green Published
DA 2024-02-19
ER

PT J
AU Zhou, D
   Hlady, RA
   Schafer, MJ
   White, TA
   Liu, C
   Choi, JH
   Miller, JD
   Roberts, LR
   LeBrasseur, NK
   Robertson, KD
AF Zhou, Dan
   Hlady, Ryan A.
   Schafer, Marissa J.
   White, Thomas A.
   Liu, Chen
   Choi, Jeong-Hyeon
   Miller, Jordan D.
   Roberts, Lewis R.
   LeBrasseur, Nathan K.
   Robertson, Keith D.
TI High fat diet and exercise lead to a disrupted and pathogenic DNA
   methylome in mouse liver
SO EPIGENETICS
LA English
DT Article
DE Aging; cancer; DNA methylation; exercise; high fat; NAFLD
ID HEPATOCELLULAR-CARCINOMA; METHYLATION; DISEASE; CANCER;
   HYPERMETHYLATION; VITAMIN-B-12; HISTONE; OBESITY; INJURY; FOLATE
AB High-fat diet consumption and sedentary lifestyle elevates risk for obesity, non-alcoholic fatty liver disease, and cancer. Exercise training conveys health benefits in populations with or without these chronic conditions. Diet and exercise regulate gene expression by mediating epigenetic mechanisms in many tissues; however, such effects are poorly documented in the liver, a central metabolic organ. To dissect the consequences of diet and exercise on the liver epigenome, we measured DNA methylation, using reduced representation bisulfite sequencing, and transcription, using RNA-seq, in mice maintained on a fast food diet with sedentary lifestyle or exercise, compared with control diet with and without exercise. Our analyses reveal that genome-wide differential DNA methylation and expression of gene clusters are induced by diet and/or exercise. A combination of fast food and exercise triggers extensive gene alterations, with enrichment of carbohydrate/lipid metabolic pathways and muscle developmental processes. Through evaluation of putative protective effects of exercise on diet-induced DNA methylation, we show that hypermethylation is effectively prevented, especially at promoters and enhancers, whereas hypomethylation is only partially attenuated. We assessed diet-induced DNA methylation changes associated with liver cancer-related epigenetic modifications and identified significant increases at liver-specific enhancers in fast food groups, suggesting partial loss of liver cell identity. Hypermethylation at a subset of gene promoters was associated with inhibition of tissue development and promotion of carcinogenic processes. Our study demonstrates extensive reprogramming of the epigenome by diet and exercise, emphasizing the functional relevance of epigenetic mechanisms as an interface between lifestyle modifications and phenotypic alterations.
C1 [Zhou, Dan; Hlady, Ryan A.; Robertson, Keith D.] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA.
   [Schafer, Marissa J.; White, Thomas A.; Miller, Jordan D.; LeBrasseur, Nathan K.] Mayo Clin, Robert & Arlene Kogod Ctr Aging, Rochester, MN 55905 USA.
   [Schafer, Marissa J.; LeBrasseur, Nathan K.] Mayo Clin, Dept Phys Med & Rehabil, Rochester, MN 55905 USA.
   [Liu, Chen] Rutgers State Univ, Dept Pathol & Lab Med, New Brunswick, NJ USA.
   [Choi, Jeong-Hyeon] Marine Biodivers Inst Korea, Dept Appl Res, Janghang Eup, Seocheon Gun, South Korea.
   [Miller, Jordan D.] Mayo Clin, Dept Surg, Rochester, MN USA.
   [Roberts, Lewis R.; Robertson, Keith D.] Mayo Clin, Ctr Canc, Rochester, MN 55905 USA.
   [Roberts, Lewis R.] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA.
   [Robertson, Keith D.] Mayo Clin, Ctr Individualized Med, Rochester, MN 55905 USA.
C3 Mayo Clinic; Mayo Clinic; Mayo Clinic; Rutgers University System;
   Rutgers University New Brunswick; Marine Biodiversity Institute of Korea
   (MABIK); Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic
RP Robertson, KD (corresponding author), Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA.; LeBrasseur, NK (corresponding author), Mayo Clin, Robert & Arlene Kogod Ctr Aging, Rochester, MN 55905 USA.; LeBrasseur, NK (corresponding author), Mayo Clin, Dept Phys Med & Rehabil, Rochester, MN 55905 USA.; Robertson, KD (corresponding author), Mayo Clin, Ctr Canc, Rochester, MN 55905 USA.; Robertson, KD (corresponding author), Mayo Clin, Ctr Individualized Med, Rochester, MN 55905 USA.
EM LeBrasseur.Nathan@mayo.edu; Robertson.Keith@mayo.edu
OI Roberts, Lewis/0000-0001-7885-8574; LeBrasseur,
   Nathan/0000-0002-2002-0418; Robertson, Keith/0000-0002-7508-3328; Liu,
   Chen/0009-0003-0430-6146; Miller, Jordan/0000-0002-9868-4097
FU National Institutes of Health [R01CA114229, R01AA19976, R01HL111121,
   AG041122, AG053832]; Center for Individualized Medicine; Cancer Center;
   Center for Biomedical Discovery of Mayo Clinic, MN; Glenn Foundation for
   Medical Research
FX This work was supported by the National Institutes of Health
   (R01CA114229 (KDR), R01AA19976 (KDR), R01HL111121 (JDM), AG041122 (NKL),
   and AG053832 (NKL)), the Center for Individualized Medicine, the Cancer
   Center, and the Center for Biomedical Discovery of Mayo Clinic, MN, and
   the Glenn Foundation for Medical Research.
CR Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600
   Bertolotti M, 2014, WORLD J GASTROENTERO, V20, P14185, DOI 10.3748/wjg.v20.i39.14185
   Brunaud L, 2003, CLIN CHEM LAB MED, V41, P1012, DOI 10.1515/CCLM.2003.155
   Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540
   Dhanasekaran R, 2015, HEPATOLOGY, V61, P1269, DOI 10.1002/hep.27658
   Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906
   Ferolla SM, 2015, WORLD J HEPATOL, V7, P2522, DOI 10.4254/wjh.v7.i24.2522
   Hlady RA, 2014, ONCOTARGET, V5, P9425, DOI 10.18632/oncotarget.2444
   Holwerda SJB, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0369
   Horvath S, 2014, P NATL ACAD SCI USA, V111, P15538, DOI 10.1073/pnas.1412759111
   Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298
   Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597
   Kim YN, 2016, NUTR RES PRACT, V10, P161, DOI 10.4162/nrp.2016.10.2.161
   Murphy SK, 2013, GASTROENTEROLOGY, V145, P1076, DOI 10.1053/j.gastro.2013.07.047
   Noureddin M, 2015, CLIN LIVER DIS, V19, P361, DOI 10.1016/j.cld.2015.01.012
   Okreglicka Katarzyna, 2015, Rocz Panstw Zakl Hig, V66, P97
   Orci LA, 2016, CLIN GASTROENTEROL H, V14, P1398, DOI 10.1016/j.cgh.2016.04.036
   Schafer MJ, 2016, DIABETES, V65, P1606, DOI 10.2337/db15-0291
   Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243
   Suelves M, 2016, BRIEF FUNCT GENOMICS, V15, P443, DOI 10.1093/bfgp/elw017
   Sun ZF, 2012, BIOINFORMATICS, V28, P2180, DOI 10.1093/bioinformatics/bts337
   Sung KC, 2016, J HEPATOL, V65, P791, DOI 10.1016/j.jhep.2016.05.026
   Thomson JP, 2016, CANCER RES, V76, P3097, DOI 10.1158/0008-5472.CAN-15-1910
   Tolba R, 2015, LAB ANIM-UK, V49, P59, DOI 10.1177/0023677215570086
   Tryndyak VP, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2617-2
   Wang LX, 2015, PHARMACOL THERAPEUT, V151, P141, DOI 10.1016/j.pharmthera.2015.04.002
   Wu ZL, 1999, J LIPID RES, V40, P2195
   Xiao MT, 2012, GENE DEV, V26, P1326, DOI 10.1101/gad.191056.112
   Yamada N, 2016, ONCOL REP, V35, P2228, DOI 10.3892/or.2016.4619
   Zhang B, 2013, GENOME RES, V23, P1522, DOI 10.1101/gr.156539.113
   Zhang YK, 2015, PHYSIOL GENOMICS, V47, P514, DOI 10.1152/physiolgenomics.00110.2014
   Zhou D, 2015, J NUTR BIOCHEM, V26, P433, DOI 10.1016/j.jnutbio.2014.10.009
NR 32
TC 35
Z9 41
U1 4
U2 23
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1559-2294
EI 1559-2308
J9 EPIGENETICS-US
JI Epigenetics
PY 2017
VL 12
IS 1
BP 55
EP 69
DI 10.1080/15592294.2016.1261239
PG 15
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA EL2KS
UT WOS:000394449200006
PM 27858497
OA Green Published, Bronze
DA 2024-02-19
ER

PT J
AU Rozenboim, I
   Mahato, J
   Cohen, NA
   Tirosh, O
AF Rozenboim, I.
   Mahato, J.
   Cohen, N. A.
   Tirosh, O.
TI Low protein and high-energy diet: a possible natural cause of fatty
   liver hemorrhagic syndrome in caged White Leghorn laying hens
SO POULTRY SCIENCE
LA English
DT Article
DE liver damage; nutrition; hen-day egg production; ageing; laying hens
ID ENZYME-ACTIVITIES; PERFORMANCE; PARAMETERS; INDUCTION
AB Fatty liver hemorrhagic syndrome (FLHS) is a metabolic condition of chicken and other birds caused by diverse nutritional, hormonal, environmental, and metabolic factors. Here we studied the effect of different diet composition on the induction of FLHS in single comb White Leghorn (WL) Hy-line laying hens. Seventy six (76) young WL (26 wks old) laying hens and 69 old hens (84 wks old) of the same breed were each divided into 4 treatment groups and provided 4 different diet treatments. The diet treatments included: control (C), 17.5% CP, 3.5% fat (F); normal protein, high fat (HF), 17.5% CP, 7% F; low protein, normal fat (LP), 13% CP, 3.5% F; and low protein, high fat (LPHF), 13% CP, 6.5% F. The diets containing high fat also had a higher ME of 3,000 kcal/kg of feed while the other 2 diets with normal fat had a regular lower amount of ME (2750 kcal/kg). Hen-day egg production (HDEP), ADFI, BW, egg weight, plasma enzymes indicating liver damage (alkaline phosphatase [ALP], aspartate aminotransferase AST], gamma-glutamyl transferase [GGT]), liver and abdominal fat weight, liver color score (LCS), liver hemorrhagic score (LHS), liver fat content (LFC), liver histological examination, lipid peroxidation product in the liver, and genes indicating liver inflammation were evaluated. HDEP, ADFI, BW, and egg weight were significantly decreased in the LPHF diet group, while egg weight was also decreased in the LP diet group. In the young hens (LPHF group), ALP was found significantly higher at 30 d of diet treatment and was numerically higher throughout the experiment, while AST was significantly higher at 105 d of treatment. LCS, LHS, and LFC were significantly higher in young hens on the LPHF diet treatment. A liver histological examination shows more lipid vacuolization in the LPHF treatment diet. HF or LP alone had no significant effect on LFC, LHS, or LCS. We suggest that LP in the diet with higher ME from fat can be a possible natural cause for predisposing laying hens to FLHS.
C1 [Rozenboim, I.; Mahato, J.; Cohen, N. A.] Hebrew Univ Jerusalem, Dept Anim Sci, Robert H Smith Fac Agr Food & Environm Qual Sci, IL-76100 Rehovot, Israel.
   [Tirosh, O.] Hebrew Univ Jerusalem, Inst Biochem Food Sci & Nutr, Robert H Smith Fac Agr Food & Environm Qual Sci, IL-76100 Rehovot, Israel.
C3 Hebrew University of Jerusalem; Hebrew University of Jerusalem
RP Tirosh, O (corresponding author), Hebrew Univ Jerusalem, Inst Biochem Food Sci & Nutr, Robert H Smith Fac Agr Food & Environm Qual Sci, IL-76100 Rehovot, Israel.
EM oren.tirosh@mail.huji.ac.il
RI Rozenboim, Israel/ABA-3738-2021
FU chief scientist of the ministry of agriculture in Israel
FX The study was supported by a grant of the chief scientist of the
   ministry of agriculture in Israel to OT and IR.
CR Butler E J, 1976, Avian Pathol, V5, P1, DOI 10.1080/03079457608418164
   Cherian G, 2002, LIPIDS, V37, P751, DOI 10.1007/s11745-002-0957-4
   Choi YI, 2012, ASIAN AUSTRAL J ANIM, V25, P1145, DOI 10.5713/ajas.2011.11418
   Diaz GJ, 1999, AVIAN DIS, V43, P768, DOI 10.2307/1592746
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Grobas S, 1999, POULTRY SCI, V78, P1542, DOI 10.1093/ps/78.11.1542
   HAGHIGHIRAD F, 1982, POULTRY SCI, V61, P2465, DOI 10.3382/ps.0612465
   HANSEN RJ, 1993, ADV VET SCI COMP MED, V37, P451
   Harms RH, 2000, J APPL POULTRY RES, V9, P535, DOI 10.1093/japr/9.4.535
   IVY CA, 1973, POULTRY SCI, V52, P281, DOI 10.3382/ps.0520281
   Jiang S, 2013, POULTRY SCI, V92, P1443, DOI 10.3382/ps.2012-02800
   Lee BK, 2010, POULTRY SCI, V89, P2660, DOI 10.3382/ps.2010-00686
   Mete A., 2013, CASE REPORT CAUSES M
   PEARSON AW, 1981, RES VET SCI, V31, P259, DOI 10.1016/S0034-5288(18)32507-4
   POLIN D, 1977, J NUTR, V107, P873, DOI 10.1093/jn/107.5.873
   POLIN D, 1976, POULTRY SCI, V55, P325, DOI 10.3382/ps.0550325
   Sathyanarayan M. L., 2007, FATTY LIVER SYNDROME
   Shini A., 2012, AUST POULT SCI S, V23, P193
   SHINI S, 2006, WORLD POULT SCI AS B, V62, P601
   Shini S., 2009, AECL PUBLICATION
   SPURLOCK ME, 1993, POULTRY SCI, V72, P2095, DOI 10.3382/ps.0722095
   SQUIRES EJ, 1988, BRIT VET J, V144, P602, DOI 10.1016/0007-1935(88)90031-0
   Trott KA., 2014, VET PATHOL, V51, P787
   WALZEM RL, 1993, POULTRY SCI, V72, P1479, DOI 10.3382/ps.0721479
   XiaoQuan G., 2012, CHINESE J VET SCI, V32, P754
   Yousefi M., 2005, International Journal of Poultry Science, V4, P568
   Zhang J, 2008, Int J of Poult Sci, V12, P1232, DOI DOI 10.3923/IJPS.2008.1232.1236
NR 27
TC 80
Z9 89
U1 3
U2 52
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0032-5791
EI 1525-3171
J9 POULTRY SCI
JI Poult. Sci.
PD MAR
PY 2016
VL 95
IS 3
BP 612
EP 621
DI 10.3382/ps/pev367
PG 10
WC Agriculture, Dairy & Animal Science
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Agriculture
GA DG4XC
UT WOS:000372075400015
PM 26755655
OA hybrid
DA 2024-02-19
ER

PT J
AU Hayashi, T
   Goto, S
AF Hayashi, T
   Goto, S
TI Age-related changes in the 20S and 26S proteasome activities in the
   liver of male F344 rats
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE aging; rat; liver; proteasome; protease; peptidase
ID MULTICATALYTIC PROTEINASE COMPLEX; SODIUM DODECYL-SULFATE; OXIDATIVE
   STRESS; FOOD RESTRICTION; PROTEOLYSIS; DEGRADATION; CELLS; INACTIVATION;
   PURIFICATION; EXPRESSION
AB Accumulation of altered proteins in old animals has been ascribed to slower turnover of proteins. Since proteasomes can be regarded as the major proteolytic enzymes responsible for the degradation of the majority of cellular proteins, we examined age-related changes of 20S and 26S proteasomes in the liver of young (8-10-month-old), middle-aged (15-18-month-old) and old (25-28-month-old) Fischer 344 male rats. The two forms of proteasomes were separated by glycerol gradient centrifugation. Fluorogenic peptides were used as substrates to evaluate three types of peptidase activities. The ratio of peptidase activities in the 20S proteasome vs. those in the 26S form did not appear to change with age. Unstimulated chymotrypsin-like activity found only in the 26S form decreased by 30% in the old rats as compared with that in the young ones, while no change in the activity was observed during aging when stimulated by sodium dodecyl sulfate. The trypsin-like activity declined significantly by 17% to an apparently similar extent in both 20S and 26S forms. The peptidylglutamyl peptide hydrolyzing activity exhibited gradual decrease with age, resulting in 60% lower Value in the old rats as compared with the young animals. These changes are considered to account for the age-related extension of half-life of proteins. Since the amount of total proteasomes measured by immunoblot did not appear to change with age, posttranslational modifications or subunit replacement is possibly responsible for the decrease in the activities. (C) 1998 Elsevier Science Ireland Ltd. All rights reserved.
C1 Toho Univ, Sch Pharmaceut Sci, Dept Biochem, Funabashi, Chiba 274, Japan.
C3 Toho University
RP Goto, S (corresponding author), Toho Univ, Sch Pharmaceut Sci, Dept Biochem, 2-2-1 Miyama, Funabashi, Chiba 274, Japan.
EM goto@phar.toho-u.ac.jp
CR AGARWAL S, 1994, ARCH BIOCHEM BIOPHYS, V309, P24, DOI 10.1006/abbi.1994.1078
   CARNEY JM, 1991, P NATL ACAD SCI USA, V88, P3633, DOI 10.1073/pnas.88.9.3633
   CHU-PING M, 1992, Journal of Biological Chemistry, V267, P10515
   Conconi M, 1996, ARCH BIOCHEM BIOPHYS, V331, P232, DOI 10.1006/abbi.1996.0303
   Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101
   FUJIWARA T, 1989, BIOCHEMISTRY-US, V28, P7332, DOI 10.1021/bi00444a028
   GACZYNSKA M, 1993, NATURE, V365, P264, DOI 10.1038/365264a0
   GERARDS WLH, 1994, FEBS LETT, V346, P151, DOI 10.1016/0014-5793(94)00454-4
   GOTO S, 1995, MCBU, P151
   Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0
   GrossMesilaty S, 1997, FEBS LETT, V405, P175, DOI 10.1016/S0014-5793(97)00181-6
   GRUNE T, 1995, J BIOL CHEM, V270, P2344, DOI 10.1074/jbc.270.5.2344
   Hilt W, 1996, TRENDS BIOCHEM SCI, V21, P96, DOI 10.1016/S0968-0004(96)10012-8
   HOUGH R, 1987, J BIOL CHEM, V262, P8303
   ISHIGAMI A, 1990, ARCH BIOCHEM BIOPHYS, V277, P189, DOI 10.1016/0003-9861(90)90568-J
   ISHIGAMI A, 1988, MECH AGEING DEV, V46, P125, DOI 10.1016/0047-6374(88)90120-0
   IVY GO, 1989, BRAIN RES, V498, P360, DOI 10.1016/0006-8993(89)91117-7
   KAWAHARA H, 1994, DEV BIOL, V166, P623, DOI 10.1006/dbio.1994.1342
   KOPP F, 1995, J MOL BIOL, V248, P264
   OHTSUKA H, 1995, J GERONTOL A-BIOL, V50, pB27
   ORINO E, 1991, FEBS LETT, V284, P206, DOI 10.1016/0014-5793(91)80686-W
   ORLOWSKI M, 1993, BIOCHEMISTRY-US, V32, P1563, DOI 10.1021/bi00057a022
   ORLOWSKI M, 1989, BIOCHEMISTRY-US, V28, P9270, DOI 10.1021/bi00450a006
   PETERS JM, 1994, J BIOL CHEM, V269, P7709
   RECHSTEINER M, 1993, J BIOL CHEM, V268, P6065
   REZNICK AZ, 1979, MECH AGEING DEV, V11, P403, DOI 10.1016/0047-6374(79)90016-2
   REZNICK AZ, 1985, MODIFICATION PROTEIN, P69
   ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6
   ROTHSTEIN M, 1982, BIOCH APPROACHES AGI, P213
   SAHAKIAN JA, 1995, ARCH BIOCHEM BIOPHYS, V318, P411, DOI 10.1006/abbi.1995.1248
   SAITOH Y, 1989, BIOCHEM BIOPH RES CO, V162, P334, DOI 10.1016/0006-291X(89)92000-7
   Shibatani T, 1996, J GERONTOL A-BIOL, V51, pB175, DOI 10.1093/gerona/51A.2.B175
   Shibatani T, 1996, J GERONTOL A-BIOL, V51, pB316, DOI 10.1093/gerona/51A.5.B316
   STARKEREED PE, 1989, ARCH BIOCHEM BIOPHYS, V275, P559, DOI 10.1016/0003-9861(89)90402-5
   Stein RL, 1996, BIOCHEMISTRY-US, V35, P3899, DOI 10.1021/bi952262x
   TAKAHASHI N, 1993, ENZYME PROTEIN, V47, P241
   TANAKA K, 1995, MOL BIOL REP, V21, P21, DOI 10.1007/BF00990966
   TANAKA K, 1989, J BIOCHEM-TOKYO, V106, P495, DOI 10.1093/oxfordjournals.jbchem.a122880
   UGAI S, 1993, J BIOCHEM, V113, P754, DOI 10.1093/oxfordjournals.jbchem.a124116
   VANKAER L, 1994, IMMUNITY, V1, P533, DOI 10.1016/1074-7613(94)90043-4
   YANG Y, 1995, J BIOL CHEM, V270, P27687, DOI 10.1074/jbc.270.46.27687
NR 41
TC 107
Z9 114
U1 0
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD MAY 1
PY 1998
VL 102
IS 1
BP 55
EP 66
DI 10.1016/S0047-6374(98)00011-6
PG 12
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA ZT633
UT WOS:000074107400006
PM 9663792
DA 2024-02-19
ER

PT J
AU Shen, YH
   Yang, WS
   Lee, TH
   Lee, LT
   Chen, CY
   Huang, KC
AF Shen, YH
   Yang, WS
   Lee, TH
   Lee, LT
   Chen, CY
   Huang, KC
TI Bright liver and alanine aminotransferase are associated with metabolic
   syndrome in adults
SO OBESITY RESEARCH
LA English
DT Article
DE metabolic syndrome; National Cholesterol Education Panel criteria;
   bright liver; elevated alanine aminotransferase; waist circumference
ID NONALCOHOLIC FATTY LIVER; CARDIOVASCULAR RISK-FACTORS; ANTHROPOMETRIC
   INDEXES; INSULIN-RESISTANCE; US ADULTS; PREVALENCE; DISEASE;
   STEATOHEPATITIS; STEATOSIS; OBESITY
AB Objectives: The metabolic syndrome has become a significant health problem worldwide. In this study, we investigated the relationship between the metabolic syndrome, bright liver (BL) by ultrasonography (US), and plasma alanine aminotransferase (ALT) levels among apparently healthy adults.
   Research Methods and Procedures: A total of 15,430 nonalcoholic healthy adults without hepatitis B or C were recruited from four nationwide MJ Health Screening Centers in Taiwan in 2000. Metabolic syndrome was defined using the National Cholesterol Education Panel (NCEP) metabolic syndrome criteria or modified NCEP criteria. Based on liver US, subjects were classified into either having BL or not. The relationship between the metabolic syndrome, BL, and ALT levels was examined using multivariate logistic regression analysis.
   Results: The crude OR of the metabolic syndrome was 13.92 (12.19 using modified NCEP criteria), and the age-BMI-sex-adjusted OR was 3.77 (3.71 using modified NCEP criteria) in subjects with BL vs. subjects without BL, respectively. The ORs of the metabolic syndrome were significantly higher in subjects with elevated ALT levels than in those with normal ALT levels. After adjustment for age, sex, and BMI, BL and elevated ALT level were independently associated with increased risk of the metabolic syndrome.
   Discussion: Presence of BL and elevated plasma ALT level was independently associated with increased risk of the metabolic syndrome in adults. These factors contribute to a list of well-known. risk factors, including obesity, aging, and male sex, and thus can be applied as an additional evaluation for the metabolic syndrome in a clinical setting.
C1 Natl Taiwan Univ Hosp, Dept Family Med, Taipei 100, Taiwan.
   Natl Taiwan Univ Hosp, Dept Internal Med, Div Endocrinol & Metab, Taipei 100, Taiwan.
   Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan.
   Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.
   Far Eastern Mem Hosp, Dept Internal Med, Div Gastroenterol, Taipei, Taiwan.
   E DA Hosp, Kaohsiung, Taiwan.
C3 National Taiwan University; National Taiwan University Hospital;
   National Taiwan University; National Taiwan University Hospital;
   National Taiwan University; Academia Sinica - Taiwan; Far Eastern
   Memorial Hospital; E-Da Hospital
RP Huang, KC (corresponding author), Natl Taiwan Univ Hosp, Dept Family Med, 7 Chung Shan S Rd, Taipei 100, Taiwan.
EM chin3@ha.mc.ntu.edu.tw
OI HUANG, KUO-CHIN/0000-0002-6029-5520; YANG,
   WEI-SHIUNG/0000-0001-5087-373X; CHEN, CHING-YU/0000-0002-4095-4197; Lee,
   Long-Teng/0000-0002-9551-990X
CR Angelico F, 2003, J GASTROEN HEPATOL, V18, P588, DOI 10.1046/j.1440-1746.2003.02958.x
   Bellentani S, 2000, ANN INTERN MED, V132, P112, DOI 10.7326/0003-4819-132-2-200001180-00004
   Clark JM, 2003, AM J GASTROENTEROL, V98, P960, DOI [10.1016/S0002-9270(03)00265-X, 10.1111/j.1572-0241.2003.07486.x]
   Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486
   *DEP HLTH, 2002, TAIW PUBL HLTH REP 2
   Falck-Ytter Y, 2001, SEMIN LIVER DIS, V21, P17, DOI 10.1055/s-2001-12926
   Festi D, 2004, Obes Rev, V5, P27, DOI 10.1111/j.1467-789X.2004.00126.x
   Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723
   Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356
   HAFFNER SM, 1992, DIABETES, V41, P715, DOI 10.2337/diabetes.41.6.715
   Huang KC, 2002, INT J OBESITY, V26, P1060, DOI 10.1038/sj.ijo.0802047
   James P T, 2001, Obes Res, V9 Suppl 4, p228S, DOI 10.1038/oby.2001.123
   Jia W P, 2002, Obes Rev, V3, P157
   JOSEPH AEA, 1991, CLIN RADIOL, V43, P26, DOI 10.1016/S0009-9260(05)80350-2
   Kojima S, 2003, J GASTROENTEROL, V38, P954, DOI 10.1007/s00535-003-1178-8
   Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709
   Lin WY, 2002, INT J OBESITY, V26, P1232, DOI 10.1038/sj.ijo.0802040
   Marceau P, 1999, J CLIN ENDOCR METAB, V84, P1513, DOI 10.1210/jc.84.5.1513
   Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161
   Marchesini G, 1999, AM J MED, V107, P450, DOI 10.1016/S0002-9343(99)00271-5
   Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844
   Mofrad P, 2003, HEPATOLOGY, V37, P1286, DOI 10.1053/jhep.2003.50229
   Nakanishi N, 2004, DIABETES CARE, V27, P1427, DOI 10.2337/diacare.27.6.1427
   Pagano G, 2002, HEPATOLOGY, V35, P367, DOI 10.1053/jhep.2002.30690
   Panagiotakos DB, 2004, AM HEART J, V147, P106, DOI 10.1016/S0002-8703(03)00442-3
   Park HS, 2004, INT J EPIDEMIOL, V33, P328, DOI 10.1093/ije/dyh032
   QUINN SF, 1985, AM J ROENTGENOL, V145, P753, DOI 10.2214/ajr.145.4.753
   Ruhl CE, 2003, GASTROENTEROLOGY, V124, P71, DOI 10.1053/gast.2003.50004
   Saadeh S, 2002, GASTROENTEROLOGY, V123, P745, DOI 10.1053/gast.2002.35354
   SAVERYMUTTU SH, 1986, BRIT MED J, V292, P13, DOI 10.1136/bmj.292.6512.13
   Sheth SG, 1997, ANN INTERN MED, V126, P137, DOI 10.7326/0003-4819-126-2-199701150-00008
   Tan CE, 2004, DIABETES CARE, V27, P1182, DOI 10.2337/diacare.27.5.1182
   Torgerson JS, 1997, OBES RES, V5, P105, DOI 10.1002/j.1550-8528.1997.tb00650.x
   Vozarova B, 2002, DIABETES, V51, P1889, DOI 10.2337/diabetes.51.6.1889
   WHO, 2004, LANCET, V363, P902
NR 35
TC 33
Z9 37
U1 0
U2 0
PU NORTH AMER ASSOC STUDY OBESITY
PI SILVER SPRING
PA 8630 FENTON ST, SUITE 918, SILVER SPRING, MD 20910 USA
SN 1071-7323
J9 OBES RES
JI Obes. Res.
PD JUL
PY 2005
VL 13
IS 7
BP 1238
EP 1245
DI 10.1038/oby.2005.147
PG 8
WC Endocrinology & Metabolism; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA 955GE
UT WOS:000231212800016
PM 16076994
OA Bronze
DA 2024-02-19
ER

PT J
AU Szafranska, K
   Neuman, T
   Baster, Z
   Rajfur, Z
   Szelest, O
   Holte, C
   Kubisiak, A
   Kus, E
   Wolfson, DL
   Chlopicki, S
   Ahluwalia, BS
   Lekka, M
   Szymonski, M
   McCourt, P
   Zapotoczny, B
AF Szafranska, Karolina
   Neuman, Tanja
   Baster, Zbigniew
   Rajfur, Zenon
   Szelest, Oskar
   Holte, Christopher
   Kubisiak, Agata
   Kus, Edyta
   Wolfson, Deanna L.
   Chlopicki, Stefan
   Ahluwalia, Balpreet S.
   Lekka, Malgorzata
   Szymonski, Marek
   McCourt, Peter
   Zapotoczny, Bartlomiej
TI From fixed-dried to wet-fixed to live - comparative super-resolution
   microscopy of liver sinusoidal endothelial cell fenestrations
SO NANOPHOTONICS
LA English
DT Article; Early Access
DE atomic force microscopy (AFM); fenestration; liver sinusoidal
   endothelial cell (LSEC); scanning electron microscopy (SEM); stimulated
   emission depletion (STED) microscopy; structured illumination microscopy
   (SIM)
ID ATOMIC-FORCE MICROSCOPY; SCANNING ELECTRON-MICROSCOPY; CYTOSKELETON;
   SIEVE; ATHEROSCLEROSIS; AFM
AB Fenestrations in liver sinusoidal endothelial cells (LSEC) are transcellular nanopores of 50-350 nm diameter that facilitate bidirectional transport of solutes and macromolecules between the bloodstream and the parenchyma of the liver. Liver diseases, ageing, and various substances such as nicotine or ethanol can negatively influence LSECs fenestrations and lead to defenestration. Over the years, the diameter of fenestrations remained the main challenge for imaging of LSEC in vitro. Several microscopy, or rather nanoscopy, approaches have been used to quantify fenestrations in LSEC to assess the effect of drugs and, and toxins in different biological models. All techniques have their limitations, and measurements of the "true" size of fenestrations are hampered because of this. In this study, we approach the comparison of different types of microscopy in a correlative manner. We combine scanning electron microscopy (SEM) with optical nanoscopy methods such as structured illumination microscopy (SIM) or stimulated emission depletion (STED) microscopy. In addition, we combined atomic force microscopy (AFM) with SEM and STED, all to better understand the previously reported differences between the reports of fenestration dimensions. We conclude that sample dehydration alters fenestration diameters. Finally, we propose the combination of AFM with conventional microscopy that allows for easy super-resolution observation of the cell dynamics with additional chemical information that can be traced back for the whole experiment. Overall, by pairing the various types of imaging techniques that provide topological 2D/3D/label-free/chemical information we get a deeper insight into both limitations and strengths of each type microscopy when applied to fenestration analysis.
C1 [Szafranska, Karolina; Holte, Christopher; McCourt, Peter; Zapotoczny, Bartlomiej] Arctic Univ Norway, Dept Med Biol, Vasc Biol Res Grp, Univ Tromso UiT, Tromso, Norway.
   [Zapotoczny, Bartlomiej] Polish Acad Sci, Inst Nucl Phys, Krakow, Poland.
   [Neuman, Tanja] Bruker Nano GmbH, Nano Surfaces & Metrol Div, JPK BioAFM Business, Berlin, Germany.
   [Baster, Zbigniew; Rajfur, Zenon; Kubisiak, Agata; Szymonski, Marek] Jagiellonian Univ, Fac Phys Astron & Appl Comp Sci, Marian Smoluchowski Inst Phys, Krakow, Poland.
   [Kus, Edyta; Chlopicki, Stefan] Jagiellonian Univ, Jagiellonian Ctr Expt Therapeut JCET, Krakow, Poland.
   [Wolfson, Deanna L.; Ahluwalia, Balpreet S.] UiT Arctic Univ Norway, Dept Phys & Technol, Tromso, Norway.
   [Chlopicki, Stefan] Jagiellonian Univ, Chair Pharmacol, Coll Med, Krakow, Poland.
   [Lekka, Malgorzata] Polish Acad Sci, Inst Nucl Phys, Krakow, Poland.
C3 UiT The Arctic University of Tromso; Polish Academy of Sciences;
   Institute of Nuclear Physics - Polish Academy of Sciences; Bruker
   Corporation; Bruker Nano GmbH; Jagiellonian University; Jagiellonian
   University; UiT The Arctic University of Tromso; Jagiellonian
   University; Collegium Medicum Jagiellonian University; Polish Academy of
   Sciences; Institute of Nuclear Physics - Polish Academy of Sciences
RP Zapotoczny, B (corresponding author), Arctic Univ Norway, Dept Med Biol, Vasc Biol Res Grp, Univ Tromso UiT, Tromso, Norway.; Zapotoczny, B (corresponding author), Polish Acad Sci, Inst Nucl Phys, Krakow, Poland.
EM bartlomiej.zapotoczny@ifj.edu.pl
RI Szafranska, Karolina/AAA-4634-2020; Lekka, Malgorzata/A-3706-2016;
   Kubisiak, Agata/CAG-0151-2022; McCourt, Peter/B-3043-2009
OI Szafranska, Karolina/0000-0001-5852-2109; Lekka,
   Malgorzata/0000-0003-0844-8662; Kubisiak, Agata/0000-0003-1241-4035;
   McCourt, Peter/0000-0001-5072-4590; Zapotoczny,
   Bartlomiej/0000-0003-2129-3714; Holte, Christopher
   Florian/0000-0002-8156-9797; Rajfur, Zenon/0000-0003-1265-6480; Wolfson,
   Deanna/0000-0001-6059-2472
FU Polish National Science Centre under the "SYMFONIA 3" project
   [UMO-2015/16/W/NZ4/00070]; Research Council of Norway Nano2021 program
   [288565]; Polish National Science Centre under the "SONATA 15" Project
   [UMO-2019/35/D/NZ3/01804]; European Union [766181]
FX This work is supported by the Polish National Science Centre under the
   "SYMFONIA 3" project, grant agreement no.: UMO-2015/16/W/NZ4/00070, the
   Research Council of Norway Nano2021 program grant to "NanoChip" Grant
   no. 288565, and the Polish National Science Centre under the "SONATA 15"
   Project, Grant Agreement No.: UMO-2019/35/D/NZ3/01804, and the European
   Union's Horizon 2020 research and innovation program under the Marie
   Sklodowska-Curie grant agreement no. 766181, project "DeLIVER".
CR Bondia P, 2017, METHODS MOL BIOL, V1663, P105, DOI 10.1007/978-1-4939-7265-4_9
   Braet F, 1996, J MICROSC-OXFORD, V181, P10, DOI 10.1046/j.1365-2818.1996.72348.x
   Braet F, 1998, APPL PHYS A-MATER, V66, pS575, DOI 10.1007/s003390051204
   Braet F, 1997, J MICROSC-OXFORD, V186, P84, DOI 10.1046/j.1365-2818.1997.1940755.x
   Braet F, 1996, SCANNING MICROSCOPY SUPPLEMENT 10, 1996, P225
   Braet F, 2012, MICRON, V43, P1252, DOI 10.1016/j.micron.2012.02.010
   BRAET F, 1995, J GASTROEN HEPATOL, V10, pS3, DOI 10.1111/j.1440-1746.1995.tb01792.x
   Braet F, 2001, J ELECTRON MICROSC, V50, P283, DOI 10.1093/jmicro/50.4.283
   BRAET F, 1995, HEPATOLOGY, V21, P180, DOI 10.1002/hep.1840210130
   Braet F, 1997, INT J IMAG SYST TECH, V8, P162, DOI 10.1002/(SICI)1098-1098(1997)8:2<162::AID-IMA3>3.0.CO;2-8
   Braet F, 2018, SEMIN CELL DEV BIOL, V73, P13, DOI 10.1016/j.semcdb.2017.07.001
   Braet Filip, 2002, Comp Hepatol, V1, P1, DOI 10.1186/1476-5926-1-1
   Braet F, 2009, LIVER INT, V29, P603, DOI 10.1111/j.1478-3231.2008.01836.x
   Brunetti RM, 2021, J CELL BIOL, V221, DOI 10.1083/jcb.202104046
   Cogger VC, 2020, LIVER: BIOLOGY AND PATHOBIOLOGY, 6TH EDITION, 6 EDITION, P435
   Cogger VC, 2010, J STRUCT BIOL, V171, P382, DOI 10.1016/j.jsb.2010.06.001
   Cosentino M, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav8062
   Demmerle J, 2015, METHODS, V88, P3, DOI 10.1016/j.ymeth.2015.07.001
   Di Martino J, 2019, HEPATOL COMMUN, V3, P213, DOI 10.1002/hep4.1301
   Di Martino J, 2018, BIOL CELL, V110, P159, DOI 10.1111/boc.201800016
   Diekmann R, 2017, NAT PHOTONICS, V11, P322, DOI [10.1038/NPHOTON.2017.55, 10.1038/nphoton.2017.55]
   Dufrêne YF, 2013, NAT METHODS, V10, P847, DOI [10.1038/nmeth.2602, 10.1038/NMETH.2602]
   FRASER R, 1995, HEPATOLOGY, V21, P863, DOI 10.1016/0270-9139(95)90542-1
   Fraser R, 2012, PATHOLOGY, V44, P181, DOI 10.1097/PAT.0b013e328351bcc8
   Giergiel M, 2022, BIOMED SIGNAL PROCES, V71, DOI 10.1016/j.bspc.2021.103097
   Gómez-Varela AI, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-57885-z
   Harke B., 2012, Optical Nanoscopy, V1, P1, DOI [10.1186/2192-2853-1-3, DOI 10.1186/2192-2853-1-3]
   Hirvonen LM, 2018, METHODS APPL FLUORES, V6, DOI 10.1088/2050-6120/aad018
   Hunt NJ, 2019, AM J PHYSIOL-GASTR L, V316, pG144, DOI 10.1152/ajpgi.00179.2018
   Kus E, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00006
   Le Couteur DG, 2002, LANCET, V359, P1612, DOI 10.1016/S0140-6736(02)08524-0
   Li PW, 2020, BBA-GEN SUBJECTS, V1864, DOI 10.1016/j.bbagen.2020.129702
   MACLEANFLETCHER S, 1980, CELL, V20, P329, DOI 10.1016/0092-8674(80)90619-4
   Mao H, 2019, NANOPHOTONICS-BERLIN, V8, P1299, DOI 10.1515/nanoph-2019-0066
   Maslak E, 2015, PHARMACOL REP, V67, P689, DOI 10.1016/j.pharep.2015.04.010
   Mönkemöller V, 2015, SCI REP-UK, V5, DOI 10.1038/srep16279
   Mönkemöller V, 2014, PHYS CHEM CHEM PHYS, V16, P12576, DOI 10.1039/c4cp01574f
   Müller M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10980
   MUTO M, 1977, ARCH HISTOL JAPON, V40, P137, DOI 10.1679/aohc1950.40.137
   Oie CI, 2018, NANOPHOTONICS-BERLIN, V7, P575, DOI 10.1515/nanoph-2017-0055
   Qin GG, 2017, CHINESE J ANAL CHEM, V45, P1813, DOI 10.1016/S1872-2040(17)61056-9
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]
   STEFFAN AM, 1987, HEPATOLOGY, V7, P1230, DOI 10.1002/hep.1840070610
   Svistounov D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046134
   Szafranska K, 2021, MICRON, V150, DOI 10.1016/j.micron.2021.103121
   Szafranska K, 2021, FRONT PHYSIOL, V12, DOI 10.3389/fphys.2021.735573
   Targosz-Korecka M, 2015, CYTOSKELETON, V72, P124, DOI 10.1002/cm.21217
   Tinguely JC, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-01473-4
   Wegel E, 2016, SCI REP-UK, V6, DOI 10.1038/srep27290
   Whelan DR, 2015, SCI REP-UK, V5, DOI 10.1038/srep07924
   WISSE E, 1985, HEPATOLOGY, V5, P683, DOI 10.1002/hep.1840050427
   Wisse E, 2010, WORLD J GASTROENTERO, V16, P2851, DOI 10.3748/wjg.v16.i23.2851
   Zapotoczny B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08555-0
   Zapotoczny B, 2017, J MOL RECOGNIT, V30, DOI 10.1002/jmr.2610
   Zapotoczny Bartlomiej, 2020, Biophys Rev, V12, P625, DOI 10.1007/s12551-020-00699-0
   Zapotoczny B, 2019, TRAFFIC, V20, P932, DOI 10.1111/tra.12700
   Zapotoczny B, 2019, HEPATOLOGY, V69, P876, DOI 10.1002/hep.30232
   Zapotoczny B, 2017, MICRON, V101, P48, DOI 10.1016/j.micron.2017.06.005
NR 58
TC 2
Z9 2
U1 2
U2 20
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 2192-8606
EI 2192-8614
J9 NANOPHOTONICS-BERLIN
JI Nanophotonics
PD 2022 MAY 13
PY 2022
VL 11
IS 10
BP 2253
EP 2270
DI 10.1515/nanoph-2021-0818
EA APR 2022
PG 18
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Optics; Physics, Applied
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics; Materials Science; Optics; Physics
GA 1D7UO
UT WOS:000783648500001
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Armeni, T
   Pieri, C
   Marra, M
   Saccucci, F
   Principato, G
AF Armeni, T
   Pieri, C
   Marra, M
   Saccucci, F
   Principato, G
TI Studies on the life prolonging effect of food restriction: glutathione
   levels and glyoxalase enzymes in rat liver
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE aging; food restriction; liver; glutathione; glyoxalases
ID FEMALE WISTAR RATS; MITOCHONDRIAL PARAMETERS; DEGENERATIVE DISEASES;
   DIETARY RESTRICTION; SPLENIC LYMPHOCYTES; PURIFICATION; FORMS
AB Cytosolic and mitochondrial levels of glutathione (GSH) as well as the activities of glyoxalase I (GI) and glyoxalase II (GII), GSH-dependent enzymes involved in the detoxification of 2-ketoaldehydes, were investigated in the liver of ad libitum (AL) fed and food restricted (FR) rat during aging. Both cytosolic and mitochondrial GSH level was lower in old than in adult AL fed rats. Food restriction did not prevent this decrease, but its extent was attenuated considering the cytosolic GSH. As regards the mitochondrial GSH, its content was higher in adult FR animals than in the age-matched AL fed ones. Thus, the subsequent age-dependent decrease of GSH, occurring also in FR animals, resulted in a thiol concentration not different from that observed in young and adult AL fed animals. Considering the enzymatic activities, cytosolic GI decreased in old rats irrespective of diet, whereas GII activity remained constant in all the experimental groups. The higher glutathione content found in both cellular compartments of old FR rats as compared to the old AL fed ones, could help to explain the life prolonging effect of FR treatment. Moreover, the observation that the activity of glyoxalases was not influenced by food restriction does not necessarily mean that the cells of diet-conditioned animals are scarcely protected against the toxic effect of methylglyoxal. Indeed, the production of this compound should be lower in FR animals as compared to AL fed ones, due to the lower level serum glucose concentration during the life span of the forcer with respect to the latter group. (C) 1998 Elsevier Science Ireland Ltd. All rights reserved.
C1 INRCA, Ctr Cytol, Gerontol Res Dept, Ancona, Italy.
C3 IRCCS INRCA
RP Principato, G (corresponding author), INRCA, Ctr Cytol, Gerontol Res Dept, Ancona, Italy.
EM prinipato@popcsi.unian.it
RI Armeni, Tatiana/J-8228-2013
OI Armeni, Tatiana/0000-0003-0931-1342
CR Akerboom T P, 1981, Methods Enzymol, V77, P373
   BALL JC, 1979, ANAL BIOCHEM, V98, P472, DOI 10.1016/0003-2697(79)90169-6
   CHUNG MH, 1992, FREE RADICAL BIO MED, V12, P523, DOI 10.1016/0891-5849(92)90105-P
   EKWALL K, 1970, ARCH BIOCHEM BIOPHYS, V137, P128, DOI 10.1016/0003-9861(70)90419-4
   GIESECKE D, 1981, COMP BIOCHEM PHYS B, V69, P85, DOI 10.1016/0305-0491(81)90213-3
   GOODRICK CL, 1982, GERONTOLOGY, V28, P233, DOI 10.1159/000212538
   Iwasaki K, 1988, J GERONTOL, V43, P13
   LAGANIERE S, 1987, BIOCHEM BIOPH RES CO, V145, P1185, DOI 10.1016/0006-291X(87)91562-2
   LAGANIERE S, 1989, MECH AGEING DEV, V48, P221, DOI 10.1016/0047-6374(89)90084-5
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MAEDA H, 1985, J GERONTOL, V40, P671, DOI 10.1093/geronj/40.6.671
   Mannervik B., 1980, ENZYMATIC BASIS DETO, V2, P263
   MASORO EJ, 1992, J GERONTOL, V47, pB202, DOI 10.1093/geronj/47.6.B202
   MCLELLAN AC, 1994, CLIN SCI, V87, P21, DOI 10.1042/cs0870021
   MCLELLAN AC, 1992, ANAL BIOCHEM, V206, P17, DOI 10.1016/S0003-2697(05)80005-3
   MODE CJ, 1984, J GERONTOL, V39, P36, DOI 10.1093/geronj/39.1.36
   MUSCARI C, 1990, BIOCHIM BIOPHYS ACTA, V1015, P200, DOI 10.1016/0005-2728(90)90021-U
   NOHL H, 1978, EUR J BIOCHEM, V82, P563, DOI 10.1111/j.1432-1033.1978.tb12051.x
   PIERI C, 1993, MECH AGEING DEV, V70, P201, DOI 10.1016/0047-6374(93)90048-V
   PIERI C, 1994, ARCH GERONTOL GERIAT, V19, P283, DOI 10.1016/0167-4943(94)00574-5
   PIERI C, 1994, ARCH GERONTOL GERIAT, V19, P31, DOI 10.1016/0167-4943(94)90023-X
   PIERI C, 1990, ARCH GERONTOL GERIAT, V11, P99, DOI 10.1016/0167-4943(90)90001-M
   PRINCIPATO G, 1996, ACT M GRUPP IT BIOEN, P26
   PRINCIPATO GB, 1987, BIOCHIM BIOPHYS ACTA, V911, P349, DOI 10.1016/0167-4838(87)90076-8
   SOHAL RS, 1990, MECH AGEING DEV, V53, P209, DOI 10.1016/0047-6374(90)90039-I
   TALESA V, 1988, BIOCHIM BIOPHYS ACTA, V955, P103, DOI 10.1016/0167-4838(88)90183-5
   TALESA V, 1989, BIOCHIM BIOPHYS ACTA, V993, P7, DOI 10.1016/0304-4165(89)90135-9
   TUBBS PK, 1961, BIOCHEM J, V81, P104, DOI 10.1042/bj0810104
   VANDERJAGT DL, 1975, BIOCHEMISTRY-US, V14, P3669, DOI 10.1021/bi00687a024
   WAHLLANDER A, 1979, FEBS LETT, V97, P138, DOI 10.1016/0014-5793(79)80069-1
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
NR 32
TC 32
Z9 33
U1 0
U2 4
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD MAR 16
PY 1998
VL 101
IS 1-2
BP 101
EP 110
DI 10.1016/S0047-6374(97)00167-X
PG 10
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA ZF487
UT WOS:000072902400008
PM 9593316
DA 2024-02-19
ER

PT J
AU Wang, ZG
   Zhai, XR
   Fang, JY
   Wu, HY
   Cheng, YY
   Gao, Y
   Chen, X
   Zheng, S
   Liu, SC
   Hao, LL
AF Wang, Zhaoguo
   Zhai, Xiaorui
   Fang, Jiayuan
   Wu, Hongyan
   Cheng, Yunyun
   Gao, Yuan
   Chen, Xi
   Zheng, Shuo
   Liu, Songcai
   Hao, Linlin
TI Peptide-Calcium Chelate from Antler (<i>Cervus elaphus</i>) Bone
   Enhances Calcium Absorption in Intestinal Caco-2 Cells and D-gal-Induced
   Aging Mouse Model
SO NUTRIENTS
LA English
DT Article
DE antler bone; peptides; calcium absorption; intestinal Caco-2 cells;
   aging mouse model
ID D-GALACTOSE; BINDING PEPTIDE; PARATHYROID-HORMONE; OXIDATIVE STRESS; RED
   DEER; COLLAGEN; SUPPLEMENTS; TRANSPORT; BENEFITS; LIVER
AB Antler bone calcium (AB-Ca) and bioactive peptides (ABPs) were extracted from antler bones (Cervus elaphus) to maximize their value. In this study, 0.14 g calcium was obtained from 1 g antler bone. The peptide-calcium chelate rate was 53.68 +/- 1.80%, and the Gly, Pro, and Glu in ABPs were identified to donate most to the increased calcium affinity through the mass spectrometry. Fourier transform infrared spectroscopy showed that calcium predominantly interacted with amino nitrogen atoms and carboxyl oxygen atoms, thereby generating a peptide-calcium chelate. The peptide-calcium chelates were characterized using scanning electron microscopy. A Caco-2 cell monolayer model showed that ABPs significantly increased calcium transport. Furthermore, the D-gal-induced aging mouse model indicated that the ABPs + AB-Ca group showed higher Ca and PINP levels, lower P, ALP, and CTX-1content in serum, and considerably higher tibia index and tibia calcium content. Results showed that ABPs + AB-Ca increased bone formation and inhibited bone resorption, thereby providing calcium supplements for ameliorating senile osteoporosis (SOP).
C1 [Wang, Zhaoguo; Zhai, Xiaorui; Fang, Jiayuan; Wu, Hongyan; Gao, Yuan; Chen, Xi; Zheng, Shuo; Liu, Songcai; Hao, Linlin] Jilin Univ, Coll Anim Sci, Changchun 130061, Peoples R China.
   [Cheng, Yunyun] Jilin Univ, Coll Publ Hlth, Changchun 130061, Peoples R China.
C3 Jilin University; Jilin University
RP Hao, LL (corresponding author), Jilin Univ, Coll Anim Sci, Changchun 130061, Peoples R China.
EM haolinlin@jlu.edu.cn
FU Jilin Scientific and Technological Development Program [20200404058YY]
FX This work was supported by Jilin Scientific and Technological
   Development Program (20200404058YY).
CR Barrett-Connor E, 2001, INT J EPIDEMIOL, V30, P423, DOI 10.1093/ije/30.3.423
   Cao Y, 2017, J AGR FOOD CHEM, V65, P2307, DOI 10.1021/acs.jafc.6b05711
   Chen D, 2013, J FUNCT FOODS, V5, P689, DOI 10.1016/j.jff.2013.01.012
   Clynes MA, 2020, BRIT MED BULL, V133, P105, DOI 10.1093/bmb/ldaa005
   Cosman F, 2014, OSTEOPOROSIS INT, V25, P2359, DOI 10.1007/s00198-014-2794-2
   Coughlan T, 2014, CLIN MED, V14, P187, DOI 10.7861/clinmedicine.14-2-187
   Cristina NM, 2021, NUTRIENTS, V13, DOI 10.3390/nu13124337
   Daniel H, 2004, PFLUG ARCH EUR J PHY, V447, P610, DOI 10.1007/s00424-003-1101-4
   DOYLE BB, 1975, BIOPOLYMERS, V14, P937, DOI 10.1002/bip.1975.360140505
   FORDTRAN JS, 1966, AM J DIG DIS, V11, P503, DOI 10.1007/BF02233563
   Gilbey A, 2012, NEW ZEAL MED J, V125, P80
   GOLDSMITH RS, 1976, J CLIN ENDOCR METAB, V43, P523, DOI 10.1210/jcem-43-3-523
   Gossiel F, 2022, OSTEOPOROSIS INT, V33, P1357, DOI 10.1007/s00198-022-06311-3
   Guo DJ, 2020, J FOOD SCI, V85, P834, DOI 10.1111/1750-3841.15067
   Guo LD, 2015, FOOD CHEM, V173, P536, DOI 10.1016/j.foodchem.2014.10.055
   [侯扶江 Hou Pujiang], 2003, [草业科学, Pratacultural Science], V20, P47
   Hou T, 2018, J FUNCT FOODS, V48, P448, DOI 10.1016/j.jff.2018.07.034
   Hou T, 2017, FOOD CHEM, V219, P428, DOI 10.1016/j.foodchem.2016.09.166
   Hou T, 2015, J AGR FOOD CHEM, V63, P8170, DOI 10.1021/acs.jafc.5b03097
   Huang G.R., 2012, ADV J FOOD SCI TECHN, V4, P207
   Huang GR, 2011, FOOD BIOPROCESS TECH, V4, P1527, DOI 10.1007/s11947-010-0416-3
   Hung YK, 2021, INT J MED SCI, V18, P1778, DOI 10.7150/ijms.53599
   Jin YG, 2011, AFR J BIOTECHNOL, V10, P10204
   Jung WK, 2005, FOOD CHEM, V91, P333, DOI 10.1016/j.foodchem.2004.06.016
   Kierdorf U, 2014, BIOL TRACE ELEM RES, V162, P124, DOI 10.1007/s12011-014-0154-x
   Landete-Castillejos T, 2007, BONE, V40, P1095, DOI 10.1016/j.bone.2006.11.022
   Landete-Castillejos T, 2019, BONE, V128, DOI 10.1016/j.bone.2019.115046
   Landete-Castillejos T, 2012, BONE, V50, P245, DOI 10.1016/j.bone.2011.10.026
   Laurent MR, 2019, MATURITAS, V122, P51, DOI 10.1016/j.maturitas.2019.01.006
   Lin QL, 2017, J FUNCT FOODS, V39, P96, DOI 10.1016/j.jff.2017.10.011
   Lin SY, 2012, INT J BIOL MACROMOL, V50, P1327, DOI 10.1016/j.ijbiomac.2012.03.013
   Liu BT, 2020, J FOOD SCI, V85, P114, DOI 10.1111/1750-3841.14975
   Liu G, 2021, FRONT NUTR, V8, DOI 10.3389/fnut.2021.743791
   Liu G, 2018, FOOD FUNCT, V9, P2251, DOI [10.1039/C7FO01709J, 10.1039/c7fo01709j]
   Liu HY, 2018, FOOD AGR IMMUNOL, V29, P316, DOI 10.1080/09540105.2017.1376037
   Liu YJ, 2021, FOOD FUNCT, V12, P2148, DOI [10.1039/D0FO02707C, 10.1039/d0fo02707c]
   Malison A, 2021, FOOD CHEM, V345, DOI 10.1016/j.foodchem.2020.128713
   Maraka S, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3783
   Mo ZZ, 2017, REJUV RES, V20, P231, DOI 10.1089/rej.2016.1870
   Morgan EN, 2021, BIOMED RES INT, V2021, DOI 10.1155/2021/5570229
   Nam SM, 2019, NUTRIENTS, V11, DOI 10.3390/nu11010176
   Nara M, 2013, BBA-BIOMEMBRANES, V1828, P2319, DOI 10.1016/j.bbamem.2012.11.025
   Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904
   Nuti R, 2019, INTERN EMERG MED, V14, P85, DOI 10.1007/s11739-018-1874-2
   Peng Z, 2017, FOOD CHEM, V221, P373, DOI 10.1016/j.foodchem.2016.10.078
   Qian JY, 2009, CARBOHYD POLYM, V78, P620, DOI 10.1016/j.carbpol.2009.05.025
   REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939
   Reid IR, 2015, J INTERN MED, V278, P354, DOI 10.1111/joim.12394
   Rinonapoli G, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22042105
   Sun N, 2020, FOOD CHEM, V310, DOI 10.1016/j.foodchem.2019.125867
   Sun N, 2017, J AGR FOOD CHEM, V65, P9782, DOI 10.1021/acs.jafc.7b03705
   Sun XD, 2021, FOOD FUNCT, V12, P8454, DOI [10.1039/D1FO01094H, 10.1039/d1fo01094h]
   Tseng SH, 2014, J ETHNOPHARMACOL, V151, P352, DOI 10.1016/j.jep.2013.10.060
   Wang L, 2018, FOOD CHEM, V239, P416, DOI 10.1016/j.foodchem.2017.06.090
   Wang LP, 2020, J ETHNOPHARMACOL, V254, DOI 10.1016/j.jep.2020.112670
   Wang PP, 2016, PHYTOMEDICINE, V23, P460, DOI 10.1016/j.phymed.2016.02.014
   Wang W, 2019, J MED BIOCHEM, V38, P353, DOI 10.2478/jomb-2018-0042
   Wang X, 2017, FOOD CHEM, V229, P487, DOI 10.1016/j.foodchem.2017.02.121
   Wang Y, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19360-1
   Weaver CM, 2002, J AGR FOOD CHEM, V50, P4974, DOI 10.1021/jf0200422
   Wémeau JL, 2013, PRESSE MED, V42, P828, DOI 10.1016/j.lpm.2013.04.003
   Whitaker M, 2012, NEW ENGL J MED, V366, P2048, DOI 10.1056/NEJMp1202619
   Wu FF, 2013, J ETHNOPHARMACOL, V145, P403, DOI 10.1016/j.jep.2012.12.008
   Wu WM, 2019, FOOD CHEM, V284, P80, DOI 10.1016/j.foodchem.2019.01.103
   Xu FR, 2017, J AGR FOOD CHEM, V65, P2056, DOI 10.1021/acs.jafc.6b04731
   Yang JQ, 2019, LIPIDS HEALTH DIS, V18, DOI 10.1186/s12944-019-1055-y
   Yang Y, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00731
   Yu YJ, 2020, BIOMED PHARMACOTHER, V128, DOI 10.1016/j.biopha.2020.110304
   Zhang H, 2000, FOOD CHEM TOXICOL, V38, P985, DOI 10.1016/S0278-6915(00)00099-5
   Zhang K, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091325
   Zhang LZ, 2013, J ETHNOPHARMACOL, V150, P181, DOI 10.1016/j.jep.2013.08.029
   Zhang L, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101434
   Zhang ZR, 2018, FOOD CHEM, V258, P269, DOI 10.1016/j.foodchem.2018.03.030
   Zhao L, 2019, J FUNCT FOODS, V52, P587, DOI 10.1016/j.jff.2018.11.044
   Zheng KX, 2020, FOOD FUNCT, V11, P7481, DOI 10.1039/d0fo01531h
   Zhou R, 2009, FOOD CHEM, V114, P1321, DOI 10.1016/j.foodchem.2008.11.010
NR 76
TC 2
Z9 2
U1 6
U2 39
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD SEP
PY 2022
VL 14
IS 18
AR 3738
DI 10.3390/nu14183738
PG 13
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 4V5EP
UT WOS:000859500200001
PM 36145113
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Solomon, TPJ
   Marchetti, CM
   Krishnan, RK
   Gonzalez, F
   Kirwan, JP
AF Solomon, Thomas P. J.
   Marchetti, Christine M.
   Krishnan, Raj K.
   Gonzalez, Frank
   Kirwan, John P.
TI Effects of aging on basal fat oxidation in obese humans
SO METABOLISM-CLINICAL AND EXPERIMENTAL
LA English
DT Article
ID HUMAN SKELETAL-MUSCLE; INSULIN-RESISTANCE; MITOCHONDRIAL-FUNCTION; AGE;
   CAPACITY; DECLINE; LIVER; RATES; METABOLISM; INACTIVITY
AB Basal fat oxidation decreases with age. In obesity, it is not known whether this age-related process occurs independently of changes in body composition and insulin sensitivity. Therefore, body composition, resting energy expenditure, basal substrate oxidation, and maximal oxygen consumption (VO(2)max) were measured in 10 older (age, 60 +/- 4 years; mean +/- SEM) and 10 younger (age, 35 +/- 4 years) body mass index-matched, obese, normal glucose-tolerant individuals. Fasting blood samples were also collected. Older subjects had slightly elevated fat mass (32.2 +/- 7.1 vs 36.5 +/- 6.7 kg, P = .16); however, waist circumference was not different between groups (104.3 +/- 10.3 vs 102.1 +/- 12.6 cm, P = .65). Basal fat oxidation was 22% lower (1.42 +/- 0.14 vs 1.17 +/- 0.22 mg/kg fat-free mass per minute, P = .03) in older subjects. The VO(2)max was also decreased in older individuals (44.6 +/- 7.1 vs 38.3 +/- 6.0 mL/kg fat-free mass per minute, P = .03); but insulin sensitivity, lipemia, and leptinemia were not different between groups (P > .05). Fat oxidation was most related to age (r = -0.61, P = .003) and VO(2)max (r = 0.52, P = .01). These data suggest that aging per se is responsible for reduced basal fat oxidation and maximal oxidative capacity in older obese individuals, independent of changes in insulin resistance, body mass, and abdominal fat. This indicates that age, in addition to obesity, is an independent risk factor for weight gain and for the metabolic complications of elevated body fat. (C) 2008 Elsevier Inc. All rights reserved.
C1 [Solomon, Thomas P. J.; Kirwan, John P.] Cleveland Clin, Lerner Res Inst, Dept Pathobiol, Cleveland, OH 44195 USA.
   [Marchetti, Christine M.; Kirwan, John P.] Metrohlth Med Ctr, Schwartz Ctr Metab & Nutr, Cleveland, OH 44109 USA.
   [Gonzalez, Frank] Mayo Clin, Dept Obstet & Gynecol, Rochester, MN 55905 USA.
   [Kirwan, John P.] Cleveland Clin, Dept Gastroenterol & Hepatol, Cleveland, OH 44195 USA.
C3 Cleveland Clinic Foundation; MetroHealth System; Mayo Clinic; Cleveland
   Clinic Foundation
RP Kirwan, JP (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Pathobiol, 9500 Euclid Ave,Block NE40, Cleveland, OH 44195 USA.
EM kirwanj@ccf.org
RI Kirwan, John P/G-6942-2012; Solomon, Thomas PJ/I-4476-2019
OI Solomon, Thomas PJ/0000-0002-0579-284X
FU NCRR NIH HHS [RR018390, RR00080, M01 RR010732-030048, M01 RR010732,
   RR10732, M01 RR018390, M01 RR000080, M01 RR000080-448000] Funding
   Source: Medline; NIA NIH HHS [R29 AG012834, R01 AG012834, R01
   AG012834-10, AG12834] Funding Source: Medline
CR Åberg W, 2006, NUTRITION, V22, P738, DOI 10.1016/j.nut.2006.04.010
   Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343
   BOFFOLI D, 1994, BBA-MOL BASIS DIS, V1226, P73, DOI 10.1016/0925-4439(94)90061-2
   Brooks GA, 2004, AM J CLIN NUTR, V79, P921
   CALLESESCANDON J, 1995, J APPL PHYSIOL, V78, P266, DOI 10.1152/jappl.1995.78.1.266
   Conley KE, 2000, J PHYSIOL-LONDON, V526, P203, DOI 10.1111/j.1469-7793.2000.t01-1-00203.x
   de Jongh RT, 2004, DIABETES, V53, P2873, DOI 10.2337/diabetes.53.11.2873
   FRAYN KN, 1983, J APPL PHYSIOL, V55, P628, DOI 10.1152/jappl.1983.55.2.628
   Gudbjörnsdóttir S, 2005, J CLIN ENDOCR METAB, V90, P1078, DOI 10.1210/jc.2004-0947
   HAGENFEL.L, 1972, J CLIN INVEST, V51, P2324, DOI 10.1172/JCI107043
   Hoppeler H, 1998, J EXP BIOL, V201, P1051
   Horber FF, 1997, NUTRITION, V13, P524, DOI 10.1016/S0899-9007(97)00031-2
   Kelley DE, 2000, DIABETES, V49, P677, DOI 10.2337/diabetes.49.5.677
   Kelley DE, 2002, ANN NY ACAD SCI, V967, P135
   Krebs M, 2005, DIABETES OBES METAB, V7, P621, DOI 10.1111/j.1463-1326.2004.00439.x
   Lafontan M, 2006, CURR OPIN PHARMACOL, V6, P580, DOI 10.1016/j.coph.2006.08.002
   Lee CK, 2002, P NATL ACAD SCI USA, V99, P14988, DOI 10.1073/pnas.232308999
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   Melanson KJ, 1997, AM J CLIN NUTR, V66, P860, DOI 10.1093/ajcn/66.4.860
   Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a
   MOKDAD AH, 2001, JAMA-J AM MED ASSOC, V289, P76, DOI DOI 10.1001/JAMA.289.1.76
   Morley JE, 2001, J LAB CLIN MED, V137, P231, DOI 10.1067/mlc.2001.113504
   Nagy TR, 1996, J APPL PHYSIOL, V80, P1743, DOI 10.1152/jappl.1996.80.5.1743
   O'Leary VB, 2006, J APPL PHYSIOL, V100, P1584, DOI 10.1152/japplphysiol.01336.2005
   Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314
   Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889
   POEHLMAN ET, 1992, J NUTR, V122, P2057, DOI 10.1093/jn/122.11.2057
   Rimbert V, 2004, FASEB J, V18, P737, DOI 10.1096/fj.03-1104fje
   Rooyackers OE, 1996, P NATL ACAD SCI USA, V93, P15364, DOI 10.1073/pnas.93.26.15364
   Ryan AS, 2000, SPORTS MED, V30, P327, DOI 10.2165/00007256-200030050-00002
   SCHUTZ Y, 1992, AM J CLIN NUTR, V55, P670, DOI 10.1093/ajcn/55.3.670
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Steinberg GR, 2002, AM J PHYSIOL-ENDOC M, V283, pE187, DOI 10.1152/ajpendo.00542.2001
   Sullivan PW, 2005, DIABETES CARE, V28, P1599, DOI 10.2337/diacare.28.7.1599
   TAYLOR HL, 1978, J CHRON DIS, V31, P741, DOI 10.1016/0021-9681(78)90058-9
   Terjung RL, 2002, INT J SPORT NUTR EXE, V12, P368, DOI 10.1123/ijsnem.12.3.368
   Toth MJ, 1996, J APPL PHYSIOL, V80, P506, DOI 10.1152/jappl.1996.80.2.506
   TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363
   Williamson DL, 1997, J GERONTOL A-BIOL, V52, pM352, DOI 10.1093/gerona/52A.6.M352
NR 41
TC 25
Z9 35
U1 0
U2 5
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0026-0495
EI 1532-8600
J9 METABOLISM
JI Metab.-Clin. Exp.
PD AUG
PY 2008
VL 57
IS 8
BP 1141
EP 1147
DI 10.1016/j.metabol.2008.03.021
PG 7
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 334BC
UT WOS:000258196300019
PM 18640394
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Iemitsu, M
   Maeda, S
   Jesmin, S
   Otsuki, T
   Miyauchi, T
AF Iemitsu, Motoyuki
   Maeda, Seiji
   Jesmin, Subrina
   Otsuki, Takeshi
   Miyauchi, Takashi
TI Exercise training improves aging-induced downregulation of VEGF
   angiogenic signaling cascade in hearts
SO AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
LA English
DT Article
DE vascular endothelial growth factor; Akt; endothelial nitric oxide
   synthase; swimming training; aged rat
ID ENDOTHELIAL GROWTH-FACTOR; NITRIC-OXIDE SYNTHASE; TYROSINE KINASE;
   NUCLEOTIDE-SEQUENCE; GENE-EXPRESSION; MESSENGER-RNA; RECEPTOR; AGE;
   LETHALITY; DECREASE
AB Exercise training improves aging-induced deterioration of angiogenesis in the heart. However, the mechanisms underlying exercise-induced improvement of capillary density in the aged heart are unclear. Vascular endothelial growth factor (VEGF) is implicated in angiogenesis, which activated angiogenic signaling cascade through Akt and endothelial nitric oxide synthase (eNOS)-related pathway. We hypothesized that VEGF angiogenic signaling cascade in the heart contributes to a molecular mechanism of exercise training-induced improvement of capillary density in old age. With the use of hearts of sedentary young rats (4 mo old), sedentary aged rats (23 mo old), and exercise-trained aged rats (23 mo old, swim training for 8 wk), the present study investigated whether VEGF and VEGF-related angiogenic molecular expression in the aged heart is affected by exercise training. Total capillary density in the heart was significantly lower in the sedentary aged rats compared with the sedentary young rats, whereas that in the exercise-trained rat was significantly higher than the sedentary aged rats. The mRNA and protein expressions of VEGF and of fms-like tyrosine kinase-1 (Flt-1) and fetal liver kinase-1 (Flk-1), which are main VEGF receptors, in the heart were significantly lower in the sedentary aged rats compared with the sedentary young rats, whereas those in the exercise-trained rats were significantly higher than those in the sedentary aged rats. The phosphorylation of Akt protein and eNOS protein in the heart corresponded to the changes in the VEGF protein levels. These findings suggest that exercise training improves aging-induced downregulation of cardiac VEGF angiogenic signaling cascade, thereby contributing to the exercise training-induced improvement of angiogenesis in old age.
C1 Univ Tsukuba, Inst Clin Med, Div Cardiovasc, Tsukuba, Ibaraki 3058575, Japan.
   Univ Tsukuba, Inst Hlth & Sport Sci, Tsukuba, Ibaraki 3058575, Japan.
   Univ Tsukuba, Ctr Tsukuba Adv Res Alliance, Tsukuba, Ibaraki 3058575, Japan.
C3 University of Tsukuba; University of Tsukuba; University of Tsukuba
RP Miyauchi, T (corresponding author), Univ Tsukuba, Inst Clin Med, Div Cardiovasc, Tsukuba, Ibaraki 3058575, Japan.
EM t-miyauc@md.tsukuba.ac.jp
OI Otsuki, Takeshi/0000-0002-1219-6974
CR Ades PA, 2000, MED CLIN N AM, V84, P251, DOI 10.1016/S0025-7125(05)70217-0
   Bellomo D, 2000, CIRC RES, V86, pE29, DOI 10.1161/01.RES.86.2.e29
   Bernatchez PN, 1999, J BIOL CHEM, V274, P31047, DOI 10.1074/jbc.274.43.31047
   BLOOR CM, 1970, LAB INVEST, V22, P160
   CAPASSO JM, 1983, AM J PHYSIOL, V245, pH72, DOI 10.1152/ajpheart.1983.245.1.H72
   Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651
   Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0
   CONN G, 1990, P NATL ACAD SCI USA, V87, P2628, DOI 10.1073/pnas.87.7.2628
   Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905
   DEVRIES C, 1992, SCIENCE, V255, P989, DOI 10.1126/science.1312256
   Dimmeler S, 2000, CIRC RES, V86, P4, DOI 10.1161/01.RES.86.1.4
   Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224
   Edelberg JM, 2003, FRONT BIOSCI-LANDMRK, V8, pS1199, DOI 10.2741/1166
   Edelberg JM, 2002, CIRCULATION, V105, P608, DOI 10.1161/hc0502.103672
   Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0
   FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0
   Fukumura D, 2001, P NATL ACAD SCI USA, V98, P2604, DOI 10.1073/pnas.041359198
   Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218
   Gavin TP, 2000, J APPL PHYSIOL, V88, P1192, DOI 10.1152/jappl.2000.88.4.1192
   Hansen PA, 1996, J APPL PHYSIOL, V80, P1605, DOI 10.1152/jappl.1996.80.5.1605
   Husain K, 2004, BIOCHEM BIOPH RES CO, V320, P1169, DOI 10.1016/j.bbrc.2004.06.058
   Iemitsu M, 2005, ACTA PHYSIOL SCAND, V185, P259, DOI 10.1111/j.1365-201X.2005.01494.x
   Iemitsu M, 2002, AM J PHYSIOL-HEART C, V283, pH1750, DOI 10.1152/ajpheart.01051.2001
   Iemitsu M, 2000, AM J PHYSIOL-REG I, V279, pR951, DOI 10.1152/ajpregu.2000.279.3.R951
   Jesmin S, 2004, J CARDIOVASC PHARM, V44, pS160, DOI 10.1097/01.fjc.0000166264.27476.60
   Jesmin S, 2003, J CEREBR BLOOD F MET, V23, P181, DOI 10.1097/01.WCB.0000043341.09
   Jesmin S, 2002, AM J PHYSIOL-HEART C, V283, pH1387, DOI 10.1152/ajpheart.00299.2002
   Kimura H, 2003, ACTA BIOCHIM POL, V50, P49
   Kumamoto H, 1999, AM J PHYSIOL-HEART C, V276, pH1117, DOI 10.1152/ajpheart.1999.276.4.H1117
   LAKATTA EG, 1987, ANNU REV PHYSIOL, V49, P519
   Larouche I, 1999, HYPERTENSION, V34, P795, DOI 10.1161/01.HYP.34.4.795
   Morbidelli L, 1996, AM J PHYSIOL-HEART C, V270, pH411, DOI 10.1152/ajpheart.1996.270.1.H411
   Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9
   NUDEL U, 1983, NUCLEIC ACIDS RES, V11, P1759, DOI 10.1093/nar/11.6.1759
   Prior BM, 2004, J APPL PHYSIOL, V97, P1119, DOI 10.1152/japplphysiol.00035.2004
   Rivard A, 1999, CIRCULATION, V99, P111, DOI 10.1161/01.CIR.99.1.111
   Sadoun E, 2003, J HISTOCHEM CYTOCHEM, V51, P1119, DOI 10.1177/002215540305100902
   SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0
   SHIBUYA M, 1990, ONCOGENE, V5, P519
   TERMAN BI, 1992, BIOCHEM BIOPH RES CO, V187, P1579, DOI 10.1016/0006-291X(92)90483-2
   Toker A, 2000, CELL, V103, P185, DOI 10.1016/S0092-8674(00)00110-0
   TOMANEK RJ, 1970, ANAT RECORD, V167, P55, DOI 10.1002/ar.1091670106
   Wen Y, 1998, J BIOL CHEM, V273, P2090, DOI 10.1074/jbc.273.4.2090
   YAMANE A, 1994, ONCOGENE, V9, P2683
   Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215
   Ziche M, 1997, J CLIN INVEST, V99, P2625, DOI 10.1172/JCI119451
NR 46
TC 93
Z9 104
U1 0
U2 1
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0363-6135
EI 1522-1539
J9 AM J PHYSIOL-HEART C
JI Am. J. Physiol.-Heart Circul. Physiol.
PD SEP
PY 2006
VL 291
IS 3
BP H1290
EP H1298
DI 10.1152/ajpheart.00820.2005
PG 9
WC Cardiac & Cardiovascular Systems; Physiology; Peripheral Vascular
   Disease
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology; Physiology
GA 072NL
UT WOS:000239680000035
PM 16617130
DA 2024-02-19
ER

PT J
AU FU, CS
   HARRIS, SB
   WILHELMI, P
   WALFORD, RL
AF FU, CS
   HARRIS, SB
   WILHELMI, P
   WALFORD, RL
TI LACK OF EFFECT OF AGE AND DIETARY RESTRICTION ON DNA SINGLE-STRANDED
   BREAKS IN BRAIN, LIVER, AND KIDNEY OF (C3H X C57BL/10)F1 MICE
SO JOURNALS OF GERONTOLOGY
LA English
DT Article
ID LONGEVITY
AB Single-stranded DNA breaks in brain, liver, and kidney of (C3H x C57BL/10)F1 mice 6 and 25 months of age on two dietary regimens (isonutrient diets at 85 and 50 kcal/week) were investigated by means of fluorometric analysis of DNA unwinding in alkaline solutions. No age-dependent alterations were found for either control or dietary restricted groups. Except for possible differences for liver in the young age groups, there were no significant differences in the amount of single-stranded DNA breaks between control and dietary restricted mice. These results suggest that the anti-aging effects of dietary restriction in rodents are not mediated by a change in the number of accumulated nuclear DNA stranded breaks in internal organs.
C1 UNIV CALIF LOS ANGELES, SCH MED, DEPT PATHOL, LOS ANGELES, CA 90024 USA.
C3 University of California System; University of California Los Angeles;
   University of California Los Angeles Medical Center; David Geffen School
   of Medicine at UCLA
FU NIA NIH HHS [AG-00424] Funding Source: Medline
CR BIRNBOIM HC, 1981, CANCER RES, V41, P1889
   CHETSANGA CJ, 1975, NATURE, V253, P130, DOI 10.1038/253130a0
   CHETSANGA CJ, 1977, BIOCHIM BIOPHYS ACTA, V474, P180, DOI 10.1016/0005-2787(77)90192-7
   DEAN RG, 1978, EXP GERONTOL, V13, P287, DOI 10.1016/0531-5565(78)90036-0
   DIXON WJ, 1983, INTRO STATISTICAL AN
   LICASTRO F, 1986, IMMUNOREGULATION AGI, P53
   MCEWEN BS, 1971, RES METHODS NEUROCHE, P139
   ONO T, 1976, EXP GERONTOL, V11, P127, DOI 10.1016/0531-5565(76)90022-X
   PRICE GB, 1971, SCIENCE, V171, P917, DOI 10.1126/science.171.3974.917
   SU CM, 1984, MECH AGEING DEV, V27, P239, DOI 10.1016/0047-6374(84)90049-6
   Tice R.R., 1985, HDB BIOL AGING, P173
   WEINDRUCH R, 1986, J NUTR, V116, P641, DOI 10.1093/jn/116.4.641
   Weindruch R., 1988, RETARDATION AGING DI
   WERAARCHAKUL N, 1988, FASEB J, V2, pA1209
   WILKINSON L, 1988, SYSTAT SYSTEM STATIS
NR 15
TC 18
Z9 18
U1 0
U2 2
PU GERONTOLOGICAL SOC AMER
PI WASHINGTON
PA 1030 15TH ST NW, STE 250, WASHINGTON, DC 20005202-842 USA
SN 0022-1422
J9 J GERONTOL
JI J. Gerontol.
PD MAR
PY 1991
VL 46
IS 2
BP B78
EP B80
DI 10.1093/geronj/46.2.B78
PG 3
WC Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA GQ139
UT WOS:A1991GQ13900006
PM 1997568
DA 2024-02-19
ER

PT J
AU Sung, B
   Park, S
   Yu, BP
   Chung, HY
AF Sung, B
   Park, S
   Yu, BP
   Chung, HY
TI Modulation of PPAR in aging, inflammation, and calorie restriction
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
ID ACTIVATED RECEPTOR-GAMMA; LOW-DENSITY-LIPOPROTEIN; FACTOR-KAPPA-B;
   PEROXISOME PROLIFERATOR; TRANSCRIPTION FACTORS; LIPID-METABOLISM;
   PROINFLAMMATORY CYTOKINES; LIVER PEROXISOMES; ENDOTHELIAL-CELLS;
   OXIDATIVE STRESS
AB Peroxisome proliferator-activated receptors (PPARs), members of the nuclear hormone receptor superfamily of transcription factors, are key regulators in various pathophysiological processes related to energy metabolism including lipid, carbohydrate metabolism, and inflammation. At present, little information is on the effect of age and calorie restriction (CR) on PPARs. In the present study, we investigated how age and CR (60% of the ad libitum intake) modulate PPARs in kidneys obtained from Fischer 344 rats, ages 13 and 25 months. Results showed that nuclear protein, mRNA level, and DNA binding activity of PPARs decreased with age, while CR blunted the reduction. Our findings were verified in separate experiments in which rats were injected with lipopolysaccharide, with the result of increased susceptibility to inflammation. Based on these findings, we conclude that the altered expression of PPARs may be due to increased oxidative stress with age, and that CR prevents these decreases through its antioxidative action.
C1 Pusan Natl Univ, Coll Pharm, Pusan 609735, South Korea.
   Univ Texas, Ctr Hlth Sci, Dept Physiol, San Antonio, TX 78285 USA.
C3 Pusan National University; University of Texas System; University of
   Texas Health Science Center at San Antonio
RP Chung, HY (corresponding author), Pusan Natl Univ, Coll Pharm, Pusan 609735, South Korea.
EM hyjung@pusan.ac.kr
RI Sung, Bokyung/AAX-5697-2021
CR Auwerx J, 1999, DIABETOLOGIA, V42, P1033, DOI 10.1007/s001250051268
   Bagi Z, 2004, AM J PHYSIOL-HEART C, V286, pH742, DOI 10.1152/ajpheart.00718.2003
   Barbier O, 2002, ARTERIOSCL THROM VAS, V22, P717, DOI 10.1161/01.ATV.0000015598.86369.04
   BEIER K, 1993, VIRCHOWS ARCH B, V63, P139, DOI 10.1007/BF02899254
   BERTRAND HA, 1999, METHODS AGING RES, P271
   CARRERA M, 2004, BIOCHEM PHARMACOL, V67, P157
   CHANDRASEKAR B, 1995, CLIN IMMUNOL IMMUNOP, V76, P291, DOI 10.1006/clin.1995.1128
   Chandrasekar B, 2001, AM J PHYSIOL-HEART C, V280, pH2094, DOI 10.1152/ajpheart.2001.280.5.H2094
   Chao C, 2002, MECH AGEING DEV, V123, P1469, DOI 10.1016/S0047-6374(02)00086-6
   Chawla A, 2001, NAT MED, V7, P48, DOI 10.1038/83336
   Chung HY, 2002, MICROSC RES TECHNIQ, V59, P264, DOI 10.1002/jemt.10203
   Chung HY, 2001, ANN NY ACAD SCI, V928, P327
   Chung SW, 2000, J BIOL CHEM, V275, P32681, DOI 10.1074/jbc.M002577200
   Delerive P, 1999, J BIOL CHEM, V274, P32048, DOI 10.1074/jbc.274.45.32048
   Delerive P, 2000, J BIOL CHEM, V275, P36703, DOI 10.1074/jbc.M004045200
   Deplanque D, 2003, J NEUROSCI, V23, P6264
   DEROCHEMONTEIXGALVE B, 1991, INFECT IMMUN, V59, P3646, DOI 10.1128/IAI.59.10.3646-3650.1991
   Espinosa-Heidmann DG, 2002, INVEST OPHTH VIS SCI, V43, P1567
   Ferré P, 2004, DIABETES, V53, pS43, DOI 10.2337/diabetes.53.2007.S43
   Guan YF, 2002, DRUG NEWS PERSPECT, V15, P147, DOI 10.1358/dnp.2002.15.3.840011
   HABIB A, 1993, J BIOL CHEM, V268, P23448
   HATTORI M, 1990, DNA CELL BIOL, V9, P777, DOI 10.1089/dna.1990.9.777
   HSIEH V, 1994, INT ARCH ALLERGY IMM, V104, P42, DOI 10.1159/000236707
   Iemitsu M, 2002, AM J PHYSIOL-HEART C, V283, pH1750, DOI 10.1152/ajpheart.01051.2001
   Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184
   KERR LD, 1995, METHOD ENZYMOL, V254, P619
   Kim HJ, 2002, MECH AGEING DEV, V123, P1589, DOI 10.1016/S0047-6374(02)00094-5
   Kwon HJ, 2001, J AM AGING ASSOC, V24, P163, DOI 10.1007/s11357-001-0017-1
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lavrovsky Y, 2000, EXP GERONTOL, V35, P521, DOI 10.1016/S0531-5565(00)00118-2
   Law RE, 2000, CIRCULATION, V101, P1311, DOI 10.1161/01.CIR.101.11.1311
   Meerarani P, 2003, J NUTR, V133, P3058, DOI 10.1093/jn/133.10.3058
   Mueller C, 2003, ARCH BIOCHEM BIOPHYS, V418, P186, DOI 10.1016/j.abb.2003.08.006
   Muthukumar AR, 2000, J CLIN IMMUNOL, V20, P354, DOI 10.1023/A:1006620130114
   Okada M, 2002, FASEB J, V16, P1861, DOI 10.1096/fj.02-0503com
   Poynter ME, 1998, J BIOL CHEM, V273, P32833, DOI 10.1074/jbc.273.49.32833
   Ricote M, 1998, P NATL ACAD SCI USA, V95, P7614, DOI 10.1073/pnas.95.13.7614
   Sanguino E, 2004, BIOCHEM PHARMACOL, V67, P157, DOI 10.1016/j.bcp.2003.08.034
   Tao L, 2003, CIRCULATION, V108, P2805, DOI 10.1161/01.CIR.0000097003.49585.5E
   Xu JY, 2003, AM J PHYSIOL-GASTR L, V285, pG20, DOI 10.1152/ajpgi.00474.2002
   Youssef J, 1999, ENVIRON HEALTH PERSP, V107, P791, DOI 10.2307/3454575
   Yu BP, 2001, ANN NY ACAD SCI, V928, P39
   Yu BP, 1996, FREE RADICAL BIO MED, V21, P651, DOI 10.1016/0891-5849(96)00162-1
NR 43
TC 125
Z9 136
U1 0
U2 5
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
EI 1758-535X
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD OCT
PY 2004
VL 59
IS 10
BP 997
EP 1006
PG 10
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA 868IQ
UT WOS:000224907700003
PM 15528772
DA 2024-02-19
ER

PT J
AU Bai, L
   Liu, ZQ
   Fang, QW
   Yan, Q
   Shi, OM
   Bao, PP
   Mu, LN
   Chen, XD
   Zhang, TJ
AF Bai, Lei
   Liu, Zhenqiu
   Fang, Qiwen
   Yan, Qiong
   Shi, Oumin
   Bao, Pingping
   Mu, Lina
   Chen, Xingdong
   Zhang, Tiejun
TI The trends and projections in the incidence and mortality of liver
   cancer in urban Shanghai: a population-based study from 1973 to 2020
SO CLINICAL EPIDEMIOLOGY
LA English
DT Article
DE liver cancer; incidence; mortality; Shanghai
ID AGE-PERIOD; TEMPORAL VARIATION; RATES; MODELS; STATISTICS; CIRRHOSIS;
   ENGLAND; FUTURE; BURDEN; CHINA
AB Background: In 2012, liver cancer ranked as the fifth and eighth most common cancer in men and women, respectively, in urban Shanghai. This study aims to present the trend and projection of age-specific incidence and mortality of liver cancer in Shanghai.
   Methods: We extracted data of liver cancer incident cases and deaths between 1973 and 2012. An age-period-cohort model was used to analyze the data.
   Results: A total of 47,344 men and 18,692 women were diagnosed with liver cancer from 1973 to 2012. The overall age-standardized incidence was 26.89 and 8.89 per 100,000 for men and women, respectively. Correspondingly, a total of 44,355 and 18,084 men and women died from liver cancer during this period. The overall age-standardized death rate was 25.34 per 100,000 in men and 9.39 per 100,000 in women. Between 1973 and 2012, liver cancer incidence and mortality in all age groups, except people aged 0-19 years, experienced a significant decline. Similar temporal patterns were detected in liver cancer mortality in both sexes when compared with incidence. Liver cancer incidence and mortality are expected to further decline among all age groups in 2013-2020 in both sexes, though the numbers of incident cases will remain stable.
   Conclusion: Incidence and mortality of liver cancer in urban Shanghai have decreased by about 40% and 50%, respectively, over the past four decades. This decline is expected to continue in the near future. However, the population is aging, which is reflected in the increasing crude rates and decreasing age-adjusted rates.
C1 [Bai, Lei] Univ Chinese Acad Sci, Chinese Acad Sci, Inst Pasteur Shanghai, Shanghai, Peoples R China.
   [Liu, Zhenqiu; Fang, Qiwen; Zhang, Tiejun] Fudan Univ, Sch Publ Hlth, Dept Epidemiol, Shanghai, Peoples R China.
   [Liu, Zhenqiu; Fang, Qiwen; Zhang, Tiejun] Fudan Univ, Key Lab Publ Hlth Safety, Minist Educ, Shanghai, Peoples R China.
   [Yan, Qiong] Fudan Univ, Sch Publ Hlth, Dept Child & Maternal Hlth, Shanghai, Peoples R China.
   [Shi, Oumin] Shenzhen Univ, Affiliated Hosp 1, Shenzhen Peoples Hosp 2, Dept Neurol, Shenzhen, Peoples R China.
   [Bao, Pingping] Shanghai Municipal Ctr Dis Control & Prevent, Dept Chron Noncommunicable Dis Surveillance, Shanghai, Peoples R China.
   [Mu, Lina] State Univ New York SUNY Buffalo, Sch Publ Hlth & Hlth Profess, Dept Epidemiol & Environm Hlth, Buffalo, NY USA.
   [Chen, Xingdong] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai, Peoples R China.
   [Chen, Xingdong] Fudan Univ, Sch Life Sci, Collaborat Innovat Ctr Genet & Dev, Shanghai, Peoples R China.
   [Chen, Xingdong] Fudan Univ, Taizhou Inst Hlth Sci, Taizhou, Peoples R China.
C3 Chinese Academy of Sciences; Shanghai Institute of Immunity and
   Infection, CAS; University of Chinese Academy of Sciences, CAS; Le
   Reseau International des Instituts Pasteur (RIIP); Fudan University;
   Fudan University; Fudan University; Shenzhen University; Shanghai Center
   for Disease Control & Prevention; State University of New York (SUNY)
   System; State University of New York (SUNY) Buffalo; Fudan University;
   Fudan University; Fudan University
RP Chen, XD (corresponding author), Fudan Univ, Sch Life Sci, Shanghai 200032, Peoples R China.; Zhang, TJ (corresponding author), Fudan Univ, Sch Publ Hlth, Shanghai 200032, Peoples R China.
EM xingdongchen@fudan.edu.cn; tjzhang@shmu.edu.cn
RI zhang, Tiejun/HGD-6858-2022; Zhang, Tiejun/HDM-7091-2022; Bai,
   Lei/HOC-2569-2023
OI Bai, Lei/0000-0001-8968-3386; Yan, Qiong/0000-0003-2559-2551; Liu,
   Zhenqiu/0000-0002-5244-6894; Mu, Lina/0000-0003-4799-7517
FU National Natural Science Foundation of China [81502870]; International
   S&T Cooperation Program of China [2015DFE32790]; China Postdoctoral
   Science Foundation [2016M601511, 2017T100272]; Key Basic Research Grants
   from Science and Technology Commission of Shanghai Municipality
   [16JC1400500]; National Key Research and Development program of China
   [2017YFC0907002, 2017YFC0907501]
FX This work was supported by the National Natural Science Foundation of
   China (grant numbers: 81502870), the International S&T Cooperation
   Program of China (grant number: 2015DFE32790), the China Postdoctoral
   Science Foundation (grant numbers: 2016M601511 and 2017T100272), the Key
   Basic Research Grants from Science and Technology Commission of Shanghai
   Municipality (grant number: 16JC1400500), and the National Key Research
   and Development program of China (grant number: 2017YFC0907002,
   2017YFC0907501).
CR Ali R, 2013, GUT, V62, P1692, DOI 10.1136/gutjnl-2012-303000
   Altekruse SF, 2014, AM J GASTROENTEROL, V109, P542, DOI 10.1038/ajg.2014.11
   [Anonymous], SHANGH STAT YB
   BESAG J, 1995, STAT SCI, V10, P3, DOI 10.1214/ss/1177010123
   Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011
   Carstensen B, 2007, STAT MED, V26, P3018, DOI 10.1002/sim.2764
   Chaturvedi AK, 2013, J CLIN ONCOL, V31, P4550, DOI 10.1200/JCO.2013.50.3870
   Chen JG, 2011, SEMIN CANCER BIOL, V21, P59, DOI 10.1016/j.semcancer.2010.11.002
   Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338
   Chen ZM, 2003, INT J CANCER, V107, P106, DOI 10.1002/ijc.11342
   Chuang SC, 2009, CANCER LETT, V286, P9, DOI 10.1016/j.canlet.2008.10.040
   CLAYTON D, 1987, STAT MED, V6, P449, DOI 10.1002/sim.4780060405
   CLAYTON D, 1987, STAT MED, V6, P469, DOI 10.1002/sim.4780060406
   Curado M-P, 2007, CANC INCIDENCE 5 CON, VIX
   Di Bisceglie Adrian M., 1998, Hepatology, V28, P1161, DOI 10.1002/hep.510280436
   Fitzmaurice C, 2017, JAMA ONCOL, V3, P524, DOI 10.1001/jamaoncol.2016.5688
   Gao S, 2012, EUR J EPIDEMIOL, V27, P39, DOI 10.1007/s10654-011-9636-8
   GAO YT, 1981, BRIT J CANCER, V43, P183, DOI 10.1038/bjc.1981.27
   Han Xue, 2012, Zhonghua Yu Fang Yi Xue Za Zhi, V46, P119
   Hankey BF, 2000, CANCER CAUSE CONTROL, V11, P31, DOI 10.1023/A:1008953201688
   Jack RH, 2013, CANCER EPIDEMIOL, V37, P34, DOI 10.1016/j.canep.2012.10.008
   JIN F, 1993, INT J CANCER, V53, P764, DOI 10.1002/ijc.2910530510
   Lindgren F, 2015, J STAT SOFTW, V63, P1, DOI 10.18637/jss.v063.i19
   Ma RCW, 2014, LANCET DIABETES ENDO, V2, P980, DOI 10.1016/S2213-8587(14)70145-7
   Ormiston-Smith Nicholas, 2006, Popul Trends, P37
   Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013
   Printz C, 2014, CANCER-AM CANCER SOC, V120, P1288, DOI 10.1002/cncr.28718
   Riebler A, 2017, BIOMETRICAL J, V59, P531, DOI 10.1002/bimj.201500263
   Ryerson AB, 2016, CANCER-AM CANCER SOC, V122, P1312, DOI 10.1002/cncr.29936
   Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208
   Smith BD, 2009, J CLIN ONCOL, V27, P2758, DOI 10.1200/JCO.2008.20.8983
   Sun BC, 2012, J HEPATOL, V56, P704, DOI 10.1016/j.jhep.2011.09.020
   TaylorRobinson SD, 1997, LANCET, V350, P1142, DOI 10.1016/S0140-6736(05)63789-0
   Teo MCC, 2013, JPN J CLIN ONCOL, V43, P219, DOI 10.1093/jjco/hys230
   Xiang Y B, 2011, IARC Sci Publ, P55
   Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292
   Yuan XJ, 2016, CANCER LETT, V375, P39, DOI 10.1016/j.canlet.2016.02.051
   Zhang Huan-zhu, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P207
   Zuo TT, 2015, CHIN J CANCER, V34, DOI 10.1186/s40880-015-0056-0
NR 39
TC 19
Z9 21
U1 1
U2 12
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1179-1349
J9 CLIN EPIDEMIOL
JI Clin. Epidemiol.
PY 2018
VL 10
BP 277
EP 288
DI 10.2147/CLEP.S153951
PG 12
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Public, Environmental & Occupational Health
GA FZ2QC
UT WOS:000427424300001
PM 29563840
OA Green Published, Green Submitted, gold
DA 2024-02-19
ER

PT J
AU Amador-Noguez, D
   Zimmerman, J
   Venable, S
   Darlington, G
AF Amador-Noguez, D
   Zimmerman, J
   Venable, S
   Darlington, G
TI Gender-specific alterations in gene expression and loss of liver sexual
   dimorphism in the long-lived Ames dwarf mice
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Ames dwarf mice; aging; gene expression profile; liver sexual
   dimorphism; mouse models of delayed aging
ID LIFE-SPAN; NUCLEAR RECEPTORS; INNATE IMMUNITY; COMPLEMENT; PROFILE;
   INHIBITION; METABOLISM; INDUCTION; HORMONES; SYSTEM
AB Genetic mutations that increase lifespan in mice frequently involve alterations in the growth hormone/insulin-like growth factor-I signaling pathway. Although several of the effects of GH on gene expression are known to be sex-dependent, an understanding of the gender-specific vs. gender-independent effects of lifespan-extending mutations of the GH/IGF-I axis is currently lacking. The Ames dwarf mice (prop1(df/df)) are GH, prolactin and thyroid- stimulating hormone deficient and exhibit an increase in mean lifespan of 49% in males and 68% in females. We used oligonucleotide arrays containing over 14,000 genes to study the gender-specific vs. gender-independent effects of the prop1(df) mutation in liver of male and female Ames mice. We identified 381 gender-independent and 110 gender-specific alterations in gene expression produced by the Prop1(df/df) genotype. The gender-specific alterations corresponded to genes with a strong sexual dimorphism in wild-type mice and produced an almost complete loss of sex-specific gene expression in the liver of Ames dwarf mice: out of 123 genes that showed sexual dimorphism in wild-type mice only six maintained a gender difference in mutant mice. However, the Prop1(df/df) genotype did not introduce new sexually dimorphic patterns of gene expression in Ames dwarf mice that were not present in the wild-type animals. The gender-specific alterations accounted for a large fraction of the most significant changes in gene expression in male and female Ames mice livers and affected several metabolic processes, particularly fatty acid metabolism, steroid hormone metabolism, and xenobiotic metabolism. (c) 2005 Elsevier Inc. All rights reserved.
C1 Baylor Coll Med, Mol & Human Genet Dept, Houston, TX 77030 USA.
   Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA.
C3 Baylor College of Medicine; Baylor College of Medicine
RP Amador-Noguez, D (corresponding author), Baylor Coll Med, Mol & Human Genet Dept, Houston, TX 77030 USA.
EM da135453@bcm.tmc.edu
CR Amador-Noguez D, 2004, AGING CELL, V3, P423, DOI 10.1111/j.1474-9728.2004.00125.x
   Bartke A, 2000, RES PRO CEL, V29, P181
   Bowen RL, 2004, GERONTOLOGY, V50, P265, DOI 10.1159/000079125
   Boylston WH, 2004, AGING CELL, V3, P283, DOI 10.1111/j.1474-9728.2004.00115.x
   BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0
   Carroll MC, 2004, NAT IMMUNOL, V5, P981, DOI 10.1038/ni1113
   CHANDRASHEKAR V, 1993, BIOL REPROD, V48, P544, DOI 10.1095/biolreprod48.3.544
   Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991
   CROSS RJ, 1992, J IMMUNOL, V148, P1347
   DeVeale B, 2004, AGING CELL, V3, P195, DOI 10.1111/j.1474-9728.2004.00106.x
   Dozmorov I, 2002, J GERONTOL A-BIOL, V57, pB99, DOI 10.1093/gerona/57.3.B99
   Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863
   ESQUIFINO AI, 1991, ACTA ENDOCRINOL-COP, V125, P67, DOI 10.1530/acta.0.1250067
   Flurkey K, 2002, MECH AGEING DEV, V123, P121, DOI 10.1016/S0047-6374(01)00339-6
   Francis GA, 2003, ANNU REV PHYSIOL, V65, P261, DOI 10.1146/annurev.physiol.65.092101.142528
   Fujita T, 2004, IMMUNOL REV, V198, P185, DOI 10.1111/j.0105-2896.2004.0123.x
   Handschin C, 2003, PHARMACOL REV, V55, P649, DOI 10.1124/pr.55.4.2
   Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857
   Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298
   Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70
   Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098
   Linton SM, 1999, MOL IMMUNOL, V36, P905, DOI 10.1016/S0161-5890(99)00113-3
   Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x
   McElwee JJ, 2004, J BIOL CHEM, V279, P44533, DOI 10.1074/jbc.M406207200
   MURPHY WJ, 1992, J IMMUNOL, V148, P3799
   Nauta AJ, 2004, INT ARCH ALLERGY IMM, V134, P310, DOI 10.1159/000079261
   Nebert DW, 2002, LANCET, V360, P1155, DOI 10.1016/S0140-6736(02)11203-7
   Sornson MW, 1996, NATURE, V384, P327, DOI 10.1038/384327a0
   Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987
   Tsuchiya T, 2004, PHYSIOL GENOMICS, V17, P307, DOI 10.1152/physiolgenomics.00039.2004
   Vakeva AP, 1998, CIRCULATION, V97, P2259, DOI 10.1161/01.CIR.97.22.2259
   Welch TR, 2002, NAT GENET, V31, P333, DOI 10.1038/ng933
NR 32
TC 40
Z9 46
U1 1
U2 3
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD JUL 15
PY 2005
VL 332
IS 4
BP 1086
EP 1100
DI 10.1016/j.bbrc.2005.05.063
PG 15
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA 937AC
UT WOS:000229895900024
PM 15925325
DA 2024-02-19
ER

PT J
AU Dong, Q
   Li, N
   Li, Q
   Zhang, CE
   Feng, WW
   Li, GQ
   Li, RY
   Tu, C
   Han, X
   Bai, ZF
   Zhang, YM
   Niu, M
   Ma, ZJ
   Xiao, XH
   Wang, JB
AF Dong, Qin
   Li, Na
   Li, Qi
   Zhang, Cong-En
   Feng, Wu-Wen
   Li, Guang-Quan
   Li, Rui-Yu
   Tu, Can
   Han, Xue
   Bai, Zhao-Fang
   Zhang, Ya-Ming
   Niu, Ming
   Ma, Zhi-Jie
   Xiao, Xiao-He
   Wang, Jia-Bo
TI Screening for biomarkers of liver injury induced by <i>Polygonum</i>
   <i>multiflorum</i>: a targeted metabolomic study
SO FRONTIERS IN PHARMACOLOGY
LA English
DT Article
DE Polygonum multiflorum; liver injury; bile acid; biomarker; LC-MS
ID SERUM BILE-ACIDS; CYTOCHROME-P450 ENZYMES; PERFORMANCE; INGESTION;
   EXTRACTS
AB Heshouwu (HSW) the dry roots of Polygonum multiflorum, a classical traditional Chinese medicine is used as a tonic for a wide range of conditions, particularly those associated with aging. However, it tends to be taken overdose or long term in these years, which has resulted in liver damage reported in many countries. In this study, the indicative roles of nine bile acids (BAs) were evaluated to offer potential biomarkers for HSW induced liver injury. Nine BAs including cholic acid (CA) and chenodeoxycholic acid (CDCA), taurocholic acid (TCA), glycocholic acid (GCA), glycochenodeoxycholic acid (GCDCA), deoxycholic acid (DCA), glycodeoxycholic acid (GDCA), ursodeoxycholic acid (UDCA), and hyodeoxycholic acid (HDCA) in rat bile and serum were detected by a developed LC-MS method after 42 days treatment. Partial least square-discriminate analysis (PLS-DA) was applied to evaluate the indicative roles of the nine BAs, and metabolism of the nine BAs was summarized. Significant change was observed for the concentrations of nine BAs in treatment groups compared with normal control; In the PLS-DA plots of nine BAs in bile, normal control and raw HSW groups were separately clustered and could be clearly distinguished, GDCA was selected as the distinguished components for raw HSW overdose treatment group. In the PLS-DA plots of nine BAs in serum, the normal control and raw HSW overdose treatment group were separately clustered and could be clearly distinguished, and HDCA was selected as the distinguished components for raw HSW overdose treatment group. The results indicated the perturbation of nine BAs was associated with HSW induced liver injury; GDCA in bile, as well as HDCA in serum could be selected as potential biomarkers for HSW induced liver injury; it also laid the foundation for the further search on the mechanisms of liver injury induced by HSW.
C1 [Dong, Qin; Li, Na; Li, Qi; Zhang, Cong-En; Feng, Wu-Wen; Li, Guang-Quan; Li, Rui-Yu; Tu, Can; Han, Xue; Bai, Zhao-Fang; Zhang, Ya-Ming; Niu, Ming; Wang, Jia-Bo] 302 Mil Hosp, China Mil Inst Chinese Med, Beijing 100039, Peoples R China.
   [Dong, Qin; Zhang, Cong-En; Feng, Wu-Wen; Li, Guang-Quan; Li, Rui-Yu; Han, Xue] Chengdu Univ Tradit Chinese Med, Coll Pharm, Chengdu, Peoples R China.
   [Ma, Zhi-Jie] Capital Med Univ, Beijing Friendship Hosp, Beijing 100039, Peoples R China.
   [Xiao, Xiao-He] 302 Mil Hosp, Integrat Med Ctr, Beijing 100039, Peoples R China.
C3 Fifth Medical Center of Chinese PLA General Hospital; Chengdu University
   of Traditional Chinese Medicine; Capital Medical University; Fifth
   Medical Center of Chinese PLA General Hospital
RP Ma, ZJ (corresponding author), Capital Med Univ, Beijing Friendship Hosp, 95 Yongan, Beijing 100039, Peoples R China.
EM 13811647091@163.com; pharmacy302xxh@126.com; pharm_sci@126.com
RI Xiao, Xiao/IAN-3011-2023; Li, Jiaai/JCO-0168-2023; xiao,
   xiang/GWU-6035-2022
OI Feng, Wuwen/0000-0001-7850-5357
FU National Key Technology RD Program [2015ZX09501-004-001-008]; National
   TCM Industry Science and Technology Program [20150700404]; National
   Natural Science Foundation of China [81373984, 81403126]; Beijing
   Natural Science Foundation [7152142]
FX This work was supported by the National Key Technology R&D Program (no.
   2015ZX09501-004-001-008), the National TCM Industry Science and
   Technology Program (no. 20150700404), the National Natural Science
   Foundation of China (nos. 81373984 and 81403126) and the Beijing Natural
   Science Foundation (7152142).
CR Alnouti Y, 2009, TOXICOL SCI, V108, P225, DOI 10.1093/toxsci/kfn268
   [Anonymous], 2015, EVID BASED COMPLEMEN
   Bechmann LP, 2013, HEPATOLOGY, V57, P1394, DOI 10.1002/hep.26225
   Bobeldijk I, 2008, J CHROMATOGR B, V871, P306, DOI 10.1016/j.jchromb.2008.05.008
   BOUCHIER IAD, 1978, GUT, V19, P492, DOI 10.1136/gut.19.6.492
   But PPH, 1996, VET HUM TOXICOL, V38, P280
   ChinaPharmacopoeiaCommittee, 2010, PHARMACOPOEIAOFTHEPE
   David LA, 2015, MBIO, V6, DOI 10.1128/mBio.00381-15
   Dong HH, 2014, COMPLEMENT THER MED, V22, P70, DOI 10.1016/j.ctim.2013.12.008
   Ennulat D, 2010, TOXICOL SCI, V116, P397, DOI 10.1093/toxsci/kfq144
   Goulet O, 2015, NUTR REV, V73, P32, DOI 10.1093/nutrit/nuv039
   Hofmann AF, 2008, CELL MOL LIFE SCI, V65, P2461, DOI 10.1007/s00018-008-7568-6
   Jaeschke H, 2002, TOXICOL SCI, V65, P166, DOI 10.1093/toxsci/65.2.166
   Jung KA, 2011, GUT LIVER, V5, P493, DOI 10.5009/gnl.2011.5.4.493
   Lin LF, 2015, J HAZARD MATER, V299, P249, DOI 10.1016/j.jhazmat.2015.06.014
   Liu J, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2015.05.017
   Luo LN, 2014, TOXICOL SCI, V137, P12, DOI 10.1093/toxsci/kft221
   Neghab M, 2000, BIOMARKERS, V5, P81, DOI 10.1080/135475000230415
   Njeru SN, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0811-4
   Park GJH, 2001, J GASTROEN HEPATOL, V16, P115, DOI 10.1046/j.1440-1746.2001.02309.x
   Park HJ, 2011, J ETHNOPHARMACOL, V135, P369, DOI 10.1016/j.jep.2011.03.028
   Péan N, 2013, HEPATOLOGY, V58, P1451, DOI 10.1002/hep.26463
   REGAL RE, 1987, CLIN PHARMACY, V6, P787
   REICHEL C, 1995, EUR J GASTROEN HEPAT, V7, P951, DOI 10.1097/00042737-199510000-00008
   Sridhar J, 2012, CHEM RES TOXICOL, V25, P357, DOI 10.1021/tx2004163
   Tu Can, 2015, Zhongguo Zhong Yao Za Zhi, V40, P654
   Unger M, 2004, RAPID COMMUN MASS SP, V18, P2273, DOI 10.1002/rcm.1621
   Vallim TQD, 2013, CELL METAB, V17, P657, DOI 10.1016/j.cmet.2013.03.013
   Wang Tao, 2012, Zhongguo Zhong Yao Za Zhi, V37, P1445
   Wang YY, 2015, XENOBIOTICA, V45, P279, DOI 10.3109/00498254.2014.976779
   Watanabe S, 2014, LIPIDS, V49, P963, DOI 10.1007/s11745-014-3947-y
   Woolbright BL, 2014, TOXICOL SCI, V142, P436, DOI 10.1093/toxsci/kfu195
   Wu XQ, 2012, FITOTERAPIA, V83, P469, DOI 10.1016/j.fitote.2011.12.012
   Yamazaki M, 2013, TOXICOL APPL PHARM, V268, P79, DOI 10.1016/j.taap.2013.01.018
   Yu J, 2011, J ETHNOPHARMACOL, V137, P1291, DOI 10.1016/j.jep.2011.07.055
   Zhao LJ, 2013, EURASIP J ADV SIG PR, DOI 10.1186/1687-6180-2013-56
NR 36
TC 45
Z9 49
U1 2
U2 37
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 1663-9812
J9 FRONT PHARMACOL
JI Front. Pharmacol.
PD OCT 2
PY 2015
VL 6
AR 217
DI 10.3389/fphar.2015.00217
PG 9
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA CX9TM
UT WOS:000366048500001
PM 26483689
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Su, HJ
   Kao, JH
   Tseng, TC
   Yang, HC
   Su, TH
   Chen, PJ
   Liu, CJ
AF Su, Hau-Jyun
   Kao, Jia-Horng
   Tseng, Tai-Chung
   Yang, Hung-Chih
   Su, Tung-Hung
   Chen, Pei-Jer
   Liu, Chun-Jen
TI Pathologic findings of patients with nonalcoholic fatty liver disease
   and the impact of concurrent hepatitis B virus infection in Taiwan
SO JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
LA English
DT Article
DE NASH; Taiwan; Histopathology; Hepatitis B; Concurrent
ID RISK-FACTORS; INSULIN-RESISTANCE; METABOLIC SYNDROME; SCORING SYSTEM;
   PREVALENCE; POPULATION; FEATURES; ASSOCIATION; VALIDATION
AB Background & aims: Pathologic data of non-alcoholic fatty liver disease (NAFLD) was limited and the association between NAFLD and chronic hepatitis B remained unclear in Taiwan. This study aimed to determine the pathological manifestations of NAFLD and the impact of concurrent hepatitis B virus (HBV) infection in a medical center.
   Methods: Retrospective review of 104 consecutive random liver biopsies with the histologic diagnosis of NAFLD or cryptogenic cirrhosis from 2009 to 2018 was conducted. Clinical, biochemical and histological data were compared among various stages of NAFLD and between those with or without concurrent HBV infection.
   Results: Advanced fibrosis was documented in 39.42% of Taiwanese patients with NAFLD according to METAVIR scoring system and was associated with aging (odds ratio, 1.06; 95% CI, 1.03-1.10), hypertension (odds ratio, 2.97; 95% CI, 1.31-6.74), diabetes mellitus (odds ratio, 4.36; 95% CI, 1.78-10.70) and concurrent HBV infection (odds ratio, 3.55; 95% CI, 1.46-8.58) by multivariate analyses. Concurrent HBV was found in 28.57% of the NAFLD patients. Patients with concurrent HBV had lower platelet counts, longer prothrombin time/INR and higher fibrosis stage than those without CHB.
   Conclusion: Advanced fibrosis in patients with NAFLD was common in the biopsy series, and was related to aging, hypertension, diabetes mellitus and concurrent HBV infection. Copyright (C) 2020, Formosan Medical Association. Published by Elsevier Taiwan LLC.
C1 [Su, Hau-Jyun] Natl Taiwan Univ Hosp, Dept Internal Med, Yunlin Branch, Huwei Township, Yunlin, Taiwan.
   [Kao, Jia-Horng; Tseng, Tai-Chung; Yang, Hung-Chih; Su, Tung-Hung; Chen, Pei-Jer; Liu, Chun-Jen] Natl Taiwan Univ, Dept Internal Med, Coll Med & Hosp, Taipei, Taiwan.
   [Kao, Jia-Horng; Chen, Pei-Jer; Liu, Chun-Jen] Natl Taiwan Univ, Grad Inst Clin Med, Coll Med & Hosp, Taipei, Taiwan.
   [Kao, Jia-Horng; Tseng, Tai-Chung; Yang, Hung-Chih; Su, Tung-Hung; Chen, Pei-Jer; Liu, Chun-Jen] Natl Taiwan Univ, Hepatitis Res Ctr, Coll Med & Hosp, Taipei, Taiwan.
C3 National Taiwan University; National Taiwan University Hospital;
   National Taiwan University; National Taiwan University; National Taiwan
   University
RP Liu, CJ (corresponding author), Natl Taiwan Univ, Grad Inst Clin Med, Coll Med & Hosp, Taipei, Taiwan.; Liu, CJ (corresponding author), Natl Taiwan Univ, Hepatitis Res Ctr, Dept Internal Med, Coll Med & Hosp, Taipei, Taiwan.; Kao, JH (corresponding author), Natl Taiwan Univ, Grad Inst Clin Med, Coll Med, 1 Chang Te St, Taipei 10002, Taiwan.
EM kaojh@ntu.edu.tw; cjliu@ntu.edu.tw
RI Yang, Chen/G-1379-2010; LIU, YU/HTR-1607-2023; Kao, JH/AAB-8947-2019;
   zhang, luyu/JJC-4227-2023
OI Kao, JH/0000-0002-2442-7952; Su, Hau-Jyun/0000-0002-0244-9288; SU,
   TUNG-HUNG/0000-0002-6747-7941; YANG, HUNG-CHIH/0000-0003-3864-9895;
   Chen, Pei-Jer/0000-0001-8316-3785
FU Ministry of Science and Technology, Taiwan; Ministry of Health and
   Welfare, Executive Yuan, Taiwan; National Taiwan University Hospital,
   Taipei, Taiwan [NTUH 109-A149]
FX This study was funded by the Ministry of Science and Technology and
   Ministry of Health and Welfare, Executive Yuan, Taiwan; National Taiwan
   University Hospital (NTUH 109-A149), Taipei, Taiwan.
CR Bondini S, 2007, LIVER INT, V27, P607, DOI 10.1111/j.1478-3231.2007.01482.x
   Chalasani N, 2018, HEPATOLOGY, V67, P328, DOI 10.1002/hep.29367
   Chan WK, 2018, ALIMENT PHARM THER, V47, P816, DOI 10.1111/apt.14506
   Charatcharoenwitthaya P, 2017, LIVER INT, V37, P542, DOI 10.1111/liv.13271
   Chen CH, 2006, J CLIN GASTROENTEROL, V40, P745, DOI 10.1097/00004836-200609000-00016
   Chitturi S, 2018, J GASTROEN HEPATOL, V33, P86, DOI 10.1111/jgh.13856
   Choi HSJ, 2020, HEPATOLOGY, V71, P539, DOI 10.1002/hep.30857
   EASL, 2016, DIABETOLOGIA, V59, P1121, DOI 10.1007/s00125-016-3902-y
   Fan JG, 2017, J HEPATOL, V67, P862, DOI 10.1016/j.jhep.2017.06.003
   Haga Y, 2015, WORLD J GASTROENTERO, V21, P12989, DOI 10.3748/wjg.v21.i46.12989
   Harrison SA, 2008, GUT, V57, P1441, DOI 10.1136/gut.2007.146019
   Huang JF, 2020, J FORMOS MED ASSOC, V119, P89, DOI 10.1016/j.jfma.2019.03.014
   Hung SC, 2013, EUR GERIATR MED, V4, P78, DOI 10.1016/j.eurger.2012.11.004
   Joo EJ, 2017, HEPATOLOGY, V65, P828, DOI 10.1002/hep.28917
   Kleiner DE, 2012, SEMIN LIVER DIS, V32, P3, DOI 10.1055/s-0032-1306421
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   Liu CJ, 2012, J GASTROEN HEPATOL, V27, P1555, DOI 10.1111/j.1440-1746.2012.07222.x
   Liu CJ, 2005, ANTIVIR THER, V10, P405
   Liu CJ, 2005, J HEPATOL, V43, P235, DOI 10.1016/j.jhep.2005.02.044
   Shen HC, 2014, CLIN INTERV AGING, V9, P501, DOI 10.2147/CIA.S59538
   Sliz E, 2018, HUM MOL GENET, V27, P2214, DOI 10.1093/hmg/ddy124
   Suliman I, 2019, CLIN LIVER DIS, V23, P433, DOI 10.1016/j.cld.2019.05.001
   Umano GR, 2018, AM J GASTROENTEROL, V113, P376, DOI 10.1038/ajg.2018.1
   Vilar-Gomez E, 2015, GASTROENTEROLOGY, V149, P367, DOI 10.1053/j.gastro.2015.04.005
   Wang CC, 2008, J GASTROEN HEPATOL, V23, P779, DOI 10.1111/j.1440-1746.2007.05216.x
   Wang CC, 2020, ALIMENT PHARM THER, V51, P216, DOI 10.1111/apt.15575
   Wong VWS, 2018, J GASTROEN HEPATOL, V33, P70, DOI 10.1111/jgh.13857
   Wong VWS, 2012, J HEPATOL, V56, P533, DOI 10.1016/j.jhep.2011.09.013
   Wu KT, 2016, J CLIN LIPIDOL, V10, P420, DOI 10.1016/j.jacl.2015.12.026
   Xiong JP, 2017, ONCOTARGET, V8, P107295, DOI 10.18632/oncotarget.22364
   Younossi Z, 2018, NAT REV GASTRO HEPAT, V15, P11, DOI 10.1038/nrgastro.2017.109
   Younossi ZM, 2018, HEPATOLOGY, V68, P349, DOI 10.1002/hep.29721
   Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431
   Yu MW, 2017, GASTROENTEROLOGY, V153, P1006, DOI 10.1053/j.gastro.2017.07.001
   Yu MW, 2008, J CLIN ONCOL, V26, P5576, DOI 10.1200/JCO.2008.16.1075
NR 35
TC 12
Z9 12
U1 0
U2 2
PU ELSEVIER TAIWAN
PI TAIPEI
PA RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2,
   TAIPEI, 10449, TAIWAN
SN 0929-6646
EI 1876-0821
J9 J FORMOS MED ASSOC
JI J. Formos. Med. Assoc.
PD OCT
PY 2020
VL 119
IS 10
BP 1476
EP 1482
DI 10.1016/j.jfma.2020.05.027
PG 7
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA NW1HK
UT WOS:000574758100003
PM 32499209
OA gold
DA 2024-02-19
ER

PT J
AU Jung, KO
   Park, SY
   Park, KY
AF Jung, KO
   Park, SY
   Park, KY
TI Longer aging time increases the anticancer and antimetastatic properties
   of <i>doenjang</i>
SO NUTRITION
LA English
DT Article
DE doenjang; sarcoma-180 cells; natural killer cells; glutathione
   S-transferase; metastasis
ID IN-VITRO ANGIOGENESIS; PROTEASE INHIBITOR; CARCINOMA-CELLS; G2/M ARREST;
   CYCLIN B1; GENISTEIN; INDUCTION; GROWTH; P21; PRODUCTS
AB Objective: Fermented soy foods, such as doenjang, are important components of the Korean diet. Doenjang has been shown to have greater antimutagenic and anticancer activities than other fermented soybean foods such as chungkukjang (Korean-style natto) and miso and non-fermented soybeans. This study investigated the effects of fermentation time of doenjang on its inhibitory activity against solid tumor formation and lung metastasis.
   Methods: Effects of methanol extracts from doenjang prepared with long-term fermentation on tumor formation, natural killer cell activity in spleen, and glutathione S-transferase activity in liver were investigated in sarcoma-180 cell-transplanted mice. Inhibitory effects of these samples on lung metastasis of colon 26-M3.1 cells were also evaluated in Balb/c mice. To determine the effect of aging on functionality, doenjang fermented for 3, 6, and 24 mo were evaluated.
   Results: Doenjang fermented for 24 mo exhibited a two- to three-fold increase in antitumor effects on sarcoma-180-injected mice and antimetastatic effects in colon 26-M 3.1 cells in mice compared with the 3- or 6-mo fermented doenjang. The 24-mo fermentation was the most effective in preventing cancer by decreasing tumor formation and increasing natural killer cell activity in spleens and glutathione S-transferase activity in livers of mice.
   Conclusions: Prolonging the fermentation period when making doenjang increases its antitumor and antimetastatic effects in vivo. (C) 2006 Elsevier Inc. All rights reserved.
C1 Pusan Natl Univ, Dept Food Sci & Nutr, Pusan, South Korea.
C3 Pusan National University
RP Park, KY (corresponding author), Pusan Natl Univ, Dept Food Sci & Nutr, Pusan, South Korea.
EM kunypark@pusan.ac.kr
CR BILLINGS PC, 1990, CARCINOGENESIS, V11, P1083, DOI 10.1093/carcin/11.7.1083
   Cai QY, 1996, NUTR CANCER, V25, P1, DOI 10.1080/01635589609514423
   CHOI Y.H., 1998, J KOREAN CANC ASS, V30, P800
   Choi YH, 1998, INT J ONCOL, V13, P391
   Choi YH, 2000, JPN J CANCER RES, V91, P164, DOI 10.1111/j.1349-7006.2000.tb00928.x
   Choi YH, 2001, ONCOL REP, V8, P1091
   Chuyen NV, 1998, ADV EXP MED BIOL, V434, P201
   ERICKSON KL, 1989, J NUTR, V119, P1311, DOI 10.1093/jn/119.9.1311
   FOTSIS T, 1995, J NUTR, V125, pS790, DOI 10.1093/jn/125.suppl_3.790S
   FOTSIS T, 1993, P NATL ACAD SCI USA, V90, P2690, DOI 10.1073/pnas.90.7.2690
   Fukutake M, 1996, FOOD CHEM TOXICOL, V34, P457, DOI 10.1016/0278-6915(96)87355-8
   HABIG WH, 1976, ARCH BIOCHEM BIOPHYS, V175, P710, DOI 10.1016/0003-9861(76)90563-4
   Hondo S., 1989, J BREW SOC J JAPAN, V84, P594
   HONG SJ, 2000, P INT S SOYB HUM HLT, P13
   HWANG KM, 2004, THESIS PUSAN NATL U
   JEONG JH, 1993, KOREAN J IMMUNOL, V15, P53
   Kamei H, 1997, CANCER BIOTHER RADIO, V12, P341, DOI 10.1089/cbr.1997.12.341
   Kim J.S., 1999, KOREAN J FOOD SCI TE, V31, P1405
   Kim K. H., 1993, Journal of the Korean Society for Microbiology, V28, P239
   Kim M.K., 1999, J FOOD SCI NUTR, V4, P260
   Lee E, 2002, CLIN INFECT DIS, V34, P365, DOI 10.1086/338149
   LIM SY, 1997, THESIS PUSAN NATL U
   Liu C, 2000, Wei Sheng Yan Jiu, V29, P178
   Llor X, 2003, CLIN NUTR, V22, P71, DOI 10.1054/clnu.2002.0627
   Onozawa M, 1998, JPN J CLIN ONCOL, V28, P360, DOI 10.1093/jjco/28.6.360
   Park K., 2005, ASIAN FUNCTIONAL FOO, P555, DOI [10.1201/9781420028119.ch20, DOI 10.1201/9781420028119.CH20]
   Park K. Y., 1990, Journal of the Korean Society of Food and Nutrition, V19, P156
   Park K. Y., 2000, J FOOD SCI NUTR, V5, P114
   Park KY, 2003, MUTAT RES-FUND MOL M, V523, P43, DOI 10.1016/S0027-5107(02)00320-2
   PARK KY, 1988, J FOOD PROTECT, V51, P938, DOI 10.4315/0362-028X-51.12.938
   Park S. K., 2000, J KOREAN SOC FOOD SC, V29, P211
   PARK SY, 2003, THESIS PUSAN NATL U
   POWRIE WD, 1986, ENVIRON HEALTH PERSP, V67, P47, DOI 10.2307/3430317
   Rauth S, 1997, BRIT J CANCER, V75, P1559, DOI 10.1038/bjc.1997.268
   RHEW TH, 1992, J KOREAN CANC ASS, V24, P493
   SEEL RGD, 1980, PRINCIPLES PROCEDURE, P187
   STEELE VE, 1995, J NUTR, V125, pS713, DOI 10.1093/jn/125.3_Suppl.713S
   SUNG MK, 2000, P INT S SOYB HUM HLT, P47
   WHITAKER JR, 1978, FOOD TECHNOL-CHICAGO, V32, P175
   WITSCHI H, 1989, CARCINOGENESIS, V10, P2275, DOI 10.1093/carcin/10.12.2275
   YAGOOB P, 1994, IMMUNOL LETT, V41, P241
   Yoon TK, 1998, INT J IMMUNOPHARMACO, V20, P163, DOI 10.1016/S0192-0561(98)00024-1
   2003, 65 DOENJANG DISHES G, P10
NR 43
TC 106
Z9 113
U1 2
U2 15
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0899-9007
EI 1873-1244
J9 NUTRITION
JI Nutrition
PD MAY
PY 2006
VL 22
IS 5
BP 539
EP 545
DI 10.1016/j.nut.2005.11.007
PG 7
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 036AQ
UT WOS:000237043500013
PM 16504476
DA 2024-02-19
ER

PT J
AU Kemmer, N
   Safdar, K
   Kaiser, TE
   Zacharias, V
   Neff, GW
AF Kemmer, Nyingi
   Safdar, Kamran
   Kaiser, Tiffany E.
   Zacharias, Victoria
   Neff, Guy W.
TI Liver transplantation trends for older recipients: Regional and ethnic
   variations
SO TRANSPLANTATION
LA English
DT Article
DE liver transplantation; age; ethnicity
ID UNITED-STATES; SURVIVAL; AGE; SEPTUAGENARIANS; DATABASE; OUTCOMES;
   DISEASE
AB Background. Liver transplantation (LT) provides long-term survival for adults with end-stage liver disease. As a result of improved survival and an aging United States population the demand for LT in older patients is expected to increase. The aim of this study was to describe the transplantation trends in the older recipient (older than 65 years).
   Methods. Using the United Network for Organ Sharing database, we identified LT recipients between 1990 and 2006. We used Kaplan-Meier method to calculate overall survival (1, 3, 5 and 10 years) and Cox regression for predictors of survival.
   Results. During the study period 5630 (7.6%) LT recipients were older than 65 years. There were 4256 (79.4%) whites, Hispanic (10.3%), African Americans (AA) (3.6%), and rest (6.7%). There was an increase in LT for older than 65 years from 4.1% in 1990 to 10.2% in 2006 (P=0.002) and a regional variation (P<0.001). The 10-year patient and graft survival was 60% and 57% for less than 65 years versus 42% and 40% for more than 65 years (P<0.0001). With age stratification (65-75 years vs. >75 years), there was no difference in survival but when adjusted for race there was a significant difference in graft survival with a 10 year (white 40%, Hispanic 44%, and AA 19%) (P=0.04).
   Conclusion. The demand for LT in recipients older than 65 years is increasing. Although their survival is lower in comparison with recipients less than 65 years, there seems to be no difference in unadjusted survival with age stratification above 65 years. Among ethnic minorities, there was a disproportionately lower percentage of African Americans LT and a decreased survival.
C1 [Kemmer, Nyingi; Safdar, Kamran; Kaiser, Tiffany E.; Zacharias, Victoria; Neff, Guy W.] Univ Cincinnati, Cincinnati, OH 45267 USA.
   [Kemmer, Nyingi] Cincinnati VA Med Ctr, Dept Internal Med, Div Digest Dis, Cincinnati, OH USA.
C3 University System of Ohio; University of Cincinnati; US Department of
   Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA
   Medical Center
RP Kemmer, N (corresponding author), Univ Cincinnati, 231 Albert Sabin Way,MSB Room 6363, Cincinnati, OH 45267 USA.
EM Nyingi.Kemmer@uc.edu
CR Angulo P, 2006, LIVER TRANSPLANT, V12, P523, DOI 10.1002/lt.20738
   Burke A, 2004, AM J TRANSPLANT, V4, P686, DOI 10.1111/j.1600-6143.2004.00432.x
   Clark JM, 2003, AM J GASTROENTEROL, V98, P960, DOI [10.1016/S0002-9270(03)00265-X, 10.1111/j.1572-0241.2003.07486.x]
   Cross TJS, 2007, LIVER TRANSPLANT, V13, P1382, DOI 10.1002/lt.21181
   Forni A, 2007, TRANSPL P, V39, P1963, DOI 10.1016/j.transproceed.2007.05.068
   Garcia CE, 2001, TRANSPLANTATION, V72, P679, DOI 10.1097/00007890-200108270-00021
   Geronimus AT, 1996, NEW ENGL J MED, V335, P1552, DOI 10.1056/NEJM199611213352102
   Herrero JI, 2003, AM J TRANSPLANT, V3, P1407, DOI 10.1046/j.1600-6143.2003.00227.x
   Lipshutz GS, 2007, ARCH SURG-CHICAGO, V142, P775, DOI 10.1001/archsurg.142.8.775
   Nair S, 2002, LANCET, V359, P287, DOI 10.1016/S0140-6736(02)07494-9
   Neff GW, 2007, TRANSPL P, V39, P3204, DOI 10.1016/j.transproceed.2007.09.031
   Nwakanma LU, 2007, J THORAC CARDIOV SUR, V133, P541, DOI 10.1016/j.jtcvs.2006.09.062
   Safdar K, 2004, TRANSPLANT P, V36, P1445, DOI 10.1016/j.transproceed.2004.04.086
   Zetterman RK, 1998, TRANSPLANTATION, V66, P500, DOI 10.1097/00007890-199808270-00015
NR 14
TC 23
Z9 23
U1 0
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0041-1337
J9 TRANSPLANTATION
JI Transplantation
PD JUL 15
PY 2008
VL 86
IS 1
BP 104
EP 107
DI 10.1097/TP.0b013e318176b4c1
PG 4
WC Immunology; Surgery; Transplantation
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology; Surgery; Transplantation
GA 328IA
UT WOS:000257790400018
PM 18622285
DA 2024-02-19
ER

PT J
AU Ohishi, W
   Kitamoto, M
   Aikata, H
   Kamada, K
   Kawakami, Y
   Ishihara, H
   Kamiyasu, M
   Nakanishi, T
   Tazuma, S
   Chayama, K
AF Ohishi, W
   Kitamoto, M
   Aikata, H
   Kamada, K
   Kawakami, Y
   Ishihara, H
   Kamiyasu, M
   Nakanishi, T
   Tazuma, S
   Chayama, K
TI Impact of aging on the development of hepatocellular carcinoma in
   patients with hepatitis C virus infection in Japan
SO SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
LA English
DT Article
DE age; alcohol consumption; atomic bomb explosions; blood transfusion;
   hepatitis C virus (HCV); hepatocellular carcinoma (HCC)
ID TERM-FOLLOW-UP; ALANINE AMINOTRANSFERASE LEVELS; LIVER FIBROSIS
   PROGRESSION; NON-A; NON-B; CIRCULATING ANTIBODIES; ITALIAN PATIENTS;
   RISK-FACTORS; POSTTRANSFUSION; PREVALENCE
AB Background: It is difficult to study the long-term outcome of hepatitis C virus (HCV) infection because chronic infection is often asymptomatic and duration of the disease is prolonged. The clinical outcome of HCV infection remains unclear in patients of advanced age. Methods: Among 575 patients consecutively diagnosed with hepatocellular carcinoma (HCC) from 1988 to 1999 at Hiroshima University, we examined 430 with HCV. We studied the differences between males and females in the following characteristics: age at first diagnosis of HCC, Child grade, various tumour factors, history of blood transfusion, duration to development of HCC, and history of alcohol intake. Results: The incidence of HCC patients with HCV increased in elderly persons, including female patients. Background liver function was significantly better for female patients ( P < 0.001). In both genders, the duration between blood transfusion and diagnosis of HCC was significantly shorter when the patients received blood transfusion at an older age ( P < 0.001). In habitual drinkers, the average age at first diagnosis of HCC was significantly younger ( P < 0.001), and duration to development of HCC significantly shorter ( P < 0.05). The percentage of atomic bomb survivors among HCV-positive HCC patients was significantly higher than that among HCV-negative HCC patients ( P < 0.05). Conclusions: Patients with HCV might exhibit slow disease progression and develop HCC finally with aging regardless of gender. Patients of advanced age with HCV, even female patients, should therefore be closely followed.
C1 Hiroshima Univ, Dept Med & Mol Sci, Div Frontier Med Sci, Programs Biomed Res,Grad Sch Biomed Sci,Minami Ku, Hiroshima 7348551, Japan.
C3 Hiroshima University
RP Ohishi, W (corresponding author), Hiroshima Univ, Dept Med & Mol Sci, Div Frontier Med Sci, Programs Biomed Res,Grad Sch Biomed Sci,Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.
EM Waka-O@sings.jp
RI Chayama, Kazuaki/B-2493-2016
OI Chayama, Kazuaki/0000-0002-5530-5341
CR Aizawa Y, 2000, CANCER, V89, P53, DOI 10.1002/1097-0142(20000701)89:1<53::AID-CNCR8>3.3.CO;2-Y
   Benhamou Y, 1999, HEPATOLOGY, V30, P1054, DOI 10.1002/hep.510300409
   Benson D, 1996, MUTAT RES-FUND MOL M, V356, P209, DOI 10.1016/0027-5107(96)00057-7
   BOSCH FX, 1997, LIVER CANCER, P13
   BRUIX J, 1989, LANCET, V2, P1004
   CAPORASO N, 1991, J HEPATOL, V12, P367, DOI 10.1016/0168-8278(91)90841-X
   CHILD CG, 1964, MAJOR PROBLEMS CLIN, P50
   CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562
   COLOMBO M, 1992, J HEPATOL, V15, P225, DOI 10.1016/0168-8278(92)90041-M
   COLOMBO M, 1989, LANCET, V2, P1006
   Degos F, 2000, GUT, V47, P131, DOI 10.1136/gut.47.1.131
   Desenclos J C, 2000, Rev Prat, V50, P1066
   Deuffic S, 1998, LANCET, V351, P214, DOI 10.1016/S0140-6736(05)78179-4
   DIBISCEGLIE AM, 1991, HEPATOLOGY, V14, P969, DOI 10.1016/0270-9139(91)90113-A
   El-Serag HB, 1999, NEW ENGL J MED, V340, P745, DOI 10.1056/NEJM199903113401001
   Freeman AJ, 2001, HEPATOLOGY, V34, P809, DOI 10.1053/jhep.2001.27831
   Friedman Scott L., 1999, American Journal of Medicine, V107, p27S
   García-Samaniego J, 2001, AM J GASTROENTEROL, V96, P179, DOI 10.1111/j.1572-0241.2001.03374.x
   Hamada H, 2002, CANCER, V95, P331, DOI 10.1002/cncr.10662
   HARUNA Y, 1994, CANCER, V73, P2253, DOI 10.1002/1097-0142(19940501)73:9<2253::AID-CNCR2820730904>3.0.CO;2-9
   HASAN F, 1990, HEPATOLOGY, V12, P589, DOI 10.1002/hep.1840120323
   HOPF U, 1990, J HEPATOL, V10, P69, DOI 10.1016/0168-8278(90)90075-3
   IKEDA K, 1993, HEPATOLOGY, V18, P47, DOI 10.1016/0270-9139(93)90505-H
   *JAP SOC HEP, 1999, TREND HEP VIR CARR, P23
   KEW MC, 1990, LANCET, V335, P873, DOI 10.1016/0140-6736(90)90474-J
   KIYOSAWA K, 1990, HEPATOLOGY, V12, P671, DOI 10.1002/hep.1840120409
   KOBAYASHI S, 1994, CANCER, V73, P48, DOI 10.1002/1097-0142(19940101)73:1<48::AID-CNCR2820730110>3.0.CO;2-L
   KORETZ RL, 1993, ANN INTERN MED, V119, P110, DOI 10.7326/0003-4819-119-2-199307150-00003
   KUO G, 1989, SCIENCE, V244, P362, DOI 10.1126/science.2496467
   KUSUMI S, 1995, SEROEPIDEMIOLOGICAL, P17
   Lemon SM, 1999, HCV AND RELATED LIVER DISEASES, P1
   LIANG TJ, 1993, HEPATOLOGY, V18, P1326, DOI 10.1016/0270-9139(93)90219-D
   *LIV CANC STUD GRO, 2000, ACTA HEPATOL JAP, V41, P799
   Liver Cancer Study Group of Japan, 1990, Ann Surg, V211, P277
   Moriya T, 1999, INTERVIROLOGY, V42, P153, DOI 10.1159/000024974
   NISHIOKA K, 1991, CANCER, V67, P429, DOI 10.1002/1097-0142(19910115)67:2<429::AID-CNCR2820670218>3.0.CO;2-#
   OKUDA K, 1997, LIVER CANC, P39
   Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8
   SAITO I, 1990, P NATL ACAD SCI USA, V87, P6547, DOI 10.1073/pnas.87.17.6547
   SBOLLI G, 1990, J MED VIROL, V30, P230, DOI 10.1002/jmv.1890300316
   Seeff Leonard B., 1999, American Journal of Medicine, V107, p10S
   Sobin LH, 1997, TNM CLASSIFICATION M
   TANAKA J, 1997, JAPAN J PUBLIC HLTH, V44, P788
   TANAKA K, 1991, CANCER RES, V51, P2842
   Tang ZY, 2000, J GASTROEN HEPATOL, V15, pG1, DOI 10.1046/j.1440-1746.2000.02257.x
   Tarao K, 1999, CANCER, V86, P589, DOI 10.1002/(SICI)1097-0142(19990815)86:4<589::AID-CNCR7>3.0.CO;2-K
   Tarao K, 2002, CANCER-AM CANCER SOC, V94, P1787, DOI 10.1002/cncr.10391
   TaylorRobinson SD, 1997, LANCET, V350, P1142, DOI 10.1016/S0140-6736(05)63789-0
   TONG MJ, 1995, NEW ENGL J MED, V332, P1463, DOI 10.1056/NEJM199506013322202
   TREMOLADA F, 1992, J HEPATOL, V16, P273, DOI 10.1016/S0168-8278(05)80657-9
   TSUKUMA H, 1993, NEW ENGL J MED, V328, P1797, DOI 10.1056/NEJM199306243282501
   VARGAS V, 1990, ANN INTERN MED, V112, P967, DOI 10.7326/0003-4819-112-12-967_2
   *WHO, 1997, WKLY EPIDEMIOL REC, V72, P341
   WILLIAMS I, 1999, AM J MED, V107, pS2, DOI DOI 10.1016/S0002-9343(99)00373-3
   Yano M, 1996, HEPATOLOGY, V23, P1334, DOI 10.1053/jhep.1996.v23.pm0008675148
   YANO M, 1993, GUT, V34, pS13, DOI 10.1136/gut.34.2_Suppl.S13
   Yano M, 1995, Nihon Rinsho, V53 Suppl, P346
   YU MC, 1990, JNCI-J NATL CANCER I, V82, P1038, DOI 10.1093/jnci/82.12.1038
NR 58
TC 32
Z9 33
U1 0
U2 0
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0036-5521
EI 1502-7708
J9 SCAND J GASTROENTERO
JI Scand. J. Gastroenterol.
PD AUG
PY 2003
VL 38
IS 8
BP 894
EP 900
DI 10.1080/00365520310004434
PG 7
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 707CA
UT WOS:000184490800016
PM 12940445
DA 2024-02-19
ER

PT J
AU Nah, EH
   Shin, SK
   Cho, S
   Park, H
   Kim, S
   Kwon, E
   Cho, HI
AF Nah, Eun-Hee
   Shin, Sug Kyun
   Cho, Seon
   Park, Hyeran
   Kim, Suyoung
   Kwon, Eunjoo
   Cho, Han-Ik
TI Chronic kidney disease in nonalcoholic fatty liver disease at primary
   healthcare centers in Korea
SO PLOS ONE
LA English
DT Article
ID FIBROSIS; IMPAIRMENT; BIOPSY; IMPACT; NAFLD
AB Background The prevalence rates of nonalcoholic fatty liver disease (NAFLD) and chronic kidney disease (CKD) are expected to increase with the rising trends in diabetes and obesity associated with aging populations. Considering the impacts of coexistent NAFLD and CKD on morbidity and mortality rates, screening strategies for groups at high-risk of CKD are needed in community-dwelling individuals with NAFLD. The aims of this study were to determine the prevalence and distribution of CKD in NAFLD, as well as the risk factors for CKD and the correlation with liver fibrosis in asymptomatic individuals with NAFLD at primary healthcare centers in Korea.
   Methods This retrospective cross-sectional study used data from 13 health-promotion centers in 10 Korean cities. Liver steatosis and stiffness were assessed using ultrasonography and magnetic resonance elastography (MRE), respectively. CKD was defined as an estimated glomerular filtration rate of <60 mL/min/1.73m(2), and urine albumin-to-creatinine ratio or proteinuria. CKD was categorized into four stages: no CKD, mild, moderate, and severe. Comparisons according to the CKD stages in NAFLD were performed using Student's t-test or the chi-square test. Multivariable logistic regression analyses were performed to identify the risk factors for CKD and the correlation with liver fibrosis in NAFLD.
   Results The prevalence of CKD was 12.4% in NAFLD. Albuminuria (16.2%) and proteinuria (8.0%) were more prevalent in NAFLD. NAFLD (odd ratio = 1.27, 95% CI = 1.09-1.48, P = 0.003) was independently associated with CKD of at least mild stage. However, there was no significant association between CKD of at least moderate stage and NAFLD after adjusting for age and a metabolically unhealthy status. CKD was associated with significant liver fibrosis as measured by MRE in NAFLD.
   Conclusion The presence of NAFLD and liver fibrosis were independent risk factors for CKD, but NAFLD was not an independent risk factor for the later stages of CKD.
C1 [Nah, Eun-Hee; Cho, Seon; Park, Hyeran; Kim, Suyoung; Kwon, Eunjoo] Korea Assoc Hlth Promot, Hlth Promot Res Inst, Seoul, South Korea.
   [Shin, Sug Kyun] Ilsan Hosp, Natl Hlth Insurance Serv, Dept Internal Med, Goyang, South Korea.
   [Cho, Han-Ik] Korea Assoc Hlth Promot, MEDlcheck Lab, Seoul, South Korea.
C3 NHIS Ilsan Hospital; National Health Insurance Service
RP Nah, EH (corresponding author), Korea Assoc Hlth Promot, Hlth Promot Res Inst, Seoul, South Korea.
EM cellonah@hanmail.net
CR Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644
   Arase Y, 2011, INTERNAL MED, V50, P1081, DOI 10.2169/internalmedicine.50.5043
   Byrne CD, 2020, J HEPATOL, V72, P785, DOI 10.1016/j.jhep.2020.01.013
   Chang Y, 2008, METABOLISM, V57, P569, DOI 10.1016/j.metabol.2007.11.022
   Chen J, 2011, RADIOLOGY, V259, P749, DOI 10.1148/radiol.11101942
   Couser WG, 2011, KIDNEY INT, V80, P1258, DOI 10.1038/ki.2011.368
   Eckardt KU, 2013, LANCET, V382, P158, DOI 10.1016/S0140-6736(13)60439-0
   Ekstedt M, 2015, HEPATOLOGY, V61, P1547, DOI 10.1002/hep.27368
   Fazel Y, 2016, METABOLISM, V65, P1017, DOI 10.1016/j.metabol.2016.01.012
   Foreman KJ, 2018, LANCET, V392, P2052, DOI [10.1016/S0140-6736(18)31694-5, 10.1016/s0140-6736(18)31694-5]
   Francque SM, 2016, J HEPATOL, V65, P425, DOI 10.1016/j.jhep.2016.04.005
   Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031
   Hwang ST, 2010, INTERN MED J, V40, P437, DOI 10.1111/j.1445-5994.2009.01979.x
   KDIGO, 2013, Kidney Int, V3, P1, DOI DOI 10.1038/KISUP.2012.73
   Lamb EJ, 2005, ANN CLIN BIOCHEM, V42, P321, DOI 10.1258/0004563054889936
   Le MH, 2019, HEPATOL COMMUN, V3, P1334, DOI 10.1002/hep4.1408
   Li GL, 2012, BIOCHEM MEDICA, V22, P92
   Loomba R, 2014, HEPATOLOGY, V60, P1920, DOI 10.1002/hep.27362
   Mantovani A, 2022, GUT, V71, P156, DOI 10.1136/gutjnl-2020-323082
   Mima A, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-22636-9
   Mima A, 2021, ADV THER, V38, P2201, DOI 10.1007/s12325-021-01735-5
   Mima A, 2018, J DIABETES COMPLICAT, V32, P720, DOI 10.1016/j.jdiacomp.2018.04.011
   Musso G, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001680
   Paik J, 2019, LIVER INT, V39, P342, DOI 10.1111/liv.13992
   Park CW, 2011, CLIN TRANSPLANT, V25, pE606, DOI 10.1111/j.1399-0012.2011.01497.x
   Rockey DC, 2006, HEPATOLOGY, V43, pS113, DOI 10.1002/hep.21046
   Saadeh S, 2002, GASTROENTEROLOGY, V123, P745, DOI 10.1053/gast.2002.35354
   Sirota JC, 2012, AM J NEPHROL, V36, P466, DOI 10.1159/000343885
   Targher G, 2017, NAT REV NEPHROL, V13, P297, DOI 10.1038/nrneph.2017.16
   Targher G, 2014, AM J KIDNEY DIS, V64, P638, DOI 10.1053/j.ajkd.2014.05.019
   Vallet-Pichard A, 2007, HEPATOLOGY, V46, P32, DOI 10.1002/hep.21669
   Vilar-Gomez E, 2017, ALIMENT PHARM THER, V45, P332, DOI 10.1111/apt.13860
   Wang L, 2019, ACAD RADIOL, V26, P863, DOI 10.1016/j.acra.2018.08.019
   Wattacheril J, 2020, GASTROENTEROL CLIN N, V49, P141, DOI 10.1016/j.gtc.2019.10.002
   Yasui K, 2011, METABOLISM, V60, P735, DOI 10.1016/j.metabol.2010.07.022
   Yin M, 2007, CLIN GASTROENTEROL H, V5, P1207, DOI 10.1016/j.cgh.2007.06.012
   Zhang M, 2020, BMC GASTROENTEROL, V20, DOI 10.1186/s12876-020-01278-z
NR 37
TC 1
Z9 1
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 20
PY 2022
VL 17
IS 12
AR e0279367
DI 10.1371/journal.pone.0279367
PG 12
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 8O4HN
UT WOS:000925796700035
PM 36538567
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Boylston, WH
   Gerstner, A
   DeFord, JH
   Madsen, M
   Flurkey, K
   Harrison, DE
   Papaconstantinou, J
AF Boylston, WH
   Gerstner, A
   DeFord, JH
   Madsen, M
   Flurkey, K
   Harrison, DE
   Papaconstantinou, J
TI Altered cholesterologenic and lipogenic transcriptional profile in
   livers of aging Snell dwarf (<i>Pit1<SUP>dw/dwJ</SUP></i>) mice
SO AGING CELL
LA English
DT Article
DE cholesterol metabolism; lipid homeostasis; longevity; Snell dwarf;
   sterol regulatory element binding proteins (SREBPs)
ID ACTIVATED RECEPTOR-GAMMA; GENE-EXPRESSION PROFILE; FATTY-ACID SYNTHESIS;
   CALORIC RESTRICTION; LIFE-SPAN; TRANSGENIC MICE; MITOCHONDRIAL-FUNCTION;
   MICROARRAY ANALYSIS; INSULIN-RECEPTOR; PPAR-GAMMA
AB Several murine models demonstrate that mammalian longevity can be increased by single gene mutations affecting endocrine signalling, particularly via the GH/IGF-1 axis. In this study, we identify age-independent patterns of hepatic gene expression characteristic of long-lived Snell (Pit1(dw/dwJ))dwarf mice. Comparative microarray analysis of young and aged male livers was performed to discover specific genes differentially expressed between Pit1(dw/dwJ) and control mice. Further examination by real-time RT-PCR confirmed that transcripts encoding HMG-CoA synthase-1, HMG-CoA reductase, farnesyl diphosphate synthase, isopentenyl pyrophosphate isomerase, mevalonate decarboxylase, squalene epoxidase, lanosterol demethylase, malic enzyme and apolipoprotein A-IV were significantly decreased in both male and female Pit1(dw/dwJ) livers at 3-5 and 24-28 months of age. In contrast, transcripts encoding the beta(3)-adrenergic receptor, lipoprotein lipase, PPARgamma and a very low-density lipoprotein receptor homologue were increased significantly in dwarf livers relative to age-matched controls. These studies reveal enduring transcriptional changes characteristic of Pit1(dw/dwJ) dwarf mice that involve genes regulating cholesterol biosynthesis, fatty acid metabolism and lipoprotein homeostasis. Linked to global energy metabolism, this stable shift in hepatic gene expression may contribute to longevity determination by influencing particular metabolic functions often compartmentalized within the mitochondrion and peroxisome; further this metabolic shift may also parallel many transcriptional changes induced by caloric restriction.
C1 Univ Texas, Med Branch, Dept Human Biol Chem & Genet, Galveston, TX 77555 USA.
   Jackson Lab, Bar Harbor, ME 04609 USA.
C3 University of Texas System; University of Texas Medical Branch
   Galveston; Jackson Laboratory
RP Papaconstantinou, J (corresponding author), Univ Texas, Med Branch, Dept Human Biol Chem & Genet, Galveston, TX 77555 USA.
EM jpapacon@utmb.edu
RI Papaconstantinou, John/E-3312-2010
FU NIA NIH HHS [P02 AG16622, AG17231, P30 AG024832] Funding Source: Medline
CR *AFF, 1908, AFF MICR SUIT US GUI
   Affymetrix, 2002, GENECHIP EXPR AN DAT
   Aigaki T, 2002, MECH AGEING DEV, V123, P1531, DOI 10.1016/S0047-6374(02)00089-1
   Akiyama TE, 2002, MOL CELL BIOL, V22, P2607, DOI 10.1128/MCB.22.8.2607-2619.2002
   Anisimov S V, 2003, Adv Gerontol, V11, P67
   Bentinger M, 2003, J MOL BIOL, V326, P795, DOI 10.1016/S0022-2836(02)01447-X
   Blüher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223
   Bramnert M, 2003, J CLIN ENDOCR METAB, V88, P1455, DOI 10.1210/jc.2002-020542
   Cao SX, 2001, P NATL ACAD SCI USA, V98, P10630, DOI 10.1073/pnas.191313598
   Casas F, 2000, FEBS LETT, V478, P4, DOI 10.1016/S0014-5793(00)01814-7
   Clancy DJ, 2002, SCIENCE, V296, P319, DOI 10.1126/science.1069366
   Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991
   Coschigano KT, 2000, ENDOCRINOLOGY, V141, P2608, DOI 10.1210/en.141.7.2608
   Coschigano KT, 2003, ENDOCRINOLOGY, V144, P3799, DOI 10.1210/en.2003-0374
   Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780
   Dowell P, 2003, J BIOL CHEM, V278, P45485, DOI 10.1074/jbc.M309069200
   Dozmorov I, 2002, J GERONTOL A-BIOL, V57, pB99, DOI 10.1093/gerona/57.3.B99
   Dozmorov I, 2001, J GERONTOL A-BIOL, V56, pB72, DOI 10.1093/gerona/56.2.B72
   Engelking LJ, 2004, J CLIN INVEST, V113, P1168, DOI 10.1172/JCI200420978
   Flurkey K, 2001, P NATL ACAD SCI USA, V98, P6736, DOI 10.1073/pnas.111158898
   Foufelle F, 2002, BIOCHEM J, V366, P377, DOI 10.1042/BJ20020430
   Frick F, 2001, AM J PHYSIOL-ENDOC M, V281, pE1230, DOI 10.1152/ajpendo.2001.281.6.E1230
   Furuyama T, 2002, MICROSC RES TECHNIQ, V59, P331, DOI 10.1002/jemt.10213
   Gems D, 2003, NATURE, V424, P259, DOI 10.1038/424259a
   Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700
   Hekimi S, 2003, SCIENCE, V299, P1351, DOI 10.1126/science.1082358
   Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298
   Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593
   Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961
   Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100
   Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089
   Johnson FB, 1999, CELL, V96, P291, DOI 10.1016/S0092-8674(00)80567-X
   Kayo T, 2001, P NATL ACAD SCI USA, V98, P5093, DOI 10.1073/pnas.081061898
   Knauf F, 2002, P NATL ACAD SCI USA, V99, P14315, DOI 10.1073/pnas.222531899
   Laffitte BA, 2003, P NATL ACAD SCI USA, V100, P5419, DOI 10.1073/pnas.0830671100
   Larsen PL, 2002, SCIENCE, V295, P120, DOI 10.1126/science.1064653
   Lee CH, 2003, ENDOCRINOLOGY, V144, P2201, DOI 10.1210/en.2003-0288
   Lee CK, 2002, P NATL ACAD SCI USA, V99, P14988, DOI 10.1073/pnas.232308999
   Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4
   Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056
   Liang GS, 2002, J BIOL CHEM, V277, P9520, DOI 10.1074/jbc.M111421200
   LIN J, 2003, J BIOL CHEM, V278, P30484
   Lin SS, 2001, J BIOL CHEM, V276, P36000, DOI 10.1074/jbc.M103509200
   Liu GY, 2003, NUCLEIC ACIDS RES, V31, P82, DOI 10.1093/nar/gkg121
   Longo VD, 2003, SCIENCE, V299, P1342, DOI 10.1126/science.1077991
   Lu TT, 2001, J BIOL CHEM, V276, P37735, DOI 10.1074/jbc.R100035200
   Matsuda M, 2001, GENE DEV, V15, P1206, DOI 10.1101/gad.891301
   Matsusue K, 2003, J CLIN INVEST, V111, P737, DOI 10.1172/JCI200317223
   Maxwell KN, 2003, J LIPID RES, V44, P2109, DOI 10.1194/jlr.M300203-JLR200
   Merry BJ, 2002, INT J BIOCHEM CELL B, V34, P1340, DOI 10.1016/S1357-2725(02)00038-9
   Miller RA, 2002, MOL ENDOCRINOL, V16, P2657, DOI 10.1210/me.2002-0142
   Murakami S, 2003, FASEB J, V17, P1565, DOI 10.1096/fj.02-1092fje
   Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789
   Olsson B, 2003, AM J PHYSIOL-ENDOC M, V285, pE504, DOI 10.1152/ajpendo.00444.2002
   Parks JS, 1999, J CLIN ENDOCR METAB, V84, P4362, DOI 10.1210/jc.84.12.4362
   Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Pletcher SD, 2002, CURR BIOL, V12, P712, DOI 10.1016/S0960-9822(02)00808-4
   Preiss-Landl K, 2002, CURR OPIN LIPIDOL, V13, P471, DOI 10.1097/00041433-200210000-00002
   Prolla TA, 2002, CHEM SENSES, V27, P299, DOI 10.1093/chemse/27.3.299
   Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100
   Rogina B, 2002, SCIENCE, V298, P1745, DOI 10.1126/science.1078986
   Roth GS, 2002, SCIENCE, V297, P811, DOI 10.1126/science.1071851
   SEO J, 2004, BIOINFORMATICS  0429
   Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656
   Shin DJ, 2003, J BIOL CHEM, V278, P34114, DOI 10.1074/jbc.M305417200
   Sreekumar R, 2002, AM J PHYSIOL-ENDOC M, V283, pE38, DOI 10.1152/ajpendo.00387.2001
   Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447
   Tobin KAR, 2002, J BIOL CHEM, V277, P10691, DOI 10.1074/jbc.M109771200
   Tollet-Egnell P, 2001, MOL ENDOCRINOL, V15, P308, DOI 10.1210/me.15.2.308
   Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498
   Van Voorhies WA, 2002, AGING CELL, V1, P91, DOI 10.1046/j.1474-9728.2002.00022.x
   Van Voorhies WA, 2002, FREE RADICAL BIO MED, V33, P587
   Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034
   Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1
   Weindruch R, 2001, J NUTR, V131, p918S, DOI 10.1093/jn/131.3.918S
NR 76
TC 32
Z9 35
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
EI 1474-9726
J9 AGING CELL
JI Aging Cell
PD OCT
PY 2004
VL 3
IS 5
BP 283
EP 296
DI 10.1111/j.1474-9728.2004.00115.x
PG 14
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 860FO
UT WOS:000224328100008
PM 15379852
OA hybrid
DA 2024-02-19
ER

PT J
AU Öngel, ME
   Yildiz, C
   Baser, O
   Yilmaz, B
   Özilgen, M
AF ongel, Melek Ece
   Yildiz, Cennet
   Baser, Oezge
   Yilmaz, Bayram
   ozilgen, Mustafa
TI Thermodynamic Assessment of the Effects of Intermittent Fasting and
   Fatty Liver Disease Diets on Longevity
SO ENTROPY
LA English
DT Article
DE intermittent fasting; diet therapy; non-alcoholic fatty liver disease;
   Child-Pugh Score; entropic age; metabolic lifespan entropy generation;
   longevity; second law of thermodynamics
ID LIFE-SPAN ENTROPY; HUMAN-BODY; CALORIC RESTRICTION; INSULIN-RESISTANCE;
   EXERGY ANALYSIS; GENERATION; INVOLVEMENT; METABOLISM; NUTRITION;
   CIRRHOSIS
AB Organisms uptake energy from their diet and maintain a highly organized structure by importing energy and exporting entropy. A fraction of the generated entropy is accumulated in their bodies, thus causing ageing. Hayflick's entropic age concept suggests that the lifespan of organisms is determined by the amount of entropy they generate. Organisms die after reaching their lifespan entropy generation limit. On the basis of the lifespan entropy generation concept, this study suggests that an intermittent fasting diet, which means skipping some meals without increasing the calories uptake in the other courses, may increase longevity. More than 1.32 million people died in 2017 because of chronic liver diseases, and a quarter of the world's population has non-alcoholic fatty liver disease. There are no specific dietary guidelines available for the treatment of non-alcoholic fatty liver diseases but shifting to a healthier diet is recommended as the primary treatment. A healthy obese person may generate 119.9 kJ/kg K per year of entropy and generate a total of 4796 kJ/kg K entropy in the first 40 years of life. If obese persons continue to consume the same diet, they may have 94 years of life expectancy. After age 40, Child-Pugh Score A, B, and C NAFLD patients may generate 126.2, 149.9, and 272.5 kJ/kg K year of entropy and have 92, 84, and 64 years of life expectancy, respectively. If they were to make a major recommended shift in their diet, the life expectancy of Child-Pugh Score A, B, and C patients may increase by 29, 32, and 43 years, respectively.
C1 [ongel, Melek Ece; Baser, Oezge; Yilmaz, Bayram] Yeditepe Univ, Fac Med, Dept Physiol, Kayisdagi, TR-34755 Istanbul, Turkiye.
   [Yildiz, Cennet; ozilgen, Mustafa] Yeditepe Univ, Dept Food Engn, Kayisdagi, Atasehir, TR-34755 Istanbul, Turkiye.
C3 Yeditepe University; Yeditepe University
RP Yilmaz, B (corresponding author), Yeditepe Univ, Fac Med, Dept Physiol, Kayisdagi, TR-34755 Istanbul, Turkiye.; Özilgen, M (corresponding author), Yeditepe Univ, Dept Food Engn, Kayisdagi, Atasehir, TR-34755 Istanbul, Turkiye.
EM byilmaz@yeditepe.edu.tr; mozilgen@yeditepe.edu.tr
RI Yildiz, Cennet/JXL-4770-2024; Yilmaz, Bayram/IXD-3395-2023
OI Yildiz, Cennet/0000-0002-5902-3608; Yilmaz, Bayram/0000-0002-2674-6535
CR AHA, 2021, SAT FAT
   ANDERSEN T, 1991, J HEPATOL, V12, P224, DOI 10.1016/0168-8278(91)90942-5
   Annamalai K, 2021, SYSTEMS-BASEL, V9, DOI 10.3390/systems9030054
   Annamalai K, 2012, ENTROPY-SWITZ, V14, P2550, DOI 10.3390/e14122550
   [Anonymous], 2020, DIET GUID AM 2020 20
   AOKI I, 1994, AGE, V17, P29, DOI 10.1007/BF02435047
   Asrih M, 2014, CLIN NUTR, V33, P186, DOI 10.1016/j.clnu.2013.11.003
   Aydin M, 2010, CELL BIOCHEM FUNCT, V28, P293, DOI 10.1002/cbf.1656
   Beard DA, 2005, AM J PHYSIOL-ENDOC M, V288, pE633, DOI 10.1152/ajpendo.00239.2004
   Bisschop PH, 2001, AM J CLIN NUTR, V73, P554
   Caliskan H, 2013, ENERG CONVERS MANAGE, V76, P169, DOI 10.1016/j.enconman.2013.07.045
   Canpolat S, 2010, J PHYSIOL BIOCHEM, V66, P23, DOI 10.1007/s13105-010-0008-8
   Çatak J, 2015, INT J EXERGY, V18, P46, DOI 10.1504/IJEX.2015.072056
   Cortez-Pinto H, 2006, CLIN NUTR, V25, P816, DOI 10.1016/j.clnu.2006.01.027
   Cotter TG, 2020, GASTROENTEROLOGY, V158, P1851, DOI 10.1053/j.gastro.2020.01.052
   Davidson HIM, 1999, HEPATOLOGY, V29, P1380, DOI 10.1002/hep.510290531
   de Cabo R, 2019, NEW ENGL J MED, V381, P2541, DOI 10.1056/NEJMra1905136
   Disley E., 2016, Evaluation of the Offender Liaison and Diversion Trial Schemes
   Durand F, 2005, J HEPATOL, V42, pS100, DOI 10.1016/j.jhep.2004.11.015
   Eslam M, 2020, J HEPATOL, V73, P202, DOI 10.1016/j.jhep.2020.03.039
   European Assoc Study Liver, 2019, J HEPATOL, V70, P172, DOI 10.1016/j.jhep.2018.06.024
   Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280
   Feher J, 2012, ACAD PR SER BIOM ENG, P1
   Fine Eugene J, 2004, Nutr Metab (Lond), V1, P15, DOI 10.1186/1743-7075-1-15
   Fisher FM, 2016, ANNU REV PHYSIOL, V78, P223, DOI 10.1146/annurev-physiol-021115-105339
   GOODRICK CL, 1982, GERONTOLOGY, V28, P233, DOI 10.1159/000212538
   Hanje A James, 2006, Nutr Clin Pract, V21, P255, DOI 10.1177/0115426506021003255
   Harris JA, 1918, P NATL ACAD SCI USA, V4, P370, DOI 10.1073/pnas.4.12.370
   Hayflick L, 2007, ANN NY ACAD SCI, V1100, P1, DOI 10.1196/annals.1395.001
   HERSHEY D, 1987, SYST RES, V4, P269, DOI 10.1002/sres.3850040406
   Jornayvaz FR, 2010, AM J PHYSIOL-ENDOC M, V299, pE808, DOI 10.1152/ajpendo.00361.2010
   Kalaitzakis E, 2007, AM J CLIN NUTR, V85, P808, DOI 10.1093/ajcn/85.3.808
   Kayali D, 2022, INT J THERMODYN, V25, P64, DOI 10.5541/ijot.1108911
   Mady CEK, 2014, INT J HEAT MASS TRAN, V77, P577, DOI 10.1016/j.ijheatmasstransfer.2014.05.039
   Kim BH, 2021, ENDOCRINOL METAB, V36, P745
   Kitada M, 2021, NAT REV ENDOCRINOL, V17, P647, DOI 10.1038/s41574-021-00551-9
   Koyuncu S, 2021, NATURE, V596, P285, DOI 10.1038/s41586-021-03781-z
   Kuddusi L, 2015, ENERGY, V80, P227, DOI 10.1016/j.energy.2014.11.065
   Kutlu S, 2004, NEUROENDOCRINOLOGY, V79, P197, DOI 10.1159/000078101
   Levy JR, 2004, HEPATOLOGY, V39, P608, DOI 10.1002/hep.20093
   Mattison JA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14063
   Mete F, 2012, INDIAN J MED RES, V135, P233
   Molliet DS, 2021, CASE STUD THERM ENG, V25, DOI 10.1016/j.csite.2021.100972
   Montano-Loza AJ, 2016, J CACHEXIA SARCOPENI, V7, P126, DOI 10.1002/jcsm.12039
   Morrow M, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b557
   Musso G, 2003, HEPATOLOGY, V37, P909, DOI 10.1053/jhep.2003.50132
   National Institutes of Health, 1998, OBES RES S2, V6, p51S, DOI DOI 10.1002/J.1550-8528.1998.TB00690.X
   Öngel ME, 2021, INT J EXERGY, V34, P411, DOI 10.1504/IJEX.2021.114091
   Öngel ME, 2021, CLIN NUTR, V40, P1186, DOI 10.1016/j.clnu.2020.07.030
   Ouyang X, 2008, J HEPATOL, V48, P993, DOI 10.1016/j.jhep.2008.02.011
   Patterson RE, 2017, ANNU REV NUTR, V37, P371, DOI 10.1146/annurev-nutr-071816-064634
   Pinter M, 2016, ESMO OPEN, V1, DOI 10.1136/esmoopen-2016-000042
   Plauth M, 2006, CLIN NUTR, V25, P285, DOI 10.1016/j.clnu.2006.01.018
   Ravussin E, 2016, MOLEC NUTRITION, P677, DOI 10.1016/B978-0-12-801816-3.00048-0
   SCHNEEWEISS B, 1990, HEPATOLOGY, V11, P387, DOI 10.1002/hep.1840110309
   Semerciöz AS, 2020, BRIT J NUTR, V124, P742, DOI 10.1017/S0007114520001646
   Sepanlou SG, 2020, LANCET GASTROENTEROL, V5, P245, DOI 10.1016/S2468-1253(19)30349-8
   Silva C.A., 2009, J. Thermodyn, V2009, P1, DOI [10.1155/2009/186723, DOI 10.1155/2009/186723]
   Silva C, 2008, ENTROPY-SWITZ, V10, P100, DOI 10.3390/entropy-e10020100
   Sinclair DA, 2005, MECH AGEING DEV, V126, P987, DOI 10.1016/j.mad.2005.03.019
   Teiusanu Adriana, 2012, Maedica (Bucur), V7, P284
   Tsoris A., 2021, STATPEARLS
   Ulu G, 2022, INT J THERMODYN, V25, P45, DOI 10.5541/ijot.1145655
   Ulu G, 2021, ENERGY STORAGE, V3, DOI 10.1002/est2.253
   Willcox BJ, 2007, ANN NY ACAD SCI, V1114, P434, DOI 10.1196/annals.1396.037
   Yang L, 2016, CELL REP, V14, P422, DOI 10.1016/j.celrep.2015.12.042
   Yildiz C, 2022, INT J EXERGY, V37, P87, DOI 10.1504/IJEX.2022.120110
   Yildiz Cennet, 2021, J Nutr Sci, V10, pe83, DOI 10.1017/jns.2021.78
   Yildiz C, 2021, INT J EXERGY, V34, P179, DOI 10.1504/IJEX.2021.113004
   Yildiz C, 2020, INT J EXERGY, V33, P444, DOI 10.1504/IJEX.2020.111691
   Yildiz C, 2020, INT J EXERGY, V31, P287, DOI 10.1504/IJEX.2020.106457
   Yilmaz B, 1996, BIOGENIC AMINES, V12, P423
   Zelber-Sagil S, 2007, J HEPATOL, V47, P711, DOI 10.1016/j.jhep.2007.06.020
   Zivkovic AM, 2007, AM J CLIN NUTR, V86, P285, DOI 10.1093/ajcn/86.2.285
NR 74
TC 0
Z9 0
U1 4
U2 6
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1099-4300
J9 ENTROPY-SWITZ
JI Entropy
PD FEB
PY 2023
VL 25
IS 2
AR 227
DI 10.3390/e25020227
PG 15
WC Physics, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physics
GA 9H8SL
UT WOS:000939095500001
PM 36832594
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Svensson, J
   Sjögren, K
   Fäldt, J
   Andersson, N
   Isaksson, O
   Jansson, JO
   Ohlsson, C
AF Svensson, Johan
   Sjogren, Klara
   Faldt, Jenny
   Andersson, Niklas
   Isaksson, Olle
   Jansson, John-Olov
   Ohlsson, Claes
TI Liver-Derived IGF-I Regulates Mean Life Span in Mice
SO PLOS ONE
LA English
DT Article
ID GROWTH-FACTOR-I; INSULIN-RECEPTOR; OXIDATIVE STRESS; DWARF MICE;
   LONGEVITY; LONG; GENE; HORMONE; MUTANT; EXTENSION
AB Background: Transgenic mice with low levels of global insulin-like growth factor-I (IGF-I) throughout their life span, including pre- and postnatal development, have increased longevity. This study investigated whether specific deficiency of liver-derived, endocrine IGF-I is of importance for life span.
   Methods and Findings: Serum IGF-I was reduced by approximately 80% in mice with adult, liver-specific IGF-I inactivation (LI-IGF-I-/- mice), and body weight decreased due to reduced body fat. The mean life span of LI-IGF-I-/- mice (n = 84) increased 10% vs. control mice (n = 137) (Cox's test, p<0.01), mainly due to increased life span (16%) of female mice [LI-IGF-I-/- mice (n = 31): 26.7 +/- 1.1 vs. control (n = 67): 23.0 +/- 0.7 months, p<0.001]. Male LI-IGF-I-/- mice showed only a tendency for increased longevity (p = 0.10). Energy expenditure, measured as oxygen consumption during and after submaximal exercise, was increased in the LI-IGF-I-/- mice. Moreover, microarray and RT-PCR analyses showed consistent regulation of three genes (heat shock protein 1A and 1B and connective tissue growth factor) in several body organs in the LI-IGF-I-/- mice.
   Conclusions: Adult inactivation of liver-derived, endocrine IGF-I resulted in moderately increased mean life span. Body weight and body fat decreased in LI-IGF-I-/- mice, possibly due to increased energy expenditure during exercise. Genes earlier reported to modulate stress response and collagen aging showed consistent regulation, providing mechanisms that could underlie the increased mean life span in the LI-IGF-I-/- mice.
C1 [Svensson, Johan; Sjogren, Klara; Faldt, Jenny; Isaksson, Olle; Ohlsson, Claes] Sahlgrens Univ Hosp, Dept Internal Med, Gothenburg, Sweden.
   [Andersson, Niklas; Jansson, John-Olov] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Gothenburg, Sweden.
   [Andersson, Niklas] Chalmers Univ Technol, Dept Chem & Biol Engn, Food Sci Unit, S-41296 Gothenburg, Sweden.
C3 Sahlgrenska University Hospital; University of Gothenburg; Chalmers
   University of Technology
RP Svensson, J (corresponding author), Sahlgrens Univ Hosp, Dept Internal Med, Gothenburg, Sweden.
EM johan.svensson@medic.gu.se
RI Ohlsson, Claes/AGP-3544-2022; Ohlsson, Claes/HIR-6959-2022
OI Ohlsson, Claes/0000-0002-9633-2805; Ohlsson, Claes/0000-0002-9633-2805;
   Andersson, Niklas/0000-0002-3493-7358; Svensson,
   Johan/0000-0002-4487-6405; Sjogren, Klara/0000-0001-5776-7278
FU Swedish Research Council; Swedish Foundation for Strategic Research;
   ALF/LUA research grant in Gothenburg; Lundberg Foundation; Torsten and
   Ragnar Soderberg's Foundation; Novo Nordisk Foundation; Swedish
   Strategic Foundation [A305:188]; European Union [FP7/2007-2013]
FX This work was supported by grants from the Swedish Research Council, the
   Swedish Foundation for Strategic Research, the ALF/LUA research grant in
   Gothenburg, the Lundberg Foundation, the Torsten and Ragnar Soderberg's
   Foundation, the Novo Nordisk Foundation, Sahlgrenska Center for
   Cardiovascular and Metabolic Research (CMR, no. A305:188), which is
   supported by the Swedish Strategic Foundation, and from the European
   Union Seventh Framework Programme (FP7/2007-2013). The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Avogaro A, 2010, PFLUG ARCH EUR J PHY, V459, P301, DOI 10.1007/s00424-009-0721-8
   Bartke A, 2001, NATURE, V414, P412, DOI 10.1038/35106646
   Berryman DE, 2008, GROWTH HORM IGF RES, V18, P455, DOI 10.1016/j.ghir.2008.05.005
   Blüher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223
   Broughton S, 2009, BIOCHEM J, V418, P1, DOI 10.1042/BJ20082102
   BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0
   Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991
   Conover CA, 2007, AGING CELL, V6, P727, DOI 10.1111/j.1474-9726.2007.00328.x
   Coschigano KT, 2000, ENDOCRINOLOGY, V141, P2608, DOI 10.1210/en.141.7.2608
   Daugaard M, 2007, FEBS LETT, V581, P3702, DOI [10.1016/j.febslet.2007.05.039, 10.1016/j.febsiet.2007.05.039]
   Drake WM, 2001, ENDOCR REV, V22, P425, DOI 10.1210/er.22.4.425
   Fäldt J, 2004, ENDOCRINOLOGY, V145, P2680, DOI 10.1210/en.2003-1319
   Flurkey K, 2001, P NATL ACAD SCI USA, V98, P6736, DOI 10.1073/pnas.111158898
   Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539
   Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221
   Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298
   Kaletsky R, 2010, DIS MODEL MECH, V3, P415, DOI 10.1242/dmm.001040
   Kappeler L, 2008, PLOS BIOL, V6, P2144, DOI 10.1371/journal.pbio.0060254
   Katic M, 2007, AGING CELL, V6, P827, DOI 10.1111/j.1474-9726.2007.00346.x
   Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002
   KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0
   Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942
   KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125
   Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766
   Le Roith D, 2001, ENDOCR REV, V22, P53, DOI 10.1210/er.22.1.53
   Li Q, 2007, REJUV RES, V10, P501, DOI 10.1089/rej.2007.0552
   Lindberg MK, 2006, BONE, V38, P85, DOI 10.1016/j.bone.2005.07.027
   Liu JL, 1998, MOL ENDOCRINOL, V12, P1452, DOI 10.1210/me.12.9.1452
   Maynard SP, 2006, AGING CELL, V5, P89, DOI 10.1111/j.1474-9726.2006.00187.x
   Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311
   Norry FM, 2003, EXP GERONTOL, V38, P673, DOI 10.1016/S0531-5565(03)00057-3
   Ohlsson C, 1998, ENDOCR REV, V19, P55, DOI 10.1210/er.19.1.55
   Ohlsson C, 2009, ENDOCR REV, V30, P494, DOI 10.1210/er.2009-0010
   Panici JA, 2010, FASEB J, V24, P5073, DOI 10.1096/fj.10-163253
   Piriz J, 2011, EXP GERONTOL, V46, P96, DOI 10.1016/j.exger.2010.08.022
   Powers MV, 2007, FEBS LETT, V581, P3758, DOI 10.1016/j.febslet.2007.05.040
   Raffaello A, 2011, BBA-MOL CELL RES, V1813, P260, DOI 10.1016/j.bbamcr.2010.10.007
   Shi-Wen X, 2008, CYTOKINE GROWTH F R, V19, P133, DOI 10.1016/j.cytogfr.2008.01.002
   Sjögren K, 1999, P NATL ACAD SCI USA, V96, P7088, DOI 10.1073/pnas.96.12.7088
   Sjögren K, 2002, J BONE MINER RES, V17, P1977, DOI 10.1359/jbmr.2002.17.11.1977
   Sjögren K, 2001, DIABETES, V50, P1539, DOI 10.2337/diabetes.50.7.1539
   Suh Y, 2008, P NATL ACAD SCI USA, V105, P3438, DOI 10.1073/pnas.0705467105
   Sun L, 2009, J GERONTOL A-BIOL, V64, P711, DOI 10.1093/gerona/glp051
   Svensson J, 2006, J ENDOCRINOL, V189, P617, DOI 10.1677/joe.1.06631
   Svensson J, 2005, AM J PHYSIOL-ENDOC M, V289, pE466, DOI 10.1152/ajpendo.00425.2004
   Svensson J, 2007, J ENDOCRINOL, V193, P359, DOI 10.1677/JOE-07-0024
   Svensson J, 2008, J ENDOCRINOL, V199, P489, DOI 10.1677/JOE-08-0406
   Svensson PA, 2006, ATHEROSCLEROSIS, V185, P32, DOI 10.1016/j.atherosclerosis.2005.05.007
   Swindell WR, 2009, MECH AGEING DEV, V130, P393, DOI 10.1016/j.mad.2009.03.004
   Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987
   Tatar M, 1997, NATURE, V390, P30, DOI 10.1038/36237
   Tivesten Å, 2002, ENDOCRINOLOGY, V143, P4235, DOI 10.1210/en.2002-220524
   Tower J, 2009, TRENDS ENDOCRIN MET, V20, P216, DOI 10.1016/j.tem.2008.12.005
   Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030
   Wallenius K, 2001, ENDOCRINOLOGY, V142, P4762, DOI 10.1210/en.142.11.4762
   Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75
   Wang CX, 2004, MECH AGEING DEV, V125, P629, DOI 10.1016/j.mad.2004.07.003
   Yakar S, 1999, P NATL ACAD SCI USA, V96, P7324, DOI 10.1073/pnas.96.13.7324
   Yakar S, 2001, DIABETES, V50, P1110, DOI 10.2337/diabetes.50.5.1110
   Yakar S, 2009, J BONE MINER RES, V24, P1481, DOI [10.1359/JBMR.090226, 10.1359/jbmr.090226]
   Yuan R, 2009, AGING CELL, V8, P277, DOI 10.1111/j.1474-9726.2009.00478.x
NR 61
TC 43
Z9 51
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 25
PY 2011
VL 6
IS 7
AR e22640
DI 10.1371/journal.pone.0022640
PG 9
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 798AP
UT WOS:000293172900060
PM 21799924
OA Green Published, gold, Green Submitted
DA 2024-02-19
ER

PT J
AU Lampignano, L
   Niro, A
   Castellana, F
   Bortone, I
   Zupo, R
   Tirelli, S
   Tatoli, R
   Griseta, C
   De Nucci, S
   Sila, A
   De Pergola, G
   Conte, C
   Alessio, G
   Boscia, F
   Sborgia, G
   Giannelli, G
   Sardone, R
AF Lampignano, Luisa
   Niro, Alfredo
   Castellana, Fabio
   Bortone, Ilaria
   Zupo, Roberta
   Tirelli, Sarah
   Tatoli, Rossella
   Griseta, Chiara
   De Nucci, Sara
   Sila, Annamaria
   De Pergola, Giovanni
   Conte, Caterina
   Alessio, Giovanni
   Boscia, Francesco
   Sborgia, Giancarlo
   Giannelli, Gianluigi
   Sardone, Rodolfo
CA Eye Clinic Res Grp
TI Liver fibrosis and retinal features in an older Mediterranean
   population: Results from the Salus in Apulia study
SO FRONTIERS IN NEUROSCIENCE
LA English
DT Article
DE liver; fibrosis; retina; older population; aging
ID MICROVASCULAR ABNORMALITIES; ATHEROSCLEROSIS RISK; NEUROVASCULAR UNIT;
   COGNITIVE FUNCTION; EPITHELIAL-CELLS; IN-VIVO; DISEASE; ASSOCIATION;
   AGE; METABOLISM
AB BackgroundAge is a leading contributor to the liver fibrosis rate and a gradual deterioration of optical function, but this association in older populations is still under-explored. The present study aimed to explore the link between vascular and neural retinal characteristics and the risk of liver fibrosis in 731 older adults from the population-based Salus in Apulia study. MethodsRetinal features were obtained using optical coherence tomography (OCT) and OCT-angiography (OCT-A). Liver fibrosis risk was taken as the fibrosis-4 (FIB-4) score. Generalized linear models (logistic regression) were used to estimate the association effect between each unit increase of OCT and OCT-A parameters as independent variables and a FIB-4 >= 2.67 score as an outcome. Generalized additive models were used to assess the non-linear association between OCT-A features and the linear FIB-4 score. ResultsIncreased gangliar cell complex (GCC) thickness was inversely associated with a FIB-4 score above the cut-off in both the raw model (OR: 0.98; 95% CI: 0.96-0.99; SE: 0.01) and after adjustment for age, sex, education, hypertension, diabetes, total cholesterol, and triglycerides (OR: 0.98; 95% CI: 0.97-0.99; SE: 0.01). ConclusionOur findings add to the growing volume of scientific literature demonstrating that liver fibrosis is associated with retinal neurodegeneration. This study raises a number of new questions, including whether OCT-A may be used to track the progression of metabolic abnormalities and define exact thresholds for predicting and classifying liver disease.
C1 [Lampignano, Luisa; Castellana, Fabio; Bortone, Ilaria; Zupo, Roberta; Tirelli, Sarah; Tatoli, Rossella; Griseta, Chiara; De Nucci, Sara; Sila, Annamaria; Sardone, Rodolfo] Res Hosp, Unit Res Methodol & Data Sci Populat Hlth, Salus Apulia Study, Natl Inst Gastroenterol,Ist Ricovero & Cura Caratt, Castellana Grotte, Italy.
   [Niro, Alfredo] Hosp SS Annunziata, Eye Clin, Azienda Sanit Locale ASL Taranto, Taranto, Italy.
   [De Pergola, Giovanni] Res Hosp, Natl Inst Gastroenterol Saverio de Bellis, Unit Geriatr & Internal Med, Bari, Italy.
   [Conte, Caterina] San Raffaele Roma Open Univ, Dept Human Sci & Promot Qual Life, Rome, Italy.
   [Conte, Caterina] IRCCS Multimed, Dept Endocrinol Nutr & Metab Dis, Milan, Italy.
   [Alessio, Giovanni; Boscia, Francesco; Sborgia, Giancarlo] Univ Bari Aldo Moro, Dept Basic Med Sci Neurosci & Sense Organs, Bari, Italy.
   [Giannelli, Gianluigi] Res Hosp, Natl Inst Gastroenterol IRCCS Saverio de Bellis, Sci Direct, Castellana Grotte, Italy.
C3 IRCCS Multimedica; Universita degli Studi di Bari Aldo Moro
RP Sardone, R (corresponding author), Res Hosp, Unit Res Methodol & Data Sci Populat Hlth, Salus Apulia Study, Natl Inst Gastroenterol,Ist Ricovero & Cura Caratt, Castellana Grotte, Italy.
EM rodolfo.sardone@irccsdebellis.it
RI Bortone, Ilaria/HPE-3696-2023; Conte, Caterina/Z-4807-2019
OI Conte, Caterina/0000-0001-7066-5292; Sborgia,
   Giancarlo/0000-0001-7271-0536; Scotti, Giacomo/0000-0002-1904-1262
FU IRCCS
FX The work reported in this publication was granted by the Italian
   Ministry of Health under the Aging Network of Italian Research Hospitals
   (IRCCS).
CR Allon R, 2021, AM J MED, V134, P36, DOI 10.1016/j.amjmed.2020.07.013
   Altamirano-Barrera A, 2017, ANN HEPATOL, V16, P48, DOI 10.5604/16652681.1226814
   Armstrong RA, 2013, OPHTHAL PHYSL OPT, V33, P7, DOI 10.1111/opo.12009
   Baker ML, 2007, STROKE, V38, P2041, DOI 10.1161/STROKEAHA.107.483586
   Beaven SW, 2011, GASTROENTEROLOGY, V140, P1052, DOI 10.1053/j.gastro.2010.11.053
   Bulut M, 2018, BRIT J OPHTHALMOL, V102, P233, DOI 10.1136/bjophthalmol-2017-310476
   Caballería L, 2018, CLIN GASTROENTEROL H, V16, P1138, DOI 10.1016/j.cgh.2017.12.048
   Cai W, 2017, AGEING RES REV, V34, P77, DOI 10.1016/j.arr.2016.09.006
   Cai YL, 2018, P NATL ACAD SCI USA, V115, pE2725, DOI 10.1073/pnas.1800184115
   Cameron JR, 2017, PROG RETIN EYE RES, V59, P131, DOI 10.1016/j.preteyeres.2017.04.003
   Carnovale E., 2022, TABELLE COMPOSIZIONE
   Chalasani N, 2012, AM J GASTROENTEROL, V107, P811, DOI 10.1038/ajg.2012.128
   Cho BJ, 2014, INVEST OPHTH VIS SCI, V55, P4430, DOI 10.1167/iovs.14-14379
   Choi JH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04774-9
   Choudhary M, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.131928
   Claeys W, 2021, JHEP REP, V3, DOI 10.1016/j.jhepr.2021.100352
   Courtney R, 2016, TRENDS ENDOCRIN MET, V27, P404, DOI 10.1016/j.tem.2016.03.018
   Czakó C, 2020, GEROSCIENCE, V42, P1499, DOI 10.1007/s11357-020-00252-7
   Czakó C, 2019, INT J RETINA VITR, V5, DOI 10.1186/s40942-019-0197-4
   Daien V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071089
   Dhillon RS, 2017, MOL CELL ENDOCRINOL, V455, P54, DOI 10.1016/j.mce.2016.12.020
   Ding J, 2008, BRIT J OPHTHALMOL, V92, P1017, DOI 10.1136/bjo.2008.141994
   Farrah TE, 2020, KIDNEY INT, V98, P323, DOI 10.1016/j.kint.2020.01.039
   Farrah TE, 2019, NAT REV CARDIOL, V16, P379, DOI 10.1038/s41569-019-0205-2
   Feng ZY, 2016, ONCOTARGET, V7, P15410, DOI 10.18632/oncotarget.7645
   Ferrington DA, 2017, REDOX BIOL, V13, P255, DOI 10.1016/j.redox.2017.05.015
   Fort PE, 2014, DIABETES, V63, P3077, DOI 10.2337/db14-0235
   Gambato C, 2015, GRAEF ARCH CLIN EXP, V253, P267, DOI 10.1007/s00417-014-2812-2
   Gardner TW, 2017, GRAEF ARCH CLIN EXP, V255, P1, DOI 10.1007/s00417-016-3548-y
   Gifford FJ, 2020, J CLIN MED, V9, DOI 10.3390/jcm9103332
   Hammer SS, 2017, EBIOMEDICINE, V22, P181, DOI 10.1016/j.ebiom.2017.07.008
   Heringa SM, 2013, J CEREBR BLOOD F MET, V33, P983, DOI 10.1038/jcbfm.2013.58
   Higashiura Yukimura, 2022, Eur Heart J Open, V2, poeac030, DOI 10.1093/ehjopen/oeac030
   Josef P, 2013, INT J ENV RES PUB HE, V10, P3409, DOI 10.3390/ijerph10083409
   Kashani AH, 2017, PROG RETIN EYE RES, V60, P66, DOI 10.1016/j.preteyeres.2017.07.002
   Kawasaki R, 2008, BRIT J OPHTHALMOL, V92, P161, DOI 10.1136/bjo.2007.127449
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   Koehler EM, 2016, HEPATOLOGY, V63, P138, DOI 10.1002/hep.27981
   Kubota M, 2016, FREE RADICAL BIO MED, V97, P513, DOI 10.1016/j.freeradbiomed.2016.07.016
   Lampignano L, 2021, FRONT AGING NEUROSCI, V13, DOI 10.3389/fnagi.2021.748888
   Le P, 2021, CURR DIABETES REP, V21, DOI 10.1007/s11892-021-01405-4
   Leoci C., 1983, G ITAL NUTR CLIN PRE, V2, P58
   Lozupone M, 2018, J ALZHEIMERS DIS, V65, P989, DOI 10.3233/JAD-180466
   Marchesini G, 2016, J HEPATOL, V64, P1388, DOI 10.1016/j.jhep.2015.11.004
   McPherson S, 2017, AM J GASTROENTEROL, V112, P740, DOI 10.1038/ajg.2016.453
   McPherson S, 2010, GUT, V59, P1265, DOI 10.1136/gut.2010.216077
   Monteiro-Henriques I, 2022, ACTA OPHTHALMOL, V100, pE1, DOI 10.1111/aos.14851
   Morgan-Warren PJ, 2016, INVEST OPHTH VIS SCI, V57, P429, DOI 10.1167/iovs.15-17511
   Mukherjee C, 2019, THER ADV OPHTHALMOL, V11, DOI 10.1177/2515841419831155
   Mutemberezi V, 2016, PROG LIPID RES, V64, P152, DOI 10.1016/j.plipres.2016.09.002
   Niro A, 2022, J CLIN MED, V11, DOI 10.3390/jcm11041098
   O'Mahony F, 2015, HEPATOLOGY, V62, P615, DOI 10.1002/hep.27645
   Ostovaneh MR, 2018, CIRC-CARDIOVASC IMAG, V11, DOI 10.1161/CIRCIMAGING.117.007241
   Pellegrini M, 2020, J CLIN MED, V9, DOI 10.3390/jcm9061706
   Peng SY, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-71251-z
   Pinhas A, 2020, OCT AND IMAGING IN CENTRAL NERVOUS SYSTEM DISEASES, 2 EDITION, P523, DOI 10.1007/978-3-030-26269-3_24
   Qiao HJ, 2015, ADV APPL PROBAB, V47, P902, DOI 10.1017/S0001867800048886
   Ratziu V, 2010, J HEPATOL, V53, P372, DOI 10.1016/j.jhep.2010.04.008
   Reiter CEN, 2003, AM J PHYSIOL-ENDOC M, V285, pE763, DOI 10.1152/ajpendo.00507.2002
   Rutledge Stephanie M, 2020, Gastroenterol Hepatol (N Y), V16, P617
   Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]
   Schonmann Y, 2021, DIGEST LIVER DIS, V53, P79, DOI 10.1016/j.dld.2020.10.014
   Seo SW, 2016, NEUROLOGY, V86, P1136, DOI 10.1212/WNL.0000000000002498
   Shah AG, 2009, CLIN GASTROENTEROL H, V7, P1104, DOI 10.1016/j.cgh.2009.05.033
   Shahlaee A, 2016, AM J OPHTHALMOL, V161, P50, DOI 10.1016/j.ajo.2015.09.026
   So-Armah KA, 2020, PROG CARDIOVASC DIS, V63, P184, DOI 10.1016/j.pcad.2020.02.010
   Song XY, 2019, P NATL ACAD SCI USA, V116, P16507, DOI 10.1073/pnas.1904719116
   Spaide RF, 2015, JAMA OPHTHALMOL, V133, P45, DOI 10.1001/jamaophthalmol.2014.3616
   Takayama K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33580-y
   Targher G, 2004, DIABETES CARE, V27, P2498, DOI 10.2337/diacare.27.10.2498
   Vadalà M, 2019, GRAEF ARCH CLIN EXP, V257, P1687, DOI 10.1007/s00417-019-04358-3
   Wang HJ, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8121597
   Wang YK, 2018, NEUROBIOL AGING, V71, P223, DOI 10.1016/j.neurobiolaging.2018.07.024
   Whelton Paul K, 2018, J Am Soc Hypertens, V12, DOI [10.1161/HYP.0000000000000065, 10.1016/j.jash.2018.06.010]
   Wong TY, 2002, STROKE, V33, P1487, DOI 10.1161/01.STR.0000016789.56668.43
   Wong TY, 2001, LANCET, V358, P1134, DOI 10.1016/S0140-6736(01)06253-5
   Yang M, 2016, BMC OPHTHALMOL, V16, DOI 10.1186/s12886-016-0361-7
   Yang W, 2015, HEPATOL INT, V9, P278, DOI 10.1007/s12072-015-9607-3
   Zhang JF, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.01009
   Zupo R, 2022, GEROSCIENCE, V44, P835, DOI 10.1007/s11357-021-00434-x
NR 80
TC 1
Z9 1
U1 0
U2 1
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 1662-453X
J9 FRONT NEUROSCI-SWITZ
JI Front. Neurosci.
PD DEC 15
PY 2022
VL 16
AR 1048375
DI 10.3389/fnins.2022.1048375
PG 12
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 7J8ZP
UT WOS:000904874000001
PM 36590297
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Asami, DK
   McDonald, RB
   Hagopian, K
   Horwitz, BA
   Warman, D
   Hsiao, A
   Warden, C
   Ramsey, JJ
AF Asami, Danny K.
   McDonald, Roger B.
   Hagopian, Kevork
   Horwitz, Barbara A.
   Warman, David
   Hsiao, Aileen
   Warden, Craig
   Ramsey, Jon J.
TI Effect of aging, caloric restriction, and uncoupling protein 3 (UCP3) on
   mitochondrial proton leak in mice
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE Aging; Knockout mice; Lipid peroxidation; Mitochondrial oxygen
   consumption; Oxidative stress; Protein carbonyls
ID OXYGEN SPECIES PRODUCTION; HYDROGEN-PEROXIDE PRODUCTION; STANDARD
   METABOLIC-RATE; FATTY-ACID-COMPOSITION; LIVER-MITOCHONDRIA; MEMBRANE;
   TERM; BIOENERGETICS; CONDUCTANCE; GENERATION
AB Mitochondrial proton leak may modulate reactive oxygen species (ROS) production and play a role ill aging. The purpose Of this Study Was to determine proton leak across the life span in skeletal mitochondria from calorie-restricted and UCP2/3 overexpressing mice. Proton leak in isolated mitochondria and markers of oxidative stress in whole tissue were Measured in female C57BL/6J mice fed ad-libitum (WT-Control) or a 30% calorie-restricted (WT-CR) diet, and ill mice overexpressing UCP2 and UCP3 (Positive-TG), their non-overexpressing littermates (Negative-TG) and UCP3 knockout mice (UCP3KO). Proton leak in WT-CR mice was lower than that of control mice at 8 and 26 months of age. The Positive-TG mice had greater proton leak than the Negative-TG and UCP3KO mice at 8 months of age, but this difference disappeared by 19 and 26 months. Lipid peroxidation was generally lower in WT-CR vs. WT-Control mice and UCP3KO mice had greater concentrations of T-BARS (thiobarbituric acid reactive Substances, a measure of lipid peroxidation) than did Positive-TG and Negative-TG. The results of this study indicate that Sustained increases ill muscle mitochondrial proton leak are not responsible for alterations in life span with caloric restriction or UCP3 overexpression in mice. However, UCP3 may contribute to the actions of CR through mechanisms distinct from increasing basal proton leak. (c) 2008 Elsevier Inc. All rights reserved.
C1 [Asami, Danny K.; McDonald, Roger B.; Hsiao, Aileen] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA.
   [Hagopian, Kevork; Ramsey, Jon J.] Univ Calif Davis, Dept Mol Biosci, Davis, CA 95616 USA.
   [Horwitz, Barbara A.; Warman, David] Univ Calif Davis, Sect Neurobiol Physiol & Behav, Davis, CA 95616 USA.
   [Warden, Craig] Univ Calif Davis, Dept Pediat, Davis, CA 95616 USA.
C3 University of California System; University of California Davis;
   University of California System; University of California Davis;
   University of California System; University of California Davis;
   University of California System; University of California Davis
RP McDonald, RB (corresponding author), Univ Calif Davis, Dept Nutr, 1 Shields Ave, Davis, CA 95616 USA.
EM rbmcdonald@ucdavis.edu
FU NIA [AG 19984]
FX The authors wish to thank Keya Walker for her technical assistance in
   the completion of this research. This work was Supported by NIA Grant AG
   19984.
CR AFFOURTIT C, 2007, NOVART FDN SYMP, V287, P80
   Affourtit Charles, 2007, Novartis Found Symp, V287, P70
   Bevilacqua L, 2005, AM J PHYSIOL-ENDOC M, V289, pE429, DOI 10.1152/ajpendo.00435.2004
   Bevilacqua L, 2004, AM J PHYSIOL-ENDOC M, V286, pE852, DOI 10.1152/ajpendo.00367.2003
   BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707
   Brand MD, 2000, EXP GERONTOL, V35, P811, DOI 10.1016/S0531-5565(00)00135-2
   BRAND MD, 1994, BBA-BIOENERGETICS, V1187, P132, DOI 10.1016/0005-2728(94)90099-X
   Brand MD, 1997, J EXP BIOL, V200, P193
   Brand MD, 2005, CELL METAB, V2, P85, DOI 10.1016/j.cmet.2005.06.002
   BRAND MD, 1995, BIOENERGETICS PRACTI, P39
   Brookes Paul S., 1998, Biochemical Society Transactions, V26, pS331
   Brookes PS, 1998, COMP BIOCHEM PHYS B, V119, P325, DOI 10.1016/S0305-0491(97)00357-X
   Brookes PS, 2005, FREE RADICAL BIO MED, V38, P12, DOI 10.1016/j.freeradbiomed.2004.10.016
   Bua EA, 2002, J APPL PHYSIOL, V92, P2617, DOI 10.1152/japplphysiol.01102.2001
   Buege J A, 1978, Methods Enzymol, V52, P302
   Cadenas S, 2002, J BIOL CHEM, V277, P2773, DOI 10.1074/jbc.M109736200
   Dirks AJ, 2006, AGEING RES REV, V5, P179, DOI 10.1016/j.arr.2006.03.002
   Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a
   Esteves TC, 2006, BIOCHEM J, V395, P619, DOI 10.1042/BJ20052004
   Graier WF, 2008, CELL CALCIUM, V44, P36, DOI 10.1016/j.ceca.2008.01.001
   Hagopian K, 2005, AM J PHYSIOL-ENDOC M, V288, pE674, DOI 10.1152/ajpendo.00382.2004
   Hansford RG, 1998, MOL CELL BIOCHEM, V184, P359, DOI 10.1023/A:1006893903113
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Harper ME, 1998, AM J PHYSIOL-ENDOC M, V275, pE197, DOI 10.1152/ajpendo.1998.275.2.E197
   Horvath TL, 2003, INT J OBESITY, V27, P433, DOI 10.1038/sj.ijo.0802257
   Hulbert AJ, 2005, J THEOR BIOL, V234, P277, DOI 10.1016/j.jtbi.2004.11.024
   Jezek P, 2004, PHYSIOL RES, V53, pS199, DOI 10.33549/physiolres.930000.53.S199
   LAGANIERE S, 1993, GERONTOLOGY, V39, P7, DOI 10.1159/000213509
   Lal SB, 2001, J GERONTOL A-BIOL, V56, pB116, DOI 10.1093/gerona/56.3.B116
   Lambert AJ, 2005, J GERONTOL A-BIOL, V60, P175, DOI 10.1093/gerona/60.2.175
   Lambert AJ, 2004, AM J PHYSIOL-REG I, V286, pR71, DOI 10.1152/ajpregu.00341.2003
   MacLellan JD, 2005, DIABETES, V54, P2343, DOI 10.2337/diabetes.54.8.2343
   MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391
   Merry BJ, 2002, INT J BIOCHEM CELL B, V34, P1340, DOI 10.1016/S1357-2725(02)00038-9
   Porter RK, 1996, AM J PHYSIOL-REG I, V271, pR1550, DOI 10.1152/ajpregu.1996.271.6.R1550
   Ramsey JJ, 2004, AM J PHYSIOL-ENDOC M, V286, pE31, DOI 10.1152/ajpendo.00283.2003
   Ramsey JJ, 2000, FREE RADICAL BIO MED, V29, P946, DOI 10.1016/S0891-5849(00)00417-2
   Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731
   ROLFE DFS, 1994, BBA-BIOENERGETICS, V1188, P405, DOI 10.1016/0005-2728(94)90062-0
   Schrauwen P, 2006, PROG LIPID RES, V45, P17, DOI 10.1016/j.plipres.2005.11.001
   Skulachev VP, 1998, BBA-BIOENERGETICS, V1363, P100, DOI 10.1016/S0005-2728(97)00091-1
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   Son C, 2004, DIABETOLOGIA, V47, P47, DOI 10.1007/s00125-003-1272-8
   Speakman JR, 2004, AGING CELL, V3, P87, DOI 10.1111/j.1474-9728.2004.00097.x
   Speakman JR, 2002, J NUTR, V132, p1583S, DOI 10.1093/jn/132.6.1583S
   Trenker M, 2007, NAT CELL BIOL, V9, P445, DOI 10.1038/ncb1556
   Winterbourn CC, 1999, METHOD ENZYMOL, V300, P106
NR 47
TC 32
Z9 39
U1 0
U2 5
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD DEC
PY 2008
VL 43
IS 12
BP 1069
EP 1076
DI 10.1016/j.exger.2008.09.010
PG 8
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 386BY
UT WOS:000261858500006
PM 18852040
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Hui, L
AF Hui, Liu
TI Two Time Point Analysis of the Change in Risk and Aging Factors for
   Major Cancers: A 10-Year Longitudinal Study in China
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID WAIST CIRCUMFERENCE; COLORECTAL-CANCER; DEATH; DISEASE; INDEX; AGES
AB Objective. To quantify the change in risk and aging factors with a two time point analysis for major cancers to assess supportive strategies. Methods. The 2004 and 2015 mortality statistics in China were accessed. The standardized mortality rates of the two periods were used to calculate the ratio of change (RC) value to assess the risk of death associated with time (social development with time) for cancers. The role of age in mortality with time was evaluated by the interaction between time and age using a Poisson regression. Results. In ascending order of RC, the factors were uterus; other malignant neoplasms; esophagus; stomach; skin; liver; leukemia; "lip, oral cavity, and pharynx"; bladder; "colon and rectum"; breast; prostate; lung; ovary; pancreas; "lymphoid, hematopoietic, and related tissue"; and cervix cancers. According to their location on the scatter diagram, the 17 neoplasms could be divided into three groups, comprising undeveloped cancers (including four cancers), developed cancers (including three cancers), and cancers insensitive to social development. Unexpectedly, about 60% (as assessed by type of cancer) and two-thirds (as assessed by constituent ratio of death from all cancers) of cancers did not change with time. Conclusions. Most cancers may be insensitive to social development. Internal factors, including aging, may be a key factor for the occurrence of cancer.
C1 [Hui, Liu] Dalian Med Univ, Dept Clin Immunol, Dalian 116044, Peoples R China.
C3 Dalian Medical University
RP Hui, L (corresponding author), Dalian Med Univ, Dept Clin Immunol, Dalian 116044, Peoples R China.
EM immunology@dmu.edu.cn
FU Special Grant for Scientific and Technological Innovation of Dalian
   [2018J12SN084]
FX This work was supported by the Special Grant for Scientific and
   Technological Innovation of Dalian (2018J12SN084).
CR An WX, 2014, ASIAN PAC J CANCER P, V15, P4125, DOI 10.7314/APJCP.2014.15.10.4125
   Cao TH, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/6232397
   Chan FY, 2012, INT J PUBLIC HEALTH, V57, P849, DOI 10.1007/s00038-012-0400-y
   Chen J, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/568959
   Feng RM, 2019, CANCER COMMUN, V39, DOI 10.1186/s40880-019-0368-6
   Gai LP, 2017, GENE, V605, P123, DOI 10.1016/j.gene.2016.12.031
   Hu N., 2009, NATL DIS MORTALITY S
   Hui L, 2018, BMC GASTROENTEROL, V18, DOI 10.1186/s12876-018-0872-1
   Hui L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08539-0
   Hui L, 2015, ARCH GERONTOL GERIAT, V60, P178, DOI 10.1016/j.archger.2014.11.002
   Hui L, 2015, EPIDEMIOLOGY, V26, pE9, DOI 10.1097/EDE.0000000000000207
   Liang Y, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-71
   Liu H, 2011, BIOMARKERS, V16, P525, DOI 10.3109/1354750X.2011.606505
   Ma L, 2014, EUR J PEDIATR, V173, P787, DOI 10.1007/s00431-013-2250-x
   Renehan AG, 2012, AM J EPIDEMIOL, V176, P1130, DOI 10.1093/aje/kws192
   Sun WP, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0487-z
   Tong FZ, 2012, ONCOL LETT, V3, P517, DOI 10.3892/ol.2011.540
   World Health Organization, 2018, International Statistical Classification of Diseases and Related Health Problems, 10th Revision
   Wu N, 2014, J EPIDEMIOL, V24, P84, DOI 10.2188/jea.JE20120230
   Xi XM, 2016, ASSESSING CHINESE LEARNERS OF ENGLISH: LANGUAGE CONSTRUCTS, CONSEQUENCES AND CONUNDRUMS, P150
   Xin G, 2014, EXP GERONTOL, V60, P83, DOI 10.1016/j.exger.2014.10.005
   Zhang YP, 2013, ENVIRON HEALTH PERSP, V121, P751, DOI 10.1289/ehp.1205983
   Zhao XY, 2013, EXP GERONTOL, V48, P422, DOI 10.1016/j.exger.2013.02.007
   Zhao YL, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1267-8
   Zhou Y, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/6578453
NR 25
TC 1
Z9 1
U1 0
U2 7
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT-UK
JI Biomed Res. Int.
PD MAY 7
PY 2020
VL 2020
AR 9043012
DI 10.1155/2020/9043012
PG 7
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA LT0ZD
UT WOS:000536804000005
PM 32462031
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Pan, XT
   Peng, HW
   Zhang, JC
   Wu, YL
   Hu, ZJ
   Peng, XE
AF Pan, Xinting
   Peng, Hewei
   Zhang, Junchao
   Wu, Yunli
   Hu, Zhijian
   Peng, Xian-E
TI Genetic variants in promoter region of TFR2 is associated with the risk
   of non-alcoholic fatty liver disease in a Chinese Han population: a
   case-control study
SO GASTROENTEROLOGY REPORT
LA English
DT Article
DE NAFLD; transferrin receptor 2; single nucleotide polymorphism;
   gene-environment interaction
ID TRANSFERRIN RECEPTOR 2; IRON-ABSORPTION; METAANALYSIS; PREVALENCE;
   DEFICIENCY
AB Background Iron overload is frequently observed in non-alcoholic fatty liver disease (NAFLD). Transferrin receptor 2 (TFR2) is an important key factor in iron regulation. We aimed to investigate whether TFR2 single nucleotide polymorphisms (SNPs) contribute to susceptibility to NAFLD in a Chinese Han population. Methods Five tag SNPs (rs10247962, rs4434553, rs2075672, rs1052897, and rs3757859) in the TFR2 gene were selected and genotyped in a case-control study on participants who visited two affiliated hospitals of Fujian Medical University between June 2011 and August 2017. Propensity score matching and inverse probability of treatment weighting analyses were used to verify the risk associated with TFR2 SNPs. Results Logistic regression analyses suggested that subjects with the rs4434553 GA or GG genotype had a lower risk of NAFLD than those carrying the AA genotype (odds ratio = 0.630, 95% confidence interval = 0.504-0.788). Moreover, the rs4434553 GA or GG genotype was negatively correlated with body mass index, hepatic steatosis index, and serum ferritin (b = -0.363, P = 0.008; b = -1.040, P = 0.009; b = -35.258, P = 0.015, respectively), and positively associated with serum hepcidin level (b = 35.308, P < 0.001). Moreover, rs10247962 and rs1052897 had multiplicative interactions with age in relation to the risk of NAFLD (P for interactions, 0.041 and 0.034, respectively). The cumulative effects of the rs10247962, rs1052897, and rs4434553 SNPs were positively associated with the risk of NAFLD (adjusted P-trend = 0.012). Conclusions In this Chinese Han population, the rs4434553 polymorphism in TFR2 may be an independent influencing factor associated with the susceptibility to NAFLD. The ageing effect on the development of NAFLD may be inhibited by SNPs rs10247962 and rs1052897.
C1 [Pan, Xinting; Peng, Hewei; Zhang, Junchao; Hu, Zhijian; Peng, Xian-E] Fujian Med Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Fujian Prov Key Lab Environm Factors & Canc, Fuzhou, Peoples R China.
   [Pan, Xinting] Fujian Med Univ, United Innovat Mengchao Hepatobiliary Technol Key, Mengchao Hepatobiliary Hosp, Fuzhou, Peoples R China.
   [Wu, Yunli; Peng, Xian-E] Fujian Med Univ, Key Lab, Minist Educ Gastrointestinal Canc, Fuzhou, Peoples R China.
C3 Fujian Medical University; Fujian Medical University; Fujian Medical
   University
RP Peng, XE (corresponding author), Dept Epidemiol & Hlth Stat, Xuefu North Rd 1st, Fuzhou 350108, Fujian, Peoples R China.
EM fmuxe@163.com
RI hu, zhijian/IVV-5949-2023; zhao, sheng/JWO-6127-2024; li,
   yifang/JVM-8060-2024; cheng, shu/IZE-4788-2023; Zhang,
   Yuting/JZE-2800-2024; li, xiao/HKV-8405-2023; Zhang,
   Yuting/JRW-3937-2023; Zhang, Yihao/JGM-3514-2023
FU National Natural Science Foundation of China [81473047]; Natural Science
   Foundation of Fujian Province [2019J01316]
FX This work was supported by the National Natural Science Foundation of
   China [grant number 81473047] and the Natural Science Foundation of
   Fujian Province [grant number 2019J01316].
CR Auguet T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187065
   Buzzetti E, 2019, LIVER INT, V39, P1325, DOI 10.1111/liv.14096
   Camaschella C, 2000, NAT GENET, V25, P14, DOI 10.1038/75534
   Chalasani N, 2018, HEPATOLOGY, V67, P328, DOI 10.1002/hep.29367
   Datz C, 2017, MINERVA ENDOCRINOL, V42, P173, DOI 10.23736/S0391-1977.16.02565-7
   Drake SF, 2007, AM J PHYSIOL-GASTR L, V292, pG323, DOI 10.1152/ajpgi.00278.2006
   Guo SH, 2020, BIOL TRACE ELEM RES, V196, P590, DOI 10.1007/s12011-019-01956-4
   Kawabata H, 1999, J BIOL CHEM, V274, P20826, DOI 10.1074/jbc.274.30.20826
   Lahelma M, 2021, NUTRIENTS, V13, DOI 10.3390/nu13010169
   Lee JH, 2010, DIGEST LIVER DIS, V42, P503, DOI 10.1016/j.dld.2009.08.002
   Li ZZ, 2014, J GASTROEN HEPATOL, V29, P42, DOI 10.1111/jgh.12428
   Loomba R, 2021, CELL, V184, P2537, DOI 10.1016/j.cell.2021.04.015
   Mitsuyoshi H, 2009, HEPATOL RES, V39, P366, DOI 10.1111/j.1872-034X.2008.00464.x
   Montesion M, 2018, RETROVIROLOGY, V15, DOI 10.1186/s12977-018-0441-2
   Moya D, 2015, CLIN NUTR, V34, P549, DOI 10.1016/j.clnu.2014.06.011
   Niccoli T, 2012, CURR BIOL, V22, pR741, DOI 10.1016/j.cub.2012.07.024
   Pan XT, 2019, ANN NUTR METAB, V74, P207, DOI 10.1159/000497228
   Peng XE, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40449-1
   Peng XE, 2012, GENE, V500, P54, DOI 10.1016/j.gene.2012.03.050
   Prentice AM, 2017, ANN NUTR METAB, V71, P40, DOI 10.1159/000480743
   Richard C, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21249713
   Roetto A, 2018, PHARMACEUTICALS-BASE, V11, DOI 10.3390/ph11040115
   Simino J, 2014, AM J HUM GENET, V95, P24, DOI 10.1016/j.ajhg.2014.05.010
   Tippairote T, 2021, J MOL NEUROSCI, V71, P545, DOI 10.1007/s12031-020-01676-8
   van Dongen J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11115
   Wang K, 2021, PLOS GENET, V17, DOI 10.1371/journal.pgen.1009427
   Wang XT, 2014, HUM GENET, V133, P1467, DOI 10.1007/s00439-014-1483-8
   Wang YW, 2017, INT J HEMATOL, V105, P521, DOI 10.1007/s12185-016-2150-8
   Wortham AM, 2020, J BIOL CHEM, V295, P3906, DOI 10.1074/jbc.RA119.010535
   Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431
   Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P245
   Zusi C, 2019, DIGEST LIVER DIS, V51, P1586, DOI 10.1016/j.dld.2019.05.029
NR 32
TC 4
Z9 4
U1 2
U2 3
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 2052-0034
J9 GASTROENTEROL REP
JI Gastroenterol. Rep.
PD JAN 25
PY 2022
VL 10
AR goac060
DI 10.1093/gastro/goac060
PG 8
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 5X0JQ
UT WOS:000878294300003
PM 36324614
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Kosola, S
   Lampela, H
   Jalanko, H
   Mäkisalo, H
   Lohi, J
   Arola, J
   Pakarinen, MP
AF Kosola, Silja
   Lampela, Hanna
   Jalanko, Hannu
   Makisalo, Heikki
   Lohi, Jouko
   Arola, Johanna
   Pakarinen, Mikko P.
TI Low-dose steroids associated with milder histological changes after
   pediatric liver transplantation
SO LIVER TRANSPLANTATION
LA English
DT Article
ID LONG-TERM SURVIVORS; METABOLIC SYNDROME; GRAFT FIBROSIS; DONOR AGE;
   FOLLOW-UP; RECIPIENTS; ALLOGRAFT; BIOPSIES; HEPATITIS; DISEASE
AB Controversy remains about the role of protocol liver biopsy for symptom-free recipients and about the long-term use of low-dose steroids after pediatric liver transplantation (LT). We conducted a national cross-sectional study of pediatric recipients who underwent LT between 1987 and 2007. Liver biopsy samples were taken from 54 patients (82% of survivors) after a median posttransplant follow-up of 11 years, and they were reviewed by 2 pathologists blinded to the clinical data. Biopsy samples from 18 patients (33%) showed nearly normal histology with no inflammation, fibrosis, or steatosis. Portal inflammation was detected in 14 samples (26%), showed no correlation with anti-nuclear antibodies, and was less frequent in the 35 patients whose immunosuppression included steroids (14% versus 47% of patients not using steroids, P = 0.008). Fibrosis was present in 21 biopsy samples (39%). According to the Metavir classification, 16 were stage 1, 3 were stage 2, and 2 were stage 3. The fibrosis stage correlated negatively with serum prealbumin levels (r = 0.364, P = 0.007) and positively with chronic cholestasis (cytokeratin 7 staining; r = 0.529, P < 0.001) and portal inflammation (r = 0.350, P = 0.01). Microvesicular steatosis was found in 23 biopsy samples (43% of patients in 5%-80% of hepatocytes), and it correlated with the body mass index (r = 0.458, P < 0.001) but not with steroid use. The age of the allograft (donor age plus follow-up time) correlated with higher serum gamma-glutamyltransferase (r = 0.472, P < 0.001) and conjugated bilirubin levels (r = 0.420, P = 0.002) as well as chronic cholestasis (r = 0.299, P = 0.03). The biopsy findings led to treatment changes in 10 patients (19%), whereas only 1 complication (subcapsular hematoma) was encountered. In conclusion, continuing low-dose steroids indefinitely after pediatric LT may have a positive effect on the long-term histological state of the liver graft. Allograft aging may lead to chronic cholestasis and thus contribute to the development of liver fibrosis. Liver Transpl 19:145154, 2013. (c) 2012 AASLD.
C1 [Kosola, Silja; Lampela, Hanna; Jalanko, Hannu; Pakarinen, Mikko P.] Univ Helsinki, Childrens Hosp, Cent Hosp, FI-00029 Helsinki, Finland.
   [Lohi, Jouko; Arola, Johanna] Univ Helsinki, HUSLAB Pathol, Cent Hosp, FI-00029 Helsinki, Finland.
   [Lohi, Jouko; Arola, Johanna] Univ Helsinki, FI-00029 Helsinki, Finland.
C3 University of Helsinki; Helsinki University Central Hospital; University
   of Helsinki; Helsinki University Central Hospital; University of
   Helsinki
RP Kosola, S (corresponding author), Univ Helsinki, Childrens Hosp, Cent Hosp, Room 609,POB 705, FI-00029 Helsinki, Finland.
EM silja.kosola@hus.fi
RI Pakarinen, Mikko/AAD-8834-2019; Lampela, Hanna/O-3619-2014
OI Lampela, Hanna/0000-0001-9619-1099; Kosola, Silja/0000-0002-2881-8299
FU Helsinki University Central Hospital; Finnish Pediatric Research
   Foundation; Finnish Transplantation Society; Sigrid Juselius Foundation;
   Paivikki and Sakari Sohlberg Foundation; Academy of Finland
FX This study was supported by Helsinki University Central Hospital
   (through a grant), the Finnish Pediatric Research Foundation, the
   Finnish Transplantation Society, the Sigrid Juselius Foundation, the
   Paivikki and Sakari Sohlberg Foundation, and the Academy of Finland.
CR Aguilera I, 2011, LIVER TRANSPLANT, V17, P779, DOI 10.1002/lt.22302
   Al-Sinani S, 2009, PEDIATR TRANSPLANT, V13, P160, DOI 10.1111/j.1399-3046.2008.01043.x
   [Anonymous], HEPATOLOGY 1
   Bateman AC, 2010, HISTOPATHOLOGY, V56, P415, DOI 10.1111/j.1365-2559.2009.03391.x
   Bell LE, 2008, AM J TRANSPLANT, V8, P2230, DOI 10.1111/j.1600-6143.2008.02415.x
   Berenguer M, 2002, HEPATOLOGY, V36, P202, DOI 10.1053/jhep.2002.33993
   Berenguer M, 2001, LIVER TRANSPLANT, V7, P790, DOI 10.1053/jlts.2001.23794
   Boström P, 2005, ARTERIOSCL THROM VAS, V25, P1945, DOI 10.1161/01.ATV.0000179676.41064.d4
   Bravo AA, 2001, NEW ENGL J MED, V344, P495, DOI 10.1056/NEJM200102153440706
   Demetris AJ, 2006, HEPATOLOGY, V44, P489, DOI 10.1002/hep.21280
   Desmet VJ, 2011, VIRCHOWS ARCH, V458, P261, DOI 10.1007/s00428-011-1049-2
   Desmet VJ, 2011, VIRCHOWS ARCH, V458, P251, DOI 10.1007/s00428-011-1048-3
   Dumortier J, 2010, AM J GASTROENTEROL, V105, P613, DOI 10.1038/ajg.2009.717
   Ekong UD, 2008, LIVER TRANSPLANT, V14, P1582, DOI 10.1002/lt.21549
   Evans HM, 2006, HEPATOLOGY, V43, P1109, DOI 10.1002/hep.21152
   Fouquet V, 2005, LIVER TRANSPLANT, V11, P152, DOI 10.1002/lt.20358
   Guthery SL, 2003, LIVER TRANSPLANT, V9, P365, DOI 10.1053/jlts.2003.50071
   Herzog D, 2008, LIVER TRANSPLANT, V14, P946, DOI 10.1002/lt.21444
   Hoare M, 2010, J HEPATOL, V53, P950, DOI 10.1016/j.jhep.2010.06.009
   Hoofnagle JH, 1996, HEPATOLOGY, V24, P89, DOI 10.1053/jhep.1996.v24.pm0008707288
   Hübscher S, 2009, LIVER TRANSPLANT, V15, pS19, DOI 10.1002/lt.21902
   Hübscher SG, 2011, J HEPATOL, V55, P702, DOI 10.1016/j.jhep.2011.03.005
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   Kosola S, 2012, AM J TRANSPLANT, V12, P2815, DOI 10.1111/j.1600-6143.2012.04147.x
   Laish I, 2011, LIVER TRANSPLANT, V17, P15, DOI 10.1002/lt.22198
   Martin SR, 2004, PEDIATR TRANSPLANT, V8, P273, DOI 10.1111/j.1399-3046.2004.00152.x
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   McDiarmid SV, 2012, AM J TRANSPLANT, V12, P1367, DOI 10.1111/j.1600-6143.2012.04085.x
   Mells G, 2008, TRANSPLANTATION, V85, P1686, DOI 10.1097/TP.0b013e318176b1fd
   Pagadala M, 2009, LIVER TRANSPLANT, V15, P1662, DOI 10.1002/lt.21952
   Peeters PMJG, 2000, TRANSPLANTATION, V70, P1581, DOI 10.1097/00007890-200012150-00008
   Saari A, 2011, ANN MED, V43, P235, DOI 10.3109/07853890.2010.515603
   Scheenstra R, 2009, HEPATOLOGY, V49, P880, DOI 10.1002/hep.22686
   Sebagh M, 2003, HEPATOLOGY, V37, P1293, DOI 10.1053/jhep.2003.50231
   Shaikh OS, 2007, LIVER TRANSPLANT, V13, P943, DOI 10.1002/lt.21202
   Sieders E, 2002, ANN SURG, V235, P125, DOI 10.1097/00000658-200201000-00016
NR 36
TC 28
Z9 28
U1 0
U2 4
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1527-6465
J9 LIVER TRANSPLANT
JI Liver Transplant.
PD FEB
PY 2013
VL 19
IS 2
BP 145
EP 154
DI 10.1002/lt.23565
PG 10
WC Gastroenterology & Hepatology; Surgery; Transplantation
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology; Surgery; Transplantation
GA 090MH
UT WOS:000314982700005
PM 23109058
OA Bronze
DA 2024-02-19
ER

PT J
AU Zupkovitz, G
   Kabiljo, J
   Kothmayer, M
   Schlick, K
   Schöfer, C
   Lagger, S
   Pusch, O
AF Zupkovitz, Gordin
   Kabiljo, Julijan
   Kothmayer, Michael
   Schlick, Katharina
   Schoefer, Christian
   Lagger, Sabine
   Pusch, Oliver
TI Analysis of Methylation Dynamics Reveals a Tissue-Specific,
   Age-Dependent Decline in 5-Methylcytosine Within the Genome of the
   Vertebrate Aging Model <i>Nothobranchius furzeri</i>
SO FRONTIERS IN MOLECULAR BIOSCIENCES
LA English
DT Article
DE aging; epigenetics; DNA methylation; DNA hydroxymethylation; epigenetic
   aging clock; African turquoise killifish; Nothobranchius furzeri
ID AFRICAN TURQUOISE KILLIFISH; DNA METHYLATION; PROVIDES INSIGHTS;
   BIOLOGICAL AGE; EXPRESSION; 5-HYDROXYMETHYLCYTOSINE; LONGEVITY;
   EVOLUTION; ISLANDS; SYSTEM
AB Erosion of the epigenetic DNA methylation landscape is a widely recognized hallmark of aging. Emerging advances in high throughput sequencing techniques, in particular DNA methylation data analysis, have resulted in the establishment of precise human and murine age prediction tools. In vertebrates, methylation of cytosine at the C5 position of CpG dinucleotides is executed by DNA methyltransferases (DNMTs) whereas the process of enzymatic demethylation is highly dependent on the activity of the ten-eleven translocation methylcytosine dioxygenase (TET) family of enzymes. Here, we report the identification of the key players constituting the DNA methylation machinery in the short-lived teleost aging model Nothobranchius furzeri. We present a comprehensive spatio-temporal expression profile of the methylation-associated enzymes from embryogenesis into late adulthood, thereby covering the complete killifish life cycle. Data mining of the N. furzeri genome produced five dnmt gene family orthologues corresponding to the mammalian DNMTs (DNMT1, 2, 3A, and 3B). Comparable to other teleost species, N. furzeri harbors multiple genomic copies of the de novo DNA methylation subfamily. A related search for the DNMT1 recruitment factor UHRF1 and TET family members resulted in the identification of N. furzeri uhrf1, tet1, tet2, and tet3. Phylogenetic analysis revealed high cross-species similarity on the amino acid level of all individual dnmts, tets, and uhrf1, emphasizing a high degree of functional conservation. During early killifish development all analyzed dnmts and tets showed a similar expression profile characterized by a strong increase in transcript levels after fertilization, peaking either at embryonic day 6 or at the black eye stage of embryonic development. In adult N. furzeri, DNA methylation regulating enzymes showed a ubiquitous tissue distribution. Specifically, we observed an age-dependent downregulation of dnmts, and to some extent uhrf1, which correlated with a significant decrease in global DNA methylation levels in the aging killifish liver and muscle. The age-dependent DNA methylation profile and spatio-temporal expression characteristics of its enzymatic machinery reported here may serve as an essential platform for the identification of an epigenetic aging clock in the new vertebrate model system N. furzeri.
C1 [Zupkovitz, Gordin; Kabiljo, Julijan; Kothmayer, Michael; Schlick, Katharina; Schoefer, Christian; Pusch, Oliver] Med Univ Vienna, Ctr Anat & Cell Biol, Vienna, Austria.
   [Zupkovitz, Gordin] Univ Appl Sci Technikum Wien, Dept Life Sci Engn, Vienna, Austria.
   [Zupkovitz, Gordin] City Vienna Competence Team Aging Tissue, Vienna, Austria.
   [Kabiljo, Julijan] Med Univ Vienna, Comprehens Canc Ctr Vienna, Dept Gen Surg, Vienna, Austria.
   [Lagger, Sabine] Univ Vet Med Vienna, Unit Lab Anim Pathol, Vienna, Austria.
C3 Medical University of Vienna; Medical University of Vienna; University
   of Veterinary Medicine Vienna
RP Pusch, O (corresponding author), Med Univ Vienna, Ctr Anat & Cell Biol, Vienna, Austria.
EM oliver.pusch@meduniwien.ac.at
RI Lagger, Sabine/GQP-6676-2022
OI Kabiljo, Julijan/0000-0002-6778-6648; Pusch, Oliver/0000-0001-7166-2800;
   Zupkovitz, Gordin/0000-0001-8101-4524
FU Austrian Science Fund (FWF)/Herzfelder'sche Familienstiftung [P 34191, P
   30642]; City of Vienna Competence Team Project Aging Tissue (MA23)
   [29-07]
FX This study was funded by the Austrian Science Fund (FWF)/Herzfelder'sche
   Familienstiftung grant P 34191 to OP. Work in the lab of CS was
   supported by the Austrian Science Fund (FWF)/Herzfelder'sche
   Familienstiftung grant P 30642. GZ was supported by the City of Vienna
   Competence Team Project Aging Tissue (MA23, #29-07).
CR Allard JB, 2013, J FISH BIOL, V82, P1733, DOI 10.1111/jfb.12099
   Almeida RD, 2012, EPIGENETICS-US, V7, P383, DOI 10.4161/epi.19375
   Amemiya CT, 2013, NATURE, V496, P311, DOI 10.1038/nature12027
   Berger SL, 2009, GENE DEV, V23, P781, DOI 10.1101/gad.1787609
   BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0
   Bocklandt S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014821
   Bogdanovic O, 2016, NAT GENET, V48, P417, DOI 10.1038/ng.3522
   Booth LN, 2016, MOL CELL, V62, P728, DOI 10.1016/j.molcel.2016.05.013
   Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939
   Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848
   Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886
   Ciccarone F, 2018, MECH AGEING DEV, V174, P3, DOI 10.1016/j.mad.2017.12.002
   Ciccarone F, 2016, AGING CELL, V15, P755, DOI 10.1111/acel.12485
   Di Cicco E, 2011, EXP GERONTOL, V46, P249, DOI 10.1016/j.exger.2010.10.011
   Dolfi L, 2019, EVODEVO, V10, DOI 10.1186/s13227-019-0142-5
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625
   Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107
   Genade T, 2005, AGING CELL, V4, P223, DOI 10.1111/j.1474-9726.2005.00165.x
   Goll MG, 2011, PROG MOL BIOL TRANSL, V101, P193, DOI 10.1016/B978-0-12-387685-0.00005-6
   Goll MG, 2006, SCIENCE, V311, P395, DOI 10.1126/science.1120976
   Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6
   Hannum G, 2013, MOL CELL, V49, P359, DOI 10.1016/j.molcel.2012.10.016
   Harel I, 2015, CELL, V160, P1013, DOI 10.1016/j.cell.2015.01.038
   Hartmann N, 2012, DEV DYNAM, V241, P1133, DOI 10.1002/dvdy.23789
   Hartmann N, 2009, MECH AGEING DEV, V130, P290, DOI 10.1016/j.mad.2009.01.003
   Hontelez S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10148
   Horvath S, 2018, NAT REV GENET, V19, P371, DOI 10.1038/s41576-018-0004-3
   Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115
   Illingworth RS, 2009, FEBS LETT, V583, P1713, DOI 10.1016/j.febslet.2009.04.012
   Jiang L, 2013, CELL, V153, P773, DOI 10.1016/j.cell.2013.04.041
   Jylhävä J, 2017, EBIOMEDICINE, V21, P29, DOI 10.1016/j.ebiom.2017.03.046
   Kabiljo J, 2019, GENE EXPR PATTERNS, V33, P11, DOI 10.1016/j.gep.2019.05.001
   Kim Y, 2016, DIS MODEL MECH, V9, P115, DOI 10.1242/dmm.023226
   Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786
   Lagger S, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006793
   Li PP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10101-7
   Li YP, 2010, EXP GERONTOL, V45, P312, DOI 10.1016/j.exger.2009.12.008
   Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Macleod D, 1999, NAT GENET, V23, P139, DOI 10.1038/13767
   Naumann B, 2018, DEV BIOL, V442, P69, DOI 10.1016/j.ydbio.2018.07.015
   Oliveira AMM, 2012, NAT NEUROSCI, V15, P1111, DOI 10.1038/nn.3151
   Petkovich DA, 2017, CELL METAB, V25, P954, DOI 10.1016/j.cmet.2017.03.016
   Platzer M, 2016, TRENDS GENET, V32, P543, DOI 10.1016/j.tig.2016.06.006
   Polanowski AM, 2014, MOL ECOL RESOUR, V14, P976, DOI 10.1111/1755-0998.12247
   Potok ME, 2013, CELL, V153, P759, DOI 10.1016/j.cell.2013.04.030
   Qian H, 2014, EXP DERMATOL, V23, P357, DOI 10.1111/exd.12375
   Reichwald K, 2015, CELL, V163, P1527, DOI 10.1016/j.cell.2015.10.071
   Schübeler D, 2015, NATURE, V517, P321, DOI 10.1038/nature14192
   Seisenberger S, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0330
   Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397
   Skvortsova K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10895-6
   Smith P, 2017, ELIFE, V6, DOI 10.7554/eLife.27014
   Stubbs TM, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1203-5
   Szulwach KE, 2011, NAT NEUROSCI, V14, P1607, DOI 10.1038/nn.2959
   Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116
   Terzibasi E, 2007, EXP GERONTOL, V42, P81, DOI 10.1016/j.exger.2006.06.039
   Terzibasi E, 2009, AGING CELL, V8, P88, DOI 10.1111/j.1474-9726.2009.00455.x
   Thompson MJ, 2017, AGING-US, V9, P1055, DOI 10.18632/aging.101211
   Valenzano DR, 2006, AGING CELL, V5, P275, DOI 10.1111/j.1474-9726.2006.00212.x
   Valenzano DR, 2015, CELL, V163, P1539, DOI 10.1016/j.cell.2015.11.008
   Valenzano DR, 2011, G3-GENES GENOM GENET, V1, P531, DOI 10.1534/g3.111.001271
   Valenzano DR, 2006, CURR BIOL, V16, P296, DOI 10.1016/j.cub.2005.12.038
   Veenstra GJC, 2001, BBA-GENE STRUCT EXPR, V1521, P39, DOI 10.1016/S0167-4781(01)00280-9
   Wang TN, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1186-2
   Wang XG, 2020, EPIGENETICS-US, V15, P483, DOI 10.1080/15592294.2019.1695341
   Wang XG, 2019, EPIGENETICS-US, V14, P611, DOI 10.1080/15592294.2019.1605816
   Weidner CI, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r24
   Xiao YM, 2008, CELL BIOL TOXICOL, V24, P265, DOI 10.1007/s10565-007-9035-9
   Zupkovitz G, 2018, DEV GENES EVOL, V228, P255, DOI 10.1007/s00427-018-0619-6
   Zupkovitz G, 2018, HISTOCHEM CELL BIOL, V150, P255, DOI 10.1007/s00418-018-1687-4
NR 72
TC 5
Z9 6
U1 4
U2 9
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 2296-889X
J9 FRONT MOL BIOSCI
JI Front. Mol. Biosci.
PD JUN 16
PY 2021
VL 8
AR 627143
DI 10.3389/fmolb.2021.627143
PG 15
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA TB7KW
UT WOS:000668125000001
PM 34222326
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Öztezcan, S
   Kirgiz, B
   Ünlüçerçi, Y
   Dogru-Abbasoglu, S
   Bilge, H
   Uysal, M
   Aykaç-Toker, G
AF Öztezcan, S
   Kirgiz, B
   Ünlüçerçi, Y
   Dogru-Abbasoglu, S
   Bilge, H
   Uysal, M
   Aykaç-Toker, G
TI Heme oxygenase induction protects liver against oxidative stress in
   X-irradiated aged rats
SO BIOGERONTOLOGY
LA English
DT Article
DE aging; heme oxygenase-1; inducible nitric oxide synthase; oxidative
   stress; X-irradiation
ID NITRIC-OXIDE; GENE-EXPRESSION; LIPID-PEROXIDATION; TISSUE; DAMAGE;
   ACTIVATION; INCREASES; PLASMA; SYSTEM
AB We studied the effect of total body X-ray irradiation on the heme oxygenase-1 (HO-1) induction in the livers of young and aged rats. For this purpose, male rats were irradiated with a dose of 17 Gy. The animals were killed 5 h after irradiation. HO-1 protein expression was found to be increased two fold in aged rat liver, but lipid peroxide levels had decreased significantly where no change was observed either in inducible nitric oxide synthase protein expression or in glutathione levels. Contradictory results with respect to HO-1 and lipid peroxidation levels were obtained in the livers of young animals. These results suggest that the additional oxidative stress produced in irradiated rats may be compensated by HO-1 induction as decreased lipid peroxide levels were shown in the livers of aged animals.
C1 Istanbul Univ, Istanbul Fac Med, Dept Biochem, TR-34093 Istanbul, Turkey.
   Istanbul Univ, Inst Oncol, TR-34093 Istanbul, Turkey.
C3 Istanbul University; Istanbul University
RP Istanbul Univ, Istanbul Fac Med, Dept Biochem, TR-34093 Istanbul, Turkey.
EM oztezcan@istanbul.edu.tr
RI Becerir, Hatice Bilge/AAB-9793-2020; Abbasoglu, Semra/AAD-9014-2020
OI Abbasoglu, Semra/0000-0003-3467-9763
CR Agarwal A, 2000, J AM SOC NEPHROL, V11, P965, DOI 10.1681/ASN.V115965
   André M, 2003, FEBS LETT, V546, P223, DOI 10.1016/S0014-5793(03)00576-3
   Barlow C, 1999, P NATL ACAD SCI USA, V96, P9915, DOI 10.1073/pnas.96.17.9915
   BasuModak S, 1996, FREE RADICAL BIO MED, V20, P887, DOI 10.1016/0891-5849(95)02182-5
   Chang SH, 2002, J BIOL CHEM, V277, P1933, DOI 10.1074/jbc.M108921200
   Choi BM, 2003, FREE RADICAL BIO MED, V34, P1136, DOI 10.1016/S0891-5849(03)00064-9
   Datta PK, 2001, RADIAT RES, V155, P734, DOI 10.1667/0033-7587(2001)155[0734:IOHOIR]2.0.CO;2
   DEEV LI, 1985, B EXP BIOL MED+, V99, P729, DOI 10.1007/BF00839254
   DogruAbbasoglu S, 1997, MECH AGEING DEV, V98, P177, DOI 10.1016/S0047-6374(97)00082-1
   Drew B, 2002, ANN NY ACAD SCI, V959, P66, DOI 10.1111/j.1749-6632.2002.tb02084.x
   Galbraith R, 1999, P SOC EXP BIOL MED, V222, P299, DOI 10.1046/j.1525-1373.1999.d01-147.x
   HARMAN D, 1984, AGE, V7, P111, DOI 10.1007/BF02431866
   HIROSE W, 2003, LEGAL MED, V5, P360
   Immenschuh S, 2000, BIOCHEM PHARMACOL, V60, P1121, DOI 10.1016/S0006-2952(00)00443-3
   KEYSE SM, 1989, P NATL ACAD SCI USA, V86, P99, DOI 10.1073/pnas.86.1.99
   Lavrovsky Y, 2000, MECH AGEING DEV, V114, P49, DOI 10.1016/S0047-6374(00)00087-7
   Lin MT, 2003, CLIN NEUROSCI RES, V2, P305, DOI 10.1016/S1566-2772(03)00007-0
   Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517
   Mayoral P, 1999, CLIN SCI, V96, P297, DOI 10.1042/CS19980250
   Motterlini R, 1996, AM J PHYSIOL-HEART C, V270, pH107, DOI 10.1152/ajpheart.1996.270.1.H107
   Mutlu-Türkoglu Ü, 2003, CLIN BIOCHEM, V36, P397, DOI 10.1016/S0009-9120(03)00035-3
   Nakanishi Y, 1997, BIOSCI BIOTECH BIOCH, V61, P1302, DOI 10.1271/bbb.61.1302
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   Pie JE, 2002, MOL CELLS, V13, P399
   Sanz N, 2002, BBA-MOL BASIS DIS, V1587, P12, DOI 10.1016/S0925-4439(02)00048-0
   Sawle P, 2001, FEBS LETT, V508, P403, DOI 10.1016/S0014-5793(01)03117-9
   SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4
   Siles E, 2002, BRAIN RES, V956, P385, DOI 10.1016/S0006-8993(02)03575-8
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   Suzuki K, 2002, J RADIAT RES, V43, P205, DOI 10.1269/jrr.43.205
   Trutic N, 2002, COMP BIOCHEM PHYS C, V133, P461, DOI 10.1016/S1532-0456(02)00174-6
   Umegaki K, 1999, BONE MARROW TRANSPL, V23, P173, DOI 10.1038/sj.bmt.1701531
   UYSAL M, 1989, MECH AGEING DEV, V48, P85, DOI 10.1016/0047-6374(89)90028-6
   van der Loo B, 2003, BIOCHEM BIOPH RES CO, V303, P483, DOI 10.1016/S0006-291X(03)00360-7
   Wang WP, 2001, AM J PHYSIOL-GASTR L, V281, pG586, DOI 10.1152/ajpgi.2001.281.2.G586
NR 35
TC 7
Z9 7
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1389-5729
EI 1573-6768
J9 BIOGERONTOLOGY
JI Biogerontology
PY 2004
VL 5
IS 2
BP 99
EP 105
DI 10.1023/B:BGEN.0000025073.46100.01
PG 7
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 814LU
UT WOS:000220977000004
PM 15105584
DA 2024-02-19
ER

PT J
AU Wu, AML
   Gossa, S
   Samala, R
   Chung, MA
   Gril, B
   Yang, HH
   Thorsheim, HR
   Tran, AD
   Wei, D
   Taner, E
   Isanogle, K
   Yang, Y
   Dolan, EL
   Robinson, C
   Difilippantonio, S
   Lee, MP
   Khan, I
   Smith, QR
   McGavern, DB
   Wakefield, LM
   Steeg, PS
AF Wu, Alex Man Lai
   Gossa, Selamawit
   Samala, Ramakrishna
   Chung, Monika A.
   Gril, Brunilde
   Yang, Howard H.
   Thorsheim, Helen R.
   Tran, Andy D.
   Wei, Debbie
   Taner, Esra
   Isanogle, Kristine
   Yang, Yuan
   Dolan, Emma L.
   Robinson, Christina
   Difilippantonio, Simone
   Lee, Maxwell P.
   Khan, Imran
   Smith, Quentin R.
   McGavern, Dorian B.
   Wakefield, Lalage M.
   Steeg, Patricia S.
TI Aging and CNS Myeloid Cell Depletion Attenuate Breast Cancer Brain
   Metastasis
SO CLINICAL CANCER RESEARCH
LA English
DT Article
ID YOUNG-WOMEN; AGE; PROGNOSIS; ASTROCYTES; EXPRESSION; DIAGNOSIS; RISK
AB Purpose Breast cancer diagnosed in young patients is often aggressive. Because primary breast tumors from young and older patients have similar mutational patterns, we hypothesized that the young host microenvironment promotes more aggressive metastatic disease.
   Experimental Design: Triple-negative or luminal B breast cancer cell lines were injected into young and older mice side-by-side to quantify lung, liver, and brain metastases. Young and older mouse brains, metastatic and naive, were analyzed by flow cytometry. Immune populations were depleted using antibodies or a colonystimulating factor-1 receptor (CSF-1R) inhibitor, and brain metastasis assays were conducted. Effects on myeloid populations, astrogliosis, and the neuroinflammatory response were determined.
   Results: Brain metastases were 2- to 4-fold higher in young as compared with older mouse hosts in four models of triple- negative or luminal B breast cancer; no age effect was observed on liver or lung metastases. Aged brains, naive or metastatic, contained fewer resident CNS myeloid cells. Use of a CSF-1R inhibitor to deplete myeloid cells, including both microglia and infiltrating macrophages, preferentially reduced brain metastasis burden in young mice. Downstream effects of CSF-1R inhibition in young mice resembled that of an aged brain in terms of myeloid numbers, induction of astrogliosis, and Semaphorin 3A secretion within the neuroinflammatory response.
   Conclusions: Host microenvironmental factors contribute to the aggressiveness of triple-negative and luminal B breast cancer brain metastasis. CSF-1R inhibitors may hold promise for young brain metastasis patients.
C1 [Wu, Alex Man Lai; Chung, Monika A.; Gril, Brunilde; Wei, Debbie; Taner, Esra; Dolan, Emma L.; Khan, Imran; Steeg, Patricia S.] NCI, Womens Malignancies Branch, Ctr Canc Res, Bethesda, MD 20892 USA.
   [Gossa, Selamawit; McGavern, Dorian B.] NINDS, Viral Immunol & Intravital Imaging Sect, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.
   [Samala, Ramakrishna; Thorsheim, Helen R.; Smith, Quentin R.] Texas Tech Univ, Hlth Sci Ctr, Sch Pharm, Amarillo, TX USA.
   [Yang, Howard H.; Tran, Andy D.; Yang, Yuan; Lee, Maxwell P.; Wakefield, Lalage M.] NCI, Lab Canc Biol & Genet, Ctr Canc Res, Bethesda, MD 20892 USA.
   [Tran, Andy D.] NCI, CCR Microscopy Core Ctr Canc Res, Bethesda, MD 20892 USA.
   [Isanogle, Kristine; Robinson, Christina; Difilippantonio, Simone] NCI, Lab Anim Sci Program, Frederick Natl Lab Canc Res, Frederick, MD 21701 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Cancer Institute
   (NCI); National Institutes of Health (NIH) - USA; NIH National Institute
   of Neurological Disorders & Stroke (NINDS); Texas Tech University
   System; Texas Tech University Health Science Center; Texas Tech
   University Health Sciences Center Amarillo; National Institutes of
   Health (NIH) - USA; NIH National Cancer Institute (NCI); National
   Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI);
   National Institutes of Health (NIH) - USA; NIH National Cancer Institute
   (NCI); Frederick National Laboratory for Cancer Research
RP Steeg, PS (corresponding author), NCI, Womens Malignancies Branch, NIH, Bethesda, MD 20892 USA.
EM steegp@mail.nih.gov
RI Wakefield, Lalage M/M-1963-2017; McGavern, Dorian/HCH-3601-2022
OI Wakefield, Lalage M/0000-0003-4124-5250; McGavern,
   Dorian/0000-0001-9568-545X; Tran, Andy/0000-0002-2388-7121
FU NIH Intramural Research Program through an NCI FLEX award; Intramural
   program of the NCI; National Institute of Neurological Disorders Stroke;
   U.S. Department of Defense Breast Cancer Research Program [W81
   XWH-062003.3]; NCI, NIH [HHSN261200800001E]; Eunice Kennedy Shriver
   NICHD/NIH [R24HD102061]
FX This research was supported by theNIH Intramural Research Program
   through an NCI FLEX award to P.S. Steeg and L.M. Wakefield and by the
   Intramural program of the NCI, the National Institute of Neurological
   Disorders & Stroke, and the U.S. Department of Defense Breast Cancer
   Research Program, grant no.: W81 XWH-062003.3. This project has been
   funded in whole or in part with Federal funds from the NCI, NIH, under
   contract no. HHSN261200800001E. The content of this publication does not
   necessarily reflect the views or policies of the Department of Health
   and Human Services, nor does mention of trade names, commercial
   products, or organizations imply endorsement by the U.S. Government.
   NCI-Frederick is accredited by AAALAC International and follows the
   Public Health Service Policy for the Care and Use of Laboratory Animals.
   Animal care was provided in accordance with the procedures outlined in
   the "Guide for Care and Use of Laboratory Animals" (National Research
   Council, 2011; National Academy Press, Washington, D.C.). The University
   of Virginia Center for Research in Reproduction Ligand Assay and
   Analysis Core is supported by the Eunice Kennedy Shriver NICHD/NIH Grant
   No. R24HD102061.
CR Anders CK, 2008, J CLIN ONCOL, V26, P3324, DOI 10.1200/JCO.2007.14.2471
   Anders CK, 2011, J CLIN ONCOL, V29, pE18, DOI 10.1200/JCO.2010.28.9199
   Andreou KE, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00251
   Andreou T, 2020, JNCI-J NATL CANCER I, V112, P617, DOI 10.1093/jnci/djz181
   Azim HA, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0504-3
   Azim HA, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0427-5
   Azim HA, 2012, CLIN CANCER RES, V18, P1341, DOI 10.1158/1078-0432.CCR-11-2599
   Barnholtz-Sloan JS, 2004, J CLIN ONCOL, V22, P2865, DOI 10.1200/JCO.2004.12.149
   Bowman RL, 2016, CELL REP, V17, P2445, DOI 10.1016/j.celrep.2016.10.052
   Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599
   Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653
   Cancello G, 2010, ANN ONCOL, V21, P1974, DOI 10.1093/annonc/mdq072
   Costa C, 2015, MULT SCLER J, V21, P1632, DOI 10.1177/1352458515599848
   Elmore MRP, 2014, NEURON, V82, P380, DOI 10.1016/j.neuron.2014.02.040
   Erblich B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026317
   Evans AJ, 2004, CLIN ONCOL-UK, V16, P345, DOI 10.1016/j.clon.2004.03.012
   Gregorowitsch ML, 2019, BREAST CANCER RES TR, V175, P429, DOI 10.1007/s10549-019-05149-4
   Guldner IH, 2020, CELL, V183, P1234, DOI 10.1016/j.cell.2020.09.064
   Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805
   Hu ZQ, 2016, ONCOTARGET, V7, P51733, DOI 10.18632/oncotarget.10104
   Hung MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089389
   Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0
   Kang SS, 2018, J EXP MED, V215, P2235, DOI 10.1084/jem.20180653
   Kaur A, 2019, CANCER DISCOV, V9, P64, DOI 10.1158/2159-8290.CD-18-0193
   Kierdorf K, 2019, NAT REV NEUROSCI, V20, P547, DOI 10.1038/s41583-019-0201-x
   Koebele SV, 2016, MATURITAS, V87, P5, DOI 10.1016/j.maturitas.2016.01.015
   Liddelow SA, 2017, IMMUNITY, V46, P957, DOI 10.1016/j.immuni.2017.06.006
   Liedtke C, 2013, BREAST CANCER RES TR, V138, P591, DOI 10.1007/s10549-013-2461-x
   Mastorakos P, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aav0492
   Mrdjen D, 2018, IMMUNITY, V48, P380, DOI 10.1016/j.immuni.2018.01.011
   Nikolich-Zugich J, 2018, NAT IMMUNOL, V19, P10, DOI 10.1038/s41590-017-0006-x
   Ohsawa K, 2000, J CELL SCI, V113, P3073
   Palmer AL, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00337
   Partridge AH, 2016, J CLIN ONCOL, V34, P3308, DOI 10.1200/JCO.2015.65.8013
   Priego N, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01314
   Qiao S, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-018-1389-9
   Rippaus N, 2016, ONCOTARGET, V7, P41473, DOI 10.18632/oncotarget.9445
   Salter MW, 2017, NAT MED, V23, P1018, DOI 10.1038/nm.4397
   Soto MS, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00414
   Sartorius CA, 2016, ONCOGENE, V35, P2881, DOI 10.1038/onc.2015.353
   Tominaga K, 2019, P NATL ACAD SCI USA, V116, P625, DOI 10.1073/pnas.1806851116
   van der Hage JA, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2908
   Van Hove H, 2019, NAT NEUROSCI, V22, P1021, DOI 10.1038/s41593-019-0393-4
   White MC, 2014, AM J PREV MED, V46, pS7, DOI 10.1016/j.amepre.2013.10.029
   Yang MC, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00117
   Yang Y, 2017, ONCOTARGET, V8, P30621, DOI 10.18632/oncotarget.15695
   Zimmer AS, 2018, BREAST CANCER RES TR, V168, P501, DOI 10.1007/s10549-017-4615-8
NR 47
TC 12
Z9 12
U1 1
U2 16
PU AMER ASSOC CANCER RESEARCH
PI PHILADELPHIA
PA 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA
SN 1078-0432
EI 1557-3265
J9 CLIN CANCER RES
JI Clin. Cancer Res.
PD AUG 1
PY 2021
VL 27
IS 15
BP 4422
EP 4434
DI 10.1158/1078-0432.CCR-21-1549
PG 13
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA TU2HK
UT WOS:000680860800028
PM 34083229
OA Green Submitted, Green Accepted, Bronze
DA 2024-02-19
ER

PT J
AU Danjuma, MIM
   Sajid, J
   Fatima, H
   Elzouki, AN
AF Danjuma, Mohammed Ibn-Mas'ud
   Sajid, Jamal
   Fatima, Haajra
   Elzouki, Abdel-Naser
TI Novel biomarkers for potential risk stratification of drug induced liver
   injury (DILI) A narrative perspective on current trends
SO MEDICINE
LA English
DT Article
DE biomarker; DILI; liver; transaminases
ID MECHANISTIC BIOMARKERS; AMINOTRANSFERASE; KERATIN-18; MICRORNAS; MARKERS
AB Background: Drug induced liver injury (DILI) is an increasing cause of acute liver injury especially with increasing need for pharmacotherapy of widening comorbidities amongst our ever-aging population. Uncertainty however remains regarding both acceptable and widely agreeable diagnostic algorithms as well a clear understanding of mechanistic insights that most accurately underpins it. In this review, we have explored the potential role of emerging novel markers of DILI and how they could possibly be integrated into clinical care of patients.
   Methods: We explored PUBMED and all other relevant databases for scientific studies that explored potential utility of novel biomarkers of DILI, and subsequently carried out a narrative synthesis of this data. As this is a narrative review with no recourse to patient identifiable information, no ethics committee's approval was sought or required.
   Results: Novel biomarkers such as microRNA-122 (miR-122) profiles, high mobility group box-1 (HMGB1), glutamate dehydrogenase (GLDH), and cytokeratin-18 (K-18), amongst others do have the potential for reducing diagnostic uncertainties associated with DILI.
   Conclusion: With the increasing validation of some of the novel liver biomarkers such as K-18, mir-122, HMGB-1, and GLDH, there is the potential for improvement in the diagnostic uncertainty commonly associated with cases of DILI.
C1 [Danjuma, Mohammed Ibn-Mas'ud; Sajid, Jamal; Elzouki, Abdel-Naser] Hamad Med Corp, Hamad Gen Hosp, Doha, Qatar.
   [Fatima, Haajra] Hamad Med Corp, Internal Med Residency Program, Doha, Qatar.
C3 Hamad Medical Corporation; Hamad General Hospital; Hamad Medical
   Corporation
RP Danjuma, MIM (corresponding author), Qatar Univ, Coll Med, Hamad Med Corp, Dept Med,Hamad Gen Hosp, POB 2050, Doha, Qatar.
EM mdanjuma@hamad.qa
RI danjuma, mohammed/AAC-7439-2019
OI danjuma, mohammed/0000-0003-2198-5278; Elzouki,
   Abdel-Naser/0000-0002-9132-1752
FU Qatar National Library
FX The publication of this article was funded by the Qatar National
   Library.
CR Andrade RJ, 2005, GASTROENTEROLOGY, V129, P512, DOI 10.1053/j.gastro.2005.05.006
   Antoine DJ, 2013, BIOMARK MED, V7, P383, DOI [10.2217/BMM.13.42, 10.2217/bmm.13.42]
   Antoine DJ, 2012, J HEPATOL, V56, P1070, DOI 10.1016/j.jhep.2011.12.019
   BENICHOU C, 1990, J HEPATOL, V11, P272
   Beyoglu D, 2013, J HEPATOL, V59, P842, DOI 10.1016/j.jhep.2013.05.030
   Björnsson E, 2005, HEPATOLOGY, V42, P481, DOI 10.1002/hep.20800
   Dear JW, 2018, LANCET GASTROENTEROL, V3, P104, DOI 10.1016/S2468-1253(17)30266-2
   Devarbhavi H, 2016, HEPATOLOGY, V63, P993, DOI 10.1002/hep.28270
   Elzouki AN, 1996, J INTERN MED, V239, P279, DOI 10.1046/j.1365-2796.1996.408761000.x
   Ettel M, 2017, HUM PATHOL, V68, P92, DOI 10.1016/j.humpath.2017.08.029
   Harrill AH, 2012, CLIN PHARMACOL THER, V92, P214, DOI 10.1038/clpt.2012.40
   Kaplowitz N, 2005, NAT REV DRUG DISCOV, V4, P489, DOI 10.1038/nrd1750
   Kleiner DE, 2017, GASTROENTEROL CLIN N, V46, P273, DOI 10.1016/j.gtc.2017.01.004
   Kleiner DE, 2014, HEPATOLOGY, V59, P661, DOI 10.1002/hep.26709
   Kubes P, 2012, GASTROENTEROLOGY, V143, P1158, DOI 10.1053/j.gastro.2012.09.008
   Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6
   Larrey D, 2005, EUR J GASTROEN HEPAT, V17, P141, DOI 10.1097/00042737-200502000-00002
   Lewis PJS, 2011, HEPATOLOGY, V54, P1767, DOI 10.1002/hep.24538
   POPPER H, 1965, ARCH INTERN MED, V115, P128, DOI 10.1001/archinte.1965.03860140008003
   Rockey DC, 2010, HEPATOLOGY, V51, P2117, DOI 10.1002/hep.23577
   Schomaker S, 2013, TOXICOL SCI, V132, P276, DOI 10.1093/toxsci/kft009
   Sgro C, 2002, HEPATOLOGY, V36, P451, DOI 10.1053/jhep.2002.34857
   Thulin P, 2014, LIVER INT, V34, P367, DOI 10.1111/liv.12322
   Ward J, 2014, P NATL ACAD SCI USA, V111, P12169, DOI 10.1073/pnas.1412608111
   Watkins PB, 2006, JAMA-J AM MED ASSOC, V296, P87, DOI 10.1001/jama.296.1.87
   Wysowski DK, 2005, ARCH INTERN MED, V165, P1363, DOI 10.1001/archinte.165.12.1363
NR 26
TC 12
Z9 13
U1 1
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0025-7974
EI 1536-5964
J9 MEDICINE
JI Medicine (Baltimore)
PD DEC
PY 2019
VL 98
IS 50
AR e18322
DI 10.1097/MD.0000000000018322
PG 7
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA KI6BA
UT WOS:000511433000061
PM 31852121
OA Green Published
DA 2024-02-19
ER

PT J
AU Methogo, RM
   Dansette, PM
   Klarskov, K
AF Methogo, Ruth Menque
   Dansette, Patrick M.
   Klarskov, Klaus
TI Identification of liver protein targets modified by tienilic acid
   metabolites using a two-dimensional Western blot-mass spectrometry
   approach
SO INTERNATIONAL JOURNAL OF MASS SPECTROMETRY
LA English
DT Article
DE 2D immuno-blotting; tienilic acid; nanoliquid
   chromatography-electrospray ionization mass spectrometry; on-membrane
   digestion; protein modification
ID DRUG-INDUCED HEPATITIS; REACTIVE METABOLITES; ACYL GLUCURONIDE; COVALENT
   BINDING; RAT-LIVER; IN-VITRO; ELECTROPHILIC METABOLITES;
   ENDOPLASMIC-RETICULUM; IRREVERSIBLE BINDING; CYTOCHROME-P450
AB A combined approach based on two-dimensional electrophoresis-immuno-blotting and nanoliquid chromatography coupled on-line with electrospray ionization mass spectrometry (nLC-MS/MS) was used to identify proteins modified by a reactive intermediate of tienilic acid (TA). Liver homogenates from rats exposed to TA were fractionated using ultra centrifugation; four fractions were obtained and subjected to 2D electrophoresis. Following transfer to PVDF membranes, modified proteins were visualized after India ink staining, using an anti-serum raised against TA and ECL detection. immuno-reactive spots were localized on the PVDF membrane by superposition of the ECL image, protein spots of interest were excised, digested on the membrane with trypsin followed by nLC-MS/MS analysis and protein identification. A total of 15 proteins were identified as likely targets modified by a TA reactive metabolite. These include selenium binding protein 2, senescence marker protein SMP-30, adenosine kinase, Acy 1 protein, adenosylhomocysteinase, capping protein (actin filament), protein disulfide isomerase, fumarylacetoacetase, arginase chain A, ketohexokinase, proteasome endopeptidase complex, triosephosphate isomerase, superoxide dismutase, dna-type molecular chaperone hsc73 and malate dehydrogenase. (C) 2007 Elsevier B.V. All rights reserved.
C1 Univ Sherbrooke, Fac Med, Dept Pharmacol, Sherbrooke, PQ J1H 5N4, Canada.
   Univ Paris 05, CNRS, UMR 8601, F-75270 Paris, France.
C3 University of Sherbrooke; Universite Paris Cite; Centre National de la
   Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC)
RP Klarskov, K (corresponding author), Univ Sherbrooke, Fac Med, Dept Pharmacol, 3001 12e Ave Nord, Sherbrooke, PQ J1H 5N4, Canada.
EM Patrick.Dansette@univ-paris5.fr; klaus.klarskov@usherbrooke.ca
RI Dansette, Patrick/AFQ-0661-2022; DANSETTE, Patrick/B-8384-2014
OI DANSETTE, Patrick/0000-0002-3694-3348
CR Bailey MJ, 2003, CHEM-BIOL INTERACT, V145, P117, DOI 10.1016/S0009-2797(03)00020-6
   Bailey MJ, 1996, CHEM RES TOXICOL, V9, P659, DOI 10.1021/tx960017o
   BEAUNE P, 1987, P NATL ACAD SCI USA, V84, P551, DOI 10.1073/pnas.84.2.551
   Beaune PH, 1996, EUR J HAEMATOL, V57, P89
   Belghazi M, 2001, ADV EXP MED BIOL, V500, P139
   Bolze S, 2002, DRUG METAB DISPOS, V30, P404, DOI 10.1124/dmd.30.4.404
   Bonierbale E, 1999, CHEM RES TOXICOL, V12, P286, DOI 10.1021/tx980136z
   CASTILLO M, 1995, CLIN PHARMACOL THER, V57, P636, DOI 10.1016/0009-9236(95)90226-0
   DANSETTE PM, 1990, BIOCHEM PHARMACOL, V39, P911, DOI 10.1016/0006-2952(90)90207-2
   DANSETTE PM, 1991, BIOCHEM PHARMACOL, V41, P553, DOI 10.1016/0006-2952(91)90627-H
   DICKINSON RG, 1993, BIOCHEM PHARMACOL, V46, P1175, DOI 10.1016/0006-2952(93)90466-A
   HOMBERG JC, 1985, HEPATOLOGY, V5, P722, DOI 10.1002/hep.1840050504
   Isbell MA, 2005, PROTEOMICS, V5, P4197, DOI 10.1002/pmic.200401278
   Ishida Takumi, 2004, Drug Metab Pharmacokinet, V19, P290, DOI 10.2133/dmpk.19.290
   KING AR, 1993, BIOCHEM PHARMACOL, V45, P1043, DOI 10.1016/0006-2952(93)90248-U
   Koen YM, 2002, CHEM RES TOXICOL, V15, P699, DOI 10.1021/tx0101898
   Koenigs LL, 1999, BIOCHEMISTRY-US, V38, P2312, DOI 10.1021/bi9823030
   Lamé MW, 2005, PROTEOMICS, V5, P4398, DOI 10.1002/pmic.200402022
   López García MP, 2005, BIOCHEM PHARMACOL, V70, P1870, DOI 10.1016/j.bcp.2005.09.026
   MANAUTOU JE, 1995, TOXICOL ENV HLTH, V46, P263
   MARTIN JL, 1993, HEPATOLOGY, V18, P858, DOI 10.1002/hep.1840180417
   Methogo RM, 2005, J PROTEOME RES, V4, P2216, DOI 10.1021/pr050014+
   MYERS TG, 1995, CHEM RES TOXICOL, V8, P403, DOI 10.1021/tx00045a012
   Pirmohamed M, 2002, TOXICOLOGY, V181, P55, DOI 10.1016/S0300-483X(02)00255-X
   POHL LR, 1988, ANNU REV PHARMACOL, V28, P367
   Presle N, 1996, DRUG METAB DISPOS, V24, P1050
   PUMFORD NR, 1992, BIOCHEM BIOPH RES CO, V182, P1348, DOI 10.1016/0006-291X(92)91881-P
   Qiu YC, 1998, J BIOL CHEM, V273, P17940, DOI 10.1074/jbc.273.28.17940
   Robin MA, 1996, J CLIN INVEST, V98, P1471, DOI 10.1172/JCI118936
   Séguin B, 2003, CURR OPIN ALLERGY CL, V3, P235, DOI 10.1097/01.all.0000083953.99396.a2
   Shipkova M, 2004, PROTEOMICS, V4, P2728, DOI 10.1002/pmic.200300836
   SpahnLangguth H, 1996, ADV EXP MED BIOL, V387, P313
   Uetrecht J, 2005, TOXICOLOGY, V209, P113, DOI 10.1016/j.tox.2004.12.019
   Valadon P, 1996, CHEM RES TOXICOL, V9, P1403, DOI 10.1021/tx9601622
   VOLLAND C, 1991, DRUG METAB DISPOS, V19, P1080
   Williams KE, 2002, MOL CELL PROTEOMICS, V1, P885, DOI 10.1074/mcp.M200067-MCP200
   ZIMMERMAN HJ, 1984, HEPATOLOGY, V4, P315, DOI 10.1002/hep.1840040223
NR 37
TC 8
Z9 10
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1387-3806
EI 1873-2798
J9 INT J MASS SPECTROM
JI Int. J. Mass Spectrom.
PD DEC 1
PY 2007
VL 268
IS 2-3
BP 284
EP 295
DI 10.1016/j.ijms.2007.06.002
PG 12
WC Physics, Atomic, Molecular & Chemical; Spectroscopy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physics; Spectroscopy
GA 238SI
UT WOS:000251467500023
OA Green Submitted
DA 2024-02-19
ER

PT J
AU Jin, JL
   Wang, GL
   Shi, XR
   Darlington, GJ
   Timchenko, NA
AF Jin, Jingling
   Wang, Guo-Li
   Shi, Xiurong
   Darlington, Gretchen J.
   Timchenko, Nikolai A.
TI The Age-Associated Decline of Glycogen Synthase Kinase 3β Plays a
   Critical Role in the Inhibition of Liver Regeneration
SO MOLECULAR AND CELLULAR BIOLOGY
LA English
DT Article
ID CELL-CYCLE ARREST; FORKHEAD BOX M1B; C/EBP-ALPHA; PROTEIN PHOSPHATASE-1;
   TRANSCRIPTION FACTORS; PROLIFERATION; EXPRESSION; D3; MICE;
   DIFFERENTIATION
AB Aging reduces the regenerative capacities of many tissues. In this paper, we show a critical role of the glycogen synthase kinase 3 beta (GSK3 beta)-cyclin D3 pathway in the loss of the regenerative capacity of the liver. In young animals, high levels of growth hormone (GH) increase expression of GSK3 beta, which associates with cyclin D3 and triggers degradation of cyclin D3. In livers of old mice, the GSK3 beta promoter is repressed by C/EBP beta-histone deacetylase 1 (HDAC1) complexes, leading to the reduction of GSK3 beta. The treatment of old mice with GH increases expression of GSK3 beta via removal of the C/EBP beta-HDAC1 complexes from the GSK3 beta promoter. We found that the GSK3 beta-cyclin D3 pathway is also altered in young GH-deficient Little mice and that treatment of Little mice with GH corrects the GSK3 beta-cyclin D3 pathway. We present evidence that GSK3 beta regulates liver proliferation by controlling growth-inhibitory activity of C/EBP alpha. The downregulation of GSK3 beta in young mice inhibits liver proliferation after partial hepatectomy via the cyclin D3-C/EBP alpha pathway, while the elevation of GSK3 beta in old mice accelerates liver proliferation. Thus, this paper shows that GSK3 beta is a critical regulator of liver proliferation and that the reduction of GSK3 beta with age causes the loss of regenerative capacities of the liver.
C1 [Timchenko, Nikolai A.] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA.
   Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA.
C3 Baylor College of Medicine; Baylor College of Medicine
RP Timchenko, NA (corresponding author), Baylor Coll Med, Dept Pathol, 1 Baylor Plaza, Houston, TX 77030 USA.
EM nikolait@bcm.tmc.edu
OI Jin, Jingling/0000-0002-4365-1837
FU NIH [GM55188, CA100070, AG20752, AG028865, DK56338]
FX This work is supported by NIH grants GM55188, CA100070, and AG20752 (N.
   A. T.) and AG028865 and DK56338 (G. J. D.). We thank Jim Woodgett for
   GSK3 beta KO MEFs and Daniel Amador-Noguez and Adam Dean for help with
   the work with Little mice.
CR Aktas H, 1997, MOL CELL BIOL, V17, P3850, DOI 10.1128/MCB.17.7.3850
   Bartkova J, 1998, ONCOGENE, V17, P1027, DOI 10.1038/sj.onc.1202016
   Bollen M, 2001, TRENDS BIOCHEM SCI, V26, P426, DOI 10.1016/S0968-0004(01)01836-9
   Casanovas O, 2004, ONCOGENE, V23, P7537, DOI 10.1038/sj.onc.1208040
   Cenciarelli C, 1999, MOL CELL BIOL, V19, P5203
   Cohen PTW, 2002, J CELL SCI, V115, P241
   Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260
   de la Serna IL, 2001, J BIOL CHEM, V276, P41486, DOI 10.1074/jbc.M107281200
   Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384
   Doglioni C, 1998, J PATHOL, V185, P159, DOI 10.1002/(SICI)1096-9896(199806)185:2<159::AID-PATH73>3.0.CO;2-0
   EVERITT A, 1989, J GERONTOL, V44, pB139, DOI 10.1093/geronj/44.6.B139
   Flurkey K, 2001, P NATL ACAD SCI USA, V98, P6736, DOI 10.1073/pnas.111158898
   GODFREY P, 1993, NAT GENET, V4, P227, DOI 10.1038/ng0793-227
   GOFF BL, 1987, CLIN EXP IMMUNOL, V68, P580
   Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574
   Iakova P, 2003, CELL, V113, P495, DOI 10.1016/S0092-8674(03)00318-0
   INABA T, 1992, GENOMICS, V13, P565, DOI 10.1016/0888-7543(92)90126-D
   Johnson PF, 2005, J CELL SCI, V118, P2545, DOI 10.1242/jcs.02459
   Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092
   Krupczak-Hollis K, 2003, HEPATOLOGY, V38, P1552, DOI 10.1016/j.hep.2003.08.052
   Låhne HU, 2006, ONCOGENE, V25, P2468, DOI 10.1038/sj.onc.1209278
   Muise-Helmericks RC, 1998, J BIOL CHEM, V273, P29864, DOI 10.1074/jbc.273.45.29864
   Naderi S, 2004, J CELL SCI, V117, P3769, DOI 10.1242/jcs.01210
   Nelsen CJ, 2001, CANCER RES, V61, P8564
   Nerlov C, 2007, TRENDS CELL BIOL, V17, P318, DOI 10.1016/j.tcb.2007.07.004
   Reichert M, 1999, ONCOGENE, V18, P459, DOI 10.1038/sj.onc.1202308
   Rickheim DG, 2002, HEPATOLOGY, V36, P30, DOI 10.1053/jhep.2002.33996
   Sarruf DA, 2005, MOL CELL BIOL, V25, P9985, DOI 10.1128/MCB.25.22.9985-9995.2005
   Timchenko LT, 2006, J BIOL CHEM, V281, P32806, DOI 10.1074/jbc.M605701200
   Wang GL, 2006, MOL CELL BIOL, V26, P2570, DOI 10.1128/MCB.26.7.2570-2582.2006
   Wang GL, 2005, MOL CELL BIOL, V25, P1325, DOI 10.1128/MCB.25.4.1325-1338.2005
   Wang GL, 2004, GENE DEV, V18, P912, DOI 10.1101/gad.1183304
   WANG GL, 2008, J BIOL CHEM, V283, P26196
   Wang GL, 2008, J BIOL CHEM, V283, P26179, DOI 10.1074/jbc.M803545200
   Wang GL, 2008, EXP CELL RES, V314, P1626, DOI 10.1016/j.yexcr.2008.01.028
   Wang GL, 2007, J BIOL CHEM, V282, P1468, DOI 10.1074/jbc.M608226200
   Wang XH, 2002, J BIOL CHEM, V277, P44310, DOI 10.1074/jbc.M207510200
   WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x
NR 38
TC 50
Z9 54
U1 0
U2 5
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0270-7306
EI 1098-5549
J9 MOL CELL BIOL
JI Mol. Cell. Biol.
PD JUL
PY 2009
VL 29
IS 14
BP 3867
EP 3880
DI 10.1128/MCB.00456-09
PG 14
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA 469ZA
UT WOS:000267939300005
PM 19398579
OA Green Published
DA 2024-02-19
ER

PT J
AU Páez-Espinosa, EV
   Rocha, EM
   Velloso, LA
   Boschero, AC
   Saad, MJA
AF Páez-Espinosa, EV
   Rocha, EM
   Velloso, LA
   Boschero, AC
   Saad, MJA
TI Insulin-induced tyrosine phosphorylation of Shc in liver, muscle and
   adipose tissue of insulin resistant rats
SO MOLECULAR AND CELLULAR ENDOCRINOLOGY
LA English
DT Article
DE diabetes; fasting; p52Shc; Shc-Grb 2 association; hypoinsulinemia;
   hyperinsulinemia
ID ACTIVATED PROTEIN-KINASE; RECEPTOR SUBSTRATE-1; SIGNAL-TRANSDUCTION;
   SKELETAL-MUSCLE; GROWTH-FACTOR; PHOSPHATIDYLINOSITOL 3-KINASE;
   P21(RAS)-GTP FORMATION; DNA-SYNTHESIS; C ACTIVITY; IRS-1
AB Insulin stimulates rapid tyrosine phosphorylation of the protein Shc, which subsequently binds to Grb2, resulting in the activation of a complex mitogenic signaling network. In this study, we examined the levels of Shc protein, its phosphorylation state and Shc-Grb2 association in liver, muscle and adipose tissue before and after insulin administration in three animal models of insulin resistance (chronic dexamethasone treatment, 72-h starvation and aging). There were no differences in Shc protein expression between tissues from control and insulin resistant animals. In fasted hypoinsulinemic rats, there was a decrease in insulin-induced Shc phosphorylation in liver and adipose tissue.:However, a significant increase in Shc phosphorylation was observed in liver and muscle from dexamethasone-treated hyperinsulinemic rats and in liver, muscle and adipose tissue of hyperinsulinemic 20-month-old rats. Alterations in Shc phosphorylation correlated well with the level of Shc-Grb2 association. These results indicate that Shc tyrosyl phosphorylation and Shc-Grb2 association are regulated in the different types of insulin resistance and that this regulation is apparently related to the animals' plasma insulin levels. The Shc-Grb2 association is directly related to the insulin-induced tyrosyl phosphorylation of Shc. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
C1 Univ Estadual Campinas, Fac Ciencias Med, Dept Clin Med, BR-13081970 Campinas, SP, Brazil.
   Univ Estadual Campinas, Inst Biol, Dept Fisiol & Biofis, Campinas, SP, Brazil.
C3 Universidade Estadual de Campinas; Universidade Estadual de Campinas;
   Universidade de Sao Paulo
RP Saad, MJA (corresponding author), Univ Estadual Campinas, Fac Ciencias Med, Dept Clin Med, BR-13081970 Campinas, SP, Brazil.
RI Saad, Mario/ABD-8262-2020; Velloso, Licio/AAJ-3778-2020; Rocha, Eduardo
   Melani/D-6002-2011; Boschero, Antonio C/O-7525-2014
OI Rocha, Eduardo Melani/0000-0001-9888-7313; Boschero, Antonio
   C/0000-0003-3829-8570
CR AMATRUDA IM, 1985, DIABETES METAB REV, V3, P293
   ARNOLD TP, 1993, BIOCHEM J, V295, P155, DOI 10.1042/bj2950155
   BALAGE M, 1990, METABOLISM, V39, P366, DOI 10.1016/0026-0495(90)90250-G
   BARNARD RJ, 1992, AM J PHYSIOL, V262, pE619, DOI 10.1152/ajpendo.1992.262.5.E619
   Carvalho CRO, 1996, ENDOCRINOLOGY, V137, P151, DOI 10.1210/en.137.1.151
   CHEATHAM B, 1994, MOL CELL BIOL, V14, P4902, DOI 10.1128/MCB.14.7.4902
   COOPER DR, 1990, ARCH BIOCHEM BIOPHYS, V276, P486, DOI 10.1016/0003-9861(90)90749-O
   DEPIRRO R, 1981, DIABETOLOGIA, V21, P149, DOI 10.1007/BF00251283
   EGAN SE, 1993, NATURE, V363, P45, DOI 10.1038/363045a0
   GERMINARIO RJ, 1985, GERONTOLOGY, V31, P65, DOI 10.1159/000212683
   GIORGETTI S, 1994, EUR J BIOCHEM, V223, P195, DOI 10.1111/j.1432-1033.1994.tb18983.x
   GIORGINO F, 1995, J CLIN INVEST, V96, P1473, DOI 10.1172/JCI118184
   GUSTAFSON TA, 1995, MOL CELL BIOL, V15, P2500
   HABER RS, 1992, DIABETES, V41, P728, DOI 10.2337/diabetes.41.6.728
   HARUTA T, 1995, J BIOL CHEM, V270, P27991
   KONO S, 1990, AM J PHYSIOL, V259, pE27, DOI 10.1152/ajpendo.1990.259.1.E27
   Kroder G, 1996, J CLIN INVEST, V97, P1471, DOI 10.1172/JCI118569
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LAZAR DF, 1995, J BIOL CHEM, V270, P20801, DOI 10.1074/jbc.270.35.20801
   Li PM, 1996, BIOCHEM BIOPH RES CO, V223, P80, DOI 10.1006/bbrc.1996.0849
   LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B
   Myers MG, 1996, ANNU REV PHARMACOL, V36, P615, DOI 10.1146/annurev.pa.36.040196.003151
   NIVET V, 1993, METABOLISM, V42, P1291, DOI 10.1016/0026-0495(93)90127-A
   OUWENS DM, 1994, J BIOL CHEM, V269, P33116
   Páez-Espinosa V, 1998, ENDOCRINE, V8, P193, DOI 10.1385/ENDO:8:2:193
   PELICCI G, 1992, CELL, V70, P93, DOI 10.1016/0092-8674(92)90536-L
   PENICAUD L, 1985, AM J PHYSIOL, V249, pE514, DOI 10.1152/ajpendo.1985.249.5.E514
   PRONK GJ, 1993, J BIOL CHEM, V268, P5748
   RANNELS SR, 1980, AM J PHYSIOL, V238, pE564, DOI 10.1152/ajpendo.1980.238.6.E564
   RIDRAY S, 1991, AM J PHYSIOL, V261, pH190, DOI 10.1152/ajpheart.1991.261.1.H190
   ROZAKISADCOCK M, 1992, NATURE, V360, P689, DOI 10.1038/360689a0
   SAAD MJA, 1992, J CLIN INVEST, V90, P1839, DOI 10.1172/JCI116060
   SAAD MJA, 1993, J CLIN INVEST, V92, P2065, DOI 10.1172/JCI116803
   Saad MJA, 1997, DIABETOLOGIA, V40, P179, DOI 10.1007/s001250050660
   SANCHEZMARGALET V, 1994, BIOCHEM BIOPH RES CO, V204, P446, DOI 10.1006/bbrc.1994.2480
   SASAOKA T, 1994, J BIOL CHEM, V269, P10734
   SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0
   TANTI JF, 1994, J BIOL CHEM, V269, P6051
   Thirone ACP, 1998, FEBS LETT, V421, P191, DOI 10.1016/S0014-5793(97)01560-3
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   Usui I, 1997, DIABETOLOGIA, V40, P894, DOI 10.1007/s001250050765
   VANDERKUUR J, 1995, J BIOL CHEM, V270, P7587, DOI 10.1074/jbc.270.13.7587
   WANG LM, 1993, SCIENCE, V261, P1591, DOI 10.1126/science.8372354
   Ward CW, 1996, J BIOL CHEM, V271, P5603, DOI 10.1074/jbc.271.10.5603
   WATERS SB, 1993, J BIOL CHEM, V268, P22231
   WELSH GI, 1994, BIOCHEM J, V303, P15, DOI 10.1042/bj3030015
   WHITE MF, 1994, J BIOL CHEM, V269, P1
   WOLF G, 1995, J BIOL CHEM, V270, P27407, DOI 10.1074/jbc.270.46.27407
NR 48
TC 15
Z9 18
U1 0
U2 4
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0303-7207
J9 MOL CELL ENDOCRINOL
JI Mol. Cell. Endocrinol.
PD OCT 25
PY 1999
VL 156
IS 1-2
BP 121
EP 129
DI 10.1016/S0303-7207(99)00137-9
PG 9
WC Cell Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Endocrinology & Metabolism
GA 250VU
UT WOS:000083410600014
PM 10612430
DA 2024-02-19
ER

PT J
AU KRISTAL, BS
   CONRAD, CC
   RICHARDSON, A
   YU, BP
AF KRISTAL, BS
   CONRAD, CC
   RICHARDSON, A
   YU, BP
TI IS POLY(A) TAIL LENGTH ALTERED BY AGING OR DIETARY RESTRICTION
SO GERONTOLOGY
LA English
DT Article
DE POLYADENYLATION; DIETARY RESTRICTION; POLY(A) TAIL LENGTH
ID AGE-RELATED-CHANGES; MESSENGER-RNA; RIBONUCLEIC-ACID; GENE-EXPRESSION;
   RATS; TRANSCRIPTION; SEQUENCES; LONGEVITY; LEVEL
AB We examined age- and diet-related alterations in RNA poly(A) tail length using high-resolution gel electrophoresis followed by Northern hybridization. The results demonstrate conclusively that there is no age-related decrease in the size of the Poly(A) tail of RNA isolated from the male Fischer 344 rat. In contrast, our results suggest that there is actually a slight age-related increase in the length of the poly(A) tail isolated from the liver and hypothalamus of these rats. Dietary restriction did not affect either poly(A) tail length or its age-related increase. These data demonstrate conclusively that oligo(dT) probes can be used to standardize RNA hybridization experiments between animals of different ages and dietary groups. In addition, these data provide further evidence that the ratio between RNA polymerase I and RNA polymerase II activity does not change with age.
C1 UNIV TEXAS,HLTH SCI CTR,DEPT PHYSIOL,7703 FLOYD CURL DR,SAN ANTONIO,TX 78284.
   AUDIE L MURPHY MEM VET ADM MED CTR,CTR CLIN & EDUC,SAN ANTONIO,TX.
C3 University of Texas System; University of Texas Health Science Center at
   San Antonio; US Department of Veterans Affairs; Veterans Health
   Administration (VHA); Audie L. Murphy Memorial Veterans Hospital
FU NIA NIH HHS [NIA T32 AG00205, AG01048, AG01188] Funding Source: Medline
CR ALT FW, 1980, CELL, V20, P293, DOI 10.1016/0092-8674(80)90615-7
   AMARA SG, 1984, MOL CELL BIOL, V4, P2151, DOI 10.1128/MCB.4.10.2151
   ARMBRECHT HJ, 1988, J NUTR, V118, P1360, DOI 10.1093/jn/118.11.1360
   BERND A, 1982, MECH AGEING DEV, V19, P361, DOI 10.1016/0047-6374(82)90019-7
   BIRCHENALLSPARKS MC, 1985, MECH AGEING DEV, V32, P99, DOI 10.1016/0047-6374(85)90039-9
   CARTER DA, 1990, NEUROSCI LETT, V109, P180, DOI 10.1016/0304-3940(90)90559-R
   CARTER DA, 1989, J BIOL CHEM, V264, P6601
   CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005
   EARLY P, 1980, CELL, V20, P313, DOI 10.1016/0092-8674(80)90617-0
   FAURE J, 1990, J HISTOCHEM CYTOCHEM, V38, P533, DOI 10.1177/38.4.1690765
   Fourney RM., 1988, FOCUS LIFE TECHNOLOG, V10, P5
   GALLIE DR, 1991, GENE DEV, V5, P2108, DOI 10.1101/gad.5.11.2108
   HOLLANDER MC, 1990, BIOTECHNIQUES, V9, P174
   HORBACH GJMJ, 1988, LIFE SCI, V43, P1707, DOI 10.1016/0024-3205(88)90482-1
   LITTAUER UZ, 1982, PROG NUCLEIC ACID RE, V27, P53, DOI 10.1016/S0079-6603(08)60597-8
   MOTE PL, 1991, J GERONTOL, V46, pB95, DOI 10.1093/geronj/46.3.B95
   NELSON JF, 1988, ENDOCRINOLOGY, V123, P340, DOI 10.1210/endo-123-1-340
   NEVINS JR, 1981, NATURE, V290, P113, DOI 10.1038/290113a0
   PALATNIK CM, 1984, CELL, V36, P1017, DOI 10.1016/0092-8674(84)90051-5
   RICHARDSON A, 1982, LIFE SCI, V31, P605, DOI 10.1016/0024-3205(82)90761-5
   RICHARDSON A, 1982, J GERONTOL, V37, P666, DOI 10.1093/geronj/37.6.666
   SAWICKI SG, 1977, J MOL BIOL, V113, P219, DOI 10.1016/0022-2836(77)90051-1
   WERNER E, 1978, GERONTOLOGY, V25, P61
   YU BP, 1982, J GERONTOL, V37, P130, DOI 10.1093/geronj/37.2.130
   YU BP, 1985, J GERONTOL, V40, P657, DOI 10.1093/geronj/40.6.657
NR 25
TC 1
Z9 1
U1 0
U2 2
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0304-324X
J9 GERONTOLOGY
JI Gerontology
PD MAY-JUN
PY 1993
VL 39
IS 3
BP 152
EP 162
PG 11
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA LU211
UT WOS:A1993LU21100005
PM 7691690
DA 2024-02-19
ER

PT J
AU Enns, LC
   Morton, JF
   Treuting, PR
   Emond, MJ
   Wolf, NS
   McKnight, GS
   Rabinovitch, PS
   Ladiges, WC
AF Enns, Linda C.
   Morton, John F.
   Treuting, Piper R.
   Emond, Mary J.
   Wolf, Norman S.
   McKnight, G. S.
   Rabinovitch, Peter S.
   Ladiges, Warren C.
TI Disruption of Protein Kinase A in Mice Enhances Healthy Aging
SO PLOS ONE
LA English
DT Article
AB Mutations that cause a reduction in protein kinase A (PKA) activity have been shown to extend lifespan in yeast. Loss of function of mammalian RII beta, a regulatory subunit of PKA expressed in brain and adipose tissue, results in mice that are lean and insulin sensitive. It was therefore hypothesized that RIIB null (RII beta(-/-)) mice would express anti-aging phenotypes. We conducted lifespan studies using 40 mutant and 40 wild type (WT) littermates of equal gender numbers and found that both the median and maximum lifespans were significantly increased in mutant males compared to WT littermates. The median lifespan was increased from 884 days to 1005 days (p = 0.006 as determined by the log rank test) and the 80% lifespan (defined here as 80% deaths) was increased from 941 days to 1073 days (p = 0.004 as determined by the Wang-Allison test). There was no difference in either median or 80% lifespan in female genotypes. WT mice of both genders became increasingly obese with age, while mutant mice maintained their lean phenotype into old age. Adiposity was found to correlate with lifespan for males only. 50% of male mice between 30 and 35 g, corresponding to about 5% body fat, for either genotype lived over 1000 days. No male mouse outside of this weight range achieved this lifespan. During their last month of life, WT mice began losing weight (a total of 8% and 15% of body weight was lost for males and females, respectively), but RII beta(-/-) male mice maintained their lean body mass to end of life. This attenuation of decline was not seen in female mutant mice. Old male mutant mice were insulin sensitive throughout their life. Both genders showed modestly lower blood glucose levels in old mutants compared to WT. Male mutants were also resistant to age-induced fatty liver. Pathological assessment of tissues from end of life male mutant mice showed a decrease in tumor incidence, decreased severity of renal lesions, and a trend towards a decrease in age-related cardiac pathology. These findings help establish the highly conserved nature of PKA and suggest that disruption of PKA affects physiological mechanisms known to be associated with healthy aging.
RP Ladiges, WC (corresponding author), Univ Washington, Sch Med, Dept Comparat Med, Seattle, WA 98195 USA.
EM wladiges@u.washington.edu
RI Treuting, Piper M./AAB-2721-2019
OI Treuting, Piper M./0000-0002-1812-1519
FU NIDDK NIH HHS [U24 DK076126] Funding Source: Medline
CR Amieux PS, 1997, J BIOL CHEM, V272, P3993, DOI 10.1074/jbc.272.7.3993
   Arnold AP., 2002, HORMONES BRAIN BEHAV, P105, DOI 10.1016/B978-012532104-4/50065-2
   Blouin K, 2008, J STEROID BIOCHEM, V108, P272, DOI 10.1016/j.jsbmb.2007.09.001
   Blüher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223
   Blüher M, 2002, DEV CELL, V3, P25, DOI 10.1016/S1534-5807(02)00199-5
   Brandon EP, 1998, J NEUROSCI, V18, P3639
   BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0
   CEFALU WT, 1995, METABOLISM, V44, P954, DOI 10.1016/0026-0495(95)90251-1
   Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991
   Cummings DE, 1996, NATURE, V382, P622, DOI 10.1038/382622a0
   DAI DF, 2009, CIRCULATION IN PRESS
   Doherty TJ, 2003, J APPL PHYSIOL, V95, P1717, DOI 10.1152/japplphysiol.00347.2003
   DOHERTY TJ, 1993, CAN J APPL PHYSIOL, V18, P331, DOI 10.1139/h93-029
   Dominici FP, 2002, J ENDOCRINOL, V173, P81, DOI 10.1677/joe.0.1730081
   Enns LC, 2008, CRIT REV EUKAR GENE, V18, P81, DOI 10.1615/CritRevEukarGeneExpr.v18.i1.60
   Ferrannini E, 1997, HYPERTENSION, V30, P1144, DOI 10.1161/01.HYP.30.5.1144
   Flurkey K, 2002, MECH AGEING DEV, V123, P121, DOI 10.1016/S0047-6374(01)00339-6
   Fried L., 1998, PRINCIPLES GERIATRIC, P1387
   Fujimoto WY, 1999, DIABETES CARE, V22, P1808, DOI 10.2337/diacare.22.11.1808
   Gabriely I, 2002, DIABETES, V51, P2951, DOI 10.2337/diabetes.51.10.2951
   Gatford KL, 1998, J ENDOCRINOL, V157, P373, DOI 10.1677/joe.0.1570373
   Gender D., 2001, Exploring the Biological Contribution to Human Health: Does Sex Matter?
   GRIMBY G, 1983, CLIN PHYSIOL, V3, P209, DOI 10.1111/j.1475-097X.1983.tb00704.x
   Harper JM, 2003, MECH AGEING DEV, V124, P801, DOI 10.1016/S0047-6374(03)00133-7
   JUANIN J, 2008, EUR J CARDIOV PREV R, V15, pS79
   Lakatta EG, 2003, CIRCULATION, V107, P346, DOI 10.1161/01.CIR.0000048893.62841.F7
   Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709
   Lamarche B, 1998, CORONARY ARTERY DIS, V9, P473, DOI 10.1097/00019501-199809080-00002
   Lawlor DA, 2007, OBESITY, V15, P1694, DOI 10.1038/oby.2007.202
   Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126
   Longo VD, 2003, EXP GERONTOL, V38, P807, DOI 10.1016/S0531-5565(03)00113-X
   Mauras N, 1996, HORM RES, V45, P74, DOI 10.1159/000184763
   McKnight GS, 1998, RECENT PROG HORM RES, V53, P139
   Moller DE, 2005, ANNU REV MED, V56, P45, DOI 10.1146/annurev.med.56.082103.104751
   NAS AV, 2009, GEN ENDOCRINOL, V150, P1235
   Neuschwander-Tetri BA, 2003, HEPATOLOGY, V37, P1202, DOI 10.1053/jhep.2003.50193
   Perrot-Sinal TS, 2009, ENDOCRINOLOGY, V150, P1075, DOI 10.1210/en.2008-1586
   Planas JV, 1999, J BIOL CHEM, V274, P36281, DOI 10.1074/jbc.274.51.36281
   Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194
   Roos MR, 1997, MUSCLE NERVE, V20, P679
   Roth GS, 1999, J AM GERIATR SOC, V47, P896, DOI 10.1111/j.1532-5415.1999.tb03851.x
   Schreyer SA, 2001, DIABETES, V50, P2555, DOI 10.2337/diabetes.50.11.2555
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   Selman C, 2008, FASEB J, V22, P807, DOI 10.1096/fj.07-9261com
   SHIMOKATA H, 1989, J GERONTOL, V44, pM66, DOI 10.1093/geronj/44.2.M66
   Söderberg S, 2009, INT J OBESITY, V33, P123, DOI 10.1038/ijo.2008.224
   Söderberg S, 2004, J INTERN MED, V256, P128, DOI 10.1111/j.1365-2796.2004.01351.x
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   Taguchi A, 2007, SCIENCE, V317, P369, DOI 10.1126/science.1142179
   Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987
   Treuting PM, 2008, J GERONTOL A-BIOL, V63, P813, DOI 10.1093/gerona/63.8.813
   VANDERVOORT AA, 1989, EUR J APPL PHYSIOL O, V58, P389, DOI 10.1007/BF00643514
   Verdery RB, 1997, CLIN GERIATR MED, V13, P769
   Wallace AM, 2001, CIRCULATION, V104, P3052, DOI 10.1161/hc5001.101061
   Yan L, 2007, CELL, V130, P247, DOI 10.1016/j.cell.2007.05.038
   Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506
   Yki-Järvinen H, 2005, ANN MED, V37, P347, DOI 10.1080/07853890510037383
NR 57
TC 85
Z9 97
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 18
PY 2009
VL 4
IS 6
AR e5963
DI 10.1371/journal.pone.0005963
PG 11
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 459DE
UT WOS:000267079500012
PM 19536287
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Zecca, A
   Barili, V
   Olivani, A
   Biasini, E
   Boni, C
   Fisicaro, P
   Montali, I
   Tiezzi, C
   Dalla Valle, R
   Ferrari, C
   Cariani, E
   Missale, G
AF Zecca, Alessandra
   Barili, Valeria
   Olivani, Andrea
   Biasini, Elisabetta
   Boni, Carolina
   Fisicaro, Paola
   Montali, Ilaria
   Tiezzi, Camilla
   Dalla Valle, Raffaele
   Ferrari, Carlo
   Cariani, Elisabetta
   Missale, Gabriele
TI Targeting Stress Sensor Kinases in Hepatocellular Carcinoma-Infiltrating
   Human NK Cells as a Novel Immunotherapeutic Strategy for Liver Cancer
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Article
DE immunometabolism; NK-cell; immunotherapy; hepatocellular carcinoma;
   oncoimmunology
ID NATURAL-KILLER-CELLS; SENESCENCE; AUTOPHAGY
AB Natural killer (NK) cells may become functionally exhausted entering hepatocellular carcinoma (HCC), and this has been associated with tumor progression and poor clinical outcome. Hypoxia, low nutrients, immunosuppressive cells, and soluble mediators characterize the intratumor microenvironment responsible for the metabolic deregulation of infiltrating immune cells such as NK cells. HCC-infiltrating NK cells from patients undergoing liver resection for HCC were sorted, and genome-wide transcriptome profiling was performed. We have identified a marked general upregulation of gene expression profile along with metabolic impairment of glycolysis, OXPHOS, and autophagy as well as functional defects of NK cells. Targeting p38 kinase, a stress-responsive mitogen-activated protein kinase, we could positively modify the metabolic profile of NK cells with functional restoration in terms of TNF-alpha production and cytotoxicity. We found a metabolic and functional derangement of HCC-infiltrating NK cells that is part of the immune defects associated with tumor progression and recurrence. NK cell exhaustion due to the hostile tumor microenvironment may be restored with p38 inhibitors with a selective mechanism that is specific for tumor-infiltrating-not affecting liver-infiltrating-NK cells. These results may represent the basis for the development of a new immunotherapeutic strategy to integrate and improve the available treatments for HCC.
C1 [Zecca, Alessandra; Olivani, Andrea; Biasini, Elisabetta; Boni, Carolina; Fisicaro, Paola; Montali, Ilaria; Tiezzi, Camilla; Ferrari, Carlo; Missale, Gabriele] Unit Infect Dis & Hepatol, Lab Viral Immunopathol, Azienda Ospedaliero Universitaria Parma, Parma, Italy.
   [Barili, Valeria; Montali, Ilaria; Tiezzi, Camilla; Dalla Valle, Raffaele; Ferrari, Carlo; Missale, Gabriele] Univ Parma, Dept Med & Surg, Parma, Italy.
C3 University of Parma
RP Missale, G (corresponding author), Unit Infect Dis & Hepatol, Lab Viral Immunopathol, Azienda Ospedaliero Universitaria Parma, Parma, Italy.; Missale, G (corresponding author), Univ Parma, Dept Med & Surg, Parma, Italy.
RI Fisicaro, Paola/AAB-8643-2019; Olivani, Andrea/K-1325-2018; Barili,
   Valeria/HKP-1570-2023; Boni, Carolina/J-5249-2016
OI Fisicaro, Paola/0000-0003-3720-9214; Tiezzi,
   Camilla/0000-0001-5483-1908; Boni, Carolina/0000-0002-7630-5180
FU Italian Association for Cancer Research (AIRC) [IG 15485];
   HUNTER-Accelerator Award [22794]
FX This work was supported by a grant from Italian Association for Cancer
   Research (AIRC) IG 15485 and HUNTER-Accelerator Award 22794 (AIRC, CRUK,
   AECC).
CR Acerbi G, 2021, J HEPATOL, V74, P783, DOI 10.1016/j.jhep.2020.10.034
   Akbar AN, 2017, CLIN EXP IMMUNOL, V187, P4, DOI 10.1111/cei.12876
   Akbar AN, 2016, TRENDS IMMUNOL, V37, P866, DOI 10.1016/j.it.2016.09.002
   Barili V, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14137-7
   Bengsch B, 2016, IMMUNITY, V45, P358, DOI 10.1016/j.immuni.2016.07.008
   Bi JC, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00760
   Cariani E, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1154249
   Cerdeira AS, 2013, J IMMUNOL, V190, P3939, DOI 10.4049/jimmunol.1202582
   Chambers AM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02517
   Chen C, 2017, ONCOTARGET, V8, P46691, DOI 10.18632/oncotarget.17358
   Chiossone L, 2018, NAT REV IMMUNOL, V18, P671, DOI 10.1038/s41577-018-0061-z
   Cong JJ, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01989
   Cong JJ, 2018, CELL METAB, V28, P243, DOI 10.1016/j.cmet.2018.06.021
   Desideri E, 2014, AUTOPHAGY, V10, P1652, DOI 10.4161/auto.29456
   Easom NJW, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01009
   Fernández JP, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20174131
   Gao B, 2008, HEPATOLOGY, V47, P729, DOI 10.1002/hep.22034
   Gardiner CM, 2019, J LEUKOCYTE BIOL, V105, P1235, DOI 10.1002/JLB.MR0718-260R
   Gardiner CM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00367
   Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697
   Guillerey C, 2016, NAT IMMUNOL, V17, P1025, DOI 10.1038/ni.3518
   Harmon C, 2019, CANCER IMMUNOL RES, V7, P335, DOI 10.1158/2326-6066.CIR-18-0481
   Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809
   Ishiyama K, 2006, HEPATOLOGY, V43, P362, DOI 10.1002/hep.21035
   Kulik L, 2019, GASTROENTEROLOGY, V156, P477, DOI 10.1053/j.gastro.2018.08.065
   Lanna A, 2014, NAT IMMUNOL, V15, P965, DOI 10.1038/ni.2981
   Li XY, 2016, EUR J CLIN INVEST, V46, P864, DOI 10.1111/eci.12669
   Lian JY, 2020, J HEMATOL ONCOL, V13, DOI 10.1186/s13045-020-00986-z
   Liu PY, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/1206737
   Martinez P, 2019, CLIN CANCER RES, V25, P2691, DOI 10.1158/1078-0432.CCR-18-3904
   Missale G., 2018, HEPATOMA RES, V4, P22, DOI [10.20517/2394-5079.2018.72, DOI 10.20517/2394-5079.2018.72]
   Moretta A, 2002, NAT REV IMMUNOL, V2, P957, DOI 10.1038/nri956
   O'Brien KL, 2019, NAT REV IMMUNOL, V19, P282, DOI 10.1038/s41577-019-0139-2
   O'Sullivan TE, 2015, IMMUNITY, V43, P331, DOI 10.1016/j.immuni.2015.07.012
   Parodi M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02358
   Pinato DJ, 2020, ONCOGENE, V39, P3620, DOI 10.1038/s41388-020-1249-9
   Pinter M, 2021, GUT, V70, P204, DOI 10.1136/gutjnl-2020-321702
   Poznanski SM, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01414
   Poznanski SM, 2018, INFLAMM RES, V67, P813, DOI 10.1007/s00011-018-1174-3
   Slattery K., 2021, J IMMUNOTHER CANCER, V9, DOI [10.1101/648501, DOI 10.1101/648501]
   Sun C, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2016.1264562
   Sung PS, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113648
   Surace L, 2021, BLOOD ADV, V5, P26, DOI 10.1182/bloodadvances.2020003458
   Tannir N, 2018, CURR MED RES OPIN, V34, P825, DOI 10.1080/03007995.2018.1423960
   Trempolec N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11309-7
   Viel S, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad1884
   Villanueva A, 2019, NEW ENGL J MED, V380, P1450, DOI 10.1056/NEJMra1713263
   Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582
   Wang S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11023
   Wang ZX, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00202
   Webber JL, 2010, AUTOPHAGY, V6, P292, DOI 10.4161/auto.6.2.11128
   Zecca A, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10030614
   Zecca A, 2020, CANCER IMMUNOL IMMUN, V69, P1589, DOI 10.1007/s00262-020-02561-4
   Zhang QF, 2017, CELL MOL IMMUNOL, V14, P819, DOI 10.1038/cmi.2016.28
   Zheng XH, 2019, NAT IMMUNOL, V20, P1656, DOI 10.1038/s41590-019-0511-1
NR 55
TC 1
Z9 1
U1 1
U2 5
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD MAY 23
PY 2022
VL 13
AR 875072
DI 10.3389/fimmu.2022.875072
PG 14
WC Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology
GA 1X1EY
UT WOS:000807206600001
PM 35677052
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Shin, S
   Suh, DI
   Ko, JM
   Park, JD
   Lee, JM
   Yi, NJ
   Kim, YT
   Park, S
   Lee, S
   Koh, J
   Choi, YH
AF Shin, Sohyun
   Suh, Dong In
   Ko, Jung Min
   Park, June Dong
   Lee, Jeong-Moo
   Yi, Nam-Joon
   Kim, Young Tae
   Park, Samina
   Lee, Seunghyun
   Koh, Jaemoon
   Choi, Yu Hyeon
TI Combined lung and liver transplantation for noncirrhotic portal
   hypertension with severe hepatopulmonary syndrome in a patient with
   dyskeratosis congenital
SO PEDIATRIC TRANSPLANTATION
LA English
DT Article; Early Access
DE combined liver and lung transplantation; dyskeratosis congenital;
   dyspnea hepatopulmonary syndrome; hypoxemia
ID BONE-MARROW-TRANSPLANTATION; CELL TRANSPLANTATION; SURVIVAL; OUTCOMES
AB DC is caused by defects at the level of telomere maintenance, and cells from patients with this disease have abnormally short telomeres and show premature senescence. One consequence of DC is bone marrow failure. Thus, patients with DC often require HSCT. However, HSCT does not ameliorate other DC-related manifestations. In fact, HSCT can accelerate organ dysfunction due to treatment-related complications, and solid organ transplantation is required in some patients with DC. In this report, we describe the clinical course of a 5-year-old boy who was transferred to our hospital because of progressive dyspnea, 2 years after HSCT. At admission, he had tachypnea and hypoxemia. A liver biopsy was performed for suspected HPS caused by PH, and LT was considered. Eventually, his hypoxemia worsened, and he was transferred to a PICU and started on VA ECMO. He subsequently underwent a CLLT. ECMO was stopped on post-operative day 12, extubation was achieved on post-operative day 29, and the patient recovered well from the surgery. Our results show that CLLT could be a life-saving treatment option for DC patients with very severe HPS in whom a poor outcome is expected after LT.
C1 [Shin, Sohyun; Suh, Dong In; Ko, Jung Min; Park, June Dong; Choi, Yu Hyeon] Seoul Natl Univ Hosp, Dept Pediat, Seoul, South Korea.
   [Lee, Jeong-Moo; Yi, Nam-Joon] Seoul Natl Univ Hosp, Dept Surg, Seoul, South Korea.
   [Kim, Young Tae; Park, Samina] Seoul Natl Univ Hosp, Dept Thorac & Cardiovasc Surg, Seoul, South Korea.
   [Lee, Seunghyun] Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea.
   [Koh, Jaemoon] Seoul Natl Univ Hosp, Dept Pathol, Seoul, South Korea.
C3 Seoul National University (SNU); Seoul National University Hospital;
   Seoul National University (SNU); Seoul National University Hospital;
   Seoul National University (SNU); Seoul National University Hospital;
   Seoul National University (SNU); Seoul National University Hospital;
   Seoul National University (SNU); Seoul National University Hospital
RP Choi, YH (corresponding author), Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Pediat, Coll Med, 101 Daehak Ro, Seoul 03080, South Korea.
EM gugimanse@snuh.org
RI Park, June Dong/J-5496-2012
OI Kim, Young Tae/0000-0001-9006-4881; CHOI, YU HYEON/0000-0002-3057-0886;
   PARK, SAMINA/0000-0001-9625-2672; Ko, Jung Min/0000-0002-0407-7828; Lee,
   Seunghyun/0000-0003-1858-0640; Yi, Nam-Joon/0000-0002-5467-425X; Suh,
   Dong In/0000-0002-7817-8728; Park, June Dong/0000-0001-8113-1384
CR Amarasinghe K, 2007, BONE MARROW TRANSPL, V40, P913, DOI 10.1038/sj.bmt.1705839
   Bessler M, 2010, FEBS LETT, V584, P3831, DOI 10.1016/j.febslet.2010.05.019
   Brazzola P, 2005, BONE MARROW TRANSPL, V36, P1103, DOI 10.1038/sj.bmt.1705171
   Deberaldini M, 2008, TRANSPL P, V40, P3512, DOI 10.1016/j.transproceed.2008.08.134
   Castillo RD, 2020, PEDIATR TRANSPLANT, V24, DOI 10.1111/petr.13695
   Fioredda F, 2018, BRIT J HAEMATOL, V183, P110, DOI 10.1111/bjh.15495
   Gadalla SM, 2013, BIOL BLOOD MARROW TR, V19, P1238, DOI 10.1016/j.bbmt.2013.05.021
   Giri Neelam, 2011, BMC Blood Disord, V11, P3, DOI 10.1186/1471-2326-11-3
   Goldberg DS, 2014, GASTROENTEROLOGY, V146, P1256, DOI 10.1053/j.gastro.2014.01.005
   Gorgy AI, 2015, CHEST, V148, P1019, DOI 10.1378/chest.15-0825
   Gupta S, 2010, AM J TRANSPLANT, V10, P354, DOI 10.1111/j.1600-6143.2009.02822.x
   Khanna R, 2014, J HEPATOL, V60, P421, DOI 10.1016/j.jhep.2013.08.013
   Khincha PP, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01640-2016
   Lebeer M, 2018, TRANSPLANTATION, V102, P1747, DOI 10.1097/TP.0000000000002198
   Maeso-Díaz R, 2018, AGING CELL, V17, DOI 10.1111/acel.12829
   Mahansaria SS, 2015, J CLIN EXP HEPATOL, V5, P344, DOI 10.1016/j.jceh.2015.10.003
   Pascasio JM, 2014, AM J TRANSPLANT, V14, P1391, DOI 10.1111/ajt.12713
   Renoux MC, 2010, PEDIATR PULM, V45, P99, DOI 10.1002/ppul.21128
   Rocha V, 1998, BRIT J HAEMATOL, V103, P243, DOI 10.1046/j.1365-2141.1998.00949.x
   Savage SA, 2010, GENET MED, V12, P753, DOI 10.1097/GIM.0b013e3181f415b5
   Schouten JNL, 2011, HEPATOLOGY, V54, P1071, DOI 10.1002/hep.24422
   Soulaidopoulos S, 2018, WORLD J GASTROENTERO, V24, P1285, DOI 10.3748/wjg.v24.i12.1285
   Tokman S, 2015, J HEART LUNG TRANSPL, V34, P1318, DOI 10.1016/j.healun.2015.05.002
NR 23
TC 6
Z9 6
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1397-3142
EI 1399-3046
J9 PEDIATR TRANSPLANT
JI Pediatr. Transplant.
PD 2021 MAR
PY 2021
VL 25
IS 2
AR e13802
DI 10.1111/petr.13802
EA AUG 2020
PG 7
WC Pediatrics; Transplantation
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pediatrics; Transplantation
GA QM6GK
UT WOS:000558030100001
PM 32777145
DA 2024-02-19
ER

PT J
AU Lin, CM
   Huang, YL
   Lin, ZY
AF Lin, Chiou-Meei
   Huang, Yeou-Lih
   Lin, Zu-Yau
TI Influence of Gender on Serum Growth Hormone, Insulin-Like Growth
   Factor-I and Its Binding Protein-3 during Aging
SO YONSEI MEDICAL JOURNAL
LA English
DT Article
DE Growth hormone; insulin-like growth factors-I; insulin-like growth
   factor binding protein-3; menopause; middle age; aging
ID PROSTATE-CANCER RISK; IGF-I; HEPATOCELLULAR-CARCINOMA; FACTOR (IGF)-I;
   HEALTHY-ADULTS; BREAST-CANCER; GH; IGFBP-3; BRAIN; LIVER
AB Purpose: The serum concentrations of insulin-like growth factors-I (IGF-I), insulin-like growth factor binding protein-3 (IGFBP-3) and growth hormone (GH) are related to body composition, function and metabolism, and are influenced by the aging process. This study was to investigate the influence of gender on serum concentrations of IGF-I, IGFBP-3 and GH in middle and old age subjects. Materials and Methods: Sixty healthy volunteers (male 35, female 25, 36-70 years) were divided into <= 50 and > 50 years groups, based on gender. Women > 50 years were post-menopause. IGF-I, IGFBP-3, and GH were determined by immunoradiometric assay. Results: IGF-I was shown to be negatively correlated with age (women r = -0.62, p < 0.001; men r = -0.38, p < 0.05), whereas there was no correlation between IGF-I and GH values. Women > 50 years showed a significant reduction in IGF-I values than women : 50 years (p < 0.01). Women > 50 years showed smaller IGF-I/IGFBP-3 molar ratios (0.177998 0.039404) than men of same age group (0.228326 +/- 0.050979, p < 0.01) and women <= 50 years (0.247667 +/- 0.069411, p < 0.01). Age was shown to positively correlate with GH/IGF-I (r = 0.49, p < 0.05) and GH/IGFBP-3 ratios (r = 0.40, p < 0.05) in women. Conclusions: The influence of aging on serum concentrations of IGF-I is more remarkable in women than in men. Menopause causes reduction of IGF-I/IGFBP-3 molar ratio. Women have the trend of progressive hypoactivity of GH to stimulate IGF-1 and IGFBP-3 secretions with age.
C1 [Lin, Zu-Yau] Kaohsiung Med Univ Hosp, Dept Internal Med, Div Hepatobiliary Med, Kaohsiung 807, Taiwan.
   [Lin, Chiou-Meei] Kaohsiung Med Univ Hosp, Dept Nucl Med, Kaohsiung 807, Taiwan.
   [Huang, Yeou-Lih] Kaohsiung Med Univ, Coll Hlth Sci, Dept Med Lab Sci & Biotechnol, Kaohsiung, Taiwan.
   [Huang, Yeou-Lih] Kaohsiung Med Univ, Coll Med, Masters & PhD Program Med, Kaohsiung, Taiwan.
   [Lin, Zu-Yau] Kaohsiung Med Univ, Coll Med, Fac Med, Dept Internal Med, Kaohsiung, Taiwan.
C3 Kaohsiung Medical University; Kaohsiung Medical University Hospital;
   Kaohsiung Medical University; Kaohsiung Medical University Hospital;
   Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung
   Medical University
RP Lin, ZY (corresponding author), Kaohsiung Med Univ Hosp, Dept Internal Med, Div Hepatobiliary Med, 100 Tzyou 1st Rd, Kaohsiung 807, Taiwan.
EM linzuyau@yahoo.com.tw
RI Huang, Yeou-Lih/C-9121-2009; Lin, Zu-Yau/D-5152-2009
CR Åberg ND, 2006, THESCIENTIFICWORLDJO, V6, P53, DOI 10.1100/tsw.2006.22
   ARANY E, 1994, J CLIN ENDOCR METAB, V79, P1871, DOI 10.1210/jc.79.6.1871
   Arvat E, 2000, DRUG AGING, V16, P29, DOI 10.2165/00002512-200016010-00003
   Baglietto L, 2007, CANCER EPIDEM BIOMAR, V16, P763, DOI 10.1158/1055-9965.EPI-06-0960
   Benbassat CA, 1997, J CLIN ENDOCR METAB, V82, P1484, DOI 10.1210/jc.82.5.1484
   Binoux M, 1997, EUR J ENDOCRINOL, V137, P605, DOI 10.1530/eje.0.1370605
   BLUM WF, 1993, J CLIN ENDOCR METAB, V76, P1610, DOI 10.1210/jcem.76.6.7684744
   Castro-Acuña V, 2004, REV INVEST CLIN, V56, P507
   Chan JM, 1998, SCIENCE, V279, P563, DOI 10.1126/science.279.5350.563
   Cohen P, 1998, JNCI-J NATL CANCER I, V90, P876, DOI 10.1093/jnci/90.12.876
   Cuzin B, 2004, PROG UROL, V14, P1
   DAUGHADAY WH, 1989, ENDOCR REV, V10, P68, DOI 10.1210/edrv-10-1-68
   Elsammak MY, 2006, CLIN BIOCHEM, V39, P623, DOI 10.1016/j.clinbiochem.2006.01.022
   Fernandez S, 2007, GROWTH HORM IGF RES, V17, P89, DOI 10.1016/j.ghir.2007.01.006
   Ghigo E, 1996, J PEDIATR ENDOCR MET, V9, P271
   Ghigo E, 2000, J PEDIATR ENDOCR MET, V13, P1493
   Gleeson HK, 2005, EUR J ENDOCRINOL, V153, P775, DOI 10.1530/eje.1.02037
   Granada ML, 2008, CLIN ENDOCRINOL, V68, P942, DOI 10.1111/j.1365-2265.2007.03120.x
   Guay AT, 2006, AGING MALE, V9, P201, DOI 10.1080/13685530601051155
   Hankinson SE, 1998, LANCET, V351, P1393, DOI 10.1016/S0140-6736(97)10384-1
   Holman SR, 1996, GROWTH REGULAT, V6, P42
   Ibrahim YH, 2004, GROWTH HORM IGF RES, V14, P261, DOI 10.1016/j.ghir.2004.01.005
   Jenkins PJ, 2004, EUR J ENDOCRINOL, V151, pS17, DOI 10.1530/eje.0.151S017
   JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3
   Jung BH, 2008, YONSEI MED J, V49, P345, DOI 10.3349/ymj.2008.49.3.345
   JUUL A, 1994, CLIN ENDOCRINOL, V41, P85, DOI 10.1111/j.1365-2265.1994.tb03788.x
   Kiel DP, 1998, J AM GERIATR SOC, V46, P822, DOI 10.1111/j.1532-5415.1998.tb02714.x
   Lenk VS, 2005, UROLOGE, V44, P1167, DOI 10.1007/s00120-005-0905-6
   Leung KC, 2004, ENDOCR REV, V25, P693, DOI 10.1210/er.2003-0035
   Lombardi G, 2005, J Endocrinol Invest, V28, P99
   Lunenfeld B, 2003, WORLD J UROL, V21, P292, DOI 10.1007/s00345-003-0366-8
   Ma J, 1999, J NATL CANCER I, V91, P620, DOI 10.1093/jnci/91.7.620
   Mattera D, 2003, CLIN ENDOCRINOL, V59, P699, DOI 10.1046/j.1365-2265.2003.01909.x
   Mazziotti G, 2002, CANCER, V95, P2539, DOI 10.1002/cncr.11002
   Moschos SJ, 2002, ONCOLOGY-BASEL, V63, P317, DOI 10.1159/000066230
   Peeters PHM, 2007, ENDOCR-RELAT CANCER, V14, P81, DOI 10.1677/erc.1.01264
   Rosen CJ, 1999, CLIN CHEM, V45, P1384
   Serin IS, 2008, GYNECOL ENDOCRINOL, V24, P117, DOI 10.1080/09513590801895559
   Sherlock M, 2007, PITUITARY, V10, P189, DOI 10.1007/s11102-007-0039-5
   Sonntag WE, 2005, AGEING RES REV, V4, P195, DOI 10.1016/j.arr.2005.02.001
   Stuver SO, 2000, INT J CANCER, V87, P118, DOI 10.1002/1097-0215(20000701)87:1<118::AID-IJC17>3.0.CO;2-W
   Trejo JI, 2007, MOL PSYCHIATR, V12, P1118, DOI 10.1038/sj.mp.4002076
   Vahl N, 1997, AM J PHYSIOL-ENDOC M, V272, pE1108, DOI 10.1152/ajpendo.1997.272.6.E1108
   van Dam PS, 2004, EUR J PHARMACOL, V490, P87, DOI 10.1016/j.ejphar.2004.02.047
   Yu H, 2000, JNCI-J NATL CANCER I, V92, P1472, DOI 10.1093/jnci/92.18.1472
   ZAPF J, 1984, CLIN ENDOCRINOL META, V13, P3, DOI 10.1016/S0300-595X(84)80006-7
NR 46
TC 12
Z9 16
U1 0
U2 0
PU YONSEI UNIV COLL MEDICINE
PI SEOUL
PA IN-HONG CHOI, M D, PH D, 50-1 YONSEI-RO, SEODAEMUN-GU, SEOUL 120-752,
   SOUTH KOREA
SN 0513-5796
EI 1976-2437
J9 YONSEI MED J
JI Yonsei Med. J.
PD JUN 30
PY 2009
VL 50
IS 3
BP 407
EP 413
DI 10.3349/ymj.2009.50.3.407
PG 7
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA 462DF
UT WOS:000267325500015
PM 19568604
OA gold, Green Published, Green Submitted
DA 2024-02-19
ER

PT J
AU Han, AL
AF Han, A. Lum
TI Association between metabolic associated fatty liver disease and
   osteoarthritis using data from the Korean national health and nutrition
   examination survey (KNHANES)
SO INFLAMMOPHARMACOLOGY
LA English
DT Article; Early Access
DE Knee osteoarthritis; Fatty liver index; Metabolic associated fatty liver
   disease; Obesity; Metabolic dysfunction; Kellgren-Lawrence scale
ID INDEX; OBESITY; NAFLD
AB Osteoarthritis of the knee (knee OA) is on the rise due to the aging population and increasing obesity. In addition to mechanical stress attributed to weight and age, osteoarthritis is associated with obesity and metabolic dysregulation. Here, a cross-sectional study targeting retrospectively registered 17,476 adults aged 50 years or older who were enrolled in the National Health and Nutrition Survey (2010-2011) was performed to analyze the association between the newly named metabolic associated fatty liver disease (MAFLD) and knee OA. Fatty liver index (FLI) >= 60 confirmed the presence of MAFLD, and FLI < 30 indicated the absence of MAFLD. Knee OA was diagnosed according to the Kellgren-Lawrence scale based on knee radiography results. A complex sample logistic regression analysis was performed. Statistically significant factors were adjusted to estimate probability ratios, and 95% confidence intervals were used to investigate the association between knee OA and MAFLD. The probability of knee OA was 1.479 times higher in the presence of MAFLD than that in the normal group. The results indicate that MAFLD is significantly associated with knee OA, suggesting that these two disorders should be managed simultaneously.
C1 [Han, A. Lum] Wonkwang Univ Hosp, Dept Family Med, Sinyong Dong 344-2, Iksan 54538, South Korea.
C3 Wonkwang University
RP Han, AL (corresponding author), Wonkwang Univ Hosp, Dept Family Med, Sinyong Dong 344-2, Iksan 54538, South Korea.
EM qibosarang@naver.com
CR Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33
   Berenbaum F, 2013, OSTEOARTHR CARTILAGE, V21, P16, DOI 10.1016/j.joca.2012.11.012
   Berenbaum F, 2013, CURR OPIN RHEUMATOL, V25, P114, DOI 10.1097/BOR.0b013e32835a9414
   Byrne CD, 2015, J HEPATOL, V62, pS47, DOI 10.1016/j.jhep.2014.12.012
   Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762
   Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB
   Engström G, 2009, OSTEOARTHR CARTILAGE, V17, P168, DOI 10.1016/j.joca.2008.07.003
   Eslam M, 2020, HEPATOL INT, V14, P889, DOI 10.1007/s12072-020-10094-2
   Eslam M, 2020, J HEPATOL, V73, P202, DOI 10.1016/j.jhep.2020.03.039
   Eslam M, 2020, GASTROENTEROLOGY, V158, P1999, DOI 10.1053/j.gastro.2019.11.312
   Fedchuk L, 2014, ALIMENT PHARM THER, V40, P1209, DOI 10.1111/apt.12963
   Felson DT, 2013, OSTEOARTHR CARTILAGE, V21, P10, DOI 10.1016/j.joca.2012.09.012
   Fouad Y, 2020, LIVER INT, V40, P1254, DOI 10.1111/liv.14478
   Friedman SL, 2018, NAT MED, V24, P908, DOI 10.1038/s41591-018-0104-9
   Gastaldelli A, 2009, HEPATOLOGY, V49, P1537, DOI 10.1002/hep.22845
   Griffin TM, 2008, BIORHEOLOGY, V45, P387, DOI 10.3233/BIR-2008-0485
   Huang XL, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001682
   Jung J, 2018, KOREAN J FAMILY PRAC, V8, P292, DOI [10.21215/kjfp.2018.8.2.292, DOI 10.21215/KJFP.2018.8.2.292]
   KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494
   Khang AR, 2019, DIABET METAB SYND OB, V12, P181, DOI 10.2147/DMSO.S189544
   Kim D, 2012, HEPATOLOGY, V56, P605, DOI 10.1002/hep.25593
   Kim MK, 2015, MENOPAUSE, V22, P1323, DOI 10.1097/GME.0000000000000503
   Koehler EM, 2013, CLIN GASTROENTEROL H, V11, P1201, DOI 10.1016/j.cgh.2012.12.031
   Loomba R, 2013, NAT REV GASTRO HEPAT, V10, P686, DOI 10.1038/nrgastro.2013.171
   Masuko K, 2009, CLIN EXP RHEUMATOL, V27, P347
   Motamed N, 2016, WORLD J GASTROENTERO, V22, P3023, DOI 10.3748/wjg.v22.i10.3023
   Niu JB, 2017, ARTHRITIS RHEUMATOL, V69, P1194, DOI 10.1002/art.40087
   Sviklane L, 2018, J GASTROEN HEPATOL, V33, P270, DOI 10.1111/jgh.13814
   Thijssen E, 2015, RHEUMATOLOGY, V54, P588, DOI 10.1093/rheumatology/keu464
   Valenti L, 2020, LIVER INT, V40, P1016, DOI 10.1111/liv.14430
   Yoshimura N, 2011, J RHEUMATOL, V38, P921, DOI 10.3899/jrheum.100569
   Zelber-Sagi S, 2013, WORLD J GASTROENTERO, V19, P57, DOI 10.3748/wjg.v19.i1.57
   Zhuo Q, 2012, NAT REV RHEUMATOL, V8, P729, DOI 10.1038/nrrheum.2012.135
NR 33
TC 7
Z9 7
U1 1
U2 4
PU SPRINGER BASEL AG
PI BASEL
PA PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND
SN 0925-4692
EI 1568-5608
J9 INFLAMMOPHARMACOLOGY
JI Inflammopharmacology
PD 2021 AUG
PY 2021
VL 29
IS 4
BP 1111
EP 1118
DI 10.1007/s10787-021-00842-7
EA JUL 2021
PG 8
WC Immunology; Pharmacology & Pharmacy; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology; Pharmacology & Pharmacy; Toxicology
GA TR1EA
UT WOS:000673245200001
PM 34269951
OA Green Submitted
DA 2024-02-19
ER

PT J
AU Saeki, C
   Kanai, T
   Nakano, M
   Oikawa, T
   Torisu, Y
   Abo, M
   Saruta, M
   Tsubota, A
AF Saeki, Chisato
   Kanai, Tomoya
   Nakano, Masanori
   Oikawa, Tsunekazu
   Torisu, Yuichi
   Abo, Masahiro
   Saruta, Masayuki
   Tsubota, Akihito
TI Relationship between Osteosarcopenia and Frailty in Patients with
   Chronic Liver Disease
SO JOURNAL OF CLINICAL MEDICINE
LA English
DT Article
DE chronic liver disease; osteosarcopenia; frailty; vertebral fracture
ID CHAIN AMINO-ACIDS; SARCOPENIA; BONE; MORTALITY; IMPACT; MUSCLE; WOMEN
AB Osteosarcopenia and frailty have a negative health impact on an aging society. This cross-sectional study aimed to investigate the clinical characteristics and relationship of osteosarcopenia and frailty in 291 patients with chronic liver disease (CLD), who comprised 137 males and 154 females, with a median age of 70.0 years. Sarcopenia was diagnosed according to the Japan Society of Hepatology criteria. Bone mineral density was measured using dual-energy X-ray absorptiometry. Frailty was defined by five parameters (exhaustion, slowness, weakness, low physical activity, and weight loss). Among the 291 patients, 49 (16.8%) and 81 (27.8%) had osteosarcopenia and frailty, respectively. Frailty and vertebral fracture were more frequently noted in patients with osteosarcopenia than in those without osteosarcopenia (79.6% vs. 17.4% and 59.2% vs. 20.2%, respectively;p< 0.001 for both). Meanwhile, osteosarcopenia and vertebral fracture were more frequently observed in patients with frailty than in those without frailty (48.1% vs. 4.8% and 49.4% vs. 18.1%, respectively;p< 0.001 for both). On multivariate analysis, frailty was an independent factor associated with osteosarcopenia (odds ratio (OR), 9.837;p< 0.001), and vice versa (OR, 10.069;p< 0.001). Osteosarcopenia and frailty were prevalent, closely interrelated, and increased the risk of vertebral fracture in patients with CLD.
C1 [Saeki, Chisato; Kanai, Tomoya; Nakano, Masanori; Oikawa, Tsunekazu; Torisu, Yuichi; Saruta, Masayuki] Jikei Univ, Dept Internal Med, Div Gastroenterol & Hepatol, Sch Med,Minato Ku, 3-25-8 Nishi Shimbashi, Tokyo 1058461, Japan.
   [Saeki, Chisato; Kanai, Tomoya; Nakano, Masanori; Torisu, Yuichi] Fuji City Gen Hosp, Dept Internal Med, Div Gastroenterol, 50 Takashima Cho, Fuji, Shizuoka 4178567, Japan.
   [Abo, Masahiro] Jikei Univ, Dept Rehabil Med, Sch Med, Minato Ku, 3-25-8 Nishi Shimbashi, Tokyo 1058461, Japan.
   [Tsubota, Akihito] Jikei Univ, Res Ctr Med Sci, Core Res Facil, Sch Med,Minato Ku, 3-25-8 Nishi Shimbashi, Tokyo 1058461, Japan.
C3 Jikei University; Jikei University; Jikei University
RP Saeki, C (corresponding author), Jikei Univ, Dept Internal Med, Div Gastroenterol & Hepatol, Sch Med,Minato Ku, 3-25-8 Nishi Shimbashi, Tokyo 1058461, Japan.; Saeki, C (corresponding author), Fuji City Gen Hosp, Dept Internal Med, Div Gastroenterol, 50 Takashima Cho, Fuji, Shizuoka 4178567, Japan.; Tsubota, A (corresponding author), Jikei Univ, Res Ctr Med Sci, Core Res Facil, Sch Med,Minato Ku, 3-25-8 Nishi Shimbashi, Tokyo 1058461, Japan.
EM chisato@jikei.ac.jp; tomoyaaust@hotmail.com;
   masanori-nakano@jikei.ac.jp; oitsune@jikei.ac.jp; torisu@jikei.ac.jp;
   abo@jikei.ac.jp; m.saruta@jikei.ac.jp; atsubo@jikei.ac.jp
RI Saruta, Masayuki/ABL-4991-2022
OI Saruta, Masayuki/0000-0001-8172-3240; TORISU,
   YUICHI/0000-0002-2349-8855; Saeki, Chisato/0000-0002-7407-6142; Tsubota,
   Akihito/0000-0001-6860-0326; Abo, Masahiro/0000-0001-6701-4974
CR [Anonymous], 1994, World Health Organ Tech Rep Ser, V843, P1
   Bhanji RA, 2019, LIVER TRANSPLANT, V25, P14, DOI 10.1002/lt.25346
   Binkley N, 2009, J CLIN DENSITOM, V12, P413, DOI 10.1016/j.jocd.2009.06.004
   Bonnet N, 2019, J CLIN INVEST, V129, P3214, DOI 10.1172/JCI125915
   Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9
   Coelho HJ, 2020, NUTRIENTS, V12, DOI 10.3390/nu12020508
   Cruz-Jentoft AJ, 2019, AGE AGEING, V48, P16, DOI 10.1093/ageing/afy169
   Drey M, 2016, AGING CLIN EXP RES, V28, P895, DOI 10.1007/s40520-015-0494-1
   Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146
   George J, 2009, WORLD J GASTROENTERO, V15, P3516, DOI 10.3748/wjg.15.3516
   Hassan EB, 2019, CALCIFIED TISSUE INT, V105, P392, DOI 10.1007/s00223-019-00582-5
   Hassan EB, 2017, AUST FAM PHYSICIAN, V46, P849
   Hirschfeld HP, 2017, OSTEOPOROSIS INT, V28, P2781, DOI 10.1007/s00198-017-4151-8
   Jadczak Agathe D, 2018, JBI Database System Rev Implement Rep, V16, P752, DOI 10.11124/JBISRIR-2017-003551
   JafariNasabian P, 2017, INT J WOMENS HEALTH, V9, P33, DOI 10.2147/IJWH.S106107
   Kawao N, 2015, J CELL BIOCHEM, V116, P687, DOI 10.1002/jcb.25040
   Lai JC, 2014, AM J TRANSPLANT, V14, P1870, DOI 10.1111/ajt.12762
   Lai JC, 2019, GASTROENTEROLOGY, V156, P1675, DOI 10.1053/j.gastro.2019.01.028
   Lai JC, 2018, AM J GASTROENTEROL, V113, P235, DOI 10.1038/ajg.2017.443
   Lai JC, 2017, HEPATOLOGY, V66, P564, DOI 10.1002/hep.29219
   Laube R, 2018, LIVER INT, V38, P2117, DOI 10.1111/liv.13917
   Moriwaki H, 2004, BIOCHEM BIOPH RES CO, V313, P405, DOI 10.1016/j.bbrc.2003.07.016
   Morley JE, 2016, WIEN KLIN WOCHENSCHR, V128, P439, DOI 10.1007/s00508-016-1087-5
   Nishikawa H, 2016, HEPATOL RES, V46, P951, DOI 10.1111/hepr.12774
   Oleksik AM, 2005, OSTEOPOROSIS INT, V16, P861, DOI 10.1007/s00198-004-1774-3
   Ottestad I, 2018, BRIT J NUTR, V120, P445, DOI 10.1017/S0007114518001307
   Paintin J, 2018, BRIT J HOSP MED, V79, P253, DOI 10.12968/hmed.2018.79.5.253
   Saeki C, 2019, BMC MUSCULOSKEL DIS, V20, DOI 10.1186/s12891-019-2983-4
   Sepúlveda-Loyola W, 2020, J AM MED DIR ASSOC, V21, P220, DOI 10.1016/j.jamda.2019.09.005
   Stanghelle B, 2020, OSTEOPOROSIS INT, V31, P1069, DOI 10.1007/s00198-019-05256-4
   Tajiri K, 2018, TRANSL GASTROENT HEP, V3, DOI 10.21037/tgh.2018.07.06
   Tandon P, 2016, AM J GASTROENTEROL, V111, P1759, DOI 10.1038/ajg.2016.303
   Tsutsumimoto K, 2018, J CACHEXIA SARCOPENI, V9, P834, DOI 10.1002/jcsm.12330
   Wang YJ, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/482940
   Yoshimura N, 2018, OSTEOPOROSIS INT, V29, P2181, DOI 10.1007/s00198-018-4596-4
NR 35
TC 19
Z9 19
U1 2
U2 6
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2077-0383
J9 J CLIN MED
JI J. Clin. Med.
PD AUG
PY 2020
VL 9
IS 8
AR 2381
DI 10.3390/jcm9082381
PG 12
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA NH3VC
UT WOS:000564600200001
PM 32722566
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Bua, EA
   McKiernan, SH
   Aiken, JM
AF Bua, EA
   McKiernan, SH
   Aiken, JM
TI Calorie restriction limits the generation but not the progression of
   mitochondrial abnormalities in aging skeletal muscle
SO FASEB JOURNAL
LA English
DT Article
DE age; skeletal muscle; atrophy
ID DNA DELETION MUTATIONS; DIETARY RESTRICTION; RAT MUSCLE; SARCOPENIA;
   ATROPHY; STRESS; DAMAGE; LIVER
AB The effect of early-onset calorie restriction and aging on the accumulation of electron transport system (ETS) abnormalities was studied in rat skeletal muscle. Rectus femoris and vastus lateralis muscle fibers were analyzed for cytochrome c oxidase (COX) and succinate dehydrogenase (SDH) enzyme activities. Fibers displaying COX negative and SDH hyper reactive (COX-/SDH++) phenotype were followed through 1000-2000 micrometers to determine the frequency and length of these abnormalities as well as the physiological impact on fiber structure. Calorie restricted rats had fewer ETS abnormal muscle fibers. The mean length of ETS abnormal regions in ad libitum rat muscle fibers was similar to calorie restricted rat muscles. ETS abnormal fibers from both diet groups exhibited intra-fiber atrophy. A negative correlation between ETS abnormality length and fiber cross-sectional area (CSA) ratio was observed in both ad libitum and calorie-restricted rats. Although calorie restriction reduced the number of ETS abnormalities, it did not affect the length or associated fiber atrophy of ETS abnormal regions once the abnormality was established. Thus, calorie restriction affects the onset but not the progression of electron transport system abnormalities, thereby, limiting a process that ultimately results in fiber breakage and fiber loss.
C1 Univ Wisconsin, Dept Anim Hlth & Biomed Sci, Madison, WI 53706 USA.
C3 University of Wisconsin System; University of Wisconsin Madison
RP Aiken, JM (corresponding author), Univ Wisconsin, Dept Anim Hlth & Biomed Sci, 1656 Linden Dr, Madison, WI 53706 USA.
EM jma@svm.vetmed.wisc.edu
OI Aiken, Judd/0000-0001-6119-4521
CR Aspnes LE, 1997, FASEB J, V11, P573, DOI 10.1096/fasebj.11.7.9212081
   BENJAMIN IJ, 1989, CIRC RES, V65, P657, DOI 10.1161/01.RES.65.3.657
   Bua EA, 2002, J APPL PHYSIOL, V92, P2617, DOI 10.1152/japplphysiol.01102.2001
   Cao ZJ, 2001, NUCLEIC ACIDS RES, V29, P4502, DOI 10.1093/nar/29.21.4502
   Carmeli E, 2002, EXP GERONTOL, V37, P477, DOI 10.1016/S0531-5565(01)00220-0
   Cortopassi GA, 2002, MECH AGEING DEV, V123, P851, DOI 10.1016/S0047-6374(02)00022-2
   Coskun PE, 2003, P NATL ACAD SCI USA, V100, P2174, DOI 10.1073/pnas.0630589100
   Cottrell DA, 2001, NEUROPATH APPL NEURO, V27, P206, DOI 10.1046/j.1365-2990.2001.00315.x
   Dubowitz V, 1985, MUSCLE BIOPSY PRACTI, P19
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   HART RW, 1990, EFFECTS CALORIC REST, P351
   Kapahi P, 1999, FREE RADICAL BIO MED, V26, P495, DOI 10.1016/S0891-5849(98)00323-2
   LARSSON L, 1995, PROG NEUROBIOL, V45, P397, DOI 10.1016/0301-0082(95)98601-Z
   Lee CM, 1998, ANN NY ACAD SCI, V854, P182, DOI 10.1111/j.1749-6632.1998.tb09901.x
   LEXELL J, 1988, J NEUROL SCI, V84, P275, DOI 10.1016/0022-510X(88)90132-3
   Lopez ME, 2000, MUTAT RES-FUND MOL M, V452, P123, DOI 10.1016/S0027-5107(00)00059-2
   López-Torres M, 2002, FREE RADICAL BIO MED, V32, P882, DOI 10.1016/S0891-5849(02)00773-6
   MCKIERNAN SH, IN PRESS EARLY ONSET
   Merry BJ, 2002, INT J BIOCHEM CELL B, V34, P1340, DOI 10.1016/S1357-2725(02)00038-9
   Morley JE, 2001, J LAB CLIN MED, V137, P231, DOI 10.1067/mlc.2001.113504
   Nair K S, 2000, Mayo Clin Proc, V75 Suppl, pS14
   Nikolic M, 2001, COLLEGIUM ANTROPOL, V25, P545
   RAO G, 1990, J NUTR, V120, P602, DOI 10.1093/jn/120.6.602
   SELIGMAN AM, 1968, J CELL BIOL, V38, P1, DOI 10.1083/jcb.38.1.1
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   Sreekumar R, 2002, AM J PHYSIOL-ENDOC M, V283, pE38, DOI 10.1152/ajpendo.00387.2001
   VANZEELAND N, 1999, J ANTI-AGING MED, V2, P231
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
   Welle S, 2002, CAN J APPL PHYSIOL, V27, P19, DOI 10.1139/h02-002
   WERAARCHAKUL N, 1989, EXP CELL RES, V181, P197, DOI 10.1016/0014-4827(89)90193-6
NR 31
TC 37
Z9 43
U1 0
U2 2
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD JAN
PY 2004
VL 18
IS 1
BP 582
EP +
DI 10.1096/fj.03-0668fje
PG 12
WC Biochemistry & Molecular Biology; Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 772EX
UT WOS:000188829300003
PM 14734641
DA 2024-02-19
ER

PT J
AU Jia, ZX
   Liu, LR
   Fang, C
   Pan, MX
   Cong, SY
   Guo, ZH
   Yang, XQ
   Liu, J
   Li, YT
   Xiao, HB
AF Jia, Zhixin
   Liu, Lirong
   Fang, Cong
   Pan, Mingxia
   Cong, Shiyu
   Guo, Zhonghui
   Yang, Xiaoqin
   Liu, Jie
   Li, Yueting
   Xiao, Hongbin
TI A Network-Pharmacology-Combined Integrated Pharmacokinetic Strategy to
   Investigate the Mechanism of Potential Liver Injury due to <i>Polygonum
   multiflorum</i>
SO MOLECULES
LA English
DT Article
DE Polygonum multiflorum (PM); integrated pharmacokinetics; network
   pharmacology; potential liver injury
ID COMPONENTS; THUNB.; RATS; CONSTITUENTS; EXTRACT; PATHWAY; PLASMA; EMODIN
AB Polygonum multiflorum (PM) has been used as a tonic and anti-aging remedy for centuries in Asian countries. However, its application in the clinic has been hindered by its potential to cause liver injury and the lack of investigations into this mechanism. Here, we established a strategy using a network pharmacological technique combined with integrated pharmacokinetics to provide an applicable approach for addressing this issue. A fast and sensitive HPLC-QQQ-MS method was developed for the simultaneous quantification of five effective compounds (trans-2,3,5,4 '-tetrahydroxystilbene-2-O-beta-d-glucoside, emodin-8-O-beta-d-glucoside, physcion-8-O-beta-d-glucoside, aloe-emodin and emodin). The method was fully validated in terms of specificity, linearity, accuracy, precision, extraction recovery, matrix effects, and stability. The lower limits of quantification were 0.125-0.500 ng/mL. This well-validated method was successfully applied to an integrated pharmacokinetic study of PM extract in rats. The network pharmacological technique was used to evaluate the potential liver injury due to the five absorbed components. Through pathway enrichment analysis, it was found that potential liver injury is primarily associated with PI3K-Akt, MAPK, Rap1, and Ras signaling pathways. In brief, the combined strategy might be valuable in revealing the mechanism of potential liver injury due to PM.
C1 [Jia, Zhixin; Liu, Jie; Xiao, Hongbin] Beijing Univ Chinese Med, Beijing Res Inst Chinese Med, Beijing 102401, Peoples R China.
   [Jia, Zhixin; Liu, Lirong; Fang, Cong; Pan, Mingxia; Cong, Shiyu; Guo, Zhonghui; Yang, Xiaoqin; Liu, Jie; Li, Yueting; Xiao, Hongbin] Beijing Univ Chinese Med, Res Ctr Chinese Med Anal & Transformat, Beijing 102401, Peoples R China.
   [Liu, Lirong; Fang, Cong; Pan, Mingxia; Cong, Shiyu; Yang, Xiaoqin; Li, Yueting] Beijing Univ Chinese Med, Sch Chinese Mat Med, Beijing 102401, Peoples R China.
C3 Beijing University of Chinese Medicine; Beijing University of Chinese
   Medicine; Beijing University of Chinese Medicine
RP Xiao, HB (corresponding author), Beijing Univ Chinese Med, Beijing Res Inst Chinese Med, Beijing 102401, Peoples R China.; Xiao, HB (corresponding author), Beijing Univ Chinese Med, Res Ctr Chinese Med Anal & Transformat, Beijing 102401, Peoples R China.
EM hbxiao69@163.com
RI yang, zhuo/JPK-3133-2023; li, xinke/JTU-3633-2023; li,
   jincheng/GQP-6856-2022; zhao, lin/JPK-8436-2023
OI Jia, Zhixin/0000-0003-3849-2234
FU Beijing Municipal Natural Science Foundation; Fundamental Research Funds
   for the Central Universities [7214284]; National Natural Science
   Foundation of China [2020-JYB-ZDGG-105];  [81573839]
FX This research was funded by grants from the Beijing Municipal Natural
   Science Foundation (7214284), the Fundamental Research Funds for the
   Central Universities (2020-JYB-ZDGG-105), and the National Natural
   Science Foundation of China (81573839).
CR Center for Drug Evaluation and Research of the U.S. Department of health and human services food and drug administration, 2018, guidance for industry; Bioanalytical method validation
   Chan YC, 2003, AM J CHINESE MED, V31, P71, DOI 10.1142/S0192415X03000734
   Chen S.X., 2012, CHIN J DIG MED IMAGE, V2, P266, DOI DOI 10.1038/CDD.2010.68
   Cheng WH, 2022, FRONT PHARMACOL, V13, DOI 10.3389/fphar.2022.827668
   Cheng WH, 2020, INT J ANAL CHEM, V2020, DOI 10.1155/2020/4508374
   Chinese Pharmacopeia Commission, 2009, CHINESE PHARMACOPOEI, V75, P175, DOI DOI 10.1055/S-2009-1216422
   Ding MY, 2019, J ETHNOPHARMACOL, V242, DOI 10.1016/j.jep.2019.112055
   Dong HH, 2014, COMPLEMENT THER MED, V22, P70, DOI 10.1016/j.ctim.2013.12.008
   [冯素香 Feng Suxiang], 2017, [中草药, Chinese Traditional and Herbal Drugs], V48, P1971
   Han LF, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00329
   Huang JY, 2019, RSC ADV, V9, P25309, DOI 10.1039/c9ra03917a
   Huang W., 2011, CHINESE J PHARMACOVI, V8, P193
   Huang XJ, 2018, INT J BIOL SCI, V14, P1483, DOI 10.7150/ijbs.27173
   Jia ZX, 2022, PHARM BIOL, V60, P1578, DOI 10.1080/13880209.2022.2099908
   Lei X, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/459749
   Li CP, 2019, HEPATOLOGY, V70, P346, DOI 10.1002/hep.30660
   Li CY, 2016, FRONT PHARMACOL, V7, DOI [10.3389/faphr.2016.00483, 10.3389/fphar.2016.00483]
   Li JS, 2023, J ETHNOPHARMACOL, V301, DOI 10.1016/j.jep.2022.115754
   Li Xiao-Yu, 2008, Chinese Journal of Natural Medicines, V6, P377, DOI 10.3724/SP.J.1009.20008.00377
   Li XY, 2007, BIOMED CHROMATOGR, V21, P735, DOI 10.1002/bmc.813
   Lin LF, 2015, J ETHNOPHARMACOL, V159, P158, DOI 10.1016/j.jep.2014.11.009
   Liu X, 2021, BIOMED RES INT, V2021, DOI 10.1155/2021/5847153
   Lv L.S., 2007, FOOD MACH, V5, P93, DOI [10.13652/j.issn.1003-5788.2007.05.041, DOI 10.13652/J.ISSN.1003-5788.2007.05.041]
   Ma NH, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.655332
   Qian P, 2017, MOLECULES, V22, DOI 10.3390/molecules22020214
   Rao T, 2021, ACTA PHARMACOL SIN, V42, P27, DOI 10.1038/s41401-020-0360-3
   Sahlberg SH, 2017, INT J ONCOL, V50, P5, DOI 10.3892/ijo.2016.3771
   Shariati M, 2019, EXPERT OPIN INV DRUG, V28, P977, DOI 10.1080/13543784.2019.1676726
   Shen Xia, 2019, Yaoxue Xuebao, V54, P1588, DOI 10.16438/j.0513-4870.2019-0031
   Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131
   Thiruvengadam M, 2014, PROTOPLASMA, V251, P555, DOI 10.1007/s00709-013-0554-3
   Tujios S, 2011, NAT REV GASTRO HEPAT, V8, P202, DOI 10.1038/nrgastro.2011.22
   Wang MQ, 2022, ANN PALLIAT MED, V11, P806, DOI 10.21037/apm-21-3286
   Wang X, 2022, CHEM RES TOXICOL, V35, P293, DOI 10.1021/acs.chemrestox.1c00358
   Wang Y, 2013, J CHROMATOGR B, V932, P76, DOI 10.1016/j.jchromb.2013.06.021
   Wu XQ, 2012, FITOTERAPIA, V83, P469, DOI 10.1016/j.fitote.2011.12.012
   Xia XH, 2017, J ETHNOPHARMACOL, V203, P182, DOI 10.1016/j.jep.2017.03.046
   Xia ZX, 2019, BIOMED CHROMATOGR, V33, DOI 10.1002/bmc.4509
   Xian Z, 2017, BIOL PHARM BULL, V40, P1839, DOI 10.1248/bpb.b17-00218
   Xiong F, 2015, J ETHNOPHARMACOL, V163, P290, DOI 10.1016/j.jep.2014.12.067
   Xu J., 2009, MIL MED J SE CHIN, V11, P209
   Yan Lei, 2018, Yaoxue Xuebao, V53, P1660, DOI 10.16438/j.0513-4870.2018-0346
   Yang JB, 2018, BIOMED PHARMACOTHER, V99, P205, DOI 10.1016/j.biopha.2018.01.033
   Zhang L, 2020, XENOBIOTICA, V50, P515, DOI 10.1080/00498254.2019.1658138
   Zhang M, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00505
   Zhao YY, 2013, J SEP SCI, V36, P863, DOI 10.1002/jssc.201200668
   Zheng XY, 2019, DRUG DES DEV THER, V13, P3171, DOI 10.2147/DDDT.S204958
   Zhu Y., 2013, CHIN ARCH TRADIT CHI, V35, P1133
NR 48
TC 0
Z9 0
U1 9
U2 16
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1420-3049
J9 MOLECULES
JI Molecules
PD DEC
PY 2022
VL 27
IS 23
AR 8592
DI 10.3390/molecules27238592
PG 18
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA 6Y9PJ
UT WOS:000897417700001
PM 36500685
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Ito, Y
   Nakajima, K
   Masubuchi, Y
   Kikuchi, S
   Saito, F
   Akahori, Y
   Jin, ML
   Yoshida, T
   Shibutani, M
AF Ito, Yuko
   Nakajima, Kota
   Masubuchi, Yasunori
   Kikuchi, Satomi
   Saito, Fumiyo
   Akahori, Yumi
   Jin, Meilan
   Yoshida, Toshinori
   Shibutani, Makoto
TI Differential responses on energy metabolic pathway reprogramming between
   genotoxic and non-genotoxic hepatocarcinogens in rat liver cells
SO JOURNAL OF TOXICOLOGIC PATHOLOGY
LA English
DT Article
DE hepatocarcinogenesis; genotoxicity; rat; liver; oxidative
   phosphorylation; glycolysis
ID CELLULAR SENESCENCE; ABERRANT ACTIVATION; GENE-EXPRESSION;
   PYRUVATE-KINASE; DOWN-REGULATION; C-MYC; CANCER; PROLIFERATION;
   MITOCHONDRIAL; CARCINOGENS
AB To clarify difference in the responses on the reprogramming of metabolism toward carcinogenesis between genotoxic and non-genotoxic hepatocarcinogens in the liver, rats were repeatedly administered genotoxic hepatocarcinogens (N-nitrosodiethylamine, aflatoxin B-1, N-nitrosopyrrolidine, or carbadox) or non-genotoxic hepatocarcinogens (carbon tetrachloride, thioacetamide, or methapyrilene hydrochloride) for 28, 84, or 90 days. Non-genotoxic hepatocarcinogens revealed transcript expression changes suggestive of suppressed mitochondrial oxidative phosphorylation (OXPHOS) after 28 days and increased glutathione S-transferase placental form-positive (GST-P+) foci downregulating adenosine triphosphate (ATP) synthase subunit beta, mitochondrial precursor (ATPB), compared with genotoxic hepatocarcinogens after 84 or 90 days, suggesting that non-genotoxic hepatocarcinogens are prone to suppress OXPHOS from the early stage of treatment, which is in contrast to genotoxic hepatocarcinogens. Both genotoxic and non-genotoxic hepatocarcinogens upregulated glycolytic enzyme genes and increased cellular membrane solute carrier family 2, facilitated glucose transporter member 1 (GLUT1) expression in GST-P+ foci for up to 90 days, suggesting induction of a metabolic shift from OXPHOS to glycolysis at early hepatocarcinogenesis by hepatocarcinogens unrelated to genotoxic potential. Non-genotoxic hepatocarcinogens increased c-MYC+ cells after 28 days and downregulated Tp53 after 84 or 90 days, suggesting a commitment to enhanced metabolic shift and cell proliferation. Genotoxic hepatocarcinogens also enhanced c-MYC activation-related metabolic shift until 84 or 90 days. In addition, both genotoxic and non-genotoxic hepatocarcinogens upregulated glutaminolysis-related Slc1a5 or Gls, or both, after 28 days and induced liver cell foci immunoreactive for neutral amino acid transporter B(0) (SLC1A5) in the subpopulation of GST-P+ foci after 84 or 90 days, suggesting glutaminolysis-mediated facilitation of cell proliferation toward hepatocarcinogenesis. These results suggest differential responses between genotoxic and non-genotoxic hepatocarcinogens on reprogramming of energy metabolic pathways toward carcinogenesis in liver cells from the early stage of hepatocarcinogen treatment.
C1 [Ito, Yuko; Nakajima, Kota; Masubuchi, Yasunori; Kikuchi, Satomi; Yoshida, Toshinori; Shibutani, Makoto] Tokyo Univ Agr & Technol, Inst Agr, Div Anim Life Sci, Lab Vet Pathol, 3-5-8 Saiwai Cho, Fuchu, Tokyo 1838509, Japan.
   [Ito, Yuko; Nakajima, Kota; Masubuchi, Yasunori] Gifu Univ, United Grad Sch Vet Sci, Pathogenet Vet Sci, 1-1 Yanagido, Gifu, Gifu 5011193, Japan.
   [Kikuchi, Satomi; Yoshida, Toshinori; Shibutani, Makoto] Tokyo Univ Agr & Technol, Grad Sch Agr, Cooperat Div Vet Sci, 3-5-8 Saiwai Cho, Fuchu, Tokyo 1838509, Japan.
   [Saito, Fumiyo; Akahori, Yumi] Chem Evaluat & Res Inst, Bunkyo Ku, 1-4-25 Kouraku, Tokyo 1120004, Japan.
   [Jin, Meilan] Southwest Univ, Coll Anim Sci & Technol Vet Med, Lab Vet Pathol, 2 Tiansheng Rd, Chongqing 400715, Peoples R China.
   [Shibutani, Makoto] Tokyo Univ Agr & Technol, Inst Global Innovat Res, 3-5-8 Saiwai Cho, Fuchu, Tokyo 1838509, Japan.
C3 Tokyo University of Agriculture & Technology; Gifu University; Tokyo
   University of Agriculture & Technology; Southwest University - China;
   Tokyo University of Agriculture & Technology
RP Shibutani, M (corresponding author), Tokyo Univ Agr & Technol, Inst Agr, Div Anim Life Sci, Lab Vet Pathol, 3-5-8 Saiwai Cho, Fuchu, Tokyo 1838509, Japan.; Shibutani, M (corresponding author), Tokyo Univ Agr & Technol, Grad Sch Agr, Cooperat Div Vet Sci, 3-5-8 Saiwai Cho, Fuchu, Tokyo 1838509, Japan.; Shibutani, M (corresponding author), Tokyo Univ Agr & Technol, Inst Global Innovat Res, 3-5-8 Saiwai Cho, Fuchu, Tokyo 1838509, Japan.
EM mshibuta@cc.tuat.ac.jp
RI Shibutani, Makoto/C-2510-2013; Yoshida, Toshinori/B-7255-2015;
   Shibutani, Makoto/AGK-2801-2022
OI Yoshida, Toshinori/0000-0003-2476-7794; Shibutani,
   Makoto/0000-0003-3417-9697
FU Chemicals Evaluation and Research Institute, Japan; Institute of Global
   Innovation Research, Tokyo University of Agriculture and Technology
FX The authors thank Shigeko Suzuki for her technical assistance in
   preparing the histological specimens. All authors declare that there are
   no conflicts of interest that influenced the outcome of the present
   study. This work was supported by research funds from the Chemicals
   Evaluation and Research Institute, Japan, and the Institute of Global
   Innovation Research, Tokyo University of Agriculture and Technology.
CR Amoêdo ND, 2013, BIOSCIENCE REP, V33, P865, DOI 10.1042/BSR20130066
   [Anonymous], 2000, Toxic Rep Ser, V46, P1
   BARBER ED, 1981, MUTAT RES, V90, P31, DOI 10.1016/0165-1218(81)90048-3
   BECKER FF, 1983, J NATL CANCER I, V71, P553
   Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653
   Cazzaniga M, 2015, ANTICANCER RES, V35, P5789
   Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734
   DEJESUS AE, 1988, J CHROMATOGR, V450, P101, DOI 10.1016/S0021-9673(00)90719-2
   Dong GC, 2016, ONCOL LETT, V11, P1980, DOI 10.3892/ol.2016.4168
   Gambhir SS, 2002, NAT REV CANCER, V2, P683, DOI 10.1038/nrc882
   Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013
   HAYASHI Y, 1992, EXP TOXICOL PATHOL, V44, P465, DOI 10.1016/S0940-2993(11)80159-4
   Horwitz W, 2005, OFFICIAL METHODS ANA, P47
   IMAMURA K, 1972, J BIOCHEM-TOKYO, V71, P1043, DOI 10.1093/oxfordjournals.jbchem.a129852
   Isidoro A, 2004, BIOCHEM J, V378, P17, DOI 10.1042/BJ20031541
   Ito Nobuyuki, 1998, Journal of Toxicological Sciences, V23, P103
   Ito Y, 2019, TOXICOL SCI, V169, P122, DOI 10.1093/toxsci/kfz027
   Jin L, 2016, ONCOGENE, V35, P3619, DOI 10.1038/onc.2015.447
   Kanki K, 2005, MOL CARCINOGEN, V42, P9, DOI 10.1002/mc.20061
   Kimura M, 2016, J APPL TOXICOL, V36, P223, DOI 10.1002/jat.3163
   Kimura M, 2015, J TOXICOL SCI, V40, P855, DOI 10.2131/jts.40.855
   King TO, 1976, TARGET ORGAN T UNPUB
   Kon S, 2017, NAT CELL BIOL, V19, P530, DOI 10.1038/ncb3509
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   LUCIAKOVA K, 1992, EUR J BIOCHEM, V205, P1187, DOI 10.1111/j.1432-1033.1992.tb16889.x
   Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237
   MacGregor JT, 2015, MUTAT RES-GEN TOX EN, V783, P66, DOI 10.1016/j.mrgentox.2014.10.008
   Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863
   Miller DM, 2012, CLIN CANCER RES, V18, P5546, DOI 10.1158/1078-0432.CCR-12-0977
   Mizukami S, 2017, TOXICOL SCI, V159, P211, DOI 10.1093/toxsci/kfx131
   Nohmi T, 2018, TOX RESEARCH, V34, P281, DOI 10.5487/TR.2018.34.4.281
   Osthus RC, 2000, J BIOL CHEM, V275, P21797, DOI 10.1074/jbc.C000023200
   Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006
   Pfeiffer T, 2001, SCIENCE, V292, P504, DOI 10.1126/science.1058079
   Qian GQ, 2013, TOXICOL PATHOL, V41, P1093, DOI 10.1177/0192623313477256
   Shirai T, 1997, TOXICOL PATHOL, V25, P453, DOI 10.1177/019262339702500504
   Stanton RC, 2012, IUBMB LIFE, V64, P362, DOI 10.1002/iub.1017
   Suzuki S, 2009, TOXICOLOGY, V255, P160, DOI 10.1016/j.tox.2008.10.023
   Taniai E, 2012, J TOXICOL SCI, V37, P1093, DOI 10.2131/jts.37.1093
   Taniai E, 2009, CANCER SCI, V100, P813, DOI 10.1111/j.1349-7006.2009.01120.x
   Verna L, 1996, PHARMACOL THERAPEUT, V71, P57, DOI 10.1016/0163-7258(96)00062-9
   WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309
   WEISBURGER EK, 1977, ENVIRON HEALTH PERSP, V21, P7, DOI 10.2307/3428494
   Wu CH, 2007, P NATL ACAD SCI USA, V104, P13028, DOI 10.1073/pnas.0701953104
   Yafune A, 2013, TOXICOL LETT, V219, P203, DOI 10.1016/j.toxlet.2013.03.012
   Yoshida GJ, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0221-y
   Zhang Y, 2013, CANCER BIOL THER, V14, P81, DOI 10.4161/cbt.22958
NR 47
TC 2
Z9 2
U1 0
U2 2
PU JAPANESE SOC TOXICOLOGIC PATHOLOGY
PI TOKYO
PA DEPT ACAD SOC, MEDICAL TRIBUNE INC, ITALIAN CULTURAL INST BLDG 8F
   2-1-30, KUDAN MINAMI, CHIYODA, TOKYO, 102-0074, JAPAN
SN 0914-9198
EI 1881-915X
J9 J TOXICOL PATHOL
JI J. Toxicol. Pathol.
PY 2019
VL 32
IS 4
BP 261
EP 274
DI 10.1293/tox.2019-0048
PG 14
WC Pathology; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pathology; Toxicology
GA KH8IE
UT WOS:000510893100006
PM 31719753
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU James, SJ
   Muskhelishvili, L
   Gaylor, DW
   Turturro, A
   Hart, R
AF James, SJ
   Muskhelishvili, L
   Gaylor, DW
   Turturro, A
   Hart, R
TI Upregulation of apoptosis with dietary restriction: Implications for
   carcinogenesis and aging
SO ENVIRONMENTAL HEALTH PERSPECTIVES
LA English
DT Article; Proceedings Paper
CT 3rd BELLE Conference on Toxicological Defense Mechanisms and the Shape
   of Dose-Response Relationships
CY NOV 12-14, 1996
CL RES TRIANGLE PK, NORTH CAROLINA
SP Biol Effects Low Level Exposures, Advisory Comm
DE apoptosis; proliferation; homeostasis; dietary restriction; cancer;
   aging
ID GROWTH-FACTOR-I; CALORIC RESTRICTION; CELL-PROLIFERATION; B6C3F1 MICE;
   RAT-LIVER; DEATH APOPTOSIS; TUMOR PROMOTERS; CANCER; TUMORIGENESIS;
   INSULIN
AB The maintenance of cell number homeostasis in normal tissues reflects a highly regulated balance between the rates of cell proliferation and cell death. Under pathologic conditions such as exposure to cytotoxic, genotoxic, or nongenotoxic agents, an imbalance in these rates may indicate subsequent risk of carcinogenesis. Apoptotic cell death, as opposed to necrotic cell death, provides a protective mechanism by selective elimination of senescent, preneoplastic, or superfluous cells that could negatively affect normal function and/or promote cell transformation. The relative efficiency or dysfunction of the cell death program could therefore have a direct impact on the risk of degenerative or neoplastic disease. Dietary restriction of rodents is a noninvasive intervention that has been reproducibly shown to retard tumor development and most physiologic indices of aging relative to ad libitum-fed animals. As such, it provides a powerful model in which to study common mechanistic processes associated with both aging and cancer. In a recent study we established that chronic dietary restriction (DR) induces an increase in spontaneous apoptotic rate and a decrease in cell proliferation rate in hepatocytes of 12-month-old B6C3F1 DR mice relative to ad libitum (AL)-fed mice. This diet-induced shift in cell death/proliferation rates was associated with a marked reduction in subsequent development of spontaneous hepatoma and a marked increase in disease-free life span in DR relative to AL-fed mice. These results suggest that total caloric intake may modulate the rates of cell death and proliferation in a direction consistent with a cancer-protective effect in DR mice and a cancer-promoting effect in AL mice. To determine whether the increase in spontaneous apoptotic rate was maintained over the life span of DR mice, apoptotic rates were quantified in 12-, 18-, 24- and 30-month-old DR and AL mice. The rate of apoptosis was elevated with age in both diet groups; however, the rate of apoptosis was significantly and consistently higher in DR mice regardless of age. In double-labeling experiments, an age-associated increase in the glutathione S-transferase-II expression in putative preneoplastic hepatocytes in AL mice was rapidly reduced by apoptosis upon initiation of DR. Thus, interventions that promote a low-level increase in apoptotic cell death may be expected to protect genotypic and phenotypic stability with age. If during tumor promotion an adaptive increase in apoptosis effectively balances the dysregulated increase proliferation, the risk of permanent genetic error and carcinogenesis would be minimized.
C1 US FDA, Natl Ctr Toxicol Res, Div Biochem Toxicol, Jefferson, AR 72079 USA.
   US FDA, Natl Ctr Toxicol Res, Div Biometry & Risk Assessment, Jefferson, AR 72079 USA.
C3 US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)
RP James, SJ (corresponding author), US FDA, Natl Ctr Toxicol Res, Div Biochem Toxicol, 3900 NCTR Rd, Jefferson, AR 72079 USA.
EM jjames@nctr.fda.gov
CR BRASH DE, 1977, BIOL AGING, P57
   BURSCH W, 1984, CARCINOGENESIS, V5, P453, DOI 10.1093/carcin/5.4.453
   Carthew P, 1996, CANCER LETT, V106, P163, DOI 10.1016/0304-3835(96)04310-8
   COLLINS MKL, 1994, BIOESSAYS, V16, P133, DOI 10.1002/bies.950160210
   Columbano A, 1996, CARCINOGENESIS, V17, P395, DOI 10.1093/carcin/17.3.395
   Constan AA, 1996, TOXICOL PATHOL, V24, P315, DOI 10.1177/019262339602400307
   FARBER E, 1995, CANCER RES, V55, P3759
   Fernandes RS, 1996, ANTICANCER RES, V16, P1691
   FEUERS RJ, 1993, MUTAT RES, V295, P191, DOI 10.1016/0921-8734(93)90020-4
   GILL JH, 1995, CELL DEATH DIFFER, V2, P211
   Goldsworthy TL, 1996, MUTAT RES-REV GENET, V365, P71, DOI 10.1016/S0165-1110(96)90013-5
   GOLDSWORTHY TL, 1995, CIIT ACTIVITIES, V15, P1
   GREEN DR, 1995, CURR OPIN IMMUNOL, V7, P694, DOI 10.1016/0952-7915(95)80079-4
   HAASKOGAN DA, 1995, EMBO J, V14, P461, DOI 10.1002/j.1460-2075.1995.tb07022.x
   HALL PA, 1994, EUR J CANCER, V30A, P2001, DOI 10.1016/0959-8049(94)00394-K
   HART RW, 1992, EXP GERONTOL, V27, P567, DOI 10.1016/0531-5565(92)90011-N
   HOFFMAN B, 1994, ONCOGENE, V9, P1807
   Ishida M, 1996, VIRCHOWS ARCH, V428, P229
   JAMES SJ, 1994, CANCER RES, V54, P5508
   KERR JFR, 1972, J PATHOL, V107, P41, DOI 10.1002/path.1711070107
   KING KL, 1995, J CELL BIOCHEM, V58, P175, DOI 10.1002/jcb.240580206
   Kolaja KL, 1996, CARCINOGENESIS, V17, P947, DOI 10.1093/carcin/17.5.947
   Kong J, 1996, CANCER LETT, V105, P241, DOI 10.1016/0304-3835(96)04291-7
   LAGOPOULOS L, 1991, CARCINOGENESIS, V12, P311, DOI 10.1093/carcin/12.2.311
   LEDDACOLUMBANO GM, 1991, APOPTOSIS MOL BASIS, P101
   LUAN XH, 1995, IMMUNOL LETT, V47, P181, DOI 10.1016/0165-2478(95)00091-5
   MARSMANN DS, 1994, RISK ANAL, V14, P321, DOI 10.1111/j.1539-6924.1994.tb00247.x
   MARTIN SJ, 1995, CRIT REV ONCOL HEMAT, V18, P137, DOI 10.1016/1040-8428(94)00124-C
   MCDONNELL TJ, 1993, MOL CARCINOGEN, V8, P209, DOI 10.1002/mc.2940080402
   MEIKRANTZ W, 1995, J CELL BIOCHEM, V58, P160, DOI 10.1002/jcb.240580205
   MONTI D, 1992, ANN NY ACAD SCI, V673, P70, DOI 10.1111/j.1749-6632.1992.tb27438.x
   Muskhelishvili L, 1996, AM J PATHOL, V149, P1585
   MUSKHELISHVILI L, 1995, AM J PATHOL, V147, P20
   Naik P, 1996, GENE DEV, V10, P2105, DOI 10.1101/gad.10.17.2105
   RAFF MC, 1994, PHILOS T ROY SOC B, V345, P265, DOI 10.1098/rstb.1994.0104
   Reed JC, 1996, J CELL BIOCHEM, V60, P23, DOI 10.1002/(SICI)1097-4644(19960101)60:1<23::AID-JCB5>3.3.CO;2-3
   RESNICOFF M, 1995, CANCER RES, V55, P3739
   RESNICOFF M, 1995, CANCER RES, V55, P2463
   RUGGERI BA, 1989, CANCER RES, V49, P4130
   SCHULTEHERMANN R, 1994, INT ARCH ALLERGY IMM, V105, P363, DOI 10.1159/000236784
   SCHULTEHERMANN R, 1993, ENVIRON HEALTH PERSP, V101, P87, DOI 10.2307/3431847
   SchulteHermann R, 1995, MUTAT RES-FUND MOL M, V333, P81, DOI 10.1016/0027-5107(95)00134-4
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   Sorenson C, 1995, AM J PHYSIOL, V268, P73
   TROSKO JE, 1994, MOL CARCINOGEN, V11, P8, DOI 10.1002/mc.2940110103
   URAO M, 1995, J NUTR, V125, P2316, DOI 10.1093/jn/125.9.2316
   WARNER HR, 1995, J GERONTOL A-BIOL, V50, pB107, DOI 10.1093/gerona/50A.3.B107
   Weindruch R, 1996, SCI AM, V274, P46, DOI 10.1038/scientificamerican0196-46
   WEINDRUCH R, 1991, HEMATOL ONCOL CLIN N, V5, P79, DOI 10.1016/S0889-8588(18)30455-6
   WEINDRUCH R, 1986, J NUTR, V116, P641, DOI 10.1093/jn/116.4.641
   Worner W, 1996, CANCER RES, V56, P1272
NR 51
TC 42
Z9 45
U1 0
U2 1
PU US DEPT HEALTH HUMAN SERVICES PUBLIC HEALTH SERVICE
PI RES TRIANGLE PK
PA NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SERVICES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA
SN 0091-6765
J9 ENVIRON HEALTH PERSP
JI Environ. Health Perspect.
PD FEB
PY 1998
VL 106
SU 1
BP 307
EP 312
DI 10.2307/3433932
PG 6
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Toxicology
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Toxicology
GA 110WC
UT WOS:000075403700024
PM 9539024
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU RAMIREZ, M
   ARECHAGA, G
   SANCHEZ, B
   OZAITA, A
   LARDELLI, P
AF RAMIREZ, M
   ARECHAGA, G
   SANCHEZ, B
   OZAITA, A
   LARDELLI, P
TI DEVELOPMENTAL AND AGING CHANGES IN AMINOPEPTIDASE ACTIVITIES IN SELECTED
   TISSUES OF THE RAT
SO EXPERIENTIA
LA English
DT Article
DE ASPARTYL AMINOPEPTIDASE; ARGINYL AMINOPEPTIDASE; BETA-NAPHTHYLAMIDE;
   DEVELOPMENT; AGING; RAT TISSUES
ID ANGIOTENSIN-II; BRAIN; DEGRADATION; ENKEPHALIN; BINDING
AB Aminopeptidase activities, assayed as arylamidase activities, were investigated in selected tissues of 1, 6, 12 and 24-month-old rats. The enzyme activities were found to have a heterogeneous distribution and age-related changes were observed. The highest levels of soluble arginyl-aminopeptidase activity were detected in brain homogenate at all the studied ages, whereas membrane-bound activity presented the highest levels in brain and kidney in the four ages tested. Aspartyl-aminopeptidase activity was detected mainly in the particulate fraction of kidney at all four ages. In 1, 6 and 12-month-old animals, soluble aspartyl-aminopeptidase activity was also higher in the kidney than in the rest of the tissues, whereas in the group of 2-year-old rats, the highest levels were found in both kidney and liver. Age-related changes were observed in all the studied tissues and for all the assayed enzymatic activities. In general, the maximal levels were detected in both the youngest and the oldest animals, and the minimal ones in 6 and 12-month-old rats. However, in the adrenals, the soluble and membrane-bound arginyl-aminopeptidase activity was higher in 6-month and 2-year-old rats than in 1-month and 12-month-old rats. These changes may reflect the functional status of the susceptible endogenous substrates of aminopeptidases.
C1 SANDOZ PHARMA LTD,IMMUNOL,CH-4002 BASEL,SWITZERLAND.
   UNIV BASQUE COUNTRY,SCH MED,DEPT PHYSIOL,VIZCAYA,SPAIN.
C3 Novartis; Sandoz; University of Basque Country
RI Ozaita, Andres/H-3411-2015
OI Ozaita, Andres/0000-0002-2239-7403
CR ABHOLD RH, 1987, J PHARMACOL EXP THER, V242, P957
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   CHEUNG HS, 1971, BIOCHIM BIOPHYS ACTA, V242, P190, DOI 10.1016/0005-2744(71)90098-2
   DEGANDARIAS JM, 1989, HORM METAB RES, V21, P285, DOI 10.1055/s-2007-1009215
   GANONG WF, 1984, ANNU REV PHYSIOL, V46, P17
   GREENBERG LJ, 1962, BIOCHEM BIOPH RES CO, V9, P430, DOI 10.1016/0006-291X(62)90029-3
   HERSH LB, 1981, J NEUROCHEM, V36, P171, DOI 10.1111/j.1471-4159.1981.tb02392.x
   MCDERMOTT JR, 1988, J NEUROCHEM, V50, P176, DOI 10.1111/j.1471-4159.1988.tb13246.x
   MCDONALD JK, 1986, MAMMALIAN PROTEASES, V2, P23
   MIZUTANI S, 1985, ACTA ENDOCRINOL-COP, V110, P135, DOI 10.1530/acta.0.1100135
   RAMIREZ M, 1991, HORM METAB RES, V23, P452, DOI 10.1055/s-2007-1003725
   SCHNEBLI HP, 1979, BIOCHIM BIOPHYS ACTA, V569, P89, DOI 10.1016/0005-2744(79)90084-6
   VERMEULE.A, 1972, J CLIN ENDOCR METAB, V34, P730, DOI 10.1210/jcem-34-4-730
   WRIGHT JW, 1985, NEUROSCI LETT, V61, P351, DOI 10.1016/0304-3940(85)90489-6
NR 14
TC 7
Z9 8
U1 0
U2 1
PU BIRKHAUSER VERLAG AG
PI BASEL
PA PO BOX 133 KLOSTERBERG 23, CH-4010 BASEL, SWITZERLAND
SN 0014-4754
J9 EXPERIENTIA
JI Experientia
PD APR 15
PY 1993
VL 49
IS 4
BP 300
EP 303
PG 4
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA KY755
UT WOS:A1993KY75500006
PM 8477833
DA 2024-02-19
ER

PT J
AU Marquine, MJ
   Umlauf, A
   Rooney, AS
   Fazeli, PL
   Gouaux, BD
   Paul Woods, S
   Letendre, SL
   Ellis, RJ
   Grant, I
   Moore, DJ
AF Marquine, Maria J.
   Umlauf, Anya
   Rooney, Alexandra S.
   Fazeli, Pariya L.
   Gouaux, Ben D.
   Paul Woods, Steven
   Letendre, Scott L.
   Ellis, Ronald J.
   Grant, Igor
   Moore, David J.
CA HIV Neurobehav Res Program HNRP
TI The Veterans Aging Cohort Study Index is Associated With Concurrent Risk
   for Neurocognitive Impairment
SO JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
LA English
DT Article
DE comorbidity; cognition; HIV; aging; cohort study; anemia
ID QUALITY-OF-LIFE; NEUROPSYCHOLOGICAL IMPAIRMENT; COGNITIVE IMPAIRMENT;
   ANTIRETROVIRAL THERAPY; HIV-INFECTION; HEPATITIS-C; MORTALITY;
   PERFORMANCE; DEMENTIA; ERA
AB Objective: The Veterans Aging Cohort Study (VACS) Index is predictive of mortality and combines age, traditional HIV biomarkers (HIV-1 plasma RNA and current CD4 count), and non-HIV biomarkers (indicators of renal and liver function, anemia, and hepatitis C coinfection). We examined the association between the VACS Index and HIV-associated neurocognitive impairment (NCI). Design and Methods: Participants included 601 HIV-infected adults enrolled in cohort studies at the University of California, San Diego, HIV Neurobehavioral Research Program (ages: 18-76 years; 88% male; 63% white; median current CD4 = 364 cells/mm(3); 63% on antiretroviral therapy; AIDS = 64%). Biomarkers used in calculating the VACS Index were measured in prospectively collected blood samples using conventional laboratory methods. NCI was defined using global and seven domain deficit scores. Results: Higher VACS Index scores were associated with concurrent risk for global NCI [P < 0.001; odds ratio = 1.21, confidence interval (CI): 1.12 to 1.32], even when adjusting for psychiatric comorbidities. This relation was statistically significant for most cognitive domains in adjusted models. Furthermore, the VACS Index predicted concurrent NCI beyond nadir CD4 and estimated duration of infection. Older age, lower hemoglobin, and lower CD4 counts were the VACS components most strongly linked to NCI. Conclusions: The findings extend previous research on the potential usefulness of the VACS Index in predicting HIV-associated outcomes to include NCI. Although the effect size was relatively small, our findings suggest that demographic information, HIV-disease factors, and common comorbidities might each play important roles in the clinical manifestation of cognitive impairment among HIV-infected individuals. Additional research is needed to determine if a more sensitive and specific index can be developed.
C1 [Marquine, Maria J.; Umlauf, Anya; Rooney, Alexandra S.; Fazeli, Pariya L.; Gouaux, Ben D.; Paul Woods, Steven; Grant, Igor; Moore, David J.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA.
   [Letendre, Scott L.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA.
   [Ellis, Ronald J.] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA.
C3 University of California System; University of California San Diego;
   University of California System; University of California San Diego;
   University of California System; University of California San Diego
RP Moore, DJ (corresponding author), Univ Calif San Diego, Dept Psychiat, HIV Neurobehav Res Program, 220 Dickinson St,Suite B 8231, San Diego, CA 92103 USA.
EM djmoore@ucsd.edu
RI Ellis, Ronald/K-3543-2015; Letendre, Scott L./GLU-6874-2022
OI Ellis, Ronald/0000-0003-4931-752X; Woods, Steven
   Paul/0000-0003-0776-4233; Moore, David/0000-0001-9699-318X; Fazeli,
   Pariya/0000-0001-6629-0010; Gouaux, Ben/0000-0002-3672-6220
FU NIH funding through the NIMH [P30MH062512, U24 MH100928, U01MH083506,
   R24MH59745]; NIH funding through the NIDA [P30MH062512, U24 MH100928,
   U01MH083506, R24MH59745]; NIH funding through the NINDS [P30MH062512,
   U24 MH100928, U01MH083506, R24MH59745]; National Institute on Drug Abuse
   Program Project Grant [P01-DA12065];  [T32DA031098]
FX Supported by NIH funding through the NIMH, NIDA, and NINDS institutes by
   the following grants: The HIV Neurobehavioral Research Center (HNRC),
   P30MH062512; California NeuroAIDS Tissue Network (CNTN), U24 MH100928,
   U01MH083506, and R24MH59745; National Institute on Drug Abuse Program
   Project Grant, P01-DA12065; and Training in Research on Addictions in
   Interdisciplinary NeuroAIDS (TRAIN), T32DA031098.
CR Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13
   BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004
   Becker JT, 2009, NEUROLOGY, V73, P1292, DOI 10.1212/WNL.0b013e3181bd10e7
   Bhaskaran K, 2008, ANN NEUROL, V63, P213, DOI 10.1002/ana.21225
   Carey CL, 2004, J CLIN EXP NEUROPSYC, V26, P307, DOI 10.1080/13803390490510031
   Cherner M, 2007, ARCH CLIN NEUROPSYCH, V22, P343, DOI 10.1016/j.acn.2007.01.009
   Cherner M, 2005, NEUROLOGY, V64, P1343, DOI 10.1212/01.WNL.0000158328.26897.0D
   Cherner M, 2004, AIDS, V18, pS27, DOI 10.1097/00002030-200401001-00005
   Cysique LA, 2010, HIV MED, V11, P642, DOI 10.1111/j.1468-1293.2010.00834.x
   Cysique LA, 2011, J CLIN EXP NEUROPSYC, V33, P505, DOI 10.1080/13803395.2010.535504
   Deeks SG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3172
   Ellis RJ, 1997, ARCH NEUROL-CHICAGO, V54, P416, DOI 10.1001/archneur.1997.00550160054016
   Ellis RJ, 2011, AIDS, V25, P1747, DOI 10.1097/QAD.0b013e32834a40cd
   First M. B., 2016, Structured Clinical Interview for DSM-IV-TR Axis I Disorders-Nonpatient Edition
   Gorelick PB, 2010, ANN NY ACAD SCI, V1207, P155, DOI 10.1111/j.1749-6632.2010.05726.x
   Hasin DS, 1996, AM J PSYCHIAT, V153, P1195
   Heaton R K, 1995, J Int Neuropsychol Soc, V1, P231
   Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727
   Heaton R. K., 2004, REVISED COMPREHENSIV, DOI [10.1136/gut.2007.122176, DOI 10.1136/GUT.2007.122176]
   Heaton RK, 2004, J INT NEUROPSYCH SOC, V10, P317, DOI 10.1017/S1355617704102130
   Heaton RK, 2010, J NEUROVIROL, V16, P37
   Heaton RK, 2008, J NEUROVIROL, V14, P536, DOI 10.1080/13550280802378880
   Hinkin CH, 2004, AIDS, V18, pS19, DOI 10.1097/00002030-200418001-00004
   Hinkin CH, 2008, J ADDICT DIS, V27, P11, DOI 10.1300/J069v27n02_02
   Justice AC, 2010, HIV MED, V11, P143, DOI 10.1111/j.1468-1293.2009.00757.x
   Justice AC, 2013, JAIDS-J ACQ IMM DEF, V62, P149, DOI 10.1097/QAI.0b013e31827df36c
   Justice AC, 2012, CLIN INFECT DIS, V55, P751, DOI 10.1093/cid/cis539
   Justice AC, 2012, CLIN INFECT DIS, V54, P984, DOI 10.1093/cid/cir989
   Lyons JL, 2011, JAIDS-J ACQ IMM DEF, V57, P371, DOI 10.1097/QAI.0b013e3182237e54
   Marcotte TD, 2004, NEUROLOGY, V63, P1417, DOI 10.1212/01.WNL.0000141920.33580.5D
   May MT, 2006, LANCET, V368, P451, DOI 10.1016/S0140-6736(06)69152-6
   MCARTHUR JC, 1993, NEUROLOGY, V43, P2245, DOI 10.1212/WNL.43.11.2245
   McCrea M, 1996, ARCH NEUROL-CHICAGO, V53, P758, DOI 10.1001/archneur.1996.00550080076015
   Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006
   Rippeth JD, 2004, J INT NEUROPSYCH SOC, V10, P1, DOI 10.1017/S1355617704101021
   Ryan EL, 2004, NEUROLOGY, V62, P957, DOI 10.1212/01.WNL.0000115177.74976.6C
   Sacktor N, 2003, NEUROLOGY, V61, P567, DOI 10.1212/01.WNL.0000076477.71313.6E
   Sorrell JH, 2006, PSYCHIAT CLIN NEUROS, V60, P174, DOI 10.1111/j.1440-1819.2006.01483.x
   Stern Y, 2001, ARCH NEUROL-CHICAGO, V58, P473, DOI 10.1001/archneur.58.3.473
   Tate DF, 2011, ARCH CLIN NEUROPSYCH, V26, P614, DOI 10.1093/arclin/acr065
   Tate JP, 2013, AIDS, V27, P563, DOI 10.1097/QAD.0b013e32835b8c7f
   Tozzi V, 2004, INT J STD AIDS, V15, P254, DOI 10.1258/095646204773557794
   Tozzi V, 2003, AIDS RES HUM RETROV, V19, P643, DOI 10.1089/088922203322280856
   Valcour V, 2004, NEUROLOGY, V63, P822, DOI 10.1212/01.WNL.0000134665.58343.8D
   Wilkie FL, 1998, J NEUROPSYCH CLIN N, V10, P125, DOI 10.1176/jnp.10.2.125
   Woods SP, 2004, J CLIN EXP NEUROPSYC, V26, P759, DOI 10.1080/13803390490509565
   World Health Organization, 1997, COMP INT DIAGN INT
   Yaffe K, 2010, J AM GERIATR SOC, V58, P338, DOI 10.1111/j.1532-5415.2009.02670.x
NR 48
TC 60
Z9 67
U1 0
U2 8
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1525-4135
EI 1077-9450
J9 JAIDS-J ACQ IMM DEF
JI JAIDS
PD FEB 1
PY 2014
VL 65
IS 2
BP 190
EP 197
DI 10.1097/QAI.0000000000000008
PG 8
WC Immunology; Infectious Diseases
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Immunology; Infectious Diseases
GA AG8DZ
UT WOS:000335650300022
PM 24442225
OA Green Accepted, Bronze
DA 2024-02-19
ER

PT J
AU Cousins, G
   Galvin, R
   Flood, M
   Kennedy, MC
   Motterlini, N
   Henman, MC
   Kenny, RA
   Fahey, T
AF Cousins, Grainne
   Galvin, Rose
   Flood, Michelle
   Kennedy, Mary-Claire
   Motterlini, Nicola
   Henman, Martin C.
   Kenny, Rose-Anne
   Fahey, Tom
TI Potential for alcohol and drug interactions in older adults: evidence
   from the Irish longitudinal study on ageing
SO BMC GERIATRICS
LA English
DT Article
DE Drug interactions; Alcohol interactive medications; Alcohol
   drinking/epidemiology; Aged
ID RISK DRINKING; CAGE QUESTIONNAIRE; PREVALENCE; CONSUMPTION; POPULATION;
   MEDICATION; DISORDERS; VALIDITY; PROFILE; PEOPLE
AB Background: Older adults are susceptible to adverse effects from the concomitant use of prescription medications and alcohol. This study estimates the prevalence of exposure to alcohol interactive (AI) medications and concomitant alcohol use by therapeutic class in a large, nationally representative sample of older adults.
   Methods: Cross-sectional analysis of a population based sample of older Irish adults aged >= 60 years using data from The Irish Longitudinal Study on Ageing (TILDA) (N = 3,815). AI medications were identified using Stockley's Drug Interactions, the British National Formulary and the Irish Medicines Formulary. An in-home inventory of medications was used to characterise AI drug exposure by therapeutic class. Self-reported alcohol use was classified as non-drinker, light/moderate and heavy drinking. Comorbidities known to be exacerbated by alcohol were also recorded (diabetes mellitus, hypertension, peptic ulcer disease, liver disease, depression, gout or breast cancer), as well as sociodemographic and health factors.
   Results: Seventy-two per cent of participants were exposed to AI medications, with greatest exposure to cardiovascular and CNS agents. Overall, 60% of participants exposed to AI medications reported concomitant alcohol use, compared with 69.5% of non-AI exposed people (p < 0.001). Almost 28% of those reporting anti-histamine use were identified as heavy drinkers. Similarly almost one in five, combined heavy drinking with anti-coagulants/anti-platelets and cardiovascular agents, with 16% combining heavy drinking with CNS agents. Multinomial logistic regression showed that being male, younger, urban dwelling, with higher levels of education and a history of smoking, were associated with an increased risk for concomitant exposure to alcohol consumption (both light/moderate and heavier) and AI medications. Current smokers and people with increasing co-morbidities were also at greatest risk for heavy drinking in combination with AI medications.
   Conclusions: The concurrent use of alcohol with AI medications, or with conditions known to be exacerbated by alcohol, is common among older Irish adults. Prescribers should be aware of potential interactions, and screen patients for alcohol use and provide warnings to minimize patient risk.
C1 [Cousins, Grainne; Flood, Michelle] Royal Coll Surgeons Ireland, Sch Pharm, Dublin 2, Ireland.
   [Cousins, Grainne; Galvin, Rose; Motterlini, Nicola; Fahey, Tom] Royal Coll Surgeons Ireland, HRB Ctr Primary Care Res, Dept Gen Practice, Dublin 2, Ireland.
   [Kennedy, Mary-Claire; Henman, Martin C.] Trinity Coll Dublin, Sch Pharm & Pharmaceut Sci, Dublin 2, Ireland.
   [Kenny, Rose-Anne] Univ Dublin Trinity Coll, Irish Longitudinal Study Ageing, Dublin 2, Ireland.
C3 Royal College of Surgeons - Ireland; Royal College of Surgeons -
   Ireland; Health Research Board - Ireland; Trinity College Dublin;
   Trinity College Dublin
RP Cousins, G (corresponding author), Royal Coll Surgeons Ireland, Sch Pharm, Dublin 2, Ireland.
EM gcousins@rcsi.ie
RI Fahey, Tom/C-9367-2012; Galvin, Rose/AAL-6072-2020; henman, martin
   charles/D-7606-2013; Cousins, Grainne/C-4807-2015
OI Fahey, Tom/0000-0002-5896-5783; henman, martin
   charles/0000-0002-7922-7691; Cousins, Grainne/0000-0003-2985-7668;
   Kenny, Rose Anne/0000-0002-9336-8124; Galvin, Rose/0000-0002-8171-224X;
   Kennedy, Mary-Claire/0000-0002-3835-2736; Flood,
   Michelle/0000-0002-8284-1780
FU Health Research Board (HRB) of Ireland through the HRB Centre for
   Primary Care Research [HRC/2007/1]; Department of Health and Children;
   Atlantic Philanthropies; Irish Life
FX This work was supported by the Health Research Board (HRB) of Ireland
   through the HRB Centre for Primary Care Research under Grant HRC/2007/1.
   The TILDA study was supported by Department of Health and Children, The
   Atlantic Philanthropies and Irish Life.
CR ADAMS WL, 1995, J AM GERIATR SOC, V43, P1021, DOI 10.1111/j.1532-5415.1995.tb05567.x
   Adams WL, 1995, INT J ADDICT, V30, P1903, DOI 10.3109/10826089509071060
   ADAMS WL, 1990, J AM GERIATR SOC, V38, P211, DOI 10.1111/j.1532-5415.1990.tb03493.x
   Aira M, 2005, INT J GERIATR PSYCH, V20, P680, DOI 10.1002/gps.1340
   [Anonymous], 2013, IRISH MED FORMULARY, P14
   [Anonymous], 2009, STANDARD DRINK IRELA
   [Anonymous], 2005, HELP PAT WHO DRINK M
   Barnes A, 2010, ANTIGONISH REV, P25
   Baxter K, 2013, Stockley's drug interactions, VTenth
   Beekman ATF, 1997, PSYCHOL MED, V27, P231, DOI 10.1017/S0033291796003510
   BUCHSBAUM DG, 1992, J AM GERIATR SOC, V40, P662, DOI 10.1111/j.1532-5415.1992.tb01956.x
   CHRISCHILLES EA, 1992, J GERONTOL, V47, pM137, DOI 10.1093/geronj/47.5.M137
   CURTIS JR, 1989, J AM GERIATR SOC, V37, P310, DOI 10.1111/j.1532-5415.1989.tb05496.x
   Dawson DA, 2003, ALCOHOL RES HEALTH, V27, P18
   Del Boca FK, 2003, ADDICTION, V98, P1, DOI 10.1046/j.1359-6357.2003.00586.x
   EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905
   Forster L E, 1993, J Community Health, V18, P225, DOI 10.1007/BF01324433
   Grant BF, 2004, DRUG ALCOHOL DEPEN, V74, P223, DOI 10.1016/j.drugalcdep.2004.02.004
   Hallgren M, 2009, ALCHOL CONSUMPTION A
   Hoeck S, 2012, EUR J PUBLIC HLTH
   Ilomäki J, 2008, ALCOHOL, V42, P261, DOI 10.1016/j.alcohol.2008.02.002
   Immonen S, 2011, J NUTR HEALTH AGING, V15, P789, DOI 10.1007/s12603-011-0115-4
   Immonen S, 2013, SCAND J PRIM HEALTH, V31, P73, DOI 10.3109/02813432.2013.788272
   JINKS MJ, 1990, DICP ANN PHARMAC, V24, P971, DOI 10.1177/106002809002401012
   Joint_ Formulary_Committee, 2013, BRIT NATL FORMULARY
   Kearney PM, 2011, INT J EPIDEMIOL, V40, P877, DOI 10.1093/ije/dyr116
   Kirchner JE, 2007, J GEN INTERN MED, V22, P92, DOI 10.1007/s11606-006-0017-z
   Merrick EL, 2008, J AM GERIATR SOC, V56, P214, DOI 10.1111/j.1532-5415.2007.01539.x
   Moore AA, 1999, MED CARE, V37, P165, DOI 10.1097/00005650-199902000-00007
   Moore Alison A, 2007, Am J Geriatr Pharmacother, V5, P64, DOI 10.1016/j.amjopharm.2007.03.006
   Moore AA, 2006, J AM GERIATR SOC, V54, P757, DOI 10.1111/j.1532-5415.2006.00728.x
   O'Connell H, 2003, BMJ-BRIT MED J, V327, P664, DOI 10.1136/bmj.327.7416.664
   Pringle KE, 2005, J AM GERIATR SOC, V53, P1930, DOI 10.1111/j.1532-5415.2005.00474.x
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Rehm J, 2012, DRUG ALCOHOL REV, V31, P156, DOI 10.1111/j.1465-3362.2011.00395.x
   Smith RG, 2009, J AM PODIAT MED ASSN, V99, P81, DOI 10.7547/0980081
   Tanaka E, 2003, J CLIN PHARM THER, V28, P81, DOI 10.1046/j.1365-2710.2003.00459.x
   VESTAL RE, 1977, CLIN PHARMACOL THER, V21, P343
   Weathermon R, 1999, ALCOHOL RES HEALTH, V23, P40
NR 39
TC 45
Z9 47
U1 0
U2 19
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2318
J9 BMC GERIATR
JI BMC Geriatr.
PD APR 27
PY 2014
VL 14
AR 57
DI 10.1186/1471-2318-14-57
PG 10
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA AG6WE
UT WOS:000335558500001
PM 24766969
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Efimenko, A
   Dzhoyashvili, N
   Kalinina, N
   Kochegura, T
   Akchurin, R
   Tkachuk, V
   Parfyonova, Y
AF Efimenko, Anastasia
   Dzhoyashvili, Nina
   Kalinina, Natalia
   Kochegura, Tatiana
   Akchurin, Renat
   Tkachuk, Vsevolod
   Parfyonova, Yelena
TI Adipose-Derived Mesenchymal Stromal Cells From Aged Patients With
   Coronary Artery Disease Keep Mesenchymal Stromal Cell Properties but
   Exhibit Characteristics of Aging and Have Impaired Angiogenic Potential
SO STEM CELLS TRANSLATIONAL MEDICINE
LA English
DT Article
DE Adipose-derived stromal cells; Aging; Cell therapy; Therapeutic
   angiogenesis; Urokinase receptor; Coronary artery disease
ID PLASMINOGEN-ACTIVATOR INHIBITOR-1; STEM-CELLS; REGENERATIVE CELLS;
   ISCHEMIC SKELETAL; TISSUE; DIFFERENTIATION; TRANSPLANTATION; EXPRESSION;
   MECHANISMS; SECRETION
AB Tissue regeneration is impaired in aged individuals. Adipose-derived mesenchymal stromal cells (ADSCs), a promising source for cell therapy, were shown to secrete various angiogenic factors and improve vascularization of ischemic tissues. We analyzed how patient age affected the angiogenic properties of ADSCs. ADSCs were isolated from subcutaneous fat tissue of patients with coronary artery disease (CAD; n = 64,43-77 years old) and without CAD (n = 31, 2-82 years old). ADSC phenotype characterized by flow cytometry was CD90(+)/CD73(+)/CD105(+)/CD45(-)/CD31(-) for all samples, and these cells were capable of adipogenic and osteogenic differentiation. ADSCs from aged patients had shorter telomeres (quantitative reverse transcription polymerase chain reaction) and a tendency to attenuated telomerase activity. ADSC-conditioned media (ADSC-CM) stimulated capillary-like tube formation by endothelial cells (EA.hy926), and this effect significantly decreased with the age of patients both with and without CAD. Angiogenic factors (vascular endothelial growth factor, placental growth factor, hepatocyte growth factor, angiopoetin-1, and angiogenin) in ADSC-CM measured by enzyme-linked immunosorbent assay significantly decreased with patient age, whereas levels of anti-angiogenic factors thrombospondin-1 and endostatin did not. Expression of angiogenic factors in ADSCs did not change with patient age (real-time polymerase chain reaction); however, gene expression of factors related to extracellular proteolysis (urokinase and its receptor, plasminogen activator inhibitor-1) and urokinase-type plasminogen activator receptor surface expression increased in ADSCs from aged patients with CAD. ADSCs from aged patients both with and without CAD acquire aging characteristics, and their angiogenic potential declines because of decreasing proangiogenic factor secretion. This could restrict the effectiveness of autologous cell therapy with ADSCs in aged patients.
C1 [Efimenko, Anastasia; Dzhoyashvili, Nina; Kalinina, Natalia; Kochegura, Tatiana; Tkachuk, Vsevolod; Parfyonova, Yelena] Moscow MV Lomonosov State Univ, Fac Med, Moscow 119192, Russia.
   [Akchurin, Renat; Tkachuk, Vsevolod; Parfyonova, Yelena] Russian Cardiol Res & Prod Complex, Moscow, Russia.
C3 Lomonosov Moscow State University; National Medical Research Center of
   Cardiology
RP Efimenko, A (corresponding author), Moscow MV Lomonosov State Univ, Fac Med, Lomonosovsky Ave 31-5, Moscow 119192, Russia.
EM efimenkoan@gmail.com
RI Tkachuk, Vsevolod A/J-9357-2012; Tkachuk, Vsevolod/AAE-1136-2022;
   Kalinina, Natalia/AAN-6763-2020; Akchurin, Renat S/B-7762-2019;
   Efimenko, Anastasia/AAN-8692-2020; Kalinina, Natalia I./L-6475-2013;
   Parfyonova, Yelena/B-9307-2014
OI Kalinina, Natalia/0000-0003-3497-9619; Akchurin, Renat
   S/0000-0002-6726-4612; Efimenko, Anastasia/0000-0002-0696-1369;
   Kalinina, Natalia I./0000-0003-3497-9619; Tkachuk,
   Vsevolod/0000-0002-7492-747X; Parfyonova, Yelena/0000-0002-0969-5780;
   Akchurin, Renat S./0000-0002-1252-283X
FU European Union [241558]; Russian Ministry of Science and Education
   within the FTP [02.527.11.0007]; Russian Federal Agency of Science and
   Innovation [16.512.11.2251, 11.519.11.6042]; Russian Foundation for
   Basic Research [11-04-01850-a]
FX This work was supported by the European Union Seventh Framework
   Programme (FP7/2007-2013) (grant agreement no. 241558) (SICA-HF), the
   Russian Ministry of Science and Education within the FTP "R&D in
   Priority Fields of the S&T Complex of Russia 2007-2012" (no.
   02.527.11.0007), the Russian Federal Agency of Science and Innovation
   (nos. 16.512.11.2251 and 11.519.11.6042), and the Russian Foundation for
   Basic Research (no. 11-04-01850-a). The sponsors were not involved in
   the study design; in the collection, analysis, and interpretation of
   data; in the writing of the report; or in the decision to submit the
   article for publication. We thank Dr. I.O. Golubev and Dr. V.I. Makunin
   for valuable help in delivery of fat tissue samples from patients
   without cardiovascular pathology. We also thank G.V. Sharonov for
   performing flow cytometry, E.E. Starostina and E.V. Gluhanyuk for their
   contribution to data collection, and the staff of the Faculty of
   Medicine of Lomonosov Moscow State University for assistance with this
   study.
CR Alt EU, 2012, STEM CELL RES, V8, P215, DOI 10.1016/j.scr.2011.11.002
   Aranda E, 2009, BIOL RES, V42, P377, DOI [10.4067/S0716-97602009000300012, /S0716-97602009000300012]
   Bailey AM, 2010, CURR STEM CELL RES T, V5, P95
   Cai LY, 2009, STEM CELLS, V27, P230, DOI 10.1634/stemcells.2008-0273
   Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47
   Cesari M, 2010, CARDIOVASC THER, V28, pe72, DOI 10.1111/j.1755-5922.2010.00171.x
   Chae JK, 2000, ARTERIOSCL THROM VAS, V20, P2573, DOI 10.1161/01.ATV.20.12.2573
   de Girolamo L, 2009, CYTOTHERAPY, V11, P793, DOI 10.3109/14653240903079393
   Devy L, 2002, FASEB J, V16, DOI 10.1096/fj.01-0552com
   Distler JHW, 2003, Q J NUCL MED, V47, P149
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Efimenko A, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-10
   El-Ftesi S, 2009, PLAST RECONSTR SURG, V123, P475, DOI 10.1097/PRS.0b013e3181954d08
   Fan M, 2010, REJUV RES, V13, P429, DOI 10.1089/rej.2009.0986
   Fehrer C, 2005, EXP GERONTOL, V40, P926, DOI 10.1016/j.exger.2005.07.006
   Flores I, 2010, FEBS LETT, V584, P3826, DOI 10.1016/j.febslet.2010.07.042
   Gao XW, 2008, ACTA BIOCH BIOPH SIN, V40, P619, DOI 10.1111/j.1745-7270.2008.00442.x
   Ghosh AK, 2012, J CELL PHYSIOL, V227, P493, DOI 10.1002/jcp.22783
   Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09
   Gimble JM, 2011, STEM CELLS, V29, P749, DOI 10.1002/stem.629
   Harris LJ, 2010, J SURG RES, V163, pE105, DOI 10.1016/j.jss.2010.04.025
   Herrmann JL, 2011, J SURG RES, V166, P138, DOI 10.1016/j.jss.2010.05.057
   Huang SC, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-18
   Jaulmes A, 2009, THROMB RES, V124, P439, DOI 10.1016/j.thromres.2009.05.018
   JIMI S, 1995, BIOCHEM BIOPH RES CO, V211, P476, DOI 10.1006/bbrc.1995.1838
   Kachgal S, 2011, ANGIOGENESIS, V14, P47, DOI 10.1007/s10456-010-9194-9
   Katsara O, 2011, STEM CELLS DEV, V20, P1550, DOI 10.1089/scd.2010.0280
   Khan M, 2011, J CELL MOL MED, V15, P1515, DOI 10.1111/j.1582-4934.2009.00998.x
   Khan WS, 2009, INJURY, V40, P150, DOI 10.1016/j.injury.2008.05.029
   Kim M, 2012, MECH AGEING DEV, V133, P215, DOI 10.1016/j.mad.2012.03.014
   Kondo K, 2009, ARTERIOSCL THROM VAS, V29, P61, DOI 10.1161/ATVBAHA.108.166496
   Lawler PR, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006627
   Liu RM, 2010, J BIOL CHEM, V285, P16239, DOI 10.1074/jbc.M110.111732
   Madonna R, 2011, EUR J CLIN INVEST, V41, P126, DOI 10.1111/j.1365-2362.2010.02384.x
   Madonna R, 2010, J CARDIOVASC MED, V11, P71, DOI 10.2459/JCM.0b013e328330e9be
   Madonna R, 2009, ARTERIOSCL THROM VAS, V29, P1723, DOI 10.1161/ATVBAHA.109.187179
   Miranville A, 2004, CIRCULATION, V110, P349, DOI 10.1161/01.CIR.0000135466.16823.D0
   Miyahara Y, 2006, NAT MED, V12, P459, DOI 10.1038/nm1391
   Murohara T, 2009, CURR PHARM DESIGN, V15, P2784, DOI 10.2174/138161209788923796
   Nakagami H, 2006, J ATHEROSCLER THROMB, V13, P77, DOI 10.5551/jat.13.77
   Nombela-Arrieta C, 2011, NAT REV MOL CELL BIO, V12, P126, DOI 10.1038/nrm3049
   Pandey AC, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt90
   Pandey M, 2005, FASEB J, V19, P1317, DOI 10.1096/fj.04-3459fje
   Parfyonova YV, 2002, BIOCHEMISTRY-MOSCOW+, V67, P119, DOI 10.1023/A:1013964517211
   Planat-Benard V, 2004, CIRCULATION, V109, P656, DOI 10.1161/01.CIR.0000114522.38265.61
   Poettler M, 2012, THROMB HAEMOSTASIS, V108, P357, DOI 10.1160/TH11-12-0868
   Raghu H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012458
   Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1
   Reiss Y, 2010, RECENT RESULTS CANC, V180, P3, DOI 10.1007/978-3-540-78281-0_2
   Rubina K, 2009, TISSUE ENG PT A, V15, P2039, DOI 10.1089/ten.tea.2008.0359
   Sahin E, 2010, NATURE, V464, P520, DOI 10.1038/nature08982
   Sethe S, 2006, AGEING RES REV, V5, P91, DOI 10.1016/j.arr.2005.10.001
   Shevchenko EK, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-138
   Song N, 2012, ANGIOGENESIS, V15, P697, DOI 10.1007/s10456-012-9284-y
   Stolzing A, 2008, MECH AGEING DEV, V129, P163, DOI 10.1016/j.mad.2007.12.002
   Sumi M, 2007, LIFE SCI, V80, P559, DOI 10.1016/j.lfs.2006.10.020
   Sun Y, 2011, FASEB J, V25, P1474, DOI 10.1096/fj.10-161497
   Thurston G, 1999, SCIENCE, V286, P2511, DOI 10.1126/science.286.5449.2511
   Traktuev DO, 2006, KARDIOLOGIYA, V46, P53
   Traktuev DO, 2007, MOL THER, V15, P1939, DOI 10.1038/sj.mt.6300262
   Williams AR, 2011, CIRC RES, V109, P923, DOI 10.1161/CIRCRESAHA.111.243147
   Zhang DZ, 2007, CHINESE MED J-PEKING, V120, P300, DOI 10.1097/00029330-200702020-00009
   Zhu M, 2009, J TISSUE ENG REGEN M, V3, P290, DOI 10.1002/term.165
NR 63
TC 88
Z9 103
U1 0
U2 19
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2157-6564
EI 2157-6580
J9 STEM CELL TRANSL MED
JI Stem Cells Transl. Med.
PD JAN
PY 2014
VL 3
IS 1
BP 32
EP 41
DI 10.5966/sctm.2013-0014
PG 10
WC Cell & Tissue Engineering
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA 294AE
UT WOS:000330014000005
PM 24353175
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Wu, J
   Yang, SG
   Xu, KJ
   Ding, C
   Zhou, YQ
   Fu, XF
   Li, YP
   Deng, M
   Wang, CC
   Liu, XX
   Li, LJ
AF Wu, Jie
   Yang, Shigui
   Xu, Kaijin
   Ding, Cheng
   Zhou, Yuqing
   Fu, Xiaofang
   Li, Yiping
   Deng, Min
   Wang, Chencheng
   Liu, Xiaoxiao
   Li, Lanjuan
TI Patterns and Trends of Liver Cancer Incidence Rates in Eastern and
   Southeastern Asian Countries (1983-2007) and Predictions to 2030
SO GASTROENTEROLOGY
LA English
DT Article
DE Epidemiology; HCC; ICC; Hepatitis
ID LOCALLY WEIGHTED REGRESSION; HEPATOCELLULAR-CARCINOMA; HEPATITIS-B;
   INTERNATIONAL TRENDS; EPIDEMIOLOGY; INFECTION; MORTALITY; POPULATION;
   CHINA; AGE
AB BACKGROUND & AIMS: We examined temporal trends in liver cancer incidence rates overall and by histological type from 1983 through 2007. We predict trends in liver cancer incidence rates through 2030 for selected Eastern and Southeastern Asian countries. METHODS: Data on yearly liver cancer incident cases by age group and sex were drawn from 6 major selected Eastern and Southeastern Asian countries or regions with cancer registries available in the CI5plus database, including China, Japan, Hong Kong Special Administrative Region (SAR), the Philippines, Singapore, and Thailand. We also analyzed data for the United States and Australia for comparative purposes. Age-standardized incidence rates were calculated and plotted from 1983 through 2007. Numbers of new cases and incidence rates were predicted through 2030 by fitting and extrapolating age-period-cohort models. RESULTS: The incidence rates of liver cancer have been decreasing, and decreases will continue in all selected Eastern and Southeastern Asian countries, except for Thailand, whose liver cancer incidence rate will increase due to the increasing incidence rate of intrahepatic cholangiocarcinomas. Even though the incidence rates of liver cancer are predicted to decrease in most Eastern and Southeastern Asian countries, the burden, in terms of new cases, will continue to increase because of population growth and aging. CONCLUSIONS: Based on an analysis of data from cancer registries from Asian countries, incidence rates of liver cancer are expected to decrease through 2030 in most Eastern and Southeastern Asian countries. However, in Thailand, the incidence rate of intrahepatic cholangiocarcinomas is predicted to increase, so health education programs are necessary.
C1 [Wu, Jie; Yang, Shigui; Xu, Kaijin; Ding, Cheng; Zhou, Yuqing; Fu, Xiaofang; Deng, Min; Wang, Chencheng; Liu, Xiaoxiao; Li, Lanjuan] Zhejiang Univ, Coll Med, Affiliated Hosp 1,State Key Lab Diag & Treatment, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310003, Zhejiang, Peoples R China.
   [Li, Yiping] Zhejiang Inst Med Care Informat Technol, Hangzhou, Zhejiang, Peoples R China.
C3 Collaborative Innovation Center for Diagnosis & Treatment of Infectious
   Diseases; Zhejiang University
RP Li, LJ (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 1,State Key Lab Diag & Treatment, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310003, Zhejiang, Peoples R China.
EM ljli@zju.edu.cn
RI Zhou, Yujie/HZI-3990-2023; ZHOU, yf/IAO-5497-2023; Liu,
   Xiaoxiao/HNI-6180-2023; sun, rong/JRX-7214-2023; Wang,
   Jing/IQW-3496-2023; WANG, JINGYI/GSJ-1241-2022; Jiang,
   Yalin/ITV-2565-2023
OI Wang, Jing/0000-0002-8296-2961; Wu, Jie/0000-0001-8615-1667
FU Mega-Project of National Science and Technology for the 12th Five-Year
   Plan of China [2013ZX10004901, 2013ZX10004904, 2014ZX10004008]; National
   Natural Science Foundation of China [81672005]; key project for data
   center of the National Natural Science Foundation of China; Guangdong
   Provincial Government [U1611264]
FX This study was supported by grants from the Mega-Project of National
   Science and Technology for the 12th Five-Year Plan of China
   (2013ZX10004901, 2013ZX10004904, and 2014ZX10004008), the National
   Natural Science Foundation of China (81672005), and the key project for
   data center of the National Natural Science Foundation of China and
   Guangdong Provincial Government (U1611264).
CR Ahmad O., 2001, GPE DISCUSSION PAPER, V31, P1
   Amin J, 2006, LANCET, V368, P938, DOI 10.1016/S0140-6736(06)69374-4
   [Anonymous], 2017, WORLD POP PROSP
   Center MM, 2011, CANCER EPIDEM BIOMAR, V20, P2362, DOI 10.1158/1055-9965.EPI-11-0643
   Chen WQ, 2017, CANCER LETT, V401, P63, DOI 10.1016/j.canlet.2017.04.024
   Clegg LX, 2009, STAT MED, V28, P3670, DOI 10.1002/sim.3733
   CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407
   CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282
   de Martel C, 2015, HEPATOLOGY, V62, P1190, DOI 10.1002/hep.27969
   El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061
   El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683
   Fan JG, 2017, J HEPATOL, V67, P862, DOI 10.1016/j.jhep.2017.06.003
   Ferlay J., 2014, Cancer Incidence in Five Continents
   Islami F, 2017, CA-CANCER J CLIN, V67, P273, DOI 10.3322/caac.21402
   Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.3.CO;2-Q
   McGlynn KA, 2015, CLIN LIVER DIS, V19, P223, DOI 10.1016/j.cld.2015.01.001
   Mittal S, 2013, J CLIN GASTROENTEROL, V47, pS2, DOI 10.1097/MCG.0b013e3182872f29
   Moller B, 2002, EUR J CANCER PREV, V11, pS1
   National Cancer Institute, Average annual percent change (AAPC) and confidence interval
   Nordenstedt H, 2010, DIGEST LIVER DIS, V42, pS206, DOI 10.1016/S1590-8658(10)60507-5
   OSMOND C, 1985, INT J EPIDEMIOL, V14, P124, DOI 10.1093/ije/14.1.124
   Parkin DM, 2010, INT J CANCER, V127, P2918, DOI 10.1002/ijc.25517
   Ryerson AB, 2016, CANCER-AM CANCER SOC, V122, P1312, DOI 10.1002/cncr.29936
   Saengsawang P, 2013, ASIAN PAC J CANCER P, V14, P2963, DOI 10.7314/APJCP.2013.14.5.2963
   Schottenfeld D., 2006, CANC EPIDEMIOLOGY PR
   Shin A, 2011, ANN ONCOL, V22, P1435, DOI 10.1093/annonc/mdq592
   Sripa B, 2008, CURR OPIN GASTROEN, V24, P349, DOI 10.1097/MOG.0b013e3282fbf9b3
   Sripa B, 2007, PLOS MED, V4, P1148, DOI 10.1371/journal.pmed.0040201
   Sun ZT, 2013, CARCINOGENESIS, V34, P1800, DOI 10.1093/carcin/bgt007
   Tanaka H, 2008, ANN INTERN MED, V148, P820, DOI 10.7326/0003-4819-148-11-200806030-00004
   Tanaka M, 2011, J EPIDEMIOL, V21, P401, DOI 10.2188/jea.JE20100190
   Torre LA, 2016, CANCER EPIDEM BIOMAR, V25, P16, DOI 10.1158/1055-9965.EPI-15-0578
   Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262
   Virani S, 2017, CANCERS, V9, DOI [10.3390/cancers9080, 10.3390/cancers9080108]
   Welzel TM, 2013, AM J GASTROENTEROL, V108, P1314, DOI 10.1038/ajg.2013.160
   Wiangnon S, 2012, ASIAN PAC J CANCER P, V13, P1065, DOI 10.7314/APJCP.2012.13.3.1065
   Wong MCS, 2017, SCI REP-UK, V7, DOI 10.1038/srep45846
   World Health Organization, 2013, INT CLASSIFICATION D, V3rd ed.
   Zhang Y, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1113-4
NR 39
TC 62
Z9 69
U1 4
U2 49
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0016-5085
EI 1528-0012
J9 GASTROENTEROLOGY
JI Gastroenterology
PD MAY
PY 2018
VL 154
IS 6
BP 1719
EP +
DI 10.1053/j.gastro.2018.01.033
PG 15
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA GG1RO
UT WOS:000432464700038
PM 29549041
DA 2024-02-19
ER

PT J
AU Jin, JL
   Iakova, P
   Jiang, YJ
   Medrano, EE
   Timchenko, NA
AF Jin, Jingling
   Iakova, Polina
   Jiang, Yanjun
   Medrano, Estela E.
   Timchenko, Nikolai A.
TI The Reduction of SIRT1 in Livers of Old Mice Leads to Impaired Body
   Homeostasis and to Inhibition of Liver Proliferation
SO HEPATOLOGY
LA English
DT Article
ID C/EBP-ALPHA; PARTIAL-HEPATECTOMY; REGENERATION; GLUCOSE; BETA; ARREST;
   RATS
AB Age declines liver functions, leading to the development of age-associated diseases. A member of the sirtuins family, SIRT1, is involved in the control of glucose homeostasis and fat metabolism. Because aging livers have alterations in glucose and fat metabolism, we examined a possible role of SIRT1 in these alterations. We found that aged livers have a reduced expression of SIRT1 and have lost proper control of the regulation of SIRT1 after partial hepatectomy (PH). Down-regulation of SIRT1 in the liver of old mice is mediated by CCAAT/Enhancer Binding Protein/histone deacetylase 1 (C/EBP beta-HDAC1) complexes,. which bind to and repress the SIRT1 promoter. In the livers of young mice, SIRT1 is activated after PH and supports high levels of glucose and triglycerides during liver regeneration. In old mice, however, C/EBP beta-HDAC1 mediated repression of the SIRT1 promoter blocks activation of SIRT1, leading to low levels of glucose and triglycerides during liver regeneration. Down-regulation of SIRT1 in the livers of young mice resulted in alterations similar to those observed in the livers of old mice, whereas the normalization of SIRT1 in the livers of old mice corrects the levels of glucose and triglycerides after PH. The normalization of SIRT1 in old mice also improves liver regeneration via the elimination of the Cl, EBP alpha-Brm complex. These studies showed a critical role of the reduction of SIRT1 in age-associated liver dysfunctions and provide a potential tool for the correction of liver functions in old patients after surgical resections. (HEPATOLOGY 2011;54:989-998)
C1 [Timchenko, Nikolai A.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA.
   [Timchenko, Nikolai A.] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA.
   Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.
C3 Baylor College of Medicine; Baylor College of Medicine; Baylor College
   of Medicine
RP Timchenko, NA (corresponding author), Baylor Coll Med, Dept Pathol & Immunol, 1 Baylor Plaza, Houston, TX 77030 USA.
EM nikolait@bcm.tmc.edu
OI Jin, Jingling/0000-0002-4365-1837
FU National Institutes of Health [GM55188, CA100070, AG20752, AG32135]
FX This work was supported by National Institutes of Health grants GM55188,
   CA100070, AG20752 (to N.A.T.), and AG32135 (to E.E.M.).
CR Erion DM, 2009, P NATL ACAD SCI USA, V106, P11288, DOI 10.1073/pnas.0812931106
   Greenbaum LE, 1998, J CLIN INVEST, V102, P996, DOI 10.1172/JCI3135
   Herranz D, 2010, AGING-US, V2, P315, DOI 10.18632/aging.100156
   Iakova P, 2003, CELL, V113, P495, DOI 10.1016/S0092-8674(03)00318-0
   Jin JL, 2010, AGING CELL, V9, P895, DOI 10.1111/j.1474-9726.2010.00617.x
   Jin JL, 2009, MOL CELL BIOL, V29, P3867, DOI 10.1128/MCB.00456-09
   Johnson PF, 2005, J CELL SCI, V118, P2545, DOI 10.1242/jcs.02459
   LAI HS, 1992, JPEN-PARENTER ENTER, V16, P152, DOI 10.1177/0148607192016002152
   Li X, 2007, MOL CELL, V28, P91, DOI 10.1016/j.molcel.2007.07.032
   Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172
   Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002
   Ramsey KM, 2008, AGING CELL, V7, P78, DOI 10.1111/j.1474-9726.2007.00355.x
   Tajima T, 2009, BIOCHEM BIOPH RES CO, V387, P789, DOI 10.1016/j.bbrc.2009.07.115
   Timchenko NA, 2009, TRENDS ENDOCRIN MET, V20, P171, DOI 10.1016/j.tem.2009.01.005
   Wang GL, 2004, GENE DEV, V18, P912, DOI 10.1101/gad.1183304
   Wang GL, 2008, J BIOL CHEM, V283, P26169, DOI 10.1074/jbc.M803544200
   Wang GL, 2008, J BIOL CHEM, V283, P26179, DOI 10.1074/jbc.M803545200
   Wang GL, 2010, J CLIN INVEST, V120, P2549, DOI 10.1172/JCI41933
   Wang HM, 2001, MOL CELL, V8, P817, DOI 10.1016/S1097-2765(01)00366-5
   WANG ND, 1995, SCIENCE, V269, P1108, DOI 10.1126/science.7652557
   Willis-Martinez D, 2010, EXP GERONTOL, V45, P279, DOI 10.1016/j.exger.2009.10.001
   Yi JJ, 2010, BBA-PROTEINS PROTEOM, V1804, P1684, DOI 10.1016/j.bbapap.2010.05.002
NR 22
TC 74
Z9 78
U1 0
U2 3
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0270-9139
J9 HEPATOLOGY
JI Hepatology
PD SEP
PY 2011
VL 54
IS 3
BP 989
EP 998
DI 10.1002/hep.24471
PG 10
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 818FZ
UT WOS:000294738300027
PM 21638299
OA Bronze, Green Accepted
DA 2024-02-19
ER

PT J
AU Jaatinen, P
   Riikonen, J
   Riihioja, P
   Kajander, O
   Hervonen, A
AF Jaatinen, P
   Riikonen, J
   Riihioja, P
   Kajander, O
   Hervonen, A
TI Interaction of aging and intermittent ethanol exposure on brain
   cytochrome <i>c</i> oxidase activity levels
SO ALCOHOL
LA English
DT Article
DE aging; ethanol; cerebellum; prefrontal cortex; locus coeruleus; rat
ID CEREBRAL GLUCOSE-UTILIZATION; CHRONIC ALCOHOL-CONSUMPTION; RAT-LIVER
   MITOCHONDRIA; WITHDRAWAL SYMPTOMS; LOCUS-COERULEUS; LAYER VOLUMES; ANA
   RATS; AGE; NEURONS; METABOLISM
AB The effects of chronic, intermittent ethanol exposure on brain cytochrome c oxidase (CO) activity levels were studied in young (3- to 4-month-old) and aged (29- to 30-month-old) male Wistar rats. The rats were given highly intoxicating doses of ethanol three times a day by intragastric intubation for four successive days, followed by a 3-day ethanol-withdrawal period. This 4-day ethanol-exposure with 3-day ethanol-withdrawal cycle was repeated five times to simulate the binge drinking of human alcoholics. The histochemical demonstration of CO showed a markedly decreased activity level in the medial prefrontal cortex (especially layer V pyramids and neuropil) of the ethanol-exposed rats of both age groups compared with findings for the respective controls. In the cerebellar vermis, CO activity level was decreased in the Purkinje neurons of the aged ethanol-exposed rats and in the granule cells of both young and aged ethanol-exposed rats. The CO activity level in the locus coeruleus was decreased in both young and old ethanol-exposed rats, but the decrease was more pronounced in the young ethanol-exposed group. Aging per se did not markedly change CO histochemical findings in either prefrontal or cerebellar cortex, but CO activity levels were increased in the locus coeruleus. In summary, results of the current study support our conclusion that CO activity levels were decreased in the cerebral and cerebellar cortices as well as in the locus coeruleus-CNS regions known to be negatively affected by chronic ethanol exposure. Defective energy metabolism due to decreased CO activity levels might compromise neuronal energy stores and thereby contribute to ethanol-induced brain dysfunction and irreversible CNS degeneration. (C) 2003 Elsevier Inc. All rights reserved.
C1 Tampere Univ Hosp, Dept Internal Med, FIN-33521 Tampere, Finland.
   Univ Tampere, Sch Med, FIN-33014 Tampere, Finland.
   Univ Tampere, Sch Publ Hlth, FIN-33014 Tampere, Finland.
   Univ Tampere, Inst Med technol, FIN-33014 Tampere, Finland.
C3 Tampere University; Tampere University Hospital; Tampere University;
   Tampere University; Tampere University
RP Jaatinen, P (corresponding author), Tampere Univ Hosp, Dept Internal Med, POB 2000, FIN-33521 Tampere, Finland.
EM pia.jaatinen@uta.fi
RI Jaatinen, Pia/HPD-4586-2023
OI Jaatinen, Pia/0000-0002-8693-3498
CR ADAMS KM, 1993, ALCOHOL CLIN EXP RES, V17, P205, DOI 10.1111/j.1530-0277.1993.tb00750.x
   ARAI M, 1984, BIOCHIM BIOPHYS ACTA, V797, P320, DOI 10.1016/0304-4165(84)90252-6
   ASTONJONES G, 1991, PROG BRAIN RES, V88, P47
   BEAL MF, 1992, ANN NEUROL, V31, P119, DOI 10.1002/ana.410310202
   BERNSTEIN JD, 1978, BIOCHEM PHARMACOL, V27, P2337, DOI 10.1016/0006-2952(78)90141-7
   BORGES S, 1983, NEUROPATH APPL NEURO, V9, P53, DOI 10.1111/j.1365-2990.1983.tb00323.x
   BOWLING AC, 1993, J NEUROCHEM, V60, P1964, DOI 10.1111/j.1471-4159.1993.tb13430.x
   CADETELEITE A, 1990, ALCOHOL, V7, P145, DOI 10.1016/0741-8329(90)90076-O
   CAMPBELL GA, 1982, BRAIN RES, V237, P517, DOI 10.1016/0006-8993(82)90465-6
   CEDERBAUM AI, 1973, J BIOL CHEM, V248, P4977
   CLEMMESEN L, 1988, BRAIN RES, V453, P204, DOI 10.1016/0006-8993(88)90159-X
   Cottrell DA, 2001, NEUROBIOL AGING, V22, P265, DOI 10.1016/S0197-4580(00)00234-7
   CURTI D, 1990, MECH AGEING DEV, V55, P171, DOI 10.1016/0047-6374(90)90024-A
   Davis RE, 1997, P NATL ACAD SCI USA, V94, P4526, DOI 10.1073/pnas.94.9.4526
   DLUGOS CA, 1994, NEUROBIOL AGING, V15, P435, DOI 10.1016/0197-4580(94)90075-2
   ECKARDT MJ, 1988, BRAIN RES, V444, P53, DOI 10.1016/0006-8993(88)90912-2
   ERIKSSON CJ, 1973, BIOCHEM PHARMACOL, V22, P2283, DOI 10.1016/0006-2952(73)90009-9
   Fadda F, 1998, PROG NEUROBIOL, V56, P385, DOI 10.1016/S0301-0082(98)00032-X
   GAGE FH, 1984, J NEUROSCI, V4, P2856
   GRUNWALD F, 1993, J NUCL MED, V34, P793
   HARPER C, 1989, J NEUROL SCI, V92, P81, DOI 10.1016/0022-510X(89)90177-9
   HEMMINGSEN R, 1979, BRAIN RES, V173, P259, DOI 10.1016/0006-8993(79)90626-7
   HEVNER RF, 1989, J NEUROSCI, V9, P3884
   HEVNER RF, 1995, NEUROSCIENCE, V65, P313, DOI 10.1016/0306-4522(94)00514-6
   Kim JH, 2001, NEUROSCI LETT, V305, P107
   KISH SJ, 1992, J NEUROCHEM, V59, P776, DOI 10.1111/j.1471-4159.1992.tb09439.x
   KJELLSTROM C, 1993, ALCOHOL CLIN EXP RES, V17, P406, DOI 10.1111/j.1530-0277.1993.tb00784.x
   KOLB B, 1990, PROG BRAIN RES, V85, P501
   Kril JJ, 1997, NEUROSCIENCE, V79, P983, DOI 10.1016/S0306-4522(97)00083-3
   LINNOILA M, 1980, J STUD ALCOHOL, V41, P488, DOI 10.15288/jsa.1980.41.488
   LOWRY OH, 1975, BRAIN WORK COUPLING, V7, P48
   Lundqvist C, 1995, ALCOHOL ALCOHOLISM, V30, P737
   MarinGarcia J, 1995, ALCOHOL CLIN EXP RES, V19, P1463, DOI 10.1111/j.1530-0277.1995.tb01008.x
   MarinGarcia J, 1996, ALCOHOL CLIN EXP RES, V20, P1029, DOI 10.1111/j.1530-0277.1996.tb01942.x
   NEAFSEY EJ, 1990, PROG BRAIN RES, V85, P147
   PIETRZAK ER, 1989, NEUROSCI LETT, V100, P181, DOI 10.1016/0304-3940(89)90681-2
   Porrino LJ, 1998, ALCOHOL CLIN EXP RES, V22, P176, DOI 10.1097/00000374-199802000-00024
   Puzziferri I, 2000, LIFE SCI, V66, P477, DOI 10.1016/S0024-3205(99)00617-7
   Riihioja P, 1997, ALCOHOL, V14, P537, DOI 10.1016/S0741-8329(97)00044-X
   Riihioja P, 1999, ALCOHOL ALCOHOLISM, V34, P706, DOI 10.1093/alcalc/34.5.706
   Riikonen J, 1999, ALCOHOL CLIN EXP RES, V23, P1245, DOI 10.1111/j.1530-0277.1999.tb04285.x
   Rintala J, 1997, ALCOHOL CLIN EXP RES, V21, P311, DOI 10.1111/j.1530-0277.1997.tb03766.x
   Rintala J, 1998, ALCOHOL, V16, P243, DOI 10.1016/S0741-8329(98)00012-3
   Rubio S, 1996, PHARMACOL BIOCHEM BE, V55, P309, DOI 10.1016/S0091-3057(96)00098-6
   SACHS H, 1987, ARCH NEUROL-CHICAGO, V44, P1242, DOI 10.1001/archneur.1987.00520240024007
   SAMSON Y, 1986, J NEUROL NEUROSUR PS, V49, P1165, DOI 10.1136/jnnp.49.10.1165
   SMITH CB, 1980, BRAIN, V103, P351, DOI 10.1093/brain/103.2.351
   Smith DG, 2001, PHARMACOL BIOCHEM BE, V69, P543, DOI 10.1016/S0091-3057(01)00553-6
   TAVARES MA, 1987, ALCOHOL CLIN EXP RES, V11, P315, DOI 10.1111/j.1530-0277.1987.tb01315.x
   THAYER WS, 1992, ALCOHOL CLIN EXP RES, V16, P1, DOI 10.1111/j.1530-0277.1992.tb00625.x
   THAYER WS, 1990, BIOCHIM BIOPHYS ACTA, V1016, P333, DOI 10.1016/0005-2728(90)90165-Z
   THAYER WS, 1979, J BIOL CHEM, V254, P7717
   THAYER WS, 1981, J BIOL CHEM, V256, P6090
   UYLINGS HBM, 1990, PROG BRAIN RES, V85, P31
   VICTOR M, 1959, ARCH NEUROL-CHICAGO, V1, P579, DOI 10.1001/archneur.1959.03840060001001
   VOGELSPROTT M, 1984, J STUD ALCOHOL, V45, P517, DOI 10.15288/jsa.1984.45.517
   VOLKOW ND, 1992, AM J PSYCHIAT, V149, P1016
   WANG GJ, 1993, RADIOLOGY, V186, P59, DOI 10.1148/radiology.186.1.8416587
   Williams-Hemby L, 1997, ALCOHOL CLIN EXP RES, V21, P1573, DOI 10.1111/j.1530-0277.1997.tb04492.x
   WilliamsHemby L, 1996, PHARMACOL BIOCHEM BE, V54, P415, DOI 10.1016/0091-3057(95)02060-8
   WILLIAMSHEMBY L, 1994, ALCOHOL CLIN EXP RES, V18, P982, DOI 10.1111/j.1530-0277.1994.tb00070.x
   WONGRILEY M, 1979, BRAIN RES, V171, P11, DOI 10.1016/0006-8993(79)90728-5
   WONGRILEY MTT, 1989, TRENDS NEUROSCI, V12, P94, DOI 10.1016/0166-2236(89)90165-3
   YORK JL, 1993, ALCOHOL CLIN EXP RES, V17, P864, DOI 10.1111/j.1530-0277.1993.tb00855.x
NR 64
TC 23
Z9 25
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0741-8329
EI 1873-6823
J9 ALCOHOL
JI Alcohol
PD FEB
PY 2003
VL 29
IS 2
BP 91
EP 100
DI 10.1016/S0741-8329(03)00002-8
PG 10
WC Substance Abuse; Pharmacology & Pharmacy; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Substance Abuse; Pharmacology & Pharmacy; Toxicology
GA 685JA
UT WOS:000183258100005
PM 12782250
DA 2024-02-19
ER

PT J
AU Salmin, SF
   Giroux, MC
   Vachon, P
   Beaudry, F
AF Salmin, Sabrin Fuad
   Giroux, Marie-Chantal
   Vachon, Pascal
   Beaudry, Francis
TI <i>In vitro</i> metabolism of specific CYP2D and CYP3A opioid substrates
   using rat liver S9 fractions and mass spectrometry reveal a severe
   metabolic impairment with increasing age
SO BIOMEDICAL CHROMATOGRAPHY
LA English
DT Article
DE aging; cytochrome P450; drug metabolism; mass spectrometry; opioids
ID SPRAGUE-DAWLEY RATS; DRUG-METABOLISM; OLDER-ADULTS; PHARMACOKINETICS;
   OXYCODONE; XYLAZINE; PAIN; CARE; ANESTHESIA; MICROSOMES
AB Codeine and oxycodone are opioids used to alleviate pain. The outcome of the treatment is ultimately related to their metabolism by Cytochromes P450 (CYPs). Depending on the drugs used, alterations in the metabolism of drugs by CYPs can lead to severe consequences including alterations in their efficacy, safety and toxicity. The objectives of this study were to develop a novel HPLC-MS/MS method capable of quantifying codeine and oxycodone along with specific metabolites using an isotopic dilution strategy and study the rate of formation of morphine (CYP2D), norcodeine (CYP3A), oxymorphone (CYP2D) and noroxycodone (CYP3A). The chromatographic separation was achieved using a Biobasic C-18 100 x 1mm column combined with an isocratic mobile phase composed of methanol and 10mM ammonium acetate (40: 60) at a flow rate of 75 mu L/min. The mass spectrometer was operating in scan mode MS/MS and the analytical range was set at 10-10 000 nM. The precision (RSD) and accuracy (RE) observed were 4.4-11.5 and -9.1-6.1% respectively. Liver S9 fractions from 3-, 6-, 12-and 18-month-old male SpragueDawley rats were prepared and Michaelis-Menten parameters were determined. The derived maximum enzyme velocity suggested a rapid saturation of the CYP2D and CYP3A active sites in the liver S9 fractions of 18-month-old rats. Moreover, metabolic stabilities of codeine and oxycodone in rat liver S9 fractions were significantly greater for the 18-month-old rats. This study suggests that there is an impairment of CYP2D and CYP3A metabolism in aging rats.
C1 [Salmin, Sabrin Fuad; Beaudry, Francis] Univ Montreal, Fac Med Vet, Dept Biomed Vet, Grp Rech Pharmacol Anim Quebec GREPAQ, St Hyacinthe, PQ, Canada.
   [Giroux, Marie-Chantal; Vachon, Pascal] Univ Montreal, Fac Med Vet, Dept Biomed Vet, St Hyacinthe, PQ, Canada.
   [Vachon, Pascal] Ste Justine Hosp Res Ctr, Montreal, PQ, Canada.
C3 Universite de Montreal; Universite de Montreal
RP Beaudry, F (corresponding author), Univ Montreal, Fac Med Vet, Dept Biomed Vet, Grp Rech Pharmacol Anim Quebec GREPAQ, St Hyacinthe, PQ, Canada.
EM francis.beaudry@umontreal.ca
RI Beaudry, Francis/A-9462-2012
OI Beaudry, Francis/0000-0001-5403-7333
FU National Sciences and Engineering Research Council of Canada
   [386637-2010, RGPIN-2015-05071, 439748-2013]
FX This project was funded by the National Sciences and Engineering
   Research Council of Canada (F. Beaudry Discovery Grants nos 386637-2010
   and RGPIN-2015-05071). The HPLC-MS/MS analyses were performed on
   instruments funded by the National Sciences and Engineering Research
   Council of Canada (F. Beaudry Research Tools and Instruments grant no.
   439748-2013).
CR Bartelink IH, 2006, CLIN PHARMACOKINET, V45, P1077, DOI 10.2165/00003088-200645110-00003
   Beaudry F, 1999, BIOMED CHROMATOGR, V13, P401, DOI 10.1002/(SICI)1099-0801(199910)13:6<401::AID-BMC899>3.0.CO;2-C
   Biancofiore Giuseppe, 2006, Ther Clin Risk Manag, V2, P229, DOI 10.2147/tcrm.2006.2.3.229
   Bunker JP, 2001, INT J EPIDEMIOL, V30, P1260, DOI 10.1093/ije/30.6.1260
   Centre for Drug Evaluation and Research (CDER), 2001, GUID IND BIOAN METH
   Chan S, 2008, CLIN EXP PHARMACOL P, V35, P295, DOI 10.1111/j.1440-1681.2007.04821.x
   Chau DL, 2008, CLIN INTERV AGING, V3, P273, DOI 10.2147/CIA.S1847
   CLEARY J, 1994, J PHARMACOL EXP THER, V271, P1528
   Crentsil V, 2014, ANN PHARMACOTHER, V48, P306, DOI 10.1177/1060028013514376
   Curtis GB, 1999, EUR J CLIN PHARMACOL, V55, P425, DOI 10.1007/s002280050651
   Ginsburg M, 2009, GERIATR AGING, V12, P48
   Giroux MC, 2016, EXP ANIM TOKYO, V65, P63, DOI 10.1538/expanim.15-0039
   Gröer C, 2014, J PHARMACEUT BIOMED, V100, P393, DOI 10.1016/j.jpba.2014.08.016
   Hines RN, 2013, INT J PHARMACEUT, V452, P3, DOI 10.1016/j.ijpharm.2012.05.079
   Iirola T, 2012, BRIT J ANAESTH, V108, P460, DOI 10.1093/bja/aer441
   Lalovic B, 2004, DRUG METAB DISPOS, V32, P447, DOI 10.1124/dmd.32.4.447
   Lavoie DSG, 2013, BIOMED CHROMATOGR, V27, P882, DOI 10.1002/bmc.2875
   Löfdal KCS, 2013, DRUGS, V73, P533, DOI 10.1007/s40265-013-0036-0
   Martignoni M, 2006, EXPERT OPIN DRUG MET, V2, P875, DOI 10.1517/17425255.2.6.875
   Masimirembwa CM, 2001, COMB CHEM HIGH T SCR, V4, P245
   Mézière A, 2013, PRESSE MED, V42, P197, DOI 10.1016/j.lpm.2012.07.040
   Michaelis L, 1913, BIOCHEM Z, V49, P333
   Poulsen L, 1996, EUR J CLIN PHARMACOL, V51, P289, DOI 10.1007/s002280050200
   Richardson K, 2015, AGE AGEING, V44, P90, DOI 10.1093/ageing/afu141
   Rosenblum A, 2008, EXP CLIN PSYCHOPHARM, V16, P405, DOI 10.1037/a0013628
   Santamaria R., 2015, CYP3A MEDIATED KETAM
   Sheweita SA, 2000, CURR DRUG METAB, V1, P107, DOI 10.2174/1389200003339117
   Shi SJ, 2011, CURR DRUG METAB, V12, P601, DOI 10.2174/138920011796504527
   Smith HS, 2009, MAYO CLIN PROC, V84, P613, DOI 10.1016/S0025-6196(11)60750-7
   Vallejo R, 2011, PAIN PHYSICIAN, V14, pE343
   Veilleux-Lemieux D, 2013, J AM ASSOC LAB ANIM, V52, P567
   Waitel I, 2006, ANN ROY COLL SURG, V88, P514
   WOODHOUSE KW, 1988, CLIN PHARMACOKINET, V15, P287, DOI 10.2165/00003088-198815050-00002
   Zernikow Boris, 2009, Paediatr Drugs, V11, P129, DOI 10.2165/00148581-200911020-00004
NR 34
TC 8
Z9 9
U1 0
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0269-3879
EI 1099-0801
J9 BIOMED CHROMATOGR
JI Biomed. Chromatogr.
PD FEB
PY 2017
VL 31
IS 2
DI 10.1002/bmc.3786
PG 11
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Chemistry, Analytical; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry; Pharmacology & Pharmacy
GA EP3HQ
UT WOS:000397273800016
PM 27390106
DA 2024-02-19
ER

PT J
AU Xiang, C
   Teng, YO
   Yao, CR
   Li, XH
   Cao, ML
   Li, XZ
   Pan, GJ
   Lu, K
   Galons, H
   Yu, P
AF Xiang, Cen
   Teng, Yuou
   Yao, Chaoran
   Li, Xuehui
   Cao, Menglin
   Li, Xuzhe
   Pan, Guojun
   Lu, Kui
   Galons, Herve
   Yu, Peng
TI Antioxidant properties of flavonoid derivatives and their
   hepatoprotective effects on CCl<sub>4</sub> induced acute liver injury
   in mice
SO RSC ADVANCES
LA English
DT Article
ID CARBON-TETRACHLORIDE; OXIDATIVE STRESS; DISEASE; ABILITY; ROLES
AB Excessive accumulation of free radicals in the body can cause liver damage, aging, cancer, stroke, and myocardial infarction. Anastatin B, a skeletal flavonoid, was reported to have antioxidant and hepatoprotective effects. Anastatin B derivatives, compound 1 and 2, were synthesized by our group previously. In this study, their antioxidant activity and hepatoprotective mechanism were studied using chemical evaluation methods, a cellular model of hydrogen peroxide (H2O2)-induced oxidative damage, and a mouse model of carbon tetrachloride (CCl4)-induced liver injury. Results from the chemical evaluation suggested that both compounds had good antioxidant power and radical scavenging ability in vitro. MTT assay showed that both compounds had cytoprotective activity in H2O2-treated PC12 cells. Moreover, their hepatoprotective activities evaluated using a mouse model of CCl4-induced liver injury that compared with the model group, pretreatment with compound 1 and 2 significantly decreased alanine transaminase (ALT), aspartate transaminase (AST), lactate dehydrogenase (LDH), and malondialdehyde (MDA) levels; reduced the liver tissue damage; and increased glutathione content. However, compound 2 was a more effective hepatoprotectant than compound 1 was. Finally, the amount of TNF-alpha and cytochrome P450 2E1 (CYP2E1) were significantly downregulated in compound 1 and 2 pretreatment groups. Collectively, our findings demonstrate that both compounds have potential antioxidant activity and hepatoprotective effect in vitro and in vivo. Further chemo-biological study and investigation of the compounds' enzymatic targets are ongoing.
C1 [Xiang, Cen; Teng, Yuou; Yao, Chaoran; Li, Xuehui; Cao, Menglin; Li, Xuzhe; Pan, Guojun; Lu, Kui; Yu, Peng] Tianjin Univ Sci & Technol, State Key Lab Food Nutr & Safety, China Int Sci & Technol Cooperat Base Food Nutr S, Tianjin 300457, Peoples R China.
   [Galons, Herve] Univ Paris 05, INSERM, U1022, UCTBS, 4 Ave Observ, F-75006 Paris, France.
C3 Tianjin University Science & Technology; Universite Paris Cite; Institut
   National de la Sante et de la Recherche Medicale (Inserm)
RP Yu, P (corresponding author), Tianjin Univ Sci & Technol, State Key Lab Food Nutr & Safety, China Int Sci & Technol Cooperat Base Food Nutr S, Tianjin 300457, Peoples R China.; Galons, H (corresponding author), Univ Paris 05, INSERM, U1022, UCTBS, 4 Ave Observ, F-75006 Paris, France.
EM yupeng@tust.edu.cn
FU National Natural Science Foundation of China [31301142]; International
   Science & Technology Cooperation Program of China [2013DFA31160]
FX The authors sincerely thank the financial support from the National
   Natural Science Foundation of China (31301142), the International
   Science & Technology Cooperation Program of China (2013DFA31160).
CR Akhlaghi M, 2016, PHYTOTHER RES, V30, P1559, DOI 10.1002/ptr.5667
   Allameh Z, 2016, J RES PHARM PRACT, V5, P79, DOI 10.4103/2279-042X.179567
   Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292
   Bielli A, 2015, LIFE SCI, V143, P209, DOI 10.1016/j.lfs.2015.11.012
   Cano A., 2015, PHYTOCHEM ANALYSIS, V9, P196
   Cook NC, 1996, J NUTR BIOCHEM, V7, P66, DOI 10.1016/0955-2863(95)00168-9
   Dong JY, 2016, CHEMMEDCHEM, V11, P2102, DOI 10.1002/cmdc.201600316
   Egresi A, 2015, ORVOSI HETILAP, V156, P43, DOI 10.1556/OH.2015.30069
   Federico S., 2016, AGING DIS, V7, P130
   Fraunberger E. A., 2015, OXID MED CELL LONGEV, V2016
   Gassen M, 1999, J NEURAL TRANSM-SUPP, P193
   He F, 2015, INT J MOL SCI, V16, P27770, DOI 10.3390/ijms161126059
   Jackson MJ, 2016, MOL ASPECTS MED, V50, P33, DOI 10.1016/j.mam.2016.05.002
   Jiang W, 2012, BIOCHEM BIOPH RES CO, V422, P344, DOI 10.1016/j.bbrc.2012.05.022
   Kumar S., 2013, ISRN PHARM, V2013
   Li B, 2015, FREE RADICAL BIO MED, V82, P187, DOI 10.1016/j.freeradbiomed.2015.01.020
   Li S, 2015, INT J MOL SCI, V16, P26087, DOI 10.3390/ijms161125942
   Lieber C S, 1997, Adv Pharmacol, V38, P601
   Limongi D, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/6547248
   Liu J, 2015, INT J BIOL MACROMOL, V72, P1479, DOI 10.1016/j.ijbiomac.2014.09.066
   Menon VP, 2007, ADV EXP MED BIOL, V595, P105
   Noctor G, 2016, PLANT CELL ENVIRON, V39, P1140, DOI 10.1111/pce.12726
   Onyango IG, 2016, AGING DIS, V7, P201, DOI 10.14336/AD.2015.1007
   Pan GJ, 2017, EUR J MED CHEM, V138, P577, DOI 10.1016/j.ejmech.2017.06.054
   Pandley AK, 2007, NATL ACAD SCI LETT, V30, P383
   Prior RL, 2000, HORTSCIENCE, V35, P588, DOI 10.21273/HORTSCI.35.4.588
   Procházková D, 2011, FITOTERAPIA, V82, P513, DOI 10.1016/j.fitote.2011.01.018
   RICEEVANS CA, 1995, FREE RADICAL RES, V22, P375, DOI 10.3109/10715769509145649
   Singh D, 2016, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00363
   Sugimoto K, 2017, HEPATOL RES, V47, P70, DOI 10.1111/hepr.12736
   Teresa V., 2016, NUTRIENTS, V8, P211
   Weber LWD, 2003, CRIT REV TOXICOL, V33, P105, DOI 10.1080/713611034
   Wojtunik-Kulesza KA, 2016, BIOMED PHARMACOTHER, V78, P39, DOI 10.1016/j.biopha.2015.12.024
   Wu JZ, 2014, INT J MOL SCI, V15, P18525, DOI 10.3390/ijms151018525
   Xiao X, 2016, CHEM BIODIVERS, V13, P1427, DOI 10.1002/cbdv.201600060
   Yahata T, 2017, RHEUMATOLOGY, V56, P6, DOI 10.1093/rheumatology/kew044
   Yoshikawa M, 2003, BIOORG MED CHEM LETT, V13, P1045, DOI 10.1016/S0960-894X(03)00088-X
NR 37
TC 12
Z9 13
U1 0
U2 10
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2018
VL 8
IS 28
BP 15366
EP 15371
DI 10.1039/c8ra02523a
PG 6
WC Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry
GA GF3AD
UT WOS:000431813800013
PM 35539467
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU BourdelMarchasson, I
   Biran, M
   Thiaudiere, E
   Delalande, C
   Decamps, A
   Manciet, G
   Canioni, P
AF BourdelMarchasson, I
   Biran, M
   Thiaudiere, E
   Delalande, C
   Decamps, A
   Manciet, G
   Canioni, P
TI P-31 magnetic resonance spectroscopy of human liver in elderly patients:
   Changes according to nutritional status and inflammatory state
SO METABOLISM-CLINICAL AND EXPERIMENTAL
LA English
DT Article
AB Magnetic resonance spectroscopy (MRS) was used to determine the phosphorylated metabolite content in the liver of elderly patients in various nutritional states: normal, with protein deprivation, and with acute inflammatory syndrome. P-31-MRS investigations were performed at 1.5 T, and localized liver spectra were recorded using a two-dimensional chemical shift imaging sequence. Comparison to control spectra recorded on 10 healthy volunteers (age, 30.5 +/- 2.1 years) showed that the aging process does not significantly modify P-31-MRS liver spectra. Patients with protein deprivation exhibited a higher value than controls for the phosphomonoesters/nucleoside triphosphates (PME/NTP) ratio (P < .05). This increase was not due to the decrease of NTP, since the ratio of inorganic phosphate to NTP (P-i/NTP) remained constant. A decrease in the phosphodiesters to NTP (PDE/NTP) ratio (P < .04) contributed to the observed increase in the PME/PDE ratio (P < .01). In contrast, no significant difference in P-31-MRS spectra was found between elderly patients with hypoalbuminemia associated with inflammatory syndrome and the control group. We conclude that elderly patients with protein deprivation displayed changes in the level of phosphorylated metabolites in the liver that were not observed in the case of inflammatory syndrome despite lower serum albumin (Alb) concentrations. Copyright (C) 1996 by W.B. Saunders Company
C1 UNIV BORDEAUX 2, RESONANCE MAGNET SYST BIOL, UMR 5536, CNRS, F-33076 BORDEAUX, FRANCE.
C3 Centre National de la Recherche Scientifique (CNRS); Universite de
   Bordeaux; CNRS - National Institute for Biology (INSB)
RP BourdelMarchasson, I (corresponding author), CTR HOSP UNIV BORDEAUX, CTR GERIATR, HOP XAVIER ARNOZAN, AVE HAUT LEVEQUE, F-33604 PESSAC, FRANCE.
OI Thiaudiere, Eric/0000-0002-9993-4035
CR AOBA A, 1991, INT CONGR SER, V940, P227
   BOESIGER P, 1994, PEDIATR RES, V36, P436, DOI 10.1203/00006450-199410000-00004
   BROWN TR, 1982, P NATL ACAD SCI-BIOL, V79, P3523, DOI 10.1073/pnas.79.11.3523
   CUNNINGHAM CC, 1986, BIOCHIM BIOPHYS ACTA, V885, P12, DOI 10.1016/0167-4889(86)90033-9
   Meyerhoff D J, 1990, NMR Biomed, V3, P17, DOI 10.1002/nbm.1940030103
   MILLER A, 1983, BRIT MED J, V286, P266, DOI 10.1136/bmj.286.6361.266
   MURPHY EJ, 1992, BIOCHIM BIOPHYS ACTA, V1111, P51, DOI 10.1016/0005-2736(92)90273-O
   RUDMAN D, 1989, J AM GERIATR SOC, V37, P173, DOI 10.1111/j.1532-5415.1989.tb05880.x
   SHAFRITZ DA, 1988, LIVER BIOL PATHOLOGY, P1245
   THIAUDIERE E, 1994, MAGN RESON MATER PHY, V2, P425, DOI 10.1007/BF01705289
NR 10
TC 9
Z9 9
U1 0
U2 1
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0026-0495
J9 METABOLISM
JI Metab.-Clin. Exp.
PD SEP
PY 1996
VL 45
IS 9
BP 1059
EP 1061
DI 10.1016/S0026-0495(96)90002-5
PG 3
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA VF481
UT WOS:A1996VF48100003
PM 8781290
DA 2024-02-19
ER

PT J
AU Sanz, A
   Gredilla, R
   Pamplona, R
   Portero-Otín, M
   Vara, E
   Tresguerres, J
   Barja, G
AF Sanz, A
   Gredilla, R
   Pamplona, R
   Portero-Otín, M
   Vara, E
   Tresguerres, J
   Barja, G
TI Effect of insulin and growth hormone on rat heart and liver oxidative
   stress in control and caloric restricted animals
SO BIOGERONTOLOGY
LA English
DT Article
DE DNA damage; fatty acids; free radicals; insulin; mitochondria; protein
   carbonyls
ID LIFE-SPAN EXTENSION; MITOCHONDRIAL-DNA; RADICAL GENERATION;
   BODY-COMPOSITION; DWARF MICE; DAMAGE; AGE; PROTEINS; RECEPTOR; GH
AB In order to know if insulin-like signalling is involved in the control of oxidative stress in mammalian tissues in relation to aging, ad libitum-fed and caloric restricted Wistar rats were treated during 2 weeks with GH and insulin. The most consistent effect of the hormonal treatments was an increase in plasma IGF-1 levels. Caloric restriction during 6 weeks decreased ROS generation and oxidative DNA damage in heart mitochondria and this was reversed by insulin treatment. The decrease in oxidative damage to liver nuclear DNA induced by caloric restriction was also reversed by GH and insulin. In the liver, however, insulin and GH decreased mitochondrial ROS generation while they increased oxidative damage to mitochondrial DNA. GH and insulin decreased three different markers of oxidative modification of liver proteins, while they increased lipoxidation-dependent markers. This last result is related to the increase in phospholipid unsaturation induced in the liver by both hormones. The results suggest that the idea that insulin-like signalling controls oxidative stress in mammals cannot be generalized since both prooxidant and protective effects of GH and insulin are observed depending on the particular parameter and tissue selected.
C1 Univ Complutense, Fac Biol, Dept Anim Physiol 2, E-28040 Madrid, Spain.
   Univ Lleida, Fac Med, Dept Basic Med Sci, Lleida 25198, Spain.
   Univ Complutense, Fac Med, Dept Biochem, E-28040 Madrid, Spain.
   Univ Complutense, Fac Med, Dept Physiol, E-28040 Madrid, Spain.
C3 Complutense University of Madrid; Universitat de Lleida; Complutense
   University of Madrid; Complutense University of Madrid
RP Barja, G (corresponding author), Univ Complutense, Fac Biol, Dept Anim Physiol 2, E-28040 Madrid, Spain.
EM gbarja@bio.ucm.es
RI Sanz, Alberto/O-2329-2015; Barja, Gustavo/AAA-5903-2019; SANZ,
   ALBERTO/F-8432-2011; Gustavo, Barja/B-5591-2012; Pamplona,
   Reinald/A-7359-2010; Portero-Otin, Manuel/B-7122-2009
OI Sanz, Alberto/0000-0003-2149-1753; Barja, Gustavo/0000-0001-5736-4735;
   Pamplona, Reinald/0000-0003-4337-6107; Portero-Otin,
   Manuel/0000-0002-1823-0299; GREDILLA, RICARDO/0000-0003-4501-1355
CR Ahmed MU, 1997, BIOCHEM J, V324, P565, DOI 10.1042/bj3240565
   Azcoitia I, 2005, NEUROBIOL AGING, V26, P697, DOI 10.1016/j.neurobiolaging.2004.06.007
   BANG P, 1994, J CLIN ENDOCR METAB, V78, P960, DOI 10.1210/jc.78.4.960
   Barja G, 2004, BIOL REV, V79, P235, DOI 10.1017/S1464793103006213
   Barja G, 2002, J BIOENERG BIOMEMBR, V34, P227, DOI 10.1023/A:1016039604958
   Blüher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223
   BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0
   Castillo C, 2003, EXP GERONTOL, V38, P971, DOI 10.1016/S0531-5565(03)00156-6
   Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991
   Coschigano KT, 2000, ENDOCRINOLOGY, V141, P2608, DOI 10.1210/en.141.7.2608
   De Lama MAR, 2000, EUR J ENDOCRINOL, V142, P517, DOI 10.1530/eje.0.1420517
   DeLaAsuncion JG, 1996, FASEB J, V10, P333, DOI 10.1096/fasebj.10.2.8641567
   Flurkey K, 2001, P NATL ACAD SCI USA, V98, P6736, DOI 10.1073/pnas.111158898
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   French RA, 2002, ENDOCRINOLOGY, V143, P690, DOI 10.1210/en.143.2.690
   Fu MX, 1996, J BIOL CHEM, V271, P9982, DOI 10.1074/jbc.271.17.9982
   Gredilla R, 2001, FASEB J, V15, P1589, DOI 10.1096/fj.00-0764fje
   HERBERT V, 1965, J CLIN ENDOCR METAB, V25, P1375, DOI 10.1210/jcem-25-10-1375
   Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298
   HUNTER WM, 1962, NATURE, V194, P495, DOI 10.1038/194495a0
   ISAKSSON OGP, 1987, ENDOCR REV, V8, P426, DOI 10.1210/edrv-8-4-426
   Jensen A, 2003, J BIOL CHEM, V278, P19541, DOI 10.1074/jbc.M301504200
   JORGENSEN JOL, 1991, J CLIN ENDOCR METAB, V72, P582, DOI 10.1210/jcem-72-3-582
   KALUZNY MA, 1985, J LIPID RES, V26, P135
   Kenyon C, 2001, CELL, V105, P165, DOI 10.1016/S0092-8674(01)00306-3
   KNECHT KJ, 1991, DIABETES, V40, P190, DOI 10.2337/diabetes.40.2.190
   Lambert AJ, 2004, AM J PHYSIOL-REG I, V286, pR71, DOI 10.1152/ajpregu.00341.2003
   LATORRE A, 1986, P NATL ACAD SCI USA, V83, P8649, DOI 10.1073/pnas.83.22.8649
   Lichtenwalner RJ, 2001, NEUROSCIENCE, V107, P603, DOI 10.1016/S0306-4522(01)00378-5
   LIMA L, 1993, NEUROENDOCRINOLOGY, V57, P1155, DOI 10.1159/000126482
   Loft S, 1999, METHOD ENZYMOL, V300, P166
   López-Torres M, 2002, FREE RADICAL BIO MED, V32, P882, DOI 10.1016/S0891-5849(02)00773-6
   MAITER D, 1989, ENDOCRINOLOGY, V124, P2604, DOI 10.1210/endo-124-5-2604
   Markowska AL, 1998, NEUROSCIENCE, V87, P559, DOI 10.1016/S0306-4522(98)00143-2
   Pamplona R, 2002, MECH AGEING DEV, V123, P1437, DOI 10.1016/S0047-6374(02)00076-3
   Papadakis MA, 1996, ANN INTERN MED, V124, P708, DOI 10.7326/0003-4819-124-8-199604150-00002
   Requena JR, 1997, BIOCHEM J, V322, P317, DOI 10.1042/bj3220317
   Requena JR, 2001, P NATL ACAD SCI USA, V98, P69, DOI 10.1073/pnas.011526698
   Sanz A, 2002, J AM AGING ASSOC, V25, P119, DOI 10.1007/s11357-002-0010-3
   SOHAL RS, 1994, MECH AGEING DEV, V74, P121, DOI 10.1016/0047-6374(94)90104-X
   Sonntag WE, 2000, J ANAT, V197, P575, DOI 10.1046/j.1469-7580.2000.19740575.x
   WOLF E, 1993, MECH AGEING DEV, V68, P71, DOI 10.1016/0047-6374(93)90141-D
   Yamaza H, 2002, MICROSC RES TECHNIQ, V59, P325, DOI 10.1002/jemt.10212
NR 43
TC 56
Z9 61
U1 0
U2 8
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1389-5729
EI 1573-6768
J9 BIOGERONTOLOGY
JI Biogerontology
PD JAN
PY 2005
VL 6
IS 1
BP 15
EP 26
DI 10.1007/s10522-004-7380-0
PG 12
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 917ZG
UT WOS:000228507300002
PM 15834660
DA 2024-02-19
ER

PT J
AU Shahmoon, S
   Rubinfeld, H
   Wolf, I
   Cohen, ZR
   Hadani, M
   Shimon, I
   Rubinek, T
AF Shahmoon, Shiri
   Rubinfeld, Hadara
   Wolf, Ido
   Cohen, Zvi R.
   Hadani, Moshe
   Shimon, Ilan
   Rubinek, Tami
TI The aging suppressor klotho: a potential regulator of growth hormone
   secretion
SO AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
LA English
DT Article
DE klotho; growth hormone; acromegaly; basic fibroblast growth factor;
   extracellular signal-regulated kinase; insulin-like growth factor I;
   pituitary
ID PITUITARY-ADENOMAS; SIGNALING PATHWAYS; TUMOR-SUPPRESSOR; FACTOR
   RECEPTORS; GENE-EXPRESSION; SOMATOSTATIN; RETENTION; MUTATION; BINDING;
   MICE
AB Klotho is a transmembranal protein highly expressed in the kidneys, choroid plexus, and anterior pituitary. Klotho can also be cleaved and shed and acts as a circulating hormone. Klotho-deficient mice (kl/kl mice) develop a phenotype resembling early aging. Several lines of evidence suggest a role for klotho in the regulation of growth hormone (GH) secretion. The kl/kl mice are smaller compared with their wild-type counterparts, and their somatotropes show reduced numbers of secretory granules. Moreover, klotho is a potent inhibitor of the IGF-I pathway, a negative regulator of GH secretion. Therefore, we hypothesized that klotho may enhance GH secretion. The effect of klotho on GH secretion was examined in GH3 rat somatotrophs, cultured rat pituitaries, and cultured human GH-secreting adenomas. In all three models, klotho treatment increased GH secretion. Prolonged treatment of mice with intraperitoneal klotho injections increased mRNA levels of IGF-I and IGF-I-binding protein-3 mRNA in the liver, reflecting increased serum GH levels. In accord with its ability to inhibit the IGF-I pathway, klotho partially restored the inhibitory effect of IGF-I on GH secretion. Klotho is known to be a positive regulator of basic bFGF signaling. We studied rat pituitaries and human adenoma cultures and noted that bFGF increased GH secretion and stimulated ERK1/2 phosphorylation. Both effects were augmented following treatment with klotho. Taken together, our data indicate for the first time that klotho is a positive regulator of GH secretion and suggest the IGF-I and bFGF pathways as potential mediators of this effect.
C1 [Shahmoon, Shiri; Wolf, Ido; Rubinek, Tami] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Inst Oncol, IL-69978 Tel Aviv, Israel.
   [Shahmoon, Shiri; Rubinfeld, Hadara; Wolf, Ido; Cohen, Zvi R.; Hadani, Moshe; Shimon, Ilan] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel.
   [Rubinfeld, Hadara; Shimon, Ilan] Rabin Med Ctr, Felsenstein Med Res Ctr, Petah Tiqwa, Israel.
   [Cohen, Zvi R.; Hadani, Moshe] Chaim Sheba Med Ctr, Dept Neurosurg, IL-52621 Tel Hashomer, Israel.
C3 Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Sackler
   Faculty of Medicine; Tel Aviv University; Rabin Medical Center; Chaim
   Sheba Medical Center
RP Shahmoon, S (corresponding author), Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Inst Oncol, IL-69978 Tel Aviv, Israel.
EM rubinekt@gmail.com
FU Israel Cancer Association; Sackler Faculty of Medicine, Tel Aviv
   University, Tel Aviv, Israel
FX This research was supported in part by grants from The Israel Cancer
   Association, The Sackler Faculty of Medicine, Tel Aviv University, Tel
   Aviv, Israel.
CR Abbass SAA, 1997, J CLIN ENDOCR METAB, V82, P1160, DOI 10.1210/jc.82.4.1160
   Abramovitz L, 2011, CLIN CANCER RES, V17, P4254, DOI 10.1158/1078-0432.CCR-10-2749
   ATKIN SL, 1993, J CLIN ENDOCR METAB, V77, P831, DOI 10.1210/jc.77.3.831
   Bidlingmaier M, 2007, PITUITARY, V10, P115, DOI 10.1007/s11102-007-0030-1
   BLACK EG, 1990, J ENDOCRINOL, V127, P39, DOI 10.1677/joe.0.1270039
   Cha SK, 2008, P NATL ACAD SCI USA, V105, P9805, DOI 10.1073/pnas.0803223105
   Chang JP, 2012, CELL CALCIUM, V51, P240, DOI 10.1016/j.ceca.2011.11.001
   Chang Q, 2005, SCIENCE, V310, P490, DOI 10.1126/science.1114245
   Chen CD, 2007, P NATL ACAD SCI USA, V104, P19796, DOI 10.1073/pnas.0709805104
   Chen CD, 2013, J NEUROSCI, V33, P1927, DOI 10.1523/JNEUROSCI.2080-12.2013
   Chen TH, 2013, EUR J PHARMACOL, V698, P67, DOI 10.1016/j.ejphar.2012.09.032
   Clemmons DR, 2011, CLIN CHEM, V57, P555, DOI 10.1373/clinchem.2010.150631
   D'Angelo D, 2012, J CLIN ENDOCR METAB, V97, P2011
   Hu MC, 2013, ANNU REV PHYSIOL, V75, P503, DOI 10.1146/annurev-physiol-030212-183727
   Kashimada K, 2002, J ENDOCRINOL, V174, P403, DOI 10.1677/joe.0.1740403
   Kola B, 2003, CLIN ENDOCRINOL, V59, P328, DOI 10.1046/j.1365-2265.2003.01851.x
   Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285
   Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200
   Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766
   Kurosu H, 2009, MOL CELL ENDOCRINOL, V299, P72, DOI 10.1016/j.mce.2008.10.052
   Liu HZ, 2013, BRATISL MED J, V114, P376, DOI 10.4149/BLL_2013_085
   MORMEDE P, 1988, ENDOCRINOLOGY, V122, P2265, DOI 10.1210/endo-122-5-2265
   Morris DG, 2005, EUR J ENDOCRINOL, V153, P143, DOI 10.1530/eje.1.01937
   Murray RD, 2004, J CLIN INVEST, V114, P349, DOI 10.1172/jci200419933
   Neidert MC, 2013, EUR J ENDOCRINOL, V168, P575, DOI 10.1530/EJE-12-1045
   Ranke MB, 1997, HORM RES, V48, P9, DOI 10.1159/000191304
   Rosenfeld RG, 2009, HORM RES, V71, P36, DOI 10.1159/000192434
   Rubinek T, 2005, ENDOCRINE, V28, P209, DOI 10.1385/ENDO:28:2:209
   Rubinek T, 2012, BREAST CANCER RES TR, V133, P649, DOI 10.1007/s10549-011-1824-4
   Ruebel KH, 2006, ENDOCRINE, V29, P435, DOI 10.1385/ENDO:29:3:435
   Steyn FJ, 2011, ENDOCRINOLOGY, V152, P3165, DOI 10.1210/en.2011-0253
   Sze L, 2012, J INTERN MED, V272, P93, DOI 10.1111/j.1365-2796.2012.02542.x
   Tulipano G, 2013, MOL CELL ENDOCRINOL, V365, P197, DOI 10.1016/j.mce.2012.10.017
   Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315
   van Neck JW, 2000, J ENDOCRINOL, V167, P295, DOI 10.1677/joe.0.1670295
   Wolf I, 2010, ONCOGENE, V29, P26, DOI 10.1038/onc.2009.301
   Wolf I, 2008, ONCOGENE, V27, P7094, DOI 10.1038/onc.2008.292
   Yakar S, 2004, J CLIN INVEST, V113, P96, DOI 10.1172/JCI200417763
   Yamazaki Y, 2010, BIOCHEM BIOPH RES CO, V398, P513, DOI 10.1016/j.bbrc.2010.06.110
   Yee D, 2006, BRIT J CANCER, V94, P465, DOI 10.1038/sj.bjc.6602963
NR 40
TC 24
Z9 28
U1 0
U2 11
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0193-1849
EI 1522-1555
J9 AM J PHYSIOL-ENDOC M
JI Am. J. Physiol.-Endocrinol. Metab.
PD AUG 1
PY 2014
VL 307
IS 3
BP E326
EP E334
DI 10.1152/ajpendo.00090.2014
PG 9
WC Endocrinology & Metabolism; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Physiology
GA AO9WB
UT WOS:000341709200008
PM 24939736
DA 2024-02-19
ER

PT J
AU Xu, YC
   Sun, ZJ
AF Xu, Yuechi
   Sun, Zhongjie
TI Regulation of S-formylglutathione hydrolase by the anti-aging gene
   klotho
SO ONCOTARGET
LA English
DT Article
DE klotho; receptor; binding; S-formylglutathione hydrolase; GSH;
   Gerotarget
ID MICROSOMAL LIPID-PEROXIDATION; HUMAN ESTERASE-D; OXIDATIVE STRESS;
   FORMALDEHYDE DETOXIFICATION; ARABIDOPSIS-THALIANA; MOLECULAR-BASIS;
   HUMAN LIVER; PROTEIN; PURIFICATION; CELLS
AB Klotho is an aging-suppressor gene. The purpose of this study is to investigate the binding sites (receptors) and function of short-form Klotho (Skl). We showed that Skl physically bound to multiple proteins. We found physical and functional interactions between Skl and S-formylglutathione hydrolase (FGH), a key enzyme in the generation of the major cellular anti-oxidant GSH, using co-immunoprecipitation-coupled mass spectrometry. We further confirmed the colocalization of Skl and FGH around the nucleus in kidney cells using immunofluorescent staining. Skl positively regulated FGH gene expression via Kid3 transcription factor. Overexpression of Skl increased FGH mRNA and protein expression while silencing of Skl attenuated FGH mRNA and protein expression. Klotho gene mutation suppressed FGH expression in red blood cells and kidneys resulting in anemia and kidney damage in mice. Overexpression of Skl increased total GSH production and the GSH/GSSG ratio, an index of antioxidant capacity, leading to a decrease in intracellular H2O2 and superoxide levels. The antioxidant activity of Skl was eliminated by silencing of FGH, indicating that Skl increased GSH via FGH. Interestingly, Skl directly interacted with FGH and regulated its function. Site-directed mutagenesis of the N-glycan-modified residues in Skl abolished its antioxidant activity, suggesting that these N-glycan moieties are important features that interact with FGH. Specific mutation of Asp to Ala at site 285 resulted in a loss of anti-oxidant activity of Skl, suggesting that N-glycosylation at site 285 is the key mechanism that determines Skl activity. Therefore, this study demonstrates, for the first time, that Skl regulates anti-oxidant GSH generation via interaction with FGH through N-glycosylation.
C1 [Xu, Yuechi; Sun, Zhongjie] Univ Oklahoma, Hlth Sci Ctr, Coll Med, Dept Physiol, Oklahoma City, OK 73190 USA.
C3 University of Oklahoma System; University of Oklahoma Health Sciences
   Center
RP Sun, ZJ (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Coll Med, Dept Physiol, Oklahoma City, OK 73190 USA.
EM Zhongjie-Sun@ouhsc.edu
FU NIH R01 grants [HL118558, DK093403, HL116863, HL122166, HL105302,
   HL102074, AG049780]
FX This work was supported by NIH R01 grants HL118558, DK093403, HL116863,
   HL122166, HL105302, HL102074, and AG049780.
CR APESHIOTIS F, 1986, HUM GENET, V74, P176, DOI 10.1007/BF00282086
   Ben-Dov IZ, 2007, J CLIN INVEST, V117, P4003, DOI 10.1172/JCI32409
   Carelli S, 1997, SCIENCE, V277, P1681, DOI 10.1126/science.277.5332.1681
   Ceppioglu SK, 2011, RENAL FAILURE, V33, P866, DOI 10.3109/0886022X.2011.605534
   Chen K, 2015, HYPERTENSION, V66, P1006, DOI 10.1161/HYPERTENSIONAHA.115.06033
   Cummins I, 2006, J MOL BIOL, V359, P422, DOI 10.1016/j.jmb.2006.03.048
   Degrassi G, 1999, APPL ENVIRON MICROB, V65, P3470
   EIBERG H, 1986, HUM GENET, V74, P174, DOI 10.1007/BF00282085
   Fan J, 2016, STEM CELLS, V34, P1615, DOI 10.1002/stem.2305
   Fernández L, 2000, APPL ENVIRON MICROB, V66, P1360, DOI 10.1128/AEM.66.4.1360-1368.2000
   FRYDMAN M, 1985, P NATL ACAD SCI USA, V82, P1819, DOI 10.1073/pnas.82.6.1819
   Gao DS, 2016, HYPERTENSION, V68, P1191, DOI 10.1161/HYPERTENSIONAHA.116.07709
   Gonzalez CF, 2006, J BIOL CHEM, V281, P14514, DOI 10.1074/jbc.M600996200
   Gumpricht E, 1996, BIOCHEM MOL BIOL INT, V38, P559
   Harms N, 1996, J BACTERIOL, V178, P6296, DOI 10.1128/jb.178.21.6296-6299.1996
   Herring CD, 2004, J BACTERIOL, V186, P6714, DOI 10.1128/JB.186.20.6714-6720.2004
   Hsieh CC, 2010, AGING-US, V2, P582, DOI 10.18632/aging.100194
   Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010
   HUGHES RE, 1964, NATURE, V203, P1068, DOI 10.1038/2031068a0
   Imura A, 2004, FEBS LETT, V565, P143, DOI 10.1016/j.febslet.2004.03.090
   Izbeki F, 2010, J PHYSIOL-LONDON, V588, P3101, DOI 10.1113/jphysiol.2010.191023
   Kordic S, 2002, ARCH BIOCHEM BIOPHYS, V399, P232, DOI 10.1006/abbi.2002.2772
   Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285
   Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200
   Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766
   LEE WH, 1986, P NATL ACAD SCI USA, V83, P6790, DOI 10.1073/pnas.83.18.6790
   Lin Y, 2016, HYPERTENSION, V67, P564, DOI 10.1161/HYPERTENSIONAHA.115.06825
   Lin Y, 2015, DIABETES, V64, P4298, DOI 10.2337/db15-0066
   Lin Y, 2015, DIABETES, V64, P1444, DOI 10.2337/db14-0632
   Matsumura Y, 1998, BIOCHEM BIOPH RES CO, V242, P626, DOI 10.1006/bbrc.1997.8019
   McAuley KE, 2003, ACTA CRYSTALLOGR D, V59, P2272, DOI 10.1107/S0907444903020031
   Nagai Taku, 2003, FASEB Journal, V17, P50
   Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143
   Recktenwald CV, 2008, CANCER RES, V68, P10086, DOI 10.1158/0008-5472.CAN-08-0360
   REDDY CC, 1982, LIFE SCI, V31, P571, DOI 10.1016/0024-3205(82)90486-6
   Scholz RW, 1997, FREE RADICAL BIO MED, V23, P815, DOI 10.1016/S0891-5849(97)00067-1
   SPARKES RS, 1983, SCIENCE, V219, P971, DOI 10.1126/science.6823558
   Tohyama O, 2004, J BIOL CHEM, V279, P9777, DOI 10.1074/jbc.M312392200
   UOTILA L, 1974, J BIOL CHEM, V249, P7653
   UOTILA L, 1974, J BIOL CHEM, V249, P7664
   van der Wel H, 2011, BIOCHEMISTRY-US, V50, P1700, DOI 10.1021/bi101977w
   van Straaten KE, 2009, PROTEIN SCI, V18, P2196, DOI 10.1002/pro.216
   Wang XQ, 2012, HYPERTENSION, V60, P818, DOI 10.1161/HYPERTENSIONAHA.112.199281
   Wang YH, 2012, AGING CELL, V11, P410, DOI 10.1111/j.1474-9726.2012.00796.x
   Xu YC, 2015, ENDOCR REV, V36, P174, DOI 10.1210/er.2013-1079
   Xu YC, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-31
   Xu YC, 2012, J BIOL CHEM, V287, P25098, DOI 10.1074/jbc.M112.355446
   Zhou XL, 2016, J AM SOC NEPHROL, V27, P1765, DOI 10.1681/ASN.2015010093
   Zhou XL, 2015, J AM SOC NEPHROL, V26, P121, DOI 10.1681/ASN.2013101033
NR 49
TC 9
Z9 11
U1 1
U2 3
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
EI 1949-2553
J9 ONCOTARGET
JI Oncotarget
PD OCT 24
PY 2017
VL 8
IS 51
BP 88259
EP 88275
DI 10.18632/oncotarget.19111
PG 17
WC Oncology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Cell Biology
GA FK6AP
UT WOS:000413585600005
PM 29179433
OA Green Published, Green Submitted, gold
DA 2024-02-19
ER

PT J
AU Tanaka, K
   Ozawa, K
   Teramukai, S
   Takada, Y
   Egawa, H
   Kaihara, S
   Fujimoto, Y
   Ogura, Y
   Kasahara, M
   Ono, M
   Sato, H
   Takai, K
   Fukushima, M
   Minato, N
AF Tanaka, Koichi
   Ozawa, Kazue
   Teramukai, Satoshi
   Takada, Yasutsugu
   Egawa, Hiroto
   Kaihara, Satoshi
   Fujimoto, Yasuhiro
   Ogura, Yasuhiro
   Kasahara, Mureo
   Ono, Masako
   Sato, Hiroshi
   Takai, Kenji
   Fukushima, Masanori
   Minato, Nagahiro
TI Classification of human liver transplant recipients by their
   preoperative CD8<SUP>+</SUP> T cell subpopulation and its relation to
   outcome
SO LIVER TRANSPLANTATION
LA English
DT Article
ID HEPATITIS-C; DONOR AGE; LYMPHOCYTES; PATIENT; IMPACT; GRAFT;
   IMMUNOSUPPRESSION; INFECTIONS; MECHANISM; TOXICITY
AB The primed status of T cells is markedly different among liver transplant recipients, due to a lifetime of antigen exposure and reduced thymopoiesis by aging, and diseases. This study aims to characterize the preoperative immunological status of CD8(+) T cell subpopulations and relate it to the outcome for liver transplant recipients. We classified 112 liver transplant recipients into 5 groups, based on hierarchical clustering of the CD8(+)CD45 isoform proportion of T cells. In Groups I and 11 (pediatric), the naive T cell proportion was more than 50%. In adult recipients, Group III was characterized by a naive T cell proportion of 50%, Group IV had the greatest effector/memory T cells (EM), and Group V had the greatest proportion of effector T cells. In Groups IV and V, the effector T cell proportion was considerably higher, and was accompanied by marked downregulation of the CD27(+)CD28(+) subsets and upregulation of interferon gamma (IFN)-gamma, tumor necrosis factor-alpha, and perforin expression. Group V recipients tended to be complicated postoperatively, with a significantly reduced survival rate (1 yr, 66.8%) and markedly reduced Eastern Cooperative Oncology Group performance status.
C1 Hepat Dis Res Inst, Otsu, Shiga 5200806, Japan.
   Kyoto Univ, Grad Sch Med, Dept Transplantat & Immunol, Kyoto, Japan.
   Kyoto Univ Hosp, Translat Res Ctr, Div Clin Trial Design & Management, Kyoto 606, Japan.
   Shiga Univ Med Sci, Div Biosci, Shiga, Japan.
   SRL Inc, Tokyo, Japan.
   Kyoto Univ, Grad Sch Med, Dept Immunol & Cell Biol, Kyoto, Japan.
C3 Kyoto University; Kyoto University; Shiga University of Medical Science;
   SRL Inc.; Kyoto University
RP Ozawa, K (corresponding author), Hepat Dis Res Inst, 13-45 Uchidehama, Otsu, Shiga 5200806, Japan.
EM kanzou@vesta.ocn.ne.jp
RI takada, y/HKE-5714-2023; FUJIMOTO, Yasuhiro/E-6565-2010; Ogura,
   Yasuhiro/A-2557-2016; Kasahara, Mureo/AAB-8496-2020; Teramukai,
   Satoshi/I-2249-2019
OI Ogura, Yasuhiro/0000-0001-5768-6160; Teramukai,
   Satoshi/0000-0003-2184-0597
CR Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379
   Berenguer M, 2001, J HEPATOL, V35, P666, DOI 10.1016/S0168-8278(01)00179-9
   Berenguer M, 2002, HEPATOLOGY, V36, P202, DOI 10.1053/jhep.2002.33993
   Berenguer M, 2000, J HEPATOL, V32, P673, DOI 10.1016/S0168-8278(00)80231-7
   Burak KW, 2002, LIVER TRANSPLANT, V8, P362, DOI 10.1053/jlts.2002.32282
   Busquets J, 2001, TRANSPLANTATION, V71, P1765, DOI 10.1097/00007890-200106270-00011
   CHAZOUILLERES O, 1994, GASTROENTEROLOGY, V106, P994, DOI 10.1016/0016-5085(94)90759-5
   Demetris AJ, 1997, HEPATOLOGY, V25, P658
   EVERITT BS, 2001, CLUSTER ANAL, P55
   Gane EJ, 1996, GASTROENTEROLOGY, V110, P167, DOI 10.1053/gast.1996.v110.pm8536853
   GHOBRIAL RM, 2002, TRANSPLANTATION S, V74, P88
   Guidotti LG, 2001, ANNU REV IMMUNOL, V19, P65, DOI 10.1146/annurev.immunol.19.1.65
   HENKART PA, 1985, ANNU REV IMMUNOL, V3, P31, DOI 10.1146/annurev.iy.03.040185.000335
   Inomata Y, 2000, TRANSPLANTATION, V69, P258, DOI 10.1097/00007890-200001270-00011
   Kalams SA, 1998, J EXP MED, V188, P2199, DOI 10.1084/jem.188.12.2199
   Kiuchi T, 1999, TRANSPLANTATION, V67, P321, DOI 10.1097/00007890-199901270-00024
   Kiuchi T, 2000, ACTA CHIR BELG, V100, P279
   Miyagawa-Hayashino A, 2004, TRANSPLANTATION, V78, P128, DOI 10.1097/01.TP.0000132328.33460.43
   Nakamura T, 2002, TRANSPLANTATION, V73, P1896, DOI 10.1097/00007890-200206270-00008
   Neumann UP, 2004, TRANSPLANTATION, V77, P226, DOI 10.1097/01.TP.0000101738.27552.9D
   OHNO T, 1997, J CLIN MICROBIOL, V35, P2001
   OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014
   OZAWA K, 1992, ANN SURG, V216, P547, DOI 10.1097/00000658-199211000-00004
   Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989
   Rosen HR, 2002, MICROBES INFECT, V4, P1253, DOI 10.1016/S1286-4579(02)01653-2
   Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385
   Shresta S, 1998, CURR OPIN IMMUNOL, V10, P581, DOI 10.1016/S0952-7915(98)80227-6
   Starzl TE, 2003, LANCET, V361, P1502, DOI 10.1016/S0140-6736(03)13175-3
   TANAKA K, 1992, TRANSPLANT P, V24, P2252
   Tanaka K, 2003, LIVING DONOR LIVER T
   TANIGUCHI M, 2002, TRANSPLANTATION S, V74, P88
   Tector AJ, 2004, LIVER TRANSPLANT, V10, P404, DOI 10.1002/lt.20085
   Timm JA, 1999, J IMMUNOL, V162, P711
   Waldrop SL, 1997, J CLIN INVEST, V99, P1739, DOI 10.1172/JCI119338
   Wali M, 2002, GUT, V51, P248, DOI 10.1136/gut.51.2.248
   Yamaoka Y, 1993, Clin Transpl, P179
   Yu AS, 2001, CAN J GASTROENTEROL, V15, P729, DOI 10.1155/2001/743019
NR 37
TC 15
Z9 15
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1527-6465
EI 1527-6473
J9 LIVER TRANSPLANT
JI Liver Transplant.
PD MAY
PY 2006
VL 12
IS 5
BP 792
EP 800
DI 10.1002/lt.20705
PG 9
WC Gastroenterology & Hepatology; Surgery; Transplantation
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology; Surgery; Transplantation
GA 035YG
UT WOS:000237037100016
PM 16628679
OA Bronze
DA 2024-02-19
ER

PT J
AU Schuller, S
   Sieker, J
   Riemenschneider, P
   Koehler, B
   Drucker, E
   Weiler, SME
   Dauch, D
   Sticht, C
   Goeppert, B
   Roessler, S
   Ribback, S
   Breuhahn, K
   Fend, F
   Dombrowski, F
   Singer, K
   Singer, S
AF Schuller, Stefanie
   Sieker, Jan
   Riemenschneider, Philip
   Koehler, Bianca
   Drucker, Elisabeth
   Weiler, Sofia M. E.
   Dauch, Daniel
   Sticht, Carsten
   Goeppert, Benjamin
   Roessler, Stephanie
   Ribback, Silvia
   Breuhahn, Kai
   Fend, Falko
   Dombrowski, Frank
   Singer, Kerstin
   Singer, Stephan
TI HELLS Is Negatively Regulated by Wild-Type P53 in Liver Cancer by a
   Mechanism Involving P21 and FOXM1
SO CANCERS
LA English
DT Article
DE chromatin remodeling; HCC; gene repression; P53 network
ID GENE-EXPRESSION; TRANSCRIPTIONAL REPRESSION; KAPPA-B; BINDING; TARGET;
   PROTEIN; CYCLE; COMPLEX; INHIBITOR; MIR-34A
AB Simple Summary The tumor suppressor protein P53 is a major player in preventing liver cancer development and progression. In this study we could show that P53 negatively regulates the expression of Helicase, lymphoid specific (HELLS), previously described as an important pro-tumorigenic epigenetic regulator in hepatocarcinogenesis. The regulatory mechanism included induction of the P53 target gene P21 (CDKN1A) resulting in repression of HELLS via downregulation of the transcription factor Forkhead Box Protein M1 (FOXM1). Our in vitro and in vivo findings indicate an important additional aspect of the tumor suppressive function of P53 in liver cancer linked to epigenetic regulation. The major tumor suppressor P53 (TP53) acts primarily as a transcription factor by activating or repressing subsets of its numerous target genes, resulting in different cellular outcomes (e.g., cell cycle arrest, apoptosis and senescence). P53-dependent gene regulation is linked to several aspects of chromatin remodeling; however, regulation of chromatin-modifying enzymes by P53 is poorly understood in hepatocarcinogenesis. Herein, we identified Helicase, lymphoid specific (HELLS), a major epigenetic regulator in liver cancer, as a strong and selective P53 repression target within the SNF2-like helicase family. The underlying regulatory mechanism involved P53-dependent induction of P21 (CDKN1A), leading to repression of Forkhead Box Protein M1 (FOXM1) that in turn resulted in downregulation of HELLS expression. Supporting our in vitro data, we found higher expression of HELLS in murine HCCs arising in a Trp53-/- background compared to Trp53+/+ HCCs as well as a strong and highly significant correlation between HELLS and FOXM1 expression in different HCC patient cohorts. Our data suggest that functional or mutational inactivation of P53 substantially contributes to overexpression of HELLS in HCC patients and indicates a previously unstudied aspect of P53 ' s ability to suppress liver cancer formation.
C1 [Schuller, Stefanie; Sieker, Jan; Riemenschneider, Philip; Koehler, Bianca; Drucker, Elisabeth; Ribback, Silvia; Dombrowski, Frank; Singer, Kerstin; Singer, Stephan] Univ Med Greifswald, Inst Pathol, D-17475 Greifswald, Germany.
   [Riemenschneider, Philip; Koehler, Bianca; Fend, Falko; Singer, Kerstin; Singer, Stephan] Univ Hosp Tuebingen, Inst Pathol, D-72076 Tubingen, Germany.
   [Weiler, Sofia M. E.; Goeppert, Benjamin; Roessler, Stephanie; Breuhahn, Kai] Univ Heidelberg Hosp, Inst Pathol, D-69120 Heidelberg, Germany.
   [Dauch, Daniel] Univ Hosp Tuebingen, Dept Internal Med 8, D-72076 Tubingen, Germany.
   [Dauch, Daniel] German Canc Res Ctr, German Consortium Translat Canc Res DKTK, Translat Gastrointestinal Oncol Grp, D-69120 Heidelberg, Germany.
   [Sticht, Carsten] Heidelberg Univ, Med Fac Mannheim, NGS Core Facil, Core Facil Platform Mannheim CFPM, D-68167 Mannheim, Germany.
   [Singer, Stephan] Univ Tubingen, Cluster Excellence iFIT EXC Image Guided & Funct, D-72076 Tubingen, Germany.
C3 Greifswald Medical School; Eberhard Karls University of Tubingen;
   Eberhard Karls University Hospital; Ruprecht Karls University
   Heidelberg; Eberhard Karls University of Tubingen; Eberhard Karls
   University Hospital; Helmholtz Association; German Cancer Research
   Center (DKFZ); Ruprecht Karls University Heidelberg; Eberhard Karls
   University of Tubingen
RP Singer, S (corresponding author), Univ Med Greifswald, Inst Pathol, D-17475 Greifswald, Germany.; Singer, S (corresponding author), Univ Hosp Tuebingen, Inst Pathol, D-72076 Tubingen, Germany.; Singer, S (corresponding author), Univ Tubingen, Cluster Excellence iFIT EXC Image Guided & Funct, D-72076 Tubingen, Germany.
EM stefanie.schuller@uni-greifswald.de; js132977@uni-greifswald.de;
   philip.riemenschneider@med.uni-tuebingen.de;
   Bianca.Koehler@med.uni-tuebingen.de; lisi.drucker@gmail.com;
   sofia.weiler@med.uni-heidelberg.de; daniel.dauch@uni-tuebingen.de;
   carsten.sticht@medma.uni-heidelberg.de;
   benjamin.goeppert@med.uni-heidelberg.de;
   Stephanie.Roessler@med.uni-heidelberg.de;
   silvia.ribback@uni-greifswald.de; kai.breuhahn@med.uni-heidelberg.de;
   Falko.Fend@med.uni-tuebingen.de; frank.dombrowski@uni-greifswald.de;
   Kerstin-Anna.Singer@uni-tuebingen.de;
   stephan.singer@med.uni-tuebingen.de
RI Goeppert, Benjamin/AAC-2303-2022
OI Roessler, Stephanie/0000-0002-5333-5942
FU Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under
   Germany's Excellence Strategy [EXC 2180-390900677]; Tuebinger Female
   Funding Initiative [TuFF 2621-0-0]
FX Funded by the Deutsche Forschungsgemeinschaft (DFG, German Research
   Foundation) under Germany's Excellence Strategy-EXC 2180-390900677 and
   Tuebinger Female Funding Initiative (TuFF 2621-0-0).
CR Aksoy O, 2012, GENE DEV, V26, P1546, DOI 10.1101/gad.196238.112
   Barsotti AM, 2009, ONCOGENE, V28, P4295, DOI 10.1038/onc.2009.282
   Beckerman R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000935
   Berkers CR, 2013, CELL METAB, V18, P617, DOI 10.1016/j.cmet.2013.06.019
   Böhlig L, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/464916
   Bruix J, 2016, GASTROENTEROLOGY, V150, P835, DOI 10.1053/j.gastro.2015.12.041
   Calvisi DF, 2009, GUT, V58, P679, DOI 10.1136/gut.2008.152652
   Calvisi DF, 2011, J HEPATOL, V54, P311, DOI 10.1016/j.jhep.2010.06.036
   Carvajal LA, 2012, GENE DEV, V26, P1533, DOI 10.1101/gad.184911.111
   Chand V, 2019, MOL CANCER RES, V17, P1063, DOI 10.1158/1541-7786.MCR-18-0968
   Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010
   Chen L, 2019, EPIGENET CHROMATIN, V12, DOI 10.1186/s13072-019-0302-9
   Chen X, 2013, MOL CELL BIOL, V33, P227, DOI 10.1128/MCB.00881-12
   Dauch D, 2016, NAT MED, V22, P744, DOI 10.1038/nm.4107
   Drucker E, 2019, CELL COMMUN SIGNAL, V17, DOI 10.1186/s12964-019-0456-x
   Engeland K, 2018, CELL DEATH DIFFER, V25, P114, DOI 10.1038/cdd.2017.172
   European Assoc Study Liver, 2018, J HEPATOL, V69, P182, DOI 10.1016/j.jhep.2018.03.019
   Fischer M, 2017, ONCOGENE, V36, P3943, DOI 10.1038/onc.2016.502
   Fischer M, 2015, ONCOTARGET, V6, P41402, DOI 10.18632/oncotarget.6356
   Fitzmaurice C, 2018, JAMA ONCOL, V4, P1553, DOI 10.1001/jamaoncol.2018.2706
   Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295
   Gusarova GA, 2007, J CLIN INVEST, V117, P99, DOI 10.1172/JCI27527
   HOLLSTEIN M, 1994, NUCLEIC ACIDS RES, V22, P3551
   Holzer K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10133-z
   Holzer K, 2017, AM J PATHOL, V187, P228, DOI 10.1016/j.ajpath.2016.09.022
   Jiang YQ, 2017, THERANOSTICS, V7, P3293, DOI 10.7150/thno.19988
   Johnson RA, 2001, J BIOL CHEM, V276, P27716, DOI 10.1074/jbc.C100121200
   Johnson RF, 2012, TRENDS BIOCHEM SCI, V37, P317, DOI 10.1016/j.tibs.2012.04.002
   Kalinichenko VV, 2004, GENE DEV, V18, P830, DOI 10.1101/gad.1200704
   Kastenhuber ER, 2017, CELL, V170, P1062, DOI 10.1016/j.cell.2017.08.028
   Koo CY, 2012, BBA-GENE REGUL MECH, V1819, P28, DOI 10.1016/j.bbagrm.2011.09.004
   Kumari R, 2021, FRONT CELL DEV BIOL, V09, DOI 10.3389/fcell.2021.645593
   Kurahashi T, 2020, CELL MOL GASTROENTER, V9, P425, DOI 10.1016/j.jcmgh.2019.10.008
   Law CT, 2019, HEPATOLOGY, V69, P2013, DOI 10.1002/hep.30414
   Lees A, 2021, CANCERS, V13, DOI 10.3390/cancers13133257
   Mauro C, 2011, NAT CELL BIOL, V13, P1272, DOI 10.1038/ncb2324
   NEIGEBORN L, 1984, GENETICS, V108, P845
   Park HJ, 2011, EMBO MOL MED, V3, P21, DOI 10.1002/emmm.201000107
   Pfister NT, 2015, GENE DEV, V29, P1298, DOI 10.1101/gad.263202.115
   Quaas M, 2012, CELL CYCLE, V11, P4661, DOI 10.4161/cc.22917
   Robinson MH, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50088-1
   Roessler S, 2010, CANCER RES, V70, P10202, DOI 10.1158/0008-5472.CAN-10-2607
   Shamloo B, 2019, CANCERS, V11, DOI 10.3390/cancers11081178
   STERN M, 1984, J MOL BIOL, V178, P853, DOI 10.1016/0022-2836(84)90315-2
   Sullivan KD, 2018, CELL DEATH DIFFER, V25, P133, DOI 10.1038/cdd.2017.174
   Takata A, 2017, ONCOTARGET, V8, P64840, DOI 10.18632/oncotarget.17609
   Tang ZF, 2019, NUCLEIC ACIDS RES, V47, pW556, DOI 10.1093/nar/gkz430
   Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104
   Tian C, 2018, GENE THER, V25, P312, DOI 10.1038/s41434-018-0029-4
   von Eyss B, 2012, EMBO J, V31, P972, DOI 10.1038/emboj.2011.451
   Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037
   Wang B, 2009, P NATL ACAD SCI USA, V106, P14373, DOI 10.1073/pnas.0903284106
   WANG XW, 1994, P NATL ACAD SCI USA, V91, P2230, DOI 10.1073/pnas.91.6.2230
   Weiler SME, 2017, GASTROENTEROLOGY, V152, P2037, DOI 10.1053/j.gastro.2017.02.018
   Winkler J, 2014, HEPATOLOGY, V60, P884, DOI 10.1002/hep.27207
   Yan DJ, 2019, ONCOL REP, V42, P785, DOI 10.3892/or.2019.7192
NR 56
TC 4
Z9 4
U1 0
U2 16
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6694
J9 CANCERS
JI Cancers
PD JAN
PY 2022
VL 14
IS 2
AR 459
DI 10.3390/cancers14020459
PG 20
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA YN8DR
UT WOS:000747483500001
PM 35053620
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Tanic, N
   Perovic, M
   Mladenovic, A
   Ruzdijic, S
   Kanazir, S
AF Tanic, Nikola
   Perovic, Milka
   Mladenovic, Aleksandra
   Ruzdijic, Sabera
   Kanazir, Selma
TI Effects of aging, dietary restriction and glucocorticoid treatment on
   housekeeping gene expression in rat cortex and hippocampus - Evaluation
   by real time RT-PCR
SO JOURNAL OF MOLECULAR NEUROSCIENCE
LA English
DT Article
DE TaqMan real time RT-PCR; house-keeping genes; cortex; hippocampus;
   aging; dietary restriction; dexamethasone
ID MESSENGER-RNA LEVELS; BETA-ACTIN; QUANTIFICATION; BRAIN; MODEL;
   VALIDATION; LIVER
AB Accurate normalization is the prerequisite for obtaining reliable results in the quantification of gene expression. Using TaqMan Real Time RT-PCR, we carried out an extensive evaluation of five most commonly used endogenous controls, gapdh, beta-actin, 18S rRNA, hprt and cypB, for their presumed stability of expression, in rat cortex and hippocampus, during aging, under dietary restriction and dexamethasone treatment. Valid reference genes (HKGs) were identified using GeNorm and NormFinder software packages and by direct comparison of Ct values. Analysis revealed gapdh and P-actin as the most stable HKGs for all treatments analyzed, combined or separately, in the cortex, while in the hippocampus gapdh/ hprt and beta-actin/hprt are the combination of choice for the single or combined effects of dietary restriction/dexamethasone, respectively. All treatments significantly influenced expression of 18S rRNA and cypB in both structures. In addition, we used gapdh and normalization factor, calculated by GeNorm, to compare the expression of a-syn in the cortex. Our results demonstrate the importance of the right choice of HKG and suggest the appropriate endogenous control to be used for TaqMan RT-PCR analysis of mRNA expression in rat cortex and hippocampus for selected experimental paradigms.
C1 Sinisa Stankovic Univ Belgrade, Lab Mol Neurobiol, Dept Neurobiol, Inst Biol Res, Belgrade 11060, Serbia.
C3 University of Belgrade
RP Kanazir, S (corresponding author), Sinisa Stankovic Univ Belgrade, Lab Mol Neurobiol, Dept Neurobiol, Inst Biol Res, Bul D Stefana 142, Belgrade 11060, Serbia.
EM selkan@ibiss.bg.ac.yu
RI Kanazir, Selma/E-5495-2015; Mladenovic, Aleksandra/IQR-9118-2023;
   Perović, Milka/HKV-2237-2023
OI Kanazir, Selma/0000-0002-7229-5296; Mladenovic,
   Aleksandra/0000-0001-9011-5634; Perović, Milka/0000-0003-0941-6988
CR Agardh E, 2006, METABOLISM, V55, P168, DOI 10.1016/j.metabol.2005.08.009
   Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496
   Barroso JJ, 2001, INT J INFRARED MILLI, V22, P265, DOI 10.1023/A:1010744204031
   BHATIA P, 1994, ANAL BIOCHEM, V216, P223, DOI 10.1006/abio.1994.1028
   Bond BC, 2002, MOL BRAIN RES, V106, P101, DOI 10.1016/S0169-328X(02)00417-5
   Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169
   Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023
   Bustin Stephen A, 2004, J Biomol Tech, V15, P155
   Chen J, 2006, J GERONTOL A-BIOL, V61, P20, DOI 10.1093/gerona/61.1.20
   DELEEUW WJF, 1989, NUCLEIC ACIDS RES, V17, P10137, DOI 10.1093/nar/17.23.10137
   Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03
   Gatta LB, 2002, NEUROREPORT, V13, P2031, DOI 10.1097/00001756-200211150-00008
   Gutala RV, 2004, J NEUROSCI METH, V132, P101, DOI 10.1016/j.jneumeth.2003.09.005
   Krüssel JS, 1998, J CLIN ENDOCR METAB, V83, P953, DOI 10.1210/jc.83.3.953
   Law AJ, 2003, ANN NY ACAD SCI, V1003, P426, DOI 10.1196/annals.1300.043
   Lindblom J, 2005, MOL BRAIN RES, V133, P37, DOI 10.1016/j.molbrainres.2004.09.025
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Macdonald R, 2001, MOL BRAIN RES, V90, P48, DOI 10.1016/S0169-328X(01)00086-9
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Proudnikov D, 2003, MOL BRAIN RES, V112, P182, DOI 10.1016/S0169-328X(03)00056-1
   Roth Charles M., 2002, Current Issues in Molecular Biology, V4, P93
   Sawada T, 2004, NEUROSCIENCE, V126, P461, DOI 10.1016/j.neuroscience.2004.03.001
   Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9
   Shimokawa I, 2003, NEUROBIOL AGING, V24, P117, DOI 10.1016/S0197-4580(02)00046-5
   SLAGBOOM PE, 1990, MECH AGEING DEV, V53, P243, DOI 10.1016/0047-6374(90)90042-E
   Stürzenbaum SR, 2001, COMP BIOCHEM PHYS B, V130, P281, DOI 10.1016/S1096-4959(01)00440-7
   Tatton WG, 2000, ADV RES NEURODEGENER, V8, P77
   Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7
   Tichopad A, 2004, MOL CELL PROBE, V18, P45, DOI 10.1016/j.mcp.2003.09.001
   Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034
   Wall SJ, 2002, ANAL BIOCHEM, V300, P269, DOI 10.1006/abio.2001.5458
   Webster MJ, 2002, DEV BRAIN RES, V139, P139, DOI 10.1016/S0165-3806(02)00540-0
NR 32
TC 82
Z9 92
U1 0
U2 19
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 0895-8696
EI 1559-1166
J9 J MOL NEUROSCI
JI J. Mol. Neurosci.
PY 2007
VL 32
IS 1
BP 38
EP 46
DI 10.1007/s12031-007-0006-7
PG 9
WC Biochemistry & Molecular Biology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA 191VH
UT WOS:000248159600005
PM 17873286
DA 2024-02-19
ER

PT J
AU Özsoy, M
   Zimmermann, FA
   Feichtinger, RG
   Mayr, JA
   Kofler, B
   Neureiter, D
   Klieser, E
   Schütz, S
   Weghuber, D
   Schneider, AM
AF Ozsoy, Mihriban
   Zimmermann, Franz A.
   Feichtinger, Rene G.
   Mayr, Johannes A.
   Kofler, Barbara
   Neureiter, Daniel
   Klieser, Eckhard
   Schuetz, Sebastian
   Weghuber, Daniel
   Schneider, Anna M.
TI Changes in the expression of oxidative phosphorylation complexes in the
   aging intestinal mucosa
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE Aging; Mitochondria; OXPHOS; Expression; Intestine; Colonic crypt
ID CYTOCHROME-C-OXIDASE; MITOCHONDRIAL-DNA MUTATIONS; RESPIRATORY-CHAIN;
   SKELETAL-MUSCLE; ATP SYNTHASE; DEFICIENCY; LIVER; APOPTOSIS; DELETIONS;
   DEFECTS
AB Objective: Mitochondria produce cellular energy via oxidative phosphorylation (OXPHOS), mediated by respiratory chain complexes I to IV and ATP synthase (complex V). Mitochondrial respiratory complexes have been shown to decline with age in several tissues. As the intestinal epithelium is a tissue with a high energy demand, the aim of the present study was to establish whether the expression profile of OXPHOS subunits in the intestinal mucosa changes during the aging process.
   Design: Biopsies of intestinal mucosa with no evidence of endoscopic or histomorphologic abnormalities, taken from 55 patients (mean age 42 years, age range 4-82 years; 62% female), were divided into four age groups (4-19, 20-39, 40-59, >= 60 years). Sections from different intestinal segments (terminal ileum, ascending colon, and sigmoid colon/rectum) were stained immunohistochemically (IHC) for subunits of OXPHOS complexes I-V and the voltage-dependent anion-selective channel 1 protein (VDAC1, porin), a marker of mitochondrial mass. Scores for IHC staining were determined by multiplication of the staining intensity and the percentage of positive cells. In addition, the numbers of intestinal crypts staining positive, partly positive, and negative were assessed.
   Results: The average protein expression levels of OXPHOS subunits increased continuously from childhood onward, peaked in persons aged 20 to 59 years, and declined thereafter. This was seen for complexes II to V in the terminal ileum, complexes I to V in the ascending colon, and complexes I to IV in the sigmoid colon/rectum. Across all age groups, no effect of age on expression of the porin subunit VDAC1 was detected. The number of complex I- and IV-negative crypts in different intestinal segments increased with age.
   Conclusion: The protein expression levels of OXPHOS complexes increases from childhood onward and declines in elderly individuals, while the numbers of crypts with partial or complete loss of expression of complexes I and IV increase continuously with age. These data suggest that the continued reductions in the levels of mitochondrial OXPHOS complexes in crypts might be compensated in adulthood, but that, ultimately, reduced expression levels occur in persons aged 60 years and older. These findings raise two important questions: first, can the process of aging could be delayed through (pharmacological) intervention of mitochondrial pathways, and second, pathophysiologically, are these findings associated with disorders of the intestinal mucosa, e.g. inflammation?
C1 [Ozsoy, Mihriban; Zimmermann, Franz A.; Feichtinger, Rene G.; Mayr, Johannes A.; Kofler, Barbara; Weghuber, Daniel; Schneider, Anna M.] Paracelsus Med Univ, Dept Pediat, Mullner Hauptstr 48, A-5020 Salzburg, Austria.
   [Zimmermann, Franz A.; Feichtinger, Rene G.; Kofler, Barbara] Paracelsus Med Univ, Dept Pediat, Res Program Receptor Biochem & Tumor Metab, Salzburg, Austria.
   [Neureiter, Daniel; Klieser, Eckhard] Paracelsus Med Univ, Dept Pathol, Salzburg, Austria.
   [Schuetz, Sebastian] Paris Lodron Univ, Dept Math, Salzburg, Austria.
C3 Paracelsus Private Medical University; Paracelsus Private Medical
   University; Paracelsus Private Medical University
RP Weghuber, D (corresponding author), Paracelsus Med Univ, Dept Pediat, Mullner Hauptstr 48, A-5020 Salzburg, Austria.
EM d.weghuber@salk.at
FU Paracelsus Medical University, Salzburg, Austria [E-17/25/134-WES]
FX This work was supported by a grant from Paracelsus Medical University,
   Salzburg, Austria (Grant number E-17/25/134-WES).
CR Acín-Pérez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8
   Acin-Pérez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021
   Bernstein C, 2010, WORLD J GASTRO ONCOL, V2, P429, DOI 10.4251/wjgo.v2.i12.429
   Bertram R, 2006, J THEOR BIOL, V243, P575, DOI 10.1016/j.jtbi.2006.07.019
   Bhonchal S, 2008, J GASTROEN HEPATOL, V23, pE43, DOI 10.1111/j.1440-1746.2007.05080.x
   Boengler K, 2017, J CACHEXIA SARCOPENI, V8, P349, DOI 10.1002/jcsm.12178
   Brunner E, 2017, J ROY STAT SOC B, V79, P1463, DOI 10.1111/rssb.12229
   Chen LJ, 2020, BIOL TRACE ELEM RES, V196, P481, DOI 10.1007/s12011-019-01948-4
   Childs BG, 2015, NAT MED, V21, P1424, DOI 10.1038/nm.4000
   COOPER JM, 1992, J NEUROL SCI, V113, P91, DOI 10.1016/0022-510X(92)90270-U
   Cottrell DA, 2001, NEUROBIOL AGING, V22, P265, DOI 10.1016/S0197-4580(00)00234-7
   Dakubo GD, 2010, MITOCHONDRIAL GENETICS AND CANCER, P1, DOI 10.1007/978-3-642-11416-8
   Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010
   Feichtinger RG, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/7202589
   Finsterer J, 2016, J CHILD NEUROL, V31, P1489, DOI 10.1177/0883073816661458
   Greaves LC, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003082
   Greaves LC, 2010, EXP GERONTOL, V45, P573, DOI 10.1016/j.exger.2010.01.013
   Greaves LC, 2006, P NATL ACAD SCI USA, V103, P714, DOI 10.1073/pnas.0505903103
   Hirono K, 2019, CLIN CASE REP, V7, P553, DOI 10.1002/ccr3.2050
   HSIEH RH, 1994, BIOCHEM MOL BIOL INT, V32, P1009
   Ikeda Y, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/210934
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055
   Lee HC, 2012, ADV EXP MED BIOL, V942, P311, DOI 10.1007/978-94-007-2869-1_14
   Lefai E, 1997, BBA-BIOENERGETICS, V1318, P191, DOI 10.1016/S0005-2728(96)00136-3
   Linnane AW, 1998, ANN NY ACAD SCI, V854, P202, DOI 10.1111/j.1749-6632.1998.tb09903.x
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Manzo-Avalos S, 2010, INT J ENV RES PUB HE, V7, P4281, DOI 10.3390/ijerph7124281
   Matsui H, 2011, J CLIN BIOCHEM NUTR, V48, P107, DOI 10.3164/jcbn.10-79
   Mayr JA, 2010, HUM MOL GENET, V19, P3430, DOI 10.1093/hmg/ddq254
   Moorefield EC, 2017, AGING-US, V9, P1898, DOI 10.18632/aging.101279
   MullerHocker J, 1997, HEPATOLOGY, V26, P709
   MULLERHOCKER J, 1992, MUTAT RES, V275, P115, DOI 10.1016/0921-8734(92)90016-I
   MULLERHOCKER J, 1990, J NEUROL SCI, V100, P14, DOI 10.1016/0022-510X(90)90006-9
   MULLERHOCKER J, 1989, AM J PATHOL, V134, P1167
   Nooteboom M, 2010, AGING CELL, V9, P96, DOI 10.1111/j.1474-9726.2009.00531.x
   Ojaimi J, 1999, MECH AGEING DEV, V111, P39, DOI 10.1016/S0047-6374(99)00071-8
   Oláhová M, 2018, AM J HUM GENET, V102, P494, DOI 10.1016/j.ajhg.2018.01.020
   Ortuño-Sahagún D, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/573208
   Pennings JLA, 2020, NICOTINE TOB RES, V22, P1748, DOI 10.1093/ntr/ntz203
   Pfeiffer RF, 2011, PARKINSONISM RELAT D, V17, P10, DOI 10.1016/j.parkreldis.2010.08.003
   Rath E, 2018, NAT REV GASTRO HEPAT, V15, P497, DOI 10.1038/s41575-018-0021-x
   Schiavi A, 2014, EXP GERONTOL, V56, P147, DOI 10.1016/j.exger.2014.02.015
   Silaidos C, 2018, BIOL SEX DIFFER, V9, DOI 10.1186/s13293-018-0193-7
   Snippert HJ, 2016, CELL, V165, P1564, DOI 10.1016/j.cell.2016.06.003
   Strickland M, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00158
   Su TH, 2018, GENES-BASEL, V9, DOI 10.3390/genes9040182
   Swerdlow RH, 2018, J ALZHEIMERS DIS, V62, P1403, DOI 10.3233/JAD-170585
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Varela-López A, 2016, MOLECULES, V21, DOI 10.3390/molecules21030373
   Varela-Lopez A, 2016, J GERONTOL A-BIOL, V71, P593, DOI 10.1093/gerona/glv063
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Viader A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027727
   Yang X, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00021
   YEN TC, 1989, BIOCHEM BIOPH RES CO, V165, P994, DOI 10.1016/0006-291X(89)92701-0
   Yuan Q, 2017, CHEM RES TOXICOL, V30, P2197, DOI 10.1021/acs.chemrestox.7b00275
   Zhang XY, 2010, HEPATOLOGY, V52, P2137, DOI 10.1002/hep.23909
   Zimmermann FA, 2009, BRIT J CANCER, V100, P1434, DOI 10.1038/sj.bjc.6605028
   Zimmermann FA, 2016, MITOCHONDRION, V26, P1, DOI 10.1016/j.mito.2015.11.002
NR 59
TC 9
Z9 9
U1 0
U2 9
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD JUL 1
PY 2020
VL 135
AR 110924
DI 10.1016/j.exger.2020.110924
PG 9
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA LE5WE
UT WOS:000526790700003
PM 32173460
DA 2024-02-19
ER

PT J
AU Taura, N
   Hamasaki, K
   Nakao, K
   Ichikawa, T
   Nishimura, D
   Goto, T
   Fukuta, M
   Kawashimo, H
   Miyaaki, H
   Fujimoto, M
   Kusumoto, K
   Motoyoshi, Y
   Shibata, H
   Inokuchi, K
   Eguchi, K
AF Taura, Naota
   Hamasaki, Keisuke
   Nakao, Kazuhiko
   Ichikawa, Tatsuki
   Nishimura, Daisuke
   Goto, Takashi
   Fukuta, Mariko
   Kawashimo, Hiroshi
   Miyaaki, Hisamitsu
   Fujimoto, Masumi
   Kusumoto, Kouichiro
   Motoyoshi, Yasuhide
   Shibata, Hidetaka
   Inokuchi, Kaoru
   Eguchi, Katsumi
TI Aging of patients with hepatitis C virus-associated hepatocellular
   carcinoma: Long-term trends in Japan
SO ONCOLOGY REPORTS
LA English
DT Article
DE hepatitis C virus; hepatocellular carcinoma; aging; Japan
ID PRIMARY LIVER-CANCER; UNITED-STATES; INFECTION; PREVALENCE; POPULATION;
   CIRRHOSIS; FUTURE; RISK
AB The incidence of hepatocellular carcinoma (HCC) in Japan has been increasing. The aim of the present study was to analyze epidemiological changes in Japanese HCC patients. A total of 463 patients with HCC diagnosed at our hospital between 1982 and 2001 were recruited for this study. Cohorts of patients with HCC were categorized into intervals of five years. The number of HBV- and HCV-associated HCC cases had decreased and increased in 1987-1991, respectively, and thereafter reached a plateau. The mean age of patients at diagnosis of HCV-associated HCC showed a steady significant increase from 60 to 68 years of age during the period, suggesting that these findings were associated with a shift toward an older-age group that had the highest rate of HCV infection. The mean age of patients with other types of HCC did not significantly change during the period. Since it is known that the prevalence of HCV infection in young Japanese persons is low and that the incidence of HCV infection is very low at present, our findings may indicate that the prevalence of HCC will decline in Japan, an advanced country with regard to HCV-associated HCC, in the near future.
C1 Nagasaki Univ, Sch Med, Dept Internal Med 1, Nagasaki 8528501, Japan.
   Nagasaki Tarami Hosp, Nagasaki 8590497, Japan.
C3 Nagasaki University
RP Taura, N (corresponding author), Nagasaki Univ, Sch Med, Dept Internal Med 1, Sakamoto 1-7-1, Nagasaki 8528501, Japan.
EM ntaura-gi@umin.ac.jp
CR Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802
   Armstrong GL, 2000, HEPATOLOGY, V31, P777, DOI 10.1002/hep.510310332
   Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011
   Davila JA, 2004, GASTROENTEROLOGY, V127, P1372, DOI 10.1053/j.gastro.2004.07.020
   Deuffic S, 1999, J VIRAL HEPATITIS, V6, P411, DOI 10.1046/j.1365-2893.1999.00178.x
   El-Serag HB, 2000, ARCH INTERN MED, V160, P3227, DOI 10.1001/archinte.160.21.3227
   El-Serag HB, 2002, HEPATOLOGY, V36, pS74, DOI 10.1053/jhep.2002.36807
   El-Serag HB, 2002, J CLIN GASTROENTEROL, V35, pS72, DOI 10.1097/00004836-200211002-00002
   El-Serag HB, 2002, HEPATOLOGY, V36, P1439, DOI 10.1053/jhep.2002.37191
   El-Serag HB, 1999, NEW ENGL J MED, V340, P745, DOI 10.1056/NEJM199903113401001
   HAMASAKI K, 1993, J MED VIROL, V40, P146, DOI 10.1002/jmv.1890400212
   Hassan MM, 2002, J CLIN GASTROENTEROL, V35, P266, DOI 10.1097/00004836-200209000-00013
   KATO Y, 1994, CANCER, V74, P2234, DOI 10.1002/1097-0142(19941015)74:8<2234::AID-CNCR2820740805>3.0.CO;2-6
   Kiyosawa K, 2004, GASTROENTEROLOGY, V127, pS17, DOI 10.1053/j.gastro.2004.09.012
   Kiyosawa K, 2002, ONCOLOGY-BASEL, V62, P5, DOI 10.1159/000048269
   Lafaro KJ, 2015, SURG ONCOL CLIN N AM, V24, P1, DOI 10.1016/j.soc.2014.09.001
   McGlynn KA, 2001, INT J CANCER, V94, P290, DOI 10.1002/ijc.1456
   Moriya T, 1999, INTERVIROLOGY, V42, P153, DOI 10.1159/000024974
   Okayama A, 2002, J VIRAL HEPATITIS, V9, P43, DOI 10.1046/j.1365-2893.2002.00331.x
   Planas R, 2004, J HEPATOL, V40, P823, DOI 10.1016/j.jhep.2004.01.005
   Sasaki F, 1996, J Epidemiol, V6, P198
   SHIRATORI Y, 1995, HEPATOLOGY, V22, P1027, DOI 10.1002/hep.1840220403
   Shiratori Y, 1997, CANCER, V80, P2060, DOI 10.1002/(SICI)1097-0142(19971201)80:11<2060::AID-CNCR4>3.3.CO;2-0
   Tanaka Y, 2002, P NATL ACAD SCI USA, V99, P15584, DOI 10.1073/pnas.242608099
   Yoshizawa H, 2002, ONCOLOGY-BASEL, V62, P8, DOI 10.1159/000048270
   Zanetti AR, 2003, VACCINE, V21, P692, DOI 10.1016/S0264-410X(02)00581-9
NR 26
TC 32
Z9 32
U1 0
U2 1
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1021-335X
EI 1791-2431
J9 ONCOL REP
JI Oncol. Rep.
PD OCT
PY 2006
VL 16
IS 4
BP 837
EP 843
PG 7
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA 089KI
UT WOS:000240879000029
PM 16969503
DA 2024-02-19
ER

PT J
AU CHEN, LH
   HU, N
   SNYDER, DL
AF CHEN, LH
   HU, N
   SNYDER, DL
TI LIVER DT-DIAPHORASE ACTIVITY INCREASES WITH AGE AND DIETARY RESTRICTION
   IN LOBUND-WISTAR RATS
SO AGE
LA English
DT Article
ID FOOD RESTRICTION; ENZYMES; ANTIOXIDANTS; PROTECTION; MECHANISMS;
   REDUCTASE; CALORIES; TOXICITY; RODENTS; PROTEIN
AB Effects of a 30 percent (%) dietary restriction on liver DT-diaphorase activity toward various substrates were studied in male Lobund-Wistar (L-W) rats throughout the life span. DT-diaphorase catalyzes the reduction of quinones to hydroquinones, thus playing a major role in protecting cells against oxidative stress manifested by quinones. Eighty rats were divided into 2 groups and fed ad libitum or a 30% calorie-restricted diet. Eight rats in each group were killed at 6, 12, 18, 24 and 30 months of age. DT-diaphorase activity in liver cytosol was determined. The specific activity (per mg protein) of the enzyme in the ad libitum group toward 1,4-naphthoquinone (NQ) increased with age from 6 to 30 months, while those toward 2,6-dichlorophenol-indophenol (DCPIP), 2-methyl-1,4-naphthoquinone (MNQ) and ubiquinone0 (UQ0) increased with age from 18 to 30 months. The specific activity of the enzyme toward all four substrates in the restricted group did not change between 6 and 18 months, then increased with age from 18 to 30 months. When the enzyme activity was calculated on a per gram body weight basis or a per gram liver basis, the age-associated patterns of the ad libitum and restricted groups were similar to those on per mg protein basis. Dietary restriction increased the activity of DT-diaphorase on per mg protein basis, per gram body weight basis, or per gram liver basis, at almost all age points. The results suggest that dietary restriction contributes to the delaying of the aging process by decreasing oxidative stress exerted by quinones through increased DT-diaphorase activity.
C1 UNIV NOTRE DAME,LOBUND LAB,NOTRE DAME,IN 46556.
C3 University of Notre Dame
RP CHEN, LH (corresponding author), UNIV KENTUCKY,DEPT NUTR & FOOD SCI,219 FUNKHOUSER BLDG,LEXINGTON,KY 40506, USA.
CR BENSON AM, 1980, P NATL ACAD SCI-BIOL, V77, P5216, DOI 10.1073/pnas.77.9.5216
   CHEN LH, 1993, ARCH GERONTOL GERIAT, V16, P69, DOI 10.1016/0167-4943(93)90028-G
   CHEN LH, 1989, DIETARY RESTRICTION, P247
   CHUNG MH, 1992, FREE RADICAL BIO MED, V12, P523, DOI 10.1016/0891-5849(92)90105-P
   Ernster L., 1967, METHODS ENZYMOLOGY, VVolume 10, P309, DOI [10.1016/0076-6879(67)10059-1, DOI 10.1016/0076-6879(67)10059-1]
   FRAGA CG, 1990, P NATL ACAD SCI USA, V87, P4533, DOI 10.1073/pnas.87.12.4533
   FRIDOVICH I, 1983, ANNU REV PHARMACOL, V23, P239, DOI 10.1146/annurev.pa.23.040183.001323
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HARMAN D, 1992, MUTAT RES, V275, P257, DOI 10.1016/0921-8734(92)90030-S
   IYANAGI T, 1970, BIOCHIM BIOPHYS ACTA, V216, P282, DOI 10.1016/0005-2728(70)90220-3
   JOHNSON BC, 1986, P NATL ACAD SCI USA, V83, P5659, DOI 10.1073/pnas.83.15.5659
   KOIZUMI A, 1987, J NUTR, V117, P361, DOI 10.1093/jn/117.2.361
   LAGANIERE S, 1987, BIOCHEM BIOPH RES CO, V145, P1185, DOI 10.1016/0006-291X(87)91562-2
   LAGANIERE S, 1989, MECH AGEING DEV, V48, P221, DOI 10.1016/0047-6374(89)90084-5
   LEAKEY JEA, 1991, BIOL EFFECTS DIETARY, P207
   LIND C, 1982, ARCH BIOCHEM BIOPHYS, V216, P178, DOI 10.1016/0003-9861(82)90202-8
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MASORO EJ, 1985, J NUTR, V115, P842, DOI 10.1093/jn/115.7.842
   MASORO EJ, 1988, J GERONTOL, V43, pB59, DOI 10.1093/geronj/43.3.B59
   MATSUO M, 1993, J GERONTOL, V48, pB133, DOI 10.1093/geronj/48.4.B133
   MILLER MG, 1986, BIOCHEM PHARMACOL, V35, P1177, DOI 10.1016/0006-2952(86)90157-7
   MIRABELLI F, 1989, ARCH BIOCHEM BIOPHYS, V270, P478, DOI 10.1016/0003-9861(89)90529-8
   POLLARD M, 1971, GERONTOLOGY, V17, P333, DOI 10.1159/000211839
   PROCHASKA HJ, 1991, OXIDATIVE STRESS OXI, P195
   RAO G, 1990, J NUTR, V120, P602, DOI 10.1093/jn/120.6.602
   SCHMUCKER DL, 1991, J GERONTOL, V46, pB23, DOI 10.1093/geronj/46.1.B23
   SNYDER DL, 1990, J GERONTOL, V45, pB52, DOI 10.1093/geronj/45.2.B52
   SNYDER DL, 1987, LAB ANIM SCI, V37, P320
   THOR H, 1988, ARCH BIOCHEM BIOPHYS, V266, P397, DOI 10.1016/0003-9861(88)90271-8
   TUCKER MJ, 1979, INT J CANCER, V23, P803, DOI 10.1002/ijc.2910230611
   VAN DER RIJST M. P. J., 1955, Voeding, V16, P708
   YOUNGMAN LD, 1992, P NATL ACAD SCI USA, V89, P9112, DOI 10.1073/pnas.89.19.9112
NR 32
TC 3
Z9 3
U1 0
U2 1
PU AMER AGING ASSOC
PI CHESTER
PA 2129 PROVIDENCE AVENUE, CHESTER, PA 19013
SN 0161-9152
J9 AGE
JI Age
PD APR
PY 1994
VL 17
IS 2
BP 65
EP 70
DI 10.1007/BF02434896
PG 6
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA NY905
UT WOS:A1994NY90500005
DA 2024-02-19
ER

PT J
AU Tang, HY
   Vasselli, JR
   Wu, EX
   Boozer, CN
   Gallagher, D
AF Tang, HY
   Vasselli, JR
   Wu, EX
   Boozer, CN
   Gallagher, D
TI High-resolution magnetic resonance imaging tracks changes in organ and
   tissue mass in obese and aging rats
SO AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE
   PHYSIOLOGY
LA English
DT Article
DE longitudinal body composition; in vivo; obesity; high-fat diet; small
   animal
ID BODY-COMPOSITION; COMPUTERIZED-TOMOGRAPHY; ADIPOSE-TISSUE; IN-VIVO;
   VALIDATION; FAT; GROWTH
AB Magnetic resonance imaging (MRI) has the ability to discriminate between various soft tissues in vivo. Whole body, specific organ, total adipose tissue (TAT), intra-abdominal adipose tissue (IAAT), and skeletal muscle (SM) weights determined by MRI were compared with weights determined by dissection and chemical analysis in two studies with male Sprague-Dawley rats. A 4.2-T MRI machine acquired high-resolution, in vivo, longitudinal whole body images of rats as they developed obesity or aged. Weights of the whole body and specific tissues were determined using computer image analysis software, including semiautomatic segmentation algorithms for volume calculations. High correlations were found for body weight (r = 0.98), TAT (r = 0.99), and IAAT (r = 0.98) between MRI and dissection and chemical analyses. MRI estimated the weight of the brain, kidneys, and spleen with high accuracy (r = 0.9), but overestimated IAAT, SM, and liver volumes. No differences were detected in organ weights using MRI and dissection measurements. Longitudinal MRI measurements made during the development of obesity and aging accurately represented changes in organ and tissue mass.
C1 St Lukes Roosevelt Hosp, Obes Res Ctr, New York, NY 10025 USA.
   Columbia Univ Coll Phys & Surg, Dept Radiol, New York, NY 10032 USA.
C3 Mount Sinai St. Luke's; Mount Sinai West; Columbia University
RP Gallagher, D (corresponding author), St Lukes Roosevelt Hosp, Obes Res Ctr, 1090 Amsterdam Ave, New York, NY 10025 USA.
EM dg108@columbia.edu
RI ; Wu, Ed Xuekui/C-1579-2009
OI Gallagher, Dympna/0000-0003-1769-9754; Wu, Ed Xuekui/0000-0001-5581-1546
FU NIA NIH HHS [R29-AG14715] Funding Source: Medline
CR Behnke AR, 1964, FAT TISSUE, P285
   BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8
   Callaghan P.T., 1993, PRINCIPLES NUCL MAGN
   CLARKE LP, 1995, MAGN RESON IMAGING, V13, P343, DOI 10.1016/0730-725X(94)00124-L
   COCKMAN MD, 1993, MAGNET RESON MED, V30, P355, DOI 10.1002/mrm.1910300313
   Delp MD, 1998, J APPL PHYSIOL, V85, P1813, DOI 10.1152/jappl.1998.85.5.1813
   Even PC, 2001, AM J PHYSIOL-REG I, V280, pR1887
   FERRARI A, 1960, ANN NY ACAD SCI, V87, P792, DOI 10.1111/j.1749-6632.1960.tb23236.x
   FOLCH J, 1951, J BIOL CHEM, V193, P497
   FOWLER PA, 1992, AM J CLIN NUTR, V56, P7, DOI 10.1093/ajcn/56.1.7
   FULLER MF, 1990, P NUTR SOC, V49, P423, DOI 10.1079/PNS19900050
   Gupta G, 2000, AM J PHYSIOL-REG I, V278, pR111, DOI 10.1152/ajpregu.2000.278.1.R111
   Ishikawa M, 1998, MAGN RESON IMAGING, V16, P45, DOI 10.1016/S0730-725X(97)00221-X
   JENSEN MD, 1992, J AM DIET ASSOC, V92, P454
   Johnson JA, 1998, OBES RES, V6, P448, DOI 10.1002/j.1550-8528.1998.tb00377.x
   Kleiber M., 1961, FIRE LIFE
   Levin BE, 2000, AM J PHYSIOL-REG I, V278, pR231, DOI 10.1152/ajpregu.2000.278.1.R231
   Mitsiopoulos N, 1998, J APPL PHYSIOL, V85, P115, DOI 10.1152/jappl.1998.85.1.115
   Mystkowski P, 2000, INT J OBESITY, V24, P719, DOI 10.1038/sj.ijo.0801231
   OSCAI LB, 1984, GROWTH, V48, P415
   PITTS GC, 1977, AM J PHYSIOL, V232, pR38, DOI 10.1152/ajpregu.1977.232.1.R38
   ROSS R, 1991, J APPL PHYSIOL, V70, P2164, DOI 10.1152/jappl.1991.70.5.2164
   Tang HY, 2000, ANN NY ACAD SCI, V904, P32
   Thomas EL, 1998, J APPL PHYSIOL, V85, P1778, DOI 10.1152/jappl.1998.85.5.1778
NR 24
TC 37
Z9 44
U1 3
U2 6
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0363-6119
EI 1522-1490
J9 AM J PHYSIOL-REG I
JI Am. J. Physiol.-Regul. Integr. Comp. Physiol.
PD MAR
PY 2002
VL 282
IS 3
BP R890
EP R899
DI 10.1152/ajpregu.0527.2001
PG 10
WC Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology
GA 520JR
UT WOS:000173779200033
PM 11832412
DA 2024-02-19
ER

PT J
AU Moon, YJ
   Park, JH
   Oh, J
   Lee, S
   Hwang, GS
AF Moon, Young-Jin
   Park, Ji Hyun
   Oh, JongEun
   Lee, Sooho
   Hwang, Gyu-Sam
TI Harmful effect of epinephrine on postreperfusion syndrome in an elderly
   liver transplantation recipient with sigmoid ventricular septum: A case
   report
SO MEDICINE
LA English
DT Article
DE epinephrine; left ventricular outflow tract obstruction; liver
   transplantation; postreperfusion syndrome; sigmoid septum; systolic
   anterior motion of mitral valve leaflet; transesophageal
   echocardiography
ID OUTFLOW TRACT OBSTRUCTION; SHAPED INTERVENTRICULAR SEPTUM;
   TRANSESOPHAGEAL ECHOCARDIOGRAPHY; HYPERTROPHIC CARDIOMYOPATHY
AB Introduction:As a common morphological change of aging heart, sigmoid ventricular septum is frequently found during routine preoperative evaluation, but often disregarded because of its little clinical importance. However, in this report, we describe a 70-year old patient with sigmoid ventricular septum who developed severe hemodynamic deterioration during liver transplantation because of its unique morphology of heart.Methods:During the course of reperfusion of the graft, patient's hemodynamics were closely monitored using transesophageal echocardiography.Results:Immediately after graft reperfusion, epinephrine was given as a treatment of choice for postreperfusion syndrome. Surprisingly, however, hemodynamic derangement persisted and became even worse. Intraoperative transesophageal echocardiography revealed left ventricular outflow tract obstruction resulting from systolic anterior motion of the mitral valve leaflet. Therefore, the patient was treated with phenylephrine and fluid bolus under the guidance of transesophageal echocardiography.Conclusion:As more elderly recipient present for liver transplantation surgery nowadays, left ventricular outflow tract obstruction should always be considered as a possible cause for hemodynamic instability during reperfusion period. In addition, transesophageal echocardiography is a useful tool for both diagnosis of hemodynamic derangement and guidance for appropriate management during liver transplantation surgery.
C1 [Moon, Young-Jin; Park, Ji Hyun; Oh, JongEun; Lee, Sooho; Hwang, Gyu-Sam] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Anesthesiol & Pain Med,Lab Cardiovasc Dynam, 88,Olympic Ro 43 Gil, Seoul, South Korea.
C3 University of Ulsan; Asan Medical Center
RP Hwang, GS (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Anesthesiol & Pain Med,Lab Cardiovasc Dynam, 88,Olympic Ro 43 Gil, Seoul, South Korea.
EM kshwang@amc.seoul.kr
RI Hwang, Gyu-Sam/AAX-1937-2021
OI Moon, Young-Jin/0000-0003-3719-1691
CR Burger-Klepp U, 2012, TRANSPLANTATION, V94, P192, DOI 10.1097/TP.0b013e31825475c2
   Cywinski JB, 2005, LIVER TRANSPLANT, V11, P692, DOI 10.1002/lt.20440
   DALLDORF FG, 1985, HUM PATHOL, V16, P457, DOI 10.1016/S0046-8177(85)80082-4
   Funabashi N, 2013, INT J CARDIOL, V168, P4484, DOI 10.1016/j.ijcard.2013.06.129
   GOOR D, 1969, AMER J ROENTGENOL RA, V107, P366, DOI 10.2214/ajr.107.2.366
   Hensley N, 2015, ANESTH ANALG, V120, P554, DOI 10.1213/ANE.0000000000000538
   Hymel BJ, 2014, ANESTH ANALG, V118, P1197, DOI 10.1213/ANE.0000000000000196
   Levy MF, 2001, ANN SURG, V233, P107, DOI 10.1097/00000658-200101000-00016
   Markin NW, 2015, J CARDIOTHOR VASC AN, V29, P588, DOI 10.1053/j.jvca.2014.10.012
   Oxorn D, 1996, CAN J ANAESTH, V43, P278, DOI 10.1007/BF03011745
   Ranasinghe I, 2011, HEART LUNG CIRC, V20, P579, DOI 10.1016/j.hlc.2011.05.002
   Robertson A, 2010, TRANSPL P, V42, P1721, DOI 10.1016/j.transproceed.2010.02.091
   Rochon AG, 2009, CAN J ANAESTH, V56, P962, DOI 10.1007/s12630-009-9174-y
   Sato Y, 2009, INT J CARDIOL, V132, pE97, DOI 10.1016/j.ijcard.2007.08.059
   Tano A, 2013, J CARDIOL, V61, P428, DOI 10.1016/j.jjcc.2013.01.008
   Umazume T, 2013, INT J CARDIOL, V165, P551, DOI 10.1016/j.ijcard.2012.09.007
   Yokoya Takahiro, 2002, J Cardiol, V40, P167
NR 17
TC 0
Z9 0
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0025-7974
EI 1536-5964
J9 MEDICINE
JI Medicine (Baltimore)
PD AUG
PY 2016
VL 95
IS 34
AR e4394
DI 10.1097/MD.0000000000004394
PG 4
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA DX0DV
UT WOS:000384032900025
PM 27559948
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Drew, B
   Phaneuf, S
   Dirks, A
   Selman, C
   Gredilla, R
   Lezza, A
   Barja, G
   Leeuwenburgh, C
AF Drew, B
   Phaneuf, S
   Dirks, A
   Selman, C
   Gredilla, R
   Lezza, A
   Barja, G
   Leeuwenburgh, C
TI Effects of aging and caloric restriction on mitochondrial energy
   production in gastrocnemius muscle and heart
SO AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE
   PHYSIOLOGY
LA English
DT Article
DE reactive oxygen species; 8-oxo-7,8-dihydro-2 '-deoxyguanosine; hydrogen
   peroxide; oxidative stress
ID FREE-RADICAL GENERATION; RAT SKELETAL-MUSCLE; OXIDATIVE STRESS; DNA
   DELETION; DAMAGE; LIVER; AGE; ABNORMALITIES; CONSEQUENCES; EXPRESSION
AB Mitochondria are chronically exposed to reactive oxygen intermediates. As a result, various tissues, including skeletal muscle and heart, are characterized by an age-associated increase in reactive oxidant-induced mitochondrial DNA (mtDNA) damage. It has been postulated that these alterations may result in a decline in the content and rate of production of ATP, which may affect tissue function, contribute to the aging process, and lead to several disease states. We show that with age, ATP content and production decreased by similar to50% in isolated rat mitochondria from the gastrocnemius muscle; however, no decline was observed in heart mitochondria. The decline observed in skeletal muscle may be a factor in the process of sarcopenia, which increases in incidence with advancing age. Lifelong caloric restriction, which prolongs maximum life span in animals, did not attenuate the age-related decline in ATP content or rate of production in skeletal muscle and had no effect on the heart. 8-Oxo-7,8-dihydro-2'-deoxyguanosine in skeletal muscle mtDNA was unaffected by aging but decreased 30% with caloric restriction, suggesting that the mechanisms that decrease oxidative stress in these tissues with caloric restriction are independent from ATP availability. The generation of reactive oxygen species, as indicated by H2O2 production in isolated mitochondria, did not change significantly with age in skeletal muscle or in the heart. Caloric restriction tended to reduce the levels of H2O2 production in the muscle but not in the heart. These data are the first to show that an age-associated decline in ATP content and rate of ATP production is tissue specific, in that it occurs in skeletal muscle but not heart, and that mitochondrial ATP production was unaltered by caloric restriction in both tissues.
C1 Univ Florida, Biochem Aging Lab, Coll Hlth & Human Performance, Ctr Exercise Sci, Gainesville, FL 32611 USA.
   Univ Complutense, Dept Anim Biol 2, E-28040 Madrid, Spain.
   Univ Bari, Dept Biochem & Mol Biol, Ctr Study Mitochondria & Energet Metab, I-70125 Bari, Italy.
C3 State University System of Florida; University of Florida; Complutense
   University of Madrid; Universita degli Studi di Bari Aldo Moro
RP Leeuwenburgh, C (corresponding author), Univ Florida, Biochem Aging Lab, Coll Hlth & Human Performance, Ctr Exercise Sci, POB 118206, Gainesville, FL 32611 USA.
RI Gustavo, Barja/B-5591-2012; Barja, Gustavo/AAA-5903-2019
OI Barja, Gustavo/0000-0001-5736-4735; GREDILLA,
   RICARDO/0000-0003-4501-1355; Selman, Colin/0000-0002-8727-0593;
   Leeuwenburgh, Christiaan/0000-0003-0826-4257
FU NIA NIH HHS [AG-17994-01] Funding Source: Medline
CR Alway SE, 2002, AM J PHYSIOL-REG I, V282, pR411, DOI 10.1152/ajpregu.00332.2001
   Aspnes LE, 1997, FASEB J, V11, P573, DOI 10.1096/fasebj.11.7.9212081
   Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343
   Barja G, 1999, J BIOENERG BIOMEMBR, V31, P347, DOI 10.1023/A:1005427919188
   Barja G, 2002, J BIOENERG BIOMEMBR, V34, P227, DOI 10.1023/A:1016039604958
   Bejma J, 2000, ACTA PHYSIOL SCAND, V169, P343
   Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8
   Carrozzo R, 2001, NEUROLOGY, V56, P687, DOI 10.1212/WNL.56.5.687
   Conley KE, 2000, J PHYSIOL-LONDON, V526, P203, DOI 10.1111/j.1469-7793.2000.t01-1-00203.x
   Davey GP, 1998, J BIOL CHEM, V273, P12753, DOI 10.1074/jbc.273.21.12753
   Davey GP, 1997, J NEUROCHEM, V69, P2564
   de Grey ADNJ, 2000, ARCH BIOCHEM BIOPHYS, V373, P295, DOI 10.1006/abbi.1999.1509
   Dirks A, 2002, AM J PHYSIOL-REG I, V282, pR519, DOI 10.1152/ajpregu.00458.2001
   Fannin SW, 1999, ARCH BIOCHEM BIOPHYS, V372, P399, DOI 10.1006/abbi.1999.1508
   Gadaleta MN, 1998, BIOCHIMIE, V80, P863, DOI 10.1016/S0300-9084(00)88881-1
   Gredilla R, 2001, FASEB J, V15, P1589, DOI 10.1096/fj.00-0764fje
   Gredilla R, 2001, J BIOENERG BIOMEMBR, V33, P279, DOI 10.1023/A:1010603206190
   Hood DA, 2001, J APPL PHYSIOL, V90, P1137, DOI 10.1152/jappl.2001.90.3.1137
   Hoppel CL, 2002, BIOGERONTOLOGY, V3, P41, DOI 10.1023/A:1015251212039
   Lass A, 1998, FREE RADICAL BIO MED, V25, P1089, DOI 10.1016/S0891-5849(98)00144-0
   LEBEL CP, 1990, NEUROCHEM INT, V17, P435, DOI 10.1016/0197-0186(90)90025-O
   Lee J, 1999, FREE RADICAL BIO MED, V26, P260, DOI 10.1016/S0891-5849(98)00195-6
   Leeuwenburgh C, 1997, ARCH BIOCHEM BIOPHYS, V346, P74, DOI 10.1006/abbi.1997.0297
   LEEUWENBURGH C, 1994, AM J PHYSIOL, V267, pR439, DOI 10.1152/ajpregu.1994.267.2.R439
   Liu VWS, 1998, NUCLEIC ACIDS RES, V26, P1268, DOI 10.1093/nar/26.5.1268
   López-Torres M, 2002, FREE RADICAL BIO MED, V32, P882, DOI 10.1016/S0891-5849(02)00773-6
   Mazat JP, 1997, MOL CELL BIOCHEM, V174, P143, DOI 10.1023/A:1006875517267
   Moghaddas S, 2002, J GERONTOL A-BIOL, V57, pB22, DOI 10.1093/gerona/57.1.B22
   OGATA T, 1985, CELL TISSUE RES, V241, P251, DOI 10.1007/BF00217168
   OhIshi S, 1995, MECH AGEING DEV, V84, P65, DOI 10.1016/0047-6374(95)01637-F
   Okado-Matsumoto A, 2001, J BIOL CHEM, V276, P38388, DOI 10.1074/jbc.M105395200
   OLIVETTI G, 1995, J AM COLL CARDIOL, V26, P1068, DOI 10.1016/0735-1097(95)00282-8
   PALMER JW, 1977, J BIOL CHEM, V252, P8731
   Phaneuf S, 2002, AM J PHYSIOL-REG I, V282, pR423, DOI 10.1152/ajpregu.00296.2001
   Pollack M, 2001, J GERONTOL A-BIOL, V56, pB475, DOI 10.1093/gerona/56.11.B475
   Porteous WK, 1998, EUR J BIOCHEM, V257, P192, DOI 10.1046/j.1432-1327.1998.2570192.x
   Pugh KG, 2001, DRUG AGING, V18, P263, DOI 10.2165/00002512-200118040-00004
   Ramakrishna R, 2001, AM J PHYSIOL-REG I, V280, pR695, DOI 10.1152/ajpregu.2001.280.3.R695
   Sastre J, 2000, IUBMB LIFE, V49, P427
   Short K R, 2001, Exerc Sport Sci Rev, V29, P118, DOI 10.1097/00003677-200107000-00006
   SOHAL RS, 1994, MECH AGEING DEV, V74, P121, DOI 10.1016/0047-6374(94)90104-X
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   Souza-Pinto NC, 1999, NUCLEIC ACIDS RES, V27, P1935, DOI 10.1093/nar/27.8.1935
   Sreekumar R, 2002, AM J PHYSIOL-ENDOC M, V283, pE38, DOI 10.1152/ajpendo.00387.2001
   Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700
   Taylor RW, 2001, NUCLEIC ACIDS RES, V29, part. no., DOI 10.1093/nar/29.15.e74
   Wallace DC, 1997, SCI AM, V277, P40, DOI 10.1038/scientificamerican0897-40
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
   Weindruch R, 1997, NEW ENGL J MED, V337, P986, DOI 10.1056/NEJM199710023371407
   Zainal TA, 2000, FASEB J, V14, P1825, DOI 10.1096/fj.99-0881com
NR 51
TC 213
Z9 235
U1 0
U2 19
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0363-6119
J9 AM J PHYSIOL-REG I
JI Am. J. Physiol.-Regul. Integr. Comp. Physiol.
PD FEB
PY 2003
VL 284
IS 2
BP R474
EP R480
DI 10.1152/ajpregu.00455.2002
PG 7
WC Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology
GA 635LP
UT WOS:000180400700025
PM 12388443
DA 2024-02-19
ER

PT J
AU Huse, SM
   Gruppuso, PA
   Boekelheide, K
   Sanders, JA
AF Huse, Susan M.
   Gruppuso, Philip A.
   Boekelheide, Kim
   Sanders, Jennifer A.
TI Patterns of gene expression and DNA methylation in human fetal and adult
   liver
SO BMC GENOMICS
LA English
DT Article
DE Gene expression; Methylation; Liver; Fetal Development
ID GROWTH; NORMALIZATION; HEPATOCYTES; REPLICATION; MODEL
AB Background: DNA methylation is an important epigenetic control mechanism that has been shown to be associated with gene silencing through the course of development, maturation and aging. However, only limited data are available regarding the relationship between methylation and gene expression in human development.
   Results: We analyzed the methylome and transcriptome of three human fetal liver samples (gestational age 20-22 weeks) and three adult human liver samples. Genes whose expression differed between fetal and adult numbered 7,673. Adult overexpression was associated with metabolic pathways and, in particular, cytochrome P450 enzymes while fetal overexpression reflected enrichment for DNA replication and repair. Analysis for DNA methylation using the Illumina Infinium 450 K HumanMethylation BeadChip showed that 42 % of the quality filtered 426,154 methylation sites differed significantly between adult and fetal tissue (q <= 0.05). Differences were small; 69 % of the significant sites differed in their mean methylation beta value by <= 0.2. There was a trend among all sites toward higher methylation in the adult samples with the most frequent difference in beta being 0.1. Characterization of the relationship between methylation and expression revealed a clear difference between fetus and adult. Methylation of genes overexpressed in fetal liver showed the same pattern as seen for genes that were similarly expressed in fetal and adult liver. In contrast, adult overexpressed genes showed fetal hypermethylation that differed from the similarly expressed genes. An examination of gene region-specific methylation showed that sites proximal to the transcription start site or within the first exon with a significant fetal-adult difference in beta (>0.2) showed an inverse relationship with gene expression.
   Conclusions: Nearly half of the CpGs in human liver show a significant difference in methylation comparing fetal and adult samples. Sites proximal to the transcription start site or within the first exon that show a transition from hypermethylation in the fetus to hypomethylation or intermediate methylation in the adult are associated with inverse changes in gene expression. In contrast, increases in methylation going from fetal to adult are not associated with fetal-to-adult decreased expression. These findings indicate fundamentally different roles for and/or regulation of DNA methylation in human fetal and adult liver.
C1 [Huse, Susan M.; Boekelheide, Kim; Sanders, Jennifer A.] Brown Univ, Dept Pathol & Lab Med, Providence, RI 02912 USA.
   [Gruppuso, Philip A.; Sanders, Jennifer A.] Rhode Isl Hosp, Dept Pediat, Providence, RI USA.
   [Gruppuso, Philip A.; Sanders, Jennifer A.] Brown Univ, Providence, RI 02912 USA.
   [Gruppuso, Philip A.] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA.
C3 Brown University; Lifespan Health Rhode Island; Rhode Island Hospital;
   Brown University; Brown University
RP Sanders, JA (corresponding author), Brown Univ, Dept Pathol & Lab Med, Providence, RI 02912 USA.
EM jennifer_sanders@brown.edu
FU National Institute for Environmental Health Sciences (NIEHS)
   [P20ES018169]; U.S. Environmental Protection Agency (US EPA)
   [RD83459401]; National Institute for Child Health and Human Development
   (NICHD) [R01DK100301]; NIH [HHSN276201200017C]
FX These studies were supported by the National Institute for Environmental
   Health Sciences (NIEHS) grant P20ES018169, U.S. Environmental Protection
   Agency (US EPA) grant RD83459401, National Institute for Child Health
   and Human Development (NICHD) grant R01DK100301, and the Oh Zopfi
   Professorship for Pediatrics and Perinatal Research from Brown
   University and Women & Infants Hospital. The Liver Tissue Cell
   Distribution System is funded by NIH Contract #HHSN276201200017C.
CR Aran D, 2011, HUM MOL GENET, V20, P670, DOI 10.1093/hmg/ddq513
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Bestor TH, 2014, PROC NATL ACAD SCI U
   Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102
   Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913
   Bogdarina I, 2004, LIFE SCI, V74, P1407, DOI 10.1016/j.lfs.2003.08.017
   Bonder MJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-860
   Boylan JM, 2015, AM J PHYSIOL-REG I, V309, pR22, DOI 10.1152/ajpregu.00114.2015
   Brenet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014524
   Burzynski SR, 2003, MED HYPOTHESES, V60, P578, DOI 10.1016/S0306-9877(03)00050-1
   Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431
   CURRAN TR, 1993, EXP CELL RES, V209, P53, DOI 10.1006/excr.1993.1284
   De Paepe ME, 2012, PEDIATR PULM, V47, P1192, DOI 10.1002/ppul.22617
   Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107
   Ficz G, 2015, J EXP BIOL, V218, P14, DOI 10.1242/jeb.107961
   Fortin JP, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0503-2
   GRUPPUSO PA, 1991, DIABETES, V40, P51, DOI 10.2337/diab.40.2.S51
   GRUPPUSO PA, 1989, ENDOCRINOLOGY, V125, P3037, DOI 10.1210/endo-125-6-3037
   Hannum G, 2013, MOL CELL, V49, P359, DOI 10.1016/j.molcel.2012.10.016
   Heard E, 1997, ANNU REV GENET, V31, P571, DOI 10.1146/annurev.genet.31.1.571
   Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115
   Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048
   Issa JP, 2014, J CLIN INVEST, V124, P24, DOI 10.1172/JCI69735
   Jones PA, 1999, TRENDS GENET, V15, P34, DOI 10.1016/S0168-9525(98)01636-9
   Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230
   Kacevska M, 2012, BIOCHIMIE, V94, P2338, DOI 10.1016/j.biochi.2012.07.013
   KATZ NR, 1992, J NUTR, V122, P843, DOI 10.1093/jn/122.suppl_3.843
   Kuhn RM, 2013, BRIEF BIOINFORM, V14, P144, DOI 10.1093/bib/bbs038
   Lamming DW, 2014, FASEB J, V28, P300, DOI 10.1096/fj.13-237743
   Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161
   LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0
   Li Y, 2009, MOL PHARMACOL, V75, P1171, DOI 10.1124/mol.108.052993
   Liu D, 2010, HEPATOL RES, V40, P813, DOI 10.1111/j.1872-034X.2010.00683.x
   Liu D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007594
   Ma QY, 2014, DRUG DISCOV TODAY, V19, P1883, DOI 10.1016/j.drudis.2014.09.010
   Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842
   Mimura S, 2014, INT J MOL MED, V34, P1065, DOI 10.3892/ijmm.2014.1892
   Pidsley R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-293
   R Core Team, 2012, LANG ENV STAT COMP
   Sanders Jennifer A., 2012, BMC Physiology, V12, P1, DOI 10.1186/1472-6793-12-1
   Simmons R. A., 2007, DIABETES OBESITY, V14, P13, DOI DOI 10.1097/MED.0b013e328013da5b
   Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23
   Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369
   Teschendorff AE, 2013, BIOINFORMATICS, V29, P189, DOI 10.1093/bioinformatics/bts680
   Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413
   Wang D, 2012, BIOINFORMATICS, V28, P729, DOI 10.1093/bioinformatics/bts013
   Wang JH, 2015, J INVEST DERMATOL, V135, P532, DOI 10.1038/jid.2014.418
   Xu CR, 2011, SCIENCE, V332, P963, DOI 10.1126/science.1202845
   Zakim D, 1990, HEPATOLOGY TXB LIVER
NR 49
TC 24
Z9 24
U1 0
U2 4
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2164
J9 BMC GENOMICS
JI BMC Genomics
PD NOV 21
PY 2015
VL 16
AR 981
DI 10.1186/s12864-015-2066-3
PG 14
WC Biotechnology & Applied Microbiology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA CX1US
UT WOS:000365481700001
PM 26589361
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Youdim, KA
   Deans, SG
AF Youdim, KA
   Deans, SG
TI Dietary supplementation of thyme (<i>Thymus vulgaris</i> L.) essential
   oil during the lifetime of the rat:: its effects on the antioxidant
   status in liver, kidney and heart tissues
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE ageing; free radicals; antioxidants; superoxide dismutase; glutathione
   peroxidase
ID FREE-RADICAL THEORY; SUPEROXIDE-DISMUTASE; LIPID-PEROXIDATION;
   ENZYME-ACTIVITIES; AGED RATS; BRAIN; EXPRESSION; CONSEQUENCES;
   RESTRICTION; CAPACITY
AB This study aimed not only to identify age-related changes in certain antioxidant systems, but to assess whether dietary supplementation of thyme oil could address the unfavourable antioxidant-pro-oxidant balance that occurs with age. The present study has shown that there were significant declines in the superoxide dismutase activities in the liver and heart of old rats, although kidney showed no decline. Liver glutathione peroxidase (GSHPx) activity was found to have increased significantly in old rats, while a significant decrease was observed in kidney. Heart GSHPX activity was not found to differ significantly between young and old rats. There were also significant declines in the total antioxidant status in each tissue examined. A general feature of these various antioxidant parameters measured was that their activities remained higher in rats whose diets were supplemented with thyme oil, suggesting that they retained a more favourable antioxidant capacity during their life span. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
C1 Scottish Agr Coll, Aromat & Med Plant Grp, Auchincruive KA6 5HW, Ayr, Scotland.
C3 Scottish Agricultural College
RP Deans, SG (corresponding author), Scottish Agr Coll, Aromat & Med Plant Grp, Auchincruive KA6 5HW, Ayr, Scotland.
EM s.deans@au.sac.ac.uk
CR BUNKER VW, 1992, MED LAB SCI, V49, P299
   Cao GH, 1996, P SOC EXP BIOL MED, V211, P359
   Cutler R., 1984, Free Radicals in Biology, V6, P371
   CUTLER RG, 1991, AM J CLIN NUTR, V53, pS373, DOI 10.1093/ajcn/53.1.373S
   DANH HC, 1983, J NEUROCHEM, V40, P1003, DOI 10.1111/j.1471-4159.1983.tb08084.x
   DEANS SG, 1993, AGE, V16, P71, DOI 10.1007/BF02435040
   DEANS SG, 1993, ROLE FREE RADICALS B
   DEQUIROGA GB, 1990, BIOCHEM J, V272, P247
   DEQUIROGA GB, 1992, FREE RADICALS AGING, P109
   FRIDOVICH I, 1978, SCIENCE, V201, P875, DOI 10.1126/science.210504
   GREENWOOD NN, 1990, CHEM ELEMENTS, P713
   HARMAN D, 1968, J GERONTOL, V23, P476, DOI 10.1093/geronj/23.4.476
   HARMAN D, 1983, AGE, V6, P86, DOI 10.1007/BF02432509
   HARMAN D, 1971, J GERONTOL, V26, P451, DOI 10.1093/geronj/26.4.451
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HARMAN D, 1972, GERONTOLOGIST, V12, P33
   KELLOGG EW, 1975, J BIOL CHEM, V250, P8812
   KOIZUMI A, 1987, J NUTR, V117, P361, DOI 10.1093/jn/117.2.361
   KUROBE N, 1990, BIOMED RES-TOKYO, V11, P187, DOI 10.2220/biomedres.11.187
   MEDVEDEV ZA, 1980, MECH AGEING DEV, V14, P1, DOI 10.1016/0047-6374(80)90102-5
   MILLER NJ, 1993, CLIN SCI, V84, P407, DOI 10.1042/cs0840407
   ORGEL LE, 1973, NATURE, V244, P441, DOI 10.1038/243441a0
   PAGLIA DE, 1967, J LAB CLIN MED, V70, P158
   RAO G, 1990, MECH AGEING DEV, V53, P49, DOI 10.1016/0047-6374(90)90033-C
   REISS U, 1976, BIOCHEM BIOPH RES CO, V73, P255, DOI 10.1016/0006-291X(76)90701-4
   RICEEVANS C, 1993, PROG LIPID RES, V32, P71, DOI 10.1016/0163-7827(93)90006-I
   RIKANS LE, 1991, BIOCHIM BIOPHYS ACTA, V1074, P195, DOI 10.1016/0304-4165(91)90061-K
   SAWADA M, 1987, MECH AGEING DEV, V41, P125, DOI 10.1016/0047-6374(87)90057-1
   SEMSEI I, 1989, BIOCHEM BIOPH RES CO, V164, P620, DOI 10.1016/0006-291X(89)91505-2
   SEMSEI I, 1991, MECH AGEING DEV, V58, P13, DOI 10.1016/0047-6374(91)90116-H
   SOCCI DJ, 1995, BRAIN RES, V693, P88, DOI 10.1016/0006-8993(95)00707-W
   SOHAL RS, 1990, FREE RADICAL BIO MED, V9, P495, DOI 10.1016/0891-5849(90)90127-5
   Strehler BL, 1982, Lectures on gerontology, P1
   STUBBS CD, 1984, BIOCHIM BIOPHYS ACTA, V779, P89, DOI 10.1016/0304-4157(84)90005-4
   VERTECHY M, 1989, EXP GERONTOL, V24, P211, DOI 10.1016/0531-5565(89)90012-0
   WARNER HR, 1992, CHEM PHYSL NUTR TOXI, P151
   YOUDIM KA, 1997, THESIS U STRATHCLYDE
   YU BP, 1994, P SOC EXP BIOL MED, V205, P97, DOI 10.3181/00379727-205-43684
   ZSNAGY I, 1980, MECH AGEING DEV, V14, P245, DOI 10.1016/0047-6374(80)90124-4
NR 39
TC 55
Z9 59
U1 1
U2 11
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD SEP 8
PY 1999
VL 109
IS 3
BP 163
EP 175
DI 10.1016/S0047-6374(99)00033-0
PG 13
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 240XK
UT WOS:000082852200002
PM 10576332
DA 2024-02-19
ER

PT J
AU Tsubota, E
   Yasuda, T
   Iida, R
AF Tsubota, Etsuko
   Yasuda, Toshihiro
   Iida, Reiko
TI Identification of age-dependently expressed genes in mouse liver by
   differential display-PCR analysis
SO COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY D-GENOMICS & PROTEOMICS
LA English
DT Article
DE age-related; differential display-PCR; gene expression; mouse liver;
   real-time PCR
ID MITOCHONDRIAL-DNA CONTENT; ALDEHYDE DEHYDROGENASE; REGULATES EXPRESSION;
   MPV17-LIKE PROTEIN; SKELETAL-MUSCLE; AGING PROCESS; M-LP; COMPLEMENT;
   METABOLISM; COLOSTRUM
AB The aim of this study was to identify genes expressed in an age-dependent manner in mouse (Mus musculus) liver. To search for age-dependently expressed genes, we used a fluorescence differential display-PCR (FDD-PCR) technique on total RNA extracted from mouse livers collected at seven different developmental stages. All differentially expressed cDNAs detected by FDD-PCR were reamplified, subcloned and sequenced, and six genes were confirmed to show age-dependent expression by quantitative real-time PCR analysis. Nucleotide sequence analyses showed that four of them had high homology with known genes (mitochondrial DNA, cytosolic aldehyde dehydrogenase, cell division cycle 2-like 5 and complement component 8 alpha polypeptide), and two with expressed sequence tags of unknown genes. The FDD-PCR technique was effective for detecting novel age-dependently expressed genes, and also for newly characterizing individual expression patterns of known genes. The age-dependent expression patterns of known genes revealed in this study may provide an opportunity to investigate the unknown physiological roles of the proteins they encode. (C) 2007 Elsevier Inc. All rights reserved.
C1 [Tsubota, Etsuko; Iida, Reiko] Univ Fukui, Fac Med Sci, Div Forens Med, Fukui 9101193, Japan.
   [Yasuda, Toshihiro] Univ Fukui, Fac Med Sci, Div Med Genet & Biochem, Fukui 9101193, Japan.
C3 University of Fukui; University of Fukui
RP Iida, R (corresponding author), Univ Fukui, Fac Med Sci, Div Forens Med, Fukui 9101193, Japan.
EM riida@u-fukui.ac.jp
CR Bai RK, 2004, ANN NY ACAD SCI, V1011, P304, DOI 10.1196/annals.1293.029
   BALLOW M, 1974, CLIN EXP IMMUNOL, V18, P257
   Barrientos A, 1997, MOL BRAIN RES, V52, P284, DOI 10.1016/S0169-328X(97)00278-7
   Barrientos A, 1997, BIOCHEM MOL MED, V62, P165, DOI 10.1006/bmme.1997.2647
   Chen HH, 2007, BIOCHEM BIOPH RES CO, V354, P735, DOI 10.1016/j.bbrc.2007.01.049
   Choudhary S, 2005, INVEST OPHTH VIS SCI, V46, P259, DOI 10.1167/iovs.04-0120
   GADALETA MN, 1992, MUTAT RES, V275, P181, DOI 10.1016/0921-8734(92)90022-H
   Garcia-Blanco MA, 2004, NAT BIOTECHNOL, V22, P535, DOI 10.1038/nbt964
   Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   Iida R, 2003, J BIOL CHEM, V278, P6301, DOI 10.1074/jbc.M210886200
   Iida R, 2000, MECH AGEING DEV, V113, P135, DOI 10.1016/S0047-6374(99)00104-9
   Iida R, 2002, EXP GERONTOL, V37, P1121, DOI 10.1016/S0531-5565(02)00066-9
   Iida R, 2001, BIOCHEM BIOPH RES CO, V283, P292, DOI 10.1006/bbrc.2001.4769
   Iida R, 2006, BIOCHEM BIOPH RES CO, V344, P948, DOI 10.1016/j.bbrc.2006.04.008
   Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390
   Lee HC, 1998, FEBS LETT, V441, P292, DOI 10.1016/S0014-5793(98)01564-6
   Luckey SW, 2001, ARCH BIOCHEM BIOPHYS, V389, P77, DOI 10.1006/abbi.2001.2307
   Marqués F, 2000, BIOCHEM BIOPH RES CO, V279, P832, DOI 10.1006/bbrc.2000.4042
   Masuyama M, 2005, BBA-GEN SUBJECTS, V1723, P302, DOI 10.1016/j.bbagen.2005.03.001
   McCarroll SA, 2004, NAT GENET, V36, P197, DOI 10.1038/ng1291
   Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789
   NG SC, 1987, BIOCHEMISTRY-US, V26, P5229, DOI 10.1021/bi00391a003
   Park SK, 2005, CARDIOVASC RES, V66, P205, DOI 10.1016/j.cardiores.2005.01.005
   Pesce V, 2001, FREE RADICAL BIO MED, V30, P1223, DOI 10.1016/S0891-5849(01)00517-2
   ROACH B, 1981, AM J DIS CHILD, V135, P918, DOI 10.1001/archpedi.1981.02130340030011
   Vasiliou V, 2000, CHEM-BIOL INTERACT, V129, P1, DOI 10.1016/S0009-2797(00)00211-8
   Venables JP, 2004, CANCER RES, V64, P7647, DOI 10.1158/0008-5472.CAN-04-1910
   YONEMASU K, 1978, IMMUNOLOGY, V35, P523
   YOSHIDA A, 1992, ENZYME, V46, P239, DOI 10.1159/000468794
NR 30
TC 1
Z9 1
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1744-117X
EI 1878-0407
J9 COMP BIOCHEM PHYS D
JI Comp. Biochem. Physiol. D-Genomics Proteomics
PD MAR
PY 2008
VL 3
IS 1
BP 91
EP 95
DI 10.1016/j.cbd.2007.10.002
PG 5
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 280JN
UT WOS:000254422700008
PM 20483210
DA 2024-02-19
ER

PT J
AU WONG, NCW
   RAYMOND, J
   CARR, FE
AF WONG, NCW
   RAYMOND, J
   CARR, FE
TI A LIVER-SPECIFIC NUCLEAR-PROTEIN REPRESSES TRANSCRIPTION OF THE S14 GENE
   IN-VITRO AND IN-VIVO
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID HORMONE-RESPONSIVE GENE; THYROID-HORMONE; RAT-LIVER; MESSENGER-RNA;
   EXPRESSION; HYPOTHYROIDISM; PROMOTER; BINDING; REGION; LEVEL
AB P1 is a nuclear protein found exclusively in rat liver and binds to a motif that spans nucleotides -310 to -288 of the thyroid hormone responsive gene, S14. We expect P1 to play an important role in regulating gene expression because the binding motif for this factor is contained within a DNase I-hypersensitive site of S14 chromatin. In this report, we have attempted to define the function of P1 by correlating its DNA binding activity with levels of mRNA-S 14 in response to aging and obesity. Results of all studies revealed inverse relationships between the activity of P1 and levels of mRNA-S14, thus suggesting that P1 may function as a repressor of S14 gene expression. Accordingly, we tested the repressor hypothesis using cell-free transcription and transient transfection assays to measure the activity of reporter constructs with and without the P1 binding motif. In the presence of the P1 motif, S14 promoter activity was repressed and the negative effect on gene transcription was further enhanced by thyroid hormone. These observations are consistent with P1 being a repressor of S14 gene transcription.
C1 UNIV CALGARY,DEPT MED,CALGARY T2N 4N1,AB,CANADA.
   UNIV CALGARY,DEPT MED BIOCHEM,CALGARY T2N 4N1,AB,CANADA.
   WALTER REED ARMY MED CTR,KYLE METAB UNIT,WASHINGTON,DC 20307.
C3 University of Calgary; University of Calgary; United States Department
   of Defense; United States Army; Walter Reed National Military Medical
   Center
CR CARR FE, 1983, J CLIN INVEST, V72, P154, DOI 10.1172/JCI110953
   DESCHAMPS BJ, 1992, J BIOL CHEM, V267, P25167
   FREAKE HC, 1987, P NATL ACAD SCI USA, V84, P3070, DOI 10.1073/pnas.84.9.3070
   GORSKI K, 1986, CELL, V47, P767, DOI 10.1016/0092-8674(86)90519-2
   GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3
   JUMP DB, 1985, ENDOCRINOLOGY, V117, P2259, DOI 10.1210/endo-117-6-2259
   JUMP DB, 1984, J BIOL CHEM, V259, P2789
   JUMP DB, 1988, J BIOL CHEM, V263, P7254
   JUMP DB, 1986, ENDOCRINOLOGY, V118, P1892, DOI 10.1210/endo-118-5-1892
   JUMP DB, 1987, J BIOL CHEM, V262, P778
   JUMP DB, 1989, J BIOL CHEM, V264, P4698
   KINLAW WB, 1989, J BIOL CHEM, V264, P19779
   KINLAW WB, 1987, ENDOCRINOLOGY, V120, P1563, DOI 10.1210/endo-120-4-1563
   KNOWLES BB, 1984, ADV HEPATITIS RES
   LAMERS WH, 1982, P NATL ACAD SCI-BIOL, V79, P5137, DOI 10.1073/pnas.79.17.5137
   LIAW C, 1983, BIOCHEMISTRY-US, V22, P213, DOI 10.1021/bi00270a031
   LIAW CW, 1984, J BIOL CHEM, V259, P7253
   Maniatis T., 1982, MOL CLONING
   MARIASH CN, 1982, ANAL BIOCHEM, V121, P388, DOI 10.1016/0003-2697(82)90498-5
   NARAYAN P, 1985, MOL CELL BIOL, V5, P2642, DOI 10.1128/MCB.5.10.2642
   OPPENHEIMER JH, 1987, ENDOCR REV, V8, P288, DOI 10.1210/edrv-8-3-288
   PEREZCASTILLO A, 1987, AM J PHYSIOL, V253, pE530
   PTASHNE M, 1990, NATURE, V346, P329, DOI 10.1038/346329a0
   RUSSELL JC, 1989, ARTERIOSCLEROSIS, V9, P869, DOI 10.1161/01.ATV.9.6.869
   SEELIG S, 1981, P NATL ACAD SCI-BIOL, V78, P4733, DOI 10.1073/pnas.78.8.4733
   WATANABE K, 1987, J BIOL CHEM, V262, P4812
   WONG NCW, 1990, J BIOL CHEM, V265, P8775
   WONG NCW, 1989, J BIOL CHEM, V264, P4466
NR 28
TC 3
Z9 3
U1 0
U2 0
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PD SEP 15
PY 1993
VL 268
IS 26
BP 19431
EP 19435
PG 5
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA LW819
UT WOS:A1993LW81900045
PM 7690031
DA 2024-02-19
ER

PT J
AU Etienne, J
   Joanne, P
   Catelain, C
   Riveron, S
   Bayer, AC
   Lafable, J
   Punzon, I
   Blot, S
   Agbulut, O
   Vilquin, JT
AF Etienne, Jessy
   Joanne, Pierre
   Catelain, Cyril
   Riveron, Stephanie
   Bayer, Alexandra Clarissa
   Lafable, Jeremy
   Punzon, Isabel
   Blot, Stephane
   Agbulut, Onnik
   Vilquin, Jean-Thomas
TI Aldehyde dehydrogenases contribute to skeletal muscle homeostasis in
   healthy, aging, and Duchenne muscular dystrophy patients
SO JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE
LA English
DT Article; Early Access
DE Aging; Aldehyde dehydrogenase; Dog model; Duchenne muscular dystrophy;
   Human; Skeletal muscle; Myogenic; Non-human primate
ID RETINOIC ACID SYNTHESIS; PROGENITOR CELLS; STEM-CELL; MOLECULAR-CLONING;
   GENE-EXPRESSION; MYOGENIC CELLS; CANCER; ENZYMES; MARKER; LIVER
AB Background Aldehyde dehydrogenases (ALDHs) are key players in cell survival, protection, and differentiation via the metabolism and detoxification of aldehydes. ALDH activity is also a marker of stem cells. The skeletal muscle contains populations of ALDH-positive cells amenable to use in cell therapy, whose distribution, persistence in aging, and modifications in myopathic context have not been investigated yet. Methods The Aldefluor (R) (ALDEF) reagent was used to assess the ALDH activity of muscle cell populations, whose phenotypic characterizations were deepened by flow cytometry. The nature of ALDH isoenzymes expressed by the muscle cell populations was identified in complementary ways by flow cytometry, immunohistology, and real-time PCRex vivoandin vitro. These populations were compared in healthy, aging, or Duchenne muscular dystrophy (DMD) patients, healthy non-human primates, and Golden Retriever dogs (healthy vs. muscular dystrophic model, Golden retriever muscular dystrophy [GRMD]). Results ALDEF(+)cells persisted through muscle aging in humans and were equally represented in several anatomical localizations in healthy non-human primates. ALDEF(+)cells were increased in dystrophic individuals in humans (nine patients with DMD vs. five controls: 14.9 +/- 1.63% vs. 3.6 +/- 0.39%,P= 0.0002) and dogs (three GRMD dogs vs. three controls: 10.9 +/- 2.54% vs. 3.7 +/- 0.45%,P= 0.049). In DMD patients, such increase was due to the adipogenic ALDEF(+)/CD34(+)populations (11.74 +/- 1.5 vs. 2.8 +/- 0.4,P= 0.0003), while in GRMD dogs, it was due to the myogenic ALDEF(+)/CD34(-)cells (3.6 +/- 0.6% vs. 1.03 +/- 0.23%,P= 0.0165). Phenotypic characterization associated the ALDEF(+)/CD34(-)cells with CD9, CD36, CD49a, CD49c, CD49f, CD106, CD146, and CD184, some being associated with myogenic capacities. Cytological and histological analyses distinguished several ALDH isoenzymes (ALDH1A1, 1A2, 1A3, 1B1, 1L1, 2, 3A1, 3A2, 3B1, 3B2, 4A1, 7A1, 8A1, and 9A1) expressed by different cell populations in the skeletal muscle tissue belonging to multinucleated fibres, or myogenic, endothelial, interstitial, and neural lineages, designing them as potential new markers of cell type or of metabolic activity. Important modifications were noted in isoenzyme expression between healthy and DMD muscle tissues. The level of gene expression of some isoenzymes (ALDH1A1, 1A3, 1B1, 2, 3A2, 7A1, 8A1, and 9A1) suggested their specific involvement in muscle stability or regenerationin situorin vitro. Conclusions This study unveils the importance of the ALDH family of isoenzymes in the skeletal muscle physiology and homeostasis, suggesting their roles in tissue remodelling in the context of muscular dystrophies.
C1 [Etienne, Jessy; Catelain, Cyril; Riveron, Stephanie; Bayer, Alexandra Clarissa; Lafable, Jeremy; Vilquin, Jean-Thomas] Sorbonne Univ, Ctr Rech Myol, Hop Pitie Salpetriere, AP HP,UMRS 974,INSERM,AIM, Paris, France.
   [Joanne, Pierre; Agbulut, Onnik] Sorbonne Univ, Inst Biol Paris Seine, UMR Biol Adaptat & Ageing 8256, CNRS,INSERM, Paris, France.
   [Punzon, Isabel; Blot, Stephane] Univ Paris Est Creteil, Inst Mondor Rech Biomed, U955 E10, ENVA, Maisons Alfort, France.
   [Etienne, Jessy] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.
   [Etienne, Jessy] Univ Calif Berkeley, Inst QB3, Berkeley, CA 94720 USA.
C3 Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire
   Pitie-Salpetriere - APHP; Hopital Universitaire Paul-Brousse - APHP;
   Universite Paris Cite; Hopital Universitaire Hotel-Dieu - APHP; Institut
   National de la Sante et de la Recherche Medicale (Inserm); Sorbonne
   Universite; Centre National de la Recherche Scientifique (CNRS); CNRS -
   National Institute for Biology (INSB); Sorbonne Universite; Institut
   National de la Sante et de la Recherche Medicale (Inserm); Ecole
   Nationale Veterinaire d'Alfort (ENVA); Universite
   Paris-Est-Creteil-Val-de-Marne (UPEC); University of California System;
   University of California Berkeley; University of California System;
   University of California Berkeley
RP Vilquin, JT (corresponding author), Sorbonne Univ, Hop Pitie Salpetriere, AP HP, INSERM,AIM,Ctr Rech Myol,UMRS 974,Fac Med, 105 Blvd Hop, F-75013 Paris, France.
EM jt.vilquin@institut-myologie.org
RI ETIENNE, Jessy/ACO-5477-2022; Joanne, Pierre/D-1866-2012; Blot,
   Stijn/H-9015-2013; Blot, Stephane/F-7420-2011
OI ETIENNE, Jessy/0000-0003-2173-6191; Blot, Stijn/0000-0003-2145-0345;
   Agbulut, Onnik/0000-0003-1923-8871; Joanne, Pierre/0000-0002-5873-7000;
   Vilquin, Jean-Thomas/0000-0003-0050-0219; Blot,
   Stephane/0000-0002-8982-0317
FU DIM-STEMPOLE from Region Ile-de-France; Association Francaise contre les
   Myopathies (AFM); Duchenne Parent Project from the Netherlands (DPP);
   Ligue contre la Cardiomyopathie; Agence de Biomedecine; MYOBANK-AFM (the
   AFM tissue bank for research, Paris, France) [BB-0033-00012]
FX This work was supported by the DIM-STEMPOLE from Region Ile-de-France
   (J.E.), the Association Francaise contre les Myopathies (AFM; C.C.,
   S.R., and J.L.), and by grants from the Duchenne Parent Project from the
   Netherlands (DPP), from the Ligue contre la Cardiomyopathie, and from
   the Agence de Biomedecine. We thank M. Stephane Vasseur and Ms. Maud
   Chapart, and MYOBANK-AFM (the AFM tissue bank for research,
   BB-0033-00012, Paris, France), for their invaluable help and expertise
   in providing human muscle biopsies. We thank Dr. Veronique Sazdovitch
   for the providing the human kidney and liver tissues (Departement de
   Neuropathologie R. Escourolle, Paris, France). We thank Dr. Chantal
   Francois and Mrs. Elodie Laffrat (Institut du Cerveau et de la Moelle,
   Paris, France), Dr. Marjorie Lagrevol and Dr. Kevin Thibault-Duprey
   (SANOFI, Alfortville, France), Dr. Claire-Maelle Fovet (MIRCen-CEA,
   Fontenay-aux-Roses, France), and Dr. P. Pradeau (IMASSA, France) for the
   kind gift of biopsies from euthanized macaques. We thank Dr. Ines
   Barthelemy (Ecole Nationale Veterinaire d'Alfort, ENVA) for the kind and
   invaluable gift of biopsies from healthy and GRMD dogs. We thank Mrs.
   Catherine Blanc and Mrs. Brigitte Hoareau-Coudert (Flow Cytometry Core
   CyPS, Pierre & Marie Curie University, PitieSalpetriere Hospital, Paris)
   for invaluable help in cell sorting, and Dr. Valerie Vanneaux (Cell
   Therapy Laboratory, Saint Louis Hospital, Paris) for her FACS expertise.
   We thank Drs. Valerie Allamand, Sonia Berrih-Aknin, Raphaelle Grifone,
   Martine Oloko, and Frederique Truffault for their expert skills, advice,
   and discussions.
CR Ahadome SD, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.87012
   Ahadome SD, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.87001
   Anthony TE, 2007, J COMP NEUROL, V500, P368, DOI 10.1002/cne.21179
   Aral B, 1996, CR ACAD SCI III-VIE, V319, P171
   Babcock HE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101782
   Bae WJ, 2016, ONCOL LETT, V12, P5315, DOI 10.3892/ol.2016.5336
   Balber AE, 2011, STEM CELLS, V29, P570, DOI 10.1002/stem.613
   Barrera G, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7080102
   Begemann G, 2001, DEVELOPMENT, V128, P3081
   Bell GI, 2012, STEM CELLS DEV, V21, P1863, DOI 10.1089/scd.2011.0634
   Bellanti F, 2018, MATURITAS, V109, P6, DOI 10.1016/j.maturitas.2017.12.002
   Boldrin L, 2010, J HISTOCHEM CYTOCHEM, V58, P941, DOI 10.1369/jhc.2010.956201
   Brocker C, 2011, CHEM-BIOL INTERACT, V191, P269, DOI 10.1016/j.cbi.2011.02.016
   Brzóska E, 2006, DIFFERENTIATION, V74, P105, DOI 10.1111/j.1432-0436.2005.00059.x
   Cerletti M, 2006, J CELL SCI, V119, P3117, DOI 10.1242/jcs.03056
   CHAMBLISS KL, 1995, J BIOL CHEM, V270, P461, DOI 10.1074/jbc.270.1.461
   Chang C, 1997, GENOMICS, V40, P80, DOI 10.1006/geno.1996.4547
   Chen CH, 2014, PHYSIOL REV, V94, P1, DOI 10.1152/physrev.00017.2013
   Corti S, 2006, STEM CELLS, V24, P975, DOI 10.1634/stemcells.2005-0217
   Dellavalle A, 2007, NAT CELL BIOL, V9, P255, DOI 10.1038/ncb1542
   Dey D, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/730683
   Dimmeler S, 2008, CIRC RES, V102, P1319, DOI 10.1161/CIRCRESAHA.108.175943
   Dollé L, 2012, HEPATOLOGY, V55, P540, DOI 10.1002/hep.24693
   Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002
   El Haddad M, 2017, CELL MOL LIFE SCI, V74, P1923, DOI 10.1007/s00018-016-2445-1
   El Haddad M, 2012, J CELL SCI, V125, P6147, DOI 10.1242/jcs.115220
   Fan XH, 2003, MOL CELL BIOL, V23, P4637, DOI 10.1128/MCB.23.13.4637-4648.2003
   Foo LC, 2013, GLIA, V61, P1533, DOI 10.1002/glia.22539
   Froeschlé A, 1998, ONCOGENE, V16, P3369, DOI 10.1038/sj.onc.1201894
   Gentry T, 2007, CYTOTHERAPY, V9, P259, DOI 10.1080/14653240701218516
   Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014
   Gonnet F, 2008, PROTEOMICS, V8, P264, DOI 10.1002/pmic.200700261
   Hamade A, 2006, DEV BIOL, V289, P127, DOI 10.1016/j.ydbio.2005.10.019
   Hardy WR, 2017, STEM CELLS, V35, P1273, DOI 10.1002/stem.2599
   Hong M, 1999, BIOCHEM MOL BIOL INT, V47, P407
   Hoshino Y, 2015, AM J PATHOL, V185, P1457, DOI 10.1016/j.ajpath.2015.01.011
   Hu CA, 1996, J BIOL CHEM, V271, P9795, DOI 10.1074/jbc.271.16.9795
   Ioannou M, 2013, DEV BIOL, V374, P153, DOI 10.1016/j.ydbio.2012.10.030
   Jackson Brian, 2011, Human Genomics, V5, P283
   Jackson BC, 2015, EXPERT OPIN DRUG MET, V11, P1839, DOI 10.1517/17425255.2016.1108406
   Jean E, 2011, J CELL MOL MED, V15, P119, DOI 10.1111/j.1582-4934.2009.00942.x
   Keegan BR, 2005, SCIENCE, V307, P247, DOI 10.1126/science.1101573
   Koninckx R, 2013, CARDIOVASC RES, V97, P413, DOI 10.1093/cvr/cvs427
   Kumar S, 2012, BBA-MOL CELL BIOL L, V1821, P198, DOI 10.1016/j.bbalip.2011.04.004
   Lecourt S, 2010, EXP CELL RES, V316, P2513, DOI 10.1016/j.yexcr.2010.04.020
   Lin SW, 1996, GENOMICS, V34, P376, DOI 10.1006/geno.1996.0300
   Liu YL, 2014, HISTOCHEM CELL BIOL, V142, P685, DOI 10.1007/s00418-014-1248-4
   Ma I, 2011, STEM CELL REV REP, V7, P292, DOI 10.1007/s12015-010-9208-4
   Ma ZY, 2016, BIOCHEM BIOPH RES CO, V471, P576, DOI 10.1016/j.bbrc.2016.02.029
   Marcato P, 2011, CELL CYCLE, V10, P1378, DOI 10.4161/cc.10.9.15486
   Marchitti SA, 2008, EXPERT OPIN DRUG MET, V4, P697, DOI 10.1517/17425255.4.6.697 
   Marchitti SA, 2010, J HISTOCHEM CYTOCHEM, V58, P765, DOI [10.1369/jhc.2010.955773, 10.1369/jhc.2009.955773]
   Mic FA, 2004, J BIOL CHEM, V279, P26698, DOI 10.1074/jbc.M401920200
   Moreb JS, 2012, CHEM-BIOL INTERACT, V195, P52, DOI 10.1016/j.cbi.2011.10.007
   Morgan CA, 2015, CHEM-BIOL INTERACT, V234, P18, DOI 10.1016/j.cbi.2014.12.008
   Muzio G, 2012, FREE RADICAL BIO MED, V52, P735, DOI 10.1016/j.freeradbiomed.2011.11.033
   Niederreither K, 2002, MECH DEVELOP, V110, P165, DOI 10.1016/S0925-4773(01)00561-5
   Niu HX, 2016, J LEUKOCYTE BIOL, V99, P797, DOI 10.1189/jlb.2HI0415-146RR
   Okuno M, 1997, HEPATOLOGY, V26, P913, DOI 10.1053/jhep.1997.v26.pm0009328313
   Pisani DF, 2010, STEM CELLS, V28, P2182, DOI 10.1002/stem.537
   Porpiglia E, 2017, NAT CELL BIOL, V19, P558, DOI 10.1038/ncb3507
   Pors K, 2014, DRUG DISCOV TODAY, V19, P1953, DOI 10.1016/j.drudis.2014.09.009
   Povsic TJ, 2007, J AM COLL CARDIOL, V50, P2243, DOI 10.1016/j.jacc.2007.08.033
   Povsic TJ, 2010, J GERONTOL A-BIOL, V65, P1042, DOI 10.1093/gerona/glq110
   Przewozniak M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061760
   Puttini S, 2018, FRONT CARDIOVASC MED, V5, DOI 10.3389/fcvm.2018.00090
   Qazi TH, 2019, J CACHEXIA SARCOPENI, V10, P501, DOI 10.1002/jcsm.12416
   Rankin AC, 2013, BRIT J PHARMACOL, V170, P1177, DOI 10.1111/bph.12348
   Rodriguez-Guzman M, 2007, DEV BIOL, V302, P267, DOI 10.1016/j.ydbio.2006.09.034
   Roehrich ME, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/503047
   Rovira M, 2010, P NATL ACAD SCI USA, V107, P75, DOI 10.1073/pnas.0912589107
   Ryan T, 2012, STEM CELL REV REP, V8, P482, DOI 10.1007/s12015-011-9284-0
   Saw YT, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-329
   Shuang ZY, 2014, CANCER LETT, V354, P320, DOI 10.1016/j.canlet.2014.08.030
   Singh S, 2015, BIOCHEM BIOPH RES CO, V463, P768, DOI 10.1016/j.bbrc.2015.06.011
   Skuk D, 2017, CELL TRANSPLANT, V26, P1763, DOI 10.1177/0963689717724798
   Sládek NE, 2003, J BIOCHEM MOL TOXIC, V17, P7, DOI 10.1002/jbt.10057
   Sobreira TJP, 2011, P NATL ACAD SCI USA, V108, P226, DOI 10.1073/pnas.1011223108
   Song BJ, 2011, J PROTEOMICS, V74, P2691, DOI 10.1016/j.jprot.2011.05.013
   Song YM, 2017, EXP THER MED, V13, P1209, DOI 10.3892/etm.2017.4105
   Spinazzola JM, 2016, EXPERT OPIN ORPHAN D, V4, P1179, DOI 10.1080/21678707.2016.1240613
   Stagos D, 2010, DRUG METAB DISPOS, V38, P1679, DOI 10.1124/dmd.110.034678
   Sterrenburg E, 2004, NEUROMUSCULAR DISORD, V14, P507, DOI 10.1016/j.nmd.2004.03.008
   Stewart MJ, 1996, J INVEST MED, V44, P42
   Storms RW, 1999, P NATL ACAD SCI USA, V96, P9118, DOI 10.1073/pnas.96.16.9118
   Tachibana I, 1999, J CELL BIOL, V146, P893, DOI 10.1083/jcb.146.4.893
   Terry EE, 2018, ELIFE, V7, DOI 10.7554/eLife.34613
   Unguryte A, 2016, OSTEOARTHR CARTILAGE, V24, P873, DOI 10.1016/j.joca.2015.11.019
   VALENTINE BA, 1992, AM J MED GENET, V42, P352, DOI 10.1002/ajmg.1320420320
   van den Brink SC, 2017, NAT METHODS, V14, P935, DOI 10.1038/nmeth.4437
   Vasiliou V, 2013, CHEM-BIOL INTERACT, V202, P22, DOI 10.1016/j.cbi.2012.12.018
   Vasiliou V, 2013, CHEM-BIOL INTERACT, V202, P2, DOI 10.1016/j.cbi.2012.10.026
   Vauchez K, 2009, MOL THER, V17, P1948, DOI 10.1038/mt.2009.204
   Vella JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029226
   Verdijk LB, 2014, AGE, V36, P545, DOI 10.1007/s11357-013-9583-2
   Vilquin JT, 2005, GENE THER, V12, P1651, DOI 10.1038/sj.gt.3302565
   von Haehling S, 2019, J CACHEXIA SARCOPENI, V10, P1143, DOI 10.1002/jcsm.12501
   Walter MC, 2017, J CACHEXIA SARCOPENI, V8, P681, DOI 10.1002/jcsm.12245
   Wilschut KJ, 2011, STEM CELL RES, V7, P112, DOI 10.1016/j.scr.2011.05.001
   Xavier-Neto J, 2015, BBA-GENE REGUL MECH, V1849, P94, DOI 10.1016/j.bbagrm.2014.08.003
   Xu XT, 2015, STEM CELL REP, V5, P419, DOI 10.1016/j.stemcr.2015.07.016
   Zhao XL, 2009, CURR BIOL, V19, P1050, DOI 10.1016/j.cub.2009.04.059
   Zhou P, 2009, HEPATOLOGY, V49, P1992, DOI 10.1002/hep.22862
NR 103
TC 12
Z9 13
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2190-5991
EI 2190-6009
J9 J CACHEXIA SARCOPENI
JI J. Cachexia Sarcopenia Muscle
PD 2020 AUG
PY 2020
VL 11
IS 4
BP 1047
EP 1069
DI 10.1002/jcsm.12557
EA MAR 2020
PG 23
WC Geriatrics & Gerontology; Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology; General & Internal Medicine
GA NA8HA
UT WOS:000562291500001
PM 32157826
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Chung, KW
   Kim, KM
   Choi, YJ
   An, HJ
   Lee, B
   Kim, DH
   Lee, EK
   Im, E
   Lee, J
   Im, DS
   Yu, BP
   Chung, HY
AF Chung, Ki Wung
   Kim, Kyung Mok
   Choi, Yeon Ja
   An, Hye Jin
   Lee, Bonggi
   Kim, Dae Hyun
   Lee, Eun Kyeong
   Im, Eunok
   Lee, Jaewon
   Im, Dong Soon
   Yu, Byung Pal
   Chung, Hae Young
TI The critical role played by endotoxin-induced liver autophagy in the
   maintenance of lipid metabolism during sepsis
SO AUTOPHAGY
LA English
DT Article
DE aging; autophagy; endotoxin; lipid metabolism; lipophagy; liver; sepsis
ID INFLAMMATION; INJURY; CONSEQUENCES; ACCUMULATION; SENSITIVITY;
   INHIBITION; TLR4
AB Macroautophagy/autophagy is a central mechanism by which cells maintain integrity and homeostasis, and endotoxin-induced autophagy plays important roles in innate immunity. Although TLR4 stimulation mediated by lipopolysaccharide (LPS) also upregulates autophagy in hepatocytes and liver, its physiological role remains elusive. The objective of this study was to determine the role of LPS-induced autophagy in the regulation of liver lipid metabolism. LPS treatment (5 mg/kg) increased autophagy, as detected by LC3 conversion and transmission electron microscopy (TEM) analysis in C57BL6 mouse livers. AC2F hepatocytes also showed increased autophagic flux after LPS treatment (1 mu g/ml). To investigate the role of LPS-induced autophagy further, liver lipid metabolism changes in LPS-treated mice and fasted controls were compared. Interestingly, LPS-treated mice showed less lipid accumulation in liver than fasted mice despite increased fatty acid uptake and lipid synthesis-associated genes. In vitro analysis using AC2F hepatocytes demonstrated LPS-induced autophagy influenced the degradation of lipid droplets. Inhibition of LPS-induced autophagy using bafilomycin A(1) or Atg7 knockdown significantly increased lipid accumulation in AC2F hepatocytes. In addition, pretreatment with chloroquine aggravated LPS-induced lipid accumulation and inflammation in C57BL6 mouse livers. The physiological importance of autophagy was verified in LPS-treated young and aged rats. Autophagic response was diminished in LPS-treated aged rats and lipid metabolism was impaired during sepsis, indicating autophagy response is important for regulating lipid metabolism after endotoxin challenge. Our findings demonstrate endotoxin-induced autophagy is important for the regulation of lipid metabolism, and suggest that autophagy helps maintain lipid metabolism homeostasis during sepsis.
C1 [Chung, Ki Wung; Kim, Kyung Mok; Choi, Yeon Ja; An, Hye Jin; Lee, Bonggi; Kim, Dae Hyun; Lee, Eun Kyeong; Im, Eunok; Lee, Jaewon; Im, Dong Soon; Chung, Hae Young] Pusan Natl Univ, Coll Pharm, Mol Inflammat Res Ctr Aging Intervent MRCA, Busan 609735, South Korea.
   [Lee, Bonggi] KIOM, Korean Med KM Applicat Ctr, Daegu, South Korea.
   [Yu, Byung Pal] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA.
C3 Pusan National University; Korea Institute of Oriental Medicine (KIOM);
   University of Texas System; University of Texas Health Science Center at
   San Antonio
RP Chung, HY (corresponding author), Pusan Natl Univ, Coll Pharm, Mol Inflammat Res Ctr Aging Intervent MRCA, Busan 609735, South Korea.
EM hyjung@pusan.ac.kr
RI Im, Dong-Soon/AAH-9104-2020
OI IM, DONG-SOON/0000-0001-8054-8946
FU National Research Foundation of Korea (NRF) - Korea government (MSIP)
   [2009-0083538, 2015R1A2A2A01004137]; Bio & Medical Technology
   Development Program of the NRF - Ministry of Science, ICT & Future
   Planning [2015M3A9B 8029074]
FX This work was supported by the National Research Foundation of Korea
   (NRF) funded by the Korea government (MSIP) (grant no. 2009-0083538);
   National Research Foundation of Korea (NRF) funded by the Korea
   government (MSIP) (grant no. 2015R1A2A2A01004137); Bio & Medical
   Technology Development Program of the NRF funded by the Ministry of
   Science, ICT & Future Planning (grant no. 2015M3A9B 8029074).
CR Amir M, 2013, CELL DEATH DIFFER, V20, P878, DOI 10.1038/cdd.2013.21
   Carchman EH, 2013, FASEB J, V27, P4703, DOI 10.1096/fj.13-229476
   Carchman EH, 2011, HEPATOLOGY, V53, P2053, DOI 10.1002/hep.24324
   Chen C, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/267350
   Choi AMK, 2013, NEW ENGL J MED, V368, P1845, DOI 10.1056/NEJMc1303158
   Chung KW, 2015, AGING CELL, V14, P524, DOI 10.1111/acel.12305
   Ding WX, 2014, HEPATOLOGY, V59, P1235, DOI 10.1002/hep.26736
   Dupont N, 2014, CURR BIOL, V24, P609, DOI 10.1016/j.cub.2014.02.008
   Ezaki J, 2011, AUTOPHAGY, V7, P727, DOI 10.4161/auto.7.7.15371
   FEINGOLD KR, 1992, J LIPID RES, V33, P1765
   Fujita KI, 2011, P NATL ACAD SCI USA, V108, P1427, DOI 10.1073/pnas.1014156108
   GERSHONI JM, 1983, ANAL BIOCHEM, V131, P1, DOI 10.1016/0003-2697(83)90128-8
   Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697
   Jia L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4878
   Jiang PD, 2014, CELL RES, V24, P69, DOI 10.1038/cr.2013.161
   Kaushik S, 2015, NAT CELL BIOL, V17, P759, DOI 10.1038/ncb3166
   Khovidhunkit W, 2004, J LIPID RES, V45, P1169, DOI 10.1194/jlr.R300019-JLR200
   Lee SJ, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/327167
   Leventhal JS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150001
   Nedjic J, 2008, NATURE, V455, P396, DOI 10.1038/nature07208
   Newberry EP, 2003, J BIOL CHEM, V278, P51664, DOI 10.1074/jbc.M309377200
   Ohhira M, 2007, J GASTROENTEROL, V42, P969, DOI 10.1007/s00535-007-2119-8
   Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497
   Rautou PE, 2010, J HEPATOL, V53, P1123, DOI 10.1016/j.jhep.2010.07.006
   Rui LY, 2014, COMPR PHYSIOL, V4, P177, DOI 10.1002/cphy.c130024
   Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383
   Schmid D, 2007, IMMUNITY, V26, P79, DOI 10.1016/j.immuni.2006.10.018
   Schroeder B, 2015, HEPATOLOGY, V61, P1896, DOI 10.1002/hep.27667
   Seiliez I, 2016, AUTOPHAGY, V12, P343, DOI 10.1080/15548627.2015.1117732
   Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663
   Settembre C, 2013, NAT CELL BIOL, V15, P647, DOI 10.1038/ncb2718
   Shi CS, 2012, NAT IMMUNOL, V13, P255, DOI 10.1038/ni.2215
   Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976
   Takahashi W, 2013, CRIT CARE, V17, DOI 10.1186/cc12839
   Ward C, 2016, BBA-MOL CELL BIOL L, V1861, P269, DOI 10.1016/j.bbalip.2016.01.006
   Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022
   Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005
   Yang SQ, 1997, P NATL ACAD SCI USA, V94, P2557, DOI 10.1073/pnas.94.6.2557
   Yuan H, 2009, AM J PHYSIOL-HEART C, V296, pH470, DOI 10.1152/ajpheart.01051.2008
   Zhang QH, 2016, SCI REP-UK, V6, DOI 10.1038/srep24609
NR 40
TC 54
Z9 59
U1 1
U2 53
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1554-8627
EI 1554-8635
J9 AUTOPHAGY
JI Autophagy
PY 2017
VL 13
IS 7
BP 1113
EP 1129
DI 10.1080/15548627.2017.1319040
PG 17
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA FB6IF
UT WOS:000406244200003
PM 28575583
OA Green Published, Bronze
DA 2024-02-19
ER

PT J
AU Gowda, C
   Newcomb, CW
   Liu, Q
   Carbonari, DM
   Lewis, JD
   Forde, KA
   Goldberg, DS
   Reddy, KR
   Roy, JA
   Marks, AR
   Schneider, JL
   Kostman, JR
   Tate, JP
   Lim, JK
   Justice, AC
   Goetz, MB
   Corley, DA
   Lo Re, V
AF Gowda, Charitha
   Newcomb, Craig W.
   Liu, Qing
   Carbonari, Dena M.
   Lewis, James D.
   Forde, Kimberly A.
   Goldberg, David S.
   Reddy, K. Rajender
   Roy, Jason A.
   Marks, Amy R.
   Schneider, Jennifer L.
   Kostman, Jay R.
   Tate, Janet P.
   Lim, Joseph K.
   Justice, Amy C.
   Goetz, Matthew Bidwell
   Corley, Douglas A.
   Lo Re, Vincent, III
TI Risk of Acute Liver Injury With Antiretroviral Therapy by Viral
   Hepatitis Status
SO OPEN FORUM INFECTIOUS DISEASES
LA English
DT Article
DE antiretroviral; drug-induced liver injury; hepatotoxicity; HIV
ID PROTEASE INHIBITORS; DIAGNOSTIC CODES; HEART-FAILURE; HEPATOTOXICITY;
   EFAVIRENZ; INFECTION; VIRUS; COMBINATION; DYSFUNCTION; POPULATION
AB Background. The risk of hepatotoxicity with antiretroviral therapy (ART) remains unknown. We determined the comparative risk of acute liver injury (ALI) for antiretroviral drugs, classes, and regimens, by viral hepatitis status.
   Methods. We followed a cohort of 10 083 human immunodeficiency virus (HIV)-infected persons in Kaiser Permanente Northern California (n = 2099) from 2004 to 2010 and the Veterans Aging Cohort Study (n = 7984) from 2004 to 2012. Within the first year of ART, we determined occurrence of (1) liver aminotransferases >200 U/L and (2) severe ALI (coagulopathy with hyper-bilirubinemia). We used Cox regression to determine hazard ratios (HRs) with 95% confidence intervals (CIs) of endpoints among initiators of nucleos(t) ide analogue combinations, antiretroviral classes, and ART regimens, all stratified by viral hepatitis status.
   Results. Liver aminotransferases >200 U/L developed in 206 (2%) persons and occurred more frequently among HIV/viral hepatitis-coinfected than HIV-monoinfected persons (116.1 vs 20.7 events/1000 person-years; P <.001). No evidence of differential risk was found between initiators of abacavir/lamivudine versus tenofovir/emtricitabine among coinfected (HR, 0.68; 95% CI,.29-1.57) or HIV-monoinfected (HR, 1.19; 95% CI,.47-2.97) groups. Coinfected patients had a higher risk of aminotransferases >200 U/L after initiation with a protease inhibitor than nonnucleoside reverse-transcriptase inhibitor (HR, 2.01; 95% CI, 1.36-2.96). Severe ALI (30 events; 0.3%) occurred more frequently in coinfected persons (15.9 vs 3.1 events/1000 person-years; P <.001) but was too uncommon to evaluate in adjusted analyses.
   Conclusions. Within the year after ART initiation, aminotransferase elevations were infrequently observed and rarely led to severe ALI. Protease inhibitor use was associated with a higher risk of aminotransferase elevations among viral hepatitis-coinfected patients.
C1 [Gowda, Charitha] Nationwide Childrens Hosp, Div Pediat Infect Dis, Columbus, OH USA.
   [Gowda, Charitha] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA.
   [Newcomb, Craig W.; Liu, Qing; Carbonari, Dena M.; Lewis, James D.; Forde, Kimberly A.; Goldberg, David S.; Roy, Jason A.; Lo Re, Vincent, III] Univ Penn, Perelman Sch Med, Dept Biostat & Epidemiol, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA.
   [Carbonari, Dena M.; Lewis, James D.; Forde, Kimberly A.; Goldberg, David S.; Reddy, K. Rajender; Roy, Jason A.; Lo Re, Vincent, III] Univ Penn, Perelman Sch Med, Ctr Pharmacoepidemiol Res & Training, Philadelphia, PA 19104 USA.
   [Lewis, James D.; Forde, Kimberly A.; Goldberg, David S.; Reddy, K. Rajender] Univ Penn, Dept Med, Perelman Sch Med, Div Gastroenterol, Philadelphia, PA 19104 USA.
   [Marks, Amy R.; Schneider, Jennifer L.; Corley, Douglas A.] Kaiser Permanente Northern Calif, Div Res, Oakland, CA USA.
   [Kostman, Jay R.] Philadelphia FIGHT, Jonathan Lax Treatment Ctr, Philadelphia, PA USA.
   [Tate, Janet P.; Lim, Joseph K.; Justice, Amy C.] VA Connecticut Healthcare Syst, West Haven, CT USA.
   [Tate, Janet P.; Lim, Joseph K.; Justice, Amy C.] Yale Univ, Sch Med, New Haven, CT USA.
   [Goetz, Matthew Bidwell] VA Greater Los Angeles Healthcare Syst, Los Angeles, CA USA.
   [Goetz, Matthew Bidwell] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.
   [Lo Re, Vincent, III] Univ Penn, Dept Med, Perelman Sch Med, Div Infect Dis, Philadelphia, PA 19104 USA.
C3 University System of Ohio; Ohio State University; Nationwide Childrens
   Hospital; University System of Ohio; Ohio State University; University
   of Pennsylvania; University of Pennsylvania; University of Pennsylvania;
   Kaiser Permanente; US Department of Veterans Affairs; Veterans Health
   Administration (VHA); VA Connecticut Healthcare System; Yale University;
   US Department of Veterans Affairs; Veterans Health Administration (VHA);
   VA Greater Los Angeles Healthcare System; University of California
   System; University of California Los Angeles; University of California
   Los Angeles Medical Center; David Geffen School of Medicine at UCLA;
   University of Pennsylvania
RP Lo Re, V (corresponding author), Univ Penn, Perelman Sch Med, Ctr Clin Epidemiol & Biostat, 836 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.
EM vincentl@mail.med.upenn.edu
RI Carbonari, Dena M/H-3366-2011; Goetz, Matthew Bidwell/GPX-4090-2022
OI Carbonari, Dena M/0000-0003-0310-270X; Goetz,
   Matthew/0000-0003-4542-992X
FU Agency for Healthcare Research and Quality [R01 HS018372]; National
   Institutes of Health [F32 AI120363, K24 DK078228]; National Institute on
   Alcohol Abuse and Alcoholism [U01 AA13566, U24 AA20794, U01 AA20790]
FX This study was funded by research grants from the Agency for Healthcare
   Research and Quality (Grant R01 HS018372; to V.L.R.), the National
   Institutes of Health (Grants F32 AI120363 [to C.G.] and K24 DK078228 [to
   J.D.L.]), and the National Institute on Alcohol Abuse and Alcoholism
   (Grants U01 AA13566, U24 AA20794, and U01 AA20790; to A.C.J.).
CR *AIDS CLIN TRIALS, 1996, TABL GRAD SEV AD ADV
   Aithal GP, 2011, CLIN PHARMACOL THER, V89, P806, DOI 10.1038/clpt.2011.58
   [Anonymous], 2000, Pharmacoepidemiology
   Arroyo V, 2016, SEMIN LIVER DIS, V36, P109, DOI 10.1055/s-0036-1583202
   Bell LN, 2009, SEMIN LIVER DIS, V29, P337, DOI 10.1055/s-0029-1240002
   Boyd MA, 2009, CURR OPIN HIV AIDS, V4, P194, DOI 10.1097/COH.0b013e328329fc8d
   Bruno R, 2006, DIGEST LIVER DIS, V38, P363, DOI 10.1016/j.dld.2006.01.020
   Butt AA, 2004, HEPATOLOGY, V40, P115, DOI 10.1002/hep.20289
   Chalasani N, 2015, GASTROENTEROLOGY, V148, P1340, DOI 10.1053/j.gastro.2015.03.006
   Collett D, 2015, Modelling Survival Data in Medical Research
   den Brinker M, 2000, AIDS, V14, P2895, DOI 10.1097/00002030-200012220-00011
   FISHER SG, 1995, AM J EPIDEMIOL, V141, P242, DOI 10.1093/oxfordjournals.aje.a117426
   FREEDMAN VA, 1995, DEMOGRAPHY, V32, P459, DOI 10.2307/2061691
   Fultz SL, 2006, MED CARE, V44, pS25, DOI 10.1097/01.mlr.0000223670.00890.74
   Goldberg DS, 2015, GASTROENTEROLOGY, V148, P1353, DOI 10.1053/j.gastro.2015.02.050
   Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7
   Hosmer W, 1999, APPL SURVIVAL ANAL R
   Jones M, 2012, SEMIN LIVER DIS, V32, P167, DOI 10.1055/s-0032-1316472
   Justice AC, 2006, MED CARE, V44, pS52, DOI 10.1097/01.mlr.0000228003.08925.8c
   Katlama C, 2007, AIDS, V21, P395, DOI 10.1097/QAD.0b013e328013d9d7
   Lennox JL, 2009, LANCET, V374, P796, DOI 10.1016/S0140-6736(09)60918-1
   Lo Re V, 2015, PHARMACOEPIDEM DR S, V24, P676, DOI 10.1002/pds.3774
   Lo Re V, 2013, PHARMACOEPIDEM DR S, V22, P861, DOI 10.1002/pds.3470
   Newgard CD, 2015, JAMA-J AM MED ASSOC, V314, P940, DOI 10.1001/jama.2015.10516
   Núñez M, 2001, J ACQ IMMUN DEF SYND, V27, P426, DOI 10.1097/00126334-200108150-00002
   Polson J, 2005, HEPATOLOGY, V41, P1179, DOI 10.1002/hep.20703
   Prati D, 2002, ANN INTERN MED, V137, P1, DOI 10.7326/0003-4819-137-1-200207020-00006
   Riddle TM, 2001, J BIOL CHEM, V276, P37514, DOI 10.1074/jbc.M104557200
   Saczynski JS, 2012, PHARMACOEPIDEM DR S, V21, P129, DOI 10.1002/pds.2313
   Samsky MD, 2013, J AM COLL CARDIOL, V61, P2397, DOI 10.1016/j.jacc.2013.03.042
   Scott IA, 2015, JAMA INTERN MED, V175, P827, DOI 10.1001/jamainternmed.2015.0324
   Soriano V, 2008, AIDS, V22, P1, DOI 10.1097/QAD.0b013e3282f0e2fd
   Squires K, 2004, JAIDS-J ACQ IMM DEF, V36, P1011, DOI 10.1097/00126334-200408150-00003
   Sulkowski MS, 2004, AIDS, V18, P2277, DOI 10.1097/00002030-200411190-00008
   Sulkowski MS, 2002, HEPATOLOGY, V35, P182, DOI 10.1053/jhep.2002.30319
   Sulkowski MS, 2000, JAMA-J AM MED ASSOC, V283, P74, DOI 10.1001/jama.283.1.74
   Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961
   Torti C, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-58
   Vispo E, 2013, AIDS, V27, P1187, DOI 10.1097/QAD.0b013e32835cb815
   Wu XD, 2014, CURR OPIN PHARMACOL, V19, P61, DOI 10.1016/j.coph.2014.07.008
NR 40
TC 5
Z9 5
U1 0
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 2328-8957
J9 OPEN FORUM INFECT DI
JI Open Forum Infect. Dis.
PD SPR
PY 2017
VL 4
IS 2
DI 10.1093/ofid/ofx012
PG 10
WC Immunology; Infectious Diseases; Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology; Infectious Diseases; Microbiology
GA FA8HD
UT WOS:000405685900003
PM 28470014
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Valle, A
   Guevara, R
   García-Palmer, FJ
   Roca, P
   Oliver, J
AF Valle, A.
   Guevara, R.
   Garcia-Palmer, F. J.
   Roca, P.
   Oliver, J.
TI Sexual dimorphism in liver mitochondrial oxidative capacity is conserved
   under caloric restriction conditions
SO AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
LA English
DT Article
DE oxidative phosphorylation; free radicals; antioxidant enzymes;
   mitochondrial transcription factor A
ID HYDROGEN-PEROXIDE PRODUCTION; OXYGEN SPECIES PRODUCTION; BROWN
   ADIPOSE-TISSUE; FACTOR-A TFAM; RAT-LIVER; DIETARY RESTRICTION;
   ANTIOXIDANT ENZYMES; SKELETAL-MUSCLE; GENE-EXPRESSION; H2O2 PRODUCTION
AB Caloric restriction (CR) without malnutrition has been shown to increase maximal life span and delay the rate of aging in a wide range of species. It has been proposed that reduction in energy expenditure and oxidative damage may explain the life-extending effect of CR. Sex-related differences also have been shown to influence longevity and energy expenditure in many mammalian species. The aim of the present study was to determine the sex-related differences in rat liver mitochondrial machinery, bioenergetics, and oxidative balance in response to short-term CR. Mitochondria were isolated from 6-mo-old male and female Wistar rats fed ad libitum or subjected to 40% CR for 3 mo. Mitochondrial O-2 consumption, activities of the oxidative phosphorylation system (complexes I, III, IV, and V), antioxidative activities [MnSOD, glutathione peroxidase (GPx)], mitochondrial DNA and protein content, mitochondrial H2O2 production, and markers of oxidative damage, as well as cytochrome C oxidase and mitochondrial transcription factor A levels, were measured. Female rats showed a higher oxidative capacity and GPx activity than males. This sexual dimorphism was not modified by CR. Restricted rats showed slightly increased oxygen consumption, complex III activity, and GPx antioxidant activity together with lower levels of oxidative damage. In conclusion, the sexual dimorphism in liver mitochondrial oxidative capacity was unaffected by CR, with females showing higher mitochondrial functionality and ROS protection than males.
C1 Univ Illes Balears, Dept Biol Fonamental & Ciencies Salut, Grp Metab Energet & Nutr, E-07122 Palma de Mallorca, Spain.
   Univ Illes Balears, Inst Univ Invest Ciencies Salut, E-07122 Palma de Mallorca, Spain.
   Inst Salud Carlos III, Palma de Mallorca, Spain.
C3 Universitat de les Illes Balears; Universitat de les Illes Balears;
   Instituto de Salud Carlos III
RP Oliver, J (corresponding author), Univ Illes Balears, Dept Biol Fonamental & Ciencies Salut, Grp Metab Energet & Nutr, Cra Valldemossa Km 7-5, E-07122 Palma de Mallorca, Spain.
EM jordi.oliver@uib.es
RI Roca, Pilar/L-7578-2014; Oliver, Jordi/H-8073-2013; Valle,
   Adamo/H-7042-2017
OI Roca, Pilar/0000-0003-3878-5424; Oliver, Jordi/0000-0002-5702-7306;
   Valle, Adamo/0000-0001-7217-2811
CR Anson RM, 2003, P NATL ACAD SCI USA, V100, P6216, DOI 10.1073/pnas.1035720100
   Barazzoni R, 2005, ENDOCRINOLOGY, V146, P2098, DOI 10.1210/en.2004-1396
   Borrás C, 2005, AGING CELL, V4, P113, DOI 10.1111/j.1474-9726.2005.00151.x
   Borrás C, 2003, FREE RADICAL BIO MED, V34, P546, DOI 10.1016/S0891-5849(02)01356-4
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Buege J A, 1978, Methods Enzymol, V52, P302
   Colom B, 2007, CARDIOVASC RES, V74, P456, DOI 10.1016/j.cardiores.2007.02.001
   Cortright RN, 2000, CAN J APPL PHYSIOL, V25, P288, DOI 10.1139/h00-023
   DJOUADI F, 1994, AM J PHYSIOL, V267, pC245, DOI 10.1152/ajpcell.1994.267.1.C245
   Dröge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001
   Fernández-Silva P, 2003, EXP PHYSIOL, V88, P41, DOI 10.1113/eph8802514
   Forster MJ, 2000, J GERONTOL A-BIOL, V55, pB522, DOI 10.1093/gerona/55.11.B522
   Garstka HL, 2003, NUCLEIC ACIDS RES, V31, P5039, DOI 10.1093/nar/gkg717
   GOODRICK CL, 1990, MECH AGEING DEV, V55, P69, DOI 10.1016/0047-6374(90)90107-Q
   Gredilla R, 2001, J BIOENERG BIOMEMBR, V33, P279, DOI 10.1023/A:1010603206190
   Hagopian K, 2005, AM J PHYSIOL-ENDOC M, V288, pE674, DOI 10.1152/ajpendo.00382.2004
   Higami Y, 2006, J GERONTOL A-BIOL, V61, P1099, DOI 10.1093/gerona/61.11.1099
   HILL JO, 1986, J NUTR, V116, P2000, DOI 10.1093/jn/116.10.2000
   HOYENGA KB, 1982, PHYSIOL BEHAV, V28, P545, DOI 10.1016/0031-9384(82)90153-6
   Justo R, 2005, AM J PHYSIOL-CELL PH, V289, pC372, DOI 10.1152/ajpcell.00035.2005
   Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682
   Koekemoer TC, 1998, NUCLEIC ACIDS RES, V26, P2829, DOI 10.1093/nar/26.11.2829
   Koekemoer TC, 2001, INT J BIOCHEM CELL B, V33, P889, DOI 10.1016/S1357-2725(01)00064-4
   KRAHENBUHL S, 1991, J BIOL CHEM, V266, P20998
   Lambert AJ, 2005, J GERONTOL A-BIOL, V60, P175, DOI 10.1093/gerona/60.2.175
   Lambert AJ, 2004, AM J PHYSIOL-REG I, V286, pR71, DOI 10.1152/ajpregu.00341.2003
   Lass A, 1998, FREE RADICAL BIO MED, V25, P1089, DOI 10.1016/S0891-5849(98)00144-0
   Lee I, 2002, MOL CELL BIOCHEM, V234, P63, DOI 10.1023/A:1015921513720
   LEON TI, 2001, LIPIDS, V36, P589
   López-Lluch G, 2006, P NATL ACAD SCI USA, V103, P1768, DOI 10.1073/pnas.0510452103
   López-Torres M, 2002, FREE RADICAL BIO MED, V32, P882, DOI 10.1016/S0891-5849(02)00773-6
   Mahoney LB, 2006, LIPIDS HEALTH DIS, V5, DOI 10.1186/1476-511X-5-13
   Maniura-Weber K, 2004, NUCLEIC ACIDS RES, V32, P6015, DOI 10.1093/nar/gkh921
   MASORO EJ, 1982, P NATL ACAD SCI-BIOL, V79, P4239, DOI 10.1073/pnas.79.13.4239
   Mura CV, 1996, MECH AGEING DEV, V91, P115, DOI 10.1016/0047-6374(96)01780-0
   Nicholls DG, 2004, AGING CELL, V3, P35, DOI 10.1111/j.1474-9728.2003.00079.x
   PARISI MA, 1991, SCIENCE, V252, P965, DOI 10.1126/science.2035027
   Quick KL, 2000, J NEUROSCI METH, V97, P139, DOI 10.1016/S0165-0270(00)00179-5
   Ragan C. I., 1987, MITOCHONDRIA PRACTIC
   Ramkumar K M, 2005, J Basic Clin Physiol Pharmacol, V16, P245
   Ramsey JJ, 2004, AM J PHYSIOL-ENDOC M, V286, pE31, DOI 10.1152/ajpendo.00283.2003
   RAO G, 1990, J NUTR, V120, P602, DOI 10.1093/jn/120.6.602
   Rodríguez-Cuenca S, 2002, J BIOL CHEM, V277, P42958, DOI 10.1074/jbc.M207229200
   Smith AD, 2001, INT J VITAM NUTR RES, V71, P87, DOI 10.1024/0300-9831.71.1.87
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   THOMAS PS, 1978, ANAL BIOCHEM, V89, P35, DOI 10.1016/0003-2697(78)90724-8
   Valle A, 2005, AM J PHYSIOL-ENDOC M, V289, pE15, DOI 10.1152/ajpendo.00553.2004
   Valle A, 2007, CELL PHYSIOL BIOCHEM, V19, P195, DOI 10.1159/000099207
   Weindruch R., 1988, RETARDATION AGING DI
   WEINDRUCH RH, 1980, MECH AGEING DEV, V12, P375, DOI 10.1016/0047-6374(80)90070-6
   WIDDOWSON EM, 1976, P NUTR SOC, V35, P175, DOI 10.1079/PNS19760030
   Yu BP, 1996, FREE RADICAL BIO MED, V21, P651, DOI 10.1016/0891-5849(96)00162-1
NR 52
TC 67
Z9 74
U1 0
U2 5
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0363-6143
EI 1522-1563
J9 AM J PHYSIOL-CELL PH
JI Am. J. Physiol.-Cell Physiol.
PD OCT
PY 2007
VL 293
IS 4
BP C1302
EP C1308
DI 10.1152/ajpcell.00203.2007
PG 7
WC Cell Biology; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Physiology
GA 218YR
UT WOS:000250052400012
PM 17652427
DA 2024-02-19
ER

PT J
AU Zhu, L
   Wang, N
   Guo, G
   Fan, ZQ
   Shi, XQ
   Ji, XL
AF Zhu, Lin
   Wang, Na
   Guo, Guang
   Fan, ZuoQing
   Shi, XinQin
   Ji, XianLing
TI Male zooid extracts of <i>Antheraea pernyi</i> ameliorates non-alcoholic
   fatty liver disease and intestinal dysbacteriosis in mice induced by a
   high-fat diet
SO FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
LA English
DT Article
DE tussah male moth; NAFLD; hypolipidemic; intestinal microbial diversity;
   high-fat diet
ID GUT MICROBIOTA
AB The male zooid of Antheraea pernyi (A. pernyi) accumulates several nutrients and physiological activity-related substances for reproduction. Some components in the extracts of the male zooid of A. pernyi (EMZAP) have several functions, such as protecting the liver, enhancing immunity, antiatheroscloresis, anti-aging, and antitumor effects. In this study, we investigated the ameliorating effects on high-fat diet (HFD)-induced non-alcoholic fatty liver disease (NAFLD). The EMZAP treatment could ameliorate NAFLD and effectively decrease the serum total cholesterol, triglyceride and low-density lipoprotein levels and a significant increase in serum high-density lipoprotein levels was observed. Additionally, the EMZAP treatment reduced the levels of liver-function enzymes and pro-inflammatory cytokines (i.e., IL-6, IL-8, TNF-alpha, TGF-beta(1)) and also the oxidative stress indices and regulated the expression of genes associated with fatty acid metabolism (SREBP-1c, PPAR alpha, ACOX-1, CPT-1) in the liver to prevent the development of NAFLD. Furthermore, EMZAP enhanced the diversity and richness of the beneficial intestinal microbes, suggesting its potential as a dietary supplement and functional food to combat NAFLD induced by HFD.
C1 [Zhu, Lin; Wang, Na; Guo, Guang; Fan, ZuoQing; Shi, XinQin] Shandong Inst Sericulture, Yantai, Peoples R China.
   [Ji, XianLing] Shandong Agr Univ, Coll Forestry, Tai An, Peoples R China.
C3 Shandong Academy of Agricultural Sciences; Shandong Agricultural
   University
RP Zhu, L (corresponding author), Shandong Inst Sericulture, Yantai, Peoples R China.
EM zhulin_0517@163.com
FU Shandong~Province Modern Agricultural System Innovation Team
   [SDAIT-18-01]; Yantai Science and Technology Innovation and Development
   Program Project [2022MSGY068]
FX This work was supported by Shandong~Province Modern Agricultural System
   Innovation Team (No. SDAIT-18-01). Yantai Science and Technology
   Innovation and Development Program Project (2022MSGY068).
CR Aksoy GK, 2019, PEDIATR GASTROENTERO, V22, P470, DOI 10.5223/pghn.2019.22.5.470
   An M, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-82282-5
   Chen HT, 2020, WORLD J GASTROENTERO, V26, P1901, DOI 10.3748/wjg.v26.i16.1901
   Chen XuanHong, 2021, Shipin Kexue / Food Science, V42, P143, DOI 10.7506/spkx1002-6630-20200907-097
   Cui YZ, 2019, J AGR FOOD CHEM, V67, P2754, DOI 10.1021/acs.jafc.9b00080
   Culafic M, 2019, MEDICINA-LITHUANIA, V55, DOI 10.3390/medicina55060243
   de Vos WM, 2022, GUT, V71, P1020, DOI 10.1136/gutjnl-2021-326789
   Gao LL, 2021, INT J BIOL MACROMOL, V183, P1379, DOI 10.1016/j.ijbiomac.2021.05.066
   He LH, 2021, FRONT MICROBIOL, V12, DOI 10.3389/fmicb.2021.761836
   Huang DIQ, 2021, NAT REV GASTRO HEPAT, V18, P223, DOI 10.1038/s41575-020-00381-6
   Jasirwan COM, 2021, BIOSCI MICROB FOOD H, V40, P50, DOI 10.12938/bmfh.2020-046
   Jia Q., 2009, CHIN J MED GUIDE, V11, P83
   Li Xiao-lin, 2020, Yaoxue Xuebao, V55, P15, DOI 10.16438/j.0513-4870.2019-0614
   Lin DB, 2022, EVID-BASED COMPL ALT, V2022, DOI 10.1155/2022/4897463
   Ma JL, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101124
   Nyangale EP, 2012, J PROTEOME RES, V11, P5573, DOI 10.1021/pr300637d
   Park E, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10102634
   Pi AW, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.752148
   [邱邦东 Qiu Bangdong], 2017, [中国实验方剂学杂志, Chinese Journal of Experimental Traditional Medical Formulae], V23, P145
   Shen CY, 2021, FOOD FUNCT, V12, P10097, DOI [10.1039/d1fo01373d, 10.1039/D1FO01373D]
   Sun QM, 2022, FRONT CELL INFECT MI, V12, DOI 10.3389/fcimb.2022.854879
   Tilg H, 2021, NAT METAB, V3, P1596, DOI 10.1038/s42255-021-00501-9
   Wang ZY, 2021, J AGR FOOD CHEM, V69, P3585, DOI 10.1021/acs.jafc.1c00751
   Zhang XY, 2021, NANOSCALE, V13, P12613, DOI 10.1039/d1nr02366g
   Zhang YW, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-6251-7
   Zhao WH, 2008, WORLD J GASTROENTERO, V14, P2094, DOI 10.3748/wjg.14.2094
   Zhao WY, 2022, NUTRIENTS, V14, DOI 10.3390/nu14091699
   Zhu J, 2022, J FOOD BIOCHEM, V46, DOI 10.1111/jfbc.13947
   Zhu L, 2021, SCIENCEASIA, V47, P162, DOI 10.2306/scienceasia1513-1874.2021.021
NR 29
TC 0
Z9 0
U1 4
U2 12
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2235-2988
J9 FRONT CELL INFECT MI
JI Front. Cell. Infect. Microbiol.
PD OCT 28
PY 2022
VL 12
AR 1059647
DI 10.3389/fcimb.2022.1059647
PG 13
WC Immunology; Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology; Microbiology
GA 6E8VO
UT WOS:000883651600001
PM 36389153
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Kasahara, K
   Nishikawa, A
   Furukawa, F
   Ikezaki, S
   Tanakamaru, Z
   Takagi, H
   Ikeda, T
   Imazawa, T
   Takahashi, M
AF Kasahara, K
   Nishikawa, A
   Furukawa, F
   Ikezaki, S
   Tanakamaru, Z
   Takagi, H
   Ikeda, T
   Imazawa, T
   Takahashi, M
TI Suppressive effects of josamycin on the development of altered liver
   cell loci and chronic nephropathy in a carcinogenicity study
SO FOOD AND CHEMICAL TOXICOLOGY
LA English
DT Article
DE josamycin; liver cell foci; nephropathy; carcinogenicity
ID CHRONIC FOOD RESTRICTION; AGING RATS; TETRACYCLINE
AB The carcinogenicity of josamycin was examined in Fischer 344 (F344) rats. Groups of 50 males and 50 females were given the compound in their diet at concentrations of 0 (control), 1.25 or 2.5% for 104-weeks; these dose levels were selected on the basis of the results of a subchronic study, in which animals rather rejected 5% josamycin. All surviving rats were killed at wk 106. A variety of rumours developed in all groups, including the control group, but all the neoplastic lesions were histologically similar to those known to occur spontaneously in this strain of rats, and no statistically significant increase in the incidence of any tumour was found in the treated groups of either sex. Interestingly, the josamycin treatment significantly reduced the development of altered liver cell foci and chronic nephropathy in a dose-dependent manner. Thus, it was concluded that, under the present experimental conditions, josamycin is not carcinogenic in F344 rats. (C) 1998 Elsevier Science Ltd. All rights reserved.
C1 Natl Inst Hlth Sci, Div Pathol, Setagaya Ku, Tokyo 1588501, Japan.
C3 National Institute of Health Sciences - Japan
RP Nishikawa, A (corresponding author), Natl Inst Hlth Sci, Div Pathol, Setagaya Ku, 1-18-1 Kamiyoga, Tokyo 1588501, Japan.
CR CHANDRA M, 1992, CANCER LETT, V62, P49, DOI 10.1016/0304-3835(92)90197-4
   DIETZ DD, 1991, FUND APPL TOXICOL, V17, P335, DOI 10.1016/0272-0590(91)90223-Q
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Hazato H, 1969, Jpn J Antibiot, V22, P242
   IKEZAKI S, 1995, EISEI SHIKENJO HOUKO, V113, P44
   IWASAKI K, 1988, ACTA PATHOL JAPON, V38, P1119
   KEENAN KP, 1994, TOXICOL PATHOL, V22, P300, DOI 10.1177/019262339402200308
   KROON AM, 1984, CANCER LETT, V25, P33, DOI 10.1016/S0304-3835(84)80023-3
   Kuriaki K, 1969, Jpn J Antibiot, V22, P219
   LAGANIERE S, 1989, MECH AGEING DEV, V48, P221, DOI 10.1016/0047-6374(89)90084-5
   LAGANIERE S, 1989, MECH AGEING DEV, V48, P207, DOI 10.1016/0047-6374(89)90083-3
   Lee D W, 1990, Aging (Milano), V2, P357
   MACHADO FC, 1995, J INORG BIOCHEM, V60, P163, DOI 10.1016/0162-0134(95)00017-I
   MAEKAWA A, 1983, JPN J CANCER RES, V74, P365
   Menninger J R, 1995, J Basic Clin Physiol Pharmacol, V6, P229
   MIURA M, 1987, Japanese Journal of Antibiotics, V40, P588
   SAVAGE DC, 1968, J EXP MED, V128, P97, DOI 10.1084/jem.128.1.97
   SONAKA I, 1994, J GERONTOL, V49, pB157, DOI 10.1093/geronj/49.4.B157
   STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616
   TUBIS M, 1966, INT J APPL RADIAT IS, V17, P603, DOI 10.1016/0020-708X(66)90034-2
   YAMAMOTO K, 1986, JPN J VET SCI, V48, P1, DOI 10.5331/seppyo.48.1
   YU BP, 1990, REV BIOL RES AGING, V4, P349
   YU BP, 1989, OXYGEN RADICALS BIOL, P1067
NR 23
TC 3
Z9 3
U1 0
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0278-6915
EI 1873-6351
J9 FOOD CHEM TOXICOL
JI Food Chem. Toxicol.
PD JAN
PY 1999
VL 37
IS 1
BP 61
EP 67
DI 10.1016/S0278-6915(98)00100-8
PG 7
WC Food Science & Technology; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Toxicology
GA 157CQ
UT WOS:000078042200007
PM 10069483
DA 2024-02-19
ER

PT J
AU Raimundo, JRS
   Alves, BDA
   Encinas, JFA
   Siqueira, AM
   de Gois, KC
   Perez, MM
   Petri, G
   dos Santos, JFR
   Fonseca, FLA
   da Veiga, GL
AF Raimundo, Joyce Regina Santos
   da Costa Aguiar Alves, Beatriz
   Encinas, Jessica Freitas Araujo
   Siqueira, Andressa Moreira
   de Gois, Katharyna Cardoso
   Perez, Matheus Moreira
   Petri, Giuliana
   dos Santos, Jose Francisco Ramos
   Fonseca, Fernando Luiz Affonso
   da Veiga, Glaucia Luciano
TI Expression of TNFR1, VEGFA, CD147 and MCT1 as early biomarkers of
   diabetes complications and the impact of aging on this profile
SO SCIENTIFIC REPORTS
LA English
DT Article
ID MONOCARBOXYLATE TRANSPORTERS; INCREASED RISK; KIDNEY; NEPHROPATHY;
   MECHANISMS; RATS; APOPTOSIS; INJURY; INFLAMMATION; PROGRESSION
AB Hyperglycemia leads to microvascular lesions in various tissues. In diabetic nephropathy-DN, alterations in usual markers reflect an already installed disease. The study of new biomarkers for the early detection of diabetic complications can bring new prevention perspectives. Rats were divided into diabetic adult-DMA-or elderly-DME and control sham adult-CSA-or control sham elderly-CSE. Blood and urine samples were collected for biochemical analysis. Bulbar region, cardiac, hepatic and renal tissues were collected for target gene expression studies. As result, DMA showed decreased TNFR1, MCT1 and CD147 expression in the bulbar region, TNFR1 in the heart, VEGFA and CD147 in the kidney and TNFR1 in blood. Positive correlations were found between TNFR1 and MCT1 in the bulbar region and HbA1c and plasma creatinine, respectively. DME showed positive correlation in the bulbar region between TNFR1 and glycemia, in addition to negative correlations between CD147 in the heart versus glycemia and urea. We concluded that the initial hyperglycemic stimulus already promotes changes in the expression of genes involved in the inflammatory and metabolic pathways, and aging alters this profile. These changes prior to the onset of diseases such as DN, show that they have potential for early biomarkers studies.
C1 [Raimundo, Joyce Regina Santos; da Costa Aguiar Alves, Beatriz; Encinas, Jessica Freitas Araujo; Siqueira, Andressa Moreira; de Gois, Katharyna Cardoso; Perez, Matheus Moreira; Fonseca, Fernando Luiz Affonso; da Veiga, Glaucia Luciano] Ctr Univ, Fac Med ABC FMABC, Lab Anal Clin, Ave Lauro Gomes 2000, BR-09060650 Santo Andre, SP, Brazil.
   [Fonseca, Fernando Luiz Affonso] Univ Fed Sao Paulo UNIFESP, Dept Ciencias Farmaceut, Campus Diadema,Rua Prof Artur Riedel 275, BR-09972270 Diadema, SP, Brazil.
   [Petri, Giuliana; dos Santos, Jose Francisco Ramos] Fac Med ABC FMABC, Vivarium & Anim Experimentat Lab, Ave Lauro Gomes 2000, BR-09060650 Santo Andre, SP, Brazil.
C3 Faculdade de Medicina do ABC; Universidade Federal de Sao Paulo
   (UNIFESP); Faculdade de Medicina do ABC
RP Raimundo, JRS (corresponding author), Ctr Univ, Fac Med ABC FMABC, Lab Anal Clin, Ave Lauro Gomes 2000, BR-09060650 Santo Andre, SP, Brazil.
EM joyce.regina@gmail.com
FU CAPES [88887.373913/2019-00]; FAPESP [FAPESP 2018/24808-0]
FX We thank CAPES (88887.373913/2019-00) and FAPESP for the financial
   support (FAPESP 2018/24808-0). Credits to the entire team at the
   clinical analysis laboratory at Centro Universitario FMABC.
CR Amer Diabet Assoc Professional Pra, 2022, DIABETES CARE, V45, pS175, DOI 10.2337/dc22-S011
   Araujo RVDS., 2010, Revista de Ciencias Medicas e Biologicas/J. Med. Biol. Sci, V10, P7, DOI [10.9771/cmbio.v10i1.5046, DOI 10.9771/CMBIO.V10I1.5046]
   Bao W, 2010, AM J PHYSIOL-CELL PH, V299, pC1212, DOI 10.1152/ajpcell.00228.2010
   Barbosa JHP, 2008, ARQ BRAS ENDOCRINOL, V52, P940, DOI 10.1590/S0004-27302008000600005
   Barutta F, 2021, ACTA DIABETOL, V58, P819, DOI 10.1007/s00592-020-01656-9
   Becker HM, 2010, AM J PHYSIOL-RENAL, V299, pF141, DOI 10.1152/ajprenal.00488.2009
   Besseling PJ, 2021, AM J PHYSIOL-RENAL, V320, pF518, DOI 10.1152/ajprenal.00656.2020
   Boddana Preetham, 2009, Nephron Clin Pract, V111 Suppl 1, pc269, DOI 10.1159/000210003
   Brennan E, 2021, NAT REV NEPHROL, V17, P725, DOI 10.1038/s41581-021-00454-y
   Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797
   Cabiati M, 2020, EXP GERONTOL, V133, DOI 10.1016/j.exger.2020.110879
   Carlsson AC, 2014, J AM SOC NEPHROL, V25, P1313, DOI 10.1681/ASN.2013080860
   Casare F., 2008, Avaliacao da funcao renal em ratos suplementados de forma cronica com acidos graxos poliinsaturados
   Cheng L, 2022, RENAL FAILURE, V44, P293, DOI 10.1080/0886022X.2022.2039194
   Chiu PF, 2018, FREE RADICAL RES, V52, P1456, DOI 10.1080/10715762.2018.1523545
   Castro Bárbara Bruna Abreu de, 2014, Braz. J. Nephrol., V36, P139, DOI 10.5935/0101-2800.20140023
   Dear JW, 2007, CRIT CARE MED, V35, P2319, DOI 10.1097/01.CCM.0000281858.44387.A2
   Delanaye P, 2017, NEPHRON, V136, P302, DOI 10.1159/000469669
   Deora AA, 2005, P NATL ACAD SCI USA, V102, P16245, DOI 10.1073/pnas.0504419102
   Derakhshanian H, 2020, ARQ BRAS CARDIOL, V115, P102, DOI 10.36660/abc.20180397
   Di KL, 2022, FRONT BIOENG BIOTECH, V10, DOI 10.3389/fbioe.2022.948757
   dos Santos A., 2016, Analise da frequencia cardiaca de ratos induzidos ao diabetes mellitus tipo 1 e tipo 2
   Dusse L. M. S., 2017, Revista Brasileira de Analise Clinicas
   Enesa K, 2008, J BIOL CHEM, V283, P7036, DOI 10.1074/jbc.M708690200
   Federiuk IF, 2004, COMPARATIVE MED, V54, P252
   Fisel P, 2018, CTS-CLIN TRANSL SCI, V11, P352, DOI 10.1111/cts.12551
   Forbes JM, 2013, PHYSIOL REV, V93, P137, DOI 10.1152/physrev.00045.2011
   Gohda T, 2012, J AM SOC NEPHROL, V23, P516, DOI 10.1681/ASN.2011060628
   Guo Y, 2018, BBA-MOL BASIS DIS, V1864, P238, DOI 10.1016/j.bbadis.2017.09.029
   Güzel A, 2022, ULUS TRAVMA ACIL CER, V28, P344, DOI 10.14744/tjtes.2021.15740
   Halestrap AP, 2012, IUBMB LIFE, V64, P109, DOI 10.1002/iub.572
   Hall J.E., 2020, Guyton and Hall Textbook of Medical Physiology
   Hamid T, 2016, AM J PHYSIOL-HEART C, V311, pH1189, DOI 10.1152/ajpheart.00904.2015
   Jiang HF, 2022, EUR REV MED PHARMACO, V26, P7379, DOI 10.26355/eurrev_202210_30007
   Jing L, 2013, INT J BIOL SCI, V9, P190, DOI 10.7150/ijbs.5844
   Kirk P, 2000, EMBO J, V19, P3896, DOI 10.1093/emboj/19.15.3896
   Klein JD, 2011, COMPR PHYSIOL, V1, P699, DOI 10.1002/cphy.c100030
   Lenzen S, 2008, DIABETOLOGIA, V51, P216, DOI 10.1007/s00125-007-0886-7
   Lerco MM., 2003, Acta Cir. Bras, V18, P132, DOI DOI 10.1590/S0102-86502003000200010
   Li H, 2017, ONCOTARGET, V8, P51331, DOI 10.18632/oncotarget.17376
   Lin CL, 2010, DIABETES, V59, P1915, DOI 10.2337/db09-0663
   Liu L, 2020, RENAL FAILURE, V42, P513, DOI 10.1080/0886022X.2020.1764854
   Lousa I, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23063284
   Ma CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092419
   MacIsaac RJ, 2019, J DIABETES INVEST, V10, P1537, DOI 10.1111/jdi.13061
   Mattisson IY, 2017, EBIOMEDICINE, V26, P187, DOI 10.1016/j.ebiom.2017.11.023
   Min XX, 2020, THERANOSTICS, V10, P8573, DOI 10.7150/thno.44321
   Mohanty S, 2022, CLIN INFECT DIS, V75, P11, DOI 10.1093/cid/ciab907
   Omote K, 2014, AM J PHYSIOL-RENAL, V306, pF1335, DOI 10.1152/ajprenal.00509.2013
   Pang XX, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.921894
   Papazian I, 2021, J NEUROINFLAMM, V18, DOI 10.1186/s12974-021-02200-4
   Pereira W., 2013, Analises bioquimicas, biometricas, histologicas e imunologicas em ratos com nefropatia induzida pela doxorrubicina
   Pérez-Escuredo J, 2016, BBA-MOL CELL RES, V1863, P2481, DOI 10.1016/j.bbamcr.2016.03.013
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Pichler R, 2017, AM J PHYSIOL-RENAL, V312, pF716, DOI 10.1152/ajprenal.00314.2016
   Poulain S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-423
   Rashedinia M, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/8297984
   Sahin I, 2014, EUR REV MED PHARMACO, V18, P2895
   SBD SBdDBSoD, 2019, Guidelines of the Brazilian Society of Diabetes 2019/2020
   Shi JB, 2019, AM J TRANSL RES, V11, P5501
   Silva VDD., 2015, Revista de Ciencias Farmaceuticas Basica e Aplicada/J. Basic Appl. Pharm. Sci, V36, P8
   Sodre LF., 2007, Jornal Brasileiro de Patologia e Medicina Laboratorial, V43, P8
   Takahashi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048974
   Tate M, 2017, DIABETES VASC DIS RE, V14, P423, DOI 10.1177/1479164117710390
   Tesfamichael DH, 2020, J VET DIAGN INVEST, V32, P737, DOI 10.1177/1040638720938026
   Veron D, 2022, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.788886
   Wang NA, 2022, FRONT ENDOCRINOL, V13, DOI 10.3389/fendo.2022.824279
   Xu Lingzhi, 2019, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V35, P217
   Xu TT, 2021, FRONT ENDOCRINOL, V12, DOI 10.3389/fendo.2021.781417
   Yamagata K, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0949-8
   Yanase T, 2018, ENDOCR J, V65, P1, DOI 10.1507/endocrj.EJ17-0390
   Yoshioka T, 2019, AM J PATHOL, V189, P1338, DOI 10.1016/j.ajpath.2019.04.003
   Zeng Y, 2020, CELL CYCLE, V19, P3406, DOI 10.1080/15384101.2020.1838780
   Zhai Y, 2016, J MOL MED, V94, P71, DOI 10.1007/s00109-015-1334-7
   Zhang J, 2018, REV ASSOC MED BRAS, V64, P85, DOI 10.1590/1806-9282.64.01.85
   Zhang Q, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000010415
   Zhao L, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000016723
   Zhao WB, 2020, RENAL FAILURE, V42, P323, DOI 10.1080/0886022X.2020.1745235
   Zhu Xiao-Na, 2018, Nan Fang Yi Ke Da Xue Xue Bao, V38, P296
NR 79
TC 0
Z9 0
U1 5
U2 5
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD OCT 20
PY 2023
VL 13
IS 1
AR 17927
DI 10.1038/s41598-023-41061-0
PG 13
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA U8YH8
UT WOS:001087596300056
PM 37863950
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Mooijaart, SP
   Kuningas, M
   Westendorp, RGJ
   Houwing-Duistermaat, JJ
   Slagboom, PE
   Rensen, PCN
   van Heemst, D
AF Mooijaart, Simon P.
   Kuningas, Maris
   Westendorp, Rudi G. J.
   Houwing-Duistermaat, Jeanine J.
   Slagboom, P. Eline
   Rensen, Patrick C. N.
   van Heemst, Diana
TI Liver X receptor alpha associates with human life span
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
ID NECROSIS-FACTOR-ALPHA; CAENORHABDITIS-ELEGANS; C-ELEGANS;
   INSULIN-RECEPTOR; INNATE IMMUNITY; DAUER FORMATION; OLD-AGE;
   CARDIOVASCULAR MORTALITY; DEVELOPMENTAL AGE; HUMAN LONGEVITY
AB In the nematode Caenorhabditis elegans, nuclear hormone receptor DAF-12 regulates the decision to go into a resistant dauer diapause, in which the worm exhibits a decreased rate of aging. Using sequence similarity searches, we previously identified the liver X receptor alpha (LXR alpha) as one of the human nuclear hormone receptors the protein sequence of which is most similar to C. elegans DAF-12. Here, we studied whether variation in the gene encoding LXR alpha associates with human life span. In the Leiden 85-Plus Study, a population-based prospective follow-up study, we genotyped four polymorphisms spanning the gene coding for LXR alpha (NR1H3) and tagged four common haplotypes. Among 563 participants, haplotype 2 associated with reduced mortality during the 7-year follow-up (hazard ratio 0.78; p = .015), predominantly caused by reduced mortality from infectious disease (hazard ratio 0.31; p = .023). Haplotype 2 also associated with higher levels of plasma apolipoprotein E, a target gene of the LXR alpha (p = .018), and higher levels of triglycerides (p = .041). Genetic variation in the gene coding for the LXR alpha (NR1H3) associates with human life span.
C1 Leiden Univ, Dept Gerontol & Geriatr, Med Ctr, NL-2300 RC Leiden, Netherlands.
   Leiden Univ, Dept Med Stat & Bioinformat, Med Ctr, NL-2300 RC Leiden, Netherlands.
   Leiden Univ, Sect Mol Epidemiol, Med Ctr, NL-2300 RC Leiden, Netherlands.
   Leiden Univ, Dept Gen Internal Med Endocrinol & Metab Dis, Med Ctr, NL-2300 RC Leiden, Netherlands.
   Univ Tartu, Inst Mol & Cell Biol, Dept Biotechnol, EE-50090 Tartu, Estonia.
C3 Leiden University - Excl LUMC; Leiden University; Leiden University
   Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University;
   Leiden University Medical Center (LUMC); Leiden University; Leiden
   University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden
   University; Leiden University Medical Center (LUMC); Leiden University -
   Excl LUMC; University of Tartu
RP Mooijaart, SP (corresponding author), Leiden Univ, Dept Gerontol & Geriatr, Med Ctr, C-2-R,POB 9600, NL-2300 RC Leiden, Netherlands.
RI Kuningas, Maris/A-6280-2009; Houwing-Duistermaat, Jeanne/V-9048-2018;
   Mooijaart, Simon P./A-5306-2008; Rensen, Patrick C.N./D-7176-2018;
   Slagboom, Pieternella/R-4790-2016
OI Mooijaart, Simon P./0000-0003-3106-3568; Rensen, Patrick
   C.N./0000-0002-8455-4988; Houwing-Duistermaat,
   Jeanine/0000-0002-4505-7137; Slagboom, Pieternella/0000-0002-2875-4723
CR Antebi A, 2000, GENE DEV, V14, P1512
   Antebi A, 1998, DEVELOPMENT, V125, P1191
   Barcia AM, 2005, CLIN INFECT DIS, V41, pS498, DOI 10.1086/432005
   Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457
   Blüher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223
   Bootsma-van der Wiel A, 2002, J CLIN EPIDEMIOL, V55, P1119, DOI 10.1016/S0895-4356(02)00505-X
   de Craen AJM, 2005, GENES IMMUN, V6, P167, DOI 10.1038/sj.gene.6364162
   Fisher AL, 2006, AGING CELL, V5, P127, DOI 10.1111/j.1474-9726.2006.00203.x
   Grefhorst A, 2002, J BIOL CHEM, V277, P34182, DOI 10.1074/jbc.M204887200
   Haukim N, 2002, GENES IMMUN, V3, P313, DOI 10.1038/sj.gene.6363881
   Held JM, 2006, AGING CELL, V5, P283, DOI 10.1111/j.1474-9726.2006.00218.x
   Hjelmborg JV, 2006, HUM GENET, V119, P312, DOI 10.1007/s00439-006-0144-y
   Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298
   Janowski BA, 1999, P NATL ACAD SCI USA, V96, P266, DOI 10.1073/pnas.96.1.266
   Jönsson EG, 2003, BIOL PSYCHIAT, V53, P577, DOI 10.1016/S0006-3223(02)01732-8
   Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820
   Joseph SB, 2002, P NATL ACAD SCI USA, V99, P7604, DOI 10.1073/pnas.112059299
   Joseph SB, 2004, CELL, V119, P299, DOI 10.1016/j.cell.2004.09.032
   KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0
   Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942
   KLASS M, 1976, NATURE, V260, P523, DOI 10.1038/260523a0
   Landis MS, 2002, J BIOL CHEM, V277, P4713, DOI 10.1074/jbc.M108807200
   Levin N, 2005, ARTERIOSCL THROM VAS, V25, P135, DOI 10.1161/01.ATV.0000150044.84012.68
   Lu TT, 2001, J BIOL CHEM, V276, P37735, DOI 10.1074/jbc.R100035200
   Mooijaart SP, 2006, PLOS MED, V3, P874, DOI 10.1371/journal.pmed.0030176
   Mooijaart SP, 2005, AGEING RES REV, V4, P351, DOI 10.1016/j.arr.2005.03.006
   Motola DL, 2006, CELL, V124, P1209, DOI 10.1016/j.cell.2006.01.037
   Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4
   Rensen PCN, 1997, J CLIN INVEST, V99, P2438, DOI 10.1172/JCI119427
   Repa JJ, 2002, NAT MED, V8, P1243, DOI 10.1038/nm1102-1243
   Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524
   Rottiers V, 2006, DEV CELL, V10, P473, DOI 10.1016/j.devcel.2006.02.008
   Schoenmaker M, 2006, EUR J HUM GENET, V14, P79, DOI 10.1038/sj.ejhg.5201508
   Tangirala RK, 2002, P NATL ACAD SCI USA, V99, P11896, DOI 10.1073/pnas.182199799
   Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987
   van den Biggelaar AHJ, 2004, FASEB J, V18, P1022, DOI 10.1096/fj.03-1162fje
   van den Biggelaar AHJ, 2004, EXP GERONTOL, V39, P1407, DOI 10.1016/j.exger.2004.06.009
   van den Elzen P, 2005, NATURE, V437, P906, DOI 10.1038/nature04001
   van der Linden MW, 1998, J IMMUNOL METHODS, V218, P63, DOI 10.1016/S0022-1759(98)00108-2
   van Heemst D, 2005, AGING CELL, V4, P79, DOI 10.1111/j.1474-9728.2005.00148.x
   VANVLIJMEN BJM, 1994, J CLIN INVEST, V93, P1403, DOI 10.1172/JCI117117
   WeverlingRijnsburger AWE, 1997, LANCET, V350, P1119, DOI 10.1016/S0140-6736(97)04430-9
NR 42
TC 19
Z9 19
U1 0
U2 4
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
EI 1758-535X
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD APR
PY 2007
VL 62
IS 4
BP 343
EP 349
DI 10.1093/gerona/62.4.343
PG 7
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA 228WN
UT WOS:000250763400001
PM 17452725
OA Green Submitted, Bronze
DA 2024-02-19
ER

PT J
AU Tannapfel, A
   Benicke, M
   Katalinic, A
   Uhlmann, D
   Köckerling, F
   Hauss, J
   Wittekind, C
AF Tannapfel, A
   Benicke, M
   Katalinic, A
   Uhlmann, D
   Köckerling, F
   Hauss, J
   Wittekind, C
TI Frequency of p16<SUP>INK4A</SUP> alterations and k-<i>ras</i> mutations
   in intrahepatic cholangiocarcinoma of the liver
SO GUT
LA English
DT Article
DE cholangiocarcinoma; p16; K-ras; histopathology; prognosis; methylation
ID PRIMARY SCLEROSING CHOLANGITIS; HEPATOCELLULAR-CARCINOMA; ONCOGENIC RAS;
   CANCER; P53; SENESCENCE; EXPRESSION; GENES; ELECTROPHORESIS;
   TRANSFORMATION
AB Background-Inactivation of the tumour suppressor gene p16 (CDKN2/MTS-1/INK4A) and K-ras mutations are among the most frequent genetic alterations in human malignancies.
   Aims-To investigate the tumour suppressor gene p16 and its possible association with K-ras mutations in intrahepatic cholangiocarcinomas of the liver.
   Methods-The status of p16 was evaluated in 41 cholangiocarcinomas by methylation specific polymerase chain reaction, microsatellite analysis, DNA sequencing, and immunohistochemical staining. K-ras mutations were determined by direct DNA sequencing analyses after microdissection. The results obtained were correlated with histopathological variables and patient survival.
   Results-Hypermethylation of the 5' CpG island of the p16 gene was found in 34 of 41 (83%) carcinomas. Homozygous deletion at the p16 region was present in two (5%), and loss of heterozygosity (LOH) in eight cases (20%). We failed to detect p16 gene missense mutations. K-ras mutations were found in 22 of 41 (54%) cholangiocarcinomas and in two cases of tumour surrounding non-neoplastic liver tissue. All 22 cancers with K-ras mutations also exhibited methylated p16. We failed to observe a correlation between K-ras or p16 status and histopathological factors or prognosis of patients.
   Conclusion-These data suggest that inactivation of the p16 gene is a frequent event in cholangiocarcinoma. The most common somatic alteration is promotor methylation of the p16 gene which is closely associated with K-ras mutations. We failed to establish p16 or K-ras status as independent prognostic factors in these tumours.
C1 Univ Leipzig, Inst Pathol, D-04103 Leipzig, Germany.
   Univ Lubeck, Inst Canc Epidemiol, D-23564 Lubeck, Germany.
   Univ Leipzig, Dept Surg 2, D-04103 Leipzig, Germany.
   Surg Clin Hannover, Dept Surg, D-30449 Hannover, Germany.
C3 Leipzig University; University of Lubeck; Leipzig University
RP Tannapfel, A (corresponding author), Univ Leipzig, Inst Pathol, Liebigstr 26, D-04103 Leipzig, Germany.
RI Katalinic, Alexander/D-2512-2010
OI Katalinic, Alexander/0000-0003-0490-1554
CR Ahrendt SA, 1999, J SURG RES, V84, P88, DOI 10.1006/jsre.1999.5615
   Andreyev HJN, 1997, GUT, V41, P323, DOI 10.1136/gut.41.3.323
   Bjorheim J, 1998, MUTAT RES-FUND MOL M, V403, P103, DOI 10.1016/S0027-5107(98)00057-8
   Brierley J., 2017, TNM Classification of Malignant Tumours
   Chaubert P, 1997, HEPATOLOGY, V25, P1376, DOI 10.1002/hep.510250613
   Deng C, 1998, BIOL CHEM, V379, P1113, DOI 10.1515/bchm.1998.379.8-9.1113
   Dogliotti E, 1998, RECENT RES CANCER, V154, P97
   Guan RJ, 1999, GASTROENTEROLOGY, V116, P1063, DOI 10.1016/S0016-5085(99)70009-0
   HUSSUSSIAN CJ, 1994, NAT GENET, V8, P15, DOI 10.1038/ng0994-15
   ISHAK T, 1994, HISTOLOGICAL TYPING
   KIBA T, 1993, MOL CARCINOG, V8, P321
   Kjoller L, 1999, EXP CELL RES, V253, P166, DOI 10.1006/excr.1999.4674
   Liew CT, 1999, ONCOGENE, V18, P789, DOI 10.1038/sj.onc.1202359
   MACLEOD AR, 1995, J BIOL CHEM, V270, P1337
   Matsuda Y, 1999, GASTROENTEROLOGY, V116, P394, DOI 10.1016/S0016-5085(99)70137-X
   MORRIN M, 1994, GUT, V35, P1627, DOI 10.1136/gut.35.11.1627
   NIGAM AK, 1994, GUT, V35, P996, DOI 10.1136/gut.35.7.996
   Pantoja C, 1999, ONCOGENE, V18, P4974, DOI 10.1038/sj.onc.1202880
   Rashid A, 1999, GUT, V44, P826, DOI 10.1136/gut.44.6.826
   Rizzi PM, 1996, GUT, V38, P265, DOI 10.1136/gut.38.2.265
   Roussel MF, 1999, ONCOGENE, V18, P5311, DOI 10.1038/sj.onc.1202998
   Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9
   SERRANO M, 1995, SCIENCE, V267, P249, DOI 10.1126/science.7809631
   Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X
   SOMAN NR, 1993, P NATL ACAD SCI USA, V90, P2045, DOI 10.1073/pnas.90.5.2045
   Tannapfel A, 1999, J NATL CANCER I, V91, P1154, DOI 10.1093/jnci/91.13.1154
   Tannapfel A, 1999, BRIT J CANCER, V80, P1069, DOI 10.1038/sj.bjc.6690465
   Wei S, 1999, CANCER RES, V59, P1539
   Wittekind C., 1995, PROGNOSTIC FACTORS C, P88
NR 29
TC 166
Z9 169
U1 0
U2 7
PU BRITISH MED JOURNAL PUBL GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0017-5749
J9 GUT
JI Gut
PD NOV
PY 2000
VL 47
IS 5
BP 721
EP 727
DI 10.1136/gut.47.5.721
PG 7
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 368BD
UT WOS:000090096900023
PM 11034592
OA Green Published, Bronze, Green Submitted
DA 2024-02-19
ER

PT J
AU Bejarano, E
   Murray, JW
   Wang, XT
   Pampliega, O
   Yin, D
   Patel, B
   Yuste, A
   Wolkoff, AW
   Cuervo, AM
AF Bejarano, Eloy
   Murray, John W.
   Wang, Xintao
   Pampliega, Olatz
   Yin, David
   Patel, Bindi
   Yuste, Andrea
   Wolkoff, Allan W.
   Cuervo, Ana Maria
TI Defective recruitment of motor proteins to autophagic compartments
   contributes to autophagic failure in aging
SO AGING CELL
LA English
DT Article
DE autophagosomes; autophagy; dynein; intracellular traffic; lysosomes;
   molecular motors; vesicles
ID AGE-RELATED-CHANGES; RAT-LIVER; DYNEIN; LIPOFUSCIN; ACCUMULATION;
   CYTOSKELETON; LYSOSOMES; TRANSPORT; FUSION; CELL
AB Inability to preserve proteostasis with age contributes to the gradual loss of function that characterizes old organisms. Defective autophagy, a component of the proteostasis network for delivery and degradation of intracellular materials in lysosomes, has been described in multiple old organisms, while a robust autophagy response has been linked to longevity. The molecular mechanisms responsible for defective autophagic function with age remain, for the most part, poorly characterized. In this work, we have identified differences between young and old cells in the intracellular trafficking of the vesicular compartments that participate in autophagy. Failure to reposition autophagosomes and lysosomes toward the perinuclear region with age reduces the efficiency of their fusion and the subsequent degradation of the sequestered cargo. Hepatocytes from old mice display lower association of two microtubule-based minus-end-directed motor proteins, the well-characterized dynein, and the less-studied KIFC3, with autophagosomes and lysosomes, respectively. Using genetic approaches to mimic the lower levels of KIFC3 observed in old cells, we confirmed that reduced content of this motor protein in fibroblasts leads to failed lysosomal repositioning and diminished autophagic flux. Our study connects defects in intracellular trafficking with insufficient autophagy in old organisms and identifies motor proteins as a novel target for future interventions aiming at correcting autophagic activity with anti-aging purposes.
C1 [Bejarano, Eloy; Patel, Bindi; Yuste, Andrea; Cuervo, Ana Maria] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY USA.
   [Bejarano, Eloy; Patel, Bindi; Yuste, Andrea; Cuervo, Ana Maria] Albert Einstein Coll Med, Inst Aging Studies, Bronx, NY USA.
   [Murray, John W.; Wang, Xintao; Yin, David; Wolkoff, Allan W.; Cuervo, Ana Maria] Albert Einstein Coll Med, Marion Bessin Liver Res Ctr, Bronx, NY USA.
   [Murray, John W.; Wang, Xintao; Wolkoff, Allan W.; Cuervo, Ana Maria] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA.
   [Pampliega, Olatz] Univ Bordeaux, UMR5293, Inst Malad Neurodegnerat, Bordeaux, France.
   [Pampliega, Olatz] CNRS, Inst Malad Neurodegerat, UMR 5293, Bordeaux C, France.
   [Wolkoff, Allan W.] Albert Einstein Coll Med, Div Hepatol, Bronx, NY USA.
   [Wolkoff, Allan W.] Montefiore Med Ctr, Bronx, NY USA.
C3 Yeshiva University; Albert Einstein College of Medicine; Yeshiva
   University; Albert Einstein College of Medicine; Yeshiva University;
   Albert Einstein College of Medicine; Yeshiva University; Albert Einstein
   College of Medicine; Universite de Bordeaux; Centre National de la
   Recherche Scientifique (CNRS); CNRS - National Institute for Biology
   (INSB); Centre National de la Recherche Scientifique (CNRS); Yeshiva
   University; Albert Einstein College of Medicine; Yeshiva University;
   Albert Einstein College of Medicine; Montefiore Medical Center
RP Wolkoff, AW (corresponding author), Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA.; Bejarano, E (corresponding author), JeanMayer USDA Human Nutr Res Ctr Aging, Lab Nutr & Vision Res, Boston, MA 02111 USA.
EM Eloy.Bejarano@tufts.edu; allan.wolkoff@einstein.yu.edu
RI Bejarano, Eloy/AAJ-4708-2021; Pampliega, Olatz/K-9037-2019; Pampliega,
   Olatz/A-9204-2015
OI Bejarano, Eloy/0000-0001-8390-1581; Pampliega,
   Olatz/0000-0002-7924-6374; Pampliega, Olatz/0000-0002-7924-6374; Murray,
   John/0000-0002-4347-7824
FU Glenn Foundation for Medical Research [Einstein P-2]; National Institute
   of Diabetes and Digestive and Kidney Diseases [DK098408]; National
   Institute on Aging [AG054108, AG021904, AG031782]
FX Glenn Foundation for Medical Research, Grant/Award Number: Einstein P-2;
   National Institute of Diabetes and Digestive and Kidney Diseases,
   Grant/Award Number: DK098408; National Institute on Aging, Grant/Award
   Number: AG054108, AG021904, AG031782
CR Alesutan I, 2015, KIDNEY BLOOD PRESS R, V40, P490, DOI 10.1159/000368524
   Bejarano E, 2014, NAT CELL BIOL, V16, P401, DOI 10.1038/ncb2934
   Bergamini E., 1990, PROTEIN METABOLISM A, V9, P361
   Bitto A, 2014, AGE, V36, P1123, DOI 10.1007/s11357-014-9626-3
   Cardoso CMP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004424
   Cavallini G, 2001, EXP GERONTOL, V36, P497, DOI 10.1016/S0531-5565(00)00224-2
   Chang JT, 2017, ELIFE, V6, DOI 10.7554/eLife.18459
   Cuervo AM, 2008, TRENDS GENET, V24, P604, DOI 10.1016/j.tig.2008.10.002
   Dietrich D, 2013, BBA-MOL CELL RES, V1833, P3013, DOI 10.1016/j.bbamcr.2013.08.002
   Donati A, 2001, J GERONTOL A-BIOL, V56, pB375, DOI 10.1093/gerona/56.9.B375
   Fu MM, 2014, DEV CELL, V29, P577, DOI 10.1016/j.devcel.2014.04.015
   Galluzzi L, 2017, EMBO J, V36, P1811, DOI 10.15252/embj.201796697
   García-Prat L, 2016, NATURE, V529, P37, DOI 10.1038/nature16187
   Geeraert C, 2010, J BIOL CHEM, V285, P24184, DOI 10.1074/jbc.M109.091553
   Gourlay CW, 2004, J CELL BIOL, V164, P803, DOI 10.1083/jcb.200310148
   Hara K, 1997, J BIOL CHEM, V272, P26457, DOI 10.1074/jbc.272.42.26457
   HAYASAKA S, 1989, JPN J OPHTHALMOL, V33, P36
   Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774
   Huynh KK, 2007, EMBO J, V26, P313, DOI 10.1038/sj.emboj.7601511
   IVY GO, 1984, SCIENCE, V226, P985, DOI 10.1126/science.6505679
   Jahreiss L, 2008, TRAFFIC, V9, P574, DOI 10.1111/j.1600-0854.2008.00701.x
   Katayama H, 2011, CHEM BIOL, V18, P1042, DOI 10.1016/j.chembiol.2011.05.013
   Katsumata K, 2010, AUTOPHAGY, V6, P378, DOI 10.4161/auto.6.3.11262
   Kaushik S, 2015, NAT MED, V21, P1406, DOI 10.1038/nm.4001
   Kennedy BK, 2014, CELL, V159, P708, DOI 10.1016/j.cell.2014.10.039
   Kimura N, 2016, AM J PATHOL, V186, P1952, DOI 10.1016/j.ajpath.2016.03.006
   Kimura S, 2008, CELL STRUCT FUNCT, V33, P109, DOI 10.1247/csf.08005
   Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451
   Kitani K, 1999, MECH AGEING DEV, V107, P299, DOI 10.1016/S0047-6374(98)00139-0
   Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845
   Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356
   Koga H, 2010, AUTOPHAGY, V6, P825, DOI 10.1096/fj.09-144519
   Koga H, 2011, AGEING RES REV, V10, P205, DOI 10.1016/j.arr.2010.02.001
   Komatsu M, 2007, P NATL ACAD SCI USA, V104, P14489, DOI 10.1073/pnas.0701311104
   Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723
   Korolchuk VI, 2011, NAT CELL BIOL, V13, P453, DOI 10.1038/ncb2204
   Levine B, 2017, P NATL ACAD SCI USA, V114, P201, DOI 10.1073/pnas.1619876114
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Lucanus AJ, 2018, ONCOGENE, V37, P833, DOI 10.1038/onc.2017.406
   Mackeh R, 2013, J CELL SCI, V126, P1071, DOI 10.1242/jcs.115626
   Madeo F, 2015, J CLIN INVEST, V125, P85, DOI 10.1172/JCI73946
   MARZELLA L, 1982, J CELL BIOL, V93, P144, DOI 10.1083/jcb.93.1.144
   Maxwell MM, 2011, HUM MOL GENET, V20, P3986, DOI 10.1093/hmg/ddr326
   Menzies FM, 2017, NEURON, V93, P1015, DOI 10.1016/j.neuron.2017.01.022
   Mitchell SJ, 2016, CELL METAB, V23, P1093, DOI 10.1016/j.cmet.2016.05.027
   Monastyrska I, 2009, BIOL REV, V84, P431, DOI 10.1111/j.1469-185X.2009.00082.x
   Murray John W, 2007, Methods Mol Biol, V392, P143
   Nakano M, 1995, GERONTOLOGY, V41, P69
   Pampliega O, 2013, NATURE, V502, P194, DOI 10.1038/nature12639
   Park SK, 2016, NUTR RES PRACT, V10, P3, DOI 10.4162/nrp.2016.10.1.3
   Perluigi M, 2015, NEUROBIOL DIS, V84, P39, DOI 10.1016/j.nbd.2015.03.014
   RAES M, 1987, EXP GERONTOL, V22, P47, DOI 10.1016/0531-5565(87)90014-3
   Randall TS, 2017, P NATL ACAD SCI USA, V114, P13738, DOI 10.1073/pnas.1715115115
   ROTTEM S, 1975, J BACTERIOL, V121, P631, DOI 10.1128/JB.121.2.631-639.1975
   Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030
   Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823
   SAKAI M, 1989, J ELECTRON MICR TECH, V12, P101, DOI 10.1002/jemt.1060120206
   Schatten H, 1999, J CELL BIOCHEM, V74, P229, DOI 10.1002/(SICI)1097-4644(19990801)74:2<229::AID-JCB9>3.3.CO;2-R
   Schiavi A, 2014, EXP GERONTOL, V56, P147, DOI 10.1016/j.exger.2014.02.015
   Stupina A. S., 1994, Tsitologiya i Genetika, V28, P15
   Sun WB, 1998, WORLD J GASTROENTERO, V4, P77
   TAUCHI H, 1980, MECH AGEING DEV, V12, P183, DOI 10.1016/0047-6374(80)90094-9
   Terman A, 1995, GERONTOLOGY, V41, P319
   Toda H, 2008, GENE DEV, V22, P3292, DOI 10.1101/gad.1734608
   Tormos AM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171738
   Venere M, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac6762
   Wiesner D, 2015, HUM MOL GENET, V24, P2228, DOI 10.1093/hmg/ddu741
   Xu M, 2014, J CELL MOL MED, V18, P2165, DOI 10.1111/jcmm.12326
   Zaarur N, 2014, MOL CELL BIOL, V34, P1336, DOI 10.1128/MCB.00103-14
NR 69
TC 28
Z9 29
U1 1
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
EI 1474-9726
J9 AGING CELL
JI Aging Cell
PD AUG
PY 2018
VL 17
IS 4
AR e12777
DI 10.1111/acel.12777
PG 18
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA GO2AU
UT WOS:000439767700022
PM 29845728
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Tang, LX
   Li, DK
   Ma, YDY
   Cui, FP
   Wang, JN
   Tian, YH
AF Tang, Linxi
   Li, Dankang
   Ma, Yudiyang
   Cui, Feipeng
   Wang, Jianing
   Tian, Yaohua
TI The association between telomere length and non-alcoholic fatty liver
   disease: a prospective study
SO BMC MEDICINE
LA English
DT Article
DE Telomere length; Genetic susceptibility; Air pollution; Lifestyle;
   Non-alcoholic fatty liver disease
ID USE REGRESSION-MODELS; MEDIATION ANALYSIS; DYSFUNCTION; EXPOSURE;
   DIETARY; RISK; SENESCENCE; SURVIVAL; THERAPY; IMPACT
AB BackgroundResearch on the association between telomere length (TL) and incident non-alcoholic fatty liver disease (NAFLD) is limited. This study examined this association and further assessed how TL contributes to the association of NAFLD with its known risk factors.MethodsQuantitative PCR (polymerase chain reaction) was employed to assess leucocyte telomere length. Polygenic risk score (PRS) for NAFLD, air pollution score, and lifestyle index were constructed. Cox proportional hazard models were conducted to estimate the hazard ratios (HRs) and 95% confidence intervals.ResultsAmong 467,848 participants in UK Biobank, we identified 4809 NAFLD cases over a median follow-up of 12.83 years. We found that long TL was associated with decreased risk of incident NAFLD, as each interquartile range increase in TL resulted in an HR of 0.93 (95% CI 0.89, 0.96). TL partly mediated the association between age and NAFLD (proportion mediated: 15.52%). When assessing the joint effects of TL and other risk factors, the highest risk of NAFLD was found in participants with low TL and old age, low TL and high air pollution score, low TL and unfavorable lifestyle, and low TL and high PRS, compared to each reference group. A positive addictive interaction was observed between high PRS and low TL, accounting for 14.57% (2.51%, 27.14%) of the risk of NAFLD in participants with low telomere length and high genetic susceptibility.ConclusionsLong telomere length was associated with decreased risk of NAFLD incidence. Telomere length played an important role in NAFLD.
C1 [Tang, Linxi; Li, Dankang; Ma, Yudiyang; Cui, Feipeng; Wang, Jianing; Tian, Yaohua] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Minist Educ,Key Lab Environm & Hlth, 13 Hangkong Rd, Wuhan 430030, Peoples R China.
   [Tang, Linxi; Li, Dankang; Ma, Yudiyang; Cui, Feipeng; Wang, Jianing; Tian, Yaohua] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, State Key Lab Environm Hlth Incubating,Minist Educ, 13 Hangkong Rd, Wuhan 430030, Peoples R China.
   [Tang, Linxi; Li, Dankang; Ma, Yudiyang; Cui, Feipeng; Wang, Jianing; Tian, Yaohua] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Maternal & Child Hlth, 13 Hangkong Rd, Wuhan 430030, Peoples R China.
   [Tian, Yaohua] Chinese Acad Med Sci, Peking Union Med Coll, Sch Populat Med & Publ Hlth, 31 Beijige 3, Beijing 100730, Peoples R China.
C3 Huazhong University of Science & Technology; Huazhong University of
   Science & Technology; Huazhong University of Science & Technology;
   Chinese Academy of Medical Sciences - Peking Union Medical College;
   Peking Union Medical College
RP Tian, YH (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Minist Educ,Key Lab Environm & Hlth, 13 Hangkong Rd, Wuhan 430030, Peoples R China.; Tian, YH (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, State Key Lab Environm Hlth Incubating,Minist Educ, 13 Hangkong Rd, Wuhan 430030, Peoples R China.; Tian, YH (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Maternal & Child Hlth, 13 Hangkong Rd, Wuhan 430030, Peoples R China.; Tian, YH (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Sch Populat Med & Publ Hlth, 31 Beijige 3, Beijing 100730, Peoples R China.
EM yaohua_tian@hust.edu.cn
FU We are grateful to all the staff and participants in the UK Biobank for
   their contributions to this study. This research has been conducted
   using the UK Biobank resource under application number 69741. [69741]
FX We are grateful to all the staff and participants in the UK Biobank for
   their contributions to this study. This research has been conducted
   using the UK Biobank resource under application number 69741.
CR Abul-Husn NS, 2018, NEW ENGL J MED, V378, P1096, DOI 10.1056/NEJMoa1712191
   Alexander M, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1321-x
   Alves-Paiva RM, 2018, LIVER INT, V38, P144, DOI 10.1111/liv.13529
   Alwahsh SM, 2017, ARCH TOXICOL, V91, P1545, DOI 10.1007/s00204-016-1892-7
   Anstee QM, 2020, J HEPATOL, V73, P505, DOI 10.1016/j.jhep.2020.04.003
   Aravinthan A, 2013, J HEPATOL, V58, P549, DOI 10.1016/j.jhep.2012.10.031
   Bär C, 2015, HAEMATOLOGICA, V100, P1267, DOI 10.3324/haematol.2015.129239
   Bär C, 2016, BLOOD, V127, P1770, DOI 10.1182/blood-2015-08-667485
   Batty GD, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m131
   Beelen R, 2013, ATMOS ENVIRON, V72, P10, DOI 10.1016/j.atmosenv.2013.02.037
   Blackburn EH, 2000, NATURE, V408, P53, DOI 10.1038/35040500
   BLANE D, 1989, BRIT J SOCIOL, V40, P344, DOI 10.2307/590279
   Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466
   Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z
   Chalasani N, 2012, GASTROENTEROLOGY, V142, P1592, DOI 10.1053/j.gastro.2012.04.001
   Chen Lin, 2024, J Hepatol, V80, pe64, DOI 10.1016/j.jhep.2023.08.021
   Codd V, 2021, A major population resource of 474,074 participants in UK Biobank to investigate determinants and biomedical consequences of leukocyte telomere length
   Cui FP, 2023, EUR RESPIR J, V61, DOI 10.1183/13993003.00777-2022
   Daniali L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2602
   Duell PB, 2022, ARTERIOSCL THROM VAS, V42, pE168, DOI 10.1161/ATV.0000000000000153
   Eeftens M, 2012, ENVIRON SCI TECHNOL, V46, P11195, DOI 10.1021/es301948k
   Fry A, 2017, AM J EPIDEMIOL, V186, P1026, DOI 10.1093/aje/kwx246
   Guo W, 2022, NUTRIENTS, V14, DOI 10.3390/nu14245335
   Hagstrom Hannes, 2024, J Hepatol, V80, pe76, DOI 10.1016/j.jhep.2023.08.026
   Hagström H, 2021, HEPATOLOGY, V74, P474, DOI 10.1002/hep.31726
   Hardy T, 2016, ANNU REV PATHOL-MECH, V11, P451, DOI 10.1146/annurev-pathol-012615-044224
   Haycock PC, 2017, JAMA ONCOL, V3, P636, DOI 10.1001/jamaoncol.2016.5945
   Huang YQ, 2021, AM J RESP CRIT CARE, V204, P817, DOI 10.1164/rccm.202011-4063OC
   Korkiakoski A, 2022, SCAND J CLIN LAB INV, V82, P173, DOI 10.1080/00365513.2022.2059698
   Laish I, 2016, CYTOGENET GENOME RES, V150, P93, DOI 10.1159/000454654
   Li FR, 2023, LIVER INT, V43, P299, DOI 10.1111/liv.15416
   Li RL, 2007, ANN EPIDEMIOL, V17, P227, DOI 10.1016/j.annepidem.2006.10.009
   Li X, 2021, PLOS MED, V18, DOI 10.1371/journal.pmed.1003767
   Lin SD, 2018, NATURE, V556, P244, DOI 10.1038/s41586-018-0004-7
   Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Mahdessian H, 2014, P NATL ACAD SCI USA, V111, P8913, DOI 10.1073/pnas.1323785111
   Mozaffarian D, 2016, CIRCULATION, V133, P187, DOI 10.1161/CIRCULATIONAHA.115.018585
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Ooi DSQ, 2021, PEDIATR OBES, V16, DOI 10.1111/ijpo.12771
   Paik JM, 2020, HEPATOLOGY, V72, P1605, DOI 10.1002/hep.31173
   Papatheodoridi AM, 2020, HEPATOLOGY, V71, P363, DOI 10.1002/hep.30834
   Perazzo Hugo, 2024, J Hepatol, V80, pe72, DOI 10.1016/j.jhep.2023.08.025
   Petermann-Rocha F, 2023, BMC MED, V21, DOI 10.1186/s12916-023-02793-y
   Petermann-Rocha F, 2022, J HEPATOL, V76, P1021, DOI 10.1016/j.jhep.2022.01.010
   Powell EE, 2021, LANCET, V397, P2212, DOI 10.1016/S0140-6736(20)32511-3
   Riazi K, 2022, LANCET GASTROENTEROL, V7, P851, DOI 10.1016/S2468-1253(22)00165-0
   Rinella ME, 2023, HEPATOLOGY, V78, P1966, DOI 10.1097/HEP.0000000000000520
   Rossiello F, 2022, NAT CELL BIOL, V24, P135, DOI 10.1038/s41556-022-00842-x
   Rudolph KL, 2000, SCIENCE, V287, P1253, DOI 10.1126/science.287.5456.1253
   Schneider CV, 2022, JAMA INTERN MED, V182, P291, DOI 10.1001/jamainternmed.2021.7804
   Shin HK, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-97385-2
   Smirne C., 2022, Livers, V2, P30, DOI 10.3390/livers2010003
   Song Sherlot Juan, 2024, J Hepatol, V80, pe54, DOI 10.1016/j.jhep.2023.07.021
   Townsley DM, 2016, NEW ENGL J MED, V374, P1922, DOI 10.1056/NEJMoa1515319
   Trenell MI, 2015, J HEPATOL, V63, P1064, DOI 10.1016/j.jhep.2015.08.009
   Valeri L, 2015, EPIDEMIOLOGY, V26, pE23, DOI 10.1097/EDE.0000000000000253
   Valeri L, 2013, PSYCHOL METHODS, V18, P137, DOI 10.1037/a0031034
   Wang MY, 2021, EUR HEART J, V42, P1582, DOI 10.1093/eurheartj/ehaa1031
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
   Wilman HR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172921
   Wojcicki JM, 2017, INT J HEPATOL, V2017, DOI 10.1155/2017/8435178
   Zhang M, 2019, CHINESE MED J-PEKING, V132, P2927, DOI 10.1097/CM9.0000000000000559
NR 63
TC 0
Z9 0
U1 7
U2 7
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1741-7015
J9 BMC MED
JI BMC Med.
PD NOV 9
PY 2023
VL 21
IS 1
AR 427
DI 10.1186/s12916-023-03136-7
PG 13
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA X3HS7
UT WOS:001097402800001
PM 37940980
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Catalano, D
   Trovato, GM
   Ragusa, A
   Martines, GF
   Tonzuso, A
   Pirri, C
   Buccheri, MA
   Trovato, FM
AF Catalano, D.
   Trovato, G. M.
   Ragusa, A.
   Martines, G. F.
   Tonzuso, A.
   Pirri, C.
   Buccheri, M. A.
   Trovato, F. M.
TI Non-alcoholic fatty liver disease (NAFLD) and MTHFR 1298A &gt; C gene
   polymorphism
SO EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
LA English
DT Article
DE Homocysteine; Fatty liver; Mediterranean diet; Genetic MTHFR
   polymorphism; Insulin resistance; Obesity
ID CHRONIC HEPATITIS-C; METHYLENETETRAHYDROFOLATE REDUCTASE POLYMORPHISM;
   COLORECTAL-CANCER RISK; INSULIN-RESISTANCE; MEDITERRANEAN DIET;
   ALCOHOL-CONSUMPTION; C677T POLYMORPHISM; STEATOSIS; FOLATE; ASSOCIATION
AB INTRODUCTION: Non-Alcoholic Fatty Liver Disease (NAFLD) is related to unhealthy habits, mainly to unfavorable dietary profiles. MTHFR gene encodes MethyleneTetraHydroFolate Reductase, a regulatory enzyme whose polymorphisms are associated with hyperhomocysteinemia. Among polymorphisms, C677T, a thermolabile form, but not A1298C, thermostable, was associated with fatty liver and insulin resistance.
   AIM: to investigate if NAFLD, in subjects referred for nutritional assessment and counselling, has any difference of prevalence and severity when associated with isolated MTHFR A1298C polymorphism and hyperhomocysteinemia.
   PATIENTS AND METHODS: 94 subjects, age 55.65 +/- 15.43 years, BMI 27.88 +/- 5.17 kg/m(2), 26 with MTHFR Wild type genotype (1298AA) and 68 with MTHFRA1298C single polymorphism were studied: of them, 35 were homozygous (MTHFR1298CC), 33 were heterozygous (MHTFR 1298AC). Insulin resistance was assessed by HOMA-IR, NAFLD by UltraSound Brigh-Liver-Score (BLS).
   RESULTS: MTHFR subgroups (wild and A1298C single polymorphism) were not different for age, gender, dietary profile and BMI. In NAFLD, MTHFR 1298AC (heterozygous) vs. homozygous wild genotype (MTHFR 1298AA) patients had more severe NAFLD (BLS: 1.12 +/- 1.14 vs. 0.54 +/- 0.76, p < 0.029), greater insulin resistance (HOMA 3.20 +/- 2.35 vs. 2.12 +/- 1.12; p < 0.036), higher AST and gammaGT.
   CONCLUSIONS: MTHFR1298AC gene heterozygous polymorphisms can be weakly predictive for NAFLD severity. This mutation occurs frequently in populations with low prevalence of overall mortality and of atherosclerosis-associated disease: it could have maintained and maintain its persistence by an heterozygosis advantage mechanism, within significant adherence to healthy nutritional profiles. Interactions of nutrition, genetics and health are a part of the aging process throughout the life span and a greater consideration to the genetic characteristics of populations and individuals is warranted.
C1 [Catalano, D.; Trovato, G. M.; Tonzuso, A.; Pirri, C.; Buccheri, M. A.; Trovato, F. M.] Univ Catania, Dept Med & Pediat Sci, Catania, Italy.
   [Ragusa, A.; Buccheri, M. A.] AOU & Policlin, Catania, Italy.
   [Martines, G. F.] AOU & Policlin, Internal & Emergency Med Dept, Catania, Italy.
C3 University of Catania
RP Trovato, FM (corresponding author), Univ Catania, Dept Med & Pediat Sci, Catania, Italy.
EM trovato.eu@gmail.com
OI Trovato, Francesca Maria/0000-0002-8048-1646; Trovato, Guglielmo
   M/0000-0002-1168-1919
CR Adinolfi LE, 2005, HEPATOLOGY, V41, P995, DOI 10.1002/hep.20664
   Allen LH, 2008, FOOD NUTR BULL, V29, pS20, DOI 10.1177/15648265080292S105
   Anstee QM, 2011, SEMIN LIVER DIS, V31, P128, DOI 10.1055/s-0031-1276643
   Blom HJ, 2001, EUR J CLIN INVEST, V31, P6, DOI 10.1046/j.1365-2362.2001.00759.x
   Bravata DM, 2007, JAMA-J AM MED ASSOC, V298, P2296, DOI 10.1001/jama.298.19.2296
   Catalano D, 2008, LIVER INT, V28, P1280, DOI 10.1111/j.1478-3231.2008.01742.x
   Catalano D, 2011, HEPATOL INT, V5, P822, DOI 10.1007/s12072-011-9254-2
   Chen J, 1996, CANCER RES, V56, P4862
   COLEMAN DL, 1979, SCIENCE, V203, P663, DOI 10.1126/science.760211
   Dai J, 2008, AM J CLIN NUTR, V88, P1364, DOI 10.3945/ajcn.2008.26528
   de Jonge R, 2009, BLOOD, V113, P2284, DOI 10.1182/blood-2008-07-165928
   Dedoussis GV, 2004, AM J CLIN NUTR, V80, P849, DOI 10.1093/ajcn/80.4.849
   Dorner TE, 2012, INT J CARDIOL, V155, P56, DOI 10.1016/j.ijcard.2011.01.076
   Fabris C, 2009, ALCOHOL CLIN EXP RES, V33, P102, DOI 10.1111/j.1530-0277.2008.00816.x
   Ferenci P, 2011, J HEPATOL, V55, P753, DOI 10.1016/j.jhep.2011.02.025
   Fimognari FL, 2008, INTERN EMERG MED, V3, P213, DOI 10.1007/s11739-008-0128-0
   FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111
   Guéant-Rodriguez RM, 2006, AM J CLIN NUTR, V83, P701, DOI 10.1093/ajcn.83.3.701
   Gupta AC, 2011, HEPATOL INT, V5, P575, DOI 10.1007/s12072-010-9225-z
   Harmon RC, 2009, LIVER INT, V29, P4, DOI 10.1111/j.1478-3231.2008.01959.x
   Hu KQ, 2007, DIGEST DIS SCI, V52, P570, DOI 10.1007/s10620-006-9418-4
   Hultdin J, 2011, CLIN CHEM LAB MED, V49, P1555, DOI 10.1515/CCLM.2011.234
   Kalhan SC, 2011, CLIN SCI, V121, P179, DOI 10.1042/CS20110060
   Koehler KM, 2001, AM J CLIN NUTR, V73, P628
   Lee JE, 2012, CANCER CAUSE CONTROL, V23, P537, DOI 10.1007/s10552-012-9911-3
   Levine AJ, 2010, CANCER EPIDEM BIOMAR, V19, P89, DOI 10.1158/1055-9965.EPI-09-0727
   Livadas S, 2009, HORM RES, V72, P337, DOI 10.1159/000249161
   Ma J, 1997, CANCER RES, V57, P1098
   Mathiesen UL, 2002, DIGEST LIVER DIS, V34, P516, DOI 10.1016/S1590-8658(02)80111-6
   Negro F, 2012, J VIRAL HEPATITIS, V19, P42, DOI 10.1111/j.1365-2893.2011.01523.x
   Negro F, 2008, LIVER INT, V28, P294, DOI 10.1111/j.1478-3231.2008.01679.x
   Platek ME, 2009, CANCER EPIDEM BIOMAR, V18, P2453, DOI 10.1158/1055-9965.EPI-09-0159
   Reiss Gary, 2005, Rev Gastroenterol Disord, V5, P195
   Riquelme A, 2009, LIVER INT, V29, P82, DOI 10.1111/j.1478-3231.2008.01823.x
   Rutter MK, 2008, CIRCULATION, V117, P1003, DOI 10.1161/CIRCULATIONAHA.107.727727
   Saffroy R, 2004, CARCINOGENESIS, V25, P1443, DOI 10.1093/carcin/bgh147
   Sazci A, 2008, CELL BIOCHEM FUNCT, V26, P291, DOI 10.1002/cbf.1424
   Serin E, 2007, DIGEST DIS SCI, V52, P1183, DOI 10.1007/s10620-006-9565-7
   Stickel F, 2012, GUT, V61, P150, DOI 10.1136/gutjnl-2011-301239
   Toniutto P, 2008, LIVER INT, V28, P257, DOI 10.1111/j.1478-3231.2007.01591.x
   Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039
   Virdis A, 2003, ARTERIOSCL THROM VAS, V23, P1352, DOI 10.1161/01.ATV.0000083297.47245.DA
   Wallace TM, 2002, DIABETIC MED, V19, P527, DOI 10.1046/j.1464-5491.2002.00745.x
   Winkelmayer WC, 2004, EUR J CLIN INVEST, V34, P613, DOI 10.1111/j.1365-2362.2004.01394.x
   Yamada K, 2001, P NATL ACAD SCI USA, V98, P14853, DOI 10.1073/pnas.261469998
   Yu Andy S, 2002, Rev Gastroenterol Disord, V2, P11
   Yu AS, 2003, AM J GASTROENTEROL, V98, P955
   Zhang WL, 2010, CLIN SCI, V118, P187, DOI 10.1042/CS20090142
NR 48
TC 12
Z9 13
U1 0
U2 6
PU VERDUCI PUBLISHER
PI ROME
PA VIA GREGORIO VII, ROME, 186-00165, ITALY
SN 1128-3602
J9 EUR REV MED PHARMACO
JI Eur. Rev. Med. Pharmacol. Sci.
PD JAN
PY 2014
VL 18
IS 2
BP 151
EP 159
PG 9
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA AA9UC
UT WOS:000331437400002
PM 24488901
DA 2024-02-19
ER

PT J
AU Radák, Z
   Takahashi, R
   Kumiyama, A
   Nakamoto, H
   Ohno, H
   Ookawara, T
   Goto, S
AF Radák, Z
   Takahashi, R
   Kumiyama, A
   Nakamoto, H
   Ohno, H
   Ookawara, T
   Goto, S
TI Effect of aging and late onset dietary restriction on antioxidant
   enzymes and proteasome activities, and protein carbonylation of rat and
   skeletal muscle and tendon
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE dietary restriction; late onset; aging; protein carbonylation;
   proteasome; antioxidant enzyme; skeletal muscle; tendon
ID OXIDATIVE DAMAGE; CALORIC RESTRICTION; LIPID-PEROXIDATION; COGNITIVE
   FUNCTION; AGE; ACCUMULATION; EXERCISE; LIVER; MITOCHONDRIAL; BRAIN
AB Many studies have shown that lifelong dietary restriction (DR) can retard aging processes. Very few reports, however, are found that examined the effect of late onset DR on biochemical parameters in aging animals [Goto, S., Takahashi, R., Araki, S., Nakamoto, H., 2002b, Dietary restriction initiated in late adulthood can reverse age-related alterations of protein and protein metabolism. Ann. NY Acad. Sci. 959, 50-56]. We studied the effect of every-other-day feeding, initiated at the age of 26.5 months and continued for 3.5 months, on antioxidant enzymes, protein carbonyls, and proteasomes of the gastrocnemius muscle and tendon in rats. Age-related increase in the activity and content of Cu, Zn-SOD and the content of Mn-SOD was attenuated by the DR in both tissues. The same was true for glutathione peroxidase and catalase activities. Significant increase with age in protein reactive carbonyl derivatives (RCD) in the tendon was noted that was partially reversed by the DR, No significant change of RCD, however, was observed in the skeletal muscle. The age-related and DR-induced changes of the RCD in the tendon appeared to be associated with proteasome activity that decreases with age and increases by the DR. It is suggested that the late onset DR can have beneficial effects on the locomotive functions by reducing age-associated potentially detrimental oxidative protein damage in the tendon, (C) 2002 Elsevier Science Inc. All rights reserved.
C1 Toho Univ, Fac Pharmaceut Sci, Dept Biochem, Chiba 2748510, Japan.
   Semmelweis Univ, Sch Phys Educ, Exercise Physiol Lab, Budapest, Hungary.
   Kyorin Univ, Sch Med, Dept Hyg, Tokyo, Japan.
C3 Toho University; University of Physical Education; Semmelweis
   University; Kyorin University
RP Goto, S (corresponding author), Toho Univ, Fac Pharmaceut Sci, Dept Biochem, Miyama 2-2-1, Chiba 2748510, Japan.
EM goto@phar.toho.u-ac.jp
OI Radak, Zsolt/0000-0003-1297-6804
CR AEBI H, 1984, METHOD ENZYMOL, V105, P121
   Anselmi B, 1998, J GERONTOL A-BIOL, V53, pB173, DOI 10.1093/gerona/53A.3.B173
   Aspnes LE, 1997, FASEB J, V11, P573, DOI 10.1096/fasebj.11.7.9212081
   Bejma J, 1999, J APPL PHYSIOL, V87, P465, DOI 10.1152/jappl.1999.87.1.465
   Butterfield DA, 1997, P NATL ACAD SCI USA, V94, P674, DOI 10.1073/pnas.94.2.674
   CARNEY JM, 1991, P NATL ACAD SCI USA, V88, P3633, DOI 10.1073/pnas.88.9.3633
   CHEN JJ, 1994, FREE RADICAL BIO MED, V17, P411, DOI 10.1016/0891-5849(94)90167-8
   Crapo J D, 1978, Methods Enzymol, V53, P382
   ERSTNER L, 1967, METHOD ENZYMOL, V10, P309
   Forster MJ, 1996, P NATL ACAD SCI USA, V93, P4765, DOI 10.1073/pnas.93.10.4765
   Goto S, 1999, MECH AGEING DEV, V107, P245, DOI 10.1016/S0047-6374(98)00133-X
   Goto S, 2002, ANN NY ACAD SCI, V959, P50, DOI 10.1111/j.1749-6632.2002.tb02082.x
   Goto S, 2001, ANN NY ACAD SCI, V928, P54
   Goto S, 1997, AGE, V20, P81, DOI 10.1007/s11357-997-0008-y
   GOTO S, 2002, OXIDATIVE STRESS AGI
   Grune T, 1997, FASEB J, V11, P526, DOI 10.1096/fasebj.11.7.9212076
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   Hayashi T, 1998, MECH AGEING DEV, V102, P55, DOI 10.1016/S0047-6374(98)00011-6
   HOLLOSZY JO, 1991, MECH AGEING DEV, V60, P199, DOI 10.1016/0047-6374(91)90131-I
   HOUGH R, 1987, J BIOL CHEM, V262, P8303
   ISHIGAMI A, 1990, ARCH BIOCHEM BIOPHYS, V283, P362, DOI 10.1016/0003-9861(90)90655-I
   JI LL, 1990, AM J PHYSIOL, V258, pR918, DOI 10.1152/ajpregu.1990.258.4.R918
   JI LL, 1993, MED SCI SPORT EXER, V25, P225
   Kaneko T, 1996, MUTAT RES-DNAGING G, V316, P277, DOI 10.1016/S0921-8734(96)90010-7
   Kaneko T, 1997, FREE RADICAL BIO MED, V23, P76, DOI 10.1016/S0891-5849(96)00622-3
   LEEUWENBURGH C, 1994, AM J PHYSIOL, V267, pR439, DOI 10.1152/ajpregu.1994.267.2.R439
   LEVINE RL, 1981, P NATL ACAD SCI-BIOL, V78, P2120, DOI 10.1073/pnas.78.4.2120
   LEXELL J, 1983, MUSCLE NERVE, V6, P588, DOI 10.1002/mus.880060809
   LUHTALA TA, 1994, J GERONTOL, V49, pB231, DOI 10.1093/geronj/49.5.B231
   Masoro EJ, 2000, EXP GERONTOL, V35, P299, DOI 10.1016/S0531-5565(00)00084-X
   Mecocci P, 1999, FREE RADICAL BIO MED, V26, P303, DOI 10.1016/S0891-5849(98)00208-1
   MIYAZAWA T, 1993, LIPIDS, V28, P789, DOI 10.1007/BF02536232
   Nakamura A, 1996, J BIOCHEM, V119, P768
   OhIshi S, 1995, MECH AGEING DEV, V84, P65, DOI 10.1016/0047-6374(95)01637-F
   ORLOWSKI M, 1993, BIOCHEMISTRY-US, V32, P1563, DOI 10.1021/bi00057a022
   Radák Z, 1998, PFLUG ARCH EUR J PHY, V435, P439, DOI 10.1007/s004240050537
   Radák Z, 2001, NEUROCHEM INT, V38, P17, DOI 10.1016/S0197-0186(00)00063-2
   RADAK Z, 1995, J APPL PHYSIOL, V79, P129, DOI 10.1152/jappl.1995.79.1.129
   Radak Z, 1997, FREE RADICAL BIO MED, V22, P1109, DOI 10.1016/S0891-5849(96)00350-4
   Radak Z., 1998, OXIDATIVE STRESS SKE, P87
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465
   Sato A, 1998, BIOL PHARM BULL, V21, P1271, DOI 10.1248/bpb.21.1271
   Shibatani T, 1996, J GERONTOL A-BIOL, V51, pB175, DOI 10.1093/gerona/51A.2.B175
   Smith R K, 1999, Equine Vet J Suppl, P201
   SOHAL RS, 1993, P NATL ACAD SCI USA, V90, P7255, DOI 10.1073/pnas.90.15.7255
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142
   TAKAHASHI R, 1987, ARCH BIOCHEM BIOPHYS, V257, P200, DOI 10.1016/0003-9861(87)90559-5
   TAKAHASHI R, 1987, ARCH GERONTOL GERIAT, V6, P73, DOI 10.1016/0167-4943(87)90040-9
   Tappel A L, 1978, Methods Enzymol, V52, P506
   WEINDRUCH RH, 1980, MECH AGEING DEV, V12, P375, DOI 10.1016/0047-6374(80)90070-6
   Yu BP, 1996, FREE RADICAL BIO MED, V21, P651, DOI 10.1016/0891-5849(96)00162-1
NR 53
TC 74
Z9 78
U1 0
U2 8
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD DEC
PY 2002
VL 37
IS 12
BP 1423
EP 1430
AR PII S0531-5565(02)00116-X
DI 10.1016/S0531-5565(02)00116-X
PG 8
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 630MX
UT WOS:000180112900014
PM 12559411
DA 2024-02-19
ER

PT J
AU Higurashi, M
   Maruyama, T
   Nogami, Y
   Ishikawa, F
   Yoshida, Y
   Mori, K
   Fujita, K
   Shibanuma, M
AF Higurashi, Masato
   Maruyama, Tsuyoshi
   Nogami, Yusuke
   Ishikawa, Fumihiro
   Yoshida, Yukiko
   Mori, Kazunori
   Fujita, Ken-ichi
   Shibanuma, Motoko
TI High expression of FOXM1 critical for sustaining cell proliferation in
   mitochondrial DNA-less liver cancer cells
SO EXPERIMENTAL CELL RESEARCH
LA English
DT Article
DE FOXM1; B-MYB; OTUB1; Mitochondrial DNA copy number; Hepatocellular
   carcinoma (HCC) cell line
ID FORKHEAD BOX M1; SMALL HEPATOCELLULAR-CARCINOMA; TRANSCRIPTION-FACTOR-A;
   POOR-PROGNOSIS; COPY NUMBER; TUMOR PROGRESSION; BREAST-CANCER; D-LOOP;
   PROMOTES; DEUBIQUITINATION
AB The copy number of mitochondrial DNA (mtDNA) is decreased in most cancer types, including hepatocellular carcinoma (HCC), compared to normal counterparts. However, a decrease in mtDNA usually leads to defects in cell proliferation, which contradicts the robustness of cancer cell proliferation. In this study, we found that four out of seven HCC cell lines were of the mtDNA-less type. Interestingly, FOXM1, a member of the FOX transcription factor family, was highly expressed in a subset of them with proliferative potential maintained. B-MYB, a partner of FOXM1, was also expressed in the same cell lines. RNAi-mediated experiments demonstrated that when FOXM1/B-MYB was silenced in the cell lines, cell cycle-related genes were downregulated, while p21Cip1 was induced with senescence-associated beta-galactosidase, resulting in G1/S cell cycle arrest. These results suggest that high expression of FOXM1/B-MYB is critical for sustaining cell proliferation in mtDNA-less cells. In addition, we found that high expression of FOXM1 was mediated by the deubiquitinating enzyme, OTUB1, in one cell line. Thus, interference with FOXM1/B-MYB expression, such as through OTUB1 inhibition, may induce a dormant state of senescence-like proliferation arrest in mtDNA-less cancer cells. This finding may be utilized for the development of precision medicine for relevant cancers.
C1 [Higurashi, Masato; Maruyama, Tsuyoshi; Nogami, Yusuke; Ishikawa, Fumihiro; Mori, Kazunori; Fujita, Ken-ichi; Shibanuma, Motoko] Showa Univ, Sch Pharm, Dept Pharmaceut Sci, Div Canc Cell Biol, Tokyo 1428555, Japan.
   [Yoshida, Yukiko] Tokyo Metropolitan Inst Med Sci, Dept Adv Sci Biomol, Tokyo 1568506, Japan.
C3 Showa University; Tokyo Metropolitan Institute of Medical Science
RP Shibanuma, M (corresponding author), Showa Univ, Sch Pharm, Dept Pharmaceut Sci, Shinagawa Ku,Div Canc Cell Biol, 1-5-8 Hatanodai, Tokyo 1428555, Japan.
EM smotoko@pharm.showa-u.ac.jp
RI Yoshida, Yukiko/ABB-7218-2020
OI Yoshida, Yukiko/0000-0002-0629-0219; Mori, Kazunori/0000-0001-7121-9956
FU JSPS KAKENHI [JP26460399]; Private University Research Branding Project
FX We thank Ms S. Fujiwara, Mr K. Naka, Ms Y. Shikama, Mr Y. Tsuchiya, Mr
   T. Imai, Ms M. Iwanami, and Ms K.Takehana for contributing to this work
   as part of their Bachelor's degrees. This work was supported in part by
   JSPS KAKENHI Grant Number JP26460399 and by Private University Research
   Branding Project. The authors would also like to thank Enago
   (www.enago.jp) for the English language review.
CR Anders L, 2011, CANCER CELL, V20, P620, DOI 10.1016/j.ccr.2011.10.001
   Cai JB, 2015, HEPATOLOGY, V61, P1603, DOI 10.1002/hep.27682
   Calvisi DF, 2011, HEPATOLOGY, V53, P1226, DOI 10.1002/hep.24174
   Chai N, 2018, BIOCHEM BIOPH RES CO, V500, P924, DOI 10.1016/j.bbrc.2018.04.201
   Chatterjee A, 2011, CANCER PREV RES, V4, P638, DOI 10.1158/1940-6207.CAPR-10-0326
   Chen YH, 2016, EMBO J, V35, P668, DOI 10.15252/embj.201592810
   Dai J, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/352478
   Dong W, 2014, WORLD J GASTROENTERO, V20, P10174, DOI 10.3748/wjg.v20.i29.10174
   Egawa M, 2017, HEPATOL RES, V47, P1196, DOI 10.1111/hepr.12854
   Fan ST, 2011, ANN SURG, V253, P745, DOI 10.1097/SLA.0b013e3182111195
   Gartel AL, 2017, CANCER RES, V77, P3135, DOI 10.1158/0008-5472.CAN-16-3566
   Guan Z, 2018, CURR RES TRANSL MED, V66, P27, DOI 10.1016/j.retram.2017.11.002
   Halasi M, 2013, MOL CANCER THER, V12, P245, DOI 10.1158/1535-7163.MCT-12-0712
   He MJ, 2017, PHARMACOL THERAPEUT, V177, P96, DOI 10.1016/j.pharmthera.2017.03.001
   Hjerpe R, 2009, EMBO REP, V10, P1250, DOI 10.1038/embor.2009.192
   Hsu CC, 2013, WORLD J GASTROENTERO, V19, P8880, DOI 10.3748/wjg.v19.i47.8880
   Huang G, 2015, ONCOL REP, V34, P2917, DOI 10.3892/or.2015.4296
   Ishikawa F, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.583
   Ju YS, 2014, ELIFE, V3, DOI 10.7554/eLife.02935
   Kang DC, 1997, J BIOL CHEM, V272, P15275, DOI 10.1074/jbc.272.24.15275
   Kang D, 2007, MITOCHONDRION, V7, P39, DOI 10.1016/j.mito.2006.11.017
   Kanki T, 2004, MOL CELL BIOL, V24, P9823, DOI 10.1128/MCB.24.22.9823-9834.2004
   Karunarathna U, 2016, ONCOGENE, V35, P1433, DOI 10.1038/onc.2015.208
   Kim IM, 2006, CANCER RES, V66, P2153, DOI 10.1158/0008-5472.CAN-05-3003
   King M P, 1996, Methods Enzymol, V264, P304, DOI 10.1016/S0076-6879(96)64029-4
   Lam EWF, 2013, NAT REV CANCER, V13, P482, DOI 10.1038/nrc3539
   Laoukili J, 2008, CELL CYCLE, V7, P2720, DOI 10.4161/cc.7.17.6580
   Laoukili J, 2007, BBA-REV CANCER, V1775, P92, DOI 10.1016/j.bbcan.2006.08.006
   Lee HC, 2004, MUTAT RES-FUND MOL M, V547, P71, DOI 10.1016/j.mrfmmm.2003.12.011
   Li L, 2012, J GASTROEN HEPATOL, V27, P51, DOI 10.1111/j.1440-1746.2011.06947.x
   Li TY, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0182-5
   Liang CJ, 2018, ONCOTARGETS THER, V11, P3561, DOI 10.2147/OTT.S155541
   Masuike Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193159
   McClurg UL, 2015, ONCOTARGET, V6, P9657, DOI 10.18632/oncotarget.3922
   Mori K, 2016, CANCER SCI, V107, P963, DOI 10.1111/cas.12953
   Mowla SN, 2014, AGING CELL, V13, P773, DOI 10.1111/acel.12242
   Ness SA, 2003, BLOOD CELL MOL DIS, V31, P192, DOI 10.1016/S1079-9796(03)00151-7
   Ni QG, 2017, ACTA BIOCH BIOPH SIN, V49, P680, DOI 10.1093/abbs/gmx056
   Ning Z, 2014, INT J ONCOL, V45, P1594, DOI 10.3892/ijo.2014.2531
   Nomoto S, 2002, CLIN CANCER RES, V8, P481
   Okabe H, 2001, CANCER RES, V61, P2129
   Park HJ, 2008, MOL CELL BIOL, V28, P5162, DOI 10.1128/MCB.00387-08
   Park SY, 2004, BIOCHEM BIOPH RES CO, V325, P1399, DOI 10.1016/j.bbrc.2004.10.182
   Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093
   Reznik E., 2017, ELIFE, P6
   Reznik E, 2016, ELIFE, V5, DOI 10.7554/eLife.10769
   Sadasivam S, 2013, NAT REV CANCER, V13, P585, DOI 10.1038/nrc3556
   Schauen M, 2006, J CELL PHYSIOL, V209, P103, DOI 10.1002/jcp.20711
   Shibanuma M, 2012, CANCER SCI, V103, P1803, DOI 10.1111/j.1349-7006.2012.02369.x
   Shibanuma M, 2011, FREE RADICAL RES, V45, P672, DOI 10.3109/10715762.2011.564169
   Song BN, 2018, EXP MOL MED, V50, DOI 10.1038/emm.2017.159
   Sun HC, 2011, ONCOL REP, V25, P1533, DOI 10.3892/or.2011.1230
   Tang B, 2015, ONCOTARGET, V6, P12654, DOI 10.18632/oncotarget.3705
   Tao J, 2014, WORLD J GASTROENTERO, V20, P9497, DOI 10.3748/wjg.v20.i28.9497
   Uhlen M, 2017, SCIENCE, V357, P660, DOI 10.1126/science.aan2507
   Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365
   Wang XJ, 2018, MED SCI MONITOR, V24, P1742, DOI 10.12659/MSM.909368
   Wang YQ, 2016, ONCOTARGET, V7, P36681, DOI 10.18632/oncotarget.9160
   Wierstra I, 2013, ADV CANCER RES, V119, P191, DOI 10.1016/B978-0-12-407190-2.00016-2
   Yamada S, 2006, EJSO-EUR J SURG ONC, V32, P303, DOI 10.1016/j.ejso.2006.01.002
   Yin PH, 2004, BRIT J CANCER, V90, P2390, DOI 10.1038/sj.bjc.6601838
   Yoshida Y, 2015, P NATL ACAD SCI USA, V112, P4630, DOI 10.1073/pnas.1422313112
   Yu M, 2016, TUMOR BIOL, V37, P1289, DOI 10.1007/s13277-015-3436-9
   Zhang S, 2018, LAB INVEST, V98, P883, DOI 10.1038/s41374-018-0050-7
NR 64
TC 9
Z9 8
U1 1
U2 6
PU ELSEVIER INC
PI SAN DIEGO
PA 525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0014-4827
EI 1090-2422
J9 EXP CELL RES
JI Exp. Cell Res.
PD APR 1
PY 2020
VL 389
IS 1
AR 111889
DI 10.1016/j.yexcr.2020.111889
PG 11
WC Oncology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Cell Biology
GA LC5XZ
UT WOS:000525406300003
PM 32032602
DA 2024-02-19
ER

PT J
AU Peng, LX
   Fang, BW
   Wang, Y
   Gao, SN
AF Peng Longxi
   Fang Buwu
   Wang Yuan
   Gao Sinan
TI Expression of p53 in the Effects of Artesunate on Induction of Apoptosis
   and Inhibition of Proliferation in Rat Primary Hepatic Stellate Cells
SO PLOS ONE
LA English
DT Article
ID FIBROSIS
AB Background: Activation of hepatic stellate cells (HSCs) plays an important role in the development of cirrhosis through the increased production of collagen. p53, the "guardian of the genome", is a transcription factor that can bind to promoter regions of hundreds of genes where it either activates or suppresses gene expression. Thereby, p53 serves as a tumor suppressor by inducing cell cycle arrest, apoptosis, senescence and DNA repair. Artesunate is a derivative of Artemisinin, Scholars had found it had more extensive pharmacological effects past 10 years. However, little is known about the expression of p53 in the effects of Artesunate on induction of apoptosis and inhibition of proliferation in rat HSCs.
   Methodology/Principal Findings: Isolated and cultured rat primary HSCs in the flask for 10 days to make cells activated. HSCs were divided into two groups: experimental groups and control groups, experimental groups included with various concentrations of Artesunate (125, 150, 175, 200, 225 mu mol/L) for 24, 48 and 72 hours. Analysis of MTT revealed that activated HSCs treated with various concentrations of Artesunate (150-225 mu mol/L) were inhibited on dose and time-effect relationships; Concentration of hydroxyproline in supernatant was detected by digestive method; Analysis of flow cytometry demonstrated that Artesunate could arrest cell cycle in G1 and induce apoptosis; The nuclear morphological changes in apoptotic cells were evaluated with DNA staining by Hoechst 33258 dye; The expression of p53 were up-regulated showed by western blotting and RT-PCR.
   Conclusion: Artesunate could inhibit HSCs proliferation in dose-dependent and time-dependent manners in vitro through increase the expression of p53.
C1 [Peng Longxi; Fang Buwu; Wang Yuan; Gao Sinan] Tianjin Med Univ, Dept Pharmacol, Tianjin, Peoples R China.
C3 Tianjin Medical University
RP Peng, LX (corresponding author), Tianjin Med Univ, Dept Pharmacol, Tianjin, Peoples R China.
EM fangdch1962@163.com
FU National Natural Science Foundation of China [30772856]
FX This work was supported by National Natural Science Foundation of China
   (No. 30772856). The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Aprigliano I, 2008, LIVER INT, V28, P546, DOI 10.1111/j.1478-3231.2008.01682.x
   Bai LG, 2001, MOL CELL BIOL, V21, P4670, DOI 10.1128/MCB.21.14.4670-4683.2001
   Bunt J, 2010, MOL CANCER RES, V8, P1344, DOI 10.1158/1541-7786.MCR-09-0546
   [方步武 Fang Buwu], 2005, [中国药理学通报, Chinese Pharmacological Bulletin], V21, P762
   Ferreira JFS, 2010, MOLECULES, V15, P3135, DOI 10.3390/molecules15053135
   Friedman SL, 2010, NAT REV GASTRO HEPAT, V7, P425, DOI 10.1038/nrgastro.2010.97
   FRIEDMAN SL, 1987, ANAL BIOCHEM, V161, P207, DOI 10.1016/0003-2697(87)90673-7
   Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247
   Green DR, 2006, CELL, V126, P30, DOI 10.1016/j.cell.2006.06.032
   Gressner AM, 2006, J CELL MOL MED, V10, P76, DOI 10.1111/j.1582-4934.2006.tb00292.x
   Jerry DJ, 2002, J DAIRY SCI, V85, P1103, DOI 10.3168/jds.S0022-0302(02)74171-4
   Jin OY, 2009, CELL MOL IMMUNOL, V6, P461, DOI 10.1038/cmi.2009.58
   [来丽娜 Lai Lina], 2006, [中药药理与临床, Pharmacology and Clinics of Chinese Materia Medica], V22, P25
   [来丽娜 Lai Lina], 2006, [中药药理与临床, Pharmacology and Clinics of Chinese Materia Medica], V22, P35
   Michaelis M, 2010, BIOCHEM PHARMACOL, V79, P130, DOI 10.1016/j.bcp.2009.08.013
   Murakami Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016081
   Nakahara T, 2003, AM J PHYSIOL-ENDOC M, V285, pE1273, DOI 10.1152/ajpendo.00019.2003
   Neubauer K, 1996, J HEPATOL, V24, P719, DOI 10.1016/S0168-8278(96)80269-8
   Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395
   Ruddell RG, 2006, AM J PATHOL, V169, P861, DOI 10.2353/ajpath.2006.050767
   Sun X, 2009, BIOL PHARM BULL, V32, P1533, DOI 10.1248/bpb.32.1533
NR 21
TC 7
Z9 11
U1 0
U2 20
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 28
PY 2011
VL 6
IS 10
AR e26500
DI 10.1371/journal.pone.0026500
PG 9
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 876BL
UT WOS:000299081800018
PM 22053192
OA gold, Green Submitted, Green Published
DA 2024-02-19
ER

PT J
AU SALGANIK, RI
   SOLOVYOVA, NA
   DIKALOV, SI
   GRISHAEVA, ON
   SEMENOVA, LA
   POPOVSKY, AV
AF SALGANIK, RI
   SOLOVYOVA, NA
   DIKALOV, SI
   GRISHAEVA, ON
   SEMENOVA, LA
   POPOVSKY, AV
TI INHERITED ENHANCEMENT OF HYDROXYL RADICAL GENERATION AND
   LIPID-PEROXIDATION IN THE S-STRAIN RATS RESULTS IN DNA REARRANGEMENTS,
   DEGENERATIVE DISEASES, AND PREMATURE AGING
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
ID INDUCTION; DAMAGE
AB Previously by selection and inbreeding of Wistar rats susceptible or resistant to the cataractogenic effect of galactose the S and R rat strains differing in the intensity of hexose transport into the animal cells were developed. High level of OH-radical generation and enhanced lipid peroxidation are revealed in the liver and myocardium of the S rats in contrast to the R rats. Data are obtained supporting the view that enhanced generation of OH-radicals within the S rat tissues is due to oxidation and autooxidation of the abundant amounts of monosaccharides intensely accumulating in the rat cells. In spite of continuous inbreeding for more than 40 generations and a high rate of homozygosity,numerous DNA rearrangements are revealed in the S rat genomes. Fragility of the S rat cell membranes is detected. Cataracts and other lens lesions, emphysema, tumors, cardiomyopathy-like changes in the myocardium, scoliosis, brain disfunctions are characteristic of the S rats, as well as low fertility and short life-span indica- tive of premature aging. (C) 1994 Academic Press, Inc.
C1 RUSSIAN ACAD SCI, INST KINET & COMBUST, NOVOSIBIRSK 630090, RUSSIA.
C3 Voevodsky Institute of Chemical Kinetics & Combustion SB RAS; Russian
   Academy of Sciences
RP SALGANIK, RI (corresponding author), RUSSIAN ACAD SCI, INST CYTOL & GENET, NOVOSIBIRSK 630090, RUSSIA.
RI Stecuk, Evgen/GQZ-6378-2022
OI Stecuk, Evgen/0000-0002-4239-2618; Dikalov, Sergey/0000-0003-2976-6184
CR ADELMAN R, 1988, P NATL ACAD SCI USA, V85, P2706, DOI 10.1073/pnas.85.8.2706
   AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   BARABOY VA, 1991, LIPID PEROXIDATION R
   BIRD RP, 1983, ANAL BIOCHEM, V128, P240, DOI 10.1016/0003-2697(83)90371-8
   BUETTNER GR, 1978, BIOCHEM BIOPH RES CO, V83, P69, DOI 10.1016/0006-291X(78)90398-4
   DUVE CD, 1955, BIOCHEM J, V60, P604, DOI 10.1042/bj0600604
   ELISEEVA AG, 1975, GENETIKA+, V11, P72
   GRISHAEVA ON, 1993, IN PRESS VOPR MED KH
   IMLAY JA, 1988, SCIENCE, V240, P1302, DOI 10.1126/science.3287616
   KOLODNY EH, 1976, CLIN CHIM ACTA, V70, P247, DOI 10.1016/0009-8981(76)90426-5
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MASHINO T, 1987, ARCH BIOCHEM BIOPHYS, V254, P547, DOI 10.1016/0003-9861(87)90136-6
   MORITA J, 1983, AGR BIOL CHEM TOKYO, V47, P11, DOI 10.1080/00021369.1983.10865576
   NURNBERG P, 1989, HUM GENET, V84, P75, DOI 10.1007/BF00210676
   OKUNO Y, 1986, FEBS LETT, V195, P303, DOI 10.1016/0014-5793(86)80182-X
   SALGANIK RI, 1992, MUTAT RES, V266, P163, DOI 10.1016/0027-5107(92)90183-3
   SCHNEIDER WC, 1948, J BIOL CHEM, V176, P259
   SOLOVEVA NA, 1975, GENETIKA+, V11, P63
   SOLOVYOVA NA, 1987, VOPR MED KHIMII, V33, P984
   STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616
   THORNALLEY P, 1984, BIOCHIM BIOPHYS ACTA, V797, P276, DOI 10.1016/0304-4165(84)90131-4
NR 21
TC 58
Z9 62
U1 0
U2 1
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD MAR 15
PY 1994
VL 199
IS 2
BP 726
EP 733
DI 10.1006/bbrc.1994.1289
PG 8
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA NA914
UT WOS:A1994NA91400044
PM 8135816
DA 2024-02-19
ER

PT J
AU Kozurková, M
   Letavayová, L
   Misurová, E
AF Kozurkova, M.
   Letavayova, L.
   Misurova, E.
TI Influence of gamma irradiation on DNA methylation in liver of male rats
   and their offspring
SO ACTA VETERINARIA BRNO
LA English
DT Article
DE DNA methylation; aging; ionizing radiation; liver; parental generation;
   progeny
ID IONIZING-RADIATION; RIBOSOMAL DNA; ENZYMES; PROGENY
AB In the present work, the influence of gamma radiation (3 Gy) on DNA methylation in slowly proliferating liver tissue of adult male rats and their offspring was studied. Total methylation of DNA was determined on the basis of presence of 5-methylcytosine at the inner cytosine of the C-C-G-G sequence by using restriction enzymes, endonuclease Msp I and its isoschisomer Hpa II. It was found that in the liver of control animals, molecular weight distribution of both Msp I and Hpa H digestion products of DNA and the level of DNA methylation were influenced by age mainly between the 3(rd) and the Th days of life. At this time, significant difference was found especially in products of cleavage with enzyme Msp 1, where an increase in DNA fragments of medium molecular weight (1 -7 kb) occurred. The changes in the molecular weight distribution of DNA digestion products in the offspring of control rats were accompanied by an increase in the level of total DNA methylation from 29.8% to 67%. In the offspring of irradiated males, the level of DNA methylation was higher in comparison with the offspring of non-irradiated control males, especially on the 3(rd) day after birth. We suppose that this finding is conjoined with a transgeneration transfer of radiation-induced genome damage.
C1 Safarik Univ, Prirodovedecka Fak, Kosice 04167, Slovakia.
   Safarik Univ, Fac Sci, Inst Chem, Dept Biochem, Kosice, Slovakia.
   Safarik Univ, Fac Sci, Inst Biol & Ecol Sci, Dept Cellular Biol, Kosice, Slovakia.
C3 University of Pavol Jozef Safarik Kosice; University of Pavol Jozef
   Safarik Kosice; University of Pavol Jozef Safarik Kosice
RP Kozurková, M (corresponding author), Safarik Univ, Prirodovedecka Fak, Moyzesova 11, Kosice 04167, Slovakia.
EM kozurkom@kosice.upjs.sk
RI Kozurkova, Maria/G-7433-2016
OI Kozurkova, Maria/0000-0002-2789-8397; Kozurkova,
   Maria/0000-0002-8344-0671
CR Antequera F, 2003, CELL MOL LIFE SCI, V60, P1647, DOI 10.1007/s00018-003-3088-6
   Baylin SB, 1998, ADV CANCER RES, V72, P141
   Benová K, 2003, ACTA VET BRNO, V72, P201, DOI 10.2754/avb200372020201
   Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102
   BIRD AP, 1978, J MOL BIOL, V118, P27, DOI 10.1016/0022-2836(78)90242-5
   Blagoi Yu. P., 1994, Biophysics (English Translation of Biofizika), V39, P641
   Clayton-Smith J, 2003, BRIT MED J, V327, P1121, DOI 10.1136/bmj.327.7424.1121
   Dubrova YE, 2003, ONCOGENE, V22, P7087, DOI 10.1038/sj.onc.1206993
   Dvorák P, 2006, B VET I PULAWY, V50, P221
   GRUENBAUM Y, 1981, NUCLEIC ACIDS RES, V9, P2509, DOI 10.1093/nar/9.11.2509
   Jones PA, 1996, CANCER RES, V56, P2463
   Ke X, 2003, ANN HUM GENET, V67, P242, DOI 10.1046/j.1469-1809.2003.00038.x
   Kovarík A, 2000, CHROMOSOME RES, V8, P527, DOI 10.1023/A:1009223823327
   KOZURKOVA M, 1995, MECH AGEING DEV, V78, P1
   KOZURKOVA M, 1993, MECH AGEING DEV, V72, P37, DOI 10.1016/0047-6374(93)90129-F
   Kropácová K, 2002, J RADIAT RES, V43, P125, DOI 10.1269/jrr.43.125
   KUNNATH L, 1982, BIOCHIM BIOPHYS ACTA, V699, P264, DOI 10.1016/0167-4781(82)90116-6
   Luke GA, 1997, MUTAGENESIS, V12, P147, DOI 10.1093/mutage/12.3.147
   Oakes CC, 2003, P NATL ACAD SCI USA, V100, P1775, DOI 10.1073/pnas.0437971100
   Oligny Luc Laurier, 2003, Adv Pediatr, V50, P59
   RIDEOUT WM, 1990, SCIENCE, V249, P1288, DOI 10.1126/science.1697983
   Sambrook J, 1989, MOL CLONING LAB MANU
   SANOVA S, 2004, 2 C RAD KOS, P128
   Sanová T, 2005, NEUROTOXICOL TERATOL, V27, P145, DOI 10.1016/j.ntt.2004.10.003
   Serman A, 2006, COLLEGIUM ANTROPOL, V30, P665
   Slovinská L, 2004, MUTAT RES-GEN TOX EN, V559, P29, DOI 10.1016/j.mrgentox.2003.12.005
   Volpe P, 2005, BIOCHEMISTRY-MOSCOW+, V70, P584, DOI 10.1007/s10541-005-0152-x
   Vorobtsova IE, 2000, MUTAGENESIS, V15, P33, DOI 10.1093/mutage/15.1.33
   Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413
NR 29
TC 2
Z9 2
U1 0
U2 3
PU VETERINARNI A FARMACEUTICKA UNIVERZITA BRNO
PI BRNO
PA PALACKEHO 1-3, BRNO CS-612 42, CZECH REPUBLIC
SN 0001-7213
EI 1801-7576
J9 ACTA VET BRNO
JI Acta Vet. BRNO
PD JUN
PY 2007
VL 76
IS 2
BP 215
EP +
DI 10.2754/avb200776020215
PG 9
WC Veterinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Veterinary Sciences
GA 190TY
UT WOS:000248084700008
OA Green Submitted, hybrid
DA 2024-02-19
ER

PT J
AU De Fré, CH
   De Fré, MA
   Kwanten, WJ
   Op de Beeck, BJ
   Van Gaal, LF
   Francque, SM
AF De Fre, C. H.
   De Fre, M. A.
   Kwanten, W. J.
   Op de Beeck, B. J.
   Van Gaal, L. F.
   Francque, S. M.
TI Sarcopenia in patients with non-alcoholic fatty liver disease: is it a
   clinically significant entity?
SO OBESITY REVIEWS
LA English
DT Article
DE Non-alcoholic fatty liver disease (NAFLD); pathogenesis; review;
   sarcopenia
ID INDEPENDENT RISK-FACTOR; SKELETAL-MUSCLE MASS; LOW VITAMIN-D;
   INSULIN-RESISTANCE; NATIONAL-HEALTH; TERM OUTCOMES; WHITE FAT; OBESITY;
   FIBROSIS; STEATOHEPATITIS
AB Sarcopenia, described as the loss of muscle mass and/or strength, is gaining importance as it can be increasingly related to many chronic diseases. It is also associated with chronic liver disease, and recently it has been more frequently linked to non-alcoholic fatty liver disease (NAFLD) in particular. Both sarcopenia and NAFLD are subject to complex and intermingled pathophysiological processes, of which some are in common. Furthermore, it is presently unclear if sarcopenia directly contributes to NAFLD or vice versa. The mechanisms that are involved may include obesity, insulin resistance, vitamin D deficiency, aging, physical inactivity and certain cytokines. Current clinical evidence is subject to an important heterogeneity in methods and definitions, with additionally also a relative overrepresentation of evidence in Asian ethnicities. Nonetheless, all studies so far point towards the same association between sarcopenia and NAFLD, including an association with NAFLD-severity and NAFLD-related fibrosis. Since the field is in its infancy, clear definitions and further research are needed to aid to improve understanding of the association between NAFLD and sarcopenia. This can eventually lead to additional potential therapeutic interventions. This review attempts to give an overview of the current published literature that links sarcopenia to NAFLD, followed by a discussion of the presumably involved pathophysiological factors, and ends by discussing current unmet needs.
C1 [De Fre, C. H.; De Fre, M. A.; Kwanten, W. J.; Van Gaal, L. F.; Francque, S. M.] Univ Antwerp, LEMP, Antwerp, Belgium.
   [Kwanten, W. J.; Francque, S. M.] Antwerp Univ Hosp, Dept Gastroenterol & Hepatol, Antwerp, Belgium.
   [Op de Beeck, B. J.] Antwerp Univ Hosp, Dept Radiol, Antwerp, Belgium.
   [Van Gaal, L. F.] Antwerp Univ Hosp, Dept Endocrinol Diabetol & Metab Dis, Antwerp, Belgium.
C3 University of Antwerp; University of Antwerp; University of Antwerp;
   University of Antwerp
RP Francque, SM (corresponding author), Antwerp Univ Hosp, Wilrijkstr 10, B-2650 Edegem, Belgium.
EM sven.francque@uza.be
RI Francque, Sven M/E-4526-2017; Kwanten, Wilhelmus/GLU-4741-2022
OI Francque, Sven M/0000-0002-7527-4714; Kwanten,
   Wilhelmus/0000-0001-9474-6695
CR Abbatecola AM, 2011, J NUTR HEALTH AGING, V15, P890, DOI 10.1007/s12603-011-0366-0
   Addison O, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/309570
   Alway SE, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00246
   Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80
   Angulo P, 2015, GASTROENTEROLOGY, V149, P389, DOI 10.1053/j.gastro.2015.04.043
   Antoniak AE, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014619
   Atkins JL, 2015, REV CLIN GERONTOL, V25, P86, DOI 10.1017/S0959259815000076
   Batsis JA, 2011, MED COMPLICATIONS TY, P233
   Bertolotti M, 2014, WORLD J GASTROENTERO, V20, P14185, DOI 10.3748/wjg.v20.i39.14185
   Biolo G, 2014, CLIN NUTR, V33, P737, DOI 10.1016/j.clnu.2014.03.007
   Bodine SC, 2013, INT J BIOCHEM CELL B, V45, P2200, DOI 10.1016/j.biocel.2013.06.011
   Boström P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777
   Bugianesi E, 2005, HEPATOLOGY, V42, P987, DOI 10.1002/hep.20920
   Byeon CH, 2015, J GERIATR CARDIOL, V12, P366, DOI 10.11909/j.issn.1671-5411.2015.04.007
   Cabrera D, 2016, DIGEST DIS SCI, V61, P3190, DOI 10.1007/s10620-016-4285-0
   Carias S, 2016, J GASTROEN HEPATOL, V31, P628, DOI 10.1111/jgh.13166
   Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762
   Charlton MR, 2011, GASTROENTEROLOGY, V141, P1249, DOI 10.1053/j.gastro.2011.06.061
   Cooper C, 2013, CALCIFIED TISSUE INT, V93, P201, DOI 10.1007/s00223-013-9757-z
   Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034
   Dichtel LE, 2017, CLIN TRANSL GASTROEN, V8, DOI 10.1038/ctg.2016.72
   dos Santos VR, 2017, DIABETES METAB SYND, V11, pS115, DOI 10.1016/j.dsx.2016.12.019
   EASL, 2016, DIABETOLOGIA, V59, P1121, DOI 10.1007/s00125-016-3902-y
   Eckardt K, 2014, DIABETOLOGIA, V57, P1087, DOI 10.1007/s00125-014-3224-x
   Ekstedt M, 2015, HEPATOLOGY, V61, P1547, DOI 10.1002/hep.27368
   Eliades M, 2013, ALIMENT PHARM THER, V38, P246, DOI 10.1111/apt.12377
   Francque SM, 2016, J HEPATOL, V65, P425, DOI 10.1016/j.jhep.2016.04.005
   Guichelaar MMJ, 2014, HEPATOLOGY, V59, P1668, DOI 10.1002/hep.27058
   Hamdy O, 2006, CURR DIABETES REV, V2, P367, DOI 10.2174/1573399810602040367
   Hamrick Mark W, 2017, J Bone Metab, V24, P1, DOI 10.11005/jbm.2017.24.1.1
   Hamrick MW, 2010, BIOCHEM BIOPH RES CO, V400, P379, DOI 10.1016/j.bbrc.2010.08.079
   Hansen J, 2011, ENDOCRINOLOGY, V152, P164, DOI 10.1210/en.2010-0868
   Hasselager R, 2014, LANGENBECK ARCH SURG, V399, P287, DOI 10.1007/s00423-014-1174-x
   Hong HC, 2014, HEPATOLOGY, V59, P1772, DOI 10.1002/hep.26716
   Issa D, 2014, HEPATOLOGY, V60, P428, DOI 10.1002/hep.26908
   Ix JH, 2009, J CLIN ENDOCR METAB, V94, P4492, DOI 10.1210/jc.2009-0916
   Jeremic N, 2017, J CELL PHYSIOL, V232, P61, DOI 10.1002/jcp.25450
   Kalinkovich A, 2017, AGEING RES REV, V35, P200, DOI 10.1016/j.arr.2016.09.008
   Kalyani RR, 2014, LANCET DIABETES ENDO, V2, P819, DOI 10.1016/S2213-8587(14)70034-8
   Kim HY, 2016, HEPATOB PANCREAT DIS, V15, P39, DOI 10.1016/S1499-3872(15)60030-3
   Kim W, 2016, J HEPATOL, V64, pS502, DOI 10.1016/S0168-8278(16)00867-9
   Koo BK, 2017, J HEPATOL, V66, P123, DOI 10.1016/j.jhep.2016.08.019
   Lan F, 2014, DIABETES, V63, P1649, DOI 10.2337/db13-0728
   Lang T, 2010, OSTEOPOROSIS INT, V21, P543, DOI 10.1007/s00198-009-1059-y
   Lee DC, 2016, FUTUR SCI OA, V2, DOI 10.4155/fsoa-2016-0028
   Lee YH, 2016, HEPATOLOGY, V63, P776, DOI 10.1002/hep.28376
   Lee YH, 2015, J HEPATOL, V63, P486, DOI 10.1016/j.jhep.2015.02.051
   Liu J, 2015, METABOLISM, V64, P380, DOI 10.1016/j.metabol.2014.11.009
   Lonardo A, 2015, DIGEST LIVER DIS, V47, P181, DOI 10.1016/j.dld.2014.09.020
   Malin SK, 2014, MED SCI SPORT EXER, V46, P2085, DOI 10.1249/MSS.0000000000000338
   Masuda T, 2014, LIVER TRANSPLANT, V20, P401, DOI 10.1002/lt.23811
   Meex RCR, 2017, NAT REV ENDOCRINOL, V13, P508, DOI 10.1038/nrendo.2017.56
   Merli M, 2015, J HEPATOL, V63, P309, DOI 10.1016/j.jhep.2015.05.014
   Misu H, 2017, NAT MED, V23, P508, DOI 10.1038/nm.4295
   Moon JS, 2013, DIABETES METAB J, V37, P278, DOI 10.4093/dmj.2013.37.4.278
   Oelmann S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154319
   Oh KJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010008
   Pang Q, 2016, HEPATOLOGY, V63, P675, DOI 10.1002/hep.28010
   Peng PD, 2011, HPB, V13, P439, DOI 10.1111/j.1477-2574.2011.00301.x
   Petta S, 2017, ALIMENT PHARM THER, V45, P510, DOI 10.1111/apt.13889
   Poggiogalle E, 2017, WORLD J GASTROENTERO, V23, P1747, DOI 10.3748/wjg.v23.i10.1747
   Rector RS, 2011, J APPL PHYSIOL, V111, P1828, DOI 10.1152/japplphysiol.00384.2011
   Rodino-Klapac LR, 2009, MUSCLE NERVE, V39, P283, DOI 10.1002/mus.21244
   Rolland Y, 2008, J NUTR HEALTH AGING, V12, P433, DOI 10.1007/BF02982704
   Rossi AP, 2017, DRUG AGING, V34, P833, DOI 10.1007/s40266-017-0496-0
   Rush Elaine, 2004, N Z Med J, V117, pU1203
   Sáinz N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006808
   Sanchis-Gomar F, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00156
   Satapathy SK, 2015, SEMIN LIVER DIS, V35, P221, DOI 10.1055/s-0035-1562943
   Schaap LA, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.10.049
   Shanaki M, 2017, DIABETES METAB SYND, V11, pS467, DOI 10.1016/j.dsx.2017.03.037
   Smith GI, 2015, AM J CLIN NUTR, V102, P115, DOI 10.3945/ajcn.114.105833
   Srikanthan P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010805
   Stenholm S, 2008, CURR OPIN CLIN NUTR, V11, P693, DOI 10.1097/MCO.0b013e328312c37d
   Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487
   van Zutphen T, 2016, J HEPATOL, V65, P1198, DOI 10.1016/j.jhep.2016.05.046
   Visser M, 2003, J CLIN ENDOCR METAB, V88, P5766, DOI 10.1210/jc.2003-030604
   Visser M, 2009, J NUTR HEALTH AGING, V13, P713, DOI 10.1007/s12603-009-0202-y
   Wang Q, 2012, J PHYSIOL-LONDON, V590, P2151, DOI 10.1113/jphysiol.2011.226001
   Waters DL, 2011, CLIN GERIATR MED, V27, P401, DOI 10.1016/j.cger.2011.03.007
   Wattacheril Julia, 2016, Curr Hepatol Rep, V15, P134
   Wise Jacqui, 2014, BMJ, V348, pg3582, DOI 10.1136/bmj.g3582
   Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431
NR 83
TC 37
Z9 37
U1 0
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1467-7881
EI 1467-789X
J9 OBES REV
JI Obes. Rev.
PD FEB
PY 2019
VL 20
IS 2
BP 353
EP 363
DI 10.1111/obr.12776
PG 11
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA HM8HY
UT WOS:000459722600011
PM 30474288
DA 2024-02-19
ER

PT J
AU Poynter, ME
   Daynes, RA
AF Poynter, ME
   Daynes, RA
TI Peroxisome proliferator-activated receptor α activation modulates
   cellular redox status, represses nuclear factor κB signaling, and
   reduces inflammatory cytokine production in aging
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID AGE-ASSOCIATED DECLINE; TRANSCRIPTION FACTOR; LIPID-PEROXIDATION;
   PPAR-ALPHA; FATTY-ACIDS; RAT-LIVER; DIFFERENTIAL EXPRESSION; DIETARY
   RESTRICTION; TARGETED DISRUPTION; BINDING-EFFICIENCY
AB In aged mice, the redox-regulated transcription factor nuclear factor-kappa B (NF-kappa B) becomes constitutively active in many tissues, as well as in cells of the hematopoietic system. This oxidative stress-induced activity promotes the production of a number of pro-inflammatory cytokines, which can contribute to the pathology of many disease states associated with aging. The administration to aged mice of agents capable of activating the alpha isoform of the peroxisome proliferator-activated receptor (PPAR alpha) was found to restore the cellular redox balance, evidenced by a lowering of tissue lipid peroxidation, an elimination of constitutively active NF-kappa B, and a loss in spontaneous inflammatory cytokine production. Aged animals bearing a null mutation in PPAR alpha failed to elicit these changes following treatment with PPAR alpha activators, but remained responsive to vitamin E supplementation. Aged C57BL/6 mice were found to express reduced transcript levels of PPAR alpha and the peroxisome-associated genes acyl-CoA oxidase and catalase. Supplementation of these aged mice with PPAR alpha activators or with vitamin E caused elevations in these transcripts to levels seen in young animals. Our results suggest that PPAR alpha and the genes under its control play a role in the evolution of oxidative stress excesses observed in aging.
C1 Univ Utah, Dept Pathol, Salt Lake City, UT 84132 USA.
   Vet Affairs Med Ctr, Ctr Geriatr Res Educ & Clin, Salt Lake City, UT 84112 USA.
C3 Utah System of Higher Education; University of Utah; US Department of
   Veterans Affairs; Veterans Health Administration (VHA); Geriatric
   Research Education & Clinical Center
RP Daynes, RA (corresponding author), Univ Utah, Dept Pathol, 50 N Med Dr, Salt Lake City, UT 84132 USA.
EM daynes.office@path.med.utah.edu
OI Poynter, Matthew/0000-0002-7578-4570
FU NCI NIH HHS [CA25917] Funding Source: Medline; NIA NIH HHS [AG11475]
   Funding Source: Medline; NICHD NIH HHS [5T32 HD07491] Funding Source:
   Medline
CR AMMENDOLA R, 1992, J BIOL CHEM, V267, P17944
   AMMENDOLA R, 1994, EUR J BIOCHEM, V225, P483, DOI 10.1111/j.1432-1033.1994.t01-1-00483.x
   Aoyama T, 1998, J BIOL CHEM, V273, P5678, DOI 10.1074/jbc.273.10.5678
   ARAGNO M, 1993, BIOCHEM PHARMACOL, V46, P1689, DOI 10.1016/0006-2952(93)90572-E
   BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.iy.12.040194.001041
   Barja G, 1996, LIPIDS, V31, P963, DOI 10.1007/BF02522690
   Beharka A, 1997, METHOD ENZYMOL, V282, P247
   Beier K, 1997, FEBS LETT, V412, P385, DOI 10.1016/S0014-5793(97)00805-3
   BEIER K, 1993, VIRCHOWS ARCH B, V63, P139, DOI 10.1007/BF02899254
   Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313
   Boccuzzi G, 1997, FREE RADICAL BIO MED, V22, P1289, DOI 10.1016/S0891-5849(96)00543-6
   BOGGS SS, 1978, P SOC EXP BIOL MED, V157, P424
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354
   Buege J A, 1978, Methods Enzymol, V52, P302
   BUNKER VW, 1992, MED LAB SCI, V49, P299
   CHANDRA RK, 1992, LANCET, V340, P1124, DOI 10.1016/0140-6736(92)93151-C
   CHEN F, 1993, BIOCHEM BIOPH RES CO, V196, P671, DOI 10.1006/bbrc.1993.2302
   CHOE M, 1995, FREE RADICAL BIO MED, V18, P977, DOI 10.1016/0891-5849(94)00217-8
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   Chorinchath BB, 1996, J IMMUNOL, V156, P1525
   DANENBERG HD, 1992, ANTIMICROB AGENTS CH, V36, P2275, DOI 10.1128/AAC.36.10.2275
   DAYNES RA, 1993, J IMMUNOL, V150, P5219
   DEMOZ A, 1992, LIPIDS, V27, P968, DOI 10.1007/BF02535573
   Devchand PR, 1996, NATURE, V384, P39, DOI 10.1038/384039a0
   DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475
   DREYER C, 1992, CELL, V68, P879, DOI 10.1016/0092-8674(92)90031-7
   ERSHLER WB, 1993, J AM GERIATR SOC, V41, P176, DOI 10.1111/j.1532-5415.1993.tb02054.x
   ERSHLER WB, 1993, LYMPHOKINE CYTOK RES, V12, P225
   Fan CY, 1996, J BIOL CHEM, V271, P24698, DOI 10.1074/jbc.271.40.24698
   Fan CY, 1998, J BIOL CHEM, V273, P15639, DOI 10.1074/jbc.273.25.15639
   FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0
   FRANKENBERGER M, 1994, BIOCHEM J, V304, P87, DOI 10.1042/bj3040087
   GEARING KL, 1994, J NUTR, V124, pS1284, DOI 10.1093/jn/124.suppl_8.1284S
   GEARING KL, 1994, BIOCHEM BIOPH RES CO, V199, P255, DOI 10.1006/bbrc.1994.1222
   GEARING KL, 1993, P NATL ACAD SCI USA, V90, P1440, DOI 10.1073/pnas.90.4.1440
   Gonzalez FJ, 1995, TOXICOL LETT, V82-3, P117, DOI 10.1016/0378-4274(95)03548-6
   GOTTLICHER M, 1992, P NATL ACAD SCI USA, V89, P4653, DOI 10.1073/pnas.89.10.4653
   HAGIHARA M, 1984, J GERONTOL, V39, P269, DOI 10.1093/geronj/39.3.269
   Helenius M, 1996, J MOL CELL CARDIOL, V28, P487, DOI 10.1006/jmcc.1996.0045
   Helenius M, 1996, BIOCHEM J, V318, P603, DOI 10.1042/bj3180603
   HERTZ R, 1987, BIOCHIM BIOPHYS ACTA, V917, P57, DOI 10.1016/0005-2760(87)90283-9
   HOFFMAN R, 1992, ATHEROSCLEROSIS, V93, P105, DOI 10.1016/0021-9150(92)90204-T
   HUBERMAN M, 1995, J NEUROL SCI, V130, P161, DOI 10.1016/0022-510X(95)00016-U
   HUELL M, 1995, ACTA NEUROPATHOL, V89, P544
   HYDE SR, 1992, INFECT IMMUN, V60, P976, DOI 10.1128/IAI.60.3.976-982.1992
   Inoue I, 1997, BIOCHEM BIOPH RES CO, V237, P606, DOI 10.1006/bbrc.1997.7196
   Inoue I, 1998, LIFE SCI, V63, P135, DOI 10.1016/S0024-3205(98)00249-5
   ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0
   Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184
   JugeAubry C, 1997, J BIOL CHEM, V272, P25252, DOI 10.1074/jbc.272.40.25252
   KLIEWER SA, 1994, P NATL ACAD SCI USA, V91, P7355, DOI 10.1073/pnas.91.15.7355
   KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9
   KLIEWER SA, 1992, NATURE, V358, P771, DOI 10.1038/358771a0
   KLUCIS E, 1984, MOL CELL BIOCHEM, V65, P73
   Korhonen P, 1997, NEUROSCI LETT, V225, P61, DOI 10.1016/S0304-3940(97)00190-0
   Lee SST, 1996, ANN NY ACAD SCI, V804, P524, DOI 10.1111/j.1749-6632.1996.tb18642.x
   LEE SST, 1995, MOL CELL BIOL, V15, P3012
   Lehmann JM, 1997, J BIOL CHEM, V272, P3406, DOI 10.1074/jbc.272.6.3406
   LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953
   Lemberger T, 1996, J BIOL CHEM, V271, P1764, DOI 10.1074/jbc.271.3.1764
   LEMBERGER T, 1994, J BIOL CHEM, V269, P24527
   Lemberger T, 1996, ANNU REV CELL DEV BI, V12, P335, DOI 10.1146/annurev.cellbio.12.1.335
   MASTERS CJ, 1995, MECH AGEING DEV, V80, P69, DOI 10.1016/0047-6374(94)01563-2
   MEYDANI SN, 1986, MECH AGEING DEV, V34, P191, DOI 10.1016/0047-6374(86)90034-5
   MEYDANI SN, 1995, AM J CLIN NUTR, V62, P1462
   MIHARA M, 1980, BIOCHEM MED METAB B, V23, P302, DOI 10.1016/0006-2944(80)90040-X
   Miyata KS, 1996, J BIOL CHEM, V271, P9189, DOI 10.1074/jbc.271.16.9189
   MOHAN PF, 1993, AM J MED SCI, V306, P10, DOI 10.1097/00000441-199307000-00004
   Muller JM, 1997, METHODS, V11, P301, DOI 10.1006/meth.1996.0424
   PALMER CNA, 1995, J BIOL CHEM, V270, P16114, DOI 10.1074/jbc.270.27.16114
   Parmentier JH, 1997, BIOCHEM PHARMACOL, V54, P889, DOI 10.1016/S0006-2952(97)00256-6
   Peters JM, 1996, MOL PHARMACOL, V50, P67
   Rao MS, 1996, ANN NY ACAD SCI, V804, P573, DOI 10.1111/j.1749-6632.1996.tb18646.x
   Ren B, 1996, J BIOL CHEM, V271, P17167, DOI 10.1074/jbc.271.29.17167
   Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178
   SCHMIDT A, 1992, MOL ENDOCRINOL, V6, P1634, DOI 10.1210/me.6.10.1634
   Schoonjans K, 1996, J LIPID RES, V37, P907
   SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x
   SCHRECK R, 1994, METHOD ENZYMOL, V234, P151
   SCHRECK R, 1992, J EXP MED, V175, P1181, DOI 10.1084/jem.175.5.1181
   SEMSEI I, 1989, BIOCHEM BIOPH RES CO, V164, P620, DOI 10.1016/0006-291X(89)91505-2
   Sen CK, 1996, FASEB J, V10, P709, DOI 10.1096/fasebj.10.7.8635688
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   Sohal R. S., 1981, AGE PIGMENTS
   Soliman MS, 1997, BIOCHEM PHARMACOL, V53, P1369, DOI 10.1016/S0006-2952(97)87956-7
   Spencer NFL, 1995, ANN NY ACAD SCI, V774, P200
   Spencer NFL, 1997, INT IMMUNOL, V9, P745, DOI 10.1093/intimm/9.5.745
   Spencer NFL, 1996, EXP GERONTOL, V31, P393, DOI 10.1016/0531-5565(95)02033-0
   Spencer NFL, 1997, INT IMMUNOL, V9, P1581, DOI 10.1093/intimm/9.10.1581
   Staels B, 1998, NATURE, V393, P790, DOI 10.1038/31701
   Sterchele PF, 1996, ARCH BIOCHEM BIOPHYS, V326, P281, DOI 10.1006/abbi.1996.0077
   SUPAKAR PC, 1995, J BIOL CHEM, V270, P837, DOI 10.1074/jbc.270.2.837
   TAMURA H, 1990, CARCINOGENESIS, V11, P445
   VANDENBOSCH H, 1992, ANNU REV BIOCHEM, V61, P157, DOI 10.1146/annurev.bi.61.070192.001105
   Vazquez M, 1996, BRIT J PHARMACOL, V117, P1155, DOI 10.1111/j.1476-5381.1996.tb16710.x
   YU K, 1995, J BIOL CHEM, V270, P23975, DOI 10.1074/jbc.270.41.23975
NR 97
TC 461
Z9 488
U1 0
U2 12
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI ROCKVILLE
PA 11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD DEC 4
PY 1998
VL 273
IS 49
BP 32833
EP 32841
DI 10.1074/jbc.273.49.32833
PG 9
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 144RP
UT WOS:000077329100069
PM 9830030
OA hybrid
DA 2024-02-19
ER

PT J
AU Duval, C
   Cohen, C
   Chagnoleau, C
   Flouret, V
   Bourreau, E
   Bernerd, F
AF Duval, Christine
   Cohen, Catherine
   Chagnoleau, Corinne
   Flouret, Virginie
   Bourreau, Emilie
   Bernerd, Francoise
TI Key Regulatory Role of Dermal Fibroblasts in Pigmentation as
   Demonstrated Using a Reconstructed Skin Model: Impact of Photo-Aging
SO PLOS ONE
LA English
DT Article
ID STEM-CELL FACTOR; HEPATOCYTE GROWTH-FACTOR; NORMAL HUMAN MELANOCYTES;
   SUN EXPOSURE; HYPERPIGMENTATION; MORPHOGENESIS; KERATINOCYTES;
   EXPRESSION; MECHANISM; HORMONE
AB To study cutaneous pigmentation in a physiological context, we have previously developed a functional pigmented reconstructed skin model composed of a melanocyte-containing epidermis grown on a dermal equivalent comprising living fibroblasts. The present studies, using the same model, aimed to demonstrate that dermal fibroblasts influence skin pigmentation up to the macroscopic level. The proof of principle was performed with pigmented skins differing only in the fibroblast component. First, the in vitro system was reconstructed with or without fibroblasts in order to test the global influence of the presence of this cell type. We then assessed the impact of the origin of the fibroblast strain on the degree of pigmentation using fetal versus adult fibroblasts. In both experiments, impressive variation in skin pigmentation at the macroscopic level was observed and confirmed by quantitative parameters related to skin color, melanin content and melanocyte numbers. These data confirmed the responsiveness of the model and demonstrated that dermal fibroblasts do indeed impact the degree of skin pigmentation. We then hypothesized that a physiological state associated with pigmentary alterations such as photo-aging could be linked to dermal fibroblasts modifications that accumulate over time. Pigmentation of skin reconstructed using young unexposed fibroblasts (n=3) was compared to that of tissues containing natural photo-aged fibroblasts (n=3) which express a senescent phenotype. A stimulation of pigmentation in the presence of the natural photo-aged fibroblasts was revealed by a significant increase in the skin color (decrease in Luminance) and an increase in both epidermal melanin content and melanogenic gene expression, thus confirming our hypothesis. Altogether, these data demonstrate that the level of pigmentation of the skin model is influenced by dermal fibroblasts and that natural photo-aged to fibroblasts can contribute to the hyperpigmentation that is associated with photoaging.
C1 [Duval, Christine; Cohen, Catherine; Chagnoleau, Corinne; Flouret, Virginie; Bourreau, Emilie; Bernerd, Francoise] LOreal Res & Innovat, Aulnay Sous Bois, France.
C3 L'Oreal Group
RP Duval, C (corresponding author), LOreal Res & Innovat, Aulnay Sous Bois, France.
EM cduval@rd.loreal.com
FU L'Oreal Research Innovation
FX The authors received no specific funding for this work. L'Oreal Research
   & Innovation provided support in the form of salaries for all authors,
   but did not have any additional role in the study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript. The specific roles of these authors are articulated in the
   "author contributions" section.
CR ABDELMALEK Z, 1995, P NATL ACAD SCI USA, V92, P1789, DOI 10.1073/pnas.92.5.1789
   ADZICK NS, 1994, ANN SURG, V220, P10, DOI 10.1097/00000658-199407000-00003
   ASSELINEAU D, 1985, EXP CELL RES, V159, P536, DOI 10.1016/S0014-4827(85)80027-6
   Bastiaens M, 2004, PIGM CELL RES, V17, P225, DOI 10.1111/j.1600-0749.2004.00131.x
   Bernerd F, 1997, DEV BIOL, V183, P123, DOI 10.1006/dbio.1996.8465
   BREATHNACH AS, 1991, PIGM CELL RES, V4, P71, DOI 10.1111/j.1600-0749.1991.tb00318.x
   BUFFEY JA, 1994, BRIT J DERMATOL, V131, P836, DOI 10.1111/j.1365-2133.1994.tb08586.x
   Cardinali G, 2009, EUR J DERMATOL, V19, P469, DOI 10.1684/ejd.2009.0724
   Cario-André M, 2006, PIGM CELL RES, V19, P434, DOI 10.1111/j.1600-0749.2006.00326.x
   Castanet J, 1997, ARCH DERMATOL, V133, P1296, DOI 10.1001/archderm.133.10.1296
   Choi W, 2010, J CELL SCI, V123, P3102, DOI 10.1242/jcs.064774
   Chung H, 2014, J BIOL CHEM, V289, P21751, DOI 10.1074/jbc.M113.541177
   CIE, 1986, COL, P29
   Duval C, 2001, PIGM CELL RES, V14, P348, DOI 10.1034/j.1600-0749.2001.140506.x
   Duval C, 2012, TISSUE ENG PART C-ME, V18, P947, DOI [10.1089/ten.tec.2011.0676, 10.1089/ten.TEC.2011.0676]
   Enomoto A, 2011, AM J PATHOL, V178, P679, DOI 10.1016/j.ajpath.2010.10.021
   Gilliver SC, 2011, EXP DERMATOL, V20, P1, DOI 10.1111/j.1600-0625.2010.01194.x
   Halaban R, 2000, PIGM CELL RES, V13, P4, DOI 10.1034/j.1600-0749.2000.130103.x
   Hedley SJ, 2002, PIGM CELL RES, V15, P49, DOI 10.1034/j.1600-0749.2002.00067.x
   Hedley SJ, 1997, PIGM CELL RES, V10, P54, DOI 10.1111/j.1600-0749.1997.tb00466.x
   Hirobe T, 2005, PIGM CELL RES, V18, P2, DOI 10.1111/j.1600-0749.2004.00198.x
   HOLZLE E, 1992, BRIT J DERMATOL, V127, P48, DOI 10.1111/j.1365-2133.1992.tb16989.x
   Imokawa G, 1998, BIOCHEM J, V330, P1235, DOI 10.1042/bj3301235
   Imokawa G, 2004, PIGM CELL RES, V17, P96, DOI 10.1111/j.1600-0749.2003.00126.x
   Itahana Koji, 2007, Methods Mol Biol, V371, P21
   Kawabata K, 2014, SKIN RES TECHNOL, V20, P155, DOI 10.1111/srt.12099
   Kihira C, 1999, J DERMATOL SCI, V20, P72, DOI 10.1016/S0923-1811(98)00077-2
   Kim E, 2013, CANCER RES, V73, P6874, DOI 10.1158/0008-5472.CAN-13-1720
   Kovacs D, 2010, BRIT J DERMATOL, V163, P1020, DOI 10.1111/j.1365-2133.2010.09946.x
   Lavker Robert M., 1995, P123
   Marionnet C, 2006, EXP DERMATOL, V15, P625, DOI 10.1111/j.1600-0625.2006.00454.x
   MATSUMOTO K, 1992, BIOCHEM BIOPH RES CO, V188, P235, DOI 10.1016/0006-291X(92)92375-8
   MATSUMOTO K, 1991, BIOCHEM BIOPH RES CO, V176, P45, DOI 10.1016/0006-291X(91)90887-D
   Meier F, 2000, AM J PATHOL, V156, P193, DOI 10.1016/S0002-9440(10)64719-0
   Mildner M, 2007, J INVEST DERMATOL, V127, P2637, DOI 10.1038/sj.jid.5700938
   Monestier S, 2006, BRIT J DERMATOL, V154, P438, DOI 10.1111/j.1365-2133.2005.06996.x
   Nakazawa K, 1997, PIGM CELL RES, V10, P382, DOI 10.1111/j.1600-0749.1997.tb00696.x
   Namazi MR, 2011, INT J DERMATOL, V50, P85, DOI 10.1111/j.1365-4632.2010.04678.x
   Nouveau-Richard S, 2005, J DERMATOL SCI, V40, P187, DOI 10.1016/j.jdermsci.2005.06.006
   Okazaki M, 2005, SCAND J PLAST RECONS, V39, P339, DOI 10.1080/02844310500300362
   Okazaki M, 2003, BRIT J DERMATOL, V148, P689, DOI 10.1046/j.1365-2133.2003.05283.x
   Ortonne JP, 2008, J INVEST DERM SYMP P, V13, P10, DOI 10.1038/jidsymp.2008.7
   Pouyani T, 2012, IN VITRO CELL DEV-AN, V48, P493, DOI 10.1007/s11626-012-9541-9
   Ramelet AA, 2009, EXP GERONTOL, V44, P208, DOI 10.1016/j.exger.2008.11.004
   RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8
   Scott G, 1997, J INVEST DERMATOL, V108, P147, DOI 10.1111/1523-1747.ep12332650
   Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9
   Shin J, 2012, J EUR ACAD DERMATOL, V26, P1577, DOI 10.1111/j.1468-3083.2011.04223.x
   Shishido E, 2001, J INVEST DERMATOL, V117, P627, DOI 10.1046/j.0022-202x.2001.01440.x
   Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003
   Slominski A, 2000, PHYSIOL REV, V80, P979, DOI 10.1152/physrev.2000.80.3.979
   Slominski A, 2012, PIGM CELL MELANOMA R, V25, P14, DOI 10.1111/j.1755-148X.2011.00898.x
   Slominski AT, 2013, ENDOCR REV, V34, P827, DOI 10.1210/er.2012-1092
   Slominski AT., 2012, ADV ANAT EMBRYOL CEL, V212, P1
   Souto Luís Ricardo Martinhão, 2006, Sao Paulo Med. J., V124, P71, DOI 10.1590/S1516-31802006000200005
   SWOPE VB, 1991, J INVEST DERMATOL, V96, P180, DOI 10.1111/1523-1747.ep12460991
   Varani J, 2004, J INVEST DERMATOL, V122, P1471, DOI 10.1111/j.0022-202X.2004.22614.x
   Wlaschek M, 2001, J PHOTOCH PHOTOBIO B, V63, P41, DOI 10.1016/S1011-1344(01)00201-9
   Yaar M, 1995, Adv Dermatol, V10, P63
   Yamaguchi Y, 2004, J CELL BIOL, V165, P275, DOI 10.1083/jcb.200311122
   Yamaguchi Y, 2008, FASEB J, V22, P1009, DOI 10.1096/fj.07-9475com
   Yamaguchi Y, 2009, BIOFACTORS, V35, P193, DOI 10.1002/biof.29
   Yamamoto T, 2001, BRIT J DERMATOL, V144, P199, DOI 10.1046/j.1365-2133.2001.03983.x
   Zuliani T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070408
NR 64
TC 70
Z9 75
U1 0
U2 26
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 9
PY 2014
VL 9
IS 12
AR e114182
DI 10.1371/journal.pone.0114182
PG 25
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA AY3YM
UT WOS:000347515300018
PM 25490395
OA gold, Green Published, Green Submitted
DA 2024-02-19
ER

PT J
AU Karlic, H
   Lohninger, S
   Koeck, T
   Lohninger, A
AF Karlic, H
   Lohninger, S
   Koeck, T
   Lohninger, A
TI Dietary L-carnitine stimulates carnitine acyltransferases in the liver
   of aged rats
SO JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
LA English
DT Article
DE carnitine palmitoyltransferases (CPT1 and CPT2); carnitine
   acetyltransferase (CRAT); transcription rate; enzyme activity; rat liver
ID PALMITOYLTRANSFERASE-I; FATTY-ACIDS; MALONYL-COA; PHOSPHATIDYLCHOLINE
   CONTENT; MITOCHONDRIAL DECAY; GENE-EXPRESSION; OLD RATS; CPT-I;
   INHIBITION; HEPATOCYTES
AB Aging affects oxidative metabolism in liver and other tissues. Carnitine acyltransferases are key enzymes of this process in mitochondria. As previously shown, the rate of transcription and activity of carnitine palmitoyltransferase CPT1 are also related to carnitine levels. In this study we compared the effect of dietary L-carnitine (100 mg L-carnitine/kg body weight/day over 3 months) on liver enzymes of aged rats (months 21-24) to adult animals (months 6-9) and age-related controls for both groups. The transcription rate of CPT1, CPT2, and carnitine acetyltransferase (CRAT) was determined by quantitative reverse transcription real-time PCR (RTQPCR) and compared to the activity of the CPT1A enzyme. The results showed that the transcription rates of CPT1, CPT2, and CRAT were similar in aged and adult control animals. Carnitine-fed old rats had a significant (p<0.05) 8-12-fold higher mean transcription rate of CPT1 and CRAT compared to aged controls, adult carnitine-fed animals, and adult controls, whereas the transcription rate of CPT2 was stimulated 2-3-fold in carnitine-fed animals of both age groups. With regard to the enzymatic activity of CPT1 there was a 1.5-fold increase in the old carnitine group compared to all other groups. RNA in situ hybridization also indicated an enhanced expression of CPT1A in hepatocytes from L-carnitine-supplemented animals. These results suggest that L-carnitine stimulates transcription of CPT1, CPT2, and CRAT as well as the enzyme activity of CPT1 in the livers of aged rats.
C1 Univ Vienna, Dept Med Chem, Ludwig Boltzmann Inst Leukemia Res & Hematol, A-1090 Vienna, Austria.
   Vet Univ Vienna, A-1030 Vienna, Austria.
C3 Ludwig Boltzmann Institute; University of Vienna; University of
   Veterinary Medicine Vienna
RP Lohninger, A (corresponding author), Univ Vienna, Dept Med Chem, Ludwig Boltzmann Inst Leukemia Res & Hematol, Wahringer Str 10, A-1090 Vienna, Austria.
CR Abo-Hashema KAH, 1999, J BIOL CHEM, V274, P35577, DOI 10.1074/jbc.274.50.35577
   BIEBER LL, 1972, ANAL BIOCHEM, V50, P509, DOI 10.1016/0003-2697(72)90061-9
   BODENNER DL, 1992, BIOCHEM BIOPH RES CO, V189, P1050, DOI 10.1016/0006-291X(92)92310-T
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   BRADY LJ, 1991, J NUTR, V121, P525, DOI 10.1093/jn/121.4.525
   BRADY PS, 1989, BIOCHEM J, V258, P677, DOI 10.1042/bj2580677
   BRADY PS, 1989, BIOCHEM PHARMACOL, V38, P811, DOI 10.1016/0006-2952(89)90235-9
   BREMER J, 1967, EUR J BIOCHEM, V1, P427, DOI 10.1111/j.1432-1033.1967.tb00091.x
   Broadway NM, 1999, ADV EXP MED BIOL, V466, P59
   Brown NF, 1997, BIOCHEM J, V327, P225, DOI 10.1042/bj3270225
   Chatelain F, 1996, EUR J BIOCHEM, V235, P789, DOI 10.1111/j.1432-1033.1996.00789.x
   Chiu KM, 1999, AGE AGEING, V28, P211, DOI 10.1093/ageing/28.2.211
   COOK GA, 1980, BIOCHEM J, V192, P955, DOI 10.1042/bj1920955
   COOK GA, 1984, J BIOL CHEM, V259, P2030
   Cook GA, 2001, J MOL CELL CARDIOL, V33, P317, DOI 10.1006/jmcc.2000.1304
   COSTELL M, 1989, BIOCHEM BIOPH RES CO, V161, P1135, DOI 10.1016/0006-291X(89)91360-0
   DUNNETT CW, 1964, BIOMETRICS, V20, P482, DOI 10.2307/2528490
   GADALETA MN, 1990, FEBS LETT, V277, P191, DOI 10.1016/0014-5793(90)80841-6
   GRANTHAM BD, 1988, BIOCHEM J, V249, P409, DOI 10.1042/bj2490409
   GUZMAN M, 1994, FEBS LETT, V344, P239, DOI 10.1016/0014-5793(94)00405-6
   Hagen TM, 1997, P NATL ACAD SCI USA, V94, P3064, DOI 10.1073/pnas.94.7.3064
   Hagen TM, 1998, P NATL ACAD SCI USA, V95, P9562, DOI 10.1073/pnas.95.16.9562
   HARANO Y, 1985, FEBS LETT, V188, P267, DOI 10.1016/0014-5793(85)80385-9
   Harrison DC, 2000, MOL BRAIN RES, V75, P143, DOI 10.1016/S0169-328X(99)00305-8
   Heo KN, 2000, J NUTR, V130, P2467, DOI 10.1093/jn/130.10.2467
   Jansen MS, 2000, J BIOL CHEM, V275, P34989, DOI 10.1074/jbc.M001752200
   JIN SJ, 1992, J BIOL CHEM, V267, P119
   JONAT C, 1990, CELL, V62, P1189, DOI 10.1016/0092-8674(90)90395-U
   Kerner J, 2000, BBA-MOL CELL BIOL L, V1486, P1, DOI 10.1016/S1388-1981(00)00044-5
   LOHNINGER A, 1986, J CLIN CHEM CLIN BIO, V24, P361
   Lohninger A, 1996, EUR J CLIN CHEM CLIN, V34, P387
   LOHNINGER A, 1986, PEDIATR RES, V20, P185
   MACCARI F, 1990, EXP GERONTOL, V25, P127, DOI 10.1016/0531-5565(90)90043-2
   MAEBASHI M, 1982, TOHOKU J EXP MED, V138, P231, DOI 10.1620/tjem.138.231
   McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x
   MOIR AMB, 1995, BIOCHEM J, V305, P953, DOI 10.1042/bj3050953
   Nowotny H, 1996, ANN HEMATOL, V72, P291, DOI 10.1007/s002770050175
   ODIET JA, 1995, MECH AGEING DEV, V79, P127, DOI 10.1016/0047-6374(94)01552-W
   Saheki T, 2000, MOL GENET METAB, V71, P545, DOI 10.1006/mgme.2000.3093
   Schmittgen TD, 2000, ANAL BIOCHEM, V285, P194, DOI 10.1006/abio.2000.4753
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   Starritt EC, 2000, AM J PHYSIOL-ENDOC M, V278, pE462, DOI 10.1152/ajpendo.2000.278.3.E462
   Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02
   THAKUR MK, 1997, MOL CELL BIOCHEM, V171, P445
   van der Leij FR, 2000, MOL GENET METAB, V71, P139, DOI 10.1006/mgme.2000.3055
   Van Leeuwen FW, 2000, ANN NY ACAD SCI, V908, P267
   Velasco G, 1998, FEBS LETT, V439, P317, DOI 10.1016/S0014-5793(98)01400-8
   Wang ZW, 2001, FASEB J, V15, P108, DOI 10.1096/fj.00-0310com
   Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085
   Wittwer CT, 1997, BIOTECHNIQUES, V22, P176, DOI 10.2144/97221pf02
NR 50
TC 81
Z9 89
U1 0
U2 8
PU HISTOCHEMICAL SOC INC
PI SEATTLE
PA UNIV WASHINGTON, DEPT BIOSTRUCTURE, BOX 357420, SEATTLE, WA 98195 USA
SN 0022-1554
J9 J HISTOCHEM CYTOCHEM
JI J. Histochem. Cytochem.
PD FEB
PY 2002
VL 50
IS 2
BP 205
EP 212
DI 10.1177/002215540205000208
PG 8
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA 516JB
UT WOS:000173549200008
PM 11799139
OA Bronze
DA 2024-02-19
ER

PT J
AU Bito, R
   Hino, S
   Baba, A
   Tanaka, M
   Watabe, H
   Kawabata, H
AF Bito, R
   Hino, S
   Baba, A
   Tanaka, M
   Watabe, H
   Kawabata, H
TI Degradation of oxidative stress-induced denatured albumin in rat liver
   endothelial cells
SO AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
LA English
DT Article
DE serum albumin; denaturation; scavenger receptor; caveolae
ID LOW-DENSITY-LIPOPROTEIN; CONFORMATIONALLY MODIFIED ALBUMINS;
   GLYCOSYLATION END-PRODUCTS; SERUM-ALBUMIN; SCAVENGER RECEPTOR;
   BINDING-PROTEINS; CAPILLARY-PERMEABILITY; AMINO-GROUPS; ENDOCYTOSIS;
   TRANSCYTOSIS
AB We previously identified conformationally denatured albumin (D2 and D3 albumin) in rats with endotoxicosis (Bito R, Shikano T, and Kawabata H. Biochim Biophys Acta 1646: 100-111, 2003). In the present study, we attempted first to confirm whether the denatured albumins generally increase in conditions of oxidative stress and second to characterize the degradative process of the denatured albumin using primary cultured rat liver endothelial cells. We used five models of oxidative stress, including endotoxicosis, ischemic heart disease, diabetes, acute inflammation, and aging, and found that serum concentrations of D3 albumin correlate with the serum levels of thiobarbituric acid-reactive substance (R = 0.87), whereas the concentrations of D2 albumin are 0.52. Ligand blot analysis showed that the D3 albumin binds to gp18 and gp30, which are known endothelial scavenger receptors for chemically denatured albumin. Primary cultured rat liver endothelial cells degraded the FITC-D3 albumin, and the degradation rate decreased to similar to 60% of control levels in response to anti-gp18 and anti-gp30 antibodies, respectively. An equimolar mixture of these antibodies produced an additive inhibitory effect on both uptake and degradation, resulting in levels similar to 20% those of the control. Furthermore, filipin and digitonin, inhibitors of the caveolae-related endocytic pathway, reduced the FITC-D3 albumin uptake and degradation to < 20%. Laser-scanning confocal microscopic observation supported these data regarding the uptake and degradation of D3 albumin. These results indicate that conformationally denatured D3 albumin occurs generally under oxidative stress and is degraded primarily via gp18 and gp30-mediated and caveolae-related endocytosis in liver endothelial cells.
C1 Meiji Univ, Lab Nutr Biochem, Sch Agr, Tama Ku, Kawasaki, Kanagawa 2148571, Japan.
C3 Meiji University
RP Kawabata, H (corresponding author), Meiji Univ, Lab Nutr Biochem, Sch Agr, Tama Ku, 1-1-1 Higashi Mita, Kawasaki, Kanagawa 2148571, Japan.
EM kawabata@isc.meiji.ac.jp
CR Adachi H, 1997, J BIOL CHEM, V272, P31217, DOI 10.1074/jbc.272.50.31217
   ANTOHE F, 1991, EUR J CELL BIOL, V56, P34
   Bates SR, 2000, AM J PHYSIOL-LUNG C, V278, pL443, DOI 10.1152/ajplung.2000.278.3.L443
   Bito R, 2003, BBA-PROTEINS PROTEOM, V1646, P100, DOI 10.1016/S1570-9639(03)00002-5
   BLOMHOFF R, 1984, BIOCHEM J, V218, P81, DOI 10.1042/bj2180081
   Brown D, 2000, AM J PHYSIOL-RENAL, V278, pF192, DOI 10.1152/ajprenal.2000.278.2.F192
   BUTLER PJG, 1969, BIOCHEM J, V112, P679, DOI 10.1042/bj1120679
   Canali R, 2000, FREE RADICAL BIO MED, V28, P1661, DOI 10.1016/S0891-5849(00)00285-9
   CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153
   Chan SS, 1998, FREE RADICAL BIO MED, V24, P1411, DOI 10.1016/S0891-5849(98)00010-0
   CHEN YH, 1972, BIOCHEMISTRY-US, V11, P4120, DOI 10.1021/bi00772a015
   DAVIES KJA, 1987, J BIOL CHEM, V262, P9908
   DICE JF, 1987, FASEB J, V1, P349, DOI 10.1096/fasebj.1.5.2824267
   Djoussé L, 2003, STROKE, V34, P53, DOI 10.1161/01.STR.0000048675.97975.84
   DOBRIAN A, 1993, BIOCHIM BIOPHYS ACTA, V1169, P12, DOI 10.1016/0005-2760(93)90076-L
   ERA S, 1995, BBA-PROTEIN STRUCT M, V1247, P12, DOI 10.1016/0167-4838(94)00166-E
   FIELDS R, 1971, BIOCHEM J, V124, P581, DOI 10.1042/bj1240581
   Gekle M, 2001, J PHYSIOL-LONDON, V531, P619, DOI 10.1111/j.1469-7793.2001.0619h.x
   Greive KA, 2003, AM J NEPHROL, V23, P38, DOI 10.1159/000066297
   Hansen B, 2005, EXP CELL RES, V303, P160, DOI 10.1016/j.yexcr.2004.09.017
   HORIUCHI S, 1985, J BIOL CHEM, V260, P475
   John TA, 2001, J PHYSIOL-LONDON, V533, P547, DOI 10.1111/j.1469-7793.2001.0547a.x
   Jono T, 2002, FEBS LETT, V511, P170, DOI 10.1016/S0014-5793(01)03325-7
   Junqueira Virginia B. C., 2004, Molecular Aspects of Medicine, V25, P5, DOI 10.1016/j.mam.2004.02.003
   Kataoka C, 2004, AM J PHYSIOL-HEART C, V286, pH768, DOI 10.1152/ajpheart.00937.2002
   Khan MA, 2002, INT J BIOL MACROMOL, V30, P171, DOI 10.1016/S0141-8130(02)00017-X
   KODAMA T, 1990, NATURE, V343, P531, DOI 10.1038/343531a0
   KODAMA T, 1988, P NATL ACAD SCI USA, V85, P9238, DOI 10.1073/pnas.85.23.9238
   Li YM, 1996, P NATL ACAD SCI USA, V93, P11047, DOI 10.1073/pnas.93.20.11047
   Mahesh T, 2004, PHYTOTHER RES, V18, P123, DOI 10.1002/ptr.1374
   MEGO JL, 1984, BIOCHEM J, V218, P775, DOI 10.1042/bj2180775
   Minshall RD, 2002, HISTOCHEM CELL BIOL, V117, P105, DOI 10.1007/s00418-001-0367-x
   NEEPER M, 1992, J BIOL CHEM, V267, P14998
   Ohgami N, 2001, J BIOL CHEM, V276, P13348, DOI 10.1074/jbc.M011613200
   Ohgami N, 2001, J BIOL CHEM, V276, P3195, DOI 10.1074/jbc.M006545200
   OHSHITA T, 1986, J BIOCHEM-TOKYO, V100, P623, DOI 10.1093/oxfordjournals.jbchem.a121754
   OHSHITA T, 1995, ANAL BIOCHEM, V230, P41, DOI 10.1006/abio.1995.1435
   OTTNAD E, 1990, BIOCHEM J, V265, P689, DOI 10.1042/bj2650689
   OTTNAD E, 1992, BIOCHEM J, V281, P745, DOI 10.1042/bj2810745
   Panes J, 1996, CIRCULATION, V93, P161, DOI 10.1161/01.CIR.93.1.161
   Peters T. J., 1996, ALL ALBUMIN BIOCH GE
   RADI R, 1991, ARCH BIOCHEM BIOPHYS, V286, P117, DOI 10.1016/0003-9861(91)90016-C
   Sawamura T, 1997, NATURE, V386, P73, DOI 10.1038/386073a0
   SCHMIDT AM, 1992, J BIOL CHEM, V267, P14987
   SCHNITZER JE, 1988, P NATL ACAD SCI USA, V85, P6773, DOI 10.1073/pnas.85.18.6773
   SCHNITZER JE, 1993, J BIOL CHEM, V268, P7562
   SCHNITZER JE, 1992, J BIOL CHEM, V267, P24544
   SCHNITZER JE, 1995, AM J PHYSIOL-HEART C, V268, pH48, DOI 10.1152/ajpheart.1995.268.1.H48
   SCHNITZER JE, 1994, J BIOL CHEM, V269, P6072
   Schnitzer JE, 2001, ADV DRUG DELIVER REV, V49, P265, DOI 10.1016/S0169-409X(01)00141-7
   SCHNITZER JE, 1994, J CELL BIOL, V127, P1217, DOI 10.1083/jcb.127.5.1217
   SCHREIBER G, 1982, J BIOL CHEM, V257, P271
   Sinha MK, 2003, CIRCULATION, V107, P2403, DOI 10.1161/01.CIR.0000072764.18315.6B
   SUZUKI E, 1992, DIABETES RES CLIN PR, V18, P153, DOI 10.1016/0168-8227(92)90140-M
   Tamura Y, 2003, J BIOL CHEM, V278, P12613, DOI 10.1074/jbc.M210211200
   Tiruppathi C, 1996, P NATL ACAD SCI USA, V93, P250, DOI 10.1073/pnas.93.1.250
   Tiruppathi C, 1997, J BIOL CHEM, V272, P25968, DOI 10.1074/jbc.272.41.25968
   Vogel SM, 2001, MICROVASC RES, V61, P87, DOI 10.1006/mvre.2000.2274
   YAGI K, 1984, METHOD ENZYMOL, V105, P328
   YAMANE A, 1994, ONCOGENE, V9, P2683
NR 60
TC 43
Z9 44
U1 0
U2 7
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0363-6143
EI 1522-1563
J9 AM J PHYSIOL-CELL PH
JI Am. J. Physiol.-Cell Physiol.
PD SEP
PY 2005
VL 289
IS 3
BP C531
EP C542
DI 10.1152/ajpcell.00431.2004
PG 12
WC Cell Biology; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Physiology
GA 955EI
UT WOS:000231207800005
PM 15872008
DA 2024-02-19
ER

PT J
AU Zhang, TR
   Li, HX
   Ouyang, CH
   Cao, GQ
   Gao, JG
   Wu, JL
   Yang, JM
   Yu, NW
   Min, Q
   Zhang, C
   Zhang, WC
AF Zhang, Tianran
   Li, Hongxuan
   Ouyang, Changhan
   Cao, Guangqing
   Gao, Jiangang
   Wu, Jiliang
   Yang, Jianmin
   Yu, Nengwang
   Min, Qing
   Zhang, Cheng
   Zhang, Wencheng
TI Liver kinase B1 inhibits smooth muscle calcification via high mobility
   group box 1
SO REDOX BIOLOGY
LA English
DT Article
DE Vascular calcification; LKB1; HMGB1; Runx2
ID CALCIUM-PHOSPHATE CRYSTALS; CHRONIC KIDNEY-DISEASE; VASCULAR
   CALCIFICATION; SIGNALING PATHWAYS; PHENOTYPE; CELLS; DIFFERENTIATION;
   METABOLISM; ACTIVATION; MECHANISM
AB Vascular calcification is a common pathological feature of atherosclerosis, chronic kidney disease, vascular injury, and aging. Liver kinase B1 (LKB1) plays pivotal roles in cellular processes such as apoptosis, metabolism, and cell cycle regulation. In addition, growing evidence has indicated that LKB1 functions as a tumor suppressor gene. However, its role in vascular calcification has not been reported. LKB1(flox/flox) mice were hybridized with SM22-CreER(T2) transgenic mice and adult mice received tamoxifen to obtain smooth muscle-specific LKB1-knockout (LKB1(SMKO)) mice. LKB1 expression was decreased under calcifying conditions, and LKB1 overexpression had a protective effect on vascular calcification. However, high mobility group box 1 (HMGB1) overexpression partially counteracted the promotion of vascular calcification induced by LKB1 overexpression. Mechanically, LKB1 could bind to HMGB1 to promote HMGB1 degradation. Furthermore, LKB1 LKB1(SMKO) mice showed intensified vascular calcification, which was alleviated by treatment with the HMGB1 inhibitor glycyrrhizic acid. Based on our results, LKB1 may inhibit vascular calcification via inhibiting HMGB1 expression.
C1 [Zhang, Tianran; Li, Hongxuan; Yang, Jianmin; Zhang, Cheng; Zhang, Wencheng] Shandong Univ, Key Lab Cardiovasc Remodeling & Funct Res, Chinese Minist Educ, Chinese Natl Hlth Commiss, Jinan, Peoples R China.
   [Zhang, Tianran; Li, Hongxuan; Yang, Jianmin; Zhang, Cheng; Zhang, Wencheng] Shandong Univ, Chinese Acad Med Sci, State & Shandong Prov Joint Key Lab Translat Card, Cheeloo Coll Med,Dept Cardiol,Qilu Hosp, Jinan, Peoples R China.
   [Ouyang, Changhan; Wu, Jiliang; Min, Qing; Zhang, Wencheng] Hubei Univ Sci & Technol, Sch Pharm, Xianning, Hubei, Peoples R China.
   [Cao, Guangqing] Shandong Univ, Dept Cardiovasc Surg, Qilu Hosp, Jinan, Shandong, Peoples R China.
   [Gao, Jiangang] Shandong Univ, Sch Life Sci, Jinan, Peoples R China.
   [Gao, Jiangang] Shandong Univ, Key Lab, Minist Educ Expt Teratol, Jinan, Peoples R China.
   [Yu, Nengwang] Shandong Univ, Dept Urol, Qilu Hosp, Jinan, Peoples R China.
C3 Shandong University; Shandong University; Chinese Academy of Medical
   Sciences - Peking Union Medical College; Hubei University of Science &
   Technology; Shandong University; Shandong University; Shandong
   University; Shandong University
RP Zhang, C; Zhang, WC (corresponding author), 107 Wen Hua Xi Rd, Jinan 250012, Shandong, Peoples R China.; Min, Q (corresponding author), 88 Xianning Rd, Xianning 437100, Hubei, Peoples R China.
EM baimin0628@hbust.edu.cn; zhangc@sdu.edu.cn; zhangwencheng@sdu.edu.cn
RI zhang, lin/IZQ-4870-2023; Zhang, Wencheng/AAO-8445-2020; Yang,
   Jianmin/AAB-4237-2020
FU National Natural Science Foundation of China [81770473, 81970198,
   81970366]; Taishan Scholar Project of Shandong Province of China
   [tsqn20161066]; Natural Science Foundation for Distinguished Young
   Scholars of Shandong Province [ZR201910230308]
FX This work was supported by the National Natural Science Foundation of
   China (no. 81770473, 81970198, 81970366); the Taishan Scholar Project of
   Shandong Province of China (no. tsqn20161066); the Natural Science
   Foundation for Distinguished Young Scholars of Shandong Province
   (ZR201910230308).
CR Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702
   Cai T, 2016, EXP CELL RES, V345, P206, DOI 10.1016/j.yexcr.2016.06.007
   Chen Q, 2017, CELL PHYSIOL BIOCHEM, V42, P427, DOI 10.1159/000477591
   Dai XY, 2013, KIDNEY INT, V83, P1042, DOI 10.1038/ki.2012.482
   Evrard S, 2015, CLIN CHIM ACTA, V438, P401, DOI 10.1016/j.cca.2014.08.034
   Ewence AE, 2008, CIRC RES, V103, pE28, DOI 10.1161/CIRCRESAHA.108.181305
   Gambardella J, 2020, ATHEROSCLEROSIS, V310, P88, DOI 10.1016/j.atherosclerosis.2020.07.025
   Giardiello FM, 2006, CLIN GASTROENTEROL H, V4, P408, DOI 10.1016/j.cgh.2005.11.005
   Han X, 2016, ATHEROSCLEROSIS, V244, P1, DOI 10.1016/j.atherosclerosis.2015.10.102
   Hayashi K, 1998, J BIOL CHEM, V273, P28860, DOI 10.1074/jbc.273.44.28860
   Hou ML, 2016, MOL CELL BIOCHEM, V420, P151, DOI 10.1007/s11010-016-2778-y
   Ikeda Y, 2009, J BIOL CHEM, V284, P35839, DOI 10.1074/jbc.M109.057273
   Jiang YF, 2017, BBA-MOL BASIS DIS, V1863, P3001, DOI 10.1016/j.bbadis.2017.08.009
   Jin X., 2018, CELL DEATH DIS, V9, P1
   Katajisto P, 2007, BBA-REV CANCER, V1775, P63, DOI 10.1016/j.bbcan.2006.08.003
   Kim H, 2012, J CELL MOL MED, V16, P273, DOI 10.1111/j.1582-4934.2011.01294.x
   Kim SG, 2018, J MED FOOD, V21, P146, DOI 10.1089/jmf.2017.4052
   Kühbandner S, 2000, GENESIS, V28, P15, DOI 10.1002/1526-968X(200009)28:1<15::AID-GENE20>3.0.CO;2-C
   Li HX, 2019, J MOL CELL CARDIOL, V130, P131, DOI 10.1016/j.yjmcc.2019.03.021
   Li Y., 2019, FASEB J OFFICIAL PUB
   Lin ME, 2015, AM J PATHOL, V185, P1958, DOI 10.1016/j.ajpath.2015.03.020
   Liu K, 2017, CELL CYCLE, V16, P578, DOI 10.1080/15384101.2017.1288324
   Liu Z., 2017, CIRC RES, V121
   Millar SA, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00369
   Mizobuchi M, 2009, J AM SOC NEPHROL, V20, P1453, DOI 10.1681/ASN.2008070692
   Moral-Sanz J, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aau0296
   Nadra I, 2005, CIRC RES, V96, P1248, DOI 10.1161/01.RES.0000171451.88616.c2
   Nakada D, 2010, NATURE, V468, P653, DOI 10.1038/nature09571
   Parhami F, 1996, J Atheroscler Thromb, V3, P90
   Pescatore L.A., 2019, MULTIFACETED MECH VA
   Proudfoot D, 2002, CIRCULATION, V106, P3044, DOI 10.1161/01.CIR.0000041429.83465.41
   Rennenberg RJMW, 2009, VASC HEALTH RISK MAN, V5, P185
   Rong S, 2014, CELL PHYSIOL BIOCHEM, V34, P2049, DOI 10.1159/000366400
   Sánchez-Duffhues G, 2019, J PATHOL, V247, P333, DOI 10.1002/path.5193
   Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676
   Shanahan CM, 2011, CIRC RES, V109, P697, DOI 10.1161/CIRCRESAHA.110.234914
   Shanahan CM, 1999, CIRCULATION, V100, P2168, DOI 10.1161/01.CIR.100.21.2168
   Steitz SA, 2001, CIRC RES, V89, P1147, DOI 10.1161/hh2401.101070
   Tang XQ, 2017, CIRCULATION, V136, P2051, DOI 10.1161/CIRCULATIONAHA.117.028728
   Vimalraj S, 2015, INT J BIOL MACROMOL, V78, P202, DOI 10.1016/j.ijbiomac.2015.04.008
   Voelkl J, 2018, J CLIN INVEST, V128, P3024, DOI 10.1172/JCI96477
   Wang B, 2016, J THORAC CARDIOV SUR, V151, P255, DOI 10.1016/j.jtcvs.2015.09.077
   Yadav SS, 2019, LIFE SCI, V220, P169, DOI 10.1016/j.lfs.2019.02.005
   Ylikorkala A, 2001, SCIENCE, V293, P1323, DOI 10.1126/science.1062074
   Zhang C, 2019, MOL MED, V25, DOI 10.1186/s10020-019-0099-9
   Zhang W., 2017, ONCOGENE, V36
   Zhang WC, 2014, CIRCULATION, V129, P1428, DOI 10.1161/CIRCULATIONAHA.113.004146
   Zhao D, 2020, J BIOL CHEM, V295, P16314, DOI 10.1074/jbc.RA120.015486
NR 48
TC 4
Z9 4
U1 5
U2 19
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2213-2317
J9 REDOX BIOL
JI Redox Biol.
PD JAN
PY 2021
VL 38
AR 101828
DI 10.1016/j.redox.2020.101828
PG 15
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA PO0ZM
UT WOS:000604900500003
PM 33338919
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Diniz, DG
   Foro, CAR
   Sosthenes, MCK
   Demachki, S
   Gomes, GF
   Malerba, GA
   Naves, TB
   Cavalcante, EAD
   Sousa, AMC
   Ferreira, FAB
   Anjos, PCS
   Neto, ALC
   Pinho, BG
   Brito, MV
   Freitas, PSL
   Casseb, SMM
   Silva, EVP
   Nunes, MRT
   Diniz, JAP
   Cunningham, C
   Perry, VH
   Vasconcelos, PFC
   Diniz, CWP
AF Diniz, D. G.
   Foro, C. A. R.
   Sosthenes, M. C. K.
   Demachki, S.
   Gomes, G. F.
   Malerba, G. A.
   Naves, T. B.
   Cavalcante, E. A. D.
   Sousa, A. M. C.
   Ferreira, F. A. B.
   Anjos, P. C. S.
   Neto, A. L. C.
   Pinho, B. G.
   Brito, M. V.
   Freitas, P. S. L.
   Casseb, S. M. M.
   Silva, E. V. P.
   Nunes, M. R. T.
   Diniz, J. A. P.
   Cunningham, C.
   Perry, V. H.
   Vasconcelos, P. F. C.
   Diniz, C. W. P.
TI AGING AND ENVIRONMENTAL ENRICHMENT EXACERBATE INFLAMMATORY RESPONSE ON
   ANTIBODY-ENHANCED DENGUE DISEASE IN IMMUNOCOMPETENT MURINE MODEL
SO EUROPEAN JOURNAL OF INFLAMMATION
LA English
DT Article
DE dengue infection; immunocompetent mice model; aging; environment; serial
   antibody-enhanced dengue disease; T lymphocytes and inflammation
ID T-CELLS; HEMORRHAGIC-FEVER; VIRUS-INFECTION; MICE; DEXAMETHASONE
AB We previously demonstrated in young mice that in comparison with animals raised in an impoverished environment (1E), animals from an enriched environment (EE) show more severe dengue disease, associated with an increased expansion of memory T target cells. Because active older adults show less functional decline in T-cell adaptive immunity, we hypothesized that aged mice from EE would show higher mortality and T-lymphocyte expansion than mice from IE. To test this hypothesis, we administered serial i.p. injections of anti-DENV2 hyperimmune serum, followed 24 h later by DENV3 (genotype III)-infected brain homogenate. Control mice received equal volumes of serum but received uninfected brain homogenate. The presence of virus or viral antigens was indirectly detected by realtime quantitative RT-PCR and immunohistochemistry. Compared to infected IE animals, EE mice, independent of age, showed higher mortality and more intense clinical signs. Compared to young mice, the higher mortality of aged mice was associated with a higher degree of T lymphocytic hyperplasia in the spleen and infiltration in kidneys, liver, and lungs, but less viral antigen immunolabeling. We propose that a higher expansion of T cells and serotype cross-reactive antibodies are associated with disease severity in aged mice.
C1 [Diniz, D. G.; Foro, C. A. R.; Sosthenes, M. C. K.; Demachki, S.; Gomes, G. F.; Malerba, G. A.; Naves, T. B.; Cavalcante, E. A. D.; Sousa, A. M. C.; Ferreira, F. A. B.; Anjos, P. C. S.; Diniz, C. W. P.] Fed Univ Para, Inst Cieneias Biol, Lab Invest Neurodegeneracao & Infeccao, Hosp Univ Joao Barros Barreto, BR-66073005 Belem, Para, Brazil.
   [Pinho, B. G.] Ctr Estudos Super Estado CESUPA, Belem, Para, Brazil.
   [Neto, A. L. C.] UEPA, Belem, Para, Brazil.
   [Brito, M. V.; Freitas, P. S. L.; Casseb, S. M. M.; Silva, E. V. P.; Nunes, M. R. T.; Diniz, J. A. P.; Vasconcelos, P. F. C.] IEC, Dept Arbovirol & Febres Hemorrag, Ananindeua, Para, Brazil.
   [Cunningham, C.] Trinity Coll Dublin, Trin Coll Inst Neurosci, Sch Biochem & Immunol, Dublin, Ireland.
   [Perry, V. H.] Univ Southampton, Ctr Biol Sci, Southampton, Hants, England.
C3 Universidade Federal do Para; Centro Universitario do Estado do Para
   (CESUPA); Universidade do Estado do Para (UEPA); Trinity College Dublin;
   University of Southampton
RP Diniz, CWP (corresponding author), Fed Univ Para, Inst Cieneias Biol, Lab Invest Neurodegeneracao & Infeccao, Hosp Univ Joao Barros Barreto, Mundueurus 4487, BR-66073005 Belem, Para, Brazil.
EM cwpdiniz@gmail.com
RI Sosthenes, Marcia/AAL-8306-2021; Foro, Cesar A R Augusto
   Raiol/W-8561-2018; Sosthenes, Marcia Consentino Kronka/AEF-5223-2022;
   Diniz, Cristovam Wanderley Picanço/IZP-8092-2023; Gomes, Giovanni
   Freitas/ABE-7314-2021; Casseb, Samir Mansour Moraes/AAB-1439-2021;
   Vasconcelos, Pedro/AAH-3142-2019; Diniz, Daniel Guerreiro/E-1840-2011;
   Perry, V. Hugh/Y-2935-2019; Nunes, Manuel R/P-1488-2017; Cunningham,
   Colm/A-1743-2010; Diniz, Cristovam W.P./G-1474-2010; Nunes, Marcio
   RT/B-2238-2016
OI Foro, Cesar A R Augusto Raiol/0000-0002-5435-124X; Diniz, Cristovam
   Wanderley Picanço/0000-0001-6611-6880; Gomes, Giovanni
   Freitas/0000-0002-4855-3056; Casseb, Samir Mansour
   Moraes/0000-0002-7419-3381; Diniz, Daniel Guerreiro/0000-0001-7369-2165;
   Cunningham, Colm/0000-0003-1423-5209; Diniz, Cristovam
   W.P./0000-0001-6611-6880; Nunes, Marcio RT/0000-0001-9739-5499
FU CNPq [300460/2005-8, 301955/2007-7, 471444/2006-5]; INCT-FHV/CNPq/CAPES/
   FAPESPA [573739/2008-0]; FINEP/ FADESP [01.04.0043.00];
   PROPESP-UFPA-FADESP; Instituto Nacional de Febres Hemorragicas Virais
   (INCT-FHV/CNPq); Instituto Brasileiro de Neurociencias IBNnet/ FINEP
FX This study had financial support from CNPq (grant no. 300460/2005-8,
   301955/2007-7, and 471444/2006-5), INCT-FHV/CNPq/CAPES/ FAPESPA (grant
   no. 573739/2008-0), FINEP/ FADESP (grant no. 01.04.0043.00) and
   PROPESP-UFPA-FADESP. Instituto Nacional de Febres Hemorragicas Virais
   (INCT-FHV/CNPq) supported SMMK, EVPS, JAPD, MRTN, CWPD and PFCV.
   Instituto Brasileiro de Neurociencias IBNnet/FINEP supported CWPD.
CR Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790
   Beaumier CM, 2008, J INFECT DIS, V197, P608, DOI 10.1086/526790
   Beaumier CM, 2010, VIRAL IMMUNOL, V23, P477, DOI 10.1089/vim.2010.0034
   Boonnak K, 2011, J VIROL, V85, P1671, DOI 10.1128/JVI.00220-10
   Castle SC, 2000, CLIN INFECT DIS, V31, P578, DOI 10.1086/313947
   Chang P E J, 2007, Singapore Med J, V48, pe71
   Cunningham C, 2007, BRAIN BEHAV IMMUN, V21, P490, DOI 10.1016/j.bbi.2006.12.007
   de Sousa AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015597
   Decman V, 2010, J IMMUNOL, V184, P5151, DOI 10.4049/jimmunol.0902063
   Diniz DG, 2012, MEM I OSWALDO CRUZ, V107, P1021, DOI 10.1590/S0074-02762012000800010
   Falconar AKI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021024
   Friberg H, 2011, SCI REP-UK, V1, DOI 10.1038/srep00051
   Gibbons RV, 2007, AM J TROP MED HYG, V77, P910, DOI 10.4269/ajtmh.2007.77.910
   Gubler DJ, 1999, ADV VIRUS RES, V53, P35, DOI 10.1016/S0065-3527(08)60342-5
   Guzman Maria G., 2002, International Journal of Infectious Diseases, V6, P118, DOI 10.1016/S1201-9712(02)90072-X
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4
   Jiang J, 2009, MECH AGEING DEV, V130, P713, DOI 10.1016/j.mad.2009.08.007
   Kularatne SAM, 2009, POSTGRAD MED J, V85, P525, DOI 10.1136/pgmj.2008.078444
   Lee SY, 2012, BRAIN RES, V1478, P48, DOI 10.1016/j.brainres.2012.08.035
   Lu YS, 2010, HEPATOB PANCREAT DIS, V9, P376
   Reis SRNI, 2007, MEM I OSWALDO CRUZ, V102, P983, DOI 10.1590/S0074-02762007000800014
   Premaratna R, 2012, INT J INFECT DIS, V16, pE565, DOI 10.1016/j.ijid.2012.02.014
   Rothman AL, 2010, CURR TOP MICROBIOL, V338, P83, DOI 10.1007/978-3-642-02215-9_7
   Sergerie Y, 2007, J INFECT DIS, V195, P817, DOI 10.1086/511987
   Simpson RJ, 2012, AGEING RES REV, V11, P404, DOI 10.1016/j.arr.2012.03.003
   Simpson RJ, 2010, GERONTOLOGY, V56, P449, DOI 10.1159/000270905
   Suaya JA, 2009, AM J TROP MED HYG, V80, P846, DOI 10.4269/ajtmh.2009.80.846
   Teeling JL, 2010, BRAIN BEHAV IMMUN, V24, P409, DOI 10.1016/j.bbi.2009.11.006
   Thomas Stephen J, 2003, Adv Virus Res, V61, P235, DOI 10.1016/S0065-3527(03)61006-7
   Van Laethem F, 2001, J EXP MED, V193, P803, DOI 10.1084/jem.193.7.803
   Zompi S, 2012, VIRUSES-BASEL, V4, P62, DOI 10.3390/v4010062
NR 32
TC 5
Z9 5
U1 0
U2 3
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1721-727X
EI 2058-7392
J9 EUR J INFLAMM
JI Eur. J. Inflamm.
PD SEP-DEC
PY 2013
VL 11
IS 3
BP 719
EP 731
DI 10.1177/1721727X1301100315
PG 13
WC Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology
GA 287HS
UT WOS:000329533300015
DA 2024-02-19
ER

PT J
AU Parentini, I
   Bergamini, E
   Cecchi, L
   Cavallini, G
   Donati, A
   Maccheroni, M
   Tamburini, I
   Gori, Z
AF Parentini, I
   Bergamini, E
   Cecchi, L
   Cavallini, G
   Donati, A
   Maccheroni, M
   Tamburini, I
   Gori, Z
TI The effect of carbon tetrachloride and ultraviolet radiation on dolichol
   levels in liver cells isolated from 3-and 24-month-old male
   Sprague-Dawley rats
SO BIOGERONTOLOGY
LA English
DT Article; Proceedings Paper
CT 3rd European Congress of Biogerontology
CY NOV 08-11, 2002
CL MONTECATINI TERME, ITALY
DE ageing; carbon tetrachloride; dolichol; liver cells; rats; UV-radiation
ID AGE-RELATED-CHANGES; ACCUMULATION; METABOLISM; PATHWAYS; ORGANS
AB Dolichol ( D) is a long- chain polyprenoid broadly distributed in the cell membranes, possibly endowed with a free-radical scavenging activity, whose concentration in tissues increases with increasing age. No enzyme pathway for D degradation has been discovered. In order to test the hypothesis that D might undergo a non- enzymatic free-radical mediated decomposition the effects of a xenobiotic agent ( carbon tetrachloride, CCl4) and ultraviolet- B ( UV- B) radiation on D levels were studied in liver cells isolated from male ad libitum fed Sprague- Dawley rats aged 3 or 24 months. Liver cells ( 90 mg/ ml) were incubated in sealed flasks ( 6 ml cell suspension each) for 0, 5, 10 and 20 min after the addition of 25, 50 or 200 mul CCl4 in the central well. 50 ml of a 6 mg/ ml liver cell suspension were poured in a 120 cm(2) Petri dish and the sediment liver cell monolayer was exposed to UVB radiation for 0, 5, 10, 20 and 40 min. At the given time, cells were taken and D was extracted and assayed by the HPLC procedure. D levels were remarkably higher in older than in younger cells as expected ( P < 0.001). Treatment with CCl4 and UVB caused a highly significant decrease in D ( P < 0.001) whose percentage was larger in younger than in older cells. The conclusions are that free- radicals generated either by chemical or by physical agents cause a very rapid depletion of D in liver cells, and that the effect of the free radical attack on D decomposition may be lower percentage wise in older than in younger cells, which might account at least in part for the accumulation of D in older tissues.
C1 Univ Pisa, Ctr Ric Interdipartimentale Biol & Patol Invecchi, Pisa, Italy.
   Azienda Osped Pisana, Pisa, Italy.
C3 University of Pisa; University of Pisa; Azienda Ospedaliero
   Universitaria Pisana
RP Bergamini, E (corresponding author), Univ Pisa, Ctr Ric Interdipartimentale Biol & Patol Invecchi, Pisa, Italy.
EM ebergamini@ipg.med.unipi.it
CR Bizzarri R, 2003, BIOGERONTOLOGY, V4, P353, DOI 10.1023/B:BGEN.0000006555.87407.04
   Boll M, 2001, Z NATURFORSCH C, V56, P649
   CARROLL KK, 1992, BIOCHEM CELL BIOL, V70, P382, DOI 10.1139/o92-059
   CHOJNACKI T, 1988, BIOCHEM J, V251, P1
   CRICK DC, 1987, BIOCHEM CELL BIOL, V65, P317, DOI 10.1139/o87-041
   de Gruijl FR, 2001, J PHOTOCH PHOTOBIO B, V63, P19, DOI 10.1016/S1011-1344(01)00199-3
   De Tata V, 2001, EXP GERONTOL, V36, P507, DOI 10.1016/S0531-5565(00)00259-X
   DIFFEY BL, 1991, PHYS MED BIOL, V36, P299, DOI 10.1088/0031-9155/36/3/001
   Dolfi C, 2003, BIOGERONTOLOGY, V4, P113, DOI 10.1023/A:1023304021679
   Donati A, 2001, J GERONTOL A-BIOL, V56, pB375, DOI 10.1093/gerona/56.9.B375
   ELMBERGER PG, 1987, EUR J BIOCHEM, V168, P1, DOI 10.1111/j.1432-1033.1987.tb13379.x
   HONG JY, 1987, BIOCHEM BIOPH RES CO, V142, P1077, DOI 10.1016/0006-291X(87)91525-7
   ISHINAGA M, 1993, P SOC EXP BIOL MED, V203, P74, DOI 10.3181/00379727-203-43575
   KALEN A, 1989, LIPIDS, V24, P579, DOI 10.1007/BF02535072
   KELLER RK, 1986, LIPIDS, V21, P353, DOI 10.1007/BF02535700
   Marino M, 1998, J GERONTOL A-BIOL, V53, pB87, DOI 10.1093/gerona/53A.2.B87
   PRONZATO MA, 1990, FREE RADICAL RES COM, V11, P267, DOI 10.3109/10715769009088924
   PULLARKAT RK, 1984, BIOCHIM BIOPHYS ACTA, V793, P494, DOI 10.1016/0005-2760(84)90269-8
   RECKNAGEL RO, 1973, CRC CRIT R TOXICOL, V27, P263
   Sarasin A, 1999, MUTAT RES-FUND MOL M, V428, P5, DOI 10.1016/S1383-5742(99)00025-3
   Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5
   Tedesco AC, 1997, BRAZ J MED BIOL RES, V30, P561, DOI 10.1590/S0100-879X1997000500002
   THELIN A, 1994, MECH AGEING DEV, V76, P165, DOI 10.1016/0047-6374(94)91591-1
NR 23
TC 14
Z9 15
U1 1
U2 1
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1389-5729
EI 1573-6768
J9 BIOGERONTOLOGY
JI Biogerontology
PY 2003
VL 4
IS 6
BP 365
EP 370
DI 10.1023/B:BGEN.0000006556.76899.29
PG 6
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Geriatrics & Gerontology
GA 750BM
UT WOS:000186971500005
PM 14739707
DA 2024-02-19
ER

PT J
AU Nikolic, I
   Todorovic, V
   Petrovic, A
   Petrovic, V
   Jovic, M
   Vladicic, J
   Puskas, N
AF Nikolic, Ivan
   Todorovic, Vera
   Petrovic, Aleksandar
   Petrovic, Vladimir
   Jovic, Marko
   Vladicic, Jelena
   Puskas, Nela
TI Immunohistochemical Heterogeneity of the Endothelium of Blood and
   Lymphatic Vessels in the Developing Human Liver and in Adulthood
SO CELLS TISSUES ORGANS
LA English
DT Article
DE Human liver; Endothelium; Antigen expression; CD31; CD34; D2-40; LYVE-1
ID EMBRYONIC-DEVELOPMENT; VASCULAR DEVELOPMENT; EXPRESSION; CELLS;
   ORGANOGENESIS; DIFFERENTIATION; CD34; FETUSES
AB The endothelium of liver sinusoids in relation to the endothelium of other blood vessels has specific antigen expression similar to the endothelium of lymphatic vessels. Bearing in mind that there is no consensus as to the period or intensity of the expression of certain antigens in the endothelium of blood and lymphatic vessels in the liver, the aim of our study was to immunohistochemically investigate the dynamic patterns of the expression of CD31, CD34, D2-40, and LYVE-1 antigens during liver development and in adulthood on paraffin tissue sections of human livers of 4 embryos, 38 fetuses, 6 neonates, and 6 adults. The results show that, in a histologically immature liver at the end of the embryonic period, CD34 molecules are expressed only on vein endothelium localized in developing portal areas, whereby the difference between portal venous branches and CD34-negative central veins belongs to the collecting venous system. In the fetal period, with aging, expression of CD34 and CD31 molecules on the endothelium of central veins and blood vessels of the portal areas increases. Sinusoidal endothelium shows light and sporadic CD34 immunoreactivity in the late embryonic and fetal periods, and is lost in the neonatal and adult periods, unlike CD31 immunoreactivity, which is poorly expressed in the fetal and neonatal periods but is present in adults. The endothelium of sinusoids and lymphatic vessels express LYVE-1, and the endothelium of lymphatic vessels express LYVE-1 and D2-40 but not CD34. Similarity between the sinusoidal and lymphatic endothelium includes the fact that both types are LYVE-1 positive and CD34 negative. (C) 2016 S. Karger AG, Basel
C1 [Nikolic, Ivan; Petrovic, Aleksandar; Petrovic, Vladimir; Jovic, Marko] Univ Nis, Fac Med, Dept Histol & Embryol, Bulevard Dr Zorana Dindica 81, RS-18000 Nish, Serbia.
   [Todorovic, Vera] Univ Business Acad, Fac Stomatol, Dept Histol & Embryol, Novi Sad, Serbia.
   [Puskas, Nela] Univ Belgrade, Sch Med, Inst Histol & Embryol, Belgrade, Serbia.
   [Vladicic, Jelena] Univ East Sarajevo, Fac Med Foca, Dept Histol & Embryol, Sarajevo, Bosnia & Herceg.
C3 University of Nis; University of Belgrade; University of East Sarajevo
RP Jovic, M (corresponding author), Univ Nis, Fac Med, Dept Histol & Embryol, Bulevard Dr Zorana Dindica 81, RS-18000 Nish, Serbia.
EM marko.jovic@medfak.ni.ac.rs
OI Petrovic, Vladimir/0000-0001-8618-694X; Puskas, Nela/0000-0002-5921-974X
FU Ministry of Education, Science and Technological Development of the
   Republic of Serbia [175061, 175015]
FX This study was supported by grants for scientific projects (No. 175061
   and 175015) from the Ministry of Education, Science and Technological
   Development of the Republic of Serbia.
CR Abe S, 2011, SURG RADIOL ANAT, V33, P919, DOI 10.1007/s00276-011-0854-2
   Amarapurkar AD, 2007, ANN HEPATOL, V6, P170, DOI 10.1016/S1665-2681(19)31924-6
   Arimoto J, 2010, J GASTROENTEROL, V45, P317, DOI 10.1007/s00535-009-0152-5
   Braet Filip, 2002, Comp Hepatol, V1, P1, DOI 10.1186/1476-5926-1-1
   Carreira CM, 2001, CANCER RES, V61, P8079
   Civin CI, 1989, LEUKOCYTE TYPING, P818
   Collardeau-Frachon S, 2008, ANAT REC, V291, P614, DOI 10.1002/ar.20679
   COUVELARD A, 1993, AM J PATHOL, V143, P738
   Couvelard A, 1996, BLOOD, V87, P4568, DOI 10.1182/blood.V87.11.4568.bloodjournal87114568
   Daneker GW, 1998, IN VITRO CELL DEV-AN, V34, P370, DOI 10.1007/s11626-998-0018-9
   Duncan SA, 2003, MECH DEVELOP, V120, P19, DOI 10.1016/S0925-4773(02)00328-3
   ELFILALI E, 2014, MOL THER-METH CLIN D, V1, P1
   Elvevold K, 2008, AM J PHYSIOL-GASTR L, V294, pG391, DOI 10.1152/ajpgi.00167.2007
   ENZAN H, 1983, ACTA PATHOL JAPON, V33, P447
   Gligorijevic J, 2010, VOJNOSANIT PREGL, V67, P459, DOI 10.2298/VSP1006459G
   Gouysse G, 2002, J HEPATOL, V37, P730, DOI 10.1016/S0168-8278(02)00282-9
   Lalor PF, 2006, WORLD J GASTROENTERO, V12, P5429, DOI 10.3748/wjg.v12.i34.5429
   Nonaka H, 2007, DEV DYNAM, V236, P2258, DOI 10.1002/dvdy.21227
   O'Rahilly R., 1987, DEV STAGES HUMAN EMB, P1
   Pusztaszeri MP, 2006, J HISTOCHEM CYTOCHEM, V54, P385, DOI 10.1369/jhc.4A6514.2005
   Salmi M, 2005, NAT REV IMMUNOL, V5, P760, DOI 10.1038/nri1705
   Si-Tayeb K, 2010, DEV CELL, V18, P175, DOI 10.1016/j.devcel.2010.01.011
   Sidney LE, 2014, STEM CELLS, V32, P1380, DOI 10.1002/stem.1661
   Tavian M, 2005, INT J DEV BIOL, V49, P243, DOI 10.1387/ijdb.041957mt
   WISSE E, 1985, HEPATOLOGY, V5, P683, DOI 10.1002/hep.1840050427
   Wróbel T, 2005, LYMPHOLOGY, V38, P107
   Zeng WJ, 2010, ANN SURG ONCOL, V17, P1564, DOI 10.1245/s10434-009-0900-z
   Zhao R, 2005, HEPATOLOGY, V41, P956, DOI 10.1002/hep.20691
NR 28
TC 3
Z9 4
U1 0
U2 3
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1422-6405
EI 1422-6421
J9 CELLS TISSUES ORGANS
JI Cells Tissues Organs
PY 2017
VL 203
IS 4
BP 243
EP 257
DI 10.1159/000452214
PG 15
WC Anatomy & Morphology; Cell Biology; Developmental Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Anatomy & Morphology; Cell Biology; Developmental Biology
GA ES8YO
UT WOS:000399843000004
PM 27889769
DA 2024-02-19
ER

PT J
AU Noordam, R
   Vermond, D
   Drenth, H
   Wijman, CA
   Akintola, AA
   van der Kroef, S
   Jansen, SWM
   Huurman, NC
   Schutte, BAM
   Beekman, M
   Slagboom, PE
   Mooijaart, SP
   van Heemst, D
AF Noordam, Raymond
   Vermond, Debbie
   Drenth, Hermijntje
   Wijman, Carolien A.
   Akintola, Abimbola A.
   van der Kroef, Sabrina
   Jansen, Steffy W. M.
   Huurman, Neline C.
   Schutte, Bianca A. M.
   Beekman, Marian
   Slagboom, P. Eline
   Mooijaart, Simon P.
   van Heemst, Diana
TI High Liver Enzyme Concentrations are Associated with Higher Glycemia,
   but not with Glycemia Variability, in Individuals without Diabetes
   Mellitus
SO FRONTIERS IN ENDOCRINOLOGY
LA English
DT Article
DE continuous glucose monitoring; liver enzymes; glycemia; glycemic
   variability; cross-sectional cohort study
ID GAMMA-GLUTAMYL-TRANSFERASE; IMPAIRED FASTING GLUCOSE; FATTY LIVER;
   ALANINE AMINOTRANSFERASE; INSULIN-RESISTANCE; CARDIOVASCULAR-DISEASE;
   LEIDEN LONGEVITY; RISK; ADULTS; METAANALYSIS
AB Background: Elevated concentrations of liver enzymes have been associated with an increased risk of developing type 2 diabetes mellitus. However, it remains unclear to which specific aspects of diurnal glucose metabolism these associate most. We aimed to investigate the associations between liver enzyme concentrations and 24 h-glucose trajectories in individuals without diabetes mellitus from three independent cohorts.
   Methods: This cross-sectional study included 436 participants without diabetes mellitus from the Active and Healthy Aging Study, the Switchbox Study, and the Growing Old Together Study. Fasting blood samples were drawn to measure gammaglutamyltransferase (GGT), alanine transaminase, and aspartate transaminase. Measures of glycemia (e.g., nocturnal and diurnal mean glucose levels) and glycemic variability (e.g., mean amplitude of glucose excursions) were derived from continuous glucose monitoring. Analyses were performed separately for the three cohorts; derived estimates were additionally meta-analyzed.
   results: After meta-analyses of the three cohorts, elevated liver enzyme concentrations, and specifically elevated GGT concentrations, were associated with higher glycemia. More specific, participants in the highest GGT tertile (GGT >= 37.9 U/L) had a 0.39 mmol/L (95% confidence interval: 0.23, 0.56) higher mean nocturnal glucose (3: 00 to 6: 00 a. m.) and a 0.23 mmol/L (0.10, 0.36) higher diurnal glucose (6: 00 to 0: 00 a. m.) than participants in the lowest GGT tertile (GGT <21.23 U/L). However, elevated liver enzyme concentrations were not associated with a higher glycemic variability.
   conclusion: Though elevated liver enzyme concentrations did not associate with higher glycemic variability in participants without diabetes mellitus, specifically, elevated GGT concentrations associated with higher glycemia.
C1 [Noordam, Raymond; Vermond, Debbie; Drenth, Hermijntje; Wijman, Carolien A.; Akintola, Abimbola A.; van der Kroef, Sabrina; Jansen, Steffy W. M.; Huurman, Neline C.; Mooijaart, Simon P.; van Heemst, Diana] Leiden Univ, Med Ctr, Dept Internal Med, Sect Gerontol & Geriatr, Leiden, Netherlands.
   [Vermond, Debbie; Drenth, Hermijntje] Leyden Acad Vital & Ageing, Leiden, Netherlands.
   [Schutte, Bianca A. M.; Beekman, Marian; Slagboom, P. Eline] Leiden Univ, Med Ctr, Dept Med Stat & Bioinformat, Sect Mol Epidemiol, Leiden, Netherlands.
   [Mooijaart, Simon P.] IEMO, Inst Evidence Based Med Old Age, Leiden, Netherlands.
C3 Leiden University - Excl LUMC; Leiden University; Leiden University
   Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University;
   Leiden University Medical Center (LUMC)
RP Noordam, R (corresponding author), Leiden Univ, Med Ctr, Dept Internal Med, Sect Gerontol & Geriatr, Leiden, Netherlands.
EM r.noordam@lumc.nl
RI Mooijaart, Simon P./A-5306-2008; Slagboom, P. Eline/R-4790-2016;
   Beekman, Marian/L-3004-2019; Akintola, Abi/T-5361-2019
OI Mooijaart, Simon P./0000-0003-3106-3568; Beekman,
   Marian/0000-0003-0585-6206; Noordam, Raymond/0000-0001-7801-809X
FU Philips Consumer Lifestyle; Netherlands Genomics Initiative/Netherlands
   Organization for scientific research (NGI/NWO) [05040202, 050-060-810];
   European Commission project Switchbox (FP7) [Health-F2-2010-259772]; the
   Netherlands Consortium for Healthy Ageing [050-060-810]; European
   Commission [Health-2013-INNOVATION-1-602757]
FX The AGO study was financially supported by Philips Consumer Lifestyle,
   and the Netherlands Genomics Initiative/Netherlands Organization for
   scientific research (NGI/NWO; 05040202 and 050-060-810). The Switchbox
   Study was funded by the European Commission project Switchbox (FP7,
   Health-F2-2010-259772). The GOTO study was financially supported by the
   Netherlands Consortium for Healthy Ageing (grant 050-060-810), in the
   framework of the Netherlands Genomics Initiative, Netherlands
   Organization for Scientific Research (NWO). The present study was funded
   by the European Commission funded project HUMAN
   (Health-2013-INNOVATION-1-602757). All the funders had no role in the
   design and performance of the study, nor in the analyses or
   interpretation of the data, or in the drafting of the manuscript.
CR Akehi Y, 2010, ENDOCR J, V57, P981, DOI 10.1507/endocrj.K10E-174
   Akintola AA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139973
   André P, 2005, DIABETES METAB, V31, P542, DOI 10.1016/S1262-3636(07)70229-X
   Atlas D., 2015, IDF DIABETES ATLAS, V33
   Bi YF, 2012, DIABETES-METAB RES, V28, P32, DOI 10.1002/dmrr.2352
   Ceriello A, 2004, ARTERIOSCL THROM VAS, V24, P816, DOI 10.1161/01.ATV.0000122852.22604.78
   Fraser A, 2007, HEPATOLOGY, V46, P158, DOI 10.1002/hep.21667
   Fraser A, 2009, DIABETES CARE, V32, P741, DOI 10.2337/dc08-1870
   Hotamisligil GS, 2003, INT J OBESITY, V27, pS53, DOI 10.1038/sj.ijo.0802502
   Jansen SW, 2015, SCI REP-UK, V5, DOI 10.1038/srep11525
   Kelley DE, 2003, AM J PHYSIOL-ENDOC M, V285, pE906, DOI 10.1152/ajpendo.00117.2003
   Kim HJ, 2004, ARCH INTERN MED, V164, P2169, DOI 10.1001/archinte.164.19.2169
   Kunutsor SK, 2014, ANN EPIDEMIOL, V24, P809, DOI 10.1016/j.annepidem.2014.09.001
   Lee YS, 2016, HUM MOL GENET, V25, P3877, DOI 10.1093/hmg/ddw226
   Liang J, 2014, CELL BIOCHEM BIOPHYS, V70, P1823, DOI 10.1007/s12013-014-0136-9
   Mahajan A, 2014, NAT GENET, V46, P234, DOI 10.1038/ng.2897
   Mastrototaro J J, 2000, Diabetes Technol Ther, V2 Suppl 1, pS13, DOI 10.1089/15209150050214078
   MOLNAR GD, 1972, DIABETOLOGIA, V8, P342, DOI 10.1007/BF01218495
   Nalysnyk L, 2010, DIABETES OBES METAB, V12, P288, DOI 10.1111/j.1463-1326.2009.01160.x
   Noordam R, 2016, INT J EPIDEMIOL, V45, P1953, DOI 10.1093/ije/dyw306
   Radetti G, 2006, ACTA PAEDIATR, V95, P833, DOI 10.1080/08035250500449890
   Sala M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091085
   Schoenmaker M, 2006, EUR J HUM GENET, V14, P79, DOI 10.1038/sj.ejhg.5201508
   SERVICE FJ, 1970, DIABETES, V19, P644, DOI 10.2337/diab.19.9.644
   SONKSEN PH, 1978, LANCET, V1, P729
   Succurro E, 2011, NUTR METAB CARDIOVAS, V21, P713, DOI 10.1016/j.numecd.2011.02.002
   Targher G, 2008, DIABETOLOGIA, V51, P1947, DOI 10.1007/s00125-008-1135-4
   van de Rest O, 2016, AGING-US, V8, P111, DOI 10.18632/aging.100877
   van der Kroef S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149992
   Westendorp RGJ, 2009, J AM GERIATR SOC, V57, P1634, DOI 10.1111/j.1532-5415.2009.02381.x
   Wijsman CA, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2843
   Wijsman CA, 2013, AGING CELL, V12, P207, DOI 10.1111/acel.12042
   Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047
   Xie JH, 2016, J HUAZHONG U SCI-MED, V36, P53, DOI 10.1007/s11596-016-1541-7
   Yueh CY, 2011, DIABETES RES CLIN PR, V94, P64, DOI 10.1016/j.diabres.2011.05.038
   Zhou J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056072
NR 36
TC 8
Z9 7
U1 0
U2 4
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015,
   SWITZERLAND
SN 1664-2392
J9 FRONT ENDOCRINOL
JI Front. Endocrinol.
PD SEP 13
PY 2017
VL 8
AR 236
DI 10.3389/fendo.2017.00236
PG 8
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA FG9HA
UT WOS:000410748300001
PM 28955304
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU KUMAGAI, H
   MATSUURA, M
   MURAKAMI, A
   HIROSE, S
AF KUMAGAI, H
   MATSUURA, M
   MURAKAMI, A
   HIROSE, S
TI EFFECT OF AGING, CASTRATION, AND TESTOSTERONE ADMINISTRATION ON
   RIBONUCLEASE AND RIBONUCLEASE-INHIBITOR ACTIVITIES IN THE PROSTATE OF
   RATS
SO CHEMICAL & PHARMACEUTICAL BULLETIN
LA English
DT Article
DE RNASE-INHIBITOR; RNASE; PROSTATE; AGING; CASTRATION; TESTOSTERONE; RAT
ID ALKALINE RIBONUCLEASE; PURIFICATION; LIVER; POLYAMINES; COMPLEX; UTERUS;
   GLAND
AB Free ribonuclease (RNase)-inhibitor activities in both ventral and dorsal prostates had their highest peaks in 4-week-old rats and smallest peaks in around 7-week-old animals. Total RNase activity in the ventral prostate decreased overall with age, while that in the dorsal prostate increased. No significant amount of free RNase activity was found in either prostate.
   Weight, protein content, and free RNase-inhibitor activity in both prostates decreased after castration and increased after administration of testosterone to castrated rats. Total RNase activity in the ventral prostate was increased by castration and decreased by testosterone administration. In the dorsal prostate, total RNase activity had two peaks, 7d after castration and 2d after testosterone administration. A large amount of free RNase activity was found in the ventral prostate 7 d after castration and this activity was decreased by testosterone administration. In the dorsal prostate, free RNase activity was not detected after castration and testosterone administration.
   These results suggest that changes in the level of RNase-inhibitor in both prostates are involved in the regulation of their RNA content through the control of free RNase activity.
RP KUMAGAI, H (corresponding author), CHIBA UNIV, FAC PHARMACEUT SCI, 1-33 YAYOI CHO, CHIBA 260, JAPAN.
CR BLACKBURN P, 1977, J BIOL CHEM, V252, P5904
   BROCKDORFF NA, 1986, MOL CELL ENDOCRINOL, V44, P117, DOI 10.1016/0303-7207(86)90053-5
   COFFEY DS, 1968, ARCH BIOCHEM BIOPHYS, V124, P181
   FOMINAYA JM, 1988, BIOCHIM BIOPHYS ACTA, V954, P216, DOI 10.1016/0167-4838(88)90074-X
   GOODLAD GAJ, 1975, BIOCHIM BIOPHYS ACTA, V378, P221, DOI 10.1016/0005-2787(75)90110-0
   GREIF RL, 1972, BIOCHIM BIOPHYS ACTA, V286, P350, DOI 10.1016/0304-4165(72)90270-X
   HIROSE S, 1977, J BIOCHEM-TOKYO, V82, P1605, DOI 10.1093/oxfordjournals.jbchem.a131856
   IMARIE RC, 1965, BIOCHIM BIOPHYS ACTA, V108, P106
   KERSHNER RM, 1976, BIOCHEM BIOPH RES CO, V70, P513, DOI 10.1016/0006-291X(76)91076-7
   KRAFT N, 1970, BIOCHIM BIOPHYS ACTA, V217, P164, DOI 10.1016/0005-2787(70)90133-4
   KUMAGAI H, 1979, BIOCHIM BIOPHYS ACTA, V566, P192, DOI 10.1016/0005-2744(79)90261-4
   KUMAGAI H, 1983, J BIOCHEM-TOKYO, V94, P71, DOI 10.1093/oxfordjournals.jbchem.a134356
   KUMAGAI H, 1977, J BIOCHEM-TOKYO, V81, P381, DOI 10.1093/oxfordjournals.jbchem.a131469
   LIU DK, 1977, BIOCHEM J, V164, P371, DOI 10.1042/bj1640371
   LIU DK, 1975, BIOCHEM J, V148, P67, DOI 10.1042/bj1480067
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MAINWARING WI, 1973, J ENDOCRINOL, V59, P121, DOI 10.1677/joe.0.0590121
   MATSUO Y, 1987, TAMPAKUSHITSU KAKUSA, V32, P1126
   MCGREGOR CW, 1981, J STEROID BIOCHEM, V14, P415, DOI 10.1016/0022-4731(81)90351-4
   MOORE RJ, 1973, ENDOCRINOLOGY, V93, P581, DOI 10.1210/endo-93-3-581
   MUNRO J, 1982, J STEROID BIOCHEM, V16, P293, DOI 10.1016/0022-4731(82)90179-0
   ROTH JS, 1967, METHOD CANCER RES, V3, P153
   SCHAUER RC, 1981, HORM METAB RES, V13, P50, DOI 10.1055/s-2007-1019165
   SHIMAZAKI J, 1969, ENDOCRINOL JAPON, V16, P453
   SHORTMAN K, 1961, BIOCHIM BIOPHYS ACTA, V51, P37, DOI 10.1016/0006-3002(61)91014-9
   SHORTMAN K, 1962, BIOCHIM BIOPHYS ACTA, V61, P50, DOI 10.1016/0926-6550(62)90028-2
   SIERAKOWSKA H, 1977, PROG NUCL ACID RES M, V20, P60
   TVETER KJ, 1969, ENDOCRINOLOGY, V85, P683, DOI 10.1210/endo-85-4-683
   ZANKOWALCZEWSKA M, 1975, BIOCHEM BIOPH RES CO, V65, P833, DOI 10.1016/S0006-291X(75)80461-X
NR 29
TC 3
Z9 3
U1 0
U2 0
PU PHARMACEUTICAL SOC JAPAN
PI TOKYO
PA 2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN
SN 0009-2363
J9 CHEM PHARM BULL
JI Chem. Pharm. Bull.
PD JAN
PY 1991
VL 39
IS 1
BP 137
EP 141
PG 5
WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology &
   Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy; Chemistry
GA EX001
UT WOS:A1991EX00100028
PM 2049797
DA 2024-02-19
ER

PT J
AU Musallam, KM
   Cappellini, MD
   Wood, JC
   Motta, I
   Graziadei, G
   Tamim, H
   Taher, AT
AF Musallam, Khaled M.
   Cappellini, Maria Domenica
   Wood, John C.
   Motta, Irene
   Graziadei, Giovanna
   Tamim, Hani
   Taher, Ali T.
TI Elevated liver iron concentration is a marker of increased morbidity in
   patients with β thalassemia intermedia
SO HAEMATOLOGICA-THE HEMATOLOGY JOURNAL
LA English
DT Article
DE thalassemia intermedia; liver iron concentration; iron overload;
   vascular disease; endocrine disease; osteoporosis
ID SICKLE-CELL-DISEASE; PULMONARY ARTERIAL-HYPERTENSION;
   MAGNETIC-RESONANCE; INEFFECTIVE ERYTHROPOIESIS; SPLENECTOMIZED PATIENTS;
   HYPERCOAGULABLE STATE; CHELATING THERAPY; SERUM FERRITIN; HEART-DISEASE;
   OVERLOAD
AB Background
   Patients with beta thalassemia intermedia can have substantial iron overload, irrespectively of their transfusion status, secondary to increased intestinal iron absorption. This study evaluates whether iron overload in patients with beta thalassemia intermedia is associated with morbidity.
   Design and Methods
   This was a cross-sectional study of 168 patients with beta thalassemia intermedia treated at two centers in Lebanon and Italy. Data on demographics, splenectomy status, transfusion status, and presence of co-morbidities were retrieved. Laboratory values of serum ferritin, fetal and total hemoglobin levels, as well as platelet and nucleated red blood cell counts were also obtained. Iron burden was determined directly by measuring liver iron concentration using magnetic resonance imaging. Patients were subdivided according to transfusion and splenectomy status into groups with phenotypes of different severity.
   Results
   The mean age of the patients was 35.2 +/- 12.6 years and 42.9% of them were male. The mean liver iron concentration was 8.4 +/- 6.7 mg Fe/g dry weight. On multivariate logistic regression analysis, after adjusting for age, gender, splenectomy status, transfusion status, and laboratory indices, an increase in 1 mg Fe/g dry weight liver iron concentration was independently and significantly associated with higher odds of thrombosis, pulmonary hypertension, hypothyroidism, osteoporosis, and hypogonadism. A liver iron concentration of at least 7 and at least 6 mg Fe/g dry weight were the best thresholds for discriminating the presence and absence of vascular and endocrine/bone morbidities, respectively (area under the receiver-operating characteristic curve: 0.72, P<0.001). Elevated liver iron concentration was associated with an increased rate of morbidity in patients with phenotypes of all severity, with a steeper increase in the rate of vascular morbidity being attributed to aging, and an earlier appearance of endocrine and bone disease.
   Conclusions
   Elevated liver iron concentration in patients with beta thalassemia intermedia is a marker of increased vascular, endocrine, and bone disease.
C1 [Musallam, Khaled M.; Tamim, Hani; Taher, Ali T.] Amer Univ Beirut, Dept Internal Med, Div Hematol & Oncol, Med Ctr, Beirut, Lebanon.
   [Cappellini, Maria Domenica; Motta, Irene; Graziadei, Giovanna] Univ Milan, Dept Internal Med, Fdn IRCCS Ca Granda, Milan, Italy.
   [Wood, John C.] Univ So Calif, Childrens Hosp Los Angeles, Div Pediat Cardiol, Los Angeles, CA USA.
   [Wood, John C.] Univ So Calif, Childrens Hosp Los Angeles, Div Radiol, Los Angeles, CA USA.
   [Wood, John C.] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA.
C3 American University of Beirut; University of Milan; IRCCS Ca Granda
   Ospedale Maggiore Policlinico; Children's Hospital Los Angeles;
   University of Southern California; Children's Hospital Los Angeles;
   University of Southern California; University of Southern California
RP Taher, AT (corresponding author), Amer Univ Beirut, Dept Internal Med, Div Hematol & Oncol, Med Ctr, POB 11-0236,Riad El Solh 1107 2020, Beirut, Lebanon.
EM ataher@aub.edu.lb
RI Motta, Irene/AAC-3087-2019; Wood, John/ISS-3666-2023; CAPPELLINI, MARIA
   DOMENICA/B-4475-2017; Giovanna, Graziadei/AAC-1722-2019
OI CAPPELLINI, MARIA DOMENICA/0000-0001-8676-6864; Taher,
   Ali/0000-0001-8515-2238; Graziadei, Giovanna/0000-0002-6801-5730; Motta,
   Irene/0000-0001-5701-599X; Musallam, Khaled/0000-0003-3935-903X
CR Aessopos A, 2005, CHEST, V127, P1523, DOI 10.1378/chest.127.5.1523
   Aessopos A, 2001, BLOOD, V97, P3411, DOI 10.1182/blood.V97.11.3411
   Aessopos A, 2007, HAEMATOL-HEMATOL J, V92, P658, DOI 10.3324/haematol.10915
   Aessopos A, 2007, TRANSFUSION, V47, P792, DOI 10.1111/j.1537-2995.2007.01192.x
   Anderson LJ, 2001, EUR HEART J, V22, P2171, DOI 10.1053/euhj.2001.2822
   Angelucci E, 2000, NEW ENGL J MED, V343, P327, DOI 10.1056/NEJM200008033430503
   Angelucci E, 2002, BLOOD, V100, P17, DOI 10.1182/blood.V100.1.17
   Atichartakarn V, 2003, INT J HEMATOL, V78, P139, DOI 10.1007/BF02983382
   Balla J, 2003, NEPHROL DIAL TRANSPL, V18, P8, DOI 10.1093/ndt/gfg1034
   Barst RJ, 2004, J AM COLL CARDIOL, V43, p40S, DOI 10.1016/j.jacc.2004.02.032
   Baskin HJ., 2002, ENDOCR PRACT, V8, P457, DOI [DOI 10.4158/1934-2403-8.6.457), 10.4158/1934-2403-8.6.457, DOI 10.4158/1934-2403-8.6.457]
   BORENSTAINBENYASHAR V, 1993, AM J HEMATOL, V44, P63
   Brittenham GM, 2011, NEW ENGL J MED, V364, P146, DOI 10.1056/NEJMct1004810
   BRITTENHAM GM, 1994, NEW ENGL J MED, V331, P567, DOI 10.1056/NEJM199409013310902
   CAMASCHELLA C, 1995, HAEMATOLOGICA, V80, P58
   Cappellini MD, 2010, ANN NY ACAD SCI, V1202, P231, DOI 10.1111/j.1749-6632.2010.05548.x
   Cappellini MD, 2000, BRIT J HAEMATOL, V111, P467, DOI 10.1046/j.1365-2141.2000.02376.x
   El-Hajj Fuleihan G, 2008, J CLIN DENSITOM, V11, P383, DOI 10.1016/j.jocd.2008.02.006
   Fung EB, 2006, BRIT J HAEMATOL, V135, P574, DOI 10.1111/j.1365-2141.2006.06332.x
   Gardenghi S, 2010, J CLIN INVEST, V120, P4466, DOI 10.1172/JCI41717
   Gardenghi S, 2010, HEMATOL ONCOL CLIN N, V24, P1089, DOI 10.1016/j.hoc.2010.08.003
   Jensen PD, 2003, BLOOD, V101, P91, DOI 10.1182/blood-2002-06-1704
   KLEBER FX, 1992, BRIT HEART J, V67, P289
   Li HH, 2010, NAT MED, V16, P177, DOI 10.1038/nm.2073
   Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025
   O'Donnell A, 2007, P NATL ACAD SCI USA, V104, P9440, DOI 10.1073/pnas.0703424104
   Oliva EN, 2010, TRANSFUSION, V50, P1568, DOI 10.1111/j.1537-2995.2010.02617.x
   Olivieri NF, 1997, BLOOD, V89, P739, DOI 10.1182/blood.V89.3.739
   Origa R, 2007, HAEMATOL-HEMATOL J, V92, P583, DOI 10.3324/haematol.10842
   Origa R, 2008, HAEMATOL-HEMATOL J, V93, P1095, DOI 10.3324/haematol.12484
   Ramos P, 2010, ANN NY ACAD SCI, V1202, P24, DOI 10.1111/j.1749-6632.2010.05596.x
   Roghi A, 2010, ANN HEMATOL, V89, P585, DOI 10.1007/s00277-009-0879-3
   St Pierre TG, 2005, BLOOD, V105, P855, DOI 10.1182/blood-2004-01-0177
   Steinberg MH, 2009, DISORDERS OF HEMOGLOBIN: GENETICS, PATHOPHYSIOLOGY, AND CLINICAL MANAGEMENT, 2ND EDITION, P1, DOI 10.1017/CBO9780511596582
   Sundaram N, 2010, BLOOD, V116, P109, DOI 10.1182/blood-2009-09-244830
   Taher AT, 2010, J THROMB HAEMOST, V8, P2152, DOI 10.1111/j.1538-7836.2010.03940.x
   Taher AT, 2010, J THROMB HAEMOST, V8, P54, DOI 10.1111/j.1538-7836.2009.03651.x
   Taher A, 2008, HAEMATOL-HEMATOL J, V93, P1584, DOI 10.3324/haematol.13098
   Taher A, 2006, THROMB HAEMOSTASIS, V96, P488, DOI 10.1160/TH06-05-0267
   Taher A, 2009, BRIT J HAEMATOL, V147, P634, DOI 10.1111/j.1365-2141.2009.07848.x
   Taher A, 2009, BRIT J HAEMATOL, V146, P569, DOI 10.1111/j.1365-2141.2009.07810.x
   Taher AT, 2011, BRIT J HAEMATOL, V152, P512, DOI 10.1111/j.1365-2141.2010.08486.x
   Taher AT, 2010, BRIT J HAEMATOL, V150, P486, DOI 10.1111/j.1365-2141.2010.08220.x
   Taher AT, 2010, AM J HEMATOL, V85, P288, DOI 10.1002/ajh.21626
   Taher AT, 2010, BLOOD, V115, P1886, DOI 10.1182/blood-2009-09-243154
   Telfer PT, 2000, BRIT J HAEMATOL, V110, P971, DOI 10.1046/j.1365-2141.2000.02298.x
   Wood JC, 2005, BLOOD, V106, P1460, DOI 10.1182/blood-2004-10-3982
   Wood JC, 2007, CURR OPIN HEMATOL, V14, P183, DOI 10.1097/MOH.0b013e3280d2b76b
NR 48
TC 139
Z9 147
U1 0
U2 5
PU FERRATA STORTI FOUNDATION
PI PAVIA
PA VIA GIUSEPPE BELLI 4, 27100 PAVIA, ITALY
SN 0390-6078
EI 1592-8721
J9 HAEMATOL-HEMATOL J
JI Haematol-Hematol. J.
PD NOV
PY 2011
VL 96
IS 11
BP 1605
EP 1612
DI 10.3324/haematol.2011.047852
PG 8
WC Hematology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Hematology
GA 851BR
UT WOS:000297243800009
PM 21791471
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Qiao, Y
   Xu, ZJ
   Yu, YZ
   Hou, SL
   Geng, JS
   Xiao, TQ
   Liang, Y
   Dong, Q
   Mei, Y
   Wang, B
   Qiao, H
   Dai, JW
   Suo, GL
AF Qiao, Yong
   Xu, Zhongjuan
   Yu, Yanzhen
   Hou, Shulan
   Geng, Junsa
   Xiao, Tongqian
   Liang, Yu
   Dong, Qun
   Mei, Yan
   Wang, Bin
   Qiao, Hong
   Dai, Jianwu
   Suo, Guangli
TI Single cell derived spheres of umbilical cord mesenchymal stem cells
   enhance cell stemness properties, survival ability and therapeutic
   potential on liver failure
SO BIOMATERIALS
LA English
DT Article
DE Umbilical cord mesenchymal stem cell; Single cell chip; Single cell
   derived sphere; Acute liver failure; Therapeutic potential
ID STROMAL CELLS; CULTURE; TRANSPLANTATION; ANGIOGENESIS; METABOLISM;
   RESISTANCE; SENESCENCE; COMPACTION; MIGRATION; EFFICACY
AB Umbilical cord mesenchymal stem cells (UCMSCs) have shown great potentials in regenerative medicine for their extensive sources, multilineage differentiation potential, low immunogenicity and self-renewal ability. However, the clinical application of UCMSCs still confronts many challenges including the requirement of large quantity of cells, low survival ability in vivo and the loss of main original characteristics due to two-dimensional (2D) culture. The traditional three-dimensional (3D)-spheroid culture can mimic in vivo conditions, but still has limitations in clinical application due to large size of spheroid against direct injection and inner cell death. Based on self-renewal tenet, we produced single cell derived sphere (SCDS) of UCMSCs through combining single cell pattern on chip with 3D culture. Compared with the 2D and traditional 3D culture, SCDS culture has many advantages to meet clinical requirements, including small size, higher abilities of survival and migration, and stronger hypoxia resistance and stemness maintenance. Furthermore, SCDS culture promotes angiogenesis in UCMSCs-xenografts and displays greater therapeutic potential on acute liver failure (ALF) in vivo. Our results suggest that SCDS culture may serve as a simple and effective strategy for UCMSCs optimization to meet clinical demand.
C1 [Qiao, Yong; Xu, Zhongjuan; Yu, Yanzhen; Hou, Shulan; Geng, Junsa; Xiao, Tongqian; Liang, Yu; Suo, Guangli] Chinese Acad Sci, Suzhou Inst Nanotech & Nanobion, CAS Key Lab Nanobio Interface, Nanjing 215123, Jiangsu, Peoples R China.
   [Xu, Zhongjuan; Yu, Yanzhen; Geng, Junsa] Univ Sci & Technol China, Hefei 230026, Anhui, Peoples R China.
   [Liang, Yu] Shanghai Univ, Sch Life Sci, Shanghai 200444, Peoples R China.
   [Hou, Shulan] Xi An Jiao Tong Univ, Sch Pharm, Xian 710061, Shaanxi, Peoples R China.
   [Dong, Qun] Taikang Xianlin Drum Tower Hosp, Dept Pathol, Nanjing 210046, Jiangsu, Peoples R China.
   [Mei, Yan] Greepharma Inc, Nanjing 211100, Jiangsu, Peoples R China.
   [Wang, Bin] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Ctr Clin Stem Cell Res, Nanjing 210008, Jiangsu, Peoples R China.
   [Qiao, Hong] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA.
   [Dai, Jianwu] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing 100190, Peoples R China.
   [Xiao, Tongqian] Univ Chinese Acad Sci, Beijing 100049, Peoples R China.
C3 Chinese Academy of Sciences; Suzhou Institute of Nano-Tech &
   Nano-Bionics, CAS; Chinese Academy of Sciences; University of Science &
   Technology of China, CAS; Shanghai University; Xi'an Jiaotong
   University; Nanjing University; University of Texas System; University
   of Texas Austin; Chinese Academy of Sciences; Institute of Genetics &
   Developmental Biology, CAS; Chinese Academy of Sciences; University of
   Chinese Academy of Sciences, CAS
RP Dai, JW; Suo, GL (corresponding author), Chinese Acad Sci, Suzhou Inst Nanotech & Nanobion, 398 Ruoshui Rd,Suzhou Ind Pk, Suzhou 215123, Jiangsu, Peoples R China.
EM jwdai@genetics.ac.cn; glsuo2013@sinano.ac.cn
RI Liu, Jingyi/JWP-6326-2024; wang, xi/JNT-5162-2023; Jiang,
   Yuan/JED-3759-2023
FU Ministry of Science and Technology (MOST) [2017YFA0104301]; National
   Natural Science Foundation of China [31870975]; Suzhou Science and
   Technology Development Program [SYG201835]; Development Program of
   Ministry of Science and Technology [2016YFC1000802, 2016YFC1000801];
   CAS/SAFEA International Innovation Teams program
FX We thank Zhijun Zhang, Renjun Pei, Guosheng Cheng, and Qiangbin Wang for
   insightful comments on the study, Xiang He for her excellent technical
   assistance. This research was supported by funds from the Ministry of
   Science and Technology (MOST) (Grant 2017YFA0104301), National Natural
   Science Foundation of China (Grant 31870975), Suzhou Science and
   Technology Development Program (Grant SYG201835), Development Program of
   Ministry of Science and Technology (2016YFC1000802 and 2016YFC1000801),
   and the CAS/SAFEA International Innovation Teams program.
CR Antoni D, 2015, INT J MOL SCI, V16, P5517, DOI 10.3390/ijms16035517
   Bartosh TJ, 2013, STEM CELLS, V31, P2443, DOI 10.1002/stem.1499
   Ben-Sahra I, 2017, CURR OPIN CELL BIOL, V45, P72, DOI 10.1016/j.ceb.2017.02.012
   Bhang SH, 2012, TISSUE ENG PT A, V18, P2138, DOI [10.1089/ten.tea.2011.0640, 10.1089/ten.TEA.2011.0640]
   Bongso A, 2013, STEM CELL REV REP, V9, P226, DOI 10.1007/s12015-012-9418-z
   Carroll B, 2017, J CELL BIOL, V216, P1949, DOI 10.1083/jcb.201610113
   Cheng NC, 2013, STEM CELL TRANSL MED, V2, P584, DOI 10.5966/sctm.2013-0007
   Cheung TH, 2013, NAT REV MOL CELL BIO, V14, P329, DOI 10.1038/nrm3591
   Chou KJ, 2017, EXP CELL RES, V350, P91, DOI 10.1016/j.yexcr.2016.11.010
   Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126
   Cui YB, 2017, BEHAV BRAIN RES, V320, P291, DOI 10.1016/j.bbr.2016.12.021
   De Becker A, 2016, WORLD J STEM CELLS, V8, P73, DOI 10.4252/wjsc.v8.i3.73
   Devine SM, 2003, BLOOD, V101, P2999, DOI 10.1182/blood-2002-06-1830
   Dhawan J, 2015, J CELL SCI, V128, P4467, DOI 10.1242/jcs.177758
   Ding DC, 2015, CELL TRANSPLANT, V24, P339, DOI 10.3727/096368915X686841
   Domnina A, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0801-9
   Edmondson R, 2014, ASSAY DRUG DEV TECHN, V12, P207, DOI 10.1089/adt.2014.573
   El Omar R, 2014, TISSUE ENG PART B-RE, V20, P523, DOI [10.1089/ten.TEB.2013.0664, 10.1089/ten.teb.2013.0664]
   Emmert MY, 2013, BIOMATERIALS, V34, P6339, DOI 10.1016/j.biomaterials.2013.04.034
   English K, 2010, CELL STEM CELL, V7, P431, DOI 10.1016/j.stem.2010.09.009
   Fennema E, 2013, TRENDS BIOTECHNOL, V31, P108, DOI 10.1016/j.tibtech.2012.12.003
   Gao L, 2016, J CLIN ONCOL, V34, P2843, DOI 10.1200/JCO.2015.65.3642
   Guo L, 2014, J CELL MOL MED, V18, P2009, DOI 10.1111/jcmm.12336
   Guo L, 2014, STEM CELLS DEV, V23, P978, DOI 10.1089/scd.2013.0338
   Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039
   Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010
   Huang GS, 2011, BIOMATERIALS, V32, P6929, DOI 10.1016/j.biomaterials.2011.05.092
   Ifkovits JL, 2009, ACS APPL MATER INTER, V1, P1878, DOI 10.1021/am900403k
   Jensen JB, 2006, MOL NEUROBIOL, V34, P153, DOI 10.1385/MN:34:3:153
   Jiang B, 2017, BIOMATERIALS, V133, P275, DOI 10.1016/j.biomaterials.2017.03.050
   Klubo-Gwiezdzinska J, 2012, ENDOCR-RELAT CANCER, V19, P447, DOI 10.1530/ERC-12-0046
   Laschke MW, 2017, TRENDS BIOTECHNOL, V35, P133, DOI 10.1016/j.tibtech.2016.08.004
   Lee JH, 2016, BIOMOL THER, V24, P260, DOI 10.4062/biomolther.2015.146
   Lee J, 2008, TISSUE ENG PART B-RE, V14, P61, DOI 10.1089/teb.2007.0150
   Lemoinne S, 2016, CELL TISSUE RES, V365, P583, DOI 10.1007/s00441-016-2443-5
   Lewis NS, 2017, J TISSUE ENG, V8, DOI 10.1177/2041731417704428
   Li Y, 2015, CELL TISSUE RES, V360, P297, DOI 10.1007/s00441-014-2055-x
   Liao WB, 2009, TRANSPLANTATION, V87, P350, DOI 10.1097/TP.0b013e318195742e
   Lim M, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0888-z
   Lin Ruei-Zhen, 2008, Biotechnology Journal, V3, P1172, DOI 10.1002/biot.200700228
   Liu J, 2013, CYTOTHERAPY, V15, P185, DOI 10.1016/j.jcyt.2012.09.005
   Ma JL, 2014, STEM CELL TRANSL MED, V3, P98, DOI 10.5966/sctm.2013-0126
   Ma LY, 2016, ANAL BIOANAL CHEM, V408, P7753, DOI 10.1007/s00216-016-9872-6
   Monge C, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0556-8
   Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046
   Nacarelli T, 2017, MOL CELL ENDOCRINOL, V455, P83, DOI 10.1016/j.mce.2016.08.049
   Ng TL, 2012, CELL DEATH DIFFER, V19, P501, DOI 10.1038/cdd.2011.119
   Ong CS, 2018, BIOTECHNOL ADV, V36, P494, DOI 10.1016/j.biotechadv.2018.02.003
   Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007
   Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637
   Popa C, 2007, J LIPID RES, V48, P751, DOI 10.1194/jlr.R600021-JLR200
   Potapova IA, 2007, STEM CELLS, V25, P1761, DOI 10.1634/stemcells.2007-0022
   Psaltis PJ, 2008, STEM CELLS, V26, P2201, DOI 10.1634/stemcells.2008-0428
   Qian Yingjuan, 2013, Methods Mol Biol, V965, P37, DOI 10.1007/978-1-62703-239-1_3
   Qiao Y, 2017, ACS APPL MATER INTER, V9, P36525, DOI 10.1021/acsami.7b08460
   Rayavarapu RR, 2015, J BIOL CHEM, V290, P8722, DOI 10.1074/jbc.M114.612754
   Saleh Fatima A, 2012, Methods Mol Biol, V916, P31, DOI 10.1007/978-1-61779-980-8_4
   Salem HK, 2010, STEM CELLS, V28, P585, DOI 10.1002/stem.269
   Schneider RK, 2010, BIOMATERIALS, V31, P467, DOI 10.1016/j.biomaterials.2009.09.059
   Seiberg M, 1997, J INVEST DERMATOL, V109, P370, DOI 10.1111/1523-1747.ep12336244
   Sun LY, 2010, ARTHRITIS RHEUM-US, V62, P2467, DOI 10.1002/art.27548
   Sun Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20975-0
   Tancharoen W, 2017, ACTA HISTOCHEM, V119, P113, DOI 10.1016/j.acthis.2016.11.009
   Tolar J, 2010, STEM CELLS, V28, P1446, DOI 10.1002/stem.459
   Toma C, 2009, CIRC RES, V104, P398, DOI 10.1161/CIRCRESAHA.108.187724
   Tsai AC, 2015, TISSUE ENG PT A, V21, P1705, DOI [10.1089/ten.tea.2014.0314, 10.1089/ten.TEA.2014.0314]
   Tuccitto A, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2233
   Wang HS, 2004, STEM CELLS, V22, P1330, DOI 10.1634/stemcells.2004-0013
   Wang LM, 2013, STEM CELLS DEV, V22, P3192, DOI 10.1089/scd.2013.0023
   Wang ZB, 2012, SOFT MATTER, V8, P7630, DOI 10.1039/c2sm25835h
   Wright WE, 2006, NAT PROTOC, V1, P2088, DOI 10.1038/nprot.2006.374
   Xiao TQ, 2019, IUBMB LIFE, V71, P183, DOI 10.1002/iub.1949
   Xie LL, 2016, STEM CELLS DEV, V25, P203, DOI 10.1089/scd.2015.0278
   Xie ZY, 2016, STEM CELLS, V34, P627, DOI 10.1002/stem.2238
   Xu LX, 2018, EUR J MED RES, V23, DOI 10.1186/s40001-018-0311-3
   Xue HL, 2015, TRANSPL P, V47, P412, DOI 10.1016/j.transproceed.2014.10.048
   Yan JY, 2018, COLLOID SURFACE B, V171, P241, DOI 10.1016/j.colsurfb.2018.07.034
   Yang MC, 2010, BIOMATERIALS, V31, P854, DOI 10.1016/j.biomaterials.2009.09.096
   Yin Q, 2016, ONCOL LETT, V11, P2353, DOI 10.3892/ol.2016.4270
   Zare H, 2018, J CELL BIOCHEM, V119, P5834, DOI 10.1002/jcb.26772
   Zhang QZ, 2012, STEM CELLS DEV, V21, P937, DOI 10.1089/scd.2011.0252
   Zhang SC, 2015, BIOMATERIALS, V41, P15, DOI 10.1016/j.biomaterials.2014.11.019
   Zhang SC, 2012, TISSUE ENG PT A, V18, P1352, DOI [10.1089/ten.tea.2011.0516, 10.1089/ten.TEA.2011.0516]
   Zhao XR, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/8316094
   Zhou Y, 2018, CHIN J NAT MEDICINES, V16, P801, DOI 10.1016/S1875-5364(18)30122-5
   Zhou YS, 2018, ONCOGENE, V37, P6152, DOI 10.1038/s41388-018-0349-2
   Zhu H, 2017, SCI REP-UK, V7, DOI 10.1038/srep39889
NR 87
TC 34
Z9 37
U1 0
U2 81
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2020
VL 227
AR 119573
DI 10.1016/j.biomaterials.2019.119573
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Engineering; Materials Science
GA JP5AF
UT WOS:000498276700006
PM 31670080
DA 2024-02-19
ER

PT J
AU Biolo, G
   Cederholm, T
   Muscaritoli, M
AF Biolo, Gianni
   Cederholm, Tommy
   Muscaritoli, Maurizio
TI Muscle contractile and metabolic dysfunction is a common feature of
   sarcopenia of aging and chronic diseases: From sarcopenic obesity to
   cachexia
SO CLINICAL NUTRITION
LA English
DT Article
DE Sarcopenia; Cachexia; Sarcopenic obesity; Muscle metabolic dysfunction;
   Pre-cachexia; Muscle contractile dysfunction
ID RESTING ENERGY-EXPENDITURE; BODY-MASS INDEX; CHRONIC HEART-FAILURE;
   SKELETAL-MUSCLE; BED-REST; INSULIN-RESISTANCE; CANCER-PATIENTS;
   PROTEIN-METABOLISM; AMINO-ACID; NEOADJUVANT CHEMOTHERAPY
AB Skeletal muscle is the most abundant body tissue accounting for many physiological functions. However, muscle mass and functions are not routinely assessed. Sarcopenia is defined as skeletal muscle loss and dysfunction in aging and chronic diseases. Inactivity, inflammation, age-related factors, anorexia and unbalanced nutrition affect changes in skeletal muscle. Mechanisms are difficult to distinguish in individual subjects due to the multifactorial character of the condition. Sarcopenia includes both muscle loss and dysfunction which induce contractile impairment and metabolic and endocrine abnormalities, affecting whole-body metabolism and immune/inflammatory response. There are different metabolic trajectories for muscle loss versus fat changes in aging and chronic diseases. Appetite regulation and physical activity affect energy balance and changes in body fat mass. Appetite regulation by inflammatory mediators is poorly understood. In some patients, inflammation induces anorexia and fat loss in combination with sarcopenia. In others, appetite is maintained, despite activation of systemic inflammation, leading to sarcopenia with normal or increased BMI. Inactivity contributes to sarcopenia and increased fat tissue in aging and diseases. At the end of the metabolic trajectories, cachexia and sarcopenic obesity are paradigms of the two patient categories. Pre-cachexia and cachexia are observed in patients with cancer, chronic heart failure or liver cirrhosis. Sarcopenic obesity and sarcopenia with normal/increased BMI are observed in rheumatoid arthritis, breast cancer patients with adjuvant chemotherapy and in most of patients with COPD or chronic kidney disease. In these conditions, sarcopenia is a powerful prognostic factor for morbidity and mortality, independent of BMI. (C) 2014 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.
C1 [Biolo, Gianni] Univ Trieste, AOUTS, Dept Med Surg & Hlth Sci Clin Med, I-34127 Trieste, Italy.
   [Cederholm, Tommy] Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden.
   [Muscaritoli, Maurizio] Univ Roma La Sapienza, Dept Clin Med, I-00185 Rome, Italy.
C3 University of Trieste; Uppsala University; Sapienza University Rome
RP Muscaritoli, M (corresponding author), Univ Roma La Sapienza, Dept Clin Med, Viale Univ 37, I-00185 Rome, Italy.
EM maurizio.muscaritoli@uniroma1.it
RI Biolo, Gianni/AAB-4983-2022
OI BIOLO, GIANNI/0000-0002-6397-1598
CR Agostini F, 2005, J PHYSL, V586, P4775
   Agostini F, 2010, J PHYSIOL-LONDON, V588, P5089, DOI 10.1113/jphysiol.2010.198283
   Akinnusi ME, 2008, CRIT CARE MED, V36, P151, DOI 10.1097/01.CCM.0000297885.60037.6E
   Arnold AS, 2011, GERONTOLOGY, V57, P37, DOI 10.1159/000281883
   Artero EG, 2012, J CARDIOPULM REHABIL, V32, P351, DOI 10.1097/HCR.0b013e3182642688
   Aversa Z, 2012, ANN SURG ONCOL, V19, P1350, DOI 10.1245/s10434-011-1720-5
   Awad S, 2012, CLIN NUTR, V31, P74, DOI 10.1016/j.clnu.2011.08.008
   Baracos VE, 2010, AM J CLIN NUTR, V91, p1133S, DOI 10.3945/ajcn.2010.28608C
   Bauer J, 2013, J AM MED DIR ASSOC, V14, P542, DOI 10.1016/j.jamda.2013.05.021
   Binkley N, 2013, OSTEOPOROSIS INT, V24, P2955, DOI 10.1007/s00198-013-2427-1
   Biolo G, 2005, J RENAL NUTR, V15, P49, DOI 10.1053/j.jrn.2004.09.009
   Biolo G, 2005, INT J BIOCHEM CELL B, V37, P2169, DOI 10.1016/j.biocel.2005.05.001
   Biolo G, 2004, J PHYSIOL-LONDON, V558, P381, DOI 10.1113/jphysiol.2004.066365
   Biolo G, 2003, CURR OPIN CLIN NUTR, V6, P31, DOI 10.1097/00075197-200301000-00006
   Biolo G, 2008, AM J CLIN NUTR, V88, P950, DOI 10.1093/ajcn/88.4.950
   Biolo G, 2008, CRIT CARE MED, V36, P1768, DOI 10.1097/CCM.0b013e318174de32
   Biolo G, 2007, AM J CLIN NUTR, V86, P366, DOI 10.1093/ajcn/86.2.366
   Biolo G, 2013, WORLD REV NUTR DIET, V105, P12, DOI 10.1159/000341545
   Biolo G, 2011, INTERN EMERG MED, V6, P101, DOI 10.1007/s11739-011-0530-x
   Biolo G, 2007, CRIT CARE MED, V35, pS591, DOI 10.1097/01.CCM.0000278913.19123.13
   Blanc S, 1993, J CLIN ENDOCR METAB, V83, P4289
   Bonetto A, 2013, MUSCLE NERVE, V48, P387, DOI 10.1002/mus.23798
   Bonetto A, 2009, FREE RADICAL BIO MED, V47, P906, DOI 10.1016/j.freeradbiomed.2009.07.002
   Bosutti A, 2008, J CLIN ENDOCR METAB, V93, P3226, DOI 10.1210/jc.2007-1684
   Bouteloup C, 2009, J NEUROL, V256, P1236, DOI 10.1007/s00415-009-5100-z
   Braun T, 2012, CURR OSTEOPOROS REP, V10, P101, DOI 10.1007/s11914-012-0104-5
   Brocca L, 2012, J PHYSIOL-LONDON, V590, P5211, DOI 10.1113/jphysiol.2012.240267
   Cao C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043892
   Caporali R, 2012, CLIN NUTR, V31, P666, DOI 10.1016/j.clnu.2012.02.010
   Casas-Vara A, 2012, NUTRITION, V28, P616, DOI 10.1016/j.nut.2011.10.006
   Cereda E, 2010, EUR J CLIN NUTR, V64, P894, DOI 10.1038/ejcn.2010.85
   Chen PJ, 2012, J AM MED DIR ASSOC, V13, P517, DOI 10.1016/j.jamda.2012.02.002
   Chen YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044242
   Christensen HM, 2013, ENDOCRINE, V43, P626, DOI 10.1007/s12020-012-9836-3
   Cianferotti L, 2014, ENDOCRINE, V45, P165, DOI 10.1007/s12020-013-0026-8
   Coin A, 2012, CLIN NUTR, V31, P506, DOI 10.1016/j.clnu.2012.01.012
   Colín-Ramírez E, 2011, CLIN NUTR, V30, P753, DOI 10.1016/j.clnu.2011.07.005
   Cramp F, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006145.pub2
   Crocker T, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004294.pub3
   Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034
   de Boer MD, 2008, EUR J APPL PHYSIOL, V104, P401, DOI 10.1007/s00421-008-0703-0
   Del Fabbro E, 2012, ONCOLOGIST, V17, P1240, DOI 10.1634/theoncologist.2012-0169
   Demontis F, 2013, AGING CELL, V12, P943, DOI 10.1111/acel.12126
   Dronkers JJ, 2013, ANAESTHESIA, V68, P67, DOI 10.1111/anae.12066
   Drummond MJ, 2013, AM J PHYSIOL-REG I, V305, pR216, DOI 10.1152/ajpregu.00072.2013
   Engels PT, 2013, CRIT CARE MED, V41, P1790, DOI 10.1097/CCM.0b013e31828a2abf
   Evans WJ, 2008, CLIN NUTR, V27, P793, DOI 10.1016/j.clnu.2008.06.013
   Fearon KCH, 2012, CLIN NUTR, V31, P577, DOI 10.1016/j.clnu.2012.06.012
   Fearon K, 2011, J CACHEXIA SARCOPENI, V2, P1, DOI 10.1007/s13539-011-0025-7
   Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7
   Ferrando AA, 1999, J CLIN ENDOCR METAB, V84, P3515, DOI 10.1210/jc.84.10.3515
   Freedman RJ, 2004, J CLIN ENDOCR METAB, V89, P2248, DOI 10.1210/jc.2003-031874
   Fülster S, 2013, EUR HEART J, V34, P512, DOI 10.1093/eurheartj/ehs381
   Genton L, 2011, CLIN NUTR, V30, P553, DOI 10.1016/j.clnu.2011.06.004
   Genton L, 2011, CLIN NUTR, V30, P436, DOI 10.1016/j.clnu.2011.01.009
   Guadagni M, 2009, CURR OPIN CLIN NUTR, V12, P617, DOI 10.1097/MCO.0b013e32833193bd
   Guarnieri G, 2003, J RENAL NUTR, V13, P153, DOI 10.1053/jren.2003.50020
   Guillet C, 2012, OBES REV, V13, P51, DOI 10.1111/j.1467-789X.2012.01037.x
   Guillet C, 2009, J CLIN ENDOCR METAB, V94, P3044, DOI 10.1210/jc.2008-2216
   Hamburg NM, 2007, ARTERIOSCL THROM VAS, V27, P2650, DOI 10.1161/ATVBAHA.107.153288
   Han SS, 2010, J AM GERIATR SOC, V58, P312, DOI 10.1111/j.1532-5415.2009.02672.x
   Hartl WH, 2011, CLIN NUTR, V30, P20, DOI 10.1016/j.clnu.2010.03.002
   Hofmann T, 2014, PEPTIDES, V54, P89, DOI 10.1016/j.peptides.2014.01.016
   Hong HC, 2013, HEPATOLOGY
   Huang JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054976
   Hung WW, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-47
   Ji LX, 2012, CLIN NUTR, V31, P922, DOI 10.1016/j.clnu.2012.03.007
   Kalantar-Zadeh K, 2005, AM J CLIN NUTR, V81, P543
   Kalantar-Zadeh K, 2012, AM J EPIDEMIOL, V175, P793, DOI 10.1093/aje/kwr384
   Kalantar-Zadeh K, 2010, MAYO CLIN PROC, V85, P991, DOI 10.4065/mcp.2010.0336
   Kapoor JR, 2010, AM HEART J, V159, P75, DOI 10.1016/j.ahj.2009.10.026
   Kim TN, 2010, DIABETES CARE, V33, P1497, DOI 10.2337/dc09-2310
   Landi F, 2012, CLIN NUTR, V31, P652, DOI 10.1016/j.clnu.2012.02.007
   Landi F, 2012, J AM MED DIR ASSOC, V13, P121, DOI 10.1016/j.jamda.2011.07.004
   Langius JAE, 2012, CLIN NUTR, V31, P549, DOI 10.1016/j.clnu.2011.12.009
   Lim SL, 2012, CLIN NUTR, V31, P345, DOI 10.1016/j.clnu.2011.11.001
   Malmstrom TK, 2013, J FRALITY AGING, V2, P55, DOI 10.14283/jfa.2013.8
   Malmstrom TK, 2013, J AM MED DIR ASSOC, V14, P531, DOI 10.1016/j.jamda.2013.05.018
   Manini TM, 2012, J GERONTOL A-BIOL, V67, P28, DOI 10.1093/gerona/glr010
   Manini TM, 2010, AGEING RES REV, V9, P1, DOI 10.1016/j.arr.2009.08.002
   Martin L, 2013, J CLIN ONCOL, V31, P1539, DOI 10.1200/JCO.2012.45.2722
   Martín-González C, 2011, CLIN NUTR, V30, P822, DOI 10.1016/j.clnu.2011.06.010
   Masgrau A, 2012, J PHYSIOL-LONDON, V590, P5199, DOI 10.1113/jphysiol.2012.238576
   Mazzucco S, 2010, J CLIN ENDOCR METAB, V95, P2508, DOI 10.1210/jc.2009-2561
   Meijers JMM, 2012, CLIN NUTR, V31, P65, DOI 10.1016/j.clnu.2011.08.009
   Merli M, 2013, METAB BRAIN DIS, V28, P281, DOI 10.1007/s11011-012-9365-z
   Merli M, 2013, LIVER INT, V33, P714, DOI 10.1111/liv.12128
   Mijnarends DM, 2013, J AM MED DIR ASSOC, V14, P170, DOI 10.1016/j.jamda.2012.10.009
   Miller MD, 2002, J AM GERIATR SOC, V50, P1272, DOI 10.1046/j.1532-5415.2002.50316.x
   Mitch WE, 1996, NEW ENGL J MED, V335, P1897, DOI 10.1056/NEJM199612193352507
   Mitchell WK, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00260
   Montano-Loza AJ, 2012, CLIN GASTROENTEROL H, V10, P166, DOI 10.1016/j.cgh.2011.08.028
   MORSE WI, 1964, CAN MED ASSOC J, V90, P723
   Mourtzakis M, 2008, APPL PHYSIOL NUTR ME, V33, P997, DOI 10.1139/H08-075
   Müller MJ, 2013, CURR OPIN CLIN NUTR, V16, P501, DOI 10.1097/MCO.0b013e328363bdf9
   Müller MJ, 1999, AM J CLIN NUTR, V69, P1194
   Muscaritoli M, 2013, MINERVA ANESTESIOL, V79, P771
   Muscaritoli M, 2010, CLIN NUTR, V29, P154, DOI 10.1016/j.clnu.2009.12.004
   Muscaritoli M, 2013, INTERN EMERG MED, V8, P553, DOI 10.1007/s11739-012-0807-8
   Muscaritoli M, 2013, INTERN EMERG MED, V8, P373, DOI 10.1007/s11739-013-0966-2
   Muscaritoli M, 2011, INTERN EMERG MED, V6, P105, DOI 10.1007/s11739-010-0426-1
   Muscaritoli M, 2009, CURR OPIN CLIN NUTR, V12, P378, DOI 10.1097/MCO.0b013e32832c7ae1
   Norman K, 2012, CLIN NUTR, V31, P854, DOI 10.1016/j.clnu.2012.05.008
   Norman K, 2012, J CACHEXIA SARCOPENI, V3, P111, DOI 10.1007/s13539-012-0060-z
   Olsen RH, 2008, JAMA-J AM MED ASSOC, V299, P1261, DOI 10.1001/jama.299.11.1259
   Park KH, 2013, J CLIN ENDOCR METAB, V98, P4899, DOI 10.1210/jc.2013-2373
   Pasiakos SM, 2010, J NUTR, V140, P745, DOI 10.3945/jn.109.118372
   Pedersen BK, 2011, BRAIN BEHAV IMMUN, V25, P811, DOI 10.1016/j.bbi.2011.02.010
   Peng P, 2012, J GASTROINTEST SURG, V16, P1478, DOI 10.1007/s11605-012-1923-5
   Prado CMM, 2012, CLIN NUTR, V31, P583, DOI 10.1016/j.clnu.2012.06.010
   Prado CMM, 2009, CLIN CANCER RES, V15, P2920, DOI 10.1158/1078-0432.CCR-08-2242
   Prado CM, 2008, LANCET ONCOL, V9, P629
   Pupim LB, 2005, KIDNEY INT, V68, P2368, DOI 10.1111/j.1523-1755.2005.00699.x
   Raslan M, 2011, CLIN NUTR, V30, P49, DOI 10.1016/j.clnu.2010.07.002
   Rittweger J, 2009, BONE, V44, P612, DOI 10.1016/j.bone.2009.01.001
   Ritz P, 1998, EUR J APPL PHYSIOL, V78, P308, DOI 10.1007/s004210050425
   Romme EAPM, 2013, EXPERT REV RESP MED, V7, P397, DOI 10.1586/17476348.2013.814402
   Roshanravan B, 2013, J AM SOC NEPHROL, V24, P822, DOI 10.1681/ASN.2012070702
   ROUBENOFF R, 1994, J CLIN INVEST, V93, P2379, DOI 10.1172/JCI117244
   Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017
   Schols AMWJ, 2005, AM J CLIN NUTR, V82, P53, DOI 10.1093/ajcn/82.1.53
   Seelaender M, 2012, CLIN NUTR, V31, P562, DOI 10.1016/j.clnu.2012.01.011
   Sergi G, 2006, RESP MED, V100, P1918, DOI 10.1016/j.rmed.2006.03.008
   Sheetz KH, 2013, DIS ESOPHAGUS, V26, P716, DOI 10.1111/dote.12020
   Shimizu-Fujiwara M, 2012, BRAIN DEV-JPN, V34, P206, DOI 10.1016/j.braindev.2011.05.005
   Slaughter SE, 2011, CLIN NUTR, V30, P172, DOI 10.1016/j.clnu.2010.09.001
   Srikanthan P, 2011, J CLIN ENDOCR METAB, V96, P2898, DOI 10.1210/jc.2011-0435
   Swallow EB, 2007, THORAX, V62, P115, DOI 10.1136/thx.2006.062026
   Takata Y, 2012, AGING CLIN EXP RES, V24, P257, DOI 10.1007/BF03325254
   Tandon P, 2012, LIVER TRANSPLANT, V18, P1209, DOI 10.1002/lt.23495
   Tessari P, 2011, CLIN NUTR, V30, P267, DOI 10.1016/j.clnu.2011.02.009
   Thibault R, 2012, CLIN NUTR, V31, P435, DOI 10.1016/j.clnu.2011.12.011
   Vadan R, 2011, CLIN NUTR, V30, P86, DOI 10.1016/j.clnu.2010.07.019
   van Bokhorst-de van der Schueren MA.KonijnNP, 2012, CHIN MITT, V31, P1003
   Vandewoude MF, 2012, J AGING RES
   Verhage TL, 2011, CLIN NUTR, V30, P332, DOI 10.1016/j.clnu.2010.09.013
   Vermeeren MAP, 2006, RESP MED, V100, P1349, DOI 10.1016/j.rmed.2005.11.023
   Vestbo J, 2006, AM J RESP CRIT CARE, V173, P79, DOI 10.1164/rccm.200505-969OC
   Volpato S, 2014, J GERONTOL A-BIOL, V69, P438, DOI 10.1093/gerona/glt149
   Wagner D, 2011, CLIN TRANSPLANT, V25, pE396, DOI 10.1111/j.1399-0012.2011.01442.x
   Washington TA, 2011, ACTA PHYSIOL, V202, P657, DOI 10.1111/j.1748-1716.2011.02281.x
   Welc SS, 2013, J APPL PHYSIOL, V115, P1126, DOI 10.1152/japplphysiol.00636.2013
   Zainuldin R, 2011, COCHRANE DB SYST REV, V10
   Zeanandin G, 2012, CLIN NUTR, V31, P69, DOI 10.1016/j.clnu.2011.08.007
   Zhou JJ, 2013, BONE, V57, P30, DOI 10.1016/j.bone.2013.07.013
NR 145
TC 259
Z9 283
U1 3
U2 73
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0261-5614
EI 1532-1983
J9 CLIN NUTR
JI Clin. Nutr.
PD OCT
PY 2014
VL 33
IS 5
BP 737
EP 748
DI 10.1016/j.clnu.2014.03.007
PG 12
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA AY7NC
UT WOS:000347745700001
PM 24785098
HC Y
HP N
DA 2024-02-19
ER

PT J
AU Campolo, J
   Corradi, E
   Rizzardi, A
   Parolini, M
   Dellanoce, C
   Di Guglielmo, ML
   Tarlarini, P
   Cattaneo, M
   Trivella, MG
   De Maria, R
AF Campolo, Jonica
   Corradi, Ettore
   Rizzardi, Alice
   Parolini, Marina
   Dellanoce, Cinzia
   Di Guglielmo, Maria Luisa
   Tarlarini, Patrizia
   Cattaneo, Marina
   Trivella, Maria Giovanna
   De Maria, Renata
TI Irisin and markers of metabolic derangement in non-diabetic Caucasian
   subjects with stage I-II obesity during early aging
SO PLOS ONE
LA English
DT Article
ID CIRCULATING IRISIN; RESISTANCE; ADULTS; FAT
AB Irisin concentrations are decreased in subjects with overt diabetes and upregulated in those with obesity or impaired fasting glucose. However, gender-balanced data in older populations, in whom risk factors commonly culminate in overt cardiovascular disease, are scarce. We assessed in non-diabetic Caucasian subjects with stage I-II obesity in the early aging range (50 to 70 years), the relationship between irisin, body composition and markers of metabolic derangement by gender. In 60 (31 women, 29 men) non-diabetics with a body mass index >= 30 - <= 40 kg/m(2), we measured anthropometrics and body composition (Air Displacement Plethysmography). We assayed lipid and glucose profile by routine methods, plasma irisin by ELISA and measured insulin resistance by the HOMA index. Irisin levels were higher in women than in men (161 [105-198]) vs 83 [33-115] ng/ml, P< 0.001), and correlated directly with HOMA index in both (rho 0.735, P<0.001 M, rho 0.452, P = 0.011 F). Sex differences were maintained across insulin resistance severity stages. In men, irisin concentrations correlated directly with body mass index (rho 0.755, P< 0.001), waist circumference (rho 0.623, P<0.001), fat mass index (rho 0.762, P<0.001), glucose (rho 0.408, P = 0.028), the fatty liver index (rho 0.705, P<0.001) and FINDRISC score (rho 0.536, P = 0.003). Among non-diabetic Caucasian subjects with obesity in the early stages of aging, irisin levels reflect the amount of body fat and insulin resistance severity, independently of between-gender differences in the adipomyokine concentrations and are associated with markers of visceral adiposity in men but not in women.
C1 [Campolo, Jonica; Rizzardi, Alice; Parolini, Marina; Dellanoce, Cinzia; Di Guglielmo, Maria Luisa; Trivella, Maria Giovanna; De Maria, Renata] CNR, CardioThorac & Vasc Dept, Inst Clin Physiol, Milan, Italy.
   [Corradi, Ettore; Tarlarini, Patrizia; Cattaneo, Marina] ASST Grande Osped Metropolitano Niguarda, Clin Nutr Unit, Med Dept, Milan, Italy.
C3 Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica
   (IFC-CNR)
RP De Maria, R (corresponding author), CNR, CardioThorac & Vasc Dept, Inst Clin Physiol, Milan, Italy.
EM renata.demaria@ospedaleniguarda.it
RI Campolo, Jonica/ABC-5841-2020
OI CAMPOLO, JONICA/0000-0002-1711-6216
FU Regione Lombardia-CNR [19364/RCC]; AMANDA Project
FX This study was supported by Regione Lombardia-CNR 2016-2018 Framework
   Agreement, grant 19364/RCC, AMANDA Project. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Al-Daghri NM, 2014, EUR J CLIN INVEST, V44, P119, DOI 10.1111/eci.12196
   Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41
   Assyov Y, 2016, EXP CLIN ENDOCR DIAB, V124, P22, DOI 10.1055/s-0035-1564130
   Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33
   Biniaminov N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189254
   Boström P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777
   Buscemi S, 2018, INT J OBESITY, V42, P398, DOI 10.1038/ijo.2017.255
   Crujeiras AB, 2015, CLIN ENDOCRINOL, V82, P467, DOI 10.1111/cen.12627
   Crujeiras AB, 2014, AM J HUM BIOL, V26, P198, DOI 10.1002/ajhb.22493
   Cuthbertson DJ, 2014, EUR J ENDOCRINOL, V171, P561, DOI 10.1530/EJE-14-0112
   Elizondo-Montemayor L, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/2628968
   Fatouros IG, 2018, CLIN CHEM LAB MED, V56, P525, DOI 10.1515/cclm-2017-0674
   Fukushima Y, 2016, OBES SCI PRACT, V2, P203, DOI 10.1002/osp4.43
   Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404
   Kabasakalis A, 2019, J SPORT SCI, V37, P827, DOI 10.1080/02640414.2018.1530056
   Koetsier M, 2010, DIABETES TECHNOL THE, V12, P399, DOI 10.1089/dia.2009.0113
   Li Z, 2017, BIOSCIENCE REP, V37, DOI 10.1042/BSR20170213
   Lindström J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725
   Pardo M, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/857270
   Perakakis N, 2017, NAT REV ENDOCRINOL, V13, P324, DOI 10.1038/nrendo.2016.221
   Polyzos SA, 2018, ENDOCRINE, V59, P260, DOI 10.1007/s12020-017-1476-1
   Qiu SH, 2016, METABOLISM, V65, P825, DOI 10.1016/j.metabol.2016.02.006
   Qiu SH, 2015, SPORTS MED, V45, P1577, DOI 10.1007/s40279-014-0293-4
   Rask-Andersen M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08000-4
   Roca-Rivada A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060563
   Ruan QW, 2019, PEPTIDES, V113, P41, DOI 10.1016/j.peptides.2019.01.004
   Sahin-Efe A, 2018, METABOLISM, V79, P24, DOI 10.1016/j.metabol.2017.10.011
   Sanchis-Gomar F, 2015, TRENDS ENDOCRIN MET, V26, P335, DOI 10.1016/j.tem.2015.05.004
   Siri W.E., 1961, Techniques for measuring body composition, P223
   Stirban Alin, 2014, Eur Endocrinol, V10, P106, DOI 10.17925/EE.2014.10.02.106
   Martínez-Larrad MT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106641
   Tibana RA, 2017, J NUTR HEALTH AGING, V21, P241, DOI 10.1007/s12603-016-0748-4
   van Waateringe RP, 2016, EUR J CLIN INVEST, V46, P481, DOI 10.1111/eci.12627
   Yan B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094235
   Zügel M, 2016, ENDOCRINE, V54, P101, DOI 10.1007/s12020-016-0913-x
NR 35
TC 9
Z9 9
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 18
PY 2020
VL 15
IS 2
AR e0229152
DI 10.1371/journal.pone.0229152
PG 12
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA LQ7XT
UT WOS:000535212900025
PM 32069304
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU SUPAKAR, PC
   JUNG, MH
   SONG, CS
   CHATTERJEE, B
   ROY, AK
AF SUPAKAR, PC
   JUNG, MH
   SONG, CS
   CHATTERJEE, B
   ROY, AK
TI NUCLEAR FACTOR KAPPA-B FUNCTIONS AS A NEGATIVE REGULATOR FOR THE RAT
   ANDROGEN RECEPTOR GENE AND NF-KAPPA-B ACTIVITY INCREASES DURING THE
   AGE-DEPENDENT DESENSITIZATION OF THE LIVER
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID TRANSCRIPTION FACTORS; P65 SUBUNIT; PROMOTER; ACTIVATION; ENHANCER;
   EXPRESSION; SUPERFAMILY; SEQUENCES; PROTEIN
AB Transcriptional regulation of the steroid hormone receptor genes plays a central role in temporal changes of target cell sensitivity during development, maturation, and aging, Sequence-specific DNA-protein interactions mediate these regulatory functions, Progressive 5' deletion of the rat androgen receptor (rAR) gene immediately beyond the -572 base pair (bp) region causes a marked increase in its promoter activity. DNase I footprinting with nuclear proteins revealed a protected area encompassing -574- to -554-bp positions that begins with a perfectly palindromic nuclear factor kappa B (NF-kappa B) motif. Electrophoretic mobility shift analyses (EMSA) showed that the decameric rAR NF-kappa B site at positions -574 to -565 cross-competes with the authentic kappa immunoglobulin light chain enhancer for specific protein binding, Supershift with specific antibodies to NP-kappa B subunits confirmed that the two retarded bands observed in the EMSA with the labeled rAR probe are due to p50/p65 and p50/p50 dimers of the NF-kappa B/Rel proteins, Fragments of rAR promoter with either deletion or point mutation of the NF-kappa B site are found to be about 2- to S-fold more effective as compared to the wild type control in driving a heterologous reporter gene in cellulo. Thus, unlike most other known cases, NF-kappa B acts as a negative regulator for the rAR gene, The physiological relevance of this repressor function is evident from a 10-fold increase in the p50/p50 form of the NF-kappa B activity in the liver of aged rats exhibiting hepatic androgen desensitization. The newly identified repressor element is a rare example of a naturally occurring perfect palindromic binding motif for the NF-kappa B/Rel family of transcription factors, This repressor factor and the positively acting age-dependent factor, ADF, described earlier (Supakar, P. C., Song C. S., Jung, M., H., Slomczynska, M. A., Kim, J.-M., Vellanoweth, R. L., Chatterjee, B. & Poy, A. K. (1993) J. Biol. Chem. 268, 26400-26408) function to coordinate the tissue-specific down-regulation of the rAR gene during aging.
C1 UNIV TEXAS,HLTH SCI CTR,DEPT CELLULAR & STRUCT BIOL,SAN ANTONIO,TX 78284.
C3 University of Texas System; University of Texas Health Science Center at
   San Antonio
FU NIA NIH HHS [R01 AG10486, P01 AG06872] Funding Source: Medline; NIDDK
   NIH HHS [R-37 DK14744] Funding Source: Medline
CR BAARENDS WM, 1990, MOL CELL ENDOCRINOL, V74, P75, DOI 10.1016/0303-7207(90)90207-O
   BAEUERLE PA, 1991, BIOCHIM BIOPHYS ACTA, V1072, P63, DOI 10.1016/0304-419X(91)90007-8
   BALLARD DW, 1990, CELL, V63, P803, DOI 10.1016/0092-8674(90)90146-6
   BROWN AM, 1994, MOL CELL BIOL, V14, P2926, DOI 10.1128/MCB.14.5.2926
   CAULEY K, 1994, P NATL ACAD SCI USA, V91, P390, DOI 10.1073/pnas.91.1.390
   DEWET JR, 1987, MOL CELL BIOL, V2, P1044
   EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939
   FABER PW, 1993, J BIOL CHEM, V268, P9296
   FUJITA T, 1992, GENE DEV, V6, P775, DOI 10.1101/gad.6.5.775
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   HATTORI M, 1990, DNA CELL BIOL, V9, P777, DOI 10.1089/dna.1990.9.777
   JIANG J, 1993, EMBO J, V12, P3201, DOI 10.1002/j.1460-2075.1993.tb05989.x
   KIMURA A, 1986, CELL, V44, P261, DOI 10.1016/0092-8674(86)90760-9
   LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7
   LERNBECHER T, 1993, NATURE, V365, P767, DOI 10.1038/365767a0
   LINDZEY J, 1993, MOL ENDOCRINOL, V7, P1530, DOI 10.1210/me.7.12.1530
   Liou HC, 1993, CURR OPIN CELL BIOL, V5, P477, DOI 10.1016/0955-0674(93)90014-H
   LIU JK, 1991, MOL CELL BIOL, V11, P773, DOI 10.1128/MCB.11.2.773
   MIZOKAMI A, 1994, MOL ENDOCRINOL, V8, P77, DOI 10.1210/me.8.1.77
   NAKAYAMA K, 1992, MOL CELL BIOL, V12, P1736, DOI 10.1128/MCB.12.4.1736
   OMALLEY B, 1990, MOL ENDOCRINOL, V4, P363, DOI 10.1210/mend-4-3-363
   ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730
   POST DJ, 1991, ANN NY ACAD SCI, V621, P66
   ROY AK, 1983, ANNU REV PHYSIOL, V45, P37, DOI 10.1146/annurev.ph.45.030183.000345
   SCHMITZ ML, 1991, EMBO J, V10, P3805, DOI 10.1002/j.1460-2075.1991.tb04950.x
   SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x
   SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6
   SONG CS, 1993, BIOCHEM J, V294, P779, DOI 10.1042/bj2940779
   SUPAKAR PC, 1993, J BIOL CHEM, V268, P26400
   TILLEY WD, 1990, J BIOL CHEM, V265, P13776
   URBAN MB, 1991, EMBO J, V10, P1817, DOI 10.1002/j.1460-2075.1991.tb07707.x
NR 31
TC 138
Z9 145
U1 0
U2 0
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PD JAN 13
PY 1995
VL 270
IS 2
BP 837
EP 842
DI 10.1074/jbc.270.2.837
PG 6
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA QB816
UT WOS:A1995QB81600053
PM 7822319
OA hybrid
DA 2024-02-19
ER

PT J
AU Solon-Biet, SM
   McMahon, AC
   Ballard, JWO
   Ruohonen, K
   Wu, LE
   Cogger, VC
   Warren, A
   Huang, X
   Pichaud, N
   Melvin, RG
   Gokarn, R
   Khalil, M
   Turner, N
   Cooney, GJ
   Sinclair, DA
   Raubenheimer, D
   Le Couteur, DG
   Simpson, SJ
AF Solon-Biet, Samantha M.
   McMahon, Aisling C.
   Ballard, J. William O.
   Ruohonen, Kari
   Wu, Lindsay E.
   Cogger, Victoria C.
   Warren, Alessandra
   Huang, Xin
   Pichaud, Nicolas
   Melvin, Richard G.
   Gokarn, Rahul
   Khalil, Mamdouh
   Turner, Nigel
   Cooney, Gregory J.
   Sinclair, David A.
   Raubenheimer, David
   Le Couteur, David G.
   Simpson, Stephen J.
TI The Ratio of Macronutrients, Not Caloric Intake, Dictates
   Cardiometabolic Health, Aging, and Longevity in Ad Libitum-Fed Mice
SO CELL METABOLISM
LA English
DT Article
ID EXTENDS LIFE-SPAN; GEOMETRIC ANALYSIS; RESTRICTION; PROTEIN; BALANCE;
   RAPAMYCIN
AB The fundamental questions of what represents a macronutritionally balanced diet and how this maintains health and longevity remain unanswered. Here, the Geometric Framework, a state-space nutritional modeling method, was used to measure interactive effects of dietary energy, protein, fat, and carbohydrate on food intake, cardiometabolic phenotype, and longevity in mice fed one of 25 diets ad libitum. Food intake was regulated primarily by protein and carbohydrate content. Longevity and health were optimized when protein was replaced with carbohydrate to limit compensatory feeding for protein and suppress protein intake. These consequences are associated with hepatic mammalian target of rapamycin (mTOR) activation and mitochondrial function and, in turn, related to circulating branched-chain amino acids and glucose. Calorie restriction achieved by high-protein diets or dietary dilution had no beneficial effects on lifespan. The results suggest that longevity can be extended in ad libitum-fed animals by manipulating the ratio of macronutrients to inhibit mTOR activation.
C1 [Solon-Biet, Samantha M.; McMahon, Aisling C.; Cogger, Victoria C.; Warren, Alessandra; Huang, Xin; Raubenheimer, David; Le Couteur, David G.; Simpson, Stephen J.] Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia.
   [Solon-Biet, Samantha M.; McMahon, Aisling C.; Cogger, Victoria C.; Warren, Alessandra; Huang, Xin; Gokarn, Rahul; Le Couteur, David G.] Univ Sydney, Concord Hosp, Ctr Educ & Res Aging, Sydney, NSW 2139, Australia.
   [Solon-Biet, Samantha M.; McMahon, Aisling C.; Cogger, Victoria C.; Warren, Alessandra; Huang, Xin; Gokarn, Rahul; Khalil, Mamdouh; Le Couteur, David G.] Univ Sydney, Concord Hosp, ANZAC Res Inst, Sydney, NSW 2139, Australia.
   [Solon-Biet, Samantha M.; Raubenheimer, David; Simpson, Stephen J.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia.
   [Ballard, J. William O.; Pichaud, Nicolas] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia.
   [Ruohonen, Kari] EWOS Innovat, N-4335 Dirdal, Norway.
   [Wu, Lindsay E.; Sinclair, David A.] Univ New S Wales, Sch Med Sci, Lab Aging Res, Sydney, NSW 2052, Australia.
   [Melvin, Richard G.] Univ Helsinki, Inst Biotechnol, Helsinki 00014, Finland.
   [Turner, Nigel; Cooney, Gregory J.] Univ New S Wales, Garvan Inst Med Res, Darlinghurst, NSW 2010, Australia.
   [Sinclair, David A.] Harvard Univ, Sch Med, Dept Genet, Paul F Glenn Labs Biol Mech Aging, Boston, MA 02115 USA.
   [Raubenheimer, David] Massey Univ, Inst Nat Sci, Auckland 0632, New Zealand.
   [Raubenheimer, David] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia.
C3 University of Sydney; University of Sydney; Concord Repatriation General
   Hospital; University of Sydney; ANZAC Research Institute; Concord
   Repatriation General Hospital; University of Sydney; University of New
   South Wales Sydney; University of New South Wales Sydney; University of
   Helsinki; University of New South Wales Sydney; Garvan Institute of
   Medical Research; Harvard University; Harvard Medical School; Massey
   University; University of Sydney
RP Le Couteur, DG (corresponding author), Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia.
EM david.lecouteur@sydney.edu.au; stephen.simpson@sydney.edu.au
RI Melvin, Richard George/AGH-4179-2022; Wu, Lindsay/AAA-1486-2021; Turner,
   Nigel/H-7176-2013; Research Institute, ANZAC/CAE-9030-2022; Wu,
   Lindsay/GQI-1179-2022; Huang, Xin/G-8538-2012; Ballard, John William
   O./ABB-2743-2020; Solon-Biet, Samantha/R-6551-2017
OI Melvin, Richard George/0000-0001-6428-6763; Wu,
   Lindsay/0000-0002-1599-7574; Turner, Nigel/0000-0002-0119-9328; Wu,
   Lindsay/0000-0002-1599-7574; Ballard, John William
   O./0000-0002-2358-6003; Raubenheimer, David/0000-0001-9050-1447;
   Simpson, Stephen J./0000-0003-0256-7687; Le Couteur,
   David/0000-0002-4227-5817; Huang, Xin/0000-0002-7278-3070; Solon-Biet,
   Samantha/0000-0003-0608-958X; Sinclair, David/0000-0002-9936-436X;
   Pichaud, Nicolas/0000-0002-2820-8124
FU Australian National Health and Medical Research Council (NHMRC)
   [571328]; Ageing and Alzheimers Research Fund of Concord RG Hospital;
   Sydney Medical School Foundation; Australian Research Council Laureate
   Fellowship; Gravida, the National Research Centre for Growth and
   Development, New Zealand; Cancer Institute NSW (CINSW), Australia
FX Funding was obtained from the Australian National Health and Medical
   Research Council (NHMRC project grant 571328), the Ageing and Alzheimers
   Research Fund of Concord RG Hospital, and the Sydney Medical School
   Foundation. Additionally, S.J.S. was supported by an Australian Research
   Council Laureate Fellowship; D. R. was part funded by Gravida, the
   National Research Centre for Growth and Development, New Zealand; and L.
   E. W. was supported by an early career fellowship from the Cancer
   Institute NSW (CINSW), Australia. We acknowledge the assistance of the
   Departments of Biochemistry and Anatomical Pathology, Concord RG
   Hospital. We thank Leon McQuade for amino acid analyses and Andrew
   Holmes, Arthur Conigrave, and Patrick Bertolino for their contribution
   to other aspects of the study protocol. We are extremely grateful to
   John Speakman and Linda Partridge for their detailed review of earlier
   versions of the manuscript. There are no conflicts of interest to
   declare.
CR [Anonymous], 2007, DATA ANAL USING REGR
   [Anonymous], THE NATURE OF NUTRIT
   Bates D., 2012, R package version 0.999999-0
   Blumfield ML, 2012, AM J CLIN NUTR, V96, P1032, DOI 10.3945/ajcn.111.033241
   Burnett C, 2011, NATURE, V477, P482, DOI 10.1038/nature10296
   Chotechuang N, 2009, AM J PHYSIOL-ENDOC M, V297, pE1313, DOI 10.1152/ajpendo.91000.2008
   Everitt AV, 2010, CALORIE RESTRICTION, AGING AND LONGEVITY, P1, DOI 10.1007/978-90-481-8556-6
   Fanson BG, 2009, AGING CELL, V8, P514, DOI 10.1111/j.1474-9726.2009.00497.x
   Floegel A, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3801
   Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539
   Fromentin G, 2012, NUTR RES REV, V25, P29, DOI 10.1017/S0954422411000175
   Gosby AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025929
   Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221
   Hewson-Hughes AK, 2011, J EXP BIOL, V214, P1039, DOI 10.1242/jeb.049429
   Horan MP, 2012, J GERONTOL A-BIOL, V67, P1022, DOI 10.1093/gerona/glr263
   Huang X, 2013, OBESITY, V21, P85, DOI 10.1002/oby.20007
   Kapahi P, 2010, CELL METAB, V11, P453, DOI 10.1016/j.cmet.2010.05.001
   Lagiou P, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e4026
   Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185
   Le Couteur DG, 2014, J GERONTOL A-BIOL, V69, P1, DOI 10.1093/gerona/glt130
   Le Couteur DG, 2011, J GERONTOL A-BIOL, V66, P179, DOI 10.1093/gerona/glq171
   Le Couteur DG, 2010, J GERONTOL A-BIOL, V65, P1025, DOI 10.1093/gerona/glq135
   Lee KP, 2008, P NATL ACAD SCI USA, V105, P2498, DOI 10.1073/pnas.0710787105
   López-Lluch G, 2006, P NATL ACAD SCI USA, V103, P1768, DOI 10.1073/pnas.0510452103
   Martin GM, 2004, NATURE, V429, P357, DOI 10.1038/429357a
   Mayntz D, 2005, SCIENCE, V307, P111, DOI 10.1126/science.1105493
   Mayntz D, 2009, ANIM BEHAV, V77, P349, DOI 10.1016/j.anbehav.2008.09.036
   Miller RA, 2011, J GERONTOL A-BIOL, V66, P191, DOI 10.1093/gerona/glq178
   PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776
   Piper MDW, 2011, CELL METAB, V14, P154, DOI 10.1016/j.cmet.2011.06.013
   Ponton F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002223
   Simpson SJ, 2007, J GERONTOL A-BIOL, V62, P707, DOI 10.1093/gerona/62.7.707
   Simpson SJ, 2009, AGING-US, V1, P875, DOI 10.18632/aging.100098
   Sorensen A, 2008, OBESITY, V16, P566, DOI 10.1038/oby.2007.58
   Therneau TM., 2000, Modeling Survival Data: Extending the Cox Model, DOI DOI 10.1007/978-1-4757-3294-8
   Wood S. N., 2017, Generalized Additive Models: An Introduction with R
   Wood SN, 2003, J ROY STAT SOC B, V65, P95, DOI 10.1111/1467-9868.00374
   Yang JC, 2010, NUTR REV, V68, P270, DOI 10.1111/j.1753-4887.2010.00282.x
   Yee TW, 1996, J ROY STAT SOC B, V58, P481
NR 39
TC 613
Z9 677
U1 5
U2 148
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1550-4131
EI 1932-7420
J9 CELL METAB
JI Cell Metab.
PD MAR 4
PY 2014
VL 19
IS 3
BP 418
EP 430
DI 10.1016/j.cmet.2014.02.009
PG 13
WC Cell Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Endocrinology & Metabolism
GA AC3DP
UT WOS:000332395500012
PM 24606899
OA Green Accepted, hybrid
HC Y
HP N
DA 2024-02-19
ER

PT J
AU van Wijk, K
   Akabane, T
   Kimura, T
   Saitoh, S
   Okano, S
   Kelly, VP
   Takagi, M
   Kodama, K
   Takahashi, K
   Tanaka, T
   Nakajima, M
   Nakajima, O
AF van Wijk, Koen
   Akabane, Takeru
   Kimura, Tomohiro
   Saitoh, Shinichi
   Okano, Satoshi
   Kelly, Vincent P.
   Takagi, Michiaki
   Kodama, Ken
   Takahashi, Kiwamu
   Tanaka, Tohru
   Nakajima, Motowo
   Nakajima, Osamu
TI Heterozygous disruption of <i>ALAS1</i> in mice causes an accelerated
   age-dependent reduction in free heme, but not total heme, in skeletal
   muscle and liver
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Free heme; 5-Aminolevulinic acid (ALA); 5-Aminolevulinate synthase 1
   (ALAS1); Aging; Skeletal muscle; Liver
ID DELTA-AMINOLEVULINATE SYNTHASE; MITOCHONDRIAL BIOGENESIS; IRON;
   DEGRADATION; INHIBITION; EXPRESSION; DECAY; GENE
AB 5-Aminolevulinic acid (ALA) is the rate-limiting intermediate in heme biosynthesis in vertebrate species; a reaction catalyzed by the mitochondrial ALA synthase 1 (ALAS1) enzyme. Previously we reported that knockdown of the ubiquitously expressed ALAS1 gene in mice disrupts normal glucose metabolism, attenuates mitochondrial function and results in a prediabetic like phenotype when animals pass 20-weeks of age (Saitoh et al., 2018). Contrary to our expectations, the cytosolic and mitochondrial heme content of ALAS1 heterozygous (A1+/-) mice were similar to WT animals. Therefore, we speculated that regulatory "free heme" may be reduced in an age dependent manner in A1+/- mice, but not total heme.
   Here, we examine free and total heme from the skeletal muscle and liver of WT and A1+/- mice using a modified acetone extraction method and examine the effects of aging on free heme by comparing the amounts at 8-12 weeks and 30-36 weeks of age, in addition to the mRNA abundance of ALAS1. We found an age-dependent reduction in free heme in the skeletal muscle and liver of AI+/- mice, while WT mice showed only a slight decrease in the liver. Total heme levels showed no significant difference between young and aged WT and A1+/mice. ALAS1 mRNA levels showed an age-dependent reduction similar to that of free heme levels, indicating that ALAS1 mRNA expression levels are a major determinant for free heme levels. The free heme pools in skeletal muscle tissue were almost 2-fold larger than that of liver tissue, suggesting that the heme pool varies across different tissue types. The expression of heme oxygenise 1 (HO-1) mRNA, which is expressed proportionally to the amount of free heme, were similar to those of free heme levels. Taken together, this study demonstrates that the free heme pool differs across tissues, and that an age-dependent reduction in free heme levels is accelerated in mice heterozygous for ALAS1, which could account for the prediabetic phenotype and mitochondrial abnormality observed in these animals.
C1 [van Wijk, Koen; Akabane, Takeru; Kimura, Tomohiro; Saitoh, Shinichi; Okano, Satoshi; Nakajima, Osamu] Yamagata Univ, Dept Funct Genom, Sch Med, Iida Nishi 2-2-2, Yamagata 9909585, Japan.
   [van Wijk, Koen; Akabane, Takeru; Kimura, Tomohiro; Saitoh, Shinichi; Okano, Satoshi; Nakajima, Osamu] Yamagata Univ, Res Ctr Mol Genet, Inst Promot Med Sci Res, Fac Med, Yamagata, Japan.
   [Akabane, Takeru; Takagi, Michiaki] Yamagata Univ, Dept Orthoped, Sch Med, Yamagata, Japan.
   [Kelly, Vincent P.] Trinity Coll Dublin, Sch Biochem & Immunol, Trinity Biomed Sci Inst, Dublin, Ireland.
   [Kodama, Ken] Neopharma Japan Co Ltd, Chiyoda City, Tokyo, Japan.
   [Takahashi, Kiwamu; Tanaka, Tohru; Nakajima, Motowo] SBI Pharmaceut Co Ltd, Tokyo, Japan.
C3 Yamagata University; Yamagata University; Yamagata University; Trinity
   College Dublin; SBI Pharmaceuticals
RP Nakajima, O (corresponding author), Yamagata Univ, Dept Funct Genom, Sch Med, Iida Nishi 2-2-2, Yamagata 9909585, Japan.
EM nakajima@med.id.yamagata-u.ac.jp
RI Kelly, Vincent P/I-2151-2017
OI Kelly, Vincent P/0000-0001-7067-5407; Saitoh,
   Shinichi/0000-0001-7523-8177; Kimura, Tomohiro/0000-0003-0361-4633
FU JSPS KAKENHI [18K06949]; SBI Pharmaceuticals Co.,Ltd. (Tokyo, Japan);
   Neopharma Japan Co., Ltd., (Tokyo, Japan); Grants-in-Aid for Scientific
   Research [18K06949] Funding Source: KAKEN
FX This study was supported by JSPS KAKENHI (Grant-in-Aid for Scientific
   Research(C)) Grant Number 18K06949 to O. Nakajima and was a cooperative
   research effort with SBI Pharmaceuticals Co.,Ltd. (Tokyo, Japan) and
   Neopharma Japan Co., Ltd., (Tokyo, Japan), who provided financial
   support for the work.
CR Atamna H, 2004, AGEING RES REV, V3, P303, DOI 10.1016/j.arr.2004.02.002
   Atamna H, 2002, ARCH BIOCHEM BIOPHYS, V397, P345, DOI 10.1006/abbi.2001.2671
   Bairwa G, 2020, MBIO, V11, DOI 10.1128/mBio.00986-20
   Bouchez CL, 2020, J BIOL CHEM, V295, P5095, DOI 10.1074/jbc.RA120.012739
   Chertkova RV, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178280
   Espinas NA, 2012, PLANT CELL PHYSIOL, V53, P1344, DOI 10.1093/pcp/pcs067
   Galmozzi A, 2019, NATURE, V576, P138, DOI 10.1038/s41586-019-1774-2
   Ito H, 2018, EUR J PHARMACOL, V833, P25, DOI 10.1016/j.ejphar.2018.05.009
   Kubota Y, 2016, J BIOL CHEM, V291, P20516, DOI 10.1074/jbc.M116.719161
   Lignitto L, 2019, CELL, V178, P316, DOI 10.1016/j.cell.2019.06.003
   Munakata H, 2004, J BIOCHEM, V136, P233, DOI 10.1093/jb/mvh112
   Nakajima O, 1999, EMBO J, V18, P6282, DOI 10.1093/emboj/18.22.6282
   Nakajima O, 2006, GENES CELLS, V11, P685, DOI 10.1111/j.1365-2443.2006.00973.x
   Okano S, 2010, GENES CELLS, V15, P77, DOI 10.1111/j.1365-2443.2009.01366.x
   Peoc'h K, 2019, MOL GENET METAB, V128, P190, DOI 10.1016/j.ymgme.2019.01.015
   Saitoh S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189593
   Sato M, 2020, CANCER RES, V80, P1279, DOI 10.1158/0008-5472.CAN-18-4099
   SCOTTO AW, 1983, ARCH BIOCHEM BIOPHYS, V222, P150, DOI 10.1016/0003-9861(83)90512-X
   Sun JY, 2002, EMBO J, V21, P5216, DOI 10.1093/emboj/cdf516
   Suzuki H, 2004, EMBO J, V23, P2544, DOI 10.1038/sj.emboj.7600248
   Sweeny EA, 2018, J BIOL CHEM, V293, P14557, DOI 10.1074/jbc.RA118.004169
   Wiel C, 2019, CELL, V178, P330, DOI 10.1016/j.cell.2019.06.005
   YAMAMOTO M, 1983, BIOCHEM BIOPH RES CO, V115, P225, DOI 10.1016/0006-291X(83)90993-2
   YAMAUCHI K, 1980, J BIOL CHEM, V255, P1746
   Zenke-Kawasaki Y, 2007, MOL CELL BIOL, V27, P6962, DOI 10.1128/MCB.02415-06
NR 25
TC 9
Z9 9
U1 0
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JAN 15
PY 2021
VL 697
AR 108721
DI 10.1016/j.abb.2020.108721
PG 8
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA PS0KU
UT WOS:000607618300009
PM 33307066
OA Green Published, hybrid
DA 2024-02-19
ER

PT J
AU Waziry, R
   Hofman, A
   Ghanbari, M
   Tiemeier, H
   Ikram, MA
   Viswanathan, A
   Klap, J
   Ikram, MK
   Goudsmit, J
AF Waziry, Reem
   Hofman, Albert
   Ghanbari, Mohsen
   Tiemeier, Henning
   Ikram, M. A.
   Viswanathan, Anand
   Klap, Jaco
   Ikram, M. Kamran
   Goudsmit, Jaap
TI Biological aging for risk prediction of first-ever intracerebral
   hemorrhage and cerebral infarction in advanced age
SO JOURNAL OF STROKE & CEREBROVASCULAR DISEASES
LA English
DT Article
DE Biological aging; Intracerebral hemorrhage; Cerebral infarction;
   Biomarkers
ID GLOBAL BURDEN; STROKE; ROTTERDAM; DISEASE
AB Background and objectives: successful interventions to prevent cerebrovascular disease and stroke require early identification of persons at risk before clinical manifestation of disease. The literature remains to be sparse on accessible plasma-based biomarkers for monitoring brain health and cerebrovascular disease in advanced age. We assessed the predictive value of biological age (BA) as an early indicator for cerebrovascular disease and risk of first-ever intracerebral hemorrhage (ICH) and cerebral infarction (CI) in advanced age and compared these relationships with chronological age (CA) and commonly used biomarkers including tau and A ss 40 and A ss 42.
   Methods: The study included Individuals who consented for blood draw and follow-up. We computed biological age using structural equation modelling. The criteria for the biomarkers included their representability of the various body systems; their availability in the Rotterdam study and their prehypothesized reflection of aging in other populations. The algorithm integrates biomarkers that represent six body systems involved in overall cerebrovascular health including metabolic function, cardiac function, lung function, kidney function, liver function, immunity, and inflammation. Time to event analysis was conducted using Cox-regression models. Prediction analysis was conducted using Harrel's C and Area under the receiver operating characteristic curve.
   Results: The sample included a total of 1699 individuals at baseline followed up over a median of 11 years. During a period of 15, 780 and 16, 172 person-years, a total of 17 first-ever intracerebral hemorrhage and 83 cerebral infarction cases occurred. In time-to-event analysis, BA showed higher magnitude of associations with ICH compared to CA (HRBA-ICH: 2.30, 95% CI: 1.20, 4.30; HRCA-ICH: 1.40, 95% CI: 0.76, 2.53) and higher precision with CI (HRBA-CI: 1.30, 95% CI: 1.01,1.75; HR(CA-CI:)1.90, 95% CI: 1.48, 2.66). BA outperformed CA for prediction of ICH (AUC: 0.68 vs 0.53; Harrel's C: 0.72 vs 0.53) and for CI (AUC:0.63 vs 0.62; Harrel's C: 0.68 vs 0.67).
   Conclusions: Biological aging (delta biological aging) based on integrated physiology biomarkers provides a novel tool for monitoring and identification of persons at highest risk of cerebrovascular disease in advanced age with varying degrees of precision and magnitude for stroke subtypes. These variations are likely related to differences in pathophysiology of intracerebral hemorrhage and cerebral infarction. Wider validation and applicability require extension of these findings in other comparable samples and in clinical settings. (c) 2022 Elsevier Inc. All rights reserved.
C1 [Waziry, Reem] Columbia Univ, Irving Med Ctr, 168th St, New York, NY 10032 USA.
   [Waziry, Reem; Hofman, Albert; Tiemeier, Henning; Ikram, M. A.; Goudsmit, Jaap] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Cambridge, MA 02138 USA.
   [Waziry, Reem; Ghanbari, Mohsen; Ikram, M. A.; Ikram, M. Kamran] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands.
   [Viswanathan, Anand] Harvard Univ, Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Cambridge, MA 02138 USA.
   [Klap, Jaco] Janssen Prevent Ctr, Leiden, Netherlands.
   [Ikram, M. Kamran] Erasmus MC, Dept Neurol, Rotterdam, Netherlands.
   [Goudsmit, Jaap] Janssen Pharmaceut Co Johnson & Johnson, World Dis Accelerator WWDA, Leiden, Netherlands.
   [Goudsmit, Jaap] Leyden Labs, Leiden, Netherlands.
C3 Columbia University; NewYork-Presbyterian Hospital; Harvard University;
   Harvard T.H. Chan School of Public Health; Erasmus University Rotterdam;
   Erasmus MC; Harvard University; Massachusetts General Hospital; Erasmus
   University Rotterdam; Erasmus MC; Johnson & Johnson; Janssen
   Pharmaceuticals
RP Waziry, R (corresponding author), Columbia Univ, Irving Med Ctr, 168th St, New York, NY 10032 USA.
EM reemwaziry@gmail.com
RI Ikram, M. Arfan/AAM-5225-2021; Ghanbari, Mohsen/AAH-1340-2020; Tiemeier,
   Henning/H-6534-2019
OI Ghanbari, Mohsen/0000-0002-9476-7143; Tiemeier,
   Henning/0000-0002-4395-1397
FU Janssen Prevention Center; Clinical Translational Research Scholarship
   (CTRS) in Cognitive Aging and AgeRelated Memory Loss - McKnight Brain
   Research Foundation through the American Brain Foundation; American
   Academy of Neurology
FX This study was partially supported by a grant from Janssen Prevention
   Center. Dr Waziry is funded through a Clinical Translational Research
   Scholarship (CTRS) in Cognitive Aging and AgeRelated Memory Loss, funded
   by the McKnight Brain Research Foundation through the American Brain
   Foundation, in collaboration with the American Academy of Neurology.
CR [Anonymous], 2007, QUANTILE REGRESSION
   Balami JS, 2012, LANCET NEUROL, V11, P101, DOI 10.1016/S1474-4422(11)70264-2
   Belsky DW, 2015, P NATL ACAD SCI USA, V112, pE4104, DOI 10.1073/pnas.1506264112
   Bennett DA, 2006, NEUROLOGY, V66, P1837, DOI 10.1212/01.wnl.0000219668.47116.e6
   CDC, 2006, NAT HLTH NUTR EX SUR
   Chen BH, 2016, AGING-US, V8, P1844, DOI 10.18632/aging.101020
   de Wolfa F, 2020, BRAIN, V143, P1220, DOI 10.1093/brain/awaa054
   Feigin VL, 2017, CIRC RES, V120, P439, DOI 10.1161/CIRCRESAHA.116.308413
   Feigin VL, 2016, LANCET NEUROL, V15, P913, DOI 10.1016/S1474-4422(16)30073-4
   HATANO S, 1976, B WORLD HEALTH ORGAN, V54, P541
   Hayflick L, 2000, NATURE, V408, P267, DOI 10.1038/35041709
   Heshmatollah A, 2022, NEUROLOGY, V98, pE1729, DOI 10.1212/WNL.0000000000200004
   Holtzman S., 2011, P N E SAS US GROUP N
   Horvath S, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1030-0
   Ikram MA, 2020, EUR J EPIDEMIOL, V35, P483, DOI 10.1007/s10654-020-00640-5
   Ikram MA, 2017, EUR J EPIDEMIOL, V32, P807, DOI 10.1007/s10654-017-0321-4
   JORESKOG KG, 1970, BIOMETRIKA, V57, P239, DOI 10.2307/2334833
   Jylhävä J, 2017, EBIOMEDICINE, V21, P29, DOI 10.1016/j.ebiom.2017.03.046
   Klem L., 2000, READING UNDERSTANDIN, P227
   Levine ME, 2015, AGING-US, V7, P1198, DOI 10.18632/aging.100864
   Levine ME, 2014, J GERONTOL A-BIOL, V69, P297, DOI 10.1093/gerona/glt138
   Levine ME, 2013, J GERONTOL A-BIOL, V68, P667, DOI 10.1093/gerona/gls233
   Liu Zuyun, 2018, PLoS Med, V15, pe1002718, DOI 10.1371/journal.pmed.1002718
   Lopez-Garcia E, 2005, J NUTR, V135, P562, DOI 10.1093/jn/135.3.562
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Qureshi AI, 2001, NEW ENGL J MED, V344, P1450, DOI 10.1056/NEJM200105103441907
   Riley KP, 2002, ANN NEUROL, V51, P567, DOI 10.1002/ana.10161
   Schmid M, 2016, EXPERT SYST APPL, V63, P450, DOI 10.1016/j.eswa.2016.07.018
   Sebastiani P, 2017, AGING CELL, V16, P329, DOI 10.1111/acel.12557
   Vemuri P, 2019, ANN NEUROL, V86, P866, DOI 10.1002/ana.25600
   Waziry R, 2020, STROKE, V51, P824, DOI 10.1161/STROKEAHA.119.027198
   Waziry R, 2019, EUR J EPIDEMIOL, V34, P793, DOI 10.1007/s10654-019-00497-3
   Wieberdink RG, 2012, EUR J EPIDEMIOL, V27, P287, DOI 10.1007/s10654-012-9673-y
NR 33
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1052-3057
EI 1532-8511
J9 J STROKE CEREBROVASC
JI J. Stroke Cerebrovasc. Dis.
PD AUG
PY 2022
VL 31
IS 8
AR 106568
DI 10.1016/j.jstrokecerebrovasdis.2022.106568
PG 6
WC Neurosciences; Peripheral Vascular Disease
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Cardiovascular System & Cardiology
GA 3N6WC
UT WOS:000836285800001
PM 35749936
OA Green Submitted
DA 2024-02-19
ER

PT J
AU Ix, JH
   Wassel, CL
   Bauer, DC
   Toroian, D
   Tylavsky, FA
   Cauley, JA
   Harris, TB
   Price, PA
   Cummings, SR
   Shlipak, MG
AF Ix, Joachim H.
   Wassel, Christina L.
   Bauer, Douglas C.
   Toroian, Damon
   Tylavsky, Frances A.
   Cauley, Jane A.
   Harris, Tamara B.
   Price, Paul A.
   Cummings, Steven R.
   Shlipak, Michael G.
CA Hlth ABC Study
TI Fetuin-A and BMD in Older Persons: The Health Aging and Body Composition
   (Health ABC) Study
SO JOURNAL OF BONE AND MINERAL RESEARCH
LA English
DT Article
DE fetuin-A; BMD; elderly
ID ALPHA-2 HS-GLYCOPROTEIN; VASCULAR CALCIFICATION; HUMAN-BONE; SERUM;
   DISEASE; PROTEIN; MINERALIZATION; ASSOCIATION; INHIBITION; PHOSPHATE
AB Fetuin-A is a hepatic secretory protein that promotes bone mineralization in vitro. Whether fetuin-A levels are associated with BMD in humans is unknown. The Health Aging and Body Composition study enrolled 3075 well-functioning black and white persons 70-79 yr of age and measured BMD. This cross-sectional study measured serum fetuin-A using ELISA among a random sample of 508 participants within sex and race strata. Multivariate linear regression analysis evaluated the associations of fetuin-A with BMD. Among women (n = 257), higher fetuin-A levels were significantly associated with higher total hip (p = 0.02), lumbar spine (p = 0.03), and whole body BMD (p = 0.01) in models adjusted for age, race, diabetes, alcohol and tobacco use, physical activity, body mass index, C-reactive protein levels, calcium supplement, and estrogen use. For example, each SD (0.38 g/liter) higher level of fetuin-A was associated with 0.0.16 g/cm(2) higher total hip area] BMD. The association was of similar magnitude and direction for femoral neck BMD but did not reach statistical significance (p = 0.11). In contrast, among men (n = 251), fetuin-A had no significant associations with total hip (p = 0.79), lumbar spine (p = 0.35), whole body (p = 0.46), or femoral neck BMD (p = 0.54) in multivariable models. We conclude that higher fetuin-A levels are independently associated with higher BMD among well-functioning community-dwelling older women but not older men. Future studies should evaluate whether fetuin-A may refine fracture risk assessment in older women.
C1 [Ix, Joachim H.] Univ Calif San Diego, Dept Med, Div Nephrol, San Diego, CA 92161 USA.
   [Ix, Joachim H.] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA.
   [Ix, Joachim H.] Univ Calif San Diego, Dept Family & Prevent Med, Div Prevent Med, San Diego, CA 92161 USA.
   [Wassel, Christina L.] Univ Minnesota, Dept Epidemiol & Community Hlth, Minneapolis, MN USA.
   [Wassel, Christina L.; Bauer, Douglas C.; Shlipak, Michael G.] Univ Calif San Francisco, Dept Med & Epidemiol & Biostat, San Francisco, CA 94143 USA.
   [Toroian, Damon; Price, Paul A.] Univ Calif San Diego, Div Biol Sci, San Diego, CA 92161 USA.
   [Tylavsky, Frances A.] Univ Tennessee, Hlth Sci Ctr, Dept Prevent Med, Memphis, TN USA.
   [Cauley, Jane A.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA.
   [Harris, Tamara B.] NIA, Lab Epidemiol Demog & Biometry, Bethesda, MD 20892 USA.
   [Cummings, Steven R.] Calif Pacific Med Ctr, Dept Med, San Francisco, CA USA.
   [Cummings, Steven R.] San Francisco Coordinating Ctr, San Francisco, CA USA.
   [Shlipak, Michael G.] San Francisco VA Med Ctr, Gen Med Sect, San Francisco, CA USA.
C3 University of California System; University of California San Diego; US
   Department of Veterans Affairs; Veterans Health Administration (VHA); VA
   San Diego Healthcare System; University of California System; University
   of California San Diego; University of Minnesota System; University of
   Minnesota Twin Cities; University of California System; University of
   California San Francisco; University of California System; University of
   California San Diego; University of Tennessee System; University of
   Tennessee Health Science Center; Pennsylvania Commonwealth System of
   Higher Education (PCSHE); University of Pittsburgh; National Institutes
   of Health (NIH) - USA; NIH National Institute on Aging (NIA); California
   Pacific Medical Center; California Pacific Medical Center; California
   Pacific Medical Center Research Institute; US Department of Veterans
   Affairs; Veterans Health Administration (VHA); San Francisco VA Medical
   Center
RP Ix, JH (corresponding author), Univ Calif San Diego, Dept Med, Div Nephrol & Hypertens, 3350 La Jolla Village Dr,Mail Code 111-H, San Diego, CA 92161 USA.
EM joeix@ucsd.edu
RI Cauley, Jane A/N-4836-2015
OI Cauley, Jane A/0000-0003-0752-4408
FU American Diabetes Association (ADA); Atlantic Philanthropies; John A.
   Hartford Foundation; ASP; American Heart Association Fellow to Faculty
   Transition Award (JHI) [N01-AG-6-2101, N01-AG-6-2103, N01-AG6-2106];
   Intramural Research Program from the National Institutes on Aging (NIA)
FX The authors thank the other investigators, the staff, and the
   participants of the Health ABC stud), for valuable contributions and Dr
   Elsa Strotmeyer for her critical review of the manuscript. This Study
   was supported by an American Diabetes Association (ADA)-ASP Young
   Investigator Innovation Award in Geriatric Endocrinology sponsored by
   the Atlantic Philanthropies, ADA, the John A. Hartford Foundation, and
   ASP, an American Heart Association Fellow to Faculty Transition Award
   (JHI), and Contracts N01-AG-6-2101. N01-AG-6-2103, and N01-AG6-2106 and
   an Intramural Research Program from the National Institutes on Aging
   (NIA). The funding sources
CR Anderson H Clarke, 2003, Curr Rheumatol Rep, V5, P222, DOI 10.1007/s11926-003-0071-z
   ASHTON BA, 1980, CLIN SCI, V58, P435, DOI 10.1042/cs0580435
   BARAN D, 1995, J BONE MINER RES, V10, pS374
   BRANDENBURG V, 2007, AM SOC NEPHROL
   Demetriou M, 1996, J BIOL CHEM, V271, P12755, DOI 10.1074/jbc.271.22.12755
   DICKSON IR, 1975, NATURE, V256, P430, DOI 10.1038/256430a0
   DICKSON IR, 1983, CALCIFIED TISSUE INT, V35, P16, DOI 10.1007/BF02405000
   DONALDSON LJ, 1990, J EPIDEMIOL COMMUN H, V44, P241, DOI 10.1136/jech.44.3.241
   Fiore CE, 2007, ATHEROSCLEROSIS, V195, P110, DOI 10.1016/j.atherosclerosis.2006.08.052
   FUERST T, 1995, J BONE MINER RES, V10, pS370
   Giachelli CM, 2001, AM J KIDNEY DIS, V38, pS34, DOI 10.1053/ajkd.2001.27394
   GORDON PC, 1971, CAN MED ASSOC J, V105, P47
   Hamlin NJ, 2004, CALCIFIED TISSUE INT, V75, P231, DOI 10.1007/s00223-004-0190-1
   Heiss A, 2003, J BIOL CHEM, V278, P13333, DOI 10.1074/jbc.M210868200
   Ix J, 2007, KIDNEY INT, V72, P1394, DOI 10.1038/sj.ki.5002549
   Ix JH, 2007, CIRCULATION, V115, P2533, DOI 10.1161/CIRCULATIONAHA.106.682450
   Ix JH, 2006, NEPHROL DIAL TRANSPL, V21, P2144, DOI 10.1093/ndt/gfl204
   Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4
   Johnson RC, 2006, CIRC RES, V99, P1044, DOI 10.1161/01.RES.0000249379.55535.21
   Ketteler M, 2002, BLOOD PURIFICAT, V20, P473, DOI 10.1159/000063554
   Ketteler M, 2003, LANCET, V361, P827, DOI 10.1016/S0140-6736(03)12710-9
   Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002
   Lim P, 2007, CLIN CHEM, V53, P1835, DOI 10.1373/clinchem.2006.084947
   Mathews ST, 2002, DIABETES, V51, P2450, DOI 10.2337/diabetes.51.8.2450
   Melton LJ, 2005, OSTEOPOROSIS INT, V16, P1558, DOI 10.1007/s00198-005-1871-y
   MIZUNO M, 1991, BONE MINER, V13, P1, DOI 10.1016/0169-6009(91)90046-3
   National Osteoporosis Foundation, 2002, AM BON HLTH STAT OST
   PAHOR M, 1994, EUR J EPIDEMIOL, V10, P405, DOI 10.1007/BF01719664
   Price PA, 2004, J BIOL CHEM, V279, P19169, DOI 10.1074/jbc.M307880200
   Price PA, 2003, J BIOL CHEM, V278, P22144, DOI 10.1074/jbc.M300744200
   Price PA, 2002, J BIOL CHEM, V277, P3926, DOI 10.1074/jbc.M106366200
   QUELCH KJ, 1984, CALCIFIED TISSUE INT, V36, P545, DOI 10.1007/BF02405363
   Randell AG, 2000, OSTEOPOROSIS INT, V11, P460, DOI 10.1007/s001980070115
   Reynolds JL, 2005, J AM SOC NEPHROL, V16, P2920, DOI 10.1681/ASN.2004100895
   Ruffoni D, 2007, BONE, V40, P1308, DOI 10.1016/j.bone.2007.01.012
   Sarnak MJ, 2005, ANN INTERN MED, V142, P497, DOI 10.7326/0003-4819-142-7-200504050-00008
   Toroian D, 2008, CALCIFIED TISSUE INT, V82, P116, DOI 10.1007/s00223-007-9085-2
   Toroian D, 2007, J BIOL CHEM, V282, P22437, DOI 10.1074/jbc.M700591200
   van der Linden JC, 2001, J BIOMECH, V34, P1573, DOI 10.1016/S0021-9290(01)00146-4
   Vittinghoff E, 2005, STAT BIOL HEALTH, pVII
   WENDEL M, 1993, MATRIX, V13, P331, DOI 10.1016/S0934-8832(11)80029-6
NR 41
TC 25
Z9 27
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0884-0431
EI 1523-4681
J9 J BONE MINER RES
JI J. Bone Miner. Res.
PD MAR
PY 2009
VL 24
IS 3
BP 514
EP 521
DI 10.1359/JBMR.081017
PG 8
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 410JA
UT WOS:000263572100015
PM 19016589
OA Green Published, Bronze
DA 2024-02-19
ER

PT J
AU Moriguchi, S
   Hamanaka, K
   Nakamura, M
   Takaso, M
   Baba, M
   Hitosugi, M
AF Moriguchi, Shingo
   Hamanaka, Kunio
   Nakamura, Mami
   Takaso, Marin
   Baba, Mineko
   Hitosugi, Masahito
TI Aging is only significant factor causing CPR-induced injuries and
   serious injuries
SO LEGAL MEDICINE
LA English
DT Article
DE CPR-induced injury; Abbreviated injury scale score; Serious injury;
   Visceral injury; Autopsy
ID CARDIOPULMONARY-RESUSCITATION; COMPLICATIONS SECONDARY;
   COMPUTED-TOMOGRAPHY; CHEST COMPRESSIONS; CARDIAC-ARREST; GUIDELINES;
   FREQUENCY; FRACTURES; BREAKING; RIB
AB Background: Cardiopulmonary resuscitation (CPR) sometime cause severe injuries and can affect quality of life, lead to long-term disabilities or death of the patient. The aim of this study is to identify the risk factors causing CPR-induced injuries and those of serious injuries.
   Methods: This was a retrospective forensic autopsy study in a single institution. Among 885 forensic autopsies undertaken between 2011 and 2018, those in which the victim had undergone CPR immediately after cardiac arrest were recorded. 'Serious injuries' were defined as an Abbreviated Injury Scale (AIS) score >= 3. CPR-induced injuries were evaluated by three experienced forensic pathologists. With the background and history of the patient, the circumstances of cardiac arrest and risks of causing CPR-induced injuries were determined by multivariate analyses.
   Results: Seventy-five victims comprised the study cohort. CPR-induced injuries were found in 52 victims (69.3%). Rib fracture was the most common (60.0%), followed by sternal fracture (37.3%), heart injury (21.3%) and liver injury (8.0%). Multivariate analysis revealed higher age to be an independent factor causing CPR-induced injuries (odds ratio [OR], 1.07, P < 0.001). Thirty-six victims had 39 serious injuries in the chest or abdomen: fracture of >= 3 ribs (35 cases), aortic dissection (two), lung contusion (one) and rupture of the heart (one). Multivariate analysis revealed higher age to be an independent factor causing CPR-induced serious injuries (OR, 1.09; P < 0.001).
   Conclusion: Aging was the significant factor causing CPR-induced injuries and serious injuries.
C1 [Moriguchi, Shingo; Hamanaka, Kunio; Nakamura, Mami; Takaso, Marin; Hitosugi, Masahito] Shiga Univ Med Sci, Dept Legal Med, Otsu, Shiga 5202192, Japan.
   [Baba, Mineko] Keio Univ, Ctr Integrated Med Res, Sch Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.
C3 Shiga University of Medical Science; Keio University
RP Moriguchi, S (corresponding author), Shiga Univ Med Sci, Dept Legal Med, Otsu, Shiga 5202192, Japan.
EM opi717@yahoo.co.jp
CR Agnew AM, 2015, J MECH BEHAV BIOMED, V41, P302, DOI 10.1016/j.jmbbm.2014.09.002
   Association for the Advancement of Automotive Medicine, 1990, ACSP UPD, P2
   Bankhead-Kendall B, 2019, AM SURGEON, V85, P1224
   Baubin M, 1999, RESUSCITATION, V43, P9, DOI 10.1016/S0300-9572(99)00110-0
   Beom JH, 2017, SCAND J TRAUMA RESUS, V25, DOI 10.1186/s13049-017-0352-6
   Black CJ, 2004, RESUSCITATION, V63, P339, DOI 10.1016/j.resuscitation.2004.07.005
   Chrysou K, 2017, SCAND J TRAUMA RESUS, V25, DOI 10.1186/s13049-017-0384-y
   Hellevuo H, 2013, RESUSCITATION, V84, P760, DOI 10.1016/j.resuscitation.2013.02.015
   Hoke RS, 2004, RESUSCITATION, V63, P327, DOI 10.1016/j.resuscitation.2004.05.019
   Janssens JP, 1999, EUR RESPIR J, V13, P197, DOI 10.1034/j.1399-3003.1999.13a36.x
   Kaldirim U., 2015, Egypt J Forensic Sci, V6, P270, DOI [10.1016/j.ejfs.2015.07.005, DOI 10.1016/J.EJFS.2015.07.005]
   Kashiwagi Y, 2015, RESUSCITATION, V88, P86, DOI 10.1016/j.resuscitation.2014.12.022
   Kralj E, 2015, RESUSCITATION, V93, P136, DOI 10.1016/j.resuscitation.2015.02.034
   KRISCHER JP, 1987, CHEST, V92, P287, DOI 10.1378/chest.92.2.287
   Milling L, 2019, ACTA ANAESTH SCAND, V63, P789, DOI 10.1111/aas.13347
   Neumar RW, 2015, CIRCULATION, V132, pS315, DOI 10.1161/CIR.0000000000000252
   Ondruschka B, 2018, FORENSIC SCI MED PAT, V14, P515, DOI 10.1007/s12024-018-0024-5
   Pinto DC, 2013, J FORENSIC SCI, V58, P904, DOI 10.1111/1556-4029.12146
   Ram P, 2018, AM J EMERG MED, V36, P838, DOI 10.1016/j.ajem.2017.12.063
   Rudinská LI, 2016, RESUSCITATION, V103, P66, DOI 10.1016/j.resuscitation.2016.04.002
   Setälä P, 2018, ACTA ANAESTH SCAND, V62, P1290, DOI 10.1111/aas.13155
   Seung MK, 2016, RESUSCITATION, V98, P64, DOI 10.1016/j.resuscitation.2015.11.004
   Smekal D, 2014, RESUSCITATION, V85, P1708, DOI 10.1016/j.resuscitation.2014.09.017
   Yamaguchi R, 2017, INT J LEGAL MED, V131, P1655, DOI 10.1007/s00414-017-1673-8
NR 24
TC 4
Z9 4
U1 1
U2 7
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 1344-6223
J9 LEGAL MED-TOKYO
JI Leg. Med.
PD FEB
PY 2021
VL 48
AR 101828
DI 10.1016/j.legalmed.2020.101828
PG 6
WC Medicine, Legal; Social Sciences, Biomedical
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Legal Medicine; Biomedical Social Sciences
GA PY8RZ
UT WOS:000612309600007
PM 33370635
DA 2024-02-19
ER

PT J
AU Uemura, T
   Akasaka, Y
   Ikegaya, H
AF Uemura, Takeshi
   Akasaka, Yoshihisa
   Ikegaya, Hiroshi
TI Correlation of polyamines, acrolein-conjugated lysine and polyamine
   metabolic enzyme levels with age in human liver
SO HELIYON
LA English
DT Article
DE Biochemistry; Oxidative stress; Biomolecules; Aging; Biomarkers;
   Polyamine; Ornithine decarboxylase; Adenosylmethionine decarboxylase;
   Spermine oxidase; Acrolein-conjugated lysine
AB The polyamines spermidine, spermine and putrescine are essential for normal cellular functions. The contents of polyamines in tissue decreased in aged mice compared to young mice. In this study, the polyamine contents and their metabolic byproduct acrolein-conjugated lysine (N-epsilon-(3-formyl-3,4-dehydropiperidino)-lysine, FDP-Lys) in human liver tissue were measured and analyzed the correlation with age of the subjects. The putrescine and FDP-Lys levels were significantly increased with age. On the other hand, spermine level was decreased with age. Spermidine did not significantly correlate with age. The relative amount of spermine oxidase (SMOX) significantly correlated with the age of subjects whereas ornithine decarboxylase (ODC) and adenosylmethionine decarboxylase (AMD1) significantly reduced by the age. Our results suggested that an increase in oxidation and reduction in polyamine synthesis may cause the change of polyamine profile in the elderly.
C1 [Uemura, Takeshi] Amine Pharma Res Inst, Chuo Ku, 1-8-15 Inohana, Chiba 2600856, Japan.
   [Uemura, Takeshi; Akasaka, Yoshihisa; Ikegaya, Hiroshi] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Forens Med, Kamigyo Ku, 465 Kajii Cho,Kawaramachi Hirokoji, Kyoto 6028566, Japan.
C3 Kyoto Prefectural University of Medicine
RP Uemura, T (corresponding author), Amine Pharma Res Inst, Chuo Ku, 1-8-15 Inohana, Chiba 2600856, Japan.; Uemura, T (corresponding author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Forens Med, Kamigyo Ku, 465 Kajii Cho,Kawaramachi Hirokoji, Kyoto 6028566, Japan.
EM uemura@amine-pharma.com
RI Ikegaya, Hiroshi/JWP-0195-2024
OI Ikegaya, Hiroshi/0000-0002-2380-7558; Uemura,
   Takeshi/0000-0002-5227-4519
FU Japan Society for the Promotion of Science [17K09270]; Grants-in-Aid for
   Scientific Research [17K09270] Funding Source: KAKEN
FX H. Ikegaya was supported by the Grant-in-Aid for Scientific Research
   (C), Japan Society for the Promotion of Science (17K09270).
CR Bae DH, 2018, BBA-GEN SUBJECTS, V1862, P2053, DOI 10.1016/j.bbagen.2018.06.004
   Eisenberg T, 2016, NAT MED, V22, P1428, DOI 10.1038/nm.4222
   Ferioli ME, 1999, AMINO ACIDS, V17, P139, DOI 10.1007/BF01361877
   Furuhata A, 2003, J BIOL CHEM, V278, P48658, DOI 10.1074/jbc.M309401200
   Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454
   IGARASHI K, 1986, J BACTERIOL, V166, P128, DOI 10.1128/jb.166.1.128-134.1986
   Igarashi K, 2018, J BIOL CHEM, V293, P18702, DOI 10.1074/jbc.TM118.003465
   Kano Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056056
   Larqué E, 2007, NUTRITION, V23, P87, DOI 10.1016/j.nut.2006.09.006
   Minois N, 2011, AGING-US, V3, P716, DOI 10.18632/aging.100361
   Nishimura K, 2006, J BIOCHEM, V139, P81, DOI 10.1093/jb/mvj003
   Park MH, 2018, J BIOL CHEM, V293, P18710, DOI 10.1074/jbc.TM118.003341
   Pegg AE, 2016, J BIOL CHEM, V291, P14904, DOI 10.1074/jbc.R116.731661
   Pegg AE, 2013, CHEM RES TOXICOL, V26, P1782, DOI 10.1021/tx400316s
   Ramos-Molina B, 2019, FRONT NUTR, V6, DOI 10.3389/fnut.2019.00024
   Soda K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064357
   Uemura T, 2008, J BIOL CHEM, V283, P26428, DOI 10.1074/jbc.M804714200
   Uemura Takeshi, 2019, Oncotarget, V10, P5713, DOI 10.18632/oncotarget.27192
   Uemura T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14929-1
   Uemura T, 2010, AM J PHYSIOL-GASTR L, V299, pG517, DOI 10.1152/ajpgi.00169.2010
   Uemura T, 2009, INT J BIOCHEM CELL B, V41, P2538, DOI 10.1016/j.biocel.2009.08.010
   Vargas AJ, 2012, AM J CLIN NUTR, V96, P133, DOI 10.3945/ajcn.111.030353
NR 22
TC 10
Z9 10
U1 3
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
EI 2405-8440
J9 HELIYON
JI Heliyon
PD SEP
PY 2020
VL 6
IS 9
AR e05031
DI 10.1016/j.heliyon.2020.e05031
PG 5
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA OC4NY
UT WOS:000579136000198
PM 32995657
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Zeid, D
   Mooney-Leber, S
   Seemiller, LR
   Goldberg, LR
   Gould, TJ
AF Zeid, Dana
   Mooney-Leber, Sean
   Seemiller, Laurel R.
   Goldberg, Lisa R.
   Gould, Thomas J.
TI Terc Gene Cluster Variants Predict Liver Telomere Length in Mice
SO CELLS
LA English
DT Article
DE telomeres; genetic; nicotine; aging; Terc; Mynn; Lrriq4; Lrrc31; cancer
ID MOUSE TELOMERASE; CHRONIC NICOTINE; COMMON VARIANTS; SEX-DIFFERENCES;
   CANCER; POLYMORPHISMS; WITHDRAWAL; DYNAMICS
AB Variants in a gene cluster upstream-adjacent to TERC on human chromosome 3, which includes genes APRM, LRRC31, LRRC34 and MYNN, have been associated with telomere length in several human populations. Currently, the mechanism by which variants in the TERC gene cluster influence telomere length in humans is unknown. Given the proximity between the TERC gene cluster and TERC (similar to 0.05 Mb) in humans, it is speculated that cluster variants are in linkage disequilibrium with a TERC causal variant. In mice, the Terc gene/Terc gene cluster are also located on chromosome 3; however, the Terc gene cluster is located distantly downstream of Terc (similar to 60 Mb). Here, we initially aim to investigate the interactions between genotype and nicotine exposure on absolute liver telomere length (aTL) in a panel of eight inbred mouse strains. Although we found no significant impact of nicotine on liver aTL, this first experiment identified candidate single nucleotide polymorphisms (SNPs) in the murine Terc gene cluster (within genes Lrrc31, Lrriq4 and Mynn) co-varying with aTL in our panel. In a second experiment, we tested the association of these Terc gene cluster variants with liver aTL in an independent panel of eight inbred mice selected based on candidate SNP genotype. This supported our initial finding that Terc gene cluster polymorphisms impact aTL in mice, consistent with data in human populations. This provides support for mice as a model for telomere dynamics, especially for studying mechanisms underlying the association between Terc cluster variants and telomere length. Finally, these data suggest that mechanisms independent of linkage disequilibrium between the Terc/TERC gene cluster and the Terc/TERC gene mediate the cluster's regulation of telomere length.
C1 [Zeid, Dana; Seemiller, Laurel R.; Goldberg, Lisa R.; Gould, Thomas J.] Penn State Univ, Dept Biobehav Hlth, University Pk, PA 16802 USA.
   [Mooney-Leber, Sean] Univ Wisconsin, Dept Psychol, Stevens Point, WI 54481 USA.
C3 Pennsylvania Commonwealth System of Higher Education (PCSHE);
   Pennsylvania State University; Pennsylvania State University -
   University Park; University of Wisconsin System; University of Wisconsin
   Stevens Point
RP Zeid, D (corresponding author), Penn State Univ, Dept Biobehav Hlth, University Pk, PA 16802 USA.
EM duz39@psu.edu; smooneyl@uwsp.edu; lrs5307@psu.edu; lrg33@psu.edu;
   tug70@psu.edu
OI Mooney-Leber, Sean/0000-0002-6694-2493; Seemiller,
   Laurel/0000-0002-1534-5357
FU National Institute on Drug Abuse [1U01DA041632]; National Institute of
   General Medical Sciences; Penn State Jean Phillips Shibley Endowment
FX This research was funded by the National Institute on Drug Abuse, grant
   numbers 1U01DA041632 (T.J.G) and 1F31DA049395 (D.Z.); by the National
   Institute of General Medical Sciences, grant number T32GM108563
   (L.R.S.); by the Penn State Jean Phillips Shibley Endowment (T.J.G.).
CR Al Khaldi R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145721
   Barrett ELB, 2011, AGING CELL, V10, P913, DOI 10.1111/j.1474-9726.2011.00741.x
   Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641
   BEDNAREK A, 1995, CANCER RES, V55, P4566
   BLACKBURN EH, 1989, GENOME, V31, P553, DOI 10.1139/g89-104
   Broccoli D, 1996, MOL CELL BIOL, V16, P3765
   Broer L, 2013, EUR J HUM GENET, V21, P1163, DOI 10.1038/ejhg.2012.303
   Calado RT, 2013, SEMIN HEMATOL, V50, P165, DOI 10.1053/j.seminhematol.2013.03.030
   Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47
   Cheng Y., 2020, BLOOD GENOM, V4, P9, DOI [10.46701/BG.2020012020103, DOI 10.46701/BG.2020012020103]
   Codd V, 2010, NAT GENET, V42, P197, DOI 10.1038/ng.532
   Cooper JC, 2007, BIOL REPROD, V77, P274, DOI 10.1095/biolreprod.106.057125
   Davis JA, 2005, J NEUROSCI, V25, P8708, DOI 10.1523/JNEUROSCI.2853-05.2005
   Greider CW, 1996, SCI AM, V274, P92, DOI 10.1038/scientificamerican0296-92
   GREIDER CW, 1990, BIOESSAYS, V12, P363, DOI 10.1002/bies.950120803
   Grubb SC, 2014, NUCLEIC ACIDS RES, V42, pD825, DOI 10.1093/nar/gkt1159
   Gu YQ, 2016, BIOCHEM BIOPH RES CO, V472, P573, DOI 10.1016/j.bbrc.2016.03.044
   Harrell FE, 2015, SPRINGER SER STAT, P311, DOI 10.1007/978-3-319-19425-7_13
   Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9
   Jones AM, 2012, GUT, V61, P248, DOI 10.1136/gut.2011.239772
   KIPLING D, 1990, NATURE, V347, P400, DOI 10.1038/347400a0
   Kolishovski G, 2019, MAMM GENOME, V30, P353, DOI 10.1007/s00335-019-09821-4
   Krämer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703
   Kroupa M, 2020, MUTAGENESIS, V35, P491, DOI 10.1093/mutage/geaa030
   Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345
   Lee J, 2016, NUCLEIC ACIDS RES, V44, pW35, DOI 10.1093/nar/gkw310
   LEVY MZ, 1992, J MOL BIOL, V225, P951, DOI 10.1016/0022-2836(92)90096-3
   Manning EL, 2002, MAMM GENOME, V13, P234, DOI 10.1007/s003350020027
   Muñoz-Lorente MA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12664-x
   Nakao R, 2017, MOL GENET METAB, V121, P190, DOI 10.1016/j.ymgme.2017.04.001
   Njajou OT, 2007, P NATL ACAD SCI USA, V104, P12135, DOI 10.1073/pnas.0702703104
   O'Callaghan NJ, 2011, BIOL PROCED ONLINE, V13, DOI 10.1186/1480-9222-13-3
   Polat F, 2019, UROL J, V16, P50, DOI 10.22037/uj.v0i0.4083
   Portugal GS, 2012, BEHAV GENET, V42, P133, DOI 10.1007/s10519-011-9489-7
   PROWSE KR, 1995, P NATL ACAD SCI USA, V92, P4818, DOI 10.1073/pnas.92.11.4818
   Sethi I, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-63510-w
   Shen Q, 2011, EUR J HUM GENET, V19, P721, DOI 10.1038/ejhg.2011.4
   Vera E, 2012, CELL REP, V2, P732, DOI 10.1016/j.celrep.2012.08.023
   Watson RL, 2017, MOL ECOL, V26, P3230, DOI 10.1111/mec.13992
   Went M., 2020, THESIS U LONDON LOND
   WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934
   Wright WE, 2000, NAT MED, V6, P849, DOI 10.1038/78592
NR 42
TC 0
Z9 0
U1 0
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2073-4409
J9 CELLS-BASEL
JI Cells
PD OCT
PY 2021
VL 10
IS 10
AR 2623
DI 10.3390/cells10102623
PG 12
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA WP9BJ
UT WOS:000713419000001
PM 34685603
OA Green Published, Green Submitted, gold
DA 2024-02-19
ER

PT J
AU Hsu, CK
   Yeh, JY
   Wei, JH
AF Hsu, Cheng-Kuang
   Yeh, Jan-Ying
   Wei, Ji-Hung
TI Protective effects of the crude extracts from yam (<i>Dioscorea
   alata</i>) peel on <i>tert</i>-butylhydroperoxide-induced oxidative
   stress in mouse liver cells
SO FOOD CHEMISTRY
LA English
DT Article
DE Yam; tert-Butylhydroperoxide; Lipid peroxidation; Antioxidative enzymes
ID LIPID-PEROXIDATION; SUPEROXIDE-DISMUTASE; ANTIOXIDANT ACTIVITY;
   GLUTATHIONE; PROTEIN; SENESCENCE; RADICALS; ASSAY; MICE; FOOD
AB Researchers have shown that yam extracts contain antioxidative activity; however, there are few reports regarding the antioxidant activities of yam peel. The effects of water and 50% ethanolic extracts from Darsan yam (Dioscorea alata) peel on the oxidative status of tert-butylhydroperoxide (t-BHP)-treated mouse Hepa 1-6 and FL83B liver cell lines were investigated. The cytosols were analysed for H(2)O(2) and malondialdehyde (MDA) levels and antioxidative enzymes activities, including superoxide dismutase, glutathione peroxidase (GPx) and catalase activities. Both water and 50% ethanolic extracts from yam peel did not affect cellular MDA level in t-BHP-treated cells, but they altered the level of H(2)O(2). Water extract from yam peel amplified the t-BHP-induced cytotoxicity in Hepa 1-6 whilst the ethanolic extract showed protection in FL83B cells. GPx activity might play an important role in the protective effect associated with t-BHP-induced oxidative stress. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Hsu, Cheng-Kuang] Natl Chiayi Univ, Dept Food Sci, Chiayi 60004, Taiwan.
   [Hsu, Cheng-Kuang; Yeh, Jan-Ying; Wei, Ji-Hung] Asia Univ, Dept Biotechnol, Taichung 413, Taiwan.
C3 National Chiayi University; Asia University Taiwan
RP Hsu, CK (corresponding author), Natl Chiayi Univ, Dept Food Sci, 300 Syuefu Rd, Chiayi 60004, Taiwan.
EM ckhsu@asia.edu.tw
FU National Science Council in Taiwan, ROC [NSC97-2313-B-468-002-MY3]
FX This research was partially supported by the National Science Council in
   Taiwan, ROC (NSC97-2313-B-468-002-MY3).
CR Aebi H., 1983, METHODS ENZYM, P673
   Araghiniknam M, 1996, LIFE SCI, V59, pPL147, DOI 10.1016/0024-3205(96)00396-7
   BOTSOGLOU NA, 1994, J AGR FOOD CHEM, V42, P1931, DOI 10.1021/jf00045a019
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Chan YC, 2004, INT J FOOD SCI TECH, V39, P99, DOI 10.1046/j.0950-5423.2003.00751.x
   Chan YC, 2006, J SCI FOOD AGR, V86, P1517, DOI 10.1002/jsfa.2536
   Chen PY, 2004, J AGR FOOD CHEM, V52, P1945, DOI 10.1021/jf0351826
   Chiang BH, 2005, J SCI FOOD AGR, V85, P2385, DOI 10.1002/jsfa.2228
   Chou ST, 2006, FOOD CHEM, V98, P618, DOI 10.1016/j.foodchem.2005.06.039
   Chung YC, 2008, INT J FOOD SCI TECH, V43, P859, DOI 10.1111/j.1365-2621.2007.01528.x
   DAVIES MJ, 1989, BIOCHEM J, V257, P603, DOI 10.1042/bj2570603
   FANG MC, 2002, IMMUNOBIOACTIVE YAM, P66
   Han SK, 1996, J NEUROCHEM, V66, P501
   HE S, 1994, J CHINA PHARM U, V25, P373
   Hikino H, 1986, PLANTA MED, V52, P168
   Hou WC, 2001, J AGR FOOD CHEM, V49, P4956, DOI 10.1021/jf010606m
   HSU HY, 1984, ESSENTIALS MAT MED
   HUSAIN SR, 1987, PHYTOCHEMISTRY, V26, P2489, DOI 10.1016/s0031-9422(00)83860-1
   Kelmanson JE, 2000, J ETHNOPHARMACOL, V69, P241, DOI 10.1016/S0378-8741(99)00147-6
   Lasztity R, 1998, FOOD REV INT, V14, P371, DOI 10.1080/87559129809541169
   MARKLUND S, 1974, European Journal of Biochemistry, V47, P469, DOI 10.1111/j.1432-1033.1974.tb03714.x
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   OBERLEY LW, 1979, CANCER RES, V39, P1141
   PAGLIA DE, 1967, J LAB CLIN MED, V70, P158
   Patel JB, 2009, J CANCER RES THER, V5, P247, DOI 10.4103/0973-1482.59898
   RUSH GF, 1985, TOXICOL APPL PHARM, V78, P473, DOI 10.1016/0041-008X(85)90255-8
   Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001
   WAITT A. W., 1963, Field Crop Abstracts, V16, P145
   WANASUNDERA JPD, 1994, PLANT FOOD HUM NUTR, V46, P33, DOI 10.1007/BF01088459
   WENDEL A, 1980, ENZYMATIC BASIS DETO, P333, DOI DOI 10.1016/B978-0-12-380001-5.50022-0
   Yeh JY, 2002, CELL MOL LIFE SCI, V59, P1972, DOI 10.1007/PL00012519
NR 31
TC 11
Z9 16
U1 0
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0308-8146
J9 FOOD CHEM
JI Food Chem.
PD MAY 15
PY 2011
VL 126
IS 2
BP 429
EP 434
DI 10.1016/j.foodchem.2010.11.004
PG 6
WC Chemistry, Applied; Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry; Food Science & Technology; Nutrition & Dietetics
GA 715BK
UT WOS:000286855200006
DA 2024-02-19
ER

PT J
AU Kong, HY
   Zhao, X
   Wang, KR
AF Kong, Hai-Ying
   Zhao, Xian
   Wang, Kui-Rong
TI Intraoperative management and early post-operative outcomes of patients
   with coronary artery disease who underwent orthotopic liver
   transplantation
SO HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL
LA English
DT Article
DE Orthotopic liver transplantation; Coronary artery disease;
   Post-reperfusion syndrome
ID POSTREPERFUSION SYNDROME; MANNITOL; IMPACT
AB Background: Coronary artery disease (CAD) is frequently observed in aging end-stage liver disease (ESLD) patients who require orthotopic liver transplantation (OLT). This situation is challenging for both the patients and the medical staff.
   Methods: We retrospectively studied the case records of 26 ESLD patients with CAD who underwent OLT with total clamping of the inferior vena cava between 2014 and 2018. We analyzed the details of the pre-operative evaluation, intraoperative anesthetic management and post-operative prognosis of these patients.
   Results: All patients tolerated the anhepatic stage well. Post-reperfusion syndrome (PRS) was observed in 13 patients (50%) and 2 of them were severe but corrected well. ST-segment depression was frequently observed during the anhepatic stage and reperfusion stage. No mortality due to cardiac-related events occurred among the patients during hospitalization. OLT with the modified piggyback technique could successfully be performed in ESLD patients with mild and moderate CAD.
   Conclusions: A thorough evaluation and optimization of recipients, strict monitoring and optimized management of circulation, knowledge of the complicated changes during OLT procedures, and strategies to ameliorate post-reperfusion syndrome favorite the outcomes. (C) 2020 First Affiliated Hospital, Zhejiang University School of Medicine in China. Published by Elsevier B.V. All rights reserved.
C1 [Kong, Hai-Ying; Wang, Kui-Rong] Zhejiang Univ, Affiliated Hosp 1, Dept Anesthesiol, Sch Med, Hangzhou 310003, Peoples R China.
   [Zhao, Xian] Zhejiang Univ, Int Hosp, Dept Anesthesiol, Hangzhou 310000, Peoples R China.
C3 Zhejiang University; Zhejiang University
RP Wang, KR (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Dept Anesthesiol, Sch Med, Hangzhou 310003, Peoples R China.
EM wangkr@zju.edu.cn
CR Axelrod D, 2004, LIVER TRANSPLANT, V10, P1386, DOI 10.1002/lt.20244
   Ayhan A, 2015, TRANSPL P, V47, P1199, DOI 10.1016/j.transproceed.2015.03.002
   Chen XH, 2017, J CANCER RES CLIN, V143, P1337, DOI 10.1007/s00432-017-2376-8
   ELLIS SG, 1990, CIRCULATION, V82, P1193, DOI 10.1161/01.CIR.82.4.1193
   Fayed N, 2013, J CRIT CARE, V28, P775, DOI 10.1016/j.jcrc.2013.02.016
   Hilmi I, 2008, LIVER TRANSPLANT, V14, P504, DOI 10.1002/lt.21381
   Hofer I, 2015, LIVER TRANSPLANT, V21, P89, DOI 10.1002/lt.24014
   Kork F, 2018, BMC ANESTHESIOL, V18, DOI 10.1186/s12871-018-0493-9
   Mandell MS, 2008, WORLD J GASTROENTERO, V14, P3445, DOI 10.3748/wjg.14.3445
   Millis JM, 1997, TRANSPLANTATION, V63, P397, DOI 10.1097/00007890-199702150-00012
   Moller S, 2002, HEART, V87, P9, DOI 10.1136/heart.87.1.9
   Raval Z, 2011, J AM COLL CARDIOL, V58, P223, DOI 10.1016/j.jacc.2011.03.026
   Rudnick MR, 2015, WORLD J HEPATOL, V7, P1302, DOI 10.4254/wjh.v7.i10.1302
   Sahmeddini MA, 2014, PROG TRANSPLANT, V24, P121, DOI 10.7182/pit2014483
   Satapathy SK, 2017, TRANSPLANTATION, V101, P793, DOI 10.1097/TP.0000000000001647
   Seo H, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002328
   Skaro AI, 2016, J CARDIOVASC MED, V17, P875, DOI 10.2459/JCM.0000000000000207
   Srivastava P, 2013, INDIAN J ANAESTH, V57, P599, DOI 10.4103/0019-5049.123335
   Ustunsoy H, 2009, HEART SURG FORUM, V12, pE202, DOI 10.1532/HSF98.20091020
   Wiesen Patricia, 2016, World J Transplant, V6, P220, DOI 10.5500/wjt.v6.i1.220
   Xu ZD, 2012, HEPATOB PANCREAT DIS, V11, P34, DOI 10.1016/S1499-3872(11)60123-9
   Zhao X, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000008780
NR 22
TC 0
Z9 0
U1 0
U2 8
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1499-3872
EI 2352-9377
J9 HEPATOB PANCREAT DIS
JI Hepatob. Pancreatic. Dis. Int.
PD FEB
PY 2020
VL 19
IS 1
BP 12
EP 16
DI 10.1016/j.hbpd.2019.12.003
PG 5
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA KN4UR
UT WOS:000514834500003
PM 31932196
DA 2024-02-19
ER

PT J
AU Wong, GLH
   Wong, VWS
   Yuen, BWY
   Tse, YK
   Luk, HWS
   Yip, TCF
   Hui, VWK
   Liang, LY
   Lui, GCY
   Chan, HLY
AF Wong, Grace Lai-Hung
   Wong, Vincent Wai-Sun
   Yuen, Becky Wing-Yan
   Tse, Yee-Kit
   Luk, Hester Wing-Sum
   Yip, Terry Cheuk-Fung
   Hui, Vicki Wing-Ki
   Liang, Lilian Yan
   Lui, Grace Chung-Yan
   Chan, Henry Lik-Yuen
TI An Aging Population of Chronic Hepatitis B With Increasing
   Comorbidities: A Territory-Wide Study From 2000 to 2017
SO HEPATOLOGY
LA English
DT Article; Early Access
ID TENOFOVIR DISOPROXIL FUMARATE; METABOLIC SYNDROME INCREASES; LONG-TERM
   SAFETY; VIRUS INFECTION; LIVER FIBROSIS; FATTY LIVER; RISK; ALAFENAMIDE;
   CIRRHOSIS; ANALOGS
AB Patients with chronic hepatitis B (CHB) are aging because of improved survival under better health care. This has an important implication on the choice of antiviral treatment (AVT), given that long-term safety would be a concern in the presence of multiple comorbidities. We aimed to determine the prevalence of key comorbidities and concomitant medications in a territory-wide CHB cohort in Hong Kong in 2000-2017. CHB patients who have been under the care at primary, secondary, and tertiary medical centers in the public sector were identified through the Clinical Data Analysis and Reporting System of the Hospital Authority, Hong Kong. The demographics and prevalence of key comorbidities, including diabetes mellitus, hypertension, chronic kidney disease, osteopenia/osteoporosis based on diagnosis codes, relevant medications, and/or laboratory parameters, were determined according to CHB patients' first appearance in four time periods: 2000-2004, 2005-2009, 2010-2013, and 2014-2017. In the final analysis, 135,395 CHB patients were included; the mean age increased with time: 41 +/- 15 years in 2000-2004; 46 +/- 17 years in 2005-2009; 51 +/- 16 years in 2010-2013; and 55 +/- 15 years in 2014-2017. There was a trend of increasing prevalence of several common comorbidities over the four periods: hypertension 25.5%, 23.8%, 27.2%, and 28.6%; diabetes mellitus 10.6%, 12.5%, 16.1%, and 20.1%; cardiovascular disease 12.5%, 16.9%, 20.9%, and 22.2%; and malignancy 7.0%, 13.2%, 17.3%, and 23.6%, respectively (all P < 0.001). Conclusion: CHB patients are getting older with increasing prevalence of common comorbidities. These comorbidities should be taken into account when choosing AVT.
C1 [Wong, Grace Lai-Hung; Wong, Vincent Wai-Sun; Yuen, Becky Wing-Yan; Tse, Yee-Kit; Yip, Terry Cheuk-Fung; Liang, Lilian Yan; Chan, Henry Lik-Yuen] Chinese Univ Hong Kong, Inst Digest Dis, Hong Kong, Peoples R China.
   [Wong, Grace Lai-Hung; Wong, Vincent Wai-Sun; Tse, Yee-Kit; Luk, Hester Wing-Sum; Yip, Terry Cheuk-Fung; Liang, Lilian Yan; Lui, Grace Chung-Yan; Chan, Henry Lik-Yuen] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Peoples R China.
   [Wong, Grace Lai-Hung; Wong, Vincent Wai-Sun; Chan, Henry Lik-Yuen] Chinese Univ Hong Kong, State Key Lab Digest Dis, Hong Kong, Peoples R China.
   [Hui, Vicki Wing-Ki] Chinese Univ Hong Kong, Dept Stat, Hong Kong, Peoples R China.
C3 Chinese University of Hong Kong; Chinese University of Hong Kong;
   Chinese University of Hong Kong; Chinese University of Hong Kong
RP Chan, HLY (corresponding author), 9 F Prince Wales Hosp, Dept Med & Therapeut, Shatin, 30-32 Ngan Shing St, Hong Kong, Peoples R China.
EM hlychan@cuhk.edu.hk
RI Chan, Henry Lik-Yuen/B-9636-2008; Chan, Henry/JKI-4211-2023; Wong,
   Vincent WS/K-3864-2014; Yuen, Becky Wing-Yan/GPX-8736-2022; Yip, Terry
   Cheuk-Fung/ABH-3221-2021; Wong, Grace L. H./L-8586-2014; Lui, Chung Yan
   Grace/N-5178-2016
OI Wong, Vincent WS/0000-0003-2215-9410; Yuen, Becky
   Wing-Yan/0000-0001-9835-842X; Yip, Terry Cheuk-Fung/0000-0002-1819-2464;
   Wong, Grace L. H./0000-0002-2863-9389; Lui, Chung Yan
   Grace/0000-0001-5242-2967
FU Gilead Sciences [IN-US-988-5290]
FX Supported by the Investigator Sponsored Research of Gilead Sciences
   (Reference: IN-US-988-5290).
CR Agarwal K, 2018, J HEPATOL, V68, P672, DOI 10.1016/j.jhep.2017.11.039
   Amer Diabet Assoc, 2018, DIABETES CARE, V41, pS13, DOI [10.2337/dc11-S011, 10.2337/dc18-S002, 10.2337/dc09-S062, 10.2337/dc19-S002, 10.2337/dc12-S064]
   Buti M, 2016, LANCET GASTROENTEROL, V1, P90, DOI [10.1016/S2468-1253(16)30107-8, 10.1016/S2468-1253(16)30020-6]
   Cathcart AL, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.01064-18
   Chan HL, 2017, J HEPATOL, V66, pS25, DOI 10.1016/S0168-8278(17)30312-4
   Chan HLY, 2016, LANCET GASTROENTEROL, V1, P185, DOI 10.1016/S2468-1253(16)30024-3
   Chan HLY, 2004, GUT, V53, P1494, DOI 10.1136/gut.2003.033324
   Cheng JYK, 2016, HEPATOLOGY, V64, P1507, DOI 10.1002/hep.28778
   Cheng MC., 2010, MEDINFO 2010: Studies in Health Technology and Informatics, P1468
   European Assoc Study Liver, 2017, J HEPATOL, V67, P370, DOI 10.1016/j.jhep.2017.03.021
   Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170
   LAI KN, 1991, NEW ENGL J MED, V324, P1457, DOI 10.1056/NEJM199105233242103
   Liang LLY, 2019, CLIN MOL HEPATOL, V25, P172, DOI 10.3350/cmh.2018.0106
   Liu KSH, 2019, J INFECT DIS, V219, P1924, DOI 10.1093/infdis/jiz038
   Lo AOS, 2014, EXPERT REV GASTROENT, V8, P607, DOI 10.1586/17474124.2014.909724
   Marcellin P, 2013, LANCET, V381, P468, DOI 10.1016/S0140-6736(12)61425-1
   Nguyen MH, 2019, HEPATOLOGY, V69, P959, DOI 10.1002/hep.30246
   Razavi-Shearer D, 2018, LANCET GASTROENTEROL, V3, P383, DOI 10.1016/S2468-1253(18)30056-6
   Sarin SK, 2016, HEPATOL INT, V10, P1, DOI 10.1007/s12072-015-9675-4
   Szeto CC, 2014, CLIN J AM SOC NEPHRO, V9, P779, DOI 10.2215/CJN.06620613
   Terrault Norah A, 2018, Clin Liver Dis (Hoboken), V12, P33, DOI [10.1002/hep.29800, 10.1002/cld.728]
   Wong GLH, 2018, ALIMENT PHARM THER, V47, P730, DOI 10.1111/apt.14497
   Wong GLH, 2014, ALIMENT PHARM THER, V39, P883, DOI 10.1111/apt.12658
   Wong GLH, 2010, ALIMENT PHARM THER, V31, P1095, DOI 10.1111/j.1365-2036.2010.04276.x
   Wong GLH, 2009, GUT, V58, P111, DOI 10.1136/gut.2008.157735
   Wong GLH, 2018, ALIMENT PHARM THER, V48, P984, DOI 10.1111/apt.14945
   Wong GLH, 2018, J HEPATOL, V69, P793, DOI 10.1016/j.jhep.2018.05.009
   Wong GLH, 2015, HEPATOLOGY, V62, P684, DOI 10.1002/hep.27894
   Wong GLH, 2015, CLIN GASTROENTEROL H, V13, P783, DOI 10.1016/j.cgh.2014.09.050
   Wong GLH, 2013, HEPATOLOGY, V58, P1537, DOI 10.1002/hep.26301
   Wong GLH, 2013, GASTROENTEROLOGY, V144, P933, DOI 10.1053/j.gastro.2013.02.002
   Wong JCT, 2017, ALIMENT PHARM THER, V46, P1001, DOI 10.1111/apt.14341
   Wong VWS, 2012, J HEPATOL, V56, P533, DOI 10.1016/j.jhep.2011.09.013
   Wong VWS, 2012, GUT, V61, P409, DOI 10.1136/gutjnl-2011-300342
   Yip TCF, 2018, J HEPATOL, V68, P63, DOI 10.1016/j.jhep.2017.09.018
   Yip TCF, 2017, J HEPATOL, V67, P902, DOI 10.1016/j.jhep.2017.06.019
NR 36
TC 54
Z9 56
U1 2
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD 2020 FEB
PY 2020
VL 71
IS 2
BP 444
EP 455
DI 10.1002/hep.30833
EA AUG 2019
PG 12
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA LP3AA
UT WOS:000481222500001
PM 31237366
DA 2024-02-19
ER

PT J
AU Kepchia, D
   Huang, L
   Currais, A
   Liang, ZB
   Fischer, W
   Maher, P
AF Kepchia, Devin
   Huang, Ling
   Currais, Antonio
   Liang, Zhibin
   Fischer, Wolfgang
   Maher, Pamela
TI The Alzheimer's disease drug candidate J147 decreases blood plasma fatty
   acid levels via modulation of AMPK/ACC1 signaling in the liver
SO BIOMEDICINE & PHARMACOTHERAPY
LA English
DT Article; Early Access
DE Dementia; Aging; Blood biomarkers; Liver; Lipidomics; Drug discovery
ID TARGET ENGAGEMENT; GENE-EXPRESSION; MODEL; SAMP8; PATHWAY; FUTURE; AMPK
AB J147 is a novel drug candidate developed to treat neurological dysfunction. Numerous studies have demonstrated the beneficial effects of J147 in cellular and animal models of disease which has led to the transitioning of the compound into human clinical trials. However, no biomarkers for its target engagement have been identified. Here, we determined if specific metabolites in the plasma could be indicative of J147 ' s activity in vivo. Plasma lipidomics data from three independent rodent studies were assessed along with liver lipidomics data from one of the studies. J147 consistently reduced plasma free fatty acid (FFA) levels across the independent studies. Decreased FFA levels were also found in the livers of J147-treated mice that correlated well with those in the plasma. These changes in the liver were associated with activation of the AMP-activated protein kinase/acetylCoA carboxylase 1 signaling pathway. A reduction in FFA levels by J147 was confirmed in HepG2 cells, where activation of the AMPK/ACC1 pathway was seen along with increases in acetyl-CoA and ATP levels which correlated with enhanced cellular bioenergetics. Our data show that J147 targets liver cells to activate the AMPK/ACC1 signaling pathway and preserve energy at the expense of inhibiting FFA synthesis.
C1 [Kepchia, Devin; Currais, Antonio; Liang, Zhibin; Fischer, Wolfgang; Maher, Pamela] Salk Inst Biol Studies, Cellular Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.
   [Huang, Ling] Salk Inst Biol Studies, Razavi Newman Integrat Genom & Bioinformat Core, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.
C3 Salk Institute; Salk Institute
RP Kepchia, D (corresponding author), Salk Inst Biol Studies, Cellular Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.
EM dkepchia@salk.edu; pmaher@salk.edu
RI Liang, Zhibin/B-9783-2015; Currais, Antonio/C-1149-2009
OI Liang, Zhibin/0000-0002-8855-1696; Currais, Antonio/0000-0003-4142-7054
FU NIH [RO1 AG069206, RF1 AG054714]; Shiley-Marcos Alzheimer's Disease
   Research Center at University of California San Diego; Paul F. Glenn
   Center for Biology of Aging Research at the Salk Institute Fellowship;
   Bundy Foundation; NIH-NCI [CCSG: P30 014195]; Helmsley Trust
FX This work was supported by grants from NIH (RO1 AG069206, RF1 AG054714)
   to P.M., the Shiley-Marcos Alzheimer's Disease Research Center at
   University of California San Diego to A.C., the Paul F. Glenn Center for
   Biology of Aging Research at the Salk Institute Fellowship to Z.L., a
   Bundy Foundation Fellowship to D.K., and NIH-NCI CCSG: P30 014195, and
   the Helmsley Trust to L.H.
CR ADEN DP, 1979, NATURE, V282, P615, DOI 10.1038/282615a0
   Akiguchi I, 2017, NEUROPATHOLOGY, V37, P293, DOI 10.1111/neup.12373
   Bertolotti M, 2014, WORLD J GASTROENTERO, V20, P14185, DOI 10.3748/wjg.v20.i39.14185
   Butterfield DA, 2005, EXP GERONTOL, V40, P774, DOI 10.1016/j.exger.2005.05.007
   Carling D, 2017, CURR OPIN CELL BIOL, V45, P31, DOI 10.1016/j.ceb.2017.01.005
   Chen Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027865
   Chin RM, 2014, NATURE, V510, P397, DOI 10.1038/nature13264
   Currais A, 2019, ELIFE, V8, DOI 10.7554/eLife.47866
   Currais A, 2015, AGING-US, V7, P937, DOI 10.18632/aging.100838
   Currais A, 2012, AGING CELL, V11, P1017, DOI 10.1111/acel.12002
   DASHTI N, 1987, J LIPID RES, V28, P423
   Daugherty D, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-017-0277-3
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Durham TB, 2015, BIOORG MED CHEM LETT, V25, P998, DOI 10.1016/j.bmcl.2014.12.076
   Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207
   Goldberg J, 2018, AGING CELL, V17, DOI 10.1111/acel.12715
   Hardie DG, 2016, TRENDS CELL BIOL, V26, P190, DOI 10.1016/j.tcb.2015.10.013
   Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004
   Hodson L, 2019, NAT REV ENDOCRINOL, V15, P689, DOI 10.1038/s41574-019-0256-9
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923
   Huang L, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-03020-9
   Kepchia D, 2021, AGING-US, V13, P3269, DOI 10.18632/aging.202631
   Liu HW, 2015, J AGR FOOD CHEM, V63, P8407, DOI 10.1021/acs.jafc.5b02501
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Maher P, 2020, CELL CHEM BIOL, V27, P1456, DOI 10.1016/j.chembiol.2020.10.010
   Panwar P, 2018, MATRIX BIOL, V65, P30, DOI 10.1016/j.matbio.2017.06.004
   Parola M, 2019, MOL ASPECTS MED, V65, P37, DOI 10.1016/j.mam.2018.09.002
   Prior M, 2016, ALZHEIMERS DEMENT, V12, P678, DOI 10.1016/j.jalz.2016.03.016
   Prior M, 2014, ACS CHEM NEUROSCI, V5, P503, DOI 10.1021/cn500051h
   Prior M, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt179
   Schubert D, 2018, TRENDS PHARMACOL SCI, V39, P1004, DOI 10.1016/j.tips.2018.09.008
   Shin SY, 2014, NAT GENET, V46, P543, DOI 10.1038/ng.2982
   Simon GM, 2013, NAT CHEM BIOL, V9, P200, DOI 10.1038/nchembio.1211
   Takeda T, 2009, NEUROCHEM RES, V34, P639, DOI 10.1007/s11064-009-9922-y
   Ye X, 2004, HISTOL HISTOPATHOL, V19, P1141, DOI 10.14670/HH-19.1141
NR 36
TC 6
Z9 6
U1 1
U2 7
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI ISSY-LES-MOULINEAUX
PA 65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE
SN 0753-3322
EI 1950-6007
J9 BIOMED PHARMACOTHER
JI Biomed. Pharmacother.
PD 2022 MAR
PY 2022
VL 147
AR 112648
DI 10.1016/j.biopha.2022.112648
EA JAN 2022
PG 11
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA YJ5RS
UT WOS:000744590600002
PM 35051863
OA Green Accepted, gold
DA 2024-02-19
ER

PT J
AU KUROBE, N
   KATO, K
AF KUROBE, N
   KATO, K
TI SENSITIVE ENZYME-IMMUNOASSAY FOR RAT MN SUPEROXIDE-DISMUTASE - TISSUE
   DISTRIBUTION AND DEVELOPMENTAL PROFILES IN THE RAT CENTRAL
   NERVOUS-TISSUE, LIVER, AND KIDNEY
SO BIOMEDICAL RESEARCH-TOKYO
LA English
DT Article
ID MANGANESE; PROTEINS; MOUSE; HEART; BRAIN; AGE; IGG
AB Sensitive enzyme immunoassay for measurement of rat Mn superoxide dismutase (Mn SOD) was established by using purified antibodies against rat Mn SOD, which were raised in rabbits with Mn-SOD purified from rat liver. The assay system consisted of polystyrene balls with immobilized anti-Mn SOD F(ab')2 fragments and the same antibody Fab' fragments labeled with beta-D-galactosidase from Escherichia coli. The assay was highly sensitive, and the minimum detection limit was 1 pg of Mn-SOD/assay tube. The immunoreactive Mn-SOD was detectable in all rat tissues examined, and it was present at high levels in the adrenal, heart, kidney, brain, stomach, duodenum, slow twitch muscles, and liver. Concentrations of Mn SOD in the central nervous tissue, kidney and liver were low at birth. But they increased gradually, reaching the adult levels by 5 weeks of age. Immunoreactive Cu/Zn SOD determined in the same samples showed similar increases after birth in each organ. However, the concentrations of Cu/Zn SOD were much higher than those of Mn SOD. Mn SOD concentrations decreased slightly during aging in the liver and kidney, and the concentrations at 25 months of age were significantly low as compared with those at 3 months of age.
C1 AICHI PREFECTURAL COLONY, INST DEV RES, DEPT BIOCHEM, KASUGAI, AICHI 48003, JAPAN.
CR BARET A, 1980, FEBS LETT, V112, P25, DOI 10.1016/0014-5793(80)80118-9
   Beauchamp C., 1971, ANAL BIOCHEM, V44, P276, DOI DOI 10.1016/0003-2697(71)90370-8
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   FRIDOVICH I, 1975, ANNU REV BIOCHEM, V44, P147, DOI 10.1146/annurev.bi.44.070175.001051
   Harman D., 1986, FREE RADICALS AGING, P3
   HERBENER GH, 1976, J GERONTOL, V31, P8, DOI 10.1093/geronj/31.1.8
   KATO K, 1980, CLIN CHIM ACTA, V102, P261, DOI 10.1016/0009-8981(80)90043-1
   KATO K, 1983, METHOD ENZYMOL, V92, P345
   KATO K, 1977, J BIOCHEM-TOKYO, V81, P1557
   KATO K, 1976, J IMMUNOL, V116, P1554
   KATO K, 1981, J NEUROCHEM, V37, P998, DOI 10.1111/j.1471-4159.1981.tb04487.x
   KATO K, 1979, J APPL BIOCHEM, V1, P479
   KELLOGG EW, 1976, J GERONTOL, V31, P405, DOI 10.1093/geronj/31.4.405
   KUROBE N, 1990, CLIN CHIM ACTA, V187, P11, DOI 10.1016/0009-8981(90)90257-S
   KUROBE N, 1990, BIOMED RES-TOKYO, V11, P187, DOI 10.2220/biomedres.11.187
   KUROBE N, 1990, CLIN CHIM ACTA, V192, P171, DOI 10.1016/0009-8981(90)90219-I
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LAYNE E, 1957, METHOD ENZYMOL, V3, P447, DOI 10.1016/S0076-6879(57)03413-8
   MCCORD JM, 1969, J BIOL CHEM, V244, P6049
   NISHIMURA N, 1982, J PHARMACOBIO-DYNAM, V5, P869
   REISS U, 1976, BIOCHEM BIOPH RES CO, V73, P255, DOI 10.1016/0006-291X(76)90701-4
   RHODIN JAG, 1977, HISTOLOGY TEXT ATLAS, P3222
   Tauchi H., 1964, AGE FUTURE, P203
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   VANELLA A, 1989, J NEUROSCI RES, V22, P351, DOI 10.1002/jnr.490220316
NR 25
TC 25
Z9 25
U1 0
U2 0
PU BIOMEDICAL RESEARCH PRESS LTD
PI SAPPORO
PA HOKKAIDO UNIV, LAB HISTOLOGY & CYTOLOGY, C/O TOSHIHIKO IWANAGA, KITA
   15-NISHI 7, SAPPORO, 060-8638, JAPAN
SN 0388-6107
EI 1880-313X
J9 BIOMED RES-TOKYO
JI Biomed. Res.
PD APR
PY 1991
VL 12
IS 2
BP 97
EP 103
DI 10.2220/biomedres.12.97
PG 7
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA FJ184
UT WOS:A1991FJ18400005
OA Bronze
DA 2024-02-19
ER

PT J
AU MIZOGUCHI, M
   NAITO, H
   KURATA, Y
   SHIBATA, MA
   TSUDA, H
   WILD, CP
   MONTESANO, R
   FUKUSHIMA, S
AF MIZOGUCHI, M
   NAITO, H
   KURATA, Y
   SHIBATA, MA
   TSUDA, H
   WILD, CP
   MONTESANO, R
   FUKUSHIMA, S
TI INFLUENCE OF AGING ON MULTIORGAN CARCINOGENESIS IN RATS INDUCED BY
   N-METHYL-N-NITROSOUREA
SO JAPANESE JOURNAL OF CANCER RESEARCH
LA English
DT Article
DE AGING AND CANCER; MULTIORGAN CARCINOGENESIS; N-METHYL-N-NITROSOUREA;
   O6-METHYLDEOXYGUANINE; CELL PROLIFERATION
ID DNA ALKYLATION; MOUSE SKIN; AGE; LIVER; DIETHYLNITROSAMINE;
   3,2'-DIMETHYL-4-AMINOBIPHENYL; HEPATOCYTES; INDUCTION; LESIONS; STRAIN
AB The effects of aging on the multi-organ carcinogenesis induced in rats by N-methyl-N-nitrosourea (MNU), a direct carcinogen which does not need metabolic activation to exert carcinogenicity, were examined in male F344 rats. In the first experiment, rats at 6, 52, and 98 weeks of age were treated with MNU (20 mg/kg body weight, i.p.) twice weekly for 6 weeks and then maintained without any further treatment for 24 weeks in the case of young and middle-aged rats and for 18 weeks in the case of the old rats. In young rats, malignant lymphomas, particularly thymic types, were observed at significantly high incidence. A striking result in the middle-aged rats was the significantly higher incidence of adenocarcinomas in the small intestine than in young or old animals. The induction of proliferative and neoplastic lesions of the large intestine also tended to be increased in middle-aged rats. In addition, epithelial hyperplasia of the tongue, but not the forestomach, occurred at the highest incidence in the middle-aged group. There were no differences in the induction of epithelial lesions in the urinary bladder among the groups. In a second experiment, investigation of DNA synthesis in the tongue, small and large intestines, urinary bladder and lymph nodes did reveal significant increases or tendency for increase in the MNU-treated groups, but without differences with age. In contrast, the thymus of young rats showed significantly increased incorporation of BrdU label after administration of MNU, whereas it was markedly reduced in middle-aged rats. In a third experiment, O6-methyldeoxyguanine (O6-medG) DNA adduct formation was immunohistochemically detected in various organs including the thymus, forestomach, and small intestine without any differences with age. Thus, the results demonstrated that while the target organs of MNU are modified by the age of the animals, levels of DNA synthesis and O6-medG DNA adduct formation in most cases can not explain the observed differences in carcinogenic susceptibility.
C1 FUJITA HLTH UNIV,SCH MED,DEPT PATHOL 2,TOYOAKE,AICHI 47011,JAPAN.
   INT AGCY RES CANC,MECHANISMS CARCINOGENESIS UNIT,F-69372 LYON,FRANCE.
   OSAKA CITY UNIV,SCH MED,DEPT PATHOL 1,ABENO KU,OSAKA 545,JAPAN.
C3 Fujita Health University; World Health Organization; International
   Agency for Research on Cancer (IARC); Osaka Metropolitan University
RP MIZOGUCHI, M (corresponding author), NAGOYA CITY UNIV,SCH MED,DEPT PATHOL 1,1 KAWASUMI,MIZUHO CHO,MIZUHO KU,NAGOYA,AICHI 467,JAPAN.
RI Wild, Christopher/ABC-6260-2020; Shibata, Masa-Aki/L-1624-2019; naito,
   hiroyoshi/E-7083-2011
OI Wild, Christopher/0000-0003-0249-8669; Shibata,
   Masa-Aki/0000-0002-3350-7305; naito, hiroyoshi/0000-0002-8138-6077
CR ANISIMOV VN, 1981, MECH AGEING DEV, V15, P399, DOI 10.1016/0047-6374(81)90044-0
   ANISIMOV VN, 1981, EXP PATHOL-JENA, V19, P81, DOI 10.1016/S0232-1513(81)80038-2
   ASAMOTO M, 1991, EXP PATHOL-JENA, V41, P71, DOI 10.1016/S0232-1513(11)80004-6
   COHEN SM, 1990, SCIENCE, V249, P1007, DOI 10.1126/science.2204108
   EBBESEN P, 1974, SCIENCE, V183, P217, DOI 10.1126/science.183.4121.217
   FUKUSHIMA S, 1987, JNCI-J NATL CANCER I, V79, P263
   GOTH R, 1974, P NATL ACAD SCI USA, V71, P639, DOI 10.1073/pnas.71.3.639
   HASEGAWA R, 1991, JPN J CANCER RES, V82, P293, DOI 10.1111/j.1349-7006.1991.tb01845.x
   ISHIKAWA T, 1986, CANCER RES, V46, P1344
   KIMURA M, 1979, GANN, V70, P521
   KURIHARA M, 1984, CANCER MORTALITY STA, P85
   LEWIS JG, 1983, CARCINOGENESIS, V4, P529, DOI 10.1093/carcin/4.5.529
   LU SJ, 1992, CARCINOGENESIS, V13, P857, DOI 10.1093/carcin/13.5.857
   REUBER MD, 1976, EXP CELL BIOL, V44, P65
   SHIBATA MA, 1989, FOOD CHEM TOXICOL, V27, P403, DOI 10.1016/0278-6915(89)90147-6
   SHIRAI T, 1991, CARCINOGENESIS, V12, P1335, DOI 10.1093/carcin/12.7.1335
   SHIRAI T, 1989, JPN J CANCER RES, V80, P312, DOI 10.1111/j.1349-7006.1989.tb02312.x
   SMULOW JB, 1983, CARCINOGENESIS, V4, P1085, DOI 10.1093/carcin/4.9.1085
   STENBACK F, 1981, BRIT J CANCER, V44, P24, DOI 10.1038/bjc.1981.143
   SUKUMAR S, 1983, NATURE, V306, P658, DOI 10.1038/306658a0
   TICE RR, 1987, GENETICS AGING, P53
   TOTH B, 1968, CANCER RES, V28, P727
   VESSELINOVITCH SD, 1984, J CANCER RES CLIN, V108, P60, DOI 10.1007/BF00390974
   WARD JM, 1990, CANCER LETT, V52, P187, DOI 10.1016/0304-3835(90)90186-2
   WATANABE H, 1988, CARCINOGENESIS, V9, P1317, DOI 10.1093/carcin/9.7.1317
   WOODHEAD AD, 1985, J NATL CANCER I, V75, P1141
   YAROSH DB, 1985, MUTAT RES, V145, P1, DOI 10.1016/0167-8817(85)90034-3
NR 27
TC 11
Z9 14
U1 0
U2 2
PU JAPANESE CANCER ASSOCIATION
PI TOKYO
PA EDITORIAL OFFICE 7TH FLOOR, JOHKOH BLDG 2-23-11, KOISHIKAWA, TOKYO 112,
   JAPAN
SN 0910-5050
J9 JPN J CANCER RES
JI Jpn. J. Cancer Res.
PD FEB
PY 1993
VL 84
IS 2
BP 139
EP 146
DI 10.1111/j.1349-7006.1993.tb02847.x
PG 8
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA KN143
UT WOS:A1993KN14300008
PM 8463131
OA hybrid, Green Published
DA 2024-02-19
ER

PT J
AU Chandwaney, R
   Leichtweis, S
   Leeuwenburgh, C
   Ji, LL
AF Chandwaney, R
   Leichtweis, S
   Leeuwenburgh, C
   Ji, LL
TI Oxidative stress and mitochondrial function in skeletal muscle: Effects
   of aging and exercise training
SO AGE
LA English
DT Article
DE aging; antioxidant enzyme; mitochondria; oxidative phosphorylation;
   reactive oxygen species; skeletal muscle; training
ID FREE-RADICAL PRODUCTION; HYDROGEN-PEROXIDE; SUPEROXIDE-DISMUTASE; HEART;
   RATS; LIVER; RESPIRATION; GLUTATHIONE; GENERATION; RESPONSES
AB The rate of oxidative phosphorylation was investigated in isolated mitochondria from hindlimb muscles of young (4.5 mo) and old (26.5 mo) male Fischer 344 rats with or without endurance training. Further, the susceptibility of the muscle mitochondria to exogenous reactive oxygen species was examined. State 3 and 4 respiration, as well as the respiratory control index (RCI), were significantly lower in muscle mitochondria from aged vs. young rats (P<0.05), using either the site 1 substrates malate-pyruvate (M-P) and 2-oxoglutarate (2-OG), or the site 2 substrate succinate. In both young and old rats, training increased state 4 respiration with M-P, but had no effect on state 3 respiration, resulting in a reduction of RCI. Training also increased state 4 respiration with 2-OG and decreased RCI in young vats. When muscle mitochondria were exposed to superoxide radicals (O-2 radical anion ) and hydrogen peroxide (H2O2) generated by xanthine oxidase and hypoxanthine, or H2O2 alone in vitro, state 3 respiration and RCI in both age groups were severely hampered, but those from the old rats were inhibited to a less extent than the young rats. In contrast, state 4 respiration was impaired by O-2 radical anion and/or H2O2 to a greater extent in the old rats. Muscle mitochondria from trained young rats showed a greater resistance to the O-2 radical anion and/or H2O2-induced state 3 and RCI inhibition than those from untrained young rats. Muscle from aged rats had significantly higher total activities of superoxide dismutase (SOD), catalase, glutathione peroxidase (GPX), and glutathione reductase than that from young rats, however, training increased SOD and GPX activities in young but not old rats. The results of this study suggest that mitochondrial capacity for oxidative phosphorylation is compromised in aging skeletal muscle. Further, the increased mitochondrial resistance to reactive oxygen species demonstrated in aged and young trained muscles may be attributed to enhanced antioxidant enzyme activities.
C1 Univ Wisconsin, Dept Kinesiol, Madison, WI 53706 USA.
C3 University of Wisconsin System; University of Wisconsin Madison
RP Ji, LL (corresponding author), Biodynam Lab, 2000 Observ Dr, Madison, WI 53706 USA.
RI Leichtweis, Steven Boyd/M-5835-2014; Leichtweis, Steven
   Boyd/V-1314-2019; Leichtweis, Steven Boyd/GPW-9697-2022
OI Leichtweis, Steven Boyd/0000-0002-4381-2901; Leichtweis, Steven
   Boyd/0000-0002-4381-2901; Leeuwenburgh, Christiaan/0000-0003-0826-4257
CR AEBI H, 1984, METHOD ENZYMOL, V105, P121
   BARJA G, 1994, FREE RADICAL RES, V21, P317, DOI 10.3109/10715769409056584
   BOBYLEVAGUARRIERO V, 1986, ARCH BIOCHEM BIOPHYS, V245, P470, DOI 10.1016/0003-9861(86)90239-0
   BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707
   Brierley EJ, 1997, MOL CELL BIOCHEM, V174, P325, DOI 10.1023/A:1006847319162
   BROOKS GA, 1978, J APPL PHYSIOL, V45, P1009, DOI 10.1152/jappl.1978.45.6.1009
   CARLBERG I, 1985, METHOD ENZYMOL, V113, P484
   CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527
   CHANCE B, 1956, ADV ENZYMOL REL S BI, V17, P65
   CHEN JJ, 1994, FREE RADICAL BIO MED, V17, P411, DOI 10.1016/0891-5849(94)90167-8
   COOPER JM, 1992, J NEUROL SCI, V113, P91, DOI 10.1016/0022-510X(92)90270-U
   DARNOLD JR, 1990, MECH AGEING DEV, V53, P157, DOI 10.1016/0047-6374(90)90067-P
   DAVIES KJA, 1982, BIOCHEM BIOPH RES CO, V107, P1198, DOI 10.1016/S0006-291X(82)80124-1
   DAVIES KJA, 1981, ARCH BIOCHEM BIOPHYS, V209, P539, DOI 10.1016/0003-9861(81)90312-X
   FARRAR RP, 1981, EUR J APPL PHYSIOL O, V46, P91, DOI 10.1007/BF00422181
   FLOHE L, 1984, METHOD ENZYMOL, V105, P114
   Forman HJ, 1997, FASEB J, V11, P374, DOI 10.1096/fasebj.11.5.9141504
   HANSFORD RG, 1983, BIOCHIM BIOPHYS ACTA, V726, P41, DOI 10.1016/0304-4173(83)90010-1
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Herrero A, 1997, MECH AGEING DEV, V98, P95, DOI 10.1016/S0047-6374(97)00076-6
   HIGUCHI M, 1985, J GERONTOL, V40, P281, DOI 10.1093/geronj/40.3.281
   Ji L L, 1995, Exerc Sport Sci Rev, V23, P135
   JI LL, 1990, AM J PHYSIOL, V258, pR918, DOI 10.1152/ajpregu.1990.258.4.R918
   JI LL, 1994, BIOCHEM PHARMACOL, V47, P877
   JI LL, 1993, MED SCI SPORT EXER, V25, P225
   LACAGNIN LB, 1990, AM J PHYSIOL, V259, pL57, DOI 10.1152/ajplung.1990.259.2.L57
   LAWLER JM, 1993, MED SCI SPORT EXER, V25, P1259
   Leeuwenburgh C, 1997, AM J PHYSIOL-REG I, V272, pR363, DOI 10.1152/ajpregu.1997.272.1.R363
   LEEUWENBURGH C, 1994, AM J PHYSIOL, V267, pR439, DOI 10.1152/ajpregu.1994.267.2.R439
   LUHTALA TA, 1994, J GERONTOL, V49, pB231, DOI 10.1093/geronj/49.5.B231
   Matsuo M., 1993, FREE RADICALS AGING, P143
   MEYDANI M, 1993, FREE RADICALS AGING, P183
   Miquel J., 1986, FREE RADICALS AGING, P51
   MISRA HP, 1972, J BIOL CHEM, V247, P3170
   NOHL H, 1980, MECH AGEING DEV, V14, P137, DOI 10.1016/0047-6374(80)90112-8
   NOHL H, 1986, BIOL AGING, P77
   Rogers M A, 1993, Exerc Sport Sci Rev, V21, P65
   SAWADA M, 1992, J CELL BIOCHEM, V48, P296, DOI 10.1002/jcb.240480310
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   SOHAL RS, 1991, MECH AGEING DEV, V57, P187, DOI 10.1016/0047-6374(91)90034-W
   TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0
   Yu BP, 1996, ANN NY ACAD SCI, V786, P1, DOI 10.1111/j.1749-6632.1996.tb39047.x
   ZHAN H, 1992, MECH AGEING DEV, V62, P111, DOI 10.1016/0047-6374(92)90047-H
   ZHANG Y, 1990, J BIOL CHEM, V265, P16330
NR 44
TC 33
Z9 41
U1 0
U2 8
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0161-9152
EI 1574-4647
J9 AGE
JI Age
PD JUL
PY 1998
VL 21
IS 3
BP 109
EP 117
DI 10.1007/s11357-998-0017-5
PG 9
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 179PU
UT WOS:000079338500002
PM 23604368
OA Green Published
DA 2024-02-19
ER

PT J
AU Kane, AE
   Huizer-Pajkos, A
   Mach, J
   McKenzie, C
   Mitchell, SJ
   de Cabo, R
   Jones, B
   Cogger, V
   Le Couteur, DG
   Hilmer, SN
AF Kane, Alice Elizabeth
   Huizer-Pajkos, Aniko
   Mach, John
   McKenzie, Catriona
   Mitchell, Sarah Jayne
   de Cabo, Rafael
   Jones, Brett
   Cogger, Victoria
   Le Couteur, David G.
   Hilmer, Sarah Nicole
TI <i>N</i>-Acetyl cysteine does not prevent liver toxicity from chronic
   low-dose plus subacute high-dose paracetamol exposure in young or old
   mice
SO FUNDAMENTAL & CLINICAL PHARMACOLOGY
LA English
DT Article
DE ageing; chronic; hepatotoxicity; N-acetyl cysteine; paracetamol;
   supratherapeutic
ID ACETAMINOPHEN TOXICITY; CHRONIC HEPATOTOXICITY; HEPATIC-NECROSIS; RATS;
   ACETYLCYSTEINE; MITOCHONDRIAL; EXPLANATION; MANAGEMENT; CYP2E1; ADULTS
AB Paracetamol is an analgesic commonly used by people of all ages, which is well documented to cause severe hepatotoxicity with acute overexposures. The risk of hepatotoxicity from nonacute paracetamol exposures is less extensively studied, and this is the exposure most common in older adults. Evidence on the effectiveness of N-acetyl cysteine (NAC) for nonacute paracetamol exposures, in any age group, is lacking. This study aimed to examine the effect of long-term exposure to therapeutic doses of paracetamol and subacute paracetamol overexposure, in young and old mice, and to investigate whether NAC was effective at preventing paracetamol hepatotoxicity induced by these exposures. Young and old male C57BL/6 mice were fed a paracetamol-containing (1.33 g/kg food) or control diet for 6 weeks. Mice were then dosed orally eight times over 3 days with additional paracetamol (250 mg/kg) or saline, followed by either one or two doses of oral NAC (1200 mg/kg) or saline. Chronic low-dose paracetamol exposure did not cause hepatotoxicity in young or old mice, measured by serum alanine aminotransferase (ALT) elevation, and confirmed by histology and a DNA fragmentation assay. Subacute paracetamol exposure caused significant hepatotoxicity in young and old mice, measured by biochemistry (ALT) and histology. Neither a single nor double dose of NAC protected against this toxicity from subacute paracetamol in young or old mice. This finding has important clinical implications for treating toxicity due to different paracetamol exposure types in patients of all ages, and implies a need to develop new treatments for subacute paracetamol toxicity.
C1 [Kane, Alice Elizabeth; Huizer-Pajkos, Aniko; Mach, John; Jones, Brett; Hilmer, Sarah Nicole] Royal N Shore Hosp, Kolling Inst Med Res, Reserve Rd, St Leonards, NSW 2065, Australia.
   [Kane, Alice Elizabeth; Huizer-Pajkos, Aniko; Mach, John; Jones, Brett; Hilmer, Sarah Nicole] Royal N Shore Hosp, Reserve Rd, St Leonards, NSW 2065, Australia.
   [Kane, Alice Elizabeth; Mach, John; Jones, Brett; Cogger, Victoria; Le Couteur, David G.; Hilmer, Sarah Nicole] Univ Sydney, Sydney Med Sch, Camperdown, NSW, Australia.
   [McKenzie, Catriona] Royal Prince Alfred Hosp, Missenden Rd, Camperdown, NSW 2050, Australia.
   [Mitchell, Sarah Jayne; de Cabo, Rafael] NIA, NIH, Nathan Shock Dr, Baltimore, MD 21224 USA.
   [Cogger, Victoria; Le Couteur, David G.] Ctr Educ & Res Ageing, Hosp Rd, Concord, NSW, Australia.
   [Cogger, Victoria; Le Couteur, David G.] ANZAC Res Inst, Hosp Rd, Concord, NSW, Australia.
C3 Royal North Shore Hospital; University of Sydney; Kolling Institute of
   Medical Research; Royal North Shore Hospital; University of Sydney;
   University of Sydney; NSW Health; Royal Prince Alfred Hospital; National
   Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA);
   University of Sydney; ANZAC Research Institute
RP Kane, AE (corresponding author), Royal N Shore Hosp, Kolling Inst Med Res, Reserve Rd, St Leonards, NSW 2065, Australia.; Kane, AE (corresponding author), Royal N Shore Hosp, Reserve Rd, St Leonards, NSW 2065, Australia.; Kane, AE (corresponding author), Univ Sydney, Sydney Med Sch, Camperdown, NSW, Australia.
EM alice.kane@sydney.edu.au
RI de Cabo, Rafael Carlos/E-7996-2010; Research Institute,
   ANZAC/CAE-9030-2022; Hilmer, Sarah/AAW-8554-2020; de Cabo,
   Rafael/J-5230-2016
OI de Cabo, Rafael Carlos/0000-0003-2830-5693; Hilmer,
   Sarah/0000-0002-5970-1501; de Cabo, Rafael/0000-0002-3354-2442; Kane,
   Alice/0000-0002-4303-0491; Mckenzie, Catriona/0000-0002-6452-4976; Le
   Couteur, David/0000-0002-4227-5817
FU Intramural NIH HHS [Z99 AG999999] Funding Source: Medline
CR Antoine DJ, 2013, HEPATOLOGY, V58, P777, DOI 10.1002/hep.26294
   Bateman DN, 2015, BRIT J CLIN PHARMACO, V80, P45, DOI 10.1111/bcp.12604
   Burke A., 2009, GOODMAN GILMANS THER
   Chen PJ, 2012, J FOOD DRUG ANAL, V20, P41
   Civan Jesse M, 2014, Gastroenterol Hepatol (N Y), V10, P27
   CORCORAN GB, 1985, J PHARMACOL EXP THER, V232, P864
   Craig DGN, 2011, BRIT J CLIN PHARMACO, V71, P273, DOI 10.1111/j.1365-2125.2010.03819.x
   Daly FFS, 2008, MED J AUSTRALIA, V188, P296, DOI 10.5694/j.1326-5377.2008.tb01625.x
   de Meijer VE, 2013, JPEN-PARENTER ENTER, V37, P268, DOI 10.1177/0148607112450735
   Ferner RE, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2218
   Ghanem CI, 2009, BIOCHEM PHARMACOL, V77, P1621, DOI 10.1016/j.bcp.2009.02.006
   Holt MP, 2006, AAPS J, V8, pE48, DOI 10.1208/aapsj080106
   James LP, 2003, TOXICOL SCI, V75, P458, DOI 10.1093/toxsci/kfg181
   Kane A, 2012, AUSTRALAS J AGEING, V31, P190, DOI 10.1111/j.1741-6612.2012.00598.x
   Kim SJ, 2009, J PHARMACOL SCI, V111, P175, DOI 10.1254/jphs.09151FP
   Kondo K, 2012, J TOXICOL SCI, V37, P911, DOI 10.2131/jts.37.911
   Lane JE, 2002, J EMERG MED, V23, P253, DOI 10.1016/S0736-4679(02)00526-7
   Larson Anne M, 2007, Clin Liver Dis, V11, P525, DOI 10.1016/j.cld.2007.06.006
   Mach J, 2016, FUND CLIN PHARMACOL, V30, P23, DOI 10.1111/fcp.12157
   Mach J, 2015, EXP GERONTOL, V67, P54, DOI 10.1016/j.exger.2015.04.009
   Mach J, 2014, J GERONTOL A-BIOL, V69, P387, DOI 10.1093/gerona/glt095
   McGill MR, 2012, TOXICOL APPL PHARM, V264, P387, DOI 10.1016/j.taap.2012.08.015
   MITCHELL JR, 1973, J PHARMACOL EXP THER, V187, P211
   O'Brien PJ, 2000, HUM EXP TOXICOL, V19, P277, DOI 10.1191/096032700678815918
   Qato DM, 2008, JAMA-J AM MED ASSOC, V300, P2867, DOI 10.1001/jama.2008.892
   RIKANS LE, 1988, DRUG CHEM TOXICOL, V11, P237, DOI 10.3109/01480548809017880
   ROBERTS BJ, 1995, BIOCHEM PHARMACOL, V49, P1665, DOI 10.1016/0006-2952(95)00098-K
   Rumack BH, 2012, CLIN TOXICOL, V50, P91, DOI 10.3109/15563650.2012.659252
   Shayiq RM, 1999, HEPATOLOGY, V29, P451, DOI 10.1002/hep.510290241
   SNAWDER JE, 1994, BIOCHEM BIOPH RES CO, V203, P532, DOI 10.1006/bbrc.1994.2215
   Soeda J, 2014, HEPATOLOGY, V60, P1023, DOI 10.1002/hep.27266
   Tarloff JB, 1996, FUND APPL TOXICOL, V30, P13, DOI 10.1006/faat.1996.0038
   Watkins PB, 2006, JAMA-J AM MED ASSOC, V296, P87, DOI 10.1001/jama.296.1.87
   Yisarakun W, 2014, MICROVASC RES, V94, P36, DOI 10.1016/j.mvr.2014.04.012
   Zyoud SH, 2011, FUND CLIN PHARMACOL, V25, P405, DOI 10.1111/j.1472-8206.2010.00831.x
NR 35
TC 7
Z9 8
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0767-3981
EI 1472-8206
J9 FUND CLIN PHARMACOL
JI Fundam. Clin. Pharmacol.
PD JUN
PY 2016
VL 30
IS 3
BP 263
EP 275
DI 10.1111/fcp.12184
PG 13
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA DM2BN
UT WOS:000376151100007
PM 26821200
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Pan, WJ
   Li, WS
   Wu, H
   Xie, XY
   Xie, MW
   Nie, Q
   Liu, ZH
   Cai, SX
AF Pan, Wenjing
   Li, Wangshu
   Wu, Huan
   Xie, Xinya
   Xie, Mingwei
   Nie, Qing
   Liu, Zhonghua
   Cai, Shuxian
TI Aging-Accelerated Mouse Prone 8 (SAMP8) Mice Experiment and Network
   Pharmacological Analysis of Aged Liupao Tea Aqueous Extract in Delaying
   the Decline Changes of the Body
SO ANTIOXIDANTS
LA English
DT Article
DE aged Liupao tea; aging-accelerated mouse prone 8 (SAMP8) mice;
   degenerative changes; network pharmacology; molecular docking
ID CHAIN FATTY-ACIDS; OXIDATIVE STRESS; LIPID-PEROXIDATION; FTIR
   SPECTROSCOPY; BARRIER FUNCTION; OBESITY; GUT; PROLIFERATION;
   CARBONYLATION; MIGRATION
AB Aging and metabolic disorders feedback and promote each other and are closely related to the occurrence and development of cardiovascular disease, type 2 diabetes, neurodegeneration and other degenerative diseases. Liupao tea is a geographical indication product of Chinese dark tea, with a "red, concentrated, aged and mellow" flavor quality. In this study, the aqueous extract of aged Liupao tea (ALPT) administered by continuous gavage significantly inhibited the increase of visceral fat and damage to the intestinal-liver-microbial axis in high-fat modeling of SAMP8 (P8+HFD) mice. Its potential mechanism is that ALPT significantly inhibited the inflammation and aggregation formation pathway caused by P8+HFD, increased the abundance of short-chain fatty acid producing bacteria Alistipes, Alloprevotella and Bacteroides, and had a calorie restriction effect. The results of the whole target metabolome network pharmacological analysis showed that there were 139 potential active components in the ALPT aqueous extract, and the core targets of their actions were SRC, TP53, AKT1, MAPK3, VEGFA, EP300, EGFR, HSP90AA1, CASP3, etc. These target genes were mainly enriched in cancer, neurodegenerative diseases, glucose and lipid metabolism and other pathways of degenerative changes. Molecular docking further verified the reliability of network pharmacology. The above results indicate that Liupao tea can effectively delay the body's degenerative changes through various mechanisms and multi-target effects. This study revealed that dark tea such as Liupao tea has significant drinking value in a modern and aging society.
C1 [Pan, Wenjing; Li, Wangshu; Wu, Huan; Xie, Xinya; Xie, Mingwei; Nie, Qing; Liu, Zhonghua; Cai, Shuxian] Hunan Agr Univ, Natl Res Ctr Engn Technol Utilizat Bot Funct Ingre, Changsha 410128, Peoples R China.
   [Pan, Wenjing; Li, Wangshu; Wu, Huan; Xie, Xinya; Xie, Mingwei; Nie, Qing; Liu, Zhonghua; Cai, Shuxian] Hunan Agr Univ, Key Lab Minist Educ Tea Sci, Changsha 410128, Peoples R China.
   [Pan, Wenjing; Li, Wangshu; Wu, Huan; Xie, Xinya; Xie, Mingwei; Nie, Qing; Liu, Zhonghua; Cai, Shuxian] Hunan Agr Univ, Coinnovat Ctr Educ Minist Utilizat Bot Funct Ingre, Changsha 410128, Peoples R China.
   [Pan, Wenjing; Li, Wangshu; Wu, Huan; Xie, Xinya; Xie, Mingwei; Nie, Qing; Liu, Zhonghua; Cai, Shuxian] Hunan Agr Univ, Key Lab Evaluat & Utilizat Gene Resources Hort Cro, Minist Agr & Rural Affairs China, Changsha 410128, Peoples R China.
   [Pan, Wenjing] Wuzhou Inst Agr, Wuzhou 543003, Peoples R China.
C3 Hunan Agricultural University; Hunan Agricultural University; Hunan
   Agricultural University; Ministry of Agriculture & Rural Affairs; Hunan
   Agricultural University
RP Liu, ZH; Cai, SX (corresponding author), Hunan Agr Univ, Natl Res Ctr Engn Technol Utilizat Bot Funct Ingre, Changsha 410128, Peoples R China.; Liu, ZH; Cai, SX (corresponding author), Hunan Agr Univ, Key Lab Minist Educ Tea Sci, Changsha 410128, Peoples R China.; Liu, ZH; Cai, SX (corresponding author), Hunan Agr Univ, Coinnovat Ctr Educ Minist Utilizat Bot Funct Ingre, Changsha 410128, Peoples R China.; Liu, ZH; Cai, SX (corresponding author), Hunan Agr Univ, Key Lab Evaluat & Utilizat Gene Resources Hort Cro, Minist Agr & Rural Affairs China, Changsha 410128, Peoples R China.
EM zhonghua-liu@hunau.edu.cn; caishuxian@hunau.edu.cn
OI Cai, Shuxian/0000-0002-6907-3780
FU Guangxi Innovation Driven Development Special Fund Project [AA20302018];
   National Key R&D Program of China [2018YFC1604405]; Key R&D Program of
   Hunan Province [2020WK2017]; National Tea Industry Technology System
   Research Project of China [CARS-19-C01]; National Natural Science
   Foundation Project of China [31471590, 31100501]; Self-Science
   Foundation of Hunan Province, China [2019jj50237]
FX This research was funded by the Guangxi Innovation Driven Development
   Special Fund Project (No. AA20302018), the National Key R&D Program of
   China (2018YFC1604405), the Key R&D Program of Hunan Province
   (2020WK2017), National Tea Industry Technology System Research Project
   of China (CARS-19-C01), National Natural Science Foundation Project of
   China (31471590, 31100501) and Self-Science Foundation of Hunan
   Province, China (2019jj50237).
CR Al Zahrani NA, 2020, EUR J MED CHEM, V204, DOI 10.1016/j.ejmech.2020.112609
   Jorge ASB, 2018, OBES RES CLIN PRACT, V12, P1, DOI 10.1016/j.orcp.2016.03.009
   Bazzoni G, 2000, J BIOL CHEM, V275, P20520, DOI 10.1074/jbc.M905251199
   Blagosklonny MV, 2022, AGING-US, V14, P4176, DOI 10.18632/aging.204082
   Cai SX, 2018, FOOD FUNCT, V9, P5455, DOI 10.1039/c8fo01512k
   Caldeira MV, 2014, PROG NEUROBIOL, V112, P50, DOI 10.1016/j.pneurobio.2013.10.003
   Camandola S, 2019, NEUROCHEM RES, V44, P214, DOI 10.1007/s11064-018-2492-0
   Canfora EE, 2015, NAT REV ENDOCRINOL, V11, P577, DOI 10.1038/nrendo.2015.128
   Castelo-Branco C, 2014, GYNECOL ENDOCRINOL, V30, P16, DOI 10.3109/09513590.2013.852531
   Chiu HF, 2016, FOOD FUNCT, V7, P893, DOI 10.1039/c5fo01271f
   Choi YJ, 2016, ONCOTARGET, V7, P52685, DOI 10.18632/oncotarget.10943
   Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107
   Daffu G, 2013, INT J MOL SCI, V14, P19891, DOI 10.3390/ijms141019891
   Daina A, 2019, NUCLEIC ACIDS RES, V47, pW357, DOI 10.1093/nar/gkz382
   Daina A, 2017, SCI REP-UK, V7, DOI 10.1038/srep42717
   de Mello VDF, 2014, ANN MED, V46, P103, DOI 10.3109/07853890.2013.857259
   De Meutter J, 2021, EUR BIOPHYS J BIOPHY, V50, P641, DOI 10.1007/s00249-021-01507-7
   Depciuch J, 2019, J ALZHEIMERS DIS, V68, P281, DOI 10.3233/JAD-181008
   Dillon SM, 2017, AIDS, V31, P510, DOI 10.1097/QAD.0000000000001366
   Ding QZ, 2019, BIOMED PHARMACOTHER, V118, DOI 10.1016/j.biopha.2019.109262
   Downes J, 2013, INT J SYST EVOL MICR, V63, P1214, DOI 10.1099/ijs.0.041376-0
   Du J., 2022, SCI TECHNOLOGY FOOD, V43, P50
   Du YJ, 2021, GUT MICROBES, V13, DOI 10.1080/19490976.2021.1994835
   Erbaba B, 2021, AGEING RES REV, V66, DOI 10.1016/j.arr.2020.101228
   Falandry C, 2014, J CLIN ONCOL, V32, P2604, DOI 10.1200/JCO.2014.55.1432
   Fougère B, 2017, J GERONTOL A-BIOL, V72, P1218, DOI 10.1093/gerona/glw240
   Fraga CG, 2010, ANAL CHEM, V82, P4165, DOI 10.1021/ac1003568
   Franco C, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph182111328
   Gill LE, 2015, CURR OBES REP, V4, P379, DOI 10.1007/s13679-015-0161-z
   Gong ZP, 2020, BIOMED PHARMACOTHER, V130, DOI 10.1016/j.biopha.2020.110514
   Groschwitz KR, 2009, J ALLERGY CLIN IMMUN, V124, P3, DOI 10.1016/j.jaci.2009.05.038
   Gutiérrez-Cuevas J, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10030629
   Hamjane N, 2020, MICROVASC RES, V131, DOI 10.1016/j.mvr.2020.104023
   Hong MY, 2022, NUTRIENTS, V14, DOI 10.3390/nu14153012
   Huang J., 2011, MOL PATHOL LIB
   Huang SY, 2018, NUTRIENTS, V10, DOI 10.3390/nu10070894
   Huang SY, 2022, J FOOD SCI, V87, P4203, DOI 10.1111/1750-3841.16274
   JACKSON M, 1995, CRIT REV BIOCHEM MOL, V30, P95, DOI 10.3109/10409239509085140
   Kang OH, 2008, EUR J PHARMACOL, V601, P179, DOI 10.1016/j.ejphar.2008.10.012
   Kato Y, 1999, J PEDIATR SURG, V34, P18, DOI 10.1016/S0022-3468(99)90221-X
   Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041
   Kopp W, 2019, DIABET METAB SYND OB, V12, P2221, DOI 10.2147/DMSO.S216791
   Kuzmic M, 2016, FREE RADICAL BIO MED, V101, P465, DOI 10.1016/j.freeradbiomed.2016.11.004
   Laffin M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48749-2
   Leonov A, 2017, ONCOTARGET, V8, P69328, DOI 10.18632/oncotarget.20614
   Li BY, 2021, OXID MED CELL LONGEV, V2021, DOI 10.1155/2021/5188205
   Li H., 2013, FOOD SCI TECH-BRAZIL, V38, P123, DOI [10.13684/j.cnki.spkj.2013.08.058, DOI 10.13684/J.CNKI.SPKJ.2013.08.058]
   Li L, 2020, AM J CHINESE MED, V48, P899, DOI 10.1142/S0192415X20500433
   Libby P, 2014, CIRC RES, V114, P1867, DOI 10.1161/CIRCRESAHA.114.302699
   Liguori I, 2018, CLIN INTERV AGING, V13, P757, DOI 10.2147/CIA.S158513
   Liu Fen, 2021, Journal of Food Safety and Quality, V12, P9165
   Liu HY, 2018, ONCOTARGET, V9, P2887, DOI [10.18632/oncotarget.20812, 10.18632/oncotarget.23208]
   Liu JN, 2016, EUR J PHARMACOL, V791, P297, DOI 10.1016/j.ejphar.2016.09.007
   Lv HP, 2017, FOOD RES INT, V100, P486, DOI 10.1016/j.foodres.2016.10.024
   Ma WanJun, 2020, Journal of Tea Science, V40, P289
   Machate DJ, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21114093
   Matsumoto M, 2006, BIOSCI BIOTECH BIOCH, V70, P1287, DOI 10.1271/bbb.50464
   Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256
   Mosleh G, 2021, BIOMED RES INT, V2021, DOI 10.1155/2021/5526644
   Mouries J, 2019, J HEPATOL, V71, P1216, DOI 10.1016/j.jhep.2019.08.005
   Mukherjee K, 2015, FREE RADICAL BIO MED, V84, P11, DOI 10.1016/j.freeradbiomed.2015.03.011
   Natesan V, 2021, BIOMOL THER, V29, P596, DOI 10.4062/biomolther.2021.122
   Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029
   Noor F, 2022, PHARMACEUTICALS-BASE, V15, DOI 10.3390/ph15050572
   Onishi S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195753
   Palikaras K, 2017, J LIPID RES, V58, P72, DOI 10.1194/jlr.M069385
   Pan YN, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091280
   Patterson GT, 2022, FRONT IMMUNOL, V13, DOI 10.3389/fimmu.2022.846155
   Perfilyeva YV, 2019, INFLAMMATION, V42, P276, DOI 10.1007/s10753-018-0892-6
   Piekarska J, 2011, EXP PARASITOL, V128, P419, DOI 10.1016/j.exppara.2011.05.019
   Qian Y, 2018, MOLECULES, V23, DOI 10.3390/molecules23112848
   Qin TT, 2017, BEHAV BRAIN RES, V317, P147, DOI 10.1016/j.bbr.2016.09.039
   Qiu S., 2021, ASTROPHYS J, V44, P56, DOI [10.13557/j.cnki.issn1002-2813.2021.04.014, DOI 10.13557/J.CNKI.ISSN1002-2813.2021.04.014]
   Qureshi S, 2016, VET WORLD, V9, P269, DOI 10.14202/vetworld.2016.269-275
   Rhea EM, 2017, EXP GERONTOL, V94, P64, DOI 10.1016/j.exger.2016.12.009
   Rothenberg DO, 2018, MOLECULES, V23, DOI 10.3390/molecules23051176
   Seo E, 2019, AGING CELL, V18, DOI 10.1111/acel.12895
   Severcan F, 2005, ANAL BIOCHEM, V339, P36, DOI 10.1016/j.ab.2005.01.011
   Shang F, 2011, FREE RADICAL BIO MED, V51, P5, DOI 10.1016/j.freeradbiomed.2011.03.031
   Shi R., 2020, NATURE, P43, DOI [10.15905/j.cnki.33-1157/ts.2020.02.009, DOI 10.15905/J.CNKI.33-1157/TS.2020.02.009]
   Stelzer Gil, 2016, Curr Protoc Bioinformatics, V54, DOI 10.1002/cpbi.5
   Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131
   TAKEDA T, 1981, MECH AGEING DEV, V17, P183, DOI 10.1016/0047-6374(81)90084-1
   Tang GY, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20246196
   Teng CuiQin, 2014, Journal of Tea Science, V34, P230
   Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414
   Wan J, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10101513
   Wang F, 2020, AM J TRANSL RES, V12, P2295
   Wang HB, 2012, DIGEST DIS SCI, V57, P3126, DOI 10.1007/s10620-012-2259-4
   Wang YB, 2022, FRONT PLANT SCI, V13, DOI 10.3389/fpls.2022.1025317
   Wei XY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22094-2
   Wu LX, 2022, FOOD FUNCT, V13, P1218, DOI [10.1039/D1FO02079J, 10.1039/d1fo02079j]
   Wu Ping, 2014, Journal of Tea Science, V34, P408
   Wu Y, 2021, J FOOD SCI, V86, P215, DOI 10.1111/1750-3841.15551
   Xu XY, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8120572
   Yamagishi S, 2015, EUR J MED RES, V20, DOI 10.1186/s40001-015-0090-z
   Yang J, 2022, GASTROENTEROLOGY, V162, P135, DOI 10.1053/j.gastro.2021.08.041
   Yao HW, 2014, J SPECTROSC, V2014, DOI 10.1155/2014/213890
   Yin HY, 2011, CHEM REV, V111, P5944, DOI 10.1021/cr200084z
   Zhang YP, 2002, MECH AGEING DEV, V123, P245, DOI 10.1016/S0047-6374(01)00349-9
   Zhao L, 2017, FOOD FUNCT, V8, P4644, DOI [10.1039/C7FO01383C, 10.1039/c7fo01383c]
   Zheng X, 2021, J PHOTOCH PHOTOBIO B, V224, DOI 10.1016/j.jphotobiol.2021.112304
   Zhou Y, 2016, KIDNEY BLOOD PRESS R, V41, P901, DOI 10.1159/000452591
   Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6
   Zhu JX, 2021, FOOD RES INT, V148, DOI 10.1016/j.foodres.2021.110594
   Zhu MZ, 2020, FOOD CHEM, V312, DOI 10.1016/j.foodchem.2019.126043
NR 106
TC 2
Z9 2
U1 12
U2 26
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-3921
J9 ANTIOXIDANTS-BASEL
JI Antioxidants
PD MAR
PY 2023
VL 12
IS 3
AR 685
DI 10.3390/antiox12030685
PG 21
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Food Science
   & Technology
GA A7PV3
UT WOS:000957010900001
PM 36978933
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Hauck, SJ
   Aaron, JM
   Wright, C
   Kopchick, JJ
   Bartke, A
AF Hauck, SJ
   Aaron, JM
   Wright, C
   Kopchick, JJ
   Bartke, A
TI Antioxidant enzymes, free-radical damage, and response to paraquat in
   liver and kidney of long-living growth hormone receptor/binding protein
   gene-disrupted mice
SO HORMONE AND METABOLIC RESEARCH
LA English
DT Article
DE growth hormone; aging; antioxidant enzymes; lipid peroxidation; protein
   oxidation; free radical damage
ID SUPEROXIDE-DISMUTASE; DROSOPHILA-MELANOGASTER; GLUTATHIONE-PEROXIDASE;
   CAENORHABDITIS-ELEGANS; OXIDATIVE DAMAGE; LIFE-SPAN; CATALASE; ASSAY;
   OVEREXPRESSION; RESTRICTION
AB Numerous studies have shown that the lifespan can be extended by caloric restriction or by altering the growth hormone (GH)-insulin-like growth factor 1 signaling pathway. Both of these manipulations produce physiological alterations, such as increased insulin sensitivity, and reduced glucose levels and body size. However, it is difficult to evaluate whether these are merely correlates of delayed aging or whether they have a direct causal effect on lifespan. One parameter that has been demonstrated to have causal, positive effects on longevity in invertebrates is improved antioxidant defenses. We measured activities of antioxidant enzymes Cu/Zn superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx) and quantified free-radical damage by lipid peroxidation (LP) and protein oxidation (PO) measurements in liver and kidney tissues, and evaluated the response to paraquat-induced oxygen toxicity in the long-living GH receptor/binding protein gene knockout (GHR-KO) mouse. We found that in the kidney, SOD was lower and GPx was higher in GHR-KO mice, and LP was higher in female GHR-KO mice only. in the liver, female GHR-KO mice had lower GPx, while male GHR-KO mice had lower CAT and higher LP. GHR-KO males were also more susceptible to paraquat toxicity compared to females or normal males. We conclude that in long-living GHR-KO mice, GH-resistance does not confer longevity by improved free-radical scavenging in the liver and kidney, suggesting that greater free-radical defenses in other tissues, or altered glucose metabolism may have a more central role in extending the lifespan of these animals.
C1 So Illinois Univ, Sch Med, Dept Physiol, Carbondale, IL 62901 USA.
   Ohio Univ, Edison Biotechnol Inst, Athens, OH 45701 USA.
   Ohio Univ, Dept Biomed Sci, Athens, OH USA.
C3 Southern Illinois University System; Southern Illinois University;
   University System of Ohio; Ohio University; University System of Ohio;
   Ohio University
RP Hauck, SJ (corresponding author), So Illinois Univ, Sch Med, Dept Physiol, Carbondale, IL 62901 USA.
EM shauck@siumed.edu
RI Bartke, Andzej/D-6640-2017
OI Bartke, Andzej/0000-0002-2569-557X
CR Aebi H., 1974, Methods of enzymatic analysis, P673, DOI [10.1016/B978-0-12-091302-2.50032-3, DOI 10.1016/B978-0-12-091302-2.50032-3]
   Bartke A, 2000, RES PRO CEL, V29, P181
   Bellush LL, 2000, ENDOCRINOLOGY, V141, P163, DOI 10.1210/en.141.1.163
   BOLZAN AD, 1995, EXP GERONTOL, V30, P169, DOI 10.1016/0531-5565(94)00053-0
   BREESE CR, 1991, J GERONTOL, V46, pB180, DOI 10.1093/geronj/46.5.B180
   Brown-Borg HM, 1999, ENDOCRINE, V11, P41, DOI 10.1385/ENDO:11:1:41
   Coschigano KT, 2000, ENDOCRINOLOGY, V141, P2608, DOI 10.1210/en.141.7.2608
   Crapo J D, 1978, Methods Enzymol, V53, P382
   FARRINGTON JA, 1973, BIOCHIM BIOPHYS ACTA, V314, P372, DOI 10.1016/0005-2728(73)90121-7
   GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Hauck SJ, 2000, FREE RADICAL BIO MED, V28, P970, DOI 10.1016/S0891-5849(00)00186-6
   Hauck SJ, 2001, EXP BIOL MED, V226, P552
   HAWKSWORTH GM, 1981, TOXICOL APPL PHARM, V57, P139, DOI 10.1016/0041-008X(81)90273-8
   Ho YS, 1998, ENVIRON HEALTH PERSP, V106, P1219, DOI 10.2307/3433989
   JONES DP, 1981, ARCH BIOCHEM BIOPHYS, V210, P505, DOI 10.1016/0003-9861(81)90215-0
   LARSEN PL, 1995, GENETICS, V139, P1567
   Leal AM, 1998, BIOCHEM PHARMACOL, V56, P1463, DOI 10.1016/S0006-2952(98)00248-2
   Lu YP, 1997, CANCER RES, V57, P1468
   MEITES J, 1993, J REPROD FERTIL, P1
   ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730
   PAMPORI NA, 1994, BIOCHEM PHARMACOL, V47, P1221, DOI 10.1016/0006-2952(94)90394-8
   PeledKamar M, 1997, P NATL ACAD SCI USA, V94, P3883, DOI 10.1073/pnas.94.8.3883
   REZNICK AZ, 1994, METHOD ENZYMOL, V233, P357
   Riha VF, 1996, J GERONTOL A-BIOL, V51, pB284, DOI 10.1093/gerona/51A.4.B284
   Ruiz-Larrea MB, 2000, CHEM PHYS LIPIDS, V105, P179, DOI 10.1016/S0009-3084(00)00120-1
   SAENGHIRUNVATTANA S, 1992, CHEST, V101, P833, DOI 10.1378/chest.101.3.833
   SOHAL RS, 1995, J BIOL CHEM, V270, P15671, DOI 10.1074/jbc.270.26.15671
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   SUN Y, 1988, CLIN CHEM, V34, P497
   SUN Y, 1994, CLIN CHIM ACTA, V226, P101, DOI 10.1016/0009-8981(94)90108-2
   Tappel A L, 1978, Methods Enzymol, V52, P506
   Taub J, 1999, NATURE, V399, P162, DOI 10.1038/20208
   UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1
   Weindruch R, 1997, NEW ENGL J MED, V337, P986, DOI 10.1056/NEJM199710023371407
   Whitin JC, 1998, MOL GENET METAB, V65, P238, DOI 10.1006/mgme.1998.2760
   YANG CW, 1993, KIDNEY INT, V43, pS90
   Youn YK, 1998, J BURN CARE REHABIL, V19, P542, DOI 10.1097/00004630-199811000-00015
   Zhou YH, 1997, P NATL ACAD SCI USA, V94, P13215, DOI 10.1073/pnas.94.24.13215
NR 39
TC 57
Z9 57
U1 0
U2 7
PU GEORG THIEME VERLAG KG
PI STUTTGART
PA RUDIGERSTR 14, D-70469 STUTTGART, GERMANY
SN 0018-5043
EI 1439-4286
J9 HORM METAB RES
JI Horm. Metab. Res.
PD SEP
PY 2002
VL 34
IS 9
BP 481
EP 486
DI 10.1055/s-2002-34787
PG 6
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 608PT
UT WOS:000178856100003
PM 12384824
DA 2024-02-19
ER

PT J
AU Hassan-Smith, ZK
   Morgan, SA
   Sherlock, M
   Hughes, B
   Taylor, AE
   Lavery, GG
   Tomlinson, JW
   Stewart, PM
AF Hassan-Smith, Zaki K.
   Morgan, Stuart A.
   Sherlock, Mark
   Hughes, Beverly
   Taylor, Angela E.
   Lavery, Gareth G.
   Tomlinson, Jeremy W.
   Stewart, Paul M.
TI Gender-Specific Differences in Skeletal Muscle 11β-HSD1 Expression
   Across Healthy Aging
SO JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
LA English
DT Article
ID 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; ADIPOSE-TISSUE; CORTISOL
   METABOLISM; GLUCOCORTICOID EXPOSURE; POSTMENOPAUSAL WOMEN;
   SEXUAL-DIMORPHISM; RECEPTOR-BETA; IN-VIVO; AGE; LIVER
AB Context: Cushing's syndrome is characterized by marked changes in body composition (sarcopenia, obesity, and osteoporosis) that have similarities with those seen in aging. 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1) converts glucocorticoids to their active form (cortisone to cortisol in humans), resulting in local tissue amplification of effect.
   Objective: To evaluate 11 beta-HSD1 expression and activity with age, specifically in muscle. To determine putative causes for increased activity with age and its consequences upon phenotypic markers of adverse aging.
   Design: Cross-sectional observational study.
   Setting: National Institute for Health Research-Wellcome Trust Clinical Research Facility, Birmingham, United Kingdom.
   Patients or Other Participants: Healthy human volunteers age 20 to 81 years (n = 134; 77 women, 57 men).
   Interventions: Day attendance at research facility for baseline observations, body composition analysis by dual-energy x-ray absorptiometry, jump-plate mechanography, grip strength analysis, baseline biochemical profiling, urine collection, and vastus lateralis muscle biopsy.
   Main Outcome Measure(s): Skeletal muscle gene expression, urine steroid profile, bivariate correlations between expression/activity and phenotypic/biochemical variables.
   Results: Skeletal muscle 11 beta-HSD1 expression was increased 2.72-fold in women over 60 years of age compared to those aged 20-40 years; no differences were observed in men. There was a significant positive correlation between skeletal muscle 11 beta-HSD1 expression and age inwomenacross the group (rho = 0.40; P = .009). No differences in expression of 11 beta-HSD type 2, glucocorticoid receptor, or hexose-6-phosphate dehydrogenase between age groups were observed in either sex. Urinary steroid markers of 11 beta-HSD1, 11 beta-HSD type 2, or 5 alpha-reductase were similar between age groups. Skeletal muscle 11 beta-HSD1 expression was associated with reduced grip strength in both sexes and correlated positively with percentage of body fat, homeostasis model of assessment for insulin resistance, total cholesterol, LH, and FSH and negatively with bone mineral content and IGF-1 in women.
   Conclusions: Skeletal muscle 11 beta-HSD1 is up-regulated with age in women and is associated with reduced grip strength, insulin resistance, and an adverse body composition profile. Selective inhibition of 11 beta-HSD1 may offer a novel strategy to prevent and/or reverse age-related sarcopenia.
C1 [Hassan-Smith, Zaki K.; Morgan, Stuart A.; Hughes, Beverly; Taylor, Angela E.; Lavery, Gareth G.] Univ Birmingham, Inst Biomed Res, Sch Clin & Expt Med, Ctr Endocrinol Diabet & Metab, Edgbaston B15 2TT, England.
   [Sherlock, Mark] Adelaide & Meath Hosp, Dept Endocrinol, Dublin 24, Ireland.
   [Sherlock, Mark] Trinity Coll Dublin, Dublin 2, Ireland.
   [Tomlinson, Jeremy W.] Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LE, England.
   [Stewart, Paul M.] Univ Leeds, Fac Med & Hlth, Leeds LS2 9NL, W Yorkshire, England.
C3 University of Birmingham; Trinity College Dublin; Trinity College
   Dublin; University of Oxford; University of Leeds
RP Hassan-Smith, ZK (corresponding author), Univ Birmingham, Inst Biomed Res, Sch Clin & Expt Med, Ctr Endocrinol Diabet & Metab, Second Floor, Edgbaston B15 2TT, England.
EM z.hassansmith@bham.ac.uk
OI Taylor, Angela, E/0000-0002-5835-5643; Tomlinson,
   Jeremy/0000-0002-3170-8533; , Zaki/0000-0002-8387-3039
FU European Research Council (Advanced Grant "Precort"); MRC [MR/K015176/2,
   MR/K00414X/1] Funding Source: UKRI; Medical Research Council
   [MR/K00414X/1, MR/K015176/2] Funding Source: researchfish; National
   Institute for Health Research [NF-SI-0508-10356] Funding Source:
   researchfish
FX The study was funded by the European Research Council (Advanced Grant
   "Precort" to P.M.S.).
CR ALBISTON AL, 1995, MOL CELL ENDOCRINOL, V109, P183, DOI 10.1016/0303-7207(95)03501-W
   Alemany Maria, 2012, Front Endocrinol (Lausanne), V3, P27, DOI 10.3389/fendo.2012.00027
   Andersson T, 2010, OBESITY, V18, P470, DOI 10.1038/oby.2009.294
   Andersson T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008475
   Apostolova G, 2005, AM J PHYSIOL-ENDOC M, V288, pE957, DOI 10.1152/ajpendo.00442.2004
   Arlt W, 2011, J CLIN ENDOCR METAB, V96, P3775, DOI 10.1210/jc.2011-1565
   Biedasek K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016674
   Campino C, 2013, AM J HYPERTENS, V26, P481, DOI 10.1093/ajh/hps080
   Cooper MS, 2002, J BONE MINER RES, V17, P979, DOI 10.1359/jbmr.2002.17.6.979
   DODT C, 1994, EUR J ENDOCRINOL, V131, P443, DOI 10.1530/eje.0.1310443
   Douglas M, 2014, NEUROMUSCULAR DISORD, P1341
   Frajese Giovanni V, 2004, Horm Res, V61, P246, DOI 10.1159/000077135
   Gathercole LL, 2013, ENDOCR REV, V34, P525, DOI 10.1210/er.2012-1050
   Gomez-Sanchez EP, 2003, AM J PHYSIOL-ENDOC M, V285, pE272, DOI 10.1152/ajpendo.00409.2002
   Ho CKM, 1999, J ENDOCRINOL, V163, P425, DOI 10.1677/joe.0.1630425
   Hughes KA, 2012, DIABETES, V61, P1357, DOI 10.2337/db11-1345
   Jang C, 2006, CLIN ENDOCRINOL, V65, P800, DOI 10.1111/j.1365-2265.2006.02669.x
   Kilgour AHM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084057
   Lavery GG, 2012, ENDOCRINOLOGY, V153, P3236, DOI 10.1210/en.2012-1019
   LOW SC, 1994, J ENDOCRINOL, V143, P541, DOI 10.1677/joe.0.1430541
   McInnes KJ, 2012, MENOPAUSE, V19, P1347, DOI 10.1097/gme.0b013e318258aad7
   McNelis JC, 2013, AM J PHYSIOL-ENDOC M, V305, pE1134, DOI 10.1152/ajpendo.00314.2012
   Messier V, 2011, MATURITAS, V68, P331, DOI 10.1016/j.maturitas.2011.01.014
   Morgan SA, 2014, P NATL ACAD SCI USA, V111, pE2482, DOI 10.1073/pnas.1323681111
   Morgan SA, 2009, DIABETES, V58, P2506, DOI 10.2337/db09-0525
   Newell-Price J, 2006, LANCET, V367, P1605, DOI 10.1016/S0140-6736(06)68699-6
   Nwe KHH, 2000, STEROIDS, V65, P40, DOI 10.1016/S0039-128X(99)00078-1
   Richards J, 2012, CANCER RES, V72, P2176, DOI 10.1158/0008-5472.CAN-11-3980
   Ricketts ML, 1998, J CLIN ENDOCR METAB, V83, P1325, DOI 10.1210/jc.83.4.1325
   SHACKLETON CHL, 1993, J STEROID BIOCHEM, V45, P127, DOI 10.1016/0960-0760(93)90132-G
   Stewart PM, 1999, J CLIN ENDOCR METAB, V84, P1022, DOI 10.1210/jc.84.3.1022
   Stimson RH, 2009, DIABETES, V58, P46, DOI 10.2337/db08-0969
   Tarnopolsky MA, 2011, MUSCLE NERVE, V43, P717, DOI 10.1002/mus.21945
   Tiganescu A, 2013, J CLIN INVEST, V123, P3051, DOI 10.1172/JCI64162
   Tomlinson JW, 2007, J CLIN ENDOCR METAB, V92, P857, DOI 10.1210/jc.2006-2325
   Tomlinson JW, 2004, ENDOCR REV, V25, P831, DOI 10.1210/er.2003-0031
   Toogood AA, 2000, J CLIN ENDOCR METAB, V85, P1727, DOI 10.1210/jc.85.4.1727
   Toogood AA, 2000, CLIN ENDOCRINOL, V52, P61
   VanCauter E, 1996, J CLIN ENDOCR METAB, V81, P2468, DOI 10.1210/jc.81.7.2468
   Whorwood CB, 2001, J CLIN ENDOCR METAB, V86, P2296, DOI 10.1210/jc.86.5.2296
NR 40
TC 56
Z9 59
U1 0
U2 20
PU ENDOCRINE SOC
PI WASHINGTON
PA 2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA
SN 0021-972X
EI 1945-7197
J9 J CLIN ENDOCR METAB
JI J. Clin. Endocrinol. Metab.
PD JUL
PY 2015
VL 100
IS 7
BP 2673
EP 2681
DI 10.1210/jc.2015-1516
PG 9
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA CQ8EZ
UT WOS:000360840600039
PM 25989394
OA Bronze
DA 2024-02-19
ER

PT J
AU Wang, RS
   Nakajima, T
   Kawamoto, T
   Honma, T
AF Wang, RS
   Nakajima, T
   Kawamoto, T
   Honma, T
TI Effects of aldehyde dehydrogenase-2 genetic polymorphisms on metabolism
   of structurally different aldehydes in human liver
SO DRUG METABOLISM AND DISPOSITION
LA English
DT Article
ID ALCOHOL; JAPANESE; ALDH2; ALLELE; DEFICIENCY; DOMINANCE; GENOTYPE;
   VARIANT; DISEASE; MUTANT
AB Genotype analysis of the aldehyde dehydrogenase (ALDH)-2 gene was performed using an improved simplified method, and effects of the genotype on the metabolism of a variety of aldehydes in different fractions of human liver cells were investigated. The effects of sex, aging, smoking, drinking alcohol, liver function, and various drugs on ALDH activity were also analyzed. Of the 39 subjects, eight were heterozygotes of the wild (ALDH2*1) and mutant (ALDH2*2) alleles, and the others were homozygotes of the wild allele. ALDH activity toward acetaldehyde in liver mitochondria from subjects with a mutant allele was less than 10% of that with two alleles of wild-type, and the activities toward formaldehyde, propionaldehyde, n-butyraldehyde, capronaldehyde, and heptaldehyde were also significantly lower in the ALDH2*1/*2 rather than ALDH2*1/*1 group. However, the metabolism of octylaldehyde, decylaldehyde, retinaldehyde, benzaldehyde, 3-hydroxybenzaldehyde, and 2,5-dihydroxybenzaldehyde was similar in the two genotypes. Changes in activity in the cytosolic fraction were similar to those in mitochondria. There was no significant difference in ALDH activity in microsomes between the two groups. Total activities of ALDH toward acetaldehyde and other short-chain aliphatic aldehydes in supernatant fractions of homogenized liver were affected in a manner similar to that in mitochondria. Our results suggest that the single nucleotide polymorphisms of the ALDH2 gene only alter the metabolism of aldehydes with a short aliphatic chain. Furthermore, sex, drinking alcohol, and smoking had little effect on ALDH activity, although the activity in elderly individuals tended to be lower albeit statistically insignificant.
C1 Natl Inst Ind Hlth, Div Hlth Effects Res, Kawasaki, Kanagawa 2148585, Japan.
   Shinshu Univ, Sch Med, Dept Hyg, Matsumoto, Nagano 390, Japan.
   Univ Occupat & Environm Hlth, Dept Environm Hlth, Kitakyushu, Fukuoka 807, Japan.
C3 Shinshu University; University of Occupational & Environmental Health -
   Japan
RP Wang, RS (corresponding author), Natl Inst Ind Hlth, Div Hlth Effects Res, Nagao 6-21-1, Kawasaki, Kanagawa 2148585, Japan.
EM wang@niih.go.jp
OI Nakajima, Tamie/0000-0002-0474-7019
CR AMBROZIAK W, 1991, J BIOL CHEM, V266, P13011
   Chou WY, 1999, ALCOHOL CLIN EXP RES, V23, P963, DOI 10.1097/00000374-199906000-00002
   CRABB DW, 1989, J CLIN INVEST, V83, P314, DOI 10.1172/JCI113875
   HARADA S, 1993, ALCOHOL ALCOHOLISM, V28, P11
   HARADA S, 1980, AM J HUM GENET, V32, P8
   HARADA S, 1981, LANCET, V2, P982
   HSU LC, 1985, P NATL ACAD SCI USA, V82, P3771, DOI 10.1073/pnas.82.11.3771
   Klyosov AA, 1996, BIOCHEMISTRY-US, V35, P4457, DOI 10.1021/bi9521102
   KURYS G, 1989, J BIOL CHEM, V264, P4715
   Lai CL, 2000, ALCOHOL CLIN EXP RES, V24, P1625, DOI 10.1097/00000374-200011000-00004
   LINDAHL R, 1992, CRIT REV BIOCHEM MOL, V27, P283, DOI 10.3109/10409239209082565
   NAKAMURA K, 1993, BIOCHEM MOL BIOL INT, V31, P439
   NOVORADOVSKY A, 1995, ALCOHOL CLIN EXP RES, V19, P1105, DOI 10.1111/j.1530-0277.1995.tb01587.x
   Pares A, 1987, Alcohol Alcohol Suppl, V1, P513
   Peterson RJ, 1999, HUM GENET, V104, P177, DOI 10.1007/s004390050932
   SHIBUYA A, 1988, American Journal of Human Genetics, V43, pA201
   SINGH S, 1989, HUM GENET, V83, P119, DOI 10.1007/BF00286702
   SREERAMA L, 1994, CANCER RES, V54, P2176
   TAKIMOTO K, 1992, ARCH BIOCHEM BIOPHYS, V298, P492, DOI 10.1016/0003-9861(92)90440-8
   TORRONEN R, 1992, CHEM-BIOL INTERACT, V83, P107, DOI 10.1016/0009-2797(92)90040-R
   TU GC, 1993, EUR J CLIN CHEM CLIN, V31, P591
   Väkeväinen S, 2000, ALCOHOL CLIN EXP RES, V24, P873, DOI 10.1111/j.1530-0277.2000.tb02068.x
   Vasiliou V, 1999, PHARMACOGENETICS, V9, P421, DOI 10.1097/00008571-199910000-00004
   Vasiliou V, 2000, PHARMACOLOGY, V61, P192, DOI 10.1159/000028400
   Vidal F, 1998, ALCOHOL, V15, P3, DOI 10.1016/S0741-8329(97)00073-6
   Wang RS, 1999, TOXICOLOGY, V132, P9, DOI 10.1016/S0300-483X(98)00132-2
   Wong RH, 1998, MUTAT RES-GEN TOX EN, V420, P99, DOI 10.1016/S1383-5718(98)00150-8
   XIAO Q, 1995, J CLIN INVEST, V96, P2180, DOI 10.1172/JCI118272
   YIN SJ, 1994, ALCOHOL CLIN EXP RES, V18, P1256, DOI 10.1111/j.1530-0277.1994.tb00115.x
   Yokoyama A, 1999, ALCOHOL CLIN EXP RES, V23, P1705, DOI 10.1097/00000374-199911000-00001
   YOSHIDA A, 1984, P NATL ACAD SCI-BIOL, V81, P258, DOI 10.1073/pnas.81.1.258
   Yoshida A, 1998, EUR J BIOCHEM, V251, P549, DOI 10.1046/j.1432-1327.1998.2510549.x
NR 32
TC 69
Z9 80
U1 0
U2 2
PU AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA
SN 0090-9556
EI 1521-009X
J9 DRUG METAB DISPOS
JI Drug Metab. Dispos.
PD JAN
PY 2002
VL 30
IS 1
BP 69
EP 73
DI 10.1124/dmd.30.1.69
PG 5
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA 505PU
UT WOS:000172925400012
PM 11744614
DA 2024-02-19
ER

PT J
AU Panda, H
   Pandey, RS
   Debata, PR
   Supakar, PC
AF Panda, Harekrushna
   Pandey, Ravi S.
   Debata, Priya R.
   Supakar, Prakash C.
TI Cloning, expression, and functional analysis of rat liver cytosolic
   inorganic pyrophosphatase gene and characterization of its functional
   promoter
SO GENE EXPRESSION
LA English
DT Article
DE inorganic pyrophosphatase; gene expression; in-gel assay; transcription
   start site; protein-DNA interaction
ID NF-KAPPA-B; NUCLEOSIDE TRIPHOSPHATE; TRANSCRIPTION FACTORS; AGE;
   ACTIVATION; PRECIPITATION; MITOCHONDRIA; METABOLISM; APOPTOSIS; SP1
AB Inorganic pyrophosphate (PPi) is formed in several metabolic processes and its hydrolysis by the ubiquitously expressed enzyme inorganic pyrophosphatase (iPPase) is essential for the reactions to proceed in the direction of biosynthesis. Recently, we have reported differential expression and activity of cytosolic iPPase in rat liver with aging. In this article we report the cloning of the coding region of rat liver cytosolic iPPase gene in a bacterial expression vector, its expression, purification, and functional analysis by in-gel enzyme assay. SDS-PAGE and Western blot analysis of this expressed protein revealed that its molecular weight (MW) is similar to 33 kDa, while in-gel assay showed that it is functionally active just as the liver cytosolic iPPase. We have determined the genomic organization of this gene by genome blast approach. We have also cloned and characterized its proximal similar to 1 kb functional promoter (-1009 to +82) by transient transfection and luciferase assay of different 5'-deleted iPPase promoter-luciferase constructs and also established its transcription start site by primer extension analysis, along with protein-DNA interaction studies for a few putative transcription factor binding sites.
C1 Inst Life Sci, Bhubaneswar 751023, Orissa, India.
C3 Department of Biotechnology (DBT) India; Institute of Life Sciences
   India (ILS)
RP Supakar, PC (corresponding author), Inst Life Sci, Nalco Sq, Bhubaneswar 751023, Orissa, India.
EM pcsupakar@hotmail.com
RI Debata, Priya Ranjan/AAY-7142-2021
CR [Anonymous], 1989, MOL CLONING LAB MANU
   BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.iy.12.040194.001041
   BAEUERLE PA, 1996, CELL, V87, P132
   Barkett M, 1999, ONCOGENE, V18, P6910, DOI 10.1038/sj.onc.1203238
   DAVIDSON AM, 1988, BIOCHEM J, V254, P379, DOI 10.1042/bj2540379
   DUSING MR, 1994, NUCLEIC ACIDS RES, V22, P669, DOI 10.1093/nar/22.4.669
   Gupta A, 1999, KIDNEY INT, V55, P1891, DOI 10.1046/j.1523-1755.1999.00436.x
   GUYNN RW, 1974, BIOCHEMISTRY-US, V140, P369, DOI 10.1042/bj1400369
   HAGER DA, 1980, ANAL BIOCHEM, V109, P76, DOI 10.1016/0003-2697(80)90013-5
   HORN A, 1967, EUR J BIOCHEM, V2, P243, DOI 10.1111/j.1432-1033.1967.tb00131.x
   Johnson K, 2001, J RHEUMATOL, V28, P2681
   Kim HJ, 2000, FREE RADICAL BIO MED, V28, P683, DOI 10.1016/S0891-5849(99)00274-9
   Kornberg A., 1962, Horizons in Biochemistry, P251
   LAHTI R, 1983, MICROBIOL REV, V47, P169, DOI 10.1128/MMBR.47.2.169-178.1983
   Lavrovsky Y, 2000, MECH AGEING DEV, V114, P49, DOI 10.1016/S0047-6374(00)00087-7
   MANSUROVA SE, 1989, BIOCHIM BIOPHYS ACTA, V977, P237, DOI 10.1016/S0005-2728(89)80078-7
   Michels PAM, 1997, EUR J BIOCHEM, V250, P698, DOI 10.1111/j.1432-1033.1997.00698.x
   NORDLIE RC, 1965, J BIOL CHEM, V240, P2155
   PANDA H, IN PRESS BIOGERONTOL
   RACHOW JW, 1988, RHEUM DIS CLIN N AM, V14, P289
   SHATTON JB, 1983, CANCER RES, V43, P3742
   Shimakura J, 2005, AM J PHYSIOL-GASTR L, V289, pG471, DOI 10.1152/ajpgi.00025.2005
   Simonovic AD, 2004, ANAL BIOCHEM, V334, P312, DOI 10.1016/j.ab.2004.07.010
   SMIRNOVA I N, 1989, Biokhimiya, V54, P228
   Supakar PC, 1996, BIOL SIGNAL, V5, P170
   Terkeltaub RA, 2001, AM J PHYSIOL-CELL PH, V281, pC1, DOI 10.1152/ajpcell.2001.281.1.C1
   Terzic N, 2003, J GERONTOL A-BIOL, V58, P297
   Tollet-Egnell P, 2001, MOL ENDOCRINOL, V15, P308, DOI 10.1210/me.15.2.308
   WEAVER J, 1990, BIOCHEM J, V265, P415, DOI 10.1042/bj2650415
   Wu DY, 2004, BRAIN BEHAV IMMUN, V18, P487, DOI 10.1016/j.bbi.2004.05.003
   YOSHIDA C, 1982, CANCER RES, V42, P3526
   Zhang J, 2001, ANTIOXID REDOX SIGN, V3, P493, DOI 10.1089/15230860152409121
NR 32
TC 2
Z9 3
U1 0
U2 0
PU COGNIZANT COMMUNICATION CORP
PI ELMSFORD
PA 3 HARTSDALE ROAD, ELMSFORD, NY 10523-3701 USA
SN 1052-2166
J9 GENE EXPRESSION
JI Gene Expr.
PY 2007
VL 14
IS 1
BP 13
EP 22
DI 10.3727/000000007783991754
PG 10
WC Biotechnology & Applied Microbiology; Gastroenterology & Hepatology;
   Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Gastroenterology & Hepatology;
   Genetics & Heredity
GA 218SS
UT WOS:000250035800002
PM 17933215
OA Green Published
DA 2024-02-19
ER

PT J
AU Titanji, BK
   Lee, MT
   Wang, ZY
   Chen, JY
   Hui, Q
   Lo Re, V
   So-Armah, K
   Justice, AC
   Xu, K
   Freiberg, M
   Gwinn, M
   Marconi, VC
   Sun, YV
AF Titanji, Boghuma K. K.
   Lee, Mitch
   Wang, Zeyuan
   Chen, Junyu
   Hui, Qin
   Lo Re, Vincent, III
   So-Armah, Kaku
   Justice, Amy C. C.
   Xu, Ke
   Freiberg, Matthew
   Gwinn, Marta
   Marconi, Vincent C. C.
   Sun, Yan V. V.
TI Epigenome-wide association study of biomarkers of liver function
   identifies albumin-associated DNA methylation sites among male veterans
   with HIV
SO FRONTIERS IN GENETICS
LA English
DT Article
DE EWAS; liver disease; HIV; biomarkers; albumin (ALB)
ID ACTIVE ANTIRETROVIRAL THERAPY; SIMPLE NONINVASIVE INDEX; CHRONIC
   HEPATITIS; SIGNIFICANT FIBROSIS; INFECTED PATIENTS; BIOLOGICAL AGE;
   SOCS3; ALCOHOL; INFLAMMATION; MORTALITY
AB Background: Liver disease (LD) is an important cause of morbidity and mortality for people with HIV (PWH). The molecular factors linked with LD in PWH are varied and incompletely characterized. We performed an epigenome-wide association study (EWAS) to identify associations between DNA methylation (DNAm) and biomarkers of liver function-aspartate transaminase, alanine transaminase, albumin, total bilirubin, platelet count, FIB-4 score, and APRI score-in male United States veterans with HIV. Methods: Blood samples and clinical data were obtained from 960 HIV-infected male PWH from the Veterans Aging Cohort Study. DNAm was assessed using the Illumina 450K or the EPIC 850K array in two mutually exclusive subsets. We performed a meta-analysis for each DNAm site measured by either platform. We also examined the associations between four measures of DNAm age acceleration (AA) and liver biomarkers. Results: Nine DNAm sites were positively associated with serum albumin in the meta-analysis of the EPIC and 450K EWAS after correcting for multiple testing. Four DNAm sites (cg16936953, cg18942579, cg01409343, and cg12054453), annotated within the TMEM49 and four of the remaining five sites (cg18181703, cg03546163, cg20995564, and cg23966214) annotated to SOCS3, FKBP5, ZEB2, and SAMD14 genes, respectively. The DNAm site, cg12992827, was not annotated to any known coding sequence. No significant associations were detected for the other six liver biomarkers. Higher PhenoAA was significantly associated with lower level of serum albumin (beta = -0.007, p-value = 8.6 x 10(-4), CI: -0.011116, -0.002884). Conclusion: We identified epigenetic associations of both individual DNAm sites and DNAm AA with liver function through serum albumin in men with HIV. Further replication analyses in independent cohorts are warranted to confirm the epigenetic mechanisms underlying liver function and LD in PWH.
C1 [Titanji, Boghuma K. K.; Marconi, Vincent C. C.] Emory Sch Med, Div Infect Dis, Atlanta, GA USA.
   [Lee, Mitch; Wang, Zeyuan; Chen, Junyu; Hui, Qin; Sun, Yan V. V.] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA.
   [Lo Re, Vincent, III] Univ Penn, Div Infect Dis, Ctr Clin Epidemiol, Dept Med, Philadelphia, PA USA.
   [Lo Re, Vincent, III] Perelman Sch Med Univ Penn, Ctr Clin Epidemiol & Biostat, Perelman Sch Med, Philadelphia, PA USA.
   [So-Armah, Kaku] Boston Univ, Med Sch, Boston, MA USA.
   [Xu, Ke] Connecticut Vet Hlth Syst, West Haven, CT USA.
   [Xu, Ke] Yale Univ, Sch Med, New Haven, CT USA.
   [Freiberg, Matthew] Vanderbilt Univ Sch Med, Cardiovasc Med Div, Nashville, TN USA.
   [Freiberg, Matthew] Vanderbilt Univ, Med Ctr, Tennessee Valley Healthcare System, Nashville, TN USA.
   [Gwinn, Marta] Ctr Dis Control & Prevent, Hubert Dept Global Hlth, Atlanta, GA USA.
   [Marconi, Vincent C. C.; Sun, Yan V. V.] Atlanta Vet Affairs Hlth Care Syst, Emory Vaccine Ctr, Yerkes Natl Primate Res Ctr, Atlanta, GA 30033 USA.
C3 Emory University; Emory University; Rollins School Public Health;
   University of Pennsylvania; University of Pennsylvania; Boston
   University; Yale University; Vanderbilt University; Vanderbilt
   University; US Department of Veterans Affairs; Veterans Health
   Administration (VHA); VA Tennessee Valley Healthcare System; Centers for
   Disease Control & Prevention - USA; Emory University
RP Sun, YV (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA.; Sun, YV (corresponding author), Atlanta Vet Affairs Hlth Care Syst, Emory Vaccine Ctr, Yerkes Natl Primate Res Ctr, Atlanta, GA 30033 USA.
EM yan.v.sun@emory.edu
RI Marconi, Vincent/GRJ-4553-2022; Sun, Yan V./A-7461-2008; Marconi,
   Vincent/N-3210-2014; Titanji, Boghuma/AAH-1557-2020
OI Marconi, Vincent/0000-0001-8409-4689; Marconi,
   Vincent/0000-0001-8409-4689; Titanji, Boghuma/0000-0002-6881-2764; Sun,
   Yan/0000-0002-2838-1824
FU National Institute of Health [R01DK125187]; Emory CFAR [P30AI050409];
   National Institute on Drug Abuse [R01DA042691, R01DA047820,
   R01DA047063]; NIH [K01HL134147]; VACS - NIH NIAAA [U24 AA020794, U01
   AA020790, U10 AA013566]
FX This work was supported by the following grants: BT, ML, ZW, JC, QH, VM
   and YS received support from the National Institute of Health
   (R01DK125187), VM and YS received support from Emory CFAR (P30AI050409),
   KX received support from the National Institute on Drug Abuse
   (R01DA042691, R01DA047820, R01DA047063), KS received support from NIH
   K01HL134147, VACS - NIH NIAAA U24 AA020794, U01 AA020790, U10 AA013566
   completed.
CR Ali O, 2016, EPIGENETICS-US, V11, P699, DOI 10.1080/15592294.2016.1216284
   Bell CG, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1824-y
   Cai MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032838
   Carow B, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00058
   Carvalho JR, 2018, ANN HEPATOL, V17, P547, DOI 10.5604/01.3001.0012.0916
   Chambers JC, 2015, LANCET DIABETES ENDO, V3, P526, DOI 10.1016/S2213-8587(15)00127-8
   Chen BH, 2016, AGING-US, V8, P1844, DOI 10.18632/aging.101020
   Chen JY, 2020, CLIN INFECT DIS, V70, P667, DOI 10.1093/cid/ciz240
   De Pablo-Bernal RS, 2014, J ANTIMICROB CHEMOTH, V69, P3041, DOI 10.1093/jac/dku263
   Deeks SG, 2013, IMMUNITY, V39, P633, DOI 10.1016/j.immuni.2013.10.001
   Dees C, 2020, J CLIN INVEST, V130, P2347, DOI 10.1172/JCI122462
   DINARELLO CA, 1984, NEW ENGL J MED, V311, P1413
   Freiberg M, 2010, JAIDS-J ACQ IMM DEF, V53, P247, DOI 10.1097/QAI.0b013e3181c6c4b7
   French SW, 2013, ALCOHOL RES-CURR REV, V35, P57
   Garcovich M, 2009, BLOOD TRANSFUS-ITALY, V7, P268, DOI 10.2450/2008.0080-08
   Gross AM, 2016, MOL CELL, V62, P157, DOI 10.1016/j.molcel.2016.03.019
   Hannum G, 2013, MOL CELL, V49, P359, DOI 10.1016/j.molcel.2012.10.016
   Horvath S, 2015, J INFECT DIS, V212, P1563, DOI 10.1093/infdis/jiv277
   Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86
   Jadid FZ, 2018, INFECT GENET EVOL, V66, P1, DOI 10.1016/j.meegid.2018.08.027
   Jo D, 2005, NAT MED, V11, P892, DOI 10.1038/nm1269
   Justice AC, 2006, MED CARE, V44, pS13, DOI 10.1097/01.mlr.0000223741.02074.66
   Juvinao-Quintero DL, 2021, CLIN EPIGENETICS, V13, DOI 10.1186/s13148-021-01027-3
   Kaspar MB, 2017, BMJ OPEN GASTROENTER, V4, DOI 10.1136/bmjgast-2017-000166
   Kim HN, 2016, JAIDS-J ACQ IMM DEF, V72, P437, DOI 10.1097/QAI.0000000000000992
   Kim WR, 2016, J HEPATOL, V64, P773, DOI 10.1016/j.jhep.2015.11.012
   Konopnicki D, 2005, AIDS, V19, P593, DOI 10.1097/01.aids.0000163936.99401.fe
   Kusumanchi P, 2021, HEPATOLOGY, V74, P1234, DOI 10.1002/hep.31800
   Lemoine M, 2012, CURR OPIN INFECT DIS, V25, P10, DOI 10.1097/QCO.0b013e32834ef599
   Levine ME, 2018, AGING-US, V10, P573, DOI 10.18632/aging.101414
   Levine ME, 2015, AGING-US, V7, P1198, DOI 10.18632/aging.100864
   Levine ME, 2015, AGING-US, V7, P690, DOI 10.18632/aging.100809
   Ligthart S, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1119-5
   Liu Zuyun, 2018, PLoS Med, V15, pe1002718, DOI 10.1371/journal.pmed.1002718
   Lu AT, 2019, AGING-US, V11, P303, DOI 10.18632/aging.101684
   Marioni RE, 2018, MOL PSYCHIATR, V23, P2133, DOI 10.1038/s41380-017-0008-y
   Mathur R, 2019, J INFECT DIS, V219, P1959, DOI 10.1093/infdis/jiz023
   Mendelson MM, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002215
   Molejon MI, 2013, SCI REP-UK, V3, DOI 10.1038/srep01055
   Moran S, 2016, EPIGENOMICS-UK, V8, P389, DOI 10.2217/epi.15.114
   Nishida N, 2008, HEPATOLOGY, V47, P908, DOI 10.1002/hep.22110
   Ogata H, 2006, ONCOGENE, V25, P2520, DOI 10.1038/sj.onc.1209281
   Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16
   PERLMUTTER DH, 1986, J CLIN INVEST, V78, P1349, DOI 10.1172/JCI112721
   Phillips AN, 2010, AIDS, V24, P1561, DOI 10.1097/QAD.0b013e32833a6056
   Rickabaugh TM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119201
   Ronit A, 2018, AIDS, V32, P1837, DOI 10.1097/QAD.0000000000001900
   Ronit A, 2018, J INFECT DIS, V217, P405, DOI 10.1093/infdis/jix350
   Rosen AD, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-018-0233-4
   Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4
   Sidibeh CO, 2018, ENDOCRINE, V62, P116, DOI 10.1007/s12020-018-1674-5
   Smith CJ, 2014, LANCET, V384, P241, DOI 10.1016/S0140-6736(14)60604-8
   Solomon O, 2018, EPIGENETICS-US, V13, P655, DOI 10.1080/15592294.2018.1497386
   Stechschulte LA, 2016, ENDOCRINOLOGY, V157, P3888, DOI 10.1210/en.2015-1996
   Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178
   Su PF, 2007, INT J CANCER, V121, P1257, DOI 10.1002/ijc.22849
   Sun DJY, 2019, CIRC RES, V125, P824, DOI 10.1161/CIRCRESAHA.119.315397
   Vaccaro MI, 2003, PANCREATOLOGY, V3, P69, DOI 10.1159/000069150
   Varela-Rey M, 2013, ALCOHOL RES-CURR REV, V35, P25
   Ventham NT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13507
   Wahl S, 2017, NATURE, V541, P81, DOI 10.1038/nature20784
   Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346
   Xu K, 2018, BIOL PSYCHOL, V131, P63, DOI 10.1016/j.biopsycho.2016.11.001
   Xu XY, 2020, INT J CLIN ONCOL, V25, P1105, DOI 10.1007/s10147-020-01647-4
   Zakhari S, 2013, ALCOHOL RES-CURR REV, V35, P6
   Zannas AS, 2016, NEUROPSYCHOPHARMACOL, V41, P261, DOI 10.1038/npp.2015.235
   Zhang XF, 2021, EUR J CLIN INVEST, V51, DOI 10.1111/eci.13479
   Zhang XY, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02326-1
   Zhao YX, 2014, CLIN EPIGENETICS, V6, DOI 10.1186/1868-7083-6-30
   Zhao YX, 2018, CELL CYCLE, V17, P250, DOI 10.1080/15384101.2017.1417708
NR 70
TC 1
Z9 1
U1 0
U2 1
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 1664-8021
J9 FRONT GENET
JI Front. Genet.
PD OCT 11
PY 2022
VL 13
AR 1020871
DI 10.3389/fgene.2022.1020871
PG 13
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 5U4BE
UT WOS:000876493500001
PM 36303554
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Sanz, A
   Caro, P
   Barja, G
AF Sanz, A
   Caro, P
   Barja, G
TI Protein restriction without strong caloric restriction decreases
   mitochondrial oxygen radical production and oxidative DNA damage in rat
   liver
SO JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
LA English
DT Article
DE mitochondria; free radicals; oxygen radicals; DNA damage; protein
   restriction; caloric restriction; 8-hydroxydeoxyguanosine; mitochondrial
   DNA; nuclear DNA
ID DIETARY-PROTEIN; BODY-WEIGHT; LIFE-SPAN; NUTRITIONAL INFLUENCES;
   FISCHER-344 RATS; H2O2 PRODUCTION; LONGEVITY; GROWTH; GENERATION;
   SURVIVAL
AB Previous studies have shown that caloric restriction decreases mitochondrial oxygen radical production and oxidative DNA damage in rat organs, which can be linked to the slowing of aging rate induced by this regime. These two characteristics are also typical of long-lived animals. However, it has never been investigated if those decreases are linked to the decrease in the intake of calories themselves or to decreases in specific dietary components. In this study the possible role of the dietary protein was investigated. Using semipurified diets, the ingestion of proteins of Wistar rats was decreased by 40% below that of controls while the other dietary components were ingested at the same level as in animals fed ad libitum. After seven weeks in this regime the liver of the protein restricted animals showed 30-40% decreases in mitochondrial production of reactive oxygen species (ROS) and in oxidative damage to nuclear and mitochondrial DNA. The decreases in ROS generation occurred specifically at complex I. They also occurred without changes in mitochondrial oxygen consumption. Instead, there was a decrease in the percent free radical leak (the percentage of total electron flow leading to ROS generation in the respiratory chain). These results are strikingly similar to those previously obtained after 40% caloric restriction in the liver of Wistar rats. Thus, the results suggest that part of the decrease in aging rate induced by caloric restriction can be due to the decreased intake of proteins acting through decreases in mitochondrial ROS production and oxidative DNA damage. Interestingly, these tissue oxidative stress-linked parameters can be lowered by restricting only the intake of dietary protein, probably a more feasible option than caloric restriction for adult humans.
C1 Univ Complutense, Dept Fisiol Anim 2, Fac Ciencias Biol, E-28040 Madrid, Spain.
C3 Complutense University of Madrid
RP Sanz, A (corresponding author), Univ Complutense, Dept Fisiol Anim 2, Fac Ciencias Biol, C Jose Antonio Novais 2, E-28040 Madrid, Spain.
EM gbarja@bio.ucm.es
RI Sanz, Alberto/O-2329-2015; Gustavo, Barja/B-5591-2012; Barja,
   Gustavo/AAA-5903-2019; SANZ, ALBERTO/F-8432-2011
OI Sanz, Alberto/0000-0003-2149-1753; Barja, Gustavo/0000-0001-5736-4735;
   Caro, Pilar/0000-0002-7531-3234
CR Archer VE, 2003, MED HYPOTHESES, V60, P924, DOI 10.1016/S0306-9877(03)00097-5
   Armeni T, 2003, J BIOENERG BIOMEMBR, V35, P181, DOI 10.1023/A:1023754305218
   ASUNCION JG, 1996, FASEB J, V10, P333
   Barger JL, 2003, EXP GERONTOL, V38, P1343, DOI 10.1016/j.exger.2003.10.017
   Barja G, 2000, FASEB J, V14, P312, DOI 10.1096/fasebj.14.2.312
   Barja G, 2004, BIOL REV, V79, P235, DOI 10.1017/S1464793103006213
   Barja G, 2002, AGEING RES REV, V1, P397, DOI 10.1016/S1568-1637(02)00008-9
   Barja G, 1999, J BIOENERG BIOMEMBR, V31, P347, DOI 10.1023/A:1005427919188
   Barja G, 2002, J BIOENERG BIOMEMBR, V34, P227, DOI 10.1023/A:1016039604958
   BARROWS CH, 1975, GROWTH, V39, P525
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   DAVIS TA, 1983, EXP GERONTOL, V18, P427, DOI 10.1016/0531-5565(83)90021-9
   DIBAK O, 1984, PHYSIOL BOHEMOSLOV, V33, P320
   Djuric Z, 2002, TOXICOL SCI, V66, P125, DOI 10.1093/toxsci/66.1.125
   Doi SQ, 2001, AM J NEPHROL, V21, P331, DOI 10.1159/000046270
   Dröge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001
   FERNANDES G, 1976, P NATL ACAD SCI USA, V73, P1279, DOI 10.1073/pnas.73.4.1279
   GOODRICK CL, 1978, J GERONTOL, V33, P184, DOI 10.1093/geronj/33.2.184
   Gredilla R, 2003, ADV CELL AGING GERON, V14, P105
   Gredilla R, 2002, MICROSC RES TECHNIQ, V59, P273, DOI 10.1002/jemt.10204
   Gredilla R, 2001, FASEB J, V15, P1589, DOI 10.1096/fj.00-0764fje
   Gredilla R, 2001, J BIOENERG BIOMEMBR, V33, P279, DOI 10.1023/A:1010603206190
   HORAKOVA M, 1988, MECH AGEING DEV, V45, P1, DOI 10.1016/0047-6374(88)90014-0
   Hubert MF, 2000, TOXICOL SCI, V58, P195, DOI 10.1093/toxsci/58.1.195
   Keenan KP, 1997, J NUTR, V127, pS851, DOI 10.1093/jn/127.5.851S
   LATORRE A, 1986, P NATL ACAD SCI USA, V83, P8649, DOI 10.1073/pnas.83.22.8649
   LETO S, 1976, J GERONTOL, V31, P144, DOI 10.1093/geronj/31.2.144
   Loft S, 1999, METHOD ENZYMOL, V300, P166
   López-Torres M, 2002, FREE RADICAL BIO MED, V32, P882, DOI 10.1016/S0891-5849(02)00773-6
   MAEDA H, 1985, J GERONTOL, V40, P671, DOI 10.1093/geronj/40.6.671
   MARK MCM, 1995, J GERONTOL A-BIOL, V50, pB148
   MASORO EJ, 1991, ANN NY ACAD SCI, V621, P337
   Mattison JA, 2003, EXP GERONTOL, V38, P35, DOI 10.1016/S0531-5565(02)00146-8
   RAMANADHAM M, 1979, NUTR METAB, V23, P235
   RICHIE JP, 1994, FASEB J, V8, P1302, DOI 10.1096/fasebj.8.15.8001743
   RODRIGUES MAM, 1991, FOOD CHEM TOXICOL, V29, P757, DOI 10.1016/0278-6915(91)90184-9
   SAMBUICHI EJ, 1991, NUTR RES, V11, P1415, DOI 10.1016/S0271-5317(05)80474-9
   STOLTZNER G, 1977, GROWTH, V41, P337
   Wang C, 2004, INT J OBESITY, V28, P357, DOI 10.1038/sj.ijo.0802518
   YOUNGMAN LD, 1992, P NATL ACAD SCI USA, V89, P9112, DOI 10.1073/pnas.89.19.9112
   YOUNGMAN LD, 1993, MUTAT RES, V295, P165, DOI 10.1016/0921-8734(93)90018-X
   YU BP, 1985, J GERONTOL, V40, P657, DOI 10.1093/geronj/40.6.657
   Zimmerman JA, 2003, EXP GERONTOL, V38, P47, DOI 10.1016/S0531-5565(02)00149-3
NR 43
TC 102
Z9 116
U1 0
U2 21
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0145-479X
EI 1573-6881
J9 J BIOENERG BIOMEMBR
JI J. Bioenerg. Biomembr.
PD DEC
PY 2004
VL 36
IS 6
BP 545
EP 552
DI 10.1007/s10863-004-9001-7
PG 8
WC Biophysics; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biophysics; Cell Biology
GA 892RM
UT WOS:000226667700005
PM 15692733
DA 2024-02-19
ER

PT J
AU Rotskaya, UN
   Rogozin, IB
   Vasyunina, EA
   Malyarchuk, BA
   Nevinsky, GA
   Sinitsyna, OI
AF Rotskaya, Ulyana N.
   Rogozin, Igor B.
   Vasyunina, Elena A.
   Malyarchuk, Boris A.
   Nevinsky, Georgy A.
   Sinitsyna, Olga I.
TI High frequency of somatic mutations in rat liver mitochondrial DNA
SO MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
LA English
DT Article; Proceedings Paper
CT 1st Russian-European Workshop on DNA Repair and Epigenetic Regulation of
   Genome Stability
CY JUN 24-26, 2008
CL St Petersburg, RUSSIA
SP RAS Siberian Div, Inst Chem Biol & Fundamental Med, RAS, Inst Cytol
DE Mitochondrial DNA; Displacement loop; Nucleotide substitutions;
   Age-related somatic mutagenesis; Wistar rats
ID D-LOOP REGION; POINT MUTATIONS; POLYMERASE-GAMMA; MTDNA MUTATIONS;
   REPAIR; MUTAGENESIS; REPLICATION; MICE; APOPTOSIS; FIDELITY
AB Somatic mutations in mitochondrial DNA (mtDNA) are thought to play an important role in both aging and neurodegenerative diseases although their specific contributions remain a subject of intense debate. We analyzed somatic mutations in the mtDNA control regions in the liver of Wistar rats. The mutation rate was found to be high and increased with age from 5.3 x 10(-4) mutations per position to 4.48 x 10(-3) mutations per position at 3 and 12 months of age, respectively. The vast majority of nucleotide substitutions are transitions (similar to 95%) with A:T>G:C transitions being the most frequent type of substitution (>50%). In 3-month-old Wistar rats, approximately 40% of somatic mutations in the control region of mtDNA are significantly consistent with the model of dislocation mutagenesis which is a signature of error-prone DNA synthesis by mtDNA polymerase gamma. The results are consistent with the previous hypothesis that normal intramitochondrial dNTP pool asymmetries, which have been shown to reduce the fidelity of mtDNA polymerase gamma, substantially contribute to somatic mutagenesis of the rat mtDNA. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Rotskaya, Ulyana N.; Rogozin, Igor B.; Vasyunina, Elena A.; Nevinsky, Georgy A.; Sinitsyna, Olga I.] Russian Acad Sci, Siberian Div, Inst Cytol & Genet, Novosibirsk 630090, Russia.
   [Rogozin, Igor B.] Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA.
   [Malyarchuk, Boris A.] Russian Acad Sci, Far Eastern Div, Inst Biol Problems N, Magadan 685000, Russia.
   [Nevinsky, Georgy A.] Russian Acad Sci, Siberian Div, Inst Chem Biol & Fundamental Med, Novosibirsk 630090, Russia.
C3 Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB
   RAS; National Institutes of Health (NIH) - USA; NIH National Library of
   Medicine (NLM); Russian Academy of Sciences; Institute of Biological
   Problems of the North; Russian Academy of Sciences; Institute of
   Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS
RP Sinitsyna, OI (corresponding author), Russian Acad Sci, Siberian Div, Inst Cytol & Genet, Pr Lavrentyeva 10, Novosibirsk 630090, Russia.
EM olgasin1@yandex.ru
RI Nevinsky, Georgy/E-6053-2012; Malyarchuk, Boris/D-5783-2018; Sinitsyna,
   Olga/U-3682-2019
OI Malyarchuk, Boris/0000-0002-0304-0652; Rotskaya,
   Ulyana/0000-0002-4919-5262; Rogozin, Igor/0000-0003-0802-4851
FU Intramural NIH HHS Funding Source: Medline
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Bogenhagen DF, 1999, AM J HUM GENET, V64, P1276, DOI 10.1086/302392
   BROWN WM, 1980, P NATL ACAD SCI-BIOL, V77, P3605, DOI 10.1073/pnas.77.6.3605
   CARPET F, 1988, NUCLEIC ACIDS RES, V16, P10881
   Chomyn A, 2003, BIOCHEM BIOPH RES CO, V304, P519, DOI 10.1016/S0006-291X(03)00625-9
   CLAYTON DA, 1991, ANNU REV CELL BIOL, V7, P453, DOI 10.1146/annurev.cb.07.110191.002321
   Copeland WC, 2003, ACTA BIOCHIM POL, V50, P155
   Copeland WC, 2002, CANCER INVEST, V20, P557, DOI 10.1081/CNV-120002155
   Glazko GB, 1998, J THEOR BIOL, V192, P475, DOI 10.1006/jtbi.1998.0668
   Kang D, 2002, CURR GENET, V41, P311, DOI 10.1007/s00294-002-0312-0
   Khan SM, 2007, AM J PHYSIOL-CELL PH, V292, pC658, DOI 10.1152/ajpcell.00224.2006
   Khrapko K, 2007, NAT GENET, V39, P445, DOI 10.1038/ng0407-445
   Khrapko K, 2006, AGING CELL, V5, P279, DOI 10.1111/j.1474-9726.2006.00209.x
   Khrapko K, 2009, TRENDS GENET, V25, P91, DOI 10.1016/j.tig.2008.11.007
   Krishnan KJ, 2007, ANN NY ACAD SCI, V1100, P227, DOI 10.1196/annals.1395.024
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kujoth GC, 2007, PLOS GENET, V3, P161, DOI 10.1371/journal.pgen.0030024
   Larizza A, 2002, J MOL EVOL, V54, P145, DOI 10.1007/s00239-001-0063-4
   Lin MT, 2002, HUM MOL GENET, V11, P133, DOI 10.1093/hmg/11.2.133
   Longley MJ, 2001, J BIOL CHEM, V276, P38555, DOI 10.1074/jbc.M105230200
   Malyarchuk BA, 2004, ANN HUM GENET, V68, P324, DOI 10.1046/j.1529-8817.2004.00099.x
   Mandavilli BS, 2002, MUTAT RES-FUND MOL M, V509, P127, DOI 10.1016/S0027-5107(02)00220-8
   Marcelino LA, 1999, MUTAT RES-DNA REPAIR, V434, P177, DOI 10.1016/S0921-8777(99)00028-2
   Mason PA, 2003, NUCLEIC ACIDS RES, V31, P1052, DOI 10.1093/nar/gkg167
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465
   Rogozin Igor B., 2003, Briefings in Bioinformatics, V4, P210, DOI 10.1093/bib/4.3.210
   Rotskaya UN, 2009, BIOCHEMISTRY-MOSCOW+, V74, P430, DOI 10.1134/S0006297909040117
   SACCONE C, 1991, J MOL EVOL, V33, P83, DOI 10.1007/BF02100199
   Sbisà E, 1997, GENE, V205, P125, DOI 10.1016/S0378-1119(97)00404-6
   Song SW, 2005, P NATL ACAD SCI USA, V102, P4990, DOI 10.1073/pnas.0500253102
   Tamura K, 2000, GENE, V259, P189, DOI 10.1016/S0378-1119(00)00443-1
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Trifunovic A, 2006, BBA-BIOENERGETICS, V1757, P611, DOI 10.1016/j.bbabio.2006.03.003
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Wang D, 1998, MUTAT RES-FUND MOL M, V400, P99, DOI 10.1016/S0027-5107(98)00066-9
   Zhang DK, 2000, GENOMICS, V69, P151, DOI 10.1006/geno.2000.6333
NR 40
TC 5
Z9 6
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0027-5107
EI 1873-135X
J9 MUTAT RES-FUND MOL M
JI Mutat. Res.-Fundam. Mol. Mech. Mutagen.
PD MAR 1
PY 2010
VL 685
IS 1-2
SI SI
BP 97
EP 102
DI 10.1016/j.mrfmmm.2009.12.010
PG 6
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology
GA 569JA
UT WOS:000275591200013
PM 20036675
DA 2024-02-19
ER

PT J
AU Gaubatz, JW
   Tan, BH
AF Gaubatz, JW
   Tan, BH
TI Introduction, distribution, and removal of 7-methylguanine in different
   liver chromatin fi actions of young and old mice
SO MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
LA English
DT Article
DE DNA damage; DNA repair; 7-methylguanine; mammalian aging; DNA
   alkylation; N-methylpurine-DNA glycosylase; chromatin structure;
   carcinogenesis; N-methyl-N-nitrosourea
ID DIHYDROFOLATE-REDUCTASE GENE; METHYL-N-NITROSOUREA; RING-OPENED
   7-METHYLGUANINE; HAMSTER OVARY CELLS; ALKALI-LABILE SITES; DNA-DAMAGE;
   ELECTROCHEMICAL DETECTION; LIQUID-CHROMATOGRAPHY; TRANSCRIBED STRAND;
   ALKYLATING-AGENTS
AB The distribution and elimination of 7-methylguanine (m(7)Gua) from different liver DNA chromatin fractions has been studied after treating young and old mice with N-methyl-N-nitrosourea (MNU). Guanine methylation kinetics was first studied in total liver DNA following intraperitoneal injections of 25 mg/kg and 50 mg/kg MNU doses. MNU-induced DNA alkylation, as measured by m(7)Gua levels, was dose-dependent in liver tissues of young (9-11 month) and old mice (28-29 month). However, liver DNA in old mice incurred approximately 50% more damage than young mice for weight-normalized doses of MNU. The kinetics of adduct removal from total DMA was biphasic. A more rapid phase of m(7)Gua removal was observed during the first 24 h to 48 h following MNU administration; thereafter, the remaining m(7)Gua adducts were hydrolyzed much more slowly. Similar amounts of m(7)Gua were removed by 24 h at both the 25 mg/kg and 50 mg/kg MNU doses for a single age-group, but old liver tissue removed significantly more m(7)Gua than young liver tissue during this initial phase. Following a single injection of carcinogen (50 mg/kg), liver nuclei were isolated and chromatin was sheared by limited Micrococcal nuclease digestion. Chromatin was separated into nuclease-soluble, low-salt, high-salt and nuclear matrix fractions. All four fractions of young liver chromatin were methylated to the same degree. In contrast, then were differences in m(7)Gua levels between old liver chromatin fractions. DNA in the nuclease-sensitive fraction was most heavily alkylated, whereas nuclear matrix sequences were modified the least. Removal of m(7)Gua occurred at relatively uniform rates in all chromatin fractions regardless of age, indicating that m(7)Gua was not preferentially repaired in different nuclease-susceptible regions of chromatin. These results suggest that the N-methylpurine-DNA glycosylase responsible for eliminating m(7)Gua from the mammalian genome is not deficient in senescent liver tissue. However, there may be age-related changes in chromatin composition or structure that make some genomic sequences more accessible to alkylating agents in liver tissue of older animals.
RP Gaubatz, JW (corresponding author), UNIV S ALABAMA,COLL MED,DEPT BIOCHEM & MOL BIOL,MOBILE,AL 36688, USA.
FU NIA NIH HHS [AG-07860] Funding Source: Medline
CR Aucher M., 1982, NUTRITIONAL TOXICOLO, P328
   BARROWS LR, 1982, CARCINOGENESIS, V3, P349, DOI 10.1093/carcin/3.3.349
   BARTSCH H, 1984, CARCINOGENESIS, V5, P1381, DOI 10.1093/carcin/5.11.1381
   BLOOM KS, 1978, CELL, V15, P141, DOI 10.1016/0092-8674(78)90090-9
   BOFFA LC, 1992, MOL CARCINOGEN, V5, P174, DOI 10.1002/mc.2940050303
   BOHR VA, 1987, CANCER RES, V47, P6426
   BREZENEY R, 1977, J CELL BIOL, V73, P616
   DURANTE M, 1989, CARCINOGENESIS, V10, P1357, DOI 10.1093/carcin/10.8.1357
   FREI JV, 1978, BIOCHEM J, V174, P1031, DOI 10.1042/bj1741031
   GAUBATZ J, 1979, FED PROC, V38, P1973
   GAUBATZ JW, 1994, ANN NY ACAD SCI, V719, P97, DOI 10.1111/j.1749-6632.1994.tb56822.x
   GAUBATZ JW, 1989, ARCH GERONTOL GERIAT, V8, P47, DOI 10.1016/0167-4943(89)90069-1
   GAUBATZ JW, 1993, MUTAT RES, V295, P81, DOI 10.1016/0921-8734(93)90004-M
   GAUBATZ JW, 1986, J MOL CELL CARDIOL, V18, P1317, DOI 10.1016/S0022-2828(86)80435-7
   HALL J, 1990, MUTAT RES, V233, P247, DOI 10.1016/0027-5107(90)90167-3
   HARTLEY JA, 1992, NUCLEIC ACIDS RES, V20, P3175, DOI 10.1093/nar/20.12.3175
   HELLAND DE, 1987, J CELL SCI S, V6, P139
   HERRON DC, 1981, CANCER RES, V41, P3967
   KADLUBAR FF, 1984, CARCINOGENESIS, V5, P587, DOI 10.1093/carcin/5.5.587
   KUNSTYR I, 1975, J GERONTOL, V30, P157, DOI 10.1093/geronj/30.2.157
   LAWRENCE CW, 1990, NUCLEIC ACIDS RES, V18, P2153, DOI 10.1093/nar/18.8.2153
   LEDOUX SP, 1991, CANCER RES, V51, P775
   LEDOUX SP, 1990, J BIOL CHEM, V265, P14875
   LOEB LA, 1985, CELL, V40, P483, DOI 10.1016/0092-8674(85)90191-6
   Magee P. N., 1976, ACS MONOGR SER, V173, P491
   MALE R, 1987, EUR J BIOCHEM, V165, P13, DOI 10.1111/j.1432-1033.1987.tb11188.x
   Margison G, 1979, CHEM CARCINOGENS DNA, P111
   MASSIE HR, 1991, AGE, V14, P53, DOI 10.1007/BF02434838
   MAY A, 1993, J BIOL CHEM, V268, P1650
   MELLON I, 1987, CELL, V51, P241, DOI 10.1016/0092-8674(87)90151-6
   MUSTONEN R, 1992, CARCINOGENESIS, V13, P1951, DOI 10.1093/carcin/13.11.1951
   MUSTONEN R, 1991, CARCINOGENESIS, V12, P1423, DOI 10.1093/carcin/12.8.1423
   NELSON WG, 1986, ANNU REV BIOPHYS BIO, V15, P457, DOI 10.1146/annurev.bb.15.060186.002325
   O'Connor P, 1979, ENV CARCINOGENESIS O, P73
   OCONNOR TR, 1988, NUCLEIC ACIDS RES, V16, P5879, DOI 10.1093/nar/16.13.5879
   PARK JW, 1988, P NATL ACAD SCI USA, V85, P7467, DOI 10.1073/pnas.85.20.7467
   PARK JW, 1989, CARCINOGENESIS, V10, P827, DOI 10.1093/carcin/10.5.827
   PEGG AE, 1983, REV BIOCHEM TOXICOL, V5, P83
   ROY R, 1995, BIOCHEMISTRY-US, V33, P15131
   RYAN AJ, 1986, CARCINOGENESIS, V7, P1497, DOI 10.1093/carcin/7.9.1497
   SAFFHILL R, 1985, BIOCHIM BIOPHYS ACTA, V823, P111, DOI 10.1016/0304-419X(85)90009-5
   SCICCHITANO DA, 1989, P NATL ACAD SCI USA, V86, P3050, DOI 10.1073/pnas.86.9.3050
   SEEBERG E, 1995, TRENDS BIOCHEM SCI, V20, P391, DOI 10.1016/S0968-0004(00)89086-6
   SHIELDS PG, 1990, CANCER RES, V50, P6580
   SINGER B, 1982, ANNU REV BIOCHEM, V51, P655, DOI 10.1146/annurev.bi.51.070182.003255
   SMITH CA, 1990, ADV MUTAGENESIS RES, V1, P153
   STRAMENTINOLI G, 1977, J GERONTOL, V4, P392
   TAN BH, 1990, MUTAT RES, V237, P229, DOI 10.1016/0921-8734(90)90004-B
   WANG W, 1995, BIOCHEMISTRY-US, V34, P1798, DOI 10.1021/bi00005a037
   WASSERMANN K, 1990, J BIOL CHEM, V265, P13906
   Wynder E. L., 1967, Tobacco and tobacco smoke: studies in experimental carcinogenesis, P179
NR 51
TC 11
Z9 11
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0027-5107
J9 MUTAT RES-FUND MOL M
JI Mutat. Res.-Fundam. Mol. Mech. Mutagen.
PD APR 14
PY 1997
VL 375
IS 1
BP 25
EP 35
DI 10.1016/S0027-5107(96)00246-1
PG 11
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology
GA WU893
UT WOS:A1997WU89300004
PM 9129677
DA 2024-02-19
ER

PT J
AU Hagopian, K
   Ramsey, JJ
   Weindruch, R
AF Hagopian, K
   Ramsey, JJ
   Weindruch, R
TI Fructose metabolizing enzymes from mouse liver: influence of age and
   caloric restriction
SO BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
LA English
DT Article
DE aging; aldolase; calorie restriction; fructokinase;
   fructose-1-phosphate; triokinase
ID RAT-LIVER; GLUCOKINASE ACTIVITY; HORMONAL-REGULATION; REGULATORY
   PROTEIN; KINASE-ACTIVITY; ALDOLASE-B; PHOSPHOFRUCTOKINASE; 1-PHOSPHATE;
   DIETARY; RABBIT
AB The influence of caloric restriction (CR) on the activities of liver fructose metabolizing enzymes and metabolite levels were studied in young (3 months) and old (30 months) mice. Fructokinase activity was increased (P<0.05) in both young and old CR mice when compared to controls while triokinase activity was increased (P<0.05) only in old CR versus control mice. Aldolase was not altered by CR in either old or young mice. No age-related differences in activities were observed in controls although a trend towards an increase was observed for triokinase, while significant age-related increases were observed for fructokinase and triokinase, but not aldolase, in CR mice. Both young and old mice on CR showed significant decreases in fructose and fructose-1-phosphate, however, no age-related changes in metabolite levels were observed for either control or CR mice. A fructose-1-phosphate kinase activity was also measured and found to be unchanged in both young and old mice on CR, but the activity was significantly lower in the old mice compared with young. We show here that the enzymes involved in fructose metabolism are influenced by CR and that this could contribute to alterations in gluconeogenesis and glycolysis observed with CR. (C) 2004 Elsevier B.V. All rights reserved.
C1 Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, Davis, CA 95616 USA.
   Univ Wisconsin, Sch Med, Dept Med, Madison, WI 53706 USA.
   William S Middleton Mem Vet Adm Med Ctr, Ctr Geriatr Res Educ & Clin, Madison, WI 53705 USA.
C3 University of California System; University of California Davis;
   University of Wisconsin System; University of Wisconsin Madison;
   Geriatric Research Education & Clinical Center; US Department of
   Veterans Affairs; Veterans Health Administration (VHA); William S
   Middleton Memorial Veterans Hospital
RP Hagopian, K (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, 1 Shields Ave, Davis, CA 95616 USA.
EM khagopian@ucdavis.edu
FU NIA NIH HHS [R01 AG17902, P01 AG11915] Funding Source: Medline
CR ADELMAN RC, 1966, J BIOL CHEM, V241, P5467
   Agius L, 1998, ADV ENZYME REGUL, V38, P303, DOI 10.1016/S0065-2571(97)00001-0
   Beutler HO., 1988, METHODS ENZYMATIC AN, VVI, P321
   BISMUT H, 1993, EUR J BIOCHEM, V213, P721, DOI 10.1111/j.1432-1033.1993.tb17812.x
   COX TM, 1994, FASEB J, V8, P62, DOI 10.1096/fasebj.8.1.8299892
   DAVIES DR, 1990, EUR J BIOCHEM, V192, P283, DOI 10.1111/j.1432-1033.1990.tb19225.x
   EGGLESTON LV, 1984, METHOD ENZYMAT AN, V6, P328
   FUKUDA H, 1984, BIOCHIM BIOPHYS ACTA, V795, P79, DOI 10.1016/0005-2760(84)90106-1
   GOPHER A, 1990, P NATL ACAD SCI USA, V87, P5449, DOI 10.1073/pnas.87.14.5449
   Hagopian K, 2003, EXP GERONTOL, V38, P267, DOI 10.1016/S0531-5565(02)00202-4
   Hagopian K, 2003, EXP GERONTOL, V38, P253, DOI 10.1016/S0531-5565(02)00203-6
   HENRY RR, 1991, ANNU REV NUTR, V11, P21, DOI 10.1146/annurev.nu.11.070191.000321
   Hers H, 1957, METABOLISME FRUCTOSE
   HERS HG, 1953, BIOCHIM BIOPHYS ACTA, V11, P427, DOI 10.1016/0006-3002(53)90062-6
   KARADSHEH NS, 1973, BIOCHIM BIOPHYS ACTA, V327, P66, DOI 10.1016/0005-2744(73)90104-6
   Kevork HA, 2004, EXP GERONTOL, V39, P1145, DOI 10.1016/j.exger.2004.04.009
   KONO N, 1974, J BIOL CHEM, V249, P1490
   KORIEH A, 1991, ARCH INT PHYSIOL BIO, V99, P455
   MAYES PA, 1993, AM J CLIN NUTR, V58, P754
   McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63
   MUNNICH A, 1985, J CLIN INVEST, V75, P1045, DOI 10.1172/JCI111766
   Pugh TD, 1999, NEUROBIOL AGING, V20, P157, DOI 10.1016/S0197-4580(99)00043-3
   SHAFRIR E, 1984, COMP BIOCHEM PHYS B, V78, P493, DOI 10.1016/0305-0491(84)90064-6
   SILLERO MAG, 1969, EUR J BIOCHEM, V10, P345, DOI 10.1111/j.1432-1033.1969.tb00696.x
   SLEIN MW, 1950, J BIOL CHEM, V186, P763
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   UYEDA K, 1972, J BIOL CHEM, V247, P1692
   Uyeda K, 1979, Adv Enzymol Relat Areas Mol Biol, V48, P193
   Van den Berghe G, 1986, Prog Biochem Pharmacol, V21, P1
   VANDENBERGHE G, 1994, ANNU REV NUTR, V14, P41, DOI 10.1146/annurev.nu.14.070194.000353
   VanSchaftingen E, 1997, BIOCHEM SOC T, V25, P136, DOI 10.1042/bst0250136
   VANSCHAFTINGEN E, 1989, EUR J BIOCHEM, V179, P179
   VANSCHAFTINGEN E, 1994, FASEB J, V8, P414, DOI 10.1096/fasebj.8.6.8168691
   VENEZIALE CM, 1972, EUR J BIOCHEM, V31, P59, DOI 10.1111/j.1432-1033.1972.tb02500.x
   WALKER D. G., 1965, ADVANCE ENZYME REGULAT, V3, P163, DOI 10.1016/0065-2571(65)90051-8
   Weindruch R., 1988, RETARDATION AGING DI
NR 36
TC 11
Z9 11
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-4165
EI 1872-8006
J9 BBA-GEN SUBJECTS
JI Biochim. Biophys. Acta-Gen. Subj.
PD JAN 18
PY 2005
VL 1721
IS 1-3
BP 37
EP 43
DI 10.1016/j.bbagen.2004.10.001
PG 7
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA 889DA
UT WOS:000226422500005
PM 15652177
DA 2024-02-19
ER

PT J
AU Majaw, T
   Sharma, R
AF Majaw, Teikur
   Sharma, Ramesh
TI Arginase I expression is upregulated by dietary restriction in the liver
   of mice as a function of age
SO MOLECULAR AND CELLULAR BIOCHEMISTRY
LA English
DT Article
DE Arginase I; Dietary restriction; Liver; Mice; Aging
ID CALORIC RESTRICTION; LIFE-SPAN; GENE; TERM
AB Arginase is a cytosolic enzyme that catalyzes the hydrolysis of l-arginine to l-ornithine and urea. This reaction comprises the final step of the urea cycle, which provides the principal route for the disposal of nitrogenous waste from protein catabolism. The present study investigates the normal endogenous activity and expression level of arginase I as a function of age in the liver of 2-, 6-, and 18-month-old mice. The effect of dietary restriction (DR) on the expression of arginase I was also investigated in two age groups of mice, 2- and 18-month old. Arginase I activity was assessed spectrophotometrically, and the level of arginase I protein was further confirmed by Western blotting analyses. Arginase I mRNA level was measured using real-time PCR. Our results show that the arginase I activity (U/mg protein) and protein level in liver was higher in 2-month-old mice and decreased gradually with age. In contrast, arginase I mRNA was observed to be higher in the older mice as compared to the younger mice. DR was seen to upregulate the arginase I activity and expression in both 2- and 18-month-old mice. The findings concluded that arginase I is down-regulated with the advancement of age in the liver of mice and is upregulated by DR. This suggests that DR plays an important role in maintaining related metabolic processes as a function of age in mice.
C1 [Majaw, Teikur; Sharma, Ramesh] North Eastern Hill Univ, Dept Biochem, Shillong 793022, Meghalaya, India.
C3 North Eastern Hill University
RP Sharma, R (corresponding author), North Eastern Hill Univ, Dept Biochem, Shillong 793022, Meghalaya, India.
EM sharamesh@gmail.com
FU Council of Scientific and Industrial Research (CSIR), New Delhi
   [09/347(0194)/2010-EMR-I]
FX The authors are thankful to the Department of Biochemistry,
   North-Eastern Hill University, Shillong for providing research
   facilities under UGC-UPE, DRS, and DST-FIST, New Delhi. TM thanks
   Council of Scientific and Industrial Research (CSIR), New Delhi for the
   Fellowship as JRF and SRF (F.No: 09/347(0194)/2010-EMR-I).
CR Akiba T, 2002, J BIOCHEM, V132, P621, DOI 10.1093/oxfordjournals.jbchem.a003265
   Anderson RM, 2010, TRENDS ENDOCRIN MET, V21, P134, DOI 10.1016/j.tem.2009.11.005
   Ash DE, 2000, MET IONS BIOL SYST, V37, P407
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Cao SX, 2001, P NATL ACAD SCI USA, V98, P10630, DOI 10.1073/pnas.191313598
   Dani D, 2010, BIOGERONTOLOGY, V11, P321, DOI 10.1007/s10522-009-9254-y
   Fafournoux P, 2000, BIOCHEM J, V351, P1, DOI 10.1042/0264-6021:3510001
   Gotoh T, 1997, J BIOL CHEM, V272, P3694, DOI 10.1074/jbc.272.6.3694
   Ito Y, 2004, AM J PHYSIOL-GASTR L, V286, pG60, DOI 10.1152/ajpgi.00217.2003
   Iyer RK, 2002, MOL CELL BIOL, V22, P4491, DOI 10.1128/MCB.22.13.4491-4498.2002
   Jourdan M, 2008, AM J PHYSIOL-REG I, V294, pR748, DOI 10.1152/ajpregu.00291.2007
   KANUNGO MS, 1970, EXP GERONTOL, V5, P261, DOI 10.1016/0531-5565(70)90047-1
   Kharbhih WJ, 2014, BIOGERONTOLOGY, V15, P81, DOI 10.1007/s10522-013-9481-0
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Mair W, 2008, ANNU REV BIOCHEM, V77, P727, DOI 10.1146/annurev.biochem.77.061206.171059
   MARTEN NW, 1994, FASEB J, V8, P538, DOI 10.1096/fasebj.8.8.8181673
   McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63
   MERRY BJ, 1987, MECH AGEING DEV, V39, P189, DOI 10.1016/0047-6374(87)90008-X
   Morgan T. E., 2007, V35, P83
   MORRIS SM, 1992, ANNU REV NUTR, V12, P81, DOI 10.1146/annurev.nu.12.070192.000501
   Munder M, 2009, BRIT J PHARMACOL, V158, P638, DOI 10.1111/j.1476-5381.2009.00291.x
   Nowicki MJ, 2003, PEDIATR RES, V54, P732, DOI 10.1203/01.PDR.0000086904.52847.2A
   Nowotny K, 2014, EXP GERONTOL, V57, P122, DOI 10.1016/j.exger.2014.05.016
   OHTAKE A, 1988, J BIOL CHEM, V263, P2245
   PATNAIK SK, 1989, BIOCHEM INT, V18, P709
   Redman LM, 2009, MOL CELL ENDOCRINOL, V299, P129, DOI 10.1016/j.mce.2008.10.014
   Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731
   SATOH PS, 1968, ANAL BIOCHEM, V23, P219, DOI 10.1016/0003-2697(68)90353-9
   Sharma R, 2004, CURR SCI INDIA, V87, P1203
   Shi O, 1998, MAMM GENOME, V9, P822, DOI 10.1007/s003359900874
   Speakman JR, 2007, J NUTR, V137, P1078, DOI 10.1093/jn/137.4.1078
   Suchiang K, 2011, BIOGERONTOLOGY, V12, P581, DOI 10.1007/s10522-011-9356-1
   Swindell WR, 2008, MECH AGEING DEV, V129, P138, DOI 10.1016/j.mad.2007.11.003
   Tavernarakis N, 2002, MECH AGEING DEV, V123, P215, DOI 10.1016/S0047-6374(01)00341-4
   Wu GY, 1998, BIOCHEM J, V336, P1, DOI 10.1042/bj3360001
NR 36
TC 5
Z9 5
U1 0
U2 4
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0300-8177
EI 1573-4919
J9 MOL CELL BIOCHEM
JI Mol. Cell. Biochem.
PD SEP
PY 2015
VL 407
IS 1-2
BP 1
EP 7
DI 10.1007/s11010-015-2448-5
PG 7
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA CP3KX
UT WOS:000359778900001
PM 25976668
DA 2024-02-19
ER

PT J
AU Babenko, NA
   Kharchenko, VS
AF Babenko, N. A.
   Kharchenko, V. S.
TI Ceramides Inhibit Phospholipase D-Dependent Insulin Signaling in Liver
   Cells of Old Rats
SO BIOCHEMISTRY-MOSCOW
LA English
DT Article
DE ceramide; myriocin; phospholipase D; hepatocytes; insulin resistance;
   aging
ID ADP-RIBOSYLATION FACTOR; GLUCOSE-TRANSPORT; PHOSPHATIDYLCHOLINE;
   DIACYLGLYCEROL; ACTIVATION; BRAIN; NOVO; HYDROLYSIS; MODULATION;
   RESISTANCE
AB Ceramides are a novel class of biologically active molecules involved in the regulation of different signaling pathways. Ceramide is involved in regulation of the phospholipase D (PLD) activity and development of cell resistance to insulin. In this work, we have studied age-related features of insulin regulation of PLD activity and glucose metabolism in intact cells and modeled their resistance to insulin by exogenous ceramide and palmitic acid. Contents of ceramides and of free fatty acids (FFA) are found to increase with age, as well as on incubation of liver cells of young rats in the presence of the ceramide precursor palmitic acid. Under these conditions, the ability of insulin to activate PLD, the cell uptake of glucose, and glycogen synthesis sharply decreased. On incubation of hepatocytes of young animals in the presence of exogenous C2-ceramide, the contents of endogenous ceramides increased but not the contents of FFAs and of neutral lipids. These events were accompanied by suppression of the insulin-induced production of phosphatidylethanol (a result of ethanol transphosphatidylation by PLD), glucose uptake, and glycogen synthesis. Incubation of insulin-resistant liver cells of young rats and also of hepatocytes of old rats in the presence of myriocin (an inhibitor of the de novo synthesis of ceramide) was associated with a decrease in ceramide content in the cells and an increase in the cell sensitivity to insulin. The findings indicate an important role of ceramide in disturbance of insulin signaling due to inhibition of the PLD-dependent link in the liver cells of old animals.
C1 [Babenko, N. A.; Kharchenko, V. S.] Kharkov Natl Univ, Dept Physiol Ontogenesis, Biol Res Inst, UA-61077 Kharkov, Ukraine.
C3 Ministry of Education & Science of Ukraine; VN Karazin Kharkiv National
   University
RP Babenko, NA (corresponding author), Kharkov Natl Univ, Dept Physiol Ontogenesis, Biol Res Inst, Svoboda Sq 4, UA-61077 Kharkov, Ukraine.
EM babenko@univer.kharkov.ua
FU research program "Approaches to overcome cell resistance to
   physiological stimuli in animals of different age" [0106U001577]
FX This work was supported by the research program "Approaches to overcome
   cell resistance to physiological stimuli in animals of different age"
   (State Registration No. 0106U001577).
CR Abousalham A, 1997, J BIOL CHEM, V272, P1069, DOI 10.1074/jbc.272.2.1069
   Babenko NA, 2006, EXP GERONTOL, V41, P32, DOI 10.1016/j.exger.2005.08.008
   Babenko NA, 2010, EXP GERONTOL, V45, P375, DOI 10.1016/j.exger.2010.02.010
   BILLAH MM, 1990, BIOCHEM J, V269, P281, DOI 10.1042/bj2690281
   Blair AS, 1999, J BIOL CHEM, V274, P36293, DOI 10.1074/jbc.274.51.36293
   BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
   Chavez JA, 2005, J BIOL CHEM, V280, P20148, DOI 10.1074/jbc.M412769200
   Chavez JA, 2003, J BIOL CHEM, V278, P10297, DOI 10.1074/jbc.M212307200
   Cutler RG, 2001, MECH AGEING DEV, V122, P895, DOI 10.1016/S0047-6374(01)00246-9
   DONCHENKO V, 1994, BBA-MOL CELL RES, V1222, P492, DOI 10.1016/0167-4889(94)90059-0
   Exton JH, 2002, FEBS LETT, V531, P58, DOI 10.1016/S0014-5793(02)03405-1
   Farese RV, 2002, AM J PHYSIOL-ENDOC M, V283, pE1, DOI 10.1152/ajpendo.00045.2002
   Farese RV, 2001, EXP BIOL MED, V226, P283, DOI 10.1177/153537020122600404
   Gidwani A, 2003, J CELL SCI, V116, P3177, DOI 10.1242/jcs.00621
   GOMEZMUNOZ A, 1994, J BIOL CHEM, V269, P8937
   Grether-Beck S, 2005, J INVEST DERMATOL, V125, P545, DOI 10.1111/j.0022-202X.2005.23782.x
   Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200
   HOFFMAN JM, 1991, BIOCHEMISTRY-US, V30, P3315, DOI 10.1021/bi00227a021
   Holland WL, 2008, ENDOCR REV, V29, P381, DOI 10.1210/er.2007-0025
   Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002
   Huang P, 2005, MOL BIOL CELL, V16, P2614, DOI 10.1091/mbc.e04-12-1124
   Karnam P, 1997, J BIOL CHEM, V272, P6136, DOI 10.1074/jbc.272.10.6136
   Kates M., 1975, TECHNIQUES LIPIDOLOG
   Kavok NS, 2003, EXP GERONTOL, V38, P441, DOI 10.1016/S0531-5565(02)00246-2
   Kellett GL, 2005, DIABETES, V54, P3056, DOI 10.2337/diabetes.54.10.3056
   Kooijman EE, 2003, TRAFFIC, V4, P162, DOI 10.1034/j.1600-0854.2003.00086.x
   Kotronen A, 2010, OBESITY, V18, P937, DOI 10.1038/oby.2009.326
   LAUTER CJ, 1962, J LIPID RES, V3, P136
   Lingtile S. A., 2000, MECH AGEING DEV, V120, P111
   Lyn-Cook LE, 2009, J ALZHEIMERS DIS, V16, P715, DOI 10.3233/JAD-2009-0984
   MARSH JB, 1966, J LIPID RES, V7, P574
   Mebarek S, 2007, J CELL SCI, V120, P407, DOI 10.1242/jcs.03331
   Mizutani T, 1998, MECH AGEING DEV, V105, P151, DOI 10.1016/S0047-6374(98)00094-3
   MOEHREN G, 1994, J BIOL CHEM, V269, P838
   Ogretmen B, 2002, J BIOL CHEM, V277, P12960, DOI 10.1074/jbc.M110699200
   Petrenko A Iu, 1991, Biokhimiia, V56, P1647
   Singh IN, 2001, BIOCHEMISTRY-US, V40, P11227, DOI 10.1021/bi010787l
   Slaaby R, 2000, BIOCHEM J, V351, P613, DOI 10.1042/0264-6021:3510613
   TURINSKY J, 1990, J BIOL CHEM, V265, P16880
   VENABLE ME, 1994, J BIOL CHEM, V269, P26040
   Venable ME, 1995, J BIOL CHEM, V270, P30701, DOI 10.1074/jbc.270.51.30701
   Webb LM, 2010, MOL CELL BIOCHEM, V337, P153, DOI 10.1007/s11010-009-0294-z
   Yang G, 2009, AM J PHYSIOL-ENDOC M, V297, pE211, DOI 10.1152/ajpendo.91014.2008
   Zaid H, 2008, BIOCHEM J, V413, P201, DOI 10.1042/BJ20080723
NR 44
TC 15
Z9 17
U1 0
U2 2
PU MAIK NAUKA/INTERPERIODICA/SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013-1578 USA
SN 0006-2979
EI 1608-3040
J9 BIOCHEMISTRY-MOSCOW+
JI Biochem.-Moscow
PD FEB
PY 2012
VL 77
IS 2
BP 180
EP 186
DI 10.1134/S0006297912020095
PG 7
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 900IE
UT WOS:000300879500009
PM 22348478
DA 2024-02-19
ER

PT J
AU Ramsey, JJ
   Hagopian, K
   Kenny, TM
   Koomson, EK
   Bevilacqua, L
   Weindruch, R
   Harper, ME
AF Ramsey, JJ
   Hagopian, K
   Kenny, TM
   Koomson, EK
   Bevilacqua, L
   Weindruch, R
   Harper, ME
TI Proton leak and hydrogen peroxide production in liver mitochondria from
   energy-restricted rats
SO AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
LA English
DT Article
DE calorie restriction; energy expenditure; mitochondrial lipids; aging;
   oxidative stress
ID TERM CALORIC RESTRICTION; FATTY-ACID COMPOSITION; ATP TURNOVER
   REACTIONS; OXIDATIVE DNA-DAMAGE; FOOD RESTRICTION; DIETARY RESTRICTION;
   METABOLIC-RATE; ANTIOXIDANT ENZYMES; OXYGEN-CONSUMPTION; RADICAL
   PRODUCTION
AB Energy restriction ( ER), without malnutrition, is the only environmental intervention that consistently increases maximum life span in laboratory rodents. One theory proposes that a reduction in energy expenditure and reactive oxygen species production is the mechanism responsible for this action of ER. To further test this theory, proton leak, H2O2 production, lipid peroxidation, and protein carbonyls were measured in mitochondria from FBNF1 rats fed either a control or 40% ER diet ( onset at 6 mo of age). Liver mitochondria were isolated at 7 and 12 mo of age. Liver weight decreased 25 and 36% at 1 and 6 mo of ER, respectively ( P < 0.05). ER resulted in an increase ( P < 0.05) in percent total polyunsaturates, n-6 polyunsaturates, and total unsaturates ( 6 mo only) in mitochondrial lipids. These changes, however, were not associated with significant alterations in mitochondrial function. State 4 respiration and membrane potential were not different ( P > 0.05) between groups at either assessment period. Similarly, proton leak kinetics were not different between control and ER animals. Top-down metabolic control analysis and its extension, elasticity analysis, were used at the 6-mo assessment and revealed no difference in control of the oxidative phosphorylation system between control and ER rats. H2O2 production with either succinate or pyruvate/ malate substrates was also not different ( P > 0.05) between groups at either time point. In conclusion, ER did not alter proton leak or H2O2 production at this age or stage of restriction in liver.
C1 Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, Davis, CA 95616 USA.
   Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada.
   Univ Wisconsin, Dept Med, Madison, WI 53606 USA.
C3 University of California System; University of California Davis;
   University of Ottawa; University of Wisconsin System; University of
   Wisconsin Madison
RP Ramsey, JJ (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, Davis, CA 95616 USA.
RI Harper, Mary-Ellen/C-3103-2009
OI Harper, Mary-Ellen/0000-0003-3864-5886
FU NIA NIH HHS [R01 AG 17902] Funding Source: Medline; NIDDK NIH HHS [DK
   35747] Funding Source: Medline
CR Anantharaju A, 2002, GERONTOLOGY, V48, P343, DOI 10.1159/000065506
   BEVILACQUA L, IN PRESS EFFECT SHOR
   BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707
   Brand MD, 1996, J THEOR BIOL, V182, P351, DOI 10.1006/jtbi.1996.0174
   BRAND MD, 1994, COMP BIOCHEM PHYS B, V108, P181, DOI 10.1016/0305-0491(94)90064-7
   BRAND MD, 1995, BIOENERGETICS PRACTI
   Brookes PS, 1998, COMP BIOCHEM PHYS B, V119, P325, DOI 10.1016/S0305-0491(97)00357-X
   Buege J A, 1978, Methods Enzymol, V52, P302
   BURRIN DG, 1989, BRIT J NUTR, V62, P23, DOI 10.1079/BJN19890005
   BURRIN DG, 1992, J ANIM SCI, V70, P1137, DOI 10.2527/1992.7041137x
   BURRIN DG, 1988, J NUTR, V118, P1547, DOI 10.1093/jn/118.12.1547
   Chappell J. B., 1972, SUBCELLULAR COMPONEN
   FREETLY HC, 1995, J ANIM SCI, V73, P843
   Gomi F, 1998, J GERONTOL A-BIOL, V53, pB161, DOI 10.1093/gerona/53A.3.B161
   Gredilla R, 2001, J BIOENERG BIOMEMBR, V33, P279, DOI 10.1023/A:1010603206190
   Greenberg JA, 2000, MECH AGEING DEV, V113, P37, DOI 10.1016/S0047-6374(99)00094-9
   Guerrero A, 1999, FREE RADICAL BIO MED, V26, P73, DOI 10.1016/S0891-5849(98)00173-7
   HAFNER RP, 1988, EUR J BIOCHEM, V178, P511, DOI 10.1111/j.1432-1033.1988.tb14477.x
   HAFNER RP, 1990, EUR J BIOCHEM, V188, P313, DOI 10.1111/j.1432-1033.1990.tb15405.x
   Hardy RW, 2002, J NUTR, V132, P3172, DOI 10.1093/jn/131.10.3172
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Harper ME, 1998, AM J PHYSIOL-ENDOC M, V275, pE197, DOI 10.1152/ajpendo.1998.275.2.E197
   HARPER ME, 1993, J BIOL CHEM, V268, P14850
   HARPER ME, 1995, P SOC EXP BIOL MED, V208, P228
   HERLIHY JT, 1990, MECH AGEING DEV, V53, P9, DOI 10.1016/0047-6374(90)90030-J
   HYSLOP PA, 1984, ANAL BIOCHEM, V141, P280, DOI 10.1016/0003-2697(84)90457-3
   Jansen PLM, 2002, BEST PRACT RES CL GA, V16, P149, DOI 10.1053/bega.2002.0271
   Johnson D., 1967, Methods Enzymol, V10, P94, DOI DOI 10.1016/0076-6879(67)10018-9
   Kaneko T, 1997, FREE RADICAL BIO MED, V23, P76, DOI 10.1016/S0891-5849(96)00622-3
   KOONG LJ, 1985, J NUTR, V115, P1383, DOI 10.1093/jn/115.10.1383
   LAGANIERE S, 1993, GERONTOLOGY, V39, P7, DOI 10.1159/000213509
   LAGANIERE S, 1989, MECH AGEING DEV, V48, P207, DOI 10.1016/0047-6374(89)90083-3
   Lal SB, 2001, J GERONTOL A-BIOL, V56, pB116, DOI 10.1093/gerona/56.3.B116
   LEVINE RL, 1990, METHOD ENZYMOL, V186, P464
   López-Torres M, 2002, FREE RADICAL BIO MED, V32, P882, DOI 10.1016/S0891-5849(02)00773-6
   MALEY GF, 1955, J BIOL CHEM, V215, P377
   MASORO EJ, 1995, OBES RES, V3, pS241, DOI 10.1002/j.1550-8528.1995.tb00470.x
   Nedergaard J, 2003, EXP PHYSIOL, V88, P65, DOI 10.1113/eph8802502
   ORTIGUES I, 1995, BRIT J NUTR, V73, P209, DOI 10.1079/BJN19950024
   Pearl R., 1928, RATE LIVING
   Perez-Campo R, 1998, J COMP PHYSIOL B, V168, P149, DOI 10.1007/s003600050131
   PORTER RK, 1993, NATURE, V362, P628, DOI 10.1038/362628a0
   Porter RK, 1996, AM J PHYSIOL-REG I, V271, pR1550, DOI 10.1152/ajpregu.1996.271.6.R1550
   Ramsey JJ, 2000, FREE RADICAL BIO MED, V29, P946, DOI 10.1016/S0891-5849(00)00417-2
   Rolfe DFS, 1997, BIOSCIENCE REP, V17, P9, DOI 10.1023/A:1027327015957
   ROLFE DFS, 1994, BIOCHIM BIOPHYS ACTA, V1118, P405
   Sarkela TM, 2001, J BIOL CHEM, V276, P6945, DOI 10.1074/jbc.M007625200
   Selman C, 2003, EXP GERONTOL, V38, P897, DOI 10.1016/S0531-5565(03)00091-3
   SOHAL RS, 1990, MECH AGEING DEV, V53, P209, DOI 10.1016/0047-6374(90)90039-I
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   Tian LQ, 1998, FREE RADICAL BIO MED, V24, P1477, DOI 10.1016/S0891-5849(98)00025-2
   Venditti P, 2003, ARCH BIOCHEM BIOPHYS, V411, P121, DOI 10.1016/S0003-9861(02)00720-8
   Watkins SM, 2001, LIPIDS, V36, P247, DOI 10.1007/s11745-001-0714-8
   Weindruch R, 1997, NEW ENGL J MED, V337, P986, DOI 10.1056/NEJM199710023371407
   WEINDRUCH RH, 1980, MECH AGEING DEV, V12, P375, DOI 10.1016/0047-6374(80)90070-6
   Wu AG, 2003, J APPL PHYSIOL, V94, P947, DOI 10.1152/japplphysiol.00779.2002
NR 56
TC 58
Z9 64
U1 0
U2 6
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0193-1849
J9 AM J PHYSIOL-ENDOC M
JI Am. J. Physiol.-Endocrinol. Metab.
PD JAN 1
PY 2004
VL 286
IS 1
BP E31
EP E40
DI 10.1152/ajpendo.00283.2003
PG 10
WC Endocrinology & Metabolism; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Physiology
GA 751ND
UT WOS:000187072700006
PM 14662512
DA 2024-02-19
ER

PT J
AU Reliene, R
   Goad, MEP
   Schiestl, RH
AF Reliene, Ramune
   Goad, Marry E. P.
   Schiestl, Robert H.
TI Developmental cell death in the liver and newborn lethality of Ku86
   deficient mice suppressed by antioxidant <i>N</i>-acetyl-cysteine
SO DNA REPAIR
LA English
DT Article
DE Ku86; mouse; fetal liver; apoptosis; necrosis; N-acetyl-cysteine
   oxidative stress
ID DOUBLE-STRAND BREAKS; DNA-DAMAGE; V(D)J RECOMBINATION; REPAIR;
   APOPTOSIS; PROTEIN; CANCER; REARRANGEMENT; CONNECTION; MECHANISMS
AB Repair of DNA double-strand breaks (DSBs) is essential for genome integrity and cell survival. Ku86 is involved in the repair of DNA DSBs by non-homologous end joining (NHEJ). Mice deficient in Ku86 show growth retardation, dwarfism, premature aging, and immunodeficiency. In this study, we observed severely compromised survival of Ku86(-/-) mice, such that most Ku86(-/-) mice died within the first postnatal weeks and only 1.5% of the expected 25% from heterozygous crosses survived for 1 month. Since post-mortem analysis was not possible due to parental cannibalism, histopathological examination was performed on Ku86(-/-) fetuses to assess possible causes of newborn death. Eighty percent and 75% of Ku86(-/-) fetuses exhibited apoptosis and necrosis in the liver, while only 20% and 10% of Ku86(-/-) littermates had apoptosis and necrosis, respectively. In addition, the severity of liver damage was significantly higher in Ku86(-/-) fetuses. Developmental liver damage may have led to postnatal lethality because the fetal liver with pre-existing injury may not be able to undergo transformation from a lymphohematopoietic to an indispensable metabolic organ. Free radicals can cause chromosomal breaks and lead to cell death. We postulated that endogenous oxidative stress might be involved in the resulting liver damage and animal lethality in Ku86(-/-) mice deficient in DNA DSB repair. This hypothesis was tested by treating KU86(-/-) mice with the well known free radical scavenger, thiol antioxidant N-acetyl-cysteine (NAC), during embryonic development. We found that a significantly higher percentage, 7.7% of NAC treated Ku86(-/-) offspring versus 1.5% untreated Ku86(-/-) mice were alive at 1 month of age. in addition, the incidence of liver necrosis decreased by 21% and the severity of necrosis significantly reduced. Thus, Ku86 deficiency results in severe developmental liver damage and newborn lethality associated with oxidative stress. (c) 2006 Elsevier B.V. All rights reserved.
C1 Univ Calif Los Angeles, Geffen Sch Med, Dept Pathol, Los Angeles, CA 90024 USA.
   Univ Calif Los Angeles, Sch Publ Hlth, Dept Environm Hlth, Los Angeles, CA 90024 USA.
   Univ Calif Los Angeles, Geffen Sch Med, Dept Radiat Oncol, Los Angeles, CA 90024 USA.
   Peptimmune Inc, Cambridge, MA 02139 USA.
C3 University of California System; University of California Los Angeles;
   University of California Los Angeles Medical Center; David Geffen School
   of Medicine at UCLA; University of California System; University of
   California Los Angeles; University of California System; University of
   California Los Angeles; University of California Los Angeles Medical
   Center; David Geffen School of Medicine at UCLA
RP Schiestl, RH (corresponding author), Univ Calif Los Angeles, Geffen Sch Med, Dept Pathol, 650 Charles E Young Dr S, Los Angeles, CA 90024 USA.
EM rschiestl@mednet.ucla.edu
RI Reliene, Ramune/AAK-3492-2021
FU NIEHS NIH HHS [R01 ES09519] Funding Source: Medline
CR ALT F, 1981, CELL, V27, P381, DOI 10.1016/0092-8674(81)90421-9
   Collis SJ, 2005, ONCOGENE, V24, P949, DOI 10.1038/sj.onc.1208332
   De Flora S, 2001, CARCINOGENESIS, V22, P999, DOI 10.1093/carcin/22.7.999
   Dzierzak E, 1998, IMMUNOL TODAY, V19, P228, DOI 10.1016/S0167-5699(98)01258-4
   Featherstone C, 1999, MUTAT RES-DNA REPAIR, V434, P3, DOI 10.1016/S0921-8777(99)00006-3
   FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES
   Gu YS, 2000, P NATL ACAD SCI USA, V97, P2668, DOI 10.1073/pnas.97.6.2668
   Guimaraes CA, 2004, EUR J BIOCHEM, V271, P1638, DOI 10.1111/j.1432-1033.2004.04084.x
   GULLO C, 2006, BIOCH BIOPHYS ACTA
   Hefferin ML, 2005, DNA REPAIR, V4, P639, DOI 10.1016/j.dnarep.2004.12.005
   Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232
   HOUSSAINT E, 1981, CELL DIFFER DEV, V10, P243, DOI 10.1016/0045-6039(81)90007-5
   Izzotti A, 2003, FASEB J, V17, P1127, DOI 10.1096/fj.02-0967fje
   KANAMURA S, 1990, J ELECTRON MICR TECH, V14, P92, DOI 10.1002/jemt.1060140204
   Karanjawala ZE, 2003, DNA REPAIR, V2, P1429, DOI 10.1016/j.dnarep.2003.08.011
   Karanjawala ZE, 2002, CURR BIOL, V12, P397, DOI 10.1016/S0960-9822(02)00684-X
   Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798
   Kuby J., 1997, IMMUNOLOGY
   Lees-Miller SP, 2003, BIOCHIMIE, V85, P1161, DOI 10.1016/j.biochi.2003.10.011
   Leist M, 1997, BIOCHEM BIOPH RES CO, V236, P1, DOI 10.1006/bbrc.1997.6890
   MAKI R, 1980, SCIENCE, V209, P1366, DOI 10.1126/science.6774416
   Miyajima A, 2000, CYTOKINE GROWTH F R, V11, P177, DOI 10.1016/S1359-6101(00)00003-4
   Narasimhaiah R, 2005, CEREB CORTEX, V15, P696, DOI 10.1093/cercor/bhh171
   Nussenzweig A, 1996, NATURE, V382, P551, DOI 10.1038/382551a0
   Nussenzweig A, 1997, P NATL ACAD SCI USA, V94, P13588, DOI 10.1073/pnas.94.25.13588
   Reliene R, 2006, CARCINOGENESIS, V27, P240, DOI 10.1093/carcin/bgi222
   Reliene R, 2004, CANCER RES, V64, P5148, DOI 10.1158/0008-5472.CAN-04-0442
   Reliene R, 2004, DNA REPAIR, V3, P103, DOI 10.1016/j.dnarep.2003.09.010
   SCHLISSEL MS, 1994, J IMMUNOL, V153, P1645
   STRASSER A, 1989, J EXP MED, V170, P1973, DOI 10.1084/jem.170.6.1973
   Tuteja R, 2000, CRIT REV BIOCHEM MOL, V35, P1, DOI 10.1080/10409230091169177
   van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049
   Vogel H, 1999, P NATL ACAD SCI USA, V96, P10770, DOI 10.1073/pnas.96.19.10770
NR 33
TC 13
Z9 14
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1568-7864
J9 DNA REPAIR
JI DNA Repair
PD NOV 8
PY 2006
VL 5
IS 11
BP 1392
EP 1397
DI 10.1016/j.dnarep.2006.06.007
PG 6
WC Genetics & Heredity; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity; Toxicology
GA 105TR
UT WOS:000242055700010
PM 16916625
DA 2024-02-19
ER

PT J
AU Toda, T
   Saito, N
   Ikarashi, N
   Ito, K
   Yamamoto, M
   Ishige, A
   Watanabe, K
   Sugiyama, K
AF Toda, T.
   Saito, N.
   Ikarashi, N.
   Ito, K.
   Yamamoto, M.
   Ishige, A.
   Watanabe, K.
   Sugiyama, K.
TI Intestinal flora induces the expression of Cyp3a in the mouse liver
SO XENOBIOTICA
LA English
DT Article
DE Intestinal flora; germ-free; Cyp3a; nuclear transcription factors;
   pregnane - receptor (PXR); lithocholic acid
ID PREGNANE-X-RECEPTOR; CONSTITUTIVE ANDROSTANE RECEPTOR; CYTOCHROME-P450
   GENES; NUCLEAR RECEPTORS; INDUCTION; MICROFLORA; METABOLISM; INHIBITORS;
   COMPOUND; PXR
AB In order to determine the effects of intestinal flora on the expression of cytochrome P450 (CYP), the mRNA expression of CYP was compared between specific pathogen-free (SPF) and germ-free (GF) mice. Most of the major CYP isozymes showed higher expression in the livers of SPF mice compared with GF mice. Nuclear factors such as pregnane - receptor (PXR) and constitutive androstane receptor (CAR), as well as transporters and conjugation enzymes involved in the detoxification of lithocholic acid (LCA), also showed higher expression in SPF mice. The findings suggest that in the livers of SPF mice, LCA produced by intestinal flora increases the expression of CYPs via activation of PXR and CAR. Drugs such as antibiotics, some diseases and ageing, etc. are known to alter intestinal flora. The present findings suggest that such changes also affect CYP and are one of the factors responsible for individual differences in pharmacokinetics.
C1 [Sugiyama, K.] Hoshi Univ, Dept Clin Pharmacokinet, Shinagawa Ku, Tokyo 1428501, Japan.
   [Yamamoto, M.] Tsumura & Co, Ibaraki, Japan.
   [Ishige, A.; Watanabe, K.] Keio Univ, Tokyo, Japan.
C3 Hoshi University; Tsumura & Company; Keio University
RP Sugiyama, K (corresponding author), Hoshi Univ, Dept Clin Pharmacokinet, Shinagawa Ku, 2-4-41 Ebara, Tokyo 1428501, Japan.
EM sugiyama@hoshi.ac.jp
CR [Anonymous], 2008, DRUG METAB PHARMACOK, V23, P14, DOI 10.2133/dmpk.23.14
   Bailey MT, 1999, DEV PSYCHOBIOL, V35, P146, DOI 10.1002/(SICI)1098-2302(199909)35:2<146::AID-DEV7>3.0.CO;2-G
   CHIN NX, 1984, ANTIMICROB AGENTS CH, V25, P319, DOI 10.1128/AAC.25.3.319
   Choudhary D, 2003, ARCH BIOCHEM BIOPHYS, V414, P91, DOI 10.1016/S0003-9861(03)00174-7
   Emoto C, 2000, XENOBIOTICA, V30, P943, DOI 10.1080/00498250050200104
   Fukumori S, 2007, DRUG METAB PHARMACOK, V22, P377, DOI 10.2133/dmpk.22.377
   Hayashi H, 2002, MICROBIOL IMMUNOL, V46, P819, DOI 10.1111/j.1348-0421.2002.tb02769.x
   Hernandez JP, 2006, TOXICOL APPL PHARM, V216, P186, DOI 10.1016/j.taap.2006.05.014
   Ikeda M, 2007, J CLIN BIOCHEM NUTR, V41, P169, DOI 10.3164/jcbn.2007023
   Ishizaki T, 1999, ALIMENT PHARM THERAP, V13, P27
   ITOH S, 1994, EUR J BIOCHEM, V226, P877, DOI 10.1111/j.1432-1033.1994.t01-1-00877.x
   Jackson JP, 2006, DRUG METAB DISPOS, V34, P2003, DOI 10.1124/dmd.106.012005
   Jung D, 2006, J BIOL CHEM, V281, P19081, DOI 10.1074/jbc.M600116200
   Kitada H, 2003, J BIOL CHEM, V278, P17838, DOI 10.1074/jbc.M210634200
   Klaassen CD, 2005, CURR DRUG METAB, V6, P309, DOI 10.2174/1389200054633826
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lee IJ, 1996, MOL PHARMACOL, V49, P980
   Levert KL, 2002, J BIOL CHEM, V277, P16347, DOI 10.1074/jbc.C200113200
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MADSEN D, 1976, J LIPID RES, V17, P107
   MAEJIMA K, 1975, Experimental Animals (Tokyo), V24, P177
   Maglich JM, 2002, MOL PHARMACOL, V62, P638, DOI 10.1124/mol.62.3.638
   Masubuchi Y, 2004, DRUG METAB DISPOS, V32, P437, DOI 10.1124/dmd.32.4.437
   MITSUOKA T, 1977, ZBL BAKT-INT J MED M, V238, P228
   MORISHITA Y, 1970, JPN J VET SCI, V32, P19, DOI 10.1292/jvms1939.32.19
   Muller M, 1997, AM J PHYSIOL-GASTR L, V272, pG1285, DOI 10.1152/ajpgi.1997.272.6.G1285
   Neut C, 2002, AM J GASTROENTEROL, V97, P939, DOI 10.1111/j.1572-0241.2002.05613.x
   OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H
   Perloff MD, 2000, J PHARMACOL EXP THER, V292, P618
   PICHARD L, 1990, DRUG METAB DISPOS, V18, P595
   RADOMINSKA A, 1993, SEMIN LIVER DIS, V13, P219, DOI 10.1055/s-2007-1007351
   Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200
   Sakuma T, 2000, ARCH BIOCHEM BIOPHYS, V377, P153, DOI 10.1006/abbi.2000.1747
   SAVAGE DC, 1968, J EXP MED, V127, P67, DOI 10.1084/jem.127.1.67
   Sonoda J, 2002, P NATL ACAD SCI USA, V99, P13801, DOI 10.1073/pnas.212494599
   Staudinger JL, 2001, P NATL ACAD SCI USA, V98, P3369, DOI 10.1073/pnas.051551698
   Stevens JC, 2003, J PHARMACOL EXP THER, V307, P573, DOI 10.1124/jpet.103.054841
   SUZUKI K, 1983, JPN J VET SCI, V45, P331
   Teng S, 2007, BRIT J PHARMACOL, V151, P367, DOI 10.1038/sj.bjp.0707235
   Xie HJ, 2003, BONE MARROW TRANSPL, V31, P197, DOI 10.1038/sj.bmt.1703815
   Xie W, 2001, P NATL ACAD SCI USA, V98, P3375, DOI 10.1073/pnas.051014398
   YAMAOKA K, 1981, J PHARMACOBIO-DYNAM, V4, P879, DOI 10.1248/bpb1978.4.879
   Yoshinari K, 2006, BIOL PHARM BULL, V29, P1634, DOI 10.1248/bpb.29.1634
   Zhang J, 2004, J BIOL CHEM, V279, P49517, DOI 10.1074/jbc.M409041200
NR 44
TC 73
Z9 89
U1 2
U2 16
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0049-8254
EI 1366-5928
J9 XENOBIOTICA
JI Xenobiotica
PY 2009
VL 39
IS 4
BP 323
EP 334
AR PII 909819882
DI 10.1080/00498250802651984
PG 12
WC Pharmacology & Pharmacy; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy; Toxicology
GA 434VU
UT WOS:000265303000005
PM 19350455
DA 2024-02-19
ER

PT J
AU Gardner, JL
   Gallagher, EP
AF Gardner, JL
   Gallagher, EP
TI Development of a peptide antibody specific to human glutathione
   S-transferase alpha 4-4 (hGSTA4-4) reveals preferential localization in
   human liver mitochondria
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE peptide antibody; hGSTA4-4; mitochondria; human liver
ID HIGH CATALYTIC EFFICIENCY; OXIDATIVE STRESS; LIPID-PEROXIDATION;
   ALDEHYDE DEHYDROGENASE; ISOENZYMES; PRODUCTS; ENZYMES; CELLS; A4-4;
   SUSCEPTIBILITY
AB The reactive cellular products generated during the peroxidation of membrane lipids have been implicated as causative agents in a variety of degenerative diseases and aging. In particular, 4-hydroxynon-2-enal (4HNE) is among the most of the produced during lipid peroxidation. In humans and rodent species, the alpha 4 subclass of glutathione S-transferases (mGSTA4-4, rGSTA4-4, hGST-5.8, and hGSTA4-4) exhibits uniquely high glutathione conjugation activity toward 4HNE and other hydroxyalkenals. In human liver, hGSTA4-4-mediated 4HNE conjugation appears to represent the high-affinity pathway for 4HNE detoxification. In the present study, a highly specific polyclonal antibody was developed against hGSTA4-4. Western blotting analysis of human liver subcellular fractions as well as N-terminal sequencing revealed that hGSTA4-4 was localized to mitochondrial fractions, but was not detected in cytosolic fractions. Our results provide evidence that in adult liver, hGSTA4-4 is specifically targeted to the mitochondrion to the apparent exclusion of the cytosol. Targeting of hGSTA4-4 to the mitochondrion holds implications for degenerative diseases associated with oxidative stress that arise from aerobic respiration. (C) 2001 Academic Press.
C1 Univ Florida, Dept Physiol Sci, Gainesville, FL 32611 USA.
C3 State University System of Florida; University of Florida
RP Gallagher, EP (corresponding author), Univ Florida, Dept Physiol Sci, Box 110885, Gainesville, FL 32611 USA.
FU NIEHS NIH HHS [R01-ES09427] Funding Source: Medline
CR ADDYA S, 1994, ARCH BIOCHEM BIOPHYS, V310, P82, DOI 10.1006/abbi.1994.1143
   BELL DA, 1992, ENVIRON HEALTH PERSP, V98, P113, DOI 10.2307/3431256
   Bhagwat SV, 1998, BIOCHEM PHARMACOL, V56, P831, DOI 10.1016/S0006-2952(98)00228-7
   BOARD PG, 1987, BIOCHEM J, V248, P937, DOI 10.1042/bj2480937
   Bruns CM, 1999, J MOL BIOL, V288, P427, DOI 10.1006/jmbi.1999.2697
   CANUTO RA, 1994, CARCINOGENESIS, V15, P1359, DOI 10.1093/carcin/15.7.1359
   CHEN Q, 1995, CHUNG HUA HSUEH TSA, V75, P581
   Desmots F, 1998, BIOCHEM J, V336, P437, DOI 10.1042/bj3360437
   Dykens James A., 1997, P29
   ECKL PM, 1993, MUTAT RES, V290, P183, DOI 10.1016/0027-5107(93)90158-C
   Edman P, 1970, Mol Biol Biochem Biophys, V8, P211
   ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6
   Hamilton RF, 1996, AM J RESP CELL MOL, V15, P275, DOI 10.1165/ajrcmb.15.2.8703485
   Harries LW, 1997, CARCINOGENESIS, V18, P641, DOI 10.1093/carcin/18.4.641
   HARRIS JM, 1991, BIOCHEM J, V278, P137, DOI 10.1042/bj2780137
   HARTLEY DP, 1995, ARCH BIOCHEM BIOPHYS, V316, P197, DOI 10.1006/abbi.1995.1028
   Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491
   HAYES JD, 1996, IARC SCI PUBL, V139, P175
   HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824
   Hubatsch I, 1998, BIOCHEM J, V330, P175, DOI 10.1042/bj3300175
   HUSSEY AJ, 1986, BIOCHIM BIOPHYS ACTA, V874, P1, DOI 10.1016/0167-4838(86)90094-4
   KASAI H, 1987, CARCINOGENESIS, V8, P1959, DOI 10.1093/carcin/8.12.1959
   KNELLER DG, 1990, J MOL BIOL, V214, P171, DOI 10.1016/0022-2836(90)90154-E
   LITTLE RG, 1983, COMP BIOCHEM PHYS C, V74, P271, DOI 10.1016/0742-8413(83)90101-9
   LIU YH, 1991, CARCINOGENESIS, V12, P2269, DOI 10.1093/carcin/12.12.2269
   MANNERVIK B, 1988, CRC CR REV BIOCH MOL, V23, P283, DOI 10.3109/10409238809088226
   Muller K, 1996, FEBS LETT, V388, P165, DOI 10.1016/0014-5793(96)00559-5
   NAZARSTEWART V, 1993, CANCER RES, V53, P2313
   NISHINAKA T, 1993, CURR EYE RES, V12, P333, DOI 10.3109/02713689308999457
   POLSON A, 1990, IMMUNOL INVEST, V19, P253
   Poyton RO, 1995, METHOD ENZYMOL, V260, P97, DOI 10.1016/0076-6879(95)60133-3
   RICE JE, 1997, PRACTICAL APPROACH S, V173, P135
   Rubin M S, 1978, Methods Enzymol, V53, P73
   SANETO RP, 1980, BIOCHEM J, V191, P11, DOI 10.1042/bj1910011
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   STATHAM CN, 1977, BIOCHEM PHARMACOL, V26, P1395, DOI 10.1016/0006-2952(77)90363-X
   Strobel H W, 1978, Methods Enzymol, V52, P89
   SUZUKI T, 1991, BIOCHEM J, V274, P405, DOI 10.1042/bj2740405
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   TSUKAMOTO H, 1995, J GASTROEN HEPATOL, V10, pS50, DOI 10.1111/j.1440-1746.1995.tb01798.x
   TSUKAMOTO H, 1993, ALCOHOL, V10, P465, DOI 10.1016/0741-8329(93)90066-W
   VOLKL A, 1997, PRACTICAL APPROACH S, V173, P150
   VOOS W, 1994, MITOCHONDRIA DNA PRO, P55
   Wang RW, 1997, DRUG METAB DISPOS, V25, P762
   Wellings DA, 1997, METHOD ENZYMOL, V289, P44
   Zhao TJ, 1999, ARCH BIOCHEM BIOPHYS, V367, P216, DOI 10.1006/abbi.1999.1277
   Zimniak L, 1997, TOXICOL APPL PHARM, V143, P221, DOI 10.1006/taap.1996.8070
   ZIMNIAK P, 1992, FEBS LETT, V313, P173, DOI 10.1016/0014-5793(92)81438-R
NR 48
TC 36
Z9 39
U1 0
U2 2
PU ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0003-9861
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JUN 1
PY 2001
VL 390
IS 1
BP 19
EP 27
DI 10.1006/abbi.2001.2352
PG 9
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA 441NU
UT WOS:000169237100003
PM 11368510
DA 2024-02-19
ER

PT J
AU Zhang, Z
   Li, JW
   Zeng, PH
   Gao, WH
   Tian, XF
AF Zhang, Zhen
   Li, Jun-wei
   Zeng, Pu-hua
   Gao, Wen-hui
   Tian, Xue-fei
TI Data Mining and Systems Pharmacology to Elucidate Effectiveness and
   Mechanisms of Chinese Medicine in Treating Primary Liver Cancer
SO CHINESE JOURNAL OF INTEGRATIVE MEDICINE
LA English
DT Article; Early Access
DE Chinese medicine; primary liver cancer; system pharmacology;
   bioinformatics; tumor microenvironment
ID PROGRESSION; SURVIVAL; STRESS; ALPHA
AB Objective To identify specific Chinese medicines (CM) that may benefit patients with primary liver cancer (PLC), and to explore the mechanism of action of these medicines. Methods In this retrospective, singlecenter study, prescription information from PLC patients was used in combination with Traditional Chinese Medicine Inheritance Supports System to identify the specific core drugs. A system pharmacology approach was employed to explore the mechanism of action of these medicines. Results Taking CM more than 6 months was significantly associated with improved survival outcomes. In total, 77 putative targets and 116 bioactive ingredients of the core drugs were identified and included in the analysis (P<0.05). A total of 1,036 gene ontology terms were found to be enriched in PLC. A total of 75 pathways identified from Kyoto Encyclopedia of Genes and Genomes were also enriched in this disease, including fluid shear stress, interleukin-17 signaling, signaling between advanced glycan end products and their receptors, cellular senescence, tumor necrosis factor signaling, p53 signaling, cell cycle signaling, steroid hormone biosynthesis, T-helper 17 cell differentiation, and metabolism of xenobiotics by cytochrome. Docking studies suggested that the ingredients in the core drugs exert therapeutic effects in PLC by modulating c-Jun and interleukin-6. Conclusions Receiving CM for 6 months or more improves survival for the patients with PLC. The core drugs that really benefit for PLC patients likely regulates the tumor microenvironment and tumor itself.
C1 [Zhang, Zhen; Tian, Xue-fei] Hunan Univ Chinese Med, Coll Integrated Chinese & Western Med, Dept Internal Med, Changsha 410208, Peoples R China.
   [Zhang, Zhen; Gao, Wen-hui; Tian, Xue-fei] Hunan Univ Chinese Med, Hunan Key Lab TCM Prescript & Syndromes Translat, Changsha 410208, Peoples R China.
   [Li, Jun-wei] Jinan Univ, Shenzhen Peoples Hosp, Clin Med Coll 2, Dept Pharm, Shenzhen 518020, Guangdong, Peoples R China.
   [Li, Jun-wei] Southern Univ Sci & Technol, Affiliated Hosp 1, Shenzhen 518020, Guangdong, Peoples R China.
   [Zeng, Pu-hua] Hunan Acad Tradit Chinese Med, Affiliated Hosp, Dept Oncol, Changsha 410006, Peoples R China.
C3 Hunan University of Chinese Medicine; Hunan University of Chinese
   Medicine; Jinan University; Southern University of Science & Technology
RP Tian, XF (corresponding author), Hunan Univ Chinese Med, Coll Integrated Chinese & Western Med, Dept Internal Med, Changsha 410208, Peoples R China.; Tian, XF (corresponding author), Hunan Univ Chinese Med, Hunan Key Lab TCM Prescript & Syndromes Translat, Changsha 410208, Peoples R China.
EM 003640@hnucm.edu.cn
OI Zhang, Zhen/0000-0001-9257-1449
CR Ahmed Saleem, 2016, HPB Surg, V2016, P6120143, DOI 10.1155/2016/6120143
   Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235
   Blagih J, 2020, J CELL SCI, V133, DOI 10.1242/jcs.237453
   Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901
   Chen CL, 2018, HEPATOL COMMUN, V2, P1392, DOI 10.1002/hep4.1229
   Chen Y, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.11895
   Commission CP., 2020, Pharmacopoeia of the People's Republic of China
   Dai Qian-Lan, 2018, Zhongguo Zhong Yao Za Zhi, V43, P4541, DOI 10.19540/j.cnki.cjcmm.20180912.001
   Dogra G, 2011, HUM IMMUNOL, V72, P935, DOI 10.1016/j.humimm.2011.06.008
   He Lan-Juan, 2016, Zhongguo Zhong Yao Za Zhi, V41, P2344, DOI 10.4268/cjcmm20161228
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Hyler AR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194170
   Jain RK, 2014, ANNU REV BIOMED ENG, V16, P321, DOI 10.1146/annurev-bioeng-071813-105259
   Jain RK, 2013, J CLIN ONCOL, V31, P2205, DOI 10.1200/JCO.2012.46.3653
   Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10
   Kohles N, 2012, TUMOR BIOL, V33, P2401, DOI 10.1007/s13277-012-0504-2
   Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018
   Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723
   Li JS, 2015, SCI REP-UK, V5, DOI 10.1038/srep15290
   Li J, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0329-z
   Li XX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043918
   Liu H, 2013, J ETHNOPHARMACOL, V146, P773, DOI 10.1016/j.jep.2013.02.004
   Liu XL, 2019, PHYTOMEDICINE, V62, DOI 10.1016/j.phymed.2019.152930
   Liu ZY, 2016, SCI REP-UK, V6, DOI 10.1038/srep21146
   Momin BR, 2017, CANCER-AM CANCER SOC, V123, P5059, DOI 10.1002/cncr.30820
   Noguchi T, 2003, NUCLEIC ACIDS RES, V31, P492, DOI 10.1093/nar/gkg022
   Palanissami G, 2018, HORM CANCER-US, V9, P295, DOI 10.1007/s12672-018-0342-9
   Ru JL, 2014, J CHEMINFORMATICS, V6, DOI 10.1186/1758-2946-6-13
   Shi HZ, 2012, ASIAN PAC J CANCER P, V13, P6217, DOI 10.7314/APJCP.2012.13.12.6217
   Shiani A, 2017, CANCER CONTROL, V24, DOI 10.1177/1073274817729240
   Stylianopoulos T, 2013, CANCER RES, V73, P3833, DOI 10.1158/0008-5472.CAN-12-4521
   Sun JH, 2020, BIOMED PHARMACOTHER, V125, DOI 10.1016/j.biopha.2020.109900
   Szczepankiewicz BG, 2006, J MED CHEM, V49, P3563, DOI 10.1021/jm060199b
   Tian S, 2015, ADV DRUG DELIVER REV, V86, P2, DOI 10.1016/j.addr.2015.01.009
   Triantafillu UL, 2017, INT J ONCOL, V50, P993, DOI 10.3892/ijo.2017.3865
   Walter W, 2015, BIOINFORMATICS, V31, P2912, DOI 10.1093/bioinformatics/btv300
   Wang DM, 2017, ANN MED, V49, P652, DOI 10.1080/07853890.2017.1364417
   Wang JJ, 2019, SCAND J IMMUNOL, V90, DOI 10.1111/sji.12819
   Wang MG, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.920310
   Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958
   Xu HY, 2019, NUCLEIC ACIDS RES, V47, pD976, DOI 10.1093/nar/gky987
   Yan GJ, 2017, CURR DRUG METAB, V18, P535, DOI 10.2174/1389200218666170316094104
   Zhang JP, 2009, J HEPATOL, V50, P980, DOI 10.1016/j.jhep.2008.12.033
   Zhang M, 2019, ONCOL LETT, V17, P4948, DOI 10.3892/ol.2019.10193
   Zhou W, 2020, BMC COMPLEMENT MED, V20, DOI 10.1186/s12906-019-2787-y
   Zhu NQ, 2020, COMPUT BIOL CHEM, V85, DOI 10.1016/j.compbiolchem.2020.107240
NR 46
TC 2
Z9 2
U1 0
U2 10
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1672-0415
EI 1993-0402
J9 CHIN J INTEGR MED
JI Chin. J. Integr. Med.
PD 2022 JUL
PY 2022
VL 28
IS 7
BP 636
EP 643
DI 10.1007/s11655-021-3449-8
EA AUG 2021
PG 8
WC Integrative & Complementary Medicine
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Integrative & Complementary Medicine
GA 2P5NS
UT WOS:000688388500004
PM 34432201
DA 2024-02-19
ER

PT J
AU Magnussen, LV
   Andersen, PE
   Diaz, A
   Ostojic, J
   Hojlund, K
   Hougaard, DM
   Christensen, AN
   Nielsen, TL
   Andersen, M
AF Magnussen, L. V.
   Andersen, P. E.
   Diaz, A.
   Ostojic, J.
   Hojlund, K.
   Hougaard, D. M.
   Christensen, A. N.
   Nielsen, T. L.
   Andersen, M.
TI MR spectroscopy of hepatic fat and adiponectin and leptin levels during
   testosterone therapy in type 2 diabetes: a randomized, double-blinded,
   placebo-controlled trial
SO EUROPEAN JOURNAL OF ENDOCRINOLOGY
LA English
DT Article
ID C-REACTIVE PROTEIN; INSULIN-RESISTANCE; ADIPOSE-TISSUE; BODY-FAT;
   METABOLIC SYNDROME; CARDIOVASCULAR-DISEASE; REPLACEMENT THERAPY;
   GLYCEMIC CONTROL; HYPOGONADAL MEN; ELDERLY-MEN
AB Background: Men with type 2 diabetes mellitus (T2D) often have lowered testosterone levels and an increased risk of cardiovascular disease (CVD). Ectopic fat increases the risk of CVD, whereas subcutaneous gluteofemoral fat protects against CVD and has a beneficial adipokine-secreting profile. Hypothesis: Testosterone replacement therapy (TRT) may reduce the content of ectopic fat and improve the adipokine profile in men with T2D.
   Design and methods: A randomized, double-blinded, placebo-controlled study in 39 men aged 50-70 years with T2D and bioavailable testosterone levels <7.3 nmol/L. Patients were randomized to TRT (n = 20) or placebo gel (n = 19) for 24 weeks. Thigh subcutaneous fat area (TFA, % fat of total thigh volume), subcutaneous abdominal adipose tissue (SAT, % fat of total abdominal volume) and visceral adipose tissue (VAT, % fat of total abdominal volume) were measured by magnetic resonance (MR) imaging. Hepatic fat content was estimated by single-voxel MR spectroscopy. Adiponectin and leptin levels were measured by in-house immunofluorometric assay. Coefficients (b) represent the placebo-controlled mean effect of intervention.
   Results: TFA (b = -3.3 percentage points (pp), P = 0.009), SAT (b = -3.0 pp, P = 0.006), levels of adiponectin (b = -0.4 mg/L, P = 0.045), leptin (b = -4.3 mu g/mL, P < 0.001), leptin: adiponectin ratio (b = -0.53, P = 0.001) and HDL cholesterol (b = -0.11 mmol/L, P = 0.009) decreased during TRT compared with placebo. Hepatic fat content and VAT were unchanged.
   Conclusions: The effects of TRT on cardiovascular risk markers were ambiguous. We observed potentially harmful changes in cardiovascular risk parameters, markedly reduced subcutaneous fat and unchanged ectopic fat during TRT and a reduction in adiponectin levels. On the other hand, the decrease in leptin and leptin: adiponectin ratio assessments could reflect an amelioration of the cardiovascular risk profile linked to hyperleptinaemia in ageing men with T2D.
C1 [Magnussen, L. V.; Hojlund, K.; Nielsen, T. L.; Andersen, M.] Odense Univ Hosp, Dept Endocrinol & Metab, Odense, Denmark.
   [Andersen, P. E.; Diaz, A.] Odense Univ Hosp, Dept Radiol, Odense, Denmark.
   [Andersen, P. E.] Univ Southern Denmark, Clin Inst, Odense, Denmark.
   [Ostojic, J.] Univ Novi Sad, Fac Med, Clin Ctr Vojvodina, Ctr Radiol, Novi Sad, Serbia.
   [Hojlund, K.] Univ Southern Denmark, Inst Mol Med, Sect Mol Diabet & Metab, Odense, Denmark.
   [Hougaard, D. M.] Statens Serum Inst, Dept Congenital Disorders, Copenhagen, Denmark.
   [Christensen, A. N.] Tech Univ Denmark, Dept Appl Math & Comp Sci, Lyngby, Denmark.
C3 University of Southern Denmark; Odense University Hospital; University
   of Southern Denmark; Odense University Hospital; University of Southern
   Denmark; University of Novi Sad; University of Southern Denmark; Statens
   Serum Institut; Technical University of Denmark
RP Magnussen, LV (corresponding author), Odense Univ Hosp, Dept Endocrinol & Metab, Odense, Denmark.
EM line.magnussen@rsyd.dk
RI Hougaard, David/AAD-6368-2019; Andersen, Peter/HTT-1434-2023; Nielsen,
   Torben/AAC-7424-2021; Andersen, Marianne Skovsager/AAE-1751-2019;
   Magnussen, Line Velling/HTP-4569-2023; Christensen, Anders Nymark
   N./L-2596-2016
OI Nielsen, Torben/0000-0001-7798-5061; Andersen, Marianne
   Skovsager/0000-0002-4603-9504; Christensen, Anders Nymark
   N./0000-0002-3668-3128; Magnussen, Line/0000-0002-7009-0043; Ostojic,
   Jelena/0000-0002-2303-7979; Hojlund, Kurt/0000-0002-0891-4224
FU Novo Nordisk Foundation; Danish Diabetes Academy through the Novo
   Nordisk Foundation; Odense University Hospital; Institute of Clinical
   Research at the University of Southern Denmark; Region of Southern
   Denmark; Consultant Council Scholarship Committee of Odense University
   Hospital; Christenson-Ceson Family Foundation
FX Our study was not funded by the pharmaceutical industry. Grants and
   fellowships were received from the Novo Nordisk Foundation, Danish
   Diabetes Academy through a grant from the Novo Nordisk Foundation,
   Odense University Hospital, Institute of Clinical Research at the
   University of Southern Denmark, the Region of Southern Denmark,
   Consultant Council Scholarship Committee of Odense University Hospital
   and the Christenson-Ceson Family Foundation.
CR Al-Hamodi Z, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-99
   Araujo AB, 2011, J CLIN ENDOCR METAB, V96, P3007, DOI 10.1210/jc.2011-1137
   Bays Harold E, 2008, Expert Rev Cardiovasc Ther, V6, P343, DOI 10.1586/14779072.6.3.343
   Birzniece V, 2009, CLIN ENDOCRINOL, V71, P715, DOI 10.1111/j.1365-2265.2009.03524.x
   Blüher M, 2015, METABOLISM, V64, P131, DOI 10.1016/j.metabol.2014.10.016
   Carter S, 2013, CLIN INTERV AGING, V8, P829, DOI 10.2147/CIA.S36367
   Christian Thode L, 2014, LECT NOTES COMPUTER
   Nguyen CP, 2015, NEW ENGL J MED, V373, P689, DOI 10.1056/NEJMp1506632
   De Maddalena C, 2012, J CELL PHYSIOL, V227, P3744, DOI 10.1002/jcp.24096
   Dhindsa S, 2016, DIABETES CARE, V39, P82, DOI 10.2337/dc15-1518
   Fasshauer M, 2015, TRENDS PHARMACOL SCI, V36, P461, DOI 10.1016/j.tips.2015.04.014
   Fischer S, 2002, ACTA DIABETOL, V39, P105, DOI 10.1007/s005920200027
   Frederiksen L, 2012, EUR J ENDOCRINOL, V166, P469, DOI 10.1530/EJE-11-0565
   Frederiksen L, 2009, J CLIN ENDOCR METAB, V94, P4010, DOI 10.1210/jc.2009-0980
   Frederiksen L, 2012, AGE, V34, P145, DOI 10.1007/s11357-011-9213-9
   Frystyk J, 2005, DIABETOLOGIA, V48, P1911, DOI 10.1007/s00125-005-1850-z
   Gianatti EJ, 2014, DIABETES CARE, V37, P2098, DOI 10.2337/dc13-2845
   Gibney J, 2005, AM J PHYSIOL-ENDOC M, V289, pE266, DOI 10.1152/ajpendo.00483.2004
   Grossmann M, 2008, J CLIN ENDOCR METAB, V93, P1834, DOI 10.1210/jc.2007-2177
   Haider A, 2010, EXP CLIN ENDOCR DIAB, V118, P167, DOI 10.1055/s-0029-1202774
   Heilbronn L, 2004, INT J OBESITY, V28, pS12, DOI 10.1038/sj.ijo.0802853
   Heufelder AE, 2009, J ANDROL, V30, P726, DOI 10.2164/jandrol.108.007005
   Hou N, 2011, CLIN EXP PHARMACOL P, V38, P905, DOI 10.1111/j.1440-1681.2011.05619.x
   Hoyos CM, 2012, EUR J ENDOCRINOL, V167, P531, DOI 10.1530/EJE-12-0525
   Huang G, 2013, J GERONTOL A-BIOL, V68, P954, DOI 10.1093/gerona/gls259
   Hwang K, 2015, ASIAN J ANDROL, V17, P187, DOI 10.4103/1008-682X.146968
   Isidori AM, 2005, CLIN ENDOCRINOL, V63, P280, DOI 10.1111/j.1365-2265.2005.02339.x
   Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126
   Kalinchenko SY, 2010, CLIN ENDOCRINOL, V73, P602, DOI 10.1111/j.1365-2265.2010.03845.x
   Kapoor D, 2007, EUR J ENDOCRINOL, V156, P595, DOI 10.1530/EJE-06-0737
   Katznelson L, 1998, AM J ROENTGENOL, V170, P423, DOI 10.2214/ajr.170.2.9456958
   Koplay M, 2015, WORLD J HEPATOL, V7, P769, DOI 10.4254/wjh.v7.i5.769
   Kotronen A, 2008, DIABETES CARE, V31, P165, DOI 10.2337/dc07-1463
   Li K, 2006, IEEE T PATTERN ANAL, V28, P119, DOI 10.1109/TPAMI.2006.19
   Magnussen LV, 2016, DIABETES OBES METAB, V18, P980, DOI 10.1111/dom.12701
   Manolopoulos KN, 2010, INT J OBESITY, V34, P949, DOI 10.1038/ijo.2009.286
   Münzer T, 2001, J CLIN ENDOCR METAB, V86, P3604, DOI 10.1210/jc.86.8.3604
   Neeland IJ, 2015, J AM COLL CARDIOL, V65, P2150, DOI 10.1016/j.jacc.2015.01.061
   Neeland IJ, 2013, OBESITY, V21, pE439, DOI [10.1038/oby.20135, 10.1002/oby.20135]
   Rosmond R, 1996, OBES RES, V4, P245, DOI 10.1002/j.1550-8528.1996.tb00542.x
   Satoh N, 2004, DIABETES CARE, V27, P2488, DOI 10.2337/diacare.27.10.2488
   Sattler F, 2014, J GERONTOL GERIATR R, V3, DOI [DOI 10.4172/2167-7182.1000159, 10.4172/2167-7182.1000159]
   Schroeder ET, 2004, J CLIN ENDOCR METAB, V89, P4863, DOI 10.1210/jc.2004-0784
   Schulze MB, 2004, DIABETES CARE, V27, P1680, DOI 10.2337/diacare.27.7.1680
   Singh R, 2003, ENDOCRINOLOGY, V144, P5081, DOI 10.1210/en.2003-0741
   Stanley S, 2005, PHYSIOL REV, V85, P1131, DOI 10.1152/physrev.00015.2004
   Stefan N, 2016, LANCET DIABETES ENDO, V4, P789, DOI 10.1016/S2213-8587(16)00082-6
   Stefan N, 2013, NAT REV ENDOCRINOL, V9, P144, DOI 10.1038/nrendo.2012.258
   Stern JH, 2016, CELL METAB, V23, P770, DOI 10.1016/j.cmet.2016.04.011
   Svartberg J, 2008, INT J IMPOT RES, V20, P378, DOI 10.1038/ijir.2008.19
   Tanna MS, 2015, CURR ATHEROSCLER REP, V17, DOI 10.1007/s11883-015-0490-0
   Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063
   Unger RH, 2003, ANNU REV PHYSIOL, V65, P333, DOI 10.1146/annurev.physiol.65.092101.142622
   Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930
   Wium C, 2014, SCAND J CLIN LAB INV, V74, P700, DOI 10.3109/00365513.2014.953571
   Xu L, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-108
   XU XF, 1991, ENDOCRINOLOGY, V128, P379, DOI 10.1210/endo-128-1-379
NR 57
TC 20
Z9 21
U1 0
U2 4
PU BIOSCIENTIFICA LTD
PI BRISTOL
PA STARLING HOUSE, 1600 BRISTOL PARKWAY N, BRISTOL, ENGLAND
SN 0804-4643
EI 1479-683X
J9 EUR J ENDOCRINOL
JI Eur. J. Endocrinol.
PD AUG
PY 2017
VL 177
IS 2
BP 157
EP 168
DI 10.1530/EJE-17-0071
PG 12
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA FB9TA
UT WOS:000406480700011
PM 28522646
OA Green Published, Bronze
DA 2024-02-19
ER

PT J
AU Li, J
   Xie, Y
   Yuan, F
   Song, B
   Tang, CW
AF Li, Jing
   Xie, Yi
   Yuan, Fang
   Song, Bin
   Tang, Chengwei
TI Noninvasive Quantification of Pancreatic Fat in Healthy Male Population
   Using Chemical Shift Magnetic Resonance Imaging <i>Effect of Aging on
   Pancreatic Fat Content</i>
SO PANCREAS
LA English
DT Article
DE pancreatic steatosis; aging; chemical shift gradient-echo magnetic
   resonance imaging; healthy population
ID LIVER STEATOSIS; INFILTRATION; MRI; REPLACEMENT; LIPOMATOSIS; OBESITY;
   PHASE; MICE; AGE
AB Objectives: This study was aimed to establish a database of pancreatic fat fractions for healthy men aged 20 to 70 years using double-echo chemical shift gradient-echo magnetic resonance imaging.
   Methods: The double-echo chemical shift gradient-echo magnetic resonance imaging technique was used in this study. A phantom of fat-water mixtures was established to test the accuracy of the sequence. In addition, 126 healthy male volunteers (20-70 years, body mass index <= 25) were enrolled. Fat content of the pancreas (head, body, and tail) was examined.
   Results: On the phantom, a significant positive linear correlation and linear regression was found between the calculated and actual fat fractions of fat emulsions. For volunteers, there was no significant difference regarding fat fractions among the 3 regions of pancreata in each age group (P > 0.05). Pancreatic fat fraction (6.32% +/- 1.18%) of healthy men aged 50 to 70 years was approximately 1-fold higher than that (2.8% +/- 0.66%) of those aged 20 to 50 years (P < 0.01).
   Conclusions: Double-echo chemical shift gradient-echo magnetic resonance imaging is useful for quantifying pancreatic fat fraction. This noninvasive technique has revealed (1) an even distribution of pancreatic fat in healthy men, (2) aging as an independent risk factor for pancreatic steatosis, and (3) the increase in pancreatic fat fraction beginning in the fifth decade.
C1 [Li, Jing; Yuan, Fang; Song, Bin; Tang, Chengwei] Sichuan Univ, Dept Gastroenterol, W China Hosp, Chengdu 610041, Peoples R China.
   [Li, Jing; Tang, Chengwei] Minist Educ, Key Lab Biotherapy Human Dis, Div Peptides Related Human Dis, Chengdu, Peoples R China.
   [Yuan, Fang; Song, Bin] Sichuan Univ, Dept Radiol, W China Hosp, Chengdu 610041, Peoples R China.
C3 Sichuan University; Sichuan University
RP Tang, CW (corresponding author), Sichuan Univ, Dept Gastroenterol, W China Hosp, Chengdu 610041, Peoples R China.
EM chengweitang@163.com
RI Song, Bin/AAD-3670-2020; Wang, Peiyun/JVE-1196-2024; cheng,
   shu/IZE-4788-2023; Li, Ly/JCD-4746-2023
OI Song, Bin/0000-0002-7269-2101
FU Natural Science Fund of China [30700352]
FX This study is supported by grant no. 30700352 of Natural Science Fund of
   China.
CR Bydder M, 2008, MAGN RESON IMAGING, V26, P347, DOI 10.1016/j.mri.2007.08.012
   Campbell-Tofte J, 2007, PROSTAG LEUKOTR ESS, V76, P9, DOI 10.1016/j.plefa.2006.09.002
   Cassidy FH, 2009, RADIOGRAPHICS, V29, P231, DOI 10.1148/rg.291075123
   DIXON WT, 1984, RADIOLOGY, V153, P189, DOI 10.1148/radiology.153.1.6089263
   Feigelson J, 2000, J PEDIATR GASTR NUTR, V30, P145, DOI 10.1097/00005176-200002000-00010
   Fishbein M, 2005, J CLIN GASTROENTEROL, V39, P619, DOI 10.1097/00004836-200508000-00012
   Fraulob JC, 2010, J CLIN BIOCHEM NUTR, V46, P212, DOI 10.3164/jcbn.09-83
   Heni M, 2010, DIABETES-METAB RES, V26, P200, DOI 10.1002/dmrr.1073
   Kawamoto S, 2009, J COMPUT ASSIST TOMO, V33, P90, DOI 10.1097/RCT.0b013e31815cff0d
   Kim HJ, 2007, AM J ROENTGENOL, V188, P429, DOI 10.2214/AJR.05.1095
   LEVENSON H, 1991, AM J ROENTGENOL, V156, P307, DOI 10.2214/ajr.156.2.1898804
   Li J, 2010, ALCOHOL CLIN EXP RES, V34, P1843, DOI 10.1111/j.1530-0277.2010.01272.x
   Lingvay I, 2009, J CLIN ENDOCR METAB, V94, P4070, DOI 10.1210/jc.2009-0584
   MATSUMOTO S, 1995, RADIOLOGY, V194, P453, DOI 10.1148/radiology.194.2.7824726
   Muoio DM, 2006, ANNU REV BIOCHEM, V75, P367, DOI 10.1146/annurev.biochem.75.103004.142512
   OLSEN TS, 1978, ACTA PATH MICRO IM A, V86, P367
   Pilleul F, 2005, GASTROEN CLIN BIOL, V29, P1143, DOI 10.1016/S0399-8320(05)82179-7
   Rosso E, 2009, J GASTROINTEST SURG, V13, P1845, DOI 10.1007/s11605-009-0974-8
   Saisho Y, 2007, CLIN ANAT, V20, P933, DOI 10.1002/ca.20543
   Schick F, 2002, MAGNET RESON MED, V47, P720, DOI 10.1002/mrm.10107
   Schwenzer NF, 2008, INVEST RADIOL, V43, P330, DOI 10.1097/RLI.0b013e31816a88c6
   Yang DM, 2010, J CLIN ULTRASOUND, V38, P45, DOI 10.1002/jcu.20632
NR 22
TC 41
Z9 52
U1 0
U2 7
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0885-3177
J9 PANCREAS
JI Pancreas
PD MAR
PY 2011
VL 40
IS 2
BP 295
EP 299
DI 10.1097/MPA.0b013e318201669f
PG 5
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 719VN
UT WOS:000287239700020
PM 21178651
DA 2024-02-19
ER

PT J
AU Fiebig, R
   Gore, MT
   Chandwaney, R
   Leeuwenburgh, C
   Ji, LL
AF Fiebig, R
   Gore, MT
   Chandwaney, R
   Leeuwenburgh, C
   Ji, LL
TI Alteration of myocardial antioxidant enzyme activity and glutathione
   content with aging and exercise training
SO AGE
LA English
DT Article
ID SUPEROXIDE-DISMUTASE; SKELETAL-MUSCLE; RAT-HEART; LIVER; CATALASE;
   DAMAGE
AB Antioxidant enzyme activities and glutathione (GSH) content were investigated in the ventricular myocardia of adult (4.5 mo.), mid-age (14.5 mo.), and old (26.5 mo.) male Fischer 344 rats. In addition, the effect of 10 wks of exercise training (T) on these antioxidant systems was evaluated at each age. T was performed on a rodent treadmill for 1 hr/day, 5 days/wk at a speed and grade adjusted for the animal's age. Activities of superoxide dismutase (SOD), glutathione peroxidase (GPX), and glutathone disulfide (GSSG) reductase were increased by 39%, 27% and 38%, respectively (p < 0.05), in old vs young rats. T has no significant effect on antioxidant enzyme activities at any age. Myocardial protein concentration of the aged heart was significantly lower compared to that of the adult or young rats. Total glutathione concentration in the heart was increased in old (12.5 +/- 0.6) vs adult (10.7 +/- 1.2) and mid-age (9.7 +/- 0.9 nmol/mg protein) rats (p < 0.05), however the GSH/GSSG ratio was not altered by T in any age group. Myocardial malondialdehyde (MDA) content was increased (p < 0.001) with aging. However, MDA content in mid-age and old T rats was decreased by 21 and 25%, respectively, compared to their untrained counterparts (p < 0.05). It is concluded that aged hearts are susceptible to oxidative stress despited increased antioxidant capacity and that training may attenuate the age-associated increase in lipid peroxidation in the heart.
C1 UNIV WISCONSIN, DEPT KINESIOL, MADISON, WI USA.
C3 University of Wisconsin System; University of Wisconsin Madison
OI Leeuwenburgh, Christiaan/0000-0003-0826-4257
CR AEBI H, 1984, METHOD ENZYMOL, V105, P121
   AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858
   CARLBERG I, 1985, METHOD ENZYMOL, V113, P484
   FLOHE L, 1984, METHOD ENZYMOL, V105, P114
   HANSFORD RG, 1983, BIOCHIM BIOPHYS ACTA, V726, P41, DOI 10.1016/0304-4173(83)90010-1
   HAZELTON GA, 1985, MECH AGEING DEV, V29, P71, DOI 10.1016/0047-6374(85)90048-X
   HIGUCHI M, 1985, J GERONTOL, V40, P281, DOI 10.1093/geronj/40.3.281
   JI LL, 1994, ACTA PHYSIOL SCAND, V151, P279, DOI 10.1111/j.1748-1716.1994.tb09747.x
   JI LL, 1991, AM J PHYSIOL, V261, pR386, DOI 10.1152/ajpregu.1991.261.2.R386
   JI LL, 1992, J APPL PHYSIOL, V72, P549, DOI 10.1152/jappl.1992.72.2.549
   JI LL, 1994, EXERCISE OXYGEN TOXI, P249
   JI LL, 1995, PHARM EXERCISE SPORT, P97
   KANTER MM, 1985, J APPL PHYSIOL, V59, P1298, DOI 10.1152/jappl.1985.59.4.1298
   KIHLSTROM M, 1990, J APPL PHYSIOL, V68, P1672, DOI 10.1152/jappl.1990.68.4.1672
   KUMAR CT, 1992, MOL CELL BIOCHEM, V111, P109
   LAKATTA EG, 1982, AM J PHYSIOL, V242, pH927, DOI 10.1152/ajpheart.1982.242.6.H927
   MASORO EJ, 1993, FREE RADICALS AGING
   MATSUO M, 1993, FREE RADICAL AGING
   Meister A, 1981, Methods Enzymol, V77, P237
   MEYCIANI M, 1993, FREE RADICALS AGING
   MISRA HP, 1972, J BIOL CHEM, V247, P3170
   NIKI E, 1991, AM J CLIN NUTR, V53, pS201, DOI 10.1093/ajcn/53.1.201S
   NOHL H, 1993, BRIT MED BULL, V49, P653, DOI 10.1093/oxfordjournals.bmb.a072638
   POWERS SK, 1993, AM J PHYSIOL, V265, pH2094, DOI 10.1152/ajpheart.1993.265.6.H2094
   REED DJ, 1980, ANAL BIOCHEM, V106, P55, DOI 10.1016/0003-2697(80)90118-9
   SAWADA M, 1987, MECH AGEING DEV, V41, P125, DOI 10.1016/0047-6374(87)90057-1
   SEN CK, 1992, J APPL PHYSIOL, V73, P1265, DOI 10.1152/jappl.1992.73.4.1265
   STIO M, 1994, BIOCHEM CELL BIOL, V72, P58, DOI 10.1139/o94-010
   UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1
   VEGA JA, 1992, MECH AGEING DEV, V64, P37, DOI 10.1016/0047-6374(92)90094-T
   YU BP, 1994, PHYSIOL REV, V74, P139, DOI 10.1152/physrev.1994.74.1.139
NR 31
TC 16
Z9 17
U1 0
U2 1
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0161-9152
EI 1574-4647
J9 AGE
JI Age
PD JUL
PY 1996
VL 19
IS 3
BP 83
EP 89
DI 10.1007/BF02434087
PG 7
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA WH863
UT WOS:A1996WH86300002
DA 2024-02-19
ER

PT J
AU Ochoa, JJ
   Quiles, JL
   López-Frías, M
   Huertas, JR
   Mataix, J
AF Ochoa, Julio J.
   Quiles, Jose L.
   Lopez-Frias, Magdalena
   Huertas, Jesus R.
   Mataix, Jose
TI Effect of lifelong coenzyme Q<sub>10</sub> supplementation on
   age-related oxidative stress and mitochondrial function in liver and
   skeletal muscle of rats fed on a polyunsaturated fatty acid (PUFA)-rich
   diet
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
ID FREE-RADICAL THEORY; GENE-EXPRESSION; OLIVE OIL; SPAN; HYDROPEROXIDE;
   UBIQUINONE; LONGEVITY; PROTECTS; DEPENDS; TISSUE
AB This study investigates aging-related changes in lipid peroxidation and functionality in liver and skeletal-muscle mitochondria in rats fed a diet rich in polyunsaturated fatty acids (PUFA), depending on supplementation or not with coenzyme Q(10) (CoQ(10)). Two groups of rats were fed for 24 months on a PUFA-rich diet, differing in supplementation or not with CoQ(10). At 6 and 24 months mitochondria were analyzed for fatty acid profile; hydroperoxides; alpha-tocopherol; CoQ(9); CoQ(10); cytochromes b, c+c(1), and a+a(3) contents; cytochrome c oxidase activity; and catalase activity in cytosol. Results of this study showed for the supplemented group an age-associated decrease in the peroxidizability index, an increase in catalase activity in skeletal muscle, and modulation of the aging-related changes in different mitochondrial electron-transport-chain components in skeletal muscle. These findings provide mechanisms to explain the effect of CoQ(10) in extending the life span of animals fed a PUFA-rich diet.
C1 [Ochoa, Julio J.; Quiles, Jose L.; Lopez-Frias, Magdalena; Huertas, Jesus R.; Mataix, Jose] Inst Nutr & Food Technol, Dept Phytol, Granada 18071, Spain.
RP Ochoa, JJ (corresponding author), Inst Nutr & Food Technol, Dept Phytol, C-Ramon & Cajal,4, Granada 18071, Spain.
EM joh@ugr.es
RI Huertas, Jesus Francisco Rodriguez/G-8188-2015; Ochoa,
   Julio/L-8733-2014; /AAB-6832-2019; Quiles, José L./C-6911-2013
OI Huertas, Jesus Francisco Rodriguez/0000-0002-7446-0857; Ochoa,
   Julio/0000-0001-8976-6296; /0000-0002-8479-4658; Quiles, José
   L./0000-0002-9048-9086
CR Aebi H, 1984, Methods Enzymol, V105, P121
   Armeni T, 2003, J BIOENERG BIOMEMBR, V35, P181, DOI 10.1023/A:1023754305218
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   Bello RI, 2005, EXP GERONTOL, V40, P694, DOI 10.1016/j.exger.2005.07.003
   Bentinger M, 2003, FREE RADICAL BIO MED, V34, P563, DOI 10.1016/S0891-5849(02)01357-6
   Brown-Borg HM, 2000, EXP GERONTOL, V35, P199, DOI 10.1016/S0531-5565(00)00079-6
   Çelik S, 2006, CELL BIOCHEM FUNCT, V24, P561, DOI 10.1002/cbf.1295
   Gorelick C, 2004, AM J OBSTET GYNECOL, V190, P1432, DOI 10.1016/j.ajog.2004.01.076
   Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341
   Harman D, 2006, ANN NY ACAD SCI, V1067, P10, DOI 10.1196/annals.1354.003
   Hu FB, 2001, J AM COLL NUTR, V20, P5, DOI 10.1080/07315724.2001.10719008
   JIANG ZY, 1992, ANAL BIOCHEM, V202, P384, DOI 10.1016/0003-2697(92)90122-N
   Kopsidas G, 1998, MUTAT RES-FUND MOL M, V421, P27, DOI 10.1016/S0027-5107(98)00150-X
   Kroger A, 1978, Methods Enzymol, V53, P579
   Lass A, 1997, J BIOL CHEM, V272, P19199, DOI 10.1074/jbc.272.31.19199
   LEE CK, 2004, FREE RADIC BIOL MED, V27, P273
   Lee J, 1999, FREE RADICAL BIO MED, V26, P260, DOI 10.1016/S0891-5849(98)00195-6
   LEPAGE G, 1986, J LIPID RES, V27, P114
   Linnane AW, 2002, ANN NY ACAD SCI, V959, P396, DOI 10.1111/j.1749-6632.2002.tb02110.x
   Mataix J, 2004, GRASAS ACEITES, V55, P84
   Meydani M, 2001, ANN NY ACAD SCI, V928, P226
   Ochoa JJ, 2005, J GERONTOL A-BIOL, V60, P970, DOI 10.1093/gerona/60.8.970
   Ochoa JJ, 2003, J BIOENERG BIOMEMBR, V35, P267, DOI 10.1023/A:1024615816839
   Ochoa JJ, 1999, NUTR METAB CARDIOVAS, V9, P284
   Park SK, 2005, CARDIOVASC RES, V66, P205, DOI 10.1016/j.cardiores.2005.01.005
   Quiles JL, 2006, J GERONTOL A-BIOL, V61, P107, DOI 10.1093/gerona/61.2.107
   Quiles JL, 2003, BIOFACTORS, V18, P265, DOI 10.1002/biof.5520180229
   Quiles JL, 2004, EXP GERONTOL, V39, P189, DOI 10.1016/j.exger.2003.10.002
   Quiles JL, 2002, J BIOENERG BIOMEMBR, V34, P517, DOI 10.1023/A:1022530512096
   Quiles JL, 2001, J BIOENERG BIOMEMBR, V33, P127, DOI 10.1023/A:1010700515071
   Quiles JL, 2005, BIOFACTORS, V25, P73, DOI 10.1002/biof.5520250109
   Salvioli S, 2001, FEBS LETT, V492, P9, DOI 10.1016/S0014-5793(01)02199-8
   Sanz A, 2006, ANTIOXID REDOX SIGN, V8, P582, DOI 10.1089/ars.2006.8.582
   Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   Sohal RS, 2006, FREE RADICAL BIO MED, V40, P480, DOI 10.1016/j.freeradbiomed.2005.08.037
   Solfrizzi V, 2005, EXP GERONTOL, V40, P335, DOI 10.1016/j.exger.2005.01.003
   Thomas RP, 2002, J GASTROINTEST SURG, V6, P445, DOI 10.1016/S1091-255X(01)00010-5
   Turunen M, 2004, BBA-BIOMEMBRANES, V1660, P171, DOI 10.1016/j.bbamem.2003.11.012
   van der Loo B, 2002, CIRCULATION, V105, P1635, DOI 10.1161/01.CIR.0000014986.29834.71
NR 40
TC 24
Z9 28
U1 0
U2 3
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
EI 1758-535X
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD NOV
PY 2007
VL 62
IS 11
BP 1211
EP 1218
DI 10.1093/gerona/62.11.1211
PG 8
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA 272AH
UT WOS:000253829300004
PM 18000140
OA Bronze
DA 2024-02-19
ER

PT J
AU Xu, FQ
   Xu, QY
   Zhu, ZJ
   Jin, L
   Ye, TW
   Du, CF
   Gao, ZY
   Huang, XK
   Zhang, Z
   Jin, LM
   Yao, WF
AF Xu, Fei-Qi
   Xu, Qing-Yun
   Zhu, Zhang-Ji
   Jin, Lei
   Ye, Tai-Wei
   Du, Cheng-Fei
   Gao, Zhen-Yu
   Huang, Xiao-Kun
   Zhang, Zhe
   Jin, Li-Ming
   Yao, Wei-Feng
TI Visceral and ectopic fat are more predictively associated with primary
   liver cancer than overall obesity from genetic sights: A Mendelian
   randomization study
SO INTERNATIONAL JOURNAL OF CANCER
LA English
DT Article; Early Access
DE liver fat; mendelian randomization; obesity; primary liver cancer;
   visceral adipose tissue
ID WEAK INSTRUMENTS; INFLAMMATION; RISK; IL-6
AB Several observational studies have reported an association between obesity and primary liver cancer (PLC), while the causality behind this association and the comparison of the risk effects of different obesity indicators on PLC remain unclear. In this study, we performed two-sample Mendelian randomization (MR) analyses to assess the associations of genetically determined liver fat, visceral adipose tissue (VAT), and body mass index (BMI) with the risk of PLC. The summary statistics of exposures were obtained from two genome-wide association studies (GWASs) based on the UK Biobank (UKB) imaging cohort and the Genetic Epidemiology Research on Adult Health and Aging (GERA) cohort. GWAS summary statistics for PLC were obtained from FinnGen consortium R7 release data, including 304 PLC cases and 218 488 controls. Inverse-variance weighted (IVW) was used as the primary analysis, and a series of sensitivity analyses were performed to further verify the robustness of these findings. IVW analysis highlighted a significant association of genetically determined liver fat (OR per SD increase: 7.14; 95% CI: 5.10-9.99; P = 2.35E-30) and VAT (OR per SD increase: 5.70; 95% CI: 1.32-24.72; P = .020) with PLC but not of BMI with PLC. The findings were further confirmed by a series of MR methods. No evidence of horizontal pleiotropy between these associations existed. Our study suggested that genetically determined liver fat and VAT rather than BMI were associated with an increased risk of PLC, which suggested that visceral fat distribution is more predictive of the clinical risk of PLC than common in vitro measures.
C1 [Xu, Fei-Qi; Jin, Lei; Ye, Tai-Wei; Du, Cheng-Fei; Gao, Zhen-Yu; Huang, Xiao-Kun; Zhang, Zhe; Jin, Li-Ming; Yao, Wei-Feng] Zhejiang Prov Peoples Hosp, Affiliated Peoples Hosp, Hangzhou Med Coll, Canc Ctr,Gen Surg,Dept Hepatobiliary & Pancreat Su, Hangzhou, Zhejiang, Peoples R China.
   [Xu, Fei-Qi; Zhu, Zhang-Ji; Jin, Lei; Ye, Tai-Wei; Du, Cheng-Fei; Zhang, Zhe] Zhejiang Chinese Med Univ, Sch Clin Med 2, Hangzhou, Peoples R China.
   [Xu, Qing-Yun] Soochow Univ, Sch Publ Hlth, Suzhou Med Coll, Dept Epidemiol, Suzhou, Peoples R China.
   [Xu, Qing-Yun] Soochow Univ, Suzhou Med Coll, Jiangsu Key Lab Prevent & Translat Med Geriatr Dis, Suzhou, Peoples R China.
C3 Zhejiang Provincial People's Hospital; Hangzhou Medical College;
   Zhejiang Chinese Medical University; Soochow University - China; Soochow
   University - China
RP Yao, WF (corresponding author), Zhejiang Prov Peoples Hosp, Affiliated Peoples Hosp, Hangzhou Med Coll, Canc Ctr,Gen Surg,Dept Hepatobiliary & Pancreat Su, Hangzhou, Zhejiang, Peoples R China.
EM joe2118@126.com
OI Xu, Qingyun/0000-0001-7733-3813; Xu, Feiqi/0000-0002-7996-7040
FU We thank the investigators of UKB imaging cohort, GERA cohort and
   FinnGen consortium for making their results publicly available. Full
   acknowledgement and funding statements for each of these resources are
   available via the relevant cited reports.
FX We thank the investigators of UKB imaging cohort, GERA cohort and
   FinnGen consortium for making their results publicly available. Full
   acknowledgement and funding statements for each of these resources are
   available via the relevant cited reports.
CR Barberio AM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08159-w
   Beller E, 2019, EUR RADIOL, V29, P6662, DOI 10.1007/s00330-019-06276-8
   Bowden J, 2019, RES SYNTH METHODS, V10, P486, DOI 10.1002/jrsm.1346
   Brahma MK, 2021, ONCOGENE, V40, P5155, DOI 10.1038/s41388-021-01950-y
   Brion MJA, 2013, INT J EPIDEMIOL, V42, P1497, DOI 10.1093/ije/dyt179
   Burgess Stephen, 2019, Wellcome Open Res, V4, P186, DOI 10.12688/wellcomeopenres.15555.1
   Burgess S, 2017, EUR J EPIDEMIOL, V32, P377, DOI 10.1007/s10654-017-0255-x
   Burgess S, 2016, STAT MED, V35, P1880, DOI 10.1002/sim.6835
   Burgess S, 2013, GENET EPIDEMIOL, V37, P658, DOI 10.1002/gepi.21758
   Burgess S, 2011, INT J EPIDEMIOL, V40, P755, DOI 10.1093/ije/dyr036
   Davies NM, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k601
   Davies NM, 2015, STAT MED, V34, P454, DOI 10.1002/sim.6358
   George J, 2022, HEPATOL INT, V16, P733, DOI 10.1007/s12072-022-10352-5
   Hidayat K, 2018, OBES REV, V19, P1385, DOI 10.1111/obr.12705
   Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137
   Hodge DR, 2005, EUR J CANCER, V41, P2502, DOI 10.1016/j.ejca.2005.08.016
   Hoffmann TJ, 2018, GENETICS, V210, P499, DOI 10.1534/genetics.118.301479
   Ioannou GN, 2021, J HEPATOL, V75, P1476, DOI 10.1016/j.jhep.2021.08.012
   Jiang N, 2014, DRUG DES DEV THER, V8, P2295, DOI 10.2147/DDDT.S69004
   Kurki MI, 2023, NATURE, V613, P508, DOI 10.1038/s41586-022-05473-8
   Liu Y, 2021, ELIFE, V10, DOI 10.7554/eLife.65554
   Milic S, 2014, WORLD J GASTROENTERO, V20, P9330, DOI 10.3748/wjg.v20.i28.9330
   Montano-Loza AJ, 2018, HEPATOLOGY, V67, P914, DOI 10.1002/hep.29578
   Nougaret S, 2020, EUR RADIOL, V30, P4752, DOI 10.1007/s00330-020-06757-1
   Ong JS, 2019, GENET EPIDEMIOL, V43, P609, DOI 10.1002/gepi.22207
   Ooi GJ, 2021, J HEPATOL, V75, P524, DOI 10.1016/j.jhep.2021.04.013
   Parida S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20102519
   Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052
   Petrick JL, 2018, AM J GASTROENTEROL, V113, P1494, DOI 10.1038/s41395-018-0207-4
   Powell EE, 2021, LANCET, V397, P2212, DOI 10.1016/S0140-6736(20)32511-3
   Rees JMB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222362
   Rumgay H, 2022, J HEPATOL, V77, P1598, DOI 10.1016/j.jhep.2022.08.021
   Rumgay H, 2022, EUR J CANCER, V161, P108, DOI 10.1016/j.ejca.2021.11.023
   Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059
   Skrivankova VW, 2021, JAMA-J AM MED ASSOC, V326, P1614, DOI 10.1001/jama.2021.18236
   Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070
   Sohn W, 2021, CLIN MOL HEPATOL, V27, P157, DOI 10.3350/cmh.2020.0176
   Sung H, 2021, CA-CANCER J CLIN, V71, P209, DOI 10.3322/caac.21660
   Zeng Q, 2021, METABOLISM, V115, DOI 10.1016/j.metabol.2020.154456
   Zhao QY, 2020, ANN STAT, V48, P1742, DOI 10.1214/19-AOS1866
   Zheng Jie, 2017, Curr Epidemiol Rep, V4, P330, DOI 10.1007/s40471-017-0128-6
NR 41
TC 0
Z9 0
U1 4
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0020-7136
EI 1097-0215
J9 INT J CANCER
JI Int. J. Cancer
PD 2023 OCT 10
PY 2023
DI 10.1002/ijc.34751
EA OCT 2023
PG 8
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA U0BV3
UT WOS:001081555400001
PM 37815300
OA hybrid
DA 2024-02-19
ER

PT J
AU Owen, T
   Carpino, G
   Chen, LX
   Kundu, D
   Wills, P
   Ekser, B
   Onori, P
   Gaudio, E
   Alpini, G
   Francis, H
   Kennedy, L
AF Owen, Travis
   Carpino, Guido
   Chen, Lixian
   Kundu, Debjyoti
   Wills, Payton
   Ekser, Burcin
   Onori, Paolo
   Gaudio, Eugenio
   Alpini, Gianfranco
   Francis, Heather
   Kennedy, Lindsey
TI Endothelin Receptor-A Inhibition Decreases Ductular Reaction, Liver
   Fibrosis, and Angiogenesis in a Model of Cholangitis
SO CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY
LA English
DT Article
DE Midkine; Endothelial Cells; Liver Fibrosis; Cholangiopathies
ID GROWTH-FACTOR BETA-1; SCLEROSING CHOLANGITIS; PORTAL-HYPERTENSION;
   COLLAGEN-SYNTHESIS; STELLATE CELLS; MESSENGER-RNA; KAPPA-B; EXPRESSION;
   VEGF; ACTIVATION
AB BACKGROUND & AIMS: Primary sclerosing cholangitis (PSC) leads to ductular reaction and fibrosis and is complicated by vascular dysfunction. Cholangiocyte and endothelial cell crosstalk modulates their proliferation in cholestatic models. Endothelin (ET)-1 and ET-2 bind to their receptor, ET-A, and cholangiocytes are a key source of ET-1 after bile duct ligation. We aimed to evaluate the therapeutic potential of ET-A inhibition in PSC and biliary-endothelial crosstalk mediated by this pathway.
   METHODS: Wild-type and multidrug resistance 2 knockout (Mdr2(-/-)) mice at 12 weeks of age were treated with vehicle or Ambrisentan (ET-A antagonist) for 1 week by daily intraperitoneal injections. Human control and PSC samples were used.
   RESULTS: Mdr2(-/-) mice at 4, 8, and 12 weeks displayed angiogenesis that peaked at 12 weeks. Mdr2(-/-) mice at 12 weeks had enhanced biliary ET-1/ET-2/ET-A expression and secretion, whereas human PSC had enhanced ET-1/ET-A expression and secretion. Ambrisentan reduced biliary damage, immune cell infiltration, and fibrosis in Mdr2(-/-) mice. Mdr2(-/-) mice had squamous cholangiocytes with blunted microvilli and dilated arterioles lacking cilia; however, Ambrisentan reversed these alterations. Ambrisentan decreased cholangiocyte expression of proangiogenic factors, specifically midkine, through the regulation of cFOS. In vitro, ET-1/ET-A caused cholangiocyte senescence, endothelial cell angiogenesis, and macrophage inflammation. In vitro, human PSC cholangiocyte supernatants increased endothelial cell migration, which was blocked with Ambrisentan treatment.
   CONCLUSIONS: ET-A inhibition reduced biliary and liver damage in Mdr2(-/-) mice. ET-A promotes biliary angiocrine signaling that may, in turn, enhance angiogenesis. Targeting ETA may prove therapeutic for PSC, specifically patients displaying vascular dysfunction.
C1 [Owen, Travis; Chen, Lixian; Kundu, Debjyoti; Wills, Payton; Alpini, Gianfranco; Francis, Heather; Kennedy, Lindsey] Indiana Univ Sch Med, Dept Med, Div Gastroenterol & Hepatol, Indianapolis, IN USA.
   [Carpino, Guido; Onori, Paolo; Gaudio, Eugenio] Sapienza Univ Rome, Dept Anat Histol Forens Med & Orthoped Sci, Rome, Italy.
   [Ekser, Burcin] Indiana Univ Sch Med, Dept Surg, Div Transplant Surg, Indianapolis, IN USA.
   [Alpini, Gianfranco; Francis, Heather; Kennedy, Lindsey] Richard L Roudebush VA Med Ctr, Dept Res, Indianapolis, IN USA.
   [Kennedy, Lindsey] Indiana Univ Sch Med, Richard L Roudebush VA Med Ctr, Dept Med, Dept Res, 702 Rotary Circle,Room 007, Indianapolis, IN 46202 USA.
C3 Indiana University System; Indiana University Bloomington; Sapienza
   University Rome; Indiana University System; Indiana University
   Bloomington; US Department of Veterans Affairs; Veterans Health
   Administration (VHA); Richard L. Roudebush VA Medical Center; Indiana
   University System; Indiana University Bloomington; US Department of
   Veterans Affairs; Veterans Health Administration (VHA); Richard L.
   Roudebush VA Medical Center
RP Kennedy, L (corresponding author), Indiana Univ Sch Med, Richard L Roudebush VA Med Ctr, Dept Med, Dept Res, 702 Rotary Circle,Room 007, Indianapolis, IN 46202 USA.
EM linkenn@iu.edu
OI CARPINO, Guido/0000-0001-8570-2519; Ekser, Burcin/0000-0003-0741-8007
FU John B. Hickam Endowed Chair, Gastroenterology and Hepatology, Medicine,
   Indiana University School of Medicine; Indiana University Health-Indiana
   University School of Medicine Strategic Research Initiative; VA Merit
   award [DK119421]; NIH [DK115184, DK076898, DK107310, DK110035, DK062975,
   IK6 BX004601, 5I01BX000574, IK6BX005226]; Sapienza University of Rome,
   Rome, Italy; Senior Career Scientist Award; United States Department of
   Veteran's Affairs, Biomedical Laboratory Research and Development
   Service;  [1I01BX003031];  [DK108959];  [DK054811]
FX Supported by the John B. Hickam Endowed Chair, Gastroenterology and
   Hepatology, Medicine, Indiana University School of Medicine; the Indiana
   University Health-Indiana University School of Medicine Strategic
   Research Initiative; the Senior Career Scientist Award (IK6 BX004601) ,
   and the VA Merit award (5I01BX000574) to GA, the Career Scientist Award
   (IK6BX005226) and the VA Merit award (1I01BX003031) to HF, and Career
   Development Award-2 to LK (1IK2BX005306) from the United States
   Department of Veteran's Affairs, Biomedical Laboratory Research and
   Development Service; and NIH grants DK108959 and DK119421 (HF) ,
   DK054811, DK115184, DK076898, DK107310, DK110035, and DK062975 (GA) . EG
   and PO were supported by Grants (Progetti di Ateneo) from Sapienza
   University of Rome, Rome, Italy. Portions of these studies were
   supported by resources at the Richard L. Roudebush VA Medical Center,
   Indianapolis, IN. The views expressed in this article are those of the
   authors and do not necessarily represent the views of the Department of
   Veterans Affairs.
CR Bahde R, 2014, HEPATOLOGY, V59, P1107, DOI 10.1002/hep.26766
   BLOCH KD, 1991, GENOMICS, V10, P236, DOI 10.1016/0888-7543(91)90505-9
   BLUHM RE, 1993, HEPATOLOGY, V18, P961, DOI 10.1002/hep.1840180430
   Bravo M, 2021, DIS MODEL MECH, V14, DOI 10.1242/dmm.048884
   Browatzki M, 2000, BASIC RES CARDIOL, V95, P98, DOI 10.1007/s003950050170
   Caligiuri A, 1998, AM J PHYSIOL-GASTR L, V275, pG835, DOI 10.1152/ajpgi.1998.275.4.G835
   Chen CC, 1996, CYTOKINE, V8, P58, DOI 10.1006/cyto.1995.0008
   Cho JJ, 2000, GASTROENTEROLOGY, V118, P1169, DOI 10.1016/S0016-5085(00)70370-2
   Coll M, 2022, HEPATOLOGY, V75, P353, DOI 10.1002/hep.32140
   Corpechot C, 2002, HEPATOLOGY, V35, P1010, DOI 10.1053/jhep.2002.32524
   Davenport AP, 2016, PHARMACOL REV, V68, P357, DOI 10.1124/pr.115.011833
   De Gottardi Andrea, 2006, Comp Hepatol, V5, P9, DOI 10.1186/1476-5926-5-9
   de Jong IEM, 2022, HEPATOLOGY, V75, P814, DOI 10.1002/hep.32166
   Dinsmore C, 2016, EMBO REP, V17, P156, DOI 10.15252/embr.201541019
   DISALVO J, 1995, J BIOL CHEM, V270, P7717, DOI 10.1074/jbc.270.13.7717
   Ehling J, 2014, GUT, V63, P1960, DOI 10.1136/gutjnl-2013-306294
   Elisa T, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/147616
   Enholm B, 1997, ONCOGENE, V14, P2475, DOI 10.1038/sj.onc.1201090
   Farré D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605
   Fickert P, 2002, GASTROENTEROLOGY, V123, P1238, DOI 10.1053/gast.2002.35948
   Fickert P, 2004, GASTROENTEROLOGY, V127, P261, DOI 10.1053/j.gastro.2004.04.009
   Gabriel A, 1999, J HEPATOL, V30, P440, DOI 10.1016/S0168-8278(99)80103-2
   Gandhi CR, 2000, EUR J PHARMACOL, V406, P311, DOI 10.1016/S0014-2999(00)00683-X
   GANDHI CR, 1990, J BIOL CHEM, V265, P17432
   Gopinathan G, 2015, CANCER RES, V75, P3098, DOI 10.1158/0008-5472.CAN-15-1227
   Govaere O, 2019, J PATHOL, V248, P66, DOI 10.1002/path.5228
   Hegeman MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015653
   Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727
   Ikenaga N, 2015, AM J PATHOL, V185, P325, DOI 10.1016/j.ajpath.2014.10.013
   ISALES CM, 1993, BIOCHEM BIOPH RES CO, V191, P1244, DOI 10.1006/bbrc.1993.1351
   Iwashima A, 1997, IN VITRO CELL DEV-AN, V33, P751
   Kennedy L, 2023, J HEPATOL, V78, P99, DOI 10.1016/j.jhep.2022.07.034
   Kennedy L, 2020, AM J PATHOL, V190, P1018, DOI 10.1016/j.ajpath.2020.01.013
   Koch DG, 2012, DIGEST DIS SCI, V57, P516, DOI 10.1007/s10620-011-1905-6
   Koda Masahiko, 2006, Comp Hepatol, V5, P5, DOI 10.1186/1476-5926-5-5
   Königshofer P, 2022, HEPATOLOGY, V75, P610, DOI 10.1002/hep.32220
   Korff T, 2012, CARDIOVASC RES, V94, P510, DOI 10.1093/cvr/cvs124
   Koyama Y, 2012, GLIA, V60, P1954, DOI 10.1002/glia.22411
   Kyritsi K, 2021, HEPATOLOGY, V73, P2397, DOI 10.1002/hep.31497
   Lambers C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073399
   Lautz T, 2018, EBIOMEDICINE, V27, P237, DOI 10.1016/j.ebiom.2017.11.020
   Lazaridis KN, 2016, NEW ENGL J MED, V375, P1161, DOI 10.1056/NEJMra1506330
   Lemoinne S, 2015, HEPATOLOGY, V61, P1041, DOI 10.1002/hep.27318
   Ling L, 2012, LIFE SCI, V91, P716, DOI 10.1016/j.lfs.2012.02.003
   Luo B, 2005, GASTROENTEROLOGY, V129, P682, DOI 10.1053/j.gastro.2005.05.050
   Mahabeleshwar GH, 2006, J EXP MED, V203, P2495, DOI 10.1084/jem.20060807
   McCartney SA, 2002, LIFE SCI, V71, P1893, DOI 10.1016/S0024-3205(02)01923-9
   McKenna S, 2015, J IMMUNOL, V195, P3866, DOI 10.4049/jimmunol.1501017
   Mende S, 2013, DIGEST DIS SCI, V58, P1271, DOI 10.1007/s10620-012-2499-3
   Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333
   Oh H, 1999, J BIOL CHEM, V274, P15732, DOI 10.1074/jbc.274.22.15732
   Patsenker E, 2009, HEPATOLOGY, V50, P1501, DOI 10.1002/hep.23144
   Reimegård J, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-02142-w
   Reinehr R, 2002, HEPATOLOGY, V36, P861, DOI 10.1053/jhep.2002.35623
   Said EA, 2022, PLOS ONE, V17, DOI 10.1371/journal.pone.0267662
   Saida K, 2000, GENOMICS, V64, P51, DOI 10.1006/geno.1999.6083
   Salani D, 2000, AM J PATHOL, V157, P1703, DOI 10.1016/S0002-9440(10)64807-9
   Sato K, 2019, HEPATOLOGY, V69, P420, DOI 10.1002/hep.30150
   Schaub JR, 2018, NATURE, V557, P247, DOI 10.1038/s41586-018-0075-5
   Schneider MP, 2007, ANNU REV PHARMACOL, V47, P731, DOI 10.1146/annurev.pharmtox.47.120505.105134
   Senavirathna LK, 2020, PHYSIOL REP, V8, DOI 10.14814/phy2.14343
   Storey JD, 2007, AM J HUM GENET, V80, P502, DOI 10.1086/512017
   Sun LK, 2022, CELL REP, V38, DOI 10.1016/j.celrep.2022.110349
   Tabibian JH, 2014, HEPATOLOGY, V59, P2263, DOI 10.1002/hep.26993
   Tanos T, 2005, J BIOL CHEM, V280, P18842, DOI 10.1074/jbc.M500620200
   Tièhe S, 2001, J HEPATOL, V34, P38, DOI 10.1016/S0168-8278(00)00031-3
   Tsuneyama K, 2003, HISTOPATHOLOGY, V43, P55, DOI 10.1046/j.1365-2559.2003.01658.x
   Tugues S, 2007, HEPATOLOGY, V46, P1919, DOI 10.1002/hep.21921
   Verstegen MMA, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-79082-8
   Vohra BPS, 2007, DEV DYNAM, V236, P106, DOI 10.1002/dvdy.21028
   Weckbach LT, 2012, AM J PHYSIOL-HEART C, V303, pH429, DOI 10.1152/ajpheart.00934.2011
   Wu LC, 2011, FOOD FUNCT, V2, P204, DOI 10.1039/c0fo00158a
   Yi ET, 2012, ACTA PHARMACOL SIN, V33, P1518, DOI 10.1038/aps.2012.115
   Zachary I, 2003, BIOCHEM SOC T, V31, P1171
   Zipprich A, 2021, LIVER INT, V41, P554, DOI 10.1111/liv.14757
NR 75
TC 1
Z9 1
U1 3
U2 3
PU ELSEVIER INC
PI SAN DIEGO
PA 525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 2352-345X
J9 CELL MOL GASTROENTER
JI Cell. Mol. Gastroenterol. Hepatol.
PY 2023
VL 16
IS 4
BP 513
EP 540
DI 10.1016/j.jcmgh.2023.06.005
EA AUG 2023
PG 28
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA R2NZ0
UT WOS:001062779500001
PM 37336290
OA Green Published
DA 2024-02-19
ER

PT J
AU Timchenko, LT
   Salisbury, E
   Wang, GL
   Nguyen, H
   Albrecht, JH
   Hershey, JWB
   Timchenko, NA
AF Timchenko, Lubov T.
   Salisbury, Elizabeth
   Wang, Guo-Li
   Nguyen, Heather
   Albrecht, Jeffrey H.
   Hershey, John W. B.
   Timchenko, Nikolai A.
TI Age-specific CUGBP1-eIF2 complex increases translation of
   CCAAT/enhancer-binding protein β in old liver
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID TRANSCRIPTIONAL INHIBITORY PROTEIN; ACUTE-PHASE RESPONSE; C/EBP-ALPHA;
   MESSENGER-RNA; POSTTRANSCRIPTIONAL REGULATION; ISOFORM EXPRESSION; LIP;
   CALRETICULIN; INITIATION; INTERACTS
AB The RNA-binding protein CUGBP1 regulates translation of proteins in a variety of biological processes. In this study, we show that aging liver increases CUGBP1 translational activities by induction of a high molecular weight protein-protein complex of CUGBP1. The complex contains CUGBP1, subunits alpha, beta, and gamma of the initiation translation factor eIF2, and four proteins of the endoplasmic reticulum, eR90, CRT, eR60, and Grp78. The induction of the CUGBP1-eIF2 complex in old livers is associated with the elevation of protein levels of CUGBP1 and with the hyper-phosphorylation of CUGBP1 by a cyclin D3-cdk4 kinase, activity of which is increased with age. We have examined the role of the elevation of CUGBP1 and the role of cyclin D3-cdk4 mediated phosphorylation of CUGBP1 in the formation of the CUGBP1-eIF2 complex by using CUGBP1 transgenic mice and young animals expressing high levels of cyclin D3 after injection with cyclin D3 plasmid. These studies showed that both the increased levels of CUGBP1 and cdk4-mediated hyper-phosphorylation of CUGBP1 are involved in the age-associated induction of the CUGBP1-eIF2 complex. The CUGBP1-eIF2 complex is bound to C/EBP beta mRNA in the liver of old animals, and this binding correlates with the increased amounts of liver-enriched activator protein and liver-enriched inhibitory protein. Consistent with these observations, the purified CUGBP1-eIF2 complex binds to the 5' region of C/EBP beta mRNA and significantly increases translation of the three isoforms of C/EBP beta in a cell-free translation system, in cultured cells, and in the liver. Thus, these studies demonstrated that age-mediated induction of the CUGBP1-eIF2 complex changes translation of C/EBP beta in old livers.
C1 Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA.
   Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA.
   Baylor Coll Med, Dept Med, Houston, TX 77030 USA.
   Hennepin Cty Med Ctr, Div Gastroenterol, Minneapolis, MN 55415 USA.
   Univ Calif Davis, Sch Med, Dept Biochem & Mol Med, Davis, CA 95616 USA.
C3 Baylor College of Medicine; Baylor College of Medicine; Baylor College
   of Medicine; Hennepin County Medical Center; University of California
   System; University of California Davis
RP Timchenko, NA (corresponding author), Baylor Coll Med, Dept Pathol, 1 Baylor Plaza, Houston, TX 77030 USA.
EM nikolait@bcm.tmc.edu
OI Salisbury, Elizabeth/0000-0003-3607-2367
FU NCI NIH HHS [CA 100070] Funding Source: Medline; NIAMS NIH HHS [AR
   052791, AR 44387, AR 49222] Funding Source: Medline; NIA NIH HHS [AG
   20752, AG 025477] Funding Source: Medline; NIDDK NIH HHS [DK 54921]
   Funding Source: Medline; NIGMS NIH HHS [GM 55188] Funding Source:
   Medline
CR An MR, 1996, MOL CELL BIOL, V16, P2295
   Baldwin BR, 2004, MOL CELL BIOL, V24, P3682, DOI 10.1128/MCB.24.9.3682-3691.2004
   Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854
   Calkhoven CF, 2000, GENE DEV, V14, P1920
   DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3
   Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448
   Hsieh CC, 1998, MOL BIOL CELL, V9, P1479, DOI 10.1091/mbc.9.6.1479
   Iakova P, 2004, EMBO J, V23, P406, DOI 10.1038/sj.emboj.7600052
   Kowenz-Leutz E, 1999, MOL CELL, V4, P735, DOI 10.1016/S1097-2765(00)80384-6
   Lincoln AJ, 1998, J BIOL CHEM, V273, P9552, DOI 10.1074/jbc.273.16.9552
   Luedde T, 2004, HEPATOLOGY, V40, P356, DOI 10.1002/hep.20333
   Sebastian T, 2005, EMBO J, V24, P3301, DOI 10.1038/sj.emboj.7600789
   Shao JH, 2005, DIABETES, V54, P976, DOI 10.2337/diabetes.54.4.976
   Timchenko LT, 2002, MOL CELL BIOL, V22, P7242, DOI 10.1128/MCB.22.20.7242-7257.2002
   Timchenko NA, 1999, NUCLEIC ACIDS RES, V27, P4517, DOI 10.1093/nar/27.22.4517
   Timchenko NA, 2005, J BIOL CHEM, V280, P20549, DOI 10.1074/jbc.M409563200
   Timchenko NA, 2004, J BIOL CHEM, V279, P13129, DOI 10.1074/jbc.M312923200
   Wang GL, 2006, MOL CELL BIOL, V26, P2570, DOI 10.1128/MCB.26.7.2570-2582.2006
   Wang WG, 2000, MOL CELL BIOL, V20, P760, DOI 10.1128/MCB.20.3.760-769.2000
   Welm AL, 1999, MOL CELL BIOL, V19, P1695
   Welm AL, 2000, J BIOL CHEM, V275, P27406
   WIMONWATWATEE T, 1994, AM J PHYSIOL, V267, pG201, DOI 10.1152/ajpgi.1994.267.2.G201
   Xiong W, 2001, NUCLEIC ACIDS RES, V29, P3087, DOI 10.1093/nar/29.14.3087
NR 23
TC 78
Z9 94
U1 0
U2 6
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI ROCKVILLE
PA 11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD OCT 27
PY 2006
VL 281
IS 43
BP 32806
EP 32819
DI 10.1074/jbc.M605701200
PG 14
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 096ZB
UT WOS:000241414500079
PM 16931514
OA hybrid
DA 2024-02-19
ER

PT J
AU MASELLA, R
   PIGNATELLI, E
   MARINELLI, T
   MODESTI, D
   VERNA, R
   CANTAFORA, A
AF MASELLA, R
   PIGNATELLI, E
   MARINELLI, T
   MODESTI, D
   VERNA, R
   CANTAFORA, A
TI AGE-RELATED VARIATIONS IN PLASMA AND LIVER LIPIDS OF YOSHIDA RATS - A
   COMPARISON WITH WISTAR RATS
SO COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR
   BIOLOGY
LA English
DT Article
DE YOSHIDA RAT; LIPOPROTEIN; LIVER; PLASMA; CHOLESTEROL;
   HYPERCHOLESTEROLEMIA; AGING; HYPERTRIGLYCERIDEMIA
ID DESATURASE ACTIVITIES; CORPULENT RAT; SERUM-LIPIDS; LIPOPROTEINS;
   METABOLISM; PHOSPHATIDYLCHOLINE; CIRRHOSIS; JCR
AB Lipoprotein and liver lipids of spontaneously hyperlipidemic Yoshida rats were compared with those of normolipidemic Wistar animals for studying their age- and strain-related differences. Both strains showed an age-related increase in the total plasma cholesterol concentration. However, the Yoshida strain had a higher content of cholesteryl esters and triglycerides than the Wistar strain in both young and adult animals (2- and 8-month-old animals, respectively). The free cholesterol content was also higher, but only in the 8-month-old animals. Both strains showed an age-related increase in the proportion of HDL1 and a symmetrical decrease in both the HDL2 and HDL3 subfractions, but the variations were more evident in the Yoshida strain. The study of strain-related differences suggested that the spontaneous hypertriglyceridemia of the Yoshida strain was not only related to the higher amount and proportion of the VLDL fraction, but also to the higher content of triglycerides in the LDL fraction. The livers of Yoshida rats accumulated more triglycerides (with an age-related progression) than those of Wistar rats. The major lipid classes in the liver of Yoshida rats contained a significantly higher proportion of monounsaturated fatty acyls. Furthermore, this proportion showed an age-related increase in all the lipid classes, but in cholesteryl esters. This suggested that liver desaturases had a relevant role in the development of hyperlipidemia, and of its age-related variations, in the Yoshida strain. In conclusion, Yoshida rats appeared a better model for the study of age-related alterations in the liver lipid metabolism since the alterations are stronger and earlier than in Wistar animals and are not complicated by the development of degenerative pathologies typical of old rats.
C1 IST SUPER SANITA,METAB & PATHOL BIOCHEM LAB,I-00161 ROME,ITALY.
   UNIV LAQUILA,DIPARTIMENTO MED SPERIMENTALE,I-67100 LAQUILA,ITALY.
C3 Istituto Superiore di Sanita (ISS); University of L'Aquila
RI Masella, Roberta/B-4109-2015
OI Masella, Roberta/0000-0002-3173-1573; VERNA, Roberto/0000-0002-1869-3912
CR ALVARO D, 1986, BIOCHIM BIOPHYS ACTA, V878, P216, DOI 10.1016/0005-2760(86)90149-9
   BLOND JP, 1989, LIPIDS, V24, P389, DOI 10.1007/BF02535146
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   CANTAFORA A, 1992, EUR J CLIN INVEST, V22, P777, DOI 10.1111/j.1365-2362.1992.tb01446.x
   CANTAFORA A, 1993, ARCH GERONTOL GERIAT, V16, P249, DOI 10.1016/0167-4943(93)90036-H
   CANTAFORA A, 1993, P SOC EXP BIOL MED, V204, P90, DOI 10.3181/00379727-204-43639
   CANTAFORA A, 1992, ARCH GERONTOL GERI S, V3, P93
   DIBIASE A, 1989, ITAL J GASTROENTEROL, V21, P204
   DOLPHIN PJ, 1990, BIOCHIM BIOPHYS ACTA, V1042, P99, DOI 10.1016/0005-2760(90)90062-3
   DOLPHIN PJ, 1987, BIOCHIM BIOPHYS ACTA, V919, P140, DOI 10.1016/0005-2760(87)90200-1
   FANTAPPIE S, 1992, LIFE SCI, V50, P1913, DOI 10.1016/0024-3205(92)90552-Z
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   GIGANTI MG, 1991, BIOTECHNOLOGY CELL R, P457
   LEIKIN AI, 1987, BIOCHIM BIOPHYS ACTA, V922, P294, DOI 10.1016/0005-2760(87)90052-X
   PETIT D, 1988, ARCH INT PHYSIOL BIO, V96, P51, DOI 10.3109/13813458809079625
   ROSE HG, 1965, J LIPID RES, V6, P428
   TARUGI P, 1991, J LIPID RES, V32, P1675
   VANCE JE, 1990, J LIPID RES, V31, P1491
   WAHLE KWJ, 1977, LIPIDS, V12, P135, DOI 10.1007/BF02533282
NR 19
TC 5
Z9 5
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0305-0491
J9 COMP BIOCHEM PHYS B
JI Comp. Biochem. Physiol B-Biochem. Molec. Biol.
PD JUN
PY 1995
VL 111
IS 2
BP 319
EP 327
DI 10.1016/0305-0491(94)00217-I
PG 9
WC Biochemistry & Molecular Biology; Zoology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Zoology
GA RE801
UT WOS:A1995RE80100020
PM 7599992
DA 2024-02-19
ER

PT J
AU Cui, SS
   Chen, YY
   Guo, YF
   Wang, X
   Chen, DH
   Andl, CD
   Hosui, A
AF Cui, Shuaishuai
   Chen, Yuanyuan
   Guo, Yunfei
   Wang, Xing
   Chen, Dahu D.
   Andl, Claudia
   Hosui, Atsushi
TI Hsa-miR-22-3p inhibits liver cancer cell EMT and cell migration/
   invasion by indirectly regulating SPRY2
SO PLOS ONE
LA English
DT Article
ID HEPATOCELLULAR-CARCINOMA; BREAST-CANCER; TARGETING MIR-22-3P;
   TUMOR-SUPPRESSOR; DOWN-REGULATION; EXPRESSION; MICRORNA-22; ACTIVATION;
   SPROUTY2; PATHWAY
AB The general mechanism for microRNAs to play biological function is through their inhibition on the expression of their target genes. In cancer, microRNAs may accelerate cell senescence, block angiogenesis, decrease energy supplies, repress tumor cell cycle and promote apoptosis to function as the tumor repressors. On the other hand, microRNAs can modulate tumor suppressor molecules to activate oncogene relevant signaling pathway to initiate tumorigenesis and promote tumor progression. By targeting different genes, miR-22 can function as either a tumor suppressor or a tumor promoter in different types of cancer. In liver cancer, miR-22 mainly functions as a tumor suppressor via its regulation on different genes. In this study, we demonstrated that miR-22 indirectly regulates SPRY2 by inhibiting CBL, an E3 ligase for SPRY2 that has been confirmed. As one of the modulators of the MAPK (mitogen-activated protein kinase)/ERK (extracellular signal-regulated kinase) signaling pathway, SPRY2 plays important roles in many developmental and physiological processes, and its deregulation has been reported in different types of cancer and shown to affect cancer development, progression, and metastasis. By inhibiting the expression of CBL, which stabilizes SPRY2, miR-22 indirectly upregulates SPRY2, thereby suppressing the epithelial-mesenchymal transition (EMT), cell migration, and invasion and decreasing the expression of liver cancer stem cell (CSC) marker genes. The inhibitory effects of miR-22 on EMT, cell migration, and invasion can be blocked by the knockdown of SPRY2 expression in miR-22 overexpressing cells. Additionally, we demonstrated that miR-22 expression inhibits the ERK signaling pathway and that this effect is due to its upregulation of SPRY2. Overall, our study revealed a novel miR-22-3p/CBL/SPRY2/ERK axis that plays an important role in EMT, cell migration, and invasion of liver cancer cells.
C1 [Cui, Shuaishuai; Chen, Yuanyuan; Guo, Yunfei; Chen, Dahu D.] Shandong Univ Technol, Sch Life Sci & Med, Zibo, Peoples R China.
   [Wang, Xing] Jiangsu Normal Univ, Sch Life Sci, Xuzhou, Peoples R China.
C3 Shandong University of Technology; Jiangsu Normal University
RP Chen, DH (corresponding author), Shandong Univ Technol, Sch Life Sci & Med, Zibo, Peoples R China.
EM dahuchen@sdut.edu.cn
OI CHEN, DAHU/0000-0003-2470-2173
FU National Natural Science Foundation of China [81872005]
FX This study was supported by National Natural Science Foundation of China
   (81872005) to DC. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Budd WT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142373
   Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406
   Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997
   Chen B, 2015, CANCER LETT, V356, P410, DOI 10.1016/j.canlet.2014.09.028
   Chen M, 2016, ONCOTARGET, V7, P80751, DOI 10.18632/oncotarget.13037
   Chen X, 2002, MOL BIOL CELL, V13, P1929, DOI 10.1091/mbc.02-02-0023
   Dong XY, 2016, INT J MOL MED, V38, P446, DOI 10.3892/ijmm.2016.2634
   Edwin F, 2010, J BIOL CHEM, V285, P255, DOI 10.1074/jbc.M109.030882
   Fan T, 2021, JCPSP-J COLL PHYSICI, V31, P937, DOI 10.29271/jcpsp.2021.08.937
   Fan WX, 2016, MOL MED REP, V13, P4800, DOI 10.3892/mmr.2016.5101
   Feng YH, 2011, CANCER BIOL THER, V11, P111, DOI 10.4161/cbt.11.1.13965
   Fong CW, 2006, CANCER RES, V66, P2048, DOI 10.1158/0008-5472.CAN-05-1072
   Fritzsche S, 2006, ENDOCR-RELAT CANCER, V13, P839, DOI 10.1677/erc.1.01190
   Hall AB, 2003, CURR BIOL, V13, P308, DOI 10.1016/S0960-9822(03)00086-1
   Han XM, 2022, DIS MARKERS, V2022, DOI 10.1155/2022/3750734
   He Y, 2018, CELL PHYSIOL BIOCHEM, V47, P1465, DOI 10.1159/000490839
   He Z, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3121-z
   Hong SY, 2018, CANCER RES, V78, P4984, DOI 10.1158/0008-5472.CAN-17-3858
   Huang W, 2021, CELL CYCLE, V20, P490, DOI 10.1080/15384101.2021.1875665
   Huang ZP, 2014, TRENDS CARDIOVAS MED, V24, P267, DOI 10.1016/j.tcm.2014.07.005
   Hussain SA, 2001, ANN ONCOL, V12, P161, DOI 10.1023/A:1008370324827
   Ibrahim AF, 2011, CANCER RES, V71, P5214, DOI 10.1158/0008-5472.CAN-10-4645
   Kong LM, 2014, CANCER RES, V74, P3764, DOI 10.1158/0008-5472.CAN-13-3555
   Lai ECH, 2005, SURG-J R COLL SURG E, V3, P210, DOI 10.1016/S1479-666X(05)80043-5
   Lee SA, 2008, HEPATOLOGY, V47, P1200, DOI 10.1002/hep.22169
   Li B, 2020, J CELL PHYSIOL, V235, P4605, DOI 10.1002/jcp.29338
   Li J, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1046-x
   Li WX, 2008, INT J CANCER, V123, P1616, DOI 10.1002/ijc.23693
   Liu XB, 2019, LIFE SCI, V217, P57, DOI 10.1016/j.lfs.2018.11.057
   Liu YQ, 2018, MOL CANCER, V17, DOI 10.1186/s12943-017-0751-3
   Llovet JM, 2018, NAT REV CLIN ONCOL, V15, P599, DOI 10.1038/s41571-018-0073-4
   Lo TL, 2004, CANCER RES, V64, P6127, DOI 10.1158/0008-5472.CAN-04-1207
   Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888
   Luo B, 2020, EUR REV MED PHARMACO, V24, P5996, DOI 10.26355/eurrev_202006_21493
   Luo LJ, 2017, CANCER CELL INT, V17, DOI 10.1186/s12935-016-0380-8
   Lv WQ, 2022, OPEN MED-WARSAW, V17, P556, DOI 10.1515/med-2022-0429
   Ma DJ, 2021, ACTA BIOCHIM POL, V68, P667, DOI 10.18388/abp.2020_5540
   Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174
   Ma XT, 2014, INT J MED SCI, V11, P810, DOI 10.7150/ijms.8647
   Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027
   Masoumi-Moghaddam S, 2014, CANCER METAST REV, V33, P695, DOI 10.1007/s10555-014-9497-1
   Minowada G, 1999, DEVELOPMENT, V126, P4465
   Nadeau RJ, 2007, J CELL BIOCHEM, V100, P151, DOI 10.1002/jcb.21040
   Palacios F, 2015, LEUKEMIA, V29, P115, DOI 10.1038/leu.2014.158
   Pan GZ, 2022, BIOENGINEERED, V13, P1346, DOI 10.1080/21655979.2021.2017565
   Savi F, 2014, CLIN SCI, V127, P233, DOI 10.1042/CS20130580
   Song K, 2012, HEPATOB PANCREAT DIS, V11, P177, DOI 10.1016/S1499-3872(12)60145-3
   Sutterlüty H, 2007, MOL CANCER RES, V5, P509, DOI 10.1158/1541-7786.MCR-06-0273
   Tan XH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159275
   Tian YD, 2021, ONCOTARGETS THER, V14, P1219, DOI 10.2147/OTT.S282151
   Wang B, 2017, INT REV IMMUNOL, V36, P176, DOI 10.1080/08830185.2017.1281272
   Wang CM, 2012, J HEPATOL, V57, P577, DOI 10.1016/j.jhep.2012.04.026
   Wang Lijun, 2020, Liver Res, V4, P74, DOI 10.1016/j.livres.2020.06.001
   Wang MN, 2018, BIOCHEM BIOPH RES CO, V504, P283, DOI 10.1016/j.bbrc.2018.08.175
   Wang WB, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-102
   Wang XH, 2021, PPAR RES, V2021, DOI 10.1155/2021/6661828
   Wang Y, 2021, J ONCOL, V2021, DOI 10.1155/2021/3874478
   Wongjampa W, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206644
   Wu C, 2021, 3 BIOTECH, V11, DOI 10.1007/s13205-021-02981-8
   Xiong YJ, 2010, HEPATOLOGY, V51, P836, DOI 10.1002/hep.23380
   Xu MJ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0206-1
   Yamashita T, 2007, CANCER RES, V67, P10831, DOI 10.1158/0008-5472.CAN-07-0908
   Yawut N, 2020, CANCER MANAG RES, V12, P10243, DOI 10.2147/CMAR.S271109
   Yim DGR, 2015, ONCOGENE, V34, P474, DOI 10.1038/onc.2013.564
   You Y, 2016, ONCOTARGET, V7, P57099, DOI 10.18632/oncotarget.10981
   Zeng Z, 2020, ARTIF CELL NANOMED B, V48, P683, DOI 10.1080/21691401.2019.1703723
   Zhang GJ, 2012, MED ONCOL, V29, P3108, DOI 10.1007/s12032-012-0233-9
   Zhang J, 2010, BRIT J CANCER, V103, P1215, DOI 10.1038/sj.bjc.6605895
   Zhang W, 2020, NEOPLASMA, V67, P484, DOI 10.4149/neo_2020_190418N350
   Zhang X, 2017, BIOL RES, V50
   Zhang X, 2021, INFLAMMATION, V44, P91, DOI 10.1007/s10753-020-01311-z
   Zhao LJ, 2019, AGING-US, V11, P7098, DOI 10.18632/aging.102240
   Zhou L, 2013, J INT MED RES, V41, P1009, DOI 10.1177/0300060513484436
   Zuo QF, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.297
NR 74
TC 3
Z9 3
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 7
PY 2023
VL 18
IS 2
AR e0281536
DI 10.1371/journal.pone.0281536
PG 15
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA G4OF8
UT WOS:000988961000001
PM 36749775
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Gravina, S
   Dong, X
   Yu, B
   Vijg, J
AF Gravina, Silvia
   Dong, Xiao
   Yu, Bo
   Vijg, Jan
TI Single-cell genome-wide bisulfite sequencing uncovers extensive
   heterogeneity in the mouse liver methylome
SO GENOME BIOLOGY
LA English
DT Article
DE Single-cell epigenomics; Epivariations; Epigenetic instability;
   Single-cell DNA methylomics; Aging
ID EPIGENETIC HETEROGENEITY; METHYLATION PATTERNS
AB Background: Transmission fidelity of CpG DNA methylation patterns is not foolproof, with error rates from less than 1 to well over 10 % per CpG site, dependent on preservation of the methylated or unmethylated state and the type of sequence. This suggests a fairly high chance of errors. However, the consequences of such errors in terms of cell-to-cell variation have never been demonstrated by experimentally measuring intra-tissue heterogeneity in an adult organism.
   Results: We employ single-cell DNA methylomics to analyze heterogeneity of genome-wide 5-methylcytosine (5mC) patterns within mouse liver. Our results indicate a surprisingly high level of heterogeneity, corresponding to an average epivariation frequency of approximately 3.3 %, with regions containing H3K4me1 being the most variable and promoters and CpG islands the most stable. Our data also indicate that the level of 5mC heterogeneity is dependent on genomic features. We find that non-functional sites such as repeat elements and introns are mostly unstable and potentially functional sites such as gene promoters are mostly stable.
   Conclusions: By employing a protocol for whole-genome bisulfite sequencing of single cells, we show that the liver epigenome is highly unstable with an epivariation frequency in DNA methylation patterns of at least two orders of magnitude higher than somatic mutation frequencies.
C1 [Gravina, Silvia; Dong, Xiao; Yu, Bo; Vijg, Jan] Albert Einstein Coll Med, Michael F Price Ctr, Dept Genet, 1301 Morris Pk Ave, Bronx, NY 10461 USA.
   [Yu, Bo] Albert Einstein Coll Med, Dept Obstet & Gynecol & Womens Hlth, Bronx, NY 10461 USA.
   [Gravina, Silvia] Illumina Inc, San Diego, CA 92122 USA.
   [Yu, Bo] Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA.
C3 Yeshiva University; Albert Einstein College of Medicine; Yeshiva
   University; Albert Einstein College of Medicine; Illumina; University of
   Washington; University of Washington Seattle
RP Gravina, S; Vijg, J (corresponding author), Albert Einstein Coll Med, Michael F Price Ctr, Dept Genet, 1301 Morris Pk Ave, Bronx, NY 10461 USA.; Gravina, S (corresponding author), Illumina Inc, San Diego, CA 92122 USA.
EM sgravina@illumina.com; jan.vijg@einstein.yu.edu
RI t, lf/AAJ-4924-2020
FU National Institutes of Health [AG17242, AG034421]; SENS Research
   Foundation
FX This work was supported by National Institutes of Health grants AG17242
   and AG034421, and the SENS Research Foundation.
CR Angermueller C, 2016, NAT METHODS, V13, P229, DOI 10.1038/nmeth.3728
   Becker C, 2011, NATURE, V480, P245, DOI 10.1038/nature10555
   Busuttil RA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000876
   Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511
   Dey SS, 2015, NAT BIOTECHNOL, V33, P285, DOI 10.1038/nbt.3129
   Faggioli F, 2008, HEPATOLOGY, V48, P1655, DOI 10.1002/hep.22488
   Farlik M, 2015, CELL REP, V10, P1386, DOI 10.1016/j.celrep.2015.02.001
   Feinberg JH, 2008, MIL MED, V173, P217, DOI 10.7205/MILMED.173.2.217
   Fernández AF, 2015, GENOME RES, V25, P27, DOI 10.1101/gr.169011.113
   Garcia Ana Maria, 2007, Methods Mol Biol, V371, P267
   Gravina S, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv366
   Greenland P, 2002, INT J EPIDEMIOL, V31, P1129, DOI 10.1093/ije/31.6.1129
   Halpern KB, 2015, MOL CELL, V58, P147, DOI 10.1016/j.molcel.2015.01.027
   Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089
   Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167
   Laird CD, 2004, P NATL ACAD SCI USA, V101, P204, DOI 10.1073/pnas.2536758100
   Li WG, 2015, MUTAT RES-FUND MOL M, V772, P55, DOI 10.1016/j.mrfmmm.2015.01.002
   Lin S, 2014, P NATL ACAD SCI USA, V111, P17224, DOI 10.1073/pnas.1413624111
   Macaulay IC, 2015, NAT METHODS, V12, P519, DOI 10.1038/nmeth.3370
   Mo A, 2015, NEURON, V86, P1369, DOI 10.1016/j.neuron.2015.05.018
   Mödder UIL, 2004, ENDOCRINOLOGY, V145, P913, DOI 10.1210/en.2003-1089
   Otten J, 2011, LEUKEMIA, V25, P375, DOI 10.1038/leu.2010.273
   Smallwood SA, 2014, NAT METHODS, V11, P817, DOI [10.1038/NMETH.3035, 10.1038/nmeth.3035]
NR 23
TC 84
Z9 97
U1 1
U2 23
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1474-760X
J9 GENOME BIOL
JI Genome Biol.
PD JUL 5
PY 2016
VL 17
AR 150
DI 10.1186/s13059-016-1011-3
PG 8
WC Biotechnology & Applied Microbiology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA DQ6MW
UT WOS:000379320300005
PM 27380908
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Engler, MB
   Engler, MM
AF Engler, MB
   Engler, MM
TI Influence of aging on the relaxant responses to omega-3 fatty acids in
   fischer 344 rat aorta
SO GERONTOLOGY
LA English
DT Article
DE aging; rat aorta; Fischer 344 rats; omega-3 fatty acids; fish oil;
   docosahexaenoic; eicosapentaenoic; vascular smooth muscle
ID VASCULAR SMOOTH-MUSCLE; CARDIAC SARCOPLASMIC-RETICULUM; COD-LIVER OIL;
   FISH OIL; EICOSAPENTAENOIC ACID; EXTRACELLULAR CALCIUM;
   ENDOTHELIAL-CELLS; CYCLIC-GMP; REACTIVITY; AGE
AB The effect of age on the vasorelaxant properties of the omega-3 fatty acids, docosahexaenoic (DHA) and eicosapentaenoic (EPA), in isolated rat aortic rings were investigated in 4-, 15- and 24-month-old Fischer 344 rats. Increased aortic wall thickness was seen in both 15- and 24-month-old rats. Maximal contractile responses to norepinephrine (NE) were greater in intact and de-endothelialized (ENDO-) rings from 15- and 24-month-old rats; although increased sensitivity to NE was exhibited in 4-month-old rings. DHA- and EPA-induced (1-100 mu mol/l) responses were similar between the three age groups in intact rings. Removal of the endothelium enhanced relaxant responses to both DHA and EPA in all three groups. EPA-induced (1-100 mu mol/l) responses ranged from -4 to -28% for both 4- and 15-month ENDO- rings and -1 to -18% in 24-month ENDO-rings. DHA ENDO- ring responses (1-100 mu mol/l) were -4 to -13% in 4 months, -5 to -23% in 15 months, and -0.8 to -16% in 24 months. Age differences were apparent with the ENDO- ring responses to DHA and EPA. These differences were seen with greater relaxant responses to both EPA and DHA in the 4- and 15-month-old aortic rings. Increased sensitivity and a greater maximal relaxant response to acetylcholine (ACH) was noted in the 15-month-old group. Four- and 24-month rings exhibited similar sensitivity and maximal relaxant responses to ACH. However, relaxation was decreased in 24-month rings at low ACH concentrations. These findings suggest that both functional and morphological changes occur with aging. DHA- and EPA-induced responses are not altered by aging in intact rings; however, removal of the endothelium enhances their vasorelaxant properties in all three age groups. This may be related to the direct actions of DHA and EPA on vascular smooth muscle, rather than on mechanisms associated with generation of endothelium-derived relaxing factor.
RP Engler, MB (corresponding author), UNIV CALIF SAN FRANCISCO,LAB CARDIOVASC PHYSIOL,DEPT PHYSIOL NURSING,ROOM N611Y,BOX 0610,SAN FRANCISCO,CA 94143, USA.
FU NINR NIH HHS [NR-02407] Funding Source: Medline
CR BILLMAN GE, 1994, P NATL ACAD SCI USA, V91, P4427, DOI 10.1073/pnas.91.10.4427
   CARRIER GO, 1979, RES COMMUN CHEM PATH, V26, P433
   COHEN ML, 1976, BLOOD VESSELS, V13, P139
   COX RH, 1989, AM J PHYSIOL, V257, pH494, DOI 10.1152/ajpheart.1989.257.2.H494
   EGLEME C, 1984, BRIT J PHARMACOL, V81, P16, DOI 10.1111/j.1476-5381.1984.tb10736.x
   Engler M B, 1994, J Cardiovasc Nurs, V8, P53
   Engler M B, 1994, J Cardiovasc Risk, V1, P75, DOI 10.1097/00043798-199406000-00012
   ENGLER MB, 1990, EUR J PHARMACOL, V185, P223, DOI 10.1016/0014-2999(90)90644-L
   ENGLER MB, 1992, EUR J PHARMACOL, V215, P325, DOI 10.1016/0014-2999(92)90050-E
   ENGLER MB, 1992, CAN J PHYSIOL PHARM, V70, P675, DOI 10.1139/y92-086
   ENGLER MB, 1992, CARDIOVASC DRUG THER, V6, P605, DOI 10.1007/BF00052562
   ENGLER MB, 1994, CIRCULATION, V90, P591
   HALLAQ H, 1992, P NATL ACAD SCI USA, V89, P1760, DOI 10.1073/pnas.89.5.1760
   HAZZARD DG, 1992, J GERONTOL, V47, pB63, DOI 10.1093/geronj/47.3.B63
   HENNESSY JF, 1988, MECH AGEING DEV, V43, P153, DOI 10.1016/0047-6374(88)90043-7
   ISRAEL DH, 1992, J AM COLL CARDIOL, V19, P174, DOI 10.1016/0735-1097(92)90070-4
   JIANG MT, 1990, MECH AGEING DEV, V54, P87, DOI 10.1016/0047-6374(90)90018-B
   Juan H, 1987, Prog Clin Biol Res, V242, P57
   KARMAZYN M, 1987, CAN J PHYSIOL PHARM, V65, P201, DOI 10.1139/y87-037
   KINSELLA JE, 1990, JPEN-PARENTER ENTER, V14, pS200, DOI 10.1177/014860719001400511
   KOGA T, 1992, HYPERTENSION, V19, P286, DOI 10.1161/01.HYP.19.3.286
   KOGA T, 1988, J HYPERTENS, V6, pS243, DOI 10.1097/00004872-198812040-00073
   LOCKETTE WE, 1982, PROSTAGLANDINS, V24, P631, DOI 10.1016/0090-6980(82)90033-8
   LUES I, 1984, N-S ARCH PHARMACOL, V328, P160, DOI 10.1007/BF00512066
   LUSCHER TF, 1991, ENDOTHELIAL MECHANIS, P143
   MASORO EJ, 1991, NEUROBIOL AGING, V12, P639, DOI 10.1016/0197-4580(91)90114-Y
   MCLENNAN PL, 1993, OMEGA 3 NEWS, V8, P1
   MICHEL JB, 1990, J CARDIOVASC PHARM, V16, pS4, DOI 10.1097/00005344-199006161-00003
   MILLER RC, 1984, BRIT J PHARMACOL, V83, P903, DOI 10.1111/j.1476-5381.1984.tb16530.x
   SHIMOKAWA H, 1987, CIRCULATION, V76, P898, DOI 10.1161/01.CIR.76.4.898
   SOLTIS EE, 1988, CIRC RES, V62, P889
   SWANSON JE, 1989, J NUTR, V119, P364, DOI 10.1093/jn/119.3.364
   UEDA H, 1991, ARCH INT PHARMACOD T, V310, P35
   WANSTALL JC, 1989, EUR J PHARMACOL, V159, P241, DOI 10.1016/0014-2999(89)90154-4
   WEBER PC, 1990, BIOCHEM SOC T, V18, P1045, DOI 10.1042/bst0181045
   WEINHEIMER G, 1990, EXPERIENTIA, V46, P1008, DOI 10.1007/BF01940656
   WOODCOCK BE, 1984, BRIT MED J, V288, P592, DOI 10.1136/bmj.288.6417.592
   YANAGISAWA A, 1987, BASIC RES CARDIOL, V82, P186, DOI 10.1007/BF01907066
   YANAGISAWA A, 1987, BASIC RES CARDIOL, V82, P156
   YERRAM NR, 1989, LIPIDS, V24, P594, DOI 10.1007/BF02535075
   YIN K, 1991, BRIT J PHARMACOL, V102, P991, DOI 10.1111/j.1476-5381.1991.tb12289.x
   YIN K, 1988, CLIN EXP PHARMACOL P, V15, P275, DOI 10.1111/j.1440-1681.1988.tb01072.x
   YOSHIMURA T, 1986, PROSTAGLANDINS, V32, P179, DOI 10.1016/0090-6980(86)90123-1
NR 43
TC 13
Z9 14
U1 0
U2 0
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0304-324X
J9 GERONTOLOGY
JI Gerontology
PD JAN-FEB
PY 1996
VL 42
IS 1
BP 25
EP 35
PG 11
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA TR989
UT WOS:A1996TR98900005
PM 8641598
DA 2024-02-19
ER

PT J
AU Pasquinelli, F
   Belli, G
   Mazzoni, LN
   Grazioli, L
   Colagrande, S
AF Pasquinelli, Filippo
   Belli, Giacomo
   Mazzoni, Lorenzo Nicola
   Grazioli, Luigi
   Colagrande, Stefano
TI Magnetic resonance diffusion-weighted imaging: quantitative evaluation
   of age-related changes in healthy liver parenchyma
SO MAGNETIC RESONANCE IMAGING
LA English
DT Article
DE Aging; Apparent diffusion coefficient; Perfusion fraction;
   Pseudodiffusion; DwI
ID PRELIMINARY EXPERIENCE; IN-VIVO; FIBROSIS; MRI; COEFFICIENT;
   REPRODUCIBILITY; SEQUENCES; PERFUSION; SYSTEM; MICROCIRCULATION
AB The purpose of this study was to verify in healthy liver parenchyma the possible influence of age on DwI-related parameters: apparent diffusion coefficient (ADC), perfusion fraction (PF), diffusion and pseudodiffusion coefficient (D and D*). Forty healthy adult volunteers (age range 26-86 years), divided into four age groups, were prospectively submitted to a breath-hold magnetic resonance diffusion imaging (MR-DwI) (two b values, 0-300 and 0-1000 s/mm(2)). A smaller cohort of 16 subjects underwent a free-breath multi-b acquisition (16 b values, 0-750 s/mm(2)). Quantitative analysis was performed by two observers with manually defined regions of interest, on the most homogeneous portion of the right liver lobe. Individual and group statistical analysis of data was performed: ANOVA to establish differences between groups and Pearson correlation coefficient to investigate the association between DwI parameters and age. The mean, S.D. and 95% limits of agreement of ADC values for each age-defined group are reported. ANOVA showed no significant differences between group means (P always >.05). No significant correlation between subjects' age and DwI parameters was established, both in breath-hold and free-breath acquisitions, on the whole range of adopted b values. Our study conducted on healthy liver parenchyma shows that there are no significant differences in ADC, PF, D and D* of younger or older subjects. (C) 2011 Elsevier Inc. All rights reserved.
C1 [Pasquinelli, Filippo; Colagrande, Stefano] Univ Florence, Azienda Osped Univ Careggi, Sect Radiodiagnost, Dept Clin Physiopathol, I-50134 Florence, Italy.
   [Belli, Giacomo] Azienda Osped Univ Careggi, Sect Med Phys, I-50134 Florence, Italy.
   [Mazzoni, Lorenzo Nicola] Univ Florence, Azienda Osped Univ Careggi, CIRM, I-50134 Florence, Italy.
   [Grazioli, Luigi] Azienda Osped Spedali Civili Brescia, Dept Radiol, I-25123 Brescia, Italy.
C3 University of Florence; Azienda Ospedaliero Universitaria Careggi;
   University of Florence; Azienda Ospedaliero Universitaria Careggi;
   University of Florence; Azienda Ospedaliero Universitaria Careggi;
   Hospital Spedali Civili Brescia
RP Colagrande, S (corresponding author), Univ Florence, Azienda Osped Univ Careggi, Sect Radiodiagnost, Dept Clin Physiopathol, I-50134 Florence, Italy.
EM stefano.colagrande@unifi.it
RI Colagrande, Stefano/AFS-5040-2022; Mazzoni, Lorenzo N/G-4753-2010
OI Colagrande, Stefano/0000-0003-0137-8606; 
CR Abramoff M.D., 2004, Biophotonics Int, V11, P36, DOI DOI 10.1201/9781420005615.AX4
   Annet L, 2007, J MAGN RESON IMAGING, V25, P122, DOI 10.1002/jmri.20771
   [Anonymous], 2009, NEOPLASIA, V11, P102, DOI 10.1593/neo.81328
   Braithwaite AC, 2009, RADIOLOGY, V250, P459, DOI 10.1148/radiol.2502080849
   Callot V, 2003, MAGN RESON MED, V50, P531, DOI 10.1002/mrm.10568
   Colagrande S, 2005, RADIOL MED, V109, P1
   Colagrande S, 2008, J COMPUT ASSIST TOMO, V32, P463, DOI 10.1097/RCT.0b013e31811ec6d4
   Colagrande S, 2010, J MAGN RESON IMAGING, V31, P912, DOI 10.1002/jmri.22117
   Conturo TE, 1995, NMR BIOMED, V8, P307, DOI 10.1002/nbm.1940080706
   Cui Y, 2008, RADIOLOGY, V248, P894, DOI 10.1148/radiol.2483071407
   Girometti R, 2007, RADIOL MED, V112, P394, DOI 10.1007/s11547-007-0149-1
   Girometti R, 2008, J MAGN RESON IMAGING, V28, P411, DOI 10.1002/jmri.21461
   Holzapfel K, 2010, EUR J RADIOL, V76, P89, DOI 10.1016/j.ejrad.2009.05.014
   IBER FL, 1994, DRUG AGING, V5, P34, DOI 10.2165/00002512-199405010-00004
   Istratov AA, 1999, REV SCI INSTRUM, V70, P1233, DOI 10.1063/1.1149581
   Ito Y, 2007, EXP GERONTOL, V42, P789, DOI 10.1016/j.exger.2007.04.008
   Jansen PLM, 2002, BEST PRACT RES CL GA, V16, P149, DOI 10.1053/bega.2002.0271
   Kandpal H, 2009, AM J ROENTGENOL, V192, P915, DOI 10.2214/AJR.08.1260
   Kwee TC, 2009, MAGN RESON MATER PHY, V22, P319, DOI 10.1007/s10334-009-0183-1
   Kwee TC, 2008, J MAGN RESON IMAGING, V28, P1141, DOI 10.1002/jmri.21569
   Langer DL, 2010, RADIOLOGY, V255, P485, DOI 10.1148/radiol.10091343
   Le Bihan D, 2008, RADIOLOGY, V249, P748, DOI 10.1148/radiol.2493081301
   Le Couteur DG, 1998, CLIN PHARMACOKINET, V34, P359, DOI 10.2165/00003088-199834050-00003
   Le Couteur DG, 2002, LANCET, V359, P1612, DOI 10.1016/S0140-6736(02)08524-0
   LEBIHAN D, 1988, RADIOLOGY, V168, P497, DOI 10.1148/radiology.168.2.3393671
   Lee SW, 2007, RADIOLOGY, V244, P479, DOI 10.1148/radiol.2442061177
   Luciani A, 2008, RADIOLOGY, V249, P891, DOI 10.1148/radiol.2493080080
   Marugami N, 2009, CARDIOVASC INTER RAD, V32, P638, DOI 10.1007/s00270-009-9532-8
   McLean AJ, 2004, PHARMACOL REV, V56, P163, DOI 10.1124/pr.56.2.4
   MULLER MF, 1994, RADIOLOGY, V190, P475
   Mürtz P, 2002, RADIOLOGY, V224, P258, DOI 10.1148/radiol.2241011117
   Naganawa Shinji, 2005, Magn Reson Med Sci, V4, P175, DOI 10.2463/mrms.4.175
   Parikh T, 2008, RADIOLOGY, V246, P812, DOI 10.1148/radiol.2463070432
   Patel J, 2010, J MAGN RESON IMAGING, V31, P589, DOI 10.1002/jmri.22081
   POPPER H, 1986, PROG LIVER DIS, V8, P659
   Sandrasegaran K, 2009, ACAD RADIOL, V16, P1208, DOI 10.1016/j.acra.2009.05.013
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Schraml C, 2009, J MAGN RESON IMAGING, V29, P1308, DOI 10.1002/jmri.21770
   Talwalkar JA, 2008, HEPATOLOGY, V47, P332, DOI 10.1002/hep.21972
   Taouli B, 2003, RADIOLOGY, V226, P71, DOI 10.1148/radiol.2261011904
   Taouli B, 2007, AM J ROENTGENOL, V189, P799, DOI 10.2214/AJR.07.2086
   Taouli B, 2009, J MAGN RESON IMAGING, V30, P561, DOI 10.1002/jmri.21876
   Tha KK, 2010, RADIOLOGY, V255, P563, DOI 10.1148/radiol.10090988
   Wirestam R, 2001, ACTA RADIOL, V42, P123, DOI 10.1080/028418501127346459
   WYNNE HA, 1989, AGE AGEING, V18, P415, DOI 10.1093/ageing/18.6.415
   Zeeh J, 1990, Fortschr Med, V108, P651
NR 46
TC 21
Z9 22
U1 0
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0730-725X
EI 1873-5894
J9 MAGN RESON IMAGING
JI Magn. Reson. Imaging
PD JUL
PY 2011
VL 29
IS 6
BP 805
EP 812
DI 10.1016/j.mri.2011.02.014
PG 8
WC Radiology, Nuclear Medicine & Medical Imaging
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Radiology, Nuclear Medicine & Medical Imaging
GA 787EG
UT WOS:000292358800006
PM 21550742
OA Green Published
DA 2024-02-19
ER

PT J
AU Tao, RD
   Leclerc, J
   Yildiz, K
   Park, SH
   Jung, B
   Gius, D
   Özden, Ö
AF Tao, Randa
   Leclerc, Jamie
   Yildiz, Kuebra
   Park, Seong-Hoon
   Jung, Barbara
   Gius, David
   Oezden, Oezkan
TI Changes in gene expression in <i>SIRT3</i> knockout liver cells
SO TURKISH JOURNAL OF BIOLOGY
LA English
DT Article
DE SIRT3; mitochondria; gene expression; cancer; metabolism; liver
ID NITRIC-OXIDE SYNTHASE; FACTOR BINDING PROTEIN-1;
   HEPATOCELLULAR-CARCINOMA; TRANSCRIPTION FACTOR; LYSINE ACETYLATION;
   TRANSGENIC MICE; BREAST-CANCER; C-JUN; GROWTH; TUMORIGENESIS
AB The sirtuin (SIRT) gene family is reported to regulate critical intracellular processes from aging to cellular metabolism and repair. SIRT3 knockout (SIRT3(-/-)) mice develop receptor positive mammary tumors starting at 13 months and SIRT3 expression is decreased in human breast cancer samples as well as several other diseases. It is established that carcinogenesis results from the accumulation of multiple aberrant genetic events including the activation of oncogenes and inactivation of tumor-suppressor genes. To determine the potential early genomic events that may play a role in the tumor-permissive phenotype observed in SIRT3(-/-) cells, we compared gene expression profile in SIRT3(-/-) and wild-type (SIRT3(+/+)) mouse livers. Differences between the expression profiles of genes important in the p53 and apoptosis pathway and signal transduction pathways, as well as genes involved with insulin and cholesterol metabolism, were determined. These results demonstrate that the expression of several oncogenes including Cdkn1, Myc, and Nos2 are increased. In contrast, several genes shown to be downregulated in human breast cancer including Btg2, Egr-1, Fos, Jun, Gadd4, and Wnt1 had decreased expression. The current work demonstrates that the loss of function of SIRT3 results in a cellular environment permissive for carcinogenesis and is characterized by altered metabolism.
C1 [Tao, Randa; Leclerc, Jamie; Park, Seong-Hoon; Gius, David; Oezden, Oezkan] Northwestern Univ, Feinberg Sch Med, Robert Lurie Canc Ctr, Dept Radiat Oncol, Chicago, IL 60611 USA.
   [Yildiz, Kuebra; Jung, Barbara; Oezden, Oezkan] Univ Illinois, Dept Med, Div Gastroenterol & Hepatol, Chicago, IL USA.
C3 Robert H. Lurie Comprehensive Cancer Center; Northwestern University;
   Feinberg School of Medicine; University of Illinois System; University
   of Illinois Chicago; University of Illinois Chicago Hospital
RP Özden, Ö (corresponding author), Northwestern Univ, Feinberg Sch Med, Robert Lurie Canc Ctr, Dept Radiat Oncol, Chicago, IL 60611 USA.
RI Ozden, Ozkan/Y-5934-2019
OI Ozden, Ozkan/0000-0002-9467-3761
CR Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105
   Armengol C, 2013, CRIT REV IMMUNOL, V33, P57
   Behrens A, 2002, EMBO J, V21, P1782, DOI 10.1093/emboj/21.7.1782
   Ben Lagha N, 2006, ENDOCRINOLOGY, V147, P4730, DOI 10.1210/en.2006-0171
   Calogero A, 2004, CANCER CELL INT, V4, DOI 10.1186/1475-2867-4-1
   Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371
   Dellas C, 2005, THROMB HAEMOSTASIS, V93, P631, DOI 10.1160/TH05-01-0033
   Du XM, 2011, J CELL BIOL, V192, P121, DOI 10.1083/jcb.201004142
   Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209
   Eferl R, 2003, CELL, V112, P181, DOI 10.1016/S0092-8674(03)00042-4
   Ellies LG, 2003, INT J CANCER, V106, P1, DOI 10.1002/ijc.11178
   Esrefoglu M, 2014, TURK J BIOL, V38, P493, DOI 10.3906/biy-1401-90
   Finley LWS, 2012, TRENDS MOL MED, V18, P516, DOI 10.1016/j.molmed.2012.05.004
   Gao Y, 2014, J LIPID RES, V55, P1622, DOI 10.1194/jlr.M041988
   Gay E, 1997, ENDOCRINOLOGY, V138, P2937, DOI 10.1210/en.138.7.2937
   Gholami L, 2014, TURK J BIOL, V38, P380, DOI 10.3906/biy-1309-51
   Green MF, 2013, J GERONTOL A-BIOL, V68, P105, DOI 10.1093/gerona/gls132
   Heemskerk VH, 1999, CYTOKINE GROWTH F R, V10, P5, DOI 10.1016/S1359-6101(98)00022-7
   Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778
   HUANG RP, 1994, ONCOGENE, V9, P1367
   Jacobs KM, 2008, INT J BIOL SCI, V4, P291
   Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389
   Kaeberlein M, 2002, MECH AGEING DEV, V123, P1115, DOI 10.1016/S0047-6374(02)00011-8
   Kanwar JR, 2009, CURR MED CHEM, V16, P2373, DOI 10.2174/092986709788682155
   Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023
   Kisley LR, 2002, CANCER RES, V62, P6850
   Lee PDK, 1997, P SOC EXP BIOL MED, V216, P319
   Lemieux ME, 2005, MECH AGEING DEV, V126, P1097, DOI 10.1016/j.mad.2005.04.006
   Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07
   Longo VD, 2006, CELL, V126, P257, DOI 10.1016/j.cell.2006.07.002
   Lu ZP, 2011, EMBO REP, V12, P840, DOI 10.1038/embor.2011.121
   Lu ZP, 2009, CIRC RES, V105, P830, DOI 10.1161/CIRCRESAHA.109.204974
   Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033
   Mikula M, 2003, ONCOGENE, V22, P6725, DOI 10.1038/sj.onc.1206781
   Musso G, 2011, AM J CLIN NUTR, V94, P1033, DOI 10.3945/ajcn.111.015610
   Nam KT, 2004, CLIN CANCER RES, V10, P8105, DOI 10.1158/1078-0432.CCR-04-0896
   Okawara M, 2007, BIOCHEM PHARMACOL, V73, P550, DOI 10.1016/j.bcp.2006.11.003
   Orucevic A, 1999, INT J CANCER, V81, P889, DOI 10.1002/(SICI)1097-0215(19990611)81:6<889::AID-IJC9>3.0.CO;2-2
   Ozden O, 2011, AGING-US, V3, P102, DOI 10.18632/aging.100291
   Park SH, 2011, INT J MOL SCI, V12, P6226, DOI 10.3390/ijms12096226
   Peck B, 2010, MOL CANCER THER, V9, P844, DOI 10.1158/1535-7163.MCT-09-0971
   Reveneau S, 1999, LAB INVEST, V79, P1215
   Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101
   Roninson IB, 2005, CANCER BIOL THER, V4, P794, DOI 10.4161/cbt.4.7.1927
   Ronski K, 2005, CANCER-AM CANCER SOC, V104, P925, DOI 10.1002/cncr.21262
   Sarbia M, 1998, CLIN CANCER RES, V4, P2991
   Scharf JG, 2004, ENDOCRINOLOGY, V145, P3463, DOI 10.1210/en.2003-1541
   Schwer B, 2008, CELL METAB, V7, P104, DOI 10.1016/j.cmet.2007.11.006
   Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383
   Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002
   Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013
   Thiel G, 2002, J CELL PHYSIOL, V193, P287, DOI 10.1002/jcp.10178
   Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638
   van Gent R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098438
   VERICEL E, 1994, MOL CELL BIOCHEM, V132, P25, DOI 10.1007/BF00925671
   Wagayama H, 2002, HUM PATHOL, V33, P429, DOI 10.1053/hupa.2002.124724
   Wang JX, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-297
   Winters ZE, 2001, EUR J CANCER, V37, P2405, DOI 10.1016/S0959-8049(01)00327-6
   Younossi ZM, 2005, LIVER INT, V25, P760, DOI 10.1111/j.1478-3231.2005.01117.x
   Yu SS, 2013, BRIT J PHARMACOL, V168, P117, DOI 10.1111/j.1476-5381.2012.01903.x
   Zhang B, 2013, ASIAN PAC J TROP MED, V6, P649, DOI 10.1016/S1995-7645(13)60112-1
   Zhang CZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051703
   Zhang YY, 2012, BIOCHEM BIOPH RES CO, V423, P26, DOI 10.1016/j.bbrc.2012.05.053
   Zhang Yuxia, 2011, Cancers (Basel), V3, P198, DOI 10.3390/cancers3010198
   Zhu YM, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-15
NR 65
TC 0
Z9 0
U1 0
U2 11
PU Tubitak Scientific & Technological Research Council Turkey
PI ANKARA
PA ATATURK BULVARI NO 221, KAVAKLIDERE, TR-06100 ANKARA, TURKIYE
SN 1300-0152
EI 1303-6092
J9 TURK J BIOL
JI Turk. J. Biol.
PY 2015
VL 39
IS 3
BP 380
EP 387
DI 10.3906/biy-1408-40
PG 8
WC Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics
GA CK6SM
UT WOS:000356358200004
OA Bronze
DA 2024-02-19
ER

PT J
AU Sani, M
   Sebai, H
   Gadacha, W
   Boughattas, NA
   Reinberg, A
   Mossadok, BA
AF Sani, Mamane
   Sebai, Hichem
   Gadacha, Wafa
   Boughattas, Naceur A.
   Reinberg, Alain
   Mossadok, Ben Attia
TI Catalase activity and rhythmic patterns in mouse brain, kidney and liver
SO COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR
   BIOLOGY
LA English
DT Article
DE antioxidant; circadian rhythm; enzyme; H2O2; hydrogen peroxide;
   photophase; prominent rhythm; ROS, reactive oxygen species; scotophase;
   ultradian rhythm
ID ANTIOXIDANT ENZYME-ACTIVITIES; LIPID-PEROXIDATION; OXIDATIVE STRESS;
   SUPEROXIDE-DISMUTASE; CIRCADIAN CLOCK; GLUTATHIONE-PEROXIDASE;
   ENDOSYMBIOTIC ALGAE; FREE-RADICALS; AGING PROCESS; MICE
AB To protect tissues from damaging effects of reactive oxygen species (ROS), organisms possess enzymatic and non-enzymatic antioxidant systems. Cytosolic-enzyme catalase (CAT) is a component of the antioxidant defence system that reduces hydrogen peroxide (H2O2) to water (H2O). The aim of this study was to assess the variation of antioxidant enzyme CAT activity in brain, kidney and liver of adult male mice according to tissue-specific and temporal patterns within a 24-h period (12:12 L/D). The CAT activity was assayed at 4-h intervals. The Cosinor test programme was used to detect and confirm the best corresponding rhythm. In liver, the circadian rhythm of CAT was associated with ultradian components. The prominent circadian rhythm (with a period tau=24 h) showed a peak located at the middle of the dark phase, more precisely congruent to 17 HALO (Hours After Light Onset). In kidney, only a circadian rhythm of CAT was validated with a peak time located at congruent to 17 HALO. However, in brain, the time pattern of CAT activity showed two peak times at congruent to 1 and congruent to 17 HALO, illustrating the existence of an ultradian rhythm (with a period tau=12 h). The results showed significant organ differences with the highest activity in liver, compared with kidney (-89%) and brain (-98%). This might be related to several factors such as their respective physiological function, the risk of exposure to oxidative damage and the balance between synthesis and degradation of proteins during "normal metabolism". Moreover, CAT activity revealed differences in time-related changes across a 24-h period that were more obvious in peak levels between the three tissues. (c) 2006 Elsevier Inc. All rights reserved.
C1 Fac Sci Bizerte, Lab Biosurveillance Environm, Unite Toxicometrie & Chrobobiometrie, Zarzouna 702132, Tunisia.
   Fac Med, Pharmacol Lab, Monastir 5019, Tunisia.
   Fdn A Rothschild, Unite Chronobiol, F-75940 Paris, France.
   Fac Sci Bizerte, Dept Sci Vie, Zarzouna, Tunisia.
C3 Universite de Carthage; Universite de Monastir; Universite de Carthage
RP Sani, M (corresponding author), Fac Sci Bizerte, Lab Biosurveillance Environm, Unite Toxicometrie & Chrobobiometrie, Zarzouna 702132, Tunisia.
EM sanimamane@yahoo.fr
CR Ancoli-Israel S, 2001, PSYCHOSOM MED, V63, P778, DOI 10.1097/00006842-200109000-00011
   BALZER I, 1992, CHRONOBIOL INT, V9, P260, DOI 10.3109/07420529209064535
   Baran D, 2000, Rom J Physiol, V37, P23
   Barata C, 2005, COMP BIOCHEM PHYS B, V140, P81, DOI 10.1016/j.cbpc.2004.09.025
   Baydas G, 2002, NEUROSCI LETT, V323, P195, DOI 10.1016/S0304-3940(02)00144-1
   BINGHAM C, 1982, CHRONOBIOLOGIA, V9, P397
   Castillo MR, 2004, AM J PHYSIOL-REG I, V287, pR551, DOI 10.1152/ajpregu.00247.2004
   CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527
   Choi SW, 2004, MUTAT RES-FUND MOL M, V551, P109, DOI 10.1016/j.mrfmmm.2004.03.006
   Claiborne A.J.F.C.P., 1985, HDB METHODS OXYGEN R, DOI DOI 10.1016/0531-5565(85)90021-X
   Coto-Montes A, 2001, FREE RADICAL BIO MED, V30, P785, DOI 10.1016/S0891-5849(01)00468-3
   Davidson AJ, 2003, GENES BRAIN BEHAV, V2, P32, DOI 10.1034/j.1601-183X.2003.00005.x
   DEPRINS J, 1993, CHRONOBIOL INT, V10, P395, DOI 10.3109/07420529309064493
   DYKENS JA, 1982, NATURE, V297, P579, DOI 10.1038/297579a0
   DYKENS JA, 1992, J EXP BIOL, V168, P219
   Fukada Y, 2002, MOL NEUROBIOL, V25, P19, DOI 10.1385/MN:25:1:019
   Fukada Yoshitaka, 2003, No To Shinkei, V55, P13
   Gillette MU, 1999, RECENT PROG HORM RES, V54, P33
   GONZALES R, 1984, CANCER RES, V44, P4137
   Gutteridge J. M. C., 1989, FREE RADICALS BIOL M
   GUTTERIDGE JMC, 1995, CLIN CHEM, V41, P1819
   HALBERG F, 1977, Chronobiologia, V4, P1
   HALBERG F, 1965, ACTA ENDOCR-COP S103, V50, P1
   Hardeland R., 1993, TRENDS COMP BIOCH PH, V1, P71
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   Hochman A, 2000, CELL MOL BIOL, V46, P41
   Ibrahim W, 2000, FREE RADICAL BIO MED, V28, P397, DOI 10.1016/S0891-5849(99)00253-1
   Inal ME, 2001, CLIN CHIM ACTA, V305, P75, DOI 10.1016/S0009-8981(00)00422-8
   INOUYE SIT, 1982, BRAIN RES, V250, P183, DOI 10.1016/0006-8993(82)90967-2
   Luo H, 1997, Hua Xi Yi Ke Da Xue Xue Bao, V28, P401
   Moore RY, 1997, ANNU REV MED, V48, P253, DOI 10.1146/annurev.med.48.1.253
   MOORE RY, 1972, BRAIN RES, V42, P201, DOI 10.1016/0006-8993(72)90054-6
   MROSOVSKY N, 1990, CHRONOBIOL INT, V7, P35, DOI 10.3109/07420529009056952
   NELSON W, 1979, CHRONOBIOLOGIA, V6, P305
   NORTH C, 1981, AM J ANAT, V162, P183, DOI 10.1002/aja.1001620302
   Pashkov A. N., 2000, Vestnik Rossiiskoi Akademii Meditsinskikh Nauk, P45
   PITTENDRIGH CS, 1960, COLD SPRING HARB SYM, V25, P159, DOI 10.1101/SQB.1960.025.01.015
   PITTENDRIGH CS, 1993, ANNU REV PHYSIOL, V55, P16
   REINBERG A, 1983, BIOL RHYTHMS MED CEL, P24
   Reinberg A E, 2003, CHRONOBIOLOGIE MED C
   Rikans LE, 1997, BBA-MOL BASIS DIS, V1362, P116, DOI 10.1016/S0925-4439(97)00067-7
   Sahin E, 2004, BEHAV BRAIN RES, V155, P241, DOI 10.1016/j.bbr.2004.04.022
   Sani M, 2006, CHRONOBIOL INT, V23, P551, DOI 10.1080/07420520600651016
   Sastre J, 2003, FREE RADICAL BIO MED, V35, P1, DOI 10.1016/S0891-5849(03)00184-9
   Senthil SS, 2004, CLIN CHIM ACTA, V348, P131, DOI 10.1016/j.cccn.2004.05.004
   Sohal RS, 1997, FASEB J, V11, P1269, DOI 10.1096/fasebj.11.14.9409545
   Sohal RS, 2000, RES PRO CEL, V29, P45
   SOUTHORN PA, 1988, MAYO CLIN PROC, V63, P381, DOI 10.1016/S0025-6196(12)64861-7
   Stephan FK, 2002, J BIOL RHYTHM, V17, P284, DOI 10.1177/074873002129002591
   Suzuki T, 2001, MAMM GENOME, V12, P272, DOI 10.1007/s003350010280
   Suzuki T, 2001, AM J OBSTET GYNECOL, V185, P1247, DOI 10.1067/mob.2001.118308
   WILSON SK, 1990, CIRC RES, V66, P722, DOI 10.1161/01.RES.66.3.722
NR 52
TC 50
Z9 52
U1 0
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1096-4959
J9 COMP BIOCHEM PHYS B
JI Comp. Biochem. Physiol. B-Biochem. Mol. Biol.
PD NOV-DEC
PY 2006
VL 145
IS 3-4
BP 331
EP 337
DI 10.1016/j.cbpb.2006.08.005
PG 7
WC Biochemistry & Molecular Biology; Zoology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Zoology
GA 122HG
UT WOS:000243215800010
PM 17045502
DA 2024-02-19
ER

PT J
AU Yoon, HJ
   Kim, K
   Nam, YS
   Yun, JM
   Park, M
AF Yoon, Hyung-Jin
   Kim, Kyaehyung
   Nam, You-Seon
   Yun, Jae-Moon
   Park, Minseon
TI Mean corpuscular volume levels and all-cause and liver cancer mortality
SO CLINICAL CHEMISTRY AND LABORATORY MEDICINE
LA English
DT Article
DE all-cause mortality; liver cancer mortality; MCV; oxidative stress
ID OXIDATIVE STRESS; MACROCYTOSIS; EPIDEMIOLOGY; ASSOCIATION; CARCINOMA
AB Background: An elevated mean corpuscular volume (MCV) is associated with aging, nutrition, alcohol abuse and more, and it is known as a survival predictor in chronically ill patients. The aim of this study was to investigate the association between MCV levels and mortality from all-causes, cancer and site-specific cancer in a non-anemic healthy population.
   Methods: A total of 36,260 participants aged 40 years or older who underwent routine check-ups at Seoul National University Hospital Health Promotion Center between 1995 and 2008 were followed-up for mortality until December 31, 2008, retrospectively.
   Results: During an average follow-up of 8.0 years, 1107 deaths including 547 cancer deaths were observed. The adjusted hazard ratios (aHRs) of the subjects with the highest quartile of MCV >= 95.8 fL in men and MCV >= 94.2 fL in women for all-cause and cancer mortality were 1.44 [95% confidence interval (CI), 1.15-1.80] and 1.51 (95% CI, 1.10-2.07) for men and 1.55 (95% CI, 1.08-2.22) and 1.25 (95% CI, 0.74-2.11) for women, respectively, compared with those in the reference group (90.5 fL <= MC <93.0 fL in men and 89.2 fL <= MCV <91.6 fL in women). Elevated MCV level was related to an increased risk of liver cancer mortality in men (aHR, 3.55; 95% CI, 1.75-7.21).
   Conclusions: This study suggests that the elevated MCV level in non-anemic cancer-free individuals was associated with increased all-cause mortality in both men and women, and with cancer mortality, in particular liver cancer mortality in men. Future prospective studies are required to consolidate our findings.
C1 [Kim, Kyaehyung; Nam, You-Seon; Yun, Jae-Moon; Park, Minseon] Seoul Natl Univ Hosp, Dept Family Med, Ctr Hlth Promot, 101 Daehak Ro, Seoul 110744, South Korea.
   [Yoon, Hyung-Jin] Seoul Natl Univ, Coll Med, Dept Biomed Engn, Seoul, South Korea.
C3 Seoul National University (SNU); Seoul National University Hospital;
   Seoul National University (SNU)
RP Park, M (corresponding author), Seoul Natl Univ Hosp, Dept Family Med, Ctr Hlth Promot, 101 Daehak Ro, Seoul 110744, South Korea.
EM msp20476@hanmail.net
OI Kim, Kyae Hyung/0000-0001-9954-6422
CR [Anonymous], J AM HEART ASS
   Bérard E, 2011, CURR MED RES OPIN, V27, P1963, DOI 10.1185/03007995.2011.616191
   Cardin R, 2014, WORLD J GASTROENTERO, V20, P3078, DOI 10.3748/wjg.v20.i12.3078
   Chuang SC, 2009, CANCER LETT, V286, P9, DOI 10.1016/j.canlet.2008.10.040
   Japanese Society for Dialysis Therapy (JSDT), 2008, TOSEKI KAI SHI, V41, P661
   Kaferle J, 2009, AM FAM PHYSICIAN, V79, P203
   Kahraman S, 2005, J RENAL NUTR, V15, P377, DOI 10.1053/j.jrn.2005.07.004
   Ko YJ, 2012, CANCER EPIDEM BIOMAR, V21, P2076, DOI 10.1158/1055-9965.EPI-12-0611
   La Vecchia C, 2000, EUR J CANCER, V36, P909, DOI 10.1016/S0959-8049(00)00052-6
   Mena S, 2009, MUTAT RES-GEN TOX EN, V674, P36, DOI 10.1016/j.mrgentox.2008.09.017
   Mohanty JG, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00084
   Myojo M, 2012, ATHEROSCLEROSIS, V221, P148, DOI 10.1016/j.atherosclerosis.2011.11.044
   National Statistical Office, 2014, 2008 ANN REP CAUS DE
   Nordenstedt H, 2010, DIGEST LIVER DIS, V42, pS206, DOI 10.1016/S1590-8658(10)60507-5
   Sánchez-Lara K, 2012, NUTR CANCER, V64, P526, DOI 10.1080/01635581.2012.668744
   Solak Y, 2013, NEPHROLOGY, V18, P728, DOI 10.1111/nep.12130
   Tennankore KK, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-19
   Tsantes AE, 2006, ANTIOXID REDOX SIGN, V8, P1205, DOI 10.1089/ars.2006.8.1205
   Yeo Y, 2013, ASIAN PAC J CANCER P, V14, P6227, DOI 10.7314/APJCP.2013.14.11.6227
   Yokoyama A, 2003, CARCINOGENESIS, V24, P1773, DOI 10.1093/carcin/bgg142
NR 20
TC 36
Z9 38
U1 0
U2 7
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 1434-6621
EI 1437-4331
J9 CLIN CHEM LAB MED
JI Clin. Chem. Lab. Med.
PD JUL
PY 2016
VL 54
IS 7
BP 1247
EP 1257
DI 10.1515/cclm-2015-0786
PG 11
WC Medical Laboratory Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Medical Laboratory Technology
GA DO1OS
UT WOS:000377548500028
PM 26630695
DA 2024-02-19
ER

PT J
AU Greenberg, JA
   Boozer, CN
AF Greenberg, JA
   Boozer, CN
TI Metabolic mass, metabolic rate, caloric restriction, and aging in male
   Fischer 344 rats
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE rate of living theory; organ weights; metabolically-active tissue mass;
   aging and diet
ID ENERGY-METABOLISM; ENZYMES
AB Previous investigators have found the metabolic rate to be the same in calorically-restricted and ad-libitum fed rodents, and hence concluded that the Rate of Living Theory does not help explain the longer lifespan of the calorically-restricted (CR) animal. However, these previous instigators may not have used reliable estimates of metabolic mass in their calculations of metabolic rate. Hence the present study investigated the reliability of ten different estimates of metabolic mass (MM) in 21-month-old male Fischer 344 rats fed three different diets to yield a wide range of body compositions. Two criteria were used to rank each estimate of metabolic mass: strong correlation with daily caloric intake (DCI); and zero Y-intercept on the regression curve of DCI versus the MM. The combined weight of the heart, liver, kidneys and brain (OW) was found to be the best estimate of MM. Statistical analysis of the differences in metabolic rate in the three groups of rats showed that the significance of these differences depended on the estimate of MM used. OW yielded different results than did fat-free mass (FFM), body weight (BW), BW0.75, and BW0.67. Therefore, because previous investigators used FFM, BW, BW0.75, or BW0.67, rather than a more reliable estimate such as OW, their finding that metabolic rate was not different in the CR and ad-lib groups, and their conclusion that the Rate of Living Theory does not help explain the longer lifespan of the CR animal, are called into question. (C) 2000 Published by Elsevier Science Ireland Ltd. All rights reserved.
C1 CUNY Brooklyn Coll, Dept Hlth & Nutr Sci, Brooklyn, NY 11210 USA.
   St Lukes Roosevelt Hosp, New York Obes Res Ctr, New York, NY 10025 USA.
C3 City University of New York (CUNY) System; Brooklyn College (CUNY);
   Mount Sinai West; Mount Sinai St. Luke's
RP Greenberg, JA (corresponding author), CUNY Brooklyn Coll, Dept Hlth & Nutr Sci, Brooklyn, NY 11210 USA.
FU NIDDK NIH HHS [P30DK26687] Funding Source: Medline
CR ALLISON DB, 1995, INT J OBESITY, V19, P644
   Cohen J, 1983, APPL MULTIPLE REGRES, P56
   DUFFY PH, 1989, MECH AGEING DEV, V48, P117, DOI 10.1016/0047-6374(89)90044-4
   ELIA J, 1992, ENERGY METABOLISM TI, P61
   FEUERS RJ, 1989, MECH AGEING DEV, V48, P179, DOI 10.1016/0047-6374(89)90049-3
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   FORSUM E, 1981, J NUTR, V111, P1691, DOI 10.1093/jn/111.10.1691
   Gallagher D, 1998, AM J PHYSIOL-ENDOC M, V275, pE249, DOI 10.1152/ajpendo.1998.275.2.E249
   Greenberg JA, 1999, MED HYPOTHESES, V52, P15, DOI 10.1054/mehy.1997.0619
   HEUSNER AA, 1985, ANNU REV NUTR, V5, P267, DOI 10.1146/annurev.nu.05.070185.001411
   HUNTINGTON GB, 1990, REPROD NUTR DEV, V30, P35, DOI 10.1051/rnd:19900103
   KNAPKA JJ, 1982, MOUSE BIOMEDICAL RES, V3, P52
   LEAKEY JEA, 1989, MECH AGEING DEV, V48, P157, DOI 10.1016/0047-6374(89)90047-X
   LEAKEY JEA, 1989, MECH AGEING DEV, V48, P145, DOI 10.1016/0047-6374(89)90046-8
   MASORO EJ, 1982, P NATL ACAD SCI USA, V79, P4230
   MCCARTER RJ, 1992, AM J PHYSIOL, V263, pE448, DOI 10.1152/ajpendo.1992.263.3.E448
   SACHER GA, 1977, HDB BIOL AGING
   TZANKOFF SP, 1977, J APPL PHYSIOL, V43, P1001, DOI 10.1152/jappl.1977.43.6.1001
   WEBSTER AJF, 1981, P NUTR SOC, V40, P121, DOI 10.1079/PNS19810017
   WEINDRUCH R, 1986, J NUTR, V116, P641, DOI 10.1093/jn/116.4.641
NR 20
TC 66
Z9 71
U1 0
U2 2
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD JAN 24
PY 2000
VL 113
IS 1
BP 37
EP 48
DI 10.1016/S0047-6374(99)00094-9
PG 12
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 283TJ
UT WOS:000085291600003
PM 10708248
DA 2024-02-19
ER

PT J
AU Salter, ML
   Lau, B
   Go, VF
   Mehta, SH
   Kirk, GD
AF Salter, Megan L.
   Lau, Bryan
   Go, Vivian F.
   Mehta, Shruti H.
   Kirk, Gregory D.
TI HIV Infection, Immune Suppression, and Uncontrolled Viremia Are
   Associated With Increased Multimorbidity Among Aging Injection Drug
   Users
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
ID UNITED-STATES; RISK-FACTORS; COMORBIDITY; PREVALENCE; TRENDS;
   DETERMINANTS; DISEASE; IMPACT; AGE
AB Background. Despite an increasing burden of age-associated non-AIDS outcomes, few studies have investigated the prevalence or correlates of multimorbidity among aging human immunodeficiency virus (HIV)-infected and epidemiologically comparable at-risk populations.
   Methods. Among 1262 AIDS Linked to the IntraVenous Experience (ALIVE) study participants followed in a community-based observational cohort, we defined the prevalence of 7 non-AIDS-defining chronic conditions (diabetes, obstructive lung disease, liver disease, anemia, obesity, kidney dysfunction, and hypertension) using clinical and laboratory criteria. Ordinal logistic regression was used to model the odds of increased multimorbidity associated with demographic, behavioral, and clinical factors. Self-reported prevalence was compared with clinically defined prevalence.
   Results. Participants were a median of 48.9 years of age; 65.1% were male, 87.5% were African-American, and 28.7% were HIV infected. In multivariable analysis, HIV infection (odds ratio [OR], 1.50; 95% confidence interval [CI], 1.13-1.99) was positively associated with increased multimorbidity. Among HIV-infected participants, multimorbidity was increased with lower nadir CD4 T-cell count (OR, 1.14 per 100-cell decrease; 95% CI, 1.00-1.29) and higher current HIV RNA (OR, 1.32 per log(10) increase; 95% CI, 1.08-1.60). Older age, being female, not using cigarettes or drugs, and having depressive symptoms were also associated with increased multimorbidity. A substantial proportion of multimorbid conditions in HIV-infected and HIV-uninfected participants were unrecognized and untreated.
   Conclusions. HIV-infected participants experienced increased numbers of multimorbid conditions; risk increased with advanced immunosuppression and higher viremia. These results underscore the heavy burden of multimorbidity associated with HIV and highlight the need for incorporating routine assessment and integrated management of chronic diseases as part of comprehensive healthcare for aging, HIV-infected persons.
C1 [Salter, Megan L.; Lau, Bryan; Go, Vivian F.; Mehta, Shruti H.; Kirk, Gregory D.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.
   [Kirk, Gregory D.] Johns Hopkins Sch Med, Div Infect Dis, Dept Med, Baltimore, MD USA.
C3 Johns Hopkins University; Johns Hopkins Bloomberg School of Public
   Health; Johns Hopkins University; Johns Hopkins Medicine
RP Salter, ML (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, 615 N Wolfe St,W6604, Baltimore, MD 21205 USA.
EM msalter@jhsph.edu
FU National Institutes of Health [RC1-AI-086053, R01-DA-04334,
   R01-DA-12568, R01-HL-90483, R01-DA-16078, K01-AI071754]; American Cancer
   Society [MRSG 07 284 01 CCE]
FX This work was supported by the National Institutes of Health (grants
   RC1-AI-086053, R01-DA-04334, R01-DA-12568, R01-HL-90483, and
   R01-DA-16078; and grant K01-AI071754 to B. L.) and the American Cancer
   Society (MRSG 07 284 01 CCE to G. K.).
CR Armstrong GL, 2007, ARCH INTERN MED, V167, P166, DOI 10.1001/archinte.167.2.166
   Beutler E, 2006, BLOOD, V107, P1747, DOI 10.1182/blood-2005-07-3046
   Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P897
   Chu C, 2011, J URBAN HEALTH, V88, P507, DOI 10.1007/s11524-010-9540-7
   Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756
   Drummond MB, 2011, INT J CHRONIC OBSTR, V6, P89, DOI 10.2147/COPD.S15968
   Effros RB, 2008, CLIN INFECT DIS, V47, P542, DOI 10.1086/590150
   Egan BM, 2010, JAMA-J AM MED ASSOC, V303, P2043, DOI 10.1001/jama.2010.650
   El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360
   Ferrucci L, 2004, AGING CLIN EXP RES, V16, P240, DOI 10.1007/BF03327390
   Fillenbaum GG, 2000, J GERONTOL A-BIOL, V55, pM84
   Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014
   Fortin Martin, 2005, Can Fam Physician, V51, P244
   Fortin M, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-111
   Gijsen R, 2001, J CLIN EPIDEMIOL, V54, P661, DOI 10.1016/S0895-4356(00)00363-2
   Goulet JL, 2007, CLIN INFECT DIS, V45, P1593, DOI 10.1086/523577
   Guralnik JM, 1996, ANN EPIDEMIOL, V6, P376, DOI 10.1016/S1047-2797(96)00060-9
   Justice AC, 2010, HIV MED, V11, P143, DOI 10.1111/j.1468-1293.2009.00757.x
   Kirk GD, 2009, CLIN INFECT DIS, V48, P963, DOI 10.1086/597350
   Kitahata Mari M, 2010, Top HIV Med, V18, P121
   Klein RS, 2011, SUBST USE MISUSE, V46, P233, DOI 10.3109/10826084.2011.522843
   Marengoni A, 2011, AGEING RES REV, V10, P430, DOI 10.1016/j.arr.2011.03.003
   Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805
   *NAT CTR HLTH STAT, 2009, HLTH US 2008 CHARTB
   Nixon DE, 2010, CURR OPIN HIV AIDS, V5, P498, DOI 10.1097/COH.0b013e32833ed6f4
   O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188
   Oursler KK, 2006, AIDS PATIENT CARE ST, V20, P782, DOI 10.1089/apc.2006.20.782
   Oursler KK, 2011, AIDS PATIENT CARE ST, V25, P13, DOI 10.1089/apc.2010.0242
   Parekh AK, 2010, JAMA-J AM MED ASSOC, V303, P1303, DOI 10.1001/jama.2010.381
   Pleis John R, 2009, Vital Health Stat 10, P1
   Röling J, 2006, CLIN INFECT DIS, V42, P1488, DOI 10.1086/503566
   Saydah S., 2007, Morbidity and Mortality Weekly Report, V56, P161
   SMITH G, 2005, AGING HEARING HIV 50
   Swendeman D, 2009, AIDS CARE, V21, P1321, DOI 10.1080/09540120902803158
   van den Akker M, 1998, J CLIN EPIDEMIOL, V51, P367, DOI 10.1016/S0895-4356(97)00306-5
   Vlahov D, 1991, NIDA Res Monogr, V109, P75
   WEISSMAN MM, 1977, AM J EPIDEMIOL, V106, P203, DOI 10.1093/oxfordjournals.aje.a112455
   Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269
   Yancik R, 2007, J GERONTOL A-BIOL, V62, P275, DOI 10.1093/gerona/62.3.275
   Yanik EL, 2010, CLIN J AM SOC NEPHRO, V5, P1836, DOI 10.2215/CJN.01030210
NR 40
TC 77
Z9 84
U1 0
U2 3
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD DEC 15
PY 2011
VL 53
IS 12
BP 1256
EP 1264
DI 10.1093/cid/cir673
PG 9
WC Immunology; Infectious Diseases; Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Immunology; Infectious Diseases; Microbiology
GA 851OF
UT WOS:000297279700016
PM 21976463
OA Bronze, Green Published
DA 2024-02-19
ER

PT J
AU Gindin, Y
   Gaggar, A
   Lok, AS
   Janssen, HLA
   Ferrari, C
   Subramanian, GM
   Jiang, ZS
   Masur, H
   Emmanuel, B
   Poonia, B
   Kottilil, S
AF Gindin, Yevgeniy
   Gaggar, Anuj
   Lok, Anna S.
   Janssen, Harry L. A.
   Ferrari, Carlo
   Subramanian, G. Mani
   Jiang, Zhaoshi
   Masur, Henry
   Emmanuel, Benjamin
   Poonia, Bhawna
   Kottilil, Shyam
TI DNA Methylation and Immune Cell Markers Demonstrate Evidence of
   Accelerated Aging in Patients with Chronic Hepatitis B Virus or
   Hepatitis C Virus, with or without Human Immunodeficienct Virus
   Co-infection
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE DNAm; Horvath clock; biological aging
ID GENOTYPE 1; MITOCHONDRIAL DYSFUNCTION; VIROLOGICAL RESPONSE; AGE;
   REGULARIZATION; INFECTION; REGIMENS
AB Background. Several chronic diseases accelerate biological aging. We investigated age acceleration and the association between peripheral blood DNA methylation (DNAm) and immune cell markers in patients chronically infected with the hepatitis B virus (HBV) or the hepatitis C virus (HCV) with and without human immunodeficiency virus (HIV) co-infection.
   Methods. Age acceleration was measured as the difference between epigenetic age (Horvath clock) and chronological age. The immune marker model of age acceleration was developed using Elastic Net regression to select both the immune markers and their associated weights in the final linear model.
   Results. Patients with chronic HBV (n = 51) had a significantly higher median epigenetic age compared to chronological age (age accelerated) (P < .001). In patients with chronic HCV infection (n = 63), age acceleration was associated with liver fibrosis as assessed by histology (P < .05), or presence of HIV co-infection (P < .05), but not HCV mono-infection. Age acceleration defined by immune markers was concordant with age acceleration by DNA methylation (correlation coefficient = .59 in HBV; P = .0025). One-year treatment of HBV patients with nucleoside therapy was associated with a modest reduction in age acceleration, as measured using the immune marker model (-.65 years, P = .018).
   Conclusion. Our findings suggest that patients with chronic viral hepatitis have accelerated epigenetic aging, that immune markers define biological age, and have the potential to assess the effects of therapeutic intervention on age acceleration.
C1 [Gindin, Yevgeniy; Gaggar, Anuj; Subramanian, G. Mani; Jiang, Zhaoshi] Gilead Sci, Foster City, CA USA.
   [Lok, Anna S.] Univ Michigan Hlth Syst, Div Gastroenterol & Hepatol, Ann Arbor, MI USA.
   [Janssen, Harry L. A.] Univ Toronto, Univ Hlth Network, Toronto Gen Hosp, Toronto Ctr Liver Dis,Sandra Rotman Ctr Global Hl, Toronto, ON, Canada.
   [Ferrari, Carlo] Univ Parma, Dept Infect Dis, Parma, Italy.
   [Masur, Henry] NIH, Crit Care Med Dept, Clin Ctr, Bldg 10, Bethesda, MD 20892 USA.
   [Emmanuel, Benjamin; Poonia, Bhawna; Kottilil, Shyam] Univ Maryland, Sch Med, Div Clin Care & Res, Inst Human Virol, Baltimore, MD 21201 USA.
C3 Gilead Sciences; University of Michigan System; University of Michigan;
   University of Toronto; University Health Network Toronto; Toronto
   General Hospital; University of Parma; National Institutes of Health
   (NIH) - USA; NIH Clinical Center (CC); University System of Maryland;
   University of Maryland Baltimore
RP Kottilil, S (corresponding author), Inst Human Virol, Div Clin Care & Res, 725 W Lombard St, Baltimore, MD 21201 USA.
EM SKottilil@ihv.umaryland.edu
RI Kottilil, Shyam/ABF-7605-2021
FU Gilead Sciences
FX This work was supported by Gilead Sciences.
CR Ahuja N, 1998, CANCER RES, V58, P5489
   Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049
   Boni C, 2019, GASTROENTEROLOGY, V157, P227, DOI 10.1053/j.gastro.2019.03.044
   Camacho-Pereira J, 2016, CELL METAB, V23, P1127, DOI 10.1016/j.cmet.2016.05.006
   de Armas LR, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.95726
   Fahy GM, 2019, AGING CELL, V18, DOI 10.1111/acel.13028
   Fausto A, 2006, BONE, V38, P893, DOI 10.1016/j.bone.2005.11.001
   Fisicaro P, 2017, NAT MED, V23, P327, DOI 10.1038/nm.4275
   Hannum G, 2013, MOL CELL, V49, P359, DOI 10.1016/j.molcel.2012.10.016
   Hearps AC, 2012, AGING CELL, V11, P867, DOI 10.1111/j.1474-9726.2012.00851.x
   Horvath S, 2015, AGING-US, V7, P1159, DOI 10.18632/aging.100861
   Horvath S, 2015, J INFECT DIS, V212, P1563, DOI 10.1093/infdis/jiv277
   Horvath S, 2015, AGING CELL, V14, P491, DOI 10.1111/acel.12325
   Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115
   ISSA JPJ, 1994, NAT GENET, V7, P536, DOI 10.1038/ng0894-536
   Kattakuzhy S, 2015, CLIN INFECT DIS, V62, pCIV897
   Kohli A, 2015, ANN INTERN MED, V163, P899, DOI 10.7326/M15-0642
   Kohli A, 2015, LANCET, V385, P1107, DOI 10.1016/S0140-6736(14)61228-9
   Levine ME, 2018, AGING-US, V10, P573, DOI 10.18632/aging.101414
   Lok AS, 2016, J HEPATOL, V65, P509, DOI 10.1016/j.jhep.2016.05.016
   Loomba R, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.96685
   Lu AT, 2019, AGING-US, V11, P303, DOI 10.18632/aging.101684
   Lucas GM, 2007, AIDS, V21, P2435, DOI 10.1097/QAD.0b013e32827038ad
   Maierhofer A, 2017, AGING-US, V9, P1143, DOI 10.18632/aging.101217
   Meissner EG, 2017, HEPATOL COMMUN, V1, P586, DOI 10.1002/hep4.1074
   Morrisette-Thomas V, 2014, MECH AGEING DEV, V139, P49, DOI 10.1016/j.mad.2014.06.005
   Osinusi A, 2015, JAMA-J AM MED ASSOC, V313, P1232, DOI 10.1001/jama.2015.1373
   Osinusi A, 2014, ANN INTERN MED, V161, P634, DOI 10.7326/M14-1211
   Osinusi A, 2013, JAMA-J AM MED ASSOC, V310, P804, DOI 10.1001/jama.2013.109309
   Paiardini M, 2013, IMMUNOL REV, V254, P78, DOI 10.1111/imr.12079
   Perna L, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0228-z
   Pidsley R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-293
   Roetker NS, 2018, CIRC-GENOM PRECIS ME, V11, DOI 10.1161/CIRCGEN.117.001937
   Rosenthal ES, 2016, J HEPATOL, V64, pS760, DOI 10.1016/S0168-8278(16)01482-3
   Sean D, 2007, BIOINFORMATICS, V23, P1846, DOI 10.1093/bioinformatics/btm254
   Shrivastava S, 2018, HEPATOL COMMUN, V2, P1451, DOI 10.1002/hep4.1258
   Simon N, 2011, J STAT SOFTW, V39, P1
   Triche TJ, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt090
   Wilson EM, 2016, CLIN INFECT DIS, V62, P280, DOI 10.1093/cid/civ874
   Wolf EJ, 2018, PSYCHONEUROENDOCRINO, V92, P123, DOI 10.1016/j.psyneuen.2017.12.007
   Zhang Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14617
   Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x
NR 42
TC 13
Z9 14
U1 0
U2 3
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD JUL 1
PY 2021
VL 73
IS 1
BP E184
EP E190
DI 10.1093/cid/ciaa1371
PG 7
WC Immunology; Infectious Diseases; Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology; Infectious Diseases; Microbiology
GA UV9XJ
UT WOS:000699822100027
PM 32915202
OA Green Published
DA 2024-02-19
ER

PT J
AU Suetta, C
   Frandsen, U
   Mackey, AL
   Jensen, L
   Hvid, LG
   Bayer, ML
   Petersson, SJ
   Schroder, HD
   Andersen, JL
   Aagaard, P
   Schjerling, P
   Kjaer, M
AF Suetta, C.
   Frandsen, U.
   Mackey, A. L.
   Jensen, L.
   Hvid, L. G.
   Bayer, M. L.
   Petersson, S. J.
   Schroder, H. D.
   Andersen, J. L.
   Aagaard, P.
   Schjerling, P.
   Kjaer, M.
TI Ageing is associated with diminished muscle re-growth and myogenic
   precursor cell expansion early after immobility-induced atrophy in human
   skeletal muscle
SO JOURNAL OF PHYSIOLOGY-LONDON
LA English
DT Article
ID HEPATOCYTE GROWTH-FACTOR; SATELLITE-CELL; OLDER MEN; RESISTANCE
   EXERCISE; GENE-EXPRESSION; FACTOR-I; IGF-I; MYOFIBER HYPERTROPHY;
   MYONUCLEAR ADDITION; PROGENITOR CELLS
AB Recovery of skeletal muscle mass from immobilisation-induced atrophy is faster in young than older individuals, yet the cellular mechanisms remain unknown. We examined the cellular and molecular regulation of muscle recovery in young and older human subjects subsequent to 2 weeks of immobility-induced muscle atrophy. Retraining consisted of 4 weeks of supervised resistive exercise in 9 older (OM: mean age) 67.3, range 61-74 yrs) and 11 young (YM: mean age 24.4, range 21-30 yrs) males. Measures of myofibre area (MFA), Pax7-positive satellite cells (SCs) associated with type I and type II muscle fibres, as well as gene expression analysis of key growth and transcription factors associated with local skeletal muscle milieu, were performed after 2 weeks immobility (Imm) and following 3 days (+3d) and 4 weeks (+4wks) of retraining. OM demonstrated no detectable gains in MFA (vastus lateralis muscle) and no increases in number of Pax7-positive SCs following 4wks retraining, whereas YM increased their MFA (P < 0.05), number of Pax7-positive cells, and had more Pax7-positive cells per type II fibre than OM at +3d and +4wks (P < 0.05). No age-related differences were observed in mRNA expression of IGF-1Ea, MGF, MyoD1 and HGF with retraining, whereas myostatin expression levels were more down-regulated in YM compared to OM at +3d (P < 0.05). In conclusion, the diminished muscle re-growth after immobilisation in elderly humans was associated with a lesser response in satellite cell proliferation in combination with an age-specific regulation of myostatin. In contrast, expression of local growth factors did not seem to explain the age-related difference in muscle mass recovery.
C1 [Suetta, C.; Mackey, A. L.; Bayer, M. L.; Andersen, J. L.; Schjerling, P.; Kjaer, M.] Univ Copenhagen, Bispebjerg Hosp, Fac Hlth & Med Sci, Inst Sports Med, DK-2600 Glostrup, Denmark.
   [Suetta, C.; Mackey, A. L.; Bayer, M. L.; Andersen, J. L.; Schjerling, P.; Kjaer, M.] Univ Copenhagen, Bispebjerg Hosp, Fac Hlth & Med Sci, Ctr Hlth Ageing, DK-2600 Glostrup, Denmark.
   [Suetta, C.] Univ Copenhagen, Glostrup Hosp, Dept Clin Physiol & Nucl Med, DK-2600 Glostrup, Denmark.
   [Frandsen, U.; Jensen, L.; Hvid, L. G.; Aagaard, P.] Univ Southern Denmark, Inst Exercise Physiol & Clin Biomech, Odense, Denmark.
   [Petersson, S. J.; Schroder, H. D.] Odense Univ Hosp, Dept Pathol, DK-5000 Odense, Denmark.
C3 University of Copenhagen; Bispebjerg Hospital; University of Copenhagen;
   Bispebjerg Hospital; University of Copenhagen; University of Southern
   Denmark; University of Southern Denmark; Odense University Hospital
RP Suetta, C (corresponding author), Univ Copenhagen, Glostrup Hosp, Dept Clin Physiol & Nucl Med, Ndr Ringvej 57, DK-2600 Glostrup, Denmark.
EM csuetta@gmail.com
RI Mackey, Abigail/D-1060-2009; Aagaard, Per/IQW-6548-2023; Schrøder,
   Henrik Daa/E-2077-2013; Kjaer, Michael/W-6842-2019; Andersen, Jesper
   Løvind/W-6813-2019; Bayer, Monika/ABE-4909-2020; Kjaer,
   Michael/JDW-2112-2023; Schjerling, Peter/F-6194-2011; suetta,
   charlotte/AAK-1257-2020
OI Mackey, Abigail/0000-0002-2017-4580; Schrøder, Henrik
   Daa/0000-0001-7588-235X; Kjaer, Michael/0000-0002-4582-8755; Andersen,
   Jesper Løvind/0000-0001-8302-0071; Kjaer, Michael/0000-0002-4582-8755;
   Schjerling, Peter/0000-0001-7138-3211; G Hvid, Lars/0000-0003-3233-0429;
   Aagaard, Per/0000-0002-9773-7361; Suetta, charlotte/0000-0001-8063-6508;
   Dalgaard, Line Barner/0000-0001-7676-5323
FU Danish Medical Research Council; Danish Rheumatology Association;
   Faculty of Health Sciences, University of Copenhagen; Danish Ministry of
   Culture; Lundbeck Foundation; EU; Nordea Foundation
FX This study was supported by grants from the Danish Medical Research
   Council, the Danish Rheumatology Association, Faculty of Health
   Sciences, University of Copenhagen, The Danish Ministry of Culture,
   Lundbeck Foundation, EU 7th framework programme 'Myoage', and Nordea
   Foundation (Healthy Ageing Grant).
CR Aagaard P, 2010, SCAND J MED SCI SPOR, V20, P49, DOI 10.1111/j.1600-0838.2009.01084.x
   Adams GR, 1996, J APPL PHYSIOL, V81, P2509, DOI 10.1152/jappl.1996.81.6.2509
   ALLEN RE, 1989, J CELL PHYSIOL, V138, P311, DOI 10.1002/jcp.1041380213
   ALLEN RE, 1995, J CELL PHYSIOL, V165, P307, DOI 10.1002/jcp.1041650211
   Alway SE, 2001, EXP PHYSIOL, V86, P509, DOI 10.1113/eph8602235
   Anastasi S, 1997, J CELL BIOL, V137, P1057, DOI 10.1083/jcb.137.5.1057
   Andersen JL, 2003, SCAND J MED SCI SPOR, V13, P40, DOI 10.1034/j.1600-0838.2003.00299.x
   BERGSTROM J, 1962, SCAND J CLIN LAB INV, V14, P1
   BROOKE MH, 1970, ARCH NEUROL-CHICAGO, V23, P369, DOI 10.1001/archneur.1970.00480280083010
   CARLSON BM, 1989, AM J PHYSIOL, V256, pC1262
   Carlson ME, 2007, AGING CELL, V6, P371, DOI 10.1111/j.1474-9726.2007.00286.x
   Carlson ME, 2009, EMBO MOL MED, V1, P381, DOI 10.1002/emmm.200900045
   Chakkalakal JV, 2012, NATURE, V490, P355, DOI 10.1038/nature11438
   Chakravarthy MV, 2000, J BIOL CHEM, V275, P35942, DOI 10.1074/jbc.M005832200
   Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260
   Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573
   Coqueret O, 2003, TRENDS CELL BIOL, V13, P65, DOI 10.1016/S0962-8924(02)00043-0
   Costa A, 2007, EUR J APPL PHYSIOL, V101, P427, DOI 10.1007/s00421-007-0510-z
   Coutu DL, 2011, AGING-US, V3, P920, DOI 10.18632/aging.100369
   Dedkov EI, 2003, CELL TISSUE RES, V311, P401, DOI 10.1007/s00441-002-0686-9
   Dreyer HC, 2006, MUSCLE NERVE, V33, P242, DOI 10.1002/mus.20461
   Edström E, 2005, AGING CELL, V4, P65, DOI 10.1111/j.1474-9728.2005.00145.x
   Esmarck B, 2001, J PHYSIOL-LONDON, V535, P301, DOI 10.1111/j.1469-7793.2001.00301.x
   Gopinath SD, 2008, AGING CELL, V7, P590, DOI 10.1111/j.1474-9726.2008.00399.x
   Guerra B, 2011, J APPL PHYSIOL, V110, P1708, DOI 10.1152/japplphysiol.00091.2011
   Haddad F, 2006, J APPL PHYSIOL, V100, P1188, DOI 10.1152/japplphysiol.01227.2005
   Hameed M, 2003, J PHYSIOL-LONDON, V547, P247, DOI 10.1113/jphysiol.2002.032136
   Heslop L, 2001, GENE THER, V8, P778, DOI 10.1038/sj.gt.3301463
   Hespel P, 2001, J PHYSIOL-LONDON, V536, P625, DOI 10.1111/j.1469-7793.2001.0625c.xd
   Hikida Robert S, 2011, Curr Aging Sci, V4, P279
   Horsley V, 2003, J CELL BIOL, V161, P111, DOI 10.1083/jcb.200208085
   Hvid L, 2010, J APPL PHYSIOL, V109, P1628, DOI 10.1152/japplphysiol.00637.2010
   Hvid LG, 2011, J PHYSIOL-LONDON, V589, P4745, DOI 10.1113/jphysiol.2011.215434
   JENNISCHE E, 1993, AM J PHYSIOL, V265, pC122, DOI 10.1152/ajpcell.1993.265.1.C122
   Jones SW, 2004, FASEB J, V18, P1025, DOI 10.1096/fj.03-1228fje
   Kadi F, 2004, J PHYSIOL-LONDON, V558, P1005, DOI 10.1113/jphysiol.2004.065904
   Kadi F, 2004, MUSCLE NERVE, V29, P120, DOI 10.1002/mus.10510
   Kadi F, 2006, HISTOCHEM CELL BIOL, V126, P83, DOI 10.1007/s00418-005-0102-0
   Kim JS, 2005, J APPL PHYSIOL, V99, P2149, DOI 10.1152/japplphysiol.00513.2005
   Kim JS, 2005, AM J PHYSIOL-ENDOC M, V288, pE1110, DOI 10.1152/ajpendo.00464.2004
   Kosek DJ, 2006, J APPL PHYSIOL, V101, P531, DOI 10.1152/japplphysiol.01474.2005
   Lange KHW, 2002, J CLIN ENDOCR METAB, V87, P513, DOI 10.1210/jc.87.2.513
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lorenzon P, 2004, EXP GERONTOL, V39, P1545, DOI 10.1016/j.exger.2004.07.008
   Machida S, 2004, MED SCI SPORT EXER, V36, P52, DOI 10.1249/01.MSS.0000106175.24978.84
   Machida S, 2003, J CELL PHYSIOL, V196, P523, DOI 10.1002/jcp.10339
   Mackey AL, 2010, J APPL PHYSIOL, V109, P1920, DOI 10.1152/japplphysiol.00789.2010
   MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493
   MCCORMICK KM, 1994, DEV DYNAM, V199, P52, DOI 10.1002/aja.1001990106
   McCroskery S, 2003, J CELL BIOL, V162, P1135, DOI 10.1083/jcb.200207056
   McKay BR, 2012, FASEB J, V26, P2509, DOI 10.1096/fj.11-198663
   McKay BR, 2008, J PHYSIOL-LONDON, V586, P5549, DOI 10.1113/jphysiol.2008.160176
   McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0
   MEZZOGIORNO A, 1993, MECH AGEING DEV, V70, P35, DOI 10.1016/0047-6374(93)90057-X
   Mitchell PO, 2004, AM J PHYSIOL-CELL PH, V287, pC1753, DOI 10.1152/ajpcell.00292.2004
   MOSS FP, 1970, J CELL BIOL, V44, P459, DOI 10.1083/jcb.44.2.459
   Owino V, 2001, FEBS LETT, V505, P259, DOI 10.1016/S0014-5793(01)02825-3
   Pallafacchina G, 2012, NUTR METAB IN PRESS, DOI 10.1016/j.numecd.2012.02.002
   Petrella JK, 2008, J APPL PHYSIOL, V104, P1736, DOI 10.1152/japplphysiol.01215.2007
   Petrella JK, 2006, AM J PHYSIOL-ENDOC M, V291, pE937, DOI 10.1152/ajpendo.00190.2006
   Psilander N, 2003, J APPL PHYSIOL, V95, P1038, DOI 10.1152/japplphysiol.00903.2002
   Raue U, 2006, J APPL PHYSIOL, V101, P53, DOI 10.1152/japplphysiol.01616.2005
   Renault V, 2002, EXP GERONTOL, V37, P1513, DOI 10.1016/S0531-5565(02)00095-5
   ROSENBLATT JD, 1994, MUSCLE NERVE, V17, P608, DOI 10.1002/mus.880170607
   Roth SM, 2003, EXP BIOL MED, V228, P706, DOI 10.1177/153537020322800609
   Roth SM, 2000, ANAT REC, V260, P351, DOI 10.1002/1097-0185(200012)260:4<350::AID-AR30>3.0.CO;2-6
   Sheehan SM, 2000, MUSCLE NERVE, V23, P239, DOI 10.1002/(SICI)1097-4598(200002)23:2<239::AID-MUS15>3.0.CO;2-U
   Sheehan SM, 1999, J CELL PHYSIOL, V181, P499, DOI 10.1002/(SICI)1097-4652(199912)181:3<499::AID-JCP14>3.0.CO;2-1
   Shefer G, 2006, DEV BIOL, V294, P50, DOI 10.1016/j.ydbio.2006.02.022
   Suetta C, 2004, J AM GERIATR SOC, V52, P2016, DOI 10.1111/j.1532-5415.2004.52557.x
   Suetta C, 2004, J APPL PHYSIOL, V97, P1954, DOI 10.1152/japplphysiol.01307.2003
   Suetta C, 2009, J APPL PHYSIOL, V107, P1172, DOI 10.1152/japplphysiol.00290.2009
   Suetta C, 2012, PLOS ONE, V12, P1
   Suetta C, 2008, J APPL PHYSIOL, V105, P180, DOI 10.1152/japplphysiol.01354.2007
   Suetta C, 2010, GROWTH HORM IGF RES, V20, P134, DOI 10.1016/j.ghir.2009.11.005
   Tatsumi R, 1998, DEV BIOL, V194, P114, DOI 10.1006/dbio.1997.8803
   Tatsumi R, 2009, AM J PHYSIOL-CELL PH, V297, pC238, DOI 10.1152/ajpcell.00161.2009
   Thornell LE, 2003, SCAND J MED SCI SPOR, V13, P48, DOI 10.1034/j.1600-0838.2003.20285.x
   Trendelenburg AU, 2009, AM J PHYSIOL-CELL PH, V296, pC1258, DOI 10.1152/ajpcell.00105.2009
   Verdijk LB, 2007, AM J PHYSIOL-ENDOC M, V292, pE151, DOI 10.1152/ajpendo.00278.2006
   Verney J, 2008, MUSCLE NERVE, V38, P1147, DOI 10.1002/mus.21054
   Yamada M, 2010, AM J PHYSIOL-CELL PH, V298, pC465, DOI 10.1152/ajpcell.00449.2009
   Yang SY, 2002, FEBS LETT, V522, P156, DOI 10.1016/S0014-5793(02)02918-6
   Zarnegar R, 1995, EXS, V74, P33
NR 84
TC 122
Z9 132
U1 0
U2 20
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3751
EI 1469-7793
J9 J PHYSIOL-LONDON
JI J. Physiol.-London
PD AUG 1
PY 2013
VL 591
IS 15
BP 3789
EP 3804
DI 10.1113/jphysiol.2013.257121
PG 16
WC Neurosciences; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Physiology
GA 199JE
UT WOS:000322990000014
PM 23732643
OA Green Published
DA 2024-02-19
ER

PT J
AU Gupta, S
   Pathak, RU
   Kanungo, MS
AF Gupta, Sanjay
   Pathak, Rashmi U.
   Kanungo, Madhu S.
TI DNA methylation induced changes in chromatin conformation of the
   promoter of the vitellogenin II gene of Japanese quail during aging
SO GENE
LA English
DT Article
DE nuclease hypersensitivity; cis-acting elements; trans-acting factors
ID HISTONE DEACETYLASE; PREFERENTIAL BINDING; REPRESSOR MDBP-2; CPG
   METHYLATION; IN-VITRO; 5 END; ESTROGEN; SEQUENCE; RECEPTOR;
   IDENTIFICATION
AB One approach to the understanding of the molecular basis of aging in higher organisms may be to use genes whose timing and rate of expression during the life span run parallel with specific functions that can be monitored. The genes for egg proteins, such as vitellogenin (VTG), which is expressed in the liver, and ovalbumin, lysozyme etc. that are expressed in the oviduct of birds, meet these requirements. Egg laying function is dependent on the production of these proteins, which, in turn, depends on the expression of their genes. In this communication we present the age-related studies on the VTG 11 gene of the bird, Japanese quail. The gene is expressed only in the liver and its expression is considerably lower in old birds that do not lay eggs. Comparison of the promoter region of the gene carrying the two important cis-acting elements, estrogen responsive element (ERE) and progesterone responsive element (PRE), shows it to be 100% homologous to the corresponding region of the chicken VTG II gene. Methylation of DNA and conformation of chromatin of this region were studied, as they are known to be important for regulation of expression of genes. Our studies show that in the liver of adult female quails which lay eggs, a -CCGG- sequence located in this region is hypomethylated, and the chromatin encompassing this region of the gene is relaxed. In the old, the -CCGG- sequence is hypermethylated and the chromatin is compact. This is correlated with a decrease in the expression of the gene and decrease in egg production. Further, electrophoretic mobility shift assay (EMSA) shows that the levels/affinity of specific trans-acting factors that bind to ERE and PRE present in the region, are not different in adult and old birds. Hence the methylation status of the -CCGG- sequence that is located in-between the ERE and the PRE may be crucial for the conformation of chromatin and availability of these two important cis-acting elements for the binding of the trans-acting factors. This, in turn, may downregulate the expression of the gene in old birds. (c) 2006 Elsevier B.V. All rights reserved.
C1 Banaras Hindu Univ, Dept Zool, Mol Biol Lab, Varanasi 221005, Uttar Pradesh, India.
C3 Banaras Hindu University (BHU)
RP Kanungo, MS (corresponding author), Banaras Hindu Univ, Dept Zool, Mol Biol Lab, Varanasi 221005, Uttar Pradesh, India.
EM kanungo@bhu.ac.in
CR BEATO M, 1995, CELL, V83, P851, DOI 10.1016/0092-8674(95)90201-5
   Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9
   BRUHAT A, 1995, P NATL ACAD SCI USA, V92, P3678, DOI 10.1073/pnas.92.9.3678
   BURCH JBE, 1984, NUCLEIC ACIDS RES, V12, P1117, DOI 10.1093/nar/12.2.1117
   BURCH JBE, 1988, MOL CELL BIOL, V8, P1123, DOI 10.1128/MCB.8.3.1123
   CASTLE T, 1978, MECH AGEING DEV, V8, P383, DOI 10.1016/0047-6374(78)90037-4
   CATO ACB, 1988, MOL CELL BIOL, V8, P5323, DOI 10.1128/MCB.8.12.5323
   CHATURVEDI MM, 1985, MOL BIOL REP, V10, P215
   COMB M, 1990, NUCLEIC ACIDS RES, V18, P3975, DOI 10.1093/nar/18.13.3975
   GEISER M, 1983, J BIOL CHEM, V258, P9024
   GORSKI K, 1986, CELL, V47, P767, DOI 10.1016/0092-8674(86)90519-2
   HERRMANN BG, 1987, METHOD ENZYMOL, V152, P180
   IGUCHIARIGA SMM, 1989, GENE DEV, V3, P612, DOI 10.1101/gad.3.5.612
   Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561
   JOST JP, 1992, P NATL ACAD SCI USA, V89, P9499, DOI 10.1073/pnas.89.20.9499
   JOST JP, 1991, NUCLEIC ACIDS RES, V19, P5771, DOI 10.1093/nar/19.20.5771
   JOST JP, 1984, P NATL ACAD SCI-BIOL, V81, P429, DOI 10.1073/pnas.81.2.429
   JOST JP, 1993, DNA METHYLATION MOL
   KANUNGO MS, 1994, GENES AGING
   KASS SU, 1993, MOL CELL BIOL, V13, P7372, DOI 10.1128/MCB.13.12.7372
   KESHET I, 1985, P NATL ACAD SCI USA, V82, P2560, DOI 10.1073/pnas.82.9.2560
   KRAUS WL, 1993, ENDOCRINOLOGY, V132, P2371, DOI 10.1210/en.132.6.2371
   KUHL D, 1987, CELL, V50, P1057, DOI 10.1016/0092-8674(87)90172-3
   LEAVITT WW, 1988, HORMONE ANTAGONISTS, P212
   LEVYWILSON B, 1988, MOL CELL BIOL, V8, P71, DOI 10.1128/MCB.8.1.71
   LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Mahendra G, 1999, ARCH GERONTOL GERIAT, V28, P149, DOI 10.1016/S0167-4943(99)00002-3
   MEEHAN RR, 1989, CELL, V58, P499, DOI 10.1016/0092-8674(89)90430-3
   MEIJLINK FCPW, 1983, NUCLEIC ACIDS RES, V11, P1361, DOI 10.1093/nar/11.5.1361
   Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764
   Ng HH, 1999, CURR OPIN GENET DEV, V9, P158, DOI 10.1016/S0959-437X(99)80024-0
   ONO T, 1993, AGE AGEING, V22, pS34, DOI 10.1093/ageing/22.suppl_1.S34
   PAWLAK A, 1991, NUCLEIC ACIDS RES, V19, P1029
   ROOP DR, 1978, CELL, V15, P671, DOI 10.1016/0092-8674(78)90035-1
   Sambrook J, 1989, MOL CLONING LAB MANU
   SCHEIDEREIT C, 1986, DNA-J MOLEC CELL BIO, V5, P383, DOI 10.1089/dna.1986.5.383
   Takatsu M, 1999, MECH AGEING DEV, V110, P37, DOI 10.1016/S0047-6374(99)00041-X
   TAZI J, 1990, CELL, V60, P909, DOI 10.1016/0092-8674(90)90339-G
   VANHETSCHIP FD, 1987, J MOL BIOL, V196, P245, DOI 10.1016/0022-2836(87)90688-7
   WILKS A, 1984, NUCLEIC ACIDS RES, V12, P1163, DOI 10.1093/nar/12.2.1163
   Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924
NR 42
TC 19
Z9 23
U1 0
U2 14
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0378-1119
EI 1879-0038
J9 GENE
JI Gene
PD AUG 1
PY 2006
VL 377
BP 159
EP 168
DI 10.1016/j.gene.2006.04.020
PG 10
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 072JI
UT WOS:000239669300017
PM 16766142
DA 2024-02-19
ER

PT J
AU Farré, P
   Jones, MJ
   Meaney, MJ
   Emberly, E
   Turecki, G
   Kobor, MS
AF Farre, Pau
   Jones, Meaghan J.
   Meaney, Michael J.
   Emberly, Eldon
   Turecki, Gustavo
   Kobor, Michael S.
TI Concordant and discordant DNA methylation signatures of aging in human
   blood and brain
SO EPIGENETICS & CHROMATIN
LA English
DT Article
DE DNA methylation; Principal component analysis; Aging; Brain; Blood;
   Epigenetics
ID CELLULAR HETEROGENEITY; WIDE; AGE; 5-HYDROXYMETHYLCYTOSINE;
   5-METHYLCYTOSINE; TISSUE; CELLS; ANNOTATION; VALIDATION; PROFILES
AB Background: DNA methylation is an epigenetic mark that balances plasticity with stability. While DNA methylation exhibits tissue specificity, it can also vary with age and potentially environmental exposures. In studies of DNA methylation, samples from specific tissues, especially brain, are frequently limited and so surrogate tissues are often used. As yet, we do not fully understand how DNA methylation profiles of these surrogate tissues relate to the profiles of the central tissue of interest.
   Results: We have adapted principal component analysis to analyze data from the Illumina 450K Human Methylation array using a set of 17 individuals with 3 brain regions and whole blood. All of the top five principal components in our analysis were associated with a variable of interest: principal component 1 (PC1) differentiated brain from blood, PCs 2 and 3 were representative of tissue composition within brain and blood, respectively, and PCs 4 and 5 were associated with age of the individual (PC4 in brain and PC5 in both brain and blood). We validated our age-related PCs in four independent sample sets, including additional brain and blood samples and liver and buccal cells. Gene ontology analysis of all five PCs showed enrichment for processes that inform on the functions of each PC.
   Conclusions: Principal component analysis (PCA) allows simultaneous and independent analysis of tissue composition and other phenotypes of interest. We discovered an epigenetic signature of age that is not associated with cell type composition and required no correction for cellular heterogeneity.
C1 [Farre, Pau; Emberly, Eldon] Simon Fraser Univ, Dept Phys, Burnaby, BC V5A 1S6, Canada.
   [Jones, Meaghan J.; Kobor, Michael S.] Child & Family Res Inst, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 4H4, Canada.
   [Jones, Meaghan J.; Kobor, Michael S.] Univ British Columbia, Dept Med Genet, Vancouver, BC V5Z 4H4, Canada.
   [Meaney, Michael J.] McGill Univ, Douglas Mental Hlth Univ Inst, Ludmer Ctr Neuroinformat & Mental Hlth, Verdun, PQ H4H 1R3, Canada.
   [Meaney, Michael J.] Singapore Inst Clin Sci, Singapore 117609, Singapore.
   [Meaney, Michael J.; Kobor, Michael S.] Canadian Inst Adv Res, Toronto, ON, Canada.
   [Turecki, Gustavo] McGill Univ, Dept Psychiat, Verdun, PQ H4H 1R3, Canada.
C3 Simon Fraser University; Child & Family Research Institute; University
   of British Columbia; McGill University; Agency for Science Technology &
   Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences
   (SICS); Canadian Institute for Advanced Research (CIFAR); McGill
   University
RP Kobor, MS (corresponding author), Child & Family Res Inst, Ctr Mol Med & Therapeut, 950 W 28th ave, Vancouver, BC V5Z 4H4, Canada.
EM msk@cmmt.ubc.ca
RI Meaney, Michael/N-5931-2019; Turecki, Gustavo/K-5100-2015; Jones,
   Meaghan J/J-7672-2017
OI Jones, Meaghan J/0000-0003-1593-997X; Turecki,
   Gustavo/0000-0003-4075-2736; Kobor, Michael/0000-0003-4140-1743
FU NSERC; Brain Canada/Garfield Weston Foundation; NeuroDevNet NCE; Mining
   for Miracles Post-doctoral fellowship from the Child and Family Research
   Institute
FX We thank Lucia Lam for excellent technical assistance. MSK is the
   co-lead of the Biology Working Group of the Canadian Longitudinal Study
   of Aging and the Canada Research Chair in Social Epigenetics. This study
   was supported by funds from NSERC (EE), Brain Canada/Garfield Weston
   Foundation (MSK, MJM, GT), and NeuroDevNet NCE (MSK). MJJ was supported
   by a Mining for Miracles Post-doctoral fellowship from the Child and
   Family Research Institute. MJM and MSK are Senior Fellows of the
   Canadian Institute for Advanced Research.
CR Ahrens M, 2013, CELL METAB, V18, P296, DOI 10.1016/j.cmet.2013.07.004
   Banovich NE, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004663
   Bell JT, 2012, PLOS GENET, V8, P189, DOI 10.1371/journal.pgen.1002629
   Berko ER, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004402
   Bjornsson HT, 2004, TRENDS GENET, V20, P350, DOI 10.1016/j.tig.2004.06.009
   Boks MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006767
   Booth MJ, 2012, SCIENCE, V336, P934, DOI 10.1126/science.1220671
   Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602
   Chung NC, 2015, BIOINFORMATICS, V31, P545, DOI 10.1093/bioinformatics/btu674
   Davies MN, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r43
   Dedeurwaerder S, 2011, EPIGENOMICS-UK, V3, P771, DOI [10.2217/EPI.11.105, 10.2217/epi.11.105]
   Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224
   Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008
   Florath I, 2014, HUM MOL GENET, V23, P1186, DOI 10.1093/hmg/ddt531
   Fraga MF, 2007, TRENDS GENET, V23, P413, DOI 10.1016/j.tig.2007.05.008
   Guintivano J, 2013, EPIGENETICS-US, V8, P290, DOI 10.4161/epi.23924
   Hannum G, 2013, MOL CELL, V49, P359, DOI 10.1016/j.molcel.2012.10.016
   Heijmans BT, 2012, INT J EPIDEMIOL, V41, P74, DOI 10.1093/ije/dyr225
   Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115
   Horvath S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-10-r97
   Houseman EA, 2014, BIOINFORMATICS, V30, P1431, DOI 10.1093/bioinformatics/btu029
   Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923
   Illingworth RS, 2009, FEBS LETT, V583, P1713, DOI 10.1016/j.febslet.2009.04.012
   Jaffe AE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r31
   Jiang RW, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/s12989-014-0071-3
   Jiao YM, 2014, BIOINFORMATICS, V30, P2360, DOI 10.1093/bioinformatics/btu316
   Jin SG, 2011, NUCLEIC ACIDS RES, V39, P5015, DOI 10.1093/nar/gkr120
   Johansson Å, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067378
   Koestler DC, 2013, EPIGENETICS-US, V8, P816, DOI 10.4161/epi.25430
   Ladd-Acosta C, 2014, MOL PSYCHIATR, V19, P862, DOI 10.1038/mp.2013.114
   Lam LL, 2012, P NATL ACAD SCI USA, V109, P17253, DOI 10.1073/pnas.1121249109
   Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825
   Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905
   Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514
   Lowe R, 2013, EPIGENETICS-US, V8, P445, DOI 10.4161/epi.24362
   McClay JL, 2014, HUM MOL GENET, V23, P1175, DOI 10.1093/hmg/ddt511
   McGirr A, 2009, AM J PSYCHIAT, V166, P1124, DOI 10.1176/appi.ajp.2009.08111744
   Poulsen P, 2007, PEDIATR RES, V61, p38R, DOI 10.1203/pdr.0b013e31803c7b98
   Price EM, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-4
   Ramsahoye BH, 2000, P NATL ACAD SCI USA, V97, P5237, DOI 10.1073/pnas.97.10.5237
   Reinius LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041361
   Sequeira A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006585
   Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi
   Slieker RC, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-26
   Song CX, 2013, CELL, V153, P678, DOI 10.1016/j.cell.2013.04.001
   Stewart SK, 2015, METHODS, V72, P9, DOI 10.1016/j.ymeth.2014.08.009
   Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116
   Teschendorff AE, 2013, HUM MOL GENET, V22, pR7, DOI 10.1093/hmg/ddt375
   Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990
   Weidner CI, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r24
   Wen L, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r49
   Yuen RKC, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-7
   Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433
   Zou J, 2014, NAT METHODS, V11, P309, DOI [10.1038/nmeth.2815, 10.1038/NMETH.2815]
NR 56
TC 107
Z9 115
U1 0
U2 30
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1756-8935
J9 EPIGENET CHROMATIN
JI Epigenetics Chromatin
PD MAY 9
PY 2015
VL 8
AR 19
DI 10.1186/s13072-015-0011-y
PG 17
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA CI0NE
UT WOS:000354433100001
PM 25977707
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Shang, Y
   Nasr, P
   Ekstedt, M
   Widman, L
   Stål, P
   Hultcrantz, R
   Kechagias, S
   Hagström, H
AF Shang, Ying
   Nasr, Patrik
   Ekstedt, Mattias
   Widman, Linnea
   Stal, Per
   Hultcrantz, Rolf
   Kechagias, Stergios
   Hagstrom, Hannes
TI Non-alcoholic fatty liver disease does not increase dementia risk
   although histology data might improve risk prediction
SO JHEP REPORTS
LA English
DT Article; Early Access
DE NAFLD; Histological pathology; Dementia; Prediction
ID SCORING SYSTEM; FIBROSIS; EPIDEMIOLOGY; ASSOCIATION; POPULATION;
   PREVALENCE; ALGORITHM; INSULIN; NAFLD
AB Background & Aims: Non-alcoholic fatty liver disease (NAFLD) is common in the general population, but its association with dementia is unclear. We aimed to assess the risk of dementia related to NAFLD, and to determine whether histological parameters could improve the predictive capacity of a conventional risk model for dementia in patients with biopsy-proven NAFLD.
   Methods: A retrospective matched cohort study of 656 NAFLD patients underwent liver biopsy at 2 hospitals between 1971 and 2009. Up to 10 individuals (controls) from the general population (n = 6,436) were matched for age, sex, and municipality to each patient. Dementia was ascertained from National registers until 2014. Using Cox regression, we estimated hazard ratios for dementia with 95% confidence intervals. In the biopsy cohort, the discriminative power of adding histological markers to a conventional risk model was assessed by Harrell's C-index and compared with a likelihood-ratio test.
   Results: During a mean follow-up of 19.7 +/- 8.7 years, 3.3% of the NAFLD patients and 4.9% of the controls developed dementia (p = 0.07). Overall, NAFLD was not significantly associated with incident dementia. In the biopsy cohort, the model of conventional risk factors (age, sex, hypertension, and cardiovascular diseases) had a C-index of 0.912 to predict incident dementia. Adding individual histological parameters significantly increased the prediction of dementia, with the most pronounced improvement for fibrosis stage (C-index = 0.938, p <0.05).
   Conclusions: Although NAFLD was not associated with the risk of dementia, we found that adding histological markers to a conventional risk model for dementia enhanced the predictive capacity, indicating a shared metabolic origin.
   Lay summary: Both non-alcoholic fatty liver disease (NAFLD) and dementia are increasing in prevalence because of a more sedentary lifestyle, increased prevalence of obesity and population ageing. However, the link between these 2 diseases is not well studied. We investigated the association between NAFLD and the risk of dementia and found no association. However, liver histology parameters, especially fibrosis, could significantly improve the prediction of dementia risk. (C) 2020 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).
C1 [Shang, Ying] Karolinska Inst, Dept Neurobiol Care Sci & Soc NVS, Stockholm, Sweden.
   [Nasr, Patrik; Ekstedt, Mattias; Kechagias, Stergios] Linkoping Univ, Dept Gastroenterol & Hepatol, Dept Hlth Med & Caring Sci, Linkoping, Sweden.
   [Widman, Linnea] Karolinska Inst, Inst Environm Med, Div Biostat, Stockholm, Sweden.
   [Stal, Per; Hultcrantz, Rolf; Hagstrom, Hannes] Karolinska Univ Hosp, Dept Upper GI, Div Hepatol, C1 77, S-14186 Stockholm, Sweden.
   [Stal, Per; Hultcrantz, Rolf; Hagstrom, Hannes] Karolinska Inst, Dept Med, Stockholm, Sweden.
   [Hagstrom, Hannes] Karolinska Inst, Dept Med, Clin Epidemiol Unit, Stockholm, Sweden.
C3 Karolinska Institutet; Linkoping University; Karolinska Institutet;
   Karolinska Institutet; Karolinska University Hospital; Karolinska
   Institutet; Karolinska Institutet
RP Hagström, H (corresponding author), Karolinska Univ Hosp, Dept Upper GI, Div Hepatol, C1 77, S-14186 Stockholm, Sweden.; Shang, Y (corresponding author), Karolinska Inst, Dept Neurobiol Care Sci & Soc NVS, NVS, S-17165 Stockholm, Sweden.
EM ying.shang@ki.se; Hannes.hagstrom@ki.se
RI Shang, Ying/ABB-6503-2020; Hagström, Hannes/I-2036-2019; Stål,
   Per/J-2154-2019; Ekstedt, Mattias/AAP-9770-2020
OI Shang, Ying/0000-0002-1496-1799; Hagström, Hannes/0000-0002-8474-1759;
   Stål, Per/0000-0003-2915-1964; Ekstedt, Mattias/0000-0002-5590-8601;
   Widman, Linnea/0000-0003-4851-0256
CR Bedossa P, 2014, HEPATOLOGY, V60, P565, DOI 10.1002/hep.27173
   Bedossa P, 2012, HEPATOLOGY, V56, P1751, DOI 10.1002/hep.25889
   Bertolotti M, 2014, WORLD J GASTROENTERO, V20, P14185, DOI 10.3748/wjg.v20.i39.14185
   Brooke HL, 2017, EUR J EPIDEMIOL, V32, P765, DOI 10.1007/s10654-017-0316-1
   Celikbilek A, 2018, EUR J GASTROEN HEPAT, V30, P944, DOI 10.1097/MEG.0000000000001131
   Chang Y, 2013, AM J GASTROENTEROL, V108, P1861, DOI 10.1038/ajg.2013.349
   COTE RA, 1980, JAMA-J AM MED ASSOC, V243, P756, DOI 10.1001/jama.243.8.756
   Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327
   Elliott C, 2013, DIGEST DIS SCI, V58, P2383, DOI 10.1007/s10620-013-2657-2
   Ghareeb DA, 2011, METAB BRAIN DIS, V26, P253, DOI 10.1007/s11011-011-9261-y
   Hagström H, 2019, LIVER INT, V39, P197, DOI 10.1111/liv.13973
   Hagström H, 2017, J HEPATOL, V67, P1265, DOI 10.1016/j.jhep.2017.07.027
   Hou XH, 2019, J NEUROL NEUROSUR PS, V90, P373, DOI 10.1136/jnnp-2018-318212
   Khemka VK, 2014, J ALZHEIMERS DIS, V41, P525, DOI 10.3233/JAD-140006
   Kim SU, 2017, ATHEROSCLEROSIS, V260, P156, DOI 10.1016/j.atherosclerosis.2017.02.005
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   Labenz C, 2021, DIGEST DIS SCI, V66, P3179, DOI 10.1007/s10620-020-06644-1
   Livingston Gill, 2017, Lancet, V390, P2673, DOI 10.1016/S0140-6736(17)31363-6
   Lombardi R, 2019, DIGEST LIVER DIS, V51, P1214, DOI 10.1016/j.dld.2019.05.015
   Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450
   Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y
   Mahady SE, 2017, CLIN GASTROENTEROL H, V15, P1453, DOI 10.1016/j.cgh.2017.02.031
   Petta S, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003446
   Pohanka M, 2014, CURR MED CHEM, V21, P356
   Poli Giuseppe, 2000, Molecular Aspects of Medicine, V21, P49, DOI 10.1016/S0098-2997(00)00004-2
   Román GC, 2002, LANCET NEUROL, V1, P426, DOI 10.1016/S1474-4422(02)00190-4
   Seo SW, 2016, NEUROLOGY, V86, P1136, DOI 10.1212/WNL.0000000000002498
   Shang Y, 2020, ALZHEIMERS DEMENT, V16, P1003, DOI 10.1002/alz.12101
   Tang EYH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136181
   Targher G, 2006, DIABETES CARE, V29, P1325, DOI 10.2337/dc06-0135
   Weinstein G, 2019, LIVER INT, V39, P1713, DOI 10.1111/liv.14161
   Weinstein G, 2018, JAMA NEUROL, V75, P97, DOI 10.1001/jamaneurol.2017.3229
   Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038
   Yilmaz Y, 2009, HEPATOLOGY, V49, P698, DOI 10.1002/hep.22752
   Younossi ZM, 2015, HEPATOLOGY, V62, p739A
NR 35
TC 25
Z9 26
U1 1
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
EI 2589-5559
J9 JHEP REP
JI JHEP Rep.
PD 2021 APR
PY 2021
VL 3
IS 2
AR 100218
DI 10.1016/j.jhepr.2020.100218
EA JAN 2021
PG 8
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA RZ9TI
UT WOS:000648941700005
PM 33554097
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Conconi, M
   Szweda, LI
   Levine, RL
   Stadtman, ER
   Friguet, B
AF Conconi, M
   Szweda, LI
   Levine, RL
   Stadtman, ER
   Friguet, B
TI Age-related decline of rat liver multicatalytic proteinase activity and
   protection from oxidative inactivation by heat-shock protein 90
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE aging; multicatalytic proteinase; rat liver; oxidative inactivation;
   heat shock protein 90
ID GLUTAMINE-SYNTHETASE; OXIDIZED PROTEINS; COMPLEX; DEGRADATION;
   PROTEOLYSIS; PROTEASES; BRAIN; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE;
   ELECTROPHORESIS; PURIFICATION
AB To test whether an observed age-related increase in the level of oxidized protein in rat liver is due to a decrease in the activity of the multicatalytic proteinase (MCP), this protease was isolated from liver of young (8-month-old) and old (24-month-old) male Fischer 344 rats. Three peptidase activities of the MCP were assayed using fluorogenic peptides: trypsin-like, chymotrypsin-like, and peptidylglutamyl-peptide hydrolase, Only peptidylglutamyl-peptide hydrolase activity declined with age, with protease from old animals exhibiting approximately 50% of the activity of that from young animals, Bidimensional gel electrophoresis and thermostability studies did not reveal age-related structural modifications of the MCP subunits. Peptidylglutamyl-peptide hydrolase activity and trypsin-like activity were sensitive to metal-catalyzed oxidation. In some preparations, a 95-kDa protein that has been identified as the heat shock protein 90 copurified with the MCP, In the presence of HSP 90, trypsin-like activity is protected from oxidative inactivation and chymotrypsin-like activity is slightly activated. Peptidylglutamyl-peptide hydrolase activity remained sensitive to oxidation in protease isolated from young rats, but that from old rats was resistant to oxidative inactivation, Furthermore, addition of rat HSP 90 to rat liver MCP (purified from 8-month-old animals and free of contaminating HSP 90) was found to protect trypsin-like activity from oxidative inactivation. (C) 1996 Academic Press, Inc.
C1 INST PASTEUR, UNITE BIOCHIM CELLULAIRE, F-75724 PARIS 15, FRANCE.
   CASE WESTERN RESERVE UNIV, SCH MED, DEPT PHYSIOL & BIOPHYS, CLEVELAND, OH 44106 USA.
   NHLBI, BIOCHEM LAB, BETHESDA, MD 20892 USA.
C3 Le Reseau International des Instituts Pasteur (RIIP); Universite Paris
   Cite; Institut Pasteur Paris; University System of Ohio; Case Western
   Reserve University; National Institutes of Health (NIH) - USA; NIH
   National Heart Lung & Blood Institute (NHLBI)
RI Levine, Rodney L/D-9885-2011
OI Friguet, Bertrand/0000-0001-8085-1961
CR AGARWAL S, 1994, ARCH BIOCHEM BIOPHYS, V309, P24, DOI 10.1006/abbi.1994.1078
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   AMES BN, 1992, ANN NY ACAD SCI, V663, P85, DOI 10.1111/j.1749-6632.1992.tb38652.x
   ARRIBAS J, 1990, J BIOL CHEM, V265, P13969
   BABA A, 1981, J BIOL CHEM, V256, P3679
   CARNEY JM, 1991, P NATL ACAD SCI USA, V88, P3633, DOI 10.1073/pnas.88.9.3633
   DAHLMANN B, 1989, FEBS LETT, V251, P125, DOI 10.1016/0014-5793(89)81441-3
   DAS DK, 1993, CARDIOVASC RES, V27, P578, DOI 10.1093/cvr/27.4.578
   DAVIES KJA, 1987, J BIOL CHEM, V262, P9914
   DJABALLAH H, 1992, BIOCHEMISTRY-US, V31, P4133, DOI 10.1021/bi00131a033
   FRIGUET B, 1994, ARCH BIOCHEM BIOPHYS, V311, P168, DOI 10.1006/abbi.1994.1222
   FRIGUET B, 1994, J BIOL CHEM, V269, P21639
   GOLDBERG AL, 1992, EUR J BIOCHEM, V203, P9, DOI 10.1111/j.1432-1033.1992.tb19822.x
   GRUNE T, 1995, J BIOL CHEM, V270, P2344, DOI 10.1074/jbc.270.5.2344
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025
   HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553
   JAKOB U, 1994, TRENDS BIOCHEM SCI, V19, P205, DOI 10.1016/0968-0004(94)90023-X
   KAWASAKI H, 1990, ANAL BIOCHEM, V191, P332, DOI 10.1016/0003-2697(90)90227-Z
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   MORRISSEY JH, 1981, ANAL BIOCHEM, V117, P307, DOI 10.1016/0003-2697(81)90783-1
   OFARRELL PH, 1975, J BIOL CHEM, V250, P4007
   OLIVER CN, 1987, J BIOL CHEM, V262, P5488
   ORLOWSKI M, 1991, BIOCHEMISTRY-US, V30, P5999, DOI 10.1021/bi00238a025
   ORLOWSKI M, 1993, BIOCHEMISTRY-US, V32, P1563, DOI 10.1021/bi00057a022
   ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730
   PACIFICI RE, 1989, FREE RADICAL BIO MED, V7, P521, DOI 10.1016/0891-5849(89)90028-2
   PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253
   RECHSTEINER M, 1993, J BIOL CHEM, V268, P6065
   RIVETT AJ, 1985, J BIOL CHEM, V260, P2600
   RIVETT AJ, 1985, J BIOL CHEM, V260, P300
   RIVETT AJ, 1991, BIOCHEM J, V278, P171, DOI 10.1042/bj2780171
   Rothstein M., 1982, BIOCH APPROACHES AGI
   SAHAKIAN JA, 1995, ARCH BIOCHEM BIOPHYS, V318, P411, DOI 10.1006/abbi.1995.1248
   SHAUGHNESSY SG, 1993, ARCH BIOCHEM BIOPHYS, V304, P314, DOI 10.1006/abbi.1993.1356
   SIERRA F, 1992, J BIOL CHEM, V267, P10665
   SMITH CD, 1991, P NATL ACAD SCI USA, V88, P10540, DOI 10.1073/pnas.88.23.10540
   Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142
   STARKEREED PE, 1989, ARCH BIOCHEM BIOPHYS, V275, P559, DOI 10.1016/0003-9861(89)90402-5
   TAMURA T, 1995, CURR BIOL, V5, P766, DOI 10.1016/S0960-9822(95)00153-9
   TSUBUKI S, 1994, FEBS LETT, V344, P229, DOI 10.1016/0014-5793(94)00388-2
   WAGNER BJ, 1995, ARCH BIOCHEM BIOPHYS, V323, P455, DOI 10.1006/abbi.1995.0067
NR 43
TC 186
Z9 200
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JUL 15
PY 1996
VL 331
IS 2
BP 232
EP 240
DI 10.1006/abbi.1996.0303
PG 9
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA UX874
UT WOS:A1996UX87400010
PM 8660703
DA 2024-02-19
ER

PT J
AU Koh, EK
   Kim, JE
   Go, J
   Song, SH
   Sung, JE
   Son, HJ
   Jung, YJ
   Kim, BH
   Jung, YS
   Hwang, DY
AF Koh, Eun Kyoung
   Kim, Ji Eun
   Go, Jun
   Song, Sung Hwa
   Sung, Ji Eun
   Son, Hong Joo
   Jung, Young Jin
   Kim, Bae Hwan
   Jung, Young Suk
   Hwang, Dae Youn
TI Protective effects of the antioxidant extract collected from <i>Styela
   clava</i> tunics on UV radiation-induced skin aging in hairless mice
SO INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
LA English
DT Article
DE skin aging; antioxidant; ultraviolet radiation; Styela clava tunics;
   inflammation
ID INDUCED OXIDATIVE STRESS; ORAL INTAKE; KAPPA-B; DAMAGE; IRRADIATION;
   EXPRESSION; SULFATE; INFLAMMATION; PREVENTION; QUERCETIN
AB Ultraviolet (UV) radiation is considered a primary cause of skin damage, which is characterized by deep wrinkles, roughness, laxity and pigmentation through oxidative stress and oxidative photodamage. To examine the therapeutic effects of ethanol extract of Styela clava tunics (EtSCT) on UV radiation-induced skin aging in hairless mice, alterations in skin phenotype, histological structures, inflammation, endoplasmic reticulum (ER) stress, oxidative conditions and toxicity were investigated during 13 weeks of UV irradiation and topical application of EtSCT. EtSCT showed high reducing power (3.1%), 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging activity (92.7%) and NO scavenging activity (15.6%) due to its high total flavonoids (15.3 mg/ml) and total phenolics (36.8 mg/ml). The topical application of EtSCT suppressed photoaging of the skin of UV-irradiated mice, and this was demonstrated by the inhibition of wrinkle formation, the suppression of the erythema index as well as the prevention of transepidermal water loss. Additionally, the epidermal thickness and adipocytes number were recovered to a similar level as that in the no radiation group in the UV + EtSCT-treated groups compared with the UV + vehicle-treated group, and the expression of collagen I increased. The attenuation of mitogen-activated protein kinase and ER stress signaling pathways activated by reactive oxygen species was also detected in the UV + EtSCT-treated group. Inflammatory responses including the infiltration of mast cells, CD31 expression and interleukin-6 secretion were significantly lower in the UV + EtSCT-treated groups. Moreover, the concentration of malondialdehyde was reduced and the activity of superoxide dismutase was effectively recovered in the UV + EtSCT-treated groups compared with that in the vehicle-treated groups. Liver and kidney toxicity factors were maintained at a constant level. These results suggest that EtSCT has the potential for use as therapeutic drug which protects against skin aging by regulating the skin morphology, histopathological structures, ER stress, inflammation and oxidative conditions.
C1 [Koh, Eun Kyoung; Kim, Ji Eun; Go, Jun; Song, Sung Hwa; Sung, Ji Eun; Son, Hong Joo; Jung, Young Jin; Hwang, Dae Youn] Pusan Natl Univ, Dept Biomat Sci, Coll Nat Resources & Life Sci, Life & Ind Convergence Res Inst, 50 Cheonghak Ri, Miryang 50463, Gyeongsangnam D, South Korea.
   [Kim, Bae Hwan] Keimyung Univ, Dept Publ Hlth, Daegu 42601, South Korea.
   [Jung, Young Suk] Pusan Natl Univ, Coll Pharm, Busan 46241, South Korea.
C3 Pusan National University; Keimyung University; Pusan National
   University
RP Hwang, DY (corresponding author), Pusan Natl Univ, Dept Biomat Sci, Coll Nat Resources & Life Sci, Life & Ind Convergence Res Inst, 50 Cheonghak Ri, Miryang 50463, Gyeongsangnam D, South Korea.
EM dyhwang@pusan.ac.kr
CR Ahn SH, 2003, J BIOTECHNOL BIOENG, V18, P180
   Baba H, 2010, BIOSCI BIOTECH BIOCH, V74, P18, DOI 10.1271/bbb.90370
   BISSETT DL, 1987, PHOTOCHEM PHOTOBIOL, V46, P367, DOI 10.1111/j.1751-1097.1987.tb04783.x
   Brennan M, 2003, PHOTOCHEM PHOTOBIOL, V78, P43, DOI 10.1562/0031-8655(2003)078<0043:MMITMC>2.0.CO;2
   CARLISLE DB, 1954, J MAR BIOL ASSOC UK, V33, P329, DOI 10.1017/S0025315400008365
   Casagrande R, 2006, J PHOTOCH PHOTOBIO B, V84, P21, DOI 10.1016/j.jphotobiol.2006.01.006
   CHEN S, 1992, J INVEST DERMATOL, V98, P248, DOI 10.1111/1523-1747.ep12556066
   Davis Martin H., 2008, Aquatic Invasions, V3, P125, DOI 10.3391/ai.2008.3.2.2
   Fisher GJ, 2000, J CLIN INVEST, V106, P663, DOI 10.1172/JCI9362
   Gosline J, 2002, PHILOS T R SOC B, V357, P121, DOI 10.1098/rstb.2001.1022
   Hanson KM, 1998, P NATL ACAD SCI USA, V95, P10576, DOI 10.1073/pnas.95.18.10576
   Heim AJ, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2367660
   Hwang IS, 2012, INT J MOL MED, V30, P392, DOI 10.3892/ijmm.2012.1011
   IOZUMI K, 1993, J INVEST DERMATOL, V100, P806, DOI 10.1111/1523-1747.ep12476630
   이상미, 2014, [JOURNAL OF ENVIRONMENTAL SCIENCE INTERNATIONAL, 한국환경과학회지], V23, P89, DOI 10.5322/JESI.2014.23.1.89
   Jia Z, 1999, FOOD CHEM, V64, P555, DOI 10.1016/S0308-8146(98)00102-2
   Jung ES, 2008, J KOR SOC FOOD SCI N, V37, P1674, DOI [10.3746/jkfn.2008.37.12.1674, DOI 10.3746/JKFN.2008.37.12.1674]
   Jung YJ, 2008, STYELA CLAVA TUNICS, V12, P71
   Jung YJ, 2008, J KOR FISH SOC, V41, P237, DOI DOI 10.5657/KFAS.2008.41.4.237
   Kang P.A., 1980, B FISH RES DEV AGENC, V25, P29
   Kang TH, 2009, J ETHNOPHARMACOL, V123, P446, DOI 10.1016/j.jep.2009.03.022
   Katiyar SK, 2001, J LEUKOCYTE BIOL, V69, P719
   곽문화, 2013, [Biomaterials Research, 생체재료학회지], V17, P91
   김형진, 2010, Laboratory Animal Research, V26, P7
   Kim SM, 2005, J KOR ASSOC ORAL MAX, V31, P440
   Koshiishi I, 1999, BBA-GEN SUBJECTS, V1428, P327, DOI 10.1016/S0304-4165(99)00081-1
   Krolikiewicz-Renimel I, 2013, J ETHNOPHARMACOL, V148, P537, DOI 10.1016/j.jep.2013.05.001
   Langton A. K., 2010, International Journal of Cosmetic Science, V32, P330, DOI 10.1111/j.1468-2494.2010.00574.x
   Lee CW, 2013, INT J MOL SCI, V14, P3860, DOI 10.3390/ijms14023860
   Lopez-Torres M, 1998, BRIT J DERMATOL, V138, P207
   MARCOCCI L, 1994, BIOCHEM BIOPH RES CO, V201, P748, DOI 10.1006/bbrc.1994.1764
   MILLAR RH, 1960, J MAR BIOL ASSOC UK, V39, P509, DOI 10.1017/S0025315400013503
   Münzel T, 2010, EUR HEART J, V31, P2741, DOI 10.1093/eurheartj/ehq396
   Nacional Loda M., 2011, Fisheries and Aquatic Sciences, V14, P243
   Nam So Hee, 2010, Laboratory Animal Research, V26, P37
   Oh H, 2003, PHYTOTHER RES, V17, P417, DOI 10.1002/ptr.1148
   OYAIZU M, 1986, Japanese Journal of Nutrition, V44, P307
   Park CH, 2006, PHOTOCHEM PHOTOBIOL, V82, P574, DOI 10.1562/2005-07-26-RA-623
   김진주, 2005, [Journal of the Korean Society of Food Science and Nutrition, 한국식품영양과학회지], V34, P937
   김진주, 2006, [Journal of the Korean Society of Food Science and Nutrition, 한국식품영양과학회지], V35, P278
   Park JW, 2010, KOREAN SOC FOOD SCI, V40, P350, DOI [10.3746/jkfn.2011.40.3.350, DOI 10.3746/JKFN.2011.40.3.350]
   Philips N, 2004, SKIN PHARMACOL PHYS, V17, P147, DOI 10.1159/000077242
   Philips N, 2009, ARCH DERMATOL RES, V301, P487, DOI 10.1007/s00403-009-0950-x
   Pinnell SR, 2003, J AM ACAD DERMATOL, V48, P1, DOI 10.1067/mjd.2003.16
   Roginsky V, 2005, J AGR FOOD CHEM, V53, P4529, DOI 10.1021/jf040382i
   Shin YK, 2014, J ENVIRON BIOL, V32, P216, DOI 10.11626/KJEB.2014.32.3.216
   SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144
   Song SH, 2014, J MATER SCI-MATER M, V25, P1519, DOI 10.1007/s10856-014-5182-8
   박정현, 2013, [Journal of the Korean Association of Geographic Information Studies, 한국지리정보학회지], V16, P81, DOI 10.11108/kagis.2013.16.3.081
   Sumiyoshi M, 2009, PHYTOMEDICINE, V16, P1137, DOI 10.1016/j.phymed.2009.06.003
   Tsoyi K, 2008, J AGR FOOD CHEM, V56, P8969, DOI 10.1021/jf801345c
   Uhm YK, 2010, PHYTOTHER RES, V24, P1339, DOI 10.1002/ptr.3117
   Vicentini FTMC, 2010, J PHARM PHARM SCI, V13, P274, DOI 10.18433/J3830G
   Xu CX, 2008, CANCER LETT, V264, P93, DOI 10.1016/j.canlet.2008.01.022
   Yaar M, 2007, BRIT J DERMATOL, V157, P874, DOI 10.1111/j.1365-2133.2007.08108.x
   Yamaguchi Y, 2006, FASEB J, V20, P1486, DOI 10.1096/fj.06-5725fje
   Yan SX, 2005, J DERMATOL SCI, V37, P137, DOI 10.1016/j.jdermsci.2004.11.005
   Yoysungnoen P, 2008, WORLD J GASTROENTERO, V14, P2003, DOI 10.3748/wjg.14.2003
   최소영, 2009, [Environmental Health and Toxicology, 환경독성보건학회지], V24, P351
NR 59
TC 10
Z9 10
U1 0
U2 17
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1107-3756
EI 1791-244X
J9 INT J MOL MED
JI Int. J. Mol. Med.
PD NOV
PY 2016
VL 38
IS 5
BP 1565
EP 1577
DI 10.3892/ijmm.2016.2740
PG 13
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA ED4SP
UT WOS:000388841800028
PM 27665714
OA Bronze
DA 2024-02-19
ER

PT J
AU Martins, PN
   Chang, S
   Mahadevapa, B
   Martins, AB
   Sheiner, P
AF Martins, Paulo N.
   Chang, Sue
   Mahadevapa, Basant
   Martins, Ann-Britt
   Sheiner, Patricia
TI Liver grafts from selected older donors do not have significantly more
   ischaemia reperfusion injury
SO HPB
LA English
DT Article
DE liver; transplantation; ischaemia reperfusion injury; outcomes; aging
ID HEAT-SHOCK RESPONSE; EXTENDED CRITERIA; COLD ISCHEMIA; RISK-FACTORS;
   PRIMARY NONFUNCTION; AGE; TRANSPLANTATION; SURVIVAL; IMPACT;
   ISCHEMIA/REPERFUSION
AB Background:
   There is a general concern that aged organs are more susceptible to ischaemia. In the light of recent proposals to change the liver allocation system by expanding regional sharing, it is feared that increased cold ischaemia time of grafts from older donors may reduce graft survival. The aim of this study was to correlate donor age and the patterns of ischaemia reperfusion injury and synthetic function early after liver transplantation.
   Methods:
   We performed a retrospective study of first transplants using a single-centre electronic database. Patterns of liver injury (based on transaminases and post-reperfusion biopsy), synthetic function (international normalized ratio [INR]), and graft and patient survival in recipients receiving liver grafts from donors aged >= 65 years (group 1, n = 50) were compared with equivalent patterns in a matched cohort of recipients transplanted with grafts from donors aged < 65 years (group 2, n = 50).
   Results:
   There was no significant difference in transaminase levels from day 0 to day 6 after transplantation. When groups 1 and 2 were subdivided into two subgroups based on the duration of graft cold ischaemia time (< 8 h and >= 8 h), there was no statistical difference in transaminase levels during the first 7 days. There were two cases (4%) of primary non-function in group 1 and one (2%) in group 2. Initial poor function did not differ significantly between the groups (26% vs. 24%; P = 0.81). In addition, there was no difference in histological changes in post-reperfusion biopsies (21% vs. 34%; P = 0.078) and rate of acute rejection episodes in the first year (30% vs. 32%; P = 0.99). There was no significant difference between groups 1 and 2 in 1-year patient and graft survivals (78% vs. 90% [P = 0.17]; 88% vs. 94% [P = 0.48], respectively).
   Conclusions:
   Judiciously selected livers from aged donors are not associated with major increased susceptibility to ischaemia reperfusion injury.
C1 [Martins, Paulo N.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Surg,Transplant Ctr, Boston, MA 02114 USA.
   [Chang, Sue; Mahadevapa, Basant; Martins, Ann-Britt; Sheiner, Patricia] New York Med Coll, Dept Surg, Div Hepatobiliary Surg & Transplantat, New York, NY USA.
C3 Harvard University; Massachusetts General Hospital; Harvard Medical
   School; New York Medical College
RP Martins, PN (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Surg,Transplant Ctr, 55 Fruit St, Boston, MA 02114 USA.
EM pnmartins@partners.org
RI Martins, Paulo/JMC-3453-2023; Martins, Paulo N/AAO-5680-2021
OI Martins, Paulo N/0000-0001-9333-0233
CR ADAM R, 1995, TRANSPLANT P, V27, P1181
   ALEXANDER JW, 1991, TRANSPLANTATION, V51, P135, DOI 10.1097/00007890-199101000-00021
   Anderson CD, 2008, J AM COLL SURGEONS, V207, P847, DOI 10.1016/j.jamcollsurg.2008.08.009
   Berenguer M, 2008, LIVER TRANSPLANT, V14, pS45, DOI 10.1002/lt.21617
   Brown RS, 2005, AM J TRANSPLANT, V5, P203, DOI 10.1111/j.1600-6143.2005.00769.x
   BUCKEL E, 1993, TRANSPLANT P, V25, P1558
   Busuttil RW, 2005, ANN SURG, V241, P905, DOI 10.1097/01.sla.0000164077.77912.98
   Calne RY, 2000, IMMUNOL REV, V174, P280, DOI 10.1034/j.1600-0528.2002.017419.x
   Cameron AM, 2006, ANN SURG, V243, P748, DOI 10.1097/01.sla.0000219669.84192.b3
   Cassuto JR, 2008, J SURG RES, V148, P38, DOI 10.1016/j.jss.2008.03.018
   Cescon M, 2008, LIVER TRANSPLANT, V14, P672, DOI 10.1002/lt.21433
   COSSARIZZA A, 1989, FEBS LETT, V248, P141, DOI 10.1016/0014-5793(89)80449-1
   Deschênes M, 1999, LIVER TRANSPLANT SUR, V5, P357, DOI 10.1002/lt.500050501
   Detre K M, 1995, Liver Transpl Surg, V1, P311, DOI 10.1002/lt.500010507
   Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969
   Feng S, 2006, AM J TRANSPLANT, V6, P783, DOI 10.1111/j.1600-6143.2006.01242.x
   Gastaca M, 2005, TRANSPLANT P, V37, P3851, DOI 10.1016/j.transproceed.2005.10.040
   Globerson A, 2000, IMMUNOL TODAY, V21, P515, DOI 10.1016/S0167-5699(00)01714-X
   Grande L, 1998, Clin Transpl, P297
   GREIG PD, 1989, TRANSPLANTATION, V48, P447, DOI 10.1097/00007890-198909000-00020
   Gruttadauria S, 2008, LIVER TRANSPLANT, V14, P220, DOI 10.1002/lt.21359
   Hoofnagle JH, 1996, HEPATOLOGY, V24, P89, DOI 10.1053/jhep.1996.v24.pm0008707288
   Kemmer N, 2007, TRANSPL P, V39, P1477, DOI 10.1016/j.transproceed.2006.11.012
   KLOTZ U, 1975, J CLIN INVEST, V55, P347, DOI 10.1172/JCI107938
   Lee YK, 1996, BIOL SIGNAL, V5, P180
   Liu A Y, 1996, EXS, V77, P393
   MAKOWKA L, 1987, TRANSPLANT P, V19, P2378
   Mangus RS, 2009, LIVER TRANSPLANT, V15, P640, DOI 10.1002/lt.21726
   Marsman WA, 1996, TRANSPLANTATION, V62, P1246, DOI 10.1097/00007890-199611150-00011
   Martins PNA, 2006, TRANSPL INT, V19, P351, DOI 10.1111/j.1432-2277.2006.00301.x
   Martins PNA, 2005, TRANSPLANTATION, V79, P127, DOI 10.1097/01.TP.0000146258.79425.04
   Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104
   Moore DE, 2005, ARCH SURG-CHICAGO, V140, P273, DOI 10.1001/archsurg.140.3.273
   Neipp M, 2004, TRANSPLANT INT, V17, P416, DOI 10.1007/s00147-004-0735-2
   Okaya T, 2005, SHOCK, V24, P421, DOI 10.1097/01.shk.0000181282.14050.11
   Park Y, 2007, J SURG RES, V137, P96, DOI 10.1016/j.jss.2006.08.013
   PLOEG RJ, 1993, TRANSPLANTATION, V55, P807, DOI 10.1097/00007890-199304000-00024
   POPPER H, 1986, PROG LIVER DIS, V8, P659
   Reese PP, 2008, TRANSPLANTATION, V85, P1737, DOI 10.1097/TP.0b013e3181722f75
   Rosen HR, 1998, TRANSPLANTATION, V65, P68, DOI 10.1097/00007890-199801150-00013
   SAKAI Y, 1993, TRANSPLANTATION, V55, P18, DOI 10.1097/00007890-199301000-00005
   Santori G, 2004, TRANSPLANT P, V36, P2909, DOI 10.1016/j.transproceed.2004.10.069
   SCHNEGG M, 1986, J HEPATOL, V3, P164, DOI 10.1016/S0168-8278(86)80022-8
   *SCI REG TRANSPL R, 2005, 2005 ANN REP US ORG
   Segev DL, 2008, AM J TRANSPLANT, V8, P658, DOI 10.1111/j.1600-6143.2007.02108.x
   Segev DL, 2007, HEPATOLOGY, V46, p487A
   STAHL JE, 2008, PLOS ONE, V3, pNIL16, DOI DOI 10.1016/J.TRANSPROCEED.2006.11.012
   STRASBERG SM, 1994, HEPATOLOGY, V20, P829, DOI 10.1002/hep.1840200410
   Tekin K, 2004, TRANSPLANTATION, V77, P411, DOI 10.1097/01.TP.0000110318.70879.20
   Terasaki PI, 1997, CLIN TRANSPLANT, V11, P366
   Tullius SG, 2000, J AM SOC NEPHROL, V11, P1317, DOI 10.1681/ASN.V1171317
   Uemura T, 2007, LIVER TRANSPLANT, V13, P227, DOI 10.1002/lt.20992
   Verbeke P, 2001, CELL BIOL INT, V25, P845, DOI 10.1006/cbir.2001.0789
   WOODHOUSE KW, 1990, BRIT MED BULL, V46, P22, DOI 10.1093/oxfordjournals.bmb.a072387
   Zapletal C, 2005, TRANSPL P, V37, P1182, DOI 10.1016/j.transproceed.2004.11.056
   Zhao Yi, 2004, Asian J Surg, V27, P114, DOI 10.1016/S1015-9584(09)60323-7
NR 56
TC 19
Z9 21
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1365-182X
EI 1477-2574
J9 HPB
JI HPB
PD MAR
PY 2011
VL 13
IS 3
BP 212
EP 220
DI 10.1111/j.1477-2574.2010.00275.x
PG 9
WC Gastroenterology & Hepatology; Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology; Surgery
GA 719VY
UT WOS:000287240800012
PM 21309940
OA Green Published, hybrid
DA 2024-02-19
ER

PT J
AU TSUKADA, M
   WADA, Y
   HAMADE, N
   MASUDA, H
   KOIZUMI, A
AF TSUKADA, M
   WADA, Y
   HAMADE, N
   MASUDA, H
   KOIZUMI, A
TI STABLE LYONIZATION OF X-LINKED PGK-1 GENE DURING AGING IN NORMAL-TISSUES
   AND TUMORS OF MICE CARRYING SEARLE TRANSLOCATION
SO JOURNALS OF GERONTOLOGY
LA English
DT Article
ID CHROMOSOME INACTIVATION; PHOSPHOGLYCERATE KINASE; DIETARY RESTRICTION;
   MOUSE; CANCER; AGE; REACTIVATION; METHYLATION; EXPRESSION;
   ELECTROPHORESIS
AB We investigated whether age-dependent reactivation of a repressed X-linked gene occurs. Subjects were female mice, carrying the X-autosomal translocation, T(X;16)16H (Searle's translocation). The mice were also heterozygous, for the X-linked gene coding for phosphoglycerate kinase (T16H pgk-1b/+ pgk-1a and pgk-1a was selectively repressed in these mice (McMahon and Monk, 1983). An electrophoretic method was applied to determine the PGK-1 allozyme patterns in blood, bone marrow, brain, gastrointestinal tract, liver, heart, spleen, and uterus (including tumor tissues when found). Samples were collected from mice of three different ages: 2 months (n = 4), 11 to 12 months (n = 10), or 18 to 21 months (n = 15). The lowest detection limit of the relative cellular population expressing the PGK-1A allozyme was found to be 2%, which was sensitive enough to detect the reported reactivation ratio (more than 10% of cells in a lower power microscopic field). We could not detect PGK-1A activity in any organ, including tumors in any age group, leading to the conclusion that reactivation of the repressed pgk-1a gene did not occur during aging.
C1 AKITA UNIV, SCH MED, DEPT HYG, AKITA 010, JAPAN.
   AKITA UNIV, DEPT PATHOL 2, AKITA 010, JAPAN.
C3 Akita University; Akita University
CR BISHOP JM, 1987, SCIENCE, V235, P305, DOI 10.1126/science.3541204
   BUCHER T, 1980, FEBS LETT, V115, P319, DOI 10.1016/0014-5793(80)81197-5
   CATTANACH BM, 1974, GENET RES, V23, P291, DOI 10.1017/S0016672300014932
   CREW MD, 1987, ENDOCRINOLOGY, V121, P1251, DOI 10.1210/endo-121-4-1251
   CULLEN CR, 1986, EMBO J, V5, P2223, DOI 10.1002/j.1460-2075.1986.tb04488.x
   CURTIS HJ, 1966, BIOL MECHANISMS AGIN
   CUTLER RG, 1985, MOL BIOL AGING GENE, P307
   DIX D, 1980, J THEOR BIOL, V83, P163, DOI 10.1016/0022-5193(80)90377-X
   GOLDMAN MA, 1987, SCIENCE, V236, P593, DOI 10.1126/science.2437652
   GOODMAN DG, 1980, TOXICOL APPL PHARM, V55, P433, DOI 10.1016/0041-008X(80)90045-9
   HALUSKA FG, 1987, ANNU REV GENET, V21, P321, DOI 10.1146/annurev.ge.21.120187.001541
   HANNIBAL M C, 1986, American Journal of Human Genetics, V39, pA201
   HANSEN RS, 1990, P NATL ACAD SCI USA, V87, P4174, DOI 10.1073/pnas.87.11.4174
   KEITH DH, 1986, MOL CELL BIOL, V6, P4122, DOI 10.1128/MCB.6.11.4122
   KOIZUMI A, 1990, ARCH TOXICOL, V64, P181, DOI 10.1007/BF02010723
   KOIZUMI A, 1987, J NUTR, V117, P361, DOI 10.1093/jn/117.2.361
   KOIZUMI A, 1990, J NUTR, V120, P1401, DOI 10.1093/jn/120.11.1401
   LYON MF, 1964, CYTOGENETICS, V3, P306, DOI 10.1159/000129820
   LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0
   MCMAHON A, 1983, GENET RES, V41, P69, DOI 10.1017/S0016672300021078
   MIGEON BR, 1988, NATURE, V335, P93, DOI 10.1038/335093a0
   PITOT HC, 1989, J GERONTOL, V44, P5, DOI 10.1093/geronj/44.6.5
   RICHARDSON A, 1987, J BIOL CHEM, V262, P12821
   SEDMAK JJ, 1977, ANAL BIOCHEM, V79, P544, DOI 10.1016/0003-2697(77)90428-6
   SMITH GS, 1973, J NATL CANCER I, V50, P1195, DOI 10.1093/jnci/50.5.1195
   SU CM, 1984, MECH AGEING DEV, V27, P239, DOI 10.1016/0047-6374(84)90049-6
   TAKAGI N, 1980, CHROMOSOMA, V81, P439, DOI 10.1007/BF00368155
   WAREHAM KA, 1987, NATURE, V327, P725, DOI 10.1038/327725a0
   WEST JD, 1978, GENET RES, V32, P91, DOI 10.1017/S0016672300018565
   WOLF SF, 1984, P NATL ACAD SCI-BIOL, V81, P2806, DOI 10.1073/pnas.81.9.2806
   YEN PH, 1984, P NATL ACAD SCI-BIOL, V81, P1759, DOI 10.1073/pnas.81.6.1759
NR 31
TC 7
Z9 7
U1 0
U2 2
PU GERONTOLOGICAL SOC AMER
PI WASHINGTON
PA 1030 15TH ST NW, STE 250, WASHINGTON, DC 20005202-842 USA
SN 0022-1422
J9 J GERONTOL
JI J. Gerontol.
PD NOV
PY 1991
VL 46
IS 6
BP B213
EP B216
DI 10.1093/geronj/46.6.B213
PG 4
WC Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA GN524
UT WOS:A1991GN52400004
PM 1940071
DA 2024-02-19
ER

PT J
AU Han, WM
   Apornpong, T
   Chattranukulchai, P
   Siwamogsatham, S
   Lwin, HMS
   Boonrungsirisap, J
   Wichiansan, T
   Gatechompol, S
   Ubolyam, S
   Kerr, SJ
   Tangkijvanich, P
   Avihingsanon, A
AF Han, Win Min
   Apornpong, Tanakorn
   Chattranukulchai, Pairoj
   Siwamogsatham, Sarawut
   Lwin, Hay Mar Su
   Boonrungsirisap, Jedsadakorn
   Wichiansan, Thanathip
   Gatechompol, Sivaporn
   Ubolyam, Sasiwimol
   Kerr, Stephen J.
   Tangkijvanich, Pisit
   Avihingsanon, Anchalee
TI Metabolic-Associated Fatty Liver Disease (MAFLD) is associated with
   immune activation, increased epicardial fat volume, and steatohepatitis
   among people with HIV in a Thai cohort
SO HIV MEDICINE
LA English
DT Article; Early Access
DE aging; Asia; liver steatosis; metabolic-associated fatty liver disease;
   HIV
ID CARDIOVASCULAR-DISEASE; FIBROSIS; OBESITY
AB Introduction: A change in terminology from fatty liver disease to metabolic-associated fatty liver disease (MAFLD), along with modified diagnostic criteria, was proposed in 2020, and data regarding MAFLD burden in people living with HIV are limited. We investigated associations between MAFLD and immune activation, cardiovascular disease (CVD) risks including epicardial fat volume, and steatohepatitis in an Asian cohort.
   Methods: We evaluated CVD risk (epicardial fat tissue, coronary artery calcium [CAC] score, and 10-year atherosclerotic CVD [ASCVD] score) in people living with HIV aged >50 years. Individuals with excessive alcohol consumption and viral hepatitis infections were excluded. MAFLD diagnosis was based on 2020 International Consensus criteria. Non-alcoholic steatohepatitis (NASH) with significant activity and liver fibrosis was defined as FibroScan-aspartate aminotransferase (FAST) score >= 0.67 and >0.35. Multivariate logistic regression models were used to investigate factors associated with MAFLD and NASH with significant activity and liver fibrosis.
   Results: The median age was 54 years (interquartile range [IQR] 52-60) and current CD4 count was 613 (IQR 467-804) cells/mm(3). A total of 37% were female, and most (98%) people living with HIV were virally suppressed. The prevalence of MAFLD and non-alcoholic fatty liver disease was 35% and 38%, respectively. In multivariate analyses, higher body mass index, albumin, epicardial fat volume, and liver stiffness were significantly associated with MAFLD. A higher CD4/CD8 ratio was associated with a lower risk of MAFLD. People with HIV with MAFLD had higher odds of having NASH with significant activity and liver fibrosis (adjusted odds ratio 3.3; 95% confidence interval 1.6-6.6), and similar associations were also observed among different MAFLD categories.
   Conclusions: The complex relationship between MAFLD and immune activation, steatohepatitis, and epicardial fat tissue suggests an increased risk of advanced liver disease and CVDs beyond the traditional risk factors in people living with HIV with fatty liver disease.
C1 [Han, Win Min; Apornpong, Tanakorn; Lwin, Hay Mar Su; Boonrungsirisap, Jedsadakorn; Wichiansan, Thanathip; Gatechompol, Sivaporn; Ubolyam, Sasiwimol; Kerr, Stephen J.; Avihingsanon, Anchalee] Thai Red Cross AIDS Res Ctr, HIV NAT, Bangkok, Thailand.
   [Han, Win Min; Kerr, Stephen J.] Univ New South Wales, Kirby Inst, Sydney, NSW, Australia.
   [Chattranukulchai, Pairoj] Chulalongkorn Univ, King Chulalongkorn Mem Hosp, Fac Med, Div Cardiovasc Med, Bangkok, Thailand.
   [Siwamogsatham, Sarawut] Chulalongkorn Univ, Div Ambulatory & Hosp Med, Fac Med, Bangkok, Thailand.
   [Siwamogsatham, Sarawut] Chulalongkorn Univ, Fac Med, Chula Clin Res Ctr, Bangkok, Thailand.
   [Gatechompol, Sivaporn; Ubolyam, Sasiwimol; Avihingsanon, Anchalee] Chulalongkorn Univ, Ctr Excellence TB Fac Med, Bangkok, Thailand.
   [Kerr, Stephen J.] Chulalongkorn Univ, Fac Med, Biostat Excellence Ctr, Bangkok, Thailand.
   [Tangkijvanich, Pisit] Chulalongkorn Univ, Fac Med, Ctr Excellence Hepatitis & Liver Canc, Dept Biochem, Bangkok, Thailand.
   [Avihingsanon, Anchalee] Thai Red Cross AIDS Res Ctr, 104 Ratchadamri, Bangkok 10330, Thailand.
C3 Thai Red Cross Society; University of New South Wales Sydney; Kirby
   Institute; Chulalongkorn University; Chulalongkorn University;
   Chulalongkorn University; Chulalongkorn University; Chulalongkorn
   University; Chulalongkorn University; Thai Red Cross Society
RP Avihingsanon, A (corresponding author), Thai Red Cross AIDS Res Ctr, 104 Ratchadamri, Bangkok 10330, Thailand.
EM anchaleea2009@gmail.com
RI Kerr, Stephen/J-6126-2012; Han, Win Min/ABB-5988-2020
OI Kerr, Stephen/0000-0002-1919-4525; Han, Win Min/0000-0003-3731-7960
FU Chulalongkorn University; Office of the Higher Education Commission;
   Ratchadapiseksompotch Fund
FX Chulalongkorn University; Office of the Higher Education
   Commission;Ratchadapiseksompotch Fund
CR Adams LA, 2017, GUT, V66, P1138, DOI 10.1136/gutjnl-2017-313884
   Bischoff J, 2021, ECLINICALMEDICINE, V40, DOI 10.1016/j.eclinm.2021.101116
   Campos-Varela I, 2021, AM J TRANSPLANT, V21, P3148, DOI 10.1111/ajt.16569
   Chamroonkul N, 2019, NAT REV GASTRO HEPAT, V16, P1, DOI 10.1038/s41575-018-0085-7
   Emamat H, 2021, EXCLI J, V20, P1091, DOI 10.17179/excli2021-3815
   Eslam M, 2020, J HEPATOL, V73, P202, DOI 10.1016/j.jhep.2020.03.039
   Eslam M, 2020, GASTROENTEROLOGY, V158, P1999, DOI 10.1053/j.gastro.2019.11.312
   Garcia-Martinez R, 2013, HEPATOLOGY, V58, P1836, DOI 10.1002/hep.26338
   Goff DC, 2014, CIRCULATION, V129, pS49, DOI [10.1161/01.cir.0000437741.48606.98, 10.1016/j.jacc.2013.11.005]
   Guaraldi G., NAFLD MAFLD IMPLICAT
   Han WM, 2021, JAIDS-J ACQ IMM DEF, V86, P463, DOI 10.1097/QAI.0000000000002585
   Hiransuthikul A, 2019, AIDS RES HUM RETROV, V35, P1170, DOI [10.1089/aid.2019.0139, 10.1089/AID.2019.0139]
   Iacobellis G, 2022, NAT REV CARDIOL, V19, P593, DOI 10.1038/s41569-022-00679-9
   Liu DP, 2021, J GASTROEN HEPATOL, V36, P1670, DOI 10.1111/jgh.15320
   Marcus JL, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.7954
   Maurice JB, 2017, AIDS, V31, P1621, DOI 10.1097/QAD.0000000000001504
   Neesgaard B, 2022, LANCET HIV, V9, pE474, DOI 10.1016/S2352-3018(22)00094-7
   Newsome PN, 2020, LANCET GASTROENTEROL, V5, P362, DOI 10.1016/S2468-1253(19)30383-8
   O'Halloran JA, 2022, CLIN INFECT DIS, V75, P2060, DOI 10.1093/cid/ciac355
   Price JC, 2022, CLIN INFECT DIS, V75, P2119, DOI 10.1093/cid/ciac337
   Sarwar R, 2018, DIABET METAB SYND OB, V11, P533, DOI 10.2147/DMSO.S146339
   Seth Aradhna, 2019, Top Antivir Med, V27, P75
   Siwamogsatham S, 2019, AIDS RES HUM RETROV, V35, P1160, DOI [10.1089/aid.2019.0126, 10.1089/AID.2019.0126]
   Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178
   Teeraananchai S, 2017, HIV MED, V18, P256, DOI 10.1111/hiv.12421
   Tumkosit M, 2022, AIDS, V36, P1073, DOI 10.1097/QAD.0000000000003204
   VanWagner LB, 2018, HEPATOL COMMUN, V2, P5, DOI 10.1002/hep4.1143
   Wong RJ, 2014, WORLD J HEPATOL, V6, P263, DOI 10.4254/wjh.v6.i5.263
NR 28
TC 2
Z9 2
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1464-2662
EI 1468-1293
J9 HIV MED
JI HIV Med.
PD 2023 SEP
PY 2023
VL 24
IS 9
BP 1000
EP 1012
DI 10.1111/hiv.13499
EA MAY 2023
PG 13
WC Infectious Diseases
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Infectious Diseases
GA R8RL4
UT WOS:000986519500001
PM 37165782
DA 2024-02-19
ER

PT J
AU Gao, PY
   Ou, YN
   Huang, YM
   Wang, ZB
   Fu, Y
   Ma, YH
   Li, QY
   Ma, LY
   Cui, RP
   Mi, YC
   Tan, L
   Yu, JT
AF Gao, Pei-Yang
   Ou, Ya-Nan
   Huang, Yi-Ming
   Wang, Zhi-Bo
   Fu, Yan
   Ma, Ya-Hui
   Li, Qiong-Yao
   Ma, Li-Yun
   Cui, Rui-Ping
   Mi, Yin-Chu
   Tan, Lan
   Yu, Jin-Tai
TI Associations between liver function and cerebrospinal fluid biomarkers
   of Alzheimer&apos;s disease pathology in non-demented adults: The CABLE
   study
SO JOURNAL OF NEUROCHEMISTRY
LA English
DT Article; Early Access
DE Alzheimer's disease; amyloid; cerebrospinal fluid; liver function; tau
ID SUBJECTIVE COGNITIVE DECLINE; ADENOSINE-DEAMINASE; ALZHEIMERS-DISEASE;
   BETA; PROTEIN; FRAMEWORK; ALBUMIN
AB Liver function has been suggested as a possible factor in the progression of Alzheimer's disease (AD) development. However, the association between liver function and cerebrospinal fluid (CSF) levels of AD biomarkers remains unclear. In this study, we analyzed the data from 1687 adults without dementia from the Chinese Alzheimer's Biomarker and LifestylE study to investigate differences in liver function between pathological and clinical AD groups, as defined by the 2018 National Institute on Aging-Alzheimer's Association Research Framework. We also examined the linear relationship between liver function, CSF AD biomarkers, and cognition using linear regression models. Furthermore, mediation analyses were applied to explore the potential mediation effects of AD pathological biomarkers on cognition. Our findings indicated that, with AD pathological and clinical progression, the concentrations of total protein (TP), globulin (GLO), and aspartate aminotransferase/alanine transaminase (ALT) increased, while albumin/globulin (A/G), adenosine deaminase, alpha-L-fucosidase, albumin, prealbumin, ALT, and glutamate dehydrogenase (GLDH) concentrations decreased. Furthermore, we also identified significant relationships between TP (beta = -0.115, p(FDR) < 0.001), GLO (beta = -0.184, p(FDR) < 0.001), and A/G (beta = 0.182, p(FDR) < 0.001) and CSF beta-amyloid(1-42) (A beta(1-42)) (and its related CSF AD biomarkers). Moreover, after 10 000 bootstrapped iterations, we identified a potential mechanism by which TP and GLDH may affect cognition by mediating CSF AD biomarkers, with mediation effect sizes ranging from 3.91% to 16.44%. Overall, our results suggested that abnormal liver function might be involved in the clinical and pathological progression of AD. Amyloid and tau pathologies also might partially mediate the relationship between liver function and cognition. Future research is needed to fully understand the underlying mechanisms and causality to develop an approach to AD prevention and treatment approach.
   We have included 1687 non-demented participants from the CABLE study and observed the associations between liver function and cerebrospinal fluid biomarkers of Alzheimer's disease.image
C1 [Gao, Pei-Yang; Ou, Ya-Nan; Huang, Yi-Ming; Wang, Zhi-Bo; Fu, Yan; Li, Qiong-Yao; Ma, Li-Yun; Cui, Rui-Ping; Tan, Lan] Qingdao Univ, Qingdao Municipal Hosp, Dept Neurol, Qingdao, Peoples R China.
   [Wang, Zhi-Bo; Yu, Jin-Tai] Fudan Univ, Shanghai Med Coll, Dept Neurol, Shanghai, Peoples R China.
   [Wang, Zhi-Bo; Yu, Jin-Tai] Fudan Univ, Huashan Hosp, Shanghai Med Coll, Natl Ctr Neurol Disorders,State Key Lab Med Neurob, Shanghai, Peoples R China.
   [Wang, Zhi-Bo; Yu, Jin-Tai] Fudan Univ, Shanghai Med Coll, MOE Frontiers Ctr Brain Sci, Shanghai, Peoples R China.
   [Wang, Zhi-Bo] Capital Med Univ, Xuanwu Hosp, Natl Ctr Neurol Disorders, Innovat Ctr Neurol Disorders, Beijing, Peoples R China.
   [Wang, Zhi-Bo] Capital Med Univ, Xuanwu Hosp, Natl Ctr Neurol Disorders, Dept Neurol, Beijing, Peoples R China.
   [Ma, Ya-Hui] Qingdao Univ, Dept Neurol, Affiliated Hosp, Qingdao, Peoples R China.
   [Mi, Yin-Chu] Dalian Med Univ, Qingdao Municipal Hosp, Dept Neurol, Qingdao, Peoples R China.
   [Yu, Jin-Tai] Fudan Univ, Huashan Hosp, Shanghai Med Coll, Natl Ctr Neurol Dis China,Dept Neurol, 12th Wulumuqi Zhong Rd, Shanghai 200040, Peoples R China.
   [Yu, Jin-Tai] Fudan Univ, Huashan Hosp, Inst Neurol, Shanghai Med Coll, 12th Wulumuqi Zhong Rd, Shanghai 200040, Peoples R China.
   [Tan, Lan] Qingdao Univ, Qingdao Municipal Hosp, Dept Neurol, Qingdao 266071, Peoples R China.
C3 Qingdao Municipal Hospital; Qingdao University; Fudan University; Fudan
   University; Fudan University; Capital Medical University; Capital
   Medical University; Qingdao University; Qingdao Municipal Hospital;
   Dalian Medical University; Fudan University; Fudan University; Qingdao
   University; Qingdao Municipal Hospital
RP Yu, JT (corresponding author), Fudan Univ, Huashan Hosp, Shanghai Med Coll, Natl Ctr Neurol Dis China,Dept Neurol, 12th Wulumuqi Zhong Rd, Shanghai 200040, Peoples R China.; Yu, JT (corresponding author), Fudan Univ, Huashan Hosp, Inst Neurol, Shanghai Med Coll, 12th Wulumuqi Zhong Rd, Shanghai 200040, Peoples R China.; Tan, L (corresponding author), Qingdao Univ, Qingdao Municipal Hosp, Dept Neurol, Qingdao 266071, Peoples R China.
EM dr.tanlan@163.com; jintai_yu@fudan.edu.cn
OI Wang, Zhi-Bo/0009-0000-1152-6591; Huang, YiMing/0009-0004-6096-2989;
   Gao, Pei-Yang/0009-0002-7559-1215
FU Excellence 2025 Talent CultivationProgram at Fudan University; Science
   and Technology Innovation [2022ZD0211600]; National Natural Science
   Foundation of China [82071201, 91849126]; Shanghai Municipal Science and
   Technology Major Project [2018SHZDZX01]; Research Start-Up Fund of Hua
   shanHospital [2022QD002]; Shanghai Talent Development Funding for The
   Proiect [2019074];  [3030277001]
FX The authors thank all participants of the present study as well as all
   members of staff of the CABLE study for their role in data collection.
   Medical arts of central illustration used pictures from Servier Medical
   Art (), licensed under a Creative Commons Attribution 3.0 License ().
   This study was supported by grants from the Science and Technology
   Innovation 2030 Major Projects (2022ZD0211600), National Natural Science
   Foundation of China (82071201, 91849126), Shanghai Municipal Science and
   Technology Major Project (2018SHZDZX01), Research Start-Up Fund of Hua
   shanHospital (2022QD002), Excellence 2025 Talent CultivationProgram at
   Fudan University (3030277001), and Shanghai Talent Development Funding
   for The Proiect (2019074).
CR Andersen JV, 2021, NEUROPHARMACOLOGY, V196, DOI 10.1016/j.neuropharm.2021.108719
   Araghi M, 2021, NEUROL SCI, V42, P5093, DOI 10.1007/s10072-021-05191-5
   BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173
   Bennett DA, 2006, NEUROLOGY, V66, P1837, DOI 10.1212/01.wnl.0000219668.47116.e6
   Butterfield DA, 2019, NAT REV NEUROSCI, V20, P148, DOI 10.1038/s41583-019-0132-6
   Cheng Y, 2020, TRANSL NEURODEGENER, V9, DOI 10.1186/s40035-020-00195-1
   Clarke JR, 2018, J ALZHEIMERS DIS, V64, pS405, DOI 10.3233/JAD-179911
   Cristalli G, 2001, MED RES REV, V21, P105, DOI 10.1002/1098-1128(200103)21:2<105::AID-MED1002>3.0.CO;2-U
   Drews L, 2020, DIS MODEL MECH, V13, DOI 10.1242/dmm.047134
   Ellinger JJ, 2011, J BIOMOL NMR, V49, P221, DOI 10.1007/s10858-011-9481-9
   ELOVAARA I, 1986, ACTA NEUROL SCAND, V74, P245, DOI 10.1111/j.1600-0404.1986.tb07863.x
   Garcia-Martinez R, 2013, HEPATOLOGY, V58, P1836, DOI 10.1002/hep.26338
   He XY, 2022, TRANSL PSYCHIAT, V12, DOI 10.1038/s41398-022-02082-x
   Hohnholt MC, 2018, J CEREBR BLOOD F MET, V38, P1754, DOI 10.1177/0271678X17714680
   Hu H, 2022, ANN NEUROL, V92, P439, DOI 10.1002/ana.26439
   Hua X, 2022, J ALZHEIMERS DIS, V86, P1399, DOI 10.3233/JAD-215511
   Huang ZH, 2022, NUTRIENTS, V14, DOI 10.3390/nu14204298
   Hulette CM, 1998, J NEUROPATH EXP NEUR, V57, P1168, DOI 10.1097/00005072-199812000-00009
   Hunt NJ, 2022, ADV DRUG DELIVER REV, V190, DOI 10.1016/j.addr.2022.114537
   Jack CR, 2018, ALZHEIMERS DEMENT, V14, P535, DOI 10.1016/j.jalz.2018.02.018
   Jansen IE, 2019, NAT GENET, V51, P404, DOI 10.1038/s41588-018-0311-9
   Jessen F, 2014, ALZHEIMERS DEMENT, V10, P844, DOI 10.1016/j.jalz.2014.01.001
   Jiang ZG, 2018, CLIN GASTROENTEROL H, V16, P1170, DOI 10.1016/j.cgh.2017.11.028
   Johansen MB, 2018, CLIN CHEM LAB MED, V56, P1524, DOI 10.1515/cclm-2018-0025
   Johnston JL, 2023, NEUROTHERAPEUTICS, V20, P431, DOI 10.1007/s13311-022-01325-5
   Kapogiannis D, 2011, LANCET NEUROL, V10, P187, DOI 10.1016/S1474-4422(10)70277-5
   Kim AY, 2019, NEUROCHEM RES, V44, P147, DOI 10.1007/s11064-018-2467-1
   Kim TS, 2006, INT J GERIATR PSYCH, V21, P344, DOI 10.1002/gps.1469
   Korthauer K, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1716-1
   Koyama T, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0776-z
   Lee YB, 2020, INT J GERIATR PSYCH, V35, P1105, DOI 10.1002/gps.5332
   Li W, 2022, FRONT MED-LAUSANNE, V9, DOI 10.3389/fmed.2022.780174
   Livingston G, 2020, LANCET, V396, P413, DOI 10.1016/S0140-6736(20)30367-6
   Long JM, 2019, CELL, V179, P312, DOI 10.1016/j.cell.2019.09.001
   Lu YF, 2021, J ALZHEIMERS DIS, V79, P1775, DOI 10.3233/JAD-201241
   Ma LZ, 2020, MOL NEURODEGENER, V15, DOI 10.1186/s13024-020-00374-8
   Maeda S, 2019, GERIATR GERONTOL INT, V19, P967, DOI 10.1111/ggi.13751
   Molinuevo JL, 2017, ALZHEIMERS DEMENT, V13, P296, DOI 10.1016/j.jalz.2016.09.012
   Morris JC, 2010, ANN NEUROL, V67, P122, DOI 10.1002/ana.21843
   Nho K, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.7978
   Parikh NS, 2023, ALZHEIMERS DEMENT, V19, P1518, DOI 10.1002/alz.12795
   Parikh NS, 2022, EUR J NEUROL, V29, P2622, DOI 10.1111/ene.15437
   Plaitakis A, 2017, BIOLOGY-BASEL, V6, DOI 10.3390/biology6010011
   Reiman EM, 2009, P NATL ACAD SCI USA, V106, P6820, DOI 10.1073/pnas.0900345106
   Rogers MH, 2001, J PEDIATR-US, V139, P44, DOI 10.1067/mpd.2001.115023
   Rowe CC, 2010, NEUROBIOL AGING, V31, P1275, DOI 10.1016/j.neurobiolaging.2010.04.007
   Rui LY, 2014, COMPR PHYSIOL, V4, P177, DOI 10.1002/cphy.c130024
   Scheltens P, 2021, LANCET, V397, P1577, DOI 10.1016/S0140-6736(20)32205-4
   SCHWARZMAN AL, 1994, P NATL ACAD SCI USA, V91, P8368, DOI 10.1073/pnas.91.18.8368
   Toledo JB, 2017, ALZHEIMERS DEMENT, V13, P965, DOI 10.1016/j.jalz.2017.01.020
   VanHunsel F, 1996, PSYCHIAT RES, V65, P159, DOI 10.1016/S0165-1781(96)03010-7
   Wang YR, 2017, MOL NEUROBIOL, V54, P2338, DOI 10.1007/s12035-016-9826-1
   Wu KY, 2022, FRONT AGING NEUROSCI, V14, DOI 10.3389/fnagi.2022.1012219
   Xiang Y, 2015, ACTA NEUROPATHOL, V130, P487, DOI 10.1007/s00401-015-1477-1
   Xiao T, 2022, NEUROLOGY, V99, pE565, DOI 10.1212/WNL.0000000000200770
   Yin F, 2016, FREE RADICAL BIO MED, V100, P108, DOI 10.1016/j.freeradbiomed.2016.04.200
   Yin XY, 2022, FRONT PSYCHIATRY, V13, DOI 10.3389/fpsyt.2022.957671
   Zhang M, 2019, PROG MOL BIOL TRANSL, V162, P349, DOI 10.1016/bs.pmbts.2018.12.008
NR 58
TC 0
Z9 0
U1 3
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3042
EI 1471-4159
J9 J NEUROCHEM
JI J. Neurochem.
PD 2024 JAN
PY 2024
VL 168
IS 1
BP 39
EP 51
DI 10.1111/jnc.16025
EA DEC 2023
PG 13
WC Biochemistry & Molecular Biology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA DJ5P7
UT WOS:001114786800001
PM 38055867
DA 2024-02-19
ER

PT J
AU Yu, Z
   Wang, R
   Fok, WC
   Coles, A
   Salmon, AB
   Pérez, VI
AF Yu, Zhen
   Wang, Rong
   Fok, Wilson C.
   Coles, Alexander
   Salmon, Adam B.
   Perez, Viviana I.
TI Rapamycin and Dietary Restriction Induce Metabolically Distinctive
   Changes in Mouse Liver
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
DE Rapamycin; Dietary restriction; Metabolites; beta-oxidation
ID INDUCED INSULIN-RESISTANCE; FATTY-ACID-METABOLISM; CALORIC RESTRICTION;
   GLUCOSE-METABOLISM; LIFE-SPAN; SMOOTH-MUSCLE; ACTIVATION; SIROLIMUS;
   HOMEOSTASIS; INHIBITION
AB Dietary restriction (DR) is the gold standard intervention used to delay aging, and much recent research has focused on the identification of possible DR mimetics. Energy sensing pathways, including insulin/IGF1 signaling, sirtuins, and mammalian Target of Rapamycin (mTOR), have been proposed as pathways involved in the antiaging actions of DR, and compounds that affect these pathways have been suggested to act as DR mimetics, including metformin (insulin/IGF1 signaling), resveratrol (sirtuins), and rapamycin (mTOR). Rapamycin is a promising DR mimetic because it significantly increases both health span and life span in mice. Unfortunately, rapamycin also leads to some negative effects, foremost among which is the induction of insulin resistance, potentially limiting its translation into humans. To begin clarifying the mechanism(s) involved in insulin resistance induced by rapamycin, we compared several aspects of liver metabolism in mice treated with DR or rapamycin for 6 months. Our data suggest that although both DR and rapamycin inhibit lipogenesis, activate lipolysis, and increased serum levels of nonesterified fatty acids, only DR further activates beta-oxidation of the fatty acids leading to the production of ketone bodies.
C1 [Yu, Zhen; Wang, Rong; Perez, Viviana I.] Oregon State Univ, Linus Pauling Inst, Corvallis, OR 97331 USA.
   [Fok, Wilson C.] Univ Oklahoma, Hlth Sci Ctr, Dept Geriatr Med, Norman, OK 73019 USA.
   [Fok, Wilson C.] Oklahoma City VA Med Ctr, Oklahoma City, OK USA.
   [Coles, Alexander] Univ Michigan Flint, Dept Chem & Biochem, Flint, MI USA.
   [Salmon, Adam B.] South Texas Vet Hlth Care Syst, Dept Mol Med, San Antonio, TX USA.
   [Salmon, Adam B.] Barshop Inst Longev & Aging Studies, San Antonio, TX USA.
   [Salmon, Adam B.] Audie Murphy VA Hosp, South Texas Vet Hlth Care Syst, San Antonio, TX USA.
   [Perez, Viviana I.] Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA.
C3 Oregon State University; University of Oklahoma System; University of
   Oklahoma Health Sciences Center; University of Oklahoma - Norman;
   University of Oklahoma System; University of Oklahoma Health Sciences
   Center; University of Michigan System; University of Michigan Flint; US
   Department of Veterans Affairs; Veterans Health Administration (VHA);
   Audie L. Murphy Memorial Veterans Hospital; US Department of Veterans
   Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial
   Veterans Hospital; Oregon State University
RP Pérez, VI (corresponding author), Oregon State Univ, Linus Pauling Inst, Dept Biochem & Biophys, Linus Pauling Sci Ctr 307, Corvallis, OR 97331 USA.
EM viviana.perez@oregonstate.edu
OI Fok, Wilson Chun Yim/0000-0003-3289-2093
FU National Institutional of Health (NIH) [AG036613]; San Antonio Nathan
   Shock Aging Center [1P30-AG-13319]; NIH [AG021890]; Ellison Medical
   Foundation; Department of Biochemistry and Biophysics; Linus Pauling
   Institute
FX Financial support was provided by National Institutional of Health (NIH)
   RC2 Grand Opportunity grant (AG036613 to A.R.), The San Antonio Nathan
   Shock Aging Center (1P30-AG-13319 to A.R.), NIH T32 Training Grant
   (AG021890 to W.F.), and The Ellison Medical Foundation (V.I.P.), and
   start-up funds from the Department of Biochemistry and Biophysics and
   The Linus Pauling Institute (V.I.P.).
CR Badman MK, 2009, AM J PHYSIOL-ENDOC M, V297, pE1197, DOI 10.1152/ajpendo.00357.2009
   Boden G, 2003, EXP CLIN ENDOCR DIAB, V111, P121, DOI 10.1055/s-2003-39781
   Bonen A, 1999, AM J PHYSIOL-ENDOC M, V276, pE642, DOI 10.1152/ajpendo.1999.276.4.E642
   Chen BJ, 2000, BIOL BLOOD MARROW TR, V6, P529, DOI 10.1016/S1083-8791(00)70062-0
   Coburn CT, 2000, J BIOL CHEM, V275, P32523, DOI 10.1074/jbc.M003826200
   Corton JC, 2005, J GERONTOL A-BIOL, V60, P1494, DOI 10.1093/gerona/60.12.1494
   Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322
   Das M, 2004, Obes Rev, V5, P13, DOI 10.1111/j.1467-789X.2004.00115.x
   Dhahbi JM, 2005, PHYSIOL GENOMICS, V23, P343, DOI 10.1152/physiolgenomics.00069.2005
   Dong B, 2009, P NATL ACAD SCI USA, V106, P18831, DOI 10.1073/pnas.0909731106
   Fang YM, 2013, AGING-US, V5, P328, DOI 10.18632/aging.100554
   Fok WC, 2014, AGING CELL, V13, P311, DOI 10.1111/acel.12175
   Fok WC, 2013, J GERONTOL A-BIOL, V68, P108, DOI 10.1093/gerona/gls127
   Griffin ME, 1999, DIABETES, V48, P1270, DOI 10.2337/diabetes.48.6.1270
   Harber MP, 2005, AM J PHYSIOL-ENDOC M, V289, pE306, DOI 10.1152/ajpendo.00069.2005
   Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221
   Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778
   Hood DA, 2001, J APPL PHYSIOL, V90, P1137, DOI 10.1152/jappl.2001.90.3.1137
   Houde VP, 2010, DIABETES, V59, P1338, DOI 10.2337/db09-1324
   HUPPE HC, 1992, PLANT PHYSIOL, V100, P2096, DOI 10.1104/pp.100.4.2096
   IKEDA Y, 1985, J BIOL CHEM, V260, P1311
   Johnston O, 2008, J AM SOC NEPHROL, V19, P1411, DOI 10.1681/ASN.2007111202
   Kirkland JL, 2010, AGING-US, V2, P894, DOI 10.18632/aging.100247
   Lamming DW, 2013, AGING CELL, V12, P712, DOI 10.1111/acel.12097
   Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135
   LEHNINGER AL, 1960, J BIOL CHEM, V235, P2450
   Longo N, 2006, AM J MED GENET C, V142C, P77, DOI 10.1002/ajmg.c.30087
   Ma KL, 2007, TRANSPLANTATION, V84, P1029, DOI 10.1097/01.tp.0000286095.55685.e9
   Ma KL, 2010, AM J PHYSIOL-HEART C, V298, pH1646, DOI 10.1152/ajpheart.00492.2009
   MASORO EJ, 1992, J GERONTOL, V47, pB202, DOI 10.1093/geronj/47.6.B202
   Miller RA, 2014, AGING CELL, V13, P468, DOI 10.1111/acel.12194
   Morrisett JD, 2002, J LIPID RES, V43, P1170, DOI 10.1194/jlr.M100392-JLR200
   Neff F, 2013, J CLIN INVEST, V123, P3272, DOI 10.1172/JCI67674
   Pravenec M, 2003, J BIOL CHEM, V278, P45209, DOI 10.1074/jbc.M304869200
   Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362
   Rezzi S, 2009, EXP GERONTOL, V44, P356, DOI 10.1016/j.exger.2009.02.008
   Shiraki T, 2003, J BIOL CHEM, V278, P11344, DOI 10.1074/jbc.M212859200
   Smith DL, 2010, J GERONTOL A-BIOL, V65, P468, DOI 10.1093/gerona/glq033
   Soliman GA, 2010, LIPIDS, V45, P1089, DOI 10.1007/s11745-010-3488-y
   Stanfel MN, 2009, BBA-GEN SUBJECTS, V1790, P1067, DOI 10.1016/j.bbagen.2009.06.007
   Wetter TJ, 1999, AM J PHYSIOL-ENDOC M, V276, pE728
   Wieneke N, 2007, FEBS LETT, V581, P5617, DOI 10.1016/j.febslet.2007.11.011
   Wilkinson JE, 2012, AGING CELL, V11, P675, DOI 10.1111/j.1474-9726.2012.00832.x
   Yahagi N, 2002, J BIOL CHEM, V277, P19353, DOI 10.1074/jbc.M201584200
   Ye Lan, 2012, Frontiers in Genetics, V3, P177, DOI 10.3389/fgene.2012.00177
   Zhang YQ, 2014, J GERONTOL A-BIOL, V69, P119, DOI 10.1093/gerona/glt056
NR 46
TC 29
Z9 36
U1 0
U2 15
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
EI 1758-535X
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD APR
PY 2015
VL 70
IS 4
BP 410
EP 420
DI 10.1093/gerona/glu053
PG 11
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA CH2ZW
UT WOS:000353896100002
PM 24755936
OA Green Published
DA 2024-02-19
ER

PT J
AU IVY, GO
   KANAI, S
   OHTA, M
   SATO, Y
   OTSUBO, K
   KITANI, K
AF IVY, GO
   KANAI, S
   OHTA, M
   SATO, Y
   OTSUBO, K
   KITANI, K
TI LEUPEPTIN CAUSES AN ACCUMULATION OF LIPOFUSCIN-LIKE SUBSTANCES IN
   LIVER-CELLS OF YOUNG-RATS
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE LEUPEPTIN; CEROID-LIPOFUSCIN; AGE PIGMENT; PROTEASE INHIBITOR MODEL; RAT
   LIVER
ID PROTEASE; FLUORESCENCE; INHIBITION; ALDOLASE; BODIES; INVIVO; BRAIN
AB Leupeptin, a thiol protease inhibitor, has previously been shown to cause a dense accumulation of substances resembling age pigment and called ceroid-lipofuscin, in brain cells of young rats [1].  Thus far, however, attempts to produce age pigments in hepatocytes of normal young rats with protease inhibitor(s) have not been successful.  The present study provides the first demonstration that leupeptin induces lipofuscin-like substances in normal young rat hepatocytes.  Male Fischer-344 rats (age 4-6 weeks) were continuously infused with leupeptin or saline i.p.  for 2 weeks by an osmotic minipump (dosage, 1-50 mg/100 g per day).  Liver tissues were then examined by light, fluorescence and electron microscopy.  Both hepatocytes and non-parenchymal cells of livers treated with leupeptin, but not saline, showed a dense accumulation of pigments which stained deeply with toluidine blue, were PAS-positive and were brightly autofluorescent.  After UV excitation the pigments had an emission spectrum with a broad peak at 480-540 nm extending to 650 nm resembling the spectrum of age pigment from livers of normal aged rats.  Electron microscopic examination revealed numerous lipofuscin-like deposits with heterogeneous morphology in the cytoplasm of both hepatocytes and non-parenchymal cells; lipid and myelin-like bodies were also present in hepatocytes.  The results indicate that the perturbation of proteolytic activity in liver by leupeptin causes an accumulation of substances which by several criteria resemble lipofuscin.  These results thus provide further support for the 'Protease Inhibitor Model of Lipofuscin Formation' [2] as well as a potential experimental model for studying hepatocellular aging processes.
C1 TOKYO METROPOLITAN GERIATR HOSP & INST GERONTOL,CLIN PHYSIOL LAB 1,35-2 SAKAECHO,ITABASHI KU,TOKYO 173,JAPAN.
   UNIV TORONTO,SCARBOROUGH COLL,DIV LIFE SCI,SCARBOROUGH M1C 1A4,ONTARIO,CANADA.
   TOKYO METROPOLITAN GERIATR HOSP & INST GERONTOL,DEPT CLIN PATHOL,ITABASHI KU,TOKYO 173,JAPAN.
C3 University of Toronto; University Toronto Scarborough
CR AOYAGI T, 1969, J ANTIBIOT, V22, P558, DOI 10.7164/antibiotics.22.558
   BRANDES D, 1978, AGING, V4, P127
   DENNIS PA, 1985, ARCH BIOCHEM BIOPHYS, V240, P768, DOI 10.1016/0003-9861(85)90085-2
   ELDRED GE, 1982, SCIENCE, V216, P757, DOI 10.1126/science.7079738
   FREISE J, 1983, ENZYME, V30, P209, DOI 10.1159/000469576
   Ivy G.O., 1988, Lipofuscin-1987: State of the Art, V1st ed., P83
   IVY GO, 1989, BRAIN RES, V498, P360, DOI 10.1016/0006-8993(89)91117-7
   IVY GO, 1984, SCIENCE, V226, P985, DOI 10.1126/science.6505679
   IVY GO, 1990, LIPOFUSCIN CEROID PI, P31
   IVY GO, 1986, LIVER AGING 1986, P389
   JOSHI UM, 1989, BIOCHIM BIOPHYS ACTA, V1004, P309, DOI 10.1016/0005-2760(89)90078-7
   KATZ ML, 1989, MECH AGEING DEV, V49, P23, DOI 10.1016/0047-6374(89)90065-1
   KIKUGAWA K, 1988, LIPOFUSCIN 1987 STAT, P51
   KMIEC Z, 1983, EXP GERONTOL, V18, P173, DOI 10.1016/0531-5565(83)90030-X
   KOMINAMI E, 1987, BIOCHEM BIOPH RES CO, V144, P749, DOI 10.1016/S0006-291X(87)80028-1
   KOMINAMI E, 1980, BIOCHEM BIOPH RES CO, V93, P713, DOI 10.1016/0006-291X(80)91136-5
   KOMINAMI E, 1981, BIOCHIM BIOPHYS ACTA, V659, P378, DOI 10.1016/0005-2744(81)90064-4
   KUNZE H, 1983, PHARMACOL RES COMMUN, V15, P451, DOI 10.1016/S0031-6989(83)80065-4
   LASZLO L, 1990, FEBS LETT, V261, P365, DOI 10.1016/0014-5793(90)80593-8
   NOKUBO M, 1985, J GERONTOL, V40, P409, DOI 10.1093/geronj/40.4.409
   PORTA EA, 1988, LIPOFUSCIN 1987 STAT, P341
   RUSS U, 1977, LIVER AGEING, P199
   Shima A, 1988, LIPOFUSCIN 1987 STAT, P147
   SIERRA F, 1989, MOL CELL BIOL, V9, P5610, DOI 10.1128/MCB.9.12.5610
   TOYOOKA T, 1978, BIOCHEM BIOPH RES CO, V82, P484, DOI 10.1016/0006-291X(78)90900-2
   WITKOP CJ, 1988, LIPOFUCHSIN 1987 STA, P413
   ZSNAGY I, 1988, LIPOFUSCIN 1987 STAT
NR 27
TC 28
Z9 28
U1 0
U2 1
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD MAR
PY 1991
VL 57
IS 3
BP 213
EP 231
DI 10.1016/0047-6374(91)90048-5
PG 19
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA EZ038
UT WOS:A1991EZ03800002
PM 2056777
DA 2024-02-19
ER

PT J
AU Wang, XP
   Zhu, QL
   Xue, Q
   Li, Y
   Qian, XS
   Wang, ZL
   Wang, SW
AF Wang Xue-ping
   Zhu Qing-lei
   Xue Qiao
   Li Yang
   Qian Xiao-shun
   Wang Zhong-liang
   Wang Shi-wen
TI Role of the lung in the progression of multiple organ dysfunction
   syndrome in ageing rat model
SO CHINESE MEDICAL JOURNAL
LA English
DT Article
DE multiple organ dysfunction syndrome; the elderly; mechanism; lung;
   animal model
ID ELDERLY-PATIENTS; INFLAMMATION; FAILURE; TLR4
AB Background Multiple organ dysfunction syndrome in the elderly (MODSE) is a problem with high Mortality in the critical care of elderly patients. The pathogenesis of MODSE remains elusive. This study aimed to establish rat models of MODSE and to investigate the pathogenetic mechanism responsible for the development of MODSE in the rat models.
   Methods Twenty-four-month old rats (elderly) received intravenous injection of lipopolysaccharide (LPS) to induce rat model of MODSE. In the model, we observed the physical responses, biochemical indices changes, histopathological features of vital organs, including lung, liver, heart, and kidney. We also investigated the sequence of individual organ dysfunction and changes of proinflammatory factors. Three-month-old rats, serving as young rat controls, received parallel procedures. Besides, normal saline injection was also performed on elderly and young control rats.
   Results All rats displayed different degree of physical response after LPS injection, preceded by deterioration of respiratory status. At 6 hours, lung injury was observed, which started earlier than other organ injury that was observed in about 24 hours. Furthermore, all vital organ injury was more severe in elderly rats than in young rats at the same time points. After LPS injection, pulmonary alveolar macrophages apoptosis rate increased obviously, and was more significant in elderly rats ((43.4 +/- 8.4)%) than in young rats ((24.2 +/- 3.0)%). LPS injection also enhanced tumor necrosis factor alpha (TNF-alpha) concentration significantly in these organs. Its peak concentration appeared at 6 hours in lung tissue and at 24 hours in other organs after LPS injection. TNF-alpha level was higher in elderly rats than in young rats at the same time points. The increase was most significant in lung tissue. After intravenous administration of LPS, toll-like receptor 4 (TLR4) expression in lung tissue was upregulated markedly, and peaked at 6 hours. In contrast, upregulation of TLR4 expression in liver peaked at 24 hours, lagging behind that in the lung.
   Conclusion Lung is the first and most seriously injured organ in rat model of MODSE and it may play an "initiating" role in the development of MODSE. Chin Med J 2012;125(15):2708-2713
C1 [Wang Xue-ping; Zhu Qing-lei; Xue Qiao; Li Yang; Wang Zhong-liang; Wang Shi-wen] Chinese Peoples Liberat Army Gen Hosp, Inst Geriatr Cardiol, Beijing 100853, Peoples R China.
   [Qian Xiao-shun] Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Resp Dis, Beijing 100853, Peoples R China.
C3 Chinese People's Liberation Army General Hospital; Chinese People's
   Liberation Army General Hospital
RP Wang, SW (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Inst Geriatr Cardiol, Beijing 100853, Peoples R China.
EM wangsw301@yahoo.com.cn
RI Wang, Xinhua/ISR-8520-2023; , qlzhu/S-8690-2019
FU National Key Basic Research and Development Plan Program of China ("973"
   Projects) [G2000057004]
FX This work was supported by a grant from the National Key Basic Research
   and Development Plan Program of China ("973" Projects) (No.
   G2000057004).
CR Bannerman DD, 1999, LAB INVEST, V79, P1181
   Eachempati SR, 2007, J TRAUMA, V63, P344, DOI 10.1097/TA.0b013e3180eea5a1
   Holliday R, 2004, J GERONTOL A-BIOL, V59, pB534
   Hoshino K, 1999, J IMMUNOL, V162, P3749
   Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333
   Nick JA, 2000, J IMMUNOL, V164, P2151, DOI 10.4049/jimmunol.164.4.2151
   Nin N, 2008, INTENS CARE MED, V34, P923, DOI 10.1007/s00134-007-0960-0
   Sevransky JE, 2003, CLIN GERIATR MED, V19, P205, DOI 10.1016/S0749-0690(02)00065-4
   van Meurs M, 2009, CRIT CARE, V13, DOI 10.1186/cc7153
   WANG SW, 1990, CHINESE MED J-PEKING, V103, P763
   Wang SW, 1999, J INTERN CRIT CARE M, V5, P146
   Wang SW, 2004, CHIN CRIT CARE EMERG, V16, P1
   Wang SW, 1987, ACAD J PLA POSTGRAD, V12, P189
   Wang SW, 1988, NATL MED J CHINA, V68, P187
   Wang SW, 2002, CHIN J MULT ORGAN DI, V1, P7
   WANG SW, 2004, J GERIATR CARDIOL, V1, P55
   [薛桥 Xue Qiao], 2005, [中华老年医学杂志, Chinese Journal of Geriatrics], V24, P140
   [薛桥 Xue Qiao], 2003, [解放军医学杂志, Medical Journal of Chinese People's Liberation Army], V28, P911
   Zhang Jian, 2003, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V25, P320
   Zhou H, 2009, J IMMUNOL, V183, P5244, DOI 10.4049/jimmunol.0901309
   杨敏福, 2002, [中华核医学杂志, Chinese Journal of Nuclear Medicine], V22, P250
NR 21
TC 4
Z9 4
U1 1
U2 6
PU CHINESE MEDICAL ASSOC
PI BEIJING
PA 42 DONGSI XIDAJIE, BEIJING 100710, PEOPLES R CHINA
SN 0366-6999
J9 CHINESE MED J-PEKING
JI Chin. Med. J.
PD AUG 5
PY 2012
VL 125
IS 15
BP 2708
EP 2713
DI 10.3760/cma.j.issn.0366-6999.2012.15.011
PG 6
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA 991BY
UT WOS:000307677700011
PM 22931979
DA 2024-02-19
ER

PT J
AU Meng, Z
   Gao, FF
   Liu, C
   Huang, SC
   Hu, K
   Wang, RS
AF Meng, Zhen
   Gao, Feifei
   Liu, Chang
   Huang, Shengcai
   Hu, Kai
   Wang, Rensheng
TI External beam radiation therapy in a centenarian with primary liver
   cancer A case report
SO MEDICINE
LA English
DT Article
DE case report; elderly patient; primary liver cancer; radiation therapy;
   super-elderly
ID STEREOTACTIC BODY RADIOTHERAPY; HEPATOCELLULAR-CARCINOMA;
   ELDERLY-PATIENTS; FEASIBILITY; EFFICACY; OLDER
AB Rationale: Due to unprecedented global aging, the number of elderly and super-elderly patients with cancer is increasing. However, restricted by comorbidities or fragility, many elderly patients are considered ineligible to receive invasive therapies. A centenarian with primary liver cancer (PLC) was treated by external beam radiation therapy (EBRT). This rare case deserves our attention. Patient concerns: We present a rare case of a centenarian with PLC. The super-elderly male patient complained that 2 liver lesions were found by abdominal ultrasonography in June 2016. Diagnoses: The Segment 7 (S7) lesion and the Segment 5/8 (S5/8) lesion were clinically diagnosed as PLC successively. Interventions: The S7 lesion was considered PLC initially and treated by EBRT in October 2016. In the 1-year follow-up after EBRT, the S7 lesion was well controlled. Unfortunately, the S5/8 lesion had increased in size, was diagnosed as PLC and subsequently treated by CyberKnife in another hospital. However, local failure of the S5/8 lesion was suggested 15 months after CyberKnife. At the age of 102 years, the patient received re-irradiation for the S5/8 lesion. Outcomes: Three months after re-irradiation, des-gamma-carboxy-prothrombin decreased to normal; no significant change in the S5/8 lesion was found in Magnetic Resonance Imaging. No severe acute or late toxicities were reported after each course of EBRT. Unfortunately, the patient died of respiratory failure caused by severe pneumonia in mid-March 2020. Conclusion: Advanced age is not a contraindication for elderly patients with cancer to receive radiotherapy and even re-irradiation.
C1 [Meng, Zhen; Gao, Feifei; Liu, Chang; Hu, Kai; Wang, Rensheng] Guangxi Med Univ, Dept Radiat Oncol, Affiliated Hosp 1, Nanning 530021, Guangxi, Peoples R China.
   [Meng, Zhen; Gao, Feifei; Liu, Chang; Hu, Kai; Wang, Rensheng] Radiat Oncol Clin Med Res Ctr Guangxi, Nanning, Guangxi, Peoples R China.
   [Huang, Shengcai] Guangxi Med Univ, Dept Radiol, Affiliated Hosp 1, Nanning, Guangxi, Peoples R China.
C3 Guangxi Medical University; Guangxi Medical University
RP Wang, RS (corresponding author), Guangxi Med Univ, Dept Radiat Oncol, Affiliated Hosp 1, Nanning 530021, Guangxi, Peoples R China.
EM 13807806008@163.com
FU Self-founding project of Gaungxi health Commission [Z20170558]; Guangxi
   Science and Technology Cooperation and Exchange Project [GKH
   159905-2-11]; Guangxi Science and Technology Program Project [GK
   AD17129013]
FX The authors thank the support by the Self-founding project of Gaungxi
   health Commission (NO. Z20170558), Guangxi Science and Technology
   Cooperation and Exchange Project (GKH 159905-2-11), and Guangxi Science
   and Technology Program Project (GK AD17129013). The authors would like
   to extend our heartfelt gratitude to the patient and his family, for
   understanding and willingness for publication.
CR Chargari C, 2014, EUR J CANCER, V50, P1490, DOI 10.1016/j.ejca.2014.02.012
   Choi SH, 2018, CLIN MOL HEPATOL, V24, P114, DOI 10.3350/cmh.2017.0073
   DeSantis CE, 2019, CA-CANCER J CLIN, V69, P452, DOI 10.3322/caac.21577
   El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061
   Gomez-Millan J, 2009, CRIT REV ONCOL HEMAT, V71, P70, DOI 10.1016/j.critrevonc.2008.11.004
   Hata M, 2007, INT J RADIAT ONCOL, V69, P805, DOI 10.1016/j.ijrobp.2007.04.016
   Kinoshita A, 2017, GERIATR GERONTOL INT, V17, P189, DOI 10.1111/ggi.12747
   Oishi K, 2014, WORLD J GASTROENTERO, V20, P15028, DOI 10.3748/wjg.v20.i41.15028
   Price TR, 2012, CANCER-AM CANCER SOC, V118, P3191, DOI 10.1002/cncr.26404
   Rim CH, 2019, J MED IMAG RADIAT ON, V63, P812, DOI 10.1111/1754-9485.12948
   Rim CH, 2019, RADIOTHER ONCOL, V131, P135, DOI 10.1016/j.radonc.2018.12.005
   Seo YS, 2018, CANCER RES TREAT, V50, P345, DOI 10.4143/crt.2017.096
   Shiba S, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3724-4
   Sun J, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-6063-9
NR 14
TC 1
Z9 1
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0025-7974
EI 1536-5964
J9 MEDICINE
JI Medicine (Baltimore)
PD NOV 20
PY 2020
VL 99
IS 47
AR e22473
DI 10.1097/MD.0000000000022473
PG 4
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA PE3BD
UT WOS:000598241400005
PM 33217790
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Zhang, T
   Gu, HW
   Gao, JX
   Li, YS
   Tang, HB
AF Zhang, Ting
   Gu, Hong-Wei
   Gao, Jin-Xing
   Li, Yu-Sang
   Tang, He-Bin
TI Ethanol supernatant extracts of<i> Gynura</i><i> procumbens</i> could
   treat nanodiethylnitrosamine-induced mouse liver cancer by interfering
   with inflammatory factors for the tumor microenvironment
SO JOURNAL OF ETHNOPHARMACOLOGY
LA English
DT Article
DE Ethanol extract of Gynura procumbens stems; Liver cancer;
   Nanodiethylnitrosamine; Caffeoylquinic acid; Non-caffeoylquinic acid;
   Tumor microenvironment
ID HEPATITIS-B; FIBROSIS; HYPOXIA; DIETHYLNITROSAMINE; HIF-1-ALPHA;
   RESPONSES; PATHWAY; GROWTH
AB Ethnopharmacological relevance: Gynura procumbens (Lour.) Merr, (Family Asteraceae), which serves as both medicine and food in traditional ethnic medicine, has the effects of diminishing inflammation, relieving cough, reducing blood glucose and lipids levels, mitigating hepatotoxicity, and can be used for liver cancer prevention and treatment.Aim of the study: To explore how the ethanol extract of Gynura procumbens stems (EEGS) can effectively intervene in the tumor microenvironment, it is necessary to study the mechanism of EEGS on the chemical toxicant nanodiethylnitrosamine (nanoDEN) that induces liver cancer.Materials and methods: EEGS contains large quantities of caffeoylquinic acid (CAC) and non-caffeoylquinic acid (n-CAC), which can be separated by high-performance liquid chromatography. The liver cancer model that was induced by the chemical toxin, nanoDEN, was used to clarify the effective mechanism for tumor intervention of the EEGS and its active ingredients.Results: (1) after interventions with the four drugs on liver cancer, the tumor nodules were obviously reduced and inflammation levels improved. (2) The immunohistochemical staining results showed that both the EEGS and its active ingredients could significantly reverse the abnormal changes in inflammation, proliferation, aging and hypoxia-related proteins in mouse liver tissues that were caused by nanoDEN. (3) Real-time PCR results showed that compared with the nanoDEN group, the expression levels of inflammatory, fatty, and fibrosis-related factors in each group after drug intervention were decreased. (4) The transmission electron microscopy measurements showed that the EEGS significantly reversed the nanostructure changes in hepatocytes that were induced by nanoDEN.Conclusion: The EEGS component of Gynura procumbens is effective in preventing and treating liver cancer by interfering with the inflammatory microenvironment during oncogenesis induced by nanoDEN.
C1 [Zhang, Ting; Gu, Hong-Wei; Gao, Jin-Xing; Li, Yu-Sang; Tang, He-Bin] South Cent Univ Nationalities, Sch Pharmaceut Sci, Lab Hepatopharmacol & Ethnopharmacol, 182 Minyuan Rd, Wuhan 430074, Peoples R China.
   [Gu, Hong-Wei] Mental Hlth Ctr Wuhan, Pharm Dept, 93 Youyi Rd, Wuhan 430074, Peoples R China.
C3 South Central Minzu University
RP Li, YS; Tang, HB (corresponding author), South Cent Univ Nationalities, Sch Pharmaceut Sci, Lab Hepatopharmacol & Ethnopharmacol, 182 Minyuan Rd, Wuhan 430074, Peoples R China.
EM 977919903@qq.com; ghw901025@126.com; 705209528@qq.com;
   liys2006@mail.scuec.edu.cn; hbtang2006@mail.scuec.edu.cn
FU National Natural Science Foundation of China [82174110, 81673711,
   81573887]; Health Research Foundation of Wuhan Municipal Health
   Commission, China [WZ19A16]
FX Acknowledgements This work was supported by the National Natural Science
   Foundation of China (82174110, 81673711 and 81573887) and by the Health
   Research Foundation of Wuhan Municipal Health Commission, China
   (WZ19A16) .
CR Algariri Khalid, 2014, Trop Life Sci Res, V25, P75
   Anwanwan D, 2020, BBA-REV CANCER, V1873, DOI 10.1016/j.bbcan.2019.188314
   Arnold M, 2020, GASTROENTEROLOGY, V159, P335, DOI 10.1053/j.gastro.2020.02.068
   Bedossa P, 2010, GASTROEN CLIN BIOL, V34, pS103, DOI 10.1016/S0399-8320(10)70028-2
   Boehm EM, 2016, ENZYMES, V39, P231, DOI 10.1016/bs.enz.2016.03.003
   Cai Yu, 2003, Zhonghua Yi Xue Za Zhi, V83, P1122
   Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221
   Che K, 2021, BIOSCIENCE REP, V41, DOI 10.1042/BSR20203982
   de Conti A, 2017, ONCOTARGET, V8, P88517, DOI 10.18632/oncotarget.19774
   Dhanasekaran R, 2010, J SURG ONCOL, V101, P476, DOI 10.1002/jso.21522
   DUCK BW, 1976, P ROY SOC MED, V69, P307, DOI 10.1177/003591577606900428
   El-Serag HB, 2008, GASTROENTEROLOGY, V134, P1752, DOI 10.1053/j.gastro.2008.02.090
   Feng JY, 2019, THERANOSTICS, V9, P5227, DOI 10.7150/thno.34273
   Mansilla SF, 2020, GENES-BASEL, V11, DOI 10.3390/genes11060593
   Goverment, 2005, CHINESE MAT MED
   Han J, 2019, J CELL BIOCHEM, V120, P14735, DOI 10.1002/jcb.28734
   Healy ME, 2016, SCI REP-UK, V6, DOI 10.1038/srep22292
   Hu Y, 2020, CLIN CHIM ACTA, V506, P196, DOI 10.1016/j.cca.2020.03.024
   Huang S, 2019, THERANOSTICS, V9, P6745, DOI 10.7150/thno.34674
   Katoh M, 2018, INT J MOL MED, V42, P713, DOI 10.3892/ijmm.2018.3689
   Krishna Murli, 2021, Clin Liver Dis (Hoboken), V17, P222, DOI 10.1002/cld.1014
   Lan T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129743
   Li XJ, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01487
   Li XJ, 2015, J AGR FOOD CHEM, V63, P8460, DOI 10.1021/acs.jafc.5b03504
   Li YS, 2016, TOXICOL RES-UK, V5, P210, DOI 10.1039/c5tx00317b
   Li YS, 2012, J PHARMACOL SCI, V118, P43, DOI 10.1254/jphs.11160FP
   Li ZQ, 1998, WORLD J GASTROENTERO, V4, P360, DOI 10.3748/wjg.v4.i4.360
   Liang Y, 2018, HEPATOLOGY, V67, P1807, DOI 10.1002/hep.29661
   Liu M, 2019, BIOMED CHROMATOGR, V33, DOI 10.1002/bmc.4635
   Lotowska JM, 2010, EUR J GASTROEN HEPAT, V22, P741, DOI 10.1097/MEG.0b013e32832e2c09
   Masoud GN, 2015, ACTA PHARM SIN B, V5, P378, DOI 10.1016/j.apsb.2015.05.007
   Meng XH, 2021, J ETHNOPHARMACOL, V276, DOI 10.1016/j.jep.2021.114145
   Murugesu K, 2017, CURR PHARM BIOTECHNO, V18, P1132, DOI 10.2174/1389201019666180322111800
   Nisa F, 2012, ADV PHARM BULL, V2, P99, DOI 10.5681/apb.2012.014
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Ohkoshi S, 2015, WORLD J GASTROENTERO, V21, P12150, DOI 10.3748/wjg.v21.i42.12150
   Povero D, 2010, HISTOL HISTOPATHOL, V25, P1075, DOI 10.14670/HH-25.1075
   Rerknimitr P, 2016, J ALTERN COMPLEM MED, V22, P669, DOI 10.1089/acm.2016.0100
   Semenza GL, 2013, J CLIN INVEST, V123, P3664, DOI 10.1172/JCI67230
   Shang RZ, 2016, WORLD J GASTROENTERO, V22, P9933, DOI 10.3748/wjg.v22.i45.9933
   Signorelli P, 2015, NUTR CANCER, V67, P494, DOI 10.1080/01635581.2015.1004591
   Talks KL, 2000, AM J PATHOL, V157, P411, DOI 10.1016/S0002-9440(10)64554-3
   Tan HL, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00052
   Yamashita Tatsuya, 2016, Rinsho Byori, V64, P787
   Yang F, 2018, J PROTEOME RES, V17, P1091, DOI 10.1021/acs.jproteome.7b00761
   Zhang WK, 2017, NANOMED-NANOTECHNOL, V13, P701, DOI 10.1016/j.nano.2016.09.017
   Zhang Y, 2020, J HEMATOL ONCOL, V13, DOI 10.1186/s13045-020-00990-3
NR 47
TC 8
Z9 9
U1 3
U2 8
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-8741
EI 1872-7573
J9 J ETHNOPHARMACOL
JI J. Ethnopharmacol.
PD MAR 1
PY 2022
VL 285
AR 114917
DI 10.1016/j.jep.2021.114917
PG 11
WC Plant Sciences; Chemistry, Medicinal; Integrative & Complementary
   Medicine; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary
   Medicine
GA 0X3SZ
UT WOS:000789631900002
PM 34919988
DA 2024-02-19
ER

PT J
AU Kunelius, P
   Lukkarinen, O
   Hannuksela, ML
   Itkonen, O
   Tapanainen, JS
AF Kunelius, P
   Lukkarinen, O
   Hannuksela, ML
   Itkonen, O
   Tapanainen, JS
TI The effects of Transdermal dihydrotestosterone in the aging male: a
   prospective, randomized, double blind study
SO JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
LA English
DT Article
ID BENIGN PROSTATIC HYPERPLASIA; MIDDLE-AGED MEN; LONG-TERM; BIOAVAILABLE
   TESTOSTERONE; REPLACEMENT THERAPY; HYPOGONADAL MALES; ANDROGEN LEVELS;
   ELDERLY-MEN; ADULT MEN; OLDER MEN
AB The objective of the study was to investigate the effects of dihydrotestosterone (DHT) gel on general well-being, sexual function, and the prostate in aging men. A total of 120 men participated in this randomized, placebo-controlled study (60 DHT and 60 placebo). All subjects had nocturnal penile tumescence once per week or less, andropause symptoms, and a serum T level of 15 nmol/liter or less and/or a serum SHBG level greater than 30 nmol/liter. The mean age was 58 yr (range, 50-70 yr). Of these subjects, 114 men completed the study. DHT was administered transdermally for 6 months, and the dose varied from 125-250 mg/d. General well-being symptoms and sexual function were evaluated using a questionnaire, and prostate symptoms were evaluated using the International Prostate Symptoms Score, transrectal ultrasonography, and assay of serum prostate-specific antigen.
   Early morning erections improved transiently in the DHT group at 3 months of treatment (P < 0.003), and the ability to maintain erection improved in the DHT group compared with the placebo group (P < 0.04). No significant changes were observed in general well-being between the placebo and the DHT group. Serum concentrations of LH, FSH, E2, T, and SHBG decreased significantly during DHT treatment. Treatment with DHT did not affect liver function or the lipid profile. Hemoglobin concentrations increased from 146.0 +/- 8.2 to 154.8 +/- 11.4 g/liter, and hematocrit from 43.5 +/- 2.5% to 45.8 +/- 3.4% (P < 0.001). Prostate weight and prostate-specific antigen levels did not change during the treatment. No major adverse events were observed.
   Transdermal administration of DHT improves sexual function and may be a useful alternative for androgen replacement. As estrogens are thought to play a role in the pathogenesis of prostate hyperplasia, DHT may be beneficial, compared with aromatizing androgens, in the treatment of aging men.
C1 Univ Oulu, Dept Surg, Div Urol, FIN-90014 Oulu, Finland.
   Univ Oulu, Dept Internal Med, FIN-90014 Oulu, Finland.
   Univ Oulu, Bioctr Oulu, FIN-90014 Oulu, Finland.
   Univ Oulu, Dept Obstet & Gynecol, FIN-90014 Oulu, Finland.
   Univ Helsinki, Dept Clin Chem, FIN-00290 Helsinki, Finland.
C3 University of Oulu; University of Oulu; University of Oulu; University
   of Oulu; University of Helsinki
RP Tapanainen, JS (corresponding author), Univ Oulu, Oulu Univ Hosp, Dept Obstet & Gynecol, POB 5000, FIN-90014 Oulu, Finland.
EM juha.tapanainen@oulu.fi
CR BAGATELL CJ, 1994, J CLIN ENDOCR METAB, V78, P711, DOI 10.1210/jc.78.3.711
   BAGATELL CJ, 1994, J CLIN ENDOCR METAB, V79, P561, DOI 10.1210/jc.79.2.561
   BAGATELL CJ, 1995, PROG CARDIOVASC DIS, V38, P255, DOI 10.1016/S0033-0620(95)80016-6
   Barrett-Connor E, 1999, J CLIN ENDOCR METAB, V84, P573, DOI 10.1210/jc.84.2.573
   BARRETTCONNOR E, 1992, ANN INTERN MED, V117, P807, DOI 10.7326/0003-4819-117-10-807
   BOSCH RJLH, 1989, J UROLOGY, V141, P68, DOI 10.1016/S0022-5347(17)40591-X
   BREMNER WJ, 1983, J CLIN ENDOCR METAB, V56, P1278, DOI 10.1210/jcem-56-6-1278
   BURRIS AS, 1992, J ANDROL, V13, P297
   Couillard C, 2000, J CLIN ENDOCR METAB, V85, P1026, DOI 10.1210/jc.85.3.1026
   De Lignieres B, 1980, PERCUTANEOUS ABSORPT, P273
   DELIGNIERES B, 1993, ANN MED, V25, P235, DOI 10.3109/07853899309147869
   FRICK J, 1998, TESTOSTERONE ACTION, P259
   GORMLEY GJ, 1992, NEW ENGL J MED, V327, P1185, DOI 10.1056/NEJM199210223271701
   GRAY A, 1991, J CLIN ENDOCR METAB, V73, P1016, DOI 10.1210/jcem-73-5-1016
   GREENBLATT RB, 1976, J AM GERIATR SOC, V24, P173, DOI 10.1111/j.1532-5415.1976.tb04294.x
   Griffin J.E., 1998, Williams Textbook of Endocrinology, P819
   HABENICHT UF, 1987, PROSTATE, V11, P313, DOI 10.1002/pros.2990110404
   Hajjar RR, 1997, J CLIN ENDOCR METAB, V82, P3793, DOI 10.1210/jc.82.11.3793
   HENDERSON BE, 1982, CANCER RES, V42, P3232
   HOLMANG S, 1993, PROSTATE, V23, P99, DOI 10.1002/pros.2990230203
   HORTON R, 1984, J AM GERIATR SOC, V32, P380, DOI 10.1111/j.1532-5415.1984.tb02044.x
   KORENMAN SG, 1990, J CLIN ENDOCR METAB, V71, P963, DOI 10.1210/jcem-71-4-963
   KUHN JM, 1986, CONTRACEPT FERTIL S, V14, P1031
   MCCONNELL JD, 1992, J CLIN ENDOCR METAB, V74, P505, DOI 10.1210/jc.74.3.505
   MORALES AJ, 1994, J CLIN ENDOCR METAB, V78, P1360, DOI 10.1210/jc.78.6.1360
   NAHOUL K, 1990, J STEROID BIOCHEM, V35, P293, DOI 10.1016/0022-4731(90)90287-3
   Ozata M, 1996, J CLIN ENDOCR METAB, V81, P3372, DOI 10.1210/jc.81.9.3372
   POLLARD M, 1987, PROSTATE, V10, P325, DOI 10.1002/pros.2990100406
   REITER T, 1963, J AM GERIATR SOC, V11, P540, DOI 10.1111/j.1532-5415.1963.tb00553.x
   Rosen RC, 1997, UROLOGY, V49, P822, DOI 10.1016/S0090-4295(97)00238-0
   SHAHIDI NT, 1973, NEW ENGL J MED, V289, P72, DOI 10.1056/NEJM197307122890205
   Simon D, 1997, J CLIN ENDOCR METAB, V82, P682, DOI 10.1210/jc.82.2.682
   SORVA R, 1988, ATHEROSCLEROSIS, V69, P191, DOI 10.1016/0021-9150(88)90014-7
   SUZUKI K, 1994, PROSTATE, V25, P169, DOI 10.1002/pros.2990250402
   SWERDLOFF RS, 1993, EXP GERONTOL, V28, P435, DOI 10.1016/0531-5565(93)90069-P
   Tenover JL, 1996, ANDROGENS AND THE AGING MALE, P191
   TENOVER JS, 1992, J CLIN ENDOCR METAB, V75, P1092, DOI 10.1210/jc.75.4.1092
   TENOVER JS, 1994, ENDOCRIN METAB CLIN, V23, P877, DOI 10.1016/S0889-8529(18)30073-2
   WALSH PC, 1976, J CLIN INVEST, V57, P1093, DOI 10.1172/JCI108353
   Wang C, 1998, J CLIN ENDOCR METAB, V83, P2749, DOI 10.1210/jc.83.8.2749
   Wang C, 1997, ANN MED, V29, P365, DOI 10.3109/07853899708999363
   WIKLUND I, 1990, CONTROL CLIN TRIALS, V11, P169, DOI 10.1016/0197-2456(90)90011-P
   Zgliczynski S, 1996, ATHEROSCLEROSIS, V121, P35, DOI 10.1016/0021-9150(95)05673-4
NR 43
TC 92
Z9 93
U1 0
U2 4
PU ENDOCRINE SOC
PI WASHINGTON
PA 2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA
SN 0021-972X
EI 1945-7197
J9 J CLIN ENDOCR METAB
JI J. Clin. Endocrinol. Metab.
PD APR
PY 2002
VL 87
IS 4
BP 1467
EP 1472
DI 10.1210/jc.87.4.1467
PG 6
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 541AM
UT WOS:000174963100005
PM 11932266
DA 2024-02-19
ER

PT J
AU Masternak, MM
   Al-Regaiey, KA
   Lim, MMD
   Jimenez-Ortega, V
   Panici, JA
   Bonkowski, MS
   Bartke, A
AF Masternak, MM
   Al-Regaiey, KA
   Lim, MMD
   Jimenez-Ortega, V
   Panici, JA
   Bonkowski, MS
   Bartke, A
TI Effects of caloric restriction on insulin pathway gene expression in the
   skeletal muscle and liver of normal and long-lived GHR-KO mice
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE caloric restriction; aging; GHR-KO; insulin
ID LIFE-SPAN; DWARF MICE; GLUCOSE; MOUSE
AB Growth hormone receptor/binding protein knockout (GHR-KO) mice are characterized by resistance to growth hormone (GH), reduced insulin like growth factor 1 (IGF1) levels and enhanced insulin sensitivity and markedly increased lifespan. Findings in these and other long-lived mutant mice, and in normal animals subjected to caloric restriction (CR) indicate that insulin signaling is importantly involved in the control of longevity. We have examined the mRNA expression level of genes involved in insulin/IGF1 action in the skeletal muscle and liver of normal and GHR-KO mice fed ad libitum or subjected to long term 30% CR. The levels of IR, IRS 1, IRS2, GLUT4 and IGF1 message in the skeletal muscle were reduced by CR in both normal and GHR-KO mice. In the liver, the results indicate that in GHR-KO mice mRNA expression of genes related to early steps of insulin signaling is up-regulated in the liver but not in the muscle. The results also show that improved insulin sensitivity in response to CR is not due to increased mRNA expression of the above genes in either normal or GHR-KO animals. (c) 2005 Elsevier Inc. All rights reserved.
C1 So Illinois Univ, Sch Med, Dept Internal Med, Springfield, IL 62794 USA.
   So Illinois Univ, Sch Med, Dept Physiol, Springfield, IL 62794 USA.
   So Illinois Univ, Sch Med, Dept Geriatr Res, Springfield, IL 62794 USA.
C3 Southern Illinois University System; Southern Illinois University;
   Southern Illinois University System; Southern Illinois University;
   Southern Illinois University System; Southern Illinois University
RP Masternak, MM (corresponding author), So Illinois Univ, Sch Med, Dept Internal Med, 801 N Rutledge St,Room 4389,POB 19628, Springfield, IL 62794 USA.
EM mmasternak@siumed.edu
RI Ortega, Vanesa Jimenez/F-1285-2016; Bartke, Andzej/D-6640-2017;
   Al-Regaiey, Khalid/AAG-4217-2019
OI Ortega, Vanesa Jimenez/0000-0001-7553-5446; Bartke,
   Andzej/0000-0002-2569-557X; Al-Regaiey, Khalid/0000-0001-9770-5637;
   Bonkowski, Michael/0000-0003-3416-4612
FU NIA NIH HHS [U19 AG023122, AG 19899] Funding Source: Medline
CR Al-Regaiey KA, 2005, ENDOCRINOLOGY, V146, P851, DOI 10.1210/en.2004-1120
   Argentino DP, 2005, J GERONTOL A-BIOL, V60, P28, DOI 10.1093/gerona/60.1.28
   BACKER JM, 1992, EMBO J, V11, P3469, DOI 10.1002/j.1460-2075.1992.tb05426.x
   Bartke A, 2001, NATURE, V414, P412, DOI 10.1038/35106646
   Berryman DE, 2004, GROWTH HORM IGF RES, V14, P309, DOI 10.1016/j.ghir.2004.02.005
   BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0
   CARTEE GD, 1994, AM J PHYSIOL, V266, pR1443, DOI 10.1152/ajpregu.1994.266.5.R1443
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   Coschigano KT, 2000, ENDOCRINOLOGY, V141, P2608, DOI 10.1210/en.141.7.2608
   Coschigano KT, 2003, ENDOCRINOLOGY, V144, P3799, DOI 10.1210/en.2003-0374
   Czech MP, 1999, J BIOL CHEM, V274, P1865, DOI 10.1074/jbc.274.4.1865
   Dean DJ, 1998, AM J PHYSIOL-ENDOC M, V275, pE957, DOI 10.1152/ajpendo.1998.275.6.E957
   Dominici FP, 2003, MECH AGEING DEV, V124, P819, DOI 10.1016/S0047-6374(03)00136-2
   Flurkey K, 2001, P NATL ACAD SCI USA, V98, P6736, DOI 10.1073/pnas.111158898
   Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298
   Liu JL, 2004, AM J PHYSIOL-ENDOC M, V287, pE405, DOI 10.1152/ajpendo.00423.2003
   MASTERNAK MM, 2005, IN PRESS J GERONTOL
   Mattison JA, 2000, J AM AGING ASSOC, V23, P9, DOI 10.1007/s11357-000-0002-0
   Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a
   SUN XJ, 1995, NATURE, V377, P173, DOI 10.1038/377173a0
   Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447
   THORENS B, 1990, DIABETES CARE, V13, P209, DOI 10.2337/diacare.13.3.209
   Zhou YH, 1997, P NATL ACAD SCI USA, V94, P13215, DOI 10.1073/pnas.94.24.13215
NR 23
TC 51
Z9 63
U1 0
U2 8
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD AUG-SEP
PY 2005
VL 40
IS 8-9
BP 679
EP 684
DI 10.1016/j.exger.2005.06.003
PG 6
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 970SO
UT WOS:000232330100007
PM 16054319
DA 2024-02-19
ER

PT J
AU Zheng, WX
   Li, RD
   Zhou, Y
   Shi, FC
   Song, Y
   Liao, YT
   Zhou, F
   Zheng, XH
   Lv, JW
   Li, QY
AF Zheng, Wenxuan
   Li, Ruiding
   Zhou, Yang
   Shi, Fengcui
   Song, Yao
   Liao, Yanting
   Zhou, Fan
   Zheng, Xiaohua
   Lv, Jingwen
   Li, Quanyang
TI Effect of dietary protein content shift on aging in elderly rats by
   comprehensive quantitative score and metabolomics analysis
SO FRONTIERS IN NUTRITION
LA English
DT Article
DE comprehensive quantitative score; metabolomics; aging; dietary patterns;
   nuclear magnetic resonance
ID CHAIN AMINO-ACIDS; DECREASED CONSUMPTION; GUT MICROBIOTA; METABOLISM;
   RESTRICTION; IMPACT; OBESITY; MASS; LONGEVITY; GLUTAMATE
AB In the protein nutrition strategy of middle-aged and elderly people, some believe that low protein is good for health, while others believe high protein is good for health. Facing the contradictory situation, the following hypothesis is proposed. There is a process of change from lower to higher ratio of protein nutritional requirements that are good for health in the human body after about 50 years of age, and the age at which the switch occurs is around 65 years of age. Hence, in this study, 50, 25-month-old male rats were randomly divided into five groups: Control (basal diet), LP (low-protein diet with a 30% decrease in protein content compared to the basal diet), HP (high-protein diet with a 30% increase in protein content compared to the basal diet), Model 1 (switched from LP to HP feed at week 4), and Model 2 (switched from LP to HP feed at week 7). After a total of 10 weeks intervention, the liver and serum samples were examined for aging-related indicators, and a newly comprehensive quantitative score was generated using principal component analysis (PCA). The effects of the five protein nutritional modalities were quantified in descending order: Model 1 > HP > LP > Control > Model 2. Furthermore, the differential metabolites in serum and feces were determined by orthogonal partial least squares discriminant analysis, and 15 differential metabolites, significantly associated with protein intake, were identified by Spearman's correlation analysis (p < 0.05). Among the fecal metabolites, 10 were positively correlated and 3 were negatively correlated. In the serum, tyrosine and lactate levels were positively correlated, and acetate levels were negatively correlated. MetaboAnalyst analysis identified that the metabolic pathways influenced by protein intake were mainly related to amino acid and carbohydrate metabolism. The results of metabolomic analysis elucidate the mechanisms underlying the preceding effects to some degree. These efforts not only contribute to a unified protein nutrition strategy but also positively impact the building of a wiser approach to protein nutrition, thereby helping middle-aged and older populations achieve healthy aging.
C1 [Zheng, Wenxuan; Li, Ruiding; Shi, Fengcui; Song, Yao; Liao, Yanting; Zhou, Fan; Zheng, Xiaohua; Lv, Jingwen; Li, Quanyang] Guangxi Univ, Sch Light Ind & Food Engn, Nanning, Peoples R China.
   [Zhou, Yang] Wangdingdi Hosp, Tianjin, Peoples R China.
C3 Guangxi University
RP Li, QY (corresponding author), Guangxi Univ, Sch Light Ind & Food Engn, Nanning, Peoples R China.; Zhou, Y (corresponding author), Wangdingdi Hosp, Tianjin, Peoples R China.
EM zhouyangtj@sina.com; liquanyang@gxu.edu.cn
RI wang, yu/IUQ-6654-2023; Liu, Chang/ISV-3950-2023; Liu, DY/JPL-4171-2023;
   yang, peng/JEZ-8452-2023; liu, xy/JEP-3175-2023; li, jian/IAQ-2794-2023;
   Zhang, Yihao/JGM-3514-2023; wang, wei/JBS-7400-2023; li,
   xiao/HJP-5134-2023; Tang, Wei/IZQ-1283-2023; wang, qiang/IZW-1751-2023;
   Liu, Kai/IST-6808-2023; wang, yitian/JFA-6804-2023; wang,
   qi/ITT-9652-2023; lu, yang/IWE-3635-2023; zhang, xu/JEO-4879-2023;
   Zhang, Lijun/JEZ-7925-2023
CR Aguirre M, 2016, RES MICROBIOL, V167, P114, DOI 10.1016/j.resmic.2015.09.006
   Andreollo NA, 2012, ABCD-ARQ BRAS CIR DI, V25, P49, DOI 10.1590/S0102-67202012000100011
   Arthur ST, 2012, INT J BIOL SCI, V8, P731, DOI 10.7150/ijbs.4262
   Baccolo G, 2018, INT REV CEL MOL BIO, V340, P1, DOI 10.1016/bs.ircmb.2018.05.001
   Baik SH, 2019, CELL METAB, V30, P493, DOI 10.1016/j.cmet.2019.06.005
   Bhupathiraju SN, 2016, CIRC RES, V118, P1723, DOI 10.1161/CIRCRESAHA.115.306825
   Bronikowski AM, 2022, AGING CELL, V21, DOI 10.1111/acel.13542
   Brosnan JT, 2000, J NUTR, V130, p988S, DOI 10.1093/jn/130.4.988S
   Brunet A, 2017, CURR OPIN CELL BIOL, V45, P1, DOI 10.1016/j.ceb.2016.12.009
   Bussche JV, 2015, ANAL CHEM, V87, P10927, DOI 10.1021/acs.analchem.5b02688
   Chak CM, 2019, METABOLITES, V9, DOI 10.3390/metabo9030044
   Cui CM, 2022, FASEB BIOADV, V4, P560, DOI 10.1096/fba.2021-00152
   Cummings NE, 2018, J PHYSIOL-LONDON, V596, P623, DOI 10.1113/JP275075
   Miyaguti NAD, 2020, NUTRIENTS, V12, DOI 10.3390/nu12072106
   Deelen J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11311-9
   Deutz NEP, 2014, CLIN NUTR, V33, P929, DOI 10.1016/j.clnu.2014.04.007
   Durainayagam B, 2019, FRONT NUTR, V6, DOI 10.3389/fnut.2019.00180
   Elias Merrill F, 2005, Neurobiol Aging, V26 Suppl 1, P11, DOI 10.1016/j.neurobiolaging.2005.08.019
   Fernstrom JD, 2007, J NUTR, V137, p1539S, DOI 10.1093/jn/137.6.1539S
   Fontana L, 2016, CELL REP, V16, P520, DOI 10.1016/j.celrep.2016.05.092
   Fontana L, 2013, ONCOTARGET, V4, P2451, DOI 10.18632/oncotarget.1586
   Furuhashi M, 2020, AM J PHYSIOL-ENDOC M, V319, pE827, DOI 10.1152/ajpendo.00378.2020
   Gavrilova NS, 2012, GERONTOLOGY, V58, P221, DOI 10.1159/000329894
   Grandison RC, 2009, NATURE, V462, P1061, DOI 10.1038/nature08619
   Green CL, 2022, CELL METAB, V34, P209, DOI 10.1016/j.cmet.2021.12.018
   Hahn O, 2019, NAT METAB, V1, P1059, DOI 10.1038/s42255-019-0121-0
   Hahn O, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1187-1
   Halbesma N, 2009, J AM SOC NEPHROL, V20, P1797, DOI 10.1681/ASN.2008060649
   Hamezah HS, 2017, EXP GERONTOL, V99, P69, DOI 10.1016/j.exger.2017.09.008
   Han KC, 2022, FRONT NUTR, V9, DOI 10.3389/fnut.2022.853365
   Hanjani NA, 2018, INT J PREVENTIVE MED, V9, DOI 10.4103/ijpvm.IJPVM_397_16
   Harro J, 2018, BEHAV BRAIN RES, V352, P81, DOI 10.1016/j.bbr.2017.10.016
   Hou YQ, 2020, ADV EXP MED BIOL, V1265, P21, DOI 10.1007/978-3-030-45328-2_2
   Jendrach M, 2005, MECH AGEING DEV, V126, P813, DOI 10.1016/j.mad.2005.03.002
   Kanbay M, 2016, EUR J INTERN MED, V29, P3, DOI 10.1016/j.ejim.2015.11.026
   Kim HK, 2021, FRONT NUTR, V8, DOI 10.3389/fnut.2021.797004
   Kouvari M, 2022, NUTRIENTS, V14, DOI 10.3390/nu14020333
   Levine ME, 2014, CELL METAB, V19, P407, DOI 10.1016/j.cmet.2014.02.006
   Liu XJ, 2021, AGING-US, V13, P3798, DOI 10.18632/aging.202340
   Longo VD, 2022, CELL, V185, P1455, DOI 10.1016/j.cell.2022.04.002
   Longo VD, 2015, AGING CELL, V14, P497, DOI 10.1111/acel.12338
   Louis P, 2007, J APPL MICROBIOL, V102, P1197, DOI 10.1111/j.1365-2672.2007.03322.x
   Lu RJ, 2022, BRIEF FUNCT GENOMICS, V21, P43, DOI 10.1093/bfgp/elab009
   Mair W, 2005, PLOS BIOL, V3, P1305, DOI 10.1371/journal.pbio.0030223
   Matsuda M, 2013, OBES RES CLIN PRACT, V7, pE330, DOI 10.1016/j.orcp.2013.05.004
   Mei LH, 2021, NUTRIENTS, V13, DOI 10.3390/nu13113891
   Meynial-Denis D, 2016, NUTR REV, V74, P225, DOI 10.1093/nutrit/nuv052
   Mitchell SE, 2015, ONCOTARGET, V6, P23213, DOI 10.18632/oncotarget.4003
   Mitsuishi M, 2013, AM J PHYSIOL-ENDOC M, V305, pE776, DOI 10.1152/ajpendo.00145.2013
   Mu WC, 2018, NUTRIENTS, V10, DOI 10.3390/nu10070918
   Palmer ND, 2015, J CLIN ENDOCR METAB, V100, pE463, DOI 10.1210/jc.2014-2357
   Venegas DP, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00277
   Pietri P, 2021, J AM COLL CARDIOL, V77, P189, DOI 10.1016/j.jacc.2020.11.023
   Pignatti C, 2020, GERIATRICS-BASEL, V5, DOI 10.3390/geriatrics5040095
   Prokopidis K, 2020, NUTRIENTS, V12, DOI 10.3390/nu12082285
   Rios-Covian D, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00973
   Rodríguez-Mañas L, 2022, GEROSCIENCE, V44, P1095, DOI 10.1007/s11357-021-00384-4
   Sampathkumar NK, 2020, HUM GENET, V139, P333, DOI 10.1007/s00439-019-02082-w
   Sedzikowska A, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22189987
   Seibenhener ML, 2015, JOVE-J VIS EXP, DOI 10.3791/52434
   Siddik MA, 2019, ENDOCRINOL METAB, V34, P234, DOI 10.3803/EnM.2019.34.3.234
   Sluijs I, 2010, DIABETES CARE, V33, P43, DOI 10.2337/dc09-1321
   Snelson M, 2021, MOL NUTR FOOD RES, V65, DOI 10.1002/mnfr.202000851
   Solon-Biet SM, 2020, CELL METAB, V31, P654, DOI 10.1016/j.cmet.2020.01.010
   Timmons JF, 2021, FRONT SPORTS ACT LIV, V3, DOI 10.3389/fspor.2021.653962
   Tomé D, 2018, ANN NUTR METAB, V73, P15, DOI 10.1159/000494777
   Traylor DA, 2018, ADV NUTR, V9, P171, DOI 10.1093/advances/nmy003
   Ulaszewska MM, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201800384
   Walrand S, 2008, AM J PHYSIOL-ENDOC M, V295, pE921, DOI 10.1152/ajpendo.90536.2008
   Wang DN, 2022, FREE RADICAL BIO MED, V178, P226, DOI 10.1016/j.freeradbiomed.2021.12.009
   Wolf PA, 2007, CURR ALZHEIMER RES, V4, P111, DOI 10.2174/156720507780362263
   Wolfe RR, 2012, BRIT J NUTR, V108, pS88, DOI 10.1017/S0007114512002590
   Yao J, 2022, CLIN IMMUNOL, V238, DOI 10.1016/j.clim.2022.109013
   Yu HN, 2016, AMINO ACIDS, V48, P1601, DOI 10.1007/s00726-016-2219-y
   Zhang YQ, 2012, ANN RHEUM DIS, V71, P1448, DOI 10.1136/annrheumdis-2011-201215
   Zhao D, 2021, REJUV RES, V24, P86, DOI 10.1089/rej.2020.2352
   Zhao FF, 2018, FOOD FUNCT, V9, P4814, DOI 10.1039/c8fo00740c
   Zhu YY, 2014, MOL BIOSYST, V10, P304, DOI 10.1039/c3mb70392d
NR 78
TC 1
Z9 1
U1 0
U2 14
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-861X
J9 FRONT NUTR
JI Front. Nutr.
PD NOV 3
PY 2022
VL 9
AR 1051964
DI 10.3389/fnut.2022.1051964
PG 18
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 6I9TT
UT WOS:000886473200001
PM 36407526
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Fulop, GA
   Ramirez-Perez, FI
   Kiss, T
   Tarantini, S
   Ares, MNV
   Toth, P
   Yabluchanskiy, A
   Conley, SM
   Ballabh, P
   Martinez-Lemus, LA
   Ungvari, Z
   Csiszar, A
AF Fulop, Gabor A.
   Ramirez-Perez, Francisco I.
   Kiss, Tamas
   Tarantini, Stefano
   Ares, Marta Noa Valcarcel
   Toth, Peter
   Yabluchanskiy, Andriy
   Conley, Shannon M.
   Ballabh, Praveen
   Martinez-Lemus, Luis A.
   Ungvari, Zoltan
   Csiszar, Anna
TI IGF-1 Deficiency Promotes Pathological Remodeling of Cerebral Arteries:
   A Potential Mechanism Contributing to the Pathogenesis of Intracerebral
   Hemorrhages in Aging
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
DE Vascular aging; Remodeling; Vascular smooth muscle cell; IGF-1;
   Neuroendocrine aging; Hypertension
ID VASCULAR OXIDATIVE STRESS; SMOOTH-MUSCLE-CELLS; GROWTH-HORMONE; MICE;
   HYPERTENSION; PROLIFERATION; MICROHEMORRHAGES; MICROBLEEDS; DYSFUNCTION;
   ACTIVATION
AB Clinical and experimental studies show that age-related decline in circulating insulin-like growth factor-1 (IGF-1) levels promotes the pathogenesis of intracerebral hemorrhages, which critically contribute to the development of vascular cognitive impairment and disability in older adults. Yet, the mechanisms by which IGF-1 deficiency compromises structural integrity of the cerebral vasculature are not completely understood. To determine the role of IGF-1 deficiency in pathological remodeling of middle cerebral arteries (MCAs), we compared alterations in vascular mechanics, morphology, and remodeling-related gene expression profile in mice with liver-specific knockdown of IGF-1 (Igf1(f/f) + TBG-Cre-AAV8) and control mice with or without hypertension induced by angiotensin-II treatment. We found that IGF-1 deficiency resulted in thinning of the media and decreased wall-to-lumen ratio in MCAs. MCAs of control mice exhibited structural adaptation to hypertension, manifested as a significant increase in wall thickness, vascular smooth muscle cell (VSMC) hypertrophy, decreased internal diameter and up-regulation of extracellular matrix (ECM)-related genes. IGF-1 deficiency impaired hypertension-induced adaptive media hypertrophy and dysregulated ECM remodeling, decreasing elastin content and attenuating adaptive changes in ECM-related gene expression. Thus, circulating IGF-1 plays a critical role in maintenance of the structural integrity of cerebral arteries. Alterations of VSMC phenotype and pathological remodeling of the arterial wall associated with age-related IGF-1 deficiency have important translational relevance for the pathogenesis of intracerebral hemorrhages and vascular cognitive impairment in elderly hypertensive patients.
C1 [Fulop, Gabor A.; Kiss, Tamas; Tarantini, Stefano; Ares, Marta Noa Valcarcel; Toth, Peter; Yabluchanskiy, Andriy; Conley, Shannon M.; Ungvari, Zoltan; Csiszar, Anna] Univ Oklahoma, Hlth Sci Ctr, Dept Geriatr Med, Reynolds Oklahoma Ctr Aging, 975 NE 10th St, Oklahoma City, OK 73104 USA.
   [Fulop, Gabor A.] Univ Debrecen, Fac Med, Div Clin Physiol, Debrecen, Hungary.
   [Ramirez-Perez, Francisco I.; Martinez-Lemus, Luis A.] Univ Missouri, Dalton Cardiovasc Res Ctr, Columbia, MO USA.
   [Ramirez-Perez, Francisco I.; Martinez-Lemus, Luis A.] Univ Missouri, Dept Biol Engn, Columbia, MO USA.
   [Ramirez-Perez, Francisco I.; Martinez-Lemus, Luis A.] Univ Missouri, Dept Med Pharmacol & Physiol, Columbia, MO USA.
   [Kiss, Tamas; Ungvari, Zoltan; Csiszar, Anna] Univ Szeged, Dept Med Phys & Informat, Szeged, Hungary.
   [Toth, Peter] Univ Pecs, Med Sch, Dept Neurosurg, Pecs, Hungary.
   [Conley, Shannon M.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK USA.
   [Ballabh, Praveen] Albert Einstein Coll Med, Dept Pediat, New York, NY USA.
   [Ungvari, Zoltan] Semmelweis Univ, Dept Pulmonol, Budapest, Hungary.
C3 University of Oklahoma System; University of Oklahoma Health Sciences
   Center; University of Debrecen; University of Missouri System;
   University of Missouri Columbia; University of Missouri System;
   University of Missouri Columbia; University of Missouri System;
   University of Missouri Columbia; Szeged University; University of Pecs;
   University of Oklahoma System; University of Oklahoma Health Sciences
   Center; Yeshiva University; Semmelweis University
RP Csiszar, A (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Geriatr Med, Reynolds Oklahoma Ctr Aging, 975 NE 10th St, Oklahoma City, OK 73104 USA.
EM anna-csiszar@ouhsc.edu
RI Wrong, Wrong/ADU-0095-2022; Ramirez-Perez, Francisco/HSC-3380-2023;
   Tarantini, Stefano/JMQ-7733-2023; Ramirez-Perez, Francisco
   I./ABC-8674-2020; Ungvari, Zoltan/GZK-8127-2022
OI Ramirez-Perez, Francisco/0000-0003-4920-383X; Tarantini,
   Stefano/0000-0001-5627-1430; Yabluchanskiy, Andriy/0000-0002-9648-7161;
   Kiss, Tamas/0000-0001-5339-5227
FU American Heart Association; National Institute on Aging [R01-AG055395,
   R01-AG047879, R01-AG038747]; National Institute of Neurological
   Disorders and Stroke (NINDS) [R01-NS056218, R01-NS100782]; National
   Center for Complementary and Alternative Medicine [R01-AT006526];
   National Heart, Lung and Blood Institute (NHLBI) [R01-HL-088105];
   NIA-supported Geroscience Training Program in Oklahoma [T32AG052363];
   NIA-supported Oklahoma Nathan Shock Center [3P30AG050911-02S1];
   NIH-supported Oklahoma Shared Clinical and Translational Resources
   [NIGMS U54GM104938]; College of Medicine Alumni Association; Hungarian
   Academy of Sciences Bolyai Research Scholarship [BO/00634/15]; PTE
   AOK-KA [3/2016 04.01/F, NKFI-FK123798, UNKP-17-4-I-PTE-7]; Oklahoma
   Center for the Advancement of Science and Technology; Presbyterian
   Health Foundation; EU-funded Hungarian grant [EFOP-3.6.1-16-2016-00008];
   Reynolds Foundation
FX This work was supported by grants from the American Heart Association
   (to ST, MNVA), the National Institute on Aging (R01-AG055395 to ZU,
   R01-AG047879 to AC; R01-AG038747), the National Institute of
   Neurological Disorders and Stroke (NINDS; R01-NS056218 to AC,
   R01-NS100782 to ZU), the National Center for Complementary and
   Alternative Medicine (R01-AT006526 to ZU), the National Heart, Lung and
   Blood Institute (NHLBI, R01-HL-088105 to LAML), the NIA-supported
   Geroscience Training Program in Oklahoma (T32AG052363), the
   NIA-supported Oklahoma Nathan Shock Center (to ZU and AC;
   3P30AG050911-02S1), NIH-supported Oklahoma Shared Clinical and
   Translational Resources (to AY, NIGMS U54GM104938), College of Medicine
   Alumni Association (to AY), the Hungarian Academy of Sciences Bolyai
   Research Scholarship BO/00634/15, the PTE AOK-KA 3/2016 04.01/F,
   NKFI-FK123798 and UNKP-17-4-I-PTE-7 (to PT), the Oklahoma Center for the
   Advancement of Science and Technology (to AC, ZU, AY), the Presbyterian
   Health Foundation (to ZU, AC, AY), the EU-funded Hungarian grant
   EFOP-3.6.1-16-2016-00008, and the Reynolds Foundation (to ZU and AC).
CR Akoudad S, 2016, JAMA NEUROL, V73, P934, DOI 10.1001/jamaneurol.2016.1017
   BADESCH DB, 1989, BIOCHEM BIOPH RES CO, V160, P382, DOI 10.1016/0006-291X(89)91667-7
   Bailey-Downs LC, 2012, J GERONTOL A-BIOL, V67, P313, DOI 10.1093/gerona/glr164
   BAUMBACH GL, 1989, HYPERTENSION, V13, P968, DOI 10.1161/01.HYP.13.6.968
   Baumbach GL, 2003, HYPERTENSION, V41, P50, DOI 10.1161/01.HYP.0000042427.05390.5C
   Behmoaras J, 2005, AM J PHYSIOL-HEART C, V288, pH769, DOI 10.1152/ajpheart.00544.2004
   Bender SB, 2015, AM J PHYSIOL-HEART C, V309, pH574, DOI 10.1152/ajpheart.00155.2015
   Brüel A, 2002, MECH AGEING DEV, V123, P1353, DOI 10.1016/S0047-6374(02)00073-8
   Chen Y, 1998, GROWTH HORM IGF RES, V8, P299, DOI 10.1016/S1096-6374(98)80125-1
   Cheng JZ, 2007, ARTERIOSCL THROM VAS, V27, P1744, DOI 10.1161/ATVBAHA.107.147371
   Chillon JM, 1999, HYPERTENSION, V33, P856, DOI 10.1161/01.HYP.33.3.856
   Csiszar A, 2008, AM J PHYSIOL-HEART C, V295, pH1882, DOI 10.1152/ajpheart.412.2008
   Diaz-Otero JM, 2016, AM J PHYSIOL-HEART C, V310, pH365, DOI 10.1152/ajpheart.00562.2015
   Duca L, 2016, CARDIOVASC RES, V110, P298, DOI 10.1093/cvr/cvw061
   HAJDU MA, 1991, HYPERTENSION, V17, P308, DOI 10.1161/01.HYP.17.3.308
   Hasan DM, 2015, HYPERTENSION, V66, P211, DOI 10.1161/HYPERTENSIONAHA.115.05332
   Higashi Y, 2012, J GERONTOL A-BIOL, V67, P626, DOI 10.1093/gerona/gls102
   HOPKINS KD, 1993, CLIN SCI, V84, P593, DOI 10.1042/cs0840593
   Izzard AS, 2006, J HYPERTENS, V24, P875, DOI 10.1097/01.hjh.0000222757.54111.06
   Izzard AS, 2003, AM J PHYSIOL-HEART C, V285, pH1489, DOI 10.1152/ajpheart.00352.2003
   Kato H, 2002, STROKE, V33, P1536, DOI 10.1161/01.STR.0000018012.65108.86
   Kuramoto K, 2010, GERIATR GERONTOL INT, V10, P94, DOI 10.1111/j.1447-0594.2009.00559.x
   Li YX, 2003, ARTERIOSCL THROM VAS, V23, P2178, DOI 10.1161/01.ATV.0000099788.31333.DB
   Liu G, 2011, EXP CELL RES, V317, P2420, DOI 10.1016/j.yexcr.2011.07.016
   Martínez-Revelles S, 2017, ANTIOXID REDOX SIGN, V27, P379, DOI 10.1089/ars.2016.6642
   Meschiari CA, 2017, GEROSCIENCE, V39, P7, DOI 10.1007/s11357-017-9959-9
   Pennington KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155377
   Pereira L, 1999, P NATL ACAD SCI USA, V96, P3819, DOI 10.1073/pnas.96.7.3819
   Poels MMF, 2012, NEUROLOGY, V78, P326, DOI 10.1212/WNL.0b013e3182452928
   Poels MMF, 2011, STROKE, V42, P656, DOI 10.1161/STROKEAHA.110.607184
   Reddy AK, 2014, J GERONTOL A-BIOL, V69, P152, DOI 10.1093/gerona/glt055
   Rizzoni D, 2009, J HYPERTENS, V27, P838, DOI 10.1097/HJH.0b013e32832401ea
   Shai SY, 2010, ARTERIOSCL THROM VAS, V30, P1916, DOI 10.1161/ATVBAHA.110.210831
   SMEDA JS, 1992, CAN J PHYSIOL PHARM, V70, P552, DOI 10.1139/y92-070
   Sonntag WE, 2005, ENDOCRINOLOGY, V146, P2920, DOI 10.1210/en.2005-0058
   Sonntag WE, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00027
   Springo Z, 2015, J GERONTOL A-BIOL, V70, P1355, DOI 10.1093/gerona/glu244
   Standley PR, 1999, AM J PHYSIOL-ENDOC M, V276, pE697, DOI 10.1152/ajpendo.1999.276.4.E697
   Tarantini S, 2017, AGING CELL, V16, P469, DOI 10.1111/acel.12583
   Tarantini S, 2016, AGE, V38, P273, DOI 10.1007/s11357-016-9931-0
   Toth P, 2015, AGING CELL, V14, P1034, DOI 10.1111/acel.12372
   Toth P, 2015, AGING CELL, V14, P400, DOI 10.1111/acel.12315
   Toth P, 2014, J CEREBR BLOOD F MET, V34, P1887, DOI 10.1038/jcbfm.2014.156
   Toth P, 2013, AM J PHYSIOL-HEART C, V305, pH1698, DOI 10.1152/ajpheart.00377.2013
   Toth P, 2013, J CEREBR BLOOD F MET, V33, P1732, DOI 10.1038/jcbfm.2013.143
   Ungvari Z, 2017, AM J PHYSIOL-HEART C, V312, pH1128, DOI 10.1152/ajpheart.00780.2016
   Ungvari Z, 2011, J GERONTOL A-BIOL, V66, P866, DOI 10.1093/gerona/glr092
   Ungvari Z, 2011, AM J PHYSIOL-HEART C, V301, pH363, DOI 10.1152/ajpheart.01134.2010
   van Asch CJJ, 2010, LANCET NEUROL, V9, P167, DOI 10.1016/S1474-4422(09)70340-0
   von der Thüsen JH, 2011, AM J PATHOL, V178, P924, DOI 10.1016/j.ajpath.2010.10.007
   Wakisaka Y, 2010, STROKE, V41, P790, DOI 10.1161/STROKEAHA.109.569616
   Wang L, 2014, ANN BIOMED ENG, V42, P776, DOI 10.1007/s10439-013-0957-5
   WOLFE BL, 1993, J BIOL CHEM, V268, P12418
NR 53
TC 26
Z9 30
U1 1
U2 10
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
EI 1758-535X
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD APR
PY 2019
VL 74
IS 4
BP 446
EP 454
DI 10.1093/gerona/gly144
PG 9
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA HQ7LM
UT WOS:000462601700002
PM 29931048
OA Green Published
DA 2024-02-19
ER

PT J
AU BIAGI, PL
   BORDONI, A
   HRELIA, S
   CELADON, M
   TURCHETTO, E
AF BIAGI, PL
   BORDONI, A
   HRELIA, S
   CELADON, M
   TURCHETTO, E
TI THE EFFECT OF DIETARY POLYENYLPHOSPHATIDYLCHOLINE ON MICROSOMAL
   DELTA-6-DESATURASE ACTIVITY, FATTY-ACID COMPOSITION, AND MICROVISCOSITY
   IN RAT-LIVER UNDER OXIDATIVE STRESS
SO JOURNAL OF NUTRITIONAL BIOCHEMISTRY
LA English
DT Article
DE POLYENYLPHOSPHATIDYLCHOLINE; OXIDATIVE STRESS; DELTA-6-DESATURASE; FATTY
   ACIDS; MICROVISCOSITY; MALONDIALDEHYDE; LIVER MICROSOMES
ID ESSENTIAL PHOSPHOLIPIDS; AGING INFLUENCE; TISSUE-INJURY; ANIMALS
AB Polyenylphosphatidylcholine is a choline-glycerophospholipid containing up to 80% of total fatty acids as linoleic acid and may be an important factor in ensuring normal functioning of cell membranes. We tested the effect of a polyenylphosphatidylcholine-supplemented diet and compared it with both a trilinolein-supplemented and a laboratory chow diet on the fatty acid composition, microviscosity, and delta-6-desaturase activity of liver microsomal membranes of 12-month-old rats, in the absence or presence of oxidative stress induced by adriamycin. Polyenylphosphatidylcholine- and trilinolein-supplemented diets showed a similar increase in linoleic acid content and delta-6-desaturase activity in liver microsomes, indicating that low amounts of linoleic acid are able to partially restore the enzyme activity in old rats, independent of the source of linoleic acid. After adriamycin treatment, delta-6-desaturase activity increased in polyenylphosphatidylcholine and trilinolein groups, indicating a protective mechanism against the damage induced by polyunsaturated fatty acid peroxidation. The measurement of malondialdehyde production showed a protective effect on adriamycin-induced lipid peroxidation by polyenylphosphatidylcholine supplementation only. Microsomal membrane microviscosity did not change independent of diet and adriamycin treatment, suggesting that the response of microsomes to lipid peroxidation might be the maintenance of a given membrane order. Administration of polyenylphosphatidylcholine can prevent or minimize the liver damage induced by adriamycin treatment.
RP BIAGI, PL (corresponding author), UNIV BOLOGNA,DIPARTIMENTO BIOCHIM G MORUZZI,VIA IRNERIO 48,I-40126 BOLOGNA,ITALY.
RI Bordoni, Alessandra/J-3047-2012; Hrelia, Silvana/P-2864-2015
OI Hrelia, Silvana/0000-0001-7857-4512; Bordoni,
   Alessandra/0000-0003-4579-1662
CR BARTSCH GG, 1975, ACTA HEPATO-GASTRO, V22, P228
   BIAGI PL, 1991, BIOCHIM BIOPHYS ACTA, V1083, P187, DOI 10.1016/0005-2760(91)90041-F
   BLOMSTRAND R, 1955, ACTA PHYSIOL SCAND, V34, P147, DOI 10.1111/j.1748-1716.1955.tb01234.x
   BORDONI A, 1988, BIOCHEM INT, V17, P1001
   Buege J A, 1978, Methods Enzymol, V52, P302
   CHEN XS, 1986, J NUTR, V116, P2453, DOI 10.1093/jn/116.12.2453
   DEMANT EJF, 1983, EUR J BIOCHEM, V132, P551
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Fox JM, 1979, NUTR BRAIN, V5, P95
   FREEMAN BA, 1982, LAB INVEST, V47, P412
   Halliwell B, 1985, FREE RADICALS BIOL M, DOI 10.1016/0748-5514(85)90140-0
   HEGNER D, 1975, MECH AGEING DEV, V4, P191, DOI 10.1016/0047-6374(75)90021-4
   HORROBIN DF, 1991, MED HYPOTHESES, V35, P23, DOI 10.1016/0306-9877(91)90078-D
   HORROBIN DF, 1989, HDB FREE RADICALS AN, V2, P17
   HRELIA S, 1989, BIOCHEM BIOPH RES CO, V163, P348, DOI 10.1016/0006-291X(89)92142-6
   HRELIA S, 1990, BIOCHEM INT, V22, P659
   LEKIM D, 1976, ARZNEIMITTEL-FORSCH, V26, P1772
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MATAIX FJ, 1992, LIFE SCI, V50, P2111
   NAGOAKA S, 1986, J NUTR, V116, P726
   POROKHNYAK LA, 1987, ANTIBIOT MED BIOTEK, V32, P282
   RUBIN MS, 1973, P SOC EXP BIOL MED, V143, P1008
   SAMOCHOW.L, 1970, J MED, V1, P299
   SKAKUN NP, 1986, ANTIBIOT MED BIOTEK, V31, P781
   SLATER TF, 1984, BIOCHEM J, V222, P1
   STOFFEL W, 1959, ANAL CHEM, V31, P307, DOI 10.1021/ac60146a047
   WHYTE M, 1965, J LIPID RES, V6, P233
   WITTERS LA, 1979, J BIOL CHEM, V254, P245
NR 28
TC 14
Z9 15
U1 0
U2 0
PU BUTTERWORTH-HEINEMANN
PI WOBURN
PA 225 WILDWOOD AVE #UNITB PO BOX 4500, WOBURN, MA 01801-2084
SN 0955-2863
J9 J NUTR BIOCHEM
JI J. Nutr. Biochem.
PD DEC
PY 1993
VL 4
IS 12
BP 690
EP 694
DI 10.1016/0955-2863(93)90108-9
PG 5
WC Biochemistry & Molecular Biology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Nutrition & Dietetics
GA MJ979
UT WOS:A1993MJ97900004
DA 2024-02-19
ER

PT J
AU Watanabe, Y
   Kuboki, S
   Shimizu, H
   Ohtsuka, M
   Yoshitomi, H
   Furukawa, K
   Miyazaki, M
AF Watanabe, Yoshihiro
   Kuboki, Satoshi
   Shimizu, Hiroaki
   Ohtsuka, Masayuki
   Yoshitomi, Hideyuki
   Furukawa, Katsunori
   Miyazaki, Masaru
TI A New Proposal of Criteria for the Future Remnant Liver Volume in Older
   Patients Undergoing Major Hepatectomy for Biliary Tract Cancer
SO ANNALS OF SURGERY
LA English
DT Article
DE biliary tract cancer; extrahepatic bile duct resection; immune function;
   liver regeneration; major hepatectomy; older patients; severe
   postoperative complications
ID ELDERLY-PATIENTS; HILAR CHOLANGIOCARCINOMA; SEVERE SEPSIS; DONOR AGE;
   RESECTION; REGENERATION; IMPACT; TRANSPLANTATION; CLASSIFICATION;
   SURGERY
AB Objective: To evaluate whether advanced age increases the risk of severe complications after major hepatectomy with bile duct resection (BDR) in patients with biliary tract cancer, and to establish new criteria for the percentage of the future remnant liver volume (%FLV) in older patients undergoing this operation.
   Background: Advanced age is reported to inhibit liver regeneration and suppress immune function; however, little is known about the risk of aging in high-stress surgery, such as biliary tract surgery.
   Methods: Consecutive patients who underwent major hepatectomy with BDR between 2000 and 2013 were retrospectively reviewed. Severe postoperative complications were defined as Clavien-Dindo grade >= IV.
   Results: In 225 patients undergoing major hepatectomy with BDR, advanced age was significantly correlated with the incidence of severe postoperative complications, with cut-off value of 69 years. In comparing postoperative complications, the incidences of hyperbilirubinemia, liver failure, respiratory failure, sepsis, severe complications, and operation-related death were more frequent in the older group. Moreover, advanced age (>= 69 years) was an independent risk factor associated with severe complications after major hepatectomy with BDR. Delayed liver regeneration was the reason for the age-related risks. The incidence of severe postoperative complications in older patients was significantly decreased if %FLV was set at >= 45%.
   Conclusions: Advanced age is a strong independent risk factor for severe complications after major hepatectomy with BDR. To decrease the risk of advanced age, the minimum limit of %FLV for this operation should be set at >= 45% in patients aged >= 69 years.
C1 [Watanabe, Yoshihiro; Kuboki, Satoshi; Shimizu, Hiroaki; Ohtsuka, Masayuki; Yoshitomi, Hideyuki; Furukawa, Katsunori; Miyazaki, Masaru] Chiba Univ, Grad Sch Med, Dept Gen Surg, Chiba, Japan.
C3 Chiba University
RP Kuboki, S (corresponding author), Chiba Univ, Grad Sch Med, Dept Gen Surg, Chuo Ku, 1-8-1 Inohana, Chiba 2600856, Japan.
EM satoshi.kuboki@faculty.chiba-u.jp
RI Yoshitomi, Hideyuki/AAN-8812-2020
OI Yoshitomi, Hideyuki/0000-0003-2911-8056
CR Aldrighetti L, 2004, AM SURGEON, V70, P453
   Cescon M, 2003, ARCH SURG-CHICAGO, V138, P547, DOI 10.1001/archsurg.138.5.547
   Cho JY, 2006, LIVER TRANSPLANT, V12, P201, DOI 10.1002/lt.20592
   Cuende N, 2005, TRANSPLANTATION, V79, P1445, DOI 10.1097/01.TP.0000158877.74629.AA
   Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae
   Du ZG, 2014, WORLD J GASTROENTERO, V20, P274, DOI 10.3748/wjg.v20.i1.274
   Ettorre GM, 2001, BRIT J SURG, V88, P73, DOI 10.1046/j.1365-2168.2001.01629.x
   Fan ST, 2000, ARCH SURG-CHICAGO, V135, P336, DOI 10.1001/archsurg.135.3.336
   Girard TD, 2005, CLIN INFECT DIS, V40, P719, DOI 10.1086/427876
   Hogan BV, 2011, SURG-J R COLL SURG E, V9, P38, DOI 10.1016/j.surge.2010.07.011
   Iakova P, 2003, CELL, V113, P495, DOI 10.1016/S0092-8674(03)00318-0
   Inoue S, 2014, CRIT CARE, V18, DOI 10.1186/cc13941
   Inoue S, 2013, CRIT CARE MED, V41, P810, DOI 10.1097/CCM.0b013e318274645f
   Iwamoto T, 2008, TRANSPLANTATION, V85, P1240, DOI 10.1097/TP.0b013e31816c7e90
   Kubota K, 1997, HEPATOLOGY, V26, P1176
   Kusano T, 2009, EJSO-EUR J SURG ONC, V35, P1179, DOI 10.1016/j.ejso.2009.04.008
   Malinis MF, 2014, ANN TRANSPL, V19, DOI 10.12659/AOT.890934
   Sánchez-Hidalgo JM, 2012, J SURG RES, V175, pE1, DOI 10.1016/j.jss.2011.11.1022
   Menon KV, 2006, J AM COLL SURGEONS, V203, P677, DOI 10.1016/j.jamcollsurg.2006.07.025
   Miyazaki M, 2007, SURGERY, V141, P581, DOI 10.1016/j.surg.2006.09.016
   Miyazaki M, 2015, J HEPATO-BIL-PAN SCI, V22, P181, DOI 10.1002/jhbp.211
   Mullen JT, 2007, J AM COLL SURGEONS, V204, P854, DOI 10.1016/j.jamcollsurg.2006.12.032
   Nagino M, 2010, ANN SURG, V252, P115, DOI 10.1097/SLA.0b013e3181e463a7
   Natsume S, 2012, ANN SURG, V255, P754, DOI 10.1097/SLA.0b013e31824a8d82
   Ono Y, 2011, SURGERY, V150, P154, DOI 10.1016/j.surg.2011.05.004
   Sawada T, 2008, HEPATO-GASTROENTEROL, V55, P1971
   Schmucker Douglas L, 2011, Curr Gerontol Geriatr Res, V2011, P526379, DOI 10.1155/2011/526379
   Seyama Y, 2009, HEPATOL RES, V39, P107, DOI 10.1111/j.1872-034X.2008.00441.x
   Shirabe K, 2009, WORLD J SURG, V33, P1927, DOI 10.1007/s00268-009-0122-3
   Singh P, 2011, J GERONTOL A-BIOL, V66, P944, DOI 10.1093/gerona/glr094
   Takahashi Y, 2013, J HEPATO-BIL-PAN SCI, V20, P324, DOI 10.1007/s00534-012-0529-3
   Unno M, 2010, J HEPATO-BIL-PAN SCI, V17, P463, DOI 10.1007/s00534-009-0206-3
NR 32
TC 16
Z9 18
U1 0
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0003-4932
EI 1528-1140
J9 ANN SURG
JI Ann. Surg.
PD FEB
PY 2018
VL 267
IS 2
BP 338
EP 345
DI 10.1097/SLA.0000000000002080
PG 8
WC Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Surgery
GA FU7KT
UT WOS:000424031700048
PM 27849659
DA 2024-02-19
ER

PT J
AU Dauch, D
   Rudalska, R
   Cossa, G
   Nault, JC
   Kang, TW
   Wuestefeld, T
   Hohmeyer, A
   Imbeaud, S
   Yevsa, T
   Hoenicke, L
   Pantsar, T
   Bozko, P
   Malek, NP
   Longerich, T
   Laufer, S
   Poso, A
   Zucman-Rossi, J
   Eilers, M
   Zender, L
AF Dauch, Daniel
   Rudalska, Ramona
   Cossa, Giacomo
   Nault, Jean-Charles
   Kang, Tae-Won
   Wuestefeld, Torsten
   Hohmeyer, Anja
   Imbeaud, Sandrine
   Yevsa, Tetyana
   Hoenicke, Lisa
   Pantsar, Tatu
   Bozko, Przemyslaw
   Malek, Nisar P.
   Longerich, Thomas
   Laufer, Stefan
   Poso, Antti
   Zucman-Rossi, Jessica
   Eilers, Martin
   Zender, Lars
TI A MYC-aurora kinase A protein complex represents an actionable drug
   target in p53-altered liver cancer
SO NATURE MEDICINE
LA English
DT Article
ID HEPATOCELLULAR-CARCINOMA; N-MYC; INHIBITION; IDENTIFICATION; ACTIVATION;
   P53; SURVEILLANCE; DEGRADATION; RESISTANCE; SENESCENCE
AB MYC oncoproteins are involved in the genesis and maintenance of the majority of human tumors but are considered undruggable. By using a direct in vivo shRNA screen, we show that liver cancer cells that have mutations in the gene encoding the tumor suppressor protein p53 (Trp53 in mice and TP53 in humans) and that are driven by the oncoprotein NRAS become addicted to MYC stabilization via a mechanism mediated by aurora kinase A (AURKA). This MYC stabilization enables the tumor cells to overcome a latent G2/M cell cycle arrest that is mediated by AURKA and the tumor suppressor protein p19(ARF). MYC directly binds to AURKA, and inhibition of this protein-protein interaction by conformation-changing AURKA inhibitors results in subsequent MYC degradation and cell death. These conformation-changing AURKA inhibitors, with one of them currently being tested in early clinical trials, suppressed tumor growth and prolonged survival in mice bearing Trp53-deficient, NRAS-driven MYC-expressing hepatocellular carcinomas (HCCs). TP53-mutated human HCCs revealed increased AURKA expression and a positive correlation between AURKA and MYC expression. In xenograft models, mice bearing TP53-mutated or TP53-deleted human HCCs were hypersensitive to treatment with conformation-changing AURKA inhibitors, thus suggesting a therapeutic strategy for this subgroup of human HCCs.
C1 [Dauch, Daniel; Rudalska, Ramona; Kang, Tae-Won; Wuestefeld, Torsten; Hohmeyer, Anja; Yevsa, Tetyana; Hoenicke, Lisa; Poso, Antti; Zender, Lars] Univ Tubingen, Dept Internal Med 1, Div Translat Gastrointestinal Oncol, Tubingen, Germany.
   [Cossa, Giacomo; Eilers, Martin] Univ Wurzburg, Bioctr, Theodor Boveri Inst, Wurzburg, Germany.
   [Nault, Jean-Charles; Imbeaud, Sandrine; Zucman-Rossi, Jessica] INSERM, Paris, France.
   [Kang, Tae-Won; Zender, Lars] German Canc Res Ctr, German Consortium Translat Canc Res DKTK, Translat Gastrointestinal Oncol Grp, Heidelberg, Germany.
   [Pantsar, Tatu; Poso, Antti] Univ Eastern Finland, Sch Pharm, Kuopio, Finland.
   [Bozko, Przemyslaw; Malek, Nisar P.] Univ Tubingen, Dept Internal Med 1, Tubingen, Germany.
   [Longerich, Thomas] Univ Hosp RWTH Aachen, Inst Pathol, Aachen, Germany.
   [Laufer, Stefan] Univ Tubingen, Dept Pharmaceut Chem, Tubingen, Germany.
   [Eilers, Martin] Univ Wurzburg, Comprehens Canc Ctr Mainfranken, Wurzburg, Germany.
C3 Eberhard Karls University of Tubingen; University of Wurzburg; Institut
   National de la Sante et de la Recherche Medicale (Inserm); Helmholtz
   Association; German Cancer Research Center (DKFZ); University of Eastern
   Finland; Eberhard Karls University of Tubingen; RWTH Aachen University;
   RWTH Aachen University Hospital; Eberhard Karls University of Tubingen;
   University of Wurzburg
RP Zender, L (corresponding author), Univ Tubingen, Dept Internal Med 1, Div Translat Gastrointestinal Oncol, Tubingen, Germany.; Zender, L (corresponding author), German Canc Res Ctr, German Consortium Translat Canc Res DKTK, Translat Gastrointestinal Oncol Grp, Heidelberg, Germany.
EM Lars.Zender@med.uni-tuebingen.de
RI zucman-rossi, Jessica/B-5098-2009; j, zucman-rossi/AAV-3594-2021; Kang,
   Tae Won/S-4864-2019; Imbeaud, Sandrine/P-8780-2017; Cossa,
   Giacomo/AAE-7255-2020
OI zucman-rossi, Jessica/0000-0002-5687-0334; j,
   zucman-rossi/0000-0002-5687-0334; Kang, Tae Won/0000-0003-1497-8926;
   Imbeaud, Sandrine/0000-0001-8439-6732; Cossa,
   Giacomo/0000-0001-5826-5165; Pantsar, Tatu/0000-0002-0369-2909; Laufer,
   Stefan/0000-0001-6952-1486; nault, jean charles/0000-0002-4875-9353;
   Yevsa, Tetyana/0000-0003-0377-9198; Poso, Antti/0000-0003-4196-4204;
   Eilers, Martin/0000-0002-0376-6533; Hoenicke, Lisa/0000-0003-0613-8337
FU German Research Foundation (DFG) [FOR2314, SFB685]; Gottfried Wilhelm
   Leibniz Program; European Research Council; German Ministry for
   Education and Research. (BMBF); German Universities Excellence
   Initiative; German Center for Translational Cancer Research (DKTK);
   German-Israeli Cooperation in Cancer Research (DKFZ-MOST)
FX We thank K. Schulze-Osthoff, S.W. Lowe, W Albrecht, K. Breuhahn, R.
   Geffers, S. Nahnsen, M. Gehringer, E. Rist, C. Fellmeth, P. Katiyar, S.
   Fillinger, M. Jarek, M. Scharfe, M. Diefenbacher and the members of the
   Zender laboratory for fruitful discussions, technical assistance or
   reagents. We thank the Center for Scientific Computing (Espoo, Finland)
   for software and hardware support. This work was supported by the German
   Research Foundation (DFG; grants FOR2314 (L.Z., D.D. and M.E.) and
   SFB685 (L.Z.)), the Gottfried Wilhelm Leibniz Program (L.Z.), the
   European Research Council (projects 'CholangioConcepf (L.Z.),
   'Heptromic' (L.Z.) and 'Auromyc' (M.E.)), the German Ministry for
   Education and Research. (BMBF) (eMed (Multiscale HCC), the German
   Universities Excellence Initiative (third funding line: 'future
   concept') (L.Z.);the German Center for Translational Cancer Research
   (DKTK) (L.Z.) and the German-Israeli Cooperation in Cancer Research
   (DKFZ-MOST) (L.Z.).
CR Aliagas-Martin I, 2009, J MED CHEM, V52, P3300, DOI 10.1021/jm9000314
   Amati B, 2004, P NATL ACAD SCI USA, V101, P8843, DOI 10.1073/pnas.0403046101
   Beltran H, 2011, CANCER DISCOV, V1, P487, DOI 10.1158/2159-8290.CD-11-0130
   Braumüller H, 2013, NATURE, V494, P361, DOI 10.1038/nature11824
   Brockmann M, 2013, CANCER CELL, V24, P75, DOI 10.1016/j.ccr.2013.05.005
   Bruix J, 2014, GUT, V63, P844, DOI 10.1136/gutjnl-2013-306627
   Burgess DJ, 2008, P NATL ACAD SCI USA, V105, P9053, DOI 10.1073/pnas.0803513105
   Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408
   Calvisi DF, 2006, GASTROENTEROLOGY, V130, P1117, DOI 10.1053/j.gastro.2006.01.006
   Carlson CM, 2005, P NATL ACAD SCI USA, V102, P17059, DOI 10.1073/pnas.0502974102
   Carpinelli P, 2007, MOL CANCER THER, V6, P3158, DOI 10.1158/1535-7163.MCT-07-0444
   Chan KL, 2004, HUM PATHOL, V35, P1324, DOI 10.1016/j.humpath.2004.06.012
   Crane R, 2004, BIOL CELL, V96, P215, DOI 10.1016/j.biolcel.2003.09.008
   Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017
   Diefenbacher ME, 2015, CANCER RES, V75, P1181, DOI 10.1158/0008-5472.CAN-14-1726
   EILERS M, 1991, EMBO J, V10, P133, DOI 10.1002/j.1460-2075.1991.tb07929.x
   Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408
   Falchook G, 2014, INVEST NEW DRUG, V32, P1181, DOI 10.1007/s10637-014-0121-6
   Fancelli D, 2006, J MED CHEM, V49, P7247, DOI 10.1021/jm060897w
   Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934
   Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6
   Gustafson WC, 2014, CANCER CELL, V26, P414, DOI 10.1016/j.ccr.2014.07.015
   Huesken D, 2005, NAT BIOTECHNOL, V23, P995, DOI 10.1038/nbt1118
   Ito Y, 1998, HEPATOLOGY, V27, P951, DOI 10.1002/hep.510270409
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Katayama Hiroshi, 2003, Cancer and Metastasis Reviews, V22, P451, DOI 10.1023/A:1023789416385
   Katsha A, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0375-4
   Khwaja A, 1997, EMBO J, V16, P2783, DOI 10.1093/emboj/16.10.2783
   Kimura MT, 2005, CANCER RES, V65, P3548, DOI 10.1158/0008-5472.CAN-04-2149
   Klein A, 2008, MOL BIOL CELL, V19, P3667, DOI 10.1091/mbc.E08-01-0042
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Liu JB, 2012, EUR J CANCER, V48, P2328, DOI 10.1016/j.ejca.2012.03.001
   Lord R, 2011, INT J CLIN PRACT, V65, P182, DOI 10.1111/j.1742-1241.2010.02545.x
   Lu LY, 2008, J BIOL CHEM, V283, P31785, DOI 10.1074/jbc.M805880200
   Lu LF, 2015, MOL CARCINOGEN, V54, P1467, DOI 10.1002/mc.22223
   Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716
   Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231
   Mosquera JM, 2013, NEOPLASIA, V15, P1, DOI 10.1593/neo.121550
   Otto T, 2009, CANCER CELL, V15, P67, DOI 10.1016/j.ccr.2008.12.005
   Podsypanina K, 2008, P NATL ACAD SCI USA, V105, P5242, DOI 10.1073/pnas.0801197105
   Rudalska R, 2014, NAT MED, V20, P1138, DOI 10.1038/nm.3679
   Schmidt CM, 1997, BIOCHEM BIOPH RES CO, V236, P54, DOI 10.1006/bbrc.1997.6840
   Shachaf CM, 2004, NATURE, V431, P1112, DOI 10.1038/nature03043
   Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954
   Sherr CJ, 1998, GENE DEV, V12, P2984, DOI 10.1101/gad.12.19.2984
   Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260
   TAMAYO RP, 1983, HEPATOLOGY, V3, P112
   Tannapfel A, 2001, ONCOGENE, V20, P7104, DOI 10.1038/sj.onc.1204902
   Taub R, 1996, FASEB J, V10, P413, DOI 10.1096/fasebj.10.4.8647340
   Tward AD, 2005, COLD SH Q B, V70, P217, DOI 10.1101/sqb.2005.70.058
   Vert JP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-520
   Watson JD, 2002, J BIOL CHEM, V277, P36921, DOI 10.1074/jbc.M201493200
   Welsch C, 2012, GUT, V61, P36, DOI 10.1136/gutjnl-2012-302144
   White DL, 2012, CLIN GASTROENTEROL H, V10, P1342, DOI 10.1016/j.cgh.2012.10.001
   White P, 2005, J BIOL CHEM, V280, P3715, DOI 10.1074/jbc.M410844200
   Wuestefeld T, 2013, CELL, V153, P389, DOI 10.1016/j.cell.2013.03.026
   Yuan HF, 2012, CARCINOGENESIS, V33, P285, DOI 10.1093/carcin/bgr278
   Zender L, 2003, P NATL ACAD SCI USA, V100, P7797, DOI 10.1073/pnas.1330920100
   Zender L, 2008, CELL, V135, P852, DOI 10.1016/j.cell.2008.09.061
   Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334
NR 60
TC 186
Z9 204
U1 3
U2 61
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1078-8956
EI 1546-170X
J9 NAT MED
JI Nat. Med.
PD JUL
PY 2016
VL 22
IS 7
BP 744
EP 753
DI 10.1038/nm.4107
PG 10
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA DQ7DK
UT WOS:000379366900013
PM 27213815
DA 2024-02-19
ER

PT J
AU BERGMANN, P
   MILITZER, K
   SCHMIDT, P
   BUTTNER, D
AF BERGMANN, P
   MILITZER, K
   SCHMIDT, P
   BUTTNER, D
TI SEX-DIFFERENCES IN AGE DEVELOPMENT OF A MOUSE INBRED STRAIN -
   BODY-COMPOSITION, ADIPOCYTE SIZE AND ORGAN WEIGHTS OF LIVER, HEART AND
   MUSCLES
SO LABORATORY ANIMALS
LA English
DT Article
DE MOUSE; ONTOGENY; BODY WEIGHT; BODY COMPOSITION; ORGAN WEIGHTS; SEX
   DIMORPHISM
ID MICE; FAT; GROWTH
AB The mouse inbred strain HLG has only recently been submitted for international registration. It has been widely used in radiological studies. Since these mice tend to become obese, they may be of interest for studies concerning fat metabolism. Therefore, the present ageing study examines the sex-specific development of body weight, body composition, adipocyte size as well as the organ weight of liver, heart and thigh muscles of the inbred strain HLG (54 males/53 virgin females) between day 40 and 360 of life.
   The body weight development showed a distinct sexual dimorphism, quickly increasing in the case of males but comparatively protracted in females until maturity. Significantly higher values for body and fat-free dry weight as well as body water were found in males of all ages. Body fat and adipocyte diameter were only higher in the 80 and 120 day-old males. Thus, the increase in female body weight resulted largely through a rise in body fat as additionally evidenced by the sex-specific correlation of characteristics. A 2-fold analysis of variance showed sex differences in the relative weights of liver and muscle, but not of the heart. A sex-specific close correlation was observed between body and liver weights in males until day 180. Correlations between body fat and other characteristics were only rarely found. Differences in coefficients of variation largely depended on the characteristics. A higher variability was also found for some characteristics in the youngest groups (40 days). A sex-specific difference was only seen in the case of body fat content for 60 day-old mice (female>male).
RP BERGMANN, P (corresponding author), UNIV ESSEN GESAMTHSCH,CENT ANIM LAB,HUFELANDSTR 55,D-45122 ESSEN,GERMANY.
CR DAWSON NJ, 1970, COMP BIOCHEM PHYSIOL, V37, P589, DOI 10.1016/0010-406X(70)90104-0
   DIGIROLAMO M, 1971, AM J PHYSIOL, V221, P850, DOI 10.1152/ajplegacy.1971.221.3.850
   EISEN EJ, 1981, GROWTH, V45, P100
   EISEN EJ, 1978, J NUTR, V108, P1652, DOI 10.1093/jn/108.10.1652
   GARTNER K, 1978, DEUT TIERARZTL WOCH, V85, P245
   GARTNER K, 1976, Z VERSUCHSTIERKD, V18, P148
   HASTINGS IM, 1991, GENET RES, V58, P253, DOI 10.1017/S0016672300030007
   HERGENROEDER AC, 1990, PEDIATR CLIN N AM, V37, P1057
   Jackson CM, 1913, AM J ANAT, V15, P1, DOI 10.1002/aja.1000150102
   KLOTING I, 1986, Z VERSUCHSTIERKD, V28, P59
   KLUGE R, 1982, Z VERSUCHSTIERKD, V24, P149
   MARTIN R, 1979, GROWTH, V43, P167
   MCKINNEY TD, 1973, BIOL REPROD, V9, P279, DOI 10.1093/biolreprod/9.3.279
   MILITZER K, 1990, EXP PATHOL-JENA, V40, P139, DOI 10.1016/S0232-1513(11)80337-3
   RAPP KG, 1991, QUALITATSKRITERIEN V, P149
   RODBELL M, 1964, J BIOL CHEM, V239, P375
   SCHAFER A, 1970, Biologisches Zentralblatt, V89, P751
   SCOTELLARO PA, 1991, MED SCI SPORT EXER, V23, P275, DOI 10.1249/00005768-199103000-00002
   SOLOMON S, 1973, BIOL NEONATE, V22, P222, DOI 10.1159/000240555
   1985, LISTE ERREGEM SPEZIF
NR 20
TC 24
Z9 26
U1 0
U2 3
PU ROYAL SOC MEDICINE SERVICES LTD
PI LONDON
PA 1 WIMPOLE STREET, LONDON, ENGLAND W1M 8AE
SN 0023-6772
J9 LAB ANIM
JI Lab. Anim.
PD JAN
PY 1995
VL 29
IS 1
BP 102
EP 109
DI 10.1258/002367795780740447
PG 8
WC Veterinary Sciences; Zoology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Veterinary Sciences; Zoology
GA QC738
UT WOS:A1995QC73800013
PM 7707674
DA 2024-02-19
ER

PT J
AU Chu, MW
   Siegmund, KD
   Eckstam, CL
   Kim, JY
   Yang, AS
   Kanel, GC
   Tavaré, S
   Shibata, D
AF Chu, Michelle W.
   Siegmund, Kimberly D.
   Eckstam, Carrie L.
   Kim, Jung Yeon
   Yang, Allen S.
   Kanel, Gary C.
   Tavare, Simon
   Shibata, Darryl
TI Lack of increases in methylation at three CpG-rich genomic loci in
   non-mitotic adult tissues during aging
SO BMC MEDICAL GENETICS
LA English
DT Article
ID STEM-CELLS; CANCER; AGE; DIVISIONS; KIDNEY; GROWTH
AB Background: Cell division occurs during normal human development and aging. Despite the likely importance of cell division to human pathology, it has been difficult to infer somatic cell mitotic ages (total numbers of divisions since the zygote) because direct counting of lifetime numbers of divisions is currently impractical. Here we attempt to infer relative mitotic ages with a molecular clock hypothesis. Somatic genomes may record their mitotic ages because greater numbers of replication errors should accumulate after greater numbers of divisions. Mitotic ages will vary between cell types if they divide at different times and rates.
   Methods: Age-related increases in DNA methylation at specific CpG sites (termed "epigenetic molecular clocks") have been previously observed in mitotic human epithelium like the intestines and endometrium. These CpG rich sequences or "tags" start unmethylated and potentially changes in methylation during development and aging represent replication errors. To help distinguish between mitotic versus time-associated changes, DNA methylation tag patterns at 8-20 CpGs within three different genes, two on autosomes and one on the X-chromosome were measured by bisulfite sequencing from heart, brain, kidney and liver of autopsies from 21 individuals of different ages.
   Results: Levels of DNA methylation were significantly greater in adult compared to fetal or newborn tissues for two of the three examined tags. Consistent with the relative absence of cell division in these adult tissues, there were no significant increases in tag methylation after infancy.
   Conclusion: Many somatic methylation changes at certain CpG rich regions or tags appear to represent replication errors because this methylation increases with chronological age in mitotic epithelium but not in non-mitotic organs. Tag methylation accumulates differently in different tissues, consistent with their expected genealogies and mitotic ages. Although further studies are necessary, these results suggest numbers of divisions and ancestry are at least partially recorded by epigenetic replication errors within somatic cell genomes.
C1 Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA.
   Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA.
   Univ So Calif, Keck Sch Med, Dept Med, Los Angeles, CA 90033 USA.
   Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA.
   Univ Cambridge, Dept Oncol, Cambridge, England.
   Inje Univ Sanggye, Paik Hosp, Dept Pathol, Seoul, South Korea.
C3 University of Southern California; University of Southern California;
   University of Southern California; University of Southern California;
   University of Cambridge; Inje University
RP Shibata, D (corresponding author), Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA.
EM waichu@usc.edu; kims@usc.edu; carrieeckstam@gmail.com;
   pck2973@unitel.co.kr; yang_a@ccnt.hsc.usc.edu; gckanel@aol.com;
   stavare@usc.edu; dshibata@usc.edu
RI Siegmund, Kim/JQJ-5136-2023
FU NCI NIH HHS [CA11194, R33 CA111940] Funding Source: Medline
CR Anversa P, 2002, NATURE, V415, P240, DOI 10.1038/415240a
   Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102
   Bromham L, 2003, NAT REV GENET, V4, P216, DOI 10.1038/nrg1020
   DOBBING J, 1973, ARCH DIS CHILD, V48, P757, DOI 10.1136/adc.48.10.757
   Frumkin D, 2005, PLOS COMPUT BIOL, V1, P382, DOI 10.1371/journal.pcbi.0010050
   Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7
   Greenbaum LE, 2004, CANCER BIOL THER, V3, P1200, DOI 10.4161/cbt.3.12.1392
   HOLLIDAY R, 1987, SCIENCE, V238, P163, DOI 10.1126/science.3310230
   Issa JP, 2000, CURR TOP MICROBIOL, V249, P101
   Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947
   KASISKE BL, 1987, KIDNEY INT, V31, P1153, DOI 10.1038/ki.1987.122
   Kay H. E., 1965, LANCET, V286, P418, DOI 10.1016/S0140-6736(65)90763-4
   Kim JY, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-10
   Kim JY, 2005, P NATL ACAD SCI USA, V102, P17739, DOI 10.1073/pnas.0503976102
   Kim JY, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-2
   KOMURO I, 1993, P NATL ACAD SCI USA, V90, P8145, DOI 10.1073/pnas.90.17.8145
   Menè P, 2003, J NEPHROL, V16, P186
   Mollaaghababa R, 2003, ONCOGENE, V22, P3024, DOI 10.1038/sj.onc.1206442
   Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114
   POTTEN CS, 1990, DEVELOPMENT, V110, P1001
   Salipante SJ, 2006, P NATL ACAD SCI USA, V103, P5448, DOI 10.1073/pnas.0601265103
   SCHOLZ DG, 1988, MAYO CLIN PROC, V63, P126, DOI 10.1016/S0025-6196(12)64945-3
   Sell S, 2001, HEPATOLOGY, V33, P738, DOI 10.1053/jhep.2001.21900
   Shibata D, 2006, CELL CYCLE, V5, P610, DOI 10.4161/cc.5.6.2570
   Velicescu M, 2002, CANCER RES, V62, P2378
   Wang TL, 2002, P NATL ACAD SCI USA, V99, P3076, DOI 10.1073/pnas.261714699
   Woese C, 1998, P NATL ACAD SCI USA, V95, P6854, DOI 10.1073/pnas.95.12.6854
   Yatabe Y, 2001, P NATL ACAD SCI USA, V98, P10839, DOI 10.1073/pnas.191225998
NR 28
TC 31
Z9 33
U1 0
U2 6
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2350
J9 BMC MED GENET
JI BMC Med. Genet.
PD JUL 31
PY 2007
VL 8
AR 50
DI 10.1186/1471-2350-8-50
PG 10
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 203BM
UT WOS:000248950100002
PM 17672908
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Bai, KK
   Hong, BH
   Hong, Z
   Sun, JP
   Wang, CS
AF Bai, Kaikai
   Hong, Bihong
   Hong, Zhuan
   Sun, Jipeng
   Wang, Changsen
TI Selenium nanoparticles-loaded chitosan/citrate complex and its
   protection against oxidative stress in D-galactose-induced aging mice
SO JOURNAL OF NANOBIOTECHNOLOGY
LA English
DT Article
DE Selenium; Nano; Chitosan; Citrate; Oxidative stress
ID ELEMENTAL SELENIUM; NANO-SE; CELLULAR UPTAKE; IN-VITRO; ANTICANCER
   EFFICACY; SURFACE DECORATION; CONTROLLED-RELEASE; TOXICITY;
   ACCUMULATION; METABOLISM
AB Background: Selenium (Se) is an indispensable trace element required for animals and humans, and extra Se-supplement is necessary, especially for those having Se deficiency. Recently, selenium nanoparticles (SeNPs), as a special form of Se supplement, have attracted worldwide attention due to their distinguished properties and excellent bioactivities. In this present study, an eco-friendly and economic way to prepare stable SeNPs was introduced. SeNPs were synthesized in the presence of chitosan (CTS) and then embedded into chitosan/citrate gel, generating selenium nanoparticles-loaded chitosan/citrate complex (SeNPs-C/C). Additionally, the clinical potential of SeNPs-C/C was evaluated by using D-galactose (D-gal)-induced aging mice model.
   Results: SeNPs in high uniform with an average diameter of around 50 nm were synthesized in the presence of chitosan, and reversible ionic gelation between chitosan and citrate was utilized to load SeNPs. Subsphaeroidal SeNPsC/C microspheres of 1-30 mu m were obtained by spay-drying. Single SeNPs were physically separated and embedded inside SeNPs-C/C microparticles, with excellent stability and acceptable release. Acute fetal test showed SeNPs-C/C was safer than selenite, with a median lethal dose (LD50) of approximately 4-fold to 11-fold of that of selenite. Oral administration of SeNPs-C/C remarkably retarded the oxidative stress of D-gal in Kunming mice by enhancing the activity of antioxidase, as evidenced by its significant protection of the growth, liver, Se retention and antioxidant biomarkers of mice against D-gal.
   Conclusions: The design of SeNPs-C/C opens a new path for oral delivery of SeNPs with excellent stability, energy-conservation and environment-friendliness. SeNPs-C/C, as a novel supplement of Se, could be further developed to defend the aging process induced by D-gal.
C1 [Bai, Kaikai; Hong, Bihong; Hong, Zhuan; Sun, Jipeng; Wang, Changsen] State Ocean Adm, Inst Oceanog 3, Xiamen 361005, Peoples R China.
   [Bai, Kaikai; Hong, Bihong; Hong, Zhuan; Sun, Jipeng] State Ocean Adm, Engn Res Ctr Marine Biol Resource Comprehens Util, Xiamen 361005, Peoples R China.
C3 Third Institute of Oceanography, Ministry of Natural Resources
RP Bai, KK (corresponding author), State Ocean Adm, Inst Oceanog 3, Xiamen 361005, Peoples R China.
EM kkbai@tio.org.cn
FU Scientific and Technological Projects of Fujian Province, People's
   Republic of China [2016N0018]; Scientific Research Foundation of Third
   Institute of Oceanography, State Oceanic Administration, People's
   Republic of China [2014010]; Science & Technology Major Projects of
   Fujian province [2014NZ0001]; Xiamen Oceanic Research and Development
   Institute; Public Science & Technology Research Funds Project of Ocean
   [201405016]; Southern Ocean Research Center Project of Xiamen
   [13GYY001NF05]; Fujian Collaborative Innovation Center for Exploitation
   and Utilization of Marine Biological Resources, Third Institute of
   Oceanography, State Oceanic Administration, Xiamen, Fujian, People's
   Republic of China
FX This work was supported by grants from Scientific and Technological
   Projects of Fujian Province, People's Republic of China (No. 2016N0018),
   the Scientific Research Foundation of Third Institute of Oceanography,
   State Oceanic Administration, People's Republic of China (No. 2014010),
   the Science & Technology Major Projects of Fujian province (No.
   2014NZ0001) and the co-sponsored Project by Xiamen Oceanic Research and
   Development Institute. The authors also thank the support from the
   Public Science & Technology Research Funds Project of Ocean (No.
   201405016), Southern Ocean Research Center Project of Xiamen (No.
   13GYY001NF05) and Fujian Collaborative Innovation Center for
   Exploitation and Utilization of Marine Biological Resources, Third
   Institute of Oceanography, State Oceanic Administration, Xiamen, Fujian,
   People's Republic of China.
CR Blessy M, 2014, J Pharm Anal, V4, P159, DOI 10.1016/j.jpha.2013.09.003
   Bliss CI, 1935, ANN APPL BIOL, V22, P134, DOI 10.1111/j.1744-7348.1935.tb07713.x
   Chen T, 2008, COLLOID SURFACE B, V67, P26, DOI 10.1016/j.colsurfb.2008.07.010
   Dai HC, 2007, ASIAN AUSTRAL J ANIM, V20, P850, DOI 10.5713/ajas.2007.850
   Dhanjal S, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-52
   Dufailly V, 2006, ANAL CHIM ACTA, V565, P214, DOI 10.1016/j.aca.2006.02.046
   Feng YX, 2014, DALTON T, V43, P1854, DOI 10.1039/c3dt52468j
   Gao XY, 2002, ADV MATER, V14, P290, DOI 10.1002/1521-4095(20020219)14:4<290::AID-ADMA290>3.0.CO;2-U
   Hong WZ, 2005, J BIOL CHEM, V280, P27029, DOI 10.1074/jbc.M503934200
   Hu CH, 2012, ANIM FEED SCI TECH, V177, P204, DOI 10.1016/j.anifeedsci.2012.08.010
   Huang B, 2003, FREE RADICAL BIO MED, V35, P805, DOI 10.1016/S0891-5849(03)00428-3
   HUGHES J, 1990, Biotechnology Techniques, V4, P55, DOI 10.1007/BF00156611
   Kong HL, 2014, INT J BIOL MACROMOL, V65, P155, DOI 10.1016/j.ijbiomac.2014.01.011
   Langi B, 2010, MATER RES BULL, V45, P668, DOI 10.1016/j.materresbull.2010.03.005
   Lee S, 2009, CARBOHYD RES, V344, P260, DOI 10.1016/j.carres.2008.10.023
   Lei LH, 2016, J CHIN MED ASSOC, V79, P205, DOI 10.1016/j.jcma.2015.06.023
   Li Q, 2010, MATER LETT, V64, P614, DOI 10.1016/j.matlet.2009.12.019
   Loeschner K, 2014, METALLOMICS, V6, P330, DOI 10.1039/c3mt00309d
   Loftsson T, 2014, DRUG STABILITY FOR PHARMACEUTICAL SCIENTISTS, P121
   Manda K, 2003, BIOGERONTOLOGY, V4, P133, DOI 10.1023/A:1024102007763
   Navarro-Alarcon M, 2008, SCI TOTAL ENVIRON, V400, P115, DOI 10.1016/j.scitotenv.2008.06.024
   Newton RG, 1973, CHAPTER 2 SPHERICALL, P30
   Peng DG, 2007, J INORG BIOCHEM, V101, P1457, DOI 10.1016/j.jinorgbio.2007.06.021
   Ramamurthy C, 2013, BIOPROC BIOSYST ENG, V36, P1131, DOI 10.1007/s00449-012-0867-1
   Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001
   Rivera Gil P, 2010, ACS NANO, V4, P5527, DOI 10.1021/nn1025687
   Rivera Gil P, 2010, PHARMACOL RES, V62, P115, DOI 10.1016/j.phrs.2010.01.009
   Rivera-Gil P, 2013, ACCOUNTS CHEM RES, V46, P743, DOI 10.1021/ar300039j
   Rowntree JE, 2004, J ANIM SCI, V82, P2995
   Sharma G, 2014, MOLECULES, V19, P2761, DOI 10.3390/molecules19032761
   Shi LG, 2011, SMALL RUMINANT RES, V96, P49, DOI 10.1016/j.smallrumres.2010.11.005
   Shirazi AN, 2014, MOL PHARMACEUT, V11, P3631, DOI 10.1021/mp500364a
   Shu XZ, 2001, INT J PHARM, V212, P19, DOI 10.1016/S0378-5173(00)00582-2
   Shu XZ, 2002, INT J PHARM, V233, P217, DOI 10.1016/S0378-5173(01)00943-7
   Spanilá M, 2006, J SEP SCI, V29, P2234, DOI 10.1002/jssc.200500461
   Tian Y, 2011, FOOD CHEM TOXICOL, V49, P1728, DOI 10.1016/j.fct.2011.04.018
   Tran Phong A, 2011, Int J Nanomedicine, V6, P1553, DOI 10.2147/IJN.S21729
   Vyskocilova E., 2013, BIOMED RES INT, V2, P199
   Wang H, 2005, J PINEAL RES, V39, P156, DOI 10.1111/j.1600-079X.2005.00231.x
   Wang HL, 2007, FREE RADICAL BIO MED, V42, P1524, DOI 10.1016/j.freeradbiomed.2007.02.013
   Wickens AP, 2001, RESP PHYSIOL, V128, P379, DOI 10.1016/S0034-5687(01)00313-9
   Wu DM, 2008, NEUROBIOL LEARN MEM, V90, P19, DOI 10.1016/j.nlm.2008.01.010
   Wu SS, 2013, J AGR FOOD CHEM, V61, P7268, DOI 10.1021/jf4000083
   Wu Y, 2005, INT J PHARMACEUT, V295, P235, DOI 10.1016/j.ijpharm.2005.01.042
   Xia YY, 2007, MATER LETT, V61, P4321, DOI 10.1016/j.matlet.2007.01.095
   Yang F, 2012, INT J NANOMED, V7, P835, DOI 10.2147/IJN.S28278
   Yazdi MH, 2012, BIOL TRACE ELEM RES, V149, P22, DOI 10.1007/s12011-012-9402-0
   Yu B, 2012, INORG CHEM, V51, P8956, DOI 10.1021/ic301050v
   Zhang CY, 2015, CARBOHYD POLYM, V134, P158, DOI 10.1016/j.carbpol.2015.07.065
   Zhang ES, 2005, LIFE SCI, V76, P1099, DOI 10.1016/j.lfs.2004.08.015
   Zhang JS, 2008, TOXICOL SCI, V101, P22, DOI 10.1093/toxsci/kfm221
   Zhang SY, 2004, MATER LETT, V58, P2590, DOI 10.1016/j.matlet.2004.03.031
   Zhang YB, 2013, NANOMED-NANOTECHNOL, V9, P74, DOI 10.1016/j.nano.2012.04.002
   Zhang ZF, 2009, FOOD CHEM TOXICOL, V47, P496, DOI 10.1016/j.fct.2008.12.005
   Zheng GQ, 2016, J FUNCT FOODS, V27, P310, DOI 10.1016/j.jff.2016.09.015
   Zheng JS, 2011, COLLOID SURFACE B, V83, P183, DOI 10.1016/j.colsurfb.2010.11.023
   Zhou XX, 2013, PHYTOCHEM LETT, V6, P372, DOI 10.1016/j.phytol.2013.05.002
   Zhu YJ, 2004, MATER LETT, V58, P1234, DOI 10.1016/j.matlet.2003.09.044
NR 58
TC 42
Z9 44
U1 4
U2 58
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1477-3155
J9 J NANOBIOTECHNOL
JI J. Nanobiotechnol.
PD DEC 20
PY 2017
VL 15
AR 92
DI 10.1186/s12951-017-0324-z
PG 14
WC Biotechnology & Applied Microbiology; Nanoscience & Nanotechnology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Science & Technology - Other
   Topics
GA FR1ZW
UT WOS:000418867600001
PM 29262862
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Cheung, SY
   Choi, HL
   James, AE
   Chen, ZY
   Huang, Y
   Chan, FL
AF Cheung, SY
   Choi, HL
   James, AE
   Chen, ZY
   Huang, Y
   Chan, FL
TI Spontaneous mammary tumors in aging Noble rats
SO INTERNATIONAL JOURNAL OF ONCOLOGY
LA English
DT Article
DE spontaneous mammary tumors; mammary gland; Noble rat; tumor incidence
ID SPONTANEOUS NEOPLASMS; NONNEOPLASTIC LESIONS; WISTAR RATS; FEMALE RATS;
   NB RATS; GLAND; ESTROGEN; CARCINOGENESIS; SUSCEPTIBILITY; ENDOCRINE
AB Noble (Nb) rat strain has been used for the study of hormonal carcinogenesis of mammary and prostate glands, for its susceptibility to develop premalignant lesions as well as carcinomas in these organs by sex hormones. However, background information on the spontaneously developed mammary tumors in this rat strain is scarce. We report on the incidence rate, latency period and histopathology of mammary tumors spontaneously developed in the senile intact and untreated Nb rats compared with those induced by either combined treatments with sex steroids or 7,12-dimethylbenz[a]anthracene (DMBA) in the same rat strain. We observed that the incidence rate of spontaneous mammary tumors was 45% in female Nb rats and 3% in the males. The average age of the female Nb rats to develop palpable tumors was 14 months and rarely detected in animals less than 12 months old. It was also noted that the incidence rate of the spontaneous mammary tumors was similar to those induced by combined treatments with sex steroids for 8-10 months (46.7% for T+E-2 and 55.6% for T+DES) but less than those by DMBA treatment in 8 months (over 80%). Histologically, majority of the spontaneous mammary tumors were fibroadenomas, which comprised 70% of all collected tumors and about 20% were carcinomas whereas tumors induced by steroid hormones and DMBA were all carcinomas. Distant metastases of spontaneous mammary carcinomas to lung, liver and lymph nodes were also noted, but rarely.
C1 Chinese Univ Hong Kong, Fac Med, Dept Anat, Shatin, Hong Kong, Peoples R China.
   Chinese Univ Hong Kong, Fac Med, Dept Biochem, Shatin, Hong Kong, Peoples R China.
   Chinese Univ Hong Kong, Fac Med, Dept Physiol, Shatin, Hong Kong, Peoples R China.
   Chinese Univ Hong Kong, Fac Med, Lab Anim Serv Ctr, Shatin, Hong Kong, Peoples R China.
C3 Chinese University of Hong Kong; Chinese University of Hong Kong;
   Chinese University of Hong Kong; Chinese University of Hong Kong
RP Chan, FL (corresponding author), Chinese Univ Hong Kong, Fac Med, Dept Anat, Shatin, Hong Kong, Peoples R China.
EM franky-chan@cuhk.edu.hk
RI Chan, Franky L./M-1043-2018; Huang, Yu/K-2866-2017
OI Chan, Franky L./0000-0003-0567-2052; Huang, Yu/0000-0002-1277-6784;
   Chen, Zhen-Yu/0000-0001-5615-1682
CR Andersen ME, 1997, J TOXICOL ENV HEALTH, V52, P189, DOI 10.1080/009841097159656
   Attia MA, 1996, ARCH TOXICOL, V70, P461, DOI 10.1007/s002040050300
   BOVEN E, 1991, NUDE MOUSE ONCOLOGY, P89
   CHAN FL, 1995, HISTOCHEM CELL BIOL, V104, P369, DOI 10.1007/BF01458131
   CHANDRA M, 1992, CANCER LETT, V62, P49, DOI 10.1016/0304-3835(92)90197-4
   CHANDRA M, 1992, ARCH TOXICOL, V66, P496, DOI 10.1007/BF01970675
   COLERANGLE JB, 1995, CANCER LETT, V94, P55, DOI 10.1016/0304-3835(95)03824-G
   CUTTS JH, 1964, CANCER RES, V24, P1116
   DUNNING WF, 1947, CANCER RES, V7, P511
   DURBIN PW, 1966, CANCER RES, V26, P400
   Eiben R, 1999, EXP TOXICOL PATHOL, V51, P523, DOI 10.1016/S0940-2993(99)80133-X
   GOODMAN DG, 1979, TOXICOL APPL PHARM, V48, P237, DOI 10.1016/0041-008X(79)90029-2
   GOULD MN, 1991, ENVIRON HEALTH PERSP, V93, P161, DOI 10.2307/3431184
   HAAG JD, 1992, CARCINOGENESIS, V13, P1933, DOI 10.1093/carcin/13.10.1933
   Harvell DME, 2000, P NATL ACAD SCI USA, V97, P2779, DOI 10.1073/pnas.050569097
   Haseman JK, 1998, TOXICOL PATHOL, V26, P428, DOI 10.1177/019262339802600318
   HOLLAND MB, 1995, CARCINOGENESIS, V16, P1955, DOI 10.1093/carcin/16.8.1955
   ISAACS JT, 1986, CANCER RES, V46, P3958
   KOMITOWSKI D, 1982, J NATL CANCER I, V68, P147
   Kwong J, 2000, PROSTATE, V42, P219, DOI 10.1002/(SICI)1097-0045(20000215)42:3<219::AID-PROS8>3.0.CO;2-J
   LEAV I, 1989, PROSTATE, V15, P23, DOI 10.1002/pros.2990150104
   LEAV I, 1988, J NATL CANCER I, V80, P1045, DOI 10.1093/jnci/80.13.1045
   Li SC, 2001, PROSTATE, V49, P58, DOI 10.1002/pros.1118
   Liao DZJ, 1998, CARCINOGENESIS, V19, P2173, DOI 10.1093/carcin/19.12.2173
   LU KH, 1979, BIOL REPROD, V21, P193, DOI 10.1095/biolreprod21.1.193
   MAEKAWA A, 1986, JPN J CANCER RES, V77, P882
   MAEKAWA A, 1975, J NATL CANCER I, V55, P1437, DOI 10.1093/jnci/55.6.1437
   MAEKAWA A, 1983, JPN J CANCER RES, V74, P365
   MARSELOS M, 1993, EUR J CANCER, V29A, P149, DOI 10.1016/0959-8049(93)90597-9
   Nagaoka T, 2000, JPN J CANCER RES, V91, P375, DOI 10.1111/j.1349-7006.2000.tb00955.x
   NAGAOKA T, 1990, J CANCER RES CLIN, V116, P623, DOI 10.1007/BF01637084
   NAGASAWA H, 1982, ACTA ENDOCRINOL-COP, V101, P51, DOI 10.1530/acta.0.1010051
   NOBLE RL, 1977, CANCER RES, V37, P82
   NOBLE RL, 1982, INT REV EXP PATHOL, V23, P113
   NOBLE RL, 1959, CANCER RES, V19, P1125
   NOBLE RL, 1975, CANCER RES, V35, P766
   OKADA M, 1981, BRIT J CANCER, V43, P689, DOI 10.1038/bjc.1981.100
   Poteracki J, 1998, TOXICOL SCI, V45, P1
   PREJEAN JD, 1973, CANCER RES, V33, P2768
   Russo J, 1996, BREAST CANCER RES TR, V39, P7, DOI 10.1007/BF01806074
   RUSSO J, 1990, LAB INVEST, V62, P244
   Russo J, 1990, IARC Sci Publ, P47
   Russo J, 2000, J MAMMARY GLAND BIOL, V5, P187, DOI 10.1023/A:1026443305758
   Russo J, 1989, MONOGRAPHS PATHOLOGY, P275
   SACKSTEDER MR, 1976, J NATL CANCER I, V57, P1371, DOI 10.1093/jnci/57.6.1371
   SASS B, 1975, J NATL CANCER I, V54, P1449, DOI 10.1093/jnci/54.6.1449
   Shepel L A, 1999, Prog Exp Tumor Res, V35, P158
   SHER SP, 1972, TOXICOL APPL PHARM, V22, P562, DOI 10.1016/0041-008X(72)90285-2
   Shull JD, 1997, CARCINOGENESIS, V18, P1595, DOI 10.1093/carcin/18.8.1595
   THOMPSON SW, 1961, J NATL CANCER I, V27, P1037
   Vonderhaar BK, 1999, ENDOCR-RELAT CANCER, V6, P389, DOI 10.1677/erc.0.0060389
   WALSH KM, 1994, FUND APPL TOXICOL, V22, P65, DOI 10.1006/faat.1994.1009
   WELSCH CW, 1970, CANCER RES, V30, P2310
   WELSCH CW, 1985, CANCER RES, V45, P3415
   WELSCH CW, 1977, CANCER RES, V37, P951
   Xie B, 1999, CARCINOGENESIS, V20, P1597, DOI 10.1093/carcin/20.8.1597
   Xie B, 1999, CARCINOGENESIS, V20, P1069, DOI 10.1093/carcin/20.6.1069
NR 57
TC 2
Z9 2
U1 0
U2 4
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1019-6439
EI 1791-2423
J9 INT J ONCOL
JI Int. J. Oncol.
PD FEB
PY 2003
VL 22
IS 2
BP 449
EP 457
PG 9
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA 638AW
UT WOS:000180547500029
PM 12527947
DA 2024-02-19
ER

PT J
AU Ortmeyer, HK
   Sajan, MP
   Miura, A
   Kanoh, Y
   Rivas, J
   Li, YX
   Standaert, ML
   Ryan, AS
   Bodkin, NL
   Farese, RV
   Hansen, BC
AF Ortmeyer, Heidi K.
   Sajan, Mini P.
   Miura, Atsushi
   Kanoh, Yoshinore
   Rivas, Jose
   Li, Yongxiang
   Standaert, Mary L.
   Ryan, Alice S.
   Bodkin, Noni L.
   Farese, Robert V.
   Hansen, Barbara C.
TI Insulin Signaling and Insulin Sensitizing in Muscle and Liver of Obese
   Monkeys: Peroxisome Proliferator-Activated Receptor Gamma Agonist
   Improves Defective Activation of Atypical Protein Kinase C
SO ANTIOXIDANTS & REDOX SIGNALING
LA English
DT Article
ID STIMULATED GLUCOSE-TRANSPORT; GLYCOGEN-SYNTHASE ACTIVITY; NF-KAPPA-B;
   SKELETAL-MUSCLE; RHESUS-MONKEYS; CALORIE RESTRICTION; PHOSPHOINOSITIDE
   3-KINASE; PPAR-GAMMA; PHOSPHATIDYLINOSITOL 3-KINASE; DEPENDENT
   ACTIVATION
AB Obesity, the metabolic syndrome, and aging share several pathogenic features in both humans and non-human primates, including insulin resistance and inflammation. Since muscle and liver are considered key integrators of metabolism, we sought to determine in biopsies from lean and obese aging rhesus monkeys the nature of defects in insulin activation and, further, the potential for mitigation of such defects by an in vivo insulin sensitizer, rosiglitazone, and a thiazolidinedione activator of the peroxisome proliferator-activated receptor gamma. The peroxisome proliferator-activated receptor gamma agonist reduced hyperinsulinemia, improved insulin sensitivity, lowered plasma triglycerides and free fatty acids, and increased plasma adiponectin. In muscle of obese monkeys, previously shown to exhibit defective insulin signaling, the insulin sensitizer improved insulin activation of atypical protein kinase C (aPKC), the defective direct activation of aPKC by phosphatidylinositol (PI)-3,4,5-(PO4)(3), and 5'-AMP-activated protein kinase and increased carnitine palmitoyltransferase-1 mRNA expression, but it did not improve insulin activation of insulin receptor substrate (IRS)-1-dependent PI 3-kinase (IRS-1/PI3K), protein kinase B, or glycogen synthase. We found that, although insulin signaling was impaired in muscle, insulin activation of IRS-1/PI3K, IRS-2/PI3K, protein kinase B, and aPKC was largely intact in liver and that rosiglitazone improved insulin signaling to aPKC in muscle by improving responsiveness to PI-3,4,5-(PO4)(3). Antioxid. Redox Signal. 14, 207-219.
C1 [Ortmeyer, Heidi K.; Bodkin, Noni L.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA.
   [Ryan, Alice S.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA.
   [Ortmeyer, Heidi K.; Ryan, Alice S.] Ctr Geriatr Res Educ & Clin, Baltimore Dept Veteran Affairs Med Ctr, Baltimore, MD USA.
   [Sajan, Mini P.; Li, Yongxiang; Standaert, Mary L.; Farese, Robert V.] James A Haley Vet Hosp, Res Serv, Baltimore, MD USA.
   [Sajan, Mini P.; Rivas, Jose; Li, Yongxiang; Standaert, Mary L.; Farese, Robert V.; Hansen, Barbara C.] Univ S Florida, Dept Internal Med, Tampa, FL 33612 USA.
   [Miura, Atsushi; Kanoh, Yoshinore] Gifu Univ, Sch Med, Dept Internal Med 3, Gifu 500, Japan.
   [Hansen, Barbara C.] Univ S Florida, Coll Med, Dept Pediat, Tampa, FL 33612 USA.
C3 University System of Maryland; University of Maryland Baltimore;
   University System of Maryland; University of Maryland Baltimore;
   Geriatric Research Education & Clinical Center; State University System
   of Florida; University of South Florida; Gifu University; State
   University System of Florida; University of South Florida
RP Hansen, BC (corresponding author), Univ S Florida, Coll Med, Dept Internal Med, 801 6th St S 9340, St Petersburg, FL 33701 USA.
EM bchansen@aol.com
RI Farese, Robert V/B-3605-2015; Hansen, Barbara C/J-8723-2012; li,
   yongxiang/GPW-6930-2022; Ortmeyer, Heidi K/AAM-9223-2021; li,
   yong/HDN-3885-2022
OI Hansen, Barbara C/0000-0001-9646-3525; Ortmeyer, Heidi
   K/0000-0002-9376-7029; 
FU National Institutes of Health [HHSN26320800022C, RO1-AG-1-9310,
   DK-38079-09A1]; National Institute on Aging (NIA) [NO1-AG-0-2100];
   Department of Veterans Affairs and Veterans Affairs Medical Center
   Baltimore Geriatric Research, Education and Clinical Center (GRECC);
   Claude D. Pepper Older Americans Independence Cente [P30-AG028747];
   NIDDK Mid-Atlantic Nutrition Obesity Research Center [NIH P30 DK072488];
   Veterans Administration Merit Review Program; New England Regional
   Primate Research Center [P51RR00168-40]; GlaxoSmithKline
FX Support was provided by the National Institutes of Health, National
   Institute on Aging NO1-AG-0-2100 (B.C.H., N.L.B., H.K.O.), and NIH
   HHSN26320800022C (B.C.H.) and RO1-AG-1-9310 (A.S.R.); Department of
   Veterans Affairs and Veterans Affairs Medical Center Baltimore Geriatric
   Research, Education and Clinical Center (GRECC) (H.K.O. and A.S.R.); The
   National Institute on Aging (NIA) Claude D. Pepper Older Americans
   Independence Center P30-AG028747 (H.K.O. and A.S.R.); The NIDDK
   Mid-Atlantic Nutrition Obesity Research Center (NIH P30 DK072488)
   (H.K.O. and A.S.R.); Veterans Administration Merit Review Program
   (R.V.F., M.L.S.); NIH DK-38079-09A1 (R.V.F.); and the New England
   Regional Primate Research Center grant P51RR00168-40. Funding for the
   RSGZ portion of this study was provided by GlaxoSmithKline to B.C.H.
CR Bae SS, 2003, J BIOL CHEM, V278, P49530, DOI 10.1074/jbc.M306782200
   Bandyopadhyay G, 2000, ENDOCRINOLOGY, V141, P4120, DOI 10.1210/en.141.11.4120
   Bandyopadhyay G, 1997, J BIOL CHEM, V272, P2551
   Bandyopadhyay G, 2002, J CLIN ENDOCR METAB, V87, P716, DOI 10.1210/jc.87.2.716
   Bandyopadhyay G, 1997, ENDOCRINOLOGY, V138, P4721, DOI 10.1210/en.138.11.4721
   Beeson M, 2003, DIABETES, V52, P1926, DOI 10.2337/diabetes.52.8.1926
   Beeson M, 2004, METAB SYNDR RELAT D, V2, P49, DOI 10.1089/met.2004.2.49
   Bodkin NL, 2003, HORM METAB RES, V35, P617, DOI 10.1055/s-2003-43510
   BODKIN NL, 1993, INT J OBESITY, V17, P53
   BODKIN NL, 1989, AM J PHYSIOL, V256, pE676, DOI 10.1152/ajpendo.1989.256.5.E676
   Chavez AO, 2008, DIABETES, V57, P899, DOI 10.2337/db07-0790
   Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728
   Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635
   Cusi K, 2000, J CLIN INVEST, V105, P311, DOI 10.1172/JCI7535
   Daitoku H, 2003, DIABETES, V52, P642, DOI 10.2337/diabetes.52.3.642
   Ding SY, 2007, METABOLISM, V56, P1334, DOI 10.1016/j.metabol.2007.05.019
   Ding SY, 2007, METABOLISM, V56, P838, DOI 10.1016/j.metabol.2007.01.015
   FOLLI F, 1993, J CLIN INVEST, V92, P1787, DOI 10.1172/JCI116768
   Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200
   Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247
   Gresl TA, 2003, AM J PHYSIOL-REG I, V285, pR1340, DOI 10.1152/ajpregu.00651.2002
   Hansen BC, 2008, CONTEMP ENDOCRINOL S, P373, DOI 10.1007/978-1-60327-116-5_19
   HANSEN BC, 1993, DIABETES, V42, P1809, DOI 10.2337/diabetes.42.12.1809
   Hansen BC, 2004, DIABETES MELLITUS FU, P1060
   Hill MM, 1999, MOL CELL BIOL, V19, P7771
   Hotta K, 1998, INT J OBESITY, V22, P1000, DOI 10.1038/sj.ijo.0800718
   Kanoh Y, 2000, J BIOL CHEM, V275, P16690, DOI 10.1074/jbc.M000287200
   Kanoh Y, 2003, ENDOCRINOLOGY, V144, P947, DOI 10.1210/en.2002-221017
   Kanoh Y, 2001, ENDOCRINOLOGY, V142, P1595, DOI 10.1210/en.142.4.1595
   KEMNITZ JW, 1986, PHYSIOL BEHAV, V38, P477, DOI 10.1016/0031-9384(86)90414-2
   KEMNITZ JW, 1989, J CLIN ENDOCR METAB, V69, P287, DOI 10.1210/jcem-69-2-287
   KEMNITZ JW, 1994, DIABETES, V43, P204, DOI 10.2337/diabetes.43.2.204
   Kim YB, 1999, J CLIN INVEST, V104, P733, DOI 10.1172/JCI6928
   Kim YB, 2002, J BIOL CHEM, V277, P32915, DOI 10.1074/jbc.M204710200
   Kim YB, 2003, DIABETES, V52, P1935, DOI 10.2337/diabetes.52.8.1935
   Kim YB, 2002, DIABETES, V51, P443, DOI 10.2337/diabetes.51.2.443
   Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372
   Kotani K, 1998, MOL CELL BIOL, V18, P6971, DOI 10.1128/MCB.18.12.6971
   Krook A, 1998, DIABETES, V47, pA237
   Lane MA, 1999, TOXICOL SCI, V52, P41, DOI 10.1093/toxsci/52.2.41
   Lane MA, 2000, EXP GERONTOL, V35, P533, DOI 10.1016/S0531-5565(00)00102-9
   Litwak KN, 1998, METABOLISM, V47, P947, DOI 10.1016/S0026-0495(98)90349-3
   Matsumoto M, 2003, J CLIN INVEST, V112, P935, DOI 10.1172/JCI200318816
   Mattison JA, 2003, EXP GERONTOL, V38, P35, DOI 10.1016/S0531-5565(02)00146-8
   Mattison Julie A., 2007, V35, P137
   Mayerson AB, 2002, DIABETES, V51, P797, DOI 10.2337/diabetes.51.3.797
   McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x
   Miura A, 2004, BIOCHEMISTRY-US, V43, P15503, DOI 10.1021/bi049221y
   Moore CM, 2007, AGE, V29, P15, DOI 10.1007/s11357-006-9016-6
   NAITHANI VK, 1984, H-S Z PHYSIOL CHEM, V365, P571, DOI 10.1515/bchm2.1984.365.1.571
   Oliver WR, 2001, P NATL ACAD SCI USA, V98, P5306, DOI 10.1073/pnas.091021198
   Ortmeyer H K, 2000, Int J Exp Diabetes Res, V1, P195, DOI 10.1155/EDR.2000.195
   Ortmeyer H. K., 1997, Journal of Basic and Clinical Physiology and Pharmacology, V8, P223
   Ortmeyer H K, 1994, Obes Res, V2, P549
   Ortmeyer HK, 2005, AM J PHYSIOL-REG I, V288, pR1509, DOI 10.1152/ajpregu.00692.2004
   Ortmeyer HK, 2004, FASEB J, V18, pA95
   Ortmeyer HK, 1998, AM J PHYSIOL-GASTR L, V274, pG1005, DOI 10.1152/ajpgi.1998.274.6.G1005
   ORTMEYER HK, 1993, AM J PHYSIOL, V265, pR552, DOI 10.1152/ajpregu.1993.265.3.R552
   ORTMEYER HK, 1993, DIABETOLOGIA, V36, P200, DOI 10.1007/BF00399950
   ORTMEYER HK, 1994, DIABETOLOGIA, V37, P127, DOI 10.1007/s001250050082
   Ortmeyer HK, 1998, HORM METAB RES, V30, P705, DOI 10.1055/s-2007-978963
   Ortmeyer HK, 1997, AM J PHYSIOL-ENDOC M, V272, pE133, DOI 10.1152/ajpendo.1997.272.1.E133
   ORTMEYER HK, 2002, FRONT ANIM DIAB RES, V4, P285
   Peak M, 1998, DIABETOLOGIA, V41, P16, DOI 10.1007/s001250050861
   Peraldi P, 1997, J CLIN INVEST, V100, P1863, DOI 10.1172/JCI119715
   Raman A, 2005, J GERONTOL A-BIOL, V60, P1518, DOI 10.1093/gerona/60.12.1518
   Roth GS, 2004, SCIENCE, V305, P1423, DOI 10.1126/science.1102541
   Sajan MP, 2009, DIABETOLOGIA, V52, P1197, DOI 10.1007/s00125-009-1336-5
   Sajan MP, 2006, J BIOL CHEM, V281, P17466, DOI 10.1074/jbc.M510803200
   Sajan MP, 2009, J LIPID RES, V50, P1133, DOI 10.1194/jlr.M800520-JLR200
   Sajan MP, 2004, MOL ENDOCRINOL, V18, P2513, DOI 10.1210/me.2004-0045
   Sajan MP, 2004, J CLIN ENDOCR METAB, V89, P3994, DOI 10.1210/jc.2004-0106
   Schmoll D, 2000, J BIOL CHEM, V275, P36324, DOI 10.1074/jbc.M003616200
   Standaert ML, 2004, J BIOL CHEM, V279, P24929, DOI 10.1074/jbc.M402440200
   Standaert ML, 2002, DIABETES, V51, pA312
   Standaert ML, 1997, J BIOL CHEM, V272, P30075, DOI 10.1074/jbc.272.48.30075
   Taniguchi CM, 2006, CELL METAB, V3, P343, DOI 10.1016/j.cmet.2006.04.005
   Tanti JF, 1997, ENDOCRINOLOGY, V138, P2005, DOI 10.1210/en.138.5.2005
   Tremblay F, 2001, DIABETES, V50, pA296
   Ueki K, 2000, J CLIN INVEST, V105, P1437, DOI 10.1172/JCI7656
   Valverde A, 2003, DIABETES, V52, pA17
   Vollenweider P, 2002, DIABETES, V51, P1052, DOI 10.2337/diabetes.51.4.1052
   Wagner JD, 2001, TOXICOL PATHOL, V29, P142, DOI 10.1080/019262301301418955
   Wang QH, 1999, MOL CELL BIOL, V19, P4008
   Winegar DA, 2001, J LIPID RES, V42, P1543
   Wojtaszewski JFP, 2000, J PHYSIOL-LONDON, V528, P221, DOI 10.1111/j.1469-7793.2000.t01-1-00221.x
   Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788
   Ye JM, 2001, DIABETES, V50, P411, DOI 10.2337/diabetes.50.2.411
   Zierath JR, 1998, ENDOCRINOLOGY, V139, P5034, DOI 10.1210/en.139.12.5034
NR 89
TC 9
Z9 9
U1 0
U2 2
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1523-0864
EI 1557-7716
J9 ANTIOXID REDOX SIGN
JI Antioxid. Redox Signal.
PD JAN
PY 2011
VL 14
IS 2
BP 207
EP 219
DI 10.1089/ars.2010.3234
PG 13
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA 695RR
UT WOS:000285390800004
PM 20518698
OA Green Published
DA 2024-02-19
ER

PT J
AU Zhao, JH
   Xu, XY
   Wei, XH
   Zhang, S
   Xu, HF
   Wei, XD
   Zhang, Y
   Zhang, J
AF Zhao, Jinhan
   Xu, Xiaoyi
   Wei, Xinhuan
   Zhang, Shuang
   Xu, Hangfei
   Wei, Xiaodie
   Zhang, Yang
   Zhang, Jing
TI <i>SAMM50</i>-<i>rs2073082</i>, -<i>rs738491</i> and -<i>rs3761472</i>
   Interactions Enhancement of Susceptibility to Non-Alcoholic Fatty Liver
   Disease
SO BIOMEDICINES
LA English
DT Article
DE nonalcoholic fatty liver disease; SAMM50; single nucleotide
   polymorphism; SNP-SNP interactions; aging
ID MITOCHONDRIAL DYSFUNCTION; ENVIRONMENT INTERACTIONS; FIBROSIS;
   ASSOCIATION; GENES
AB Background and aim: Several studies have identified that three SAMM50 polymorphisms (rs2073082, rs738491, rs3761472) are associated with an increased risk of non-alcoholic fatty liver disease (NAFLD). However, the clinical significance of the SAMM50 SNP in relation to NAFLD remains largely unknown. Therefore, we conducted a clinical study and SNP-SNP interaction analysis to further elucidate the effect of the SAMM50 SNP on the progression of NAFLD in the elderly. Methods: A total of 1053 patients over the age of 65 years were recruited. Liver fat and fibrosis were detected by abdominal ultrasound or FibroScan, respectively. Genomic DNA was extracted and then genotyped by Fluidigm 96.96 Dynamic Array. Multivariable logistic regression was used to evaluate the association between NAFLD and SNP. SNP-SNP interactions were analyzed using generalized multivariate dimensionality reduction (GMDR). Results: The risk of NAFLD was substantially higher in people who carried SAMM50-rs2073082 G and -rs738491 T alleles (OR, 1.962; 95% CI, 1.448-2.659; p < 0.001; OR, 1.532; 95% CI, 1.246-1.884; p = 0.021, respectively) compared to noncarriers. Carriers of the rs738491 T and rs3761472 G alleles in the cohort showed a significant increase in liver stiffness measurements (LSM). The combination of the three SNPs showed the highest predictive power for NAFLD. The rs2073082 G allele, rs738491 T allele and rs3761472 G carriers had a two-fold higher risk of NAFLD compared to noncarriers. Conclusions: Our research has demonstrated a strong correlation between the genetic polymorphism of SAMM50 and NAFLD in the elderly, which will contribute to a better understanding of the impact of age and genetics on this condition. Additionally, this study provides a potential predictive model for the early clinical warning of NAFLD.
C1 [Zhao, Jinhan; Xu, Xiaoyi; Wei, Xinhuan; Zhang, Shuang; Xu, Hangfei; Wei, Xiaodie; Zhang, Jing] Capital Med Univ, Beijing Youan Hosp, Dept Hepatol, Unit 3, Beijing 100069, Peoples R China.
   [Zhao, Jinhan; Xu, Xiaoyi; Xu, Hangfei; Zhang, Yang] Capital Med Univ, Beijing Youan Hosp, Beijing Inst Hepatol, Beijing 100069, Peoples R China.
   [Zhang, Shuang] Menkuang Hosp, Beijing Jingmei Grp Gen Hosp, Beijing Energy Holding Co Ltd, Beijing 102399, Peoples R China.
C3 Capital Medical University; Capital Medical University
RP Zhang, J (corresponding author), Capital Med Univ, Beijing Youan Hosp, Dept Hepatol, Unit 3, Beijing 100069, Peoples R China.; Zhang, Y (corresponding author), Capital Med Univ, Beijing Youan Hosp, Beijing Inst Hepatol, Beijing 100069, Peoples R China.
EM zhaojinhan@mail.ccmu.edu.cn; xiaoyixu2020@163.com;
   weixinhuan@mail.ccmu.edu.cn; zhangshuang@ccmu.edu.cn;
   xuhangfei@mail.ccmu.edu.cn; weixiaodie@aliyun.com;
   yang518@mail.ccmu.edu.cn; zjyouan@ccmu.edu.cn
OI Zhang, Yang/0000-0001-7462-2935
FU National Natural Science Foundation of China [82070627]; Beijing
   Municipal Natural Science Foundation [7222090]; Beijing Municipal
   Institute of Public Medical Research Development and Reform Pilot
   Project [2021-10]; Scientific Research Project of Beijing Youan
   Hospital, CCMU [BJYAYY-YN2022-17]; Jiangxi National Science Foundation
   [2020BABL206092]; Capitals's Funds for Health Improvement and Research
   [2022-2Z-2187]
FX This work was supported by the National Natural Science Foundation of
   China (82070627);the Beijing Municipal Natural Science Foundation
   (7222090); the Beijing Municipal Institute of Public Medical Research
   Development and Reform Pilot Project (2021-10); the Scientific Research
   Project of Beijing Youan Hospital, CCMU, 2022 (BJYAYY-YN2022-17); and
   the Jiangxi National Science Foundation(No. 2020BABL206092). Capitals's
   Funds for Health Improvement and Research (2022-2Z-2187).
CR Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8
   Allen AM, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-169
   Amarapurkar D, 2007, ANN HEPATOL, V6, P161, DOI 10.1016/S1665-2681(19)31922-2
   Chalasani N, 2018, HEPATOLOGY, V67, P328, DOI 10.1002/hep.29367
   Chen LZ, 2015, HEPAT MON, V15, DOI 10.5812/hepatmon.31076
   Portela CLD, 2015, NUTR HOSP, V32, P2038, DOI 10.3305/nh.2015.32.5.9674
   Dongiovanni P, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/460190
   Durand M, 2021, OXID MED CELL LONGEV, V2021, DOI 10.1155/2021/9986299
   Eddowes PJ, 2019, GASTROENTEROLOGY, V156, P1717, DOI 10.1053/j.gastro.2019.01.042
   Frith J, 2009, GERONTOLOGY, V55, P607, DOI 10.1159/000235677
   Gieseler RK, 2023, Z GASTROENTEROL, V61, P83, DOI 10.1055/a-1955-5297
   Hamaguchi M, 2005, ANN INTERN MED, V143, P722, DOI 10.7326/0003-4819-143-10-200511150-00009
   Hu YY, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000012931
   Jang HR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23014-0
   Jian FL, 2018, CELL REP, V23, P2989, DOI 10.1016/j.celrep.2018.05.015
   Jonas W, 2020, MOL METAB, V50, DOI 10.1016/j.molmet.2020.101111
   Kitamoto T, 2013, HUM GENET, V132, P783, DOI 10.1007/s00439-013-1294-3
   Kovalic AJ, 2018, J CLIN EXP HEPATOL, V8, P390, DOI 10.1016/j.jceh.2018.04.001
   Kozlitina J, 2014, NAT GENET, V46, P352, DOI 10.1038/ng.2901
   Kruger FC, 2011, SAMJ S AFR MED J, V101, P477
   Lee KJ, 2022, PEDIATR OBES, V17, DOI 10.1111/ijpo.12852
   Li Z, 2021, BIOGERONTOLOGY, V22, P165, DOI 10.1007/s10522-021-09910-5
   Li ZY, 2021, FEBS OPEN BIO, V11, P1893, DOI 10.1002/2211-5463.13146
   Longo M, 2022, CELL MOL GASTROENTER, V13, P759, DOI 10.1016/j.jcmgh.2021.11.007
   Loomba R, 2015, GASTROENTEROLOGY, V149, P1784, DOI 10.1053/j.gastro.2015.08.011
   Lou XY, 2007, AM J HUM GENET, V80, P1125, DOI 10.1086/518312
   Lu R, 2023, DIABETES OBES METAB, V25, P13, DOI 10.1111/dom.15014
   Miwa S, 2022, J CLIN INVEST, V132, DOI 10.1172/JCI158447
   Miyaaki H, 2008, LIVER INT, V28, P519, DOI 10.1111/j.1478-3231.2007.01614.x
   Ong JP, 2008, J HEPATOL, V49, P608, DOI 10.1016/j.jhep.2008.06.018
   Ott C, 2012, MOL CELL BIOL, V32, P1173, DOI 10.1128/MCB.06388-11
   Passos JF, 2007, PLOS BIOL, V5, P1138, DOI 10.1371/journal.pbio.0050110
   Peng KY, 2018, J LIPID RES, V59, P1977, DOI 10.1194/jlr.M085613
   Qiao M, 2022, MEDICINE, V101, DOI 10.1097/MD.0000000000029958
   Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276
   Sohal A, 2023, CLIN LIVER DIS, V27, P333, DOI 10.1016/j.cld.2023.01.006
   Sun N, 2016, MOL CELL, V61, P654, DOI 10.1016/j.molcel.2016.01.028
   Teo K, 2021, J HEPATOL, V74, P20, DOI 10.1016/j.jhep.2020.08.027
   Vamecq J, 2012, CURR DRUG METAB, V13, P1388, DOI 10.2174/138920012803762792
   Vilar-Gomez E, 2022, HEPATOLOGY, V76, P1482, DOI 10.1002/hep.32491
   Xu HM, 2016, CURR GENOMICS, V17, P396, DOI 10.2174/1389202917666160513102612
   Xu K, 2022, J CLIN TRANSL HEPATO, V10, P219, DOI 10.14218/JCTH.2021.00067
   Zhang XR, 2022, HEPATOLOGY, V76, P1409, DOI 10.1002/hep.32476
   Zhou JH, 2020, HEPATOLOGY, V71, P1851, DOI 10.1002/hep.31150
NR 44
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2227-9059
J9 BIOMEDICINES
JI Biomedicines
PD SEP
PY 2023
VL 11
IS 9
AR 2416
DI 10.3390/biomedicines11092416
PG 15
WC Biochemistry & Molecular Biology; Medicine, Research & Experimental;
   Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Research & Experimental Medicine;
   Pharmacology & Pharmacy
GA T1OC4
UT WOS:001075738600001
PM 37760857
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Chen, ML
   Tsai, SH
   Ip, SP
   Ko, KM
   Che, CT
AF Chen, Meng-Li
   Tsai, Sam-Hip
   Ip, Siu-Po
   Ko, Kam-Ming
   Che, Chun-Tao
TI Long-Term Treatment with a "Yang-Invigorating" Chinese Herbal Formula,
   Wu-Zi-Yan-Zong-Wan, Reduces Mortality and Liver Oxidative Damage in
   Chronic Alcohol-Intoxicated Rats
SO REJUVENATION RESEARCH
LA English
DT Article
ID LIPID-PEROXIDATION; MITOCHONDRIAL GLUTATHIONE; SCHISANDRIN-B; YIN-YANG;
   ETHANOL; STRESS; INJURY; DISEASE; INDUCTION; MECHANISM
AB Long-term alcohol consumption has been reported to increase oxidative stress in multiple organs and accelerate the aging process. A previous study in our laboratory has shown that Wu-Zi-Yan-Zong-Wan (WZ), a "Yang-invigorating" Chinese herbal formula, protected against ethanol-induced toxicity in HepG2 cells transfected to express human CYP2E1, presumably by enhancing mitochondrial antioxidant status and functional ability. The present study aims to investigate whether WZ extract treatment can afford protection against chronic ethanol-induced oxidative stress (a major risk factor of aging) and mortality in rats. The effect of the extract (1.8 g, 4.5 g, and 9 g raw materials/kg per day) on chronic ethanol hepatotoxicity was investigated in rats receiving steady intragastric infusion of ethanol-containing liquid diet. The results showed that long-term (42 days) herbal co-treatment protected against chronic ethanol-induced mortality and hepatotoxicity and in rats, as evidenced by decreased plasma transaminases activities. The extract also suppressed the pathological development of fatty liver, as assessed by histopathological examination and the ratio of liver weight to body weight. The hepato-protection afforded by the extract was associated with decreases in the extents of reactive oxygen species production, lipid peroxidation, and oxidative modification of proteins, as well as the reversal of altered mitochondrial reduced glutathione level. The results suggest that the suppressive effect of WZ on chronic ethanol-induced oxidative stress and mortality may be attributed to the antioxidant action, particularly in mitochondria.
C1 [Chen, Meng-Li; Tsai, Sam-Hip; Ip, Siu-Po; Che, Chun-Tao] Chinese Univ Hong Kong, Sch Chinese Med, Shatin, Hong Kong, Peoples R China.
   [Chen, Meng-Li] Gen Hosp Chinese PLA, Dept Clin Pharmacol, Beijing, Peoples R China.
   [Ko, Kam-Ming] Hong Kong Univ Sci & Technol, Dept Biochem, Hong Kong, Hong Kong, Peoples R China.
C3 Chinese University of Hong Kong; Hong Kong University of Science &
   Technology
RP Ip, SP (corresponding author), Chinese Univ Hong Kong, Sch Chinese Med, Shatin, Hong Kong, Peoples R China.
EM paulip@cuhk.edu.hk
RI Che, Chun-Tao/AAV-2795-2020; Ip, Paul/M-8831-2014; 陈, 梦丽/HGB-6013-2022
OI Ip, Paul/0000-0001-8657-6585; 
CR Addabbo F, 2009, HYPERTENSION, V53, P885, DOI 10.1161/HYPERTENSIONAHA.109.130054
   Agartz I, 2003, PSYCHIAT RES-NEUROIM, V122, P21, DOI 10.1016/S0925-4927(02)00084-7
   Albano E, 1996, HEPATOLOGY, V23, P155, DOI 10.1002/hep.510230121
   Amanvermez R, 2005, ADV THER, V22, P548, DOI 10.1007/BF02849949
   AMES BN, 1992, ANN NY ACAD SCI, V663, P85, DOI 10.1111/j.1749-6632.1992.tb38652.x
   AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   An RB, 2005, ARCH PHARM RES, V28, P529, DOI 10.1007/BF02977753
   Aytacoglu BN, 2006, RESPIRATION, V73, P100, DOI 10.1159/000088680
   BLUSEWICZ MJ, 1977, J CLIN PSYCHOL, V33, P1149, DOI 10.1002/1097-4679(197710)33:4<1149::AID-JCLP2270330451>3.0.CO;2-C
   Chen ML, 2010, J ETHNOPHARMACOL, V128, P116, DOI 10.1016/j.jep.2009.12.036
   Chiu PY, 2008, REJUV RES, V11, P43, DOI 10.1089/rej.2007.0577
   Chiu PY, 2002, PLANTA MED, V68, P951, DOI 10.1055/s-2002-35661
   Dalle-Donne I, 2003, CLIN CHIM ACTA, V329, P23, DOI 10.1016/S0009-8981(03)00003-2
   EDES I, 1986, CARDIOVASC RES, V20, P542, DOI 10.1093/cvr/20.7.542
   Femandez-Checa JC, 2005, TOXICOL APPL PHARM, V204, P263, DOI 10.1016/j.taap.2004.10.001
   Gouillon ZQ, 2000, P SOC EXP BIOL MED, V224, P302, DOI 10.1046/j.1525-1373.2000.22435.x
   Haorah J, 2008, FREE RADICAL BIO MED, V45, P1542, DOI 10.1016/j.freeradbiomed.2008.08.030
   Harrison DG, 2009, MED CLIN N AM, V93, P621, DOI 10.1016/j.mcna.2009.02.015
   Hoek JB, 2002, GASTROENTEROLOGY, V122, P2049, DOI 10.1053/gast.2002.33613
   HOLDEN KL, 1988, J CLIN PSYCHOL, V44, P286, DOI 10.1002/1097-4679(198803)44:2<286::AID-JCLP2270440233>3.0.CO;2-1
   Hommer DW, 2001, AM J PSYCHIAT, V158, P198, DOI 10.1176/appi.ajp.158.2.198
   Iimuro Y, 1997, HEPATOLOGY, V26, P1530
   Ip SP, 1997, BIOCHEM PHARMACOL, V54, P317, DOI 10.1016/S0006-2952(97)00164-0
   Ip SP, 1996, FREE RADICAL BIO MED, V21, P709, DOI 10.1016/0891-5849(96)00179-7
   KAMIMURA S, 1992, HEPATOLOGY, V16, P448, DOI 10.1002/hep.1840160225
   Kessova I, 2003, CURR MOL MED, V3, P509, DOI 10.2174/1566524033479609
   Kono H, 1999, AM J PHYSIOL-GASTR L, V277, pG1259, DOI 10.1152/ajpgi.1999.277.6.G1259
   Kono H, 2000, J CLIN INVEST, V106, P867, DOI 10.1172/JCI9020
   Leung HY, 2005, REJUV RES, V8, P238, DOI 10.1089/rej.2005.8.238
   Liu S, 2010, TOXICOL IN VITRO, V24, P516, DOI 10.1016/j.tiv.2009.03.006
   Minamiyama Y, 2004, FREE RADICAL BIO MED, V37, P703, DOI 10.1016/j.freeradbiomed.2004.05.022
   NANJI AA, 1994, ALCOHOL CLIN EXP RES, V18, P1280, DOI 10.1111/j.1530-0277.1994.tb00119.x
   NANJI AA, 1994, J PHARMACOL EXP THER, V269, P1280
   NANJI AA, 1989, LIFE SCI, V44, P223, DOI 10.1016/0024-3205(89)90599-7
   NOONBERG A, 1985, ALCOHOL CLIN EXP RES, V9, P334, DOI 10.1111/j.1530-0277.1985.tb05555.x
   NORDMANN R, 1994, ALCOHOL ALCOHOLISM, V29, P513
   Ou BX, 2003, FASEB J, V17, P127, DOI 10.1096/fj.02-0527hyp
   Polavarapu R, 1998, HEPATOLOGY, V27, P1317, DOI 10.1002/hep.510270518
   Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7
   Roberts CK, 2009, LIFE SCI, V84, P705, DOI 10.1016/j.lfs.2009.02.026
   Rouach H, 1997, HEPATOLOGY, V25, P351
   RYAN C, 1980, ALCOHOL CLIN EXP RES, V4, P288, DOI 10.1111/j.1530-0277.1980.tb04816.x
   Szeto YT, 2006, J ETHNOPHARMACOL, V108, P361, DOI 10.1016/j.jep.2006.05.033
   TSUKAMOTO H, 1985, HEPATOLOGY, V5, P224, DOI 10.1002/hep.1840050212
   TSUKAMOTO H, 1984, AM J PHYSIOL, V247, pR595, DOI 10.1152/ajpregu.1984.247.3.R595
   Yu BP, 1996, ANN NY ACAD SCI, V786, P1, DOI 10.1111/j.1749-6632.1996.tb39047.x
   Zawia NH, 2009, FREE RADICAL BIO MED, V46, P1241, DOI 10.1016/j.freeradbiomed.2009.02.006
   Zhao BL, 2009, NEUROCHEM RES, V34, P630, DOI 10.1007/s11064-008-9900-9
NR 48
TC 3
Z9 4
U1 2
U2 16
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1549-1684
EI 1557-8577
J9 REJUV RES
JI Rejuv. Res.
PD AUG
PY 2010
VL 13
IS 4
BP 459
EP 467
DI 10.1089/rej.2009.0985
PG 9
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 642XU
UT WOS:000281256000010
PM 20583953
DA 2024-02-19
ER

PT J
AU Kaneko, T
   Tahara, S
   Matsuo, M
AF Kaneko, T
   Tahara, S
   Matsuo, M
TI Retarding effect of dietary restriction on the accumulation of
   8-hydroxy-2'-deoxyguanosine in organs of Fischer 344 rats during aging
SO FREE RADICAL BIOLOGY AND MEDICINE
LA English
DT Article
DE aging; oxidative DNA damage; dietary restriction;
   8-hydroxy-2'-deoxyguanosine; nuclear DNA; free radicals
ID OXIDATIVE DAMAGE; FOOD RESTRICTION; 8-HYDROXYGUANINE MOIETY; NUTRITIONAL
   INFLUENCES; DNA DAMAGE; AGE; 8-HYDROXYDEOXYGUANOSINE; CARCINOGENESIS;
   MITOCHONDRIAL; ACID
AB An age-related accumulation in rats of 8-hydroxy-2'-deoxyguanoside (8-OHdG), a marker of oxidative DNA damage, and the effect of dietary restriction on the accumulation of 8-OHdC were examined. The 8-OHdG concentrations of nuclear DNA in organs of ad libitum fed rats were similar in young and middle age, but increased significantly in kidney at 24 months of age, in heart and liver at 27 months of age, and in brain at 30 months of age. The 8-OHdG concentration in dietary-restricted rats showed no changes in any organ up to 30 months of age and then was increased at 33 months of age. Dietary restriction retarded the onset of the age-related increase in 8-OHdG concentration, although it did not reduce the concentration in young and middle age. These results suggest that the effect of dietary restriction on the extension of life-span in rats might be related to a reduction in oxidative damage. (C) 1997 Elsevier Science Inc.
RP Kaneko, T (corresponding author), TOKYO METROPOLITAN INST GERONTOL,ITABASHI KU,35-2 SAKAECHO,TOKYO 173,JAPAN.
CR AMES BN, 1989, FREE RADICAL RES COM, V7, P121, DOI 10.3109/10715768909087933
   [Anonymous], MODERN BIOL THEORIES
   CHUNG MH, 1992, FREE RADICAL BIO MED, V12, P523, DOI 10.1016/0891-5849(92)90105-P
   DEMOPOULOS HB, 1980, J ENVIRON PATHOL TOX, V3, P273
   DIZDAROGLU M, 1986, ANAL BIOCHEM, V156, P182, DOI 10.1016/0003-2697(86)90171-5
   DIZDAROGLU M, 1985, BIOCHEMISTRY-US, V24, P4476, DOI 10.1021/bi00337a032
   FLOYD RA, 1990, CARCINOGENESIS, V11, P1447, DOI 10.1093/carcin/11.9.1447
   FRAGA CG, 1990, P NATL ACAD SCI USA, V87, P4533, DOI 10.1073/pnas.87.12.4533
   GUPTA RC, 1990, P NATL ACAD SCI USA, V87, P4533
   HARMAN D, 1982, FREE RADICAL BIO MED, V5, P255
   HIRAI S, 1982, LIPID PEROXIDES BIOL, P303
   Kaneko T, 1996, MUTAT RES-DNAGING G, V316, P277, DOI 10.1016/S0921-8734(96)90010-7
   KASAI H, 1989, CANCER RES, V49, P2603
   KASAI H, 1984, NUCLEIC ACIDS RES, V12, P2137, DOI 10.1093/nar/12.4.2137
   KASAI H, 1986, CARCINOGENESIS, V7, P1849, DOI 10.1093/carcin/7.11.1849
   KASAI H, 1987, CARCINOGENESIS, V8, P1959, DOI 10.1093/carcin/8.12.1959
   LAGANIERE S, 1987, BIOCHEM BIOPH RES CO, V145, P1185, DOI 10.1016/0006-291X(87)91562-2
   LAGANIERE S, 1989, MECH AGEING DEV, V48, P221, DOI 10.1016/0047-6374(89)90084-5
   Lee D W, 1990, Aging (Milano), V2, P357
   MAEDA H, 1985, J GERONTOL, V40, P671, DOI 10.1093/geronj/40.6.671
   MATSUO M, 1993, J GERONTOL, V48, pB133, DOI 10.1093/geronj/48.4.B133
   MULER R, 1980, J CANC RES ONCOL, V102, P99
   NOY N, 1985, MECH AGEING DEV, V29, P63, DOI 10.1016/0047-6374(85)90047-8
   Oberley LW, 1986, Free radicals, aging, and degenerative diseases, P325
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465
   ROSS MH, 1961, J NUTR, V75, P197, DOI 10.1093/jn/75.2.197
   SHUMIYA S, 1994, AGING ENV FACTORS, P9
   SOHAL RS, 1994, MECH AGEING DEV, V74, P121, DOI 10.1016/0047-6374(94)90104-X
   SOHAL RS, 1994, MECH AGEING DEV, V76, P215, DOI 10.1016/0047-6374(94)91595-4
   STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616
   YU BP, 1985, J GERONTOL, V40, P657, DOI 10.1093/geronj/40.6.657
NR 31
TC 82
Z9 89
U1 0
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0891-5849
J9 FREE RADICAL BIO MED
JI Free Radic. Biol. Med.
PY 1997
VL 23
IS 1
BP 76
EP 81
DI 10.1016/S0891-5849(96)00622-3
PG 6
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA WZ437
UT WOS:A1997WZ43700009
PM 9165299
DA 2024-02-19
ER

PT J
AU Youdim, KA
   Shukitt-Hale, B
   Martin, A
   Wang, H
   Denisova, N
   Bickford, PC
   Joseph, JA
AF Youdim, KA
   Shukitt-Hale, B
   Martin, A
   Wang, H
   Denisova, N
   Bickford, PC
   Joseph, JA
TI Short-term dietary supplementation of blueberry polyphenolics:
   Beneficial effects on aging brain performance and peripheral tissue
   function
SO NUTRITIONAL NEUROSCIENCE
LA English
DT Article
DE behavior; aging; blueberry; health
ID NEURONAL SIGNAL-TRANSDUCTION; ALZHEIMERS-DISEASE; OXIDATIVE STRESS;
   VITAMIN-C; INTESTINAL-ABSORPTION; BEHAVIORAL DEFICITS;
   ENDOTHELIAL-CELLS; STRIATAL DOPAMINE; ASCORBIC-ACID; WATER-MAZE
AB Emerging evidence from our lab indicate that fruits and vegetables, in particular blueberry (BB) extracts, are able to ameliorate age-related declines in neuronal and cognitive function, common in disorders such as Alzheimer disease. The current study examined if the beneficial effects were also discernable with supplementation of BB extracts, in an already well balanced diet. Indeed, following an 8 week supplementation regime, age-related declines in several behavioral parameters such as balance, coordination, working memory and reference memory were still protected against. Similarly, BB extracts also potentiated oxotremorine enhancement of K+-evoked release of dopamine from striatal slices. Decline in the dopaminergic system have been shown to have a profound effect on cognitive functions. The improvement in dopamine release may have been due in part to the observed increase in striatal vitamin C levels. Although assessment of serum transaminase levels in BB supplemented animals appeared to suggest improved liver function, this was not thought to be the reason for the elevated vitamin C levels. The underlying mechanism for this is unclear. Together these findings highlight the diverse in vivo actions of dietary polyphenolics, a number of which may be important against age-related declines in certain brain functions. Furthermore they are to be able to mediate protective effects despite the diet containing sufficient concentrations of antioxidants.
C1 Tufts Univ, Jean Mayer Human Nutr Res Ctr Aging, USDA, Dept Neurosci, Boston, MA 02111 USA.
   Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, Denver, CO 80262 USA.
   Dept Vet Affairs Med Ctr, Denver, CO USA.
C3 United States Department of Agriculture (USDA); Tufts University;
   University of Colorado System; University of Colorado Denver; University
   of Colorado Anschutz Medical Campus
RP Youdim, KA (corresponding author), Tufts Univ, Jean Mayer Human Nutr Res Ctr Aging, USDA, Dept Neurosci, Boston, MA 02111 USA.
RI Bickford, Paula C/J-5970-2012
OI Bickford, Paula C/0000-0001-9657-7725; Shukitt-Hale,
   Barbara/0000-0002-3810-1910
CR BARTUS RT, 1990, J AM GERIATR SOC, V38, P680, DOI 10.1111/j.1532-5415.1990.tb01430.x
   Bickford PC, 1999, MECH AGEING DEV, V111, P141, DOI 10.1016/S0047-6374(99)00063-9
   BRANDEIS R, 1989, INT J NEUROSCI, V48, P29, DOI 10.3109/00207458909002151
   Cao GH, 1998, J NUTR, V128, P2383, DOI 10.1093/jn/128.12.2383
   CHOI JH, 1995, FREE RADICAL BIO MED, V18, P133, DOI 10.1016/0891-5849(94)00106-T
   Christen Y, 2000, AM J CLIN NUTR, V71, p621S, DOI 10.1093/ajcn/71.2.621s
   CRAIG WJ, 1996, J AM DIET ASSOC, V5, pS199
   DEANGELIS L, 1995, BRAIN RES, V670, P303, DOI 10.1016/0006-8993(94)01305-2
   Dormehl IC, 1999, CLIN NUCL MED, V24, P29, DOI 10.1097/00003072-199901000-00007
   Egashira T, 1996, JPN J PHARMACOL, V72, P57, DOI 10.1254/jjp.72.57
   Flynn BL, 1999, ANN PHARMACOTHER, V33, P840, DOI 10.1345/aph.17093
   FORNSTEDT B, 1991, J NEUROCHEM, V56, P407, DOI 10.1111/j.1471-4159.1991.tb08166.x
   GIRBE F, 1994, NEUROREPORT, V5, P1027, DOI 10.1097/00001756-199405000-00002
   Harkany T, 1999, PROG NEURO-PSYCHOPH, V23, P963, DOI 10.1016/S0278-5846(99)00058-5
   Hendrie HC, 1998, AM J GERIAT PSYCHIAT, V6, pS3, DOI 10.1097/00019442-199821001-00002
   HERMAN P, 1994, BBA-BIOMEMBRANES, V1190, P1, DOI 10.1016/0005-2736(94)90028-0
   Hollman PCH, 1997, BIOMED PHARMACOTHER, V51, P305, DOI 10.1016/S0753-3322(97)88045-6
   Hollman PCH, 1996, FOOD CHEM, V57, P43, DOI 10.1016/0308-8146(96)00065-9
   INGRAM DK, 1994, PATHOBIOLOGY AGING R, V2, P149
   JAFFE EA, 1974, P NATL ACAD SCI USA, V71, P1906, DOI 10.1073/pnas.71.5.1906
   Joseph JA, 1999, J NEUROSCI, V19, P8114
   JOSEPH JA, 1988, BRAIN RES, V454, P140, DOI 10.1016/0006-8993(88)90812-8
   Joseph JA, 1998, J NEUROSCI, V18, P8047
   JOSEPH JA, 1978, J GERONTOL, V33, P643, DOI 10.1093/geronj/33.5.643
   Joseph JA, 1997, J NEUROCHEM, V69, P1252
   Joseph JA, 1999, RADIAT RES, V152, P637, DOI 10.2307/3580259
   JOSEPH JA, 1990, BRAIN RES, V537, P40, DOI 10.1016/0006-8993(90)90337-B
   JOSEPH JA, 1983, NEUROBIOL AGING, V4, P313, DOI 10.1016/0197-4580(83)90008-8
   KESSLER AR, 1985, INT J NEUROSCI, V28, P73, DOI 10.3109/00207458509070821
   KLUGER A, 1997, J GERONTOL B-PSYCHOL, V52, P28
   Kornhuber J, 1996, J NEURAL TRANSM, V103, P45, DOI 10.1007/BF01292615
   LEE MJ, 1995, CANCER EPIDEM BIOMAR, V4, P393
   Linderkamp O, 1997, CLIN HEMORHEOL MICRO, V17, P279
   Markesbery WR, 1997, FREE RADICAL BIO MED, V23, P134, DOI 10.1016/S0891-5849(96)00629-6
   Martin A, 1997, ARTERIOSCL THROM VAS, V17, P1583, DOI 10.1161/01.ATV.17.8.1583
   McGeer EG, 1999, CURR PHARM DESIGN, V5, P821
   Miyazawa T, 1999, J AGR FOOD CHEM, V47, P1083, DOI 10.1021/jf9809582
   MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4
   Nakagawa K, 1997, J NUTR SCI VITAMINOL, V43, P679, DOI 10.3177/jnsv.43.679
   Pietta P, 1998, BIOCHEM MOL BIOL INT, V46, P895
   Prasad KN, 2000, CLIN NEUROPHARMACOL, V23, P2, DOI 10.1097/00002826-200001000-00002
   Riviere S, 1998, INT J GERIATR PSYCH, V13, P749
   Sano M, 1997, NEW ENGL J MED, V336, P1216, DOI 10.1056/NEJM199704243361704
   Scheuer K, 1999, PHARMACOPSYCHIATRY, V32, P10, DOI 10.1055/s-2007-979231
   SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2
   Shimoi K, 1998, FEBS LETT, V438, P220, DOI 10.1016/S0014-5793(98)01304-0
   Shukitt-Hale B, 1998, EXP GERONTOL, V33, P615, DOI 10.1016/S0531-5565(98)00024-2
   Shukitt-Hale B, 1999, AGE, V22, P9, DOI 10.1007/s11357-999-0002-7
   Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0
   YOUDIM KA, IN PRESS BIOCH BIOPH
NR 50
TC 116
Z9 130
U1 0
U2 15
PU HARWOOD ACAD PUBL GMBH
PI READING
PA C/O STBS LTD, PO BOX 90, READING RG1 8JL, BERKS, ENGLAND
SN 1028-415X
J9 NUTR NEUROSCI
JI Nutr. Neurosci.
PY 2000
VL 3
IS 6
BP 383
EP 397
DI 10.1080/1028415X.2000.11747338
PG 15
WC Neurosciences; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Nutrition & Dietetics
GA 388PC
UT WOS:000166189200002
DA 2024-02-19
ER

PT J
AU Reeves, WR
   McDonald, TJ
   Bordelon, NR
   George, SE
   Donnelly, KC
AF Reeves, WR
   McDonald, TJ
   Bordelon, NR
   George, SE
   Donnelly, KC
TI Impacts of aging on in vivo and in vitro measurements of soil-bound
   polycyclic aromatic hydrocarbon availability
SO ENVIRONMENTAL SCIENCE & TECHNOLOGY
LA English
DT Article
ID TAR-CONTAMINATED SOILS; BIOAVAILABILITY; METABOLITES; RAT;
   PHARMACOKINETICS; KINETICS; PYRENE; URINE; PAH
AB Ingestion of contaminated soil is an exposure pathway at approximately one-half of the Superfund sites in the United States. This study was designed to evaluate the impacts of aging in soil on the availability of polycyclic aromatic hydrocarbons (PAHs). Two coal tar (CT)-amended soils were prepared. One was aged for 270 days and the other was not aged. Both of these treatments were incorporated into pellets and fed to male Fischer 344 rats. Excretion of l-hydroxypyrene (1-OHP) in urine and PAH concentrations in the liver were monitored as end points. Additionally, soil:water partitioning and desorption were measured as comparisons to the in vivo results. After 5 days of ingesting their respective treatments, rats in the aged soil group excreted 4.41 +/- 1.67 ppm 1-OHP/mg of pyrene ingested while rats in the unaged soil group excreted 5.27 +/- 1.37 ppm/mg of pyrene ingested. Animals fed aged CT soil had 0.051 +/- 0.011 ppm carcinogenic PAHs in livers/mg ingested while rats fed unaged CT soil had 0.063 +/- 0.037 ppm carcinogenic PAHs in livers/mg ingested. Partitioning and desorption results revealed a similar results. These results indicate that, at high application rates, soil contact time may not play as significant a role in determining availability as simple dispersion and sorption on soil.
C1 Texas A&M Univ, Dept Vet Anat & Publ Hlth, College Stn, TX 77843 USA.
   Texas A&M Univ, Dept Civil Engn, College Stn, TX 77843 USA.
   NIEHS, Res Triangle Pk, NC 27711 USA.
   US EPA, Res Triangle Pk, NC 27711 USA.
C3 Texas A&M University System; Texas A&M University College Station; Texas
   A&M University System; Texas A&M University College Station; National
   Institutes of Health (NIH) - USA; NIH National Institute of
   Environmental Health Sciences (NIEHS); United States Environmental
   Protection Agency
RP Donnelly, KC (corresponding author), Texas A&M Univ, Dept Vet Anat & Publ Hlth, College Stn, TX 77843 USA.
OI Reeves, William/0000-0001-5109-6696
FU NIEHS NIH HHS [ES04917] Funding Source: Medline
CR Bordelon NR, 2000, TOXICOL SCI, V56, P37, DOI 10.1093/toxsci/56.1.37
   Bouchard M, 1996, TOXICOL APPL PHARM, V139, P301, DOI 10.1006/taap.1996.0169
   Cornelissen G, 1997, ENVIRON TOXICOL CHEM, V16, P1351, DOI [10.1002/etc.5620160703, 10.1897/1551-5028(1997)016&lt;1351:DKOCPA&gt;2.3.CO;2]
   FOTH H, 1988, FOOD CHEM TOXICOL, V26, P45, DOI 10.1016/0278-6915(88)90040-3
   Hack A, 1996, TOXICOL LETT, V88, P199, DOI 10.1016/0378-4274(96)03738-1
   JONGENEELEN FJ, 1987, J CHROMATOGR-BIOMED, V413, P227, DOI 10.1016/0378-4347(87)80230-X
   Koganti A, 1998, ENVIRON SCI TECHNOL, V32, P3104, DOI 10.1021/es980082f
   Pignatello JJ, 1996, ENVIRON SCI TECHNOL, V30, P1, DOI 10.1021/es940683g
   Robertson BK, 1998, ENVIRON TOXICOL CHEM, V17, P1034, DOI [10.1897/1551-5028(1998)017&lt;1034:SODADI&gt;2.3.CO;2, 10.1002/etc.5620170608]
   RUBY MV, 1993, ENVIRON SCI TECHNOL, V27, P2870, DOI 10.1021/es00049a030
   SCHRICKER BR, 1981, AM J CLIN NUTR, V34, P2257, DOI 10.1093/ajcn/34.10.2257
   Till M, 1999, CHEM-BIOL INTERACT, V117, P135, DOI 10.1016/S0009-2797(98)00105-7
   *US EPA, 1996, 1311 US EPA US DEP C, P211
   vanSchooten FJ, 1997, ARCH ENVIRON CON TOX, V33, P317, DOI 10.1007/s002449900259
   WITHEY JR, 1991, J TOXICOL ENV HEALTH, V32, P429, DOI 10.1080/15287399109531494
NR 15
TC 24
Z9 30
U1 1
U2 26
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0013-936X
J9 ENVIRON SCI TECHNOL
JI Environ. Sci. Technol.
PD APR 15
PY 2001
VL 35
IS 8
BP 1637
EP 1643
DI 10.1021/es0017110
PG 7
WC Engineering, Environmental; Environmental Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Engineering; Environmental Sciences & Ecology
GA 422BX
UT WOS:000168099000013
PM 11329714
DA 2024-02-19
ER

PT J
AU Tsugawa, H
   Ohki, T
   Tsubaki, S
   Tanaka, R
   Matsuzaki, J
   Suzuki, H
   Hozumi, K
AF Tsugawa, Hitoshi
   Ohki, Takuto
   Tsubaki, Shogo
   Tanaka, Rika
   Matsuzaki, Juntaro
   Suzuki, Hidekazu
   Hozumi, Katsuto
TI Gas6 ameliorates intestinal mucosal immunosenescence to prevent the
   translocation of a gut pathobiont, <i>Klebsiella pneumoniae</i>, to the
   liver
SO PLOS PATHOGENS
LA English
DT Article
ID AGE-RELATED-CHANGES; MICROBIOTA; EMERGENCE; CELLS
AB Immunosenescence refers to the development of weakened and/or dysfunctional immune responses associated with aging. Several commensal bacteria can be pathogenic in immunosuppressed individuals. Although Klebsiella pneumoniae is a commensal bacterium that colonizes human mucosal surfaces, the gastrointestinal tract, and the oropharynx, it can cause serious infectious diseases, such as pneumonia, urinary tract infections, and liver abscesses, primarily in elderly patients. However, the reason why K. pneumoniae is a more prevalent cause of infection in the elderly population remains unclear. This study aimed to determine how the host's intestinal immune response to K. pneumoniae varies with age. To this end, the study analyzed an in vivo K. pneumoniae infection model using aged mice, as well as an in vitro K. pneumoniae infection model using a Transwell insert co-culture system comprising epithelial cells and macrophages. In this study, we demonstrate that growth arrest-specific 6 (Gas6), released by intestinal macrophages that recognize K. pneumoniae, inhibits bacterial translocation from the gastrointestinal tract by enhancing tight-junction barriers in the intestinal epithelium. However, in aging mice, Gas6 was hardly secreted under K. pneumoniae infection due to decreasing intestinal mucosal macrophages; therefore, K. pneumoniae can easily invade the intestinal epithelium and subsequently translocate to the liver. Moreover, the administration of Gas6 recombinant protein to elderly mice prevented the translocation of K. pneumoniae from the gastrointestinal tract and significantly prolonged their survival. From these findings, we conclude that the age-related decrease in Gas6 secretion in the intestinal mucosa is the reason why K. pneumoniae can be pathogenic in the elderly, thereby indicating that Gas6 could be effective in protecting the elderly against infectious diseases caused by gut pathogens.
   Author summaryAging causes a weakened/dysfunctional human immune system, reducing the ability to combat pathogens. Understanding the molecular mechanisms underlying age-related immunosenescence is critical for the development of preventive therapies against bacterial infectious diseases in elderly individuals. Klebsiella pneumoniae is a representative "pathobiont" that causes serious systemic infections such as pneumonia, urinary tract infections, and liver abscesses, mainly in the elderly. However, it remains unclear how K. pneumoniae is a more prevalent cause of infection in the elderly population. Here, we show that growth arrest-specific 6 (Gas6), released by intestinal macrophages that recognize K. pneumoniae, inhibits bacterial invasion into the intestinal epithelium and subsequent translocation to the liver. However, in elderly mice, Gas6 is hardly secreted due to decreased intestinal mucosal macrophages; therefore, K. pneumoniae can easily translocate to the liver from the gastrointestinal tract. We concluded that the reason K. pneumoniae can be pathogenic to the elderly is the age-related decrease in Gas6 secretion in the intestinal mucosa. Moreover, we revealed that the administration of Gas6 to elderly mice significantly prevented systemic translocation of orally infected K. pneumoniae. Our findings provide new insights into the prevention of infectious diseases in the elderly.
C1 [Tsugawa, Hitoshi; Tsubaki, Shogo] Tokai Univ, Div Host Def Mech, Transkingdom Signaling Res Unit, Sch Med, Isehara, Japan.
   [Ohki, Takuto] Nagoya Univ, Dept Hand Surg, Grad Sch Med, Nagoya, Japan.
   [Tanaka, Rika; Hozumi, Katsuto] Tokai Univ, Dept Immunol, Div Host Def Mech, Sch Med, Isehara, Japan.
   [Matsuzaki, Juntaro] Keio Univ, Div Pharmacotherapeut, Fac Pharm, Tokyo, Japan.
   [Suzuki, Hidekazu] Tokai Univ, Dept Internal Med, Div Gastroenterol & Hepatol, Sch Med, Isehara, Japan.
C3 Tokai University; Nagoya University; Tokai University; Keio University;
   Tokai University
RP Tsugawa, H (corresponding author), Tokai Univ, Div Host Def Mech, Transkingdom Signaling Res Unit, Sch Med, Isehara, Japan.
EM tsugawa.hitoshi.r@tokai.ac.jp
RI Tsugawa, Hitoshi/J-4941-2013
OI Tsugawa, Hitoshi/0000-0002-4344-4475
FU Kao Research Council for the Study of Healthcare Science [C93102]; 2021
   Tokai University School of Medicine Research Aid grant [210049]; Tokai
   University Research Organization [21NS331825]; Japan Agency for Medical
   Research and Development [21ck0106701h0001]; Ohyama Health Foundation
   Inc. [113]
FX This study was supported by the Kao Research Council for the Study of
   Healthcare Science (C93102) (to H.T.). The infection models in this work
   were partly supported by a 2021 Tokai University School of Medicine
   Research Aid grant (210049) (to H.T.), Tokai University Research
   Organization Grant (21NS331825) (to H.T.), Ohyama Health Foundation Inc.
   (113) (to H.T.), and the Japan Agency for Medical Research and
   Development (21ck0106701h0001) (to J.M.). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Aiello A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02247
   Centers for Disease Control and Prevention (CDC), 2013, MMWR Morb Mortal Wkly Rep, V62, P165
   CHENG DL, 1991, ARCH INTERN MED, V151, P1557
   Chow J, 2010, CELL HOST MICROBE, V7, P265, DOI 10.1016/j.chom.2010.03.004
   Constantinides MG, 2019, SCIENCE, V366, P445, DOI 10.1126/science.aax6624
   Di Stasi R, 2020, DRUG DISCOV TODAY, V25, P2130, DOI 10.1016/j.drudis.2020.09.022
   Duttal D, 2017, CURR OPIN IMMUNOL, V48, P15, DOI 10.1016/j.coi.2017.07.012
   Fodah RA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107394
   Fumagalli O, 1997, INFECT IMMUN, V65, P4445, DOI 10.1128/IAI.65.11.4445-4451.1997
   Gavazzi G, 2002, LANCET INFECT DIS, V2, P659, DOI 10.1016/S1473-3099(02)00437-1
   Gomez CR, 2005, CURR OPIN IMMUNOL, V17, P457, DOI 10.1016/j.coi.2005.07.013
   Gu DX, 2018, LANCET INFECT DIS, V18, P37, DOI [10.1016/S1473-3099(17)30489-9, 10.1016/s1473-3099(17)30489-9]
   Hall JA, 2008, IMMUNITY, V29, P637, DOI 10.1016/j.immuni.2008.08.009
   Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490
   Hu M, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11121117
   Jochum L, 2020, TRENDS MICROBIOL, V28, P789, DOI 10.1016/j.tim.2020.04.011
   Linton PJ, 2004, NAT IMMUNOL, V5, P133, DOI 10.1038/ni1033
   LIU YC, 1986, ARCH INTERN MED, V146, P1913, DOI 10.1001/archinte.146.10.1913
   Nakamoto N, 2019, NAT MICROBIOL, V4, P492, DOI 10.1038/s41564-018-0333-1
   Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901
   Oelschlaeger TA, 1997, INFECT IMMUN, V65, P2950, DOI 10.1128/IAI.65.7.2950-2958.1997
   Ogawa T, 2000, MECH AGEING DEV, V117, P57, DOI 10.1016/S0047-6374(00)00137-8
   Paczosa MK, 2016, MICROBIOL MOL BIOL R, V80, P629, DOI 10.1128/MMBR.00078-15
   Pan YJ, 2011, INFECT IMMUN, V79, P997, DOI 10.1128/IAI.00906-10
   Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002
   Rock C, 2014, INFECT CONT HOSP EP, V35, P426, DOI 10.1086/675598
   Sequeira RP, 2020, NAT MICROBIOL, V5, P304, DOI 10.1038/s41564-019-0640-1
   Shankar C, 2018, BMC MICROBIOL, V18, DOI 10.1186/s12866-017-1148-6
   Stecher B, 2008, TRENDS MICROBIOL, V16, P107, DOI 10.1016/j.tim.2007.12.008
   TAKAHASHI I, 1985, ACTA MED OKAYAMA, V39, P447
   Dao TT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091999
   Tsugawa H, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000813
   Willing BP, 2011, NAT REV MICROBIOL, V9, P233, DOI 10.1038/nrmicro2536
   Yao H, 2018, LANCET INFECT DIS, V18, P25, DOI 10.1016/S1473-3099(17)30628-X
   Zhang YW, 2016, ANTIMICROB AGENTS CH, V60, P6115, DOI 10.1128/AAC.01127-16
   Zhang YW, 2015, J INFECTION, V71, P553, DOI 10.1016/j.jinf.2015.07.010
NR 36
TC 0
Z9 0
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD JUN
PY 2023
VL 19
IS 6
AR e1011139
DI 10.1371/journal.ppat.1011139
PG 25
WC Microbiology; Parasitology; Virology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microbiology; Parasitology; Virology
GA I5OK8
UT WOS:001003271100001
PM 37289655
OA Green Published, Green Submitted, gold
DA 2024-02-19
ER

PT J
AU Cassuto, JR
   Patel, SA
   Tsoulfas, G
   Orloff, MS
   Abt, PL
AF Cassuto, James R.
   Patel, Siddharth A.
   Tsoulfas, Georgios
   Orloff, Mark S.
   Abt, Peter L.
TI The cumulative effects of cold ischemic time and older donor age on
   liver graft survival
SO JOURNAL OF SURGICAL RESEARCH
LA English
DT Article
DE liver transplant; cold ischemia time; graft survival
ID RISK-FACTORS; TRANSPLANTATION
AB Introduction. To provide greater equity among those awaiting a liver transplant, expanded geographic sharing of cadaveric organs has been proposed. A potential unintended consequence could be an increase in cold ischemia time (CIT), which may be deleterious to organs from older donors. This study sought to quantify the relative risk (RR) associated with increased CIT among older donors. Methods. A retrospective study examining 18,787 liver transplants within the United Network for Organ Sharing database from 2002 to 2006 was performed. Cox Regression analysis was used to model the RR of graft loss with respect to increased CIT among older donors (> 60 years) relative to younger donors (< 60 years), while controlling for multiple donor and recipient characteristics. Results. Relative to younger donors with minimal CIT (< 6 h), a 73.0% increase in the risk of graft loss was observed for older donors with a CIT between 8 and 10 h, a 56.9% increase for CIT between 10 and 12 h, and a 92.7% increase for a CIT of 12 or more hours. Additionally, the RR of graft loss for older donors with minimal CIT (< 6 h) was greater than the RR for younger donors with a CIT between 0 and 12 h. Conclusion. The additive effects of increased donor age and cold ischemic time greatly impair graft survival. Quantification of the adverse nature of increasing CIT as a potential consequence of wider geographic organ sharing should be considered as allocation policies are modified to improve recipient equity in the face of an aging donor pool. (C) 2008 Elsevier Inc. All rights reserved.
C1 [Abt, Peter L.] Hosp Univ Penn, Dept Surg, Div Transplant Surg, Philadelphia, PA 19104 USA.
   [Cassuto, James R.; Patel, Siddharth A.; Tsoulfas, Georgios; Orloff, Mark S.] Univ Rochester, Med Ctr, Dept Surg, Rochester, NY 14642 USA.
C3 University of Pennsylvania; University of Rochester
RP Abt, PL (corresponding author), Hosp Univ Penn, Dept Surg, Div Transplant Surg, 3400 Spruce St,1 Founders, Philadelphia, PA 19104 USA.
EM peter.l.abt@uphs.upenn.edu
RI Tsoulfas, Georgios/K-4801-2012; Abt, Peter/AAD-6856-2019
OI Tsoulfas, Georgios/0000-0001-5043-7962; 
CR ADAM R, 1995, TRANSPLANT P, V27, P1181
   Briceño J, 2002, TRANSPLANTATION, V74, P522, DOI 10.1097/01.TP.0000026307.14572.8D
   Busquets J, 2001, TRANSPLANTATION, V71, P1765, DOI 10.1097/00007890-200106270-00011
   Busuttil RW, 2003, LIVER TRANSPLANT, V9, P651, DOI 10.1053/jlts.2003.50105
   Ciccocioppo R, 2003, ALIMENT PHARM THER, V17, P271, DOI 10.1046/j.1365-2036.2003.01413.x
   Detre K M, 1995, Liver Transpl Surg, V1, P311, DOI 10.1002/lt.500010507
   Engler MM, 1998, BIOCHEM MOL BIOL INT, V46, P1117
   Feng S, 2006, AM J TRANSPLANT, V6, P783, DOI 10.1111/j.1600-6143.2006.01242.x
   FURUKAWA H, 1991, TRANSPLANTATION, V51, P1000, DOI 10.1097/00007890-199105000-00013
   González FR, 2002, TRANSPL P, V34, P233, DOI 10.1016/S0041-1345(01)02738-5
   Grazi GL, 2005, TRANSPLANT P, V37, P2582, DOI 10.1016/j.transproceed.2005.06.056
   Guichelaar MMJ, 2003, AM J TRANSPLANT, V3, P885, DOI 10.1034/j.1600-6143.2003.00165.x
   Hoofnagle JH, 1996, HEPATOLOGY, V24, P89, DOI 10.1053/jhep.1996.v24.pm0008707288
   Iakova P, 2003, CELL, V113, P495, DOI 10.1016/S0092-8674(03)00318-0
   Institute of Medicine Committee on Organ Procurement and Transplantation Policy, 1999, ORG PROC TRANSPL ASS, P1
   Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172
   Malinchoc M, 2000, HEPATOLOGY, V31, P864, DOI 10.1053/he.2000.5852
   Maya-Mendoza A, 2005, MECH AGEING DEV, V126, P767, DOI 10.1016/j.mad.2005.01.011
   Merion RM, 2005, AM J TRANSPLANT, V5, P307, DOI 10.1111/j.1600-6143.2004.00703.x
   Nardo B, 2004, AM J TRANSPLANT, V4, P1139, DOI 10.1111/j.1600-6143.2004.00472.x
   Oh CK, 2000, CLIN TRANSPLANT, V14, P386, DOI 10.1034/j.1399-0012.2000.14040502.x
   Piratvisuth T, 1995, Liver Transpl Surg, V1, P296, DOI 10.1002/lt.500010505
   PLOEG RJ, 1993, TRANSPLANTATION, V55, P807, DOI 10.1097/00007890-199304000-00024
   Schmucker DL, 2001, DRUG AGING, V18, P837, DOI 10.2165/00002512-200118110-00005
   Suttner SW, 2001, INTENS CARE MED, V27, P1762, DOI 10.1007/s00134-001-1126-0
   Totsuka E, 2002, SURG TODAY, V32, P792, DOI 10.1007/s005950200152
   Uemura T, 2007, LIVER TRANSPLANT, V13, P227, DOI 10.1002/lt.20992
   *US ORG PROC TRANS, 2005 ANN REP US ORG
   Velidedeoglu E, 2004, TRANSPLANTATION, V77, P1834, DOI 10.1097/01.tp.0000130468.36131.0d
   WYNNE HA, 1989, HEPATOLOGY, V9, P297, DOI 10.1002/hep.1840090222
   YEN TC, 1989, BIOCHEM BIOPH RES CO, V165, P994, DOI 10.1016/0006-291X(89)92701-0
   YERSIZ H, 1995, TRANSPLANTATION, V60, P790, DOI 10.1097/00007890-199510270-00005
NR 32
TC 36
Z9 38
U1 0
U2 3
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0022-4804
EI 1095-8673
J9 J SURG RES
JI J. Surg. Res.
PD JUL
PY 2008
VL 148
IS 1
BP 38
EP 44
DI 10.1016/j.jss.2008.03.018
PG 7
WC Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Surgery
GA 316FZ
UT WOS:000256936000007
PM 18570929
DA 2024-02-19
ER

PT J
AU Kharbhih, WJ
   Sharma, R
AF Kharbhih, Wanaiborlang Jala
   Sharma, Ramesh
TI Age-dependent increased expression and activity of inorganic
   pyrophosphatase in the liver of male mice and its further enhancement
   with short- and long-term dietary restriction
SO BIOGERONTOLOGY
LA English
DT Article
DE Inorganic pyrophosphatase; Aging; Dietary restriction; Liver; Fasting
ID CALORIC RESTRICTION; RAT-LIVER; PROTEOMIC ANALYSIS; GENE; CALCIFICATION;
   DECLINE; BINDING; PROFILE
AB Intracellular orthophosphate and inorganic pyrophosphate (PPi) are by-products of multiple biosynthetic reactions. PPi hydrolysis by soluble inorganic pyrophosphatase (iPPase) has been considered as an important homeostatic mechanism. We investigated the expression and activities (U/mg protein) of iPPase in the liver of young and old mice subjected to short- and long-term dietary restriction. The expression level of iPPase was ascertained by the Western blot analysis using anti-iPPase and differential polymerase chain reaction using iPPase specific primer. Older mice showed a significant increase in the expression and activity of iPPase as compared to younger ones. Short-term fasting of 24 h increased the expression and activity of iPPase in the liver of both young and old mice which were reversed upon 24 h of re-feeding them. However, both young and old mice on long-term dietary restriction showed a cumulative increase in the expression and activity of iPPase when compared with their age-matched controls. This might be due to accumulative adaptation to refill energy deficiency of long-term dietary restricted mice for ATP generation via oxidative phosphorylation, where fatty acid activation could be driven by elevated iPPase.
C1 [Kharbhih, Wanaiborlang Jala; Sharma, Ramesh] North Eastern Hill Univ, Dept Biochem, Shillong 793022, Meghalaya, India.
C3 North Eastern Hill University
RP Sharma, R (corresponding author), North Eastern Hill Univ, Dept Biochem, Shillong 793022, Meghalaya, India.
EM sharamesh@gmail.com
FU CSIR, New Delhi [09/347(0185)/2009-EMR-1]
FX Authors are thankful to the Department of Biochemistry, North-Eastern
   Hill University, Shillong for providing research facilities under
   UGC-UPE, DRS and DST-FIST, New Delhi. WJK thanks CSIR, New Delhi for the
   Fellowship as JRF and SRF (F.No: 09/347(0185)/2009-EMR-1).
CR BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Cavallini G, 2001, EXP GERONTOL, V36, P497, DOI 10.1016/S0531-5565(00)00224-2
   Chen GA, 2002, CLIN CANCER RES, V8, P2298
   Clark JM, 2006, J CLIN GASTROENTEROL, V40, pS5
   Dhahbi JM, 2001, MECH AGEING DEV, V122, P1033, DOI 10.1016/S0047-6374(01)00230-5
   Donati A, 2008, J GERONTOL A-BIOL, V63, P550, DOI 10.1093/gerona/63.6.550
   Everitt AV, 2010, CALORIE RESTRICTION, AGING AND LONGEVITY, P1, DOI 10.1007/978-90-481-8556-6
   Goyary D, 2008, BIOGERONTOLOGY, V9, P11, DOI 10.1007/s10522-007-9112-8
   Hagopian K, 2003, EXP GERONTOL, V38, P267, DOI 10.1016/S0531-5565(02)00202-4
   Heinonen JK, 2001, BIOLOGICAL ROLE INOR
   Higami Y, 2006, J GERONTOL A-BIOL, V61, P1099, DOI 10.1093/gerona/61.11.1099
   Huang SB, 2008, TRENDS PLANT SCI, V13, P221, DOI 10.1016/j.tplants.2008.02.007
   Johnson K, 2001, J RHEUMATOL, V28, P2681
   Kuhla B, 2007, PROTEOMICS, V7, P3602, DOI 10.1002/pmic.200700248
   Lexander H, 2005, ANAL QUANT CYTOL, V27, P263
   Martin GG, 2008, J NUTR, V138, P1859, DOI 10.1093/jn/138.10.1859
   OBLED C, 1991, J NUTR, V121, P1990, DOI 10.1093/jn/121.12.1990
   Panda H, 2007, BIOGERONTOLOGY, V8, P517, DOI 10.1007/s10522-007-9094-6
   Polewski MD, 2010, BONE, V46, P81, DOI 10.1016/j.bone.2009.08.055
   Sang-Ho J, 2012, TUMOR BIOL, V33, P1889
   Sharma R, 2004, CURR SCI INDIA, V87, P1203
   SHATTON JB, 1983, ANAL BIOCHEM, V130, P114, DOI 10.1016/0003-2697(83)90657-7
   Speakman JR, 2007, J NUTR, V137, P1078, DOI 10.1093/jn/137.4.1078
   Suchiang K, 2011, BIOGERONTOLOGY, V12, P581, DOI 10.1007/s10522-011-9356-1
   Syiem DK, 1996, INDIAN J BIOCHEM BIO, V33, P363
   Terkeltaub RA, 2001, AM J PHYSIOL-CELL PH, V281, pC1, DOI 10.1152/ajpcell.2001.281.1.C1
   Tollet-Egnell P, 2001, MOL ENDOCRINOL, V15, P308, DOI 10.1210/me.15.2.308
   Weinert BT, 2003, J APPL PHYSIOL, V95, P1706, DOI 10.1152/japplphysiol.00288.2003
   Weissen-Plenz G, 2008, ADV CLIN CHEM, V46, P263, DOI 10.1016/S0065-2423(08)00407-1
NR 29
TC 10
Z9 11
U1 0
U2 5
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1389-5729
EI 1573-6768
J9 BIOGERONTOLOGY
JI Biogerontology
PD FEB
PY 2014
VL 15
IS 1
BP 81
EP 86
DI 10.1007/s10522-013-9481-0
PG 6
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA AA0GW
UT WOS:000330774600007
PM 24271717
DA 2024-02-19
ER

PT J
AU Kim, C
   Jadhav, RR
   Gustafson, CE
   Smithey, MJ
   Hirsch, AJ
   Uhrlaub, JL
   Hildebrand, WH
   Nikolich-Zugich, J
   Weyand, CM
   Goronzy, JJ
AF Kim, Chulwoo
   Jadhav, Rohit R.
   Gustafson, Claire E.
   Smithey, Megan J.
   Hirsch, Alec J.
   Uhrlaub, Jennifer L.
   Hildebrand, William H.
   Nikolich-Zugich, Janko
   Weyand, Cornelia M.
   Goronzy, Jorg J.
TI Defects in Antiviral T Cell Responses Inflicted by Aging-Associated
   miR-181a Deficiency
SO CELL REPORTS
LA English
DT Article
ID INFLUENZA VACCINE; EXPRESSION; VIRUS; SELECTION; EFFECTOR; IMMUNITY;
   PHASE; IMMUNOSENESCENCE; DIFFERENTIATION; IMMUNOGENICITY
AB Generation of protective immunity to infections and vaccinations declines with age. Studies in healthy individuals have implicated reduced miR-181a expression in T cells as contributing to this defect. To understand the impact of miR-181a expression on antiviral responses, we examined LCMV infection in mice with miR-181ab1-deficient T cells. We found that miR-181a deficiency delays viral clearance, thereby biasing the immune response in favor of CD4 over CD8 T cells. Antigen-specific CD4 T cells in mice with miR-181a-deficient T cells expand more and have a broader TCR repertoire with preferential expansion of high-affinity T cells than in wild-type mice. Importantly, generation of antigen-specific miR-181a-deficient CD8 effector T cells is particularly impaired, resulting in lower frequencies of CD8 T cells in the liver even at time points when the infection has been cleared. Consistent with the mouse model, CD4 memory T cells in individuals infected with West Nile virus at older ages tend to be more frequent and of higher affinity.
C1 [Kim, Chulwoo; Jadhav, Rohit R.; Gustafson, Claire E.; Weyand, Cornelia M.; Goronzy, Jorg J.] Stanford Univ, Dept Med, Div Immunol & Rheumatol, Stanford, CA 94305 USA.
   [Kim, Chulwoo; Jadhav, Rohit R.; Gustafson, Claire E.; Weyand, Cornelia M.; Goronzy, Jorg J.] Palo Alto Vet Adm Healthcare Syst, Dept Med, Palo Alto, CA 94306 USA.
   [Smithey, Megan J.; Uhrlaub, Jennifer L.; Nikolich-Zugich, Janko] Univ Arizona, Dept Immunobiol, Coll Med, Tucson, AZ 85724 USA.
   [Smithey, Megan J.; Uhrlaub, Jennifer L.; Nikolich-Zugich, Janko] Univ Arizona, Arizona Ctr Aging, Coll Med, Tucson, AZ 85724 USA.
   [Hirsch, Alec J.] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97006 USA.
   [Hildebrand, William H.] Univ Oklahoma, Dept Microbiol & Immunol, Hlth Sci Ctr, Oklahoma City, OK 73104 USA.
C3 Stanford University; University of Arizona; University of Arizona;
   Oregon Health & Science University; University of Oklahoma System;
   University of Oklahoma Health Sciences Center
RP Goronzy, JJ (corresponding author), Stanford Univ, Dept Med, Div Immunol & Rheumatol, Stanford, CA 94305 USA.; Goronzy, JJ (corresponding author), Palo Alto Vet Adm Healthcare Syst, Dept Med, Palo Alto, CA 94306 USA.
EM jgoronzy@stanford.edu
RI Kim, Chulwoo/AAL-8854-2021; Jadhav, Rohit/D-2254-2016; Weyand,
   Cornelia/AAH-3343-2021
OI Kim, Chulwoo/0000-0001-5736-8170; Jadhav, Rohit/0000-0002-2999-6329;
   Gustafson, Claire/0000-0002-1437-6709; Goronzy, Jorg/0000-0001-7670-1856
FU National Institutes of Health (NIH) [R01 AI108891, R01 AG045779, U19
   AI057266, R01 AI129191, R01 AR042527, R01 HL117913, R01 AI108906, P01
   HL129941, N01 AI00017]
FX We thank Dr. C.Z. Chen (Stanford University) for generously providing
   miR181ab1fl/fl mice and Dr. R. Ahmed (Emory University) and Dr. S. Hale
   (University of Utah) for providing SMARTA mice and LCMV-Armstrong and
   Lm-gp61 constructs. We thank Y.S. Choi (Seoul National University, South
   Korea) for LMPd-Ametrine vector and the NIH tetramer core facility
   (Atlanta, GA) for providing tetramers. This work was supported by the
   National Institutes of Health (NIH) (R01 AI108891, R01 AG045779, U19
   AI057266, R01 AI129191 to J.J.G.; R01 AR042527, R01 HL117913, R01
   AI108906, and P01 HL129941 to C.M.W.; and N01 AI00017 to J.N.-Z.). The
   content is solely the responsibility of the authors and does not
   necessarily represent the official views of the NIH.
CR Agius E, 2009, J EXP MED, V206, P1929, DOI 10.1084/jem.20090896
   AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521
   Akondy RS, 2017, NATURE, V552, P362, DOI 10.1038/nature24633
   [Anonymous], 2001, T CELL RECEPTOR FACT
   BENDER BS, 1991, IMMUNOLOGY, V72, P514
   Bolotin DA, 2015, NAT METHODS, V12, P380, DOI 10.1038/nmeth.3364
   Brien JD, 2009, J EXP MED, V206, P2735, DOI 10.1084/jem.20090222
   Choi YS, 2015, METHODS MOL BIOL, V1291, P49, DOI 10.1007/978-1-4939-2498-1_5
   Cramer JP, 2016, VACCINE, V34, P4579, DOI 10.1016/j.vaccine.2016.07.029
   Czesnikiewicz-Guzik M, 2008, CLIN IMMUNOL, V127, P107, DOI 10.1016/j.clim.2007.12.002
   D'Acremont V, 2006, J TRAVEL MED, V13, P78, DOI 10.1111/j.1708-8305.2006.00001.x
   Daniels MA, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00617
   Ebert PJR, 2009, NAT IMMUNOL, V10, P1162, DOI 10.1038/ni.1797
   Fragoso R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002855
   Goronzy JJ, 2013, NAT IMMUNOL, V14, P428, DOI 10.1038/ni.2588
   Goronzy JJ, 2019, NAT REV IMMUNOL, V19, P573, DOI 10.1038/s41577-019-0180-1
   Goronzy JJ, 2017, IMMUNITY, V46, P364, DOI 10.1016/j.immuni.2017.03.010
   Gustafson CE, 2019, AGING CELL, V18, DOI 10.1111/acel.12879
   Henao-Mejia J, 2013, IMMUNITY, V38, P984, DOI 10.1016/j.immuni.2013.02.021
   Herati RS, 2014, J IMMUNOL, V193, P3528, DOI 10.4049/jimmunol.1302503
   James EA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005375
   Jelley-Gibbs DM, 2005, J EXP MED, V202, P697, DOI 10.1084/jem.20050227
   Jílková E, 2009, EXPERT OPIN BIOL TH, V9, P797, DOI 10.1517/14712590903066711
   Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010
   Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720
   Kapasi ZF, 2002, EUR J IMMUNOL, V32, P1567, DOI 10.1002/1521-4141(200206)32:6<1567::AID-IMMU1567>3.0.CO;2-P
   Kim C, 2017, CLIN EXP IMMUNOL, V187, P71, DOI 10.1111/cei.12829
   Kim C, 2018, CELL REP, V25, P2148, DOI 10.1016/j.celrep.2018.10.074
   Krishnamoorthy V, 2017, IMMUNITY, V47, P481, DOI 10.1016/j.immuni.2017.09.001
   Kumar BV, 2018, IMMUNITY, V48, P202, DOI 10.1016/j.immuni.2018.01.007
   Langley JM, 2011, J INFECT DIS, V203, P1729, DOI 10.1093/infdis/jir172
   Lelic A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003076
   Li GJ, 2012, NAT MED, V18, P1518, DOI 10.1038/nm.2963
   Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008
   Lindsey Nicole P., 2010, Morbidity and Mortality Weekly Report, V59, P1
   McKinstry KK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6377
   Moskowitz DM, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aag0192
   Nikolich-Zugich J, 2018, NAT IMMUNOL, V19, P10, DOI 10.1038/s41590-017-0006-x
   Nikolich-Zugich J, 2012, SEMIN IMMUNOL, V24, P356, DOI 10.1016/j.smim.2012.04.009
   Obst R, 2005, J EXP MED, V201, P1555, DOI 10.1084/jem.20042521
   Pallett LJ, 2017, J EXP MED, V214, P1567, DOI 10.1084/jem.20162115
   Pera A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088538
   Piazza P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015343
   Qi Q, 2014, P NATL ACAD SCI USA, V111, P13139, DOI 10.1073/pnas.1409155111
   Roukens AH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027753
   Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641
   Schaffert SA, 2015, J IMMUNOL, V195, P1470, DOI 10.4049/jimmunol.1401587
   Schulz AR, 2015, J IMMUNOL, V195, P4699, DOI 10.4049/jimmunol.1500598
   Smithey MJ, 2018, P NATL ACAD SCI USA, V115, pE6817, DOI 10.1073/pnas.1719451115
   Smithey MJ, 2011, EUR J IMMUNOL, V41, P1352, DOI 10.1002/eji.201041141
   Snook JP, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aas9103
   Stewart JJ, 1997, MOL IMMUNOL, V34, P1067, DOI 10.1016/S0161-5890(97)00130-2
   Targonski PV, 2007, VACCINE, V25, P3066, DOI 10.1016/j.vaccine.2007.01.025
   Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179
   Van Epps P, 2014, IMMUN AGEING, V11, DOI 10.1186/1742-4933-11-14
   Weinberger B, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01035
   Williams MA, 2004, J IMMUNOL, V173, P6694, DOI 10.4049/jimmunol.173.11.6694
   Williams MA, 2008, IMMUNITY, V28, P533, DOI 10.1016/j.immuni.2008.02.014
   Ye ZD, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05552-3
   Zhang DJ, 2005, J IMMUNOL, V174, P6725, DOI 10.4049/jimmunol.174.11.6725
   Zhou B, 2012, DIABETOLOGIA, V55, P2032, DOI 10.1007/s00125-012-2539-8
   Zhou Y, 2016, J LEUKOCYTE BIOL, V100, P1201, DOI 10.1189/jlb.5A0316-119RR
NR 62
TC 25
Z9 26
U1 1
U2 6
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD NOV 19
PY 2019
VL 29
IS 8
BP 2202
EP +
DI 10.1016/j.celrep.2019.10.044
PG 20
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA JP0IA
UT WOS:000497954200010
PM 31747595
OA Green Accepted, Green Published, gold
DA 2024-02-19
ER

PT J
AU Ribeiro, H
   Rodrigues, I
   Napoleao, L
   Lira, L
   Marques, D
   Veríssimo, M
   Andrade, JP
   Dourado, M
AF Ribeiro, Hugo
   Rodrigues, Ines
   Napoleao, Leonardo
   Lira, Luis
   Marques, Denise
   Verissimo, Manuel
   Andrade, Jose Paulo
   Dourado, Marilia
TI Non-steroidal anti-inflammatory drugs (NSAIDs), pain and aging:
   Adjusting prescription to patient features
SO BIOMEDICINE & PHARMACOTHERAPY
LA English
DT Article; Early Access
DE Anti-inflammatory drugs; Pharmacokinetics; Pain; Aging; Narrative review
ID PRODRUGS
AB A narrative review of papers published from January 2011 to December 2021, after a literature search in selected databases using the terms "pharmacokinetics", "ibuprofen", "diclofenac", "acemetacin", "naproxen", "etodolac" and "etoricoxib" was performed. From 828 articles identified, only eight met the inclusion criteria. Selective COX-2 inhibitors are associated with higher cardiovascular risk, while non-selective COX inhibitors are associated with higher gastrointestinal risk. NSAIDs with lower renal excretion with phase 2 metabolism are less likely to induce adverse effects and drug-drug interactions. Patients with frequent NSAID use needs, such as elderly patients and patients with cardiovascular disease or impaired renal function, will benefit from lower renal excretion (e.g. acemethacin, diclofenac, and etodolac) (level of evidence 3). Polymedicated patients, elderly patients, and patients with chronic alcohol abuse will be at a lower risk for adverse effects with NSAIDs that undergo phase 2 liver biotransformation, namely, acemethacin and diclofenac (level of evidence 3). Young patients, patients dealing with acute pain, or with active and/or chronic symptomatic gastritis, selective COX-2 inhibitors (celecoxib or etoricoxib) may be a better option (level of evidence 2). Knowing the individual characteristics of the patients, combined with knowledge on basic pharmacology, offers greater safety and better adherence to therapy.
   Perspective: Although there are several NSAIDs options to treat pain, physicians usually take special care to its prescription regarding cardiovascular and gastrointestinal side effects, despite the age of the patient. In this paper, based on the best evidence, the authors present a review of the safest NSAIDs to use in the elderly.
C1 [Ribeiro, Hugo] Univ Porto, PhD Palliat Care Student Fac Med, Palliat Care Unit Hlth Ctr Cluster Gaia, Porto, Portugal.
   [Ribeiro, Hugo; Verissimo, Manuel; Dourado, Marilia] Univ Coimbra, Fac Med, Coimbra, Portugal.
   [Rodrigues, Ines; Lira, Luis] Family Hlth Unit Barao Corvo Hlth Ctr Cluster Gai, Gaia, Portugal.
   [Napoleao, Leonardo] Family Hlth Unit Canelas Hlth Ctr Cluster Espinho, Gaia, Portugal.
   [Marques, Denise] Bial Med Dept, Lisbon, Portugal.
   [Verissimo, Manuel] Coimbra Univ Hosp, Coimbra, Portugal.
   [Andrade, Jose Paulo] Univ Porto, Fac Med, Unit Anat, Dept Biomed, Porto, Portugal.
C3 Universidade do Porto; Universidade de Coimbra; Universidade de Coimbra;
   Centro Hospitalar e Universitario de Coimbra (CHUC); Universidade do
   Porto
RP Ribeiro, H (corresponding author), R Bartolomeu Dias 316, P-4430043 Vila Nova De Gaia, Portugal.
EM haribeiro@arsnorte.min-saude.pt
RI Napoleão, Leonardo/AHB-6311-2022; Andrade, Jose Paulo/L-8036-2013
OI Napoleão, Leonardo/0000-0002-3280-7867; Dourado,
   Marilia/0000-0002-5003-4722; Verissimo, Manuel/0000-0002-2793-2129;
   Andrade, Jose Paulo/0000-0003-2585-200X; O. Rodrigues,
   Ines/0000-0003-0335-0156; Ribeiro, Hugo/0000-0001-6623-7420
CR [Anonymous], 2021, REP PUBL ONL AMR
   Arfè A, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4857
   Crofford LJ, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4174
   Davies NM, 2000, CLIN PHARMACOKINET, V38, P377, DOI 10.2165/00003088-200038050-00001
   Ferrell B, 2009, J AM GERIATR SOC, V57, P1331, DOI 10.1111/j.1532-5415.2009.02376.x
   Fialova D, 2019, EUR J CLIN PHARMACOL, V75, P451, DOI 10.1007/s00228-018-2603-5
   Gunter BR, 2017, J CLIN PHARM THER, V42, P27, DOI 10.1111/jcpt.12484
   Halen PK, 2009, MINI-REV MED CHEM, V9, P124, DOI 10.2174/138955709787001695
   MacDonald TM, 2017, EUR HEART J, V38, P1843, DOI 10.1093/eurheartj/ehw387
   Novaes PH, 2017, INT J CLIN PHARM-NET, V39, P818, DOI 10.1007/s11096-017-0470-2
   Pelletier JP, 2016, SEMIN ARTHRITIS RHEU, V45, pS22, DOI 10.1016/j.semarthrit.2015.11.009
   Qandil AM, 2012, INT J MOL SCI, V13, P17244, DOI 10.3390/ijms131217244
   Rao PNP, 2008, J PHARM PHARM SCI, V11, P81, DOI 10.18433/J3T886
   Sehajpal S, 2018, MINI-REV MED CHEM, V18, P1199, DOI 10.2174/1389557518666180330112416
   Sondergaard KB, 2017, EUR HEART J-CARD PHA, V3, P100, DOI 10.1093/ehjcvp/pvw041
   Suthar SK, 2015, MED RES REV, V35, P341, DOI 10.1002/med.21331
   Wallace JL, 2003, FUND CLIN PHARMACOL, V17, P11, DOI 10.1046/j.1472-8206.2003.00125.x
   Whittle BJR, 2003, FUND CLIN PHARMACOL, V17, P301, DOI 10.1046/j.1472-8206.2003.00135.x
NR 18
TC 17
Z9 18
U1 3
U2 9
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI ISSY-LES-MOULINEAUX
PA 65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE
SN 0753-3322
EI 1950-6007
J9 BIOMED PHARMACOTHER
JI Biomed. Pharmacother.
PD 2022 JUN
PY 2022
VL 150
AR 112958
DI 10.1016/j.biopha.2022.112958
EA APR 2022
PG 6
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA 2H4KZ
UT WOS:000814266700003
PM 35453005
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Sun, HD
   Gao, YC
   Lu, KM
   Zhao, GM
   Li, XH
   Li, Z
   Chang, H
AF Sun, Huidong
   Gao, Yanchao
   Lu, Kemei
   Zhao, Guimei
   Li, Xuehua
   Li, Zhu
   Chang, Hong
TI Overexpression of Klotho suppresses liver cancer progression and induces
   cell apoptosis by negatively regulating wnt/β-catenin signaling pathway
SO WORLD JOURNAL OF SURGICAL ONCOLOGY
LA English
DT Article
DE Klotho; beta-catenin; Apoptosis; Liver cancer
ID LUNG-CANCER; GROWTH; RISK; INHIBITION; INVASION; CHINA
AB Background: Klotho is a discovered aging suppressor gene, and its overexpression in mice extends the life span of the animal. Recently, Klotho is also identified as a tumor suppressor gene in variety of tumors; however, the potential role and the antitumor mechanism remain unclarified in liver cancers.
   Methods: RT-PCR and western blotting analysis were used to detect the expression of Klotho, beta-catenin, C-myc, and Cyclin D1. MTT assay was used to detect the survival rates of HepG2 and SMMC-7721 cells. Colony formation assay was used to test the proliferation ability in Klotho transfected cells. FACS was used to detect the cell apoptosis rate in different groups.
   Results: The results showed that lower expression of Klotho were found in liver cancer cell lines than the immortalized liver cell L02. Also, MTT assay results found that overexpression or recombinant Klotho administration suppressed the proliferation of liver cancer cells HepG2 and SMMC-7721. Moreover, the colony formation assay results showed that the number of colonies was significantly lower in the cells with transfection with pCMV-Klotho than the controls. Thus, functional analysis demonstrated that Klotho expression inhibited the proliferation of liver cancer cells and Klotho worked as an important antitumor gene in tumor progression. Next, the mechanism was partly clarified that Klotho expression induced cell apoptosis in HepG2 and SMMC-7721 cells, and this phenomenon was mainly involved in the Wnt/beta-catenin signaling pathway. The western blotting analysis revealed that overexpression or recombinant administration of Klotho obviously decreased the expression levels of beta-catenin, C-myc, and Cyclin D1 in HepG2 cells. Most importantly, the antitumor mechanism for Klotho due to that overexpression of Klotho not only decreased the endogenous beta-catenin levels but also inhibited the nuclear translocation of beta-catenin to delay the cell cycle progression.
   Conclusions: Klotho was a tumor suppressor gene, and overexpression of Klotho suppressed the proliferation of liver cancer cells partly due to negative regulation of Wnt/beta-catenin signaling pathway. So, Klotho might be used as a potential target, and the study will contribute to treatment for therapy of liver cancer patients.
C1 [Sun, Huidong; Gao, Yanchao; Zhao, Guimei; Li, Xuehua; Li, Zhu] Surg Liaocheng Peoples Hosp, Dept Hepatobiliary, Liaocheng 252000, Shandong, Peoples R China.
   [Lu, Kemei] Liaocheng Peoples Hosp, Dept Gastroenterol, Liaocheng 252000, Shandong, Peoples R China.
   [Sun, Huidong; Chang, Hong] Shandong Univ, Shandong Prov Hosp, Dept Hepatobiliary Surg, Jinan 250021, Shandong, Peoples R China.
C3 Shandong University; Shandong First Medical University & Shandong
   Academy of Medical Sciences
RP Chang, H (corresponding author), Shandong Univ, Shandong Prov Hosp, Dept Hepatobiliary Surg, Jinan 250021, Shandong, Peoples R China.
EM changhong_1998@163.com
CR Bester L, 2014, J MED IMAG RADIAT ON, V58, P341, DOI 10.1111/1754-9485.12163
   Borena W, 2012, INT J CANCER, V131, P193, DOI 10.1002/ijc.26338
   Chang B, 2012, ONCOL REP, V28, P1022, DOI 10.3892/or.2012.1865
   Chen B, 2012, CANCER BIOL THER, V13, P1221, DOI 10.4161/cbt.21420
   Chen B, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-99
   Chen WQ, 2013, CHIN J CANCER, V32, P162, DOI 10.5732/cjc.013.10027
   Chuang SC, 2010, CANCER EPIDEM BIOMAR, V19, P1261, DOI 10.1158/1055-9965.EPI-09-1297
   Darvesh AS, 2012, CURR PHARM BIOTECHNO, V13, P218
   Dërmaku-Sopjani M, 2013, MOL MEMBR BIOL, V30, P369, DOI 10.3109/09687688.2013.837518
   Doi S, 2011, J BIOL CHEM, V286, P8655, DOI 10.1074/jbc.M110.174037
   Fang Jia-Ying, 2015, Asian Pac J Cancer Prev, V16, P1959
   Gao J, 2013, EUR J CANCER PREV, V22, P448, DOI 10.1097/CEJ.0b013e32835de82a
   Kudo M, 2012, CURR CANCER DRUG TAR, V12, P1062
   Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285
   Lee EY, 2015, EPIDEMIOL HEALTH, V37, DOI 10.4178/epih/e2015016
   Li XX, 2014, INT J ONCOL, V45, P611, DOI 10.3892/ijo.2014.2430
   Lojkin I, 2015, CANC LETT
   Lu L, 2008, CANCER INVEST, V26, P185, DOI 10.1080/07357900701638343
   Pan HM, 2011, ANTI-CANCER AGENT ME, V11, P493, DOI 10.2174/187152011796011073
   Persson EC, 2012, BRIT J CANCER, V107, P195, DOI 10.1038/bjc.2012.193
   Sun ZT, 2013, CARCINOGENESIS, V34, P1800, DOI 10.1093/carcin/bgt007
   Usuda J, 2011, LUNG CANCER, V74, P332, DOI 10.1016/j.lungcan.2011.03.004
   Wang LJ, 2011, AM J CANCER RES, V1, P111
   Xie B, 2013, PATHOL ONCOL RES, V19, P611, DOI 10.1007/s12253-013-9663-8
   Zhang ZM, 2014, ASIAN PAC J CANCER P, V15, P8823, DOI 10.7314/APJCP.2014.15.20.8823
NR 25
TC 36
Z9 41
U1 0
U2 9
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1477-7819
J9 WORLD J SURG ONCOL
JI World J. Surg. Oncol.
PD OCT 24
PY 2015
VL 13
AR 307
DI 10.1186/s12957-015-0717-0
PG 8
WC Oncology; Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Surgery
GA CU6LB
UT WOS:000363642400001
PM 26499380
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Ishii, M
   Kaikita, K
   Sakamoto, K
   Seki, T
   Kawakami, K
   Nakai, M
   Sumita, Y
   Nishimura, K
   Miyamoto, Y
   Noguchi, T
   Yasuda, S
   Tsutsui, H
   Komuro, I
   Saito, Y
   Ogawa, H
   Tsujita, K
AF Ishii, Masanobu
   Kaikita, Koichi
   Sakamoto, Kenji
   Seki, Tomotsugu
   Kawakami, Koji
   Nakai, Michikazu
   Sumita, Yoko
   Nishimura, Kunihiro
   Miyamoto, Yoshihiro
   Noguchi, Teruo
   Yasuda, Satoshi
   Tsutsui, Hiroyuki
   Komuro, Issei
   Saito, Yoshihiko
   Ogawa, Hisao
   Tsujita, Kenichi
CA JROAD Investigators
TI Characteristics and in-hospital mortality of patients with myocardial
   infarction in the absence of obstructive coronary artery disease in
   super-aging society
SO INTERNATIONAL JOURNAL OF CARDIOLOGY
LA English
DT Article
ID MODELS
AB Background: Myocardial infarction with nonobstructive coronary arteries (MINOCA) is a common presentation of acute myocardial infarction (AMI) and has a better prognosis. However, there were few reports on large-scale, high aged population. The aim of this study was to determine the differences in the clinical characteristics and short-term prognosis between MINOCA and myocardial infarction with obstructive coronary artery disease (MI-CAD) using a nationwide administrative database in the super-aging society, Japan.
   Methods: This was an observational study using data of 137,673 AMI patients who underwent angiography between April 2012 through March 2016. Using the international classification of diseases 10th revision, AMI patients were divided into two groups based on the presence or absence of revascularization and coronary atherosclerosis, identifying 123,633 MI-CAD and 14,045 working diagnosis of MINOCA patients. The true MINOCA (n 13,022) was defined as the MINOCA excluding non-ischemic causes. We assessed in-hospital mortality within 30 days.
   Results: Both MINOCA groups were typically found in non-obese, non-smoker young females, with a low grade on Killip classification, and non-low ADL status. Compared to MI-CAD, chronic pulmonary diseases, peripheral vascular diseases, liver diseases, renal diseases, and cerebrovascular diseases were more common, whereas diabetes was less common in the MINOCA groups. In-hospital mortality within 30 days was higher in both MINOCA groups than in MI-CAD. Multivariate frailty model identified both MINOCA groups as an independent risk factor for in-hospital mortality.
   Conclusions: Our large-population study demonstrated that MINOCA was associated with a high risk of in hospital mortality compared with MI-CAD in the super-aging society. (C) 2019 Elsevier B.V. All rights reserved.
C1 [Ishii, Masanobu; Kaikita, Koichi; Sakamoto, Kenji; Tsujita, Kenichi] Kumamoto Univ, Grad Sch Med Sci, Kumamoto, Japan.
   [Ishii, Masanobu; Seki, Tomotsugu; Kawakami, Koji] Kyoto Univ, Grad Sch Med & Publ Hlth, Kyoto, Japan.
   [Ishii, Masanobu; Nakai, Michikazu; Sumita, Yoko; Nishimura, Kunihiro; Miyamoto, Yoshihiro; Noguchi, Teruo; Yasuda, Satoshi] Natl Cerebral & Cardiovasc Ctr, Suita, Osaka, Japan.
   [Saito, Yoshihiko; Ogawa, Hisao] Nara Med Univ, Sch Med, Kashihara, Nara, Japan.
   [Tsutsui, Hiroyuki] Kyusyri Univ, Fac Med Sci, Fukuoka, Japan.
   [Komuro, Issei] Univ Tokyo, Grad Sch Med, Tokyo, Japan.
   [Komuro, Issei] Univ Tokyo, Fac Med, Tokyo, Japan.
C3 Kumamoto University; Kyoto University; National Cerebral &
   Cardiovascular Center - Japan; Nara Medical University; University of
   Tokyo; University of Tokyo
RP Kaikita, K (corresponding author), Kumamoto Univ, Grad Sch Med Sci, Dept Cardiovasc Med, 1-1-1,14onjo, Kumamoto 8608556, Japan.
EM kaikitak@kumamoto-u.ac.jp
RI Ishii, Masanobu/CAF-7899-2022; Kawakami, Koji/GZA-6582-2022; Ishii,
   Masanobu/CAG-0498-2022; Miyamoto, Yoshihiro/L-8583-2013; Tsujita,
   Kenichi/AAG-4562-2021; Nakai, Michikazu/ADJ-0980-2022; Seki,
   Tomotsugu/JKI-4447-2023
OI Ishii, Masanobu/0000-0003-4137-9136; Kawakami, Koji/0000-0002-7477-4071;
   Ishii, Masanobu/0000-0003-4137-9136; Miyamoto,
   Yoshihiro/0000-0002-1337-0508; Seki, Tomotsugu/0000-0002-3387-9774;
   Sakamoto, Kenji/0000-0003-4076-8981
FU Minister of Education, Science, Sports and Culture; JSPS KAKENHI
   [JP19K17531]
FX This study was supported by Scholarship from the Minister of Education,
   Science, Sports and Culture, who entrusts the head with the management
   of accounts, and JSPS KAKENHI Grant-in-Aid for Early-Career Scientists
   Grand Number JP19K17531.
CR Agewall S, 2017, EUR HEART J, V38, P143, DOI 10.1093/eurheartj/ehw149
   Austin PC, 2017, INT STAT REV, V85, P185, DOI 10.1111/insr.12214
   Beltrame JF, 2017, EUR HEART J, V38, P2565, DOI 10.1093/eurheartj/ehv351
   Beltrame JF, 2013, J INTERN MED, V273, P182, DOI 10.1111/j.1365-2796.2012.02591.x
   Biesheuvel CJ, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-48
   Deyama J, 2018, INT J CARDIOL, V257, P7, DOI 10.1016/j.ijcard.2017.08.002
   Jaffa MA, 2016, J APPL STAT, V43, P1447, DOI 10.1080/02664763.2015.1103708
   Kanaoka K, 2018, CIRC J, V82, P2845, DOI 10.1253/circj.CJ-18-0487
   Lindahl B, 2017, CIRCULATION, V135, P1481, DOI 10.1161/CIRCULATIONAHA.116.026336
   Marshall A, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-57
   Nakayama N, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000795
   Pasupathy S, 2017, CIRCULATION, V135, P1490, DOI 10.1161/CIRCULATIONAHA.117.027666
   Pasupathy S, 2015, CIRC J, V80, P11, DOI 10.1253/circj.CJ-15-1096
   Pasupathy S, 2015, CIRCULATION, V131, P861, DOI 10.1161/CIRCULATIONAHA.114.011201
   Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83
   Quan HD, 2011, AM J EPIDEMIOL, V173, P676, DOI 10.1093/aje/kwq433
   Sá FM, 2018, CORONARY ARTERY DIS, V29, P511, DOI 10.1097/MCA.0000000000000619
   Safdar B, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.009174
   Tamis-Holland JE, 2019, CIRCULATION, V139, pE891, DOI 10.1161/CIR.0000000000000670
   Tamis-Holland JE, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.009635
   Thygesen K, 2012, GLOB HEART, V7, DOI 10.1016/j.gheart.2012.08.001
   Yamana H, 2017, J EPIDEMIOL, V27, P476, DOI 10.1016/j.je.2016.09.009
   Yasuda S, 2018, CIRCULATION, V138, P965, DOI 10.1161/CIRCULATIONAHA.118.035858
   Yasuda S, 2016, CIRC J, V80, P2327, DOI 10.1253/circj.CJ-16-0196
NR 24
TC 29
Z9 30
U1 0
U2 22
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0167-5273
EI 1874-1754
J9 INT J CARDIOL
JI Int. J. Cardiol.
PD FEB 15
PY 2020
VL 301
BP 108
EP 113
DI 10.1016/j.ijcard.2019.09.037
PG 6
WC Cardiac & Cardiovascular Systems
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology
GA KC0NP
UT WOS:000506884700024
PM 31740139
DA 2024-02-19
ER

PT J
AU Zahid, S
   Dafre, AL
   Currais, A
   Yu, JT
   Schubert, D
   Maher, P
AF Zahid, Saadia
   Dafre, Alcir L. L.
   Currais, Antonio
   Yu, Jingting
   Schubert, David
   Maher, Pamela
TI The Geroprotective Drug Candidate CMS121 Alleviates Diabetes, Liver
   Inflammation, and Renal Damage in db/db Leptin Receptor Deficient Mice
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE geroneuroprotector; Alzheimer's disease; obesity; metabolic disorders;
   inflammation; kidney damage
ID ALZHEIMERS-DISEASE; INSULIN-RESISTANCE; OXIDATIVE STRESS; ACID;
   MITOCHONDRIAL; METABOLOME; FISETIN; DYSFUNCTION; INHIBITION; CONTRIBUTE
AB db/db mice, which lack leptin receptors and exhibit hyperphagia, show disturbances in energy metabolism and are a model of obesity and type 2 diabetes. The geroneuroprotector drug candidate CMS121 has been shown to be effective in animal models of Alzheimer's disease and aging through the modulation of metabolism. Thus, the hypothesis was that CMS121 could protect db/db mice from metabolic defects and thereby reduce liver inflammation and kidney damage. The mice were treated with CMS121 in their diet for 6 months. No changes were observed in food and oxygen consumption, body mass, or locomotor activity compared to control db/db mice, but a 5% reduction in body weight was noted. Improved glucose tolerance and reduced HbA1c and insulin levels were also seen. Blood and liver triglycerides and free fatty acids decreased. Improved metabolism was supported by lower levels of fatty acid metabolites in the urine. Markers of liver inflammation, including NF-?B, IL-18, caspase 3, and C reactive protein, were lowered by the CMS121 treatment. Urine markers of kidney damage were improved, as evidenced by lower urinary levels of NGAL, clusterin, and albumin. Urine metabolomics studies provided further evidence for kidney protection. Mitochondrial protein markers were elevated in db/db mice, but CMS121 restored the renal levels of NDUFB8, UQCRC2, and VDAC. Overall, long-term CMS121 treatment alleviated metabolic imbalances, liver inflammation, and reduced markers of kidney damage. Thus, this study provides promising evidence for the potential therapeutic use of CMS121 in treating metabolic disorders.
C1 [Zahid, Saadia; Dafre, Alcir L. L.; Currais, Antonio; Schubert, David; Maher, Pamela] Salk Inst Biol Studies, Cellular Neurobiol Lab, La Jolla, CA 92037 USA.
   [Zahid, Saadia] Natl Univ Sci & Technol NUST, Atta ur Rahman Sch Appl Biosci, Neurobiol Res Lab, Islamabad 44000, Pakistan.
   [Dafre, Alcir L. L.] Univ Fed Santa Catarina, Biochem Dept, BR-88040900 Florianopolis, SC, Brazil.
   [Yu, Jingting] Salk Inst Biol Studies, Razavi Newman Integrat Genom & Bioinformat Core, La Jolla, CA 92037 USA.
C3 Salk Institute; National University of Sciences & Technology - Pakistan;
   Universidade Federal de Santa Catarina (UFSC); Salk Institute
RP Dafre, AL; Maher, P (corresponding author), Salk Inst Biol Studies, Cellular Neurobiol Lab, La Jolla, CA 92037 USA.; Dafre, AL (corresponding author), Univ Fed Santa Catarina, Biochem Dept, BR-88040900 Florianopolis, SC, Brazil.
EM alcir.dafre@ufsc.br; pmaher@salk.edu
RI Yu, Jingting/AAW-1416-2021; Currais, Antonio/C-1149-2009
OI Currais, Antonio/0000-0003-4142-7054; Zahid, Saadia/0000-0003-1667-554X;
   Dafre, Alcir/0000-0001-8097-4611
FU National Institutes of Health [RF1AG054714, RF1AG061296, RO1AG069206,
   R01AG067331]
FX This work was funded by grants RF1AG054714 (D.S. and P.M.), RF1AG061296
   (P.M.), RO1AG069206 (P.M.), and R01AG067331 (A.C.) from the National
   Institutes of Health.
CR Alfadhel Majid, 2018, Sudan J Paediatr, V18, P10, DOI 10.24911/SJP.2018.1.3
   [Anonymous], LANCET, V352, P837, DOI DOI 10.1016/S0140-6736(98)07019-6
   Arvanitakis Z, 2020, CURR NEUROL NEUROSCI, V20, DOI 10.1007/s11910-020-01085-9
   Asadi M, 2022, BIOTECHNOL APPL BIOC, V69, P1633, DOI 10.1002/bab.2233
   Ates G, 2020, REDOX BIOL, V36, DOI 10.1016/j.redox.2020.101648
   Bakhtiani P, 2022, CURR OPIN ENDOCRINOL, V29, P52, DOI 10.1097/MED.0000000000000698
   Barone E, 2021, FREE RADICAL BIO MED, V176, P16, DOI 10.1016/j.freeradbiomed.2021.09.006
   Barouei J, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201700184
   Benedé-Ubieto R, 2020, DIABET METAB SYND OB, V13, P439, DOI 10.2147/DMSO.S234665
   Bernard L, 2022, KIDNEY MED, V4, DOI 10.1016/j.xkme.2022.100522
   Bhori M, 2022, MOL BIOL REP, V49, P687, DOI 10.1007/s11033-021-06837-5
   Bugnicourt JM, 2013, J AM SOC NEPHROL, V24, P353, DOI 10.1681/ASN.2012050536
   Carter NS, 2021, MICROORGANISMS, V9, DOI 10.3390/microorganisms9020267
   Carvalho C, 2023, CURR OPIN NEUROBIOL, V79, DOI 10.1016/j.conb.2023.102694
   Cater M, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms231911562
   CDC Center for The Disease Control Nd Prevention, 2011, NAT DIAB FACT SHEET
   Chen J, 2021, J AGR FOOD CHEM, V69, P14176, DOI 10.1021/acs.jafc.1c05596
   Chen Q, 2021, J NAT MED-TOKYO, V75, P84, DOI 10.1007/s11418-020-01452-3
   Chen TT, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201801064
   Chiruta C, 2012, J MED CHEM, V55, P378, DOI 10.1021/jm2012563
   Cleveland KH, 2020, AM J PHYSIOL-RENAL, V319, pF773, DOI 10.1152/ajprenal.00427.2020
   Court M, 2011, PROTEOMICS, V11, P1160, DOI 10.1002/pmic.201000566
   Currais A, 2019, ELIFE, V8, DOI 10.7554/eLife.47866
   Currais A, 2015, AGING-US, V7, P937, DOI 10.18632/aging.100838
   Dai MX, 2022, J PHARMACEUT BIOMED, V219, DOI 10.1016/j.jpba.2022.114979
   Eddy S, 2020, NAT REV NEPHROL, V16, P657, DOI 10.1038/s41581-020-0286-5
   Faaitiiti KL, 2022, J FOOT ANKLE SURG, V61, P401, DOI 10.1053/j.jfas.2021.11.003
   Friederich-Persson M, 2020, AM J PHYSIOL-RENAL, V318, pF683, DOI 10.1152/ajprenal.00417.2019
   Galvan DL, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.745279
   Gao JR, 2017, EXP THER MED, V14, P1496, DOI 10.3892/etm.2017.4668
   Garris DR, 2006, PROG HISTOCHEM CYTO, V40, P181, DOI 10.1016/j.proghi.2006.02.002
   Hadley G, 2022, J NEUROL NEUROSUR PS, V93, P246, DOI 10.1136/jnnp-2021-328158
   Heng XP, 2020, CHIN J INTEGR MED, V26, P62, DOI 10.1007/s11655-018-3053-8
   Hu ZX, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/8010614
   Huang J, 2021, NPJ AGING MECH DIS, V7, DOI 10.1038/s41514-021-00057-8
   Huang JL, 2021, METABOLITES, V11, DOI 10.3390/metabo11020089
   Jackson EK, 2019, AM J PHYSIOL-REG I, V316, pR783, DOI 10.1152/ajpregu.00401.2018
   Jangra V, 2022, CUREUS J MED SCIENCE, V14, DOI 10.7759/cureus.31273
   Jiang YC, 2021, EVID-BASED COMPL ALT, V2021, DOI 10.1155/2021/9003603
   Jiang ZM, 2022, AM J PHYSIOL-ENDOC M, V324, pE24, DOI 10.1152/ajpendo.00179.2022
   Jo HA, 2021, KIDNEY INT, V99, P443, DOI 10.1016/j.kint.2020.06.031
   Kalantari S, 2019, BIOMARK MED, V13, P577, DOI 10.2217/bmm-2019-0008
   Kan E, 2015, INT OPHTHALMOL, V35, P115, DOI 10.1007/s10792-014-0029-3
   Kang YM, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22189885
   Kepchia D, 2021, AGING-US, V13, P3269, DOI 10.18632/aging.202631
   Kido J, 2020, CASE REP PEDIAT, V2020, DOI 10.1155/2020/4709548
   Korman SH, 2000, J INHERIT METAB DIS, V23, P425, DOI 10.1023/A:1005624523611
   Korolenko TA, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10102557
   LAUBE H, 1973, DIABETOLOGIA, V9, P400, DOI 10.1007/BF01239436
   Li L, 2017, MOL BIOSYST, V13, P2392, DOI 10.1039/c7mb00167c
   Lindblom Runa, 2015, Rev Diabet Stud, V12, P134, DOI 10.1900/RDS.2015.12.134
   Liu HY, 2020, FOOD FUNCT, V11, P2466, DOI 10.1039/c9fo02266j
   Liu JJ, 2018, J CLIN ENDOCR METAB, V103, P4357, DOI 10.1210/jc.2018-00947
   Liu X, 2022, J MOL CELL CARDIOL, V165, P76, DOI 10.1016/j.yjmcc.2021.12.015
   Maher P., LARGE SCALE METABOLO
   Maher P, 2020, CELL CHEM BIOL, V27, P1456, DOI 10.1016/j.chembiol.2020.10.010
   Maher Pamela, 2021, Brain Plast, V6, P155, DOI 10.3233/BPL-200104
   Maher P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021226
   Marrano N, 2023, BIOMOLECULES, V13, DOI 10.3390/biom13010183
   Mina AI, 2018, CELL METAB, V28, P656, DOI 10.1016/j.cmet.2018.06.019
   Miranda AS, 2017, CLIN SCI, V131, P1093, DOI 10.1042/CS20160927
   Mishima E, 2015, J AM SOC NEPHROL, V26, P1787, DOI 10.1681/ASN.2014060530
   Mizdrak M, 2022, J PERS MED, V12, DOI 10.3390/jpm12040548
   Ntrinias Theodoros, 2019, Pril (Makedon Akad Nauk Umet Odd Med Nauki), V40, P27, DOI 10.2478/prilozi-2020-0002
   O'Farrell M, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-19459-z
   Okajima Y, 2022, BBA-MOL BASIS DIS, V1868, DOI 10.1016/j.bbadis.2022.166339
   Onaolapo AY, 2023, CURR DIABETES REV, V19, DOI 10.2174/1573399819666230102141154
   Oyarzún C, 2017, MOL ASPECTS MED, V55, P75, DOI 10.1016/j.mam.2017.01.004
   Pelantová H, 2016, MOL CELL ENDOCRINOL, V431, P88, DOI 10.1016/j.mce.2016.05.003
   Pernow J, 2016, CURR VASC PHARMACOL, V14, P155, DOI 10.2174/1570161114666151202205617
   Polis B, 2018, NEUROTHERAPEUTICS, V15, P1036, DOI 10.1007/s13311-018-0669-5
   Posada-Ayala M, 2014, KIDNEY INT, V85, P103, DOI 10.1038/ki.2013.328
   Prasath GS, 2014, EUR J PHARMACOL, V740, P248, DOI 10.1016/j.ejphar.2014.06.065
   Prasath GS, 2011, EUR J PHARMACOL, V668, P492, DOI 10.1016/j.ejphar.2011.07.021
   Prior M, 2014, ACS CHEM NEUROSCI, V5, P503, DOI 10.1021/cn500051h
   Rajaram RD, 2019, NEPHROL DIAL TRANSPL, V34, P567, DOI 10.1093/ndt/gfy161
   Saucedo AL, 2018, CURR MED CHEM, V25, P3719, DOI 10.2174/0929867325666180307110908
   Saulnier PJ, 2018, METABOLOMICS, V14, DOI 10.1007/s11306-018-1380-6
   Sekula P, 2016, J AM SOC NEPHROL, V27, P1175, DOI 10.1681/ASN.2014111099
   Shahzad K, 2021, J AM SOC NEPHROL, V32, P3066, DOI 10.1681/ASN.2021040431
   Sheer R, 2022, J PRIM CARE COMMUNIT, V13, DOI 10.1177/21501319211063726
   Soriano-Castell D, 2021, BRIT J PHARMACOL, V178, P3611, DOI 10.1111/bph.15517
   Suriano F, 2021, MICROBIOME, V9, DOI 10.1186/s40168-021-01097-8
   Tang GY, 2021, ACTA PHARM SIN B, V11, P2749, DOI 10.1016/j.apsb.2020.12.020
   Tesch GH, 2011, AM J PHYSIOL-RENAL, V300, pF301, DOI 10.1152/ajprenal.00607.2010
   Thackrey E, 2022, NUTRITION, V94, DOI 10.1016/j.nut.2021.111536
   Thomas HY, 2022, J BIOL ENG, V16, DOI 10.1186/s13036-022-00299-4
   Wallace AS, 2022, J CLIN ENDOCR METAB, V107, P1247, DOI 10.1210/clinem/dgab927
   Wang BX, 2014, CURR DIABETES REV, V10, P131, DOI 10.2174/1573399810666140508121012
   Wei XC, 2016, NATURE, V539, P294, DOI 10.1038/nature20117
   Wen J, 2022, BMC MED, V20, DOI 10.1186/s12916-022-02599-4
   WHO World Health Organization, 2003, SCREEN TYP 2 DIAB RE
   Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047
   Wu MQ, 2019, AM J PHYSIOL-RENAL, V317, pE593, DOI 10.1152/ajprenal.00076.2019
   Wu XL, 2020, INT IMMUNOPHARMACOL, V84, DOI 10.1016/j.intimp.2020.106559
   Yan L, 2021, EXP THER MED, V21, DOI 10.3892/etm.2020.9457
   Yang LM, 2020, INT IMMUNOPHARMACOL, V89, DOI 10.1016/j.intimp.2020.106987
   Yang Q, 2018, FREE RADICAL BIO MED, V124, P466, DOI 10.1016/j.freeradbiomed.2018.06.042
   Yang X, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00497
   Yang Y, 2022, FRONT ENDOCRINOL, V13, DOI 10.3389/fendo.2022.872918
   Yap SC, 2012, CURR OPIN NEPHROL HY, V21, P24, DOI 10.1097/MNH.0b013e32834d2ec9
   YOSHIOKA K, 1994, J CHROMATOGR B, V655, P189, DOI 10.1016/0378-4347(94)80022-7
   You YH, 2016, J AM SOC NEPHROL, V27, P466, DOI 10.1681/ASN.2015030302
   Yu B, 2016, AM J EPIDEMIOL, V183, P650, DOI 10.1093/aje/kwv213
   Zeng HF, 2021, DIABET METAB SYND OB, V14, P3229, DOI 10.2147/DMSO.S312137
   Zeraattalab-Motlagh S, 2022, EUR J NUTR, V61, P1735, DOI 10.1007/s00394-021-02761-3
   Zhang Y, 2022, OXID MED CELL LONGEV, V2022, DOI 10.1155/2022/2297268
   Zhao GS, 2020, MOL NUTR FOOD RES, V64, DOI 10.1002/mnfr.202000505
NR 108
TC 0
Z9 0
U1 0
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD APR
PY 2023
VL 24
IS 7
AR 6828
DI 10.3390/ijms24076828
PG 22
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA D5BO8
UT WOS:000968887400001
PM 37047807
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Bachar, GN
   Cohen, M
   Belenky, A
   Atar, E
   Gideon, S
AF Bachar, GN
   Cohen, M
   Belenky, A
   Atar, E
   Gideon, S
TI Effect of aging on the adult extrahepatic bile duct - A sonographic
   study
SO JOURNAL OF ULTRASOUND IN MEDICINE
LA English
DT Article
DE aging; bile ducts; sonography
ID COMMON; DIAMETER; AGE; ULTRASOUND
AB Objective. To determine whether the size of the extrahepatic bile duct increases with age in adults. Methods. We prospectively collected data on 251 patients aged 20 years or older who underwent abdominal sonography. None of the patients had a history of liver, gallbladder, biliary, or pancreatic disease or surgery. The extrahepatic bile duct was measured at 3 locations: in the porta hepatis, in the most distal aspect of the head of the pancreas, and midway between these points. Least squares linear regression was used to correlate patient age and the size of the extrahepatic bile duct. Results. There were 126 men and 125 women aged 20 to 94 years (mean +/- SD, 52.5 +/- 17.63 years). Twelve percent of the study population were younger than 30 years, and 12% were older than 80 years. The mean diameters of the common bile duct in the 3 locations were as follows: proximal, 3.39 +/- 1.14 mm; middle, 3.72 +/- 1.28 mm; and distal, 4.28 +/- 1.18 mm. The overall mean for all measures was 3.66 +/- 1.15 mm. The width of the common bile duct ranged from 1.0 to 8.6 mm. There was a significant correlation between common bile duct size and age (r = 0.535; P <.001). Mean common bile duct sizes were 3.128 +/- 0.862 mm in the patients younger than 50 years and 4.19 +/- 1.15 mm in the patients older than 50 years (P <.001 by independent t test for equality of means). We have found that the duct gradually dilated 0.04 mm/y. Conclusions. This study revealed an age-dependent change in the diameter of the extrahepatic bile duct. We suggest that the upper normal limit of the duct in elderly persons be set at 8.5 mm.
C1 Rabin Med Ctr, Dept Radiol, IL-49100 Petah Tiqwa, Israel.
   Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel.
C3 Rabin Medical Center; Sackler Faculty of Medicine
RP Bachar, GN (corresponding author), Rabin Med Ctr, Dept Radiol, Beilinson Campus, IL-49100 Petah Tiqwa, Israel.
EM drbachar@netvision.net.il
CR BARTHET M, 1995, GASTROEN CLIN BIOL, V19, P156
   Bowie JD, 2000, AM J GASTROENTEROL, V95, P897
   Horrow MM, 2001, RADIOLOGY, V221, P411, DOI 10.1148/radiol.2212001700
   Kaim A, 1998, EUR RADIOL, V8, P1413, DOI 10.1007/s003300050563
   KAUDE JV, 1983, EUR J RADIOL, V3, P115
   Kialian G P, 1995, Morfologiia, V108, P10
   Laing FC, 1998, DIAGNOSTIC ULTRASOUN, V1, P175
   Majeed AW, 1999, CLIN RADIOL, V54, P170, DOI 10.1016/S0009-9260(99)91008-5
   PARULEKAR SG, 1979, RADIOLOGY, V133, P703, DOI 10.1148/133.3.703
   Perret RS, 2000, J ULTRAS MED, V19, P727
   WU CC, 1984, J CLIN ULTRASOUND, V12, P473, DOI 10.1002/jcu.1870120804
NR 11
TC 64
Z9 70
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0278-4297
EI 1550-9613
J9 J ULTRAS MED
JI J. Ultrasound Med.
PD SEP
PY 2003
VL 22
IS 9
BP 879
EP 882
DI 10.7863/jum.2003.22.9.879
PG 4
WC Acoustics; Radiology, Nuclear Medicine & Medical Imaging
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Acoustics; Radiology, Nuclear Medicine & Medical Imaging
GA 718MN
UT WOS:000185150700004
PM 14510259
DA 2024-02-19
ER

PT J
AU Zieger, M
   Borel, F
   Greer, C
   Gernoux, G
   Blackwood, M
   Flotte, TR
   Mueller, C
AF Zieger, Marina
   Borel, Florie
   Greer, Cynthia
   Gernoux, Gwladys
   Blackwood, Meghan
   Flotte, Terence R.
   Mueller, Christian
TI Liver-directed <i>SERPINA1</i> gene therapy attenuates progression of
   spontaneous and tobacco smoke-induced emphysema in α1-antitrypsin null
   mice
SO MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT
LA English
DT Article; Early Access
ID ADENOASSOCIATED-VIRUS; NEUTROPHIL ELASTASE; ALPHA1-ANTITRYPSIN
   DEFICIENCY; CLINICAL-TRIAL; SERUM-LEVELS; CATHEPSIN-G; LUNG; VECTOR;
   EXPRESSION; PROTEINASE-3
AB alpha(1)-antitrypsin deficiency is a rare genetic condition that can cause liver and/or lung disease. There is currently no cure for this disorder, although repeated infusions of plasma-purified protein may slow down emphysema progression. Gene therapy in which a single recombinant adeno-associated viral vector (rAAV) administration would lead to sustained protein expression could therefore similarly affect disease progression, and provide the added benefits of reducing treatment burden and thereby improving the patient's quality of life. The study presented here tests whether treating the Serpina1a-e knockout mouse model of alpha(1)-antitrypsin-deficiency lung disease with gene therapy would have an impact on the disease course, either on spontaneous disease caused by aging or on accelerated disease caused by exposure to cigarette smoke. Liver-directed gene therapy led to dose-dependent levels of biologically active human alpha(1)-antitrypsin protein. Furthermore, decreased lung compliance and increased elastic recoil indicate that treated mice had largely preserved lung tissue elasticity and alveolar wall integrity compared with untreated mice. rAAV-mediated gene augmentation is therefore able to compensate for the loss of function and restore a beneficial lung protease-antiprotease balance. This work constitutes a preclinical study report of a disease-modifying treatment in the Serpina1a-e knockout mouse model using a liver-specific rAAV serotype 8 capsid.
C1 [Zieger, Marina; Borel, Florie; Greer, Cynthia; Gernoux, Gwladys; Blackwood, Meghan; Flotte, Terence R.; Mueller, Christian] Horae Gene Therapy Ctr, Li Weibo Inst Rare Dis Res, 368 Plantat St, Worcester, MA 01605 USA.
   [Gernoux, Gwladys; Flotte, Terence R.; Mueller, Christian] Univ Massachusetts, Dept Pediat, Chan Med Sch, 368 Plantat St, Worcester, MA 01605 USA.
   [Zieger, Marina; Borel, Florie; Mueller, Christian] Apic Bio Inc, 35 Cambridgepk Dr,Suite 350, Cambridge, MA 02140 USA.
C3 University of Massachusetts System; University of Massachusetts
   Worcester
RP Mueller, C (corresponding author), Horae Gene Therapy Ctr, Li Weibo Inst Rare Dis Res, 368 Plantat St, Worcester, MA 01605 USA.
EM christian.mueller4@sanofi.com
RI GERNOUX, Gwladys/D-3267-2019; Zieger, Marina/AAF-3355-2020
OI GERNOUX, Gwladys/0000-0002-1268-7001; Zieger, Marina/0000-0003-2693-3901
FU Alpha-1 Foundation; National Institutes of Health grant [PO1H2131471]
FX This work was supported by the Alpha-1 Foundation and a National
   Institutes of Health grant (PO1H2131471). The graphical abstract was
   created with BioRender.com. We would like to thank our colleagues at the
   Department of Animal Medicineat the University of Massachusetts Chan
   Medical School, for helping us with cigarette smoke exposure studies,
   and to acknowledge Guangping Gao, Alisha Gruntman, Claudio Punzo, Yu
   Liu, and Jayme Heywosz for services provided at the University of
   Massachusetts Chan Medical School Viral Vector Core, Respiratory
   Core,Microscopy Core and Morphology Core, respectively.
CR Akram KM, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010128
   Borel F, 2018, P NATL ACAD SCI USA, V115, P2788, DOI 10.1073/pnas.1713689115
   Bornhorst JA, 2013, CHEST, V143, P1000, DOI 10.1378/chest.12-0564
   Brantly ML, 2006, HUM GENE THER, V17, P1177, DOI 10.1089/hum.2006.17.1177
   Brantly ML, 2009, P NATL ACAD SCI USA, V106, P16363, DOI 10.1073/pnas.0904514106
   BRANTLY ML, 1988, AM REV RESPIR DIS, V138, P327, DOI 10.1164/ajrccm/138.2.327
   Brigham KL, 2000, HUM GENE THER, V11, P1023, DOI 10.1089/10430340050015338
   Cazzola M, 2020, EUR RESPIR REV, V29, DOI 10.1183/16000617.0073-2019
   Chiuchiolo MJ, 2016, ANN AM THORAC SOC, V13, pS352, DOI 10.1513/AnnalsATS.201506-344KV
   Chiuchiolo MJ, 2013, HUM GENE THER CL DEV, V24, P161, DOI 10.1089/humc.2013.168
   Chulay JD, 2011, HUM GENE THER, V22, P155, DOI 10.1089/hum.2010.118
   Conlon TJ, 2005, MOL THER, V12, P867, DOI 10.1016/j.ymthe.2005.05.016
   Craig TJ, 2018, ALLERGY, V73, P2110, DOI 10.1111/all.13558
   De B, 2004, MOL THER, V10, P1003, DOI 10.1016/j.ymthe.2004.08.022
   De BP, 2006, MOL THER, V13, P67, DOI 10.1016/j.ymthe.2005.09.003
   de Serres FJ, 2012, THER ADV RESPIR DIS, V6, P277, DOI 10.1177/1753465812457113
   Flotte TR, 2011, HUM GENE THER, V22, P1239, DOI 10.1089/hum.2011.053
   Fregonese L, 2008, RESP MED, V102, P876, DOI 10.1016/j.rmed.2008.01.009
   GADEK JE, 1979, SCIENCE, V206, P1315, DOI 10.1126/science.316188
   GADEK JE, 1981, J CLIN INVEST, V68, P889, DOI 10.1172/JCI110344
   Gao GP, 2002, P NATL ACAD SCI USA, V99, P11854, DOI 10.1073/pnas.182412299
   Genschmer KR, 2019, CELL, V176, P113, DOI 10.1016/j.cell.2018.12.002
   Guyot N, 2014, AM J PATHOL, V184, P2197, DOI 10.1016/j.ajpath.2014.04.015
   Halbert CL, 2010, MOL THER, V18, P1165, DOI 10.1038/mt.2010.51
   Janciauskiene S, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00341
   JANOFF A, 1983, AM REV RESPIR DIS, V127, P540, DOI 10.1164/arrd.1983.127.5.540
   Joshi R, 2018, AM J RESP CELL MOL, V59, P167, DOI 10.1165/rcmb.2017-0361OC
   Kawabata K, 2002, EUR J PHARMACOL, V451, P1, DOI 10.1016/S0014-2999(02)02182-9
   Korkmaz B, 2008, BIOCHIMIE, V90, P227, DOI 10.1016/j.biochi.2007.10.009
   Kotton DN, 2014, NAT MED, V20, P822, DOI 10.1038/nm.3642
   LARSSON C, 1978, ACTA MED SCAND, V204, P345, DOI 10.1111/j.0954-6820.1978.tb08452.x
   LAURELL CB, 1971, SCAND J CLIN LAB INV, V28, P1, DOI 10.3109/00365517109090655
   Lockett AD, 2012, MOL MED, V18, P445, DOI 10.2119/molmed.2011.00207
   Lomas DA, 2018, COPD-J COPD FDN, V5, P233, DOI 10.15326/jcopdf.5.4.2017.0165
   Lorincz R, 2020, AM J RESP CELL MOL, V63, P560, DOI 10.1165/rcmb.2020-0159PS
   McElvaney NG, 2017, LANCET RESP MED, V5, P51, DOI 10.1016/S2213-2600(16)30430-1
   McGovern TK, 2013, JOVE-J VIS EXP, DOI 10.3791/50172
   Meyer KC, 1999, THORAX, V54, P697, DOI 10.1136/thx.54.8.697
   Mueller C, 2017, MOL THER, V25, P1387, DOI 10.1016/j.ymthe.2017.03.029
   Mueller C, 2013, J CLIN INVEST, V123, P5310, DOI 10.1172/JCI70314
   Mueller C, 2013, COPD, V10, P44, DOI 10.3109/15412555.2013.764978
   Mueller C, 2012, MOL THER, V20, P590, DOI 10.1038/mt.2011.292
   Needham M, 2004, THORAX, V59, P441, DOI 10.1136/thx.2003.006510
   Newby PR, 2019, ERJ OPEN RES, V5, DOI 10.1183/23120541.00095-2019
   NUKIWA T, 1987, BIOCHEMISTRY-US, V26, P5259, DOI 10.1021/bi00391a008
   Parameswaran H, 2006, J APPL PHYSIOL, V100, P186, DOI 10.1152/japplphysiol.00424.2005
   Petrache I, 2006, AM J PATHOL, V169, P1155, DOI 10.2353/ajpath.2006.060058
   Ronnow SR, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40785-2
   SALAZAR E, 1964, J APPL PHYSIOL, V19, P97, DOI 10.1152/jappl.1964.19.1.97
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Schulte H, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01466
   de Serres F, 2014, J INTERN MED, V276, P311, DOI 10.1111/joim.12239
   Sinden NJ, 2013, EUR RESPIR J, V41, P1042, DOI 10.1183/09031936.00089712
   Song S, 1998, P NATL ACAD SCI USA, V95, P14384, DOI 10.1073/pnas.95.24.14384
   Song S, 2001, GENE THER, V8, P1299, DOI 10.1038/sj.gt.3301422
   Stockley RA, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.04.25
   Stoller JK, 2012, AM J RESP CRIT CARE, V185, P246, DOI 10.1164/rccm.201108-1428CI
   Stoller JK, 2005, LANCET, V365, P2225, DOI 10.1016/S0140-6736(05)66781-5
   Strange C, 2020, CLIN CHEST MED, V41, P339, DOI 10.1016/j.ccm.2020.05.003
   Sun ZW, 2018, J THORAC DIS, V10, P1084, DOI 10.21037/jtd.2018.01.46
   Weiss DJ, 2021, RESP RES, V22, DOI 10.1186/s12931-021-01734-8
   Xiao WD, 1998, J VIROL, V72, P10222, DOI 10.1128/JVI.72.12.10222-10226.1998
NR 62
TC 4
Z9 4
U1 0
U2 1
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
EI 2329-0501
J9 MOL THER-METH CLIN D
JI Mol.Ther.-Methods Clin. Dev.
PD 2022 JUN 9
PY 2022
VL 25
BP 425
EP 438
DI 10.1016/j.omtm.2022.04.003
EA MAY 2022
PG 14
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA 1L6BX
UT WOS:000799372500009
PM 35592360
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Sulpice, L
   Rayar, M
   Campillo, B
   Pery, C
   Guillaud, A
   Meunier, B
   Boudjema, K
AF Sulpice, Laurent
   Rayar, Michel
   Campillo, Boris
   Pery, Claire
   Guillaud, Antoine
   Meunier, Bernard
   Boudjema, Karim
TI Advanced Age Remains an Achilles Heel for Liver Resections
SO WORLD JOURNAL OF SURGERY
LA English
DT Article
ID ELDERLY-PATIENTS; HEPATOCELLULAR-CARCINOMA; HEPATECTOMY; METASTASES;
   COMPLICATIONS; COMORBIDITY; OUTCOMES; IMPACT; OLD
AB As the general population is aging, surgery in elderly patients has become a major public health issue. This basic question is especially true for liver resection (LR). The aim of this study was to evaluate the operative risks of LR in the elderly.
   Retrospective analysis of a large recent and monocentric database of LR was performed between January 1, 2005 and May 31, 2011. Patients were categorized into three groups (< 60, 60-74, and a parts per thousand yen75 years old) to analyze postoperative outcomes and 1-year mortality. Clinicopathologic factors likely to influence outcomes were assessed by univariate and multivariate analysis.
   Altogether, 1,001 consecutive LRs were performed in 912 patients (mean age 62 +/- A 13 years). The distribution of the LR by age was 372 (37.2 %), 477 (47.6 %), and 152 (15.2 %) in patients < 60, 60-74, and a parts per thousand yen75 years, respectively. The overall morbidity and mortality rates were 33.3 and 2.5 %, respectively. Age a parts per thousand yen75 years was independently associated with postoperative mortality [odds ratio (OR) 4.75, 95 % confidence interval (CI) 1.5-15.1; p = 0.008] and 1-year mortality (OR 2.8, 95 % CI 1.2-6.6; p = 0.015). The postoperative complication rate (p = 0.216) was not increased, even for major complications (p = 0.09). The other independent risk factors for mortality were a cirrhotic liver (p = 0.017), preoperative arterial chemoembolization (p = 0.001), caval vein clamping (p = 0.001), and intraoperative blood transfusion (p = 0.044).
   Age beyond 75 years represent a risk factor of death after LR and should be avoided after chemoembolization or in cirrhotic patients. A specific assessment using geriatric indexes might be the key to success in this population.
C1 [Sulpice, Laurent; Rayar, Michel; Pery, Claire; Guillaud, Antoine; Meunier, Bernard; Boudjema, Karim] Univ Rennes 1, Ctr Hosp Univ Rennes, Hop Pontchaillou, Serv Chirurg Hepatobiliaire & Digest, Rennes, France.
   [Sulpice, Laurent; Boudjema, Karim] Univ Rennes 1, INSERM, UMR991, Rennes, France.
   [Campillo, Boris] Univ Rennes 1, INSERM, UMR936, Dept Med Informat, Rennes, France.
C3 CHU Rennes; Universite de Rennes; Institut National de la Sante et de la
   Recherche Medicale (Inserm); Universite de Rennes; Institut National de
   la Sante et de la Recherche Medicale (Inserm); Universite de Rennes
RP Sulpice, L (corresponding author), Univ Rennes 1, Ctr Hosp Univ Rennes, Hop Pontchaillou, Serv Chirurg Hepatobiliaire & Digest, Rennes, France.
EM laurent.sulpice@chu-rennes.fr
RI Sulpice, Laurent/AAA-3881-2019; meunier, bernard/K-9938-2018; michel,
   rayar/F-6106-2016
OI Sulpice, Laurent/0000-0002-8817-1685; michel, rayar/0000-0003-3113-2260;
   Boudjema, Karim/0000-0002-3894-8767
CR Aapro MS, 2005, ONCOLOGIST, V10, P198, DOI 10.1634/theoncologist.10-3-198
   Adam R, 2010, BRIT J SURG, V97, P366, DOI 10.1002/bjs.6889
   [Anonymous], 2012, LANCET, V379, P1274, DOI 10.1016/S0140-6736(12)60540-6
   Arai H, 2012, GERIATR GERONTOL INT, V12, P16, DOI 10.1111/j.1447-0594.2011.00776.x
   Balzan S, 2005, ANN SURG, V242, P824, DOI 10.1097/01.sla.0000189131.90876.9e
   Bentrem DJ, 2009, ARCH SURG-CHICAGO, V144, P1013, DOI 10.1001/archsurg.2009.114
   Buntinx F, 2002, J CLIN EPIDEMIOL, V55, P1144, DOI 10.1016/S0895-4356(02)00485-7
   Carino ND, 2008, CRIT REV ONCOL HEMAT, V67, P273, DOI 10.1016/j.critrevonc.2008.05.003
   CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8
   Cho SW, 2011, ANN SURG ONCOL, V18, P1088, DOI 10.1245/s10434-010-1404-6
   Cook EJ, 2012, COLORECTAL DIS, V14, P1210, DOI 10.1111/j.1463-1318.2012.02946.x
   Di Benedetto F, 2011, J AM GERIATR SOC, V59, P2282, DOI 10.1111/j.1532-5415.2011.03734.x
   Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae
   Extermann M, 2000, EUR J CANCER, V36, P453, DOI 10.1016/S0959-8049(99)00319-6
   Ferrero A, 2005, WORLD J SURG, V29, P1101, DOI 10.1007/s00268-005-7768-2
   Figueras J, 2007, CLIN TRANSL ONCOL, V9, P392, DOI 10.1007/s12094-007-0072-x
   Gruttadauria S, 2011, J SURG ONCOL, V103, P140, DOI 10.1002/jso.21796
   Hanazaki K, 2001, J AM COLL SURGEONS, V192, P38, DOI 10.1016/S1072-7515(00)00778-X
   Ide T, 2013, J SURG RES, V185, P614, DOI 10.1016/j.jss.2013.07.016
   JAMES OFW, 1983, CLIN GASTROENTEROL, V12, P671
   Sánchez-Hidalgo JM, 2012, J SURG RES, V175, pE1, DOI 10.1016/j.jss.2011.11.1022
   Menon KV, 2006, J AM COLL SURGEONS, V203, P677, DOI 10.1016/j.jamcollsurg.2006.07.025
   Mirici-Cappa F, 2010, GUT, V59, P387, DOI 10.1136/gut.2009.194217
   Poon RTP, 1999, AM J GASTROENTEROL, V94, P2460
   Reddy SK, 2011, J AM COLL SURGEONS, V212, P787, DOI 10.1016/j.jamcollsurg.2010.12.048
   Riffat F, 2006, HPB, V8, P206, DOI 10.1080/13651820500497173
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Shiba H, 2009, J GASTROINTEST SURG, V13, P1636, DOI 10.1007/s11605-009-0963-y
   Strasberg SM, 2005, J HEPATO-BILIARY-PAN, V12, P351, DOI 10.1007/s00534-005-0999-7
   Sulpice L, 2012, J SURG RES, V178, P181, DOI 10.1016/j.jss.2012.03.075
   United Nations, 2002, WORLD POP AG, P35
   WYNNE HA, 1989, HEPATOLOGY, V9, P297, DOI 10.1002/hep.1840090222
   Yamada S, 2012, HEPATOL RES, V42, P454, DOI 10.1111/j.1872-034X.2011.00952.x
NR 33
TC 17
Z9 17
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0364-2313
EI 1432-2323
J9 WORLD J SURG
JI World J.Surg.
PD APR
PY 2014
VL 38
IS 4
BP 918
EP 926
DI 10.1007/s00268-013-2367-0
PG 9
WC Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Surgery
GA AD3ND
UT WOS:000333151900024
PM 24337318
OA Green Submitted
DA 2024-02-19
ER

PT J
AU Drew, B
   Leeuwenburgh, C
AF Drew, B
   Leeuwenburgh, C
TI Method for measuring ATP production in isolated mitochondria: ATP
   production in brain and liver mitochondria of Fischer-344 rats with age
   and caloric restriction
SO AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE
   PHYSIOLOGY
LA English
DT Article
DE firefly luciferase; bioluminescence assay; ATP production; aging;
   caloric restriction
ID COMPLEX-I DEFICIENCY; OXIDATIVE DNA-DAMAGE; SKELETAL-MUSCLE;
   PARKINSONS-DISEASE; HUNTINGTONS-DISEASE; ALZHEIMERS-DISEASE; SENSITIVE
   METHOD; AGING MICE; SYNTHASE; OXIDASE
AB The production of ATP is vital for muscle contraction, chemiosmotic homeostasis, and normal cellular function. Many studies have measured ATP content or qualitative changes in ATP production, but few have quantified ATP production in vivo in isolated mitochondria. Because of the importance of understanding the energy capacity of mitochondria in biology, physiology, cellular dysfunction, and ultimately, disease pathologies and normal aging, we modified a commercially available bioluminescent ATP determination assay for quantitatively measuring ATP content and rate of ATP production in isolated mitochondria. The bioluminescence assay is based on the reaction of ATP with recombinant firefly luciferase and its substrate luciferin. The stabilities of the reaction mixture as well as relevant ATP standards were quantified. The luminescent signals of the reaction mixture and a 0.5 muM ATP standard decreased linearly at rates of 2.16 and 1.39% decay/min, respectively. For a 25 muM ATP standard, the luminescent signal underwent a logarithmic decay, due to intrinsic deviations from the Beer- Lambert law. Moreover, to test the functionality of isolated mitochondria, they were incubated with 1 and 5 mM oligomycin, an inhibitor of oxidative phosphorylation. The rate of ATP production in the mitochondria declined by 34 and 83%, respectively. Due to the sensitivity and stability of the assay and methodology, we were able to quantitatively measure in vivo the effects of age and caloric restriction on the ATP content and production in isolated mitochondria from the brain and liver of young and old Fischer-344 rats. In both tissues, neither age nor caloric restriction had any significant effect on the ATP content or the rate of ATP production. This study introduces a highly sensitive, reproducible, and quick methodology for measuring ATP in isolated mitochondria.
C1 Univ Florida, Biochem Aging Lab, Gainesville, FL 32611 USA.
C3 State University System of Florida; University of Florida
RP Leeuwenburgh, C (corresponding author), Univ Florida, Biochem Aging Lab, POB 118206, Gainesville, FL 32611 USA.
OI Leeuwenburgh, Christiaan/0000-0003-0826-4257
FU NIA NIH HHS [AG-21042, AG-17994, AG-10485] Funding Source: Medline
CR ALI SF, 1994, SYNAPSE, V18, P27, DOI 10.1002/syn.890180105
   Bejma J, 1999, J APPL PHYSIOL, V87, P465, DOI 10.1152/jappl.1999.87.1.465
   Boenisch O, 2002, J NEPHROL, V15, P547
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Branchini BR, 2000, BIOCHEMISTRY-US, V39, P5433, DOI 10.1021/bi9928804
   BRENNAN WA, 1985, J NEUROCHEM, V44, P1948, DOI 10.1111/j.1471-4159.1985.tb07192.x
   Davey GP, 1998, J BIOL CHEM, V273, P12753, DOI 10.1074/jbc.273.21.12753
   Davey GP, 1997, J NEUROCHEM, V69, P2564
   de Grey ADNJ, 2000, ARCH BIOCHEM BIOPHYS, V373, P295, DOI 10.1006/abbi.1999.1509
   Dirks A, 2002, AM J PHYSIOL-REG I, V282, pR519, DOI 10.1152/ajpregu.00458.2001
   Drew B, 2003, AM J PHYSIOL-REG I, V284, pR474, DOI 10.1152/ajpregu.00455.2002
   Filburn CR, 1996, MECH AGEING DEV, V87, P35, DOI 10.1016/0047-6374(96)01696-X
   Gadaleta MN, 1998, BIOCHIMIE, V80, P863, DOI 10.1016/S0300-9084(00)88881-1
   Gredilla R, 2001, FASEB J, V15, P1589, DOI 10.1096/fj.00-0764fje
   Gredilla R, 2001, J BIOENERG BIOMEMBR, V33, P279, DOI 10.1023/A:1010603206190
   Greenamyre JT, 1999, BIOCHEM SOC SYMP, V66, P85, DOI 10.1042/bss0660085
   Hempel G, 2002, CANCER CHEMOTH PHARM, V49, P133, DOI 10.1007/s00280-001-0392-4
   HOOD DA, 1994, CAN J APPL PHYSIOL, V19, P12, DOI 10.1139/h94-002
   KRICKA LJ, 1988, ANAL BIOCHEM, V175, P14, DOI 10.1016/0003-2697(88)90354-5
   Lass A, 1998, FREE RADICAL BIO MED, V25, P1089, DOI 10.1016/S0891-5849(98)00144-0
   Leeuwenburgh C, 1997, ARCH BIOCHEM BIOPHYS, V346, P74, DOI 10.1006/abbi.1997.0297
   Lodi R, 2000, ANN NEUROL, V48, P72
   Loft S, 2003, HUM REPROD, V18, P1265, DOI 10.1093/humrep/deg202
   Mansouri A, 1997, GASTROENTEROLOGY, V113, P599, DOI 10.1053/gast.1997.v113.pm9247482
   MUTISYA EM, 1994, J NEUROCHEM, V63, P2179
   Navarro A, 2002, AM J PHYSIOL-REG I, V282, pR985, DOI 10.1152/ajpregu.00537.2001
   Nicoletti VG, 1995, NEUROCHEM RES, V20, P1465, DOI 10.1007/BF00970595
   Ojaimi J, 1999, MECH AGEING DEV, V111, P39, DOI 10.1016/S0047-6374(99)00071-8
   Olgun A, 2002, EXP GERONTOL, V37, P639, DOI 10.1016/S0531-5565(02)00009-8
   PARKER WD, 1990, NEUROLOGY, V40, P1302, DOI 10.1212/WNL.40.8.1302
   Pollack M., 2000, MOL MECH OXIDATIVE S
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Saks VA, 2001, BIOCHEM J, V356, P643, DOI 10.1042/0264-6021:3560643
   SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0
   SCHAPIRA AHV, 1990, J NEUROCHEM, V55, P2142, DOI 10.1111/j.1471-4159.1990.tb05809.x
   SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x
   Senior AE, 2002, BBA-BIOENERGETICS, V1553, P188, DOI 10.1016/S0005-2728(02)00185-8
   Shelke RRJ, 2003, FASEB J, V17, P494, DOI 10.1096/fj.02-0803fje
   SINGER TP, 1990, FEBS LETT, V274, P1, DOI 10.1016/0014-5793(90)81315-F
   SOHAL RS, 1994, MECH AGEING DEV, V74, P121, DOI 10.1016/0047-6374(94)90104-X
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   Sreekumar R, 2002, AM J PHYSIOL-ENDOC M, V283, pE38, DOI 10.1152/ajpendo.00387.2001
   Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700
   Susan PP, 2001, J CELL PHYSIOL, V187, P48, DOI 10.1002/1097-4652(2001)9999:9999<00::AID-JCP1050>3.0.CO;2-I
   Tsay HJ, 2000, J BIOMED SCI, V7, P466
   Wallace DC, 1997, SCI AM, V277, P40, DOI 10.1038/scientificamerican0897-40
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
   WIBOM R, 1990, SCAND J CLIN LAB INV, V50, P143, DOI 10.3109/00365519009089146
   WU EY, 1990, ARCH BIOCHEM BIOPHYS, V282, P358, DOI 10.1016/0003-9861(90)90129-M
   YEN TC, 1992, BIOCHEM INT, V26, P457
NR 50
TC 122
Z9 136
U1 6
U2 45
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0363-6119
J9 AM J PHYSIOL-REG I
JI Am. J. Physiol.-Regul. Integr. Comp. Physiol.
PD NOV 1
PY 2003
VL 285
IS 5
BP R1259
EP R1267
DI 10.1152/ajpregu.00264.2003
PG 9
WC Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology
GA 731VY
UT WOS:000185908200044
PM 12855419
DA 2024-02-19
ER

PT J
AU MOSONI, L
   HOULIER, ML
   MIRAND, PP
   BAYLE, G
   GRIZARD, J
AF MOSONI, L
   HOULIER, ML
   MIRAND, PP
   BAYLE, G
   GRIZARD, J
TI EFFECT OF AMINO-ACIDS ALONE OR WITH INSULIN ON MUSCLE AND LIVER
   PROTEIN-SYNTHESIS IN ADULT AND OLD RATS
SO AMERICAN JOURNAL OF PHYSIOLOGY
LA English
DT Article
DE HYPERAMINOACIDEMIA; EUGLYCEMIC CLAMP; PROTEIN TURNOVER; MUSCLE ATROPHY;
   AGING
ID SKELETAL-MUSCLE; WHOLE-BODY; SUBSTRATE AVAILABILITY; LEUCINE METABOLISM;
   TISSUES; GROWTH; TURNOVER; INVIVO; DEGRADATION; INFUSION
AB This study was carried out to analyze age-related changes on amino acid and insulin effects on muscle and liver protein synthesis. Conscious male rats, aged 12 (adult) and 24 (old) mo, were infused for 90 min with either saline, amino acids, or amino acids with insulin and glucose. Protein synthesis was measured during the last 15 min of infusion (flooding dose of valine with L-[2,3,4-3H]valine). Gastrocnemius protein mass was 29% lower in old rats than in adults. However, basal muscle absolute synthesis rates were unchanged with age, and fractional synthesis rates (FSR) were increased. Amino acids significantly stimulated muscle FSR to a similar extent (18-20%) in adult (P < 0.01) and old rats (P = 0.03 when variability introduced by muscle atrophy was taken into account by a variance-covariance analysis). Insulin did not elicit any additional effect. Liver protein synthesis did not change with age or in response to infusions. We conclude that, despite an age-related loss of muscle proteins, capacity of muscle protein synthesis to be stimulated is preserved with age.
RP MOSONI, L (corresponding author), INRA, CTR CLERMONT FERRAND THEIX, LAB ETUD METAB AZOTE, F-63122 CEYRAT, FRANCE.
OI Mosoni, Laurent/0000-0002-5409-6760
CR [Anonymous], 1988, SAS STAT USERS GUIDE
   ATTAIX D, 1986, BIOCHIM BIOPHYS ACTA, V882, P389, DOI 10.1016/0304-4165(86)90263-1
   BAILLIE AGS, 1991, AM J PHYSIOL, V260, pE891, DOI 10.1152/ajpendo.1991.260.6.E891
   BAILLIE AGS, 1992, AM J PHYSIOL, V262, pE1, DOI 10.1152/ajpendo.1992.262.1.E1
   BENNET WM, 1989, CLIN SCI, V76, P447, DOI 10.1042/cs0760447
   BLAZEJOWSKI CA, 1983, MECH AGEING DEV, V21, P345, DOI 10.1016/0047-6374(83)90051-9
   BLOOMGARDEN ZT, 1981, AM J PHYSIOL, V241, pE90, DOI 10.1152/ajpendo.1981.241.1.E90
   BROWN M, 1992, MECH AGEING DEV, V63, P69, DOI 10.1016/0047-6374(92)90017-8
   CASTELLINO P, 1987, J CLIN INVEST, V80, P1784, DOI 10.1172/JCI113272
   CHEREL Y, 1991, CLIN SCI, V81, P611, DOI 10.1042/cs0810611
   ELHAJ AJ, 1986, COMP BIOCHEM PHYS A, V85, P281, DOI 10.1016/0300-9629(86)90251-3
   FIATARONE MA, 1990, JAMA-J AM MED ASSOC, V263, P3029, DOI 10.1001/jama.263.22.3029
   FORBES GB, 1976, HUM BIOL, V48, P161
   FRONTERA WR, 1988, J APPL PHYSIOL, V64, P1038, DOI 10.1152/jappl.1988.64.3.1038
   FUKAGAWA NK, 1989, AM J PHYSIOL, V256, pE288, DOI 10.1152/ajpendo.1989.256.2.E288
   GARLICK PJ, 1988, BIOCHEM J, V254, P579, DOI 10.1042/bj2540579
   GARLICK PJ, 1980, BIOCHEM J, V192, P719, DOI 10.1042/bj1920719
   GELFAND RA, 1986, AM J PHYSIOL, V250, pE407, DOI 10.1152/ajpendo.1986.250.4.E407
   GOLDSPINK DF, 1987, EXP GERONTOL, V22, P67, DOI 10.1016/0531-5565(87)90016-7
   HOLLOSZY JO, 1991, MECH AGEING DEV, V60, P199, DOI 10.1016/0047-6374(91)90131-I
   KLITGAARD H, 1989, J APPL PHYSIOL, V67, P1409, DOI 10.1152/jappl.1989.67.4.1409
   LEWIS SEM, 1984, BIOCHEM J, V217, P517, DOI 10.1042/bj2170517
   LOEFFLER M, 1990, EXP GERONTOL, V25, P483, DOI 10.1016/0531-5565(90)90036-2
   MAKRIDES SC, 1983, BIOL REV, V58, P343, DOI 10.1111/j.1469-185X.1983.tb00394.x
   MAYS PK, 1991, MECH AGEING DEV, V59, P229, DOI 10.1016/0047-6374(91)90134-L
   MOSONI L, IN PRESS MECH AGING
   NISHIMURA H, 1988, AM J PHYSIOL, V254, pE92, DOI 10.1152/ajpendo.1988.254.1.E92
   PACY PJ, 1988, CLIN SCI, V75, P225, DOI 10.1042/cs0750225
   PLUSKAL MG, 1984, J GERONTOL, V39, P385, DOI 10.1093/geronj/39.4.385
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   SONNTAG WE, 1985, J GERONTOL, V40, P689, DOI 10.1093/geronj/40.6.689
   TESSARI P, 1987, J CLIN INVEST, V79, P1062, DOI 10.1172/JCI112919
   WATERLOW JC, 1978, PROTEIN TURNOVER MAM, P697
NR 33
TC 71
Z9 72
U1 0
U2 3
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0002-9513
J9 AM J PHYSIOL
JI Am. J. Physiol.
PD APR
PY 1993
VL 264
IS 4
BP E614
EP E620
DI 10.1152/ajpendo.1993.264.4.E614
PN 1
PG 7
WC Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology
GA KZ603
UT WOS:A1993KZ60300058
PM 8476040
DA 2024-02-19
ER

PT J
AU Yu, CX
   Song, C
   Lv, J
   Zhu, M
   Yu, CQ
   Guo, Y
   Yang, L
   Chen, YP
   Chen, ZM
   Jiang, T
   Ma, HX
   Jin, GF
   Shen, HB
   Hu, ZB
   Li, LM
AF Yu, Chengxiao
   Song, Ci
   Lv, Jun
   Zhu, Meng
   Yu, Canqing
   Guo, Yu
   Yang, Ling
   Chen, Yiping
   Chen, Zhengming
   Jiang, Tao
   Ma, Hongxia
   Jin, Guangfu
   Shen, Hongbing
   Hu, Zhibin
   Li, Liming
CA China Kadoorie Biobank Collaborati
TI Prediction and clinical utility of a liver cancer risk model in Chinese
   adults: A prospective cohort study of 0.5 million people
SO INTERNATIONAL JOURNAL OF CANCER
LA English
DT Article; Early Access
DE cohort study; liver cancer; risk prediction model
ID CHRONIC HEPATITIS-B; HEPATOCELLULAR-CARCINOMA; NATURAL-HISTORY; SCORING
   SYSTEM; METAANALYSIS; POPULATION; VALIDATION; DISEASE; VACCINATION;
   PREVENTION
AB China has made rapid progress in reducing the incidence of HBV infection in the past three decades, along with a rapidly changing lifestyle and aging population. We aimed to develop and validate an up-to-date liver cancer risk prediction model with routinely available predictors and evaluate its applicability for screening guidance. Using data from the China Kadoorie Biobank, we included 486 285 participants in this analysis. Fifteen risk factors were included in the model. Flexible parametric survival models were used to estimate the 10-year absolute risk of liver cancer. Decision curve analysis was performed to evaluate the net benefit of the model to quantify clinical utility. A total of 2706 participants occurred liver cancer over the 4 814 320 person-years of follow-up. Excellent discrimination of the model was observed in both development and validation datasets, with c-statistics (95% CI) of 0.80 (0.79-0.81) and 0.80 (0.78-0.82) respectively, as well as excellent calibration of observed and predicted risks. Decision curve analysis revealed that use of the model in selecting participants for screening improved benefit at a threshold of 2% 10-year risk, compared to current guideline of screening all HBsAg carriers. Our model was more sensitive than current guideline for cancer screening (28.17% vs 25.96%). We developed and validated a CKB-PLR (Prediction for Liver cancer Risk Based on the China Kadoorie Biobank Study) model to predict the absolute risk of liver cancer for both HBsAg seropositive and seronegative populations. Application of the model is beneficial for precisely identifying the high-risk groups among the general population.
C1 [Yu, Chengxiao; Song, Ci; Zhu, Meng; Jiang, Tao; Ma, Hongxia; Jin, Guangfu; Shen, Hongbing; Hu, Zhibin] Nanjing Med Univ, China Int Cooperat Ctr Environm & Human Hlth, Ctr Global Hlth, Sch Publ Hlth,Dept Epidemiol, Nanjing, Peoples R China.
   [Yu, Chengxiao; Song, Ci; Zhu, Meng; Jiang, Tao; Ma, Hongxia; Jin, Guangfu; Shen, Hongbing; Hu, Zhibin] Nanjing Med Univ, Collaborat Innovat Ctr Canc Personalized Med, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Nanjing, Peoples R China.
   [Lv, Jun; Yu, Canqing; Li, Liming] Peking Univ Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing, Peoples R China.
   [Lv, Jun] Peking Univ, Minist Educ, Key Lab Mol Cardiovasc Sci, Beijing, Peoples R China.
   [Guo, Yu] Chinese Acad Med Sci, Beijing, Peoples R China.
   [Yang, Ling; Chen, Yiping; Chen, Zhengming] Univ Oxford, Nuffield Dept Populat Hlth, Clin Trial Serv Unit, Oxford, England.
   [Yang, Ling; Chen, Yiping; Chen, Zhengming] Univ Oxford, Nuffield Dept Populat Hlth, Epidemiol Studies Unit, Oxford, England.
C3 Nanjing Medical University; Nanjing Medical University; Peking
   University; Peking University; Chinese Academy of Medical Sciences -
   Peking Union Medical College; University of Oxford; University of Oxford
RP Hu, ZB (corresponding author), Nanjing Med Univ, Dept Epidemiol, Ctr Global Hlth, Sch Publ Hlth, 101 Longmian Ave, Nanjing 21116, Peoples R China.; Li, LM (corresponding author), Peking Univ Hlth Sci Ctr, Dept Epidemiol & Biostat, 38 Xueyuan Rd, Beijing 100191, Peoples R China.
EM zhibin_hu@njmu.edu.cn; lmlee@vip.163.com
RI wang, xueting/JPY-2782-2023; wang, hang/JND-8481-2023; Cheng,
   Yuan/JKJ-0794-2023; shen, hong/HTQ-6147-2023; Zhang,
   Yishan/JQW-9580-2023
OI Ma, Hongxia/0000-0002-9821-6955; Yu, Chengxiao/0000-0002-6735-0027; YU,
   Canqing/0000-0002-0019-0014; Shen, Hongbing/0000-0002-2581-5906
FU National Natural Science Foundation of China [81903382, 91846303,
   81390540]; Natural Science Foundation of Jiangsu Province [BK20190652];
   National Key RAMP;D Program of China [2016YFC0900500, 2016YFC0900501,
   2016YFC0900504]; China Postdoctoral Science Foundation [2019M651900];
   Kadoorie Charitable Foundation in Hong Kong; UK Wellcome Trust
   [212946/Z/18/Z, 202922/Z/16/Z, 104085/Z/14/Z, 088158/Z/09/Z]; Chinese
   Ministry of Science and Technology [2011BAI09B01]; MRC [MC_UU_12026/2,
   MC_UU_00017/1, MC_U137686851] Funding Source: UKRI
FX The authors would like to thank all the study participants and members
   of the survey teams in each of the 10 study regions, as well as the
   project development and management teams based in Beijing, Oxford and
   the survey regions. Our study was supported by National Natural Science
   Foundation of China (81903382, 91846303), Natural Science Foundation of
   Jiangsu Province (BK20190652), grants from the National Key R&D Program
   of China (2016YFC0900500, 2016YFC0900501, 2016YFC0900504), China
   Postdoctoral Science Foundation (General Program, 2019M651900). The CKB
   baseline survey and the first re-survey were supported by a grant from
   the Kadoorie Charitable Foundation in Hong Kong. The long-term follow-up
   is supported by grants from the UK Wellcome Trust (212946/Z/18/Z,
   202922/Z/16/Z, 104085/Z/14/Z, 088158/Z/09/Z), National Natural Science
   Foundation of China (81390540) and Chinese Ministry of Science and
   Technology (2011BAI09B01).
CR Arbuthnot P, 2001, INT J EXP PATHOL, V82, P77, DOI 10.1111/j.1365-2613.2001.iep178.x
   Arem H, 2018, CANCER MED-US, V7, P1450, DOI 10.1002/cam4.1343
   Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199
   Campbell PT, 2016, CANCER RES, V76, P6076, DOI 10.1158/0008-5472.CAN-16-0787
   Chen CL, 2008, GASTROENTEROLOGY, V135, P111, DOI 10.1053/j.gastro.2008.03.073
   Chen ZM, 2011, INT J EPIDEMIOL, V40, P1652, DOI 10.1093/ije/dyr120
   Cui FQ, 2017, EMERG INFECT DIS, V23, P765, DOI 10.3201/eid2305.161477
   Duncan MS, 2019, JAMA-J AM MED ASSOC, V322, P642, DOI 10.1001/jama.2019.10298
   DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504
   El-Serag Hashem B, 2011, Therap Adv Gastroenterol, V4, P5, DOI 10.1177/1756283X10385964
   Fattovich G, 2008, J HEPATOL, V48, P335, DOI 10.1016/j.jhep.2007.11.011
   Heimbach JK, 2018, HEPATOLOGY, V67, P358, DOI 10.1002/hep.29086
   Hung YC, 2015, HEPATOLOGY, V61, P1934, DOI 10.1002/hep.27610
   Inoue M, 2009, CANCER CAUSE CONTROL, V20, P741, DOI 10.1007/s10552-008-9287-6
   Ioannou GN, 2019, J HEPATOL, V71, P523, DOI 10.1016/j.jhep.2019.05.008
   Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.21492, 10.3322/caac.20107]
   Ji MF, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31119-9
   Kerr KF, 2016, J CLIN ONCOL, V34, P2534, DOI 10.1200/JCO.2015.65.5654
   Lee HW, 2016, WORLD J GASTROENTERO, V22, P8314, DOI 10.3748/wjg.v22.i37.8314
   Lee YCA, 2009, INT J EPIDEMIOL, V38, P1497, DOI 10.1093/ije/dyp280
   Liang XF, 2009, VACCINE, V27, P6550, DOI 10.1016/j.vaccine.2009.08.048
   Liao XY, 2015, HUM VACC IMMUNOTHER, V11, P1534, DOI 10.4161/21645515.2014.980206
   Liu J, 2019, B WORLD HEALTH ORGAN, V97, P230, DOI [10.2471/BLT.18.219469, 10.2471/blt.18.219469]
   Liu J, 2016, LANCET INFECT DIS, V16, P80, DOI 10.1016/S1473-3099(15)00218-2
   Llovet JM, 1999, HEPATOLOGY, V29, P62, DOI 10.1002/hep.510290145
   Lv J., 2021, IEEE T GEOSCI ELECT, P1, DOI DOI 10.1109/TGRS.2021.3058549
   McGlynn KA, 2015, CLIN LIVER DIS, V19, P223, DOI 10.1016/j.cld.2015.01.001
   Michikawa T, 2012, PREV MED, V55, P137, DOI 10.1016/j.ypmed.2012.05.017
   Millwood IY, 2013, INT J EPIDEMIOL, V42, P816, DOI 10.1093/ije/dyt078
   Muller DC, 2017, J CLIN ONCOL, V35, P861, DOI 10.1200/JCO.2016.69.2467
   Omata M, 2017, HEPATOL INT, V11, P317, DOI 10.1007/s12072-017-9799-9
   Pang YJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36460-7
   Pang YJ, 2018, HEPATOLOGY, V68, P1308, DOI 10.1002/hep.30083
   Pharoah PDP, 2008, NEW ENGL J MED, V358, P2796, DOI 10.1056/NEJMsa0708739
   Rau HH, 2016, COMPUT METH PROG BIO, V125, P58, DOI 10.1016/j.cmpb.2015.11.009
   Razavi-Shearer D, 2018, LANCET GASTROENTEROL, V3, P383, DOI 10.1016/S2468-1253(18)30056-6
   Royston P, 2002, STAT MED, V21, P2175, DOI 10.1002/sim.1203
   Satriano L, 2019, NAT REV GASTRO HEPAT, V16, P748, DOI 10.1038/s41575-019-0217-8
   Shaffer EA, 2006, BEST PRACT RES CL GA, V20, P981, DOI 10.1016/j.bpg.2006.05.004
   Tammemägi MC, 2013, NEW ENGL J MED, V368, P728, DOI 10.1056/NEJMoa1211776
   Turati F, 2014, ANN ONCOL, V25, P1526, DOI 10.1093/annonc/mdu020
   Vickers AJ, 2006, MED DECIS MAKING, V26, P565, DOI 10.1177/0272989X06295361
   Vickers AJ, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-53
   Vogtmann E, 2014, J EPIDEMIOL COMMUN H, V68, P565, DOI 10.1136/jech-2013-203503
   Wang CG, 2012, INT J CANCER, V130, P1639, DOI 10.1002/ijc.26165
   Wang FS, 2014, HEPATOLOGY, V60, P2099, DOI 10.1002/hep.27406
   Wen CP, 2012, J NATL CANCER I, V104, P1599, DOI 10.1093/jnci/djs372
   Wong VWS, 2010, J CLIN ONCOL, V28, P1660, DOI 10.1200/JCO.2009.26.2675
   Yang GH, 2006, INT J EPIDEMIOL, V35, P741, DOI 10.1093/ije/dyi181
   Yang HI, 2011, LANCET ONCOL, V12, P568, DOI 10.1016/S1470-2045(11)70077-8
   Yuen MF, 2009, J HEPATOL, V50, P80, DOI 10.1016/j.jhep.2008.07.023
NR 51
TC 3
Z9 6
U1 1
U2 26
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0020-7136
EI 1097-0215
J9 INT J CANCER
JI Int. J. Cancer
PD 2021 JUN 15
PY 2021
VL 148
IS 12
BP 2924
EP 2934
DI 10.1002/ijc.33487
EA FEB 2021
PG 11
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA RP2EO
UT WOS:000618088100001
PM 33521941
OA Green Published, Green Accepted
DA 2024-02-19
ER

PT J
AU Zou, JY
   Guo, SJ
   Xiong, MT
   Xu, YC
   Shao, JL
   Tong, ZK
   Zhang, P
   Pan, L
   Peng, AM
   Li, X
AF Zou, Junyong
   Guo, Shijie
   Xiong, Meng Ting
   Xu, Yingchun
   Shao, Jiale
   Tong, Zhongkai
   Zhang, Peng
   Pan, Long
   Peng, Aimei
   Li, Xuan
TI Ageing as key factor for distant metastasis patterns and prognosis in
   patients with extensive-stage Small Cell Lung Cancer
SO JOURNAL OF CANCER
LA English
DT Article
DE age-related; small cell lung cancer; metastasis; survival; prognosis
ID CLINICAL-TRIALS; SURVIVAL; AGE; IMMUNOSENESCENCE; EPIDEMIOLOGY;
   SURVEILLANCE
AB Background: Small cell lung cancer (SCLC) represents about 13% of lung cancer cases, which is highly invasive and has a high mortality rate, with the 5-year overall survival (OS) rate being only 6.3%. Age at diagnosis of advanced SCLC is much older, but studies describing the ageing factor for distant metastasis patterns and prognosis of extensive-stage SCLC (ES-SCLC) are limited.
   Methods: Using the Surveillance, Epidemiology, and End Results (SEER) registry, we identified 18,682 patients with ES-SCLC (9,089 women and 9,053 men) who had complete clinical information between 2008 and 2015. Patients were classified into three groups (older group: >= 80 yrs, middle-aged group: 60-79 yrs, and younger group: <= 59 yrs). The role of different age at diagnosis of ES-SCLC (especially older group) in metastasis patterns was investigated, and OS and cancer-specific survival (CSS) of different age groups of metastatic ES-SCLC was assessed.
   Results: The most metastasis of ES-SCLC patients in the three groups was multiorgan metastases (MOM) metastasis (71.2%, 70.3% and 66.3%, respectively), the most single organ metastasis in the younger group was the lung (3.3%), the middle-aged group and the older group were the brain (3.5%, 3.1%, respectively). The analysis revealed that older patients were less likely to have MOM, but more likely to have all organs metastases than other two groups (p<0.001). Older group had the worst OS (p<0.001) and CSS (p<0.001). Furthermore, Radiotherapy and chemotherapy can improve survival (p<0.001), but the rate of radiotherapy and chemotherapy in older patients is lower than that in middle-aged and younger patients (50.4% vs 38.6% vs 20.7%, p<0.05). Compared with other two group, older group (odds ratios, ORs) for lung, all organ metastases, and MOM were 0.43 (95% CI 0.27-0.67), 1.77 (95% CI 1.55-2.03), 0.68 (95% CI 0.6-0.77), respectively.
   Conclusion: The mortality risk is highest with MOM and all organs metastasis followed by brain, lung, bone and liver metastases in elderly ES-SCLC patients. These results will be helpful for pre-treatment evaluation regarding the prognosis of ES-SCLC patients.
C1 [Zou, Junyong; Peng, Aimei; Li, Xuan] Tongji Univ, Shanghai Peoples Hosp 10, Dept Resp Med, Sch Med, 301 Mid Yanchang Rd, Shanghai 200072, Peoples R China.
   [Zou, Junyong; Shao, Jiale; Tong, Zhongkai] Univ Chinese Acad Sci, Hwamei Hosp, Dept Resp Med, Ningbo 315010, Peoples R China.
   [Zou, Junyong] Univ Chinese Acad Sci, Ningbo Inst Life & Hlth Ind, Ningbo 315010, Peoples R China.
   [Guo, Shijie] Tongji Univ, Shanghai Peoples Hosp 10, Dept Neurol, Sch Med, Shanghai 200072, Peoples R China.
   [Xiong, Meng Ting] Torigii Univ, Pulm Hosp, Dept TB, Sch Med, Shanghai 200072, Peoples R China.
   [Xu, Yingchun] Tongji Univ, Sch Med, Shanghai 200092, Peoples R China.
   [Zhang, Peng] Tongji Univ, Shanghai Peoples Hosp 10, Dept CardioThorac Surg, Sch Med, Shanghai 200072, Peoples R China.
   [Pan, Long] Tongji Univ, Shanghai Peoples Hosp 10, Dept Intervent & Vasc Surg, Sch Med, Shanghai 200072, Peoples R China.
C3 Tongji University; Chinese Academy of Sciences; University of Chinese
   Academy of Sciences, CAS; Chinese Academy of Sciences; University of
   Chinese Academy of Sciences, CAS; Tongji University; Tongji University;
   Tongji University; Tongji University
RP Peng, AM; Li, X (corresponding author), Tongji Univ, Shanghai Peoples Hosp 10, Dept Resp Med, Sch Med, 301 Mid Yanchang Rd, Shanghai 200072, Peoples R China.
EM peng-ai-mei@hotmail.com; lixuan11299211@163.com
RI Zhang, Hui/HHN-8494-2022; 胥, 胥迎春/GPT-3680-2022; Penghui,
   Zhang/HGB-7353-2022
OI 胥, 胥迎春/0000-0003-4857-5201; Penghui, Zhang/0000-0002-9518-7079; Zou,
   Junyong/0000-0001-5307-2647
FU Ningbo Health Branding Subject Fund [PPXK2018-05]; Research Foundation
   of Hwa Mei Hospital, University of Chinese Academy of Sciences, China
   [2019HMZD07]; Medical Scientific Research Foundation of Zhejiang
   Province, China [2019KY594]
FX This work was supported by Ningbo Health Branding Subject Fund (Grant
   No. PPXK2018-05), the Research Foundation of Hwa Mei Hospital,
   University of Chinese Academy of Sciences, China (No. 2019HMZD07),
   Medical Scientific Research Foundation of Zhejiang Province, China (No.
   2019KY594).
CR Abdel-Rahman O, 2018, CLIN RESPIR J, V12, P1093, DOI 10.1111/crj.12632
   Amini A, 2014, CANCER-AM CANCER SOC, V120, P790, DOI 10.1002/cncr.28505
   Asmis TR, 2008, J CLIN ONCOL, V26, P54, DOI 10.1200/JCO.2007.12.8322
   Bianchi-Frias D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012501
   Cai HC, 2018, FUTURE ONCOL, V14, P1397, DOI 10.2217/fon-2017-0706
   Dunn C, 2017, CANCER EPIDEMIOL, V51, P113, DOI 10.1016/j.canep.2017.11.002
   Ferrara R, 2017, CANCER TREAT REV, V60, P60, DOI 10.1016/j.ctrv.2017.08.003
   Fulop T, 2010, ANN NY ACAD SCI, V1197, P158, DOI 10.1111/j.1749-6632.2009.05370.x
   Hsu CL, 2015, J GERIATR ONCOL, V6, P38, DOI 10.1016/j.jgo.2014.09.178
   Kalemkerian GP, 2016, SEMIN RESP CRIT CARE, V37, P783, DOI 10.1055/s-0036-1592116
   Kalemkerian GP, 2013, J NATL COMPR CANC NE, V11, P78, DOI 10.6004/jnccn.2013.0011
   Kaur A, 2016, NATURE, V532, P250, DOI 10.1038/nature17392
   Lally BE, 2009, LUNG CANCER, V64, P226, DOI 10.1016/j.lungcan.2008.08.010
   Langley RR, 2011, INT J CANCER, V128, P2527, DOI 10.1002/ijc.26031
   Larbi A, 2008, PHYSIOLOGY, V23, P64, DOI 10.1152/physiol.00040.2007
   Nakazawa K, 2012, ONCOL LETT, V4, P617, DOI 10.3892/ol.2012.792
   Owonikoko TK, 2007, J CLIN ONCOL, V25, P5570, DOI 10.1200/JCO.2007.12.5435
   Palma DA, 2016, CLIN LUNG CANCER, V17, P239, DOI 10.1016/j.cllc.2015.09.007
   Riihimäki M, 2014, LUNG CANCER, V86, P78, DOI 10.1016/j.lungcan.2014.07.020
   Riihimäki M, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-36
   Rudin CM, 2016, J ONCOL PRACT, V12, P83, DOI 10.1200/JOP.2015.008201
   Siegel RL, 2019, CA-CANCER J CLIN, V69, P7, DOI 10.3322/caac.21551
   Tas F, 1999, ACTA ONCOL, V38, P1011
   Vavala T, 2017, LUNG CANCER, V107, P84, DOI 10.1016/j.lungcan.2016.05.021
   Wakuda K, 2019, IN VIVO, V33, P2229, DOI 10.21873/invivo.11727
NR 25
TC 6
Z9 7
U1 0
U2 6
PU IVYSPRING INT PUBL
PI LAKE HAVEN
PA PO BOX 4546, LAKE HAVEN, NSW 2263, AUSTRALIA
SN 1837-9664
J9 J CANCER
JI J. Cancer
PY 2021
VL 12
IS 6
BP 1575
EP 1582
DI 10.7150/jca.49681
PG 8
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA QD2NK
UT WOS:000615361600001
PM 33613744
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Moulahoum, H
   Ghorbanizamani, F
   Khiari, Z
   Toumi, M
   Benazzoug, Y
   Tok, K
   Timur, S
   Zihnioglu, F
AF Moulahoum, Hichem
   Ghorbanizamani, Faezeh
   Khiari, Zineb
   Toumi, Mohamed
   Benazzoug, Yasmina
   Tok, Kerem
   Timur, Suna
   Zihnioglu, Figen
TI <i>Artemisia</i> alleviates AGE-induced liver complications via MAPK and
   RAGE signaling pathways modulation: a combinatorial study
SO MOLECULAR AND CELLULAR BIOCHEMISTRY
LA English
DT Article; Early Access
DE Artemisia herba-alba; Network pharmacology; Diabetes; Age-related
   diseases; Advanced glycation end-products; Signaling pathway
ID GLYCATION END-PRODUCTS; IN-VITRO; INHIBITORY-ACTIVITY; OXIDATIVE STRESS;
   ESSENTIAL OIL; GROWING WILD; KAPPA-B; ANTIOXIDANT; GLYCOTOXINS;
   APOPTOSIS
AB Artemisia herba-alba (AHA) is a traditionally used plant to treat various diseases, including diabetes and metabolic dysfunctions. Plant extracts are generally explored empirically without a deeper assessment of their mechanism of action. Here, we describe a combinatorial study of biochemical, molecular, and bioinformatic (metabolite-protein pharmacology network) analyses to elucidate the mechanism of action of AHA and shed light on its multilevel effects in the treatment of diabetes-related advanced glycation end-products (AGE)-induced liver damages. The extract's polyphenols and flavonoids content were measured and then identified via LC-Q-TOF-MS/MS. Active compounds were used to generate a metabolite-target interaction network via Swiss Target Prediction and other databases. The extract was tested for its antiglycation and aggregation properties. Next, THLE-2 liver cells were challenged with AGEs, and the mechanistic markers were measured [TNF-alpha, IL-6, nitric oxide, total antioxidant capacity, lipid peroxidation (LPO), and caspase 3]. Metabolite and network screening showed the involvement of AHA in diabetes, glycation, liver diseases, aging, and apoptosis. Experimental confirmation showed that AHA inhibited protein modification and AGE formation. Additionally, AHA reduced inflammatory mediators (IL-6, TNF alpha), oxidative stress markers (NO, LPO), and apoptosis (Caspase 3). On the other hand, cellular total antioxidant capacity was restored to normal levels. The combinatorial study showed that AHA regulates AGE-induced liver damages through MAPK-AKT and AGE-RAGE signaling pathways. This report highlights the combination of experimental and network pharmacology for the exact elucidation of AHA mechanism of action as a multitarget option in the therapy of diabetes and AGEs-related diseases.
C1 [Moulahoum, Hichem; Ghorbanizamani, Faezeh; Tok, Kerem; Timur, Suna; Zihnioglu, Figen] Ege Univ, Fac Sci, Biochem Dept, TR-35100 Izmir, Turkey.
   [Khiari, Zineb] Higher Normal Sch Kouba, Dept Nat Sci, Lab Ethnobotany & Nat Subst, BP 92, Algiers 16308, Algeria.
   [Khiari, Zineb; Benazzoug, Yasmina] USTHB, Fac Biol Sci FSB, Lab Cellular & Mol Biol BCM, Biochem & Extracellular Matrix Remodelling, BP 31, Algiers 16111, Algeria.
   [Toumi, Mohamed] Univ Algiers, Fac Sci, Lab REVIECO, 1 Benyoucef Benkhedda, Algiers, Algeria.
   [Timur, Suna] Ege Univ, Cent Res Test & Anal Lab Applicat & Res Ctr, TR-35100 Izmir, Turkey.
C3 Ege University; University Science & Technology Houari Boumediene; Ege
   University
RP Moulahoum, H (corresponding author), Ege Univ, Fac Sci, Biochem Dept, TR-35100 Izmir, Turkey.
EM hic_moul@hotmail.com
RI MOULAHOUM, Hichem/DIC-3335-2022; Tok, Kerem/AAG-6529-2021; Timur,
   Suna/CAG-0914-2022
OI MOULAHOUM, Hichem/0000-0003-3934-6415; Timur, Suna/0000-0002-1981-7577;
   TOK, Kerem/0000-0002-7244-3949; ZIHNIOGLU, FIGEN/0000-0001-8216-7004
FU Scientific and Technological Research Council of Turkey-TUBITAK
   [120Z200]; Projets de Recherche-Formation Universitaire (PRFU)
   [D01N01UN160420180008]
FX This project was funded by The Scientific and Technological Research
   Council of Turkey-TUBITAK (120Z200). The current project was partially
   funded by the Projets de Recherche-Formation Universitaire (PRFU)
   (D01N01UN160420180008). EGE MATAL (EGE University) is acknowledged for
   the LC-Q-TOF-MS/MS analyses and cell culture experiments.
CR Abu-Darwish MS, 2015, J ETHNOPHARMACOL, V174, P153, DOI 10.1016/j.jep.2015.08.005
   Albensi BC, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00154
   Amri I, 2013, NAT PROD COMMUN, V8, P407
   Banerjee S, 2019, PHYTOMEDICINE, V60, DOI 10.1016/j.phymed.2019.152944
   Bisht D, 2021, ARCH PHARM RES, V44, P439, DOI 10.1007/s12272-021-01328-4
   Cepas V, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9020142
   Chaudhuri J, 2018, CELL METAB, V28, P337, DOI 10.1016/j.cmet.2018.08.014
   Craig WJ, 1999, AM J CLIN NUTR, V70, p491S, DOI 10.1093/ajcn/70.3.491s
   Cui CB, 2009, J KOREAN SOC APPL BI, V52, P655, DOI 10.3839/jksabc.2009.109
   Dzib-Guerra WD, 2016, PHARMACOGN RES, V8, P276
   Fernandes ACF, 2020, PREP BIOCHEM BIOTECH, V50, P794, DOI 10.1080/10826068.2020.1737941
   Fernando DH, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20205037
   Fernandes ACF, 2020, FOOD CHEM TOXICOL, V145, DOI 10.1016/j.fct.2020.111619
   Fernandes ACF, 2020, J FOOD PROCESS PRES, V44, DOI 10.1111/jfpp.14397
   Ghanbari M, 2022, AVICENNA J PHYTOMEDI, V12, P54, DOI [10.22038/AJP.2021.18829, 10.22038/ajp.2021.18829]
   GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X
   Henning C, 2016, GLYCOCONJUGATE J, V33, P499, DOI 10.1007/s10719-016-9694-y
   Hopkins AL, 2007, NAT BIOTECHNOL, V25, P1110, DOI 10.1038/nbt1007-1110
   Huang JH, 2017, MOL MED REP, V16, P4583, DOI 10.3892/mmr.2017.7149
   Hutchinson L, 2011, NAT REV CLIN ONCOL, V8, P189, DOI [10.1038/nrclinonc.2011.34, 10.1038/nrclinonc.2010.204]
   Jeong D, 2014, J ETHNOPHARMACOL, V152, P487, DOI 10.1016/j.jep.2014.01.030
   Jeong SH, 2018, FOOD AGR IMMUNOL, V29, P688, DOI 10.1080/09540105.2018.1439454
   Jung HA, 2012, ARCH PHARM RES, V35, P1021, DOI 10.1007/s12272-012-0610-0
   Leung C, 2014, J HEPATOL, V60, P832, DOI 10.1016/j.jhep.2013.11.033
   Li XM, 2014, J AGR FOOD CHEM, V62, P12152, DOI 10.1021/jf504132x
   Mahali S, 2011, J BIOL CHEM, V286, P34903, DOI 10.1074/jbc.M111.279190
   Marvibaigi M, 2014, J TEKNOL, V70
   Moldogazieva NT, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/3085756
   Moulahoum H, 2019, INT J BIOL MACROMOL, V137, P583, DOI 10.1016/j.ijbiomac.2019.07.003
   Mukhopadhyay S, 2005, BBA-MOL CELL RES, V1745, P145, DOI 10.1016/j.bbamcr.2005.03.010
   Munro B, 2015, ANTIOXIDANTS, V4, P647, DOI 10.3390/antiox4040647
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   Quettier-Deleu C, 2000, J ETHNOPHARMACOL, V72, P35, DOI 10.1016/S0378-8741(00)00196-3
   Rungratanawanich W, 2021, EXP MOL MED, V53, P168, DOI 10.1038/s12276-021-00561-7
   Sayej WN, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/7867852
   Song QH, 2021, BIOMED PHARMACOTHER, V140, DOI 10.1016/j.biopha.2021.111750
   Taabazuing CY, 2017, CELL CHEM BIOL, V24, P507, DOI 10.1016/j.chembiol.2017.03.009
   Tupe RS, 2010, BRIT J NUTR, V103, P370, DOI 10.1017/S0007114509991929
   Uribarri J, 2007, J GERONTOL A-BIOL, V62, P427, DOI 10.1093/gerona/62.4.427
   Vijaykrishnaraj M, 2021, BIOMED PHARMACOTHER, V144, DOI 10.1016/j.biopha.2021.112336
   Wang X, 2018, BIOMED PHARMACOTHER, V104, P390, DOI 10.1016/j.biopha.2018.05.054
   Xiao WP, 2019, NAT PROD COMMUN, V14, DOI 10.1177/1934578X19883071
   Xiong GL, 2021, NUCLEIC ACIDS RES, V49, pW5, DOI 10.1093/nar/gkab255
   Younsi F, 2018, PHYTOCHEMISTRY, V148, P48, DOI 10.1016/j.phytochem.2018.01.014
   Yu WZ, 2018, J FUNCT FOODS, V40, P272, DOI 10.1016/j.jff.2017.11.003
NR 45
TC 2
Z9 2
U1 0
U2 11
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0300-8177
EI 1573-4919
J9 MOL CELL BIOCHEM
JI Mol. Cell. Biochem.
PD 2022 OCT
PY 2022
VL 477
IS 10
BP 2345
EP 2357
DI 10.1007/s11010-022-04437-w
EA MAY 2022
PG 13
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA 4S0LJ
UT WOS:000793625100001
PM 35543857
DA 2024-02-19
ER

PT J
AU Kaneko, T
   Tahara, S
   Tanno, M
   Taguchi, T
AF Kaneko, T
   Tahara, S
   Tanno, M
   Taguchi, T
TI Effect of age on the induction of 8-oxo-2′deoxyguanosine-releasing
   enzyme in rat liver by γ-ray irradiation
SO ARCHIVES OF GERONTOLOGY AND GERIATRICS
LA English
DT Article
DE oxidative damage; 8-oxo-2 '-deoxyguanosine; repair enzyme; gamma-ray
   irradiation; aging
ID OXYGEN RADICALS; 8-HYDROXYGUANINE MOIETY; DEOXYRIBONUCLEIC-ACID;
   DNA-DAMAGE; REPAIR; 8-HYDROXY-2-DEOXYGUANOSINE; 8-OXO-2'-DEOXYGUANOSINE;
   8-HYDROXYDEOXYGUANOSINE; HYDROPEROXIDE; MITOCHONDRIAL
AB Aged (27 months of age) and young (6 months of age) Fischer 344/DuCrj rats were exposed to gamma-ray irradiation, and their livers were compared for levels of oxidative DNA modifications and repair enzyme activities. The amounts of 8-oxo-2'-deoxyguanosine (8-oxodG) in the nuclear DNA of the livers of both young and aged rats increased immediately after irradiation, by 1.7-fold in the livers of young rats and 2.7-fold in the livers of the aged rats. Also, the rate of 8-oxodG decay was slower in the livers of the aged rats than in young rat liver, and remained above the baseline level even I week after irradiation. The activities of 8-oxodG-releasing enzymes peaked 2 and 6 h after irradiation in the livers of young and aged rats, respectively. The repair activity in the livers of the young rats was increased by sevenfold 2 It after irradiation, while the livers of the aged rats showed a twofold increase 6 h after irradiation. These results suggest that the ability to repair damaged DNA is lower in aged rats, and that the accumulation of oxidative DNA damage that takes place during aging may be related to this decline in repair activity. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
C1 Tokyo Metropolitan Inst Gerontol, Redox Regulat Res Grp, Itabashi Ku, Tokyo 1730015, Japan.
   Tokyo Metropolitan Geriatr Hosp, Dept Nucl Med & Radiol Sci, Itabashi Ku, Tokyo 1730015, Japan.
   Tokyo Metropolitan Inst Gerontol, Dept Gene Regulat & Prot Funct, Itabashi Ku, Tokyo 1730015, Japan.
C3 Tokyo Metropolitan Institute of Gerontology; Tokyo Metropolitan
   Institute of Gerontology
RP Kaneko, T (corresponding author), Tokyo Metropolitan Inst Gerontol, Redox Regulat Res Grp, Itabashi Ku, 35-2 Sakaecho, Tokyo 1730015, Japan.
EM kaneko@center.tmig.or.jp
CR AMES BN, 1983, SCIENCE, V221, P1256, DOI 10.1126/science.6351251
   [Anonymous], 1993, DNA FREE RADICALS
   Arai K, 1997, ONCOGENE, V14, P2857, DOI 10.1038/sj.onc.1201139
   ARUOMA OI, 1989, J BIOL CHEM, V264, P20509
   BESSHO T, 1993, J BIOL CHEM, V268, P19416
   BURGER RM, 1980, J BIOL CHEM, V255, P1832
   Cardozo-Pelaez F, 2000, FREE RADICAL BIO MED, V28, P779, DOI 10.1016/S0891-5849(00)00172-6
   CATHCART R, 1984, P NATL ACAD SCI-BIOL, V81, P5633, DOI 10.1073/pnas.81.18.5633
   CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527
   Cooke MS, 2000, FREE RADICAL RES, V32, P381, DOI 10.1080/10715760000300391
   CROSS CE, 1987, ANN INTERN MED, V107, P526, DOI 10.7326/0003-4819-107-4-526
   de Souza-Pinto NC, 2001, FREE RADICAL BIO MED, V30, P916, DOI 10.1016/S0891-5849(01)00483-X
   DIZDAROGLU M, 1985, BIOCHEMISTRY-US, V24, P4476, DOI 10.1021/bi00337a032
   Dreher D, 1996, EUR J CANCER, V32A, P30, DOI 10.1016/0959-8049(95)00531-5
   FEIG DI, 1994, J MOL BIOL, V235, P33, DOI 10.1016/S0022-2836(05)80009-9
   FRAGA CG, 1990, P NATL ACAD SCI USA, V87, P4533, DOI 10.1073/pnas.87.12.4533
   Kaneko T, 1996, MUTAT RES-DNAGING G, V316, P277, DOI 10.1016/S0921-8734(96)90010-7
   Kaneko T, 2000, LIPIDS, V35, P961, DOI 10.1007/s11745-000-0606-y
   KASAI H, 1986, CARCINOGENESIS, V7, P1849, DOI 10.1093/carcin/7.11.1849
   KASAI H, 1984, JPN J CANCER RES, V75, P1037
   KOHDA K, 1990, CHEM PHARM BULL, V38, P3072, DOI 10.1248/cpb.38.3072
   KUCHINO Y, 1987, NATURE, V327, P77, DOI 10.1038/327077a0
   LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0
   MCGOLDRICK JP, 1995, MOL CELL BIOL, V15, P989
   MO JY, 1992, P NATL ACAD SCI USA, V89, P11021, DOI 10.1073/pnas.89.22.11021
   PRAET M, 1988, BIOCHEM PHARMACOL, V37, P4617, DOI 10.1016/0006-2952(88)90329-2
   Rosenquist TA, 1997, P NATL ACAD SCI USA, V94, P7429, DOI 10.1073/pnas.94.14.7429
   Shen HM, 1996, MUTAT RES-REV GENET, V366, P23, DOI 10.1016/S0165-1110(96)90005-6
   SHIGENAGA MK, 1989, P NATL ACAD SCI USA, V86, P9697, DOI 10.1073/pnas.86.24.9697
   TOTTER JR, 1980, P NATL ACAD SCI-BIOL, V77, P1763, DOI 10.1073/pnas.77.4.1763
   WOOD ML, 1990, BIOCHEMISTRY-US, V29, P7024, DOI 10.1021/bi00482a011
   YAMAMOTO F, 1992, JPN J CANCER RES, V83, P351, DOI 10.1111/j.1349-7006.1992.tb00114.x
NR 32
TC 16
Z9 16
U1 0
U2 5
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0167-4943
EI 1872-6976
J9 ARCH GERONTOL GERIAT
JI Arch. Gerontol. Geriatr.
PD JAN-FEB
PY 2003
VL 36
IS 1
BP 23
EP 35
AR PII S0167-4943(02)00056-0
DI 10.1016/S0167-4943(02)00056-0
PG 13
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 621XY
UT WOS:000179617300004
PM 12849096
DA 2024-02-19
ER

PT J
AU Pamplona, R
   Portero-Otin, M
   Sanz, A
   Requena, J
   Barja, G
AF Pamplona, R
   Portero-Otin, M
   Sanz, A
   Requena, J
   Barja, G
TI Modification of the longevity-related degree of fatty acid unsaturation
   modulates oxidative damage to proteins and mitochondrial DNA in liver
   and brain
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE free radical; aging; polyunsaturated fatty acids; mitochondrial DNA;
   lipid peroxidation; 8-hydroxydeoxyguanosine; malondialdehyde; protein
   carbonyls; AGES; glycoxidation
ID MAXIMUM LIFE-SPAN; LIPID-PEROXIDATION; HEART-MITOCHONDRIA; RATS;
   MALONDIALDEHYDE; PHOSPHOLIPIDS; MECHANISM; ADDUCTS; PRODUCT; STRESS
AB Previous studies have shown that tissue fatty acid unsaturation correlates inversely with maximum longevity. However, it is unclear if this is related to the effects of fatty acid unsaturation only on lipids, or also on proteins and DNA, specially on mitochondrial DNA (mtDNA) oxidative damage. In this investigation the degree of fatty acid unsaturation of liver and brain was successfully manipulated in Wistar rats by chronic feeding with specially designed semipurified diets rich in saturated or unsaturated fats. The brain, an organ of special relevance for aging, was most profoundly affected by the increase in fatty acid unsaturation, and showed significant increases in malondialdehyde (MDA)-lysine, aminoadipic semialdehyde (a protein carbonyl), N-epsilon-(carboxymethyl)lysine, and N-epsilon-(carboxyethyl)lysine in proteins, as well as in 8-oxo,7,8-dihydro-2'-deoxyguanosine (8-oxodG) in mtDNA without changes in nuclear DNA (nDNA). In the liver 8-oxodG was also increased in mtDNA and not in nDNA. These DNA results are consistent with the presence of a high density of mitochondrial inner membranes (rich in lipids and in reactive oxygen species generation capacity) near mtDNA but not near nDNA. Among the protein markers analyzed, MDA-lysine was most consistent and responsive to fatty acid unsaturation, since it increased in both organs and showed the highest increase. These results, together with previous data from our laboratories, show that increasing the degree of fatty unsaturation of postmitotic tissues in vivo can raise not only lipid but also protein and mtDNA oxidative damage. This is mechanistically relevant in relation to the constitutively low tissue fatty acid unsaturation of long-lived animals. (C) 2004 Elsevier Inc. All rights reserved.
C1 Univ Lleida, Fac Med, Dept Basic Med Sci, Lleida 25198, Spain.
   Univ Santiago de Compostela, Fac Med, Dept Microbiol, Prion Res Unit, Santiago De Compostela, Spain.
   Univ Complutense, Fac Biol, Dept Anim Physiol 2, Madrid 28040, Spain.
C3 Universitat de Lleida; Universidade de Santiago de Compostela;
   Complutense University of Madrid
RP Barja, G (corresponding author), Univ Lleida, Fac Med, Dept Basic Med Sci, Lleida 25198, Spain.
EM gbarja@bio.ucm.es
RI Barja, Gustavo/AAA-5903-2019; Gustavo, Barja/B-5591-2012; Sanz,
   Alberto/O-2329-2015; Portero-Otin, Manuel/B-7122-2009; Pamplona,
   Reinald/A-7359-2010; SANZ, ALBERTO/F-8432-2011
OI Barja, Gustavo/0000-0001-5736-4735; Sanz, Alberto/0000-0003-2149-1753;
   Portero-Otin, Manuel/0000-0002-1823-0299; Pamplona,
   Reinald/0000-0003-4337-6107; 
CR ABRING M, 1977, PNAS US, V74, P1348
   Ahmed MU, 1997, BIOCHEM J, V324, P565, DOI 10.1042/bj3240565
   Barja G, 2000, FASEB J, V14, P312, DOI 10.1096/fasebj.14.2.312
   BARJA G, 1994, COMP BIOCHEM PHYS B, V108, P501, DOI 10.1016/0305-0491(94)90103-1
   BARJA G, 2004, IN PRESS BIOL REV
   Cadenas S, 1997, CARCINOGENESIS, V18, P2373, DOI 10.1093/carcin/18.12.2373
   CHO SH, 1995, J NUTR SCI VITAMINOL, V41, P61, DOI 10.3177/jnsv.41.61
   CHUNG FL, 1992, CARCINOGENESIS, V13, P1269, DOI 10.1093/carcin/13.7.1269
   Clarke SD, 2001, J NUTR, V131, P1129, DOI 10.1093/jn/131.4.1129
   DEKOK TMCM, 1994, CARCINOGENESIS, V15, P1399, DOI 10.1093/carcin/15.7.1399
   Draper HH, 2000, FREE RADICAL BIO MED, V29, P1071, DOI 10.1016/S0891-5849(00)00367-1
   DRAPER HH, 1995, LIPIDS, V30, P959, DOI 10.1007/BF02537489
   Fang JL, 1996, CARCINOGENESIS, V17, P1035, DOI 10.1093/carcin/17.5.1035
   FORSMARKANDREE P, 1995, FREE RADICAL BIO MED, V19, P749, DOI 10.1016/0891-5849(95)00076-A
   Fu MX, 1996, J BIOL CHEM, V271, P9982, DOI 10.1074/jbc.271.17.9982
   Harman D, 1998, EXP GERONTOL, V33, P95, DOI 10.1016/S0531-5565(97)00059-4
   Herrero A, 2001, MECH AGEING DEV, V122, P427, DOI 10.1016/S0047-6374(01)00214-7
   HOCH FL, 1992, BIOCHIM BIOPHYS ACTA, V1113, P71, DOI 10.1016/0304-4157(92)90035-9
   Hulbert AJ, 2002, COMP BIOCHEM PHYS B, V132, P515, DOI 10.1016/S1096-4959(02)00066-0
   KNECHT KJ, 1991, DIABETES, V40, P190, DOI 10.2337/diabetes.40.2.190
   LATORRE A, 1986, P NATL ACAD SCI USA, V83, P8649, DOI 10.1073/pnas.83.22.8649
   Loft S, 1999, METHOD ENZYMOL, V300, P166
   Loft S, 1998, FREE RADICAL RES, V29, P595, DOI 10.1080/10715769800300641
   MARESCA B, 1993, NATURE, V365, P606, DOI 10.1038/365606a0
   Marnett LJ, 2000, CARCINOGENESIS, V21, P361, DOI 10.1093/carcin/21.3.361
   Mecocci P, 1999, FREE RADICAL BIO MED, V26, P303, DOI 10.1016/S0891-5849(98)00208-1
   Pamplona R, 2000, J GERONTOL A-BIOL, V55, pB286, DOI 10.1093/gerona/55.6.B286
   Pamplona R, 2002, ANN NY ACAD SCI, V959, P475, DOI 10.1111/j.1749-6632.2002.tb02118.x
   Pamplona R, 1999, MECH AGEING DEV, V106, P283, DOI 10.1016/S0047-6374(98)00121-3
   Pamplona R, 1998, J LIPID RES, V39, P1989
   Refsgaard HHF, 2000, P NATL ACAD SCI USA, V97, P611, DOI 10.1073/pnas.97.2.611
   Requena JR, 1997, BIOCHEM J, V322, P317, DOI 10.1042/bj3220317
   Requena JR, 2001, P NATL ACAD SCI USA, V98, P69, DOI 10.1073/pnas.011526698
   SATO A, 2000, BIOL PHARM BULL, V21, P1271
   Soriguer FJ, 2000, EUR J EPIDEMIOL, V16, P585, DOI 10.1023/A:1007684808188
   Umegaki K, 2001, FREE RADICAL RES, V34, P427, DOI 10.1080/10715760100300361
   Vigouroux S, 2003, INT J BIOCHEM CELL B, V35, P749, DOI 10.1016/S1357-2725(02)00389-8
NR 37
TC 56
Z9 60
U1 0
U2 10
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD MAY
PY 2004
VL 39
IS 5
BP 725
EP 733
DI 10.1016/j.exger.2004.01.006
PG 9
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 823SM
UT WOS:000221633400006
PM 15130667
DA 2024-02-19
ER

PT J
AU Lampignano, L
   Donghia, R
   Griseta, C
   Lagravinese, G
   Sciarra, S
   Zupo, R
   Castellana, F
   Bortone, I
   Guerra, V
   Tirelli, S
   De Nucci, S
   Tatoli, R
   Lozupone, M
   Sborgia, G
   Leo, A
   De Pergola, G
   Giannelli, G
   Panza, F
   Sardone, R
AF Lampignano, Luisa
   Donghia, Rossella
   Griseta, Chiara
   Lagravinese, Gianvito
   Sciarra, Sabrina
   Zupo, Roberta
   Castellana, Fabio
   Bortone, Ilaria
   Guerra, Vito
   Tirelli, Sarah
   De Nucci, Sara
   Tatoli, Rossella
   Lozupone, Madia
   Sborgia, Giancarlo
   Leo, Antonio
   De Pergola, Giovanni
   Giannelli, Gianluigi
   Panza, Francesco
   Sardone, Rodolfo
TI Liver Health and Dementia in an Italian Older Population: Findings From
   the Salus in Apulia Study
SO FRONTIERS IN AGING NEUROSCIENCE
LA English
DT Article
DE NAFLD (non-alcoholic fatty liver disease); aging; dementia; older
   population; neurodegenerative diseases; liver
ID APOLIPOPROTEIN-E; ALZHEIMERS-DISEASE; INSULIN-RESISTANCE; RISK-FACTOR;
   COGNITIVE IMPAIRMENT; ALL-CAUSE; PREVALENCE; PREVENTION; MANAGEMENT;
   INTERVENTION
AB Objectives: Non-alcoholic fatty liver disease (NAFLD) currently affects a quarter of the global population. Systemic inflammation, metabolic syndrome, and coronary artery disease, all conditions associated with NAFLD, have also been related to cognitive dysfunction in older age. The present study aimed to investigate the relationship between NAFLD risk and a dementia diagnosis in a large population-based sample aged > 65 years.Methods: We selected 1,542 participants (723 men) from the Salus in Apulia Study. To assess the risk of fat distribution in the liver, we used the Fatty Liver Index (FLI). Dementia was diagnosed according to the American Psychiatric Association criteria (DSM-5).Results: The overall prevalence of dementia was 8.5% [95% confidence interval (CI): 7-10%]. Subjects with dementia were older [effect size (ES): -0.89, 95% CI: -1.07 to -0.70], had a lower level of education (ES:0.88, 95% CI:0.69-1.06), higher levels of gamma-glutamyl transferase (ES: -0.21, 95% CI: -0.39 to -0.03), lower levels of total cholesterol (ES: -0.24, 95% CI: -0.42 to -0.06) and low-density lipoprotein cholesterol (ES: -0.20, 95% CI: -0.38 to 0.02), and a higher FLI (ES: -0.22, 95% CI: -0.39 to -0.04). In the logistic regression model adjusted for age, sex, education, hypertension, diabetes mellitus, alcohol consumption, smoking habits, stroke, cholesterol, and Apo-E, a dementia diagnosis was positively associated with FLI > 60 [odds ratio (OR):1.81; standard error (SE): 0.53; 95% CI: 1.02-3.21].Conclusion: Our findings suggested that an increased NAFLD risk may be associated to dementia and cognitive decline in older age. Considering the high NAFLD prevalence, the possible adverse disease effects on cognitive performance pose a health problem with significant social and economic implications.
C1 [Lampignano, Luisa; Donghia, Rossella; Griseta, Chiara; Sciarra, Sabrina; Zupo, Roberta; Castellana, Fabio; Bortone, Ilaria; Guerra, Vito; Tirelli, Sarah; De Nucci, Sara; Tatoli, Rossella; De Pergola, Giovanni; Giannelli, Gianluigi; Panza, Francesco; Sardone, Rodolfo] Salus Apulia Study Natl Inst Gastroenterol S de B, Unit Res Methodol & Data Sci Populat Hlth, Bari, Italy.
   [Lagravinese, Gianvito] IRCCS ICS Maugeri, Bari, Italy.
   [Lozupone, Madia; Sborgia, Giancarlo] Univ Bari Aldo Moro, Dept Basic Med Neurosci & Sense Organs, Bari, Italy.
   [Leo, Antonio] Santa Chiara Inst, Lecce, Italy.
   [De Pergola, Giovanni] Univ Bari Aldo Moro, Sch Med, Dept Biomed Sci & Human Oncol, Bari, Italy.
C3 Istituti Clinici Scientifici Maugeri IRCCS; Universita degli Studi di
   Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro
RP Lampignano, L; Sardone, R (corresponding author), Salus Apulia Study Natl Inst Gastroenterol S de B, Unit Res Methodol & Data Sci Populat Hlth, Bari, Italy.
EM luisa.lampignano@irccsdebellis.it; rodolfo.sardone@irccsdebellis.it
RI Sardone, Rodolfo/AAM-2727-2020; Lagravinese, Gianvito/HJY-5720-2023;
   Castellana, Fabio/AAC-4919-2022; Zupo, Roberta/AAO-9103-2020; Bortone,
   Ilaria/HPE-3696-2023; Zupo, Roberta/GPT-3724-2022; Lozupone,
   Madia/F-7262-2018; Lampignano, Luisa/AAA-3108-2022
OI Sardone, Rodolfo/0000-0003-1383-1850; Lagravinese,
   Gianvito/0000-0001-7717-3071; Castellana, Fabio/0000-0002-6439-8228;
   Zupo, Roberta/0000-0001-9885-1185; Lozupone, Madia/0000-0002-1674-9724;
   Tirelli, Sarah/0000-0002-5521-2508; Sborgia,
   Giancarlo/0000-0001-7271-0536; Donghia, Rossella/0000-0002-9140-673X
FU Italian Ministry of Health; Apulia Government; Italian Ministry of
   Health, under the Studies on Aging Network, at Italian Research
   Hospitals (IRCCS)
FX This study was funded by the Italian Ministry of Health with the
   "Ricerca Corrente 2019" Grant. The Salus in Apulia Study was funded by
   Apulia Government and Italian Ministry of Health, under the Studies on
   Aging Network, at Italian Research Hospitals (IRCCS).
CR [Anonymous], 2021, ALZHEIMERS DEMENT, V17, P327, DOI 10.1002/alz.12328
   Anstey KJ, 2017, J ALZHEIMERS DIS, V56, P215, DOI 10.3233/JAD-160826
   Bassendine MF, 2020, J ALZHEIMERS DIS, V75, P1, DOI 10.3233/JAD-190848
   Bedogni G, 2005, HEPATOLOGY, V42, P44, DOI 10.1002/hep.20734
   Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33
   Bertolotti M, 2014, WORLD J GASTROENTERO, V20, P14185, DOI 10.3748/wjg.v20.i39.14185
   Buechler C, 2011, WORLD J GASTROENTERO, V17, P2801, DOI 10.3748/wjg.v17.i23.2801
   Castellana F, 2021, J AM MED DIR ASSOC, V22, P598, DOI 10.1016/j.jamda.2020.12.026
   Cheng G, 2012, INTERN MED J, V42, P484, DOI 10.1111/j.1445-5994.2012.02758.x
   Cooper J, 2001, BRIT J PSYCHIAT, V179, P85, DOI 10.1192/bjp.179.1.85-a
   CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443
   Craft S, 2007, CURR ALZHEIMER RES, V4, P147, DOI 10.2174/156720507780362137
   Debette S, 2011, NEUROLOGY, V77, P461, DOI 10.1212/WNL.0b013e318227b227
   Estrada LD, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00174
   Frank J, 2021, BIOFACTORS, V47, P522, DOI 10.1002/biof.1728
   Gale SA, 2018, AM J MED, V131, P1161, DOI 10.1016/j.amjmed.2018.01.022
   Gehrke N, 2020, GASTROENTEROLOGY, V158, P1929, DOI 10.1053/j.gastro.2020.02.020
   Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496
   Hort J, 2010, EUR J NEUROL, V17, P1236, DOI 10.1111/j.1468-1331.2010.03040.x
   HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566
   Kanekiyo T, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00093
   Kim J.J., 2005, EFFECT SIZES RES BRO
   KIRBY KS, 1957, BIOCHEM J, V66, P495, DOI 10.1042/bj0660495
   Kjærgaard K, 2021, J CLIN MED, V10, DOI 10.3390/jcm10040673
   Kumashiro N, 2011, P NATL ACAD SCI USA, V108, P16381, DOI 10.1073/pnas.1113359108
   Kunutsor SK, 2016, ALZHEIMERS DEMENT, V12, P931, DOI 10.1016/j.jalz.2016.03.003
   Lee YB, 2020, INT J GERIATR PSYCH, V35, P1105, DOI 10.1002/gps.5332
   Leoci C., 1993, G ITAL NUTR CLIN PRE, V2, P58
   Licher S, 2019, NAT MED, V25, P1364, DOI 10.1038/s41591-019-0547-7
   Livingston G, 2020, LANCET, V396, P413, DOI 10.1016/S0140-6736(20)30367-6
   Livingston Gill, 2017, Lancet, V390, P2673, DOI 10.1016/S0140-6736(17)31363-6
   Loomba R, 2013, J CLIN EXP HEPATOL, V3, P4, DOI 10.1016/j.jceh.2012.10.004
   MEASSO G, 1993, DEV NEUROPSYCHOL, V9, P77, DOI 10.1080/87565649109540545
   Morris BJ, 2019, BBA-MOL BASIS DIS, V1865, P1718, DOI 10.1016/j.bbadis.2018.08.039
   Nascimento JCR, 2020, ANN HEPATOL, V19, P24, DOI 10.1016/j.aohep.2019.07.011
   Nho K, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.7978
   Niu H, 2017, NEUROLOGIA, V32, P523, DOI 10.1016/j.nrl.2016.02.016
   Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232
   OECD & European Union, 2018, HLTH GLANC EUR 2018, DOI DOI 10.1787/HEALTH_GLANCE_EUR-2018-EN
   Oni Ebenezer T, 2020, J Clin Med Res, V12, P472, DOI 10.14740/jocmr3932
   Palta P, 2014, J INT NEUROPSYCH SOC, V20, P278, DOI 10.1017/S1355617713001483
   Peters R, 2020, BRIT J PSYCHIAT, V216, P16, DOI 10.1192/bjp.2019.156
   Rasmussen KL, 2016, ATHEROSCLEROSIS, V255, P145, DOI 10.1016/j.atherosclerosis.2016.10.037
   Rizzo MR, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21062010
   Roy B, 2021, CELL BIOSCI, V11, DOI 10.1186/s13578-021-00587-4
   Sardone R, 2020, OTOLARYNG HEAD NECK, V163, P348, DOI 10.1177/0194599820913635
   Seo SW, 2016, NEUROLOGY, V86, P1136, DOI 10.1212/WNL.0000000000002498
   Seripa D, 2006, DIAGN MOL PATHOL, V15, P180, DOI 10.1097/01.pdm.0000213451.99655.1d
   Solfrizzi V, 2020, ALZH DEMENT-TRCI, V6, DOI 10.1002/trc2.12065
   Stewart R, 2007, ARCH NEUROL-CHICAGO, V64, P103, DOI 10.1001/archneur.64.1.103
   Tamaki C, 2007, MOL PHARMACOL, V72, P850, DOI 10.1124/mol.107.036913
   Targher G, 2005, DIABETES, V54, P3541, DOI 10.2337/diabetes.54.12.3541
   Tong M, 2009, J ALZHEIMERS DIS, V17, P827, DOI 10.3233/JAD-2009-1115
   Verghese PB, 2011, LANCET NEUROL, V10, P241, DOI 10.1016/S1474-4422(10)70325-2
   Wang YR, 2017, MOL NEUROBIOL, V54, P2338, DOI 10.1007/s12035-016-9826-1
   Weinstein AA, 2018, PSYCHOSOMATICS, V59, P567, DOI 10.1016/j.psym.2018.06.001
   Weinstein G, 2019, LIVER INT, V39, P1713, DOI 10.1111/liv.14161
   Whelton Paul K, 2018, J Am Soc Hypertens, V12, DOI [10.1161/HYP.0000000000000065, 10.1016/j.jash.2018.06.010]
   World Health Organization, 2021, Dementia
   Wu H, 2019, FRONT NEUROENDOCRIN, V54, DOI 10.1016/j.yfrne.2019.100764
   Yang MH, 2005, HEPATO-GASTROENTEROL, V52, P1832
   Yilmaz Y, 2009, HEPATOLOGY, V49, P698, DOI 10.1002/hep.22752
   Younossi ZM, 2021, GASTROENTEROLOGY, V160, P912, DOI 10.1053/j.gastro.2020.11.051
   Younossi ZM, 2011, CLIN GASTROENTEROL H, V9, P524, DOI 10.1016/j.cgh.2011.03.020
NR 64
TC 11
Z9 11
U1 0
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1663-4365
J9 FRONT AGING NEUROSCI
JI Front. Aging Neurosci.
PD DEC 8
PY 2021
VL 13
AR 748888
DI 10.3389/fnagi.2021.748888
PG 9
WC Geriatrics & Gerontology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology; Neurosciences & Neurology
GA XS3NN
UT WOS:000732820000001
PM 34955810
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Radák, Z
   Chung, HY
   Naito, H
   Takahashi, R
   Jung, KJ
   Kim, HJ
   Goto, S
AF Radák, Z
   Chung, HY
   Naito, H
   Takahashi, R
   Jung, KJ
   Kim, HJ
   Goto, S
TI Age-associated increases in oxidative stress and nuclear transcription
   factor κB activation are attenuated in rat liver by regular exercise
SO FASEB JOURNAL
LA English
DT Article
DE aging; redox signaling; NF-kappa B; adaptation; oxidative stress; free
   radicals
ID INFLAMMATION HYPOTHESIS; FREE-RADICALS; PROTEINS; DAMAGE; MUSCLE;
   ANTIOXIDANT; EXPRESSION; RADIATION; DNA
AB The combined effects of aging and regular physical exercise was investigated on the production of reactive oxygen species (ROS), lipid peroxidation, glutathione status, and the activity of nuclear factor-kappaB (NF-kappaB) in rat liver. A group of 24 male F344 rats was divided into the following categories: adult control (18 months), adult exercised (18 months), and aged control (28 months) and aged exercised (28 months). The ROS formation increased as a function of age and exercise training decreased the rate of ROS formation in the two age groups. Significant positive correlation was found between ROS production and lipid peroxidation (LIPOX). The reduced glutathione (GSH) level was higher and the oxidized glutathione (GSSG) level lower in exercised groups compared with the sedentary controls (P<0.05). An age-associated increase in NF-kappa B activity was attenuated by the regular exercise. The content of p50 and p65 subunits of NF-kappa B increased with age and decreased with exercise training. The content of inhibitory factor-kappa B was inversely related to NF-kappa B activation. Regular exercise-induced adaptive responses, including attenuation of an increase in ROS production, LIPOX level, NF-kappa B activation, and reduced GSH/GSSG ratio, appear to be capable, even in old age, of reducing increases in inflammatory and other detrimental consequences that are often associated with advancing age.
C1 Semmelweis Univ, Sch Sport Sci, Exercise Physiol Lab, Budapest, Hungary.
   Pusan Natl Univ, Dept Pharm, Pusan, South Korea.
   Toho Univ, Fac Pharmaceut Sci, Dept Biochem, Funabashi, Chiba 274, Japan.
C3 Semmelweis University; Pusan National University; Toho University
RP Semmelweis Univ, Sch Sport Sci, Exercise Physiol Lab, Budapest, Hungary.
EM radak@mail.hupe.hu; hjung@pusan.ac.kr
RI Naito, Hisashi/F-5655-2011
OI Naito, Hisashi/0000-0002-0522-9512; Radak, Zsolt/0000-0003-1297-6804
CR ABERG F, 1992, ARCH BIOCHEM BIOPHYS, V295, P230, DOI 10.1016/0003-9861(92)90511-T
   Abramson JL, 2002, ARCH INTERN MED, V162, P1286, DOI 10.1001/archinte.162.11.1286
   AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   Atalay M, 1999, ANN NY ACAD SCI, V874, P169, DOI 10.1111/j.1749-6632.1999.tb09234.x
   BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.iy.12.040194.001041
   Baeuerle PA, 1998, CELL, V95, P729, DOI 10.1016/S0092-8674(00)81694-3
   Bruunsgaard H, 2001, CURR OPIN HEMATOL, V8, P131, DOI 10.1097/00062752-200105000-00001
   CADENAS E, 1995, BIOCHEM PHARMACOL, V49, P127, DOI 10.1016/S0006-2952(94)00333-5
   Canty TG, 1999, CIRCULATION, V100, P361
   CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527
   Chung HY, 2002, MICROSC RES TECHNIQ, V59, P264, DOI 10.1002/jemt.10203
   Chung HY, 2001, ANN NY ACAD SCI, V928, P327
   DAVIES KJA, 1982, BIOCHEM BIOPH RES CO, V107, P1198, DOI 10.1016/S0006-291X(82)80124-1
   Dröge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001
   Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225
   Goto S, 1999, MECH AGEING DEV, V107, P245, DOI 10.1016/S0047-6374(98)00133-X
   Goto S, 2001, ANN NY ACAD SCI, V928, P54
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HATTORI M, 1990, DNA CELL BIOL, V9, P777, DOI 10.1089/dna.1990.9.777
   Helenius M, 1996, BIOCHEM J, V318, P603, DOI 10.1042/bj3180603
   Helenius M, 2001, ANTIOXID REDOX SIGN, V3, P147, DOI 10.1089/152308601750100669
   Holloszy John O., 1995, P633
   Janssen-Heininger YMW, 2000, FREE RADICAL BIO MED, V28, P1317, DOI 10.1016/S0891-5849(00)00218-5
   Johnson FB, 1999, CELL, V96, P291, DOI 10.1016/S0092-8674(00)80567-X
   Kim HJ, 2002, FREE RADICAL BIO MED, V32, P991, DOI 10.1016/S0891-5849(02)00798-0
   Kim HJ, 2000, FREE RADICAL BIO MED, V28, P683, DOI 10.1016/S0891-5849(99)00274-9
   Kotler DP, 2000, ANN INTERN MED, V133, P622, DOI 10.7326/0003-4819-133-8-200010170-00015
   Li NX, 1998, P NATL ACAD SCI USA, V95, P13012, DOI 10.1073/pnas.95.22.13012
   Miller RA, 1996, SCIENCE, V273, P70, DOI 10.1126/science.273.5271.70
   Naito H, 2001, MED SCI SPORT EXER, V33, P729
   Pedersen BK, 2003, SCAND J MED SCI SPOR, V13, P56, DOI 10.1034/j.1600-0838.2003.20218.x
   Powers SK, 2001, MED SCI SPORT EXER, V33, P386, DOI 10.1097/00005768-200103000-00009
   Pugh KG, 2001, DRUG AGING, V18, P263, DOI 10.2165/00002512-200118040-00004
   Radák Z, 2002, PFLUG ARCH EUR J PHY, V445, P273, DOI 10.1007/s00424-002-0918-6
   Radak Z, 2001, EXERC IMMUNOL REV, V7, P90
   Radák Z, 1999, FREE RADICAL BIO MED, V27, P69, DOI 10.1016/S0891-5849(99)00038-6
   Radák Z, 2000, ARCH BIOCHEM BIOPHYS, V376, P248, DOI 10.1006/abbi.2000.1719
   RADAK Z, 2000, FREE RADICALS EXERCI, P177
   Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142
   Venditti P, 1999, ARCH BIOCHEM BIOPHYS, V368, P112, DOI 10.1006/abbi.1999.1269
   Xiao ZQ, 2000, AM J PHYSIOL-GASTR L, V278, pG855, DOI 10.1152/ajpgi.2000.278.6.G855
   Yan ZQ, 1999, ARTERIOSCL THROM VAS, V19, P2854, DOI 10.1161/01.ATV.19.12.2854
NR 42
TC 137
Z9 150
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD FEB
PY 2004
VL 18
IS 2
BP 749
EP +
DI 10.1096/fj.03-0509fje
PG 16
WC Biochemistry & Molecular Biology; Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 806HM
UT WOS:000220425000033
PM 14766800
DA 2024-02-19
ER

PT J
AU Zhang, HJ
   Doctrow, SR
   Xu, LJ
   Oberley, LW
   Beecher, B
   Morrison, J
   Oberley, TD
   Kregel, KC
AF Zhang, HJ
   Doctrow, SR
   Xu, LJ
   Oberley, LW
   Beecher, B
   Morrison, J
   Oberley, TD
   Kregel, KC
TI Redox modulation of the liver with chronic antioxidant enzyme mimetic
   treatment prevents age-related oxidative damage associated with
   environmental stress
SO FASEB JOURNAL
LA English
DT Article
DE free radicals; ROS; hyperthermia; lipid peroxidation; AP-1
ID SYNTHETIC SUPEROXIDE-DISMUTASE; GLUTATHIONE-S-TRANSFERASE;
   SALEN-MANGANESE COMPLEXES; CALORIC RESTRICTION; CATALASE MIMETICS;
   HEAT-WAVE; LIFE-SPAN; AP-1; EXTENSION; RESPONSES
AB A reduction in stress tolerance is a hallmark of the aging process, and the lowered functional capacity observed in aged organisms is associated with an increased rate of oxidative stress and a greater susceptibility of aged tissues to oxidative injury. In this report, we show that chronic systemic administration of a superoxide dismutase (SOD)/catalase mimetic (EUK-189), delivered over a 1 month period via osmotic pump, prevents heat stress-induced liver injury by dramatically decreasing oxidative damage in aged animals. Widespread liver injury was present in old but not young vehicle-treated rats in response to a 2 day heating protocol. However, SOD/catalase mimetic treatment markedly decreased the hyperthermia-induced liver injury associated in old animals. The reversal of damage with EUK-189 was associated with an improvement in intracellular redox status and a striking reduction in hepatocellular lipid peroxidation. EUK-189 treatment also blocked the activation of activator protein-1 (AP-1), which is a redox-sensitive early response transcription factor involved in the regulation of cellular stress responses. These results demonstrate that oxidative stress plays a unique role in age-related hyperthermic injury and suggest that therapeutic strategies aimed at improving redox potential, such as chronic SOD/catalase mimetic treatment, can prevent the oxidative-mediated damage associated with environmental stress.
C1 Univ Iowa, Integrat Physiol Lab, Dept Exercise Sci, Iowa City, IA 52242 USA.
   Univ Iowa, Dept Radiat Oncol, Free Rad & Radiat Biol Program, Iowa City, IA 52242 USA.
   Eukarion Inc, Bedford, MA 01730 USA.
   Univ Wisconsin, Dept Pathol, Madison, WI 53705 USA.
C3 University of Iowa; University of Iowa; University of Wisconsin System;
   University of Wisconsin Madison
RP Kregel, KC (corresponding author), Univ Iowa, Integrat Physiol Lab, Dept Exercise Sci, 532 FH, Iowa City, IA 52242 USA.
EM kevin-kregel@uiowa.edu
RI Beecher, Bryan A/E-9184-2010
OI Beecher, Bryan A/0000-0002-2741-1788; Doctrow, Susan/0000-0003-0628-9960
FU NHLBI NIH HHS [HL-61389] Funding Source: Medline; NIA NIH HHS [AG-12350,
   AG-14687] Funding Source: Medline
CR AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   Baker K, 1998, J PHARMACOL EXP THER, V284, P215
   BAUDRY M, 1993, BIOCHEM BIOPH RES CO, V192, P964, DOI 10.1006/bbrc.1993.1509
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313
   Cortopassi GA, 1999, BBA-BIOENERGETICS, V1410, P183, DOI 10.1016/S0005-2728(98)00166-2
   Doctrow S R, 1997, Adv Pharmacol, V38, P247
   Doctrow SR, 2002, J MED CHEM, V45, P4549, DOI 10.1021/jm020207y
   Dorozynski A, 2003, BRIT MED J, V327, P411, DOI 10.1136/bmj.327.7412.411
   GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6
   Hall DM, 2000, FASEB J, V14, P78, DOI 10.1096/fasebj.14.1.78
   Hall DM, 2000, J APPL PHYSIOL, V89, P749, DOI 10.1152/jappl.2000.89.2.749
   HATTORI M, 1990, DNA CELL BIOL, V9, P777, DOI 10.1089/dna.1990.9.777
   HENSCHEL A, 1969, AM J PUBLIC HEALTH N, V59, P2232, DOI 10.2105/AJPH.59.12.2232
   Johnson FB, 1999, CELL, V96, P291, DOI 10.1016/S0092-8674(00)80567-X
   Jones DP, 2002, METHOD ENZYMOL, V348, P93, DOI 10.1016/S0076-6879(02)48630-2
   Jung CW, 2001, NEUROSCI LETT, V304, P157, DOI 10.1016/S0304-3940(01)01784-0
   Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3
   KEW M, 1970, AM J MED, V49, P192, DOI 10.1016/S0002-9343(70)80075-4
   Kregel KC, 2002, J APPL PHYSIOL, V92, P2177, DOI 10.1152/japplphysiol.01267.2001
   KREGEL KC, 1995, J APPL PHYSIOL, V79, P1673, DOI 10.1152/jappl.1995.79.5.1673
   Liu RL, 2003, P NATL ACAD SCI USA, V100, P8526, DOI 10.1073/pnas.1332809100
   Malfroy B, 1997, CELL IMMUNOL, V177, P62, DOI 10.1006/cimm.1997.1091
   Melov S, 2000, SCIENCE, V289, P1567, DOI 10.1126/science.289.5484.1567
   Melov S, 2001, J NEUROSCI, V21, P8348, DOI 10.1523/JNEUROSCI.21-21-08348.2001
   OBERLEY TD, 1991, AM J PATHOL, V139, P355
   PAPACONSTANTINOU J, 1994, ANN NY ACAD SCI, V719, P195, DOI 10.1111/j.1749-6632.1994.tb56829.x
   Pinkus R, 1996, J BIOL CHEM, V271, P13422, DOI 10.1074/jbc.271.23.13422
   Pong K, 2000, BRAIN RES, V881, P182, DOI 10.1016/S0006-8993(00)02841-9
   Pong K, 2001, EXP NEUROL, V171, P84, DOI 10.1006/exnr.2001.7747
   Rong YQ, 1999, P NATL ACAD SCI USA, V96, P9897, DOI 10.1073/pnas.96.17.9897
   RYAN AJ, 1995, J APPL PHYSIOL, V78, P38, DOI 10.1152/jappl.1995.78.1.38
   Schär C, 2004, NATURE, V427, P332, DOI 10.1038/nature02300
   Semenza JC, 1996, NEW ENGL J MED, V335, P84, DOI 10.1056/NEJM199607113350203
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   Van Remmen H, 2003, EXERC SPORT SCI REV, V31, P149, DOI 10.1097/00003677-200307000-00009
   YEN TC, 1994, FREE RADICAL BIO MED, V16, P207, DOI 10.1016/0891-5849(94)90145-7
   Zhang HJ, 2003, FASEB J, V17, P2293, DOI 10.1096/fj.03-0139fje
   Zhang HJ, 2002, J VIROL, V76, P355, DOI 10.1128/JVI.76.1.355-363.2002
NR 39
TC 56
Z9 58
U1 0
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD AUG
PY 2004
VL 18
IS 11
BP 1547
EP +
DI 10.1096/fj.04-1629fje
PG 17
WC Biochemistry & Molecular Biology; Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 849QN
UT WOS:000223554900009
PM 15319374
DA 2024-02-19
ER

PT J
AU Wu, CW
   Storey, KB
AF Wu, Cheng-Wei
   Storey, Kenneth B.
TI Pattern of cellular quiescence over the hibernation cycle in liver of
   thirteen-lined ground squirrels
SO CELL CYCLE
LA English
DT Article
DE Ictidomys tridecemlineatus; torpor-arousal cycle; cyclins; Cdk; CKI
ID REVERSIBLE PHOSPHORYLATION; CDK INHIBITORS; PROGRESSION; SENESCENCE;
   EXPRESSION; RESPONSES; TARGETS; STATE; PCNA; 1ST
AB Mammalian hibernation is a state of seasonal heterothermy that consists of long periods of torpor at low body temperature interspersed with short periods of arousal back to euthermia. Entry into the hypometabolic state of torpor is achieved via a strong coordinated reduction of energy expenditures, particularly ATP-expensive activities, such as transcription and translation. The present study analyzes the status of the cell cycle during hibernation in liver of thirteen-lined ground squirrels (Ictidomys tridecemlineatus) and examines the expression levels of cell cycle regulators over six stages of the torpor-arousal cycle. Immunoblot analysis showed that the protein expression levels of cyclin D1 and cyclin E were reduced in liver (by 31% and 48%, respectively) during long-term torpor; however, during arousal from torpor, PCR analysis showed an upregulation of cyclin D1 transcript levels of about 1.5-fold. Protein expression of cyclin A and cyclin B1 were also elevated (1.57-fold and 2.44-fold, respectively) during early arousal from torpor, and in addition, cyclin A2 transcript levels increased by about 1.8-fold during arousal. Protein levels of two CKIs, p15(INK4b) and p21(CIP1), each increased by about 1.4-fold during torpor and transcript levels of p15(INK4b) also rose by 1.7-2.1 fold during torpor, whereas p21(CIP1) transcripts increased by 1.5-1.7-fold. A reduction in cyclin D and E protein expression coupled with upregulation of p15(INK4b) and p21(CIP1) inhibitors during torpor reflects markers of cell cycle arrest during hibernation. Elevated expression of cyclin A and B protein expression during arousal stages of torpor suggests cell cycle progression is reversibly arrested during torpor and is reinitiated upon return to euthermia.
C1 [Storey, Kenneth B.] Carleton Univ, Inst Biochem, Ottawa, ON K1S 5B6, Canada.
   Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada.
C3 Carleton University; Carleton University
RP Storey, KB (corresponding author), Carleton Univ, Inst Biochem, Ottawa, ON K1S 5B6, Canada.
EM kenneth_storey@carleton.ca
RI Storey, Kenneth B/G-9883-2011
OI Storey, Kenneth/0000-0002-7363-1853; Wu, Cheng-Wei/0000-0001-6370-429X
FU QEII-GSST; NSERC Canada
FX We thank Dr. J. Hallenbeck and Dr. D.C. McMullen, National Institute of
   Neurological Disorders and Stroke, Bethesda, MD for providing ground
   squirrel tissues and J.M. Storey for editorial review of the manuscript.
   K.B.S. holds the Canada Research Chair in Molecular Physiology. C-W.W.
   holds a QEII-GSST postgraduate scholarship. Supported by a discovery
   grant from NSERC Canada to K.B.S.
CR Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401
   Arellano M, 1997, INT J BIOCHEM CELL B, V29, P559, DOI 10.1016/S1357-2725(96)00178-1
   Averous J, 2008, ONCOGENE, V27, P1106, DOI 10.1038/sj.onc.1210715
   Biggar KK, 2012, CELL CYCLE
   Biggar KK, 2009, CURR GENOMICS, V10, P573, DOI 10.2174/138920209789503905
   Bloom J, 2007, NAT REV MOL CELL BIO, V8, P149, DOI 10.1038/nrm2105
   Bottazzi ME, 1997, TRENDS CELL BIOL, V7, P348, DOI 10.1016/S0962-8924(97)01114-8
   Boutros R, 2006, CURR OPIN CELL BIOL, V18, P185, DOI 10.1016/j.ceb.2006.02.003
   Cánepa ET, 2007, IUBMB LIFE, V59, P419, DOI 10.1080/15216540701488358
   Carey HV, 2003, PHYSIOL REV, V83, P1153, DOI 10.1152/physrev.00008.2003
   Cayrol C, 1998, ONCOGENE, V16, P311, DOI 10.1038/sj.onc.1201543
   Coller HA, 2006, PLOS BIOL, V4, P329, DOI 10.1371/journal.pbio.0040083
   Contreras A, 2003, MOL CELL BIOL, V23, P8626, DOI 10.1128/MCB.23.23.8626-8636.2003
   GIRARD F, 1991, CELL, V67, P1169, DOI 10.1016/0092-8674(91)90293-8
   HINDS PW, 1992, CELL, V70, P993, DOI 10.1016/0092-8674(92)90249-C
   Jackman M, 2003, NAT CELL BIOL, V5, P143, DOI 10.1038/ncb918
   Jin JP, 2003, GENE DEV, V17, P3062, DOI 10.1101/gad.1157503
   Johnson DG, 1999, ANNU REV PHARMACOL, V39, P295, DOI 10.1146/annurev.pharmtox.39.1.295
   Jones SM, 2000, ONCOGENE, V19, P5558, DOI 10.1038/sj.onc.1203858
   Kagawa S, 1999, CELL DEATH DIFFER, V6, P765, DOI 10.1038/sj.cdd.4400549
   Katsuno Y, 2009, P NATL ACAD SCI USA, V106, P3184, DOI 10.1073/pnas.0809350106
   Kim SH, 2006, J CELL SCI, V119, P2435, DOI 10.1242/jcs.02989
   Kisielewska J, 2005, BIOL CELL, V97, P221
   MacDonald JA, 1999, BIOCHEM BIOPH RES CO, V254, P424, DOI 10.1006/bbrc.1998.9960
   MacDonald JA, 2005, INT J BIOCHEM CELL B, V37, P679, DOI 10.1016/j.biocel.2004.05.023
   Mandal S, 2005, DEV CELL, V9, P843, DOI 10.1016/j.devcel.2005.11.006
   MCARTHUR MD, 1991, PHYSIOL ZOOL, V64, P940, DOI 10.1086/physzool.64.4.30157950
   McMullen DC, 2010, J COMP PHYSIOL B, V180, P927, DOI 10.1007/s00360-010-0468-8
   Morin PJ, 2006, CRYOBIOLOGY, V53, P310, DOI 10.1016/j.cryobiol.2006.08.002
   Nakayama K, 1998, BIOESSAYS, V20, P1020, DOI 10.1002/(SICI)1521-1878(199812)20:12<1020::AID-BIES8>3.3.CO;2-4
   Obaya AJ, 2002, CELL MOL LIFE SCI, V59, P126, DOI 10.1007/s00018-002-8410-1
   OHTANI K, 1994, MOL CELL BIOL, V14, P1603, DOI 10.1128/MCB.14.3.1603
   Schafer KA, 1998, VET PATHOL, V35, P461, DOI 10.1177/030098589803500601
   Scott MT, 2000, J BIOL CHEM, V275, P11529, DOI 10.1074/jbc.275.15.11529
   Shen X, 1998, MOL BIOL CELL, V9, P3309, DOI 10.1091/mbc.9.12.3309
   Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501
   SIEBERT R, 1995, BRIT J HAEMATOL, V91, P350, DOI 10.1111/j.1365-2141.1995.tb05302.x
   Storey KB, 2007, J EXP BIOL, V210, P1700, DOI 10.1242/jeb.02716
   Storey KB, 2010, ADV CLIN CHEM, V52, P77, DOI 10.1016/S0065-2423(10)52003-1
   van den Heuvel S, 2005, C ELEGANS RES COMMUN, DOI 10.1895/ worm-book.1.28.1
   Vermeulen K, 2003, CELL PROLIFERAT, V36, P131, DOI 10.1046/j.1365-2184.2003.00266.x
   Vidal A, 2000, GENE, V247, P1, DOI 10.1016/S0378-1119(00)00092-5
   WALKER DH, 1991, NATURE, V354, P314, DOI 10.1038/354314a0
   WANG LCH, 1988, CAN J ZOOL, V66, P133, DOI 10.1139/z88-017
   Wu CW, 2012, J EXP BIOL IN PRESS
NR 45
TC 52
Z9 56
U1 0
U2 6
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1538-4101
EI 1551-4005
J9 CELL CYCLE
JI Cell Cycle
PD MAY 1
PY 2012
VL 11
IS 9
BP 1714
EP 1726
DI 10.4161/cc.19799
PG 13
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA 935OL
UT WOS:000303528500007
PM 22510572
OA Bronze
DA 2024-02-19
ER

PT J
AU Register, TC
   Wagner, JD
   Zhang, L
   Hall, J
   Clarkson, TB
AF Register, TC
   Wagner, JD
   Zhang, L
   Hall, J
   Clarkson, TB
TI Effects of tibolone and conventional hormone replacement therapies on
   arterial and hepatic cholesterol accumulation and on circulating
   endothelin-1, vascular cell adhesion molecule-1, and E-selectin in
   surgically menopausal monkeys
SO MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
LA English
DT Article
DE menopause; estrogen; androgen; progestin; atherosclerosis; cholesterol;
   adhesion molecules
ID CONJUGATED EQUINE ESTROGENS; MEDROXYPROGESTERONE ACETATE; ENZYMATIC
   DETERMINATION; REPRODUCTIVE-TRACT; BONE LOSS; POSTMENOPAUSAL; ESTRADIOL;
   ATHEROSCLEROSIS; PREVENTION; LIPOPROTEIN(A)
AB Objective: Menopause and aging are associated with a marked increase in the incidence of coronary heart disease as well as reductions in circulating estrogen, progestogen, and androgen levels. The synthetic compound tibolone and its metabolites have estrogenic, progestogenic, and androgenic characteristics. In the present study, we compared the effects of tibolone, estrogen replacement therapy, and estrogen plus progestogen replacement therapy on arterial and hepatic lipid accumulation and on circulating soluble adhesion molecule and endothelin-1 concentrations in surgically postmenopausal cynomolgus monkeys.
   Design: Animals were fed an atherogenic diet for 2 years while receiving either no hormone treatment (control, n = 3 1) or the following treatments at doses designed to mimic the human dose on a daily caloric intake basis: tibolone at 2.5 mg/day (HiTib, n = 31), tibolone at 0.625 mg/day (LoTib, n = 29), conjugated equine estrogens (CEE) alone at 0,625 mg/day (CEE, n = 29), or CEE plus continuous medroxyprogesterone acetate (MPA) at 2.5 mg MPA/day (CEE + MPA, n = 30).
   Results: Relative to the control group, iliac artery total cholesterol content was not different in the HiTib, LoTib, and CEE + MPA groups but was significantly lower in the group receiving CEE only (P < 0.05). In contrast, hepatic free cholesterol content was reduced in all treatment groups [HiTib (P < 0.01), LoTib (P < 0.05), CEE (P < 0.01), and CEE + MPA (P < 0.05)], whereas hepatic total and esterified cholesterol content were reduced in the HiTib, CEE, and CEE + MPA groups (all P < 0.05). HiTib and CEE groups had lower hepatic triglyceride levels per milligram of protein (P < 0.05). Iliac arterial cholesterol content was highly correlated with hepatic cholesterol content and with previously published histomorphometrically determined coronary artery atherosclerosis, supporting the use of the iliac artery as a surrogate for the coronary artery in the monkey. Circulating levels of soluble vascular cell adhesion molecule-I were significantly reduced in the HiTib (P < 0.02) and CEE (P < 0.05) groups, whereas soluble E-selectin was reduced in the CEE group only (P < 0.01). Plasma endothelin-1 was significantly reduced in the LoTib (P < 0.05), CEE (P < 0.01), and CEE + MPA (P < 0.01) groups.
   Conclusions: These results suggest that while tibolone caused marked depression of high-density lipoprotein cholesterol and a resultant twofold increase in the total plasma cholesterol/high-density lipoprotein cholesterol ratio, those effects did not result in exacerbation of iliac artery atherosclerosis, perhaps because of beneficial effects on vascular biology or hepatic metabolism.
C1 Wake Forest Univ, Sch Med, Comparat Med Clin Res Ctr, Winston Salem, NC 27157 USA.
C3 Wake Forest University
RP Register, TC (corresponding author), Wake Forest Univ, Sch Med, Comparat Med Clin Res Ctr, Med Ctr Blvd, Winston Salem, NC 27157 USA.
EM register@wfubmc.edu
OI Register, Thomas/0000-0002-4078-0166
CR Adams MR, 1997, ARTERIOSCL THROM VAS, V17, P217, DOI 10.1161/01.ATV.17.1.217
   ADAMS MR, 1990, ARTERIOSCLEROSIS, V10, P1051, DOI 10.1161/01.ATV.10.6.1051
   ALLAIN CC, 1974, CLIN CHEM, V20, P470
   Bjarnason NH, 1997, J CLIN ENDOCR METAB, V82, P1752, DOI 10.1210/jc.82.6.1752
   Bjarnason NH, 1996, J CLIN ENDOCR METAB, V81, P2419, DOI 10.1210/jc.81.7.2419
   CARR TP, 1993, CLIN BIOCHEM, V26, P39, DOI 10.1016/0009-9120(93)90015-X
   Caulin-Glaser T, 1998, J AM COLL CARDIOL, V31, P1555, DOI 10.1016/S0735-1097(98)00145-4
   Clarkson TB, 2001, J CLIN ENDOCR METAB, V86, P5396, DOI 10.1210/jc.86.11.5396
   Cline JM, 2002, MENOPAUSE, V9, P242, DOI 10.1097/00042192-200207000-00005
   Cline JM, 2001, TOXICOL PATHOL, V29, P84, DOI 10.1080/019262301301418883
   CRONA N, 1988, MATURITAS, V9, P303, DOI 10.1016/0378-5122(88)90095-3
   CRONA N, 1983, ACTA ENDOCRINOL-COP, V102, P451, DOI 10.1530/acta.0.1020451
   Cushman M, 1999, CIRCULATION, V100, P717, DOI 10.1161/01.CIR.100.7.717
   FARISH E, 1994, MATURITAS, V20, P215, DOI 10.1016/0378-5122(94)90019-1
   Farish E, 1999, MENOPAUSE, V6, P98
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   FOSSATI P, 1982, CLIN CHEM, V28, P2077
   Haenggi W, 1999, GYNECOL ENDOCRINOL, V13, P202, DOI 10.3109/09513599909167556
   Hanke H, 1996, ATHEROSCLEROSIS, V121, P129, DOI 10.1016/0021-9150(95)05710-2
   Herrington DM, 2000, NEW ENGL J MED, V343, P522, DOI 10.1056/NEJM200008243430801
   Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605
   KICOVIC P M, 1982, Reproduccion, V6, P81
   Lippuner K, 1997, J BONE MINER RES, V12, P806, DOI 10.1359/jbmr.1997.12.5.806
   *MAN LAB OP LIP RE, 1974, US DHEW PUBLICATION
   Mendoza N, 2000, MATURITAS, V37, P37, DOI 10.1016/S0378-5122(00)00154-7
   Register TC, 1998, ARTERIOSCL THROM VAS, V18, P1164, DOI 10.1161/01.ATV.18.7.1164
   Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321
   RYMER J, 1993, ACTA ENDOCRINOL-COP, V128, P259, DOI 10.1530/acta.0.1280259
   Simoncini T, 2000, MOL CELL ENDOCRINOL, V162, P87, DOI 10.1016/S0303-7207(00)00206-9
   SUZUKI N, 1991, J CARDIOVASC PHARM, V17, pS420, DOI 10.1097/00005344-199100177-00119
   WILLIAMS JK, 1995, ARTERIOSCL THROM VAS, V15, P827, DOI 10.1161/01.ATV.15.7.827
   Zandberg P, 2001, MENOPAUSE, V8, P96, DOI 10.1097/00042192-200103000-00004
NR 32
TC 17
Z9 22
U1 0
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1072-3714
EI 1530-0374
J9 MENOPAUSE
JI Menopause-J. N. Am. Menopause Soc.
PD NOV-DEC
PY 2002
VL 9
IS 6
BP 411
EP 421
DI 10.1097/00042192-200211000-00006
PG 11
WC Obstetrics & Gynecology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Obstetrics & Gynecology
GA 614JN
UT WOS:000179185100006
PM 12439100
DA 2024-02-19
ER

EF